{"meta":{"query_hash":"f7360692ed4a","filters":{"venue":"Value in Health"},"cohort_total":2971,"direct_labels_cover":30,"predictions_cover":2971,"exported":2971,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/f7360692ed4a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Value+in+Health"},"results":[{"id":"W1480482130","doi":"10.1016/j.jval.2015.03.084","title":"Improving Parameter Estimation For A Decision-Analytic Markov Model To Evaluate The Use Of Novel Biomarker Led Strategies For Prevetion Of Cardiovascular Disease","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Censoring (clinical trials); Covariate; Markov model; Proportional hazards model; Markov chain; Computer science; Econometrics; Statistics; Mathematics; Machine learning","score_opus":0.6550297222477515,"score_gpt":0.45902683171259495,"score_spread":0.19600289053515652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1480482130","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20543005,0.0012396976,0.7851609,0.0038775457,0.00019392915,0.0034769736,0.00060641585,0.000009675137,0.000004807754],"genre_scores_gemma":[0.6743288,0.000035916706,0.3238231,0.00095086615,0.0000448074,0.00072296127,0.000036364174,0.000033295233,0.000023870196],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99508333,0.00033088343,0.0035937782,0.0004675036,0.00019104687,0.0003334472],"domain_scores_gemma":[0.9938421,0.0036006214,0.0013247158,0.0007447334,0.0002624585,0.00022535997],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03220673,0.00015955415,0.0009811429,0.00039482937,0.00008228256,0.0000578609,0.00021032456,0.00007746344,0.0000030089157],"category_scores_gemma":[0.020463835,0.00015682679,0.00031068458,0.00025359055,0.000042633277,0.00047762322,0.000039348608,0.00006154536,0.0000056666545],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021960534,0.000094872245,0.0004501062,0.0011312548,0.00011301566,2.7349516e-8,0.0009861005,0.98158514,0.0000019040215,0.011760058,0.0010333067,0.0026246095],"study_design_scores_gemma":[0.001348752,0.0001362106,0.0013887266,0.00023608116,0.00004174192,3.6649726e-7,0.00024810733,0.96375656,0.0000013478108,0.032214917,0.00049259583,0.00013458754],"about_ca_topic_score_codex":0.0056644734,"about_ca_topic_score_gemma":0.000068270965,"teacher_disagreement_score":0.46889877,"about_ca_system_score_codex":0.0005945941,"about_ca_system_score_gemma":0.0012327618,"threshold_uncertainty_score":0.9965468},"labels":[],"label_agreement":null},{"id":"W1481790705","doi":"10.1111/j.1524-4733.2007.00176.x","title":"Regarding Probabilistic Analysis and Computationally Expensive Models: Necessary and Required?","year":2007,"lang":"en","type":"letter","venue":"Value in Health","topic":"Bayesian Modeling and Causal Inference","field":"Computer Science","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PQ Corporation (Canada); McGill University","funders":"","keywords":"Probabilistic logic; Computer science; Probabilistic analysis of algorithms; Artificial intelligence","score_opus":0.0832889424429008,"score_gpt":0.303975947972131,"score_spread":0.2206870055292302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1481790705","genre_codex":"methods","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011939232,0.002223321,0.8122123,0.1836042,0.00014834419,0.00029367543,0.000010892324,0.000089219764,0.00022413263],"genre_scores_gemma":[0.13212705,0.0012629853,0.25002155,0.6153177,0.000796074,0.000049268558,0.00015859038,0.00006318037,0.0002036008],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99683267,0.0004059295,0.0007224976,0.0009951723,0.00049511733,0.0005486365],"domain_scores_gemma":[0.9981254,0.00073267485,0.000339893,0.00048507183,0.00016362121,0.00015338944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012970184,0.00030444836,0.00069120777,0.0008506479,0.00015772173,0.00023439246,0.00044333833,0.00036554184,0.0000011388115],"category_scores_gemma":[0.00007509192,0.0003059802,0.00007333265,0.0009446318,0.00011045717,0.000364497,0.00024041448,0.0010179126,0.0000017505268],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002629277,0.00009031811,0.0010592235,0.0029451165,0.00045803798,0.0008947317,0.007929823,0.7758538,0.0000025912534,0.07337919,0.10135589,0.036004975],"study_design_scores_gemma":[0.00015808333,0.000066730616,0.00024897672,0.00032433515,0.00003229983,0.000038183516,0.000018516484,0.91926724,4.483949e-7,0.07869745,0.0008610668,0.0002866428],"about_ca_topic_score_codex":0.00221432,"about_ca_topic_score_gemma":0.00004275083,"teacher_disagreement_score":0.5621908,"about_ca_system_score_codex":0.00018208147,"about_ca_system_score_gemma":0.0004329913,"threshold_uncertainty_score":0.9999392},"labels":[],"label_agreement":null},{"id":"W1485338727","doi":"10.1016/j.jval.2015.03.875","title":"The Impact Of Stroke Centers On The Length Of Stay Among Ischechemic Stroke Patients In Alberta","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Well-being Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information; Alberta Medical Association; Institute of Health Economics; University of Alberta","funders":"","keywords":"Stroke (engine); Medicine; Physical medicine and rehabilitation; Engineering","score_opus":0.049314928782137675,"score_gpt":0.35757093685525687,"score_spread":0.3082560080731192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1485338727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915038,0.0003491526,0.0000015360433,0.0016799697,0.00036931346,0.0006026597,0.00004943741,0.0000058016317,0.0054383515],"genre_scores_gemma":[0.99925756,0.00018725064,0.000009836248,0.00020905463,0.000027986813,0.000026910864,0.000004304053,0.000015317979,0.00026179073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749047,0.00077314425,0.0007038563,0.00020333854,0.0002589151,0.0005702581],"domain_scores_gemma":[0.9977142,0.0013041038,0.00036796826,0.00043045927,0.000059938902,0.00012328554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018507864,0.00014340236,0.00032746192,0.00011237831,0.00006692334,0.0000046089513,0.00026407122,0.00007756628,0.000011238582],"category_scores_gemma":[0.0005516774,0.000080934864,0.00007856167,0.00020253063,0.00013480391,0.000030107338,0.000044460303,0.00037479785,0.000012243575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002900098,0.00030044737,0.978887,0.000041930554,0.000044579512,5.819155e-7,0.011369218,0.00039846287,0.0000031438542,0.0008208352,0.005855339,0.0019884284],"study_design_scores_gemma":[0.0019051227,0.0013848617,0.992702,0.00018069946,0.000003439956,3.0638256e-7,0.002447371,0.00036986178,0.00006167386,0.0002078772,0.0006443302,0.000092471055],"about_ca_topic_score_codex":0.25532207,"about_ca_topic_score_gemma":0.0029130722,"teacher_disagreement_score":0.252409,"about_ca_system_score_codex":0.00029709234,"about_ca_system_score_gemma":0.0002770045,"threshold_uncertainty_score":0.7496368},"labels":[],"label_agreement":null},{"id":"W1502280143","doi":"10.1016/j.jval.2014.03.1657","title":"Canadian Burden Of Choroidal Neovascularization Secondary To Pathologic Myopia: Final Results","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Novartis (Canada)","funders":"","keywords":"Choroidal neovascularization; Medicine; Visual acuity; Medical record; Ophthalmology; Retrospective cohort study; Optometry; Surgery","score_opus":0.028599848927018345,"score_gpt":0.2893380672824501,"score_spread":0.26073821835543176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1502280143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98961943,0.00030860567,0.000074023184,0.007281614,0.000091142465,0.0004870833,0.00009632654,0.000011091938,0.0020306567],"genre_scores_gemma":[0.9975744,0.00006652919,0.0009865202,0.00085505936,0.00008717277,0.000010340636,0.0001525968,0.000009269307,0.0002580984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989656,0.00012369898,0.00031088153,0.00020121106,0.00015021971,0.00024836592],"domain_scores_gemma":[0.99924415,0.000033600078,0.000067184854,0.00022376557,0.000044105862,0.00038720414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036731336,0.00008090524,0.00022696862,0.00017146293,0.00003998126,0.000004720641,0.0000484703,0.00005269298,0.000028042148],"category_scores_gemma":[0.00022796931,0.00007007606,0.00005071489,0.00019464505,0.000013024294,0.000020955922,0.000011932432,0.00009310915,0.000022590642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031964497,0.0010762773,0.587209,0.0037290142,0.00020194761,0.0009886282,0.006927548,0.045761958,0.00036698062,0.005289161,0.0066499356,0.33860314],"study_design_scores_gemma":[0.0031347075,0.0021217924,0.9816371,0.0004838456,0.000026014184,0.000036502355,0.00010564437,0.0038881742,0.00003514953,0.0005117126,0.007913998,0.00010534749],"about_ca_topic_score_codex":0.43529287,"about_ca_topic_score_gemma":0.010250398,"teacher_disagreement_score":0.42504248,"about_ca_system_score_codex":0.00026667514,"about_ca_system_score_gemma":0.00069341366,"threshold_uncertainty_score":0.5719963},"labels":[],"label_agreement":null},{"id":"W1507803005","doi":"10.1016/j.jval.2015.03.874","title":"The Expansion Of Stroke Centers And The Reduction Of In-Hospital Mortality Of Ischechemic Stroke Patients In Alberta","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information; Alberta Medical Association; Institute of Health Economics; University of Alberta","funders":"","keywords":"Stroke (engine); Medicine; Reduction (mathematics); Emergency medicine; Engineering","score_opus":0.037127052017663774,"score_gpt":0.3329939989086497,"score_spread":0.29586694689098597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1507803005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937247,0.0003620115,7.591796e-7,0.004758943,0.00033520412,0.00045824007,0.000010404934,0.0000014887279,0.00034823455],"genre_scores_gemma":[0.99866444,0.0011981366,0.000026901967,0.000048390695,0.000015993794,0.0000072557254,0.000001430173,0.0000029732262,0.000034464934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982285,0.00054671447,0.00057585596,0.0001009296,0.00030815502,0.0002398688],"domain_scores_gemma":[0.99910456,0.000363675,0.0002772364,0.00012977893,0.000053581974,0.00007115386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002795707,0.000051062634,0.00022509503,0.000049536844,0.000055836783,0.0000043735945,0.00012317498,0.000051402163,0.0000011019341],"category_scores_gemma":[0.0006925213,0.000033863373,0.000028068676,0.00016630693,0.000304559,0.00007992369,0.00003226774,0.000118396834,1.0258222e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007673936,0.00008403309,0.9647794,0.00013931718,0.0000024838832,4.9790874e-8,0.028772192,0.00007552845,0.0000025254994,0.0051516844,0.0000615093,0.0008545813],"study_design_scores_gemma":[0.0019876687,0.00014787313,0.9611709,0.00027458597,0.000002631681,5.899036e-8,0.03456047,0.00034768268,0.00012469325,0.0010618893,0.0002679952,0.000053552838],"about_ca_topic_score_codex":0.68688303,"about_ca_topic_score_gemma":0.04237696,"teacher_disagreement_score":0.64450604,"about_ca_system_score_codex":0.00015956495,"about_ca_system_score_gemma":0.0004565505,"threshold_uncertainty_score":0.9750972},"labels":[],"label_agreement":null},{"id":"W1756786330","doi":"10.1016/j.jval.2015.03.1336","title":"Health Impact of Trivalent, Trivalent High Dose and Quadrivalent Influenza Vaccines In older adults In ontario, Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Influenza vaccine; Seasonal influenza; Health care; Influenza season; Emergency department; Vaccination; Gerontology; Coronavirus disease 2019 (COVID-19); Internal medicine; Virology; Nursing","score_opus":0.10939010485294352,"score_gpt":0.3949918054173741,"score_spread":0.28560170056443057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1756786330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98289365,0.010707275,9.292598e-7,0.0036228297,0.00018018551,0.0024597156,0.000054366858,0.000018024693,0.00006300998],"genre_scores_gemma":[0.9965764,0.0017094964,0.00021503623,0.0012529165,0.000052818756,0.00008118628,0.000016350186,0.000035625744,0.000060121343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949224,0.00057940115,0.0017611315,0.0005766118,0.0009630174,0.0011974154],"domain_scores_gemma":[0.9977199,0.00032726265,0.00040257562,0.0005239613,0.00020028435,0.0008260537],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0026043348,0.00036900162,0.0014671239,0.0008842141,0.000053423697,0.000010504933,0.00018297113,0.00011184924,0.000051694755],"category_scores_gemma":[0.0008389772,0.0003085045,0.000083475934,0.0008311715,0.00007436958,0.00013392014,0.00016115837,0.0008476658,0.0000024546403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.002661641,0.0006468616,0.9770203,0.0014597563,0.00004161063,0.00008913847,0.0094470745,0.0028286702,0.0000047067315,0.000038726637,0.0025778676,0.0031836266],"study_design_scores_gemma":[0.01871963,0.0017824874,0.97444946,0.002538542,0.00000530289,0.000018645107,0.0008932315,0.00055776356,0.000014865082,0.00007250353,0.0007475209,0.00020005216],"about_ca_topic_score_codex":0.9992683,"about_ca_topic_score_gemma":0.9934906,"teacher_disagreement_score":0.016057989,"about_ca_system_score_codex":0.0105599025,"about_ca_system_score_gemma":0.018539585,"threshold_uncertainty_score":0.9999367},"labels":[],"label_agreement":null},{"id":"W1823241341","doi":"10.1016/j.jval.2015.03.668","title":"Measuring Spending Trends For Those With Employer-Sponsored Insurance Using Administrative Data","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Insurance and Financial Risk Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Per capita; Context (archaeology); Prescription drug; Medical Expenditure Panel Survey; Health care; Demographic economics; Business; Actuarial science; Population; Quarter (Canadian coin); Medicine; Health insurance; Economics; Geography; Economic growth; Environmental health","score_opus":0.5335295156441321,"score_gpt":0.3729396798673468,"score_spread":0.16058983577678532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1823241341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654535,0.0040990943,0.02196399,0.0007337255,0.0007704415,0.0009080164,0.0011130754,0.000060357084,0.004897811],"genre_scores_gemma":[0.9835112,0.0002093741,0.015740726,0.000115675706,0.00014868779,0.000035002173,0.000052048617,0.00003523601,0.0001520271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805695,0.000047306658,0.0007204451,0.00059766136,0.00007824493,0.000499404],"domain_scores_gemma":[0.99868554,0.00006806226,0.00046657125,0.00061683403,0.000031470765,0.00013150083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024796824,0.0001772214,0.00049068005,0.00036265264,0.00014261833,0.00006061667,0.00041173317,0.000057392743,0.0000060721495],"category_scores_gemma":[0.00020939182,0.00019243285,0.0000387709,0.00053202116,0.000042361095,0.00047483947,0.00008758013,0.00014772614,0.000019143463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009082458,0.00037446123,0.74818474,0.00038863358,0.0000741953,0.000036460555,0.0050524413,0.023010358,0.000003247085,0.20253134,0.00069017656,0.018745719],"study_design_scores_gemma":[0.01044819,0.0023468593,0.61816627,0.0013049318,0.000019043466,0.00003052645,0.002073292,0.1961161,0.000085112595,0.038013417,0.12948889,0.0019073666],"about_ca_topic_score_codex":0.0036915177,"about_ca_topic_score_gemma":0.00037731673,"teacher_disagreement_score":0.17310575,"about_ca_system_score_codex":0.00039197766,"about_ca_system_score_gemma":0.00018569888,"threshold_uncertainty_score":0.7847184},"labels":[],"label_agreement":null},{"id":"W1842465981","doi":"10.1016/j.jval.2015.04.001","title":"Why Did the Randomized Clinical Trial Become the Primary Focus of My Career?","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Randomized controlled trial; Focus (optics); Primary (astronomy); Medicine; Medical education; Psychology; Internal medicine; Physics","score_opus":0.4361407828971169,"score_gpt":0.5114739791592267,"score_spread":0.07533319626210977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1842465981","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33014083,0.007912379,0.0003733383,0.6480289,0.0016743445,0.008355898,0.000013774615,0.000037936334,0.0034625924],"genre_scores_gemma":[0.87987,0.0046134754,0.00044934088,0.11227375,0.0022240593,0.00024010566,0.000017428143,0.0000365058,0.0002753495],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9904985,0.005361103,0.0016161297,0.00022803638,0.0013609041,0.0009353419],"domain_scores_gemma":[0.9765518,0.016622815,0.00045041137,0.00091235596,0.0002703691,0.005192249],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.061988875,0.00012430239,0.0011692828,0.00009759403,0.00007388261,0.00000945635,0.00027889444,0.00014257804,0.000030742394],"category_scores_gemma":[0.15992796,0.00005428673,0.00022646121,0.00036262991,0.0005600679,0.000036731577,0.00008300989,0.001084777,0.000018135137],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7284342,0.00074278226,0.0017289855,0.0007259527,0.00007266416,0.000038687092,0.00271661,0.000019917888,0.0000020007672,0.0010062808,0.17033207,0.09417983],"study_design_scores_gemma":[0.8263016,0.0038466363,0.0016518311,0.00045759763,0.000037103233,0.00002114261,0.00035171912,0.0014539598,0.0000074090144,0.0019370329,0.16385508,0.00007889561],"about_ca_topic_score_codex":0.013694698,"about_ca_topic_score_gemma":0.00010740172,"teacher_disagreement_score":0.54972917,"about_ca_system_score_codex":0.0003449303,"about_ca_system_score_gemma":0.018057879,"threshold_uncertainty_score":0.9928732},"labels":[],"label_agreement":null},{"id":"W1862306556","doi":"10.1016/j.jval.2015.03.401","title":"Evolution of the Market for oral Antidiabetic agents In Canada after Introduction of Dipeptidyl Peptidase-4 Inhibitors","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dipeptidyl peptidase-4; Dipeptidyl peptidase; Dipeptidyl peptidase-4 inhibitor; Pharmacology; Business; Medicine; Data science; Chemistry; Diabetes mellitus; Biochemistry; Endocrinology; Computer science; Enzyme; Type 2 diabetes","score_opus":0.02902168888322419,"score_gpt":0.26516004712297164,"score_spread":0.23613835823974746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1862306556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956554,0.00035235597,0.000008968454,0.0023291782,0.0004574072,0.0010561778,0.0000144968635,0.000003727546,0.00012226152],"genre_scores_gemma":[0.9991902,0.000017951195,0.00028966085,0.000101704376,0.000082608174,0.0000539999,0.000010846923,0.000009162756,0.00024382959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892104,0.000111198104,0.00037969634,0.00014298216,0.00023351156,0.00021156603],"domain_scores_gemma":[0.99952364,0.000027812039,0.00013981198,0.00019018564,0.00005152123,0.000067018016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000602222,0.00007899927,0.0002469678,0.00012326492,0.0000101786045,0.0000013990523,0.00004603481,0.000023729153,0.000013380357],"category_scores_gemma":[0.00010596235,0.00005932326,0.00003702656,0.0002749118,0.000026473434,0.00003920891,0.000028179184,0.000057534402,4.768572e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000250673,0.00024348203,0.9666373,0.0008430203,0.000021639062,0.0000016782457,0.0002720981,0.001003886,0.000045629753,0.00008830438,0.028489482,0.0021027746],"study_design_scores_gemma":[0.0028581885,0.00045498338,0.98653424,0.0005120223,0.000035555273,5.966437e-7,0.0005040914,0.0039332528,0.00096236647,0.0002522229,0.0038818445,0.00007065977],"about_ca_topic_score_codex":0.5829128,"about_ca_topic_score_gemma":0.22752151,"teacher_disagreement_score":0.3553913,"about_ca_system_score_codex":0.0016276013,"about_ca_system_score_gemma":0.0009897962,"threshold_uncertainty_score":0.7865742},"labels":[],"label_agreement":null},{"id":"W1868928463","doi":"10.1016/j.jval.2015.03.365","title":"The Cost-effectiveness of canagliflozin (Cana) versus Saxagliptin (Saxa) among older Individuals living with type 2 diabetes mellitus (T2dm) In canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Canagliflozin; Metformin; Medicine; Saxagliptin; Type 2 Diabetes Mellitus; Post-hoc analysis; Sitagliptin; Internal medicine; Diabetes mellitus; Endocrinology","score_opus":0.04172977108381095,"score_gpt":0.2832846464763343,"score_spread":0.24155487539252332,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1868928463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99308914,0.0033114953,0.0000022777283,0.00046621115,0.0004677996,0.0017537766,0.0000093407425,0.000015177399,0.00088478415],"genre_scores_gemma":[0.999244,0.00026229137,0.00009889346,0.00012390247,0.000030648924,0.00013827358,0.000018227885,0.000027070728,0.00005668998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977394,0.0004887343,0.00038711185,0.00027472782,0.000492357,0.00061771116],"domain_scores_gemma":[0.99792767,0.0011759133,0.0001880627,0.00034603282,0.00009308449,0.0002692681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019890699,0.00019038022,0.0004909304,0.00017343828,0.000052288276,0.000015819765,0.00014364277,0.00004239094,0.000007607632],"category_scores_gemma":[0.0003316826,0.00013446146,0.000025198462,0.0006352531,0.00006213935,0.00006744527,0.00006210863,0.00018610172,0.000002188358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013926397,0.00012276537,0.9863316,0.00044414875,0.00014014632,0.000016730113,0.00045527887,0.0041250717,0.000001521345,0.00025257753,0.00056301145,0.0074079074],"study_design_scores_gemma":[0.0038354855,0.00096631533,0.9875806,0.0019396348,0.00005793305,3.8700475e-7,0.0016170042,0.0013739036,0.00012805081,0.0000347039,0.002308456,0.00015753001],"about_ca_topic_score_codex":0.92081785,"about_ca_topic_score_gemma":0.93055,"teacher_disagreement_score":0.009732141,"about_ca_system_score_codex":0.0025414398,"about_ca_system_score_gemma":0.0034969836,"threshold_uncertainty_score":0.6645777},"labels":[],"label_agreement":null},{"id":"W1899218298","doi":"10.1016/j.jval.2015.09.1114","title":"The Economic Burden of Primary Brain Tumors in Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Indirect costs; Total cost; Brain tumor; Epidemiology; Economic cost; Population; Cost estimate; Environmental health; Emergency medicine; Pathology; Business","score_opus":0.3509244040244836,"score_gpt":0.3841116246959568,"score_spread":0.03318722067147317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1899218298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84996164,0.007058733,0.00003912157,0.13652723,0.0010244562,0.00089515944,0.00018173127,0.0000121834355,0.0042997324],"genre_scores_gemma":[0.9904847,0.0002778642,0.00046601912,0.008177735,0.00021703412,0.00006359407,0.000015946027,0.00002943831,0.0002676839],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99319595,0.0007565621,0.005016823,0.000378332,0.00009995887,0.00055238657],"domain_scores_gemma":[0.9951357,0.0021374978,0.0019546067,0.0004992185,0.000021993816,0.000250976],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02902365,0.00013995549,0.00096044946,0.00025215544,0.00007341552,0.00002173229,0.00038938713,0.000059344246,0.000030958945],"category_scores_gemma":[0.0022357178,0.00015830832,0.000044673623,0.00018976635,0.00005336997,0.00017562525,0.000056625613,0.00021775714,0.00016682326],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000618647,0.00005337245,0.38582072,0.001006736,0.000030437235,0.000005623682,0.00861309,0.2841937,4.5583784e-7,0.19969267,0.11906004,0.0014612948],"study_design_scores_gemma":[0.0049561663,0.00033851477,0.28841352,0.0007766174,0.000001939762,0.00001956239,0.016877444,0.2594544,0.0000045653087,0.08455916,0.34362382,0.00097426394],"about_ca_topic_score_codex":0.9926151,"about_ca_topic_score_gemma":0.8819987,"teacher_disagreement_score":0.22456378,"about_ca_system_score_codex":0.013974228,"about_ca_system_score_gemma":0.012815642,"threshold_uncertainty_score":0.99982446},"labels":[],"label_agreement":null},{"id":"W1899938335","doi":"10.1016/j.jval.2015.09.2160","title":"Do Free Medications Improve Observance Among Diabetic Patients?","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Medical prescription; Diabetes mellitus; Drug; Family medicine; Test (biology); Revenue; Pharmacology; Finance","score_opus":0.10052485943721029,"score_gpt":0.33842842202055123,"score_spread":0.23790356258334094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1899938335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97401756,0.0016048466,0.0004480513,0.015359511,0.0006938867,0.0010258872,0.000014579562,0.00008010148,0.006755563],"genre_scores_gemma":[0.9919369,0.00015982368,0.0024821623,0.0032428496,0.00014817264,0.0001504234,0.000035105397,0.0000130120925,0.0018315174],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984648,0.00009768977,0.00044105435,0.00025806605,0.0004497621,0.00028858814],"domain_scores_gemma":[0.998416,0.0000815896,0.00018186618,0.00065262,0.00014818086,0.0005197464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061035674,0.000094568684,0.00023547474,0.000076897464,0.000040809187,0.000007736346,0.0002049146,0.000059147784,0.00012225322],"category_scores_gemma":[0.00094609184,0.00008443628,0.000026510788,0.00034291172,0.00008627971,0.00008451258,0.000040737505,0.00023272913,0.00035574293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021069995,0.00036027274,0.94836754,0.00023461886,0.000009452366,0.0000031878362,0.0008251597,0.000054462198,0.000010105099,0.0022508968,0.037255708,0.010607539],"study_design_scores_gemma":[0.0037388846,0.0005870399,0.9577598,0.0008691671,0.000013596309,0.0000021725562,0.0004115924,0.005007868,0.00004674149,0.005080221,0.026319947,0.0001629957],"about_ca_topic_score_codex":0.0010781126,"about_ca_topic_score_gemma":0.000015543412,"teacher_disagreement_score":0.01791936,"about_ca_system_score_codex":0.00021775381,"about_ca_system_score_gemma":0.00075325416,"threshold_uncertainty_score":0.45724744},"labels":[],"label_agreement":null},{"id":"W1903355409","doi":"10.1016/j.jval.2015.09.2429","title":"The Budget Impact of Orphan Drugs In The Us and Canada: A 2007-2013 Midas Sales Data Analysis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Incentive; Medicine; Economics; Bioinformatics","score_opus":0.12856453629218972,"score_gpt":0.3496087187334243,"score_spread":0.22104418244123458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1903355409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752707,0.009968174,0.000008318063,0.012639833,0.00011338342,0.00019690263,0.0009031266,0.0000022561987,0.0008973396],"genre_scores_gemma":[0.99488676,0.003765194,0.000042966232,0.0011762227,0.00005606905,0.0000057600164,0.000037856025,0.0000073903525,0.000021760328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986001,0.00010499794,0.00067529414,0.00024727985,0.000038935606,0.0003333913],"domain_scores_gemma":[0.99864197,0.00032101863,0.0002832732,0.00058528857,0.000011847235,0.00015662365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033313297,0.0000973767,0.00037525166,0.00018189875,0.000056075532,0.000043821397,0.0005204091,0.00003650201,0.000017027773],"category_scores_gemma":[0.00016894146,0.00006981587,0.000045339657,0.00040368363,0.00006497631,0.00009286057,0.00010554059,0.00015988995,0.000010487077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038954615,0.0000760636,0.9268717,0.000044340683,0.00014860716,0.0000021301662,0.0017513837,0.012391063,1.4767797e-7,0.028507741,0.029413868,0.0007539894],"study_design_scores_gemma":[0.0009019399,0.000092988106,0.6365197,0.000014183452,0.000016836742,0.0000035205483,0.00034779235,0.2530112,6.174335e-7,0.014204855,0.09467943,0.00020698881],"about_ca_topic_score_codex":0.9689037,"about_ca_topic_score_gemma":0.7381144,"teacher_disagreement_score":0.29035205,"about_ca_system_score_codex":0.00036068753,"about_ca_system_score_gemma":0.0007264624,"threshold_uncertainty_score":0.28470084},"labels":[],"label_agreement":null},{"id":"W1903365719","doi":"10.1016/j.jval.2015.09.2063","title":"Heterogeneity in the Definition of Drug Induced Hypoglycemia in Clinical Trials: A Review","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Simon Fraser University","funders":"","keywords":"Medicine; Bedtime; Hypoglycemia; Morning; Evening; Randomized controlled trial; Internal medicine; Diabetes mellitus; Type 2 diabetes; Concordance; Clinical trial; Insulin; Pediatrics; Endocrinology","score_opus":0.7507564226154089,"score_gpt":0.5918680830648588,"score_spread":0.15888833955055004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1903365719","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013231998,0.98941857,3.183923e-7,0.0014084539,0.00023220002,0.006514556,0.000014038089,0.000008778367,0.0010798671],"genre_scores_gemma":[0.00016083014,0.9982106,0.000109266985,0.00084864517,0.00018062018,0.00030352143,0.00013386058,0.000028178127,0.000024495133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9735872,0.01954246,0.005032245,0.0004942629,0.0008227454,0.0005210664],"domain_scores_gemma":[0.9944184,0.0033860102,0.0012193247,0.00074575376,0.00006926562,0.0001612832],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09953497,0.00026796825,0.0049964567,0.0006443465,0.000015448119,0.000010340218,0.0003988398,0.00027708933,0.000016470842],"category_scores_gemma":[0.0080380635,0.00015679865,0.00057158765,0.0014898175,0.00006516382,0.00003874675,0.00011854079,0.0016599176,0.000042622072],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039263516,0.0004124505,0.00056336785,0.18976891,0.00002950422,0.000027130212,0.000059205522,3.0880716e-7,6.861703e-9,0.00017838174,0.0022547883,0.8066667],"study_design_scores_gemma":[0.0023218526,0.0005367818,0.00057960115,0.33523542,0.00025853465,0.000005775954,0.000036709822,0.00002878499,3.7980275e-8,0.00056536676,0.66025895,0.00017218973],"about_ca_topic_score_codex":0.0008695369,"about_ca_topic_score_gemma":0.00013754319,"teacher_disagreement_score":0.8064945,"about_ca_system_score_codex":0.000398193,"about_ca_system_score_gemma":0.0021038793,"threshold_uncertainty_score":0.96228933},"labels":[],"label_agreement":null},{"id":"W1905546942","doi":"10.1016/j.jval.2015.08.007","title":"Economic Evaluation of Cinacalcet in the United States: The EVOLVE Trial","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Cinacalcet; Medicine; Quality-adjusted life year; Cost-effectiveness analysis; Economic evaluation; Cost effectiveness; Internal medicine; Secondary hyperparathyroidism; Risk analysis (engineering)","score_opus":0.22693385308720265,"score_gpt":0.42405269583422944,"score_spread":0.1971188427470268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1905546942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901544,0.0025106813,0.0000048367065,0.0049399734,0.00012503673,0.0015173057,0.000008540327,0.0000041906037,0.00073505234],"genre_scores_gemma":[0.9989062,0.00025380182,0.000027487597,0.00060524093,0.000046578665,0.000071106624,0.00006992364,0.0000054217485,0.000014248613],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984171,0.0007242174,0.0003350067,0.000106883504,0.00026867026,0.00014815379],"domain_scores_gemma":[0.9993846,0.00017267698,0.00011632202,0.00023261385,0.000046185796,0.000047601246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038387633,0.000064954365,0.00018052447,0.000118092794,0.000022203527,0.0000046964255,0.00007340771,0.000031363026,0.000006436648],"category_scores_gemma":[0.0001771523,0.00003516293,0.000027657563,0.00022442588,0.000030172581,0.000025582056,0.0000084810345,0.00010521946,0.000017766271],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.039154653,0.0058301636,0.22533566,0.00015350884,0.00022604721,0.000029043787,0.10394731,0.5223558,0.0000066066928,0.0077750613,0.085336365,0.009849765],"study_design_scores_gemma":[0.26535863,0.0048530116,0.10425386,0.00012915437,0.00012800764,0.000015119186,0.016519664,0.58523905,0.00001587933,0.01696705,0.0063705076,0.00015009723],"about_ca_topic_score_codex":0.024167664,"about_ca_topic_score_gemma":0.0005437949,"teacher_disagreement_score":0.22620396,"about_ca_system_score_codex":0.00039219038,"about_ca_system_score_gemma":0.0008889477,"threshold_uncertainty_score":0.9823305},"labels":[],"label_agreement":null},{"id":"W1925827074","doi":"10.1016/j.jval.2015.09.916","title":"A Discrete Choice Experiment (Dce) To Elicit Preferences For Attributes Of A Bedside Pharmacogenetic Test – Preliminary Results","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Toronto Public Health; University of Toronto","funders":"","keywords":"Medicine; Context (archaeology); Willingness to pay; Mixed logit; Pharmacogenetics; Test (biology); Population; Logistic regression; Statistics; Internal medicine; Mathematics","score_opus":0.29704127454172824,"score_gpt":0.4739883772428298,"score_spread":0.17694710270110153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1925827074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9192045,0.02035128,0.00016526395,0.0549856,0.00032498213,0.003357679,0.0003023448,0.000047801706,0.0012605658],"genre_scores_gemma":[0.99289215,0.0009877374,0.0036014053,0.0019266197,0.00021604607,0.00021925577,0.00002115419,0.000015608111,0.000120044315],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99820626,0.00013858697,0.00062202103,0.00031002468,0.00030965396,0.00041347826],"domain_scores_gemma":[0.9971331,0.001872785,0.00019389225,0.0001868712,0.00013020259,0.00048314853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011139716,0.0001477896,0.00041293536,0.00008067593,0.00005815814,0.000008724153,0.00011800155,0.000041167285,0.000009531217],"category_scores_gemma":[0.0026250018,0.000116216055,0.000051810766,0.00025674675,0.000040418705,0.00006022495,0.00009429237,0.0001397848,0.000008473622],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10947877,0.01203538,0.2886535,0.014996493,0.0012049628,0.00012271295,0.07035955,0.027539678,0.042997845,0.0005356641,0.2401687,0.19190675],"study_design_scores_gemma":[0.027284987,0.051165514,0.07681716,0.0033898389,0.00037711533,0.000051321927,0.004413478,0.028457532,0.09197646,0.0007845535,0.7144167,0.00086536136],"about_ca_topic_score_codex":0.002905505,"about_ca_topic_score_gemma":0.00003820412,"teacher_disagreement_score":0.474248,"about_ca_system_score_codex":0.00015157537,"about_ca_system_score_gemma":0.00030526728,"threshold_uncertainty_score":0.47391534},"labels":[],"label_agreement":null},{"id":"W1935780438","doi":"10.1016/j.jval.2015.07.008","title":"Quality of Life and Asthma Symptom Control: Room for Improvement in Care and Measurement","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Asthma; Medicine; Quality of life (healthcare); EQ-5D; Disease control; Disease burden; Physical therapy; Disease; Pediatrics; Environmental health; Health related quality of life; Internal medicine","score_opus":0.08501690939907565,"score_gpt":0.34603635819109024,"score_spread":0.2610194487920146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1935780438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97858566,0.019102972,0.00014592939,0.00092712627,0.000060478054,0.0010945302,0.00003504649,0.000008204768,0.000040055736],"genre_scores_gemma":[0.9987753,0.00008038306,0.00021635405,0.0008160991,0.000050092018,0.000046493264,0.0000037161135,0.000008376934,0.0000031549437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987569,0.00014133246,0.00046120607,0.00017838507,0.00028080487,0.00018138392],"domain_scores_gemma":[0.9992353,0.00006660775,0.00012121713,0.000113581096,0.0001431968,0.00032014935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013548149,0.00008405603,0.0003754699,0.00007955303,0.000019231464,0.0000038050525,0.000023299386,0.000042369767,0.0000010075883],"category_scores_gemma":[0.0004220475,0.000068273446,0.000026708409,0.00005763873,0.000031792973,0.000024222585,0.000014958907,0.000061132705,1.8851026e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016031233,0.000347171,0.9280414,0.0051256735,0.000025428208,0.0000032838664,0.0030051644,0.00029437707,0.000579548,0.00039496305,0.00023987595,0.060339987],"study_design_scores_gemma":[0.023487555,0.004948739,0.9573195,0.00076345686,0.000013476793,0.0000016069213,0.006650472,0.0018453116,0.00016636903,0.00028002032,0.004348988,0.00017450775],"about_ca_topic_score_codex":0.0021100752,"about_ca_topic_score_gemma":0.00028320006,"teacher_disagreement_score":0.06016548,"about_ca_system_score_codex":0.00019189125,"about_ca_system_score_gemma":0.0008298374,"threshold_uncertainty_score":0.31898165},"labels":[],"label_agreement":null},{"id":"W1945804284","doi":"10.1016/j.jval.2015.09.1452","title":"Systematic Review On The Correlation Between Lung Function Or Eosinophil Levels And Health Care Resource Utilization In Asthma","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Eosinophil; Asthma; Sputum; Lung function; Correlation; Emergency department; Pulmonary function testing; Internal medicine; Intensive care medicine; Lung; Pathology","score_opus":0.15439750822267204,"score_gpt":0.36841733153849704,"score_spread":0.214019823315825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1945804284","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35478413,0.58520186,0.0013877334,0.04252623,0.00041493957,0.014927974,0.00006190461,0.00016301587,0.00053220324],"genre_scores_gemma":[0.9901117,0.0011244955,0.000026185748,0.008379076,0.00011915601,0.00007050444,0.00006561099,0.000021912449,0.00008133304],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9974609,0.00102606,0.00072532106,0.00022629114,0.0003488775,0.00021254593],"domain_scores_gemma":[0.9989328,0.00021139931,0.00030757915,0.00026170307,0.000065844324,0.00022071075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002040354,0.00013037282,0.000536451,0.00015077602,0.000096074094,0.00001083154,0.00003942605,0.000063638814,0.000007168977],"category_scores_gemma":[0.00059801474,0.00007781597,0.000030499958,0.00043580457,0.000026253543,0.000054643766,0.000016038512,0.0002049966,0.000009016277],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004953966,0.00025557858,0.14501299,0.8166447,0.000041390005,0.00003385,0.009064249,0.0022689144,6.7407444e-7,0.0012505705,0.009792421,0.015139267],"study_design_scores_gemma":[0.002998158,0.0035338644,0.46862456,0.5047888,0.00013253183,0.000043797256,0.0063076145,0.008709989,0.0000022989752,0.00009977421,0.004460561,0.00029803396],"about_ca_topic_score_codex":0.00035216336,"about_ca_topic_score_gemma":0.000049295777,"teacher_disagreement_score":0.6353276,"about_ca_system_score_codex":0.00059277186,"about_ca_system_score_gemma":0.00080511824,"threshold_uncertainty_score":0.3173243},"labels":[],"label_agreement":null},{"id":"W1955030956","doi":"10.1016/j.jval.2015.04.012","title":"Economic Evaluations in the Diagnosis and Management of Traumatic Brain Injury: A Systematic Review and Analysis of Quality","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Traumatic Brain Injury and Neurovascular Disturbances","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; University of Toronto; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Traumatic brain injury; Economic evaluation; Neurointensive care; MEDLINE; Intensive care medicine; Psychiatry; Pathology","score_opus":0.24905171037924498,"score_gpt":0.4754365974934808,"score_spread":0.2263848871142358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1955030956","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011290867,0.9907967,0.000003820086,0.0010375738,0.000022833708,0.006830414,0.000121987134,0.0000046387995,0.00005294532],"genre_scores_gemma":[0.0006388313,0.99772835,0.0001382471,0.0003632684,0.000004817587,0.0010557666,0.000051070303,0.000012494516,0.0000071813984],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99284714,0.003700507,0.0026293444,0.00033035723,0.00033176882,0.00016089818],"domain_scores_gemma":[0.99625933,0.0016399294,0.001276646,0.00072361564,0.000027764268,0.00007272974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012922754,0.0002321233,0.005090751,0.00051692146,0.00002253342,0.000008063385,0.00017553738,0.00007589001,0.000010592236],"category_scores_gemma":[0.00042276975,0.00014738645,0.00034041656,0.0010584192,0.000090055175,0.00003515982,0.000035928944,0.000189373,0.0000011771665],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028993861,0.00011465937,0.00014542349,0.95513374,0.0010165345,0.0000012211981,0.00073869916,0.0000047680815,1.0589553e-9,0.0013328026,0.00008212534,0.041427102],"study_design_scores_gemma":[0.00046133786,0.00025342536,0.0057646595,0.95756376,0.032319963,0.000015311944,0.0005029496,0.0001611651,2.142119e-8,0.00019728352,0.0025896688,0.00017046233],"about_ca_topic_score_codex":0.0005608923,"about_ca_topic_score_gemma":0.000106352214,"teacher_disagreement_score":0.04125664,"about_ca_system_score_codex":0.00017686305,"about_ca_system_score_gemma":0.00025010854,"threshold_uncertainty_score":0.6010245},"labels":[],"label_agreement":null},{"id":"W1955830745","doi":"10.1016/j.jval.2015.06.001","title":"David Sackett 1934–2015","year":2015,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Ottawa","funders":"","keywords":"Library science; Medicine; Critical appraisal; Checklist; Scopus; Alternative medicine; Family medicine; Clinical epidemiology; Biostatistics; Publication; Health care; MEDLINE; Political science; Medical education; Public health; Psychology; Epidemiology; Law; Nursing; Pathology; Computer science","score_opus":0.5992760393427071,"score_gpt":0.45880057111097233,"score_spread":0.1404754682317348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1955830745","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007593849,0.019637931,0.00024579192,0.96508294,0.0038674884,0.0018199466,0.001471375,0.00013630779,0.0069788513],"genre_scores_gemma":[0.0005757054,0.0008280898,0.0026794698,0.9805098,0.0077207256,0.00024663308,0.00083311915,0.00020230029,0.006404137],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98433286,0.0021309357,0.010066071,0.0015413665,0.00036236533,0.001566401],"domain_scores_gemma":[0.9899971,0.0017747957,0.005982072,0.0016476355,0.000116977404,0.00048143943],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.046532717,0.0006126625,0.0032278427,0.0013436602,0.00018303492,0.00013950445,0.0009232605,0.0013196204,0.00059628097],"category_scores_gemma":[0.0046728863,0.0008367961,0.00025384757,0.00050814985,0.000113711874,0.00041301877,0.00013740495,0.002572414,0.011810528],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005140835,0.000047311853,0.0027179525,0.0021009524,0.000034666384,0.000020142814,0.0014682335,0.0005025374,1.2133336e-8,0.0055102254,0.98751336,0.00007945562],"study_design_scores_gemma":[0.0007679141,0.00013649819,0.00054647605,0.0005723927,0.0000036586,0.00001801583,0.00015023757,0.002673121,8.0352734e-8,0.030893963,0.96356463,0.00067301944],"about_ca_topic_score_codex":0.032500785,"about_ca_topic_score_gemma":0.00024885923,"teacher_disagreement_score":0.04185983,"about_ca_system_score_codex":0.0053661102,"about_ca_system_score_gemma":0.0025766077,"threshold_uncertainty_score":0.9999769},"labels":[],"label_agreement":null},{"id":"W1963595383","doi":"10.1016/j.jval.2014.03.103","title":"Risk Factors Of Adverse Drug Reaction–Related Hospitalizations Among Seniors, 2006 To 2011","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Medicine; Drug; Medical prescription; Adverse effect; Drug class; Emergency medicine; Adverse drug reaction; Pharmacoepidemiology; Drug reaction; Risk factor; Intensive care medicine; Medical emergency; Internal medicine; Pharmacology","score_opus":0.05026214460626317,"score_gpt":0.35691763878873684,"score_spread":0.3066554941824737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963595383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954277,0.00008509526,0.00016719123,0.0017026161,0.00044181108,0.000633274,0.000033303495,0.000043193922,0.0014657909],"genre_scores_gemma":[0.9984578,0.00019652284,0.00032771495,0.0003975086,0.000034857476,0.000006064463,0.000035982812,0.000016922006,0.00052661076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985128,0.0003032043,0.00052317075,0.00019087913,0.00023032533,0.00023960827],"domain_scores_gemma":[0.998717,0.00040081682,0.0002897352,0.00022954929,0.000056446377,0.00030643493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006866112,0.00010859076,0.00028747856,0.00019192365,0.000065399996,0.0000021760252,0.000055879096,0.000059386908,0.00014073722],"category_scores_gemma":[0.0006160515,0.00009156765,0.000064184314,0.00030242832,0.000036326364,0.00012845203,0.000021723012,0.0002817702,0.000058450994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003856442,0.00018620197,0.9925964,0.000115073366,0.000020618812,0.0000010004808,0.0014349314,0.0038550654,0.000022067712,0.0003064596,0.0011158223,0.0003078157],"study_design_scores_gemma":[0.0009298261,0.0002933756,0.9720241,0.00015444937,0.00005152951,0.0000016133126,0.00034633803,0.013699503,0.00013466246,0.00017380825,0.012082995,0.00010783214],"about_ca_topic_score_codex":0.02511906,"about_ca_topic_score_gemma":0.00008624009,"teacher_disagreement_score":0.02503282,"about_ca_system_score_codex":0.00010657736,"about_ca_system_score_gemma":0.000073405536,"threshold_uncertainty_score":0.9813728},"labels":[],"label_agreement":null},{"id":"W1963700528","doi":"10.1016/j.jval.2014.03.516","title":"Cost Effectiveness of Different Digital Mammography Screening Scenarios for Breast Cancer in the Canadian Context","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Context (archaeology); Mammography; Medicine; Breast cancer; Demography; Breast cancer screening; Cohort; Cost effectiveness; Incidence (geometry); Cost–benefit analysis; Cancer; Internal medicine; Geography; Mathematics","score_opus":0.09650100022139844,"score_gpt":0.3590670957760673,"score_spread":0.26256609555466887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963700528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99232143,0.0006708645,0.0007362723,0.003661733,0.00013566224,0.0019384706,0.00028403068,0.000009884404,0.000241672],"genre_scores_gemma":[0.99850655,0.000029406807,0.000054765707,0.0011507277,0.00007479277,0.00014937304,0.0000190078,0.0000122427455,0.0000031131829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985681,0.00021817016,0.0003219852,0.00020597667,0.0002499195,0.00043583685],"domain_scores_gemma":[0.99898833,0.00045574465,0.00009440113,0.00018832774,0.00007840342,0.00019480592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012902896,0.00012249332,0.00037603948,0.00022435616,0.00008710031,0.000025439525,0.00013246604,0.000061961575,0.0000074695286],"category_scores_gemma":[0.00011431163,0.000087039705,0.00008379937,0.0003369031,0.0000642078,0.00007127442,0.000011713398,0.00020432721,5.748748e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004952179,0.00004959537,0.9036718,0.0005728432,0.000015757061,0.0000048494303,0.000630955,0.0026493596,0.000011177139,0.0012594813,0.00006854137,0.090570435],"study_design_scores_gemma":[0.001923216,0.00034163558,0.9867481,0.0027706432,0.000009813177,0.000024920433,0.0005494267,0.0066032927,0.000019100786,0.00024335869,0.00067557674,0.00009091019],"about_ca_topic_score_codex":0.64675856,"about_ca_topic_score_gemma":0.46739933,"teacher_disagreement_score":0.1793592,"about_ca_system_score_codex":0.000427663,"about_ca_system_score_gemma":0.00050569593,"threshold_uncertainty_score":0.54231924},"labels":[],"label_agreement":null},{"id":"W1963844670","doi":"10.1016/j.jval.2011.08.394","title":"PMS8 Prevalence of Clinical Risk Factors for Fractures in the Canadian Multicentre Osteoporosis Study","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Eli Lilly (Canada); McMaster University","funders":"","keywords":"Medicine; Osteoporosis; Osteopenia; Bone mineral; Femoral neck; Cohort; Internal medicine; Population; Pediatrics; Physical therapy","score_opus":0.19307638303079624,"score_gpt":0.449858662495608,"score_spread":0.2567822794648118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963844670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929943,0.00067235914,0.0000015492539,0.0012232487,0.00017525755,0.0046168286,0.00009057692,0.000008576853,0.00021731037],"genre_scores_gemma":[0.99764943,0.0006313556,0.0005736798,0.00092242466,0.00005939384,0.00010136535,0.0000083593095,0.000017349987,0.000036621608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960256,0.0012242903,0.0012372544,0.00035170253,0.00045515524,0.00070600316],"domain_scores_gemma":[0.9968833,0.00162677,0.00030534033,0.0004978394,0.00011494457,0.00057184184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006442291,0.0001397565,0.00054707634,0.00028114492,0.00014972626,0.0000070807073,0.00024874508,0.0001586906,0.00009434923],"category_scores_gemma":[0.003197333,0.00009140578,0.000100523735,0.00034859424,0.00009152144,0.000046574398,0.00002208632,0.00077593385,0.000005021759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034040838,0.0009821537,0.9642706,0.0008904046,0.000009240232,0.000008491786,0.029540608,0.000016689712,3.229125e-7,0.000017928383,0.00030961633,0.0036135288],"study_design_scores_gemma":[0.0024862383,0.0025708692,0.98290676,0.00017407916,0.000020302525,0.0000014459498,0.010675445,0.0006023236,0.000014883408,0.000058691603,0.0004219298,0.00006701299],"about_ca_topic_score_codex":0.88703495,"about_ca_topic_score_gemma":0.6412171,"teacher_disagreement_score":0.24581783,"about_ca_system_score_codex":0.00022742123,"about_ca_system_score_gemma":0.0026571495,"threshold_uncertainty_score":0.4713669},"labels":[],"label_agreement":null},{"id":"W1963919392","doi":"10.1016/j.jval.2013.02.004","title":"Updating the Canadian Hemophilia Outcomes–Kids Life Assessment Tool (CHO-KLAT Version2.0)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Hospital for Sick Children; Laurentian University","funders":"Canadian Institutes of Health Research; Bayer Canada; Canada Research Chairs","keywords":"Debriefing; Concordance; Quality of life (healthcare); Medicine; Reliability (semiconductor); Psychology; Physical therapy; Pediatrics; Gerontology; Internal medicine","score_opus":0.061492248775396025,"score_gpt":0.3657297734890976,"score_spread":0.3042375247137016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1963919392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8127297,0.00017595862,0.0000039446986,0.1776359,0.00028303542,0.0021636153,0.000008344538,0.00003739842,0.0069620768],"genre_scores_gemma":[0.9898669,0.00011025853,0.0009757245,0.0065611536,0.00016235693,0.00012932759,0.000036981946,0.000025973664,0.0021313322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756324,0.0002581904,0.0004746865,0.00029749016,0.0005823046,0.00082411146],"domain_scores_gemma":[0.9982437,0.00026582828,0.00007376479,0.0005071919,0.0000894366,0.0008200882],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011913859,0.00017652888,0.00035967852,0.00025081716,0.00045799502,0.00006409731,0.00018253672,0.00011256864,0.00081628293],"category_scores_gemma":[0.0003177446,0.00010667434,0.00009123515,0.00037759825,0.00007430916,0.00010147461,0.000057867415,0.0005911083,0.0004923859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012859165,0.000146293,0.9745541,0.00019279266,0.00005668412,0.000052259496,0.00062894897,0.00017172261,0.000027466958,0.0019429212,0.01183656,0.010377357],"study_design_scores_gemma":[0.0019318172,0.00029041182,0.9712669,0.00019095329,0.000013890143,0.000016766697,0.0007917873,0.011418253,0.000016537351,0.00039029034,0.0135054095,0.00016696459],"about_ca_topic_score_codex":0.53016406,"about_ca_topic_score_gemma":0.021518353,"teacher_disagreement_score":0.5086457,"about_ca_system_score_codex":0.0016128785,"about_ca_system_score_gemma":0.0038802328,"threshold_uncertainty_score":0.9963364},"labels":[],"label_agreement":null},{"id":"W1964066387","doi":"10.1016/j.jval.2011.08.016","title":"CN3 Validation Study Of The Baseline Quality Of Life As A Prognostic Indicator Of SURVIVAL: A Pooled Analysis Of Individual Patient Data From NCIC Clinical Trials","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Proportional hazards model; Hazard ratio; Quality of life (healthcare); Internal medicine; Clinical trial; Multivariate analysis; Prognostic variable; Multivariate statistics; Survival analysis; Physical therapy; Confidence interval; Statistics","score_opus":0.8648338287129885,"score_gpt":0.5589995219205318,"score_spread":0.3058343067924567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964066387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879906,0.0010151782,0.0004251762,0.0011511417,0.00043417397,0.002529397,0.006411988,0.000008369087,0.000033976095],"genre_scores_gemma":[0.99783987,0.000104649356,0.0010296477,0.0006312918,0.000060717914,0.000047886286,0.00026559483,0.000018391704,0.0000019318263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9487574,0.022837618,0.026681112,0.0008584322,0.000541902,0.0003234983],"domain_scores_gemma":[0.94621027,0.020107888,0.03063596,0.0025326998,0.00021586711,0.00029729205],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20512918,0.00018300313,0.004180797,0.0008407574,0.000050099632,0.000008362332,0.0010294904,0.00017784213,0.00029381667],"category_scores_gemma":[0.12757665,0.0001750352,0.00032015485,0.0011992769,0.00013921683,0.00018098706,0.0003091184,0.00024154423,0.000015139765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001740803,0.002845171,0.98008406,0.00049684464,0.0016018363,6.88986e-8,0.011947069,0.0007571161,0.0000012432979,0.0016725591,0.00016836543,0.00025160654],"study_design_scores_gemma":[0.0019639893,0.0006572922,0.9825553,0.00014282479,0.000370391,4.0163922e-8,0.0050142338,0.007759986,0.000011476643,0.0013627387,0.000028733399,0.0001329594],"about_ca_topic_score_codex":0.10644318,"about_ca_topic_score_gemma":0.002028995,"teacher_disagreement_score":0.10441419,"about_ca_system_score_codex":0.00013452672,"about_ca_system_score_gemma":0.0015125334,"threshold_uncertainty_score":0.8995071},"labels":[],"label_agreement":null},{"id":"W1964141029","doi":"10.1016/s1098-3015(10)70195-9","title":"PCN15 MODELING THE COST IMPACT OF POSSIBLE CROSS-PROTECTION DIFFERENCES OF TWO CERVICAL CANCERVACCINES IN CANADA USING MULTIPLE PROBABILISTIC SENSITIVITY ANALYSIS","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sensitivity (control systems); Probabilistic logic; Statistics; Computer science; Econometrics; Mathematics; Engineering","score_opus":0.5241988251709215,"score_gpt":0.443166574491618,"score_spread":0.08103225067930353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964141029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99095154,0.000657426,0.006023141,0.0010014588,0.00014073073,0.00089707284,0.00031046625,0.0000058644155,0.000012315238],"genre_scores_gemma":[0.9991543,0.00009412703,0.00046966705,0.0001712497,0.00005396699,0.00003378728,0.000008064274,0.000012049744,0.0000027645813],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9945661,0.00088877016,0.0036323639,0.00038346148,0.00012901152,0.0004003356],"domain_scores_gemma":[0.99644214,0.0011153892,0.0018535198,0.00037552154,0.00010332175,0.00011009449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009151587,0.00015253128,0.0012435459,0.00044564082,0.00016082643,0.0000136412455,0.00014498463,0.00006211282,0.000029543524],"category_scores_gemma":[0.0018630561,0.00014655161,0.00013593587,0.0010327674,0.0000589389,0.00017976925,0.000033121567,0.00021128851,0.000001661127],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013153365,0.000022191287,0.4949901,0.00017066243,0.00002541717,3.759621e-7,0.00055699755,0.5040865,0.0000011763311,0.000108717744,0.0000022417196,0.000022447352],"study_design_scores_gemma":[0.00029595755,0.000020906868,0.44802073,0.00005721559,0.0000032423293,0.0000021824483,0.000146639,0.5509029,0.000001234853,0.00048348293,5.044518e-7,0.00006498102],"about_ca_topic_score_codex":0.9986151,"about_ca_topic_score_gemma":0.97024703,"teacher_disagreement_score":0.046969384,"about_ca_system_score_codex":0.0057304907,"about_ca_system_score_gemma":0.0043866015,"threshold_uncertainty_score":0.99808633},"labels":[],"label_agreement":null},{"id":"W1964955762","doi":"10.1111/j.1524-4733.2007.00208.x","title":"Estimates of Costs of Hospital Stay for Variceal and Nonvariceal Upper Gastrointestinal Bleeding in the United States","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":148,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Upper gastrointestinal bleeding; Medicine; Hemostasis; Intensive care medicine; Surgery; Endoscopy","score_opus":0.03206507280561069,"score_gpt":0.3178627909209059,"score_spread":0.2857977181152952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1964955762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953513,0.00022159987,0.0015484357,0.0018893593,0.00004216656,0.00086758274,0.000028105522,0.000010955286,0.000040481063],"genre_scores_gemma":[0.9523347,0.00007008652,0.047351453,0.00013367306,0.000030387382,0.000019967136,0.00004389637,0.00001416893,0.0000016925634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848783,0.00004457035,0.00062300137,0.00020155223,0.00022788155,0.00041517155],"domain_scores_gemma":[0.99736995,0.0020118551,0.00024504305,0.00012174585,0.00014189446,0.00010948997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017214897,0.00014690383,0.0003787849,0.00033313324,0.00003924536,0.000008056464,0.000072998846,0.000027284354,0.000002924144],"category_scores_gemma":[0.0003140083,0.000104413826,0.00004524297,0.00043765004,0.000093636496,0.00003891214,0.000023659426,0.0001699916,2.9575872e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002840949,0.0010688318,0.99273545,0.00054891297,0.000022275479,0.000034922046,0.0016590814,0.00063191715,0.00013549601,0.002325517,0.00003993658,0.0005135765],"study_design_scores_gemma":[0.002926591,0.010203481,0.96206295,0.003039333,0.00006672766,0.0002221158,0.0034677999,0.017038345,0.00031268527,0.00055582396,0.000014113397,0.00009003804],"about_ca_topic_score_codex":0.01103823,"about_ca_topic_score_gemma":0.00006763239,"teacher_disagreement_score":0.045803018,"about_ca_system_score_codex":0.00017462412,"about_ca_system_score_gemma":0.00011545812,"threshold_uncertainty_score":0.99554735},"labels":[],"label_agreement":null},{"id":"W1965012816","doi":"10.1016/j.jval.2011.02.228","title":"PCV41 AN ESTIMATE OF SOCIETAL MONETARY BENEFITS OF SIMVASTATIN IN CANADA","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Trade and Competitiveness","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Simvastatin; Productivity; Revenue; Population; Health care; Demographic economics; Economics; Medicine; Actuarial science; Demography; Environmental health; Economic growth; Finance; Internal medicine","score_opus":0.06462865795004176,"score_gpt":0.2467718705227876,"score_spread":0.18214321257274585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965012816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979817,0.0002950575,0.0000073587053,0.0001639284,0.00014040926,0.00013158657,0.000013152355,0.0000073906244,0.0012593854],"genre_scores_gemma":[0.9990504,0.000026925796,0.0005420107,0.00030372816,0.000051816463,0.0000033500723,0.00001190332,0.000008079455,0.0000018019977],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990485,0.000024957128,0.0003894334,0.00014106746,0.0001658306,0.00023024331],"domain_scores_gemma":[0.9995976,0.000021456915,0.00020423929,0.00011910956,0.000042698764,0.00001490192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029178103,0.0000864043,0.00023321429,0.00009335798,0.000019206309,0.000005044687,0.00015208068,0.000021155467,0.000040947853],"category_scores_gemma":[0.000012071316,0.00008863872,0.000022089624,0.00033305833,0.000019928191,0.00025781285,0.00003875441,0.000071662216,0.0000022094935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003933118,0.0001747022,0.9491756,0.0008296199,0.0000058930877,0.00001003232,0.0003139183,0.022990536,0.000011882992,0.019692501,0.000033297445,0.0067226756],"study_design_scores_gemma":[0.00034180982,0.000025145033,0.9801722,0.00021232323,0.0000031250847,5.025518e-7,0.0007781434,0.016385982,0.000059403832,0.0018145897,0.0001159696,0.00009077477],"about_ca_topic_score_codex":0.9882658,"about_ca_topic_score_gemma":0.8047381,"teacher_disagreement_score":0.18352774,"about_ca_system_score_codex":0.00007606399,"about_ca_system_score_gemma":0.00033809806,"threshold_uncertainty_score":0.3614582},"labels":[],"label_agreement":null},{"id":"W1965258441","doi":"10.1016/j.jval.2012.03.253","title":"PMS64 Foqus Study (Study on Factors for Osteoporosis QOL in Japanese Subjects) - Interim Report","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Visual analogue scale; Osteoporosis; Quality of life (healthcare); McGill Pain Questionnaire; Physical therapy; Interim; Interim analysis; Osteoarthritis; Internal medicine; Clinical trial; Alternative medicine","score_opus":0.14271093447585653,"score_gpt":0.428631187741249,"score_spread":0.28592025326539244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965258441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868315,0.00042684638,0.0000017991066,0.0012758158,0.0007333655,0.010298966,0.000015831349,0.00006649785,0.00034939946],"genre_scores_gemma":[0.99770737,0.00003818783,0.00009233964,0.0006138272,0.00023661072,0.00081965944,0.000043395223,0.000071724775,0.00037687243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994738,0.00071344984,0.0015401832,0.00066394533,0.00082717306,0.0015172764],"domain_scores_gemma":[0.99702936,0.00081830466,0.00029407156,0.000852656,0.000112504626,0.00089310703],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0058836252,0.00032901936,0.0010078895,0.0007626765,0.00015640978,0.000022214901,0.00017511562,0.00015488334,0.000052184972],"category_scores_gemma":[0.0017710298,0.00027368582,0.00011219884,0.00080831733,0.000044475757,0.00014760443,0.00008862961,0.0007615329,0.000035492412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010433154,0.008280876,0.943488,0.000617011,0.000019268018,0.00011401272,0.044870365,0.000012189292,0.000047628804,0.000008059738,0.00036919554,0.0011300507],"study_design_scores_gemma":[0.005710837,0.011595651,0.91653496,0.0002851919,0.000015615093,0.00005174926,0.06475924,0.00008503295,0.00009721548,0.000009679145,0.0006538204,0.00020102448],"about_ca_topic_score_codex":0.048500966,"about_ca_topic_score_gemma":0.0025045585,"teacher_disagreement_score":0.045996405,"about_ca_system_score_codex":0.00105669,"about_ca_system_score_gemma":0.0008062778,"threshold_uncertainty_score":0.9999715},"labels":[],"label_agreement":null},{"id":"W1965362673","doi":"10.1016/j.jval.2012.08.1611","title":"PRM148 Sample Size and Power Considerations in Network Meta-Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University","funders":"","keywords":"Sample size determination; Meta-analysis; Sample (material); Power analysis; Statistics; Computer science; Statistical power; Power (physics); Network analysis; Data mining; Mathematics; Algorithm; Medicine; Engineering","score_opus":0.8668655682702049,"score_gpt":0.5548614285702957,"score_spread":0.31200413969990914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965362673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56426406,0.27011052,0.06593005,0.07333677,0.0018433506,0.009353522,0.00032906298,0.000046757323,0.014785896],"genre_scores_gemma":[0.9541137,0.00006688022,0.043025322,0.0020621293,0.00004889044,0.000055899447,0.0000023624086,0.000007062923,0.0006177063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96705514,0.020529052,0.0088554155,0.00072911254,0.002251273,0.0005800308],"domain_scores_gemma":[0.9520471,0.042169217,0.0028206196,0.002359785,0.00024493985,0.00035835433],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.17302206,0.00021719902,0.0053183986,0.0005307016,0.00014403003,0.000324845,0.00032651387,0.000068847694,0.01759429],"category_scores_gemma":[0.056634035,0.00011192212,0.0016111447,0.0034757946,0.000041486015,0.00026029025,0.00007840153,0.0001769106,0.00026433496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000032986377,0.00017687559,0.8509973,0.000057199468,0.012373946,0.0000031359552,0.004368724,0.043187246,9.4497545e-7,0.060328398,0.028142229,0.0003606991],"study_design_scores_gemma":[0.00046810735,0.00008742039,0.6460591,0.000022802215,0.028083408,0.000019668756,0.0015148445,0.02992171,0.0000011292665,0.20834179,0.084879145,0.00060090126],"about_ca_topic_score_codex":0.0021183484,"about_ca_topic_score_gemma":0.0015274668,"teacher_disagreement_score":0.3898497,"about_ca_system_score_codex":0.00005528846,"about_ca_system_score_gemma":0.0001234952,"threshold_uncertainty_score":0.9833038},"labels":[],"label_agreement":null},{"id":"W1965378925","doi":"10.1016/j.jval.2013.03.319","title":"The Usage Of 2-Octyl Cyanoacrylate Post Cesarean-Section In Canadian Hospitals: A Budget Impact Analysis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Surgical Sutures and Adhesives","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cyanoacrylate; Incidence (geometry); Population; Surgery; Adhesive","score_opus":0.012964735258339065,"score_gpt":0.2947798845468047,"score_spread":0.2818151492884656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965378925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99097216,0.001756167,0.0000014560491,0.0061220783,0.00009493609,0.0004475086,0.000019540343,0.000008547879,0.00057758455],"genre_scores_gemma":[0.9986764,0.000674768,0.000027108748,0.0004136163,0.0000673824,0.000015044311,0.000017795206,0.000009548249,0.00009831606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853104,0.00018629471,0.00043175966,0.00017895804,0.00017682984,0.00049509836],"domain_scores_gemma":[0.99893,0.00026235825,0.00012060671,0.00023810465,0.0000647882,0.00038418974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007491561,0.00010716029,0.0003653056,0.0004154676,0.00007489977,0.000020727477,0.00008379255,0.00007781728,0.00021699729],"category_scores_gemma":[0.00024926473,0.00006543578,0.00020420799,0.0011194134,0.000043181826,0.00006229461,0.000011910387,0.00021413215,0.000011394486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004401125,0.000057489444,0.9924757,0.00005593561,0.000121392965,0.000018342462,0.00075673853,0.0017961954,0.00012602107,0.00012000413,0.0001888419,0.004239355],"study_design_scores_gemma":[0.00035726192,0.0003020775,0.9932771,0.00007869929,0.000025062123,0.0000047393305,0.00035888146,0.004393757,0.00002473274,0.00012478951,0.0009895335,0.00006338853],"about_ca_topic_score_codex":0.9717888,"about_ca_topic_score_gemma":0.463733,"teacher_disagreement_score":0.5080558,"about_ca_system_score_codex":0.00045773963,"about_ca_system_score_gemma":0.00052373594,"threshold_uncertainty_score":0.54605246},"labels":[],"label_agreement":null},{"id":"W1965585875","doi":"10.1016/j.jval.2012.03.1352","title":"PSS8 Productivity Losses Associated with Vision Impairment in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cerebral Venous Sinus Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Visual impairment; Productivity; Visual acuity; Medicine; Near vision; Work productivity; Socioeconomic status; Demography; Gerontology; Environmental health; Psychiatry; Surgery; Economics; Population","score_opus":0.028623988313947114,"score_gpt":0.2868870698889689,"score_spread":0.25826308157502176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965585875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222404,0.0009274545,0.0000012141795,0.005628982,0.00018469885,0.00082225807,0.0000108810655,0.000026172951,0.00017429706],"genre_scores_gemma":[0.9987839,0.00005527832,0.00013839743,0.00079389487,0.00008377901,0.000017670669,0.000022530894,0.000022822796,0.00008173658],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817735,0.00022472008,0.00032465297,0.00022693722,0.00039615904,0.00065015606],"domain_scores_gemma":[0.9992368,0.00010569969,0.00012708093,0.00024550545,0.000039138486,0.00024577262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095472723,0.00013149212,0.00039880082,0.00011365993,0.000045886733,0.000004167596,0.000047371606,0.00004268059,0.000070290545],"category_scores_gemma":[0.0001854626,0.00010649987,0.000015833433,0.00048578525,0.000025289639,0.00012795052,0.000024924977,0.0002721609,0.000006237927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007698609,0.0014137105,0.99373734,0.00022332411,0.000014866582,0.000015501178,0.0007202896,0.00031572988,0.00004557342,0.000020736583,0.0021870674,0.0012288663],"study_design_scores_gemma":[0.0012144572,0.00068927504,0.99599683,0.00061406154,0.000007807928,0.000022059943,0.00014823063,0.00029882998,0.0001510496,0.000008989337,0.00074267667,0.00010574712],"about_ca_topic_score_codex":0.9814464,"about_ca_topic_score_gemma":0.9383615,"teacher_disagreement_score":0.043084845,"about_ca_system_score_codex":0.0061780927,"about_ca_system_score_gemma":0.003315486,"threshold_uncertainty_score":0.99763703},"labels":[],"label_agreement":null},{"id":"W1965694052","doi":"10.1016/j.jval.2012.03.884","title":"PRM28 Physicians as Pseudo-Agents in a Hospital Emergency Department Discrete Event Simulation","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Emergency department; Medicine; Discrete event simulation; Medical emergency; Event (particle physics); Hierarchy; Emergency medicine; Nursing; Simulation; Computer science","score_opus":0.09030045872833936,"score_gpt":0.4611188133448615,"score_spread":0.37081835461652213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965694052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9809853,0.00042740384,0.0050564473,0.008179091,0.001995975,0.0027445322,0.000028032657,0.00006000916,0.0005232512],"genre_scores_gemma":[0.9947297,0.00057411817,0.0025645401,0.00086581084,0.00039706106,0.00035844918,0.00013343687,0.00003634672,0.00034055155],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9958099,0.0013746928,0.0012480272,0.00029754004,0.00031754668,0.00095228065],"domain_scores_gemma":[0.9988582,0.00017723929,0.00032511214,0.00029215147,0.00009310226,0.00025419742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018050914,0.00017788477,0.0003044652,0.00020127856,0.0004894702,0.000006435624,0.00010102611,0.00016524317,0.00025822845],"category_scores_gemma":[0.00030318592,0.00017570157,0.00005205951,0.0005558658,0.000012276679,0.0003367416,0.000047929527,0.0005029126,0.0002444268],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027647275,0.00058972207,0.44172105,0.00032645717,0.0000064977316,0.0000016230144,0.019515105,0.53235567,0.0000034986494,0.0026905334,0.0005806747,0.0021815458],"study_design_scores_gemma":[0.0011677727,0.00040723948,0.37243885,0.000822482,0.000006040506,4.7681257e-7,0.0027183203,0.6156072,0.0000037046182,0.0005635254,0.0059306617,0.00033372984],"about_ca_topic_score_codex":0.0065305536,"about_ca_topic_score_gemma":0.00060084934,"teacher_disagreement_score":0.08325155,"about_ca_system_score_codex":0.0010275459,"about_ca_system_score_gemma":0.0005935678,"threshold_uncertainty_score":0.98722875},"labels":[],"label_agreement":null},{"id":"W1965757011","doi":"10.1016/j.jval.2011.08.217","title":"PIN30 Cost Analysis of Voriconazole Versus Itraconazole for Prophylaxis of Invasive Fungal Infection (IFI) in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) in Canada, France, Germany, and the United States","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Voriconazole; Medicine; Itraconazole; Tolerability; Internal medicine; Concomitant; Hematopoietic stem cell transplantation; Clinical trial; Randomized controlled trial; Surgery; Gastroenterology; Adverse effect; Antifungal; Transplantation; Dermatology","score_opus":0.03852618626752976,"score_gpt":0.2633188192122173,"score_spread":0.22479263294468751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1965757011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971838,0.0011527009,0.00007300147,0.000098718345,0.00006708451,0.0012471164,0.00013255324,0.0000038818785,0.000041146413],"genre_scores_gemma":[0.9984095,0.0013128916,0.000038553007,0.000100730256,0.0000060838865,0.000061606544,0.000047759615,0.000009766224,0.000013105062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816513,0.00027126976,0.0008081982,0.00024669178,0.00021959147,0.0002891428],"domain_scores_gemma":[0.99864644,0.00068659475,0.00025516585,0.00022821705,0.000098234894,0.000085365595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000979422,0.00013554197,0.00070529623,0.00044069823,0.00003197545,0.000002209692,0.00007407669,0.00007119389,0.000010405035],"category_scores_gemma":[0.000035201858,0.00010397685,0.00008276127,0.0011704852,0.000120228266,0.00003965397,0.000011364472,0.00021005128,1.8156435e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029731584,0.00023400958,0.9837424,0.0021132901,0.000107584456,0.000011574365,0.0066927,0.0033827461,0.0002671173,0.00017866936,0.000005472207,0.000291281],"study_design_scores_gemma":[0.005039652,0.00045867855,0.98118746,0.00027529546,0.00014360332,0.0000012687743,0.001851953,0.007849908,0.0030222882,0.00005940445,0.000014920462,0.000095548225],"about_ca_topic_score_codex":0.8823194,"about_ca_topic_score_gemma":0.8695489,"teacher_disagreement_score":0.012770494,"about_ca_system_score_codex":0.00033872577,"about_ca_system_score_gemma":0.0012266266,"threshold_uncertainty_score":0.42400527},"labels":[],"label_agreement":null},{"id":"W1966085183","doi":"10.1016/j.jval.2012.03.924","title":"PDB3 Risk of Complications in Type II Diabetic Patients With Renal Impairment: an Analysis of the Ramq Database","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada); Université de Montréal","funders":"","keywords":"Medicine; Hypoglycemia; Internal medicine; Incidence (geometry); Diabetes mellitus; Kidney disease; Metabolic acidosis; Type 2 Diabetes Mellitus; Type 2 diabetes; Endocrinology","score_opus":0.04019185679009446,"score_gpt":0.33410937749969566,"score_spread":0.2939175207096012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966085183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986037,0.00018095112,0.000012720532,0.0003220644,0.00002621588,0.0005822599,0.00005231067,0.0000040455184,0.00021571886],"genre_scores_gemma":[0.9993411,0.000052537194,0.00033005877,0.00007246721,0.0000101100095,0.000010540157,0.00013585472,0.000005707353,0.000041652216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987635,0.00026116503,0.0003007698,0.00011474156,0.00030907066,0.00025075857],"domain_scores_gemma":[0.9991168,0.00007567039,0.00016424218,0.00047385012,0.00006839089,0.00010106583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010116558,0.00005804605,0.000245432,0.0003862316,0.000049388047,0.0000019385116,0.00011651358,0.0000188567,0.000041541538],"category_scores_gemma":[0.00008637668,0.000035391506,0.000034334684,0.0015875221,0.00007341834,0.00006431135,0.00007931006,0.00013679429,0.0000016156233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005890049,0.0014198731,0.9947119,0.00016544416,0.00010099827,7.933568e-8,0.00047303623,0.0014524485,0.000012987925,0.00026492833,0.000046411475,0.0012930288],"study_design_scores_gemma":[0.0008458115,0.0004800389,0.9882508,0.00016659511,0.00014419555,1.7242659e-8,0.0000644569,0.009861577,0.000022433294,0.000014423046,0.000117993084,0.000031678133],"about_ca_topic_score_codex":0.0019828384,"about_ca_topic_score_gemma":0.00014752262,"teacher_disagreement_score":0.0084091285,"about_ca_system_score_codex":0.00007716365,"about_ca_system_score_gemma":0.00008766976,"threshold_uncertainty_score":0.29974717},"labels":[],"label_agreement":null},{"id":"W1966117900","doi":"10.1016/j.jval.2014.03.1179","title":"A microsoft-excel based tool for running and critically appraising simple network meta-analyses using winbugs – an overview and application","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Scientific Computing and Data Management","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Computer science; Microsoft excel; Software; Data mining; Programming language; Operating system","score_opus":0.6345220704923602,"score_gpt":0.5416845861432095,"score_spread":0.09283748434915073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966117900","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14050548,0.0022245243,0.8551244,0.0013727628,0.00014133468,0.0005548003,0.000018543955,0.000035282446,0.000022849741],"genre_scores_gemma":[0.8225801,0.000014587982,0.17448403,0.0027258045,0.00012534921,0.00002215175,0.000022189342,0.000012940475,0.000012840621],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9968065,0.00052841974,0.0008586426,0.00088368857,0.0005246775,0.0003980491],"domain_scores_gemma":[0.9957342,0.0029419223,0.0002721374,0.0007430871,0.00015338721,0.00015526889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018740706,0.00014315355,0.00052153267,0.00021114202,0.0004714979,0.0006244667,0.00030502904,0.00003861906,0.0000108416125],"category_scores_gemma":[0.0023808517,0.00011228739,0.000080838334,0.00069120736,0.00008235745,0.0002614527,0.00016505748,0.00007640719,0.0000018527294],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006737398,0.00017929381,0.016781937,0.0005635265,0.00012293318,0.0000013132106,0.0006647685,0.61513275,0.0006733118,0.023360739,0.0040990957,0.33835295],"study_design_scores_gemma":[0.0002711024,0.000060925293,0.0041893106,0.00003709901,0.000101468104,0.0000019434244,0.000086637214,0.95415694,0.000008499697,0.02419575,0.016767045,0.00012327736],"about_ca_topic_score_codex":0.0012156537,"about_ca_topic_score_gemma":0.000059591697,"teacher_disagreement_score":0.68207467,"about_ca_system_score_codex":0.000035371555,"about_ca_system_score_gemma":0.00008336253,"threshold_uncertainty_score":0.6495192},"labels":[],"label_agreement":null},{"id":"W1966122728","doi":"10.1016/j.jval.2014.03.703","title":"A Systematic Review, Critical Appraisal And Analysis Of The Quality Of Economic Evaluations In Stroke Imaging","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; CINAHL; Thrombolysis; Stroke (engine); Checklist; MEDLINE; Modified Rankin Scale; Psychological intervention; Critical appraisal; Emergency medicine; Intensive care medicine; Physical therapy; Internal medicine; Alternative medicine; Ischemic stroke; Pathology","score_opus":0.045801260799386914,"score_gpt":0.4299377434217208,"score_spread":0.3841364826223339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966122728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.965359,0.012546275,0.0019520457,0.016103255,0.00016644914,0.0022058983,0.000051284922,0.000011696585,0.0016041193],"genre_scores_gemma":[0.998426,0.00032042986,0.000699327,0.0004876171,0.000009856427,0.000035221816,0.000004379007,0.0000048582397,0.000012302224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975486,0.0007927024,0.0011448223,0.0001585716,0.0002226934,0.00013265145],"domain_scores_gemma":[0.99759394,0.0015758513,0.00031945252,0.00042786065,0.00003727833,0.000045646302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005315873,0.00006789049,0.0008631652,0.00022980325,0.000013679763,0.0000022826043,0.000083723935,0.000017387476,0.000013050436],"category_scores_gemma":[0.0049573155,0.000049782564,0.00009674979,0.00030641918,0.00007605685,0.000024183779,0.000055049513,0.000097714525,8.439289e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002600719,0.00019736527,0.5097941,0.47320363,0.00042612618,6.1189206e-7,0.0012434388,0.0015470926,0.00021798047,0.01250329,0.00049167004,0.00034870216],"study_design_scores_gemma":[0.0013891826,0.00009052169,0.5217644,0.067663155,0.0025856043,0.000005108393,0.00094610197,0.40519276,0.0000649253,0.00013786701,0.000029811144,0.00013055732],"about_ca_topic_score_codex":0.001827395,"about_ca_topic_score_gemma":0.00007468729,"teacher_disagreement_score":0.40554047,"about_ca_system_score_codex":0.0001509334,"about_ca_system_score_gemma":0.00011508743,"threshold_uncertainty_score":0.5934728},"labels":[],"label_agreement":null},{"id":"W1966139427","doi":"10.1016/j.jval.2014.03.1301","title":"Long-acting injectable antipsychotics treatment patterns: A RAMQ database analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health Research Topics","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Antipsychotic; Concomitant; Schizoaffective disorder; Database; Pediatrics; Internal medicine; Schizophrenia (object-oriented programming); Psychosis; Psychiatry","score_opus":0.16959042647042963,"score_gpt":0.4637416308851458,"score_spread":0.2941512044147162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966139427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812965,0.00085978414,0.010385791,0.001872891,0.00090361375,0.0011112328,0.00009951543,0.00009245593,0.0033782565],"genre_scores_gemma":[0.995409,0.0004947491,0.0016485661,0.0009893797,0.00023677186,0.0000940556,0.0001471121,0.000035151457,0.000945229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955988,0.0015373894,0.0007636683,0.00063674414,0.00036952223,0.0010938598],"domain_scores_gemma":[0.99770063,0.0005689086,0.00024385915,0.0010122285,0.000033663448,0.00044068744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002306838,0.00021785466,0.00055343716,0.0006224975,0.00017925604,0.000037236747,0.00025245722,0.00010257217,0.0009102008],"category_scores_gemma":[0.00012171734,0.00020341996,0.000106300824,0.0011493228,0.000037319038,0.0000949966,0.00005733016,0.00035957462,0.00023550769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029457934,0.0012309783,0.8798454,0.0006430009,0.00026788405,0.00007124587,0.0037883224,0.0016357348,0.000006745809,0.003420088,0.00047392063,0.108322136],"study_design_scores_gemma":[0.0080627445,0.00485366,0.8564569,0.0007540194,0.00019020309,0.00005066801,0.0029200455,0.08932036,0.00014273409,0.0007462356,0.035551794,0.00095065223],"about_ca_topic_score_codex":0.06658628,"about_ca_topic_score_gemma":0.003544965,"teacher_disagreement_score":0.10737149,"about_ca_system_score_codex":0.00073624565,"about_ca_system_score_gemma":0.00018715303,"threshold_uncertainty_score":0.99660605},"labels":[],"label_agreement":null},{"id":"W1966201494","doi":"10.1016/s1098-3015(10)73453-7","title":"PSS21 DISEASE BURDEN AND PRODUCTIVITY LOSS IN A CANADIAN ONLINE SURVEY POPULATION OF INDIVIDUALS WITH MODERATE-TO-SEVERE PLAQUE PSORIASIS","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Plaque psoriasis; Psoriasis; Productivity; Medicine; Disease; Disease burden; Demography; Gerontology; Dermatology; Internal medicine; Economics; Economic growth; Sociology","score_opus":0.06316237289037334,"score_gpt":0.34948721845064845,"score_spread":0.2863248455602751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966201494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.967669,0.00044285617,0.000003727412,0.030223569,0.000022453427,0.0013494829,0.0002583576,0.000011510494,0.000019036723],"genre_scores_gemma":[0.9985623,0.0002443652,0.00064437866,0.00027864435,0.0000852894,0.000020544876,0.000116000774,0.0000151891545,0.00003331651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977467,0.0005088357,0.00040186668,0.00039896456,0.00041217793,0.0005314718],"domain_scores_gemma":[0.99866843,0.00013238374,0.00009241685,0.00029046493,0.00012878595,0.0006875065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018073369,0.00014800021,0.0005003315,0.00059011707,0.00006591964,0.00001270302,0.00006982536,0.000050092076,0.000003812667],"category_scores_gemma":[0.0013097853,0.00012730085,0.000015342432,0.0007356884,0.000043555672,0.00011141871,0.00002459614,0.00024886537,9.4356875e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078480196,0.00016212492,0.98730576,0.00027268627,0.000014158546,0.00004068548,0.0011658117,0.005916099,0.000002634783,0.000082632236,0.00006907414,0.0041835285],"study_design_scores_gemma":[0.0013750994,0.00051995856,0.99538547,0.00052414543,0.000005776559,0.0000086048185,0.00007292279,0.0016532245,0.00000498353,0.0002781816,0.00006503721,0.000106613625],"about_ca_topic_score_codex":0.88435835,"about_ca_topic_score_gemma":0.77012515,"teacher_disagreement_score":0.11423324,"about_ca_system_score_codex":0.000623754,"about_ca_system_score_gemma":0.001510058,"threshold_uncertainty_score":0.5191178},"labels":[],"label_agreement":null},{"id":"W1966337915","doi":"10.1016/j.jval.2013.08.1399","title":"Health Care Resource Utilization and Costs Associated with Atypical Antipsychotics Use in Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Quebec, Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Centre of Excellence for Child and Youth Mental Health; Group for Research in Decision Analysis; Université de Montréal","funders":"","keywords":"Medicine; Quetiapine; Risperidone; Medical prescription; Attention deficit hyperactivity disorder; Psychiatry; Stimulant; Pediatrics; Anxiety; Health care; Schizophrenia (object-oriented programming)","score_opus":0.02550305477666069,"score_gpt":0.2854499051537697,"score_spread":0.259946850377109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966337915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940098,0.0009287803,0.000080493206,0.0029976864,0.000022550334,0.0019123033,0.000019816267,0.000024574023,0.00000398392],"genre_scores_gemma":[0.99878967,0.0002697238,0.00009739082,0.00056039874,0.000009241231,0.00002413928,0.00018382864,0.00004056558,0.000025022915],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976181,0.00054939196,0.00045755436,0.00049576577,0.00039568424,0.00048353002],"domain_scores_gemma":[0.9991109,0.00011333228,0.00024298827,0.00021873233,0.000094491515,0.00021959256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027750427,0.00022988082,0.00052312016,0.00025113352,0.00009672442,0.000046085526,0.000041035757,0.00011449826,0.0000038647977],"category_scores_gemma":[0.000178485,0.00020399343,0.00001390972,0.00059550407,0.00006804539,0.00032662816,0.000026239157,0.0005187244,7.7686735e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004753436,0.00045993243,0.9940221,0.00018321759,0.000012255163,0.0000073419183,0.00026526576,0.0005353398,0.0000024087701,0.000012407957,0.000028552076,0.003995876],"study_design_scores_gemma":[0.004902562,0.00023096331,0.9877976,0.0022950578,0.000009731998,0.000028784822,0.0020630076,0.0024769777,1.479799e-7,0.0000012047209,0.000015233729,0.0001787157],"about_ca_topic_score_codex":0.9175527,"about_ca_topic_score_gemma":0.9811828,"teacher_disagreement_score":0.06363011,"about_ca_system_score_codex":0.0013219559,"about_ca_system_score_gemma":0.000905618,"threshold_uncertainty_score":0.8318611},"labels":[],"label_agreement":null},{"id":"W1966628110","doi":"10.1016/j.jval.2013.03.1269","title":"Harmonization Of Health Technology Assessement And Regulatory Processes And Evidentiary Requirements For Drugs And Devices: Opportunities And Challenges","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Harmonization; Restructuring; Process (computing); Health technology; Process management; Risk analysis (engineering); Management science; Business; Computer science; Health care; Political science; Engineering; Law","score_opus":0.6155175674371229,"score_gpt":0.43070224839889176,"score_spread":0.18481531903823117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966628110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61783576,0.23214222,0.00054275815,0.1475837,0.00008896983,0.0016891723,0.000052508716,0.000024199046,0.000040726893],"genre_scores_gemma":[0.8747275,0.11840365,0.0038291789,0.0026841487,0.000035760673,0.0002499467,0.00001432842,0.000022582852,0.000032900763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99656385,0.00024137578,0.002390094,0.00044302794,0.000064433836,0.0002972226],"domain_scores_gemma":[0.9972848,0.0005480887,0.0017493422,0.0001876177,0.00008915707,0.00014097568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009920392,0.00013934095,0.0007528381,0.0004932279,0.00017070351,0.00004540246,0.000070279275,0.000099593555,0.0000072142193],"category_scores_gemma":[0.0007382972,0.00017185762,0.000010738925,0.00011194107,0.00013417462,0.0005486198,0.00006457193,0.000067164525,0.0000015042488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025710111,0.00028338635,0.40085256,0.1130313,0.00014253664,3.8960954e-7,0.026118336,0.000057877023,0.0000052257124,0.39427868,0.002485415,0.06271858],"study_design_scores_gemma":[0.0052139554,0.0019413015,0.644044,0.0067512593,0.000021970032,0.00002963052,0.08925072,0.020664973,0.000029481818,0.19266397,0.038238127,0.0011506005],"about_ca_topic_score_codex":0.0026444457,"about_ca_topic_score_gemma":0.00016781624,"teacher_disagreement_score":0.25689176,"about_ca_system_score_codex":0.00016953504,"about_ca_system_score_gemma":0.0003301646,"threshold_uncertainty_score":0.7008151},"labels":[],"label_agreement":null},{"id":"W1966821681","doi":"10.1016/j.jval.2012.03.1215","title":"PCN98 The Development of an Internationally-Valid Cancer-Specific Multi-Attribute Utility Instrument (MAUI) From the Eortc Core Health-Related Quality of Life (HRQOL) Questionnaire, QLQ-C30","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Rasch model; Quality of life (healthcare); Differential item functioning; Cancer; Item response theory; Descriptive statistics; Psychology; Medicine; Clinical psychology; Psychometrics; Statistics; Developmental psychology; Mathematics; Nursing","score_opus":0.6553345438472162,"score_gpt":0.46497874096596586,"score_spread":0.19035580288125037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966821681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93657994,0.02221848,0.0025124575,0.034222726,0.0015076268,0.0016375694,0.0012391723,0.000037050337,0.00004496376],"genre_scores_gemma":[0.9898412,0.0010167164,0.004789423,0.0037116748,0.00022094829,0.00018744815,0.0001688918,0.00003234918,0.000031304276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98502034,0.0027437387,0.010571067,0.0006023041,0.00035625367,0.0007062774],"domain_scores_gemma":[0.9896962,0.0018232863,0.006950995,0.00095723395,0.00016110881,0.0004111783],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.05134404,0.00028433045,0.0014716085,0.00020987143,0.00039505836,0.000031071944,0.000717873,0.00017270584,0.00031222525],"category_scores_gemma":[0.0025687402,0.0002558346,0.00014362489,0.00041490694,0.00021009818,0.0004130456,0.00012967135,0.00044776793,0.00009688101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045914745,0.0006970659,0.9255404,0.0005900248,0.00011164887,5.7264227e-8,0.028660858,0.0016769725,0.0000013485655,0.03868452,0.001223931,0.0027672823],"study_design_scores_gemma":[0.0012027344,0.00005997773,0.97661424,0.0004220148,0.000002406235,7.091769e-7,0.0022259592,0.010890562,0.0000089257055,0.00218181,0.0061600017,0.00023064895],"about_ca_topic_score_codex":0.121851735,"about_ca_topic_score_gemma":0.007864508,"teacher_disagreement_score":0.11398722,"about_ca_system_score_codex":0.0021343143,"about_ca_system_score_gemma":0.0015080081,"threshold_uncertainty_score":0.9999894},"labels":[],"label_agreement":null},{"id":"W1966839561","doi":"10.1016/s1098-3015(10)65887-1","title":"PHP28 THE ORGANIZED REGISTER OF CANADIAN HEALTH INFORMATION DATABASES (ORCHID) PROJECT: A RESEARCHER INTERFACE","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Register (sociolinguistics); Interface (matter); Database; World Wide Web; Computer science; Operating system","score_opus":0.5064793351875118,"score_gpt":0.5122980396560683,"score_spread":0.00581870446855659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966839561","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18807358,0.002650293,0.008342116,0.75898856,0.0025358195,0.015503206,0.0009362411,0.0003195424,0.022650631],"genre_scores_gemma":[0.9504357,0.0030514044,0.0044331173,0.040475868,0.00031294132,0.00026791813,0.00044636388,0.000041201583,0.00053550664],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.99478185,0.0014871927,0.0018964733,0.00016646842,0.00057810737,0.0010899251],"domain_scores_gemma":[0.997373,0.0005522941,0.0007686432,0.00055218686,0.00021840063,0.0005354858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009178892,0.00014692363,0.0003930058,0.0010661989,0.0010007849,0.000013024174,0.00032861144,0.00012292518,0.00014066372],"category_scores_gemma":[0.0022125882,0.00010418394,0.000032945773,0.0015982974,0.000110775654,0.00046867243,0.00009441758,0.0013568924,0.00021641074],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068134547,0.00022989558,0.011336472,0.022117294,0.000038096532,0.0000042625843,0.3912139,0.00254124,0.000008546634,0.16065548,0.3794685,0.031704973],"study_design_scores_gemma":[0.0044005984,0.00064313033,0.017557077,0.0065042595,0.0000040829545,0.000009369922,0.022798423,0.0027330585,0.00002060193,0.0011744,0.94389284,0.00026218317],"about_ca_topic_score_codex":0.9037015,"about_ca_topic_score_gemma":0.32424328,"teacher_disagreement_score":0.7623621,"about_ca_system_score_codex":0.0018393438,"about_ca_system_score_gemma":0.020806765,"threshold_uncertainty_score":0.98474437},"labels":[],"label_agreement":null},{"id":"W1966858810","doi":"10.1016/j.jval.2012.08.1677","title":"PDB34 Economic Evaluation of Treating Diabetes Patients According to Guidelines in South-Western Ontario, Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; Lawson Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Cohort; Diabetes mellitus; Cohort study; Intervention (counseling); Pediatrics; Emergency medicine; Internal medicine","score_opus":0.46010924351039006,"score_gpt":0.4369976809492666,"score_spread":0.023111562561123455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1966858810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99158037,0.0011199162,0.000033520584,0.0042517474,0.0011362236,0.001241076,0.00016047352,0.000010504306,0.00046617942],"genre_scores_gemma":[0.99440706,0.00001083275,0.0012971855,0.003782499,0.00023037223,0.00014143212,0.000036593014,0.000030506972,0.000063508385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9920485,0.00067612843,0.0058771223,0.00044658844,0.00019350681,0.0007581243],"domain_scores_gemma":[0.99627537,0.000659286,0.0022820178,0.00039646524,0.000106259264,0.00028062527],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.031846296,0.00020116653,0.0010670819,0.00056453486,0.000080564125,0.000023667168,0.00022138243,0.00009103474,0.0001350749],"category_scores_gemma":[0.0035566562,0.00027107305,0.00005594423,0.00021231924,0.000014067979,0.0004414939,0.000060135088,0.00014249659,0.00010347312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004682422,0.00004415336,0.95971155,0.00016783555,0.000009847237,3.13191e-8,0.005729376,0.032381456,2.6031847e-7,0.00054284424,0.00083750754,0.00057042926],"study_design_scores_gemma":[0.0012317067,0.000069794485,0.9659282,0.00039239324,0.0000039116153,1.8021498e-7,0.0014956652,0.027317468,0.0000047956873,0.0005159988,0.0027532086,0.00028666673],"about_ca_topic_score_codex":0.9742321,"about_ca_topic_score_gemma":0.9392204,"teacher_disagreement_score":0.03501169,"about_ca_system_score_codex":0.010387436,"about_ca_system_score_gemma":0.002455466,"threshold_uncertainty_score":0.99997413},"labels":[],"label_agreement":null},{"id":"W1967147071","doi":"10.1016/s1098-3015(10)72644-9","title":"PMS58 HEALTH STATUS, PHYSICIAN, DAY PROCEDURES AND HOPITALIZATION COSTS ASSOCIATED WITH RHEUMATOID-ARTHRITIS IN ONTARIO","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rheumatoid arthritis; Medicine; Family medicine; Physical therapy; Internal medicine","score_opus":0.021618522551746577,"score_gpt":0.2916455201595928,"score_spread":0.2700269976078462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967147071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813911,0.0019082247,0.000041465264,0.013239157,0.0003532803,0.0023686807,0.000036898593,0.000094668234,0.00056655874],"genre_scores_gemma":[0.9912949,0.0028376896,0.00034918508,0.0049769464,0.0000820907,0.00008720318,0.0002123987,0.00005437102,0.0001051758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958677,0.0006654949,0.0011982251,0.0005645249,0.0005179878,0.0011860603],"domain_scores_gemma":[0.99785095,0.00021233624,0.000489613,0.0003365074,0.0001620399,0.0009485419],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00348026,0.00027151307,0.0009490687,0.00040460788,0.00018703607,0.000045675515,0.000071397786,0.0002239076,0.000022418599],"category_scores_gemma":[0.00063463073,0.00024262251,0.000030012512,0.0007485665,0.00007762416,0.00021452937,0.000024292549,0.0011459024,0.000004708963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000740111,0.00034477914,0.95295167,0.0011811993,0.000016181972,0.00002151227,0.011937919,0.000043944543,0.0000107592095,0.0043716556,0.00091565406,0.02813071],"study_design_scores_gemma":[0.0036837894,0.0013224949,0.97322494,0.005915909,0.0000011662568,0.000052321924,0.00080432417,0.0009050314,0.0000023831467,0.00015478367,0.013700149,0.00023271894],"about_ca_topic_score_codex":0.85883284,"about_ca_topic_score_gemma":0.9434082,"teacher_disagreement_score":0.08457535,"about_ca_system_score_codex":0.0028751371,"about_ca_system_score_gemma":0.025212405,"threshold_uncertainty_score":0.9893859},"labels":[],"label_agreement":null},{"id":"W1967213632","doi":"10.1016/s1098-3015(10)70359-4","title":"PMH9 RETENTION RATES FOR ORAL AND DEPOT ANTIPSYCHOTIC MEDICATIONS OVER ONE YEAR IN ONTARIO, CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Radioactivity and Radon Measurements","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Depot; Antipsychotic; Medicine; Psychiatry; Family medicine; Geography; Schizophrenia (object-oriented programming); Archaeology","score_opus":0.22605271134452629,"score_gpt":0.4099362084477653,"score_spread":0.183883497103239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967213632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943879,0.0002551436,0.0001354671,0.0032323378,0.00060343096,0.0011060876,0.000014887551,0.000012724071,0.00025200844],"genre_scores_gemma":[0.99672025,0.00038538827,0.001270462,0.0009185892,0.000046038724,0.00009244602,0.000024679499,0.000013250762,0.00052888365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981837,0.0004422882,0.0004897088,0.00022509313,0.00025090924,0.00040826673],"domain_scores_gemma":[0.9992283,0.00026686958,0.00016102065,0.00015831854,0.000037712252,0.00014779743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011647461,0.00008614118,0.00024294236,0.00012100433,0.00041929452,0.0000023752343,0.00006499506,0.0000979401,0.00008642779],"category_scores_gemma":[0.00013538708,0.000086468426,0.000016461445,0.00018011774,0.000034935976,0.00008909166,0.000011549735,0.00046193897,0.0000038043302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007426131,0.000111780515,0.9914235,0.00025362504,0.000010785909,0.0000030233193,0.0019334054,0.00007656435,0.00003589762,0.00040848518,0.0054769977,0.00019169426],"study_design_scores_gemma":[0.0017288042,0.000063066545,0.9917791,0.00038684157,0.000004148374,0.0000018558155,0.0002872411,0.000733417,0.0000048669735,0.00036040085,0.004568681,0.00008156207],"about_ca_topic_score_codex":0.98750156,"about_ca_topic_score_gemma":0.9955372,"teacher_disagreement_score":0.008035667,"about_ca_system_score_codex":0.0011677498,"about_ca_system_score_gemma":0.0041738157,"threshold_uncertainty_score":0.74041694},"labels":[],"label_agreement":null},{"id":"W1967300065","doi":"10.1016/j.jval.2010.10.012","title":"Is the Health Utilities Index 3 valid for patients with ankylosing spondylitis?","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Abbott Laboratories","keywords":"Ankylosing spondylitis; Medicine; Physical therapy; Health Utilities Index; Quality of life (healthcare); Correlation; Discriminative model; Convergent validity; Health related quality of life; Psychometrics; Disease; Internal medicine; Mathematics; Clinical psychology; Artificial intelligence","score_opus":0.08882071676749032,"score_gpt":0.32093821966311437,"score_spread":0.23211750289562405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967300065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98755294,0.003655137,0.00008096655,0.004537356,0.00027661168,0.002580733,0.0005220379,0.000047394573,0.0007467933],"genre_scores_gemma":[0.9927911,0.0004938568,0.0020027328,0.0042452784,0.000070126785,0.00009801966,0.00009047779,0.000034826764,0.0001735527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826956,0.00011187263,0.00043441175,0.00031054718,0.00027421216,0.00059939566],"domain_scores_gemma":[0.99910146,0.00013541344,0.00017414187,0.00032644192,0.000094098075,0.000168452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043643307,0.00018288441,0.00042842084,0.000099334386,0.00032221532,0.000011000847,0.00007219036,0.00004444341,0.000104782026],"category_scores_gemma":[0.000052396175,0.00011670964,0.0000721496,0.00020813987,0.00010188888,0.00006283242,0.000029691395,0.00014427566,0.00000612223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014963361,0.00071818446,0.9644399,0.0005423853,0.00008668626,0.00000961458,0.014276634,0.0000017890393,6.2143954e-8,0.0016740476,0.0012887493,0.015465604],"study_design_scores_gemma":[0.00820198,0.0064149518,0.9556156,0.0011153858,0.000022540416,0.000015940668,0.0025160522,0.00015566763,0.000009351639,0.0014519005,0.024320243,0.00016039917],"about_ca_topic_score_codex":0.0118492525,"about_ca_topic_score_gemma":0.00025290888,"teacher_disagreement_score":0.023031494,"about_ca_system_score_codex":0.00029384147,"about_ca_system_score_gemma":0.00035636214,"threshold_uncertainty_score":0.99473095},"labels":[],"label_agreement":null},{"id":"W1967399362","doi":"10.1016/s1098-3015(11)72093-9","title":"PDB35 COST-CONSEQUENCE ANALYSIS OF CSII VS. MDI:A CANADIAN PERSPECTIVE","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Perspective (graphical); Medicine; Computer science; Artificial intelligence","score_opus":0.34466576956920136,"score_gpt":0.4378200209320594,"score_spread":0.09315425136285804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967399362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8896437,0.0017189996,0.0004629561,0.09559715,0.0010593924,0.0013458314,0.0013489411,0.000037080303,0.008785906],"genre_scores_gemma":[0.9866633,0.00019988602,0.0028703865,0.00986038,0.00012342563,0.00007468226,0.000036150726,0.000024558509,0.00014726444],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9943723,0.00043988656,0.0037597774,0.00063825626,0.00010400544,0.00068578764],"domain_scores_gemma":[0.9954281,0.0012979798,0.0018218512,0.0007352925,0.00013438868,0.0005823885],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.018036157,0.00018101871,0.0014005334,0.0022261776,0.00016534982,0.000037058915,0.000377052,0.0001893425,0.00079053827],"category_scores_gemma":[0.006175866,0.00024908033,0.00017886171,0.0013919297,0.00014420971,0.00024421167,0.000025668485,0.00043592625,0.0004472175],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016692,0.00011883242,0.2826855,0.00025706977,0.00028724293,0.0000061622145,0.013784203,0.010295578,0.0000060640677,0.68874854,0.0036241007,0.00016998715],"study_design_scores_gemma":[0.0017386102,0.00031755588,0.6658213,0.00022544373,0.00007038378,0.00002261912,0.008866854,0.16841333,0.000017709455,0.075072415,0.07831476,0.0011190133],"about_ca_topic_score_codex":0.9242426,"about_ca_topic_score_gemma":0.5996389,"teacher_disagreement_score":0.61367613,"about_ca_system_score_codex":0.002390014,"about_ca_system_score_gemma":0.0023754651,"threshold_uncertainty_score":0.9999961},"labels":[],"label_agreement":null},{"id":"W1967491409","doi":"10.1016/j.jval.2011.02.431","title":"PUK16 COST-EFFECTIVENESS OF VALGANCICLOVIR 200 DAYS PROPHYLAXIS VERSUS 100 DAYS PROPHYLAXIS IN KIDNEY TRANSPLANT PATIENTS AT HIGH-RISK FOR DEVELOPING CYTOMEGALOVIRUS DISEASE","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cytomegalovirus and herpesvirus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Roche (Canada); University of Alberta; Thornhill Medical (Canada)","funders":"","keywords":"Valganciclovir; Medicine; Cost-effectiveness analysis; Cost effectiveness; Dialysis; Kidney transplantation; Intensive care medicine; Internal medicine; Emergency medicine; Transplantation; Ganciclovir; Human cytomegalovirus; Immunology; Virus","score_opus":0.08356463954446439,"score_gpt":0.33028964010695827,"score_spread":0.24672500056249388,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967491409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883414,0.0006684785,0.0003851842,0.00010893155,0.0005522517,0.008362688,0.001342605,0.00005742435,0.00018104474],"genre_scores_gemma":[0.99602395,0.00087538996,0.001439481,0.00012381145,0.0000870352,0.000996088,0.0003034871,0.00010431207,0.0000464706],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947281,0.0009242043,0.0012606524,0.00094825856,0.00087953423,0.0012592585],"domain_scores_gemma":[0.9968506,0.0008071765,0.00036780402,0.00069926545,0.00032244402,0.00095270516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002699344,0.00046288263,0.0011344547,0.00094364025,0.00021588574,0.000018213077,0.00034683998,0.00026689435,0.00008295979],"category_scores_gemma":[0.0011040545,0.00041444224,0.00021677064,0.0012152937,0.00020152674,0.00020624987,0.00012258526,0.0006862587,0.00005037613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06895358,0.0025221556,0.8867578,0.015018906,0.00015410803,0.00015220833,0.0033980377,0.00023110911,0.00072023313,0.0011045717,0.000113934446,0.020873358],"study_design_scores_gemma":[0.027701475,0.007943088,0.9482488,0.0036443,0.000066722976,0.0000046054583,0.00006612985,0.0011993832,0.0073669846,0.0006075311,0.002490272,0.0006607084],"about_ca_topic_score_codex":0.03124478,"about_ca_topic_score_gemma":0.00084770174,"teacher_disagreement_score":0.061491,"about_ca_system_score_codex":0.0025087884,"about_ca_system_score_gemma":0.0030866428,"threshold_uncertainty_score":0.9998307},"labels":[],"label_agreement":null},{"id":"W1967590582","doi":"10.1016/j.jval.2011.08.575","title":"PHP24 How Does the Committee to Evaluate Drugs (CED) Make Decisions about Ambulatory Pharmaceutical Funding in Ontario?","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Reimbursement; Government (linguistics); Pharmaceutical care; Business; Medicine; Family medicine; Quality (philosophy); Health care; Actuarial science; Public economics; Economics; Pharmacy; Economic growth","score_opus":0.6263405301257549,"score_gpt":0.459053481697028,"score_spread":0.16728704842872688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967590582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92482656,0.0019316514,0.00042673838,0.06261722,0.0016397417,0.0021201414,0.0001099881,0.000056796216,0.006271141],"genre_scores_gemma":[0.9679775,0.00035452037,0.0031079112,0.027251739,0.00019479069,0.00026099244,0.000010488569,0.000054992,0.0007870165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99210393,0.0015251,0.004150074,0.0008508007,0.00023616513,0.0011339068],"domain_scores_gemma":[0.99501747,0.0024226934,0.0010408562,0.0009315423,0.000042201424,0.00054523075],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.039872706,0.00030337274,0.0011474004,0.00076965964,0.00033956757,0.00010472989,0.000689272,0.0001782612,0.0011398583],"category_scores_gemma":[0.0021471279,0.00028200806,0.00014072956,0.0004922416,0.000104759645,0.00030396867,0.00014243319,0.0008246271,0.0014780345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018056703,0.0005461131,0.69269085,0.00041871687,0.00007690869,0.0000095395035,0.08170706,0.004337152,0.0000014809855,0.20265967,0.010671422,0.006700547],"study_design_scores_gemma":[0.0022506842,0.00018650331,0.7351654,0.00076409214,0.000007994956,0.0000090271315,0.0045783278,0.020474372,0.000005737773,0.05805515,0.17780037,0.00070232],"about_ca_topic_score_codex":0.19535702,"about_ca_topic_score_gemma":0.095212676,"teacher_disagreement_score":0.16712895,"about_ca_system_score_codex":0.0030790968,"about_ca_system_score_gemma":0.00089208654,"threshold_uncertainty_score":0.9999632},"labels":[],"label_agreement":null},{"id":"W1967607156","doi":"10.1016/j.jval.2011.08.460","title":"PMS74 Use of Disease-Modifying Anti-Rheumatic Drugs for Rheumatoid Arthritis in Quebec, Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; Canadian Arthritis Patient Alliance; Université de Montréal","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Cohort; Hydroxychloroquine; Logistic regression; Comorbidity; Rheumatology; Disease","score_opus":0.07496639590177324,"score_gpt":0.2898749092248766,"score_spread":0.21490851332310335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967607156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860399,0.010454037,0.00040097785,0.00155474,0.0006152728,0.00071529206,0.00015330742,0.000018292596,0.000048180824],"genre_scores_gemma":[0.9938468,0.002546582,0.0029033916,0.00049446116,0.00000453405,0.000026165608,0.000016814063,0.00001386635,0.00014740587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980462,0.00044824558,0.0007438321,0.0002540408,0.000042712385,0.00046495718],"domain_scores_gemma":[0.99889976,0.0005692182,0.0001903804,0.00023652389,0.000035564342,0.00006854425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007185493,0.00013855698,0.0005210582,0.00013164486,0.000058476446,0.0000056046183,0.000137018,0.00012105321,0.000093611496],"category_scores_gemma":[0.00035691285,0.00012507424,0.00006507966,0.00018974638,0.000112404334,0.00007092031,0.000037381305,0.00019809877,0.0000022350546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033817876,0.0034914932,0.5994311,0.00840292,0.00054616545,0.00008288636,0.01605059,0.00076565973,0.005878211,0.044392206,0.02860175,0.28897527],"study_design_scores_gemma":[0.016025972,0.0010484401,0.8588519,0.013519885,0.00004998858,0.00003235595,0.0034504072,0.005203536,0.021445723,0.0114151025,0.06689059,0.0020661186],"about_ca_topic_score_codex":0.9500903,"about_ca_topic_score_gemma":0.7506966,"teacher_disagreement_score":0.28690913,"about_ca_system_score_codex":0.00016734978,"about_ca_system_score_gemma":0.0009551699,"threshold_uncertainty_score":0.5100379},"labels":[],"label_agreement":null},{"id":"W1967740245","doi":"10.1016/s1098-3015(10)61276-4","title":"PCV5 COST IMPACT OF AMLODIPINE IN BRITISH COLUMBIA BASED ON THE PREVENT TRIAL RESULTS","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic, Social, and Public Health Issues in Russia and Globally","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Amlodipine; Medicine; Internal medicine","score_opus":0.20224064265165737,"score_gpt":0.4183248879272593,"score_spread":0.21608424527560194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967740245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9697764,0.00040384033,0.000010423075,0.016110942,0.0009247328,0.0018790709,0.00034378417,0.00001613468,0.010534705],"genre_scores_gemma":[0.9966537,0.00034310986,0.00009062759,0.0018087905,0.00022315788,0.00004743064,0.000007124544,0.000009570571,0.00081649766],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99412125,0.0020113382,0.0021042684,0.00047804418,0.00070398557,0.00058113266],"domain_scores_gemma":[0.99465996,0.0037254035,0.0006637692,0.0006206811,0.00008196519,0.000248209],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.015010573,0.000111915746,0.0005856217,0.00015451548,0.0001829545,0.0002782606,0.00067389646,0.00013989428,0.00135042],"category_scores_gemma":[0.0061295214,0.000107175096,0.00018192505,0.00094611564,0.000116100564,0.00013780575,0.000040844137,0.00033363598,0.00006704007],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050172363,0.0040485733,0.11925798,0.00013064538,0.000028288187,0.0000483396,0.007742269,0.04318771,6.246374e-7,0.0018643141,0.6218387,0.19683532],"study_design_scores_gemma":[0.06931678,0.0073452364,0.53292036,0.0012012408,0.0000055978244,0.00001153399,0.0015064037,0.20605582,0.0000015363925,0.028456176,0.1525097,0.00066957873],"about_ca_topic_score_codex":0.28318956,"about_ca_topic_score_gemma":0.07055762,"teacher_disagreement_score":0.469329,"about_ca_system_score_codex":0.00056189275,"about_ca_system_score_gemma":0.0009212778,"threshold_uncertainty_score":0.9995625},"labels":[],"label_agreement":null},{"id":"W1967772029","doi":"10.1016/j.jval.2012.03.1204","title":"PCN87 Cost-Effectiveness of Hormone Therapies for ER+ Women with Early Breast Cancer in Canada: Exploring the Potential for the Cyp2D6 Genetic Test","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Toronto Public Health; St. Michael's Hospital","funders":"","keywords":"Tamoxifen; Medicine; Letrozole; Breast cancer; Oncology; Population; CYP2D6; Internal medicine; Gynecology; Aromatase; Cancer","score_opus":0.307823623645486,"score_gpt":0.37128906578781945,"score_spread":0.06346544214233346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967772029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675586,0.011795484,0.002743669,0.012006194,0.0005395608,0.004131837,0.0012095255,0.0000067496585,0.000008373717],"genre_scores_gemma":[0.99167824,0.00082798686,0.00036056995,0.0009028354,0.0002702515,0.0059116273,0.0000037066768,0.00003530807,0.000009454088],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968232,0.00039064002,0.0017136456,0.00027213542,0.000090978625,0.0007094014],"domain_scores_gemma":[0.99376434,0.004758899,0.00096840784,0.00032720563,0.00005958934,0.00012153162],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014554678,0.00015462941,0.0006720275,0.00013350233,0.00018676963,0.00002233697,0.0002537807,0.00004080002,0.000011740009],"category_scores_gemma":[0.00036217412,0.00012138682,0.000041685693,0.00022083755,0.00005730496,0.00022788254,0.00002281813,0.0001386928,0.0000032049584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052927784,0.0001858276,0.89019257,0.0016598935,0.00014326417,3.1529513e-7,0.015346287,0.07878024,0.000009282703,0.008245723,0.0003866394,0.004520678],"study_design_scores_gemma":[0.0012681787,0.0001628701,0.9821365,0.00013170386,0.0000035458386,0.0000037369837,0.003084277,0.011177435,0.000003030255,0.00095130724,0.0009336469,0.00014378657],"about_ca_topic_score_codex":0.8522849,"about_ca_topic_score_gemma":0.22417782,"teacher_disagreement_score":0.62810713,"about_ca_system_score_codex":0.0031046658,"about_ca_system_score_gemma":0.0014745845,"threshold_uncertainty_score":0.8118593},"labels":[],"label_agreement":null},{"id":"W1967883554","doi":"10.1016/j.jval.2014.03.1346","title":"Indirect Comparison Of The Efficacy Of Recombinant Factor Ix Fc Fusion Protein And Other Factor Ix Products For Prophylaxis: Simulating The Effect Of Compliance On Real-World Effectiveness","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Factor IX; Clinical trial; Pre-exposure prophylaxis; Internal medicine; Immunology","score_opus":0.11160240341549436,"score_gpt":0.4026727983690793,"score_spread":0.29107039495358494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1967883554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070716,0.00020180787,0.000008209481,0.0004632184,0.0001289569,0.008408891,0.000019016976,0.000012222494,0.000050526018],"genre_scores_gemma":[0.99960864,0.00000937818,0.00011158563,0.000008960096,0.000047327667,0.000108982545,0.000003491849,0.000026714759,0.00007492238],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99698216,0.0015098957,0.0005306062,0.00030046288,0.000388777,0.00028811948],"domain_scores_gemma":[0.9957975,0.0031857775,0.00041839035,0.00044024072,0.00009816397,0.000059900452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018177375,0.00017939131,0.0008105819,0.00013949537,0.000118581185,0.000004801024,0.00013618062,0.000070275986,0.0000029026514],"category_scores_gemma":[0.0014820717,0.000083883344,0.00008597687,0.00043248176,0.00015407345,0.00001907352,0.00005005076,0.00027288793,8.215712e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041720322,0.0007857019,0.8913651,0.017318299,0.0000656479,3.841284e-7,0.002014582,0.00055899157,0.03448306,0.000101475016,0.000007776369,0.049126927],"study_design_scores_gemma":[0.004090115,0.011550149,0.6628399,0.007321806,0.000016257081,5.7782023e-7,0.000025291281,0.0057405927,0.30821002,0.000040152878,0.00008364044,0.00008152133],"about_ca_topic_score_codex":0.0015736801,"about_ca_topic_score_gemma":0.000049151335,"teacher_disagreement_score":0.27372697,"about_ca_system_score_codex":0.00013283156,"about_ca_system_score_gemma":0.00014932708,"threshold_uncertainty_score":0.34206635},"labels":[],"label_agreement":null},{"id":"W1968405533","doi":"10.1016/s1098-3015(10)65607-0","title":"PPN12 TURKISH MCGILL PAIN QUESTIONNAIRE: RELIABILITY AND VALIDATION","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Turkish; McGill Pain Questionnaire; Reliability (semiconductor); Physical therapy; Psychology; Medicine; Philosophy; Physics","score_opus":0.037345918207389826,"score_gpt":0.3351686657688498,"score_spread":0.29782274756146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968405533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98875153,0.00063046836,0.0015914745,0.007653842,0.00018472529,0.0003581343,0.000004208732,0.000056307712,0.000769329],"genre_scores_gemma":[0.9938367,0.00013486005,0.0020878646,0.0037321635,0.00007824047,0.0000062560484,0.000014387096,0.000009268197,0.00010024403],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987463,0.00027130553,0.00040176508,0.00023150844,0.00010884539,0.00024031257],"domain_scores_gemma":[0.99953204,0.000040986826,0.000069514055,0.00017818598,0.00004232452,0.00013692163],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038913412,0.000079587466,0.000203066,0.00010565146,0.00004671867,0.0000030917483,0.000028913042,0.00008482159,0.000024821098],"category_scores_gemma":[0.0010706257,0.000070607835,0.00003071722,0.00016437308,0.000044662163,0.000063656866,0.000017644401,0.00017558094,0.0000123245545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018533171,0.0007790636,0.8024755,0.0020556203,0.000015942509,0.00012777153,0.0010996368,0.00017328898,0.0022395146,0.013029883,0.0066813272,0.1711371],"study_design_scores_gemma":[0.00075230014,0.0009048106,0.9903295,0.00040432476,0.0000052693686,0.000060878123,0.00007897612,0.0022931714,0.000612441,0.0020758456,0.0024011096,0.00008137653],"about_ca_topic_score_codex":0.00394626,"about_ca_topic_score_gemma":0.00008895603,"teacher_disagreement_score":0.18785396,"about_ca_system_score_codex":0.0001844893,"about_ca_system_score_gemma":0.000060478815,"threshold_uncertainty_score":0.5965591},"labels":[],"label_agreement":null},{"id":"W1968800010","doi":"10.1016/s1098-3015(10)72458-x","title":"PHP78 UNDERSTANDING DRUG REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE COMMON DRUG REVIEW (CDR)","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Business; Medicine; Pharmacology; Political science; Law; Health care","score_opus":0.1478424321879946,"score_gpt":0.33522112337367155,"score_spread":0.18737869118567696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1968800010","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15812808,0.033862505,0.00007536185,0.7770945,0.0026022973,0.0015061854,0.0008093163,0.00002220446,0.025899544],"genre_scores_gemma":[0.9349858,0.028052313,0.00006566096,0.03653293,0.00006398307,0.000046584566,0.000038040896,0.000019316978,0.0001953644],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981422,0.000089749024,0.0010354681,0.0002707169,0.00003326963,0.000428592],"domain_scores_gemma":[0.99891615,0.00027575795,0.00033632468,0.00033396904,0.0000051502593,0.00013267303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023867125,0.00012445335,0.0003933138,0.00010308005,0.0001338215,0.000030265759,0.00029932262,0.00002656685,0.00040781393],"category_scores_gemma":[0.00007478882,0.00012575094,0.000043083917,0.0002748662,0.000030056817,0.000088681445,0.000054246644,0.00058904965,0.000047258487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004774538,0.00008761096,0.03914747,0.0003988235,0.000014488415,0.0000016307442,0.00049348286,0.0004043747,0.0000012435777,0.49969724,0.45692953,0.002819305],"study_design_scores_gemma":[0.00049399846,0.0000093530225,0.0016980285,0.0003119969,0.0000020017612,0.000002437137,0.00020057833,0.01237539,0.0000070068177,0.053244337,0.93142515,0.00022972973],"about_ca_topic_score_codex":0.9280627,"about_ca_topic_score_gemma":0.8929106,"teacher_disagreement_score":0.77685773,"about_ca_system_score_codex":0.001982946,"about_ca_system_score_gemma":0.00047653934,"threshold_uncertainty_score":0.51853347},"labels":[],"label_agreement":null},{"id":"W1969110034","doi":"10.1016/j.jval.2011.02.962","title":"PCN108 CLINICAL EFFICACY AND ONCOLOGY REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE INTERIM JOINT ONCOLOGY DRUG REVIEW (IJODR)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); McMaster University","funders":"","keywords":"Medicine; Clinical endpoint; Internal medicine; Oncology; Reimbursement; Surrogate endpoint; Interim analysis; Clinical trial; Interim; Progression-free survival; Quality of life (healthcare); Cancer; Overall survival; Health care","score_opus":0.7149667211583635,"score_gpt":0.5177786426742309,"score_spread":0.19718807848413256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969110034","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16421719,0.075108625,0.00014370632,0.74691325,0.0031518068,0.003211551,0.00023975834,0.000025639942,0.0069884583],"genre_scores_gemma":[0.4688711,0.15870571,0.005590235,0.36504605,0.00038502153,0.0006167711,0.00012266166,0.00007787101,0.0005845926],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9870915,0.0036594,0.007988765,0.0006217736,0.00007542935,0.00056314183],"domain_scores_gemma":[0.99335754,0.0030990948,0.002725988,0.00053477497,0.000033112137,0.00024948083],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04668404,0.00018015674,0.001507781,0.00017799043,0.00015161461,0.000012037126,0.0003162675,0.00011074863,0.00048759283],"category_scores_gemma":[0.003715466,0.00018574626,0.000061772,0.00023372196,0.00009769039,0.00012513946,0.00011205974,0.0006292775,0.00014485727],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031374635,0.0005725488,0.055867862,0.0013236273,0.000044645843,0.0000054021807,0.0058161193,0.000032301872,1.04235866e-7,0.017659666,0.89380604,0.024840333],"study_design_scores_gemma":[0.0015430341,0.00042515644,0.058601364,0.001342165,0.000005551708,0.000015419677,0.0020876385,0.002050409,5.448192e-7,0.002512958,0.9311543,0.00026146788],"about_ca_topic_score_codex":0.9169831,"about_ca_topic_score_gemma":0.7558437,"teacher_disagreement_score":0.3818672,"about_ca_system_score_codex":0.0058781416,"about_ca_system_score_gemma":0.003816918,"threshold_uncertainty_score":0.9979381},"labels":[],"label_agreement":null},{"id":"W1969129739","doi":"10.1016/j.jval.2012.08.215","title":"PIH6 Cost-Effectiveness of Rotavirus Immunization in Vietnam: Exploring Impacts of Herd Immunity and Patterns of Breastfeedingof","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Herd immunity; Breastfeeding; Vaccination; Medicine; Rotavirus; Immunization; Rotavirus vaccine; Environmental health; Diarrhea; Pediatrics; Immunology; Immune system","score_opus":0.15002575779478663,"score_gpt":0.3885499570710366,"score_spread":0.23852419927625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969129739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745613,0.0014794191,0.00017969524,0.00013926852,0.0000583996,0.00064254913,0.00002260728,0.0000044328267,0.000017520944],"genre_scores_gemma":[0.99684924,0.0028665282,0.00017588117,0.000022030448,0.000021197375,0.00003577192,0.00001743139,0.000011185915,7.408205e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976681,0.0010869048,0.0006074697,0.00009930766,0.00014242443,0.0003958066],"domain_scores_gemma":[0.9991987,0.00018228602,0.00020818326,0.00017863279,0.000071503,0.0001607416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033172274,0.00008781907,0.00059697067,0.00026360195,0.00001550178,0.0000010751477,0.00006221844,0.0000528168,0.000008407536],"category_scores_gemma":[0.0006942868,0.00008174991,0.000035731544,0.00023009666,0.00006860134,0.00014962866,0.00007315583,0.00023397656,3.2250523e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074321625,0.00028909568,0.97015315,0.0029440094,0.000012749026,0.0000014394549,0.00092133635,0.00014046094,0.017061437,0.000077519275,0.0000010277495,0.007654563],"study_design_scores_gemma":[0.0017878242,0.00095692114,0.98998207,0.0027914913,0.0000033060928,0.000023270133,0.00042456502,0.00032807267,0.003636547,0.000025890744,0.0000050698286,0.00003499562],"about_ca_topic_score_codex":0.0388557,"about_ca_topic_score_gemma":0.00016433364,"teacher_disagreement_score":0.038691368,"about_ca_system_score_codex":0.00015017428,"about_ca_system_score_gemma":0.00008887652,"threshold_uncertainty_score":0.9675446},"labels":[],"label_agreement":null},{"id":"W1969206447","doi":"10.1016/s1098-3015(10)61621-x","title":"RX4 PATTERNS OF USE OF COXIBS AND NON-SELECTIVE NSAIDS IN THE ELDERLY POPULATION OF QUEBEC (CANADA)","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Environmental health","score_opus":0.04631080743906615,"score_gpt":0.3135544990431718,"score_spread":0.26724369160410566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969206447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997584,0.00022323105,0.00008399059,0.0014356815,0.000074781834,0.0005366112,0.000026114833,0.0000020097657,0.000033616485],"genre_scores_gemma":[0.99924535,0.00009560077,0.00043715074,0.00018621412,0.000009301397,0.0000059644567,0.0000064725446,0.000008368127,0.0000055527557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779534,0.00085328164,0.000533231,0.00014209776,0.00037798967,0.00029806278],"domain_scores_gemma":[0.9989416,0.00052275567,0.00021969038,0.00018143513,0.00006583017,0.00006865966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011754885,0.00007614967,0.00028890063,0.00019033135,0.000041950116,0.0000055038336,0.00007989183,0.000054110616,0.000004595431],"category_scores_gemma":[0.00032922783,0.000062306935,0.000020227013,0.00037711434,0.000040957108,0.00008605304,0.00000783043,0.00023787809,8.326143e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018630475,0.00015331547,0.9876745,0.0011626338,0.0000048620977,0.0000017493929,0.003172611,0.0008088984,0.00044855193,0.0011322575,0.00019562875,0.0050587244],"study_design_scores_gemma":[0.0006265491,0.0007562446,0.9931735,0.0003632727,0.000001941496,0.000001744223,0.00069744146,0.00087823323,0.002963518,0.00042842992,0.00005885564,0.000050282822],"about_ca_topic_score_codex":0.9819589,"about_ca_topic_score_gemma":0.94565064,"teacher_disagreement_score":0.03630824,"about_ca_system_score_codex":0.00028288126,"about_ca_system_score_gemma":0.00067503983,"threshold_uncertainty_score":0.2540803},"labels":[],"label_agreement":null},{"id":"W1969317201","doi":"10.1016/j.jval.2013.03.674","title":"Incremental Cost Of Brain Metastases Among Patients With Metastatic Melanoma","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Brain metastasis; Emergency department; Melanoma; Retrospective cohort study; Metastatic melanoma; Internal medicine; Population; Metastasis; Emergency medicine; Pediatrics; Cancer","score_opus":0.03632281848010789,"score_gpt":0.24369294415924497,"score_spread":0.2073701256791371,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969317201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408877,0.00084501464,0.00044215028,0.00061429973,0.0001377253,0.0009140104,0.00036034206,0.000011609316,0.0025860684],"genre_scores_gemma":[0.99751645,0.00007419057,0.0015352543,0.0006406276,0.000021690774,0.00006844909,0.000031663403,0.000024169898,0.00008748886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831444,0.00004680172,0.0009295685,0.00028182918,0.00004608104,0.0003812663],"domain_scores_gemma":[0.99879235,0.000111032634,0.000683214,0.00023784967,0.000034367065,0.00014116104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067600905,0.00015080362,0.000590318,0.00025968679,0.0000469825,0.000029380075,0.00016024492,0.000036092864,0.00052582414],"category_scores_gemma":[0.00012843037,0.00015086152,0.000055203294,0.00021345084,0.000096350974,0.00049137336,0.000034579472,0.00011680539,0.00014429826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026814685,0.00020405815,0.96468437,0.00010770754,0.00004361325,7.55087e-7,0.0003296208,0.0009951344,8.554434e-7,0.028914202,0.001515994,0.0031768822],"study_design_scores_gemma":[0.0018406844,0.0004545738,0.9866897,0.00007931938,0.0000031662344,5.3736795e-7,0.000095123796,0.0013012931,0.000029146098,0.006325359,0.0029709516,0.00021016774],"about_ca_topic_score_codex":0.04485031,"about_ca_topic_score_gemma":0.00039245575,"teacher_disagreement_score":0.044457853,"about_ca_system_score_codex":0.0002594027,"about_ca_system_score_gemma":0.00008545026,"threshold_uncertainty_score":0.9615101},"labels":[],"label_agreement":null},{"id":"W1969707302","doi":"10.1016/s1098-3015(10)61967-5","title":"PPN1 TOPIRAMATE FOR THE TREATMENT OF PERIPHERAL DIABETIC NEUROPATHY: CANADIAN CLINICAL EXPERIENCE","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Neurological Disorders and Treatments","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Topiramate; Peripheral neuropathy; Medicine; Peripheral; Diabetic neuropathy; Diabetes mellitus; Internal medicine; Endocrinology; Psychiatry","score_opus":0.1567455549542584,"score_gpt":0.3745554657895177,"score_spread":0.2178099108352593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969707302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99630785,0.00042505658,0.00002672922,0.001543316,0.00046169473,0.00087660854,0.000021206215,0.000011780751,0.00032575964],"genre_scores_gemma":[0.995483,0.0012563741,0.000082480714,0.0029311639,0.000017173435,0.0001378263,5.1021425e-7,0.000010287862,0.0000812281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983083,0.00046630346,0.0003814185,0.0003315946,0.00010063107,0.00041175174],"domain_scores_gemma":[0.9987148,0.0007551661,0.00008745138,0.00025748467,0.000010289458,0.00017479801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018953587,0.000112123715,0.00021926177,0.000035439636,0.00016597779,0.000015543003,0.00014000313,0.000036629423,0.000028592474],"category_scores_gemma":[0.0004328163,0.00006963407,0.000086656175,0.00016200657,0.00012169603,0.000029773535,0.0000055355454,0.00006099912,0.000004716919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027414283,0.005000565,0.804602,0.00013279806,0.000019310519,0.00019937976,0.008210018,0.0072738687,0.0008209116,0.065839894,0.00019091777,0.107436195],"study_design_scores_gemma":[0.015688485,0.03592387,0.5556112,0.00010761959,0.000055022163,0.000046927187,0.0009317929,0.04577685,0.013077198,0.025141533,0.3065201,0.0011193894],"about_ca_topic_score_codex":0.021826742,"about_ca_topic_score_gemma":0.0025194045,"teacher_disagreement_score":0.30632916,"about_ca_system_score_codex":0.00008867202,"about_ca_system_score_gemma":0.00021827439,"threshold_uncertainty_score":0.984687},"labels":[],"label_agreement":null},{"id":"W1969916397","doi":"10.1016/j.jval.2013.03.211","title":"Examination of patient preferences: subgroup comparisons of time trade-off and standard gamble results","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University; PharmIdeas (Canada); Université de Montréal","funders":"","keywords":"Rank correlation; Correlation; Post hoc; Medicine; Spearman's rank correlation coefficient; Demography; Post-hoc analysis; Positive correlation; Statistics; Internal medicine; Mathematics","score_opus":0.07920540595452429,"score_gpt":0.27737406434152034,"score_spread":0.19816865838699604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969916397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98706275,0.0020383247,0.00021125966,0.003844751,0.00008800007,0.00072342635,0.00030051533,0.000011035442,0.005719927],"genre_scores_gemma":[0.99769163,0.0011583053,0.0009185179,0.00013000674,0.000010659654,0.000022178938,0.000014620549,0.0000065680406,0.000047524616],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99839485,0.00009453045,0.0010414679,0.00020644553,0.00005204433,0.00021068689],"domain_scores_gemma":[0.99906397,0.00011580408,0.00054005615,0.00018008378,0.000019468389,0.00008059451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011031522,0.00007540183,0.00037963397,0.00023008589,0.000029776158,0.000009308251,0.00007380505,0.00005019076,0.000037350797],"category_scores_gemma":[0.00010057589,0.00008290601,0.000022660704,0.00018166513,0.0000399469,0.000103363665,0.00003006086,0.000080385566,0.00001751919],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019427067,0.0009419174,0.0499428,0.004219954,0.0000805611,0.0000011699851,0.035087764,0.0048391023,0.000016602573,0.67200726,0.010099357,0.22256923],"study_design_scores_gemma":[0.0029018559,0.0033242488,0.8164115,0.00067811453,0.000005660707,0.0000013965209,0.0015194984,0.058186118,0.00024567702,0.043602396,0.07268262,0.0004408959],"about_ca_topic_score_codex":0.037988517,"about_ca_topic_score_gemma":0.00020995284,"teacher_disagreement_score":0.7664687,"about_ca_system_score_codex":0.00009540309,"about_ca_system_score_gemma":0.000047434733,"threshold_uncertainty_score":0.9684176},"labels":[],"label_agreement":null},{"id":"W1970090444","doi":"10.1016/s1098-3015(10)75265-7","title":"PSS28 COST-EFFECTIVENESS OF USTEKINUMAB VERSUS ETANERCEPT IN SEVERE PLAQUE PSORIASIS PATIENTS: A CANADIAN PERSPECTIVE","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ustekinumab; Etanercept; Plaque psoriasis; Medicine; Dermatology; Perspective (graphical); Psoriasis; Internal medicine; Adalimumab; Tumor necrosis factor alpha; Computer science; Artificial intelligence","score_opus":0.30958894698844674,"score_gpt":0.4208621471682949,"score_spread":0.11127320017984815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970090444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96543336,0.0017190418,0.00011333812,0.019354396,0.0012973598,0.003510629,0.0007705763,0.000031561744,0.0077697095],"genre_scores_gemma":[0.996595,0.00020135926,0.0004905145,0.0024259978,0.000090055386,0.00010350065,0.00004612292,0.000026028405,0.00002141848],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99378043,0.0014698189,0.0032278376,0.0006617244,0.00012156064,0.000738618],"domain_scores_gemma":[0.9961432,0.0016192715,0.0012812722,0.00046452277,0.00011750533,0.00037421432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013740146,0.0002306108,0.001261948,0.001173591,0.00010535929,0.000025734353,0.00027930396,0.00021992397,0.00012130731],"category_scores_gemma":[0.0035298734,0.00032067893,0.00010082769,0.0006766631,0.000047778904,0.00035008095,0.000018903258,0.00035016573,0.00018313632],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079508324,0.0009012346,0.381814,0.0013634284,0.000077769124,0.000008716595,0.023995178,0.043988083,5.529021e-7,0.5427573,0.002436193,0.0018624763],"study_design_scores_gemma":[0.010275774,0.0011146187,0.93556195,0.00089996605,0.0000041921503,0.0000036200288,0.006305316,0.007184739,0.0000026765238,0.033503745,0.004515466,0.0006279082],"about_ca_topic_score_codex":0.70731854,"about_ca_topic_score_gemma":0.15788037,"teacher_disagreement_score":0.55374795,"about_ca_system_score_codex":0.01082864,"about_ca_system_score_gemma":0.001578463,"threshold_uncertainty_score":0.99992454},"labels":[],"label_agreement":null},{"id":"W1970310544","doi":"10.1016/s1098-3015(10)61081-9","title":"PMH15 PREVALENCE AND COSTS OF TREATMENT-RESISTANT DEPRESSION IN A CANADIAN CLAIMS DATABASE","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Depression (economics); Treatment-resistant depression; Database; Medicine; Business; Psychiatry; Computer science; Economics; Major depressive disorder","score_opus":0.18937100839147772,"score_gpt":0.40805489499402336,"score_spread":0.21868388660254565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970310544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99515355,0.002450941,0.00038069158,0.00027945847,0.000025524365,0.00089254184,0.00014084046,0.000051953837,0.0006244726],"genre_scores_gemma":[0.9828907,0.002640033,0.014295145,0.00004930969,0.000006932997,0.000047024747,0.00000398206,0.000014582402,0.000052262138],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99869484,0.00021626655,0.00040232262,0.000223414,0.00010430224,0.00035884316],"domain_scores_gemma":[0.998962,0.00035504712,0.0001283282,0.00032768943,0.00001911547,0.0002078167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052019686,0.0001179593,0.00025373034,0.000227184,0.000034020624,0.000005525052,0.00009272954,0.000059934013,0.000040809493],"category_scores_gemma":[0.00025906798,0.00010576699,0.000013438277,0.00019667059,0.0000450018,0.00011393574,0.000025187463,0.00011436694,0.0000017508668],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014272088,0.001358317,0.7541128,0.0053277113,0.000024843703,0.00026628078,0.009980057,0.0004258585,0.0035941976,0.14144275,0.0013166913,0.08200777],"study_design_scores_gemma":[0.013432639,0.009078277,0.17147034,0.05401884,0.00011170208,0.00020858625,0.0018961935,0.2071204,0.0262567,0.5071232,0.005695988,0.003587159],"about_ca_topic_score_codex":0.44734964,"about_ca_topic_score_gemma":0.29836148,"teacher_disagreement_score":0.58264244,"about_ca_system_score_codex":0.0011510894,"about_ca_system_score_gemma":0.00020584704,"threshold_uncertainty_score":0.7144416},"labels":[],"label_agreement":null},{"id":"W1970411568","doi":"10.1016/s1098-3015(10)72921-1","title":"PIN14 REDUCTION OF ACUTE OTITIS MEDIA IN CHILDREN: A COST-CONSEQUENCE ANALYSIS OF A 7-, 10-AND 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN CANADA","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acute otitis media; Pneumococcal conjugate vaccine; Conjugate; Reduction (mathematics); Medicine; Otitis; Conjugate vaccine; Pediatrics; Streptococcus pneumoniae; Microbiology; Immunology; Mathematics; Surgery; Biology; Immunization","score_opus":0.014390081505446545,"score_gpt":0.2774793763016168,"score_spread":0.26308929479617027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970411568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99680847,0.00013755528,0.0000026581567,0.0021306935,0.00019681781,0.00058928295,0.00009615115,0.000006814278,0.00003154588],"genre_scores_gemma":[0.99915284,0.0005359554,0.00003773407,0.00016610442,0.000030630606,0.00003321584,0.000026326832,0.000009073194,0.000008116128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828327,0.00016543687,0.0008121519,0.00025767987,0.00021141699,0.00027006064],"domain_scores_gemma":[0.99915045,0.00010894618,0.00024573435,0.00025067895,0.00006824495,0.00017593155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055168837,0.00012367466,0.0006627002,0.0008358664,0.000025173267,0.0000024467545,0.00006201454,0.000085648186,0.00004967691],"category_scores_gemma":[0.00015303989,0.00011517633,0.000056834815,0.0013455423,0.00007623479,0.000045438457,0.000020837688,0.00042430637,6.089269e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006372531,0.00013441336,0.96050686,0.00010442361,0.00014638982,0.000038478916,0.00046197293,0.001556969,0.036202837,0.000049719616,0.00001809184,0.00071613386],"study_design_scores_gemma":[0.0013264347,0.0001713465,0.99357617,0.00019295995,0.0001477956,0.00018495834,0.00008490821,0.0027851537,0.0013713064,0.00002955107,0.000047426955,0.00008199279],"about_ca_topic_score_codex":0.86860144,"about_ca_topic_score_gemma":0.8747997,"teacher_disagreement_score":0.03483153,"about_ca_system_score_codex":0.00037481554,"about_ca_system_score_gemma":0.0022295823,"threshold_uncertainty_score":0.46967545},"labels":[],"label_agreement":null},{"id":"W1970724291","doi":"10.1046/j.1524-4733.2001.40202-274.x","title":"PHP14: COST ANALYSIS OF PHARMACEUTICAL SERVICES IN A TEACHING INSTITUTION","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Institution; Business; Computer science; Sociology; Social science","score_opus":0.165586853516898,"score_gpt":0.47971218228590284,"score_spread":0.31412532876900484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970724291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98165214,0.0034864037,0.000121924466,0.009136379,0.0000941959,0.00039814375,0.00000675493,0.000018942692,0.0050850934],"genre_scores_gemma":[0.99176073,0.0052871597,0.00032375942,0.0025334093,0.000050759892,0.0000117972695,0.0000109864795,0.0000051020415,0.000016321503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984853,0.00028913,0.0004961978,0.00019572151,0.00022917455,0.00030447682],"domain_scores_gemma":[0.9992735,0.0003036749,0.00012402727,0.00012021898,0.000023528204,0.00015507957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015489013,0.000091857415,0.0004497377,0.00036978352,0.00006219812,0.0000064322717,0.00006390698,0.0000480087,0.00008742973],"category_scores_gemma":[0.00013501961,0.00007870795,0.000066532346,0.0010919995,0.000043395383,0.00011812679,0.000037957194,0.00044839783,0.0000063897787],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007084432,0.0008559075,0.9128921,0.0007629473,0.0002978216,0.000081218444,0.0018980294,0.008623457,0.00019193186,0.0020448281,0.000027217675,0.07161608],"study_design_scores_gemma":[0.002936576,0.00021394601,0.4669885,0.0005259573,0.00048505663,0.000024906845,0.0007864777,0.3716895,0.00007593626,0.00010603351,0.156025,0.00014208783],"about_ca_topic_score_codex":0.014098891,"about_ca_topic_score_gemma":0.000851393,"teacher_disagreement_score":0.4459036,"about_ca_system_score_codex":0.00021857659,"about_ca_system_score_gemma":0.000093311464,"threshold_uncertainty_score":0.99246633},"labels":[],"label_agreement":null},{"id":"W1970946065","doi":"10.1016/j.jval.2012.03.044","title":"DR3 Establishment of an Innovative Collaborative Between the Drug Safety and Effectiveness Network in Canada and ISPOR for Application and Development of Network Meta-Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Knowledge translation; General partnership; Systematic review; Collaborative network; Best practice; Knowledge management; Medicine; Management science; Medical education; Process management; Computer science; Engineering; Business; MEDLINE; Political science","score_opus":0.47159501745563465,"score_gpt":0.4677137395965703,"score_spread":0.003881277859064336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970946065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594846,0.00950933,0.02745597,0.00038064554,0.000034645887,0.003032325,0.000080808895,7.375241e-7,0.000020975045],"genre_scores_gemma":[0.9860884,0.000054096097,0.013550812,0.00007237619,0.000024429644,0.00017798392,0.000018846597,0.0000048822553,0.000008167051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9832941,0.009508184,0.005267591,0.0004977055,0.0011361137,0.00029628596],"domain_scores_gemma":[0.98511094,0.00996334,0.0035279915,0.000675805,0.00060156855,0.00012034933],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13195594,0.00017878348,0.0037498942,0.00020799779,0.00013178716,0.000044549193,0.00026603864,0.00003330706,0.000017123077],"category_scores_gemma":[0.0013349334,0.00008713325,0.00012535499,0.004346005,0.000057376383,0.00015470301,0.000077680575,0.00008263363,1.8874913e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036366717,0.000026080745,0.9550465,0.00022676797,0.004067287,5.4094553e-8,0.0052398723,0.020652443,7.0744676e-7,0.0015131509,0.00012333471,0.01306749],"study_design_scores_gemma":[0.00023581946,0.0000303539,0.9833268,0.00002455329,0.0021017096,2.073058e-7,0.0018466663,0.0083899,0.00001526817,0.0009979405,0.002928828,0.00010196802],"about_ca_topic_score_codex":0.14536111,"about_ca_topic_score_gemma":0.37184256,"teacher_disagreement_score":0.22648145,"about_ca_system_score_codex":0.00016303452,"about_ca_system_score_gemma":0.0007900175,"threshold_uncertainty_score":0.89383405},"labels":[],"label_agreement":null},{"id":"W1971335991","doi":"10.1016/j.jval.2013.03.112","title":"Why are the findings of cost-effectiveness analyses of biologic treatment for rheumatoid arthritis so different?","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Medicine; Cost effectiveness; Rheumatoid arthritis; Cost–benefit analysis; Confidence interval; Intensive care medicine; Actuarial science; Risk analysis (engineering); Internal medicine; Economics","score_opus":0.5440513385772044,"score_gpt":0.462304561334613,"score_spread":0.08174677724259144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971335991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97323036,0.008358573,0.0015646154,0.012573176,0.00025931504,0.0034800014,0.0004873585,0.00001382372,0.000032796845],"genre_scores_gemma":[0.9931267,0.0038447937,0.00042520207,0.0016558642,0.000039384937,0.00084642036,0.000030563766,0.000018053981,0.000013045619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99520266,0.00079700217,0.0032066812,0.00036631466,0.000056319128,0.00037102602],"domain_scores_gemma":[0.9933008,0.0038147129,0.0023190917,0.00040091292,0.00006988978,0.00009458952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068293964,0.0001754245,0.00142607,0.0003042649,0.00013618435,0.000026713886,0.00020892196,0.00010126709,0.00009225268],"category_scores_gemma":[0.0015252094,0.00014590839,0.00018287331,0.00020362681,0.00011831673,0.0001343444,0.000025745148,0.00007736365,0.00005194086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047237638,0.00049901614,0.9532008,0.0018136242,0.00015318359,1.5114902e-7,0.0018713025,0.0042789043,0.000035808855,0.033650946,0.002603697,0.0018453165],"study_design_scores_gemma":[0.0038375056,0.0013223778,0.92794234,0.0014378021,0.000005702524,0.0000035052738,0.0019956378,0.017845165,0.00060855225,0.035921354,0.008693218,0.000386824],"about_ca_topic_score_codex":0.05153278,"about_ca_topic_score_gemma":0.0007646472,"teacher_disagreement_score":0.050768133,"about_ca_system_score_codex":0.00064134644,"about_ca_system_score_gemma":0.00014992982,"threshold_uncertainty_score":0.95478314},"labels":[],"label_agreement":null},{"id":"W1971405938","doi":"10.1016/j.jval.2012.03.891","title":"PRM35 Empirical Examination of Starting Point Bias with the Bidding Game in a Willingness-to-Pay Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Consumer Market Behavior and Pricing","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; PharmIdeas (Canada); Université de Montréal","funders":"","keywords":"Bidding; Willingness to pay; Actuarial science; Preference; Population; Medicine; Economics; Environmental health; Microeconomics","score_opus":0.09765982867390809,"score_gpt":0.3187534071860312,"score_spread":0.22109357851212308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1971405938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99548465,0.00012913566,0.0009263784,0.0025815493,0.00007870535,0.00033877825,8.742788e-7,0.000024963798,0.00043494208],"genre_scores_gemma":[0.9987895,0.0000068706313,0.0002585922,0.0007589429,0.00012980036,0.000020101621,0.0000055448013,0.00001526652,0.000015371801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984506,0.00015068703,0.00049755233,0.00019520352,0.00029416385,0.0004118198],"domain_scores_gemma":[0.99907404,0.0003166633,0.00032107852,0.00020446049,0.00005905299,0.000024685593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004756839,0.00012407612,0.00029938208,0.0007852874,0.00007650115,0.000057474434,0.00013393785,0.0000347982,0.000041427713],"category_scores_gemma":[0.00023379334,0.00007998225,0.00005134631,0.0033542416,0.000024834302,0.00045881773,0.00007820643,0.00019509789,0.0000063905673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024071694,0.00007330472,0.9761299,0.00014573814,0.000013101611,0.0000012924188,0.0023269833,0.0051430175,0.000022792781,0.00017280605,0.000016817814,0.015930196],"study_design_scores_gemma":[0.00022673534,0.000012920739,0.97145677,0.00015810343,0.000065000066,3.6915773e-7,0.0010326223,0.02612094,0.000010047827,0.000033794393,0.0007720288,0.000110669425],"about_ca_topic_score_codex":0.0103200115,"about_ca_topic_score_gemma":0.0015152629,"teacher_disagreement_score":0.020977924,"about_ca_system_score_codex":0.000089431414,"about_ca_system_score_gemma":0.000039486058,"threshold_uncertainty_score":0.99627036},"labels":[],"label_agreement":null},{"id":"W1972092694","doi":"10.1016/s1098-3015(10)65093-0","title":"PMH43 POTENTIAL DRUG-DRUG INTERACTIONS WITH RISPERIDONE AND THE RISK OF DISCONTINUATION: A RETROSPECTIVE ANALYSIS OF PATIENTS IN QUEBEC, CANADA","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Discontinuation; Risperidone; Drug; Medicine; Retrospective cohort study; Pharmacology; Internal medicine; Psychiatry; Schizophrenia (object-oriented programming)","score_opus":0.015473192956747525,"score_gpt":0.3206852237765723,"score_spread":0.3052120308198248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972092694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935978,0.0006158779,0.000077465076,0.005022989,0.00006993348,0.00035376858,0.0000348225,0.000001994223,0.0002253433],"genre_scores_gemma":[0.9987741,0.0008504375,0.0000908644,0.00017431083,0.000021904183,0.00000516151,0.00000807174,0.000003855864,0.00007126168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987985,0.00022516432,0.000433423,0.00013307344,0.00025736177,0.00015247734],"domain_scores_gemma":[0.9988368,0.0005388118,0.00035883585,0.00010747157,0.00009339978,0.000064636704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009838563,0.00006996951,0.0004048175,0.0001331702,0.00005643174,0.0000037590369,0.000034051824,0.000009593799,0.000022637452],"category_scores_gemma":[0.00024124757,0.000042319705,0.0000376574,0.00073176343,0.00010757379,0.00006446722,0.000023549037,0.00023970351,7.440053e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012398998,0.00018660833,0.9924594,0.0000445725,0.00035737135,0.000003864828,0.002916904,0.00087113824,0.0000015797315,0.000099461126,0.00010301575,0.0017161503],"study_design_scores_gemma":[0.002338152,0.000044906275,0.9896286,0.00007461845,0.00035582072,4.4081665e-7,0.002046666,0.0049692616,0.000026319929,0.000018683204,0.00045893106,0.00003758305],"about_ca_topic_score_codex":0.9870243,"about_ca_topic_score_gemma":0.9933848,"teacher_disagreement_score":0.006360475,"about_ca_system_score_codex":0.00028118887,"about_ca_system_score_gemma":0.0001951363,"threshold_uncertainty_score":0.17257474},"labels":[],"label_agreement":null},{"id":"W1972734786","doi":"10.1016/j.jval.2011.02.751","title":"PMS68 ANALYSIS OF INFLIXIMAB DOSE CHANGES OVER TIME IN MEDICARE BENEFICIARIES WITH RHEUMATOID ARTHRITIS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Dosing; Infliximab; Rheumatoid arthritis; Medicaid; Quarter (Canadian coin); Internal medicine; Disease","score_opus":0.030209241115813586,"score_gpt":0.2812213840236658,"score_spread":0.25101214290785223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972734786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97302985,0.024848256,0.000010447262,0.0009243392,0.000027304843,0.00046654372,0.000045661167,0.00003479597,0.000612777],"genre_scores_gemma":[0.91628045,0.082798444,0.0005878585,0.00018251932,0.0000117817535,0.000045029683,0.00004473992,0.00002262694,0.000026541193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774396,0.0001893814,0.00060314365,0.00031185878,0.0006179001,0.00053377205],"domain_scores_gemma":[0.99890035,0.00018969139,0.00018191565,0.00038499216,0.000100079866,0.00024299092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009864041,0.00017339321,0.00092378235,0.0012168922,0.000049154136,0.000010527655,0.00012916206,0.0001019023,0.00077656435],"category_scores_gemma":[0.00019096343,0.00014269637,0.00007604487,0.0015254308,0.00018264605,0.00009929342,0.00004522047,0.00030844097,0.000012555399],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019215439,0.0011272192,0.87341076,0.0005303639,0.0009364198,0.0002865496,0.04654191,0.00044281784,0.00020190951,0.0044488264,0.0001631904,0.06998848],"study_design_scores_gemma":[0.009692538,0.0031648343,0.96505994,0.0065914746,0.000019620202,0.00006745537,0.002914274,0.008652389,0.00064847805,0.0011152264,0.0016743947,0.00039940138],"about_ca_topic_score_codex":0.02906863,"about_ca_topic_score_gemma":0.024739783,"teacher_disagreement_score":0.09164915,"about_ca_system_score_codex":0.00010888212,"about_ca_system_score_gemma":0.00047753841,"threshold_uncertainty_score":0.9930562},"labels":[],"label_agreement":null},{"id":"W1972895961","doi":"10.1111/j.1524-4733.2010.00749.x","title":"Contemporary Challenges in Deriving Summary Estimates of Comparative Effectiveness Using Meta-Analysis","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Technology Assessment and Management","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Meta-analysis; Econometrics; Data science; Computer science; Economics; Medicine; Internal medicine","score_opus":0.2589534241723927,"score_gpt":0.37356113978385524,"score_spread":0.11460771561146255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972895961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790215,0.015097888,0.004290751,0.00018669128,0.00013197633,0.00042582783,0.0000052964724,0.00012283598,0.000717247],"genre_scores_gemma":[0.9936528,0.0002039062,0.006080563,0.0000057365687,0.000004492426,0.000037350463,0.0000038370604,0.000010479369,8.102807e-7],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99904597,0.00014464337,0.00035791425,0.00017400253,0.00008888644,0.00018860065],"domain_scores_gemma":[0.9993286,0.00033365577,0.000082187835,0.00021566506,0.000012875587,0.000027029571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010129289,0.00012927326,0.0008436432,0.00059162185,0.000019827348,0.0000049379523,0.00012129281,0.00007520227,0.000008364308],"category_scores_gemma":[0.000013005872,0.00012375395,0.00011781275,0.00047928822,0.000039440827,0.000102515274,0.000042589934,0.0002460437,6.0368745e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015241403,0.00018116912,0.070404984,0.0016285472,0.013378802,0.000017228447,0.0014420338,0.8994164,0.0031905393,0.009480164,0.0000203475,0.00082454877],"study_design_scores_gemma":[0.0006573458,0.00009601362,0.16975877,0.00012782216,0.0031449255,0.0000016483219,0.00089628546,0.8160417,0.0052936603,0.003495111,0.00012239415,0.0003643481],"about_ca_topic_score_codex":0.001510414,"about_ca_topic_score_gemma":0.00078606955,"teacher_disagreement_score":0.099353775,"about_ca_system_score_codex":0.0000635792,"about_ca_system_score_gemma":0.00003520913,"threshold_uncertainty_score":0.504654},"labels":[],"label_agreement":null},{"id":"W1972926194","doi":"10.1016/s1098-3015(10)74749-5","title":"PMH30 A DYNAMIC MARKOV APPROACH ASSESSING THE BURDEN OF ILLNESS OF GENERALIZED ANXIETY (GAD) DISORDER IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Generalized anxiety disorder; Psychiatry; Anxiety; Markov chain; Psychology; Computer science; Machine learning","score_opus":0.031004992854886625,"score_gpt":0.32127003824042577,"score_spread":0.29026504538553916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972926194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98662454,0.0006199672,0.00035694445,0.010788208,0.00007477033,0.00076686265,0.000017402293,0.000011403853,0.00073991047],"genre_scores_gemma":[0.99862015,0.000519722,0.0004989215,0.00027157075,0.000011136614,0.000021836548,0.00000298319,0.000018196037,0.000035496232],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9963874,0.0011352662,0.000697839,0.00042092224,0.00071719434,0.0006413549],"domain_scores_gemma":[0.99885625,0.00029149928,0.00026379531,0.000492678,0.00001224337,0.00008353878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011019298,0.00015654367,0.00040583557,0.00018796115,0.00011159709,0.000019969571,0.0005982987,0.00005034988,0.000018948724],"category_scores_gemma":[0.0002664636,0.00012413558,0.000044791825,0.0013494184,0.000116813506,0.000117834825,0.00008936137,0.00041948745,4.9475886e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003245041,0.0016940851,0.10382539,0.0022420082,0.000016683636,0.00006845213,0.025647633,0.6590543,0.024637358,0.047258373,0.00027979264,0.13495144],"study_design_scores_gemma":[0.0015497518,0.00010779785,0.12242502,0.00018798416,0.0000026673524,0.000023287404,0.0023861332,0.8659576,0.0011619974,0.005683451,0.00023627069,0.00027801032],"about_ca_topic_score_codex":0.948501,"about_ca_topic_score_gemma":0.27387404,"teacher_disagreement_score":0.67462695,"about_ca_system_score_codex":0.0006780203,"about_ca_system_score_gemma":0.002993501,"threshold_uncertainty_score":0.7393759},"labels":[],"label_agreement":null},{"id":"W1972980211","doi":"10.1046/j.1524-4733.2001.40202-297.x","title":"PMA3: DOES WHERE YOU LIVE AFFECT IF AND HOW YOU DISCOUNT FUTURE COSTS AND BENEFITS IN ECONOMIC EVALUATION? SHOULD IT?","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Affect (linguistics); Economics; Public economics; Business; Psychology","score_opus":0.2715108484049103,"score_gpt":0.4127739445030147,"score_spread":0.1412630960981044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972980211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78136516,0.026031284,0.00002661458,0.18902056,0.0009457883,0.0018151149,0.00032342973,0.000027476839,0.00044455487],"genre_scores_gemma":[0.970422,0.02218631,0.0005702018,0.005424173,0.0007854661,0.0002639863,0.000053932283,0.00005657014,0.00023733228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99437106,0.0010177813,0.0026464318,0.0010641714,0.00015769141,0.0007428818],"domain_scores_gemma":[0.9966239,0.0009855599,0.0014600786,0.0005359381,0.0000442285,0.00035034042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.025194878,0.0003471892,0.0012649429,0.00063919724,0.00022233103,0.00020045726,0.00022277124,0.0002851951,0.00024238463],"category_scores_gemma":[0.00091707666,0.0003797992,0.000068278394,0.00022676289,0.00009345374,0.0007913843,0.000084627056,0.0004029365,0.00018288771],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049041053,0.00012934892,0.936686,0.00087352435,0.00003833224,0.000003412485,0.007734915,0.0072806003,3.2751646e-7,0.036828887,0.0053202817,0.0050553605],"study_design_scores_gemma":[0.004465643,0.00040729274,0.7848915,0.0010970063,0.000013649203,0.00004218768,0.01291939,0.13710552,0.000001050017,0.0122003425,0.04585914,0.0009973177],"about_ca_topic_score_codex":0.02018321,"about_ca_topic_score_gemma":0.023013154,"teacher_disagreement_score":0.18905686,"about_ca_system_score_codex":0.0028583612,"about_ca_system_score_gemma":0.00051342056,"threshold_uncertainty_score":0.9998654},"labels":[],"label_agreement":null},{"id":"W1972985601","doi":"10.1016/s1098-3015(10)74825-7","title":"PND31 HEALTH UTILITY SCORES ASSOCIATED WITH A HYPOTHETICAL MODERATE ALZHEIMER'S DISEASE HEALTH STATE: A CANADIAN SURVEY OF THE GENERAL PUBLIC","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Public Health Policies and Education","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Public health; Gerontology; State (computer science); Medicine; Alzheimer's disease; Psychology; Psychiatry; Computer science; Pathology","score_opus":0.2160236708222191,"score_gpt":0.4403588013999428,"score_spread":0.22433513057772372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1972985601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62234366,0.002289022,0.000084226114,0.3690047,0.0008192446,0.0036445842,0.0013273769,0.000086286425,0.00040093175],"genre_scores_gemma":[0.9401478,0.00045092657,0.0002027002,0.058527645,0.00012812292,0.00010398241,0.00025792266,0.000044552595,0.0001363189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9822661,0.011250072,0.0021071148,0.00061516656,0.000714172,0.0030473496],"domain_scores_gemma":[0.99295074,0.00083535083,0.0012734747,0.00096038816,0.00048219867,0.0034978755],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.012395926,0.0003511112,0.00096405315,0.00042591363,0.0019712944,0.00003610172,0.000508673,0.00017965076,0.00007562195],"category_scores_gemma":[0.0018501831,0.00025895113,0.00008047665,0.0018268678,0.00019876148,0.00019775504,0.00006213698,0.0012790569,0.000012433851],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037690718,0.0012291364,0.8749899,0.0007780148,0.00006848167,0.0000029862506,0.019430012,0.0025304127,2.2937998e-7,0.016014092,0.065606706,0.018973064],"study_design_scores_gemma":[0.0008936282,0.00040103882,0.9809145,0.00069409236,0.0000040702294,0.0000010386475,0.00029348835,0.010809192,1.6280943e-7,0.0015121953,0.0042831446,0.00019349315],"about_ca_topic_score_codex":0.95418143,"about_ca_topic_score_gemma":0.8086541,"teacher_disagreement_score":0.3178042,"about_ca_system_score_codex":0.003411389,"about_ca_system_score_gemma":0.11093561,"threshold_uncertainty_score":0.9999863},"labels":[],"label_agreement":null},{"id":"W1973090847","doi":"10.1016/j.jval.2012.06.011","title":"Dynamic Transmission Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-5","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 epidemiological studies","field":"Mathematics","cited_by":228,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier universitaire de Québec; Western University; Public Health Ontario; University of Toronto","funders":"","keywords":"Task force; Transmission (telecommunications); Set (abstract data type); Task (project management); Computer science; Population; Intervention (counseling); Disease transmission; Management science; Medicine; Risk analysis (engineering); Engineering; Environmental health; Virology; Political science; Systems engineering; Telecommunications","score_opus":0.6358651762576123,"score_gpt":0.5585132473413879,"score_spread":0.07735192891622444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973090847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8917309,0.0049376474,0.08145233,0.019320944,0.00020071428,0.0014633206,0.000007004055,0.00007835692,0.0008087613],"genre_scores_gemma":[0.9812997,0.0009422121,0.017244352,0.00020431803,0.000061450446,0.000054849752,0.0000019524766,0.000027611204,0.00016358537],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99508697,0.001464864,0.0014126123,0.00039479858,0.0007772289,0.00086355006],"domain_scores_gemma":[0.9941147,0.004018087,0.00080749934,0.0007058785,0.00017584224,0.00017801665],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.021154316,0.00017815483,0.00057446474,0.00012863633,0.0003312658,0.000009723128,0.00038000575,0.00016219068,0.000010436264],"category_scores_gemma":[0.015148702,0.000111216155,0.00014306625,0.00055289466,0.00008030005,0.00017387336,0.00022228679,0.0008271733,0.0000034867799],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028628387,0.0017373639,0.046124697,0.0058913636,0.00010779651,0.000022631397,0.02049085,0.85940135,0.0007156554,0.060487907,0.0007946255,0.0039394815],"study_design_scores_gemma":[0.00019748758,0.000073488656,0.0003069796,0.00044648707,0.000011452371,0.000019152381,0.0007304459,0.87348896,0.000010857527,0.1239041,0.0007090929,0.000101472244],"about_ca_topic_score_codex":0.009438826,"about_ca_topic_score_gemma":0.00013187897,"teacher_disagreement_score":0.08956875,"about_ca_system_score_codex":0.00053247245,"about_ca_system_score_gemma":0.0004278782,"threshold_uncertainty_score":0.9971574},"labels":[],"label_agreement":null},{"id":"W1973146203","doi":"10.1016/j.jval.2012.03.410","title":"PSU7 Economic Burden of Obesity and the Impact of Bariatric Surgery on Health Care Costs and Utilization","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Medicine; Underweight; Obesity; Overweight; Health care; Psychological intervention; Emergency medicine; Inpatient care; Environmental health; Internal medicine; Nursing","score_opus":0.054130828405876935,"score_gpt":0.33751195300593373,"score_spread":0.2833811246000568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973146203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98168707,0.015900947,0.0000062596882,0.0016192391,0.00019944203,0.00047337954,0.000020277555,0.000007923955,0.000085450476],"genre_scores_gemma":[0.9944938,0.005124262,0.000036481306,0.00018275181,0.00013252658,0.0000031860313,0.000012782445,0.000009222464,0.0000049939067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985747,0.00042882215,0.0005236249,0.00012530014,0.00009824994,0.00024932437],"domain_scores_gemma":[0.9978986,0.0014076252,0.00031762032,0.00018559606,0.000024327119,0.00016624565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021620817,0.00010052009,0.0006189332,0.00021545614,0.0000535984,0.0000032132368,0.000027440372,0.00005981997,0.000013151993],"category_scores_gemma":[0.00022527766,0.00006577899,0.000085169995,0.0001762802,0.000062824874,0.00005751042,0.00002017703,0.00011705031,0.0000010395198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036061226,0.000054462234,0.9813376,0.00059948344,0.000022377888,3.1504464e-7,0.003950834,0.00019457674,8.847612e-7,0.0012054845,0.00039327427,0.011880089],"study_design_scores_gemma":[0.0012150297,0.00018497034,0.99692535,0.00016318866,0.000015367184,0.00001382369,0.00051496166,0.0007618764,0.000017529594,0.0000750058,0.00006085392,0.00005205587],"about_ca_topic_score_codex":0.04297005,"about_ca_topic_score_gemma":0.000039008835,"teacher_disagreement_score":0.04293104,"about_ca_system_score_codex":0.00034161872,"about_ca_system_score_gemma":0.00070398976,"threshold_uncertainty_score":0.96340287},"labels":[],"label_agreement":null},{"id":"W1973412039","doi":"10.1016/s1098-3015(11)72233-1","title":"PRS1 RESPIRATORY SYNCYTIAL VIRUS PROPHYLAXIS IN SPECIAL POPULATIONS","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis Viruses Studies and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Respiratory system; Medicine; Virology; Virus; Internal medicine","score_opus":0.13285530061458942,"score_gpt":0.3847665239487345,"score_spread":0.25191122333414506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973412039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920623,0.00029390585,0.0000171544,0.002915385,0.0016719671,0.0005994381,0.000014007027,0.000029415116,0.002396428],"genre_scores_gemma":[0.9920465,0.00038931362,0.0014862511,0.0032124403,0.0027360104,0.000049149286,0.000007928507,0.000020547155,0.000051913743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817926,0.0002566413,0.00069694425,0.000277003,0.00014429486,0.00044585392],"domain_scores_gemma":[0.9993038,0.00013611047,0.000109310095,0.00026213922,0.000031729644,0.00015691013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011029168,0.00011610697,0.00046360865,0.00022818524,0.00008990375,0.000003829406,0.00006467541,0.00016091639,0.00017518795],"category_scores_gemma":[0.0011865103,0.00010511746,0.000050692903,0.0003057806,0.000080370985,0.000040505103,0.000040908042,0.00072011445,0.000077649565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009410855,0.00018522177,0.97972006,0.00012808335,0.000004641909,0.000055929657,0.0006298804,0.00018018018,0.00030697612,0.007256853,0.0032565836,0.008181481],"study_design_scores_gemma":[0.0010407615,0.00074116467,0.9253386,0.0001109565,0.0000031763063,0.000011827888,0.00004492405,0.0007838674,0.00001874856,0.0013513505,0.07043953,0.00011509354],"about_ca_topic_score_codex":0.07305835,"about_ca_topic_score_gemma":0.08335886,"teacher_disagreement_score":0.06718295,"about_ca_system_score_codex":0.0002492316,"about_ca_system_score_gemma":0.00043935183,"threshold_uncertainty_score":0.93336743},"labels":[],"label_agreement":null},{"id":"W1973753171","doi":"10.1016/j.jval.2011.08.525","title":"PND59 A Common Road Map for Rational Clinical and Policy Decisionmaking: Application of the MCDA-Based Evidem Framework to Growth Hormone Use in Patients with Prader-Willi Syndrome","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Syndromes and Imprinting","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Multiple-criteria decision analysis; Context (archaeology); Stakeholder; Population; Medicine; Scientific evidence; Psychology; Operations research; Political science; Geography; Public relations; Environmental health; Engineering","score_opus":0.05530843422811118,"score_gpt":0.33005054087963487,"score_spread":0.2747421066515237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1973753171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98422384,0.00012875453,0.013789418,0.00077556324,0.00003947058,0.0010219269,0.000015628819,0.0000025254997,0.0000028820914],"genre_scores_gemma":[0.97091275,0.000020918556,0.02827607,0.00066426303,0.000026152971,0.000065843284,0.000016392089,0.000014727332,0.000002874335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987132,0.00015319856,0.00050609716,0.00029127553,0.00013463062,0.00020160213],"domain_scores_gemma":[0.99923456,0.000103185695,0.00020649016,0.00030398753,0.00006960132,0.0000821503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000571351,0.00010118041,0.00020095613,0.0000735196,0.000047369762,0.00000847289,0.00014472511,0.00012196492,5.8943533e-7],"category_scores_gemma":[0.000505313,0.00007676831,0.00003977893,0.00018461797,0.000055218083,0.000004724599,0.00007567196,0.00010036962,4.7529556e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003778174,0.00017806466,0.99516284,0.000046848025,0.0000070340193,3.9004114e-8,0.00009062638,0.00037388358,0.00006164485,0.0004342713,0.000023009332,0.0035839623],"study_design_scores_gemma":[0.00089695776,0.0010456424,0.99575883,0.00013611818,0.000003331944,0.0000018705209,0.000014525272,0.0010006692,0.00007739183,0.00080641086,0.00017586617,0.00008238941],"about_ca_topic_score_codex":0.0012183074,"about_ca_topic_score_gemma":0.000088366054,"teacher_disagreement_score":0.01448665,"about_ca_system_score_codex":0.000024254425,"about_ca_system_score_gemma":0.00019404065,"threshold_uncertainty_score":0.3130521},"labels":[],"label_agreement":null},{"id":"W1974003121","doi":"10.1111/j.1524-4733.2004.75013.x","title":"Estimating Survival for Cost-Effectiveness Analyses: A Case Study in Atherothrombosis","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Radiation Oncology; McGill University","funders":"","keywords":"Medicine; Life expectancy; Observational study; Hazard ratio; Stroke (engine); Survival analysis; Myocardial infarction; Proportional hazards model; Population; Disease; Internal medicine; Confidence interval","score_opus":0.24333627678275432,"score_gpt":0.47391388457684486,"score_spread":0.23057760779409053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974003121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98738277,0.00010097096,0.0054025752,0.00055852876,0.00014505009,0.006316988,0.000008967228,0.000045428067,0.00003874745],"genre_scores_gemma":[0.994354,0.0000046204073,0.00430415,0.00028619962,0.00005893842,0.00095441594,0.000007557429,0.000025473813,0.0000046602813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822176,0.0003728617,0.0004636916,0.000365249,0.0002041967,0.00037226],"domain_scores_gemma":[0.9992509,0.00020000107,0.00008982195,0.00027121685,0.000033610304,0.0001544657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015964594,0.00015173737,0.00049693754,0.00022562304,0.000074482465,0.00001614343,0.00006178939,0.00002919066,0.000009451372],"category_scores_gemma":[0.00015794992,0.0001405119,0.00006672839,0.00046382044,0.000020745847,0.00006913854,0.000036238613,0.00012352846,0.000004735788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004104455,0.0061824615,0.4833601,0.0026384932,0.00013831565,0.003188592,0.00761905,0.4832466,0.00009927692,0.000116519084,0.000009741001,0.0129904095],"study_design_scores_gemma":[0.026402438,0.0040828865,0.81108546,0.0022713407,0.00014070791,0.00021884228,0.012696047,0.14168602,0.000036277488,0.0008967536,0.00006764597,0.00041558535],"about_ca_topic_score_codex":0.0410662,"about_ca_topic_score_gemma":0.0025400852,"teacher_disagreement_score":0.34156057,"about_ca_system_score_codex":0.0011396201,"about_ca_system_score_gemma":0.0002762246,"threshold_uncertainty_score":0.96531945},"labels":[],"label_agreement":null},{"id":"W1974343881","doi":"10.1016/s1098-3015(10)74012-2","title":"PND5 CLINICAL CONSEQUENCES OF GENERIC SWITCHES OF ANTIEPILEPTIC DRUGS-TRANSFER OF CANADIAN CLAIMS DATABASE RESULTS TO GERMANY","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Antiepileptic drug; Database; Transfer (computing); Epilepsy; Medicine; Computer science; Psychiatry; Parallel computing","score_opus":0.23252911995462644,"score_gpt":0.4461672821767221,"score_spread":0.21363816222209564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974343881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654277,0.0021545137,0.000013859341,0.029975303,0.00015069763,0.00045052968,0.00017587518,0.000006315983,0.0016452139],"genre_scores_gemma":[0.9871803,0.008017328,0.0011585691,0.0035396672,0.00006798063,0.0000023560392,0.000011811553,0.0000060656025,0.000015939588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976783,0.00024278037,0.0012437953,0.00023426465,0.0002626976,0.0003381574],"domain_scores_gemma":[0.9983741,0.0006186665,0.00017562721,0.00026853295,0.000096446456,0.0004666313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021870486,0.00010659567,0.0006213852,0.0002872213,0.000036009773,0.0000020971518,0.00011865866,0.000065877306,0.000027080865],"category_scores_gemma":[0.0005077246,0.000087875225,0.00007353111,0.0006888997,0.00017991898,0.000052216823,0.00001559375,0.00024865512,0.000004278362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025769494,0.007958402,0.3962989,0.014983122,0.0011700586,0.00063231087,0.038689755,0.0033603937,0.17106907,0.0143837435,0.03966985,0.2860149],"study_design_scores_gemma":[0.013455021,0.014473527,0.74247503,0.0055831876,0.00044501203,0.00008096022,0.0034393785,0.0029341609,0.0637344,0.0011102039,0.15142532,0.00084382755],"about_ca_topic_score_codex":0.23181963,"about_ca_topic_score_gemma":0.0057936544,"teacher_disagreement_score":0.34617612,"about_ca_system_score_codex":0.00006050664,"about_ca_system_score_gemma":0.00096973067,"threshold_uncertainty_score":0.77329576},"labels":[],"label_agreement":null},{"id":"W1974514641","doi":"10.1016/j.jval.2013.03.344","title":"Psychometric Development Of A New Pro Instrument: The Face-Q Scales For Facelift Patients","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Virtual Reality Applications and Impacts","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rasch model; Patient-reported outcome; Checklist; Differential item functioning; Psychology; Patient satisfaction; Medicine; Psychometrics; Item response theory; Quality of life (healthcare); Clinical psychology; Surgery; Developmental psychology; Cognitive psychology","score_opus":0.1038277765233961,"score_gpt":0.3239041417923375,"score_spread":0.22007636526894142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974514641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7295566,0.00022164402,0.25928554,0.008252459,0.00012056696,0.0024104968,0.0000059979557,0.000027391534,0.000119274715],"genre_scores_gemma":[0.9485722,0.00003875773,0.050723203,0.0004337022,0.000010117273,0.00016176258,0.0000036841532,0.0000048045345,0.00005172651],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988335,0.00004052105,0.00043587454,0.00019419522,0.00023215925,0.00026375998],"domain_scores_gemma":[0.9991996,0.00009380299,0.00017704065,0.00033357015,0.000062304265,0.0001336727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004320645,0.00007995383,0.00013320518,0.00016741872,0.0001114529,0.000050458453,0.0005262217,0.000029204406,0.0000027982346],"category_scores_gemma":[0.000103553044,0.00005467483,0.000025297342,0.00088182173,0.000017953744,0.00018239522,0.00006478564,0.000060965234,0.000022883014],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002456443,0.00018520995,0.0052035227,0.00007066403,0.0000046778173,3.492509e-9,0.004771172,0.0002884765,0.000013592359,0.0066724364,0.002187317,0.9806005],"study_design_scores_gemma":[0.00195721,0.00067775894,0.8709036,0.0001991815,0.0000015967735,7.767594e-7,0.00038983565,0.045352668,0.0010695828,0.018051261,0.06109725,0.00029928342],"about_ca_topic_score_codex":0.0014969524,"about_ca_topic_score_gemma":0.000029406627,"teacher_disagreement_score":0.9803012,"about_ca_system_score_codex":0.00010636904,"about_ca_system_score_gemma":0.00041688734,"threshold_uncertainty_score":0.22629541},"labels":[],"label_agreement":null},{"id":"W1974850672","doi":"10.1016/j.jval.2013.03.466","title":"Treatment patterns in pediatric antibiotic formulations: An analysis of the ramq database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); Université de Montréal","funders":"","keywords":"Antibiotics; Azithromycin; Medicine; Amoxicillin; Clarithromycin; Pediatrics; Population; Cephalosporin; Reimbursement; Internal medicine; Environmental health; Biology","score_opus":0.14458472495067942,"score_gpt":0.427859487462494,"score_spread":0.2832747625118146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974850672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935001,0.00089843565,0.000022283737,0.0048733805,0.000046104396,0.000548189,0.00002595417,0.0000053197846,0.00008019356],"genre_scores_gemma":[0.9949317,0.004358984,0.00018101718,0.00044055688,0.000039168834,0.00000900671,0.000022419472,0.0000041308786,0.000013035909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99904907,0.00018358396,0.00032358192,0.00013421799,0.00013189176,0.00017768546],"domain_scores_gemma":[0.9992766,0.00026631018,0.00011645981,0.00023517628,0.000020686026,0.000084760715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002900283,0.00006575337,0.00025750758,0.0001772844,0.00004482908,0.0000053406443,0.000050755905,0.000021117956,0.000079414785],"category_scores_gemma":[0.00009512712,0.000038862756,0.000053220843,0.00080605625,0.000013195808,0.000107313426,0.00002532714,0.00009388716,0.0000047999183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016457114,0.0003984303,0.9936621,0.00012725117,0.000049550283,0.0000019298886,0.000397113,0.0012111408,0.000007891184,0.000086961416,0.00000862662,0.0040325467],"study_design_scores_gemma":[0.0006145146,0.00017614849,0.9235196,0.000028742288,0.00023798144,9.228628e-7,0.00015323811,0.075040504,0.000016248101,0.000024230194,0.00015622718,0.000031609612],"about_ca_topic_score_codex":0.06286842,"about_ca_topic_score_gemma":0.0021467158,"teacher_disagreement_score":0.07382936,"about_ca_system_score_codex":0.00015070783,"about_ca_system_score_gemma":0.00007939966,"threshold_uncertainty_score":0.943372},"labels":[],"label_agreement":null},{"id":"W1974989328","doi":"10.1016/j.jval.2013.08.224","title":"Health Care Resource Utilization and Adherence to Antiretroviral Treatment (ART) by HIV Patients: An Analysis with the Quebec (Canada) Public Drug Plan Database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Regimen; Reimbursement; Medical record; Health plan; Retrospective cohort study; Health care; Emergency medicine; Internal medicine","score_opus":0.041847306996415215,"score_gpt":0.3230754393085002,"score_spread":0.281228132312085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1974989328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97349674,0.0013469526,0.00035101094,0.022513214,0.000010136062,0.0015339972,0.000530743,0.000023704371,0.00019350366],"genre_scores_gemma":[0.99107724,0.00017272063,0.00018842069,0.0014200837,0.000024048766,0.00011353152,0.0031511206,0.000015630727,0.0038372239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978429,0.00052519253,0.00034104052,0.0003513994,0.00047290343,0.00046655702],"domain_scores_gemma":[0.99855685,0.00006565824,0.00011197799,0.00044093153,0.00012720465,0.00069736765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028913253,0.00014073483,0.00032124767,0.00025368776,0.00023670949,0.00007040801,0.0001146021,0.000021422658,0.00009016678],"category_scores_gemma":[0.00007909202,0.00008908902,0.000035232926,0.0006584665,0.000054452175,0.00019978604,0.000032536023,0.00014693505,0.000008725611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014538276,0.0005720777,0.57662857,0.0003341548,0.00012810888,0.0000055885675,0.0064457026,0.00007526536,0.0000044306726,0.00010155561,0.2928114,0.12274779],"study_design_scores_gemma":[0.0072133555,0.055660035,0.5303323,0.0012307732,0.0001713033,0.0000070984406,0.045772612,0.047050744,0.000068364665,0.0000049066693,0.31185868,0.0006297585],"about_ca_topic_score_codex":0.9432962,"about_ca_topic_score_gemma":0.9573252,"teacher_disagreement_score":0.122118026,"about_ca_system_score_codex":0.001040207,"about_ca_system_score_gemma":0.0014719624,"threshold_uncertainty_score":0.36329448},"labels":[],"label_agreement":null},{"id":"W1975421074","doi":"10.1016/j.jval.2011.02.210","title":"PCV22 META REGRESSION ANALYSIS TO INDIRECTLY COMPARE THE SAFETY AND EFFICACY OF DALTEPARIN TO ENOXAPARIN IN PATIENTS WITH UNSTABLE CORONARY ARTERY DISEASE","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Enoxaparin sodium; Unstable angina; Internal medicine; Low molecular weight heparin; Meta-analysis; Randomized controlled trial; Relative risk; Angina; Heparin; Cardiology; Confidence interval; Myocardial infarction","score_opus":0.042920077049483044,"score_gpt":0.27334860265593436,"score_spread":0.23042852560645133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975421074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99538374,0.0013387514,0.0001853642,0.0006877239,0.000035110406,0.0021580562,0.000038977818,0.000015145736,0.00015713232],"genre_scores_gemma":[0.99797684,0.00013329882,0.0010353603,0.0006942888,0.00001882849,0.000056142155,0.000042936725,0.000018571489,0.0000237622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975837,0.0004959797,0.0006048486,0.00041286126,0.000522197,0.00038039984],"domain_scores_gemma":[0.9983819,0.00009087685,0.00014650148,0.0007778577,0.00007024186,0.00053258514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014864889,0.00018765299,0.0009914153,0.00042762718,0.000088488676,0.000006132678,0.00012129979,0.000035637375,0.000031818217],"category_scores_gemma":[0.0000902016,0.000107648484,0.00013852167,0.0013317696,0.000042096148,0.00005198942,0.00009319081,0.00020778754,0.0000027066433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0041157897,0.0006193242,0.9778347,0.00028050508,0.00079957093,0.00002268031,0.0022927495,0.0030049782,8.459418e-7,0.00009181775,0.000038350165,0.0108987],"study_design_scores_gemma":[0.0023201571,0.0006337008,0.9951537,0.00033015155,0.00060213055,0.0000020307239,0.00013676457,0.00029146703,0.000011681152,0.000014469024,0.00039658893,0.00010710554],"about_ca_topic_score_codex":0.019788487,"about_ca_topic_score_gemma":0.0014110709,"teacher_disagreement_score":0.018377418,"about_ca_system_score_codex":0.00018482647,"about_ca_system_score_gemma":0.00039757244,"threshold_uncertainty_score":0.9867388},"labels":[],"label_agreement":null},{"id":"W1975492177","doi":"10.1016/j.jval.2012.03.1115","title":"PIH83 Health Technology Assessment in Child Health","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Psychosocial; Quality of life (healthcare); Disease; Mental health; Pediatrics; Gerontology; Psychiatry","score_opus":0.4265506633807722,"score_gpt":0.47995517106010144,"score_spread":0.05340450767932925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975492177","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1208703,0.05262359,0.002643699,0.8147196,0.0021167374,0.0031348793,0.00023744087,0.00019718347,0.00345655],"genre_scores_gemma":[0.92622715,0.0033335635,0.0112658525,0.058183335,0.00046854603,0.0002750817,0.000057482834,0.00007397483,0.00011500399],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9864564,0.0017066386,0.008645936,0.00085881434,0.0001815995,0.0021506075],"domain_scores_gemma":[0.99394834,0.0005685203,0.0038761403,0.0008704511,0.000025552372,0.0007109742],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.057052203,0.00032448804,0.0021061103,0.0019464424,0.00034544113,0.00003785964,0.0004235025,0.00024750677,0.00016818216],"category_scores_gemma":[0.0011654942,0.00043646284,0.0001003171,0.001179313,0.0000840154,0.0005217804,0.000106493106,0.0009734654,0.00083126745],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006274174,0.0005643117,0.4802008,0.0012295726,0.000014365363,8.487152e-7,0.0042600217,0.0014169595,6.896636e-8,0.5017386,0.008669506,0.001898674],"study_design_scores_gemma":[0.0035174177,0.00090307527,0.69992775,0.0017330879,0.0000011502949,0.000066881585,0.0072907214,0.013200854,9.4044213e-7,0.030467965,0.24190772,0.0009824448],"about_ca_topic_score_codex":0.045013566,"about_ca_topic_score_gemma":0.001835575,"teacher_disagreement_score":0.80535686,"about_ca_system_score_codex":0.007110497,"about_ca_system_score_gemma":0.0020442859,"threshold_uncertainty_score":0.9999467},"labels":[],"label_agreement":null},{"id":"W1976011722","doi":"10.1046/j.1524-4733.2001.40202-256.x","title":"PWM4: PHARMACIST-INITIATED EMERGENCY CONTRACEPTION IN BRITISH COLUMBIA","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Pharmacist; Emergency contraception; Family medicine; Medicine; Medical emergency; Pharmacy; Family planning; Environmental health; Population","score_opus":0.08539963754696987,"score_gpt":0.365738016015765,"score_spread":0.2803383784687951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976011722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896981,0.0031872296,0.00009115832,0.0037862298,0.0008183708,0.0014739675,0.000010015922,0.0000805374,0.0008543726],"genre_scores_gemma":[0.9845522,0.012543537,0.00013226982,0.0010845127,0.0005129223,0.00010185106,0.000057276462,0.000024500803,0.0009909046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974618,0.0003456275,0.0008706954,0.0004606182,0.00026168238,0.00059956673],"domain_scores_gemma":[0.9991943,0.000034171608,0.0001694689,0.00022671906,0.000108247696,0.0002670409],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012777203,0.00010023397,0.00039073033,0.00012809786,0.00009468023,0.00002411577,0.0000537495,0.000101757294,0.0010781991],"category_scores_gemma":[0.00024406462,0.00016434902,0.000053682186,0.0006460543,0.000031451345,0.00014711046,0.000009840993,0.00040844746,0.0000877732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023104125,0.0005737624,0.8983396,0.00036487204,0.0000065636073,0.00021204758,0.00034725887,0.00013490768,0.00039772893,0.000015386726,0.003423116,0.09595368],"study_design_scores_gemma":[0.0041234917,0.00036964106,0.97447383,0.00038151417,0.0000064627443,0.00021957059,0.00019735697,0.0040852227,0.000006000637,0.000453049,0.015541754,0.00014212084],"about_ca_topic_score_codex":0.18162511,"about_ca_topic_score_gemma":0.059073146,"teacher_disagreement_score":0.12255196,"about_ca_system_score_codex":0.00047068222,"about_ca_system_score_gemma":0.0003782513,"threshold_uncertainty_score":0.99983495},"labels":[],"label_agreement":null},{"id":"W1976152155","doi":"10.1016/j.jval.2011.12.011","title":"Comment on the Use of Vignettes and the EQ-5D to Value Disease-Specific Health States","year":2012,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"EQ-5D; Anxiety; Medicine; Depression (economics); Value (mathematics); Family medicine; Health care; Disease; Psychology; Psychiatry; Gerontology; Political science; Statistics; Health related quality of life; Pathology","score_opus":0.6581043205769681,"score_gpt":0.3950368595126414,"score_spread":0.2630674610643267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976152155","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004013551,0.018992353,0.0003564645,0.96918637,0.0010669391,0.0042508235,0.0020459858,0.00003033804,0.00005717497],"genre_scores_gemma":[0.0033288195,0.0063740825,0.0009992679,0.9868542,0.0015250196,0.00041309133,0.00021377177,0.00009847457,0.00019325942],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9862048,0.0050153662,0.0063968324,0.0008842001,0.0003217722,0.0011770448],"domain_scores_gemma":[0.979725,0.013869636,0.004363626,0.0015454214,0.000053548785,0.00044275864],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.035747692,0.0004849816,0.0022398198,0.0005711721,0.0004418617,0.00015904082,0.0006336421,0.00025893017,0.00014289944],"category_scores_gemma":[0.002066496,0.0003867956,0.00020286348,0.00033724762,0.0002855786,0.00020275223,0.00016065346,0.0013014186,0.00042049473],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005328385,0.0000724997,0.0024643543,0.0014326824,0.00004191642,9.5050757e-7,0.0038735243,0.0027067503,5.7863088e-9,0.1099275,0.87928516,0.0001413655],"study_design_scores_gemma":[0.0007294423,0.00016920126,0.00457851,0.00090130756,0.0000046178047,0.0000015898222,0.00026492018,0.0040816762,1.0636233e-7,0.011360144,0.97758555,0.00032291666],"about_ca_topic_score_codex":0.026593303,"about_ca_topic_score_gemma":0.00008000132,"teacher_disagreement_score":0.09856735,"about_ca_system_score_codex":0.0016206211,"about_ca_system_score_gemma":0.00054252933,"threshold_uncertainty_score":0.9998584},"labels":[],"label_agreement":null},{"id":"W1976155214","doi":"10.1016/s1098-3015(11)71663-1","title":"PHP2: GASTROINTESTINAL DRUG POLICY, DRUG SELECTION AND RESOURCE UTILIZATION—A COMPARISON OF THE CANADIAN PROVINCES OF QUEBEC AND ONTARIO","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Selection (genetic algorithm); Resource (disambiguation); Business; Geography; Medicine; Pharmacology; Computer science","score_opus":0.04418445564258011,"score_gpt":0.30875411420654564,"score_spread":0.2645696585639655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976155214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961523,0.00032411082,0.000027223346,0.0025836837,0.000025793815,0.00029062148,0.0000020761743,0.000009819481,0.0005843925],"genre_scores_gemma":[0.9990852,0.000011633633,0.0002835165,0.00009318533,0.000039314655,0.000003615508,0.0000021638864,0.0000051345137,0.00047624693],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99923736,0.00010255613,0.0002496967,0.00012404409,0.00013806955,0.00014826794],"domain_scores_gemma":[0.999536,0.000051756448,0.00017399632,0.000075676624,0.000049537546,0.00011302776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003187276,0.00006120136,0.0001776654,0.0001686082,0.0001085251,0.00000717622,0.000028128092,0.00002068156,0.000004634318],"category_scores_gemma":[0.00011658042,0.000049692255,0.000015375059,0.00033449935,0.0000667288,0.000027665448,0.000012683801,0.00016991503,7.469816e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032635735,0.00002713906,0.98726463,0.00012619015,0.0000026113732,4.3346657e-7,0.004398306,0.00059498433,0.000033742057,0.00011811439,0.0001618049,0.0069456645],"study_design_scores_gemma":[0.00047829244,0.00062615646,0.9834601,0.0005357169,0.000007968463,0.00013233785,0.0007361939,0.0111900605,0.00040564587,0.000062295265,0.0023227297,0.000042502346],"about_ca_topic_score_codex":0.9983353,"about_ca_topic_score_gemma":0.9994767,"teacher_disagreement_score":0.010595076,"about_ca_system_score_codex":0.0007987641,"about_ca_system_score_gemma":0.002603543,"threshold_uncertainty_score":0.46185735},"labels":[],"label_agreement":null},{"id":"W1976493216","doi":"10.1016/j.jval.2013.03.1535","title":"New oral anticoagulants versus warfarin for stroke prevention in atrial fibrillation: Development of coverage decision frameworks","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Reimbursement; Warfarin; Medicine; Actuarial science; Economic evaluation; Atrial fibrillation; Cost–benefit analysis; Risk analysis (engineering); Business; Health care; Economics","score_opus":0.412273028987657,"score_gpt":0.4529828278979083,"score_spread":0.04070979891025128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976493216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8771219,0.0016244317,0.113102004,0.0040211705,0.0017261617,0.002228382,0.000059582664,0.00001704223,0.000099273784],"genre_scores_gemma":[0.8253301,0.00027128073,0.17323999,0.0004203995,0.00041487324,0.00004610455,0.000059275288,0.000029125496,0.0001888713],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99409974,0.0002605575,0.004677418,0.00042450352,0.00011966984,0.00041809378],"domain_scores_gemma":[0.9959318,0.0018686895,0.0017033996,0.00029171666,0.000044981345,0.00015943432],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01002906,0.00014873748,0.00095254614,0.00046492834,0.00008358785,0.000039997212,0.00016170803,0.0002713912,0.00020409949],"category_scores_gemma":[0.0024819796,0.00019523401,0.000113347065,0.00023695047,0.000014191329,0.00035949124,0.000041246974,0.00019910019,0.0001910959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011245213,0.00021702537,0.5452314,0.0022139628,0.00015747578,6.6314533e-7,0.009367555,0.15979932,0.0000037758944,0.062124506,0.009545972,0.21021381],"study_design_scores_gemma":[0.018001659,0.0008761219,0.60041213,0.0016675284,0.0000066291104,0.0000018770288,0.000737106,0.20486142,0.000018823974,0.14478134,0.027850196,0.0007851466],"about_ca_topic_score_codex":0.008894975,"about_ca_topic_score_gemma":0.00092912075,"teacher_disagreement_score":0.20942867,"about_ca_system_score_codex":0.0009919064,"about_ca_system_score_gemma":0.00090732524,"threshold_uncertainty_score":0.99770486},"labels":[],"label_agreement":null},{"id":"W1976878541","doi":"10.1016/j.jval.2014.08.2666","title":"Concomitant Use of Non-Steroidal Anti-Inflammatory Drugs (Nsaids) And Proton Pump Inhibitors (Ppis) in Newly Diagnosed Patients With Osteoarthritis (Oa), Rheumatoid Arthritis (Ra) or Ankylosing Spondylitis (As)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada); AstraZeneca (Canada)","funders":"","keywords":"Medicine; Diclofenac; Misoprostol; Celecoxib; Medical prescription; Osteoarthritis; Rheumatoid arthritis; Internal medicine; Concomitant; Naproxen; Esomeprazole; Ankylosing spondylitis; Pharmacy; Ketorolac; Analgesic; Anesthesia; Pharmacology; Alternative medicine; Pregnancy","score_opus":0.016329745552759595,"score_gpt":0.265600392951297,"score_spread":0.2492706473985374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976878541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915627,0.0011011616,0.000020776952,0.00032759202,0.00021293323,0.006530321,0.000117165146,0.000056835033,0.00007050079],"genre_scores_gemma":[0.99592745,0.0025714869,0.00067885825,0.00017533728,0.00007830152,0.0003612011,0.00006816889,0.000107433356,0.000031770654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943519,0.00095631514,0.0017861323,0.000772331,0.0011368921,0.0009963781],"domain_scores_gemma":[0.9967537,0.0012244052,0.00056392554,0.00067740004,0.0002401163,0.00054046017],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021260395,0.00042322566,0.0014607194,0.0008474585,0.0001097403,0.00007151349,0.00016472705,0.00023971488,0.000042807154],"category_scores_gemma":[0.0010598527,0.00035652934,0.00007204545,0.0007068909,0.0003232495,0.00044654994,0.00013126167,0.0005779505,0.000014184115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016119829,0.00032789994,0.9675848,0.0040187845,0.000022813827,0.00024341949,0.0054844194,0.000046441146,0.00031978782,0.0000470513,0.00006294375,0.020229682],"study_design_scores_gemma":[0.13872376,0.019500878,0.6663715,0.13988343,0.000028618551,0.0045711575,0.0060990723,0.006408075,0.008413164,0.00014023062,0.00797843,0.0018816437],"about_ca_topic_score_codex":0.008647775,"about_ca_topic_score_gemma":0.00080190354,"teacher_disagreement_score":0.30121323,"about_ca_system_score_codex":0.0005154319,"about_ca_system_score_gemma":0.00094210857,"threshold_uncertainty_score":0.99988866},"labels":[],"label_agreement":null},{"id":"W1976920602","doi":"10.1111/j.1524-4733.2007.00258.x","title":"Validation of a Prediction Model to Estimate Health Utilities Index Mark 3 Utility Scores from WOMAC Index Scores in Patients with Osteoarthritis of the Hip","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":28,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Calgary; Alberta Bone and Joint Health Institute; McMaster University; University of Toronto","funders":"","keywords":"WOMAC; Osteoarthritis; Physical therapy; Sample (material); Sample size determination; Statistics; Predictive validity; Index (typography); Medicine; Mathematics; Computer science","score_opus":0.1743607917446644,"score_gpt":0.3722174669120764,"score_spread":0.197856675167412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1976920602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98590505,0.0006964595,0.0060078013,0.0033083118,0.00031598285,0.002133828,0.0015084131,0.000021667094,0.00010250526],"genre_scores_gemma":[0.99649465,0.000035610476,0.0019881965,0.0012662105,0.000040469295,0.00006011042,0.00007248825,0.000027167047,0.000015069882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927982,0.00065193797,0.005152198,0.00055448763,0.00028252008,0.00056065246],"domain_scores_gemma":[0.9956387,0.00069562433,0.0027237316,0.0006304577,0.000106240084,0.00020520944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015910069,0.00020391618,0.0010493184,0.0006446506,0.00011534493,0.00001979042,0.00028123212,0.00013455229,0.00002801623],"category_scores_gemma":[0.0013984593,0.00021539355,0.000065987915,0.0005969695,0.000118889715,0.00033387996,0.000074313306,0.00025886713,0.00000880568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022524172,0.00018440078,0.94766176,0.0006073341,0.000009283913,7.5454615e-8,0.0048616338,0.043482304,3.1673716e-7,0.0017289125,0.00016431582,0.0010744077],"study_design_scores_gemma":[0.0016503965,0.0003175262,0.9288624,0.0009675904,0.0000011295297,1.8067236e-7,0.00043546682,0.059427194,0.000015969286,0.008156613,0.000036504647,0.0001290589],"about_ca_topic_score_codex":0.06304312,"about_ca_topic_score_gemma":0.0050516785,"teacher_disagreement_score":0.05799144,"about_ca_system_score_codex":0.001102619,"about_ca_system_score_gemma":0.0008087972,"threshold_uncertainty_score":0.9431962},"labels":[],"label_agreement":null},{"id":"W1977624528","doi":"10.1016/j.jval.2013.03.1093","title":"Factors That Influence Ulcerative Colitis Patients' Anxiety And Depression Following The Colectomy Surgery","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Stoma care and complications","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of Calgary","funders":"","keywords":"Anxiety; Depression (economics); Hospital Anxiety and Depression Scale; Medicine; Ulcerative colitis; Absenteeism; Logistic regression; Presenteeism; Colectomy; Patient Health Questionnaire; Psychiatry; Disease; Internal medicine; Psychology; Depressive symptoms","score_opus":0.04328662357815313,"score_gpt":0.2979284949735191,"score_spread":0.254641871395366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1977624528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735844,0.00032243325,0.00002429655,0.0011117139,0.00011013393,0.0008256732,0.000004908451,0.000028383776,0.00021404403],"genre_scores_gemma":[0.9981721,0.00011962971,0.00005000388,0.0014715306,0.000018075772,0.00012387862,0.000014686274,0.000009203526,0.000020908245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907035,0.0001474867,0.00020930088,0.0001807435,0.00017786249,0.00021425045],"domain_scores_gemma":[0.99893546,0.00058723934,0.00007743509,0.00020649258,0.00007305103,0.00012029739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017987062,0.00009049758,0.00020202977,0.00006469196,0.00017478078,0.000023616098,0.00004253781,0.000041656047,0.000015874342],"category_scores_gemma":[0.00020559096,0.00005848222,0.00005044428,0.00020816621,0.000034159806,0.000112228816,0.00002988103,0.00014309432,0.0000062672984],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007083387,0.000031977474,0.99245006,0.00003347218,0.0000070650217,4.6437094e-7,0.0012807228,0.0000075574785,0.00000990055,0.000044693064,0.0007926093,0.005334374],"study_design_scores_gemma":[0.0002458515,0.00003451848,0.997896,0.00021175848,0.0000054593447,0.0000025657212,0.0005371935,0.00020694228,0.00011770726,0.00015343717,0.0005332157,0.000055321234],"about_ca_topic_score_codex":0.0105754705,"about_ca_topic_score_gemma":0.00009987085,"teacher_disagreement_score":0.010475599,"about_ca_system_score_codex":0.000106915926,"about_ca_system_score_gemma":0.00017688108,"threshold_uncertainty_score":0.99601316},"labels":[],"label_agreement":null},{"id":"W1978008071","doi":"10.1016/j.jval.2013.03.1633","title":"Does the Process of Deliberation Change Individuals’ Health State Valuations? An Exploratory Study Using the Person Trade-Off Technique","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Deliberation; Preference; Exploratory analysis; Exploratory research; Valuation (finance); Psychology; Social psychology; Process (computing); Actuarial science; Economics; Political science; Microeconomics; Computer science; Sociology","score_opus":0.5538658593092457,"score_gpt":0.45438533273355936,"score_spread":0.09948052657568635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978008071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8989085,0.0025696626,0.002377556,0.08565691,0.000392841,0.009864045,0.00016027725,0.000050965406,0.000019241581],"genre_scores_gemma":[0.984749,0.00030509772,0.001656138,0.010578432,0.0002510864,0.0023748258,0.0000244101,0.00004764283,0.000013324646],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9907296,0.0038796782,0.004006137,0.0005707553,0.00025780615,0.0005560764],"domain_scores_gemma":[0.99489164,0.00071544555,0.0033591692,0.000752924,0.00009811719,0.00018267069],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.044455696,0.00023043419,0.00085806125,0.00042905976,0.000627412,0.000114800685,0.00046300338,0.00008870852,0.0000654711],"category_scores_gemma":[0.0006603872,0.00016115907,0.00006504513,0.0005772575,0.0000997982,0.0011614286,0.000036267476,0.00036253894,0.00003735572],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016121203,0.0013521923,0.24599542,0.001718604,0.00008792206,3.368691e-7,0.7183984,0.015179585,0.0000058001333,0.0074421763,0.0014711418,0.008332292],"study_design_scores_gemma":[0.0023036841,0.0020955114,0.43227586,0.00086772867,0.000016109527,0.000010276721,0.30409965,0.2171797,0.000035607583,0.03773691,0.002417052,0.000961927],"about_ca_topic_score_codex":0.025693657,"about_ca_topic_score_gemma":0.0021310742,"teacher_disagreement_score":0.41429877,"about_ca_system_score_codex":0.0009006512,"about_ca_system_score_gemma":0.0009139798,"threshold_uncertainty_score":0.9839339},"labels":[],"label_agreement":null},{"id":"W1978260336","doi":"10.1111/j.1524-4733.2008.00446.x","title":"A Cost-Effectiveness Model Comparing Endovascular Repair to Open Surgical Repair of Abdominal Aortic Aneurysms in Canada","year":2008,"lang":"en","type":"review","venue":"Value in Health","topic":"Aortic aneurysm repair treatments","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; London Health Sciences Centre; McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Abdominal aortic aneurysm; Perioperative; Observational study; Cohort; Cost effectiveness; Surgery; Quality-adjusted life year; Time horizon; Aneurysm; Risk analysis (engineering); Finance; Internal medicine","score_opus":0.18235106453002858,"score_gpt":0.40460089825751894,"score_spread":0.22224983372749035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978260336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.048996676,0.93556684,0.000044080683,0.00004095831,0.00018578036,0.01471654,0.00005118233,0.000103052706,0.0002948769],"genre_scores_gemma":[0.027568934,0.96749204,0.0030297814,0.00011858596,0.000047439287,0.0014372336,0.00009509177,0.0001371071,0.0000738056],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9923307,0.0018052357,0.002790745,0.0012266677,0.0008741368,0.00097251456],"domain_scores_gemma":[0.9963569,0.00087202096,0.000683761,0.001325857,0.000088523724,0.0006729126],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017607049,0.0006857457,0.005919795,0.0005268486,0.00007035023,0.0000078534995,0.00048731113,0.00023660398,0.000013283033],"category_scores_gemma":[0.00038542284,0.0006040785,0.00075638556,0.001131044,0.000070799375,0.000076341035,0.0004121703,0.00084179034,0.000009376082],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0025034575,0.004359388,0.19621432,0.26115912,0.0017094982,0.054913394,0.0011187802,0.08996821,3.2397224e-7,0.00020072059,0.0013577482,0.38649502],"study_design_scores_gemma":[0.021166224,0.0034755524,0.032573473,0.2640598,0.002070499,0.02429689,0.00025397146,0.42451465,0.0000044544213,0.000048483747,0.22469164,0.0028443653],"about_ca_topic_score_codex":0.9168984,"about_ca_topic_score_gemma":0.20482886,"teacher_disagreement_score":0.7120695,"about_ca_system_score_codex":0.008735642,"about_ca_system_score_gemma":0.022020502,"threshold_uncertainty_score":0.99964106},"labels":[],"label_agreement":null},{"id":"W1978573187","doi":"10.1016/j.jval.2014.08.101","title":"Hospital Costs Associated with Platinum-Based Doublets in the First-Line Setting for Advanced Non-Squamous Non-Small Cell Lung Cancer in China: A Retrospective Cohort Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pemetrexed; Medicine; Internal medicine; Vinorelbine; Docetaxel; Gemcitabine; Oncology; Lung cancer; Chemotherapy; Retrospective cohort study; Platinum; Cancer; Cisplatin","score_opus":0.012308531618133299,"score_gpt":0.24813489041028497,"score_spread":0.23582635879215166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978573187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99006444,0.0005223174,0.0011682847,0.0015507903,0.0003611458,0.004709093,0.00022573561,0.000020401772,0.001377805],"genre_scores_gemma":[0.99771786,0.000081456295,0.0002406613,0.0007042572,0.00012063778,0.0010204416,0.00002364901,0.000057828252,0.000033219214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972323,0.00006623706,0.0011313232,0.00071220315,0.000076152304,0.0007817921],"domain_scores_gemma":[0.9981265,0.000414757,0.000952048,0.00036854955,0.000050489325,0.00008765071],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035301058,0.0003017806,0.0009600033,0.00032730633,0.0001616819,0.000062650324,0.00033239322,0.000141233,0.00001117847],"category_scores_gemma":[0.00039410204,0.00028966882,0.00007648943,0.00056025723,0.000039272585,0.00021218958,0.000031828444,0.0004921012,0.000004186996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012968648,0.00055427087,0.9183243,0.00009700659,0.000013872877,0.000003934373,0.003787642,0.07622586,2.3471e-7,0.00040423998,0.00007319284,0.00038573655],"study_design_scores_gemma":[0.0075070406,0.001228638,0.86827374,0.0002540572,0.000005346422,1.9510009e-7,0.00019931479,0.12161668,0.0000044592402,0.000507659,0.0000857683,0.00031710652],"about_ca_topic_score_codex":0.03030671,"about_ca_topic_score_gemma":0.032459624,"teacher_disagreement_score":0.05005058,"about_ca_system_score_codex":0.0027019067,"about_ca_system_score_gemma":0.00029037654,"threshold_uncertainty_score":0.99995553},"labels":[],"label_agreement":null},{"id":"W1978857580","doi":"10.1016/j.jval.2014.03.726","title":"COMORBIDITIES AND HEALTH RESOURCE USE OF CHRONIC PLAQUE PSORIASIS PATIENTS IN CANADA: A MATCHED-COHORT STUDY","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Helminth infection and control","field":"Veterinary","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lawson Health Research Institute; Université de Montréal; Novartis (Canada)","funders":"","keywords":"Medicine; Psoriasis; Cohort; Medical record; Depression (economics); Internal medicine; Anxiety; Retrospective cohort study; Cohort study; Dermatology; Psychiatry","score_opus":0.07810382300530012,"score_gpt":0.31020363440996324,"score_spread":0.23209981140466313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978857580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997304,0.00012850702,0.00001813313,0.0010721984,0.00022048918,0.001136298,0.000030471427,0.000018733554,0.00007116051],"genre_scores_gemma":[0.9987587,0.00010622338,0.000028037746,0.0009388177,0.000050441835,0.00006810769,0.000008721193,0.000019382685,0.000021615955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972095,0.0010556373,0.0007901468,0.00028232075,0.00027208883,0.00039031895],"domain_scores_gemma":[0.99897736,0.000276558,0.00026522417,0.0002887881,0.00003138534,0.0001606643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013946033,0.00014228786,0.0005253838,0.00017688739,0.00007156754,0.000013243408,0.000082224724,0.000042465635,0.000024271947],"category_scores_gemma":[0.00011656254,0.00014475499,0.00002066465,0.00018645421,0.000024376028,0.00007969748,0.000047469388,0.00023525278,0.0000028006311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008410391,0.0002894505,0.98906153,0.00025021165,0.000011371502,0.000005454839,0.0015052232,0.00060851563,4.6282707e-7,0.000121955876,0.0007132634,0.0073484587],"study_design_scores_gemma":[0.0017896069,0.0018129125,0.9843165,0.00017330793,0.000002437875,0.0000048439892,0.00062011543,0.0062783505,0.0000013302679,0.000018766817,0.0048752846,0.00010654078],"about_ca_topic_score_codex":0.99284136,"about_ca_topic_score_gemma":0.9482805,"teacher_disagreement_score":0.044560883,"about_ca_system_score_codex":0.0019210391,"about_ca_system_score_gemma":0.0016436009,"threshold_uncertainty_score":0.5902937},"labels":[],"label_agreement":null},{"id":"W1978872749","doi":"10.1016/j.jval.2013.08.1356","title":"Statins in Canada: The Case for Disinvestment","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Disinvestment; Reimbursement; Atorvastatin; Statin; Unit (ring theory); Medicine; Unit cost; Generic drug; Public health; Business; Operations management; Health care; Economics; Drug; Internal medicine; Pharmacology; Mathematics","score_opus":0.13835606983133678,"score_gpt":0.3103241599661802,"score_spread":0.1719680901348434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978872749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94154674,0.0016034435,0.00009435564,0.05287062,0.00032891714,0.0010148986,0.0003733194,0.000004426573,0.0021632686],"genre_scores_gemma":[0.9860413,0.00028849905,0.0003172017,0.013061042,0.000047607584,0.00017032285,0.000004685871,0.00001146939,0.00005785047],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998794,0.000026249592,0.00060990074,0.0001837993,0.000010269384,0.00037576753],"domain_scores_gemma":[0.99933386,0.00022365307,0.0001467788,0.00016555584,0.0000055283094,0.00012460134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059003837,0.00007604203,0.00021864861,0.000076148,0.000057520323,0.00002545253,0.00011417195,0.000020371574,0.00011662517],"category_scores_gemma":[0.000065070526,0.00007024142,0.000026200141,0.00010872679,0.000017556284,0.00006590943,0.000022912687,0.00011555266,0.000055836546],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000066499006,0.00007449989,0.035317775,0.0001292035,0.000011250244,0.000021887334,0.00093328604,0.010426978,4.275804e-7,0.93395954,0.013837801,0.0052806963],"study_design_scores_gemma":[0.0013394207,0.00007635762,0.047306493,0.000024628363,8.764474e-7,0.000029122602,0.0004593729,0.492226,0.000007312405,0.27568367,0.18257408,0.000272666],"about_ca_topic_score_codex":0.9913377,"about_ca_topic_score_gemma":0.8742197,"teacher_disagreement_score":0.6582759,"about_ca_system_score_codex":0.0011754287,"about_ca_system_score_gemma":0.0005157687,"threshold_uncertainty_score":0.30737054},"labels":[],"label_agreement":null},{"id":"W1978914151","doi":"10.1016/j.jval.2011.02.011","title":"CO2 REAL-WORLD COST-EFFECTIVENESS ANALYSIS OF CANCER DRUGS: COMPARATIVE EFFECTIVENESS RESEARCH USING RETROSPECTIVE CANADIAN REGISTRY DATA BEFORE AND AFTER DRUG APPROVAL","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Princess Margaret Cancer Centre; Toronto Public Health; Institute for Clinical Evaluative Sciences; Cancer Care Ontario","funders":"","keywords":"Medicine; Propensity score matching; Rituximab; CHOP; Diffuse large B-cell lymphoma; Internal medicine; Vincristine; Oncology; Lymphoma; Cyclophosphamide; Chemotherapy","score_opus":0.2396598784848678,"score_gpt":0.4013781695286586,"score_spread":0.16171829104379082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1978914151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875785,0.0029303,0.00011893004,0.0000797525,0.0002742358,0.0012642088,0.0028462242,0.000011003319,0.0048968275],"genre_scores_gemma":[0.99853843,0.00070790475,0.0003150304,0.000053288208,0.00007756994,0.00015009072,0.0000570059,0.000031085045,0.000069587484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99688673,0.00042558386,0.0008767659,0.00095657667,0.000091129,0.0007632057],"domain_scores_gemma":[0.9977348,0.00030635163,0.0005612109,0.00089387107,0.00015655177,0.0003472463],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006133654,0.00023921567,0.001416719,0.0017855518,0.0001913464,0.000045132478,0.00045676573,0.00012710472,0.00009600127],"category_scores_gemma":[0.00014472872,0.000279544,0.000091942486,0.0020081284,0.0003971292,0.0004769054,0.00018121907,0.00050128624,0.000006960601],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027578147,0.0000733478,0.96410644,0.00028510048,0.00034392453,0.0000058441806,0.006125942,0.00143798,9.860247e-7,0.026806984,0.00003303449,0.0005046149],"study_design_scores_gemma":[0.00059584266,0.00008907886,0.96987706,0.00029219777,0.00004190905,5.698158e-7,0.00039081727,0.020212796,0.000030092882,0.007754635,0.00047582676,0.00023914399],"about_ca_topic_score_codex":0.95623946,"about_ca_topic_score_gemma":0.76770204,"teacher_disagreement_score":0.1885374,"about_ca_system_score_codex":0.0032572157,"about_ca_system_score_gemma":0.00097617536,"threshold_uncertainty_score":0.99996567},"labels":[],"label_agreement":null},{"id":"W1979163175","doi":"10.1016/j.jval.2013.08.615","title":"Population Based Utilization of Radiation Therapy by a Canadian Breast Cancer Cohort","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ontario Institute for Cancer Research; Health Sciences Centre; Juravinski Cancer Centre; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"","keywords":"Cohort; Medicine; Breast cancer; Stage (stratigraphy); Population; Radiation therapy; Cancer; Cancer registry; Internal medicine; Oncology; Biology; Environmental health","score_opus":0.08946777351266681,"score_gpt":0.36046273229740905,"score_spread":0.2709949587847422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979163175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908733,0.0016757351,0.00010428798,0.0062899548,0.000085803185,0.00076107675,0.000049390877,0.000013398927,0.00014708808],"genre_scores_gemma":[0.9964602,0.0005599959,0.00011247994,0.0025975949,0.00004480135,0.000046940408,0.0001493196,0.000008555451,0.00002012968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913156,0.00007115398,0.0002735721,0.00012783824,0.00019904488,0.00019682581],"domain_scores_gemma":[0.99951476,0.000018268714,0.00010827546,0.000109237364,0.000078271696,0.0001711689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002754002,0.00006331903,0.00016779071,0.00013546276,0.00003731956,0.000006502158,0.000032797514,0.000053639007,0.00028925398],"category_scores_gemma":[0.00002310949,0.000059526297,0.000021041316,0.0002903395,0.000009053749,0.00009790105,0.0000015912424,0.00006669931,0.0000038647754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019114163,0.000014655143,0.94178295,0.000040960982,0.000003987356,3.0992345e-7,0.00007610407,0.0017287135,0.000056731053,0.000035027697,0.002016806,0.054224633],"study_design_scores_gemma":[0.0005543447,0.00007305625,0.96870977,0.00017828406,0.0000028027976,0.0000023916468,0.000021039992,0.029702244,0.000088794564,0.000039768544,0.0005831985,0.00004429217],"about_ca_topic_score_codex":0.98001844,"about_ca_topic_score_gemma":0.07499754,"teacher_disagreement_score":0.90502095,"about_ca_system_score_codex":0.0007465484,"about_ca_system_score_gemma":0.00086933566,"threshold_uncertainty_score":0.94188136},"labels":[],"label_agreement":null},{"id":"W1979178718","doi":"10.1016/j.jval.2011.02.648","title":"PIN16 COST COMPARISON OF LINEZOLID VERSUS VANCOMYCIN FOR TREATMENT OF NOSOCOMIAL PNEUMONIA AND COMPLICATED SKIN AND SOFT TISSUE INFECTION CAUSED BY MRSA IN QUEBEC","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); McGill University Health Centre; Université de Montréal","funders":"","keywords":"Linezolid; Vancomycin; Medicine; Pneumonia; Antibiotics; Intensive care medicine; Internal medicine; Emergency medicine; Staphylococcus aureus; Microbiology; Bacteria; Biology","score_opus":0.46201091256911625,"score_gpt":0.4536473642016599,"score_spread":0.008363548367456342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979178718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99089587,0.002861387,0.0011754975,0.0021814718,0.00028898628,0.0021213752,0.00037729004,0.000013769254,0.000084332096],"genre_scores_gemma":[0.9976637,0.0006528673,0.0012018146,0.00014959254,0.00004700726,0.00017601751,0.000054819084,0.000020623933,0.00003356499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959108,0.0002792911,0.003102161,0.00037472355,0.00004315676,0.00028986065],"domain_scores_gemma":[0.9968924,0.0010259241,0.0016929236,0.00022693828,0.00003527835,0.00012652235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002820693,0.00015962856,0.0012597585,0.0003334193,0.000060425566,0.0000104833425,0.000067782086,0.00013156488,0.000016172626],"category_scores_gemma":[0.0003162472,0.00020121636,0.00003801314,0.00016359634,0.00007908255,0.00013151059,0.000018401583,0.0000691719,0.000007675883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004935636,0.0014788966,0.9512455,0.0022021097,0.0000710127,3.2044713e-7,0.018725598,0.0011598365,0.00012286432,0.010017705,0.0011606297,0.013322001],"study_design_scores_gemma":[0.020060828,0.004774264,0.84985185,0.00048699172,0.000018735662,0.0000015646489,0.0014822024,0.076065645,0.0011680737,0.0026834568,0.042766396,0.0006399862],"about_ca_topic_score_codex":0.404986,"about_ca_topic_score_gemma":0.06540533,"teacher_disagreement_score":0.33958068,"about_ca_system_score_codex":0.0008001779,"about_ca_system_score_gemma":0.00018031648,"threshold_uncertainty_score":0.9516486},"labels":[],"label_agreement":null},{"id":"W1979446181","doi":"10.1016/j.jval.2012.05.007","title":"Costs of Adverse Drug Events in German Hospitals—A Microcosting Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":95,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"Helmholtz Zentrum München","keywords":"Medicine; Concomitant; Propensity score matching; Emergency medicine; Adverse effect; Resource use; Medical record; Drug reaction; Drug; Surgery; Internal medicine","score_opus":0.11483599506774046,"score_gpt":0.47773021674634986,"score_spread":0.3628942216786094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979446181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955251,0.00085604546,0.0000022539364,0.00037056245,0.0011609049,0.0011990791,0.00003471515,0.00003506413,0.000816246],"genre_scores_gemma":[0.9986558,0.00025021503,0.000043586908,0.0006705636,0.00015943765,0.00007530338,0.000011660977,0.000020690099,0.00011272508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971726,0.0009832277,0.00071750744,0.00023710418,0.00016038991,0.0007291571],"domain_scores_gemma":[0.99882054,0.00041789614,0.00028848948,0.00017262505,0.000030987452,0.0002694428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024095352,0.00018519869,0.00036700632,0.00029526607,0.00011088858,0.0000010924742,0.00019846672,0.000098310826,0.00011560056],"category_scores_gemma":[0.00007134721,0.00019787179,0.000064699605,0.0004837359,0.000045679964,0.0002794977,0.000070300746,0.00082472345,0.00009082981],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009609352,0.0023196673,0.98086834,0.000104652354,0.000033711898,0.000013478344,0.007806593,0.004434205,0.002212101,0.00016350781,0.00036331272,0.0015843287],"study_design_scores_gemma":[0.007694561,0.00019075412,0.9619847,0.00030712408,0.000054622844,0.00001996153,0.004841036,0.0028120119,0.0049075466,0.00012206135,0.016590573,0.0004750361],"about_ca_topic_score_codex":0.00234408,"about_ca_topic_score_gemma":0.00016096477,"teacher_disagreement_score":0.018883636,"about_ca_system_score_codex":0.00043495823,"about_ca_system_score_gemma":0.0001688175,"threshold_uncertainty_score":0.80689776},"labels":[],"label_agreement":null},{"id":"W1979792032","doi":"10.1016/s1098-3015(10)67721-2","title":"PHP20 GENERIC DRUG PRICES REMAIN HIGHER IN CANADA THAN IN THE UNITED STATES","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Business; Economics; Medicine; Pharmacology","score_opus":0.09635049559894734,"score_gpt":0.29200393933434815,"score_spread":0.1956534437354008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979792032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94418746,0.0028993976,0.0000038762496,0.049204983,0.00020016535,0.00025162564,0.000093516624,0.000006053115,0.0031528964],"genre_scores_gemma":[0.97498506,0.0031184389,0.00014836514,0.021465927,0.00012319621,0.000025489286,0.000024552679,0.00001564629,0.00009333853],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982222,0.000101169746,0.0008423144,0.0002724288,0.000034190452,0.00052772526],"domain_scores_gemma":[0.99922097,0.00021956819,0.0002187746,0.00022942136,0.0000048569314,0.00010643192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015026813,0.0001267518,0.00032147352,0.00037614067,0.000041293923,0.000031461484,0.0003131397,0.000036565285,0.00011221136],"category_scores_gemma":[0.00003013113,0.00012315248,0.00002755964,0.00071539707,0.000021252643,0.00009715103,0.000033503493,0.00030152322,0.00005345054],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030009754,0.00022669551,0.523183,0.00015103593,0.000013472066,0.000016749005,0.0054526953,0.24467146,8.159013e-7,0.2145462,0.009876268,0.0018316064],"study_design_scores_gemma":[0.0007605275,0.000019641002,0.23096848,0.000031041913,5.3334446e-7,0.0000015760286,0.00025526067,0.18228066,0.000004521979,0.015272264,0.5701772,0.0002282879],"about_ca_topic_score_codex":0.97699606,"about_ca_topic_score_gemma":0.90443885,"teacher_disagreement_score":0.56030095,"about_ca_system_score_codex":0.0014593324,"about_ca_system_score_gemma":0.00039418103,"threshold_uncertainty_score":0.50220126},"labels":[],"label_agreement":null},{"id":"W1980134073","doi":"10.1016/j.jval.2013.03.743","title":"Estimating The Cost For Prostate Cancer (Pca) Screening Using The Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial Data","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Prostate cancer; Cancer; Prostate cancer screening; Population; Prostate; Internal medicine; Cancer screening; Gynecology; Oncology; Prostate-specific antigen; Environmental health","score_opus":0.11495073201935023,"score_gpt":0.38708975788268785,"score_spread":0.2721390258633376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980134073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94551224,0.004077335,0.026092649,0.011340509,0.0009598912,0.011675875,0.00020156582,0.00010435651,0.00003559821],"genre_scores_gemma":[0.9684536,0.00019769996,0.026779441,0.0009579877,0.0012208853,0.0021574034,0.00006255977,0.000067785266,0.00010267209],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9975229,0.0002757037,0.00061667274,0.00058435125,0.00035242748,0.00064792956],"domain_scores_gemma":[0.9982713,0.0005328104,0.00038871643,0.0004799036,0.00015143062,0.00017582807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002133988,0.00023872861,0.00041931757,0.00011114688,0.00082177855,0.00016938683,0.00023640691,0.000090794936,0.000024719957],"category_scores_gemma":[0.00044690675,0.00015217195,0.000053105265,0.00049711,0.00014228867,0.00030061443,0.00019725638,0.00053352606,4.0269325e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.061800633,0.00012001348,0.068086036,0.0013142369,0.00027976307,0.000007334149,0.008174669,0.13932732,0.00050031085,0.000056329096,0.00328178,0.71705157],"study_design_scores_gemma":[0.013004856,0.0010122351,0.013334691,0.0010966264,0.000074702046,0.000040203322,0.0006382639,0.969479,0.00006405812,0.000052382235,0.0010287248,0.00017423641],"about_ca_topic_score_codex":0.14562039,"about_ca_topic_score_gemma":0.0028401578,"teacher_disagreement_score":0.83015174,"about_ca_system_score_codex":0.0003095392,"about_ca_system_score_gemma":0.0007980699,"threshold_uncertainty_score":0.860069},"labels":[],"label_agreement":null},{"id":"W1980548624","doi":"10.1016/s1098-3015(10)62159-6","title":"PCN17 THE HEALTH CARE COST OF SMOKING IN CANADA","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Environmental health; Health care; Business; Medicine; Economics; Economic growth","score_opus":0.36986206873539157,"score_gpt":0.4110139966545315,"score_spread":0.04115192791913991,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980548624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7351731,0.027908662,0.0006030227,0.23084933,0.0013010618,0.0024277377,0.0004972793,0.000020818818,0.0012189979],"genre_scores_gemma":[0.975083,0.0005558133,0.00058740797,0.023551546,0.00009642531,0.000070436,0.000019868092,0.000023505729,0.000011997139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933,0.0006090991,0.0048777685,0.00041282835,0.00013839532,0.0006618954],"domain_scores_gemma":[0.99632305,0.00072383386,0.0022185354,0.0005145145,0.00003235141,0.00018772566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014243689,0.00015087136,0.0009937931,0.0003013408,0.00015196431,0.000016476906,0.0003312852,0.00006398329,0.000038755225],"category_scores_gemma":[0.0010058545,0.00016894385,0.000052790667,0.00044139766,0.00004172205,0.00013343774,0.000039999457,0.00032685846,0.000033737702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00001930889,0.00009654763,0.5310104,0.002590545,0.000020695863,0.0000033521953,0.030036159,0.18213749,8.856777e-8,0.24827996,0.004385825,0.0014196447],"study_design_scores_gemma":[0.0061832694,0.00047587053,0.78960264,0.0027561316,0.000002627901,0.000017177754,0.06166054,0.009814867,0.000007588723,0.038498342,0.09004028,0.0009406602],"about_ca_topic_score_codex":0.9954065,"about_ca_topic_score_gemma":0.96024513,"teacher_disagreement_score":0.25859225,"about_ca_system_score_codex":0.013138269,"about_ca_system_score_gemma":0.009874854,"threshold_uncertainty_score":0.9957382},"labels":[],"label_agreement":null},{"id":"W1980689904","doi":"10.1016/j.jval.2013.08.256","title":"RESPIRATORY Syncytial Virus Hospitalization in Infants with Congenital Airway Anomalies in the Canadian Registry of Synagis® (CARESS) Following Prophylaxis (2005-2012)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Gestational age; Hazard ratio; Respiratory system; Bronchopulmonary dysplasia; Birth weight; Internal medicine; Pregnancy; Confidence interval","score_opus":0.03527261394622639,"score_gpt":0.31807774398471705,"score_spread":0.28280513003849067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980689904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942238,0.0014668638,0.000010577476,0.00060509297,0.00013128301,0.0021839002,0.000015917944,0.00001669498,0.0013459033],"genre_scores_gemma":[0.9989356,0.00003619983,0.00009761298,0.0005112414,0.000076916775,0.00024398092,0.000011090736,0.000031391814,0.000056004996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996926,0.0007101024,0.00074933056,0.0003440109,0.0005963431,0.00067421066],"domain_scores_gemma":[0.9987397,0.00014087082,0.00016224234,0.00056540745,0.0001470311,0.0002447187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017353344,0.00018696432,0.00041418234,0.0010189712,0.00012628692,0.000057029974,0.00022293055,0.00019388678,0.00006137662],"category_scores_gemma":[0.0006219173,0.00014065688,0.000049461243,0.0013101074,0.00018303818,0.00037736652,0.00002960798,0.0006398194,0.000019059993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001247732,0.00021342281,0.99240726,0.0003925817,0.000025630516,0.00022612265,0.0017836886,0.0014862025,0.00052969,0.00025640975,0.00031042146,0.0022437773],"study_design_scores_gemma":[0.0024742675,0.0025425863,0.98922586,0.00075536873,0.0000096845815,0.000023181196,0.0012184752,0.001466571,0.0006643488,0.00007801678,0.0012823208,0.00025931175],"about_ca_topic_score_codex":0.7059703,"about_ca_topic_score_gemma":0.6814381,"teacher_disagreement_score":0.024532149,"about_ca_system_score_codex":0.0011906757,"about_ca_system_score_gemma":0.0034886927,"threshold_uncertainty_score":0.61887914},"labels":[],"label_agreement":null},{"id":"W1980721312","doi":"10.1016/j.jval.2013.03.609","title":"Associations between inhibitors, treatment regimen, and bleed frequency and health care practitioner utilisation in the haemophilia treatment centre (HTC): Global results from the haemophilia experiences, results and opportunities (HERO) study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Haemophilia; Bleed; Medicine; Regimen; Haemophilia A; On demand; Pediatrics; Physical therapy; Internal medicine; Surgery","score_opus":0.15742800027807105,"score_gpt":0.3701846942367826,"score_spread":0.21275669395871152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980721312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8509201,0.005908132,2.8671832e-7,0.13748017,0.00007675587,0.0044499827,0.00088451325,0.000030298426,0.00024977862],"genre_scores_gemma":[0.9915619,0.005910809,0.00015477983,0.0004637666,0.00025350065,0.00030204625,0.0011902566,0.000016971371,0.00014599257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99576735,0.0014163383,0.0010053774,0.00068319583,0.00056759885,0.00056013936],"domain_scores_gemma":[0.9977955,0.00089163985,0.00037092218,0.0005089551,0.000105839186,0.00032711387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013535689,0.00033666537,0.0006249988,0.00012973473,0.00060423114,0.00013357677,0.0000978293,0.00013379505,0.0000075286057],"category_scores_gemma":[0.00020912809,0.00018963269,0.00004651117,0.0003372492,0.00021325545,0.00024378538,0.00004904831,0.000233918,0.0000036449826],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025207252,0.0011609691,0.6248122,0.000049321956,0.00016203296,0.000071278904,0.3323256,0.000007215538,0.0000019818665,0.00015487036,0.0018814125,0.03912107],"study_design_scores_gemma":[0.009246668,0.0034428127,0.8033444,0.00028028063,0.00006641348,0.000013135966,0.18212076,0.00011359331,0.000009515059,0.00045643008,0.0007445653,0.00016143045],"about_ca_topic_score_codex":0.25288266,"about_ca_topic_score_gemma":0.012747086,"teacher_disagreement_score":0.24013557,"about_ca_system_score_codex":0.0020212631,"about_ca_system_score_gemma":0.00094555295,"threshold_uncertainty_score":0.7732997},"labels":[],"label_agreement":null},{"id":"W1980903352","doi":"10.1016/j.jval.2014.03.1123","title":"Identifying and characterizing trajectories of qol in persons with advanced cancer: Important contributors to decreasing QOL in people with cancer","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Rasch model; Quality of life (healthcare); Trajectory; Sample (material); Cancer; Medicine; Psychology; Gerontology; Clinical psychology; Statistics; Developmental psychology; Mathematics","score_opus":0.020390998609687055,"score_gpt":0.3062792508983643,"score_spread":0.2858882522886772,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1980903352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940882,0.0031653529,0.00007699476,0.0016215693,0.00018573413,0.000787696,0.00003608031,0.000018833116,0.000019591966],"genre_scores_gemma":[0.9978422,0.0010762741,0.00031685183,0.00046087682,0.000069282905,0.0001846247,0.0000074548752,0.000030627474,0.000011824762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832934,0.000121223966,0.00047972347,0.0003516388,0.00026293466,0.0004551547],"domain_scores_gemma":[0.9992236,0.00012082538,0.00020815969,0.00017532811,0.00006294445,0.00020916585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006003816,0.00017763836,0.00067668647,0.0002921988,0.00004592078,0.000014734485,0.00005546365,0.000053541902,0.000010270942],"category_scores_gemma":[0.00007331039,0.00014806075,0.00002233827,0.0007196699,0.00004092746,0.0001154924,0.000017847044,0.0002448543,9.503335e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009406146,0.00004209428,0.966676,0.000902592,0.000012140158,0.000014462561,0.024157163,0.00026141334,0.0011478489,0.0000616745,0.0000021312894,0.005781841],"study_design_scores_gemma":[0.002970324,0.0006048288,0.9806055,0.0065477076,0.000019173347,0.000018497089,0.007044254,0.0005541406,0.0011252231,0.000011449212,0.00029925545,0.00019966724],"about_ca_topic_score_codex":0.2997968,"about_ca_topic_score_gemma":0.44023415,"teacher_disagreement_score":0.14043738,"about_ca_system_score_codex":0.0006422581,"about_ca_system_score_gemma":0.0008239877,"threshold_uncertainty_score":0.70486593},"labels":[],"label_agreement":null},{"id":"W1981020961","doi":"10.1111/j.1524-4733.2008.00390.x","title":"Satisfaction and Adherence in Patients with Iron Overload Receiving Iron Chelation Therapy as Assessed by a Newly Developed Patient Instrument","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Radiation Oncology","funders":"","keywords":"Information and Communications Technology; Discriminant validity; Proxy (statistics); Medicine; Psychology; Clinical psychology; Internal consistency; Psychometrics; Statistics; Computer science; Mathematics","score_opus":0.025753772580764993,"score_gpt":0.2679021752747526,"score_spread":0.24214840269398757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981020961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99753475,0.0007882908,0.000036360976,0.0003314636,0.000098851786,0.0010140899,0.0000040095615,0.000021092037,0.00017107106],"genre_scores_gemma":[0.99577624,0.002193767,0.0013110999,0.0005884525,0.0000110084375,0.000031890657,0.000045783538,0.000017218741,0.000024545136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985597,0.00015620865,0.00038937238,0.00028349643,0.00034527402,0.00026591172],"domain_scores_gemma":[0.99949974,0.00004137835,0.00017480689,0.0001367661,0.000035575762,0.00011172466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001991245,0.00015006456,0.00025409096,0.00014341054,0.00008180836,0.00000882035,0.000023573382,0.00007534829,0.000026458498],"category_scores_gemma":[0.000056542274,0.00012698508,0.000012029373,0.00027031824,0.00003427854,0.00018179175,0.000011338222,0.00018733983,0.000004688758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005537703,0.0002282245,0.89653295,0.00009482511,0.0000017893744,0.0000021755861,0.0027597933,0.00018272686,0.00007372289,0.000016764809,0.00006155312,0.0994917],"study_design_scores_gemma":[0.0068709077,0.0012628089,0.990817,0.0002061378,0.000002688204,0.0000042094034,0.0002286259,0.00015508883,0.000054791955,0.000027116022,0.00024578505,0.0001248325],"about_ca_topic_score_codex":0.019038351,"about_ca_topic_score_gemma":0.00028443616,"teacher_disagreement_score":0.099366866,"about_ca_system_score_codex":0.00024856944,"about_ca_system_score_gemma":0.0003766647,"threshold_uncertainty_score":0.98749393},"labels":[],"label_agreement":null},{"id":"W1981095025","doi":"10.1016/s1098-3015(10)68752-9","title":"PDB35 ESTIMATING HEALTH-RELATED QUALITY OF LIFE FROM HYPOGLYCEMIA ELICITED FROM NON-DIABETIC AND DIABETIC RESPONDENTS IN CANADA","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hypoglycemia; Medicine; Diabetes mellitus; Quality (philosophy); Internal medicine; Gerontology; Demography; Endocrinology; Sociology","score_opus":0.0407051014722163,"score_gpt":0.3132564774822903,"score_spread":0.272551376010074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981095025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99046725,0.006125477,0.000015614658,0.0020284425,0.00022071341,0.0008561533,0.00023720111,0.000015336771,0.000033833006],"genre_scores_gemma":[0.9953379,0.00019828888,0.0024566234,0.0017310585,0.000043562064,0.000021512882,0.00018211592,0.000024438794,0.000004468908],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964537,0.00043401547,0.0016255827,0.00043899906,0.00048602273,0.0005616839],"domain_scores_gemma":[0.9967851,0.001624538,0.0004930211,0.0003548948,0.00004616929,0.0006962674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012212954,0.00020749177,0.0009839582,0.00021617093,0.000055657532,0.0000075678113,0.00008228415,0.00008746668,0.00004832638],"category_scores_gemma":[0.00053795427,0.00019946041,0.000045866516,0.0004308541,0.000041253865,0.000046013585,0.00004424819,0.0002795965,0.0000040653617],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040423704,0.00038693775,0.99197316,0.00042035055,0.000067088724,0.00005869933,0.0013896347,0.0006233,0.000056854482,0.000013472598,0.00010657687,0.004499711],"study_design_scores_gemma":[0.005351119,0.0002112862,0.98075336,0.0016835901,0.000022894461,5.7206273e-7,0.00043451044,0.010986969,0.00010117287,0.00032178534,0.000006391225,0.00012637059],"about_ca_topic_score_codex":0.9948738,"about_ca_topic_score_gemma":0.61296076,"teacher_disagreement_score":0.38191304,"about_ca_system_score_codex":0.0018629739,"about_ca_system_score_gemma":0.0036857708,"threshold_uncertainty_score":0.81337595},"labels":[],"label_agreement":null},{"id":"W1981434189","doi":"10.1016/j.jval.2012.08.1392","title":"PMS37 Economic Evaluation Model of Biologic Therapies for Moderate to Severe Psoriatic Arthritis in Germany","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Adalimumab; Medicine; Etanercept; Golimumab; Psoriatic arthritis; Infliximab; Physical therapy; Internal medicine; Psoriasis; Arthritis; Rheumatoid arthritis; Dermatology; Disease","score_opus":0.4996306489840518,"score_gpt":0.44468598770321616,"score_spread":0.05494466128083564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981434189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672318,0.008922194,0.0057061217,0.013606862,0.00071708765,0.0030277416,0.0004685015,0.00002274264,0.00029694862],"genre_scores_gemma":[0.98412955,0.00082869135,0.010101541,0.003949348,0.00021197306,0.0006750996,0.000029828469,0.00003210159,0.000041865984],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9937158,0.00065645145,0.004413571,0.0004564426,0.00007891376,0.0006787997],"domain_scores_gemma":[0.9969142,0.0008462772,0.0016074695,0.0003946421,0.000045943234,0.00019144936],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.035087857,0.00019176367,0.0011532331,0.0006328605,0.00008513843,0.000022801745,0.00019911952,0.00015076775,0.00008956035],"category_scores_gemma":[0.0012583431,0.0002466346,0.00009275707,0.00016500396,0.000028722512,0.0004646182,0.000032449327,0.00012834821,0.0002392612],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000077505014,0.00019496333,0.044031627,0.0006881121,0.000029067516,4.370816e-8,0.011981621,0.7868899,0.000006016528,0.15207833,0.0011623706,0.002860447],"study_design_scores_gemma":[0.0018016199,0.00014914622,0.024112329,0.0002083255,0.0000020865382,0.0000013489885,0.00049882836,0.8906789,0.0000062593085,0.08133987,0.00091217237,0.0002891503],"about_ca_topic_score_codex":0.0055943015,"about_ca_topic_score_gemma":0.0010232402,"teacher_disagreement_score":0.103788964,"about_ca_system_score_codex":0.0017677939,"about_ca_system_score_gemma":0.00055244815,"threshold_uncertainty_score":0.99999857},"labels":[],"label_agreement":null},{"id":"W1981444985","doi":"10.1016/j.jval.2012.03.1205","title":"PCN88 Cost-Effectiveness Analysis of Plerixafor for Stem Cell Mobilization for Poor Mobilizers in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Plerixafor; Medicine; Apheresis; Mobilization; Transplantation; Autologous stem-cell transplantation; Stem cell; Oncology; Internal medicine; Surgery; CXCR4; Inflammation","score_opus":0.06590964393684261,"score_gpt":0.35433582077139053,"score_spread":0.2884261768345479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981444985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817309,0.0005750649,0.010977955,0.00026397553,0.00017655894,0.005994331,0.00023866157,0.000009592087,0.000032983233],"genre_scores_gemma":[0.99729437,0.00006907912,0.0010686044,0.00019626893,0.000042159005,0.0011126866,0.00013619363,0.00003112326,0.000049513743],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978054,0.0002497609,0.00063684804,0.00027136857,0.0003609577,0.00067564857],"domain_scores_gemma":[0.99681276,0.0022999828,0.00019006369,0.00026594073,0.00017094745,0.00026029043],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020673524,0.00013994217,0.0007417466,0.00054999907,0.000036936282,0.0000033495896,0.00009219722,0.000081873106,0.000012958962],"category_scores_gemma":[0.00027036597,0.00012898435,0.00010766548,0.0013050818,0.000030725223,0.00007287985,0.000024299392,0.00010525322,4.961115e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0035079643,0.0009845463,0.69855404,0.014077242,0.00041563224,0.0000051548927,0.0019842095,0.2652813,0.0021632207,0.00072350685,0.0008638509,0.0114393495],"study_design_scores_gemma":[0.009854877,0.0007606864,0.1475918,0.00043668193,0.00026707663,0.000003174341,0.0020971491,0.8304248,0.007105446,0.0000341344,0.001217436,0.00020675892],"about_ca_topic_score_codex":0.790401,"about_ca_topic_score_gemma":0.29411063,"teacher_disagreement_score":0.56514347,"about_ca_system_score_codex":0.0083842715,"about_ca_system_score_gemma":0.006932115,"threshold_uncertainty_score":0.99869764},"labels":[],"label_agreement":null},{"id":"W1981640814","doi":"10.1016/j.jval.2012.03.903","title":"PRM47 Bayesian Regression Models for Estimation of Illness-Attributable Cost from Aggregate Data","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; Toronto Public Health","funders":"","keywords":"Heteroscedasticity; Econometrics; Statistics; Bayesian probability; Linear regression; Deviance information criterion; Linear model; Regression analysis; Deviance (statistics); Regression; Aggregate (composite); Computer science; Mathematics; Bayesian inference","score_opus":0.5553241385409977,"score_gpt":0.46242685935298067,"score_spread":0.09289727918801705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981640814","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1401272,0.031649195,0.7705728,0.03662726,0.0025163614,0.0053004418,0.012498678,0.00009628736,0.0006118284],"genre_scores_gemma":[0.9412739,0.0007860106,0.053641666,0.0020588243,0.00037506627,0.00019666358,0.0015295687,0.000049213853,0.000089074056],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9940594,0.00045887267,0.0041712,0.0005496904,0.000111744754,0.0006491349],"domain_scores_gemma":[0.9938172,0.0016247444,0.0031443473,0.0010948941,0.00004731909,0.00027149817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023340132,0.00018324298,0.0011177352,0.0003116635,0.00017907674,0.000023382177,0.00045363262,0.00016447219,0.00008309892],"category_scores_gemma":[0.003093074,0.0002196485,0.00006026094,0.0002396595,0.000041944626,0.0015112967,0.00010844656,0.00015232858,0.00011403424],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020445063,0.0010881186,0.09189506,0.0062694107,0.00012775116,5.506594e-7,0.017302757,0.4257437,0.0000059734753,0.36878785,0.07060201,0.01797237],"study_design_scores_gemma":[0.0009379391,0.000047362522,0.0025018663,0.00059068593,0.0000038856315,0.0000010365841,0.00041372448,0.9251852,0.000018303806,0.0569394,0.013133557,0.00022705426],"about_ca_topic_score_codex":0.019301165,"about_ca_topic_score_gemma":0.00013214418,"teacher_disagreement_score":0.80114675,"about_ca_system_score_codex":0.0007022875,"about_ca_system_score_gemma":0.00035011696,"threshold_uncertainty_score":0.9872294},"labels":[],"label_agreement":null},{"id":"W1981750179","doi":"10.1016/j.jval.2012.10.017","title":"Core Domains for a Person-Focused Outcome Measurement System in Cancer (PROMS-Cancer Core) for Routine Care: A Scoping Review and Canadian Delphi Consensus","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Cancer Care Ontario; Laurentian University; Sunnybrook Hospital; University of Toronto; University Health Network","funders":"","keywords":"Delphi method; Patient-reported outcome; Delphi; Medicine; Outcome (game theory); Relevance (law); Data collection; Quality of life (healthcare); Family medicine; Psychology; Nursing; Computer science; Artificial intelligence; Political science","score_opus":0.7098607806527949,"score_gpt":0.5635107219169783,"score_spread":0.14635005873581663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981750179","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027198128,0.9487814,0.00002705907,0.0043248706,0.00047155397,0.04536248,0.00080649654,0.00007637319,0.00012258653],"genre_scores_gemma":[0.0003629248,0.9681792,0.0016788496,0.00042881907,0.00024244981,0.02892483,0.000027064008,0.00010322133,0.00005261332],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9934437,0.0010598592,0.0018619723,0.000945888,0.00096428936,0.0017242682],"domain_scores_gemma":[0.99599546,0.0011065064,0.0009050829,0.00048208833,0.00073389773,0.00077698135],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011776209,0.0005217036,0.0031453539,0.00070420065,0.00057033414,0.00009859541,0.00066651584,0.00048811542,0.000026593334],"category_scores_gemma":[0.0018920756,0.0004743637,0.00030515596,0.0010568723,0.0002448485,0.00006163668,0.00005769303,0.000628365,0.0000036264607],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000009629488,0.000020475441,0.0005104001,0.7049276,0.000052720738,0.0000101103715,0.0027231106,0.0000057129487,4.153616e-8,0.0020636555,0.002679628,0.28699693],"study_design_scores_gemma":[0.0007195039,0.00012489245,0.000013396669,0.6327242,0.00019598438,0.000005115021,0.0017868744,0.00012692911,4.5761453e-8,0.000036632442,0.36372277,0.00054363196],"about_ca_topic_score_codex":0.8980265,"about_ca_topic_score_gemma":0.8919067,"teacher_disagreement_score":0.36104313,"about_ca_system_score_codex":0.019651987,"about_ca_system_score_gemma":0.028196441,"threshold_uncertainty_score":0.9997708},"labels":[],"label_agreement":null},{"id":"W1981868458","doi":"10.1016/j.jval.2011.08.801","title":"PCV81 Cost-Effectiveness of Ticagrelor Versus Clopidogrel in Patients with Acute Coronary Syndrome: Results from the Plato Study: A Canadian Analysis","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); University of Toronto; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Ticagrelor; Medicine; Clopidogrel; Acute coronary syndrome; Myocardial infarction; Stroke (engine); Internal medicine; Cardiology; Emergency medicine; Intensive care medicine","score_opus":0.13223122112659944,"score_gpt":0.30803283665559306,"score_spread":0.17580161552899362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981868458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946445,0.00016335407,0.0000087524195,0.00028268565,0.00020948943,0.0011634986,0.0025724794,0.0000055918126,0.0009496328],"genre_scores_gemma":[0.9993818,0.000095713986,0.000085220134,0.00026641245,0.000009133199,0.00004975628,0.00009060413,0.000017127044,0.0000042393294],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806565,0.0001744402,0.00085528503,0.00042730052,0.000046629808,0.00043068334],"domain_scores_gemma":[0.9984796,0.0004941857,0.00033217226,0.0004384654,0.000022881859,0.00023271811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014893459,0.0001534997,0.00064123084,0.0004953125,0.00006192499,0.000014069173,0.0003074975,0.00007915915,0.00006168397],"category_scores_gemma":[0.0000886075,0.00013902133,0.000069687456,0.0008725257,0.000062244726,0.0000953907,0.00004793928,0.00025910666,0.00004575127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001542673,0.00032713733,0.9902528,0.0000126748155,0.0004927072,0.00001680201,0.0016756804,0.0013431588,9.710127e-9,0.003991741,0.000015679612,0.00032894957],"study_design_scores_gemma":[0.005778526,0.00057063776,0.98870045,0.0000310486,0.000038983984,3.6155794e-7,0.00008736934,0.0034017316,5.767558e-7,0.00094507524,0.00029656987,0.00014866161],"about_ca_topic_score_codex":0.73589325,"about_ca_topic_score_gemma":0.17560342,"teacher_disagreement_score":0.5602898,"about_ca_system_score_codex":0.00061922404,"about_ca_system_score_gemma":0.0002721558,"threshold_uncertainty_score":0.8394397},"labels":[],"label_agreement":null},{"id":"W1981949269","doi":"10.1016/s1098-3015(10)68895-x","title":"PAR3 COST-EFFECTIVENESS OF LUMIRACOXIB COMPARED TO CELECOXIB FOR THE TREATMENT OF OSTEOARTHRITIS IN CANADA","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Celecoxib; Osteoarthritis; Medicine; Physical therapy; Internal medicine; Alternative medicine","score_opus":0.05299187663136262,"score_gpt":0.33012523879893735,"score_spread":0.2771333621675747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1981949269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943005,0.0012907404,0.00026186547,0.00041104073,0.00030330094,0.0032336968,0.00013296043,0.000003799486,0.00006211303],"genre_scores_gemma":[0.99916565,0.00026950368,0.0002151628,0.00016543242,0.00004237243,0.00009990521,0.000016104674,0.000010830499,0.000015037937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987143,0.000100629106,0.0005093476,0.000153028,0.0001785091,0.00034416319],"domain_scores_gemma":[0.99838907,0.0011452102,0.00011235579,0.00017804644,0.000044470507,0.00013083646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082886626,0.0000997719,0.00046114615,0.00009863779,0.000033271455,0.0000013367977,0.000042610234,0.00002648415,0.0000103146385],"category_scores_gemma":[0.00005699905,0.000070505404,0.000043821005,0.00022086021,0.000030116955,0.000012905095,0.0000069881485,0.000057018784,4.6533313e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026769063,0.0007867188,0.560897,0.0010273107,0.000034337994,0.000064445645,0.001511401,0.004671264,0.00042860283,0.00018962096,0.00016256578,0.4275498],"study_design_scores_gemma":[0.009767709,0.00378184,0.9560477,0.0009781907,0.000014580263,0.000031349296,0.0009558938,0.000998972,0.0048619905,0.000015829732,0.022439532,0.000106423795],"about_ca_topic_score_codex":0.84461534,"about_ca_topic_score_gemma":0.8647701,"teacher_disagreement_score":0.4274434,"about_ca_system_score_codex":0.0006993829,"about_ca_system_score_gemma":0.0013036532,"threshold_uncertainty_score":0.2875127},"labels":[],"label_agreement":null},{"id":"W1982075712","doi":"10.1016/j.jval.2014.03.239","title":"Predictive value of patient-reported outcomes to mucosal healing in patients with moderately to severely active ulcerative colitis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Ulcerative colitis; Odds ratio; Endoscopy; Placebo; Predictive value; Colonoscopy; Randomized controlled trial; Surgery; Colorectal cancer; Pathology","score_opus":0.009956226513502874,"score_gpt":0.25571165718539535,"score_spread":0.24575543067189248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982075712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969568,0.000006333725,0.0007757944,0.00019155224,0.000109545326,0.001601346,0.00015871505,0.000011915613,0.00018795546],"genre_scores_gemma":[0.9972701,0.0000025406916,0.0013043211,0.0011358754,0.000028375482,0.00012047086,0.00009001961,0.000033637443,0.000014638354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976283,0.00049110915,0.0006229577,0.00050530233,0.0003092922,0.00044308513],"domain_scores_gemma":[0.99882513,0.000044228247,0.00024985423,0.00034221428,0.00023261299,0.00030597555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035594526,0.00022501219,0.00035898446,0.00017692488,0.000058440357,0.000010685324,0.00012515807,0.00010347856,0.0000032839966],"category_scores_gemma":[0.00035054245,0.00021190726,0.00004600197,0.00021341527,0.00003750284,0.000012103727,0.00009066567,0.00013125534,0.0000032080925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027511455,0.00073068094,0.67316836,0.00020825156,0.0001231677,0.000024497993,0.0055159354,0.28986832,0.00008351507,0.00058084057,0.00012939748,0.0020555581],"study_design_scores_gemma":[0.0018604789,0.001722076,0.99223477,0.00015030724,0.000006053337,7.308365e-7,0.00018122958,0.002038419,0.0014253325,0.0000961289,0.000072332856,0.00021216324],"about_ca_topic_score_codex":0.001789638,"about_ca_topic_score_gemma":0.0006797961,"teacher_disagreement_score":0.31906638,"about_ca_system_score_codex":0.00019838412,"about_ca_system_score_gemma":0.0005112022,"threshold_uncertainty_score":0.86413276},"labels":[],"label_agreement":null},{"id":"W1982238087","doi":"10.1016/j.jval.2012.08.1650","title":"PDB7 Clinical and Resource Utilization Outcomes: Elderly Type 2 Diabetes Patients Initiating Insulin Pens Versus Vials","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Glycemic; Type 2 diabetes; Hazard ratio; Diabetes mellitus; Vial; Insulin; Emergency medicine; Basal (medicine); Confounding; Internal medicine; Emergency department; Retrospective cohort study; Proportional hazards model; Cohort; Basal insulin; Endocrinology; Confidence interval; Nursing","score_opus":0.260492809157935,"score_gpt":0.43904066903157063,"score_spread":0.17854785987363564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982238087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938958,0.0013445561,0.000005316552,0.00084612815,0.0006109579,0.00060093636,0.0000069898706,0.00005635039,0.0026329383],"genre_scores_gemma":[0.99816424,0.00037525053,0.00025080086,0.00086972123,0.00018507299,0.0000094125935,0.00009043021,0.000021103036,0.000033944103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821365,0.00029820882,0.0006230935,0.00021587979,0.00024684958,0.00040230647],"domain_scores_gemma":[0.9987949,0.00052133086,0.00018325892,0.00021846803,0.000043801698,0.00023822965],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011058938,0.00012695653,0.0003475621,0.000118676944,0.00006727559,0.000019312927,0.000052178522,0.000071562376,0.00004229152],"category_scores_gemma":[0.001519389,0.00011621836,0.000038061295,0.00022125476,0.00006600932,0.00011670179,0.000067509776,0.00015402619,0.000021118023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001436873,0.00034744138,0.9774246,0.00045204227,0.00003152127,0.0000012316431,0.00044986323,0.000027673876,4.290049e-7,0.00075706706,0.0005506686,0.01981377],"study_design_scores_gemma":[0.004622974,0.00090577564,0.9865984,0.00027829024,0.000041039857,1.7104287e-7,0.0005016133,0.00071687315,0.0000016400869,0.00009143102,0.0061341757,0.000107652806],"about_ca_topic_score_codex":0.00015950295,"about_ca_topic_score_gemma":0.000013362806,"teacher_disagreement_score":0.019706117,"about_ca_system_score_codex":0.00012258107,"about_ca_system_score_gemma":0.00016973229,"threshold_uncertainty_score":0.47392473},"labels":[],"label_agreement":null},{"id":"W1982378721","doi":"10.1016/j.jval.2013.08.1748","title":"Estimating Chronic Disease PREVALENCE from Claims Data: Reducing Bias by Accounting for Diseased Individuals Who Do Not Generate Claims","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Bayes' theorem; Disease; Poisson distribution; Medicine; Statistics; Estimator; Prevalence; Sampling bias; Demography; Econometrics; Bayesian probability; Epidemiology; Mathematics; Sample size determination; Internal medicine","score_opus":0.615827141474533,"score_gpt":0.5471703359299652,"score_spread":0.06865680554456777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982378721","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6727115,0.0026929735,0.29871866,0.004421031,0.0021621862,0.0068874834,0.012078076,0.0003053944,0.000022691022],"genre_scores_gemma":[0.0987673,0.00022106376,0.89747334,0.00080755557,0.0017680103,0.0005820447,0.00018871289,0.00012786563,0.00006408663],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99173486,0.002312253,0.0026675514,0.001426921,0.00077633036,0.0010821114],"domain_scores_gemma":[0.92541546,0.07014887,0.0014447161,0.00204482,0.00016356196,0.0007825503],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010493024,0.00042946037,0.0011616088,0.000120114375,0.0003426072,0.00036087798,0.0011700533,0.00020230246,0.00029362782],"category_scores_gemma":[0.08208787,0.000395622,0.0001344593,0.00034968197,0.00016627196,0.00054608926,0.0004939474,0.00057412864,0.00004707999],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009788924,0.0039367825,0.10654836,0.06481504,0.0010366591,0.00004757541,0.0038600431,0.03508821,0.002617753,0.055068012,0.1888855,0.5371172],"study_design_scores_gemma":[0.001459525,0.000111664776,0.004496109,0.002921379,0.00012713972,3.8779646e-7,0.00002827231,0.49022865,0.00010836238,0.49997994,0.00012985306,0.00040869703],"about_ca_topic_score_codex":0.0015089433,"about_ca_topic_score_gemma":0.000006052121,"teacher_disagreement_score":0.5987547,"about_ca_system_score_codex":0.00044401808,"about_ca_system_score_gemma":0.00093649863,"threshold_uncertainty_score":0.99984956},"labels":[],"label_agreement":null},{"id":"W1982640454","doi":"10.1016/j.jval.2011.08.821","title":"PCV101 Population Based Study : Impact of Adherence to Antihypertensive Agents on Cardiovascular Issues","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Stroke (engine); Dyslipidemia; Diabetes mellitus; Cohort; Atrial fibrillation; Myocardial infarction; Antihypertensive drug; Confounding; Cardiology; Population; Cohort study; Disease; Blood pressure","score_opus":0.2572403119841725,"score_gpt":0.4145455327213656,"score_spread":0.15730522073719305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982640454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976902,0.00031228396,0.000093448056,0.00019206488,0.00009837838,0.0012680512,0.0000037059792,0.000020945456,0.00032091656],"genre_scores_gemma":[0.9983618,0.00003428541,0.0007455893,0.00067046937,0.000034891218,0.000037544592,0.000008494658,0.000010538252,0.00009636204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857736,0.00017219753,0.00038657745,0.00025778424,0.00040882945,0.00019727465],"domain_scores_gemma":[0.99903774,0.000026178603,0.00011333248,0.00051787,0.00011715062,0.0001877149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005441046,0.000107013504,0.0004416337,0.00017045756,0.000027702234,0.000002310104,0.00009243353,0.000035543893,0.00029772942],"category_scores_gemma":[0.00017169882,0.00008566249,0.000119183474,0.00036318647,0.000009771006,0.000030168521,0.000011710927,0.00010828622,0.00015889596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000203083,0.0007640859,0.988944,0.00013100154,0.000076035736,0.000020461277,0.0017774393,0.0014452242,0.000026584805,0.000023995271,0.0006130238,0.0059750634],"study_design_scores_gemma":[0.0010062074,0.0041171806,0.992274,0.0005309954,0.000018538902,0.0000025087877,0.0003706216,0.0014256592,0.00008182754,0.000036678695,0.00006779741,0.00006799757],"about_ca_topic_score_codex":0.044484627,"about_ca_topic_score_gemma":0.000019452455,"teacher_disagreement_score":0.044465177,"about_ca_system_score_codex":0.0001433281,"about_ca_system_score_gemma":0.00025863838,"threshold_uncertainty_score":0.96187824},"labels":[],"label_agreement":null},{"id":"W1982661893","doi":"10.1016/s1098-3015(10)62692-7","title":"PCV51 SHORT AND LONG-TERM COST-EFFECTIVENESS OF EARLY AND SUSTAINED DUAL ORAL ANTIPLATELET THERAPY WITH CLOPIDROGREL FOLLOWING PERCUTANEOUS CORONARY INTERVENTION:A CANADIAN ECONOMIC ANALYSIS","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Percutaneous coronary intervention; Medicine; Dual (grammatical number); Term (time); Cardiology; Intervention (counseling); Internal medicine; Intensive care medicine; Myocardial infarction; Nursing","score_opus":0.023288697709602253,"score_gpt":0.3016375212899182,"score_spread":0.278348823580316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982661893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859128,0.012675374,0.00008035201,0.000147482,0.000038359412,0.0010817307,0.000028844526,0.000019822788,0.000015227383],"genre_scores_gemma":[0.9973493,0.0022609914,0.00009996278,0.00011650553,0.000038269525,0.00001989677,0.00007784056,0.000025372578,0.0000118579455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984413,0.0003560979,0.0003505381,0.00034755975,0.00015142445,0.00035308304],"domain_scores_gemma":[0.9992592,0.00009347617,0.00006452497,0.00022216923,0.000033900855,0.00032676797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008578625,0.00018947595,0.0007431608,0.000385491,0.00009288497,0.00002331726,0.00004868716,0.00008555682,0.000033072505],"category_scores_gemma":[0.0000073885276,0.0001658861,0.00025095398,0.00023971823,0.000102764185,0.00012203774,0.000015515665,0.00014255806,8.5875683e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017603778,0.000106487285,0.9368414,0.00026555854,0.0020668283,0.0010084935,0.00028108712,0.00150334,0.000023845074,0.000046357836,0.0000010066045,0.056095216],"study_design_scores_gemma":[0.0035487264,0.001246782,0.99182755,0.00035188592,0.0003488828,0.00094368437,0.00015183254,0.0012790051,0.000039480503,0.000008401798,0.00008328204,0.00017051195],"about_ca_topic_score_codex":0.037109405,"about_ca_topic_score_gemma":0.016253144,"teacher_disagreement_score":0.055924706,"about_ca_system_score_codex":0.00031752748,"about_ca_system_score_gemma":0.00042290526,"threshold_uncertainty_score":0.9693026},"labels":[],"label_agreement":null},{"id":"W1982873545","doi":"10.1016/j.jval.2012.03.530","title":"PMH85 An Application of Group-Based Modeling Approach for Trajectory Recognition: The Developmental Courses of Hyperactivity and Inattentive Symptoms","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Multinomial logistic regression; Trajectory; Demography; Socioeconomic status; Baseline (sea); Multinomial distribution; Psychology; Longitudinal study; Logistic regression; Joint (building); Medicine; Mathematics; Statistics; Population","score_opus":0.11572012945685523,"score_gpt":0.34815249365856743,"score_spread":0.2324323642017122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1982873545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89942765,0.000368344,0.098658934,0.00023774282,0.00003282179,0.001180983,0.000028824961,0.000013800797,0.000050866314],"genre_scores_gemma":[0.98502773,0.000022628237,0.014475987,0.00012425687,0.000038399066,0.00016912357,0.000121791905,0.00001755242,0.0000025570412],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989128,0.00017626895,0.00034302677,0.00018262443,0.00019036373,0.00019487993],"domain_scores_gemma":[0.99924374,0.00023404334,0.00021102089,0.0001350407,0.000099807665,0.00007637535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010014627,0.00010088369,0.0002785272,0.00011545984,0.000073792384,0.0000032057906,0.00004174132,0.00006151798,0.000003922357],"category_scores_gemma":[0.000081822735,0.00008372722,0.00004381608,0.00016657123,0.000071377886,0.00019849569,0.000011161723,0.0001394985,5.186392e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013047497,0.008911293,0.83441126,0.004117667,0.00015276617,3.3060041e-7,0.0057802694,0.020183694,0.013144242,0.0013130971,0.000012850178,0.11066779],"study_design_scores_gemma":[0.0033189682,0.00052512035,0.18261905,0.00022480366,0.0000869296,0.000033817305,0.0123658115,0.7998093,0.00063266145,0.00014603592,0.000033678625,0.00020385842],"about_ca_topic_score_codex":0.0007277348,"about_ca_topic_score_gemma":0.000014272913,"teacher_disagreement_score":0.7796256,"about_ca_system_score_codex":0.00010875198,"about_ca_system_score_gemma":0.00016879947,"threshold_uncertainty_score":0.34142968},"labels":[],"label_agreement":null},{"id":"W1983266155","doi":"10.1016/j.jval.2012.03.095","title":"PHP18 The Impact of Patent Expiries on Future Drug Spending in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Generic drug; Prescription drug; Market share; Competition (biology); Business; Audit; Medical prescription; Drug; Drug prices; Product (mathematics); Brand names; Public economics; Marketing; Medicine; Economics; Pharmacology; Accounting","score_opus":0.1685645391951565,"score_gpt":0.3302935532945758,"score_spread":0.16172901409941934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983266155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98792744,0.0036506269,0.0000013985745,0.0043386254,0.00055350043,0.00017271806,0.00014374862,0.0000024326694,0.0032094885],"genre_scores_gemma":[0.9976165,0.0011022977,0.000015150552,0.0009987085,0.00022755627,0.000007195486,0.0000031016134,0.00001071896,0.000018752287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987621,0.00004487079,0.00059027673,0.00013170356,0.00002286658,0.0004482112],"domain_scores_gemma":[0.9993155,0.00012102663,0.0002390299,0.00018630845,0.0000030581314,0.00013505583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093677005,0.00009878638,0.00030618918,0.00013330387,0.00003702438,0.000009632759,0.00015353746,0.00002630533,0.00015621432],"category_scores_gemma":[0.000032374057,0.000081466904,0.000058400186,0.00016853365,0.00001924373,0.00008364234,0.000028313136,0.00021379827,0.000030396488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016358596,0.000060148814,0.8754621,0.000038387774,0.00000978367,6.1941114e-7,0.0014592938,0.008330934,5.7526546e-7,0.11193935,0.0017255279,0.00095688744],"study_design_scores_gemma":[0.0005212823,0.000045063392,0.9616387,0.000041782612,5.641344e-7,0.0000016135496,0.00036486686,0.010488544,0.000035945148,0.0075096567,0.019187236,0.000164752],"about_ca_topic_score_codex":0.9492229,"about_ca_topic_score_gemma":0.24157228,"teacher_disagreement_score":0.7076506,"about_ca_system_score_codex":0.001447604,"about_ca_system_score_gemma":0.00032043294,"threshold_uncertainty_score":0.77226704},"labels":[],"label_agreement":null},{"id":"W1983493219","doi":"10.1016/j.jval.2010.09.002","title":"Another Study Showing that Two Preference-Based Measures of Health-Related Quality of Life (EQ-5D and SF-6D) are Not Interchangeable. But Why Should We Expect Them to be?","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institutes of Health; National Institute for Health and Care Research","keywords":"Comparability; EQ-5D; Descriptive statistics; Framing (construction); Quality of life (healthcare); Framing effect; Valuation (finance); Psychology; Medicine; Applied psychology; Social psychology; Statistics; Health related quality of life; Mathematics","score_opus":0.9434072829642454,"score_gpt":0.4452543826606597,"score_spread":0.49815290030358567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983493219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95731163,0.0044498625,0.001568496,0.03330934,0.0003962192,0.0021882143,0.00035127965,0.000050998875,0.0003739738],"genre_scores_gemma":[0.98384184,0.00021256266,0.0016988493,0.013902496,0.00004895528,0.00017433206,0.000007754412,0.00005677895,0.00005642704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9870911,0.003612155,0.0074140136,0.00088598824,0.00029962466,0.0006970694],"domain_scores_gemma":[0.9923698,0.0015081745,0.004772573,0.0008727396,0.00011049413,0.00036624048],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.04289534,0.0003371617,0.0026278938,0.000757423,0.0001677136,0.000029214789,0.00044101087,0.00017164,0.0002488671],"category_scores_gemma":[0.0030629283,0.00038479787,0.00013589383,0.0004420459,0.00010659866,0.00027036984,0.00010863471,0.00034669472,0.000037699876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032404685,0.0011136814,0.8881089,0.0031134924,0.00013578942,0.0000010313391,0.09805673,0.0010859184,0.000006256738,0.0057220543,0.0011463526,0.0011857548],"study_design_scores_gemma":[0.008251309,0.0023682923,0.89168537,0.003117323,0.000016645454,0.0000038774756,0.07716727,0.0073531284,0.00021431917,0.0068974625,0.0016766646,0.0012483282],"about_ca_topic_score_codex":0.1762273,"about_ca_topic_score_gemma":0.009148872,"teacher_disagreement_score":0.16707844,"about_ca_system_score_codex":0.0007370009,"about_ca_system_score_gemma":0.00069057796,"threshold_uncertainty_score":0.9998604},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"grok","categories":[],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":["metaresearch"],"domain":"methods","study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W1983498363","doi":"10.1016/j.jval.2012.03.963","title":"PDB42 Health Care Resources Utilization and Cost for Hypoglycemia and Metabolic Acidosis in Type Ii Diabetes: an Analysis of the Ramq Database","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada); Université de Montréal","funders":"","keywords":"Medicine; Hypoglycemia; Metabolic acidosis; Intensive care medicine; Diabetes mellitus; Acidosis; Type 2 diabetes; Emergency medicine; Complication; Pediatrics; Internal medicine; Endocrinology","score_opus":0.09970736455137315,"score_gpt":0.38521560358663337,"score_spread":0.28550823903526024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983498363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96919715,0.028004963,0.000011787955,0.0014477198,0.00006207872,0.0011674361,0.00006037625,0.000008495416,0.00003998646],"genre_scores_gemma":[0.9961001,0.0025870798,0.00036632258,0.0006413808,0.000046456415,0.000033467768,0.00016584639,0.000013013711,0.0000463121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852383,0.0002945022,0.00033870258,0.00020803117,0.00022217425,0.00041276927],"domain_scores_gemma":[0.9991874,0.00013587077,0.00012830461,0.0003061843,0.00005048733,0.00019174954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016645709,0.00009415658,0.00043098602,0.0005297653,0.00013006895,0.0000112874095,0.00008073685,0.000043059765,0.00000925027],"category_scores_gemma":[0.00022841623,0.000067061104,0.000034205852,0.0012706807,0.000077905985,0.00012074636,0.00010637892,0.0001231219,2.049752e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011142774,0.00016938391,0.9294784,0.0013679529,0.00009000028,1.0645676e-7,0.006060712,0.00014660394,0.000054336662,0.00036444998,0.000117232485,0.062039383],"study_design_scores_gemma":[0.0014384957,0.00045375925,0.9591973,0.00027203158,0.00018605564,1.0215514e-7,0.0021463525,0.024195423,0.00010733979,0.00001603811,0.011905632,0.00008150153],"about_ca_topic_score_codex":0.0014617711,"about_ca_topic_score_gemma":0.00040002578,"teacher_disagreement_score":0.06195788,"about_ca_system_score_codex":0.00008313967,"about_ca_system_score_gemma":0.00010770949,"threshold_uncertainty_score":0.27346727},"labels":[],"label_agreement":null},{"id":"W1983883585","doi":"10.1016/j.jval.2012.08.2151","title":"PCN111 The Value of Personalizing Medicine: Medical Oncologists' and Patients' Perspectives on Genomic Testing of Breast Tumours in Chemotherapy Treatment Decisions","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Medicine; Breast cancer; Personalized medicine; Family medicine; Oncology; Internal medicine; Test (biology); Adjuvant chemotherapy; Precision medicine; Clinical trial; Qualitative research; Cancer; Bioinformatics; Pathology","score_opus":0.041398487211644436,"score_gpt":0.3378483142578909,"score_spread":0.29644982704624645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1983883585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99226505,0.0050703827,0.000041208263,0.0020779937,0.00008398486,0.00027785532,0.00001671947,0.000002325202,0.00016448702],"genre_scores_gemma":[0.9967225,0.0015265578,0.0013280358,0.00024455425,0.00013089943,0.000021542144,0.000007734494,0.000012722496,0.0000054485017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880475,0.00023538891,0.0003522667,0.0001989929,0.00019531713,0.00021326052],"domain_scores_gemma":[0.999149,0.00036218116,0.00017382564,0.00018406732,0.00005112029,0.00007978673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086615054,0.00010631419,0.00020881977,0.000080673504,0.00004590683,0.0000017039446,0.000115115814,0.000078489014,0.00001191628],"category_scores_gemma":[0.00058584986,0.00007284925,0.00002928475,0.0001613819,0.00023685046,0.0000028034594,0.000033929424,0.0000923278,2.9499634e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023791057,0.0010479563,0.9075013,0.00006222645,0.000049164333,0.0000011058703,0.027139112,0.0023479944,0.005305021,0.0014956227,0.0001558846,0.054656748],"study_design_scores_gemma":[0.002400589,0.0017256783,0.98329693,0.00034424546,0.00000993664,0.000027037811,0.009085384,0.00092395226,0.0014808811,0.00015109111,0.00043426128,0.00011998835],"about_ca_topic_score_codex":0.0026494726,"about_ca_topic_score_gemma":0.00011328386,"teacher_disagreement_score":0.0757957,"about_ca_system_score_codex":0.00035778398,"about_ca_system_score_gemma":0.00056554447,"threshold_uncertainty_score":0.40052277},"labels":[],"label_agreement":null},{"id":"W1984056668","doi":"10.1016/j.jval.2014.03.1610","title":"Expected Cost-Utility Of Quadrivalent Influenza Vaccine Under A Universal Influenza Immunization Program In Ontario, Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Influenza season; Vaccination; Context (archaeology); Influenza vaccine; Family medicine; Virology; Environmental health; Geography","score_opus":0.10796801393252238,"score_gpt":0.37866680626958577,"score_spread":0.2706987923370634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984056668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99533504,0.000682855,0.00006275728,0.0007547409,0.000104999985,0.0023603493,0.000011099374,0.000055390854,0.0006327442],"genre_scores_gemma":[0.99733865,0.00006963167,0.00073151826,0.0016451288,0.000026081874,0.00009149997,0.0000254008,0.000026672606,0.000045387515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964838,0.00060562923,0.0010784084,0.0003807453,0.0007284072,0.00072302524],"domain_scores_gemma":[0.99822617,0.00031792687,0.0002735673,0.0005973154,0.0003346101,0.00025044053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001245521,0.00023843591,0.0007273695,0.00042599707,0.00009056232,0.000009332314,0.00018982205,0.00011445578,0.00013052001],"category_scores_gemma":[0.0008605038,0.00022899146,0.000052374948,0.00091627456,0.00008513315,0.00011260162,0.00013624938,0.0007037085,0.0000032137998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009216138,0.0005568289,0.98228496,0.0005985498,0.000052800075,0.000013141597,0.002890795,0.007290993,0.00006552782,0.00058710534,0.00045714766,0.004280547],"study_design_scores_gemma":[0.0050895624,0.0006007556,0.9645396,0.00055582676,0.000010548482,0.0000029340729,0.00091495906,0.008058149,0.00012317605,0.00010891003,0.019834835,0.00016078338],"about_ca_topic_score_codex":0.9950017,"about_ca_topic_score_gemma":0.9881671,"teacher_disagreement_score":0.019377686,"about_ca_system_score_codex":0.0034949072,"about_ca_system_score_gemma":0.005783254,"threshold_uncertainty_score":0.999853},"labels":[],"label_agreement":null},{"id":"W1984365279","doi":"10.1016/s1098-3015(10)72617-6","title":"PMS29 CANADIAN COST-EFFECTIVENESS ANALYSIS OF ABATACEPT (ORENCIA™) FOR THE MANAGEMENT OF MODERATELY TO SEVERELY ACTIVE RHEUMATOID ARTHRITIS IN PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Abatacept; Rheumatoid arthritis; Methotrexate; Medicine; Internal medicine; Physical therapy; Rituximab","score_opus":0.03102628711597862,"score_gpt":0.32510420139191865,"score_spread":0.29407791427594004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984365279","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99269235,0.00030059883,0.0006579827,0.0013087132,0.000055085016,0.0045720506,0.0003693807,0.000007326647,0.00003649054],"genre_scores_gemma":[0.9957001,0.001272766,0.0022418466,0.00014772662,0.0000032084456,0.0005635603,0.000035699464,0.000023969431,0.000011100303],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99763745,0.00053876283,0.00051748805,0.00033155677,0.0004153565,0.00055936666],"domain_scores_gemma":[0.99795824,0.0007830437,0.00013664248,0.00042141386,0.00027114296,0.00042952388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027399827,0.0001650424,0.0006959455,0.00125533,0.00009379618,0.000014446335,0.000173039,0.000056792538,0.000025511676],"category_scores_gemma":[0.00029713623,0.00012535979,0.00007755714,0.0017753526,0.00007059383,0.000079574485,0.00004019855,0.00024988974,0.0000026403015],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12462557,0.0011066046,0.19063365,0.000920438,0.0030422816,0.000061962804,0.020314986,0.05884006,0.0003066077,0.0032855067,0.00008469726,0.5967776],"study_design_scores_gemma":[0.004132976,0.0013787524,0.9881859,0.001148205,0.000011951108,0.000001236067,0.00060563197,0.0028136678,0.0008555874,0.00009736391,0.0006468409,0.00012189364],"about_ca_topic_score_codex":0.22309469,"about_ca_topic_score_gemma":0.2806032,"teacher_disagreement_score":0.7975522,"about_ca_system_score_codex":0.00032382587,"about_ca_system_score_gemma":0.00078480353,"threshold_uncertainty_score":0.7820788},"labels":[],"label_agreement":null},{"id":"W1984409207","doi":"10.1016/j.jval.2013.03.495","title":"Cost-effectiveness of onabotulinumtoxinA for prophylaxis of headaches in adults with chronic migraine in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Allergan (Canada)","funders":"","keywords":"Medicine; Headaches; Chronic Migraine; Migraine; Absenteeism; Cost effectiveness; Quality of life (healthcare); Placebo; Presenteeism; Cohort; Quality-adjusted life year; Observational study; Physical therapy; Pediatrics; Internal medicine; Psychiatry; Alternative medicine","score_opus":0.043580499574816675,"score_gpt":0.3023273814371241,"score_spread":0.25874688186230743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984409207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901283,0.004001495,0.000021050893,0.0012203931,0.000014000965,0.004515211,0.000026519052,0.0000044971343,0.00006855903],"genre_scores_gemma":[0.99832624,0.00029350174,0.0005993586,0.00007973788,0.000028124445,0.0005977784,0.00001620343,0.000017735249,0.000041315903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983157,0.00018263815,0.00062098517,0.00025048899,0.0002226733,0.0004075505],"domain_scores_gemma":[0.99886054,0.0005500907,0.00016482611,0.00020425556,0.00013186157,0.00008844917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075187004,0.00015094748,0.00080592127,0.00022428622,0.000016781385,0.0000010722327,0.000067701076,0.00005148293,0.000011005554],"category_scores_gemma":[0.00022949961,0.00011786299,0.00004186839,0.0005025955,0.00006422075,0.000039310216,0.000018906641,0.0002073393,4.1955374e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019982853,0.00053437083,0.9530439,0.031445812,0.000042432122,0.000015671969,0.003944669,0.0020367012,0.00041220276,0.0002455075,0.0006380175,0.0056424323],"study_design_scores_gemma":[0.0065375795,0.0039069676,0.9763686,0.0069936574,0.0000058067885,0.000005721057,0.0017051337,0.0027737655,0.0012018286,0.00014334057,0.00023007093,0.00012753047],"about_ca_topic_score_codex":0.9867638,"about_ca_topic_score_gemma":0.9784924,"teacher_disagreement_score":0.024452155,"about_ca_system_score_codex":0.0013703367,"about_ca_system_score_gemma":0.0046946285,"threshold_uncertainty_score":0.83280694},"labels":[],"label_agreement":null},{"id":"W1984627843","doi":"10.1016/j.jval.2012.03.1088","title":"PIH56 Measuring Quality of Life in Facial Aesthetic Patients: Field-Testing of a New Modular System (the FACE-Q)","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Body Image and Dysmorphia Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rasch model; Cronbach's alpha; Scale (ratio); Face validity; Patient satisfaction; Patient-reported outcome; Quality of life (healthcare); Medicine; Physical therapy; Psychology; Psychometrics; Clinical psychology; Surgery; Nursing; Developmental psychology","score_opus":0.19312952834844882,"score_gpt":0.35915619842530067,"score_spread":0.16602667007685185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984627843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99500674,0.002512507,0.00025919388,0.00057757844,0.00040911758,0.00041814978,0.000005552021,0.00001818812,0.0007929889],"genre_scores_gemma":[0.99943924,0.000010073894,0.00025410234,0.00017656846,0.00007256142,0.000018995504,8.880986e-7,0.00001083047,0.000016739123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750245,0.00074140093,0.0009496808,0.00016810642,0.00023857065,0.0003998022],"domain_scores_gemma":[0.99878865,0.00034682036,0.00039921573,0.00031230392,0.00005913366,0.00009390104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001829283,0.00011603407,0.00046561076,0.000107459775,0.000053300493,0.0000034227653,0.00015406303,0.000071364826,0.000011507319],"category_scores_gemma":[0.0006336037,0.00009430402,0.000055107692,0.00032986447,0.00004048869,0.0000622031,0.0000571484,0.00020075373,0.000012532823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066371394,0.00023567637,0.9665635,0.00047831656,0.000014332059,6.730103e-7,0.02034,0.0005061088,0.000014638513,0.0012446655,0.00013559088,0.01040012],"study_design_scores_gemma":[0.0015166336,0.00022761554,0.99113953,0.00045072896,0.000007291661,0.0000022543193,0.0058764173,0.000313651,0.000040574676,0.00013369453,0.0001580807,0.00013352532],"about_ca_topic_score_codex":0.06004485,"about_ca_topic_score_gemma":0.00016469705,"teacher_disagreement_score":0.059880152,"about_ca_system_score_codex":0.00009264568,"about_ca_system_score_gemma":0.00011671222,"threshold_uncertainty_score":0.9462144},"labels":[],"label_agreement":null},{"id":"W1984790513","doi":"10.1111/j.1524-4733.2009.00531.x","title":"Economic Evaluation of Atorvastatin for Prevention of Recurrent Stroke Based on the SPARCL Trial","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Atorvastatin; Stroke (engine); Life expectancy; Quality-adjusted life year; Emergency medicine; Clinical trial; Cost–benefit analysis; Economic evaluation; Health care; Cost effectiveness; Internal medicine; Environmental health; Population","score_opus":0.11316720568272373,"score_gpt":0.3796711519156389,"score_spread":0.2665039462329152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1984790513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895691,0.00051005813,0.0009309283,0.00314356,0.0002529299,0.0053537525,0.000031580796,0.000006230695,0.00020182048],"genre_scores_gemma":[0.9984635,0.000071714116,0.00094717613,0.00018264464,0.00018179884,0.000113263486,0.000023355831,0.0000071520544,0.000009358889],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980429,0.00061236107,0.000584818,0.00015590127,0.00044999723,0.00015404235],"domain_scores_gemma":[0.99906796,0.00015180148,0.00030685184,0.00033306112,0.00008751701,0.000052825984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007848544,0.000070835864,0.00034002066,0.00010257431,0.00002914106,0.0000022210766,0.00004595363,0.000041046656,0.000028250499],"category_scores_gemma":[0.0002948864,0.00005202259,0.00019989841,0.00007338937,0.000014640841,0.000017873399,0.0000029974253,0.0000916974,0.0000011620185],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024756417,0.0013616727,0.000584431,0.001295051,0.00007658257,2.9445764e-7,0.0004942375,0.038480163,0.00014904338,0.006992514,0.00060292287,0.92520666],"study_design_scores_gemma":[0.17591561,0.04026055,0.06453483,0.003195317,0.0003405956,0.000003538325,0.0003761456,0.6984204,0.005735763,0.008704368,0.002255776,0.00025710696],"about_ca_topic_score_codex":0.000547959,"about_ca_topic_score_gemma":0.000032549444,"teacher_disagreement_score":0.9249496,"about_ca_system_score_codex":0.0003520187,"about_ca_system_score_gemma":0.0012809348,"threshold_uncertainty_score":0.27201644},"labels":[],"label_agreement":null},{"id":"W1985698909","doi":"10.1016/j.jval.2011.08.1153","title":"PCN52 Economic Impact of Healthcare Resource Utilisation Patterns Among Patients Diagnosed with Advanced Melanoma in the UK, Italy, and France: Results From a Retrospective, Longitudinal Survey (Melody Study)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Observational study; Health care; Emergency medicine; Indirect costs; Demography; Longitudinal study; Retrospective cohort study; Family medicine; Total cost; Pediatrics; Internal medicine","score_opus":0.2575587007074151,"score_gpt":0.3797984415554727,"score_spread":0.12223974084805761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985698909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99307495,0.0005735034,0.000031991574,0.00058197894,0.00015380509,0.002540742,0.0029085109,0.000015895992,0.00011862502],"genre_scores_gemma":[0.99890804,0.00015992564,0.00016494213,0.00028926524,0.00005542831,0.00014300142,0.00023753103,0.000035859757,0.0000060260604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9918127,0.0022142634,0.004301584,0.00095479155,0.00016446851,0.0005521697],"domain_scores_gemma":[0.99380416,0.0019416687,0.0032088773,0.0007910048,0.00006965903,0.00018465136],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.017753584,0.00029680817,0.0013054635,0.0004864705,0.0001553236,0.00004009185,0.00035066798,0.00013464288,0.000049294064],"category_scores_gemma":[0.0015996846,0.00028176355,0.00007640881,0.00035727574,0.000108101834,0.0004047898,0.000053988442,0.0003742624,0.000019718274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031824206,0.00030617273,0.969115,0.000101741665,0.000035280165,0.0000024237268,0.028676009,0.0009957398,1.5090976e-8,0.00026060332,0.0000725674,0.000116188276],"study_design_scores_gemma":[0.0042089247,0.0017415789,0.98716533,0.00026007177,0.0000029339433,6.2384026e-7,0.0038146784,0.001959697,2.528111e-7,0.00059685117,0.000008931508,0.00024009567],"about_ca_topic_score_codex":0.6662957,"about_ca_topic_score_gemma":0.122417815,"teacher_disagreement_score":0.5438779,"about_ca_system_score_codex":0.001724465,"about_ca_system_score_gemma":0.00036376447,"threshold_uncertainty_score":0.99996346},"labels":[],"label_agreement":null},{"id":"W1985863126","doi":"10.1016/j.jval.2014.03.487","title":"Partially Covered Self-Expandable Metal Stents are More Cost-Effective When Compared to Plastic Stents for Patients with Distal Malignant Biliary Obstruction","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Endoscopic retrograde cholangiopancreatography; Stent; Occlusion; Surgery; Percutaneous; Randomized controlled trial; Radiology; Palliative care; Cost effectiveness","score_opus":0.019947464601942938,"score_gpt":0.26772380129703904,"score_spread":0.2477763366950961,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985863126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98897254,0.000040061146,0.0014879943,0.00043373407,0.0006938864,0.008024538,0.00024199464,0.00008052565,0.000024713374],"genre_scores_gemma":[0.9968347,0.0000069404655,0.0014387902,0.00039835187,0.00007893256,0.000794864,0.00035602655,0.00004679531,0.000044585904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997633,0.00020027958,0.0005071853,0.00054078526,0.0005093419,0.0006094398],"domain_scores_gemma":[0.9986199,0.00024896231,0.00023058805,0.0002997571,0.0002182634,0.00038250463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033360446,0.00027627347,0.00064147846,0.00017763223,0.00013848569,0.000025711939,0.00010506771,0.00008104144,0.000013463586],"category_scores_gemma":[0.00026193995,0.00021211864,0.00008752446,0.00023235843,0.000044095326,0.00012741076,0.000040285682,0.00016354688,0.000011116581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044310084,0.0018555135,0.9802992,0.0012939773,0.0002009188,0.000005384637,0.0020660306,0.005828283,0.0000623578,0.00003262655,0.0007368367,0.0031879111],"study_design_scores_gemma":[0.0129347285,0.0050693685,0.9638261,0.0008239778,0.00014376784,0.000007599475,0.0010764261,0.013890276,0.000113048365,0.00012043577,0.0016707594,0.000323469],"about_ca_topic_score_codex":0.001081745,"about_ca_topic_score_gemma":0.00025803258,"teacher_disagreement_score":0.016473008,"about_ca_system_score_codex":0.00039506954,"about_ca_system_score_gemma":0.00020029349,"threshold_uncertainty_score":0.8649947},"labels":[],"label_agreement":null},{"id":"W1985932235","doi":"10.1016/j.jval.2014.03.446","title":"A Canadian Cost Impact Analysis Comparing Maintenance Therapy with Bortezomib Versus Lenalidomide in Multiple Myeloma Patients Ineligible for Stem Cell Transplant","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Ottawa Hospital; Thames Valley Children's Centre","funders":"","keywords":"Lenalidomide; Multiple myeloma; Bortezomib; Medicine; Internal medicine; Adverse effect; Oncology; Pharmacist; Pharmacy; Family medicine","score_opus":0.06781060032788233,"score_gpt":0.32664158267949694,"score_spread":0.2588309823516146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985932235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962916,0.00020810176,0.00035526353,0.0003775794,0.000048740785,0.002331574,0.00019009502,0.000018572215,0.00017849986],"genre_scores_gemma":[0.99835336,0.00024097679,0.00056870136,0.00015431253,0.000027120232,0.00021525784,0.00037202172,0.000032664946,0.00003557592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975712,0.00020238252,0.00048052732,0.00041259587,0.00031189903,0.0010214304],"domain_scores_gemma":[0.99822026,0.00046796928,0.00012490593,0.00033380234,0.000096106945,0.0007569317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006372434,0.00023854223,0.00073215726,0.00084108446,0.00010894242,0.000024352563,0.00012409678,0.000069472306,0.000010211552],"category_scores_gemma":[0.00005165141,0.00017232627,0.00013653409,0.00084348134,0.00003206127,0.00007003018,0.0000075547896,0.00021980348,0.0000059452727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008664043,0.00034544902,0.97278076,0.00014002153,0.00022716384,0.000032493856,0.0006854544,0.010730202,0.000012362672,0.000010824733,0.000053907857,0.006317325],"study_design_scores_gemma":[0.040794443,0.0018127149,0.79371136,0.00032043096,0.000044127213,0.0000022712463,0.0001083477,0.16255604,0.00015601823,0.0000050495737,0.0003282179,0.00016099584],"about_ca_topic_score_codex":0.65316015,"about_ca_topic_score_gemma":0.5360967,"teacher_disagreement_score":0.1790694,"about_ca_system_score_codex":0.0018188155,"about_ca_system_score_gemma":0.00096569065,"threshold_uncertainty_score":0.7027261},"labels":[],"label_agreement":null},{"id":"W1985991035","doi":"10.1111/j.1524-4733.2006.00140.x","title":"Cost-Benefit Analysis of Preventing Sudden Cardiac Deaths with an Implantable Cardioverter Defibrillator versus Amiodarone","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Medtronic","keywords":"Amiodarone; Medicine; Sudden cardiac death; Implantable cardioverter-defibrillator; Euros; Cardiology; Internal medicine; Heart failure; Emergency medicine; Intensive care medicine; Atrial fibrillation","score_opus":0.04944143327188163,"score_gpt":0.32448441750422835,"score_spread":0.27504298423234674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1985991035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9292225,0.0034191865,0.00012943688,0.000023042863,0.00017658967,0.0004792276,0.00014342966,0.00005792849,0.06634865],"genre_scores_gemma":[0.9977903,0.00023723749,0.0014652053,0.000032621876,0.00017996386,0.000014110269,0.00011363248,0.000025279263,0.00014164936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998041,0.00013448794,0.000573743,0.00037015093,0.0004502025,0.00043043424],"domain_scores_gemma":[0.99882925,0.00024090386,0.00022936694,0.00043481085,0.0001278469,0.00013780287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060720294,0.00018737442,0.0016108276,0.00046223853,0.000099942576,0.00001552472,0.000020754853,0.000069589325,0.0000016862828],"category_scores_gemma":[0.000032297517,0.0001622715,0.00030828544,0.0011207252,0.00004572488,0.00008755397,0.000029080256,0.00010150007,0.000004175203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010338144,0.000061566556,0.90184665,0.00026418938,0.0023922957,0.0000017728847,0.0007198241,0.089056775,0.00010156495,0.00048165343,0.0024354365,0.0016044589],"study_design_scores_gemma":[0.0044253464,0.0010950087,0.96243936,0.00044996646,0.0030601986,0.00009860882,0.0013782274,0.002586271,0.00041258478,0.000056962235,0.023527777,0.00046971813],"about_ca_topic_score_codex":0.032437652,"about_ca_topic_score_gemma":0.00061071385,"teacher_disagreement_score":0.08647051,"about_ca_system_score_codex":0.0002483506,"about_ca_system_score_gemma":0.00019123788,"threshold_uncertainty_score":0.9740054},"labels":[],"label_agreement":null},{"id":"W1986048654","doi":"10.1016/j.jval.2013.03.657","title":"Cost Of Lost Productivity Due To Prostate Cancer: Evidence From Us National Survey Data","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Medical Expenditure Panel Survey; Cancer; Prostate; Demography; Indirect costs; Population; Gynecology; Health care; Internal medicine; Environmental health; Health insurance","score_opus":0.7484706441441304,"score_gpt":0.49857626945084527,"score_spread":0.24989437469328518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986048654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9045759,0.0048956424,0.0009455809,0.07533652,0.00086499966,0.0033793973,0.009835596,0.000021915825,0.00014444038],"genre_scores_gemma":[0.9865755,0.00072936027,0.0051784078,0.006224289,0.00037818454,0.00033581402,0.00034087375,0.000036147598,0.00020146799],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931436,0.001286985,0.003886148,0.0009791605,0.00021716925,0.00048690254],"domain_scores_gemma":[0.99334437,0.0030061633,0.0020759297,0.0010488743,0.00024667522,0.00027796178],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.036791865,0.00017329308,0.0010249638,0.00033725184,0.000094783136,0.00005801195,0.00066592975,0.00008464961,0.0004653267],"category_scores_gemma":[0.017779488,0.00022239909,0.000032075677,0.0005094835,0.000061145765,0.0010760515,0.00020216784,0.0002086656,0.0016570596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026539466,0.00013363926,0.9476859,0.00053218636,0.00002404061,2.993084e-7,0.0022217557,0.013411424,0.000003354454,0.0011258675,0.03418898,0.0006459997],"study_design_scores_gemma":[0.00032208185,0.00006389785,0.9567798,0.0004973054,9.4330005e-7,9.679053e-7,0.00010571142,0.033235017,0.0000064326077,0.0041683824,0.00460321,0.00021628258],"about_ca_topic_score_codex":0.6243244,"about_ca_topic_score_gemma":0.0228781,"teacher_disagreement_score":0.6014463,"about_ca_system_score_codex":0.0013265861,"about_ca_system_score_gemma":0.0015432753,"threshold_uncertainty_score":0.9991203},"labels":[],"label_agreement":null},{"id":"W1986511872","doi":"10.1016/j.jval.2012.08.808","title":"PMH18 Treatment Patterns and Costs in Patients With Schizophrenia in Germany","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Medical Studies","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Schizophrenia (object-oriented programming); Quarter (Canadian coin); Medicine; Psychiatry; Indirect costs; Health care; Diagnosis of schizophrenia; Inpatient care; Psychosis; Geography; Business","score_opus":0.06400115011933152,"score_gpt":0.39382248393996316,"score_spread":0.3298213338206316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986511872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99352384,0.0011878493,0.000004172179,0.0028742005,0.00033693537,0.0017291331,0.000025026713,0.000020273863,0.0002985644],"genre_scores_gemma":[0.9956907,0.0013295227,0.0001504912,0.002357242,0.00013516087,0.00026518074,0.000012538363,0.000017288516,0.000041864696],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686337,0.000824109,0.00068753894,0.00022959046,0.0002198962,0.0011754895],"domain_scores_gemma":[0.99867666,0.00044521954,0.00014281354,0.00015530012,0.000021500786,0.00055853574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011273006,0.00016071538,0.00042612752,0.00019162541,0.00018632015,0.0000019975505,0.000051250045,0.00012238113,0.00003695512],"category_scores_gemma":[0.00013532431,0.00011348565,0.00001151655,0.0002440266,0.00003393727,0.00008992546,0.00004822607,0.0004936778,0.00004102445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000212495,0.00037042957,0.96718735,0.00036321342,0.0000028693235,0.0000029283715,0.0065871356,0.0000027935341,5.1644868e-8,0.00016489024,0.00008011832,0.025025738],"study_design_scores_gemma":[0.0058804643,0.00041893576,0.9876958,0.0011845143,0.0000015819443,2.345454e-7,0.00062792294,0.000039376755,1.7548464e-7,0.00001926737,0.004035812,0.000095898635],"about_ca_topic_score_codex":0.06491786,"about_ca_topic_score_gemma":0.016440466,"teacher_disagreement_score":0.048477396,"about_ca_system_score_codex":0.0014590811,"about_ca_system_score_gemma":0.0005162256,"threshold_uncertainty_score":0.9413089},"labels":[],"label_agreement":null},{"id":"W1986612822","doi":"10.1016/j.jval.2012.08.1982","title":"PND58 Effects of BG-12 on Quality of Life in Relapsing–Remitting Multiple Sclerosis: Findings From the Phase 3 Confirm Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Neurological Institute and Hospital","funders":"","keywords":"Placebo; Medicine; Quality of life (healthcare); Glatiramer acetate; Expanded Disability Status Scale; Visual analogue scale; Multiple sclerosis; Relapsing remitting; Internal medicine; Physical therapy; Clinical endpoint; Randomized controlled trial; Psychiatry","score_opus":0.570892913816223,"score_gpt":0.4504607870046034,"score_spread":0.12043212681161958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986612822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987353,0.004720854,0.00012449783,0.0044141356,0.00089184573,0.0021420862,0.00020068373,0.000020465164,0.00013238078],"genre_scores_gemma":[0.9956513,0.00016308969,0.0005082508,0.003320343,0.00019155245,0.00010697768,0.000014832168,0.000032410084,0.00001122873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9887541,0.0027908087,0.0071171187,0.00050396274,0.0002010563,0.00063298293],"domain_scores_gemma":[0.9816755,0.013518308,0.0037962482,0.0007364692,0.000036773647,0.00023671228],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.048081983,0.00022018085,0.001668246,0.00036100633,0.00013343133,0.000019473879,0.0003555367,0.00014917753,0.00004335274],"category_scores_gemma":[0.02100958,0.00023521253,0.00011838473,0.00036388423,0.000082054685,0.00028091692,0.00006648121,0.000411984,0.000092168506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096772455,0.0016620671,0.9652391,0.00081480335,0.00003492341,1.292476e-7,0.024853058,0.0006617941,0.000016975862,0.0060236184,0.00040832817,0.00018841791],"study_design_scores_gemma":[0.0065768035,0.00041272593,0.98199373,0.0012049652,0.0000039422393,1.3533356e-7,0.005352911,0.0031273523,0.000040928506,0.00080804946,0.00026184123,0.00021658836],"about_ca_topic_score_codex":0.107164174,"about_ca_topic_score_gemma":0.0014177547,"teacher_disagreement_score":0.105746426,"about_ca_system_score_codex":0.00069508434,"about_ca_system_score_gemma":0.00027835043,"threshold_uncertainty_score":0.98723686},"labels":[],"label_agreement":null},{"id":"W1986691999","doi":"10.1016/s1098-3015(10)70208-4","title":"PCN30 COSTS RELATED TO ADVERSE EVENTS IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH TYROSINE KINASE INHIBITORS IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myeloid leukemia; Tyrosine kinase; Medicine; Adverse effect; Tyrosine-kinase inhibitor; Oncology; Internal medicine; Cancer research; Pharmacology; Cancer; Receptor","score_opus":0.014335736900875546,"score_gpt":0.24540235617157014,"score_spread":0.23106661927069458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986691999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99587506,0.0005820914,3.5946618e-7,0.00047863435,0.00018030108,0.002584946,0.00003497724,0.000044265733,0.00021939108],"genre_scores_gemma":[0.9982257,0.00035663552,0.00013401077,0.0005546146,0.000034914974,0.00013357386,0.00022672775,0.0000749877,0.00025887557],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960906,0.0002814711,0.0011416253,0.0007168436,0.00070975634,0.0010596984],"domain_scores_gemma":[0.9984458,0.00011270744,0.00023710307,0.0005430042,0.00007590966,0.0005854678],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003033501,0.00041958492,0.0008075496,0.0006378079,0.000077003875,0.000001634072,0.00014542222,0.00015361371,0.000050421037],"category_scores_gemma":[0.0001439226,0.0003813819,0.000045998426,0.0019246856,0.000045968667,0.00011935021,0.00006017088,0.00063038856,0.00004553448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00061670213,0.00032703354,0.97791183,0.0001556048,0.000024076628,0.001126051,0.0006887994,0.016244734,0.000043273238,0.0000048992474,0.00037510812,0.002481915],"study_design_scores_gemma":[0.022532985,0.0013755584,0.96953595,0.0029521775,0.000012081179,0.000065728396,0.00011384078,0.0023735578,0.00038463235,0.000002785671,0.00033920235,0.00031151847],"about_ca_topic_score_codex":0.9804895,"about_ca_topic_score_gemma":0.9110663,"teacher_disagreement_score":0.119519085,"about_ca_system_score_codex":0.14683512,"about_ca_system_score_gemma":0.027316036,"threshold_uncertainty_score":0.9998638},"labels":[],"label_agreement":null},{"id":"W1986874544","doi":"10.1016/j.jval.2014.03.108","title":"Impact Of Drug Reimbursement Modalities On Treatment Adherence In Patients Covered By Private Drug Insurance","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Reimbursement; Medicine; Cohort; Retrospective cohort study; Drug; Internal medicine; Private insurance; Drug class; Emergency medicine; Family medicine; Medicaid; Pharmacology; Health care","score_opus":0.06202613729766446,"score_gpt":0.31449148139421884,"score_spread":0.2524653440965544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986874544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951109,0.0005025609,0.000007252117,0.0006112119,0.00017153812,0.000437446,0.00085053744,0.000008134839,0.0023003658],"genre_scores_gemma":[0.99804914,0.0011521174,0.000043955035,0.0005120966,0.000026206806,0.00003389325,0.000030679952,0.00001757376,0.0001343631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813765,0.000088306275,0.0009840404,0.00033754858,0.00003837482,0.00041410667],"domain_scores_gemma":[0.9989688,0.00013239027,0.00045333154,0.0002965242,0.000010098101,0.00013887101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006648835,0.00018249442,0.0005765402,0.0002164941,0.00003141858,0.000017392134,0.00017042845,0.00004169451,0.000059308193],"category_scores_gemma":[0.00006190661,0.00018286043,0.000098276614,0.00015903327,0.00003756064,0.00009715017,0.000027445421,0.00012548355,0.00006745778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011214082,0.0007445982,0.93855417,0.000078042394,0.000021469015,1.6339914e-7,0.0012017497,0.011643723,0.0000015433596,0.044382375,0.00073379546,0.0025262232],"study_design_scores_gemma":[0.0048636687,0.0013515509,0.934184,0.00014559073,0.0000011019889,1.014277e-7,0.0000163351,0.019785136,0.000117763484,0.032111436,0.007107323,0.00031598302],"about_ca_topic_score_codex":0.0309723,"about_ca_topic_score_gemma":0.00009037274,"teacher_disagreement_score":0.030881926,"about_ca_system_score_codex":0.001153913,"about_ca_system_score_gemma":0.00007053038,"threshold_uncertainty_score":0.97548056},"labels":[],"label_agreement":null},{"id":"W1986924310","doi":"10.1016/j.jval.2014.08.591","title":"Cost-Utility of Cancer Therapies – the 'Cost' of Different Utility Generation Strategies","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Quality-adjusted life year; Medicine; Nice; Cost effectiveness; Population; Cost–utility analysis; Cost–benefit analysis; Incremental cost-effectiveness ratio; Cancer; Economic evaluation; Statistics; Actuarial science; Computer science; Mathematics; Environmental health; Internal medicine; Economics; Risk analysis (engineering)","score_opus":0.5830415155944473,"score_gpt":0.4660530533402498,"score_spread":0.11698846225419746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1986924310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589717,0.0062107975,0.0077436543,0.023762828,0.00066013384,0.0015480024,0.00028985343,0.000018330775,0.000794735],"genre_scores_gemma":[0.9967387,0.0008784537,0.0003131743,0.0016706892,0.00017804712,0.00016115798,0.000016856566,0.000013927722,0.000028998362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940311,0.0013752864,0.0037801126,0.0003696521,0.0001161795,0.00032770753],"domain_scores_gemma":[0.9958093,0.0010867307,0.0023355738,0.00060735206,0.00007396315,0.00008705731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018479377,0.00015160922,0.0009276477,0.00015225378,0.00012265983,0.000027366406,0.00025892904,0.00009600706,0.00025559714],"category_scores_gemma":[0.0009506223,0.00013709161,0.00009403529,0.00017017357,0.00014765479,0.00019791746,0.000032629978,0.00017513373,0.000017707012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044965273,0.0003597243,0.6426099,0.0021571603,0.000073072166,4.647153e-8,0.013417453,0.00900447,0.00001915788,0.31968287,0.0033111593,0.009320055],"study_design_scores_gemma":[0.0006458738,0.000110596215,0.68386155,0.00013817736,0.0000032208563,2.8851616e-7,0.0019037174,0.26889464,0.00007508829,0.035172205,0.009028923,0.00016571333],"about_ca_topic_score_codex":0.03672417,"about_ca_topic_score_gemma":0.0046699257,"teacher_disagreement_score":0.28451064,"about_ca_system_score_codex":0.00026336507,"about_ca_system_score_gemma":0.00036384084,"threshold_uncertainty_score":0.9696904},"labels":[],"label_agreement":null},{"id":"W1987053400","doi":"10.1016/j.jval.2011.08.931","title":"PIH27 Potential Health and Economic Impact of Adding Rotarixtm to Routine Infant Vaccination Programs in Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Vaccination; Rotavirus; Cohort; Health care; Emergency department; Pediatrics; Cost-effectiveness analysis; Emergency medicine; Demography; Environmental health; Cost effectiveness; Diarrhea; Immunology; Internal medicine","score_opus":0.0748640361117848,"score_gpt":0.34427337451938295,"score_spread":0.2694093384075982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987053400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99643123,0.00032241613,0.00004709829,0.0022476888,0.00006971327,0.0008197916,0.000021997896,0.000006022225,0.00003402295],"genre_scores_gemma":[0.9975429,0.00043706497,0.0014422482,0.00047073557,0.000036436333,0.000023454224,0.000032128926,0.000010036076,0.0000050028093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981723,0.00028451634,0.0006419429,0.00021457567,0.00009850334,0.0005881995],"domain_scores_gemma":[0.9991708,0.000016907403,0.0001432234,0.0001300611,0.000021403197,0.0005176464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010592467,0.00009566259,0.00047915478,0.00022129052,0.000023171915,0.00000300174,0.00005771899,0.000030406061,0.00004416915],"category_scores_gemma":[0.00015894044,0.00008525558,0.00003231136,0.00012005294,0.000010823197,0.000049464514,0.00004320513,0.00019650799,0.0000013823176],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005115926,0.00005153828,0.9748758,0.00021682007,0.000010883851,0.000017173592,0.0005867792,0.0011265106,0.000013713271,0.000040012073,0.000326471,0.022222681],"study_design_scores_gemma":[0.0012739241,0.003362719,0.9836238,0.00030007362,9.2940695e-7,0.00004636793,0.00021373878,0.011044786,0.0000040553296,0.00004247312,0.00004085257,0.00004629596],"about_ca_topic_score_codex":0.99601364,"about_ca_topic_score_gemma":0.92499655,"teacher_disagreement_score":0.071017064,"about_ca_system_score_codex":0.002866308,"about_ca_system_score_gemma":0.0043413476,"threshold_uncertainty_score":0.7701364},"labels":[],"label_agreement":null},{"id":"W1987123109","doi":"10.1016/j.jval.2014.03.1067","title":"Validation of the telephone-administered of the age and stage questionnaire and the revised-prescreening denver questionnaire: Results from the otis antidepressants in pregnancy study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TeraXion (Canada); Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Gross motor skill; Concordance; Intraclass correlation; Medicine; Cohort; Confidence interval; Pregnancy; Telephone interview; Pediatrics; Motor skill; Psychiatry; Clinical psychology; Psychometrics; Internal medicine","score_opus":0.03645342907750296,"score_gpt":0.3077229454974272,"score_spread":0.27126951641992425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987123109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887896,0.0043420345,0.00001589531,0.004160433,0.00024395002,0.0023524459,0.000039919487,0.000009956354,0.000045772773],"genre_scores_gemma":[0.9984902,0.0009267852,0.000054365675,0.000333901,0.000044168974,0.000041081374,0.0000031862965,0.000013234115,0.00009308198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99593043,0.0023533707,0.00088247826,0.00027171895,0.00035501993,0.0002069654],"domain_scores_gemma":[0.998074,0.000614025,0.00055854453,0.0006650028,0.000035248388,0.000053199918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023316576,0.00014141016,0.0003740477,0.000039935254,0.00018863317,0.000017056103,0.00022179699,0.000059863898,0.0000019559845],"category_scores_gemma":[0.0009900548,0.000066292334,0.000036547055,0.00020767708,0.0002530597,0.00006964304,0.00016355613,0.00032269635,3.4186525e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010145654,0.00016459306,0.9853512,0.0019008729,0.000013398733,0.0000048740917,0.0089911,0.00011409046,0.000028962739,0.0003365403,0.0000117559475,0.0020680572],"study_design_scores_gemma":[0.0048373807,0.0002470783,0.9530786,0.0397336,0.00002442535,0.0000076256974,0.00021823682,0.0007207069,0.0007251654,0.00032706512,0.000024306555,0.000055783577],"about_ca_topic_score_codex":0.027353814,"about_ca_topic_score_gemma":0.001072281,"teacher_disagreement_score":0.037832726,"about_ca_system_score_codex":0.000047695044,"about_ca_system_score_gemma":0.00010899797,"threshold_uncertainty_score":0.9791231},"labels":[],"label_agreement":null},{"id":"W1987412734","doi":"10.1016/j.jval.2013.08.254","title":"Respiratory Syncytial Virus Hospitalizations in the Canadian Registry for Synagis (CARESS)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Calgary; McMaster University","funders":"","keywords":"Palivizumab; Medicine; Bronchopulmonary dysplasia; Pediatrics; Gestational age; Respiratory system; Internal medicine; Pregnancy","score_opus":0.09605046312300822,"score_gpt":0.39031027203190183,"score_spread":0.2942598089088936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987412734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9688266,0.0015777365,0.00018440628,0.017047083,0.00034087608,0.0057995007,0.00007178669,0.00005242387,0.006099596],"genre_scores_gemma":[0.99234354,0.000043151635,0.00018368696,0.006099301,0.00021613271,0.00090115436,0.000022477878,0.000029249935,0.00016127566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99787426,0.0004139791,0.0005112107,0.00028702378,0.00031964667,0.00059387425],"domain_scores_gemma":[0.9986397,0.00022374807,0.000080065816,0.00057266984,0.00017687607,0.00030696057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014639761,0.00012495059,0.00024207239,0.00058095454,0.0003004414,0.00008260759,0.00021339432,0.00014818962,0.000107960586],"category_scores_gemma":[0.0010615605,0.000099757075,0.000056826924,0.00085028424,0.00011437863,0.00013641117,0.000018655644,0.00046437522,0.00008143103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018100014,0.0011774411,0.7543874,0.002854,0.000074529555,0.00027469345,0.0056816274,0.010655117,0.001117464,0.048082557,0.15740249,0.018111713],"study_design_scores_gemma":[0.004033289,0.002616679,0.70944375,0.0007625323,0.000020102607,0.000051548035,0.0015635865,0.016635913,0.0003630302,0.0033581916,0.26061934,0.0005320277],"about_ca_topic_score_codex":0.75865453,"about_ca_topic_score_gemma":0.48287305,"teacher_disagreement_score":0.27578145,"about_ca_system_score_codex":0.0012631579,"about_ca_system_score_gemma":0.0032436806,"threshold_uncertainty_score":0.575415},"labels":[],"label_agreement":null},{"id":"W1987741018","doi":"10.1016/j.jval.2010.10.008","title":"Improvements in Participation in Usual Daily Activities in Patients with Rheumatoid Arthritis Treated with Abatacept","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health; University of Ottawa","funders":"Versus Arthritis; National Institute for Health and Care Research; Bristol-Myers Squibb","keywords":"Abatacept; Medicine; Rheumatoid arthritis; Physical therapy; Internal medicine; Rheumatism; Placebo; Quality of life (healthcare); Clinical trial; Alternative medicine; Nursing; Rituximab","score_opus":0.028578445677749857,"score_gpt":0.28439325525925424,"score_spread":0.2558148095815044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987741018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733347,0.0009846577,0.000006733728,0.00010357233,0.000025518124,0.0012763339,0.000016178112,0.00002587753,0.00022766428],"genre_scores_gemma":[0.9942309,0.005086376,0.0002651363,0.000078547055,0.0000055512683,0.00023025033,0.000055835117,0.00003213445,0.000015263488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765325,0.00028703664,0.000594513,0.00034256236,0.0004216864,0.00070094137],"domain_scores_gemma":[0.9993643,0.00006446077,0.00012624006,0.00023002113,0.000040823736,0.00017414308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053525163,0.0001923732,0.00048360293,0.0006225353,0.000038925376,0.000017125274,0.00007263465,0.000067125795,0.00006405746],"category_scores_gemma":[0.000059712518,0.000157479,0.000017437149,0.0006041382,0.00010172638,0.00036307733,0.000023487437,0.00034717974,0.000006973161],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023280766,0.0014008371,0.96035856,0.000086476626,0.000012734652,0.00005624429,0.0069428603,0.000062603955,0.000015838927,0.00007953341,0.000008018056,0.028648203],"study_design_scores_gemma":[0.016819298,0.0035276755,0.9746999,0.002908841,3.1957762e-7,0.0000037698364,0.0010006451,0.00046491734,0.00031495932,0.00007570615,0.000031020834,0.00015290901],"about_ca_topic_score_codex":0.04171627,"about_ca_topic_score_gemma":0.024618192,"teacher_disagreement_score":0.028495293,"about_ca_system_score_codex":0.00034494232,"about_ca_system_score_gemma":0.00035548556,"threshold_uncertainty_score":0.99318},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":[],"domain":null,"study_design":"randomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W1987879827","doi":"10.1111/j.1524-4733.2010.00737.x","title":"Cost-Effectiveness of the Addition of Rituximab to CHOP Chemotherapy in First-Line Treatment for Diffuse Large B-Cell Lymphoma in a Population-Based Observational Cohort in British Columbia, Canada","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research","keywords":"CHOP; Rituximab; Medicine; Diffuse large B-cell lymphoma; Vincristine; Population; Cost effectiveness; Internal medicine; Oncology; Cohort; Lymphoma; Cyclophosphamide; Chemotherapy; Environmental health","score_opus":0.036195372987913865,"score_gpt":0.29702635170920827,"score_spread":0.2608309787212944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987879827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931206,0.00007755879,0.000005880559,0.0011591648,0.000115746276,0.0047607757,0.0007508058,0.0000039411448,0.000005518157],"genre_scores_gemma":[0.9970096,0.000052308544,0.00032060337,0.0005029175,0.000019592642,0.0016548049,0.0004129314,0.000016238759,0.000011040451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857575,0.0001346864,0.00056468515,0.00024652513,0.0002303107,0.00024804755],"domain_scores_gemma":[0.9988187,0.0006724002,0.00015710108,0.00021127654,0.000065126245,0.00007540582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000510319,0.00010181417,0.00049212447,0.00009477903,0.000034889843,0.0000073636425,0.00005899261,0.000073453346,0.000020095948],"category_scores_gemma":[0.00014688916,0.00011291449,0.000057722355,0.0004076611,0.0000136974195,0.000028433067,0.000007981145,0.000052743333,1.5014979e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002569423,0.012396617,0.9825778,0.00036544105,0.000009729386,0.000009158946,0.000093131865,0.0008010595,0.00002394927,0.000025281794,0.000046358306,0.0033945497],"study_design_scores_gemma":[0.05401586,0.0003753312,0.9401411,0.00091904245,0.00000738309,0.000002160221,0.00001744717,0.0037957213,0.00032309772,0.000085653875,0.00024551895,0.00007169946],"about_ca_topic_score_codex":0.98491395,"about_ca_topic_score_gemma":0.9962586,"teacher_disagreement_score":0.05375892,"about_ca_system_score_codex":0.0029108014,"about_ca_system_score_gemma":0.001866483,"threshold_uncertainty_score":0.7611644},"labels":[],"label_agreement":null},{"id":"W1987943429","doi":"10.1016/s1098-3015(10)70708-7","title":"PDB20 COST-EFFECTIVENESS OF INSULIN DETEMIR COMPARED TO NPH INSULIN FOR TYPE I DIABETES MELLITUS (TIDM) IN THE CANADIAN PAYER SETTING: MODELING ANALYSIS USING A RANDOMIZED CONTROLLED TRIAL","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Natural Products and Biological Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin detemir; NPH insulin; Medicine; Randomized controlled trial; Insulin; Type 2 Diabetes Mellitus; Diabetes mellitus; Internal medicine; Pediatrics; Endocrinology; Type 2 diabetes; Insulin glargine","score_opus":0.20318198252822156,"score_gpt":0.41479132676936425,"score_spread":0.2116093442411427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1987943429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97792876,0.0036870914,0.00020581075,0.0018873384,0.00011579921,0.01612753,0.000020052721,0.000008584804,0.000019049181],"genre_scores_gemma":[0.99743694,0.00033786971,0.0011456617,0.000506262,0.00011400379,0.00039818615,0.000044995828,0.000011188085,0.0000049141613],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99458665,0.0029637532,0.0010715798,0.00037593857,0.00038451797,0.0006175491],"domain_scores_gemma":[0.9941768,0.004724092,0.00018512995,0.00025829996,0.0003862544,0.0002694272],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014198701,0.00017645476,0.0022071607,0.0006977287,0.0001605328,0.00001521789,0.00017793366,0.00014133769,0.0000083144505],"category_scores_gemma":[0.010978162,0.000095238924,0.00030122706,0.0017583121,0.00008854249,0.000029348981,0.00002532668,0.00041282712,0.0000011221555],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8963454,0.00027851615,0.0030635209,0.00032699108,0.0003217005,0.000011914002,0.00091334496,0.09647124,0.00066543574,0.00008013767,0.0000079522115,0.001513845],"study_design_scores_gemma":[0.45980915,0.0005541833,0.00091555336,0.0002166988,0.000108013825,0.0000013152061,0.000082899074,0.5378209,0.0001375127,0.00022537202,0.000032422206,0.00009600727],"about_ca_topic_score_codex":0.14412351,"about_ca_topic_score_gemma":0.012146513,"teacher_disagreement_score":0.44134963,"about_ca_system_score_codex":0.00051994226,"about_ca_system_score_gemma":0.0015443956,"threshold_uncertainty_score":0.9973528},"labels":[],"label_agreement":null},{"id":"W1988040543","doi":"10.1016/j.jval.2011.02.355","title":"PSY22 ANALYSING THE BENEFITS AND COST SAVING OF ORAL VERSUS IV FLUDARABINE FOR MANAGEMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKAEMIA (CLL)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Fludarabine; Medicine; Adverse effect; Dose; Internal medicine; Cyclophosphamide; Gastroenterology; Chemotherapy","score_opus":0.13124816543485762,"score_gpt":0.3501985851498948,"score_spread":0.2189504197150372,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988040543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885888,0.007980892,0.00017804393,0.00015977609,0.00014903069,0.0018241935,0.000016161224,0.000016093676,0.0010870049],"genre_scores_gemma":[0.99376917,0.0026394678,0.0032969257,0.000056098987,0.000043118867,0.000056269193,0.000012571469,0.00003208364,0.00009430591],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99784946,0.00011757634,0.0007141776,0.00033909283,0.00042855353,0.0005511349],"domain_scores_gemma":[0.99857134,0.00035311887,0.00026686746,0.0005496855,0.00010218325,0.00015679497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015351298,0.00016872668,0.0005407289,0.00022383867,0.00008317825,0.0000069782172,0.00020551786,0.000076300974,0.000030854415],"category_scores_gemma":[0.00007982823,0.00013009898,0.00009919354,0.00051742414,0.00018955454,0.00005508821,0.00013558393,0.0001486713,0.000002925067],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.034985848,0.002997069,0.014874364,0.12111482,0.0033457284,0.00040531103,0.023152974,0.093005694,0.008099865,0.054343864,0.0017762393,0.6418982],"study_design_scores_gemma":[0.16249706,0.0057611284,0.012809669,0.006310513,0.00071573566,0.00010912782,0.0027567912,0.7885884,0.01810613,0.0005052407,0.0013136122,0.0005265729],"about_ca_topic_score_codex":0.017079007,"about_ca_topic_score_gemma":0.00038497717,"teacher_disagreement_score":0.69558275,"about_ca_system_score_codex":0.019879993,"about_ca_system_score_gemma":0.0067335805,"threshold_uncertainty_score":0.9988973},"labels":[],"label_agreement":null},{"id":"W1988058236","doi":"10.1016/j.jval.2013.03.280","title":"Properties of propensity score matching procedures on covariate balancing and estimation: Influence of the number of propensity score digits used on matched sets created","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Propensity score matching; Covariate; Confounding; Statistics; Matching (statistics); Confidence interval; Numerical digit; Demography; Mathematics; Medicine; Arithmetic","score_opus":0.22731307978205686,"score_gpt":0.3683948052331946,"score_spread":0.14108172545113776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988058236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967869,0.000018557905,0.00020129954,0.00027332065,0.00001928992,0.0025207466,0.000009823199,0.00007957781,0.0000904876],"genre_scores_gemma":[0.9926861,0.000014865279,0.007085636,0.00010002533,0.000004982857,0.00006548269,0.0000014905308,0.000027348746,0.000014064022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789226,0.00027220242,0.0008712924,0.00028091428,0.00041985992,0.0002634912],"domain_scores_gemma":[0.9979622,0.00026930985,0.00089624216,0.0004778025,0.0003311886,0.00006328762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007694449,0.0002228858,0.0006695695,0.00008152639,0.00008560865,0.000021735867,0.0002259475,0.00009834165,0.0000051028533],"category_scores_gemma":[0.0014888877,0.00014157477,0.00003642899,0.00029967492,0.00020274473,0.00031452673,0.00013555771,0.00028552255,0.000002226647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000574323,0.0010693568,0.8124654,0.025594564,0.00007625045,0.000004777605,0.014653712,0.0327694,0.060787603,0.050718207,0.00007338982,0.001212981],"study_design_scores_gemma":[0.0007306696,0.00046352553,0.533551,0.023195092,0.00002054633,0.000025860007,0.00019372537,0.0046960614,0.24480249,0.19199395,3.950076e-7,0.0003266859],"about_ca_topic_score_codex":0.0041399836,"about_ca_topic_score_gemma":0.00007691641,"teacher_disagreement_score":0.27891442,"about_ca_system_score_codex":0.00014955108,"about_ca_system_score_gemma":0.00036876567,"threshold_uncertainty_score":0.6258445},"labels":[],"label_agreement":null},{"id":"W1988090710","doi":"10.1016/j.jval.2011.08.288","title":"PIN102 National Cost Savings from the Brazilian HIV/AIDS Antiretroviral Universal Access Program: Analysis Versus Canada and Australia","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Impact and Responses","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Christian ministry; Distribution (mathematics); Drug pricing; Drug prices; Business; Human immunodeficiency virus (HIV); Actuarial science; Economics; Public economics; Medicine; Political science; Family medicine","score_opus":0.13049657053327746,"score_gpt":0.31909414017295407,"score_spread":0.1885975696396766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988090710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959239,0.0003629101,0.000070588416,0.0008566735,0.0003184997,0.00030287926,0.00090700365,0.00001983574,0.0012377397],"genre_scores_gemma":[0.9980456,0.00013740957,0.0007770151,0.00023476483,0.00007301324,0.000009330131,0.000060313392,0.000011667518,0.0006508655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863935,0.00008928485,0.00047999638,0.00032096155,0.00009484329,0.0003755946],"domain_scores_gemma":[0.99908376,0.0002484466,0.00027003072,0.0002054898,0.000026827223,0.00016544355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064058456,0.00014088352,0.0003464815,0.00029371495,0.00016684533,0.000073772724,0.0003381083,0.0000712076,0.00032218723],"category_scores_gemma":[0.00019406679,0.00012862954,0.00007202856,0.0008750165,0.00010145724,0.00024715767,0.00006676504,0.00020193722,0.000019195424],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014147031,0.0000522032,0.98342407,0.000012663158,0.00015230621,0.0000063657026,0.0010463697,0.00014847817,3.1811166e-7,0.01120161,0.0023884298,0.0014257316],"study_design_scores_gemma":[0.00087124493,0.00022464938,0.98004293,0.000018250506,0.000022474313,8.164656e-7,0.00036640264,0.0029555717,0.0000048996653,0.0010098633,0.014286579,0.0001962944],"about_ca_topic_score_codex":0.940676,"about_ca_topic_score_gemma":0.5383989,"teacher_disagreement_score":0.40227708,"about_ca_system_score_codex":0.0004854547,"about_ca_system_score_gemma":0.00045104133,"threshold_uncertainty_score":0.5245361},"labels":[],"label_agreement":null},{"id":"W1988518807","doi":"10.1016/j.jval.2014.03.259","title":"Budget Impact Of Converting Standard Treatment Of Flail Chest From Supportive Therapy To Surgical Fixation With Contoured Titanium Plates In Canadian Hospitals","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Trauma Management and Diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Flail chest; Medicine; Mechanical ventilation; Activity-based costing; Emergency medicine; Surgery; Anesthesia","score_opus":0.025231408577159324,"score_gpt":0.3139404790844509,"score_spread":0.28870907050729155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988518807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99660665,0.00026088406,0.000010781679,0.001788892,0.000032014468,0.0008716793,0.00009422342,0.000008807561,0.0003260801],"genre_scores_gemma":[0.99927074,0.0002237651,0.00026585054,0.00008323419,0.000034007393,0.000024987006,0.000072508614,0.000012382489,0.000012535808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887466,0.00009324823,0.00040801894,0.00017539723,0.00016317084,0.00028547583],"domain_scores_gemma":[0.9991743,0.00021890899,0.00016241675,0.00014770581,0.000055072225,0.00024159499],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037946933,0.00011638095,0.00048861606,0.00022569389,0.00001606467,0.000005228556,0.000036763926,0.00004807341,0.00007232676],"category_scores_gemma":[0.00006307655,0.000083693725,0.000049686187,0.00020581967,0.000024789635,0.000044372508,0.0000036320826,0.000045269022,0.000002145275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092544244,0.00014729255,0.98932296,0.00004537634,0.000055825607,0.000020845819,0.0030184402,0.0005183885,0.000039690465,0.0001037346,0.0000999086,0.0057021123],"study_design_scores_gemma":[0.0056177424,0.00684275,0.984055,0.0003043376,0.000010707462,7.2884706e-7,0.00033196158,0.0005805105,0.0015885024,0.0000425943,0.0005488265,0.000076339726],"about_ca_topic_score_codex":0.85161924,"about_ca_topic_score_gemma":0.20540842,"teacher_disagreement_score":0.6462108,"about_ca_system_score_codex":0.0007677585,"about_ca_system_score_gemma":0.0005705345,"threshold_uncertainty_score":0.8090908},"labels":[],"label_agreement":null},{"id":"W1988921809","doi":"10.1016/s1098-3015(10)64198-8","title":"PPT5: LONG TERM COST OF ILLNESS STUDY FOR SEVERE HEMOPHILIC CHILDREN IN TORONTO","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Term (time); Medicine; Pediatrics; Physics","score_opus":0.0536040164469517,"score_gpt":0.38237059990812156,"score_spread":0.3287665834611698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988921809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919024,0.0016664404,0.0000065422523,0.000656312,0.00009062516,0.0049892706,0.000015748567,0.000013897786,0.00065874634],"genre_scores_gemma":[0.998797,0.00029645127,0.0001599375,0.00009484402,0.00005618337,0.00017046728,0.000026132897,0.000023346156,0.00037563973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982373,0.0002416523,0.00048398727,0.0002938344,0.0002890461,0.00045415462],"domain_scores_gemma":[0.99923474,0.00015602159,0.00007313216,0.00031430766,0.00004988199,0.0001719197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011118844,0.00013655201,0.00047134183,0.00013615968,0.00005666032,0.0000050855547,0.00008696777,0.0000746373,0.000076218734],"category_scores_gemma":[0.00017140017,0.00011002419,0.00005792412,0.00024047749,0.00003441679,0.000059489263,0.000020394722,0.00015000654,0.000004153071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001922888,0.0019192228,0.9835599,0.00042052212,0.00003380924,0.000024411562,0.0023897544,0.000047383273,0.000018796361,0.0001762892,0.000057722325,0.011159889],"study_design_scores_gemma":[0.007988164,0.0016642541,0.98769695,0.00036641152,0.000013199778,0.000036616446,0.0015813711,0.00010678433,0.00026456223,0.000085047745,0.00007403246,0.00012261787],"about_ca_topic_score_codex":0.011949349,"about_ca_topic_score_gemma":0.003344447,"teacher_disagreement_score":0.0110372715,"about_ca_system_score_codex":0.00087659195,"about_ca_system_score_gemma":0.0004881969,"threshold_uncertainty_score":0.99463016},"labels":[],"label_agreement":null},{"id":"W1988994559","doi":"10.1016/j.jval.2013.08.1213","title":"Indirect Treatment Comparison and Economic Evaluation of Novel Oral Anticoagulants for the Prevention of Stroke in Patients with Atrial Fibrillation in the Netherlands","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Rivaroxaban; Apixaban; Stroke (engine); Dabigatran; Atrial fibrillation; Randomized controlled trial; Confidence interval; Relative risk; Internal medicine; Cost effectiveness; Warfarin; Intensive care medicine","score_opus":0.442145353400005,"score_gpt":0.44459944641158367,"score_spread":0.002454093011578673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1988994559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924531,0.001060448,0.00028183818,0.0019488112,0.00012684347,0.0039611356,0.00014165649,0.0000023885177,0.000023798382],"genre_scores_gemma":[0.99898297,0.00010495294,0.00064471836,0.00006561825,0.000056075878,0.000087930806,0.00004374407,0.000009411077,0.000004591032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99644214,0.00064685405,0.0023861963,0.00022899722,0.00010189359,0.00019391857],"domain_scores_gemma":[0.99668956,0.0012854778,0.0017451412,0.00021185032,0.000041196286,0.000026770867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015644874,0.000102151265,0.0006929878,0.00026710136,0.000046396297,0.000019068713,0.00009198076,0.00006383149,0.000015786418],"category_scores_gemma":[0.0003708425,0.000079129226,0.00004937021,0.00011615652,0.000034523044,0.00018412592,0.000009035105,0.00005780435,0.0000044302155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000693588,0.00009424181,0.8941054,0.00010287149,0.000022663502,2.7237623e-9,0.0027156107,0.09982182,1.8092976e-7,0.0008329137,0.000033209984,0.002201747],"study_design_scores_gemma":[0.0039194883,0.00035522715,0.6704849,0.000070954324,0.000006305488,1.0633937e-7,0.00043112916,0.32391182,0.0000011814651,0.00073110306,0.00003878068,0.00004901159],"about_ca_topic_score_codex":0.024943145,"about_ca_topic_score_gemma":0.004935289,"teacher_disagreement_score":0.22409001,"about_ca_system_score_codex":0.00064726337,"about_ca_system_score_gemma":0.00025906874,"threshold_uncertainty_score":0.98154986},"labels":[],"label_agreement":null},{"id":"W1989114084","doi":"10.1016/s1098-3015(10)73144-2","title":"QL3 ESTIMATION OF UTILITY VALUES FOR DIABETESXD-RELATED COMPLICATIONS ON QUALITY OF LIFE FOR PATIENTS WITH TYPE-2 DIABETES IN ONTARIO, CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Estimation; Type 2 diabetes; Medicine; Quality of life (healthcare); Quality (philosophy); Statistics; Gerontology; Diabetes mellitus; Demography; Intensive care medicine; Mathematics; Economics; Endocrinology; Nursing; Sociology; Philosophy","score_opus":0.2744320914219942,"score_gpt":0.38707467306777016,"score_spread":0.11264258164577595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989114084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902925,0.00026283908,0.00045083422,0.005563235,0.00017300817,0.0024077173,0.0007000427,0.00001005694,0.0001397565],"genre_scores_gemma":[0.9933808,0.000007008439,0.0042675505,0.0019289923,0.000010574693,0.00011243318,0.00026315133,0.000013409257,0.00001611418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945801,0.00030353965,0.0042736707,0.00038097298,0.00010903595,0.0003526895],"domain_scores_gemma":[0.99437463,0.0023830319,0.002567813,0.00039797495,0.00015136263,0.00012515546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00863535,0.0001423612,0.0010574855,0.00025377347,0.00007848048,0.0000075312932,0.00016087411,0.00008955985,0.000021019356],"category_scores_gemma":[0.0041173804,0.00016951257,0.000055820547,0.00025202666,0.000040417814,0.00013591356,0.000008314059,0.0001246045,0.0000027638619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007737898,0.00043807147,0.9490601,0.0008035116,0.000020051024,5.0834115e-9,0.00081022235,0.024292592,2.0082068e-7,0.023169575,0.0009281279,0.0004001877],"study_design_scores_gemma":[0.001577145,0.0005465138,0.91953707,0.00021916832,0.0000019187137,8.39691e-9,0.000073278345,0.05805487,0.0000028066593,0.01956807,0.00028569825,0.0001334751],"about_ca_topic_score_codex":0.81295717,"about_ca_topic_score_gemma":0.5907624,"teacher_disagreement_score":0.22219482,"about_ca_system_score_codex":0.0014559749,"about_ca_system_score_gemma":0.001765707,"threshold_uncertainty_score":0.6912522},"labels":[],"label_agreement":null},{"id":"W1989124972","doi":"10.1016/j.jval.2011.08.328","title":"PMH26 Direct Cost of Schizophrenia in Quebec, Canada: An Incidence-Based Microsimulation Monte-Carlo Markov Model","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Microsimulation; Health care; Cohort; Schizophrenia (object-oriented programming); Markov model; Medicine; Indirect costs; Markov chain Monte Carlo; Psychiatry; Markov chain; Monte Carlo method; Statistics; Business; Economics; Mathematics; Internal medicine; Engineering","score_opus":0.3444568625588406,"score_gpt":0.37244288263095465,"score_spread":0.027986020072114037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989124972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98995066,0.0016478547,0.001264444,0.004443558,0.00035004577,0.0013328864,0.00034874654,0.000027354674,0.00063445483],"genre_scores_gemma":[0.9880537,0.0000798508,0.008184469,0.0033598952,0.000056724086,0.0000903604,0.000028363977,0.000035855785,0.000110822264],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.993298,0.00075134775,0.0046663983,0.00059559266,0.00013773484,0.00055091956],"domain_scores_gemma":[0.9964049,0.0006039026,0.0020659762,0.00059820665,0.00006656393,0.00026043536],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012121837,0.00021310446,0.0011089433,0.0006239421,0.00008834178,0.000021493872,0.00032062523,0.00015462359,0.0000763064],"category_scores_gemma":[0.0012115873,0.00029308477,0.0000629653,0.00039045096,0.000055159617,0.00047646582,0.000030647512,0.00024165676,0.000025079167],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019101225,0.00029762866,0.39227313,0.00083359354,0.000012705393,0.0000031600302,0.005033139,0.5922507,0.0000032478204,0.0065356977,0.0018325277,0.00073346565],"study_design_scores_gemma":[0.0011702643,0.000058690715,0.20878817,0.0002725771,0.0000013224907,4.4897567e-7,0.0002536464,0.78721565,0.000011446806,0.00169616,0.00028628015,0.00024536665],"about_ca_topic_score_codex":0.9917159,"about_ca_topic_score_gemma":0.98084515,"teacher_disagreement_score":0.19496495,"about_ca_system_score_codex":0.0036262718,"about_ca_system_score_gemma":0.0041726134,"threshold_uncertainty_score":0.99995214},"labels":[],"label_agreement":null},{"id":"W1989436692","doi":"10.1016/j.jval.2012.08.794","title":"PMH4 Mirror Image Studies of Risperidone Long-Acting Injection for Chronic Schizophrenia and Schizoaffective Disorder","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Risperidone; Schizoaffective disorder; Schizophrenia (object-oriented programming); Confounding; MEDLINE; Randomization; Clinical trial; Psychiatry; Pediatrics; Internal medicine; Psychosis","score_opus":0.05931818404221899,"score_gpt":0.38127795402868736,"score_spread":0.32195976998646836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989436692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97347504,0.024112249,0.00030502808,0.000441131,0.00021515928,0.0012875173,0.000006360209,0.000047439233,0.00011006246],"genre_scores_gemma":[0.9902786,0.0006307777,0.008699582,0.000021515123,0.00011899095,0.000090071226,0.000005767328,0.000039951567,0.000114730086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989665,0.00011387575,0.00028094533,0.0002028258,0.0001290655,0.00030675653],"domain_scores_gemma":[0.999246,0.00025900474,0.00018721196,0.00015584416,0.00004638289,0.00010555646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047779502,0.00013646318,0.00038615378,0.00017031464,0.00008388605,0.0000039699435,0.000023501081,0.00005499416,0.000011790982],"category_scores_gemma":[0.00036176448,0.00011084202,0.000043619562,0.00014789213,0.0000803186,0.00015615758,0.000037100166,0.00012442112,0.000004619778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002331311,0.001214236,0.8541831,0.0060413904,0.00028568233,0.0000041848793,0.0046502207,0.000056411456,0.008153776,0.00033995073,0.0001829633,0.12255682],"study_design_scores_gemma":[0.011280111,0.0040596584,0.9738439,0.002392688,0.0001056515,0.000053917884,0.0013527084,0.0010793682,0.005078961,0.00019123047,0.00036185753,0.00020000117],"about_ca_topic_score_codex":0.0013575547,"about_ca_topic_score_gemma":0.00018098729,"teacher_disagreement_score":0.122356825,"about_ca_system_score_codex":0.0003157769,"about_ca_system_score_gemma":0.00009903841,"threshold_uncertainty_score":0.45200062},"labels":[],"label_agreement":null},{"id":"W1989477992","doi":"10.1016/j.jval.2011.02.169","title":"PHP100 PRICING AND REIMBURSEMENT OF ORPHAN DRUGS IN CANADA","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Reimbursement; Formulary; Agency (philosophy); Business; Market access; User fee; Scope (computer science); Health care; Public economics; Family medicine; Medicine; Economic growth; Political science; Geography; Economics","score_opus":0.39635368018055533,"score_gpt":0.37684578199316726,"score_spread":0.019507898187388073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989477992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987357,0.0032842122,0.00008172232,0.0061281747,0.0003250883,0.0005838086,0.00004834305,0.000006887353,0.0021847254],"genre_scores_gemma":[0.99453104,0.0004021346,0.0019419286,0.0029962389,0.000036526904,0.000029168512,0.000003597556,0.00001505051,0.00004430222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952679,0.0003242676,0.003595653,0.0003464914,0.0000744936,0.00039114093],"domain_scores_gemma":[0.9977963,0.00037957757,0.0013782894,0.0002781364,0.000016801254,0.00015092563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012231199,0.00011047818,0.0007474209,0.0003415596,0.000042731197,0.0000058690525,0.00013496583,0.00004723814,0.000120709505],"category_scores_gemma":[0.00051968667,0.00014770201,0.000021720603,0.00022399596,0.000026253587,0.00013379307,0.000034933997,0.00013853278,0.000023360257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013047399,0.00007615536,0.92220885,0.0010843554,0.000011476521,0.0000015101937,0.014552782,0.0007225648,5.4927096e-7,0.059551362,0.001106346,0.000671022],"study_design_scores_gemma":[0.0015161971,0.00016068081,0.9518749,0.00067905127,0.0000015491763,0.000003457629,0.007938609,0.018304838,0.000020947591,0.0151175475,0.0040279804,0.00035425526],"about_ca_topic_score_codex":0.98980236,"about_ca_topic_score_gemma":0.71051115,"teacher_disagreement_score":0.2792912,"about_ca_system_score_codex":0.0021285885,"about_ca_system_score_gemma":0.001491533,"threshold_uncertainty_score":0.6023113},"labels":[],"label_agreement":null},{"id":"W1989931913","doi":"10.1046/j.1524-4733.2002.54128.x","title":"A Comparison of Methods for Analyzing Health-Related Quality-of-Life Measures","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":119,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"","keywords":"Tobit model; Censored regression model; Censoring (clinical trials); Statistics; Econometrics; Regression analysis; Ceiling effect; Ordinary least squares; Regression; Medicine; Demography; Mathematics","score_opus":0.8212655393404127,"score_gpt":0.5810041040688738,"score_spread":0.24026143527153887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1989931913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40629497,0.2376866,0.2172893,0.1293405,0.0019751892,0.0053645372,0.0007121177,0.00013295992,0.0012038106],"genre_scores_gemma":[0.88279295,0.0010179253,0.11243524,0.003381972,0.00009548522,0.00011032527,0.00002477251,0.000048529873,0.00009279608],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97954786,0.0036378491,0.015431579,0.00059507485,0.00011882653,0.00066883856],"domain_scores_gemma":[0.9844405,0.005200266,0.009336785,0.0005906641,0.00010496731,0.00032683153],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07955649,0.00020725657,0.0032453365,0.0007914273,0.00016532528,0.000016256628,0.00031545263,0.0001791322,0.00014606345],"category_scores_gemma":[0.013842747,0.00027340604,0.00024963845,0.0006169652,0.0000877609,0.00018813695,0.00003412898,0.00026567234,0.0000586667],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008705235,0.0009828649,0.48017865,0.011266858,0.0002245362,6.866931e-8,0.028006468,0.028925838,0.000011838651,0.4241768,0.013652766,0.012486249],"study_design_scores_gemma":[0.007191003,0.0015444395,0.09623666,0.0017465914,0.000013510987,0.0000028842408,0.0059202663,0.76477766,0.00004686104,0.06845206,0.052866954,0.0012011129],"about_ca_topic_score_codex":0.027066087,"about_ca_topic_score_gemma":0.00029867727,"teacher_disagreement_score":0.7358518,"about_ca_system_score_codex":0.00077634165,"about_ca_system_score_gemma":0.00042037194,"threshold_uncertainty_score":0.9999718},"labels":[],"label_agreement":null},{"id":"W1990043119","doi":"10.1016/j.jval.2011.08.388","title":"PMS2 Risk and Cost of Infections in Rheumatoid Arthritis Patients Treated with anti-TNF therapy in Alberta, Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta; Institute of Health Economics","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Proportional hazards model; Hazard ratio; Cohort; Etanercept","score_opus":0.019355005633822777,"score_gpt":0.24977358452894055,"score_spread":0.23041857889511777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990043119","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948568,0.0037073225,0.0000017584682,0.00015916108,0.00002959495,0.00089158665,0.000031036438,0.0000075064295,0.00031528185],"genre_scores_gemma":[0.85685587,0.14294985,0.0000476589,0.000058048856,0.0000026781206,0.000047560865,0.00001514633,0.000015109246,0.000008095699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851084,0.00025795223,0.00044699793,0.0002021602,0.00021375551,0.00036828508],"domain_scores_gemma":[0.9993431,0.00014986051,0.000112569105,0.00016706622,0.000058702848,0.00016870101],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003080007,0.00012341763,0.00041730073,0.00030007234,0.000048063706,0.0000053345125,0.000043094227,0.000045885074,0.000045610937],"category_scores_gemma":[0.00011954739,0.00010271989,0.000015522786,0.00044091354,0.000093003124,0.000077864504,0.0000118689195,0.00025668222,0.0000011742642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023475867,0.00047058694,0.96181077,0.000036782258,0.000013875758,0.000015481333,0.0016880906,0.000032989174,0.000002995516,0.0000786272,0.000041292515,0.03557376],"study_design_scores_gemma":[0.00815003,0.0014268841,0.98771536,0.0012059449,2.1337254e-7,0.000022262622,0.00018259784,0.00022332072,0.00011265763,0.00007032166,0.0008011766,0.00008920006],"about_ca_topic_score_codex":0.99260396,"about_ca_topic_score_gemma":0.97519875,"teacher_disagreement_score":0.13924253,"about_ca_system_score_codex":0.0001569652,"about_ca_system_score_gemma":0.00083490915,"threshold_uncertainty_score":0.41887954},"labels":[],"label_agreement":null},{"id":"W1990327895","doi":"10.1016/s1098-3015(10)73565-8","title":"PDB21 ECONOMIC EVALUATION OF RAPID-ACTING INSULIN ANALOGUES FOR THE TREATMENT OF PATIENTS WITH TYPE 1 AND TYPE 2 DIABETES MELLITUS IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Type 2 Diabetes Mellitus; Insulin; Type (biology); Medicine; Type 2 diabetes; Internal medicine; Endocrinology; Diabetes mellitus; Biology","score_opus":0.04562122178715243,"score_gpt":0.2896453177501117,"score_spread":0.24402409596295926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990327895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918255,0.0064808493,5.8567986e-7,0.00032914474,0.000072276474,0.0012152259,0.000010953406,0.0000020767088,0.00006335533],"genre_scores_gemma":[0.9977761,0.0018691103,0.00018381994,0.00007411395,0.000012037682,0.000018405803,0.00005677934,0.000004912991,0.0000047028234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933356,0.00005341608,0.0002480835,0.00011060167,0.00011571701,0.00013860865],"domain_scores_gemma":[0.99950975,0.00014489196,0.0001321007,0.000113494825,0.00006851812,0.000031260945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003240827,0.00007212622,0.00023713429,0.0000740978,0.000016393684,0.0000020665527,0.00002159169,0.000013213223,0.000007088243],"category_scores_gemma":[0.00003353574,0.000046151803,0.000010958304,0.00011793371,0.000011899867,0.000023562208,0.0000029020155,0.000018442517,1.7039507e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024760337,0.00031822492,0.5689745,0.00012000185,0.000079843754,2.3330321e-7,0.00053179334,0.0042791357,0.0000031944362,0.0000551074,0.000040632993,0.4253497],"study_design_scores_gemma":[0.0041935896,0.004896375,0.9719157,0.00014391984,0.00010722703,2.4741416e-8,0.00021472122,0.017434519,0.00018446703,0.000087155815,0.00077378313,0.000048514226],"about_ca_topic_score_codex":0.21780941,"about_ca_topic_score_gemma":0.12799571,"teacher_disagreement_score":0.4253012,"about_ca_system_score_codex":0.0007750507,"about_ca_system_score_gemma":0.0007037894,"threshold_uncertainty_score":0.8879161},"labels":[],"label_agreement":null},{"id":"W1990505650","doi":"10.1016/j.jval.2014.03.1325","title":"Cost Analysis Of Implementing Expanded Umbilical Cord Blood Graft In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Medicine; Umbilical cord; Cord blood; Indirect costs; Surgery; Internal medicine; Immunology","score_opus":0.050929017935551775,"score_gpt":0.33245185259112797,"score_spread":0.2815228346555762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990505650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981864,0.000053705,0.00040683907,0.00054434,0.000041396157,0.00040539287,0.00001568501,0.0000073654796,0.00033886646],"genre_scores_gemma":[0.9987973,0.00004746101,0.0007427915,0.00030791594,0.000014373002,0.000016120042,0.000055992936,0.000008561658,0.000009481932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982231,0.00020382898,0.0007507187,0.00019587156,0.0002962521,0.00033023104],"domain_scores_gemma":[0.99911577,0.00037728396,0.00014179247,0.00020416139,0.000030383451,0.00013061194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010858654,0.00007994464,0.00050751265,0.0002970469,0.000018918674,0.0000022973497,0.00005239057,0.000032373428,0.000070548485],"category_scores_gemma":[0.00009555118,0.00007921579,0.00004505,0.00083640293,0.000013227921,0.000015105066,0.000008782475,0.00012381487,7.9959574e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050405877,0.00008355161,0.9943214,0.00058481615,0.00007507259,0.000014747127,0.00063637533,0.0010892208,0.00027763826,0.00024980775,0.000021439522,0.0025955015],"study_design_scores_gemma":[0.0029006293,0.0002008462,0.9337399,0.00043869572,0.00030098803,0.000018774945,0.00073568494,0.059720784,0.0016189581,0.00004573103,0.00017205541,0.00010694822],"about_ca_topic_score_codex":0.9538414,"about_ca_topic_score_gemma":0.92788756,"teacher_disagreement_score":0.06058152,"about_ca_system_score_codex":0.000304104,"about_ca_system_score_gemma":0.0010613468,"threshold_uncertainty_score":0.32303262},"labels":[],"label_agreement":null},{"id":"W1990511704","doi":"10.1016/j.jval.2011.02.1133","title":"PND23 ECONOMIC EVALUATION OF DEXMEDETOMIDINE FOR SEDATION IN THE INTENSIVE CARE UNIT","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Dexmedetomidine; Sedation; Midazolam; Intensive care unit; Medicine; Delirium; Mechanical ventilation; Anesthesia; Intensive care; Emergency medicine; Intensive care medicine","score_opus":0.3215562547503459,"score_gpt":0.4066438160324588,"score_spread":0.08508756128211292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990511704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967269,0.00027371445,0.000052793046,0.0009967935,0.000057425157,0.001428017,0.000004565575,0.0000041334856,0.0004556659],"genre_scores_gemma":[0.9985762,0.000048609203,0.00026510193,0.0009265471,0.00003181107,0.000073536794,0.000059285405,0.000007668149,0.0000112021435],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990111,0.00029656044,0.0003143876,0.00012000422,0.00013375668,0.00012422062],"domain_scores_gemma":[0.9992645,0.00012255482,0.00013366995,0.00015155198,0.00029940734,0.000028347067],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001558059,0.00006051339,0.00018168034,0.00012724931,0.0000222194,0.0000015015142,0.000059299688,0.00003865767,0.000033460943],"category_scores_gemma":[0.00026092917,0.00004483419,0.000029895775,0.00009367208,0.000024270377,0.000042498963,0.0000055439964,0.00007131536,0.000006504038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000996086,0.00021845993,0.7858272,0.0009809473,0.00003588579,0.000006673862,0.172047,0.0021831216,0.00021046311,0.008505391,0.0005152904,0.028473457],"study_design_scores_gemma":[0.0029090801,0.0011972737,0.8739413,0.00041010018,0.00006621049,0.000015204133,0.064913005,0.05195073,0.0020014856,0.001924349,0.00056728866,0.00010397602],"about_ca_topic_score_codex":0.0034705845,"about_ca_topic_score_gemma":0.00032504572,"teacher_disagreement_score":0.10713399,"about_ca_system_score_codex":0.00023500051,"about_ca_system_score_gemma":0.00043783843,"threshold_uncertainty_score":0.5246509},"labels":[],"label_agreement":null},{"id":"W1990529789","doi":"10.1016/j.jval.2014.03.1662","title":"Health Care Costs In Psoriasis Patients Newly Initiated On A Biologic Therapy Or Methotrexate","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Psoriasis; Medical prescription; Pharmacy; Methotrexate; Health care; Managed care; Ambulatory care; Emergency medicine; Intensive care medicine; Family medicine; Internal medicine; Dermatology; Pharmacology","score_opus":0.24153656875190177,"score_gpt":0.46779943540024216,"score_spread":0.2262628666483404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990529789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9629771,0.005390228,0.000014114341,0.027583338,0.00046866154,0.0014087526,0.000027231177,0.000060806815,0.0020697683],"genre_scores_gemma":[0.95325863,0.013507224,0.0007354998,0.03228181,0.00010688249,0.00004076526,0.00003718924,0.000018629229,0.000013363992],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996806,0.0015484049,0.0005476061,0.00033585765,0.00022569853,0.00053642865],"domain_scores_gemma":[0.9981584,0.0011009705,0.00022959236,0.00019443,0.000058786543,0.00025781587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014476422,0.00017593744,0.00057711866,0.00016092403,0.00010760244,0.000009661777,0.000085162654,0.00008169849,0.000051295658],"category_scores_gemma":[0.00087173283,0.000114878676,0.00004308167,0.00050412293,0.00003370607,0.000048665486,0.000030348163,0.00044175494,0.00002992353],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046631973,0.0009917461,0.18354833,0.00052307075,0.00004428916,0.00001799131,0.004219818,0.00017464289,0.000006751408,0.00029334257,0.0011243373,0.80439246],"study_design_scores_gemma":[0.022499705,0.018731333,0.6780295,0.001531305,0.000014742925,0.0000075856706,0.001386897,0.0022786811,0.00011108586,0.00025219793,0.27473247,0.00042452064],"about_ca_topic_score_codex":0.0130080115,"about_ca_topic_score_gemma":0.00060947647,"teacher_disagreement_score":0.80396795,"about_ca_system_score_codex":0.0006159029,"about_ca_system_score_gemma":0.00027332522,"threshold_uncertainty_score":0.9935644},"labels":[],"label_agreement":null},{"id":"W1990560008","doi":"10.1016/j.jval.2012.08.1503","title":"PRM39 Evaluation of Patient Centered Outcomes Using Individual Data From a Quality Registry and Patient Reported Abilities and Ratings of Quality in Health Care, in Diabetes Patients in Sweden","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Health care; Population; Family medicine; Environmental health","score_opus":0.29903272821268967,"score_gpt":0.4570436263931738,"score_spread":0.15801089818048414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990560008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927978,0.0041533196,8.260666e-7,0.00035193228,0.00010607546,0.0021578167,0.00039545153,0.000008850929,0.000027906432],"genre_scores_gemma":[0.99852926,0.000100148056,0.00048171487,0.00017893728,0.000009440886,0.00003228869,0.0006547212,0.000013102418,4.0311704e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937552,0.0018874996,0.0025201319,0.00048022624,0.0009237585,0.00043314445],"domain_scores_gemma":[0.99722505,0.00041477196,0.0014120364,0.0006980427,0.00010875402,0.00014137548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005186364,0.00019042178,0.0008539757,0.00032910254,0.000026965654,0.000012896467,0.0001034639,0.00007214715,0.000008018394],"category_scores_gemma":[0.0021562455,0.00018523273,0.00002657086,0.00029935697,0.00012310094,0.00030573804,0.00028797064,0.00017704304,5.0147854e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001458347,0.0008947748,0.9656422,0.0033919613,0.000028891922,6.638598e-7,0.02427171,0.00023086397,0.0000055135106,0.000052805957,0.000011597653,0.005323198],"study_design_scores_gemma":[0.004325258,0.0002951449,0.971149,0.0017492706,0.000027548593,1.6248006e-7,0.020254912,0.0017833854,0.000016248208,0.00027437205,0.0000068104673,0.000117855874],"about_ca_topic_score_codex":0.13736074,"about_ca_topic_score_gemma":0.0070256083,"teacher_disagreement_score":0.13033512,"about_ca_system_score_codex":0.0008941629,"about_ca_system_score_gemma":0.0009098149,"threshold_uncertainty_score":0.86838365},"labels":[],"label_agreement":null},{"id":"W1990596085","doi":"10.1016/s1098-3015(11)71621-7","title":"PMH12: THE COST OF TREATING SCHIZOPHRENIA IN ROUTINE CLINICAL PRACTICE: RESULTS FROM THE CANADIAN NATIONAL OUTCOMES MEASUREMENT STUDY IN SCHIZOPHRENIA (CNOMSS)","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Schizophrenia (object-oriented programming); Psychiatry; Clinical Practice; Medicine; Psychology; Family medicine","score_opus":0.2009828727177178,"score_gpt":0.429784363418869,"score_spread":0.2288014907011512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990596085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9282779,0.0010086127,0.0000019476047,0.06625664,0.00016252456,0.0034285563,0.00011313454,0.000015513571,0.00073516584],"genre_scores_gemma":[0.99651235,0.00030678645,0.0017277234,0.00096237665,0.0002140795,0.00017213197,0.000058112688,0.00002519584,0.00002121078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99242795,0.0023832791,0.0019982657,0.0005848911,0.001884348,0.00072125805],"domain_scores_gemma":[0.99410015,0.0040394743,0.00043186927,0.0006778388,0.00034297362,0.00040770386],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014240805,0.00026121424,0.00070109847,0.00041667972,0.00023048493,0.00004660978,0.00033763514,0.00011941896,0.000026130178],"category_scores_gemma":[0.01451887,0.00015444781,0.00011266317,0.0011037783,0.00012946998,0.000116388335,0.00007283073,0.0011492481,0.000024418268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01748402,0.0020640153,0.9588174,0.000013124914,0.00014421582,0.00024473132,0.0015676977,0.0009441301,8.942632e-7,0.0007603687,0.00020325849,0.01775612],"study_design_scores_gemma":[0.029772226,0.0007210221,0.9640137,0.00035990885,0.0000283532,0.000017129065,0.0015785337,0.0025208248,0.0000022830934,0.0005096691,0.00036817693,0.00010816721],"about_ca_topic_score_codex":0.82425916,"about_ca_topic_score_gemma":0.93330896,"teacher_disagreement_score":0.10904981,"about_ca_system_score_codex":0.0026625074,"about_ca_system_score_gemma":0.008025854,"threshold_uncertainty_score":0.9975977},"labels":[],"label_agreement":null},{"id":"W1990728316","doi":"10.1111/j.1524-4733.2010.00761.x","title":"Persistence Patterns with Oral Antidiabetes Drug Treatment in Newly Treated Patients—A Population-Based Study","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec; Université Laval","funders":"Merck Canada","keywords":"Discontinuation; Medicine; Persistence (discontinuity); Metformin; Hazard ratio; Proportional hazards model; Internal medicine; Medical prescription; Population; Cohort; Cohort study; Pharmacology; Confidence interval; Insulin","score_opus":0.052002486493362234,"score_gpt":0.3143623215129684,"score_spread":0.26235983501960614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1990728316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971094,0.000026543194,0.0000075064454,0.0012719136,0.000076052806,0.0014072258,0.00000785194,0.00003152049,0.00006195234],"genre_scores_gemma":[0.99860644,0.0000075424196,0.00045370602,0.00048138082,0.000022846047,0.000120886994,0.00008379522,0.00001246191,0.00021095436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986955,0.00013552904,0.00035411882,0.00029455777,0.00026045062,0.00025986703],"domain_scores_gemma":[0.99927485,0.000074979354,0.00012600906,0.000311909,0.00005169618,0.00016057375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023247207,0.00013499151,0.00030484877,0.00015952352,0.000048581358,0.0000090059275,0.00007002433,0.00003308505,0.00013800598],"category_scores_gemma":[0.00004345383,0.000099017314,0.000024705849,0.00033201562,0.000016678783,0.000047395868,0.0000052533674,0.0001759963,0.000032333675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006836986,0.0015868162,0.9937501,0.000059686252,0.000006415696,0.0000090880485,0.0007144638,0.00018131771,0.000008204934,0.000006151959,0.000018862529,0.003590513],"study_design_scores_gemma":[0.004707428,0.0014984091,0.98907197,0.00026189093,0.000010122529,6.399053e-7,0.0005215062,0.003741408,0.00003480704,0.0000060201146,0.00005962638,0.00008616541],"about_ca_topic_score_codex":0.03470603,"about_ca_topic_score_gemma":0.0047016847,"teacher_disagreement_score":0.030004345,"about_ca_system_score_codex":0.00021684545,"about_ca_system_score_gemma":0.00034472859,"threshold_uncertainty_score":0.97172195},"labels":[],"label_agreement":null},{"id":"W1991070138","doi":"10.1016/j.jval.2013.01.007","title":"Assessing the Value of Symptom Relief for Patients with Gastroesophageal Reflux Disease Treatment: Willingness to Pay Using a Discrete Choice Experiment","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); University of Calgary; McMaster University","funders":"","keywords":"GERD; Willingness to pay; Medicine; Disease; Reflux; Physical therapy; Internal medicine","score_opus":0.035716385358246346,"score_gpt":0.35500222480766047,"score_spread":0.31928583944941413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991070138","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99372905,0.00022687342,0.00090641965,0.00069185207,0.00012768137,0.0042098486,0.00005479266,0.000031841795,0.000021657448],"genre_scores_gemma":[0.9868628,0.000013416743,0.011924696,0.00034942405,0.0001188591,0.0005023349,0.00008350335,0.00006389141,0.000081111306],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749863,0.00019367223,0.0006428323,0.0005010104,0.00047116747,0.00069267926],"domain_scores_gemma":[0.9981544,0.0002513961,0.00029976136,0.00055325875,0.00015885782,0.0005823016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023559935,0.00033934478,0.00058016425,0.000133021,0.00022272642,0.00005754219,0.0001260221,0.000048386104,0.000014588138],"category_scores_gemma":[0.00011794444,0.00017565898,0.00012397951,0.0002959201,0.000072528426,0.00023969167,0.000041069205,0.00012119591,0.0000061459386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025843157,0.001341241,0.98992354,0.00031926727,0.00010458842,0.000023112774,0.00093882874,0.0040812576,0.00006140765,0.000077165576,0.000015155646,0.0028560066],"study_design_scores_gemma":[0.005898309,0.004040816,0.9818407,0.00087369385,0.00013327334,0.0000036822214,0.00012256624,0.0065329294,0.00032483356,0.00007412369,0.000052465555,0.00010255738],"about_ca_topic_score_codex":0.0025867948,"about_ca_topic_score_gemma":0.000004032565,"teacher_disagreement_score":0.011018276,"about_ca_system_score_codex":0.0007934494,"about_ca_system_score_gemma":0.0005172296,"threshold_uncertainty_score":0.7163165},"labels":[],"label_agreement":null},{"id":"W1991089695","doi":"10.1016/s1098-3015(10)72550-x","title":"PMH55 CANADIAN COST-EFFECTIVENESS ANALYSIS OF LONG-ACTING RISPERIDONE VERSUS ORAL ATYPICAL AND CONVENTIONAL DEPOT ANTIPSYCHOTICS IN PATIENTS WITH SCHIZOPHRENIA AT HIGH-RISK OF NON-COMPLIANCE: UPDATED BASED ON NEW CLINICAL DATA","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risperidone; Schizophrenia (object-oriented programming); Medicine; Psychiatry; Compliance (psychology); Psychology","score_opus":0.1113448249204588,"score_gpt":0.4060005917665752,"score_spread":0.2946557668461164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991089695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977265,0.000034176013,0.00023940642,0.0002410205,0.00020010245,0.0010675575,0.0004795369,0.0000062809345,0.0000054180205],"genre_scores_gemma":[0.989728,0.000041661246,0.008725166,0.000032347103,0.00003138622,0.000008820622,0.0014134696,0.000017383385,0.0000017628049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758863,0.0004167537,0.00064774544,0.000508577,0.0004443815,0.000393929],"domain_scores_gemma":[0.9975012,0.0007721032,0.00027591898,0.00066610187,0.00012599824,0.0006586975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012181457,0.00017149335,0.0007880196,0.0006032422,0.00006645432,0.000008550487,0.00015537343,0.00012736986,0.000075334436],"category_scores_gemma":[0.00047709304,0.00014098377,0.00006533174,0.0009981992,0.0001662535,0.000058843772,0.00005135654,0.00058289757,0.0000027600454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1080223,0.0007402712,0.88035995,0.00009372789,0.00039841942,0.000026564092,0.000010405805,0.0012297039,0.0000037226769,0.0000343029,0.000018116987,0.009062516],"study_design_scores_gemma":[0.035075217,0.001903816,0.8906298,0.00029073816,0.00022469692,9.1911687e-7,0.000005471704,0.071738794,0.000027964754,0.000007656411,0.0000064835663,0.0000883884],"about_ca_topic_score_codex":0.138142,"about_ca_topic_score_gemma":0.33425784,"teacher_disagreement_score":0.19611584,"about_ca_system_score_codex":0.00029125361,"about_ca_system_score_gemma":0.0019019297,"threshold_uncertainty_score":0.86759716},"labels":[],"label_agreement":null},{"id":"W1991140087","doi":"10.1016/j.jval.2014.03.988","title":"Comparative Costs And Effectiveness Of Asthma Controller Therapies After Discharge From An Asthma-Related Hospitalization","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Asthma; Confounding; Cohort; Propensity score matching; Adverse effect; Emergency medicine; Inhaled corticosteroids; Cohort study; Internal medicine; Intensive care medicine; Pediatrics","score_opus":0.012005756692663107,"score_gpt":0.29687091039680974,"score_spread":0.2848651537041466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991140087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99410313,0.0042429585,0.0005017654,0.00017035088,0.00008466154,0.00076700264,0.00003957078,0.000025423516,0.00006512881],"genre_scores_gemma":[0.9994471,0.00006202765,0.00007680201,0.00024979917,0.0000470038,0.00004179069,0.000052044037,0.000016269682,0.000007146079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804705,0.0010160658,0.00034061837,0.0002519982,0.00016951698,0.0001747553],"domain_scores_gemma":[0.99918556,0.0002764205,0.0001435073,0.00015244941,0.00006997452,0.0001720922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005257974,0.00014144652,0.0005531691,0.000099708406,0.00004484047,0.000009188507,0.000036574183,0.00007570281,0.000026240574],"category_scores_gemma":[0.00005181176,0.00010571327,0.000043391337,0.00013278911,0.00011172676,0.000101491416,0.000014026176,0.0001039093,0.000004980119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026677565,0.0007514155,0.9792811,0.00058065145,0.00009734022,0.000006545962,0.0048711146,0.0005346448,0.0015392548,0.0020145564,0.000017858521,0.0076377518],"study_design_scores_gemma":[0.003703785,0.0013075769,0.9839219,0.00079780014,0.000010407304,0.0000016146909,0.00029869392,0.008813659,0.00032665383,0.0004183876,0.00029929262,0.000100239224],"about_ca_topic_score_codex":0.0008605633,"about_ca_topic_score_gemma":0.000029065528,"teacher_disagreement_score":0.008279014,"about_ca_system_score_codex":0.00006511338,"about_ca_system_score_gemma":0.00008821756,"threshold_uncertainty_score":0.4310862},"labels":[],"label_agreement":null},{"id":"W1991212328","doi":"10.1016/j.jval.2013.03.170","title":"Assesing parameter importance in health economics models. Can we make it faster?","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Analysis of covariance; Statistics; Dominance (genetics); Econometrics; Subgroup analysis; Regression analysis; Mathematics; Computer science; Data mining","score_opus":0.47067665487411037,"score_gpt":0.41125062353245356,"score_spread":0.059426031341656804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991212328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63262224,0.006837232,0.0019668804,0.3523197,0.00095560687,0.0027568252,0.00024356967,0.000075988915,0.0022219326],"genre_scores_gemma":[0.91006434,0.005080237,0.014400635,0.06903829,0.00028278207,0.00040464636,0.000050358904,0.00011585478,0.0005628719],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9872599,0.0009788456,0.009127073,0.0011204408,0.00010810103,0.0014056308],"domain_scores_gemma":[0.99340504,0.0012283294,0.003836751,0.0009284138,0.000041426694,0.00056002685],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.020136563,0.0003828862,0.0019260185,0.00094199204,0.00018909486,0.0001730683,0.00045708797,0.00023416652,0.0003307528],"category_scores_gemma":[0.0009082866,0.00052527676,0.00013781518,0.00043957523,0.000070839356,0.00080872123,0.000083327854,0.00056095043,0.00071783626],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003195351,0.00058735,0.39454943,0.0052083577,0.00006989069,0.000005805102,0.02026835,0.27420455,4.4791443e-7,0.27306163,0.02181871,0.010193533],"study_design_scores_gemma":[0.0017600055,0.00023101606,0.03509357,0.00093674107,0.0000012146204,0.00001488473,0.0028300493,0.6888535,6.0468597e-7,0.23575296,0.033704683,0.0008207457],"about_ca_topic_score_codex":0.10677096,"about_ca_topic_score_gemma":0.015090336,"teacher_disagreement_score":0.41464898,"about_ca_system_score_codex":0.0044713942,"about_ca_system_score_gemma":0.0014170053,"threshold_uncertainty_score":0.99971986},"labels":[],"label_agreement":null},{"id":"W1991222191","doi":"10.1111/j.1524-4733.2008.00433.x","title":"Comparing the Health Utilities Index Mark 3 (HUI3) with the Short Form-36 Preference-Based SF-6D in Chronic Kidney Disease","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Intraclass correlation; Medicine; Health Utilities Index; Psychology; Internal medicine; Physical therapy; Psychometrics; Clinical psychology; Disease; Health related quality of life","score_opus":0.10349825238547762,"score_gpt":0.2955851727326257,"score_spread":0.19208692034714808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991222191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9481266,0.003906984,0.00032051638,0.04309478,0.00011725491,0.0025428585,0.000027234933,0.000058446276,0.0018053047],"genre_scores_gemma":[0.9900162,0.00082523917,0.000045157904,0.008382762,0.00012294446,0.00019384803,0.0000704621,0.000025177906,0.00031819107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972568,0.00046744884,0.000581569,0.0003782165,0.00064227136,0.00067366863],"domain_scores_gemma":[0.9984465,0.00014496426,0.00014254104,0.0006474338,0.000038641203,0.00057990284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012913651,0.00023286547,0.00051909726,0.00021712936,0.00031298216,0.000028440143,0.0002504782,0.000034427976,0.000047522364],"category_scores_gemma":[0.00006678747,0.00011943997,0.00010600969,0.00057469134,0.00022599203,0.000063160885,0.00007513826,0.00040520172,0.00000886459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027536,0.0009842806,0.925621,0.00403862,0.00012650114,0.00014290794,0.0035782978,0.038961798,0.0000010392354,0.0018897745,0.014826785,0.007075438],"study_design_scores_gemma":[0.0018634921,0.0004597874,0.9001513,0.0014853529,0.000032221393,0.000003719549,0.00056168716,0.08494701,0.0000016018905,0.000105224615,0.0102455495,0.00014302696],"about_ca_topic_score_codex":0.009645102,"about_ca_topic_score_gemma":0.0019287325,"teacher_disagreement_score":0.04598521,"about_ca_system_score_codex":0.0010172501,"about_ca_system_score_gemma":0.0044942047,"threshold_uncertainty_score":0.99694973},"labels":[],"label_agreement":null},{"id":"W1991289860","doi":"10.1016/j.jval.2013.03.555","title":"Health care resource utilization (HRU) and costs associated with disease activity in systemic lupus erythematosus (SLE): A retrospective observational cohort analysis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Cohort; Observational study; Retrospective cohort study; Emergency medicine; Medical record; Medical prescription; Health care; Diagnosis code; Rheumatology; Pharmacy; Internal medicine; Intensive care unit; Family medicine; Population; Environmental health","score_opus":0.046898916535208904,"score_gpt":0.3240767267311913,"score_spread":0.2771778101959824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991289860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885821,0.0037760313,0.00015350798,0.0027834156,0.00006916198,0.0043346295,0.00007610977,0.000086581145,0.00013847355],"genre_scores_gemma":[0.9982747,0.00033631566,0.00011333479,0.00027925725,0.000040291692,0.0003893733,0.00030075878,0.000050101884,0.00021587794],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99509865,0.0013575796,0.00085533987,0.00077707943,0.0011660896,0.00074526115],"domain_scores_gemma":[0.9973239,0.000525893,0.00052409904,0.00056226214,0.00041835476,0.00064552535],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002049835,0.0002882814,0.0012465258,0.0009153776,0.00016491451,0.00005140634,0.00012160708,0.00014131187,0.000021211308],"category_scores_gemma":[0.0009139268,0.0002478955,0.00008476605,0.00289061,0.0001055929,0.00019543803,0.000064135915,0.000475844,0.000006850616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003656007,0.00020915564,0.99195886,0.0019559625,0.00021412378,0.00003329013,0.003725747,0.00074393774,0.000008233702,0.00015738842,0.00031191244,0.00031577502],"study_design_scores_gemma":[0.0028083452,0.0003540365,0.9580059,0.0043678368,0.000072498115,0.0003829356,0.0026871616,0.031089894,0.0000029646608,0.00003307691,0.0000117730715,0.00018359623],"about_ca_topic_score_codex":0.018837167,"about_ca_topic_score_gemma":0.002939036,"teacher_disagreement_score":0.033952992,"about_ca_system_score_codex":0.0073704803,"about_ca_system_score_gemma":0.0019176202,"threshold_uncertainty_score":0.9999973},"labels":[],"label_agreement":null},{"id":"W1991297890","doi":"10.1111/j.1524-4733.2005.03086.x","title":"Probabilistic Markov Model to Assess the Cost-Effectiveness of Bronchodilator Therapy in COPD Patients in Different Countries","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":106,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Salmeterol; Ipratropium; Medicine; COPD; Exacerbation; Anticholinergic; Bronchodilator; Tiotropium bromide; Quality of life (healthcare); Physical therapy; Randomized controlled trial; Intensive care medicine; Internal medicine; Asthma; Lung function; Lung","score_opus":0.06925652454250496,"score_gpt":0.3641312806389096,"score_spread":0.2948747560964046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991297890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904073,0.0008186888,0.00007434639,0.0016295842,0.000078910976,0.0067670303,0.00008807283,0.000014060128,0.00012200457],"genre_scores_gemma":[0.9983642,0.00031158645,0.00015522643,0.00036327314,0.00004842,0.00066711934,0.000027715903,0.000033095566,0.000029353516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660856,0.0010224591,0.0006590092,0.00043186985,0.0006764043,0.0006016854],"domain_scores_gemma":[0.9981306,0.0009045006,0.00011404648,0.00046325906,0.00015780726,0.00022979405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015697705,0.00022408586,0.0006164085,0.00032570888,0.00004521504,0.00001261613,0.00022288825,0.00008369523,0.0000358672],"category_scores_gemma":[0.00033380187,0.00015809131,0.000059578415,0.000530735,0.00013868621,0.000089372064,0.00008703055,0.0004165168,0.0000064154115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026043623,0.0018676841,0.9206583,0.0022633406,0.000015106891,0.000008113427,0.0010336809,0.05462942,0.000051238894,0.00073377596,0.00007189759,0.016063085],"study_design_scores_gemma":[0.0044352156,0.00032710185,0.9032844,0.0009951119,0.0000035429266,0.0000013232927,0.00007875963,0.09006692,0.00011241018,0.00042134253,0.00015831248,0.00011561826],"about_ca_topic_score_codex":0.0026750932,"about_ca_topic_score_gemma":0.00071911124,"teacher_disagreement_score":0.035437495,"about_ca_system_score_codex":0.0034777115,"about_ca_system_score_gemma":0.0012309258,"threshold_uncertainty_score":0.9094094},"labels":[],"label_agreement":null},{"id":"W1991488768","doi":"10.1016/j.jval.2012.08.2068","title":"PSS21 Evaluation of Health Utility in Patients With Retinal Vein Occlusion","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); St Joseph's Health Care","funders":"","keywords":"Medicine; Context (archaeology); Central retinal vein occlusion; Branch retinal vein occlusion; Visual acuity; Occlusion; Observational study; Ophthalmology; Optometry; Macular edema; Internal medicine; Geography","score_opus":0.4419316813334235,"score_gpt":0.4389533432612799,"score_spread":0.0029783380721435937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1991488768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813064,0.004496441,0.00043424757,0.01042267,0.00047560545,0.0020113438,0.00012256493,0.000018884635,0.00071189186],"genre_scores_gemma":[0.9953968,0.00008307537,0.0019236215,0.002342397,0.000085284766,0.000053091826,0.0000765006,0.000025703235,0.000013520945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.988877,0.0033182898,0.006039364,0.0005261987,0.0004070528,0.0008320788],"domain_scores_gemma":[0.9950846,0.00050271564,0.0034841597,0.0005511941,0.00012730209,0.0002500261],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.1031767,0.0001875734,0.0011538588,0.0005992944,0.00012459855,0.000012906259,0.00018683494,0.00011925758,0.00021321357],"category_scores_gemma":[0.002112786,0.00022090207,0.00005310594,0.0005263176,0.00005776941,0.0005061004,0.000049815062,0.00026360847,0.00013051958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046051257,0.0005356339,0.9833468,0.0006253677,0.0000063298526,3.954444e-8,0.0046282164,0.0014570659,4.0481545e-8,0.007116158,0.00066413387,0.0015741428],"study_design_scores_gemma":[0.0022699127,0.000284496,0.976187,0.0003983649,0.0000016123821,5.7481054e-7,0.0005349953,0.016146643,6.0100444e-7,0.0027520217,0.0012518433,0.00017195396],"about_ca_topic_score_codex":0.024676086,"about_ca_topic_score_gemma":0.0005937048,"teacher_disagreement_score":0.101063915,"about_ca_system_score_codex":0.002682512,"about_ca_system_score_gemma":0.0010429232,"threshold_uncertainty_score":0.9818187},"labels":[],"label_agreement":null},{"id":"W1992633728","doi":"10.1016/s1098-3015(11)73249-1","title":"PIH4 COST OF PUBLIC HEALTH DELIVERY OF CHILDHOOD IMMUNIZATIONS IN NOVA SCOTIA","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Impact and Responses","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nova scotia; Nova (rocket); Medicine; Pediatrics; History; Engineering; Ethnology","score_opus":0.08054979427281597,"score_gpt":0.28772185169424175,"score_spread":0.20717205742142578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992633728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99042594,0.0028724887,0.0003896337,0.004139083,0.00038555256,0.00042392357,0.00025366098,0.000011118799,0.0010986049],"genre_scores_gemma":[0.9969962,0.0011176342,0.0014676609,0.0002724634,0.00003052359,0.0000033069944,0.000023138155,0.000018851206,0.00007020053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979258,0.00012785668,0.0012823698,0.00020003092,0.000047087953,0.00041682596],"domain_scores_gemma":[0.99859375,0.00019360283,0.00064971193,0.00037755814,0.000036256173,0.00014913191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026733496,0.000106146246,0.000540044,0.0009952368,0.00004640022,0.00001382938,0.00024204899,0.000094316,0.00017901875],"category_scores_gemma":[0.0005772331,0.00012056496,0.0000620738,0.0010042085,0.00008703408,0.0001568416,0.000046543057,0.00032912704,0.000047743753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018288953,0.0009965101,0.9007206,0.00027767709,0.000019553514,8.8173925e-7,0.0058250385,0.0012530321,0.000062047424,0.08257164,0.0005450453,0.0077096783],"study_design_scores_gemma":[0.0010485118,0.00026632298,0.98973966,0.00014765043,6.06521e-7,0.000004767189,0.00036926678,0.0021347508,0.0000602468,0.0015424038,0.004526277,0.00015953748],"about_ca_topic_score_codex":0.042500973,"about_ca_topic_score_gemma":0.0056571816,"teacher_disagreement_score":0.08901905,"about_ca_system_score_codex":0.00013111359,"about_ca_system_score_gemma":0.00074138143,"threshold_uncertainty_score":0.9638751},"labels":[],"label_agreement":null},{"id":"W1992859792","doi":"10.1016/j.jval.2014.03.027","title":"How Canadians Value Rare Diseases Given Their Opportunity Cost?","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Value (mathematics); Medicine; Mathematics; Statistics","score_opus":0.07074710787147058,"score_gpt":0.29251430695483643,"score_spread":0.22176719908336584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1992859792","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08614489,0.00069166423,0.0005170181,0.89178413,0.0017334596,0.0012608444,0.00014449343,0.00025926085,0.017464213],"genre_scores_gemma":[0.82233244,0.0001485634,0.00006727406,0.17519602,0.0018194333,0.00005286881,0.00013243621,0.000032871136,0.00021805931],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.997527,0.00028802437,0.0005080479,0.00036159455,0.00016972888,0.0011456045],"domain_scores_gemma":[0.99855334,0.00031677936,0.00034128196,0.00041305146,0.00009047535,0.0002850914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018028059,0.00022555715,0.0005137955,0.0002863509,0.0003204362,0.00015149407,0.00036122865,0.0001144037,0.00006242031],"category_scores_gemma":[0.0022547022,0.00019549596,0.00008355233,0.00048244034,0.0000808185,0.00047816304,0.00012212238,0.00026817765,0.00005629912],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019299265,0.00010288809,0.033931732,0.0012821691,0.000013024949,0.000009984775,0.00012484561,0.014987851,5.5662355e-7,0.24685608,0.6830137,0.01965791],"study_design_scores_gemma":[0.00030570728,0.000024362065,0.021620836,0.000089943256,0.000004233045,0.000002006503,0.0004209661,0.071746275,5.6553443e-8,0.009181974,0.8964346,0.00016901594],"about_ca_topic_score_codex":0.6417887,"about_ca_topic_score_gemma":0.009876215,"teacher_disagreement_score":0.7361876,"about_ca_system_score_codex":0.0002811604,"about_ca_system_score_gemma":0.00049656007,"threshold_uncertainty_score":0.7972094},"labels":[],"label_agreement":null},{"id":"W1993141230","doi":"10.1016/s1098-3015(10)70938-4","title":"PSS43 WORK RELATED LOST PRODUCTIVITY AND ITS ECONOMIC IMPACT IN CANADIAN PATIENTS WITH MODERATE TO SEVERE PSORIASIS","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Parasites and Host Interactions","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Work productivity; Productivity; Psoriasis; Work (physics); Economics; Medicine; Business; Demographic economics; Dermatology; Economic growth; Engineering; Mechanical engineering","score_opus":0.020301276297253402,"score_gpt":0.2753116829952242,"score_spread":0.25501040669797076,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993141230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971856,0.00049716234,3.873106e-7,0.0012068511,0.00027310854,0.0004729209,0.00011250231,0.000010061292,0.00024139322],"genre_scores_gemma":[0.99930465,0.000065512664,0.000019019586,0.000115612835,0.000010211291,0.0000119420365,0.000042927208,0.0000114549875,0.00041867045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99885666,0.00016982638,0.00023374204,0.00027685473,0.000013824654,0.00044906867],"domain_scores_gemma":[0.9996119,0.000052560114,0.00006609214,0.00013745879,0.000022324362,0.00010962458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017225523,0.000119010474,0.00022983665,0.00026487836,0.00014800992,0.00000642713,0.000056007604,0.000099633835,0.000120250894],"category_scores_gemma":[0.000038460093,0.00010577422,0.000017360644,0.00019293914,0.000025372048,0.000118823205,0.000014528782,0.0002774336,0.00029209268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039039282,0.00007750871,0.9759717,0.000009724886,0.000034009052,0.0000056697627,0.001806157,0.020344213,0.000022936918,0.00008971536,0.000708984,0.00053898507],"study_design_scores_gemma":[0.0009939353,0.00025285056,0.9966922,0.00007846288,0.0000023708617,0.000050562092,0.000018384866,0.00011741691,0.000048706737,0.000023699717,0.0015892471,0.00013217099],"about_ca_topic_score_codex":0.52311337,"about_ca_topic_score_gemma":0.2728441,"teacher_disagreement_score":0.25026926,"about_ca_system_score_codex":0.0008983487,"about_ca_system_score_gemma":0.0007638614,"threshold_uncertainty_score":0.7404246},"labels":[],"label_agreement":null},{"id":"W1993515803","doi":"10.1016/j.jval.2014.03.274","title":"Cost Of Drug Therapy For Ankylosing Spondylitis In The Brazilian Public Health System","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Adalimumab; Ankylosing spondylitis; Infliximab; Etanercept; Sulfasalazine; Internal medicine; BASDAI; Pediatrics; Disease; Psoriatic arthritis; Rheumatoid arthritis","score_opus":0.08611378252083714,"score_gpt":0.3474435951617377,"score_spread":0.26132981264090055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993515803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94375193,0.011555713,0.00020734081,0.03923887,0.00034075914,0.004053196,0.00019164466,0.00003961248,0.00062094483],"genre_scores_gemma":[0.9949429,0.0012434354,0.00082726113,0.0025549443,0.000113382164,0.0002003738,0.000069824135,0.000021868169,0.000025994219],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977669,0.0005359971,0.0006393771,0.0002563634,0.00025118695,0.0005501547],"domain_scores_gemma":[0.99881965,0.0004378409,0.00022106728,0.00033437787,0.00005419573,0.00013287338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029582435,0.00014068057,0.00057603774,0.00018195274,0.00015240582,0.000014447808,0.00010440231,0.000039880648,0.000008091055],"category_scores_gemma":[0.00012037031,0.00009919988,0.000080964746,0.00037909334,0.00005287453,0.000046829464,0.000014406738,0.00013457194,0.0000025900513],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010246448,0.0021956414,0.40821052,0.005742178,0.00011812049,0.000040898987,0.03784245,0.0000900589,0.000014719944,0.052016806,0.0032516131,0.48945236],"study_design_scores_gemma":[0.03770083,0.007250571,0.62643284,0.0064191218,0.000017008164,0.0002408196,0.02167191,0.006015041,0.000060584534,0.00089565484,0.2928867,0.00040889627],"about_ca_topic_score_codex":0.011416626,"about_ca_topic_score_gemma":0.0009903999,"teacher_disagreement_score":0.48904344,"about_ca_system_score_codex":0.00044262796,"about_ca_system_score_gemma":0.00035837546,"threshold_uncertainty_score":0.9951664},"labels":[],"label_agreement":null},{"id":"W1993551769","doi":"10.1016/j.jval.2014.03.656","title":"Intra-Hospital Cost Of Implanting A Left Ventricular Assistance Device: A Canadian Perspective","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Institut National d'Excellence en Santé et en Services Sociaux; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Activity-based costing; Ventricular assist device; Emergency medicine; Total cost; Average cost; Index (typography); Resource use; Medical emergency; Surgery; Heart failure; Cardiology","score_opus":0.01427494557019083,"score_gpt":0.24615116988540528,"score_spread":0.23187622431521446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993551769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932861,0.0016369657,0.0017030288,0.00047865306,0.0005262872,0.00055428286,0.000037591948,0.00010349498,0.0016736113],"genre_scores_gemma":[0.9992205,0.000010253064,0.0005491478,0.000116786294,0.00006100634,0.000008644878,0.000005839992,0.000025998965,0.0000018270989],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99861234,0.000099894954,0.0004141314,0.00021136405,0.00017729048,0.0004850007],"domain_scores_gemma":[0.99923843,0.000105506675,0.00008303727,0.00021943478,0.00005069349,0.00030290653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006981044,0.00012891785,0.00030219372,0.00017530449,0.000047487803,0.000013225535,0.00016004518,0.000078535464,0.000042186402],"category_scores_gemma":[0.00016770542,0.00014218797,0.000046211037,0.00026220063,0.000016557642,0.00007332652,0.000010970604,0.0002338448,0.000019879548],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016137295,0.00019790883,0.62932163,0.0037044294,0.00020141581,0.00041276685,0.0104640955,0.21579267,0.00033344823,0.13186474,0.001179297,0.0065114484],"study_design_scores_gemma":[0.0018841057,0.00044835653,0.29372182,0.0019267438,0.00004045109,0.00018517618,0.0040992205,0.66072065,0.0018142939,0.0055348575,0.028147923,0.0014763849],"about_ca_topic_score_codex":0.10906237,"about_ca_topic_score_gemma":0.036625963,"teacher_disagreement_score":0.444928,"about_ca_system_score_codex":0.00072622474,"about_ca_system_score_gemma":0.00024844363,"threshold_uncertainty_score":0.9809531},"labels":[],"label_agreement":null},{"id":"W1993753125","doi":"10.1016/j.jval.2014.03.291","title":"Health Care Resource Utilization In The Management Of Knee Osteoarthritis With Hyaluronic Acid In A Canadian Real-World Population","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); Western University","funders":"","keywords":"Medicine; Osteoarthritis; Physical therapy; Observational study; Population; Health care; Knee pain; Emergency medicine; Internal medicine; Alternative medicine","score_opus":0.023654662536083844,"score_gpt":0.28561463170526064,"score_spread":0.2619599691691768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993753125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98720044,0.002412199,0.00000853641,0.0035826822,0.00006747624,0.0024036563,0.000015157816,0.00002080514,0.0042890618],"genre_scores_gemma":[0.9978724,0.00020729755,0.00069848425,0.0007479934,0.00002816521,0.0000875716,0.000270829,0.000022282871,0.000064991116],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980404,0.0003975589,0.0005040857,0.0002667034,0.00028475752,0.0005065051],"domain_scores_gemma":[0.99930274,0.000032078853,0.00014696005,0.000327437,0.00002111401,0.00016963662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009031479,0.00013684579,0.00035196354,0.00055530405,0.000066869914,0.000008669075,0.00006979946,0.000049185328,0.000007450015],"category_scores_gemma":[0.000010149575,0.00011284293,0.000025601075,0.00076526817,0.000019299778,0.000049186732,0.000011220278,0.00016776015,0.0000026824328],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031552845,0.00018231227,0.37293038,0.0017074089,0.000009480514,0.00010659853,0.010590093,0.001157888,0.00000364867,0.025221966,0.000038696377,0.587736],"study_design_scores_gemma":[0.012742486,0.011797449,0.95150155,0.007822766,0.000025169575,0.000037813254,0.006734196,0.0009781289,0.00003456931,0.00049432175,0.0075749676,0.00025658787],"about_ca_topic_score_codex":0.6149951,"about_ca_topic_score_gemma":0.931079,"teacher_disagreement_score":0.5874794,"about_ca_system_score_codex":0.0011855391,"about_ca_system_score_gemma":0.0004467301,"threshold_uncertainty_score":0.4601601},"labels":[],"label_agreement":null},{"id":"W1993841889","doi":"10.1016/s1098-3015(10)72639-5","title":"PMS53 UTILISATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS IN QUEBEC, CANADA: IS THERE A CHANGE IN THE PATIENT RISK PROFILE AFTER THE WITHDRAWAL OF ROFECOXIB?","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rofecoxib; Nonsteroidal; Medicine; Pharmacology; Intensive care medicine; Cyclooxygenase; Chemistry","score_opus":0.015298626307932946,"score_gpt":0.2627011976653525,"score_spread":0.24740257135741955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993841889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99222934,0.0015744502,1.03876694e-7,0.0045196745,0.00014246095,0.001322639,0.000050382114,0.0000026952412,0.00015825845],"genre_scores_gemma":[0.9989674,0.00018060653,0.000014897269,0.0005074585,0.000038618295,0.0002616681,0.000003689086,0.000007679242,0.000017959517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879855,0.00019912516,0.00039819453,0.00014199586,0.00026574035,0.00019642424],"domain_scores_gemma":[0.9993841,0.00012852778,0.00019814465,0.00022144387,0.000038648133,0.000029132867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045147803,0.000103255064,0.00027633112,0.000074290474,0.000035401965,0.000002965482,0.00006619492,0.000041916497,0.00004095989],"category_scores_gemma":[0.00003291703,0.00005594394,0.00003180759,0.00019890277,0.00007431223,0.000036124653,0.00002640325,0.00026735672,4.7138963e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002681733,0.00015442062,0.9231415,0.00018390638,0.000013900403,0.0000089036685,0.06428301,0.000005728818,0.000013006124,0.000020098569,0.0001298632,0.011777485],"study_design_scores_gemma":[0.000817053,0.00022568717,0.99310714,0.00021974105,0.000008966809,0.0000017762104,0.0045836084,0.0004120351,0.00016464402,0.000014359183,0.0004016449,0.000043326065],"about_ca_topic_score_codex":0.97114855,"about_ca_topic_score_gemma":0.98704827,"teacher_disagreement_score":0.06996566,"about_ca_system_score_codex":0.00022046182,"about_ca_system_score_gemma":0.0007685597,"threshold_uncertainty_score":0.22813275},"labels":[],"label_agreement":null},{"id":"W1993902708","doi":"10.1016/j.jval.2013.08.1529","title":"Long-Term Benefits Over More Than 4 Years of Certolizumab Pegol Combination Therapy on Workplace and Household Productivity, and Participation in Social Activities in Rheumatoid Arthritis: Results from the Open-Label Extension Study of Rapid1","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Presenteeism; Absenteeism; Randomized controlled trial; Rheumatoid arthritis; Work productivity; Productivity; Bristol-Myers; Internal medicine; Physical therapy; Family medicine; Demography; Psychology","score_opus":0.17862936133495377,"score_gpt":0.4155487041716613,"score_spread":0.2369193428367075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993902708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98964316,0.0016986934,4.1435217e-7,0.004083806,0.0001377531,0.004356347,0.000060315277,0.000012463494,0.0000070759747],"genre_scores_gemma":[0.99475414,0.004840169,0.0000106890775,0.00009713007,0.00007248561,0.00017274794,0.000023193184,0.000021733405,0.00000772043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99601805,0.0020361925,0.0009133611,0.00037493184,0.00030775645,0.00034971177],"domain_scores_gemma":[0.9979062,0.0011544881,0.00056023756,0.00025673365,0.000056305274,0.00006602069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011275302,0.00014261881,0.00046599252,0.00019279057,0.0002125865,0.000014809933,0.00012782088,0.00015322879,0.0000037664931],"category_scores_gemma":[0.00021821348,0.0001225369,0.0000105799145,0.0003596944,0.000059141003,0.00026883426,0.00012138385,0.00054072385,5.59432e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010170795,0.0015860044,0.9013729,0.00017338582,0.000003963529,0.0000024870567,0.06568359,0.00004895272,0.000010799487,0.00015839869,0.000107644475,0.029834762],"study_design_scores_gemma":[0.011129755,0.00056151825,0.98195285,0.0015511569,0.0000013296107,4.6321418e-7,0.0041352417,0.00031951876,0.000005397501,0.00024673762,0.0000025510249,0.00009345568],"about_ca_topic_score_codex":0.06613867,"about_ca_topic_score_gemma":0.014756564,"teacher_disagreement_score":0.080579944,"about_ca_system_score_codex":0.00014579568,"about_ca_system_score_gemma":0.00027203915,"threshold_uncertainty_score":0.94008},"labels":[],"label_agreement":null},{"id":"W1993993055","doi":"10.1016/j.jval.2011.08.368","title":"PMH69 Deprivation and Use of Atipycal Antipsychotics in Schizophrenia","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Université de Sherbrooke; Université Laval","funders":"","keywords":"Social deprivation; Cohort; Schizophrenia (object-oriented programming); Medicine; Population; Psychiatry; Cohort study; Public health; Diagnosis of schizophrenia; Pediatrics; Demography; Gerontology; Psychosis; Internal medicine; Environmental health","score_opus":0.14186572682858725,"score_gpt":0.33816296625425524,"score_spread":0.19629723942566799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1993993055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962476,0.00032855175,0.00006445375,0.0028443013,0.00003107281,0.0004379666,0.0000038979615,0.0000111897825,0.000030991087],"genre_scores_gemma":[0.9707593,0.00048551694,0.028249077,0.00045189727,0.000021577966,0.000008545314,0.0000071574723,0.000009588437,0.0000073625038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989631,0.000115978226,0.00033382897,0.00017315581,0.00018236048,0.00023153616],"domain_scores_gemma":[0.9994644,0.00011779217,0.000064927866,0.00019457792,0.000030492292,0.00012781123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031282738,0.000077289755,0.0002240438,0.0002667696,0.000017054967,0.000004312757,0.000032743414,0.000058484366,0.000015471413],"category_scores_gemma":[0.00018143737,0.00006607583,0.00002000018,0.00028175826,0.00004998961,0.0000700532,0.000018402232,0.00020096493,0.000004684521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0071391403,0.0004538547,0.9696567,0.00023691273,0.00001561405,0.00009630161,0.00071879145,0.000019629098,0.00006674618,0.0050943675,0.000086987704,0.016414944],"study_design_scores_gemma":[0.0040737614,0.00058805296,0.989597,0.00025726756,0.0000037317807,0.000022830123,0.00002716407,0.0024246252,0.0003845312,0.0025352065,0.000040987554,0.000044818],"about_ca_topic_score_codex":0.004300044,"about_ca_topic_score_gemma":0.00031131,"teacher_disagreement_score":0.028184624,"about_ca_system_score_codex":0.00008681711,"about_ca_system_score_gemma":0.00025846524,"threshold_uncertainty_score":0.65004086},"labels":[],"label_agreement":null},{"id":"W1994369386","doi":"10.1016/j.jval.2011.02.695","title":"PMS9 COST CONSEQUENCE OF COLCHICINE APPROVAL IN THE MEDICAID PROGRAMS IN THE UNITED STATES","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicaid; Medicine; Medical prescription; Prescription drug; Colchicine; Quarter (Canadian coin); Cost sharing; Medicare Part D; Family medicine; Business; Health care; Pharmacology; Internal medicine; Economics; Geography; Nursing","score_opus":0.15071151779282413,"score_gpt":0.32807904393824644,"score_spread":0.1773675261454223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994369386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791963,0.00036253582,0.000032768876,0.017399015,0.00007094639,0.0018428065,0.000009302228,0.000016417116,0.0010699105],"genre_scores_gemma":[0.99634284,0.00052442926,0.0002621396,0.0025978703,0.000020805608,0.00012857247,0.00009797187,0.000008221618,0.000017153043],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9981213,0.0006187546,0.00052929204,0.0001479947,0.00028026756,0.00030237014],"domain_scores_gemma":[0.9990781,0.00040280135,0.0001129415,0.00029286728,0.00004489374,0.00006838442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017639573,0.000093258204,0.00024015657,0.00023849624,0.000042307813,0.000004539418,0.00019164984,0.00008574663,0.000031516112],"category_scores_gemma":[0.00018920588,0.000049189945,0.000027694025,0.0012022095,0.0003393956,0.000024441097,0.0000132740715,0.0006100406,0.0000053624385],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013761778,0.010357227,0.34692007,0.0014533713,0.00032793233,0.003156827,0.5031846,0.001679818,0.0004172235,0.11802585,0.0022515133,0.01084936],"study_design_scores_gemma":[0.023013886,0.010326103,0.6972231,0.0079761995,0.00053324015,0.0027806924,0.15096542,0.05199148,0.0003357128,0.043271907,0.010860905,0.0007213242],"about_ca_topic_score_codex":0.032294013,"about_ca_topic_score_gemma":0.00060236634,"teacher_disagreement_score":0.3522192,"about_ca_system_score_codex":0.000069091446,"about_ca_system_score_gemma":0.0004145034,"threshold_uncertainty_score":0.97415},"labels":[],"label_agreement":null},{"id":"W1994471959","doi":"10.1016/j.jval.2012.09.006","title":"A Quantitative Benefit-Risk Analysis of Isoniazid for Treatment of Latent Tuberculosis Infection Using Incremental Benefit Framework","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; Queen's University; University of British Columbia","funders":"","keywords":"Medicine; Latent tuberculosis; Isoniazid; Tuberculosis; Vaccination; Tuberculin; Internal medicine; Demography; Pediatrics; Immunology; Mycobacterium tuberculosis; Pathology","score_opus":0.10680985462292221,"score_gpt":0.41154076528345557,"score_spread":0.30473091066053337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994471959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940206,0.0014880712,0.001503692,0.0013471395,0.000059512106,0.0014209516,0.00013380889,0.000012274155,0.000013949902],"genre_scores_gemma":[0.97246295,0.004704722,0.022428047,0.00013802182,0.00003549915,0.00013523875,0.00007113313,0.00001665345,0.000007758074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788237,0.0002460706,0.00090292224,0.00030567573,0.00022166326,0.00044130112],"domain_scores_gemma":[0.99790084,0.001021477,0.0003991639,0.00027814595,0.00020522108,0.00019517381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079168694,0.0001607643,0.0010865548,0.00082777167,0.000069213726,0.0000045227953,0.00004465745,0.00014358544,0.00008802616],"category_scores_gemma":[0.0005759992,0.00012960847,0.0003513783,0.0010266807,0.0000693952,0.00006903349,0.000021982081,0.00011115692,0.0000039759757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035539365,0.0007381825,0.9386905,0.00030607486,0.0015523279,5.43675e-7,0.0010233113,0.049057957,0.00094609073,0.0015594478,0.000020237281,0.0057499716],"study_design_scores_gemma":[0.00095336034,0.0044197366,0.67537713,0.00022598176,0.00050674425,0.0000019090276,0.00014359507,0.31630504,0.00061948877,0.0013469475,0.000024874169,0.00007518216],"about_ca_topic_score_codex":0.2815441,"about_ca_topic_score_gemma":0.0018057837,"teacher_disagreement_score":0.2797383,"about_ca_system_score_codex":0.00073019386,"about_ca_system_score_gemma":0.00013750499,"threshold_uncertainty_score":0.72324014},"labels":[],"label_agreement":null},{"id":"W1994544362","doi":"10.1016/j.jval.2013.08.1189","title":"Real-World Utilization Data Over 4 Years of Ranibizumab Injections for the Treatment of Wet Age-Related Macular Degeneration in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Joseph's Health Care; Novartis (Canada)","funders":"","keywords":"Ranibizumab; Medicine; Macular degeneration; Regimen; Ophthalmology; Surgery; Chemotherapy; Bevacizumab","score_opus":0.09718450744588003,"score_gpt":0.3532856428395149,"score_spread":0.2561011353936349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994544362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99688554,0.0009220571,0.00002681288,0.00042787314,0.00008191707,0.0014564531,0.00014213736,0.000003509896,0.000053725813],"genre_scores_gemma":[0.99699706,0.0020277612,0.000233706,0.00003263517,0.000013555102,0.000063081476,0.0005115851,0.000009131998,0.000111495516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992057,0.000067382054,0.0003515534,0.00013386404,0.00012764921,0.00011381545],"domain_scores_gemma":[0.9994019,0.00009958647,0.00011443446,0.0003050096,0.000030550138,0.000048472128],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008954082,0.000060547976,0.0001864397,0.00008197749,0.000023977957,0.0000027388573,0.000044408676,0.000018882056,0.000037971004],"category_scores_gemma":[0.000027053493,0.000044432192,0.000027080721,0.0002510356,0.0000149656835,0.000037049893,0.0000072915736,0.000025539288,6.633646e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066789304,0.0022656366,0.8791477,0.0007419856,0.00032043367,0.000039333798,0.0013842827,0.029318618,0.00038504277,0.0025441782,0.002927066,0.08025781],"study_design_scores_gemma":[0.002588541,0.00040350438,0.9195422,0.00013362046,0.00006108663,0.0000013711498,0.000108536406,0.076163664,0.00012694787,0.0001358885,0.0006985215,0.000036141355],"about_ca_topic_score_codex":0.98013127,"about_ca_topic_score_gemma":0.7902459,"teacher_disagreement_score":0.18988533,"about_ca_system_score_codex":0.0006773373,"about_ca_system_score_gemma":0.00096678955,"threshold_uncertainty_score":0.21358156},"labels":[],"label_agreement":null},{"id":"W1994898532","doi":"10.1016/j.jval.2014.03.1152","title":"Meta-analysis of preference-based quality of life values in heart failure","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Pooling; Medicine; Meta-analysis; Covariate; Meta-regression; Population; Statistics; Matching (statistics); Preference; Demography; Internal medicine; Environmental health; Mathematics; Computer science; Pathology","score_opus":0.7562204205864942,"score_gpt":0.46230247832421945,"score_spread":0.29391794226227475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994898532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.926854,0.005213732,0.0041572237,0.061433293,0.00017039037,0.0010779968,0.0006224464,0.000028779252,0.00044210613],"genre_scores_gemma":[0.98459274,0.00004252424,0.009165988,0.0059883296,0.00003820214,0.00007829278,0.000038491406,0.000019298208,0.00003613907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.985271,0.0036957175,0.009724988,0.00063769676,0.00021103838,0.00045960973],"domain_scores_gemma":[0.99019724,0.0040303837,0.0045512132,0.0009124922,0.00008982545,0.00021883888],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06348233,0.00021032162,0.0046883924,0.0016886969,0.000048922873,0.000015765887,0.00033651607,0.00017203303,0.00045940006],"category_scores_gemma":[0.0065996726,0.0002435129,0.00067702675,0.0013358813,0.000093882,0.00018712107,0.000035837074,0.0002285145,0.00006503049],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003959863,0.00042904634,0.68773556,0.0024475623,0.0044148415,5.2205014e-8,0.002544624,0.18043455,0.0000032456344,0.12041079,0.0015193493,0.000020748368],"study_design_scores_gemma":[0.00220932,0.0003723336,0.74499315,0.00013163773,0.0012516297,1.6444123e-7,0.0009876284,0.2110952,0.000026834245,0.033579003,0.0047249626,0.000628143],"about_ca_topic_score_codex":0.06355852,"about_ca_topic_score_gemma":0.0042644273,"teacher_disagreement_score":0.08683179,"about_ca_system_score_codex":0.0003873702,"about_ca_system_score_gemma":0.00059988035,"threshold_uncertainty_score":0.9930168},"labels":[],"label_agreement":null},{"id":"W1994994165","doi":"10.1016/j.jval.2013.03.1477","title":"Cost-effectiveness of catheter-based renal denervation for resistant hypertension – a canadian perspective","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Université de Montréal; University of Alberta; Medtronic (Canada)","funders":"","keywords":"Medicine; Stroke (engine); Life expectancy; Internal medicine; Framingham Risk Score; Cohort; Cardiology; Relative risk; Blood pressure; Coronary artery disease; Framingham Heart Study; Clinical trial; Emergency medicine; Cost effectiveness; Confidence interval; Disease; Population","score_opus":0.13440615050639138,"score_gpt":0.3361803147857972,"score_spread":0.2017741642794058,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1994994165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9709854,0.005851978,0.00040461228,0.017007513,0.00019084621,0.0050847945,0.000060841583,0.000034262037,0.00037976462],"genre_scores_gemma":[0.995846,0.0000449733,0.0017258277,0.0020120542,0.000045593093,0.00026953596,0.000017424745,0.000016864791,0.000021734171],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9988485,0.0001961679,0.00028822946,0.0002307301,0.00015445883,0.000281903],"domain_scores_gemma":[0.9983926,0.00055096165,0.00009243728,0.00019634975,0.00059028825,0.00017737523],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069117936,0.00010609195,0.0004835039,0.00025451413,0.00009552793,0.000005448652,0.000040043462,0.0000723634,0.000009493592],"category_scores_gemma":[0.0003442378,0.00008610312,0.00007202054,0.00019847888,0.000042800548,0.00004175846,0.000008618165,0.00010256893,0.0000037875038],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025544383,0.011605056,0.3247719,0.03215545,0.0033810763,0.0005141997,0.02896936,0.022515023,0.34725535,0.0685214,0.09621276,0.03855403],"study_design_scores_gemma":[0.013192513,0.007261286,0.88945234,0.007908278,0.0005075958,0.00006378752,0.0037668482,0.039545387,0.016136285,0.0055412794,0.015982013,0.000642369],"about_ca_topic_score_codex":0.65598124,"about_ca_topic_score_gemma":0.028187847,"teacher_disagreement_score":0.6277934,"about_ca_system_score_codex":0.0002479416,"about_ca_system_score_gemma":0.0009244848,"threshold_uncertainty_score":0.98954517},"labels":[],"label_agreement":null},{"id":"W1995179131","doi":"10.1016/j.jval.2012.08.2030","title":"PRS31 Cost-Effectiveness of an Intensive Intervention Program in the Control of Allergic Rhinitis Due to Ragweed Pollen in Quebec, Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Santé Montérégie; Université de Montréal","funders":"","keywords":"Ragweed; Medicine; Population; Psychological intervention; Pollen; Context (archaeology); Economic evaluation; Demography; Environmental health; Allergy; Immunology; Geography; Botany; Pathology; Psychiatry; Biology","score_opus":0.03565311623246579,"score_gpt":0.3247470897121378,"score_spread":0.289093973479672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995179131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933101,0.00043292323,0.00018625114,0.0020679305,0.00018101252,0.003676231,0.000016729753,0.000007923832,0.000120909346],"genre_scores_gemma":[0.99884135,0.000031392963,0.00011340445,0.00072816195,0.000040564228,0.00015757685,0.00006131015,0.000013857112,0.000012358339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710923,0.0014318824,0.0006960191,0.00016157475,0.00028104847,0.00032022744],"domain_scores_gemma":[0.9988879,0.00037747083,0.00021234386,0.00019884076,0.00020241551,0.00012101385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001904349,0.000117242256,0.0005449113,0.00022079799,0.000018193106,0.000004763296,0.00008230391,0.00006818808,0.000010402681],"category_scores_gemma":[0.00048578257,0.00009291538,0.00004497165,0.00041628658,0.000034113167,0.000095031326,0.000015153648,0.0001994333,5.456628e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012134706,0.010668412,0.47831428,0.008586025,0.0002952703,0.0010059697,0.10273704,0.038214564,0.0014425096,0.008505123,0.0010895472,0.33700657],"study_design_scores_gemma":[0.0048111733,0.00095773843,0.979886,0.0019762528,0.000008736913,0.00004426446,0.0055889934,0.0061411723,0.00018284106,0.0000713172,0.00023345486,0.000098057084],"about_ca_topic_score_codex":0.9616757,"about_ca_topic_score_gemma":0.90210915,"teacher_disagreement_score":0.5015717,"about_ca_system_score_codex":0.00053060026,"about_ca_system_score_gemma":0.0005755629,"threshold_uncertainty_score":0.37889794},"labels":[],"label_agreement":null},{"id":"W1995578096","doi":"10.1111/j.1524-4733.2009.00613.x","title":"Impact of the 1997 Canadian Guidelines on the Conduct of Canadian-Based Economic Evaluations in the Published Literature","year":2009,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Economic evaluation; Discounting; Actuarial science; Valuation (finance); Systematic review; Equity (law); Health technology; Cost–benefit analysis; Health economics; Perspective (graphical); Presentation (obstetrics); Public economics; Medicine; Psychology; MEDLINE; Accounting; Economics; Health care; Political science; Public health; Computer science; Nursing; Finance; Economic growth","score_opus":0.6841444648732653,"score_gpt":0.5303070318286566,"score_spread":0.15383743304460873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995578096","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014616735,0.84750956,0.0000011673911,0.13644007,0.0007333739,0.0044975616,0.007597712,0.00000630221,0.0017525741],"genre_scores_gemma":[0.010988331,0.95899403,0.0002333308,0.02776475,0.0005689452,0.0005137956,0.00070626766,0.00009791014,0.00013265203],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9855316,0.004109663,0.008646398,0.0006801809,0.00018305458,0.0008490951],"domain_scores_gemma":[0.9885703,0.0037284878,0.0052729337,0.0019230794,0.00015202563,0.00035317626],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.05080117,0.00046431914,0.0028792913,0.0032489952,0.0002680524,0.00014811127,0.0016891813,0.0004572004,0.00030279896],"category_scores_gemma":[0.009764552,0.00030011838,0.0007351063,0.0020871651,0.00011629669,0.00019724194,0.000021840151,0.0010032163,0.000121358775],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000013336281,0.00026646847,0.0071086325,0.016289566,0.0003253575,0.0000041966377,0.006991026,0.062092453,1.1547443e-8,0.29278892,0.5850145,0.029105475],"study_design_scores_gemma":[0.00038566472,0.00014859282,0.005815438,0.011117437,0.00002284979,0.000007500898,0.00017145493,0.0049399403,2.3506443e-8,0.0046882355,0.97235185,0.00035098474],"about_ca_topic_score_codex":0.9610065,"about_ca_topic_score_gemma":0.87384987,"teacher_disagreement_score":0.38733733,"about_ca_system_score_codex":0.0076457327,"about_ca_system_score_gemma":0.030910946,"threshold_uncertainty_score":0.9999451},"labels":[],"label_agreement":null},{"id":"W1995681843","doi":"10.1016/j.jval.2013.11.009","title":"Specification of the Utility Function in Discrete Choice Experiments","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Calgary","funders":"","keywords":"Function (biology); Specification; Valuation (finance); Econometrics; Marginal utility; Contingent valuation; Willingness to pay; Discrete choice; Expected utility hypothesis; Economics; Nonlinear system; Computer science; Mathematical optimization; Mathematical economics; Microeconomics; Mathematics; Accounting","score_opus":0.1865132108318176,"score_gpt":0.2666681982838322,"score_spread":0.0801549874520146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995681843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912193,0.0003518334,0.0022833585,0.00055776763,0.0003217514,0.0002268348,0.0000076003316,0.0000037835434,0.0050277766],"genre_scores_gemma":[0.99949914,0.00006615491,0.00014424346,0.00015057146,0.000032879903,0.000010127084,0.000005736676,0.0000058561327,0.00008527055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901944,0.000057835114,0.0005872084,0.00018607875,0.000024003153,0.00012541602],"domain_scores_gemma":[0.99939424,0.000049413287,0.0003023923,0.00022903491,0.0000019042467,0.000023022769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014940045,0.000051711155,0.00014934145,0.000079757294,0.000028903325,0.0000044070316,0.00008764935,0.000038924234,0.00010664867],"category_scores_gemma":[0.000060840423,0.000052274623,0.000029909168,0.0001163168,0.000029167213,0.00009011983,0.000022462504,0.00007623864,0.000054584394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000068334384,0.000047156922,0.96327806,0.000020940071,0.0000013591148,5.495776e-9,0.00027032202,0.0015744817,0.000014693541,0.03354104,0.000034188648,0.0012108973],"study_design_scores_gemma":[0.00028758243,0.000028490922,0.96313316,0.000016505268,2.66955e-7,6.477664e-8,0.000054632448,0.023985328,0.00008032408,0.009108768,0.0032622265,0.000042683056],"about_ca_topic_score_codex":0.0050747106,"about_ca_topic_score_gemma":0.00011950818,"teacher_disagreement_score":0.024432272,"about_ca_system_score_codex":0.00025210378,"about_ca_system_score_gemma":0.000008945743,"threshold_uncertainty_score":0.76714784},"labels":[],"label_agreement":null},{"id":"W1995707423","doi":"10.1111/j.1524-4733.2009.00532.x","title":"The Impact of Drug Vintage on Patient Survival: A Patient-Level Analysis Using Quebec's Provincial Health Plan Data","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Toronto","funders":"GlaxoSmithKline","keywords":"Medicine; Medical prescription; Prescription drug; Hazard ratio; Confidence interval; Demography; Drug; Proportional hazards model; Population; Residence; Vintage; Gerontology; Environmental health; Internal medicine; Pharmacology","score_opus":0.19530042698819106,"score_gpt":0.41335030030419107,"score_spread":0.218049873316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995707423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9917684,0.0007526438,0.0006264672,0.0052721645,0.00013779037,0.0010264977,0.00022500187,0.000024511914,0.0001665137],"genre_scores_gemma":[0.997371,0.00019177332,0.00056706887,0.0015360159,0.00006491126,0.00000638045,0.00019254551,0.0000096548165,0.00006061641],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973407,0.0004457246,0.0008617443,0.0003616112,0.0005784808,0.00041177517],"domain_scores_gemma":[0.9977572,0.00018463521,0.0006381135,0.0010704456,0.00006980258,0.0002798117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011926151,0.00015213352,0.0005273626,0.00021734199,0.00015301212,0.000014842457,0.0002842201,0.000038728787,0.000042535612],"category_scores_gemma":[0.00024051557,0.0001000041,0.00010138638,0.000815034,0.000049600523,0.00006672586,0.00004759312,0.00026663148,0.000012549753],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020363794,0.0036556905,0.2466248,0.00061826763,0.0005850516,0.00003033994,0.015445288,0.018656347,0.00013494828,0.0022032277,0.02648424,0.68352544],"study_design_scores_gemma":[0.0019671188,0.0045950706,0.8414252,0.0014397963,0.00008790305,0.000010171149,0.0022085917,0.14562172,0.00005318909,0.00045099814,0.0018342235,0.00030602276],"about_ca_topic_score_codex":0.15689623,"about_ca_topic_score_gemma":0.0050106,"teacher_disagreement_score":0.68321943,"about_ca_system_score_codex":0.0006456152,"about_ca_system_score_gemma":0.0027876508,"threshold_uncertainty_score":0.84871805},"labels":[],"label_agreement":null},{"id":"W1995866174","doi":"10.1016/s1098-3015(10)62979-8","title":"PDB46 WILLINGNESS-TO-PAY FOR INHALED INSULIN—A CANADIAN PERSPECTIVE","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Willingness to pay; Perspective (graphical); Business; Economics; Public economics; Microeconomics; Computer science; Artificial intelligence","score_opus":0.07237457608782537,"score_gpt":0.3685482669494155,"score_spread":0.2961736908615901,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1995866174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5006088,0.0029309376,0.004264869,0.4748953,0.00066072086,0.0045744223,0.00005859324,0.00011975725,0.011886586],"genre_scores_gemma":[0.96963847,0.00013377392,0.0074069444,0.020350728,0.0003786436,0.00015646947,0.000012917513,0.00001605507,0.001905999],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99884117,0.000041519488,0.00030784935,0.00026182944,0.00015905216,0.0003885655],"domain_scores_gemma":[0.99883103,0.0000708227,0.00006551347,0.00023299898,0.00014521224,0.00065440306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045462896,0.000092400915,0.00023109556,0.0001751261,0.00008338086,0.000007038974,0.000096912096,0.00005830525,0.00022367263],"category_scores_gemma":[0.00038006072,0.00007861109,0.0000344212,0.00035014117,0.0000196688,0.00004034072,0.0000067916726,0.00018347827,0.0005130023],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001402881,0.0019560214,0.24769717,0.0025005173,0.0001782696,0.00018018101,0.05477699,0.008809789,0.00045420486,0.17180285,0.19638295,0.31385818],"study_design_scores_gemma":[0.005480997,0.0013501232,0.14652605,0.0016002991,0.000019637142,0.00010639407,0.003648257,0.03156362,0.0002705929,0.005366185,0.80359644,0.0004714321],"about_ca_topic_score_codex":0.19514184,"about_ca_topic_score_gemma":0.02782587,"teacher_disagreement_score":0.60721344,"about_ca_system_score_codex":0.0009480697,"about_ca_system_score_gemma":0.0025365327,"threshold_uncertainty_score":0.98991376},"labels":[],"label_agreement":null},{"id":"W1996179381","doi":"10.1046/j.1524-4733.2001.40202-183.x","title":"PID25: ECONOMIC EVALUATION OF MACROLIDES AND FLUOROQUINOLONES FOR THE TREATMENT OF RESPIRATORY TRACT INFECTIONS","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); Université de Montréal","funders":"","keywords":"Respiratory tract infections; Respiratory tract; Medicine; Intensive care medicine; Respiratory system; Internal medicine","score_opus":0.12896302962989714,"score_gpt":0.39270221464208416,"score_spread":0.263739185012187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996179381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941651,0.0029644915,0.00003962955,0.0013704804,0.00017495708,0.0011446497,0.000017864553,0.000010715809,0.000112095346],"genre_scores_gemma":[0.9970264,0.0025657723,0.000021315496,0.00011108494,0.00009025951,0.00016181136,0.0000022653696,0.000008165092,0.000012965221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915946,0.00013073887,0.0003791608,0.00011746074,0.000088077315,0.00012508192],"domain_scores_gemma":[0.9992442,0.00031304915,0.00015756562,0.00017360291,0.000063844,0.000047714035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073951384,0.00007253249,0.00022905448,0.00015673395,0.00008957326,0.000002694039,0.00002030935,0.000047291942,0.000016702073],"category_scores_gemma":[0.00006686239,0.000049947812,0.000066550114,0.00009446198,0.00007324347,0.00003413803,0.0000031629365,0.000042039163,0.0000011682881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011958272,0.0019814058,0.8611305,0.00024801723,0.00011966328,0.0000011049455,0.001437484,0.01894478,0.004036455,0.0010533719,0.00007081125,0.11085684],"study_design_scores_gemma":[0.004016795,0.0066977334,0.94019294,0.00014021488,0.00020027887,0.00005779325,0.0002595806,0.017349219,0.0012615002,0.0005282932,0.029214576,0.000081099],"about_ca_topic_score_codex":0.0013822067,"about_ca_topic_score_gemma":0.00028518646,"teacher_disagreement_score":0.11077574,"about_ca_system_score_codex":0.0002615782,"about_ca_system_score_gemma":0.0004771855,"threshold_uncertainty_score":0.20894922},"labels":[],"label_agreement":null},{"id":"W1996198481","doi":"10.1111/j.1524-4733.2009.00515.x","title":"QALYs: The Basics","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":754,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"U.S. Public Health Service; Agency for Healthcare Research and Quality","keywords":"Computer science","score_opus":0.5249616492072903,"score_gpt":0.44856372384064697,"score_spread":0.0763979253666433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996198481","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11134723,0.014803611,0.0052736606,0.84452426,0.0013974372,0.0017528129,0.00012064257,0.00012799294,0.020652376],"genre_scores_gemma":[0.88821846,0.00070300937,0.0026030156,0.107319765,0.00052115525,0.000041525083,0.000012965735,0.000023148235,0.0005569682],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9946135,0.00063243124,0.0037091658,0.00041863046,0.00008971161,0.0005365522],"domain_scores_gemma":[0.9968962,0.00092469464,0.0013718753,0.00061866635,0.000021849122,0.00016673325],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.026543714,0.00014301487,0.00068845146,0.00023815403,0.00022062896,0.000055922337,0.00034687988,0.0000934677,0.00015201521],"category_scores_gemma":[0.0020463816,0.00014645314,0.000087709945,0.00036037585,0.00004085098,0.00022288784,0.000021277352,0.0002785175,0.0015945476],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000058015785,0.00009508015,0.018205104,0.00012969127,0.0000087514145,8.71034e-7,0.0031275423,0.004528761,1.887897e-7,0.9511037,0.02183722,0.00095730566],"study_design_scores_gemma":[0.00095425104,0.00026279275,0.16344555,0.00019686036,0.0000018343638,0.000010153223,0.0011767645,0.038880784,0.0000016858187,0.3987003,0.39596745,0.0004015723],"about_ca_topic_score_codex":0.0047413534,"about_ca_topic_score_gemma":0.00012061385,"teacher_disagreement_score":0.7768712,"about_ca_system_score_codex":0.0007629126,"about_ca_system_score_gemma":0.000297913,"threshold_uncertainty_score":0.9991828},"labels":[],"label_agreement":null},{"id":"W1996276843","doi":"10.1016/s1098-3015(10)67180-x","title":"QL6 ADALIMUMAB REDUCES FATIGUE IN PATIENTS WITH ACTIVE ANKYLOSING SPONDYLITIS (AS)—6-MONTH RESULTS OF A CANADIAN AS STUDY","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ankylosing spondylitis; Adalimumab; Medicine; Spondylitis; Physical therapy; Internal medicine; Tumor necrosis factor alpha","score_opus":0.03898885411725983,"score_gpt":0.30641082877210996,"score_spread":0.2674219746548501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996276843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948122,0.00022823058,1.473607e-7,0.0015040664,0.000044664237,0.0014706652,0.00036634252,0.000011505615,0.0015622133],"genre_scores_gemma":[0.99913526,0.000064357904,0.00016488826,0.00035106164,0.00003568769,0.000016305505,0.00016036257,0.000018734852,0.0000533415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980709,0.00034515403,0.0005329832,0.00028336662,0.0003482016,0.00041936946],"domain_scores_gemma":[0.9988821,0.00008461482,0.00018613724,0.00034518942,0.00011376457,0.0003882079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043801655,0.00014770059,0.00038939097,0.0007011498,0.00007638329,0.000009163994,0.000100770216,0.000051391504,0.000054135257],"category_scores_gemma":[0.00021988888,0.00012877687,0.000031219985,0.0007863648,0.0000473597,0.00015917586,0.00002347764,0.00026568637,0.0000047101544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012451306,0.0047781277,0.90285176,0.0002485606,0.00010140771,0.00009838939,0.04423228,0.00092790526,0.0000068665017,0.00009692444,0.0002128224,0.03399365],"study_design_scores_gemma":[0.009922279,0.004710756,0.97768396,0.0008345096,0.000022253951,0.0000027664412,0.0058148913,0.00015389132,0.00010007003,0.000023643757,0.0006118077,0.00011917547],"about_ca_topic_score_codex":0.9195217,"about_ca_topic_score_gemma":0.17833652,"teacher_disagreement_score":0.7411851,"about_ca_system_score_codex":0.00091237697,"about_ca_system_score_gemma":0.0020392993,"threshold_uncertainty_score":0.8366567},"labels":[],"label_agreement":null},{"id":"W1996510950","doi":"10.1016/j.jval.2011.08.1228","title":"PCN127 Health State Utility Assessment for Breast Cancer","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Visual analogue scale; Breast cancer; Tamoxifen; Disease; Quality of life (healthcare); Health care; Physical therapy; Scale (ratio); Cancer; Oncology; Family medicine; Internal medicine; Nursing","score_opus":0.6324016376744286,"score_gpt":0.49387811206445414,"score_spread":0.13852352560997444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996510950","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31226072,0.022626545,0.10753818,0.50311255,0.0076994044,0.015233183,0.023595657,0.00046727658,0.007466495],"genre_scores_gemma":[0.9077838,0.002562434,0.041721217,0.045685112,0.00048020968,0.0010417718,0.00007539842,0.00010994131,0.0005401034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916109,0.0008123189,0.005603006,0.0008297069,0.00011445566,0.0010296503],"domain_scores_gemma":[0.9952747,0.00060110184,0.0029424382,0.00062889454,0.00007289819,0.00047991882],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.033831194,0.00024600074,0.0013639793,0.00037848027,0.00028230867,0.00003741764,0.00031486843,0.00010308284,0.0007169129],"category_scores_gemma":[0.0004053787,0.00031517615,0.00013409334,0.00027831513,0.00006438914,0.00035383715,0.000049201215,0.00027636986,0.0002012449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010445666,0.00086138665,0.705676,0.005438158,0.000099456316,0.0000011134334,0.014954079,0.001443546,2.78637e-7,0.2157259,0.03802335,0.017672265],"study_design_scores_gemma":[0.0017744228,0.00026565234,0.85004836,0.00038223524,0.000001962828,0.000006241594,0.00083058595,0.03872608,0.0000010455896,0.06398286,0.043523557,0.0004570091],"about_ca_topic_score_codex":0.12304454,"about_ca_topic_score_gemma":0.002849086,"teacher_disagreement_score":0.5955231,"about_ca_system_score_codex":0.002791361,"about_ca_system_score_gemma":0.002142481,"threshold_uncertainty_score":0.99993},"labels":[],"label_agreement":null},{"id":"W1996668070","doi":"10.1016/j.jval.2013.02.016","title":"Measuring the Quality of a Childhood Cancer Care Delivery System: Assessing Stakeholder Agreement","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital; Pediatric Oncology Group; University of Toronto; Hamilton Health Sciences; Hospital for Sick Children","funders":"Canadian Institutes of Health Research","keywords":"Multidisciplinary approach; Delphi method; Stakeholder; Medicine; Stakeholder engagement; Panel discussion; Quality (philosophy); Delphi; Family medicine; Nursing; Business; Computer science; Public relations","score_opus":0.1951986824977106,"score_gpt":0.37222408206902846,"score_spread":0.17702539957131785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996668070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97628516,0.0134295495,0.000071266644,0.007137256,0.000444276,0.0017713141,0.00002645558,0.000060787468,0.00077390776],"genre_scores_gemma":[0.99706006,0.00025013764,0.0005516714,0.0016446131,0.00029062713,0.00013948946,0.000009072729,0.00003137126,0.000022968614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955907,0.0011274792,0.0013586666,0.00039067178,0.0010335968,0.0004989071],"domain_scores_gemma":[0.99784267,0.0003442512,0.0006120014,0.00069368904,0.00029578558,0.00021159602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028127823,0.00021404888,0.00073778967,0.00013516156,0.00016503586,0.00003890181,0.00020856835,0.00008295562,0.00006915862],"category_scores_gemma":[0.00020049262,0.00016158655,0.00013150752,0.0003535792,0.000075756376,0.00016129889,0.000078003424,0.0004065757,0.000015089536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013605945,0.0010593627,0.735441,0.040716175,0.00047548139,0.000012645575,0.15207084,0.007002221,0.0009810352,0.0017822689,0.001650832,0.058672052],"study_design_scores_gemma":[0.001694241,0.00013745157,0.94707257,0.0060720774,0.000034405635,0.0000089842215,0.043794855,0.0003775198,0.00036012573,0.00003609309,0.00021995461,0.00019174383],"about_ca_topic_score_codex":0.29951468,"about_ca_topic_score_gemma":0.0029423088,"teacher_disagreement_score":0.2965724,"about_ca_system_score_codex":0.0011818283,"about_ca_system_score_gemma":0.0015018274,"threshold_uncertainty_score":0.7051499},"labels":[],"label_agreement":null},{"id":"W1997046311","doi":"10.1016/s1098-3015(10)63222-6","title":"PHP4 ASSESSING THERAPEUTIC IMPROVEMENT IN CANADA AND FRANCE: A COMPARISON OF PMPRB AND ASMR CLASSIFICATIONS","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Regional science; Geography","score_opus":0.3544075399784798,"score_gpt":0.4285324704531383,"score_spread":0.07412493047465851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997046311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97393245,0.009498901,0.000613874,0.01488167,0.00017429395,0.0005375982,0.00005892719,0.000006312828,0.00029597853],"genre_scores_gemma":[0.99671614,0.00020171296,0.0011290282,0.0018068921,0.000042309883,0.000044822304,0.0000090789235,0.000012252077,0.00003777877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959201,0.00024077488,0.0031375056,0.00033020446,0.00007108948,0.00030029623],"domain_scores_gemma":[0.997685,0.0006197952,0.0013739332,0.00021829834,0.000019450912,0.000083491126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055073267,0.00010733516,0.0007093821,0.00023486321,0.00009280464,0.00002962556,0.00008271566,0.000055121414,0.000016241289],"category_scores_gemma":[0.00017990088,0.00013901596,0.000016232461,0.00019428543,0.00004753844,0.00016258078,0.000018818037,0.00015833873,0.0000043137306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000019196984,0.00006964473,0.97422314,0.00050925073,0.0000042655297,1.47501e-7,0.00083775754,0.0019252708,0.000007724957,0.020640707,0.0002976085,0.0014825573],"study_design_scores_gemma":[0.0005992957,0.000044451856,0.9020346,0.00014004261,0.0000010059917,6.5787447e-7,0.0016711305,0.085989736,0.000005359924,0.0069440515,0.0024422158,0.00012746172],"about_ca_topic_score_codex":0.9634706,"about_ca_topic_score_gemma":0.6958804,"teacher_disagreement_score":0.26759017,"about_ca_system_score_codex":0.0011323579,"about_ca_system_score_gemma":0.0010616658,"threshold_uncertainty_score":0.56689066},"labels":[],"label_agreement":null},{"id":"W1997146792","doi":"10.1111/j.1524-4733.2005.03074.x","title":"Comparing the Discriminative Validity of Two Generic and One Disease-Specific Health-Related Quality of Life Measures in a Sample of Patients with Dry Eye","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":102,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Quality of life (healthcare); Medicine; Visual analogue scale; Discriminative model; KERATOCONJUNCTIVITIS SICCA; Disease; Severity of illness; SF-36; EQ-5D; Scale (ratio); Physical therapy; Internal medicine; Health related quality of life; Ophthalmology","score_opus":0.1864433561320804,"score_gpt":0.3380318615003349,"score_spread":0.15158850536825447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997146792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935944,0.0038554738,0.00018832849,0.0015249405,0.000024772267,0.00073250104,0.000058332746,0.0000067430183,0.000014478485],"genre_scores_gemma":[0.99830735,0.000461715,0.0010270859,0.00014380479,0.000013225006,0.000007595025,0.00002514252,0.000011969213,0.0000021284584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734825,0.0008227895,0.000963287,0.00020019058,0.00043632064,0.00022917162],"domain_scores_gemma":[0.998568,0.00030794126,0.00055051164,0.00029653465,0.00011086858,0.00016611679],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001531716,0.00011531576,0.00073420454,0.00011019631,0.000038660037,0.0000023231516,0.00007055334,0.000028443843,0.000005984955],"category_scores_gemma":[0.00021821518,0.00008218024,0.000045714616,0.00030942846,0.00012409307,0.000052220938,0.00003253529,0.0001937106,2.6294163e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00065242307,0.0007882416,0.9892981,0.0007894001,0.000027848033,3.3445798e-7,0.004268985,0.0017044973,0.000026865051,0.0008254834,0.0000019258928,0.0016159005],"study_design_scores_gemma":[0.0029769547,0.00038317277,0.9938991,0.0006097931,0.000013475189,2.4976393e-8,0.00050700066,0.0012630691,0.000066352826,0.00019423982,0.000021926604,0.00006488109],"about_ca_topic_score_codex":0.026617063,"about_ca_topic_score_gemma":0.0029869082,"teacher_disagreement_score":0.023630155,"about_ca_system_score_codex":0.00015735962,"about_ca_system_score_gemma":0.0004902346,"threshold_uncertainty_score":0.9798648},"labels":[],"label_agreement":null},{"id":"W1997197001","doi":"10.1016/j.jval.2013.08.1800","title":"Potential Predictors of Alzheimer’s Disease: An Analysis with the Quebec Provincial Drug Reimbursement Program Database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); Université de Montréal","funders":"","keywords":"Rivastigmine; Medicine; Donepezil; Galantamine; Dementia; Disease; Neuroticism; Retrospective cohort study; Psychiatry; Internal medicine; Pediatrics; Personality; Psychology","score_opus":0.07531625157706488,"score_gpt":0.38963183489439124,"score_spread":0.31431558331732634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997197001","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98285854,0.0009271744,0.0001294881,0.012576436,0.00011520703,0.0032284262,0.000053852327,0.00004755334,0.00006331919],"genre_scores_gemma":[0.99780923,0.00007806334,0.00065757346,0.0008650356,0.00013790661,0.00015816814,0.00019392633,0.000014695315,0.00008541602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797446,0.00038897272,0.00044607683,0.00028033732,0.00058056123,0.00032959008],"domain_scores_gemma":[0.998646,0.000090238296,0.00026727808,0.0004628487,0.00008106167,0.00045256095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006727065,0.00013953651,0.00033929336,0.00014941678,0.0000800814,0.000024205592,0.0001263087,0.000024128589,0.00015196475],"category_scores_gemma":[0.000053806,0.00007928529,0.00009071947,0.0004911496,0.00011733163,0.00026530898,0.00004493816,0.00025808465,0.000006402026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010893818,0.0028530061,0.9642981,0.0005923732,0.0009120157,0.00003492697,0.0011794617,0.0058188215,0.00003065381,0.0003136955,0.0014243901,0.021453125],"study_design_scores_gemma":[0.0019255554,0.0011292807,0.828356,0.00016661551,0.002699946,0.0000028882791,0.00068156276,0.1590504,0.000056290184,0.000021215948,0.005731107,0.00017909202],"about_ca_topic_score_codex":0.10860781,"about_ca_topic_score_gemma":0.0036967874,"teacher_disagreement_score":0.15323158,"about_ca_system_score_codex":0.00008647921,"about_ca_system_score_gemma":0.0006319424,"threshold_uncertainty_score":0.897328},"labels":[],"label_agreement":null},{"id":"W1997204561","doi":"10.1016/s1098-3015(10)62661-7","title":"PCV20 DECREASING HOSPITALIZATIONS FOR HEART FAILURE IN BRITISH COLUMBIA, CANADA, 1993-2001","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Heart failure; Medicine; Demography; Gerontology; Geography; Cardiology; Sociology","score_opus":0.03761294726238197,"score_gpt":0.3726367960521882,"score_spread":0.33502384878980623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997204561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9502157,0.0021822273,0.000098137425,0.04112237,0.0011755577,0.004228277,0.00041635396,0.00012035029,0.000441033],"genre_scores_gemma":[0.9619628,0.00025913684,0.018503526,0.016664797,0.0006804682,0.0005447599,0.00016160232,0.000081027516,0.0011418699],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948168,0.0009306003,0.0015001122,0.00052874547,0.0004096521,0.0018141238],"domain_scores_gemma":[0.9975374,0.00095882517,0.00029664804,0.00036697282,0.00022442135,0.00061577273],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019443469,0.00016547897,0.00059974194,0.00013102203,0.00089651474,0.00004156236,0.00023207846,0.00026100644,0.0002437437],"category_scores_gemma":[0.0011149814,0.00028844955,0.000053541167,0.00077112514,0.000040183,0.00018386313,0.00006541648,0.00064804143,0.000042671934],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000008397673,0.0000906662,0.6334115,0.00073500077,0.0000028548448,0.000007184411,0.00084504765,0.0008655315,6.3241214e-7,0.000284788,0.36286372,0.00088463066],"study_design_scores_gemma":[0.0013975537,0.00010592077,0.48797408,0.0022411998,0.0000031077495,0.000010396479,0.0027055284,0.0027813278,4.1918466e-7,0.00058362546,0.50194865,0.00024821347],"about_ca_topic_score_codex":0.99855804,"about_ca_topic_score_gemma":0.9998975,"teacher_disagreement_score":0.1454375,"about_ca_system_score_codex":0.0053504263,"about_ca_system_score_gemma":0.010354859,"threshold_uncertainty_score":0.9999568},"labels":[],"label_agreement":null},{"id":"W1997577436","doi":"10.1111/j.1524-4733.2008.00485.x","title":"Cost-Effectiveness of Disease-Modifying Therapies in the Management of Multiple Sclerosis for the Medicare Population","year":2009,"lang":"en","type":"review","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Capital District Health Authority","funders":"U.S. Public Health Service","keywords":"Medicine; Cost effectiveness; Discontinuation; Quality-adjusted life year; Glatiramer acetate; Intensive care medicine; Population; Incremental cost-effectiveness ratio; Cohort; Disease management; Physical therapy; Disease; Internal medicine; Environmental health","score_opus":0.42943937149323447,"score_gpt":0.4730947963063267,"score_spread":0.04365542481309226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997577436","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005964282,0.98305005,0.00014551962,0.00064556743,0.0000855221,0.015317901,0.00013526247,0.000010433654,0.000013313989],"genre_scores_gemma":[0.06452742,0.93245757,0.00037468388,0.000043510867,0.00005538017,0.002386223,0.00012457022,0.000027664044,0.0000030073452],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99583304,0.0016565474,0.0010194225,0.00034238765,0.0007566424,0.00039194795],"domain_scores_gemma":[0.99342674,0.005325282,0.00047624455,0.0006039983,0.00009089422,0.00007686151],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005657996,0.00026443542,0.0015562967,0.00029948374,0.00011485772,0.000008808738,0.0003615039,0.00009179567,0.000002706882],"category_scores_gemma":[0.0006122411,0.00013707537,0.00034966896,0.00068098574,0.00011591661,0.000032689513,0.000077401535,0.00035053052,4.5338734e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018589232,0.0002111452,0.0020559204,0.15728413,0.00019912727,0.0000013947304,0.00065279123,0.00027039342,2.510031e-7,0.00019473495,0.000024086328,0.8389201],"study_design_scores_gemma":[0.0036302323,0.000453009,0.63211673,0.30613485,0.0005280085,0.0000012274083,0.001588575,0.002198109,7.784207e-7,0.0001689552,0.052951906,0.00022763948],"about_ca_topic_score_codex":0.0025558001,"about_ca_topic_score_gemma":0.00007973232,"teacher_disagreement_score":0.8386925,"about_ca_system_score_codex":0.00046350452,"about_ca_system_score_gemma":0.00023744072,"threshold_uncertainty_score":0.5589772},"labels":[],"label_agreement":null},{"id":"W1997794981","doi":"10.1016/j.jval.2012.10.018","title":"Need for Speed: An Efficient Algorithm for Calculation of Single-Parameter Expected Value of Partial Perfect Information","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Probabilistic and Robust Engineering Design","field":"Decision Sciences","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia; Vancouver Coastal Health","funders":"Canadian Institutes of Health Research","keywords":"Estimator; Maximization; Probabilistic logic; Sensitivity (control systems); Computer science; Sequence (biology); Computation; Monte Carlo method; Mathematical optimization; Measure (data warehouse); Algorithm; Fraction (chemistry); Expected value; Mathematics; Data mining; Statistics; Artificial intelligence","score_opus":0.1062230686482538,"score_gpt":0.341457258818786,"score_spread":0.2352341901705322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997794981","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3893252,0.000037175272,0.60904145,0.00009603467,0.00025333834,0.0011948275,0.00002671848,0.000016074942,0.000009177927],"genre_scores_gemma":[0.8613553,0.0000016581907,0.1384495,0.00003678068,0.000050789047,0.000062584426,0.000024818419,0.000008351271,0.000010195394],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976334,0.00018160976,0.0012167839,0.00019939934,0.0005007134,0.0002680738],"domain_scores_gemma":[0.99687684,0.0018209872,0.00045442817,0.00030085162,0.0004456985,0.00010118642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027241716,0.00011037211,0.00035831012,0.00035033666,0.000054151606,0.00004070628,0.00020617308,0.00008672724,0.000013944854],"category_scores_gemma":[0.002984472,0.000085983134,0.00009490271,0.00044112068,0.00004895776,0.00030771177,0.0000191294,0.00005425713,0.00000522435],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004187034,0.00014577225,0.00020331673,0.00010977808,0.000005438076,3.1226538e-8,0.0020653643,0.942119,0.00040735182,0.0018253253,0.0002824851,0.05279425],"study_design_scores_gemma":[0.000706553,0.00069415366,0.0024072968,0.000051275892,0.0000047368517,8.914458e-7,0.00030384026,0.9915441,0.0012939933,0.002765565,0.0001415174,0.000086039494],"about_ca_topic_score_codex":0.00084755657,"about_ca_topic_score_gemma":0.0000013648629,"teacher_disagreement_score":0.4720301,"about_ca_system_score_codex":0.00010720917,"about_ca_system_score_gemma":0.00016607078,"threshold_uncertainty_score":0.35729074},"labels":[],"label_agreement":null},{"id":"W1998396770","doi":"10.1016/j.jval.2014.03.025","title":"Preferences For Prostate Cancer Outcomes: A Comparison Of Patient And General Population Perspectives","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Prostate cancer; Medicine; Population; Sexual function; Health Utilities Index; Preference; Cancer; Demography; Gynecology; Statistics; Environmental health; Internal medicine; Disease; Mathematics","score_opus":0.3908310125194966,"score_gpt":0.46740650632291003,"score_spread":0.07657549380341344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998396770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98084515,0.0042818473,0.00063180097,0.012562302,0.00025005877,0.0011697735,0.0001732978,0.000013435331,0.00007235848],"genre_scores_gemma":[0.99348676,0.0002291457,0.0048666857,0.0010775727,0.000065890716,0.00020649115,0.000017660544,0.00001303468,0.000036727783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99644315,0.0003252268,0.0025929431,0.00033692125,0.000056343575,0.00024541855],"domain_scores_gemma":[0.99726576,0.0006663795,0.0017748973,0.00016553087,0.000040348325,0.0000870891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055225594,0.00010566893,0.0008237317,0.00021382046,0.0000862855,0.000018386347,0.00006931981,0.0000565658,0.000014243164],"category_scores_gemma":[0.0012576303,0.00011788579,0.000042756445,0.00008802221,0.00003167742,0.00014304688,0.000016726566,0.00007240525,0.000005337701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014870261,0.0000727792,0.9016478,0.00066557515,0.00001157501,4.3188324e-9,0.017079128,0.0082446635,2.2847922e-7,0.07068342,0.0003301728,0.0012497543],"study_design_scores_gemma":[0.0009899966,0.0004135367,0.7938719,0.00019299545,0.0000022761808,2.1213104e-7,0.00434471,0.15876536,0.0000024677738,0.038457744,0.0027692248,0.00018961144],"about_ca_topic_score_codex":0.04139956,"about_ca_topic_score_gemma":0.0011634602,"teacher_disagreement_score":0.1505207,"about_ca_system_score_codex":0.0003733327,"about_ca_system_score_gemma":0.00009448862,"threshold_uncertainty_score":0.9649838},"labels":[],"label_agreement":null},{"id":"W1998532326","doi":"10.1111/j.1524-4733.2010.00775.x","title":"Discrete Event Simulation: The Preferred Technique for Health Economic Evaluations?","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":149,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Discrete event simulation; Event (particle physics); Computer science; Markov chain; Health care; Markov model; Risk analysis (engineering); Management science; Operations research; Data science; Machine learning; Simulation; Medicine; Economics; Mathematics","score_opus":0.1450206997427288,"score_gpt":0.518710997552107,"score_spread":0.37369029780937824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998532326","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.056088086,0.00052113703,0.62896657,0.2813613,0.004592574,0.02713037,0.00033659066,0.00026311947,0.00074025244],"genre_scores_gemma":[0.95597523,0.00016039764,0.034459557,0.0047328803,0.0006586646,0.003348935,0.00019653369,0.000050482136,0.00041733673],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99547577,0.0017097427,0.0015269024,0.00039740937,0.00020433903,0.0006858467],"domain_scores_gemma":[0.9968355,0.0015949281,0.00053976814,0.000607934,0.00019047716,0.00023141658],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.009128366,0.00017350526,0.0003459131,0.00017444395,0.002103956,0.000025821048,0.0002233652,0.00021868004,0.00019030842],"category_scores_gemma":[0.0007353568,0.00013487431,0.00007215328,0.00024987388,0.000045133198,0.00016479263,0.000044564084,0.0009543334,0.0000577478],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004815839,0.00005270992,0.0033337143,0.00040710435,0.0000069503044,8.5089795e-8,0.004214689,0.9613977,0.000034234592,0.024616104,0.0017941309,0.004094426],"study_design_scores_gemma":[0.000885258,0.00024347873,0.0068664486,0.00031146005,0.0000036768668,0.0000013481747,0.00056323106,0.9485584,0.000009925391,0.0034667274,0.038920872,0.00016916366],"about_ca_topic_score_codex":0.0056199534,"about_ca_topic_score_gemma":0.004242226,"teacher_disagreement_score":0.89988714,"about_ca_system_score_codex":0.00083788845,"about_ca_system_score_gemma":0.0054743877,"threshold_uncertainty_score":0.99919516},"labels":[],"label_agreement":null},{"id":"W1998810596","doi":"10.1016/j.jval.2013.03.481","title":"Clinical and neuroradiological effect of BG-12 (dimethyl fumarate) in subgroups of patients with relapsing–remitting multiple sclerosis (RRMS): An integrated analysis of the phase 3 define and confirm studies","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NeuroRx Research (Canada); Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Placebo; Multiple sclerosis; Relapsing remitting; Internal medicine; Confidence interval; Dimethyl fumarate; Clinical endpoint; Population; Cohort; Stock options; Clinical trial; Pathology; Immunology","score_opus":0.14270224083334035,"score_gpt":0.3908760924970197,"score_spread":0.24817385166367936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998810596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654007,0.0016057695,0.000008740256,0.00024133461,0.00003934236,0.0015116907,0.00003888982,0.000009538144,0.000004618652],"genre_scores_gemma":[0.9967139,0.0024234843,0.00072377856,0.000055014774,0.000009210842,0.00003980857,0.00001912554,0.000013751153,0.000001935405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953729,0.002137652,0.0013260118,0.00043217232,0.00039322797,0.00033805837],"domain_scores_gemma":[0.994611,0.0040024696,0.0005444642,0.0003623065,0.00031701263,0.00016272005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032820962,0.00021502508,0.0017368005,0.00040797202,0.00006658327,0.0000060512302,0.000113747985,0.000103826394,0.000007109984],"category_scores_gemma":[0.0063127135,0.00011533161,0.00010172421,0.0011591318,0.0010337281,0.00008051236,0.00014615316,0.00046154892,1.4098809e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013380313,0.00069798745,0.9798335,0.0005926235,0.00039450187,8.0176363e-7,0.0010031371,0.00023797786,0.0011728805,0.000004574822,0.000010840737,0.014713156],"study_design_scores_gemma":[0.00950466,0.0050816108,0.9659728,0.0009714437,0.00017093099,4.3420945e-7,0.0004723433,0.01733288,0.0004066253,0.0000044123994,0.0000024090662,0.00007946557],"about_ca_topic_score_codex":0.0071831993,"about_ca_topic_score_gemma":0.00073111727,"teacher_disagreement_score":0.0170949,"about_ca_system_score_codex":0.00006554879,"about_ca_system_score_gemma":0.00008273593,"threshold_uncertainty_score":0.99942803},"labels":[],"label_agreement":null},{"id":"W1999287793","doi":"10.1016/j.jval.2013.08.849","title":"Investigating the Economic Impacts of New Public Pharmaceutical Policies in Greece","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cost sharing; Reimbursement; Medicine; Quarter (Canadian coin); Population; Average cost; Business; Public economics; Environmental health; Economics; Health care; Economic growth; Geography","score_opus":0.22237617927370337,"score_gpt":0.36778010867386485,"score_spread":0.14540392940016147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999287793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92378753,0.0029895776,0.000014549429,0.0670159,0.00024457695,0.00045829266,0.00004552553,0.000014020291,0.005429989],"genre_scores_gemma":[0.99047023,0.0012808492,0.000264584,0.0077088377,0.00017161279,0.000023203995,0.0000031932266,0.000022275748,0.000055210574],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.997588,0.00007964942,0.0013381797,0.00028791773,0.00002673982,0.0006795611],"domain_scores_gemma":[0.9985927,0.00027313794,0.00043534418,0.00029498042,0.000008563174,0.00039531806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014877138,0.00015590621,0.00048447945,0.00037331783,0.000056701036,0.0000801899,0.0003890892,0.00008100601,0.00044129064],"category_scores_gemma":[0.00027642385,0.00015179513,0.00007710355,0.00030638173,0.00013401423,0.00032392735,0.000105878025,0.00036683187,0.0005135224],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003925084,0.000059878268,0.31124273,0.00012899825,0.000018762772,3.4811842e-7,0.0022401302,0.0047973557,0.000023607665,0.67139375,0.004283651,0.005806868],"study_design_scores_gemma":[0.0019595963,0.0001080044,0.26880878,0.00009805197,0.0000019104366,0.000008684305,0.0002277101,0.33351916,0.00015149143,0.32652548,0.06816189,0.00042922466],"about_ca_topic_score_codex":0.1209733,"about_ca_topic_score_gemma":0.00075333606,"teacher_disagreement_score":0.34486827,"about_ca_system_score_codex":0.0006073215,"about_ca_system_score_gemma":0.00048163725,"threshold_uncertainty_score":0.88488024},"labels":[],"label_agreement":null},{"id":"W1999763833","doi":"10.1016/j.jval.2013.03.693","title":"The Cost-Effectiveness Of Companion Diagnostics In Cancer Therapy","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cancer therapy; Medicine; Cancer; Medical physics; Intensive care medicine; Internal medicine","score_opus":0.03923871380500899,"score_gpt":0.32846259437408654,"score_spread":0.28922388056907755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999763833","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808857,0.017233968,0.00009220073,0.00050369825,0.00026803173,0.0009089588,0.000021045058,0.0000019794784,0.00008444708],"genre_scores_gemma":[0.9352287,0.06413584,0.00004986724,0.00024443565,0.00006430503,0.00024110537,0.000015680313,0.00001138513,0.000008673463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909014,0.00021645233,0.0002508903,0.00015493878,0.000069339294,0.00021823696],"domain_scores_gemma":[0.99920017,0.0004070665,0.00008912703,0.00020497706,0.00005270679,0.000045977966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005155989,0.00008060212,0.00014297677,0.000030179039,0.000038252896,0.000011492032,0.00012840985,0.00005698922,0.0000047655553],"category_scores_gemma":[0.00014511381,0.00006322867,0.00002850031,0.000104688705,0.000052959087,0.0000017543427,0.00003930356,0.00007883019,0.000001996428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037395404,0.0006373107,0.73953605,0.00037192038,0.000047096994,0.0000024254082,0.000431774,0.087346874,0.045843273,0.0044835573,0.004862335,0.11606341],"study_design_scores_gemma":[0.0022523466,0.00062857085,0.9191926,0.000301161,0.0000020080063,0.0000018292773,0.00012913039,0.0028834736,0.033340406,0.0018324336,0.03921255,0.00022348537],"about_ca_topic_score_codex":0.021517625,"about_ca_topic_score_gemma":0.0013673425,"teacher_disagreement_score":0.17965654,"about_ca_system_score_codex":0.00008236313,"about_ca_system_score_gemma":0.00026384357,"threshold_uncertainty_score":0.98499817},"labels":[],"label_agreement":null},{"id":"W2000010128","doi":"10.1016/j.jval.2014.03.1584","title":"Costs Of Adverse Events Associated With Treatment Of Hepatitis C Virus Infection: An Analysis Using The Quebec Provincial Drug Reimbursement Program Database","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Université de Montréal","funders":"","keywords":"Medicine; Telaprevir; Boceprevir; Ribavirin; Reimbursement; Rash; Pharmacy; Adverse effect; Pegylated interferon; Hepatitis C; Emergency medicine; Internal medicine; Hepatitis C virus; Health care; Pediatrics; Family medicine; Immunology; Virus","score_opus":0.058357585096954274,"score_gpt":0.3828190457100333,"score_spread":0.324461460613079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000010128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693424,0.00005167517,0.00044364252,0.00015373217,0.0000449203,0.00216394,0.00012549086,0.000029541281,0.000052849617],"genre_scores_gemma":[0.9980991,0.00036361394,0.0010280076,0.000043806776,0.000054525077,0.00011115319,0.00023669994,0.000020798132,0.000042307558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967854,0.0011991331,0.00062336546,0.00029453816,0.000741177,0.00035639753],"domain_scores_gemma":[0.99846715,0.00015987948,0.0004004256,0.000550039,0.00022640551,0.0001960814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014144531,0.00015667411,0.0005901233,0.00037789057,0.00009848001,0.000003863107,0.00008351845,0.000052765245,0.000033812314],"category_scores_gemma":[0.00024957763,0.00010677109,0.00010132915,0.0011814524,0.000111082525,0.00010484788,0.000029511319,0.00014163608,0.000001302803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020185373,0.0022895967,0.96438354,0.00013223916,0.00035611936,0.000010648224,0.0010638669,0.0050029187,0.00008054834,0.00005451645,0.0000063815846,0.026417771],"study_design_scores_gemma":[0.0031416672,0.005247205,0.7947837,0.0007102032,0.00047951433,0.0000023442394,0.00011534428,0.19412513,0.0009361724,0.000007833594,0.0003116726,0.00013918098],"about_ca_topic_score_codex":0.8929407,"about_ca_topic_score_gemma":0.7289521,"teacher_disagreement_score":0.18912221,"about_ca_system_score_codex":0.0021681942,"about_ca_system_score_gemma":0.0012503135,"threshold_uncertainty_score":0.56697524},"labels":[],"label_agreement":null},{"id":"W2000345837","doi":"10.1016/j.jval.2012.08.1803","title":"PHS30 Health Care Costs in Psoriatic Arthritis (PSA) Patients Newly Initiated on a Biologic Disease-Modifying Anti-Rheumatic Drug (DMARDS) or Methotrexate (MTX)","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Psoriatic arthritis; Pharmacy; Medical prescription; Health care; Methotrexate; Emergency medicine; Internal medicine; Disease; Family medicine; Pharmacology","score_opus":0.07261658889146184,"score_gpt":0.3644348889219784,"score_spread":0.29181830003051656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000345837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.939445,0.054142192,0.000033414322,0.0029138247,0.0005052273,0.0025717015,0.00014409678,0.00012221915,0.00012230189],"genre_scores_gemma":[0.9231802,0.073272906,0.0008209467,0.0021181237,0.00008426233,0.00017817829,0.00026747247,0.00006393229,0.00001393805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993419,0.0022663292,0.0012912804,0.0005440257,0.0007575705,0.0017217773],"domain_scores_gemma":[0.9968934,0.00085435424,0.00037735395,0.00051842164,0.00012171007,0.0012347519],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002139118,0.00040101254,0.0011728001,0.00077843695,0.00025520285,0.000048134458,0.00019536584,0.00010513685,0.00009628658],"category_scores_gemma":[0.0019498988,0.00032373398,0.00012014989,0.0009153319,0.00011239037,0.00027686538,0.000078209494,0.0007038778,0.00010499581],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022730534,0.0029072978,0.49090475,0.0039955215,0.00010468801,0.00017225255,0.022418972,0.0004437859,0.000013723684,0.00078195,0.0010972029,0.4748868],"study_design_scores_gemma":[0.033358973,0.0051909457,0.9103676,0.03479008,0.000008945737,0.000047431346,0.0061003687,0.00490707,0.00006805768,0.00049471215,0.0035937876,0.0010720025],"about_ca_topic_score_codex":0.009520129,"about_ca_topic_score_gemma":0.0008788198,"teacher_disagreement_score":0.47381482,"about_ca_system_score_codex":0.0013565819,"about_ca_system_score_gemma":0.0014123794,"threshold_uncertainty_score":0.9999215},"labels":[],"label_agreement":null},{"id":"W2000828606","doi":"10.1016/j.jval.2012.08.2198","title":"PCN158 Adherence to Human Epidermal Growth Factor Receptor-2 (HER2) Testing & Adjuvant Trastuzumab Treatment Guidelines in a Canadian Province","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Bone and Joint Health Institute; Princess Margaret Cancer Centre; McMaster University; Cancer Care Ontario; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Trastuzumab; Internal medicine; Cohort; Breast cancer; Oncology; Odds ratio; Cancer registry; Cancer","score_opus":0.33491114660301574,"score_gpt":0.46467707360967625,"score_spread":0.1297659270066605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000828606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98437166,0.0019736313,0.000022907105,0.008725889,0.00032683313,0.0029491403,0.00009714053,0.00007369189,0.0014591328],"genre_scores_gemma":[0.98684865,0.00014848894,0.009641665,0.001444962,0.0005946708,0.00033148768,0.000031898362,0.00006910003,0.0008890587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99529016,0.00045147366,0.0011080301,0.0005586854,0.0005592677,0.0020323945],"domain_scores_gemma":[0.99680144,0.00031836863,0.00013873917,0.00050162454,0.00021608672,0.002023719],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018902406,0.00031958093,0.0006851423,0.0006423672,0.00015561626,0.000025973308,0.00023064819,0.00013828925,0.00035238266],"category_scores_gemma":[0.0025280623,0.00028561905,0.0000609845,0.0008985461,0.00005463583,0.0001365882,0.00005179127,0.0004795904,0.00024128672],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000733977,0.00032823664,0.8823046,0.0005939527,0.000014019185,0.00005514684,0.004472435,0.0002127229,0.0007844491,0.00013057113,0.0030806728,0.10794977],"study_design_scores_gemma":[0.0037450371,0.0054498385,0.8725051,0.0037815948,0.000014575096,0.00011527172,0.0006097067,0.0012556342,0.0009930265,0.00009207205,0.11066162,0.0007765197],"about_ca_topic_score_codex":0.9656567,"about_ca_topic_score_gemma":0.81146055,"teacher_disagreement_score":0.15419619,"about_ca_system_score_codex":0.009171613,"about_ca_system_score_gemma":0.008022923,"threshold_uncertainty_score":0.9999596},"labels":[],"label_agreement":null},{"id":"W2000963673","doi":"10.1016/j.jval.2011.08.401","title":"PMS15 Costs of Tumor Necrosis Factor Blockers per Treated Patient Across Adult Indications Using Real-World Data in US Commercially-Insured Population","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Intelligent Mechatronic Systems (Canada)","funders":"","keywords":"Medicine; Adalimumab; Etanercept; Infliximab; Psoriatic arthritis; Rheumatoid arthritis; Ankylosing spondylitis; Internal medicine; Discontinuation; Psoriasis; Population; Surgery; Tumor necrosis factor alpha; Dermatology","score_opus":0.14651859472891726,"score_gpt":0.3822495205097888,"score_spread":0.23573092578087151,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2000963673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997819,0.0001785091,0.000027023021,0.00039834122,0.00019439685,0.0004713054,0.0008392749,0.000021445429,0.000050723895],"genre_scores_gemma":[0.99410623,0.000116413816,0.0050838604,0.00037067308,0.000007972438,0.000007718028,0.000276177,0.000015184512,0.000015751059],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740076,0.000891015,0.0008406868,0.00037294047,0.000059394668,0.0004352303],"domain_scores_gemma":[0.9987231,0.0001802367,0.0004258981,0.00054556155,0.00007226801,0.00005291656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064507703,0.00016111527,0.00047245662,0.00023753151,0.00011989849,0.0000068646727,0.00027919078,0.00015083657,0.0000759457],"category_scores_gemma":[0.00020111284,0.00014268742,0.000046126286,0.0005831918,0.00019000977,0.00008298174,0.00013847073,0.0003083839,0.0000054513007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022449467,0.00048127852,0.98733586,0.000047220452,0.000036023786,0.000001847906,0.0016437484,0.000010139739,0.0026325902,0.00033303504,0.00007678243,0.007176965],"study_design_scores_gemma":[0.0008163556,0.0002207184,0.9938716,0.00020095352,0.000017056209,0.0000035130938,0.00025172136,0.00064254366,0.003596743,0.0000771154,0.00014885252,0.00015281083],"about_ca_topic_score_codex":0.30971995,"about_ca_topic_score_gemma":0.03163941,"teacher_disagreement_score":0.27808052,"about_ca_system_score_codex":0.0002866105,"about_ca_system_score_gemma":0.00013493116,"threshold_uncertainty_score":0.98603064},"labels":[],"label_agreement":null},{"id":"W2001099147","doi":"10.1016/s1098-3015(10)70638-0","title":"PCV50 UP-TITRATION OF STATIN THERAPY TO MEET CANADIAN TARGET LIPID GOALS: ECONOMIC IMPACT OFTITRATION ASSOCIATED WITH COMPARATIVE EFFICACY OF ROSUVASTATIN, ATORVASTATIN, SIMVASTATIN AND PRAVASTATIN","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rosuvastatin; Pravastatin; Simvastatin; Atorvastatin; Statin; Medicine; Pharmacology; Internal medicine; Cholesterol","score_opus":0.053754054396429926,"score_gpt":0.3198960244048216,"score_spread":0.2661419700083917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001099147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946698,0.0006555292,0.00076478365,0.0005419542,0.00007058993,0.0026194733,0.00049581274,0.000025708789,0.00015633008],"genre_scores_gemma":[0.99071276,0.000332543,0.008202241,0.00033617613,0.000062234445,0.000060357423,0.00022732481,0.00004478465,0.000021551841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964634,0.0007780594,0.0012049034,0.00045538266,0.0005132595,0.00058499654],"domain_scores_gemma":[0.99757934,0.00040972815,0.00068818027,0.0003738118,0.0003019813,0.0006469692],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019427899,0.00031269074,0.0011850528,0.00046987567,0.00014705324,0.000015148894,0.00008598704,0.000099711855,0.000047521622],"category_scores_gemma":[0.0002829268,0.0002661914,0.00012489092,0.0005437629,0.00014030012,0.00016719048,0.000012446179,0.00021368919,0.000003145875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007960299,0.002045158,0.44189337,0.0022543448,0.0024626702,0.0001222036,0.20910113,0.28775856,0.0056849895,0.003150459,0.008741212,0.02882561],"study_design_scores_gemma":[0.014567234,0.011145043,0.9446616,0.0013460617,0.000055446726,0.00007999516,0.003604549,0.016471727,0.006741632,0.00015941546,0.0005461816,0.00062109815],"about_ca_topic_score_codex":0.31690118,"about_ca_topic_score_gemma":0.074787244,"teacher_disagreement_score":0.5027682,"about_ca_system_score_codex":0.0010028512,"about_ca_system_score_gemma":0.0066916444,"threshold_uncertainty_score":0.999979},"labels":[],"label_agreement":null},{"id":"W2001113760","doi":"10.1016/j.jval.2013.08.262","title":"Factors Associated with Compliance with Palivizumab Prophylaxis in the Canadian RSV Evaluation Study for Synagis (CARESS) Registry (2005-2012)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Gestational age; Respiratory system; Internal medicine; Pregnancy","score_opus":0.283670720677122,"score_gpt":0.4190594965825489,"score_spread":0.13538877590542686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001113760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875385,0.000218107,0.000023201708,0.0018899329,0.000055317127,0.009900001,0.000028001445,0.000024426387,0.00032248552],"genre_scores_gemma":[0.99778354,0.000003563662,0.000047252463,0.00034906162,0.000042505355,0.0015681,0.00005258427,0.000032950815,0.00012044602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964396,0.0011149669,0.00043657157,0.00039593328,0.0009016945,0.0007112739],"domain_scores_gemma":[0.9980679,0.00036184958,0.00018079155,0.0005727109,0.00054201554,0.00027469257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033133542,0.0001935164,0.0003655362,0.0004122387,0.00031551716,0.00009474726,0.00019489799,0.000109149994,0.000075520904],"category_scores_gemma":[0.00090266485,0.000114074486,0.00002756175,0.00101123,0.00011129541,0.0001828188,0.000012168121,0.0005954382,0.000010429204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011528145,0.0006995727,0.9897126,0.00026913613,0.000057317808,0.000015648373,0.002703028,0.0028291447,0.000010300187,0.00004712745,0.0009863207,0.0025545028],"study_design_scores_gemma":[0.002984098,0.0048563182,0.98031604,0.00045651547,0.000019056275,0.000004201986,0.0029244614,0.007878143,0.000011178177,0.000059945807,0.00034249545,0.00014754696],"about_ca_topic_score_codex":0.57011765,"about_ca_topic_score_gemma":0.816109,"teacher_disagreement_score":0.24599135,"about_ca_system_score_codex":0.0028241733,"about_ca_system_score_gemma":0.003921227,"threshold_uncertainty_score":0.7385115},"labels":[],"label_agreement":null},{"id":"W2001433987","doi":"10.1016/s1098-3015(10)63952-6","title":"PES8: BURDEN OF ILLNESS OF ECZEMA IN CANADA","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.06479325149091672,"score_gpt":0.3910864457120979,"score_spread":0.3262931942211812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001433987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946253,0.0009834034,0.0000069324915,0.00038192878,0.0004792776,0.00045119209,0.000020896177,0.000005086277,0.003046023],"genre_scores_gemma":[0.9992884,0.00037661285,0.00009662437,0.00006671261,0.000039802937,0.000028235983,0.000002525151,0.000013027202,0.000088088564],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9970763,0.0011947558,0.0009249661,0.0001390806,0.00023298716,0.0004319631],"domain_scores_gemma":[0.998846,0.00048235295,0.00031316766,0.00018593426,0.00007470876,0.000097812655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012996035,0.00008368194,0.0006483888,0.00011239852,0.00009206991,6.280056e-7,0.00011402021,0.000091413225,0.0001501972],"category_scores_gemma":[0.00026070335,0.000080498845,0.000022625354,0.00042302647,0.000026192569,0.000030255162,0.000021144142,0.00030143195,0.0000033308877],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022931481,0.00007066319,0.8208644,0.0030591544,0.0000063883585,0.000009533366,0.13171597,0.003457719,0.000015954582,0.037923586,0.00007494537,0.0027787744],"study_design_scores_gemma":[0.0022628743,0.00012264219,0.21347138,0.002997385,0.000004590865,1.8832115e-7,0.7637167,0.001079058,0.00026250776,0.0052323323,0.010511066,0.00033924895],"about_ca_topic_score_codex":0.9979763,"about_ca_topic_score_gemma":0.98866194,"teacher_disagreement_score":0.63200074,"about_ca_system_score_codex":0.0007751455,"about_ca_system_score_gemma":0.007399614,"threshold_uncertainty_score":0.99822754},"labels":[],"label_agreement":null},{"id":"W2001616961","doi":"10.1016/j.jval.2011.02.665","title":"PIN34 INTRANASAL LIVE ATTENUATED (LAIV) VERSUS INJECTABLE INACTIVATED (TIV) INFLUENZA VACCINE FOR CHILDREN AND ADOLESCENTS: A CANADIAN COST EFFECTIVENESS ANALYSIS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Live attenuated influenza vaccine; Medicine; Vaccination; Pediatrics; Christian ministry; Influenza vaccine; Cost–benefit analysis; Immunology","score_opus":0.10758982972760871,"score_gpt":0.3787116477136801,"score_spread":0.2711218179860714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001616961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993614,0.0015317248,0.00007893503,0.0003001765,0.00011160786,0.0039728363,0.0002071044,0.00006370229,0.000119899305],"genre_scores_gemma":[0.9980552,0.0003542097,0.00031409884,0.0008013331,0.0000703166,0.00025605864,0.00009263785,0.00004650209,0.000009622529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969375,0.00048290635,0.00057431485,0.000599999,0.00029813053,0.0011071162],"domain_scores_gemma":[0.9980203,0.00034870158,0.000157874,0.00038207567,0.00038142773,0.0007096036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013689578,0.0003185116,0.00095634774,0.0013511506,0.00029025722,0.00002326467,0.00015091729,0.00016801809,0.000041748815],"category_scores_gemma":[0.0009960663,0.00029535595,0.00011657443,0.0018817015,0.00009973407,0.00016284024,0.000075666845,0.0005099184,0.000013100333],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011056251,0.00030229834,0.9788769,0.0008387274,0.0017648091,0.000027811167,0.0025537622,0.00043232818,0.00010245295,0.00009907783,0.00021450187,0.003731063],"study_design_scores_gemma":[0.01269877,0.0015584803,0.98188317,0.0007062643,0.0002902643,0.0000066702023,0.00031438516,0.0016033979,0.00037129698,0.000026874419,0.00028666353,0.00025377868],"about_ca_topic_score_codex":0.80148053,"about_ca_topic_score_gemma":0.15915796,"teacher_disagreement_score":0.64232254,"about_ca_system_score_codex":0.001711406,"about_ca_system_score_gemma":0.0011646481,"threshold_uncertainty_score":0.9999499},"labels":[],"label_agreement":null},{"id":"W2001762110","doi":"10.1016/s1098-3015(10)74861-0","title":"PSY18 THE BURDEN OF OBESITY IN ONTARIO","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Well-being Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Obesity; Medicine; Gerontology; Internal medicine","score_opus":0.058757583248402384,"score_gpt":0.36054247986881355,"score_spread":0.3017848966204112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001762110","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608086,0.0013096879,0.000008884528,0.021934133,0.00039715527,0.00038268545,0.0000015967413,0.0000147850005,0.015142515],"genre_scores_gemma":[0.996355,0.00008335775,0.0001012789,0.0026561182,0.0000932332,0.000009313955,0.0000010841054,0.0000046757636,0.00069593533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983917,0.00038296622,0.0004855466,0.00018676846,0.00012014057,0.00043286133],"domain_scores_gemma":[0.99932384,0.0002053985,0.00011400465,0.00028304127,0.000015898217,0.00005778321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013927739,0.000084676365,0.0002651804,0.000093903356,0.00006938956,0.0000028766578,0.00015418214,0.00006638266,0.0000858219],"category_scores_gemma":[0.00005218293,0.000063929285,0.000030450748,0.00021822247,0.000038426482,0.000017806573,0.000015233309,0.00037620385,0.000048955844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019488152,0.00065919233,0.7225364,0.00017420616,0.000017420438,0.000035332658,0.19583304,0.002874993,0.000005598745,0.033615194,0.01745979,0.026593933],"study_design_scores_gemma":[0.00053445215,0.00030383264,0.97547036,0.00010416541,0.0000012695891,0.0000033683998,0.0007763848,0.00007370649,0.0000019687814,0.0048266794,0.017842786,0.00006099973],"about_ca_topic_score_codex":0.83893603,"about_ca_topic_score_gemma":0.112236775,"teacher_disagreement_score":0.72669923,"about_ca_system_score_codex":0.0002539709,"about_ca_system_score_gemma":0.00036250992,"threshold_uncertainty_score":0.9039626},"labels":[],"label_agreement":null},{"id":"W2001790155","doi":"10.1016/j.jval.2013.03.255","title":"Determining the current state-of-play for variants of the ‘short form' health-related quality of life instrument in spinal cord injury: A systematic literature review","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Praxis Spinal Cord Institute; University of British Columbia","funders":"","keywords":"Descriptive statistics; Spinal cord injury; Quality of life (healthcare); Systematic review; SF-36; Medicine; Missing data; Data collection; Psychology; Gerontology; MEDLINE; Health related quality of life; Statistics; Spinal cord; Psychiatry; Disease; Pathology; Mathematics","score_opus":0.17875907636888982,"score_gpt":0.4633291999414676,"score_spread":0.28457012357257777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001790155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9316867,0.05306186,0.000027773858,0.0037898256,0.0002526323,0.011090261,0.00007144988,0.000007465694,0.000012039077],"genre_scores_gemma":[0.988266,0.010316548,0.000336854,0.00056946126,0.000018208693,0.00045005168,0.000012834267,0.000020516944,0.000009558036],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99351525,0.0016683384,0.00328924,0.0002736158,0.000766421,0.00048710883],"domain_scores_gemma":[0.9969397,0.0004411177,0.0012844617,0.0007409948,0.00041005964,0.00018362654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00824942,0.00019311205,0.0015096217,0.00022654016,0.00006125889,0.000009966105,0.0003618352,0.000054447217,0.0000072585462],"category_scores_gemma":[0.0027323496,0.000107498934,0.0001669164,0.0011130024,0.000100580335,0.00009763649,0.00010905724,0.0006642419,0.0000016285763],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026074639,0.00056094816,0.059192646,0.77069646,0.000059552152,7.4753837e-7,0.0011624383,0.000009555787,0.00006266119,0.0004297483,0.00038977218,0.164828],"study_design_scores_gemma":[0.0014467525,0.010202021,0.57048213,0.4152852,0.000028046685,0.000009882379,0.00012260285,0.0016181946,0.000052297324,0.00058086426,0.000044194145,0.00012781148],"about_ca_topic_score_codex":0.0016490972,"about_ca_topic_score_gemma":0.00007539016,"teacher_disagreement_score":0.5112895,"about_ca_system_score_codex":0.00039946736,"about_ca_system_score_gemma":0.0017085641,"threshold_uncertainty_score":0.43836793},"labels":[],"label_agreement":null},{"id":"W2001855618","doi":"10.1016/j.jval.2011.12.006","title":"Guidelines for Health Technologies: Specific Guidance for Oncology Products in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; University of Alberta; Toronto Public Health; BC Cancer Agency; University of Ottawa; University of Calgary; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Canadian Agency for Drugs and Technologies in Health; University of British Columbia; Artificial Intelligence in Medicine (Canada); Health Sciences Centre; University Health Network; University of Toronto; Hamilton Health Sciences; McMaster University; Group for Research in Decision Analysis","funders":"","keywords":"Agency (philosophy); Health technology; Government (linguistics); Medicine; Time horizon; Quality (philosophy); Economic evaluation; Oncology; Health care; Business; Political science; Finance; Pathology","score_opus":0.7003080386820904,"score_gpt":0.49854132817164004,"score_spread":0.2017667105104503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001855618","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030813407,0.097952686,0.0072466517,0.8524114,0.0036806618,0.0066346917,0.0009310427,0.000096721495,0.00023273205],"genre_scores_gemma":[0.5156873,0.009278212,0.3372708,0.12902522,0.0024631615,0.005228675,0.00022138248,0.00021417301,0.00061111955],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9904059,0.00038053168,0.0070315683,0.0006963458,0.00008979357,0.0013958619],"domain_scores_gemma":[0.9943666,0.001813699,0.0028609643,0.0006248087,0.0001520947,0.00018183602],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.039147332,0.00022644032,0.0015041089,0.00050004135,0.00016707148,0.000016662501,0.0003766269,0.00015430497,0.0000149610805],"category_scores_gemma":[0.012740408,0.00028857874,0.00006240302,0.00045973063,0.00004231602,0.00027690336,0.00004515509,0.00022015482,0.000048589227],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00007363265,0.00029927332,0.10163788,0.0055659204,0.0000215551,5.194104e-7,0.0028021252,0.005522954,0.0000012855575,0.19472784,0.67856306,0.010783941],"study_design_scores_gemma":[0.0012235424,0.00021383211,0.0078091123,0.00029493033,5.0276657e-7,0.0000039473275,0.0026437002,0.008003394,0.000006218142,0.008525524,0.97098875,0.000286532],"about_ca_topic_score_codex":0.77577245,"about_ca_topic_score_gemma":0.47617966,"teacher_disagreement_score":0.72338617,"about_ca_system_score_codex":0.012028358,"about_ca_system_score_gemma":0.007065852,"threshold_uncertainty_score":0.9999566},"labels":[],"label_agreement":null},{"id":"W2001887499","doi":"10.1016/j.jval.2011.08.539","title":"PUK4 Comparing Projected Outcomes of Renal Transplant Recipients Based on Trial Endpoint of Renal Function and Receiving Different Immunosuppressive Regimens in the United States","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Belatacept; Medicine; Dialysis; Tacrolimus; Renal function; Urology; Kidney transplantation; Quality of life (healthcare); Clinical endpoint; Transplantation; Internal medicine; Clinical trial; Kidney transplant","score_opus":0.09503194658494024,"score_gpt":0.31417667175080133,"score_spread":0.2191447251658611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001887499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803627,0.000050240433,0.00021149057,0.00024207671,0.000114829345,0.0012027356,0.000046659334,0.000011396728,0.00008432004],"genre_scores_gemma":[0.9991073,0.0002491334,0.00021509672,0.00011698089,0.000009057351,0.000042400312,0.00023924073,0.000011521673,0.000009294546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979673,0.00050155533,0.00077147223,0.00020981555,0.00033109065,0.00021878777],"domain_scores_gemma":[0.9989045,0.00046100531,0.0003252469,0.00021078302,0.00003943594,0.000059018814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052415434,0.0001662519,0.0005429499,0.00043149744,0.000041459763,0.00000477973,0.00006859385,0.000055334793,0.000013085009],"category_scores_gemma":[0.000039145427,0.00009908078,0.00007142938,0.0002870906,0.000049436283,0.000035952165,0.0000060190446,0.00022148031,2.929755e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050165348,0.0015590792,0.9350529,0.0005086541,0.00013975338,0.000032135893,0.010029229,0.0019113675,0.00018736531,0.00017511561,0.0000033428105,0.00023575425],"study_design_scores_gemma":[0.03307777,0.002687613,0.95403624,0.0026046801,0.00007823085,0.000006347442,0.00023939965,0.0061715343,0.0009375821,0.00008646584,0.0000027068784,0.00007143448],"about_ca_topic_score_codex":0.0056246393,"about_ca_topic_score_gemma":0.00013430402,"teacher_disagreement_score":0.018983383,"about_ca_system_score_codex":0.000086839034,"about_ca_system_score_gemma":0.00007733111,"threshold_uncertainty_score":0.850281},"labels":[],"label_agreement":null},{"id":"W2001978706","doi":"10.1016/j.jval.2014.03.903","title":"Vitamin B12 Status In Frail Older Adults Admitted In A Geriatric Assessment Unit: Can The Use Of Certain Drugs Be Determinant?","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire de Gériatrie de Montréal; Université de Montréal","funders":"","keywords":"Metformin; Medicine; Vitamin B12; Vitamin D and neurology; Internal medicine; Calcium; Pharmacist; Diabetes mellitus; Endocrinology; Pharmacy; Family medicine","score_opus":0.05766473200620884,"score_gpt":0.3572564103019301,"score_spread":0.29959167829572125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2001978706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935143,0.00020612925,0.000013921121,0.004728393,0.000102976235,0.0013170964,0.000027588278,0.0000132472605,0.00007637798],"genre_scores_gemma":[0.99738955,0.000655421,0.00055149,0.0009451509,0.00004504526,0.000074230236,0.00003638348,0.000031182746,0.00027154599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961972,0.0011194707,0.0008342976,0.00036567976,0.0005713998,0.000911931],"domain_scores_gemma":[0.9979797,0.0009525544,0.00017205077,0.0005415076,0.00009076905,0.00026342718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021117975,0.00018841955,0.0005394596,0.0008121182,0.0000482666,0.000017601637,0.00016852024,0.0001365872,0.0000360677],"category_scores_gemma":[0.0005370076,0.00013728882,0.000055181426,0.00147456,0.0000765144,0.00008344852,0.00008341464,0.0007028303,0.0000033883484],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049966725,0.0010705702,0.89451694,0.0015558759,0.000017146678,0.00010233393,0.014125715,0.0006673729,0.0002225884,0.00013797455,0.00049001403,0.08659381],"study_design_scores_gemma":[0.0047157113,0.0008552489,0.94218636,0.0010530377,0.000006725654,0.000007680604,0.0014476558,0.046302337,0.0000915865,0.000025002191,0.003174748,0.00013391158],"about_ca_topic_score_codex":0.16240571,"about_ca_topic_score_gemma":0.0178419,"teacher_disagreement_score":0.14456382,"about_ca_system_score_codex":0.0005829235,"about_ca_system_score_gemma":0.0015176568,"threshold_uncertainty_score":0.99561983},"labels":[],"label_agreement":null},{"id":"W2002055673","doi":"10.1111/j.1524-4733.2007.00227.x","title":"Costs Associated with Diffuse Large B-Cell Lymphoma Patient Treatment in a Canadian Integrated Cancer Care Center","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary","funders":"","keywords":"Medicine; Rituximab; CHOP; Diffuse large B-cell lymphoma; Vincristine; Context (archaeology); Cancer; Intensive care medicine; Lymphoma; Cyclophosphamide; Internal medicine; Chemotherapy","score_opus":0.0221471912515148,"score_gpt":0.24127005745096178,"score_spread":0.219122866199447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002055673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98288995,0.005662231,0.000021447768,0.00043170032,0.0003673804,0.00064175454,0.0014315452,0.00001883093,0.008535163],"genre_scores_gemma":[0.9973419,0.00092905,0.0000492905,0.0012606108,0.000039398976,0.0000603814,0.00010486237,0.000038634167,0.00017592529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975698,0.00003357603,0.00080565567,0.0004194816,0.0000354042,0.0011360686],"domain_scores_gemma":[0.9988942,0.000051502273,0.00036214798,0.00022295068,0.00003818517,0.0004309741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005003149,0.00023020984,0.00054636836,0.0005691965,0.00008882871,0.00003417832,0.00012156141,0.00014939102,0.000063015024],"category_scores_gemma":[0.000053552743,0.00023361701,0.00005729506,0.000424964,0.000028184837,0.00013857908,0.000013883026,0.00013572951,0.000043310007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083372826,0.001110599,0.97808975,0.00002917878,0.000018984389,0.000046524776,0.0059010424,0.00031269048,1.9189176e-7,0.003058813,0.00016482933,0.011183994],"study_design_scores_gemma":[0.019026387,0.0010063302,0.8112853,0.00047408944,0.0000038317116,0.000002590841,0.0018048512,0.0022441486,0.00003805137,0.0002565942,0.16320047,0.0006573455],"about_ca_topic_score_codex":0.937331,"about_ca_topic_score_gemma":0.96255255,"teacher_disagreement_score":0.16680446,"about_ca_system_score_codex":0.017914139,"about_ca_system_score_gemma":0.0011632658,"threshold_uncertainty_score":0.98585594},"labels":[],"label_agreement":null},{"id":"W2002325793","doi":"10.1016/j.jval.2013.03.1625","title":"Cost-Effectiveness of the 21-Gene Assay for Guiding Adjuvant Chemotherapy Decisions in Early Breast Cancer","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; University Health Network; Princess Margaret Cancer Centre; Ministry of Health and Long Term Care; Toronto Public Health","funders":"","keywords":"Medicine; Breast cancer; Oncology; Adjuvant; Cohort; Internal medicine; Cost effectiveness; Estrogen receptor; Cancer; Gynecology; Risk analysis (engineering)","score_opus":0.05785129053001063,"score_gpt":0.3413311520532718,"score_spread":0.28347986152326116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002325793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935383,0.0022161307,0.00038661,0.0019400256,0.0001943217,0.001543779,0.00015130671,0.0000039845245,0.000025548557],"genre_scores_gemma":[0.99717623,0.0011436545,0.00044869754,0.00025005208,0.00006678299,0.0008674567,0.000011445107,0.000020349036,0.000015338614],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988673,0.0002305288,0.00026758976,0.00026025137,0.00009904095,0.00027529564],"domain_scores_gemma":[0.99931985,0.00017340404,0.000114164235,0.00026078985,0.00008752876,0.000044279852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054038456,0.0001250273,0.00024081329,0.000042356776,0.00006316164,0.000006157796,0.00015428964,0.00007031428,0.000004950993],"category_scores_gemma":[0.000076902346,0.00009020821,0.00007215743,0.00016243308,0.000049475766,0.000004258894,0.00005904676,0.000046460707,9.220285e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005953004,0.00041970456,0.8467197,0.00020769685,0.00013555611,5.63528e-7,0.00075920386,0.0059142685,0.078454435,0.0001474902,0.00067398296,0.06597213],"study_design_scores_gemma":[0.0017853661,0.00008355135,0.95852494,0.00033604755,0.0000046720234,0.0000041443523,0.000054369957,0.00021554752,0.03817393,0.00028067306,0.00043981933,0.00009695224],"about_ca_topic_score_codex":0.0169062,"about_ca_topic_score_gemma":0.00051752664,"teacher_disagreement_score":0.11180526,"about_ca_system_score_codex":0.00018843393,"about_ca_system_score_gemma":0.0002409456,"threshold_uncertainty_score":0.9896403},"labels":[],"label_agreement":null},{"id":"W2002396150","doi":"10.1016/j.jval.2014.03.411","title":"A Comparison of Toxicity and Supportive Care Use Between Four Cytotoxic Agents Used in the Management of Metastatic Breast Cancer (MBC))","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Neutropenia; Internal medicine; Metastatic breast cancer; Capecitabine; Anemia; Toxicity; Gemcitabine; Adverse effect; Vinorelbine; Breast cancer; Eribulin; Cancer; Oncology; Chemotherapy; Colorectal cancer","score_opus":0.17380227733604714,"score_gpt":0.4436858291776548,"score_spread":0.26988355184160767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002396150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973216,0.00046948396,0.000022231932,0.0009902654,0.00004455117,0.00097452645,0.000121140416,0.0000042380584,0.000051976032],"genre_scores_gemma":[0.99913615,0.00023770834,0.00027709856,0.00022564104,0.000022307999,0.00005447201,0.000020153211,0.000007965919,0.00001852374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986963,0.0003255851,0.0004367549,0.0001581718,0.00018820171,0.0001949349],"domain_scores_gemma":[0.9993593,0.00019675896,0.00020908163,0.00014104153,0.000028532739,0.00006529849],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041222046,0.000098405464,0.0004971567,0.00011432064,0.000020581429,0.0000029025816,0.000060936847,0.000025705956,0.000036708378],"category_scores_gemma":[0.0000057680304,0.00007159338,0.000035436893,0.00020840918,0.000051252286,0.000031887073,0.000025415193,0.000114335744,6.2628635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016699478,0.00040091592,0.9841156,0.0018143589,0.000120587945,0.000010384161,0.008051655,0.00017836709,0.000084226456,0.000054158307,0.0001285527,0.0048741773],"study_design_scores_gemma":[0.003514856,0.00063683366,0.99236494,0.00042739947,0.00016937919,0.0000036551644,0.0014976879,0.00062535255,0.0005434588,0.00004644691,0.00011972312,0.00005027084],"about_ca_topic_score_codex":0.011122099,"about_ca_topic_score_gemma":0.0011572933,"teacher_disagreement_score":0.009964806,"about_ca_system_score_codex":0.0002030729,"about_ca_system_score_gemma":0.0000978985,"threshold_uncertainty_score":0.9954629},"labels":[],"label_agreement":null},{"id":"W2002657022","doi":"10.1016/j.jval.2014.08.2673","title":"Evolution of Drug Reimbursement in Canada: The Pan-Canadian Pharmaceutical Alliance for New Drugs","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Fulbright Canada; Global Affairs Canada; Institute of Health Economics; University of Ottawa","funders":"","keywords":"Negotiation; Reimbursement; Alliance; Business; Agency (philosophy); Pharmaceutical care; Health care; Process (computing); Drug prices; Pharmaceutical industry; Public relations; Public economics; Political science; Economic growth; Economics; Medicine; Pharmacology; Law; Sociology; Pharmacy","score_opus":0.31515287839522266,"score_gpt":0.40830782513114877,"score_spread":0.09315494673592611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002657022","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49316123,0.013790134,0.0040698173,0.4803736,0.0021054584,0.0041541005,0.00039881028,0.000017752429,0.0019291115],"genre_scores_gemma":[0.985079,0.0002680098,0.0012904406,0.012769012,0.00024636215,0.00010831531,0.000011131034,0.000019566894,0.00020816938],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99508137,0.0005438478,0.0032504005,0.00038099912,0.00010232312,0.00064106024],"domain_scores_gemma":[0.9968588,0.0013606175,0.0010447705,0.00037335328,0.000030409015,0.00033208288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020551946,0.00012777252,0.00065850076,0.00021263534,0.00010686453,0.000013373133,0.00030132616,0.00005535405,0.000058597077],"category_scores_gemma":[0.0015831041,0.00014558391,0.00005229016,0.00025826553,0.000033293974,0.00011042018,0.000018096936,0.00019781303,0.000054428034],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000034113247,0.000072929935,0.2681297,0.0012829674,0.000023850898,3.5225833e-7,0.004947287,0.03059173,5.7731836e-7,0.59189665,0.09925596,0.0037638624],"study_design_scores_gemma":[0.0022384422,0.000082680395,0.19337563,0.00041352693,0.0000033595127,0.0000011863148,0.0025649276,0.31786484,0.0000059609656,0.048620164,0.4344744,0.0003548764],"about_ca_topic_score_codex":0.99841547,"about_ca_topic_score_gemma":0.9932032,"teacher_disagreement_score":0.5432765,"about_ca_system_score_codex":0.008725094,"about_ca_system_score_gemma":0.007820916,"threshold_uncertainty_score":0.9978038},"labels":[],"label_agreement":null},{"id":"W2002712595","doi":"10.1016/j.jval.2014.03.021","title":"Benefits From Incorporating Network Meta-Analysis Within Stratified Cost-Effectiveness Analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge; Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"","keywords":"Dabigatran; Medicine; Apixaban; Rivaroxaban; Warfarin; Internal medicine; Atrial fibrillation; Cost-effectiveness analysis; Clinical trial; Stroke (engine); Cost effectiveness; Risk analysis (engineering)","score_opus":0.5991842699832463,"score_gpt":0.4407767059495713,"score_spread":0.15840756403367495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002712595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7750733,0.017685125,0.17582062,0.022488875,0.001136818,0.0040604565,0.0017683993,0.00021031724,0.0017560908],"genre_scores_gemma":[0.98073524,0.00004641797,0.012296965,0.0058287405,0.00032514744,0.00034653296,0.00033705696,0.000038904043,0.00004501722],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9860416,0.0047414126,0.007097092,0.001218541,0.00020762377,0.00069370057],"domain_scores_gemma":[0.98723716,0.0057681254,0.005436541,0.0011081676,0.00008533939,0.00036468403],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.066694885,0.00035545306,0.0048170546,0.0012253936,0.0003306187,0.00015042654,0.00040194113,0.00022192932,0.00035291325],"category_scores_gemma":[0.0025726531,0.0004172151,0.0010192597,0.0033967302,0.00005724552,0.00037535836,0.00006604404,0.0003729726,0.0002842102],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009521799,0.00005028479,0.15629494,0.00010069941,0.018070577,2.4415152e-7,0.0005429393,0.71358275,8.917935e-8,0.111194015,0.00010114614,0.00005279202],"study_design_scores_gemma":[0.0005923078,0.00009323503,0.2826095,0.00003345584,0.0077890265,3.2284825e-7,0.00023595078,0.6604813,0.0000017357488,0.047153063,0.00051194004,0.00049816666],"about_ca_topic_score_codex":0.09171342,"about_ca_topic_score_gemma":0.014560776,"teacher_disagreement_score":0.20566192,"about_ca_system_score_codex":0.0008367228,"about_ca_system_score_gemma":0.00027446498,"threshold_uncertainty_score":0.999828},"labels":[],"label_agreement":null},{"id":"W2002858450","doi":"10.1016/j.jval.2014.03.503","title":"Parameter Values Associated with the Development of a Global Economic Model to Value Companion Diagnostics in Advanced/Metastatic Cancer Treatment","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Value (mathematics); Medicine; Cancer; Oncology; Intensive care medicine; Internal medicine; Statistics; Mathematics","score_opus":0.065465505589564,"score_gpt":0.2995608975078517,"score_spread":0.2340953919182877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002858450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893639,0.0014108298,0.0056630406,0.001612994,0.00020297011,0.000734622,0.0002617852,0.000013969857,0.00073587266],"genre_scores_gemma":[0.9923754,0.00052029686,0.0061052674,0.0006962248,0.000029944038,0.00018472564,0.0000098143555,0.000024956158,0.00005338831],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99783224,0.00007365048,0.0011128734,0.00041903963,0.0000457658,0.0005164391],"domain_scores_gemma":[0.9985871,0.00035572777,0.0006117758,0.00028822833,0.000020534922,0.00013666681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001097919,0.0002338367,0.00079701835,0.00013692699,0.000079815676,0.000026929589,0.00022270526,0.000059893504,0.000013737548],"category_scores_gemma":[0.00019902158,0.00020236874,0.000059929796,0.00023021674,0.000056122204,0.00014186061,0.000039198098,0.00010795317,0.00003299084],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055902707,0.000172967,0.22182837,0.00003624425,0.000039812872,3.9476907e-7,0.0021944516,0.73681766,3.4160766e-7,0.03166456,0.00011584296,0.007073429],"study_design_scores_gemma":[0.0027404302,0.0006699505,0.5570607,0.00042531602,0.000009732385,7.7276724e-7,0.00015926635,0.40225977,0.00002722602,0.033908725,0.0022662808,0.00047184023],"about_ca_topic_score_codex":0.0077331928,"about_ca_topic_score_gemma":0.008545415,"teacher_disagreement_score":0.33523232,"about_ca_system_score_codex":0.0035487737,"about_ca_system_score_gemma":0.00058524316,"threshold_uncertainty_score":0.9988744},"labels":[],"label_agreement":null},{"id":"W2003499981","doi":"10.1016/j.jval.2013.03.1080","title":"Economic Burden Associated With Ulcerative Colitis In Canada: An Analysis Using The Ramq Database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Ulcerative colitis; Inflammatory bowel disease; Reimbursement; Retrospective cohort study; Infliximab; Internal medicine; Health care; Disease; Database","score_opus":0.017332666108628873,"score_gpt":0.2584357248386728,"score_spread":0.2411030587300439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003499981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990955,0.000045736637,0.000038113325,0.00019492593,0.000034310408,0.000394366,0.00015801494,0.000002951978,0.000036090903],"genre_scores_gemma":[0.9990688,0.000019685882,0.00010683856,0.00040442235,0.000052708765,0.000033524357,0.00027890492,0.000012679085,0.000022421638],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9985719,0.0005095906,0.0002642328,0.00026327794,0.00008745083,0.00030359288],"domain_scores_gemma":[0.99934316,0.000026151029,0.0001300358,0.0003359637,0.000036488196,0.00012820658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040576322,0.000107742926,0.00016670558,0.0000642857,0.00007837747,0.00002208455,0.00014383518,0.000040164752,0.000044296983],"category_scores_gemma":[0.00004547993,0.000087944085,0.000024712675,0.0001420337,0.000038930106,0.000010190943,0.000037108428,0.0000936065,0.0000018133957],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001353867,0.000042957086,0.47579074,0.000027237264,0.00020116726,0.000052107003,0.0005137266,0.52234364,0.00034699423,0.0001246544,0.00024473955,0.00017663666],"study_design_scores_gemma":[0.000475476,0.00004157362,0.84630066,0.000026315192,0.000023574254,0.0000012342292,0.0008017276,0.15202396,0.00010129632,0.000014244521,0.000054831653,0.00013512715],"about_ca_topic_score_codex":0.96895003,"about_ca_topic_score_gemma":0.98885894,"teacher_disagreement_score":0.3705099,"about_ca_system_score_codex":0.0009205595,"about_ca_system_score_gemma":0.00387616,"threshold_uncertainty_score":0.68761414},"labels":[],"label_agreement":null},{"id":"W2003988980","doi":"10.1016/j.jval.2014.03.1003","title":"Long-Acting Muscarinic Antagonists (Lama) In Chronic Obstructive Pulmonary Disease (Copd): A Rare Events Meta Analysis Of Clinically Relevant Adverse Events","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Adverse effect; COPD; Placebo; Relative risk; Internal medicine; Lama; Randomized controlled trial; Mace; Tiotropium bromide; Clinical trial; Meta-analysis; Intensive care medicine; Confidence interval; Myocardial infarction; Lung; Lung function","score_opus":0.05684557326132262,"score_gpt":0.36583496113924896,"score_spread":0.30898938787792635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2003988980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903186,0.0050728703,0.00013229313,0.0013179501,0.00024688733,0.0022717111,0.0002631587,0.00006349783,0.00031302057],"genre_scores_gemma":[0.99750066,0.00077698246,0.0005983354,0.00019311102,0.00016425071,0.0001754595,0.0003077474,0.00008789899,0.00019552899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9914796,0.0018989787,0.0025337269,0.0014158005,0.0013793673,0.0012925733],"domain_scores_gemma":[0.9950901,0.0010728439,0.0009793515,0.0014847806,0.00024969512,0.001123183],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003059974,0.000529164,0.0023889602,0.0015310311,0.00013783484,0.0000075457697,0.0005099698,0.00021762289,0.0003410623],"category_scores_gemma":[0.0015405047,0.00050920196,0.001288593,0.0029224327,0.00025318304,0.00027448442,0.00037591578,0.0010548973,0.000027869115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031312234,0.0013608249,0.96097976,0.003947815,0.005324444,0.00053515134,0.00034858036,0.016730336,0.000048757032,0.00015689399,0.0000060707976,0.007430142],"study_design_scores_gemma":[0.002382699,0.0004033555,0.900175,0.00055489544,0.005511946,0.000013839834,0.00024611517,0.089647055,0.000007857058,0.00063499965,0.00009553009,0.00032674355],"about_ca_topic_score_codex":0.005122217,"about_ca_topic_score_gemma":0.0005904275,"teacher_disagreement_score":0.072916724,"about_ca_system_score_codex":0.00350848,"about_ca_system_score_gemma":0.003562738,"threshold_uncertainty_score":0.99973595},"labels":[],"label_agreement":null},{"id":"W2004185897","doi":"10.1016/j.jval.2012.08.2065","title":"PSS18 Ranibizumab for the Treatment of Macular Edema Due to Retinal Vein Occlusion (RVO) in the UK: A Cost-Utility Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Ranibizumab; Medicine; Branch retinal vein occlusion; Macular edema; Central retinal vein occlusion; Cost effectiveness; Visual acuity; Ophthalmology; Optometry; Surgery; Bevacizumab","score_opus":0.40044308701219467,"score_gpt":0.4503677563069999,"score_spread":0.04992466929480521,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004185897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9166904,0.008796138,0.009428178,0.05912742,0.00042036324,0.00489468,0.0003990238,0.0000128691,0.00023094735],"genre_scores_gemma":[0.99215007,0.0004650598,0.0018649368,0.0047440417,0.00022921922,0.0004394187,0.000038425613,0.00001688065,0.00005194251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993846,0.0012496497,0.0036607895,0.00044131285,0.00014040562,0.00066182157],"domain_scores_gemma":[0.9944098,0.0032287524,0.0013074566,0.00083637366,0.00004310434,0.00017453874],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03773983,0.00018955179,0.0011951353,0.0005059003,0.00023543595,0.00002794019,0.000349552,0.00010781405,0.00014230174],"category_scores_gemma":[0.0015919695,0.00015237204,0.00026703626,0.0008939388,0.00004796243,0.0001186173,0.000030958643,0.000119214616,0.000084447325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033616152,0.0015503592,0.86034614,0.00072217843,0.00028880127,0.000001954151,0.06684726,0.016652012,0.0000011004474,0.04584267,0.0046466948,0.0027646688],"study_design_scores_gemma":[0.0021908123,0.0006315745,0.8459394,0.00008811149,0.000053239026,0.000007157077,0.004760459,0.08596246,0.000006200634,0.0033870258,0.05669751,0.00027602847],"about_ca_topic_score_codex":0.037841316,"about_ca_topic_score_gemma":0.003842735,"teacher_disagreement_score":0.0754597,"about_ca_system_score_codex":0.0013767566,"about_ca_system_score_gemma":0.00027525655,"threshold_uncertainty_score":0.9908493},"labels":[],"label_agreement":null},{"id":"W2004203873","doi":"10.1016/j.jval.2011.02.356","title":"PSY23 ECONOMIC EVALUATION OF ERYTHROPOIESIS STIMULATING AGENTS IN CRITICALLY ILL TRAUMA PATIENTS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Randomized controlled trial; Population; Intensive care medicine; Emergency medicine; Critically ill; Economic evaluation; Relative risk; Intensive care unit; Cost–benefit analysis; Quality-adjusted life year; Cost effectiveness; Surgery; Internal medicine; Confidence interval; Risk analysis (engineering); Environmental health","score_opus":0.4413554712897895,"score_gpt":0.4875394786313302,"score_spread":0.046184007341540656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004203873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99633837,0.0004684402,0.000026814421,0.00020710983,0.0001673837,0.0004827993,0.000016211266,0.000007606291,0.00228525],"genre_scores_gemma":[0.9950653,0.00017244702,0.004411034,0.0002768941,0.000027058153,0.0000120873165,0.000016917005,0.000012599709,0.0000056928075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832785,0.00026375978,0.0007308391,0.00018036654,0.00028187936,0.0002152882],"domain_scores_gemma":[0.9990816,0.00017006557,0.00016783542,0.00016416374,0.00033484754,0.00008145303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011625421,0.00009158188,0.00037448815,0.00020778793,0.000015237034,0.0000013304015,0.00005590831,0.00006116656,0.00018405227],"category_scores_gemma":[0.0011656183,0.00009105782,0.000046508543,0.00012387164,0.000052031737,0.00006553613,0.000016402782,0.00009769556,0.000009693303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009833018,0.0003554169,0.96720344,0.00042866747,0.000015021217,0.0000014992494,0.008200514,0.0014404702,0.000012011868,0.00018315198,0.00006318306,0.021998316],"study_design_scores_gemma":[0.0032011764,0.0006842419,0.9565733,0.0017904332,0.00002836069,3.8480758e-7,0.0010307471,0.035100408,0.0005735592,0.0008621428,0.000071680355,0.00008353629],"about_ca_topic_score_codex":0.008951819,"about_ca_topic_score_gemma":0.00020620222,"teacher_disagreement_score":0.03365994,"about_ca_system_score_codex":0.00045382843,"about_ca_system_score_gemma":0.000273877,"threshold_uncertainty_score":0.99764764},"labels":[],"label_agreement":null},{"id":"W2004686712","doi":"10.1111/j.1524-4733.2009.00523.x","title":"Challenges of Patient-Reported Outcome Assessment in Hemophilia Care—a State of the Art Review","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Laurentian University","funders":"","keywords":"Medicine; Quality of life (healthcare); Perspective (graphical); Health care; Patient-reported outcome; Disease; MEDLINE; Outcomes research; Inclusion (mineral); Family medicine; Alternative medicine; Nursing; Psychology","score_opus":0.1379055901142577,"score_gpt":0.41872518914176254,"score_spread":0.28081959902750486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004686712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90462273,0.05108491,4.2358542e-7,0.03973069,0.00008283423,0.001799667,0.000005465443,0.000009241737,0.0026640308],"genre_scores_gemma":[0.9557775,0.043373268,0.00019958672,0.00050394895,0.000009799889,0.000015656111,0.0000066039806,0.000007696004,0.00010591108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775,0.00028850016,0.0009804476,0.00019523072,0.0005141136,0.0002717086],"domain_scores_gemma":[0.9990147,0.000076040946,0.0002687885,0.0004548361,0.00009344671,0.00009223327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091785647,0.00010883748,0.00059274235,0.0001419766,0.000017794588,0.0000011160542,0.00008712258,0.000037375878,0.000013581196],"category_scores_gemma":[0.00014820548,0.00006619199,0.00009384884,0.00036313603,0.000040680574,0.000023213077,0.000027366896,0.00027208842,0.000003131369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000114914554,0.0016655074,0.71638507,0.01818996,0.000050370527,0.00011930121,0.0036435055,0.00021081742,0.00017726037,0.00070575933,0.0003815793,0.25835595],"study_design_scores_gemma":[0.0017230739,0.0012480329,0.98391736,0.010418278,0.000021571264,0.000016960717,0.00033019893,0.00010975817,0.0004840226,0.00053550454,0.0011083089,0.00008694497],"about_ca_topic_score_codex":0.000428756,"about_ca_topic_score_gemma":0.00006199211,"teacher_disagreement_score":0.26753226,"about_ca_system_score_codex":0.00028754157,"about_ca_system_score_gemma":0.0005937007,"threshold_uncertainty_score":0.2699231},"labels":[],"label_agreement":null},{"id":"W2004994781","doi":"10.1016/j.jval.2014.01.010","title":"Sharing Risk between Payer and Provider by Leasing Health Technologies: An Affordable and Effective Reimbursement Strategy for Innovative Technologies?","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Institute for Health and Care Research","keywords":"Reimbursement; Health technology; Payment; Business; Health care; Cost sharing; Actuarial science; Risk analysis (engineering); Finance; Medicine; Economics; Nursing","score_opus":0.3155536276160359,"score_gpt":0.4309103615139781,"score_spread":0.11535673389794221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2004994781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8704694,0.0149109615,0.04615276,0.059698984,0.00021925627,0.0070879385,0.0007066754,0.000548776,0.00020528573],"genre_scores_gemma":[0.98813564,0.0010668671,0.008618348,0.0014140079,0.000060186176,0.00057709595,0.00005162208,0.000047399033,0.00002883736],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9945492,0.00049509347,0.0030021481,0.0010607829,0.000081647806,0.0008111342],"domain_scores_gemma":[0.9952127,0.0015036634,0.002565091,0.0005334411,0.00006528538,0.000119861455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02610201,0.000278697,0.0012617032,0.0005772601,0.0005055351,0.00011934691,0.00025804256,0.00025930363,0.00000280948],"category_scores_gemma":[0.0042907614,0.00032436816,0.000031686763,0.00045709172,0.00016666228,0.0005264759,0.00013183319,0.0004552851,0.000009401902],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046096848,0.00017962462,0.6247833,0.0042522918,0.00010158175,2.3081132e-7,0.0042631165,0.0011568258,0.0000033126835,0.1646238,0.0024782189,0.19811161],"study_design_scores_gemma":[0.006387303,0.0058873207,0.10830291,0.0018128016,0.000014141345,0.000008245298,0.031257574,0.1512596,0.00011079639,0.63840485,0.054875948,0.0016785276],"about_ca_topic_score_codex":0.01081078,"about_ca_topic_score_gemma":0.00017202563,"teacher_disagreement_score":0.5164804,"about_ca_system_score_codex":0.0010844477,"about_ca_system_score_gemma":0.00022291002,"threshold_uncertainty_score":0.99992085},"labels":[],"label_agreement":null},{"id":"W2005055126","doi":"10.1016/j.jval.2014.08.2332","title":"Resources Utilization for the Investigation of Pulmonary Nodules in a University Hospital Center in Quebec, Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôtel-Dieu de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Lung cancer; Nodule (geology); Thoracoscopy; Thoracotomy; Solitary pulmonary nodule; Lung cancer screening; Radiology; Lung; Medical record; Surgery; Internal medicine","score_opus":0.025447363524502182,"score_gpt":0.253704586114502,"score_spread":0.22825722258999978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005055126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863915,0.00038011177,0.000016109887,0.012552683,0.00006582909,0.0005312166,0.000010641012,0.0000028067861,0.000049145845],"genre_scores_gemma":[0.99935263,0.00023348535,0.000058429716,0.000259427,0.00002076126,0.000009072774,0.000021991256,0.0000040193127,0.000040158895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99946547,0.00008377171,0.00015428061,0.00010561234,0.00008823555,0.00010260924],"domain_scores_gemma":[0.99962014,0.00016746156,0.00006666073,0.00009302184,0.000018542714,0.0000341536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020558335,0.000043753404,0.000119208504,0.00006592088,0.00002002411,0.0000016854309,0.000033662836,0.000021430971,0.0000018408775],"category_scores_gemma":[0.000039555875,0.000033797976,0.000013391368,0.00015110393,0.00002111921,0.000026850654,0.000008366096,0.000045272314,9.322505e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055762255,0.000107113345,0.99260145,0.00024195327,0.000003869385,0.0000032372045,0.00124672,0.000955998,0.0000015552882,0.00034209047,0.00036581495,0.004074445],"study_design_scores_gemma":[0.0010483214,0.00010176895,0.98230726,0.00048744766,0.0000044940357,3.7265076e-7,0.00054851116,0.011918125,0.000038830007,0.00006870785,0.0034477368,0.00002843924],"about_ca_topic_score_codex":0.9662496,"about_ca_topic_score_gemma":0.9627395,"teacher_disagreement_score":0.012961199,"about_ca_system_score_codex":0.000877848,"about_ca_system_score_gemma":0.00032420745,"threshold_uncertainty_score":0.2295542},"labels":[],"label_agreement":null},{"id":"W2005078632","doi":"10.1016/s1098-3015(10)73341-6","title":"PCN105 GUIDELINES AND CANCER SCREENING IN THE UNITED STATES AND CANADIAN HEALTH SYSTEMS","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cancer; Family medicine; Medicine; Environmental health; Internal medicine","score_opus":0.13371601050493395,"score_gpt":0.32103323820038426,"score_spread":0.1873172276954503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005078632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77793795,0.12593187,0.00020607871,0.09394361,0.0002833618,0.0006291839,0.00031786578,0.000014599807,0.0007354428],"genre_scores_gemma":[0.92621434,0.052413978,0.0003086469,0.020810543,0.00014148444,0.000017215705,0.000023282737,0.00001287246,0.000057621666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827594,0.000058292873,0.00084984466,0.0002782824,0.000025215413,0.00051243725],"domain_scores_gemma":[0.9992415,0.000067587316,0.00028474885,0.0001601843,0.000020842337,0.00022516212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020958234,0.00012728882,0.0004131338,0.0005061852,0.00014117951,0.000091843205,0.00012324656,0.000063501124,0.0000071469894],"category_scores_gemma":[0.000095003845,0.00012269961,0.000016642412,0.0003413109,0.000036127432,0.00015179436,0.000010305403,0.0001890079,0.000003324069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003347295,0.0000353996,0.56929415,0.00026128718,0.000017255536,0.000010616817,0.009874207,0.0641117,1.5789021e-7,0.29039982,0.014786859,0.051175047],"study_design_scores_gemma":[0.0009887529,0.00025402728,0.6364688,0.00046671278,0.000001117598,0.000012665767,0.0012643996,0.11037509,1.8073108e-7,0.015516363,0.23432887,0.00032299478],"about_ca_topic_score_codex":0.9558991,"about_ca_topic_score_gemma":0.22444215,"teacher_disagreement_score":0.731457,"about_ca_system_score_codex":0.00032602597,"about_ca_system_score_gemma":0.00029805014,"threshold_uncertainty_score":0.78970975},"labels":[],"label_agreement":null},{"id":"W2005158100","doi":"10.1016/s1098-3015(10)70028-0","title":"CA4 THE EARLY CLINICAL AND ECONOMIC BENEFITS OF ATORVASTATIN IN A CANADIAN SETTING","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atorvastatin; Economics; Medicine; Internal medicine","score_opus":0.052219693821782334,"score_gpt":0.3114592046918989,"score_spread":0.2592395108701166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005158100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99196637,0.0031421734,0.0000013732937,0.0040225484,0.00009505243,0.0005680502,0.000014343629,0.0000051989196,0.00018492117],"genre_scores_gemma":[0.996806,0.0017787104,0.00034027622,0.00089082203,0.00014594506,0.000011731567,0.0000023421571,0.000012216057,0.000011942299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984062,0.00029519605,0.00061721075,0.00019291294,0.0001235219,0.00036496023],"domain_scores_gemma":[0.99916995,0.00012620278,0.000094141666,0.00027079353,0.000016509586,0.00032240473],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032182708,0.000073973126,0.0003835583,0.00012561264,0.000069024456,0.0000030513934,0.000050714767,0.00006708801,0.0000061029327],"category_scores_gemma":[0.0001321794,0.00005766991,0.00006526051,0.000117815565,0.00008027759,0.000026818232,0.000015514657,0.0002835208,0.000004707842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019994557,0.000018450452,0.9742586,0.0001256128,0.000011975028,0.000021686776,0.0015826309,0.00041356852,2.8336225e-7,0.00059022923,0.00007264129,0.022884345],"study_design_scores_gemma":[0.0010592534,0.00019718688,0.99565744,0.0002342029,0.0000037679238,0.00008904785,0.00013183783,0.0012203484,0.0000038021903,0.000036223064,0.0013198198,0.000047063793],"about_ca_topic_score_codex":0.9437766,"about_ca_topic_score_gemma":0.43819812,"teacher_disagreement_score":0.50557846,"about_ca_system_score_codex":0.00024375047,"about_ca_system_score_gemma":0.0027852408,"threshold_uncertainty_score":0.5720533},"labels":[],"label_agreement":null},{"id":"W2005161350","doi":"10.1016/j.jval.2012.03.1309","title":"PIN33 Pharmacoeconomic Evaluation of 13-Valent Pneumococcal Conjugate and 23-Valent Pneumococcal Polysaccharide Vaccine in Canadian Adults","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Pfizer (Canada); Institute of Health Economics","funders":"","keywords":"Medicine; Pneumococcal conjugate vaccine; Pneumococcal polysaccharide vaccine; Pneumococcal pneumonia; Streptococcus pneumoniae; Vaccination; Population; Herd immunity; Pneumococcal disease; Conjugate vaccine; Pneumonia; Pediatrics; Meningitis; Serotype; Intensive care medicine; Immunology; Internal medicine; Environmental health; Immunization; Biology; Antibiotics; Microbiology","score_opus":0.041745774133618914,"score_gpt":0.33577031721905665,"score_spread":0.29402454308543774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005161350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914256,0.002013501,0.0000015022591,0.0038450365,0.0006559727,0.0016533908,0.00004461739,0.000024616242,0.00033581757],"genre_scores_gemma":[0.9978148,0.00084018277,0.000013737259,0.000916286,0.00023104026,0.00011889562,0.000019358333,0.000029711917,0.00001598615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99705905,0.00048427787,0.0009681878,0.00034596235,0.00028877278,0.0008537623],"domain_scores_gemma":[0.9983089,0.000106522086,0.0002336704,0.00027351984,0.0001043439,0.000973076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002984687,0.00022823451,0.00055347406,0.000755426,0.00009276564,0.000008590914,0.00008085374,0.00013998663,0.000101410864],"category_scores_gemma":[0.0001623284,0.00022163462,0.00007694474,0.00031157202,0.00004888302,0.00017709655,0.000032495496,0.00042841592,0.000038885188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121116915,0.00038037047,0.9742937,0.00052363664,0.000032666256,0.000008572381,0.0012604151,0.0015224708,0.01718423,0.00017156304,0.00007178664,0.0044294684],"study_design_scores_gemma":[0.004729442,0.00036157374,0.9710456,0.00051398407,0.00006528999,0.00010107636,0.00014926256,0.02011789,0.001024042,0.00004948025,0.0016513984,0.0001909534],"about_ca_topic_score_codex":0.29122788,"about_ca_topic_score_gemma":0.09816076,"teacher_disagreement_score":0.19306712,"about_ca_system_score_codex":0.0014297478,"about_ca_system_score_gemma":0.0018296422,"threshold_uncertainty_score":0.91829544},"labels":[],"label_agreement":null},{"id":"W2005279725","doi":"10.1016/j.jval.2012.08.1106","title":"PIN39 A Cost Consequence Analysis of a Quadrivalent Meningococcal Vaccine (MenACWY-TT) in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph","funders":"","keywords":"Neisseria meningitidis; Medicine; Booster (rocketry); Vaccination; Booster dose; Meningococcal disease; Meningococcal vaccine; Incidence (geometry); Cost effectiveness; Pediatrics; Immunization; Immunology; Immune system","score_opus":0.035238139365360764,"score_gpt":0.28721243780360745,"score_spread":0.2519742984382467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005279725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962488,0.0021494832,0.000026069429,0.00060198316,0.000576713,0.00027836155,0.000060201004,0.00000936541,0.00004903555],"genre_scores_gemma":[0.9994362,0.00023401632,0.000042226624,0.00014273581,0.000018592433,0.00003321672,0.000049368693,0.0000063633724,0.00003727607],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832034,0.00041556868,0.00061665307,0.00016475224,0.000019802721,0.00046290987],"domain_scores_gemma":[0.99930507,0.0002090599,0.00019639266,0.000209717,0.000031423908,0.000048360827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062591274,0.00011501354,0.00050537585,0.00036780705,0.00004760584,0.0000025576846,0.000098337056,0.00007886448,0.0004208852],"category_scores_gemma":[0.00006961535,0.00010494298,0.000052137133,0.00085481105,0.000020898342,0.000059500686,0.000036058813,0.0001957697,0.0000087432245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010647673,0.00023104675,0.97138816,0.00006971255,0.00024073,0.0000021252972,0.00073318667,0.0018266059,0.02256444,0.0009348529,0.00049458275,0.0014081027],"study_design_scores_gemma":[0.0013471415,0.00012133894,0.98516625,0.00010312219,0.00007256653,0.000035639026,0.00037692836,0.00037988598,0.0029580467,0.000021838376,0.009247314,0.00016990949],"about_ca_topic_score_codex":0.9851198,"about_ca_topic_score_gemma":0.90162057,"teacher_disagreement_score":0.083499245,"about_ca_system_score_codex":0.0006465863,"about_ca_system_score_gemma":0.0009875735,"threshold_uncertainty_score":0.46083975},"labels":[],"label_agreement":null},{"id":"W2005425729","doi":"10.1016/j.jval.2011.02.733","title":"PMS48 IMPACT OF ANTI-TNF ON HEALTH CARE UTILIZATION AND COSTS IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ALBERTA, CANADA","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Calgary; Institute of Health Economics","funders":"","keywords":"Medicine; Rheumatoid arthritis; Propensity score matching; Ambulatory; Cohort; TNF inhibitor; Emergency department; Confidence interval; Emergency medicine; Health care; Family medicine; Internal medicine; Adalimumab; Nursing","score_opus":0.023800642146917884,"score_gpt":0.28404052632327254,"score_spread":0.26023988417635463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2005425729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99025047,0.0081869755,0.0000010809056,0.00036262648,0.00003780487,0.00095450244,0.00004379284,0.0000057676784,0.00015696484],"genre_scores_gemma":[0.966791,0.032868348,0.00006662594,0.00016747776,0.0000033021938,0.00001543368,0.00006533866,0.00002052974,0.000001968188],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998118,0.00025330106,0.00054463313,0.00024651812,0.00035478294,0.0004827626],"domain_scores_gemma":[0.99921715,0.00009318104,0.00014927484,0.00019830247,0.00007370926,0.0002683967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00030898396,0.00014635563,0.0005261704,0.00033294494,0.00004217763,0.0000056880704,0.000053035124,0.00004480135,0.000025370648],"category_scores_gemma":[0.00011310462,0.00012228054,0.00001972313,0.0003659887,0.000057776815,0.000080261525,0.000015419377,0.00022338038,8.870866e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052783795,0.0002447122,0.9413284,0.00017048896,0.000009133287,0.0000119916,0.0047786087,0.00006256362,4.349262e-7,0.00016013002,0.00009525899,0.05261043],"study_design_scores_gemma":[0.0058052875,0.0028390307,0.98642313,0.003945529,1.1404998e-7,0.000006591479,0.00057164585,0.00017613923,0.000020480695,0.000021913527,0.000100697,0.00008943864],"about_ca_topic_score_codex":0.9838032,"about_ca_topic_score_gemma":0.9491001,"teacher_disagreement_score":0.05252099,"about_ca_system_score_codex":0.00093171804,"about_ca_system_score_gemma":0.0028398472,"threshold_uncertainty_score":0.5037767},"labels":[],"label_agreement":null},{"id":"W2006235275","doi":"10.1016/j.jval.2013.03.348","title":"Responsiveness Of The Face-Q: A New Pro For Facial Aesthetic Paitents","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Facial Rejuvenation and Surgery Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rasch model; Patient satisfaction; Medicine; Patient-reported outcome; Significant difference; Mean difference; Facial symmetry; Psychology; Audiology; Orthodontics; Surgery; Internal medicine; Quality of life (healthcare); Developmental psychology","score_opus":0.07493864893221157,"score_gpt":0.34224721310071254,"score_spread":0.26730856416850096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006235275","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91050005,0.0002057479,0.0010414679,0.08379078,0.0002004715,0.0037600477,0.000008248434,0.000055259676,0.00043793803],"genre_scores_gemma":[0.99376416,0.000033864042,0.0008683327,0.0038810729,0.0000145573,0.00012267426,0.0000034933078,0.000012491039,0.0012993291],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910474,0.00013255583,0.0003201565,0.000111972964,0.00015784956,0.00017274353],"domain_scores_gemma":[0.9994509,0.00008748138,0.00010433112,0.00017385658,0.0000931563,0.00009022958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047289717,0.00006529575,0.00021268261,0.00010351179,0.00003819205,0.000005196584,0.00007009651,0.000056276236,0.000025837366],"category_scores_gemma":[0.00043290353,0.000044106873,0.00007556827,0.00020405829,0.00003240252,0.000033550845,0.000016010186,0.00008800789,0.0000055172013],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015186081,0.0009495511,0.10658627,0.0016592329,0.00002954038,0.0000055921446,0.00940884,0.00032961217,0.0075520035,0.018016018,0.10709555,0.7468492],"study_design_scores_gemma":[0.0045880917,0.0019636366,0.20191541,0.0025284726,0.00001544877,0.000046383775,0.00083052466,0.009564227,0.017613146,0.03373929,0.72683036,0.00036499515],"about_ca_topic_score_codex":0.0021732566,"about_ca_topic_score_gemma":0.000011899844,"teacher_disagreement_score":0.74648416,"about_ca_system_score_codex":0.00008609987,"about_ca_system_score_gemma":0.00066251436,"threshold_uncertainty_score":0.32853284},"labels":[],"label_agreement":null},{"id":"W2006311134","doi":"10.1016/j.jval.2013.03.983","title":"Designing a patient preferences survey on specialist referral for total joint replacement patient choice with alternative specifications of the status-quo","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Manitoba; BC Cancer Agency; Concordia Hospital; Dalhousie University; University of Calgary","funders":"","keywords":"Reputation; Referral; Status quo; Medicine; Waiting list; Health care; Patient choice; Family medicine; Operations management; Surgery; Economics; Political science","score_opus":0.3492325743885576,"score_gpt":0.4178022307521056,"score_spread":0.068569656363548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006311134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98548406,0.000081174454,0.00030836347,0.0018847866,0.0015508973,0.009217217,0.00068690535,0.00004054312,0.0007460233],"genre_scores_gemma":[0.99385977,0.000061339546,0.002711693,0.00075075694,0.0001145968,0.0022222167,0.00010109767,0.00004154401,0.00013696677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9924126,0.0034529355,0.0018036177,0.0005774778,0.0007527742,0.0010005449],"domain_scores_gemma":[0.9939367,0.002600314,0.0017465401,0.0007276778,0.00067963044,0.0003091179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011108838,0.00026958412,0.00049408624,0.00022257405,0.0008428802,0.00001366413,0.00019354449,0.00012233522,0.00021175704],"category_scores_gemma":[0.0013121082,0.00018477281,0.00006682489,0.00049369736,0.00010633557,0.000120676836,0.00009641065,0.00071360654,0.000034972094],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041192066,0.00020573492,0.96314913,0.00049619505,0.000028427363,1.5763167e-7,0.0179973,0.00800369,0.000028481587,0.0017745626,0.0045856135,0.0033187678],"study_design_scores_gemma":[0.0010609287,0.0024489989,0.9868921,0.0014840005,0.000004471616,4.1999195e-7,0.005100131,0.0010351875,0.00022856695,0.00062591984,0.00092827046,0.00019097651],"about_ca_topic_score_codex":0.16267489,"about_ca_topic_score_gemma":0.00847749,"teacher_disagreement_score":0.15419741,"about_ca_system_score_codex":0.0019920035,"about_ca_system_score_gemma":0.0015818162,"threshold_uncertainty_score":0.84290093},"labels":[],"label_agreement":null},{"id":"W2006347360","doi":"10.1016/j.jval.2013.08.597","title":"A Prospective Time and Motion Analysis Comparing Intravenous (IV) Vesus Subcutaneous (SC) Bortezomib in Patients with Multiple Myeloma (MM)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Bortezomib; Multiple myeloma; Premedication; Vial; Clinical trial; Surgery; Internal medicine","score_opus":0.017021210463844503,"score_gpt":0.2620738018861646,"score_spread":0.24505259142232008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006347360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969321,0.00015539974,0.000027358145,0.0002028041,0.000016697399,0.0024652143,0.000018043836,0.000036885423,0.00014549977],"genre_scores_gemma":[0.99852747,0.000035195786,0.0010589221,0.000043031865,0.000020588956,0.00009981071,0.00015180832,0.000023938957,0.000039206865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979585,0.00018103735,0.00042922044,0.0004535113,0.00039653337,0.0005812184],"domain_scores_gemma":[0.9989819,0.0001644583,0.00012500801,0.00027164194,0.000114630704,0.00034233936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002417961,0.00019256384,0.00063117896,0.000602929,0.000083544575,0.000033057437,0.000060368726,0.000069370784,0.000039818307],"category_scores_gemma":[0.0001528342,0.00015794727,0.000043087544,0.0008469108,0.0000666519,0.00011066926,0.000039086095,0.0002770196,0.000044372788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001030147,0.0008758839,0.98142856,0.00009295764,0.00021782766,0.00009371231,0.0009440429,0.0014645396,0.000017356977,0.000007105075,0.0000043504083,0.013823539],"study_design_scores_gemma":[0.0062192823,0.0015482833,0.8661572,0.0001670603,0.000044651893,0.000013577969,0.000053692867,0.12563026,0.000019207473,0.000037477555,0.0000017161988,0.0001076338],"about_ca_topic_score_codex":0.04308112,"about_ca_topic_score_gemma":0.0013421575,"teacher_disagreement_score":0.12416572,"about_ca_system_score_codex":0.00070631714,"about_ca_system_score_gemma":0.0001464449,"threshold_uncertainty_score":0.9632911},"labels":[],"label_agreement":null},{"id":"W2006395984","doi":"10.1016/s1098-3015(10)67196-3","title":"PR2 PERCEIVED UTILITY OF HEALTH STATES INDUCED BY CHRONIC HEPATITIS B: ESTIMATES FROM UNINFECTED PERSONS IN CANADA","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic hepatitis; Environmental health; Medicine; Virology; Gerontology","score_opus":0.23937722452857832,"score_gpt":0.3778678338727331,"score_spread":0.13849060934415477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006395984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9401003,0.009845677,0.00018179258,0.04615571,0.00027282196,0.0010349007,0.0022711027,0.000030738174,0.0001069462],"genre_scores_gemma":[0.9917262,0.0013825437,0.0015302065,0.0048401863,0.00007879464,0.00006739049,0.00031962837,0.000035659847,0.000019363082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913689,0.0011670581,0.005785804,0.0006822548,0.00015122844,0.00084475015],"domain_scores_gemma":[0.99499875,0.0015718626,0.0025655136,0.0005162816,0.00004074795,0.0003068291],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009881376,0.00025634535,0.001670836,0.00035323974,0.00013806343,0.000022809425,0.00028080336,0.00011752169,0.00051593524],"category_scores_gemma":[0.0013639488,0.0003502953,0.000061604034,0.00042204143,0.000054188484,0.00028974545,0.000041726787,0.0003779298,0.00006527709],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000010750163,0.00018455299,0.97234374,0.00085352577,0.000028602824,6.2674735e-7,0.006440734,0.0065268744,0.0000051654897,0.00083111407,0.0109268,0.0018475325],"study_design_scores_gemma":[0.00097281206,0.00013073545,0.76627153,0.000380052,0.0000010455508,6.6031794e-7,0.0008570107,0.22622485,0.0000069192893,0.0011951113,0.003712544,0.0002467456],"about_ca_topic_score_codex":0.9984568,"about_ca_topic_score_gemma":0.9793486,"teacher_disagreement_score":0.21969797,"about_ca_system_score_codex":0.010219126,"about_ca_system_score_gemma":0.008329585,"threshold_uncertainty_score":0.9998949},"labels":[],"label_agreement":null},{"id":"W2006608952","doi":"10.1016/j.jval.2010.09.004","title":"Cost-Utility of Laparoscopic Nissen Fundoplication versus Proton Pump Inhibitors for Chronic and Controlled Gastroesophageal Reflux Disease: A 3-Year Prospective Randomized Controlled Trial and Economic Evaluation","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Toronto; Population Health Research Institute; McMaster University; Hospital for Sick Children; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"Canadian Institutes of Health Research","keywords":"Medicine; GERD; Randomized controlled trial; Cost–utility analysis; Heartburn; Quality of life (healthcare); Nissen fundoplication; Quality-adjusted life year; Physical therapy; Cost effectiveness; Reflux; Economic evaluation; Internal medicine; Disease","score_opus":0.06775329233822375,"score_gpt":0.3586556570420004,"score_spread":0.2909023647037767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006608952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9251676,0.0013093286,0.000052917712,0.0001471667,0.0002538073,0.07288642,0.00004042078,0.00002461946,0.000117708456],"genre_scores_gemma":[0.9824129,0.00019530082,0.00034940962,0.000015047467,0.00014663968,0.016772496,0.000055518467,0.000022359683,0.000030373429],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99703103,0.00075089553,0.0011134585,0.0004933773,0.0002625931,0.00034864267],"domain_scores_gemma":[0.9979844,0.00067589467,0.00065707735,0.00027064726,0.00012855078,0.00028342998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003401156,0.00024598915,0.0019643037,0.00017917808,0.00008843281,0.000014729898,0.00004566505,0.00008635559,0.000041550364],"category_scores_gemma":[0.0011029125,0.00018595948,0.00021021278,0.00006952837,0.00017792002,0.00010558369,0.00002198517,0.00013087205,0.0000021353824],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.96454674,0.00043715845,0.033008743,0.00048524124,0.0002754492,0.00000277222,0.00031787102,0.000014001251,0.000009820806,0.0003585584,0.0000036474942,0.0005400066],"study_design_scores_gemma":[0.93683684,0.003787607,0.039129898,0.000121434394,0.0005517921,0.0000015026878,0.000029359302,0.018264921,0.00021950212,0.0010008923,0.000001364383,0.00005489979],"about_ca_topic_score_codex":0.0003074477,"about_ca_topic_score_gemma":0.000019597468,"teacher_disagreement_score":0.057245247,"about_ca_system_score_codex":0.00057241163,"about_ca_system_score_gemma":0.0011503588,"threshold_uncertainty_score":0.7583207},"labels":[],"label_agreement":null},{"id":"W2006764012","doi":"10.1016/j.jval.2012.03.1044","title":"PIH12 Budget Impact Analysis of Adding a New Fixed-Dose Combination Therapy of Dutasteride and Tamsulosin to the Treatment of Symptomatic Benign Prostatic Hyperplasia in Quebec, Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Tamsulosin; Dutasteride; Doxazosin; Medicine; Urology; Alfuzosin; Population; Fixed-dose combination; Internal medicine; Hyperplasia; Prostate; Lower urinary tract symptoms","score_opus":0.17197680642209104,"score_gpt":0.3917688298033008,"score_spread":0.21979202338120976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006764012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987092,0.0038805844,0.000086915905,0.007027996,0.00009392577,0.0015130368,0.00027864263,0.000003212498,0.000023697263],"genre_scores_gemma":[0.99817985,0.0004991269,0.00059128663,0.00055351,0.000023366294,0.000074764495,0.000028499371,0.000013177483,0.000036425776],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99570805,0.00053219177,0.003114652,0.00021334231,0.000105599705,0.00032619495],"domain_scores_gemma":[0.99641377,0.0012090283,0.0018421356,0.00032904165,0.000029774339,0.00017622765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005003229,0.00014412204,0.001206513,0.0007204378,0.000037865237,0.000011029478,0.00011077351,0.000045939,0.00003780237],"category_scores_gemma":[0.00045941726,0.00013263457,0.00007802188,0.0007890483,0.000026216225,0.00017055398,0.000012058153,0.000050957282,0.0000025920099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054067143,0.00044038394,0.93954957,0.0004615737,0.00023544594,1.7551467e-7,0.031210454,0.020579081,0.0000080522195,0.005000789,0.00046708895,0.0019933258],"study_design_scores_gemma":[0.0013163062,0.0004448522,0.9648496,0.00022819123,0.000015830332,7.4252426e-7,0.0016237295,0.030285008,0.000023097144,0.00027926106,0.00080762507,0.00012578716],"about_ca_topic_score_codex":0.96069247,"about_ca_topic_score_gemma":0.75154555,"teacher_disagreement_score":0.20914689,"about_ca_system_score_codex":0.0016576241,"about_ca_system_score_gemma":0.00091104244,"threshold_uncertainty_score":0.5408681},"labels":[],"label_agreement":null},{"id":"W2006914242","doi":"10.1016/j.jval.2012.03.348","title":"PMD8 Efficacy of Systemic Hyperbaric Oxygen Therapy for Non-Healing Diabetic Ulcers of the Lower Limb: Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetic Foot Ulcer Assessment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Amputation; Observational study; Randomized controlled trial; Diabetes mellitus; Diabetic foot; Relative risk; Cochrane Library; Hyperbaric oxygen; MEDLINE; Meta-analysis; Systematic review; Clinical trial; Internal medicine; Surgery; Confidence interval","score_opus":0.06908462568192623,"score_gpt":0.34239596643679754,"score_spread":0.2733113407548713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2006914242","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39422923,0.57549065,0.00062504533,0.008175211,0.00034890222,0.020801185,0.000033915774,0.00003145211,0.00026442172],"genre_scores_gemma":[0.9910045,0.0065279105,0.00052397855,0.0014095305,0.000019360998,0.00032191386,0.0000054084485,0.000021376878,0.00016601874],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9975596,0.0003758617,0.0011658431,0.0002096378,0.00034679528,0.0003422387],"domain_scores_gemma":[0.99804384,0.00046974904,0.00064617116,0.00063976564,0.00008301968,0.00011744032],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033959746,0.00018031911,0.0024386586,0.00022054689,0.0000396776,0.00000585099,0.00015782272,0.000046289268,0.0000249731],"category_scores_gemma":[0.0001693733,0.00010288845,0.0006563234,0.0007439318,0.00004543432,0.000043278007,0.00004324519,0.000093965886,0.0000013182838],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007525619,0.0010886855,0.004725033,0.94645935,0.04437484,4.0553672e-7,0.001413646,0.00048164808,0.00010414891,0.000794773,0.0003623373,0.00011988941],"study_design_scores_gemma":[0.0058344053,0.0031077843,0.04058107,0.050380986,0.8922477,0.0000134642705,0.0014041286,0.0051321303,0.00029082783,0.00011535065,0.00023993527,0.0006522382],"about_ca_topic_score_codex":0.00028286886,"about_ca_topic_score_gemma":0.0000029255789,"teacher_disagreement_score":0.89607835,"about_ca_system_score_codex":0.000102435784,"about_ca_system_score_gemma":0.00011076199,"threshold_uncertainty_score":0.41956693},"labels":[],"label_agreement":null},{"id":"W2007128909","doi":"10.1016/j.jval.2013.03.1151","title":"Effect Of Certolizumab Pegol On The Multiple Facets Of Psoriatic Arthritis As Reported By Patients: 24-Week Patient Reported Outcome Results Of A Phase 3 Double Blind Randomized Placebo-Controlled Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Psoriatic arthritis; Dermatology Life Quality Index; Placebo; Internal medicine; Randomized controlled trial; Quality of life (healthcare); Psoriasis; Physical therapy; Arthritis; Etanercept; Rheumatoid arthritis; Dermatology","score_opus":0.04403238897080384,"score_gpt":0.3055460466635542,"score_spread":0.26151365769275037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007128909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811781,0.0012645829,0.0000025106287,0.00023200783,0.00074874226,0.016259175,0.00016550219,0.000029702564,0.0001196898],"genre_scores_gemma":[0.99787265,0.00015676997,0.000015826476,0.000020271378,0.000008121718,0.0015181049,0.0002450309,0.00002656787,0.000136679],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9900194,0.0050097327,0.0037936016,0.0005059039,0.00022615868,0.00044519687],"domain_scores_gemma":[0.99009955,0.005319886,0.0034581085,0.00081725453,0.00024801856,0.00005720273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023700346,0.00038125922,0.002579367,0.00028687654,0.000117965305,0.000007775884,0.00019948873,0.00021533607,0.00009805411],"category_scores_gemma":[0.004517693,0.00023309543,0.00038522773,0.00032548344,0.00016431932,0.00006655166,0.000050742914,0.00024569425,0.000024981648],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9571363,0.009993199,0.008999869,0.00016209736,0.001890497,0.000030039342,0.004845524,0.000086332504,0.0022983605,0.000013983708,0.00046666336,0.014077157],"study_design_scores_gemma":[0.9563799,0.01554159,0.000889223,0.00026860583,0.00033829283,0.00002378196,0.0004203863,0.00014066609,0.025762716,0.00002748693,0.00002713032,0.00018024218],"about_ca_topic_score_codex":0.020043124,"about_ca_topic_score_gemma":0.00008918624,"teacher_disagreement_score":0.023464356,"about_ca_system_score_codex":0.00010369443,"about_ca_system_score_gemma":0.00017645782,"threshold_uncertainty_score":0.9864825},"labels":[],"label_agreement":null},{"id":"W2007252444","doi":"10.1016/s1098-3015(10)62293-0","title":"PNL20 UTILIZATION OF IMMUNOMODULATORY DRUG THERAPIES IN MULTIPLE SCLEROSIS (MS) IN NOVA SCOTIA, CANADA 1998—2003","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nova scotia; Multiple sclerosis; Nova (rocket); Drug; Medicine; Pharmacology; Geography; Psychiatry; Engineering; Archaeology; Aeronautics","score_opus":0.10492736208862953,"score_gpt":0.3177903009562386,"score_spread":0.2128629388676091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007252444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99128205,0.0063851466,0.000020611582,0.0013932881,0.0002180713,0.0005731138,0.000008510739,0.000009732264,0.0001095035],"genre_scores_gemma":[0.99840474,0.0010293837,0.00020716609,0.000265931,0.000014888242,0.000012114232,0.000017364573,0.000015065977,0.000033356704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985445,0.00019201882,0.00053438806,0.00019271726,0.00018972573,0.00034662764],"domain_scores_gemma":[0.99949336,0.00006033324,0.00008737074,0.0002409109,0.00006594751,0.00005206896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006954603,0.00010234718,0.00032387814,0.00044029937,0.000041010935,0.000004314724,0.00007557514,0.00007248077,0.000027464608],"category_scores_gemma":[0.00018038551,0.00009875497,0.000023216562,0.0011749795,0.00009116451,0.00008134292,0.000025288513,0.0003682268,0.000006238518],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017342783,0.00060269795,0.9733295,0.00030550885,0.000022356764,0.000011900739,0.002283288,0.012554882,0.004164242,0.0002863615,0.00013363556,0.0061322255],"study_design_scores_gemma":[0.0034040753,0.00025542683,0.9898428,0.00092457276,0.0000017291708,0.0000052366627,0.00078582,0.002070257,0.002167028,0.000078528195,0.00037740942,0.00008715504],"about_ca_topic_score_codex":0.98344076,"about_ca_topic_score_gemma":0.9221272,"teacher_disagreement_score":0.061313592,"about_ca_system_score_codex":0.0011315239,"about_ca_system_score_gemma":0.0025846679,"threshold_uncertainty_score":0.45850897},"labels":[],"label_agreement":null},{"id":"W2007354604","doi":"10.1016/j.jval.2014.03.1279","title":"Antidepressant adherence in older adults and different quality of life outcome measures","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health Treatment and Access","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Quality of life (healthcare); Anxiety; Medicine; Depression (economics); Mental health; Antidepressant; Polypharmacy; Psychiatry; Visual analogue scale; Population; Clinical psychology; Gerontology; Psychology; Physical therapy; Internal medicine","score_opus":0.15862155233194938,"score_gpt":0.43420717676112586,"score_spread":0.27558562442917645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007354604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568653,0.002162827,0.00003245851,0.0005684452,0.00035293162,0.0006942582,0.000012121365,0.00001600797,0.00047440728],"genre_scores_gemma":[0.9991939,0.00015916249,0.00005861185,0.00043215585,0.000032889187,0.00005886804,0.0000053387057,0.000010393259,0.000048651196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714726,0.0009841616,0.00097354536,0.0003338794,0.00019910422,0.00036207546],"domain_scores_gemma":[0.99886024,0.00038859303,0.00028967753,0.00027809938,0.000016449325,0.00016696683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012632592,0.00013979306,0.00051752647,0.00012776158,0.00004284032,0.000006385303,0.00012315139,0.00007906533,0.00008468379],"category_scores_gemma":[0.00010610015,0.00011124979,0.000029909228,0.00012421125,0.000047613263,0.000045006578,0.000038408914,0.00016928313,0.000009477817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023711273,0.00047969908,0.97027254,0.0008004893,0.0000049232917,0.0000012072364,0.0021348135,0.00000789825,0.0000027307292,0.002402517,0.000036346715,0.023619713],"study_design_scores_gemma":[0.0031013929,0.00022220411,0.9952896,0.0003701273,0.0000014136396,6.28589e-7,0.00031302634,0.00021834155,0.000014648568,0.000357677,0.000021331318,0.00008960663],"about_ca_topic_score_codex":0.050607692,"about_ca_topic_score_gemma":0.0020433539,"teacher_disagreement_score":0.04856434,"about_ca_system_score_codex":0.00006138445,"about_ca_system_score_gemma":0.000025610027,"threshold_uncertainty_score":0.9557144},"labels":[],"label_agreement":null},{"id":"W2007554762","doi":"10.1016/j.jval.2014.03.415","title":"Have New Therapies Changed the Face of Metastatic Castrate-Resistant Prostate Cancer Treatment in Canada?","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Enzalutamide; Cabazitaxel; Docetaxel; Medicine; Prostate cancer; Abiraterone acetate; Denosumab; Oncology; Internal medicine; Abiraterone; Ketoconazole; Zoledronic acid; Prednisone; Taxane; Regimen; Chemotherapy; Cancer; Androgen deprivation therapy; Androgen receptor; Breast cancer; Dermatology","score_opus":0.09755681097515691,"score_gpt":0.3626020282345248,"score_spread":0.2650452172593679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007554762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.950034,0.015236761,0.0000050301387,0.032676753,0.0000841457,0.0017743283,0.00006001149,0.0000068782956,0.00012208137],"genre_scores_gemma":[0.9935604,0.00464333,0.00009100663,0.0003046317,0.000036398586,0.00016978278,0.000013725947,0.000017127955,0.0011636388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836946,0.00029033347,0.00037351862,0.00020628466,0.00031192068,0.0004484653],"domain_scores_gemma":[0.999273,0.00017132802,0.00011868934,0.0002391161,0.000034856796,0.00016300152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044147845,0.0001486348,0.00042104148,0.0001039041,0.000047932266,0.0000071749632,0.00007376341,0.00001851806,0.000038847804],"category_scores_gemma":[0.000024520925,0.00008212627,0.00003470537,0.00024556532,0.000050966846,0.00002552019,0.000012497719,0.00013591076,0.0000011546186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0053553684,0.0010392191,0.67760104,0.0029018177,0.00068104,0.0003166565,0.09313271,0.0134748705,0.002471044,0.000580339,0.0021515223,0.20029439],"study_design_scores_gemma":[0.028575076,0.007346264,0.8735283,0.0031940385,0.00014615056,0.000028678533,0.028031198,0.01972032,0.01431675,0.0010840679,0.023450302,0.00057882466],"about_ca_topic_score_codex":0.99248827,"about_ca_topic_score_gemma":0.9685837,"teacher_disagreement_score":0.19971557,"about_ca_system_score_codex":0.002164824,"about_ca_system_score_gemma":0.0077153356,"threshold_uncertainty_score":0.99791},"labels":[],"label_agreement":null},{"id":"W2007566316","doi":"10.1016/s1098-3015(10)62659-9","title":"PCV18 USE OF β-BLOCKERS FOR TREATING HEART FAILURE AMONG THE ELDERLY IN BRITISH COLUMBIA, CANADA, 1993-2001","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Heart failure; Medicine; Gerontology; Internal medicine","score_opus":0.05280241733596275,"score_gpt":0.362250066577057,"score_spread":0.30944764924109425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007566316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.971964,0.0009830497,0.0000066917432,0.022554265,0.0005065035,0.0035677867,0.000304929,0.0000436303,0.00006914535],"genre_scores_gemma":[0.9869306,0.000116867246,0.0068846503,0.0043683057,0.00030839487,0.00032840433,0.00003416199,0.00005082958,0.0009777526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99451524,0.0013835143,0.0016936262,0.00042900568,0.00044693754,0.001531647],"domain_scores_gemma":[0.995859,0.0026264978,0.0005240172,0.00044631635,0.00020026832,0.00034386825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002425498,0.000164322,0.00066163874,0.00009394156,0.00068823766,0.000033231798,0.0002547379,0.00023808423,0.00009463154],"category_scores_gemma":[0.0010431145,0.00021243113,0.00007007276,0.00060828554,0.00009122986,0.00018517775,0.00006243681,0.0008175099,0.000007746105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017922352,0.000056191475,0.70168686,0.00075025385,0.0000047443045,0.000004562437,0.0014269125,0.00092407246,0.000001678749,0.000028056105,0.29219902,0.002899715],"study_design_scores_gemma":[0.0016244015,0.00034912175,0.73315203,0.0033011546,0.0000063907537,0.0000070276005,0.0070797615,0.0038898478,0.0000025414267,0.0001195104,0.25024375,0.00022444727],"about_ca_topic_score_codex":0.99935704,"about_ca_topic_score_gemma":0.9998919,"teacher_disagreement_score":0.04195525,"about_ca_system_score_codex":0.0025920875,"about_ca_system_score_gemma":0.005669573,"threshold_uncertainty_score":0.99996734},"labels":[],"label_agreement":null},{"id":"W2007708250","doi":"10.1016/j.jval.2011.08.771","title":"PCV50 Hospital Costs Associated with Atrial Fibrillation in Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); University of Toronto; McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Atrial fibrillation; Emergency medicine; Ambulatory; Healthcare Cost and Utilization Project; Emergency department; Hospital admission; Medical emergency; Pediatrics; Health care; Internal medicine","score_opus":0.3089192706438901,"score_gpt":0.3535026320569011,"score_spread":0.044583361413011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007708250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864785,0.0014265203,0.00007875773,0.008712037,0.0007973293,0.0009789472,0.00017131698,0.000023556644,0.0013329991],"genre_scores_gemma":[0.99703187,0.00012468867,0.0007040569,0.0018365713,0.0001733901,0.000013680164,0.00004005119,0.000027690721,0.000048027832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951238,0.0005518132,0.0032132112,0.00044420955,0.00011491724,0.0005520664],"domain_scores_gemma":[0.9969245,0.00075701403,0.0018068266,0.00028723985,0.000034322755,0.00019010378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009896429,0.00015670565,0.0008127498,0.00030404015,0.00007912856,0.000017941362,0.00015378035,0.00009773659,0.0001375541],"category_scores_gemma":[0.002270648,0.0001985227,0.000047980226,0.00039172257,0.000024664045,0.00026677691,0.000021286656,0.00020060777,0.00010870579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022897022,0.000023419454,0.98036885,0.00008059823,0.000016910015,0.0000032836322,0.0021798036,0.004479075,1.5706998e-8,0.011698403,0.0009862062,0.0001405536],"study_design_scores_gemma":[0.0016585774,0.00022738345,0.97343177,0.00030045112,0.000001313563,0.0000015681023,0.0008720431,0.01863178,5.936365e-7,0.0028863926,0.0016850597,0.00030307207],"about_ca_topic_score_codex":0.9852379,"about_ca_topic_score_gemma":0.92499864,"teacher_disagreement_score":0.060239226,"about_ca_system_score_codex":0.008662128,"about_ca_system_score_gemma":0.0030338448,"threshold_uncertainty_score":0.9951434},"labels":[],"label_agreement":null},{"id":"W2007726673","doi":"10.1016/j.jval.2013.08.1167","title":"Economic Evaluation of Ranibuzumab for the Treatment of Myopic Choroidal Neovascularization in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Ranibizumab; Medicine; Cost effectiveness; Quality-adjusted life year; Quality of life (healthcare); Cohort; Optometry; Demography; Bevacizumab; Surgery; Nursing","score_opus":0.0442521457096476,"score_gpt":0.31507671043253466,"score_spread":0.2708245647228871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007726673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99440217,0.0024746757,0.000019590609,0.0007395227,0.000074472715,0.002238622,0.000016143886,0.0000011970803,0.00003359297],"genre_scores_gemma":[0.99893415,0.0006730193,0.000085702755,0.000032267893,0.000019070016,0.00020238594,0.00003603928,0.0000056457116,0.000011698581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992711,0.000078786106,0.0003043885,0.00009359193,0.0001458205,0.000106320214],"domain_scores_gemma":[0.99956733,0.000094803305,0.00010675413,0.00014284127,0.000049008788,0.000039282182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019931827,0.000055175748,0.0001950165,0.000043822547,0.0000143470315,0.0000015979957,0.000023643794,0.000015100266,0.000047714308],"category_scores_gemma":[0.00002421181,0.000036810736,0.000045263554,0.000053563672,0.000008745021,0.000020484535,0.000001972401,0.000014621992,0.000001138871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023552804,0.0005574057,0.7845513,0.00038511565,0.00013787262,9.3499295e-7,0.0005709592,0.083151296,0.000028936025,0.00038316767,0.00007071492,0.12992673],"study_design_scores_gemma":[0.0041480847,0.0005122329,0.8265535,0.00007215818,0.00006202743,7.3541577e-7,0.0001264098,0.1680391,0.0000926045,0.0003157021,0.00005501749,0.000022408612],"about_ca_topic_score_codex":0.9721524,"about_ca_topic_score_gemma":0.4386217,"teacher_disagreement_score":0.5335307,"about_ca_system_score_codex":0.0020378102,"about_ca_system_score_gemma":0.0024475777,"threshold_uncertainty_score":0.57162195},"labels":[],"label_agreement":null},{"id":"W2007759454","doi":"10.1016/j.jval.2011.02.324","title":"PSS22 SYSTEMATIC REVIEW OF THE QUALITY OF LIFE LITERATURE IN CHILDREN WITH ATOPIC DERMATITIS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PharmIdeas (Canada)","funders":"","keywords":"Atopic dermatitis; Quality of life (healthcare); Medicine; Dermatology Life Quality Index; MEDLINE; Population; Family medicine; Pediatrics; Dermatology; Environmental health","score_opus":0.04034031361524508,"score_gpt":0.3146911391873157,"score_spread":0.27435082557207063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007759454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82489777,0.17200425,0.00000312675,0.0012300375,0.00003234588,0.0015028828,0.0000189425,0.000007527403,0.00030309233],"genre_scores_gemma":[0.9911082,0.0053875684,0.00012183062,0.0033218425,0.0000059405697,0.000030619376,0.0000069690363,0.0000051345614,0.000011941154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778134,0.0009089694,0.0009073845,0.00009959368,0.00018071156,0.00012198417],"domain_scores_gemma":[0.9989554,0.00010235398,0.00043174965,0.00039062585,0.000054886812,0.000064939195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000785739,0.00008030627,0.00089792156,0.00006664331,0.000014192276,0.0000011029904,0.000107692336,0.000050667204,0.000019239887],"category_scores_gemma":[0.00076836534,0.0000436042,0.000072893046,0.00033019105,0.00006318704,0.00003299752,0.000017392684,0.00015262797,0.0000015032948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005971818,0.00010067856,0.64472485,0.35372642,0.000023567538,0.0000020208163,0.0006931038,6.369627e-7,1.1827015e-7,0.000556028,0.00015999633,0.000006633875],"study_design_scores_gemma":[0.00036692456,0.000030116405,0.76281434,0.23647936,0.000032485914,0.000054545835,0.00003374748,0.000006366755,0.0000111325935,0.0001411442,0.0000013460397,0.00002848909],"about_ca_topic_score_codex":0.0010132936,"about_ca_topic_score_gemma":0.000039346647,"teacher_disagreement_score":0.1666167,"about_ca_system_score_codex":0.000024745223,"about_ca_system_score_gemma":0.0003144994,"threshold_uncertainty_score":0.17781276},"labels":[],"label_agreement":null},{"id":"W2008044647","doi":"10.1016/j.jval.2011.02.716","title":"PMS31 TITLE: THE RELATIVE COST-EFFECTIVENESS OF THE MOST COMMON NON-SURGICAL TREATMENTS FOR NECK PAIN","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health; Public Health Ontario; University of Toronto; Toronto Public Health","funders":"","keywords":"Medicine; Neck pain; Adverse effect; Incremental cost-effectiveness ratio; Cost effectiveness; Willingness to pay; Quality-adjusted life year; Economic evaluation; Population; Cost–benefit analysis; Quality of life (healthcare); Physical therapy; Internal medicine; Alternative medicine; Environmental health","score_opus":0.09779977955075692,"score_gpt":0.3682265488186903,"score_spread":0.2704267692679334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008044647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9392463,0.0012223345,0.00050594663,0.0016333604,0.0006382028,0.0039399746,0.000043009975,0.000020552798,0.05275032],"genre_scores_gemma":[0.99857956,0.00007979245,0.00021464391,0.00026786202,0.000028613511,0.00010586,0.000007674782,0.000009545515,0.00070642075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992456,0.00032400095,0.00016672151,0.00008405459,0.000054421314,0.00012524074],"domain_scores_gemma":[0.99958533,0.00013738991,0.000062964784,0.00016105303,0.000022889537,0.000030365585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006878522,0.000053840085,0.00016532729,0.000018220691,0.000045277488,0.0000010269574,0.000060776434,0.00004382361,0.00003236763],"category_scores_gemma":[0.00011408357,0.000026978885,0.000060168935,0.00009008245,0.00005401601,0.00001373282,0.000017286156,0.0000915959,0.000015178936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002855047,0.0035951687,0.52253985,0.0024443115,0.00065949303,0.000118129145,0.007741182,0.00005012718,0.0006806709,0.15940891,0.042048126,0.257859],"study_design_scores_gemma":[0.0035948672,0.0032708477,0.970404,0.00097412296,0.000043402575,0.00002942827,0.00013549578,0.0040007755,0.0014159138,0.0050519397,0.010993523,0.00008564156],"about_ca_topic_score_codex":0.0008197932,"about_ca_topic_score_gemma":0.000018036284,"teacher_disagreement_score":0.4478642,"about_ca_system_score_codex":0.000073857045,"about_ca_system_score_gemma":0.00008150712,"threshold_uncertainty_score":0.12392876},"labels":[],"label_agreement":null},{"id":"W2008076313","doi":"10.1016/j.jval.2012.03.739","title":"PGI12 The Impact of TNF Inhibitors for Crohn'S Disease on Health Care Resource Utilization: an Analysis Using the Ramq Database","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); Western University; Université de Montréal","funders":"","keywords":"Medicine; Infliximab; Adalimumab; Medical prescription; Health care; Internal medicine; Population; Prednisone; Cohort; Disease; Crohn's disease; Retrospective cohort study; Physical therapy; Pharmacology; Environmental health","score_opus":0.05615533555198375,"score_gpt":0.371480929344842,"score_spread":0.31532559379285824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008076313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99427617,0.0029947974,0.0007930576,0.00032568327,0.00007980927,0.00090804085,0.0006026402,0.000007858483,0.000011932364],"genre_scores_gemma":[0.9978421,0.00007082098,0.00017311433,0.00071530713,0.00034771982,0.000033390163,0.0007843732,0.000026128326,0.0000070753154],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99793196,0.00075852947,0.00040650595,0.0002712606,0.00019003738,0.0004416927],"domain_scores_gemma":[0.99835324,0.00005463029,0.00028898095,0.0008736688,0.00007600628,0.00035344376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001144134,0.00016345849,0.00019668876,0.00010316896,0.00030575995,0.000017843155,0.00022553217,0.000046361838,0.0000066252096],"category_scores_gemma":[0.0001806606,0.00010422256,0.0002227251,0.000310186,0.00009198339,0.0000118219805,0.00006292981,0.00009373355,5.0674595e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037216723,0.00095457706,0.3661248,0.001148951,0.0004510251,0.000016199243,0.007076041,0.60983765,0.0006130284,0.0011933164,0.0038992146,0.0049635237],"study_design_scores_gemma":[0.0014662443,0.0006182973,0.9347259,0.0001783764,0.000233906,0.0000031576083,0.003908708,0.053187322,0.0006318791,0.000037749283,0.0045775636,0.00043090372],"about_ca_topic_score_codex":0.0015149206,"about_ca_topic_score_gemma":0.00014164341,"teacher_disagreement_score":0.5686011,"about_ca_system_score_codex":0.0001698174,"about_ca_system_score_gemma":0.0008901557,"threshold_uncertainty_score":0.42500728},"labels":[],"label_agreement":null},{"id":"W2008220621","doi":"10.1016/j.jval.2012.03.725","title":"PCV122 An Assessment of the Modified Rankin Scale As a Stroke Outcome Measure in Economic Analyses of Acute Ischemic Stroke Outcomes","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Modified Rankin Scale; Medicine; Reliability (semiconductor); Stroke (engine); Physical therapy; Face validity; Scale (ratio); Measure (data warehouse); Physical medicine and rehabilitation; Psychometrics; Ischemic stroke; Clinical psychology; Computer science; Data mining; Psychiatry; Ischemia","score_opus":0.09426771280421589,"score_gpt":0.41603464618201474,"score_spread":0.3217669333777988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008220621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899568,0.00032993103,0.00018775158,0.0019259229,0.00030075174,0.0011742234,0.0001299638,0.000022953634,0.0059716795],"genre_scores_gemma":[0.99569005,0.00008368207,0.0028635364,0.0005363883,0.00006386939,0.000050187035,0.00001896388,0.000034763198,0.0006585877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996642,0.00033417254,0.0014533666,0.000355607,0.000601531,0.0006133204],"domain_scores_gemma":[0.9979605,0.00015584519,0.00066616584,0.0009608847,0.000044992583,0.00021163178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020233453,0.0002808984,0.0011565088,0.0004249626,0.00003616422,0.000006952791,0.00039749133,0.00013114954,0.00006508492],"category_scores_gemma":[0.00007936601,0.00020719698,0.00026973672,0.0002863351,0.00010759067,0.00017351261,0.00018530215,0.00046073776,0.0000056003423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011380662,0.00048951595,0.9822841,0.00032322496,0.00029160024,0.0000023537987,0.00060000113,0.002041238,0.012599028,0.00030178597,0.0003497743,0.00060351496],"study_design_scores_gemma":[0.004594714,0.00028608425,0.97246194,0.00026987665,0.00029627202,0.000012218156,0.0008236124,0.0066443165,0.014103893,0.00001635861,0.0002829257,0.0002077835],"about_ca_topic_score_codex":0.007956973,"about_ca_topic_score_gemma":0.00013822863,"teacher_disagreement_score":0.009822212,"about_ca_system_score_codex":0.00088292465,"about_ca_system_score_gemma":0.00050221774,"threshold_uncertainty_score":0.9986491},"labels":[],"label_agreement":null},{"id":"W2008422538","doi":"10.1016/j.jval.2012.08.1386","title":"PMS31 Economic Evaluation of Adalimumab Versus Other Biologic Treatments for Moderate to Severe Psoriatic Arthritis in Italy","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"","keywords":"Golimumab; Adalimumab; Medicine; Etanercept; Psoriatic arthritis; Infliximab; Internal medicine; Psoriasis; Physical therapy; Arthritis; Rheumatoid arthritis; Dermatology","score_opus":0.5709032516440831,"score_gpt":0.47133191755514803,"score_spread":0.09957133408893504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008422538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97861755,0.0070729954,0.00043801172,0.007981107,0.001536338,0.003156014,0.0005534119,0.000019672107,0.0006249209],"genre_scores_gemma":[0.9936269,0.0003100942,0.0033554928,0.0015990137,0.00024768105,0.0007204244,0.00004187041,0.00003730962,0.00006124509],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99392194,0.00082162715,0.0039927806,0.00048758162,0.00009853471,0.00067753973],"domain_scores_gemma":[0.99669254,0.0010486594,0.0015981244,0.0004032515,0.000045964673,0.0002114334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.027594185,0.00020508176,0.0011363339,0.0005928764,0.0000750473,0.000021108832,0.00016835539,0.00014951384,0.00017156759],"category_scores_gemma":[0.0017753952,0.0002620181,0.00010095689,0.00019119018,0.000017335084,0.00039286754,0.000027065133,0.000094767405,0.000446835],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014073915,0.0016118784,0.29795304,0.0016629458,0.00038849583,3.7449718e-7,0.023333536,0.49007967,0.0000051577704,0.15274009,0.0065688477,0.024248568],"study_design_scores_gemma":[0.052811928,0.0030797715,0.18918663,0.001489815,0.00005656112,0.0000073109763,0.0039126873,0.62811744,0.000054232598,0.10297191,0.016397387,0.0019143466],"about_ca_topic_score_codex":0.019677155,"about_ca_topic_score_gemma":0.0022408743,"teacher_disagreement_score":0.13803776,"about_ca_system_score_codex":0.006217681,"about_ca_system_score_gemma":0.0005308279,"threshold_uncertainty_score":0.9999832},"labels":[],"label_agreement":null},{"id":"W2008583396","doi":"10.1016/j.jval.2012.03.1378","title":"MO1 New Concepts in Discrete Choice Preference Measurement: An Application to Drug Treatment for Juvenile Idiopathic Arthritis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; BC Cancer Agency","funders":"","keywords":"Willingness to pay; Population; Mixed logit; Face validity; Statistics; Discrete choice; Econometrics; Medicine; Logistic regression; Mathematics; Psychometrics; Economics; Environmental health","score_opus":0.377698079506034,"score_gpt":0.5160363231796056,"score_spread":0.13833824367357156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008583396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9221938,0.033787977,0.004814178,0.028883735,0.0024679047,0.006862328,0.0001385678,0.00015674904,0.0006947092],"genre_scores_gemma":[0.99126446,0.0017753209,0.00048687775,0.0048538027,0.0006540709,0.0007812092,0.000026268897,0.000019373048,0.0001386013],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99688053,0.0011565649,0.0006320971,0.0003550357,0.00023126349,0.00074448204],"domain_scores_gemma":[0.9981054,0.000483213,0.0002211136,0.00019940383,0.000041838008,0.0009490076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004088369,0.00019339997,0.0003716357,0.00011298796,0.00014717576,0.000011529812,0.00020009457,0.00013558425,0.00007895999],"category_scores_gemma":[0.00044794526,0.00018556831,0.000043747485,0.00023722902,0.000040668987,0.00040231022,0.000027727838,0.00047493924,0.000059436807],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001527521,0.0032763572,0.046782263,0.00058187166,0.00006964998,0.000006282405,0.02418656,0.008791167,0.008780902,0.0044737007,0.004546531,0.8969772],"study_design_scores_gemma":[0.0076553924,0.00081124477,0.008473717,0.00028647314,0.0000432448,0.000008088128,0.00029872236,0.011990284,0.010413809,0.0011810671,0.9584672,0.00037074363],"about_ca_topic_score_codex":0.0076354514,"about_ca_topic_score_gemma":0.0020458011,"teacher_disagreement_score":0.95392066,"about_ca_system_score_codex":0.0007009478,"about_ca_system_score_gemma":0.00061878545,"threshold_uncertainty_score":0.9989728},"labels":[],"label_agreement":null},{"id":"W2008651219","doi":"10.1046/j.1524-4733.2003.00213.x","title":"Oseltamivir for Treatment of Influenza in Healthy Adults: Pooled Trial Evidence and Cost-Effectiveness Model for Canada","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph's Hospital","funders":"","keywords":"Oseltamivir; Medicine; Formulary; Neuraminidase inhibitor; Confidence interval; Randomized controlled trial; Quality-adjusted life year; Emergency medicine; Internal medicine; Placebo; Pediatrics; Cost effectiveness; Intensive care medicine; Family medicine; Coronavirus disease 2019 (COVID-19); Disease","score_opus":0.2790570195396019,"score_gpt":0.4654737312966299,"score_spread":0.186416711757028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008651219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97164214,0.010926957,0.00047089855,0.00076409365,0.00011512272,0.015905846,0.00015183976,0.000009703109,0.000013413482],"genre_scores_gemma":[0.99119204,0.0022487424,0.0017448273,0.0009214646,0.000042973727,0.0038025426,0.000006122795,0.00002602151,0.000015268979],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99756724,0.00041047123,0.00073041196,0.0003780897,0.00029224582,0.00062153017],"domain_scores_gemma":[0.99636406,0.0028345415,0.00016621292,0.00023101605,0.00019717493,0.00020699862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017995739,0.00018881675,0.0008362543,0.00021048848,0.00009161432,0.000004890767,0.000053917865,0.00007288709,0.0000010456346],"category_scores_gemma":[0.0031651447,0.00016014327,0.000058894184,0.00025701796,0.000062244915,0.00006955141,0.0000134219,0.00008887301,1.4597502e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7818924,0.002715876,0.087269746,0.021810677,0.00024064875,0.000020628922,0.007142685,0.05847338,0.00014404012,0.0034162665,0.00031401834,0.036559626],"study_design_scores_gemma":[0.54446095,0.054212134,0.03334491,0.007030702,0.00009075768,0.000010551435,0.0011449363,0.3482216,0.0010663794,0.0014913318,0.008344973,0.0005807859],"about_ca_topic_score_codex":0.52031535,"about_ca_topic_score_gemma":0.26010737,"teacher_disagreement_score":0.28974822,"about_ca_system_score_codex":0.0025191982,"about_ca_system_score_gemma":0.00607174,"threshold_uncertainty_score":0.9995629},"labels":[],"label_agreement":null},{"id":"W2008857237","doi":"10.1111/j.1524-4733.2007.00296.x","title":"Time and Expected Value of Sample Information Wait for No Patient","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Accrual; Sample size determination; Time horizon; Population; Randomized controlled trial; Medicine; Sample (material); Clinical trial; Actuarial science; Statistics; Econometrics; Economics; Accounting; Mathematics; Surgery; Finance; Internal medicine","score_opus":0.35320465913671856,"score_gpt":0.5024651963903233,"score_spread":0.14926053725360472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008857237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465746,0.0001783386,0.00031610843,0.003125312,0.000080692545,0.0010429557,0.000057819685,0.000020687059,0.000520613],"genre_scores_gemma":[0.9655894,0.0013663911,0.030453706,0.0021762634,0.000081007565,0.000055588775,0.00009641679,0.000015921638,0.00016532646],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984169,0.0001005057,0.000675005,0.00012015613,0.00045926112,0.00022818375],"domain_scores_gemma":[0.99323136,0.0059082205,0.00014649118,0.00020914584,0.00034859087,0.00015620435],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0017051145,0.00006133351,0.0002582714,0.00013271366,0.00005940442,0.0000028907739,0.000052843505,0.00013340371,0.000036977322],"category_scores_gemma":[0.015824959,0.000054034517,0.000034939992,0.00016307253,0.00013148451,0.00007669432,0.000041500112,0.00039016697,0.000022394208],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014628191,0.0060716975,0.3590496,0.0548745,0.0003920873,0.000053737447,0.17480901,0.012430511,0.0024400454,0.19140851,0.04685981,0.1369823],"study_design_scores_gemma":[0.024736311,0.03400585,0.2339974,0.006963995,0.00004564437,0.00012962341,0.002072852,0.54662156,0.004149118,0.08016653,0.06620245,0.00090863],"about_ca_topic_score_codex":0.0027730349,"about_ca_topic_score_gemma":0.000014963303,"teacher_disagreement_score":0.5341911,"about_ca_system_score_codex":0.00012106936,"about_ca_system_score_gemma":0.0007778523,"threshold_uncertainty_score":0.99246514},"labels":[],"label_agreement":null},{"id":"W2009048225","doi":"10.1016/j.jval.2014.03.845","title":"An Examination Of Disparity In Access To Mental Health Services Among People Living With Human Immunodeficiency Virus (Hiv) And Co-Morbid Depression In Ontario","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Toronto Public Health; Institute for Clinical Evaluative Sciences; Ontario HIV Treatment Network; McMaster University; University Health Network; University of Toronto","funders":"","keywords":"Mental health; Depression (economics); Medicine; Cohort; Specialty; Logistic regression; Psychiatry; Population; Distress; Cohort study; Family medicine; Environmental health; Clinical psychology; Internal medicine","score_opus":0.033242445306943307,"score_gpt":0.3732077589229016,"score_spread":0.3399653136159583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009048225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981284,0.00017206617,0.00012960713,0.00024821403,0.000012907223,0.00083381025,0.000010037345,0.000010975187,0.00045398585],"genre_scores_gemma":[0.999462,0.000068492904,0.0001894779,0.00009508006,0.000008556548,0.00003804528,0.00005937577,0.000011480199,0.00006748106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800056,0.0005330579,0.0005084176,0.00028812917,0.00031057015,0.00035927992],"domain_scores_gemma":[0.99930656,0.00007007913,0.00014439458,0.0002306394,0.000033253014,0.00021507069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019942862,0.00010409327,0.00034049735,0.00050391036,0.00011259486,0.000033206383,0.00014554989,0.000042393593,0.000047402187],"category_scores_gemma":[0.000040868865,0.000090765156,0.000018978217,0.00036425298,0.000037154125,0.0003634145,0.000072316776,0.0003020582,0.000001288144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056611054,0.0006579343,0.9784137,0.00081359444,0.0000020492519,9.905565e-7,0.015627805,0.00019345373,0.00053437456,0.00003243714,0.00001822913,0.0036488294],"study_design_scores_gemma":[0.0009386826,0.0024998083,0.9795226,0.004414811,0.0000011911376,0.0000032290668,0.0011529408,0.011249451,0.000120330624,0.000011085549,0.000017571652,0.0000683292],"about_ca_topic_score_codex":0.7729066,"about_ca_topic_score_gemma":0.8903948,"teacher_disagreement_score":0.1174882,"about_ca_system_score_codex":0.0005371896,"about_ca_system_score_gemma":0.00023976092,"threshold_uncertainty_score":0.37012956},"labels":[],"label_agreement":null},{"id":"W2009287143","doi":"10.1016/j.jval.2013.03.085","title":"Why are the findings of indirect comparisons of boceprevir and telaprevir for hepatitis C infection different? A methodological review","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Boceprevir; Telaprevir; Medicine; Meta-analysis; Internal medicine; Pegylated interferon; Hepatitis C virus; Ribavirin; Immunology; Virus","score_opus":0.5103839472343782,"score_gpt":0.5053342467469973,"score_spread":0.005049700487380848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009287143","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009355567,0.9876645,0.0002571906,0.0011286037,0.000096470685,0.009662215,0.00017084843,0.000019328092,0.000065295295],"genre_scores_gemma":[0.00011416035,0.99638706,0.001782712,0.00051167345,0.000063770654,0.0009812696,0.00007906112,0.000047799407,0.00003251313],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99241126,0.0042271065,0.0019880289,0.0004730993,0.00045767624,0.0004428488],"domain_scores_gemma":[0.99287665,0.004944018,0.0012283173,0.00058101583,0.00017196813,0.00019802798],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048962687,0.00038033156,0.0052960594,0.00038454455,0.00007197212,0.000011605983,0.00021996806,0.00032568997,0.00008933178],"category_scores_gemma":[0.005540729,0.00021900063,0.0005233644,0.0007042359,0.00022012732,0.000047257075,0.00014947058,0.00091070594,0.000005997918],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000946473,0.00011813866,0.025314042,0.411652,0.00010632373,0.0000012767321,0.000040814826,3.207052e-7,2.672182e-7,0.00007130545,0.008877333,0.5538087],"study_design_scores_gemma":[0.0003112248,0.00064271124,0.0062617282,0.23023926,0.00039827698,0.000025050196,0.0000038488643,0.000078014404,0.0000030727301,0.000046362795,0.7618466,0.0001438644],"about_ca_topic_score_codex":0.007780827,"about_ca_topic_score_gemma":0.00018177384,"teacher_disagreement_score":0.75296926,"about_ca_system_score_codex":0.00028588515,"about_ca_system_score_gemma":0.00046838613,"threshold_uncertainty_score":0.99882644},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2009316549","doi":"10.1111/j.1524-4733.2010.00754.x","title":"Apples and Oranges? Assessing Comparative Effectiveness and Comparative Value in the US and Other Countries","year":2010,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Health technology; Value (mathematics); Medicine; Political science; Computer science; Health care; Law","score_opus":0.3929639032331637,"score_gpt":0.4719043599450187,"score_spread":0.07894045671185501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009316549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8266262,0.04634924,0.00026591923,0.0072355117,0.11163086,0.0047877687,0.0020209574,0.000043218137,0.0010403491],"genre_scores_gemma":[0.8419543,0.006588194,0.0029078259,0.0071249576,0.13983843,0.0011089637,0.00024315818,0.00015792111,0.000076235134],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99163306,0.003597891,0.0030024596,0.0009810302,0.00022120515,0.0005643365],"domain_scores_gemma":[0.9786385,0.01834514,0.0023679773,0.00040820934,0.000071530965,0.00016858621],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.035244342,0.00044467454,0.0025513195,0.0005209273,0.00037142384,0.00040207143,0.00026454957,0.00064524816,0.00001376496],"category_scores_gemma":[0.0017169568,0.0004439909,0.000045387605,0.00023773753,0.0004549035,0.00040850716,0.00008342439,0.001344031,0.000029546052],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030644785,0.00048682233,0.3471937,0.019754138,0.0002899245,0.000010901626,0.12071168,0.002776526,0.0000020872567,0.23082659,0.2774129,0.00022829775],"study_design_scores_gemma":[0.002887524,0.00028669013,0.122907184,0.002134035,0.000015026725,0.0000116270985,0.005307496,0.008005076,0.0000013509649,0.010788282,0.84683555,0.0008201266],"about_ca_topic_score_codex":0.03772385,"about_ca_topic_score_gemma":0.004175148,"teacher_disagreement_score":0.56942266,"about_ca_system_score_codex":0.00059247453,"about_ca_system_score_gemma":0.00073261803,"threshold_uncertainty_score":0.99980116},"labels":[],"label_agreement":null},{"id":"W2009416878","doi":"10.1016/j.jval.2013.08.814","title":"A 10-Year Review of the Canadian Common Drug Review: Pharmaceutical Manufacturers’ Success Rate","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Formulary; Medicine; Reimbursement; Listing (finance); Family medicine; Business; Health care; Political science","score_opus":0.18501130182309475,"score_gpt":0.3940084444685437,"score_spread":0.20899714264544897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009416878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000025662623,0.96418136,2.3219319e-7,0.016390916,0.0005522608,0.0031722968,0.0011206027,0.000010653498,0.014569135],"genre_scores_gemma":[0.000017600476,0.9709925,0.000023974999,0.027418263,0.00014348053,0.00020161668,0.00008624295,0.00007122483,0.0010451027],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944764,0.0006839295,0.003259137,0.00064331765,0.0000704708,0.00086674665],"domain_scores_gemma":[0.9961055,0.00031597965,0.0018746539,0.0010136458,0.00003567394,0.00065457006],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.0047362475,0.0004968586,0.0038883998,0.00036554204,0.0001460261,0.000049381866,0.0012701688,0.0002385875,0.0058981674],"category_scores_gemma":[0.00032745383,0.0004088976,0.00076722406,0.000668112,0.00013680493,0.00010674029,0.0001795735,0.0011956115,0.003052882],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000018204219,0.000056790705,0.00005452532,0.59785175,0.00009172309,0.0000027535198,0.000028360479,0.000006899519,9.139307e-10,0.026620483,0.2424439,0.132841],"study_design_scores_gemma":[0.00014315906,0.000012249746,0.000014674145,0.123480715,0.000054197073,0.000006758474,4.6241186e-7,0.0000872949,1.2046976e-7,0.0009887546,0.87489796,0.00031363888],"about_ca_topic_score_codex":0.15528753,"about_ca_topic_score_gemma":0.006361374,"teacher_disagreement_score":0.6324541,"about_ca_system_score_codex":0.0014266757,"about_ca_system_score_gemma":0.0015297807,"threshold_uncertainty_score":0.99983627},"labels":[],"label_agreement":null},{"id":"W2009563819","doi":"10.1016/s1098-3015(10)65228-x","title":"PCN70 UTILITYVALUES FOR HEALTH STATES FOR CHRONIC MYELOGENOUS LEUKAEMIA (CML): ESTIMATES FROM LAYPERSONS IN AUSTRALIA, THE UNITED KINGDOM (UK) AND CANADA","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Kingdom; Family medicine; Chronic myelogenous leukemia; Environmental health; Gerontology; Leukemia; Immunology; Biology","score_opus":0.0916650070418641,"score_gpt":0.3684696056787971,"score_spread":0.276804598636933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2009563819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828533,0.0035318907,0.00035506568,0.008893089,0.00023699668,0.0034786556,0.0006035845,0.000040565617,0.0000068787945],"genre_scores_gemma":[0.99109226,0.00043085605,0.005021804,0.0021852322,0.00017504403,0.00016656975,0.00078936137,0.00005127738,0.00008759551],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969622,0.00013657745,0.0008578999,0.00054420636,0.0002910824,0.0012080214],"domain_scores_gemma":[0.9966511,0.0022170688,0.00026259595,0.00043330915,0.000066967455,0.0003689272],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017507287,0.0003118353,0.00070172956,0.00023306232,0.00025774186,0.000021063901,0.00015482107,0.00012509373,0.000022653106],"category_scores_gemma":[0.00033021875,0.0002472439,0.00006166216,0.0003658833,0.00012502474,0.000041378305,0.00003687515,0.0003538838,0.0000012033673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0037954433,0.00095615094,0.89319164,0.008361341,0.00065508566,0.00024296423,0.01887809,0.020204224,0.00031415222,0.0022607788,0.018925948,0.032214183],"study_design_scores_gemma":[0.035382923,0.005744204,0.74692184,0.0039971042,0.00020547828,0.00015815183,0.0045676753,0.15015039,0.0013470397,0.00516085,0.045321025,0.0010433428],"about_ca_topic_score_codex":0.9910551,"about_ca_topic_score_gemma":0.93741935,"teacher_disagreement_score":0.14626983,"about_ca_system_score_codex":0.011054204,"about_ca_system_score_gemma":0.008104096,"threshold_uncertainty_score":0.999998},"labels":[],"label_agreement":null},{"id":"W2010336850","doi":"10.1016/s1098-3015(10)61943-2","title":"PNM4 COST-EFFECTIVENESS STUDY OF RIZATRIPTAN VS. USUAL CARE IN THE TREATMENT OF MIGRAINE IN CANADA","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Migration, Health and Trauma","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rizatriptan; Migraine; Medicine; Intensive care medicine; Anesthesia; Internal medicine; Sumatriptan","score_opus":0.05855402618442098,"score_gpt":0.3673086918477131,"score_spread":0.3087546656632921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010336850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933695,0.0028532853,0.000002601404,0.00013217384,0.00028498474,0.0030453906,0.000045243967,0.000002976197,0.00026381275],"genre_scores_gemma":[0.9993893,0.00013182848,0.000012534607,0.00011984886,0.0000144584565,0.00030027353,0.000013540306,0.000010104741,0.000008103578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99576634,0.0027344006,0.0006877711,0.00024662307,0.00020355574,0.00036130165],"domain_scores_gemma":[0.99889183,0.00049890945,0.00017121306,0.00032404083,0.00003896407,0.000075059055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090433954,0.00012812247,0.00042140213,0.00019499016,0.000034546385,0.0000018021792,0.000107804764,0.000049603852,0.000028364544],"category_scores_gemma":[0.00004396611,0.0000991312,0.000025662524,0.0006568378,0.000017249962,0.000016414191,0.0000027555204,0.00012461939,8.5124805e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002445362,0.0017720105,0.873538,0.000216764,0.000009818041,0.000025156505,0.117737345,0.0014947889,6.7672386e-7,0.0008338129,0.000040159786,0.0040869033],"study_design_scores_gemma":[0.0048870817,0.0031919212,0.9322991,0.00005916552,0.0000043535824,0.0000033024496,0.058236916,0.00004445162,0.000016825485,0.000041235267,0.0011504089,0.000065240485],"about_ca_topic_score_codex":0.9920297,"about_ca_topic_score_gemma":0.99556684,"teacher_disagreement_score":0.05950043,"about_ca_system_score_codex":0.0011823485,"about_ca_system_score_gemma":0.0017791152,"threshold_uncertainty_score":0.4042453},"labels":[],"label_agreement":null},{"id":"W2010515258","doi":"10.1016/j.jval.2011.02.459","title":"PMD19 COST-EFFECTIVENESS OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE MUTATION TESTING IN THE SELECTION OF FIRST-LINE THERAPY FOR PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER IN ONTARIO","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Public Health; Ministry of Health and Long Term Care; Juravinski Cancer Centre; University of Toronto","funders":"","keywords":"Gefitinib; Medicine; Epidermal growth factor receptor; Oncology; Cost effectiveness; Lung cancer; Internal medicine; Mutation; Cost-effectiveness analysis; Gene mutation; Cancer; Gene; Biology; Genetics","score_opus":0.0712671127274582,"score_gpt":0.26850658738859984,"score_spread":0.19723947466114164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010515258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952037,0.00045155632,0.0015878666,0.000028612778,0.00016974816,0.0022621343,0.0001392954,0.0000037615912,0.00015334046],"genre_scores_gemma":[0.9971841,0.00028835458,0.0020823884,0.0000510463,0.000019180976,0.00033430348,0.00001580283,0.000019971048,0.0000048458296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860305,0.000056440615,0.0007671365,0.0002636348,0.000029215835,0.00028052845],"domain_scores_gemma":[0.9987023,0.0003359857,0.0007297569,0.000109504006,0.000089511464,0.000032935863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008790587,0.00013307396,0.00046001794,0.00023055104,0.00003704686,0.00000547912,0.000120326455,0.0000729834,0.000022527309],"category_scores_gemma":[0.00010614826,0.00012318973,0.000038686267,0.0003029707,0.00002331879,0.00021334729,0.000008398893,0.00015745395,5.515495e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005658462,0.0003096918,0.98182845,0.00031102062,0.000007300279,1.456832e-7,0.0035470105,0.010860453,0.0000137959405,0.00023054614,0.0000014755254,0.0023242766],"study_design_scores_gemma":[0.0033742648,0.0009628747,0.98898685,0.0002294973,0.0000013698296,1.3869229e-7,0.000032596665,0.0046155765,0.0009520426,0.0006872935,0.000030459016,0.00012702796],"about_ca_topic_score_codex":0.25777265,"about_ca_topic_score_gemma":0.062320117,"teacher_disagreement_score":0.19545254,"about_ca_system_score_codex":0.00081488816,"about_ca_system_score_gemma":0.00028271214,"threshold_uncertainty_score":0.9547901},"labels":[],"label_agreement":null},{"id":"W2010653668","doi":"10.1016/s1098-3015(10)73690-1","title":"PRS27 ASTHMA-RELATED PRODUCTIVITY LOSSES IN ALBERTA, CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Occupational exposure and asthma","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Productivity; Agricultural economics; Business; Natural resource economics; Environmental science; Economics; Economic growth","score_opus":0.015606436745457048,"score_gpt":0.27620653984825494,"score_spread":0.2606001031027979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010653668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95317525,0.00039685264,0.0000031651277,0.04387531,0.00016814108,0.0004388354,0.0000037786913,0.000013195127,0.0019254902],"genre_scores_gemma":[0.9970539,0.000022242386,0.00022361254,0.0016815508,0.00009752598,0.0000050049043,0.000024076699,0.000007871772,0.00088418886],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869263,0.00010899759,0.00039708105,0.00024567384,0.00025670714,0.00029891773],"domain_scores_gemma":[0.99947166,0.000099148114,0.000082411156,0.00018481036,0.000036110607,0.00012586186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039431383,0.00010229867,0.00026491977,0.000115667695,0.000031096864,0.000004140025,0.00004567069,0.000049586666,0.000031751984],"category_scores_gemma":[0.00026154701,0.000093719165,0.000021346375,0.00042634513,0.000015180897,0.000061691375,0.0000066745415,0.00025911862,0.000009544762],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038691715,0.0013479195,0.9173918,0.00043570885,0.000021336364,0.0002812267,0.0015375046,0.008366003,0.00021853513,0.007536391,0.008924027,0.053552628],"study_design_scores_gemma":[0.00085497875,0.00037444598,0.98596394,0.00027018908,0.0000015434136,0.000040437295,0.000030514766,0.0009022788,0.00018610043,0.0007180154,0.010561025,0.00009654049],"about_ca_topic_score_codex":0.924875,"about_ca_topic_score_gemma":0.78404456,"teacher_disagreement_score":0.14083043,"about_ca_system_score_codex":0.0004390195,"about_ca_system_score_gemma":0.0027882594,"threshold_uncertainty_score":0.49462524},"labels":[],"label_agreement":null},{"id":"W2010793469","doi":"10.1016/j.jval.2014.03.684","title":"Cost-Effectiveness Of Rivaroxaban For The Treatment Of Pulmonary Embolism In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Rivaroxaban; Medicine; Pulmonary embolism; Vitamin K antagonist; Deep vein; Low molecular weight heparin; Thrombosis; Venous thrombosis; Internal medicine; Surgery; Atrial fibrillation; Warfarin","score_opus":0.43154489897013504,"score_gpt":0.4254823225805965,"score_spread":0.006062576389538554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010793469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97430056,0.005670711,0.0028137423,0.011547206,0.00079600926,0.00401763,0.00049961737,0.0000062709146,0.00034827733],"genre_scores_gemma":[0.99778134,0.0006334169,0.00035724157,0.0006778273,0.000076301854,0.0004226253,0.000015572037,0.000016551714,0.000019147512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956787,0.00082145265,0.0028252015,0.0002846235,0.00006186971,0.0003281462],"domain_scores_gemma":[0.99177533,0.0063935528,0.0013325685,0.00038761762,0.000029841218,0.0000810977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014352349,0.000117085285,0.001005566,0.00019766382,0.000053693147,0.0000043850487,0.0001748214,0.00005168759,0.000014556787],"category_scores_gemma":[0.00091108994,0.00011652112,0.0000687142,0.0001845721,0.000034899665,0.0000654592,0.000010726489,0.000059369384,0.0000062395757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014868131,0.0006095637,0.71387756,0.004462314,0.000059204092,6.372539e-7,0.003901877,0.08974993,0.000003179541,0.1769693,0.00042535708,0.009792379],"study_design_scores_gemma":[0.0020969145,0.00035903105,0.7359206,0.0003775696,0.0000032797852,0.0000016793438,0.00090364413,0.21697614,0.00003517224,0.014066058,0.029066568,0.00019330985],"about_ca_topic_score_codex":0.9614994,"about_ca_topic_score_gemma":0.4419113,"teacher_disagreement_score":0.51958805,"about_ca_system_score_codex":0.0027085908,"about_ca_system_score_gemma":0.0012413702,"threshold_uncertainty_score":0.7082871},"labels":[],"label_agreement":null},{"id":"W2010942314","doi":"10.1016/j.jval.2011.02.381","title":"PSY48 A WORKPLACE HEALTH PROGRAM FOR BRITISH COLUMBIA PUBLIC SERVICE AGENCY (CANADA)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); GlaxoSmithKline (Canada); Canadian Sport Centre Pacific; Abbott (Canada); McMaster University","funders":"","keywords":"Psychological intervention; Medicine; Agency (philosophy); Public health; Intervention (counseling); Health care; Family medicine; Nursing; Gerontology; Environmental health; Political science","score_opus":0.09298624747056707,"score_gpt":0.3683094388361123,"score_spread":0.27532319136554523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010942314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7157651,0.012155549,0.0014803489,0.17470254,0.012217036,0.052019726,0.0005947054,0.0020949503,0.028970009],"genre_scores_gemma":[0.7926293,0.0032365073,0.044245522,0.13975963,0.0016324271,0.009361854,0.0003725963,0.0004077983,0.008354376],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906253,0.0021314595,0.0022535487,0.0008888115,0.00060008076,0.0035007524],"domain_scores_gemma":[0.99536073,0.00088641664,0.0010019684,0.00070064986,0.000354314,0.0016959038],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.005620152,0.00029770713,0.0009296634,0.00015337263,0.0026676368,0.00008040007,0.0005528332,0.00036823342,0.0007374465],"category_scores_gemma":[0.0004954558,0.00044788187,0.00009369396,0.0014978454,0.000048378693,0.00023691292,0.00013806879,0.0014734854,0.00006123181],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018763042,0.0008474244,0.39238808,0.0155513,0.000032509663,0.00003306437,0.011525206,0.000033256267,4.12517e-7,0.0024861195,0.39109004,0.18582495],"study_design_scores_gemma":[0.004761019,0.0013136043,0.29651883,0.005710059,0.000010669498,0.000029608611,0.0043740124,0.004155363,3.8270696e-7,0.0075848983,0.6746748,0.0008667269],"about_ca_topic_score_codex":0.9889088,"about_ca_topic_score_gemma":0.9945245,"teacher_disagreement_score":0.28358477,"about_ca_system_score_codex":0.0022618927,"about_ca_system_score_gemma":0.025079994,"threshold_uncertainty_score":0.9997973},"labels":[],"label_agreement":null},{"id":"W2010984173","doi":"10.1016/j.jval.2011.02.296","title":"PCV109 BEYOND CASE FATALITY: A NEW METHOD TO ESTIMATE THE EFFECT OF INCREASING TREATMENT UPTAKE ON MORTALITY","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Toronto Public Health","funders":"","keywords":"Case fatality rate; Medicine; Population; Epidemiology; Mortality rate; Polypharmacy; Estimation; Incidence (geometry); Demography; Statistics; Intensive care medicine; Environmental health; Internal medicine; Mathematics","score_opus":0.5126907974081895,"score_gpt":0.51407341029486,"score_spread":0.00138261288667052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2010984173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815714,0.00096129463,0.0042696972,0.008274254,0.00039293186,0.002274455,0.0002645766,0.00004065767,0.0019507844],"genre_scores_gemma":[0.96037316,0.000045849265,0.034631453,0.004422881,0.00018868627,0.00017190595,0.000015699368,0.00004745075,0.00010288103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99174935,0.0029018573,0.0040234434,0.0006482725,0.00011458743,0.0005625059],"domain_scores_gemma":[0.9939228,0.0029798055,0.0017269346,0.00093807245,0.000021355978,0.00041099716],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.044898123,0.0002760452,0.0014039824,0.00035577075,0.00019544538,0.000030382182,0.00024808114,0.00011208481,0.00010878818],"category_scores_gemma":[0.0027494384,0.00024683462,0.00015652995,0.00035950137,0.00004303815,0.00015500725,0.000051638974,0.00017864081,0.00027538146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007665117,0.00081943965,0.60580313,0.003166583,0.0004953623,0.00015324057,0.05739763,0.025113475,0.0000069069697,0.26249617,0.0031279994,0.040653564],"study_design_scores_gemma":[0.011303287,0.015522967,0.7506207,0.0018836992,0.0001361878,0.0008754648,0.003116238,0.09068492,0.000797988,0.09398944,0.028876498,0.0021926013],"about_ca_topic_score_codex":0.3379113,"about_ca_topic_score_gemma":0.0025379804,"teacher_disagreement_score":0.33537334,"about_ca_system_score_codex":0.0012777176,"about_ca_system_score_gemma":0.00038473535,"threshold_uncertainty_score":0.9999984},"labels":[],"label_agreement":null},{"id":"W2011263698","doi":"10.1016/j.jval.2011.08.923","title":"PIH19 Public Health Costs Associated with Outbreaks of Meningoccocal Disease: A Systematic Review","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Toronto Public Health","funders":"","keywords":"Outbreak; Medicine; Public health; Attack rate; Environmental health; Demography; Virology; Pathology","score_opus":0.12511865870328998,"score_gpt":0.33442628377403394,"score_spread":0.20930762507074396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011263698","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016609201,0.98729455,0.00012453106,0.0006391123,0.000117922005,0.010898022,0.00021605445,0.00007409095,0.0006190876],"genre_scores_gemma":[0.00026523124,0.9958326,0.00018818157,0.0021548127,0.00002206947,0.0009999273,0.00023274333,0.00014998906,0.000154449],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98428863,0.007836486,0.0036679648,0.0014031257,0.0011998701,0.0016039097],"domain_scores_gemma":[0.9916608,0.0009371548,0.0045421855,0.0014179416,0.0000238558,0.0014180801],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012464372,0.000842537,0.0056186174,0.00029855646,0.00022496597,0.000026144911,0.00085665396,0.00024323349,0.0003586847],"category_scores_gemma":[0.0018849963,0.00065411924,0.00037562472,0.0015264921,0.00032778984,0.00023921896,0.00033788363,0.0010781672,0.00035154555],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000033934832,0.00037493967,0.00062299304,0.91101116,0.00009099733,0.000020622849,0.00032003006,0.000007807542,4.484109e-9,0.00011852529,0.00027996168,0.08714955],"study_design_scores_gemma":[0.0003140237,0.0003088785,0.00076162984,0.9140044,0.000336462,0.000026756708,0.000036608573,0.00007530156,1.16547865e-8,0.000017849989,0.0835491,0.00056900707],"about_ca_topic_score_codex":0.0063467515,"about_ca_topic_score_gemma":0.0003753286,"teacher_disagreement_score":0.08658055,"about_ca_system_score_codex":0.00835217,"about_ca_system_score_gemma":0.0024411262,"threshold_uncertainty_score":0.999591},"labels":[],"label_agreement":null},{"id":"W2011510968","doi":"10.1016/j.jval.2014.03.585","title":"Reimbursement Recommendations for Cancer Products Without Statistically Significant Overall Survival Data: A Review of Canadian Pcodr Decisions","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Clinical trial; Randomized controlled trial; Clinical endpoint; Confounding; Internal medicine; Overall survival; Cancer; Oncology; Family medicine; Health care","score_opus":0.788566139445565,"score_gpt":0.5512781060284331,"score_spread":0.2372880334171319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011510968","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.074424e-7,0.8810551,0.0027181443,0.07648944,0.0017133342,0.007270656,0.030403506,0.000018551296,0.00033065802],"genre_scores_gemma":[0.0000017857207,0.9593798,0.02523063,0.0087259915,0.0005022011,0.0013965737,0.0043891203,0.00010706089,0.0002668533],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9819487,0.0022238248,0.013091711,0.0015534374,0.00020899328,0.00097335543],"domain_scores_gemma":[0.98359454,0.0055030626,0.007781212,0.0022744408,0.00026159416,0.00058517646],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.056263734,0.0004965393,0.0062737,0.0016160727,0.00022552349,0.000052181327,0.0011406441,0.0002540676,0.0002842636],"category_scores_gemma":[0.026244074,0.00056364975,0.00023923586,0.0009198733,0.000072521696,0.0002280457,0.00012837318,0.00047804115,0.00018715738],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004945552,0.00013760038,0.00012748427,0.37124118,0.00018779845,6.278635e-7,0.00017721232,0.000061997496,2.8608167e-9,0.10667845,0.43014014,0.09124256],"study_design_scores_gemma":[0.000286377,0.00008570915,0.000031161835,0.11556397,0.000064534695,0.0000016902694,0.000018290668,0.0008070904,5.148171e-9,0.0013910956,0.8813525,0.00039757797],"about_ca_topic_score_codex":0.42905504,"about_ca_topic_score_gemma":0.069721475,"teacher_disagreement_score":0.45121235,"about_ca_system_score_codex":0.0031667678,"about_ca_system_score_gemma":0.011559136,"threshold_uncertainty_score":0.9996815},"labels":[],"label_agreement":null},{"id":"W2011853618","doi":"10.1016/j.jval.2011.08.1443","title":"PRS56 Assessing Patient Report of Function: Content Validity of the Functional Performance Inventory-Short form (FPI-SF) in Patients with Chronic Obstructive Pulmonary Disease","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Education and Validation","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Content validity; Respondent; CLARITY; Pulmonary disease; COPD; Medicine; Qualitative research; Cognitive interview; Physical therapy; Psychology; Clinical psychology; Psychometrics; Cognition; Psychiatry; Internal medicine","score_opus":0.2722016692258324,"score_gpt":0.3456475280748192,"score_spread":0.0734458588489868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2011853618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99654555,0.000052677242,0.000047841615,0.00035921112,0.001067181,0.00096609525,0.000006847521,0.000010315717,0.0009442488],"genre_scores_gemma":[0.9996205,0.000025747218,0.00006768401,0.000088781635,0.00006591006,0.00006231864,0.000023473218,0.000007635545,0.000037939415],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767214,0.00049747893,0.00072233233,0.00021832384,0.00061812054,0.00027161452],"domain_scores_gemma":[0.99872154,0.0000633971,0.0005491213,0.00022800904,0.00027977434,0.00015818492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013404674,0.00009299646,0.00018218243,0.00011704828,0.00024262024,0.0000073228975,0.00010222405,0.000053360225,0.000058994876],"category_scores_gemma":[0.00017420368,0.00007205876,0.0000419872,0.00048026952,0.0001742309,0.00039463906,0.000025167847,0.00017221547,9.006799e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001071107,0.00039319953,0.9889931,0.0002028513,0.0000033242682,5.8203096e-7,0.004993738,0.00019309612,7.1321773e-7,0.00084557105,0.000014744653,0.004251944],"study_design_scores_gemma":[0.00022528578,0.00017220419,0.99679357,0.0002541985,0.0000056640165,5.8160964e-7,0.0014917717,0.00027357292,0.000020731044,0.00019554459,0.00049836386,0.00006849794],"about_ca_topic_score_codex":0.009472444,"about_ca_topic_score_gemma":0.00068067946,"teacher_disagreement_score":0.008791764,"about_ca_system_score_codex":0.0010899808,"about_ca_system_score_gemma":0.00351312,"threshold_uncertainty_score":0.99712354},"labels":[],"label_agreement":null},{"id":"W2012056050","doi":"10.1016/j.jval.2011.05.046","title":"Elicitation of Informed General Population Health State Utility Values: A Review of the Literature","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"Chongqing University of Arts and Sciences; Canadian Institutes of Health Research; University of Sheffield","keywords":"Population; Health care; Deliberation; Context (archaeology); Population health; Resource (disambiguation); Actuarial science; Medicine; Management science; Computer science; Business; Economics; Environmental health; Economic growth; Political science; Geography","score_opus":0.5271155693396244,"score_gpt":0.4932220970146238,"score_spread":0.03389347232500067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012056050","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00018569182,0.9893882,0.000088807996,0.0032487132,0.00072697847,0.0047197337,0.0013967946,0.000019849711,0.00022520927],"genre_scores_gemma":[0.00006352657,0.9912742,0.001966241,0.005733085,0.00012532934,0.00015960855,0.0005082737,0.000052278,0.00011745307],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9782081,0.00395419,0.01637551,0.00066469796,0.00021771599,0.00057974446],"domain_scores_gemma":[0.97772944,0.0011016101,0.019606017,0.0012176954,0.00014720249,0.00019803438],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.037433863,0.00042243482,0.0054029417,0.00070118625,0.00012898984,0.000020271886,0.0005877097,0.00029157355,0.000076587006],"category_scores_gemma":[0.0050828434,0.00038662736,0.00063681894,0.0012393574,0.000079421014,0.00032858277,0.000082706414,0.0005822944,0.000055600703],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000055764344,0.000113717586,0.0017642304,0.86228514,0.00006299814,9.082621e-8,0.004146292,0.000048306083,9.705371e-10,0.023752838,0.0056243716,0.10219645],"study_design_scores_gemma":[0.0002762818,0.00012335117,0.0046245772,0.30482846,0.000018123445,0.000005275977,0.000048672908,0.00033157007,2.1288658e-8,0.008946108,0.6804926,0.00030500873],"about_ca_topic_score_codex":0.020667113,"about_ca_topic_score_gemma":0.00028036057,"teacher_disagreement_score":0.67486817,"about_ca_system_score_codex":0.0018447363,"about_ca_system_score_gemma":0.003116397,"threshold_uncertainty_score":0.99985856},"labels":[],"label_agreement":null},{"id":"W2012100061","doi":"10.1111/j.1524-4733.2007.00254.x","title":"Assessing the Impact of Censoring of Costs and Effects on Health-Care Decision-Making: an Example Using the Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Study","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University","funders":"","keywords":"Censoring (clinical trials); Econometrics; Medicine; Actuarial science; Statistics; Economics; Mathematics","score_opus":0.4008945131707424,"score_gpt":0.49100570927550086,"score_spread":0.09011119610475848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012100061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123704,0.002319846,0.002792214,0.00075343216,0.00041837274,0.0024160207,0.000026151256,0.00000931237,0.00002763244],"genre_scores_gemma":[0.9951924,0.000106079264,0.0041347938,0.00032985996,0.0002020942,0.0000053415183,0.0000070432557,0.000021865044,5.373387e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938982,0.0013633901,0.003793095,0.0003940664,0.00020654892,0.0003446841],"domain_scores_gemma":[0.99057084,0.0049281977,0.0037951444,0.00052530965,0.00007488189,0.00010564905],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.030250877,0.00015799404,0.00083552726,0.00047198424,0.00025647777,0.000040867904,0.00014907736,0.000067833964,0.0000028448744],"category_scores_gemma":[0.0011419199,0.0001360503,0.00011045573,0.00046085098,0.000060387767,0.00030373601,0.000052297248,0.00013889205,0.0000011443675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002072818,0.000069606256,0.7324268,0.0021828983,0.00011950252,8.4219874e-7,0.046225823,0.17536128,0.0000075307157,0.006953279,0.0000731061,0.036372036],"study_design_scores_gemma":[0.0018921306,0.0011141885,0.93139064,0.0016418828,0.000009549149,0.0000031276072,0.016262462,0.04436058,0.0000108281765,0.0031142188,0.00004426414,0.00015611714],"about_ca_topic_score_codex":0.0313622,"about_ca_topic_score_gemma":0.000536227,"teacher_disagreement_score":0.19896384,"about_ca_system_score_codex":0.0013546221,"about_ca_system_score_gemma":0.0002575378,"threshold_uncertainty_score":0.9985608},"labels":[],"label_agreement":null},{"id":"W2012247185","doi":"10.1016/j.jval.2012.03.556","title":"PSY22 Health Care Costs for Inflammatory Bowel Disease Patients who are Adherent Versus Non-Adherent With Infliximab Therapy","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Infliximab; Inflammatory bowel disease; Ulcerative colitis; Internal medicine; Rheumatoid arthritis; Propensity score matching; Crohn's disease; Gastroenterology; Methotrexate; Disease","score_opus":0.08736662849698322,"score_gpt":0.41016364263869937,"score_spread":0.32279701414171613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012247185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9512065,0.021622105,0.00012045446,0.0068530794,0.004367533,0.014639298,0.0007444234,0.0001965817,0.00025001474],"genre_scores_gemma":[0.9858797,0.0034329554,0.00035316762,0.005931711,0.0019700176,0.0016588959,0.00048626313,0.00015666414,0.00013063406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99287826,0.0016111606,0.0015975827,0.0006491902,0.0007639573,0.0024998586],"domain_scores_gemma":[0.99480116,0.00065618486,0.0012731208,0.00073696394,0.00043867674,0.0020938618],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014689818,0.0005384537,0.00086022966,0.0003055287,0.001229028,0.000015952202,0.00032823955,0.00029940365,0.00007047137],"category_scores_gemma":[0.00017310273,0.00044971574,0.0001430547,0.00039228197,0.00006362206,0.0003260553,0.00010478696,0.0011548437,0.000104559644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034233283,0.0004686095,0.9448893,0.006161009,0.000020705414,0.0000017041223,0.016618287,0.00007559677,5.3167234e-8,0.00022870023,0.017629843,0.010482836],"study_design_scores_gemma":[0.016838105,0.0016647266,0.91150385,0.003096318,0.000012379376,1.6345355e-7,0.009150165,0.00018051,7.0632944e-7,0.000018452649,0.057019796,0.00051483593],"about_ca_topic_score_codex":0.004335072,"about_ca_topic_score_gemma":0.0014228049,"teacher_disagreement_score":0.039389953,"about_ca_system_score_codex":0.0036419234,"about_ca_system_score_gemma":0.004917636,"threshold_uncertainty_score":0.99979544},"labels":[],"label_agreement":null},{"id":"W2012363877","doi":"10.1016/j.jval.2013.03.182","title":"Valuing EQ-5D-5L: Can latent utilities derived from a discrete choice model be transformed to health utilities derived from time trade-off tasks?","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Econometrics; EQ-5D; Parametric statistics; Mathematics; Statistics; Transformation (genetics); Polynomial regression; Polynomial; Regression; Computer science; Mathematical optimization; Medicine","score_opus":0.3432951478116914,"score_gpt":0.3684009967356993,"score_spread":0.025105848924007912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012363877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7835535,0.006182642,0.0037554423,0.19676332,0.00056555733,0.0033218465,0.005389662,0.00018479023,0.00028326924],"genre_scores_gemma":[0.9379372,0.0011757294,0.010315077,0.04819629,0.00042848173,0.0007404701,0.0006555137,0.00014831689,0.00040290802],"study_design_codex":"qualitative","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9875178,0.0014494453,0.0072722146,0.0015471791,0.00035080456,0.0018625973],"domain_scores_gemma":[0.99286354,0.0026292193,0.0020450754,0.0011105429,0.000068760164,0.001282865],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008658369,0.0006651116,0.00273748,0.00067710463,0.0005664601,0.00025076032,0.0007099385,0.00032644885,0.0009100498],"category_scores_gemma":[0.0014982694,0.0008321325,0.00029471828,0.00039354924,0.00015859373,0.00090309023,0.00010367341,0.00061883975,0.00081412884],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004411426,0.0013972052,0.14167948,0.0064972625,0.0010731932,0.000008755417,0.5648707,0.18601838,0.00041604243,0.024633821,0.059523903,0.013440078],"study_design_scores_gemma":[0.003007921,0.00046254962,0.17521048,0.001173697,0.000014586887,0.0000032304151,0.0098659415,0.76617545,0.000046573707,0.034226954,0.00844361,0.001369006],"about_ca_topic_score_codex":0.43631488,"about_ca_topic_score_gemma":0.011744135,"teacher_disagreement_score":0.5801571,"about_ca_system_score_codex":0.0032258404,"about_ca_system_score_gemma":0.0017410239,"threshold_uncertainty_score":0.9999639},"labels":[],"label_agreement":null},{"id":"W2012735388","doi":"10.1016/j.jval.2011.08.967","title":"PIH65 What Are We Missing in Meningococcal Disease Modelling to Better Understand the Health and Economic Impact of New Vaccines?","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; University of Guelph; University of Saskatchewan","funders":"","keywords":"Neisseria meningitidis; Meningococcal disease; Herd immunity; Carriage; Population; Outbreak; Transmission (telecommunications); Vaccination; Meningococcal vaccine; Medicine; Disease; Epidemiology; Bacteremia; Meningitis; Immunology; Intensive care medicine; Environmental health; Virology; Biology; Immunization; Pediatrics; Computer science; Microbiology; Immune system","score_opus":0.11830472906280515,"score_gpt":0.3202182206712417,"score_spread":0.20191349160843658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012735388","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98181283,0.008168231,0.00067477237,0.008617488,0.0003358441,0.0003592791,0.000012504148,0.000011413646,0.000007620016],"genre_scores_gemma":[0.9968409,0.0024681673,0.00018512123,0.00041748272,0.000042588374,0.0000050718545,0.0000063346847,0.000012822048,0.000021518243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876684,0.00025198644,0.00043171068,0.00021578098,0.000008642719,0.00032501205],"domain_scores_gemma":[0.9994234,0.00008526137,0.00017539899,0.00018783749,0.000009312135,0.000118782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040068442,0.0001288935,0.00031498188,0.00016922221,0.000110561334,0.000023108014,0.00008232791,0.00006626594,0.00008234217],"category_scores_gemma":[0.0000119851165,0.00009364102,0.000048125672,0.00010452285,0.000023378527,0.00016847895,0.000040473384,0.00017057748,0.0000068841414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052077593,0.0006522186,0.72395533,0.0009177939,0.00028919333,0.0000056083522,0.09335896,0.09147713,0.0022172271,0.002952757,0.007222281,0.07174373],"study_design_scores_gemma":[0.012886201,0.0046633394,0.8940727,0.0062944763,0.000058344962,0.00012838618,0.020417836,0.026776584,0.0007428922,0.024199592,0.008296375,0.0014632909],"about_ca_topic_score_codex":0.043101005,"about_ca_topic_score_gemma":0.0007965193,"teacher_disagreement_score":0.17011735,"about_ca_system_score_codex":0.0002945864,"about_ca_system_score_gemma":0.0005787701,"threshold_uncertainty_score":0.9632711},"labels":[],"label_agreement":null},{"id":"W2012773708","doi":"10.1016/j.jval.2012.08.503","title":"MO1 Comprehensive Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Depression","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Tolerability; Discontinuation; Medicine; Health care; Major depressive disorder; Time horizon; Cohort; Clinical trial; Depression (economics); Adverse effect; Actuarial science; Psychiatry; Internal medicine; Economics; Finance","score_opus":0.6168177502446268,"score_gpt":0.513549665098622,"score_spread":0.10326808514600483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2012773708","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61218303,0.1671436,0.16659476,0.042837296,0.00096009934,0.0096260095,0.00046482086,0.000094085764,0.000096267635],"genre_scores_gemma":[0.9946078,0.00048724754,0.003209688,0.0011118811,0.000060285085,0.00044542516,0.000047520407,0.000023170849,0.0000069478756],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9939014,0.0009242451,0.0040566376,0.00036712398,0.00019924984,0.00055138144],"domain_scores_gemma":[0.9948947,0.0018637684,0.0025461803,0.00049585174,0.00013167722,0.00006784005],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029496897,0.00015315964,0.0007992726,0.00042385212,0.00018576415,0.000013020931,0.00021267476,0.00013481284,0.0000071292184],"category_scores_gemma":[0.0025416494,0.0001528251,0.000083510226,0.00026874276,0.00004844813,0.00033235087,0.000053691718,0.00018100384,0.000014680089],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015526608,0.00005401016,0.042087473,0.0007343469,0.0000079930605,6.3607235e-9,0.010702952,0.9299047,3.3885865e-7,0.008964067,0.00019632003,0.0073322793],"study_design_scores_gemma":[0.0009299396,0.000053933185,0.04685959,0.0002530294,0.0000029304292,2.509024e-7,0.0077835624,0.9339778,0.0000027830886,0.009144494,0.00087286957,0.00011884471],"about_ca_topic_score_codex":0.004847497,"about_ca_topic_score_gemma":0.00033586536,"teacher_disagreement_score":0.38242477,"about_ca_system_score_codex":0.0020990134,"about_ca_system_score_gemma":0.0005509347,"threshold_uncertainty_score":0.9993372},"labels":[],"label_agreement":null},{"id":"W2013217692","doi":"10.1016/j.jval.2012.08.058","title":"PHP7 Health Care Decision Making in Mainland China, Korea, and Taiwan: The Road Ahead?","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Delphi method; Mainland China; Health care; Medicine; Government (linguistics); Economic growth; China; Epidemiology; Business; Environmental health; Political science","score_opus":0.263109887327422,"score_gpt":0.43093615130429613,"score_spread":0.1678262639768741,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013217692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8225792,0.08620851,0.0013129052,0.08511447,0.0011881448,0.0018992609,0.00017577088,0.000039532828,0.0014822008],"genre_scores_gemma":[0.98010683,0.0011964812,0.0037554419,0.014347758,0.0004099247,0.000086568114,0.000017453749,0.000039681567,0.000039848972],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929827,0.0011595215,0.004092261,0.0005580038,0.00014238535,0.0010651575],"domain_scores_gemma":[0.9964598,0.0009927927,0.0016220927,0.0005846985,0.000020034948,0.00032058777],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.031793952,0.00023671756,0.0010825188,0.00052727014,0.00035582914,0.00007205146,0.00027279387,0.00014581622,0.00006989671],"category_scores_gemma":[0.0015158643,0.0002400724,0.00006682,0.00040350182,0.00006992836,0.00042581157,0.00009435808,0.0004389853,0.00020864046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039504772,0.00013065746,0.85454357,0.0011858656,0.000012333807,0.0000011953427,0.05884074,0.0020756314,6.7715995e-8,0.05608228,0.006162758,0.020925373],"study_design_scores_gemma":[0.0011816972,0.00014235334,0.9391794,0.0007840033,0.000001158503,0.000018922427,0.0062586595,0.008944924,1.4260132e-7,0.009991438,0.033179764,0.0003174993],"about_ca_topic_score_codex":0.028319957,"about_ca_topic_score_gemma":0.0025442939,"teacher_disagreement_score":0.15752764,"about_ca_system_score_codex":0.0020196016,"about_ca_system_score_gemma":0.00046136393,"threshold_uncertainty_score":0.9969719},"labels":[],"label_agreement":null},{"id":"W2013825351","doi":"10.1016/j.jval.2011.01.005","title":"Bridging Trial and Decision: A Checklist to Frame Health Technology Assessments for Resource Allocation Decisions","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Technology Assessment international","keywords":"Checklist; Bridging (networking); Resource allocation; Computer science; Resource (disambiguation); Frame (networking); Management science; Operations research; Psychology; Engineering; Computer security; Telecommunications","score_opus":0.6475406595978148,"score_gpt":0.5445912012304652,"score_spread":0.10294945836734959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013825351","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016227656,0.9170185,0.054298304,0.016484682,0.0011342575,0.010036529,0.0006408037,0.000085316264,0.00013938328],"genre_scores_gemma":[0.000047718288,0.92987883,0.060186055,0.006715052,0.0005816737,0.002144596,0.00017229561,0.00013140652,0.0001423787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9848924,0.00093983044,0.011284593,0.0016458123,0.00015875277,0.0010785798],"domain_scores_gemma":[0.98743916,0.004358381,0.006260617,0.0012240147,0.00007392809,0.0006439201],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.041213255,0.00053524773,0.005236788,0.0026770849,0.0004535495,0.000120663375,0.0006911495,0.00068883714,0.00003653695],"category_scores_gemma":[0.011060168,0.00065055897,0.00030065494,0.0010901183,0.000070646835,0.00020791563,0.00021117934,0.0006920968,0.00033821084],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019140691,0.00016976577,0.000052309017,0.009691855,0.000054023054,5.04005e-7,0.00050085766,0.000055956352,9.473267e-10,0.07819715,0.01775043,0.89333576],"study_design_scores_gemma":[0.0039879857,0.0007312557,0.000043013482,0.013746714,0.0000119435645,0.0000143175885,0.00015906284,0.0012372272,4.1966186e-9,0.014725432,0.9648978,0.00044525546],"about_ca_topic_score_codex":0.0041447966,"about_ca_topic_score_gemma":0.00028084326,"teacher_disagreement_score":0.94714737,"about_ca_system_score_codex":0.0032654696,"about_ca_system_score_gemma":0.0027271581,"threshold_uncertainty_score":0.99959457},"labels":[],"label_agreement":null},{"id":"W2013955204","doi":"10.1016/j.jval.2014.03.875","title":"Impact Of Educational Intervention On Quality Of Life Of Patients Nearing End Of Life: An Evidence Based Analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Medicine; Quality of life (healthcare); Psychological intervention; Cohort; Intervention (counseling); End-of-life care; Cohort study; Protocol (science); Population; Randomized controlled trial; Disease; Family medicine; Health care; Physical therapy; Alternative medicine; Palliative care; Internal medicine; Nursing; Pathology","score_opus":0.3214730691888535,"score_gpt":0.5314031706523847,"score_spread":0.20993010146353125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2013955204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986449,0.0005705143,0.0003176855,0.00018131688,0.000042307816,0.00015595487,0.00004968854,0.0000019733104,0.000035658533],"genre_scores_gemma":[0.9988447,0.00009927358,0.0009052668,0.000052060263,0.000026642763,0.0000027079836,0.000060971997,0.00000499216,0.0000034088007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977825,0.00056745036,0.0010340535,0.0001399233,0.00037285715,0.00010319048],"domain_scores_gemma":[0.9972461,0.001012489,0.0009903723,0.00027838245,0.00035254323,0.00012014943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015317664,0.000075512784,0.0006406539,0.00034543098,0.000008565537,9.025289e-7,0.0000794759,0.000042029253,0.00009219809],"category_scores_gemma":[0.0048246295,0.00006523332,0.00023030186,0.00047570388,0.00006675548,0.000066969864,0.00001334954,0.00007384076,3.8139945e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049986586,0.0009394773,0.9884773,0.0018802218,0.00012533471,1.3220561e-8,0.0009806423,0.005315289,0.00021868966,0.00016998789,0.00001389218,0.001379303],"study_design_scores_gemma":[0.00083522475,0.0017967704,0.9870362,0.0026857457,0.000053982687,8.4067375e-9,0.000108426815,0.0062821703,0.0010961057,0.000066229826,0.0000026411938,0.000036458878],"about_ca_topic_score_codex":0.03989148,"about_ca_topic_score_gemma":0.00017644995,"teacher_disagreement_score":0.039715033,"about_ca_system_score_codex":0.000113799535,"about_ca_system_score_gemma":0.0005551927,"threshold_uncertainty_score":0.96650195},"labels":[],"label_agreement":null},{"id":"W2014207635","doi":"10.1016/s1098-3015(10)63265-2","title":"PAR6 COST-UTILITY ANALYSIS OF RITUXIMAB AS A NEW THERAPEUTIC OPTION FOR RHEUMATOID ARTHRITIS PATIENTS IN CANADA","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rheumatoid arthritis; Rituximab; Medicine; Physical therapy; Internal medicine; Lymphoma","score_opus":0.026475969947324877,"score_gpt":0.2964060608218043,"score_spread":0.26993009087447944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014207635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843933,0.012504109,0.000249699,0.0012353491,0.00007024217,0.0013572432,0.00009882538,0.000011455533,0.000079796664],"genre_scores_gemma":[0.9794686,0.019673819,0.00030182028,0.0002502258,0.000012223672,0.00007108775,0.00019070956,0.000014185654,0.000017321938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778146,0.00020005781,0.0008052395,0.00027120614,0.00044713207,0.0004949367],"domain_scores_gemma":[0.9990076,0.00023000604,0.00016666934,0.00025333627,0.000108062246,0.00023435484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058271195,0.00013072765,0.0007053735,0.00041844413,0.000051509734,0.000010364693,0.00008103069,0.000049243525,0.00007672053],"category_scores_gemma":[0.00019372001,0.00012864845,0.000103499704,0.0008353412,0.000041985575,0.00006930243,0.0000137985535,0.00016036701,0.000002344188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051882863,0.00063339673,0.8689578,0.00013476521,0.00011540049,0.0000062182435,0.00028624223,0.0013656906,0.000013784179,0.0011512942,0.0005091928,0.12630738],"study_design_scores_gemma":[0.011256217,0.00054010545,0.9508617,0.00072158064,0.000006633259,0.000004135142,0.00025735586,0.027595684,0.00013534797,0.0032120151,0.0052597574,0.00014947036],"about_ca_topic_score_codex":0.988075,"about_ca_topic_score_gemma":0.951982,"teacher_disagreement_score":0.12615791,"about_ca_system_score_codex":0.0006668779,"about_ca_system_score_gemma":0.0041518263,"threshold_uncertainty_score":0.7365162},"labels":[],"label_agreement":null},{"id":"W2014308842","doi":"10.1016/j.jval.2012.08.860","title":"PMD11 The Cost of Poor Sample Quality: Assessing the Financial Impact of Sample Rejection and Recollection in Health Care Insitutions","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Becton Dickinson (Canada)","funders":"","keywords":"Sample (material); Sample size determination; Total cost; Health care; Medicine; Statistics; Financial institution; Equating; Demography; Actuarial science; Operations management; Finance; Economics; Accounting; Mathematics; Economic growth","score_opus":0.18342515748719224,"score_gpt":0.4029019156364297,"score_spread":0.21947675814923745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014308842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96909297,0.007282863,0.008082486,0.012438981,0.00059084006,0.0015313793,0.00045430756,0.000014367651,0.0005117829],"genre_scores_gemma":[0.9971477,0.0013681939,0.0006204156,0.00069610216,0.00009214755,0.000043132266,0.00001770627,0.000008855789,0.0000057504562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978843,0.00041326592,0.0010885191,0.00017390546,0.0000505112,0.00038950884],"domain_scores_gemma":[0.9983803,0.00057785434,0.00070299924,0.00023184165,0.000028316008,0.00007868072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043765446,0.00009408732,0.0003742605,0.00031690593,0.0002647345,0.000018636601,0.00008469998,0.00006442339,0.000012747696],"category_scores_gemma":[0.0011066095,0.000076345874,0.00006507217,0.0007313374,0.00005779745,0.00018239005,0.000039157327,0.00022155012,0.0000013329343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044836033,0.00024282445,0.6643331,0.0011394763,0.000019807017,7.999542e-8,0.027219726,0.006431963,0.0000013466382,0.26791966,0.00043999418,0.0322072],"study_design_scores_gemma":[0.0004190861,0.00022263007,0.971014,0.0001088356,0.0000013833869,0.000001367653,0.0019995477,0.002210419,0.0000037686723,0.008668539,0.015259015,0.000091381975],"about_ca_topic_score_codex":0.7159179,"about_ca_topic_score_gemma":0.019214498,"teacher_disagreement_score":0.6967034,"about_ca_system_score_codex":0.0010314068,"about_ca_system_score_gemma":0.00045995973,"threshold_uncertainty_score":0.99868226},"labels":[],"label_agreement":null},{"id":"W2014318252","doi":"10.1016/j.jval.2011.07.003","title":"The MacNew Heart Disease Health-Related Quality of Life Questionnaire in Patients with Angina and Patients with Ischemic Heart Failure","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":71,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Calgary","funders":"U.S. Food and Drug Administration; European Society of Cardiology; Canadian Cardiovascular Society","keywords":"Medicine; Angina; Heart failure; Myocardial infarction; Hospital Anxiety and Depression Scale; Quality of life (healthcare); Heart disease; Physical therapy; Anxiety; Cardiology; Internal medicine; Psychiatry","score_opus":0.023634926980018157,"score_gpt":0.28810727050774754,"score_spread":0.26447234352772936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014318252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98453426,0.0025344142,0.0000032695684,0.009966055,0.00011965186,0.002717077,0.000055458124,0.000034670535,0.00003515659],"genre_scores_gemma":[0.9954555,0.00014649998,0.0005001469,0.0037037742,0.000023145414,0.00005715375,0.00006769425,0.000035074903,0.000011016745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996357,0.0006954758,0.001194777,0.00042331396,0.0005656256,0.00076380355],"domain_scores_gemma":[0.9975942,0.000106859894,0.0004120064,0.00044731217,0.00013849062,0.0013011594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016623357,0.00023644642,0.000790419,0.00017648612,0.0001884575,0.000006354359,0.0000654106,0.00008881476,0.000006302634],"category_scores_gemma":[0.00019876008,0.00015891554,0.000049547652,0.00051640964,0.00017037692,0.00010871059,0.000034079443,0.0004647971,0.0000038763324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003944194,0.00066873035,0.990291,0.0024670125,0.0000082705365,0.0000011099273,0.0011926575,0.0000081312955,2.6428862e-7,0.00011639167,0.00054987933,0.0007523521],"study_design_scores_gemma":[0.0069296686,0.0020740672,0.98779285,0.002279567,0.000007656978,0.0000022964596,0.00019098188,0.000024121928,0.0000013330728,0.000049824223,0.00051255303,0.00013507598],"about_ca_topic_score_codex":0.033826485,"about_ca_topic_score_gemma":0.0010224184,"teacher_disagreement_score":0.03280407,"about_ca_system_score_codex":0.0005165624,"about_ca_system_score_gemma":0.0025072712,"threshold_uncertainty_score":0.9726074},"labels":[],"label_agreement":null},{"id":"W2014505829","doi":"10.1046/j.1524-4733.2000.36006.x","title":"Predictors of Long-term Persistence on Statins in a Subsidized Clinical Population","year":2000,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôtel-Dieu de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Pravastatin; Cohort; Statin; Persistence (discontinuity); Population; Medical record; Demography; Pediatrics; Internal medicine; Environmental health","score_opus":0.07645816296236467,"score_gpt":0.35671550069685415,"score_spread":0.28025733773448946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014505829","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997187,0.0006932616,0.000014766599,0.0006814886,0.00014062684,0.0009792892,0.000008482774,0.00002228749,0.000272773],"genre_scores_gemma":[0.996953,0.0019258551,0.0003931325,0.00044835635,0.00015308776,0.000017945667,0.00002940186,0.00001613412,0.0000630803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974025,0.00057109544,0.00096543937,0.00029867733,0.00045788544,0.0003044133],"domain_scores_gemma":[0.99912655,0.0001096975,0.00013909397,0.00040658296,0.000027972692,0.00019007592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024499246,0.00010754374,0.0005986897,0.00016298237,0.000028011196,0.0000032434727,0.00006215999,0.000106736414,0.00008944152],"category_scores_gemma":[0.00016287748,0.000094642084,0.00017410032,0.00033991062,0.000039675822,0.000041171763,0.000007804248,0.000324353,0.000010788354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004804444,0.0004101858,0.9436663,0.00064534025,0.000020608635,0.00003628778,0.00051131693,0.0010509376,0.0000023447267,0.0000622916,0.000010585523,0.053103402],"study_design_scores_gemma":[0.0028907189,0.0010984209,0.99331385,0.0010313715,0.0000115848,0.000015687796,0.00004701613,0.0014334234,0.0000110783385,0.000022270533,0.00006016256,0.00006441517],"about_ca_topic_score_codex":0.010800065,"about_ca_topic_score_gemma":0.0004345043,"teacher_disagreement_score":0.05303899,"about_ca_system_score_codex":0.00026605185,"about_ca_system_score_gemma":0.00039234382,"threshold_uncertainty_score":0.9957871},"labels":[],"label_agreement":null},{"id":"W2014624650","doi":"10.1016/j.jval.2014.03.899","title":"Cardiovascular Agents - Most Common Class Involved In Adverse Drug Reactions In Indian Elderly Inpatients","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Drug reaction; Drug; Observational study; Drug class; Adverse drug reaction; Adverse effect; Internal medicine; Pharmacology; Intensive care medicine","score_opus":0.1203278776865381,"score_gpt":0.3797380571844018,"score_spread":0.2594101794978637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014624650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936087,0.00041716438,0.000008221927,0.0027711918,0.0004896741,0.001106693,0.000008832393,0.000029694856,0.0015598304],"genre_scores_gemma":[0.9962035,0.00052510016,0.00014745574,0.00287502,0.000059532278,0.000042136966,0.000059814523,0.000025006191,0.00006247297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968804,0.0009858498,0.0008109424,0.0003463401,0.00046588492,0.0005105788],"domain_scores_gemma":[0.9986301,0.0003946889,0.00017899352,0.0004456905,0.000028312888,0.00032218636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019267981,0.00017732124,0.0005883196,0.00047873252,0.00006193665,0.000009294448,0.000119504104,0.00011443994,0.000029505785],"category_scores_gemma":[0.00046249505,0.00017346519,0.00011930356,0.0007515948,0.000041503885,0.00022652136,0.00005138326,0.0008713291,0.000051855903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001751639,0.00061498076,0.97991896,0.0005794583,0.00003941494,0.000065592445,0.002317254,0.0061995303,0.0000059854415,0.00010214094,0.00021382218,0.009767723],"study_design_scores_gemma":[0.010584504,0.0006215239,0.8105076,0.001484323,0.000048523565,0.000012937188,0.001308242,0.046500582,0.000042050335,0.00042608994,0.12812717,0.0003364785],"about_ca_topic_score_codex":0.04179215,"about_ca_topic_score_gemma":0.00329381,"teacher_disagreement_score":0.16941136,"about_ca_system_score_codex":0.00060009875,"about_ca_system_score_gemma":0.00020744691,"threshold_uncertainty_score":0.96458864},"labels":[],"label_agreement":null},{"id":"W2014744074","doi":"10.1016/s1098-3015(10)67771-6","title":"PMH25 EFFECTIVENESS AND TOLERABILITY OUTCOMES OF RISPERIDONE LONG-ACTING INJECTION COMPARED TO CONVENTIONAL DEPOT ANTIPSYCHOTICS IN A LARGE CANADIAN PSYCHIATRIC HOSPITAL","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risperidone; Tolerability; Psychiatry; Medicine; Depot; Schizophrenia (object-oriented programming); Pharmacology; Adverse effect; Political science","score_opus":0.2874956640059928,"score_gpt":0.5048416024944938,"score_spread":0.21734593848850103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014744074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792248,0.00048680342,0.00035461917,0.015337331,0.0014041546,0.0029259515,0.000109493485,0.000041725776,0.000115091905],"genre_scores_gemma":[0.99554574,0.000097288896,0.0017851326,0.002234502,0.0001549669,0.00012292592,0.00001861679,0.00003128344,0.000009536479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99075264,0.0053864783,0.0018703153,0.00057662994,0.00037456708,0.0010393612],"domain_scores_gemma":[0.99607635,0.0020088323,0.00066795805,0.0003853262,0.00021776636,0.0006437669],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009973325,0.00023860055,0.0008650859,0.0007503722,0.00048552526,0.000013369406,0.00016731578,0.0002552404,0.000057714486],"category_scores_gemma":[0.0019334875,0.00025687268,0.000062455416,0.0010222144,0.00005420139,0.00031205924,0.00006897994,0.0011396061,0.000030248626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024944425,0.00048163108,0.9882154,0.0018470349,0.000013971839,0.0000031458603,0.0054464065,0.00080202665,0.0000029236262,0.00064546074,0.000053577565,0.0022389812],"study_design_scores_gemma":[0.002192309,0.0002803217,0.9916653,0.00062079495,0.0000056185368,0.0000029516136,0.0022943525,0.0018619264,0.0000025548914,0.00022224065,0.0006520356,0.00019959055],"about_ca_topic_score_codex":0.5670865,"about_ca_topic_score_gemma":0.6837784,"teacher_disagreement_score":0.11669192,"about_ca_system_score_codex":0.0020916772,"about_ca_system_score_gemma":0.0026875571,"threshold_uncertainty_score":0.9999884},"labels":[],"label_agreement":null},{"id":"W2014803877","doi":"10.1016/s1098-3015(10)71995-1","title":"HT3 MULTICRITERIA DECISION ANALYSIS (MCDA) FOR DRUG COVERAGE DECISION BY A PUBLIC HEALTH PLAN: CASE STUDY OF TRAMADOL FOR CHRONIC NON-CANCER PAIN (CNCP) IN CANADA","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Animal testing and alternatives","field":"Veterinary","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tramadol; Multiple-criteria decision analysis; Decision analysis; Plan (archaeology); Medicine; Operations research; Engineering; Pharmacology; Analgesic; Mathematics; Statistics; Geography","score_opus":0.17389799455223806,"score_gpt":0.43364011490538434,"score_spread":0.25974212035314626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014803877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840509,0.0005488148,0.01141023,0.0004572139,0.00034885845,0.0024582937,0.00070341106,0.00002034043,0.0000019301763],"genre_scores_gemma":[0.99399996,0.00007805159,0.0050562485,0.00028745682,0.00010087078,0.00037852908,0.000043733988,0.000043015294,0.00001210789],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9963477,0.0005579062,0.0012927513,0.00066175376,0.00038409524,0.00075574016],"domain_scores_gemma":[0.9942905,0.0043150284,0.0005665574,0.00041931932,0.00010999317,0.00029865673],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0044770334,0.00026840274,0.0008682814,0.00045945647,0.00021313565,0.000042231513,0.00030427685,0.00006632272,0.000030783114],"category_scores_gemma":[0.0009233003,0.00025246732,0.000111163856,0.0007500729,0.00002674374,0.00013423875,0.00006203659,0.000357557,4.3168808e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003234808,0.00391357,0.44048658,0.002216314,0.00036017512,0.00064678845,0.021667533,0.015194829,0.0011072428,0.000037027796,0.004858583,0.50627655],"study_design_scores_gemma":[0.009279644,0.007955953,0.06276856,0.00072206336,0.00004367059,0.00006977793,0.007879036,0.90882677,0.000028329,0.00022791224,0.0016524742,0.000545783],"about_ca_topic_score_codex":0.96411914,"about_ca_topic_score_gemma":0.9679341,"teacher_disagreement_score":0.89363194,"about_ca_system_score_codex":0.0014901885,"about_ca_system_score_gemma":0.002978116,"threshold_uncertainty_score":0.9999927},"labels":[],"label_agreement":null},{"id":"W2014915905","doi":"10.1016/j.jval.2013.03.887","title":"Use Of Biologic Agents In The Treatment Of Psoriasis: An Analysis Of The Quebec Provincial Drug Reimbursement Program Database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Adalimumab; Golimumab; Etanercept; Ustekinumab; Infliximab; Tocilizumab; Psoriasis; Psoriatic arthritis; Abatacept; Internal medicine; Rituximab; Rheumatoid arthritis; Physical therapy; Dermatology; Disease; Lymphoma","score_opus":0.2732841672577958,"score_gpt":0.45399428710685424,"score_spread":0.18071011984905844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2014915905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99349445,0.0007510445,0.0000012939933,0.0035826487,0.00005749973,0.0020320972,0.000050225743,0.000004523516,0.000026230644],"genre_scores_gemma":[0.9969061,0.0021782105,0.00034732866,0.00035640766,0.000027682772,0.00013696516,0.0000255195,0.0000034683815,0.000018286786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981576,0.0007191421,0.00053317787,0.00015856435,0.00024306195,0.00018845171],"domain_scores_gemma":[0.9988597,0.00034115548,0.0003289583,0.00036608404,0.000049146092,0.000054973076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000786884,0.00009012851,0.0004057468,0.000099572615,0.00003479635,0.0000052932182,0.0001174389,0.000025222538,0.000037192607],"category_scores_gemma":[0.0001527007,0.000041057756,0.00009563886,0.00065036357,0.000091717724,0.00007728704,0.000030815572,0.00008932669,5.9560983e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035145372,0.008309724,0.8656967,0.00037442523,0.00054213253,0.0000039564206,0.0070905862,0.0007273166,0.00014178334,0.00029711062,0.00019618408,0.11626861],"study_design_scores_gemma":[0.0010670118,0.0017501285,0.9758031,0.000121909456,0.0005804575,5.219334e-7,0.0017969682,0.010309504,0.0004000199,0.000027712043,0.008087733,0.00005495121],"about_ca_topic_score_codex":0.49315068,"about_ca_topic_score_gemma":0.044528533,"teacher_disagreement_score":0.44862214,"about_ca_system_score_codex":0.00015188378,"about_ca_system_score_gemma":0.00014509371,"threshold_uncertainty_score":0.97290635},"labels":[],"label_agreement":null},{"id":"W2015115414","doi":"10.1016/j.jval.2011.08.1666","title":"PMH1 Comparing The Effectiveness Of Paliperidone Palmitate Versus Olanzapine Pamoate For Relapse Prevention In Schizophrenia: Post Hoc Indirect Analysis Using Published Placebo-Controlled Studies","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Paliperidone Palmitate; Olanzapine; Placebo; Medicine; Post-hoc analysis; Internal medicine; Schizophrenia (object-oriented programming); Paliperidone; Randomization; Relapse prevention; Randomized controlled trial; Atypical antipsychotic; Antipsychotic; Psychiatry","score_opus":0.13928824246581012,"score_gpt":0.3663091897198219,"score_spread":0.22702094725401178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015115414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990765,0.004954399,0.0001195226,0.00016193515,0.0003307301,0.0035615317,0.000011345588,0.000038499846,0.00005703864],"genre_scores_gemma":[0.99689126,0.0003084388,0.0023952802,0.000012787516,0.00003755324,0.00026339045,0.000048564827,0.000027786135,0.000014940854],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9962221,0.0017416701,0.0009084681,0.00042620808,0.00030999305,0.00039157388],"domain_scores_gemma":[0.99683183,0.0019415155,0.00053376367,0.0004323687,0.0001707138,0.000089777976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005015387,0.00024457552,0.0015530769,0.00078292965,0.00010543613,0.000014222092,0.00012984526,0.00009442929,0.000007358243],"category_scores_gemma":[0.0013597156,0.00016422675,0.00027931904,0.0010404253,0.000076044365,0.00017386982,0.00007193444,0.0002493918,0.0000010481215],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.51874167,0.0018643046,0.4431996,0.0032830925,0.0058223098,0.000054896198,0.0077135353,0.014674922,0.0019741436,0.00027107212,0.000013551935,0.0023868894],"study_design_scores_gemma":[0.17697544,0.0034908387,0.78114355,0.0036477065,0.0022253022,0.000010512137,0.001307234,0.028483486,0.0018157748,0.0006258508,0.000004187829,0.00027014065],"about_ca_topic_score_codex":0.0026995894,"about_ca_topic_score_gemma":0.0008194331,"teacher_disagreement_score":0.34176624,"about_ca_system_score_codex":0.0005104571,"about_ca_system_score_gemma":0.00022893974,"threshold_uncertainty_score":0.6696973},"labels":[],"label_agreement":null},{"id":"W2015168093","doi":"10.1016/j.jval.2013.03.1478","title":"Cost-effectiveness of ticagrelor versus generic clopidogrel in patients with acute coronary syndromes in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; University Health Network; St. Paul's Hospital; McMaster University; Programs for Assessment of Technology in Health Research Institute; AstraZeneca (Canada); University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Ticagrelor; Clopidogrel; Medicine; Acute coronary syndrome; Myocardial infarction; Quality-adjusted life year; Internal medicine; Stroke (engine); Emergency medicine; Cardiology; Aspirin; Cost effectiveness","score_opus":0.03387759758753904,"score_gpt":0.2694890968173862,"score_spread":0.23561149922984714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015168093","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965699,0.0015119604,0.000010783219,0.00008371397,0.00014624593,0.0016229321,0.000017466022,0.000006731057,0.000030294283],"genre_scores_gemma":[0.9991395,0.0004637072,0.00010539047,0.000119435565,0.000008250992,0.000097012635,0.00004530481,0.000017666156,0.0000037497723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985272,0.00032715767,0.0003089598,0.00021337577,0.0003122383,0.00031103136],"domain_scores_gemma":[0.9993653,0.00016292621,0.0000708083,0.0002219369,0.000047547375,0.0001314305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026370466,0.00012708596,0.000508982,0.00013225456,0.000015428537,0.0000023517564,0.000067243986,0.00004253095,0.000029489831],"category_scores_gemma":[0.000023056658,0.00010428963,0.00004811779,0.00038307812,0.000038186532,0.00006199807,0.000017344475,0.00014678919,0.0000037820455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023446572,0.00023292677,0.980442,0.0004343878,0.00015067372,0.00016322735,0.00007579064,0.002336517,0.0000031297939,0.000018087896,0.000022838425,0.013775773],"study_design_scores_gemma":[0.009895213,0.0007057827,0.9880591,0.00060526526,0.000022805834,0.000012294255,0.000105993626,0.00041010507,0.000021683127,0.000012207308,0.000051562853,0.000097998534],"about_ca_topic_score_codex":0.7317905,"about_ca_topic_score_gemma":0.076866,"teacher_disagreement_score":0.6549245,"about_ca_system_score_codex":0.00088072615,"about_ca_system_score_gemma":0.0018640708,"threshold_uncertainty_score":0.9399788},"labels":[],"label_agreement":null},{"id":"W2015241337","doi":"10.1016/j.jval.2014.08.877","title":"Systematic Review of the Economics of Multiple Sclerosis in Latin America","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Fingolimod; Latin Americans; MEDLINE; Medicine; Work productivity; Multiple sclerosis; Natalizumab; Family medicine; Productivity; Political science; Economic growth; Economics; Psychiatry","score_opus":0.03738025541272694,"score_gpt":0.25585409724819513,"score_spread":0.2184738418354682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015241337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8475089,0.06784522,0.00012365927,0.08026961,0.00029086342,0.0030894491,0.000007905444,0.000030064444,0.0008343127],"genre_scores_gemma":[0.9501373,0.047116283,0.00044562118,0.0022605204,0.0000050747904,0.000010868386,8.5205073e-7,0.0000049829264,0.000018483282],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989677,0.0001949084,0.0006216046,0.000078372665,0.000041994164,0.00009544072],"domain_scores_gemma":[0.9991786,0.00018680333,0.00030364835,0.00029782823,0.000013373015,0.000019777752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007280201,0.00004702061,0.00051571935,0.00006582743,0.000010827007,3.016159e-7,0.00008105162,0.00030009047,0.0000054616316],"category_scores_gemma":[0.00064944505,0.000029513103,0.00004886257,0.00022576442,0.00006574666,0.0000070683377,0.000020671032,0.00051093183,0.0000028757868],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025907962,0.0002131035,0.025061881,0.96646154,0.000040783565,4.048288e-7,0.00059908925,0.00063148764,0.00018248268,0.005077738,0.00016194435,0.0015436241],"study_design_scores_gemma":[0.001369569,0.00041494475,0.03374558,0.94074386,0.000068648216,0.000009284324,0.0001773806,0.021669168,0.0011694386,0.0003066352,0.0002303072,0.000095184245],"about_ca_topic_score_codex":0.0009418102,"about_ca_topic_score_gemma":0.000026174903,"teacher_disagreement_score":0.1026284,"about_ca_system_score_codex":0.000040873892,"about_ca_system_score_gemma":0.00007781663,"threshold_uncertainty_score":0.23145725},"labels":[],"label_agreement":null},{"id":"W2015267237","doi":"10.1016/j.jval.2013.08.2069","title":"Acute Exposure of Bisphenol-A from Electronic Gadgets Does Not Induce Oxidative Stress in the Rat Brain","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Effects and risks of endocrine disrupting chemicals","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Oxidative stress; Glutathione peroxidase; Superoxide dismutase; Catalase; Glutathione; Endocrinology; Internal medicine; Striatum; Chemistry; Antioxidant; Glutathione reductase; Biochemistry; Biology; Enzyme; Medicine; Dopamine","score_opus":0.012976075739126094,"score_gpt":0.3153462837023737,"score_spread":0.30237020796324765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015267237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993518,0.0001935822,0.0000048912034,0.0054203873,0.000060328486,0.00054313685,0.000026260193,0.000010941015,0.00022246782],"genre_scores_gemma":[0.9984758,0.00017554335,0.0002784983,0.00090961496,0.00002967794,0.000047839618,0.000013909411,0.00001105779,0.00005808056],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99818933,0.00039154614,0.0003702764,0.0002985471,0.00026669903,0.00048359716],"domain_scores_gemma":[0.99875396,0.0007191014,0.00016161875,0.0002983244,0.0000057562793,0.00006121389],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005284531,0.00013864588,0.00023750216,0.000034398687,0.00004929731,0.00001831788,0.0003871599,0.000052710308,0.00022200313],"category_scores_gemma":[0.00013084395,0.00007841125,0.00003837516,0.00023953409,0.000101748155,0.00014411742,0.000101033474,0.0003438567,0.00004441736],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008881997,0.0009509025,0.34612378,0.00015028115,0.000045186254,0.00002475119,0.018542372,0.005471226,0.60807383,0.00081087975,0.0037837187,0.015934216],"study_design_scores_gemma":[0.0026971828,0.0010980777,0.44686618,0.0005686333,0.000018241584,0.000006869722,0.004084198,0.0033460527,0.525845,0.013516752,0.0012798274,0.00067296834],"about_ca_topic_score_codex":0.05757964,"about_ca_topic_score_gemma":0.0016492779,"teacher_disagreement_score":0.1007424,"about_ca_system_score_codex":0.00016488126,"about_ca_system_score_gemma":0.00003887007,"threshold_uncertainty_score":0.948696},"labels":[],"label_agreement":null},{"id":"W2015321922","doi":"10.1046/j.1524-4733.2001.45038.x","title":"The Impact of Risk on Preference Values: Implications for Evaluations of Postmenopausal Osteoporosis Therapy","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Raloxifene; Breast cancer; Osteoporosis; Hormone replacement therapy (female-to-male); Population; Physical therapy; Hip fracture; Menopause; Disease; Demography; Gynecology; Internal medicine; Cancer; Environmental health; Tamoxifen","score_opus":0.17587978099360377,"score_gpt":0.4486038905858972,"score_spread":0.27272410959229343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015321922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903702,0.0029728743,0.000076269906,0.0028178978,0.00007003206,0.002992747,0.00039347933,0.00001712068,0.00028934833],"genre_scores_gemma":[0.98936534,0.009254653,0.000841981,0.00015905719,0.000043120825,0.00020752095,0.000056887628,0.00002245149,0.00004900259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980734,0.0002884882,0.00076449226,0.00022259146,0.00023836042,0.00041269715],"domain_scores_gemma":[0.9969498,0.0014353659,0.00055316737,0.0005957217,0.00023982658,0.00022610837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013671869,0.0001563392,0.00039894116,0.00015510315,0.00023855282,0.000006966999,0.00011389254,0.000062706444,0.000024161898],"category_scores_gemma":[0.0006014998,0.000091237656,0.000040966013,0.00038411963,0.00006733208,0.000042328462,0.0000100816815,0.00013834225,0.0000036692759],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00968108,0.00707584,0.6360003,0.0007177077,0.00074047304,0.0000016853672,0.008925395,0.010925307,0.006100978,0.006835721,0.0024624597,0.31053308],"study_design_scores_gemma":[0.005486007,0.024966896,0.9590297,0.00029782468,0.000048824957,0.000009777606,0.00009533769,0.0009809883,0.00023512288,0.008597716,0.00017794696,0.00007385967],"about_ca_topic_score_codex":0.010725075,"about_ca_topic_score_gemma":0.00006805734,"teacher_disagreement_score":0.32302943,"about_ca_system_score_codex":0.0003838178,"about_ca_system_score_gemma":0.0013245211,"threshold_uncertainty_score":0.9958626},"labels":[],"label_agreement":null},{"id":"W2015813113","doi":"10.1016/j.jval.2012.08.515","title":"UT3 Estimating Preference-Based Index from Cancer-Specific Quality of Life Measures for Use in Cost-Utility-Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Statistics; Mean squared error; Ordinary least squares; Econometrics; Standard error; Mathematics; Preference; Health Utilities Index; Quality of life (healthcare); Regression; Quality-adjusted life year; Linear regression; Medicine; Demography; Health related quality of life; Cost effectiveness; Internal medicine","score_opus":0.8132519896969925,"score_gpt":0.48554798356360784,"score_spread":0.3277040061333847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015813113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8852553,0.0075281705,0.09726828,0.0050060297,0.0006452505,0.001941112,0.0022738206,0.000030782,0.00005127121],"genre_scores_gemma":[0.9696851,0.00014477024,0.026879951,0.0024119536,0.00024307212,0.0004731281,0.000121831916,0.000028718678,0.000011495082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98896813,0.0018084837,0.0075941323,0.00066296256,0.0001959632,0.00077032245],"domain_scores_gemma":[0.9883844,0.0063883006,0.004000167,0.0007444166,0.000108303444,0.00037438684],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.041285273,0.000236655,0.0021618386,0.00092203787,0.000118099844,0.00004846869,0.0003053405,0.00020612263,0.00020828162],"category_scores_gemma":[0.008873031,0.00030568338,0.00023244905,0.00084094604,0.00007094074,0.0005204946,0.00003433122,0.00028480223,0.0000330645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078076715,0.00022993621,0.91837597,0.0006495227,0.00008834713,3.0035245e-8,0.0019433263,0.07092775,4.781599e-7,0.006512192,0.00044639513,0.0007479543],"study_design_scores_gemma":[0.0011351248,0.00002575328,0.6732479,0.00014565633,0.000008341583,2.3347015e-8,0.00036282724,0.32026413,0.000002564668,0.0027917107,0.0018066502,0.00020932536],"about_ca_topic_score_codex":0.26675323,"about_ca_topic_score_gemma":0.016486898,"teacher_disagreement_score":0.2502663,"about_ca_system_score_codex":0.0014593462,"about_ca_system_score_gemma":0.00083863485,"threshold_uncertainty_score":0.9999395},"labels":[],"label_agreement":null},{"id":"W2015965950","doi":"10.1016/j.jval.2011.08.1289","title":"PCN190 Use of Surrogate Measures of Survival in Economic Evaluations of Metastatic Breast Cancer Treatments","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Context (archaeology); Breast cancer; Pearson product-moment correlation coefficient; Metastatic breast cancer; Oncology; Population; Internal medicine; Covariate; Clinical trial; Progression-free survival; Cancer; Overall survival; Statistics","score_opus":0.7290232337247132,"score_gpt":0.47050470245681997,"score_spread":0.25851853126789326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2015965950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99175876,0.002041002,0.00015890095,0.0017812268,0.0004556571,0.0010576475,0.0024325685,0.00000917742,0.00030507267],"genre_scores_gemma":[0.995246,0.0010923379,0.0032264958,0.00020188635,0.000027225096,0.000102390935,0.00001981086,0.000029477967,0.00005436213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9916147,0.0012246105,0.006205961,0.0004284332,0.0001309858,0.0003953387],"domain_scores_gemma":[0.99435663,0.0010929309,0.0038173052,0.00051039166,0.00009070177,0.00013206276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015784124,0.00018729738,0.0016707963,0.00084823824,0.000035391455,0.0000068441514,0.00022552615,0.00008061742,0.00039220162],"category_scores_gemma":[0.00085909077,0.00023209573,0.00013117515,0.00031567807,0.00011014611,0.0003863926,0.00003439688,0.000117999,0.00005269848],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008631585,0.000607002,0.91968286,0.0011549186,0.00015451682,5.116531e-7,0.007394938,0.030355597,0.000008193318,0.03968363,0.00014875502,0.00072275294],"study_design_scores_gemma":[0.0023526375,0.00020963188,0.9636906,0.0005862341,0.000019386738,0.0000025036738,0.0008128316,0.021949304,0.000079226316,0.009877036,0.0001785314,0.00024210391],"about_ca_topic_score_codex":0.27757046,"about_ca_topic_score_gemma":0.010255254,"teacher_disagreement_score":0.2673152,"about_ca_system_score_codex":0.0011392428,"about_ca_system_score_gemma":0.001060803,"threshold_uncertainty_score":0.94645894},"labels":[],"label_agreement":null},{"id":"W2016226558","doi":"10.1016/j.jval.2011.08.1274","title":"PCN175 Reimbursement of Anticancer Drugs in Canada: What Can We Learn from the Nice New Appraisal Process for Life-Extending End-of-Life Treatments?","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Institut National d'Excellence en Santé et en Services Sociaux","funders":"","keywords":"Nice; Medicine; Reimbursement; Excellence; Formulary; Drug; Family medicine; Pharmacology; Health care","score_opus":0.44875200289416417,"score_gpt":0.43011521313592066,"score_spread":0.01863678975824351,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016226558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9332861,0.019059774,0.00030144752,0.043418605,0.001253084,0.0018754395,0.00056341477,0.000011234593,0.00023090171],"genre_scores_gemma":[0.9906606,0.0033664457,0.001220962,0.004238593,0.00021111111,0.00017035221,0.000033329183,0.00003670792,0.00006186206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940586,0.00040755802,0.004257556,0.0005317574,0.00017084189,0.000573655],"domain_scores_gemma":[0.993894,0.002518181,0.0027462004,0.00049101986,0.000046301742,0.00030431704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007612433,0.00020672649,0.0012103707,0.00022112463,0.000091996044,0.000020158192,0.00038896446,0.00008419679,0.00020985067],"category_scores_gemma":[0.002131578,0.00021654447,0.0000813178,0.00030390237,0.0000593343,0.00031576338,0.000036801168,0.00018630597,0.0000150636915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019129021,0.00033388348,0.88837725,0.0019285148,0.00020915421,7.1566546e-7,0.059848636,0.0057285847,8.425546e-7,0.033105124,0.0049010157,0.005375001],"study_design_scores_gemma":[0.0103017315,0.0007804627,0.75916016,0.004295875,0.000048245853,0.0000017923247,0.12500201,0.043905124,0.00009442942,0.034165967,0.021020282,0.0012238881],"about_ca_topic_score_codex":0.98124194,"about_ca_topic_score_gemma":0.65536565,"teacher_disagreement_score":0.32587627,"about_ca_system_score_codex":0.0019715263,"about_ca_system_score_gemma":0.00915047,"threshold_uncertainty_score":0.99646676},"labels":[],"label_agreement":null},{"id":"W2016421052","doi":"10.1016/j.jval.2012.08.2019","title":"PRS20 Cost-Benefit Analysis for a Treatment of Pulmonary Arterial Hypertension","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University; PharmIdeas (Canada)","funders":"","keywords":"Treprostinil; Medicine; Cohort; Population; Pulmonary hypertension; Willingness to pay; Emergency medicine; Internal medicine; Environmental health; Economics","score_opus":0.12435056726254615,"score_gpt":0.36138201002754905,"score_spread":0.2370314427650029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2016421052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99249184,0.003535338,0.000077548255,0.0016443965,0.00015170222,0.0018471581,0.00009871031,0.0000209057,0.00013238429],"genre_scores_gemma":[0.9964198,0.0010487334,0.001408556,0.00020939752,0.0001569116,0.00020525503,0.0002465063,0.000018181381,0.00028666708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984029,0.00008336121,0.00043275973,0.00024053545,0.00026962665,0.00057084305],"domain_scores_gemma":[0.998842,0.00018484374,0.000110093155,0.00032604462,0.00009224551,0.0004447465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028190145,0.00015472824,0.00073161337,0.00042141427,0.00006290151,0.000003490808,0.000041127794,0.00007400008,0.000049770188],"category_scores_gemma":[0.00005372273,0.00011147084,0.00023531327,0.0005055136,0.00003286636,0.00006782241,0.000014711501,0.00003910326,0.000012555174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004959675,0.015367631,0.9170698,0.00050081883,0.0013159548,0.00042357028,0.00035963178,0.00048686596,0.004809637,0.00028302113,0.00023518529,0.05418819],"study_design_scores_gemma":[0.0072345072,0.0036559242,0.9426208,0.00018211047,0.0006004235,0.00028409917,0.00016265902,0.03525594,0.0011901642,0.00014877357,0.008481515,0.00018306455],"about_ca_topic_score_codex":0.0029196877,"about_ca_topic_score_gemma":0.000018146671,"teacher_disagreement_score":0.054005124,"about_ca_system_score_codex":0.00031189324,"about_ca_system_score_gemma":0.00018788553,"threshold_uncertainty_score":0.4545649},"labels":[],"label_agreement":null},{"id":"W2017147270","doi":"10.1016/j.jval.2014.08.2664","title":"What Could the Future Hold? Simulating the Demand for Osteoarthritis (oa) Care in Alberta to Plan a Sustainable Oa Care System","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Interprofessional Education and Collaboration","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Waterloo; University of Toronto; University of Saskatchewan; Alberta Innovates; University of Calgary","funders":"","keywords":"Operations management; Medicine; Population; Psychological intervention; Sustainability; Population ageing; Business; Medical emergency; Nursing; Engineering; Environmental health","score_opus":0.023281904578395768,"score_gpt":0.3861871882145921,"score_spread":0.36290528363619634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017147270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85544187,0.005750871,0.00022559483,0.11879387,0.007428927,0.010690242,0.000046491383,0.000060988405,0.0015611424],"genre_scores_gemma":[0.9876446,0.000033089305,0.00010980727,0.00831305,0.0009786765,0.0014966251,0.00007797334,0.000032241875,0.0013139535],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99613553,0.001890822,0.0007060842,0.00031661155,0.00026196457,0.0006890078],"domain_scores_gemma":[0.99673,0.0019414,0.0002662275,0.00041628839,0.00051253865,0.0001334952],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0018117634,0.00016777233,0.0002897755,0.00013218074,0.0016393751,0.00007045169,0.00026440798,0.00020527522,0.000015315267],"category_scores_gemma":[0.00044926393,0.00010819147,0.000042238054,0.0005204564,0.00001958551,0.0001940157,0.000083508596,0.00061036926,0.000027972661],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006724492,0.000050234514,0.028077928,0.008883788,0.000008620913,0.000002808638,0.79039836,0.03219595,0.0000061988358,0.11794613,0.007168699,0.014588836],"study_design_scores_gemma":[0.0010579899,0.00027300944,0.005202581,0.0027679193,0.000004205636,0.0000010697414,0.88359416,0.010907976,0.0000026065345,0.00024356021,0.09581574,0.00012917406],"about_ca_topic_score_codex":0.015226045,"about_ca_topic_score_gemma":0.05833416,"teacher_disagreement_score":0.1322027,"about_ca_system_score_codex":0.0012174274,"about_ca_system_score_gemma":0.0019614394,"threshold_uncertainty_score":0.9996604},"labels":[],"label_agreement":null},{"id":"W2017249113","doi":"10.1016/j.jval.2012.02.007","title":"Cost-Effectiveness of Expanded Newborn Screening in Texas","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services","funders":"","keywords":"Medicine; Newborn screening; Quality-adjusted life year; Population; Cohort; Cost effectiveness; Cost–benefit analysis; Medical Expenditure Panel Survey; Pediatrics; Health care; Health insurance; Environmental health; Economics","score_opus":0.06399642146045026,"score_gpt":0.34178277459631434,"score_spread":0.2777863531358641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017249113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869488,0.007219874,0.004623467,0.000052018146,0.0001560538,0.0004608944,0.0000074457685,0.0000031473032,0.000528295],"genre_scores_gemma":[0.99617034,0.0005669395,0.0029964864,0.00010454152,0.000062358435,0.00002405919,0.000030496403,0.000012189558,0.0000325868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987258,0.00041603943,0.0002647264,0.0001692826,0.00009061664,0.00033354256],"domain_scores_gemma":[0.999574,0.000039871808,0.000075328215,0.00020487346,0.000017059238,0.00008888141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013157325,0.00009104169,0.0001978545,0.000079501384,0.0000147700475,0.0000027984763,0.00009908644,0.00007862902,0.000008558324],"category_scores_gemma":[0.00009717706,0.00009112464,0.000034746008,0.00015566844,0.00003296891,0.0000034002471,0.000044834556,0.00006879769,0.0000026394487],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002086993,0.00025946184,0.9219307,0.0003172842,0.00001264265,5.386151e-7,0.00030724134,0.005900249,0.0134725645,0.00046801852,0.000099187295,0.057023436],"study_design_scores_gemma":[0.0016603955,0.00012851073,0.95097184,0.00015351012,0.0000028542092,0.0000028831091,0.00018298958,0.00019659419,0.02678581,0.00016020983,0.01960566,0.00014871232],"about_ca_topic_score_codex":0.0016401133,"about_ca_topic_score_gemma":0.0000673734,"teacher_disagreement_score":0.056874722,"about_ca_system_score_codex":0.0000058258797,"about_ca_system_score_gemma":0.00010379755,"threshold_uncertainty_score":0.3715955},"labels":[],"label_agreement":null},{"id":"W2017734769","doi":"10.1016/j.jval.2011.05.002","title":"Impact of Measures to Enhance the Value of Observational Surveys in Rare Diseases: The Fabry Outcome Survey (FOS)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Centre Hospitalier Universitaire de Sherbrooke; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Fabry disease; Medicine; Enzyme replacement therapy; Observational study; Natural history; Disease; Blood pressure; Internal medicine; Intensive care medicine","score_opus":0.24879448948216032,"score_gpt":0.4349657942901129,"score_spread":0.18617130480795258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2017734769","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954073,0.0013207215,0.0003698208,0.0012321532,0.00007450124,0.0012723568,0.00019845107,0.00000931134,0.00011541369],"genre_scores_gemma":[0.99933213,0.00010351132,0.00010232711,0.0002726191,0.000026633421,0.000049718776,0.000032776876,0.000021670932,0.00005863204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99332875,0.0041946685,0.00087226543,0.0002728755,0.00088224676,0.00044918788],"domain_scores_gemma":[0.9972923,0.0013873996,0.00021092992,0.0006160286,0.00031030996,0.00018304656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009783986,0.00015321684,0.0005161811,0.0001904643,0.000058166283,0.000006089228,0.0004374392,0.0000652574,0.000101760175],"category_scores_gemma":[0.0049569104,0.00008623334,0.00013439497,0.0011562697,0.00014458869,0.00006861316,0.000099863144,0.00034045972,0.000008865852],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030733243,0.00041378543,0.9921171,0.00022231205,0.000033409986,0.000004881004,0.0025267864,0.0012057341,0.000042538777,0.00015622229,0.0001939646,0.0027759287],"study_design_scores_gemma":[0.000504354,0.00044478598,0.9974938,0.00017185012,0.0000048805496,0.0000018028359,0.00021795154,0.0007310652,0.00005726037,0.0002917105,0.000009681665,0.00007087073],"about_ca_topic_score_codex":0.21868874,"about_ca_topic_score_gemma":0.0058262744,"teacher_disagreement_score":0.21286246,"about_ca_system_score_codex":0.00034818385,"about_ca_system_score_gemma":0.001419996,"threshold_uncertainty_score":0.7865141},"labels":[],"label_agreement":null},{"id":"W2018123025","doi":"10.1016/j.jval.2014.03.156","title":"Dissecting The Delays: The Impact Of New Policies And Practices On Total Time To Reimbursement In Ontario","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Formulary; Reimbursement; Receipt; Notice; Business; Medicine; Actuarial science; Operations management; Accounting; Family medicine; Health care; Economics; Political science","score_opus":0.15040004591590553,"score_gpt":0.37749601616266476,"score_spread":0.22709597024675923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018123025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97456354,0.00027463687,0.000006138593,0.016501084,0.000069859096,0.00027058792,0.000011495698,0.0000030898716,0.008299597],"genre_scores_gemma":[0.9977096,0.00007319113,0.000041873303,0.0016577018,0.00009427354,0.0000069726766,8.915375e-7,0.000008349505,0.00040717807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99900436,0.00004663876,0.00049154053,0.00017270603,0.000020239579,0.00026451264],"domain_scores_gemma":[0.998888,0.00040354815,0.00039776653,0.00019994429,0.0000054452894,0.00010525146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016371179,0.00008844752,0.00024341034,0.00012648206,0.00006006512,0.000040986288,0.00013837562,0.000029104613,0.000098722325],"category_scores_gemma":[0.00036346566,0.00006191741,0.000043433287,0.0001343692,0.000023223914,0.00006739253,0.00005153775,0.00022585606,0.000071500595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016548469,0.0002464877,0.574214,0.000047252448,0.00006991746,6.192523e-7,0.03763558,0.15423119,0.00002011676,0.22258426,0.003170355,0.007614774],"study_design_scores_gemma":[0.0005441449,0.000568877,0.9131129,0.00006251731,0.00000176941,0.000003765144,0.00014751361,0.04039482,0.000013660848,0.02292811,0.022073448,0.00014851667],"about_ca_topic_score_codex":0.67857176,"about_ca_topic_score_gemma":0.02737067,"teacher_disagreement_score":0.65120107,"about_ca_system_score_codex":0.00037351748,"about_ca_system_score_gemma":0.00012214277,"threshold_uncertainty_score":0.9903773},"labels":[],"label_agreement":null},{"id":"W2018206144","doi":"10.1016/j.jval.2011.08.975","title":"PSY2 Coexistence of Immuno-Mediated Inflammatory Diseases: an Analysis of the Quebec Administrative Health Databases","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Abbott (Canada); Université de Montréal","funders":"","keywords":"Medicine; Medical diagnosis; Cohort; Rheumatoid arthritis; Ankylosing spondylitis; Psoriatic arthritis; Population; Psoriasis; Medical prescription; Internal medicine; Inflammatory bowel disease; Comorbidity; Adalimumab; Disease; Database; Dermatology; Pathology","score_opus":0.15194359115498005,"score_gpt":0.39158991520259373,"score_spread":0.23964632404761368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018206144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488467,0.0025870465,0.000035587178,0.00046440723,0.00010737604,0.0012609451,0.00046053706,0.000027679851,0.0001717777],"genre_scores_gemma":[0.99863684,0.00045073908,0.00039175726,0.00020602168,0.000024576188,0.00004155958,0.0001381059,0.000021349328,0.00008907035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956903,0.0013331285,0.0013861115,0.00036828718,0.0007725327,0.00044966655],"domain_scores_gemma":[0.996733,0.00048853783,0.00086346053,0.0013115987,0.00022599078,0.00037742994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018467031,0.00017652626,0.0010216438,0.0005433254,0.00007474659,0.0000041188077,0.0003799587,0.00005620659,0.00009704793],"category_scores_gemma":[0.0007754071,0.0001236659,0.00017872248,0.0017381123,0.00038976193,0.000121153025,0.00009699265,0.00026217152,0.0000043835707],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004170642,0.0006967323,0.9744738,0.003287793,0.00031575764,0.000013057255,0.018742627,0.00005968103,0.00016007353,0.0014754675,0.00010750554,0.0002504895],"study_design_scores_gemma":[0.0015681483,0.0009484904,0.9715298,0.0030326033,0.00018399295,0.00008293307,0.016740639,0.005186565,0.00041962275,0.000038925693,0.00011479365,0.00015347717],"about_ca_topic_score_codex":0.17509072,"about_ca_topic_score_gemma":0.017508753,"teacher_disagreement_score":0.15758196,"about_ca_system_score_codex":0.0004985627,"about_ca_system_score_gemma":0.005427359,"threshold_uncertainty_score":0.9770295},"labels":[],"label_agreement":null},{"id":"W2018405956","doi":"10.1016/j.jval.2012.08.2121","title":"PCN81 Cost Effectiveness of Pazopanib in Soft Tissue Sarcoma","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Pazopanib; Medicine; Placebo; Ifosfamide; Oncology; Internal medicine; Nintedanib; Soft tissue sarcoma; Adverse effect; Urology; Sarcoma; Chemotherapy; Cancer; Sunitinib","score_opus":0.06680090485340451,"score_gpt":0.3659782292824633,"score_spread":0.2991773244290588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018405956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849099,0.012766473,0.000040146024,0.00065276574,0.00016832359,0.0011705885,0.0000075159196,0.000016237958,0.00026808464],"genre_scores_gemma":[0.99882627,0.00036026826,0.00044495906,0.00018714424,0.00005713888,0.00008319425,0.00001570607,0.000017443748,0.000007895681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860936,0.00035203865,0.00031853802,0.00016042686,0.00017312652,0.00038651965],"domain_scores_gemma":[0.99892676,0.00058170897,0.00007810381,0.00022424341,0.000020494846,0.00016870865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012275543,0.00010986574,0.00044510863,0.00013309128,0.000021060028,0.0000023254775,0.00004567347,0.000060388596,0.000055020202],"category_scores_gemma":[0.00010394507,0.00009596276,0.000039052906,0.000227247,0.000030786705,0.000045794248,0.000022293565,0.00012932249,0.000049879258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000119665594,0.0016357584,0.9582597,0.0007136072,0.000011915011,0.000030929987,0.00064214534,0.000087998524,0.00018695548,0.0005789393,0.00005561103,0.03767678],"study_design_scores_gemma":[0.0026365481,0.00034073272,0.9914565,0.0011066606,0.000010291854,0.000031452277,0.00007982513,0.00014023125,0.0025295687,0.0001671671,0.0014331755,0.00006784772],"about_ca_topic_score_codex":0.011639564,"about_ca_topic_score_gemma":0.00012384572,"teacher_disagreement_score":0.037608933,"about_ca_system_score_codex":0.00033695015,"about_ca_system_score_gemma":0.0001430617,"threshold_uncertainty_score":0.994942},"labels":[],"label_agreement":null},{"id":"W2018452892","doi":"10.1016/j.jval.2011.02.032","title":"CE3 COST-EFFECTIVENESS ANALYSIS AND BUDGET IMPACT ASSESSMENT: A GRAPHICAL WAY TO COMBINE THE TWO FOR THE AID OF DECISION-MAKERS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Budget constraint; Health technology; Cost effectiveness; Economic evaluation; Incremental cost-effectiveness ratio; Operations research; Computer science; Cost-effectiveness analysis; Health care; Operations management; Risk analysis (engineering); Economics; Actuarial science; Environmental economics; Business; Microeconomics; Engineering","score_opus":0.3345532783764616,"score_gpt":0.4825495918838026,"score_spread":0.147996313507341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018452892","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90209204,0.0015910463,0.07749172,0.014009496,0.00033272177,0.003898871,0.00043571627,0.000014846749,0.0001335671],"genre_scores_gemma":[0.9922247,0.0002530974,0.0042146994,0.0027741329,0.000050566952,0.00044490997,0.000011683142,0.000020518179,0.0000057070124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99537295,0.0009585491,0.0026607036,0.00046243993,0.0001097459,0.0004355883],"domain_scores_gemma":[0.98704374,0.0108075,0.0012128301,0.00064249383,0.000074216645,0.00021920819],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03811908,0.00017191589,0.0011104875,0.0006169689,0.0002595218,0.000036966725,0.00033320332,0.0000763227,0.000073099],"category_scores_gemma":[0.002474933,0.00012988767,0.00023816073,0.0010208889,0.00010862124,0.0001355412,0.000063917105,0.00019659741,0.000017256856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024951354,0.0002724093,0.7949329,0.0004269329,0.00058323896,5.7289077e-7,0.0051236474,0.015073591,9.385362e-7,0.17925042,0.00077253283,0.0033132813],"study_design_scores_gemma":[0.0014842583,0.00039187865,0.89237714,0.00009938334,0.00003451865,0.0000023636367,0.0006281995,0.065079324,0.000002142837,0.038095545,0.0016464117,0.00015884113],"about_ca_topic_score_codex":0.045865003,"about_ca_topic_score_gemma":0.001523485,"teacher_disagreement_score":0.14115487,"about_ca_system_score_codex":0.0004946826,"about_ca_system_score_gemma":0.00022866676,"threshold_uncertainty_score":0.99045885},"labels":[],"label_agreement":null},{"id":"W2018514398","doi":"10.1016/j.jval.2013.08.225","title":"Tobramycin Powder for Inhalation for the Treatment of Cystic Fibrosis: Analysis of the RAMQ Data","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Medicine; Tobramycin; Reimbursement; Inhalation; Antibiotics; Pediatrics; Population; Emergency medicine; Internal medicine; Health care; Anesthesia; Environmental health","score_opus":0.08666310165572542,"score_gpt":0.3470194326840225,"score_spread":0.2603563310282971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018514398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98402005,0.0021540336,0.0025553503,0.00638591,0.00022767796,0.0043270555,0.00026909116,0.0000106456755,0.000050172268],"genre_scores_gemma":[0.997971,0.00011649831,0.0009818664,0.00043535169,0.00006195127,0.000111690635,0.00010846035,0.000008452098,0.00020475211],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990554,0.00009754355,0.00044271778,0.00014310933,0.0001361711,0.00012507313],"domain_scores_gemma":[0.9983881,0.0006603751,0.00022925908,0.0005751252,0.00011309211,0.000034041146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004443629,0.00006862732,0.00028462883,0.0001338947,0.00007117265,0.000004650176,0.000109013185,0.00004347982,0.000031655214],"category_scores_gemma":[0.0001553261,0.0000341751,0.00012694542,0.00040645423,0.000041239044,0.000042599542,0.000014960332,0.000031342563,0.0000012505809],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023843714,0.005594636,0.21859872,0.0062716887,0.006233205,0.0000011345219,0.024295611,0.31071752,0.010506613,0.0056214225,0.015413542,0.39436153],"study_design_scores_gemma":[0.0027559283,0.0009545319,0.12842593,0.00019807564,0.0010458609,9.739582e-7,0.00078293524,0.854895,0.0016135783,0.00011241923,0.009135633,0.000079142985],"about_ca_topic_score_codex":0.0012971855,"about_ca_topic_score_gemma":0.00007222235,"teacher_disagreement_score":0.5441775,"about_ca_system_score_codex":0.00009089233,"about_ca_system_score_gemma":0.0001961201,"threshold_uncertainty_score":0.19609652},"labels":[],"label_agreement":null},{"id":"W2018622513","doi":"10.1016/j.jval.2013.08.1531","title":"Sustained Improvements in Productivity at Paid Work and Within Household, and Increased Participation in Daily Activities Over Time with Certolizumab Pegol in Patients with Psoriatic Arthritis: 48-Week Results from the Rapid-PsA Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Placebo; Psoriatic arthritis; Randomized controlled trial; Work productivity; Bristol-Myers; Internal medicine; Productivity; Arthritis; Rheumatoid arthritis; Adalimumab; Alternative medicine","score_opus":0.1213449115631311,"score_gpt":0.31204295326556436,"score_spread":0.19069804170243326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018622513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98800343,0.00045536069,0.0000041261624,0.006013896,0.00009322717,0.0051988703,0.00018998394,0.000019882793,0.00002119499],"genre_scores_gemma":[0.99860585,0.000051094336,0.00018364696,0.00044723312,0.000047297643,0.0005554338,0.000054139782,0.000036510013,0.00001881156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939428,0.0016044438,0.0028615377,0.0008438683,0.00018601066,0.0005613522],"domain_scores_gemma":[0.99640876,0.0013565139,0.0015466652,0.00050906744,0.000032093412,0.00014687116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006153833,0.00026602644,0.0009606474,0.0004054761,0.00012713751,0.0001017555,0.0001300839,0.000091635906,0.000030522122],"category_scores_gemma":[0.001396496,0.00024326585,0.000015040511,0.00049844856,0.00009302012,0.00082753965,0.0000930665,0.00030682902,0.000012950458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092684367,0.00090956985,0.9770008,0.00012189274,0.000021415795,0.0000035722344,0.019243883,0.0006741463,2.3785977e-7,0.000073438234,0.00012187391,0.0009023751],"study_design_scores_gemma":[0.012796885,0.0007256183,0.97837955,0.000400323,0.0000030535123,6.299185e-7,0.0028128338,0.0037216768,7.7998664e-7,0.00089318043,0.000010077755,0.0002554221],"about_ca_topic_score_codex":0.1263522,"about_ca_topic_score_gemma":0.031074999,"teacher_disagreement_score":0.095277205,"about_ca_system_score_codex":0.0012508237,"about_ca_system_score_gemma":0.00027773605,"threshold_uncertainty_score":0.99200934},"labels":[],"label_agreement":null},{"id":"W2018660330","doi":"10.1016/j.jval.2014.08.2321","title":"The Cost-Effectiveness of Second-Line Crizotinib in Eml4-Alk Rearranged Advanced Non-Small Cell Lung Cancer","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; Canadian Centre for Applied Research in Cancer Control; St. Michael's Hospital","funders":"","keywords":"Crizotinib; Docetaxel; Medicine; Pemetrexed; Lung cancer; Oncology; Internal medicine; Cost effectiveness; Chemotherapy; Cisplatin","score_opus":0.02990311617713927,"score_gpt":0.373961673780633,"score_spread":0.34405855760349374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018660330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882808,0.0036316328,0.0002355756,0.0011490115,0.00040050893,0.0025971974,0.0000351143,0.000018047263,0.0036521116],"genre_scores_gemma":[0.9976267,0.0007380092,0.00038553588,0.00027502037,0.000066403336,0.00047617266,0.000019864738,0.00002483346,0.00038741456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854296,0.0003370138,0.0004140479,0.00023988081,0.00014261433,0.00032348072],"domain_scores_gemma":[0.9987393,0.000627472,0.0001635593,0.0002836036,0.00007902412,0.00010705509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010242874,0.00012789978,0.00038046064,0.00010265033,0.00007654506,0.0000059591744,0.00007918177,0.000054662036,0.00002772872],"category_scores_gemma":[0.000087939494,0.00009119117,0.00004953532,0.00028769177,0.000038043574,0.000038129205,0.000016901715,0.00020586152,0.0000023838486],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030375693,0.001959578,0.75025785,0.0145807015,0.00022810992,0.00003721232,0.012180586,0.056881588,0.01067888,0.0016347785,0.00069986354,0.1478233],"study_design_scores_gemma":[0.022308797,0.0017161984,0.92301184,0.0049097645,0.0001173269,0.000007912979,0.0008253104,0.0210882,0.0093749445,0.00041481556,0.015911335,0.00031354843],"about_ca_topic_score_codex":0.008582105,"about_ca_topic_score_gemma":0.0033257308,"teacher_disagreement_score":0.172754,"about_ca_system_score_codex":0.00052955025,"about_ca_system_score_gemma":0.0006963439,"threshold_uncertainty_score":0.9980198},"labels":[],"label_agreement":null},{"id":"W2018708446","doi":"10.1016/j.jval.2014.03.997","title":"Respiratory Syncytial Virus Prophylaxis In Down Syndrome: A Prospective Cohort Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Incidence (geometry); Rate ratio; Pediatrics; Prospective cohort study; Respiratory tract infections; Cohort; Poisson regression; Lower respiratory tract infection; Cohort study; Internal medicine; Respiratory system; Confidence interval; Population","score_opus":0.04908918480151305,"score_gpt":0.37501298333502725,"score_spread":0.3259237985335142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018708446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99102294,0.00026591777,0.000031406038,0.00018412207,0.00019555287,0.0062906877,0.000004158988,0.000092819755,0.0019123607],"genre_scores_gemma":[0.9983545,0.000013890701,0.000075113254,0.0004286808,0.0001349203,0.0008089283,0.000001978349,0.000045850047,0.00013614386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952942,0.0015969164,0.0009006558,0.00072076434,0.00080497534,0.0006824987],"domain_scores_gemma":[0.9985123,0.00018841025,0.0001357057,0.0007344689,0.00013129076,0.0002977823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049962183,0.00023090257,0.00073401676,0.0010455719,0.00013371583,0.000032923297,0.00016646856,0.0001490809,0.00009887202],"category_scores_gemma":[0.0011090421,0.00020735328,0.00006300513,0.0016206088,0.0001271252,0.0001427165,0.00009353866,0.0011036969,0.00021215311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025801428,0.0016288499,0.9935919,0.00028697235,0.000023155293,0.00023807911,0.00057886256,0.00041509038,0.0002835086,0.00023166586,0.00007025192,0.0023936306],"study_design_scores_gemma":[0.002976618,0.011027237,0.98334223,0.0001902523,0.0000066585853,0.00004630499,0.00014273619,0.00069248857,0.00015958944,0.0001637658,0.0010849724,0.0001671585],"about_ca_topic_score_codex":0.01744152,"about_ca_topic_score_gemma":0.0014358505,"teacher_disagreement_score":0.01600567,"about_ca_system_score_codex":0.0017892652,"about_ca_system_score_gemma":0.0010800571,"threshold_uncertainty_score":0.9891014},"labels":[],"label_agreement":null},{"id":"W2018803855","doi":"10.1016/j.jval.2011.08.1488","title":"PSS23 Pharmacoeconomic Analyses of Partially Hydrolyzed Infant Formulas in Prevention of Atopic Dermatitis: Comparative Results From 5 European Countries","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Child Nutrition and Feeding Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PharmIdeas (Canada)","funders":"","keywords":"Christian ministry; Medicine; Infant formula; Atopic dermatitis; Pediatrics; Environmental health; Dermatology; Theology","score_opus":0.18388614880415427,"score_gpt":0.3936753880208357,"score_spread":0.2097892392166814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018803855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964081,0.0010277266,0.000041184463,0.00045424677,0.00007017108,0.0004050844,0.00006920918,0.00001653929,0.0015077301],"genre_scores_gemma":[0.99799424,0.00089053874,0.00077416154,0.00020905118,0.00004266408,0.0000045651354,0.00006325059,0.000007456993,0.000014042965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99836403,0.00025612736,0.0009803174,0.00015648529,0.00010564915,0.00013738823],"domain_scores_gemma":[0.9992556,0.00010769793,0.00039086465,0.00014087175,0.000040151015,0.000064836146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005190231,0.00008894784,0.00047367453,0.00021137175,0.000016755372,0.0000030470808,0.00006177009,0.00002879338,0.00005740686],"category_scores_gemma":[0.000046999026,0.00008519583,0.0000563849,0.00013538105,0.000058315654,0.00008731295,0.000018145665,0.00010608828,0.0000090596495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005646005,0.0035139262,0.8135706,0.0027506498,0.00044957342,0.000070284186,0.15660493,0.0026288459,0.007837074,0.0020791013,0.0021700517,0.0026789263],"study_design_scores_gemma":[0.009048591,0.00040894595,0.9276001,0.001773331,0.000037488855,0.0000036720887,0.0005334181,0.0047926586,0.05436944,0.00063571136,0.0006980129,0.00009862227],"about_ca_topic_score_codex":0.011161371,"about_ca_topic_score_gemma":0.000513207,"teacher_disagreement_score":0.15607151,"about_ca_system_score_codex":0.00006757742,"about_ca_system_score_gemma":0.00010989179,"threshold_uncertainty_score":0.9954234},"labels":[],"label_agreement":null},{"id":"W2018946414","doi":"10.1016/j.jval.2013.08.368","title":"Measuring Pros That Matter to Bariatric and Body Contouring Surgery: The Body-Q","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Body Contouring and Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Body contouring; Medicine; Quality of life (healthcare); Physical therapy; Quality (philosophy); Scars; Health care; Surgery; Weight loss; Psychology; Obesity; Nursing","score_opus":0.06139275314795122,"score_gpt":0.2628801023407883,"score_spread":0.20148734919283706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2018946414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655394,0.0013810161,0.00004292205,0.030637814,0.00037175644,0.0011193001,0.0000016504686,0.000064341504,0.00084178796],"genre_scores_gemma":[0.9942337,0.00015556396,0.00016910722,0.0041179177,0.00049738056,0.000120230354,0.0000018410336,0.000033637254,0.00067061116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981062,0.00023625579,0.0004365852,0.00032649425,0.00030830287,0.00058619754],"domain_scores_gemma":[0.99860185,0.0005398306,0.00010069619,0.0003777435,0.000050584902,0.00032926895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019411744,0.00017014025,0.00047125274,0.00026071537,0.000158535,0.00007131948,0.000077041324,0.000070298585,0.0000910019],"category_scores_gemma":[0.00022849128,0.000118814605,0.00007309994,0.0002497842,0.000031140058,0.00010834991,0.000060849245,0.00030563824,0.00015127701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004428947,0.000059512728,0.971249,0.0005103377,0.000023433278,0.000024162946,0.000873827,0.00003236768,0.00032468626,0.00008166175,0.02247674,0.0042999866],"study_design_scores_gemma":[0.00045774074,0.000055100118,0.9924819,0.000736676,0.000012742092,0.00005269625,0.00015575073,0.0011373301,0.00024356013,0.0001310023,0.004361922,0.00017359006],"about_ca_topic_score_codex":0.015033448,"about_ca_topic_score_gemma":0.00002592801,"teacher_disagreement_score":0.028694298,"about_ca_system_score_codex":0.00014600182,"about_ca_system_score_gemma":0.00025215463,"threshold_uncertainty_score":0.99152553},"labels":[],"label_agreement":null},{"id":"W2019871381","doi":"10.1016/j.jval.2011.10.014","title":"Comparative Health-Care Cost Advantage of Ipratropium over Tiotropium in COPD Patients","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Health; University of British Columbia","funders":"National Institute on Aging","keywords":"Ipratropium; Medicine; COPD; Indirect costs; Health care; Propensity score matching; Confounding; Percentile; Emergency medicine; Asthma; Internal medicine; Bronchodilator; Statistics; Business","score_opus":0.043932319701181645,"score_gpt":0.3801277253972995,"score_spread":0.33619540569611783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019871381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98110765,0.012746013,0.000022995893,0.0011332195,0.0004239871,0.002884926,0.00026923732,0.000025497578,0.0013865011],"genre_scores_gemma":[0.99788356,0.00036458284,0.00045006233,0.0006978754,0.00017145171,0.00007537226,0.0002441085,0.000034483288,0.00007848177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99636024,0.0006411783,0.000883173,0.0003730663,0.000705783,0.0010365471],"domain_scores_gemma":[0.9982838,0.00017580947,0.00029926424,0.00043665312,0.00016701093,0.0006374867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004760439,0.00023169126,0.00083964056,0.00041467143,0.00006929833,0.0000060717925,0.00013997397,0.00009213243,0.00019817066],"category_scores_gemma":[0.00008923416,0.0002248122,0.000088984154,0.00061315054,0.00015800896,0.00022152853,0.00010452195,0.00055246544,0.000051445546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055425003,0.0012753044,0.9840834,0.003001209,0.000018885146,0.000009932838,0.0055273334,0.00017122937,0.000027513284,0.0007853896,0.0015559384,0.0029896183],"study_design_scores_gemma":[0.004424732,0.0005383648,0.98434424,0.0006513556,0.000005974822,0.0000038278968,0.0024842317,0.0007239283,0.00007533829,0.000024467281,0.0065768645,0.00014666289],"about_ca_topic_score_codex":0.004946118,"about_ca_topic_score_gemma":0.0003000768,"teacher_disagreement_score":0.01677596,"about_ca_system_score_codex":0.0032491307,"about_ca_system_score_gemma":0.0015681287,"threshold_uncertainty_score":0.9167575},"labels":[],"label_agreement":null},{"id":"W2019980223","doi":"10.1016/j.jval.2012.08.488","title":"RU1 Cholinesterase Inhibitors: A Population-Based Assessment of Resource Utilization and Costs for Patients With Alzheimer'S Dementia","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cholinesterase and Neurodegenerative Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Galantamine; Rivastigmine; Donepezil; Medicine; Medical prescription; Dementia; Formulary; Health care; Gerontology; Disease; Environmental health; Family medicine; Nursing; Internal medicine","score_opus":0.0662050661486376,"score_gpt":0.36189544733122103,"score_spread":0.29569038118258345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019980223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652076,0.0015817761,0.00023735421,0.00029530466,0.000055927845,0.0012241596,0.000062885185,0.000013259281,0.000008578172],"genre_scores_gemma":[0.9963316,0.000021477977,0.00200926,0.0007977633,0.00010690193,0.000059148744,0.00065215916,0.000020430458,0.0000012731867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989272,0.00013004789,0.00037165798,0.00017250875,0.00020010391,0.00019849384],"domain_scores_gemma":[0.99925905,0.00013749121,0.0001827691,0.00014181243,0.00010386457,0.00017501971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024343276,0.00011420835,0.00022564371,0.00013845594,0.000053046544,0.0000074695727,0.000020424195,0.000031081385,0.000004011163],"category_scores_gemma":[0.00006649638,0.0000934971,0.000027392129,0.00015815318,0.000017745939,0.00011211835,0.00000910218,0.000052960437,1.4022505e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023969318,0.0007619984,0.9957143,0.00023641011,0.00003334119,3.3735927e-7,0.000089590096,0.00040210554,0.00002610656,0.0000664259,0.00007596552,0.002353703],"study_design_scores_gemma":[0.0036655432,0.0005404879,0.9894687,0.00047575144,0.00011849659,8.162825e-7,0.00002217533,0.0048625856,0.00036905936,0.0000025561937,0.0003893458,0.00008451755],"about_ca_topic_score_codex":0.00031801846,"about_ca_topic_score_gemma":0.000015322286,"teacher_disagreement_score":0.0062456583,"about_ca_system_score_codex":0.00005837526,"about_ca_system_score_gemma":0.0001457607,"threshold_uncertainty_score":0.38127014},"labels":[],"label_agreement":null},{"id":"W2020038531","doi":"10.1016/j.jval.2011.02.306","title":"PSS4 SYSTEMATIC REVIEW OF THE EPIDEMIOLOGIC LITERATURE ON ATOPIC DERMATITIS IN CHILDREN","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Food Allergy and Anaphylaxis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PharmIdeas (Canada)","funders":"","keywords":"Atopic dermatitis; Medicine; Epidemiology; Incidence (geometry); Population; Demography; Asthma; Prevalence; Pediatrics; Systematic review; Allergy; MEDLINE; Dermatology; Environmental health; Pathology; Immunology","score_opus":0.06742044411482051,"score_gpt":0.3369425972754791,"score_spread":0.2695221531606586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020038531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6167833,0.361774,0.0000032362884,0.0142083615,0.00015453991,0.004347518,0.000015242618,0.000025305582,0.0026884605],"genre_scores_gemma":[0.9544343,0.038627855,0.00010273928,0.006677571,0.0000213594,0.000043845277,0.000006218655,0.0000066169437,0.00007953572],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99771565,0.0010869564,0.000636498,0.00014340457,0.00019552879,0.00022194775],"domain_scores_gemma":[0.9991718,0.00017863323,0.00016447129,0.00038935014,0.00003118486,0.00006457167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001651346,0.00008722955,0.000583433,0.000116590396,0.000025701844,0.0000017333178,0.00015886052,0.000069015594,0.000038196376],"category_scores_gemma":[0.0013565418,0.00004752403,0.000086714135,0.00052600174,0.00003786886,0.000021614169,0.000029249384,0.00040517692,0.000013210247],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000135348455,0.00030119598,0.15571335,0.8315471,0.000039496095,0.000018452985,0.0012221877,0.000013999383,0.0000018443166,0.009677668,0.0009689131,0.0004822567],"study_design_scores_gemma":[0.0002804096,0.00029230784,0.5146019,0.48392525,0.000002414927,0.0000414373,0.000017806145,0.00007045298,0.000019807889,0.0006707838,0.000035074376,0.000042340303],"about_ca_topic_score_codex":0.0010019827,"about_ca_topic_score_gemma":0.00003018594,"teacher_disagreement_score":0.35888857,"about_ca_system_score_codex":0.000075152195,"about_ca_system_score_gemma":0.00012648621,"threshold_uncertainty_score":0.19379738},"labels":[],"label_agreement":null},{"id":"W2020143870","doi":"10.1016/j.jval.2012.03.048","title":"MA2 Comparison of Health Care Costs for Crohn's Disease Patients Who are Adherent Versus Intermittently Adherent with Infliximab Therapy","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Infliximab; Internal medicine; Tolerability; Rheumatoid arthritis; Propensity score matching; Crohn's disease; Gastroenterology; Disease; Surgery; Adverse effect","score_opus":0.1784092953410798,"score_gpt":0.46343330872369903,"score_spread":0.28502401338261923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020143870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560828,0.027292205,0.00016885712,0.0034766647,0.0027777916,0.009330388,0.0006625751,0.00009055133,0.0001181613],"genre_scores_gemma":[0.9949417,0.0011737094,0.00032516822,0.0017896034,0.0006092583,0.0006221429,0.00038590643,0.000089417525,0.00006308635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931158,0.002008333,0.0019915772,0.00049575965,0.0006476148,0.0017409332],"domain_scores_gemma":[0.9952682,0.0007077989,0.0018608193,0.0005798141,0.00047551567,0.0011078103],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011993203,0.00041744558,0.0012081608,0.00027338183,0.0006683864,0.00000891967,0.00030344678,0.00021803343,0.00005920353],"category_scores_gemma":[0.00018719674,0.00034202874,0.0001409194,0.00040343034,0.000070101036,0.00020482016,0.000101682286,0.00086346647,0.000028414126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037916626,0.00090031896,0.92547566,0.0058553657,0.000022044302,8.6623544e-7,0.020856252,0.000047324585,5.153958e-8,0.00020517754,0.009039348,0.033805944],"study_design_scores_gemma":[0.012191172,0.0020534988,0.9441091,0.003649039,0.000014283032,7.858941e-8,0.018711578,0.00017445363,0.0000014758217,0.000011841422,0.018757274,0.00032619757],"about_ca_topic_score_codex":0.0055607148,"about_ca_topic_score_gemma":0.001004405,"teacher_disagreement_score":0.0388589,"about_ca_system_score_codex":0.002171484,"about_ca_system_score_gemma":0.0024542883,"threshold_uncertainty_score":0.9999032},"labels":[],"label_agreement":null},{"id":"W2020394649","doi":"10.1016/j.jval.2011.07.009","title":"Development of a Composite Questionnaire, the Valuation of Lost Productivity, to Value Productivity Losses: Application in Rheumatoid Arthritis","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital; University of British Columbia","funders":"Canadian Institutes of Health Research; Health Canada; Canadian Arthritis Network; Pfizer","keywords":"Presenteeism; Absenteeism; Productivity; Valuation (finance); Wage; Medicine; Operations management; Economics; Actuarial science; Demographic economics; Business; Psychology; Labour economics; Social psychology; Accounting; Economic growth","score_opus":0.05540399910224962,"score_gpt":0.3113782031732845,"score_spread":0.2559742040710349,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020394649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98875874,0.0038066816,0.0027925228,0.0017743347,0.00006907405,0.0026433517,0.0000055908063,0.000019271336,0.00013044367],"genre_scores_gemma":[0.9876177,0.0027464032,0.009326434,0.000039505372,0.000022270355,0.00021296347,0.0000100919315,0.000017797847,0.000006880736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974079,0.0004876002,0.0008661386,0.0003655398,0.00055046333,0.00032231948],"domain_scores_gemma":[0.99886155,0.00007362381,0.00026875208,0.00045890352,0.00021900651,0.00011815769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035531872,0.0001383334,0.00044158733,0.00034643427,0.00007847798,0.00000675324,0.00014288462,0.000047639565,0.000007961159],"category_scores_gemma":[0.00044923698,0.00011533053,0.000036878828,0.00076039124,0.00014805951,0.00013851184,0.00006541013,0.00021596163,0.000016014494],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011322142,0.002999704,0.49372846,0.0015346144,0.00006724444,0.000005024142,0.06211318,0.0014352874,0.02040333,0.015492373,0.0000461906,0.40104237],"study_design_scores_gemma":[0.0018258574,0.00065812445,0.93657404,0.0047954093,0.0000011456088,0.0000497423,0.0004932766,0.0015437666,0.04759198,0.0056253974,0.0006640503,0.00017718704],"about_ca_topic_score_codex":0.009754506,"about_ca_topic_score_gemma":0.0020806547,"teacher_disagreement_score":0.44284558,"about_ca_system_score_codex":0.00027857648,"about_ca_system_score_gemma":0.0011369383,"threshold_uncertainty_score":0.99683964},"labels":[],"label_agreement":null},{"id":"W2020568545","doi":"10.1016/j.jval.2012.03.1048","title":"PIH16 Cost-Effectiveness of a New Fixed-Dose Combination of Dutasteride and Tamsulosin for the Treatment of Symptomatic Benign Prostatic Hyperplasia in Quebec, Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Hôpital Saint-François d'Assise; GlaxoSmithKline (Canada)","funders":"","keywords":"Tamsulosin; Medicine; Dutasteride; Urology; Cohort; Population; Cost effectiveness; International Prostate Symptom Score; Economic evaluation; Combination therapy; Benign prostatic hyperplasia (BPH); Prostate; Hyperplasia; Gynecology; Internal medicine; Lower urinary tract symptoms","score_opus":0.06336307415147649,"score_gpt":0.35540785252499585,"score_spread":0.2920447783735194,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020568545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99159217,0.0033418366,0.00004713166,0.00082112313,0.000050627903,0.004087081,0.00004210647,0.0000022402455,0.000015707956],"genre_scores_gemma":[0.9990057,0.00052915025,0.00016805624,0.000016943759,0.000010515443,0.00017068905,0.000020758436,0.0000109249395,0.000067307104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998698,0.00032323512,0.0004174643,0.000103642444,0.00020650408,0.0002511851],"domain_scores_gemma":[0.9981327,0.0014143938,0.00013522687,0.0001541319,0.00005262477,0.000110925925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007743082,0.00009217305,0.00040561554,0.00012054543,0.000022183838,0.0000023565938,0.000037609185,0.000028094602,0.0000045786282],"category_scores_gemma":[0.00009832218,0.00006395897,0.000025524545,0.00020727998,0.000050144503,0.000052047628,0.000010217543,0.000053421623,9.7972766e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043350244,0.0036321855,0.8671683,0.023191333,0.00016151492,0.000009702473,0.022357289,0.00087784673,0.0024380528,0.0012006256,0.00016445555,0.07446364],"study_design_scores_gemma":[0.008564818,0.0043595675,0.97038096,0.0016253308,0.000043335753,0.00001770298,0.0012314602,0.0059056347,0.0072462605,0.00023039669,0.00031628224,0.000078230405],"about_ca_topic_score_codex":0.8651726,"about_ca_topic_score_gemma":0.2937494,"teacher_disagreement_score":0.57142323,"about_ca_system_score_codex":0.00045306046,"about_ca_system_score_gemma":0.0015623604,"threshold_uncertainty_score":0.71913785},"labels":[],"label_agreement":null},{"id":"W2020672080","doi":"10.1016/j.jval.2012.08.1567","title":"PRM104 Examination of Patient Preference: Comparisons of Results From the Time Trade-Off and Standard Gamble Instruments","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; PharmIdeas (Canada)","funders":"","keywords":"Data extraction; Time-trade-off; Medicine; MEDLINE; Systematic review; Population; Quality of life (healthcare); Preference; Inclusion and exclusion criteria; Health related quality of life; Quality-adjusted life year; Disease; Family medicine; Alternative medicine; Statistics; Environmental health; Cost effectiveness; Nursing; Pathology","score_opus":0.34955987864284616,"score_gpt":0.38648002668605114,"score_spread":0.03692014804320498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020672080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837566,0.003976597,0.00008875785,0.008611158,0.00024235329,0.00080844737,0.0016847556,0.0000092786595,0.0008220444],"genre_scores_gemma":[0.99689317,0.00040616814,0.0018352283,0.0006805681,0.00006111044,0.000022943554,0.00006849263,0.000011591388,0.000020718762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99477625,0.000833745,0.0036953546,0.00025940157,0.00013248135,0.00030279014],"domain_scores_gemma":[0.9954614,0.001408793,0.0026311225,0.0003484326,0.000025870273,0.00012437488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0138444705,0.00011172384,0.0007196905,0.00014624413,0.000080027065,0.000012577158,0.00014062216,0.00008517582,0.00004835701],"category_scores_gemma":[0.001464626,0.000113422255,0.000035401386,0.00016181254,0.00007315441,0.00025523815,0.00004186288,0.00013843815,0.000034588767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027838617,0.0008731654,0.79464835,0.0012478534,0.0001298045,1.15601445e-7,0.10311188,0.0021755425,0.000011532936,0.05992652,0.018099297,0.019497558],"study_design_scores_gemma":[0.0019314862,0.00039183043,0.9590012,0.0004744295,0.0000056461413,8.495906e-7,0.0026746881,0.014354304,0.00006142367,0.00276569,0.018149719,0.00018876219],"about_ca_topic_score_codex":0.007040499,"about_ca_topic_score_gemma":0.000077269695,"teacher_disagreement_score":0.16435283,"about_ca_system_score_codex":0.000326767,"about_ca_system_score_gemma":0.0001716609,"threshold_uncertainty_score":0.9995717},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"grok","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"opus","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2020694466","doi":"10.1016/j.jval.2014.08.1855","title":"Development Of A Global Economic Model To Evaluate The Cost-Effectiveness Of Targeted Treatments Using Companion Diagnostics In Advanced/Metastatic Cancer Treatment","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Population; Health care; Cancer; Prostate cancer; Cost effectiveness; Oncology; Intensive care medicine; Internal medicine; Environmental health; Risk analysis (engineering)","score_opus":0.14076879950580196,"score_gpt":0.3665633751447875,"score_spread":0.22579457563898553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2020694466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890563,0.0021905692,0.006386195,0.00011310216,0.00026520598,0.001400013,0.00038249826,0.000005308458,0.00020079165],"genre_scores_gemma":[0.99224967,0.000797902,0.006603046,0.000080855156,0.00001616984,0.00021952929,0.000009218037,0.000018000017,0.0000055977293],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.997956,0.000112986,0.001175252,0.00034098007,0.000038110455,0.0003766866],"domain_scores_gemma":[0.9989242,0.00021401649,0.00048253563,0.00025446597,0.000024702465,0.000100091434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013578314,0.0001981901,0.00083893054,0.00014934552,0.000054614335,0.000009604057,0.00016152769,0.00004518824,0.000011576158],"category_scores_gemma":[0.00009663996,0.00018507343,0.000067136396,0.00020774305,0.000040585735,0.00011474807,0.00003801866,0.00005766023,0.00001282744],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116203206,0.00018947387,0.17386542,0.0001160833,0.000039685496,2.2437429e-7,0.0008453715,0.79936194,0.00001544932,0.014330262,0.000003516533,0.011116345],"study_design_scores_gemma":[0.003297812,0.00032451013,0.45965138,0.00044120665,0.000011454176,7.011934e-7,0.00006484341,0.52312046,0.00034323768,0.012109228,0.0003930036,0.00024217642],"about_ca_topic_score_codex":0.016202733,"about_ca_topic_score_gemma":0.0019678734,"teacher_disagreement_score":0.28578594,"about_ca_system_score_codex":0.00473877,"about_ca_system_score_gemma":0.0006851057,"threshold_uncertainty_score":0.99908185},"labels":[],"label_agreement":null},{"id":"W2021006304","doi":"10.1111/j.1524-4733.2008.00334.x","title":"Cost-Effectiveness of LTBI Treatment for TB Contacts in British Columbia","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Centre for Disease Control; Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Medicine; Tuberculin; Latent tuberculosis; Vaccination; Cost effectiveness; Tuberculosis; Demography; Family medicine; Mycobacterium tuberculosis; Immunology; Risk analysis (engineering)","score_opus":0.18480053028488877,"score_gpt":0.4209927875626003,"score_spread":0.2361922572777115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021006304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448085,0.0013511922,0.000039336832,0.0009252308,0.000070511465,0.0029460005,0.000051039395,0.000011634812,0.00012421639],"genre_scores_gemma":[0.9955603,0.002951973,0.00041577706,0.00039122073,0.00004060565,0.00045559963,0.0000476774,0.000013105063,0.00012377124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981168,0.00065280404,0.0004247047,0.00023152345,0.00011120136,0.0004629972],"domain_scores_gemma":[0.99816936,0.0013542115,0.00006811347,0.00015454837,0.000056479148,0.00019730492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013941114,0.00006436343,0.0006528963,0.000086290725,0.000044023556,0.0000036098172,0.00004320204,0.00008373741,0.000021600506],"category_scores_gemma":[0.0009343418,0.00008319047,0.00007119929,0.00017849357,0.00006540694,0.000027915195,0.000010888235,0.000118747426,0.0000033420224],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045188004,0.0006641165,0.98486876,0.00078301074,0.000024759995,0.00011713352,0.0001977075,0.00026954187,0.00017895247,0.000031106138,0.0012884487,0.011124585],"study_design_scores_gemma":[0.006570734,0.0030597097,0.984225,0.00070323807,0.0000037420837,0.00013662176,0.000050659775,0.0015672204,0.00015076077,0.00020179403,0.0032724638,0.000058071593],"about_ca_topic_score_codex":0.5570486,"about_ca_topic_score_gemma":0.10380824,"teacher_disagreement_score":0.4532404,"about_ca_system_score_codex":0.0007698797,"about_ca_system_score_gemma":0.0006911126,"threshold_uncertainty_score":0.9125449},"labels":[],"label_agreement":null},{"id":"W2021231893","doi":"10.1016/s1098-3015(10)63543-7","title":"PMH11 RATIONAL CHOICE OF TREATMENT STRATEGY IN MODERATE TO SEVERE ALZHEIMER'S DISEASE PATIENTS LIVING IN CANADA","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacy and Medical Practices","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Medicine; Gerontology; Alzheimer's disease; Pediatrics; Internal medicine","score_opus":0.19072651486364875,"score_gpt":0.4512488658251738,"score_spread":0.2605223509615251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021231893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949029,0.0012789486,0.0000035461355,0.0021104396,0.0003354933,0.0006444609,0.000117393625,0.0000067854635,0.0005999985],"genre_scores_gemma":[0.99670017,0.0002142999,0.000029427787,0.0028079504,0.00007757016,0.00007022562,0.000039039627,0.000009528418,0.000051785155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975378,0.00094510557,0.0006184572,0.00024752948,0.00018052802,0.00047056723],"domain_scores_gemma":[0.9982492,0.0011260404,0.00016276987,0.00008855944,0.00003076394,0.00034269257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000628233,0.00014578742,0.00026021613,0.00013728421,0.00006210038,0.0000049228315,0.0001114233,0.00006036025,0.00022370933],"category_scores_gemma":[0.00016150011,0.00014384113,0.000022592976,0.0002651632,0.000025328342,0.00014435728,0.000028495599,0.00036810274,0.000005646132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030232823,0.00073808053,0.5572723,0.000052938445,0.000013879706,0.000026248747,0.0001985762,0.4360464,0.000013325512,0.00017085657,0.0006866662,0.0044783796],"study_design_scores_gemma":[0.0033939567,0.00021445435,0.8646788,0.00014565125,0.000028403221,0.0000010020042,0.000085588494,0.11889127,0.00018564078,0.00034955505,0.0118136015,0.00021205372],"about_ca_topic_score_codex":0.9166845,"about_ca_topic_score_gemma":0.80325884,"teacher_disagreement_score":0.31715512,"about_ca_system_score_codex":0.0011549848,"about_ca_system_score_gemma":0.00412079,"threshold_uncertainty_score":0.7310104},"labels":[],"label_agreement":null},{"id":"W2021469786","doi":"10.1016/j.jval.2012.03.149","title":"PHP73 Budget Impact Analysis: Do Canadian Guidelines Meet the Needs of Public Drug Plan Managers?","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Allowance (engineering); Liberian dollar; Business; Population; Pharmacy; Plan (archaeology); Actuarial science; Marketing; Medicine; Operations management; Family medicine; Environmental health; Finance; Geography; Economics","score_opus":0.47771202601597984,"score_gpt":0.44708418151341905,"score_spread":0.030627844502560786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021469786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73895,0.028939685,0.00051953946,0.22219497,0.0010633903,0.0012571787,0.0010750841,0.000042532203,0.005957591],"genre_scores_gemma":[0.9860361,0.00046806157,0.0007010429,0.012050874,0.0004291397,0.000051687537,0.000057030185,0.000030052897,0.00017598316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99217105,0.001146468,0.005114167,0.0003070036,0.00014124122,0.0011200941],"domain_scores_gemma":[0.9949196,0.00093516393,0.0023651384,0.00089143857,0.000097526456,0.00079111464],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05423141,0.00022643813,0.0012729896,0.002386604,0.00023502036,0.00008596462,0.00054694363,0.000121688434,0.00037551226],"category_scores_gemma":[0.002981495,0.00021732225,0.00026485673,0.0018587552,0.00007266701,0.0005245938,0.000045612298,0.00021285682,0.00029551386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000039224487,0.00008828736,0.7583349,0.00025905098,0.00029889244,2.9010837e-7,0.009507343,0.0072482154,5.9431418e-8,0.15670648,0.06735629,0.00019629483],"study_design_scores_gemma":[0.002141934,0.0001598468,0.6251669,0.00031875697,0.000094641626,0.000014178948,0.029796666,0.075335115,0.0000018314616,0.020886818,0.24490467,0.0011786261],"about_ca_topic_score_codex":0.7344705,"about_ca_topic_score_gemma":0.12464717,"teacher_disagreement_score":0.6098233,"about_ca_system_score_codex":0.0017517146,"about_ca_system_score_gemma":0.0010551978,"threshold_uncertainty_score":0.9738678},"labels":[],"label_agreement":null},{"id":"W2021488729","doi":"10.1016/j.jval.2012.08.1859","title":"PHS86 A Population-Based Study of the Resource Utilization and Costs of Treating Resectable Non-Small Cell Lung Cancer","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Cohort; Lung cancer; Retrospective cohort study; Cancer registry; Population; Cancer; Chemotherapy; Cohort study; Surgery; Emergency medicine; Internal medicine","score_opus":0.06515700393521344,"score_gpt":0.29259252724216994,"score_spread":0.2274355233069565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021488729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99081105,0.0065897973,0.000102718,0.00011739092,0.00014198697,0.0005859355,0.000050206298,0.0000040998243,0.0015967896],"genre_scores_gemma":[0.99947035,0.00015712735,0.00010667302,0.00010182565,0.000052355947,0.00002484632,0.0000030071685,0.000014742058,0.000069085254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988372,0.000053544267,0.0006772014,0.000162559,0.000029542813,0.00023997914],"domain_scores_gemma":[0.9989064,0.00010722389,0.0006977519,0.00021046911,0.000019282323,0.00005887391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087971025,0.0000854446,0.00033359622,0.00013866821,0.00007534505,0.000008805807,0.000097852055,0.000051592153,0.000019396568],"category_scores_gemma":[0.000096204385,0.00008355095,0.000030365216,0.00024553324,0.000015644666,0.00011418816,0.000028270211,0.00009057321,6.2450124e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020075342,0.00016430096,0.98304325,0.00015870643,0.000004886628,2.6027832e-8,0.0022915453,0.01168907,0.0000027125077,0.0017653881,0.000034331166,0.0008257327],"study_design_scores_gemma":[0.00093652867,0.000104424274,0.9697584,0.00016765305,0.0000041632043,8.733113e-8,0.0003712128,0.02813816,0.00006609112,0.00013143498,0.00023636466,0.00008547972],"about_ca_topic_score_codex":0.091091126,"about_ca_topic_score_gemma":0.0015536362,"teacher_disagreement_score":0.08953749,"about_ca_system_score_codex":0.00031332622,"about_ca_system_score_gemma":0.00009143018,"threshold_uncertainty_score":0.9149614},"labels":[],"label_agreement":null},{"id":"W2021663333","doi":"10.1016/j.jval.2014.03.1026","title":"Cost-Effectiveness Analysis Of Nurse-Administered Oral Corticosteroids At Triage In Pediatric Asthma","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa","funders":"","keywords":"Medicine; Triage; Emergency department; Asthma; Emergency medicine; Confounding; Health care; Pediatrics; Internal medicine; Nursing","score_opus":0.07824416446811817,"score_gpt":0.3822319371602224,"score_spread":0.30398777269210425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021663333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99604994,0.0015712021,0.0001031746,0.00047852297,0.00031735774,0.0008124567,0.000024746329,0.000018376782,0.00062420435],"genre_scores_gemma":[0.9983938,0.001006926,0.00014105732,0.00022448304,0.00006994082,0.000057629662,0.000032926662,0.000014307286,0.000058926078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976499,0.0006844904,0.00076160196,0.0003126406,0.0002489769,0.0003423888],"domain_scores_gemma":[0.99876165,0.0005131275,0.00022666265,0.0003000936,0.000074750365,0.00012368697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015347757,0.0001521366,0.0009815238,0.00069785427,0.000043205873,0.0000025909862,0.00007389445,0.00007598383,0.000041176052],"category_scores_gemma":[0.0005709999,0.00013473081,0.0001627777,0.0017509101,0.00004619168,0.000035963585,0.00003656405,0.0001680374,0.000005862719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005707303,0.00029343955,0.99129623,0.0007979839,0.00012513364,0.000015914171,0.0012386799,0.00077897985,0.00006631206,0.00013703559,0.00017413062,0.0045054452],"study_design_scores_gemma":[0.0027428002,0.0009854902,0.99058026,0.00015788448,0.0002539395,0.0000030248852,0.00020546357,0.0041455384,0.00011021166,0.000039025505,0.00066468806,0.000111664616],"about_ca_topic_score_codex":0.0015085732,"about_ca_topic_score_gemma":0.0007793876,"teacher_disagreement_score":0.0043937806,"about_ca_system_score_codex":0.00029900827,"about_ca_system_score_gemma":0.00012238571,"threshold_uncertainty_score":0.5494163},"labels":[],"label_agreement":null},{"id":"W2021695117","doi":"10.1016/s1098-3015(10)70232-1","title":"PCN54 A COST-UTILITY ANALYSIS OF PRIMARY PROPHYLAXIS VERSUS SECONDARY PROPHYLAXIS WITH COLONY-STIMULATING FACTOR IN ELDERLY PATIENTS WITH DIFFUSE AGGRESSIVE LYMPHOMA RECEIVING CURATIVE-INTENT CHEMOTHERAPY USING ONTARIO HEALTH ECONOMIC DATA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Secondary prophylaxis; Lymphoma; Chemotherapy; Intensive care medicine; Oncology; Internal medicine","score_opus":0.09503515220976427,"score_gpt":0.31487770632662865,"score_spread":0.21984255411686437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021695117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951147,0.0004584397,0.00013415494,0.0001689194,0.00014316422,0.0033366715,0.0005343164,0.000030330051,0.00007933435],"genre_scores_gemma":[0.9932826,0.00019742758,0.0051795826,0.00043212474,0.000028113758,0.00004352927,0.00076432584,0.000054203043,0.000018067316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957523,0.00045360462,0.001402793,0.0010974744,0.00054892554,0.0007449235],"domain_scores_gemma":[0.99647367,0.00037617894,0.0015209932,0.0011156986,0.00016544721,0.0003480001],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006436678,0.00044530243,0.0018301606,0.000774556,0.00021837061,0.000019700934,0.0003146789,0.00014144841,0.0001634848],"category_scores_gemma":[0.00011160804,0.00036681493,0.00011239333,0.0009834445,0.00025776436,0.00048574794,0.00010984486,0.0006125551,9.218331e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008682744,0.0008712157,0.9229995,0.0006276221,0.00053400197,0.000045068697,0.009489653,0.005659872,0.000014518006,6.229911e-7,0.000012529868,0.051062677],"study_design_scores_gemma":[0.018816441,0.0074907416,0.936972,0.0008260503,0.000060711645,0.00001189815,0.00032808297,0.035075236,0.000023154893,0.000001035878,0.000085773245,0.000308827],"about_ca_topic_score_codex":0.25802973,"about_ca_topic_score_gemma":0.12828507,"teacher_disagreement_score":0.12974468,"about_ca_system_score_codex":0.009348418,"about_ca_system_score_gemma":0.013676158,"threshold_uncertainty_score":0.9998784},"labels":[],"label_agreement":null},{"id":"W2021792499","doi":"10.1016/j.jval.2014.03.1130","title":"The inherent bias from using partitioned survival models in economic evaluation","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Lethbridge; University of Ottawa","funders":"","keywords":"Survival analysis; Clinical trial; Markov model; Medicine; Randomized controlled trial; Progression-free survival; Markov chain; Overall survival; Statistics; Oncology; Internal medicine; Mathematics","score_opus":0.659809391040091,"score_gpt":0.4838394291682127,"score_spread":0.17596996187187824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021792499","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9032632,0.00015632705,0.09425202,0.000601588,0.00023741605,0.0008367977,0.00000998983,0.00008642672,0.0005562523],"genre_scores_gemma":[0.98079264,0.00011746749,0.018831493,0.00006482278,0.00007166897,0.00008867445,0.0000084502,0.000020365069,0.0000044263948],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9975692,0.0010725181,0.0006430996,0.00021725977,0.00021470523,0.0002832049],"domain_scores_gemma":[0.9977784,0.0015266382,0.00026085068,0.0003475578,0.000036039924,0.00005051854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045220363,0.00011328184,0.0002407303,0.00008218908,0.00008870357,0.000028688508,0.00013812602,0.00006485141,0.000022324573],"category_scores_gemma":[0.0004938836,0.00009474047,0.00002722952,0.00009373007,0.000034829965,0.00017563548,0.00004006315,0.00017958188,0.000008862351],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029144345,0.000085842395,0.0025443668,0.000050419087,0.0000067711976,4.0232635e-7,0.0012228097,0.43762007,0.000077549164,0.54616493,0.00010257732,0.012095127],"study_design_scores_gemma":[0.00016187255,0.000021432861,0.00029383224,0.00008775027,0.0000017404993,1.7466138e-7,0.000077284174,0.48002997,0.00009145158,0.5191428,0.00004073249,0.000050927196],"about_ca_topic_score_codex":0.009182096,"about_ca_topic_score_gemma":0.003958184,"teacher_disagreement_score":0.077529445,"about_ca_system_score_codex":0.0009843702,"about_ca_system_score_gemma":0.0002592042,"threshold_uncertainty_score":0.99741584},"labels":[],"label_agreement":null},{"id":"W2021838863","doi":"10.1016/s1098-3015(10)70844-5","title":"PMS42 A COMPARISON OF PROVINCIAL PRESCRIPTION-ONLY PHARMACEUTICAL DATABASE WITH SELF-REPORTED USAGE OF ACETAMINOPHEN AND NSAIDS ACCORDING TO OSTEOARTHRITIS STAGE IN BRITISH COLUMBIA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Drug-Induced Hepatotoxicity and Protection","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acetaminophen; Medical prescription; Medicine; Stage (stratigraphy); Osteoarthritis; Database; Alternative medicine; Pharmacology; Computer science","score_opus":0.16174659231288674,"score_gpt":0.41356990151361844,"score_spread":0.2518233092007317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021838863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609685,0.0005718884,0.00012322962,0.00012409594,0.0002959379,0.002251309,0.0003096652,0.000054097294,0.00017290564],"genre_scores_gemma":[0.99733657,0.0004524192,0.001624899,0.0002723119,0.000066986104,0.00010925326,0.000028304165,0.000025018224,0.000084222265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964948,0.001148497,0.0010697681,0.0004593803,0.00030135908,0.00052614626],"domain_scores_gemma":[0.9987017,0.00029638785,0.00039640407,0.00019810963,0.00009461201,0.00031281385],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018493184,0.00016828241,0.0006657298,0.00021956828,0.00022721902,0.000024121731,0.00015804236,0.00024385961,0.000082470586],"category_scores_gemma":[0.00018670505,0.0002506861,0.00003981016,0.0006542256,0.00020268136,0.00025709116,0.000105737265,0.0009800323,0.000002650455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005340402,0.0011161173,0.95230466,0.0010055507,0.000053007458,0.00016912224,0.0036450997,0.0012203421,0.010961211,0.000028741342,0.000092809634,0.028869284],"study_design_scores_gemma":[0.025155408,0.006494948,0.85717165,0.0023955747,0.00022425302,0.0013116274,0.0035007945,0.046082374,0.04046556,0.0001118953,0.015666688,0.001419225],"about_ca_topic_score_codex":0.075149216,"about_ca_topic_score_gemma":0.06525033,"teacher_disagreement_score":0.09513302,"about_ca_system_score_codex":0.00021808632,"about_ca_system_score_gemma":0.00073335745,"threshold_uncertainty_score":0.9999945},"labels":[],"label_agreement":null},{"id":"W2021865256","doi":"10.1016/j.jval.2014.08.1050","title":"Value of Life And Cost of Pre-Mature Deaths With The Perspective Of Productivity As Net Tax Revenue: A Comparison In Usa, Canada, Japan and Australia","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Life expectancy; Productivity; Revenue; Human capital; Government (linguistics); Economics; Present value; Value (mathematics); Tax revenue; Net profit; Economic growth; Public economics; Demography; Finance; Population; Sociology","score_opus":0.05357586082127073,"score_gpt":0.41037441252761336,"score_spread":0.3567985517063426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2021865256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98944265,0.0017239009,0.0000060711327,0.0060082125,0.00015729487,0.0022415188,0.00022602515,0.0000034782406,0.00019084156],"genre_scores_gemma":[0.99888414,0.00009990525,0.00034257604,0.00033530072,0.0000679022,0.000047681824,0.000003419412,0.000014717078,0.00020436506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99586535,0.0020695725,0.0008252941,0.00035168938,0.0003960956,0.0004920141],"domain_scores_gemma":[0.9973665,0.00089881144,0.0008589314,0.0003922509,0.00026386368,0.0002196336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024127616,0.00017064957,0.00079035707,0.000104624116,0.00014179727,0.0000022683857,0.00015167182,0.00014934877,0.000011680472],"category_scores_gemma":[0.0010325526,0.00012717786,0.000015746122,0.0004113435,0.00021780925,0.000060313476,0.000074317984,0.0007712558,0.0000011090749],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045586683,0.000102821454,0.95471746,0.003582982,0.0000127413205,7.511858e-7,0.023974039,0.0012170252,0.000017565984,0.007824496,0.00799544,0.000098797704],"study_design_scores_gemma":[0.00093200314,0.0006032964,0.9848,0.0017414853,0.00000954425,0.0000028119434,0.009254695,0.00048699745,0.00002840902,0.0004736543,0.0015690738,0.00009803718],"about_ca_topic_score_codex":0.9805416,"about_ca_topic_score_gemma":0.9357474,"teacher_disagreement_score":0.044794187,"about_ca_system_score_codex":0.00052265794,"about_ca_system_score_gemma":0.0027910161,"threshold_uncertainty_score":0.51861626},"labels":[],"label_agreement":null},{"id":"W2022638664","doi":"10.1016/j.jval.2013.03.1175","title":"Reduction Of Pulmonary Arterial Hypertension (Pah)-Related Hospitalizations With Macitentan In The Randomized Controlled Trial Seraphin","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Victoria Hospital; London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Internal medicine; Placebo; Endothelin receptor antagonist; Bosentan; Post-hoc analysis; Proportional hazards model; Randomized controlled trial; Endothelin receptor; Receptor; Pathology","score_opus":0.024120504382993947,"score_gpt":0.2797003736023233,"score_spread":0.25557986921932935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2022638664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784107,0.00063910853,0.000007484566,0.0083856825,0.0002398393,0.01194085,0.0000049367954,0.000020316887,0.00035105672],"genre_scores_gemma":[0.9976865,0.0007324473,0.00016073618,0.00024716626,0.00006285087,0.0008582363,0.00009905195,0.00001677604,0.00013623011],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99669385,0.0013186203,0.0009274503,0.00025485017,0.00048656316,0.0003186787],"domain_scores_gemma":[0.9988148,0.00037397473,0.00024799706,0.0002911721,0.00014233397,0.000129682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013578987,0.00016410272,0.0012037135,0.0003879902,0.000077000266,0.000014304393,0.00007984221,0.00008807875,0.0000866771],"category_scores_gemma":[0.00027566488,0.000083897045,0.000152878,0.0006234075,0.00014489974,0.00012311476,0.000012845667,0.00022484144,0.000010540575],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.991583,0.0032467162,0.0020295868,0.00008118616,0.00016406352,0.00036081515,0.0003738409,0.0002492128,0.00078095583,0.00027714705,0.00022912219,0.0006243434],"study_design_scores_gemma":[0.96204454,0.0013513295,0.010532413,0.00036092178,0.0000675158,0.0004031383,0.00045703124,0.023862505,0.000014626007,0.0008068773,0.000015311913,0.000083811945],"about_ca_topic_score_codex":0.005935664,"about_ca_topic_score_gemma":0.000011189608,"teacher_disagreement_score":0.029538492,"about_ca_system_score_codex":0.000085234424,"about_ca_system_score_gemma":0.00028370117,"threshold_uncertainty_score":0.89729875},"labels":[],"label_agreement":null},{"id":"W2023573506","doi":"10.1016/j.jval.2011.08.1043","title":"PRM12 An Application of a Proposed Framework for Formulary Listing in Low-income Countries: Case of Côte d'Ivoire","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Formulary; Reimbursement; Listing (finance); Actuarial science; Medicine; Prior authorization; Family medicine; Business; Health care; Finance; Economics; Pharmacology; Economic growth","score_opus":0.12049046560661278,"score_gpt":0.3506844670838989,"score_spread":0.2301940014772861,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2023573506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98617685,0.00069171103,0.010589999,0.0004262699,0.00010074739,0.0010709383,0.00036254196,0.000011088031,0.0005698587],"genre_scores_gemma":[0.9880286,0.00018289647,0.011278628,0.0003705201,0.00004862391,0.000059348768,0.000008038801,0.000020046473,0.0000033195483],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9981994,0.000028423054,0.0011931208,0.0002606144,0.000016659113,0.00030175614],"domain_scores_gemma":[0.99873745,0.00018346902,0.0006684739,0.00027940812,0.000026323109,0.000104848616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014717553,0.00010200486,0.00045814275,0.00027467034,0.000039444618,0.000006996989,0.00015694194,0.00011494917,0.000021404412],"category_scores_gemma":[0.00016969735,0.00012468298,0.000054473112,0.00022613644,0.000051535542,0.00015087948,0.00002877089,0.000152491,0.000006425876],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009881532,0.00022237487,0.07924147,0.0015907347,0.000008912975,0.0000040449167,0.0037843173,0.0009100549,0.000002905717,0.9126045,0.0000030871681,0.0015287525],"study_design_scores_gemma":[0.0013085353,0.00042420474,0.014130431,0.00036285078,0.0000030889003,0.00001568274,0.00016331555,0.41168517,0.00031317945,0.56981677,0.0015092264,0.00026754453],"about_ca_topic_score_codex":0.012435428,"about_ca_topic_score_gemma":0.00030688598,"teacher_disagreement_score":0.41077513,"about_ca_system_score_codex":0.00017694007,"about_ca_system_score_gemma":0.00012358584,"threshold_uncertainty_score":0.99414086},"labels":[],"label_agreement":null},{"id":"W2024206659","doi":"10.1016/j.jval.2013.02.005","title":"Authors’ Response to “Comparative Effectiveness and Personalized Medicine” by Dr. J.C. Hornberger","year":2013,"lang":"en","type":"letter","venue":"Value in Health","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Indeterminate; Malignancy; Thyroid cancer; Population; Thyroid nodules; Test (biology); Cohort; General surgery; Cancer; Radiology; Internal medicine","score_opus":0.06390139838189203,"score_gpt":0.36656782235860574,"score_spread":0.3026664239767137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024206659","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10929525,0.02708355,0.000016143893,0.8591474,0.00070653576,0.0034483136,0.0001050051,0.000053918655,0.00014382835],"genre_scores_gemma":[0.07329678,0.005073194,0.00042655208,0.90006584,0.0025115027,0.0037755582,0.00047753638,0.00022229274,0.014150717],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955168,0.0017626422,0.0006064155,0.0008779678,0.0005723684,0.00066383986],"domain_scores_gemma":[0.99705315,0.0017123692,0.00022643547,0.00046551702,0.00009767925,0.00044484253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014964774,0.0005116407,0.001707007,0.00041419137,0.0000983957,0.000022982922,0.00011244502,0.00045365546,0.00022540794],"category_scores_gemma":[0.00016712077,0.00038372274,0.00010091588,0.00035499816,0.00016829999,0.000043843826,0.000049053528,0.001151846,0.00009200611],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012999107,0.00011364639,0.0012582561,0.0010917813,0.00013686139,0.00017537137,0.0028049974,0.0000064991564,0.00009587766,0.00002797961,0.99197435,0.0010144699],"study_design_scores_gemma":[0.004196485,0.0026190826,0.02658489,0.006246512,0.00011384404,0.000043653326,0.00014162945,0.000036702197,0.00008877545,0.00009153605,0.9595144,0.00032251867],"about_ca_topic_score_codex":0.012145275,"about_ca_topic_score_gemma":0.000011617424,"teacher_disagreement_score":0.040918414,"about_ca_system_score_codex":0.001171742,"about_ca_system_score_gemma":0.00052778656,"threshold_uncertainty_score":0.9998615},"labels":[],"label_agreement":null},{"id":"W2024319360","doi":"10.1016/s1098-3015(10)66206-7","title":"CASE2 DOTECHNOLOGY EVALUATIONS BASED ON EVIDENCE FROM CONDITIONAL FUNDING LEAD TO AN INCREASE IN POLICY FORMATION?: FINDINGS FROM, AND IMPLICATIONS OF, ONTARIO'S EVIDENCE-BASED HTA PROCESS","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Qualitative Comparative Analysis Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lead (geology); Process (computing); Real world evidence; Economics; Psychology; Public economics; Positive economics; Computer science; Medicine; Internal medicine; Biology","score_opus":0.4399434492178733,"score_gpt":0.5455695355291414,"score_spread":0.10562608631126813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024319360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96124184,0.00016501425,0.007449528,0.0300324,0.00001234503,0.00084003847,0.00014638319,0.000023598592,0.00008884249],"genre_scores_gemma":[0.99574274,0.00006447141,0.00272885,0.001029963,0.000038068494,0.00025803954,0.0001050127,0.0000073833153,0.000025500049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955431,0.002187458,0.0006576103,0.00044217124,0.00076270284,0.0004069223],"domain_scores_gemma":[0.99372345,0.0050896187,0.00022400533,0.00030261814,0.00040487642,0.00025543294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032857037,0.0001316064,0.0003375691,0.0012815372,0.00060988404,0.000038736587,0.00037082372,0.000101235244,0.00027755022],"category_scores_gemma":[0.007836006,0.00014220279,0.000038895967,0.0021474112,0.00041718493,0.0007970147,0.000034455352,0.0003202901,0.000023114126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002999544,0.00054305396,0.7539207,0.000088543726,0.000018137784,0.000007242919,0.13854061,0.08647542,0.001575992,0.016956965,0.00040154046,0.001171839],"study_design_scores_gemma":[0.000641236,0.00042181282,0.9130429,0.0011465051,0.000008337846,6.311034e-7,0.003902489,0.05850407,0.00058419217,0.021406421,0.00013166277,0.00020973434],"about_ca_topic_score_codex":0.8014055,"about_ca_topic_score_gemma":0.56940836,"teacher_disagreement_score":0.23199713,"about_ca_system_score_codex":0.0028642938,"about_ca_system_score_gemma":0.008945274,"threshold_uncertainty_score":0.9966731},"labels":[],"label_agreement":null},{"id":"W2024334414","doi":"10.1111/j.1524-4733.2009.00650.x","title":"Cost-Effectiveness of Using Recombinant Human Thyroid-Stimulating Hormone before Radioiodine Ablation for Thyroid Cancer: The Canadian Perspective","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Context (archaeology); Ablation; Thyroid cancer; Thyroid; Hormone; Surgery; Urology; Internal medicine","score_opus":0.09952962790393761,"score_gpt":0.39659389500315745,"score_spread":0.29706426709921985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024334414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9774205,0.011156487,0.0001062691,0.006368197,0.00022639133,0.0044843135,0.00007999799,0.000023197157,0.00013463017],"genre_scores_gemma":[0.9984067,0.00038390333,0.0004690915,0.0002977628,0.00014128227,0.00022076539,0.000042090127,0.0000251063,0.000013304562],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99831724,0.00020601685,0.0004546579,0.0003319655,0.0002122505,0.00047789622],"domain_scores_gemma":[0.99883974,0.00022547784,0.0002500996,0.00027282943,0.00020367444,0.00020819309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010627666,0.00019191207,0.0005180054,0.00021910315,0.00042350104,0.000016954826,0.00008538442,0.00008410184,0.0000045250713],"category_scores_gemma":[0.00009509279,0.00014393013,0.00011304366,0.0003737639,0.000054817523,0.00007011203,0.000008794099,0.00019507941,4.1424857e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035483246,0.002925934,0.36662832,0.0018793825,0.00075331854,0.00008642723,0.033202674,0.39526904,0.017600538,0.11903129,0.0014620848,0.057612684],"study_design_scores_gemma":[0.015055746,0.011666757,0.903165,0.0024676183,0.00021049364,0.000036301528,0.0012641512,0.05148903,0.0017890129,0.012211739,0.00029972687,0.00034441496],"about_ca_topic_score_codex":0.6906816,"about_ca_topic_score_gemma":0.11679406,"teacher_disagreement_score":0.57388747,"about_ca_system_score_codex":0.006055884,"about_ca_system_score_gemma":0.0013730642,"threshold_uncertainty_score":0.9977597},"labels":[],"label_agreement":null},{"id":"W2024886597","doi":"10.1016/s1098-3015(10)67256-7","title":"PCN18 LETROZOLE (FEMARA) IS A COST-EFFECTIVE TREATMENT IN THE EXTENDED ADJUVANT SETTING IN WOMEN WITH EARLY BREAST CANCER: AN APPLICATION TO CANADA","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Letrozole; Adjuvant; Medicine; Breast cancer; Oncology; Cancer; Internal medicine; Gynecology; Tamoxifen","score_opus":0.013551900936592733,"score_gpt":0.2988200622366946,"score_spread":0.28526816130010185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2024886597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734314,0.00047264638,0.000025287409,0.022167943,0.00004568179,0.0036548788,0.0000952623,0.000013824409,0.00009305064],"genre_scores_gemma":[0.98771864,0.0000822026,0.0000517569,0.0076018893,0.00014546687,0.0043456997,0.000011378012,0.000018651132,0.000024296218],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99835914,0.00024606212,0.00027975882,0.00034271347,0.00029808847,0.0004742623],"domain_scores_gemma":[0.9992921,0.00008482257,0.00007965776,0.00030745822,0.000037185786,0.00019881531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005433548,0.00015411955,0.0003166703,0.00013606272,0.00004867908,0.000011855535,0.000090490685,0.000038216098,0.000011777413],"category_scores_gemma":[0.0000064338556,0.00010941056,0.000014487009,0.0005940741,0.000014611309,0.00005060607,0.000010231728,0.00019397514,0.0000017542078],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010672136,0.0002865045,0.18336615,0.00011548124,0.000013082582,0.000028762463,0.06269486,0.0034926366,0.000032004267,0.000024308121,0.00008623927,0.74879277],"study_design_scores_gemma":[0.0022064927,0.0010191305,0.9787382,0.00036247468,0.0000066142757,0.000027586013,0.008055066,0.0022095297,0.0000678743,0.000011520592,0.007160205,0.00013530425],"about_ca_topic_score_codex":0.9843226,"about_ca_topic_score_gemma":0.98897797,"teacher_disagreement_score":0.79537207,"about_ca_system_score_codex":0.0072843772,"about_ca_system_score_gemma":0.001730525,"threshold_uncertainty_score":0.9965265},"labels":[],"label_agreement":null},{"id":"W2025010019","doi":"10.1111/j.1524-4733.2010.00770.x","title":"Use of a Disease-Specific Instrument in Economic Evaluations: Mapping WOMAC onto the EQ-5D Utility Index","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"WOMAC; Statistics; Sample size determination; EQ-5D; Mathematics; Confidence interval; Estimator; Osteoarthritis; Mean squared error; Medicine; Physical therapy; Internal medicine; Disease","score_opus":0.6357394324851724,"score_gpt":0.41937057721580606,"score_spread":0.21636885526936633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025010019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587141,0.0018257188,0.00049083174,0.035014395,0.0012186122,0.0020371273,0.00032678273,0.00002794277,0.0003444822],"genre_scores_gemma":[0.99393225,0.0005870656,0.001470547,0.003427277,0.00019545856,0.0002662468,0.000028628683,0.00003161525,0.000060888924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913677,0.0010821729,0.0060297023,0.00073353254,0.0001554723,0.00063140533],"domain_scores_gemma":[0.9941759,0.0019650864,0.002378666,0.0011502104,0.000044264332,0.00028583253],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.030171856,0.00023496705,0.0010038563,0.00070149644,0.00018384481,0.00008544563,0.00044693015,0.00014771297,0.0004809862],"category_scores_gemma":[0.0024059068,0.00026541494,0.00013271047,0.00036549236,0.00015622788,0.000583313,0.00009653809,0.0005558854,0.00034279865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057132336,0.0002522992,0.8475419,0.00049910974,0.00002188298,5.842366e-7,0.0042764726,0.012014827,0.000002497107,0.13108484,0.0022807107,0.001967726],"study_design_scores_gemma":[0.000805836,0.00004145472,0.78768945,0.00020576129,0.0000013079007,0.0000013014087,0.00072975707,0.13776247,0.000001348622,0.027709791,0.044819802,0.00023170287],"about_ca_topic_score_codex":0.036114164,"about_ca_topic_score_gemma":0.006934575,"teacher_disagreement_score":0.12574765,"about_ca_system_score_codex":0.0016862925,"about_ca_system_score_gemma":0.001205249,"threshold_uncertainty_score":0.9999798},"labels":[],"label_agreement":null},{"id":"W2025042808","doi":"10.1016/j.jval.2013.03.1158","title":"Improvements In Productivity At Paid Work And Within Household, And Increased Participation In Daily Activities After 24 Weeks Of Certolizumab Pegol Treatment Of Patients With Psoriatic Arthritis: Results Of A Phase 3 Double Blind Randomized Placebo-Controlled Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Presenteeism; Medicine; Placebo; Work productivity; Absenteeism; Psoriatic arthritis; Productivity; Bristol-Myers; Randomized controlled trial; Internal medicine; Physical therapy; Arthritis; Rheumatoid arthritis; Adalimumab; Alternative medicine; Psychology","score_opus":0.030234618528876364,"score_gpt":0.26830918071231474,"score_spread":0.23807456218343837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025042808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897017,0.0016773522,7.197711e-7,0.000054058186,0.000105067294,0.008345031,0.000104389044,0.000007728862,0.000003935305],"genre_scores_gemma":[0.9977823,0.00018753082,0.00005055881,0.000002510284,0.0000056312915,0.0018767266,0.00005457183,0.000014587638,0.00002560412],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99654925,0.0015634965,0.0011356466,0.00038016573,0.0000887399,0.000282679],"domain_scores_gemma":[0.99835753,0.0005880029,0.00072513113,0.0002483071,0.000044992383,0.000036053763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006768937,0.00024008637,0.0013983898,0.00033508163,0.00003564208,0.00000611711,0.000043137075,0.000103506274,0.00001022519],"category_scores_gemma":[0.00009998063,0.00017251696,0.00004697891,0.00022452233,0.00015261062,0.00014641623,0.000029029658,0.000075824595,4.335326e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6780735,0.0076950938,0.29453206,0.0001100983,0.0002716218,0.000005214484,0.011695445,0.000044443812,0.0003999126,0.0000020930433,0.000001081183,0.0071694497],"study_design_scores_gemma":[0.7634392,0.004255837,0.2279962,0.00024430506,0.00011132766,0.0000012615806,0.00047308378,0.000034751225,0.0033080052,0.000022949745,4.007205e-7,0.00011272639],"about_ca_topic_score_codex":0.014810302,"about_ca_topic_score_gemma":0.0042555747,"teacher_disagreement_score":0.08536566,"about_ca_system_score_codex":0.00014520716,"about_ca_system_score_gemma":0.00012219811,"threshold_uncertainty_score":0.9917502},"labels":[],"label_agreement":null},{"id":"W2025551428","doi":"10.1016/j.jval.2014.03.1250","title":"Cost-effectiveness of guanfacine extended-release versus atomoxetine for the treatment of children and adolescents with attention-deficit/hyperactivity disorder in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Atomoxetine; Attention deficit hyperactivity disorder; Guanfacine; Discontinuation; Medicine; Methylphenidate; Psychiatry; Pediatrics; Internal medicine","score_opus":0.03802359208698872,"score_gpt":0.3245071610614566,"score_spread":0.2864835689744679,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025551428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99455833,0.0008167484,0.0009268857,0.00055464584,0.00008943732,0.0029771205,0.000063741456,0.000006830165,0.000006241265],"genre_scores_gemma":[0.9992585,0.0003884405,0.00009877908,0.000023021295,0.00001693467,0.00014546058,0.00003746458,0.000025081055,0.000006284037],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839306,0.00035083026,0.00039844224,0.00030715234,0.00026880577,0.00028174018],"domain_scores_gemma":[0.9984407,0.0008116046,0.00024564128,0.0003129006,0.0000941856,0.000094986375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000505109,0.00018794437,0.00059906347,0.00011605087,0.000056034605,0.0000033308572,0.00005300858,0.00004222851,0.0000052798114],"category_scores_gemma":[0.00016796935,0.00013003871,0.000054827713,0.00026852038,0.000068830224,0.00005645835,0.000013775167,0.00012396925,3.6129546e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004356548,0.0014018059,0.975125,0.00068000366,0.00005889261,0.0000016943018,0.00005281318,0.0047757328,0.00008235723,0.000063436506,9.2789924e-7,0.013400776],"study_design_scores_gemma":[0.017741738,0.0016188151,0.9725395,0.000728479,0.00006752867,0.000010992153,0.0004562886,0.0066681877,0.000032304022,0.0000062188146,0.000028088169,0.00010189028],"about_ca_topic_score_codex":0.7837453,"about_ca_topic_score_gemma":0.43533528,"teacher_disagreement_score":0.34840998,"about_ca_system_score_codex":0.000535244,"about_ca_system_score_gemma":0.0007196608,"threshold_uncertainty_score":0.5749684},"labels":[],"label_agreement":null},{"id":"W2025672805","doi":"10.1016/j.jval.2012.08.1772","title":"PSY49 Treatment Patterns in Psoriatic Arthritis (PSA) Patients Newly Initiated on Non-Biologic Disease Modifying Anti-Rheumatic Drugs (DMARDs)","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Discontinuation; Psoriatic arthritis; Internal medicine; Methotrexate; Rheumatoid arthritis; Ankylosing spondylitis; Sulfasalazine; Disease","score_opus":0.05877108886640592,"score_gpt":0.32845779078471077,"score_spread":0.26968670191830485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025672805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910056,0.00563009,0.000024555593,0.0010091203,0.00035232754,0.0017064192,0.00008912095,0.00005872301,0.000124043],"genre_scores_gemma":[0.94319504,0.05562654,0.000131729,0.00052968325,0.000067931556,0.00020762478,0.00018976927,0.00003970078,0.000011975679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99663013,0.0005724467,0.000809738,0.00037529194,0.000486081,0.0011263337],"domain_scores_gemma":[0.998325,0.00028985486,0.0001733674,0.00039947408,0.000047397927,0.00076489174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071071927,0.00030641904,0.0007209968,0.00047641885,0.00012498676,0.000030624393,0.00010785427,0.00008784938,0.000091749294],"category_scores_gemma":[0.0003061361,0.00025145832,0.00010563535,0.00034723186,0.000057847425,0.00019101503,0.000036804522,0.0003099366,0.00011928294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032423568,0.002496111,0.8839087,0.00042711047,0.000038143404,0.000047855825,0.0037659404,0.00032484162,0.000006884758,0.000097373566,0.000050906565,0.10851189],"study_design_scores_gemma":[0.012494458,0.0020790051,0.9740138,0.0056548566,0.0000033054648,0.0000069524012,0.00045514942,0.004480608,0.000036684603,0.00027443594,0.00023682976,0.0002639288],"about_ca_topic_score_codex":0.0079754805,"about_ca_topic_score_gemma":0.00015009365,"teacher_disagreement_score":0.10824796,"about_ca_system_score_codex":0.00070429937,"about_ca_system_score_gemma":0.0003553022,"threshold_uncertainty_score":0.99999374},"labels":[],"label_agreement":null},{"id":"W2025771461","doi":"10.1016/j.jval.2014.03.1100","title":"Evaluation of current data sources in Europe for the conduct of real-world studies on lung and renal cell carcinoma: A systematic literature review","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Lung cancer; Renal cell carcinoma; Cancer; Real world data; Population; Kidney cancer; Clinical trial; MEDLINE; Cancer registry; Cohort; Oncology; Systematic review; Internal medicine; Intensive care medicine; Data science; Computer science; Environmental health","score_opus":0.2568931885691528,"score_gpt":0.47826495939832736,"score_spread":0.22137177082917459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025771461","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19417442,0.7998481,0.0000115729235,0.0015974059,0.00014675803,0.004046324,0.000069601534,0.000003412934,0.00010241166],"genre_scores_gemma":[0.95612466,0.043387864,0.00009540538,0.00012473314,0.00003645756,0.00013989303,0.000058654965,0.000007194886,0.000025112471],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9983743,0.00060040393,0.00051683636,0.0001616863,0.00026150228,0.00008529234],"domain_scores_gemma":[0.9984369,0.00057714275,0.0003160467,0.00035703593,0.00028682555,0.000026022379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004199725,0.000073975774,0.00042560734,0.00009638904,0.000029081975,0.0000034196103,0.00006248119,0.000010628759,7.8645263e-7],"category_scores_gemma":[0.0008441433,0.000040334973,0.000017151036,0.00030351276,0.000025813946,0.000031410906,0.000023828796,0.0000737481,1.4050492e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007949163,0.00042290072,0.017437255,0.9590682,0.00014201633,0.0000013660399,0.012717243,0.001132982,0.00003236396,0.001979218,0.0023348625,0.004652135],"study_design_scores_gemma":[0.010023641,0.001982354,0.064251475,0.8102097,0.004876838,0.000012240992,0.0014179879,0.105265416,0.00024021411,0.00040480163,0.0010851067,0.00023022405],"about_ca_topic_score_codex":0.00030290158,"about_ca_topic_score_gemma":0.00016948715,"teacher_disagreement_score":0.76195025,"about_ca_system_score_codex":0.00012276863,"about_ca_system_score_gemma":0.00031235404,"threshold_uncertainty_score":0.16448125},"labels":[],"label_agreement":null},{"id":"W2025792594","doi":"10.1111/j.1524-4733.2007.00171.x","title":"Mapping from Disease-Specific Measures to Utility: An Analysis of the Relationships between the Inflammatory Bowel Disease Questionnaire and Crohn's Disease Activity Index in Crohn's Disease and Measures of Utility","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Decile; Inflammatory bowel disease; Crohn's disease; Medicine; Statistics; Mathematics; Disease; Physical therapy; Internal medicine","score_opus":0.055559435881920846,"score_gpt":0.28396766535511914,"score_spread":0.22840822947319828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025792594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923031,0.0036254881,0.0012574724,0.00065788266,0.00006782885,0.0012177381,0.0008476313,0.000017475331,0.0000054210486],"genre_scores_gemma":[0.9993713,0.00019950564,0.000032824726,0.00012062484,0.00010076857,0.000052856474,0.00008893446,0.00002803816,0.000005165373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99523705,0.0020193628,0.00087204954,0.00080460566,0.00061124587,0.0004556902],"domain_scores_gemma":[0.99652195,0.0002100391,0.0003859859,0.0013620271,0.00017034581,0.0013496253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031671855,0.0003233417,0.00040801804,0.00036311094,0.00031752387,0.00004034003,0.00038063142,0.00012401624,0.000004815651],"category_scores_gemma":[0.0015964757,0.00026397873,0.00020152032,0.0006394961,0.00052849157,0.000045828237,0.00026031627,0.00033967223,3.5064986e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032827621,0.00022084182,0.98900694,0.00032102343,0.000114302165,0.000072944305,0.00059254566,0.003652425,0.000099072895,0.00009640875,0.00001339611,0.0025273191],"study_design_scores_gemma":[0.0004905109,0.000013828848,0.99261653,0.00025621217,0.00020039541,8.7864684e-8,0.00020494228,0.0049315216,0.00002409533,0.00093834,0.00008545332,0.00023807502],"about_ca_topic_score_codex":0.001244403,"about_ca_topic_score_gemma":0.0022462881,"teacher_disagreement_score":0.0070682196,"about_ca_system_score_codex":0.0001134427,"about_ca_system_score_gemma":0.00091536465,"threshold_uncertainty_score":0.9999812},"labels":[],"label_agreement":null},{"id":"W2025890050","doi":"10.1016/j.jval.2013.03.997","title":"Age-related emergency department reliance (EDR) and health care resource utilization in patients with sickle cell disease (SCD)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Emergency department; Ambulatory; Medicaid; Emergency medicine; Complication; Odds ratio; Ambulatory care; Disease; Public health; Health care; Pediatrics; Internal medicine","score_opus":0.01604863529426406,"score_gpt":0.2601304947168928,"score_spread":0.24408185942262875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2025890050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97691745,0.015060392,0.000009923844,0.0051441467,0.00010667497,0.0022484933,0.00001393804,0.000047427497,0.0004515372],"genre_scores_gemma":[0.9948942,0.003440598,0.00019593604,0.0009263037,0.000012550601,0.0000511356,0.00025945742,0.00003379365,0.00018601875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980761,0.00017421179,0.0006223567,0.00037834267,0.00027694218,0.00047208817],"domain_scores_gemma":[0.99900544,0.000014578037,0.00018640781,0.00026872644,0.000060010698,0.00046484297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002198764,0.00017853756,0.00031707494,0.00016963105,0.00010607697,0.000008370124,0.00005082468,0.00008991247,0.000050942162],"category_scores_gemma":[0.000028750312,0.00014304026,0.00002708222,0.0005167328,0.00004627427,0.000073322604,0.000026165257,0.00027806507,0.000019719773],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002249167,0.00069211033,0.9749675,0.0016897806,0.000009838327,0.000021629252,0.004764782,0.0030469606,0.000001033514,0.00006938057,0.003434795,0.011077316],"study_design_scores_gemma":[0.0041442863,0.0010386155,0.98746735,0.00087016384,0.000010657384,9.3181063e-7,0.0009732469,0.0019781196,0.0000021827466,0.0000829579,0.003264631,0.0001668543],"about_ca_topic_score_codex":0.00512465,"about_ca_topic_score_gemma":0.00015342286,"teacher_disagreement_score":0.01797674,"about_ca_system_score_codex":0.00035710796,"about_ca_system_score_gemma":0.0003815822,"threshold_uncertainty_score":0.77469724},"labels":[],"label_agreement":null},{"id":"W2026063780","doi":"10.1016/j.jval.2012.06.016","title":"Conceptualizing a Model: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-2","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":246,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Institute on Alcohol Abuse and Alcoholism","keywords":"Conceptualization; Management science; Computer science; Process (computing); Problem statement; Health care; Set (abstract data type); Outcomes research; Knowledge management; Medicine; Artificial intelligence; Engineering; Political science","score_opus":0.7933000356806883,"score_gpt":0.5493459970661612,"score_spread":0.24395403861452714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026063780","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90820956,0.015669731,0.012602309,0.052952465,0.0010743492,0.0023026909,0.00013952696,0.000052954707,0.006996417],"genre_scores_gemma":[0.99097896,0.00033496483,0.0049446095,0.002722273,0.00033775455,0.00012411433,0.000009604391,0.000044107634,0.0005036298],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9901899,0.0018557466,0.0059909676,0.00057977904,0.0003208387,0.0010627822],"domain_scores_gemma":[0.99070394,0.0019521558,0.005850344,0.0010613666,0.00014951456,0.00028266502],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.1021241,0.00017411655,0.0009487456,0.0004272422,0.00034986655,0.000042186683,0.00048442927,0.00017729553,0.000040491737],"category_scores_gemma":[0.015143071,0.00018262769,0.0001318762,0.0006135146,0.00012311502,0.0008518301,0.00016071324,0.0006270807,0.000119147895],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002318714,0.00027568758,0.12795222,0.0013576454,0.000038254064,0.0000014911673,0.02716974,0.34173918,0.000007775234,0.49801514,0.0033545042,0.00006519118],"study_design_scores_gemma":[0.00046967814,0.00005528666,0.00151795,0.00039674866,0.0000027732565,0.000030082145,0.005158226,0.9523141,0.000005774459,0.03294348,0.0068974337,0.00020850002],"about_ca_topic_score_codex":0.028514827,"about_ca_topic_score_gemma":0.0002455886,"teacher_disagreement_score":0.6105749,"about_ca_system_score_codex":0.001168794,"about_ca_system_score_gemma":0.001157784,"threshold_uncertainty_score":0.9931528},"labels":[],"label_agreement":null},{"id":"W2026414768","doi":"10.1016/j.jval.2014.03.704","title":"Factors Influencing Management Of Patients With Atrial Fibrillation In Canada And Sweden","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Discontinuation; Medicine; Atrial fibrillation; Stroke (engine); Retrospective cohort study; Major bleeding; Internal medicine; Emergency medicine; Pediatrics","score_opus":0.05125982074651023,"score_gpt":0.2968373017688667,"score_spread":0.24557748102235646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026414768","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989012,0.00005826678,0.000020784973,0.0002922448,0.00008601658,0.0005171315,0.000001977849,0.000005716952,0.000116685886],"genre_scores_gemma":[0.9995283,0.000038797447,0.0002897728,0.000042163923,0.000056963898,1.8884558e-7,0.000015143633,0.0000068140466,0.000021837803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990922,0.000060399605,0.0003458134,0.00012541519,0.00023594861,0.0001402088],"domain_scores_gemma":[0.99959964,0.000093380375,0.00013844196,0.00009520875,0.000018063227,0.000055298966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002332888,0.00007462799,0.00024264239,0.0001229716,0.000018351118,0.0000034228412,0.000020885687,0.000017902184,0.0000063714874],"category_scores_gemma":[0.000030490668,0.000057778336,0.000017894183,0.00019316576,0.00000862323,0.000047741574,0.00002143131,0.000040953102,2.50453e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010275363,8.6314003e-7,0.98364514,0.00032279492,0.000012411654,4.834291e-7,0.00016534723,0.011755191,2.0603102e-7,0.00030268438,0.0000052389387,0.0036869145],"study_design_scores_gemma":[0.0019622194,0.00010917089,0.995016,0.00021403177,0.000010339196,5.1124506e-8,0.0001773788,0.0019500911,0.0000025852482,0.00004048459,0.00046696662,0.00005071421],"about_ca_topic_score_codex":0.6795264,"about_ca_topic_score_gemma":0.21414909,"teacher_disagreement_score":0.4653773,"about_ca_system_score_codex":0.0003281459,"about_ca_system_score_gemma":0.00016274203,"threshold_uncertainty_score":0.8001906},"labels":[],"label_agreement":null},{"id":"W2026670035","doi":"10.1016/j.jval.2012.03.079","title":"PHP2 Value of Patient Submissions in Drug Coverage Processes","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Deliberation; Session (web analytics); Family medicine; Medicine; Drug; Value (mathematics); Actuarial science; Psychology; Computer science; Business; Political science; Psychiatry; Advertising","score_opus":0.3020330375488585,"score_gpt":0.41064183416976036,"score_spread":0.10860879662090184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026670035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96809,0.013046121,0.00026190287,0.013756073,0.00075609237,0.0010740379,0.00019381751,0.000027605418,0.002794343],"genre_scores_gemma":[0.9929144,0.0009586707,0.0014181606,0.0042927996,0.00014420765,0.00009775609,0.000020717638,0.00003051343,0.00012282441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931131,0.0007106641,0.0049364385,0.0003882403,0.00012793021,0.00072361756],"domain_scores_gemma":[0.99512327,0.0013379595,0.0027585318,0.00042145525,0.000041833453,0.00031697183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015923973,0.00017790876,0.0010141723,0.00059179665,0.00008924406,0.000016258848,0.0002131858,0.00010692673,0.00017606815],"category_scores_gemma":[0.005243456,0.00022173964,0.0000649817,0.000595093,0.000043755033,0.00048485378,0.00005418966,0.00024634163,0.00028262704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002171887,0.00080920267,0.79934055,0.003720159,0.000013815484,8.2035325e-7,0.025489125,0.01143526,0.0000012672359,0.15304537,0.005765509,0.00035719736],"study_design_scores_gemma":[0.0047442233,0.0005474077,0.66669023,0.0038013319,0.0000072156604,0.00001917416,0.009581704,0.019318955,0.00015678295,0.08108263,0.21240363,0.0016467423],"about_ca_topic_score_codex":0.027254794,"about_ca_topic_score_gemma":0.00038844717,"teacher_disagreement_score":0.20663811,"about_ca_system_score_codex":0.0009957168,"about_ca_system_score_gemma":0.0007258731,"threshold_uncertainty_score":0.9792228},"labels":[],"label_agreement":null},{"id":"W2026842194","doi":"10.1016/j.jval.2014.03.268","title":"Cost-Of-Illness Studies For Juvenile Idiopathic Arthritis: A Systematic Review","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; Mount Sinai Hospital; York University; University of Toronto","funders":"","keywords":"Medicine; Indirect costs; Arthritis; MEDLINE; Medical costs; Medical record; Family medicine; Internal medicine; Health care","score_opus":0.37859998596425676,"score_gpt":0.5323551595095677,"score_spread":0.15375517354531093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2026842194","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.0232928e-7,0.95632774,0.00019371336,0.0010760919,0.0023400593,0.039653648,0.0002982351,0.0000854895,0.000024753004],"genre_scores_gemma":[0.0000126701425,0.9837294,0.0001784525,0.001791216,0.0010374566,0.0127551695,0.00013118995,0.00013786447,0.00022654088],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97635156,0.011989116,0.009072246,0.0007279516,0.00052141503,0.0013377185],"domain_scores_gemma":[0.98598814,0.005785371,0.0062805414,0.0010531949,0.0005113442,0.00038139246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.017317083,0.0006822778,0.014339963,0.00045710217,0.0005946172,0.0000046932314,0.0005549347,0.0007615643,0.000014675372],"category_scores_gemma":[0.0078994725,0.0005193087,0.00076288026,0.0009240833,0.00005880008,0.000059959293,0.00015833057,0.0017969985,0.00017415154],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004245339,0.000035551177,0.000008784903,0.89720064,0.000048865473,0.0000030489628,0.0013670769,7.773265e-7,2.1889869e-10,0.0006915678,0.0050087124,0.09563074],"study_design_scores_gemma":[0.00030643918,0.00010632103,2.2570788e-7,0.6180148,0.00033272358,0.000005423847,0.0005035839,0.000011151501,1.2618604e-9,0.00011518965,0.38035578,0.000248373],"about_ca_topic_score_codex":0.0007119402,"about_ca_topic_score_gemma":0.00019017661,"teacher_disagreement_score":0.37534708,"about_ca_system_score_codex":0.0015594428,"about_ca_system_score_gemma":0.0076814936,"threshold_uncertainty_score":0.9997259},"labels":[],"label_agreement":null},{"id":"W2027067783","doi":"10.1016/s1098-3015(10)73444-6","title":"PSS12 COST-UTILITY ANALYSIS OF POSTERIOR LAMELLAR KERATOPLASTY IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Nonmelanoma Skin Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Optometry; Ophthalmology; Medicine","score_opus":0.03120846788730503,"score_gpt":0.3045202192584103,"score_spread":0.27331175137110525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027067783","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304986,0.0018512766,0.00000882475,0.0040271254,0.0001095259,0.00044128313,0.000053486492,0.0000063100865,0.00045231875],"genre_scores_gemma":[0.997869,0.000267275,0.00030657506,0.0014884137,0.0000227014,0.0000079549045,0.000011595384,0.0000059768972,0.000020493859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832624,0.00014631062,0.00063495146,0.0002561256,0.00029285808,0.00034353448],"domain_scores_gemma":[0.9992196,0.00013750255,0.00014749724,0.00032383722,0.000046079014,0.0001254708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004821851,0.000119018034,0.0007725332,0.00029212018,0.000024890453,0.00000239165,0.000068453905,0.000039093688,0.000051357125],"category_scores_gemma":[0.00010091689,0.000112681846,0.000059180118,0.0012216363,0.00002737625,0.000024009812,0.0000209671,0.00019095898,0.0000010147127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012968008,0.00007889508,0.9885903,0.00012423364,0.000073074836,0.000047738748,0.00045807104,0.0010048826,0.000017550974,0.000024222978,0.00021983338,0.009231525],"study_design_scores_gemma":[0.0007308219,0.00016621371,0.99389535,0.00014052035,0.000052241106,0.000005293619,0.00022789475,0.0037478167,0.00014013181,0.000023008037,0.0007996122,0.00007111503],"about_ca_topic_score_codex":0.9372663,"about_ca_topic_score_gemma":0.9433445,"teacher_disagreement_score":0.00916041,"about_ca_system_score_codex":0.0015262343,"about_ca_system_score_gemma":0.0024899354,"threshold_uncertainty_score":0.45950323},"labels":[],"label_agreement":null},{"id":"W2027256506","doi":"10.1016/j.jval.2012.08.1711","title":"PDB68 Physician Beliefs About Insulin Pens Versus Vials, Therapy Choice Factors, and Patient Characteristics Among Elderly Type 2 Diabetes Patients","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Vial; Medicine; Diabetes mellitus; Type 2 diabetes; Basal (medicine); Insulin; Internal medicine; Family medicine; Emergency medicine; Endocrinology","score_opus":0.0624983580471539,"score_gpt":0.3137289067175666,"score_spread":0.25123054867041267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027256506","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954001,0.0025664782,0.0000020650077,0.00038556338,0.0007928755,0.00056422135,0.000017302296,0.00003075639,0.0002406451],"genre_scores_gemma":[0.9963594,0.0017688831,0.00007951374,0.0014143848,0.00021626061,0.000020792017,0.00008851577,0.000019833711,0.000032416105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863636,0.00009612112,0.00039032506,0.0002023954,0.00027354708,0.00040127288],"domain_scores_gemma":[0.9989486,0.00016128311,0.0002473108,0.0002400524,0.00008761277,0.00031514003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016146577,0.00016042999,0.0003255329,0.000068249145,0.00008490722,0.000012060412,0.00006742436,0.00007235055,0.000073795636],"category_scores_gemma":[0.00020057494,0.0001327313,0.000027065815,0.00017136068,0.00006077169,0.00009357611,0.000020942798,0.0001952647,0.000063114814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006359137,0.00035865634,0.92878616,0.00008957986,0.000015277015,2.6813169e-7,0.0014423162,5.976779e-7,0.00006107867,0.000060850583,0.0002903287,0.06883132],"study_design_scores_gemma":[0.0014070369,0.001225192,0.98176956,0.00029986812,0.0000057747616,9.7961e-8,0.000102441016,0.00007284572,0.00013563008,0.000012886524,0.014852827,0.00011585244],"about_ca_topic_score_codex":0.0005454587,"about_ca_topic_score_gemma":0.000006326046,"teacher_disagreement_score":0.06871546,"about_ca_system_score_codex":0.000087520784,"about_ca_system_score_gemma":0.00010087845,"threshold_uncertainty_score":0.5412625},"labels":[],"label_agreement":null},{"id":"W2027282720","doi":"10.1016/s1098-3015(10)63601-7","title":"PSU3 DEMOGRAPHIC PREDICTORS OF RESOURCE UTILIZATION AND COSTS OF SOLID ORGAN TRANSPLANTATION IN BRITISH COLUMBIA, CANADA","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Mining and Resource Management","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transplantation; Resource (disambiguation); Solid organ; Organ transplantation; Demography; Medicine; Geography; Computer science; Internal medicine; Sociology","score_opus":0.008579645426126922,"score_gpt":0.19597561194551089,"score_spread":0.18739596651938395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027282720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983725,0.00094648486,0.00014669872,0.000020144387,0.0000463642,0.000167253,0.000039079896,0.000017484765,0.0002439808],"genre_scores_gemma":[0.99929136,0.0005677801,0.000059159323,0.00001149071,0.000010991075,0.0000035330625,0.000027543745,0.000010566629,0.000017570615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992589,0.000059132715,0.00033362868,0.00008442234,0.00012189739,0.00014206242],"domain_scores_gemma":[0.9998173,0.000037998474,0.00004925913,0.00005758052,0.000009034581,0.000028835164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024479546,0.000039813633,0.00013428029,0.00009059775,0.000018260882,0.000005914877,0.000035699344,0.00003275033,0.0000027673523],"category_scores_gemma":[0.000007372694,0.00006596877,0.000007609947,0.000286684,0.000018122391,0.000013921013,0.0000042399106,0.000058449186,1.943647e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000033319168,0.000025215824,0.72041976,0.0011610413,0.000006032666,0.000008326127,0.00058282696,0.27227926,0.000033965563,0.00002188068,0.00073536683,0.0047229794],"study_design_scores_gemma":[0.00051291176,0.00004316564,0.94498825,0.000861338,0.000005174449,0.0000049090763,0.00037849369,0.052385688,0.000064819316,0.000014032324,0.0006655947,0.0000756021],"about_ca_topic_score_codex":0.9534122,"about_ca_topic_score_gemma":0.97019064,"teacher_disagreement_score":0.22456849,"about_ca_system_score_codex":0.000088683846,"about_ca_system_score_gemma":0.00005483585,"threshold_uncertainty_score":0.26901284},"labels":[],"label_agreement":null},{"id":"W2027804344","doi":"10.1016/j.jval.2012.08.1217","title":"PCN24 Treatment and Response Patterns in Chronic Myeloid Leukemia: Evidence from a Retrospective Study in Canada, Australia, and South Korea","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Nilotinib; Dasatinib; Imatinib; Myeloid leukemia; Internal medicine; Pediatrics; Demography","score_opus":0.07667985724548108,"score_gpt":0.330722337570888,"score_spread":0.2540424803254069,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027804344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923587,0.0047641955,0.0000011599391,0.0005837394,0.00011312559,0.0020683103,0.00009155507,0.000013470635,0.000005785847],"genre_scores_gemma":[0.9985139,0.0008743123,0.00008358765,0.0000928947,0.00010751929,0.00016832355,0.000012507184,0.000028515198,0.00011847058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686474,0.0007229444,0.00064838794,0.00061938603,0.00033299671,0.0008115297],"domain_scores_gemma":[0.9984789,0.00048557136,0.00015945228,0.0004481796,0.000018117986,0.0004097632],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010330197,0.0003229593,0.0007559497,0.0002717363,0.00004842027,0.000012867548,0.0000716296,0.000102505226,0.000051426938],"category_scores_gemma":[0.00021963818,0.00028499652,0.00002557149,0.0003241736,0.0000456555,0.00014943359,0.000066577,0.00042839817,0.000006949078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0009816588,0.00023573806,0.9785803,0.000102112135,0.000035226483,0.00028598635,0.018465519,0.00012314535,0.00008158514,0.000002699714,0.000015609818,0.0010904047],"study_design_scores_gemma":[0.0089971265,0.0019529251,0.98345464,0.0013228013,0.000036215144,0.000034411565,0.003286896,0.0006121307,0.00009152458,0.000011632058,0.000018766712,0.00018094231],"about_ca_topic_score_codex":0.99433094,"about_ca_topic_score_gemma":0.96557516,"teacher_disagreement_score":0.088664375,"about_ca_system_score_codex":0.097747535,"about_ca_system_score_gemma":0.009083157,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W2027823501","doi":"10.1016/j.jval.2014.03.1200","title":"Exploring the impact of structural uncertainty in partitioned survival models for oncology","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Survival analysis; Hazard ratio; Parametric statistics; Marginal structural model; Set (abstract data type); Statistics; Extrapolation; Econometrics; Proportional hazards model; Medicine; Computer science; Mathematics; Confidence interval","score_opus":0.7358476749632621,"score_gpt":0.4907542901269787,"score_spread":0.2450933848362834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2027823501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97731024,0.00041627782,0.004175996,0.01576631,0.00061336893,0.0010669137,0.00017430655,0.000014312867,0.0004623005],"genre_scores_gemma":[0.9975873,0.00011349596,0.00094592693,0.0008635855,0.00018836651,0.0002510876,0.000021266858,0.000017793953,0.0000111690715],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99474865,0.0010073791,0.0033864167,0.00032734033,0.00005821067,0.00047200287],"domain_scores_gemma":[0.9950755,0.003011323,0.0014169523,0.00034858577,0.000039756564,0.00010786682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026007693,0.00012714473,0.0009457556,0.00028350335,0.00010463205,0.000015032471,0.0002121626,0.00006930034,0.000026569001],"category_scores_gemma":[0.0021476168,0.000121214565,0.0001242089,0.00022261258,0.00005389492,0.0003396074,0.00002579297,0.00016859428,0.000020449537],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038725928,0.00003677527,0.024624463,0.00022856312,0.00001185499,5.7917052e-8,0.0039639273,0.7704929,4.2054495e-7,0.1999095,0.0002123561,0.0004804298],"study_design_scores_gemma":[0.0009930109,0.00029282534,0.082251176,0.00007447453,6.9498685e-7,8.1610784e-7,0.0007161882,0.7553007,6.5901554e-7,0.15965214,0.0006038595,0.000113413604],"about_ca_topic_score_codex":0.06549262,"about_ca_topic_score_gemma":0.0020306455,"teacher_disagreement_score":0.063461974,"about_ca_system_score_codex":0.0016121247,"about_ca_system_score_gemma":0.00044452507,"threshold_uncertainty_score":0.94073033},"labels":[],"label_agreement":null},{"id":"W2028081096","doi":"10.1016/j.jval.2011.08.335","title":"PMH35 A Cost-Effectiveness Analysis of Paliperidone Palmitate Versus Olanzapine Pamoate in the Treatment of Schizophrenia in Norway","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thornhill Medical (Canada); University of Toronto","funders":"","keywords":"Paliperidone; Paliperidone Palmitate; Olanzapine; Medicine; Economic evaluation; Schizophrenia (object-oriented programming); Psychiatry; Antipsychotic","score_opus":0.28181152279169774,"score_gpt":0.4357920238968458,"score_spread":0.15398050110514805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028081096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927072,0.0046756025,0.0000064593264,0.0009957714,0.00008829235,0.0009312947,0.000024048208,0.000003755873,0.0005676071],"genre_scores_gemma":[0.9898327,0.009791202,0.00017105007,0.00008273447,0.000018668292,0.00008431097,0.0000081095,0.000006863277,0.000004336256],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810636,0.000698883,0.0005238179,0.00020187454,0.00019700557,0.0002720828],"domain_scores_gemma":[0.99845314,0.0010105117,0.00019406287,0.00023079595,0.00003943967,0.00007206033],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012666669,0.00012810274,0.00071284635,0.00039839037,0.000023667371,0.0000022671024,0.00007776842,0.000042206826,0.000059945814],"category_scores_gemma":[0.00013464378,0.00008128538,0.00009925102,0.0018593433,0.0000688219,0.00004002132,0.000016301266,0.00014706614,0.0000036145134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02969609,0.0051431796,0.881055,0.0008680706,0.001320824,0.0001459892,0.020405542,0.0020229865,0.0004393886,0.00075831637,0.000006061467,0.058138568],"study_design_scores_gemma":[0.010319467,0.0025940614,0.9799158,0.00023292594,0.0003721434,0.000001711192,0.0008832121,0.0036281669,0.00052198285,0.00007294494,0.0013760234,0.00008155648],"about_ca_topic_score_codex":0.023417013,"about_ca_topic_score_gemma":0.00250065,"teacher_disagreement_score":0.09886082,"about_ca_system_score_codex":0.00021490252,"about_ca_system_score_gemma":0.000099270655,"threshold_uncertainty_score":0.9830861},"labels":[],"label_agreement":null},{"id":"W2028224503","doi":"10.1016/s1098-3015(10)61076-5","title":"PMH10 THE BURDEN OF DEPRESSION IN CANADA","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Depression (economics); Medicine; Psychiatry; Economics; Keynesian economics","score_opus":0.0967378677926974,"score_gpt":0.3867573053891308,"score_spread":0.2900194375964334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028224503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900147,0.0025201256,0.0000027398728,0.0037430183,0.0003673006,0.00047123732,0.000008914251,0.000008059866,0.002863953],"genre_scores_gemma":[0.9986587,0.00073494506,0.000024418217,0.00023442166,0.00014353792,0.000038341575,0.0000014028165,0.000010276321,0.0001539459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976996,0.0009776698,0.0005831047,0.00012380742,0.00021728208,0.0003985133],"domain_scores_gemma":[0.9989145,0.0005965987,0.00018135639,0.00020457979,0.00002954517,0.00007344698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007820594,0.00006938132,0.00032868498,0.000053394568,0.00020589978,0.0000013821849,0.00016468976,0.00007043892,0.00028368444],"category_scores_gemma":[0.00011418031,0.000048473015,0.000016575474,0.0002876044,0.000020537735,0.000029357172,0.00004645748,0.00044266006,0.000014623737],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010874277,0.000038643724,0.85419536,0.0005713031,0.0000029359626,0.00000817535,0.12686382,0.004840632,0.00000583834,0.0012365179,0.001039204,0.011186705],"study_design_scores_gemma":[0.0017932121,0.000066293636,0.5822387,0.0029573636,0.0000036882004,2.1502422e-7,0.33657286,0.045883637,0.000023512463,0.0016494147,0.028537052,0.00027410756],"about_ca_topic_score_codex":0.9985131,"about_ca_topic_score_gemma":0.9855859,"teacher_disagreement_score":0.2719567,"about_ca_system_score_codex":0.00064432615,"about_ca_system_score_gemma":0.0010716289,"threshold_uncertainty_score":0.3106146},"labels":[],"label_agreement":null},{"id":"W2028440405","doi":"10.1016/s1098-3015(10)73886-9","title":"PIH18 A COST EFFECTIVENESS ANALYSIS OF A GENERAL VACCINATION PROGRAMME WITH THE NEW 10- VALENT PNEUMOCOCCAL NON- TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN-D CONJUGATE VACCINE (PHID-CV) IN SWEDEN","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Haemophilus influenzae; Conjugate vaccine; Medicine; Vaccination; Pneumococcal conjugate vaccine; Conjugate; Haemophilus; Pneumococcal disease; Virology; Microbiology; Streptococcus pneumoniae; Immunization; Immunology; Biology; Antibody; Bacteria; Antibiotics; Genetics; Mathematics","score_opus":0.036978897905005,"score_gpt":0.33256284719297496,"score_spread":0.29558394928796994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028440405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98789823,0.00022633946,0.00033123314,0.0071233837,0.000040815983,0.0040454306,0.000007434415,0.000044495762,0.000282628],"genre_scores_gemma":[0.9985409,0.000039901082,0.00015920908,0.0006876902,0.00009490383,0.00023960974,0.000023505985,0.000021239193,0.00019305538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975021,0.0005995785,0.00065033993,0.0003901895,0.0003353789,0.00052241335],"domain_scores_gemma":[0.998698,0.00017055104,0.00030373674,0.0004203119,0.00016639713,0.00024100809],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015782347,0.00024186552,0.00079195044,0.000778984,0.00010881957,0.00002232781,0.0001301679,0.0001413483,0.00003218408],"category_scores_gemma":[0.00014753835,0.00015995828,0.00013527236,0.0030367554,0.00002688429,0.00010189469,0.000025029733,0.0004434864,0.000008086838],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044932524,0.0042581474,0.56208175,0.001982105,0.0013225606,0.00021267276,0.003417765,0.28190503,0.09066335,0.0014700978,0.0003616649,0.04783157],"study_design_scores_gemma":[0.0047415774,0.0028229998,0.97340524,0.00050781464,0.0002553461,0.000029294697,0.000054387612,0.015038601,0.00143082,0.0001480961,0.0013870345,0.00017879694],"about_ca_topic_score_codex":0.0067920857,"about_ca_topic_score_gemma":0.001519653,"teacher_disagreement_score":0.41132346,"about_ca_system_score_codex":0.000611068,"about_ca_system_score_gemma":0.0009601537,"threshold_uncertainty_score":0.9998218},"labels":[],"label_agreement":null},{"id":"W2028465701","doi":"10.1016/j.jval.2013.03.608","title":"Key cost drivers in the cost of care for sickle cell disease patients: Results of a systematic literature search and a survey of payers and key opinion leaders","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Key (lock); Disease; Opinion leadership; Medicine; Business; Intensive care medicine; Actuarial science; Computer science; Political science; Public relations; Computer security; Pathology","score_opus":0.03862994519277962,"score_gpt":0.3004888794024748,"score_spread":0.2618589342096952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028465701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983212,0.01030736,0.0000058858095,0.0007405869,0.00005936335,0.0052135508,0.0004271112,0.000003129511,0.000031036354],"genre_scores_gemma":[0.9968683,0.0027132104,0.000060643517,0.000097459684,0.0000044008852,0.00005420815,0.00018494656,0.000010110718,0.000006716407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821293,0.00054614764,0.0006165176,0.00017885081,0.00023568787,0.00020986512],"domain_scores_gemma":[0.9986626,0.00053624646,0.00019211178,0.00021472652,0.0002645808,0.00012972542],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009680337,0.000104109386,0.00045458795,0.0001617946,0.000031851476,0.0000072516195,0.00006787954,0.00008821344,7.336109e-7],"category_scores_gemma":[0.00055492873,0.00006762998,0.000036002843,0.00034830955,0.00014165696,0.000049491387,0.000019053843,0.00017359921,2.398587e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016334222,0.00059410144,0.5200499,0.312812,0.000029456507,0.000002757025,0.16198353,0.0015403486,0.000029022107,0.00006444114,0.0006066216,0.00065434043],"study_design_scores_gemma":[0.01638165,0.0025427514,0.8236429,0.0554199,0.00004459893,0.0000023275231,0.09056627,0.011082264,0.000052053,0.000023543862,0.00005650516,0.00018520403],"about_ca_topic_score_codex":0.011199302,"about_ca_topic_score_gemma":0.00021218006,"teacher_disagreement_score":0.30359298,"about_ca_system_score_codex":0.00006074327,"about_ca_system_score_gemma":0.00021975549,"threshold_uncertainty_score":0.9953852},"labels":[],"label_agreement":null},{"id":"W2028649541","doi":"10.1016/j.jval.2011.08.240","title":"PIN54 Cost-Effectiveness of 2+1 Dosing of 13-Valent Pneumococcal Conjugate Vaccine Compared with 2+1 Dosing of 10-Valent Conjugate Vaccine in Preventing Pneumococcal Disease in Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Pneumococcal conjugate vaccine; Medicine; Pneumococcal disease; Vaccination; Dosing; Streptococcus pneumoniae; Immunization; Population; Environmental health; Immunology; Internal medicine; Antibiotics; Microbiology; Biology; Antigen","score_opus":0.04973701197539053,"score_gpt":0.2954728751303512,"score_spread":0.24573586315496065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028649541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99580985,0.00052467623,0.000043734406,0.00022178158,0.00021858938,0.0029665013,0.00007146409,0.00002139085,0.000122026286],"genre_scores_gemma":[0.999481,0.00013852346,0.000075037606,0.00006962825,0.0000308153,0.00012355979,0.00002578291,0.000049091443,0.0000065634376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951254,0.0011027954,0.002016282,0.0005455133,0.0004838162,0.0007261585],"domain_scores_gemma":[0.99745035,0.00048420404,0.0008889594,0.0005136959,0.00022840923,0.00043440604],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017317082,0.0003791783,0.0015835603,0.0006588474,0.000068236695,0.0000049536466,0.00018484658,0.00009762888,0.000041239306],"category_scores_gemma":[0.00021044874,0.00033389463,0.00012509107,0.0009911762,0.000088613386,0.00013500496,0.00009018099,0.0005226764,0.0000010485454],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028726808,0.0012189685,0.93205786,0.0059191813,0.00006511062,0.0001332676,0.000716849,0.018989481,0.037614603,0.00006470128,0.0000029854025,0.00034431042],"study_design_scores_gemma":[0.008104742,0.0009311996,0.9611615,0.009583545,0.00007763028,0.000031161155,0.00025780025,0.006132465,0.013380588,0.000047306425,0.00003673539,0.00025530453],"about_ca_topic_score_codex":0.58087575,"about_ca_topic_score_gemma":0.24268198,"teacher_disagreement_score":0.3381938,"about_ca_system_score_codex":0.0012754718,"about_ca_system_score_gemma":0.0036863924,"threshold_uncertainty_score":0.9999113},"labels":[],"label_agreement":null},{"id":"W2028678413","doi":"10.1016/s1098-3015(10)66890-8","title":"PMC52 LINGUISTIC VALIDATION OF THE FRENCH FOR CANADA WORK PRODUCTIVITY AND ACTIVITY IMPAIRMENT QUESTIONNAIRE, GENERAL HEALTHVERSION (WPAI:GH)","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Work productivity; Productivity; Work (physics); Psychology; Linguistics; Geography; Engineering; Economics; Economic growth; Philosophy","score_opus":0.10837437364863692,"score_gpt":0.40818280225358705,"score_spread":0.29980842860495016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028678413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97298336,0.00076036336,0.0002337534,0.020108147,0.0025845708,0.0031524287,0.000056474753,0.00002551656,0.00009538575],"genre_scores_gemma":[0.9976618,0.00016692023,0.0005571965,0.000473085,0.00057731755,0.00017248093,0.000007565008,0.000019631581,0.00036395772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99385965,0.0039089224,0.0008436583,0.0003903252,0.0004020412,0.00059541943],"domain_scores_gemma":[0.9969538,0.0012513495,0.00090861815,0.00040281125,0.00025129487,0.00023215383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045608873,0.00016493176,0.0004250269,0.00008312197,0.001293477,0.0000038750186,0.0001240362,0.00014493655,0.000008841167],"category_scores_gemma":[0.0021557948,0.00012814719,0.000041158262,0.00041314503,0.000058700945,0.0001123719,0.00006900026,0.0006010935,0.000001154697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022614033,0.00021288668,0.9641213,0.006742859,0.00001607076,0.0000028667246,0.010862455,0.0014588158,0.00002620961,0.0007867553,0.009430801,0.0061128507],"study_design_scores_gemma":[0.0008466353,0.0003044476,0.96271825,0.0015680059,0.0000073147885,0.000008423217,0.00022827776,0.001372833,0.00008471354,0.00042661835,0.032267276,0.00016722066],"about_ca_topic_score_codex":0.9469763,"about_ca_topic_score_gemma":0.43240315,"teacher_disagreement_score":0.51457316,"about_ca_system_score_codex":0.0013252296,"about_ca_system_score_gemma":0.008602427,"threshold_uncertainty_score":0.99701786},"labels":[],"label_agreement":null},{"id":"W2028726004","doi":"10.1016/j.jval.2012.03.1167","title":"PCN50 A Pilot Assessment to Determine Cost of Apheresis Treatment","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Apheresis; Medicine; Context (archaeology); Activity-based costing; Protocol (science); Transplantation; Emergency medicine; Surgery; Internal medicine; Business","score_opus":0.1437139223347846,"score_gpt":0.4393718895048983,"score_spread":0.2956579671701137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028726004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894343,0.001995122,0.00066770386,0.0042173616,0.00016085757,0.0022405982,0.000040620573,0.000029208166,0.0012142214],"genre_scores_gemma":[0.96336573,0.00030189764,0.035471596,0.00032090477,0.000109833614,0.0001660676,0.000009451998,0.000018406628,0.00023613288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830693,0.00015798189,0.0004184251,0.0001774914,0.0003820764,0.00055708503],"domain_scores_gemma":[0.9986753,0.00033846468,0.00008356677,0.00032041405,0.00004526218,0.00053703313],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005965081,0.00011854403,0.00040591854,0.00020229738,0.000030843166,0.000004404618,0.00006493145,0.000022309074,0.00013832866],"category_scores_gemma":[0.00023131425,0.000092552895,0.000042902815,0.0003343398,0.00003517913,0.000058277627,0.000035697944,0.0000914595,0.000031202653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022383267,0.007639709,0.6149348,0.002727534,0.00012174512,0.000046174773,0.0023967964,0.0014540185,0.026905276,0.001933418,0.002315433,0.33728677],"study_design_scores_gemma":[0.005358185,0.018769149,0.9201931,0.0013996427,0.00002946862,0.000052200252,0.00042358527,0.0028064817,0.0071028857,0.00014634233,0.043486234,0.00023273028],"about_ca_topic_score_codex":0.006151198,"about_ca_topic_score_gemma":0.00018942863,"teacher_disagreement_score":0.33705404,"about_ca_system_score_codex":0.00095254456,"about_ca_system_score_gemma":0.000460914,"threshold_uncertainty_score":0.9298813},"labels":[],"label_agreement":null},{"id":"W2028730671","doi":"10.1016/s1098-3015(10)70711-7","title":"PDB23 COST-EFFECTIVENESS ANALYSIS OF CONTINUOUS SUBCUTANEOUS INSULIN INJECTION VS. MULTIPLE DAILY INJECTIONS IN TYPE I DIABETES PATIENTS: A CANADIAN PERSPECTIVE","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Perspective (graphical); Medicine; Type 2 diabetes; Insulin; Subcutaneous injection; Diabetes mellitus; Internal medicine; Type 1 diabetes; Intensive care medicine; Endocrinology; Computer science; Artificial intelligence","score_opus":0.034423426643432516,"score_gpt":0.2995289651068589,"score_spread":0.2651055384634264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028730671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963755,0.0017573192,0.00003238601,0.00024711955,0.00047412212,0.0007392656,0.00017721581,0.00002164939,0.00017541848],"genre_scores_gemma":[0.9991186,0.00031769954,0.0001568692,0.0002413429,0.000010075103,0.00003229935,0.0000718087,0.000012780556,0.00003849815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710506,0.0013967952,0.0005426459,0.00038751963,0.00005305803,0.0005149076],"domain_scores_gemma":[0.9984928,0.0007734479,0.00017283493,0.00021930668,0.00026008746,0.000081565515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007868661,0.00017245412,0.00071908743,0.0012849917,0.0001583606,0.0000048355546,0.00012242328,0.00029630252,0.00007227063],"category_scores_gemma":[0.0010088076,0.00016459958,0.00011935443,0.002642239,0.00021232529,0.00005397433,0.000028454704,0.0003897625,0.000008521204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004452347,0.00053637265,0.9906725,0.000038004648,0.00037710974,0.000010628094,0.0016951921,0.0031648513,0.00047548255,0.00025995472,0.00009179268,0.0022328603],"study_design_scores_gemma":[0.0015404491,0.0017132406,0.9920735,0.00008719966,0.00010160557,0.000012859806,0.0006440372,0.0018894303,0.0007089584,0.00015410618,0.00085874903,0.00021589066],"about_ca_topic_score_codex":0.5624056,"about_ca_topic_score_gemma":0.23323955,"teacher_disagreement_score":0.32916602,"about_ca_system_score_codex":0.0010530702,"about_ca_system_score_gemma":0.00051528617,"threshold_uncertainty_score":0.7807518},"labels":[],"label_agreement":null},{"id":"W2028744677","doi":"10.1016/j.jval.2013.03.724","title":"Patient Preferences: Understanding Risk-Benefit Trade-Offs Of Genomic Testing In Chemotherapy Decisions For Breast Cancer Patients","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Princess Margaret Cancer Centre; Sunnybrook Health Science Centre; Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"Medicine; Breast cancer; Mixed logit; Oncology; Internal medicine; Logistic regression; Cancer; Family medicine","score_opus":0.3589665301960837,"score_gpt":0.408837780949174,"score_spread":0.04987125075309029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028744677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867759,0.0012327906,0.00014882204,0.0036442599,0.00056674547,0.0067141745,0.0006607167,0.000055430122,0.00020118483],"genre_scores_gemma":[0.9900801,0.0010688397,0.0058347876,0.0009814512,0.000050371633,0.0018815178,0.000036841124,0.00005852159,0.0000075595954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99481636,0.0011424221,0.0022663928,0.0004745189,0.0003629341,0.0009373575],"domain_scores_gemma":[0.9922825,0.004922731,0.001577155,0.0006672324,0.0002835319,0.00026684243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006982409,0.00025178198,0.0005949306,0.0004337792,0.0006267661,0.000010317742,0.0004214573,0.00023013457,0.00013435574],"category_scores_gemma":[0.00073481497,0.0002380266,0.000067881956,0.00066845305,0.0000657711,0.00021088743,0.00013070552,0.0008004616,0.000014637477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009592145,0.00027410584,0.9370985,0.00072976615,0.00001031125,6.247477e-8,0.02334964,0.0035851356,0.00001563298,0.0006914432,0.00026346406,0.033885993],"study_design_scores_gemma":[0.0028218036,0.00039572184,0.94225293,0.0035439695,0.0000045585484,2.9953657e-7,0.01194599,0.022076838,0.000003920457,0.016581945,0.00014167964,0.00023033029],"about_ca_topic_score_codex":0.09498787,"about_ca_topic_score_gemma":0.0045253495,"teacher_disagreement_score":0.09046252,"about_ca_system_score_codex":0.003224746,"about_ca_system_score_gemma":0.0014126305,"threshold_uncertainty_score":0.9706443},"labels":[],"label_agreement":null},{"id":"W2028802309","doi":"10.1016/j.jval.2014.08.1262","title":"Paliperidone Versus Atypical Long-Acting Antipsychotics for Relapsed Chronic Schizophrenia: an Economic Analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Paliperidone; Schizophrenia (object-oriented programming); Paliperidone Palmitate; Medicine; Psychiatry; Antipsychotic","score_opus":0.37381317833837174,"score_gpt":0.4468566755425673,"score_spread":0.07304349720419556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2028802309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9210811,0.0019426415,0.049082156,0.022459313,0.003067441,0.0015055911,0.00031750632,0.00012890929,0.00041531224],"genre_scores_gemma":[0.9841995,0.00030840497,0.011664638,0.002024034,0.0013583318,0.00012857831,0.00017164876,0.000070034825,0.000074794356],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9922205,0.0008230769,0.0049144397,0.0010578794,0.0000890987,0.00089500163],"domain_scores_gemma":[0.99382293,0.0023180868,0.0024130864,0.0009710135,0.000037958525,0.00043693828],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.021672683,0.00029343547,0.001723898,0.0009277133,0.0003314464,0.00015237994,0.00050122675,0.00024801426,0.00021182088],"category_scores_gemma":[0.0021465064,0.0004054384,0.0002961972,0.00050266855,0.00007504843,0.00060178596,0.000051354145,0.00033223376,0.000563023],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022996066,0.00046895462,0.16744633,0.0019663242,0.0007947453,0.0000013146155,0.002515141,0.3678349,0.000002494794,0.4481064,0.0036763134,0.0048874565],"study_design_scores_gemma":[0.006384123,0.0009315356,0.07877212,0.000111398476,0.000040574898,0.0000018621855,0.00026926352,0.8836025,0.0000024942535,0.0076622805,0.021623833,0.0005980289],"about_ca_topic_score_codex":0.0042748908,"about_ca_topic_score_gemma":0.0033254814,"teacher_disagreement_score":0.5157676,"about_ca_system_score_codex":0.002681658,"about_ca_system_score_gemma":0.0005937753,"threshold_uncertainty_score":0.9998397},"labels":[],"label_agreement":null},{"id":"W2029108361","doi":"10.1016/j.jval.2014.03.513","title":"Cost–Effectiveness Analysis Parallel to a Randomized Controlled Trial Comparing Vertical Scar Reduction (VSR) and Inverted T-Shaped Reduction (ITR) Mammoplasty","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; University of Toronto; McMaster University","funders":"","keywords":"Randomized controlled trial; Medicine; Cost-effectiveness analysis; Quality-adjusted life year; Quality of life (healthcare); Reduction Mammoplasty; EQ-5D; Economic evaluation; Cost–benefit analysis; Physical therapy; Cost effectiveness; Surgery; Internal medicine; Health related quality of life; Nursing; Risk analysis (engineering); Breast cancer; Pathology","score_opus":0.047619420798137524,"score_gpt":0.32097462633369855,"score_spread":0.27335520553556103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029108361","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826016,0.0001461524,0.0084228795,0.0010470486,0.0012255658,0.0064154733,0.0000017360107,0.00008033294,0.000059244147],"genre_scores_gemma":[0.9979307,0.00007515461,0.000992245,0.00004238808,0.00042593983,0.00045173112,0.000039054037,0.000017530469,0.000025267133],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9956081,0.002251943,0.0009927488,0.0004680116,0.00029934986,0.00037985257],"domain_scores_gemma":[0.99854374,0.0005976876,0.00019558152,0.00020920437,0.00009518126,0.00035860678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041086087,0.00022462342,0.00241536,0.00078259746,0.00014057744,0.000032102962,0.000042880623,0.00016711613,0.000015362335],"category_scores_gemma":[0.0004429007,0.00017600767,0.0002989076,0.00077731075,0.0001387958,0.00009421441,0.000023322415,0.00031272665,0.00000916766],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97821784,0.00019604579,0.0021980784,0.00017454404,0.00064557826,0.0000018038994,0.0003818715,0.0052760225,0.0004865784,0.00042149427,0.000017413133,0.011982753],"study_design_scores_gemma":[0.71755964,0.00037084537,0.006038174,0.00029139762,0.00066421705,0.0011526532,0.00010812487,0.27338105,0.000051367093,0.00022814305,0.000009899417,0.00014449569],"about_ca_topic_score_codex":0.0021570108,"about_ca_topic_score_gemma":0.00004470697,"teacher_disagreement_score":0.26810503,"about_ca_system_score_codex":0.0002940003,"about_ca_system_score_gemma":0.0001797848,"threshold_uncertainty_score":0.71773845},"labels":[],"label_agreement":null},{"id":"W2029111709","doi":"10.1016/j.jval.2011.09.009","title":"A Review of the Cost of Atrial Fibrillation","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Sinai Health System; Toronto Rehabilitation Institute; University of Toronto","funders":"","keywords":"Atrial fibrillation; Medicine; Cardiology","score_opus":0.3126281603514576,"score_gpt":0.4505405811053328,"score_spread":0.13791242075387522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029111709","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000016910478,0.994373,0.0000065184636,0.00042312592,0.0004731196,0.0040423064,0.000017062324,0.000008488422,0.000654664],"genre_scores_gemma":[0.000004190515,0.99879944,0.00014444035,0.00011113819,0.00066046865,0.0000018607418,0.000037876838,0.000019883326,0.0002207201],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974004,0.0005036059,0.0015666267,0.00016650697,0.00022152459,0.00014131487],"domain_scores_gemma":[0.997639,0.00028422708,0.0015260887,0.00044688504,0.000057260346,0.000046563113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013473143,0.00016162859,0.0020411122,0.00016534133,0.000018857789,0.0000013245601,0.0001142067,0.00011187469,0.00008807271],"category_scores_gemma":[0.0006147596,0.000097018834,0.00094691373,0.0006402596,0.000036931906,0.000021451293,0.00006403716,0.00014688155,0.000011163271],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011412769,0.0000011809867,0.0007877303,0.3909276,0.000042068543,1.355903e-7,0.00001979339,0.0000069749963,3.776252e-9,0.0011088143,0.0005269852,0.6065673],"study_design_scores_gemma":[0.00022156182,0.000049616243,0.00015536006,0.25415558,0.00031973506,0.0000031662653,0.0000013267412,0.000008609106,5.3225133e-8,0.000027472897,0.74501085,0.000046628567],"about_ca_topic_score_codex":0.0004684198,"about_ca_topic_score_gemma":0.0000030126891,"teacher_disagreement_score":0.7444839,"about_ca_system_score_codex":0.00013007698,"about_ca_system_score_gemma":0.0007672045,"threshold_uncertainty_score":0.3956313},"labels":[],"label_agreement":null},{"id":"W2029343549","doi":"10.1016/j.jval.2011.02.705","title":"PMS20 HEALTH CARE RESOURCES UTILIZATION IN THE MANAGEMENT OF JUVENILE IDIOPATHIC ARTHRITIS: ANALYSES WITH THE RAMQ DATABASE","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); Université de Montréal","funders":"","keywords":"Medicine; Medical prescription; Psychological intervention; Arthritis; Rheumatoid arthritis; Juvenile rheumatoid arthritis; Health care; Health plan; Utilization management; Database; Emergency medicine; Internal medicine; Pediatrics; Physical therapy","score_opus":0.283381160982861,"score_gpt":0.4478998170322493,"score_spread":0.1645186560493883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029343549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81984085,0.130674,0.0010676893,0.034866143,0.0006413532,0.009361114,0.0002896248,0.0001431394,0.0031160715],"genre_scores_gemma":[0.98559433,0.00947798,0.00062191015,0.003836689,0.00016792917,0.00016857017,0.000069779766,0.000027314009,0.00003548849],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9926557,0.004323548,0.001345921,0.00037016894,0.0005328426,0.00077180815],"domain_scores_gemma":[0.9979819,0.00026532746,0.00078271836,0.0007218103,0.000100196085,0.00014806532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052683344,0.0001953051,0.0005227528,0.00024124686,0.0007075077,0.000006397555,0.00043205576,0.00010950861,0.00004027778],"category_scores_gemma":[0.000044127337,0.00011509252,0.00004529099,0.0012247817,0.00008013504,0.00009965874,0.00009879885,0.00091781677,0.000016024633],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00062529836,0.0005082447,0.3616802,0.024206053,0.000040372513,0.00008655044,0.56233466,0.00049562694,7.430305e-7,0.008945303,0.006495978,0.034580987],"study_design_scores_gemma":[0.004005294,0.0012019913,0.3968548,0.014935945,0.000041401818,0.000007637167,0.55330044,0.00064255274,0.0000050259373,0.00038579231,0.028209768,0.00040937398],"about_ca_topic_score_codex":0.04746325,"about_ca_topic_score_gemma":0.016336603,"teacher_disagreement_score":0.16575347,"about_ca_system_score_codex":0.000337412,"about_ca_system_score_gemma":0.0012055938,"threshold_uncertainty_score":0.95887977},"labels":[],"label_agreement":null},{"id":"W2029549447","doi":"10.1016/j.jval.2011.02.887","title":"PCN29 TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) USING RITUXIMAB (R) WITH FLUDARABINE (F) AND CYCLOPHOSPHAMIDE (C): ASSESSING THE FINANCIAL IMPACT OF THE ROUTE OF ADMINISTRATION AT PRINCESS MARGARET HOSPITAL (PMH)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Roche (Canada)","funders":"","keywords":"Medicine; Fludarabine; Rituximab; Dosing; Cyclophosphamide; Route of administration; Regimen; Internal medicine; Chemotherapy; Lymphoma","score_opus":0.048381589222184065,"score_gpt":0.3374780089602432,"score_spread":0.28909641973805916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029549447","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544907,0.0028083348,0.000068556255,0.000073437135,0.000086254935,0.0013711413,0.000026561178,0.00001004118,0.000106631596],"genre_scores_gemma":[0.99852353,0.00068600563,0.0006304328,0.000013665336,0.00006155449,0.000020705,0.000008510311,0.000029910696,0.000025674895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99766695,0.00022421891,0.00078493176,0.0003210663,0.00054665684,0.0004561596],"domain_scores_gemma":[0.9982842,0.00019958183,0.0006411711,0.0006120215,0.00013225184,0.00013075111],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005629646,0.00024003793,0.00069416524,0.000103474726,0.00013230096,0.000009690694,0.00018121372,0.000112199305,0.000021304963],"category_scores_gemma":[0.00013293867,0.00012907703,0.00013577059,0.00047371082,0.00052139634,0.00011484352,0.00009249637,0.00014337513,4.926841e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.008968035,0.0038085575,0.87093306,0.010600809,0.00088842656,0.00036639775,0.027762588,0.04088593,0.005720806,0.0013249032,0.000051649964,0.028688844],"study_design_scores_gemma":[0.037823837,0.011862883,0.7021689,0.0028435122,0.00018620542,0.00055310887,0.00034872186,0.21795128,0.025825975,0.00015422954,0.000024295277,0.00025707824],"about_ca_topic_score_codex":0.06960542,"about_ca_topic_score_gemma":0.00095237937,"teacher_disagreement_score":0.17706536,"about_ca_system_score_codex":0.08370877,"about_ca_system_score_gemma":0.075429045,"threshold_uncertainty_score":0.93659014},"labels":[],"label_agreement":null},{"id":"W2029582792","doi":"10.1016/s1098-3015(10)62723-4","title":"PHPI2 SOCIAL AND ECONOMIC FACTORS AFFECTING INTENTIONAL PRESCRIPTION DRUG NON-COMPLIANCE AMONG NOVA SCOTIA SENIORS","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nova scotia; Medical prescription; Compliance (psychology); Nova (rocket); Drug; Prescription drug; Medicine; Psychology; Gerontology; Psychiatry; Sociology; Nursing; Social psychology; Engineering; Aeronautics","score_opus":0.08421301469231025,"score_gpt":0.34973813814937554,"score_spread":0.2655251234570653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2029582792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99470335,0.00017656556,0.00029760922,0.0032209984,0.00034743498,0.0004595342,0.0000050456783,0.00003627744,0.00075316953],"genre_scores_gemma":[0.9974059,0.000047017922,0.00090635964,0.0005092533,0.00031913328,0.000006733483,0.000020051119,0.000012981599,0.00077256834],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988174,0.000073337724,0.00039461578,0.0002897338,0.00015405269,0.00027088894],"domain_scores_gemma":[0.99944574,0.000060918817,0.00019322529,0.000120775214,0.000026918242,0.00015244899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047292025,0.00012069262,0.00025709035,0.00010820825,0.00009953872,0.000017946963,0.000067281864,0.00005416446,0.00032548138],"category_scores_gemma":[0.000044744436,0.000119262004,0.000043778582,0.00010357683,0.00008616334,0.000163457,0.000023489474,0.00026701565,0.00024813606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036346213,0.000098327815,0.9865105,0.00039321964,0.0000147382,0.0000015828546,0.0026653972,0.00032987,0.00023538384,0.00024867858,0.0048497897,0.004616132],"study_design_scores_gemma":[0.0008461644,0.000052298743,0.97919667,0.0005823728,0.0000060551897,0.000010984623,0.00093606656,0.01730465,0.00017075233,0.00006617321,0.00072144077,0.00010638675],"about_ca_topic_score_codex":0.008502143,"about_ca_topic_score_gemma":0.00079404743,"teacher_disagreement_score":0.01697478,"about_ca_system_score_codex":0.0003334374,"about_ca_system_score_gemma":0.0002183467,"threshold_uncertainty_score":0.99810034},"labels":[],"label_agreement":null},{"id":"W2030159996","doi":"10.1016/j.jval.2011.08.1467","title":"PSS2 Prevalence, Demographics and Treatment Characteristics of Visual Impairment Due to Diabetic Macular Edema in A Representative Canadian Cohort","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Lawson Health Research Institute","funders":"","keywords":"Medicine; Cohort; Diabetes mellitus; Diabetic retinopathy; Demographics; Comorbidity; Diabetic macular edema; Visual acuity; Medical record; Concomitant; Pediatrics; Ophthalmology; Internal medicine; Demography","score_opus":0.03386000403553887,"score_gpt":0.3236163984960389,"score_spread":0.28975639446050006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030159996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99696237,0.00062342576,0.000003318473,0.00031968855,0.000042956264,0.0018204517,0.00009586919,0.000006849037,0.00012508855],"genre_scores_gemma":[0.9976087,0.0015013582,0.00045315136,0.00020780673,0.000015427573,0.00013969593,0.000027745691,0.000014871904,0.000031237378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857515,0.00015278468,0.00043620056,0.0003015584,0.0001701695,0.0003641121],"domain_scores_gemma":[0.99900115,0.000044954915,0.00009880495,0.00018659847,0.000037487287,0.0006309856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023496388,0.0001511161,0.00044982164,0.0003660103,0.000032629374,0.0000042487636,0.000037815567,0.00004889173,0.000033075637],"category_scores_gemma":[0.000046540295,0.00012731052,0.00005343003,0.00029937003,0.000051343206,0.000024789944,0.000017630042,0.00006461432,0.0000037400582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022735013,0.00087052846,0.9936428,0.00037566535,0.00006511966,0.00043943958,0.0022491044,0.0000036295658,0.0000035718815,0.00009168738,0.00000916981,0.0020219146],"study_design_scores_gemma":[0.0012015669,0.003356894,0.99384516,0.0005998855,0.00007060554,0.000023787825,0.00022809893,0.00045583057,0.000031204145,0.000083218605,0.000022192451,0.00008155308],"about_ca_topic_score_codex":0.27728516,"about_ca_topic_score_gemma":0.011299877,"teacher_disagreement_score":0.26598528,"about_ca_system_score_codex":0.00046511993,"about_ca_system_score_gemma":0.0005246503,"threshold_uncertainty_score":0.72752744},"labels":[],"label_agreement":null},{"id":"W2030487647","doi":"10.1016/s1098-3015(10)62211-5","title":"PMH14 CANADIAN NETWORK FOR BIPOLAR DISORDER (CAN-BD): FREQUENCY OF RELAPSE IN AN OBSERVATIONAL STUDY","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Observational study; Bipolar disorder; Psychiatry; Medicine; Psychology; Internal medicine; Cognition","score_opus":0.5468399153985716,"score_gpt":0.440128909151986,"score_spread":0.10671100624658558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030487647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9562516,0.005968823,0.0005480242,0.033271972,0.0005750112,0.0026730567,0.00062497525,0.00001736668,0.000069134345],"genre_scores_gemma":[0.9818962,0.00017882379,0.010082869,0.0070550707,0.00026182027,0.00031473255,0.00013828269,0.000043367727,0.000028808165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99367076,0.0004888822,0.004497245,0.00054301915,0.00009310148,0.00070700963],"domain_scores_gemma":[0.9971743,0.00060524227,0.0013289225,0.00048466376,0.00006536466,0.0003414805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018966991,0.00017231207,0.0009118602,0.00063995883,0.00017276694,0.000024587218,0.0002942755,0.00014023659,0.000054003885],"category_scores_gemma":[0.0016594206,0.00024153742,0.00006509224,0.0005864537,0.000037025704,0.00033403622,0.000016083713,0.0002213643,0.00004235232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006107079,0.00023540287,0.7598631,0.00019554925,0.0000089440155,6.2001556e-7,0.003127974,0.08753986,9.662183e-8,0.14864245,0.0002897627,0.0000901853],"study_design_scores_gemma":[0.002258143,0.000512052,0.85623807,0.00018509776,0.0000017865694,9.216763e-7,0.0013988804,0.0069661317,1.4699884e-7,0.12510945,0.007051208,0.00027811155],"about_ca_topic_score_codex":0.85216975,"about_ca_topic_score_gemma":0.82307917,"teacher_disagreement_score":0.09637502,"about_ca_system_score_codex":0.0024480238,"about_ca_system_score_gemma":0.0024787674,"threshold_uncertainty_score":0.98496103},"labels":[],"label_agreement":null},{"id":"W2030870464","doi":"10.1016/j.jval.2014.03.1243","title":"Analysis perspective for assessing the financial impact of interventions used in rural/remote settings – a canadian case study of fomepizole for toxic alcohol poisoning","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Medicine; Psychological intervention; Medical emergency; Health care; Ethylene glycol poisoning; Rural area; Environmental health; Nursing","score_opus":0.13102339261074783,"score_gpt":0.5209401950551297,"score_spread":0.38991680244438187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030870464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873709,0.0002462212,0.002055251,0.005700486,0.00019313402,0.004209834,0.00013204769,0.000013832545,0.00007828446],"genre_scores_gemma":[0.9976716,0.000008382172,0.0009608101,0.0009973102,0.000079839876,0.00021281745,0.000018828174,0.000024175863,0.000026213605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99567676,0.0015245072,0.0015301063,0.00028080313,0.00016425615,0.0008235683],"domain_scores_gemma":[0.9950836,0.0031776107,0.00088610465,0.0003798116,0.00026153447,0.00021136006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057207383,0.0001739649,0.0009167152,0.0011246745,0.0008201346,0.000010341485,0.00020873788,0.00013573286,0.000018225737],"category_scores_gemma":[0.001710768,0.00013763767,0.00044606507,0.0014561667,0.00003467899,0.00013705401,0.00004725564,0.00046754186,6.0247515e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009841719,0.00032868618,0.9041273,0.001738748,0.00019872776,0.0000110866495,0.07890326,0.004592307,0.000008632667,0.00067326,0.00028590817,0.0090337],"study_design_scores_gemma":[0.004499513,0.0015227041,0.7942168,0.0008537733,0.00021846595,0.0000072309153,0.14796865,0.049271487,0.00000142265,0.0011191628,0.00011742473,0.00020333451],"about_ca_topic_score_codex":0.92311966,"about_ca_topic_score_gemma":0.868397,"teacher_disagreement_score":0.109910436,"about_ca_system_score_codex":0.0034403112,"about_ca_system_score_gemma":0.0057290182,"threshold_uncertainty_score":0.99990755},"labels":[],"label_agreement":null},{"id":"W2030895155","doi":"10.1016/j.jval.2011.02.177","title":"PHP108 THE CASE OF RARE DISEASE DRUGS BEFORE AND AFTER THE INTRODUCTION OF PRICING BODIES: LESSONS LEARNED FROM BRAZIL AND CANADA, IMPLICATIONS FOR THE UNITED STATES","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Drug prices; Purchasing; Natalizumab; Drug pricing; Disease; Economics; Business; Public economics; Actuarial science; Medicine; Marketing; Pathology","score_opus":0.10565085449068398,"score_gpt":0.323450803452887,"score_spread":0.21779994896220303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2030895155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88452893,0.002385401,0.000094530544,0.110643014,0.00006362881,0.00035973312,0.0018971384,0.0000022316676,0.000025395391],"genre_scores_gemma":[0.99563605,0.0024375166,0.000049670343,0.0017129371,0.00006608604,0.000054251504,0.000021878295,0.000008466724,0.000013136855],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9992639,0.000035792662,0.00038240437,0.00015993447,0.000009526869,0.0001484583],"domain_scores_gemma":[0.9990297,0.00039678093,0.00023575652,0.00024819584,0.000021258698,0.00006832571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052046584,0.000066857385,0.00016197037,0.00005771166,0.0001630171,0.000012823586,0.000096522606,0.00001845427,0.000014583888],"category_scores_gemma":[0.000106159736,0.000043742428,0.000023721817,0.00008561332,0.00012760867,0.00004262966,0.00004174984,0.00009200095,2.4977638e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049832615,0.00016674832,0.27937484,0.0006426921,0.00022683768,0.0000028397576,0.061705656,0.0043697436,0.0000029561056,0.61956424,0.0046178834,0.028827272],"study_design_scores_gemma":[0.00079600967,0.00007846821,0.5863044,0.000034387136,0.0000343643,0.000009131501,0.003694988,0.0859485,0.000017163738,0.2798359,0.043081544,0.00016509109],"about_ca_topic_score_codex":0.7582309,"about_ca_topic_score_gemma":0.2194919,"teacher_disagreement_score":0.538739,"about_ca_system_score_codex":0.00006134934,"about_ca_system_score_gemma":0.000106398664,"threshold_uncertainty_score":0.79475033},"labels":[],"label_agreement":null},{"id":"W2031005096","doi":"10.1016/j.jval.2012.03.241","title":"PMS52 Validation of Remission of Rheumatoid Arthritis by Traditional Disease Activity Score and Provisional Criteria by American College of Rheumatology and European League Agaisnt Rheumatism: Analysis Based on Patient Reported Outcomes from 3 Phase III Clinical Trials of Golimumab","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Rheumatism; Rheumatology; Golimumab; Placebo; Bristol-Myers; Physical therapy; Complete remission; Gastroenterology; Etanercept; Alternative medicine; Chemotherapy","score_opus":0.11017951032015214,"score_gpt":0.399706067098394,"score_spread":0.2895265567782419,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031005096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873736,0.005330393,0.00046362146,0.0007626141,0.000065868706,0.0008765372,0.005105118,0.000011661113,0.000010597575],"genre_scores_gemma":[0.975435,0.023012584,0.0006578498,0.000035894747,0.0000053728486,0.000018989991,0.00081198826,0.00002097574,0.0000013026656],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9912941,0.004259836,0.0030908089,0.0003857423,0.00068110984,0.00028840627],"domain_scores_gemma":[0.99302703,0.003381204,0.0025058158,0.00037413105,0.00016887317,0.0005429614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005938273,0.00021698719,0.0023107808,0.00043254526,0.00006036404,0.0000051567536,0.000073904404,0.00007112753,0.00010762568],"category_scores_gemma":[0.004398388,0.0001807166,0.00024977743,0.00040808972,0.0005933185,0.0001355266,0.00003918397,0.00021333613,2.0071964e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0153804645,0.008241317,0.8708741,0.0005959546,0.0007491787,0.000011833141,0.000855766,0.000056469213,0.0068373615,0.00019951888,0.0017489042,0.09444913],"study_design_scores_gemma":[0.039832443,0.007520629,0.9156336,0.007515823,0.000081025944,0.000029882229,0.00054495886,0.017644597,0.010223577,0.00042015963,0.00016475882,0.0003885522],"about_ca_topic_score_codex":0.004412056,"about_ca_topic_score_gemma":0.000010312558,"teacher_disagreement_score":0.09406058,"about_ca_system_score_codex":0.000049592905,"about_ca_system_score_gemma":0.00043882927,"threshold_uncertainty_score":0.7369409},"labels":[],"label_agreement":null},{"id":"W2031046511","doi":"10.1016/s1098-3015(10)63267-6","title":"PAR8 TRENDS IN PRESCRIPTION CLAIMS FOLLOWING THE WITHDRAWAL OF ROFECOXIB FROM THE CANADIAN MARKET","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rofecoxib; Medical prescription; Business; Medicine; Pharmacology; Chemistry","score_opus":0.3219178323889248,"score_gpt":0.4965416050266483,"score_spread":0.1746237726377235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031046511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93617624,0.003500015,0.0000034369111,0.049905952,0.0014915842,0.0006379227,0.00021486406,0.00002584428,0.008044129],"genre_scores_gemma":[0.9920642,0.00011862186,0.000031029434,0.00672945,0.00037801045,0.000055614142,0.000060620256,0.000016899621,0.0005455483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951504,0.0027911805,0.000745204,0.00029195574,0.0002091466,0.00081213086],"domain_scores_gemma":[0.9982739,0.00096080935,0.00017119275,0.00026452562,0.000027628994,0.00030195893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003395175,0.00018586357,0.00031131727,0.00017231013,0.00046863127,0.000019474457,0.00038874336,0.0004608713,0.00086919335],"category_scores_gemma":[0.00006473607,0.00013052637,0.0000967359,0.00066064316,0.0001722851,0.00009630883,0.000040126455,0.0022509585,0.000013269854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032977885,0.00027796897,0.9236316,0.00008226648,0.00005378336,0.00006748331,0.0024457609,0.010236378,0.00018827105,0.005620226,0.03870508,0.018361378],"study_design_scores_gemma":[0.0021311764,0.000111980895,0.81014794,0.00016112153,0.0000428754,0.0000069999924,0.00055429863,0.03420039,0.00044438892,0.0058412235,0.14611682,0.00024081177],"about_ca_topic_score_codex":0.73476565,"about_ca_topic_score_gemma":0.65971035,"teacher_disagreement_score":0.11348371,"about_ca_system_score_codex":0.0005705415,"about_ca_system_score_gemma":0.0007846673,"threshold_uncertainty_score":0.97794193},"labels":[],"label_agreement":null},{"id":"W2031248090","doi":"10.1016/j.jval.2011.02.927","title":"PCN72 GENE EXPRESSION PROFILING FOR GUIDING ADJUVANT CHEMOTHERAPY DECISIONS IN WOMEN WITH EARLY BREAST CANCER: A COST-EFFECTIVENESS ANALYSIS OF 1000 STRATEGIES FOR THE PROVISION OF ADJUVANT! ONLINE, ONCOTYPE DX AND CHEMOTHERAPY","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Health and Long Term Care; University of Toronto","funders":"","keywords":"Medicine; Oncology; Breast cancer; Internal medicine; Adjuvant chemotherapy; Chemotherapy; Stage (stratigraphy); Adjuvant; Gynecology; Cancer","score_opus":0.3458329580443284,"score_gpt":0.4306384910490784,"score_spread":0.08480553300475002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031248090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708998,0.0027235665,0.019147187,0.0017401887,0.00008933338,0.0042084847,0.0011664998,0.000011571419,0.0000133474505],"genre_scores_gemma":[0.98320204,0.0024504333,0.012604695,0.000556185,0.000050577906,0.0010693191,0.000021735224,0.000039558174,0.0000054415855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99604577,0.00034929492,0.0025686158,0.00051255844,0.00010247183,0.00042128723],"domain_scores_gemma":[0.9948018,0.0025505375,0.0020016765,0.00039303515,0.00014686187,0.00010608435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013164841,0.00019592335,0.0014212218,0.00066450407,0.0001205655,0.000022027507,0.00022726525,0.000115310955,0.000020813648],"category_scores_gemma":[0.00030438104,0.00016720472,0.00009010276,0.0006406414,0.000078237426,0.00027429295,0.000023131333,0.00009940988,4.6522226e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005353062,0.0010634233,0.83675313,0.0028567477,0.0007082155,4.5722962e-7,0.05349515,0.05131025,0.0005641883,0.010981487,0.00007499971,0.036838885],"study_design_scores_gemma":[0.0043631615,0.00084873877,0.8766913,0.0011878886,0.00002735738,0.0000011762902,0.00601539,0.10590699,0.0004959237,0.00398529,0.00020217354,0.00027461385],"about_ca_topic_score_codex":0.016022827,"about_ca_topic_score_gemma":0.00095060695,"teacher_disagreement_score":0.05459675,"about_ca_system_score_codex":0.0006297112,"about_ca_system_score_gemma":0.0007095729,"threshold_uncertainty_score":0.99052954},"labels":[],"label_agreement":null},{"id":"W2031368239","doi":"10.1016/j.jval.2013.08.1826","title":"The Cost Effectiveness of BG-12 (Dimethyl Fumarate) for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Glatiramer acetate; Discontinuation; Expanded Disability Status Scale; Multiple sclerosis; Dimethyl fumarate; Quality-adjusted life year; Adverse effect; Relapsing remitting; Cost effectiveness; Quality of life (healthcare); Physical therapy; Pediatrics; Internal medicine; Psychiatry","score_opus":0.44461160527161564,"score_gpt":0.3869448230535893,"score_spread":0.05766678221802635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031368239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752928,0.010368908,0.0005554329,0.008318211,0.0007251525,0.004455986,0.00018372673,0.0000057691987,0.0000940263],"genre_scores_gemma":[0.9964225,0.0016979391,0.0005190182,0.0004359981,0.00004972267,0.0008126153,0.000008426517,0.000021694063,0.00003203674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99467915,0.0010588556,0.0034149112,0.00031270116,0.00008133929,0.0004530389],"domain_scores_gemma":[0.97720736,0.020300789,0.0018955918,0.00044831878,0.000060770286,0.00008715098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01879993,0.00014308917,0.0008706899,0.00013803176,0.00020296768,0.000019964915,0.00022761669,0.00006285763,0.000016005117],"category_scores_gemma":[0.0026287558,0.00011753771,0.00008620644,0.00022405312,0.00006209194,0.00011332568,0.000017307564,0.00010075308,0.000014621954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010434199,0.0002598568,0.89976674,0.0016779004,0.0000836054,1.211142e-7,0.0035398074,0.073551245,0.00001706838,0.010211869,0.0010413381,0.009746084],"study_design_scores_gemma":[0.0028587615,0.00029766932,0.81325287,0.000719357,0.0000038287026,5.130457e-7,0.0022158008,0.17229861,0.00011807584,0.002753339,0.0052973055,0.00018388196],"about_ca_topic_score_codex":0.97759205,"about_ca_topic_score_gemma":0.663206,"teacher_disagreement_score":0.3143861,"about_ca_system_score_codex":0.0036784357,"about_ca_system_score_gemma":0.0013016654,"threshold_uncertainty_score":0.96189815},"labels":[],"label_agreement":null},{"id":"W2031464368","doi":"10.1016/j.jval.2012.03.1381","title":"MO4 Economic Evaluation of Treatment Strategies for Late-Presentation Acute Ischemic Stroke","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Thrombolysis; Medicine; Willingness to pay; Economic evaluation; Stroke (engine); Emergency medicine; Cost effectiveness; Activity-based costing; Cost–benefit analysis; Quality-adjusted life year; Randomized controlled trial; Surgery; Internal medicine; Myocardial infarction","score_opus":0.0956277062667423,"score_gpt":0.3880759459339206,"score_spread":0.29244823966717826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031464368","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894764,0.00085558655,0.0006480435,0.0010536036,0.0002627661,0.0020384544,0.00006803355,0.000024157423,0.0055729435],"genre_scores_gemma":[0.99415535,0.00031210994,0.004380025,0.00010617342,0.00023110321,0.00025658152,0.00013868563,0.00001961279,0.00040037575],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987145,0.00009493443,0.00046402944,0.00018262208,0.0002079339,0.0003359698],"domain_scores_gemma":[0.9992588,0.00010018649,0.00023012799,0.0002581347,0.00005369695,0.00009902514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011703705,0.00012764949,0.00032992754,0.0001565415,0.0000262851,0.000007094064,0.000055289453,0.000056098186,0.0000582793],"category_scores_gemma":[0.00003212087,0.00011685371,0.00007598261,0.000059944923,0.000024258097,0.00017649482,0.000019243944,0.00005750372,0.00001394998],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035483902,0.003173936,0.29985097,0.0049419524,0.0037240467,0.0000051546667,0.028716503,0.20473221,0.10643658,0.013543997,0.10735777,0.22396848],"study_design_scores_gemma":[0.038724486,0.0054111723,0.08689339,0.0007166967,0.0025182117,0.00003759209,0.012045148,0.7108765,0.08707438,0.0009797788,0.05393621,0.0007864339],"about_ca_topic_score_codex":0.0015928609,"about_ca_topic_score_gemma":0.00001783824,"teacher_disagreement_score":0.5061443,"about_ca_system_score_codex":0.0016309706,"about_ca_system_score_gemma":0.0006531307,"threshold_uncertainty_score":0.47651562},"labels":[],"label_agreement":null},{"id":"W2031638627","doi":"10.1016/j.jval.2012.08.1813","title":"PHS40 An Example of Irrational Decision Making in the Elderly: Why are Pharmacological Therapies Preferentially Reimbursed Over Non-Pharmacological Therapies for Insomnia?","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cognitive behavioral therapy for insomnia; Medicine; Adverse effect; Insomnia; Cognition; Psychological intervention; Cognitive therapy; Reimbursement; Psychiatry; Intensive care medicine; Cognitive behavioral therapy; Internal medicine; Health care","score_opus":0.5709257559665363,"score_gpt":0.48488125502769336,"score_spread":0.08604450093884292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031638627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97661495,0.0037922075,0.006595776,0.009645176,0.00076066056,0.002261909,0.00015170986,0.000025692538,0.00015191206],"genre_scores_gemma":[0.9788345,0.000406947,0.006959682,0.012769862,0.0005167223,0.0004471045,0.000029507783,0.000026201407,0.000009473872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938018,0.0014423033,0.003356116,0.00050917617,0.00022793682,0.000662693],"domain_scores_gemma":[0.99364966,0.0039148354,0.0019035145,0.0003198218,0.00007723941,0.00013494662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028761508,0.0002302213,0.0009225454,0.0003721606,0.00022162606,0.00005901662,0.0004628504,0.00020247554,0.00051227224],"category_scores_gemma":[0.0008793568,0.00020248856,0.00012331633,0.0002892506,0.000088636094,0.00060036575,0.000044724417,0.00032767156,0.000028152046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014422648,0.005750955,0.5993104,0.0015800808,0.00032011428,0.000002629244,0.08530987,0.0140400985,0.00024560842,0.24336995,0.03805505,0.0105729755],"study_design_scores_gemma":[0.005167997,0.001301069,0.85442513,0.00035874711,0.00001551599,0.0000054485845,0.0054617,0.028262395,0.000021498709,0.061203454,0.04319908,0.0005779425],"about_ca_topic_score_codex":0.0023674713,"about_ca_topic_score_gemma":0.00041690728,"teacher_disagreement_score":0.25511476,"about_ca_system_score_codex":0.0005489929,"about_ca_system_score_gemma":0.00024696696,"threshold_uncertainty_score":0.99682224},"labels":[],"label_agreement":null},{"id":"W2031741473","doi":"10.1111/j.1524-4733.2008.00355.x","title":"Health State Utilities in Latent and Active Tuberculosis","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; Providence Health Care; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Medicine; Health Utilities Index; Construct validity; Tuberculosis; Public health; Quality of life (healthcare); Latent tuberculosis; Ceiling effect; Population; Visual analogue scale; Health related quality of life; Physical therapy; Gerontology; Environmental health; Psychometrics; Alternative medicine; Internal medicine; Clinical psychology; Mycobacterium tuberculosis; Pathology; Nursing; Disease","score_opus":0.4461640304858526,"score_gpt":0.4130930283048962,"score_spread":0.03307100218095643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031741473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8976712,0.009933351,0.00017082531,0.09004199,0.00031174536,0.0009931714,0.00028223475,0.000037895523,0.000557578],"genre_scores_gemma":[0.97183025,0.010669533,0.0018802005,0.015080417,0.00008640266,0.00009831497,0.000022283903,0.00003506603,0.00029751754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99351925,0.00089412165,0.004136801,0.0006130156,0.000096671545,0.00074015633],"domain_scores_gemma":[0.9972396,0.00080524705,0.0012875602,0.00033491245,0.000022203494,0.00031047646],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013105917,0.0001935395,0.0012374215,0.000654443,0.00020703187,0.00002240547,0.00013492278,0.000087983884,0.00005976109],"category_scores_gemma":[0.0008309203,0.00025658988,0.00005420844,0.00032668756,0.00010058988,0.0003644578,0.00004908215,0.00030820453,0.00020115105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060705104,0.0003293952,0.8761704,0.0020823886,0.000036222,0.000006799604,0.06504722,0.005490955,2.3666709e-7,0.04284457,0.0045550256,0.0033760855],"study_design_scores_gemma":[0.0015107738,0.00027939654,0.9425159,0.0004046324,5.327759e-7,0.000026304624,0.002180026,0.014119762,0.0000014845315,0.02115035,0.017438322,0.00037252522],"about_ca_topic_score_codex":0.116567224,"about_ca_topic_score_gemma":0.0030515923,"teacher_disagreement_score":0.11351564,"about_ca_system_score_codex":0.0019443379,"about_ca_system_score_gemma":0.0006949962,"threshold_uncertainty_score":0.9999886},"labels":[],"label_agreement":null},{"id":"W2031771150","doi":"10.1016/j.jval.2012.08.2176","title":"PCN136 Expenditures on Orphan Drugs in Canada, Europe (EU5 + Belgium, Sweden and the Netherlands) and Australia in 2009","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Orphan drug; Per capita; Authorization; Agency (philosophy); Eu countries; European union; Medicine; Demography; Business; Environmental health; International trade; Population; Biology","score_opus":0.09226563942851991,"score_gpt":0.3095126234444604,"score_spread":0.2172469840159405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031771150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821881,0.0058223945,6.9263683e-7,0.008884966,0.00029556346,0.00028113247,0.000082710285,0.000003142187,0.002441267],"genre_scores_gemma":[0.99252105,0.0027728828,0.00001638352,0.0043805623,0.00014572835,0.0000160935,0.0000035564342,0.000013954489,0.00012981372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985458,0.000108247965,0.0005800936,0.00023258616,0.000026160436,0.0005071148],"domain_scores_gemma":[0.9992653,0.00023086778,0.00015435868,0.00015697505,0.0000023827486,0.00019009819],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014637293,0.00013030422,0.0003700193,0.0001815658,0.000045459932,0.000030398825,0.00012721994,0.000050001632,0.00007548522],"category_scores_gemma":[0.00005068532,0.00011670656,0.000016469057,0.00012646706,0.00005179659,0.000098634126,0.000045877947,0.00030010098,0.000031770323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009836045,0.000066612956,0.8136658,0.00006561391,0.00000850454,0.000003301387,0.0027594315,0.00096896733,5.914873e-7,0.17714939,0.004201628,0.001011783],"study_design_scores_gemma":[0.0027691582,0.000043910462,0.8995297,0.000052829542,0.0000011491082,0.0000049122345,0.00015819575,0.005917942,0.000007866884,0.007926606,0.08334349,0.00024424435],"about_ca_topic_score_codex":0.90344775,"about_ca_topic_score_gemma":0.43541387,"teacher_disagreement_score":0.46803388,"about_ca_system_score_codex":0.0003404844,"about_ca_system_score_gemma":0.0001212431,"threshold_uncertainty_score":0.57488835},"labels":[],"label_agreement":null},{"id":"W2031786236","doi":"10.1111/j.1524-4733.2009.00554.x","title":"Health Technology Assessment in Canada: 20 Years Strong?","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Regional science; Political science; Geography","score_opus":0.30957318467275047,"score_gpt":0.4359357859488792,"score_spread":0.12636260127612875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031786236","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4065164,0.0073229526,0.0006315624,0.58166623,0.0007702443,0.0013915248,0.0002229083,0.00005835325,0.0014198057],"genre_scores_gemma":[0.9659281,0.00052684126,0.0042916182,0.028957594,0.000107124186,0.000051827355,0.000027171161,0.000022412265,0.000087339344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99289644,0.0005309977,0.0048795687,0.0006156633,0.0001299964,0.0009473635],"domain_scores_gemma":[0.99715847,0.00031157196,0.001709886,0.00052668253,0.000018659262,0.00027473472],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.014185833,0.00017971592,0.0012708621,0.0008849354,0.00009342141,0.000021835203,0.00032060067,0.00011931667,0.000083551466],"category_scores_gemma":[0.00053050445,0.00026305224,0.000041806812,0.0006622278,0.000027547807,0.00017334193,0.00003169223,0.000535815,0.00012594067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000086316,0.00021960174,0.5015011,0.00033986932,0.000014292677,0.000010551221,0.001078336,0.016848262,2.4121252e-7,0.44878644,0.024686998,0.006505694],"study_design_scores_gemma":[0.0014437477,0.00034718408,0.89225936,0.00031137897,5.361293e-7,0.000008590602,0.0024734037,0.02727931,3.643357e-7,0.027469857,0.048017453,0.0003888393],"about_ca_topic_score_codex":0.9467731,"about_ca_topic_score_gemma":0.84444195,"teacher_disagreement_score":0.55941164,"about_ca_system_score_codex":0.013133497,"about_ca_system_score_gemma":0.009507362,"threshold_uncertainty_score":0.9999822},"labels":[],"label_agreement":null},{"id":"W2031866730","doi":"10.1016/s1098-3015(10)62952-x","title":"PDB19 COLLECTION OF COST DATA FOR DIABETES COMPLICATIONS IN CANADA AND AUSTRALIA","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Data collection; Medicine; Diabetes mellitus; Optometry; Statistics; Mathematics; Endocrinology","score_opus":0.14772263675935948,"score_gpt":0.3702852720350237,"score_spread":0.22256263527566422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031866730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98839784,0.00012411956,0.000019961019,0.010410824,0.00008779918,0.0008096667,0.000043887256,0.000003649169,0.000102259306],"genre_scores_gemma":[0.9974793,0.000053046148,0.001477646,0.00046973457,0.000036487774,0.000045687826,0.00023594355,0.0000041954777,0.00019791372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99943656,0.000021574262,0.00022195827,0.00011968521,0.000060815375,0.00013938657],"domain_scores_gemma":[0.999592,0.00008326181,0.00006374366,0.00019357711,0.00001936169,0.000048040474],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031490382,0.000037353424,0.00012075819,0.00009514197,0.000021384889,0.000002983485,0.000048705213,0.0000125327,0.00000856018],"category_scores_gemma":[0.00007004975,0.000039561928,0.0000044279413,0.00019337887,0.000010738605,0.000052588286,0.000015112561,0.000040937455,6.6787265e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009129969,0.00008946612,0.9657121,0.00044632994,0.0000055872993,3.8366743e-8,0.000112114794,0.00042022322,0.000025525072,0.00026934507,0.02597154,0.006938609],"study_design_scores_gemma":[0.0005884204,0.000054925207,0.9502427,0.00014288438,0.000006941128,1.4980611e-7,0.000102042766,0.03097528,0.000038371123,0.00007394945,0.017739648,0.00003468515],"about_ca_topic_score_codex":0.78743905,"about_ca_topic_score_gemma":0.8101601,"teacher_disagreement_score":0.030555056,"about_ca_system_score_codex":0.0003928221,"about_ca_system_score_gemma":0.0005449375,"threshold_uncertainty_score":0.21397641},"labels":[],"label_agreement":null},{"id":"W2031928304","doi":"10.1016/j.jval.2011.02.368","title":"PSY35 VALIDATION OF THE LUPUS IMPACT TRACKER","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Construct validity; Cronbach's alpha; Convergent validity; Psychology; Scale (ratio); Quality of life (healthcare); Reliability (semiconductor); Anxiety; Physical therapy; SF-36; Criterion validity; Rating scale; Clinical psychology; Medicine; Internal medicine; Psychometrics; Disease; Internal consistency; Psychiatry; Developmental psychology; Health related quality of life; Cartography","score_opus":0.11830893730476091,"score_gpt":0.37147213210857666,"score_spread":0.25316319480381577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031928304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951464,0.0005041195,0.000021541528,0.00064197247,0.0003352789,0.0008130619,0.0000052778805,0.000016519838,0.0025158105],"genre_scores_gemma":[0.99898106,0.000084809086,0.0002893103,0.00008138484,0.00005283156,0.000014284237,0.0000024189328,0.000017274802,0.000476623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983692,0.00032994908,0.00046021445,0.00015042475,0.00040368576,0.00028648338],"domain_scores_gemma":[0.99908674,0.00009886937,0.00015709702,0.00046919283,0.000073170384,0.00011493508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013563719,0.000082787985,0.000273106,0.00013693002,0.000031320895,0.000002905875,0.00013268586,0.00006365394,0.00017073427],"category_scores_gemma":[0.0002530517,0.000048698046,0.00008626854,0.00039661757,0.000054450258,0.000042195385,0.000029764633,0.0001964455,0.000034182598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010993736,0.000154298,0.9887932,0.00089764904,0.00001714677,0.000004178357,0.0074549983,0.000042397176,0.00046761727,0.00035013928,0.00112368,0.0005847497],"study_design_scores_gemma":[0.007926864,0.0020723133,0.9282745,0.0072079487,0.000046715133,0.009981306,0.0036300034,0.004290339,0.03096667,0.0043365345,0.0009104896,0.00035631706],"about_ca_topic_score_codex":0.006306468,"about_ca_topic_score_gemma":0.000018405715,"teacher_disagreement_score":0.060518708,"about_ca_system_score_codex":0.00030904898,"about_ca_system_score_gemma":0.000633331,"threshold_uncertainty_score":0.95335346},"labels":[],"label_agreement":null},{"id":"W2031933270","doi":"10.1016/j.jval.2012.03.1054","title":"PIH22 Quality of Pediatric Cost-Utility Analyses 1997-2009","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Dalhousie University; Hospital for Sick Children","funders":"","keywords":"Medicine; Quality (philosophy); Prospective cohort study; MEDLINE; Health care; Population; Economic evaluation; Regression analysis; Cost–utility analysis; Confidence interval; Sample size determination; Family medicine; Pediatrics; Demography; Environmental health; Statistics; Cost effectiveness; Surgery; Pathology; Internal medicine","score_opus":0.44011271817740993,"score_gpt":0.4370819508789966,"score_spread":0.0030307672984133394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2031933270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94246316,0.027351832,0.0028830182,0.011258214,0.0012224757,0.0012726163,0.00096556987,0.00006789908,0.01251523],"genre_scores_gemma":[0.9958038,0.001894409,0.00058370206,0.0013221805,0.00027048512,0.000024324558,0.000015318688,0.000011177327,0.00007465347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973284,0.00023643603,0.0014975907,0.00026464195,0.000064909465,0.00060800806],"domain_scores_gemma":[0.99847126,0.00018914588,0.0006634852,0.0004212789,0.000016949843,0.00023787079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055176504,0.000119002994,0.0005626651,0.00038848643,0.00006278691,0.000008336495,0.00016834069,0.00007877975,0.0001315407],"category_scores_gemma":[0.0004047891,0.00013776156,0.00009820485,0.0006145877,0.000029343159,0.00016126217,0.000059519236,0.00017626269,0.00015268623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016755337,0.00036670757,0.69424385,0.00091459136,0.000015262,2.605961e-7,0.0010506661,0.0002861972,3.2212117e-7,0.29848427,0.002104022,0.0025171216],"study_design_scores_gemma":[0.0004401272,0.00007337249,0.9024534,0.000014534707,0.000003343212,3.3552442e-7,0.000115737515,0.0011506049,0.000008097525,0.0125361765,0.08301415,0.00019010263],"about_ca_topic_score_codex":0.11285092,"about_ca_topic_score_gemma":0.00032435986,"teacher_disagreement_score":0.2859481,"about_ca_system_score_codex":0.00022996034,"about_ca_system_score_gemma":0.00009678147,"threshold_uncertainty_score":0.8930567},"labels":[],"label_agreement":null},{"id":"W2032037488","doi":"10.1016/j.jval.2014.03.1145","title":"How well do generic promis fatigue measures perform in rheumatoid arthritis?","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Patient-Reported Outcomes Measurement Information System; Medicine; Computerized adaptive testing; Rheumatoid arthritis; Physical therapy; Item response theory; Convergent validity; Item bank; Quality of life (healthcare); Concurrent validity; Psychometrics; Clinical psychology; Internal medicine; Nursing","score_opus":0.04755227641084049,"score_gpt":0.28930159731955235,"score_spread":0.24174932090871187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032037488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9479797,0.04114493,0.00016865223,0.008154299,0.00015897318,0.0009683874,0.000004592059,0.00006842884,0.0013520666],"genre_scores_gemma":[0.86587155,0.13270694,0.00081800326,0.00027829295,0.00007793974,0.000099488,0.000012531194,0.0000361623,0.00009912185],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971931,0.0004375861,0.00054239365,0.00040387738,0.0006054771,0.00081754994],"domain_scores_gemma":[0.9988811,0.00013496813,0.000111946705,0.00041202942,0.000073094205,0.00038685845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018979427,0.00021094459,0.000606604,0.00041705166,0.000116105395,0.00009012175,0.00015222753,0.00010335401,0.0001023842],"category_scores_gemma":[0.00048726946,0.00018883217,0.0000760872,0.00042916567,0.000113009766,0.00017468292,0.00003932268,0.000494382,0.000053199812],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038279113,0.00050115155,0.25441843,0.00072772615,0.00003745667,0.00007770929,0.004041563,0.00047009747,0.0006817479,0.00571655,0.0021544327,0.7307904],"study_design_scores_gemma":[0.04195752,0.007618426,0.24356952,0.021675961,0.0000022595596,0.0010722876,0.0047065625,0.073210925,0.0046076756,0.012458908,0.5872565,0.0018634732],"about_ca_topic_score_codex":0.0033468339,"about_ca_topic_score_gemma":0.000859499,"teacher_disagreement_score":0.7289269,"about_ca_system_score_codex":0.00022339921,"about_ca_system_score_gemma":0.0004666336,"threshold_uncertainty_score":0.77003527},"labels":[],"label_agreement":null},{"id":"W2032492472","doi":"10.1016/s1098-3015(10)74430-2","title":"PIH9 PREVALENCE AND BURDEN OF ILLNESS OF MENOPAUSE: A CANADIAN OBSERVATIONAL STUDY","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Evolutionary Psychology and Human Behavior","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Observational study; Menopause; Medicine; Environmental health; Gerontology; Internal medicine","score_opus":0.125764171995935,"score_gpt":0.39647342798392626,"score_spread":0.2707092559879912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032492472","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955038,0.0013401306,0.0000026616324,0.0014653539,0.00019778684,0.0005069308,0.000042765216,0.000007675377,0.0009329393],"genre_scores_gemma":[0.9991148,0.000034201697,0.000118623015,0.0002138471,0.000035322133,0.000018610941,0.000005378692,0.0000050118656,0.00045418725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871683,0.0002910421,0.00042998698,0.00022276497,0.000116369054,0.00022303392],"domain_scores_gemma":[0.99939066,0.00007947448,0.00014252383,0.00023618514,0.00004742335,0.00010375716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069002964,0.00007704481,0.00020520296,0.0002042219,0.00006861528,0.0000016501352,0.00013345992,0.00006986553,0.00034405847],"category_scores_gemma":[0.000020669731,0.00008223094,0.000012404015,0.00017309925,0.000083238316,0.000044526365,0.000007888504,0.00013093089,0.0000059336157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008906933,0.0007330191,0.9283302,0.00009050445,0.00001510236,0.000015762074,0.029887952,0.00017582574,0.000047692298,0.03788719,0.0007350721,0.0019926385],"study_design_scores_gemma":[0.000664682,0.0009649558,0.9953954,0.00005846473,0.0000074832546,0.000010002121,0.0010006125,0.000020112268,9.543296e-7,0.0015964095,0.00021552111,0.00006540041],"about_ca_topic_score_codex":0.15238424,"about_ca_topic_score_gemma":0.010276132,"teacher_disagreement_score":0.1421081,"about_ca_system_score_codex":0.0000696775,"about_ca_system_score_gemma":0.00023653556,"threshold_uncertainty_score":0.8532601},"labels":[],"label_agreement":null},{"id":"W2032565720","doi":"10.1016/j.jval.2014.08.2365","title":"Skeletal-Related Events (SRES) Impact Significantly the Health-Related Quality of Life (HRQOL) of Chemo-Naive Men With Metastatic Castration Resistant Prostate Cancer (MCRPC)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Prostate cancer; Radiation therapy; Asymptomatic; Quality of life (healthcare); Internal medicine; Placebo; Spinal cord compression; Oncology; Surgery; Cancer; Pathology; Spinal cord","score_opus":0.06869137059026577,"score_gpt":0.386963759052084,"score_spread":0.31827238846181827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032565720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98321885,0.0049234773,0.00001703264,0.008359893,0.000053533604,0.00294702,0.00017740001,0.00002673574,0.00027605955],"genre_scores_gemma":[0.99755985,0.0014824508,0.00017217937,0.00012411384,0.00001932053,0.00010775223,0.0001173242,0.000038085494,0.0003789094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99494714,0.0015344805,0.0016342347,0.00039688495,0.00084748474,0.00063979044],"domain_scores_gemma":[0.997264,0.00041547418,0.0011912549,0.0004855738,0.0002706087,0.0003730835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004130503,0.00026091776,0.001050348,0.00021478743,0.00013206663,0.000008657635,0.0001458824,0.00007532648,0.000066099106],"category_scores_gemma":[0.00028157953,0.00014901736,0.00012772005,0.00088816375,0.0002418579,0.00008939863,0.000028594512,0.0004387144,0.000003637857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.070341356,0.0067628473,0.66357017,0.034678277,0.0066282917,0.00008919996,0.09209396,0.045558672,0.03213538,0.0048434306,0.0035955438,0.039702892],"study_design_scores_gemma":[0.022459587,0.011764333,0.94129175,0.0037344794,0.00017115408,0.000019708661,0.0033447866,0.011675039,0.0033124574,0.0017025642,0.00010549395,0.00041865345],"about_ca_topic_score_codex":0.09506013,"about_ca_topic_score_gemma":0.0008305608,"teacher_disagreement_score":0.27772158,"about_ca_system_score_codex":0.00086252793,"about_ca_system_score_gemma":0.0040275874,"threshold_uncertainty_score":0.9109659},"labels":[],"label_agreement":null},{"id":"W2032796993","doi":"10.1016/j.jval.2014.03.734","title":"Screening For Type 2 Diabetes: A Methodological Review And Cost Analysis","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Observational study; CINAHL; Randomized controlled trial; MEDLINE; Type 2 diabetes; Systematic review; Meta-analysis; Family medicine; Pediatrics; Intensive care medicine; Diabetes mellitus; Internal medicine; Psychological intervention; Psychiatry","score_opus":0.4163917733336442,"score_gpt":0.48618512545398085,"score_spread":0.06979335212033666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2032796993","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000034824313,0.989912,0.0036271792,0.00033186958,0.00011571195,0.005832466,0.000053905598,0.000049532682,0.000073887575],"genre_scores_gemma":[0.0000016466868,0.9732253,0.02346271,0.0018032247,0.00031559984,0.00063899404,0.00039462393,0.0000617273,0.00009619432],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9945963,0.0024593929,0.0012703661,0.00075384014,0.00029965412,0.00062042655],"domain_scores_gemma":[0.99662066,0.0016228027,0.0005271006,0.0007729122,0.000095849064,0.00036070944],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0115622785,0.00042921572,0.008522951,0.0005298111,0.00007744561,0.000021095573,0.00016110786,0.00034188997,0.000036949437],"category_scores_gemma":[0.0031851071,0.0003114758,0.0017155398,0.0015051734,0.00006993443,0.000027399765,0.00006901711,0.0005713955,0.000010694852],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000039723773,0.000021466343,0.000033146276,0.20341253,0.0013457327,0.0000022191925,0.00000728291,0.0000073646634,1.5439368e-9,0.000022529133,0.00046259788,0.79468113],"study_design_scores_gemma":[0.00036594362,0.00033993035,0.00012460291,0.0690908,0.015677061,0.0000106683465,0.0000026534824,0.00021323626,3.3072695e-8,0.000026720241,0.91390544,0.00024289198],"about_ca_topic_score_codex":0.0018550564,"about_ca_topic_score_gemma":0.000048122103,"teacher_disagreement_score":0.91344285,"about_ca_system_score_codex":0.00015780912,"about_ca_system_score_gemma":0.00038898233,"threshold_uncertainty_score":0.9999337},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2033131912","doi":"10.1016/j.jval.2011.02.831","title":"PRM23 MEASURING THE IMPACT OF PREVIOUS TREATMENT CYCLES ON HEALTH UTILITY IN PATIENTS RECEIVING BOTULINUM TOXIN TYPE A (BONTA) IN A PROSPECTIVE OBSERVATIONAL COHORT STUDY: MOBILITY STUDY","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; West Park Healthcare Centre; Children's & Women's Health Centre of British Columbia; London Health Sciences Centre; McGill University; Allergan (Canada)","funders":"","keywords":"Medicine; Internal medicine; Observational study","score_opus":0.15797226487274912,"score_gpt":0.3619040065768854,"score_spread":0.20393174170413625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033131912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882475,0.00023881158,5.689651e-7,0.00032227545,0.00007881007,0.010872267,0.000008137117,0.000029253055,0.00020236682],"genre_scores_gemma":[0.9993294,0.00022765709,0.00003407022,0.00013747235,0.000009750432,0.00023028387,0.0000064142987,0.00001791483,0.0000070190463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958417,0.0016107529,0.0010716685,0.0005890605,0.00043559266,0.00045123405],"domain_scores_gemma":[0.998731,0.00027240822,0.0003076492,0.0004680204,0.000083195795,0.00013769514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026074378,0.0002460216,0.00079224084,0.00016819246,0.00007604113,0.000004884246,0.00012763601,0.00009602615,0.000020045312],"category_scores_gemma":[0.00045681023,0.00014946084,0.00009526241,0.0007566789,0.00006473221,0.00005199263,0.000045967245,0.0005717275,0.000002384289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002396045,0.027719032,0.9498794,0.000067109475,0.00007479389,0.000009814123,0.016241126,0.0011172852,9.89129e-7,0.0000063604107,0.000004776969,0.0024832697],"study_design_scores_gemma":[0.005157947,0.023381006,0.9686458,0.00021895817,0.000012122132,9.034447e-7,0.0011541639,0.0010391809,0.0000031953148,0.0002966744,5.034187e-7,0.00008951906],"about_ca_topic_score_codex":0.065168716,"about_ca_topic_score_gemma":0.006800015,"teacher_disagreement_score":0.058368698,"about_ca_system_score_codex":0.0015061258,"about_ca_system_score_gemma":0.0007107095,"threshold_uncertainty_score":0.94105643},"labels":[],"label_agreement":null},{"id":"W2033160068","doi":"10.1111/j.1524-4733.2004.71249.x","title":"Modeling the Efficiency of Reaching a Target Intermediate End Point: A Case Study in Type 2 Diabetes in the United States","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Radiation Oncology; McGill University","funders":"","keywords":"Glycemic; Nateglinide; Medicine; Metformin; Postprandial; Type 2 diabetes; Diabetes mellitus; Endocrinology","score_opus":0.04393572366586446,"score_gpt":0.31595252541208896,"score_spread":0.2720168017462245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033160068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99574625,0.00072965975,0.000029441315,0.0018907688,0.00006935591,0.0014648143,0.0000025560391,0.00001406431,0.00005308523],"genre_scores_gemma":[0.99886566,0.0001761459,0.00015358195,0.0007040665,0.000015971642,0.000048184404,0.000020789847,0.000012055053,0.0000035185315],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984229,0.00036007556,0.00048456885,0.00018536442,0.00021140168,0.00033564057],"domain_scores_gemma":[0.99935675,0.00022592256,0.00007994556,0.00027440843,0.000022730545,0.000040240455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024188051,0.00012021538,0.00027408169,0.00041953244,0.000046508285,0.000011927909,0.00012219088,0.000022347716,0.0000035813423],"category_scores_gemma":[0.00014333815,0.000068908004,0.000027441069,0.0008667923,0.00003431541,0.000045820736,0.000051573494,0.00025452027,0.000001752031],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010382913,0.003660854,0.21160936,0.00050218246,0.00005475528,0.0011118368,0.1462132,0.63352126,0.0000106287225,0.00043036346,0.000012253817,0.002769497],"study_design_scores_gemma":[0.008003802,0.004026077,0.016888715,0.0014652344,0.00007509943,0.00002815256,0.10487605,0.8612848,0.000036783335,0.003077835,0.000042324802,0.00019511656],"about_ca_topic_score_codex":0.04945579,"about_ca_topic_score_gemma":0.0022877313,"teacher_disagreement_score":0.22776358,"about_ca_system_score_codex":0.00023987562,"about_ca_system_score_gemma":0.00011114513,"threshold_uncertainty_score":0.95687395},"labels":[],"label_agreement":null},{"id":"W2033202473","doi":"10.1016/j.jval.2011.05.003","title":"Patient Preference for Latent Tuberculosis Infection Preventive Treatment: A Discrete Choice Experiment","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; Providence Health Care Research Institute; Centre for Advancing Health Outcomes; University of British Columbia","funders":"British Columbia Centre for Disease Control","keywords":"Medicine; Latent class model; Preference; Latent tuberculosis; Tuberculosis; Covariate; Active tuberculosis; Demography; Statistics; Mycobacterium tuberculosis","score_opus":0.16554978235422713,"score_gpt":0.38474586200098937,"score_spread":0.21919607964676224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033202473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930822,0.0011827283,0.000267923,0.0018197234,0.00016185004,0.0027497765,0.00002684637,0.00004668384,0.00066221674],"genre_scores_gemma":[0.99410176,0.0020657375,0.0018722136,0.00043181353,0.00007504039,0.0012508298,0.00004766991,0.000020172922,0.0001347384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980132,0.00038623088,0.0004959155,0.0003868263,0.00014850701,0.00056934473],"domain_scores_gemma":[0.99902683,0.00022159939,0.00011989368,0.00026730195,0.00005826595,0.00030613155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004220595,0.00016819246,0.0004197224,0.00016477912,0.00008295393,0.000004756611,0.000039714512,0.000088684625,0.000070564034],"category_scores_gemma":[0.00030537436,0.00012557895,0.00013484669,0.00015593515,0.000041204825,0.00007085664,0.00003078851,0.00013476831,0.000020908135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001979902,0.003407562,0.9013333,0.001000933,0.000393419,0.000013896973,0.015267854,0.00039329063,0.00070695014,0.0017223832,0.001334912,0.072445616],"study_design_scores_gemma":[0.004611345,0.021535704,0.9416288,0.0007938409,0.000063634856,0.000027753505,0.00021382957,0.009391373,0.00824949,0.0011678413,0.012017059,0.00029931284],"about_ca_topic_score_codex":0.052037105,"about_ca_topic_score_gemma":0.0004657939,"teacher_disagreement_score":0.072146304,"about_ca_system_score_codex":0.000803808,"about_ca_system_score_gemma":0.00020849958,"threshold_uncertainty_score":0.9542755},"labels":[],"label_agreement":null},{"id":"W2033419530","doi":"10.1016/j.jval.2012.08.2093","title":"PGI10 Factors Associated With Treatment Adherence and Persistence in Canadian Patients With Ulcerative Colitis (Uc): Analysis of Prescription Claims From the Ramq Database","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Odds ratio; Medical prescription; Internal medicine; Confidence interval; Logistic regression; Persistence (discontinuity); Diabetes mellitus; Ulcerative colitis; Retrospective cohort study; Database; Pediatrics; Disease","score_opus":0.06828120501300997,"score_gpt":0.28442082283523773,"score_spread":0.21613961782222776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033419530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703383,0.0005023958,0.000004177119,0.0003271609,0.00003184996,0.0008893964,0.0011604063,0.0000071788745,0.00004357683],"genre_scores_gemma":[0.99871325,0.000088493325,0.0001051968,0.00018085189,0.00001295881,0.00003162218,0.0008376522,0.0000114764025,0.00001846954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984251,0.00035053396,0.00029461063,0.0002448619,0.00026982307,0.00041503782],"domain_scores_gemma":[0.9988051,0.0003096177,0.00018446683,0.00026840836,0.000083402076,0.00034898682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031892766,0.00015062506,0.00044297412,0.0002379078,0.00007780852,0.000009381559,0.000056320427,0.000057165,0.00003332807],"category_scores_gemma":[0.00013255153,0.00009295757,0.000027415124,0.000780546,0.00011806296,0.00014634061,0.0000106472535,0.0001454523,4.1492314e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013527571,0.00024353006,0.98758703,0.000018434905,0.00025106748,0.0000048388815,0.011247469,0.00009413912,0.0000026356959,0.00003391308,0.000009984287,0.0003716883],"study_design_scores_gemma":[0.0018315072,0.0010107455,0.99386567,0.00043021908,0.00027091027,4.656579e-7,0.0013750541,0.0010947844,0.000021898091,0.0000050639055,0.00001327309,0.00008041191],"about_ca_topic_score_codex":0.8845355,"about_ca_topic_score_gemma":0.8593867,"teacher_disagreement_score":0.025148781,"about_ca_system_score_codex":0.0014060035,"about_ca_system_score_gemma":0.00065511325,"threshold_uncertainty_score":0.37906995},"labels":[],"label_agreement":null},{"id":"W2033426385","doi":"10.1016/j.jval.2013.03.656","title":"The Direct Health Care Cost Of Prostate Cancer: Evidence From Us National Survey Data","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Medical Expenditure Panel Survey; Cancer; Health care; National Health Interview Survey; Demography; Indirect costs; Prostate; Population; Disease burden; Disease; Gerontology; Family medicine; Environmental health; Health insurance; Internal medicine","score_opus":0.6712998744756645,"score_gpt":0.49669409387577823,"score_spread":0.1746057805998863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033426385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50807154,0.23730496,0.00024910393,0.21684141,0.002624541,0.0071087535,0.026903355,0.00007562391,0.00082067796],"genre_scores_gemma":[0.9664116,0.01947825,0.0014555282,0.0109545635,0.00031223413,0.00045563348,0.0007358355,0.00004459235,0.00015175146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9911275,0.002266268,0.0049612424,0.00077036326,0.00025084414,0.0006237994],"domain_scores_gemma":[0.9881181,0.0069080717,0.0034162467,0.0010708204,0.00023845506,0.00024831353],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.038614713,0.00018015638,0.0009905683,0.00019268412,0.0003429922,0.00009449659,0.0008666723,0.00008115923,0.0001380934],"category_scores_gemma":[0.009368465,0.00018543142,0.00004694043,0.00037556377,0.00010361449,0.0006680725,0.00016455291,0.00024823094,0.00036028202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023710301,0.00005333778,0.91217464,0.0007117147,0.000037747075,1.1228729e-7,0.0061348234,0.0058133462,2.0164994e-7,0.0021197745,0.070436284,0.0024942982],"study_design_scores_gemma":[0.0005535789,0.00009901562,0.921728,0.00077364914,0.0000011170628,4.9012107e-7,0.0010825838,0.038894325,0.0000012820663,0.0024663762,0.03415757,0.0002420001],"about_ca_topic_score_codex":0.739244,"about_ca_topic_score_gemma":0.05838671,"teacher_disagreement_score":0.68085724,"about_ca_system_score_codex":0.0022414406,"about_ca_system_score_gemma":0.0032586067,"threshold_uncertainty_score":0.99897605},"labels":[],"label_agreement":null},{"id":"W2033722427","doi":"10.1016/j.jval.2012.08.304","title":"PCN6 Lenalidomide Versus Bortezomib for Treatment of Relapsed/Refractory Multiple Myeloma (MM): A Number Needed to Treat (NNT) Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Number needed to treat; Lenalidomide; Bortezomib; Multiple myeloma; Thalidomide; Refractory (planetary science); Clinical trial; Internal medicine; Oncology; Confidence interval; Relative risk","score_opus":0.10816854373297373,"score_gpt":0.39398734399835283,"score_spread":0.2858188002653791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033722427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99361664,0.0011383083,0.00022006642,0.0013209694,0.00021685242,0.0026396664,0.00021130824,0.000048555892,0.0005876312],"genre_scores_gemma":[0.99093777,0.0004418411,0.0065081315,0.00017484627,0.00023532289,0.0005115953,0.00026348908,0.000051297156,0.00087571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969322,0.0002634177,0.0007938714,0.00044996943,0.00047141628,0.0010891183],"domain_scores_gemma":[0.996758,0.0011767229,0.0002169256,0.00066271384,0.00012668659,0.0010589779],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056978536,0.00032992693,0.0011582869,0.00064241874,0.00011133397,0.000011775644,0.00010334317,0.00013773696,0.00015203384],"category_scores_gemma":[0.00054746674,0.0002609129,0.0004588652,0.0010076487,0.000052310108,0.0001268567,0.00003088003,0.00009592014,0.0000890577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030045558,0.0068549216,0.9030348,0.0006857492,0.0025286868,0.00006005922,0.0054964777,0.00079399906,0.0013195227,0.00017846734,0.001672987,0.047328744],"study_design_scores_gemma":[0.14583741,0.019321382,0.7589076,0.0005268551,0.0026598503,0.000043953423,0.003381565,0.013303105,0.020511873,0.000054556633,0.03450805,0.00094377145],"about_ca_topic_score_codex":0.03323161,"about_ca_topic_score_gemma":0.0008256662,"teacher_disagreement_score":0.14412719,"about_ca_system_score_codex":0.0017448331,"about_ca_system_score_gemma":0.0004659078,"threshold_uncertainty_score":0.9999843},"labels":[],"label_agreement":null},{"id":"W2033845558","doi":"10.1016/s1098-3015(10)63441-9","title":"PCN11 PHARMACOECONOMIC ANALYSES OF ERLOTINIB COMPARED WITH BEST SUPPORTIVE CARE (BSC) FOR THE TREATMENT OF RELAPSED NON-SMALL CELL LUNG CANCER (NSCLC) FROM THE CANADIAN PUBLIC HEALTH CARE PERSPECTIVE","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Erlotinib; Medicine; Lung cancer; Perspective (graphical); Health care; Public health; Public health care; Intensive care medicine; Oncology; Internal medicine; Cancer; Nursing; Health policy; Political science; Computer science","score_opus":0.09596028306643296,"score_gpt":0.3300170494965055,"score_spread":0.23405676643007256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2033845558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85530716,0.12113711,0.00028985325,0.0077570584,0.0004826751,0.00303902,0.009253654,0.00001142492,0.002722022],"genre_scores_gemma":[0.99466866,0.0036580106,0.00036781715,0.00052860135,0.0002452787,0.0002663247,0.00013981182,0.00004558386,0.00007992061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749345,0.0000637369,0.0011871457,0.0005160213,0.00004383576,0.0006958],"domain_scores_gemma":[0.9973837,0.00033231717,0.0014245673,0.0004442707,0.00019532055,0.00021983586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003917812,0.00028265486,0.0009894085,0.00026182606,0.00036549798,0.000050635204,0.00035286453,0.00008897426,0.000072478644],"category_scores_gemma":[0.000019298559,0.00021850946,0.00020960078,0.00026715902,0.00016675863,0.00013376612,0.000015131674,0.00015802577,0.0000051087236],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044405914,0.00057534606,0.79570276,0.0006028342,0.0006096748,0.0000027786396,0.119612746,0.059580863,0.0000062149707,0.016042972,0.0030760127,0.0037437659],"study_design_scores_gemma":[0.022416074,0.0053536147,0.73573387,0.0006655865,0.0003153779,0.0000025679321,0.1209413,0.029364562,0.0011357274,0.0019888254,0.08036806,0.0017144656],"about_ca_topic_score_codex":0.9743268,"about_ca_topic_score_gemma":0.85561544,"teacher_disagreement_score":0.13936147,"about_ca_system_score_codex":0.005626516,"about_ca_system_score_gemma":0.0044561,"threshold_uncertainty_score":0.9981907},"labels":[],"label_agreement":null},{"id":"W2034329485","doi":"10.1016/j.jval.2012.08.2066","title":"PSS19 Economic Evaluation of Ranibizumab for the Treatment of Macular Edema Secondary to Branch and Central Retinal Vein Occlusion in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Ranibizumab; Medicine; Quality-adjusted life year; Branch retinal vein occlusion; Central retinal vein occlusion; Macular edema; Cost effectiveness; Visual acuity; Optometry; Emergency medicine; Ophthalmology; Surgery; Bevacizumab","score_opus":0.26521633392205735,"score_gpt":0.4028775755391202,"score_spread":0.13766124161706284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034329485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9682689,0.012210537,0.00029491773,0.015653206,0.0005889864,0.0024348919,0.00043493658,0.000003096637,0.00011055607],"genre_scores_gemma":[0.9974863,0.00055900216,0.00058457436,0.0010423141,0.00015136591,0.00011926037,0.000023465538,0.000017856712,0.000015840495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99565846,0.0005702699,0.0028336565,0.00031491093,0.00011459557,0.00050812564],"domain_scores_gemma":[0.9971288,0.0011263114,0.0012150604,0.0003131196,0.000037074617,0.00017967308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014742144,0.00014314709,0.0008196959,0.00023418847,0.00008149355,0.000008251961,0.0001244495,0.00006353905,0.00011382339],"category_scores_gemma":[0.00044152248,0.00015050164,0.000060879538,0.00011559015,0.000026715172,0.00015112193,0.000019973733,0.00006871165,0.000009520202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035788456,0.0005085104,0.8189874,0.0022863315,0.0001138533,4.0074056e-7,0.036632862,0.09535247,0.000016685224,0.02428831,0.0056844596,0.015770828],"study_design_scores_gemma":[0.00460506,0.00047759668,0.855631,0.00019705616,0.000014437218,0.000004737108,0.0027575453,0.11784836,0.000053917567,0.001977808,0.01617672,0.00025576333],"about_ca_topic_score_codex":0.81366414,"about_ca_topic_score_gemma":0.49043286,"teacher_disagreement_score":0.32323128,"about_ca_system_score_codex":0.005978474,"about_ca_system_score_gemma":0.0025949278,"threshold_uncertainty_score":0.9978374},"labels":[],"label_agreement":null},{"id":"W2034399548","doi":"10.1016/j.jval.2014.03.1251","title":"Cost-effectiveness of guanfacine extended-release as an adjunctive therapy to a long-acting stimulant versus long-acting stimulant monotherapy for the treatment of attention-deficit/hyperactivity disorder in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Stimulant; Guanfacine; Methylphenidate; Attention deficit hyperactivity disorder; Medicine; Psychiatry; Amphetamine; Internal medicine; Dopamine","score_opus":0.10477924058421971,"score_gpt":0.3917650936636607,"score_spread":0.28698585307944097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034399548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97842115,0.0008297264,0.0137824705,0.0005821616,0.00038527214,0.0058761444,0.00008357085,0.000024977213,0.000014531026],"genre_scores_gemma":[0.9982308,0.00055170467,0.000331927,0.00011287813,0.00006286562,0.00055083743,0.000070958646,0.00007592292,0.000012086305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99631697,0.0010197246,0.0008565072,0.00065506715,0.0005303271,0.0006213858],"domain_scores_gemma":[0.9935705,0.0047395313,0.0005418245,0.00065964827,0.00025927342,0.00022923676],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013546513,0.0004083274,0.0011462327,0.00028774005,0.00017132718,0.000014276458,0.00015137922,0.00009674983,0.000037821406],"category_scores_gemma":[0.00063371484,0.0003136712,0.00018228289,0.0005699907,0.000056891484,0.00018301817,0.000021463915,0.00027205923,0.0000019034037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018030293,0.0036275603,0.62824345,0.000470804,0.0002550584,0.000017329434,0.00093321694,0.15317103,0.0013265332,0.00010397371,8.219921e-7,0.19381994],"study_design_scores_gemma":[0.023829682,0.009776672,0.8794663,0.0006586943,0.000068684225,0.000012727062,0.00418891,0.08121755,0.00031120866,0.000036106343,0.00010926341,0.00032417686],"about_ca_topic_score_codex":0.8356822,"about_ca_topic_score_gemma":0.42037252,"teacher_disagreement_score":0.4153097,"about_ca_system_score_codex":0.001826838,"about_ca_system_score_gemma":0.0016030624,"threshold_uncertainty_score":0.9999315},"labels":[],"label_agreement":null},{"id":"W2034399712","doi":"10.1016/s1098-3015(10)73802-x","title":"PCV40 COST-EFFECTIVENESS ANALYSIS OF THE INSERTABLE CARDIAC MONITOR FOR DETECTING RECURRENT ATRIAL FIBRILLATION (AF) FOLLOWING RADIOFREQUENCY CATHETER ABLATION (RCA): A CANADIAN PERSPECTIVE","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Atrial fibrillation; Cardiology; Medicine; Internal medicine; Radiofrequency catheter ablation; Catheter ablation; Perspective (graphical); Catheter; Ablation; Radiofrequency ablation; Surgery; Computer science; Artificial intelligence","score_opus":0.03712866215844075,"score_gpt":0.34552907054276283,"score_spread":0.3084004083843221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034399712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890281,0.005425023,0.00051028037,0.0010486832,0.0012226104,0.0024964528,0.000086516884,0.000023717519,0.00015864221],"genre_scores_gemma":[0.99895436,0.00008659705,0.00040909622,0.00007359074,0.00039495208,0.000024902653,0.0000358711,0.000015338705,0.0000052888736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983142,0.00038587503,0.0004058334,0.00028734517,0.00024167684,0.00036506174],"domain_scores_gemma":[0.9983839,0.00078184385,0.00018842904,0.00028782856,0.00019425208,0.00016374017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013417896,0.00014030281,0.0005924177,0.000519735,0.00019032003,0.000019194835,0.000052133997,0.00008284855,0.0000012117804],"category_scores_gemma":[0.0019448744,0.00012207477,0.0007422991,0.0012023628,0.000018496323,0.00007699,0.000006921557,0.00016798567,5.179151e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030495375,0.000046488134,0.8113943,0.00016535308,0.0007496197,0.0000033758267,0.0063254023,0.14099437,0.0003535642,0.00040275263,0.00003371129,0.039226152],"study_design_scores_gemma":[0.002071542,0.0005753867,0.9440762,0.00071911217,0.0014580558,0.000003569449,0.0008557225,0.04820599,0.00079394225,0.0005900482,0.00043528827,0.00021516986],"about_ca_topic_score_codex":0.3516314,"about_ca_topic_score_gemma":0.004905665,"teacher_disagreement_score":0.34672573,"about_ca_system_score_codex":0.0023812603,"about_ca_system_score_gemma":0.00100128,"threshold_uncertainty_score":0.6526861},"labels":[],"label_agreement":null},{"id":"W2034571284","doi":"10.1016/j.jval.2011.02.948","title":"PCN93 ATTACHMENT STYLE AND HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH PROSTATE CANCER","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Metropolitan University","funders":"","keywords":"Attachment theory; Psychosocial; Affect (linguistics); Sexual orientation; Quality of life (healthcare); Social support; Prostate cancer; Psychology; Clinical psychology; Mental health; Sexual function; Medicine; Developmental psychology; Cancer; Psychiatry; Social psychology; Psychotherapist; Internal medicine","score_opus":0.08976130765903019,"score_gpt":0.34704290429588636,"score_spread":0.2572815966368562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034571284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99348706,0.003558118,0.0000021030003,0.0016454449,0.00013434867,0.0009626506,0.00003918885,0.000014931335,0.0001561424],"genre_scores_gemma":[0.99827737,0.0005272273,0.000091323054,0.0009718689,0.000010653594,0.000044807814,0.000017126793,0.000014794571,0.000044853132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982529,0.00022853752,0.00072519726,0.00023669221,0.0002611051,0.0002955312],"domain_scores_gemma":[0.9991904,0.000027178834,0.0002978123,0.00019287386,0.0000614218,0.00023031872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009833226,0.00010813388,0.00050105987,0.0001182367,0.000024585184,0.0000021117942,0.000036771344,0.000047147365,0.000042760355],"category_scores_gemma":[0.000021912916,0.000087865395,0.000019241847,0.00028876436,0.000048747363,0.000041395226,0.000020845411,0.000192307,9.2056666e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011386913,0.00028378968,0.97581524,0.0012451102,0.00001357624,0.0000011371184,0.017292505,0.000028412764,4.6781287e-7,0.00010807747,0.000052172818,0.004020817],"study_design_scores_gemma":[0.003847326,0.0010291481,0.9934111,0.00078105205,0.0000031333668,2.9653094e-7,0.0006646272,0.00004516324,0.0000068133554,0.000042738808,0.00009147111,0.00007707678],"about_ca_topic_score_codex":0.4626086,"about_ca_topic_score_gemma":0.030738663,"teacher_disagreement_score":0.43186995,"about_ca_system_score_codex":0.00035535544,"about_ca_system_score_gemma":0.0007864332,"threshold_uncertainty_score":0.98694783},"labels":[],"label_agreement":null},{"id":"W2034652315","doi":"10.1016/j.jval.2011.08.1103","title":"PCN2 A Retrospective Longitudinal Study of Treatment Patterns and Outcomes Among Patients with Unresectable Stage IIIc/IV Melanoma in Canada (Melody)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Bristol-Myers Squibb (Canada)","funders":"","keywords":"Medicine; Melanoma; Adverse effect; Randomized controlled trial; Stage (stratigraphy); Internal medicine; Clinical trial; Disease; Retrospective cohort study; Medical record; Surgery; Oncology","score_opus":0.036569155253819936,"score_gpt":0.2600523915613234,"score_spread":0.2234832363075035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2034652315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99766296,0.000023569677,0.0000070350357,0.000039929295,0.00009978074,0.0017639792,0.000024428895,0.000012499611,0.00036581283],"genre_scores_gemma":[0.99951077,0.000029265078,0.000051353003,0.00004633484,0.00000732399,0.000058598995,0.0000051191114,0.000017454602,0.0002737884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985323,0.000111951784,0.0004172427,0.00032813803,0.0003038399,0.00030652698],"domain_scores_gemma":[0.9993407,0.00003927616,0.000173477,0.00025845706,0.000042269545,0.00014582807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001739833,0.00017151136,0.00051520567,0.00023312228,0.000041431595,0.000005297193,0.00004993619,0.000025165558,0.00007782642],"category_scores_gemma":[0.000019738458,0.0001278991,0.000018601002,0.00022557793,0.00002082577,0.000042866017,0.000037601494,0.0001248552,4.644863e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039905793,0.0010728778,0.99431694,0.00012566906,0.00008562831,0.00021275003,0.0031626232,0.00007037668,2.1179443e-7,0.000021197895,0.0000063525645,0.00052633445],"study_design_scores_gemma":[0.005313008,0.0069992184,0.98339784,0.00012457168,0.000024048199,0.0000049642304,0.0037923,0.00021140394,0.000009497309,0.0000054149987,0.000018330858,0.00009940615],"about_ca_topic_score_codex":0.993326,"about_ca_topic_score_gemma":0.9890301,"teacher_disagreement_score":0.010919084,"about_ca_system_score_codex":0.0023611079,"about_ca_system_score_gemma":0.000479225,"threshold_uncertainty_score":0.6174215},"labels":[],"label_agreement":null},{"id":"W2035091359","doi":"10.1016/s1098-3015(10)61688-9","title":"PCV44 PHARMACOECONOMIC EVALUATION OF VASOTEC® IN HYPERTENSIVE PATIENTS WITH CONGESTIVE HEART FAILURE: AN UPDATE OF THE RETROSPECTIVE CANADIAN ANALYSIS BASED ON THE STUDIES OF LEFT VENTRICULAR DYSFUNCTION (SOLVD)","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Heart failure; Cardiology; Internal medicine","score_opus":0.04538850401264468,"score_gpt":0.3076127527828836,"score_spread":0.2622242487702389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035091359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969083,0.0004853567,0.000007566011,0.001472069,0.00009110223,0.0008629792,0.000041122817,0.0000030529125,0.00012843352],"genre_scores_gemma":[0.9995389,0.000030277211,0.0000466591,0.00034360026,0.000009586174,0.000011562222,0.000010778022,0.0000070940177,0.0000015216714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794996,0.00093508477,0.0003704383,0.00019915684,0.0003953933,0.00014997605],"domain_scores_gemma":[0.9982936,0.00031533762,0.00031486087,0.0002630926,0.00075999444,0.00005314641],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019719931,0.000104652136,0.0006238215,0.00039016985,0.00007782957,0.0000020360887,0.000018273315,0.0000328535,0.0000070474907],"category_scores_gemma":[0.0009123675,0.00006372392,0.000097511554,0.00082064397,0.00010812745,0.000033185574,0.0000059872154,0.00013068858,5.413341e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008703805,0.00004959492,0.85311663,0.000034865465,0.00028685055,2.4244682e-7,0.0007521795,0.14541687,0.000009379847,0.00008179988,0.00012767084,0.00003690569],"study_design_scores_gemma":[0.0017904777,0.00034651047,0.987865,0.00017501976,0.00045438143,0.0000016058964,0.0017021191,0.0069799195,0.0005162254,0.00005659034,0.000057607343,0.000054564414],"about_ca_topic_score_codex":0.022252435,"about_ca_topic_score_gemma":0.015044774,"teacher_disagreement_score":0.13843694,"about_ca_system_score_codex":0.0006945041,"about_ca_system_score_gemma":0.0006877625,"threshold_uncertainty_score":0.9842585},"labels":[],"label_agreement":null},{"id":"W2035535489","doi":"10.1016/j.jval.2014.03.430","title":"The Utilization of Video-Assisted Thoracic Surgery (VATS) Versus Open Thoracotomy for Stage 1 And Stage 2 Non-Small Cell Lung Cancer in Canadian Hospitals: A Budget Impact Analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Thoracotomy; Activity-based costing; Lung cancer; Cardiothoracic surgery; Surgery; General surgery; Emergency medicine; Internal medicine","score_opus":0.054754742431034835,"score_gpt":0.4035281241172074,"score_spread":0.34877338168617256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035535489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906464,0.0043277964,0.000085523345,0.0017761079,0.00015802187,0.0024465327,0.00035568973,0.000007517559,0.00019638926],"genre_scores_gemma":[0.9954969,0.0034137685,0.00018841664,0.00015490824,0.00003324472,0.00047069424,0.00008981509,0.000026227446,0.00012596873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809885,0.0002675995,0.0005738758,0.0003589201,0.00017009432,0.000530667],"domain_scores_gemma":[0.9977297,0.0011163616,0.00033055496,0.0003838017,0.00009966272,0.0003399127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022948924,0.00017915487,0.00068031996,0.00044581853,0.00012860904,0.000059520917,0.00012625605,0.00007971188,0.000032533473],"category_scores_gemma":[0.00018888034,0.0001281565,0.00012845465,0.0009386541,0.00003635154,0.00008877167,0.000035024794,0.00011116953,3.2802112e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050181523,0.00012233971,0.981861,0.0009587805,0.00025615128,0.0000061079054,0.0006235712,0.0033730683,0.0000047159256,0.00005081593,0.00036515942,0.011876481],"study_design_scores_gemma":[0.0019454664,0.0004041543,0.9393664,0.0005369033,0.0002898945,2.8501236e-7,0.00027961264,0.055280305,0.0002072041,0.0000099770195,0.0015442511,0.00013556023],"about_ca_topic_score_codex":0.8630374,"about_ca_topic_score_gemma":0.7512297,"teacher_disagreement_score":0.11180769,"about_ca_system_score_codex":0.0019151476,"about_ca_system_score_gemma":0.0026895006,"threshold_uncertainty_score":0.5226071},"labels":[],"label_agreement":null},{"id":"W2035548232","doi":"10.1016/s1098-3015(11)72692-4","title":"PHP27 COMPARISON OF THE USE OF PRESCRIBED MEDICATIONS BETWEEN QUEBEC RESIDENTS COVERED BY PUBLIC AND PRIVATE DRUG INSURANCE:THE REMED REGISTRY","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Private insurance; Drug; Public health insurance; Medicine; Business; Family medicine; Actuarial science; Health insurance; Pharmacology; Political science; Health care; Law","score_opus":0.24982172217399892,"score_gpt":0.4252768541333004,"score_spread":0.17545513195930149,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035548232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9594012,0.00051554636,0.000016448173,0.038960833,0.00019669907,0.0007647589,0.00008153511,0.000009485634,0.00005348636],"genre_scores_gemma":[0.99853736,0.00023646455,0.00022325024,0.0006978408,0.000037417823,0.000009782055,0.000024091216,0.000009141457,0.00022466177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980895,0.00042825832,0.00068477244,0.00015737637,0.00044282814,0.00019725991],"domain_scores_gemma":[0.9973219,0.0013191657,0.00061987434,0.00051120995,0.00006900571,0.00015882147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092336227,0.00008806123,0.0003364331,0.000048302067,0.00009299826,0.000014907123,0.0002104933,0.000066617366,0.000014411999],"category_scores_gemma":[0.0019786481,0.00005325032,0.0000401451,0.00026511488,0.00028110965,0.000154226,0.000081740094,0.0006250228,8.637877e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006392368,0.00015050753,0.9914921,0.0003350633,0.000030896637,1.5867295e-7,0.00085584976,0.000010193934,0.00064294616,0.00034309842,0.004853723,0.0012215695],"study_design_scores_gemma":[0.0011807284,0.000049294864,0.95715237,0.00023877158,0.000037260183,0.0000016064106,0.00008215097,0.0013780211,0.0011354496,0.00013278054,0.03856085,0.0000507359],"about_ca_topic_score_codex":0.030177131,"about_ca_topic_score_gemma":0.0015191196,"teacher_disagreement_score":0.03913614,"about_ca_system_score_codex":0.000041701445,"about_ca_system_score_gemma":0.0003208835,"threshold_uncertainty_score":0.976281},"labels":[],"label_agreement":null},{"id":"W2035660013","doi":"10.1016/s1098-3015(10)65058-9","title":"PMH8 RISPERIDONE LONG-ACTING INJECTION (RLAI) IN THE TREATMENT OF SCHIZOPHRENIA: 3 MONTH PRELIMINARY RESULTS FROM E-STAR PROJECT IN CANADA","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health and Psychiatry","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Risperidone; Schizophrenia (object-oriented programming); Psychology; Psychiatry; Medicine","score_opus":0.06554929625418444,"score_gpt":0.29274705405158813,"score_spread":0.2271977577974037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2035660013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99243057,0.0023692637,0.0000013283579,0.00082127727,0.00094711944,0.0010417622,0.0001850163,0.000009968535,0.002193706],"genre_scores_gemma":[0.99855256,0.00042912146,0.00014496298,0.00029058824,0.00039409424,0.000032593038,0.00007804596,0.000013202383,0.000064822445],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99777794,0.00030485488,0.00094327866,0.000266236,0.00025149615,0.0004561881],"domain_scores_gemma":[0.9989807,0.0004293291,0.00026909064,0.00023467108,0.000015774482,0.00007041471],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000980617,0.00015590586,0.00029106214,0.00021311663,0.00016168677,0.000014872777,0.00010895943,0.00004360282,0.000029475172],"category_scores_gemma":[0.000021886552,0.00011722359,0.000032416196,0.00017138518,0.00003461727,0.00008083395,0.000008681195,0.00023261641,0.000001933387],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028510911,0.003517956,0.17708565,0.0013384712,0.00004064174,0.0002546664,0.67325175,0.004347707,0.0000033124884,0.0032154426,0.0024447262,0.10598873],"study_design_scores_gemma":[0.018358568,0.014562578,0.66665554,0.002577254,0.000023214232,0.00002060655,0.24911073,0.009071583,0.00010466216,0.0011023025,0.037609924,0.0008030266],"about_ca_topic_score_codex":0.9980648,"about_ca_topic_score_gemma":0.9977815,"teacher_disagreement_score":0.4895699,"about_ca_system_score_codex":0.0013729974,"about_ca_system_score_gemma":0.0014675686,"threshold_uncertainty_score":0.47802395},"labels":[],"label_agreement":null},{"id":"W2036228685","doi":"10.1016/j.jval.2012.08.258","title":"PRM6 Transferability of Indirect Cost of Chronic Disease: A Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Gross domestic product; Meta-analysis; Medicine; Per capita; Econometrics; Statistics; Meta-regression; Indirect costs; Bootstrapping (finance); Demography; Mathematics; Economics; Environmental health; Population; Internal medicine","score_opus":0.7227879199059023,"score_gpt":0.5048307046954711,"score_spread":0.2179572152104312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036228685","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000047987605,0.98245853,0.00022512366,0.0022570959,0.00008846634,0.010897275,0.0040088897,0.00001490756,0.00004492309],"genre_scores_gemma":[0.00043184878,0.9966068,0.000193214,0.00076826394,0.0000416497,0.0016914125,0.00014783023,0.000049741193,0.00006918453],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97444797,0.005895709,0.018055113,0.00084903935,0.0001937249,0.00055842096],"domain_scores_gemma":[0.9833611,0.0033275038,0.011280918,0.0015206712,0.00007477943,0.00043499493],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.063950755,0.00051794533,0.027713588,0.0011785709,0.00006330864,0.000016363072,0.0004604659,0.00024617364,0.0004740057],"category_scores_gemma":[0.0030683826,0.00048944616,0.0024231214,0.001390544,0.000121221885,0.00020190324,0.00005177107,0.00037018672,0.00007381366],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[9.96844e-7,0.00014016402,0.00012413105,0.9785647,0.016700849,1.651417e-7,0.00021350977,0.000042288113,1.9070516e-10,0.0038652183,0.000048804734,0.00029921433],"study_design_scores_gemma":[0.00049761595,0.00025876708,0.00036171242,0.2684878,0.62761456,0.000009704789,0.00006095411,0.00077231874,2.5158375e-8,0.0011390592,0.09943129,0.0013662002],"about_ca_topic_score_codex":0.002977144,"about_ca_topic_score_gemma":0.00023322552,"teacher_disagreement_score":0.71007687,"about_ca_system_score_codex":0.0015437185,"about_ca_system_score_gemma":0.0014561379,"threshold_uncertainty_score":0.99975574},"labels":[],"label_agreement":null},{"id":"W2036347212","doi":"10.1016/j.jval.2012.08.973","title":"PCV30 Assessment of the Hospital Costs of Mitral Regurgitation (MR) Patients, a French National Hospital Database Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada)","funders":"","keywords":"Medicine; Percentile; Rehabilitation; Demographics; Database; Emergency medicine; Population; Hospital discharge; Heart failure; Internal medicine; Physical therapy; Demography","score_opus":0.0930934804347014,"score_gpt":0.47058053726861687,"score_spread":0.3774870568339155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036347212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888858,0.0005458864,0.00019938349,0.00490252,0.0017731094,0.0016902358,0.0006112739,0.000013966145,0.0013778011],"genre_scores_gemma":[0.99718785,0.00007642073,0.0018801788,0.00027852508,0.00019794193,0.0001027378,0.00018930408,0.000014726424,0.00007232019],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99325293,0.003500639,0.0015097037,0.00023671704,0.000945664,0.0005543258],"domain_scores_gemma":[0.9953274,0.0016885154,0.001781604,0.0004067258,0.000589298,0.00020645648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005714573,0.00014411038,0.00047446726,0.00030357932,0.00029099942,0.000004670167,0.00021347447,0.00014521873,0.00010767121],"category_scores_gemma":[0.0013822446,0.000108853725,0.00016642988,0.0011715823,0.000054152708,0.00045728206,0.00009262957,0.00057126366,0.000007869185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007824586,0.00055937644,0.9803433,0.000695025,0.000092709895,1.3721582e-7,0.0059511303,0.00017038717,0.0000033076608,0.009521292,0.0021404102,0.0005151318],"study_design_scores_gemma":[0.000646723,0.0002206384,0.99240196,0.000488481,0.000043405085,1.3102574e-7,0.0018489321,0.0012039964,0.0000030461274,0.00007619397,0.0029654673,0.00010101838],"about_ca_topic_score_codex":0.043243233,"about_ca_topic_score_gemma":0.00091155135,"teacher_disagreement_score":0.04233168,"about_ca_system_score_codex":0.0008322735,"about_ca_system_score_gemma":0.0019430366,"threshold_uncertainty_score":0.9631279},"labels":[],"label_agreement":null},{"id":"W2036561689","doi":"10.1016/j.jval.2011.02.973","title":"PCN119 VALIDATION OF A NEW MEASURE OF PATIENT EMPOWERMENT IN ONCOLOGY: FIVE HEALTH EDUCATION IMPACT QUESTIONNAIRE (HEIQ) SCALES","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McGill University; Université Laval","funders":"","keywords":"Structural equation modeling; Confirmatory factor analysis; Cronbach's alpha; Construct validity; Psychometrics; Population; Empowerment; Psychology; Clinical psychology; Medicine; Context (archaeology); Statistics","score_opus":0.05665829154552438,"score_gpt":0.36670900290939484,"score_spread":0.31005071136387047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036561689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929239,0.0015522899,0.00003141216,0.0032893578,0.00044950147,0.0011027416,0.0000030274816,0.000014278807,0.00063344627],"genre_scores_gemma":[0.99766326,0.00028105843,0.0015218396,0.00031932793,0.000052944488,0.00003117125,0.000059904007,0.000011738964,0.000058759433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982298,0.00029520143,0.000786754,0.00019669898,0.00024637728,0.00024514485],"domain_scores_gemma":[0.9988838,0.000039678594,0.0005707328,0.00022702939,0.00010506,0.00017371916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011223233,0.000111253794,0.00038997695,0.00046323513,0.000021179503,0.00000268332,0.000060955903,0.000065155196,0.000036064383],"category_scores_gemma":[0.00020826426,0.00010331275,0.00005515361,0.00044770056,0.00003122188,0.00010473688,0.00001740089,0.00012618027,0.0000050230574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033528951,0.0040114,0.59623307,0.0017398664,0.000035306763,6.9339865e-7,0.06574694,0.00074573304,0.000048090602,0.0011688686,0.005849469,0.3240853],"study_design_scores_gemma":[0.0012222741,0.0034044331,0.9838479,0.0033309879,0.000016794724,0.0000022017982,0.004499276,0.00030682544,0.00057553354,0.0023271337,0.00036107743,0.00010556414],"about_ca_topic_score_codex":0.027754469,"about_ca_topic_score_gemma":0.00037534186,"teacher_disagreement_score":0.38761485,"about_ca_system_score_codex":0.0012874681,"about_ca_system_score_gemma":0.0038937447,"threshold_uncertainty_score":0.9787198},"labels":[],"label_agreement":null},{"id":"W2036598552","doi":"10.1016/s1098-3015(10)72344-5","title":"PGI26 CANADIAN COST-UTILITY ANALYSIS OF INITIATION AND MAINTENANCE TREATMENT WITH ANTI-TNF DRUGS FOR REFRACTORY CROHN'S DISEASE","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Refractory (planetary science); Crohn's disease; Medicine; Disease; Tumor necrosis factor alpha; Maintenance therapy; Intensive care medicine; Internal medicine; Biology; Chemotherapy","score_opus":0.014365908025332524,"score_gpt":0.2726173675196867,"score_spread":0.25825145949435413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036598552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815863,0.00014434179,0.000116318486,0.00021918873,0.000047834645,0.00064781285,0.00059536326,0.000003821441,0.00006665688],"genre_scores_gemma":[0.9989374,0.00012797603,0.00022931196,0.0002357414,0.000032760927,0.00007985772,0.0003165623,0.000011113027,0.00002925204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991051,0.000080022386,0.00022160496,0.00027443492,0.00007064469,0.00024821283],"domain_scores_gemma":[0.99909705,0.00002381511,0.00012315478,0.00031233937,0.00008740819,0.00035621377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029063132,0.00010767631,0.0001770127,0.00014273288,0.00006716568,0.000008260098,0.000057449983,0.000062762374,0.000008054338],"category_scores_gemma":[0.00008179623,0.00009454712,0.000057319772,0.00012400626,0.0000779551,0.000005361375,0.0000094667885,0.000051159226,3.0036924e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014358623,0.00029737293,0.9852234,0.00035226782,0.00029666538,0.00007327163,0.0005195307,0.0020466403,0.0013372396,0.0005537827,0.0001516688,0.0077122673],"study_design_scores_gemma":[0.0008134221,0.000132238,0.9890516,0.000017163058,0.00009251799,4.4967257e-7,0.00004758092,0.0060153636,0.00015731607,0.000033187316,0.003537465,0.00010171619],"about_ca_topic_score_codex":0.030265301,"about_ca_topic_score_gemma":0.116459414,"teacher_disagreement_score":0.08619411,"about_ca_system_score_codex":0.00007908854,"about_ca_system_score_gemma":0.0012006856,"threshold_uncertainty_score":0.97619224},"labels":[],"label_agreement":null},{"id":"W2036769704","doi":"10.1016/j.jval.2014.03.1652","title":"Prevalence, Incidence And Characteristics Of Patients With Choroidal Neovascularization Secondary To Pathologic Myopia In A Representative Canadian Cohort","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lawson Health Research Institute; Université de Montréal; Novartis (Canada)","funders":"","keywords":"Incidence (geometry); Cohort; Medicine; Choroidal neovascularization; Ophthalmology; Optometry; Neovascularization; Demography; Internal medicine; Macular degeneration; Angiogenesis; Optics","score_opus":0.009413417416776492,"score_gpt":0.2539320940616185,"score_spread":0.244518676644842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2036769704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813735,0.00003174087,0.00017541982,0.0006150799,0.00002876497,0.00078628166,0.000058262685,0.000004069626,0.00016302161],"genre_scores_gemma":[0.9982377,0.00006278598,0.0010602138,0.0004780093,0.000014356934,0.000028744287,0.000071336726,0.000005613992,0.0000411864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908173,0.00013006879,0.00028266228,0.00019482934,0.00014278541,0.00016795222],"domain_scores_gemma":[0.99944687,0.00006600742,0.00008410897,0.0001361905,0.00008358292,0.0001832226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004340597,0.000067559115,0.00021986953,0.00020353467,0.000030329726,0.0000047006997,0.000035562145,0.000036003556,0.000024229848],"category_scores_gemma":[0.00033025426,0.000056886103,0.0000107472915,0.00024486915,0.000046239686,0.000044527907,0.000015772916,0.00013124544,0.0000014643423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045927343,0.000039384155,0.9966344,0.00027343517,0.0000034382101,0.000009441233,0.00081965723,0.00006557107,0.0000045478996,0.00016304915,0.0000111373265,0.0019299609],"study_design_scores_gemma":[0.0005535737,0.00062909565,0.9972777,0.0004381279,0.000008109194,0.000006586295,0.00005590553,0.000849751,0.000004569803,0.00008404021,0.00004031478,0.000052264342],"about_ca_topic_score_codex":0.05668022,"about_ca_topic_score_gemma":0.009995776,"teacher_disagreement_score":0.046684444,"about_ca_system_score_codex":0.000117677664,"about_ca_system_score_gemma":0.00036454553,"threshold_uncertainty_score":0.9496014},"labels":[],"label_agreement":null},{"id":"W2037559088","doi":"10.1016/j.jval.2014.03.043","title":"The Potential Impact Of Recommendations Made Through The Common Drug Review Program At The Canadian Agency For Drugs And Technologies In Health","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Formulary; Counterfactual thinking; Agency (philosophy); Listing (finance); Cost–benefit analysis; Medicine; Actuarial science; Operations research; Business; Family medicine; Finance; Engineering","score_opus":0.25731075421596555,"score_gpt":0.4578073954217232,"score_spread":0.20049664120575766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037559088","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04616787,0.08975775,0.000106312335,0.8574261,0.00032810654,0.005478924,0.00034419654,0.000036562706,0.00035419455],"genre_scores_gemma":[0.89811957,0.080747254,0.0019669847,0.017462496,0.000104606304,0.0012635973,0.00008216665,0.000040475938,0.00021287336],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99401206,0.00140082,0.0035103443,0.00034669097,0.00007666154,0.0006534499],"domain_scores_gemma":[0.99477684,0.0022791214,0.002103525,0.00069664675,0.000035868525,0.00010798179],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03603151,0.00015831372,0.00077757257,0.00016118141,0.0010052349,0.000057675545,0.00045131912,0.00008168118,0.000019823754],"category_scores_gemma":[0.0022435999,0.00010848171,0.00011672891,0.0003725088,0.00020512717,0.00013707014,0.00007092467,0.00030898812,0.000021402819],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004539156,0.00030097284,0.07122787,0.011077858,0.00013005912,3.0639842e-7,0.026759133,0.004644989,2.1163721e-7,0.36697924,0.32774872,0.19108525],"study_design_scores_gemma":[0.0011599832,0.0005447642,0.060690083,0.0024726244,0.0000071496193,0.000010557013,0.004666908,0.03149803,6.833996e-7,0.15243511,0.7461367,0.0003773591],"about_ca_topic_score_codex":0.6296271,"about_ca_topic_score_gemma":0.3877025,"teacher_disagreement_score":0.85195166,"about_ca_system_score_codex":0.0019384008,"about_ca_system_score_gemma":0.0009527729,"threshold_uncertainty_score":0.9926084},"labels":[],"label_agreement":null},{"id":"W2037604674","doi":"10.1016/s1098-3015(10)70902-5","title":"PSS7 THE COST-EFFECTIVENESS OF RANIBIZUMAB COMPARED TO PDT-VAND BSC FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Macular degeneration; Ranibizumab; Medicine; Ophthalmology; Oncology; Internal medicine; Optometry; Chemotherapy","score_opus":0.11774405482990875,"score_gpt":0.3684899964738832,"score_spread":0.25074594164397446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037604674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907678,0.0018627355,0.00013745399,0.0011689183,0.00010637769,0.005878605,0.000029680195,0.0000037764269,0.00004469774],"genre_scores_gemma":[0.9983635,0.0009340107,0.00008918122,0.00008826808,0.000024233115,0.00033860354,0.000029725632,0.00001542986,0.00011707965],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9983282,0.0005370235,0.00041441087,0.00016432018,0.00030588286,0.00025017103],"domain_scores_gemma":[0.9985165,0.00093121274,0.0000811288,0.00030852048,0.000084208994,0.00007845872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009082951,0.00009890077,0.00040550777,0.000094872354,0.00007333047,0.0000022582938,0.00008749132,0.000033225806,0.000035100144],"category_scores_gemma":[0.00006296938,0.000059166643,0.00005683436,0.0003931153,0.00005577943,0.000011564809,0.00000830704,0.00009323201,5.301795e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018798731,0.0022618526,0.22248444,0.002057026,0.0005020991,0.00016836499,0.022951579,0.54141915,0.10814286,0.00079174543,0.0010109695,0.0794112],"study_design_scores_gemma":[0.037350778,0.005376308,0.6878572,0.0010028357,0.0000788347,0.000106343025,0.0013940714,0.10813898,0.14440538,0.0002147972,0.013778467,0.0002959966],"about_ca_topic_score_codex":0.8777398,"about_ca_topic_score_gemma":0.57010126,"teacher_disagreement_score":0.46537277,"about_ca_system_score_codex":0.0019665533,"about_ca_system_score_gemma":0.0021077038,"threshold_uncertainty_score":0.5142469},"labels":[],"label_agreement":null},{"id":"W2037626000","doi":"10.1016/j.jval.2012.08.874","title":"PMD25 Financial Impact of Adaptive Cardiac Resynchronization Therapy (ACRT) Device Algorithms in the United Kigdom, Germany, Australia and Canada: Are There Savings Associated With Device Selection?","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac pacing and defibrillation studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Medtronic (Canada)","funders":"","keywords":"Cardiac resynchronization therapy; Medicine; Algorithm; Heart failure; Finance; Emergency medicine; Cardiology; Computer science; Ejection fraction; Business","score_opus":0.06930863501827055,"score_gpt":0.33728759712808537,"score_spread":0.2679789621098148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037626000","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99684674,0.001973626,0.000023265404,0.00030461728,0.000081458704,0.0005649797,0.000053461023,0.000016310441,0.00013554774],"genre_scores_gemma":[0.9991699,0.0003236511,0.00006506131,0.00023288983,0.00012882896,0.000015119144,0.000027924034,0.000015308007,0.000021361111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832267,0.00050430495,0.00033203006,0.00016338762,0.0003285947,0.00034901508],"domain_scores_gemma":[0.9989185,0.00038201836,0.0002690032,0.0001256679,0.00021438215,0.00009047904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009558579,0.00015972798,0.00050443155,0.0001422203,0.00011818559,0.000008607543,0.000021196256,0.00008060005,0.0000022600495],"category_scores_gemma":[0.00022311333,0.00010612706,0.00005010907,0.001043805,0.00004844595,0.000075704214,0.000011245903,0.00023384202,4.2975685e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014670339,0.000050568644,0.993446,0.00004868275,0.00010115144,0.0000025509594,0.0029895788,0.0017855553,0.000013164788,0.000053670847,0.0011136947,0.00024870172],"study_design_scores_gemma":[0.0009666314,0.00029391912,0.99601763,0.00038431588,0.000026857322,0.000022895769,0.0010741451,0.0003962557,0.000015934362,0.000005686599,0.0006937417,0.00010198438],"about_ca_topic_score_codex":0.81323475,"about_ca_topic_score_gemma":0.1442311,"teacher_disagreement_score":0.6690036,"about_ca_system_score_codex":0.0009102774,"about_ca_system_score_gemma":0.0010129168,"threshold_uncertainty_score":0.87138444},"labels":[],"label_agreement":null},{"id":"W2037713656","doi":"10.1016/j.jval.2012.08.611","title":"PHP69 United States Valuation of Child Health Outcomes","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Valuation (finance); Quality of life (healthcare); Child health; Informatics; Quality-adjusted life year; Health care; Gerontology; Family medicine; Nursing; Cost effectiveness","score_opus":0.5145116243981976,"score_gpt":0.4549319923069301,"score_spread":0.05957963209126754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037713656","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61556315,0.019686814,0.005234314,0.35257676,0.001984335,0.002503221,0.00071682927,0.00012039762,0.0016141691],"genre_scores_gemma":[0.9416851,0.0016587855,0.0037665253,0.0520198,0.00026494384,0.00008351859,0.0003089278,0.000054002052,0.00015843572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9908698,0.0013952692,0.0062698815,0.0004038036,0.00017829267,0.0008829117],"domain_scores_gemma":[0.993873,0.0012205198,0.003893813,0.0005516302,0.000057060628,0.00040396795],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.041976005,0.00021759032,0.0014117232,0.0010281461,0.00019314642,0.000021115831,0.00023414408,0.00011558096,0.00016739339],"category_scores_gemma":[0.0024004576,0.00026595802,0.000113930546,0.0006499595,0.0000586274,0.0004720235,0.00004374574,0.00026066657,0.00048526967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012675214,0.00044592103,0.70940334,0.0014571869,0.00004600622,1.0127328e-7,0.0128702065,0.013620391,1.1525021e-7,0.25079894,0.010847674,0.00049743033],"study_design_scores_gemma":[0.0024062993,0.00038711366,0.79126734,0.0006792724,0.000004131351,0.000006439516,0.003438619,0.050400585,0.0000050099725,0.030659784,0.120155245,0.0005901795],"about_ca_topic_score_codex":0.038105875,"about_ca_topic_score_gemma":0.00019888181,"teacher_disagreement_score":0.3261219,"about_ca_system_score_codex":0.0013390621,"about_ca_system_score_gemma":0.0003710609,"threshold_uncertainty_score":0.99997926},"labels":[],"label_agreement":null},{"id":"W2037809152","doi":"10.1016/j.jval.2012.04.012","title":"Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-7","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":460,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Transparency (behavior); Documentation; Face validity; External validity; Computer science; Rigour; Management science; Health care; Medicine; Engineering; Psychology; Political science","score_opus":0.789119629476609,"score_gpt":0.5333343149104329,"score_spread":0.25578531456617604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2037809152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9198566,0.009124973,0.00948358,0.056262422,0.00046199656,0.0014110004,0.00011495105,0.000022385693,0.0032621063],"genre_scores_gemma":[0.99334735,0.0006998698,0.004351912,0.00094413274,0.00019672402,0.000088957844,0.000011568757,0.000025294627,0.00033418788],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.993226,0.001084228,0.004359516,0.00045914433,0.00023559651,0.000635505],"domain_scores_gemma":[0.9945904,0.0010855343,0.0033169903,0.00069401134,0.00009922663,0.00021384403],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06867388,0.00013259977,0.0006661045,0.00033422062,0.00028427827,0.00003525735,0.00027242696,0.00013320215,0.000026431102],"category_scores_gemma":[0.0053612497,0.00013853483,0.000068843656,0.000410938,0.00007708861,0.0007770153,0.00006128896,0.00040065986,0.000033475375],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028658791,0.0003337625,0.39956278,0.0025658065,0.00003854984,0.0000010452173,0.024398098,0.23947078,0.000008936759,0.33189976,0.0015419417,0.00014988724],"study_design_scores_gemma":[0.00050348067,0.00006159274,0.0082331225,0.0003101935,0.0000040088553,0.000031191656,0.0018243777,0.9398763,0.000008037845,0.04609377,0.0028584881,0.00019543432],"about_ca_topic_score_codex":0.013207415,"about_ca_topic_score_gemma":0.00017161104,"teacher_disagreement_score":0.70040554,"about_ca_system_score_codex":0.00048757045,"about_ca_system_score_gemma":0.0006705373,"threshold_uncertainty_score":0.99336374},"labels":[],"label_agreement":null},{"id":"W2038104538","doi":"10.1016/j.jval.2014.03.1624","title":"Health State Utility Values Of Hiv Infected Patients In Kenya","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Quality of life (healthcare); Asymptomatic; Human immunodeficiency virus (HIV); Depression (economics); Population; Cohort; Internal medicine; Analysis of variance; Post-hoc analysis; Diarrhea; Immunology; Environmental health","score_opus":0.05912182703972757,"score_gpt":0.4219660423674894,"score_spread":0.36284421532776184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038104538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881154,0.00065407564,0.00015216459,0.004878665,0.001284523,0.0029502625,0.00019135661,0.0001490932,0.0016244793],"genre_scores_gemma":[0.9948372,0.00067051133,0.0012025366,0.0028808939,0.00009660893,0.000054871503,0.00010128933,0.00004787298,0.00010820005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9862945,0.0074956585,0.0031125015,0.0006378341,0.00067570165,0.0017837961],"domain_scores_gemma":[0.99535763,0.0016355099,0.0012774253,0.00078226253,0.00034924835,0.0005979306],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0076398677,0.00031783152,0.0012709599,0.0005311096,0.0003359762,0.000004777248,0.00034053487,0.00024335443,0.00008683135],"category_scores_gemma":[0.0018816084,0.0003147743,0.00007297348,0.0011258926,0.000109444016,0.00015824918,0.00018884498,0.0011870718,0.0002457675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013336478,0.00041220657,0.9734562,0.0031917598,0.0000036334245,8.102475e-7,0.008676034,0.0004081131,5.1999064e-7,0.00091236795,0.006436091,0.0063688955],"study_design_scores_gemma":[0.0025318724,0.00063491135,0.97515434,0.0023877455,0.0000013594259,2.399138e-7,0.0004833245,0.0033586991,0.0000032097334,0.0036327355,0.011624457,0.00018707692],"about_ca_topic_score_codex":0.12443701,"about_ca_topic_score_gemma":0.012051472,"teacher_disagreement_score":0.11238554,"about_ca_system_score_codex":0.0016918072,"about_ca_system_score_gemma":0.0024765434,"threshold_uncertainty_score":0.99993044},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2038154696","doi":"10.1016/j.jval.2012.08.1362","title":"PMS7 Biologic Disease-Modifying Anti-Rheumatic Drugs and the Risk of Non-Vertebral Osteoporotic Fractures in Patients With Rheumatoid Arthritis Aged 50 Years and Over","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval; Université de Montréal","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Osteoporosis; Odds ratio; Confidence interval; Hazard ratio; Rheumatology; Logistic regression; Physical therapy; Surgery","score_opus":0.010155705536033854,"score_gpt":0.2638107750659042,"score_spread":0.2536550695298704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038154696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647588,0.033765003,0.000008063573,0.00022019655,0.000051254676,0.0011413239,0.000029985315,0.000011937887,0.000013422134],"genre_scores_gemma":[0.929757,0.0697577,0.0002736141,0.00013157491,0.00001093972,0.00003169886,0.000016591157,0.000018971448,0.000001902462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979535,0.0004951439,0.0004817019,0.00021602158,0.0003474843,0.0005061638],"domain_scores_gemma":[0.99885064,0.0003891097,0.00021374678,0.00024093589,0.00002360629,0.0002819858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012806421,0.00016705351,0.0005829313,0.00020482176,0.00010484393,0.000022829547,0.00006900488,0.00005484823,0.000027471899],"category_scores_gemma":[0.00031396738,0.00010392226,0.00004056221,0.0001917926,0.00038575687,0.00017115317,0.000055804714,0.00035013817,0.0000023311754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006822108,0.00018935236,0.97835696,0.00025378246,0.000034746718,0.0000043860596,0.0052357214,0.00002592868,0.000004449488,0.00007549533,0.000021493106,0.015115459],"study_design_scores_gemma":[0.0122644985,0.0003168431,0.9834021,0.002176575,0.0000024122107,0.000009094091,0.00048069944,0.00077516964,0.000004933971,0.00043683278,0.00002703227,0.00010380915],"about_ca_topic_score_codex":0.004936756,"about_ca_topic_score_gemma":0.00010456807,"teacher_disagreement_score":0.035992693,"about_ca_system_score_codex":0.000046802958,"about_ca_system_score_gemma":0.00012914246,"threshold_uncertainty_score":0.7462931},"labels":[],"label_agreement":null},{"id":"W2038404497","doi":"10.1016/j.jval.2012.08.1991","title":"PND67 The Impact of Memantine and Cholinesterase Inhibitors Initiation for Alzheimer'S Disease on the Use of Antipsychotics Agents: Analysis Using the Ramq Database","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Memantine; Antipsychotic; Medical prescription; Galantamine; Medicine; Dementia; Donepezil; Psychiatry; Internal medicine; Pharmacology; Disease; Schizophrenia (object-oriented programming)","score_opus":0.5645188513476347,"score_gpt":0.514326525692037,"score_spread":0.050192325655597725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038404497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931814,0.0010631691,0.0003100946,0.004077854,0.00011624364,0.0010789823,0.00016579384,0.0000036924148,0.0000027771218],"genre_scores_gemma":[0.9975414,0.00045391428,0.00023177633,0.0015969566,0.00010740238,0.000007331386,0.00004955215,0.000010324469,0.0000013092222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857885,0.0004185387,0.00046036878,0.000110385816,0.00022133792,0.00021050852],"domain_scores_gemma":[0.99688995,0.0021296109,0.00040562364,0.00036137702,0.000062647545,0.00015078513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001422821,0.00010587334,0.00025482682,0.000118198994,0.00010522303,0.000012977004,0.00006472877,0.00001980317,0.000012994907],"category_scores_gemma":[0.00084260054,0.000045803805,0.00013741737,0.00047296332,0.00008499048,0.00021178523,0.00002819207,0.000163692,2.9245268e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015569978,0.0006780507,0.97802895,0.00024449226,0.00054449664,0.0000011273127,0.001156309,0.016598698,0.000094103205,0.00030841198,0.00026393065,0.00052444584],"study_design_scores_gemma":[0.0013791474,0.00023033693,0.5189598,0.00028426707,0.001890914,0.000003517387,0.00020424418,0.47617146,0.00021382389,0.00003237628,0.0005442858,0.00008577045],"about_ca_topic_score_codex":0.0008945909,"about_ca_topic_score_gemma":0.000004406881,"teacher_disagreement_score":0.45957276,"about_ca_system_score_codex":0.000028509321,"about_ca_system_score_gemma":0.0000886636,"threshold_uncertainty_score":0.18678251},"labels":[],"label_agreement":null},{"id":"W2038468017","doi":"10.1016/j.jval.2011.02.749","title":"PMS66 EARLY AND SUSTAINED REMISSION ASSOCIATED WITH NORMALIZED PHYSICAL FUNCTION AND HEALTH-RELATED QUALITY OF LIFE AND SIGNIFICANTLY IMPROVED PRODUCTIVITY IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS TREATED WITH GOLIMUMAB: TWO YEAR DATA FROM THE PHASE III GO-REVEAL CLINICAL TRIAL","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Golimumab; Psoriatic arthritis; Placebo; Physical therapy; Internal medicine; Rheumatology; Quality of life (healthcare); Absenteeism; Arthritis; Rheumatoid arthritis; Etanercept; Alternative medicine","score_opus":0.10356296293681677,"score_gpt":0.3664057822691256,"score_spread":0.26284281933230885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2038468017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953256,0.0005871217,0.000012241244,0.0004922471,0.000029090555,0.003321846,0.00019142398,0.000031143343,0.000009277411],"genre_scores_gemma":[0.9986991,0.00075047615,0.00012919468,0.00004278533,0.000043745054,0.000035800378,0.0002651482,0.000027775388,0.0000059211106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956525,0.001914376,0.0009401349,0.0006403641,0.0004335639,0.00041908713],"domain_scores_gemma":[0.9976807,0.0006191808,0.0006938048,0.00046498788,0.00016952271,0.00037175452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029257014,0.0002252343,0.0010949352,0.000095878815,0.00013417967,0.000022756885,0.000088838875,0.00008799729,0.000005866832],"category_scores_gemma":[0.0009093533,0.00013546375,0.000022066506,0.00038222253,0.000417992,0.00028804963,0.00006497785,0.00056617375,2.3503898e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.36656636,0.0033189869,0.6012188,0.00009754641,0.00028553052,0.0000056321605,0.0036021136,8.6890526e-7,0.000043161497,0.00005592557,0.0000150428905,0.024790017],"study_design_scores_gemma":[0.23066628,0.016855538,0.75034964,0.0007059179,0.00001381022,0.0000011205096,0.0005522583,0.0005642118,0.000011129843,0.00015831529,0.000001717952,0.000120040124],"about_ca_topic_score_codex":0.047853958,"about_ca_topic_score_gemma":0.0031005614,"teacher_disagreement_score":0.14913084,"about_ca_system_score_codex":0.00010105432,"about_ca_system_score_gemma":0.00087808666,"threshold_uncertainty_score":0.95848644},"labels":[],"label_agreement":null},{"id":"W2039340241","doi":"10.1016/s1098-3015(10)73442-2","title":"PSS10 ECONOMIC BURDEN OF MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Plaque psoriasis; Medicine; Psoriasis; Dermatology","score_opus":0.21867146087439654,"score_gpt":0.37677347320939225,"score_spread":0.1581020123349957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039340241","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8974365,0.0026726264,0.00020833705,0.095961675,0.00074942014,0.0011687874,0.00038824588,0.000018265284,0.0013961586],"genre_scores_gemma":[0.99023163,0.00045107745,0.0011712379,0.0076496773,0.00029676457,0.000048050926,0.000016213904,0.00002533457,0.00010998453],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99314976,0.00041063258,0.00502419,0.0006158576,0.000087202825,0.00071233284],"domain_scores_gemma":[0.9971756,0.0005224344,0.0014365502,0.0005365509,0.00002128628,0.00030763337],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008518532,0.00021145439,0.001345159,0.00057506195,0.00006743678,0.000023135692,0.00034414913,0.000109157685,0.0002008208],"category_scores_gemma":[0.0004966182,0.00030399664,0.00006177284,0.00028087478,0.00001543633,0.0002397829,0.00003237478,0.00024614678,0.00029715642],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00004873203,0.00004582691,0.018437978,0.0004924729,0.000014894277,0.0000027190194,0.0028845675,0.9175208,0.0000011870982,0.04939924,0.009837724,0.0013138612],"study_design_scores_gemma":[0.005865393,0.0008687439,0.15979925,0.0014448158,0.0000040215355,0.000020045587,0.0028960651,0.7263221,0.000037276233,0.051991247,0.04921019,0.0015408307],"about_ca_topic_score_codex":0.9801675,"about_ca_topic_score_gemma":0.8680564,"teacher_disagreement_score":0.19119866,"about_ca_system_score_codex":0.013860476,"about_ca_system_score_gemma":0.006626661,"threshold_uncertainty_score":0.99994123},"labels":[],"label_agreement":null},{"id":"W2039395549","doi":"10.1016/s1098-3015(10)70193-5","title":"PCN13 BUDGET IMPACT ANALYSIS OF SORAFENIB IN THE TREATMENT OF HEPATOCELLULAR CARCINOMA IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sorafenib; Hepatocellular carcinoma; Oncology; Internal medicine; Medicine; Business","score_opus":0.05953024344832142,"score_gpt":0.25438323346857195,"score_spread":0.19485299002025053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039395549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910651,0.007124247,0.000013165962,0.0003382147,0.00008073052,0.00030171656,0.00028870386,0.0000014105487,0.0007867071],"genre_scores_gemma":[0.99645674,0.0033057095,0.00003592402,0.00012758965,0.000018876313,0.000017344864,0.000014977494,0.000009351414,0.000013459434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811506,0.000057291225,0.0011957509,0.00023733282,0.000043167565,0.00035141176],"domain_scores_gemma":[0.9989425,0.00012420095,0.00051446387,0.00034176424,0.000012280815,0.00006479822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057287456,0.00013423672,0.0009543474,0.0006720335,0.00002434141,0.0000036902047,0.00018526883,0.00005207455,0.000055856788],"category_scores_gemma":[0.000029281347,0.00012124434,0.0001532921,0.0010587841,0.000042011103,0.000076812816,0.000008351343,0.00008893031,0.0000026385687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028690167,0.00016922677,0.9579012,0.00002417044,0.000043431075,0.000016356886,0.002772418,0.03688254,5.488901e-7,0.0017361167,0.000045099787,0.00038021267],"study_design_scores_gemma":[0.0007195156,0.00022957829,0.95754457,0.000012226258,0.0000062827016,0.0000013200382,0.00017532459,0.039815087,0.000018322715,0.00065804145,0.0007210597,0.000098675715],"about_ca_topic_score_codex":0.99434984,"about_ca_topic_score_gemma":0.847064,"teacher_disagreement_score":0.14728582,"about_ca_system_score_codex":0.0023056732,"about_ca_system_score_gemma":0.0012234262,"threshold_uncertainty_score":0.6029255},"labels":[],"label_agreement":null},{"id":"W2039558840","doi":"10.1016/j.jval.2013.10.009","title":"Health Utility Scores in Alzheimer’s Disease: Differences Based on Calculation With American and Canadian Preference Weights","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Intraclass correlation; Preference; Medicine; Quality of life (healthcare); Demography; Population; EQ-5D; Correlation; Gerontology; Disease; Physical therapy; Psychometrics; Clinical psychology; Statistics; Health related quality of life; Environmental health; Mathematics; Internal medicine","score_opus":0.35809334277501637,"score_gpt":0.38547374206667473,"score_spread":0.027380399291658364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039558840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9023932,0.002148557,0.001034426,0.09213826,0.00016766702,0.0013292569,0.00025841437,0.000033797733,0.00049639354],"genre_scores_gemma":[0.98615617,0.0001553117,0.0013192502,0.012141318,0.00006517106,0.00008805859,0.00004536223,0.000020244079,0.000009127443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950423,0.0012641794,0.0021883196,0.0007188607,0.00012786279,0.00065846246],"domain_scores_gemma":[0.9965416,0.00092674344,0.0012227067,0.00046428165,0.000023478075,0.00082117843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009602423,0.00020975152,0.0009650112,0.00073670933,0.00020719966,0.000052318373,0.00016720236,0.0000566233,0.000030238552],"category_scores_gemma":[0.00079952774,0.0002247855,0.000029646375,0.0003833718,0.00013837141,0.00017414309,0.000013293432,0.00022978387,0.00004380723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003133637,0.00007226202,0.96751136,0.00023451773,0.0000050577896,4.5375444e-7,0.0007273946,0.0027133182,3.809358e-9,0.026289659,0.00022018138,0.0021944814],"study_design_scores_gemma":[0.00043194988,0.00022973299,0.7612818,0.0003305869,9.29461e-7,2.9108165e-7,0.000063302665,0.2330447,5.021378e-8,0.0032567678,0.0011998533,0.00016006395],"about_ca_topic_score_codex":0.7546202,"about_ca_topic_score_gemma":0.42690438,"teacher_disagreement_score":0.32771584,"about_ca_system_score_codex":0.000984414,"about_ca_system_score_gemma":0.0015916881,"threshold_uncertainty_score":0.9166486},"labels":[],"label_agreement":null},{"id":"W2039662438","doi":"10.1016/j.jval.2013.03.1170","title":"Use Of Biologic Agents In The Treatment Of Rheumatoid Arthritis: An Analysis Of The Quebec Provincial Drug Reimbursement Program Database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Adalimumab; Golimumab; Etanercept; Infliximab; Ustekinumab; Tocilizumab; Abatacept; Concomitant; Rheumatoid arthritis; Psoriatic arthritis; Internal medicine; Psoriasis; Rituximab; Reimbursement; Physical therapy; Dermatology; Health care; Tumor necrosis factor alpha","score_opus":0.080934973597592,"score_gpt":0.3508776962823573,"score_spread":0.2699427226847653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039662438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99138296,0.004543184,0.0000030644262,0.000925781,0.000034931152,0.0029908344,0.00009959832,0.00000984754,0.000009795238],"genre_scores_gemma":[0.9479353,0.05117173,0.0004156458,0.00007346498,0.00000848932,0.00028363912,0.00009099344,0.000007878228,0.000012879785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972851,0.0009072231,0.0008171775,0.00022312529,0.0004411883,0.00032618272],"domain_scores_gemma":[0.9986658,0.00018236706,0.00030267943,0.0006628426,0.00009188648,0.00009442341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083380175,0.00013043523,0.00059769134,0.000328493,0.000047153968,0.000014628796,0.00019132007,0.000037373346,0.000059563856],"category_scores_gemma":[0.00013285557,0.0000690529,0.00014682034,0.00083085796,0.00023409711,0.00012177403,0.000030899828,0.000111767244,0.0000013903343],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020861713,0.0064292806,0.7945814,0.0001663514,0.00028631013,0.00000841986,0.008923102,0.0005306497,0.00036801017,0.00079380814,0.00014289145,0.18756114],"study_design_scores_gemma":[0.0027139944,0.0035014087,0.97816265,0.0011238031,0.00001367634,0.000005199932,0.0025821815,0.00855624,0.0009882692,0.00012912844,0.002119733,0.00010369463],"about_ca_topic_score_codex":0.49490747,"about_ca_topic_score_gemma":0.12561639,"teacher_disagreement_score":0.3692911,"about_ca_system_score_codex":0.00015342273,"about_ca_system_score_gemma":0.00043726523,"threshold_uncertainty_score":0.89033884},"labels":[],"label_agreement":null},{"id":"W2039766872","doi":"10.1016/j.jval.2014.03.1589","title":"Assessment Of Real-Life Predictive Power Of A New Cost-Effectiveness Model In Hiv: Antiretroviral Analysis By Monte Carlo Individual Simulation (ARAMIS-DTG)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Observational study; Cohort; Incidence (geometry); Cohort study; Population; Human immunodeficiency virus (HIV); Demography; Internal medicine; Immunology; Environmental health","score_opus":0.06561090207368656,"score_gpt":0.41923851700285714,"score_spread":0.3536276149291706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039766872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90770304,0.00017014013,0.08980091,0.00017814102,0.000017445109,0.0011482047,0.00029592143,0.000014189421,0.0006719959],"genre_scores_gemma":[0.99855363,0.000089612695,0.0008740876,0.00003763713,0.000017583685,0.000043145385,0.000104772014,0.000016234548,0.0002633143],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969243,0.0008697608,0.00083855074,0.0003156062,0.0006914108,0.0003603801],"domain_scores_gemma":[0.9985105,0.00040311393,0.00029205406,0.00032728552,0.00016600182,0.00030104964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002229877,0.00014235561,0.0007746116,0.00086934725,0.00003006296,0.000008126893,0.00012567102,0.00010583981,0.000036305704],"category_scores_gemma":[0.0006292708,0.00013411527,0.00020657523,0.0011314816,0.00007019063,0.00013348558,0.000048826674,0.00033001797,0.0000011443811],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022759908,0.0004771173,0.4142531,0.00032533347,0.00019062801,0.0000010173468,0.0008798058,0.5815864,0.0001400729,0.0002915527,0.00029866054,0.0013287141],"study_design_scores_gemma":[0.0016335923,0.0026218726,0.3881267,0.0003504136,0.00005983982,1.7723363e-7,0.00014112853,0.606922,0.00004306358,0.000043512046,0.000009357538,0.000048399168],"about_ca_topic_score_codex":0.025322055,"about_ca_topic_score_gemma":0.0002680734,"teacher_disagreement_score":0.09085056,"about_ca_system_score_codex":0.0004244012,"about_ca_system_score_gemma":0.0009146186,"threshold_uncertainty_score":0.9811684},"labels":[],"label_agreement":null},{"id":"W2039799345","doi":"10.1016/j.jval.2014.03.1178","title":"Survival crossover adjustment and cost effectiveness analysis: An empirical and methodological review with application","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); McMaster University","funders":"","keywords":"Crossover; Crossover study; Weighting; Ranking (information retrieval); Meta-analysis; Medicine; Statistics; Inverse probability weighting; Survival analysis; MEDLINE; Study heterogeneity; Placebo; Internal medicine; Computer science; Mathematics; Propensity score matching; Alternative medicine; Artificial intelligence; Pathology","score_opus":0.578580919710754,"score_gpt":0.5312975249278556,"score_spread":0.047283394782898336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2039799345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6861617,0.046057727,0.22976111,0.032820284,0.00021673659,0.0043502282,0.00012826397,0.000076598,0.00042737758],"genre_scores_gemma":[0.94566745,0.009369749,0.018950354,0.024871174,0.00023191186,0.00072703016,0.000118715936,0.000038654707,0.0000249783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99257696,0.004228238,0.0020318183,0.0007401032,0.00009186024,0.00033101146],"domain_scores_gemma":[0.99520946,0.0030199876,0.0010368979,0.0004165638,0.000036603487,0.00028048432],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05100311,0.00016805867,0.001468562,0.0002359605,0.00012671674,0.00003715163,0.00010556089,0.00010176733,0.000021197135],"category_scores_gemma":[0.0017889923,0.00016476557,0.000047543897,0.00043639477,0.00009022779,0.00020054624,0.00003606606,0.0001715047,0.00003656565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009790133,0.00022716491,0.88558674,0.0061029345,0.00014668108,5.6851144e-7,0.0007444734,0.004979721,5.899241e-7,0.09715435,0.0002856022,0.0046732686],"study_design_scores_gemma":[0.0009740916,0.0003349851,0.92017466,0.0003489044,0.000033567772,0.000006178923,0.000085349166,0.0615291,3.2172173e-7,0.0057723597,0.010506504,0.00023397936],"about_ca_topic_score_codex":0.004231615,"about_ca_topic_score_gemma":0.00035931927,"teacher_disagreement_score":0.25950575,"about_ca_system_score_codex":0.00036607293,"about_ca_system_score_gemma":0.000090818845,"threshold_uncertainty_score":0.977192},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2040123860","doi":"10.1016/j.jval.2014.03.385","title":"Reimbursement Based Economics: An Application To Triptans For Migraine Therapy","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"","keywords":"Triptans; Reimbursement; Migraine; Health economics; Activity-based costing; Business; Public economics; Medicine; Actuarial science; Health care; Economics; Marketing; Psychiatry; Economic growth","score_opus":0.405138943961024,"score_gpt":0.4416399727600366,"score_spread":0.03650102879901257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040123860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38551304,0.001106216,0.3545529,0.24942784,0.0009562711,0.006970884,0.00049980776,0.00013156068,0.00084149005],"genre_scores_gemma":[0.83933914,0.0002558121,0.045203313,0.11169873,0.0008946277,0.0020974446,0.00021347536,0.000093998584,0.0002034497],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944427,0.00049162144,0.003680149,0.00077432254,0.000052881565,0.00055832014],"domain_scores_gemma":[0.99651104,0.0008938381,0.001397145,0.00078215846,0.000044748762,0.00037106615],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.027585508,0.00019794307,0.00088080677,0.00050179736,0.00017047772,0.00005307585,0.00032381547,0.00011431964,0.000059083377],"category_scores_gemma":[0.0010642649,0.0002644472,0.00010418927,0.00020250416,0.000022959897,0.00021585409,0.000014303378,0.00010854778,0.00032747624],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021941058,0.00076057424,0.03327294,0.00091145496,0.000040577066,9.011183e-8,0.004438349,0.16391435,0.000011391519,0.751155,0.018703721,0.026572106],"study_design_scores_gemma":[0.001929854,0.0006963817,0.010336974,0.000053778353,9.043927e-7,3.7907563e-7,0.00021684203,0.43778017,0.000010553382,0.029629055,0.5190501,0.00029501808],"about_ca_topic_score_codex":0.007893622,"about_ca_topic_score_gemma":0.0007747871,"teacher_disagreement_score":0.72152597,"about_ca_system_score_codex":0.0011470971,"about_ca_system_score_gemma":0.0002951284,"threshold_uncertainty_score":0.99998075},"labels":[],"label_agreement":null},{"id":"W2040162225","doi":"10.1016/j.jval.2014.08.2668","title":"Parents’ Willingness to Pay for Biologic Treatments in Juvenile Idiopathic Arthritis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; SickKids Foundation; University of Toronto; Institute for Clinical Evaluative Sciences; Public Health Ontario; Hospital for Sick Children","funders":"Hospital for Sick Children","keywords":"Willingness to pay; Medicine; Confidence interval; Arthritis; Logistic regression; Physical therapy; Mixed logit; Internal medicine; Economics","score_opus":0.0550804887820391,"score_gpt":0.342290654409629,"score_spread":0.28721016562758994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040162225","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990181,0.0029536514,0.0005527971,0.004277304,0.00016410943,0.001653816,0.00000994217,0.000037786205,0.00016959281],"genre_scores_gemma":[0.99700487,0.0010338925,0.00040189127,0.00088251324,0.00006521019,0.00034966215,0.000030406392,0.000020382298,0.00021119452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980969,0.00024242979,0.00064963696,0.00030540396,0.0001706333,0.00053502683],"domain_scores_gemma":[0.9993456,0.000103311184,0.00008683826,0.00026581532,0.000040558753,0.0001578922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016141137,0.00012876306,0.00057071936,0.00020473135,0.000071138216,0.0000089673895,0.000096933,0.000094658615,0.000017410031],"category_scores_gemma":[0.00048951467,0.00009614482,0.00005772006,0.0003171835,0.000022345006,0.000043084096,0.000030470452,0.00019605624,0.000058134337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004124613,0.00064451894,0.71286166,0.00088936096,0.000015562344,0.000025028394,0.0016629159,0.0010737162,0.00036648818,0.00065329537,0.00037904247,0.28101593],"study_design_scores_gemma":[0.019011986,0.010387144,0.8470796,0.005493406,0.000011682006,0.000031422544,0.0011551897,0.01986218,0.0008465766,0.0052736863,0.09026401,0.0005831523],"about_ca_topic_score_codex":0.0022644883,"about_ca_topic_score_gemma":0.00016273872,"teacher_disagreement_score":0.28043276,"about_ca_system_score_codex":0.00027358765,"about_ca_system_score_gemma":0.0003840251,"threshold_uncertainty_score":0.39206716},"labels":[],"label_agreement":null},{"id":"W2040419430","doi":"10.1016/s1098-3015(10)63173-7","title":"CV3 COST-EFFECTIVENESSS OF INTENSIVE STATIN THERAPY COMPARED TO MODERATE STATIN THERAPY IN PATIENTS WITH ACUTE CORONARY SYNDROME: ANALYSIS FROM CANADA, GERMANY AND THE UK","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acute coronary syndrome; Medicine; Statin; Internal medicine; Cardiology; Physical therapy; Myocardial infarction","score_opus":0.01443540087236686,"score_gpt":0.25798223398127923,"score_spread":0.24354683310891237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2040419430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918089,0.0017997595,0.00043683578,0.001380262,0.00004981674,0.004176671,0.0003309155,0.000009261093,0.0000075737335],"genre_scores_gemma":[0.99563414,0.00053706375,0.00042307022,0.0029414357,0.000016223972,0.0002082596,0.00020572025,0.000026383485,0.0000077333725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99706006,0.00088519324,0.0006333834,0.00039738658,0.00063080265,0.00039314994],"domain_scores_gemma":[0.99840134,0.00035702222,0.0002430715,0.00046883913,0.00036891986,0.0001608289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009207345,0.00022854428,0.0012121312,0.00023746707,0.000080952195,0.000012827862,0.00009562297,0.000050187053,0.000014634654],"category_scores_gemma":[0.0000329197,0.00014489381,0.000088730754,0.00083271053,0.00008964368,0.00004029483,0.00002489862,0.0002516946,3.8485985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010670838,0.00026984385,0.94941837,0.000095701354,0.0013845739,0.00012605145,0.002375221,0.02659316,0.000013330854,0.000046057135,0.00012866843,0.008878178],"study_design_scores_gemma":[0.014567414,0.0008206758,0.9792339,0.00019568641,0.00007979475,0.0000075418116,0.00036698644,0.0044022617,0.000059905764,0.00009127408,0.000038622074,0.00013591096],"about_ca_topic_score_codex":0.9565663,"about_ca_topic_score_gemma":0.364183,"teacher_disagreement_score":0.59238327,"about_ca_system_score_codex":0.00047627705,"about_ca_system_score_gemma":0.0011093533,"threshold_uncertainty_score":0.64741904},"labels":[],"label_agreement":null},{"id":"W2041764633","doi":"10.1016/s1098-3015(10)74033-x","title":"PND26 UTILITIES FOR MODERATE ALZHEIMER'S DISEASE: RESULTS FROM A SURVEY OF THE GENERAL PUBLIC IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Porphyrin Metabolism and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Gerontology; Medicine; Geography; Pathology","score_opus":0.05602174317592969,"score_gpt":0.28365728067656093,"score_spread":0.22763553750063123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041764633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862256,0.009744833,0.00003441606,0.0018456632,0.00015368333,0.00029537722,0.0016425243,0.0000017851265,0.00005611728],"genre_scores_gemma":[0.9978842,0.00041124475,0.00015609087,0.0010397647,0.00003982469,0.000012342737,0.0004253357,0.0000065767126,0.000024588096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998711,0.00030457205,0.000358033,0.0002367534,0.000113151786,0.00027649486],"domain_scores_gemma":[0.99936044,0.000047807913,0.00013823781,0.00031741828,0.000043371627,0.00009274379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050584093,0.000093033115,0.00016759233,0.000026843996,0.000038022717,0.0000074445697,0.00018711259,0.000038616,0.00000136891],"category_scores_gemma":[0.00040738174,0.00007597285,0.000034835703,0.000117883,0.0000256473,0.0000032481798,0.00002836721,0.000054685428,7.8678696e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006699888,0.0008026325,0.8079637,0.00017272198,0.00014303098,0.0000070358046,0.00089502125,0.11302569,0.0030841914,0.0039047431,0.028737495,0.034563847],"study_design_scores_gemma":[0.0011748766,0.0000402931,0.9867531,0.000018001792,0.000003393477,1.2769094e-7,0.000045131103,0.0076546283,0.0008194283,0.0012129525,0.0021760494,0.000102020895],"about_ca_topic_score_codex":0.95154655,"about_ca_topic_score_gemma":0.87470114,"teacher_disagreement_score":0.17878939,"about_ca_system_score_codex":0.000034584216,"about_ca_system_score_gemma":0.0030252854,"threshold_uncertainty_score":0.53667265},"labels":[],"label_agreement":null},{"id":"W2041778976","doi":"10.1016/j.jval.2012.08.813","title":"PMH23 A Cost-Effectiveness Analysis of the Long-Acting Antispychotic Drugs Paliperidone Palmitate, Olanzapine Pamoate and Risperidone in the Treatment of Schizophrenia in Finland","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thornhill Medical (Canada); University of Toronto","funders":"","keywords":"Paliperidone Palmitate; Risperidone; Medicine; Paliperidone; Olanzapine; Schizophrenia (object-oriented programming); Emergency medicine; Pediatrics; Psychiatry","score_opus":0.11804106600118082,"score_gpt":0.41254212276617264,"score_spread":0.29450105676499183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2041778976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98457634,0.012413642,0.000009646425,0.0016791623,0.00009198743,0.0011107454,0.000018898932,0.0000031547108,0.000096403965],"genre_scores_gemma":[0.988184,0.011504152,0.000056456825,0.00014742873,0.000038368427,0.0000506527,0.0000048519078,0.000008582427,0.0000055448877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997679,0.0010402378,0.0005167714,0.00018546105,0.00022029261,0.00035822732],"domain_scores_gemma":[0.9977091,0.0017011224,0.00024854782,0.0002334363,0.00002491499,0.000082912615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020032008,0.00014844773,0.0007072356,0.0001996499,0.00005772654,0.00000660012,0.00007189363,0.000045888723,0.000015337606],"category_scores_gemma":[0.0001795702,0.000080914,0.00008879323,0.0013731043,0.00009844038,0.00007553988,0.000028417173,0.00021072291,8.758412e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010678977,0.0009137851,0.97053194,0.00045493018,0.00024114257,0.0000068915783,0.008455461,0.0006378949,0.00018101998,0.00003612665,0.0000017150123,0.017471217],"study_design_scores_gemma":[0.0040287254,0.00035937593,0.98902696,0.00035117718,0.00026331158,0.000007525871,0.0008260657,0.0041694306,0.00029169078,0.000015145518,0.00059037894,0.00007023614],"about_ca_topic_score_codex":0.010770037,"about_ca_topic_score_gemma":0.0007654111,"teacher_disagreement_score":0.018495018,"about_ca_system_score_codex":0.00015364407,"about_ca_system_score_gemma":0.000052134135,"threshold_uncertainty_score":0.9958173},"labels":[],"label_agreement":null},{"id":"W2042085280","doi":"10.1016/j.jval.2013.03.1631","title":"Impact of Interventions on Medication Adherence and Blood Pressure Control in Patients with Essential Hypertension: A Systematic Review by the ISPOR Medication Adherence and Persistence Special Interest Group","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":156,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care; Lawson Health Research Institute; Centre for Advancing Health Outcomes; Western University","funders":"","keywords":"Medicine; Psychological intervention; Medication adherence; MEDLINE; Randomized controlled trial; Clinical trial; Intensive care medicine; Blood pressure; Intervention (counseling); Alternative medicine; Narrative review; Family medicine; Physical therapy; Internal medicine; Nursing","score_opus":0.11344278995458666,"score_gpt":0.36572879870923475,"score_spread":0.2522860087546481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042085280","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001923605,0.9892541,0.000048300964,0.000535525,0.00012597464,0.008011611,0.000064301654,0.0000115950215,0.00002496387],"genre_scores_gemma":[0.040649325,0.9577034,0.000047347265,0.0003033927,0.00008146622,0.00094605586,0.00016347165,0.000022073706,0.00008343384],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99589723,0.0009275197,0.0017777397,0.0005429447,0.0005871531,0.0002674186],"domain_scores_gemma":[0.9965529,0.0004840033,0.0018930689,0.0006524521,0.00017759303,0.00024000402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012855454,0.00035254826,0.0022122478,0.00018695433,0.00006188471,0.000018485181,0.00030651502,0.00016811662,0.00020669245],"category_scores_gemma":[0.00078709563,0.00019468155,0.0001891942,0.00041792786,0.0002562646,0.00010031116,0.0000433327,0.00058718014,0.000022769696],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006919446,0.0008939084,0.0018360042,0.94622904,0.00034963703,0.0000035476048,0.00018478499,3.7971225e-7,4.1784708e-7,0.000101749014,0.0025310696,0.04780028],"study_design_scores_gemma":[0.0021618453,0.0025004,0.007240899,0.98408693,0.0023295414,0.0000702612,0.0000671634,0.00017371665,6.413381e-8,0.000012253602,0.0011622817,0.0001946434],"about_ca_topic_score_codex":0.00070587767,"about_ca_topic_score_gemma":0.00003185913,"teacher_disagreement_score":0.047605637,"about_ca_system_score_codex":0.00009928915,"about_ca_system_score_gemma":0.00054939697,"threshold_uncertainty_score":0.79388833},"labels":[],"label_agreement":null},{"id":"W2042180137","doi":"10.1016/s1098-3015(11)72413-5","title":"PCV70 COST SAVINGS OF ENOXAPARIN OVER UFH IN MEDICAL PATIENTS IN CANADIAN HOSPITAL SETTING","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Emergency medicine; Medical costs; Operations management; Business; Economics; Health care","score_opus":0.018170281145432798,"score_gpt":0.3092774166623963,"score_spread":0.2911071355169635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042180137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929524,0.000027737977,3.615826e-7,0.0041336613,0.000514634,0.00088543416,0.000018042849,0.00001266064,0.0014550404],"genre_scores_gemma":[0.9985024,0.000055162312,0.00020604051,0.0010616436,0.000073965944,0.000025502064,0.00003474219,0.00002854107,0.000012033348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99732673,0.00014680342,0.0008704968,0.00035183874,0.00046410653,0.0008400131],"domain_scores_gemma":[0.9984917,0.00017124103,0.00014661989,0.000312652,0.00004884591,0.00082891196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001573661,0.00016971535,0.00062498596,0.00057010143,0.00003942596,0.000008320511,0.00018304927,0.00029727846,0.00023941195],"category_scores_gemma":[0.0013064541,0.00016976513,0.000047366546,0.0005579979,0.00008090681,0.00009627133,0.000063423744,0.0011044812,0.000020987172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015962802,0.00038146117,0.9893839,0.0001668593,0.0000059903605,0.000050978306,0.0020321405,0.0000070731053,0.00015752646,0.0005691958,0.0001073104,0.0071216514],"study_design_scores_gemma":[0.0025924144,0.00024815372,0.993344,0.00073896686,0.000003646089,0.000005452458,0.00010727255,0.0011028822,0.00019119319,0.000097803415,0.0014295834,0.00013864547],"about_ca_topic_score_codex":0.9100675,"about_ca_topic_score_gemma":0.7911561,"teacher_disagreement_score":0.118911386,"about_ca_system_score_codex":0.00080202095,"about_ca_system_score_gemma":0.0030630752,"threshold_uncertainty_score":0.69228214},"labels":[],"label_agreement":null},{"id":"W2042215339","doi":"10.1016/s1098-3015(11)70806-3","title":"PMDH6: AN ECONOMIC EVALUATION OF PHARMACEUTICAL COST CONTAINMENT POLICIES IN ALBERTA, CANADA","year":2000,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Containment (computer programming); Business; Computer science","score_opus":0.13911449783376312,"score_gpt":0.3716451540720326,"score_spread":0.23253065623826946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042215339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97333914,0.000911743,0.0000023274179,0.00755756,0.00024359839,0.00064072286,0.0002453346,0.0000045927395,0.017055001],"genre_scores_gemma":[0.9952075,0.0010186916,0.000032062002,0.0034820673,0.000079679514,0.000052886495,0.000023692126,0.000018368359,0.00008506363],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976731,0.00014977144,0.0012564823,0.00035085686,0.00005890655,0.00051090773],"domain_scores_gemma":[0.9990922,0.00014913232,0.00023501086,0.0002576629,0.000011473387,0.00025447021],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002349377,0.00014748528,0.000498698,0.0002145421,0.00003862835,0.000019157509,0.00020766596,0.00006668456,0.002251083],"category_scores_gemma":[0.000049809296,0.00019205161,0.000043894644,0.00013331785,0.000048882313,0.00015442235,0.000020751178,0.00019244813,0.0001108432],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001491137,0.00048709317,0.18743296,0.00014571907,0.000042930977,0.0000025647048,0.0021350943,0.41216615,0.0000046036075,0.3578428,0.0012326563,0.038358323],"study_design_scores_gemma":[0.002907603,0.00010100058,0.08550211,0.00003851899,0.0000046407,0.0000034990724,0.00007750007,0.77581215,0.00008467656,0.01723193,0.1179238,0.00031258242],"about_ca_topic_score_codex":0.9652375,"about_ca_topic_score_gemma":0.75195116,"teacher_disagreement_score":0.363646,"about_ca_system_score_codex":0.0027429126,"about_ca_system_score_gemma":0.0010900338,"threshold_uncertainty_score":0.998661},"labels":[],"label_agreement":null},{"id":"W2042321639","doi":"10.1016/j.jval.2014.03.1629","title":"Determinants Of Quality Of Life In Newly Diagnosed Hiv Infected Patients In Kenya","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Quality of life (healthcare); Depression (economics); Anxiety; Internal medicine; Diarrhea; Appetite; Disease; Human immunodeficiency virus (HIV); Coping (psychology); Physical therapy; Psychiatry; Immunology","score_opus":0.060584411557581694,"score_gpt":0.3959434982699557,"score_spread":0.33535908671237397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042321639","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99859005,0.00009513436,0.000030394225,0.00029376082,0.000030044812,0.0005464435,0.000028797142,0.000006542247,0.00037885347],"genre_scores_gemma":[0.9994403,0.0001329761,0.00017484167,0.00009609953,0.000015350624,0.000019055065,0.000021808302,0.000009251844,0.00009028772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714345,0.0008926754,0.0011819525,0.00016451847,0.00030160253,0.00031581413],"domain_scores_gemma":[0.9987607,0.00045879214,0.00023893273,0.00025450485,0.00009651515,0.00019056059],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017340516,0.00008021962,0.00055013044,0.00047619722,0.000011270935,0.0000020813095,0.00009168583,0.00006677986,0.000053448763],"category_scores_gemma":[0.0064341533,0.00007374505,0.000068492074,0.0005179842,0.00005578747,0.00005570086,0.000039002203,0.0002315265,0.000010005104],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015535056,0.0011770381,0.9874354,0.001117912,0.0000028123268,0.0000020918546,0.0006408914,0.000045326826,0.000055009437,0.00007877391,0.00039781514,0.008891582],"study_design_scores_gemma":[0.0049233665,0.0018860213,0.9848474,0.001520616,0.0000010500692,1.8511865e-7,0.00006539841,0.006382482,0.00012858323,0.00011232902,0.000084409025,0.000048106474],"about_ca_topic_score_codex":0.05698426,"about_ca_topic_score_gemma":0.010398986,"teacher_disagreement_score":0.046585277,"about_ca_system_score_codex":0.00013632711,"about_ca_system_score_gemma":0.00035171938,"threshold_uncertainty_score":0.94929534},"labels":[],"label_agreement":null},{"id":"W2042503957","doi":"10.1016/s1098-3015(10)75091-9","title":"PIN33 POTENTIAL HEALTH AND ECONOMIC IMPACT OF NEW PNEUMOCOCCAL VACCINES IN CANADA: A MARKOV MODELLING APPROACH","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Markov chain; Markov model; Pneumococcal disease; Medicine; Virology; Computer science; Streptococcus pneumoniae; Biology; Machine learning; Microbiology","score_opus":0.034273044790419614,"score_gpt":0.29680151148760725,"score_spread":0.26252846669718766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042503957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939809,0.0011090597,0.00049414433,0.0036874386,0.00009493936,0.0004981186,0.000010162539,0.000011976753,0.00011325048],"genre_scores_gemma":[0.99808365,0.0007139618,0.00034315645,0.0007122298,0.00010938025,0.0000037259258,0.000008010585,0.0000112333555,0.0000146406555],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99852943,0.00011598745,0.0006174588,0.00024335776,0.000099031095,0.0003947245],"domain_scores_gemma":[0.99917716,0.000028582353,0.00015849811,0.00017108995,0.000012347336,0.0004523484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034011476,0.00013859378,0.0005274378,0.00025276933,0.000048829912,0.000005505157,0.000048357375,0.000054876313,0.0000070092],"category_scores_gemma":[0.000013255058,0.000120540324,0.000060493898,0.00017859925,0.000011027371,0.000053075066,0.000011208952,0.0002614192,5.486867e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015787383,0.00017256827,0.19146913,0.00038111059,0.00002273558,0.000016168555,0.00065844326,0.79797095,0.00028640375,0.00016604434,0.0003608182,0.0083377585],"study_design_scores_gemma":[0.0021104873,0.0011726841,0.5168302,0.00028735423,0.000006504642,0.00017625977,0.00018183135,0.4786162,0.0000067873543,0.00035495491,0.00011661894,0.00014011655],"about_ca_topic_score_codex":0.9566116,"about_ca_topic_score_gemma":0.21827278,"teacher_disagreement_score":0.7383388,"about_ca_system_score_codex":0.0022211003,"about_ca_system_score_gemma":0.01587052,"threshold_uncertainty_score":0.9897086},"labels":[],"label_agreement":null},{"id":"W2042746249","doi":"10.1016/s1098-3015(10)64509-3","title":"PMH8 COST-EFFECTIVENESS OF VENLAFAXINE: A CANADIAN PERSPECTIVE","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venlafaxine; Perspective (graphical); Medicine; Psychiatry; Computer science; Artificial intelligence; Anxiety","score_opus":0.09630133463843947,"score_gpt":0.3330484847993053,"score_spread":0.23674715016086584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042746249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8286979,0.008467525,0.0002267078,0.008224624,0.00071782246,0.0014100375,0.0011028637,0.000027165115,0.15112536],"genre_scores_gemma":[0.99890107,0.00020419083,0.00010268338,0.00060146285,0.0000861477,0.00003309522,0.00001102486,0.000017221368,0.00004309696],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.998654,0.00006845314,0.00056068733,0.00027262224,0.000017180404,0.0004270321],"domain_scores_gemma":[0.9992691,0.00014242527,0.00019277171,0.00018284665,0.000023444903,0.00018938686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012403647,0.00010390344,0.00040459214,0.0004175432,0.00004945328,0.0000144436335,0.00014191057,0.00006759906,0.00009993872],"category_scores_gemma":[0.00008345419,0.00013527091,0.000068743306,0.00029102506,0.00004924721,0.00007292544,0.000017664364,0.00015947153,0.00013108764],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016205993,0.00006725391,0.04122269,0.00009201968,0.0000084963185,0.0000024516594,0.0001687945,0.0069534103,0.0000044543895,0.9510577,0.00027906374,0.0001275056],"study_design_scores_gemma":[0.0015912874,0.00013967826,0.29461336,0.000112230875,0.0000019637698,0.00000592807,0.000086140266,0.021732606,0.00014100946,0.60270554,0.078527585,0.00034267438],"about_ca_topic_score_codex":0.8729861,"about_ca_topic_score_gemma":0.041086685,"teacher_disagreement_score":0.83189934,"about_ca_system_score_codex":0.0014466131,"about_ca_system_score_gemma":0.0003574353,"threshold_uncertainty_score":0.976411},"labels":[],"label_agreement":null},{"id":"W2042960958","doi":"10.1016/j.jval.2012.09.005","title":"Cost-Effectiveness of Gene-Expression Profiling for Tumor-Site Origin","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Medicine; Medicaid; Confidence interval; Regimen; Internal medicine; Observational study; Chemotherapy; Medical diagnosis; Chemotherapy regimen; Oncology; Emergency medicine; Health care; Pathology","score_opus":0.10286865395309963,"score_gpt":0.38247872336414457,"score_spread":0.27961006941104494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2042960958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98290634,0.00034118307,0.008772992,0.00039502725,0.000153665,0.0071548778,0.000027294169,0.0000329935,0.0002156239],"genre_scores_gemma":[0.936238,0.000023679844,0.062145557,0.0004265241,0.000049775987,0.00091272336,0.00007721281,0.000028904607,0.00009764992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851096,0.00028319834,0.00042558362,0.00024659865,0.0002463516,0.00028730664],"domain_scores_gemma":[0.9989455,0.00033440563,0.00017297508,0.00028041768,0.00009585717,0.00017084478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014874651,0.00011080916,0.00037936508,0.00016428805,0.00003172843,0.0000067414967,0.000065061744,0.000025044197,0.0000578406],"category_scores_gemma":[0.00030916164,0.00009495166,0.00006334529,0.00016996883,0.000025239528,0.00007501725,0.00002329478,0.000090058325,0.000024395269],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036185787,0.003114426,0.7311305,0.08553807,0.00014705406,0.00006416667,0.0015585661,0.0103302635,0.13310993,0.00839883,0.00406669,0.018922932],"study_design_scores_gemma":[0.0299808,0.003322848,0.54723513,0.012836687,0.00021676646,0.000024800507,0.001333597,0.18279348,0.20792408,0.0074419016,0.0060652206,0.00082468207],"about_ca_topic_score_codex":0.0009168118,"about_ca_topic_score_gemma":0.0000011183106,"teacher_disagreement_score":0.18389536,"about_ca_system_score_codex":0.00013588129,"about_ca_system_score_gemma":0.00023087978,"threshold_uncertainty_score":0.38720164},"labels":[],"label_agreement":null},{"id":"W2043068352","doi":"10.1111/j.1524-4733.2010.00747.x","title":"Conditionally Funded Field Evaluations: PATHs Coverage with Evidence Development Program for Ontario","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Evaluation and Performance Assessment","field":"Decision Sciences","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Field (mathematics); Data science; Computer science; Mathematics","score_opus":0.34842160670139555,"score_gpt":0.5381083385528902,"score_spread":0.18968673185149465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043068352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97512865,0.00006492715,0.010704194,0.00881839,0.0006602845,0.0029348542,0.00000931538,0.000049179154,0.0016301872],"genre_scores_gemma":[0.92396253,0.000015344993,0.07163932,0.0022378569,0.000059134585,0.0008961983,0.000028954459,0.000008383986,0.0011522877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963334,0.0002147348,0.0009839463,0.00042923223,0.0017131163,0.00032555853],"domain_scores_gemma":[0.99553746,0.0029824341,0.00036944737,0.00039320756,0.00056927133,0.00014820052],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010772634,0.00013138702,0.00023264159,0.00022058382,0.00029527498,0.00018847057,0.0003550909,0.00007092844,0.0021182832],"category_scores_gemma":[0.002044435,0.00009557,0.00004243393,0.00041667582,0.000038147427,0.0004412933,0.000035209167,0.00029652353,0.000098074655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031115056,0.0007011216,0.47577655,0.0001022514,0.000023709672,0.000002921974,0.007921266,0.019759588,0.000069350055,0.017819902,0.0055880323,0.47192416],"study_design_scores_gemma":[0.0016683406,0.0015865468,0.82163817,0.00032989742,0.0000061564983,0.000008792685,0.00026581637,0.022472907,0.00023578605,0.029065434,0.12243057,0.000291587],"about_ca_topic_score_codex":0.0060016755,"about_ca_topic_score_gemma":0.13695493,"teacher_disagreement_score":0.47163257,"about_ca_system_score_codex":0.0003429317,"about_ca_system_score_gemma":0.0075503094,"threshold_uncertainty_score":0.9987939},"labels":[],"label_agreement":null},{"id":"W2043105813","doi":"10.1111/j.1524-4733.2009.00565.x","title":"Why Do Patients with Inflammatory Arthritis Often Score States “Worse than Death” on the EQ-5D? An Investigation of the EQ-5D Classification System","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital","funders":"Versus Arthritis","keywords":"EQ-5D; Medicine; Arthritis; Quality of life (healthcare); Feeling; Physical therapy; Internal medicine; Health related quality of life; Disease; Psychology","score_opus":0.3782288335853667,"score_gpt":0.3338093192686601,"score_spread":0.0444195143167066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043105813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9626836,0.0005684835,0.00009547414,0.033900093,0.00031289246,0.0019359891,0.00021440642,0.000046175082,0.00024287707],"genre_scores_gemma":[0.9867862,0.00010920988,0.00029660278,0.012452686,0.00012891366,0.000108724336,0.0000673457,0.000030244864,0.0000200617],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939714,0.001489684,0.0033338855,0.000532813,0.0002469436,0.00042527847],"domain_scores_gemma":[0.9948093,0.0007002083,0.0032166042,0.00095442915,0.0001254252,0.000194022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011457408,0.00022644727,0.0006854826,0.00030483134,0.00032788076,0.00007603445,0.00041599263,0.00013619146,0.000022484757],"category_scores_gemma":[0.0006249464,0.00018326195,0.00007184805,0.00039851526,0.000113152004,0.00043450366,0.000025278847,0.00029476592,0.000071837916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036590263,0.00010744295,0.7833746,0.00048042767,0.000014955357,2.0494225e-7,0.004808927,0.0031544685,0.0000013612927,0.20569356,0.0020219488,0.00030551836],"study_design_scores_gemma":[0.0008314369,0.00044380614,0.97157055,0.0014315472,0.0000028504664,0.0000013437187,0.0018417102,0.011142348,0.000009933702,0.011307526,0.0012008122,0.00021616228],"about_ca_topic_score_codex":0.0029392382,"about_ca_topic_score_gemma":0.00061622175,"teacher_disagreement_score":0.19438602,"about_ca_system_score_codex":0.0010380407,"about_ca_system_score_gemma":0.0004123774,"threshold_uncertainty_score":0.74732053},"labels":[],"label_agreement":null},{"id":"W2043111603","doi":"10.1016/j.jval.2012.03.993","title":"PDB72 The Impact on Utilities of Weight Loss and Weight Gain Among Canadian Patients With Type 2 Diabetes","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Weight loss; Type 2 diabetes; Weight gain; Medicine; Weight change; Body mass index; Psychosocial; Obesity; Diabetes mellitus; Demography; Body weight; Gerontology; Internal medicine; Endocrinology; Psychiatry","score_opus":0.014891815029242444,"score_gpt":0.25271789705141107,"score_spread":0.23782608202216862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043111603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99507415,0.0012512088,1.673145e-7,0.0006933869,0.00011361856,0.00060420076,0.000018527777,0.000008913511,0.002235802],"genre_scores_gemma":[0.9990915,0.00017131516,0.00003360794,0.00038443308,0.000049008577,0.000013666892,0.000032798227,0.00001455771,0.0002090959],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990153,0.00008400289,0.00017152813,0.00011356993,0.00016039687,0.00045522835],"domain_scores_gemma":[0.99931663,0.00010019252,0.000070536975,0.00020857375,0.000030021334,0.00027407127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033546684,0.00012529836,0.00023379871,0.00015316678,0.000053953765,0.0000062377185,0.000045015164,0.00003132721,0.000048282942],"category_scores_gemma":[0.000024787798,0.0000653042,0.000024034991,0.00016750551,0.00008773093,0.000068061076,0.0000140414695,0.00008692392,0.000006102853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045808432,0.00016405147,0.9948152,0.00012875519,0.00006538813,0.0000010874488,0.00080293504,0.000022488395,2.3363447e-7,0.000462144,0.00091949984,0.002572425],"study_design_scores_gemma":[0.00084960536,0.0009775327,0.9958471,0.00026895397,0.00002574824,1.2749446e-7,0.00008105473,0.00019821174,0.00004198766,0.00007003721,0.001578738,0.00006087554],"about_ca_topic_score_codex":0.07567701,"about_ca_topic_score_gemma":0.003508459,"teacher_disagreement_score":0.072168544,"about_ca_system_score_codex":0.0002351108,"about_ca_system_score_gemma":0.0001408877,"threshold_uncertainty_score":0.93047816},"labels":[],"label_agreement":null},{"id":"W2043167021","doi":"10.1016/j.jval.2013.08.2140","title":"Comparative Efficacy of Blood Pressure Lowering Drugs in Primary Prevention for Elderly Patients","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Université du Québec à Trois-Rivières; Université de Sherbrooke","funders":"","keywords":"Medicine; Internal medicine; Comorbidity; Odds ratio; Diabetes mellitus; Cohort; Blood pressure; Logistic regression; Disease; Medical prescription; Population","score_opus":0.05176733157603818,"score_gpt":0.3213225125935554,"score_spread":0.2695551810175172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043167021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98704183,0.009592077,0.000013034097,0.0006290058,0.00009666682,0.0022059504,0.0000073204105,0.00001551809,0.00039857908],"genre_scores_gemma":[0.99810505,0.00014044016,0.0010874995,0.00033016663,0.000038047474,0.0001017346,0.00001856032,0.000010294984,0.00016822624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988313,0.00007960968,0.00049944385,0.00019717992,0.00017371155,0.00021878199],"domain_scores_gemma":[0.99925137,0.00023988711,0.00015999937,0.00015319034,0.00013538719,0.000060174847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002743808,0.00010101722,0.00061535137,0.00012497888,0.00003295356,0.000004022723,0.000046799905,0.00005649301,0.000012061456],"category_scores_gemma":[0.000050926697,0.00008674121,0.000057343957,0.00013839098,0.000027049415,0.00007250628,0.000030875723,0.00013360975,0.0000035081177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030362664,0.024743566,0.73866194,0.024681505,0.0030068927,0.00000956733,0.07151652,0.0026439335,0.004538164,0.00054276467,0.026426382,0.1001925],"study_design_scores_gemma":[0.012117703,0.0026061598,0.97733086,0.0020486042,0.0004213703,0.000002057441,0.0004300371,0.0005910372,0.0012257985,0.00029281175,0.0027771725,0.00015639047],"about_ca_topic_score_codex":0.0012403396,"about_ca_topic_score_gemma":0.000017626542,"teacher_disagreement_score":0.23866892,"about_ca_system_score_codex":0.000011181256,"about_ca_system_score_gemma":0.00011017089,"threshold_uncertainty_score":0.35372037},"labels":[],"label_agreement":null},{"id":"W2043172649","doi":"10.1016/j.jval.2011.08.1460","title":"PRS73 Systematic Review of the Guidelines on the Prevention of Allergic Manifestations in Children","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Infant Health and Development","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PharmIdeas (Canada)","funders":"","keywords":"Context (archaeology); Medicine; MEDLINE; Breastfeeding; Family medicine; Systematic review; Atopic dermatitis; Medical literature; Pediatrics; Pathology; Dermatology; Political science","score_opus":0.22239571024502794,"score_gpt":0.444569469168676,"score_spread":0.22217375892364807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043172649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87350374,0.038618416,0.00010132443,0.034476943,0.0013067572,0.04001299,0.00007577217,0.000057284156,0.011846786],"genre_scores_gemma":[0.9236115,0.04163578,0.0033513727,0.028406482,0.00009305654,0.001913682,0.00002793751,0.00004590348,0.00091428065],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9941125,0.0026140995,0.00249248,0.0001456008,0.00031495016,0.0003203732],"domain_scores_gemma":[0.99759,0.00045424484,0.001235979,0.00048749257,0.00017874906,0.000053517368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006764942,0.00010532682,0.00045867148,0.00011355045,0.00018496985,6.48855e-7,0.0002715583,0.000068879446,0.00009858249],"category_scores_gemma":[0.0014078867,0.00005578456,0.00006301173,0.0004221265,0.000027794185,0.00003134209,0.000054487908,0.00035054242,0.000027215385],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041043433,0.00030063486,0.094927154,0.82574093,0.00002953804,7.957321e-7,0.014003401,0.00008847284,0.0000015188726,0.060058117,0.0046588653,0.00014955379],"study_design_scores_gemma":[0.00053161365,0.00014389082,0.3301634,0.6634446,0.000019209854,0.00000484577,0.0012212924,0.0002260251,0.0000100363195,0.004041037,0.00009175055,0.000102335245],"about_ca_topic_score_codex":0.005396318,"about_ca_topic_score_gemma":0.0003366157,"teacher_disagreement_score":0.23523623,"about_ca_system_score_codex":0.0001745052,"about_ca_system_score_gemma":0.0014858254,"threshold_uncertainty_score":0.8157655},"labels":[],"label_agreement":null},{"id":"W2043188252","doi":"10.1016/j.jval.2014.03.453","title":"Cost Comparison of Different Forms of Androgen Ablative Therapies in Metastatic Castration-Resistant Prostate Cancer in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Cabazitaxel; Prostate cancer; Docetaxel; Castration; Goserelin; Androgen deprivation therapy; Enzalutamide; Abiraterone; Oncology; Abiraterone acetate; Urology; Androgen; Internal medicine; Cancer; Gynecology; Hormone; Androgen receptor","score_opus":0.09347933362338731,"score_gpt":0.38975220975759584,"score_spread":0.2962728761342085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043188252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938603,0.0035166254,0.0000050850126,0.0011856857,0.000035541125,0.0012444108,0.00009004832,0.0000021244616,0.0000601529],"genre_scores_gemma":[0.9988142,0.0009022119,0.00006913354,0.00003478962,0.000005392924,0.0001114865,0.000026046644,0.0000092353,0.000027475053],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984688,0.00018391003,0.00061286014,0.00014873048,0.00029565924,0.0002900448],"domain_scores_gemma":[0.99937594,0.00017865795,0.00018749223,0.00012078232,0.00005407856,0.000083067665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036217022,0.00010481423,0.0005535652,0.00017515173,0.000017312967,0.0000025882061,0.0000481745,0.00001824241,0.000018891058],"category_scores_gemma":[0.000030068788,0.00007126244,0.000020979365,0.0002898231,0.000050015442,0.00003566331,0.000011598735,0.00015057759,1.4179906e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008030972,0.00027462724,0.9746604,0.0010553455,0.000043558735,0.000008697494,0.008591434,0.0036955993,0.00063516543,0.00021723019,0.000020731393,0.009994121],"study_design_scores_gemma":[0.005971336,0.0009977008,0.95654905,0.0015445977,0.000012611293,0.0000010533417,0.0055084927,0.018500725,0.01010317,0.00061846594,0.00008616488,0.000106655774],"about_ca_topic_score_codex":0.9140489,"about_ca_topic_score_gemma":0.9437062,"teacher_disagreement_score":0.029657317,"about_ca_system_score_codex":0.0012745179,"about_ca_system_score_gemma":0.002851406,"threshold_uncertainty_score":0.5058272},"labels":[],"label_agreement":null},{"id":"W2043316051","doi":"10.1016/j.jval.2012.08.2082","title":"PSS35 Frequency of Ranibizumab Injections for the Treatment of Wet Age-Related Macular Degeneration: Canadian Real-World Utilization Data","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Joseph's Health Care; Novartis (Canada)","funders":"","keywords":"Ranibizumab; Medicine; Macular degeneration; Regimen; Ophthalmology; Surgery; Chemotherapy; Bevacizumab","score_opus":0.18199751143387952,"score_gpt":0.3924994368099349,"score_spread":0.21050192537605536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043316051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97242886,0.016653914,0.00033020295,0.0032708724,0.00055018184,0.003919672,0.0013409436,0.00002568527,0.0014796545],"genre_scores_gemma":[0.9946688,0.002797284,0.00090768974,0.000051236995,0.00007158119,0.000057284196,0.0012123315,0.000014121357,0.00021968417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903184,0.000090067006,0.00039374633,0.00014283542,0.00011996052,0.00022156318],"domain_scores_gemma":[0.9990674,0.000080652906,0.00013225703,0.0004710324,0.00005407606,0.00019455374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020850448,0.000090726666,0.00022304055,0.00015024409,0.000101524965,0.000003506287,0.00006417464,0.000037728176,0.000050754225],"category_scores_gemma":[0.000038888244,0.00006260236,0.00005677959,0.00032411574,0.000035041732,0.0000610562,0.0000056291606,0.00003164846,0.0000021977992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003319071,0.002847687,0.92858535,0.0007560286,0.0005851882,0.000021235679,0.0028790936,0.0021571475,0.00015371223,0.034586754,0.0014465438,0.025649335],"study_design_scores_gemma":[0.005699971,0.0018877548,0.9600483,0.00032481458,0.00063425547,0.000022003918,0.00030392414,0.018412227,0.0005411133,0.00073925796,0.011232928,0.00015343013],"about_ca_topic_score_codex":0.5625997,"about_ca_topic_score_gemma":0.13294972,"teacher_disagreement_score":0.42965,"about_ca_system_score_codex":0.00049026427,"about_ca_system_score_gemma":0.00072312786,"threshold_uncertainty_score":0.8828717},"labels":[],"label_agreement":null},{"id":"W2043318040","doi":"10.1111/j.1524-4733.2008.00318.x","title":"The Hanover Consensus: Helpful for German Decision-Makers?","year":2008,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"German; Business; Computer science; History; Archaeology","score_opus":0.4163924085645023,"score_gpt":0.44269240579141084,"score_spread":0.02629999722690851,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043318040","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027848887,0.016915338,0.0013964353,0.9687439,0.004164418,0.0034718153,0.0016164224,0.0000714099,0.0008353526],"genre_scores_gemma":[0.00066303974,0.0034933984,0.005187759,0.98029816,0.005156262,0.00060274795,0.00024596244,0.0001819907,0.0041707046],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98712,0.0010509245,0.008839023,0.0012392543,0.00026232516,0.0014884864],"domain_scores_gemma":[0.9729532,0.020114755,0.005138973,0.0014341039,0.00012621316,0.00023276135],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.025730276,0.0005087293,0.0021850483,0.00065354735,0.00087260426,0.00015634675,0.00079813,0.0009276303,0.00011511307],"category_scores_gemma":[0.009533693,0.00054033473,0.00039856337,0.00031223294,0.00022537123,0.00014042344,0.0000873536,0.001469173,0.0018571111],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023330078,0.00002906133,0.00033734355,0.00089125236,0.000048260743,0.000011462811,0.000939975,0.00037287996,1.6424647e-8,0.008561618,0.98847234,0.00031247194],"study_design_scores_gemma":[0.0009619852,0.0001135068,0.00042637083,0.00048581682,0.0000031857762,0.00003010422,0.00015059485,0.006609503,1.3646923e-7,0.038856484,0.95188636,0.00047595912],"about_ca_topic_score_codex":0.007498373,"about_ca_topic_score_gemma":0.0002770103,"teacher_disagreement_score":0.036585975,"about_ca_system_score_codex":0.0025089025,"about_ca_system_score_gemma":0.001604178,"threshold_uncertainty_score":0.99970484},"labels":[],"label_agreement":null},{"id":"W2043401953","doi":"10.1111/j.1524-4733.2009.00578.x","title":"Cost–Benefit Analysis of Preventing Nosocomial Bloodstream Infections among Hemodialysis Patients in Canada in 2004","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Nosocomial Infections in ICU","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Public Health Agency of Canada","funders":"","keywords":"Medicine; Hemodialysis; Infection control; Investment (military); Disease control; Cost–benefit analysis; Total cost; Incidence (geometry); Bloodstream infection; Emergency medicine; Intensive care medicine; Environmental health; Business; Surgery","score_opus":0.022917383750277513,"score_gpt":0.3002798418810529,"score_spread":0.27736245813077537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043401953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979204,0.0001028504,0.00002491896,0.00033226446,0.00018798807,0.0010257079,0.000032311575,0.000017172903,0.00035637923],"genre_scores_gemma":[0.9991156,0.00013797077,0.00032512276,0.00023271255,0.000045462064,0.00004848701,0.00006446087,0.000013061738,0.000017157914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973657,0.0002386995,0.001239306,0.0003410352,0.00033952086,0.00047571497],"domain_scores_gemma":[0.9987594,0.00025689026,0.00036206405,0.00036556952,0.00009328758,0.00016280275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064359844,0.00017704666,0.0008638441,0.0017293376,0.00005735269,0.000007713973,0.00009398977,0.00010460975,0.00004780532],"category_scores_gemma":[0.0003836208,0.00019655554,0.00015302301,0.0046512815,0.000032738542,0.00009580397,0.000026378297,0.00044564626,0.0000011746387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002071247,0.0008673326,0.84701085,0.000048914113,0.00008235187,0.000006809874,0.00028365463,0.14713435,0.0000150423175,0.000019573397,0.0000857128,0.004424676],"study_design_scores_gemma":[0.0020768158,0.0002010786,0.9910757,0.00032498967,0.00016394017,0.0000011606047,0.00010378296,0.0055508344,0.00022608893,0.00009401395,0.000053811866,0.0001277703],"about_ca_topic_score_codex":0.98275393,"about_ca_topic_score_gemma":0.98438185,"teacher_disagreement_score":0.14406484,"about_ca_system_score_codex":0.0035494533,"about_ca_system_score_gemma":0.0014528683,"threshold_uncertainty_score":0.9281697},"labels":[],"label_agreement":null},{"id":"W2043684445","doi":"10.1016/j.jval.2011.08.1166","title":"PCN65 Cost-Effectiveness of Treating Metastatic Renal Cell Carcinoma (mRCC) Patients Whose Disease Failed on one Prior VEGF-TKI Therapy with Everolimus Compared to Treating with Best Supportive Care (BSC) Alone in Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Everolimus; Medicine; Quality-adjusted life year; Renal cell carcinoma; Cost-effectiveness analysis; Cost effectiveness; Internal medicine; Oncology; Incremental cost-effectiveness ratio; Markov model; Cost–benefit analysis; Intensive care medicine; Markov chain; Statistics","score_opus":0.29771767826339157,"score_gpt":0.35571420652786806,"score_spread":0.05799652826447649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043684445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929049,0.00071253645,0.0001287343,0.0003572831,0.00009356745,0.0045890436,0.0008614226,0.000013072188,0.0003394652],"genre_scores_gemma":[0.99623656,0.00002822217,0.0021109176,0.0007455156,0.000026874934,0.0006406561,0.0001361493,0.0000642785,0.000010843829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938073,0.001398925,0.003013387,0.00080345233,0.00025512863,0.00072177756],"domain_scores_gemma":[0.99517864,0.0013658976,0.0022385092,0.00054225244,0.00016167763,0.0005130134],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039460943,0.00035980516,0.0016811336,0.00053885195,0.00014876273,0.000020382447,0.00024227402,0.000049566028,0.000040431558],"category_scores_gemma":[0.00045012994,0.0003743599,0.000057120335,0.0005228566,0.00004915993,0.00022546454,0.000030378722,0.00023561704,0.000021761809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017263305,0.00071452104,0.96526146,0.0017707974,0.0000414294,0.000013814583,0.016031712,0.013703847,9.3243017e-7,0.00020442036,0.000017639548,0.0005130997],"study_design_scores_gemma":[0.007663126,0.0021925252,0.97969544,0.0015651162,0.000012848974,6.121793e-7,0.0054586255,0.0027753036,0.00010255701,0.000109395514,0.000026451173,0.00039796988],"about_ca_topic_score_codex":0.90759575,"about_ca_topic_score_gemma":0.5330228,"teacher_disagreement_score":0.37457296,"about_ca_system_score_codex":0.00478872,"about_ca_system_score_gemma":0.0032418524,"threshold_uncertainty_score":0.99987084},"labels":[],"label_agreement":null},{"id":"W2043769648","doi":"10.1016/j.jval.2013.03.755","title":"Lessons Learned From The Dedicated Oncology Drug Review Process In Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Population; Clinical trial; Oncology; Cancer; Internal medicine; Intensive care medicine; Family medicine; Health care; Environmental health","score_opus":0.5594581036707623,"score_gpt":0.47084717646158847,"score_spread":0.08861092720917385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043769648","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27038366,0.044352386,0.00002306485,0.6823167,0.00042285316,0.0015811624,0.0001409851,0.000017012711,0.0007621581],"genre_scores_gemma":[0.80341375,0.024741914,0.0004030353,0.17035536,0.00020102308,0.0006460127,0.000072943054,0.00003695339,0.00012903164],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927366,0.0015352457,0.0044588665,0.0005486203,0.000117297444,0.0006033756],"domain_scores_gemma":[0.9944643,0.0027047906,0.0019982469,0.00054977596,0.000047922706,0.00023497656],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.017735472,0.0001636282,0.0011746787,0.00013351133,0.0001245892,0.000024357852,0.00049281,0.00008248908,0.0007845799],"category_scores_gemma":[0.0039989436,0.00016497921,0.000043625198,0.0004567767,0.000044094068,0.0002110583,0.000043926997,0.0004739521,0.0009337741],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00001408335,0.00027192087,0.43273324,0.0057780324,0.00005429459,0.000006943399,0.010698908,0.0065586437,3.2626346e-7,0.025603045,0.5070088,0.011271796],"study_design_scores_gemma":[0.0023487904,0.00009806274,0.39644837,0.0059618154,0.0000065457466,0.0000069321504,0.008377102,0.05185588,0.0000014316622,0.091581635,0.4424934,0.0008200392],"about_ca_topic_score_codex":0.99496526,"about_ca_topic_score_gemma":0.9212375,"teacher_disagreement_score":0.5330301,"about_ca_system_score_codex":0.0044634407,"about_ca_system_score_gemma":0.006532786,"threshold_uncertainty_score":0.99984413},"labels":[],"label_agreement":null},{"id":"W2043816730","doi":"10.1016/j.jval.2012.09.004","title":"What Is Wrong with Orphan Drug Policies?","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Orphan drug; Business; Bioinformatics; Biology","score_opus":0.1068436613679914,"score_gpt":0.32903839067299734,"score_spread":0.22219472930500594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2043816730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9178277,0.02178853,0.000078201454,0.04159255,0.0012867494,0.00040608068,0.00010972743,0.00004089371,0.016869549],"genre_scores_gemma":[0.97310513,0.0055900025,0.0003065683,0.019950412,0.00035809996,0.000018865401,0.0000053506556,0.000032125296,0.00063342904],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99830735,0.000031496078,0.0006052117,0.00025663528,0.000026887832,0.00077243923],"domain_scores_gemma":[0.9990151,0.000069481874,0.00025392103,0.00028678196,0.0000073033048,0.00036744477],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0010731455,0.00014723075,0.00037919314,0.00023944143,0.00008107169,0.00009097789,0.00017807126,0.000054567146,0.00040515652],"category_scores_gemma":[0.00001616593,0.0001564841,0.00005316387,0.00025235157,0.000049305312,0.0007034296,0.000047917954,0.00020890738,0.0009743754],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028618675,0.00025358883,0.26574966,0.00016963732,0.0000339072,0.00000126383,0.009866913,0.00075921864,0.0000013492112,0.7127651,0.0075385906,0.0028321662],"study_design_scores_gemma":[0.0014314024,0.0001129177,0.050309613,0.0001409249,0.0000030244173,0.000015578926,0.0005140444,0.010636137,0.00010759523,0.030660031,0.90547216,0.0005965818],"about_ca_topic_score_codex":0.0074958545,"about_ca_topic_score_gemma":0.0000632816,"teacher_disagreement_score":0.89793354,"about_ca_system_score_codex":0.00031640043,"about_ca_system_score_gemma":0.000067162495,"threshold_uncertainty_score":0.9998035},"labels":[],"label_agreement":null},{"id":"W2045171199","doi":"10.1016/j.jval.2013.08.1566","title":"Easing Decision-Making by Expanding Methods of Multiple Treatment Comparison Meta-Analysis – Incorporating Non-Comparative Studies Via Informative Priors","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University","funders":"","keywords":"Prior probability; Bayesian probability; Meta-analysis; Frequentist inference; Markov chain Monte Carlo; Statistics; Econometrics; Medicine; Bayesian inference; Mathematics; Internal medicine","score_opus":0.8488595570590012,"score_gpt":0.639732342098657,"score_spread":0.20912721496034414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045171199","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43235525,0.011728552,0.55275637,0.00024673197,0.00014435539,0.0024005126,0.000024004441,0.000008508633,0.0003357118],"genre_scores_gemma":[0.6862465,0.000036788522,0.31339183,0.00006399404,0.000010939385,0.00016707157,0.0000051761745,0.000008456785,0.00006924326],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9536316,0.022162752,0.019072883,0.0010915609,0.003512187,0.00052905414],"domain_scores_gemma":[0.9196765,0.05492927,0.020756079,0.0026951458,0.0016665609,0.000276492],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.095953375,0.00056787505,0.014236182,0.0016971626,0.000369244,0.00040567672,0.0009769619,0.00009219226,0.0007469071],"category_scores_gemma":[0.017284438,0.00027538394,0.0036070691,0.0053709857,0.00012643464,0.0007818803,0.00020919027,0.00022278001,0.000181759],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004547521,0.0006163955,0.15219387,0.0003933879,0.11857738,0.0000030785995,0.19450091,0.40799436,0.0002559877,0.0003119625,0.004116811,0.120990396],"study_design_scores_gemma":[0.00035914403,0.00024332984,0.004393739,0.00012614255,0.012232559,0.0000022450595,0.05409557,0.92272794,0.0003865823,0.004843461,0.0002629458,0.00032635382],"about_ca_topic_score_codex":0.0023517418,"about_ca_topic_score_gemma":0.00034888333,"teacher_disagreement_score":0.51473355,"about_ca_system_score_codex":0.0004643913,"about_ca_system_score_gemma":0.00016307071,"threshold_uncertainty_score":0.99996984},"labels":[],"label_agreement":null},{"id":"W2045458376","doi":"10.1016/j.jval.2012.03.1066","title":"PIH34 Impact of Medicare Part D Coverage Gap on Beneficiaries' Adherence to Prescription Medications","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Medicare Part D; Medicine; Medicaid; Prescription drug; Medication adherence; Quarter (Canadian coin); Family medicine; Internal medicine; Health care; Pharmacology","score_opus":0.14756406454640125,"score_gpt":0.40628327471426595,"score_spread":0.2587192101678647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045458376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981499,0.001754858,0.0014680659,0.0071209506,0.00061679224,0.0013179743,0.000058162208,0.000060608534,0.0061035547],"genre_scores_gemma":[0.9962065,0.0005066786,0.00043659206,0.0019965135,0.00025317437,0.00011253459,0.000056827208,0.00001269061,0.0004184759],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807525,0.00014576191,0.0005944151,0.00021550333,0.0005623246,0.0004067582],"domain_scores_gemma":[0.9983964,0.00015900201,0.00023212981,0.00047942915,0.0000969208,0.00063611387],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009202897,0.0001280325,0.00033926402,0.00017185933,0.00005637729,0.000004450241,0.0001383905,0.00008390902,0.0013428045],"category_scores_gemma":[0.0006058138,0.00010583319,0.000066998604,0.00047712924,0.000045086435,0.00008578383,0.000023461336,0.00025190413,0.00043697155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076146785,0.0035296415,0.69501704,0.0017778173,0.00016793163,0.000009263972,0.013487082,0.0040759863,0.0014062047,0.03328239,0.13223226,0.114252925],"study_design_scores_gemma":[0.0022726986,0.0049205986,0.9524916,0.005057995,0.000044310487,0.000034629138,0.00079712516,0.0030075542,0.00042451514,0.0011804883,0.02943461,0.00033391034],"about_ca_topic_score_codex":0.0027609712,"about_ca_topic_score_gemma":0.000022742679,"teacher_disagreement_score":0.25747454,"about_ca_system_score_codex":0.00030177998,"about_ca_system_score_gemma":0.0008619378,"threshold_uncertainty_score":0.99957013},"labels":[],"label_agreement":null},{"id":"W2045580548","doi":"10.1016/s1098-3015(10)70642-2","title":"PCV54 THE COST-UTILITY OF ALISKIREN IN THE TREATMENT OF MILD TO MODERATE HYPERTENSION. A CANADIAN HEALTH CARE SYSTEM PERSPECTIVE","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aliskiren; Perspective (graphical); Medicine; Intensive care medicine; Health care; Internal medicine; Economics; Computer science; Renin–angiotensin system; Economic growth; Blood pressure; Artificial intelligence","score_opus":0.1723879157701996,"score_gpt":0.36863286731372774,"score_spread":0.19624495154352814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045580548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87716734,0.016587492,0.000013167276,0.10026281,0.00017362878,0.0047641913,0.0001917925,0.000019143485,0.0008204582],"genre_scores_gemma":[0.99103147,0.001628223,0.0003438869,0.0067966017,0.000060821196,0.00010169639,0.000014876358,0.00001206649,0.0000103682205],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99766487,0.0006793839,0.00066783035,0.00025016128,0.00028477685,0.00045300162],"domain_scores_gemma":[0.9986817,0.00018762352,0.00015141178,0.00043258112,0.00019762473,0.00034906293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008456511,0.00013252803,0.00059902895,0.00027663787,0.00023664016,0.0000029955168,0.000100921134,0.000053794487,0.0000059783188],"category_scores_gemma":[0.000050970786,0.00007989273,0.000067125664,0.0005043389,0.00007009864,0.000018010192,0.0000068431273,0.00018663087,0.0000025983495],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018232471,0.0023460595,0.15737154,0.0067372597,0.000081439466,0.0003190689,0.7947925,0.002784612,0.000013832634,0.012074703,0.011022509,0.010633281],"study_design_scores_gemma":[0.0082749035,0.004582418,0.7640337,0.004260132,0.000029807594,0.00043876976,0.19033596,0.016637783,0.00013099372,0.00020261883,0.010807891,0.00026503505],"about_ca_topic_score_codex":0.8539043,"about_ca_topic_score_gemma":0.22047499,"teacher_disagreement_score":0.63342935,"about_ca_system_score_codex":0.0026928186,"about_ca_system_score_gemma":0.0032250576,"threshold_uncertainty_score":0.79374933},"labels":[],"label_agreement":null},{"id":"W2045655256","doi":"10.1016/j.jval.2011.02.839","title":"PRM32 VALIDITY EVIDENCE AND VALIDATION PRACTICE IN PAPERS PUBLISHED IN VALUE IN HEALTH (1998-2010): A SYSTEMATIC REVIEW","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Discriminant validity; Construct validity; External validity; Criterion validity; Convergent validity; Content validity; Predictive validity; Medicine; Internal validity; Outcomes research; MEDLINE; Systematic review; Psychology; Psychometrics; Clinical psychology; Alternative medicine; Social psychology; Political science; Pathology","score_opus":0.6947092138980646,"score_gpt":0.4952521304909449,"score_spread":0.1994570834071197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045655256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008666034,0.96163964,0.000027729167,0.020559072,0.0009081073,0.01618679,0.00014189073,0.000045720124,0.00040437962],"genre_scores_gemma":[0.00011125755,0.986254,0.0014155654,0.0095379045,0.00013252208,0.0021522206,0.000121450204,0.00011878015,0.00015633849],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9380125,0.026534306,0.03062599,0.002609943,0.00043506233,0.0017822311],"domain_scores_gemma":[0.96579164,0.013831629,0.017914131,0.0018155895,0.00008083227,0.0005661724],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20334335,0.000874281,0.011470089,0.0029089237,0.00014888967,0.00020466709,0.0009174796,0.00067010126,0.00010009966],"category_scores_gemma":[0.06618656,0.0009911135,0.00033033325,0.0024043457,0.000089543646,0.0021847675,0.0001626698,0.00182383,0.000513246],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000061403766,0.0002859008,0.0016840916,0.9818454,0.000029471732,0.0000075703238,0.0025367613,0.000110766305,8.4498847e-10,0.010941649,0.0007624461,0.0017897976],"study_design_scores_gemma":[0.000624435,0.000193194,0.00057195826,0.7801116,0.00004347315,0.000059467224,0.0003079989,0.0008327176,4.957986e-9,0.0015143224,0.21500038,0.00074047706],"about_ca_topic_score_codex":0.10800716,"about_ca_topic_score_gemma":0.0031633363,"teacher_disagreement_score":0.21423793,"about_ca_system_score_codex":0.007847046,"about_ca_system_score_gemma":0.0054142983,"threshold_uncertainty_score":0.9992539},"labels":[],"label_agreement":null},{"id":"W2045754070","doi":"10.1016/j.jval.2011.08.1155","title":"PCN54 Hospital Costs Related to Hepatitis C Virus Infection: First Analysis of the French Hospital National Data Base","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Cirrhosis; Internal medicine; Hepatitis C virus; Hepatitis C; Liver cancer; Liver transplantation; Hepatitis; Emergency medicine; Virus; Transplantation; Virology","score_opus":0.08819980210912574,"score_gpt":0.35306261405267914,"score_spread":0.2648628119435534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045754070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911466,0.00016542203,0.00007614646,0.0039066253,0.00039886872,0.0010527151,0.00067388394,0.00003502884,0.0025446874],"genre_scores_gemma":[0.9976574,0.00080488314,0.00072493905,0.00037364123,0.000049417707,0.000044374294,0.0002161426,0.000021584054,0.0001075838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99715334,0.0003014044,0.00071823184,0.00046568693,0.0009820334,0.00037932218],"domain_scores_gemma":[0.99799716,0.00020470146,0.00019219534,0.0009989796,0.00032080864,0.00028615294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014556905,0.00014511636,0.00043460078,0.00070584705,0.00013207959,0.000012157739,0.0003839413,0.00011319255,0.00069359347],"category_scores_gemma":[0.0020009337,0.00012047112,0.0001166671,0.0033102075,0.000108008324,0.00016626966,0.0003103599,0.00041411968,0.00007559186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001636852,0.0005252093,0.98997694,0.00007500431,0.00025452767,0.000018211469,0.0017126875,0.0003327521,0.0000058979826,0.00029186008,0.004732172,0.0020583572],"study_design_scores_gemma":[0.0005321785,0.000650202,0.9775393,0.00020149407,0.0000749262,0.0000023633668,0.000015697633,0.018809086,0.00006851568,0.0000886759,0.0019051149,0.00011244741],"about_ca_topic_score_codex":0.41166672,"about_ca_topic_score_gemma":0.052466154,"teacher_disagreement_score":0.35920057,"about_ca_system_score_codex":0.0007519929,"about_ca_system_score_gemma":0.0009087319,"threshold_uncertainty_score":0.96482384},"labels":[],"label_agreement":null},{"id":"W2045905486","doi":"10.1111/j.1524-4733.2010.00755.x","title":"An Ounce of Prevention Is Worth a Pound of Cure: A Cost-Effectiveness Analysis of Incidentally Detected Aneurysms in Functional MRI Research","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Functional Brain Connectivity Studies","field":"Neuroscience","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Advancing Health Outcomes","funders":"Institute of Neurosciences, Mental Health and Addiction; National Institute of Mental Health; Canadian Institutes of Health Research; National Institutes of Health; Vancouver Coastal Health Research Institute; Canada Research Chairs","keywords":"Medicine; Family history; Cost effectiveness; Quality-adjusted life year; Cost–benefit analysis; Cost–utility analysis; Pound (networking); Cost-effectiveness analysis; Magnetic resonance imaging; Medical physics; Surgery; Radiology; Computer science","score_opus":0.17259730777231916,"score_gpt":0.4202609213229881,"score_spread":0.24766361355066893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045905486","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978951,0.00005620506,0.00032255176,0.000412498,0.0002050036,0.0009406341,0.00008998442,0.000013179382,0.00006483764],"genre_scores_gemma":[0.9995752,0.00004578221,0.0001512742,0.00007548181,0.000020045476,0.00009175142,0.000006503806,0.000012423417,0.000021537779],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9953266,0.0020848743,0.0006873593,0.00058426114,0.0009907972,0.0003261403],"domain_scores_gemma":[0.9920384,0.006747681,0.0003702068,0.00042614108,0.00034426144,0.00007326256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044791857,0.0001290183,0.00051301863,0.0015765259,0.00009776339,0.0000098778855,0.0002400577,0.00009141956,0.00006392041],"category_scores_gemma":[0.0056034653,0.00013412292,0.000110257795,0.0050694975,0.00033689785,0.00024035951,0.00009825817,0.00052391936,0.0000015524552],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009812296,0.0014512836,0.47175527,0.0004950803,0.00006492006,0.0000054927464,0.001387134,0.03073861,0.4901077,0.0019143417,0.000046300444,0.0010526723],"study_design_scores_gemma":[0.00069939345,0.00078845967,0.9346403,0.00012038074,0.00001970315,0.000006242677,0.00015453936,0.017030371,0.044670496,0.0017488954,0.000029269304,0.000091947004],"about_ca_topic_score_codex":0.0077043762,"about_ca_topic_score_gemma":0.009644342,"teacher_disagreement_score":0.46288505,"about_ca_system_score_codex":0.00023578756,"about_ca_system_score_gemma":0.00052325096,"threshold_uncertainty_score":0.9989034},"labels":[],"label_agreement":null},{"id":"W2045934399","doi":"10.1016/s1098-3015(10)69128-0","title":"PMC30 GUIDELINES FOR BUDGET IMPACT ANALYSIS IN CANADA","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Evaluation and Performance Assessment","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.4295872366019313,"score_gpt":0.5961427506262914,"score_spread":0.16655551402436009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2045934399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9776376,0.00035091612,0.009002554,0.011616675,0.00037165728,0.00042301367,0.00004091772,0.0000069647836,0.00054969423],"genre_scores_gemma":[0.99225473,0.00005552203,0.0042840904,0.0031183185,0.000067210734,0.000010997193,0.00001340479,0.0000049855507,0.00019072929],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962626,0.0002057288,0.0015656333,0.00030394152,0.001217987,0.00044410743],"domain_scores_gemma":[0.9971571,0.0015863435,0.00029285668,0.0003543333,0.00043688287,0.00017247825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021484036,0.000098357166,0.00037485856,0.0008636789,0.00006650589,0.0000391477,0.00030725868,0.000032507935,0.00037492462],"category_scores_gemma":[0.0023460276,0.000070514565,0.000098653305,0.002870448,0.000010441812,0.0001327186,0.000023296798,0.000097105956,0.000012326651],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002321882,0.000016453598,0.6912045,0.00000593971,0.0000104610335,0.000001449816,0.00022995172,0.27412364,0.0000019256966,0.00018105155,0.008911373,0.025290046],"study_design_scores_gemma":[0.0003459486,0.000053979405,0.62880635,0.000012656796,0.0000042333995,5.6728595e-7,0.000870469,0.3585579,0.000011416444,0.0014765704,0.009786264,0.00007366994],"about_ca_topic_score_codex":0.96581537,"about_ca_topic_score_gemma":0.9910357,"teacher_disagreement_score":0.08443427,"about_ca_system_score_codex":0.0014963644,"about_ca_system_score_gemma":0.0063417484,"threshold_uncertainty_score":0.99929136},"labels":[],"label_agreement":null},{"id":"W2046059662","doi":"10.1016/j.jval.2013.03.156","title":"Impact of multiple treatment comparison meta-analysis on value of information evaluations: a case study of pharmacotherapies for chronic obstructive pulmonary diseases","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemodynamic Monitoring and Therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia","funders":"","keywords":"Medicine; COPD; Placebo; Pulmonary disease; Randomized controlled trial; Bayesian probability; Bayes' theorem; Internal medicine; Statistics; Mathematics; Pathology","score_opus":0.13615359724571932,"score_gpt":0.4536132285066741,"score_spread":0.3174596312609548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046059662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99382436,0.0023120502,0.00036042414,0.00006016046,0.000039472117,0.0031847642,0.00020349707,0.000011043524,0.0000042098],"genre_scores_gemma":[0.99866307,0.00012954284,0.00064543774,0.000007848596,0.000024815,0.00046137228,0.000051915944,0.000010062686,0.000005914859],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981598,0.00032158263,0.00091809453,0.00014545592,0.00029044412,0.00016459335],"domain_scores_gemma":[0.9981905,0.0005849722,0.0006037554,0.00030697178,0.00022119716,0.0000925722],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036540264,0.00015574097,0.0011336008,0.0005004398,0.00004290202,0.0000039974157,0.000048412563,0.0000337406,0.000045285065],"category_scores_gemma":[0.00006651562,0.00010654916,0.0005152907,0.00043359556,0.00003216464,0.00011641079,0.0000058642245,0.00005853284,7.2961456e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007516358,0.006570513,0.38581625,0.00060889666,0.048453167,0.000004487451,0.016905282,0.5052817,0.0003007711,0.000030851686,0.0000074180657,0.035269007],"study_design_scores_gemma":[0.0049587726,0.0095178215,0.30853784,0.0000474218,0.015558524,0.000010557931,0.004906282,0.6557846,0.00049738167,0.00007894183,0.0000046480927,0.00009722018],"about_ca_topic_score_codex":0.07762068,"about_ca_topic_score_gemma":0.00011271724,"teacher_disagreement_score":0.15050286,"about_ca_system_score_codex":0.00060688256,"about_ca_system_score_gemma":0.00039661184,"threshold_uncertainty_score":0.9285215},"labels":[],"label_agreement":null},{"id":"W2046214493","doi":"10.1111/j.1524-4733.2008.00445.x","title":"The Costs of Change: Direct Medical Costs of Solid Organ Transplantation in British Columbia, Canada, 1995–2003","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Advancing Health Outcomes; Vancouver Native Health Society; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Transplantation; Liver transplantation; Activity-based costing; Population; Emergency medicine; Total cost; Indirect costs; Organ transplantation; Intensive care medicine; Surgery; Environmental health; Business","score_opus":0.04258307607988245,"score_gpt":0.30753770257338936,"score_spread":0.26495462649350693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046214493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962321,0.0014460997,0.000009837669,0.0009653377,0.00018837191,0.0007158011,0.00020977146,0.000007410654,0.00022527885],"genre_scores_gemma":[0.981592,0.017604945,0.00006866606,0.00046192398,0.000024491601,0.00002796817,0.00009476566,0.000012394619,0.00011282784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982082,0.00018983074,0.0006153008,0.0001499407,0.000563231,0.00027348212],"domain_scores_gemma":[0.9992224,0.00027073684,0.00014516323,0.00012097571,0.00007707295,0.00016367492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044151672,0.000071772614,0.0003779046,0.000050992796,0.00007445943,0.000003610991,0.00007230861,0.00006448591,0.000032907647],"category_scores_gemma":[0.00009772657,0.00007733251,0.000029665458,0.00042764397,0.000072845316,0.000032317046,0.000003846395,0.00014469508,6.9785676e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010216024,0.00022124217,0.9870192,0.0006518706,0.00003450673,0.0007735931,0.00091752503,0.00002908208,0.00001043057,0.000027562884,0.00022679573,0.009986075],"study_design_scores_gemma":[0.0032650097,0.00023569446,0.99235564,0.0029656615,0.000015658343,0.00037828294,0.00011083048,0.0003261452,0.00014339283,0.0000058140463,0.00013526539,0.00006261291],"about_ca_topic_score_codex":0.98958004,"about_ca_topic_score_gemma":0.99084777,"teacher_disagreement_score":0.016158847,"about_ca_system_score_codex":0.00040895803,"about_ca_system_score_gemma":0.0017913217,"threshold_uncertainty_score":0.31777278},"labels":[],"label_agreement":null},{"id":"W2046353944","doi":"10.1016/j.jval.2014.03.1273","title":"Investigating economic risk factors that impact mental health status of former army personnel","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Employment and Welfare Studies","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Mental health; Military personnel; Anxiety; Educational attainment; Logistic regression; Probit model; Medicine; Environmental health; Psychology; Gerontology; Psychiatry; Statistics; Economics; Geography","score_opus":0.11811398967294795,"score_gpt":0.4173879733712102,"score_spread":0.29927398369826225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046353944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923843,0.0010363637,0.000031721647,0.0033758702,0.0007828215,0.0011161002,0.00031557246,0.000064433574,0.00089280517],"genre_scores_gemma":[0.9957769,0.0026610347,0.0003615881,0.00081509043,0.00014267536,0.000035024852,0.00006704881,0.000042003318,0.00009865033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99545264,0.0014973441,0.0010675497,0.0003444768,0.00022552082,0.0014124676],"domain_scores_gemma":[0.9972157,0.0008207732,0.001157742,0.00028030423,0.000026423528,0.0004990906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022907394,0.00026275893,0.00075914036,0.00022011997,0.0011445857,0.000006273346,0.0001432782,0.00010432886,0.00013455634],"category_scores_gemma":[0.00025728563,0.00021125848,0.00012563239,0.00013715394,0.000099490324,0.0001614873,0.000108275555,0.00060464995,0.000041008956],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001460827,0.000034070985,0.93280303,0.0004483753,0.00003033061,3.5079196e-8,0.060422998,0.0003854496,0.0000034681977,0.0007528048,0.0038314618,0.0012733788],"study_design_scores_gemma":[0.0017051934,0.0007742097,0.95308065,0.0008136681,0.000006723415,2.8083232e-7,0.030897181,0.003786996,0.000012760622,0.0013304317,0.00734093,0.00025094816],"about_ca_topic_score_codex":0.3253114,"about_ca_topic_score_gemma":0.0049019824,"teacher_disagreement_score":0.32040942,"about_ca_system_score_codex":0.001748315,"about_ca_system_score_gemma":0.0012231811,"threshold_uncertainty_score":0.8803344},"labels":[],"label_agreement":null},{"id":"W2046640806","doi":"10.1016/j.jval.2012.08.267","title":"PRM16 Evaluation of Personalized Breast Cancer Test-Treatment Strategies - A Cross-Validation Study Between a Discrete-Event Simulation and a Markov Model","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; University of Toronto","funders":"","keywords":"Breast cancer; Medicine; Markov model; Quality-adjusted life year; Cohort; Quality of life (healthcare); Cancer; Actuarial science; Computer science; Markov chain; Cost effectiveness; Internal medicine; Risk analysis (engineering); Machine learning","score_opus":0.49866942640792916,"score_gpt":0.5256237887241147,"score_spread":0.026954362316185587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046640806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874116,0.0030471964,0.0024314572,0.003175202,0.00013124221,0.0028654449,0.0008258435,0.000022448636,0.00008957061],"genre_scores_gemma":[0.99819076,0.00014957621,0.0007578923,0.00014475743,0.00019779717,0.0004253984,0.000056605022,0.000027869286,0.00004934504],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9945345,0.0010416784,0.0032512038,0.00045780136,0.00027087977,0.00044393164],"domain_scores_gemma":[0.9962201,0.0010412284,0.002087561,0.00031583515,0.00013721795,0.00019803428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025018962,0.0002129802,0.0008829314,0.00033909033,0.0001593226,0.00007084212,0.000094510964,0.00010104154,0.00010442171],"category_scores_gemma":[0.0008486032,0.00023926963,0.0000675606,0.00021975911,0.00006213029,0.0009195499,0.000030052659,0.000100531724,0.000018726316],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021574371,0.00033008293,0.68450105,0.00024102359,0.000036103593,2.3900878e-8,0.011024494,0.3014518,6.7161284e-7,0.0016170532,0.000010917779,0.00076521246],"study_design_scores_gemma":[0.001581229,0.00014013468,0.49495426,0.00008789091,0.000018022356,6.074559e-7,0.0018189094,0.4990608,8.406282e-7,0.002179545,0.000029044671,0.00012870539],"about_ca_topic_score_codex":0.018141245,"about_ca_topic_score_gemma":0.0002628252,"teacher_disagreement_score":0.197609,"about_ca_system_score_codex":0.0022622957,"about_ca_system_score_gemma":0.00081176875,"threshold_uncertainty_score":0.98839706},"labels":[],"label_agreement":null},{"id":"W2046655585","doi":"10.1111/j.1524-4733.2004.75007.x","title":"Cost-Effectiveness of Interferon Beta-1a, Interferon Beta-1b, and Glatiramer Acetate in Newly Diagnosed Non-primary Progressive Multiple Sclerosis","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Glatiramer acetate; Medicine; Cost effectiveness; Quality-adjusted life year; Life expectancy; Quality of life (healthcare); Interferon beta-1b; Internal medicine; Interferon beta; Multiple sclerosis; Interferon beta-1a; Population; Physical therapy; Immunology; Disease; Environmental health","score_opus":0.14525115917866463,"score_gpt":0.36734868299023504,"score_spread":0.2220975238115704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046655585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98896825,0.0035438442,0.00026729508,0.0016274066,0.00016382661,0.0052314275,0.000060193044,0.000043872402,0.00009390786],"genre_scores_gemma":[0.9936844,0.0029166015,0.0022044021,0.00024372383,0.00006235547,0.0007628525,0.000053264546,0.000063369815,0.000009042805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957609,0.00084156345,0.001093279,0.0007718196,0.0006109793,0.0009214225],"domain_scores_gemma":[0.9970094,0.001579422,0.0003437605,0.0005097751,0.00019440507,0.00036322896],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022117542,0.00041582374,0.0014641456,0.0006427582,0.00009912611,0.000029208097,0.00022356895,0.00016623561,0.000014156618],"category_scores_gemma":[0.00072443427,0.00036251443,0.00013623832,0.0006926755,0.0004590619,0.00023433773,0.0003585414,0.00078778574,0.000011410997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009025097,0.0035205681,0.82464844,0.011233457,0.0003531923,0.00014155918,0.01263167,0.0070169936,0.034558874,0.00006856963,0.000115294104,0.096686274],"study_design_scores_gemma":[0.021349631,0.0037014803,0.95084083,0.011017354,0.000029018256,0.000008214517,0.00066450797,0.0022183661,0.009784918,0.00006334511,0.00004243626,0.00027991718],"about_ca_topic_score_codex":0.014144854,"about_ca_topic_score_gemma":0.0009392795,"teacher_disagreement_score":0.12619236,"about_ca_system_score_codex":0.0014111092,"about_ca_system_score_gemma":0.0005036951,"threshold_uncertainty_score":0.9998827},"labels":[],"label_agreement":null},{"id":"W2046709389","doi":"10.1016/j.jval.2014.03.1259","title":"Resource use and associated costs of long acting injectable antipsychotics: A RAMQ database analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Database; Resource (disambiguation); Computer science; Medicine","score_opus":0.06428476794766586,"score_gpt":0.3503839857935865,"score_spread":0.28609921784592063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046709389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980585,0.00044740783,0.0002938371,0.00072316296,0.000017305882,0.00033836078,0.00002902321,0.000021498985,0.00007088204],"genre_scores_gemma":[0.9967168,0.00025998394,0.0026692296,0.00015324893,0.000023586008,0.0000056893,0.00011475957,0.000012762164,0.000043958553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982634,0.00045311518,0.000351012,0.00026366592,0.00031312287,0.0003556618],"domain_scores_gemma":[0.99833804,0.0008197095,0.00016151532,0.00034582763,0.0000648631,0.00027005255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015360152,0.00010083877,0.0004538451,0.0004338098,0.00006448938,0.000021319745,0.000049009326,0.00004991547,0.00001369362],"category_scores_gemma":[0.001659681,0.00008649676,0.000056032408,0.0009384355,0.000039998245,0.00008137036,0.00003797984,0.0002165631,0.0000024200317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020977897,0.00041004116,0.98605776,0.0001963594,0.0003898088,0.00003982917,0.00029221765,0.00045027756,0.000083579325,0.00026965202,0.000116598094,0.009596078],"study_design_scores_gemma":[0.0055352966,0.0007480598,0.942461,0.00078125147,0.00021582506,0.000012121971,0.00017252364,0.049465504,0.0003603382,0.000060740535,0.00008411811,0.00010319134],"about_ca_topic_score_codex":0.011592321,"about_ca_topic_score_gemma":0.0015475297,"teacher_disagreement_score":0.049015224,"about_ca_system_score_codex":0.0002305897,"about_ca_system_score_gemma":0.00019335239,"threshold_uncertainty_score":0.9949896},"labels":[],"label_agreement":null},{"id":"W2046807908","doi":"10.1016/s1098-3015(10)73673-1","title":"PRS10 RETURN ON INVESTMENT FROM SMOKING CESSATION INSURANCE COVERAGE IN THE WORKPLACE: A CANADIAN EMPLOYER'S PERSPECTIVE","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Retirement, Disability, and Employment","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Perspective (graphical); Investment (military); Actuarial science; Business; Health insurance; Smoking cessation; Economics; Medicine; Political science; Law; Economic growth; Health care; Computer science","score_opus":0.1605810974715046,"score_gpt":0.4042600981576011,"score_spread":0.24367900068609652,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046807908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9334587,0.00048734547,0.0000028622628,0.04146014,0.0002661753,0.0009589107,0.000020426556,0.000020013738,0.023325423],"genre_scores_gemma":[0.9901894,0.00044972345,0.000027011023,0.00908633,0.00016613497,0.000035447396,0.000007894983,0.000006011888,0.000032093867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702317,0.0012883416,0.00031812306,0.0003271983,0.00054177316,0.00050142023],"domain_scores_gemma":[0.9991838,0.00024956264,0.00010963616,0.00024371053,0.000034588043,0.00017873534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024114545,0.00011644907,0.00017174786,0.00012626851,0.00040073728,0.00008686624,0.0002584544,0.000085818836,0.000034319964],"category_scores_gemma":[0.0002946235,0.00009902099,0.000035187622,0.00053212367,0.00008526322,0.00013381924,0.0000071316463,0.00030023998,0.0000061841492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003264353,0.00022628623,0.6979163,0.000011862516,0.0000049177734,0.0000076038705,0.24175432,0.0017752593,8.61363e-7,0.0545351,0.00079203455,0.002942795],"study_design_scores_gemma":[0.00043949054,0.0002025854,0.8836759,0.00023118743,0.000001773099,1.1981797e-7,0.02161619,0.00011271545,0.000003228328,0.08959953,0.003983926,0.00013337084],"about_ca_topic_score_codex":0.93438286,"about_ca_topic_score_gemma":0.8112482,"teacher_disagreement_score":0.22013813,"about_ca_system_score_codex":0.0045668534,"about_ca_system_score_gemma":0.0010367089,"threshold_uncertainty_score":0.99925447},"labels":[],"label_agreement":null},{"id":"W2046820446","doi":"10.1016/j.jval.2014.03.1435","title":"Burden of illness of diabetic foot ulcers in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetic Foot Ulcer Assessment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Emergency medicine; Incidence (geometry); Emergency department; Population; Psychological intervention; Foot (prosody); Diabetes mellitus; Pediatrics; Environmental health","score_opus":0.017907920729721968,"score_gpt":0.2722092171650025,"score_spread":0.25430129643528054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2046820446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912216,0.00016708057,0.00004215968,0.0029065898,0.00023665767,0.00045122672,0.0000029094033,0.0000053045733,0.004966453],"genre_scores_gemma":[0.9992119,0.000060533923,0.0003036166,0.00026970863,0.000026789572,0.000013772191,0.0000053480817,0.000010824681,0.000097497126],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864274,0.00011530953,0.0005201024,0.00014931214,0.000301009,0.00027154654],"domain_scores_gemma":[0.9993701,0.000121060206,0.00014636332,0.00024232092,0.000028024338,0.0000921596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070412224,0.00008383675,0.0004221811,0.0001865903,0.000008879242,0.000001400455,0.00009095183,0.000023581482,0.00004426802],"category_scores_gemma":[0.00007602888,0.00007928515,0.00002564635,0.00028775603,0.000030716626,0.000017957236,0.000033695742,0.00009586012,0.0000010241364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022963797,0.00066658144,0.73975676,0.014892658,0.00013074582,0.000029894582,0.0060085226,0.03602334,0.00046263615,0.021010203,0.004642807,0.17614622],"study_design_scores_gemma":[0.008700271,0.0019134252,0.89208674,0.004151051,0.000072580006,0.0000025129132,0.007055617,0.061081234,0.0023539332,0.0024227675,0.0196704,0.0004894467],"about_ca_topic_score_codex":0.95778036,"about_ca_topic_score_gemma":0.40962803,"teacher_disagreement_score":0.5481524,"about_ca_system_score_codex":0.00048701206,"about_ca_system_score_gemma":0.0012174278,"threshold_uncertainty_score":0.60114473},"labels":[],"label_agreement":null},{"id":"W2047307438","doi":"10.1016/j.jval.2011.02.896","title":"PCN38 FIRST-YEAR COSTS FOR THE 19 MOST COMMON CANCER DIAGNOSES IN ONTARIO","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Public Health; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre; Health Sciences Centre; University Health Network","funders":"","keywords":"Medicine; Cancer; Cancer registry; Radiation therapy; Medical diagnosis; Activity-based costing; Total cost; Prostate cancer; Health care; Emergency medicine; Diagnosis code; Skin cancer; Pediatrics; Surgery; Internal medicine; Environmental health; Pathology","score_opus":0.13361914292070673,"score_gpt":0.28096325793350385,"score_spread":0.14734411501279712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047307438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94918394,0.019349197,0.00043468922,0.0076373774,0.002233935,0.0020439934,0.0004483195,0.000033905795,0.018634666],"genre_scores_gemma":[0.9912888,0.0050503616,0.00040673433,0.002168715,0.000119785,0.00033220358,0.0000070210162,0.000028928123,0.0005974521],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837977,0.000017989887,0.00076823775,0.00031978244,0.000022238068,0.00049199455],"domain_scores_gemma":[0.9989196,0.00030847843,0.00034022846,0.00030601787,0.000014232706,0.000111412315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009900539,0.00014548948,0.00045568874,0.00016258995,0.00012878646,0.000028923305,0.00028675923,0.00009818336,0.00038324285],"category_scores_gemma":[0.0001484952,0.00014368058,0.000068005924,0.0001693977,0.00005810781,0.00020982287,0.0000410758,0.00025904074,0.00006792018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006553184,0.00008178007,0.8909536,0.000042699347,0.000010005305,0.0000012721115,0.002833815,0.001269045,2.4497048e-8,0.099095,0.003463726,0.0021835056],"study_design_scores_gemma":[0.0010656519,0.00014539268,0.797201,0.000099819576,0.0000017834166,7.101548e-7,0.00014084208,0.0014333276,0.0000043590976,0.026181422,0.17352311,0.00020258914],"about_ca_topic_score_codex":0.9155548,"about_ca_topic_score_gemma":0.84659487,"teacher_disagreement_score":0.17005938,"about_ca_system_score_codex":0.0018278884,"about_ca_system_score_gemma":0.00036751322,"threshold_uncertainty_score":0.5859124},"labels":[],"label_agreement":null},{"id":"W2047325091","doi":"10.1016/j.jval.2013.03.660","title":"The Labor Productivity Effects Of Prostate Cancer Patients On Spouses And Other Family Members: Evidence From Us National Survey Data","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Retirement, Disability, and Employment","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Prostate cancer; Productivity; Medicine; Spillover effect; Medical Expenditure Panel Survey; Demography; Cancer; Prostate; Population; Gynecology; Environmental health; Health care; Internal medicine; Economics; Economic growth","score_opus":0.3553784444461985,"score_gpt":0.46235816298782006,"score_spread":0.10697971854162158,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047325091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487305,0.0011099057,2.4975517e-7,0.0019918934,0.0003686021,0.001363938,0.00020940462,0.00000879691,0.00007418502],"genre_scores_gemma":[0.9979031,0.0015566463,0.0000257455,0.00031199478,0.00007160544,0.00007518459,0.000007934359,0.000006223073,0.000041548024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972834,0.0013784091,0.00023012383,0.0003047135,0.0005832709,0.0002200674],"domain_scores_gemma":[0.99755883,0.0018099467,0.00015095071,0.00026181497,0.00015095664,0.00006748669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003001069,0.00007217992,0.00012777887,0.000019998026,0.0002159724,0.000045822104,0.00024616564,0.00002644177,0.00001262139],"category_scores_gemma":[0.0031168445,0.000050340903,0.000008754574,0.00017044856,0.00023613943,0.00024433748,0.000068875335,0.00006980385,0.0000040186405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027488748,0.00015079023,0.9902873,0.000093469396,0.000006729368,2.558847e-8,0.005726283,0.000056188852,0.000007287363,0.000084061765,0.0009514922,0.0026088606],"study_design_scores_gemma":[0.00015864825,0.000085849366,0.9972595,0.00024190109,0.0000015565815,2.6302103e-9,0.00021967325,0.00010333107,0.0000302391,0.0008249388,0.0010227693,0.000051586914],"about_ca_topic_score_codex":0.7795539,"about_ca_topic_score_gemma":0.10707103,"teacher_disagreement_score":0.67248285,"about_ca_system_score_codex":0.00022481568,"about_ca_system_score_gemma":0.00047868368,"threshold_uncertainty_score":0.9092226},"labels":[],"label_agreement":null},{"id":"W2047386501","doi":"10.1016/j.jval.2011.08.1477","title":"PSS12 C-Reality (Canadian Burden of Diabetic Macular Edema Observational Study): Three-Month Findings","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Observational study; Visual acuity; Quality of life (healthcare); Macular edema; Diabetes mellitus; Diabetic macular edema; Diabetic retinopathy; Ophthalmology; Telephone interview; Optometry; Internal medicine","score_opus":0.19398659916561622,"score_gpt":0.35620017870497095,"score_spread":0.16221357953935472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047386501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99568135,0.00049473165,0.0000059168106,0.001381631,0.00008125642,0.0010985362,0.000060472,0.0000140657185,0.0011820644],"genre_scores_gemma":[0.99904037,0.000034727036,0.00045811682,0.00024656308,0.000049347138,0.00004078901,0.000054896453,0.000016048096,0.000059165573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853987,0.0001045125,0.00045145172,0.00024703972,0.0003086563,0.00034849328],"domain_scores_gemma":[0.99904335,0.000044704128,0.000100764126,0.00029909288,0.00006561487,0.000446505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041818546,0.00012833103,0.00035707233,0.00015296487,0.000063598236,0.0000044959133,0.00009196495,0.00005080652,0.00022885998],"category_scores_gemma":[0.000087077446,0.00011144834,0.000080184465,0.00024147262,0.000040282088,0.00004466569,0.000019933712,0.00010042069,0.000022079315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110333494,0.0005841042,0.99575263,0.00022863226,0.00006234793,0.00007894103,0.0012866927,0.000050195988,0.0000037971204,0.0009416718,0.00012511208,0.0007755518],"study_design_scores_gemma":[0.00144528,0.0009358283,0.99410814,0.00023132953,0.000052354673,0.0000038332564,0.00026701792,0.0010100142,0.000010684057,0.0017248419,0.00013714726,0.000073529656],"about_ca_topic_score_codex":0.6760623,"about_ca_topic_score_gemma":0.021432407,"teacher_disagreement_score":0.6546299,"about_ca_system_score_codex":0.00030821364,"about_ca_system_score_gemma":0.00075705175,"threshold_uncertainty_score":0.9964239},"labels":[],"label_agreement":null},{"id":"W2047429877","doi":"10.1016/j.jval.2012.08.2107","title":"PCN67 Economic Evaluation of Mono and Sequential Hormone Therapies for ER+ Women With Early Breast Cancer in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Ministry of Health and Long Term Care; Toronto Public Health; St. Michael's Hospital","funders":"","keywords":"Breast cancer; Tamoxifen; Medicine; Quality-adjusted life year; Oncology; Aromatase; Cancer; Cost effectiveness; Gynecology; Internal medicine; Risk analysis (engineering)","score_opus":0.2859693099425884,"score_gpt":0.395296503625064,"score_spread":0.10932719368247562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047429877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9803901,0.009752973,0.00007452738,0.007056854,0.00032398792,0.0013668411,0.00094661437,0.000006148258,0.00008195345],"genre_scores_gemma":[0.9974766,0.0005652548,0.0004242465,0.0007554849,0.00017708534,0.0005506377,0.000009240229,0.000027296219,0.000014148565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961864,0.00042669114,0.0023450025,0.0003314826,0.00010888431,0.000601546],"domain_scores_gemma":[0.9977223,0.00041336202,0.0013830878,0.00023438987,0.000048254267,0.00019859271],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018992167,0.0001526329,0.0007887571,0.000280283,0.000066484645,0.000018602695,0.00011264871,0.00006572989,0.000115710456],"category_scores_gemma":[0.00013504164,0.00017978867,0.000021604077,0.000118782315,0.000040186114,0.00042289295,0.00001800382,0.0001080826,0.000008742248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017768303,0.00007728529,0.95138025,0.00058910827,0.00007424307,1.17623415e-7,0.01345945,0.021614088,0.00000474554,0.009164925,0.0005537109,0.002904415],"study_design_scores_gemma":[0.0023743443,0.0001266314,0.95269597,0.00011460093,0.0000043858463,0.000004332225,0.0023418427,0.038634602,0.0000027930669,0.0028338316,0.00063577254,0.000230887],"about_ca_topic_score_codex":0.9510279,"about_ca_topic_score_gemma":0.58468014,"teacher_disagreement_score":0.36634773,"about_ca_system_score_codex":0.007686955,"about_ca_system_score_gemma":0.003354754,"threshold_uncertainty_score":0.99612236},"labels":[],"label_agreement":null},{"id":"W2047594089","doi":"10.1016/j.jval.2012.08.1610","title":"PRM147 Comparison of Indirect and Mixed Treatment Comparison (MTC) Meta-Analysis Techniques Used in the Evaluation of New Protease Inhibitors for the Treatment of Chronic Hepatitis C","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Telaprevir; Boceprevir; Ribavirin; Medicine; Meta-analysis; Internal medicine; Publication bias; Chronic hepatitis; Oncology; Gastroenterology; Virology","score_opus":0.4475224363997746,"score_gpt":0.49907620779884393,"score_spread":0.051553771399069304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2047594089","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96369314,0.026106026,0.00016210448,0.0012756318,0.00002571332,0.008637652,0.00006632219,0.000008934166,0.000024465344],"genre_scores_gemma":[0.99573493,0.0015106511,0.0012030242,0.000012605929,0.00005434187,0.0014100807,0.0000458114,0.000014893131,0.000013632432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958369,0.0015862678,0.0011538604,0.00021745126,0.0008742349,0.00033125404],"domain_scores_gemma":[0.99766403,0.001016033,0.00056750275,0.0004866409,0.00015162343,0.0001141941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042429715,0.00018365841,0.0015652183,0.0004910785,0.000051531162,0.000006367961,0.000096601056,0.00008307834,0.00003506777],"category_scores_gemma":[0.00024407757,0.00009829995,0.00034910603,0.00085332786,0.000104459126,0.00005594544,0.000013544214,0.0001031192,4.112923e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016935276,0.0031187742,0.8262091,0.00035685915,0.0051186276,3.1747973e-7,0.017958878,0.0010497926,0.00018111093,0.000034971265,0.00010989746,0.14569226],"study_design_scores_gemma":[0.007300569,0.018336182,0.6238111,0.00022666556,0.045041878,0.0000019222707,0.0016013478,0.14651074,0.15371592,0.00011298511,0.0031069375,0.00023375405],"about_ca_topic_score_codex":0.11444484,"about_ca_topic_score_gemma":0.019027343,"teacher_disagreement_score":0.20239805,"about_ca_system_score_codex":0.0011288299,"about_ca_system_score_gemma":0.0009869102,"threshold_uncertainty_score":0.9988729},"labels":[],"label_agreement":null},{"id":"W2048142373","doi":"10.1016/j.jval.2012.03.472","title":"PMH27 Economic Impact Associated with Antidepressant Use in Depression and Anxiety in Community Living Older Adults","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Sherbrooke","funders":"","keywords":"Depression (economics); Anxiety; Antidepressant; Medicine; Mental health; Psychiatry; Population; Demography; Gerontology; Environmental health","score_opus":0.045695538816775884,"score_gpt":0.3473912005392989,"score_spread":0.301695661722523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048142373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976781,0.0010911054,0.0000017709563,0.0003715321,0.00013299409,0.00049091555,0.000016093509,0.00002461033,0.00019288776],"genre_scores_gemma":[0.9973281,0.0019665065,0.00006505917,0.0005510475,0.000042908778,0.000015483907,0.000004503111,0.000013260034,0.000013115078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99607694,0.0022671768,0.00042516016,0.00016310484,0.00015208757,0.0009155554],"domain_scores_gemma":[0.99762857,0.001688568,0.00016538467,0.00017893549,0.000014008772,0.00032455014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051822495,0.00012434003,0.00033601865,0.00014978457,0.00034087547,0.000052968036,0.00013104962,0.00013514768,0.000026907517],"category_scores_gemma":[0.0007951941,0.00010711797,0.000024904903,0.00022568302,0.00008123272,0.0006393096,0.00006891183,0.00052958576,0.0000018052833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002348888,0.00012839596,0.96083826,0.000103394574,0.0000022626782,9.0900386e-7,0.036902834,0.0005194724,9.799208e-8,0.00013397951,0.000054464588,0.0012924436],"study_design_scores_gemma":[0.0005890292,0.000029416473,0.989731,0.002009251,0.0000010261791,6.8633443e-7,0.0060890093,0.0013091086,5.9943784e-7,0.000028770775,0.00009540485,0.00011666157],"about_ca_topic_score_codex":0.8399249,"about_ca_topic_score_gemma":0.44019565,"teacher_disagreement_score":0.39972922,"about_ca_system_score_codex":0.0013713639,"about_ca_system_score_gemma":0.00058849633,"threshold_uncertainty_score":0.5700193},"labels":[],"label_agreement":null},{"id":"W2048344726","doi":"10.1016/j.jval.2010.10.019","title":"Cost-Effectiveness of Transdermal Nitroglycerin Use for Preterm Labor","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Preterm Birth and Chorioamnionitis","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; McMaster University; Public Health Ontario; University of Toronto; Kingston General Hospital; Ottawa Hospital; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Gestational age; Neonatal intensive care unit; Randomized controlled trial; Placebo; Cost effectiveness; Obstetrics; Pregnancy; Pediatrics; Surgery","score_opus":0.1579969204747736,"score_gpt":0.3458991948890179,"score_spread":0.18790227441424429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048344726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957329,0.0003594175,0.0010164315,0.00010189372,0.00019356179,0.0021869668,0.0001697225,0.000033472566,0.00020562022],"genre_scores_gemma":[0.9960431,0.00019717874,0.0032026495,0.00022273313,0.00004497154,0.00021697223,0.00002910994,0.000021896243,0.000021403781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988319,0.00019445192,0.000340157,0.00019361328,0.000117306896,0.00032254512],"domain_scores_gemma":[0.9992094,0.00025128853,0.000085993845,0.00021256006,0.00007104968,0.00016970964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048956595,0.00010871581,0.00035593775,0.00010823336,0.000029275274,0.000003739767,0.00006684719,0.000077060875,0.000027264743],"category_scores_gemma":[0.00010864428,0.00010180189,0.00008047702,0.00013350054,0.00004959662,0.00009447301,0.000009010335,0.00012636854,0.0000018971072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014824681,0.0010519766,0.9054217,0.016156292,0.00012361447,0.00008175199,0.009316461,0.00008746571,0.0050064134,0.0057141893,0.00011925053,0.04209624],"study_design_scores_gemma":[0.0070904586,0.0027699037,0.9622304,0.0015202825,0.000031746495,0.000054063326,0.00009580389,0.0011146086,0.022355253,0.0008187328,0.001739169,0.00017956842],"about_ca_topic_score_codex":0.0021171106,"about_ca_topic_score_gemma":0.000029314602,"teacher_disagreement_score":0.056808744,"about_ca_system_score_codex":0.00008977681,"about_ca_system_score_gemma":0.00028444413,"threshold_uncertainty_score":0.41513604},"labels":[],"label_agreement":null},{"id":"W2048399100","doi":"10.1016/j.jval.2013.08.892","title":"Canadian Private Payers’ Perceptions and Expectations of Submission Requests for Drug Reimbursement Submitted by the Pharmaceutical Industry","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Reimbursement; Agency (philosophy); Business; Actuarial science; Population; Productivity; Private sector; Family medicine; Health care; Medicine; Economics; Environmental health","score_opus":0.3024639696780433,"score_gpt":0.43516995105489825,"score_spread":0.13270598137685496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048399100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7919417,0.0023834119,0.00032592894,0.20257255,0.00021410051,0.0019824186,0.00031397655,0.000015447895,0.0002504703],"genre_scores_gemma":[0.9914092,0.00032905914,0.0014312486,0.005913717,0.00008888888,0.00044536655,0.000055992106,0.0000226782,0.0003038904],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963231,0.00044075685,0.002339687,0.0003539738,0.00007071501,0.00047173278],"domain_scores_gemma":[0.9976316,0.0007932842,0.00077646686,0.0003083146,0.000054871045,0.00043545064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069435784,0.00012748057,0.0004550673,0.00027756757,0.00029413795,0.00004287919,0.00017249599,0.00014334531,0.0002734912],"category_scores_gemma":[0.001045233,0.0001321348,0.000046501325,0.0002008633,0.00007385625,0.00021933629,0.000021509526,0.00030698066,0.00008455892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017971402,0.00027960804,0.559162,0.0013890938,0.00007458699,4.149013e-7,0.029796198,0.0010680073,0.000050082293,0.13074598,0.2750667,0.002349371],"study_design_scores_gemma":[0.004412551,0.00038479434,0.56239545,0.0008846053,0.000020566591,0.000016394935,0.039039645,0.16273065,0.00006794222,0.059649594,0.16928616,0.0011116094],"about_ca_topic_score_codex":0.293602,"about_ca_topic_score_gemma":0.009953834,"teacher_disagreement_score":0.28364816,"about_ca_system_score_codex":0.0010307501,"about_ca_system_score_gemma":0.000473847,"threshold_uncertainty_score":0.71110195},"labels":[],"label_agreement":null},{"id":"W2048879818","doi":"10.1016/j.jval.2014.08.119","title":"Abraxane Versus Taxol For Patients with Advanced Breast Cancer: A Prospective Time and Motion Analysis from a Chinese Health Care Perspective","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Premedication; Breast cancer; Paclitaxel; Adverse effect; Cancer; Psychological intervention; Emergency medicine; Internal medicine; Anesthesia","score_opus":0.008759623679871185,"score_gpt":0.329815392597895,"score_spread":0.3210557689180238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2048879818","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99029785,0.0020842187,0.00010809279,0.0039252737,0.00015227922,0.002360392,0.0009505711,0.000038791266,0.00008252327],"genre_scores_gemma":[0.99748665,0.00024510798,0.0010168692,0.00038684075,0.00016542732,0.00029441682,0.00035910885,0.0000218073,0.000023744737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99872875,0.00011979441,0.00023172077,0.0004564675,0.00016014143,0.0003031074],"domain_scores_gemma":[0.9990627,0.00017575065,0.00020443818,0.00015110114,0.0002031467,0.00020281899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011336902,0.00018114582,0.00060072273,0.00020680977,0.00011080762,0.0000072102507,0.00003401225,0.00004537123,0.000046037738],"category_scores_gemma":[0.000031581163,0.00013966914,0.000063467334,0.0005101704,0.00004299605,0.00006657954,0.000012622388,0.00012326983,0.0000016098352],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015167665,0.0007021991,0.9378925,0.00024615144,0.0008681107,0.0000015912422,0.012814152,0.0018214716,0.000008608632,0.00007103348,0.00008119097,0.030325316],"study_design_scores_gemma":[0.023539666,0.0052490947,0.9642735,0.00013555338,0.00035123754,0.0000011938963,0.000558177,0.0055476073,0.0000045848656,0.00008497216,0.00011305579,0.00014136771],"about_ca_topic_score_codex":0.046662584,"about_ca_topic_score_gemma":0.0056897667,"teacher_disagreement_score":0.040972818,"about_ca_system_score_codex":0.0019470726,"about_ca_system_score_gemma":0.00037342065,"threshold_uncertainty_score":0.9596858},"labels":[],"label_agreement":null},{"id":"W2049697547","doi":"10.1016/s1098-3015(10)61262-4","title":"PHP24 USE OF POLICY MODELING TO PROMOTE INFORMED DECISION MAKING: DEVELOPMENT AND APPLICATION OF THE CANADIAN STROKE POLICY MODEL","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stroke (engine); Policy making; Policy development; Business; Actuarial science; Public administration; Political science; Engineering","score_opus":0.47286894067765156,"score_gpt":0.43394753715072243,"score_spread":0.03892140352692913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049697547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9368578,0.0003463363,0.03375549,0.026564552,0.000074822565,0.0016285059,0.00021471518,0.000010832453,0.00054690795],"genre_scores_gemma":[0.9540493,0.000084242805,0.040887643,0.0047967923,0.000048661128,0.000056475412,0.00000294953,0.000016795384,0.00005714001],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9959923,0.00009414844,0.0031241346,0.0002857098,0.00011482412,0.00038888463],"domain_scores_gemma":[0.99788857,0.00027709416,0.0011050288,0.0004210868,0.000060789516,0.00024743928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004665802,0.000119291864,0.0005161248,0.0010364236,0.00017245088,0.000027496275,0.00021223167,0.00010065441,0.0000054195402],"category_scores_gemma":[0.0033013166,0.00013122674,0.000038054826,0.00048540227,0.000029109995,0.00020707847,0.000059951042,0.000116982,0.000028922648],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007944008,0.000044009874,0.01484766,0.00047745946,0.000010039916,3.6835573e-8,0.012370913,0.82579225,9.937932e-7,0.1351975,0.00022787075,0.011023302],"study_design_scores_gemma":[0.00023125502,0.000023035776,0.006841017,0.00024054297,5.7229755e-7,0.0000010075563,0.00010622536,0.9801676,0.0000040158293,0.008668121,0.0036108296,0.00010574216],"about_ca_topic_score_codex":0.37926102,"about_ca_topic_score_gemma":0.09123491,"teacher_disagreement_score":0.2880261,"about_ca_system_score_codex":0.0025349932,"about_ca_system_score_gemma":0.0022669388,"threshold_uncertainty_score":0.9253477},"labels":[],"label_agreement":null},{"id":"W2049719754","doi":"10.1016/j.jval.2013.03.574","title":"Cost to society due to underemployment in persons with hemophilia A and B – hemophilia utilization group study v (HUGS V)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Underemployment; Medicine; Earnings; Wage; Pediatrics; Demography; Compensation (psychology); Unemployment; Psychology; Labour economics; Economics; Finance; Social psychology","score_opus":0.12784024138465724,"score_gpt":0.37361998689373804,"score_spread":0.2457797455090808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049719754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9642038,0.00018170092,0.000110752524,0.027795868,0.00004454246,0.007474609,0.0000069279195,0.00004310191,0.00013869572],"genre_scores_gemma":[0.9947501,0.000093873125,0.0019338644,0.0018639322,0.00006082166,0.00055342156,0.000017633862,0.00003870765,0.00068764534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763536,0.00019457994,0.000407258,0.00057606655,0.00052869495,0.00065802305],"domain_scores_gemma":[0.99877536,0.00011187088,0.00004489928,0.00034357823,0.00007073345,0.0006535565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007642744,0.00022978995,0.00048654506,0.00030766355,0.00012527163,0.0000408541,0.00009059369,0.000080844635,0.000058778005],"category_scores_gemma":[0.00005846356,0.00017406532,0.000039712155,0.0009669486,0.000049020473,0.00009536754,0.000087814304,0.00027609942,0.000060616374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041218585,0.0031416311,0.94375974,0.00060010905,0.00007789385,0.0001563298,0.030668782,0.00042906334,0.00027420087,0.00022206784,0.0026751715,0.017582834],"study_design_scores_gemma":[0.0061825444,0.0070150387,0.96814305,0.00078254007,0.000019970668,0.00006138716,0.011889437,0.0045211674,0.00007095722,0.00016592372,0.0008544026,0.00029360192],"about_ca_topic_score_codex":0.012656537,"about_ca_topic_score_gemma":0.0014505726,"teacher_disagreement_score":0.030546298,"about_ca_system_score_codex":0.00082089717,"about_ca_system_score_gemma":0.00031946079,"threshold_uncertainty_score":0.99391824},"labels":[],"label_agreement":null},{"id":"W2049810647","doi":"10.1016/j.jval.2012.08.740","title":"PHP198 From Science to Service: The Ontario Patient Reported Outcomes of Symptoms and Toxicity (On-PROST) Research Unit","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Prom; Standardization; Medicine; Quality of life (healthcare); Health care; Family medicine; Nursing; Computer science; Political science","score_opus":0.14552885857160391,"score_gpt":0.40306017889567075,"score_spread":0.25753132032406684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2049810647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99143714,0.00030306837,0.0000018321452,0.0063988497,0.00037064232,0.00069766474,0.000010348809,0.000011279912,0.00076917035],"genre_scores_gemma":[0.9964651,0.00001600399,0.000065135144,0.0032734193,0.000050307346,0.000026543512,0.0000032667517,0.000008558434,0.00009169325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978949,0.0001877285,0.00037150306,0.00024797564,0.00083410845,0.0004637745],"domain_scores_gemma":[0.9984834,0.00032541144,0.000092981136,0.0005404709,0.0002232861,0.0003344433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027951635,0.00008869874,0.00025689977,0.00019123648,0.00014971473,0.000013414979,0.00013527351,0.000041107145,0.00003463517],"category_scores_gemma":[0.0003011821,0.000058079633,0.000022115271,0.00092217186,0.0001286943,0.00006248094,0.00012934432,0.0003489635,0.0000059293257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011217345,0.000121452045,0.9563882,0.000067403445,0.000008996037,0.0000024616238,0.039515078,0.000025799916,0.0003014471,0.00028700972,0.000055959885,0.0031140675],"study_design_scores_gemma":[0.00034363774,0.0004970602,0.9923423,0.0002588079,0.000005426529,0.0000043404834,0.0022064298,0.000048006947,0.0017913495,0.00012598315,0.0023192645,0.0000573976],"about_ca_topic_score_codex":0.6659501,"about_ca_topic_score_gemma":0.109934725,"teacher_disagreement_score":0.55601543,"about_ca_system_score_codex":0.0005487822,"about_ca_system_score_gemma":0.0010614002,"threshold_uncertainty_score":0.9063066},"labels":[],"label_agreement":null},{"id":"W2050050244","doi":"10.1016/j.jval.2012.03.351","title":"PMD11 Budget Impact of Converting Standard Treatment of Menorrhagia from Rollerball to Thermal Balloon Ablation in Canadian Hospitals","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Balloon; Ablation; Surgery; Activity-based costing; Environmental science; Business","score_opus":0.029963244373344435,"score_gpt":0.27413896234862156,"score_spread":0.24417571797527712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050050244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902305,0.0054291133,0.000039153016,0.00035630146,0.00023462059,0.00046770164,0.0012019281,0.0000041859034,0.0020365142],"genre_scores_gemma":[0.99921036,0.00020180456,0.00029895816,0.00012616221,0.00007466777,0.0000202905,0.000021539006,0.000018817422,0.000027423244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816054,0.000040006915,0.0009917833,0.00020076362,0.000033717595,0.0005731989],"domain_scores_gemma":[0.9989131,0.00005882286,0.0005028424,0.0001997429,0.000020276482,0.0003051914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088762277,0.00013695813,0.00066313735,0.00040838556,0.00003631182,0.000008270605,0.000107921,0.000073368305,0.00017137488],"category_scores_gemma":[0.00006788038,0.00015354133,0.00009256216,0.00022861452,0.00001825192,0.00019516617,0.00001590002,0.00007127276,0.00002348299],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009612556,0.00008391138,0.9688836,0.00001729101,0.000025500864,0.0000012058468,0.0045098937,0.020285409,0.000014768242,0.0031584084,0.00005741405,0.002866523],"study_design_scores_gemma":[0.0010850396,0.00087573245,0.992256,0.000044869932,0.0000019045815,4.706596e-7,0.00010231221,0.0031081722,0.00009593812,0.0013585669,0.0009175679,0.00015346767],"about_ca_topic_score_codex":0.9263972,"about_ca_topic_score_gemma":0.064510934,"teacher_disagreement_score":0.86188626,"about_ca_system_score_codex":0.0034444437,"about_ca_system_score_gemma":0.00055732025,"threshold_uncertainty_score":0.9525593},"labels":[],"label_agreement":null},{"id":"W2050130923","doi":"10.1016/j.jval.2014.03.069","title":"Role Of Patient Input In The Cedac Drug Reimbursement Decision Making Process","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Reimbursement; Medicine; Drug; Placebo; Agency (philosophy); Logistic regression; Family medicine; Internal medicine; Health care; Pharmacology; Alternative medicine; Political science","score_opus":0.20506975669043787,"score_gpt":0.4179627945694909,"score_spread":0.21289303787905306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050130923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97854906,0.002483434,0.0006191166,0.014819325,0.00029911747,0.0011129599,0.000029052619,0.000013635695,0.0020743152],"genre_scores_gemma":[0.9901209,0.00010399324,0.0019069655,0.0076289396,0.00009532647,0.00011264766,0.0000056659455,0.000017991077,0.0000075965268],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99346185,0.00096592936,0.0045326552,0.00043019233,0.000176586,0.0004327901],"domain_scores_gemma":[0.9954924,0.0017656977,0.0021064219,0.00052436366,0.000035315876,0.00007578739],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.030849619,0.00013741106,0.0007157828,0.00045266259,0.00009461144,0.000028456618,0.00035876082,0.0000714789,0.000045087894],"category_scores_gemma":[0.0026439473,0.00013977854,0.00005871557,0.00038223714,0.000032681277,0.00017998488,0.000042294825,0.00022451105,0.00011437641],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007452867,0.0007441837,0.43862158,0.0023130358,0.000018688066,9.2868027e-7,0.09252716,0.103093326,0.0000011918588,0.33550668,0.0042600785,0.02283863],"study_design_scores_gemma":[0.0020786354,0.0005580404,0.23038623,0.0028690451,0.0000030956871,0.000006587934,0.021233106,0.21152446,0.00001546845,0.48271164,0.047984798,0.0006288922],"about_ca_topic_score_codex":0.0054809605,"about_ca_topic_score_gemma":0.0006144784,"teacher_disagreement_score":0.20823534,"about_ca_system_score_codex":0.00057989167,"about_ca_system_score_gemma":0.00021206355,"threshold_uncertainty_score":0.99794424},"labels":[],"label_agreement":null},{"id":"W2050176772","doi":"10.1016/j.jval.2013.03.1357","title":"Excite – A New Collaborative Model Of Pre-Market Evaluation Of Health Technologies","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Health and Long Term Care; Ottawa Hospital; University of Ottawa; University of Toronto; McMaster University; Programs for Assessment of Technology in Health Research Institute; Toronto Public Health; MaRS","funders":"","keywords":"Health technology; Commercialization; Government (linguistics); Reimbursement; Excellence; Business; Public relations; Health care; Marketing; Political science","score_opus":0.4841969374519139,"score_gpt":0.44856431479494646,"score_spread":0.03563262265696743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050176772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7123173,0.06305511,0.023444338,0.18373892,0.0006733569,0.01058367,0.0007507763,0.00018816192,0.0052483645],"genre_scores_gemma":[0.97861665,0.001408379,0.017385442,0.0018625126,0.000033672837,0.00030447054,0.000019591855,0.000032036372,0.00033723383],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99039924,0.0014322777,0.006839309,0.0005364372,0.0002788271,0.0005139357],"domain_scores_gemma":[0.9924167,0.0007854596,0.005715796,0.0006621489,0.00030048253,0.00011946282],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.042477526,0.00019177214,0.0015057179,0.00075789343,0.000087705856,0.000021668715,0.00031734793,0.00017134655,0.00023532032],"category_scores_gemma":[0.005614193,0.00023739197,0.00007786863,0.00072364754,0.00010275927,0.0004947229,0.000060881226,0.00019354388,0.0001057728],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007655266,0.00071769446,0.04246128,0.006207677,0.00014962055,9.8057576e-8,0.03278108,0.5029052,0.000017525965,0.26816148,0.11779729,0.02872451],"study_design_scores_gemma":[0.0011781084,0.00024148477,0.018261744,0.00047455495,0.0000026871114,5.449557e-7,0.003130291,0.7958184,0.000013100262,0.17954609,0.0011415434,0.0001914877],"about_ca_topic_score_codex":0.035555974,"about_ca_topic_score_gemma":0.00028759934,"teacher_disagreement_score":0.29291317,"about_ca_system_score_codex":0.0013711051,"about_ca_system_score_gemma":0.0037277995,"threshold_uncertainty_score":0.9859709},"labels":[],"label_agreement":null},{"id":"W2050192040","doi":"10.1016/s1098-3015(10)70023-1","title":"CASE 2 DRUG ELUTING STENTS—AN EXAMPLE OFTHETRANSITION FROM EVIDENCETO POLICYTHROUGHTHE ONTARIO COMPREHENSIVE APPROACHTOTHE DIFFUSION OF HEALTHTECHNOLOGIES","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Diffusion; Drug-eluting stent; Medicine; Internal medicine; Pharmacology; Stent; Physics; Thermodynamics; Restenosis","score_opus":0.3444027444756034,"score_gpt":0.32492176232762154,"score_spread":0.01948098214798183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050192040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939861,0.0018014312,0.00037485446,0.0022544973,0.00019726645,0.00048435037,0.00022289495,0.00005113265,0.0006274359],"genre_scores_gemma":[0.9940467,0.00169219,0.0022886025,0.0017610268,0.00009440816,0.000020237536,0.00002860142,0.000027031338,0.00004121788],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99752545,0.00011554257,0.0012578894,0.0005295157,0.000049979706,0.00052162295],"domain_scores_gemma":[0.9984679,0.00022933651,0.00059944304,0.0005004647,0.00002450731,0.00017834941],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006533971,0.0002008372,0.0007049634,0.00032820046,0.00023471036,0.000017494693,0.00025609776,0.00013103266,0.0001041572],"category_scores_gemma":[0.00003855581,0.00022519736,0.000103065046,0.0002693887,0.00015248457,0.0002601567,0.00008162966,0.00041014678,0.0000419142],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004996975,0.0028357382,0.32462403,0.0012661981,0.00020864354,0.0004387782,0.23043147,0.035026174,0.00029497108,0.3904182,0.0010199867,0.012936102],"study_design_scores_gemma":[0.011332387,0.0018703955,0.23752207,0.00091253966,0.000030006906,0.0017449382,0.011259444,0.33662942,0.001180536,0.33094978,0.06371096,0.0028575135],"about_ca_topic_score_codex":0.84050316,"about_ca_topic_score_gemma":0.0341028,"teacher_disagreement_score":0.80640036,"about_ca_system_score_codex":0.0005840835,"about_ca_system_score_gemma":0.00020851962,"threshold_uncertainty_score":0.9835223},"labels":[],"label_agreement":null},{"id":"W2050365725","doi":"10.1016/j.jval.2014.03.492","title":"Cost-Effectiveness of Arsenic Trioxide in the Treatment of Relapsed/Refractory Acute Promyelocytic Lymphoma LEUKEMIA in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Arsenic trioxide; Acute promyelocytic leukemia; Refractory (planetary science); Internal medicine; Adverse effect; Oncology; Retinoic acid; Arsenic","score_opus":0.022179697083158992,"score_gpt":0.273917739624355,"score_spread":0.251738042541196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050365725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967436,0.0021982847,0.000053213225,0.000044724446,0.000089756686,0.00072207267,0.000010420786,0.000001627205,0.00013630332],"genre_scores_gemma":[0.9976751,0.0019737734,0.00008416201,0.00006085335,0.000026372494,0.00011675552,0.000031871114,0.000013670249,0.000017446191],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9979434,0.00084168965,0.0004964457,0.0002708313,0.00016561811,0.00028201682],"domain_scores_gemma":[0.9991357,0.00023027064,0.0001996529,0.00035949377,0.000030759365,0.000044178272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008897518,0.00014782863,0.00035456454,0.00007536709,0.000018706774,0.0000028990432,0.00021063488,0.000099309356,0.0000011336224],"category_scores_gemma":[0.000098306555,0.00011247039,0.00005031356,0.00023556466,0.00005559906,0.0000033316003,0.000018000857,0.00007561817,3.3685785e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045673144,0.0026834388,0.39545032,0.00715019,0.00029215662,0.00020606154,0.0056701065,0.10199895,0.32136387,0.0011927214,0.00022460154,0.15920028],"study_design_scores_gemma":[0.014966518,0.005673114,0.21587095,0.0010706899,0.000040683753,0.00006355888,0.0011493268,0.0055124606,0.7407416,0.0006049797,0.013736151,0.00056997413],"about_ca_topic_score_codex":0.5800205,"about_ca_topic_score_gemma":0.18285067,"teacher_disagreement_score":0.41937774,"about_ca_system_score_codex":0.002015221,"about_ca_system_score_gemma":0.0060327733,"threshold_uncertainty_score":0.9996021},"labels":[],"label_agreement":null},{"id":"W2050464419","doi":"10.1016/j.jval.2013.03.153","title":"Modelling drug class effects in bayesian multiple treatment comparison meta-analysis: Applications in early and advanced parkinson's disease","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Drug class; Drug; Medicine; Random effects model; Parkinson's disease; Class (philosophy); Pharmacology; Disease; Internal medicine; Computer science; Meta-analysis; Artificial intelligence","score_opus":0.4652705594039648,"score_gpt":0.5116672727313282,"score_spread":0.04639671332736339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050464419","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4414352,0.0021850704,0.5499641,0.0011855231,0.000051760853,0.005033686,0.00006453044,0.000052311752,0.00002783959],"genre_scores_gemma":[0.5904666,0.000092406786,0.4079313,0.00005273883,0.000013674469,0.0014109508,0.0000031681416,0.000016930906,0.000012218094],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99479955,0.002459126,0.001461255,0.00059944333,0.00024956636,0.00043105494],"domain_scores_gemma":[0.9578192,0.04092507,0.00034664065,0.0005317617,0.00003134066,0.00034596285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002270046,0.00024806111,0.0018501424,0.00032972993,0.00005475485,0.000036377314,0.00014624045,0.000081813865,0.000017054894],"category_scores_gemma":[0.003820179,0.00019784574,0.0002468055,0.00075934804,0.0000581172,0.0000825153,0.00003931157,0.000266038,0.000006896084],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019474879,0.003024486,0.24185283,0.0013201936,0.0032937515,0.000014531146,0.0030801073,0.6847629,0.0000036551507,0.052477084,0.000025031733,0.009950672],"study_design_scores_gemma":[0.0010660802,0.00006827646,0.014187052,0.000037807233,0.0019227645,4.4887333e-8,0.00006852679,0.6379082,0.000006484946,0.3445453,0.000053487107,0.0001359492],"about_ca_topic_score_codex":0.008650179,"about_ca_topic_score_gemma":0.00089683576,"teacher_disagreement_score":0.2920682,"about_ca_system_score_codex":0.0002780516,"about_ca_system_score_gemma":0.000083722305,"threshold_uncertainty_score":0.9979513},"labels":[],"label_agreement":null},{"id":"W2050640972","doi":"10.1046/j.1524-4733.2001.40202-259.x","title":"PWM7: THE EFFECT AND ECONOMIC IMPACT OF STANDARDIZED ORDERS ON THE PREVENTION AND TREATMENT OF PONV IN HOSPITALIZED GYNECOLOGICAL SURGERY PATIENTS","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital","funders":"","keywords":"Medicine; Intensive care medicine; General surgery; Surgery","score_opus":0.023877990398167206,"score_gpt":0.31673299721049153,"score_spread":0.29285500681232435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050640972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738383,0.00045613095,5.400876e-7,0.00091674936,0.00003913663,0.0010241466,0.000006050289,0.0000037730376,0.0001696585],"genre_scores_gemma":[0.99779856,0.0020871018,0.0000062597715,0.000044662796,0.000009237169,0.00002390003,0.0000050834374,0.0000053718654,0.000019807312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865055,0.0006230493,0.00034945598,0.00012401633,0.00010247957,0.00015046561],"domain_scores_gemma":[0.9963226,0.0033673416,0.00012216822,0.00012501214,0.000009314368,0.000053578777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011404598,0.00009794774,0.0007049307,0.000074498894,0.000023745824,0.0000038184985,0.000018685683,0.00004607926,0.000026890682],"category_scores_gemma":[0.0002572806,0.000043692078,0.00019831225,0.000077783014,0.00007011133,0.000016127995,0.000006506274,0.00005155021,4.7029144e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001427377,0.00013341352,0.9873347,0.000037991224,0.00004152225,0.0000070642527,0.00020776248,0.00013490491,0.0000015837973,0.00012382268,0.000012463312,0.010537348],"study_design_scores_gemma":[0.003477419,0.00403418,0.9917218,0.00009287847,0.000017972197,0.000005889342,0.000029161449,0.0001925533,0.0000134162765,0.000045016226,0.00033389553,0.00003580992],"about_ca_topic_score_codex":0.0034843679,"about_ca_topic_score_gemma":0.00004265504,"teacher_disagreement_score":0.010501538,"about_ca_system_score_codex":0.0003556255,"about_ca_system_score_gemma":0.00014708526,"threshold_uncertainty_score":0.5267345},"labels":[],"label_agreement":null},{"id":"W2050988623","doi":"10.1016/j.jval.2013.03.009","title":"Adjusting For Inflation In Economic Evaluations Of Health Technologies: Are We Doing It Wrong?","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Inflation (cosmology); Economics; Discounting; Real interest rate; Econometrics; Interest rate; Macroeconomics","score_opus":0.4809796062102137,"score_gpt":0.46421806928495524,"score_spread":0.016761536925258447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2050988623","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43505514,0.02057298,0.019389158,0.5130596,0.0011951987,0.009121737,0.0004643268,0.00021174832,0.0009301131],"genre_scores_gemma":[0.9755344,0.001532021,0.018561704,0.003170991,0.000099631856,0.000935926,0.000046305133,0.00004871195,0.00007032129],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.990172,0.00062345207,0.007742739,0.0006403199,0.00009059636,0.00073087116],"domain_scores_gemma":[0.9916292,0.0021539584,0.005510615,0.00054488576,0.00006861661,0.00009272033],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02870313,0.0002111833,0.0013964977,0.001214882,0.00019203525,0.000043282766,0.0003093173,0.00020107046,0.00011190511],"category_scores_gemma":[0.0035446733,0.00028946926,0.000101173246,0.00038569042,0.00006281862,0.00062200014,0.000059274134,0.00026293972,0.00028634517],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022515545,0.00032116254,0.3721503,0.009121153,0.000051875562,2.506634e-7,0.015017432,0.38487485,0.000004320189,0.16827518,0.018826231,0.031334713],"study_design_scores_gemma":[0.0030801268,0.0003834479,0.11701227,0.0032527298,0.0000033300894,0.0000031357526,0.023986084,0.7180496,0.000008824497,0.10706775,0.026498439,0.0006542551],"about_ca_topic_score_codex":0.027298603,"about_ca_topic_score_gemma":0.0019818426,"teacher_disagreement_score":0.54047924,"about_ca_system_score_codex":0.00320146,"about_ca_system_score_gemma":0.0010344413,"threshold_uncertainty_score":0.9999558},"labels":[],"label_agreement":null},{"id":"W2051446824","doi":"10.1016/j.jval.2011.02.913","title":"PCN58 IS CYP2D6 GENETIC TEST IN COMBINATION WITH HORMONE THERAPY FOR ER+ HORMONE SENSITIVE WOMEN WITH EARLY BREAST CANCER COST-EFFECTIVE?","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; St. Michael's Hospital","funders":"","keywords":"Tamoxifen; Medicine; Breast cancer; Oncology; Aromatase; Internal medicine; Genetic testing; CYP2D6; Aromatase inhibitor; Hormone therapy; Cancer; Gynecology","score_opus":0.01956320537545525,"score_gpt":0.2750943489068541,"score_spread":0.25553114353139883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051446824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923299,0.0020279824,0.0015755827,0.00054975325,0.000046843463,0.0031599815,0.0002245579,0.000012482741,0.00007290771],"genre_scores_gemma":[0.99219245,0.0016917929,0.0024558885,0.0006502237,0.00007450422,0.0028128945,0.000028751885,0.00005282423,0.000040663926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985164,0.0001325498,0.0002627359,0.0004822745,0.00015032402,0.0004557561],"domain_scores_gemma":[0.9991995,0.000054552525,0.00016946744,0.00027470975,0.00019818991,0.00010358839],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032910763,0.00021006688,0.00024234662,0.00012649354,0.00007360162,0.000014349191,0.00011186316,0.00011886501,0.000005982511],"category_scores_gemma":[0.00001283037,0.00018149705,0.000023451226,0.00032491316,0.000109965564,0.000010702566,0.000022740924,0.00013612624,0.00000179985],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029836403,0.0040009613,0.4481505,0.0004243237,0.0007484852,0.000068248046,0.061587095,0.010008768,0.1357707,0.00020227184,0.0019100333,0.30729222],"study_design_scores_gemma":[0.006226299,0.0067848433,0.9718151,0.000078776786,0.000007730081,0.000046512192,0.00051667605,0.00070197287,0.012832208,0.00015510547,0.00051318284,0.00032156537],"about_ca_topic_score_codex":0.004647505,"about_ca_topic_score_gemma":0.0005022483,"teacher_disagreement_score":0.52366465,"about_ca_system_score_codex":0.0005654372,"about_ca_system_score_gemma":0.000598487,"threshold_uncertainty_score":0.7401235},"labels":[],"label_agreement":null},{"id":"W2051531643","doi":"10.1016/j.jval.2012.08.1227","title":"PCN34 Relationship Between Progression-Free Survival and Overall Survival in Chronic Lymphocytic Leukemia","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Manitoba; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Context (archaeology); Progression-free survival; Chronic lymphocytic leukemia; Oncology; Surrogate endpoint; Population; Clinical endpoint; Overall survival; Clinical trial; Leukemia","score_opus":0.10165529097467764,"score_gpt":0.3796639260114467,"score_spread":0.2780086350367691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051531643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879773,0.007776094,0.00003453291,0.0009956518,0.00035359347,0.0012743325,0.000014966175,0.00008691889,0.0014866134],"genre_scores_gemma":[0.9973616,0.0004824048,0.00068135426,0.000104083236,0.0008433839,0.00006859873,0.000049455994,0.00006605302,0.00034306955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99522245,0.00080522476,0.0009410328,0.0005144818,0.0010484175,0.0014683895],"domain_scores_gemma":[0.9958686,0.0023228363,0.00017856003,0.00083371095,0.000050934115,0.0007453274],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0047056386,0.00029281754,0.0007628631,0.00048634966,0.0001277715,0.000029161127,0.000262613,0.00029208092,0.000043080923],"category_scores_gemma":[0.0018964908,0.0002682292,0.00006992323,0.00072649017,0.00019181942,0.00027066845,0.0002889034,0.0007815736,0.00006487222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00022993296,0.00006390774,0.98665315,0.001813782,0.000021667827,0.000060130966,0.0010771229,0.0010339818,0.000018225539,0.0057708584,0.0003408653,0.0029163617],"study_design_scores_gemma":[0.029311066,0.00045450722,0.9366959,0.001558346,0.000020045389,0.00010078427,0.00015814263,0.028570062,0.000045269197,0.0015458468,0.0012333118,0.00030675158],"about_ca_topic_score_codex":0.029775376,"about_ca_topic_score_gemma":0.0005540129,"teacher_disagreement_score":0.12857385,"about_ca_system_score_codex":0.1792936,"about_ca_system_score_gemma":0.050719753,"threshold_uncertainty_score":0.999977},"labels":[],"label_agreement":null},{"id":"W2051978677","doi":"10.1016/j.jval.2012.03.279","title":"PMS90 the Influence of ‘Weak Links' on Comparative Treatment Effects in Multiple Treatment Comparison Meta-Analysis: A Simulation Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University","funders":"","keywords":"Meta-analysis; Spurious relationship; Statistics; Cluster (spacecraft); Treatment effect; Confidence interval; Treatment and control groups; Multiple comparisons problem; Medicine; Econometrics; Mathematics; Computer science; Internal medicine","score_opus":0.8576107612714143,"score_gpt":0.6472244818715237,"score_spread":0.21038627939989063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2051978677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907921,0.00049465836,0.0037511762,0.00018321835,0.000094485105,0.0045751217,0.00004126042,0.000024331715,0.000043652257],"genre_scores_gemma":[0.94970626,0.000014362735,0.049660157,0.000059456182,0.00004365675,0.0004853531,0.0000019919623,0.000014974515,0.000013790351],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9878067,0.008958008,0.0019755678,0.0003760873,0.00046115127,0.00042251364],"domain_scores_gemma":[0.86422557,0.13421199,0.00074352266,0.0006404758,0.000049293274,0.0001291644],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0054290113,0.00030612075,0.0029172353,0.00025021136,0.00007777522,0.000012720807,0.00016946955,0.00012259536,0.000019471961],"category_scores_gemma":[0.010611228,0.00017037876,0.00042961902,0.00085069926,0.000081504855,0.000053740092,0.000033139837,0.000285703,0.000012901883],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033279505,0.013549867,0.12339442,0.000102733604,0.0099987155,0.0000017949181,0.018623173,0.82729405,0.0000028876543,0.005863128,0.0000044461726,0.00083197514],"study_design_scores_gemma":[0.009135355,0.014114069,0.54110974,0.00012735299,0.037242964,3.780286e-7,0.0027344562,0.340041,0.00034462838,0.05462462,0.00006581949,0.0004596248],"about_ca_topic_score_codex":0.004625303,"about_ca_topic_score_gemma":0.0009547141,"teacher_disagreement_score":0.48725304,"about_ca_system_score_codex":0.0005983798,"about_ca_system_score_gemma":0.00008266838,"threshold_uncertainty_score":0.9977228},"labels":[],"label_agreement":null},{"id":"W2052331218","doi":"10.1016/j.jval.2014.08.180","title":"Loyalty To A Pharmacy Is Associated With A Better Quality Of Antidiabetes Drug Use","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Rimouski; Université Laval","funders":"","keywords":"Pharmacy; Medicine; Drug; Medical prescription; Odds ratio; Pharmacology; Internal medicine; Family medicine","score_opus":0.25734515814398945,"score_gpt":0.45994033944541707,"score_spread":0.20259518130142762,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052331218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750843,0.00008102661,0.00006293405,0.0238723,0.00008203589,0.0005611819,0.000039443505,0.000028215843,0.00018855506],"genre_scores_gemma":[0.9695774,0.000035834357,0.0010298251,0.02916634,0.000039724724,0.000008307509,0.000012709912,0.000016093914,0.00011378276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978618,0.0006559355,0.0005465457,0.00022356906,0.00036599181,0.00034617493],"domain_scores_gemma":[0.99765396,0.0014733801,0.00026483528,0.00022099727,0.00007958143,0.00030725342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019375768,0.00012033873,0.00049134885,0.000106241445,0.00003852317,0.000010552432,0.000067157045,0.000028830651,0.000071305854],"category_scores_gemma":[0.0011768863,0.0000906307,0.000053844706,0.00032901973,0.00003852244,0.00012623069,0.000029357238,0.00028437725,0.000017398197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003373349,0.00036328667,0.99418473,0.00042869887,0.000045049666,0.0000023553625,0.0010932287,0.000065504086,0.0001774582,0.00009296354,0.0011255,0.0020838978],"study_design_scores_gemma":[0.006040965,0.0008952381,0.9451329,0.0011333723,0.000070897535,0.0000024644876,0.000076096185,0.017075006,0.0027181315,0.00025568294,0.026322275,0.0002769661],"about_ca_topic_score_codex":0.0066829217,"about_ca_topic_score_gemma":0.00006113876,"teacher_disagreement_score":0.049051818,"about_ca_system_score_codex":0.00009477479,"about_ca_system_score_gemma":0.00013408938,"threshold_uncertainty_score":0.99993163},"labels":[],"label_agreement":null},{"id":"W2052523186","doi":"10.1016/j.jval.2012.08.2162","title":"PCN122 Pilot Survey to Estimate Willingness to Pay (WTP) for Prophylactic Granulocyte Colony-Stimulating Factors (G-CSFs) Among Previously Treated Breast Cancer Patients","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Pegfilgrastim; Filgrastim; Breast cancer; Willingness to pay; Febrile neutropenia; Granulocyte colony-stimulating factor; Population; Internal medicine; Cancer; Intensive care medicine; Emergency medicine; Chemotherapy; Neutropenia; Family medicine","score_opus":0.07195591865236585,"score_gpt":0.3759923843507202,"score_spread":0.30403646569835435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052523186","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925404,0.000080473284,0.0002920645,0.00052251946,0.000837054,0.005324067,0.0002685055,0.00010561523,0.000029293955],"genre_scores_gemma":[0.99774444,0.000016086682,0.00034028233,0.00045413905,0.0002062041,0.0008953638,0.000102174374,0.00008292986,0.0001583991],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99729407,0.00028402754,0.0006706364,0.00044956655,0.00031759412,0.0009841365],"domain_scores_gemma":[0.99804926,0.00030137718,0.0002240615,0.00030447583,0.0002937301,0.00082706957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086836086,0.00030272204,0.00063820067,0.00020840806,0.00027647344,0.00003268452,0.000107134314,0.0000740411,0.000037538695],"category_scores_gemma":[0.00030333232,0.00023032275,0.000072596114,0.0008119932,0.000032601696,0.0001941132,0.000042416596,0.00024946147,0.000017243712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088588375,0.00057842786,0.98634756,0.0005915218,0.000024915642,9.17477e-7,0.0010380857,0.008264719,0.000104763734,0.000008258317,0.00012714481,0.0020278012],"study_design_scores_gemma":[0.002034451,0.0021887184,0.9935222,0.00055634766,0.000051961764,0.000004160602,0.000018764953,0.00090673997,0.00020988648,0.0000046455334,0.00025063413,0.00025144787],"about_ca_topic_score_codex":0.07148412,"about_ca_topic_score_gemma":0.005225221,"teacher_disagreement_score":0.06625889,"about_ca_system_score_codex":0.0011700828,"about_ca_system_score_gemma":0.0004132682,"threshold_uncertainty_score":0.9392289},"labels":[],"label_agreement":null},{"id":"W2052701606","doi":"10.1016/j.jval.2014.03.540","title":"Physicians’ Preferences for Bone Metastases Treatments in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Medicine; Prostate cancer; Logistic regression; Web survey; Ordered logit; Internal medicine; Physical therapy; Cancer","score_opus":0.06192680202814914,"score_gpt":0.3237420691066812,"score_spread":0.26181526707853203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052701606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938628,0.0012740502,0.000021297063,0.0029781505,0.00019122251,0.0012361537,0.000077719764,0.00001424231,0.00034437008],"genre_scores_gemma":[0.9957967,0.00020151025,0.0015227469,0.00201161,0.000033860495,0.00018576984,0.00008304605,0.000014174661,0.00015062578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857056,0.00013602963,0.0004061179,0.00024302896,0.000176513,0.00046776858],"domain_scores_gemma":[0.9992793,0.00021949284,0.000111252695,0.00017947885,0.000020377334,0.00019006626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028038007,0.00012902053,0.00046094108,0.000100425146,0.000046724417,0.0000033313204,0.000035257395,0.000028716751,0.000009204923],"category_scores_gemma":[0.00007495467,0.000106281856,0.000032356213,0.00018009698,0.000011797869,0.00003490009,0.00000671393,0.00008906574,0.0000045653055],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044020155,0.0009248816,0.7939611,0.0011866066,0.000060530787,0.000034350825,0.0004205029,0.00038481937,0.000008240027,0.0006212939,0.0017819359,0.20017555],"study_design_scores_gemma":[0.011437101,0.0021375867,0.9657125,0.0010130547,0.000056855388,0.000014628314,0.00029901904,0.005063086,0.00023372719,0.0019385368,0.011884146,0.00020976552],"about_ca_topic_score_codex":0.98335713,"about_ca_topic_score_gemma":0.9236724,"teacher_disagreement_score":0.19996579,"about_ca_system_score_codex":0.0010394984,"about_ca_system_score_gemma":0.0023544575,"threshold_uncertainty_score":0.43340483},"labels":[],"label_agreement":null},{"id":"W2052781276","doi":"10.1016/j.jval.2013.03.915","title":"A cost-minimization analysis of a new fixed-dose combination of dutasteride and tamsulosin compared to concomitant administration of both monotherapies for the treatment of symptomatic benign prostatic hyperplasia in Quebec, Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Hôpital Saint-François d'Assise; GlaxoSmithKline (Canada)","funders":"","keywords":"Dutasteride; Tamsulosin; Concomitant; Medicine; Combination therapy; Urology; Cohort; Hyperplasia; Internal medicine; Prostate","score_opus":0.057907778313355134,"score_gpt":0.34207798974834147,"score_spread":0.28417021143498633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052781276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298275,0.0006225129,0.00033639706,0.002402867,0.000012924887,0.0035539109,0.00008187227,0.0000019395989,0.0000048133056],"genre_scores_gemma":[0.9983581,0.0003211884,0.0010146521,0.0000340563,0.000003074581,0.00014862197,0.00006509126,0.000007530019,0.000047725243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998645,0.00015218946,0.00072896696,0.000120879275,0.00021612157,0.00013685224],"domain_scores_gemma":[0.99872845,0.0006309146,0.00028429792,0.00015831816,0.000119424876,0.00007857785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024134947,0.00008748712,0.00054690574,0.0002986864,0.000017680002,0.0000052396254,0.000040356495,0.000024314631,0.000012920933],"category_scores_gemma":[0.00006793575,0.00006474302,0.000035686346,0.00054248393,0.00004341059,0.000045414992,0.0000056293206,0.000028070386,4.3117364e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007494708,0.0042520007,0.76223093,0.007941983,0.0016170866,0.0000069911166,0.11165489,0.042607978,0.0063686967,0.00066971435,0.0005024367,0.05465261],"study_design_scores_gemma":[0.0046809064,0.004652641,0.7413202,0.00046896827,0.00017371858,0.0000020753002,0.0040617036,0.24116261,0.0032724126,0.00009253038,0.000044805714,0.00006743473],"about_ca_topic_score_codex":0.84307796,"about_ca_topic_score_gemma":0.6562491,"teacher_disagreement_score":0.19855464,"about_ca_system_score_codex":0.00024315096,"about_ca_system_score_gemma":0.0014111015,"threshold_uncertainty_score":0.35002348},"labels":[],"label_agreement":null},{"id":"W2052823328","doi":"10.1016/j.jval.2012.08.1031","title":"PCV88 Venous Thromboembolism: A Systematic Literature Review to Identify Multi-Attribute Utility Values for Use in Economic Models","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Venous thromboembolism; Preference; Medicine; Rivaroxaban; Population; Systematic review; Economic evaluation; MEDLINE; Actuarial science; Statistics; Surgery; Internal medicine; Economics; Pathology; Environmental health; Mathematics","score_opus":0.5817296022474935,"score_gpt":0.48568281790191614,"score_spread":0.09604678434557734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2052823328","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2864809,0.63300925,0.019901115,0.028969375,0.0040218346,0.023494061,0.0038309158,0.00017796269,0.00011454594],"genre_scores_gemma":[0.88321096,0.048283413,0.024972126,0.038457524,0.000772512,0.0035727944,0.00023711531,0.0001934868,0.00030007583],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9879664,0.0017182583,0.008006364,0.0009054944,0.00012231962,0.0012811371],"domain_scores_gemma":[0.9937347,0.0020808245,0.0024388847,0.0011113408,0.0000758238,0.00055842614],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.045931567,0.0003927991,0.0034317567,0.0007761946,0.00017462486,0.00015633028,0.00047575074,0.00025371337,0.0000541332],"category_scores_gemma":[0.0048212404,0.00048252934,0.00025430127,0.0004972194,0.0000348289,0.0017309411,0.000093511204,0.00035889694,0.0008514878],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000419874,0.0020183697,0.10597736,0.70161587,0.00019785429,0.00000447284,0.034054253,0.021565465,7.9805e-7,0.09455527,0.039818954,0.00014935083],"study_design_scores_gemma":[0.004971903,0.0005147561,0.15942776,0.22562085,0.00006681029,0.00006770225,0.0017217068,0.57352966,0.0000027169706,0.023259448,0.008284296,0.002532403],"about_ca_topic_score_codex":0.005121974,"about_ca_topic_score_gemma":0.0004273553,"teacher_disagreement_score":0.59673005,"about_ca_system_score_codex":0.0026320436,"about_ca_system_score_gemma":0.00027018407,"threshold_uncertainty_score":0.99992645},"labels":[],"label_agreement":null},{"id":"W2053237380","doi":"10.1016/j.jval.2013.03.1195","title":"The Humanistic And Economic Impact Of Following Evidence-Based Asthma Controller Therapy: A Simulation Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Asthma; Status quo; Medicine; Guideline; Exacerbation; Actuarial science; Intensive care medicine; Environmental health; Economics; Internal medicine","score_opus":0.46680825583966806,"score_gpt":0.4745853399092269,"score_spread":0.007777084069558848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053237380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980666,0.008707693,0.00045761213,0.0069812443,0.0002505924,0.0028414342,0.000023890925,0.000019112284,0.0000524645],"genre_scores_gemma":[0.9981892,0.0002520335,0.00016215049,0.0010518904,0.00009869376,0.0001894065,0.0000022767656,0.000025078345,0.000029287718],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99437624,0.0010843179,0.003639681,0.0004154119,0.00008191991,0.00040243816],"domain_scores_gemma":[0.9910865,0.006379673,0.0019469318,0.0004085108,0.00003649629,0.00014191758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020527672,0.00017790114,0.00093550317,0.00027122378,0.00028198012,0.00012177844,0.0002027655,0.000068636786,0.0001020251],"category_scores_gemma":[0.0021186534,0.00016151792,0.00015661567,0.00012120492,0.000053921583,0.00044560398,0.00002437933,0.00014408796,0.00018673528],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007566901,0.00017872326,0.5927364,0.00015069671,0.00012347673,3.3752613e-7,0.0030757124,0.39556563,0.0000021896253,0.006419446,0.00054900936,0.0011227143],"study_design_scores_gemma":[0.0017454948,0.00066336046,0.44550112,0.00012902211,0.0000015341988,2.7106813e-7,0.0005399473,0.54567075,2.1843532e-7,0.0053848177,0.00023192256,0.00013154761],"about_ca_topic_score_codex":0.06432013,"about_ca_topic_score_gemma":0.00037471662,"teacher_disagreement_score":0.1501051,"about_ca_system_score_codex":0.0014029674,"about_ca_system_score_gemma":0.0005685235,"threshold_uncertainty_score":0.9419106},"labels":[],"label_agreement":null},{"id":"W2053356357","doi":"10.1016/j.jval.2011.08.1468","title":"PSS3 Incidence and Characteristics of Patients with Macular Edema Secondary to Retinal Vein Occlusion in A Representative Canadian Cohort","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Lawson Health Research Institute","funders":"","keywords":"Medicine; Cohort; Incidence (geometry); Retinal Vein; Macular edema; Occlusion; Visual acuity; Comorbidity; Pediatrics; Ophthalmology; Optometry; Surgery; Internal medicine","score_opus":0.020360646970622544,"score_gpt":0.28634583049189966,"score_spread":0.2659851835212771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053356357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998246,0.00013993836,0.000005432108,0.0003080031,0.000022905697,0.0008783157,0.00009001285,0.0000036937834,0.00030566737],"genre_scores_gemma":[0.99848676,0.00007917238,0.00088308885,0.00044180057,0.000007692174,0.000013886143,0.000056808905,0.000010580207,0.000020224177],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989782,0.000095879885,0.00027895626,0.00023291941,0.00018596926,0.0002280951],"domain_scores_gemma":[0.9992554,0.000025434703,0.000103802384,0.00015078083,0.00006742358,0.00039714837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020271156,0.00009579846,0.000279022,0.00019060307,0.000031332285,0.0000029960006,0.000039062994,0.000033512144,0.000048211215],"category_scores_gemma":[0.0000669371,0.00007888913,0.000015262245,0.00019088855,0.00003849771,0.000040739476,0.000029994044,0.00010158978,0.0000031056973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007273373,0.00015731943,0.99482775,0.00018998967,0.000012179706,0.0002919281,0.0024133623,0.0000013955861,0.0000022989493,0.00002923994,0.00004344258,0.0013037848],"study_design_scores_gemma":[0.0010496882,0.0011693053,0.9967128,0.00062675826,0.000014943158,0.00000849825,0.00018543104,0.00008896353,0.000014266442,0.000029058974,0.00003876752,0.00006149696],"about_ca_topic_score_codex":0.33297774,"about_ca_topic_score_gemma":0.01647337,"teacher_disagreement_score":0.31650436,"about_ca_system_score_codex":0.00025143227,"about_ca_system_score_gemma":0.00057802506,"threshold_uncertainty_score":0.9192527},"labels":[],"label_agreement":null},{"id":"W2053407368","doi":"10.1016/s1098-3015(10)72231-2","title":"PCN143 COST-EFFECTIVENESS OBSERVATIONS AND ONCOLOGY DRUG REIMBURSEMENT RECOMMENDATIONS IN CANADA BY THE JOINT ONCOLOGY DRUG REVIEW","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; Medicine; Oncology; Internal medicine; Cancer drugs; Medical physics; Pharmacology; Health care; Political science","score_opus":0.5093231635004623,"score_gpt":0.45965030460700906,"score_spread":0.04967285889345319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053407368","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22891182,0.024832213,0.000107997796,0.7384186,0.0019709235,0.0042320136,0.00056651456,0.000025439964,0.0009345204],"genre_scores_gemma":[0.7186199,0.054177128,0.003393994,0.21844256,0.0003548037,0.004292172,0.00023399215,0.00012336326,0.00036208052],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9916388,0.0027654395,0.0043420955,0.0005784811,0.00011290985,0.0005623132],"domain_scores_gemma":[0.9925193,0.004749298,0.0019155826,0.0005281023,0.0000786903,0.0002089781],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04734965,0.00018811312,0.0011900925,0.00019387856,0.00030712318,0.000022954231,0.00026778784,0.000093706316,0.00018967396],"category_scores_gemma":[0.0040901382,0.00020262627,0.000047921098,0.00037092628,0.00007902087,0.0002307012,0.00007249191,0.0007440352,0.00004080421],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00002112895,0.0005369417,0.21577364,0.00383519,0.00005781877,0.0000044813964,0.005254979,0.001099493,0.0000046560403,0.110785104,0.6372275,0.025399063],"study_design_scores_gemma":[0.0009333936,0.00006368117,0.08892844,0.000791079,0.000004070411,0.00001028561,0.0011238812,0.0039191647,0.0000022208621,0.003495119,0.9005018,0.00022690455],"about_ca_topic_score_codex":0.9446515,"about_ca_topic_score_gemma":0.96413875,"teacher_disagreement_score":0.519976,"about_ca_system_score_codex":0.0099576395,"about_ca_system_score_gemma":0.0056640403,"threshold_uncertainty_score":0.99997294},"labels":[],"label_agreement":null},{"id":"W2053604687","doi":"10.1016/j.jval.2012.08.744","title":"PHP202 Bridging the Gap Between Institutional Levels Using Systems Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; McMaster University","funders":"","keywords":"Referral; Bridging (networking); Health care; Bridge (graph theory); Process (computing); Discrete event simulation; Process management; Resource (disambiguation); Healthcare system; Work (physics); Risk analysis (engineering); Medicine; Operations management; Computer science; Management science; Nursing; Business; Engineering; Political science; Simulation","score_opus":0.43726074280246835,"score_gpt":0.4912338118245542,"score_spread":0.05397306902208587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053604687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81082153,0.002054369,0.17755869,0.005766842,0.0015956953,0.0014339447,0.00012446432,0.000077144134,0.0005673293],"genre_scores_gemma":[0.99274397,0.000069426766,0.0046958625,0.00084338494,0.0013648297,0.0000616945,0.000075236254,0.000017715012,0.00012785557],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9951181,0.0024459667,0.0010851863,0.00021875497,0.0003360767,0.00079593045],"domain_scores_gemma":[0.99834573,0.000612241,0.0003201288,0.00033210966,0.00013231169,0.00025748424],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0062143877,0.00013534422,0.0003922101,0.00036379386,0.0021927021,0.000026702433,0.00014276986,0.00015942041,0.00007072642],"category_scores_gemma":[0.00028853636,0.00010308511,0.000067753164,0.0015542903,0.000043670803,0.0002713034,0.000052410876,0.00066562503,0.000049739923],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000024485673,0.000022823038,0.43361375,0.00019949632,0.00004310922,3.572821e-7,0.0036140243,0.5508781,0.000004256455,0.011140419,0.00008541307,0.00039582636],"study_design_scores_gemma":[0.00031922295,0.000018381465,0.19493954,0.00043539793,0.00006579792,0.0000024827789,0.0018198515,0.7984449,0.0000011839666,0.00004358406,0.003745081,0.00016456713],"about_ca_topic_score_codex":0.035581615,"about_ca_topic_score_gemma":0.00018436872,"teacher_disagreement_score":0.24756682,"about_ca_system_score_codex":0.0009777698,"about_ca_system_score_gemma":0.0016714347,"threshold_uncertainty_score":0.9991063},"labels":[],"label_agreement":null},{"id":"W2053813657","doi":"10.1016/s1098-3015(10)75067-1","title":"PIN8 BUDGET-IMPACT ANALYSIS OF ADDING THE NEW 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION (PHID-CV) TO ROUTINE INFANT VACCINATION IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vaccination; Medicine; Pneumococcal vaccination; Pneumococcal conjugate vaccine; Pediatrics; Conjugate vaccine; Virology; Immunization; Immunology; Streptococcus pneumoniae; Microbiology; Biology","score_opus":0.03519441871529376,"score_gpt":0.38077839402442115,"score_spread":0.3455839753091274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053813657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95574665,0.00039809613,0.0001335714,0.04082251,0.0003354561,0.0020911202,0.00008242249,0.000030819145,0.00035935352],"genre_scores_gemma":[0.99385905,0.00030835773,0.000090492926,0.0052847373,0.00020786001,0.000009268872,0.000090821595,0.000018182693,0.00013120582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948364,0.0013952166,0.0018412943,0.00044109373,0.0005339014,0.0009520946],"domain_scores_gemma":[0.997514,0.0006572387,0.00073428696,0.00048340714,0.00014221994,0.00046884324],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029735877,0.0002481751,0.0008152593,0.00087474537,0.00032349344,0.000010196127,0.0002878932,0.000113705195,0.00040703657],"category_scores_gemma":[0.0005641157,0.00019078601,0.000114266106,0.0028637424,0.0000046110877,0.00012530747,0.000061445804,0.00075855135,0.00001333731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0005129538,0.00036973145,0.75412095,0.0006448849,0.00009999416,0.000008702063,0.014449703,0.17435537,0.00019137353,0.0026909064,0.012946871,0.03960857],"study_design_scores_gemma":[0.0013012118,0.00021815905,0.9649211,0.0006054783,0.00003299044,5.8112175e-7,0.000925716,0.03080456,0.000014234923,0.00016345194,0.000854896,0.00015757864],"about_ca_topic_score_codex":0.92720586,"about_ca_topic_score_gemma":0.8877872,"teacher_disagreement_score":0.2108002,"about_ca_system_score_codex":0.0050524995,"about_ca_system_score_gemma":0.0077417674,"threshold_uncertainty_score":0.9987669},"labels":[],"label_agreement":null},{"id":"W2053867416","doi":"10.1016/s1098-3015(10)74367-9","title":"PCN116 A SURVIVAL BASED COST-EFFECTIVENESS ANALYSIS OF 5 YEARS LETROZOLE VERSUS TAMOXIFEN AS ADJUVANT THERAPY IN POSTMENOPAUSAL WOMEN WITH EARLY BREAST CANCER: CANADIAN PERSPECTIVE","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Letrozole; Tamoxifen; Medicine; Oncology; Postmenopausal women; Breast cancer; Adjuvant; Perspective (graphical); Adjuvant therapy; Internal medicine; Gynecology; Cancer; Computer science","score_opus":0.20833622063429436,"score_gpt":0.4100900685544098,"score_spread":0.20175384792011547,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2053867416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98114765,0.0013323536,0.00003909462,0.01409574,0.00023087022,0.001480715,0.0012056963,0.000018538749,0.00044936515],"genre_scores_gemma":[0.996534,0.0002693202,0.00011906784,0.0027301346,0.000062836356,0.0002179236,0.000028274411,0.000028346494,0.000010101625],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952435,0.0011140401,0.0019768963,0.00066653464,0.00016709794,0.0008319409],"domain_scores_gemma":[0.99685776,0.0010189258,0.0011105512,0.00044932857,0.0001118954,0.00045156508],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011117772,0.00023428691,0.0015904871,0.0020463897,0.00008638348,0.000036617017,0.00026104267,0.0001295249,0.0002109202],"category_scores_gemma":[0.0003894676,0.00028604767,0.00007843328,0.0018275396,0.000067620684,0.00024240628,0.000010111047,0.00026290087,0.000040765623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021504092,0.0004442882,0.8666376,0.00012625863,0.00049972045,0.00001657101,0.015033727,0.084954664,0.0000040518325,0.028614499,0.000048552338,0.0014696661],"study_design_scores_gemma":[0.0038313062,0.0013824718,0.9847208,0.0001284333,0.000009902836,9.767093e-7,0.0021403925,0.0063986843,0.0000012831711,0.0008495649,0.0002674636,0.00026871276],"about_ca_topic_score_codex":0.9192067,"about_ca_topic_score_gemma":0.2768019,"teacher_disagreement_score":0.64240474,"about_ca_system_score_codex":0.00995965,"about_ca_system_score_gemma":0.0029772667,"threshold_uncertainty_score":0.9999592},"labels":[],"label_agreement":null},{"id":"W2054041177","doi":"10.1046/j.1524-4733.2001.40202-108.x","title":"PCV34: DECISION ANALYSIS MODEL OF ABCIXIMAB, EPTIFIBATIDE OR STANDARD THERAPY IN ELECTIVE STENT PLACEMENT: A CANADIAN PERSPECTIVE","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"London Health Sciences Centre","funders":"","keywords":"Eptifibatide; Abciximab; Perspective (graphical); Medicine; Stent; Computer science; Internal medicine; Artificial intelligence; Conventional PCI","score_opus":0.4078045772591365,"score_gpt":0.4431745297970234,"score_spread":0.035369952537886884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054041177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667554,0.003328354,0.012629252,0.013002688,0.0001569549,0.0016235553,0.0006660384,0.000017864839,0.0018198737],"genre_scores_gemma":[0.9886295,0.0031174647,0.004740263,0.003165952,0.000047267735,0.00010782798,0.000020404399,0.000030753,0.00014054732],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99367166,0.00057551765,0.0041267998,0.0007154247,0.00018598598,0.00072464376],"domain_scores_gemma":[0.9967697,0.0009964784,0.0012095157,0.0005171112,0.00014842108,0.00035872994],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.015981108,0.00022191128,0.0014763877,0.0026923714,0.00013336874,0.000034586417,0.000268297,0.00014096657,0.00029965647],"category_scores_gemma":[0.0017391407,0.0002556154,0.00015903788,0.0017347983,0.000050345334,0.00028514417,0.000023067198,0.0002571512,0.000059451384],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005392539,0.00019933323,0.30130115,0.00008373091,0.00016863599,0.0000033826996,0.018342713,0.63382065,7.3308905e-7,0.04422039,0.0006299578,0.0006900318],"study_design_scores_gemma":[0.0036370147,0.0007424655,0.09226686,0.00025914802,0.000010533506,0.0000027568537,0.0082889255,0.84493047,0.000004968841,0.047799207,0.0015995937,0.00045806187],"about_ca_topic_score_codex":0.66411805,"about_ca_topic_score_gemma":0.5131095,"teacher_disagreement_score":0.21110979,"about_ca_system_score_codex":0.009783135,"about_ca_system_score_gemma":0.0027320448,"threshold_uncertainty_score":0.9999896},"labels":[],"label_agreement":null},{"id":"W2054212101","doi":"10.1016/j.jval.2011.02.213","title":"PCV25 MANAGEMENT OF ACUTE ISCHEMIC STROKE AND ITS LONG TERM EVOLUTION IN THE UNITED STATES AND CANADA","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Term (time); Medicine; Acute stroke; Stroke (engine); Ischemic stroke; Intensive care medicine; Cardiology; Internal medicine; Ischemia; Engineering; Physics","score_opus":0.029079602563535933,"score_gpt":0.2677637973450324,"score_spread":0.2386841947814965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054212101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99502057,0.0009737141,0.000047522677,0.0012165495,0.000042355077,0.00071772124,0.000023965142,0.000007591993,0.0019499881],"genre_scores_gemma":[0.9966477,0.001929835,0.00044520485,0.0005882173,0.000010384381,0.000021484086,0.0000332499,0.000009180417,0.00031474902],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894655,0.00006929554,0.0003243769,0.00018815341,0.00022362215,0.00024798216],"domain_scores_gemma":[0.9995717,0.000041190866,0.00010823842,0.00018875184,0.000021034277,0.00006909022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004473616,0.00010570927,0.00019837727,0.00017139109,0.000025759993,0.0000032605535,0.000087024506,0.00002908121,0.000009953279],"category_scores_gemma":[0.00000852731,0.00008214359,0.000010797627,0.00021613427,0.00003404673,0.000035592602,0.00007929287,0.00014838968,4.6456415e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034440076,0.00023909236,0.9704954,0.0040620416,0.00034957676,0.00042116488,0.0055741225,0.00007809231,0.0004215189,0.0012560766,0.013888701,0.0028698095],"study_design_scores_gemma":[0.0016730798,0.00018749293,0.9906708,0.00064226845,0.00008661579,0.00003347785,0.0026317537,0.0024940565,0.00044174094,0.00001498141,0.0010263879,0.00009732728],"about_ca_topic_score_codex":0.55108577,"about_ca_topic_score_gemma":0.031689614,"teacher_disagreement_score":0.5193961,"about_ca_system_score_codex":0.0002709861,"about_ca_system_score_gemma":0.00011283844,"threshold_uncertainty_score":0.98597956},"labels":[],"label_agreement":null},{"id":"W2054319555","doi":"10.1016/s1098-3015(10)69035-3","title":"PIN14 A CANADIAN COST-EFFECTIVENESS ANALYSIS OF DARUNAVIR FOR HIV INFECTION IN TREATMENTEXPERIENCED ADULTS","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Darunavir; Human immunodeficiency virus (HIV); Medicine; Virology; Antiretroviral therapy; Viral load","score_opus":0.05760583743073214,"score_gpt":0.4241122929084349,"score_spread":0.3665064554777028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054319555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945298,0.00015965082,0.002379458,0.00029327025,0.000029856294,0.0018242269,0.00008874909,0.000008933028,0.0006860573],"genre_scores_gemma":[0.9990948,0.00010226554,0.00016737178,0.000046992107,0.000016042775,0.000254939,0.00014558938,0.000008218411,0.00016382514],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986321,0.00017162572,0.00042236407,0.00020243552,0.00014401104,0.00042746187],"domain_scores_gemma":[0.99911815,0.00022805939,0.000069645415,0.00016584458,0.00009441615,0.00032389746],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013837437,0.000080072095,0.0003644178,0.0017598934,0.00004951952,0.0000042802017,0.000039543585,0.000056733294,0.000048831684],"category_scores_gemma":[0.00040965455,0.00007445368,0.0001511181,0.0017189014,0.00003773786,0.000055813223,0.0000064319897,0.00011541869,0.000003005112],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094224536,0.00061894004,0.9418334,0.0005620235,0.00017910883,0.000019607347,0.0023275907,0.0010641096,0.00011425252,0.00044785303,0.00012603666,0.051764872],"study_design_scores_gemma":[0.00361356,0.0032475821,0.95406806,0.00082537025,0.0000465732,0.0000022576262,0.0005446617,0.03552901,0.0005951794,0.000030815347,0.001429925,0.00006698859],"about_ca_topic_score_codex":0.81101537,"about_ca_topic_score_gemma":0.7654435,"teacher_disagreement_score":0.051697884,"about_ca_system_score_codex":0.0014001162,"about_ca_system_score_gemma":0.0006075956,"threshold_uncertainty_score":0.36612552},"labels":[],"label_agreement":null},{"id":"W2054449667","doi":"10.1016/s1098-3015(10)70784-1","title":"PIH10 THE COST-EFFECTIVENESS OF ROUTINE SCREENING FOR VASA PREVIA AT 18-20 WEEKS GESTATION IN ONTARIO","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Banana Cultivation and Research","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gestation; Medicine; Obstetrics; Pregnancy; Biology","score_opus":0.25225103845987457,"score_gpt":0.3499825312487835,"score_spread":0.09773149278890891,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054449667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99679136,0.00009946639,0.000059219936,0.0015882239,0.000039625942,0.0012667915,0.000012954726,0.000007602456,0.0001347636],"genre_scores_gemma":[0.9992132,0.000053687658,0.00014373641,0.000069970716,0.00002425473,0.000082775245,0.000058920064,7.1944595e-7,0.00035273994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987733,0.00043599546,0.0002509944,0.00015606316,0.0001630371,0.00022064595],"domain_scores_gemma":[0.9989152,0.00085797935,0.000089005276,0.00003857329,0.000054421445,0.00004480365],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015289851,0.00006127933,0.00014979178,0.000019483821,0.00017921187,0.0000059177164,0.00011351008,0.000047906888,0.00006398131],"category_scores_gemma":[0.00010887931,0.000021522705,0.000038558246,0.00030455316,0.000048333175,0.000047808808,0.000030275258,0.00014089012,0.0000021695805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002932563,0.00015688958,0.9520454,0.00011979296,0.00000537365,0.0000018329541,0.0010951178,0.0037795063,0.0061481968,0.00051867554,0.0002047828,0.035631184],"study_design_scores_gemma":[0.00038298775,0.00021650454,0.9932004,0.00012571685,5.87432e-7,0.0000024489739,0.00007964532,0.0015834401,0.00040399513,0.000089312576,0.003869041,0.000045875717],"about_ca_topic_score_codex":0.2148905,"about_ca_topic_score_gemma":0.24887185,"teacher_disagreement_score":0.04115505,"about_ca_system_score_codex":0.00021991658,"about_ca_system_score_gemma":0.000070625734,"threshold_uncertainty_score":0.7903376},"labels":[],"label_agreement":null},{"id":"W2055167882","doi":"10.1016/j.jval.2011.08.708","title":"PHP158 Determining the Monetary Value of a Quality-Adjusted Life Year (QALY): Systematic Review of the Evidence","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Valuation (finance); Quality-adjusted life year; Medicine; Actuarial science; Economics; Econometrics; Cost effectiveness; Accounting","score_opus":0.6681938736228007,"score_gpt":0.4472842326389003,"score_spread":0.22090964098390037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055167882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5846015,0.34350705,0.0006931088,0.05531105,0.0017350873,0.011674447,0.00036027297,0.000068572415,0.0020488878],"genre_scores_gemma":[0.95847726,0.015378143,0.0016652994,0.024069883,0.00009451314,0.00019832535,0.000004570318,0.00004128549,0.00007073762],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9852018,0.0043689944,0.009318185,0.00043930317,0.00025357926,0.00041816558],"domain_scores_gemma":[0.98675996,0.0037321942,0.007754078,0.0014779364,0.00012144446,0.00015436522],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.05686416,0.00020550718,0.0021638845,0.00020231734,0.0001291539,0.000012005942,0.00089983566,0.000106673666,0.00009742426],"category_scores_gemma":[0.026914446,0.0001621229,0.00026279414,0.00055985403,0.00014123165,0.00025619444,0.00012098073,0.0002896672,0.00014312284],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017871183,0.00017075027,0.14522915,0.7359708,0.00008927101,2.6736424e-7,0.008736335,0.00036539917,6.428966e-7,0.107958324,0.0014425784,0.000018609137],"study_design_scores_gemma":[0.0011849273,0.00034559786,0.50099874,0.46909755,0.00009386345,0.000006115168,0.0035163187,0.012033999,0.000013226122,0.011854084,0.00023354121,0.0006220574],"about_ca_topic_score_codex":0.015644886,"about_ca_topic_score_gemma":0.000113721915,"teacher_disagreement_score":0.37387574,"about_ca_system_score_codex":0.00036866733,"about_ca_system_score_gemma":0.00065162714,"threshold_uncertainty_score":0.99091},"labels":[],"label_agreement":null},{"id":"W2055539075","doi":"10.1016/j.jval.2014.03.314","title":"what happens when personalized medicine guidelines don’t agree? A systematic review of clinical guidelines for thiopurine methyltransferase testing for dose selection of thiopurines","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Thiopurine methyltransferase; Medicine; Dosing; Pharmacogenomics; Azathioprine; Mercaptopurine; MEDLINE; Family medicine; Intensive care medicine; Internal medicine; Disease; Pharmacology","score_opus":0.4437603056896165,"score_gpt":0.5448023567234817,"score_spread":0.10104205103386515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055539075","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009517944,0.9604763,0.00520772,0.009508253,0.0007825164,0.023795582,0.00013016418,0.00006981435,0.000020144356],"genre_scores_gemma":[0.0000018401208,0.92767346,0.065004446,0.0023698697,0.0017882617,0.0020905875,0.00037228258,0.0001963569,0.00050291367],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9775368,0.0025902786,0.01615224,0.0012140974,0.001563245,0.0009433491],"domain_scores_gemma":[0.96494764,0.019852925,0.0055573126,0.0012767096,0.0078069395,0.0005584801],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03547233,0.0009697857,0.016541867,0.0009051548,0.00010978215,0.000019803589,0.0006960311,0.00067308627,0.000054049357],"category_scores_gemma":[0.14934117,0.00062203803,0.0017868212,0.0012628365,0.00033217642,0.00015856905,0.000107174805,0.00075078703,0.000004397815],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024310761,0.0001657763,0.00001695338,0.91425544,0.0005093045,0.0000051262264,0.00010653224,0.000008451426,0.0000025490383,0.0002147398,0.010242927,0.074229114],"study_design_scores_gemma":[0.005227557,0.00285462,0.000001153202,0.8505542,0.004204339,0.00030807187,0.000111522066,0.008175342,0.0000023833445,0.00015973095,0.1280618,0.00033923905],"about_ca_topic_score_codex":0.0021459823,"about_ca_topic_score_gemma":0.000062745705,"teacher_disagreement_score":0.11781887,"about_ca_system_score_codex":0.0008525957,"about_ca_system_score_gemma":0.008324587,"threshold_uncertainty_score":0.9996231},"labels":[],"label_agreement":null},{"id":"W2055783092","doi":"10.1016/j.jval.2012.03.1248","title":"PCN131 Patients' Out-of-Pocket (OOP) Costs for Granulocyte Colony-Stimulating Factors (G-CSF)","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pegfilgrastim; Filgrastim; Medicine; Quarter (Canadian coin); Pharmacy; Emergency medicine; Internal medicine; Granulocyte colony-stimulating factor; Chemotherapy; Family medicine","score_opus":0.08375457258882472,"score_gpt":0.36424041647867067,"score_spread":0.28048584388984593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2055783092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99511886,0.00039757745,0.00023980871,0.00046831643,0.0014475376,0.0014352383,0.000094240306,0.000039278668,0.00075916277],"genre_scores_gemma":[0.9981743,0.00004488395,0.00068080873,0.0005836614,0.00020549793,0.00007643892,0.00006916616,0.00002906777,0.00013614095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985501,0.000101508616,0.0004958792,0.00017545001,0.00019993688,0.00047712206],"domain_scores_gemma":[0.99893266,0.00030708255,0.00019760693,0.00020982214,0.00010749843,0.0002453017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004486604,0.00013367685,0.00038974482,0.00013345163,0.00011141687,0.0000057557413,0.000054142947,0.00007384134,0.0000640093],"category_scores_gemma":[0.000223849,0.00011986588,0.000094089235,0.00020104044,0.000035121207,0.000117082694,0.000021380587,0.00017556915,0.000010857993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012557229,0.00033095674,0.99223286,0.00039305314,0.00001656948,2.7200616e-7,0.0011066328,0.00019922187,0.00013528326,0.00034507882,0.0016358417,0.0034786446],"study_design_scores_gemma":[0.00568284,0.0022559536,0.9502039,0.00064665196,0.00006957462,0.0000032267553,0.00028761075,0.0010064269,0.0022900717,0.000107402404,0.03716798,0.0002783601],"about_ca_topic_score_codex":0.0025632633,"about_ca_topic_score_gemma":0.000097310796,"teacher_disagreement_score":0.042028975,"about_ca_system_score_codex":0.0004379649,"about_ca_system_score_gemma":0.00020999236,"threshold_uncertainty_score":0.4887989},"labels":[],"label_agreement":null},{"id":"W2056341565","doi":"10.1016/j.jval.2010.11.018","title":"Trends in Health Care Utilization in British Columbia Following Public Coverage for Tiotropium","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Poisoning and overdose treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Confidence interval; Emergency medicine; Public health; Emergency department; Health care; Medical emergency; Environmental health; Internal medicine","score_opus":0.10419377702165145,"score_gpt":0.34219033860804804,"score_spread":0.2379965615863966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056341565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993921,0.0032541803,0.00012754656,0.0007502765,0.00033701098,0.0008140878,0.000044419026,0.000055132616,0.0006963524],"genre_scores_gemma":[0.9968328,0.00036514903,0.0010329823,0.00085634575,0.000040284038,0.00008188371,0.00026755108,0.000030889038,0.0004921433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981326,0.00018920886,0.00058945233,0.0003350631,0.00017923272,0.00057445624],"domain_scores_gemma":[0.9994159,0.000050913466,0.00012856977,0.00018940377,0.000026898459,0.00018831677],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051187776,0.00010123087,0.00043983525,0.00030959127,0.00008759408,0.000038703005,0.00006186535,0.00009521145,0.000039860483],"category_scores_gemma":[0.000132347,0.00015299124,0.00007701941,0.0006547373,0.000013101495,0.00012154882,0.000015996653,0.00017213868,0.0000024189824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041594412,0.00037938615,0.9147463,0.00045857904,0.000010564617,0.00005885189,0.004207245,0.00004120485,9.229098e-7,0.000058904603,0.000719177,0.07927728],"study_design_scores_gemma":[0.006642235,0.0011153327,0.98599553,0.0014740642,0.000005482538,0.00001638031,0.00071205694,0.0015289314,0.0000034560417,0.00015792355,0.0022214518,0.00012717284],"about_ca_topic_score_codex":0.3889486,"about_ca_topic_score_gemma":0.26024783,"teacher_disagreement_score":0.12870075,"about_ca_system_score_codex":0.0014714904,"about_ca_system_score_gemma":0.0006824275,"threshold_uncertainty_score":0.7532507},"labels":[],"label_agreement":null},{"id":"W2056901430","doi":"10.1016/j.jval.2014.08.612","title":"Nice's Proposed Value-Based Assessment of Health Technologies: Concerns of Inconsistent Consideration of Social Values","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Nice; Value (mathematics); Data science; Psychology; Computer science; Statistics; Mathematics","score_opus":0.39677503866398867,"score_gpt":0.4619698324915159,"score_spread":0.06519479382752724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2056901430","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7984922,0.005420846,0.03690138,0.15016782,0.0010492372,0.004805552,0.0007785514,0.0001901505,0.002194288],"genre_scores_gemma":[0.98321545,0.00013234917,0.014234881,0.0022287944,0.000050394447,0.000054134696,0.000038712307,0.000029531075,0.000015756563],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98735553,0.00231475,0.008986419,0.000567597,0.00026508124,0.0005106448],"domain_scores_gemma":[0.98802847,0.0019344676,0.0091816615,0.00059685373,0.00017727213,0.00008129163],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.037046503,0.00022685315,0.0022883934,0.0007207539,0.00017246437,0.000015673411,0.00030732757,0.00022026934,0.000045638324],"category_scores_gemma":[0.0034020026,0.00027914235,0.00017938239,0.00041456457,0.00034319508,0.0001668923,0.00005977426,0.00025991662,0.000011591626],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035128876,0.0007366237,0.1121296,0.009916292,0.00008525853,2.0157186e-7,0.0051397835,0.021473035,0.0000402689,0.8471208,0.0017010999,0.0016218837],"study_design_scores_gemma":[0.010619999,0.0045316126,0.22619408,0.0036645902,0.000026988699,0.0000044135268,0.015794441,0.56163806,0.0009702056,0.16674903,0.008550794,0.0012558058],"about_ca_topic_score_codex":0.0117976,"about_ca_topic_score_gemma":0.0001410874,"teacher_disagreement_score":0.6803718,"about_ca_system_score_codex":0.0012682066,"about_ca_system_score_gemma":0.0026774725,"threshold_uncertainty_score":0.9999661},"labels":[],"label_agreement":null},{"id":"W2057094301","doi":"10.1016/j.jval.2014.03.421","title":"Mammographic Density in Association with Smoking Status and Smoking Histories in a Sample of Postmenopausal Women: Results From a Cross-Sectional Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Digital Radiography and Breast Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Breast cancer; Body mass index; Family history; Hormone replacement therapy (female-to-male); Anthropometry; Cross-sectional study; Menopause; Demography; Gynecology; Internal medicine; Risk factor; Obstetrics; Cancer; Oncology","score_opus":0.019237735544096368,"score_gpt":0.2757718721181258,"score_spread":0.25653413657402946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057094301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.999076,0.00014685262,0.000016458132,0.00013455383,0.00010068881,0.00036608244,0.00006841715,0.00001912806,0.00007181624],"genre_scores_gemma":[0.99950325,0.000016875696,0.00027620717,0.0001014022,0.000036219793,0.000015689053,0.000035521272,0.000011540554,0.0000033022259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980606,0.0002177497,0.0005987201,0.00032232198,0.00040866883,0.00039194355],"domain_scores_gemma":[0.99873054,0.00067749334,0.00027880786,0.00014091648,0.00006545231,0.00010677503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022042964,0.00011878018,0.00037327735,0.0006076271,0.000049418657,0.000032706954,0.000037085414,0.000058494705,0.0000015151232],"category_scores_gemma":[0.0006015686,0.00011319388,0.000019120922,0.00078398455,0.00005453506,0.00016994844,0.000023323591,0.00029063298,5.703219e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011512368,0.00044331476,0.9891741,0.00007817015,0.00003125865,0.000011126138,0.0076117036,0.00021059524,0.000012319892,0.000076489174,0.0000010524985,0.0011985805],"study_design_scores_gemma":[0.004973347,0.0011767795,0.99138045,0.00023576137,0.0000058516453,0.0000062032527,0.00090571103,0.00025888483,0.000006707374,0.0009322842,0.000030023008,0.00008797544],"about_ca_topic_score_codex":0.08498365,"about_ca_topic_score_gemma":0.0041718534,"teacher_disagreement_score":0.0808118,"about_ca_system_score_codex":0.00096375076,"about_ca_system_score_gemma":0.0001888034,"threshold_uncertainty_score":0.9211095},"labels":[],"label_agreement":null},{"id":"W2057212052","doi":"10.1016/j.jval.2014.03.940","title":"A Cost-Minimization Analysis Of Carbetocin For The Prevention Of Postpartum Hemorrhage In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Maternal and fetal healthcare","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Caesarean section; Uterine atony; Uterotonic; Obstetrics; Total cost; Cost-minimization analysis; Clinical Practice; Emergency medicine; Intensive care medicine; Pregnancy; Oxytocin; Family medicine; Surgery; Hysterectomy; Internal medicine","score_opus":0.05148314105794193,"score_gpt":0.3302652339010418,"score_spread":0.27878209284309985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057212052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946267,0.0003745936,0.0012013417,0.00261002,0.00008784581,0.0010020584,0.000045032273,0.0000025570098,0.000049840048],"genre_scores_gemma":[0.9990849,0.00007116187,0.00036178273,0.00031735958,0.000018641036,0.000034363842,0.000044092994,0.0000052852615,0.000062442465],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99895495,0.00013065201,0.00050419004,0.000101223995,0.00016266321,0.00014631188],"domain_scores_gemma":[0.9993034,0.0002117223,0.00021526063,0.00014964759,0.000065721215,0.000054230328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006252203,0.000052079897,0.00034635668,0.00015523235,0.000015969628,9.0202235e-7,0.0000459525,0.00002612492,0.00001286452],"category_scores_gemma":[0.00010513337,0.00003774843,0.000051567196,0.00049074326,0.000010841886,0.000013998015,0.000007886798,0.000064214095,9.771207e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072724186,0.00017604444,0.90539014,0.007843119,0.00010983206,0.000004248937,0.0015972155,0.042638317,0.00007876305,0.0011436262,0.00007721486,0.04021421],"study_design_scores_gemma":[0.0006605052,0.00027286878,0.4972164,0.00026917824,0.00007569805,0.0000016558085,0.00033996548,0.5007228,0.00020341546,0.000104184975,0.00010099081,0.000032327447],"about_ca_topic_score_codex":0.9446296,"about_ca_topic_score_gemma":0.8479583,"teacher_disagreement_score":0.4580845,"about_ca_system_score_codex":0.00029024063,"about_ca_system_score_gemma":0.00088973466,"threshold_uncertainty_score":0.15783511},"labels":[],"label_agreement":null},{"id":"W2057335144","doi":"10.1016/j.jval.2012.08.1059","title":"PCV116 Impact of the Type of Drug Insurance on Cost of Statins and Anti-Depressants","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cohort; Medical prescription; Statin; Prescription drug; Drug; Antidepressant; Cohort study; Emergency medicine; Internal medicine; Psychiatry; Pharmacology","score_opus":0.2471445488612375,"score_gpt":0.48627114832293605,"score_spread":0.23912659946169856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057335144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973168,0.0013037631,0.0000012884209,0.00038561304,0.00013901021,0.0003678922,0.000050482235,0.0000022897339,0.00043290807],"genre_scores_gemma":[0.99894077,0.0007629717,0.000053798878,0.0002042445,0.000015731513,8.967339e-7,0.0000013097874,0.0000057619136,0.000014541033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914503,0.00017566286,0.00029493577,0.000060216327,0.000173397,0.00015077999],"domain_scores_gemma":[0.99901915,0.0004454573,0.0002585079,0.00015150801,0.00003491255,0.0000904598],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005072089,0.000055737473,0.00025219534,0.00004053149,0.0000136764465,7.1638425e-7,0.0000430257,0.000020571191,0.000019688641],"category_scores_gemma":[0.00030784437,0.000032471995,0.00003478756,0.00015646804,0.000058526402,0.000056025172,0.00002041217,0.00014268798,9.684915e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025659922,0.00028570087,0.9953942,0.0005219417,0.000016381358,1.980397e-7,0.0010392368,0.0002982028,0.0006062705,0.00011009262,0.000080710386,0.0013904722],"study_design_scores_gemma":[0.0008561142,0.0002531415,0.9958282,0.00034919646,0.000009250079,0.0000020131515,0.000050582443,0.0006913962,0.0017186264,0.000019697962,0.00019638948,0.000025390611],"about_ca_topic_score_codex":0.0023730705,"about_ca_topic_score_gemma":0.000004198495,"teacher_disagreement_score":0.0023688718,"about_ca_system_score_codex":0.000029921042,"about_ca_system_score_gemma":0.000114573944,"threshold_uncertainty_score":0.35873884},"labels":[],"label_agreement":null},{"id":"W2057347108","doi":"10.1016/j.jval.2011.02.768","title":"PRS7 USE OF INHALED TOBRAMYCIN IS ASSOCIATED WITH REDUCED MORTALITY IN PATIENTS WITH CYSTIC FIBROSIS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Tobramycin; Cystic fibrosis; Internal medicine; Odds ratio; Underweight; Surgery; Body mass index; Pseudomonas aeruginosa; Overweight","score_opus":0.07752399317682819,"score_gpt":0.32210120288856214,"score_spread":0.24457720971173397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057347108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980851,0.00007489368,0.00003002382,0.00011399625,0.000029366527,0.0014587262,0.00009053997,0.000029800873,0.00008757564],"genre_scores_gemma":[0.9936473,0.00002102958,0.006010352,0.00012805471,0.000008386781,0.000044846554,0.000060441926,0.000033208707,0.000046406443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724495,0.00035737062,0.00067958434,0.0003908338,0.0007649215,0.0005623532],"domain_scores_gemma":[0.99839264,0.00036267977,0.00031805562,0.00045914462,0.00021389572,0.0002535869],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066446204,0.00019132163,0.0006593018,0.0003132311,0.00003264028,0.00000892967,0.000107213724,0.00008364591,0.00006949391],"category_scores_gemma":[0.0012405276,0.00014270273,0.0000344344,0.00089577603,0.00014900218,0.00020154676,0.00003986385,0.00033226277,0.0000038739295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024636944,0.0011392633,0.99341065,0.00051586627,0.000054318978,0.00004500802,0.0015388802,0.00016129907,0.00013870688,0.000028785596,0.000066319706,0.0004372041],"study_design_scores_gemma":[0.004356117,0.0035892793,0.9876587,0.0025674116,0.00001963967,0.0000032756773,0.000074975265,0.0006969014,0.00081649603,0.00007168125,0.000013645072,0.00013188628],"about_ca_topic_score_codex":0.01801242,"about_ca_topic_score_gemma":0.00078986306,"teacher_disagreement_score":0.017222555,"about_ca_system_score_codex":0.000499791,"about_ca_system_score_gemma":0.0006858707,"threshold_uncertainty_score":0.9885267},"labels":[],"label_agreement":null},{"id":"W2057593057","doi":"10.1016/s1098-3015(10)66669-7","title":"PDB22 COST-EFFECTIVENESS OF INSULIN GLARGINE COMPARED TO INSULIN DETEMIR FOR TYPE 1 (T1DM) AND TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS IN THE CANADIAN PAYER SETTING","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin detemir; Insulin glargine; Medicine; Internal medicine; Type 1 diabetes; Type 2 Diabetes Mellitus; Endocrinology; Insulin; Diabetes mellitus; Hypoglycemia","score_opus":0.06534911467961803,"score_gpt":0.31825093423238787,"score_spread":0.25290181955276986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057593057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932783,0.0015658952,0.0000035265743,0.0009928051,0.00015618809,0.0038323686,0.00003314649,0.000011578702,0.0001261436],"genre_scores_gemma":[0.99764323,0.00035276733,0.00062905025,0.0009952142,0.000027385639,0.00017426336,0.00014568452,0.000019400692,0.000013010438],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850416,0.0002477532,0.00037187594,0.0002457785,0.00018563739,0.0004448018],"domain_scores_gemma":[0.9989645,0.00041896637,0.00008552202,0.00021448499,0.00012077674,0.00019577435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010639335,0.00014852303,0.0004148842,0.0002904829,0.00009535737,0.000008461786,0.00009084304,0.00005658482,0.000004196886],"category_scores_gemma":[0.00029014406,0.00011502076,0.000028094983,0.00056591915,0.00003812696,0.000041048625,0.000029032324,0.00011689544,0.000006208839],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036242369,0.00041930945,0.97941804,0.0010111912,0.00004652579,0.00000952229,0.0020816748,0.000569936,0.000025297863,0.00018001664,0.0004307454,0.015445318],"study_design_scores_gemma":[0.00398435,0.0012929334,0.9829801,0.0005649682,0.000021546508,6.7159783e-7,0.000093164475,0.0014748636,0.00016932601,0.00011544729,0.009186146,0.00011649587],"about_ca_topic_score_codex":0.06722331,"about_ca_topic_score_gemma":0.025328526,"teacher_disagreement_score":0.041894782,"about_ca_system_score_codex":0.0004270742,"about_ca_system_score_gemma":0.00033679526,"threshold_uncertainty_score":0.9924567},"labels":[],"label_agreement":null},{"id":"W2057727326","doi":"10.1016/j.jval.2014.03.589","title":"Comparison of Oncology Therapy Reimbursement Recommendations Made by Health Technology Assessment Agencies in Australia, Canada, Sweden, And United Kingdom","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Reimbursement; Excellence; Health technology; Agency (philosophy); Medicine; Health care; Cost effectiveness; Family medicine; Product (mathematics); Advisory committee; Business; Political science; Public administration","score_opus":0.6039519350051378,"score_gpt":0.5326902229922519,"score_spread":0.07126171201288589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057727326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.728131,0.0021062815,0.00092632265,0.26706606,0.00041719107,0.0009635946,0.00019976708,0.000019560779,0.00017021994],"genre_scores_gemma":[0.98217356,0.0010130653,0.0057292525,0.010671756,0.000040164305,0.00011395677,0.00012301814,0.000019917916,0.00011528852],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99251276,0.0013448193,0.004974078,0.00048339405,0.00010458765,0.0005803831],"domain_scores_gemma":[0.99556243,0.0010081169,0.0028410442,0.00037932146,0.000040540603,0.00016853516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016300542,0.00017742647,0.0013658068,0.0009431292,0.00014340608,0.00001634956,0.00022727669,0.00016195599,0.00008859082],"category_scores_gemma":[0.0005804468,0.00022987022,0.00002767071,0.0006024919,0.00008757375,0.00009766714,0.00004448057,0.00039429747,0.000009329918],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017905671,0.0005369885,0.7284484,0.00071283785,0.00004237188,4.8205305e-7,0.0044552055,0.0056040767,0.000009854205,0.16910873,0.086288184,0.004774973],"study_design_scores_gemma":[0.003014214,0.0015899645,0.17011444,0.00046354288,0.0000018989974,0.00000422115,0.008883536,0.046010584,0.000021527536,0.010118484,0.7593135,0.00046402746],"about_ca_topic_score_codex":0.8900229,"about_ca_topic_score_gemma":0.42565355,"teacher_disagreement_score":0.67302537,"about_ca_system_score_codex":0.0044832285,"about_ca_system_score_gemma":0.0017074654,"threshold_uncertainty_score":0.9993384},"labels":[],"label_agreement":null},{"id":"W2057903895","doi":"10.1016/j.jval.2012.08.941","title":"PMD92 Inhaler Use in Five European Countries: Analysis of Sales Data From Q4 2005 to Q4 2011","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Inhaler; Metered-dose inhaler; Quarter (Canadian coin); Asthma; Internal medicine","score_opus":0.13740169962952348,"score_gpt":0.35055419160383117,"score_spread":0.2131524919743077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057903895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956972,0.0019436617,0.00007572807,0.0010153811,0.00018916259,0.00033071253,0.00039701862,0.000019534158,0.00033158896],"genre_scores_gemma":[0.9934843,0.0005143066,0.0007464294,0.004166942,0.00019232536,0.0000027902206,0.0005026266,0.000021662207,0.00036859064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789417,0.00051161693,0.0006772678,0.0002779794,0.00028743036,0.00035153443],"domain_scores_gemma":[0.9984674,0.00027273723,0.00017503044,0.00075375184,0.000064690576,0.00026642915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017041604,0.00012140435,0.0004703115,0.0007206531,0.000030126854,0.000010824352,0.00017588711,0.000060225066,0.00050000695],"category_scores_gemma":[0.00024726233,0.000106376254,0.000047524896,0.0005748069,0.00004433771,0.00027580856,0.00011533064,0.00018914955,0.00044587188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029297682,0.000551863,0.9486066,0.00021976781,0.00024649125,0.000050631494,0.011146687,0.0074695842,0.00020341726,0.00011148468,0.030052815,0.0010476727],"study_design_scores_gemma":[0.0011829297,0.000085345586,0.9309874,0.00038954642,0.00018285504,0.0000020387033,0.00089618104,0.009493789,0.00006656926,0.0000015143045,0.056535244,0.00017659379],"about_ca_topic_score_codex":0.012632995,"about_ca_topic_score_gemma":0.0017701256,"teacher_disagreement_score":0.026482431,"about_ca_system_score_codex":0.00016307495,"about_ca_system_score_gemma":0.00023490684,"threshold_uncertainty_score":0.99394196},"labels":[],"label_agreement":null},{"id":"W2057906239","doi":"10.1016/j.jval.2013.03.083","title":"Composite endpoints in treatment of type-2 diabetes","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Exenatide; Sitagliptin; Liraglutide; Metformin; Type 2 diabetes; Internal medicine; Clinical endpoint; Randomized controlled trial; Hypoglycemia; Diabetes mellitus; Insulin; Endocrinology","score_opus":0.035271391749435894,"score_gpt":0.2928516543339031,"score_spread":0.2575802625844672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2057906239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930994,0.0016898536,6.226122e-7,0.0017371468,0.00009450419,0.0009458101,0.0000017976004,0.000017141938,0.0024137418],"genre_scores_gemma":[0.99750227,0.0006902442,0.000890099,0.0002798163,0.00002080065,0.000059848488,0.000022239494,0.000010671125,0.0005240304],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99911684,0.000058634618,0.00030731127,0.00014770316,0.00010480315,0.00026468156],"domain_scores_gemma":[0.9995932,0.00005774847,0.000063913874,0.00018407624,0.000018131763,0.00008293699],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000116337105,0.00009725929,0.0003423118,0.00019816877,0.0000102683425,0.0000042568754,0.00003203869,0.000027175014,0.000088817906],"category_scores_gemma":[0.000009859594,0.00007635338,0.000035427656,0.00021222135,0.000020196792,0.000039856084,0.000013555334,0.00003367455,0.00008772372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031319927,0.0016401306,0.93734103,0.0003869669,0.0000587949,0.00001071868,0.00079381734,0.00020522097,0.00062335376,0.0004812933,0.00035698846,0.058070336],"study_design_scores_gemma":[0.004527991,0.0035158717,0.9791209,0.0006095873,0.000027799259,6.754289e-7,0.00011976991,0.004489688,0.0029889233,0.0006674694,0.003815611,0.00011571011],"about_ca_topic_score_codex":0.0040047127,"about_ca_topic_score_gemma":0.00003467646,"teacher_disagreement_score":0.057954624,"about_ca_system_score_codex":0.00029781891,"about_ca_system_score_gemma":0.000055149667,"threshold_uncertainty_score":0.60539544},"labels":[],"label_agreement":null},{"id":"W2058235380","doi":"10.1016/s1098-3015(10)61147-3","title":"PIN12 COSTS OF TREATMENT FOR AMBULATORY LOWER RESPIRATORY TRACT INFECTION IN QUEBEC SENIORS","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ambulatory; Respiratory tract infections; Medicine; Respiratory tract; Respiratory system; Intensive care medicine; Lower respiratory tract infection; Gerontology; Internal medicine","score_opus":0.13581580391997225,"score_gpt":0.40969890809713094,"score_spread":0.27388310417715866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058235380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957767,0.0010477913,0.00005530945,0.00038850773,0.00022361649,0.0019262946,0.000010479973,0.000040082086,0.000531183],"genre_scores_gemma":[0.9983803,0.0002932618,0.00010806742,0.00037804936,0.0001259551,0.00021358619,0.000004210595,0.000033808843,0.0004627397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978523,0.00038364745,0.000759684,0.00032299804,0.00024523446,0.00043608225],"domain_scores_gemma":[0.9989493,0.00024059696,0.00015723502,0.0003748912,0.0000904569,0.00018755959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095051434,0.00016790889,0.00045867104,0.0008506692,0.00005986355,0.000010118847,0.000046763733,0.0001527059,0.00011223677],"category_scores_gemma":[0.00027637786,0.00015387195,0.000119966375,0.00066592934,0.000080619386,0.00014642894,0.000012246285,0.0002664811,0.00003203769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046376555,0.0038048085,0.92063445,0.00091054157,0.000036153408,0.00004171472,0.00084904087,0.006921915,0.0033325271,0.00065325917,0.0010685927,0.06128321],"study_design_scores_gemma":[0.01126291,0.015751025,0.8971203,0.001027032,0.000024748344,0.000024659563,0.00011993495,0.013808351,0.0031103971,0.00009737045,0.057291985,0.00036126398],"about_ca_topic_score_codex":0.13614275,"about_ca_topic_score_gemma":0.0154772885,"teacher_disagreement_score":0.12066546,"about_ca_system_score_codex":0.004308412,"about_ca_system_score_gemma":0.0006393168,"threshold_uncertainty_score":0.99951386},"labels":[],"label_agreement":null},{"id":"W2058239771","doi":"10.1016/s1098-3015(10)70269-2","title":"PCN93 THREE SCIENTIFIC PARADIGMS IN HEALTH TECHNOLOGY ASSESSMENT: EXPERIENCES OF THE COMMITTEE TO EVALUATE DRUGS IN ONTARIO, CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health technology; Engineering ethics; Medicine; Management science; Political science; Engineering; Health care; Law","score_opus":0.19027085715727324,"score_gpt":0.4226542366476403,"score_spread":0.23238337949036705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058239771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9607243,0.00064995285,0.000005265346,0.036137853,0.000737985,0.0012707389,0.0000036574697,0.00001000179,0.0004602706],"genre_scores_gemma":[0.99631757,0.00006025466,0.00043900876,0.002951234,0.000010208673,0.0000727095,0.0000034812574,0.000009144788,0.00013641772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970946,0.00038826076,0.0009059643,0.0003454202,0.00068489695,0.0005808681],"domain_scores_gemma":[0.99873966,0.00029755835,0.0002740134,0.00044041732,0.000038224436,0.00021010975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002121991,0.00013833397,0.0005034708,0.00035817668,0.00016753524,0.0000075069693,0.00028778348,0.00005788356,0.00008421302],"category_scores_gemma":[0.00019786965,0.000102264414,0.00003452185,0.0013759255,0.00019911183,0.00008116279,0.000096464726,0.0007383367,0.0000021898575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006306829,0.0002291858,0.9778339,0.00015281074,0.0000045810984,0.000014140757,0.018081464,0.0013692807,0.0000081620965,0.0006767575,0.00044636303,0.0011202475],"study_design_scores_gemma":[0.0022597266,0.0005063289,0.9598717,0.00076478254,0.000004166839,0.000028981478,0.008774537,0.008622271,0.00009493024,0.000544112,0.018373124,0.00015532285],"about_ca_topic_score_codex":0.97282374,"about_ca_topic_score_gemma":0.9785949,"teacher_disagreement_score":0.035593264,"about_ca_system_score_codex":0.002045485,"about_ca_system_score_gemma":0.01020586,"threshold_uncertainty_score":0.9954054},"labels":[],"label_agreement":null},{"id":"W2058288379","doi":"10.1016/s1098-3015(11)72234-3","title":"PRS2 CARESS:THE CANADIAN REGISTRY OF SYNAGIS (2006–2009)","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Wine Industry and Tourism","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Computer science","score_opus":0.02808434884272132,"score_gpt":0.24670058702261327,"score_spread":0.21861623817989195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058288379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8645601,0.00015753377,0.000005128687,0.09663561,0.0018223999,0.00046610128,0.00003548354,0.000048387832,0.03626923],"genre_scores_gemma":[0.99277234,0.0000025751797,0.00007046805,0.0029980673,0.00358498,0.000009227754,0.000012880306,0.000015174944,0.00053430523],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989242,0.000021344998,0.00032637757,0.00016999184,0.0001762235,0.00038188865],"domain_scores_gemma":[0.9992124,0.000045726316,0.00022109061,0.00040087977,0.00007994249,0.00003996375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008444624,0.00010331378,0.00016112429,0.0001931378,0.00021723434,0.00007800518,0.00032102037,0.00013407542,0.00013123863],"category_scores_gemma":[0.00024730124,0.00008392744,0.000036599948,0.00043078448,0.00007847821,0.00020026657,0.00003971794,0.00059150805,0.00005395508],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002869165,0.00015968422,0.31600174,0.001182092,0.000028397422,0.0001177544,0.0004429621,0.003441483,0.000116725576,0.07642406,0.59542894,0.006627442],"study_design_scores_gemma":[0.00031000547,0.000010074892,0.0604245,0.0001339092,0.000008155397,0.000007442134,0.00016392958,0.0026484753,0.000028085537,0.0031235314,0.932977,0.00016484309],"about_ca_topic_score_codex":0.9126167,"about_ca_topic_score_gemma":0.38509336,"teacher_disagreement_score":0.52752334,"about_ca_system_score_codex":0.000051227726,"about_ca_system_score_gemma":0.0005173076,"threshold_uncertainty_score":0.62612706},"labels":[],"label_agreement":null},{"id":"W2058457641","doi":"10.1016/s1098-3015(10)73868-7","title":"PCV110 DO CANADIAN PHYSICIANS CORRECTLY IDENTIFY HIGH RISK CV PATIENTS?","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine; Business","score_opus":0.036664136060565705,"score_gpt":0.38392735764746,"score_spread":0.34726322158689427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058457641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9353596,0.00083429617,0.000042167878,0.03503862,0.005855696,0.0023795294,0.00041736107,0.00020133887,0.019871365],"genre_scores_gemma":[0.899446,0.00090413145,0.0003858453,0.097570136,0.00055412645,0.00005802583,0.00012720843,0.000040454885,0.00091408135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942654,0.0015594427,0.0013913267,0.00052259915,0.00042394648,0.0018372989],"domain_scores_gemma":[0.99719286,0.0005896834,0.00063753733,0.0006327942,0.00018212722,0.0007649946],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017974185,0.00027858966,0.0006718394,0.00050667964,0.0013489542,0.000019767367,0.0003666978,0.00030144906,0.00037145038],"category_scores_gemma":[0.0003608624,0.00027983275,0.00009978382,0.0006908914,0.000035124485,0.00020993117,0.000045645647,0.001585255,0.0008861309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00006503839,0.00017140566,0.7365999,0.00034282962,0.000010768857,0.000015091714,0.0073326943,0.00017178115,0.0000017012418,0.0035502592,0.14390974,0.107828766],"study_design_scores_gemma":[0.0013367856,0.00040041085,0.91727215,0.00033292946,0.000008530965,4.702358e-7,0.000737982,0.000096359385,8.1985206e-7,0.0041063926,0.07545317,0.0002539978],"about_ca_topic_score_codex":0.86504054,"about_ca_topic_score_gemma":0.26862207,"teacher_disagreement_score":0.5964185,"about_ca_system_score_codex":0.0046862997,"about_ca_system_score_gemma":0.007151302,"threshold_uncertainty_score":0.99996537},"labels":[],"label_agreement":null},{"id":"W2058645160","doi":"10.1016/s1098-3015(11)70578-2","title":"PSG11: COST ANALYSIS OF INHALED AGENTS IN CANADIAN PEDIATRIC HOSPITALS","year":2000,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Business; Medical emergency","score_opus":0.0815528420381569,"score_gpt":0.3081901838395258,"score_spread":0.2266373418013689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058645160","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812576,0.0017458915,0.000010665927,0.0060898755,0.00011717414,0.000535452,0.00026279656,0.000008414611,0.009972109],"genre_scores_gemma":[0.99262726,0.0053016203,0.00008099727,0.0015853893,0.00003901186,0.000031851952,0.00002765838,0.000011185167,0.00029499733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978521,0.0000749127,0.0011050855,0.0003069837,0.000042213942,0.00061872683],"domain_scores_gemma":[0.9991186,0.000046984165,0.00022652729,0.00029261757,0.000009752416,0.00030547814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016557506,0.00010233415,0.0005555936,0.002405577,0.00003960362,0.00001202699,0.00017541587,0.00007870582,0.00071357563],"category_scores_gemma":[0.00008347147,0.00013447991,0.00008321323,0.0025545843,0.000014114015,0.00007624876,0.000013979076,0.00013536755,0.00016636317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000046548867,0.00007600022,0.9382789,0.00016884899,0.00004184013,0.000016642925,0.0011394349,0.022673676,6.7464057e-9,0.03248247,0.0005373472,0.0045801415],"study_design_scores_gemma":[0.0003715295,0.000052360145,0.94102806,0.000017517208,0.000008904673,3.2130615e-7,0.000032366694,0.01811832,2.2525354e-7,0.0019379721,0.038292684,0.00013975537],"about_ca_topic_score_codex":0.981101,"about_ca_topic_score_gemma":0.65361655,"teacher_disagreement_score":0.32748443,"about_ca_system_score_codex":0.0007583628,"about_ca_system_score_gemma":0.0002936657,"threshold_uncertainty_score":0.7813153},"labels":[],"label_agreement":null},{"id":"W2058723778","doi":"10.1111/j.1524-4733.2006.00156.x","title":"The Cost-Effectiveness of Expanding Newborn Screening for up to 21 Inherited Metabolic Disorders Using Tandem Mass Spectrometry: Results from a Decision-Analytic Model","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Newborn screening; Medicine; Formulary; Cohort; Cost effectiveness; Pediatrics; Health technology; Environmental health; Family medicine; Health care; Internal medicine; Risk analysis (engineering)","score_opus":0.06360169128029618,"score_gpt":0.3648034541926976,"score_spread":0.3012017629124014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058723778","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4840514,0.0025962922,0.5122268,0.000063738386,0.00015604748,0.00078702165,0.000083386214,0.00000447936,0.00003079519],"genre_scores_gemma":[0.8956991,0.0009129663,0.103004895,0.00011828663,0.000093023635,0.000035041794,0.00007619841,0.0000370465,0.000023475472],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99760866,0.0002567214,0.0007453659,0.00053288095,0.00026424462,0.00059215486],"domain_scores_gemma":[0.99829775,0.0006890192,0.00025106437,0.0004948076,0.00008618013,0.0001811669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038754197,0.00020944653,0.0004291306,0.0002100771,0.00018861244,0.000029098872,0.0003020959,0.00012522051,0.0000014081111],"category_scores_gemma":[0.0011298031,0.00017756551,0.0001400732,0.00061970315,0.00005864205,0.000006280236,0.00008487623,0.000110088855,4.4056802e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056114006,0.00012801605,0.010975833,0.00010505677,0.0002437105,9.875345e-7,0.0008480188,0.6832725,0.1681504,0.0007111341,0.00015551923,0.12979744],"study_design_scores_gemma":[0.022263136,0.0012185043,0.16921107,0.0011475926,0.00026372648,0.0000053588915,0.004926082,0.6564105,0.08894375,0.023383528,0.030518513,0.0017082457],"about_ca_topic_score_codex":0.0018899472,"about_ca_topic_score_gemma":0.0005484217,"teacher_disagreement_score":0.41164765,"about_ca_system_score_codex":0.000028781498,"about_ca_system_score_gemma":0.0002396799,"threshold_uncertainty_score":0.7240911},"labels":[],"label_agreement":null},{"id":"W2058872565","doi":"10.1016/j.jval.2013.03.047","title":"Examining Ontario's Universal Influenza Immunization Program With A New Dynamic Influenza Model","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); University of Guelph; GlaxoSmithKline (Canada)","funders":"","keywords":"Immunization; Demography; Homogeneous; Influenza A virus subtype H5N1; Influenza vaccine; Medicine; Attack rate; Confidence interval; Epidemic model; Age groups; Geography; Virology; Statistics; Mathematics; Immunology; Internal medicine; Vaccination; Antibody; Combinatorics; Environmental health; Virus; Outbreak; Population","score_opus":0.15035310682991376,"score_gpt":0.3855507249212832,"score_spread":0.23519761809136946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058872565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928935,0.00090049574,0.0006680055,0.0007260781,0.00003777489,0.0029419684,0.0000030971946,0.00022200929,0.0016070643],"genre_scores_gemma":[0.9494369,0.00020598219,0.043543167,0.004580501,0.000060762846,0.00028681025,0.000027289147,0.00010437122,0.0017541883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99736005,0.0001280368,0.0006021059,0.00042606026,0.00062554766,0.00085820915],"domain_scores_gemma":[0.99849045,0.00010865334,0.00019112875,0.0005303358,0.00026523517,0.0004142028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050688663,0.00028145715,0.0005146772,0.00046027987,0.00018664544,0.00005838397,0.00018232965,0.00012452321,0.00009135791],"category_scores_gemma":[0.00020196722,0.00023713364,0.00004078111,0.0007287948,0.00014048534,0.00042872518,0.00013366602,0.0007290347,0.000075253854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010750943,0.0006917451,0.6334912,0.00092910195,0.00023159171,0.000044536126,0.028502762,0.2757104,0.00038819644,0.000841461,0.0009441411,0.05714977],"study_design_scores_gemma":[0.009068629,0.003836173,0.55196637,0.0018276401,0.000041270843,0.00003778323,0.002151106,0.42179528,0.00003413436,0.0006013146,0.008101477,0.0005387993],"about_ca_topic_score_codex":0.3533117,"about_ca_topic_score_gemma":0.018626729,"teacher_disagreement_score":0.33468497,"about_ca_system_score_codex":0.0021586784,"about_ca_system_score_gemma":0.0039585684,"threshold_uncertainty_score":0.99928075},"labels":[],"label_agreement":null},{"id":"W2058901727","doi":"10.1111/j.1524-4733.2009.00511.x","title":"The Cost-Utility of Sequential Adjuvant Trastuzumab in Women with Her2/Neu-Positive Breast Cancer: An Analysis Based On Updated Results from the HERA Trial","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Trastuzumab; Medicine; Breast cancer; Oncology; Internal medicine; Adjuvant; Economic evaluation; Relative risk; Demography; Cancer; Confidence interval","score_opus":0.057001828599170044,"score_gpt":0.3867357524686461,"score_spread":0.3297339238694761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058901727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97081655,0.00023271695,0.000038512157,0.024275936,0.000102921775,0.0026535038,0.0017103407,0.000025408113,0.00014409375],"genre_scores_gemma":[0.997567,0.00023075737,0.00006259243,0.0015707324,0.00020277513,0.00014227601,0.00019011695,0.00002032853,0.000013438529],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9942905,0.0023099794,0.0009745497,0.0006144299,0.0010605798,0.0007499978],"domain_scores_gemma":[0.9973445,0.00090360123,0.00030470328,0.00095882796,0.00018293,0.0003054236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004464751,0.0002271013,0.00076824374,0.00023359375,0.00016416857,0.0000359856,0.000346443,0.000110494606,0.00012522703],"category_scores_gemma":[0.00017990694,0.00013010867,0.00008750954,0.0018565671,0.00021646525,0.00006405965,0.000020699103,0.0008253837,0.0000018557919],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.69803506,0.0025653716,0.031404525,0.000065633365,0.00040892104,0.00012019818,0.009774342,0.045670155,0.00010163308,0.000030162393,0.0006345199,0.2111895],"study_design_scores_gemma":[0.04376943,0.0052848854,0.8342984,0.00053536403,0.00008125597,0.0000031540035,0.0011746527,0.114184044,0.00017784876,0.00007195375,0.00026839337,0.00015064409],"about_ca_topic_score_codex":0.16736041,"about_ca_topic_score_gemma":0.020606149,"teacher_disagreement_score":0.8028939,"about_ca_system_score_codex":0.0021686337,"about_ca_system_score_gemma":0.0034591423,"threshold_uncertainty_score":0.9972652},"labels":[],"label_agreement":null},{"id":"W2058930342","doi":"10.1016/j.jval.2011.08.714","title":"PHP164 A Typology of Outcomes for Health Research","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Dalhousie University","funders":"","keywords":"Typology; Health care; Consistency (knowledge bases); Medicine; Quality of life (healthcare); Outcomes research; Quality (philosophy); Nursing; Psychology; Alternative medicine; Political science","score_opus":0.8994448236542348,"score_gpt":0.5845002268700461,"score_spread":0.31494459678418874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2058930342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51101965,0.017312434,0.008608061,0.43315327,0.0033296398,0.009571183,0.0014591615,0.0001434729,0.015403129],"genre_scores_gemma":[0.95329374,0.00066477543,0.026426528,0.01843929,0.00018050372,0.00036930715,0.000023463206,0.000057340796,0.0005450789],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9913036,0.0014839919,0.0055757477,0.00056084973,0.00011730848,0.0009584555],"domain_scores_gemma":[0.9941609,0.002717715,0.002143606,0.0005992937,0.000100839694,0.00027763666],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06325322,0.00014377812,0.0014482882,0.000924677,0.00018790278,0.00001013407,0.00035800296,0.00014227284,0.00020024527],"category_scores_gemma":[0.005692576,0.00017700893,0.000117458585,0.00038423593,0.00013845268,0.00015719407,0.000056836045,0.00028358938,0.00032791987],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004078363,0.00026879262,0.19866559,0.0018359032,0.00002745748,2.8782847e-7,0.010810732,0.000085446605,2.7250147e-7,0.7691423,0.018795403,0.00032697103],"study_design_scores_gemma":[0.0037144716,0.0024962863,0.4471706,0.00055793714,0.000002137846,0.0000072272983,0.00644187,0.00754269,0.000012502914,0.440623,0.09087393,0.0005573807],"about_ca_topic_score_codex":0.05026449,"about_ca_topic_score_gemma":0.0010156492,"teacher_disagreement_score":0.44227406,"about_ca_system_score_codex":0.0010069966,"about_ca_system_score_gemma":0.00089362165,"threshold_uncertainty_score":0.964578},"labels":[],"label_agreement":null},{"id":"W2059131296","doi":"10.1016/j.jval.2013.03.1104","title":"Patient Outcomes Of Hip Resurfacing Compared To Total Hip Arthroplasty: A Systematic Review","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Alexandra Hospital; Alberta Health Services; University of Alberta; Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"Medicine; Hip resurfacing; Adverse effect; Surgery; Systematic review; Arthroplasty; MEDLINE; Internal medicine","score_opus":0.1004289237552772,"score_gpt":0.36014630645227863,"score_spread":0.2597173826970014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059131296","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005149922,0.9855409,0.000009761303,0.0004787262,0.00071535056,0.012427933,0.00015423479,0.000049784747,0.00010826572],"genre_scores_gemma":[0.00023673354,0.9971589,0.00062301074,0.0010945665,0.000053698568,0.00044781802,0.00008392987,0.000076021824,0.0002253468],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9930441,0.0010318884,0.0038943973,0.0005744664,0.0007689014,0.00068629644],"domain_scores_gemma":[0.9961433,0.00066644856,0.0016297388,0.00092730543,0.00011063193,0.00052256475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014292748,0.00061249186,0.008346853,0.0004319481,0.0000697389,0.000016038117,0.00012535499,0.00018187451,0.0001249825],"category_scores_gemma":[0.0009487661,0.00039930837,0.00060520734,0.000586438,0.000050848546,0.000051124898,0.00012304241,0.0005633842,0.00033670478],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000055238957,0.0001330155,0.00011125717,0.87957585,0.00013756339,0.000036294725,0.00020553477,0.000009594366,2.6420947e-8,0.000028944985,0.0015286664,0.11822772],"study_design_scores_gemma":[0.00039935278,0.00045558464,0.00006310794,0.8836531,0.0005591381,0.00042759374,0.000072519,0.000028967868,6.61287e-8,0.0000017478626,0.11405551,0.0002833229],"about_ca_topic_score_codex":0.0009937668,"about_ca_topic_score_gemma":0.000011782332,"teacher_disagreement_score":0.1179444,"about_ca_system_score_codex":0.00039140208,"about_ca_system_score_gemma":0.0010974567,"threshold_uncertainty_score":0.99984586},"labels":[],"label_agreement":null},{"id":"W2059731285","doi":"10.1016/j.jval.2012.03.552","title":"PSY18 Economic Burden of Psoriasis (PSO) and Obesity in Patients With Psoriasis in the United States","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Poisson regression; Body mass index; Obesity; Psoriasis; Comorbidity; Psoriatic arthritis; Demography; Internal medicine; Population; Environmental health","score_opus":0.021890551546225996,"score_gpt":0.24641965959571305,"score_spread":0.22452910804948706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2059731285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968598,0.0019397475,0.0000013142409,0.00027637574,0.00029345934,0.00049188186,0.000079096775,0.0000095753385,0.000048741615],"genre_scores_gemma":[0.9987487,0.00080773263,0.00007361818,0.00009185278,0.000028383543,0.000030489293,0.00018758001,0.000011696368,0.000019938645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802774,0.0008522639,0.0004323484,0.00020751939,0.000037707487,0.0004424276],"domain_scores_gemma":[0.9991794,0.00036520514,0.00017486863,0.00023417055,0.000016607171,0.000029706744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094894535,0.00016594962,0.00036418546,0.0003499785,0.0000615132,0.0000052690834,0.00014458894,0.00013506034,0.00003605497],"category_scores_gemma":[0.00002712294,0.000116798816,0.000027160135,0.00029870312,0.00008417929,0.00010036206,0.000032109143,0.00016559157,0.000021568063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037763128,0.0003986809,0.98479664,0.000054635333,0.000042773412,9.148181e-7,0.009079023,0.0005661713,0.000009476895,0.00034550845,0.00007567822,0.004252858],"study_design_scores_gemma":[0.0044459742,0.00037323608,0.99238247,0.00009347122,0.000020362555,0.0000033741194,0.0012524027,0.000036409776,0.00015961411,0.00013368356,0.00097051513,0.0001284951],"about_ca_topic_score_codex":0.034151018,"about_ca_topic_score_gemma":0.00089499773,"teacher_disagreement_score":0.03325602,"about_ca_system_score_codex":0.00015505595,"about_ca_system_score_gemma":0.0000770754,"threshold_uncertainty_score":0.9722807},"labels":[],"label_agreement":null},{"id":"W2060451477","doi":"10.1016/j.jval.2011.08.1013","title":"PSY41 Health Status and Health-Related Quality of Life Reported by Females with Bleeding Disorders from the Canadian National Haemophilia Registry","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; McMaster University; Utilities Kingston (Canada)","funders":"","keywords":"Medicine; Haemophilia; Quality of life (healthcare); Health Utilities Index; Demography; Statistical significance; Population; Normative; Physical therapy; Gerontology; Pediatrics; Disease; Health related quality of life; Internal medicine; Environmental health","score_opus":0.23724394420194225,"score_gpt":0.38585226076112955,"score_spread":0.1486083165591873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060451477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89362127,0.008273323,0.0000041699695,0.09602856,0.00006812546,0.0010428476,0.00017486287,0.000026321295,0.00076050754],"genre_scores_gemma":[0.99527127,0.0021339199,0.00049233186,0.0016157882,0.000037104743,0.000020331123,0.0002726888,0.000024177501,0.00013242163],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966884,0.00046821093,0.001072418,0.00039676338,0.0006717215,0.00070247694],"domain_scores_gemma":[0.9976842,0.0002441762,0.00056580256,0.0003332719,0.00012646482,0.0010461172],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031404493,0.00017213938,0.0005924491,0.00017480437,0.0003582097,0.000013632503,0.000096580305,0.00011073031,0.000050670038],"category_scores_gemma":[0.00042033882,0.00011591603,0.00004109386,0.00045289198,0.0003004534,0.00006217474,0.0000222808,0.0004527725,0.000002221726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002248312,0.00019699764,0.9882456,0.00041831928,0.00011785482,0.000006565986,0.005650774,0.000012859198,0.0000039344786,0.000980759,0.002637931,0.0015035892],"study_design_scores_gemma":[0.0021874357,0.0007134618,0.9927652,0.00055152643,0.000006559315,0.0000104896335,0.0015747312,0.00031883255,0.0000066460907,0.0012085354,0.0005468991,0.00010972152],"about_ca_topic_score_codex":0.96921533,"about_ca_topic_score_gemma":0.581723,"teacher_disagreement_score":0.3874924,"about_ca_system_score_codex":0.000995781,"about_ca_system_score_gemma":0.011302084,"threshold_uncertainty_score":0.9943029},"labels":[],"label_agreement":null},{"id":"W2060461219","doi":"10.1016/j.jval.2011.08.502","title":"PND36 Factors Associated with Utility and Disutility Values in Relapsing Form of Multiple Sclerosis (RMS) Patients Using Data from Temso, A Teriflunomide Pivotal Phase III Trial","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Expanded Disability Status Scale; Multiple sclerosis; Teriflunomide; Medicine; Relapsing remitting; Quality of life (healthcare); Physical therapy; Internal medicine; Immunology; Fingolimod","score_opus":0.47951139703153695,"score_gpt":0.3949137589754587,"score_spread":0.08459763805607823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060461219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603206,0.00026421202,0.000069595735,0.000029224277,0.00013865822,0.002395473,0.0010122254,0.00003431207,0.000024268184],"genre_scores_gemma":[0.9983112,0.00017974261,0.0010039815,0.0000195528,0.000034605753,0.000021452128,0.0003967336,0.000030925406,0.0000017940491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99605465,0.00065579946,0.0012223207,0.000757555,0.0006514418,0.0006582501],"domain_scores_gemma":[0.9973438,0.0009359979,0.0005018781,0.00080098945,0.00013437684,0.00028298234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002261435,0.00029131168,0.0010848343,0.00026895566,0.00016528636,0.00001739022,0.00024215432,0.00013828647,0.000028845163],"category_scores_gemma":[0.00428591,0.00023145208,0.00005903186,0.000454279,0.00035347312,0.00039316644,0.0004135111,0.0004680002,3.3324264e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021168448,0.0028454456,0.9655439,0.00018154239,0.000085764324,0.0000023941107,0.006978004,0.0000048244115,0.0005607038,5.115242e-7,0.00001603868,0.0026123857],"study_design_scores_gemma":[0.08386284,0.0011452658,0.86413854,0.0017024325,0.000034318204,1.4381042e-7,0.0009324364,0.047653,0.00033886245,0.000038019025,0.0000021885205,0.00015196066],"about_ca_topic_score_codex":0.10554816,"about_ca_topic_score_gemma":0.004713023,"teacher_disagreement_score":0.101405405,"about_ca_system_score_codex":0.00056780345,"about_ca_system_score_gemma":0.00042126726,"threshold_uncertainty_score":0.9438342},"labels":[],"label_agreement":null},{"id":"W2060573155","doi":"10.1046/j.1524-4733.2001.004001016.x","title":"A Multinational Pharmacoeconomic Evaluation of Acute Major Depressive Disorder (MDD): a Comparison of Cost-Effectiveness Between Venlafaxine, SSRIs and TCAs","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":60,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Concordia University","funders":"","keywords":"Venlafaxine; Major depressive disorder; Economic evaluation; Psychiatry; Medicine; Antidepressant; Cost-effectiveness analysis; Cost effectiveness; Psychology; Mood","score_opus":0.10573103869184178,"score_gpt":0.4449140680461696,"score_spread":0.33918302935432787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060573155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938224,0.0027004892,0.00028373752,0.0005160077,0.00007595126,0.002392077,0.00008307866,0.000014641305,0.00011160389],"genre_scores_gemma":[0.99873537,0.00023033806,0.0006434535,0.000024488289,0.000045138895,0.00016883436,0.00012145103,0.000018261831,0.000012663051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791324,0.0005617065,0.00060558,0.0002899938,0.0004223081,0.0002071891],"domain_scores_gemma":[0.99855083,0.0005346562,0.0004441707,0.00018429608,0.00017345538,0.00011260165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012011678,0.00014750627,0.00059351034,0.0002561557,0.000049112496,0.0000037998566,0.00006201907,0.00007844521,0.00005227283],"category_scores_gemma":[0.00013052307,0.00013658781,0.000055499746,0.00018076699,0.000065784596,0.00009942344,0.000042900756,0.00015362754,0.00000345868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005374032,0.0005944632,0.927805,0.00036678754,0.00016672871,0.00000306581,0.00051032036,0.0032659932,0.0010391758,0.000025292584,0.000031811396,0.06565397],"study_design_scores_gemma":[0.013587463,0.0004625653,0.92849016,0.00059082976,0.00035529357,0.000014916853,0.00006712797,0.05166574,0.0044042594,0.00017115954,0.00010373305,0.00008672549],"about_ca_topic_score_codex":0.0022306368,"about_ca_topic_score_gemma":0.000032270036,"teacher_disagreement_score":0.06556725,"about_ca_system_score_codex":0.00033650713,"about_ca_system_score_gemma":0.0003034667,"threshold_uncertainty_score":0.55698895},"labels":[],"label_agreement":null},{"id":"W2060709908","doi":"10.1016/j.jval.2012.08.1727","title":"PSY4 Lenalidomide or Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma (MM): A Comparative Effectiveness Analysis Using Indirect Statistical Techniques","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Lenalidomide; Refractory (planetary science); Bortezomib; Internal medicine; Randomization; Clinical trial; Randomized controlled trial; Multiple myeloma; Surgery; Oncology","score_opus":0.17379470947664805,"score_gpt":0.4471904382956076,"score_spread":0.27339572881895957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060709908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98010075,0.0027253183,0.012339384,0.00010178139,0.0000766801,0.0042364877,0.00034554367,0.000040088376,0.000033978675],"genre_scores_gemma":[0.97953165,0.0005342164,0.019073779,0.000029758714,0.00009830165,0.0005647154,0.000109158704,0.000024668429,0.000033729888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997318,0.00083263573,0.00056866364,0.00030183772,0.00034634068,0.0006325015],"domain_scores_gemma":[0.9932413,0.0057342295,0.00023295669,0.00037491522,0.00010971481,0.00030685344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011938207,0.00024041723,0.0010733576,0.00042033775,0.00016713649,0.000010499869,0.000078004465,0.00008987966,0.000033910612],"category_scores_gemma":[0.00037694807,0.00013643266,0.00021204694,0.0006874186,0.00014573013,0.00008398309,0.000018422028,0.00014270624,0.0000028073516],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017911034,0.0064324844,0.9069903,0.0009554979,0.004063624,0.00004663359,0.005118451,0.0007987849,0.0014241722,0.0002199787,0.0000676809,0.05597137],"study_design_scores_gemma":[0.011499004,0.0068914886,0.892131,0.00043294035,0.0010939135,0.000028644743,0.00064703065,0.062280335,0.022631025,0.000053320364,0.0020788873,0.00023246526],"about_ca_topic_score_codex":0.008910425,"about_ca_topic_score_gemma":0.00040997888,"teacher_disagreement_score":0.06148155,"about_ca_system_score_codex":0.0011628057,"about_ca_system_score_gemma":0.0005177721,"threshold_uncertainty_score":0.9976893},"labels":[],"label_agreement":null},{"id":"W2060731727","doi":"10.1016/j.jval.2012.03.599","title":"PSY65 Meta-Analysis of Health-Related Quality of Life Outcomes – Methods for Enhancing Interpretability of Findings","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Resilience and Mental Health","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Interpretability; Medicine; Psychological intervention; Odds ratio; Meta-analysis; Odds; Physical therapy; Quality of life (healthcare); Strictly standardized mean difference; Internal medicine; Computer science; Artificial intelligence; Logistic regression","score_opus":0.3513708642939531,"score_gpt":0.5762473485840216,"score_spread":0.2248764842900685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060731727","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690134,0.012656074,0.014986763,0.0012829329,0.0004919496,0.0012398945,0.00013246914,0.000015522111,0.00018097291],"genre_scores_gemma":[0.98260885,0.00005550305,0.016584976,0.00056189013,0.0000071709687,0.00008000424,0.000015816478,0.00001514867,0.00007062255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98911715,0.0051307185,0.0043729274,0.0003946351,0.00028545334,0.0006991318],"domain_scores_gemma":[0.9930587,0.0036875636,0.002137275,0.00074131106,0.00010013547,0.00027502107],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03021588,0.00019675145,0.0035653159,0.0005693725,0.000056523015,0.0000019259876,0.000263701,0.0001502639,0.00037007913],"category_scores_gemma":[0.0011915114,0.00015990298,0.0010975513,0.0011660742,0.00013948312,0.00011338604,0.00004914425,0.00020964914,0.0000023315163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047880583,0.0020599987,0.8844247,0.004600021,0.019351492,5.4469453e-8,0.05326566,0.00057347224,0.00050056167,0.018553654,0.00006764803,0.016123936],"study_design_scores_gemma":[0.0011453158,0.0008593214,0.98359054,0.00006281341,0.0046018464,8.152375e-7,0.0057252743,0.0006745752,0.0014668436,0.0015465135,0.00009070599,0.0002354428],"about_ca_topic_score_codex":0.068973586,"about_ca_topic_score_gemma":0.0007013023,"teacher_disagreement_score":0.099165834,"about_ca_system_score_codex":0.00022317316,"about_ca_system_score_gemma":0.00039877289,"threshold_uncertainty_score":0.99859685},"labels":[],"label_agreement":null},{"id":"W2060830215","doi":"10.1016/j.jval.2013.02.014","title":"NICE’s Selective Application of Differential Discounting: Ambiguous, Inconsistent, and Unjustified","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Discounting; Nice; Differential (mechanical device); Life expectancy; Actuarial science; Psychological intervention; Medicine; Psychology; Economics; Computer science; Psychiatry; Environmental health; Engineering","score_opus":0.2352479979104761,"score_gpt":0.3863833612284052,"score_spread":0.15113536331792912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2060830215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717914,0.0014649538,0.005446621,0.018377718,0.00026408097,0.001594031,0.0000806753,0.000032424567,0.0009481226],"genre_scores_gemma":[0.99636155,0.00018135255,0.0013610944,0.0016391339,0.000115334886,0.00019565232,0.000022977812,0.000021966905,0.00010095127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954849,0.00035034554,0.0032538627,0.00047543825,0.00007568585,0.00035979252],"domain_scores_gemma":[0.99694765,0.00045303348,0.0020571032,0.00033434853,0.000058049412,0.00014980222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052481797,0.0001452542,0.0008138761,0.0003252133,0.00011159622,0.00003940925,0.0001440409,0.00010615094,0.00006464587],"category_scores_gemma":[0.0008546747,0.00018087373,0.00005016138,0.00023136951,0.00008253671,0.00028711,0.000048775833,0.00017508745,0.00020655572],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036111058,0.00052481063,0.5762266,0.0039818645,0.000094479925,2.631571e-7,0.008440817,0.0015930496,0.0001114459,0.39908442,0.0054613026,0.004444851],"study_design_scores_gemma":[0.0014222942,0.00018541394,0.8220077,0.00022615651,0.0000056231925,0.000004830261,0.0015609484,0.114215754,0.000024691666,0.057730675,0.0022203734,0.0003955291],"about_ca_topic_score_codex":0.084322326,"about_ca_topic_score_gemma":0.00045995697,"teacher_disagreement_score":0.34135374,"about_ca_system_score_codex":0.00045729586,"about_ca_system_score_gemma":0.00017369437,"threshold_uncertainty_score":0.9217753},"labels":[],"label_agreement":null},{"id":"W2061161840","doi":"10.1016/j.jval.2011.08.617","title":"PHP66 Impact of Type of Drug Insurance on the Use of Health Care Services Among Users of Antidepressants","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Medicine; Medical prescription; Prescription drug; Logistic regression; Retrospective cohort study; Emergency department; Emergency medicine; Public health; Health insurance; Family medicine; Private insurance; Antidepressant; Psychiatry; Health care; Internal medicine; Pharmacology","score_opus":0.5730610181554715,"score_gpt":0.43495048787518775,"score_spread":0.13811053028028375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061161840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927778,0.0041300575,0.000016267953,0.0009469756,0.00023278563,0.0008675276,0.0008153626,0.000008287877,0.00020490552],"genre_scores_gemma":[0.9975446,0.000926802,0.00071697304,0.0007328836,0.000020736581,0.000010304464,0.000012709895,0.000024936646,0.0000100710595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929692,0.0010342316,0.0051784036,0.00032527346,0.00013750658,0.00035535963],"domain_scores_gemma":[0.9910423,0.0011168476,0.0068209697,0.0007563195,0.0001547019,0.000108818516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01018545,0.0001666085,0.0014655148,0.0004044586,0.000061068786,0.000005691905,0.00037309536,0.00008432387,0.0000691812],"category_scores_gemma":[0.00082612684,0.000157981,0.00015271857,0.00044048467,0.00014332111,0.00028127743,0.000044075707,0.00016699516,0.000013504963],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006195988,0.00015098848,0.9589826,0.0035769138,0.0000465802,9.6231766e-8,0.024812562,0.0068883817,0.0000015719667,0.004882468,0.00048335566,0.00011254815],"study_design_scores_gemma":[0.00048199526,0.00040658,0.992083,0.0011228551,0.0000017433783,3.078304e-7,0.0021946214,0.0027796414,0.000057173555,0.0006559039,0.00010617935,0.00011000407],"about_ca_topic_score_codex":0.28009796,"about_ca_topic_score_gemma":0.0012305275,"teacher_disagreement_score":0.27886742,"about_ca_system_score_codex":0.00034798772,"about_ca_system_score_gemma":0.00062153576,"threshold_uncertainty_score":0.7246959},"labels":[],"label_agreement":null},{"id":"W2061177824","doi":"10.1016/s1098-3015(10)61762-7","title":"PMH4 2-YEAR OUTCOMES OF RISPERDAL® CONSTATM-THE FIRST ATYPICAL LONG ACTING INJECTABLE ANTIPSYCHOTIC: RESULTS FROM THE CANADIAN NATIONAL OUTCOMES MEASUREMENT STUDY IN SCHIZOPHRENIA","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Schizophrenia (object-oriented programming); Atypical antipsychotic; Antipsychotic; Psychiatry; Negative symptom; Pediatrics; Psychosis","score_opus":0.11280805076470828,"score_gpt":0.35279425058833297,"score_spread":0.23998619982362468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061177824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97418994,0.00044630974,0.0000032091596,0.022576759,0.0002065137,0.0019343267,0.000082749924,0.000013735164,0.000546474],"genre_scores_gemma":[0.9983766,0.000043891494,0.00084319705,0.00058447634,0.000038658534,0.00005381396,0.000015222474,0.000019101968,0.00002505378],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99611384,0.00068541704,0.00083974755,0.00039910641,0.0013543284,0.00060759013],"domain_scores_gemma":[0.9974227,0.0014054589,0.00017892632,0.0004882481,0.00020235559,0.0003023175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004088488,0.00020722947,0.00052400434,0.00026859963,0.00032620018,0.000050953742,0.00024254314,0.0000713558,0.0000465604],"category_scores_gemma":[0.004042437,0.000120044395,0.00008776847,0.00060615677,0.000110117704,0.00007048144,0.000036716337,0.0005854038,0.000024305356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027885726,0.00063121534,0.99229455,0.000019960988,0.0001652722,0.000046430403,0.0013173232,0.00029648776,6.9250575e-7,0.0014106415,0.00034772916,0.00068112917],"study_design_scores_gemma":[0.013506418,0.00030242375,0.9835378,0.00018644432,0.000018938694,0.00000517066,0.0012307971,0.00017715256,0.000017080345,0.0006969094,0.00022991815,0.00009092995],"about_ca_topic_score_codex":0.5149742,"about_ca_topic_score_gemma":0.8657599,"teacher_disagreement_score":0.35078573,"about_ca_system_score_codex":0.0016245046,"about_ca_system_score_gemma":0.0048411926,"threshold_uncertainty_score":0.8588068},"labels":[],"label_agreement":null},{"id":"W2061182213","doi":"10.1016/j.jval.2011.08.1213","title":"PCN112 Cost-Utility of Treatment for Acute Lymphoblastic Leukemia (ALL) in Childhood","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Utilities Kingston (Canada); McMaster University","funders":"","keywords":"Medicine; Pediatrics; Confidence interval; Quality of life (healthcare); Quality-adjusted life year; Economic evaluation; Ambulatory; Demography; Cost effectiveness; Internal medicine","score_opus":0.09980374962432322,"score_gpt":0.36196723210034437,"score_spread":0.26216348247602117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061182213","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99211484,0.00041287905,0.0008429667,0.0004893907,0.00015840193,0.0040310556,0.00014050172,0.000048741807,0.0017612055],"genre_scores_gemma":[0.9942045,0.00052640063,0.0042455303,0.0003633726,0.0000681799,0.0003297215,0.000051661144,0.000045709723,0.00016490651],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713886,0.00020300708,0.0009502711,0.0005050021,0.0003387436,0.00086413283],"domain_scores_gemma":[0.9982112,0.0005498751,0.00019853038,0.0005740147,0.00009345528,0.0003728912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009250204,0.0002575691,0.00083375484,0.0004112031,0.00004056399,0.000004584917,0.00018964671,0.00017414654,0.00009847378],"category_scores_gemma":[0.0003706933,0.0002152868,0.00013837936,0.00046795237,0.00012840355,0.00007175534,0.000060297152,0.00019505604,0.000022848748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.02568335,0.019307718,0.6242409,0.008506812,0.0025095656,0.0011791397,0.077760406,0.002925599,0.0022569546,0.008865025,0.007062436,0.2197021],"study_design_scores_gemma":[0.049942866,0.012018025,0.74425554,0.0016444909,0.00023950651,0.00028921638,0.0007782021,0.18009055,0.0054370286,0.0025752357,0.0022022917,0.0005270453],"about_ca_topic_score_codex":0.021777902,"about_ca_topic_score_gemma":0.00033460662,"teacher_disagreement_score":0.21917504,"about_ca_system_score_codex":0.008065085,"about_ca_system_score_gemma":0.0075580203,"threshold_uncertainty_score":0.9980682},"labels":[],"label_agreement":null},{"id":"W2061389534","doi":"10.1016/j.jval.2012.03.075","title":"UT3 Firm- and Drug-Specific Patterns of Generic Drug Prices Experienced by United States Medicaid Programs: 1991-2008","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicaid; Generic drug; Reimbursement; Unit price; Drug prices; Quarter (Canadian coin); Drug; Business; Relative price; Economics; Actuarial science; Demographic economics; Monetary economics; Medicine; Health care; Pharmacology; Microeconomics; Economic growth","score_opus":0.09323204748075149,"score_gpt":0.30785787904224043,"score_spread":0.21462583156148896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061389534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655316,0.029946158,0.00006369139,0.0031881365,0.00031301295,0.0003375193,0.00029679417,0.000022100096,0.000301006],"genre_scores_gemma":[0.97123605,0.026477395,0.00029523898,0.0015775138,0.00011679118,0.00005295983,0.00015591671,0.000025093035,0.000063051346],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979581,0.000060491722,0.000939487,0.0003126107,0.000046475932,0.00068283034],"domain_scores_gemma":[0.9987941,0.00013320213,0.0004475081,0.00022797693,0.000013009365,0.00038421754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011847602,0.00016905338,0.00046241147,0.00030189208,0.00007902157,0.000032756125,0.00020477147,0.00005936763,0.00011499431],"category_scores_gemma":[0.000028313967,0.00018324629,0.000047037163,0.00035495122,0.000108032815,0.00021479004,0.00007747098,0.00018054234,0.000029847984],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006658283,0.0013887492,0.8062767,0.0010616235,0.00008260245,0.000002691416,0.06232034,0.0007266254,0.0000281246,0.08320036,0.018570822,0.026274804],"study_design_scores_gemma":[0.0010656805,0.00010060532,0.017738614,0.00008179254,0.0000022181794,0.000004124498,0.001412626,0.014922783,0.000102268365,0.002445275,0.96173036,0.00039365003],"about_ca_topic_score_codex":0.012525097,"about_ca_topic_score_gemma":0.000036947647,"teacher_disagreement_score":0.9431595,"about_ca_system_score_codex":0.00014185328,"about_ca_system_score_gemma":0.000029267449,"threshold_uncertainty_score":0.99405056},"labels":[],"label_agreement":null},{"id":"W2061477176","doi":"10.1016/j.jval.2014.03.1457","title":"Cost-effectiveness analysis of hCG and human gonadotropins in men with hypogonadotropic hypogonadism in the context of an assisted reproduction program","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Ovarian function and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux","funders":"","keywords":"Human chorionic gonadotropin; Context (archaeology); Medicine; Infertility; Fertility; Gynecology; Human reproduction; Hypogonadotropic hypogonadism; Gonadotropin; Spermatogenesis; Obstetrics; Pregnancy; Andrology; Internal medicine; Population; Hormone; Biology","score_opus":0.06000457560296947,"score_gpt":0.34694920745879676,"score_spread":0.2869446318558273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061477176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965266,0.00016781857,0.00006653727,0.0009676211,0.000033745022,0.0016752401,0.0000048412844,0.000015968255,0.00054163206],"genre_scores_gemma":[0.99930316,0.000029572457,0.00026992985,0.00018378379,0.00002151136,0.00011758426,0.00004890411,0.000011011632,0.000014543276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977725,0.0009447549,0.0004988163,0.00035530224,0.00022336881,0.00020522272],"domain_scores_gemma":[0.9990792,0.00015339779,0.00021013111,0.00041584222,0.000065511435,0.00007590739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001599192,0.00011760153,0.0005802976,0.00067339407,0.000037642134,0.0000069481207,0.00006415624,0.00006327523,0.000006712163],"category_scores_gemma":[0.00015413285,0.00008506384,0.000042841806,0.0014251001,0.00012877109,0.000064414504,0.0000100277775,0.00019868903,2.501619e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001976529,0.00253678,0.87709445,0.0008325643,0.00017929,0.000007781452,0.004711482,0.0029653192,0.0004543517,0.005754011,0.000016204927,0.10347125],"study_design_scores_gemma":[0.0037527129,0.0019235029,0.9863774,0.00016564572,0.00008733544,0.000009113606,0.0018421407,0.005148864,0.000037338377,0.00015801334,0.00042648768,0.000071418624],"about_ca_topic_score_codex":0.029412853,"about_ca_topic_score_gemma":0.0062717427,"teacher_disagreement_score":0.10928299,"about_ca_system_score_codex":0.00014031417,"about_ca_system_score_gemma":0.00014338327,"threshold_uncertainty_score":0.97705036},"labels":[],"label_agreement":null},{"id":"W2061597312","doi":"10.1016/j.jval.2014.03.998","title":"Prevalence And Incidence Of Interstitial Pulmonary Diseases With Fibrosis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Idiopathic pulmonary fibrosis; Incidence (geometry); COPD; Interstitial lung disease; Pulmonary fibrosis; Mortality rate; Internal medicine; Epidemiology; Pediatrics; Lung","score_opus":0.01085552478387926,"score_gpt":0.2564979780784433,"score_spread":0.24564245329456405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061597312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933755,0.0038873642,0.00041890636,0.0010998424,0.00009794732,0.00046508398,0.000068715024,0.000035411245,0.00055125536],"genre_scores_gemma":[0.99810505,0.00063954777,0.000698955,0.00034168077,0.00010868642,0.000017481609,0.000010094175,0.000015802781,0.000062709725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987317,0.0001346011,0.00034983747,0.00029029217,0.00024587105,0.0002477487],"domain_scores_gemma":[0.9992023,0.00013073727,0.00012863925,0.00023528081,0.000052236224,0.00025081867],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023706126,0.00013412401,0.00033750545,0.00012026118,0.00004651037,0.000007831254,0.00008006373,0.0000433933,0.000027074027],"category_scores_gemma":[0.00010926301,0.00010756121,0.000049817754,0.00015301937,0.00018987924,0.00011104759,0.00005271203,0.00012700063,0.0000025950135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010600673,0.0007361765,0.95386493,0.017267086,0.000034236844,0.00010848778,0.00063483824,0.0004626329,0.0009944864,0.004541248,0.00020663704,0.01054854],"study_design_scores_gemma":[0.0014432175,0.0155357,0.9304517,0.015549325,0.00012567126,0.0002991452,0.00019565532,0.03449587,0.0001914514,0.00082107936,0.0005615911,0.00032961415],"about_ca_topic_score_codex":0.00168365,"about_ca_topic_score_gemma":0.0000068426266,"teacher_disagreement_score":0.034033235,"about_ca_system_score_codex":0.0000793067,"about_ca_system_score_gemma":0.0002139476,"threshold_uncertainty_score":0.43862188},"labels":[],"label_agreement":null},{"id":"W2061621007","doi":"10.1016/s1098-3015(10)74332-1","title":"PCN81 COST EFFECTIVENESS ANALYSIS OF BORTEZOMIB IN PREVIOUSLY UNTREATED MULTIPLE MYELOMA PATIENTS IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bortezomib; Multiple myeloma; Oncology; Internal medicine; Medicine","score_opus":0.0321674714575426,"score_gpt":0.32276034153599403,"score_spread":0.2905928700784514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061621007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710447,0.0003428474,0.0000047515487,0.00018731628,0.00003289692,0.0021511149,0.00008004283,0.000009129767,0.000087412205],"genre_scores_gemma":[0.9991924,0.00021444961,0.00009369821,0.00012117999,0.0000063830144,0.000063205596,0.00028798613,0.000012021385,0.000008650277],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971896,0.00061319943,0.0007164897,0.00036763342,0.00046798092,0.000645123],"domain_scores_gemma":[0.9986559,0.00048192055,0.00015162518,0.0003257577,0.00008915867,0.00029563005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006323863,0.00018090736,0.0009082073,0.0009703115,0.000025360261,0.0000044086178,0.00009415322,0.00006378023,0.000019732935],"category_scores_gemma":[0.0005021705,0.00016047494,0.000072528055,0.0024092982,0.000021598675,0.000051713087,0.000019325498,0.00023240093,0.000001993641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009795922,0.0008780049,0.9622897,0.00022058937,0.00012407338,0.00017899711,0.00023640708,0.0070913997,0.000022088998,0.000006549546,0.000010924504,0.027961662],"study_design_scores_gemma":[0.009080059,0.0005877912,0.9530235,0.00052539987,0.000041122126,0.0000010656807,0.000049531867,0.036372513,0.00020199802,0.000009415073,0.00001658302,0.00009102781],"about_ca_topic_score_codex":0.98619807,"about_ca_topic_score_gemma":0.95807743,"teacher_disagreement_score":0.029281111,"about_ca_system_score_codex":0.0037865925,"about_ca_system_score_gemma":0.0022154276,"threshold_uncertainty_score":0.9901808},"labels":[],"label_agreement":null},{"id":"W2061626579","doi":"10.1016/j.jval.2014.03.1150","title":"Integrating the child’s voice in adverse event reporting in oncology trials: Initial steps in the pediatric pro-ctcae initiative","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Common Terminology Criteria for Adverse Events; Medicine; Adverse effect; Grading (engineering); Clinical trial; Terminology; MEDLINE; Family medicine; Pediatric cancer; Pediatric oncology; Physical therapy; Cancer; Internal medicine","score_opus":0.1989368860584612,"score_gpt":0.45933098145925555,"score_spread":0.2603940954007944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061626579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95057,0.00083970797,0.000097890035,0.041511126,0.00086143625,0.0034472991,0.000007982082,0.000034811244,0.002629763],"genre_scores_gemma":[0.9863089,0.0002487345,0.00047317296,0.01063375,0.00197801,0.0003034193,0.000017326789,0.000032057258,0.000004629803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97603774,0.015213183,0.006385769,0.00067873823,0.00082126167,0.00086328964],"domain_scores_gemma":[0.9859188,0.009500165,0.0037027176,0.00064495177,0.000086311695,0.00014701624],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06799486,0.0002859265,0.0014008607,0.00062902615,0.0001241317,0.000018093802,0.00033184845,0.0002102508,0.000014875875],"category_scores_gemma":[0.046814375,0.00018778595,0.00016037979,0.0015417894,0.00008974276,0.00014022797,0.000104138824,0.0021868313,0.000010904982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092560524,0.0015777888,0.7202584,0.0012154919,0.000027848688,0.00023195644,0.2512482,0.0031665124,0.000003625782,0.0017341594,0.000550168,0.019060228],"study_design_scores_gemma":[0.012875464,0.0024877186,0.8792231,0.0036569808,0.000057002457,0.00024104699,0.08566757,0.0084669655,0.000018588238,0.0027697978,0.004055354,0.00048042522],"about_ca_topic_score_codex":0.040055532,"about_ca_topic_score_gemma":0.039006792,"teacher_disagreement_score":0.16558063,"about_ca_system_score_codex":0.001174681,"about_ca_system_score_gemma":0.0023014136,"threshold_uncertainty_score":0.97852886},"labels":[],"label_agreement":null},{"id":"W2061702676","doi":"10.1016/j.jval.2014.08.598","title":"Health Utility in Patients Following Cardiovascular Events","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Myocardial infarction; Angina; Stroke (engine); Unstable angina; Diabetes mellitus; Quality of life (healthcare); EQ-5D; Demographics; Canadian Cardiovascular Society; Emergency medicine; Internal medicine; Disease; Physical therapy; Health related quality of life; Demography","score_opus":0.032618380386977675,"score_gpt":0.3279255276756159,"score_spread":0.2953071472886382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061702676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887152,0.0027208505,0.00012245691,0.0036462254,0.0012160001,0.0024652556,0.000013818392,0.00006210702,0.0010381266],"genre_scores_gemma":[0.99196833,0.0005233318,0.0006365693,0.0065344074,0.00014998158,0.00004948762,0.00007477849,0.000036340403,0.000026742413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994878,0.0012844444,0.0012236967,0.0005903938,0.00078958215,0.0012339095],"domain_scores_gemma":[0.997947,0.00012456339,0.00017092784,0.00068564113,0.000034148754,0.0010377668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006852171,0.000227652,0.0013022744,0.00033950384,0.00013569105,0.0000048764005,0.00009241624,0.00012295655,0.000008194642],"category_scores_gemma":[0.00024386452,0.00022926097,0.00039985607,0.00060200994,0.00001962527,0.000080589896,0.000049071336,0.0005477678,0.000038174745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015862267,0.00048883003,0.90181357,0.002236078,0.00001717411,0.0000056462527,0.00071612606,0.00013481097,1.6127268e-7,0.000060578936,0.00027854994,0.09408985],"study_design_scores_gemma":[0.0064666965,0.0009412326,0.97397333,0.0012044947,0.000008399041,0.000007233249,0.00009759595,0.0010713632,0.0000020868222,0.00015733692,0.015926696,0.00014355742],"about_ca_topic_score_codex":0.053511668,"about_ca_topic_score_gemma":0.0003707743,"teacher_disagreement_score":0.09394629,"about_ca_system_score_codex":0.0019475489,"about_ca_system_score_gemma":0.0016039573,"threshold_uncertainty_score":0.9527911},"labels":[],"label_agreement":null},{"id":"W2061800352","doi":"10.1016/j.jval.2012.03.386","title":"PMD46 Doctor Knows Best: The Effect of Yea-Saying Bias on Willingness to Pay in Choice-Format Conjoint-Analysis Studies","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Conjoint analysis; Test (biology); Respondent; Willingness to pay; Colonoscopy; Preference; Medicine; Actuarial science; Psychology; Ordered probit; Econometrics; Social psychology; Statistics; Demography; Family medicine; Economics; Cancer; Mathematics; Colorectal cancer; Political science; Internal medicine; Microeconomics","score_opus":0.2860897329741851,"score_gpt":0.32753943633819854,"score_spread":0.041449703364013435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061800352","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939097,0.0034899951,0.000079283025,0.0007675448,0.00041500575,0.00049627566,0.000035232544,0.000006052738,0.00080088124],"genre_scores_gemma":[0.9984236,0.00084477523,0.000088016604,0.00034079296,0.000086113825,0.00006967241,0.000007020171,0.0000136224335,0.00012643679],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982574,0.00015717953,0.0009492513,0.00023472634,0.00004731568,0.00035415697],"domain_scores_gemma":[0.9985848,0.00063859223,0.00040531092,0.00028766235,0.000004513917,0.00007912171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040822304,0.00014307258,0.0006668246,0.00036223762,0.000070874914,0.000012496179,0.00014067617,0.00005354634,0.0000665667],"category_scores_gemma":[0.00029079433,0.00010644376,0.00011737849,0.00045445893,0.000039273356,0.0001731742,0.000055490458,0.00015698973,0.0003837913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013439576,0.000050519942,0.94436985,0.000092215996,0.00007939176,1.0173705e-7,0.0021273422,0.048678212,0.0000010582218,0.0033311965,0.000056136287,0.0012005249],"study_design_scores_gemma":[0.00067828014,0.0003862239,0.9849287,0.00010653525,0.00002852172,3.9502004e-7,0.00043904452,0.009019277,0.00009356814,0.00043976132,0.0036873235,0.00019234554],"about_ca_topic_score_codex":0.00461389,"about_ca_topic_score_gemma":0.00026156692,"teacher_disagreement_score":0.040558863,"about_ca_system_score_codex":0.0005799124,"about_ca_system_score_gemma":0.000010835412,"threshold_uncertainty_score":0.6974852},"labels":[],"label_agreement":null},{"id":"W2061917309","doi":"10.1016/j.jval.2014.03.1053","title":"Chronic Obstructive Pulmonary Disease (Copd) Drug Utilization: An Analysis With The Ramq Database","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"COPD; Medicine; Pulmonary disease; Fixed-dose combination; Database; Asthma; Drug; Population; Internal medicine; Compliance (psychology); Pediatrics; Pharmacology","score_opus":0.04095539428027161,"score_gpt":0.32998720421437844,"score_spread":0.2890318099341068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2061917309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96849835,0.009424215,0.002513675,0.015138227,0.00016510951,0.0026481487,0.00032875888,0.00016830962,0.0011152056],"genre_scores_gemma":[0.9964938,0.0002753014,0.00040199872,0.0006577948,0.0005872077,0.00015396903,0.00086193223,0.00006650789,0.0005014747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99544334,0.0011655221,0.0005221505,0.0009678509,0.0010383518,0.0008627717],"domain_scores_gemma":[0.9964405,0.00032743355,0.00021709832,0.0016966019,0.00020878171,0.0011096325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012607991,0.00034389025,0.0006089007,0.00053154904,0.00039062114,0.000049102993,0.00040629023,0.000058931128,0.0003911886],"category_scores_gemma":[0.00018300592,0.00024287775,0.00016135476,0.0022904822,0.00048065252,0.00035712103,0.00015107072,0.0005830914,0.000037395006],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043279664,0.0016443601,0.854429,0.0047938153,0.0006599989,0.0007528796,0.0015778856,0.06517207,0.000052198204,0.012326571,0.0006313665,0.053631913],"study_design_scores_gemma":[0.0010730089,0.00020984042,0.7080184,0.0001969184,0.0003114236,0.000020133646,0.00068202073,0.28515032,0.000010937617,0.00035188405,0.0037526484,0.00022241862],"about_ca_topic_score_codex":0.0046644206,"about_ca_topic_score_gemma":0.0007316224,"teacher_disagreement_score":0.21997827,"about_ca_system_score_codex":0.0015847532,"about_ca_system_score_gemma":0.0023858899,"threshold_uncertainty_score":0.9904267},"labels":[],"label_agreement":null},{"id":"W2062039889","doi":"10.1016/j.jval.2012.03.551","title":"PSY17 Economic Burden Associated With Workplace Productivity Losses (WPL) in Patients With Psoriasis in a Population in the United States","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Absenteeism; Medicine; Psoriatic arthritis; Sick leave; Confounding; Population; Indirect costs; Psoriasis; Demography; Presenteeism; Physical therapy; Environmental health; Internal medicine; Psychology","score_opus":0.2019867242562362,"score_gpt":0.36899198346965506,"score_spread":0.16700525921341886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062039889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98306197,0.0004154184,0.000020604302,0.0141304415,0.00022825047,0.0019255483,0.00011153965,0.0000208679,0.00008535328],"genre_scores_gemma":[0.9976816,0.00008347937,0.00026352218,0.0013170794,0.00012756904,0.00018316116,0.00028366258,0.00003614742,0.000023787801],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938022,0.0018723764,0.002865578,0.0005369991,0.000131857,0.00079098565],"domain_scores_gemma":[0.99621683,0.0013984132,0.001778562,0.0004591376,0.000030158386,0.000116866235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024683146,0.00023622137,0.0009121092,0.0011399854,0.00009231265,0.0000549397,0.00023920793,0.00013429487,0.000026064889],"category_scores_gemma":[0.0016331355,0.0002264022,0.000027760805,0.0010907303,0.00004785541,0.00076431705,0.000025944613,0.0004104052,0.000064042884],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009132822,0.00035555768,0.91309845,0.00014792268,0.00001107343,3.1306516e-7,0.009162413,0.07457523,4.825753e-9,0.0023221152,0.00016550066,0.00007007845],"study_design_scores_gemma":[0.002341963,0.00016434655,0.9848159,0.0004057759,0.000001688593,5.110767e-7,0.0013488493,0.008579452,1.1426963e-7,0.0015089522,0.0005833026,0.00024913365],"about_ca_topic_score_codex":0.16412722,"about_ca_topic_score_gemma":0.03283466,"teacher_disagreement_score":0.13129255,"about_ca_system_score_codex":0.0036414687,"about_ca_system_score_gemma":0.00025848593,"threshold_uncertainty_score":0.9848136},"labels":[],"label_agreement":null},{"id":"W2062069494","doi":"10.1016/j.jval.2011.02.1143","title":"PND33 UTILIZING A PAPER STANDARD GAMBLE INSTRUMENT TO ASSESS HEALTH UTILITY IN PATIENTS WITH HEMOPHILIA B","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Rank correlation; Visual analogue scale; Reliability (semiconductor); Spearman's rank correlation coefficient; Physical therapy; Test (biology); Convergent validity; Correlation; Statistics; Surgery; Patient satisfaction; Mathematics; Internal consistency","score_opus":0.15506022220186508,"score_gpt":0.3641884533417673,"score_spread":0.20912823113990223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062069494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98983705,0.000231246,0.00001748411,0.0047951923,0.00014996962,0.0026359246,0.000032067754,0.000048416354,0.0022526314],"genre_scores_gemma":[0.99464285,0.00014976306,0.0033923371,0.0014874038,0.000031802327,0.00007760147,0.000032958098,0.000036266396,0.0001490243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964789,0.0003729067,0.0007293341,0.00057474355,0.0008255293,0.0010185702],"domain_scores_gemma":[0.99843544,0.00006526682,0.000114047354,0.0005346309,0.00011042029,0.00074019993],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017060544,0.00024748783,0.0006935275,0.00040477462,0.00011481486,0.000014349359,0.00013258164,0.00009132705,0.00023957151],"category_scores_gemma":[0.00008262991,0.00018427956,0.000050904157,0.00077001547,0.000062854706,0.00013365566,0.000082362865,0.00045253278,0.000032744054],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019448095,0.0012352968,0.9682623,0.00062216347,0.000021299857,0.000035421745,0.003408973,0.000010239629,0.0000039806796,0.0002550762,0.00030054746,0.023899887],"study_design_scores_gemma":[0.0057337848,0.005052346,0.98463297,0.0012671077,0.000004853771,0.00000408059,0.0006637533,0.00013925471,0.00015058983,0.00020336753,0.0019776437,0.00017025605],"about_ca_topic_score_codex":0.014321291,"about_ca_topic_score_gemma":0.0010342919,"teacher_disagreement_score":0.02372963,"about_ca_system_score_codex":0.0012026009,"about_ca_system_score_gemma":0.0017883187,"threshold_uncertainty_score":0.99224246},"labels":[],"label_agreement":null},{"id":"W2062373581","doi":"10.1016/j.jval.2011.11.011","title":"An Exploratory Study of Response Shift in Health-Related Quality of Life and Utility Assessment Among Patients with Osteoarthritis Undergoing Total Knee Replacement Surgery in a Tertiary Hospital in Singapore","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Total Knee Arthroplasty Outcomes","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Singapore General Hospital; National University of Singapore","keywords":"Medicine; Quality of life (healthcare); Physical therapy; Health related quality of life; Osteoarthritis; Univariate analysis; Knee replacement; Test (biology); Surgery; Internal medicine; Arthroplasty; Multivariate analysis","score_opus":0.03437952248052896,"score_gpt":0.31169052694669946,"score_spread":0.2773110044661705,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062373581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961042,0.00066326803,0.0000033381828,0.0005199937,0.00015632094,0.0025092657,0.000019578814,0.000021078844,0.000002947322],"genre_scores_gemma":[0.999624,0.00002239771,0.00014086757,0.0000878317,0.000008004618,0.00006537404,0.000021372793,0.000028857628,0.000001301342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9910761,0.004734111,0.0025322519,0.0004542592,0.0005988577,0.000604397],"domain_scores_gemma":[0.99686277,0.0014474858,0.00079808116,0.00048551892,0.000045042405,0.00036110124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010486601,0.00023557617,0.0011630177,0.0006759468,0.000044251734,0.0000066450693,0.000045634224,0.000099724115,0.000009177673],"category_scores_gemma":[0.0009985126,0.00022756272,0.000039578907,0.000609231,0.00013189427,0.00045130373,0.00007772873,0.00050980685,2.9480276e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004069549,0.006515003,0.95292616,0.0009159491,0.000015711368,0.000017068613,0.03429397,0.00023656445,0.000003998041,0.0000064580427,0.0000025886343,0.0009969806],"study_design_scores_gemma":[0.0113140885,0.006173254,0.9632415,0.001750254,0.0000030392375,0.0000015289806,0.017159162,0.00018551294,0.000002872451,0.000010143914,4.1417513e-7,0.00015820465],"about_ca_topic_score_codex":0.019673707,"about_ca_topic_score_gemma":0.019888546,"teacher_disagreement_score":0.017134808,"about_ca_system_score_codex":0.0006895626,"about_ca_system_score_gemma":0.001375109,"threshold_uncertainty_score":0.9979959},"labels":[],"label_agreement":null},{"id":"W2062614029","doi":"10.1016/j.jval.2012.03.365","title":"PMD25 Comparison of Statistical Methods Used to Model Health Care Costs by Dialysis Modality in the Treatment of Kidney Failure","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Covariate; Censoring (clinical trials); Statistics; Medicine; Confidence interval; Dialysis; Regression analysis; Econometrics; Hemodialysis; Regression; Linear regression; Censored regression model; Mathematics; Internal medicine","score_opus":0.500834585883865,"score_gpt":0.5381588928736892,"score_spread":0.03732430698982425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062614029","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66597664,0.017039021,0.15427959,0.15061933,0.00048265935,0.004549033,0.0067136036,0.000028904466,0.00031118965],"genre_scores_gemma":[0.9255365,0.00021788919,0.06786563,0.0059296144,0.00006521943,0.00018280665,0.00016757146,0.000023908338,0.000010846123],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98897845,0.0037793068,0.0058665397,0.00046833002,0.00017868687,0.0007287073],"domain_scores_gemma":[0.9941227,0.0024569207,0.0020959226,0.0006759746,0.000045568024,0.0006029308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023786146,0.00021562044,0.002064828,0.00040913094,0.000096789336,0.000015646927,0.00027666418,0.00012574975,0.000036904476],"category_scores_gemma":[0.002381602,0.00021649442,0.000111328896,0.00048207966,0.000060481943,0.00015322996,0.000025153979,0.00017079093,0.000030311236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006769423,0.002399514,0.5846134,0.0024724156,0.0000687154,1.3450261e-7,0.24025118,0.0369971,0.000004343206,0.10644366,0.022729324,0.0039525293],"study_design_scores_gemma":[0.008133014,0.004102015,0.15200819,0.0009771243,0.000043457985,0.0000025812355,0.06491754,0.6837476,0.0001355265,0.015214612,0.069243915,0.001474416],"about_ca_topic_score_codex":0.068460055,"about_ca_topic_score_gemma":0.001982679,"teacher_disagreement_score":0.6467505,"about_ca_system_score_codex":0.0032018404,"about_ca_system_score_gemma":0.0009454784,"threshold_uncertainty_score":0.9377431},"labels":[],"label_agreement":null},{"id":"W2062656631","doi":"10.1016/j.jval.2012.03.1227","title":"PCN110 Health-Related Quality of Life in Advanced Non-Small Cell Lung Cancer (NSCLC) Patients","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Adverse effect; Lung cancer; Disease; Palliative care; Performance status; Stage (stratigraphy); Health care; Cancer; Internal medicine; Physical therapy","score_opus":0.04398484578602466,"score_gpt":0.3838714521447991,"score_spread":0.33988660635877443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062656631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825692,0.012742982,0.000026198408,0.0017665743,0.00051223167,0.0015571774,0.000063096595,0.000020868118,0.0007416786],"genre_scores_gemma":[0.9965652,0.0009446923,0.00089938013,0.0011648928,0.000047458005,0.00011971123,0.00006893243,0.00002555435,0.0001641523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763215,0.00024560484,0.0011148067,0.00022972077,0.00023310217,0.00054462586],"domain_scores_gemma":[0.99869156,0.00011603203,0.0004833183,0.0002525772,0.00007244958,0.00038403925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007139522,0.00014888446,0.0006123797,0.00017991419,0.000050048922,0.0000024681683,0.00005808912,0.00007834869,0.000049795257],"category_scores_gemma":[0.000085708234,0.00013331046,0.000058722868,0.0004187102,0.00002368747,0.00009442135,0.000020993102,0.000226374,0.000006309459],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013738927,0.0011195735,0.9830074,0.0015738967,0.000026131951,6.264541e-7,0.008803884,0.0012102905,0.000019443169,0.00008529773,0.00023396136,0.0037821492],"study_design_scores_gemma":[0.007035706,0.00030726707,0.9903675,0.0009089938,0.000016102573,3.2156214e-7,0.00042321527,0.00052139576,0.000046854668,0.000020938556,0.0002450767,0.00010668383],"about_ca_topic_score_codex":0.10514345,"about_ca_topic_score_gemma":0.0011622928,"teacher_disagreement_score":0.10398115,"about_ca_system_score_codex":0.0012198308,"about_ca_system_score_gemma":0.0017650966,"threshold_uncertainty_score":0.9008155},"labels":[],"label_agreement":null},{"id":"W2062933247","doi":"10.1016/j.jval.2014.03.1236","title":"Antidepressant use during pregnancy and risk of autism spectrum disorders in children: A population-based cohort study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Medicine; Pregnancy; Antidepressant; Hazard ratio; Confounding; Cohort study; Cohort; Autism spectrum disorder; Proportional hazards model; Population; Obstetrics; Confidence interval; Autism; Pediatrics; Psychiatry; Internal medicine; Environmental health; Biology","score_opus":0.013287872478203585,"score_gpt":0.27712179179133295,"score_spread":0.2638339193131294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062933247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960886,0.00089296495,0.000013371601,0.00043731593,0.00010113554,0.0024039096,0.000015985568,0.00002772681,0.000018993529],"genre_scores_gemma":[0.99829775,0.0013963674,0.00015699159,0.000033460456,0.000015768348,0.000049620518,0.000011497064,0.000020055857,0.00001848632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801356,0.00044871887,0.0006511236,0.00032317964,0.00022667379,0.00033676732],"domain_scores_gemma":[0.99917257,0.00014095845,0.00024859645,0.00029676402,0.0000040333766,0.00013708309],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000530419,0.00014292738,0.00043888742,0.00024525772,0.00007378634,0.0000075113026,0.000052124065,0.000051324052,0.000007769779],"category_scores_gemma":[0.00007893789,0.00013364626,0.000029591607,0.00017365372,0.000024551964,0.00007336073,0.000027887518,0.00025292023,0.0000010805462],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015522179,0.0004967713,0.9950331,0.0023448276,0.000014612445,0.0000043624427,0.0003177862,0.0012450335,6.0702126e-7,0.0001414684,1.3443149e-7,0.00024611098],"study_design_scores_gemma":[0.0029089362,0.0005900021,0.98319584,0.009732143,0.000016716436,0.000010476433,0.000010515642,0.0031281426,0.000030722815,0.00027877334,7.937887e-7,0.00009692205],"about_ca_topic_score_codex":0.0934459,"about_ca_topic_score_gemma":0.00208514,"teacher_disagreement_score":0.091360755,"about_ca_system_score_codex":0.000104962244,"about_ca_system_score_gemma":0.0000614774,"threshold_uncertainty_score":0.9125909},"labels":[],"label_agreement":null},{"id":"W2062977654","doi":"10.1016/s1098-3015(10)73443-4","title":"PSS11 ECONOMIC BURDEN OF SEVERE CHRONIC HAND ECZEMA/ DERMATITIS IN CANADIAN ADULTS","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hand eczema; Medicine; Dermatology; Hand dermatitis; Allergic contact dermatitis; Allergy; Contact dermatitis; Immunology","score_opus":0.045542947335915566,"score_gpt":0.3570987363039822,"score_spread":0.3115557889680666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2062977654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9391367,0.009287131,5.6698747e-7,0.047059473,0.00012010457,0.00041676383,0.00002471328,0.000006846342,0.00394772],"genre_scores_gemma":[0.99228066,0.005111005,0.0000822349,0.0023454102,0.00012988591,0.0000044647077,0.000006225982,0.0000056945255,0.000034397024],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99892086,0.00008072426,0.00036694913,0.00014622002,0.00007470682,0.00041054463],"domain_scores_gemma":[0.999369,0.0001121461,0.00008888832,0.000116048664,0.000012617359,0.0003012783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003724253,0.00008203984,0.00029235173,0.00012656249,0.000048562786,0.0000064959913,0.000057378293,0.00005081717,0.00016601606],"category_scores_gemma":[0.00007106526,0.00007835047,0.000026526966,0.00011189605,0.000029560604,0.0000704359,0.000009765441,0.00020773469,0.000032015607],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008877738,0.00049688265,0.37053066,0.0060655735,0.00015348109,0.0006068837,0.021411961,0.040587932,0.00011329491,0.004163529,0.017507995,0.53747404],"study_design_scores_gemma":[0.0070185084,0.0014908696,0.63491243,0.0023539707,0.00002479942,0.00014289611,0.0005824341,0.06000565,0.00016409876,0.00075546704,0.2922537,0.0002951511],"about_ca_topic_score_codex":0.8912129,"about_ca_topic_score_gemma":0.557769,"teacher_disagreement_score":0.5371789,"about_ca_system_score_codex":0.0011448417,"about_ca_system_score_gemma":0.0010884944,"threshold_uncertainty_score":0.45030057},"labels":[],"label_agreement":null},{"id":"W2063170531","doi":"10.1016/j.jval.2011.02.310","title":"PSS8 SYSTEMATIC REVIEW OF THE ECONOMIC LITERATURE ON ATOPIC DERMATITIS IN CHILDREN","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PharmIdeas (Canada)","funders":"","keywords":"Economic evaluation; Atopic dermatitis; Medicine; Homeopathy; Medical prescription; MEDLINE; Family medicine; Population; Systematic review; Quality of life (healthcare); Health care; Pediatrics; Alternative medicine; Environmental health; Dermatology; Political science; Economic growth; Nursing; Economics; Pathology","score_opus":0.07955682508136554,"score_gpt":0.36506516751533974,"score_spread":0.2855083424339742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063170531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5383589,0.43185717,5.8923473e-7,0.01881557,0.0003334963,0.004133265,0.000030326248,0.00001690881,0.006453732],"genre_scores_gemma":[0.89606166,0.09172438,0.00004617774,0.0120590115,0.000032274165,0.00003233136,0.0000028656466,0.000005973368,0.000035340523],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9988938,0.00033068814,0.00046321616,0.00009574094,0.00008295164,0.00013360458],"domain_scores_gemma":[0.9994213,0.0001281113,0.00018849668,0.00020469968,0.000010092219,0.00004731293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006439599,0.000067918,0.00040878577,0.000033994762,0.000023149398,0.0000025989941,0.0000823217,0.000028590546,0.00006204904],"category_scores_gemma":[0.00018090158,0.00003947875,0.000044399458,0.0001235223,0.000017837836,0.000035249308,0.000024657898,0.00022416472,0.000021712429],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019960975,0.00023610695,0.13093513,0.859662,0.00007842141,0.000008722427,0.002064962,0.000009860695,5.7109355e-7,0.0048380867,0.0013301473,0.00081599987],"study_design_scores_gemma":[0.0010020003,0.00020106879,0.4357896,0.56090415,0.000080988815,0.00009299992,0.00004147112,0.00024458527,0.000032248507,0.00039541651,0.0011226864,0.00009283732],"about_ca_topic_score_codex":0.0016340165,"about_ca_topic_score_gemma":0.000027134769,"teacher_disagreement_score":0.3577027,"about_ca_system_score_codex":0.00014415265,"about_ca_system_score_gemma":0.00007481807,"threshold_uncertainty_score":0.2470155},"labels":[],"label_agreement":null},{"id":"W2063375359","doi":"10.1016/j.jval.2013.03.891","title":"Cost-Effectiveness Of Dexamethasone Intravitreal Implant In The Treatment Of Macular Edema (ME) Following Central Retinal Vein Occlusion (CRVO)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Allergan (Canada)","funders":"","keywords":"Central retinal vein occlusion; Medicine; Visual acuity; Macular edema; Emergency medicine; Intensive care medicine; Optometry; Surgery","score_opus":0.04709375615256383,"score_gpt":0.3497714693295924,"score_spread":0.3026777131770286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063375359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994573,0.001796793,0.000033647015,0.00047469215,0.00010701105,0.0028931163,0.00003007925,0.000008153003,0.00008352797],"genre_scores_gemma":[0.9984283,0.0008001061,0.00045621852,0.00005854266,0.00003124937,0.00012345554,0.000079043566,0.000015552898,0.0000075721814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764436,0.0007891674,0.00053608307,0.0002559509,0.0003434669,0.00043096428],"domain_scores_gemma":[0.9989097,0.00044139256,0.00016918649,0.0002872406,0.000033172906,0.0001593144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005972714,0.00018296976,0.00060411816,0.00013543326,0.000041958756,0.000006623401,0.00008463427,0.00006716353,0.000022290116],"category_scores_gemma":[0.000057459947,0.00011478417,0.00019257881,0.00028029666,0.00004447486,0.000045746212,0.000017048455,0.00009534508,0.0000041257767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016333596,0.004569904,0.96518373,0.0011576762,0.00013768322,0.00059039664,0.0035316832,0.00047402948,0.0020038146,0.000323379,0.000023371795,0.020370964],"study_design_scores_gemma":[0.005253659,0.0039811702,0.9851894,0.0013429052,0.00008534797,0.00008007448,0.0006118975,0.0013754611,0.0015105362,0.00044072914,0.000045157998,0.000083675164],"about_ca_topic_score_codex":0.04046538,"about_ca_topic_score_gemma":0.0000902024,"teacher_disagreement_score":0.04037518,"about_ca_system_score_codex":0.00052545127,"about_ca_system_score_gemma":0.00025674253,"threshold_uncertainty_score":0.96592426},"labels":[],"label_agreement":null},{"id":"W2063551124","doi":"10.1016/j.jval.2013.08.1785","title":"The 2013 Revision to Nice’s Discounting Guidelines: Differential Discounting Has Gone But Unjustified Selective Application Remains","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nice; Discounting; Differential (mechanical device); Actuarial science; Excellence; Medicine; Economics; Computer science; Political science; Finance; Law; Engineering","score_opus":0.3863733243511255,"score_gpt":0.43466809500455084,"score_spread":0.048294770653425356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063551124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4849164,0.003374196,0.056996744,0.4479082,0.0011702866,0.0048236717,0.000106369196,0.000107209,0.0005969475],"genre_scores_gemma":[0.9791113,0.0011358139,0.0054842792,0.011081973,0.001424009,0.00072672626,0.00006369424,0.00008367476,0.00088854035],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9910478,0.00066540256,0.0062709674,0.0009023491,0.00020790932,0.0009055484],"domain_scores_gemma":[0.9940204,0.0016889838,0.0029178737,0.0008501627,0.00023610087,0.000286455],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.019642923,0.0002875968,0.0009618566,0.00034422977,0.0010060184,0.00040805206,0.00050594145,0.00014651795,0.00007699825],"category_scores_gemma":[0.0055286875,0.00027909147,0.00011075206,0.00055379525,0.00008022751,0.00059011404,0.00013838705,0.00037807977,0.0023795844],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011086983,0.00054821424,0.08308183,0.00338899,0.00017061278,9.631705e-7,0.018468872,0.040151402,0.00022703999,0.28837332,0.547126,0.018351888],"study_design_scores_gemma":[0.0017512473,0.00028157502,0.09979477,0.001596064,0.00001301769,0.000008531484,0.0083495,0.61915207,0.000020514566,0.039977185,0.22774847,0.0013070531],"about_ca_topic_score_codex":0.07695524,"about_ca_topic_score_gemma":0.0023416635,"teacher_disagreement_score":0.57900065,"about_ca_system_score_codex":0.0015369133,"about_ca_system_score_gemma":0.0003801892,"threshold_uncertainty_score":0.99996614},"labels":[],"label_agreement":null},{"id":"W2063564660","doi":"10.1016/j.jval.2011.08.293","title":"PIN107 Tobramycin Inhaled Solution Utilization by Cystic Fibrosis Patients: An Analysis with the RAMQ Database","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Tobramycin; Medicine; Cystic fibrosis; Reimbursement; Pharmacy; Drug; Internal medicine; Database; Pseudomonas aeruginosa; Aminoglycoside; Pediatrics; Incidence (geometry); Antibiotics; Gentamicin; Health care; Pharmacology","score_opus":0.06548265668506846,"score_gpt":0.3332555487297448,"score_spread":0.2677728920446763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063564660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95675474,0.0010628327,0.039013635,0.001203237,0.000050797742,0.0014985454,0.00020330847,0.00008065666,0.00013221824],"genre_scores_gemma":[0.98967195,0.000176025,0.008593783,0.0004116003,0.000032318614,0.00006975063,0.00096457556,0.000024752033,0.000055263943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973527,0.0006198256,0.00046427036,0.0004303442,0.00063524785,0.0004976009],"domain_scores_gemma":[0.99855745,0.0002510593,0.0002040733,0.0005503653,0.00014050255,0.0002965223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010625634,0.00016896597,0.00039423362,0.00034068082,0.00017862137,0.000023216657,0.00016610566,0.000053021384,0.00014445299],"category_scores_gemma":[0.0004937598,0.00011157015,0.000052195584,0.0015640543,0.00014356941,0.00031464084,0.000048852806,0.00024683314,0.000015381784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011247494,0.007910464,0.88248825,0.0034455932,0.00087554177,0.000071598435,0.012973705,0.0079086255,0.0049630296,0.0022826851,0.011054855,0.05477816],"study_design_scores_gemma":[0.005838464,0.006672967,0.7508617,0.000920303,0.00049340876,0.000020796257,0.0015336906,0.22812596,0.001687807,0.0002129941,0.0031385073,0.0004934231],"about_ca_topic_score_codex":0.011845238,"about_ca_topic_score_gemma":0.00085647067,"teacher_disagreement_score":0.22021733,"about_ca_system_score_codex":0.0003522149,"about_ca_system_score_gemma":0.00024551633,"threshold_uncertainty_score":0.99473494},"labels":[],"label_agreement":null},{"id":"W2063601276","doi":"10.1016/j.jval.2011.08.909","title":"PIH4 A Comparative Study of Respiratory Syncytial Virus (RSV) Prophylaxis in Premature Infants","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Gestational age; Respiratory system; Group B; Birth weight; Pregnancy; Internal medicine","score_opus":0.22659380654776934,"score_gpt":0.4325750486823068,"score_spread":0.20598124213453745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063601276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99397206,0.00069553655,0.0000042454544,0.00002478757,0.00011592735,0.0031385543,0.000008019825,0.000032932025,0.0020079634],"genre_scores_gemma":[0.99941045,0.000016938184,0.00014599836,0.00014681889,0.000058355217,0.00016285211,0.0000012418171,0.000022059285,0.00003527672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963872,0.0012314792,0.0009758907,0.00040692207,0.00055559556,0.0004429426],"domain_scores_gemma":[0.9987504,0.00011828513,0.00021974952,0.0005617596,0.00015405632,0.00019576888],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016408551,0.00018528989,0.0007212316,0.00092800846,0.00006088535,0.0000072294115,0.00016592405,0.00014902007,0.00009878708],"category_scores_gemma":[0.00029157638,0.0001591744,0.000048028858,0.0013205336,0.00012085036,0.00013503882,0.00008430772,0.0009101386,0.000036014382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002891359,0.008535009,0.93228567,0.0012599061,0.00006301311,0.00023227767,0.04751416,0.0005717054,0.0036499426,0.00027820034,0.00021461537,0.0025041355],"study_design_scores_gemma":[0.0050223297,0.019348117,0.96678656,0.00057441124,0.000008533666,0.0000110799265,0.0029336982,0.00046527508,0.0041658143,0.000120071054,0.00037830358,0.00018577497],"about_ca_topic_score_codex":0.02088005,"about_ca_topic_score_gemma":0.0028592658,"teacher_disagreement_score":0.04458046,"about_ca_system_score_codex":0.00043366573,"about_ca_system_score_gemma":0.00093639543,"threshold_uncertainty_score":0.98564},"labels":[],"label_agreement":null},{"id":"W2063782400","doi":"10.1016/s1098-3015(10)60913-8","title":"PHP54 PREVENTABLE DRUG-RELATED MORBIDITY IN OLDER ADULTS IN NOVA SCOTIA, CANADA: DEVELOPMENT OF QUALITY INDICATORS","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nova scotia; Medicine; Nova (rocket); Drug; Gerontology; Geography; Psychiatry; Engineering","score_opus":0.07128710831080154,"score_gpt":0.344993820162382,"score_spread":0.27370671185158046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063782400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990743,0.0016378401,0.0000041530957,0.0057872157,0.00026008306,0.0010243631,0.000009429536,0.000016453127,0.00051751017],"genre_scores_gemma":[0.99672306,0.0001687658,0.0015545952,0.0013493401,0.000019882993,0.000017290295,0.000020981444,0.000015188704,0.00013091115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99678653,0.0003457867,0.0016024323,0.00031042215,0.0004251956,0.00052961445],"domain_scores_gemma":[0.9990672,0.00011833001,0.0003079133,0.00021780304,0.00003387047,0.00025491475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019798924,0.00013777615,0.00055925676,0.0005420347,0.000038570786,0.000002336077,0.00009034759,0.00009199829,0.00036019794],"category_scores_gemma":[0.00011960876,0.00014643982,0.000024159284,0.0010676238,0.000032101743,0.000048838938,0.00002877639,0.0005204847,0.000011098545],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007327709,0.0012279797,0.97748405,0.00389251,0.0000068384793,0.000028917753,0.00876848,0.00012974943,0.000008244055,0.00014959666,0.0019780735,0.0062522776],"study_design_scores_gemma":[0.0047845226,0.000034871915,0.98812157,0.004070638,0.0000016329676,0.0000054474094,0.0007614726,0.0010194398,0.0002821667,0.000042355157,0.00074843643,0.00012746012],"about_ca_topic_score_codex":0.90514505,"about_ca_topic_score_gemma":0.8570224,"teacher_disagreement_score":0.048122678,"about_ca_system_score_codex":0.0019807531,"about_ca_system_score_gemma":0.0022253501,"threshold_uncertainty_score":0.5971643},"labels":[],"label_agreement":null},{"id":"W2063912686","doi":"10.1016/s1098-3015(10)61281-8","title":"PCV10 COST OF UNCONTROLLED HYPERTENSION IN CANADA","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Business","score_opus":0.44516032277882844,"score_gpt":0.3652437628175603,"score_spread":0.07991655996126812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2063912686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91539127,0.010346514,0.00014250437,0.06887946,0.0009595631,0.0015715049,0.0001958457,0.000016236543,0.0024970812],"genre_scores_gemma":[0.9878587,0.00066679437,0.00053655775,0.010653023,0.000073517316,0.00005359624,0.000007207264,0.000020033178,0.00013058278],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9935548,0.0005488277,0.00489599,0.00039080382,0.000106884814,0.000502722],"domain_scores_gemma":[0.9965645,0.0012146384,0.0016161852,0.00039166564,0.00003179204,0.00018120342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010118404,0.00013821296,0.0012821855,0.00040743858,0.00005334468,0.000009026435,0.00018801179,0.00007822337,0.00035874112],"category_scores_gemma":[0.0021761402,0.00017808197,0.000052185147,0.00036399715,0.000024006771,0.00014242507,0.00002344587,0.00020553816,0.00019253259],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000503632,0.00040640088,0.82256144,0.0015584385,0.000033626366,0.000017015056,0.0031222717,0.078366786,0.000003281668,0.04451229,0.04704029,0.0023278135],"study_design_scores_gemma":[0.0062862798,0.00017058285,0.25021914,0.000641546,0.0000019725946,0.000011781495,0.0016135394,0.6985332,0.000004326836,0.006130752,0.03587565,0.0005112535],"about_ca_topic_score_codex":0.9835887,"about_ca_topic_score_gemma":0.86719465,"teacher_disagreement_score":0.62016636,"about_ca_system_score_codex":0.003362821,"about_ca_system_score_gemma":0.0009928552,"threshold_uncertainty_score":0.879366},"labels":[],"label_agreement":null},{"id":"W2064958574","doi":"10.1016/j.jval.2011.08.005","title":"Quantifying the Impact of Drug Exposure Misclassification due to Restrictive Drug Coverage in Administrative Databases: A Simulation Cohort Study","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian VIGOUR Centre; Alliance for Canadian Health Outcomes Research in Diabetes; University of Alberta","funders":"Institute of Nutrition, Metabolism and Diabetes; Ministry of Health, Saskatchewan; Canadian Institutes of Health Research; Alberta Innovates; Alberta Innovates - Health Solutions","keywords":"Metformin; Medicine; Hazard ratio; Sulfonylurea; Cohort; Drug; Formulary; Confidence interval; Database; Proportional hazards model; Internal medicine; Pharmacology; Computer science","score_opus":0.31609772792014873,"score_gpt":0.4528445267944198,"score_spread":0.13674679887427105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064958574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99454933,0.00012301723,0.0011545557,0.0004954361,0.00005241422,0.0029406555,0.000016395727,0.000014128949,0.00065406086],"genre_scores_gemma":[0.99922645,0.000046425634,0.00027971747,0.00014303923,0.000025905354,0.00015631091,0.0000273985,0.000009509273,0.00008525562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797785,0.0005493706,0.00064970565,0.0003040656,0.00032335962,0.00019563687],"domain_scores_gemma":[0.99854046,0.0004024627,0.00032342412,0.00049829716,0.00010689615,0.00012843999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015738435,0.00011865968,0.00033300853,0.0001755505,0.00005538657,0.0000055970168,0.00012995319,0.00002329613,0.000086517925],"category_scores_gemma":[0.0005258209,0.00008414408,0.000037854556,0.000710844,0.00003509608,0.000101952435,0.0000220411,0.00024141125,0.000024134279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003417623,0.00084357656,0.97014487,0.00007018794,0.000020466421,0.000012593889,0.022509687,0.0049733636,0.000041700358,0.00012449107,0.00030784006,0.00060946256],"study_design_scores_gemma":[0.0008342654,0.0006068388,0.9761606,0.0003879018,0.000008993079,0.0000029781488,0.007812798,0.013988899,0.000055133412,0.000056863853,0.000019531946,0.000065202265],"about_ca_topic_score_codex":0.024186712,"about_ca_topic_score_gemma":0.00042889608,"teacher_disagreement_score":0.023757815,"about_ca_system_score_codex":0.00027449842,"about_ca_system_score_gemma":0.0008453173,"threshold_uncertainty_score":0.9823113},"labels":[],"label_agreement":null},{"id":"W2064960060","doi":"10.1016/j.jval.2012.03.895","title":"PRM39 Examination of Starting Point Bias with the Bidding Game: Evidence from a Systematic Review of the Literature on Willingness-to-Pay Analyses","year":2012,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"PharmIdeas (Canada); Université de Montréal","funders":"","keywords":"Bidding; Willingness to pay; Population; Publication bias; Point (geometry); Inclusion (mineral); Percentage point; Willingness to accept; Medicine; Actuarial science; Psychology; Demography; Economics; Meta-analysis; Statistics; Social psychology; Marketing; Business; Environmental health; Mathematics; Sociology; Pathology","score_opus":0.7213534432219904,"score_gpt":0.506946011328283,"score_spread":0.21440743189370737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2064960060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006195308,0.98531425,0.00021161432,0.0067723556,0.00032050945,0.006322041,0.0003753544,0.000013266282,0.000051072202],"genre_scores_gemma":[0.0071583577,0.98802906,0.00052639213,0.0034697994,0.00019904067,0.00047677153,0.00003558772,0.000058375772,0.000046641093],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9816202,0.006994303,0.009907924,0.0006527442,0.00036003988,0.00046478008],"domain_scores_gemma":[0.9712509,0.01016357,0.01677201,0.0015136529,0.00015602708,0.00014382337],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06060115,0.00042446243,0.005423937,0.0005360181,0.00012911166,0.000059037164,0.00080992887,0.00019465228,0.000028276],"category_scores_gemma":[0.016160708,0.00023976713,0.00042194882,0.0017531571,0.000064020554,0.00029858042,0.00009197879,0.0006130013,0.00006892973],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000025943564,0.000044910434,0.00030565358,0.99091107,0.000105983236,1.9125841e-7,0.004489505,0.00036504975,2.2078058e-8,0.0018255957,0.00013306984,0.0018163692],"study_design_scores_gemma":[0.00008656484,0.00010010704,0.00048673214,0.9907389,0.00020223843,0.000003130305,0.00028840522,0.00046860243,2.9714226e-7,0.00015340475,0.0072313547,0.00024022051],"about_ca_topic_score_codex":0.0024459986,"about_ca_topic_score_gemma":0.00008238775,"teacher_disagreement_score":0.04444044,"about_ca_system_score_codex":0.0011618204,"about_ca_system_score_gemma":0.0006586924,"threshold_uncertainty_score":0.9921266},"labels":[],"label_agreement":null},{"id":"W2065035332","doi":"10.1016/j.jval.2014.03.1009","title":"Economic Impact Of Alberta’s Pcv7 Childhood Immunization Program (2003-2008)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta; Institute of Health Economics","funders":"","keywords":"Herd immunity; Vaccination; Medicine; Population; Environmental health; Incidence (geometry); Economic impact analysis; Disease burden; Demography; Immunology; Economics","score_opus":0.015383546183351105,"score_gpt":0.31791061161648443,"score_spread":0.30252706543313335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065035332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566936,0.00012056359,0.00004096484,0.00090304343,0.0002342688,0.0007153313,0.0000044147855,0.000044801614,0.0022672482],"genre_scores_gemma":[0.99918586,0.00012691022,0.00017452295,0.00024835186,0.000113092115,0.000024530671,0.000025019019,0.000018767232,0.00008292816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989788,0.00014937251,0.0004079849,0.00014590246,0.00006974774,0.00024822002],"domain_scores_gemma":[0.99932444,0.000057746518,0.00015451257,0.0002754817,0.000046605022,0.00014118357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034224437,0.00010072564,0.00029126144,0.00018857772,0.000056575325,0.0000059346517,0.00005126118,0.00007498156,0.000060164122],"category_scores_gemma":[0.0001779757,0.000082368984,0.0000743061,0.00028073852,0.00003635009,0.000049592534,0.000012499763,0.00015863797,0.000047151087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004619216,0.0013468734,0.9097372,0.00037630956,0.00010329487,0.0000016631623,0.0019844614,0.0343839,0.0007733505,0.002180457,0.0011090272,0.047957253],"study_design_scores_gemma":[0.001336872,0.002369378,0.97037125,0.00023163353,0.000013859039,0.000049042123,0.000025075906,0.015083215,0.00009900262,0.00010377337,0.010213142,0.00010375615],"about_ca_topic_score_codex":0.018792748,"about_ca_topic_score_gemma":0.00032460262,"teacher_disagreement_score":0.060634036,"about_ca_system_score_codex":0.00039086724,"about_ca_system_score_gemma":0.0011739946,"threshold_uncertainty_score":0.9877412},"labels":[],"label_agreement":null},{"id":"W2065048462","doi":"10.1016/j.jval.2011.02.071","title":"QA2 CROSS-WALKING CANCER-SPECIFIC INSTRUMENTS TO THE EQ-5D AND SF-6D","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"EQ-5D; Quality of life (healthcare); Statistics; Medicine; Sample (material); Cancer; Psychological intervention; Physical therapy; Econometrics; Mathematics; Health related quality of life; Internal medicine; Psychiatry; Disease","score_opus":0.6856772738266621,"score_gpt":0.4328283091010654,"score_spread":0.2528489647255967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065048462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.955585,0.0075102695,0.00039113083,0.03081529,0.001577166,0.0012195125,0.00018315147,0.000041273877,0.002677186],"genre_scores_gemma":[0.9776259,0.0016320794,0.0024734528,0.017343098,0.00039001778,0.00020390667,0.00000604092,0.000039206487,0.0002862805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950179,0.00043011594,0.0031721585,0.0006305727,0.00010141947,0.00064784713],"domain_scores_gemma":[0.99754643,0.00038166222,0.0011812383,0.0005575422,0.000032910306,0.00030020092],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.015944406,0.00018810776,0.00070123276,0.0003217936,0.0003526507,0.00010174096,0.0003577708,0.00010542879,0.00036420472],"category_scores_gemma":[0.00064856565,0.00020147585,0.000053141197,0.000325216,0.00007477792,0.00031248791,0.00010463166,0.0002559183,0.00080691435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044252123,0.00012849084,0.7877209,0.0006361252,0.00003703072,0.0000020005814,0.034206804,0.0011364381,8.6424313e-7,0.15572344,0.010587063,0.0097765755],"study_design_scores_gemma":[0.0010386385,0.00017547862,0.7906802,0.00035073172,0.0000015928222,0.000009267226,0.0014809836,0.004356304,0.000008198316,0.018379513,0.18309954,0.0004195279],"about_ca_topic_score_codex":0.042527128,"about_ca_topic_score_gemma":0.0012604225,"teacher_disagreement_score":0.17251247,"about_ca_system_score_codex":0.00095374516,"about_ca_system_score_gemma":0.00025158594,"threshold_uncertainty_score":0.9999711},"labels":[],"label_agreement":null},{"id":"W2065155741","doi":"10.1016/j.jval.2014.03.1099","title":"Real world research in latin america: Opportunities, sources and barriers","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Latin Americans; Principal (computer security); Medicine; Data sharing; Population; Corporate governance; Political science; Family medicine; Geography; Environmental health; Business; Alternative medicine; Pathology","score_opus":0.7550532230897441,"score_gpt":0.6019259355331338,"score_spread":0.15312728755661031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065155741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90292037,0.00048111862,0.000011384434,0.06919329,0.00008610253,0.0005744342,0.00000509944,0.000033207758,0.026695007],"genre_scores_gemma":[0.98222464,0.009208282,0.001975169,0.002189923,0.00019719139,0.000036785816,0.0000068472414,0.000030141679,0.0041309963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950363,0.0019064592,0.00070193864,0.00042797826,0.0011539464,0.00077338784],"domain_scores_gemma":[0.9803354,0.01808739,0.00008521537,0.0004857279,0.00015876185,0.0008474943],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.024963694,0.00010062965,0.00041772926,0.00080981816,0.00012817346,0.000025894555,0.00017095082,0.00016813973,0.000090483794],"category_scores_gemma":[0.013545094,0.00009216048,0.000026149011,0.0009211476,0.0007512235,0.00004222254,0.00017279705,0.0032581782,0.000016369988],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040014955,0.0001695632,0.8004807,0.0021741078,0.000011765704,0.00013038197,0.005004303,0.00016997785,0.000024934248,0.14520869,0.0016261967,0.044599183],"study_design_scores_gemma":[0.00582597,0.004462629,0.5311563,0.0074695502,0.0000075853472,0.000016867369,0.0152788265,0.028827704,0.000056517976,0.283452,0.122942954,0.00050312176],"about_ca_topic_score_codex":0.05190895,"about_ca_topic_score_gemma":0.0057954956,"teacher_disagreement_score":0.26932448,"about_ca_system_score_codex":0.00035775782,"about_ca_system_score_gemma":0.0022689542,"threshold_uncertainty_score":0.9990413},"labels":[],"label_agreement":null},{"id":"W2065391462","doi":"10.1111/j.1524-4733.2005.00049.x","title":"Health and Economic Consequences of Sevelamer Use for Hyperphosphatemia in Patients on Hemodialysis","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Royal Victoria Hospital","funders":"","keywords":"Sevelamer; Hyperphosphatemia; Medicine; Phosphate binder; Hemodialysis; Population; Kidney disease; Internal medicine; Cohort; End stage renal disease; Calcification; Intensive care medicine; Environmental health","score_opus":0.042040039044323255,"score_gpt":0.3172889578808493,"score_spread":0.2752489188365261,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065391462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931692,0.0028833216,0.0000031889963,0.003013538,0.000040853356,0.0007946093,0.00005069481,0.0000056729023,0.000038915252],"genre_scores_gemma":[0.9955391,0.0015474475,0.0013175203,0.0014693349,0.000012770716,0.000030144856,0.000035571582,0.000009557618,0.00003850372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989753,0.00006395257,0.00044366918,0.00021163299,0.00007352348,0.00023192426],"domain_scores_gemma":[0.99943984,0.00012943521,0.00015859051,0.00012063592,0.000014095302,0.00013743194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002363904,0.00009723159,0.0004179564,0.00015115173,0.000029187713,0.000004384553,0.000025322968,0.00003974621,0.0000026300972],"category_scores_gemma":[0.000051289495,0.00008567079,0.000033009892,0.00007529064,0.000044551678,0.00006252307,0.0000068586155,0.00005938119,0.000005516666],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004517175,0.0004342601,0.9883287,0.00007203747,0.000017160306,7.2779585e-7,0.00069136993,0.0012538796,0.0000029753514,0.00030377813,0.00052759016,0.0079158],"study_design_scores_gemma":[0.014670136,0.0029162369,0.97520125,0.00025020156,0.00001212467,0.0000022526694,0.00016390876,0.0043435725,0.00022009999,0.00032004892,0.0017566475,0.00014354743],"about_ca_topic_score_codex":0.012190811,"about_ca_topic_score_gemma":0.00045864956,"teacher_disagreement_score":0.014218419,"about_ca_system_score_codex":0.00039151846,"about_ca_system_score_gemma":0.0005076063,"threshold_uncertainty_score":0.9943871},"labels":[],"label_agreement":null},{"id":"W2065516393","doi":"10.1016/j.jval.2014.03.1102","title":"Overview of patient-centered outcome measures available in the patient-reported outcome and quality of life instruments database (PROQOLID) for use in Quebec","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Outcome (game theory); Patient-reported outcome; Database; Medicine; Quality (philosophy); Quality of life (healthcare); Computer science; Nursing; Economics","score_opus":0.6962402521865839,"score_gpt":0.45332900488758443,"score_spread":0.2429112472989995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065516393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915325,0.002223803,0.00015931811,0.0029034144,0.00028729686,0.0022494101,0.00055939495,0.000008895494,0.00007597176],"genre_scores_gemma":[0.99207956,0.0003206897,0.0017780625,0.0055301,0.00002190584,0.00016064948,0.000061472245,0.000023374045,0.000024212819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9864078,0.001971318,0.010379885,0.00056043157,0.0002029221,0.0004776088],"domain_scores_gemma":[0.99200255,0.0019880426,0.0049782307,0.00081434543,0.00006771316,0.0001490998],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03150258,0.00020737291,0.0016722111,0.00053862797,0.000059492144,0.000033601482,0.0002578136,0.00011423041,0.000030712064],"category_scores_gemma":[0.012687127,0.00021251377,0.00009940004,0.00034444666,0.00007168496,0.0004939827,0.00007653228,0.00020346511,0.000017936261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073033574,0.00033088477,0.98059547,0.0029809054,0.000015463724,1.4953073e-7,0.0024325117,0.00022206518,9.583505e-7,0.012407251,0.0003229717,0.000618316],"study_design_scores_gemma":[0.0055578775,0.00036599286,0.9669939,0.0008059893,0.0000052317305,0.0000010710718,0.0020187686,0.010333307,0.000005567537,0.002017319,0.011511248,0.00038370054],"about_ca_topic_score_codex":0.3597678,"about_ca_topic_score_gemma":0.04832625,"teacher_disagreement_score":0.31144154,"about_ca_system_score_codex":0.00049642654,"about_ca_system_score_gemma":0.00032271584,"threshold_uncertainty_score":0.9972719},"labels":[],"label_agreement":null},{"id":"W2065529416","doi":"10.1016/j.jval.2012.08.903","title":"PMD54 Trans-Catheter Aortic Valve Implantation for the Non-Operative Management of Aortic Stenosis: A Cost-Effectiveness Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Cost effectiveness; Stenosis; Aortic valve replacement; Incremental cost-effectiveness ratio; Quality-adjusted life year; Emergency medicine; Aortic valve; Cost-effectiveness analysis; Cohort; Internal medicine","score_opus":0.045736385803368314,"score_gpt":0.4078133234805198,"score_spread":0.3620769376771515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065529416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98715246,0.0016355031,0.006616812,0.0002067226,0.00014407492,0.0040438487,0.00013433183,0.000010602464,0.00005563584],"genre_scores_gemma":[0.997669,0.00061117794,0.00023627061,0.00016899574,0.000037512244,0.0011472282,0.000098942095,0.000016949174,0.0000139622025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99871033,0.00017899179,0.00036474504,0.00019619345,0.0002134054,0.00033632337],"domain_scores_gemma":[0.99911636,0.00030225056,0.00012160462,0.0002607671,0.00006167664,0.00013734675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006192443,0.000138519,0.00045292676,0.00015568842,0.00007887276,0.000007777098,0.00004613722,0.000033232263,0.00001606688],"category_scores_gemma":[0.000008653391,0.00009263032,0.00093056133,0.00045367604,0.000028405913,0.00006502219,0.000011103707,0.00006007027,0.000004151443],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074157165,0.0014669923,0.9518461,0.0020025258,0.011755501,0.0000016464174,0.0034408874,0.0035819716,0.00002633424,0.00024215863,0.00001070514,0.02488357],"study_design_scores_gemma":[0.0023543602,0.00034967833,0.98494333,0.00027495384,0.0071114055,9.793547e-7,0.0008743423,0.0038505525,0.00010941096,0.000032797638,0.00002105941,0.000077113276],"about_ca_topic_score_codex":0.0014973457,"about_ca_topic_score_gemma":0.000005050387,"teacher_disagreement_score":0.03309721,"about_ca_system_score_codex":0.00024601954,"about_ca_system_score_gemma":0.000068309244,"threshold_uncertainty_score":0.37773547},"labels":[],"label_agreement":null},{"id":"W2065815846","doi":"10.1016/j.jval.2013.03.1242","title":"Public Engagment Mechanisms In Health Technology Assessment (HTA): An Early Assessment Of Canada's National HTA Public Engagement Initiatives","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Public engagement; Transparency (behavior); Public relations; Agency (philosophy); Accountability; Political science; Health technology; Equity (law); Public health; Public involvement; Feeling; Psychology; Business; Medicine; Health care; Social psychology; Nursing; Sociology","score_opus":0.495847758993547,"score_gpt":0.4499077397856174,"score_spread":0.04594001920792962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065815846","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47625694,0.0014244585,0.01192332,0.4990143,0.0010635172,0.005026645,0.0005292186,0.00009847711,0.0046631396],"genre_scores_gemma":[0.9627364,0.00030188644,0.026045442,0.009716859,0.000076294185,0.0009208727,0.00009892318,0.000043675558,0.000059595328],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9855126,0.0034483962,0.00809248,0.0010119961,0.000582355,0.0013521395],"domain_scores_gemma":[0.99331033,0.0010988666,0.0041158767,0.0006614155,0.00026839852,0.0005451234],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.049251076,0.00032308558,0.0014916183,0.0020889787,0.00035968816,0.00012276148,0.00061670603,0.00019407553,0.0005594983],"category_scores_gemma":[0.0022303013,0.00041936466,0.00006838645,0.0009954816,0.000083759754,0.0010810612,0.00015692842,0.0008057662,0.000040178795],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000016407392,0.0005502894,0.12203403,0.0005710209,0.000037233345,8.148922e-7,0.0009322774,0.001855657,0.0000021572168,0.8722749,0.0012357434,0.00050426455],"study_design_scores_gemma":[0.0019608887,0.0008780482,0.7906061,0.00031742296,0.0000010468572,0.0000030372933,0.007424568,0.071500786,0.000003526878,0.1210612,0.005706901,0.0005364958],"about_ca_topic_score_codex":0.5157021,"about_ca_topic_score_gemma":0.15259965,"teacher_disagreement_score":0.75121367,"about_ca_system_score_codex":0.012020721,"about_ca_system_score_gemma":0.014555544,"threshold_uncertainty_score":0.99982584},"labels":[],"label_agreement":null},{"id":"W2065957912","doi":"10.1016/j.jval.2011.08.1137","title":"PCN36 The Economic Impact of Treating Early Lung Cancer: A Systematic Review","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Lung cancer; MEDLINE; Systematic review; Thoracotomy; Intensive care medicine; Cost–benefit analysis; Surgery; General surgery; Oncology","score_opus":0.09985187474057891,"score_gpt":0.4319987463059518,"score_spread":0.3321468715653729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2065957912","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000060600883,0.990611,3.3351725e-7,0.00013749242,0.0001627045,0.0086497925,0.00011014624,0.000016017364,0.00025187066],"genre_scores_gemma":[0.00019046848,0.99711543,0.00002267644,0.00012590886,0.00011644287,0.002278955,0.000023541268,0.000057424902,0.000069134265],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965639,0.000682847,0.0018892711,0.0003536327,0.00014503031,0.0003653196],"domain_scores_gemma":[0.9967842,0.0005031121,0.0017025049,0.0008206048,0.000031572494,0.0001580238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012300579,0.00039451866,0.005083091,0.00014574132,0.000046416262,0.000009194629,0.00020134247,0.0001103517,0.00011073569],"category_scores_gemma":[0.00008107973,0.00019294138,0.0009878315,0.00023328632,0.000030173682,0.00003053561,0.0000330688,0.00029884125,0.000022343957],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000035536975,0.000043415574,0.0009170294,0.9621554,0.0007354399,0.0000054491825,0.00020689955,0.000013171236,3.3311723e-10,0.00008214395,0.00053644826,0.03530105],"study_design_scores_gemma":[0.000295899,0.0003711235,0.00015491717,0.98956674,0.0046238834,0.000049874645,0.000004115761,0.00007661182,2.1652221e-8,0.0000041556464,0.00472729,0.0001253826],"about_ca_topic_score_codex":0.09704951,"about_ca_topic_score_gemma":0.00016479733,"teacher_disagreement_score":0.09688472,"about_ca_system_score_codex":0.009041942,"about_ca_system_score_gemma":0.0056743165,"threshold_uncertainty_score":0.99996257},"labels":[],"label_agreement":null},{"id":"W2066154496","doi":"10.1016/s1098-3015(11)70796-3","title":"PNR8: A CANADIAN ADAPTATION OF A DECISION ANALYTIC MODEL FOR THE ECONOMIC EVALUATION OF OPIOIDS FOR CHRONIC PAIN","year":2000,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Adaptation (eye); Chronic pain; Medicine; Psychology; Psychiatry; Neuroscience","score_opus":0.1976929358220843,"score_gpt":0.34649293925527536,"score_spread":0.14880000343319105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066154496","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4194614,0.013250101,0.5290675,0.024231348,0.0005340116,0.01034172,0.0018895682,0.000017363482,0.0012069568],"genre_scores_gemma":[0.99588394,0.0007804376,0.0025113143,0.00039579452,0.000055804292,0.00027170815,0.000021930528,0.000012130117,0.00006693987],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985539,0.000067155706,0.000859955,0.0002035904,0.000041197694,0.00027420805],"domain_scores_gemma":[0.9989539,0.0004015951,0.00028999106,0.00023940903,0.00003995455,0.00007517581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008435359,0.000071279224,0.00026521317,0.0003113338,0.000077886725,0.000007640845,0.00013297674,0.00005223583,0.000064446634],"category_scores_gemma":[0.00024683913,0.00007383176,0.000078938865,0.0001282216,0.000017812557,0.00006397942,0.0000051672623,0.00004294905,0.0000067835317],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018825564,0.000010263248,0.000134134,0.00017467258,0.0000098040155,1.0044579e-8,0.00070328097,0.7723948,4.643538e-8,0.07399244,0.00019492318,0.15236682],"study_design_scores_gemma":[0.00069102296,0.0001698493,0.0009299237,0.000054695007,0.0000059749295,8.2826155e-8,0.00007052581,0.92689615,7.879512e-7,0.061856557,0.00926921,0.00005519778],"about_ca_topic_score_codex":0.6352376,"about_ca_topic_score_gemma":0.36759198,"teacher_disagreement_score":0.5764225,"about_ca_system_score_codex":0.0017991563,"about_ca_system_score_gemma":0.0016000933,"threshold_uncertainty_score":0.64394784},"labels":[],"label_agreement":null},{"id":"W2066322049","doi":"10.1016/j.jval.2013.08.2092","title":"Contribution of Latin America to Mental Health in Pregnancy","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Mental health; Pregnancy; Latin Americans; Medicine; Anxiety; Psychiatry; Systematic review; Abortion; MEDLINE; Postpartum depression; Substance abuse; Family medicine; Environmental health; Political science","score_opus":0.03246864860856583,"score_gpt":0.32582488741472737,"score_spread":0.2933562388061615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066322049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9455722,0.0042664465,0.000055346107,0.046125043,0.00031749974,0.0033993078,0.000039037088,0.00003017045,0.000194961],"genre_scores_gemma":[0.9928498,0.0012559416,0.001381151,0.004150333,0.000028199162,0.00011550358,0.000046628127,0.000013754342,0.00015869105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980273,0.0002237571,0.00082444836,0.00021909187,0.00019379916,0.00051160355],"domain_scores_gemma":[0.9991625,0.000057338897,0.00021987493,0.00019384809,0.00003501723,0.00033141428],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003508308,0.00011596222,0.00047217976,0.0002125323,0.000042717176,0.0000040324794,0.00006365138,0.00004530092,0.00007505984],"category_scores_gemma":[0.00006193318,0.00010865844,0.00003215815,0.000334195,0.000024227635,0.00006145883,0.000031682925,0.00019152224,0.00009443165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013591947,0.0026496684,0.85021037,0.026627703,0.000026812311,0.00003000981,0.017060418,0.0008253469,0.000691685,0.0044210097,0.0026995796,0.09339822],"study_design_scores_gemma":[0.003422594,0.0032663625,0.9322846,0.05443695,0.0000017949043,0.000022709486,0.00022269334,0.0018388289,0.0009784129,0.00057815766,0.0027711466,0.00017573666],"about_ca_topic_score_codex":0.026922602,"about_ca_topic_score_gemma":0.00013338201,"teacher_disagreement_score":0.093222484,"about_ca_system_score_codex":0.0005106375,"about_ca_system_score_gemma":0.00030436888,"threshold_uncertainty_score":0.9795572},"labels":[],"label_agreement":null},{"id":"W2066572766","doi":"10.1016/s1098-3015(10)70687-2","title":"PCV102 THE ASSESSING CARDIOVASCULAR TARGETS (ACT '07) PROGRAM: PRELIMINARY RESULTS FROM A PRACTICE REFLECTIVE ASSESSMENT ACROSS CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medical education","score_opus":0.05575158235247265,"score_gpt":0.38110445431533446,"score_spread":0.32535287196286183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2066572766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9367091,0.0373979,0.0003931531,0.016497996,0.0016544958,0.004871158,0.00020172757,0.00019837692,0.002076059],"genre_scores_gemma":[0.98206204,0.0048967847,0.009642063,0.0022995113,0.00061616156,0.00018628735,0.00018544873,0.00006381197,0.000047903974],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99334437,0.0018900328,0.0010717302,0.000856336,0.0016680941,0.0011694382],"domain_scores_gemma":[0.99595004,0.0013949474,0.00040636698,0.0013576805,0.00029567388,0.00059531746],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0044838544,0.00035435378,0.0010471804,0.0000636725,0.0008810405,0.000048929207,0.00021287888,0.00018818307,0.000006062643],"category_scores_gemma":[0.0018115796,0.00025415802,0.00049663696,0.0006665423,0.00014115608,0.00025558416,0.000103183644,0.0013981834,0.000007725295],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013580206,0.0051933243,0.13468732,0.0031715196,0.010068272,0.021046199,0.06655592,0.07589552,0.00003984069,0.00009187688,0.032265402,0.6374046],"study_design_scores_gemma":[0.0049885972,0.0010177887,0.6979261,0.00061253266,0.00022711015,0.0011405373,0.0048888437,0.0035447294,0.000047511126,0.000019263369,0.28522247,0.00036453237],"about_ca_topic_score_codex":0.95563066,"about_ca_topic_score_gemma":0.08181423,"teacher_disagreement_score":0.87381643,"about_ca_system_score_codex":0.0030316731,"about_ca_system_score_gemma":0.011124518,"threshold_uncertainty_score":0.99999106},"labels":[],"label_agreement":null},{"id":"W2067131555","doi":"10.1016/j.jval.2011.08.079","title":"PMD6 Efficacy and Safety of Artificial Disc Arthroplasty Compared to Surgical Fusion for Single Level Cervical and Lumbar Degenerative Disc Disease: A Bayesian Meta-analysis","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Spine and Intervertebral Disc Pathology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Degenerative disc disease; Randomized controlled trial; Meta-analysis; Lumbar; Oswestry Disability Index; Physical therapy; Adverse effect; Surgery; Cochrane Library; Internal medicine; Low back pain","score_opus":0.2500162964736499,"score_gpt":0.36580496006000934,"score_spread":0.11578866358635942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067131555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97852546,0.0013523564,0.014864718,0.0035720696,0.00006530111,0.0011450734,0.0003645555,0.00001637406,0.00009410346],"genre_scores_gemma":[0.9943084,0.00004800488,0.005081824,0.00029203377,0.000057667934,0.000052537674,0.00008547009,0.000015101955,0.000058972688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979454,0.00029768862,0.00081110024,0.00045952198,0.00018121357,0.0003050212],"domain_scores_gemma":[0.9990115,0.000057788715,0.0001527334,0.00024345693,0.00006861695,0.0004658708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004908843,0.00018529172,0.0013235877,0.00022459016,0.000094986,0.000007932032,0.00005051672,0.00007210569,0.00023240311],"category_scores_gemma":[0.00017414137,0.00013277227,0.0003146374,0.00034630383,0.00013046511,0.00006098861,0.00007539774,0.00011425596,0.0000018932212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05362978,0.040736035,0.4926635,0.01074172,0.082357034,0.0015682242,0.09200853,0.0074437084,0.01870884,0.10913982,0.0040727607,0.08693005],"study_design_scores_gemma":[0.003146932,0.002460868,0.9621568,0.00008908958,0.009633797,0.000029035558,0.0004143314,0.020614835,0.00053697464,0.00042361015,0.00022869605,0.00026504285],"about_ca_topic_score_codex":0.001029461,"about_ca_topic_score_gemma":0.00105684,"teacher_disagreement_score":0.4694933,"about_ca_system_score_codex":0.0000385988,"about_ca_system_score_gemma":0.00009794927,"threshold_uncertainty_score":0.5414296},"labels":[],"label_agreement":null},{"id":"W2067294597","doi":"10.1016/j.jval.2014.03.906","title":"Follow-Up Of Psychoactive Drug Use In Newly Diagnosed Patients With Autism Spectrum Disorder (Asd) In Quebec (Canada)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hôpital Rivière-des-Prairies; Université de Montréal","funders":"","keywords":"Cohort; Medicine; Psychoactive drug; Gee; Pediatrics; Drug; Cohort study; Autism; Psychiatry; Generalized estimating equation; Internal medicine","score_opus":0.02254508124643511,"score_gpt":0.2725899782287596,"score_spread":0.25004489698232446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067294597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9861131,0.000048373877,0.00009046339,0.011787639,0.0002481811,0.0013596152,0.00003039008,0.000024826133,0.00029744447],"genre_scores_gemma":[0.99884313,0.000085532774,0.00009440615,0.0005637937,0.000009291144,0.00006817102,0.000005933516,0.000051070154,0.00027867328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951399,0.0012523697,0.00073281,0.0007912189,0.0010368007,0.0010469187],"domain_scores_gemma":[0.9977449,0.0011621055,0.00028108308,0.00058485573,0.000009016747,0.00021804393],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006282012,0.00026943692,0.000529377,0.0006048383,0.000082394814,0.0000381954,0.0004817462,0.000078585814,0.000040539064],"category_scores_gemma":[0.0007271281,0.00025475788,0.000038267994,0.001656784,0.00015104844,0.00040668342,0.00010381868,0.00067375216,0.00000761725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032523173,0.00073240255,0.9745539,0.000103970095,0.0000025114255,0.00002306803,0.0024165385,0.0031918879,0.000021200103,0.016973423,0.0001295052,0.001526378],"study_design_scores_gemma":[0.006449168,0.0002724931,0.98323745,0.00027120835,0.0000011365186,5.143153e-7,0.00012791979,0.0037746874,0.00019645705,0.0049900603,0.00042386385,0.0002550325],"about_ca_topic_score_codex":0.9821324,"about_ca_topic_score_gemma":0.9946158,"teacher_disagreement_score":0.012730061,"about_ca_system_score_codex":0.00096475333,"about_ca_system_score_gemma":0.0015421048,"threshold_uncertainty_score":0.99999046},"labels":[],"label_agreement":null},{"id":"W2067438068","doi":"10.1016/j.jval.2014.11.004","title":"Implications of the Minimal Clinically Important Difference for Health-Related Quality-of-Life Outcomes: A Comparison of Sample Size Requirements for an Incontinence Treatment Trial","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":41,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre; Université de Montréal","funders":"","keywords":"Sample size determination; Medicine; Sample (material); Quality of life (healthcare); Quality (philosophy); Minimal clinically important difference; Randomized controlled trial; Internal medicine; Statistics; Nursing; Mathematics","score_opus":0.7902993482473498,"score_gpt":0.5689957086966181,"score_spread":0.22130363955073173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067438068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9508639,0.00090036873,0.0035942288,0.034735203,0.0006468983,0.006128221,0.003086345,0.000015605849,0.00002923797],"genre_scores_gemma":[0.97724843,0.00007786025,0.020027444,0.0018488284,0.00006796872,0.00061272905,0.00006244282,0.00002532708,0.000028943428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9797508,0.0011840194,0.017917525,0.0005335948,0.0001545948,0.00045944503],"domain_scores_gemma":[0.9708173,0.012024308,0.0156633,0.0009303793,0.00021117243,0.0003535288],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.034880742,0.00020515363,0.0026954918,0.00016682864,0.00012878652,0.000011325468,0.00046682413,0.00014630823,0.00000954195],"category_scores_gemma":[0.038142487,0.00019057465,0.0003020953,0.0002578006,0.0001276537,0.00012553611,0.000045815144,0.000108144726,0.0000021041542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020709664,0.0015400352,0.94269097,0.0010264243,0.00007584225,4.4543227e-9,0.0066251922,0.0005323565,0.000002971775,0.044582162,0.00051586085,0.00033719366],"study_design_scores_gemma":[0.060921792,0.0118537955,0.7910486,0.0004444587,0.000020677464,3.8423977e-7,0.0038824426,0.025101462,0.000010561888,0.104574434,0.0016872919,0.00045413992],"about_ca_topic_score_codex":0.03868093,"about_ca_topic_score_gemma":0.0021702135,"teacher_disagreement_score":0.15164243,"about_ca_system_score_codex":0.00084142946,"about_ca_system_score_gemma":0.0026700306,"threshold_uncertainty_score":0.99379337},"labels":[],"label_agreement":null},{"id":"W2067469511","doi":"10.1016/j.jval.2014.08.2137","title":"Health State Utilities for Pressure Ulcers – A Comparison of Condition-Specific and Generic Measures and Time-Trade-Off (Tto)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"EQ-5D; Medicine; Time-trade-off; Multivariate statistics; Body mass index; Quality of life (healthcare); Demographics; Wheelchair; Explanatory power; Demography; Physical therapy; Internal medicine; Health related quality of life; Statistics; Mathematics","score_opus":0.3339837931306228,"score_gpt":0.41160672769014556,"score_spread":0.07762293455952274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067469511","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65501577,0.20687146,0.017453695,0.10895576,0.0010177082,0.0057876147,0.004127862,0.0001306442,0.00063950266],"genre_scores_gemma":[0.98638725,0.0038206545,0.0051657143,0.004070214,0.00015197204,0.00012386628,0.0000863477,0.00004393473,0.00015002268],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99433196,0.0008252654,0.0036860346,0.00054692675,0.00010486457,0.0005049592],"domain_scores_gemma":[0.99553496,0.0016856663,0.002150286,0.00032400788,0.0000368642,0.00026823857],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.015762182,0.0001939563,0.0014957974,0.00035948644,0.00022486325,0.000045512257,0.00012818868,0.0000958023,0.000030205945],"category_scores_gemma":[0.00072021846,0.00024666064,0.000057138514,0.0001387465,0.00015362955,0.00020235042,0.000027732407,0.00015410884,0.000019704914],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029665735,0.0006553877,0.2871964,0.023385156,0.00028228483,3.60585e-7,0.06408635,0.025904983,0.000011171429,0.39116526,0.16055425,0.046461746],"study_design_scores_gemma":[0.0030333253,0.0011895805,0.11371599,0.0005996001,0.000006907712,0.000007925229,0.0023793636,0.22970703,0.00000985784,0.040495038,0.60828274,0.00057265634],"about_ca_topic_score_codex":0.0040256036,"about_ca_topic_score_gemma":0.00021442508,"teacher_disagreement_score":0.44772848,"about_ca_system_score_codex":0.0002661127,"about_ca_system_score_gemma":0.00026791063,"threshold_uncertainty_score":0.99999857},"labels":[],"label_agreement":null},{"id":"W2067896112","doi":"10.1016/j.jval.2011.02.724","title":"PMS39 MOST EFFECTIVE ADHERENCE-ENHANCING INTERVENTIONS FOR OSTEOPOROSIS MEDICATIONS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Psychological intervention; CINAHL; Raloxifene; Osteoporosis; Randomized controlled trial; MEDLINE; Concordance; Cochrane Library; Physical therapy; Intensive care medicine; Internal medicine; Nursing; Breast cancer","score_opus":0.16436579111409882,"score_gpt":0.3968226440368519,"score_spread":0.2324568529227531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067896112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6275678,0.013536414,0.2446341,0.0247544,0.0039005075,0.022812976,0.00016102592,0.00076086784,0.061871894],"genre_scores_gemma":[0.9798488,0.00032342918,0.014865293,0.0014424652,0.00011072564,0.0015218753,0.000051944295,0.00001859575,0.0018168626],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99854845,0.00010952147,0.0005940333,0.00027751035,0.00018275248,0.00028773834],"domain_scores_gemma":[0.9988617,0.0002260321,0.00022836075,0.00031951547,0.0001241332,0.00024029176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008495977,0.00010583854,0.00029888356,0.00016637382,0.00011006461,0.0000052257733,0.0001252974,0.00006554847,0.00072956673],"category_scores_gemma":[0.0004926603,0.000098289456,0.00010540037,0.0004125291,0.00006797324,0.00006852203,0.000020800762,0.00019167279,0.00027593668],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092460314,0.0064128977,0.16496544,0.02480861,0.0005060398,0.000030139063,0.055838846,0.00009556429,0.0026713535,0.06346764,0.062368616,0.61791027],"study_design_scores_gemma":[0.016042471,0.013809256,0.81821793,0.04900696,0.0004074148,0.0001616377,0.020184863,0.014350334,0.011154117,0.032455362,0.022934148,0.001275525],"about_ca_topic_score_codex":0.0018608128,"about_ca_topic_score_gemma":0.00016577743,"teacher_disagreement_score":0.6532525,"about_ca_system_score_codex":0.00016646915,"about_ca_system_score_gemma":0.000496387,"threshold_uncertainty_score":0.79882437},"labels":[],"label_agreement":null},{"id":"W2067975415","doi":"10.1016/j.jval.2015.04.009","title":"Comparison Costs of ERCP and MRCP in Patients with Suspected Biliary Obstruction Based on a Randomized Trial","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Magnetic resonance cholangiopancreatography; Medicine; Endoscopic retrograde cholangiopancreatography; Randomized controlled trial; Indirect costs; Medical costs; Cost analysis; Surgery; Radiology; General surgery; Operations research","score_opus":0.03561002533832573,"score_gpt":0.31008351287254776,"score_spread":0.274473487534222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2067975415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960349,0.00012760944,0.000023481784,0.00066408154,0.00022427634,0.0027028676,0.000004763549,0.000017685576,0.00020030774],"genre_scores_gemma":[0.9992711,0.000014660595,0.00042759892,0.00016404779,0.000024131612,0.000030843723,0.000051141214,0.000011900977,0.000004591594],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99823606,0.00049330806,0.0005444026,0.00020424752,0.00033541454,0.00018653956],"domain_scores_gemma":[0.99920017,0.0002491314,0.0001699015,0.00015961935,0.00008496305,0.0001362035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009692476,0.00011291101,0.0007263425,0.0002886618,0.000014125885,0.0000042297547,0.000030063058,0.00006362834,0.000008079317],"category_scores_gemma":[0.00049895444,0.00008142073,0.000031449683,0.00032809188,0.00008171196,0.000033145127,0.000007190835,0.00018748733,8.5322625e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.638633,0.0009507749,0.35723087,0.000115879084,0.000009871685,0.0000015532723,0.00056517316,0.0011417578,0.0000018713932,0.00003593309,0.00012214265,0.001191147],"study_design_scores_gemma":[0.81364596,0.0031058148,0.16544029,0.00037011827,0.000016982698,6.684613e-7,0.00030939796,0.016919369,0.000013034841,0.000093969684,0.000011824102,0.00007258556],"about_ca_topic_score_codex":0.004392604,"about_ca_topic_score_gemma":0.00018951014,"teacher_disagreement_score":0.1917906,"about_ca_system_score_codex":0.00021448695,"about_ca_system_score_gemma":0.00039104206,"threshold_uncertainty_score":0.66403323},"labels":[],"label_agreement":null},{"id":"W2068001764","doi":"10.1016/j.jval.2014.08.869","title":"Epidemiology of Multiple Sclerosis in Latin America: Critical Analysis of the Literature","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Latin Americans; Epidemiology; Incidence (geometry); Medicine; Multiple sclerosis; Demography; Pediatrics; MEDLINE; SciELO; Internal medicine; Immunology","score_opus":0.18200729017780698,"score_gpt":0.40457932834523613,"score_spread":0.22257203816742915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068001764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853023,0.0022200576,0.00018771928,0.011642117,0.00006563083,0.00042545985,0.000052863517,0.000008726423,0.00009510765],"genre_scores_gemma":[0.99462306,0.001004548,0.0035218326,0.00076025905,0.000033978533,0.000025903613,0.000009503692,0.000008746792,0.00001215579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629223,0.0017955821,0.0009386288,0.00027515195,0.00027770744,0.00042069738],"domain_scores_gemma":[0.99266356,0.006382203,0.00020755676,0.00048958097,0.00014067395,0.00011639355],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0026009344,0.00011233604,0.0011250996,0.00054752314,0.00003857332,0.0000011074899,0.00015151761,0.00009148338,0.000019463383],"category_scores_gemma":[0.029260544,0.000073795796,0.00019554218,0.002534181,0.0003798279,0.000025355519,0.00010943049,0.00041482583,0.000001238279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007451385,0.00020159461,0.9890226,0.00053822686,0.00008224781,3.946575e-7,0.0015967444,0.004436688,0.00053291605,0.00056576286,0.00008689035,0.002861415],"study_design_scores_gemma":[0.00062062946,0.00017667073,0.90450466,0.0009653914,0.0000334968,2.5896406e-7,0.00015159776,0.09322998,0.00009954054,0.00010835849,0.00006774256,0.000041659372],"about_ca_topic_score_codex":0.009122131,"about_ca_topic_score_gemma":0.00058508175,"teacher_disagreement_score":0.08879329,"about_ca_system_score_codex":0.000120942874,"about_ca_system_score_gemma":0.000108143104,"threshold_uncertainty_score":0.9974762},"labels":[],"label_agreement":null},{"id":"W2068004048","doi":"10.1016/s1098-3015(10)70811-1","title":"PMS9 COST-EFFECTIVENESS OF ABATACEPT IN PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS (RA)AND INADEQUATE RESPONSE TO METHOTREXATE (MTX) ORTUMOR NECROSIS FACTOR-ALPHA INHIBITORS (ANTI-TNFS):A CANADIAN PERSPECTIVE","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Abatacept; Rheumatoid arthritis; Medicine; Methotrexate; Perspective (graphical); Tumor necrosis factor alpha; Alpha (finance); Internal medicine; Surgery; Computer science; Patient satisfaction","score_opus":0.028544803212729692,"score_gpt":0.29906851359808084,"score_spread":0.27052371038535117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068004048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992124,0.0028266893,0.000015933027,0.0011688342,0.000091274276,0.0033887152,0.00029479398,0.00002798786,0.00006173037],"genre_scores_gemma":[0.9898614,0.009390051,0.0002966832,0.00013127034,0.000010860193,0.00020873461,0.000027232505,0.0000603669,0.000013369838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99546057,0.0016734893,0.0006454039,0.00063525065,0.0006133394,0.0009719758],"domain_scores_gemma":[0.99727696,0.000789701,0.00018699544,0.0003582819,0.00036834143,0.0010197402],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014904325,0.0003364562,0.0010535325,0.0013296934,0.00022130777,0.000022354438,0.000131406,0.00011566675,0.000037193167],"category_scores_gemma":[0.0011485941,0.00030829766,0.00006750458,0.001079886,0.0003005138,0.0002772222,0.000057124034,0.00054746855,0.000010651901],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020129958,0.0007716052,0.8912425,0.00031218457,0.00014984042,0.00039956858,0.040851288,0.00033181097,0.0006657648,0.0003354536,0.000049434486,0.044760566],"study_design_scores_gemma":[0.0094226515,0.003003158,0.977868,0.003729869,0.0000010923146,0.000056748595,0.0017098571,0.000054722477,0.0033312028,0.00010242546,0.00043422251,0.0002860047],"about_ca_topic_score_codex":0.539956,"about_ca_topic_score_gemma":0.071396165,"teacher_disagreement_score":0.46855983,"about_ca_system_score_codex":0.0022276095,"about_ca_system_score_gemma":0.003720385,"threshold_uncertainty_score":0.99993694},"labels":[],"label_agreement":null},{"id":"W2068006815","doi":"10.1016/s1098-3015(10)64399-9","title":"PAR18 HEALTH-RELATED QUALITY OF LIFE (HRQL) IN OSTEOARTHRITIS: A SYSTEMATIC REVIEW TO ASSESS THE MEASUREMENT PROPERTIES OFTHEWOMAC (WESTERN ONTARIO MCMASTER OSTEOARTHRITIS INDEX) FOR DISCRIMINATIVE AND EVALUATIVE RESEARCH","year":2006,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteoarthritis; Discriminative model; Medicine; Physical therapy; Index (typography); Quality of life (healthcare); Health related quality of life; Gerontology; Alternative medicine; Computer science; Artificial intelligence; Internal medicine; World Wide Web; Pathology; Nursing","score_opus":0.649206594847244,"score_gpt":0.5016871108665037,"score_spread":0.14751948398074022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068006815","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001101512,0.9244948,0.000024766863,0.009927474,0.00022712923,0.06388424,0.00020643698,0.000028925131,0.000104685736],"genre_scores_gemma":[0.01177741,0.9711321,0.000107196574,0.0022197606,0.00013192803,0.014073049,0.000089910645,0.00014746262,0.0003211687],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.94974136,0.0317309,0.011505992,0.0015052635,0.0035144577,0.0020020462],"domain_scores_gemma":[0.9905927,0.0022660668,0.003082274,0.0012252103,0.0017836961,0.0010500108],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.08620263,0.0008303311,0.010519403,0.0010640874,0.0003377863,0.00007498007,0.00048341733,0.0005148033,0.000012976991],"category_scores_gemma":[0.008066729,0.00053252553,0.00044516523,0.0017767798,0.00025789568,0.00015552573,0.00020059693,0.0023188274,0.000010003891],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00012629227,0.00023322973,0.0003894576,0.87898344,0.00008522147,0.0000059473373,0.011408173,0.0000029769376,6.146518e-8,0.0002146462,0.00019454396,0.108356],"study_design_scores_gemma":[0.0022260884,0.0038043023,0.0012722504,0.95734906,0.0001268621,0.000071078655,0.0020463932,0.000016552396,1.1651363e-7,0.00009683048,0.03259237,0.00039810842],"about_ca_topic_score_codex":0.42973977,"about_ca_topic_score_gemma":0.35945684,"teacher_disagreement_score":0.10795789,"about_ca_system_score_codex":0.007177805,"about_ca_system_score_gemma":0.03120924,"threshold_uncertainty_score":0.99998283},"labels":[],"label_agreement":null},{"id":"W2068373153","doi":"10.1016/j.jval.2011.08.890","title":"PGI19 Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists or Sucralfate: A Cost-Effectiveness Analysis","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Sucralfate; Medicine; Stress ulcer; Intensive care medicine; Intensive care; Internal medicine; Pneumonia","score_opus":0.07665271134877463,"score_gpt":0.3218228923073096,"score_spread":0.24517018095853496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068373153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298257,0.00017637304,0.00010971252,0.0005617095,0.00014553685,0.0057009463,0.000047588026,0.000109741035,0.00016582014],"genre_scores_gemma":[0.993681,0.00014596384,0.004233686,0.00008013853,0.0001267526,0.001526931,0.000069376045,0.00005353907,0.00008259022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971901,0.00030300175,0.0006151513,0.0006993229,0.00047868627,0.0007137396],"domain_scores_gemma":[0.9984624,0.00022626661,0.0003118774,0.00038455077,0.0001968682,0.00041804378],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009581379,0.00036531474,0.000899036,0.0005607466,0.00015304287,0.000038383994,0.000112832655,0.000102117345,0.00014288614],"category_scores_gemma":[0.00015777808,0.00023916506,0.0001472879,0.0013426706,0.000102556485,0.00013178088,0.000047657064,0.00038220172,0.000023298206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025057313,0.0017895879,0.9897636,0.0016454706,0.00041761794,0.00022713897,0.0010652775,0.0002690018,0.00020224032,0.000052078136,0.000048703827,0.002013509],"study_design_scores_gemma":[0.0066486993,0.021007055,0.92883295,0.0076304413,0.00071573537,0.0001836083,0.00067168084,0.0013040663,0.03198397,0.000026291373,0.00047262103,0.00052285986],"about_ca_topic_score_codex":0.017020779,"about_ca_topic_score_gemma":0.00036225075,"teacher_disagreement_score":0.060930673,"about_ca_system_score_codex":0.0008627256,"about_ca_system_score_gemma":0.00051235885,"threshold_uncertainty_score":0.98952496},"labels":[],"label_agreement":null},{"id":"W2068481437","doi":"10.1016/j.jval.2011.08.157","title":"PMD86 A Systematic Review of Economic Evaluations Conducted for Assessment of Genetic Testing Technologies","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Context (archaeology); Health technology; Psychological intervention; Economic evaluation; Medicine; Actuarial science; Systematic review; Univariate; MEDLINE; Health care; Computer science; Pathology; Business; Nursing; Multivariate statistics; Economics","score_opus":0.7813519360318189,"score_gpt":0.5588575542055235,"score_spread":0.22249438182629533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068481437","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010128357,0.9814314,0.0011412195,0.00081971684,0.00045451746,0.014259671,0.001417508,0.00006709626,0.0003987091],"genre_scores_gemma":[0.000038431943,0.96367604,0.032185294,0.00034632988,0.000055014294,0.003450597,0.00011378967,0.00008503888,0.000049475213],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97503906,0.0019326039,0.021445744,0.00087627367,0.0001236556,0.00058266515],"domain_scores_gemma":[0.96825016,0.006502814,0.02349117,0.0014417309,0.00020287906,0.000111271445],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.041946508,0.0004871346,0.010388965,0.0013064307,0.00009814115,0.000018358389,0.00084055174,0.00039366615,0.0000697493],"category_scores_gemma":[0.019578362,0.00053879665,0.0005928191,0.0006212661,0.00012528739,0.00015413786,0.00010821623,0.00035894546,0.00010397602],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[4.8935715e-7,0.00007110103,0.00010669628,0.9524556,0.00013637537,1.1380624e-7,0.00009443949,0.00009336766,7.805341e-9,0.043073375,0.00041923957,0.00354922],"study_design_scores_gemma":[0.000393362,0.00029513426,0.000047749007,0.9517826,0.0002966046,0.000015290792,0.00017665663,0.005447962,6.7645516e-8,0.008650857,0.03239672,0.00049702835],"about_ca_topic_score_codex":0.0029661127,"about_ca_topic_score_gemma":0.000044961107,"teacher_disagreement_score":0.034422517,"about_ca_system_score_codex":0.0024934085,"about_ca_system_score_gemma":0.004569259,"threshold_uncertainty_score":0.9997063},"labels":[],"label_agreement":null},{"id":"W2068563979","doi":"10.1111/j.1524-4733.2010.00757.x","title":"Clustering Rasch Results: A Novel Method for Developing Rheumatoid Arthritis States for Use in Valuation Studies","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Rasch model; Polytomous Rasch model; Valuation (finance); Rheumatoid arthritis; Cluster analysis; Medicine; Physical therapy; Dimension (graph theory); Psychology; Psychometrics; Computer science; Artificial intelligence; Clinical psychology; Item response theory; Mathematics","score_opus":0.6305306781792499,"score_gpt":0.5016083572936013,"score_spread":0.1289223208856486,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068563979","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18371086,0.0039534126,0.7592541,0.045607775,0.0018498527,0.004405022,0.0011389655,0.00006045635,0.000019554263],"genre_scores_gemma":[0.042916927,0.0039163036,0.94506735,0.006010491,0.00023940853,0.0015574506,0.00016171495,0.000067830006,0.000062525265],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9919089,0.00039770766,0.0061452314,0.0007657077,0.00009019758,0.0006922347],"domain_scores_gemma":[0.9879949,0.009096497,0.0022274682,0.00039772812,0.00016641968,0.000116994735],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06033754,0.00022061719,0.0012675648,0.00069552794,0.00023924546,0.000093236245,0.00019280096,0.00016227626,0.0000043346367],"category_scores_gemma":[0.0238474,0.0002946419,0.00009352649,0.00030835465,0.00003778978,0.00060457486,0.000054049033,0.00025764655,0.000030071595],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010130806,0.00078964845,0.068470486,0.01440416,0.00036526835,0.0000018464921,0.08923916,0.21791656,0.00012315318,0.56295395,0.016895784,0.027826924],"study_design_scores_gemma":[0.007147061,0.00019685522,0.009656489,0.0013848011,0.0000014610891,0.000008470292,0.0032409038,0.8818046,0.000019523073,0.058598783,0.03742214,0.0005189526],"about_ca_topic_score_codex":0.011486738,"about_ca_topic_score_gemma":0.012964071,"teacher_disagreement_score":0.663888,"about_ca_system_score_codex":0.0011348124,"about_ca_system_score_gemma":0.00059150526,"threshold_uncertainty_score":0.9999506},"labels":[],"label_agreement":null},{"id":"W2068570909","doi":"10.1016/s1098-3015(10)65092-9","title":"PMH42 THE PREVALENCE OF POTENTIAL DRUG-DRUG INTERACTIONS ASSOCIATED WITH ATYPICAL ANTIPSYCHOTICS WITHIN ONTARIO DRUG BENEFIT CLAIMS","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Medicine; Antipsychotic drug; Psychiatry; Schizophrenia (object-oriented programming); Antipsychotic","score_opus":0.06552113906250694,"score_gpt":0.3735865414050376,"score_spread":0.30806540234253066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2068570909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842868,0.00086377905,0.00011297283,0.012754534,0.00060315704,0.0006382382,0.000015305626,0.000030850046,0.000694349],"genre_scores_gemma":[0.9950088,0.0005743543,0.00052829407,0.0013880003,0.00012365401,0.000006520572,0.000006559859,0.000017811806,0.00234596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978711,0.00020410802,0.00069781253,0.0002816195,0.00048611357,0.00045923205],"domain_scores_gemma":[0.99797326,0.0009948355,0.00042046694,0.0002648409,0.00013411786,0.00021248555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023468484,0.00016882726,0.00038102613,0.000078204976,0.00022545322,0.000014808457,0.00015899708,0.00003969861,0.0001534927],"category_scores_gemma":[0.00017083695,0.00010863896,0.00007565709,0.00037827718,0.00016387629,0.00011946787,0.000054200827,0.0010410296,0.000009145455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013333306,0.0029424906,0.9274136,0.001530932,0.0005520896,0.00011809388,0.038306538,0.004235483,0.00013413333,0.0024077278,0.004430379,0.0045952653],"study_design_scores_gemma":[0.002293108,0.00031640616,0.97941315,0.0013060566,0.00023618677,0.00007010347,0.0015714848,0.0045710998,0.00022631993,0.00063532754,0.009171125,0.00018961518],"about_ca_topic_score_codex":0.025148433,"about_ca_topic_score_gemma":0.07454259,"teacher_disagreement_score":0.051999606,"about_ca_system_score_codex":0.00044739732,"about_ca_system_score_gemma":0.00032262498,"threshold_uncertainty_score":0.9813432},"labels":[],"label_agreement":null},{"id":"W2069120076","doi":"10.1016/s1098-3015(10)61255-7","title":"PHP16 GENERIC DRUG PRICES ARE TYPICALLY HIGHER IN CANADA THAN IN THE UNITED STATES","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Business; Drug prices; Economics; Medicine; Public economics; Pharmacology","score_opus":0.14704572244072,"score_gpt":0.3536881509725271,"score_spread":0.2066424285318071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069120076","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8905279,0.007944095,5.9575456e-7,0.10013324,0.00013550624,0.0003117082,0.000006653799,0.0000079865,0.0009322938],"genre_scores_gemma":[0.9716361,0.008783308,0.00007459101,0.01929151,0.00007224344,0.000019724735,0.0000072122393,0.000008415131,0.0001068542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985329,0.00034448688,0.00032622708,0.00016338644,0.00025654622,0.00037645918],"domain_scores_gemma":[0.9989628,0.0006721609,0.00010409107,0.00013494243,0.000019045188,0.0001069406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005773551,0.00009928288,0.00023203764,0.000086633496,0.000051700772,0.000009550021,0.000113322676,0.000023431394,0.00015933394],"category_scores_gemma":[0.0000989791,0.00006351247,0.000014688452,0.00078594155,0.000023003811,0.000042170785,0.000026779036,0.00040857532,0.0000087162325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016320398,0.00039599746,0.9683515,0.00045777982,0.000023694896,0.00032936645,0.00432562,0.003225351,0.0000038661365,0.00027819368,0.017705739,0.0047397236],"study_design_scores_gemma":[0.0008793417,0.0000675273,0.6829363,0.00017098672,0.000006847924,0.0000062791637,0.0021261103,0.013460481,0.000003636143,0.00009667351,0.30015782,0.00008800556],"about_ca_topic_score_codex":0.9532071,"about_ca_topic_score_gemma":0.83888245,"teacher_disagreement_score":0.28541517,"about_ca_system_score_codex":0.0004941514,"about_ca_system_score_gemma":0.0002067734,"threshold_uncertainty_score":0.2589963},"labels":[],"label_agreement":null},{"id":"W2069289436","doi":"10.1016/j.jval.2014.03.1482","title":"Persistence rate and adherence level to oral antidiabetics and their associated determinants","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Nutrition, Health and Food Behavior","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Saint-Luc; Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Persistence (discontinuity); Dyslipidemia; Cohort; Logistic regression; Medical prescription; Proportional hazards model; Internal medicine; Cohort study; Demography; Disease","score_opus":0.13437080323293193,"score_gpt":0.33503806515445633,"score_spread":0.2006672619215244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069289436","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99597394,0.00042956034,0.000032598226,0.002676891,0.00035943373,0.00042911325,0.00005205176,0.000033601755,0.0000127865505],"genre_scores_gemma":[0.99713075,0.00013162084,0.00087187195,0.0017727641,0.00003844878,0.000014007836,0.0000044460044,0.000016786558,0.000019330058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826527,0.00045886848,0.00035360118,0.00031183063,0.000098353696,0.000512108],"domain_scores_gemma":[0.99910975,0.000231552,0.00011623619,0.00015286564,0.000053846557,0.00033574016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012510463,0.00014196067,0.00031341385,0.00011436491,0.00020343042,0.00003530142,0.00008272926,0.00009241946,0.0000030465483],"category_scores_gemma":[0.0003071333,0.00013272653,0.000018439368,0.00022773711,0.000059035767,0.00008053206,0.00003115109,0.00017637506,0.0000055917735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020110836,0.00030727094,0.8653434,0.00093772396,0.0000039135057,0.0000033403776,0.006182295,0.000026850477,0.0016762253,0.000049960396,0.00056194013,0.124705955],"study_design_scores_gemma":[0.0012549942,0.0019272813,0.9865827,0.0007696777,0.000006663609,0.000008885445,0.00038525995,0.006569425,0.0009209884,0.00051369943,0.00083495624,0.00022549892],"about_ca_topic_score_codex":0.001949232,"about_ca_topic_score_gemma":0.0006572618,"teacher_disagreement_score":0.12448046,"about_ca_system_score_codex":0.00011035705,"about_ca_system_score_gemma":0.000064042986,"threshold_uncertainty_score":0.5412431},"labels":[],"label_agreement":null},{"id":"W2069316653","doi":"10.1016/j.jval.2011.08.200","title":"PIN12 Epidemiology, Outcomes, and Costs of Hospitalization Due to Pneumonia, Meningitis, and Septicemia in Canada from 2004 to 2010","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); Dalhousie University","funders":"","keywords":"Medicine; Incidence (geometry); Case fatality rate; Meningitis; Pneumonia; Epidemiology; Pediatrics; Population; Diagnosis code; Internal medicine; Environmental health","score_opus":0.04894306927741858,"score_gpt":0.3030747949701776,"score_spread":0.254131725692759,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069316653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99309254,0.00053957035,0.00012453871,0.0052707205,0.0002694541,0.0005462629,0.000047743026,0.000009648311,0.00009953157],"genre_scores_gemma":[0.9950957,0.000118079035,0.0007181095,0.00398354,0.0000197952,0.000024058758,0.000008380771,0.00001186675,0.000020487774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987102,0.00018526241,0.0005133168,0.00023897494,0.00008459433,0.00026765355],"domain_scores_gemma":[0.99910253,0.00025124947,0.00010475631,0.00016954323,0.000032640353,0.00033927985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047327977,0.000108532746,0.0004753859,0.00018523066,0.000034732257,0.0000017329539,0.00003846322,0.00007171379,0.000014598353],"category_scores_gemma":[0.00049753825,0.000098697165,0.000014016279,0.0002258741,0.000029149978,0.00003542904,0.000032565396,0.00015233194,0.0000024344615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016949192,0.000036040343,0.9963167,0.00005444017,0.000009429017,0.000023635672,0.000886507,0.00021421422,0.00038668563,0.00017680887,0.00032572765,0.0015528653],"study_design_scores_gemma":[0.00051687454,0.00030745447,0.9976305,0.00033297765,0.0000076156666,0.000018586612,0.0001678793,0.00029245045,0.000050404204,0.00013215035,0.00046015176,0.00008295912],"about_ca_topic_score_codex":0.9721641,"about_ca_topic_score_gemma":0.801839,"teacher_disagreement_score":0.17032506,"about_ca_system_score_codex":0.00056895724,"about_ca_system_score_gemma":0.00076635735,"threshold_uncertainty_score":0.40247536},"labels":[],"label_agreement":null},{"id":"W2069328529","doi":"10.1016/s1098-3015(10)72318-4","title":"PDB76 AN OPEN-SOURCE, INTERACTIVE MODEL TO ASSESS THE OUTCOMES AND ECONOMICS OF DIABETES INTERVENTIONS IN CANADA","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychological intervention; Open source; Economics; Public economics; Environmental economics; Computer science; Medicine; Nursing; Operating system","score_opus":0.10419690314383404,"score_gpt":0.3726661779194348,"score_spread":0.2684692747756008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069328529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919234,0.000020159954,0.00002324871,0.006728009,0.00024541267,0.00061568513,0.0000068935515,0.000003188003,0.00043401177],"genre_scores_gemma":[0.99759704,0.0000141081855,0.000806574,0.0012966071,0.00001512692,0.00005389724,0.000010134648,0.0000087575,0.00019775209],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993,0.00005578802,0.00030872025,0.0001330599,0.00004693675,0.0001554652],"domain_scores_gemma":[0.9994517,0.00013498578,0.000100623416,0.0002022035,0.00002145361,0.00008904019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006469436,0.00006107726,0.00020980764,0.00012215873,0.000024917066,0.000022510189,0.00014524643,0.000015526035,0.000013657513],"category_scores_gemma":[0.00011860853,0.000048317976,0.000015223058,0.00009909576,0.000015035709,0.00013929901,0.00009389539,0.00015666767,6.7453243e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000106671505,0.00017463279,0.9779203,0.00016227717,0.00001635953,1.136988e-7,0.0011706245,0.0060354224,0.000022800872,0.0016476142,0.00033565125,0.012503532],"study_design_scores_gemma":[0.00044947438,0.00011967232,0.8893526,0.00020510204,0.000008275604,1.3477627e-7,0.0015267273,0.10693528,0.00003513112,0.0007998045,0.0005097076,0.00005807711],"about_ca_topic_score_codex":0.6287383,"about_ca_topic_score_gemma":0.8209698,"teacher_disagreement_score":0.19223154,"about_ca_system_score_codex":0.00021265808,"about_ca_system_score_gemma":0.00059785065,"threshold_uncertainty_score":0.37373397},"labels":[],"label_agreement":null},{"id":"W2069359870","doi":"10.1016/s1098-3015(10)64771-7","title":"PHP22 PRESCRIPTION DRUG PRICE COMPARISONS BETWEEN CANADIAN AND US ON-LINE PHARMACIES OVER A SIX-MONTH PERIOD","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Pharmacy; Period (music); Prescription drug; Medicine; Drug; Family medicine; Pharmacology","score_opus":0.11288744499185155,"score_gpt":0.3256395606394327,"score_spread":0.21275211564758117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069359870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675993,0.0029659648,0.000042446536,0.013481978,0.00031767364,0.00042486028,0.0009312239,0.000025687812,0.014210876],"genre_scores_gemma":[0.99536794,0.0006435248,0.00016692703,0.0031196414,0.00028584292,0.000019362258,0.000045144407,0.000023635155,0.00032798506],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982455,0.000045472345,0.0007250867,0.00037530955,0.000030650124,0.00057798374],"domain_scores_gemma":[0.99913216,0.0000790263,0.0002233458,0.0001853055,0.000009051925,0.00037109305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068934116,0.00016801825,0.00044168445,0.0003904495,0.00016772753,0.00008659941,0.00014212634,0.00006651595,0.0001382601],"category_scores_gemma":[0.000025191765,0.00020766181,0.00005080378,0.00019289432,0.0000566091,0.00014542119,0.000031456475,0.0002851616,0.000118217824],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030210005,0.00015050685,0.84162754,0.0001439774,0.000026752705,0.0000052379414,0.000688914,0.008576779,0.0000031014765,0.13039048,0.017443549,0.00091297325],"study_design_scores_gemma":[0.0011873966,0.00008020425,0.33095035,0.00002985235,0.0000032356147,0.0000024325627,0.00001873548,0.08937585,0.000012063163,0.006516118,0.5715492,0.00027460678],"about_ca_topic_score_codex":0.53336835,"about_ca_topic_score_gemma":0.043936696,"teacher_disagreement_score":0.5541056,"about_ca_system_score_codex":0.00057445705,"about_ca_system_score_gemma":0.0001599625,"threshold_uncertainty_score":0.97350895},"labels":[],"label_agreement":null},{"id":"W2069609467","doi":"10.1016/j.jval.2013.03.1465","title":"Estimating the costs of cardiac rehabilitation programs in heart failure (HF) in colombia: construction based on expert consensus","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Rehabilitation; Reimbursement; Session (web analytics); Health care; Negotiation; Medicine; Service provider; Matching (statistics); Delphi; Delphi method; Systematic review; Actuarial science; Physical therapy; Computer science; Service (business); Business; MEDLINE; Political science; Artificial intelligence","score_opus":0.21066911102537772,"score_gpt":0.3844284712451952,"score_spread":0.17375936021981747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069609467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8781903,0.00057318393,0.00008857756,0.11726221,0.0005318106,0.0031294555,0.00003458239,0.000022436798,0.00016746004],"genre_scores_gemma":[0.94647396,0.000013546279,0.04985176,0.0029134226,0.00007333881,0.0006280013,0.000018867611,0.000021668422,0.00000544831],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99332374,0.001749462,0.003915732,0.00045649483,0.00012144531,0.00043314684],"domain_scores_gemma":[0.9942027,0.0038262657,0.0013805331,0.00042900114,0.000062764266,0.00009873305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018150654,0.0001565324,0.0009180311,0.0005190554,0.000084785854,0.000036918143,0.00013477435,0.00014836308,0.000039308543],"category_scores_gemma":[0.0047705323,0.00017369863,0.00007731915,0.0005358139,0.00015503442,0.0001559179,0.0000175144,0.00030882648,0.000101725505],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030492965,0.00029598892,0.8802853,0.0007640654,0.0000079711035,2.487592e-7,0.0058230083,0.087383874,0.000004826501,0.015251786,0.0072633917,0.002889029],"study_design_scores_gemma":[0.001621884,0.0006232201,0.293646,0.0015581346,9.667527e-7,0.0000024203632,0.0084767565,0.68388766,0.0000039007273,0.0066327667,0.0032442387,0.00030207218],"about_ca_topic_score_codex":0.07235482,"about_ca_topic_score_gemma":0.0015657939,"teacher_disagreement_score":0.5965038,"about_ca_system_score_codex":0.0017554748,"about_ca_system_score_gemma":0.00042936104,"threshold_uncertainty_score":0.93382245},"labels":[],"label_agreement":null},{"id":"W2069921048","doi":"10.1016/j.jval.2014.03.914","title":"Budget Impact Of Utilizing Various Types Of Advanced Bipolar Energy (Abe) Devices Versus Conventional Bipolar Energy (Cbe) In Total Laparoscopic Hysterectomy In Canadian Hospitals","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Thyroid and Parathyroid Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Activity-based costing; Randomized controlled trial; Medicine; Health care; Business; Surgery; Accounting; Economics","score_opus":0.017538782439533895,"score_gpt":0.29350409919183323,"score_spread":0.27596531675229935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069921048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794477,0.0194254,0.000010437619,0.00017381542,0.0003356901,0.00017122268,0.00007494172,0.0000133244375,0.000347469],"genre_scores_gemma":[0.99872965,0.0007494756,0.00015520895,0.00013018065,0.00006650394,0.000014629212,0.0000785408,0.000028102952,0.00004771041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99748653,0.00040073504,0.0008781991,0.0003215094,0.00025576653,0.0006572703],"domain_scores_gemma":[0.9986167,0.0003962573,0.00028965494,0.00028209595,0.000067554116,0.00034775588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008381921,0.00021738911,0.0008399012,0.00090015004,0.00003200488,0.000006906825,0.00011473316,0.00015319177,0.000035625973],"category_scores_gemma":[0.00021953223,0.00021245584,0.00013024907,0.0006511516,0.0000657792,0.00011316958,0.000024489875,0.00020539404,0.0000025692757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010267298,0.000446242,0.9607653,0.0006255535,0.00010183335,0.0000426755,0.00095663907,0.010751721,0.0082197925,0.008627246,0.00014028019,0.008296007],"study_design_scores_gemma":[0.009518315,0.0032176366,0.961065,0.0016518096,0.000020244774,0.000022378228,0.0002740987,0.008586337,0.0049455822,0.00021491676,0.01003713,0.00044656257],"about_ca_topic_score_codex":0.8036131,"about_ca_topic_score_gemma":0.31500512,"teacher_disagreement_score":0.488608,"about_ca_system_score_codex":0.0006140977,"about_ca_system_score_gemma":0.0020381408,"threshold_uncertainty_score":0.8663698},"labels":[],"label_agreement":null},{"id":"W2069995897","doi":"10.1016/j.jval.2011.08.894","title":"PGI23 Economic Impact of Medication Adherence and Persistence in the Treatment of Ulcerative Colitis in Canada: Analyses with the Ramq Database","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Medical prescription; Ulcerative colitis; Persistence (discontinuity); Statistical significance; Internal medicine; Retrospective cohort study; Health care; Disease","score_opus":0.07067016900751559,"score_gpt":0.3155075950698969,"score_spread":0.2448374260623813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2069995897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991045,0.00038305196,0.0000039141264,0.00007271583,0.000008134032,0.0002780222,0.00009671541,3.025792e-7,0.000052620195],"genre_scores_gemma":[0.99933213,0.0005247483,0.000042473563,0.000038232156,0.0000064389974,0.000028294784,0.000022993452,0.0000026171542,0.0000020959124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930906,0.0002403009,0.000177706,0.00011846463,0.000051550145,0.00010289992],"domain_scores_gemma":[0.99960536,0.000032447704,0.000117871554,0.00019709203,0.000013440093,0.000033782435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023467926,0.00006039304,0.00010402339,0.000026705631,0.000016274287,0.0000014829176,0.00008502973,0.000015633448,0.0000071391532],"category_scores_gemma":[0.000014536488,0.000033938588,0.000015798541,0.00004490777,0.00008117988,0.0000034435875,0.000008198869,0.000027060261,9.499308e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012456513,0.00020488795,0.98014176,0.00013089024,0.00007401235,0.00004017632,0.010480664,0.005263268,0.0007601042,0.0001861481,0.00012077456,0.0013516907],"study_design_scores_gemma":[0.00047801214,0.00045175065,0.99542177,0.000033870914,0.000005712899,0.0000024660014,0.0016821137,0.0011353084,0.0007352087,0.000008136591,0.000010126381,0.000035521072],"about_ca_topic_score_codex":0.8862521,"about_ca_topic_score_gemma":0.9210138,"teacher_disagreement_score":0.03476166,"about_ca_system_score_codex":0.00026196754,"about_ca_system_score_gemma":0.0025767896,"threshold_uncertainty_score":0.4571114},"labels":[],"label_agreement":null},{"id":"W2070028004","doi":"10.1016/j.jval.2014.03.485","title":"Cost Effectiveness of Trametinib as First-Line (1l) Treatment for Braf V600 Positive Advanced or Metastatic Melanoma — A Canadian Societal Perspective","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Trametinib; Dacarbazine; Vemurafenib; Medicine; Internal medicine; Oncology; Melanoma; Metastatic melanoma; Chemotherapy; Cancer research; Biology","score_opus":0.0471651896086674,"score_gpt":0.34261534361423285,"score_spread":0.29545015400556546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070028004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99304396,0.00064485916,0.002322613,0.00045501455,0.00016245455,0.0023128802,0.0005046987,0.0000077896575,0.00054571475],"genre_scores_gemma":[0.99656427,0.00016047664,0.0023482589,0.00017636461,0.00007155928,0.00032406923,0.00022261332,0.000028754997,0.00010365435],"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99841756,0.0003682311,0.0002917186,0.0004169065,0.00008919149,0.0004163854],"domain_scores_gemma":[0.99895996,0.00031404672,0.00013701279,0.00023383033,0.00011780703,0.00023731733],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005976671,0.00020119837,0.00041229266,0.00008249712,0.0001060073,0.000007478056,0.00010665675,0.00009422216,0.000009730421],"category_scores_gemma":[0.0003466972,0.00016774511,0.00013777126,0.00011587237,0.000060441806,0.0000043663013,0.00001595613,0.000060787188,0.0000032528342],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.042015847,0.010133645,0.013061912,0.010305859,0.0043002516,0.00025513236,0.032406937,0.07226029,0.29268682,0.12039375,0.0008062577,0.4013733],"study_design_scores_gemma":[0.048321962,0.14315161,0.030188741,0.001660128,0.00033842644,0.00030229034,0.0068779318,0.010196001,0.7002456,0.01042271,0.046086658,0.0022079009],"about_ca_topic_score_codex":0.104307584,"about_ca_topic_score_gemma":0.05927528,"teacher_disagreement_score":0.40755883,"about_ca_system_score_codex":0.00041802425,"about_ca_system_score_gemma":0.001139958,"threshold_uncertainty_score":0.9578905},"labels":[],"label_agreement":null},{"id":"W2070034803","doi":"10.1016/j.jval.2010.11.015","title":"Economic Impact of Nonpersistence with Antidepressant Treatment in the Adult Population of Quebec: A Comparative Cost-Effectiveness Approach","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Jewish General Hospital; Université de Montréal","funders":"","keywords":"Venlafaxine; Paroxetine; Medicine; Citalopram; Fluoxetine; Discontinuation; Antidepressant; Population; Health care; Retrospective cohort study; Fluvoxamine; Psychiatry; Internal medicine; Environmental health; Anxiety; Serotonin","score_opus":0.13052952788326674,"score_gpt":0.36672598097144404,"score_spread":0.2361964530881773,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070034803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966484,0.00023496382,0.00004250764,0.000027982824,0.000017023765,0.0024667531,0.000021872907,0.0000075135204,0.00053303357],"genre_scores_gemma":[0.9989039,0.000056307585,0.00083908834,0.000007756981,0.0000080194095,0.00013600216,0.00003491476,0.00000914832,0.0000048728193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857694,0.0005055374,0.0003707937,0.0002266828,0.00014090638,0.00017914562],"domain_scores_gemma":[0.99914753,0.00018647271,0.000274671,0.0003061771,0.000032607997,0.000052547795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035916112,0.00014761547,0.00054899434,0.00015752194,0.0000212434,0.0000024064095,0.00007434316,0.000044213237,0.000005914826],"category_scores_gemma":[0.000011766414,0.00007925769,0.00007907399,0.00014842606,0.000064332075,0.00008046265,0.00000932142,0.00008143903,0.000001050891],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018372757,0.0013179191,0.97388875,0.00024395659,0.000067184774,0.0000070125466,0.008672078,0.012606099,0.00005970928,0.00023837462,0.000002266536,0.0010593694],"study_design_scores_gemma":[0.0036677613,0.0030950217,0.98390555,0.0007016914,0.000032462394,0.000022220567,0.000854928,0.006914551,0.0007192251,0.000027372436,4.92241e-7,0.00005870266],"about_ca_topic_score_codex":0.46837932,"about_ca_topic_score_gemma":0.0065404684,"teacher_disagreement_score":0.46183884,"about_ca_system_score_codex":0.001119179,"about_ca_system_score_gemma":0.00037479267,"threshold_uncertainty_score":0.5351608},"labels":[],"label_agreement":null},{"id":"W2070061188","doi":"10.1016/j.jval.2013.03.756","title":"Comparison Of Cancer Therapy Reimbursement Decisions Made In Canada To Australia, Sweden And The United Kingdom","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Reimbursement; Excellence; Medicine; Family medicine; Agency (philosophy); Health care; Political science","score_opus":0.6697425343161323,"score_gpt":0.508924229910039,"score_spread":0.16081830440609324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070061188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89948034,0.0023886357,0.000075603864,0.09607693,0.0003078356,0.0015345233,0.00006907835,0.0000044337276,0.000062590465],"genre_scores_gemma":[0.9880832,0.0005984099,0.0006503743,0.010234862,0.000050807394,0.00027146854,0.0000071634645,0.000013610577,0.000090121815],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949616,0.0006025263,0.003596723,0.00032031673,0.00011389071,0.00040490195],"domain_scores_gemma":[0.9964426,0.0018072064,0.0011580947,0.00035880046,0.000040752562,0.00019252278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008304612,0.00012821097,0.00091495854,0.00039457364,0.00008615737,0.000027821014,0.00024239338,0.00005390755,0.0002660328],"category_scores_gemma":[0.0009259162,0.00012168975,0.00002982805,0.00046099798,0.000047171332,0.00009164059,0.000039857834,0.00019832858,0.00005316564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029177027,0.000055179444,0.91210544,0.0001029884,0.000019108367,1.9127432e-7,0.004250548,0.037556674,0.000001159244,0.031049797,0.014178264,0.00065145444],"study_design_scores_gemma":[0.0021020998,0.00007273456,0.9257771,0.00035330196,0.0000010976054,4.623577e-7,0.0024771348,0.039729916,0.0000059824256,0.005479859,0.023812644,0.00018772083],"about_ca_topic_score_codex":0.9985746,"about_ca_topic_score_gemma":0.8998986,"teacher_disagreement_score":0.098676,"about_ca_system_score_codex":0.0018245963,"about_ca_system_score_gemma":0.000879978,"threshold_uncertainty_score":0.4962364},"labels":[],"label_agreement":null},{"id":"W2070290298","doi":"10.1016/j.jval.2014.03.1562","title":"Development Of Risk-Index Tool To Predict Surgical Site Infections","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Logistic regression; Stepwise regression; Emergency medicine; Surgical site infection; Bivariate analysis; Risk factor; Risk assessment; Internal medicine; Multivariate analysis; Surgery; Statistics","score_opus":0.020828293263380423,"score_gpt":0.2954117848195151,"score_spread":0.27458349155613465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070290298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404407,0.0000729112,0.0014145263,0.0010765956,0.000116857715,0.0003886897,0.0000039951583,0.000044473152,0.0028378682],"genre_scores_gemma":[0.99462026,0.00005494848,0.004579004,0.0003644786,0.00012438431,0.000021893617,0.000008808077,0.000012632841,0.00021357222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984305,0.00022966477,0.000566075,0.00019310717,0.00030888402,0.00027178897],"domain_scores_gemma":[0.9987058,0.00070703815,0.00008860635,0.00020845905,0.000039929677,0.00025014018],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015805666,0.00010367484,0.0005937004,0.00018351586,0.0000611957,0.000004823534,0.000039028888,0.000071319795,0.00004593506],"category_scores_gemma":[0.00038191967,0.00008459472,0.00013782576,0.00032107873,0.000021806944,0.000021111638,0.000024342904,0.00017688135,0.00005591281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001271941,0.0002048139,0.9650117,0.00016777552,0.000020532425,0.000017583696,0.0013640326,0.0011208197,0.000012510371,0.0021731926,0.00008474185,0.029695062],"study_design_scores_gemma":[0.00097272545,0.00015898008,0.65314484,0.00013340302,0.000008351693,0.000041347477,0.000027992985,0.0007353855,0.0000436332,0.000017631446,0.34464368,0.00007203812],"about_ca_topic_score_codex":0.0010427001,"about_ca_topic_score_gemma":0.00006140062,"teacher_disagreement_score":0.34455895,"about_ca_system_score_codex":0.00013966362,"about_ca_system_score_gemma":0.00031634755,"threshold_uncertainty_score":0.34496725},"labels":[],"label_agreement":null},{"id":"W2070396091","doi":"10.1016/j.jval.2014.03.416","title":"Evolving Treatment Patterns in Metastatic Melanoma in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vemurafenib; Trametinib; Dacarbazine; Internal medicine; Metastatic melanoma; Ipilimumab; Oncology; Salvage therapy; Melanoma; Lomustine; Temozolomide; Targeted therapy; Cancer; Chemotherapy; Vincristine; Immunotherapy","score_opus":0.06466749246790013,"score_gpt":0.34066119184665805,"score_spread":0.27599369937875795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070396091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99518764,0.0005380607,0.000015199568,0.0028666721,0.00009119711,0.00068342686,0.0000070957085,0.0000071056493,0.0006036177],"genre_scores_gemma":[0.9984754,0.00030073355,0.00021508169,0.0005365525,0.000041588195,0.000054825014,0.000011527601,0.000020585221,0.00034373382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998052,0.0004608478,0.00042608735,0.00023788607,0.00031525682,0.0005079481],"domain_scores_gemma":[0.99910605,0.00037165763,0.000049696842,0.00027572605,0.000015762585,0.00018111688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091066724,0.00011504634,0.00041214834,0.0002845509,0.000016712733,0.0000063388047,0.00006854928,0.000022743649,0.00052143517],"category_scores_gemma":[0.000108262655,0.00009995074,0.00002593558,0.00030833157,0.000010081622,0.000026270212,0.000016820373,0.00021575931,0.00000765281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079641366,0.0001560187,0.95481277,0.0002857868,0.000011575058,0.00018983646,0.001148299,0.0011679546,0.00016563726,0.000043785047,0.00006550121,0.041873176],"study_design_scores_gemma":[0.004911445,0.00096970843,0.9296562,0.00064680725,0.0000047209205,0.000031582877,0.0006984485,0.05937283,0.00030037656,0.00013806614,0.0031340457,0.0001357413],"about_ca_topic_score_codex":0.9965118,"about_ca_topic_score_gemma":0.98933923,"teacher_disagreement_score":0.058204878,"about_ca_system_score_codex":0.005886759,"about_ca_system_score_gemma":0.002967911,"threshold_uncertainty_score":0.99792945},"labels":[],"label_agreement":null},{"id":"W2070404256","doi":"10.1111/j.1524-4733.2010.00694.x","title":"Quantifying Women's Stated Benefit–Risk Trade-Off Preferences for IBS Treatment Outcomes","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Seriousness; Irritable bowel syndrome; Diarrhea; Preference; Adverse effect; Constipation; Risk perception; Risk assessment; Internal medicine; Psychology; Statistics","score_opus":0.091878811014854,"score_gpt":0.350731241562248,"score_spread":0.258852430547394,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070404256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935799,0.00017970063,0.000099173005,0.004584141,0.00023635881,0.0011028084,0.000067483605,0.000076489654,0.00007389519],"genre_scores_gemma":[0.9928025,0.0002431203,0.006283137,0.00036693446,0.000036833513,0.00013271568,0.000034164146,0.000018616334,0.000081969374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984565,0.00007006207,0.0004542507,0.0003153085,0.00016520898,0.0005386679],"domain_scores_gemma":[0.99884385,0.00046157918,0.0001438602,0.0002499771,0.00002862686,0.00027211002],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005672368,0.00018146748,0.00045238133,0.00013555713,0.000116440664,0.00001596548,0.000070438786,0.000065542285,0.000046678888],"category_scores_gemma":[0.0004397182,0.00013801192,0.00008780837,0.0001501667,0.000051197025,0.000055521974,0.000008881611,0.0002642307,0.0000066525913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030095724,0.00065240206,0.94979835,0.0003344203,0.000027777585,0.0000034185573,0.0026681595,0.00038100258,0.000077073426,0.00045411784,0.00002599156,0.045276318],"study_design_scores_gemma":[0.0037779894,0.0038083862,0.9807681,0.00016235968,0.000023434457,0.000014720062,0.0020195874,0.004500243,0.00005426489,0.002656878,0.0020887123,0.0001253439],"about_ca_topic_score_codex":0.004782402,"about_ca_topic_score_gemma":0.0020264443,"teacher_disagreement_score":0.045150973,"about_ca_system_score_codex":0.00018972708,"about_ca_system_score_gemma":0.00032342057,"threshold_uncertainty_score":0.72295934},"labels":[],"label_agreement":null},{"id":"W2070706497","doi":"10.1016/j.jval.2011.08.447","title":"PMS61 Rapid Reductions in Fatigue and Sleep Problems and Correlation with Improvements in Patient-Reported Outcomes in Patients with Active RA Treated with Certolizumab Pegol in the realistic 12-Week Phase IIIB Randomised Controlled Study","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Certolizumab pegol; Medicine; Correlation; Internal medicine; Mathematics; Tumor necrosis factor alpha; Adalimumab","score_opus":0.055732624353642936,"score_gpt":0.3028389791417251,"score_spread":0.24710635478808216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070706497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842189,0.00011039072,0.000019164969,0.0002882108,0.000021739745,0.015233009,0.00001173127,0.000015126846,0.00008173382],"genre_scores_gemma":[0.99839735,0.000049526203,0.000087321125,0.000008397523,0.0000024575447,0.0013251452,0.000084260246,0.00003180935,0.0000137532215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99635875,0.00095100264,0.0010373405,0.00054633105,0.00056783215,0.00053873315],"domain_scores_gemma":[0.9986914,0.0003320409,0.00039770312,0.0003340032,0.000102007085,0.00014285317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059296767,0.00030496047,0.0009935002,0.00079564966,0.00007880516,0.000019678413,0.0000758239,0.0000890831,0.000014199699],"category_scores_gemma":[0.0002154872,0.00017601838,0.000022416,0.0008746253,0.00015000982,0.00019356505,0.000021945298,0.00056676177,2.5667563e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08105353,0.007429589,0.87759686,0.000464119,0.00014810247,0.00040431647,0.030187381,0.0004205826,0.00000672388,0.000007580149,0.0000015863034,0.0022796053],"study_design_scores_gemma":[0.3289683,0.013816387,0.64632815,0.0010415008,0.000053149175,0.00005697635,0.0046586483,0.004912995,0.0000043508967,0.00001844857,1.7768936e-7,0.00014089658],"about_ca_topic_score_codex":0.037039854,"about_ca_topic_score_gemma":0.003111313,"teacher_disagreement_score":0.24791476,"about_ca_system_score_codex":0.00056933344,"about_ca_system_score_gemma":0.00046746296,"threshold_uncertainty_score":0.9693726},"labels":[],"label_agreement":null},{"id":"W2070810062","doi":"10.1016/j.jval.2011.02.837","title":"PRM29 METHODOLOGICAL DIFFERENCES IN EQ-5D SCORING SYSTEMS: A SYSTEMATIC REVIEW AND ANALYSIS","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"EQ-5D; Valuation (finance); Preference; Scoring system; Population; MEDLINE; Medicine; Actuarial science; Statistics; Computer science; Mathematics; Environmental health; Health related quality of life; Disease; Pathology","score_opus":0.9174960492409031,"score_gpt":0.5352999173954806,"score_spread":0.38219613184542256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070810062","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000037697955,0.98982704,0.00074773916,0.0008730037,0.00040620877,0.0076019755,0.0002593114,0.00004592235,0.00020111018],"genre_scores_gemma":[0.0000912566,0.994551,0.0015905497,0.0014600337,0.00009694409,0.0019509881,0.000050629904,0.000054284446,0.00015428585],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96574134,0.013739611,0.018014947,0.0014764162,0.00014788746,0.0008797822],"domain_scores_gemma":[0.980471,0.0074204463,0.010547986,0.001150866,0.00004222748,0.00036746092],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.10189743,0.0006598513,0.020206667,0.0024932693,0.000120697114,0.00010783153,0.0005799295,0.00051238673,0.00008410668],"category_scores_gemma":[0.012863888,0.00062287046,0.00060325273,0.0019853222,0.000079626865,0.00024166123,0.00014823994,0.00077871646,0.00033242267],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.3217486e-7,0.000053851505,0.0029627718,0.9704072,0.00036346848,0.000003214002,0.00041169737,0.000016910119,8.195729e-11,0.02530619,0.000090070855,0.00038381363],"study_design_scores_gemma":[0.00028470941,0.00013223555,0.0010526708,0.96304506,0.0014273054,0.00005075048,0.00029620124,0.0021187952,5.7036303e-10,0.0016428299,0.028937584,0.0010118667],"about_ca_topic_score_codex":0.015950058,"about_ca_topic_score_gemma":0.0002806629,"teacher_disagreement_score":0.089033544,"about_ca_system_score_codex":0.0018778587,"about_ca_system_score_gemma":0.00060844433,"threshold_uncertainty_score":0.9996223},"labels":[],"label_agreement":null},{"id":"W2070812863","doi":"10.1016/j.jval.2013.08.448","title":"Potential Long-Term Cost Savings Due to Significant Clinical Benefit of Obinutuzumab (Ga101) in Combination with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Obinutuzumab; Chlorambucil; Medicine; Chronic lymphocytic leukemia; Bendamustine; Population; Ofatumumab; Rituximab; Internal medicine; Leukemia; Oncology; Chemotherapy; Lymphoma; Environmental health; Cyclophosphamide","score_opus":0.0337281984678595,"score_gpt":0.329314392531407,"score_spread":0.29558619406354747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070812863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99229115,0.00061874604,0.00012209892,0.00063373154,0.00013953826,0.006037788,0.000008598563,0.000054789984,0.00009355138],"genre_scores_gemma":[0.9978707,0.00063739094,0.00034435905,0.00031420917,0.000103102924,0.0003630771,0.000079880025,0.00007559756,0.00021172843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99433994,0.00045442235,0.0020772493,0.00088367163,0.00096741127,0.0012773292],"domain_scores_gemma":[0.9973654,0.00051789253,0.00039917848,0.0008187317,0.00028707436,0.00061169075],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023127832,0.000368404,0.0013347265,0.0008334134,0.00004932393,0.000042089767,0.0003684827,0.00031994857,0.00015499815],"category_scores_gemma":[0.0004999856,0.00032458096,0.00010577776,0.0016364628,0.00024045,0.00020167149,0.0001566073,0.00070015265,0.00012314234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.011240244,0.002644751,0.46214238,0.013754458,0.00026272133,0.0054639336,0.00638547,0.36682382,0.0015247364,0.0009885292,0.0007605869,0.12800838],"study_design_scores_gemma":[0.070560195,0.005729153,0.5752446,0.0061350125,0.000032391297,0.00035642387,0.00014894053,0.3406772,0.00056096265,0.00013423919,0.000024802874,0.00039607543],"about_ca_topic_score_codex":0.2102106,"about_ca_topic_score_gemma":0.0070913294,"teacher_disagreement_score":0.20311928,"about_ca_system_score_codex":0.2545,"about_ca_system_score_gemma":0.08224641,"threshold_uncertainty_score":0.9999206},"labels":[],"label_agreement":null},{"id":"W2070916539","doi":"10.1016/j.jval.2012.08.1693","title":"PDB50 Health Care Resource Utilization in the Management of Cushing Disease: An Analysis From South-Western Ontario","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Lawson Health Research Institute","funders":"","keywords":"Medicine; Population; Retrospective cohort study; Diabetes mellitus; Dyslipidemia; Cushing's disease; Internal medicine; Surgery; Disease; Endocrinology","score_opus":0.06842937746593254,"score_gpt":0.33636194579491374,"score_spread":0.2679325683289812,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070916539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98855835,0.009241595,0.00018893885,0.0011472753,0.000036966278,0.0005814297,0.000044456345,0.00001148293,0.0001894998],"genre_scores_gemma":[0.9978088,0.00017254458,0.00029661466,0.0008775223,0.000028211196,0.00001857893,0.0007482445,0.000009006621,0.000040472267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99855995,0.0002700066,0.00037855736,0.00020167282,0.0002826977,0.00030712952],"domain_scores_gemma":[0.9992421,0.000029496518,0.00013600384,0.00037722365,0.000011254338,0.00020390913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044580386,0.000107521824,0.00031232793,0.00019073233,0.00006405785,0.00000800722,0.00008399608,0.000027348802,0.000019010513],"category_scores_gemma":[0.0000042884517,0.00007722649,0.00006218827,0.00040754417,0.0000131308525,0.00008297459,0.000021615318,0.00010617072,0.0000023353987],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112282825,0.00043190084,0.9441102,0.00022809247,0.00008896849,0.00001052034,0.05062772,0.0011780232,2.7709651e-8,0.00008925051,0.00001222858,0.0031107822],"study_design_scores_gemma":[0.0012293268,0.00013445863,0.9859852,0.0002399756,0.00016559793,3.5277716e-7,0.010686537,0.0006715479,1.9560925e-7,0.000045900906,0.00078759086,0.00005329622],"about_ca_topic_score_codex":0.25627467,"about_ca_topic_score_gemma":0.062535785,"teacher_disagreement_score":0.19373888,"about_ca_system_score_codex":0.00041347244,"about_ca_system_score_gemma":0.00017347562,"threshold_uncertainty_score":0.9545705},"labels":[],"label_agreement":null},{"id":"W2070984843","doi":"10.1016/j.jval.2013.08.1684","title":"Development of an Interviewer-Administered Version of the Asthma Control Questionnaire (ACQ-IA) for 6-10 Year Old Patients in 11 Languages","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Wheeze; Cognitive interview; Norwegian; Interview; Asthma; Medicine; Psychology; Cognition; Psychiatry; Linguistics; Political science","score_opus":0.02048521501703865,"score_gpt":0.3135804685956585,"score_spread":0.2930952535786199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070984843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982775,0.00022726858,0.00001849574,0.00037511336,0.0000883502,0.00096152886,0.00002066609,0.000006722933,0.000024389967],"genre_scores_gemma":[0.9987946,0.0000052957516,0.000713987,0.0003379171,0.000021393103,0.000040808696,0.00001582672,0.00000940283,0.00006077829],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989882,0.00014679394,0.00044003004,0.000121866746,0.00016319871,0.00013991857],"domain_scores_gemma":[0.99941653,0.000037527454,0.0001788597,0.00017203703,0.000110692425,0.000084356834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029141255,0.000073569434,0.00023606479,0.000083984676,0.000025363037,0.000002336151,0.00008106462,0.00004540856,0.000038388993],"category_scores_gemma":[0.00018149032,0.00004969865,0.000043012937,0.000109963075,0.000033976314,0.000043480835,0.00002291044,0.000053764266,0.0000051362067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005335731,0.0015593386,0.9085876,0.0027427985,0.000016032209,0.0000019349916,0.0043802136,0.00007963226,0.00033725798,0.000115858784,0.0007590351,0.08088675],"study_design_scores_gemma":[0.0031023936,0.0006516218,0.9905898,0.0016968047,0.000004361082,3.6368135e-7,0.0009001094,0.00051429303,0.0005581196,0.00001256323,0.0019181507,0.00005140344],"about_ca_topic_score_codex":0.0007741098,"about_ca_topic_score_gemma":0.00020255694,"teacher_disagreement_score":0.082002245,"about_ca_system_score_codex":0.000096541735,"about_ca_system_score_gemma":0.00033195838,"threshold_uncertainty_score":0.20266521},"labels":[],"label_agreement":null},{"id":"W2070989950","doi":"10.1016/s1098-3015(10)68992-9","title":"PGI10 INCORPORATING NON-ADHERENCE RESULTING FROM MULTIPLE DAILY DOSE REGIMENS INTO ECONOMIC MODELS: COST-UTILITY ANALYSIS OF ALTERNATIVE GASTROINTESTINAL PROPHYLAXIS STRATEGIES IN PREVENTING NSAID ASSOCIATED GASTROINTESTINAL COMPLICATIONS IN CANADA","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Intensive care medicine; Economic analysis; Economics","score_opus":0.05623047274190623,"score_gpt":0.3094703326098955,"score_spread":0.25323985986798925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2070989950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929344,0.000059109585,0.0050591496,0.00041685314,0.000055631932,0.0011632458,0.00017361842,0.000027913236,0.00011004526],"genre_scores_gemma":[0.97529006,0.000008781178,0.024305223,0.000082535626,0.000026049633,0.000060794355,0.0001999146,0.000023697361,0.0000029420005],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99509865,0.00057153136,0.0023714318,0.0007695259,0.00032264617,0.0008662417],"domain_scores_gemma":[0.99617094,0.0013996346,0.0014628933,0.00044095106,0.00026880595,0.00025676456],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027287225,0.0003359217,0.0011485881,0.0007988479,0.00011506256,0.000018021059,0.0002610156,0.00006566323,0.00000595311],"category_scores_gemma":[0.0017758294,0.0003684373,0.0000916373,0.0012759408,0.00016055604,0.00023800613,0.00015252497,0.001059388,0.0000011854613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003721348,0.00023597239,0.83126414,0.00007930908,0.00012920043,0.00007150543,0.001870667,0.16494802,0.0004608955,0.000015343427,0.0000038923736,0.00054891873],"study_design_scores_gemma":[0.0015943085,0.00035050645,0.5842542,0.001282308,0.00003559217,0.000011460414,0.00344429,0.40870556,0.000026404588,0.0002044706,1.6343331e-7,0.000090728056],"about_ca_topic_score_codex":0.97336215,"about_ca_topic_score_gemma":0.97891897,"teacher_disagreement_score":0.24700993,"about_ca_system_score_codex":0.0046278196,"about_ca_system_score_gemma":0.0033343602,"threshold_uncertainty_score":0.99987674},"labels":[],"label_agreement":null},{"id":"W2071460680","doi":"10.1111/j.1524-4733.2007.00278.x","title":"Evaluating Health-Related Quality of Life in Cancer Clinical Trials: The National Cancer Institute of Canada Clinical Trials Group Experience","year":2007,"lang":"en","type":"review","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Queen's University; Telus (Canada)","funders":"","keywords":"Concordance; Clinical trial; Quality of life (healthcare); Medicine; Protocol (science); Attrition; Cancer; Alternative medicine; Data quality; Missing data; Nursing; Operations management; Internal medicine; Pathology; Computer science","score_opus":0.8816006046583914,"score_gpt":0.7031660732317366,"score_spread":0.17843453142665477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071460680","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009902701,0.9736824,0.000013690252,0.0025180995,0.008584901,0.004616982,0.0005908119,0.000013572372,0.00007682222],"genre_scores_gemma":[0.005468858,0.9892949,0.00010988057,0.002752438,0.0015801644,0.0006002476,0.00009233763,0.000045283625,0.000055889144],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.85380226,0.08667538,0.05179128,0.0018251378,0.004440649,0.0014652724],"domain_scores_gemma":[0.95096225,0.033409405,0.013734197,0.0006779946,0.00054697145,0.00066916674],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2893006,0.0004656591,0.012360189,0.00034078248,0.000099733355,0.000008931547,0.00047663556,0.00068928156,0.0001981552],"category_scores_gemma":[0.08644347,0.00031327983,0.0012764799,0.0015849198,0.0003852253,0.00006642608,0.00009312278,0.0022315166,7.2207996e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008068741,0.00032896115,0.009636825,0.028481584,0.00029775806,0.000003881794,0.001271439,0.00033421573,6.5765214e-8,0.00044155825,0.0016600201,0.9567368],"study_design_scores_gemma":[0.009490764,0.0010212976,0.015296569,0.10280946,0.00041153617,0.000009374607,0.0010470565,0.0008396503,2.6818952e-7,0.0001322986,0.86828023,0.0006614961],"about_ca_topic_score_codex":0.97327286,"about_ca_topic_score_gemma":0.9215909,"teacher_disagreement_score":0.9560753,"about_ca_system_score_codex":0.0036110317,"about_ca_system_score_gemma":0.10569177,"threshold_uncertainty_score":0.99993193},"labels":[],"label_agreement":null},{"id":"W2071777263","doi":"10.1016/s1098-3015(10)64192-7","title":"PDB27: RISKING HEALTH TO AVOIDING INJECTIONS—STATED PREFERENCES OF TYPE 2 DIABETICS IN THE US AND CANADA","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Type (biology); Medicine; Business; Biology","score_opus":0.05050798770985763,"score_gpt":0.3116711660891891,"score_spread":0.26116317837933145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2071777263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939336,0.0006344053,0.000010175629,0.0039938954,0.0002626049,0.00046220695,0.0000016785322,0.0000051836187,0.00069625734],"genre_scores_gemma":[0.99771446,0.00036352105,0.00033893215,0.0015000529,0.000018437524,0.000008913772,0.0000061337046,0.0000051698494,0.0000444051],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99893093,0.00030413567,0.00028264237,0.000115323484,0.00014514127,0.00022184382],"domain_scores_gemma":[0.99954474,0.00015126314,0.00008846299,0.00011376888,0.000027925089,0.0000738183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014210246,0.00005680668,0.00016286728,0.00014901283,0.00006614659,0.000008303021,0.000039848455,0.000015886968,0.000006481819],"category_scores_gemma":[0.0003537518,0.000045587647,0.0000058386627,0.0005293723,0.000011297017,0.000025627653,0.000008000396,0.000142467,6.2218174e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015005658,0.000112319176,0.9787872,0.00068596425,0.0000084143985,9.071991e-7,0.0073896097,0.0020667268,0.000008167439,0.0012547747,0.0034004266,0.006270501],"study_design_scores_gemma":[0.0006549438,0.0007990304,0.9709423,0.00090148946,0.00001072652,0.0000024374676,0.009574491,0.0016660448,0.00006992255,0.00087923085,0.014380892,0.00011848022],"about_ca_topic_score_codex":0.7316807,"about_ca_topic_score_gemma":0.31941366,"teacher_disagreement_score":0.41226703,"about_ca_system_score_codex":0.00024848105,"about_ca_system_score_gemma":0.0010575252,"threshold_uncertainty_score":0.69300526},"labels":[],"label_agreement":null},{"id":"W2072633689","doi":"10.1016/j.jval.2013.08.1598","title":"Assessment of a Canadian Primary Care Electronic Medical Record Database for Use in Observational Studies","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada); AstraZeneca (Canada)","funders":"","keywords":"Observational study; Medicine; Medical prescription; Medical diagnosis; Family medicine; Population; Demographics; Medical record; Primary care; Electronic medical record; Health care; Pediatrics; Demography; Environmental health; Internal medicine","score_opus":0.5934330804911623,"score_gpt":0.5291985014007754,"score_spread":0.06423457909038688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2072633689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580317,0.0016220518,0.00062393403,0.032244332,0.0009839386,0.0050676176,0.00021194831,0.000037191472,0.0011772935],"genre_scores_gemma":[0.93016785,0.0067966073,0.024418555,0.034029312,0.00034224844,0.0025669965,0.0014311817,0.000033602762,0.00021366584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964124,0.00064684334,0.001439059,0.00018750624,0.00045285083,0.00086131826],"domain_scores_gemma":[0.99645835,0.0022408986,0.000319703,0.00020855365,0.00030442703,0.00046806803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004065218,0.00010354829,0.00041276994,0.0006293598,0.000273437,0.0000035866806,0.00014140113,0.00017156225,0.00017007234],"category_scores_gemma":[0.0020232832,0.00009236388,0.000026352945,0.0005115145,0.000036139085,0.00025168978,0.000041913754,0.00084018,0.000013675048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003937621,0.00007748728,0.88593996,0.019586936,0.00001557928,0.0000018783061,0.008525362,0.0002040941,0.000001795175,0.040718023,0.027671997,0.01721754],"study_design_scores_gemma":[0.002155581,0.0003492961,0.8874233,0.004940174,0.000003637787,6.369587e-7,0.00520146,0.038705446,3.1591097e-7,0.0012556014,0.059813157,0.00015140358],"about_ca_topic_score_codex":0.6290123,"about_ca_topic_score_gemma":0.582636,"teacher_disagreement_score":0.046376288,"about_ca_system_score_codex":0.0033270717,"about_ca_system_score_gemma":0.021721745,"threshold_uncertainty_score":0.9838242},"labels":[],"label_agreement":null},{"id":"W2073059673","doi":"10.1016/j.jval.2012.03.538","title":"PSY4 Prevalence of Autoimmune Diseases and Other Comorbidities in Patients With Psoriasis in the United States","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Psoriatic arthritis; Comorbidity; Ankylosing spondylitis; Psoriasis; Internal medicine; Rheumatoid arthritis; McNemar's test; Population; Immunology","score_opus":0.028100096501049172,"score_gpt":0.25833581647333254,"score_spread":0.23023571997228337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073059673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888967,0.010267808,9.485376e-7,0.00012671408,0.00013637797,0.0003627365,0.00017964318,0.000008662159,0.000020367319],"genre_scores_gemma":[0.9987299,0.00092148694,0.000026636195,0.00015368497,0.0000072734724,0.00003617416,0.000079848345,0.000008306341,0.00003672002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985324,0.0007449851,0.00027493393,0.00011887685,0.000040148487,0.00028861623],"domain_scores_gemma":[0.999365,0.00032470474,0.000113592425,0.00016755855,0.000014031452,0.000015141592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040596444,0.000111113644,0.0002178636,0.0001950929,0.000043216205,0.0000031727438,0.00010058853,0.000058573758,0.000034713215],"category_scores_gemma":[0.000028216491,0.000071071016,0.000015570948,0.00026783414,0.000114728806,0.00006579356,0.000019372197,0.00009294921,0.000004352266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026226486,0.00055915635,0.9906937,0.00017470871,0.00002064093,5.7111333e-7,0.006439475,0.00008104208,0.000008122032,0.0002992039,0.00003725965,0.0014238548],"study_design_scores_gemma":[0.002107464,0.00026263023,0.9958541,0.00019929663,0.00001578656,0.0000015046049,0.0007198321,0.000009029204,0.00004923535,0.00007053355,0.00063837157,0.00007223051],"about_ca_topic_score_codex":0.007869799,"about_ca_topic_score_gemma":0.00010343327,"teacher_disagreement_score":0.009833127,"about_ca_system_score_codex":0.000042686825,"about_ca_system_score_gemma":0.000041056854,"threshold_uncertainty_score":0.99873686},"labels":[],"label_agreement":null},{"id":"W2073148411","doi":"10.1016/s1098-3015(10)73421-5","title":"PMS46 PHYSICAL ACTIVITY IN CANADIAN ADULTS WITH ARTHRITIS: A POPULATION-BASED STUDY","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Physical activity; Medicine; Gerontology; Physical therapy","score_opus":0.012541118848318595,"score_gpt":0.3033424882101355,"score_spread":0.2908013693618169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073148411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923832,0.00008576039,0.0000056598597,0.0059669274,0.000024681789,0.001406404,0.0000036337049,0.000016651336,0.00010708501],"genre_scores_gemma":[0.9993739,0.0000057428288,0.00012300094,0.00040548007,0.000032248634,0.000029817864,0.000016513855,0.000007936962,0.000005336619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898183,0.0001553578,0.0001653732,0.00021999574,0.00018508396,0.00029236896],"domain_scores_gemma":[0.9995075,0.00005492537,0.000043370324,0.00015441282,0.000023487606,0.00021631626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002624181,0.0000905893,0.0002492698,0.00023221591,0.00004280409,0.0000052960886,0.000025584035,0.00003409203,0.0000061619603],"category_scores_gemma":[0.000074752024,0.00007451441,0.000028642595,0.00037972032,0.000010235187,0.00004806834,0.0000014690402,0.00017485188,0.0000028564527],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024090351,0.0019505769,0.944774,0.0001690707,0.0000025353047,0.000020082314,0.0021706258,0.0035245025,0.000004962361,0.0001245489,0.000008892716,0.04700934],"study_design_scores_gemma":[0.002860047,0.0026855466,0.97304666,0.00055239536,0.0000020067046,6.9060934e-7,0.00046011613,0.02017752,8.960698e-7,0.00013204673,0.000010924861,0.000071150884],"about_ca_topic_score_codex":0.8577485,"about_ca_topic_score_gemma":0.7608369,"teacher_disagreement_score":0.09691165,"about_ca_system_score_codex":0.00040556534,"about_ca_system_score_gemma":0.00070939935,"threshold_uncertainty_score":0.30386096},"labels":[],"label_agreement":null},{"id":"W2073289375","doi":"10.1016/j.jval.2014.03.713","title":"Impact Of Access To Transcatheter Aortic Valve Replacement On The Inoperable Aortic Stenosis Mortality In The Canadian Health Care System","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Medtronic (Canada)","funders":"","keywords":"Medicine; Population; Stenosis; Economic shortage; Health care; Aortic valve replacement; Aortic valve stenosis; Emergency medicine; Medical emergency; Intensive care medicine; Cardiology; Environmental health; Economic growth; Government (linguistics)","score_opus":0.13341399667018136,"score_gpt":0.34920080602151116,"score_spread":0.2157868093513298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073289375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96270496,0.00043278086,0.00009863123,0.031681392,0.00023581336,0.002217547,0.00018425004,0.00001234938,0.002432289],"genre_scores_gemma":[0.988789,0.0001103265,0.00002430747,0.0107830865,0.000053179447,0.00020333494,0.000009431253,0.000018789928,0.00000854239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968579,0.0005726735,0.001263691,0.00041209237,0.000118353,0.000775331],"domain_scores_gemma":[0.9983261,0.00016738492,0.00034894986,0.0008379945,0.000028777404,0.00029075966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005463126,0.00017606554,0.0005412851,0.00047250747,0.0002278407,0.0000764358,0.00054675527,0.00006263298,0.000023934108],"category_scores_gemma":[0.00013594862,0.00012725998,0.00018967204,0.00062355225,0.000023917386,0.000080370046,0.000031909614,0.00026681976,0.000038378977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042481166,0.00021710571,0.7001643,0.002028455,0.00010269754,7.2666273e-7,0.045143902,0.025282284,9.2471566e-8,0.22207755,0.0014145467,0.0035258394],"study_design_scores_gemma":[0.00036293795,0.000838292,0.9899561,0.0003240781,0.0000036691868,4.0728193e-7,0.001299117,0.004202707,0.0000012717215,0.00079922413,0.002046369,0.00016586052],"about_ca_topic_score_codex":0.9700817,"about_ca_topic_score_gemma":0.43799093,"teacher_disagreement_score":0.5320907,"about_ca_system_score_codex":0.0031508834,"about_ca_system_score_gemma":0.00062426424,"threshold_uncertainty_score":0.82394505},"labels":[],"label_agreement":null},{"id":"W2073345699","doi":"10.1016/s1098-3015(10)61453-2","title":"PES1 COST OF ILLNESS OF GLAUCOMA IN CANADA: ANALYSES BASED ON VISUAL FIELD MEASUREMENTS AND PHYSICIAN'S ASSESSMENT","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glaucoma; Optometry; Visual field; Ophthalmology; Medicine; Field (mathematics); Audiology; Mathematics","score_opus":0.07698847291706483,"score_gpt":0.3584319520229234,"score_spread":0.28144347910585854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073345699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99634373,0.00035784201,0.000032910946,0.0019657593,0.00006256369,0.0003781001,0.0000049309333,0.000002746223,0.0008513976],"genre_scores_gemma":[0.9987592,0.00006187006,0.00011235205,0.0010299939,0.000009751345,0.000008312513,0.000004347019,0.000007135998,0.000007045648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987197,0.00015168295,0.0003866076,0.00014849866,0.00039830428,0.00019523993],"domain_scores_gemma":[0.9994638,0.00015117579,0.00013865059,0.00012386648,0.000041493837,0.00008099489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025589002,0.000093833776,0.00038297073,0.00015890192,0.000020059864,0.0000014351398,0.000042513086,0.00003179832,0.00002729363],"category_scores_gemma":[0.00006153564,0.00007989958,0.000029783769,0.00027701675,0.00002429396,0.000015552016,0.000008922449,0.00013927055,2.4746893e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010308389,0.0005164651,0.98989624,0.00069258694,0.000014261573,0.000016050182,0.00016452509,0.00036889702,0.0004289665,0.000027135853,0.00022409325,0.0075476957],"study_design_scores_gemma":[0.0016236891,0.0007275576,0.92395794,0.0007962839,0.000013538355,0.0000011184593,0.0005632438,0.070824124,0.0013571313,0.000011297367,0.000052571526,0.00007151255],"about_ca_topic_score_codex":0.803887,"about_ca_topic_score_gemma":0.22752668,"teacher_disagreement_score":0.57636034,"about_ca_system_score_codex":0.00030999872,"about_ca_system_score_gemma":0.00064290216,"threshold_uncertainty_score":0.78656894},"labels":[],"label_agreement":null},{"id":"W2073444771","doi":"10.1016/j.jval.2014.03.113","title":"Use Of Economic Evidence To Inform Drug Reimbursement Decision Making: The Case For Ontario","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Formulary; Reimbursement; Logistic regression; Medicine; Evidence-based medicine; Actuarial science; Family medicine; Business; Alternative medicine; Economics; Economic growth; Health care","score_opus":0.6180299669526403,"score_gpt":0.479337443169149,"score_spread":0.13869252378349134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073444771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92781097,0.00079152046,0.013980763,0.052960165,0.001166273,0.00291619,0.00012628024,0.000021112788,0.00022674371],"genre_scores_gemma":[0.961141,0.00007330476,0.024362111,0.013604909,0.00018077601,0.00024906927,0.000005197322,0.000028898903,0.00035474962],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936341,0.00033552042,0.004957878,0.00050074514,0.00007850327,0.00049323874],"domain_scores_gemma":[0.98902714,0.0077355923,0.0021569042,0.0008393962,0.00005187627,0.00018910733],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.033899512,0.00017451578,0.0008623784,0.00039007256,0.00025095136,0.0000817634,0.0003467215,0.000076537355,0.00011955778],"category_scores_gemma":[0.005897607,0.00018253045,0.00011909932,0.00016507834,0.00003998441,0.00049858843,0.0000907736,0.00016629472,0.00032693497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002322455,0.00013879305,0.10860906,0.0015133807,0.000051653566,0.0000032633393,0.025199447,0.22227423,3.33669e-7,0.5256269,0.10689675,0.009453954],"study_design_scores_gemma":[0.0015436556,0.00086905045,0.055737056,0.002547948,0.000009988792,0.00007058729,0.001681401,0.23531236,0.0000062582103,0.073065415,0.6284133,0.00074296416],"about_ca_topic_score_codex":0.24248481,"about_ca_topic_score_gemma":0.12319788,"teacher_disagreement_score":0.52151656,"about_ca_system_score_codex":0.0031062467,"about_ca_system_score_gemma":0.0006930914,"threshold_uncertainty_score":0.9948038},"labels":[],"label_agreement":null},{"id":"W2073559015","doi":"10.1111/j.1524-4733.2007.00298.x","title":"The Role of Economic Evidence in Canadian Oncology Reimbursement Decision-Making: To Lambda and Beyond","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Regional Cancer Foundation; University of Alberta","funders":"","keywords":"Reimbursement; Transparency (behavior); Formulary; Context (archaeology); Actuarial science; Medicine; Public relations; Public economics; Political science; Psychology; Family medicine; Business; Economics; Law; Geography","score_opus":0.34604171872337475,"score_gpt":0.4530476766272725,"score_spread":0.10700595790389777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073559015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9131081,0.021104222,0.00005993158,0.06094514,0.00053522777,0.0011427267,0.00007437945,0.000008150698,0.0030221276],"genre_scores_gemma":[0.9874988,0.0035408437,0.002441441,0.006289785,0.00008179724,0.00008325384,0.0000015148773,0.000016663787,0.0000458547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9947312,0.0004805505,0.0036201666,0.00046068965,0.00006554934,0.00064187933],"domain_scores_gemma":[0.9941846,0.0039589205,0.0010148623,0.00043986985,0.000023336326,0.00037837768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021553723,0.00012828296,0.00075074466,0.00063691026,0.00022566943,0.000020475829,0.00029899576,0.000107127955,0.00005410484],"category_scores_gemma":[0.0036588758,0.00014703827,0.000039000864,0.00021844506,0.000083005056,0.00018292833,0.000058936213,0.00018340776,0.000278583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006919166,0.000068701396,0.70875144,0.00015967755,0.000017426632,0.000006553876,0.011737274,0.017782377,8.0431846e-7,0.24009442,0.007578239,0.013733888],"study_design_scores_gemma":[0.0010402778,0.00073902763,0.47544888,0.0012505313,0.0000019092565,0.00003807288,0.0039458717,0.049489792,0.0000039928404,0.123866275,0.34367278,0.00050260924],"about_ca_topic_score_codex":0.57234085,"about_ca_topic_score_gemma":0.5498485,"teacher_disagreement_score":0.33609453,"about_ca_system_score_codex":0.004385728,"about_ca_system_score_gemma":0.0026643348,"threshold_uncertainty_score":0.99943626},"labels":[],"label_agreement":null},{"id":"W2073646785","doi":"10.1016/j.jval.2012.08.387","title":"PIN18 Antimicrobial Resistance (AMR) in Thailand: A Systematic Review","year":2012,"lang":"en","type":"review","venue":"Value in Health","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Antibiotic resistance; CLARITY; Epidemiology; Intensive care medicine; Environmental health; Health care; Economic growth; Pathology; Antibiotics","score_opus":0.06234755627801146,"score_gpt":0.32160753529680125,"score_spread":0.2592599790187898,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073646785","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003224836,0.9941246,0.0000061702885,0.00022520711,0.0009427161,0.0040892456,0.00008521583,0.00004499872,0.00047865516],"genre_scores_gemma":[0.000038059603,0.9947853,0.00006244406,0.00056031084,0.000057393576,0.000095540585,0.00017675437,0.00006123487,0.0041629397],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9925811,0.0031836503,0.0025537417,0.0006094436,0.00007335859,0.0009987014],"domain_scores_gemma":[0.9973069,0.0004712434,0.0012846363,0.0008528809,0.000027444465,0.000056891422],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0027892676,0.00056250935,0.0052989954,0.00036724162,0.00010323304,0.000011766996,0.00058629643,0.00067701703,0.00008032093],"category_scores_gemma":[0.00020714938,0.00041246566,0.00040670694,0.0007031342,0.000121654484,0.000067709865,0.00009466892,0.0011076849,0.0010432544],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008317947,0.00012847794,0.0000129956925,0.9936147,0.000080803366,0.000019738349,0.000109383654,2.2961869e-7,4.0082568e-7,0.000380901,0.0035304145,0.0021136885],"study_design_scores_gemma":[0.0001879405,0.000016239315,0.000003229261,0.6048177,0.00024424895,0.0000658143,0.000008115073,7.020997e-8,3.3131317e-7,0.000006540339,0.3944117,0.00023807176],"about_ca_topic_score_codex":0.00070387515,"about_ca_topic_score_gemma":0.00039961952,"teacher_disagreement_score":0.3908813,"about_ca_system_score_codex":0.00044814672,"about_ca_system_score_gemma":0.0008544111,"threshold_uncertainty_score":0.9998327},"labels":[],"label_agreement":null},{"id":"W2073702283","doi":"10.1016/j.jval.2013.03.1142","title":"Cost-Utility Analysis Of Tocilizumab In The Treatment Of Active Systemic Juvenile Idiopathic Arthritis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Tocilizumab; Medicine; Methotrexate; Internal medicine; Arthritis; Placebo; Indirect costs; Physical therapy; Rheumatoid arthritis; Alternative medicine","score_opus":0.14257477856525244,"score_gpt":0.4194890069655089,"score_spread":0.2769142284002565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073702283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98496544,0.008056029,0.000039533923,0.0019734728,0.00021366686,0.0043586367,0.00017925633,0.000016284013,0.00019768062],"genre_scores_gemma":[0.9944037,0.00458991,0.0000369181,0.00029537547,0.000096101816,0.0005107334,0.000030315046,0.000010873364,0.000026079955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99263823,0.0042049265,0.0019212178,0.00029408248,0.00034746007,0.00059410447],"domain_scores_gemma":[0.99724275,0.0011049529,0.000809451,0.0005337045,0.00017059874,0.00013855063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00239678,0.00016288004,0.00111075,0.00046476233,0.00016677791,0.0000023822618,0.00019009494,0.0002153668,0.00015364651],"category_scores_gemma":[0.00018750479,0.000116915755,0.00015911857,0.0016627216,0.000047567293,0.000072444745,0.000021515956,0.0004499176,0.000028989409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001223969,0.0006191528,0.8508445,0.0022456495,0.000056310746,0.0000045846587,0.08312692,0.00044767495,0.000003887162,0.0002970662,0.00022646693,0.062005375],"study_design_scores_gemma":[0.0025449647,0.0007773679,0.9493534,0.0016063653,0.000073678486,0.0000014817166,0.036983863,0.0073950184,0.000006636505,0.0003553313,0.0007604477,0.0001414622],"about_ca_topic_score_codex":0.19891357,"about_ca_topic_score_gemma":0.014303518,"teacher_disagreement_score":0.18461005,"about_ca_system_score_codex":0.0010830647,"about_ca_system_score_gemma":0.0015505166,"threshold_uncertainty_score":0.8064209},"labels":[],"label_agreement":null},{"id":"W2073777169","doi":"10.1016/s1098-3015(10)63610-8","title":"PAA8 A COMPARISON OF CLAIMS RATIO BETWEEN PRIMARY AND SECONDARY DRUGS IN THE MANAGEMENT OF ASTHMA. A CANADIAN ANALYSIS","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Primary (astronomy); Asthma; Asthma management; Medicine; Family medicine; Internal medicine; Physics","score_opus":0.02109791865848181,"score_gpt":0.3012188155261278,"score_spread":0.28012089686764596,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073777169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943284,0.002723062,0.000030488509,0.0010249572,0.000011178236,0.0004345711,0.000042971937,0.0000035436603,0.0014008578],"genre_scores_gemma":[0.9992319,0.00004749665,0.00024387412,0.0003430676,0.000027511647,0.000009840694,0.00006398794,0.0000054632214,0.000026859701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987322,0.00018748996,0.00053578854,0.0001449407,0.00020821874,0.00019136914],"domain_scores_gemma":[0.999469,0.000070986396,0.0001411361,0.00019278118,0.000019059125,0.00010705174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005640417,0.00007856353,0.0004407242,0.000418356,0.000035392786,0.000003988786,0.000065526416,0.000039570245,0.000015463227],"category_scores_gemma":[0.0000028453087,0.000058349124,0.00005712614,0.0006758542,0.000060897644,0.000023542745,0.000014095222,0.00012810277,5.646143e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028167382,0.00014048006,0.9797512,0.0010714384,0.00007542405,0.0000144234455,0.0014048456,0.00067816646,0.0000041991225,0.00041343778,0.0002757581,0.016142441],"study_design_scores_gemma":[0.000656496,0.00014130319,0.9948152,0.00017731228,0.00009076807,5.6759825e-7,0.0017375706,0.0007498985,0.00001283894,0.000073541065,0.001499604,0.000044901677],"about_ca_topic_score_codex":0.18060406,"about_ca_topic_score_gemma":0.030505175,"teacher_disagreement_score":0.15009889,"about_ca_system_score_codex":0.00012811631,"about_ca_system_score_gemma":0.0004760332,"threshold_uncertainty_score":0.9871856},"labels":[],"label_agreement":null},{"id":"W2073893218","doi":"10.1016/j.jval.2011.08.1494","title":"PSS29 Treatment Patterns of Psoriasis Patients and Trends Over Time","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Psoriasis; Medicine; Body mass index; Psoriasis Area and Severity Index; Population; Dermatology; Internal medicine; Body surface area; Retrospective cohort study","score_opus":0.03972298619910637,"score_gpt":0.25619942129535445,"score_spread":0.2164764350962481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073893218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972688,0.0013617096,0.0000017965522,0.000039058265,0.00032197294,0.00016760961,0.0001953919,0.000020931846,0.000622717],"genre_scores_gemma":[0.99785477,0.0006648778,0.00009113482,0.00004318406,0.000013641077,0.000023259501,0.00011945409,0.000012952285,0.0011767239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988579,0.00025788264,0.0003386303,0.00023823434,0.000027761636,0.00027956066],"domain_scores_gemma":[0.9995463,0.00006994851,0.00014795958,0.0001861679,0.00001536311,0.000034282093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013396244,0.00015862334,0.00034045597,0.00019774436,0.000052509797,0.0000019133804,0.00006636666,0.00012444018,0.0006518639],"category_scores_gemma":[0.000008238338,0.00012705296,0.00006238136,0.00010904703,0.000036498794,0.000042422063,0.000023861172,0.000047855516,0.00006290784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025294579,0.00096682756,0.75711185,0.000037010075,0.00015216669,0.00000368291,0.0035780563,0.0000014942915,0.00030156894,0.00020914446,0.00015583399,0.23722944],"study_design_scores_gemma":[0.004003467,0.0015063991,0.9887239,0.00005126401,0.00004294396,0.0000045601537,0.000040149982,0.0000055583273,0.004270703,0.00006869707,0.0011602644,0.00012213526],"about_ca_topic_score_codex":0.010111196,"about_ca_topic_score_gemma":0.00010740152,"teacher_disagreement_score":0.2371073,"about_ca_system_score_codex":0.000094553696,"about_ca_system_score_gemma":0.000037580015,"threshold_uncertainty_score":0.9964806},"labels":[],"label_agreement":null},{"id":"W2073944554","doi":"10.1016/j.jval.2014.08.2598","title":"The Costs of Diagnosis and Treatment of Ankle Sprains and Fractures, 1980-2013: A Systematic Review","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Foot and Ankle Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Ankle; CINAHL; MEDLINE; Ankle sprain; Psychological intervention; Physical therapy; Systematic review; Surgery","score_opus":0.08916200535843594,"score_gpt":0.38326918283172184,"score_spread":0.2941071774732859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073944554","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000118386604,0.99420977,4.0570157e-7,0.0008087037,0.00009262015,0.004686275,0.00003920718,0.0000067920987,0.000037848113],"genre_scores_gemma":[0.00024282235,0.9990007,0.000026764072,0.00018430062,0.000061173225,0.00038930855,0.00002574558,0.000025841358,0.00004330486],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9969889,0.0008659458,0.0014668552,0.00023647846,0.00021944921,0.00022240297],"domain_scores_gemma":[0.9955794,0.0026868044,0.0010676021,0.00048161848,0.000041623694,0.00014291256],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017413298,0.00027116266,0.004310991,0.00013493527,0.000044565473,0.0000062380677,0.00006469183,0.00012536795,0.0000036285185],"category_scores_gemma":[0.00065655477,0.00013508057,0.0002496562,0.00020812821,0.00009699038,0.000013146413,0.000024527422,0.0001417899,0.0000019483596],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000034333202,0.00007637386,0.00017783754,0.7416772,0.000081185986,0.000004111371,0.000051776067,3.975256e-8,4.8539253e-9,0.00011940649,0.00031478787,0.25749382],"study_design_scores_gemma":[0.00017352006,0.00039230043,0.00005429003,0.64319843,0.0006357687,0.00003356763,0.000007829533,0.0000046675955,1.2157274e-7,0.0000068724094,0.3554273,0.000065379376],"about_ca_topic_score_codex":0.0020056544,"about_ca_topic_score_gemma":0.0000951585,"teacher_disagreement_score":0.3551125,"about_ca_system_score_codex":0.00017103222,"about_ca_system_score_gemma":0.00040436353,"threshold_uncertainty_score":0.5508426},"labels":[],"label_agreement":null},{"id":"W2073954775","doi":"10.1016/j.jval.2014.03.018","title":"Real-World Cost Effectiveness Of The Mitraclip For The Treatment Of High-Risk Mitral Regurgitation","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute","funders":"","keywords":"MitraClip; Medicine; Mitral regurgitation; Heart failure; Mitral valve repair; Cardiology; Internal medicine; Surgery; Emergency medicine","score_opus":0.03276416190139207,"score_gpt":0.3755307631934019,"score_spread":0.3427666012920098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2073954775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955011,0.0007696179,0.00009880392,0.00039126957,0.000297188,0.002674996,0.00014951937,0.000007702542,0.000109817025],"genre_scores_gemma":[0.99857247,0.0008384961,0.0001443361,0.000032764612,0.000071887,0.00022770379,0.00003550269,0.000014313034,0.00006250545],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998795,0.00042737857,0.00029514727,0.00015428758,0.00016165909,0.0001665268],"domain_scores_gemma":[0.9975435,0.0017440817,0.00022182353,0.00036151192,0.00006788419,0.00006118729],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005571044,0.00010111259,0.00036784096,0.000057053832,0.00006810374,0.0000029049845,0.000046257293,0.0000280625,0.0000024349588],"category_scores_gemma":[0.00011089338,0.000053035266,0.0006473089,0.00019288978,0.000056293648,0.000015929098,0.0000056880235,0.000040475137,8.745555e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015527841,0.0010327058,0.95538265,0.00082092435,0.0005056801,3.4756258e-7,0.0004316643,0.0034789823,0.0000306056,0.0041156095,0.000049386297,0.032598644],"study_design_scores_gemma":[0.004812923,0.0012195241,0.9899296,0.00032674268,0.0004245776,5.7116114e-7,0.000046829326,0.00084674335,0.0008089137,0.0012326055,0.0003138719,0.00003709403],"about_ca_topic_score_codex":0.03528215,"about_ca_topic_score_gemma":0.00020551143,"teacher_disagreement_score":0.03507664,"about_ca_system_score_codex":0.00029417998,"about_ca_system_score_gemma":0.00016426381,"threshold_uncertainty_score":0.971142},"labels":[],"label_agreement":null},{"id":"W2074096414","doi":"10.1016/j.jval.2013.08.589","title":"Stage-Based Utilization of Chemotherapy Agents in a Canadian Breast Cancer Population","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cancer Care Ontario; Ontario Institute for Cancer Research; Princess Margaret Cancer Centre; University of Toronto; University Health Network; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Epirubicin; Medicine; Docetaxel; Breast cancer; Cyclophosphamide; Population; Chemotherapy; Internal medicine; Doxorubicin; Cancer; Stage (stratigraphy); Oncology; Regimen; Surgery","score_opus":0.09369422543786671,"score_gpt":0.40639499045647415,"score_spread":0.31270076501860744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074096414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898923,0.00028238122,0.0000036903605,0.008830184,0.00010504691,0.00073769933,0.00003741313,0.000006741427,0.00010454825],"genre_scores_gemma":[0.9971222,0.00023733392,0.00006537334,0.002264568,0.00003408469,0.000059997423,0.000065772176,0.000009608417,0.00014106269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993252,0.00006176554,0.00022128997,0.000105176005,0.00007758544,0.00020896205],"domain_scores_gemma":[0.9996751,0.000015610705,0.0000699576,0.000071883966,0.000028696602,0.00013875535],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00012704717,0.000058449667,0.00016256346,0.00018898211,0.0000144606765,0.0000020827497,0.000021688586,0.000042082524,0.0014163668],"category_scores_gemma":[0.000004442836,0.000056052588,0.00001646105,0.00025939223,0.000009961702,0.00003295958,0.0000015099679,0.000057699424,0.0000036744711],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005437866,0.00011725618,0.9847544,0.00016762802,0.000005712613,0.0000020143948,0.00029332977,0.0029068624,0.000051706505,0.000026161153,0.00052014244,0.011100419],"study_design_scores_gemma":[0.0022382843,0.00008811032,0.9679942,0.00014076286,0.0000031939114,9.34423e-7,0.000012736634,0.02863262,0.00006727648,0.000024237543,0.00076322583,0.000034391218],"about_ca_topic_score_codex":0.9911357,"about_ca_topic_score_gemma":0.61894906,"teacher_disagreement_score":0.37218666,"about_ca_system_score_codex":0.0011117824,"about_ca_system_score_gemma":0.00092663005,"threshold_uncertainty_score":0.99949646},"labels":[],"label_agreement":null},{"id":"W2074289341","doi":"10.1111/j.1524-4733.2009.00510.x","title":"The Impact of Two Pharmaceutical Risk-Sharing Agreements on Pricing, Promotion, and Net Health Benefits","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Ontario Ministry of Research and Innovation; Organisation de Coopération et de Développement Économiques","keywords":"Business; Formulary; Actuarial science; Cost sharing; Risk management; Promotion (chess); Risk analysis (engineering); Finance; Medicine","score_opus":0.47412836305372663,"score_gpt":0.5044659273780143,"score_spread":0.03033756432428769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074289341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93841183,0.008520146,0.00025576795,0.050462183,0.00025221787,0.0014365041,0.0001586426,0.000029004665,0.00047372578],"genre_scores_gemma":[0.99203956,0.0033353772,0.000589357,0.003783142,0.00015557914,0.000022595019,0.0000118328635,0.000018827495,0.000043732347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941467,0.000701894,0.0038238417,0.00052439456,0.00012780339,0.0006753816],"domain_scores_gemma":[0.99567026,0.0007276433,0.002783839,0.00045001504,0.000036312857,0.00033191903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026191423,0.00019062604,0.0008222473,0.00029666873,0.00038633824,0.000055609806,0.00024174618,0.0000628706,0.000032607928],"category_scores_gemma":[0.0013412457,0.00018046635,0.00008719814,0.00027979127,0.000049571277,0.00018306487,0.00003819721,0.00033427408,0.00006998205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060196147,0.0005606214,0.747084,0.000498924,0.00006408588,6.42532e-7,0.004034402,0.044292342,6.533415e-7,0.18058774,0.0041895504,0.018626822],"study_design_scores_gemma":[0.002165082,0.0017193478,0.8156923,0.0005473914,0.000002333475,0.0000070062906,0.00015672445,0.13915066,0.0000032003231,0.03904402,0.0012593624,0.00025256287],"about_ca_topic_score_codex":0.020141887,"about_ca_topic_score_gemma":0.00017753139,"teacher_disagreement_score":0.14154372,"about_ca_system_score_codex":0.0012738018,"about_ca_system_score_gemma":0.00036127047,"threshold_uncertainty_score":0.9863831},"labels":[],"label_agreement":null},{"id":"W2074469810","doi":"10.1016/j.jval.2012.08.1742","title":"PSY19 A Cost-Consequence Analysis of Patient Self-Management Versus Physician-Managed Monitoring of Long-Term Oral Anticoagulation Therapy in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Medicine; Context (archaeology); Pharmacist; Health care; Quality of life (healthcare); Perspective (graphical); Pharmacy; Family medicine; Nursing","score_opus":0.04092273519297076,"score_gpt":0.3086628603900941,"score_spread":0.26774012519712337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074469810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945225,0.0044702007,0.000059058577,0.000044044667,0.00019851945,0.00065415807,0.00000622361,0.000009804395,0.000035459892],"genre_scores_gemma":[0.9968583,0.0027528496,0.00023761872,0.00007280503,0.000026908529,0.000020853551,0.000018959385,0.000010560644,0.0000011178533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998459,0.0002264264,0.00045765613,0.00016244703,0.00040193452,0.00029254332],"domain_scores_gemma":[0.9992912,0.00007616646,0.00019910082,0.0002950965,0.000040995794,0.000097437485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038480532,0.000114869865,0.00054488715,0.00031468074,0.000023239027,0.0000024048977,0.00006350131,0.000027562312,0.0000061504475],"category_scores_gemma":[0.000010249565,0.00010974148,0.00015394279,0.00096846634,0.000023172119,0.00007337392,0.000014155637,0.00008590403,3.638136e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005499227,0.00032756475,0.92063105,0.00028717273,0.001349759,0.000043663596,0.00073239015,0.015317647,0.000051615894,0.000043657506,0.0000017309127,0.060663853],"study_design_scores_gemma":[0.00234453,0.00015243114,0.9940769,0.000275065,0.00029358588,0.0000011393603,0.0005809884,0.0012531286,0.00091596326,0.0000037586508,0.00001674902,0.000085748215],"about_ca_topic_score_codex":0.35663775,"about_ca_topic_score_gemma":0.018640617,"teacher_disagreement_score":0.33799714,"about_ca_system_score_codex":0.00059165293,"about_ca_system_score_gemma":0.00034716178,"threshold_uncertainty_score":0.9992666},"labels":[],"label_agreement":null},{"id":"W2074540431","doi":"10.1046/j.1524-4733.2001.40202-231.x","title":"PPN9: HOW IS PAIN FELT ACROSS COUNTRIES? THE SHORT-FORM MCGILL PAIN QUESTIONNAIRE (SF-MPQ) IN 10 LANGUAGES","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"McGill Pain Questionnaire; Psychology; Medicine; Physical therapy","score_opus":0.025725501928478094,"score_gpt":0.34005244138416124,"score_spread":0.31432693945568313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2074540431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8822059,0.0028798794,0.00020312445,0.11266517,0.00015761502,0.0013719783,0.000030192867,0.000093876624,0.00039227112],"genre_scores_gemma":[0.9876099,0.00082671875,0.00019672136,0.009979596,0.00019191271,0.00007449051,0.000034269167,0.000027240341,0.0010591046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692786,0.0012935818,0.0004842813,0.00033288033,0.00040039213,0.00056101556],"domain_scores_gemma":[0.9984296,0.00081344624,0.00010026697,0.00041642142,0.00008222399,0.00015802267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009561451,0.00018867143,0.00034957766,0.00012406157,0.00019814869,0.000024537867,0.00012247362,0.00015900785,0.00007739552],"category_scores_gemma":[0.001933863,0.0001296555,0.0000971805,0.00052886445,0.00014169315,0.00010424425,0.000027147964,0.0003909519,0.000023680266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003597094,0.00060930266,0.711393,0.006185556,0.000040161027,0.00008271341,0.021837963,0.0004487029,0.00016228636,0.0019579257,0.01887382,0.23804888],"study_design_scores_gemma":[0.0020528114,0.0016257681,0.8269099,0.0038755608,0.000010077511,0.000028721219,0.01459205,0.022603236,0.000047208676,0.0012764505,0.12654205,0.00043614054],"about_ca_topic_score_codex":0.0064458377,"about_ca_topic_score_gemma":0.0019687475,"teacher_disagreement_score":0.23761274,"about_ca_system_score_codex":0.00051316543,"about_ca_system_score_gemma":0.00017473995,"threshold_uncertainty_score":0.9744221},"labels":[],"label_agreement":null},{"id":"W2075000311","doi":"10.1016/j.jval.2013.08.921","title":"Analysis of Transparency Amongst International Health Technology Assessment Organizations","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); University of Toronto","funders":"","keywords":"Transparency (behavior); Excellence; Reimbursement; Health technology; Accounting; Medicine; Delphi method; Stakeholder; Health care; Political science; Business; Family medicine; Public administration; Public relations","score_opus":0.2629132221712331,"score_gpt":0.43963578407233767,"score_spread":0.17672256190110458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075000311","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3809179,0.0029365688,0.046893425,0.5623943,0.0013142043,0.0020704935,0.0008036509,0.00013293697,0.0025364982],"genre_scores_gemma":[0.984537,0.0007092916,0.0091736475,0.005068278,0.0000744401,0.00012640368,0.00016021427,0.000023443765,0.00012726198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99305576,0.0003642351,0.0055401553,0.0004915736,0.00012358747,0.00042471057],"domain_scores_gemma":[0.99599695,0.00036618294,0.0028136924,0.000496423,0.00014738437,0.00017934658],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008258389,0.00014586946,0.0012513394,0.0024106083,0.00012173401,0.000031808646,0.000389982,0.00012261611,0.0014511987],"category_scores_gemma":[0.0009951398,0.0001921937,0.00009449888,0.002656509,0.00006946673,0.0003033509,0.000036917085,0.00021294152,0.00025445793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[9.643223e-7,0.0002039107,0.7683493,0.00021301061,0.00020206602,1.0623521e-7,0.0016776643,0.016166998,0.0000010183533,0.21014103,0.0025870006,0.0004569203],"study_design_scores_gemma":[0.0006019858,0.00014208039,0.80700326,0.00012256615,0.000011536792,0.0000012456052,0.0021102722,0.17168936,0.0000012147207,0.012606087,0.0054781344,0.00023225315],"about_ca_topic_score_codex":0.03698696,"about_ca_topic_score_gemma":0.000892544,"teacher_disagreement_score":0.6036191,"about_ca_system_score_codex":0.0013826209,"about_ca_system_score_gemma":0.00077143597,"threshold_uncertainty_score":0.9994616},"labels":[],"label_agreement":null},{"id":"W2075229705","doi":"10.1016/j.jval.2013.03.443","title":"Discriminative Ability Of The Sf-12 In Kiswahili By Hiv Stage In Patients In Kenya","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Linguistics and Cultural Studies","field":"Arts and Humanities","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of British Columbia","funders":"","keywords":"Viral load; Kenya; Medicine; Internal medicine; Population; Human immunodeficiency virus (HIV); Immunology; Biology; Environmental health","score_opus":0.05185623428332612,"score_gpt":0.25490239113841134,"score_spread":0.20304615685508523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075229705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928059,0.0001931666,8.880339e-8,0.0011116762,0.00020024827,0.00055901037,0.00008206776,0.0000037104696,0.0050441213],"genre_scores_gemma":[0.9991457,0.000056463217,0.000006837518,0.00016680654,0.000027194854,0.000032551794,0.000007716479,0.0000052539735,0.00055147975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987994,0.00019220744,0.00046784748,0.00015706471,0.00014846289,0.00023505579],"domain_scores_gemma":[0.99958044,0.00009865447,0.00011688357,0.00012101758,0.000058058547,0.000024938852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003288123,0.00009506722,0.00022619349,0.000047459576,0.00006843991,0.000018866585,0.00012286732,0.000023767268,0.00012403108],"category_scores_gemma":[0.00022176257,0.000058942194,0.000026966785,0.000063667845,0.00014392317,0.00006274998,0.000070873095,0.00017920675,0.0000052084392],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012507549,0.00051124726,0.8101312,0.00020451716,0.0000030287322,3.3963e-7,0.15650561,0.00009597485,0.0000017170936,0.030369803,0.0013359843,0.000828101],"study_design_scores_gemma":[0.0006634913,0.00009501702,0.9740257,0.00020188768,8.1756303e-7,8.509224e-9,0.012306705,0.0003083689,0.000007840444,0.0065133055,0.0057803197,0.00009652926],"about_ca_topic_score_codex":0.1306973,"about_ca_topic_score_gemma":0.043539662,"teacher_disagreement_score":0.16389455,"about_ca_system_score_codex":0.0002114755,"about_ca_system_score_gemma":0.000034415127,"threshold_uncertainty_score":0.97391325},"labels":[],"label_agreement":null},{"id":"W2075638718","doi":"10.1016/j.jval.2014.08.2164","title":"Overall Survival in Patients with HER2+ Early Stage Breast Cancer Patients Treated with Trastuzumab in the US Department of Defense Practice Setting","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Trastuzumab; Medicine; Adjuvant; Internal medicine; Breast cancer; Oncology; Stage (stratigraphy); Adjuvant therapy; Cancer; Clinical trial; Clinical Practice; Surgery; Physical therapy","score_opus":0.026365130467483195,"score_gpt":0.33172896818348613,"score_spread":0.30536383771600295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075638718","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590534,0.00006044731,0.0000047852336,0.0012786327,0.000045113717,0.0021781845,0.00015235772,0.000013558588,0.0003615511],"genre_scores_gemma":[0.99880016,0.00006326079,0.00024164663,0.0005997927,0.000033979733,0.00014615514,0.000052187912,0.000044473632,0.000018342407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956364,0.0014362816,0.0006301238,0.00040497255,0.0012182851,0.0006739529],"domain_scores_gemma":[0.9983365,0.0005361681,0.0003168011,0.0004004512,0.00024447098,0.0001656092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002053138,0.0002165864,0.0004838654,0.00022986442,0.000049494123,0.000019246841,0.00015883349,0.00007230056,0.000022480242],"category_scores_gemma":[0.00022200287,0.00013885362,0.000026189304,0.0006836049,0.00007546844,0.0001521513,0.000031673408,0.0005727801,0.0000028563315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003531314,0.0015776441,0.9868777,0.0004098811,0.000026655733,0.000024518013,0.0029967998,0.0018492157,9.849385e-7,0.000030179186,0.000036630514,0.0026385188],"study_design_scores_gemma":[0.009126879,0.0038949086,0.98452485,0.0011232103,0.000014538154,0.000004110654,0.00026722593,0.00051837065,0.000009715808,0.0000036934834,0.0003842884,0.00012821356],"about_ca_topic_score_codex":0.15105693,"about_ca_topic_score_gemma":0.00952634,"teacher_disagreement_score":0.14153059,"about_ca_system_score_codex":0.0014059958,"about_ca_system_score_gemma":0.0009133293,"threshold_uncertainty_score":0.85459626},"labels":[],"label_agreement":null},{"id":"W2075738853","doi":"10.1016/j.jval.2013.01.009","title":"Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":151,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Apixaban; Dabigatran; Medicine; Rivaroxaban; Warfarin; Atrial fibrillation; Cost effectiveness; Stroke (engine); Quality-adjusted life year; Internal medicine; Anesthesia","score_opus":0.10777609511540608,"score_gpt":0.34251584165148924,"score_spread":0.23473974653608315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075738853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995882,0.00024253743,0.00019049685,0.000066807916,0.000053343723,0.0035220946,0.0000032308023,0.000010617597,0.000028901268],"genre_scores_gemma":[0.9989966,0.000016465709,0.0008350308,0.000011586136,0.000066819906,0.0000027692445,0.00001800039,0.000017115615,0.00003556885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983979,0.00039143462,0.00042205135,0.00022938328,0.0003300901,0.00022916972],"domain_scores_gemma":[0.99944264,0.00012580109,0.0001590802,0.0001626161,0.0000373036,0.000072584204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008526043,0.00012658769,0.00065677584,0.0002602215,0.000018675162,0.00000656348,0.000032543154,0.000046834462,0.000010058335],"category_scores_gemma":[0.00005673841,0.00009822235,0.00006222607,0.00031839212,0.000019140316,0.0001265404,0.000026760335,0.000083374085,0.000002049595],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010936458,0.000012285762,0.9519964,0.000404429,0.000090330046,8.3560616e-7,0.0002362615,0.041523974,0.0000027260896,0.000014910466,0.0000015684415,0.004622664],"study_design_scores_gemma":[0.014118823,0.0003289775,0.9801408,0.0009837577,0.000032490603,7.35411e-7,0.000058155685,0.004100861,0.000012414495,0.000033157838,0.0000991315,0.00009071245],"about_ca_topic_score_codex":0.018621735,"about_ca_topic_score_gemma":0.00020266179,"teacher_disagreement_score":0.037423115,"about_ca_system_score_codex":0.00013363504,"about_ca_system_score_gemma":0.00010916032,"threshold_uncertainty_score":0.98791337},"labels":[],"label_agreement":null},{"id":"W2076434268","doi":"10.1016/j.jval.2013.03.1595","title":"Evaluation of health related quality of life outcomes among patients with schizophrenia switched to lurasidone from other antipsychotics","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Lurasidone; Quality of life (healthcare); Psychosocial; Schizophrenia (object-oriented programming); Medicine; Clinical endpoint; Antipsychotic; Psychiatry; Psychology; Internal medicine; Clinical trial","score_opus":0.09874209941898587,"score_gpt":0.3699057994241986,"score_spread":0.2711637000052127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076434268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919673,0.0005251744,0.00004929464,0.0039966265,0.000087733446,0.0032590074,0.000060709524,0.000024439863,0.000029666062],"genre_scores_gemma":[0.99279475,0.0000293983,0.0067018815,0.00027906484,0.000014706582,0.000069722875,0.00006940486,0.000030232348,0.000010817791],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99492764,0.001246195,0.0014111159,0.00035041617,0.0016638536,0.0004008002],"domain_scores_gemma":[0.99734396,0.00029050678,0.00067872903,0.00057311385,0.00063058763,0.0004830912],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033118152,0.00018762123,0.000942988,0.00029551965,0.00004929963,0.0000075204503,0.00010241989,0.00008206839,0.00018717833],"category_scores_gemma":[0.001014526,0.00013366889,0.00007103512,0.0005486178,0.0000681918,0.00008570941,0.00002538223,0.0002143819,0.000030301133],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035663473,0.0011029786,0.98237896,0.00017681994,0.00020356926,3.0966365e-7,0.0007189426,0.0004408434,0.00001990065,0.0001110739,0.00006989997,0.011210345],"study_design_scores_gemma":[0.017158605,0.0012708744,0.9779783,0.0005254464,0.00003016003,1.5362978e-7,0.00013537923,0.0014937406,0.00004547818,0.001268279,9.711292e-7,0.00009259965],"about_ca_topic_score_codex":0.11698345,"about_ca_topic_score_gemma":0.002089149,"teacher_disagreement_score":0.1148943,"about_ca_system_score_codex":0.0004283111,"about_ca_system_score_gemma":0.0017903346,"threshold_uncertainty_score":0.88889664},"labels":[],"label_agreement":null},{"id":"W2076572084","doi":"10.1016/s1098-3015(10)74873-7","title":"PSY30 COST-UTILITY OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) COMPARED WITH CORTICOSTEROIDS FOR THE TREATMENT OF CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY (CIDP) IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Intramuscular injections and effects","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic inflammatory demyelinating polyneuropathy; Medicine; Guillain-Barre syndrome; Antibody; Intravenous Immunoglobulins; Polyneuropathy; Polyradiculoneuropathy; Immunology; Internal medicine","score_opus":0.022655251409575347,"score_gpt":0.2752466484121199,"score_spread":0.2525913970025445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076572084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395156,0.0027002115,0.00036686883,0.00056209665,0.00012649802,0.0022382787,0.00002004348,0.000008275099,0.000026154203],"genre_scores_gemma":[0.9991838,0.00034502588,0.00020202866,0.00013607525,0.000047517166,0.000059344115,0.0000102413105,0.000012385381,0.0000036167246],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983914,0.00017815625,0.0006648138,0.00018477584,0.0002022573,0.00037862003],"domain_scores_gemma":[0.99899024,0.00030025243,0.00023632403,0.00032205626,0.00008010993,0.000071016475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000495244,0.00014049791,0.00047763728,0.000091389185,0.00006599548,0.000003289297,0.000072075956,0.00003716876,0.000005498195],"category_scores_gemma":[0.000060559272,0.00009599986,0.000054715583,0.00025468392,0.000052052386,0.000020586069,0.000005511715,0.00015275655,2.1023683e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046074716,0.003766052,0.24361292,0.002869719,0.00021239356,0.00013970473,0.008223096,0.08788697,0.0022810316,0.00038912185,0.00007432105,0.6459372],"study_design_scores_gemma":[0.005281767,0.008392466,0.8360944,0.00073500973,0.00004651165,0.00006612069,0.0007105802,0.14638093,0.001701862,0.00003129326,0.00044486037,0.00011423404],"about_ca_topic_score_codex":0.66059035,"about_ca_topic_score_gemma":0.43070555,"teacher_disagreement_score":0.645823,"about_ca_system_score_codex":0.0016223426,"about_ca_system_score_gemma":0.0033479033,"threshold_uncertainty_score":0.59390366},"labels":[],"label_agreement":null},{"id":"W2076711619","doi":"10.1016/j.jval.2011.02.072","title":"QA3 DOES COST-EFFECTIVENESS ANALYSIS DISCRIMINATE AGAINST PATIENTS WITH SHORTER LIFE EXPECTANCY?","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Life expectancy; Expectancy theory; Gerontology; Medicine; Psychology; Environmental health; Social psychology","score_opus":0.3683636880228536,"score_gpt":0.3924260390934216,"score_spread":0.024062351070568033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076711619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866658,0.0007952884,0.0044645807,0.0022098722,0.0005602965,0.002190961,0.00034739063,0.000067704175,0.002698134],"genre_scores_gemma":[0.9928594,0.0001313078,0.0018388381,0.004479247,0.00009481184,0.00039609527,0.00009939536,0.000049735896,0.00005112296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934565,0.0011520706,0.0036112415,0.0008876982,0.00015635754,0.0007361694],"domain_scores_gemma":[0.99615914,0.00069036597,0.0018855669,0.0007450392,0.00008525729,0.00043464682],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01131173,0.00029967868,0.0015908423,0.000992522,0.0001975737,0.00004958047,0.00030974598,0.00013537446,0.0002609677],"category_scores_gemma":[0.00096547656,0.00028056325,0.00016928492,0.0008372526,0.0000848443,0.0005080571,0.000052815143,0.00024941305,0.00028077993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007473135,0.00035253368,0.974949,0.00048034432,0.00022039843,0.0000015801222,0.0056279413,0.0017241258,6.727251e-8,0.01611826,0.00017802969,0.00027297574],"study_design_scores_gemma":[0.0013526841,0.00021913144,0.98576015,0.00019542042,0.000024120294,2.3167384e-7,0.000990184,0.0065984405,0.000002649675,0.0034122644,0.0010271171,0.00041760408],"about_ca_topic_score_codex":0.012755553,"about_ca_topic_score_gemma":0.0009190591,"teacher_disagreement_score":0.012705997,"about_ca_system_score_codex":0.0011172293,"about_ca_system_score_gemma":0.00029074136,"threshold_uncertainty_score":0.99996465},"labels":[],"label_agreement":null},{"id":"W2077261810","doi":"10.1016/j.jval.2011.02.369","title":"PSY36 DEVELOPMENT OF THE LUPUS IMPACT TRACKER: A TOOL FOR PATIENTS AND PHYSICIANS TO ASSESS AND MONITOR THE IMPACT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Confirmatory factor analysis; Goodness of fit; Stepwise regression; Index (typography); Psychology; Statistics; Medicine; Regression analysis; Clinical psychology; Mathematics; Structural equation modeling; Computer science","score_opus":0.07404468639528143,"score_gpt":0.3596493479168701,"score_spread":0.28560466152158864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077261810","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938807,0.00097012107,0.000084157706,0.00010454224,0.0003669306,0.0044822097,0.00006719213,0.0000130570015,0.000031129435],"genre_scores_gemma":[0.9985376,0.000104463856,0.0009865079,0.00002830333,0.00004424036,0.00018174447,0.000003513018,0.00004069665,0.00007291189],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974068,0.00030943446,0.0009405073,0.0003087295,0.0005099988,0.00052456115],"domain_scores_gemma":[0.99814683,0.0004762545,0.0004317229,0.00051817927,0.00024612978,0.0001808958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014776809,0.00023893818,0.00075689796,0.00018370031,0.00011894291,0.000012986778,0.00023162056,0.00009039784,0.000004077715],"category_scores_gemma":[0.00033156763,0.00012342048,0.00014413572,0.00039062387,0.0001077041,0.00006441566,0.00010562131,0.00018233473,0.0000015101871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056302483,0.00034163255,0.9485459,0.0036460536,0.0001324847,0.0000011868074,0.042244155,0.000029675224,0.00087004574,0.000033799748,0.00042804587,0.003164046],"study_design_scores_gemma":[0.010214249,0.00431459,0.9450545,0.016372297,0.00009409882,0.0046639782,0.012630427,0.0022628447,0.0035790694,0.0003127972,0.000033783755,0.00046737504],"about_ca_topic_score_codex":0.0017867992,"about_ca_topic_score_gemma":0.000029897566,"teacher_disagreement_score":0.029613728,"about_ca_system_score_codex":0.0005472324,"about_ca_system_score_gemma":0.000898271,"threshold_uncertainty_score":0.5032941},"labels":[],"label_agreement":null},{"id":"W2077906229","doi":"10.1016/j.jval.2012.03.1200","title":"PCN83 Novel Targeted Drug Therapies in the Cancer Setting: A Descriptive Comparison of Efficacy and Cost","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Oncology; Internal medicine; Multiple myeloma; Clinical trial; Rituximab; Trastuzumab; Cancer; Breast cancer; Lymphoma","score_opus":0.11164825978064685,"score_gpt":0.3199651482289862,"score_spread":0.20831688844833934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2077906229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94507974,0.049326535,0.00023705441,0.0031905095,0.0003461341,0.0005515145,0.00013008564,0.000007441751,0.0011309622],"genre_scores_gemma":[0.9969539,0.0016090968,0.00049305364,0.00074128085,0.00010646216,0.00004561582,0.0000037073949,0.000014897618,0.000032008684],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850625,0.000051228577,0.0007761263,0.00020981177,0.000030239944,0.00042633052],"domain_scores_gemma":[0.9990348,0.00020715591,0.00048260242,0.00018631287,0.000013447985,0.000075664284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018000093,0.00012465678,0.00049205776,0.00017658318,0.00006219711,0.000022670507,0.00017831588,0.000059948146,0.00003069644],"category_scores_gemma":[0.00012957978,0.00011488161,0.000034740555,0.00022345447,0.00008557768,0.00023430292,0.000029583582,0.00022904403,0.000008611877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048463753,0.0003103129,0.875622,0.00008088701,0.000015422125,1.368412e-7,0.057319026,0.0009583183,0.000015416737,0.060064152,0.00086300017,0.0047028787],"study_design_scores_gemma":[0.0014262552,0.000076919125,0.9640159,0.00011653214,0.0000020774671,9.787896e-7,0.0027827378,0.0037678687,0.00004018632,0.0022538009,0.025332794,0.00018392167],"about_ca_topic_score_codex":0.027158344,"about_ca_topic_score_gemma":0.0007458972,"teacher_disagreement_score":0.08839394,"about_ca_system_score_codex":0.00024970435,"about_ca_system_score_gemma":0.00008554021,"threshold_uncertainty_score":0.9793199},"labels":[],"label_agreement":null},{"id":"W2078226086","doi":"10.1111/j.1524-4733.2009.00690.x","title":"Impact of Waist Circumference Difference on Health-Care Cost among Overweight and Obese Subjects: The PROCEED Cohort","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier de l'Université Laval","funders":"","keywords":"Overweight; Medicine; Waist; Body mass index; Obesity; Circumference; Demography; Cohort; Health care; Prospective cohort study; Gerontology; Internal medicine","score_opus":0.037634788514898994,"score_gpt":0.36020839509979025,"score_spread":0.32257360658489126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078226086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99022275,0.0009446061,0.000007667009,0.0056008543,0.00022551788,0.0021219521,0.000034128425,0.00004161787,0.0008008918],"genre_scores_gemma":[0.9964803,0.0012381652,0.00017128415,0.001862863,0.00011625604,0.000068097106,0.00001850773,0.000022069478,0.000022465838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978115,0.00012910429,0.0006461807,0.00037845728,0.00044680762,0.00058793894],"domain_scores_gemma":[0.99828637,0.00025051873,0.0003068333,0.0004383583,0.00019225669,0.00052564347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011825835,0.00018877575,0.0005387314,0.000267005,0.0002778387,0.000024207262,0.0001503787,0.000090984584,0.00003523704],"category_scores_gemma":[0.00032995737,0.00012637975,0.00005709323,0.0004871111,0.00036427972,0.000060644277,0.00003759506,0.0009257495,0.0000039202387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018951068,0.00022504445,0.9852403,0.0020095278,0.000009435049,0.0000037007624,0.002818088,0.0000035599799,0.00040284052,0.0019665018,0.0002433367,0.0068882033],"study_design_scores_gemma":[0.0013987152,0.0010155342,0.99443716,0.0013478849,0.0000053203166,0.000028253427,0.00036025463,0.0006625097,0.00012610525,0.0002814683,0.00024016152,0.00009662438],"about_ca_topic_score_codex":0.012475971,"about_ca_topic_score_gemma":0.0006945233,"teacher_disagreement_score":0.011781448,"about_ca_system_score_codex":0.00053812657,"about_ca_system_score_gemma":0.0020548366,"threshold_uncertainty_score":0.99410003},"labels":[],"label_agreement":null},{"id":"W2078308946","doi":"10.1016/j.jval.2011.08.961","title":"PIH59 Are Older Mothers More prone to Having Children with Disabilities? Lifetime Disability Outcomes Versus Multiple Birth Reductions Arising from In-Vitro Fertilization (IVF) Treatments in Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Assisted Reproductive Technology and Twin Pregnancy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Multiple birth; Demography; Medicine; Fertility; Confidence interval; Live birth; Birth rate; Multiple disabilities; Pregnancy; Population; Psychology; Environmental health; Biology","score_opus":0.049108507840925124,"score_gpt":0.2869369968429913,"score_spread":0.23782848900206616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078308946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944219,0.00030796445,0.000033213826,0.002958771,0.00019261168,0.0019092158,0.00006852682,0.00006749964,0.000040283754],"genre_scores_gemma":[0.99744844,0.00001891626,0.0021148885,0.00010063386,0.000025914287,0.0001613233,0.000053980097,0.00003427214,0.00004160967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979775,0.0001769728,0.00051141245,0.0006889831,0.0002119467,0.0004332133],"domain_scores_gemma":[0.998895,0.00014087671,0.00014758867,0.00064202806,0.000033015756,0.00014148856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019067863,0.00022992738,0.00052341237,0.00016436356,0.00009087523,0.0000044541284,0.00010200681,0.000106738626,0.000025788633],"category_scores_gemma":[0.00058706134,0.00019034183,0.00003393573,0.0005473257,0.00017355448,0.00010956663,0.00004073951,0.00036170374,0.0000019339598],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008010843,0.0007620499,0.9898009,0.00006469127,0.00006826276,0.00000779723,0.004413115,0.00052563514,0.000028536271,0.000006207316,0.0000044825056,0.00351728],"study_design_scores_gemma":[0.0030177392,0.0001669419,0.9873307,0.00059786777,0.000025526688,0.0000043407294,0.007990855,0.00018245213,0.00046066416,0.00006687786,0.0000017141823,0.00015432318],"about_ca_topic_score_codex":0.8889597,"about_ca_topic_score_gemma":0.6764041,"teacher_disagreement_score":0.2125556,"about_ca_system_score_codex":0.0030808272,"about_ca_system_score_gemma":0.00071487913,"threshold_uncertainty_score":0.8056256},"labels":[],"label_agreement":null},{"id":"W2078796473","doi":"10.1111/j.1524-4733.2008.00437.x","title":"Economic Evaluation of Influenza Pandemic Mitigation Strategies in the United States Using a Stochastic Microsimulation Transmission Model","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 epidemiological studies","field":"Mathematics","cited_by":143,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Public Health; University Health Network; Monsanto (Canada)","funders":"National Institute of General Medical Sciences","keywords":"Per capita; Pandemic; Transmission (telecommunications); Microsimulation; Closure (psychology); Influenza pandemic; Medicine; Environmental health; Economic cost; Cost–benefit analysis; Pandemic influenza; Economics; Coronavirus disease 2019 (COVID-19); Population; Computer science; Political science; Microeconomics","score_opus":0.5550505989832692,"score_gpt":0.49947935587985953,"score_spread":0.05557124310340972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078796473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93309444,0.00035229718,0.065369405,0.000292756,0.000017441884,0.000838063,0.0000084060175,0.000021296157,0.0000058672927],"genre_scores_gemma":[0.99583,0.0001515503,0.003645525,0.00030383532,0.000013143571,0.000029570792,0.000016207605,0.000009721909,4.4932463e-7],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9972047,0.0011783376,0.0009213998,0.00020587683,0.0002625239,0.00022715512],"domain_scores_gemma":[0.99680036,0.002571009,0.00036303521,0.00015893659,0.00007682633,0.000029815541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048747254,0.00012798495,0.0003234865,0.00021185163,0.000120629025,0.0000075241264,0.00010674966,0.000082385224,0.0000050857134],"category_scores_gemma":[0.0007781499,0.00009519551,0.000041930252,0.00028334765,0.00008160745,0.00012745356,0.000015496475,0.00017345541,7.057613e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032708755,0.000052833606,0.008364897,0.0001436698,0.0000042329534,1.6034632e-7,0.009559394,0.979672,0.00014200633,0.0017714173,0.0000111703275,0.0002455043],"study_design_scores_gemma":[0.0006055444,0.000044308534,0.0114849275,0.00018697776,0.000011362034,0.0000015730894,0.00074032095,0.791941,0.000008307701,0.19490634,0.000003236334,0.000066145156],"about_ca_topic_score_codex":0.008717106,"about_ca_topic_score_gemma":0.00034428705,"teacher_disagreement_score":0.19313492,"about_ca_system_score_codex":0.00082037965,"about_ca_system_score_gemma":0.00058190565,"threshold_uncertainty_score":0.9978839},"labels":[],"label_agreement":null},{"id":"W2078865041","doi":"10.1016/s1098-3015(10)63725-4","title":"PEY19 PROSTAGLANDIN AGONIST USE WITH AND WITHOUT ADJUNCTIVE THERAPY FOR THE TREATMENT OF GLAUCOMA: A CANADIAN POPULATION BASED ANALYSIS","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Glaucoma; Agonist; Medicine; Prostaglandin analogue; Prostaglandin; Ophthalmology; Internal medicine; Receptor","score_opus":0.024606585280628694,"score_gpt":0.2820566062511154,"score_spread":0.2574500209704867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2078865041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994214,0.0010064548,0.00020076304,0.0027863188,0.000016797116,0.0016973214,0.000053004474,0.0000073024858,0.000018053794],"genre_scores_gemma":[0.9985574,0.00016796766,0.0007079646,0.00018232074,0.000019951814,0.00008160034,0.00019216182,0.000011507216,0.00007912584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992632,0.00006595086,0.00020022776,0.00016229918,0.00010942858,0.00019888915],"domain_scores_gemma":[0.99951,0.00011326793,0.00009623793,0.00014793567,0.000044576438,0.00008798557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014283194,0.000103467326,0.00028825196,0.00022317626,0.00010905455,0.000011317258,0.000019500298,0.0000351777,0.0000035454582],"category_scores_gemma":[0.000009564264,0.00005525803,0.000060403043,0.00036188294,0.000042162224,0.000021557844,8.696815e-7,0.0000362454,8.881406e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008318772,0.00018061518,0.9970281,0.000048715312,0.00009457188,0.0000016612511,0.00034104104,0.00026312677,0.0000046386963,0.0001323393,0.000014344531,0.0010589388],"study_design_scores_gemma":[0.00340111,0.0019868286,0.97341466,0.000044740344,0.00016020304,0.0000026606576,0.00012800402,0.019851102,0.000014340388,0.00004080083,0.0009009781,0.000054551543],"about_ca_topic_score_codex":0.8950247,"about_ca_topic_score_gemma":0.57929987,"teacher_disagreement_score":0.31572488,"about_ca_system_score_codex":0.0002505177,"about_ca_system_score_gemma":0.00037111694,"threshold_uncertainty_score":0.42837682},"labels":[],"label_agreement":null},{"id":"W2079213767","doi":"10.1016/j.jval.2012.08.928","title":"PMD79 A Population-Based Study on the Use of Blood Glucose Monitoring Test Strips","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada); Université Laval","funders":"","keywords":"Medicine; Metformin; Insulin; Cohort; Sulfonylurea; Glucose test; Population; Diabetes mellitus; Internal medicine; Cohort study; Endocrinology; Environmental health","score_opus":0.14458997614660202,"score_gpt":0.3360439226074668,"score_spread":0.19145394646086478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079213767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975163,0.00028276845,0.0000023659059,0.0007368195,0.00013660197,0.0012501713,0.000004286861,0.000024080106,0.000046661098],"genre_scores_gemma":[0.99912107,0.000017100263,0.0004180943,0.00020098075,0.00010010047,0.000052598552,0.0000076213546,0.000012602854,0.00006981812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989951,0.00014289077,0.0002735991,0.00010928145,0.00023727663,0.00024184401],"domain_scores_gemma":[0.998853,0.0006516792,0.000105019884,0.00028732244,0.000017810724,0.00008511244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057668606,0.00009072119,0.00019026473,0.00011632083,0.000053608674,0.000007817005,0.000042733853,0.000019418634,0.000009747956],"category_scores_gemma":[0.0002144959,0.00006027502,0.000032729782,0.00020557627,0.000006657469,0.000051086754,0.00001547621,0.000103700695,0.0000075889384],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022361648,0.003495284,0.9935382,0.00008062731,0.00004027585,0.0000023705848,0.00045236314,0.0005644965,0.000027226257,0.00016657438,0.000043750533,0.0015664651],"study_design_scores_gemma":[0.0014383367,0.0012080721,0.9956044,0.0002617999,0.00007274747,1.3116413e-7,0.00030648263,0.00032900632,0.00043226083,0.00000721772,0.00029516226,0.000044385422],"about_ca_topic_score_codex":0.0027937405,"about_ca_topic_score_gemma":0.000011200435,"teacher_disagreement_score":0.00278254,"about_ca_system_score_codex":0.00010864566,"about_ca_system_score_gemma":0.000045074685,"threshold_uncertainty_score":0.42233184},"labels":[],"label_agreement":null},{"id":"W2079685634","doi":"10.1016/j.jval.2011.08.1310","title":"PDB7 Prevalence, Demographics and Treatment Characteristics of Diabetes with Lantus, NPH and Premix Insulin in a Representative Canadian Cohort","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); Lawson Health Research Institute","funders":"","keywords":"Medicine; Diabetes mellitus; Population; Incidence (geometry); Internal medicine; NPH insulin; Insulin; Type 2 diabetes; Comorbidity; Cohort; Pediatrics; Endocrinology; Insulin glargine; Environmental health","score_opus":0.031495247184333934,"score_gpt":0.2588369720333785,"score_spread":0.22734172484904458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079685634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961752,0.0014816205,8.814026e-7,0.00023899603,0.00002207257,0.0013418114,0.00004468878,0.000010139457,0.0006845588],"genre_scores_gemma":[0.9920848,0.0067081973,0.00084809575,0.000120220386,0.000010135044,0.000090655194,0.000027193291,0.000012725003,0.00009797499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989333,0.000087065724,0.00030200358,0.00026306382,0.000109053966,0.0003055094],"domain_scores_gemma":[0.9993913,0.00006890642,0.00011152719,0.0001722521,0.000026386888,0.00022962654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028818904,0.00013898482,0.0003937314,0.00035712947,0.000026652711,0.0000054213965,0.00003078897,0.00004468645,0.000008865143],"category_scores_gemma":[0.000028957593,0.00010675941,0.000015679725,0.00023977789,0.000103682156,0.00004973907,0.000017683516,0.00007425149,5.58791e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006970322,0.0002404636,0.99061227,0.00056922884,0.000092348935,0.000031779942,0.0024205223,0.0000013336801,0.0000029472305,0.0004029903,0.0000129909085,0.0055434015],"study_design_scores_gemma":[0.0016532355,0.0016736405,0.9949568,0.0006923409,0.000077727804,0.0000020605764,0.00019574148,0.00041558864,0.000042988682,0.00007002102,0.0001383179,0.000081561426],"about_ca_topic_score_codex":0.09976596,"about_ca_topic_score_gemma":0.028567707,"teacher_disagreement_score":0.07119825,"about_ca_system_score_codex":0.00016931898,"about_ca_system_score_gemma":0.00021865954,"threshold_uncertainty_score":0.9891584},"labels":[],"label_agreement":null},{"id":"W2079700016","doi":"10.1016/j.jval.2012.08.525","title":"CL3 Calibrating Bayesian Multiple Treatment Comparison Meta-Analysis With Multiple Cost-Effectiveness Acceptability Curves","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University","funders":"","keywords":"Bayesian probability; Markov chain Monte Carlo; Computer science; Calibration; Bayesian inference; Meta-analysis; Statistics; Frequentist inference; Econometrics; Mathematics; Medicine; Internal medicine","score_opus":0.8366525448897001,"score_gpt":0.5640449137754371,"score_spread":0.272607631114263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079700016","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6944488,0.042087458,0.24672455,0.0026895634,0.00036817693,0.012559515,0.0002916139,0.000053939326,0.000776355],"genre_scores_gemma":[0.9849743,0.000057066227,0.013686949,0.00026952405,0.00004958429,0.00072974066,0.000041736406,0.000021653394,0.00016944637],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.93225724,0.052050367,0.009557764,0.0014627097,0.0038119627,0.00085997715],"domain_scores_gemma":[0.96814185,0.021661934,0.0051346095,0.004020368,0.00042950644,0.0006117384],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.1356963,0.000574966,0.01069887,0.0006613065,0.0002620052,0.00034662694,0.000976893,0.00010035863,0.004817494],"category_scores_gemma":[0.014927577,0.00025572887,0.004028982,0.0043609557,0.00009294394,0.00058571796,0.00009854377,0.00023490822,0.00022173641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002233326,0.0005234777,0.94567853,0.0002472096,0.010937431,7.6588935e-7,0.001352505,0.0374362,0.0000018486901,0.0000939969,0.00023729545,0.003468405],"study_design_scores_gemma":[0.00070859864,0.00023122097,0.5986202,0.000042200307,0.025749795,0.0000039885035,0.0012161338,0.36464354,0.000079047444,0.00011844228,0.008191898,0.00039496462],"about_ca_topic_score_codex":0.009352127,"about_ca_topic_score_gemma":0.005292297,"teacher_disagreement_score":0.34705836,"about_ca_system_score_codex":0.00042980834,"about_ca_system_score_gemma":0.00022172788,"threshold_uncertainty_score":0.9999895},"labels":[],"label_agreement":null},{"id":"W2079882865","doi":"10.1016/j.jval.2014.03.176","title":"Evidence-Based Practice Recommendations: Health Quality Ontario’s Approach","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Best practice; Evidence-based practice; Health care; Timeline; Relevance (law); Evidence-based medicine; Medicine; Systematic review; MEDLINE; Medical education; Public relations; Psychology; Political science; Alternative medicine","score_opus":0.7211036529612455,"score_gpt":0.504715750597193,"score_spread":0.21638790236405248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079882865","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010065268,0.011747414,0.0982011,0.8632545,0.0017022478,0.0030447738,0.00016155992,0.00019220149,0.011630961],"genre_scores_gemma":[0.31256253,0.0024680072,0.27711785,0.40405613,0.0009288079,0.00074529625,0.00029892442,0.0001341356,0.0016883266],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9818659,0.007113472,0.008693764,0.0011205772,0.00024163762,0.00096464937],"domain_scores_gemma":[0.98414516,0.00821219,0.0059265103,0.0010965839,0.000106123785,0.00051341276],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.13386057,0.00028633224,0.0015820833,0.0005002828,0.00050531223,0.00014933333,0.0004367943,0.00017270153,0.00035112127],"category_scores_gemma":[0.022904234,0.00038034853,0.00014173122,0.0004991751,0.00006773388,0.0011777565,0.000054117063,0.0006205032,0.0007649203],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013828493,0.00151092,0.106822036,0.004807072,0.000067871195,5.67668e-7,0.016724689,0.034156468,1.9819991e-7,0.7023819,0.12682572,0.006564289],"study_design_scores_gemma":[0.0027124027,0.0007759997,0.06954908,0.002053115,0.0000046626838,0.000010807734,0.003173999,0.098550655,7.191313e-7,0.029975396,0.7922408,0.0009523751],"about_ca_topic_score_codex":0.62810904,"about_ca_topic_score_gemma":0.023288764,"teacher_disagreement_score":0.6724065,"about_ca_system_score_codex":0.0063550593,"about_ca_system_score_gemma":0.0030565027,"threshold_uncertainty_score":0.9998648},"labels":[],"label_agreement":null},{"id":"W2079932358","doi":"10.1016/s1098-3015(10)66668-5","title":"PDB21 COST-EFFECTIVENESS OF INSULIN GLARGINE PLUS ORAL ANTIDIABETIC DRUGS (OADS) COMPARED TO PREMIXED INSULIN FOR TYPE 2 DIABETES MELLITUS (T2DM) PATIENTS IN THE CANADIAN PAYER SETTING","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin glargine; Medicine; Insulin; Type 2 Diabetes Mellitus; Diabetes mellitus; Type 2 diabetes; Internal medicine; Pharmacology; Endocrinology","score_opus":0.06785303927349089,"score_gpt":0.34792985404669796,"score_spread":0.28007681477320706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2079932358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924293,0.0013572301,0.0000064113924,0.0012701027,0.0002540426,0.0045324606,0.00009111257,0.000015614081,0.00004373775],"genre_scores_gemma":[0.9971076,0.00022051336,0.00045398623,0.0016995219,0.000036090445,0.00025944662,0.00019605258,0.000020341933,0.0000064028286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750286,0.0008199669,0.0005061667,0.00030324646,0.00022924576,0.0006385112],"domain_scores_gemma":[0.99841124,0.00078898075,0.00012389616,0.00023029573,0.00015708446,0.00028851072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016694622,0.00019063232,0.0006254684,0.00031549306,0.00017203708,0.0000048721463,0.00015108488,0.00011401254,0.000009959934],"category_scores_gemma":[0.00032606142,0.00015162183,0.000054229393,0.00061839883,0.00007069102,0.000046137895,0.00002672877,0.00027517162,0.000012541552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011151858,0.0010871218,0.98226273,0.0009794867,0.00006671399,0.00002921601,0.0064015826,0.00422137,0.000111364214,0.000042363627,0.00045617198,0.003226721],"study_design_scores_gemma":[0.009242892,0.0010157315,0.9806093,0.00056047156,0.00003413254,0.0000026110129,0.00011018195,0.0045285863,0.0023270021,0.00006210503,0.0013658645,0.00014114859],"about_ca_topic_score_codex":0.08654642,"about_ca_topic_score_gemma":0.014750177,"teacher_disagreement_score":0.071796246,"about_ca_system_score_codex":0.0012730601,"about_ca_system_score_gemma":0.001458209,"threshold_uncertainty_score":0.91953635},"labels":[],"label_agreement":null},{"id":"W2080012507","doi":"10.1016/j.jval.2014.03.1345","title":"Indirect Comparison Of The Efficacy Of Recombinant Factor Viii Fc Fusion Protein And Other Factor Viii Products For ProphylaxisModeling The Effect Of Compliance","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bleed; Pooled analysis; Clinical trial; Internal medicine; Poisson regression; Surgery; Meta-analysis; Population","score_opus":0.11426605902276414,"score_gpt":0.3796847273387593,"score_spread":0.26541866831599514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080012507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915971,0.0007382293,0.000040134248,0.0015966913,0.00012367152,0.005854956,0.000019142353,0.000008981619,0.000021083875],"genre_scores_gemma":[0.9993321,0.00002245821,0.0004046832,0.000016165237,0.00004308536,0.000070180504,0.0000031203056,0.000020973463,0.000087241744],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9980192,0.00056110224,0.0005493478,0.00024548714,0.00035579997,0.00026905147],"domain_scores_gemma":[0.99842966,0.00066718203,0.0003398969,0.00040350753,0.000100261095,0.000059491154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011455165,0.00014508664,0.00066750695,0.0000935795,0.00010126537,0.0000040154505,0.00014505928,0.00007196576,0.000004035448],"category_scores_gemma":[0.00080039684,0.00006650449,0.00007741002,0.00027330266,0.00015218662,0.000019019999,0.000053697815,0.00021957462,8.008154e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004987157,0.0016524208,0.67366993,0.02674294,0.00013814386,5.714878e-7,0.009076959,0.0005171426,0.16185068,0.00017166608,0.00008745216,0.12110492],"study_design_scores_gemma":[0.008905064,0.015972689,0.2431661,0.00773137,0.000038481263,0.000003911334,0.00011418754,0.031268544,0.69180715,0.00011183293,0.00069770886,0.00018298975],"about_ca_topic_score_codex":0.0007387909,"about_ca_topic_score_gemma":0.000014405778,"teacher_disagreement_score":0.52995646,"about_ca_system_score_codex":0.000069831105,"about_ca_system_score_gemma":0.00017869794,"threshold_uncertainty_score":0.27119744},"labels":[],"label_agreement":null},{"id":"W2080026856","doi":"10.1016/j.jval.2013.08.223","title":"Adherence Interventions to Improve Adherence to Antiretroviral Therapy in Low Income Settings: An Individual Patient Data Network Meta-Analysis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of British Columbia","funders":"","keywords":"Psychological intervention; Medicine; Randomized controlled trial; Meta-analysis; Odds ratio; Confidence interval; MEDLINE; Family medicine; Physical therapy; Internal medicine; Psychiatry","score_opus":0.2155514973063242,"score_gpt":0.43392805823790376,"score_spread":0.21837656093157956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080026856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987494,0.0019504607,0.0023206556,0.0033809168,0.00011694273,0.0039067366,0.0006353598,0.000056963865,0.00013799728],"genre_scores_gemma":[0.98876464,0.00009422512,0.0077248593,0.001583426,0.00009020613,0.00064689637,0.00040143286,0.000026909329,0.0006674143],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99521506,0.00095667335,0.0013986505,0.0008428188,0.0006702415,0.00091656926],"domain_scores_gemma":[0.9971154,0.0001706934,0.00024221087,0.001479462,0.00018189807,0.0008103676],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026200137,0.00025045977,0.0010873117,0.00096327125,0.00011328538,0.00012705638,0.0008236179,0.000086974,0.0016995519],"category_scores_gemma":[0.00064377574,0.00020504264,0.00052490813,0.0028608106,0.000050890812,0.0004898318,0.00049137394,0.0005653911,0.0002464842],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054166885,0.0063996185,0.30410472,0.002194142,0.019824851,0.00008543498,0.01204707,0.014517927,0.00036062417,0.00041849253,0.052711498,0.58679396],"study_design_scores_gemma":[0.0066266684,0.30189973,0.47151858,0.005587369,0.008850316,0.000024724715,0.0064347857,0.1921822,0.00029811138,0.0017217974,0.0027552792,0.0021004542],"about_ca_topic_score_codex":0.05448768,"about_ca_topic_score_gemma":0.0062886807,"teacher_disagreement_score":0.5846935,"about_ca_system_score_codex":0.00020219755,"about_ca_system_score_gemma":0.00034447003,"threshold_uncertainty_score":0.99921304},"labels":[],"label_agreement":null},{"id":"W2080084883","doi":"10.1111/j.1524-4733.2007.00249.x","title":"Cost-Effectiveness of Intraperitoneal Chemohyperthermia in the Treatment of Peritoneal Carcinomatosis from Colorectal Cancer","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"","keywords":"Medicine; Peritoneal carcinomatosis; Confidence interval; Colorectal cancer; Cost effectiveness; Surgery; Palliative care; Chemotherapy; Cancer; Oncology; Internal medicine","score_opus":0.06107763484381537,"score_gpt":0.34520580408878027,"score_spread":0.28412816924496487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080084883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99423015,0.0032811393,0.000006054284,0.00048801696,0.0002048097,0.0015406902,0.000086602944,0.000012421848,0.00015014192],"genre_scores_gemma":[0.9984114,0.0009053761,0.0002085936,0.00013270893,0.00014436725,0.00014722989,0.000028450857,0.000018888193,0.0000029532655],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980257,0.0002950484,0.0006712101,0.00026416502,0.00031037076,0.0004335012],"domain_scores_gemma":[0.9988376,0.000643735,0.00016838884,0.00019996047,0.00005310903,0.00009721602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078379567,0.00019436574,0.00074431696,0.00015103834,0.00004289148,0.0000042619245,0.00011850299,0.000116874755,0.000036428475],"category_scores_gemma":[0.000021448872,0.0001320861,0.000113607006,0.00044014002,0.00018515225,0.000036184007,0.000011468871,0.00015880045,0.0000014824266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034071242,0.0023810787,0.83464587,0.0010567429,0.0000693942,0.00015219409,0.020948552,0.0002598413,0.11262826,0.0004345218,0.000006920183,0.02400951],"study_design_scores_gemma":[0.002424486,0.0018226171,0.79577315,0.0006926328,0.00002427342,0.00003285267,0.0025491954,0.00041100004,0.19580524,0.000044995762,0.00031521547,0.0001043497],"about_ca_topic_score_codex":0.13329685,"about_ca_topic_score_gemma":0.0017770968,"teacher_disagreement_score":0.13151975,"about_ca_system_score_codex":0.0004905917,"about_ca_system_score_gemma":0.00038846544,"threshold_uncertainty_score":0.8724746},"labels":[],"label_agreement":null},{"id":"W2080332677","doi":"10.1016/j.jval.2011.02.1009","title":"PGI12 DOSE VARIATIONS WITH ADALIMUMAB AND INFLIXIMAB IN THE TREATMENT OF CROHN'S DISEASE: A CANADIAN ASSESSMENT","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Abbott (Canada); Université de Montréal","funders":"","keywords":"Infliximab; Adalimumab; Medicine; Internal medicine; Cohort; Retrospective cohort study; Confidence interval; Gastroenterology; Disease","score_opus":0.024289072830972844,"score_gpt":0.27428448758075485,"score_spread":0.249995414749782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080332677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980651,0.00047773382,0.000036748963,0.00027643036,0.000023073735,0.0005663419,0.000070095106,0.0000023501004,0.00048213112],"genre_scores_gemma":[0.9987359,0.00025549214,0.00057602045,0.00024151143,0.000021204807,0.00010594259,0.000037928377,0.000009093954,0.000016883312],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914783,0.00019350508,0.0001902152,0.0001733491,0.00008379771,0.00021131831],"domain_scores_gemma":[0.9994459,0.00001200957,0.00006454598,0.0002784215,0.000022355049,0.00017676565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020320674,0.0000938771,0.0000969746,0.0000768192,0.000050722378,0.000007245887,0.00007831083,0.000035803103,0.000009140373],"category_scores_gemma":[0.000011689462,0.00006749564,0.000020506797,0.00008167896,0.000046081102,0.0000036411784,0.000008533541,0.00003663154,5.5246664e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012492797,0.0016671306,0.96787834,0.00025847208,0.00008103124,0.0008581285,0.008578155,0.0019385357,0.00009896747,0.013793818,0.00010674821,0.003491376],"study_design_scores_gemma":[0.0011460467,0.00033838692,0.9964449,0.000027385437,0.000009579957,0.000002750034,0.00013837639,0.0005288103,0.000012514453,0.0001776604,0.0011003811,0.00007322629],"about_ca_topic_score_codex":0.10043441,"about_ca_topic_score_gemma":0.10899473,"teacher_disagreement_score":0.028566524,"about_ca_system_score_codex":0.00011518092,"about_ca_system_score_gemma":0.0015059871,"threshold_uncertainty_score":0.9072638},"labels":[],"label_agreement":null},{"id":"W2080411162","doi":"10.1016/j.jval.2014.03.611","title":"Systematic Review And Network Meta-Analysis Of All Agents For Stroke Prevention In Patients With Atrial Fibrillation","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; University of Toronto","funders":"","keywords":"Medicine; Dabigatran; Rivaroxaban; Apixaban; Warfarin; Aspirin; Stroke (engine); Atrial fibrillation; Edoxaban; Internal medicine; Placebo; Randomized controlled trial; Relative risk; Clopidogrel; Meta-analysis; Anesthesia; Cardiology; Confidence interval","score_opus":0.1562548928342169,"score_gpt":0.3848907493300748,"score_spread":0.22863585649585788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080411162","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81227046,0.10772634,0.015068623,0.011235106,0.00045514683,0.052848164,0.0000988568,0.000089579946,0.00020773841],"genre_scores_gemma":[0.99327075,0.0016681723,0.0036429677,0.0005440205,0.00017942439,0.000016448737,0.0002654127,0.00002009374,0.0003927328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824005,0.0003777051,0.00086485065,0.00016256179,0.00021919295,0.00013565578],"domain_scores_gemma":[0.9988836,0.00029411915,0.000551921,0.00017489374,0.000052192285,0.000043278833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019684022,0.00009088014,0.0015911686,0.00022216428,0.0000179291,0.000004989068,0.000025232526,0.000031208892,0.000014206213],"category_scores_gemma":[0.00029340756,0.000063227206,0.00035171772,0.00044149335,0.000007421616,0.000051938743,0.000011954097,0.000029992596,5.26664e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002820799,0.0000100205325,0.7922434,0.14050564,0.020926267,8.6367784e-8,0.00010056642,0.04466835,6.364519e-8,0.0009902607,0.00006923782,0.00020398136],"study_design_scores_gemma":[0.0064013544,0.0014352993,0.6106301,0.010069646,0.32233578,2.1858182e-7,0.000017961263,0.047991116,3.3340538e-7,0.00036606705,0.0005427,0.00020940631],"about_ca_topic_score_codex":0.00012191246,"about_ca_topic_score_gemma":0.000044063076,"teacher_disagreement_score":0.3014095,"about_ca_system_score_codex":0.000051028208,"about_ca_system_score_gemma":0.000022854938,"threshold_uncertainty_score":0.25783306},"labels":[],"label_agreement":null},{"id":"W2080445759","doi":"10.1016/j.jval.2012.08.1361","title":"PMS6 Anti-Tumour Necrosis Factor (TNF) Drugs for the Treatment of Psoriatic Arthritis (PsA)","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Golimumab; Adalimumab; Medicine; Psoriatic arthritis; Etanercept; Infliximab; Internal medicine; Psoriasis; Oncology; Psoriasis Area and Severity Index; Meta-analysis; Tumor necrosis factor alpha; Rheumatoid arthritis; Physical therapy; Dermatology","score_opus":0.04878508233628078,"score_gpt":0.28875065714799253,"score_spread":0.23996557481171174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080445759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92922926,0.06638049,0.00007328674,0.00076838804,0.0019831893,0.0011021429,0.00037892733,0.000032094344,0.00005224431],"genre_scores_gemma":[0.98574436,0.0131164305,0.00027284925,0.00008956094,0.00013414997,0.00022893408,0.00007640573,0.00002164118,0.00031568506],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99834824,0.00031706027,0.00047512894,0.00020723758,0.00004194337,0.00061037706],"domain_scores_gemma":[0.99857587,0.0008346778,0.0002230146,0.00029076106,0.000028316506,0.000047339792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035919354,0.0002065713,0.0004892883,0.00010035042,0.00021040336,0.000006750559,0.00012916545,0.00014569737,0.00014655537],"category_scores_gemma":[0.000038251495,0.00013905749,0.00018146158,0.00015342681,0.00007333049,0.00006855379,0.000013605185,0.00006359437,0.000077048295],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004378159,0.0032735202,0.07440105,0.00023745983,0.00078347087,0.0000020261807,0.024682898,0.0001729623,0.0074053486,0.0022309106,0.0013056172,0.8850669],"study_design_scores_gemma":[0.025405321,0.0064034495,0.65311277,0.000528039,0.00045903798,0.00007358182,0.0029065346,0.00019596175,0.13539058,0.00075714826,0.17381047,0.00095712236],"about_ca_topic_score_codex":0.0034155163,"about_ca_topic_score_gemma":0.00007059838,"teacher_disagreement_score":0.8841098,"about_ca_system_score_codex":0.00016602689,"about_ca_system_score_gemma":0.00012778625,"threshold_uncertainty_score":0.56706},"labels":[],"label_agreement":null},{"id":"W2080514612","doi":"10.1016/j.jval.2012.03.274","title":"PMS85 Why the Findings of Published Rheumatoid Arthritis Multiple Treatment Comparisons are So Different - An Overview of Recurrent Methodological Shortcomings","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University","funders":"","keywords":"Medicine; Rheumatoid arthritis; MEDLINE; Clinical trial; Systematic review; Inclusion and exclusion criteria; Set (abstract data type); Intensive care medicine; Alternative medicine; Internal medicine; Pathology; Computer science","score_opus":0.29114910579217845,"score_gpt":0.4201042715320374,"score_spread":0.12895516573985893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080514612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8783121,0.1166017,0.00014125218,0.0036325466,0.00018496145,0.0010058938,0.00006375593,0.000028256512,0.000029516217],"genre_scores_gemma":[0.8264954,0.171588,0.0015720973,0.00017070145,0.000034783036,0.00007286604,0.00004199702,0.000018673574,0.000005443864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959423,0.0014841923,0.0010301614,0.00029782692,0.00054082455,0.0007047053],"domain_scores_gemma":[0.9973722,0.0012037808,0.00034933697,0.00053885917,0.000095454314,0.0004403546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024651473,0.00024321408,0.0012278797,0.0002042644,0.00014294495,0.000031143187,0.00020506601,0.00009772981,0.00019606201],"category_scores_gemma":[0.0008520861,0.00014665393,0.00020574073,0.00028370586,0.0002865954,0.00019075263,0.00007786499,0.0003399937,0.0000038355474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000527869,0.0031647861,0.93648034,0.00045180146,0.00011466999,0.0000042529596,0.005626512,0.000025978667,0.00026650203,0.0042338497,0.0015903673,0.047513075],"study_design_scores_gemma":[0.0060693277,0.004084466,0.9465824,0.004313555,0.000006985475,0.00009972129,0.002254941,0.0022357595,0.0025932307,0.0007098535,0.030781085,0.0002687027],"about_ca_topic_score_codex":0.006007581,"about_ca_topic_score_gemma":0.00078645477,"teacher_disagreement_score":0.054986306,"about_ca_system_score_codex":0.00021169151,"about_ca_system_score_gemma":0.00019283057,"threshold_uncertainty_score":0.9081706},"labels":[],"label_agreement":null},{"id":"W2080705326","doi":"10.1111/j.1524-4733.2007.00297.x","title":"The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":162,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Medicine; Hepatocellular carcinoma; Quality of life (healthcare); Environmental health; Mainland China; China; Demography; Geography; Internal medicine; Nursing","score_opus":0.4000795073752126,"score_gpt":0.44576979118670296,"score_spread":0.04569028381149037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080705326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944112,0.002322157,0.000041008407,0.0011622574,0.00010319576,0.00089299364,0.00095157215,0.000011478835,0.00010414929],"genre_scores_gemma":[0.99899423,0.00065168587,0.00011095611,0.00010457275,0.000049056067,0.000035609402,0.000023714483,0.00001289083,0.000017290175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99386334,0.0014590811,0.0040106047,0.0002877686,0.00013377459,0.00024543508],"domain_scores_gemma":[0.9911043,0.00525339,0.003048284,0.00038170078,0.0001031091,0.00010920452],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008360611,0.00013551638,0.0010472861,0.0003000729,0.00015995,0.0000069319885,0.00014341608,0.000075498654,0.00006572705],"category_scores_gemma":[0.0059893373,0.00013288636,0.00009206545,0.00028280678,0.00018489998,0.00011469934,0.000035468074,0.00016208432,0.0000067388646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004659975,0.00059114216,0.97664344,0.0002553279,0.000080495694,1.1044359e-7,0.0121047655,0.0036917878,0.000002104404,0.0062715127,0.0002458495,0.000066836736],"study_design_scores_gemma":[0.0016176688,0.0010604479,0.9708028,0.00009865709,0.000001370501,4.3855405e-7,0.0012162867,0.023845363,0.0000018080257,0.0012310992,0.00003444551,0.00008962117],"about_ca_topic_score_codex":0.46541768,"about_ca_topic_score_gemma":0.0071882294,"teacher_disagreement_score":0.45822945,"about_ca_system_score_codex":0.00067588664,"about_ca_system_score_gemma":0.0010081091,"threshold_uncertainty_score":0.7170229},"labels":[],"label_agreement":null},{"id":"W2080840536","doi":"10.1016/j.jval.2014.08.1845","title":"Validation of A Global Economic Model to Evaluate The Cost-Effectiveness Of Targeted Treatments Using Companion Diagnostics In Advanced/Metastatic Cancer Treatment Using Kras Testing For Cetuximab Therapy In Metastatic Colorectal Cancer","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cetuximab; KRAS; Medicine; Colorectal cancer; Oncology; Internal medicine; Cancer; Cost effectiveness; Cost-effectiveness analysis; Clinical trial","score_opus":0.18990676041061058,"score_gpt":0.44365032983370684,"score_spread":0.2537435694230963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2080840536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897688,0.0028630015,0.00075747294,0.00011492894,0.0001457548,0.0059799897,0.00035564197,0.000007661973,0.0000067206693],"genre_scores_gemma":[0.9919565,0.0007554585,0.005689862,0.000041958276,0.0000169748,0.0014939664,0.000020504249,0.000024008143,7.8662345e-7],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979027,0.000505332,0.00070157065,0.00034268489,0.00017518872,0.00037250723],"domain_scores_gemma":[0.998229,0.0011394687,0.0002961379,0.00014484355,0.000120715296,0.00006981661],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008229107,0.0002538761,0.00095581944,0.00014984225,0.0000730955,0.000006644986,0.0000598629,0.000028060433,0.0000025897102],"category_scores_gemma":[0.00020415327,0.00018224376,0.00007631128,0.00045848938,0.000049429556,0.00006751036,0.000022032065,0.00005782454,1.4542061e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014526863,0.00051789085,0.31378135,0.00025936737,0.00013377728,0.000001199131,0.00089299213,0.6643778,0.0015380856,0.000028551258,3.7285187e-7,0.017015914],"study_design_scores_gemma":[0.011412165,0.0030710378,0.25936958,0.0013319192,0.0001710426,0.000002955802,0.00017919054,0.7190669,0.0047823857,0.0004889148,0.0000014887013,0.00012241014],"about_ca_topic_score_codex":0.06898096,"about_ca_topic_score_gemma":0.0042651407,"teacher_disagreement_score":0.06471582,"about_ca_system_score_codex":0.006576484,"about_ca_system_score_gemma":0.0012078144,"threshold_uncertainty_score":0.9972371},"labels":[],"label_agreement":null},{"id":"W2081004753","doi":"10.1016/s1098-3015(10)73922-x","title":"PIH56 CARESS: THE CANADIAN REGISTRY OF SYNAGIS, SUMMARY OF 2006–2008 RSV SEASONS","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Conferences and Exhibitions Management","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine","score_opus":0.04848283894594548,"score_gpt":0.318694454467332,"score_spread":0.27021161552138656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081004753","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25691828,0.010667867,0.000086581305,0.36121145,0.0009230274,0.0020093676,0.00038340292,0.00006239325,0.36773762],"genre_scores_gemma":[0.99740505,0.0011759057,0.00010397027,0.00060179643,0.000065517364,0.000004715402,0.000006846233,0.0000026271102,0.00063354813],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99878496,0.0002686371,0.00023826864,0.000122065765,0.0002703515,0.00031571527],"domain_scores_gemma":[0.9993198,0.00007970436,0.00013473078,0.00024975187,0.000070549824,0.00014549983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010639363,0.000057225127,0.00014982952,0.0001055073,0.00032083673,0.000021787517,0.0002813282,0.000048774466,0.000052020092],"category_scores_gemma":[0.00011548353,0.000048383452,0.000042715776,0.00042274516,0.0001679038,0.000045792098,0.000014453038,0.00011584881,0.0000023575083],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001942433,0.0001973068,0.043298937,0.0002500881,0.00002568435,0.000016846983,0.02573925,0.005026116,0.0000052888395,0.7560793,0.12744273,0.04189902],"study_design_scores_gemma":[0.00060139433,0.00042823382,0.16994956,0.0012196496,0.000028403956,0.0000015957311,0.041574318,0.0020419203,0.000018954,0.022124842,0.7616231,0.00038803736],"about_ca_topic_score_codex":0.96014315,"about_ca_topic_score_gemma":0.93997496,"teacher_disagreement_score":0.7404868,"about_ca_system_score_codex":0.00028252913,"about_ca_system_score_gemma":0.0023024222,"threshold_uncertainty_score":0.40843982},"labels":[],"label_agreement":null},{"id":"W2081303573","doi":"10.1016/j.jval.2011.08.712","title":"PHP162 Impact of AMNOG on Pharmaceutical Pricing Trends in Germany","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Inflation (cosmology); Deflation; German; Biosimilar; Price setting; Health care; Business; Product (mathematics); Economics; Reference price; Monetary economics; Monetary policy; Geography; Medicine; Economic growth; Microeconomics","score_opus":0.26620551699215866,"score_gpt":0.40005730019361646,"score_spread":0.1338517832014578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081303573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9452559,0.00089646154,0.00002369783,0.00075051445,0.00020673304,0.00016016625,0.0000977572,0.0000139782,0.052594822],"genre_scores_gemma":[0.9979406,0.00063564815,0.00016681962,0.0010993527,0.00006235693,0.000009255562,0.000003413756,0.000022307198,0.000060244864],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9979874,0.000055293138,0.001066489,0.0003252008,0.000027003012,0.00053859735],"domain_scores_gemma":[0.9991457,0.00008739089,0.00030641892,0.00024086781,0.000006399557,0.00021323582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011399877,0.00015476532,0.0005409332,0.00088650314,0.000024929366,0.000009117988,0.00020041838,0.00008459487,0.0007838124],"category_scores_gemma":[0.00004321335,0.00016995976,0.00014653632,0.00047606582,0.000048215967,0.000106090134,0.0000407809,0.00033851175,0.00016244814],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003271928,0.0013564865,0.44070354,0.00021109449,0.000068151974,0.000017507624,0.0053155716,0.0076950556,0.000040809653,0.5219819,0.0007092615,0.021573396],"study_design_scores_gemma":[0.0025826425,0.00063461,0.84210765,0.0001111166,0.0000026147575,0.0000057568186,0.00002299103,0.11692134,0.00019623902,0.030681198,0.0063219867,0.0004118581],"about_ca_topic_score_codex":0.011260811,"about_ca_topic_score_gemma":0.000044447297,"teacher_disagreement_score":0.49130073,"about_ca_system_score_codex":0.00053300295,"about_ca_system_score_gemma":0.00007508647,"threshold_uncertainty_score":0.9953233},"labels":[],"label_agreement":null},{"id":"W2081456183","doi":"10.1016/s1098-3015(10)75101-9","title":"PIN43 COST-EFFECTIVENESS OF 13-VALENT AND 10-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION RELATIVE TO 7-VALENT PNEUMOCOCCAL CONJUGATE VACCINATION IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Conjugate; Vaccination; Pneumococcal vaccination; Pneumococcal conjugate vaccine; Medicine; Virology; Streptococcus pneumoniae; Microbiology; Mathematics; Biology; Antibiotics","score_opus":0.032753104143381985,"score_gpt":0.31742763592056944,"score_spread":0.28467453177718743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081456183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881848,0.0003739123,0.00014680777,0.0058438485,0.00041563256,0.0042287083,0.00005467902,0.000043462234,0.0007081219],"genre_scores_gemma":[0.9983591,0.00042050311,0.000038418773,0.0007850483,0.00006629065,0.00020485919,0.000034256016,0.000030086634,0.000061463084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99591756,0.0010690026,0.0012020255,0.00064131245,0.00052288774,0.00064720825],"domain_scores_gemma":[0.997928,0.00058802206,0.00036747646,0.00034819436,0.0002744102,0.0004938809],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015414456,0.0003542578,0.00088347873,0.0006399431,0.00014253691,0.000015895295,0.000115561095,0.00017068052,0.000042224434],"category_scores_gemma":[0.00046898093,0.00034184832,0.00009017713,0.00081660214,0.000029087587,0.00020996468,0.00005149271,0.00056711514,0.000012064446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027576026,0.0028721201,0.77428263,0.005170495,0.0001807776,0.0003377277,0.0042419275,0.068470664,0.08920461,0.0048185824,0.00043079795,0.047232058],"study_design_scores_gemma":[0.0039235526,0.0019393624,0.9834417,0.0011288045,0.00003451564,0.000060118215,0.00019125942,0.003972944,0.0034588655,0.0004183042,0.0011453194,0.0002852204],"about_ca_topic_score_codex":0.17268704,"about_ca_topic_score_gemma":0.11850695,"teacher_disagreement_score":0.2091591,"about_ca_system_score_codex":0.003900267,"about_ca_system_score_gemma":0.0023044439,"threshold_uncertainty_score":0.9999236},"labels":[],"label_agreement":null},{"id":"W2081978352","doi":"10.1016/j.jval.2013.08.1903","title":"Cost-Effectiveness of Expanded Newborn Screening in Texas—Author Response to Letter to the Editor","year":2013,"lang":"en","type":"letter","venue":"Value in Health","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Paragraph; Medicine; Cost effectiveness; Value (mathematics); Sentence; Newborn screening; Pediatrics; Actuarial science; Family medicine; Statistics; Computer science; Artificial intelligence; Mathematics","score_opus":0.04811401227154429,"score_gpt":0.3318210681264939,"score_spread":0.28370705585494965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2081978352","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25783223,0.0022142308,0.008021258,0.720369,0.0047718203,0.006489479,0.00020900927,0.000013565139,0.00007939074],"genre_scores_gemma":[0.02357278,0.00019664195,0.008612539,0.93924004,0.02368817,0.0014802811,0.00041391712,0.0002015107,0.0025941273],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99507284,0.0026937863,0.0006002616,0.0006597452,0.00033451323,0.00063883426],"domain_scores_gemma":[0.9984703,0.00032343258,0.0001732796,0.0008214494,0.000080563725,0.00013096216],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0030495916,0.00031235346,0.0005303833,0.00029342185,0.00004338992,0.000026525038,0.000558964,0.00054783677,0.000019860978],"category_scores_gemma":[0.00059568544,0.00025299197,0.00010329933,0.00034469142,0.000050521074,0.0000030012068,0.00020395871,0.00064021215,0.000035696994],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073046243,0.000033882912,0.0011926364,0.0002787228,0.000018889608,0.0000061491737,0.00023669074,0.003698788,0.0031289076,0.0000014527075,0.98385537,0.006818028],"study_design_scores_gemma":[0.00064703374,0.0002933138,0.0240382,0.00037603214,0.000005410873,0.000001852539,0.000040018636,0.000031441537,0.0016902923,0.00001992074,0.9726065,0.00024999748],"about_ca_topic_score_codex":0.0030475473,"about_ca_topic_score_gemma":0.00012348965,"teacher_disagreement_score":0.23425946,"about_ca_system_score_codex":0.000025279049,"about_ca_system_score_gemma":0.0003732941,"threshold_uncertainty_score":0.99999225},"labels":[],"label_agreement":null},{"id":"W2082013793","doi":"10.1016/j.jval.2011.01.006","title":"Cost Utility Analysis Based on a Head-to-Head Phase 3 Trial Comparing Ustekinumab and Etanercept in Patients with Moderate-to-Severe Plaque Psoriasis: A Canadian Perspective","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Ustekinumab; Etanercept; Medicine; Psoriasis; Clinical trial; Randomized controlled trial; Population; Physical therapy; Dermatology; Internal medicine; Infliximab; Disease; Environmental health","score_opus":0.08889802513076007,"score_gpt":0.3092991665688152,"score_spread":0.22040114143805511,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082013793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635756,0.00012103933,0.000084623774,0.00024761888,0.00022848403,0.002171989,0.00032839156,0.000027060589,0.00043322623],"genre_scores_gemma":[0.99885726,0.00000764925,0.0002730295,0.00046179435,0.000016251006,0.0001791497,0.0001636118,0.000020257366,0.000021011376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711114,0.0009053525,0.00048534418,0.0007120383,0.000081530736,0.00070460734],"domain_scores_gemma":[0.9989866,0.0001461168,0.000119457596,0.00039410286,0.00008627883,0.0002674366],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005668869,0.00031053656,0.0008082742,0.0011952275,0.00021106495,0.00001731045,0.00015096692,0.00020425858,0.0001309498],"category_scores_gemma":[0.00007434177,0.00027354722,0.00007854383,0.0010422275,0.000053661952,0.00006684788,0.000023475044,0.00028985494,0.000035933703],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23896632,0.0037728227,0.7130259,0.000045681605,0.00074318197,0.00005317373,0.023480427,0.01069178,0.000007871391,0.00022748557,0.000081328864,0.008904008],"study_design_scores_gemma":[0.1429919,0.0058183107,0.84374666,0.00022130748,0.00026955816,0.0000035348921,0.0015154692,0.004619985,0.00008193387,0.00005990678,0.00013444347,0.0005370209],"about_ca_topic_score_codex":0.5634032,"about_ca_topic_score_gemma":0.56964856,"teacher_disagreement_score":0.13072072,"about_ca_system_score_codex":0.001046632,"about_ca_system_score_gemma":0.0007155838,"threshold_uncertainty_score":0.9999717},"labels":[],"label_agreement":null},{"id":"W2082026256","doi":"10.1016/s1098-3015(10)60907-2","title":"PHP47 CHILDREN IN NEED OF PHARMACARE: ANALYSIS OF MEDICATION FUNDING REQUESTS AT THE TORONTO HOSPITAL FOR SICK CHILDREN","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sick child; Family medicine; Medicine; Business; Pediatrics","score_opus":0.08456651502037711,"score_gpt":0.4036211430551177,"score_spread":0.3190546280347406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082026256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96517265,0.01786873,0.000022785089,0.015359871,0.000094691284,0.0009990272,0.000049632945,0.000009663542,0.000422959],"genre_scores_gemma":[0.99028003,0.008702409,0.00014792816,0.00064539805,0.0001022058,0.00003024475,0.00004757952,0.000008944071,0.000035285248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856544,0.00016125334,0.0005592006,0.00018983359,0.00026635322,0.00025794012],"domain_scores_gemma":[0.99884105,0.00049644976,0.0003379812,0.00018548203,0.000041086303,0.00009796444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011356998,0.00009544501,0.00043966962,0.00009875113,0.00006202579,0.0000028331497,0.00010500603,0.00004401052,0.00022666625],"category_scores_gemma":[0.00030113623,0.00006858416,0.000104991006,0.0004951963,0.00006362942,0.000089711044,0.000043043085,0.00013767123,0.0000014164382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018050129,0.00044114827,0.9769894,0.00017393735,0.0007230322,6.2508343e-7,0.0033698792,0.00037206511,0.000088756715,0.00026127318,0.0015368895,0.015862526],"study_design_scores_gemma":[0.0022303746,0.00040873807,0.9811554,0.00012631416,0.00055961224,0.0000030066778,0.00025985652,0.013654952,0.00031784753,0.000040066367,0.0011520083,0.00009184664],"about_ca_topic_score_codex":0.022081694,"about_ca_topic_score_gemma":0.0010137405,"teacher_disagreement_score":0.025107365,"about_ca_system_score_codex":0.00036440347,"about_ca_system_score_gemma":0.000034870343,"threshold_uncertainty_score":0.9844304},"labels":[],"label_agreement":null},{"id":"W2082478455","doi":"10.1016/s1098-3015(10)72646-2","title":"PMS60 UTILIZING HEALTH SURVEY AND ADMINISTRATIVE DATA TO ESTIMATE THE BURDEN OF OSTEO-ARTHRITIS IN ONTARIO","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Survey data collection; Environmental health; Medicine; Business; Statistics; Mathematics","score_opus":0.31362382286303836,"score_gpt":0.5164293495869549,"score_spread":0.2028055267239165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082478455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9207182,0.0014738577,0.000015975242,0.07159959,0.0011656896,0.002823323,0.0005023829,0.00003815424,0.0016628548],"genre_scores_gemma":[0.98130864,0.00078534614,0.0040434976,0.01305634,0.00015319888,0.00009031833,0.00024305344,0.000037351227,0.0002822414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99386704,0.0023690502,0.0017856586,0.00058602786,0.0003329537,0.0010592581],"domain_scores_gemma":[0.994952,0.0028172676,0.0005526401,0.0011296421,0.00009736731,0.000451052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0115429945,0.00022177884,0.0008583351,0.00023386642,0.00053998805,0.000013680949,0.00061401946,0.00017955019,0.00013000875],"category_scores_gemma":[0.0010448253,0.00018026664,0.000024254437,0.00046735752,0.00010125283,0.00019143325,0.000546754,0.0022627353,0.000023838611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002541336,0.000099886216,0.89111197,0.0010795819,0.000011535511,0.0000137698635,0.060815416,0.000082864324,0.000020820933,0.0034174789,0.011068554,0.032023966],"study_design_scores_gemma":[0.0011035084,0.00040272877,0.9516231,0.0007414676,0.0000015425055,0.0000065231206,0.002881711,0.00038466565,0.0000015715216,0.00038121277,0.042310823,0.00016113564],"about_ca_topic_score_codex":0.93959326,"about_ca_topic_score_gemma":0.98426515,"teacher_disagreement_score":0.060590483,"about_ca_system_score_codex":0.00083938823,"about_ca_system_score_gemma":0.019186394,"threshold_uncertainty_score":0.9863739},"labels":[],"label_agreement":null},{"id":"W2082533143","doi":"10.1016/j.jval.2013.03.259","title":"Methodological challenges in mapping a disease specific psychometric instrument to a disease specific utility instrument: The effect of alternate utility transformations and within-instrument sub-scale correlations on model fit","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Public Health","funders":"","keywords":"Statistics; Regression; Linear regression; Mean squared error; Scale (ratio); Regression analysis; Goodness of fit; Correlation; Bayesian multivariate linear regression; Mathematics; Computer science; Cartography","score_opus":0.6579624753232105,"score_gpt":0.416521617926628,"score_spread":0.2414408573965825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082533143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92273134,0.0051749283,0.005165093,0.061265234,0.00040911336,0.0044700066,0.00042916666,0.000033555505,0.00032156796],"genre_scores_gemma":[0.9904022,0.0047195456,0.0029086897,0.0011034216,0.000057311,0.00074994884,0.00002462947,0.000024362078,0.000009879146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9914427,0.0023718935,0.0043756766,0.00091511535,0.00026579158,0.00062885374],"domain_scores_gemma":[0.9948181,0.0023716288,0.0011866472,0.00088016636,0.00003871247,0.0007047253],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02255809,0.00034156625,0.0011937912,0.0011104806,0.00025432344,0.000075871154,0.0003611841,0.00011225996,0.00009347627],"category_scores_gemma":[0.0012649363,0.00031748685,0.00015513203,0.000820852,0.00013927273,0.00042622854,0.000078054225,0.00045250962,0.00014579437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008370397,0.0013185242,0.7187709,0.004244157,0.000077873556,0.0000018735701,0.018407801,0.097327285,0.0000026172715,0.10604616,0.0008744515,0.052091304],"study_design_scores_gemma":[0.0013816572,0.00026655965,0.6424511,0.00042533857,0.0000038091732,0.0000011534519,0.0005570911,0.323976,0.0000034083841,0.029801613,0.00088099466,0.0002512611],"about_ca_topic_score_codex":0.0013305894,"about_ca_topic_score_gemma":0.00011673915,"teacher_disagreement_score":0.22664873,"about_ca_system_score_codex":0.0008868913,"about_ca_system_score_gemma":0.00017989217,"threshold_uncertainty_score":0.9999277},"labels":[],"label_agreement":null},{"id":"W2082535293","doi":"10.1016/j.jval.2012.03.1306","title":"PIN30 Economic Evaluation of a Cluster Randomized Controlled Trial of an Influenza Immunization Program Directed at Healthy Children","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Herd immunity; Randomized controlled trial; Immunization; Vaccination; Population; Herd; Cost effectiveness; Environmental health; Demography; Immunology; Internal medicine; Veterinary medicine","score_opus":0.10687086818048355,"score_gpt":0.44761079756559446,"score_spread":0.3407399293851109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082535293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96577096,0.0050064917,0.0000045649354,0.00037746463,0.00025241583,0.028240453,0.000016328488,0.00006163114,0.00026969015],"genre_scores_gemma":[0.99558675,0.0006673716,0.0011530044,0.0003430348,0.00023903513,0.0018856755,0.000081226484,0.00003125162,0.000012628958],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9910009,0.005278757,0.0020927254,0.00023995146,0.0008360291,0.0005516698],"domain_scores_gemma":[0.9968986,0.00095729355,0.0010319737,0.00045735145,0.00043722359,0.00021755764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018572694,0.0001959416,0.002135452,0.0004813524,0.00009442301,0.000006475432,0.00010532477,0.00012504247,0.000067829176],"category_scores_gemma":[0.004266693,0.00015194644,0.0002248446,0.0002809941,0.00018826805,0.00018948247,0.00007352156,0.00021395543,0.000009428051],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97522306,0.0013428095,0.011564058,0.00031567103,0.00030416666,7.753441e-8,0.0018746587,0.003019966,0.00003274777,0.00010779188,0.00004735306,0.006167632],"study_design_scores_gemma":[0.90644944,0.0019407264,0.026487395,0.00019361578,0.0001671499,0.0000027915219,0.000043770327,0.06440935,0.00009863908,0.00005306,0.000059872833,0.00009418928],"about_ca_topic_score_codex":0.005665957,"about_ca_topic_score_gemma":0.00009418894,"teacher_disagreement_score":0.06877363,"about_ca_system_score_codex":0.001078199,"about_ca_system_score_gemma":0.0012596957,"threshold_uncertainty_score":0.856527},"labels":[],"label_agreement":null},{"id":"W2082690813","doi":"10.1016/j.jval.2013.08.1319","title":"Validity of Self-Reported Dose of Patients Using Wafarin in Clinical Practice","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Well-being Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Warfarin; Medicine; Concordance; Atrial fibrillation; Internal medicine; Prospective cohort study; Therapeutic index; Cohort; Oral anticoagulant; Clinical trial; Drug","score_opus":0.1972261527360083,"score_gpt":0.4797327177595128,"score_spread":0.2825065650235045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082690813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99557406,0.00021236415,0.000022426308,0.0008865782,0.00089192606,0.0008063057,0.000005901294,0.000019238783,0.0015812037],"genre_scores_gemma":[0.995161,0.00020373533,0.0036926868,0.00083221047,0.000057808207,0.000019757676,0.000003923286,0.000014054404,0.00001480092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99491435,0.0019134805,0.0021765875,0.00030236345,0.00024160146,0.00045162748],"domain_scores_gemma":[0.99664253,0.0015973336,0.0010692016,0.00036835848,0.00020028873,0.00012230795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004443931,0.00011400462,0.0005500614,0.00016636783,0.00003850558,0.0000029758187,0.00011099108,0.00015192779,0.000053203523],"category_scores_gemma":[0.002215644,0.00010902413,0.000056129516,0.0003750652,0.00006394877,0.000096098345,0.000054314787,0.00037626948,0.000028239741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086038504,0.0017702717,0.98875767,0.00033070456,0.00003148376,0.0000069582406,0.0034027752,0.00010305851,0.0000013220814,0.00030943818,0.0007086345,0.004491647],"study_design_scores_gemma":[0.0014913456,0.00048672655,0.99496627,0.00012021724,0.000011617673,0.0000024979659,0.0003402261,0.00069379585,0.0000031727227,0.00031080542,0.0014936511,0.0000796612],"about_ca_topic_score_codex":0.09078253,"about_ca_topic_score_gemma":0.00010554383,"teacher_disagreement_score":0.090676986,"about_ca_system_score_codex":0.0001367609,"about_ca_system_score_gemma":0.00041310617,"threshold_uncertainty_score":0.91527206},"labels":[],"label_agreement":null},{"id":"W2082760996","doi":"10.1111/j.1524-4733.2007.00206.x","title":"Prices for Innovative Pharmaceutical Products That Provide Health Gain: A Comparison Between Australia and the United States","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Government (linguistics); Drug prices; Quarter (Canadian coin); Public economics; Business; Food and drug administration; Constraint (computer-aided design); Economics; Agricultural economics; Monetary economics","score_opus":0.7125117756802034,"score_gpt":0.5351256106638428,"score_spread":0.17738616501636062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2082760996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62140274,0.004252478,0.016232094,0.35093597,0.0005042442,0.0061513623,0.00039026377,0.0000636918,0.0000671286],"genre_scores_gemma":[0.9662765,0.00042743408,0.008413298,0.023779454,0.00050754484,0.00020372163,0.00023566402,0.00004117847,0.00011520404],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99235624,0.00090347935,0.004946567,0.0006807164,0.00013965789,0.0009733493],"domain_scores_gemma":[0.9910821,0.0050649545,0.0030622159,0.00036177185,0.00012822301,0.00030075436],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.069818534,0.00023881177,0.0013780254,0.0006177235,0.00036056267,0.0000853237,0.00025468293,0.00010866048,0.000012500302],"category_scores_gemma":[0.0032044342,0.0002286993,0.000046266698,0.0009678771,0.0002510901,0.00025652864,0.000054955173,0.00042562405,0.00004384585],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035622227,0.00025221222,0.5123105,0.0059952205,0.00012724017,6.2613753e-7,0.032140385,0.002418941,3.025753e-7,0.41649505,0.02829099,0.0016123205],"study_design_scores_gemma":[0.011584977,0.0009861499,0.24877696,0.00082105235,0.0000123876,0.00000846181,0.011342593,0.09044617,0.000051048697,0.048942685,0.5860805,0.0009470486],"about_ca_topic_score_codex":0.029183742,"about_ca_topic_score_gemma":0.0003697816,"teacher_disagreement_score":0.5577895,"about_ca_system_score_codex":0.0009855813,"about_ca_system_score_gemma":0.00049597904,"threshold_uncertainty_score":0.97728103},"labels":[],"label_agreement":null},{"id":"W2083054115","doi":"10.1016/j.jval.2013.08.1912","title":"Pulse Pressure and Stroke Risk: Development and Validation of a Stroke Risk Equation","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiovascular Health and Disease Prevention","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Stroke (engine); Blood pressure; Risk factor; Pulse pressure; Internal medicine; Proportional hazards model; Cardiology; Physical therapy","score_opus":0.028986974064044588,"score_gpt":0.2849339085897046,"score_spread":0.25594693452566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083054115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875208,0.008909561,0.0019751347,0.0002525342,0.00005379938,0.0011615503,0.000033060624,0.000016426067,0.000077110286],"genre_scores_gemma":[0.9936113,0.002148355,0.003963271,0.000050224637,0.00004165839,0.000059495498,0.00004087608,0.000008924145,0.000075932854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857026,0.00032626314,0.0004363057,0.00020643302,0.00026878578,0.00019196434],"domain_scores_gemma":[0.99921846,0.00007911786,0.00022627466,0.00016237819,0.00007261611,0.00024115197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011940352,0.000087314016,0.00026304903,0.00014728765,0.00007418389,0.000011285066,0.000018864801,0.000063679334,0.000026619304],"category_scores_gemma":[0.00027450046,0.00008197454,0.000044647386,0.00008638865,0.000021470934,0.000100855745,0.000022101472,0.00014265798,0.0000050990297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025008558,0.00021239935,0.6909008,0.0034492323,0.00015839897,0.0000016406478,0.0020070865,0.001378166,0.00020120518,0.00013471128,0.00008209306,0.3012242],"study_design_scores_gemma":[0.0023764218,0.00011993389,0.9845678,0.0002521532,0.00011918879,0.0000066925545,0.00018125583,0.010824496,0.00054305646,0.00029029994,0.00064547797,0.000073227566],"about_ca_topic_score_codex":0.010081594,"about_ca_topic_score_gemma":0.00003469502,"teacher_disagreement_score":0.30115095,"about_ca_system_score_codex":0.000056957273,"about_ca_system_score_gemma":0.00031732634,"threshold_uncertainty_score":0.9965104},"labels":[],"label_agreement":null},{"id":"W2083428221","doi":"10.1016/j.jval.2014.03.886","title":"Developing A Population-Based Palliative And End-Of-Life Care Decision-Analytic Policy Model","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Public Health Ontario; Sunnybrook Hospital; Toronto Public Health","funders":"","keywords":"Palliative care; Medicine; End-of-life care; Population; Cohort; Health care; Psychological intervention; Population health; Quality of life (healthcare); Gerontology; Nursing; Environmental health","score_opus":0.1948322112482882,"score_gpt":0.45928779008196297,"score_spread":0.26445557883367476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083428221","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95386505,0.0034812042,0.03935658,0.0025712345,0.00005006069,0.0003614514,0.00002702581,0.00002102578,0.0002663966],"genre_scores_gemma":[0.9389231,0.00051416847,0.059186995,0.0012458988,0.000064008214,0.00000802837,0.000033513792,0.000016318181,0.000007974613],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984282,0.00012696335,0.0006480142,0.00024061727,0.00031228672,0.000243887],"domain_scores_gemma":[0.9983038,0.0008556017,0.00025505124,0.0002221106,0.00017888067,0.00018459861],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004255953,0.00014037364,0.0006022876,0.0003990523,0.00004574776,0.0000042336624,0.00006811579,0.00007759574,0.0000054984635],"category_scores_gemma":[0.0021314952,0.00012387245,0.00006421316,0.00042625688,0.000048418788,0.000037023485,0.000024629344,0.00012367878,0.0000015934446],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013972491,0.000039717786,0.89678705,0.0016377572,0.000029943938,0.0000013663456,0.0057418705,0.06624127,0.000011854276,0.012366314,0.0000271342,0.016975982],"study_design_scores_gemma":[0.0030245886,0.00037034877,0.3789677,0.0066869766,0.00003718857,8.484135e-7,0.0010885026,0.601012,0.000247771,0.007636384,0.0006918591,0.00023581939],"about_ca_topic_score_codex":0.013467711,"about_ca_topic_score_gemma":0.00032846088,"teacher_disagreement_score":0.5347707,"about_ca_system_score_codex":0.00037840873,"about_ca_system_score_gemma":0.0018831049,"threshold_uncertainty_score":0.9931017},"labels":[],"label_agreement":null},{"id":"W2083448577","doi":"10.1016/s1098-3015(10)72690-5","title":"PND28 CROSS CULTURAL EVALUATION OF THE SHORT FORM 8 ITEM PARKINSON'S DISEASE QUESTIONNAIRE: RESULTS FROM AMERICA, CANADA, JAPAN, ITALY AND SPAIN","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Parkinson's disease; Disease; Geography; Medicine; Psychology; Gerontology; Demography; Family medicine; Sociology; Pathology","score_opus":0.03256228623691846,"score_gpt":0.3183591899501326,"score_spread":0.28579690371321415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083448577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99387664,0.0010912647,0.0000055906817,0.0030543206,0.00042001967,0.00086905726,0.0005686141,0.000016607371,0.00009791742],"genre_scores_gemma":[0.9987889,0.000102187085,0.00024071914,0.00048122928,0.00010300115,0.000052144696,0.00016358055,0.0000151451895,0.00005312159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979049,0.00022893326,0.00044627624,0.00037319065,0.00076434575,0.00028235876],"domain_scores_gemma":[0.99866796,0.00011638875,0.00018956815,0.0004325896,0.00018649155,0.0004070328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000817426,0.00016672668,0.00027581432,0.000046950616,0.00014060487,0.000020389776,0.00009224054,0.000056846282,0.000013374749],"category_scores_gemma":[0.0010502323,0.00011458327,0.00005972337,0.00019527592,0.000101184225,0.000097780125,0.00003786988,0.00020820058,0.0000013392488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005829035,0.00030248976,0.9526638,0.00012659487,0.000057349815,0.000020752692,0.00070695457,0.00029987574,0.00019120764,0.00017172603,0.0004608366,0.044415526],"study_design_scores_gemma":[0.0020335766,0.00007440454,0.9685947,0.0002970215,0.000095711504,0.000004538579,0.00010448119,0.02407206,0.00013063985,0.0005028833,0.003992012,0.00009803005],"about_ca_topic_score_codex":0.6259374,"about_ca_topic_score_gemma":0.18899773,"teacher_disagreement_score":0.4369397,"about_ca_system_score_codex":0.00045535335,"about_ca_system_score_gemma":0.00211925,"threshold_uncertainty_score":0.82580096},"labels":[],"label_agreement":null},{"id":"W2083802324","doi":"10.1016/j.jval.2013.03.1495","title":"Systematic review of cost-effectiveness analyses of dabigatran versus warfarin for atrial fibrillation across different health care systems","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; St. Joseph’s Healthcare Hamilton; McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Dabigatran; Warfarin; Medicine; Cochrane Library; Cost effectiveness; Atrial fibrillation; MEDLINE; Intensive care medicine; Systematic review; Meta-analysis; Emergency medicine; Internal medicine; Risk analysis (engineering)","score_opus":0.5688434990308752,"score_gpt":0.5244889395306325,"score_spread":0.044354559500242696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083802324","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3750231,0.57017344,0.0058277594,0.008040927,0.0028922013,0.035687067,0.0022379982,0.000058118876,0.00005935594],"genre_scores_gemma":[0.9864317,0.010983776,0.0006075955,0.0005671695,0.00028165698,0.0008608273,0.0002053387,0.00004963112,0.000012267346],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98698527,0.002489898,0.009215525,0.0005415173,0.0001901695,0.0005776179],"domain_scores_gemma":[0.9869827,0.0047100843,0.0071527846,0.00068980665,0.00024723462,0.00021736111],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.020613015,0.0002593885,0.0039037063,0.00030132572,0.0001414361,0.00003458587,0.00026684944,0.00013300101,0.000016984835],"category_scores_gemma":[0.004921967,0.00027341748,0.00040995557,0.00035220134,0.000054905664,0.00024717115,0.000037830057,0.00012506038,0.000036416426],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062441104,0.00003337407,0.0049629626,0.9746369,0.00015086945,5.3146216e-8,0.0020131732,0.009785556,0.0000015399825,0.008011634,0.00021309241,0.0001283892],"study_design_scores_gemma":[0.0172776,0.0041217743,0.042259086,0.7636735,0.00018384425,0.000010824801,0.015087176,0.15214814,0.00007266569,0.0022655688,0.0012156314,0.001684192],"about_ca_topic_score_codex":0.03253275,"about_ca_topic_score_gemma":0.00022522974,"teacher_disagreement_score":0.61140865,"about_ca_system_score_codex":0.0020677755,"about_ca_system_score_gemma":0.00051600026,"threshold_uncertainty_score":0.9999718},"labels":[],"label_agreement":null},{"id":"W2083812156","doi":"10.1111/j.1524-4733.2004.74005.x","title":"Cost–Utility of Adjuvant High-Dose Interferon Alpha Therapy in Stage III Cutaneous Melanoma in Quebec","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Watchful waiting; Melanoma; Adjuvant; Population; Adjuvant therapy; Alpha interferon; Demography; Internal medicine; Oncology; Interferon; Immunology; Cancer; Environmental health","score_opus":0.04530097712677076,"score_gpt":0.3087643641052053,"score_spread":0.2634633869784345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083812156","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99414515,0.00068883976,0.00012486854,0.0021323315,0.00031965756,0.0018484166,0.000012113652,0.00004775114,0.00068084965],"genre_scores_gemma":[0.99715424,0.0009231713,0.00024576433,0.00070405076,0.000037472717,0.000044675944,0.000014486702,0.000024407507,0.00085172354],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99774265,0.00021840763,0.00092139107,0.0003902536,0.00028599822,0.00044131995],"domain_scores_gemma":[0.99912184,0.00008479113,0.00018942743,0.00042180368,0.000031095304,0.00015102158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006828282,0.00019670482,0.0006344505,0.0005131055,0.00002403488,0.000008726474,0.0001188298,0.000104856445,0.00019310063],"category_scores_gemma":[0.00005595612,0.0001839646,0.00006279898,0.0004655339,0.000062879946,0.000051863197,0.000048304766,0.00038326127,0.000014714074],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024943177,0.010169911,0.1147022,0.003509051,0.00016076535,0.0085678985,0.03537742,0.028337365,0.0044575096,0.0061688656,0.0005810879,0.76302475],"study_design_scores_gemma":[0.08507087,0.023122856,0.7912678,0.006725447,0.000041777002,0.0012957202,0.012801843,0.022058278,0.013857912,0.0032929268,0.038890105,0.0015744417],"about_ca_topic_score_codex":0.4550819,"about_ca_topic_score_gemma":0.154696,"teacher_disagreement_score":0.7614503,"about_ca_system_score_codex":0.0011416208,"about_ca_system_score_gemma":0.00046427423,"threshold_uncertainty_score":0.86072856},"labels":[],"label_agreement":null},{"id":"W2083835995","doi":"10.1016/j.jval.2013.03.947","title":"Costs and health care resource utilization associated with asthma in canada: A systematic review","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Asthma; Medicine; Emergency department; Asthma medication; Asthma management; Health care; MEDLINE; Emergency medicine; Pediatrics; Family medicine; Internal medicine; Psychiatry","score_opus":0.20392814923903718,"score_gpt":0.46536707099998215,"score_spread":0.26143892176094496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083835995","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000023369756,0.96710896,0.0000016645952,0.0020570192,0.00035216328,0.029790252,0.00028473986,0.00008183509,0.00029999495],"genre_scores_gemma":[0.0000877518,0.98851603,0.00007674645,0.0076330504,0.00006803823,0.0025616554,0.0007869005,0.00014838578,0.00012144235],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9748432,0.015886959,0.005377413,0.00098425,0.0009918716,0.0019163182],"domain_scores_gemma":[0.9911105,0.0022745267,0.004470788,0.0009461764,0.00034991602,0.0008480996],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006573543,0.00081552484,0.007697742,0.00048949616,0.00048977626,0.000015645066,0.00044511745,0.0005290965,0.000032763113],"category_scores_gemma":[0.0017237867,0.0006298579,0.000102659185,0.0020113294,0.000042205713,0.0000983059,0.00016374924,0.0022918815,0.0000677476],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000028190996,0.000021530988,0.00038894126,0.9667057,0.00002336119,0.00001984137,0.0011259629,0.000003777896,4.0479602e-11,0.00014203455,0.01165064,0.019915406],"study_design_scores_gemma":[0.00036330143,0.00015429128,0.00041615064,0.7791996,0.00006729124,0.0000128428655,0.0020411394,0.00003355889,3.231785e-10,0.0000025923198,0.21738936,0.00031983797],"about_ca_topic_score_codex":0.9737397,"about_ca_topic_score_gemma":0.9749977,"teacher_disagreement_score":0.20573872,"about_ca_system_score_codex":0.048983924,"about_ca_system_score_gemma":0.056738757,"threshold_uncertainty_score":0.99961525},"labels":[],"label_agreement":null},{"id":"W2083869330","doi":"10.1016/j.jval.2011.02.741","title":"PMS57 ASSOCIATION OF CLINICAL REMISSION AND NORMALIZED PATIENT REPORTED OUTCOMES: A VALIDATION OF TREAT-TO-TARGET FOR THE MANAGEMENT OF RHEUMATOID ARTHRITIS USING POOLED DATA FROM 3 PHASE III GOLIMUMAB CLINICAL TRIALS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital","funders":"","keywords":"Medicine; Golimumab; Rheumatoid arthritis; Internal medicine; Placebo; Population; Physical therapy; Clinical trial; Methotrexate; Visual analogue scale; Etanercept","score_opus":0.38332310201543657,"score_gpt":0.5059408522909685,"score_spread":0.12261775027553196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2083869330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99006265,0.0036999711,0.00231556,0.0005154235,0.00023227124,0.0026909406,0.00044210535,0.000011989256,0.000029061042],"genre_scores_gemma":[0.9172412,0.06267215,0.01967057,0.00006221634,0.00002742797,0.00003394281,0.00026532117,0.000018179137,0.000008983882],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99216783,0.0017960784,0.0048388992,0.00038542834,0.00054916786,0.0002625719],"domain_scores_gemma":[0.99289334,0.0031872066,0.0027135347,0.0007579103,0.00023786712,0.00021012181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019645466,0.00013656779,0.0016371818,0.00013993245,0.00006386798,0.0000075196576,0.0001592585,0.00012701451,0.000056237404],"category_scores_gemma":[0.006916238,0.000095604984,0.0001978633,0.0001931705,0.00007685653,0.00010742605,0.00012678283,0.00017400878,4.6733174e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.026675105,0.005126034,0.4233027,0.00082214444,0.002508674,0.000030168194,0.0042304047,0.00005737722,0.0006461461,0.0002626872,0.00090044807,0.5354381],"study_design_scores_gemma":[0.39532092,0.023577858,0.39892107,0.028555755,0.0005030331,0.0000612721,0.0075506573,0.11102911,0.014291475,0.006696812,0.012551535,0.00094051013],"about_ca_topic_score_codex":0.004669388,"about_ca_topic_score_gemma":0.000029553003,"teacher_disagreement_score":0.5344976,"about_ca_system_score_codex":0.00006618069,"about_ca_system_score_gemma":0.0003584987,"threshold_uncertainty_score":0.8279882},"labels":[],"label_agreement":null},{"id":"W2084102355","doi":"10.1016/j.jval.2014.08.1582","title":"A Utility Algorithm forthe Pressure Ulcer Quality of Life – Utility Instrument (Puqol-Ui)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"EQ-5D; Valuation (finance); Quality-adjusted life year; Medicine; Quality of life (healthcare); Population; Health care; Predictive validity; Economic evaluation; Criterion validity; Actuarial science; Econometrics; Construct validity; Cost effectiveness; Psychometrics; Mathematics; Risk analysis (engineering); Clinical psychology; Environmental health; Economics; Health related quality of life; Nursing","score_opus":0.4302763309359921,"score_gpt":0.4269512398961211,"score_spread":0.0033250910398709976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084102355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8908394,0.008352449,0.03474309,0.050118044,0.0020773516,0.0038567763,0.0021531342,0.00017405838,0.007685696],"genre_scores_gemma":[0.9859883,0.00021411925,0.0075380476,0.005655856,0.00026173436,0.0000917637,0.000042565323,0.000035839395,0.00017173369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9858613,0.0030018638,0.009056131,0.0009899468,0.00027050928,0.00082023797],"domain_scores_gemma":[0.9919543,0.0018202561,0.0043011666,0.0013166188,0.000104316074,0.00050329155],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.06028952,0.00030433066,0.0021077842,0.00034298512,0.00018948362,0.000037481503,0.0004830793,0.00026294278,0.00057664176],"category_scores_gemma":[0.007250601,0.00037124846,0.00022947101,0.00037131069,0.00015915792,0.00036313757,0.00012332921,0.00040893888,0.00025278056],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009114176,0.0007968559,0.78650826,0.005350318,0.000119519726,2.0016326e-7,0.0038655133,0.0011811202,6.216821e-7,0.18143511,0.005100685,0.015550629],"study_design_scores_gemma":[0.0019941947,0.00020989963,0.6292279,0.00021134193,0.0000050939734,0.0000012497167,0.0007371353,0.21061717,0.0000054373486,0.042880695,0.11365164,0.0004582703],"about_ca_topic_score_codex":0.050195932,"about_ca_topic_score_gemma":0.0008937552,"teacher_disagreement_score":0.20943604,"about_ca_system_score_codex":0.00037324388,"about_ca_system_score_gemma":0.00075731793,"threshold_uncertainty_score":0.99987394},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2084263669","doi":"10.1016/j.jval.2014.03.1364","title":"Values Of The Canadian Public Towards Pharmaceutical Reimbursement Decisions","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Reimbursement; Equity (law); Actuarial science; Population; Socioeconomic status; Pairwise comparison; Disease; Analytic hierarchy process; Public health; Medicine; Public economics; Environmental health; Business; Health care; Operations research; Economics; Statistics; Political science; Mathematics; Economic growth; Nursing","score_opus":0.6291567395035133,"score_gpt":0.4772411318254326,"score_spread":0.15191560767808066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084263669","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33775046,0.0037433968,0.0018864366,0.6341362,0.0027469478,0.001836366,0.00030758086,0.00004428217,0.017548308],"genre_scores_gemma":[0.9768264,0.00020241532,0.0018593075,0.020661272,0.00019381502,0.00004652481,0.00000816029,0.000022650576,0.00017940489],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9936675,0.0012478909,0.0037928359,0.00042865105,0.00017814727,0.000684977],"domain_scores_gemma":[0.99632204,0.0011038113,0.0012386052,0.0007225196,0.00006551185,0.00054751395],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03395486,0.00014583391,0.000739024,0.0004942833,0.0003670643,0.00005125101,0.0005261069,0.00012351398,0.0002726106],"category_scores_gemma":[0.009481865,0.00014808393,0.00011925732,0.00044077606,0.00011642178,0.00016511577,0.000070064656,0.0002962266,0.000338295],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004076245,0.00010815232,0.11543835,0.0002461822,0.000024117995,2.5195683e-7,0.0015759118,0.0018433005,4.5188935e-7,0.8608022,0.016800331,0.0031566743],"study_design_scores_gemma":[0.0012069249,0.0001383956,0.21319132,0.00038614272,0.0000040428445,0.0000055475352,0.00049106695,0.08598311,0.0000103423945,0.11451102,0.58370954,0.00036255704],"about_ca_topic_score_codex":0.36910203,"about_ca_topic_score_gemma":0.104063176,"teacher_disagreement_score":0.74629116,"about_ca_system_score_codex":0.0019734504,"about_ca_system_score_gemma":0.0020502897,"threshold_uncertainty_score":0.9988617},"labels":[],"label_agreement":null},{"id":"W2084408716","doi":"10.1016/j.jval.2011.08.106","title":"PMD34 Cost Effectivness of Ambulatory Cardiac Monitor versus Holter","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Implantable loop recorder; Ambulatory; Medicine; Atrial fibrillation; Holter monitor; Ambulatory ECG; Stroke (engine); Probabilistic logic; Emergency medicine; Medical emergency; Cardiology; Computer science; Electrocardiography; Internal medicine; Engineering; Artificial intelligence","score_opus":0.08720318173375785,"score_gpt":0.3638927683078665,"score_spread":0.27668958657410864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084408716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870792,0.0022250218,0.000023421286,0.00034203628,0.003244137,0.0021781693,0.000042085616,0.0000524024,0.0048135077],"genre_scores_gemma":[0.9973118,0.00074448995,0.0006876724,0.00072995253,0.00032683508,0.00009801294,0.000016209284,0.00003557887,0.00004950626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99764955,0.00038678577,0.00065673905,0.00031520362,0.0003425171,0.0006491873],"domain_scores_gemma":[0.9984068,0.00022495232,0.00018197094,0.00043650437,0.000063809974,0.00068593794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014230234,0.00017403059,0.00074930146,0.00022574658,0.000063213745,0.0000022021118,0.00006825203,0.0001308272,0.000033816836],"category_scores_gemma":[0.000089285866,0.00016504874,0.00016115735,0.0003245627,0.00007603431,0.00005788492,0.000034102366,0.00035698272,0.000049007867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013993424,0.0020538839,0.77666205,0.021124534,0.00014080212,0.0001229434,0.01128227,0.00007738353,0.0005961101,0.0019713882,0.0041371165,0.16783811],"study_design_scores_gemma":[0.008357579,0.0034775115,0.9708944,0.0013811019,0.000052986714,0.00002592897,0.0006798854,0.00013540896,0.0034565134,0.00006444155,0.011203897,0.00027032028],"about_ca_topic_score_codex":0.025516216,"about_ca_topic_score_gemma":0.000027198985,"teacher_disagreement_score":0.19423239,"about_ca_system_score_codex":0.00075697765,"about_ca_system_score_gemma":0.00095300085,"threshold_uncertainty_score":0.98097295},"labels":[],"label_agreement":null},{"id":"W2084435843","doi":"10.1016/j.jval.2014.03.1318","title":"Increasing Bariatric Procedure Volume In British Columbia, CanadaA Budget Impact Analysis Over 10 Years","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Activity-based costing; Health care; Population health; Health economics; Population; Obesity; Emergency medicine; Surgery; Environmental health; Public health; Accounting; Nursing; Business; Economics","score_opus":0.09675279162230384,"score_gpt":0.3563918498950329,"score_spread":0.2596390582727291,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084435843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99219763,0.0021015543,0.00017214408,0.0036973062,0.00024715124,0.00073017617,0.00033202473,0.000037546037,0.00048446847],"genre_scores_gemma":[0.99337983,0.00017543296,0.0011078672,0.0043521253,0.0002458499,0.0000568907,0.000078343524,0.000043207852,0.00056045747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99269897,0.0012840811,0.004220672,0.00078098243,0.0001595934,0.0008557224],"domain_scores_gemma":[0.99649465,0.0008213588,0.001714038,0.0005256076,0.00004155363,0.00040281724],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.028801803,0.00016538295,0.0015278147,0.0009899021,0.00015225862,0.0002828803,0.00030242692,0.0002091422,0.0013316041],"category_scores_gemma":[0.005256337,0.00033575587,0.0001902259,0.0018676128,0.000039619794,0.0003602521,0.0000490092,0.00033760114,0.00028489405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005585969,0.000071357616,0.9710404,0.00027411926,0.000053942564,0.000002745093,0.00051096926,0.013351216,6.69439e-8,0.00032823163,0.014007314,0.00035402886],"study_design_scores_gemma":[0.000686939,0.00007309874,0.86848205,0.00010479785,0.000008317504,0.000008040712,0.00013417393,0.12001603,9.391049e-9,0.0018496406,0.008373218,0.00026367343],"about_ca_topic_score_codex":0.97082293,"about_ca_topic_score_gemma":0.80216473,"teacher_disagreement_score":0.16865823,"about_ca_system_score_codex":0.00342175,"about_ca_system_score_gemma":0.0012376799,"threshold_uncertainty_score":0.99990946},"labels":[],"label_agreement":null},{"id":"W2084509185","doi":"10.1111/j.1524-4733.2007.00247.x","title":"Comparison of Persistence Rates with Angiotensin-Converting Enzyme Inhibitors Used in Secondary and Primary Prevention of Cardiovascular Disease","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Quinapril; Medicine; Ramipril; Enalapril; Fosinopril; Cohort; Internal medicine; Lisinopril; Dyslipidemia; ACE inhibitor; Angiotensin-converting enzyme; Disease; Blood pressure","score_opus":0.08006682659150459,"score_gpt":0.3360284285008638,"score_spread":0.2559616019093592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084509185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98652774,0.012052054,0.0004567521,0.00036108107,0.000030575207,0.00043506545,0.0000013465874,0.0000067500705,0.00012863557],"genre_scores_gemma":[0.9985138,0.00015782923,0.001151599,0.00011111237,0.000019386625,0.0000044557355,0.000009241983,0.0000061824735,0.000026391423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877745,0.0000956418,0.00051829766,0.00017966004,0.00027209622,0.0001568349],"domain_scores_gemma":[0.99933666,0.000077016804,0.00020498807,0.00019722074,0.000055635857,0.00012848416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010833034,0.00007152759,0.00041199013,0.00013689691,0.000017365704,0.0000015059259,0.000035478235,0.000033112363,0.000009862005],"category_scores_gemma":[0.00006773821,0.00006320095,0.00005474032,0.00027677132,0.00008692403,0.000052121086,0.000012726248,0.00013990283,9.813224e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003005882,0.00023414932,0.9732051,0.0020243356,0.000046538444,0.000015221719,0.0016174675,0.0004302082,0.00084603106,0.000029177343,0.000039911607,0.021211293],"study_design_scores_gemma":[0.0016335424,0.0003667434,0.98755574,0.0028308914,0.000035646008,0.00000695615,0.0013328661,0.002063065,0.0039230883,0.000033503224,0.00014871836,0.00006922153],"about_ca_topic_score_codex":0.00072196027,"about_ca_topic_score_gemma":0.000016097352,"teacher_disagreement_score":0.021142071,"about_ca_system_score_codex":0.00007414832,"about_ca_system_score_gemma":0.00047380116,"threshold_uncertainty_score":0.25772598},"labels":[],"label_agreement":null},{"id":"W2084578199","doi":"10.1016/j.jval.2011.02.430","title":"PUK15 THE COST-EFFECTIVENESS OF LANTHANUM CARBONATE IN THE TREATMENT OF HYPERPHOSPHATEMIA IN DIALYSIS PATIENTS FROM A CANADIAN PERSPECTIVE","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Therapeutic Uses of Natural Elements","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Kingston General Hospital; St. Paul's Hospital; Queen's University; University of Toronto; Dalhousie University","funders":"","keywords":"Hyperphosphatemia; Medicine; Lanthanum carbonate; Sevelamer; Internal medicine; Dialysis; Urology; Kidney disease","score_opus":0.13749410801536666,"score_gpt":0.40339003614109176,"score_spread":0.2658959281257251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084578199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927137,0.0017160221,3.8520201e-7,0.000650305,0.0003032809,0.003712167,0.00023544402,0.000005212208,0.00066350977],"genre_scores_gemma":[0.9986414,0.00054028304,0.000031124557,0.0003042309,0.000019833193,0.00041451387,0.00002559646,0.00001602322,0.0000070516476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946799,0.0035761092,0.000694068,0.00025667797,0.00025036078,0.00054286415],"domain_scores_gemma":[0.9973827,0.0016911561,0.00032548542,0.0003995837,0.00010805461,0.0000930117],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016089034,0.00016145721,0.0004831758,0.00027186426,0.00011123197,0.0000018056305,0.00032897064,0.00012535926,0.000048994207],"category_scores_gemma":[0.00012639616,0.00009583348,0.00006324092,0.00060399924,0.00006558112,0.000051432937,0.000024738029,0.00036212037,0.000006711948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032112925,0.00048695185,0.8849708,0.00006448905,0.000042054548,0.0000048236784,0.11164023,0.00007635789,0.0000076031856,0.0006665176,0.000005652449,0.0017134282],"study_design_scores_gemma":[0.002799305,0.00040841344,0.98094827,0.00042222312,0.000016128915,7.726191e-8,0.012785794,0.00018504086,0.00006249379,0.0020450645,0.000248022,0.00007917971],"about_ca_topic_score_codex":0.9836667,"about_ca_topic_score_gemma":0.7611752,"teacher_disagreement_score":0.22249152,"about_ca_system_score_codex":0.002916634,"about_ca_system_score_gemma":0.0010550432,"threshold_uncertainty_score":0.76268965},"labels":[],"label_agreement":null},{"id":"W2084635253","doi":"10.1016/j.jval.2012.08.2038","title":"PRS39 Preference and Willingness to Pay for a Treatment of Pulmonary Arterial Hypertension","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; McMaster University; PharmIdeas (Canada)","funders":"","keywords":"Treprostinil; Medicine; Willingness to pay; Preference; Population; Confidence interval; Descriptive statistics; Pulmonary hypertension; Demography; Physical therapy; Internal medicine; Environmental health; Economics; Statistics","score_opus":0.26733216273145527,"score_gpt":0.33045040279658777,"score_spread":0.0631182400651325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084635253","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933392,0.0019795033,0.00031524364,0.002746065,0.0004351005,0.0005886555,0.00021762436,0.0000065482664,0.00037209908],"genre_scores_gemma":[0.99693775,0.0012506793,0.0008498256,0.0006449529,0.00019822105,0.00006221077,0.000006735175,0.000011414192,0.00003819755],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990293,0.000014875713,0.00045948982,0.00018269736,0.000010253436,0.00030343232],"domain_scores_gemma":[0.99945545,0.00009063147,0.0001345161,0.00012369228,0.000007751872,0.00018797567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035227236,0.00008663783,0.00035439522,0.00009430812,0.000034111992,0.000008478505,0.000048939415,0.0000438159,0.000014408544],"category_scores_gemma":[0.000032952743,0.000078281686,0.000034506786,0.00006774437,0.000014386951,0.00007700549,0.00001734165,0.000024173356,0.000017008007],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082791655,0.0028023333,0.51419073,0.0010580037,0.00007119404,0.000001781452,0.0073582893,0.0015531859,0.00063913106,0.36132485,0.00053507445,0.109637514],"study_design_scores_gemma":[0.0041004294,0.0015654957,0.39368212,0.00015190226,0.000010545969,0.000020796244,0.000085949134,0.10405729,0.0007374597,0.051168356,0.44376278,0.00065686513],"about_ca_topic_score_codex":0.001193749,"about_ca_topic_score_gemma":0.0000071921013,"teacher_disagreement_score":0.4432277,"about_ca_system_score_codex":0.00011451174,"about_ca_system_score_gemma":0.000031062038,"threshold_uncertainty_score":0.31922343},"labels":[],"label_agreement":null},{"id":"W2084753710","doi":"10.1016/j.jval.2013.03.251","title":"Comparing EQ-5D valuation studies: A systematic review and methodological reporting checklist","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Checklist; Valuation (finance); Respondent; EQ-5D; Cochrane Library; Population; Systematic review; Medicine; MEDLINE; Data extraction; Economic evaluation; Health care; Actuarial science; Family medicine; Meta-analysis; Psychology; Environmental health; Business; Political science; Accounting","score_opus":0.952289120364427,"score_gpt":0.6028001586182684,"score_spread":0.3494889617461586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084753710","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025405086,0.98246306,0.0005958793,0.005072904,0.00056593155,0.010892843,0.000047806738,0.00007717381,0.000258993],"genre_scores_gemma":[0.000014167671,0.98401743,0.007761589,0.005045551,0.00021540586,0.002542506,0.00006622332,0.00007806687,0.00025906862],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9499108,0.010903348,0.036619794,0.0014887315,0.00022233053,0.000854957],"domain_scores_gemma":[0.938715,0.010949956,0.048544515,0.0012656547,0.00015005106,0.00037484118],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.21151958,0.00064914796,0.018753795,0.00069235975,0.00027139508,0.00011504713,0.00043571825,0.0003945775,0.000055676835],"category_scores_gemma":[0.12296165,0.0006272181,0.0004828371,0.0006305173,0.00010002379,0.00032494724,0.0002083325,0.00079916976,0.0007393483],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[3.6569097e-7,0.000031618667,0.00013877933,0.9852263,0.00018425335,0.0000017213291,0.000589675,0.000026768505,8.571905e-10,0.010618477,0.0018368032,0.0013452922],"study_design_scores_gemma":[0.00026494515,0.00009149426,0.000051166422,0.8858279,0.0004150874,0.000120123295,0.0005496063,0.0025305648,3.6722936e-9,0.0070773633,0.10230071,0.0007710083],"about_ca_topic_score_codex":0.0028202424,"about_ca_topic_score_gemma":0.000040856616,"teacher_disagreement_score":0.100463904,"about_ca_system_score_codex":0.0031079652,"about_ca_system_score_gemma":0.0007228383,"threshold_uncertainty_score":0.99961793},"labels":[],"label_agreement":null},{"id":"W2084778838","doi":"10.1111/j.1524-4733.2008.00408.x","title":"Prevention and Management of Hyperphosphatemia with Sevelamer in Canada: Health and Economic Consequences","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Sevelamer; Medicine; Hyperphosphatemia; Population; Cohort; End stage renal disease; Internal medicine; Kidney disease; Hemodialysis; Intensive care medicine; Environmental health","score_opus":0.03477023672075777,"score_gpt":0.2830222133734211,"score_spread":0.24825197665266333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084778838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97556263,0.022353994,0.0000030777055,0.0014146359,0.000017997578,0.0004851548,0.000006122274,0.0000025462648,0.00015383263],"genre_scores_gemma":[0.9758971,0.022962555,0.0007872899,0.0002537326,0.0000021862102,0.000015145155,0.000006576454,0.0000046809464,0.000070748654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993246,0.00004340569,0.00025246284,0.00015420228,0.00006930071,0.00015600483],"domain_scores_gemma":[0.99970675,0.000015658641,0.00009634636,0.00007004787,0.000004447588,0.000106752406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012360683,0.000068156,0.00024736195,0.000053086384,0.000029118966,0.0000011226645,0.000014358226,0.00001285196,0.0000017635288],"category_scores_gemma":[0.0000014098152,0.00005629024,0.0000056547515,0.00006042058,0.000053969965,0.000028187565,0.000008178051,0.00004411571,4.148629e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000121318306,0.000069055466,0.9961806,0.00028063002,0.000025583464,0.00008124981,0.00046415988,0.00025230116,7.450009e-7,0.00037149404,0.00024176706,0.0019111262],"study_design_scores_gemma":[0.003791889,0.0006960567,0.9930654,0.00040906706,0.0000057704965,0.00012934985,0.000929555,0.00056810485,0.000016598784,0.0001329596,0.00019182632,0.000063400345],"about_ca_topic_score_codex":0.9199917,"about_ca_topic_score_gemma":0.5310081,"teacher_disagreement_score":0.38898358,"about_ca_system_score_codex":0.0004866996,"about_ca_system_score_gemma":0.0025308602,"threshold_uncertainty_score":0.4775498},"labels":[],"label_agreement":null},{"id":"W2084784038","doi":"10.1111/j.1524-4733.2009.00675.x","title":"A Median Model for Predicting United States Population-Based EQ-5D Health State Preferences","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Agency for Healthcare Research and Quality","keywords":"EQ-5D; Statistics; Econometrics; Population; Least absolute deviations; Robustness (evolution); Mathematics; Valuation (finance); Regression; Medicine; Economics; Environmental health","score_opus":0.5862599467820748,"score_gpt":0.4348619440241706,"score_spread":0.15139800275790422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2084784038","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66138446,0.0025151907,0.11080976,0.21783857,0.00070549373,0.003958689,0.002461109,0.00023021371,0.000096505246],"genre_scores_gemma":[0.9205442,0.0004729206,0.02875475,0.048495375,0.00022693287,0.00019737004,0.0011479073,0.00004755206,0.00011296013],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99204975,0.00064653245,0.005506444,0.0007049208,0.00015311629,0.000939243],"domain_scores_gemma":[0.9943046,0.0016472656,0.0030587653,0.00044276446,0.00008953643,0.00045705898],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02121781,0.00025687358,0.0011658326,0.0009754283,0.00036462993,0.000078956655,0.00027876985,0.000118534546,0.000024867908],"category_scores_gemma":[0.0027537881,0.0003260409,0.000097655386,0.0005128437,0.000028451903,0.00033842397,0.000014781512,0.000256694,0.000045722987],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003784979,0.00015283283,0.118507996,0.0010376739,0.000013694218,1.6915534e-7,0.0070468024,0.8524123,5.489572e-8,0.015777402,0.0034561986,0.0015570348],"study_design_scores_gemma":[0.000953531,0.00032334373,0.028500862,0.00030862837,0.0000010403477,3.5874e-7,0.00041706077,0.86834717,2.85209e-7,0.09950114,0.001419201,0.00022738022],"about_ca_topic_score_codex":0.051211245,"about_ca_topic_score_gemma":0.002869385,"teacher_disagreement_score":0.25915977,"about_ca_system_score_codex":0.0017094857,"about_ca_system_score_gemma":0.0013609345,"threshold_uncertainty_score":0.9999192},"labels":[],"label_agreement":null},{"id":"W2085523854","doi":"10.1016/j.jval.2011.08.830","title":"PCV110 Health-Related Quality of Life After Venous Thromboembolism","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton General Hospital","funders":"","keywords":"Medicine; Pulmonary embolism; Dabigatran; Warfarin; Body mass index; Internal medicine; Quality of life (healthcare); Deep vein; Randomized controlled trial; Venous thrombosis; Pediatrics; Thrombosis; Atrial fibrillation","score_opus":0.1100382159669182,"score_gpt":0.325878656340998,"score_spread":0.2158404403740798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085523854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98169464,0.0073367483,0.000052055657,0.004528515,0.0005487975,0.0014319872,0.000020445721,0.000091639384,0.0042951754],"genre_scores_gemma":[0.99094075,0.0019118468,0.001383538,0.005482787,0.0000757966,0.00007509793,0.000014688303,0.00004326049,0.00007224601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962202,0.0005009509,0.0017495184,0.00042562943,0.00042995848,0.0006737865],"domain_scores_gemma":[0.99812573,0.00009077804,0.0005950735,0.0006440675,0.000073609706,0.00047075175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023532093,0.00022432915,0.0017211792,0.0002792386,0.00007054052,0.0000055409914,0.00015085397,0.00012957066,0.00051572704],"category_scores_gemma":[0.00017956072,0.00020876859,0.00015737943,0.0004216652,0.00010680379,0.00009205268,0.00008440489,0.00033051896,0.00007941525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031357927,0.049785014,0.4202928,0.034806345,0.0017858405,0.00031070324,0.18369456,0.00084289454,0.00021332182,0.21769638,0.02277111,0.06466526],"study_design_scores_gemma":[0.0017474742,0.0015196218,0.99091417,0.00073937216,0.00002528992,0.0000067576557,0.0005831402,0.0001078299,0.000036025707,0.0029214197,0.0012152428,0.00018364178],"about_ca_topic_score_codex":0.08209459,"about_ca_topic_score_gemma":0.00038834274,"teacher_disagreement_score":0.57062143,"about_ca_system_score_codex":0.00027755214,"about_ca_system_score_gemma":0.0008237443,"threshold_uncertainty_score":0.92401785},"labels":[],"label_agreement":null},{"id":"W2085934885","doi":"10.1016/s1098-3015(10)70812-3","title":"PMS10 THE COST-EFFECTIVENESS OF ABATACEPT VERSUS RITUXIMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS: A PERSPECTIVE OF THE CANADIAN PUBLICLY FUNDED HEALTH CARE SYSTEM","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Abatacept; Rheumatoid arthritis; Rituximab; Medicine; Perspective (graphical); Health care; Physical therapy; Intensive care medicine; Family medicine; Internal medicine; Immunology; Economic growth; Computer science; Economics; Antibody","score_opus":0.05506993528079645,"score_gpt":0.3258128338802294,"score_spread":0.27074289859943296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085934885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98771834,0.0034301348,0.0000051851766,0.0018310787,0.00019174586,0.005463678,0.00025005863,0.00001747894,0.0010922872],"genre_scores_gemma":[0.9990856,0.0005027056,0.000050637518,0.00010216642,0.000014766611,0.0001814121,0.000026076585,0.00003339377,0.0000032076803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99545586,0.0019395086,0.0006347512,0.00037047477,0.0008823039,0.00071707217],"domain_scores_gemma":[0.99764407,0.00043016442,0.00027325662,0.0006749425,0.0006170245,0.00036056893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001685003,0.00018126942,0.00074265606,0.00041477292,0.0002888201,0.000010967954,0.00027811254,0.000097714386,0.000008139085],"category_scores_gemma":[0.0005510201,0.000119528406,0.00007069503,0.0012662438,0.0003301873,0.00009291874,0.000055838344,0.000629621,0.0000047741096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00149852,0.000434522,0.9738696,0.001764563,0.00005254705,0.00002106404,0.015696466,0.00033550174,4.65456e-7,0.0035383801,0.00008683936,0.002701537],"study_design_scores_gemma":[0.018648975,0.0019636687,0.9637235,0.005222217,0.000002681366,0.000015423695,0.009616795,0.000354036,0.000032623844,0.000011052743,0.00028931347,0.00011971373],"about_ca_topic_score_codex":0.93059856,"about_ca_topic_score_gemma":0.8269388,"teacher_disagreement_score":0.10365973,"about_ca_system_score_codex":0.0077478993,"about_ca_system_score_gemma":0.009920793,"threshold_uncertainty_score":0.9960612},"labels":[],"label_agreement":null},{"id":"W2085952377","doi":"10.1016/j.jval.2012.08.280","title":"PRM29 Preliminary Validation of the Work Productivity Activity Impairment (WPAI) in Caregivers of Children Hospitalized for Respiratory Illness (WPAI: CHRI) in Germany and Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Infant Development and Preterm Care","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Presenteeism; Absenteeism; Medicine; Productivity; Demography; Gerontology; Psychology","score_opus":0.016833975793303847,"score_gpt":0.25982972108898056,"score_spread":0.24299574529567672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2085952377","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99613076,0.00050290447,0.0000015932425,0.0006236843,0.00025247256,0.0024028118,0.000049195496,0.0000052070827,0.000031375064],"genre_scores_gemma":[0.999632,0.000029001125,0.000108518085,0.00007000925,0.000044521945,0.000081305276,0.000016604568,0.000011524008,0.000006533718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985573,0.00031207444,0.00037909852,0.00019714831,0.0002461866,0.000308173],"domain_scores_gemma":[0.99926865,0.0001155113,0.00025687116,0.00024100026,0.00004826664,0.00006970704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014129275,0.00012173811,0.00035652154,0.00013034735,0.000040786617,0.0000020688392,0.000072370174,0.000069425194,0.0000021775197],"category_scores_gemma":[0.00014685631,0.00009955594,0.000033314645,0.0002855401,0.00005214147,0.00011903234,0.000049922044,0.00016622667,2.2977542e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006769508,0.00008216278,0.98683244,0.00081003096,0.000011277543,8.9177274e-7,0.009970625,0.00009938748,0.00009141436,0.000011659899,0.0001252996,0.0012878376],"study_design_scores_gemma":[0.0015722458,0.00021703645,0.99168414,0.0006799685,0.000009348331,0.0000028810284,0.00027038765,0.00003252192,0.005278861,0.000009858141,0.00013230248,0.00011044265],"about_ca_topic_score_codex":0.21167086,"about_ca_topic_score_gemma":0.017298182,"teacher_disagreement_score":0.19437267,"about_ca_system_score_codex":0.00053948525,"about_ca_system_score_gemma":0.0011713069,"threshold_uncertainty_score":0.9652792},"labels":[],"label_agreement":null},{"id":"W2086355585","doi":"10.1016/j.jval.2014.03.586","title":"Insights Into the Pan-Canadian Oncology Drug Revew Recommendations - Three Years After its Inception","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Limiting; Clinical trial; Cost effectiveness; Family medicine; Oncology; Internal medicine; Environmental health; Risk analysis (engineering)","score_opus":0.2974276300427056,"score_gpt":0.4120224945462408,"score_spread":0.11459486450353518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086355585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.538624,0.0064537586,0.0012451513,0.44580355,0.001916502,0.0015566035,0.00007145433,0.000049070037,0.004279944],"genre_scores_gemma":[0.95482,0.0009074203,0.00199981,0.0411622,0.0004662043,0.00028798467,0.000042408632,0.000031329262,0.00028266158],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944799,0.0014486385,0.00299274,0.00049493246,0.000077162294,0.0005066247],"domain_scores_gemma":[0.99668026,0.0012343096,0.001166916,0.0005590886,0.000042652293,0.0003167462],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.016472662,0.00015641424,0.0006486686,0.000568773,0.00031025914,0.0000563117,0.00033403307,0.00015788601,0.00038581103],"category_scores_gemma":[0.0017523438,0.00017373986,0.00007194737,0.00036607235,0.00006414,0.00034118837,0.000048486814,0.00037116683,0.003594154],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003285645,0.00023455422,0.0747753,0.00070745946,0.000058638812,0.0000032297621,0.07122893,0.0026025956,0.0000011481967,0.7177045,0.09444348,0.03820732],"study_design_scores_gemma":[0.00044336866,0.00009321815,0.13425292,0.00015745836,0.0000018484473,0.0000016222491,0.00069815543,0.017166313,3.0811285e-7,0.076145686,0.770821,0.00021813397],"about_ca_topic_score_codex":0.32422408,"about_ca_topic_score_gemma":0.4300522,"teacher_disagreement_score":0.6763775,"about_ca_system_score_codex":0.0028844792,"about_ca_system_score_gemma":0.0009161492,"threshold_uncertainty_score":0.99718165},"labels":[],"label_agreement":null},{"id":"W2086591936","doi":"10.1111/j.1524-4733.2009.00611.x","title":"Cost-Effectiveness of 21 Alternative Cervical Cancer Screening Strategies","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Papanicolaou stain; Medicine; Triage; Pap test; Cervical cancer; Cost effectiveness; Cohort; Cervical cancer screening; Family medicine; Emergency medicine; Cancer; Internal medicine","score_opus":0.19472672086650325,"score_gpt":0.4735913633878683,"score_spread":0.278864642521365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2086591936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.954016,0.008498551,0.005299355,0.008738987,0.00026621332,0.003160123,0.000058630052,0.00007385407,0.019888325],"genre_scores_gemma":[0.9983341,0.0006624079,0.0003231849,0.00044978785,0.00014517535,0.000043485303,0.000008597425,0.000009854677,0.000023421953],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99838156,0.00031435722,0.00030780956,0.00023045708,0.00040463443,0.0003611681],"domain_scores_gemma":[0.9991389,0.0002862877,0.00006491471,0.00016403063,0.0001475413,0.00019834212],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092371786,0.000100868754,0.00040945498,0.00014981431,0.000037010166,0.000010871211,0.00009418051,0.00005758088,0.00038158536],"category_scores_gemma":[0.000072897026,0.00008563722,0.00005788876,0.00038106815,0.00005951954,0.00007322474,0.000023460118,0.00035213982,0.000003290343],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068301787,0.0010341229,0.10050727,0.0060231267,0.0001062805,0.00010706778,0.0028312511,0.04231849,0.001077031,0.031389628,0.0001730733,0.80760247],"study_design_scores_gemma":[0.0025734934,0.001212617,0.98016495,0.0007106333,0.000007479596,0.0000063197563,0.00037532367,0.009201697,0.0016216175,0.0035858343,0.00044805274,0.000091970265],"about_ca_topic_score_codex":0.024989355,"about_ca_topic_score_gemma":0.00022075276,"teacher_disagreement_score":0.8796577,"about_ca_system_score_codex":0.0003290179,"about_ca_system_score_gemma":0.0007827266,"threshold_uncertainty_score":0.9815033},"labels":[],"label_agreement":null},{"id":"W2087528411","doi":"10.1016/s1098-3015(10)70887-1","title":"PRS39 THE IMPACT OF FORMULARY POLICIES ON THE USE OF MEDICATION FOR RESPIRATORY DISEASE: A COMPARISON OF DRUG UTILIZATION IN THE PROVINCES OF ONTARIO AND ALBERTA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Formulary; Medicine; Drug; Disease; Environmental health; Intensive care medicine; Business; Family medicine; Pharmacology; Internal medicine","score_opus":0.6622703420405391,"score_gpt":0.4726263640761462,"score_spread":0.18964397796439292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087528411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843841,0.0020804554,0.00012794285,0.011497453,0.000035968893,0.0016963547,0.00012672428,0.0000015875573,0.000049414262],"genre_scores_gemma":[0.9985347,0.0002790182,0.00011538468,0.00093745143,0.000017429173,0.00007580704,0.000012047632,0.000007359725,0.00002082761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962617,0.0006172449,0.0026987246,0.00015704082,0.00011005979,0.00015521779],"domain_scores_gemma":[0.9926647,0.004178512,0.0026790316,0.00038262215,0.000054576867,0.000040558756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009444517,0.00008553362,0.0005491626,0.00020480675,0.000085758365,0.0000055231,0.00020410967,0.00004182639,0.000009279528],"category_scores_gemma":[0.0026918785,0.000056425924,0.000066391905,0.00019935158,0.00017355251,0.00014513999,0.00001511554,0.00010073321,6.049005e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008480285,0.00023996804,0.88139933,0.00065376033,0.000017673789,1.8707361e-8,0.065438926,0.007724906,9.485195e-7,0.042123165,0.0021574371,0.00015903584],"study_design_scores_gemma":[0.0004913192,0.0003183191,0.9528644,0.00025636845,0.0000036436752,3.31488e-7,0.0015778606,0.03843947,0.000016168025,0.0032337944,0.002735674,0.00006265537],"about_ca_topic_score_codex":0.412654,"about_ca_topic_score_gemma":0.04841823,"teacher_disagreement_score":0.3642358,"about_ca_system_score_codex":0.000395242,"about_ca_system_score_gemma":0.0013353184,"threshold_uncertainty_score":0.9689457},"labels":[],"label_agreement":null},{"id":"W2087879942","doi":"10.1016/j.jval.2011.02.315","title":"PSS13 INCREMENTAL COST-UTILITY ANALYSIS OF DEXAMETHASONE INTRAVITREAL IMPLANT FOR THE TREATMENT OF MACULAR EDEMA FOLLOWING RETINAL VEIN OCCLUSION","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Macular edema; Visual acuity; Retinal Vein; Central retinal vein occlusion; Dexamethasone; Implant; Ophthalmology; Occlusion; Surgery; Internal medicine","score_opus":0.42723641359147124,"score_gpt":0.43144971600393767,"score_spread":0.004213302412466424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087879942","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98499614,0.0034112872,0.005765716,0.0023016653,0.0003593813,0.0020636183,0.00094667345,0.000012761623,0.00014277874],"genre_scores_gemma":[0.99237096,0.00063643197,0.0061217905,0.00053886994,0.00005891552,0.0001381532,0.00009918474,0.000018099634,0.00001757412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940135,0.0006466458,0.0043066996,0.0004715822,0.000125241,0.00043636793],"domain_scores_gemma":[0.9949724,0.0018822849,0.0023813243,0.0005822937,0.000043328848,0.00013837757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018802216,0.00018632693,0.0015376934,0.00055892504,0.00016496523,0.000010088647,0.00024428734,0.00010944905,0.00013726726],"category_scores_gemma":[0.0007462953,0.0001774639,0.00043439184,0.0005471745,0.0000720975,0.00011273216,0.00003468261,0.000083787076,0.000010708719],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048316276,0.0017944415,0.92342675,0.0009918456,0.002058285,0.000004094149,0.039703872,0.0027274166,0.000027576403,0.023485802,0.00060926424,0.0046874764],"study_design_scores_gemma":[0.004042287,0.0022088476,0.72395957,0.0002272699,0.00037728963,0.000006122885,0.004998315,0.2531387,0.00028878037,0.0060937023,0.004225699,0.0004334156],"about_ca_topic_score_codex":0.08875701,"about_ca_topic_score_gemma":0.0020874368,"teacher_disagreement_score":0.25041127,"about_ca_system_score_codex":0.0009809041,"about_ca_system_score_gemma":0.0002448128,"threshold_uncertainty_score":0.917311},"labels":[],"label_agreement":null},{"id":"W2087950211","doi":"10.1016/j.jval.2011.08.1478","title":"PSS13 Economic Burden of Psoriasis and Diabetes in Patients With Psoriasis in the United States","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Psoriasis; Medicine; Diabetes mellitus; Population; Internal medicine; Dermatology; Endocrinology; Environmental health","score_opus":0.026312052098932743,"score_gpt":0.22934285807486096,"score_spread":0.2030308059759282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2087950211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99806786,0.0010293176,3.5466059e-7,0.00014583764,0.00017873633,0.00043138347,0.00007056089,0.000009422867,0.000066534],"genre_scores_gemma":[0.9990049,0.0006174439,0.000083889194,0.00007502795,0.000010732709,0.000042271873,0.00013967523,0.000011989296,0.0000140722495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983103,0.00064931373,0.00042846534,0.00023684376,0.000028823057,0.00034625153],"domain_scores_gemma":[0.9992807,0.00029388414,0.000167269,0.00022282658,0.000016247095,0.000019104307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005969762,0.00015548254,0.00035075523,0.00039227874,0.0000435518,0.000004342373,0.00015760862,0.000114403934,0.00004662409],"category_scores_gemma":[0.000022862758,0.00010734989,0.000025028958,0.00027633645,0.000096375516,0.00006295463,0.00002762965,0.00013438922,0.000014065089],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032544616,0.0002472775,0.9817141,0.00005146349,0.00005696195,0.000001591503,0.011343366,0.0002917288,0.000013377776,0.00028810615,0.00004013842,0.0056264405],"study_design_scores_gemma":[0.0044820895,0.0007355583,0.99199903,0.00012212471,0.000021381607,9.416321e-7,0.0012671032,0.000072672636,0.00044193654,0.0004136244,0.00031113267,0.00013238774],"about_ca_topic_score_codex":0.041395165,"about_ca_topic_score_gemma":0.0012610891,"teacher_disagreement_score":0.040134076,"about_ca_system_score_codex":0.00008693117,"about_ca_system_score_gemma":0.00007120964,"threshold_uncertainty_score":0.9649883},"labels":[],"label_agreement":null},{"id":"W2088184121","doi":"10.1016/j.jval.2013.08.1891","title":"Impact of Major Clinical Events on Utilities in the Context of Secondary Hyperparathyroidism (SHPT) and Chronic Kidney Disease (CKD) Treated with Dialysis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Potassium and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Humber River Regional Hospital; Dalhousie University","funders":"","keywords":"Medicine; Secondary hyperparathyroidism; Kidney disease; Dialysis; Physical therapy; Population; Stroke (engine); Context (archaeology); Parathyroidectomy; Myocardial infarction; Internal medicine; Environmental health; Parathyroid hormone","score_opus":0.02813419561552772,"score_gpt":0.3283664095623736,"score_spread":0.3002322139468459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088184121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926917,0.004138856,6.9444343e-7,0.0019377368,0.00002814529,0.0008240139,0.0000668965,0.000007557047,0.00030439638],"genre_scores_gemma":[0.9971473,0.0021347953,0.0000090371395,0.00055127207,0.000022592194,0.000029634222,0.000038893555,0.000013038595,0.000053438725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823415,0.000453903,0.0006382407,0.00021273154,0.00019867234,0.00026231035],"domain_scores_gemma":[0.99886024,0.0003127371,0.00019269252,0.00029882652,0.000036152844,0.00029935405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005286977,0.00014424609,0.0005372109,0.0001859976,0.000028725193,0.0000036579104,0.00007626805,0.00009247282,0.00007077557],"category_scores_gemma":[0.00019545884,0.00007718962,0.00011956294,0.00027737665,0.0002022865,0.00005291203,0.000013355176,0.00033681607,0.0000057393427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014612682,0.0012775272,0.98625875,0.00048545492,0.00017059506,0.000015428044,0.0020990998,0.000107529864,0.00005088392,0.000093537295,0.0012385396,0.006741415],"study_design_scores_gemma":[0.0074327583,0.0029152315,0.9859541,0.0005709877,0.00007167516,0.0000053609633,0.00090295833,0.0018523611,0.000013917897,0.0001512946,0.000050558032,0.00007881936],"about_ca_topic_score_codex":0.01915463,"about_ca_topic_score_gemma":0.00011723222,"teacher_disagreement_score":0.0190374,"about_ca_system_score_codex":0.00012151419,"about_ca_system_score_gemma":0.001402159,"threshold_uncertainty_score":0.9873769},"labels":[],"label_agreement":null},{"id":"W2088189626","doi":"10.1016/j.jval.2014.03.449","title":"A Canadian Cost Analysis Comparing the Use of Bortezomib or Lenalidomide as Maintenance Therapies in Multiple Myeloma Patients Eligible for Autologous Stem Cell Transplant","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thames Valley Children's Centre; Ottawa Hospital; Hôpital Maisonneuve-Rosemont","funders":"","keywords":"Lenalidomide; Bortezomib; Multiple myeloma; Medicine; Internal medicine; Oncology; Autologous stem-cell transplantation; Pharmacist; Adverse effect; Pharmacy; Family medicine","score_opus":0.10385737084964787,"score_gpt":0.3223793400241688,"score_spread":0.21852196917452094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088189626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995909,0.0001919795,0.00032110207,0.0010818753,0.00004312807,0.0022264142,0.0001709067,0.000012909745,0.000042730182],"genre_scores_gemma":[0.99798733,0.00026702945,0.00086385943,0.0003936037,0.000013358379,0.00019229054,0.00011408843,0.000020337227,0.00014809574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977522,0.00035364187,0.0006088821,0.00030104912,0.00026631326,0.0007179514],"domain_scores_gemma":[0.9978474,0.0011948051,0.00016577933,0.00035897316,0.00009802261,0.0003350337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071916345,0.00017055964,0.0006766284,0.00054180034,0.00011817933,0.000019705747,0.00014709396,0.00006775121,0.000010268092],"category_scores_gemma":[0.00020711693,0.000105603096,0.00012329509,0.00061729975,0.000060315695,0.000058242815,0.000013275556,0.000182382,0.000004473966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019459641,0.0002698073,0.97952926,0.00029267572,0.00018087083,0.00002707343,0.0022448576,0.0065379213,0.000019202636,0.00006263888,0.00010000689,0.008789726],"study_design_scores_gemma":[0.008242638,0.0006682119,0.77778405,0.00039425396,0.00006914723,0.0000049465652,0.000264804,0.21020363,0.00026754325,0.000022511673,0.0019690802,0.00010917258],"about_ca_topic_score_codex":0.67822206,"about_ca_topic_score_gemma":0.5973074,"teacher_disagreement_score":0.20366572,"about_ca_system_score_codex":0.00061932264,"about_ca_system_score_gemma":0.00075096765,"threshold_uncertainty_score":0.4306369},"labels":[],"label_agreement":null},{"id":"W2088252986","doi":"10.1016/s1098-3015(11)72361-0","title":"PCV18 COMPARISON OF MIXED DYSLIPIDEMIAS AMONG HIGH CARDIOVASCULAR RISK PRIMARY CARE PATIENTS: RESULTS OF A POOLED ANALYSIS OF PRIMULA DATA FROM CANADA, SPAIN, SWEDEN, AND THE UNITED KINGDOM","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes and associated disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Primula; Primary care; Medicine; Environmental health; Pooled analysis; Geography; Demography; Family medicine; Internal medicine; Biology; Meta-analysis; Botany","score_opus":0.02002227789510858,"score_gpt":0.25984833166880383,"score_spread":0.23982605377369526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088252986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938779,0.0023415752,0.000028136115,0.00006566923,0.00011758588,0.00031841898,0.0032277906,0.0000024641733,0.0000204967],"genre_scores_gemma":[0.99226725,0.00025404713,0.00023259464,0.000060931827,0.000022119013,0.0000035784635,0.0071459278,0.000012189277,0.0000013469572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975578,0.00070946646,0.00082109455,0.0003730335,0.00032129372,0.00021731302],"domain_scores_gemma":[0.9975713,0.00026900036,0.00081753905,0.0010375646,0.00023180763,0.000072791154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012431174,0.00014134502,0.0008125672,0.00012523426,0.000055575627,0.000005790557,0.00037141418,0.00014715902,0.0000012124702],"category_scores_gemma":[0.00092343404,0.00011276732,0.0001480217,0.0005082576,0.00018115256,0.0000044777935,0.00021214627,0.00020544959,2.7466323e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002914945,0.00014325112,0.966616,0.00015994646,0.0027896909,2.4315386e-7,0.00043488888,0.026614562,0.00045642228,0.000015663862,0.00037899753,0.0020988712],"study_design_scores_gemma":[0.005189861,0.00012530458,0.98049086,0.000090026246,0.0012247582,1.7662872e-8,0.00064358773,0.00946232,0.0015732294,0.000014105706,0.0010347054,0.00015119971],"about_ca_topic_score_codex":0.94739103,"about_ca_topic_score_gemma":0.53048944,"teacher_disagreement_score":0.41690156,"about_ca_system_score_codex":0.000039988037,"about_ca_system_score_gemma":0.00041119207,"threshold_uncertainty_score":0.4780779},"labels":[],"label_agreement":null},{"id":"W2088464345","doi":"10.1016/j.jval.2014.12.001","title":"Applying Dynamic Simulation Modeling Methods in Health Care Delivery Research—The SIMULATE Checklist: Report of the ISPOR Simulation Modeling Emerging Good Practices Task Force","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":229,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Health Authority; University of Saskatchewan; Alberta Bone and Joint Health Institute; University of Calgary","funders":"Agency for Healthcare Research and Quality","keywords":"Checklist; Task force; Computer science; Task (project management); Management science; Medicine; Systems engineering; Psychology; Engineering; Political science","score_opus":0.47942807207061616,"score_gpt":0.6345859861084787,"score_spread":0.15515791403786255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088464345","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00075945415,0.8106184,0.17049204,0.0018161697,0.0010662982,0.014987966,0.00006544982,0.00008542561,0.000108832275],"genre_scores_gemma":[0.0758022,0.88203555,0.03856698,0.00037671288,0.00042621585,0.0016081212,0.0006659431,0.00026983608,0.00024843038],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.96066105,0.02767647,0.007306473,0.0012531608,0.0015035308,0.0015993345],"domain_scores_gemma":[0.9826375,0.006909906,0.0062388,0.0017407575,0.0021261477,0.00034688992],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.054009344,0.0006228887,0.002385886,0.0011909987,0.0026945975,0.000068591886,0.000748337,0.00093084725,0.00000898567],"category_scores_gemma":[0.009017557,0.00045701757,0.00032226645,0.0033187103,0.00007145307,0.0005443132,0.00040649035,0.0049107033,0.0000071248696],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000024831814,0.000042953056,0.000049784456,0.025518324,0.000019096064,0.0000035092507,0.009482316,0.8250419,1.313188e-7,0.00013468279,0.0000038091798,0.13967867],"study_design_scores_gemma":[0.00040217576,0.00006735778,0.0000020034574,0.02892026,0.000045373305,0.0000049160917,0.006476205,0.9118571,1.5880085e-8,0.00025302666,0.051673077,0.0002984342],"about_ca_topic_score_codex":0.03988449,"about_ca_topic_score_gemma":0.0028033631,"teacher_disagreement_score":0.13938023,"about_ca_system_score_codex":0.0063973065,"about_ca_system_score_gemma":0.019020114,"threshold_uncertainty_score":0.99978817},"labels":[],"label_agreement":null},{"id":"W2088539861","doi":"10.1016/s1098-3015(10)70200-x","title":"PCN22 IS CAPECITABINE A COST-EFFECTIVE ADJUVANT TREATMENT OF STAGE III COLON CANCER IN ONTARIO?","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Capecitabine; Stage (stratigraphy); Colorectal cancer; Oncology; Adjuvant; Medicine; Internal medicine; Cancer; Biology","score_opus":0.07148523536523044,"score_gpt":0.35015278678222267,"score_spread":0.27866755141699223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088539861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833808,0.010441767,0.0000012441972,0.0012945466,0.00022681785,0.0035573414,0.00008621677,0.000013002626,0.0009982904],"genre_scores_gemma":[0.9884658,0.0066729807,0.000064866465,0.00026143127,0.000033296492,0.00131563,0.000010207963,0.000014090104,0.0031617142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866915,0.000074270334,0.00041676796,0.00029912713,0.0002002036,0.00034050114],"domain_scores_gemma":[0.9994286,0.00010686231,0.00012915694,0.00017441338,0.00005115451,0.00010985947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011108661,0.00018213836,0.00079879194,0.00015956076,0.0000645534,0.0000014421632,0.00003041905,0.000051075458,0.00025817813],"category_scores_gemma":[0.000012860178,0.00013908782,0.000076006596,0.000250226,0.00006885068,0.000029215213,0.000017344752,0.00012290516,0.000002821151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021501582,0.0016094893,0.9229263,0.00015889117,0.0001384496,0.00027088702,0.041436564,0.00052174134,0.00006457431,0.000029128216,0.00025336788,0.030440416],"study_design_scores_gemma":[0.010095159,0.0060520973,0.9677685,0.0003452947,0.000028412325,0.000015125873,0.0004540068,0.00032948802,0.0005532445,0.000011701298,0.01424192,0.00010505502],"about_ca_topic_score_codex":0.877288,"about_ca_topic_score_gemma":0.691832,"teacher_disagreement_score":0.18545595,"about_ca_system_score_codex":0.0064550224,"about_ca_system_score_gemma":0.0012735373,"threshold_uncertainty_score":0.99735904},"labels":[],"label_agreement":null},{"id":"W2088589445","doi":"10.1016/s1098-3015(10)70623-9","title":"PCV35 GADOFOSVESET IN THE MANAGEMENT OF PERIPHERAL ARTERIAL OCCLUSIVE DISEASE IN CANADA-A MODEL APPROACH FOCUSING ON DIAGNOSTIC CONFIDENCE","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Peripheral; Peripheral arterial occlusive disease; Arterial disease; Confidence interval; Vascular disease; Radiology; Internal medicine","score_opus":0.06984753578411113,"score_gpt":0.31307918440210514,"score_spread":0.243231648617994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2088589445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945736,0.0006761029,0.00020758739,0.0017791487,0.00009927756,0.0020598744,0.000024195553,0.0000059758354,0.00057425146],"genre_scores_gemma":[0.9983145,0.0005150384,0.00045411146,0.00044678946,0.00005343052,0.00014747663,0.000013420584,0.000018267505,0.000036988473],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.997096,0.0004728312,0.00066598115,0.0003390527,0.0008968418,0.000529295],"domain_scores_gemma":[0.99873585,0.00044821936,0.00011921846,0.00047653005,0.000036678193,0.00018349114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001005636,0.00015353081,0.00043265766,0.00020878202,0.000056258905,0.0000062637096,0.0002326406,0.000036562225,0.000008814935],"category_scores_gemma":[0.00022935378,0.000117122945,0.00003648153,0.00043809492,0.00007917541,0.000041748408,0.00005919079,0.00030634835,0.0000016901015],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015662281,0.0010538531,0.59892374,0.008798524,0.000037419824,0.0037243892,0.02549089,0.35469082,0.000024460644,0.004142659,0.001020046,0.00052697625],"study_design_scores_gemma":[0.0077527096,0.00030409283,0.27819526,0.008675517,0.000017899345,0.0008102022,0.010991834,0.69209534,0.000016331782,0.00079033436,0.000043198394,0.00030727917],"about_ca_topic_score_codex":0.6523053,"about_ca_topic_score_gemma":0.07625009,"teacher_disagreement_score":0.57605517,"about_ca_system_score_codex":0.0019644422,"about_ca_system_score_gemma":0.0035824722,"threshold_uncertainty_score":0.94060594},"labels":[],"label_agreement":null},{"id":"W2089020463","doi":"10.1016/j.jval.2011.08.408","title":"PMS22 The Burden of Illness of Osteoporosis in Canada","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; McGill University; Centre hospitalier de l'Université Laval; University of Manitoba; McMaster University","funders":"","keywords":"Medicine; Osteoporosis; Medical prescription; Emergency department; Health care; Emergency medicine; Diagnosis code; Population; Indirect costs; Family medicine; Environmental health; Internal medicine; Nursing","score_opus":0.06398796774920942,"score_gpt":0.3133601141662412,"score_spread":0.2493721464170318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089020463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919498,0.0013316735,8.6297763e-7,0.00459133,0.00012001287,0.0006942485,0.000017661852,0.0000036244655,0.0012908134],"genre_scores_gemma":[0.99875325,0.0004895532,0.00018347829,0.000435391,0.000031861015,0.000024180139,0.0000037378036,0.000011953176,0.00006659895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796087,0.0002611576,0.0007521501,0.00015556843,0.0004402371,0.00043003133],"domain_scores_gemma":[0.99896175,0.00022037553,0.00018022681,0.00035848038,0.000084751875,0.00019443646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013258057,0.000082590785,0.00042226125,0.00015249367,0.000031957952,8.8997825e-7,0.0001495088,0.000049593833,0.00012602296],"category_scores_gemma":[0.0002028635,0.000058353897,0.00003117651,0.00053280924,0.000073664996,0.000023118406,0.0000401039,0.0003040868,0.0000021049525],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012391758,0.00051389774,0.87471706,0.008449186,0.000026472433,0.00007596635,0.062757924,0.000808717,0.00045305563,0.0013918529,0.003090152,0.04647654],"study_design_scores_gemma":[0.0033918824,0.0011086145,0.953945,0.0015856214,0.000009760819,0.000028145527,0.028328482,0.003101276,0.0043268516,0.0003568156,0.0036404575,0.00017709493],"about_ca_topic_score_codex":0.9983455,"about_ca_topic_score_gemma":0.8583258,"teacher_disagreement_score":0.14001973,"about_ca_system_score_codex":0.00049072306,"about_ca_system_score_gemma":0.0073326943,"threshold_uncertainty_score":0.99829483},"labels":[],"label_agreement":null},{"id":"W2089080067","doi":"10.1016/s1098-3015(11)72174-x","title":"PMS21 THE ACUTE CARE COSTS OF OSTEOPOROSIS-RELATED FRACTURES IN CANADA","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteoporosis; Medicine; Intensive care medicine; Emergency medicine; Internal medicine","score_opus":0.01577848480748095,"score_gpt":0.32667215193456717,"score_spread":0.3108936671270862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089080067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800542,0.0025269752,2.0396882e-7,0.015136286,0.00039875094,0.0010582476,0.000042973505,0.000010389421,0.00077199395],"genre_scores_gemma":[0.9967385,0.0004991924,0.0001249187,0.002449538,0.00004277643,0.000033487595,0.00003628887,0.000020492189,0.00005478361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976265,0.00023973554,0.0007206995,0.00024016139,0.0005553438,0.0006175861],"domain_scores_gemma":[0.99854225,0.00036238812,0.0001646968,0.00046589837,0.000120424535,0.00034434098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008657949,0.00013170335,0.00043243924,0.0001663464,0.00008030229,0.000005702743,0.00017608417,0.00013439196,0.00013100567],"category_scores_gemma":[0.0002751987,0.000091002476,0.000041124524,0.0005594871,0.0000758033,0.00003286828,0.000042802145,0.0013738057,0.0000060524458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005415056,0.00021357062,0.9192323,0.0017410191,0.000035553163,0.00018454873,0.009728429,0.00058706466,0.0017220135,0.00067162473,0.005185214,0.060157146],"study_design_scores_gemma":[0.002617433,0.00038439882,0.9850045,0.00051962724,0.000009842436,0.000049596063,0.0038967412,0.0009505419,0.001213567,0.00007042963,0.005161223,0.00012212868],"about_ca_topic_score_codex":0.9879538,"about_ca_topic_score_gemma":0.9817034,"teacher_disagreement_score":0.06577216,"about_ca_system_score_codex":0.0009802504,"about_ca_system_score_gemma":0.010880525,"threshold_uncertainty_score":0.99472684},"labels":[],"label_agreement":null},{"id":"W2089179132","doi":"10.1016/j.jval.2014.03.1112","title":"Optimal information acquisition policies: Application to hepatitis c screening","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Hepatitis C; Hepatitis C virus; Demography; Quality-adjusted life year; Markov decision process; Cost effectiveness; Statistics; Immunology; Markov process; Risk analysis (engineering); Mathematics; Virus","score_opus":0.03451200899937069,"score_gpt":0.3539474941461517,"score_spread":0.319435485146781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089179132","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6452747,0.00004210438,0.33606246,0.0124440575,0.00006519327,0.0014972743,0.000020508167,0.0001148289,0.004478862],"genre_scores_gemma":[0.971912,0.00011776341,0.021709926,0.0058042104,0.00016714419,0.00012740263,0.00011411526,0.000014415724,0.0000329747],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99841017,0.00016071102,0.00046009445,0.00015382569,0.00043646366,0.00037875705],"domain_scores_gemma":[0.999163,0.000071428025,0.00008694172,0.00027865233,0.00010961844,0.0002903995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011550554,0.00009003398,0.00020685552,0.0004420334,0.00008827091,0.000029491734,0.00008212357,0.00006854796,0.000044454177],"category_scores_gemma":[0.00033004052,0.00009476187,0.000028677612,0.00053225964,0.000020525442,0.0002538338,0.00004199309,0.00018420011,0.00038091],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002195291,0.00011913526,0.24519004,0.0010497974,0.000010562412,0.0000023629261,0.005085012,0.052942388,0.00049655815,0.007826729,0.004170204,0.6828877],"study_design_scores_gemma":[0.0012920044,0.0010123937,0.37894315,0.00052638474,0.0000038243184,0.000011584469,0.00013207739,0.5033459,0.00030207235,0.00013429513,0.11412071,0.00017560218],"about_ca_topic_score_codex":0.040570986,"about_ca_topic_score_gemma":0.00013871548,"teacher_disagreement_score":0.6827121,"about_ca_system_score_codex":0.00037327196,"about_ca_system_score_gemma":0.00017530806,"threshold_uncertainty_score":0.9658179},"labels":[],"label_agreement":null},{"id":"W2089490629","doi":"10.1016/j.jval.2012.08.433","title":"PND7 Economic Impact of Dementia in the Community-Dwelling Elderly Population of Quebec (Canada)","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University","funders":"","keywords":"Dementia; Medicine; Rivastigmine; Cohort; Galantamine; Gerontology; Population; Cohort study; Retrospective cohort study; Donepezil; Environmental health; Surgery; Internal medicine; Disease","score_opus":0.37056599405166657,"score_gpt":0.42933135579479637,"score_spread":0.058765361743129796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2089490629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919604,0.0029435598,0.00013783285,0.0035297936,0.00030670743,0.0005690987,0.00011987404,0.0000051915813,0.00042755916],"genre_scores_gemma":[0.99851084,0.00011071085,0.00033493256,0.0008627113,0.00009436823,0.000019492047,0.000040529678,0.000016101834,0.000010322103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99308825,0.001853883,0.0043532676,0.00016251157,0.00008773643,0.00045435375],"domain_scores_gemma":[0.9950038,0.0018196657,0.0025466182,0.00051296136,0.000016189533,0.000100734534],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03040939,0.0001314305,0.0008145144,0.00034987164,0.00010998317,0.000013573505,0.00032428495,0.00008213871,0.00009645027],"category_scores_gemma":[0.0006782547,0.00014263723,0.00009258737,0.00019093674,0.000033506232,0.0003408832,0.000026894488,0.00030283417,0.000024047338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008797785,0.00009724122,0.9238705,0.00045974902,0.000024629102,5.3889774e-8,0.0058526564,0.03980297,4.541917e-7,0.028817989,0.00091232924,0.00015265284],"study_design_scores_gemma":[0.00041847446,0.00009316304,0.98105687,0.0001399959,0.0000023540276,0.0000011115877,0.0019969335,0.011689582,0.0000014127163,0.0039327983,0.00054292084,0.00012439111],"about_ca_topic_score_codex":0.99177253,"about_ca_topic_score_gemma":0.8881132,"teacher_disagreement_score":0.10365937,"about_ca_system_score_codex":0.0027038632,"about_ca_system_score_gemma":0.0010252644,"threshold_uncertainty_score":0.9983976},"labels":[],"label_agreement":null},{"id":"W2090016518","doi":"10.1016/s1098-3015(10)67762-5","title":"PMH16 EFFECT OF BEHAVIOURAL AND PSYCHOLOGICAL SYMPTOMS OF DEMENTIA (BPSD) ON COST OF CARE IN THE CANADIAN OUTCOMES STUDY IN DEMENTIA","year":2005,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dementia; Gerontology; Medicine; Psychiatry; Psychology; Disease","score_opus":0.12665287068158737,"score_gpt":0.4840669581968342,"score_spread":0.35741408751524684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090016518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911027,0.0020179383,1.8770413e-7,0.001572994,0.0002609366,0.004594432,0.00008331526,0.00000796668,0.00035951386],"genre_scores_gemma":[0.99887246,0.000067915396,0.0000686759,0.0007744298,0.000019752748,0.00016735701,0.000012813251,0.000013543384,0.0000030326496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99333614,0.0036950323,0.0014996965,0.0003141932,0.000431318,0.0007236251],"domain_scores_gemma":[0.9977245,0.0011733329,0.000430813,0.000402695,0.00007883665,0.0001898744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037928552,0.000192412,0.0007702078,0.00046006244,0.0001434239,0.000002748474,0.00029557702,0.00019340473,0.000036930396],"category_scores_gemma":[0.00026054177,0.00013552391,0.000046376743,0.00048176706,0.00008369709,0.00004538901,0.000055612432,0.00066514354,0.00000712794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000146716,0.00035369679,0.9804185,0.0006418172,0.000011604134,0.0000070098517,0.015853208,0.0001722161,7.1386523e-7,0.0002864798,0.0001140508,0.0019940082],"study_design_scores_gemma":[0.0029615103,0.003976099,0.9854956,0.000742276,0.000021002033,6.3171126e-7,0.0065383934,0.000041213625,0.0000047452136,0.000018091414,0.00011992499,0.000080474914],"about_ca_topic_score_codex":0.69793063,"about_ca_topic_score_gemma":0.9014083,"teacher_disagreement_score":0.20347767,"about_ca_system_score_codex":0.00071027747,"about_ca_system_score_gemma":0.00049401185,"threshold_uncertainty_score":0.55265045},"labels":[],"label_agreement":null},{"id":"W2090035412","doi":"10.1016/j.jval.2014.08.518","title":"Cost-Effectiveness of Antiviral Therapy for Chronic Hepatitis B: A Systematic Review","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Entecavir; Lamivudine; Telbivudine; Internal medicine; Adefovir; Chronic hepatitis; Pegylated interferon; Gastroenterology; Immunology; Virus","score_opus":0.18711286790757406,"score_gpt":0.44642041802870064,"score_spread":0.2593075501211266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090035412","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000067446995,0.9589346,0.00021405952,0.00007284961,0.0002786214,0.04024878,0.00015535722,0.00003846485,0.000050516293],"genre_scores_gemma":[0.00012763827,0.99048066,0.00018660787,0.00026616018,0.0001461546,0.008523182,0.00012993565,0.00010784164,0.000031800257],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9928036,0.0034065566,0.0023783636,0.00050849025,0.0003693575,0.0005336292],"domain_scores_gemma":[0.994587,0.002917383,0.0014447386,0.0007623155,0.00017800152,0.00011054315],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006058848,0.0005095354,0.010483589,0.00029653043,0.00006219038,0.000006242097,0.00021078378,0.00021075885,0.000007372457],"category_scores_gemma":[0.0016605404,0.00036507315,0.00081996777,0.0005316416,0.00008099373,0.000034234978,0.000045416222,0.00035731622,0.000030337143],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010960213,0.000085327876,0.00016356441,0.8734507,0.0002263394,0.0000045568386,0.00003286847,4.3399035e-7,4.3124377e-8,0.00018783867,0.00015205714,0.12568533],"study_design_scores_gemma":[0.0007041515,0.0011821818,0.00006794277,0.84499407,0.00066523,0.000025799101,6.047382e-7,0.000044961136,6.426892e-7,0.000022183673,0.15209022,0.0002020316],"about_ca_topic_score_codex":0.0059605814,"about_ca_topic_score_gemma":0.00030072764,"teacher_disagreement_score":0.15193817,"about_ca_system_score_codex":0.001536148,"about_ca_system_score_gemma":0.0022368862,"threshold_uncertainty_score":0.99988014},"labels":[],"label_agreement":null},{"id":"W2090049620","doi":"10.1016/j.jval.2012.03.367","title":"PMD27 Cost-Effectiveness of Sacral Nerve Stimulation in Refractory Overactive Bladder: A Canadian Perspective","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Foothills Medical Centre; Toronto Western Hospital; Jewish General Hospital; Royal Alexandra Hospital; Queen Elizabeth II Health Sciences Centre; Moncton Hospital; Medtronic (Canada)","funders":"","keywords":"Medicine; Sacral nerve stimulation; Formulary; Overactive bladder; Incremental cost-effectiveness ratio; Refractory (planetary science); Cost effectiveness; Emergency medicine; Quality-adjusted life year; Surgery; Family medicine","score_opus":0.09103576255316277,"score_gpt":0.4043551031762139,"score_spread":0.31331934062305117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090049620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99080276,0.0024039021,0.000021596808,0.0007508029,0.00013794935,0.0020844063,0.000048148,0.000012057379,0.0037383772],"genre_scores_gemma":[0.99932075,0.00021508586,0.00011967416,0.000089476234,0.00009048475,0.000065350185,0.000038041217,0.000022713351,0.000038446924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974034,0.0010245856,0.00033694372,0.00023753253,0.0003058436,0.00069168495],"domain_scores_gemma":[0.9983443,0.00071785983,0.00008954422,0.00021266074,0.00015387055,0.0004817366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021576665,0.00013429028,0.00038864542,0.0006523125,0.000052582458,0.000005543292,0.000058515707,0.0001080305,0.00009091775],"category_scores_gemma":[0.00035027988,0.00013186054,0.000050991788,0.0005625685,0.000059427548,0.0002572729,0.000022206354,0.0005399468,0.000014970177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002422759,0.0012093842,0.96702254,0.0008723545,0.00006994741,0.0001041827,0.017481133,0.0035343408,0.0006398773,0.0027209895,0.00009935365,0.0038231423],"study_design_scores_gemma":[0.0022821166,0.0010740475,0.98980397,0.00047814642,0.000008473039,0.00003149235,0.0022449915,0.0024670737,0.00035102162,0.0006823223,0.00045754062,0.00011881925],"about_ca_topic_score_codex":0.73882055,"about_ca_topic_score_gemma":0.024564525,"teacher_disagreement_score":0.714256,"about_ca_system_score_codex":0.0033761868,"about_ca_system_score_gemma":0.0022835927,"threshold_uncertainty_score":0.99323463},"labels":[],"label_agreement":null},{"id":"W2090057746","doi":"10.1016/j.jval.2012.08.1657","title":"PDB14 Characteristics of the Aboriginal People with Diabetes in the South-Western of Ontario, Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; Lawson Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Glycemic; Diabetes mellitus; Cohort; Demography; Epidemiology; Cohort study; Gerontology; Internal medicine; Endocrinology","score_opus":0.01655303372385288,"score_gpt":0.2573064008188452,"score_spread":0.24075336709499232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090057746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99727434,0.00008996961,7.255032e-7,0.0017608098,0.00026097565,0.0003451753,0.000004864625,0.000001786459,0.00026136867],"genre_scores_gemma":[0.9990463,0.000006066081,0.000041766158,0.0006074675,0.000068078625,0.000012010833,0.000009753943,0.0000056425724,0.00020290827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991609,0.00007277971,0.0002475219,0.00006267712,0.00022259349,0.00023353462],"domain_scores_gemma":[0.9994859,0.000065670116,0.00017161873,0.00021281415,0.000023636103,0.000040328854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00057317,0.000060872004,0.00018992287,0.000036415222,0.000019044495,0.0000030364745,0.00009403746,0.000015242262,0.000016986538],"category_scores_gemma":[0.000022631943,0.000034092227,0.000013969284,0.00021909716,0.000022297963,0.000035095876,0.000009464486,0.00012343742,5.927052e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011710263,0.00010524033,0.986482,0.00031851287,0.0000061819946,1.4074263e-7,0.012485032,0.000011592293,0.0000038949665,0.00013715941,0.00019452124,0.00024398074],"study_design_scores_gemma":[0.00024810046,0.000081601676,0.99501616,0.0002482127,0.000015244821,2.80501e-7,0.0007245967,0.000046025936,0.00002050412,0.000007710698,0.0035601375,0.000031433014],"about_ca_topic_score_codex":0.8960961,"about_ca_topic_score_gemma":0.86349005,"teacher_disagreement_score":0.03260607,"about_ca_system_score_codex":0.0002908981,"about_ca_system_score_gemma":0.00165603,"threshold_uncertainty_score":0.2937726},"labels":[],"label_agreement":null},{"id":"W2090096004","doi":"10.1016/j.jval.2011.08.1316","title":"PDB13 A Prospective Registry to Identify Patients' Characteristics Associated with Achieving Target Metabolic Control After Three Months Treatment with Insulin Glulisine in Type 1 And 2 Diabetes Mellitus Patients Previously Uncontrolled on Basal Insulin and/or Other Anti-Diabetic Treatment (API Registry)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brampton Civic Hospital; Sanofi (Canada); University of Toronto","funders":"","keywords":"Medicine; Diabetes mellitus; Insulin; Type 2 Diabetes Mellitus; Internal medicine; Prospective cohort study; Type 2 diabetes; Population; Type 1 diabetes; Logistic regression; Odds ratio; Endocrinology","score_opus":0.017002703349487922,"score_gpt":0.24817811634583484,"score_spread":0.23117541299634692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090096004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891046,0.0029162287,0.00000904357,0.00031039974,0.000094291376,0.007217936,0.00017024312,0.000060246017,0.000117007854],"genre_scores_gemma":[0.9961591,0.0010755971,0.00063551334,0.0006018907,0.00004481134,0.0011234246,0.00012129559,0.000090652604,0.00014775892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99686784,0.00028386543,0.00077217555,0.0008497499,0.00039917225,0.0008271967],"domain_scores_gemma":[0.998238,0.00018416217,0.00048254404,0.0005169041,0.00018989432,0.00038845552],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035564922,0.00063434994,0.0015378204,0.0003864714,0.00008962036,0.00005742811,0.00009121121,0.00013448218,0.00003341162],"category_scores_gemma":[0.00023074343,0.00039781124,0.00006009169,0.0005956274,0.00010434568,0.0001380086,0.00003989488,0.00018085628,0.0000073945916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009273516,0.005500644,0.9700118,0.00017726776,0.0007635004,0.000075983255,0.0019811864,0.000031097323,0.0000036176496,0.000028662676,0.000007305674,0.012145454],"study_design_scores_gemma":[0.035343997,0.027649071,0.93392664,0.0014477104,0.00042987536,3.920327e-7,0.000057996785,0.00048729693,0.000040370116,0.00003112685,0.00024190785,0.0003436393],"about_ca_topic_score_codex":0.0021326058,"about_ca_topic_score_gemma":0.0010892644,"teacher_disagreement_score":0.03608515,"about_ca_system_score_codex":0.0009770541,"about_ca_system_score_gemma":0.00026123153,"threshold_uncertainty_score":0.99984735},"labels":[],"label_agreement":null},{"id":"W2090440337","doi":"10.1016/s1098-3015(10)61790-1","title":"PUK7 DITROPAN XL VERSUS DETROL IN CANADA: ECONOMIC ANALYSIS","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Scientific Measurement and Uncertainty Evaluation","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Economics","score_opus":0.3559867338754549,"score_gpt":0.41029475907202934,"score_spread":0.05430802519657446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090440337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931325,0.0002385194,0.0003024739,0.0012280187,0.0021307429,0.0002602229,0.000010484883,0.000006396358,0.0026906957],"genre_scores_gemma":[0.99933386,0.000013910463,0.00023805919,0.00015394691,0.000028978266,0.000011315375,0.000005788659,0.0000044040116,0.00020973035],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9952783,0.0012253335,0.0010747242,0.0005599195,0.0014151828,0.00044656603],"domain_scores_gemma":[0.9978666,0.0010610231,0.0002961836,0.0005228072,0.000080836,0.00017259033],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.015714187,0.00010773566,0.00037789406,0.0009321479,0.000097371034,0.00008935747,0.0003866358,0.000033367847,0.0009920724],"category_scores_gemma":[0.0028177146,0.000093104725,0.000076426164,0.0022035018,0.000024108509,0.0001460903,0.000017792348,0.00012559659,0.00011046],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000044758403,0.000023482615,0.5248242,0.0000028883003,0.000019740914,0.00000262649,0.00029694097,0.46502638,0.0000075990674,0.0016825463,0.0027105978,0.0053582587],"study_design_scores_gemma":[0.0022079237,0.00008744946,0.42190254,0.000017187338,0.00002966051,6.833881e-7,0.0023470714,0.55529934,0.00008688592,0.0055870605,0.012169045,0.00026516654],"about_ca_topic_score_codex":0.9397853,"about_ca_topic_score_gemma":0.9906096,"teacher_disagreement_score":0.10292166,"about_ca_system_score_codex":0.0041308124,"about_ca_system_score_gemma":0.006702763,"threshold_uncertainty_score":0.99992114},"labels":[],"label_agreement":null},{"id":"W2090794354","doi":"10.1016/j.jval.2012.08.1720","title":"PDB77 Characteristics of Patients With Diabetes in Southwestern Ontario, Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; McMaster University; Lawson Health Research Institute","funders":"","keywords":"Medicine; Diabetes mellitus; Glycemic; Cohort; Epidemiology; Hyperlipidemia; Baseline (sea); Diabetes management; Demography; Cohort study; Type 2 diabetes; Internal medicine; Endocrinology","score_opus":0.02483377153740551,"score_gpt":0.25485371831148845,"score_spread":0.23001994677408294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2090794354","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985513,0.00009553229,8.742516e-7,0.00021868931,0.00014932953,0.00042469904,0.000031007414,0.0000069466305,0.00052161113],"genre_scores_gemma":[0.99937415,0.0000049719274,0.0000507496,0.0003256262,0.000032526183,0.000011175205,0.00008982399,0.0000119167225,0.00009904498],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888664,0.000040778075,0.0003329263,0.00011182492,0.00025675626,0.00037105384],"domain_scores_gemma":[0.9994817,0.000038661445,0.00013133457,0.00018366578,0.000023404476,0.00014127787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018188304,0.0000954338,0.00027868117,0.000089549736,0.000011875425,0.0000036156314,0.000048798887,0.000020521446,0.00011164288],"category_scores_gemma":[0.000022459955,0.0000816563,0.000012663185,0.00012673033,0.000023870225,0.00006350607,0.00002428645,0.00011538667,0.0000019131555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004871156,0.00026465795,0.99768734,0.00069309375,0.000011988874,0.000003496862,0.0005413932,0.000033969583,3.5234797e-7,0.00010497863,0.00013593562,0.0004740591],"study_design_scores_gemma":[0.0012440793,0.00013628785,0.996967,0.00041444728,0.00001136428,8.3393786e-8,0.00013328655,0.000066810106,0.000001989184,0.000008912964,0.0009492996,0.00006640409],"about_ca_topic_score_codex":0.9497967,"about_ca_topic_score_gemma":0.9105753,"teacher_disagreement_score":0.03922145,"about_ca_system_score_codex":0.0010215116,"about_ca_system_score_gemma":0.0017097071,"threshold_uncertainty_score":0.33298472},"labels":[],"label_agreement":null},{"id":"W2091052539","doi":"10.1016/j.jval.2014.03.889","title":"Comparing Public Influenza Immunization Programmes In Ontario And Québec, Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Brock University; Université de Montréal","funders":"","keywords":"Pharmacy; Medicine; Government (linguistics); Christian ministry; Family medicine; Public health; Population; Health care; Rural area; Nursing; Environmental health; Economic growth; Political science","score_opus":0.1559249845413938,"score_gpt":0.35731532416037054,"score_spread":0.20139033961897673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091052539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891647,0.002518029,0.0000085075,0.0065448787,0.00004635773,0.0005547396,5.617773e-7,0.000021533102,0.0011407026],"genre_scores_gemma":[0.99676514,0.00022372455,0.0003457988,0.0025266297,0.000021886583,0.00003604222,0.0000060691327,0.000012176996,0.00006255853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984517,0.00018771406,0.0004068343,0.00018854848,0.00029670782,0.00046849038],"domain_scores_gemma":[0.99932456,0.00015380302,0.00007170967,0.00019813985,0.00008682196,0.00016495248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095519004,0.00010510406,0.00033472438,0.00020875587,0.00009914573,0.000023331468,0.0000678529,0.000036725505,0.000013543702],"category_scores_gemma":[0.00079685316,0.00009702258,0.00001002158,0.00031001147,0.00005721634,0.00007888606,0.000079870435,0.0004030801,0.0000015545025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004034147,0.000046221878,0.98871654,0.0001983604,0.0000087930275,0.0000041553017,0.0015256652,0.00041188332,0.000003852485,0.0004626905,0.0002044708,0.008377009],"study_design_scores_gemma":[0.0012003643,0.000114547176,0.78871316,0.00017660874,0.0000014621296,0.0000039400234,0.00018838535,0.0038282385,0.0000053529,0.00004061952,0.20565969,0.00006764671],"about_ca_topic_score_codex":0.99968714,"about_ca_topic_score_gemma":0.99989146,"teacher_disagreement_score":0.20545523,"about_ca_system_score_codex":0.0024579074,"about_ca_system_score_gemma":0.006089548,"threshold_uncertainty_score":0.999545},"labels":[],"label_agreement":null},{"id":"W2091114523","doi":"10.1016/j.jval.2014.03.819","title":"Creating The Canada Pro Network","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"SWOT analysis; Process management; Business; Relevance (law); Action plan; Strategic planning; Sustainability; Process (computing); Plan (archaeology); Quality (philosophy); Knowledge management; Health care; Public relations; Political science; Computer science; Marketing","score_opus":0.26768701807157097,"score_gpt":0.48210780314110446,"score_spread":0.2144207850695335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091114523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6580252,0.0005269874,0.0022119952,0.32992342,0.001242798,0.0018601731,0.0000042235533,0.00005712182,0.0061481027],"genre_scores_gemma":[0.96852344,0.000036762427,0.0034532796,0.026982304,0.0008526793,0.00001457881,0.000011704693,0.000010900426,0.00011433898],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983572,0.00036547595,0.0006699051,0.00012670922,0.00023279259,0.0002479623],"domain_scores_gemma":[0.9969349,0.0025128855,0.00020090367,0.00021498905,0.0000420437,0.0000942925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034385638,0.00005487961,0.0001528397,0.000013023935,0.00010085171,0.000007031575,0.00005185774,0.000020309855,0.000040594616],"category_scores_gemma":[0.005069419,0.000037645656,0.000016599422,0.00016838536,0.000013643612,0.000028140912,0.00002053516,0.0002366056,0.000005483575],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022013672,0.00013017816,0.5388353,0.00051270815,0.000033704513,0.00001571445,0.00092904136,0.058924694,0.000013948036,0.009495158,0.17321339,0.21767606],"study_design_scores_gemma":[0.00226298,0.00056132284,0.29086402,0.0005304636,0.00003133831,0.00004622508,0.0009610104,0.22891238,0.000010000833,0.00237895,0.47328869,0.00015261596],"about_ca_topic_score_codex":0.91848797,"about_ca_topic_score_gemma":0.60959417,"teacher_disagreement_score":0.31049827,"about_ca_system_score_codex":0.00025746447,"about_ca_system_score_gemma":0.0014718957,"threshold_uncertainty_score":0.60689336},"labels":[],"label_agreement":null},{"id":"W2091403456","doi":"10.1111/j.1524-4733.2009.00573.x","title":"A Multinational Study of Health State Preference Values Associated with Chronic Myelogenous Leukemia","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Chronic myelogenous leukemia; Demography; Preference; Population; Estimation; Disease; Environmental health; Leukemia; Internal medicine; Statistics; Economics","score_opus":0.05893333800666009,"score_gpt":0.3183134830426154,"score_spread":0.2593801450359553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091403456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435145,0.0017190352,0.000063484666,0.0009005093,0.00005513762,0.0026348708,0.000028964056,0.00008978463,0.00015677349],"genre_scores_gemma":[0.99802023,0.0003125676,0.00080319395,0.00041261947,0.00003642505,0.0000456808,0.00008568347,0.000028824561,0.00025479778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963877,0.0006182695,0.0010303095,0.00050131656,0.0007726076,0.00068979576],"domain_scores_gemma":[0.9982629,0.00022920658,0.0006818669,0.00044339328,0.00015714069,0.00022550675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013529002,0.00026848709,0.0008622222,0.0002793991,0.0001345013,0.000008585098,0.00014392476,0.00007105301,0.000025057729],"category_scores_gemma":[0.00020498947,0.00022315118,0.000046558303,0.0006301486,0.000056984423,0.000076650664,0.000028159351,0.0003826385,0.000007191364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0016172124,0.018395985,0.5912385,0.0016516935,0.000786329,0.00028171838,0.05183184,0.098950684,0.00023060734,0.00034238794,0.00059038796,0.23408265],"study_design_scores_gemma":[0.015972279,0.020728236,0.9522364,0.0015206706,0.000029235685,0.00003319922,0.00047042666,0.008451305,0.0000575216,0.000263943,0.00005063243,0.00018610978],"about_ca_topic_score_codex":0.020146377,"about_ca_topic_score_gemma":0.0017551327,"teacher_disagreement_score":0.36099795,"about_ca_system_score_codex":0.014296712,"about_ca_system_score_gemma":0.010821356,"threshold_uncertainty_score":0.9947864},"labels":[],"label_agreement":null},{"id":"W2091498187","doi":"10.1016/j.jval.2011.02.584","title":"PDB76 DESIGNING A SERVICE FRAMEWORK FOR ELECTRONIC PERSONAL HEALTH RECORDS: A PATIENT-CENTRED APPROACH","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Electronic Health Records Systems","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Service (business); Conjoint analysis; Preference; Latent class model; Sample (material); Pairwise comparison; Type 2 diabetes; Willingness to pay; Psychology; Medicine; Marketing; Business; Computer science; Diabetes mellitus; Statistics; Economics","score_opus":0.21226584666806306,"score_gpt":0.39688217013485244,"score_spread":0.18461632346678938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091498187","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33099693,0.11237344,0.36008713,0.058709536,0.014747039,0.10741737,0.0005985725,0.0033116797,0.011758283],"genre_scores_gemma":[0.79100555,0.0022184139,0.15871379,0.03640541,0.0014630888,0.009141002,0.00017789271,0.00042838338,0.00044645037],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98503923,0.0051280484,0.0028748116,0.001190834,0.00058408495,0.005182962],"domain_scores_gemma":[0.9942434,0.0020130535,0.0017261589,0.0007355699,0.00029044948,0.0009913855],"candidate_categories":["metaepi_narrow","sts","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00498153,0.0005397402,0.0013275802,0.00047358032,0.0014910875,0.000014739254,0.0005231098,0.0006171357,0.00018736623],"category_scores_gemma":[0.00071784056,0.00054340775,0.00017202145,0.0013573883,0.000041814557,0.00020534881,0.00010525669,0.002994048,0.00016151837],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0028233915,0.0024922078,0.047029868,0.04024377,0.00022765914,0.000009151972,0.6733809,0.00034112486,0.000022072865,0.14978835,0.016652353,0.066989124],"study_design_scores_gemma":[0.021677516,0.022419164,0.0083092805,0.03163576,0.00009000554,0.0001610437,0.27427647,0.2678563,0.00004785364,0.12921338,0.23962954,0.004683697],"about_ca_topic_score_codex":0.06603188,"about_ca_topic_score_gemma":0.0030714022,"teacher_disagreement_score":0.46000862,"about_ca_system_score_codex":0.006163227,"about_ca_system_score_gemma":0.017286023,"threshold_uncertainty_score":0.99980885},"labels":[],"label_agreement":null},{"id":"W2091627021","doi":"10.1016/j.jval.2012.08.1694","title":"PDB51 Resource Utilization in the Management of Acromegaly: An Analysis From Southwest Ontario","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Lawson Health Research Institute","funders":"","keywords":"Medicine; Acromegaly; Retrospective cohort study; Population; Pegvisomant; Transsphenoidal surgery; Dyslipidemia; Internal medicine; Pediatrics; Surgery; Pituitary adenoma; Adenoma; Obesity","score_opus":0.07125471215382204,"score_gpt":0.3252908177454708,"score_spread":0.2540361055916488,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2091627021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967907,0.0010612045,0.00006530372,0.0003645245,0.000026047941,0.00032660828,0.000015642823,0.0000068309764,0.0013431057],"genre_scores_gemma":[0.99854964,0.00009859331,0.0006147084,0.00030558588,0.000018644452,0.0000123644,0.00032390017,0.000005442848,0.00007113239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990324,0.00013790847,0.00028409198,0.0001399858,0.00018793908,0.00021768037],"domain_scores_gemma":[0.99950373,0.000031660187,0.0000786084,0.00029940368,0.0000073396536,0.00007927782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047710276,0.00007855304,0.0002405697,0.0001729874,0.000032224674,0.0000044067083,0.000066555986,0.00003358789,0.000059615708],"category_scores_gemma":[0.0000035107794,0.000053693213,0.000048649366,0.0004930866,0.000013705848,0.000062186096,0.000014239575,0.00008049081,0.0000049291198],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006998229,0.0007903884,0.9841182,0.000046448702,0.00013241572,0.000008839761,0.012024385,0.0006785712,3.2373586e-7,0.00029700514,0.000015338821,0.0018180502],"study_design_scores_gemma":[0.0012176533,0.0001255975,0.99303836,0.00006852934,0.00018680525,8.02702e-7,0.0034207858,0.0006468566,0.0000017165944,0.00018301154,0.0010701016,0.00003979584],"about_ca_topic_score_codex":0.43806478,"about_ca_topic_score_gemma":0.0917822,"teacher_disagreement_score":0.3462826,"about_ca_system_score_codex":0.00017189422,"about_ca_system_score_gemma":0.00005336923,"threshold_uncertainty_score":0.92479044},"labels":[],"label_agreement":null},{"id":"W2092311018","doi":"10.1046/j.1524-4733.2001.43017.x","title":"Diabetes in Canada: Direct Medical Costs of Major Macrovascular Complications","year":2001,"lang":"en","type":"review","venue":"Value in Health","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Canadian Association of Radiation Oncology","funders":"","keywords":"Medicine; Health care; Indirect costs; Medical emergency; Intensive care medicine; Stroke (engine); Emergency medicine; Myocardial infarction; Formulary; Acute care; Business; Family medicine; Economics","score_opus":0.04498942896979092,"score_gpt":0.3179939853166421,"score_spread":0.27300455634685117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092311018","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00090446096,0.9944603,0.0000074961267,0.0005102944,0.00026500493,0.002673275,0.000119857155,0.000027490878,0.0010318607],"genre_scores_gemma":[0.00097168674,0.9974692,0.00018346663,0.00036712515,0.00019154824,0.00038356517,0.000313798,0.00008300985,0.00003661765],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944876,0.0010533349,0.0018127619,0.0006219003,0.0012336472,0.0007907779],"domain_scores_gemma":[0.9972762,0.00053902686,0.00043324867,0.0011294022,0.00007992044,0.0005422015],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027009202,0.00042245394,0.004500125,0.00053044694,0.00004400541,0.000007045327,0.00038024574,0.0003264586,0.000090199224],"category_scores_gemma":[0.00076481176,0.0003697588,0.0007587593,0.001331728,0.00009928221,0.00002818116,0.00008592429,0.00092635764,0.000017591952],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000021868304,0.00014845846,0.0016728847,0.027049866,0.00031642616,0.00008218918,0.00001672072,0.000021928974,9.452261e-9,0.00005397257,0.0005120815,0.9701233],"study_design_scores_gemma":[0.0009807375,0.000078276484,0.0045692036,0.0655042,0.0003332601,0.000053877706,0.000018848741,0.0002235372,8.5886535e-7,0.000016350681,0.92792904,0.00029179026],"about_ca_topic_score_codex":0.9900415,"about_ca_topic_score_gemma":0.9043941,"teacher_disagreement_score":0.96983147,"about_ca_system_score_codex":0.0034070176,"about_ca_system_score_gemma":0.016386895,"threshold_uncertainty_score":0.9998754},"labels":[],"label_agreement":null},{"id":"W2092377177","doi":"10.1016/j.jval.2013.08.343","title":"Resource Utilization and Costs Associated with Rituximab Treatment in Patients with Pemphigus and Pemphigoid: A Comparison of 6 Months Before and 6 Months After Treatment","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Rituximab; Adverse effect; Pemphigus; Bullous pemphigoid; Cohort; Pemphigoid; Internal medicine; Pediatrics; Dermatology; Immunology; Lymphoma; Antibody","score_opus":0.018961041333150148,"score_gpt":0.2733268364263216,"score_spread":0.2543657950931715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092377177","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915891,0.005298123,0.0000019328802,0.0004072052,0.0000075908024,0.002593698,0.00004075404,0.00002441504,0.000037132195],"genre_scores_gemma":[0.99911934,0.00024124028,0.00017660386,0.00006274154,0.0000059268787,0.0002136672,0.00010991248,0.00003111821,0.000039472176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985074,0.00016755618,0.0004355214,0.00034542766,0.00024105608,0.00030306933],"domain_scores_gemma":[0.9991995,0.000104561506,0.00023029423,0.00021485356,0.00006887361,0.00018189174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000103177204,0.0002431061,0.00068650057,0.00019304489,0.00005390428,0.00001593377,0.00002243179,0.00007886827,0.000008391728],"category_scores_gemma":[0.000048004586,0.00016493513,0.000016913216,0.00019658427,0.0001294584,0.00007890583,0.000022112468,0.00007115906,6.083537e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012797406,0.0026426867,0.969331,0.00012443961,0.000059159316,0.000011179249,0.005107152,0.000052996962,5.38998e-7,0.000006787865,0.0000130608905,0.021371247],"study_design_scores_gemma":[0.016440637,0.008596902,0.9692439,0.0010622744,0.00007508759,0.0000036787947,0.0007986337,0.0035866816,0.000009845042,0.000012725871,0.00005200252,0.00011764578],"about_ca_topic_score_codex":0.018811448,"about_ca_topic_score_gemma":0.0033498497,"teacher_disagreement_score":0.021253603,"about_ca_system_score_codex":0.00073575415,"about_ca_system_score_gemma":0.00018212618,"threshold_uncertainty_score":0.9877224},"labels":[],"label_agreement":null},{"id":"W2092399991","doi":"10.1016/j.jval.2014.03.1136","title":"EQ-5D health utilities are estimated subject to considerable uncertainty","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hospital for Sick Children","funders":"","keywords":"Standard deviation; Statistics; Mean squared error; Confidence interval; Bayesian probability; Econometrics; Mathematics; Mean absolute error; Geometric mean; Valuation (finance); Economics","score_opus":0.6195816174981952,"score_gpt":0.4378684003712079,"score_spread":0.1817132171269873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092399991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53429383,0.010632329,0.0067376685,0.4364252,0.0023554282,0.0037269143,0.00082023523,0.00039166305,0.0046167434],"genre_scores_gemma":[0.89731354,0.00041710245,0.008171332,0.092848025,0.0003270883,0.00018591153,0.00005617133,0.00007050468,0.00061030535],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9901215,0.0018040065,0.005734487,0.0009386115,0.00016147095,0.0012399241],"domain_scores_gemma":[0.9933153,0.0024791786,0.0025447214,0.0008586804,0.000078870966,0.0007232521],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.03796397,0.00031489405,0.0019193155,0.00072330097,0.0004196037,0.000105429375,0.00033453034,0.00015570565,0.000301413],"category_scores_gemma":[0.008206134,0.00041262756,0.00010995882,0.00052550394,0.00007969336,0.00027715223,0.00007246438,0.00035916796,0.0019516703],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000078068275,0.0003554437,0.24489874,0.0048653013,0.000059185335,0.000002883565,0.014488669,0.16386648,7.371508e-7,0.43778923,0.13139078,0.00220448],"study_design_scores_gemma":[0.0033133484,0.0011668535,0.17889094,0.002627374,0.0000034942761,0.000026908743,0.0063320138,0.35286716,0.000006062639,0.12678766,0.32654148,0.0014367184],"about_ca_topic_score_codex":0.10056039,"about_ca_topic_score_gemma":0.0038212894,"teacher_disagreement_score":0.36301976,"about_ca_system_score_codex":0.0024340488,"about_ca_system_score_gemma":0.0011129664,"threshold_uncertainty_score":0.9998326},"labels":[],"label_agreement":null},{"id":"W2092595881","doi":"10.1016/s1098-3015(10)70656-2","title":"PCV70 PATIENT ADHERENCE TO CHOLESTEROL TREATMENT (PACT): CANADIAN PHYSICIAN AND PATIENT PERSPECTIVES","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pact; Medicine; Family medicine; Medication adherence; Internal medicine; Political science; Law","score_opus":0.18007793387330448,"score_gpt":0.3952069943918495,"score_spread":0.215129060518545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092595881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860918,0.0012715367,0.000003020625,0.009571101,0.0001351249,0.0011917934,0.000026392909,0.000019914616,0.0016893155],"genre_scores_gemma":[0.9892633,0.0007288435,0.00028274677,0.009554462,0.000043590684,0.000044369917,0.000005359238,0.000015051613,0.00006225824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861854,0.00012805329,0.0002970747,0.00031030836,0.00020652906,0.00043950352],"domain_scores_gemma":[0.99869895,0.00009728081,0.00008233328,0.00019417852,0.000037186153,0.00089004874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000074863456,0.0001606184,0.00029850923,0.00016868846,0.00014223879,0.000010473304,0.000036338337,0.000038375438,0.000043859738],"category_scores_gemma":[0.00006330248,0.00012946136,0.00004181623,0.00019462736,0.0000436621,0.00009000216,0.000017992208,0.0001643391,0.00006101658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006597457,0.00208596,0.44564655,0.00027873766,0.00010590446,0.00034853935,0.16385324,0.0010109639,0.000114456896,0.00033816387,0.00158332,0.3839744],"study_design_scores_gemma":[0.0069062677,0.036178935,0.67975384,0.0010599397,0.0000709992,0.0002666411,0.019024225,0.0056383437,0.0008335472,0.00012400241,0.24930175,0.00084153796],"about_ca_topic_score_codex":0.21344526,"about_ca_topic_score_gemma":0.010149006,"teacher_disagreement_score":0.38313287,"about_ca_system_score_codex":0.0008619064,"about_ca_system_score_gemma":0.00049691595,"threshold_uncertainty_score":0.79179245},"labels":[],"label_agreement":null},{"id":"W2092941629","doi":"10.1046/j.1524-4733.2001.40201-16.x","title":"HP4: ASSESSING LIFESTYLE DRUGS FOR DRUG BENEFIT FORMULARIES: A COST-UTILITY ANALYSIS OF ORLISTAT AND SIBUTRAMINE FOR THE TREATMENT OF OBESITY IN ADULTS","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Sunnybrook Health Science Centre; University of Toronto","funders":"","keywords":"Orlistat; Sibutramine; Formulary; Medicine; Obesity; Drug; Pharmacology; Weight loss; Internal medicine","score_opus":0.04225855685409968,"score_gpt":0.3690607201494313,"score_spread":0.3268021632953316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2092941629","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936853,0.002159135,0.00053887564,0.0014777115,0.000037039103,0.0019354424,0.00013815361,0.000009258548,0.000019107416],"genre_scores_gemma":[0.99693334,0.001782031,0.00074938504,0.00018135566,0.000018982999,0.0001834468,0.000092932605,0.0000062769577,0.000052245836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990335,0.000057029305,0.00040212338,0.00019260657,0.00009161132,0.00022311359],"domain_scores_gemma":[0.99843687,0.001092319,0.00015765181,0.00017402228,0.00006766467,0.00007149928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005939625,0.00010436375,0.0005364903,0.00019172196,0.000072281844,0.0000041718754,0.000047725876,0.000049830272,0.0000066238636],"category_scores_gemma":[0.00006880962,0.000071449336,0.000110359666,0.00035827217,0.00006114502,0.00005380372,0.000010407849,0.00005271999,6.237914e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019422654,0.0030898377,0.96157396,0.00080867886,0.0004890221,0.000006340486,0.005452765,0.0016322804,0.000015554046,0.0002938662,0.00006395537,0.024631497],"study_design_scores_gemma":[0.008892435,0.0010863361,0.8781485,0.00020843212,0.0008618226,0.000003003807,0.00069559255,0.106741615,0.00077567104,0.0006780724,0.001821997,0.00008651892],"about_ca_topic_score_codex":0.0068819704,"about_ca_topic_score_gemma":0.0034043447,"teacher_disagreement_score":0.105109334,"about_ca_system_score_codex":0.00024165295,"about_ca_system_score_gemma":0.00016445851,"threshold_uncertainty_score":0.9997313},"labels":[],"label_agreement":null},{"id":"W2093013705","doi":"10.1016/s1098-3015(11)72158-1","title":"PMS5 PRIMARY ANTI-TNF FAILURES EXPERIENCE SUPERIOR CLINICAL RESPONSES TO A SECOND ANTI-TNF AGENT THAN SECONDARY FAILURES: ANALYSIS OF THE ALBERTA RHEUMATOID ARTHRITIS BIOLOGICS REGISTRY","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rheumatoid arthritis; Medicine; Tumor necrosis factor alpha; TNF inhibitor; Primary (astronomy); Adalimumab; Internal medicine; Oncology","score_opus":0.03540350763035594,"score_gpt":0.3397166157148023,"score_spread":0.30431310808444634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093013705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98355764,0.0067699687,0.000011363199,0.007402945,0.00052603276,0.0011766477,0.0002240986,0.00004883549,0.00028244866],"genre_scores_gemma":[0.9691943,0.027637545,0.0011442167,0.0014830165,0.000082780934,0.000096868214,0.000055059423,0.000039836068,0.00026635907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99444705,0.0012064618,0.0018207578,0.00086941506,0.000714909,0.00094138447],"domain_scores_gemma":[0.99567425,0.0014670477,0.00043617905,0.001573704,0.00018669353,0.0006621399],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0026655516,0.00037087625,0.0016127799,0.00065132603,0.00032148842,0.000084084,0.0006215412,0.00031425824,0.00096417585],"category_scores_gemma":[0.0030100166,0.00027135064,0.00054855674,0.0015525005,0.00095059385,0.00018398333,0.00031800408,0.0012977669,0.000024706846],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081941317,0.00068408035,0.95284057,0.00031081328,0.0005262822,0.00010173553,0.007710215,0.000058449572,0.012336461,0.0009323197,0.0017166474,0.021963032],"study_design_scores_gemma":[0.002123805,0.0009076779,0.9039563,0.0009804234,0.000011240616,0.00020955797,0.002236701,0.00024733067,0.0017109645,0.00009638258,0.087184146,0.00033548445],"about_ca_topic_score_codex":0.014378013,"about_ca_topic_score_gemma":0.017713305,"teacher_disagreement_score":0.085467495,"about_ca_system_score_codex":0.00009751722,"about_ca_system_score_gemma":0.0018644051,"threshold_uncertainty_score":0.9999739},"labels":[],"label_agreement":null},{"id":"W2093052141","doi":"10.1016/s1098-3015(10)63160-9","title":"ES2 DIRECT MEDICAL COSTS OF SOLID ORGAN TRANSPLANT IN BRITISH COLUMBIA, CANADA","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Solid organ; Medical costs; Organ transplantation; Medicine; Intensive care medicine; Surgery; Transplantation; Political science; Health care; Law","score_opus":0.009667657662049313,"score_gpt":0.25184442666789014,"score_spread":0.24217676900584084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093052141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960459,0.00034333867,0.000028930222,0.002300646,0.00014256458,0.00029777884,0.00013867555,0.000017091956,0.0006850805],"genre_scores_gemma":[0.9983743,0.00044038874,0.00006741492,0.00074899977,0.00004605463,0.000005070628,0.00013103096,0.000012341353,0.00017441704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985493,0.00010725045,0.0005158611,0.00015076547,0.00046219895,0.00021463627],"domain_scores_gemma":[0.99958897,0.00010837292,0.0000646762,0.00007629212,0.000030663374,0.00013104526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004167139,0.000051317456,0.0002773724,0.00006578471,0.000023723118,0.0000059580993,0.000047005684,0.00006810518,0.00024039295],"category_scores_gemma":[0.00004525828,0.00007829014,0.000018083641,0.00028669243,0.000027852342,0.000023883316,0.000002253141,0.00016846275,0.0000012882156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003248826,0.00028065674,0.9911305,0.00063026865,0.0000072241805,0.0006046101,0.00025046614,0.00015518662,0.00007983121,0.0000736658,0.0013466938,0.00540841],"study_design_scores_gemma":[0.0025139358,0.0000890382,0.99359876,0.001498335,0.0000067718975,0.0001618815,0.000054947723,0.0011345772,0.0002638344,0.000036154088,0.00056484924,0.000076890065],"about_ca_topic_score_codex":0.9965828,"about_ca_topic_score_gemma":0.9990879,"teacher_disagreement_score":0.00533152,"about_ca_system_score_codex":0.0003848602,"about_ca_system_score_gemma":0.0023191727,"threshold_uncertainty_score":0.4114113},"labels":[],"label_agreement":null},{"id":"W2093303851","doi":"10.1016/s1098-3015(10)66066-4","title":"PMC19 CHRONIC DISEASE SCORES AMONG SENIORS IN ALBERTA, CANADA","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Nuts composition and effects","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Gerontology; Medicine; Disease; Internal medicine","score_opus":0.010814259644764698,"score_gpt":0.2604966128093655,"score_spread":0.24968235316460077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093303851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846916,0.00049423584,0.0000074546624,0.013282035,0.00093984086,0.00041896073,0.0000067977353,0.000026223872,0.0001328315],"genre_scores_gemma":[0.99792343,0.000016752858,0.000053533295,0.0018041064,0.00010950537,0.000017840408,0.00001542605,0.000020557787,0.00003885745],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9985636,0.00021105928,0.00029915426,0.00024478463,0.00020584397,0.00047558776],"domain_scores_gemma":[0.9992648,0.00014062464,0.00006779234,0.00020875286,0.000009381017,0.0003086874],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019899503,0.00012492051,0.00018985567,0.00014334073,0.00008047742,0.000017575092,0.00010161358,0.000035284054,0.000019882022],"category_scores_gemma":[0.000060938128,0.00013056603,0.0000282593,0.00030320106,0.000032702883,0.00008427698,0.000016950053,0.0002192529,0.000014006391],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033319366,0.0003090256,0.46165276,0.0012173905,0.0000068133645,0.0002774307,0.0019149723,0.5257771,0.00009304721,0.0016228567,0.0030425822,0.003752839],"study_design_scores_gemma":[0.0023880703,0.00022285055,0.9784682,0.0017621381,0.0000043704026,0.0000061034193,0.00005796211,0.013150535,0.00037849526,0.0014468897,0.0018208805,0.00029352447],"about_ca_topic_score_codex":0.9925623,"about_ca_topic_score_gemma":0.9777836,"teacher_disagreement_score":0.5168154,"about_ca_system_score_codex":0.002856465,"about_ca_system_score_gemma":0.0011839531,"threshold_uncertainty_score":0.74695563},"labels":[],"label_agreement":null},{"id":"W2093339032","doi":"10.1016/j.jval.2014.08.438","title":"Detection and Evaluation of the Medication Errors in Different Hospitals in Province of the Punjab, Pakistan","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medical prescription; Teaching hospital; Quarter (Canadian coin); Medication error; Pediatrics; Family medicine; Health care; Nursing; Patient safety; Geography","score_opus":0.11584463991812799,"score_gpt":0.4284501205661476,"score_spread":0.31260548064801963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093339032","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99218136,0.00026256297,0.000021380942,0.006181961,0.00015788447,0.0010696177,0.000001104358,0.0000021639614,0.000121941],"genre_scores_gemma":[0.99966085,0.000076675016,0.000014029707,0.0002096656,0.000013333787,0.000016510136,7.1278527e-7,0.0000036510594,0.000004577002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817044,0.00081400905,0.00042236096,0.00010209796,0.00039496657,0.000096150325],"domain_scores_gemma":[0.99921864,0.0002859603,0.000268878,0.00016306803,0.000031363455,0.00003207574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002669592,0.000051603267,0.000158962,0.00006290606,0.000018293544,0.0000015918262,0.000052716798,0.000036313126,0.000004608523],"category_scores_gemma":[0.00082699663,0.000027574186,0.00002040243,0.00018276872,0.00005096011,0.000042050116,0.000023537585,0.00018221023,1.6358325e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006932591,0.00014467633,0.9706689,0.00043678918,0.0000028577672,5.4696148e-8,0.0009034939,0.00059819577,0.0006539923,0.00020728332,0.0000023838188,0.026312016],"study_design_scores_gemma":[0.0011038441,0.00012904344,0.8968106,0.00035040034,0.000013751505,7.047217e-7,0.00011512457,0.09944687,0.0012010802,0.000748655,0.000058070123,0.000021835784],"about_ca_topic_score_codex":0.0018817028,"about_ca_topic_score_gemma":0.0009603141,"teacher_disagreement_score":0.09884867,"about_ca_system_score_codex":0.00018289028,"about_ca_system_score_gemma":0.00014239372,"threshold_uncertainty_score":0.28445843},"labels":[],"label_agreement":null},{"id":"W2093551652","doi":"10.1016/j.jval.2014.08.1336","title":"Persistence And Adherence With Mirabegron, A New Beta-3 Receptor Agonist, Versus Antimuscarinics In Overactive Bladder: Early Experience In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Mirabegron; Oxybutynin; Overactive bladder; Medicine; Solifenacin; Hazard ratio; Tolterodine; Persistence (discontinuity); Internal medicine; Cohort; Urology; Proportional hazards model; Confidence interval","score_opus":0.09343225368972251,"score_gpt":0.3257674470512033,"score_spread":0.23233519336148079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093551652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99508697,0.000907865,0.000010097331,0.0021752312,0.00010580563,0.00061544287,0.000008158422,0.0000088498955,0.0010816081],"genre_scores_gemma":[0.998025,0.000861824,0.0006852103,0.00023227742,0.000035724494,0.000029458035,0.0000068626314,0.000016923268,0.00010671553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785906,0.00026761476,0.00036890293,0.00046396727,0.00043730697,0.0006031544],"domain_scores_gemma":[0.99881697,0.00041309532,0.00008609358,0.0002742945,0.000036789304,0.00037273974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042159192,0.00016917738,0.000397682,0.00015937058,0.000057447418,0.000021239284,0.00012309114,0.000055743316,0.000048214013],"category_scores_gemma":[0.000134512,0.00015112286,0.000017769027,0.0005234975,0.000091451606,0.000156842,0.00005075347,0.00055120944,0.0000033902538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003983033,0.00018254829,0.9529217,0.00037669734,0.000023377135,0.00018256456,0.021829784,0.0003509337,0.00015827257,0.000130918,0.00031048362,0.019549709],"study_design_scores_gemma":[0.009725638,0.0068301084,0.9623961,0.0011773566,0.000009344759,0.00005200893,0.010206124,0.005996567,0.00035837482,0.000045756708,0.0028086742,0.00039394596],"about_ca_topic_score_codex":0.9634299,"about_ca_topic_score_gemma":0.720106,"teacher_disagreement_score":0.24332397,"about_ca_system_score_codex":0.00062982686,"about_ca_system_score_gemma":0.0054519316,"threshold_uncertainty_score":0.9671492},"labels":[],"label_agreement":null},{"id":"W2093833819","doi":"10.1111/j.1524-4733.2010.00797.x","title":"Cost-Effectiveness of Specialized Multidisciplinary Heart Failure Clinics in Ontario, Canada","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":63,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; St. Michael's Hospital; Ministry of Health and Long Term Care; Toronto Public Health; Health Sciences Centre; University Health Network; University of Toronto; Institute for Clinical Evaluative Sciences; Sunnybrook Health Science Centre","funders":"Canadian Institutes of Health Research; University of Toronto; Institute for Clinical Evaluative Sciences","keywords":"Medicine; Life expectancy; Confidence interval; Cohort; Christian ministry; Emergency medicine; Cost effectiveness; Relative risk; Activity-based costing; Incremental cost-effectiveness ratio; Hazard ratio; Cost-effectiveness analysis; Pediatrics; Internal medicine; Population; Environmental health","score_opus":0.057231753523017855,"score_gpt":0.34958784531021114,"score_spread":0.2923560917871933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093833819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906963,0.000049909326,0.000009815087,0.006114013,0.0005543051,0.00227518,0.000006710555,0.000014610761,0.00027917215],"genre_scores_gemma":[0.99331146,0.000015710219,0.0060448144,0.00021822222,0.00005763765,0.0000814175,0.000038361417,0.000016767359,0.00021557858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983013,0.00025578742,0.0005497557,0.0002715069,0.0002647761,0.0003568299],"domain_scores_gemma":[0.9990763,0.00030388762,0.00007779931,0.00031929393,0.000038997478,0.00018372656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014051527,0.00014390658,0.00057971553,0.0001668744,0.000035599394,0.0000037940515,0.00006290461,0.00008957864,0.0001586671],"category_scores_gemma":[0.000093594936,0.00012935893,0.000057191715,0.00023930098,0.000036544745,0.000040843574,0.000047816917,0.0005092337,0.000005823546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044219123,0.000561582,0.9935253,0.00056504115,0.00002170724,0.00009249672,0.0005894506,0.00046202604,0.0002682168,0.00066060334,0.0019777813,0.0008335952],"study_design_scores_gemma":[0.004524758,0.0003472184,0.9097809,0.00048925524,0.000011231611,0.000009796954,0.00017822112,0.00042356135,0.00020065052,0.00012252576,0.08380477,0.00010707317],"about_ca_topic_score_codex":0.9913725,"about_ca_topic_score_gemma":0.99849325,"teacher_disagreement_score":0.08374438,"about_ca_system_score_codex":0.0009974899,"about_ca_system_score_gemma":0.0038464072,"threshold_uncertainty_score":0.68233615},"labels":[],"label_agreement":null},{"id":"W2093861069","doi":"10.1016/s1098-3015(10)74036-5","title":"PND29 CANADIAN PATIENT SURVEY TO ASSESS PATIENTS' PLIGHT TO MOVEMENT DISORDER DIAGNOSES AND BOTULINUM TOXIN TYPE-A (BONTA) TREATMENT – FINAL RESULTS","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Botulinum toxin; Medicine; Toxin; Surgery; Biology; Microbiology","score_opus":0.07448415369451299,"score_gpt":0.3142366595570627,"score_spread":0.2397525058625497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2093861069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674987,0.0004578612,0.000007478981,0.02910295,0.00028152505,0.0018772747,0.0001704115,0.00003554171,0.0005682297],"genre_scores_gemma":[0.97310483,0.0010007465,0.0003132647,0.025151934,0.000029132807,0.00004042852,0.00013334099,0.000020084584,0.0002062608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747264,0.00030759373,0.00062228454,0.0005922057,0.00029096042,0.00071432634],"domain_scores_gemma":[0.9981375,0.00022271051,0.000083910614,0.00032039155,0.00008260594,0.0011529023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034986786,0.00027120317,0.00045258252,0.00027615906,0.00013135363,0.000023522916,0.00008578831,0.0001554133,0.00002594675],"category_scores_gemma":[0.0004901659,0.00020707819,0.0000465186,0.00054167694,0.000022654755,0.000034790453,0.000029707668,0.00023509216,0.000044077216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0056642736,0.006638331,0.7305918,0.00012188972,0.000097875156,0.00029642673,0.0051221605,0.013804678,0.000110375746,0.00048698104,0.020059088,0.21700613],"study_design_scores_gemma":[0.0031587633,0.015487088,0.96087027,0.00014656232,0.000010969067,0.0000021695055,0.00008154171,0.0002712899,0.000052902764,0.000105996,0.019582193,0.00023027648],"about_ca_topic_score_codex":0.21777417,"about_ca_topic_score_gemma":0.13146284,"teacher_disagreement_score":0.23027846,"about_ca_system_score_codex":0.00056397315,"about_ca_system_score_gemma":0.00044180788,"threshold_uncertainty_score":0.8843857},"labels":[],"label_agreement":null},{"id":"W2094049860","doi":"10.1111/j.1524-4733.2010.00706.x","title":"International Development of the Unidimensional Fatigue Impact Scale (U-FIS)","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Dalhousie University","funders":"","keywords":"Debriefing; Psychology; Scale (ratio); Construct validity; German; Internal consistency; Content validity; Reliability (semiconductor); Clinical psychology; Cognition; Face validity; Psychometrics; Applied psychology; Social psychology; Psychiatry; Linguistics; Geography; Cartography","score_opus":0.11824150345295172,"score_gpt":0.4112257258776765,"score_spread":0.29298422242472477,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094049860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921032,0.000050934636,0.00002228168,0.005934394,0.00035904438,0.00036330006,0.000010699185,0.000009287499,0.0011468269],"genre_scores_gemma":[0.9915749,0.000055691966,0.008002492,0.00015678293,0.00007496715,0.0000143270345,0.0000069575917,0.000007846852,0.00010604569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865085,0.000074293894,0.0003558128,0.00013952797,0.0005531119,0.00022639614],"domain_scores_gemma":[0.9992986,0.00016572393,0.00009400777,0.0002097496,0.00011770624,0.00011425602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008471468,0.0000769478,0.00018295141,0.00011312512,0.00008273353,0.0000039693377,0.00014613675,0.000037308055,0.00015732113],"category_scores_gemma":[0.00054013846,0.00004636138,0.000055134533,0.00018985789,0.000096087926,0.000028558356,0.00013425092,0.00034354717,0.0000071701284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015415784,0.0005124922,0.89922655,0.00022494474,0.000091807015,0.000001875541,0.004370213,0.00065257587,0.060534358,0.00027732822,0.002506457,0.03144724],"study_design_scores_gemma":[0.0007221365,0.000049180293,0.9875966,0.00022457725,0.000001181229,0.000005212948,0.0000963718,0.002785217,0.003704815,0.000029357876,0.0047451924,0.000040208393],"about_ca_topic_score_codex":0.0012060571,"about_ca_topic_score_gemma":0.00024014406,"teacher_disagreement_score":0.08837,"about_ca_system_score_codex":0.00020500516,"about_ca_system_score_gemma":0.00095930323,"threshold_uncertainty_score":0.18905622},"labels":[],"label_agreement":null},{"id":"W2094227379","doi":"10.1016/j.jval.2011.08.1306","title":"PDB3 Hypoglycaemia-Related Emergency Department Visits and Hypoglycaemia-Related Hospitalizations Among News Users of Antidiabetes Treatments","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Emergency department; Incidence (geometry); Cohort; Population; Hypoglycemia; Emergency medicine; Pediatrics; Diabetes mellitus; Insulin; Internal medicine","score_opus":0.03634705197058996,"score_gpt":0.2902369194408759,"score_spread":0.2538898674702859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094227379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897347,0.0028350237,0.0000094717825,0.00050788006,0.00028314945,0.00171773,0.00001676482,0.00008006488,0.004815222],"genre_scores_gemma":[0.99331194,0.003704351,0.00060853706,0.000052899843,0.000018784767,0.00005573814,0.000112144175,0.00004878307,0.0020868147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997196,0.00022307802,0.0010136148,0.00047301076,0.00041727163,0.0006770115],"domain_scores_gemma":[0.9987487,0.00006461298,0.0003123726,0.00041882883,0.000092632574,0.00036284397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005770566,0.00026739025,0.00059146417,0.0005578515,0.00012190741,0.0000103155535,0.00014419005,0.00016646017,0.00030750778],"category_scores_gemma":[0.00013011257,0.00023063897,0.00011086577,0.0010009623,0.00013553888,0.0001846037,0.00010703498,0.00024170718,0.000030998217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050133105,0.0008372727,0.98692495,0.0005067263,0.00032270642,0.000028704606,0.0014396339,0.000107382664,0.00010848315,0.0011797248,0.0006823886,0.0078118998],"study_design_scores_gemma":[0.002916214,0.0015834225,0.986689,0.00060775806,0.00015577389,0.0000020586965,0.0003466278,0.00446196,0.0006528917,0.0021333718,0.00020059147,0.0002503342],"about_ca_topic_score_codex":0.0019748772,"about_ca_topic_score_gemma":0.00005493355,"teacher_disagreement_score":0.007561566,"about_ca_system_score_codex":0.00017996908,"about_ca_system_score_gemma":0.00014519955,"threshold_uncertainty_score":0.9405184},"labels":[],"label_agreement":null},{"id":"W2094268264","doi":"10.1016/j.jval.2013.08.1156","title":"Canadian Burden of Choroidal Neovascularization Secondary to Pathologic Myopia: Baseline Characteristics of Patients","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Novartis (Canada)","funders":"","keywords":"Medicine; Choroidal neovascularization; Visual acuity; Ophthalmology; Medical record; Retrospective cohort study; Pediatrics; Optometry; Surgery","score_opus":0.013072875465228404,"score_gpt":0.25386555870110916,"score_spread":0.24079268323588077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094268264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99736154,0.00013700253,0.000037304933,0.001190881,0.00007688648,0.0008195092,0.00025751005,0.000004786381,0.000114603165],"genre_scores_gemma":[0.9981482,0.00009263955,0.0006849305,0.0004779285,0.00003680127,0.000019559411,0.00046513497,0.000010563206,0.00006422128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989922,0.00008906411,0.00041676598,0.00014305336,0.00015812913,0.00020077509],"domain_scores_gemma":[0.9991731,0.000024641438,0.00012275584,0.0001834413,0.00016821366,0.00032781507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001599563,0.000082512866,0.00028902045,0.00017016569,0.00002054738,0.0000034565126,0.00004463896,0.000048347883,0.00018421722],"category_scores_gemma":[0.0001796925,0.000070828886,0.000048573558,0.0001749977,0.000013954815,0.000033423436,0.000014072924,0.000068998364,0.000018676437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006057943,0.0002709508,0.96209145,0.00065182435,0.000023358385,0.000017217966,0.00039311903,0.00017700426,0.000047306225,0.000041673233,0.00021976129,0.03600577],"study_design_scores_gemma":[0.0007910612,0.0007230816,0.9967277,0.00021371212,0.000016230575,0.0000015586443,0.000045536162,0.0010729043,0.000020725289,0.000051469666,0.0002890945,0.00004690246],"about_ca_topic_score_codex":0.37020338,"about_ca_topic_score_gemma":0.0011685733,"teacher_disagreement_score":0.3690348,"about_ca_system_score_codex":0.00020075189,"about_ca_system_score_gemma":0.0005073502,"threshold_uncertainty_score":0.63399047},"labels":[],"label_agreement":null},{"id":"W2094281515","doi":"10.1016/j.jval.2012.08.1691","title":"PDB48 Health Care Resources Utilization and Costs Associated With the Management of Patients With Acromegaly: An Analysis Based on the Ramq Database","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Medicine; Acromegaly; Pegvisomant; Lanreotide; Cohort; Retrospective cohort study; Pediatrics; Health care; Population; Pituitary adenoma; Emergency medicine; Internal medicine; Adenoma; Environmental health; Growth hormone","score_opus":0.032422634401388456,"score_gpt":0.29679873202124646,"score_spread":0.26437609761985803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094281515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957085,0.0012129071,0.00007150473,0.0017158049,0.000011825701,0.00097516103,0.00014881763,0.000012504741,0.00014297744],"genre_scores_gemma":[0.99750984,0.00012684788,0.00015495325,0.0012322596,0.000006471026,0.000025507085,0.00092388317,0.000011708559,0.00000850436],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867404,0.00032489252,0.00019790797,0.00018238676,0.00035205248,0.00026870368],"domain_scores_gemma":[0.999163,0.000099679615,0.00019621893,0.00035372964,0.000047674264,0.00013974069],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055093947,0.00012106173,0.00026395102,0.00012414422,0.00018559181,0.000009003174,0.000057038684,0.000022054579,0.000008819827],"category_scores_gemma":[0.000012207759,0.000055582077,0.000022406852,0.00061497185,0.00005168326,0.00006424728,0.000015513113,0.000084565865,3.8178413e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045022747,0.0007924293,0.992201,0.00014525311,0.00027068163,0.0000018394087,0.0025174355,0.0006329997,2.2849276e-8,0.0001212353,0.00004524511,0.002821687],"study_design_scores_gemma":[0.0028661997,0.0012328344,0.9889579,0.00033737626,0.00023732401,1.6032126e-7,0.003071494,0.0030891006,0.0000010269089,0.0000017216216,0.00014938175,0.00005550721],"about_ca_topic_score_codex":0.0035631466,"about_ca_topic_score_gemma":0.0010482607,"teacher_disagreement_score":0.0032430708,"about_ca_system_score_codex":0.0002033325,"about_ca_system_score_gemma":0.00007716274,"threshold_uncertainty_score":0.53864354},"labels":[],"label_agreement":null},{"id":"W2094313296","doi":"10.1016/j.jval.2014.03.329","title":"Preliminary Results Of Multidisciplinary Systematic Follow-Up Of Fragility Fractures In Orthopaedic Clinic","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Université de Montréal; Hôpital du Sacré-Cœur de Montréal","funders":"","keywords":"Medicine; Fragility fracture; Fragility; Ankle; Hip fracture; Physical therapy; Osteoporosis; Surgery; Internal medicine; Bone mineral","score_opus":0.038647282770936264,"score_gpt":0.35032148147875813,"score_spread":0.31167419870782187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094313296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936481,0.0025656407,0.000114690105,0.0011139542,0.0003426411,0.0014885832,0.000023409935,0.000025497297,0.00067749305],"genre_scores_gemma":[0.9985864,0.0001741666,0.0007470566,0.00021462592,0.000074038006,0.000030576968,0.00002688792,0.000021649566,0.0001245784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955099,0.0010308968,0.0022894226,0.0003685294,0.0004511353,0.00035011768],"domain_scores_gemma":[0.99638355,0.0018270568,0.0008034857,0.00072752946,0.000084912885,0.00017345806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051026065,0.00019042697,0.0013066208,0.0004029747,0.000032583164,0.000002196219,0.00015556578,0.00021529334,0.000025620655],"category_scores_gemma":[0.0036034186,0.00014643365,0.00018213506,0.00041038924,0.000105846346,0.000052390835,0.000063083615,0.00048860884,0.000009903235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016123287,0.0029821615,0.6968869,0.24038848,0.00010842039,0.000083920815,0.03351488,0.004374655,0.0002630681,0.00019624195,0.00088177633,0.004196199],"study_design_scores_gemma":[0.00795085,0.0037585038,0.94992787,0.024915885,0.000051916206,0.00001821772,0.0010133204,0.010914709,0.00032689396,0.00089195103,0.000067079774,0.0001627798],"about_ca_topic_score_codex":0.0033085507,"about_ca_topic_score_gemma":0.00021238453,"teacher_disagreement_score":0.253041,"about_ca_system_score_codex":0.00010482918,"about_ca_system_score_gemma":0.0003804013,"threshold_uncertainty_score":0.59713906},"labels":[],"label_agreement":null},{"id":"W2094358619","doi":"10.1016/j.jval.2012.03.1209","title":"PCN92 The Lifecycle Value of Oncology Medicines","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Innovator; Azacitidine; Product (mathematics); Medicine; Business; Finance","score_opus":0.48077720230712706,"score_gpt":0.47360065173735677,"score_spread":0.00717655056977029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094358619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.651028,0.02986947,0.0012224249,0.29907626,0.003488606,0.0016430456,0.00012203832,0.000055416964,0.013494755],"genre_scores_gemma":[0.9695484,0.00083804975,0.0019540996,0.026458548,0.0009135845,0.000077479526,0.000009341147,0.000028899174,0.00017160861],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99304277,0.0013227605,0.0045434413,0.00030135407,0.00011403444,0.00067564956],"domain_scores_gemma":[0.9938466,0.0028796003,0.0024266483,0.0005526225,0.00003320809,0.00026135158],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04343827,0.00015015845,0.0010716154,0.00030056087,0.00014015798,0.000009674589,0.0003308671,0.00014689256,0.0002114743],"category_scores_gemma":[0.0038790312,0.00014284506,0.00009198623,0.00031878878,0.00013233941,0.00025272314,0.000057645088,0.00027240353,0.0006232328],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018544613,0.00035673592,0.33997738,0.00091283675,0.000039895996,4.2410457e-7,0.014910554,0.0028446051,0.0000019843123,0.60734177,0.0324146,0.0011806653],"study_design_scores_gemma":[0.0019299444,0.00056600623,0.34450936,0.0003909174,0.000008052819,0.000025121606,0.0051106624,0.021146648,0.000012399858,0.041028507,0.5848466,0.00042578756],"about_ca_topic_score_codex":0.01568767,"about_ca_topic_score_gemma":0.0001502268,"teacher_disagreement_score":0.56631327,"about_ca_system_score_codex":0.0008348479,"about_ca_system_score_gemma":0.00046805106,"threshold_uncertainty_score":0.99086696},"labels":[],"label_agreement":null},{"id":"W2094436672","doi":"10.1016/j.jval.2014.03.040","title":"Cadth Recommendations As Predictors For Drug Availability In British Columbia And Ontario","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Formulary; Medicine; Listing (finance); Reimbursement; Family medicine; Agency (philosophy); Drug; Health care; Business; Pharmacology; Finance; Political science","score_opus":0.22962417074795277,"score_gpt":0.37769642851862795,"score_spread":0.14807225777067518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094436672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634977,0.00066501496,0.00032931022,0.03203445,0.00056032435,0.0016858407,0.00030194927,0.000032262247,0.0008931525],"genre_scores_gemma":[0.98028463,0.00029799776,0.005842489,0.009910497,0.00018209354,0.00041816276,0.000105510575,0.000037635356,0.0029209724],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945352,0.00064213393,0.0036376945,0.0006421315,0.000057485115,0.0004853374],"domain_scores_gemma":[0.99658984,0.00175889,0.001036113,0.00034792972,0.00003350945,0.00023374762],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028704714,0.000107843436,0.0008215854,0.00018250583,0.00021310808,0.00015858644,0.00015551788,0.00011185324,0.00040335744],"category_scores_gemma":[0.0040591,0.00022162401,0.000053404878,0.00017165473,0.000057056222,0.0003014897,0.000037902188,0.00024758175,0.0000992761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004131378,0.00010183492,0.9629298,0.00045353733,0.000006265975,1.459907e-7,0.0033419062,0.00026296166,2.3917956e-8,0.0060291155,0.026180565,0.0006897324],"study_design_scores_gemma":[0.001355692,0.00014063243,0.73155355,0.0002706634,0.0000012917833,0.000004415151,0.00054617325,0.011217531,7.68637e-8,0.050074235,0.20460461,0.00023114453],"about_ca_topic_score_codex":0.937792,"about_ca_topic_score_gemma":0.9590351,"teacher_disagreement_score":0.23137625,"about_ca_system_score_codex":0.0021156124,"about_ca_system_score_gemma":0.00065123325,"threshold_uncertainty_score":0.9948538},"labels":[],"label_agreement":null},{"id":"W2094487322","doi":"10.1016/s1098-3015(10)65671-9","title":"DB2 LABOR MARKET EFFECTS OF INSULIN DEPENDENT AND NON-INSULIN DEPENDENT DIABETES AMONG CANADIAN LABOR FORCE","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Promotion and Cardiovascular Prevention","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin; Economics; Diabetes mellitus; Internal medicine; Medicine; Labour economics; Endocrinology","score_opus":0.008624518365078299,"score_gpt":0.2586698282210919,"score_spread":0.2500453098560136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094487322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991124,0.0040934393,0.00034321257,0.001943899,0.00030378133,0.0018666858,0.00019801097,0.00004033246,0.00008668481],"genre_scores_gemma":[0.996113,0.0019656618,0.0004448483,0.0011128078,0.00008229841,0.00008518258,0.000085634994,0.000034247703,0.000076339704],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685127,0.001134915,0.0006417796,0.0003575989,0.00040632277,0.0006081036],"domain_scores_gemma":[0.99847394,0.00011929345,0.00016345816,0.0003550375,0.00010537569,0.0007828784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046519814,0.00018257966,0.0005634729,0.00036162132,0.00009614657,0.0000118442995,0.00008317024,0.00018661022,0.000025083164],"category_scores_gemma":[0.0004537163,0.00018034995,0.00010010302,0.00039160802,0.000051050312,0.0000853079,0.00003102431,0.00041156932,0.000008215162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015075087,0.0013448518,0.82919765,0.03446323,0.0004823298,0.000552726,0.004713053,0.0029708564,0.0011041202,0.0004992122,0.0007663731,0.12375484],"study_design_scores_gemma":[0.0054978887,0.00055432745,0.9886398,0.0018556861,0.000043230895,0.000018017296,0.000115922245,0.00050678325,0.0018374195,0.00033730647,0.00043650274,0.00015715619],"about_ca_topic_score_codex":0.20979223,"about_ca_topic_score_gemma":0.052105382,"teacher_disagreement_score":0.1594421,"about_ca_system_score_codex":0.0006994566,"about_ca_system_score_gemma":0.0015705853,"threshold_uncertainty_score":0.96519125},"labels":[],"label_agreement":null},{"id":"W2094708298","doi":"10.1016/j.jval.2012.08.2028","title":"PRS29 Queuing Statistical Model - A New Tool for Preliminary Cost-Effectiveness Assessments","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Quality and Safety in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Quarter (Canadian coin); Population; Emergency medicine; Statistics; Mathematics; Geography; Environmental health","score_opus":0.41015833601274315,"score_gpt":0.5745464888026014,"score_spread":0.16438815278985824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094708298","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22544292,0.0018002042,0.73736596,0.010365816,0.003429521,0.019517653,0.0009819433,0.00029277935,0.00080319715],"genre_scores_gemma":[0.9434976,0.0001869342,0.047951546,0.0042561395,0.0008150333,0.0024586436,0.00022069189,0.00008195375,0.0005314337],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9919367,0.004123099,0.0013489864,0.0004304691,0.00039636705,0.0017643668],"domain_scores_gemma":[0.9908853,0.0075130076,0.0003554285,0.00042980278,0.00012752552,0.0006889349],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008505437,0.00025496277,0.00064285216,0.00014943695,0.00080848543,0.000009275356,0.00018745424,0.00036807556,0.00007472818],"category_scores_gemma":[0.0012432722,0.0002522094,0.000073042436,0.00024590647,0.000042681426,0.00034130167,0.00011213269,0.0010608681,0.00007723842],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003706352,0.001098468,0.32261568,0.029040005,0.00005541872,0.000005581751,0.02706564,0.03526389,0.000022863256,0.50773203,0.013046161,0.060347874],"study_design_scores_gemma":[0.0069126906,0.0017935669,0.3523677,0.0056256014,0.000040835446,0.000008659545,0.004151821,0.5500063,0.000011369171,0.05732788,0.020854192,0.0008993886],"about_ca_topic_score_codex":0.009588683,"about_ca_topic_score_gemma":0.00012431985,"teacher_disagreement_score":0.7180547,"about_ca_system_score_codex":0.0016430867,"about_ca_system_score_gemma":0.0040103,"threshold_uncertainty_score":0.999993},"labels":[],"label_agreement":null},{"id":"W2094733423","doi":"10.1016/s1098-3015(10)72965-x","title":"PRS9 COMPARISON OF CHRONIC BRONCHITIS IN ONTARIO, CANADA BETWEEN 2003 AND 2009","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chronic bronchitis; Bronchitis; Medicine; Geography; Internal medicine","score_opus":0.07484444963051308,"score_gpt":0.3839269769530248,"score_spread":0.30908252732251174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2094733423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702454,0.00075649173,0.000005750755,0.0007518193,0.00014492599,0.00056548143,0.0000105328145,0.0000062382164,0.00073421554],"genre_scores_gemma":[0.9993054,0.000022092316,0.00019394628,0.00013603679,0.00006718799,0.000012246997,0.000008523571,0.000010189136,0.00024433646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858195,0.00013091734,0.00049933494,0.00018295985,0.00026893875,0.0003358954],"domain_scores_gemma":[0.9993415,0.00008919849,0.00008575729,0.00022582752,0.00006136575,0.00019636225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005944963,0.00008405133,0.000383098,0.00021808711,0.000038249604,0.000005529991,0.000058830912,0.000079574456,0.00018148826],"category_scores_gemma":[0.00018567243,0.00008240625,0.000011096316,0.00041854024,0.00006916112,0.00004079433,0.000026711903,0.0009577195,0.0000026671248],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013743897,0.000078462515,0.98817265,0.00021702396,0.0000045983425,0.00000826819,0.00018010104,0.00016289184,0.00029629737,0.000075771,0.0021606444,0.0086295605],"study_design_scores_gemma":[0.00091248495,0.0006379001,0.96862775,0.00014325947,0.0000026790651,0.0000070333886,0.00002978545,0.0009789547,0.0004698518,0.000020957566,0.028109523,0.00005981925],"about_ca_topic_score_codex":0.9983358,"about_ca_topic_score_gemma":0.9992208,"teacher_disagreement_score":0.025948878,"about_ca_system_score_codex":0.0013130347,"about_ca_system_score_gemma":0.009617197,"threshold_uncertainty_score":0.99599737},"labels":[],"label_agreement":null},{"id":"W2095042410","doi":"10.1016/j.jval.2012.06.017","title":"Cost-Effectiveness of Using a Molecular Diagnostic Test to Improve Preoperative Diagnosis of Thyroid Cancer","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Thyroid Cancer Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital; University of British Columbia","funders":"","keywords":"Medicine; Test (biology); Cancer; Thyroid cancer; Diagnostic test; Thyroid; Computer science; Radiology; Internal medicine; Pediatrics; Biology","score_opus":0.06402909451622811,"score_gpt":0.3777649230658495,"score_spread":0.3137358285496214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2095042410","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97735804,0.01810605,0.00014754463,0.00047055047,0.00028354942,0.003376361,0.00021046362,0.000011446159,0.00003599968],"genre_scores_gemma":[0.99492824,0.0020526415,0.0008207256,0.0002766955,0.00007014807,0.001808381,0.0000077648065,0.000031626256,0.0000037499608],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99828607,0.00027356527,0.00048368282,0.00026503112,0.00025805595,0.00043361523],"domain_scores_gemma":[0.9969161,0.0021719194,0.00019392697,0.000292599,0.00012978275,0.00029567222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006246649,0.00018547889,0.00065521983,0.00016278954,0.000030273888,0.00000365327,0.00006607144,0.00006122699,0.000024869601],"category_scores_gemma":[0.0009875379,0.00015858488,0.00008840992,0.00043529627,0.00004843153,0.000074403375,0.000047153728,0.00011882685,0.0000024943693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014278854,0.0018396676,0.975699,0.0014558476,0.00007956104,0.000009251881,0.00148755,0.0073988,0.008615079,0.0002708882,0.000042263855,0.0029593143],"study_design_scores_gemma":[0.0027103804,0.0021264683,0.68249536,0.004323921,0.00012956343,0.0000061720584,0.00015668842,0.00034511165,0.30738524,0.000033654036,0.00012410087,0.00016337966],"about_ca_topic_score_codex":0.022362245,"about_ca_topic_score_gemma":0.00007533052,"teacher_disagreement_score":0.29877016,"about_ca_system_score_codex":0.00091114204,"about_ca_system_score_gemma":0.0005213552,"threshold_uncertainty_score":0.9841479},"labels":[],"label_agreement":null},{"id":"W2096303420","doi":"10.1016/j.jval.2014.03.1109","title":"The impact of alternative estimates of disutilities associated with hypoglycemia on net qalys: Canagliflozin versus sitagliptin as add-on therapy in individuals with type 2 diabetes mellitus (T2DM) inadequately controlled on a background of metformin (MET) plus sulfonylurea (SU) in the canadian setting","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Canagliflozin; Sitagliptin; Medicine; Hypoglycemia; Type 2 Diabetes Mellitus; Adverse effect; Internal medicine; Endocrinology; Diabetes mellitus","score_opus":0.044760867475298415,"score_gpt":0.315457924689682,"score_spread":0.2706970572143836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096303420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948405,0.0006737438,3.3820652e-7,0.0004139964,0.000048509377,0.0021332444,0.0000624778,0.000008537786,0.001818639],"genre_scores_gemma":[0.9992512,0.00018907136,0.00007169449,0.00021003072,0.000017970468,0.00011562653,0.00008825211,0.000029807774,0.000026333606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969752,0.0007189079,0.0007337566,0.00028719413,0.00061466615,0.00067031424],"domain_scores_gemma":[0.99391335,0.004783076,0.0006571111,0.00039769968,0.00011429061,0.00013446156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028954195,0.00033140235,0.0010760115,0.00059937395,0.00008590416,0.00003159647,0.0002453491,0.00008766389,0.000014358296],"category_scores_gemma":[0.00075819547,0.0001668037,0.000089966714,0.0007798498,0.00018062277,0.000066492816,0.000017300512,0.0003195992,0.0000018722285],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045767047,0.0029011548,0.77238256,0.0005760577,0.005493669,0.000072820934,0.028617727,0.095859505,0.00003653588,0.016639877,0.00042358888,0.031229481],"study_design_scores_gemma":[0.10975537,0.1144407,0.7209816,0.0070243194,0.00040574512,0.0000016097923,0.013661787,0.028596967,0.0017081341,0.0025094505,0.00022012557,0.0006941846],"about_ca_topic_score_codex":0.47005838,"about_ca_topic_score_gemma":0.23881069,"teacher_disagreement_score":0.23124768,"about_ca_system_score_codex":0.0014637805,"about_ca_system_score_gemma":0.0011720271,"threshold_uncertainty_score":0.775079},"labels":[],"label_agreement":null},{"id":"W2096576489","doi":"10.1016/j.jval.2015.09.131","title":"Propensity Score Matching Does not Always Remove Confounding within an Economic Evaluation Based on a Non-Randomized Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Propensity score matching; Medicine; Confounding; Population; Randomized controlled trial; Abdominal aortic aneurysm; Surgery; Internal medicine; Aneurysm","score_opus":0.3116162339286345,"score_gpt":0.31267160447487585,"score_spread":0.0010553705462413299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096576489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992497,0.000053397394,0.00096686766,0.0005148573,0.0010423138,0.0030934683,0.000036877016,0.000031149382,0.0017640315],"genre_scores_gemma":[0.9976535,0.00001538394,0.0011995891,0.0007084047,0.0001070014,0.00016936749,0.000050918814,0.000037629514,0.000058239384],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99685806,0.0005408422,0.0014387049,0.00071094045,0.00011824919,0.0003332137],"domain_scores_gemma":[0.9981693,0.00018781118,0.00093460584,0.00048420115,0.000017330962,0.00020672893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020038899,0.00023020066,0.0008884249,0.00033299942,0.00014957828,0.000097436365,0.00019655227,0.00008874028,0.00011721533],"category_scores_gemma":[0.00026002777,0.0002226945,0.00008323401,0.00008197699,0.00007305525,0.00046636863,0.0000434629,0.00023256763,0.00038014655],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002479632,0.00042750695,0.2720813,0.0000405457,0.000027059958,0.0000019288677,0.01062291,0.7061772,0.000004775016,0.00782674,0.000019013974,0.00029142044],"study_design_scores_gemma":[0.03873144,0.0004719801,0.09806483,0.000066919645,0.000010165965,0.0000011595033,0.0014248022,0.8450912,0.00002635996,0.015814112,0.0000113068845,0.00028572074],"about_ca_topic_score_codex":0.018650718,"about_ca_topic_score_gemma":0.00071574136,"teacher_disagreement_score":0.17401646,"about_ca_system_score_codex":0.0024791881,"about_ca_system_score_gemma":0.0002868713,"threshold_uncertainty_score":0.98788416},"labels":[],"label_agreement":null},{"id":"W2097158867","doi":"10.1016/j.jval.2015.09.2158","title":"The Impact of Healthcare Policy Based on Drug Plan Perspective Versus The Ministry of Health Perspective: A Case Study of The Odprn Recommendations of Restricting Reimbursement of Testosterone Replacement Therapy For Hypogonadism In Ontario, Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Joseph's Health Centre; Mount Sinai Hospital","funders":"","keywords":"Reimbursement; Christian ministry; Medical prescription; Prescription drug; Actuarial science; Medicaid; Medicine; Health care; Business; Economics; Economic growth; Nursing; Political science","score_opus":0.14694393282769785,"score_gpt":0.41286666122688165,"score_spread":0.2659227283991838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097158867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9296653,0.0015936177,9.0813535e-7,0.06510471,0.000145766,0.0032390922,0.00012339346,0.0000022357501,0.00012494763],"genre_scores_gemma":[0.99957806,0.00011448639,0.00005531732,0.00008956246,0.000038218604,0.00007717588,0.0000041542435,0.000012998523,0.000030008361],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9969282,0.00089186657,0.0010810489,0.000299485,0.0004937147,0.00030566068],"domain_scores_gemma":[0.99638,0.0011151681,0.0011511709,0.0006255536,0.00063441653,0.00009373332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027673612,0.0001686391,0.00066237635,0.00016817414,0.00019498974,0.0000017333609,0.00015705018,0.000027362013,0.0000010843621],"category_scores_gemma":[0.0009605942,0.00008744795,0.00010096783,0.000558154,0.00016370897,0.000016527145,0.000049792056,0.00031880982,1.0465876e-8],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.019462258,0.006813972,0.41995907,0.0006662531,0.00085429207,0.000016005735,0.533134,0.010959462,0.00006219127,0.0024778303,0.0019496075,0.003645104],"study_design_scores_gemma":[0.0076263663,0.01646674,0.28755376,0.00048610338,0.000020792495,0.000013437097,0.6871378,0.0002296608,0.00013917382,0.00019941176,0.000053540018,0.00007325847],"about_ca_topic_score_codex":0.9983767,"about_ca_topic_score_gemma":0.95815235,"teacher_disagreement_score":0.15400378,"about_ca_system_score_codex":0.0052668117,"about_ca_system_score_gemma":0.01475735,"threshold_uncertainty_score":0.9985518},"labels":[],"label_agreement":null},{"id":"W2097255304","doi":"10.1016/j.jval.2014.08.181","title":"Content Analysis And Effectiveness Of Interventions To Enhance Oral Antidiabetic Drug (Oad) Adherence In Adults With Type 2 Diabetes: A Systematic Review And Meta-Analysis","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Behavioral Health and Interventions","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Meta-analysis; Psychological intervention; CINAHL; Medicine; Cochrane Library; Systematic review; Intervention (counseling); MEDLINE; Physical therapy; Internal medicine; Nursing","score_opus":0.2200424433132902,"score_gpt":0.4832915272636818,"score_spread":0.2632490839503916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097255304","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006099581,0.98683125,0.00012145541,0.000062773615,0.00006699309,0.006610265,0.00018565857,0.00001426761,0.000007762906],"genre_scores_gemma":[0.05238403,0.944026,0.00019181526,0.00014170722,0.000004134132,0.0029834746,0.00010382893,0.000034224035,0.00013079762],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9872832,0.008004685,0.003080846,0.0008860138,0.00022573562,0.000519538],"domain_scores_gemma":[0.99604934,0.00094383204,0.0016303867,0.0008813708,0.00019388647,0.00030119295],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006215073,0.0004793682,0.011641087,0.0017409588,0.000048134687,0.000019527677,0.00029492757,0.00015603649,0.00016708404],"category_scores_gemma":[0.00024369355,0.00033266837,0.0016984737,0.005138468,0.00008872916,0.00006020806,0.00007647468,0.00044439588,0.000019657835],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017111606,0.00027630277,0.0015384234,0.97604877,0.018429453,0.0000026411326,0.0001771168,0.0000045557786,9.22958e-9,0.00007993228,0.0000087850985,0.0034168854],"study_design_scores_gemma":[0.00023411273,0.0010980075,0.0039456002,0.51956373,0.47463095,0.0000027536867,0.00005921015,0.000015934875,1.5316219e-7,0.0000061553333,0.00011951812,0.00032390267],"about_ca_topic_score_codex":0.012212392,"about_ca_topic_score_gemma":0.005344306,"teacher_disagreement_score":0.45648506,"about_ca_system_score_codex":0.00016603571,"about_ca_system_score_gemma":0.00013781997,"threshold_uncertainty_score":0.99991256},"labels":[],"label_agreement":null},{"id":"W2097492743","doi":"10.1016/j.jval.2011.08.021","title":"MT1 Impact of the Choice of Prior Distribution on relative Effect Sizes Using Bayesian Network Meta-Analysis","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Diverse Approaches in Healthcare and Education Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Prior probability; Statistics; Deviance information criterion; Belatacept; Bayesian probability; Mathematics; Econometrics; Meta-analysis; Kidney transplant; Bayesian inference; Medicine; Kidney transplantation; Internal medicine; Transplantation","score_opus":0.37055078473436476,"score_gpt":0.4346680340335975,"score_spread":0.06411724929923274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097492743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955064,0.0021237358,0.00034371568,0.0005443759,0.00015168378,0.0008733216,0.00005177091,0.000010196082,0.0003947952],"genre_scores_gemma":[0.9988465,0.00008414353,0.0008532988,0.0000976637,0.00005528606,0.000016188704,0.000012239616,0.000007933443,0.000026765141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796546,0.0007358452,0.00058136357,0.00020257055,0.00026099483,0.00025375278],"domain_scores_gemma":[0.9981169,0.00077684055,0.0005141926,0.00039633282,0.0001084832,0.000087212095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015043643,0.000134562,0.0010146181,0.00010721864,0.00010504722,0.0000019312718,0.00008439396,0.00006590147,0.00005888657],"category_scores_gemma":[0.00052105344,0.00007671473,0.00072566245,0.0012200951,0.00010290252,0.000044897744,0.000035978665,0.00020700767,0.000001146152],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002468136,0.0002736619,0.9650704,0.00043321488,0.018962003,6.8758084e-7,0.004703102,0.008285129,0.000002600983,0.0011922395,0.00016504846,0.0006650655],"study_design_scores_gemma":[0.00038436142,0.0009934916,0.9767775,0.00013501204,0.018240592,0.0000015741659,0.0003074209,0.002571707,0.00012319053,0.00035041387,0.00003569244,0.00007903768],"about_ca_topic_score_codex":0.03010662,"about_ca_topic_score_gemma":0.000058468362,"teacher_disagreement_score":0.030048152,"about_ca_system_score_codex":0.0003534887,"about_ca_system_score_gemma":0.0003667861,"threshold_uncertainty_score":0.976352},"labels":[],"label_agreement":null},{"id":"W2097672482","doi":"10.1016/j.jval.2012.06.009","title":"An Evaluation Framework for Funding Drugs for Rare Diseases","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":59,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ministry of Health and Long Term Care; Kingston General Hospital; Centre Hospitalier Universitaire de Sherbrooke; Hospital for Sick Children; Western University; St. Michael's Hospital; University of Toronto; Queen's University; London Health Sciences Centre","funders":"","keywords":"Orphan drug; Dilemma; Enzyme replacement therapy; Medicine; Accountability; Disease; Rare disease; Drug; Business; Risk analysis (engineering); Public economics; Intensive care medicine; Political science; Pharmacology; Bioinformatics; Economics","score_opus":0.1606582134000392,"score_gpt":0.46329318029258376,"score_spread":0.30263496689254454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097672482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93850255,0.011385485,0.035800878,0.0058307643,0.0006232044,0.007554181,0.0001095735,0.00008710709,0.000106230866],"genre_scores_gemma":[0.9801983,0.00006934743,0.017335365,0.00066655513,0.00068163424,0.0007836745,0.00018916176,0.000036886562,0.00003904212],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981861,0.00020587971,0.00027671934,0.00022194302,0.0004547918,0.0006545412],"domain_scores_gemma":[0.9984403,0.00064225384,0.000078113364,0.00026529323,0.00014958682,0.00042442736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002088995,0.00009921205,0.0002390927,0.00016421065,0.00014985986,0.000017077746,0.000084084415,0.00008864824,0.00007095753],"category_scores_gemma":[0.001969415,0.0000920208,0.00007222745,0.00023671988,0.000024298453,0.00018215728,0.00001407779,0.00014034053,0.000008183655],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024812603,0.0026126509,0.6137268,0.0070450646,0.00007540051,0.0000018690133,0.014770901,0.001768624,0.00015661941,0.049480457,0.0039568543,0.30392352],"study_design_scores_gemma":[0.017701188,0.005793366,0.39001015,0.0029764853,0.00025755822,0.000017751856,0.012243661,0.4187815,0.00045314908,0.12585767,0.024996929,0.0009106109],"about_ca_topic_score_codex":0.00038813966,"about_ca_topic_score_gemma":0.000006441723,"teacher_disagreement_score":0.41701284,"about_ca_system_score_codex":0.0005922489,"about_ca_system_score_gemma":0.000535758,"threshold_uncertainty_score":0.37524992},"labels":[],"label_agreement":null},{"id":"W2097730523","doi":"10.1016/j.jval.2013.08.019","title":"Multinational Consistency of a Discrete Choice Model in Quantifying Health States for the Extended 5-Level EQ-5D","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Respondent; Statistics; Choice set; Consistency (knowledge bases); Econometrics; Preference; Demography; Mathematics","score_opus":0.7304774727936757,"score_gpt":0.47317367564234347,"score_spread":0.2573037971513322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097730523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4345588,0.019901002,0.109427124,0.42113054,0.0010181827,0.01072907,0.0027342448,0.00007294681,0.00042808225],"genre_scores_gemma":[0.95642656,0.00086110446,0.029602762,0.011936109,0.00009869914,0.0007639206,0.00007454909,0.00004225973,0.00019402447],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99246246,0.00054152193,0.0056308103,0.0005389448,0.00013645209,0.0006898106],"domain_scores_gemma":[0.99102,0.0053533684,0.0028709932,0.000465609,0.00011019256,0.0001797979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021719845,0.00019589927,0.0010885576,0.00046940485,0.00024363579,0.0000443362,0.00032647836,0.00009583166,0.00005976378],"category_scores_gemma":[0.0042409846,0.00020276364,0.000115436764,0.00030827883,0.00009723617,0.00039784831,0.000052103434,0.00024368928,0.00007129096],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038783648,0.0004426549,0.13015962,0.0046561607,0.00005782007,1.7199729e-7,0.014586707,0.30768487,0.000002813148,0.531118,0.008649018,0.0026034312],"study_design_scores_gemma":[0.0011587833,0.00008963925,0.1383798,0.0002692326,8.973657e-7,8.7036904e-7,0.0014820178,0.81485164,7.4778035e-7,0.042439245,0.0011661261,0.00016099797],"about_ca_topic_score_codex":0.09999556,"about_ca_topic_score_gemma":0.0038507963,"teacher_disagreement_score":0.52186775,"about_ca_system_score_codex":0.0009966546,"about_ca_system_score_gemma":0.0010980043,"threshold_uncertainty_score":0.90599763},"labels":[],"label_agreement":null},{"id":"W2097779933","doi":"10.1016/j.jval.2012.08.1916","title":"PIH44 Contraceptive Utilization in Women Who Had an Abortion: A Canadian Cohort-Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Abortion; Levonorgestrel; Obstetrics; Family planning; Unintended pregnancy; Gynecology; Long-acting reversible contraception; Pregnancy; Population; Intrauterine device; Medical prescription; Medroxyprogesterone acetate; Pill; Research methodology; Estrogen; Nursing; Environmental health","score_opus":0.06737318277486573,"score_gpt":0.35682318718661316,"score_spread":0.2894500044117474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097779933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99027675,0.0012561916,0.000043098735,0.0039685,0.00033659593,0.0034411594,0.000007856665,0.000035135392,0.000634683],"genre_scores_gemma":[0.9964976,0.0002970394,0.00006448705,0.0020310394,0.00052115094,0.00037425227,0.00003000165,0.00002268942,0.00016174203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714303,0.0006223588,0.0006154173,0.00040199814,0.00027423166,0.0009429574],"domain_scores_gemma":[0.99835384,0.00003897074,0.0001456386,0.00036500255,0.00011232111,0.0009842131],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003364185,0.0001496315,0.00043941053,0.00043387795,0.00011195008,0.000011438966,0.000052529776,0.00011262074,0.00011853952],"category_scores_gemma":[0.00025390953,0.00015022511,0.000020524434,0.0005940734,0.00003340749,0.0003123089,0.0000066427174,0.0003605268,0.00003182279],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024290076,0.00072706403,0.9701139,0.00008812674,0.0000079506435,0.000009187173,0.014658175,0.00011397644,0.000009055907,0.00043199793,0.00010449127,0.013493207],"study_design_scores_gemma":[0.0017008042,0.00093164906,0.9879448,0.00011853864,0.000005741886,0.000011753305,0.0045142327,0.0012673787,0.000003929445,0.00006764164,0.0033215883,0.000111976224],"about_ca_topic_score_codex":0.40993255,"about_ca_topic_score_gemma":0.111144334,"teacher_disagreement_score":0.29878822,"about_ca_system_score_codex":0.0021142531,"about_ca_system_score_gemma":0.00134257,"threshold_uncertainty_score":0.90507495},"labels":[],"label_agreement":null},{"id":"W2097900603","doi":"10.1016/j.jval.2014.03.130","title":"The Effect Of Massachusetts Health Care Reform On Hospital Inpatient Use","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Index (typography); Legislation; Health care; Demography; Population; Quarter (Canadian coin); Inpatient care; Hospital bed; Medicine; Variables; Unemployment; Health care reform; Natural experiment; Demographic economics; Economics; Statistics; Geography; Health policy; Environmental health; Political science; Economic growth; Nursing; Mathematics","score_opus":0.034448519207874714,"score_gpt":0.27197718268119475,"score_spread":0.23752866347332002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2097900603","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87872064,0.004442567,0.0002943077,0.10375401,0.0020748929,0.0026920666,0.00032512803,0.000067339206,0.007629066],"genre_scores_gemma":[0.9966279,0.000778479,0.00012729721,0.0022148741,0.000091310074,0.000058939706,0.000016584532,0.000021085376,0.00006349438],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977912,0.00027321264,0.0009917322,0.0003167153,0.00007875311,0.0005484069],"domain_scores_gemma":[0.9983635,0.00033663015,0.00058819854,0.0005363467,0.000015193458,0.00016012593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028335685,0.00014633214,0.0004703992,0.00021205364,0.00019584746,0.000027951965,0.000211917,0.000060540646,0.0000035352298],"category_scores_gemma":[0.00030566406,0.000117571384,0.00007821287,0.00021585416,0.000039156534,0.0000779627,0.0000566839,0.0002228398,0.00006212941],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089507186,0.000101309226,0.07157829,0.0016104348,0.000022193268,8.397502e-7,0.0055028494,0.0018768335,3.7020968e-8,0.86461914,0.002262403,0.052336186],"study_design_scores_gemma":[0.002197329,0.015234697,0.15521017,0.00051100214,0.0000020546242,7.153964e-7,0.0004971451,0.0048701456,0.000028441134,0.0059790364,0.8150484,0.00042087556],"about_ca_topic_score_codex":0.08323622,"about_ca_topic_score_gemma":0.00092280575,"teacher_disagreement_score":0.8586401,"about_ca_system_score_codex":0.0011830118,"about_ca_system_score_gemma":0.00007658009,"threshold_uncertainty_score":0.9228686},"labels":[],"label_agreement":null},{"id":"W2098317659","doi":"10.1016/j.jval.2014.03.564","title":"First Two Years of Health System Resources and Costs Following a Stage Defined Breast Cancer Diagnosis: A Population Based Approach","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Cancer Care Ontario; McMaster University; Ontario Institute for Cancer Research; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Cohort; Breast cancer; Stage (stratigraphy); Public health; Health care; Cancer registry; Cancer; Cohort study; Population; Total cost; Demography; Pediatrics; Internal medicine; Environmental health; Pathology","score_opus":0.03728103854955966,"score_gpt":0.2585107166206832,"score_spread":0.22122967807112354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098317659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859821,0.008811653,0.0017272643,0.0017128396,0.0002976004,0.0005134212,0.00037106464,0.00003367557,0.000550374],"genre_scores_gemma":[0.99770576,0.00049099064,0.0010560813,0.00048058404,0.00007916072,0.00013120491,0.000013235028,0.000028458007,0.000014544988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807245,0.00009493193,0.0010240796,0.00038187028,0.000047370508,0.00037929742],"domain_scores_gemma":[0.99862784,0.00014911026,0.00083343015,0.00024013882,0.000011883441,0.00013760701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021343497,0.00013851875,0.0007349953,0.0002838039,0.00011073751,0.00003621172,0.00011924869,0.00007023241,0.000010771541],"category_scores_gemma":[0.00009520643,0.0001738721,0.000077800905,0.00022394327,0.000024606352,0.00016228603,0.000026554908,0.00011797731,0.000004662434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002607858,0.000055793873,0.93206906,0.00057715096,0.000012585839,3.490637e-7,0.0006151048,0.017266482,5.8908228e-8,0.04025767,0.000061832805,0.009057855],"study_design_scores_gemma":[0.0015146104,0.00010192004,0.9097198,0.0007505108,0.0000025519694,0.0000013373185,0.00012564061,0.083799265,3.654573e-7,0.00041514367,0.0033797228,0.00018913197],"about_ca_topic_score_codex":0.21595667,"about_ca_topic_score_gemma":0.0019498448,"teacher_disagreement_score":0.21400684,"about_ca_system_score_codex":0.00092383934,"about_ca_system_score_gemma":0.000116440366,"threshold_uncertainty_score":0.7892643},"labels":[],"label_agreement":null},{"id":"W2098724822","doi":"10.1016/j.jval.2014.08.2672","title":"Toward a Functional Definition of a “Rare Disease” for Regulatory Authorities and Funding Agencies","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Kingston General Hospital; London Health Sciences Centre; Queen's University; University of Ottawa; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Reimbursement; Disease; Medicine; Sample size determination; Population; Orphan drug; Actuarial science; Identification (biology); Randomized controlled trial; Negotiation; Clinical trial; Business; Family medicine; Public economics; Environmental health; Political science; Health care; Economics; Surgery; Internal medicine; Statistics; Economic growth","score_opus":0.0746525955204533,"score_gpt":0.27052615852297884,"score_spread":0.19587356300252556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2098724822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937501,0.0036705444,0.0018232258,0.00026138913,0.00011997671,0.00016363559,0.000115811155,0.0000045063834,0.00009082605],"genre_scores_gemma":[0.99803007,0.00026899518,0.0012098635,0.00015844403,0.00011821599,0.000027996459,0.000143516,0.000008450411,0.00003445386],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9994477,0.00004767415,0.0001606854,0.00015589541,0.000056782752,0.00013128281],"domain_scores_gemma":[0.99969393,0.000028723547,0.00006263901,0.00009520641,0.000032972464,0.00008654824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023126403,0.000061241066,0.00009318166,0.000042632088,0.000057991674,0.0000068508084,0.00003278008,0.00003667284,0.000002412604],"category_scores_gemma":[0.00011219288,0.00006158922,0.000042592295,0.0000264452,0.000042745618,0.0000021814824,0.000024896488,0.000021145464,2.059796e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031882217,0.00070458394,0.14443587,0.015552292,0.00022264263,0.00000948111,0.0031349156,0.010521601,0.08845494,0.7041013,0.010463531,0.019210627],"study_design_scores_gemma":[0.0038728602,0.002261521,0.8018769,0.0008001748,0.00007133344,0.00003602704,0.0034129773,0.010334757,0.0039609903,0.13963632,0.0328058,0.00093030697],"about_ca_topic_score_codex":0.00005836981,"about_ca_topic_score_gemma":0.0000067605756,"teacher_disagreement_score":0.6574411,"about_ca_system_score_codex":0.000018638875,"about_ca_system_score_gemma":0.00018264384,"threshold_uncertainty_score":0.25115356},"labels":[],"label_agreement":null},{"id":"W2099062624","doi":"10.1016/j.jval.2013.03.189","title":"Development of the 6-10 year interviewer-administered version of the asthma control questionnaire (ACQ-IA) in Spanish for guatemala and Peru","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cognitive interview; Interview; Psychology; Debriefing; Test (biology); Age appropriate; Cognition; Developmental psychology; Psychiatry; Social psychology; Political science","score_opus":0.025300383355330792,"score_gpt":0.29902753819593014,"score_spread":0.27372715484059934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099062624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954392,0.0008417647,0.00003005209,0.0023807662,0.000120208344,0.0011286162,0.000009883735,0.000004379187,0.00004518332],"genre_scores_gemma":[0.9990521,0.000019920326,0.00033295256,0.00041618475,0.000022149943,0.00004156588,0.0000015541668,0.000008277151,0.00010531531],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989813,0.00017525452,0.0004306182,0.00012248114,0.00015380712,0.00013656417],"domain_scores_gemma":[0.99943095,0.0000587552,0.00017838868,0.0001827939,0.00008539528,0.00006372141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044415714,0.000075656855,0.00024102716,0.00004703265,0.000047039885,0.0000036007118,0.000087513516,0.000046004494,0.00003045587],"category_scores_gemma":[0.0002165943,0.00004238953,0.000051031297,0.00011649495,0.000074384785,0.000028250028,0.000045874836,0.00007752014,0.0000030959754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094878266,0.0009827616,0.8932251,0.008269417,0.000051552528,0.000002697875,0.00900206,0.00016311543,0.0021138783,0.0005761669,0.0026346843,0.08202978],"study_design_scores_gemma":[0.0023535753,0.00028065676,0.98769647,0.0029122278,0.000007721939,0.00000253504,0.0009872894,0.00090451416,0.000536206,0.000049888295,0.0042170086,0.00005191975],"about_ca_topic_score_codex":0.0002409795,"about_ca_topic_score_gemma":0.00006970635,"teacher_disagreement_score":0.09447136,"about_ca_system_score_codex":0.000082075436,"about_ca_system_score_gemma":0.0005452213,"threshold_uncertainty_score":0.17285949},"labels":[],"label_agreement":null},{"id":"W2099070683","doi":"10.1016/j.jval.2012.03.376","title":"PMD36 The Use of Chlorhexidine Gluconate Impregnated Sponge Dressings to Prevent Central-Line Associated Bloodstream Infections and Local Site Infections in Canadian Hospitals: An Economic Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chlorhexidine gluconate; Hygiene; Chlorhexidine; Emergency medicine; Intensive care medicine; Intensive care unit; Activity-based costing; Infection control; Dentistry; Business","score_opus":0.030552365887835196,"score_gpt":0.2955000746289338,"score_spread":0.2649477087410986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2099070683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99521035,0.000307482,0.000051944757,0.0031276403,0.00011213948,0.0009615451,0.00017224315,0.00003089504,0.000025746362],"genre_scores_gemma":[0.99867296,0.00020987148,0.00005589112,0.00072169467,0.000042466505,0.00006076952,0.0001579219,0.000018991426,0.000059404803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980037,0.00030754594,0.00058246084,0.0002756039,0.00012410975,0.00070655905],"domain_scores_gemma":[0.99851245,0.000092350645,0.00016478068,0.00032603508,0.000040403298,0.00086397317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007325667,0.00017583797,0.00043768884,0.0007930123,0.00011194854,0.00003108123,0.00006334836,0.000072876144,0.0000826173],"category_scores_gemma":[0.0001328822,0.00015299786,0.00008379997,0.0010202639,0.000066193716,0.00028123733,0.000046963614,0.00019581939,0.0000062976796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022565328,0.00095903955,0.9128089,0.000059174865,0.00024696524,0.0000056221866,0.0014627756,0.08231465,0.00003205818,0.0000689299,0.00006942461,0.0019499061],"study_design_scores_gemma":[0.0006827565,0.00040191715,0.9196122,0.00017302074,0.00024504124,0.0000046794194,0.00011930107,0.07766946,0.00003310968,0.000012273344,0.0009189774,0.00012723013],"about_ca_topic_score_codex":0.8221261,"about_ca_topic_score_gemma":0.7224597,"teacher_disagreement_score":0.099666394,"about_ca_system_score_codex":0.001662898,"about_ca_system_score_gemma":0.00042531278,"threshold_uncertainty_score":0.6239072},"labels":[],"label_agreement":null},{"id":"W2100194586","doi":"10.1016/j.jval.2014.03.769","title":"Cost Of Patient Care At Different Stages Of Treatment Within The Public Health Model Of Hiv Care; Analysis From An Urban Hiv Centre In Uganda","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Human immunodeficiency virus (HIV); Antiretroviral therapy; Tuberculosis; Health care; Average cost; Family medicine; Total cost; Public health; Emergency medicine; Pediatrics; Viral load; Nursing","score_opus":0.06599841589178027,"score_gpt":0.35137737897711807,"score_spread":0.28537896308533783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100194586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99284136,0.001987129,0.00032647417,0.0025047143,0.000019769828,0.0009665801,0.0012784908,0.000008052615,0.00006745188],"genre_scores_gemma":[0.998294,0.00036449498,0.0002645372,0.00006424227,0.000015188058,0.000032564018,0.00078998384,0.000014939577,0.00016007683],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99688715,0.0009454645,0.00102655,0.00028916963,0.00046387274,0.00038777242],"domain_scores_gemma":[0.99824023,0.00014670448,0.00044943875,0.0006206815,0.00018607952,0.00035687766],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039900496,0.00015894811,0.0008294206,0.0004981426,0.00006186272,0.00000625033,0.00014568603,0.00005258815,0.000057322857],"category_scores_gemma":[0.0001226645,0.00010164087,0.00021925566,0.00049827044,0.000094951,0.000045126966,0.00005640726,0.00016551511,0.0000011727984],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017547273,0.0011335983,0.8721012,0.00083808723,0.00020850838,0.0000010482034,0.097070664,0.019237302,0.00008368187,0.0003399784,0.00034393996,0.008466553],"study_design_scores_gemma":[0.0077346503,0.021602217,0.16505927,0.0020384276,0.00023136381,9.391846e-7,0.07622043,0.722825,0.0033157445,0.00011067911,0.00058722356,0.0002740415],"about_ca_topic_score_codex":0.040307127,"about_ca_topic_score_gemma":0.03260239,"teacher_disagreement_score":0.7070419,"about_ca_system_score_codex":0.0015490671,"about_ca_system_score_gemma":0.0006415,"threshold_uncertainty_score":0.9850501},"labels":[],"label_agreement":null},{"id":"W2100225964","doi":"10.1111/j.1524-4733.2007.00243.x","title":"Advanced Cutaneous Malignant Melanoma: A Systematic Review of Economic and Quality-of-Life Studies","year":2007,"lang":"en","type":"review","venue":"Value in Health","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Dacarbazine; Quality of life (healthcare); Temozolomide; MEDLINE; Meta-analysis; Cost effectiveness; Randomized controlled trial; Melanoma; Quality-adjusted life year; Internal medicine; Systematic review; Oncology; Chemotherapy","score_opus":0.17123403755941305,"score_gpt":0.4334472991656458,"score_spread":0.2622132616062327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100225964","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007090653,0.99324906,0.000008430425,0.00011766471,0.00034456415,0.0059075467,0.000028804126,0.000025872065,0.00024717156],"genre_scores_gemma":[0.00006780025,0.9986608,0.0003322484,0.0003698788,0.00004422864,0.00013656035,0.000014079249,0.000040804764,0.00033361412],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9942885,0.0007622865,0.0039506387,0.00041700542,0.00028044978,0.00030109825],"domain_scores_gemma":[0.9957761,0.0009712012,0.0023985626,0.0006018231,0.00006852837,0.00018376697],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029632254,0.00036163823,0.0073469277,0.0004698093,0.00003007686,0.000003337298,0.00011762189,0.00012434692,0.000016826898],"category_scores_gemma":[0.00095400045,0.00026999522,0.00036429983,0.0002544955,0.00007787835,0.000017605407,0.000085258485,0.00024632332,0.000016056812],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024368843,0.00005263708,0.0000031852521,0.9592137,0.0003439346,0.000048536163,0.000093972,0.000003075293,8.002615e-8,0.0008615667,0.000046885823,0.039308056],"study_design_scores_gemma":[0.00034425792,0.00044629653,7.030905e-7,0.917594,0.0008112923,0.0007637728,0.00022488362,0.000008829067,2.8956063e-7,0.000017316965,0.07960931,0.00017903725],"about_ca_topic_score_codex":0.00047156893,"about_ca_topic_score_gemma":0.000051248662,"teacher_disagreement_score":0.079562426,"about_ca_system_score_codex":0.0006666733,"about_ca_system_score_gemma":0.00065736315,"threshold_uncertainty_score":0.9999752},"labels":[],"label_agreement":null},{"id":"W2100305434","doi":"10.1016/j.jval.2014.03.776","title":"Cost-Effectiveness Analysis Of Government Insured Routine Eye Examination: Evidence From Prince Edwards Island, Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Kensington Health; Health PEI; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Eye examination; Medicine; Christian ministry; Quality-adjusted life year; Cost effectiveness; Incidence (geometry); Health care; Eye care; Demography; Cost–benefit analysis; Population; Optometry; Gerontology; Environmental health; Visual acuity; Ophthalmology","score_opus":0.033594714680181846,"score_gpt":0.31142753234559145,"score_spread":0.2778328176654096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100305434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949762,0.00071464246,0.0020190205,0.0013172792,0.00014506016,0.000583316,0.000060769795,0.000008023025,0.0001756785],"genre_scores_gemma":[0.9992395,0.00014024232,0.00020131117,0.00024080722,0.000032997574,0.00002662418,0.000035016797,0.000008688556,0.00007481756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978209,0.00061935803,0.00041009797,0.00025918317,0.0006773309,0.00021313396],"domain_scores_gemma":[0.9986743,0.00063915463,0.00020311175,0.0002918958,0.00006634103,0.00012523089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013227963,0.00011450385,0.0005232999,0.00008444822,0.0000369492,0.0000040289237,0.00009107554,0.00004869038,0.000037052956],"category_scores_gemma":[0.0006093604,0.00009655195,0.00006330858,0.0006412908,0.000033181295,0.00003341261,0.000029448343,0.00013596487,0.0000010851975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014091154,0.00009784864,0.9916665,0.00033291514,0.000121123885,0.000005572796,0.00034928013,0.0019453384,0.00013163804,0.000065989174,0.000038125003,0.005104734],"study_design_scores_gemma":[0.0007987116,0.00023853905,0.9660544,0.00071661023,0.00014755422,6.544628e-7,0.00014024916,0.030847754,0.000248758,0.000011412744,0.0007177695,0.00007757902],"about_ca_topic_score_codex":0.83614546,"about_ca_topic_score_gemma":0.55709946,"teacher_disagreement_score":0.27904603,"about_ca_system_score_codex":0.00082288985,"about_ca_system_score_gemma":0.0005378456,"threshold_uncertainty_score":0.45098233},"labels":[],"label_agreement":null},{"id":"W2100475597","doi":"10.1016/j.jval.2013.03.871","title":"Perspectives on complementary data sources in diabetes health technology assessment: An enrolling practice-based research network and a large commercial health plan","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicaid; Medicine; Population; Type 2 diabetes; Population health; Family medicine; Health care; Health information technology; Medical record; Cohort; Health plan; Diabetes mellitus; Gerontology; Demography; Environmental health; Internal medicine","score_opus":0.7130318583908806,"score_gpt":0.5501841862972764,"score_spread":0.16284767209360418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100475597","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4271771,0.014987656,0.0006882741,0.5524544,0.00025319945,0.0032783337,0.0009009566,0.00007490713,0.00018515943],"genre_scores_gemma":[0.93578625,0.0015129909,0.018929493,0.042448774,0.0004306305,0.00027666287,0.0005510713,0.00005684537,0.0000072555417],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.985834,0.0059118182,0.004555333,0.0013842253,0.0002744231,0.0020401774],"domain_scores_gemma":[0.99147534,0.004473139,0.0022703558,0.0012239672,0.00007970653,0.00047750608],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.099814534,0.0002697947,0.0014907349,0.0015553456,0.0009538754,0.00016875741,0.00072099484,0.00016383617,0.00011208599],"category_scores_gemma":[0.0020419634,0.00034362293,0.00003162676,0.0009284601,0.00017235936,0.0008855635,0.00028196233,0.0012145874,0.00009860905],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043406035,0.0012626788,0.8220525,0.0010643909,0.000038597973,0.0000015544703,0.013262612,0.0052838656,1.451549e-7,0.13837357,0.016126402,0.0024903012],"study_design_scores_gemma":[0.00555442,0.0039611883,0.3118418,0.001753636,0.000002234955,0.000004508609,0.12326216,0.4124812,2.0460963e-7,0.02557104,0.11478598,0.00078164233],"about_ca_topic_score_codex":0.07076916,"about_ca_topic_score_gemma":0.007755045,"teacher_disagreement_score":0.5102107,"about_ca_system_score_codex":0.0026764576,"about_ca_system_score_gemma":0.0017848759,"threshold_uncertainty_score":0.9999016},"labels":[],"label_agreement":null},{"id":"W2100617583","doi":"10.1016/j.jval.2013.08.2053","title":"Trends in Health Care Resources Utilization, Cost and Medication Selection in the Treatment of Diabetes","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Diabetes mellitus; Reimbursement; Emergency medicine; Population; Public health; Health care; Pediatrics; Intensive care medicine; Environmental health","score_opus":0.09491532251127154,"score_gpt":0.4299714442135625,"score_spread":0.33505612170229093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100617583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9264779,0.011053735,0.000009056013,0.059093338,0.00018164035,0.0022774842,0.00001962263,0.000029757246,0.00085744454],"genre_scores_gemma":[0.98373705,0.0064319293,0.00016830541,0.008693751,0.000097413875,0.00066375174,0.00008813698,0.000015921107,0.00010375092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955527,0.0021671224,0.0012012456,0.0002612276,0.0002322908,0.00058538176],"domain_scores_gemma":[0.9983739,0.0008080475,0.0004335846,0.00019211802,0.0000659655,0.00012634369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001623771,0.00013652195,0.00045236456,0.00063170755,0.0002803785,0.0000060261777,0.0000978055,0.00013149467,0.00008529294],"category_scores_gemma":[0.000085897525,0.00009870478,0.000026308062,0.0009142225,0.000044240496,0.0001078568,0.00001578974,0.00028927758,0.000006785374],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012053464,0.0001350109,0.8044175,0.0009504778,0.0000024904018,1.7602103e-7,0.07399534,0.00007220414,0.0000018046081,0.00043369847,0.0018443483,0.1181349],"study_design_scores_gemma":[0.0011865504,0.0005550826,0.9477981,0.00030050115,0.0000018376519,2.7069635e-7,0.009344983,0.0009060152,0.0000019551355,0.00021867297,0.039619077,0.00006698866],"about_ca_topic_score_codex":0.09427471,"about_ca_topic_score_gemma":0.029905558,"teacher_disagreement_score":0.14338057,"about_ca_system_score_codex":0.0021091998,"about_ca_system_score_gemma":0.0012227102,"threshold_uncertainty_score":0.9877961},"labels":[],"label_agreement":null},{"id":"W2100650176","doi":"10.1016/j.jval.2013.08.227","title":"Hepatitis C Virus Infection Treatment Completion: An Analysis of the Quebec Provincial Reimbursement Program Database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Université de Montréal","funders":"","keywords":"Boceprevir; Telaprevir; Medicine; Ribavirin; Pegylated interferon; Internal medicine; Reimbursement; Hepatitis C virus; Hepatitis C; Pediatrics; Virology; Virus","score_opus":0.08245448752150777,"score_gpt":0.38983497159545366,"score_spread":0.3073804840739459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100650176","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99446386,0.00008260934,0.00013264459,0.0014272288,0.000095513446,0.0034416537,0.00010218551,0.00004753166,0.0002067782],"genre_scores_gemma":[0.9965626,0.0011842927,0.0008735102,0.0002135535,0.000097764736,0.0006202829,0.00029713084,0.000016054593,0.00013480039],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759257,0.00062872045,0.00056439545,0.00029726516,0.00057389925,0.00034312642],"domain_scores_gemma":[0.9987585,0.000060254333,0.0001703596,0.00064134994,0.000153542,0.00021600277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005707768,0.00013064193,0.000441339,0.00040015302,0.00011055151,0.000024307988,0.00008957532,0.000055131663,0.00040020447],"category_scores_gemma":[0.00011412526,0.000091302936,0.00012402904,0.0011798866,0.00009573428,0.00013200041,0.000047155685,0.00016794627,0.000025609137],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003152661,0.0013495743,0.8751819,0.00014158057,0.00014260439,0.0000046477885,0.00046619316,0.0007596638,0.00024337493,0.00021709235,0.00017294635,0.1212889],"study_design_scores_gemma":[0.000672444,0.0015528882,0.9158863,0.00011141741,0.00011719235,0.0000015066191,0.000022668348,0.077002406,0.0003325134,0.000016676706,0.0042141196,0.00006985564],"about_ca_topic_score_codex":0.9764048,"about_ca_topic_score_gemma":0.75941265,"teacher_disagreement_score":0.2169921,"about_ca_system_score_codex":0.0016148015,"about_ca_system_score_gemma":0.0009342713,"threshold_uncertainty_score":0.43819582},"labels":[],"label_agreement":null},{"id":"W2100848218","doi":"10.1016/j.jval.2014.08.1394","title":"Comparing Actual Patient Level Hospital Costs To The Canadian Cmg+ Costing Estimates For Acute Myocardial Infarction","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Myocardial infarction; Emergency medicine; Outlier; Statistics; Internal medicine; Mathematics","score_opus":0.2544127783207831,"score_gpt":0.43514464078935705,"score_spread":0.18073186246857398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100848218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8695139,0.00008953158,0.016051121,0.09638037,0.006810325,0.0069164718,0.00017938142,0.00016606464,0.0038927812],"genre_scores_gemma":[0.9792918,0.000015134541,0.002993086,0.016560249,0.00055911596,0.00043554718,0.00009906439,0.000019778898,0.00002620297],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99706095,0.00045331861,0.0009421991,0.00021094093,0.00032399263,0.001008614],"domain_scores_gemma":[0.99714065,0.001424933,0.000305951,0.00023153926,0.00016637915,0.0007305279],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0036768953,0.00014460091,0.0003306792,0.00021406391,0.0023309926,0.000026646168,0.00016798533,0.00016184051,0.0000151293825],"category_scores_gemma":[0.0025918928,0.000113778005,0.00003939092,0.00024127113,0.000026646963,0.00011151796,0.000054892742,0.0007105778,0.00014530563],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035135326,0.00010756928,0.3469018,0.0020390823,0.00009975744,0.000001651458,0.1267632,0.029348342,0.0000059196404,0.026315007,0.13369124,0.33437508],"study_design_scores_gemma":[0.001855993,0.0013082984,0.3582888,0.0017157522,0.000024092513,0.0000029242765,0.002828063,0.41271052,0.0000051531247,0.00055481226,0.2203456,0.00035997469],"about_ca_topic_score_codex":0.4299538,"about_ca_topic_score_gemma":0.17702174,"teacher_disagreement_score":0.38336217,"about_ca_system_score_codex":0.0021316165,"about_ca_system_score_gemma":0.0018705054,"threshold_uncertainty_score":0.9989678},"labels":[],"label_agreement":null},{"id":"W2100857136","doi":"10.1016/j.jval.2012.08.1858","title":"PHS85 The Cost of Public Cancer Prevention in Alberta","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Christian ministry; Government (linguistics); Cancer prevention; Public health; Environmental health; Business; Behavioral Risk Factor Surveillance System; Medicine; Cancer; Political science; Nursing","score_opus":0.595256386592312,"score_gpt":0.4768351141783591,"score_spread":0.11842127241395284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100857136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79401094,0.019002503,0.0009018048,0.17826952,0.0014342151,0.002226578,0.00009125947,0.000015960126,0.0040472047],"genre_scores_gemma":[0.99341065,0.00097178057,0.00034670252,0.004284348,0.00021720515,0.00026335794,0.0000119596825,0.000018975546,0.00047502926],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944623,0.0010505187,0.003561546,0.00025568748,0.000078829406,0.0005910902],"domain_scores_gemma":[0.99646974,0.0011935137,0.001774934,0.00038486804,0.00002329702,0.00015363924],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.031843536,0.00010922692,0.00063616864,0.00033646994,0.00007417179,0.000018356757,0.00023028279,0.00009046711,0.00030478067],"category_scores_gemma":[0.0022819124,0.00011537911,0.00006251543,0.00040356646,0.00004758408,0.00044437955,0.000036231362,0.00019640216,0.00025812446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004421621,0.00019315073,0.77645224,0.00041995518,0.000011136266,3.6703693e-8,0.00438777,0.001206828,2.511941e-7,0.21317486,0.0027630858,0.0013862809],"study_design_scores_gemma":[0.0013910352,0.00008593432,0.81017834,0.00047177664,0.000002201414,0.0000026857865,0.0013779894,0.020719405,0.0000040325444,0.019341094,0.14612712,0.00029835827],"about_ca_topic_score_codex":0.14414461,"about_ca_topic_score_gemma":0.012154342,"teacher_disagreement_score":0.1993997,"about_ca_system_score_codex":0.0010978857,"about_ca_system_score_gemma":0.0004338081,"threshold_uncertainty_score":0.9969208},"labels":[],"label_agreement":null},{"id":"W2100894147","doi":"10.1016/j.jval.2013.03.515","title":"How can we use discrete event simulation to improve access to health care: an assessment of increasing access to care for children with medically refractory epilepsy","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Programs for Assessment of Technology in Health Research Institute; McMaster University","funders":"","keywords":"Multidisciplinary approach; Discrete event simulation; Resource (disambiguation); Limiting; Health care; Computer science; Operations management; Unit (ring theory); Medicine; Simulation; Engineering; Psychology","score_opus":0.24991299687988316,"score_gpt":0.47635157636593367,"score_spread":0.2264385794860505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100894147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81493413,0.00048281843,0.04123547,0.1314023,0.00041134647,0.0101344595,0.0013442026,0.000041931267,0.000013313502],"genre_scores_gemma":[0.9527294,0.00007849328,0.02218111,0.023307972,0.0003268855,0.0010356901,0.00024648343,0.00007814076,0.000015806621],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99308926,0.000956327,0.0036481633,0.0010685378,0.00029280718,0.00094493],"domain_scores_gemma":[0.99405104,0.0011138818,0.0023586645,0.00090370455,0.0003131808,0.0012595472],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008888599,0.0003250737,0.0014653681,0.00082980964,0.00030019786,0.00045241608,0.0007201715,0.00014383906,0.000023496912],"category_scores_gemma":[0.0024290949,0.0003620913,0.00008598519,0.00051990966,0.000031345455,0.0015624001,0.00018743626,0.00026268672,0.000012823844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014019162,0.00021342345,0.69405353,0.0030821247,0.000075830256,2.7889357e-7,0.03369826,0.24808402,0.0000028401216,0.00301929,0.0016720954,0.015958102],"study_design_scores_gemma":[0.0013273559,0.0023361263,0.9637774,0.0008603566,0.000005813795,0.000001095835,0.003728185,0.020646172,0.0000027401047,0.00052764354,0.006263147,0.0005239483],"about_ca_topic_score_codex":0.17495026,"about_ca_topic_score_gemma":0.017591702,"teacher_disagreement_score":0.26972386,"about_ca_system_score_codex":0.004704001,"about_ca_system_score_gemma":0.002311075,"threshold_uncertainty_score":0.9998831},"labels":[],"label_agreement":null},{"id":"W2100930670","doi":"10.1016/j.jval.2014.03.900","title":"Ovarian Stimulation Use, Including Clomiphene Citrate, And Intrauterine Insemination Use And The Risk Of Multiplicity And Major Congenital Malformations: A Meta-Analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Assisted Reproductive Technology and Twin Pregnancy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Intrauterine insemination; Relative risk; Randomized controlled trial; Gynecology; Observational study; Adverse effect; Obstetrics; Infertility; Pregnancy; Internal medicine; Confidence interval","score_opus":0.09358449022296159,"score_gpt":0.31336403048643924,"score_spread":0.21977954026347765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2100930670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98539966,0.0017904363,0.010596632,0.0014685536,0.000018620547,0.0006663707,0.000021856535,0.000025107174,0.000012748201],"genre_scores_gemma":[0.99075085,0.0010310645,0.008047101,0.000090532936,0.000012517271,0.000030819436,0.000016014632,0.0000063616126,0.000014761594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986179,0.00045517596,0.00046582049,0.00024182776,0.000103176026,0.00011611754],"domain_scores_gemma":[0.9985668,0.000712716,0.0003214668,0.00025154406,0.00009947662,0.00004797795],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018020689,0.00010782367,0.00056306325,0.0003058774,0.00014568256,0.00001952692,0.000029072884,0.00009840467,0.000003990833],"category_scores_gemma":[0.0014327404,0.000071235045,0.00006652016,0.00042010832,0.00024799278,0.00026991824,0.000059348207,0.00022400847,1.3679247e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006157608,0.00016885201,0.94209737,0.00047582152,0.012319985,0.0000021502792,0.0033761302,0.0019861704,0.00023657594,0.029593816,0.0000057541765,0.009121635],"study_design_scores_gemma":[0.0021662242,0.00011545844,0.8829634,0.000032792504,0.008566643,0.000021752923,0.00009263229,0.10239545,0.0001451032,0.0034174307,0.000016245485,0.00006683789],"about_ca_topic_score_codex":0.0031947843,"about_ca_topic_score_gemma":0.00019423418,"teacher_disagreement_score":0.100409284,"about_ca_system_score_codex":0.000028923972,"about_ca_system_score_gemma":0.000026172476,"threshold_uncertainty_score":0.48295796},"labels":[],"label_agreement":null},{"id":"W2101080120","doi":"10.1016/j.jval.2013.03.696","title":"Cost-Effectiveness Of Eml4-Alk Fusion Testing In Combination With Crizotinib Treatment For Patients With Advanced Non-Small Cell Lung Cancer Living In Ontario","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Toronto Public Health; Ontario Institute for Cancer Research; University Health Network; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Crizotinib; Medicine; Lung cancer; Oncology; Internal medicine; Cost effectiveness","score_opus":0.03934213499226,"score_gpt":0.33639221429708416,"score_spread":0.2970500793048242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101080120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911258,0.00014543759,0.00022005773,0.0000705647,0.00006703499,0.008170547,0.000010632709,0.000010655569,0.0001792252],"genre_scores_gemma":[0.9924931,0.000027112634,0.004816468,0.00003326786,0.000006650365,0.002482599,0.00005760115,0.000024819326,0.000058366524],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888134,0.00009173922,0.0003358133,0.0002702012,0.00013736486,0.00028355335],"domain_scores_gemma":[0.9989302,0.00048978947,0.00019938794,0.00012892082,0.0001752,0.00007649521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020017342,0.00015471419,0.00037093466,0.00019993847,0.000046621823,0.0000069057387,0.000031397114,0.000040823845,0.000008979455],"category_scores_gemma":[0.000037109214,0.00011169933,0.00001924677,0.00029690482,0.000014908124,0.00011064053,0.00000949166,0.00010025025,3.6325417e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003568476,0.0017509667,0.9668255,0.0008719413,0.000017194921,0.000002261536,0.004760839,0.014374871,0.00005908132,0.0000070225574,0.0000012172915,0.010972284],"study_design_scores_gemma":[0.014929366,0.0045877425,0.9675075,0.0060874615,0.000037049158,5.8819705e-7,0.0002846972,0.0062678484,0.00017485069,0.0000143018615,0.000010004167,0.00009858124],"about_ca_topic_score_codex":0.4801404,"about_ca_topic_score_gemma":0.14711456,"teacher_disagreement_score":0.33302584,"about_ca_system_score_codex":0.0035433103,"about_ca_system_score_gemma":0.0013183092,"threshold_uncertainty_score":0.9265633},"labels":[],"label_agreement":null},{"id":"W2101232021","doi":"10.1016/j.jval.2011.02.421","title":"PUK6 LOW-MOLECULAR-WEIGHT HEPARIN IN CHRONIC HEMODIALYSIS PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Programs for Assessment of Technology in Health Research Institute; McMaster University","funders":"","keywords":"Medicine; Hemodialysis; Randomized controlled trial; Low molecular weight heparin; Heparin; Meta-analysis; Thrombosis; Systematic review; Internal medicine; Extracorporeal; Intensive care medicine; MEDLINE","score_opus":0.19284003563198815,"score_gpt":0.40258645464300774,"score_spread":0.2097464190110196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101232021","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000005686141,0.9909655,0.000038537186,0.00047111142,0.000047261445,0.00826056,0.000023491682,0.000028591428,0.00015925999],"genre_scores_gemma":[0.000073670846,0.9979738,0.0001868627,0.00067953335,0.000053707743,0.00023599621,0.00026333268,0.00005270955,0.0004804139],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.993241,0.001930213,0.003213555,0.0007285564,0.0004320419,0.0004546176],"domain_scores_gemma":[0.99688953,0.0003251441,0.0015228397,0.0009782064,0.00007053164,0.00021375928],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002645827,0.0005797869,0.014353732,0.0015277031,0.000039324623,0.000024254188,0.00020440135,0.0002133099,0.00027490914],"category_scores_gemma":[0.00046862525,0.0003914486,0.0028702414,0.0028923706,0.000032430016,0.00007675277,0.0001268067,0.0003527934,0.00006796407],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000029218409,0.000021676224,0.0002663353,0.9636047,0.033212613,0.000012046377,0.000034420653,0.000012861917,1.0393766e-9,0.00029825722,0.00003630141,0.0024978642],"study_design_scores_gemma":[0.00051921466,0.00009391922,0.00007384671,0.10355531,0.8489546,0.000003501977,0.000002977897,0.00009598454,1.9924627e-8,0.00003135681,0.0462936,0.00037568217],"about_ca_topic_score_codex":0.0011641582,"about_ca_topic_score_gemma":0.00011168372,"teacher_disagreement_score":0.8600494,"about_ca_system_score_codex":0.0010065214,"about_ca_system_score_gemma":0.0005007564,"threshold_uncertainty_score":0.99985373},"labels":[],"label_agreement":null},{"id":"W2101820986","doi":"10.1016/j.jval.2014.03.464","title":"Health Care Resource Utilization in the Management of Chronic Lymphocytic Leukemia at an Ontario Cancer Centre","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Credit Valley Hospital; McMaster University; Health Sciences Centre; Juravinski Cancer Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Fludarabine; Chlorambucil; Chronic lymphocytic leukemia; Cohort; Internal medicine; Alemtuzumab; Rituximab; Retrospective cohort study; Chemotherapy regimen; Cancer; Chemotherapy; Oncology; Leukemia; Transplantation; Lymphoma; Cyclophosphamide","score_opus":0.05192244247625553,"score_gpt":0.3482144586261496,"score_spread":0.29629201614989403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101820986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98684424,0.007236971,0.00003607804,0.0019515875,0.00011918207,0.0019085655,0.000008685214,0.000032915334,0.0018617905],"genre_scores_gemma":[0.99590343,0.0014355114,0.00021640978,0.0013967067,0.00011805013,0.00005810934,0.00010675459,0.000035576373,0.00072945864],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99649596,0.00069921464,0.00074622605,0.0004730559,0.00079743087,0.00078810495],"domain_scores_gemma":[0.99853873,0.00013071914,0.00022275808,0.00082216645,0.000053794476,0.00023181488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016967468,0.0001896493,0.00049593137,0.00022030866,0.00011564476,0.000011789726,0.00029655683,0.00009457011,0.00009184399],"category_scores_gemma":[0.000024336248,0.00014990801,0.000055935932,0.0005908148,0.00008627249,0.00005449703,0.00010938064,0.00028846745,0.000012963263],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0022275676,0.0006249333,0.051430658,0.044710316,0.00017411957,0.00027182742,0.21220198,0.42147583,0.000022097473,0.008501637,0.007850627,0.25050843],"study_design_scores_gemma":[0.059115957,0.0031189658,0.11628383,0.010910008,0.000068070105,0.00016378191,0.012634817,0.63303983,0.00020288852,0.0001675318,0.16373898,0.0005553446],"about_ca_topic_score_codex":0.6801781,"about_ca_topic_score_gemma":0.4329549,"teacher_disagreement_score":0.3836363,"about_ca_system_score_codex":0.4363549,"about_ca_system_score_gemma":0.052718602,"threshold_uncertainty_score":0.9526516},"labels":[],"label_agreement":null},{"id":"W2101840350","doi":"10.1046/j.1524-4733.2002.54145.x","title":"Cost-Effectiveness and Cost-Utility of Long-Term Management Strategies for Heartburn","year":2002,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastroesophageal reflux and treatments","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University","funders":"","keywords":"Heartburn; Medicine; Quality-adjusted life year; Cost effectiveness; Intensive care medicine; Actuarial science; Risk analysis (engineering); Disease; Business; Internal medicine; Reflux","score_opus":0.1432677669857264,"score_gpt":0.39053039659987576,"score_spread":0.24726262961414935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2101840350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937281,0.0009791225,0.0009368583,0.00017018456,0.000073352094,0.0035244888,0.000026991747,0.000018718843,0.0005421946],"genre_scores_gemma":[0.99852824,0.00030432132,0.0007686893,0.000081698425,0.000016542208,0.00019568097,0.000013511844,0.000011212849,0.00008012407],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899364,0.000108734945,0.00026435888,0.00022413043,0.00013592525,0.0002732167],"domain_scores_gemma":[0.99945766,0.00012519462,0.0000700472,0.00018359839,0.0000331026,0.00013042134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039815847,0.000111506655,0.00032807785,0.00008941854,0.00004327436,0.000008521819,0.000031707015,0.000038017934,0.0000330782],"category_scores_gemma":[0.000016968595,0.000094580166,0.00004319157,0.00009977634,0.000052344898,0.00005590816,0.000019200694,0.00007517936,0.0000035655514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002262756,0.0008130237,0.87142724,0.0049576447,0.00008207858,0.00015594288,0.000339774,0.000082581515,0.000007975232,0.00073229754,0.00006677811,0.1211084],"study_design_scores_gemma":[0.0038568422,0.0008455161,0.9927509,0.00034480647,0.000028010038,0.000019808442,0.000060633167,0.0015353775,0.00010064652,0.0003738508,0.000049956732,0.00003366913],"about_ca_topic_score_codex":0.00017985828,"about_ca_topic_score_gemma":0.000010471878,"teacher_disagreement_score":0.12132365,"about_ca_system_score_codex":0.00009530317,"about_ca_system_score_gemma":0.000040394443,"threshold_uncertainty_score":0.3856867},"labels":[],"label_agreement":null},{"id":"W2102472721","doi":"10.1016/j.jval.2014.01.001","title":"Projecting Long-Term Graft and Patient Survival after Transplantation","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Bristol-Myers Squibb","keywords":"Medicine; Belatacept; Immunosuppression; Renal function; Kidney transplantation; Transplantation; Internal medicine; Urology; Kidney transplant","score_opus":0.033645014228331487,"score_gpt":0.316239323781763,"score_spread":0.2825943095534315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102472721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99782455,0.00027331317,0.00050502777,0.0005714459,0.00012458646,0.00042836228,0.0000083404775,0.000022451293,0.00024190366],"genre_scores_gemma":[0.9980842,0.0005930875,0.00078503403,0.00041336546,0.000027870145,0.000025846412,0.000032444485,0.000011161902,0.0000269772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991294,0.000111308036,0.0002625262,0.00017089918,0.00015104139,0.00017480715],"domain_scores_gemma":[0.9996647,0.00008978502,0.00005513221,0.000078209865,0.000014973097,0.00009719132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017572807,0.00008926735,0.00018351345,0.00008955902,0.00003808961,0.000009293709,0.000013516942,0.000032630927,0.000009794197],"category_scores_gemma":[0.000009111101,0.000070531656,0.000027487022,0.000084135965,0.000013817306,0.000044788892,0.0000025346721,0.00008388139,0.000005369389],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025141283,0.00008416498,0.9808861,0.0013629124,0.000014114997,0.000060664097,0.0021237943,0.000044313976,0.00001341488,0.00011146075,4.152548e-7,0.015047259],"study_design_scores_gemma":[0.0018864359,0.0004486057,0.9960219,0.0009360994,0.000021866917,0.00009284792,0.000036319463,0.0003209859,0.000107409986,0.00003885758,0.000026416921,0.00006220509],"about_ca_topic_score_codex":0.0008700575,"about_ca_topic_score_gemma":0.00010746628,"teacher_disagreement_score":0.015135877,"about_ca_system_score_codex":0.000047487873,"about_ca_system_score_gemma":0.000042130563,"threshold_uncertainty_score":0.28761974},"labels":[],"label_agreement":null},{"id":"W2102734493","doi":"10.1016/j.jval.2012.08.716","title":"PHP174 Physical Activity Matters: The Associations Between Body Mass Index, Physical Activity and Health-Realted Quality-of-Life Trajectories Over 10 Years","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Physical Activity and Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; McGill University; Statistics Canada","funders":"","keywords":"Body mass index; Medicine; Quality of life (healthcare); Demography; Gerontology; Physical activity; Leisure time; Health related quality of life; Population; Baseline (sea); Physical therapy; Environmental health; Disease","score_opus":0.16314197463775906,"score_gpt":0.42998727917368507,"score_spread":0.26684530453592603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102734493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710132,0.00010648397,0.00013006064,0.027333716,0.00013039894,0.0009187959,0.0002339409,0.000064909094,0.00006849934],"genre_scores_gemma":[0.9973175,0.00006736683,0.000056597324,0.001195908,0.0012343068,0.000035359913,0.000027948565,0.00003605644,0.000028989516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961453,0.001363121,0.00045561194,0.00038900718,0.000733186,0.00091377227],"domain_scores_gemma":[0.99620605,0.0019649495,0.00066165696,0.00043543123,0.000049479037,0.0006824555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018298599,0.000274071,0.0014676565,0.0001234342,0.00026584422,0.000020783005,0.00013056795,0.00013455874,0.000010349467],"category_scores_gemma":[0.00029191023,0.0002243422,0.0001791699,0.000572852,0.0002274627,0.00042735127,0.000074130025,0.001069606,0.000012982613],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084980874,0.01225403,0.93025935,0.0026232107,0.00030303778,0.0000014103537,0.013642538,0.00006007993,0.0022589078,0.0074385465,0.0017878772,0.0285212],"study_design_scores_gemma":[0.0012971653,0.00051863014,0.9951609,0.00012832346,0.000026943764,6.669955e-7,0.00014612288,0.0010721922,0.00023096183,0.00091613975,0.00032898533,0.00017296597],"about_ca_topic_score_codex":0.03636545,"about_ca_topic_score_gemma":0.00014091382,"teacher_disagreement_score":0.06490155,"about_ca_system_score_codex":0.0007120542,"about_ca_system_score_gemma":0.001041396,"threshold_uncertainty_score":0.97005147},"labels":[],"label_agreement":null},{"id":"W2103616822","doi":"10.1016/j.jval.2013.08.1406","title":"Cost-Effectiveness of Injectable Atypical Long-Acting Antipsychotics for Chronic Schizophrenia in Poland","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Paliperidone Palmitate; Medicine; Risperidone; Paliperidone; Marginal cost; Cost effectiveness; Quality-adjusted life year; Antipsychotic; Emergency medicine; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.08950215865121984,"score_gpt":0.385559855557367,"score_spread":0.29605769690614714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2103616822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929282,0.0017624422,0.0005315039,0.0007061614,0.00011521908,0.0038910022,0.000015276084,0.000018408555,0.00003180351],"genre_scores_gemma":[0.9949457,0.0002532699,0.004288063,0.000032087326,0.00008571908,0.00032416618,0.000034393528,0.00002372121,0.000012875016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982216,0.00027495544,0.00042951896,0.00028338892,0.00022052445,0.00057003734],"domain_scores_gemma":[0.99857605,0.00076676,0.000096810225,0.00025057627,0.00008240878,0.00022741113],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009542957,0.00013746148,0.00048620556,0.00030182544,0.000045054257,0.00001757198,0.00009214783,0.00008580276,0.000040024504],"category_scores_gemma":[0.0003250474,0.00011553881,0.000065688,0.00043715234,0.000049105984,0.00010715181,0.000033606826,0.00028064114,0.000016603608],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04514768,0.0014975094,0.8731461,0.0056512286,0.000093926785,0.00004242472,0.00026002785,0.0015538884,0.0010930622,0.0021269973,0.00011049054,0.06927662],"study_design_scores_gemma":[0.015151892,0.0019537453,0.9675595,0.0015981281,0.000007829101,0.000022370781,0.00004458477,0.010670135,0.001266039,0.0015869443,0.0000424376,0.00009638744],"about_ca_topic_score_codex":0.005718667,"about_ca_topic_score_gemma":0.0007419148,"teacher_disagreement_score":0.09441336,"about_ca_system_score_codex":0.0007430389,"about_ca_system_score_gemma":0.0012321343,"threshold_uncertainty_score":0.8644952},"labels":[],"label_agreement":null},{"id":"W2104767470","doi":"10.1016/j.jval.2013.08.234","title":"An Assessment of Unemployment Among People Living with HIV/AIDS in Canada and Europe","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neurocognitive; Unemployment; Depression (economics); Medicine; Anxiety; Logistic regression; Quality of life (healthcare); Human immunodeficiency virus (HIV); Psychiatry; Demography; Gerontology; Internal medicine; Cognition; Family medicine","score_opus":0.01874260407395505,"score_gpt":0.31143662271881145,"score_spread":0.2926940186448564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2104767470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99739975,0.00013413881,0.000047162805,0.0011820617,0.000019320076,0.00078166137,0.0000053301574,0.000008819048,0.00042178412],"genre_scores_gemma":[0.99599385,0.00016577177,0.003457574,0.00019864023,0.000007257548,0.000078210214,0.00001183256,0.000014735855,0.00007214317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988243,0.00014570146,0.0003954898,0.00020047068,0.00017940844,0.00025464137],"domain_scores_gemma":[0.9992352,0.000105955136,0.00011786137,0.00024624175,0.000057288406,0.00023746354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023748162,0.00009063354,0.00027201703,0.00012391192,0.00004228379,0.000005203239,0.00004105166,0.000022430608,0.000044778168],"category_scores_gemma":[0.000014658098,0.00007225717,0.00000640007,0.00034642036,0.000017246612,0.00005950833,0.00001522159,0.00015643123,0.0000026294476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000037685124,0.00020891541,0.9962696,0.00021901529,0.000007196449,0.000005212686,0.0005306538,0.0013585038,0.0000046431487,0.00021232509,0.00005442236,0.0011257402],"study_design_scores_gemma":[0.00071911025,0.0005948994,0.97339106,0.00083468296,0.000005553355,0.000007674286,0.00035583158,0.023992024,0.0000015667862,0.000012573974,0.000034115335,0.000050914718],"about_ca_topic_score_codex":0.979488,"about_ca_topic_score_gemma":0.8021609,"teacher_disagreement_score":0.17732714,"about_ca_system_score_codex":0.0006859377,"about_ca_system_score_gemma":0.0023354604,"threshold_uncertainty_score":0.41430062},"labels":[],"label_agreement":null},{"id":"W2105018961","doi":"10.1016/j.jval.2011.05.010","title":"Development and Validation of a Microsimulation Economic Model to Evaluate the Disease Burden Associated with Smoking and the Cost-Effectiveness of Tobacco Control Interventions in Latin America","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Smoking Behavior and Cessation","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Department for International Development, UK Government; Cancer Research UK; International Development Research Centre; American Cancer Society","keywords":"Tobacco control; Microsimulation; Latin Americans; Psychological intervention; Environmental health; Medicine; Economics; Political science; Engineering; Public health; Nursing; Transport engineering","score_opus":0.13046863903575207,"score_gpt":0.36128430342886064,"score_spread":0.23081566439310858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105018961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965234,0.000049323804,0.0017233016,0.00019629058,0.000016115117,0.0014684054,0.000009341925,0.000004247639,0.000009583767],"genre_scores_gemma":[0.9996608,0.0000111606805,0.0001424273,0.000035776662,0.0000030803965,0.0001240005,0.000014675214,0.0000062757113,0.0000018253598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990028,0.00037004048,0.00033162115,0.00011072026,0.00010033553,0.000084445805],"domain_scores_gemma":[0.9994056,0.00025560844,0.00016508433,0.000091741385,0.000045901703,0.00003602013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018382862,0.000059776346,0.00020348726,0.00009263137,0.00003907614,0.000005156084,0.000029300343,0.00002097046,0.0000024848505],"category_scores_gemma":[0.00012063322,0.000037917944,0.000019435685,0.00010596834,0.000055218934,0.000037611422,0.0000136582385,0.00006679925,5.588763e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010780878,0.000075582306,0.90329576,0.00014261219,0.000024430026,2.3465283e-7,0.007971533,0.083469875,0.0000815073,0.00023618077,3.1050902e-7,0.0036238958],"study_design_scores_gemma":[0.0037232516,0.000085854386,0.9436208,0.0011182621,0.000060302184,2.9075483e-7,0.00026731007,0.050655823,0.00027491085,0.00015779282,5.177754e-7,0.000034872883],"about_ca_topic_score_codex":0.002311528,"about_ca_topic_score_gemma":0.000074547075,"teacher_disagreement_score":0.04032506,"about_ca_system_score_codex":0.0002142178,"about_ca_system_score_gemma":0.00017716046,"threshold_uncertainty_score":0.34943542},"labels":[],"label_agreement":null},{"id":"W2105086787","doi":"10.1016/j.jval.2014.03.1334","title":"A Cost-Effectiveness Analysis Of Maternal Genotyping To Guide Treatment For Postpartum Pain And Avert Infant Adverse Events","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Hospital for Sick Children","funders":"","keywords":"Medicine; Adverse effect; Population; Pharmacotherapy; Genotyping; Breastfeeding; Dosing; Codeine; Pediatrics; Cost effectiveness; Intensive care medicine; Emergency medicine; Anesthesia; Internal medicine; Morphine; Environmental health; Genotype; Risk analysis (engineering)","score_opus":0.12684867591096954,"score_gpt":0.44454549336347055,"score_spread":0.317696817452501,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105086787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904876,0.00043368724,0.0051054945,0.002353157,0.000068742214,0.0014446464,0.000031081712,0.000008700339,0.000066917404],"genre_scores_gemma":[0.9964638,0.0005020709,0.0015556439,0.001283828,0.00003472709,0.00011921139,0.000009083491,0.0000075973862,0.00002407122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876964,0.00040546767,0.00030194494,0.00018547544,0.00011056026,0.00022691354],"domain_scores_gemma":[0.99852425,0.0010440326,0.000102587444,0.00010929707,0.000042563384,0.00017724617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022123351,0.00009199355,0.0004520441,0.00014551744,0.00005452309,0.000002100834,0.000028353066,0.000025235478,0.000009562082],"category_scores_gemma":[0.00044385993,0.00007014591,0.000071145434,0.00023436596,0.000012856986,0.000028314018,0.000025207177,0.00004362396,0.0000013274395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002337374,0.0002615361,0.89102775,0.0010391931,0.00095921516,0.0000045479396,0.0011400151,0.004709897,0.00030515064,0.00020933036,0.000030151292,0.09797584],"study_design_scores_gemma":[0.0024181362,0.0021360437,0.86524963,0.0003956051,0.0004895715,0.0000032341732,0.0001086434,0.09149284,0.00043006556,0.000060051912,0.037126776,0.00008939519],"about_ca_topic_score_codex":0.009916034,"about_ca_topic_score_gemma":0.00022490331,"teacher_disagreement_score":0.09788644,"about_ca_system_score_codex":0.0002538814,"about_ca_system_score_gemma":0.00006206873,"threshold_uncertainty_score":0.99667704},"labels":[],"label_agreement":null},{"id":"W2106175264","doi":"10.1016/j.jval.2014.08.187","title":"TC-325 in the Management of Upper and Lower GI Bleeding: A Two-Year Experience at a Single Institution","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Hemostasis; Upper gastrointestinal bleeding; Retrospective cohort study; Endoscopy; Adverse effect; Surgery; Internal medicine","score_opus":0.046505411315161664,"score_gpt":0.30863843592049245,"score_spread":0.2621330246053308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106175264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940366,0.00023658683,0.000029553124,0.0025641224,0.00007455205,0.0004223901,8.610584e-7,0.000009172091,0.0026261488],"genre_scores_gemma":[0.9965611,0.00013852262,0.0028611128,0.00033362946,0.000028086302,0.000044662807,0.0000018006838,0.000005687737,0.000025384115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99910444,0.000053865773,0.00025926076,0.0001875035,0.00019106235,0.00020385295],"domain_scores_gemma":[0.9996196,0.0000768174,0.00007151062,0.0001532031,0.000017084465,0.00006179386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005033375,0.00008563728,0.00018148452,0.000088615845,0.000043489155,0.000007780032,0.000049868893,0.000017801753,0.000009798346],"category_scores_gemma":[0.00003828445,0.00005882819,0.00002426054,0.00017434708,0.00006449141,0.00003488855,0.000051407897,0.00007725674,0.0000048238903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017174627,0.001178317,0.96552324,0.00060020573,0.000016275657,0.000051868847,0.004445567,0.00040136487,0.00027215004,0.023718989,0.00013647082,0.003483803],"study_design_scores_gemma":[0.005652217,0.003649188,0.97539407,0.005250859,0.000044828827,0.00016830556,0.0036552758,0.0027909817,0.000454249,0.00061373896,0.0021790308,0.00014724111],"about_ca_topic_score_codex":0.0011848434,"about_ca_topic_score_gemma":0.000027909735,"teacher_disagreement_score":0.02310525,"about_ca_system_score_codex":0.00020240383,"about_ca_system_score_gemma":0.000021931324,"threshold_uncertainty_score":0.2398944},"labels":[],"label_agreement":null},{"id":"W2106468952","doi":"10.1016/j.jval.2013.08.1107","title":"Interim Results from the Burden of Bowel Dysfunction in Spinal Cord Injury Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Spinal Hematomas and Complications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St Joseph's Health Care; Toronto Rehabilitation Institute; Providence Health Care; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Quality of life (healthcare); Spinal cord injury; Observational study; Physical therapy; Cohort; Cohort study; Demographics; Interim; Internal medicine; Demography; Spinal cord; Psychiatry","score_opus":0.08505414104281642,"score_gpt":0.38060058499916455,"score_spread":0.2955464439563481,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106468952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9881754,0.00023492645,0.00003562783,0.009969596,0.000121376484,0.00110428,0.000008907392,0.0000152569055,0.00033460784],"genre_scores_gemma":[0.99912435,0.000034258523,0.00022801204,0.00032514049,0.00012687813,0.00008462234,0.00001047619,0.000007863888,0.00005839798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988084,0.00012782794,0.00056524,0.00018875032,0.00016297441,0.00014681682],"domain_scores_gemma":[0.9992609,0.00009386818,0.00014431778,0.00038741188,0.00005535249,0.00005813042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042991672,0.00007263766,0.00020951276,0.00008919899,0.000033033724,0.0000066905936,0.00010225019,0.000031223844,0.000036852918],"category_scores_gemma":[0.00012022332,0.000051253508,0.000025915331,0.0002739167,0.000028995071,0.000038691505,0.000037766604,0.00019289042,0.000040957177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027567085,0.00831255,0.5472446,0.00085406646,0.00016662834,0.000040179446,0.032525964,0.001001207,0.003633701,0.004741472,0.019926049,0.3539865],"study_design_scores_gemma":[0.0014833933,0.0044599352,0.98339814,0.000602818,0.0000065522104,0.0000048265206,0.0051326617,0.0035948385,0.000040397317,0.00064863666,0.0005793413,0.000048449267],"about_ca_topic_score_codex":0.16522743,"about_ca_topic_score_gemma":0.00023933571,"teacher_disagreement_score":0.43615356,"about_ca_system_score_codex":0.0001183325,"about_ca_system_score_gemma":0.0001372309,"threshold_uncertainty_score":0.8403314},"labels":[],"label_agreement":null},{"id":"W2106526054","doi":"10.1016/j.jval.2011.08.508","title":"PND42 Impact of Relapses Leading to Hospitalisation on Health-Related Quality of Life, Fatigue and Health Care Resource Utilisation in A Population with A Relapsing Form of Multiple Sclerosis (RMS) Using Data from Temso A Teriflunonomide Pivotal Phase III Trial","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Quality of life (healthcare); Population; Multiple sclerosis; Physical therapy; Health care; Emergency medicine; Internal medicine; Psychiatry; Environmental health","score_opus":0.5087239630918277,"score_gpt":0.453494236243787,"score_spread":0.05522972684804067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106526054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376106,0.0011928991,0.00032005197,0.00043074723,0.000059607108,0.0037767175,0.0004262438,0.000022509417,0.000010178492],"genre_scores_gemma":[0.99391276,0.00028973885,0.005075003,0.000056839217,0.000038358565,0.000030253894,0.00055961224,0.00003673695,6.757717e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99482924,0.00094393827,0.0025239394,0.0006135782,0.0006010685,0.00048826335],"domain_scores_gemma":[0.99648297,0.00057567365,0.0017757377,0.0007020653,0.00013848282,0.00032505987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037196106,0.00025675073,0.0014788032,0.00076302263,0.00013654958,0.000008620262,0.00015105588,0.0001180472,0.0000058124047],"category_scores_gemma":[0.0021879694,0.00022510072,0.00007815583,0.00075748115,0.00012089005,0.0003293729,0.00012223728,0.00032358363,1.7084352e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.073179364,0.0013810453,0.802757,0.0022249203,0.00015886327,9.849306e-7,0.094809875,0.0045762244,0.0027644858,0.000025209176,0.000060485578,0.018061506],"study_design_scores_gemma":[0.052945036,0.0077329376,0.89611995,0.007527464,0.000015441037,8.5490217e-7,0.005636595,0.029596703,0.00022927004,0.000024956851,8.703599e-7,0.00016994569],"about_ca_topic_score_codex":0.56930643,"about_ca_topic_score_gemma":0.013899424,"teacher_disagreement_score":0.55540705,"about_ca_system_score_codex":0.0016108932,"about_ca_system_score_gemma":0.0011400562,"threshold_uncertainty_score":0.9179341},"labels":[],"label_agreement":null},{"id":"W2106752242","doi":"10.1016/s1098-3015(10)73674-3","title":"PRS11 QUANTIFYING COSTS AND BENEFITS OF TIMING PHARMACEUTICAL INTERVENTION: AN ECONOMIC SIMULATION MODEL OF ASTHMA IN ALBERTA, CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Asthma; Intervention (counseling); Economics; Actuarial science; Medicine; Psychiatry; Immunology","score_opus":0.25241543499388713,"score_gpt":0.453650870974838,"score_spread":0.2012354359809509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2106752242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435276,0.0016070794,0.000057645437,0.0034872415,0.00005067498,0.00024563295,0.000007753843,0.000002766585,0.0001884635],"genre_scores_gemma":[0.9985623,0.00056993647,0.00037740517,0.0004519694,0.000022146249,0.0000016264049,0.0000044858566,0.0000048173224,0.00000533594],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989807,0.000099283956,0.00049420854,0.00014780885,0.000103804254,0.00017417711],"domain_scores_gemma":[0.9993043,0.00033482673,0.00015094878,0.00007215491,0.000021284353,0.000116467374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056162075,0.000072272946,0.00027644954,0.00006553382,0.000025392801,0.000003208948,0.000032888238,0.00003183329,0.000012820669],"category_scores_gemma":[0.00009408835,0.00007134808,0.000019570372,0.000071345064,0.000018871153,0.00011291062,0.00001642491,0.0001520042,2.2572576e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005068898,0.00024953196,0.050461125,0.00057174853,0.00001501072,0.0000025366598,0.0006423134,0.84227246,0.00006341292,0.0018171612,0.000010320735,0.103387475],"study_design_scores_gemma":[0.0012021185,0.00025056503,0.0500084,0.00040236136,0.0000094914685,0.0000031876712,0.00010307906,0.94746107,0.00022241552,0.000070145645,0.00021543239,0.00005173795],"about_ca_topic_score_codex":0.56429815,"about_ca_topic_score_gemma":0.31252417,"teacher_disagreement_score":0.25177398,"about_ca_system_score_codex":0.00027579718,"about_ca_system_score_gemma":0.0002143551,"threshold_uncertainty_score":0.70002043},"labels":[],"label_agreement":null},{"id":"W2107033706","doi":"10.1016/j.jval.2014.03.112","title":"Real-World Clinical Evidence Development: An Analysis Of Relevant International Models For The Potential Implementation Of Such A Program In Quebec","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"InterDigital (Canada); Montréal InVivo; Université de Montréal","funders":"","keywords":"Reimbursement; Government (linguistics); Listing (finance); Business; Real world evidence; MEDLINE; Health care; Public relations; Medicine; Political science; Finance","score_opus":0.5424621394796939,"score_gpt":0.5464388467296969,"score_spread":0.0039767072500029865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107033706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94199455,0.00038805895,0.040072523,0.014953871,0.0004273147,0.0019656995,0.00012243171,0.000015896514,0.000059654994],"genre_scores_gemma":[0.97910583,0.00047266888,0.01930616,0.0006460445,0.00009519083,0.0002449357,0.00007573046,0.000012503061,0.00004094369],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99179614,0.0007799705,0.006594101,0.0004153357,0.00013454462,0.00027989096],"domain_scores_gemma":[0.9940007,0.0024562029,0.0029939115,0.00036096072,0.000103254555,0.00008498633],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.040002707,0.000103573984,0.0008989888,0.0008890088,0.000061201135,0.000025793357,0.00033851102,0.00006591111,0.000041866206],"category_scores_gemma":[0.001315506,0.00011003192,0.0001351591,0.0005613302,0.00005459236,0.0004039685,0.000037051846,0.000115991475,0.000004692273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008268041,0.00036021782,0.6489987,0.00051922566,0.0002228211,1.01214304e-7,0.0061148363,0.1706349,6.76366e-7,0.14703558,0.00015775108,0.025872545],"study_design_scores_gemma":[0.00047551424,0.0000994901,0.41353226,0.00009383474,0.000010494023,6.14693e-8,0.00081792835,0.58077675,0.0000013303732,0.003464264,0.0006603574,0.00006770756],"about_ca_topic_score_codex":0.33962283,"about_ca_topic_score_gemma":0.24402894,"teacher_disagreement_score":0.41014186,"about_ca_system_score_codex":0.0007119375,"about_ca_system_score_gemma":0.0007153334,"threshold_uncertainty_score":0.98851925},"labels":[],"label_agreement":null},{"id":"W2107072358","doi":"10.1111/j.1524-4733.2008.00371.x","title":"A Study on Indirect and Intangible Costs for Patients with Knee Osteoarthritis in Singapore","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Indirect costs; Human capital; Earnings; Willingness to pay; Medicine; Business; Economics; Finance; Accounting","score_opus":0.10239179691380541,"score_gpt":0.23705208760399138,"score_spread":0.13466029069018598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107072358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997707,0.00029159072,0.000013612372,0.00011935987,0.0000757554,0.0011449471,0.000053226962,0.000007034985,0.0005874838],"genre_scores_gemma":[0.9992669,0.00009423961,0.0002888649,0.0001550764,0.000013726514,0.00010283111,0.000022095433,0.000015610738,0.00004062745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990609,0.000028154904,0.00040563574,0.00028577264,0.00002461904,0.0001949055],"domain_scores_gemma":[0.9996153,0.00006383909,0.00015727096,0.00011262594,0.000003039169,0.000047908045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042865006,0.000088779096,0.00026161267,0.00021270254,0.0000707518,0.000008881269,0.0000376973,0.000035782035,0.000010428188],"category_scores_gemma":[0.000030033654,0.000100275,0.000014561352,0.00010522695,0.000025765958,0.00011356553,0.000015301752,0.0000795901,0.000022877226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004514902,0.00034185412,0.99413055,0.000012132797,0.000003617388,0.0000016281041,0.001762572,0.0004925434,4.067241e-8,0.0007311974,0.00001946917,0.0024592257],"study_design_scores_gemma":[0.003511439,0.002597068,0.9922806,0.000044994842,5.3370525e-7,0.0000012270718,0.00027297542,0.0003386978,0.0000012989934,0.00066233944,0.00018242774,0.00010642147],"about_ca_topic_score_codex":0.0013302793,"about_ca_topic_score_gemma":0.0002651252,"teacher_disagreement_score":0.00346629,"about_ca_system_score_codex":0.00041886,"about_ca_system_score_gemma":0.00001932439,"threshold_uncertainty_score":0.40890956},"labels":[],"label_agreement":null},{"id":"W2107089384","doi":"10.1016/j.jval.2015.09.802","title":"Burden of Dyslipidaemia in Patients at High Risk for Cardiovascular (Cv) Events: Results of a Canadian Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Amgen (Canada); Université de Montréal","funders":"","keywords":"Medicine; Statin; Internal medicine; Cohort; Body mass index; Risk factor; Medical prescription; Diabetes mellitus; Cohort study; Ezetimibe; Obesity; Endocrinology; Pharmacology","score_opus":0.039038384304523714,"score_gpt":0.27406148344453884,"score_spread":0.23502309914001512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107089384","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924475,0.002020362,0.000015253226,0.00031081997,0.00028739666,0.0045773555,0.00023260417,0.000009370931,0.000099370576],"genre_scores_gemma":[0.998521,0.00026856686,0.0007559627,0.000049372607,0.0001648046,0.000104720304,0.00006894418,0.000032371747,0.00003430245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99634844,0.0007014508,0.0011408067,0.00041031642,0.00086616754,0.00053281046],"domain_scores_gemma":[0.9978249,0.00006998511,0.00029999224,0.00095630524,0.00030215818,0.0005466457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066193305,0.00016872761,0.0011352256,0.0008245538,0.00004612477,0.0000020166617,0.00013183845,0.00012208929,0.0000021087512],"category_scores_gemma":[0.0009357129,0.00015529922,0.00036203722,0.0008627331,0.00002604656,0.00004416631,0.000047051963,0.00022103496,0.0000027226254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024362656,0.0009937218,0.9327652,0.0018736778,0.00090098317,0.000024491825,0.011109594,0.027074378,0.0000017627286,0.00005771413,0.00075178547,0.022010436],"study_design_scores_gemma":[0.045275163,0.0054746983,0.9366451,0.0009575946,0.00022462057,0.00000502167,0.0021729826,0.0007631544,0.000046771725,0.00016885033,0.008031869,0.00023417361],"about_ca_topic_score_codex":0.96460027,"about_ca_topic_score_gemma":0.15834643,"teacher_disagreement_score":0.80625385,"about_ca_system_score_codex":0.0015583652,"about_ca_system_score_gemma":0.001726279,"threshold_uncertainty_score":0.85701156},"labels":[],"label_agreement":null},{"id":"W2107338834","doi":"10.1016/j.jval.2013.08.1477","title":"Patients as a Source for Cost of Rheumatoid Arthritis Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Management and Organizational Practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Rheumatoid arthritis; Quarter (Canadian coin); Activity-based costing; Tariff; Physical therapy; Indirect costs; Internal medicine; Family medicine; Pediatrics","score_opus":0.025814030811021633,"score_gpt":0.2601759662571636,"score_spread":0.23436193544614198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107338834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99161273,0.00012389229,0.00040757298,0.0019741287,0.00023033332,0.002958794,0.0000014225334,0.000042494095,0.0026486153],"genre_scores_gemma":[0.99791604,0.000091145346,0.00014785948,0.001440089,0.00011190622,0.00009992201,0.000027308974,0.000019912723,0.00014584056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897045,0.000025031837,0.00041288073,0.0001732954,0.00022126538,0.00019710013],"domain_scores_gemma":[0.99919677,0.000117765405,0.0003755154,0.00012632126,0.00017193255,0.000011712834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005256944,0.00008932499,0.00017677947,0.00020324426,0.00010408556,0.00010564198,0.00013958113,0.000020603993,0.00032825442],"category_scores_gemma":[0.00042203566,0.00008837273,0.000023444858,0.00035873795,0.0000132220775,0.0008372037,0.000084823325,0.000052315947,0.00023393452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036540558,0.0010963154,0.9311817,0.0004517162,0.000022126162,4.1831234e-7,0.0003655619,0.0013267704,0.000001824003,0.018025937,0.012671622,0.034819454],"study_design_scores_gemma":[0.0069074747,0.00034450906,0.6034997,0.00042404482,0.000010992759,3.550085e-7,0.0041538253,0.029500388,0.0000071859977,0.012877622,0.34180737,0.0004665522],"about_ca_topic_score_codex":0.022092998,"about_ca_topic_score_gemma":0.00018759572,"teacher_disagreement_score":0.32913575,"about_ca_system_score_codex":0.00002412601,"about_ca_system_score_gemma":0.000025294654,"threshold_uncertainty_score":0.984419},"labels":[],"label_agreement":null},{"id":"W2107388543","doi":"10.1016/j.jval.2010.10.005","title":"Trajectory Classes of Decline in Health-Related Quality of Life in Parkinson's Disease: A Pilot Study","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Public Health Ontario; University of Toronto","funders":"Bundesministerium für Bildung und Forschung","keywords":"Quality of life (healthcare); Medicine; Disease; Depression (economics); Beck Depression Inventory; Parkinson's disease; Rating scale; Gerontology; Physical therapy; Internal medicine; Psychology; Psychiatry; Anxiety","score_opus":0.1627446575740878,"score_gpt":0.36060696727486063,"score_spread":0.19786230970077284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107388543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898607,0.0072793225,0.000009581597,0.000627389,0.000120749086,0.0019211605,0.000072867806,0.00002863303,0.00007957993],"genre_scores_gemma":[0.99816215,0.0007635494,0.0004970245,0.00039844488,0.000015104044,0.00009532913,0.000022357077,0.000029519806,0.00001650833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950856,0.0013851817,0.0021059504,0.00046773086,0.00047468193,0.00048084746],"domain_scores_gemma":[0.99798775,0.00021571758,0.00069770747,0.00047646894,0.00005832241,0.00056403986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025989527,0.00022792706,0.0012320719,0.000550923,0.000027313557,0.0000021472897,0.00013054172,0.00005597494,0.00007370883],"category_scores_gemma":[0.0004881776,0.00021046282,0.000081203034,0.0007396102,0.000060606384,0.00006227682,0.00005014917,0.0002658509,0.0000043482237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004013999,0.018828113,0.9717896,0.001670128,0.00005691981,0.00009526584,0.0021292928,0.00012690536,0.000023436647,0.00038453273,0.000015085687,0.0008667456],"study_design_scores_gemma":[0.009690131,0.004627419,0.9826118,0.00087296794,0.000017582708,0.0000011022576,0.00070348853,0.00040141627,0.000017392065,0.0008337685,0.00010434375,0.00011863525],"about_ca_topic_score_codex":0.13744688,"about_ca_topic_score_gemma":0.0075365617,"teacher_disagreement_score":0.12991032,"about_ca_system_score_codex":0.00040852523,"about_ca_system_score_gemma":0.0019986073,"threshold_uncertainty_score":0.8682969},"labels":[],"label_agreement":null},{"id":"W2107448287","doi":"10.1016/j.jval.2014.03.148","title":"Comparison Of Two Agents For The Reversal Of Neuromuscular Blockade: A Discrete Event Simulation Model Of Operating Room Efficiency In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Sugammadex; Neostigmine; Medicine; Neuromuscular Blockade; Anesthesia; Rocuronium; Intubation","score_opus":0.06494444858335226,"score_gpt":0.37208185045543196,"score_spread":0.3071374018720797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107448287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910607,0.00021607202,0.0071302233,0.00084142375,0.000053393127,0.0006567625,0.0000061995943,0.0000019716954,0.000033303975],"genre_scores_gemma":[0.99932206,0.000012647515,0.0005023916,0.00011424323,0.000015197395,0.000007138368,0.0000039562487,0.0000075488024,0.0000148020035],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985239,0.00020492064,0.00068588526,0.00011801588,0.00030857956,0.00015873057],"domain_scores_gemma":[0.9984189,0.0011037069,0.00019891217,0.00018219509,0.00004511709,0.00005115273],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009933827,0.00007145393,0.000609936,0.000053324522,0.000023414865,0.0000011853991,0.00006406121,0.0000224497,0.0000017616414],"category_scores_gemma":[0.00038955652,0.000049995855,0.000108410895,0.00014605524,0.000017677095,0.000013921197,0.000013621724,0.000091278314,4.0077992e-8],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043280514,0.000043630218,0.19007245,0.00029090434,0.0000058419496,4.7462413e-7,0.0005868135,0.8080191,0.0001064468,0.0003704407,0.0000031664533,0.0004574689],"study_design_scores_gemma":[0.001153842,0.00014393119,0.072178416,0.00018996859,0.000018242323,5.7357767e-7,0.00015646763,0.92584956,0.00018322785,0.000012958194,0.00007822988,0.000034599147],"about_ca_topic_score_codex":0.48595688,"about_ca_topic_score_gemma":0.03308682,"teacher_disagreement_score":0.45287004,"about_ca_system_score_codex":0.00013097805,"about_ca_system_score_gemma":0.00058809615,"threshold_uncertainty_score":0.98455685},"labels":[],"label_agreement":null},{"id":"W2107567298","doi":"10.1016/j.jval.2014.08.1513","title":"Regional Variation in Hospital Mortality, Length of Stay and Cost of Ischemic Stroke Patients in Alberta","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Workforce Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information; Alberta Medical Association; Institute of Health Economics; University of Alberta","funders":"","keywords":"Ischemic stroke; Medicine; Regional variation; Variation (astronomy); Stroke (engine); Emergency medicine; Demography; Medical emergency; Internal medicine; Business; Ischemia; Engineering","score_opus":0.045557371011762174,"score_gpt":0.3852976551243438,"score_spread":0.3397402841125816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2107567298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99504226,0.00015044148,0.000018154073,0.0015148048,0.0002737319,0.0015727277,0.000037347098,0.0000080508125,0.0013824699],"genre_scores_gemma":[0.9985935,0.0003942307,0.00046362184,0.00031057422,0.000038219452,0.00005814396,0.000040114173,0.00001666624,0.00008489642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99617386,0.0010890696,0.0015180607,0.00030150433,0.0003514521,0.0005660503],"domain_scores_gemma":[0.99769527,0.0010621661,0.0007086739,0.00028024972,0.00010693122,0.00014670262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019591695,0.00014133975,0.0005260778,0.00025096716,0.000061668696,0.0000015869103,0.00013748453,0.00020862608,0.00002271134],"category_scores_gemma":[0.00062407646,0.00014492241,0.000023620056,0.00037515847,0.00005949618,0.000117599666,0.00008579452,0.00048098023,0.0000051753273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006211937,0.0003165168,0.9857546,0.0010982269,0.000003485324,2.4016236e-7,0.00722271,0.0003216699,0.000005528796,0.003916964,0.0005832308,0.00071471743],"study_design_scores_gemma":[0.0023017318,0.00037403376,0.98740155,0.0017737093,0.0000024059523,9.8480655e-8,0.00058511976,0.004744826,0.0000055640667,0.0007010758,0.002008356,0.000101538935],"about_ca_topic_score_codex":0.31176424,"about_ca_topic_score_gemma":0.027924761,"teacher_disagreement_score":0.28383946,"about_ca_system_score_codex":0.0004627955,"about_ca_system_score_gemma":0.00045265042,"threshold_uncertainty_score":0.9898131},"labels":[],"label_agreement":null},{"id":"W2108278188","doi":"10.1111/j.1524-4733.2004.75009.x","title":"Comparing Medications in a Therapeutic Area Using an NNT Model","year":2004,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Association of Radiation Oncology; McGill University; Royal Victoria Hospital","funders":"","keywords":"Number needed to treat; Medicine; Population; Statistics; Confidence interval; Relative risk; Internal medicine; Mathematics; Environmental health","score_opus":0.4117238955176505,"score_gpt":0.430291325657453,"score_spread":0.0185674301398025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108278188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93652844,0.0007826949,0.055391468,0.006046326,0.000053681124,0.00041503485,8.265993e-7,0.00003592145,0.0007456306],"genre_scores_gemma":[0.9911131,0.000095654286,0.0063038417,0.0023741075,0.000030685285,0.000028645421,0.0000072600037,0.000009040139,0.00003765941],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989278,0.000057778063,0.0003724066,0.00019464089,0.00021482928,0.00023259631],"domain_scores_gemma":[0.9994008,0.000023148114,0.00008758431,0.0002794961,0.000024985697,0.00018396947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004810666,0.00007360293,0.00021664167,0.00016021446,0.000046753572,0.0000051703005,0.000094490984,0.000041566695,0.000031310712],"category_scores_gemma":[0.00002877035,0.00006937985,0.00001688818,0.00035027688,0.000039032584,0.000064929845,0.000010793363,0.00022328628,0.000030108866],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044334898,0.0014160075,0.12029617,0.00024269155,0.000011579505,0.000014163189,0.004627911,0.84066117,0.00068995834,0.029267268,0.000027097314,0.0027016462],"study_design_scores_gemma":[0.0013085094,0.00009724849,0.042987704,0.000895887,0.000004860849,0.000021358584,0.0004509982,0.94355655,0.000023252096,0.010538267,0.00004517667,0.00007021313],"about_ca_topic_score_codex":0.0042061512,"about_ca_topic_score_gemma":0.00015534172,"teacher_disagreement_score":0.10289536,"about_ca_system_score_codex":0.00047180316,"about_ca_system_score_gemma":0.001334572,"threshold_uncertainty_score":0.6358471},"labels":[],"label_agreement":null},{"id":"W2108489849","doi":"10.1111/j.1524-4733.2010.00768.x","title":"Functional Impairment and Disability across Mood States in Bipolar Disorder","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":208,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mania; Bipolar disorder; Psychosocial; Psychology; Depression (economics); Mood; Clinical psychology; Global Assessment of Functioning; Psychiatry; Bipolar I disorder; Functional impairment; Population; Medicine; Cognition","score_opus":0.0206892286380205,"score_gpt":0.31293046490420645,"score_spread":0.2922412362661859,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108489849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98862064,0.0052675,0.00001887687,0.005250866,0.00017035082,0.00057148957,0.000043476837,0.000024724606,0.00003206499],"genre_scores_gemma":[0.99860185,0.0007527259,0.00031478828,0.00014485141,0.00003825586,0.000047136808,0.000051569656,0.000012592831,0.000036197835],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988326,0.00007334115,0.0003040978,0.00027777246,0.00016219915,0.00035000464],"domain_scores_gemma":[0.9994821,0.0000847352,0.00003925218,0.00021466194,0.000015006272,0.00016424136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005605353,0.00012113086,0.0002292611,0.000041796866,0.00007146008,0.000011510027,0.000027916085,0.00006805558,0.000068171146],"category_scores_gemma":[0.000036475984,0.00009787242,0.000032882966,0.00016402737,0.00011194054,0.000056858546,0.000035101664,0.00033576248,0.000009101739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008930198,0.0013350495,0.97828865,0.000187392,0.000009984346,0.0000014135564,0.0011622504,0.00008058884,0.000025160629,0.0002436575,0.0000151269805,0.018561425],"study_design_scores_gemma":[0.002589463,0.00038380583,0.9895069,0.000038534068,0.0000043522364,0.000019066712,0.00034486497,0.0011593044,0.000017325234,0.0009153569,0.0049470705,0.00007395159],"about_ca_topic_score_codex":0.02620361,"about_ca_topic_score_gemma":0.033369057,"teacher_disagreement_score":0.018487474,"about_ca_system_score_codex":0.00014196396,"about_ca_system_score_gemma":0.00014102415,"threshold_uncertainty_score":0.98426944},"labels":[],"label_agreement":null},{"id":"W2109018400","doi":"10.1016/j.jval.2013.08.1157","title":"Costs of Incidence-Based Central Retinal Vein Occlusion in France","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Central retinal vein occlusion; Medicine; Indirect costs; Incidence (geometry); Optometry; Retinal Disorder; Retinal Vein; Ophthalmology; Pediatrics; Emergency medicine; Visual acuity; Macular edema; Retinal; Business; Accounting","score_opus":0.019168429592560286,"score_gpt":0.3033580958608818,"score_spread":0.28418966626832154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109018400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99547243,0.0011921527,0.000024066932,0.0022929688,0.00006898307,0.0006902493,0.000007272417,0.000010287734,0.00024157303],"genre_scores_gemma":[0.99838233,0.0001848356,0.000741808,0.0005823054,0.00002470293,0.000014693876,0.00001751123,0.00000905139,0.000042758467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998762,0.00012362191,0.00038061824,0.00017655549,0.00024725727,0.00030995457],"domain_scores_gemma":[0.99940854,0.000074146126,0.00011135875,0.00017469814,0.000040145416,0.00019113168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018555431,0.000089439425,0.0002558585,0.000114054856,0.000021068381,0.0000038270123,0.00005295385,0.00004415382,0.00011407773],"category_scores_gemma":[0.00010347131,0.0000750473,0.00004500614,0.00024257049,0.000034843346,0.00004438681,0.000016311513,0.00012227325,0.000026986641],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013664213,0.00042745267,0.9946822,0.000322257,0.00000273751,0.00007468745,0.00013649782,0.0005704914,0.00012093924,0.000105311745,0.00012101896,0.0032997536],"study_design_scores_gemma":[0.0018319516,0.00058049837,0.98340684,0.001790746,0.000003952567,0.0000060641464,0.000040282765,0.011914809,0.00014599708,0.00017017077,0.000058902737,0.000049774026],"about_ca_topic_score_codex":0.03702918,"about_ca_topic_score_gemma":0.00005637273,"teacher_disagreement_score":0.03697281,"about_ca_system_score_codex":0.00032982285,"about_ca_system_score_gemma":0.00040146805,"threshold_uncertainty_score":0.9693833},"labels":[],"label_agreement":null},{"id":"W2109517979","doi":"10.1111/j.1524-4733.2010.00695.x","title":"Analysis of Health Utility Data When Some Subjects Attain the Upper Bound of 1: Are Tobit and CLAD Models Appropriate?","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":162,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Tobit model; Estimator; Econometrics; Mathematics; Nonparametric statistics; Statistics; Ordinary least squares; Censoring (clinical trials); Confidence interval; Truncation (statistics)","score_opus":0.5131673730727903,"score_gpt":0.42776352995092504,"score_spread":0.08540384312186522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2109517979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92822164,0.008587083,0.0015356274,0.05800557,0.00037621718,0.0011897522,0.00190135,0.000019103409,0.0001636687],"genre_scores_gemma":[0.99102443,0.0007884566,0.0024769884,0.0053882734,0.00010112306,0.000029698984,0.00012924235,0.000024254943,0.000037521793],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9913122,0.001345687,0.0057832114,0.00082560186,0.00017401863,0.0005592824],"domain_scores_gemma":[0.9913786,0.0016000535,0.004747197,0.0020145008,0.0000703552,0.00018927851],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.056103505,0.00020129289,0.0020008977,0.0006962016,0.00021226924,0.000041659878,0.00072289247,0.00016837972,0.00008990318],"category_scores_gemma":[0.0022720003,0.00020406065,0.00011863263,0.000602807,0.00022130777,0.00056956074,0.00022032365,0.00042856298,0.000015986376],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004258739,0.00043864097,0.7759961,0.0032891482,0.0004375312,3.5217687e-7,0.012858471,0.0061533316,0.0000024478195,0.19480118,0.0038241248,0.0021560793],"study_design_scores_gemma":[0.0006750917,0.000090099624,0.44077173,0.00013357059,0.000025390336,0.0000018290383,0.0017910252,0.46328145,0.0000013315963,0.09010231,0.0028927848,0.0002333968],"about_ca_topic_score_codex":0.07836265,"about_ca_topic_score_gemma":0.0071627605,"teacher_disagreement_score":0.4571281,"about_ca_system_score_codex":0.00026976696,"about_ca_system_score_gemma":0.0008504475,"threshold_uncertainty_score":0.9719401},"labels":[],"label_agreement":null},{"id":"W2110380449","doi":"10.1111/j.1524-4733.2009.00588.x","title":"Relationship between Health-Related Quality of Life, Pain, and Functional Disability in Neuropathic Pain Patients with Failed Back Surgery Syndrome","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Regina General Hospital","funders":"Medtronic","keywords":"Medicine; Oswestry Disability Index; Visual analogue scale; Quality of life (healthcare); Physical therapy; Neuropathic pain; Physical medicine and rehabilitation; Low back pain; Anesthesia; Alternative medicine","score_opus":0.06539276988189979,"score_gpt":0.3019693009767458,"score_spread":0.236576531094846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110380449","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9880085,0.00029422992,0.00027048364,0.010126112,0.00005340955,0.0011897626,0.000013537919,0.000027980606,0.000015984682],"genre_scores_gemma":[0.9986128,0.000011038951,0.0002523273,0.0008914789,0.000019861001,0.000011057711,0.00017833161,0.000013676463,0.000009412367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9877151,0.009450088,0.0016923258,0.00039179318,0.0004286359,0.00032205132],"domain_scores_gemma":[0.98990774,0.008964225,0.00045607224,0.00029433213,0.00008457677,0.0002930675],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.025148109,0.00016145909,0.0007949563,0.00021756753,0.00006929946,0.0000050292924,0.000031349096,0.00012893714,0.000020089126],"category_scores_gemma":[0.0110650705,0.00013301003,0.00007575863,0.000731602,0.00016517854,0.00009990985,0.000009650465,0.00044575636,0.0000029693551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024323595,0.00051426585,0.99094516,0.0033063476,0.0000053737785,4.698423e-7,0.00035063355,0.00022265968,7.8645144e-7,0.00018166442,0.00004039405,0.0041890163],"study_design_scores_gemma":[0.0014195887,0.0014529699,0.9942658,0.0008732223,0.0000024754765,4.4861167e-7,0.00008971825,0.0006816386,6.013323e-8,0.0011046259,0.000005053097,0.0001044337],"about_ca_topic_score_codex":0.0029328705,"about_ca_topic_score_gemma":0.00011771322,"teacher_disagreement_score":0.014083039,"about_ca_system_score_codex":0.0002997235,"about_ca_system_score_gemma":0.000489126,"threshold_uncertainty_score":0.99726516},"labels":[],"label_agreement":null},{"id":"W2110579557","doi":"10.1111/j.1524-4733.2009.00513.x","title":"Cost-Effectiveness of Drug-Eluting Stents in a US Medicare Setting: A Cost-Utility Analysis with 3-Year Clinical Follow-Up Data","year":2009,"lang":"en","type":"review","venue":"Value in Health","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Reimbursement; Sirolimus; Coronary artery disease; Internal medicine; Drug-eluting stent; Stent; Cost-effectiveness analysis; Confidence interval; Cost effectiveness; Restenosis; Health care","score_opus":0.2893822188551691,"score_gpt":0.4988045960906108,"score_spread":0.20942237723544166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110579557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009712907,0.98165286,0.0002943035,0.00015964588,0.00034126925,0.006522675,0.0011499807,0.000036702673,0.00012968713],"genre_scores_gemma":[0.029960351,0.9654226,0.00087061117,0.000091560076,0.000103817554,0.00015643942,0.0033185587,0.000046414003,0.000029663093],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99079794,0.003958853,0.0029496218,0.0010618295,0.000658335,0.00057344156],"domain_scores_gemma":[0.99163926,0.004796033,0.0012118841,0.0017934454,0.0001884414,0.00037095282],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01133447,0.00042041062,0.004418031,0.0008417123,0.000053723805,0.000013667864,0.00055388303,0.00032817898,0.00005200297],"category_scores_gemma":[0.004329622,0.00033165576,0.00072788575,0.002318776,0.00012765678,0.00007041149,0.00028821742,0.0012618214,0.000006250409],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002610364,0.0010417973,0.27875298,0.037456263,0.0006096912,0.00014970875,0.00008118477,0.000052607287,1.7852373e-9,0.000015192253,0.00013650389,0.68144304],"study_design_scores_gemma":[0.01026258,0.002114002,0.3901082,0.36883333,0.009291549,0.00009812894,0.00059383013,0.0071972944,8.94007e-8,0.00003180279,0.21076047,0.00070873473],"about_ca_topic_score_codex":0.006107953,"about_ca_topic_score_gemma":0.0019598743,"teacher_disagreement_score":0.6807343,"about_ca_system_score_codex":0.00061106036,"about_ca_system_score_gemma":0.002696728,"threshold_uncertainty_score":0.9999136},"labels":[],"label_agreement":null},{"id":"W2110717830","doi":"10.1016/j.jval.2014.08.1633","title":"Impact of Biologics Use on Depression and Anxiety Frequency and Health Care Resource Utilization In Psoriasis: An Analysis Using the Quebec Provincial Drug Reimbursement Program Database","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada); Université de Montréal","funders":"","keywords":"Medicine; Psoriasis; Reimbursement; Depression (economics); Anxiety; Database; Quality of life (healthcare); Health care; Internal medicine; Psychiatry; Dermatology","score_opus":0.06619317030901606,"score_gpt":0.3472439568685518,"score_spread":0.28105078655953575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110717830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302083,0.005598266,0.000078595425,0.000095591226,0.00006918987,0.0009581008,0.0001482749,0.00002621019,0.0000049550085],"genre_scores_gemma":[0.9974899,0.0010109073,0.000701714,0.00007795198,0.000024273857,0.000032594442,0.00064736954,0.000010729774,0.0000045248034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967741,0.0019053572,0.00048598932,0.0004360855,0.000055989356,0.00034250395],"domain_scores_gemma":[0.99905604,0.00014196258,0.00032728756,0.00038485517,0.00003603479,0.000053803426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012988813,0.00019055084,0.00042075338,0.00029386027,0.00021680405,0.00001896417,0.0001024828,0.00013113511,0.0000038822213],"category_scores_gemma":[0.00008006701,0.00012469916,0.000061821294,0.0004509492,0.000097331606,0.000113294096,0.000051214454,0.00016652774,2.6792208e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024245099,0.00033559944,0.8407717,0.00008540074,0.00008815634,7.8312314e-7,0.0045976355,0.001457606,0.00042340963,0.00015981136,0.000014138009,0.15182333],"study_design_scores_gemma":[0.0017494778,0.001335606,0.99140275,0.00023467609,0.00012221668,0.000005998136,0.0015942476,0.0027640352,0.00040290508,0.000034025514,0.00017918681,0.00017490685],"about_ca_topic_score_codex":0.2268864,"about_ca_topic_score_gemma":0.042502586,"teacher_disagreement_score":0.18438382,"about_ca_system_score_codex":0.00034048338,"about_ca_system_score_gemma":0.00029838286,"threshold_uncertainty_score":0.97496927},"labels":[],"label_agreement":null},{"id":"W2110934964","doi":"10.1016/j.jval.2015.09.813","title":"Impact of Genetic Factors on Gastrointestinal Bleeding in a Prospective Cohort of new Warfarin users","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Montreal General Hospital; Université de Montréal","funders":"","keywords":"Medicine; Warfarin; Internal medicine; Bleed; Prospective cohort study; VKORC1; Cohort; Incidence (geometry); Atrial fibrillation; Anticoagulant; CYP2C9; Surgery","score_opus":0.16029525941492928,"score_gpt":0.3954544786121989,"score_spread":0.23515921919726962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2110934964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99841535,0.000049590395,0.00008032648,0.00027301814,0.000054386925,0.00073060807,0.0000018599354,0.00001147947,0.00038338205],"genre_scores_gemma":[0.99782765,0.000013148451,0.0019474801,0.00001306724,0.000076453536,7.028871e-7,0.0000033150561,0.000009922466,0.00010827822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989183,0.000052266525,0.00045573773,0.00014072921,0.00024369269,0.00018929527],"domain_scores_gemma":[0.99940735,0.000092866285,0.00019403196,0.00011676115,0.00004212133,0.00014685844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041812143,0.00009297177,0.00037432255,0.00030040447,0.0000071185327,0.000002427892,0.000040016057,0.000022571186,0.000015633932],"category_scores_gemma":[0.0003932695,0.00007419792,0.000070719114,0.0003516137,0.00002095234,0.000033538243,0.000018717164,0.000100352736,0.0000021893868],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032340115,0.000020401869,0.9810534,0.000077590186,0.00001572918,0.0000032483074,0.0009592426,0.01710069,0.000039631752,0.000141041,0.000075417985,0.0001902163],"study_design_scores_gemma":[0.0017254394,0.0016975519,0.9935225,0.00038012918,0.000009658698,0.0000036837152,0.00026263698,0.0020931172,0.000043968692,0.00021006005,0.00000766772,0.000043561653],"about_ca_topic_score_codex":0.020099739,"about_ca_topic_score_gemma":0.000054096563,"teacher_disagreement_score":0.020045642,"about_ca_system_score_codex":0.00048313552,"about_ca_system_score_gemma":0.00050652714,"threshold_uncertainty_score":0.9864255},"labels":[],"label_agreement":null},{"id":"W2112192429","doi":"10.1016/j.jval.2013.03.188","title":"Are canadians different from americans in stated preferences for health? valuing EQ-5D-5L health states using discrete choice experiments","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"EQ-5D; Anxiety; Discrete choice; Demography; Depression (economics); Medicine; Logistic regression; Dimension (graph theory); Psychology; Gerontology; Statistics; Mathematics; Psychiatry; Economics","score_opus":0.26433970907792953,"score_gpt":0.30935213094279884,"score_spread":0.04501242186486931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112192429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866435,0.0032789845,0.0021984912,0.0047605867,0.00032950492,0.0015547001,0.0011772694,0.000022125872,0.00003484792],"genre_scores_gemma":[0.9925355,0.0014077247,0.0023251148,0.0030246614,0.00006497821,0.00024311186,0.00030549138,0.000045814188,0.000047641366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967103,0.00017007261,0.0015149208,0.00066609064,0.00006240786,0.00087623205],"domain_scores_gemma":[0.9978323,0.00017882447,0.0013396196,0.0002836618,0.000008488165,0.00035708977],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069351617,0.0002563853,0.0008431971,0.00030738744,0.00019517877,0.00006997101,0.00019774807,0.000068240544,0.00019631325],"category_scores_gemma":[0.00004713271,0.0002950808,0.00006584867,0.00018304218,0.000054790507,0.00030813427,0.00004409764,0.00019595739,0.0000436627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010806533,0.0001259736,0.9621236,0.00014890768,0.000026547516,2.6699414e-7,0.005748574,0.029216474,0.0000049910705,0.0002639081,0.00038930305,0.0019406783],"study_design_scores_gemma":[0.0009975113,0.00022571895,0.8461544,0.00024327761,0.0000012297359,2.4484484e-7,0.002893415,0.14215517,0.000007601755,0.0065473267,0.00049165054,0.0002824886],"about_ca_topic_score_codex":0.8160482,"about_ca_topic_score_gemma":0.043798696,"teacher_disagreement_score":0.7722495,"about_ca_system_score_codex":0.0034551802,"about_ca_system_score_gemma":0.00020454008,"threshold_uncertainty_score":0.9999501},"labels":[],"label_agreement":null},{"id":"W2112440837","doi":"10.1016/j.jval.2012.08.1569","title":"PRM106 Examination of Preferences Elicited From the General Public: Comparisons of Results From the Time Trade-Off and Standard Gamble Instruments","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Brock University; PharmIdeas (Canada)","funders":"","keywords":"Time-trade-off; Medicine; Population; Data extraction; MEDLINE; Public health; Preference; Inclusion (mineral); Systematic review; Quality of life (healthcare); Family medicine; Demography; Psychology; Statistics; Environmental health; Mathematics; Social psychology; Pathology; Nursing","score_opus":0.40078522737947014,"score_gpt":0.400590321035027,"score_spread":0.00019490634444313537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112440837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95554066,0.0054017846,0.00013361231,0.03364333,0.00026716117,0.000752459,0.0037288668,0.000011862802,0.0005202734],"genre_scores_gemma":[0.99548954,0.0006211727,0.0017871308,0.0016078219,0.0002082904,0.000027457674,0.0002162451,0.000013282277,0.000029045641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99420726,0.0014806034,0.003485245,0.00030859208,0.00016322003,0.00035505497],"domain_scores_gemma":[0.9937074,0.0030580764,0.0026168716,0.00045439682,0.000036705882,0.00012655929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018158218,0.00013489107,0.00074578106,0.00012545264,0.00014701483,0.00004008706,0.00029710046,0.00010306247,0.000073268646],"category_scores_gemma":[0.0020753848,0.00011191356,0.000045162647,0.00023287917,0.00011880462,0.00036882854,0.000057047044,0.00018283042,0.000029007226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102477796,0.0002934684,0.9090704,0.00018056862,0.00013100267,4.1934886e-8,0.032697763,0.0005588196,0.000011379488,0.029893363,0.019027412,0.008033344],"study_design_scores_gemma":[0.0012285524,0.0001101414,0.9548803,0.00016287081,0.000005585109,3.3092147e-7,0.0015585797,0.022207936,0.00001978939,0.0029611827,0.016742153,0.00012258906],"about_ca_topic_score_codex":0.036072392,"about_ca_topic_score_gemma":0.0005998885,"teacher_disagreement_score":0.045809932,"about_ca_system_score_codex":0.0002514122,"about_ca_system_score_gemma":0.00022548734,"threshold_uncertainty_score":0.9703465},"labels":[],"label_agreement":null},{"id":"W2112744491","doi":"10.1016/j.jval.2011.02.1157","title":"PND47 THE HEMOPHILIA UTILIZATION GROUP STUDY (HUGS-VB): HEALTH-RELATED QUALITY OF LIFE IN HEMOPHILIA B","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Visual analogue scale; Quality of life (healthcare); Physical therapy; EQ-5D; Health related quality of life; Joint pain; Internal medicine; Disease","score_opus":0.16132879338756312,"score_gpt":0.35787421176471546,"score_spread":0.19654541837715234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112744491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870724,0.0058945725,0.00004135539,0.0033751433,0.00038181036,0.0023509462,0.0000106815705,0.000047091922,0.0008260061],"genre_scores_gemma":[0.9967915,0.00075410516,0.00024519267,0.0019809455,0.000045185963,0.000032100314,0.000026480831,0.000030186866,0.0000943423],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99495625,0.0016267154,0.001970428,0.00041453558,0.0005083932,0.0005236874],"domain_scores_gemma":[0.9982621,0.0001703529,0.00058094016,0.0006652949,0.000066143504,0.00025514918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005259379,0.00021392816,0.00090651686,0.00029941287,0.00009345953,0.000005134857,0.00020351232,0.00011852578,0.00012346008],"category_scores_gemma":[0.00065038854,0.0001641271,0.000083704654,0.0010292374,0.00012161949,0.00009031456,0.000057838646,0.00043394946,0.00002675509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010052744,0.0041598417,0.93249285,0.0017320203,0.000021797847,0.00000868898,0.036644258,0.00022393673,0.000021940406,0.016861403,0.0004992366,0.0063287583],"study_design_scores_gemma":[0.0047567403,0.0007022388,0.9851269,0.00016247715,0.000011420977,0.0000032702926,0.0061427006,0.00051281374,0.000008529989,0.00228587,0.0001533403,0.00013369728],"about_ca_topic_score_codex":0.09418884,"about_ca_topic_score_gemma":0.0022678983,"teacher_disagreement_score":0.09192094,"about_ca_system_score_codex":0.00015265815,"about_ca_system_score_gemma":0.00070630957,"threshold_uncertainty_score":0.91184306},"labels":[],"label_agreement":null},{"id":"W2112931924","doi":"10.1016/j.jval.2013.08.046","title":"Psychometric Validation of Perceived Deficits Questionnaire – Depression (PDQ-D) in Patients with Major Depressive Disorder (MDD)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cognitive Functions and Memory","field":"Psychology","cited_by":48,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cronbach's alpha; Major depressive disorder; Patient Health Questionnaire; Geriatric Depression Scale; Quality of life (healthcare); Depression (economics); Clinical psychology; Psychology; Medicine; Construct validity; Cognition; Psychiatry; Gerontology; Psychometrics; Depressive symptoms","score_opus":0.02175454803241391,"score_gpt":0.2944295655860353,"score_spread":0.2726750175536214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2112931924","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957606,0.00077720435,0.0007969797,0.00014567148,0.00040470297,0.001226715,0.000014144365,0.000026758758,0.0008472172],"genre_scores_gemma":[0.9991742,0.00003753244,0.00021585502,0.00010677949,0.000028502956,0.00023627213,0.00004428958,0.000025396965,0.00013120605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815583,0.0003905548,0.0004993848,0.0003893676,0.00023208061,0.00033275475],"domain_scores_gemma":[0.9990028,0.00013635443,0.00026457678,0.00029000704,0.00021037797,0.00009589036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026236553,0.0001549494,0.000267027,0.00080944074,0.00007277118,0.0000112414455,0.00010028183,0.00010877539,0.00037430017],"category_scores_gemma":[0.00016415337,0.00012971951,0.000033207707,0.0010720812,0.00004448848,0.00016757511,0.000024028457,0.00022461127,0.00008348849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016044747,0.0008110558,0.9512403,0.00007741158,0.000010148086,5.5557905e-7,0.0010513783,0.00061548525,0.000014370732,0.00009236506,0.00013664471,0.045789815],"study_design_scores_gemma":[0.0035501034,0.0003960525,0.9946335,0.0004540202,0.0000072057373,0.0000013967763,0.00035627885,0.00011831269,0.000014670682,0.0002970641,0.000039993152,0.00013140372],"about_ca_topic_score_codex":0.015181617,"about_ca_topic_score_gemma":0.00019690813,"teacher_disagreement_score":0.045658413,"about_ca_system_score_codex":0.00011801813,"about_ca_system_score_gemma":0.0000827014,"threshold_uncertainty_score":0.9913764},"labels":[],"label_agreement":null},{"id":"W2113215455","doi":"10.1046/j.1524-4733.2003.65253.x","title":"The Pediatric Quality Appraisal Questionnaire: An Instrument for Evaluation of the Pediatric Health Economics Literature","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":52,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"","keywords":"Inter-rater reliability; Economic evaluation; Reliability (semiconductor); Psychological intervention; Medicine; Test (biology); Population; Health care; Family medicine; Face validity; Psychology; Actuarial science; Applied psychology; Clinical psychology; Psychometrics; Nursing; Environmental health; Rating scale; Business; Developmental psychology","score_opus":0.361869871736556,"score_gpt":0.46547141386548424,"score_spread":0.10360154212892825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113215455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9169478,0.029878678,0.0010202188,0.043733686,0.0036410347,0.004108347,0.00045088638,0.000034763947,0.00018459045],"genre_scores_gemma":[0.9883077,0.004682082,0.0021284246,0.0035345533,0.0007533004,0.00046268053,0.00004101726,0.00004689245,0.00004336417],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.98504806,0.005971995,0.0071235895,0.0007867685,0.00027795156,0.0007916451],"domain_scores_gemma":[0.99036545,0.0023388255,0.005718081,0.001076286,0.00022463355,0.00027670147],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.11504303,0.00026253605,0.00096295663,0.00033784428,0.0006962302,0.00011490409,0.00050562754,0.00019263466,0.000014951914],"category_scores_gemma":[0.011445335,0.00023958278,0.00019771884,0.00067543134,0.0000689052,0.0004435501,0.000040740357,0.00035357833,0.000026723335],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023874034,0.00023010797,0.4360099,0.0014172132,0.000016478794,1.9488503e-8,0.0038638907,0.015981136,4.6219796e-8,0.53975046,0.0017540877,0.0009527684],"study_design_scores_gemma":[0.0071145105,0.0008413249,0.62039036,0.00031031852,0.000035450066,0.000014827204,0.0026042894,0.09381996,0.0000029759003,0.25015935,0.023750942,0.0009557136],"about_ca_topic_score_codex":0.0034485422,"about_ca_topic_score_gemma":0.00073276664,"teacher_disagreement_score":0.28959113,"about_ca_system_score_codex":0.002122996,"about_ca_system_score_gemma":0.0036563682,"threshold_uncertainty_score":0.99688166},"labels":[],"label_agreement":null},{"id":"W2113745570","doi":"10.1016/j.jval.2011.02.096","title":"PHP24 NUMBER AND TYPE OF DRUGS USED BY SENIORS ON PUBLIC DRUG PROGRAMS IN CANADA, 2002 TO 2008","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Drug; Drug class; Medicine; Medical prescription; Public health; Population; Adverse effect; Gerontology; Pharmacology; Family medicine; Environmental health; Pathology","score_opus":0.2671727288241618,"score_gpt":0.389536600902513,"score_spread":0.1223638720783512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113745570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99013615,0.00028583064,7.289414e-7,0.0053327507,0.00018732854,0.0006637778,0.000008931303,0.000008486926,0.0033759903],"genre_scores_gemma":[0.99648184,0.00012660818,0.00028384387,0.0026060196,0.000014992471,0.000009348679,0.0000066249113,0.00001245824,0.00045824138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987367,0.00015555823,0.00034634187,0.0001779413,0.00025985294,0.00032360828],"domain_scores_gemma":[0.9992271,0.00015738673,0.00009345884,0.0001423185,0.000029069579,0.00035065186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004667264,0.00009445405,0.00026764508,0.00007501376,0.00001735832,0.0000039489264,0.000053482443,0.000030191124,0.00019220842],"category_scores_gemma":[0.00012116621,0.000078964345,0.000014088806,0.0003489955,0.000021209587,0.000061708204,0.00002075912,0.0002374811,0.000019614932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025739896,0.0003779701,0.977771,0.0002807744,0.000010941546,0.000013431943,0.003706448,0.0000063822968,0.0000091096845,0.00017521127,0.006472187,0.010919185],"study_design_scores_gemma":[0.01323354,0.003328267,0.5837656,0.0020927924,0.000067679786,0.00005144886,0.00851512,0.01028871,0.0009376288,0.00032155387,0.37638277,0.0010148445],"about_ca_topic_score_codex":0.90012676,"about_ca_topic_score_gemma":0.21603824,"teacher_disagreement_score":0.6840885,"about_ca_system_score_codex":0.00026034372,"about_ca_system_score_gemma":0.0007839592,"threshold_uncertainty_score":0.798267},"labels":[],"label_agreement":null},{"id":"W2113782760","doi":"10.1016/j.jval.2014.03.852","title":"Impact Of The Pan-Canadian Pricing Alliance (Pcpa) On Access To Drug Treatment Options For Canadian Patients","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Medicine; Formulary; Listing (finance); Drug; Pharmacotherapy; Medical prescription; Emergency medicine; Internal medicine; Intensive care medicine; Family medicine; Pharmacology; Business; Finance","score_opus":0.13799005764256228,"score_gpt":0.3637228376764445,"score_spread":0.2257327800338822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2113782760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786195,0.00012085683,0.00002460126,0.013925955,0.00036575858,0.0011108664,0.0013561748,0.0000039652546,0.004472314],"genre_scores_gemma":[0.9947522,0.00015829907,0.00010432428,0.004735751,0.00006761088,0.00006650948,0.000011960698,0.00001696112,0.00008633216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987377,0.00003095161,0.0004646102,0.00024007008,0.000016492946,0.00051017833],"domain_scores_gemma":[0.99889076,0.000103279315,0.00017532494,0.0002836402,0.000017397819,0.0005295973],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042798917,0.00011312841,0.0002807102,0.0002764654,0.00015354496,0.000039868617,0.0002841616,0.000040448267,0.00003595998],"category_scores_gemma":[0.00012698556,0.00010155266,0.00011329424,0.00022416396,0.000015385784,0.00007029157,0.00001646191,0.00007540643,0.000061458115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020114285,0.0001600801,0.7894778,0.000052709744,0.000036537374,1.1353807e-7,0.00096023484,0.06522423,3.9653992e-7,0.12919603,0.0043761935,0.01049551],"study_design_scores_gemma":[0.0007314383,0.00032363023,0.848432,0.00005049918,0.0000017417939,1.1618902e-7,0.0000045488046,0.024183236,0.000009788906,0.007927001,0.11817656,0.00015940955],"about_ca_topic_score_codex":0.9436283,"about_ca_topic_score_gemma":0.75385684,"teacher_disagreement_score":0.18977147,"about_ca_system_score_codex":0.0027018003,"about_ca_system_score_gemma":0.0005934053,"threshold_uncertainty_score":0.70651144},"labels":[],"label_agreement":null},{"id":"W2114177140","doi":"10.1016/j.jval.2014.03.1263","title":"Pharmacoeconomic analysis of paliperidone palmitate for chronic relapsing schizophrenia in Finland","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Paliperidone Palmitate; Schizophrenia (object-oriented programming); Paliperidone; Medicine; Psychiatry; Antipsychotic","score_opus":0.0436828072457451,"score_gpt":0.3492657551623805,"score_spread":0.30558294791663543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114177140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941069,0.002436029,0.00020507365,0.0023375289,0.00008408313,0.00071670255,0.000032031283,0.00001127502,0.00007039434],"genre_scores_gemma":[0.9946235,0.0009481824,0.0040248283,0.00010762893,0.00008859427,0.00007806451,0.000059097852,0.00001712376,0.00005297121],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9983793,0.00018414801,0.00057480054,0.00029583432,0.00014092273,0.00042500976],"domain_scores_gemma":[0.9989716,0.0004077067,0.00013964501,0.00026098068,0.00002967874,0.00019042348],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001122699,0.00012433305,0.00065172947,0.0008315072,0.000036796784,0.0000072899793,0.00007077504,0.00004812938,0.00006313524],"category_scores_gemma":[0.0001364215,0.00011010728,0.00014749971,0.00064837426,0.00003930499,0.00004035408,0.00001915614,0.00016709026,0.000011292265],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.031548344,0.0014697122,0.6338741,0.0032216266,0.0022386592,0.000056978977,0.001418569,0.07577667,0.0027906552,0.0059060375,0.00050739985,0.24119121],"study_design_scores_gemma":[0.025023831,0.0016741529,0.4438187,0.0005825285,0.00028109975,0.000006785761,0.000041086063,0.525483,0.00089458737,0.0012885237,0.0007327502,0.00017296807],"about_ca_topic_score_codex":0.0026210602,"about_ca_topic_score_gemma":0.0014134486,"teacher_disagreement_score":0.44970635,"about_ca_system_score_codex":0.0005676154,"about_ca_system_score_gemma":0.0006224014,"threshold_uncertainty_score":0.44900444},"labels":[],"label_agreement":null},{"id":"W2114652540","doi":"10.1016/j.jval.2014.08.825","title":"Cost-Utility Analysis Of Screening Strategies For Nonalcoholic Steatohepatitis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Hôpital Saint-Luc","funders":"","keywords":"Medicine; Nonalcoholic fatty liver disease; Transient elastography; Liver biopsy; Population; Elastography; Internal medicine; Cost effectiveness; Quality-adjusted life year; Fatty liver; Biopsy; Radiology; Disease; Ultrasound; Environmental health","score_opus":0.11269870764277062,"score_gpt":0.37385507350653957,"score_spread":0.26115636586376895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114652540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919139,0.00062345696,0.0050519495,0.00084122416,0.00003563241,0.00092487497,0.00017159557,0.00001905122,0.00041828246],"genre_scores_gemma":[0.9967079,0.00014914406,0.0024524198,0.00038897432,0.000030092986,0.00011277637,0.00014100468,0.0000081252865,0.000009552054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989183,0.00011520971,0.00036801826,0.00021030688,0.00017604127,0.00021212111],"domain_scores_gemma":[0.99907804,0.0003335151,0.00012527037,0.00024089462,0.00007316166,0.00014912635],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005040464,0.000090910195,0.00049569906,0.00023897323,0.000040783663,0.00000835256,0.00004244999,0.00003450403,0.000046432677],"category_scores_gemma":[0.000068233756,0.00007811291,0.00018233083,0.0004047259,0.000031520718,0.00004548592,0.000011645567,0.00004909852,0.0000014447419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099544006,0.0004676717,0.9682169,0.00044412308,0.00055978104,0.0000019717324,0.0005054011,0.0039156647,0.0000027770789,0.0045367368,0.000105698025,0.021143738],"study_design_scores_gemma":[0.0013298906,0.00036231105,0.89583004,0.00016344918,0.0005380646,4.1376256e-7,0.00021794497,0.100528695,0.000039047303,0.00037217536,0.0005653343,0.000052657797],"about_ca_topic_score_codex":0.013511366,"about_ca_topic_score_gemma":0.00043984424,"teacher_disagreement_score":0.09661303,"about_ca_system_score_codex":0.000081643964,"about_ca_system_score_gemma":0.00023401309,"threshold_uncertainty_score":0.9930577},"labels":[],"label_agreement":null},{"id":"W2115230664","doi":"10.1016/j.jval.2014.03.1639","title":"Real World Drug Utilization Of Hiv Therapies In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Cohort; Medicine; Darunavir; Pharmacy; Internal medicine; Pediatrics; Antiretroviral therapy; Human immunodeficiency virus (HIV); Viral load; Family medicine","score_opus":0.03396572503607699,"score_gpt":0.28732043045250916,"score_spread":0.2533547054164322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115230664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860735,0.00032305575,0.000016866605,0.010575466,0.00008964045,0.0003148289,0.0000032405346,0.00001052422,0.0025928624],"genre_scores_gemma":[0.9955028,0.00037123534,0.0010107758,0.00023021811,0.00002164093,0.000010220759,0.000027017311,0.000008790488,0.0028172857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99908006,0.00011628695,0.0003327751,0.00011831703,0.00017648746,0.00017607717],"domain_scores_gemma":[0.99962497,0.00009552196,0.00007546773,0.00011971639,0.00001835666,0.00006596847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036209135,0.00007193666,0.00023799327,0.00017146494,0.000016579786,0.000001495862,0.000032547494,0.000012788841,0.000033739892],"category_scores_gemma":[0.000024085339,0.000059996448,0.000012853247,0.0003016709,0.000011291989,0.000019158577,0.000007711224,0.00006866506,0.0000034939753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003772588,0.00007994472,0.98417425,0.00017684829,0.000009503198,0.0000063716966,0.0026670606,0.00024361812,0.00000586818,0.001387829,0.0018809161,0.009330055],"study_design_scores_gemma":[0.0025269422,0.000050391285,0.9680562,0.0007715748,0.000006659623,0.0000018439135,0.00081540237,0.0075843697,0.00043892275,0.0005765706,0.019058237,0.000112859234],"about_ca_topic_score_codex":0.9010486,"about_ca_topic_score_gemma":0.9362356,"teacher_disagreement_score":0.035187032,"about_ca_system_score_codex":0.000734555,"about_ca_system_score_gemma":0.0016642039,"threshold_uncertainty_score":0.29522264},"labels":[],"label_agreement":null},{"id":"W2115235341","doi":"10.1046/j.1524-4733.2000.31004.x","title":"Economic Evaluation of Letrozole in the Treatment of Advanced Breast Cancer in Postmenopausal Women in Canada","year":2000,"lang":"en","type":"article","venue":"Value in Health","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Letrozole; Megestrol acetate; Medicine; Megestrol; Breast cancer; Internal medicine; Cancer; Oncology; Gynecology; Tamoxifen","score_opus":0.009119252127290237,"score_gpt":0.2725535202311246,"score_spread":0.26343426810383436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115235341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99487054,0.0042585144,2.7124088e-8,0.00025128498,0.000039477858,0.00041565183,0.000039607534,4.3932107e-7,0.00012444542],"genre_scores_gemma":[0.99644685,0.0033735207,0.00000611334,0.000043183245,0.000014024475,0.000084408675,0.000016974704,0.000005450694,0.000009456472],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9989617,0.00029745628,0.00029322412,0.00013848321,0.000088866225,0.0002202666],"domain_scores_gemma":[0.9997475,0.000016722426,0.00006873673,0.0001286673,0.000009052621,0.000029322367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005116977,0.000072171686,0.00016359534,0.000053191787,0.0000071903287,0.0000010043253,0.00006425675,0.000045794503,0.000030678104],"category_scores_gemma":[0.0000038675184,0.000057056594,0.000012474679,0.00009801425,0.000013866301,0.000002394498,0.000003933475,0.000051316467,4.2401467e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005466038,0.0004353641,0.18211651,0.000056714416,0.000021086846,0.0000057486045,0.0019957626,0.7012818,0.01114388,0.000014369648,0.000017585175,0.10236461],"study_design_scores_gemma":[0.008012855,0.002377743,0.9589653,0.000199907,0.0000092270475,0.000014139249,0.001384541,0.01679336,0.011484327,0.00010388538,0.00044160112,0.00021309317],"about_ca_topic_score_codex":0.8315929,"about_ca_topic_score_gemma":0.6917422,"teacher_disagreement_score":0.7768488,"about_ca_system_score_codex":0.0015129417,"about_ca_system_score_gemma":0.0020791711,"threshold_uncertainty_score":0.395629},"labels":[],"label_agreement":null},{"id":"W2115993828","doi":"10.1016/j.jval.2014.03.224","title":"Cost-effectiveness of adalimumab for the treatment of moderately to severely active ulcerative colitis in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada); University of Calgary","funders":"","keywords":"Adalimumab; Medicine; Infliximab; Ulcerative colitis; Golimumab; Internal medicine; Disease","score_opus":0.035570966416430795,"score_gpt":0.30337296838836847,"score_spread":0.26780200197193765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115993828","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99667454,0.000085304746,0.0007468847,0.00009235858,0.00007731862,0.0019899604,0.0002834096,0.0000010801135,0.000049131824],"genre_scores_gemma":[0.99919134,0.000065751,0.000116103576,0.000120031844,0.000023888257,0.00043068698,0.000028602872,0.000011183462,0.000012430051],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99881357,0.0004653518,0.00024415122,0.00018788592,0.00008531678,0.00020373866],"domain_scores_gemma":[0.9993112,0.00023780004,0.00009645787,0.00019819879,0.000084367384,0.00007197327],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033546632,0.00010026397,0.00020791436,0.000031272353,0.000031671876,0.0000022019271,0.00008157604,0.00003724918,0.0000016848294],"category_scores_gemma":[0.00008312537,0.00008115544,0.000037666603,0.00006470196,0.000023862574,0.0000020270109,0.000013479974,0.000026849082,1.8373312e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07113547,0.0010324433,0.027209792,0.0017654157,0.00028952712,0.000022257767,0.0043382305,0.84634894,0.0032507959,0.0042216717,0.0002893597,0.04009609],"study_design_scores_gemma":[0.0022816267,0.0010603393,0.943768,0.00010181786,0.0000069485286,9.011448e-7,0.00026370166,0.008861222,0.042192314,0.00017289343,0.0011790541,0.000111147856],"about_ca_topic_score_codex":0.598989,"about_ca_topic_score_gemma":0.73351645,"teacher_disagreement_score":0.91655827,"about_ca_system_score_codex":0.0005118187,"about_ca_system_score_gemma":0.0020414856,"threshold_uncertainty_score":0.40368134},"labels":[],"label_agreement":null},{"id":"W2116298731","doi":"10.1016/j.jval.2014.08.864","title":"Assessing the Comparative Outcomes from Teriflunomide and Dimethyl Fumarate Studies in Relapsing Ms: Use of “Number Needed to Treat” Analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Teriflunomide; Medicine; Number needed to treat; Dimethyl fumarate; Number needed to harm; Hazard ratio; Placebo; Confidence interval; Clinical endpoint; Absolute risk reduction; Relative risk; Multiple sclerosis; Internal medicine; Clinical trial; Fingolimod; Psychiatry; Alternative medicine","score_opus":0.4437821032719421,"score_gpt":0.5073067453736835,"score_spread":0.06352464210174136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116298731","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302,0.00094078196,0.00015923989,0.0051030437,0.000055392324,0.00058845954,0.000013552608,0.000013614187,0.0001059199],"genre_scores_gemma":[0.99351543,0.0007891335,0.0048887446,0.0006611711,0.000031648935,0.000037223755,0.000005973003,0.000011608275,0.000059080223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707246,0.0011918376,0.00071287085,0.00034566363,0.00032288226,0.0003542903],"domain_scores_gemma":[0.9945935,0.0046142535,0.00019921424,0.00035271022,0.00011383525,0.00012647199],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017542088,0.00018246964,0.001251256,0.00039242883,0.00012539722,0.000047382327,0.00007840406,0.00004143639,0.000009484857],"category_scores_gemma":[0.0021810345,0.0001140263,0.00008159425,0.00096471974,0.0002242393,0.00017565553,0.00014555528,0.00025462866,0.0000034537597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012647959,0.00009561871,0.96644986,0.00015782914,0.00040816577,0.0000027366389,0.024475895,0.0034068343,0.0018609068,0.000020869973,0.00022759548,0.0027671983],"study_design_scores_gemma":[0.0012082813,0.00009552388,0.97034115,0.00061074796,0.00009937576,4.4185236e-7,0.010040997,0.017006423,0.00038036727,0.000049005004,0.00007679527,0.000090895424],"about_ca_topic_score_codex":0.075765505,"about_ca_topic_score_gemma":0.0021399532,"teacher_disagreement_score":0.07362556,"about_ca_system_score_codex":0.00029535333,"about_ca_system_score_gemma":0.000086595865,"threshold_uncertainty_score":0.93038905},"labels":[],"label_agreement":null},{"id":"W2116948576","doi":"10.1016/j.jval.2013.03.514","title":"Effect of neurologist ambulatory visits on use of disease-specific pharmacotherapies for chronic neurological conditions","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Medical prescription; Medical Expenditure Panel Survey; Ambulatory; Disease; Population; Ambulatory care; Prescription drug; Health care; Physical therapy; Pediatrics; Family medicine; Internal medicine; Health insurance; Environmental health","score_opus":0.40776735081666327,"score_gpt":0.4341040026653271,"score_spread":0.02633665184866385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116948576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97746485,0.0038931542,0.00034325835,0.014481798,0.0004616488,0.0026069437,0.0006871272,0.000032336004,0.000028902607],"genre_scores_gemma":[0.9929529,0.0007464982,0.00024832727,0.0054093865,0.00015604064,0.00039092798,0.0000354374,0.000030176894,0.000030336249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949365,0.0011293762,0.002974215,0.00047450323,0.00008196538,0.0004034355],"domain_scores_gemma":[0.9921819,0.0054109287,0.001737971,0.00042384115,0.000043791733,0.00020154602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064887158,0.00018081315,0.0009913382,0.00036767937,0.00009741005,0.000022736649,0.0001989589,0.00009202491,0.00026860836],"category_scores_gemma":[0.0014105452,0.00019663705,0.00015868014,0.00016533509,0.00012711303,0.00024848556,0.000023489873,0.00017932188,0.00017371416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012275344,0.0012614005,0.46410954,0.0111121815,0.00014691388,0.000002956638,0.0011674844,0.18541189,0.00017692604,0.26297826,0.06976576,0.0026391537],"study_design_scores_gemma":[0.005357993,0.009732834,0.7430614,0.0004020965,0.000011428415,0.0000023779116,0.000033256456,0.17602037,0.00011294333,0.011596608,0.05309218,0.0005764895],"about_ca_topic_score_codex":0.0011372848,"about_ca_topic_score_gemma":0.000010186366,"teacher_disagreement_score":0.27895188,"about_ca_system_score_codex":0.0002496265,"about_ca_system_score_gemma":0.00015892324,"threshold_uncertainty_score":0.8018626},"labels":[],"label_agreement":null},{"id":"W2117521501","doi":"10.1016/j.jval.2014.08.2659","title":"An Assessment of the Association Between Rural Status and Health Service Resource Use Among Patients With Ankle Sprains in Ontario","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Rurality; Ambulatory care; Health care; Population; Environmental health; Ankle; Ambulatory; Rural area; Family medicine; Gerontology; Medical emergency","score_opus":0.17278008996928249,"score_gpt":0.46201978121283527,"score_spread":0.28923969124355275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117521501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989661,0.0000055992014,0.00007197937,0.0090130195,0.000050022405,0.0011380864,0.000020970703,0.000010305113,0.000029032628],"genre_scores_gemma":[0.9937479,0.000010573137,0.0020909945,0.0038908657,0.000037538666,0.000008319335,0.00018523603,0.00001501591,0.000013571128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968819,0.001016979,0.0010512066,0.00020528844,0.000512832,0.00033181618],"domain_scores_gemma":[0.9974437,0.0009850457,0.00095536676,0.00029411603,0.00013370755,0.00018810466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0042185485,0.00010168978,0.00036022282,0.00009598267,0.00006384793,0.000017934814,0.00006141176,0.00006116409,0.0000064473807],"category_scores_gemma":[0.0006812535,0.000076700766,0.000017620838,0.00029535207,0.000020309817,0.00025867726,0.000039040366,0.0004641925,3.1157273e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050436654,0.0002049579,0.9944509,0.00010245073,0.00001120022,1.1091412e-7,0.0017202736,0.0007971788,8.196262e-7,0.00004473783,0.000047454836,0.00256947],"study_design_scores_gemma":[0.0034856843,0.0010735297,0.9912744,0.00032681457,0.000018071807,1.857879e-7,0.0004610814,0.0024370989,7.654748e-7,0.00004220015,0.00081924663,0.00006087665],"about_ca_topic_score_codex":0.7610855,"about_ca_topic_score_gemma":0.662777,"teacher_disagreement_score":0.098308496,"about_ca_system_score_codex":0.0020489849,"about_ca_system_score_gemma":0.0012294535,"threshold_uncertainty_score":0.5358024},"labels":[],"label_agreement":null},{"id":"W2117819319","doi":"10.1016/j.jval.2013.03.204","title":"Health utilities index®: Extending the age range to pre-schoolers","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Utilities Kingston (Canada); McMaster University","funders":"","keywords":"Health Utilities Index; Gerontology; Quality of life (healthcare); Health care; Quality (philosophy); Statistics; Psychology; Medicine; Mathematics; Demography; Health related quality of life; Nursing; Pathology; Sociology","score_opus":0.10765607583187435,"score_gpt":0.45147429586694826,"score_spread":0.3438182200350739,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117819319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75734687,0.010648124,0.00033409856,0.20794767,0.0047112154,0.0131433485,0.000090203306,0.0005196674,0.005258779],"genre_scores_gemma":[0.93072325,0.0014454521,0.0012348673,0.06250647,0.00063907483,0.0011902632,0.000015635771,0.00007818308,0.0021668128],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99022925,0.0038253225,0.0019424879,0.00067010184,0.0007553948,0.0025774445],"domain_scores_gemma":[0.9957531,0.0015116074,0.0005329549,0.0010214581,0.00018437626,0.0009964667],"candidate_categories":["metaepi_narrow","sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.005388615,0.00036790458,0.00085587456,0.00037716544,0.0016402532,0.00004272114,0.00067643233,0.00024579768,0.00046782006],"category_scores_gemma":[0.0008166891,0.00028230032,0.00009340018,0.0009856836,0.00010338694,0.00027418803,0.0003052448,0.0016885245,0.0024972649],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020769832,0.00018894373,0.3353583,0.0049979924,0.000025364317,0.000018128227,0.10376297,0.0022316135,0.0000045772404,0.014101924,0.5077796,0.031322926],"study_design_scores_gemma":[0.00078830007,0.00034613436,0.7853381,0.002300665,0.0000020295643,0.0000031883155,0.015340062,0.0011253747,4.7754094e-7,0.0030482265,0.19144619,0.0002612361],"about_ca_topic_score_codex":0.3558222,"about_ca_topic_score_gemma":0.010293491,"teacher_disagreement_score":0.44997984,"about_ca_system_score_codex":0.002639597,"about_ca_system_score_gemma":0.002316328,"threshold_uncertainty_score":0.9999629},"labels":[],"label_agreement":null},{"id":"W2117861533","doi":"10.1016/j.jval.2012.08.2150","title":"PCN110 Differences in Health-Related Quality of Life Between Children Treated for Acute Lymphoblastic Leukemia (ALL) on Dana Farber Cancer Institute (DFCI) Protocols","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Utilities Kingston (Canada); McMaster University","funders":"","keywords":"Medicine; Quality of life (healthcare); Lymphoblastic Leukemia; Pediatrics; Childhood cancer; Internal medicine; Health related quality of life; Cancer; Leukemia; Disease","score_opus":0.14343582252455087,"score_gpt":0.41971786320293614,"score_spread":0.27628204067838524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2117861533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700176,0.00052626105,0.00019043994,0.0027666353,0.00016711645,0.025743099,0.00040940338,0.00008496844,0.00009447608],"genre_scores_gemma":[0.99054796,0.0002511086,0.0005947142,0.0010325864,0.00031685998,0.006753666,0.00024011915,0.00007700238,0.00018596358],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993054,0.0009576903,0.0026749857,0.0006961972,0.00095801934,0.0016591528],"domain_scores_gemma":[0.9959933,0.0012095207,0.0009471721,0.00066862896,0.00014138549,0.0010399724],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032126266,0.00047008967,0.0020601053,0.0006904896,0.00012840037,0.000017695904,0.00037933147,0.00037645022,0.00004642993],"category_scores_gemma":[0.0012008874,0.00038502074,0.00016832956,0.0011001955,0.00026998122,0.00023134194,0.00010545968,0.0006642862,0.000019131441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.002299955,0.0006810236,0.98645157,0.0022650505,0.0004357661,0.0000044116487,0.0015922744,0.00073464046,0.00010544186,0.00085244054,0.0006633403,0.0039140913],"study_design_scores_gemma":[0.015543515,0.001825601,0.9749315,0.0027107638,0.000055110595,0.000009843279,0.000068609515,0.0038231343,0.00024999309,0.00015259777,0.0002873573,0.00034200234],"about_ca_topic_score_codex":0.13546874,"about_ca_topic_score_gemma":0.00069007394,"teacher_disagreement_score":0.13477866,"about_ca_system_score_codex":0.008564753,"about_ca_system_score_gemma":0.0092809,"threshold_uncertainty_score":0.99986017},"labels":[],"label_agreement":null},{"id":"W2118267528","doi":"10.1111/j.1524-4733.2010.00767.x","title":"International Development of the Patient-Reported Outcome Indices for Multiple Sclerosis (PRIMUS)","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Dalhousie University","funders":"Multiple Sclerosis International Federation; Multiple Sclerosis Society","keywords":"Debriefing; Rasch model; Psychology; Construct validity; Scale (ratio); Quality of life (healthcare); Medicine; Clinical psychology; Psychometrics; Social psychology; Developmental psychology; Cartography; Geography","score_opus":0.21124798927657415,"score_gpt":0.3785889414697671,"score_spread":0.16734095219319298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118267528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941781,0.0000490363,0.00009059345,0.0033455857,0.00073913555,0.001386888,0.000024755338,0.00001930138,0.00016656828],"genre_scores_gemma":[0.981769,0.00004534402,0.017626965,0.00026754994,0.0000662045,0.00016356121,0.000012206396,0.0000145634185,0.000034568206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979864,0.000056579083,0.00086350157,0.00022482502,0.000565351,0.0003033494],"domain_scores_gemma":[0.99868333,0.00038285163,0.0003457188,0.00028705964,0.00019175552,0.000109269],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00087789906,0.00010771397,0.00028910665,0.00016940219,0.00013619343,0.00000846047,0.00019420403,0.00005882646,0.000034300414],"category_scores_gemma":[0.0027629032,0.000072495466,0.0000827239,0.00020194944,0.00009217722,0.000043572538,0.00015374932,0.00029227923,0.0000027269275],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009904177,0.0002592193,0.9432905,0.00026211055,0.000061325954,3.67591e-7,0.002452555,0.00004768416,0.012594327,0.000029827239,0.00018136829,0.0407217],"study_design_scores_gemma":[0.0019096175,0.000081243,0.97845477,0.00025053677,0.0000044827793,0.0000016909652,0.00036382466,0.0019677859,0.007658089,0.000013406892,0.009229582,0.000064955144],"about_ca_topic_score_codex":0.0012426082,"about_ca_topic_score_gemma":0.0006098318,"teacher_disagreement_score":0.040656745,"about_ca_system_score_codex":0.0001708267,"about_ca_system_score_gemma":0.00046935782,"threshold_uncertainty_score":0.33076528},"labels":[],"label_agreement":null},{"id":"W2118339612","doi":"10.1111/j.1524-4733.2007.00255.x","title":"Reliability of Two Instruments for Critical Assessment of Economic Evaluations","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Reliability (semiconductor); Intraclass correlation; Generalizability theory; Cronbach's alpha; Quality (philosophy); Inter-rater reliability; Variance (accounting); Statistics; Psychology; Scale (ratio); Rating scale; Mathematics; Psychometrics; Economics; Accounting; Geography","score_opus":0.4349332589155737,"score_gpt":0.5530560586814062,"score_spread":0.11812279976583245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118339612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92949295,0.0005324246,0.049822584,0.013822872,0.0011901178,0.0021391972,0.0007682553,0.000021083431,0.0022105016],"genre_scores_gemma":[0.9365428,0.000052921714,0.06209567,0.0010273221,0.00011993825,0.00008670872,0.000026975029,0.000020981672,0.000026690208],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9909812,0.0004660563,0.0074278815,0.0004995378,0.00011738226,0.0005079364],"domain_scores_gemma":[0.9927536,0.0040693507,0.002324839,0.00055218925,0.00010909827,0.00019091682],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.061335232,0.00014210731,0.0011120971,0.0004787694,0.00009399807,0.000010973942,0.0002305278,0.00010395323,0.00015147853],"category_scores_gemma":[0.005262034,0.00019174757,0.00014118383,0.00016823818,0.00012886905,0.00027137046,0.00003876455,0.00014839269,0.00004176686],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019626483,0.0002805237,0.26585922,0.0014893663,0.000016449607,5.6410432e-8,0.0006780443,0.010832732,0.0000058682785,0.7199103,0.000499824,0.00040796786],"study_design_scores_gemma":[0.003083578,0.00059534836,0.46259198,0.00036547004,0.00000801054,0.000001928868,0.0007665263,0.20868343,0.0000581636,0.32082075,0.002698845,0.00032595763],"about_ca_topic_score_codex":0.008833193,"about_ca_topic_score_gemma":0.00037315427,"teacher_disagreement_score":0.39908957,"about_ca_system_score_codex":0.0019495238,"about_ca_system_score_gemma":0.0010722309,"threshold_uncertainty_score":0.9977671},"labels":[],"label_agreement":null},{"id":"W2118440667","doi":"10.1016/j.jval.2013.06.021","title":"Cost-Utility of Metal-on-Metal Hip Resurfacing Compared to Conventional Total Hip Replacement in Young Active Patients with Osteoarthritis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"Osteoarthritis; Hip resurfacing; Medicine; Total hip replacement; Surgery; Physical therapy; Arthroplasty; Alternative medicine","score_opus":0.03932006322385087,"score_gpt":0.2950556041248372,"score_spread":0.2557355409009864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118440667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99563366,0.000051186496,0.000022855285,0.00051693537,0.00029578805,0.002593332,0.00018829186,0.000017223985,0.000680733],"genre_scores_gemma":[0.9989011,0.000007962566,0.0005241169,0.00023219718,0.00003181792,0.00008730222,0.00011796803,0.000016249181,0.00008128076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976396,0.00024727214,0.000717878,0.00038427868,0.0005745422,0.00043643452],"domain_scores_gemma":[0.9989969,0.00014612832,0.00021573264,0.00026293102,0.0001268863,0.00025137953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005974292,0.00017874304,0.00054106466,0.00021614751,0.000063216816,0.000008914454,0.00004915447,0.000052389656,0.00039493944],"category_scores_gemma":[0.00014323668,0.00014855286,0.000057431287,0.00026900152,0.00007662778,0.00011830817,0.000043114662,0.0002698156,0.000035941925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003029446,0.0011129949,0.96702105,0.00025660705,0.000047329188,0.000015973023,0.0015921167,0.00055646634,0.00007318627,0.000074915886,0.00029458792,0.025925303],"study_design_scores_gemma":[0.007956969,0.0024777572,0.98659724,0.0009011482,0.000009460846,0.000021421625,0.00063401426,0.0008486124,0.00022444228,0.000020810683,0.00017661146,0.0001314862],"about_ca_topic_score_codex":0.005824239,"about_ca_topic_score_gemma":0.0003415722,"teacher_disagreement_score":0.025793817,"about_ca_system_score_codex":0.00021293914,"about_ca_system_score_gemma":0.00025589817,"threshold_uncertainty_score":0.88045454},"labels":[],"label_agreement":null},{"id":"W2119091090","doi":"10.1016/j.jval.2015.09.1287","title":"Appraising the Value of Lenvatinib for Radio-Iodine Refractory Differentiated Thyroid Cancer (Rr-Dtc): A Multi-Country Study Applying Holistic Multicriteria Decision Analysis (Mcda)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Corporate Identity and Reputation","field":"Business, Management and Accounting","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Lenvatinib; Multiple-criteria decision analysis; Weighting; Medicine; Actuarial science; Context (archaeology); Public economics; Thyroid cancer; Business; Economics; Cancer; Geography; Operations research; Internal medicine; Engineering","score_opus":0.14538296077883522,"score_gpt":0.36211909871805126,"score_spread":0.21673613793921603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119091090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97109765,0.00095233065,0.024736982,0.00020699052,0.0009359425,0.001965493,0.000026243657,0.000058735022,0.000019617915],"genre_scores_gemma":[0.99754614,0.000055583674,0.0013520963,0.00021741769,0.00046163492,0.0001991284,0.00010557301,0.00003401022,0.000028429293],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974488,0.00015397118,0.0010047238,0.00044549908,0.0005419441,0.0004050839],"domain_scores_gemma":[0.99781024,0.00042823647,0.0009859717,0.00037541144,0.0003630286,0.00003711522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027656935,0.00023698303,0.0005989757,0.0006334122,0.00038208,0.0002443383,0.00029865163,0.00008562196,0.000012269659],"category_scores_gemma":[0.000825523,0.00018341644,0.00012864948,0.0019474342,0.0000610546,0.00055974995,0.0001365738,0.00021251304,0.0000052649716],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010677323,0.0024367715,0.39654708,0.0017604203,0.0006405446,0.000009655641,0.0042146263,0.57449,0.0008426222,0.0014489837,0.0011378804,0.015403647],"study_design_scores_gemma":[0.004609828,0.000091373506,0.24191158,0.00032905507,0.00052098726,6.6075006e-7,0.0030209292,0.7469969,0.000008312685,0.0011928929,0.0010295501,0.00028797638],"about_ca_topic_score_codex":0.049950726,"about_ca_topic_score_gemma":0.0049012904,"teacher_disagreement_score":0.17250682,"about_ca_system_score_codex":0.00021321546,"about_ca_system_score_gemma":0.00017805799,"threshold_uncertainty_score":0.9563757},"labels":[],"label_agreement":null},{"id":"W2119189721","doi":"10.1016/j.jval.2013.03.392","title":"The use of antimicrobial impregnated external ventricular drain catheter to prevent cerebrospinal fluid infection in canadian hospitals: An economic analysis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cerebrospinal fluid and hydrocephalus","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Catheter; Activity-based costing; Emergency medicine; External ventricular drain; Randomized controlled trial; Incidence (geometry); Clinical trial; Infection control; Intensive care medicine; Surgery; Cerebrospinal fluid; Internal medicine","score_opus":0.028350654933270977,"score_gpt":0.27572064163684445,"score_spread":0.24736998670357346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119189721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978547,0.00007614867,0.000052382475,0.0007935975,0.00026892204,0.00088825345,0.00003889655,0.00001586101,0.000011201001],"genre_scores_gemma":[0.9989793,0.00020904704,0.000092168215,0.0005653953,0.000048585487,0.00004493811,0.0000056218937,0.000018348233,0.00003664107],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99747795,0.00046570515,0.00069306046,0.00047721073,0.00016586845,0.00072020467],"domain_scores_gemma":[0.9988948,0.000100603975,0.00016584175,0.00039190202,0.00003113821,0.00041570637],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005855437,0.00017624749,0.00032954387,0.00071068,0.0001806393,0.00014234555,0.0002808519,0.00007554134,0.0000629998],"category_scores_gemma":[0.00015685514,0.00015227885,0.00012865223,0.0008889391,0.00005855636,0.00037284585,0.000054468015,0.00019320543,0.000053144267],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087289336,0.00068574573,0.46598622,0.00011778832,0.000047234724,0.000040904153,0.0018390975,0.48546842,0.038630363,0.0011874844,0.0003746674,0.0055347914],"study_design_scores_gemma":[0.00057816727,0.0009811927,0.75753784,0.00020856717,0.000030028124,0.000030204517,0.000018438053,0.22169773,0.017251873,0.00023107849,0.0010451257,0.00038972427],"about_ca_topic_score_codex":0.9282916,"about_ca_topic_score_gemma":0.4040782,"teacher_disagreement_score":0.52421343,"about_ca_system_score_codex":0.0010608656,"about_ca_system_score_gemma":0.00051564164,"threshold_uncertainty_score":0.62097514},"labels":[],"label_agreement":null},{"id":"W2119679249","doi":"10.1016/j.jval.2013.08.2291","title":"Budget Impact Analysis—Principles of Good Practice: Report of the ISPOR 2012 Budget Impact Analysis Good Practice II Task Force","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1169,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Reimbursement; Health care; Psychological intervention; Pharmacoeconomics; Health economics; Population; Medicine; Intervention (counseling); Listing (finance); Outcomes research; Executive summary; Task force; Health policy; Business; Accounting; Political science; Economic growth; Alternative medicine; Nursing; Public administration; Economics; Environmental health; Finance; Intensive care medicine","score_opus":0.18108804844949064,"score_gpt":0.4433726510131616,"score_spread":0.2622846025636709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119679249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9053429,0.0068925573,0.0031424281,0.072143234,0.00052727846,0.002916661,0.0013785766,0.00005040129,0.007605993],"genre_scores_gemma":[0.9894924,0.00057151093,0.005329251,0.0029096706,0.00017612049,0.00011059958,0.00014242412,0.000051342664,0.0012166561],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98480916,0.0024813302,0.010309919,0.0009856747,0.00045806868,0.0009558749],"domain_scores_gemma":[0.97229433,0.0050852494,0.019185482,0.002413213,0.00054021284,0.00048152727],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04996507,0.0004276658,0.0030720222,0.0018002988,0.00031019258,0.00008360343,0.00075545424,0.00029548406,0.0008094031],"category_scores_gemma":[0.022586986,0.0003938259,0.0012387543,0.004176065,0.00014229982,0.002073606,0.00021765332,0.00055805186,0.00016498732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008142967,0.0011004255,0.7470447,0.00067866343,0.0062155346,0.000005343086,0.0052381423,0.21045764,0.00001045319,0.022445392,0.0066279257,0.0000943796],"study_design_scores_gemma":[0.0011808396,0.0006330058,0.87474024,0.00014964289,0.0010454281,0.00007553241,0.0032300632,0.09050331,0.000015674617,0.0024690155,0.025322247,0.0006349663],"about_ca_topic_score_codex":0.19528055,"about_ca_topic_score_gemma":0.0014920187,"teacher_disagreement_score":0.19378854,"about_ca_system_score_codex":0.0018903156,"about_ca_system_score_gemma":0.0018188138,"threshold_uncertainty_score":0.99985135},"labels":[],"label_agreement":null},{"id":"W2119888109","doi":"10.1016/j.jval.2013.08.162","title":"Cost Associated with Adverse Events and Health Care Resources Utilization in Hepatitis C Virus Infection in Quebec, Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Université de Montréal","funders":"","keywords":"Medicine; Telaprevir; Boceprevir; Ribavirin; Rash; Adverse effect; Pegylated interferon; Hepatitis C virus; Hepatitis C; Internal medicine; Emergency medicine; Sofosbuvir; Health care; Medical record; Pediatrics; Virus; Immunology","score_opus":0.06804439381656101,"score_gpt":0.3442519245583697,"score_spread":0.2762075307418087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119888109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942507,0.000631019,0.000010503515,0.0028462647,0.000061024813,0.0020104747,0.000027783575,0.00002191257,0.00014029165],"genre_scores_gemma":[0.9949856,0.0035224382,0.000046744153,0.0010252881,0.000020134636,0.00013650564,0.00012653478,0.00002549835,0.00011130489],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749064,0.0006573996,0.00053140277,0.0002989455,0.00048811862,0.0005334676],"domain_scores_gemma":[0.99917996,0.00011105055,0.00015428371,0.00016500709,0.00010827966,0.00028140194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067253655,0.00013742204,0.00038242637,0.00042322557,0.000074709715,0.000009579275,0.00004395965,0.00009121683,0.000046019355],"category_scores_gemma":[0.00033957025,0.00013340604,0.0000116206775,0.00084248657,0.000033243472,0.00015500482,0.000027263084,0.00039618972,0.0000045535894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003185483,0.00008006794,0.98256934,0.00030675385,0.000005412934,0.00002595935,0.0032770277,0.0008913244,0.0000017221014,0.00000491805,0.00047362476,0.012332012],"study_design_scores_gemma":[0.0018184456,0.00028353903,0.98912275,0.0013192213,0.0000013750355,0.0000017996646,0.00038066233,0.005686205,0.00000802722,0.00000770558,0.0012750316,0.000095261676],"about_ca_topic_score_codex":0.9998107,"about_ca_topic_score_gemma":0.99992067,"teacher_disagreement_score":0.012236751,"about_ca_system_score_codex":0.0062521882,"about_ca_system_score_gemma":0.003657392,"threshold_uncertainty_score":0.99756265},"labels":[],"label_agreement":null},{"id":"W2119953457","doi":"10.1016/j.jval.2013.08.394","title":"Cost-Effectiveness of School-Based Health Promotion in Canada: A Life-Course Modeling Approach","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Obesity, Physical Activity, Diet","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University; University of Alberta","funders":"","keywords":"Overweight; Medicine; Obesity; Cost effectiveness; Population; Health promotion; Cost–benefit analysis; Investment (military); Childhood obesity; Return on investment; Promotion (chess); Gerontology; Environmental health; Demography; Public health; Economics; Nursing; Political science; Production (economics)","score_opus":0.10974496607161327,"score_gpt":0.3390924758598985,"score_spread":0.22934750978828522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2119953457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99143064,0.00031914903,0.0011797043,0.0028445583,0.00009967403,0.0040018004,0.0000134278025,0.000027778135,0.000083271305],"genre_scores_gemma":[0.9980021,0.000023333008,0.0010450663,0.00049496564,0.00006405616,0.00029288625,0.00004269385,0.00003133391,0.0000035504402],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99690944,0.0009775191,0.00063413824,0.00040447767,0.0004883926,0.0005860132],"domain_scores_gemma":[0.9985177,0.00022702581,0.00021898466,0.0003535051,0.00012249956,0.000560304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016103351,0.00019012511,0.0008148211,0.0001881545,0.000045044533,0.000007309881,0.00010705371,0.00007081618,0.000011773348],"category_scores_gemma":[0.0002327635,0.00018167774,0.00005441519,0.00047735672,0.000031118336,0.00013359927,0.000033067972,0.0005472609,0.0000064825745],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012374666,0.011920817,0.6245509,0.0091057345,0.000022077249,0.000004981466,0.0001832473,0.35161123,0.00006940086,0.0003680388,0.00006601064,0.0019738672],"study_design_scores_gemma":[0.0014248502,0.0004122345,0.4631006,0.0010498358,0.0000048474994,0.000001607961,0.0001018688,0.5333938,0.000061081766,0.0003629277,0.0000014555492,0.000084868094],"about_ca_topic_score_codex":0.97766906,"about_ca_topic_score_gemma":0.2615713,"teacher_disagreement_score":0.7160978,"about_ca_system_score_codex":0.0030389733,"about_ca_system_score_gemma":0.013664586,"threshold_uncertainty_score":0.991927},"labels":[],"label_agreement":null},{"id":"W2120645476","doi":"10.1016/j.jval.2014.03.523","title":"The Cost-Effectiveness of 2nd Line Crizotinib in EML4-Alk Rearranged Advanced NSCLC in Ontario","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Ontario Institute for Cancer Research; University of Toronto; St. Michael's Hospital","funders":"","keywords":"Crizotinib; Docetaxel; Medicine; Pemetrexed; Lung cancer; Oncology; Internal medicine; Chemotherapy; Cisplatin","score_opus":0.047150660884849434,"score_gpt":0.37851540281673596,"score_spread":0.33136474193188653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2120645476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99170786,0.00076395745,0.00008169723,0.0016199226,0.00023501285,0.0019447356,0.0000055310084,0.0000124434255,0.0036288318],"genre_scores_gemma":[0.99886477,0.00014585644,0.00036483005,0.00016663127,0.000023532559,0.00018775245,0.000024384299,0.000013947018,0.00020829009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857813,0.00039736528,0.0004121664,0.00019689376,0.00015072385,0.00026469366],"domain_scores_gemma":[0.99889725,0.0006340279,0.00010539972,0.0002447666,0.00004407809,0.000074481104],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012949097,0.00009872857,0.00034353393,0.00012966983,0.00004377745,0.0000044389303,0.000059179718,0.00004807299,0.0000112998905],"category_scores_gemma":[0.00023216572,0.00007070173,0.00003350067,0.00027439796,0.000038544018,0.00004088414,0.000013213311,0.0002510466,0.0000023467273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028113073,0.0012830081,0.832865,0.001037986,0.00005568166,0.000031153526,0.010021757,0.015166667,0.00065771106,0.0033197075,0.000057777776,0.13269226],"study_design_scores_gemma":[0.008698074,0.00090087776,0.97703564,0.0017732402,0.000013558783,0.0000046277914,0.00027544846,0.0010524897,0.0002667907,0.00077185954,0.0091286125,0.00007876377],"about_ca_topic_score_codex":0.2589223,"about_ca_topic_score_gemma":0.2988329,"teacher_disagreement_score":0.14417067,"about_ca_system_score_codex":0.0010405685,"about_ca_system_score_gemma":0.0008034752,"threshold_uncertainty_score":0.74601257},"labels":[],"label_agreement":null},{"id":"W2121226306","doi":"10.1016/j.jval.2011.02.603","title":"PIH18 THE IMPACT OF LONG-TERM DISABILITY COSTS ARISING FROM IN-VITRO FERTILIZATION (IVF) TREATMENT: THE COST-EFFECTIVENESS ANALYSIS OF REDUCING MULTIPLE BIRTHS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Demography; Fertility; Cost effectiveness; Cost–benefit analysis; Medicine; Live birth; Birth rate; Range (aeronautics); Statistics; Population; Mathematics; Pregnancy; Environmental health; Biology","score_opus":0.4693579293730064,"score_gpt":0.4575737909097473,"score_spread":0.011784138463259097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121226306","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937079,0.001520508,0.0013514434,0.00062789913,0.0001589068,0.0019516879,0.0005931795,0.000011592339,0.00007687825],"genre_scores_gemma":[0.9991877,0.00023899,0.00018320812,0.00010770796,0.000038717877,0.00013019341,0.00009135236,0.000019914276,0.0000022252123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99316674,0.0023110732,0.003570078,0.00049299933,0.00008954694,0.0003695353],"domain_scores_gemma":[0.991794,0.004761308,0.002442796,0.00085475045,0.000051614832,0.00009553876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014500715,0.00019300502,0.0013425718,0.00041133093,0.00013354847,0.000021132408,0.00027147878,0.00010295096,0.000077396406],"category_scores_gemma":[0.0021837074,0.00015123107,0.00028664267,0.0010747049,0.00016158824,0.00022123112,0.000038257996,0.00015115655,0.000011118014],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015161886,0.00040445375,0.9431058,0.00015291519,0.00024133509,2.3025392e-7,0.008912046,0.044952776,0.000016846932,0.0003467386,0.0000027588471,0.0017124579],"study_design_scores_gemma":[0.0007242474,0.00011152726,0.8660875,0.00013708313,0.000025148413,2.843711e-7,0.0004488828,0.13147566,0.00013258136,0.00075682666,0.0000021107467,0.00009813369],"about_ca_topic_score_codex":0.47991437,"about_ca_topic_score_gemma":0.006145506,"teacher_disagreement_score":0.47376886,"about_ca_system_score_codex":0.0034718225,"about_ca_system_score_gemma":0.00029523345,"threshold_uncertainty_score":0.9078695},"labels":[],"label_agreement":null},{"id":"W2121248749","doi":"10.1016/j.jval.2013.08.1188","title":"Physician Experience with Rituximab to Treat Pemphigus Vulgaris in Canada: A Questionnaire-Based Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Azathioprine; Rituximab; Pemphigus vulgaris; Adverse effect; Reimbursement; Dermatology; Family medicine; Internal medicine; Disease; Lymphoma","score_opus":0.017333070931804875,"score_gpt":0.27149783733932115,"score_spread":0.2541647664075163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121248749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922181,0.0005582143,0.000042503125,0.0043975147,0.00006371191,0.0025635194,0.000004480695,0.000050985458,0.000100964084],"genre_scores_gemma":[0.995004,0.0000047385624,0.00028725382,0.0039083404,0.0000342947,0.0006704613,0.0000054479187,0.000032934826,0.000052545452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784905,0.00022195154,0.00047319412,0.00042090536,0.00049885927,0.0005360645],"domain_scores_gemma":[0.9989078,0.00007741087,0.000102213235,0.00051509996,0.0000755218,0.00032197565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018817701,0.00020978063,0.00051874976,0.00020974953,0.00007084497,0.00001652832,0.00014898159,0.000027799535,0.00004665635],"category_scores_gemma":[0.00012935864,0.00017690682,0.000023490997,0.00062860723,0.000031966305,0.00007104837,0.000029032788,0.00018794069,0.000034731675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027129613,0.0022693702,0.98200744,0.0002143062,0.000006817699,0.00023829067,0.0054025315,0.004024935,0.0000192452,0.000015640719,0.00046089484,0.0050692405],"study_design_scores_gemma":[0.004143075,0.0011976542,0.9861337,0.0009366532,0.000009430904,0.0000060055227,0.00468386,0.0025632724,0.00005855858,0.00001552401,0.00007193834,0.00018033008],"about_ca_topic_score_codex":0.99444556,"about_ca_topic_score_gemma":0.8070656,"teacher_disagreement_score":0.18737997,"about_ca_system_score_codex":0.0026839857,"about_ca_system_score_gemma":0.00601436,"threshold_uncertainty_score":0.9996206},"labels":[],"label_agreement":null},{"id":"W2121619367","doi":"10.1016/j.jval.2010.11.013","title":"Conjoint Analysis Applications in Health—a Checklist: A Report of the ISPOR Good Research Practices for Conjoint Analysis Task Force","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":2033,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Conjoint analysis; Checklist; Task (project management); Preference; Preference elicitation; Pharmacoeconomics; Health care; Outcomes research; Research design; Management science; Computer science; Psychology; Applied psychology; Medical education; Medicine; Engineering; Political science; Statistics; Alternative medicine; Mathematics","score_opus":0.355792075055,"score_gpt":0.36722108065583964,"score_spread":0.011429005600839648,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121619367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9656301,0.0029145747,0.01571451,0.006146597,0.00012712584,0.0033628915,0.00043497182,0.000016776,0.0056524375],"genre_scores_gemma":[0.9953163,0.0005446801,0.0025860008,0.00020841685,0.00002402708,0.00042392165,0.0001013896,0.000015912912,0.00077934406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99654496,0.00021345993,0.0021201426,0.0006035649,0.00009109757,0.00042678043],"domain_scores_gemma":[0.99585444,0.0003223162,0.0028986344,0.0007798287,0.000037653335,0.00010715055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010956845,0.00012667278,0.0007849789,0.0010259395,0.00017264616,0.000018568582,0.00029170196,0.00009163425,0.00013844021],"category_scores_gemma":[0.00043630067,0.00012592462,0.00029499547,0.002159534,0.000117912685,0.00016460304,0.00008003815,0.0002474808,0.000019091434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019297337,0.00029703716,0.9214508,0.00017550896,0.00030488614,5.270435e-7,0.0025452604,0.011474029,0.0000027707931,0.06349276,0.000059977414,0.00017713568],"study_design_scores_gemma":[0.0004858143,0.00013294384,0.9267434,0.000026168638,0.000065998065,0.0000018533389,0.0013522091,0.0496846,0.000038695332,0.015783662,0.0055362466,0.00014842216],"about_ca_topic_score_codex":0.085870594,"about_ca_topic_score_gemma":0.005360855,"teacher_disagreement_score":0.08050974,"about_ca_system_score_codex":0.00083981775,"about_ca_system_score_gemma":0.00020782933,"threshold_uncertainty_score":0.9202167},"labels":[],"label_agreement":null},{"id":"W2121627749","doi":"10.1016/j.jval.2013.01.013","title":"Health-Related Quality of Life of Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes—Results from the PLATO Trial","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ticagrelor; Clopidogrel; Medicine; Acute coronary syndrome; Myocardial infarction; Quality of life (healthcare); Stroke (engine); Internal medicine; Population; Emergency medicine","score_opus":0.053571034764102334,"score_gpt":0.3010175903735779,"score_spread":0.24744655560947557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121627749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923973,0.0027090998,0.00000694416,0.0020479066,0.00027679044,0.002269828,0.00023991529,0.000018894985,0.000033308366],"genre_scores_gemma":[0.99850523,0.00064786815,0.00015807737,0.00037251078,0.000035257173,0.000026204947,0.00022547344,0.00002085131,0.000008542758],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964549,0.0008695156,0.0014608196,0.00030207552,0.0005823602,0.0003303107],"domain_scores_gemma":[0.99781615,0.0007360525,0.00058635033,0.0005486004,0.00008701215,0.0002258424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011840079,0.0001691647,0.0010558809,0.00008971133,0.0000438505,0.000004081423,0.00014203509,0.000111605645,0.00004804387],"category_scores_gemma":[0.00030099452,0.00011164844,0.00018040494,0.00037058824,0.00014046075,0.000071924056,0.000032097472,0.00028068246,0.000012031057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.44846022,0.0026556992,0.5211498,0.00053277623,0.0021513975,0.000027729902,0.0033510665,0.00089565123,0.0000032975922,0.00028278842,0.0007866956,0.019702865],"study_design_scores_gemma":[0.1405937,0.002867248,0.8554451,0.000474127,0.000042387554,0.0000018377397,0.00022824368,0.00013960151,0.000002744878,0.000066839,0.00004532709,0.000092831964],"about_ca_topic_score_codex":0.036638487,"about_ca_topic_score_gemma":0.00011626138,"teacher_disagreement_score":0.3342953,"about_ca_system_score_codex":0.00013229845,"about_ca_system_score_gemma":0.00094956637,"threshold_uncertainty_score":0.96977663},"labels":[],"label_agreement":null},{"id":"W2121937091","doi":"10.1016/j.jval.2013.03.878","title":"Utilization trends of various formulations of testosterone: An analysis of the ramq database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); Université de Montréal","funders":"","keywords":"Testosterone (patch); Testosterone replacement; Medicine; Incidence (geometry); Reimbursement; Androgen; Internal medicine; Database; Pediatrics; Hormone; Mathematics; Health care; Computer science","score_opus":0.10194910071594279,"score_gpt":0.361114729947429,"score_spread":0.2591656292314862,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2121937091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99772924,0.0005020531,0.00017844672,0.0010102398,0.00002949274,0.000210029,0.00004172021,0.0000039298397,0.00029482887],"genre_scores_gemma":[0.9991134,0.000096047006,0.0006139412,0.000033873515,0.000015068421,0.000005966548,0.000043926728,0.0000037627806,0.00007403544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991541,0.00008729714,0.00038692332,0.00011945347,0.00016728028,0.00008492761],"domain_scores_gemma":[0.99924386,0.000054436103,0.00019482353,0.00032368783,0.0001499694,0.000033198077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028634266,0.000049575065,0.0003105322,0.00027395194,0.00003331008,7.1119644e-7,0.00004701913,0.000019277608,0.000031652762],"category_scores_gemma":[0.00013530989,0.000029609653,0.000057066845,0.0011385122,0.00008182163,0.00005441595,0.000028440068,0.000051054398,3.075945e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005553761,0.00090615166,0.94811267,0.0005189809,0.00036892173,2.655787e-7,0.0071353097,0.008809062,0.0057934267,0.003541173,0.00007098464,0.02468753],"study_design_scores_gemma":[0.00024320305,0.00023027703,0.9799554,0.000064609885,0.00014989502,5.883668e-7,0.00042736396,0.01793117,0.0007988313,0.00014798275,0.00002737603,0.000023317902],"about_ca_topic_score_codex":0.013629394,"about_ca_topic_score_gemma":0.00033337853,"teacher_disagreement_score":0.031842727,"about_ca_system_score_codex":0.000030426454,"about_ca_system_score_gemma":0.000081602375,"threshold_uncertainty_score":0.99293894},"labels":[],"label_agreement":null},{"id":"W2122091982","doi":"10.1111/j.1524-4733.2006.00098.x","title":"What Decision-Makers Want and What They Have Been Getting","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital","funders":"","keywords":"Business; Data science; Computer science","score_opus":0.2529515640936211,"score_gpt":0.4057684587264326,"score_spread":0.1528168946328115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122091982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85031027,0.044022836,0.0008499058,0.1010109,0.0018792556,0.0011353702,0.000050654166,0.00006040983,0.00068041554],"genre_scores_gemma":[0.9623922,0.011940137,0.007856777,0.016785799,0.00060364977,0.000075980955,0.000031893687,0.00006423223,0.00024931415],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9935257,0.00048902794,0.0044316296,0.0007302029,0.00013233382,0.00069113285],"domain_scores_gemma":[0.9949681,0.0025673008,0.0016984919,0.0004926819,0.000035690104,0.00023771248],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.021492068,0.00022200927,0.000987659,0.0004804775,0.0002720143,0.00069344236,0.00021446342,0.00016029648,0.00006287834],"category_scores_gemma":[0.0014466409,0.00027520664,0.00008200841,0.00012759079,0.000060103885,0.0023235301,0.00007410869,0.0002634964,0.0003822182],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008950999,0.00048410232,0.42437714,0.0024809248,0.000080299076,0.000021427331,0.031285807,0.041894928,0.0000030101169,0.4254223,0.022133939,0.051726595],"study_design_scores_gemma":[0.0029111959,0.00026357517,0.13434644,0.0036705795,0.0000053372773,0.000040493618,0.030905288,0.0811883,0.00000406184,0.6520305,0.09353336,0.0011008219],"about_ca_topic_score_codex":0.026843444,"about_ca_topic_score_gemma":0.0020239793,"teacher_disagreement_score":0.29003072,"about_ca_system_score_codex":0.00093332364,"about_ca_system_score_gemma":0.00025090622,"threshold_uncertainty_score":0.99997},"labels":[],"label_agreement":null},{"id":"W2122781333","doi":"10.1016/j.jval.2013.11.011","title":"Socioeconomic Status and Nonadherence to Antihypertensive Drugs: A Systematic Review and Meta-Analysis","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":84,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal University Hospital; University of Manitoba; University of Alberta; University of Saskatchewan","funders":"","keywords":"Medicine; Meta-analysis; Socioeconomic status; Confidence interval; Medical prescription; Study heterogeneity; MEDLINE; Random effects model; Systematic review; Demography; Internal medicine; Environmental health; Population; Pharmacology","score_opus":0.18533711431793576,"score_gpt":0.42073455815054744,"score_spread":0.23539744383261169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122781333","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006034936,0.99165004,0.000039292132,0.0027959342,0.000026371737,0.005324143,0.000036963993,0.000017635964,0.000103590035],"genre_scores_gemma":[0.000023789924,0.9829663,0.00047346737,0.0143547775,0.000020476053,0.0009176026,0.000036647456,0.000024052453,0.0011828754],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996226,0.0008165495,0.0016880851,0.0006689947,0.00022699035,0.0003733918],"domain_scores_gemma":[0.9971518,0.0005194282,0.0009494069,0.0007385889,0.000095905736,0.00054485607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017540149,0.00037368905,0.010934185,0.00035624826,0.00005244925,0.000021815189,0.00014324699,0.00012450524,0.0003007847],"category_scores_gemma":[0.00037764094,0.00024982396,0.0005804153,0.0005316834,0.000057850793,0.000032153624,0.000057053672,0.0003350295,0.00072642585],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.224349e-7,0.00001541197,0.00000907982,0.9854169,0.010258024,0.0000026833086,0.000088039254,4.7088386e-7,2.1962279e-9,0.000089400826,0.0008244553,0.0032946956],"study_design_scores_gemma":[0.00020656241,0.00018375559,0.000020819287,0.24394496,0.60863894,0.00007696615,0.000103366496,0.000092617614,7.887779e-9,0.000044223583,0.14630823,0.000379572],"about_ca_topic_score_codex":0.0008125631,"about_ca_topic_score_gemma":0.000007868238,"teacher_disagreement_score":0.74147195,"about_ca_system_score_codex":0.00017959275,"about_ca_system_score_gemma":0.00078475184,"threshold_uncertainty_score":0.9999954},"labels":[],"label_agreement":null},{"id":"W2123243801","doi":"10.1016/j.jval.2013.08.1620","title":"Modeling a Switch from Trivalent to Quadrivalent Influenza Vaccine in Canada and the United Kingdom","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph; GlaxoSmithKline (Canada)","funders":"","keywords":"Influenza vaccine; Transmission (telecommunications); Population; Demography; Trivalent influenza vaccine; Seasonal influenza; Virology; Live attenuated influenza vaccine; Medicine; Geography; Vaccination; Environmental health; Internal medicine; Disease; Coronavirus disease 2019 (COVID-19); Computer science","score_opus":0.1579258293550882,"score_gpt":0.3764033495677578,"score_spread":0.21847752021266958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123243801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97615486,0.0020527318,0.000070549766,0.019378679,0.000087678214,0.002195744,0.000013381557,0.000018540868,0.000027817321],"genre_scores_gemma":[0.9848601,0.0005968566,0.00051179284,0.013679917,0.000078573,0.00023136749,0.0000054416273,0.00002401548,0.000011901452],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99711764,0.00041365472,0.00082739803,0.00035845515,0.0005907294,0.000692145],"domain_scores_gemma":[0.9983745,0.00063234835,0.00007645067,0.00042678558,0.00014314208,0.00034672665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011665155,0.00020031366,0.0006069127,0.0003982448,0.000109693676,0.000023976156,0.00016551805,0.00004625917,0.00004502058],"category_scores_gemma":[0.0010090376,0.00013404754,0.000031637886,0.00076570484,0.00002970045,0.00006129058,0.00018854426,0.00054059783,0.000017527696],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023147657,0.00016357335,0.63778764,0.00065225275,0.00012205405,0.00006309536,0.009964999,0.34110597,0.00013700835,0.00085635995,0.0017307688,0.0051015196],"study_design_scores_gemma":[0.012270746,0.00018738743,0.2801524,0.0011352235,0.000013429618,0.000005194511,0.001588968,0.70079124,0.000028528835,0.00071758224,0.0028901582,0.00021913038],"about_ca_topic_score_codex":0.99936265,"about_ca_topic_score_gemma":0.89978313,"teacher_disagreement_score":0.35968527,"about_ca_system_score_codex":0.0017178686,"about_ca_system_score_gemma":0.0017141636,"threshold_uncertainty_score":0.54663},"labels":[],"label_agreement":null},{"id":"W2123341140","doi":"10.1016/j.jval.2014.03.1114","title":"Predicting heart failure recurrence after aortic valve replacement using a competing-risks model","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Heart failure; Medicine; Atrial fibrillation; Proportional hazards model; Cardiology; Internal medicine; Hazard ratio; Multivariate statistics; valvular heart disease; Aortic valve replacement; Coronary artery disease; Population; Cohort; Multivariate analysis; Statistics; Confidence interval; Mathematics; Stenosis","score_opus":0.05513091515091708,"score_gpt":0.3821759210014847,"score_spread":0.3270450058505676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123341140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962266,0.00094106887,0.00088988326,0.0008143212,0.00018038758,0.0007486921,0.000025335694,0.000059105936,0.000114591785],"genre_scores_gemma":[0.9914777,0.00004515716,0.0072617442,0.00095245603,0.0001396016,0.00005875885,0.0000221862,0.000030311885,0.000012032283],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979869,0.00021685146,0.0005102,0.0004350873,0.00036202642,0.000488941],"domain_scores_gemma":[0.9989493,0.00009971925,0.00014598444,0.00041785528,0.000060057773,0.00032710074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007297644,0.00018841156,0.00044336708,0.00012165732,0.00010174966,0.000020221822,0.000044940713,0.00006202542,0.000018259438],"category_scores_gemma":[0.00018391875,0.0001756968,0.0004124938,0.00019267903,0.00003145976,0.000058130776,0.000053232816,0.00022692267,0.000015974794],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017891981,0.00020465416,0.97594047,0.00040009493,0.000069178306,0.0000016729858,0.00039512102,0.022110678,0.0000109336825,0.000042209966,0.00007579715,0.00057030295],"study_design_scores_gemma":[0.0015944826,0.00033374518,0.36685306,0.0015540322,0.00013949224,0.000015920963,0.00014408474,0.6289127,0.000010797849,0.00016308414,0.0001391114,0.00013948005],"about_ca_topic_score_codex":0.0029948845,"about_ca_topic_score_gemma":0.000016630916,"teacher_disagreement_score":0.60908735,"about_ca_system_score_codex":0.0004172007,"about_ca_system_score_gemma":0.0003479776,"threshold_uncertainty_score":0.7164708},"labels":[],"label_agreement":null},{"id":"W2123471793","doi":"10.1016/j.jval.2013.03.1098","title":"Treatment Patterns Of Adalimumab And Infliximab In The Treatment Of Crohn's Disease Over A Three-Year Period: A Canadian Assessment","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Adalimumab; Infliximab; Medicine; Cohort; Internal medicine; Retrospective cohort study; Confidence interval; Disease","score_opus":0.014502820346654864,"score_gpt":0.2739747627152827,"score_spread":0.25947194236862786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2123471793","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977855,0.0004857749,0.000004302976,0.00046102607,0.00002697742,0.0010027426,0.00017089395,0.0000017138249,0.0000610677],"genre_scores_gemma":[0.99899334,0.0004934873,0.00007070303,0.00012231112,0.000029031436,0.0002107111,0.000049873153,0.0000118683965,0.000018699357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895203,0.00016929861,0.00029408972,0.00021340934,0.000112233916,0.00025892621],"domain_scores_gemma":[0.99930567,0.000014901083,0.000093609335,0.00035301544,0.000024944191,0.00020786085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000105116094,0.00013854832,0.00017822895,0.00008555552,0.000033802255,0.000011933684,0.00008426738,0.000048328235,0.00003071398],"category_scores_gemma":[0.000009787383,0.00009995015,0.00005806556,0.000050132192,0.000043819568,0.000004753654,0.000013639773,0.000030165118,0.0000010955125],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001462914,0.0005300068,0.9950074,0.00013033305,0.000028967064,0.000113453396,0.0011434034,0.000377356,0.00010448186,0.0003325773,0.000018518102,0.002067244],"study_design_scores_gemma":[0.0018026299,0.000642758,0.9954441,0.000038341183,0.0000101585665,0.000001724311,0.00027131048,0.0010129206,0.000034123634,0.000068083675,0.00059197156,0.00008187671],"about_ca_topic_score_codex":0.28145108,"about_ca_topic_score_gemma":0.13388737,"teacher_disagreement_score":0.14756371,"about_ca_system_score_codex":0.0002458774,"about_ca_system_score_gemma":0.0010302174,"threshold_uncertainty_score":0.88191694},"labels":[],"label_agreement":null},{"id":"W2124193153","doi":"10.1016/j.jval.2011.08.1655","title":"PIN1 The Epidemiologic Burden Of Hepatitis C Virus Infection In Latin America","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Latin Americans; Medicine; Population; Hepatitis C virus; Hepatitis C; Asymptomatic; Disease burden; Public health; Environmental health; Demography; Immunology; Virus; Internal medicine; Pathology","score_opus":0.1905698921064476,"score_gpt":0.388271085789511,"score_spread":0.19770119368306338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124193153","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927425,0.00047858685,0.00014176386,0.002027847,0.000086775646,0.0007344942,0.000010884036,0.000023782291,0.003753381],"genre_scores_gemma":[0.9869178,0.01102557,0.0011674988,0.0006854957,0.0000668321,0.000060427752,0.0000066957255,0.000014448516,0.000055212196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973618,0.0011258732,0.0006754846,0.00020788351,0.00024036647,0.00038861108],"domain_scores_gemma":[0.99883723,0.000494832,0.00017940442,0.00032875472,0.00005130162,0.00010846671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020895256,0.00009720583,0.00042094113,0.00026554454,0.00003868679,0.0000021905873,0.000099773686,0.00008395224,0.0003038573],"category_scores_gemma":[0.001895297,0.0000695608,0.00005076037,0.00067162456,0.00013999832,0.000031946438,0.000050126324,0.00045777226,0.00007089045],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056005247,0.000102535545,0.9588077,0.00016579276,0.0000066896564,0.000016881255,0.0025353099,0.00065529393,0.0000963131,0.00031240648,0.000279159,0.036965907],"study_design_scores_gemma":[0.00045674742,0.0007844229,0.9782239,0.0002843235,0.0000026308562,0.000004252909,0.000049422433,0.016150478,0.00016929793,0.0010742339,0.002738971,0.00006127886],"about_ca_topic_score_codex":0.8443999,"about_ca_topic_score_gemma":0.016536867,"teacher_disagreement_score":0.82786304,"about_ca_system_score_codex":0.00028700376,"about_ca_system_score_gemma":0.00033729273,"threshold_uncertainty_score":0.9227961},"labels":[],"label_agreement":null},{"id":"W2124307672","doi":"10.1016/j.jval.2014.03.661","title":"Validation Of The Apixaban Cost-Effectiveness Model In Patients With Non-Valvular Atrial Fibrillation","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Apixaban; Medicine; Atrial fibrillation; Warfarin; Internal medicine; Hazard ratio; Discontinuation; Aspirin; Vitamin K antagonist; Cardiology; Stroke (engine); Proportional hazards model; Confidence interval; Rivaroxaban","score_opus":0.2519116091192355,"score_gpt":0.3885560578023482,"score_spread":0.1366444486831127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124307672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864428,0.00012364714,0.008204605,0.002289381,0.00034077052,0.002328566,0.00008344266,0.000010478439,0.00017627467],"genre_scores_gemma":[0.99842346,0.00001759009,0.0008902681,0.00044928878,0.00011861149,0.0000326233,0.00003488625,0.00002298357,0.0000102888725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954896,0.0011517477,0.0025426128,0.00037763108,0.00013782986,0.00030059143],"domain_scores_gemma":[0.99676836,0.0008242528,0.0018398967,0.00043467688,0.00005843635,0.000074376236],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017455136,0.0001344887,0.0007172589,0.00030274337,0.00008809172,0.000018183775,0.00017131331,0.00010414072,0.000009042125],"category_scores_gemma":[0.0015715144,0.00013373826,0.00008248741,0.00036290346,0.00003879712,0.0002756117,0.00003181288,0.00014653546,0.000034124492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039434457,0.00002212922,0.5443467,0.00027493792,0.0000051237944,7.737273e-9,0.000532946,0.44688994,2.5064412e-7,0.0077068037,0.00002987253,0.00015184162],"study_design_scores_gemma":[0.0022232335,0.00012418366,0.59391814,0.00027183027,0.0000015905821,1.1417489e-7,0.00002880819,0.39647895,0.00000833505,0.006586917,0.00023731166,0.00012056744],"about_ca_topic_score_codex":0.005150325,"about_ca_topic_score_gemma":0.000097128686,"teacher_disagreement_score":0.050410975,"about_ca_system_score_codex":0.0009186273,"about_ca_system_score_gemma":0.00029016525,"threshold_uncertainty_score":0.7785786},"labels":[],"label_agreement":null},{"id":"W2124367552","doi":"10.1016/j.jval.2014.03.1042","title":"The Disease Burden Associated With Infant Hospitalization For A Lower Respiratory Tract Infection (Lrti) In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Absenteeism; Pediatrics; Lower respiratory tract infection; Respiratory tract infections; Presenteeism; Socioeconomic status; Emergency medicine; Intensive care medicine; Respiratory system; Population; Environmental health; Internal medicine","score_opus":0.03956911137277135,"score_gpt":0.3345925613996971,"score_spread":0.29502345002692576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124367552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957967,0.00021752405,0.0002888007,0.0017242536,0.00017541666,0.0016400248,0.000009043791,0.000028180482,0.00012009208],"genre_scores_gemma":[0.9986426,0.00003761783,0.000011485165,0.00082661276,0.00010880071,0.00027657114,0.000015119498,0.000028792363,0.000052369633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979055,0.0005166897,0.00047279522,0.00025148952,0.0004126231,0.0004409091],"domain_scores_gemma":[0.9986269,0.0005180857,0.00015808965,0.00030187308,0.00015899724,0.00023606041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018917872,0.00012466975,0.00023219005,0.00020265144,0.00018961464,0.000029626417,0.00006461767,0.000054166645,0.000007316685],"category_scores_gemma":[0.0027406982,0.00008894942,0.000034188717,0.0006777879,0.000047864418,0.00010565404,0.000014353337,0.00029135516,0.0000021639235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034979932,0.00015751936,0.97479546,0.00017405521,0.000012255244,0.000009774568,0.000088862835,0.020390762,0.00002912799,0.0003883834,0.00044572708,0.003158244],"study_design_scores_gemma":[0.0018243336,0.0011559802,0.9565707,0.00032809703,0.0000081155085,9.965742e-7,0.000033616598,0.029623304,0.000018564599,0.00016387073,0.010166593,0.00010582274],"about_ca_topic_score_codex":0.7616363,"about_ca_topic_score_gemma":0.75771713,"teacher_disagreement_score":0.018224783,"about_ca_system_score_codex":0.002714074,"about_ca_system_score_gemma":0.004860139,"threshold_uncertainty_score":0.8621678},"labels":[],"label_agreement":null},{"id":"W2124545744","doi":"10.1016/j.jval.2015.02.017","title":"Effectiveness and Content Analysis of Interventions to Enhance Oral Antidiabetic Drug Adherence in Adults with Type 2 Diabetes: Systematic Review and Meta-Analysis","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"The Quebec Population Health Research Network","funders":"Université Laval; Pfizer Canada; Sanofi; Merck Canada; AstraZeneca Canada; AstraZeneca; Pfizer","keywords":"Meta-analysis; Drug; Medicine; Psychological intervention; Diabetes mellitus; Type 2 diabetes; Intensive care medicine; Pharmacology; Internal medicine; Endocrinology; Nursing","score_opus":0.2656848519104055,"score_gpt":0.4594744193420192,"score_spread":0.19378956743161374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2124545744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002339467,0.991795,0.00007088324,0.00014917957,0.000016320195,0.0055653616,0.000047716778,0.000008735486,0.000007321881],"genre_scores_gemma":[0.009448818,0.98864883,0.00026248262,0.0002184468,0.000002502812,0.0011957156,0.000069039874,0.000015465233,0.00013868691],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99502707,0.0019385391,0.0018299199,0.00058888766,0.00036293347,0.00025263533],"domain_scores_gemma":[0.99714184,0.0004927172,0.0011105312,0.000669176,0.00030361788,0.0002821492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041219746,0.00031944708,0.01051079,0.0010566878,0.000018680725,0.000009832617,0.00016862928,0.00007327835,0.000072504045],"category_scores_gemma":[0.0006311857,0.00020139158,0.0006380524,0.0054704607,0.00006970225,0.000044119744,0.00005019636,0.00026249647,0.000014499701],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000094450015,0.00010348125,0.000733128,0.9723161,0.024048,0.000002828101,0.00011024115,0.000010704809,2.7910072e-8,0.000008961903,0.00001501503,0.0026420956],"study_design_scores_gemma":[0.00017732801,0.00039645538,0.0008152241,0.5235574,0.47461832,0.000002185515,0.00006186488,0.00011000025,2.748068e-7,0.000002987119,0.00010299458,0.00015497251],"about_ca_topic_score_codex":0.0011259994,"about_ca_topic_score_gemma":0.00026356868,"teacher_disagreement_score":0.45057032,"about_ca_system_score_codex":0.00015954507,"about_ca_system_score_gemma":0.0004076913,"threshold_uncertainty_score":0.82125103},"labels":[],"label_agreement":null},{"id":"W2125093326","doi":"10.1111/j.1524-4733.2008.00368.x","title":"Applying the Expectancy-Value Model to Understand Health Values","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Cultural Differences and Values","field":"Psychology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Expectancy theory; Likert scale; Explanatory power; Statistics; Psychology; Univariate; Marital status; Bivariate analysis; Regression analysis; Variables; Life expectancy; Descriptive statistics; Multilevel model; Linear regression; Demography; Social psychology; Medicine; Mathematics; Environmental health; Multivariate statistics; Population","score_opus":0.3214172782029153,"score_gpt":0.42031896520742157,"score_spread":0.09890168700450624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125093326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94583213,0.009607914,0.005445552,0.027760074,0.0012616771,0.0039556893,0.000041651005,0.00022753536,0.005867786],"genre_scores_gemma":[0.98551637,0.0008615552,0.0017963332,0.009252987,0.00024367493,0.00039701417,0.000008682329,0.000040651074,0.0018827106],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9966099,0.00067582994,0.0007403572,0.00059716566,0.00041961408,0.00095708226],"domain_scores_gemma":[0.9985823,0.00022383442,0.00020916286,0.00060171285,0.00003573825,0.0003472406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000984962,0.00027681226,0.0005008346,0.00015329983,0.00070260663,0.00003352673,0.00042190345,0.0000993076,0.000113212125],"category_scores_gemma":[0.000050554223,0.00019052863,0.000111672365,0.0005304844,0.00011033406,0.00008309779,0.000079685655,0.0004044624,0.0001468777],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030534485,0.0006660711,0.013813823,0.00031679127,0.00009785977,0.00004356095,0.37726238,0.106144525,0.000057885547,0.38133758,0.09936544,0.020588743],"study_design_scores_gemma":[0.007947673,0.0052267313,0.21688859,0.002299161,0.000039876104,0.0006738429,0.21915601,0.3334918,0.000062937135,0.17679629,0.03403947,0.0033776057],"about_ca_topic_score_codex":0.017283803,"about_ca_topic_score_gemma":0.00031523782,"teacher_disagreement_score":0.2273473,"about_ca_system_score_codex":0.0004729747,"about_ca_system_score_gemma":0.0003937554,"threshold_uncertainty_score":0.9892602},"labels":[],"label_agreement":null},{"id":"W2125447577","doi":"10.1016/j.jval.2015.09.1322","title":"Assessment of Burden and Economic Impact of the Vandetanib Restricted Distribution Program in Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; AstraZeneca (Canada)","funders":"","keywords":"Vandetanib; Medicine; Health care; Guideline; Family medicine; Internal medicine; Political science","score_opus":0.04757995002017015,"score_gpt":0.30314649689723383,"score_spread":0.2555665468770637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125447577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961511,0.0011705875,0.000027963855,0.00045093556,0.0002175554,0.0004121643,0.00044021718,0.000003085414,0.0011263877],"genre_scores_gemma":[0.9994295,0.00036638667,0.000108823544,0.000018542756,0.000034343724,0.0000131791,0.000010879755,0.000007383729,0.000010942185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986895,0.00003693509,0.000830974,0.00017641835,0.000027878452,0.00023832665],"domain_scores_gemma":[0.9990507,0.000047832968,0.0005823172,0.00020255907,0.000017376662,0.00009921045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005795007,0.00008952806,0.00043115258,0.000081054626,0.000016866123,0.00000888437,0.00013326538,0.000046108424,0.000010693043],"category_scores_gemma":[0.00009659222,0.000082905666,0.00004463306,0.00017194964,0.000040968065,0.00010401297,0.00003821115,0.00012527336,7.8240373e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014521771,0.000020912921,0.9474794,0.00003872426,0.000008998553,3.669523e-7,0.00012183162,0.03371444,5.9165023e-7,0.01617016,0.00022374875,0.0022062494],"study_design_scores_gemma":[0.00069736934,0.00017061035,0.9578949,0.00004372644,8.4889405e-7,8.35856e-7,0.00006728657,0.03553331,0.0000028740483,0.004368628,0.0011448635,0.00007473753],"about_ca_topic_score_codex":0.98477477,"about_ca_topic_score_gemma":0.55648947,"teacher_disagreement_score":0.42828527,"about_ca_system_score_codex":0.0048272884,"about_ca_system_score_gemma":0.004057195,"threshold_uncertainty_score":0.998993},"labels":[],"label_agreement":null},{"id":"W2125510303","doi":"10.1016/j.jval.2014.03.257","title":"Epidemiology And Biologic Treatment Patterns Of Systemic Juvenile Idiopathic Arthritis In Ontario","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Cohort; Rheumatology; Etanercept; Arthritis; Epidemiology; Internal medicine; Pediatrics; Macrophage activation syndrome; Juvenile; Physical therapy; Rheumatoid arthritis","score_opus":0.07554338867944468,"score_gpt":0.3305031508176961,"score_spread":0.25495976213825144,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125510303","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98319185,0.015011611,0.000051172363,0.0010390762,0.000052704334,0.00052382174,0.0000027214148,0.000011138186,0.000115912386],"genre_scores_gemma":[0.9937371,0.005773139,0.00006956134,0.00021385188,0.000016344558,0.000048203416,0.000010318169,0.000008027038,0.000123479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975615,0.0008181952,0.0009528104,0.00023309783,0.00007403014,0.00036035004],"domain_scores_gemma":[0.99923545,0.00024275277,0.00018783961,0.00022673732,0.000018384444,0.00008884272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002716386,0.00010614785,0.0009699855,0.00019808701,0.000025866104,0.0000010560826,0.000046676207,0.0001132688,0.000028970311],"category_scores_gemma":[0.00032774723,0.0000833136,0.00004233434,0.00008319754,0.000049724913,0.000023074808,0.000025696818,0.00023880028,0.000008295271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056447465,0.000102730446,0.9789344,0.00046819082,0.0000059580693,0.000013607262,0.0012909954,0.00014020847,0.000087189444,0.00063458935,0.0000051733455,0.018260492],"study_design_scores_gemma":[0.0028865815,0.0027911826,0.98817927,0.0025846146,0.000002787733,0.00009714528,0.00037490512,0.0014961223,0.00004369961,0.00059231534,0.0008728038,0.00007859857],"about_ca_topic_score_codex":0.42710084,"about_ca_topic_score_gemma":0.07360459,"teacher_disagreement_score":0.35349625,"about_ca_system_score_codex":0.00053044077,"about_ca_system_score_gemma":0.00064525905,"threshold_uncertainty_score":0.9432997},"labels":[],"label_agreement":null},{"id":"W2125776201","doi":"10.1016/j.jval.2011.04.002","title":"Interpreting Indirect Treatment Comparisons and Network Meta-Analysis for Health-Care Decision Making: Report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: Part 1","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":1042,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Randomized controlled trial; Meta-analysis; Psychological intervention; Health care; Terminology; Systematic review; Pairwise comparison; Management science; Medicine; Internal validity; MEDLINE; Psychology; Computer science; Nursing; Artificial intelligence; Economics; Political science","score_opus":0.8990592469292574,"score_gpt":0.6101353465479792,"score_spread":0.28892390038127824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2125776201","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6254683,0.18429056,0.07498889,0.03157799,0.003062801,0.057172384,0.0016933604,0.00012143469,0.021624256],"genre_scores_gemma":[0.9648914,0.00036360484,0.032660834,0.00035480736,0.00006898604,0.00070748996,0.0000289569,0.000030168174,0.0008937854],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9441473,0.034622256,0.013417017,0.0021742776,0.0045728474,0.001066316],"domain_scores_gemma":[0.9453246,0.029857943,0.018687585,0.00488985,0.0008767447,0.00036324805],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.14299057,0.0005610173,0.00941936,0.0011571334,0.00088611816,0.00031240605,0.0012730728,0.00015084751,0.00043614165],"category_scores_gemma":[0.019009503,0.000248537,0.003976311,0.0045745936,0.00014847932,0.00015597198,0.00021977928,0.00036324406,0.000031485044],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008116177,0.0022577676,0.75792557,0.00055782637,0.061473344,0.000036808942,0.04922661,0.03129957,0.0000010830945,0.0024266222,0.060615838,0.03336736],"study_design_scores_gemma":[0.0027872517,0.010854979,0.13380301,0.0015962528,0.06779231,0.0001322543,0.030635973,0.1052523,0.000105838815,0.00515166,0.6405532,0.0013349645],"about_ca_topic_score_codex":0.003759038,"about_ca_topic_score_gemma":0.0072690314,"teacher_disagreement_score":0.62412256,"about_ca_system_score_codex":0.00085632975,"about_ca_system_score_gemma":0.0009441523,"threshold_uncertainty_score":0.99999666},"labels":[],"label_agreement":null},{"id":"W2126156851","doi":"10.1016/j.jval.2013.08.503","title":"Cost-Effectiveness of EML4-ALK Fusion Testing and First-Line Crizotinib Treatment for Patients with Advanced ALK Positive Non-Small Cell Lung Cancer in a Publicly Funded System (Ontario, Canada)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Ontario Institute for Cancer Research; University of Toronto; Toronto Public Health; St. Michael's Hospital","funders":"","keywords":"Crizotinib; Medicine; Oncology; Population; Lung cancer; Internal medicine; Cost effectiveness; ALK inhibitor; Environmental health","score_opus":0.030345237848856524,"score_gpt":0.3114200689726865,"score_spread":0.28107483112382997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126156851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892714,0.00043895,0.00014348386,0.0002734611,0.000119805336,0.00927982,0.00018896862,0.00001347135,0.00027063277],"genre_scores_gemma":[0.9954661,0.000036421425,0.0019486264,0.00006128735,0.00001760683,0.0022885278,0.000097275864,0.000027095282,0.000057031164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986249,0.00008665361,0.00039438414,0.00035091885,0.00018163641,0.0003614601],"domain_scores_gemma":[0.99857646,0.0005546766,0.00023255205,0.00015518648,0.00029794578,0.00018318911],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016326366,0.0001989797,0.00049469725,0.00012704347,0.00010466114,0.000011661612,0.000036172656,0.000047830465,0.000006546002],"category_scores_gemma":[0.000039320916,0.00014845455,0.000024160734,0.00024415323,0.000018198978,0.00008891974,0.000015621921,0.00008503925,1.1886311e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058321527,0.00056734204,0.9791559,0.0026695991,0.00006539463,0.000007891727,0.0016557414,0.006093507,0.000031598618,0.000013194739,0.000010949407,0.009145657],"study_design_scores_gemma":[0.015852636,0.0032507624,0.96488965,0.004497353,0.00009864839,0.000003164496,0.00047918336,0.010483086,0.00025564042,0.000005851386,0.000044850807,0.00013917526],"about_ca_topic_score_codex":0.9873343,"about_ca_topic_score_gemma":0.93775636,"teacher_disagreement_score":0.049577985,"about_ca_system_score_codex":0.0057364726,"about_ca_system_score_gemma":0.0024497455,"threshold_uncertainty_score":0.9980803},"labels":[],"label_agreement":null},{"id":"W2126806511","doi":"10.1016/j.jval.2011.02.099","title":"PHP27 CANADIAN PUBLIC DRUG PROGRAM SPENDING ON SENIORS, 2002 TO 2008","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Medical prescription; Drug; Population; Drug class; Medicine; Public health; Gerontology; Business; Demography; Environmental health; Pharmacology; Sociology; Nursing","score_opus":0.19514812031918582,"score_gpt":0.3033648646397582,"score_spread":0.10821674432057238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126806511","genre_codex":"other","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26144192,0.002899521,0.00024588784,0.22050953,0.0034333512,0.0063171093,0.0005554892,0.00036575933,0.50423145],"genre_scores_gemma":[0.9870256,0.00031333446,0.0026370669,0.0076659587,0.00015515357,0.0001248492,0.000008436585,0.000032003878,0.0020375554],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99770695,0.00006946134,0.00069774024,0.00044514745,0.00004843762,0.0010322623],"domain_scores_gemma":[0.99859214,0.000028108585,0.00016615633,0.000329134,0.00001105217,0.00087339233],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0016385305,0.00014928218,0.00032212312,0.0011156587,0.00017071435,0.000048910882,0.00026387456,0.00006671932,0.0006173777],"category_scores_gemma":[0.00013259577,0.00018380448,0.000049344017,0.00061658496,0.000017322402,0.000121786055,0.000042219155,0.00022806352,0.0025906116],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007848833,0.00020074689,0.029342761,0.00015517803,0.00001259364,0.00001978264,0.0036387257,0.000093561044,3.2822943e-8,0.9031474,0.024873547,0.038507804],"study_design_scores_gemma":[0.00022271734,0.0002141036,0.03566429,0.00006153686,4.5073753e-7,0.0000017442587,0.00013828083,0.00087932294,0.0000021660578,0.00539117,0.9572011,0.00022306743],"about_ca_topic_score_codex":0.9184183,"about_ca_topic_score_gemma":0.4057211,"teacher_disagreement_score":0.9323276,"about_ca_system_score_codex":0.0009901107,"about_ca_system_score_gemma":0.0002356444,"threshold_uncertainty_score":0.998186},"labels":[],"label_agreement":null},{"id":"W2127095817","doi":"10.1111/j.1524-4733.2007.00196.x","title":"Measuring Patient Preferences for Colorectal Cancer Screening Using a Choice-Format Survey","year":2007,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":154,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Colonoscopy; Medicine; Modalities; Test (biology); Preference; Colorectal cancer; Patient satisfaction; Fecal occult blood; Family medicine; Statistics; Surgery; Cancer; Internal medicine; Mathematics","score_opus":0.21552187787478527,"score_gpt":0.3700994276911555,"score_spread":0.15457754981637023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127095817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838802,0.0015012324,0.012921764,0.000078273086,0.0004850121,0.0009317037,0.00002379147,0.000070691596,0.000107282205],"genre_scores_gemma":[0.9946225,0.000058647158,0.0048560644,0.00016143912,0.00020528224,0.000052452586,0.00001322725,0.000021877062,0.000008481951],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998281,0.00011919554,0.0005082307,0.0002696971,0.00030875407,0.0005131124],"domain_scores_gemma":[0.9989586,0.00040857142,0.00019930434,0.000104088176,0.00013645069,0.00019301283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020553882,0.00013881364,0.00031991897,0.0002443952,0.00017150478,0.0000178733,0.0000515066,0.00008643775,0.00000821524],"category_scores_gemma":[0.00037097934,0.00012982084,0.00006339737,0.0004490085,0.000025730196,0.00009576484,0.000025443976,0.00023248531,5.7183695e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006626263,0.00008758037,0.8063771,0.000499909,0.00003766119,0.0000033539932,0.0016061957,0.015643237,0.00047806322,0.000006574447,0.000047735306,0.16858633],"study_design_scores_gemma":[0.0017053828,0.002954761,0.8986745,0.0011087134,0.000015585567,0.0000294957,0.00031847428,0.08978276,0.0045300475,0.000024662677,0.00065426587,0.00020135638],"about_ca_topic_score_codex":0.10936188,"about_ca_topic_score_gemma":0.019035948,"teacher_disagreement_score":0.16838498,"about_ca_system_score_codex":0.00067683565,"about_ca_system_score_gemma":0.00042468082,"threshold_uncertainty_score":0.9988641},"labels":[],"label_agreement":null},{"id":"W2127105530","doi":"10.1111/j.1524-4733.2006.00113.x","title":"Managing Meningococcal Disease in the United States: Hospital Case Characteristics and Costs by Age","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Bacterial Infections and Vaccines","field":"Immunology and Microbiology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Case fatality rate; Emergency medicine; Demographics; Pediatrics; Meningococcal disease; Diagnosis code; Health care; Disease; Demography; Population; Neisseria meningitidis; Environmental health; Internal medicine","score_opus":0.013928945559640518,"score_gpt":0.26037091664314643,"score_spread":0.2464419710835059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127105530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99636817,0.0007770781,0.000024190871,0.0021255256,0.00026573028,0.00028561702,0.00011332749,0.000020693544,0.000019653899],"genre_scores_gemma":[0.9986861,0.00036985666,0.000008974671,0.00024495428,0.00003155343,0.000022326272,0.00057963387,0.000007851491,0.000048759117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989846,0.00034605723,0.0002615594,0.00015010504,0.000009284313,0.00024841746],"domain_scores_gemma":[0.99963677,0.00014582787,0.00006923582,0.000116384115,0.000010094066,0.000021689108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003280436,0.00009518383,0.00014086095,0.000118630924,0.00013936646,0.000027056447,0.000052196545,0.000053301184,0.00001537503],"category_scores_gemma":[0.000023621049,0.00007361956,0.000014306507,0.00018558338,0.000050141436,0.000041511845,0.000024858948,0.0001912047,0.000006030467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064180075,0.0029145489,0.9188304,0.00057610427,0.00008018887,0.0024759083,0.010914297,0.00085741456,0.007671356,0.013496712,0.02349674,0.018044507],"study_design_scores_gemma":[0.0058548464,0.000978999,0.8222072,0.00055314146,0.000041555624,0.0009377014,0.0029531904,0.0033145512,0.00013136849,0.0018409197,0.16037941,0.00080709707],"about_ca_topic_score_codex":0.06805296,"about_ca_topic_score_gemma":0.00039807416,"teacher_disagreement_score":0.13688266,"about_ca_system_score_codex":0.000062933446,"about_ca_system_score_gemma":0.000024588688,"threshold_uncertainty_score":0.93815297},"labels":[],"label_agreement":null},{"id":"W2127840248","doi":"10.1016/j.jval.2015.12.020","title":"An Empirical Comparison of Discrete Choice Experiment and Best-Worst Scaling to Estimate Stakeholders’ Risk Tolerance for Hip Replacement Surgery","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":39,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Logit; Mixed logit; Hip replacement; Medicine; Preference; Population; Logistic regression; Physical therapy; Statistics; Arthroplasty; Surgery; Mathematics; Environmental health","score_opus":0.36313376151044174,"score_gpt":0.38080480377763987,"score_spread":0.017671042267198123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2127840248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97909904,0.0012172135,0.017663376,0.001106887,0.00018863931,0.00054662785,0.00013360567,0.000009952002,0.000034652756],"genre_scores_gemma":[0.99398,0.00026277328,0.0054245824,0.00014049189,0.00004652545,0.00008704043,0.000010675096,0.000019167845,0.00002873368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99818385,0.0000565752,0.0009912654,0.00043949275,0.00003795431,0.00029087727],"domain_scores_gemma":[0.99876237,0.00034197327,0.0004758436,0.00025927424,0.0000058765277,0.00015464317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001549649,0.00012187673,0.00048209025,0.00013393152,0.000086301494,0.000017271706,0.000078503865,0.00005014091,0.00003385819],"category_scores_gemma":[0.0001206064,0.00011909598,0.000048687492,0.0000655793,0.00003998566,0.00015919395,0.00002817188,0.000051409723,0.000018781202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005644282,0.00014718248,0.9790605,0.000064382475,0.00000688485,5.5993233e-8,0.0013858164,0.014047553,0.000032390963,0.00074081577,0.0001526199,0.004305401],"study_design_scores_gemma":[0.0016672707,0.0010027587,0.8633912,0.00034004982,0.0000058484493,6.9791867e-7,0.0006751302,0.1253019,0.0010860065,0.0025723649,0.0035536936,0.00040303066],"about_ca_topic_score_codex":0.0020278736,"about_ca_topic_score_gemma":0.0000624599,"teacher_disagreement_score":0.115669206,"about_ca_system_score_codex":0.00035795485,"about_ca_system_score_gemma":0.000025137797,"threshold_uncertainty_score":0.48565933},"labels":[],"label_agreement":null},{"id":"W2128145795","doi":"10.1016/j.jval.2013.08.1172","title":"A Quebec Economic Evaluation for 36 Months of Ranibizumab for the Treatment of Diabetic Macular Edema","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Ranibizumab; Medicine; Quality-adjusted life year; Quality of life (healthcare); Visual acuity; Cost effectiveness; Optometry; Ophthalmology; Surgery; Bevacizumab","score_opus":0.05163743765846752,"score_gpt":0.3501458834083518,"score_spread":0.2985084457498843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128145795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98545516,0.005545475,0.00010028309,0.0016590926,0.00008495521,0.0070498306,0.00006980035,0.0000044855196,0.00003094386],"genre_scores_gemma":[0.9969676,0.00059609587,0.00062746066,0.000050936887,0.000047487014,0.0015319758,0.00005276368,0.000013766262,0.000111870446],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9991282,0.00006422141,0.0003841221,0.00014579715,0.00010890782,0.00016875351],"domain_scores_gemma":[0.9991512,0.00030655097,0.0001771127,0.00022193104,0.00007380094,0.0000694335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024992292,0.00009070553,0.0003231547,0.000051135423,0.000033435943,0.0000038332614,0.000036070935,0.000030059286,0.00006214855],"category_scores_gemma":[0.000044492986,0.00005648133,0.00016379292,0.000034823424,0.000026598982,0.00002517829,0.0000031527923,0.000012723833,0.0000054199877],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006640145,0.0077268407,0.11598145,0.006557809,0.0017403598,0.0000030404851,0.0069853924,0.02551628,0.0005436806,0.005024086,0.0022409833,0.8210399],"study_design_scores_gemma":[0.021348208,0.008551985,0.52666306,0.00046909403,0.00075389625,0.0000025812456,0.0006010534,0.43505684,0.0012936095,0.00403033,0.0011078407,0.000121524965],"about_ca_topic_score_codex":0.061079565,"about_ca_topic_score_gemma":0.0005724298,"teacher_disagreement_score":0.8209184,"about_ca_system_score_codex":0.0005555031,"about_ca_system_score_gemma":0.00048466757,"threshold_uncertainty_score":0.9451728},"labels":[],"label_agreement":null},{"id":"W2128317172","doi":"10.1016/j.jval.2013.08.344","title":"Health and Social Care Resource Use by Individuals with Fragile X Syndrome: Results of Two Delphi Panels","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; University of Victoria; Queen's University; University of British Columbia; Novartis (Canada)","funders":"","keywords":"Confidence interval; Checklist; Delphi method; Demography; Medicine; Proxy (statistics); Psychology; Resource (disambiguation); Statistics; Mathematics; Computer science; Sociology","score_opus":0.09574644426963977,"score_gpt":0.3931382330911975,"score_spread":0.2973917888215577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128317172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9624883,0.0033471112,0.00003183107,0.029511493,0.00015609083,0.0032338048,0.0010007538,0.00009209178,0.0001385297],"genre_scores_gemma":[0.9909742,0.000674112,0.0010391386,0.0062476452,0.00022373046,0.00012033288,0.00041330364,0.000063196196,0.00024437634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99290884,0.0028776817,0.0017558613,0.00057661714,0.00058166013,0.0012993601],"domain_scores_gemma":[0.99645066,0.0011452909,0.0011169236,0.0003977177,0.0002161739,0.0006732478],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019076436,0.00029567565,0.0009102199,0.0002817703,0.00092416885,0.00001839798,0.00021774044,0.00030549473,0.00003845856],"category_scores_gemma":[0.00020939778,0.00025450427,0.00004366673,0.00056748994,0.00012282186,0.00023272652,0.00013339048,0.0012579276,0.00003682306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002105806,0.00014520413,0.7239101,0.0076037184,0.000020250634,0.000008117995,0.16333097,0.000073238756,0.0000018614386,0.00040588135,0.0966014,0.007688663],"study_design_scores_gemma":[0.020131841,0.0038086833,0.62663674,0.006338173,0.000030416533,0.00003150685,0.1455115,0.00045826586,0.00000449524,0.0006040856,0.19519861,0.0012456768],"about_ca_topic_score_codex":0.106537856,"about_ca_topic_score_gemma":0.00066169974,"teacher_disagreement_score":0.105876155,"about_ca_system_score_codex":0.00050244585,"about_ca_system_score_gemma":0.0025504495,"threshold_uncertainty_score":0.9999907},"labels":[],"label_agreement":null},{"id":"W2128605658","doi":"10.1016/j.jval.2015.09.2882","title":"Psychiatric Healthcare Utilization and Related Costs In Newly Diagnosed Individuals With Autism Spectrum Disorder (Asd) In Quebec (Canada)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Cohort; Medicine; Autism spectrum disorder; Psychiatry; Pediatrics; Cohort study; Diagnosis code; Health care; Autism; Population; Internal medicine; Environmental health","score_opus":0.04932327497405896,"score_gpt":0.314032585600703,"score_spread":0.26470931062664405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2128605658","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8740546,0.003017194,0.00002518995,0.120577514,0.0001984537,0.001670693,0.000023083328,0.000055407534,0.00037788085],"genre_scores_gemma":[0.99714655,0.0015185148,0.00011081489,0.00094869453,0.000011634344,0.0000779941,0.00001440687,0.000051172803,0.00012020195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99481297,0.0014662307,0.0008123892,0.0008487927,0.0009779688,0.0010816682],"domain_scores_gemma":[0.9985233,0.00039708722,0.00023948126,0.00039632688,0.000008318924,0.00043547314],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011646583,0.00026889305,0.00044784814,0.00093698915,0.00012476412,0.00006586711,0.00032180565,0.00015082225,0.000019525613],"category_scores_gemma":[0.00046584764,0.00026489983,0.000016123118,0.0035855302,0.00012287224,0.00031943235,0.00011183509,0.0008121183,0.00000809973],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094827396,0.00028460776,0.93919694,0.00015845908,0.0000017447143,0.00016063557,0.0031144447,0.0033630277,0.000002556525,0.04947687,0.00016538463,0.0039804936],"study_design_scores_gemma":[0.005404028,0.0004828915,0.96182835,0.0003115806,0.0000015848235,0.000029136061,0.0007124417,0.010400559,0.000023578754,0.019562375,0.000892199,0.00035125745],"about_ca_topic_score_codex":0.9697934,"about_ca_topic_score_gemma":0.99013704,"teacher_disagreement_score":0.12309198,"about_ca_system_score_codex":0.0019285199,"about_ca_system_score_gemma":0.005274681,"threshold_uncertainty_score":0.99998033},"labels":[],"label_agreement":null},{"id":"W2129109417","doi":"10.1016/j.jval.2012.08.1874","title":"PIH2 Duloxetine Use in Pregnancy: A Prospective, Comparative Study of Exposed Infants","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Maternal Mental Health During Pregnancy and Postpartum","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Duloxetine; Obstetrics; Medicine; Pregnancy; Alternative medicine; Biology","score_opus":0.1200776870789199,"score_gpt":0.37089626596797187,"score_spread":0.25081857888905196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129109417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931226,0.0028805991,0.0000016750793,0.000114144575,0.00031408184,0.0032474904,0.000011211127,0.000025732375,0.00028250564],"genre_scores_gemma":[0.9989754,0.00021004946,0.00029684659,0.0001283607,0.00004480966,0.00015804288,0.000004954357,0.000016617594,0.00016492233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976796,0.00041212008,0.0008373415,0.00023971376,0.0002897818,0.0005414238],"domain_scores_gemma":[0.99898076,0.00019206117,0.00025383098,0.0002881063,0.00003953671,0.00024568112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058855466,0.00016587686,0.00061603216,0.0002479756,0.000040792496,0.0000045967813,0.0000706978,0.000056321252,0.000028635814],"category_scores_gemma":[0.0000925868,0.00014616564,0.0000283157,0.00036287,0.00003386569,0.00019110438,0.00004581241,0.00031419194,0.0000114403365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009611938,0.0037784395,0.963492,0.0035485015,0.000011865037,0.000022186663,0.027770437,0.000044119417,0.000033437776,0.00019567378,0.000007642201,0.00013452629],"study_design_scores_gemma":[0.0050026015,0.002626876,0.9747915,0.015346638,0.0000063925654,0.00001690824,0.0010836325,0.00013670664,0.0008211549,0.000037301725,0.00002687466,0.00010336786],"about_ca_topic_score_codex":0.0078903455,"about_ca_topic_score_gemma":0.00049394387,"teacher_disagreement_score":0.026686804,"about_ca_system_score_codex":0.00025363473,"about_ca_system_score_gemma":0.00015293542,"threshold_uncertainty_score":0.9987162},"labels":[],"label_agreement":null},{"id":"W2129357788","doi":"10.1016/j.jval.2014.08.514","title":"Clinical Outcomes and Hospital Costs Associated with Empirical Treatment of Hospital-Acquired Pneumonia with Vancomycin or Linezolid in a Chinese Tertiary Care Hospital: A Retrospective Cohort Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"","keywords":"Medicine; Linezolid; Propensity score matching; Vancomycin; Retrospective cohort study; Odds ratio; Pneumonia; Internal medicine; Logistic regression; Hospital-acquired pneumonia; Intensive care medicine; Staphylococcus aureus","score_opus":0.017916440284492397,"score_gpt":0.3488390113081961,"score_spread":0.3309225710237037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129357788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99200886,0.00027600082,0.00001635523,0.001468748,0.00022879761,0.0058233077,0.00005677928,0.00007756193,0.000043575226],"genre_scores_gemma":[0.9984028,0.00023687242,0.0006883039,0.00021167651,0.000076796285,0.00021901335,0.00003434348,0.00008594639,0.000044253928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99585074,0.0005861455,0.0013359837,0.0009696132,0.0006030984,0.00065443816],"domain_scores_gemma":[0.9973111,0.00075600337,0.0006499053,0.0006462737,0.00029337563,0.00034330104],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000826102,0.0005325993,0.0022171459,0.00025761535,0.00008293687,0.000021339385,0.0001416476,0.00020696434,0.0000049667588],"category_scores_gemma":[0.0011181177,0.00032305392,0.0001303488,0.0007797045,0.00033953274,0.00010486663,0.000060197945,0.00033389096,0.0000015352541],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011039245,0.0074799093,0.9813781,0.0001351285,0.00028249156,0.00032133478,0.008439487,0.000026902362,0.0000027521794,0.0000031950458,0.00003023151,0.00079659105],"study_design_scores_gemma":[0.013059231,0.042013504,0.94131863,0.00097637286,0.00010400411,0.0000048172606,0.0019213614,0.00022323846,0.0000045965185,0.000009822134,0.000013275284,0.0003511606],"about_ca_topic_score_codex":0.005576586,"about_ca_topic_score_gemma":0.006335715,"teacher_disagreement_score":0.040059436,"about_ca_system_score_codex":0.001835085,"about_ca_system_score_gemma":0.00072076556,"threshold_uncertainty_score":0.99992216},"labels":[],"label_agreement":null},{"id":"W2129984566","doi":"10.1016/j.jval.2013.08.1875","title":"Economics of Dialysis Dependence Following Acute Kidney Injury (AKI) in the Intensive Care Unit (ICU)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Kidney Injury Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Renal replacement therapy; Dialysis; Medicine; Acute kidney injury; Intensive care unit; Intensive care medicine; Logistic regression; Emergency medicine; Internal medicine","score_opus":0.0585108468849773,"score_gpt":0.3631161792049629,"score_spread":0.3046053323199856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129984566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97727805,0.00029574716,0.000019911125,0.0198952,0.0001940688,0.0013818851,0.00013788749,0.000016941169,0.00078031735],"genre_scores_gemma":[0.9865649,0.0006435873,0.0006206118,0.011750868,0.000074811294,0.00013796685,0.00009555237,0.000028088272,0.000083632185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975164,0.00046670449,0.0007535339,0.00034338929,0.00035272533,0.0005672236],"domain_scores_gemma":[0.9981001,0.00032546077,0.00018532311,0.00067376957,0.00034707022,0.00036828028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011969282,0.00017715874,0.00060130743,0.00047432695,0.00006640707,0.000022907825,0.00041299264,0.00013061354,0.00008205177],"category_scores_gemma":[0.0017250732,0.00013432156,0.00014947614,0.0007485187,0.00009401453,0.0001779054,0.00013393817,0.000670101,0.00007106978],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005282901,0.0002589285,0.8911675,0.0012708077,0.00040730854,0.00020054387,0.05688727,0.00012767028,0.0015672131,0.00095301913,0.03170543,0.014926013],"study_design_scores_gemma":[0.021731647,0.009464717,0.6092555,0.0075405473,0.00081599696,0.00040046623,0.25146523,0.040441867,0.012564661,0.009073739,0.035019603,0.0022260344],"about_ca_topic_score_codex":0.019653335,"about_ca_topic_score_gemma":0.00008773096,"teacher_disagreement_score":0.281912,"about_ca_system_score_codex":0.0004441298,"about_ca_system_score_gemma":0.0017429983,"threshold_uncertainty_score":0.9868749},"labels":[],"label_agreement":null},{"id":"W2130332930","doi":"10.1016/s1098-3015(10)70314-4","title":"PIN16 COST-EFFECTIVENESS OF POSACONAZOLE VS. FLUCONAZOLE IN THE PROPHYLAXIS AGAINST INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH GRAFT-VERSUS-HOST DISEASE IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Posaconazole; Fluconazole; Medicine; Disease; Host (biology); Antifungal; Fungal disease; Internal medicine; Dermatology; Biology; Amphotericin B; Ecology","score_opus":0.030325303225254396,"score_gpt":0.27378790863176433,"score_spread":0.24346260540650994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2130332930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99552673,0.00026656382,8.8651177e-7,0.00056159217,0.00010708263,0.0032860767,0.00015238984,0.0000065181016,0.000092148315],"genre_scores_gemma":[0.998534,0.0004615623,0.000011088553,0.00034731187,0.000020483356,0.0004970742,0.00010921606,0.000017451823,0.0000017737275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971258,0.0009418623,0.00048096123,0.0003109792,0.0005757556,0.0005646283],"domain_scores_gemma":[0.9978383,0.0013092759,0.00010771377,0.0003200761,0.000117419695,0.00030718942],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071410363,0.00017622649,0.000441159,0.00043965405,0.000064559856,0.000006374071,0.00014175224,0.000050502225,0.0000142738945],"category_scores_gemma":[0.00083605933,0.00013198933,0.00003631999,0.0011972155,0.00009244036,0.00012365104,0.0000438075,0.00051416346,0.000002865204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037747822,0.001217723,0.9911458,0.00078522635,0.0000105435765,0.00027684539,0.00042934009,0.001890766,0.000017695958,0.000026558555,0.000045134955,0.00037958386],"study_design_scores_gemma":[0.0088111395,0.0014992177,0.98806703,0.0009977585,0.0000035594892,0.0000025784263,0.00017433321,0.00017003874,0.000097271935,0.000007709613,0.0000545438,0.00011483137],"about_ca_topic_score_codex":0.896784,"about_ca_topic_score_gemma":0.82263917,"teacher_disagreement_score":0.07414486,"about_ca_system_score_codex":0.0020128875,"about_ca_system_score_gemma":0.008567911,"threshold_uncertainty_score":0.9970526},"labels":[],"label_agreement":null},{"id":"W2131309958","doi":"10.1016/j.jval.2015.01.006","title":"Selecting a Dynamic Simulation Modeling Method for Health Care Delivery Research—Part 2: Report of the ISPOR Dynamic Simulation Modeling Emerging Good Practices Task Force","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Complex Systems and Decision Making","field":"Decision Sciences","cited_by":152,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Health Authority; University of Saskatchewan; University of Calgary; Alberta Health Services","funders":"Agency for Healthcare Research and Quality","keywords":"Modeling and simulation; System dynamics; Computer science; Stakeholder; Dynamic simulation; Management science; Health care; Simulation modeling; Task (project management); Checklist; Discrete event simulation; Process management; Operations research; Systems engineering; Risk analysis (engineering); Simulation; Medicine; Engineering; Artificial intelligence; Psychology","score_opus":0.6122622296140255,"score_gpt":0.6332515898710395,"score_spread":0.020989360257013923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131309958","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002856041,0.54742324,0.44742507,0.000171567,0.0008469119,0.0036857794,0.00007912515,0.00004197104,0.00004072046],"genre_scores_gemma":[0.43596083,0.44138354,0.11898075,0.00023047706,0.001106603,0.00066068076,0.00028122144,0.0005578809,0.0008380117],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9732213,0.009496808,0.008646183,0.0021854322,0.005111031,0.0013392679],"domain_scores_gemma":[0.95820177,0.022890916,0.011942308,0.0023265695,0.0042805076,0.00035793713],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.08500707,0.0006383562,0.0034426842,0.0022067633,0.001349203,0.0003909725,0.0015260465,0.00044159006,0.000006028813],"category_scores_gemma":[0.033313416,0.00046342032,0.000868997,0.0045459196,0.00004351131,0.0007211379,0.00062246696,0.0014470561,0.000006481522],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030247893,0.0000229552,0.000005072003,0.004005779,0.000019823017,0.0000027974288,0.0016960936,0.6847296,1.4565722e-7,0.00009877667,0.0000314082,0.30935732],"study_design_scores_gemma":[0.00029382706,0.0001312057,5.5652737e-7,0.014262242,0.000048362926,0.000050576175,0.0030156441,0.88839287,1.4504167e-8,0.00549077,0.087994345,0.00031960488],"about_ca_topic_score_codex":0.0069532366,"about_ca_topic_score_gemma":0.0018131691,"teacher_disagreement_score":0.43567523,"about_ca_system_score_codex":0.0034480968,"about_ca_system_score_gemma":0.008617276,"threshold_uncertainty_score":0.9999509},"labels":[],"label_agreement":null},{"id":"W2131719895","doi":"10.1111/j.1524-4733.2008.00361.x","title":"Validity, Feasibility and Acceptability of Time Trade-Off and Standard Gamble Assessments in Health Valuation Studies: A Study in a Multiethnic Asian Population in Singapore","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Interquartile range; Medicine; Visual analogue scale; Wilcoxon signed-rank test; Demography; Time-trade-off; Population; Quality of life (healthcare); Physical therapy; Mann–Whitney U test; Surgery; Internal medicine; Environmental health","score_opus":0.6314274364455043,"score_gpt":0.5205502382811612,"score_spread":0.11087719816434305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131719895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98288065,0.0053569656,0.00006505545,0.0072227023,0.00014619567,0.004163191,0.00011395928,0.000017427355,0.0000338667],"genre_scores_gemma":[0.99545854,0.001941997,0.0019036313,0.00049087673,0.00002775215,0.00012029601,0.000027478824,0.000022807792,0.0000066246957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9854648,0.004924412,0.007668116,0.0010552793,0.00026879812,0.00061856984],"domain_scores_gemma":[0.9957647,0.0012982067,0.0022561883,0.00046245838,0.00003984834,0.00017860561],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.06377946,0.0002457856,0.0019900198,0.0009452121,0.00013421517,0.000020602409,0.00013398986,0.0001450833,0.000024129457],"category_scores_gemma":[0.0037991875,0.00031969525,0.00004733609,0.00074706814,0.00010322761,0.000552527,0.000079204976,0.0003899636,0.000004261827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007519606,0.00074955693,0.966579,0.0013289931,0.000009018122,0.0000013607395,0.027292058,0.002435277,1.4071792e-7,0.00019066673,0.000031434745,0.0013072772],"study_design_scores_gemma":[0.0035671992,0.0007522019,0.9531909,0.0002916508,0.0000014720267,0.0000026564585,0.0066060405,0.027117215,1.8599363e-7,0.008254167,0.00002801859,0.00018828521],"about_ca_topic_score_codex":0.056903355,"about_ca_topic_score_gemma":0.031664375,"teacher_disagreement_score":0.059980273,"about_ca_system_score_codex":0.0047379145,"about_ca_system_score_gemma":0.0007641481,"threshold_uncertainty_score":0.9999255},"labels":[],"label_agreement":null},{"id":"W2131783795","doi":"10.1016/j.jval.2013.06.016","title":"ISPOR-SMDM Task Force’s Recommendations for Good Modeling Practices—Reply to Letter to the Editor by Corro Ramos","year":2013,"lang":"en","type":"letter","venue":"Value in Health","topic":"Scientific Computing and Data Management","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Task force; Task (project management); Computer science; Political science; Economics; Management; Public administration","score_opus":0.23778923009139066,"score_gpt":0.4265909927890908,"score_spread":0.18880176269770013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131783795","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011093788,0.000076346194,0.17651868,0.79251593,0.026702553,0.0031163427,0.0007269096,0.000059982372,0.00017232574],"genre_scores_gemma":[0.00020433537,0.000014201065,0.016173737,0.94009703,0.023464387,0.00061110395,0.000609905,0.000055389846,0.018769901],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9918304,0.0010458049,0.0020171688,0.0020514706,0.0019331656,0.0011219716],"domain_scores_gemma":[0.9887039,0.0060377293,0.0015032884,0.002993192,0.00046918573,0.00029272557],"candidate_categories":["metaresearch","metaepi_narrow","scholarly_communication","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.01875797,0.00039288666,0.000627351,0.0007693979,0.00072725693,0.0016796369,0.0031367186,0.0002472891,0.0001912986],"category_scores_gemma":[0.009453889,0.00027575128,0.00018102031,0.0014388188,0.000032578384,0.0004593549,0.00082387705,0.0012544083,0.0015764654],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010964967,0.000033749366,0.000009043274,0.000043839435,0.000009942808,0.0000017068434,0.0008213225,0.021217598,0.0000011933712,0.000036636175,0.9669383,0.010875702],"study_design_scores_gemma":[0.0001748004,0.00010705774,0.000001689186,0.00014053624,0.00000960588,0.0000015403135,0.00035827843,0.18951775,7.3698715e-7,0.0010341662,0.8084006,0.00025328854],"about_ca_topic_score_codex":0.010460439,"about_ca_topic_score_gemma":0.00014369625,"teacher_disagreement_score":0.16830015,"about_ca_system_score_codex":0.0003881386,"about_ca_system_score_gemma":0.00039391432,"threshold_uncertainty_score":0.9999695},"labels":[],"label_agreement":null},{"id":"W2131824242","doi":"10.1016/j.jval.2014.03.1137","title":"Lam employment absence and productivity scale (LEAPS): Further validation studies in major depressive disorder","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"LEAPS; Cronbach's alpha; Major depressive disorder; Scale (ratio); Psychology; Clinical psychology; Depression (economics); Medicine; Psychiatry; Psychometrics; Mood","score_opus":0.050941792659685174,"score_gpt":0.3495037221209459,"score_spread":0.2985619294612607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2131824242","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98747504,0.0040698745,0.000058779566,0.007104719,0.00015415574,0.0010126259,0.0000020743876,0.000041186446,0.00008153965],"genre_scores_gemma":[0.99778515,0.00061172625,0.0010053419,0.00013880664,0.00008388011,0.00010419295,0.0000068857344,0.000019521553,0.00024448882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843544,0.0003261743,0.00030825482,0.00041816072,0.00024738,0.00026459145],"domain_scores_gemma":[0.9992961,0.0001677764,0.00012119765,0.00028998312,0.00003798268,0.00008691208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070335687,0.00014431884,0.0003450544,0.0001422681,0.0000593215,0.0000077889445,0.00004200211,0.000051568953,0.0000070187807],"category_scores_gemma":[0.00027418387,0.00011331345,0.00002029034,0.00016683489,0.00007951717,0.00010416304,0.000060778573,0.00015292532,0.000008768419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012915018,0.00048193175,0.9666724,0.00047432192,0.000017138582,0.0000075081944,0.0042380444,0.0005111148,0.00035960905,0.000042532174,0.000106213614,0.026960008],"study_design_scores_gemma":[0.0038482535,0.000492478,0.9893197,0.0012115632,0.000018447945,0.000018681438,0.00054917793,0.0007789103,0.0020228974,0.0010971485,0.0005061374,0.00013662207],"about_ca_topic_score_codex":0.0022850768,"about_ca_topic_score_gemma":0.00048453547,"teacher_disagreement_score":0.026823387,"about_ca_system_score_codex":0.00019475094,"about_ca_system_score_gemma":0.000060779817,"threshold_uncertainty_score":0.46207884},"labels":[],"label_agreement":null},{"id":"W2132058335","doi":"10.1111/j.1524-4733.2009.00595.x","title":"Using the Incremental Net Benefit Framework for Quantitative Benefit–Risk Analysis in Regulatory Decision-Making—A Case Study of Alosetron in Irritable Bowel Syndrome","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of British Columbia","funders":"","keywords":"Medicine; Irritable bowel syndrome; Placebo; Relative risk; Confidence interval; Meta-analysis; Internal medicine; Decision analysis; Statistics; Alternative medicine","score_opus":0.3299377744357388,"score_gpt":0.46811849109529247,"score_spread":0.13818071665955367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132058335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98667246,0.0034042427,0.005604241,0.0013698047,0.00019646258,0.002385228,0.0003407097,0.000011410319,0.000015428219],"genre_scores_gemma":[0.9647791,0.00010616756,0.033966213,0.0009971748,0.00003489731,0.00007782068,0.000010609729,0.000025102663,0.0000029643863],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99197185,0.0007237602,0.0057614166,0.0007317513,0.00017805504,0.0006331403],"domain_scores_gemma":[0.9913994,0.0048229336,0.002909916,0.0006999369,0.00005410888,0.00011368206],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.028101174,0.00023907337,0.0016166343,0.0018285114,0.00024209452,0.000045630415,0.00032191715,0.00017814868,0.000032946184],"category_scores_gemma":[0.0026576365,0.0002725182,0.00015514881,0.0017338317,0.000041830324,0.00034456147,0.000051243598,0.0003990713,0.000007921316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007262719,0.00062181026,0.5292952,0.0001288668,0.000085972846,0.000022061622,0.010702538,0.4196193,1.2949889e-7,0.039150212,0.000022765355,0.00027851452],"study_design_scores_gemma":[0.0014191339,0.0008058056,0.5438002,0.0005177154,0.000026934747,0.000026028263,0.024149738,0.31147593,2.1912764e-7,0.117501244,0.000015618049,0.00026142327],"about_ca_topic_score_codex":0.10817052,"about_ca_topic_score_gemma":0.029930627,"teacher_disagreement_score":0.10814336,"about_ca_system_score_codex":0.002036897,"about_ca_system_score_gemma":0.0002125899,"threshold_uncertainty_score":0.9999727},"labels":[],"label_agreement":null},{"id":"W2132532466","doi":"10.1046/j.1524-4733.2003.64262.x","title":"Cost Implications of Administering Intravenous Proton Pump Inhibitors to All Patients Presenting to the Emergency Department with Peptic Ulcer Bleeding","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; St. Paul's Hospital; University of British Columbia; InStream Fisheries Research (Canada)","funders":"","keywords":"Medicine; Reimbursement; Emergency department; Upper gastrointestinal bleeding; Emergency medicine; Endoscopy; Proton-pump inhibitor; Incidence (geometry); General surgery; Intensive care medicine; Surgery; Internal medicine; Health care","score_opus":0.06830799306038579,"score_gpt":0.33606885142421816,"score_spread":0.26776085836383234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132532466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98876697,0.000037990914,0.00013005531,0.005267925,0.0001081985,0.0053571067,0.000010560711,0.000018637997,0.00030256904],"genre_scores_gemma":[0.99497974,0.000026612091,0.0033584796,0.00032681882,0.00004308315,0.0012073205,0.000010646539,0.00002411059,0.000023178742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984477,0.00006724966,0.0005294588,0.00028196443,0.00025891472,0.00041467958],"domain_scores_gemma":[0.9991086,0.00006710401,0.00016569748,0.00025511498,0.00012011063,0.00028334322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039273044,0.00014738421,0.0002473427,0.00012925398,0.00009936276,0.000011228687,0.00007490303,0.000020058807,0.000017830334],"category_scores_gemma":[0.00021305369,0.0001007772,0.000038645052,0.00036427387,0.000012488245,0.000030228548,0.000038158043,0.000110380686,0.000011568479],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048574886,0.00084331137,0.99365675,0.00029041685,0.000031415504,0.0000039497922,0.0018297834,0.0017740525,0.00010202714,0.00017211777,0.00024706815,0.001000511],"study_design_scores_gemma":[0.0011670471,0.0047660004,0.9848469,0.0013884057,0.000065022236,0.00004569307,0.00045660074,0.00012209894,0.0027479408,0.000043587246,0.004197084,0.00015362886],"about_ca_topic_score_codex":0.0006667858,"about_ca_topic_score_gemma":0.000073611765,"teacher_disagreement_score":0.00880988,"about_ca_system_score_codex":0.0003246708,"about_ca_system_score_gemma":0.00014255776,"threshold_uncertainty_score":0.4109575},"labels":[],"label_agreement":null},{"id":"W2132849147","doi":"10.1016/j.jval.2013.03.582","title":"Web-based study of patients and caregivers in the United States and Canada: Perspectives on improvements in stability of factor VIII products for hemophilia A","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Factor IX; Coagulation; Internal medicine","score_opus":0.04403416976802308,"score_gpt":0.3077854249119063,"score_spread":0.2637512551438832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2132849147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99290913,0.00008371356,4.942033e-8,0.002158002,0.000015456748,0.0047556246,0.000072772345,0.0000019274853,0.0000033078318],"genre_scores_gemma":[0.9997412,0.000054728873,0.000019960455,0.00005304308,0.0000039063625,0.00009400125,0.000023342702,0.0000060567304,0.0000037811046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875796,0.00023799449,0.00028916125,0.00022933036,0.000279586,0.00020594713],"domain_scores_gemma":[0.9992437,0.00030148216,0.00007605172,0.0001626182,0.00015861407,0.00005753008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040871056,0.000090607224,0.00026316554,0.00022704828,0.0000265099,0.000003224634,0.00004637376,0.000023735347,0.0000031272468],"category_scores_gemma":[0.00026927833,0.000057547128,0.000008669064,0.00028833954,0.000056249097,0.000026350608,0.000014881837,0.00011429614,3.1944076e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036816567,0.0018750428,0.97234243,0.0007778901,0.000012064952,0.0000016061758,0.02400984,0.000025255345,0.000103478684,0.0000041545354,0.000021714171,0.0004583544],"study_design_scores_gemma":[0.0074366853,0.003865533,0.9413421,0.00010987811,0.0000038576936,4.8228078e-8,0.045566685,0.0012111926,0.00040080937,0.000014844168,0.000007261048,0.000041110845],"about_ca_topic_score_codex":0.8351554,"about_ca_topic_score_gemma":0.22462226,"teacher_disagreement_score":0.6105332,"about_ca_system_score_codex":0.00041040446,"about_ca_system_score_gemma":0.0006871513,"threshold_uncertainty_score":0.78952634},"labels":[],"label_agreement":null},{"id":"W2133267529","doi":"10.1016/j.jval.2014.03.784","title":"Cost-Efectiveness Analysis Of Insulin Glargine (Lantus) Initiation By Pharmacists In A Canadian Setting: The Rxing Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Sanofi (Canada); University of Alberta","funders":"","keywords":"Medicine; Pharmacist; Insulin glargine; Hypoglycemia; Medical prescription; Insulin; Insulin pen; Type 2 diabetes; Diabetes mellitus; Pharmacy; Emergency medicine; Pediatrics; Internal medicine; Family medicine; Nursing; Endocrinology","score_opus":0.16975047061483284,"score_gpt":0.45061513872849784,"score_spread":0.280864668113665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133267529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951539,0.00035927846,0.00008785363,0.002757185,0.00009811057,0.0012361939,0.00003036384,0.000008889021,0.00026820778],"genre_scores_gemma":[0.99775803,0.00012692576,0.000023510533,0.0019590883,0.000027523465,0.00003683949,0.000052534844,0.000009276776,0.000006246103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773216,0.0009808068,0.00051162846,0.0001952893,0.00024616878,0.00033394457],"domain_scores_gemma":[0.99841344,0.0009301325,0.0002069724,0.00017894607,0.00004829092,0.00022219215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033131007,0.00009939149,0.00039588194,0.00049426395,0.00006186273,0.000008966888,0.0000847215,0.00003611906,0.000039130715],"category_scores_gemma":[0.0006874845,0.00007571095,0.00005011182,0.0013224506,0.000021088408,0.000079614314,0.000017367878,0.00032720502,0.000003088955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012966894,0.00035666034,0.986326,0.00012149574,0.00011110794,0.00000791074,0.0029088815,0.004621035,0.000028411954,0.000043489137,0.00002665717,0.0053187287],"study_design_scores_gemma":[0.0027668902,0.00025825686,0.69404835,0.000077551136,0.00021517715,0.0000025130187,0.00041130348,0.29863718,0.000053725762,0.000022015796,0.0034270482,0.00008002931],"about_ca_topic_score_codex":0.30656478,"about_ca_topic_score_gemma":0.05173898,"teacher_disagreement_score":0.29401612,"about_ca_system_score_codex":0.00037114334,"about_ca_system_score_gemma":0.0003218946,"threshold_uncertainty_score":0.9655643},"labels":[],"label_agreement":null},{"id":"W2133828904","doi":"10.1016/j.jval.2014.03.1668","title":"Using A Crossover Study Design For Early Hospital-Based Health Technology Assessment: The Cost-Effectiveness Of Clinic-Based Chloral Hydrate Sedation Versus General Anaesthesia For Paediatric Ophthalmological Procedures","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Chloral hydrate; Sedation; Cohort; Emergency medicine; Adverse effect; Anesthesia; Internal medicine","score_opus":0.20055795121420958,"score_gpt":0.44404342215727355,"score_spread":0.24348547094306397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2133828904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89818823,0.000113594535,0.0879338,0.0015163578,0.00013067889,0.012058448,0.000014453346,0.000041540807,0.0000029118821],"genre_scores_gemma":[0.980002,0.0000073946344,0.018193979,0.00041832545,0.00008741741,0.0011915141,0.000054892098,0.000040433162,0.0000040476284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963675,0.001512356,0.0007609292,0.00050771923,0.00029724714,0.0005542439],"domain_scores_gemma":[0.99699587,0.0016635975,0.000633814,0.00035227512,0.00022723147,0.00012723201],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051368447,0.00024941744,0.0007777883,0.00030674727,0.00027243965,0.00002018144,0.0001931162,0.00017249309,0.0000031253585],"category_scores_gemma":[0.00071655435,0.00018025683,0.00013801373,0.0006214359,0.00014728421,0.00006855129,0.000017484086,0.00023562025,9.762435e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014410473,0.0038148286,0.9178656,0.0023790793,0.00009110592,0.000014388046,0.00042606823,0.0570507,0.00010683943,0.0010244991,0.000035018453,0.0027814268],"study_design_scores_gemma":[0.023737118,0.049654603,0.61556506,0.0003506127,0.00009893575,0.000005592722,0.0003746032,0.30892038,0.00033681665,0.00065739424,0.00004733841,0.00025155614],"about_ca_topic_score_codex":0.0005400321,"about_ca_topic_score_gemma":0.0000075760804,"teacher_disagreement_score":0.3023005,"about_ca_system_score_codex":0.00045610665,"about_ca_system_score_gemma":0.002166914,"threshold_uncertainty_score":0.73506606},"labels":[],"label_agreement":null},{"id":"W2134384347","doi":"10.1016/j.jval.2013.08.792","title":"An Analysis of Priscription and Reimbursement of Potentially Inappropriate Medication (PIM) in a German Practice Network","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Reimbursement; Medicine; German; Quarter (Canadian coin); Health care; Family medicine; Pediatrics; Emergency medicine; Pharmacology","score_opus":0.06302499118083692,"score_gpt":0.41393594256460786,"score_spread":0.35091095138377093,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134384347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832981,0.0025289815,0.0005459884,0.0126699945,0.000063255946,0.0006100262,0.0000017759678,0.0000062096915,0.0002756647],"genre_scores_gemma":[0.989723,0.0056884843,0.0037500276,0.00075161795,0.00004202006,0.000020691385,0.000014474529,0.000004647199,0.0000050139342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998385,0.0004296197,0.00058237434,0.00016702233,0.00025800167,0.00017794326],"domain_scores_gemma":[0.99899197,0.00021016515,0.00043625632,0.00015957064,0.000092818445,0.00010921064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021637583,0.00006519347,0.0003541163,0.00017678534,0.000026849364,0.0000055125897,0.000042729054,0.00004431289,0.000043725242],"category_scores_gemma":[0.00026748577,0.000054674423,0.000026464799,0.0006041877,0.000043696506,0.00020406276,0.000025112828,0.00016391023,0.0000011074576],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021044556,0.0041152625,0.62376857,0.0030343565,0.0018888689,0.000022574473,0.014661895,0.03305707,0.0042842417,0.0074787964,0.0005821703,0.30500177],"study_design_scores_gemma":[0.0008801184,0.0005369015,0.8617241,0.00017941184,0.0004163806,0.0000030549809,0.0005442493,0.13239063,0.000036075493,0.00036479413,0.002867794,0.000056492558],"about_ca_topic_score_codex":0.027692895,"about_ca_topic_score_gemma":0.0002694003,"teacher_disagreement_score":0.30494526,"about_ca_system_score_codex":0.00007938577,"about_ca_system_score_gemma":0.00008235833,"threshold_uncertainty_score":0.97878176},"labels":[],"label_agreement":null},{"id":"W2134553529","doi":"10.1016/j.jval.2015.09.1195","title":"Economic Evaluations Of Glioblastoma","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Economic evaluation; Temozolomide; Glioblastoma; Medicine; Time horizon; MEDLINE; Bevacizumab; Carmustine; Oncology; Actuarial science; Medical physics; Internal medicine; Chemotherapy; Pathology; Mathematics; Cyclophosphamide","score_opus":0.480746801554645,"score_gpt":0.4682818930161314,"score_spread":0.01246490853851362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134553529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9071386,0.007822797,0.0025709593,0.06706679,0.0021472238,0.001680971,0.00047727887,0.00008966191,0.011005717],"genre_scores_gemma":[0.99035597,0.00015999512,0.0048983064,0.0038355724,0.0002942644,0.000090772905,0.000019551793,0.000039193874,0.0003063742],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99286836,0.00073351717,0.005358775,0.00046843145,0.00011275247,0.0004581855],"domain_scores_gemma":[0.99581075,0.0007635091,0.0024567035,0.00056609104,0.000057887682,0.0003450753],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.03099149,0.000157695,0.0010327492,0.0006409028,0.00006940336,0.000023365672,0.00028356645,0.00011319789,0.00024506912],"category_scores_gemma":[0.0029157093,0.00021864114,0.00009231712,0.0002596724,0.00006962161,0.00034939282,0.00004837831,0.00016244325,0.0024134591],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053743282,0.00026197595,0.12034497,0.000733637,0.000045940797,0.0000010113132,0.008883106,0.12509035,0.0000013786822,0.69487226,0.04915418,0.0005574382],"study_design_scores_gemma":[0.007173275,0.001763706,0.0774254,0.0008386501,0.000009207854,0.000029823119,0.006207768,0.38622624,0.000045526616,0.36955243,0.14950845,0.0012195328],"about_ca_topic_score_codex":0.016558554,"about_ca_topic_score_gemma":0.0007927536,"teacher_disagreement_score":0.32531983,"about_ca_system_score_codex":0.0020570473,"about_ca_system_score_gemma":0.0014288278,"threshold_uncertainty_score":0.99836326},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":[],"domain":null,"study_design":"design_other","genre":"other","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2135361259","doi":"10.1016/j.jval.2013.03.217","title":"Perceptions of individuals living with spinal cord injury toward preference-based quality of life instruments: A qualitative exploration","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Spinal Cord Injury Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Health Sciences Centre; Praxis Spinal Cord Institute; Sunnybrook Health Science Centre; Centre for Advancing Health Outcomes; Simon Fraser University","funders":"","keywords":"Focus group; Nonprobability sampling; Context (archaeology); Qualitative research; Health Utilities Index; Quality of life (healthcare); Population; Medicine; Applied psychology; Psychology; Preference; Spinal cord injury; Medical education; Nursing; Health related quality of life; Environmental health; Psychiatry; Marketing; Sociology; Geography; Social science; Disease; Pathology; Business","score_opus":0.3870599605776871,"score_gpt":0.49153877063198487,"score_spread":0.10447881005429777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135361259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99392176,0.00007591713,0.0016510708,0.002597114,0.000034544762,0.0014886871,0.000039795857,0.000024714827,0.00016637894],"genre_scores_gemma":[0.9890216,0.000071909126,0.01029303,0.00029183162,0.000030483781,0.00022083535,0.000025714084,0.000018721614,0.000025854613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959885,0.0013928312,0.0011035256,0.00029700194,0.0008767255,0.0003414209],"domain_scores_gemma":[0.9979971,0.00032878717,0.00053632015,0.0003609355,0.00051840575,0.00025843174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025934386,0.00015618317,0.00061451754,0.00047345535,0.00005166306,0.000013075262,0.00014338677,0.00008219365,0.0002740791],"category_scores_gemma":[0.0015266048,0.00013016874,0.000058577978,0.00072951696,0.00021629319,0.0003235476,0.0000501914,0.00035639925,0.000021104048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075254817,0.0019494961,0.9153396,0.007039986,0.000118905235,5.016967e-7,0.023226142,0.00013846048,0.005086139,0.0021328314,0.00024475608,0.03719772],"study_design_scores_gemma":[0.0013974208,0.036029276,0.9169529,0.0030605893,0.00001309414,0.0000010090644,0.040557932,0.00069035747,0.0004907558,0.0006410091,0.000012003387,0.0001536624],"about_ca_topic_score_codex":0.017154215,"about_ca_topic_score_gemma":0.000058902882,"teacher_disagreement_score":0.03704406,"about_ca_system_score_codex":0.0002816396,"about_ca_system_score_gemma":0.001962667,"threshold_uncertainty_score":0.9893906},"labels":[],"label_agreement":null},{"id":"W2135772515","doi":"10.1016/j.jval.2013.03.694","title":"Economic Evaluations Of Companion Diagnostics In Cancer Therapy","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cancer; Breast cancer; Companion diagnostic; Colorectal cancer; Lung cancer; Oncology; Medical physics; Intensive care medicine; Internal medicine","score_opus":0.7216186709408293,"score_gpt":0.6334271941979627,"score_spread":0.08819147674286665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135772515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985981,0.0008696181,0.005916151,0.0036774818,0.0009265976,0.00208456,0.000091206275,0.00002696007,0.00042641972],"genre_scores_gemma":[0.52032185,0.0056089363,0.47303092,0.00045567311,0.00017946548,0.0003431013,0.0000016872901,0.000032291267,0.00002606713],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9967526,0.0014158656,0.001252177,0.00018979615,0.0001555022,0.00023405072],"domain_scores_gemma":[0.9538641,0.04540823,0.00033318307,0.0002666299,0.00004886561,0.000079010395],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0037575897,0.00009385138,0.0005261,0.0001079651,0.000019387146,0.00000797243,0.00014310237,0.000078489255,0.000713272],"category_scores_gemma":[0.017589621,0.00008447075,0.00004148894,0.00014550905,0.000063362386,0.00004061259,0.000025681993,0.00018840187,0.000036813683],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007304498,0.0016508411,0.2063781,0.00093327806,0.000051509807,0.0000018414723,0.0024523793,0.018448874,0.000105367886,0.55556303,0.012035079,0.20230664],"study_design_scores_gemma":[0.0010192019,0.0001255599,0.087194465,0.000301227,0.0000029618438,2.0985347e-7,0.000045365385,0.020703744,0.00010132468,0.8903368,0.00008987057,0.00007925241],"about_ca_topic_score_codex":0.013407509,"about_ca_topic_score_gemma":0.0004144627,"teacher_disagreement_score":0.46711478,"about_ca_system_score_codex":0.00029282022,"about_ca_system_score_gemma":0.00033771433,"threshold_uncertainty_score":0.9931623},"labels":[],"label_agreement":null},{"id":"W2135877248","doi":"10.1016/j.jval.2013.08.1823","title":"Health Care Resources Utilization in Alzheimer’s Disease: An Analysis with the Quebec Provincial Drug Reimbursement Program Database","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada); Université de Montréal","funders":"","keywords":"Medicine; Rivastigmine; Reimbursement; Donepezil; Galantamine; Health care; Dementia; Disease; Emergency medicine; Family medicine; Pediatrics; Gerontology; Internal medicine","score_opus":0.14409761779369384,"score_gpt":0.4352954344856202,"score_spread":0.29119781669192635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2135877248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93007267,0.009170285,0.00007480662,0.054878674,0.000067698,0.005519558,0.00004668913,0.000078408644,0.00009124318],"genre_scores_gemma":[0.99375075,0.0002701205,0.0006260741,0.004419442,0.00008935839,0.00028719782,0.00049521535,0.000019707759,0.00004214314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726754,0.00084733975,0.0005062318,0.00039304694,0.00052761065,0.0004582171],"domain_scores_gemma":[0.99854153,0.00014612048,0.00026704252,0.00047349156,0.00007326243,0.0004985285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008736392,0.00016705442,0.00038418968,0.00024968464,0.00015102344,0.00005318904,0.00013322207,0.000027365686,0.000060191305],"category_scores_gemma":[0.00006718125,0.000103383296,0.000053268686,0.00092310336,0.00007160894,0.00030190276,0.000041716747,0.00033947223,0.000007174235],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006971978,0.001236237,0.8651016,0.0007321284,0.00014014127,0.000019362611,0.011304123,0.0039523705,6.446737e-7,0.00026925706,0.0007533956,0.115793556],"study_design_scores_gemma":[0.0022026573,0.0011420209,0.8290752,0.00042070978,0.000499021,0.0000020562843,0.0077259475,0.12078773,0.000005197011,0.000016163429,0.037877176,0.00024608697],"about_ca_topic_score_codex":0.29453912,"about_ca_topic_score_gemma":0.10845853,"teacher_disagreement_score":0.18608059,"about_ca_system_score_codex":0.00038525806,"about_ca_system_score_gemma":0.00094696914,"threshold_uncertainty_score":0.9078098},"labels":[],"label_agreement":null},{"id":"W2136043478","doi":"10.1016/j.jval.2015.09.2210","title":"Economic Evaluations of Treatments for Inflammatory Bowel Diseases","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Infliximab; Inflammatory Bowel Diseases; MEDLINE; Systematic review; Inflammatory bowel disease; Intensive care medicine; Internal medicine; Disease","score_opus":0.032419110136495975,"score_gpt":0.32587812726136395,"score_spread":0.293459017124868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136043478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99773306,0.000782101,0.0001362815,0.000108870656,0.00018278361,0.00067352934,0.00023794408,0.00000817097,0.00013726232],"genre_scores_gemma":[0.99835116,0.00008065482,0.0007026883,0.000115950286,0.00014866728,0.0001770933,0.00022166205,0.000021533451,0.00018057873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990757,0.00012412426,0.00032875815,0.00019959404,0.00008032139,0.0001914763],"domain_scores_gemma":[0.9993269,0.000018638364,0.00013891557,0.00027238225,0.000054690834,0.00018851439],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033913163,0.000095088,0.00011918795,0.000059135622,0.0000314636,0.0000048707475,0.00009853308,0.000052895,0.0000057406196],"category_scores_gemma":[0.00013082247,0.0001002131,0.00006786899,0.000020990994,0.000039809434,0.000004772815,0.000029584306,0.000021973861,0.000010986574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015261318,0.00062057254,0.83251834,0.00065910665,0.00020766609,0.000012923178,0.0006555012,0.14127015,0.0021587433,0.0047301794,0.012523796,0.0031169092],"study_design_scores_gemma":[0.008906888,0.001122426,0.9526244,0.00014938576,0.00009344245,0.0000047667427,0.00032056757,0.017832322,0.0032582995,0.005263133,0.009929874,0.0004945139],"about_ca_topic_score_codex":0.00012110028,"about_ca_topic_score_gemma":0.0000671059,"teacher_disagreement_score":0.12343782,"about_ca_system_score_codex":0.00012896961,"about_ca_system_score_gemma":0.0013880698,"threshold_uncertainty_score":0.4086572},"labels":[],"label_agreement":null},{"id":"W2136254236","doi":"10.1016/j.jval.2012.08.1692","title":"PDB49 Cost and Health Care Resources Utilization in the Management of Cushing'S Disease: An Analysis Based on the Ramq Database","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Novartis (Canada); Université de Montréal","funders":"","keywords":"Medicine; Medical diagnosis; Psychological intervention; Retrospective cohort study; Cushing's disease; Health care; Disease; Cohort; Intervention (counseling); Emergency medicine; Health plan; Pediatrics; Internal medicine; Nursing; Pathology","score_opus":0.09272178615220884,"score_gpt":0.3662852407929567,"score_spread":0.2735634546407479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136254236","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765131,0.011279554,0.000157938,0.010273632,0.000030660063,0.0013456215,0.0001171912,0.00001022563,0.00027209564],"genre_scores_gemma":[0.99572915,0.0009422987,0.00015978866,0.0026421044,0.00001750567,0.000040871608,0.00045647484,0.0000065504255,0.000005273243],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987025,0.00038452668,0.0002462906,0.00016504688,0.00026294877,0.00023868379],"domain_scores_gemma":[0.9992462,0.00008486358,0.00009503373,0.0004029902,0.000011636192,0.00015930625],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010649188,0.00009191258,0.00020363797,0.00017668221,0.00010901448,0.000008764098,0.0000713762,0.000015800011,0.000013023623],"category_scores_gemma":[0.000015029797,0.00005051493,0.000032539367,0.00050546293,0.000029541316,0.00005856533,0.000016172073,0.00008229858,7.429277e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019310409,0.0007592221,0.98358405,0.0006214312,0.00004856273,0.0000091782495,0.0048170756,0.0018711473,4.96743e-8,0.0012867627,0.000097698634,0.006711742],"study_design_scores_gemma":[0.001268789,0.00021633104,0.97439194,0.00030032,0.00011456123,3.8836868e-7,0.0060468605,0.016750544,5.271184e-7,0.00002954486,0.00083645736,0.00004376228],"about_ca_topic_score_codex":0.007025992,"about_ca_topic_score_gemma":0.00062660535,"teacher_disagreement_score":0.019216051,"about_ca_system_score_codex":0.00010894317,"about_ca_system_score_gemma":0.00007638641,"threshold_uncertainty_score":0.9995863},"labels":[],"label_agreement":null},{"id":"W2136665547","doi":"10.1111/j.1524-4733.2008.00500.x","title":"Health-Care Costs of Pediatric Clients Developing Adverse Events during Treatment with Antipsychotics","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Medicaid; Antipsychotic; Emergency medicine; Adverse effect; Medical prescription; Pharmacy; Retrospective cohort study; Emergency department; Medical record; Health care; Psychiatry; Pediatrics; Schizophrenia (object-oriented programming); Family medicine; Internal medicine","score_opus":0.04199900881760675,"score_gpt":0.35390610984123855,"score_spread":0.3119071010236318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136665547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99212265,0.003321748,0.000035023317,0.0030442358,0.00007315059,0.0013091118,0.000017807994,0.00003262901,0.00004366225],"genre_scores_gemma":[0.9802207,0.0056067146,0.013763806,0.00021685197,0.00008980969,0.000018316823,0.000041622203,0.000018076837,0.000024135803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979624,0.00013701947,0.0005227371,0.00032582396,0.0004604562,0.00059152767],"domain_scores_gemma":[0.99898386,0.000044022916,0.00020333311,0.00030292125,0.00007970868,0.00038613527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001885016,0.00019184973,0.00049241976,0.0003589005,0.00010451585,0.000002490399,0.00006712576,0.00004807525,0.000005074728],"category_scores_gemma":[0.000021931428,0.00014446964,0.00006177861,0.00055231346,0.00001653996,0.00004717925,0.000012010634,0.00014081442,0.000011980961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011407016,0.0015483131,0.9449152,0.0010310551,0.00008734396,0.00017596748,0.0019976106,0.0004954034,0.00000954375,0.00043821652,0.000022408562,0.03787196],"study_design_scores_gemma":[0.013313152,0.0065551205,0.97851574,0.00084102043,0.000020402396,0.00004514905,0.00026298614,0.000084156025,0.00014749834,0.000053762273,0.00004385341,0.000117138035],"about_ca_topic_score_codex":0.00094768184,"about_ca_topic_score_gemma":0.00017124777,"teacher_disagreement_score":0.037754823,"about_ca_system_score_codex":0.0023922585,"about_ca_system_score_gemma":0.0019814747,"threshold_uncertainty_score":0.62556726},"labels":[],"label_agreement":null},{"id":"W2136940899","doi":"10.1016/j.jval.2014.08.1325","title":"Cost-Effectiveness Of Mirabegron 50mg Compared To Tolterodine Er 4mg In The Treatment Of Patients With Overactive Bladder In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Mirabegron; Overactive bladder; Tolterodine; Urology; Medicine; Alternative medicine","score_opus":0.07046665692339814,"score_gpt":0.3508326581457938,"score_spread":0.28036600122239563,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136940899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996219,0.00012103453,0.000011004532,0.0005033395,0.000035730587,0.002855529,0.000053048305,0.0000017585452,0.00019954663],"genre_scores_gemma":[0.9995504,0.000056962777,0.000060379,0.00012166738,0.000010933531,0.00013456825,0.00004680054,0.000010786405,0.000007521028],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978352,0.0009121734,0.0003443892,0.00020174283,0.0003944241,0.00031207566],"domain_scores_gemma":[0.9987454,0.000758389,0.00008030039,0.00023558918,0.000078510435,0.00010184463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007050051,0.00011828973,0.0004685109,0.0001815229,0.000016744014,0.0000023613293,0.00007300546,0.0000234257,0.000015560348],"category_scores_gemma":[0.00004552269,0.00007408205,0.000018975727,0.00041511733,0.000027206244,0.000033143457,0.000012126646,0.0001325723,8.4378746e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043288837,0.0017089302,0.9807068,0.00046088733,0.000025673247,0.000015826477,0.004552112,0.003804365,0.00003530444,0.000018588544,0.00003899268,0.004303613],"study_design_scores_gemma":[0.0058026905,0.0049569416,0.9863676,0.0004294297,0.0000056927292,0.0000015028344,0.00051030004,0.0008170262,0.0005571953,0.00001832701,0.00047241795,0.00006089897],"about_ca_topic_score_codex":0.9132995,"about_ca_topic_score_gemma":0.5808016,"teacher_disagreement_score":0.3324979,"about_ca_system_score_codex":0.0012308826,"about_ca_system_score_gemma":0.0010810284,"threshold_uncertainty_score":0.42684767},"labels":[],"label_agreement":null},{"id":"W2136950115","doi":"10.1111/j.1524-4733.2006.00139.x","title":"A Checklist for Medication Compliance and Persistence Studies Using Retrospective Databases","year":2006,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":633,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Checklist; Consistency (knowledge bases); Retrospective cohort study; Compliance (psychology); Persistence (discontinuity); Pharmacoeconomics; Medicine; Database; Family medicine; Computer science; Psychology; Intensive care medicine; Internal medicine","score_opus":0.3757732714154876,"score_gpt":0.4425560263490459,"score_spread":0.06678275493355829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136950115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92839134,0.032135844,0.016042538,0.01963113,0.0003641682,0.0022102676,0.000066579785,0.00008577516,0.0010723831],"genre_scores_gemma":[0.97364634,0.0010642308,0.023352975,0.0011127685,0.00017638311,0.00007438797,0.000036232283,0.000009309393,0.0005273946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990333,0.000038882645,0.00030309375,0.00026246672,0.00017747997,0.00018479572],"domain_scores_gemma":[0.999363,0.00010892927,0.00015943378,0.00018342503,0.00011076686,0.000074448166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047723757,0.000079319216,0.00025830566,0.000060154594,0.000112173366,0.0000048008546,0.000044075663,0.000020461914,0.000012061236],"category_scores_gemma":[0.00032024726,0.00007220775,0.000019603674,0.00017484272,0.00014307715,0.00006317499,0.000016434444,0.000091122296,0.0000060902066],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042344982,0.00084355427,0.8878979,0.010394161,0.000111162306,0.000021599852,0.0033191943,0.0004931666,0.0032245559,0.054749377,0.027734457,0.010787398],"study_design_scores_gemma":[0.0041193157,0.00065053685,0.8288305,0.007586445,0.000064863045,0.00014448431,0.0049684965,0.13160056,0.00045215883,0.006813923,0.014404113,0.00036460187],"about_ca_topic_score_codex":0.001534543,"about_ca_topic_score_gemma":0.000038493163,"teacher_disagreement_score":0.1311074,"about_ca_system_score_codex":0.00024659003,"about_ca_system_score_gemma":0.00022535991,"threshold_uncertainty_score":0.2944547},"labels":[],"label_agreement":null},{"id":"W2137204969","doi":"10.1016/j.jval.2014.03.1472","title":"Methodological challenges in calculation of daily average consumption (DACON) for GLP-1 receptor agonist injectables from claims data","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Liraglutide; Medicine; Type 2 diabetes; Dosing; Internal medicine; Diabetes mellitus; Pediatrics; Animal science; Urology; Endocrinology","score_opus":0.40653566832348687,"score_gpt":0.41289773706279104,"score_spread":0.006362068739304172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137204969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9821524,0.0043704314,0.0055337953,0.005446102,0.00030670833,0.0016628354,0.00012445047,0.000044159075,0.00035913568],"genre_scores_gemma":[0.9439014,0.0045981263,0.04951855,0.0003019074,0.00012157209,0.000067909255,0.0014123073,0.000016132597,0.00006207216],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99830437,0.00048569945,0.0004657568,0.00036808883,0.00014642836,0.0002296408],"domain_scores_gemma":[0.99837935,0.0009291449,0.00016915836,0.00043138777,0.000022969032,0.00006797749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023663284,0.000111542315,0.0004588845,0.00013665883,0.000027887932,0.000006838248,0.0001087568,0.000087408094,0.000036544607],"category_scores_gemma":[0.00040401047,0.00009486125,0.000033164826,0.00008106564,0.000037142476,0.00008460807,0.00006829348,0.000089457346,0.00000870121],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015110425,0.0017964033,0.24541743,0.0047555096,0.00021547837,0.000006024419,0.0028598765,0.0023943696,0.0016199023,0.025944851,0.0028322507,0.71064687],"study_design_scores_gemma":[0.015040543,0.0033085528,0.76276284,0.0022596994,0.00015935871,0.0000015611263,0.0005029308,0.14004406,0.0010973605,0.013941904,0.06042893,0.00045223272],"about_ca_topic_score_codex":0.001690645,"about_ca_topic_score_gemma":0.00031895997,"teacher_disagreement_score":0.71019465,"about_ca_system_score_codex":0.00014387467,"about_ca_system_score_gemma":0.00005600754,"threshold_uncertainty_score":0.38683295},"labels":[],"label_agreement":null},{"id":"W2138260098","doi":"10.1016/j.jval.2013.03.275","title":"Underestimation of uncertainties in health utilities dervied from mapping algorithms involving health-related quality of life measures: statistical explanations and potential remedies","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Energy and Environment Impacts","field":"Environmental Science","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Public Health Ontario; University of Toronto","funders":"","keywords":"Estimator; Variance (accounting); Statistics; Parametric statistics; Mean squared error; Ordinary least squares; Minimum-variance unbiased estimator; Mathematics; Econometrics; Computer science; Algorithm","score_opus":0.10446381595069708,"score_gpt":0.29590750768574137,"score_spread":0.19144369173504427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138260098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985507,0.0024656479,0.0065713343,0.004853448,0.00008280063,0.00039778434,0.000054825912,0.000017290517,0.000049882347],"genre_scores_gemma":[0.98727214,0.0018925434,0.010373392,0.0003522667,0.000008550999,0.00001557982,0.00006257825,0.000009446676,0.000013474035],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9965796,0.0009879639,0.0013666153,0.00025910776,0.00043512625,0.0003715961],"domain_scores_gemma":[0.99856776,0.0005036874,0.0005323019,0.0001729523,0.000008889506,0.00021441218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001987177,0.00013783007,0.00048214543,0.000126283,0.00012543831,0.000012421231,0.00009975726,0.000071900125,0.00020047229],"category_scores_gemma":[0.000513414,0.00013352316,0.000022499578,0.00021419743,0.00028905855,0.00025874,0.00007402576,0.00017377979,0.0000047400854],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006944359,0.00042193293,0.24713805,0.0015215743,0.000044179622,0.0000013406853,0.03584516,0.6809852,0.00048526443,0.0074341986,0.0005992312,0.025454415],"study_design_scores_gemma":[0.0005545645,0.0001151538,0.9165604,0.00038181312,0.0000011931088,5.872899e-7,0.007321241,0.05678602,0.0000148957515,0.018138202,0.000017154804,0.00010876117],"about_ca_topic_score_codex":0.48540586,"about_ca_topic_score_gemma":0.008725308,"teacher_disagreement_score":0.6694224,"about_ca_system_score_codex":0.00048083745,"about_ca_system_score_gemma":0.00017980071,"threshold_uncertainty_score":0.54449165},"labels":[],"label_agreement":null},{"id":"W2138328847","doi":"10.1016/s1098-3015(10)73104-1","title":"VA2 COST EFFECTIVENESS ANALYSIS OF THE NEW 10-VALENT PNEUMOCOCCAL NON-TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN-D CONJUGATE VACCINE (PHID-CV) IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Conjugate vaccine; Haemophilus influenzae; Pneumococcal conjugate vaccine; Medicine; Conjugate; Virology; Haemophilus; Pneumococcal disease; Microbiology; Streptococcus pneumoniae; Biology; Immunization; Immunology; Genetics; Antigen; Bacteria; Mathematics","score_opus":0.024455562045806914,"score_gpt":0.29797455336864515,"score_spread":0.27351899132283825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138328847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911729,0.00024669652,0.000027701011,0.0058457917,0.00016273477,0.0021941909,0.000021208974,0.000017070613,0.00031172365],"genre_scores_gemma":[0.9980396,0.000043758562,0.00001963645,0.0016466979,0.000059854414,0.000048023543,0.00000804932,0.000015350068,0.00011900701],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974315,0.00059604464,0.00078789954,0.00034087096,0.00035684684,0.00048679236],"domain_scores_gemma":[0.99859345,0.00022498083,0.00026439174,0.0005315545,0.00009391643,0.0002917355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009745193,0.00021539751,0.00085807283,0.0004741418,0.00010189234,0.00000775929,0.00016332477,0.000110892004,0.00005010437],"category_scores_gemma":[0.00025908276,0.0001584039,0.00015321156,0.0026363651,0.000027102124,0.00005677589,0.000036197416,0.00050840125,0.000005405203],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043622643,0.00055600127,0.7693389,0.0006895476,0.0003014163,0.00008856608,0.0003663649,0.18934597,0.034777883,0.0001898251,0.000336985,0.0035722968],"study_design_scores_gemma":[0.0022876568,0.0004398453,0.9851816,0.0007177702,0.00013818336,0.000014310009,0.000035557136,0.005919219,0.0026955067,0.00011074556,0.0023177636,0.00014178322],"about_ca_topic_score_codex":0.83036786,"about_ca_topic_score_gemma":0.568315,"teacher_disagreement_score":0.26205286,"about_ca_system_score_codex":0.001954109,"about_ca_system_score_gemma":0.0060733873,"threshold_uncertainty_score":0.99956125},"labels":[],"label_agreement":null},{"id":"W2138378555","doi":"10.1016/j.jval.2011.02.637","title":"PIN5 THE PREVALENCE AND ECONOMIC BURDEN OF HEPATITIS C VIRUS INFECTION IN CANADA AND LATIN AMERICA: A SYSTEMATIC REVIEW","year":2011,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Latin Americans; Medicine; Population; Environmental health; Systematic review; Prevalence; MEDLINE; Demography; Geography; Political science","score_opus":0.08042740352937418,"score_gpt":0.28116001817932224,"score_spread":0.20073261464994807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138378555","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022981912,0.9939522,0.0000029749858,0.000107537184,0.00027849976,0.002982541,0.00027967463,0.0000042705915,0.00009411655],"genre_scores_gemma":[0.00133471,0.9981355,0.000013037206,0.000105796884,0.000038297658,0.0002867241,0.000006021533,0.000025085312,0.000054811455],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99598634,0.00038729067,0.002894879,0.00039739144,0.000036559555,0.00029751722],"domain_scores_gemma":[0.9970727,0.00014475563,0.0022603683,0.0004075352,0.000011389123,0.00010327735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021263135,0.0002445255,0.0030770078,0.00023147328,0.000047417823,0.000012509342,0.00015999089,0.00011453918,0.000019301313],"category_scores_gemma":[0.00015879408,0.00017038384,0.000089344016,0.00025805781,0.00004343433,0.00006759297,0.000057779886,0.00032323867,0.0000140045],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[3.4543163e-7,0.000004710583,0.013154645,0.96384585,0.000019254123,0.0000011112758,0.00021690402,0.0000070355363,1.7676734e-10,0.0008002242,0.000014701259,0.0219352],"study_design_scores_gemma":[0.00014370875,0.00012219245,0.014253348,0.8927723,0.000039550963,0.000054325,0.000019291383,0.00050709874,5.6283604e-9,0.00033773103,0.09135658,0.0003938301],"about_ca_topic_score_codex":0.99921966,"about_ca_topic_score_gemma":0.9136391,"teacher_disagreement_score":0.091341875,"about_ca_system_score_codex":0.0014693578,"about_ca_system_score_gemma":0.0013201399,"threshold_uncertainty_score":0.6948051},"labels":[],"label_agreement":null},{"id":"W2138660129","doi":"10.1111/j.1524-4733.2009.00583.x","title":"Relationship between Adherence Level to Statins, Clinical Issues and Health-Care Costs in Real-Life Clinical Setting","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Dyslipidemia; Confidence interval; Internal medicine; Odds ratio; Cohort; Coronary artery disease; Health care; Statin; Disease; Physical therapy; Emergency medicine; Intensive care medicine","score_opus":0.3191217327825773,"score_gpt":0.5003246325631929,"score_spread":0.1812028997806156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2138660129","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9341754,0.007781367,0.00028933358,0.05496609,0.00020211433,0.0022757216,0.000043539232,0.00007299354,0.0001934974],"genre_scores_gemma":[0.97067505,0.0032887743,0.013559093,0.0114629725,0.00085401506,0.000026898346,0.00006631222,0.00002772666,0.0000391579],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99327916,0.0020672348,0.0025923827,0.0007411034,0.0005856379,0.00073447725],"domain_scores_gemma":[0.996757,0.00093682326,0.00035690868,0.0006364038,0.00010265196,0.001210213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014044775,0.00022046821,0.0012809923,0.00024517524,0.00015635733,0.000023467543,0.0001227574,0.0002648082,0.0000047728136],"category_scores_gemma":[0.0029295294,0.00021149188,0.00015411525,0.00056860154,0.00005921389,0.0000872707,0.00005348431,0.0011717187,0.000024606652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007971189,0.000094636685,0.7922097,0.00041727332,0.000008489856,0.000015258108,0.0012387414,0.000022731278,8.1580815e-8,0.0006607061,0.0009572934,0.2042954],"study_design_scores_gemma":[0.002588687,0.0027811653,0.9897308,0.001368249,0.000010500802,0.000008656708,0.0008605496,0.000111896974,6.045073e-7,0.00023372035,0.002143061,0.00016213689],"about_ca_topic_score_codex":0.03262768,"about_ca_topic_score_gemma":0.0013810634,"teacher_disagreement_score":0.20413326,"about_ca_system_score_codex":0.0006160375,"about_ca_system_score_gemma":0.0026476954,"threshold_uncertainty_score":0.97381413},"labels":[],"label_agreement":null},{"id":"W2139092547","doi":"10.1016/j.jval.2012.08.1172","title":"PSU14 Economic Impact of Scoliosis in Canada: A RAMQ Database Analysis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Scoliosis diagnosis and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Scoliosis; Database; Business; Computer science; Medicine; Surgery","score_opus":0.06186934127925453,"score_gpt":0.36039921479546216,"score_spread":0.29852987351620763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139092547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941153,0.0045406674,0.0000021474757,0.00062726706,0.00008350705,0.0004229021,0.00010210712,0.0000047597296,0.00010132847],"genre_scores_gemma":[0.9985581,0.00081404945,0.00018996054,0.00029126406,0.000049101545,0.00004785561,0.000035449793,0.000011693008,0.0000024985827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984772,0.0001328242,0.0005769909,0.00019325309,0.00015349385,0.0004662046],"domain_scores_gemma":[0.998983,0.00012267071,0.0001712551,0.0003721915,0.000014415785,0.0003364243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060947076,0.0001307041,0.00067089376,0.0005882185,0.000017371534,0.0000033979943,0.000060502076,0.00003266246,0.00015663938],"category_scores_gemma":[0.000055132754,0.000108279,0.00014653907,0.00073745265,0.000013945514,0.00008219563,0.000024704945,0.00010656875,0.000008124226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004939535,0.00035727583,0.99041885,0.00010461945,0.0002733157,0.000009965133,0.0002106797,0.0076403012,0.000005522769,0.00008696436,0.00040713127,0.00043595058],"study_design_scores_gemma":[0.0011487524,0.0001548789,0.9928195,0.00029189992,0.00014080651,0.0000038472203,0.0001029208,0.0051045194,0.000118470394,0.0000043161835,0.000037991413,0.00007208954],"about_ca_topic_score_codex":0.996384,"about_ca_topic_score_gemma":0.9101009,"teacher_disagreement_score":0.08628311,"about_ca_system_score_codex":0.0072808824,"about_ca_system_score_gemma":0.004723624,"threshold_uncertainty_score":0.99653},"labels":[],"label_agreement":null},{"id":"W2139264675","doi":"10.1016/j.jval.2014.03.1569","title":"Budget Impact Analysis Of Dolutegravir In The Treatment Of Human Immunodeficiency Virus (Hiv) In Ontario, Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Dolutegravir; Medicine; Regimen; Formulary; Population; Pharmacy; Internal medicine; Human immunodeficiency virus (HIV); Pediatrics; Demography; Family medicine; Viral load; Environmental health; Antiretroviral therapy","score_opus":0.026532311481493216,"score_gpt":0.30557076732917104,"score_spread":0.27903845584767784,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139264675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99745524,0.0005571166,0.0000029804971,0.0006935367,0.000028100509,0.0004891857,0.000019062936,0.0000032528387,0.0007515191],"genre_scores_gemma":[0.99920034,0.0001432712,0.0001302402,0.0000718865,0.000005526306,0.000028104341,0.000099144694,0.0000075945395,0.00031387928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981001,0.00025953917,0.00076413614,0.00021090754,0.00033461305,0.00033071626],"domain_scores_gemma":[0.9991654,0.00017210591,0.00019160363,0.0003820863,0.000023300126,0.00006550204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072289613,0.00016676544,0.0007762908,0.0006228258,0.000035355188,0.0000034090563,0.00010681861,0.00004243902,0.000076292374],"category_scores_gemma":[0.000019092915,0.00010325467,0.00012327395,0.0010984002,0.000026850887,0.000021139682,0.00000835286,0.00012238849,0.0000011227564],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007356723,0.0013392306,0.98059505,0.00003870431,0.00017877496,0.000023487723,0.013966892,0.002297294,0.00009352804,0.00018672555,0.00007336943,0.0011333508],"study_design_scores_gemma":[0.0019801678,0.0007122767,0.994404,0.000111363755,0.00011884086,0.0000019532229,0.0005674556,0.0011559405,0.00016729394,0.00005344996,0.0006505571,0.00007667557],"about_ca_topic_score_codex":0.9980503,"about_ca_topic_score_gemma":0.9972074,"teacher_disagreement_score":0.01380895,"about_ca_system_score_codex":0.0030387961,"about_ca_system_score_gemma":0.002139841,"threshold_uncertainty_score":0.7946346},"labels":[],"label_agreement":null},{"id":"W2139637702","doi":"10.1016/j.jval.2013.03.690","title":"Cost-Effectiveness Of Bendamustine+Rituximab Versus Fludarabine+Rituximab In The Treatment Of Relapsed Indolent Non-Hodgkin's And Mantle Cell Lymphomas In Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Rituximab; Fludarabine; Bendamustine; Mantle cell lymphoma; Internal medicine; Oncology; Adverse effect; Lymphoma; Chemotherapy; Cyclophosphamide","score_opus":0.045726813580193156,"score_gpt":0.29543919753835685,"score_spread":0.2497123839581637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139637702","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924126,0.003001611,0.0000014668024,0.0007344021,0.00018481306,0.0032452247,0.000044130633,0.00000460968,0.00037113405],"genre_scores_gemma":[0.9971083,0.0019674876,0.00018770435,0.00009109072,0.00001906191,0.00056700583,0.000033856526,0.00001862284,0.0000068909767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997786,0.00041695076,0.0006924311,0.00034319184,0.00033971365,0.00042173633],"domain_scores_gemma":[0.99820554,0.0010309129,0.00020476551,0.0003759371,0.00005314884,0.00012971794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004957769,0.0002428211,0.00087028916,0.00022300809,0.000031263546,0.0000068641466,0.000095626616,0.00007435939,0.000024913565],"category_scores_gemma":[0.000040996303,0.00016883243,0.00006184945,0.00039755422,0.000058399844,0.000051495444,0.000023139059,0.000094103416,0.0000036851814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026742227,0.019192003,0.9203485,0.0025343467,0.00008825441,0.00035522887,0.0050082393,0.0012138535,0.00018665976,0.00023333913,0.00017084244,0.04799451],"study_design_scores_gemma":[0.0735214,0.0030670068,0.91514015,0.00076626235,0.00003768357,0.000017121492,0.0014094891,0.0018191658,0.003804937,0.000043416672,0.00024110006,0.00013227692],"about_ca_topic_score_codex":0.9543812,"about_ca_topic_score_gemma":0.3492801,"teacher_disagreement_score":0.6051011,"about_ca_system_score_codex":0.0032981557,"about_ca_system_score_gemma":0.0021034821,"threshold_uncertainty_score":0.86245626},"labels":[],"label_agreement":null},{"id":"W2139655503","doi":"10.1016/j.jval.2014.03.746","title":"The Determinants Of Place Of Death In An End-Of-Life Or Palliative Care Population","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Public Health Ontario","funders":"","keywords":"Medicine; Observational study; Palliative care; Population; Odds ratio; End-of-life care; Psychological intervention; Systematic review; Cohort study; Multidisciplinary approach; Family medicine; MEDLINE; Emergency medicine; Nursing; Internal medicine; Environmental health","score_opus":0.2260430103256356,"score_gpt":0.4686069567085623,"score_spread":0.2425639463829267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139655503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703705,0.0022392513,0.000029076302,0.00012354183,0.00008125402,0.00035358348,0.000024885174,0.000004863014,0.00010648003],"genre_scores_gemma":[0.9974299,0.0009957508,0.0014326377,0.000057849906,0.00003582781,0.0000076129095,0.000016657483,0.000010961988,0.000012785574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982993,0.000345798,0.0007673712,0.000144876,0.00025664183,0.00018599934],"domain_scores_gemma":[0.99829465,0.0007414051,0.0004849993,0.0002521177,0.00014731848,0.000079482605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067970465,0.00009711119,0.00054468017,0.00013175205,0.000021934658,0.0000012362856,0.000099751014,0.0000688926,0.000005709136],"category_scores_gemma":[0.0010628382,0.00006518074,0.000042965134,0.00023586366,0.000062061285,0.000042500393,0.000019732259,0.0001082877,4.0029437e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004359822,0.00007036403,0.97877103,0.0011531659,0.0000064264905,0.0000012466917,0.010904869,0.0005314261,0.000045570672,0.00040740654,0.0000061978935,0.0076663233],"study_design_scores_gemma":[0.0015234491,0.0013539487,0.97950315,0.0034099505,0.000011616443,4.1452776e-7,0.0042478945,0.0065787314,0.0028000532,0.00018662994,0.00031578576,0.00006839871],"about_ca_topic_score_codex":0.01685839,"about_ca_topic_score_gemma":0.0055775587,"teacher_disagreement_score":0.011280832,"about_ca_system_score_codex":0.00012275798,"about_ca_system_score_gemma":0.00037013763,"threshold_uncertainty_score":0.98968846},"labels":[],"label_agreement":null},{"id":"W2140120733","doi":"10.1016/j.jval.2014.03.172","title":"Consistency In Reimbursement Decisions At Canadian Hta Agencies: Inesss Versus Cdr","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Formulary; Health technology; Medicine; Family medicine; Medical prescription; Health care; Political science; Nursing","score_opus":0.5637319130110012,"score_gpt":0.43502488652110854,"score_spread":0.12870702648989268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140120733","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8667887,0.004818263,0.0003943538,0.09763574,0.003454532,0.001713335,0.00031319197,0.000051655556,0.024830265],"genre_scores_gemma":[0.9829766,0.00056864787,0.0019072229,0.013689347,0.00021068021,0.00013547491,0.000045158115,0.00003848439,0.00042837366],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99263746,0.000809156,0.0047782524,0.0007044624,0.0001299091,0.0009407923],"domain_scores_gemma":[0.9945999,0.0026986478,0.0012076924,0.0008004865,0.000044269033,0.0006490109],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.02441389,0.00021490398,0.0010251108,0.001087149,0.0002961684,0.000043761152,0.00036321444,0.00017361164,0.000436598],"category_scores_gemma":[0.009991257,0.0002911267,0.000084112675,0.00054133526,0.000069851114,0.00020835259,0.00006970447,0.00026680602,0.002017249],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000065227425,0.00015586865,0.29484737,0.0005587612,0.000035205197,0.0000113685755,0.008954379,0.016290456,5.756075e-7,0.63852775,0.039296288,0.0012567701],"study_design_scores_gemma":[0.0066604144,0.0005611068,0.32187232,0.0011118769,0.000005276204,0.000013864874,0.0054973396,0.09659251,0.0000016508613,0.045990348,0.5204937,0.0011995859],"about_ca_topic_score_codex":0.63677675,"about_ca_topic_score_gemma":0.56244355,"teacher_disagreement_score":0.5925374,"about_ca_system_score_codex":0.007929615,"about_ca_system_score_gemma":0.0017380993,"threshold_uncertainty_score":0.9999541},"labels":[],"label_agreement":null},{"id":"W2140659972","doi":"10.1016/j.jval.2013.03.1154","title":"Ustekinumab Improves Arthritis-Related And Skin-Related Quality Of Life In Patients With Active Psoriatic Arthritis: Patient Reported Outcomes From Randomized And Double Blinded Phase Iii Psummit I Trial","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Ustekinumab; Medicine; Psoriatic arthritis; Internal medicine; Physical therapy; Quality of life (healthcare); Randomization; Randomized controlled trial; Gastroenterology; Arthritis; Disease; Infliximab","score_opus":0.03695963094610567,"score_gpt":0.3223150798160095,"score_spread":0.2853554488699038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140659972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98697346,0.0035495327,0.000004403563,0.00045588717,0.0001494644,0.008719783,0.000019945619,0.00003542877,0.00009207578],"genre_scores_gemma":[0.9980083,0.0012709765,0.00011158877,0.00010632108,0.00001089111,0.00032900073,0.00010601758,0.000032393342,0.000024505578],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9940773,0.0010211059,0.0032433458,0.00052998785,0.00064774725,0.00048047944],"domain_scores_gemma":[0.9970531,0.0006771889,0.0013316942,0.00042277592,0.00022988323,0.00028536384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017202015,0.00029770975,0.0025292153,0.00039617636,0.00008448285,0.000031321284,0.0000703326,0.00024278293,0.000120393044],"category_scores_gemma":[0.0012768126,0.0002305514,0.00011066557,0.0003606869,0.000307812,0.00030885564,0.00006525094,0.0005789409,0.0000035155372],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.74544144,0.003121913,0.05633372,0.0003212683,0.00067811384,0.000018557528,0.008955797,0.000036031128,0.000035764442,0.00011564034,0.00002794016,0.1849138],"study_design_scores_gemma":[0.76249504,0.0018437429,0.23236924,0.0007041311,0.000026694335,0.0000011373465,0.00097414525,0.0008367676,0.000038935585,0.00052520377,0.0000049349906,0.00018003726],"about_ca_topic_score_codex":0.042358346,"about_ca_topic_score_gemma":0.0003397463,"teacher_disagreement_score":0.18473376,"about_ca_system_score_codex":0.00012711345,"about_ca_system_score_gemma":0.0007223165,"threshold_uncertainty_score":0.96401864},"labels":[],"label_agreement":null},{"id":"W2140892477","doi":"10.1016/j.jval.2014.03.1398","title":"Clinical effectiveness of surgical therapies, radiotherapy and medical interventions in cushing’s disease; A systematic literature review","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Medicine; Hypopituitarism; Cushing's disease; Cochrane Library; Population; Transsphenoidal surgery; Observational study; Systematic review; Radiation therapy; Adrenalectomy; Surgery; Pediatrics; Disease; MEDLINE; Internal medicine; Pituitary adenoma; Randomized controlled trial; Adenoma","score_opus":0.04133927102740052,"score_gpt":0.3953527818645443,"score_spread":0.3540135108371438,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140892477","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25731733,0.7380843,0.00010338202,0.0029329953,0.000096750584,0.0014043777,0.000007937686,0.000012017297,0.000040926916],"genre_scores_gemma":[0.67568403,0.32364258,0.00010509014,0.00043199654,0.000028178725,0.00006197728,0.000027108763,0.00000870615,0.000010326488],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99617165,0.0023635486,0.0008442018,0.00021968369,0.00023881687,0.00016208188],"domain_scores_gemma":[0.99839485,0.0009710482,0.00013345736,0.00021663906,0.000023277433,0.00026070734],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004505869,0.00011290042,0.00097145006,0.00010876765,0.000018677278,0.0000053062113,0.000059011913,0.000076750315,0.000018481494],"category_scores_gemma":[0.0005198417,0.000073118135,0.00016557825,0.00023092197,0.000055553526,0.000036380145,0.000015069741,0.0002211185,8.970061e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029795986,0.0010407388,0.57560223,0.41842055,0.000065722954,0.00013558839,0.00016387408,0.000002606615,9.006039e-8,0.0014043836,0.000041836014,0.0028244243],"study_design_scores_gemma":[0.0059911446,0.0006964343,0.32902282,0.6620978,0.000045346904,0.00007229223,0.000011555293,0.0012520482,6.031483e-8,0.00053281477,0.00021018404,0.00006749672],"about_ca_topic_score_codex":0.00020786583,"about_ca_topic_score_gemma":0.000022953267,"teacher_disagreement_score":0.4183667,"about_ca_system_score_codex":0.00006059198,"about_ca_system_score_gemma":0.00015261912,"threshold_uncertainty_score":0.2981671},"labels":[],"label_agreement":null},{"id":"W2140920559","doi":"10.1016/j.jval.2014.03.428","title":"Treatment and Survival Patterns Among Alk+ Nsclc Patients Following Crizotinib Discontinuation","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Crizotinib; Medicine; Discontinuation; Regimen; Internal medicine; Lung cancer; Oncology; Chemotherapy; Surgery","score_opus":0.024100602778406022,"score_gpt":0.333350544246424,"score_spread":0.309249941468018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2140920559","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996594,0.00012418332,0.00029872745,0.00096932705,0.00034298145,0.0006851219,0.00001448833,0.000028227809,0.00094292086],"genre_scores_gemma":[0.9990395,0.0000762632,0.00028523983,0.00012043962,0.00007890791,0.000055986235,0.00012561258,0.00001691543,0.00020116131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99903226,0.00011957075,0.0002666888,0.00022479924,0.00013857303,0.00021808695],"domain_scores_gemma":[0.9995246,0.000088833454,0.00008322684,0.0001450693,0.000020323878,0.00013797257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016851947,0.0001145854,0.0002496844,0.00008005491,0.00008206846,0.000016096517,0.000019916268,0.000033620596,0.000007497106],"category_scores_gemma":[0.00004935893,0.00008837088,0.00004927666,0.00007552971,0.000013605448,0.00007867696,0.0000098910095,0.000050825645,0.0000040473856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017907021,0.00028720262,0.95941514,0.000041130137,0.00003665141,0.0000024832887,0.001564102,0.000034764173,0.0000035087357,0.0001597184,0.000010044032,0.03842738],"study_design_scores_gemma":[0.0047877086,0.0011047487,0.9916941,0.00025804737,0.000058162914,8.819259e-7,0.00020694516,0.0011833279,0.000019711655,0.000054586628,0.0005574603,0.000074304786],"about_ca_topic_score_codex":0.011947041,"about_ca_topic_score_gemma":0.0005405648,"teacher_disagreement_score":0.038353074,"about_ca_system_score_codex":0.00032666916,"about_ca_system_score_gemma":0.00009571806,"threshold_uncertainty_score":0.9946325},"labels":[],"label_agreement":null},{"id":"W2141663349","doi":"10.1016/j.jval.2014.01.003","title":"Questionnaire to Assess Relevance and Credibility of Modeling Studies for Informing Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":179,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Credibility; Distrust; Relevance (law); Dissemination; Management science; Health care; Task (project management); Computer science; Psychology; Knowledge management; Political science; Engineering; Economics; Management","score_opus":0.4817310823231186,"score_gpt":0.5263420092578712,"score_spread":0.044610926934752604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141663349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56881905,0.017023014,0.3798882,0.029513955,0.0010159938,0.0033194532,0.0001792304,0.000077530436,0.00016352719],"genre_scores_gemma":[0.86458033,0.0006643321,0.12691858,0.0073819472,0.00021615805,0.00016194048,0.00002422643,0.000037180613,0.00001527376],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99069923,0.00073653,0.006809975,0.00094594335,0.00019795736,0.00061033317],"domain_scores_gemma":[0.98986316,0.004078091,0.004380082,0.0008831324,0.00046375685,0.0003317871],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04863472,0.00024079633,0.001513817,0.00043071053,0.00037918708,0.00005141516,0.00022885775,0.0001397706,0.0000014690617],"category_scores_gemma":[0.05165822,0.00030168652,0.00007641889,0.00030025293,0.000049306116,0.0010461949,0.00009364844,0.00023471403,0.0000073390174],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005335824,0.00042359476,0.09185093,0.024662562,0.00011389199,0.0000040685113,0.092447706,0.5169174,0.0000028614354,0.24155588,0.001834952,0.029652532],"study_design_scores_gemma":[0.0020870324,0.0021191903,0.019595621,0.0058426154,0.000013312799,0.00008111962,0.02976217,0.8528374,0.0000033490894,0.06708083,0.019734703,0.0008426658],"about_ca_topic_score_codex":0.0060060886,"about_ca_topic_score_gemma":0.0013032409,"teacher_disagreement_score":0.33591995,"about_ca_system_score_codex":0.0018247796,"about_ca_system_score_gemma":0.00089947454,"threshold_uncertainty_score":0.99994355},"labels":[],"label_agreement":null},{"id":"W2141667151","doi":"10.1016/j.jval.2012.03.013","title":"CO2 Advancing the Methods of Cost-Effectiveness Analysis: Why It's Time to Move on from ICERs and Thresholds","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Nuclear and radioactivity studies","field":"Engineering","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Equity (law); Interpretation (philosophy); Actuarial science; Computer science; Decision analysis; Operations research; Risk analysis (engineering); Management science; Economics; Medicine; Political science; Mathematical economics; Mathematics; Law","score_opus":0.037788192031435804,"score_gpt":0.3424586716799383,"score_spread":0.3046704796485025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141667151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97897124,0.004071864,0.01276073,0.0011722774,0.00031791537,0.00073215103,0.00003999035,0.00006121408,0.0018725942],"genre_scores_gemma":[0.9960816,0.00018649305,0.0032242034,0.00041754506,0.000041983814,0.000021727146,0.0000014028044,0.00001320987,0.0000118205435],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.999049,0.00034671478,0.00016384223,0.000112872265,0.00008872594,0.00023881473],"domain_scores_gemma":[0.9984746,0.0012356138,0.00003057463,0.00017499362,0.000011329494,0.000072870665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012717535,0.00009819642,0.00033727044,0.0001501453,0.000056665125,0.000006312838,0.00006173519,0.000035705794,0.000010864207],"category_scores_gemma":[0.000082821665,0.00007391729,0.0000447717,0.00042692144,0.000021941867,0.00006559694,0.00002948565,0.00012981385,0.0000050237827],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008290783,0.00007604053,0.028158516,0.00029563304,0.0007502604,5.7218097e-7,0.0067648347,0.9198899,0.0013075977,0.00025660332,0.0012897098,0.041127384],"study_design_scores_gemma":[0.00074566476,0.0001864826,0.7783074,0.0005467543,0.0002789652,0.0000012770622,0.0017180134,0.19489542,0.003833925,0.00030503428,0.018795304,0.0003857665],"about_ca_topic_score_codex":0.0022185703,"about_ca_topic_score_gemma":0.00005377849,"teacher_disagreement_score":0.7501489,"about_ca_system_score_codex":0.00015583921,"about_ca_system_score_gemma":0.000011857823,"threshold_uncertainty_score":0.33538294},"labels":[],"label_agreement":null},{"id":"W2141925402","doi":"10.1016/j.jval.2014.03.930","title":"Cost-Effectiveness Of Long-Acting Reversible Contraception: Lng-Ius 13.5mg, A Low-Dose Contraceptive Levonorgestrel Intrauterine System Versus Oral Contraceptives","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Levonorgestrel; Medicine; Discontinuation; Family planning; Gynecology; Obstetrics; Population; Demography; Environmental health; Research methodology; Internal medicine","score_opus":0.08168405079042831,"score_gpt":0.3569799785499842,"score_spread":0.2752959277595559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2141925402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9762528,0.0016623259,0.0108713815,0.0014489924,0.0019218662,0.006165528,0.000049676717,0.00023862738,0.0013888023],"genre_scores_gemma":[0.9965962,0.0006006078,0.0014147745,0.00014956213,0.00064925477,0.0003481077,0.000079455036,0.00007789103,0.000084148676],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99313956,0.0023703552,0.0015863152,0.0011099261,0.00062644726,0.0011673836],"domain_scores_gemma":[0.9953968,0.0015660499,0.000995411,0.0008221338,0.0005970926,0.0006225042],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005275012,0.00054012536,0.0018276054,0.0004417358,0.00024241228,0.000035418267,0.00020715884,0.00032507855,0.00006191203],"category_scores_gemma":[0.0013495563,0.00053121446,0.00025589508,0.000723465,0.00031912353,0.00034658212,0.00006178657,0.00085562654,0.000054416585],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12001808,0.005457343,0.13173719,0.056693032,0.0010897914,0.00044854858,0.008106179,0.03920609,0.022575146,0.039236493,0.00034466918,0.5750874],"study_design_scores_gemma":[0.06882543,0.011449626,0.835174,0.016275842,0.00029692118,0.00044092085,0.0074638324,0.050338928,0.0050421567,0.00026580656,0.0030652243,0.0013612919],"about_ca_topic_score_codex":0.008703585,"about_ca_topic_score_gemma":0.00037872733,"teacher_disagreement_score":0.70343685,"about_ca_system_score_codex":0.0016196109,"about_ca_system_score_gemma":0.00088810304,"threshold_uncertainty_score":0.99971396},"labels":[],"label_agreement":null},{"id":"W2142200501","doi":"10.1016/j.jval.2014.08.2512","title":"Cost-Effectiveness of Fecal Microbiota Transplant in Treating Clostridium Difficile Infection in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clostridium difficile; Medicine; Fecal bacteriotherapy; Population; Internal medicine; Antibiotics; Environmental health; Microbiology; Biology","score_opus":0.04992519523411869,"score_gpt":0.3194485559266452,"score_spread":0.26952336069252647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142200501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972301,0.0002960082,0.000045524423,0.00044103753,0.00016611228,0.0014213155,0.000048954735,0.000014182871,0.0003367292],"genre_scores_gemma":[0.9991696,0.00049339834,0.00004805976,0.00005611299,0.000060332593,0.00006789665,0.00006455445,0.000027866196,0.000012200936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99672717,0.0008905037,0.00087770296,0.0004214224,0.0003819292,0.00070125033],"domain_scores_gemma":[0.99842304,0.0009049163,0.0001309212,0.00029018914,0.000056574267,0.00019436362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018100407,0.00021818608,0.00076908374,0.0005199014,0.00003889461,0.0000071506215,0.000097934404,0.00012587082,0.00002758579],"category_scores_gemma":[0.00028659363,0.0002141393,0.000070375165,0.0010111488,0.00004620228,0.00003965881,0.000029873374,0.0006439634,0.0000034849975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012799599,0.0008526375,0.9145496,0.0036906532,0.000016777787,0.000103056955,0.00046106687,0.015230017,0.052644927,0.00013289091,0.000051483148,0.010986945],"study_design_scores_gemma":[0.008023443,0.00095390284,0.7810465,0.004757317,0.000013429669,0.00007105082,0.00018060811,0.020906635,0.18325573,0.000021385962,0.00046655064,0.00030344832],"about_ca_topic_score_codex":0.9798872,"about_ca_topic_score_gemma":0.83989054,"teacher_disagreement_score":0.13999668,"about_ca_system_score_codex":0.0036425416,"about_ca_system_score_gemma":0.0032893803,"threshold_uncertainty_score":0.9525119},"labels":[],"label_agreement":null},{"id":"W2142297729","doi":"10.1016/s1098-3015(10)70319-3","title":"PIN21 COST-EFFECTIVENESS OF ANIDULAFUNGIN THERAPY IN CONFIRMED CANDIDEMIA AND OTHER FORMS OF INVASIVE CANDIDIASIS IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Anidulafungin; Invasive candidiasis; Echinocandins; Echinocandin; Medicine; Antifungal; Intensive care medicine; Micafungin; Dermatology; Fluconazole; Caspofungin","score_opus":0.06833240508313643,"score_gpt":0.3329543894010664,"score_spread":0.26462198431793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142297729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593115,0.002278889,0.0000014850124,0.00026264248,0.000048795813,0.0013712009,0.000031206306,0.0000026110174,0.000072013725],"genre_scores_gemma":[0.9967517,0.0024475434,0.000024438765,0.00067689555,0.000005571989,0.000074642616,0.0000065492895,0.000008667188,0.0000039613674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876714,0.0003322035,0.00037319053,0.00016000959,0.000119288736,0.00024819156],"domain_scores_gemma":[0.99907553,0.0005803622,0.00011612942,0.00010176367,0.000024655646,0.000101553545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000538983,0.00010543725,0.0005442319,0.00018185415,0.000018933015,4.2926635e-7,0.000039288392,0.0000621806,0.000019182537],"category_scores_gemma":[0.000060830207,0.00008754143,0.000019479892,0.0002489395,0.00006946907,0.000028317947,0.000009976925,0.00015918283,1.9550305e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000844186,0.0002258302,0.9946665,0.00044669452,0.000030947816,0.00013663305,0.0014608371,0.0005472927,0.0008067612,0.00006412776,0.000022284212,0.0007479169],"study_design_scores_gemma":[0.007081886,0.00046322308,0.97143465,0.0005246947,0.0000049553983,0.000032101452,0.00023759308,0.00019302235,0.019842999,0.00007274359,0.000050912397,0.00006124416],"about_ca_topic_score_codex":0.97780216,"about_ca_topic_score_gemma":0.9062829,"teacher_disagreement_score":0.071519226,"about_ca_system_score_codex":0.0011489653,"about_ca_system_score_gemma":0.0042635463,"threshold_uncertainty_score":0.75633484},"labels":[],"label_agreement":null},{"id":"W2142475605","doi":"10.1016/j.jval.2014.08.385","title":"Economic Evaluation of Bevacizumab Versus Ranibizumab in Neovascular Age-Related Macular Degeneration in China","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Ranibizumab; Medicine; Bevacizumab; Macular degeneration; Dosing; Regimen; Quality-adjusted life year; Economic evaluation; Ophthalmology; Cost effectiveness; Internal medicine","score_opus":0.28532994394400635,"score_gpt":0.40733061895069456,"score_spread":0.12200067500668821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2142475605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98501414,0.0036733823,0.00040552445,0.0061977385,0.0010392034,0.001712261,0.00003968023,0.000023834738,0.0018942456],"genre_scores_gemma":[0.9975966,0.00032778663,0.0012074622,0.00042497847,0.0001189707,0.00014965185,0.000109383924,0.000040173552,0.000024987068],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98900473,0.0028742305,0.006543882,0.0007736129,0.00022269867,0.0005808734],"domain_scores_gemma":[0.9964549,0.00062049006,0.0020695066,0.00067463145,0.00004258732,0.00013788468],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.063755184,0.00024269435,0.001363095,0.0012564586,0.00007489433,0.00003409063,0.00027828015,0.00025531414,0.00026590485],"category_scores_gemma":[0.0029512981,0.0003463612,0.00013714738,0.0004742272,0.00005710672,0.00041982016,0.00003933735,0.0003242562,0.00030044108],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001135593,0.00020539023,0.044814028,0.0005071754,0.000036420384,0.0000015942298,0.00570918,0.83249676,0.000007291453,0.11331432,0.00024973092,0.0025445302],"study_design_scores_gemma":[0.0116432095,0.00021893256,0.13587758,0.00030534557,0.0000075895373,0.0000026294365,0.00026003268,0.82019985,0.000018135983,0.029908037,0.0011954561,0.0003631843],"about_ca_topic_score_codex":0.036605664,"about_ca_topic_score_gemma":0.008741342,"teacher_disagreement_score":0.09106355,"about_ca_system_score_codex":0.0047465526,"about_ca_system_score_gemma":0.00076464633,"threshold_uncertainty_score":0.99989885},"labels":[],"label_agreement":null},{"id":"W2143020284","doi":"10.1016/j.jval.2014.03.529","title":"Cost-Utility Analysis of Practice Deviations From Guidelines in HER2-Targeted Testing and Treatment for Breast Cancer","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Calgary; Ontario Institute for Cancer Research; McMaster University","funders":"","keywords":"Medicine; Trastuzumab; Observational study; Breast cancer; Companion diagnostic; Population; Oncology; Internal medicine; Disease; Personalized medicine; Cancer; Bioinformatics; Environmental health; Biology","score_opus":0.6188629693344477,"score_gpt":0.5111760297159271,"score_spread":0.1076869396185206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143020284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87137085,0.0058585983,0.01104746,0.10324156,0.00029628334,0.0022686967,0.00567018,0.00003018311,0.00021620396],"genre_scores_gemma":[0.9580641,0.0006358802,0.036173943,0.0045380425,0.00014627581,0.00033020176,0.000071854985,0.000017644317,0.000022056245],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945593,0.00064216205,0.0039682062,0.0004759197,0.000057213554,0.00029723888],"domain_scores_gemma":[0.99112445,0.006024141,0.0022367614,0.0003192955,0.00017039164,0.00012497505],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015201695,0.00013362059,0.0011040309,0.0005421271,0.000090560265,0.000021414182,0.00009117839,0.00008290472,0.000054841526],"category_scores_gemma":[0.014572806,0.00016036167,0.00007078736,0.000693558,0.000029637104,0.00022203736,0.00001703947,0.00007403072,0.000007367842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002962974,0.00015297574,0.9444785,0.00017658508,0.00015960907,8.2851535e-8,0.0019429551,0.0395516,6.927679e-7,0.003877441,0.00025946542,0.00937044],"study_design_scores_gemma":[0.000630728,0.000046623296,0.54458994,0.00008444726,0.000024683397,2.9768077e-7,0.00031642016,0.44836214,5.0257967e-7,0.001983802,0.003872307,0.000088114095],"about_ca_topic_score_codex":0.40851113,"about_ca_topic_score_gemma":0.0254355,"teacher_disagreement_score":0.40881053,"about_ca_system_score_codex":0.0009637049,"about_ca_system_score_gemma":0.00036680288,"threshold_uncertainty_score":0.99372786},"labels":[],"label_agreement":null},{"id":"W2143025931","doi":"10.1016/j.jval.2013.02.002","title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS)—Explanation and Elaboration: A Report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2058,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa; Institute of Health Economics","funders":"Medical Research Council; Kela","keywords":"Task force; Elaboration; Health economics; Economic evaluation; Accounting; Task (project management); Business; Medicine; Political science; Health care; Economics; Public administration; Economic growth; Management","score_opus":0.5234036790781761,"score_gpt":0.5271619286619199,"score_spread":0.0037582495837438223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143025931","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6000874,0.008057059,0.0015888952,0.37734148,0.0017240525,0.00929612,0.0005253902,0.00010235402,0.001277256],"genre_scores_gemma":[0.98100793,0.0010025613,0.0069082254,0.008313835,0.00054362003,0.0010015098,0.00094596593,0.000080945145,0.00019538078],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.95257664,0.0040872516,0.039696746,0.001766285,0.00087571307,0.0009973516],"domain_scores_gemma":[0.81982875,0.0010152865,0.17557828,0.0014417965,0.0017485132,0.00038737306],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.26046503,0.0003845111,0.0018989033,0.0007531575,0.00066319696,0.00029540696,0.0003294329,0.00023266724,0.00031847783],"category_scores_gemma":[0.10527255,0.00042667848,0.00015559896,0.0005211088,0.000114305156,0.0022270929,0.00010118805,0.00040261762,0.0000731085],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000105935746,0.0004613763,0.52636003,0.0056686,0.0004313531,0.0000029388382,0.020607652,0.14438404,0.000044126053,0.08063309,0.1922312,0.029069645],"study_design_scores_gemma":[0.0022497529,0.00032087654,0.14349991,0.0009494298,0.000026989717,0.000207889,0.0049591903,0.81431305,0.000024163714,0.014969198,0.017874282,0.00060527964],"about_ca_topic_score_codex":0.08348769,"about_ca_topic_score_gemma":0.0047804886,"teacher_disagreement_score":0.669929,"about_ca_system_score_codex":0.010137866,"about_ca_system_score_gemma":0.015920835,"threshold_uncertainty_score":0.9998185},"labels":[],"label_agreement":null},{"id":"W2143677294","doi":"10.1016/j.jval.2015.06.007","title":"What Guidance are Economists Given on How to Present Economic Evaluations for Policymakers? A Systematic Review","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Canadian Institutes of Health Research","keywords":"Presentation (obstetrics); Viewpoints; Glossary; Terminology; Economic evaluation; Transparency (behavior); Economic data; Economic statistics; Actuarial science; Management science; Computer science; Medicine; Economics; Macroeconomics","score_opus":0.6837311489823416,"score_gpt":0.5444814760980674,"score_spread":0.13924967288427414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143677294","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000029392784,0.8734423,0.0001859619,0.09427363,0.0023252422,0.026787035,0.0026742995,0.00006897735,0.00023964097],"genre_scores_gemma":[0.000004426984,0.96423376,0.0010949941,0.017956981,0.0011607965,0.013301775,0.0003063336,0.00021544092,0.0017254943],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9786587,0.0037413188,0.0139914155,0.0020491828,0.00023895194,0.0013204736],"domain_scores_gemma":[0.977024,0.004951948,0.0143456645,0.0025133083,0.00017119574,0.0009938403],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.0636785,0.0009798324,0.012434434,0.0015330882,0.0002562692,0.00045830267,0.0012821675,0.0004896652,0.00008517749],"category_scores_gemma":[0.012741823,0.0011313654,0.0010334702,0.0004901906,0.00005733176,0.0007985241,0.00015352602,0.00051620003,0.005605851],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000049749783,0.00007864168,0.000006867058,0.83623606,0.00015348895,7.3527866e-7,0.0005308454,0.0012610797,1.8715249e-10,0.011867358,0.14777857,0.0020813781],"study_design_scores_gemma":[0.00035653546,0.00016690789,0.000004238704,0.41437885,0.00008714549,0.000009308562,0.00022185889,0.0014837967,4.440191e-9,0.0014441229,0.58127177,0.000575448],"about_ca_topic_score_codex":0.0014337617,"about_ca_topic_score_gemma":0.0003192318,"teacher_disagreement_score":0.4334932,"about_ca_system_score_codex":0.015060078,"about_ca_system_score_gemma":0.003983759,"threshold_uncertainty_score":0.9991136},"labels":[],"label_agreement":null},{"id":"W2143845636","doi":"10.1016/j.jval.2015.09.142","title":"The Cost and Length of Stay of Hospital Emergency Department Visits for Chronic Heart Failure Patients in Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Heart failure; Emergency department; Ambulatory; Emergency medicine; Demographics; Retrospective cohort study; Healthcare Cost and Utilization Project; Acute care; Patient discharge; Hospital discharge; Health care; Medical emergency; Database; MEDLINE; Intensive care medicine; Internal medicine; Demography","score_opus":0.021917497148799696,"score_gpt":0.2918268766253127,"score_spread":0.269909379476513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2143845636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98585206,0.0091060875,0.000002540417,0.003396752,0.00046267456,0.0010566964,0.00009587658,0.0000019771899,0.00002533678],"genre_scores_gemma":[0.99691063,0.002832627,0.00009587446,0.000051547286,0.000033751647,0.00004297405,0.000016130929,0.000006854392,0.000009636141],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989752,0.000051536346,0.00043178524,0.000118031916,0.00019447072,0.00022893133],"domain_scores_gemma":[0.9994827,0.00006300648,0.00011030086,0.00011383963,0.00014136257,0.00008878083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032616753,0.00007579764,0.0002529258,0.000031571417,0.000036328354,5.753587e-7,0.00003900406,0.000019351757,0.0000025621885],"category_scores_gemma":[0.00018063826,0.000054027834,0.000022465436,0.000122062935,0.000021332426,0.000021868938,0.000025275847,0.000069102556,1.13841196e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067857974,0.00011370988,0.96356046,0.00046919225,0.000028935683,7.0928223e-7,0.0010161407,0.00009342814,0.0000036266688,0.00014783308,0.032313738,0.0021843652],"study_design_scores_gemma":[0.0043033566,0.004593744,0.93314534,0.00049957016,0.000023454235,7.786631e-7,0.0040930817,0.00068108505,0.00033172645,0.00023011664,0.05193206,0.0001656931],"about_ca_topic_score_codex":0.51361793,"about_ca_topic_score_gemma":0.7589707,"teacher_disagreement_score":0.24535273,"about_ca_system_score_codex":0.00048039667,"about_ca_system_score_gemma":0.001363336,"threshold_uncertainty_score":0.48962092},"labels":[],"label_agreement":null},{"id":"W2144934383","doi":"10.1016/j.jval.2013.10.008","title":"A Synthesis of Drug Reimbursement Decision-Making Processes in Organisation for Economic Co-operation and Development Countries","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":67,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Alberta; University of Calgary","funders":"","keywords":"Formulary; Reimbursement; Transparency (behavior); Business; Medical prescription; Actuarial science; Public economics; Medicine; Economics; Health care; Family medicine; Computer science; Pharmacology; Economic growth","score_opus":0.19700052114875882,"score_gpt":0.4067100004600565,"score_spread":0.2097094793112977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144934383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9711207,0.0015816591,0.016617829,0.008535655,0.00024903007,0.0015941535,0.00011283383,0.000019166213,0.00016894494],"genre_scores_gemma":[0.97844446,0.00035096682,0.019582218,0.0012922203,0.00006896529,0.00022055105,0.000014111115,0.000020143483,0.0000063913053],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9955495,0.00023138309,0.003503613,0.00038823343,0.0000624092,0.0002648413],"domain_scores_gemma":[0.99427766,0.0040020016,0.0014534942,0.00018375348,0.0000186591,0.000064433],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018978734,0.00012398166,0.00069855055,0.0004182533,0.00012578504,0.000041501247,0.00010574352,0.0000659167,0.00009707702],"category_scores_gemma":[0.0021193589,0.00015939801,0.000018130082,0.00003976602,0.000031823776,0.00026564242,0.000018306879,0.000059491806,0.00012511545],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018822965,0.00028662093,0.6996651,0.013432401,0.0000530428,2.628546e-7,0.056368243,0.064828806,0.0000024675046,0.14737743,0.002990179,0.014807154],"study_design_scores_gemma":[0.007111677,0.0006447085,0.34425226,0.005843392,0.000013171106,0.0000098610735,0.015102406,0.34830067,0.00097492366,0.11150573,0.16421588,0.0020253374],"about_ca_topic_score_codex":0.0016279675,"about_ca_topic_score_gemma":0.0015691798,"teacher_disagreement_score":0.3554129,"about_ca_system_score_codex":0.0012395898,"about_ca_system_score_gemma":0.0008625223,"threshold_uncertainty_score":0.6577688},"labels":[],"label_agreement":null},{"id":"W2145695460","doi":"10.1016/j.jval.2015.05.008","title":"Rare Disease Terminology and Definitions—A Systematic Global Review: Report of the ISPOR Rare Disease Special Interest Group","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":604,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Terminology; Orphan drug; Rare disease; Disease; Medicine; Descriptive statistics; Family medicine; Diversity (politics); Actuarial science; Demography; Statistics; Business; Pathology; Political science; Mathematics","score_opus":0.09712492353042428,"score_gpt":0.34315913216346045,"score_spread":0.24603420863303616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145695460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010135865,0.993779,0.0000027476206,0.00025183134,0.0005680924,0.0024354127,0.0018800122,0.0000062386957,0.000063055966],"genre_scores_gemma":[0.0016517565,0.99581075,0.000030751955,0.00033408796,0.0004513758,0.00021914198,0.0014169348,0.000032462398,0.00005275502],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.996646,0.00086570537,0.001395403,0.00059667276,0.00018488658,0.0003113583],"domain_scores_gemma":[0.9972576,0.000038709364,0.0010852966,0.0010557016,0.0000981148,0.00046458983],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005976948,0.00037164526,0.0014594925,0.000059346366,0.00007521524,0.000017175917,0.00041672753,0.00016495465,0.0000080612335],"category_scores_gemma":[0.0009083551,0.00025289852,0.00046132432,0.00018464882,0.00014192326,0.0000035860257,0.00035433308,0.00015985675,0.000004973671],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005367689,0.00025020045,0.0009024862,0.9725413,0.0000952344,0.0006429386,0.0000124239095,0.000003478981,1.5606867e-7,0.000997519,0.009812929,0.014687668],"study_design_scores_gemma":[0.00035313598,0.00013373431,0.0008591418,0.26729903,0.0010221646,0.0008760911,0.000027196895,0.000004515135,6.934686e-8,0.00072784716,0.728226,0.000471094],"about_ca_topic_score_codex":0.000064471504,"about_ca_topic_score_gemma":0.000038011978,"teacher_disagreement_score":0.71841305,"about_ca_system_score_codex":0.00014319089,"about_ca_system_score_gemma":0.0022709596,"threshold_uncertainty_score":0.9999923},"labels":[],"label_agreement":null},{"id":"W2145838058","doi":"10.1016/j.jval.2015.03.162","title":"Examining The Relationship Between Health-Related Quality Of Life And Increasing Numbers Of Diseases","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Multiplicative function; Medical diagnosis; Linear model; Additive model; Statistics; Quality of life (healthcare); Mathematics; Medicine; EQ-5D; Demography; Econometrics; Health related quality of life; Psychology; Disease","score_opus":0.7419016618334474,"score_gpt":0.468172556957525,"score_spread":0.2737291048759224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2145838058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.959605,0.012341099,0.0003235959,0.026274256,0.00018883501,0.0006630258,0.00026481537,0.00002242712,0.00031695364],"genre_scores_gemma":[0.99667245,0.000102013146,0.0014198851,0.0016279491,0.00008321649,0.00001814867,0.000030702846,0.00002076492,0.000024881818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9877635,0.0038627386,0.007473513,0.00037687866,0.00015690827,0.00036643824],"domain_scores_gemma":[0.9819499,0.011520467,0.00555426,0.00047418737,0.00005779577,0.00044337506],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.0623225,0.00013879915,0.0013695179,0.0003065872,0.00015190338,0.00001806595,0.00019258013,0.000106375366,0.000011267807],"category_scores_gemma":[0.034279454,0.00015122604,0.000056861587,0.00041768196,0.00016859066,0.00024555062,0.000058120866,0.00023920115,0.000024826255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020047331,0.000035479934,0.91945696,0.00086781353,0.000016725895,4.6404356e-8,0.0053699133,0.00081355276,4.2337206e-8,0.07277953,0.0005550368,0.00008482799],"study_design_scores_gemma":[0.00083722355,0.000101827165,0.9574341,0.00026412046,0.0000019454228,0.0000010021657,0.003220954,0.0011757526,9.6605646e-8,0.036667857,0.00018223871,0.00011284288],"about_ca_topic_score_codex":0.10040294,"about_ca_topic_score_gemma":0.00025462266,"teacher_disagreement_score":0.10014832,"about_ca_system_score_codex":0.0005571802,"about_ca_system_score_gemma":0.0011295974,"threshold_uncertainty_score":0.9738552},"labels":[],"label_agreement":null},{"id":"W2146146912","doi":"10.1016/j.jval.2013.03.1610","title":"The use of selected psychotropic drugs among seniors on public drug programs in canada, 2001 to 2010","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Balance, Gait, and Falls Prevention","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Medicine; Psychotropic drug; Medical prescription; Drug; Drug class; Nursing homes; Psychotropic Agent; Psychiatry; Gerontology; Family medicine; Nursing","score_opus":0.07605956238046473,"score_gpt":0.32846199918812735,"score_spread":0.2524024368076626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146146912","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832703,0.00008643359,0.000007548568,0.012271751,0.0010327427,0.003130948,0.000013499196,0.00003472423,0.00015204946],"genre_scores_gemma":[0.99515945,0.00029923723,0.00040924922,0.0015970261,0.00008671037,0.00054442434,0.000026610775,0.000027967615,0.0018493007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955341,0.0016851682,0.0010027126,0.00030860121,0.00036791383,0.0011014595],"domain_scores_gemma":[0.99805653,0.0005843217,0.00037746358,0.00045848524,0.00018951914,0.000333707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011277425,0.00016092215,0.00032859005,0.00019152173,0.00030816114,0.000020359912,0.0002578501,0.000110441484,0.000025243979],"category_scores_gemma":[0.00023709357,0.00012166287,0.000031219766,0.0010964044,0.000038565697,0.00016893932,0.000041796065,0.0008495641,0.00005620865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034772762,0.00032484296,0.89179164,0.00024051021,0.000008502016,8.2652156e-7,0.002858624,0.000056852565,0.000039130213,0.0003500393,0.090622045,0.013672198],"study_design_scores_gemma":[0.00065533596,0.0000850116,0.98112327,0.0005645297,0.0000012304826,1.865714e-7,0.0013882648,0.00208581,4.4321567e-7,0.00019859994,0.013790072,0.00010722701],"about_ca_topic_score_codex":0.98921824,"about_ca_topic_score_gemma":0.9810784,"teacher_disagreement_score":0.089331634,"about_ca_system_score_codex":0.0011719179,"about_ca_system_score_gemma":0.0028144843,"threshold_uncertainty_score":0.49927744},"labels":[],"label_agreement":null},{"id":"W2146368704","doi":"10.1016/s1098-3015(10)73116-8","title":"HT2 HEALTH TECHNOLOGY ASSESSMENT – A COMPREHENSIVE FRAMEWORK FOR EVIDENCE-BASED RECOMMENDATIONS IN ONTARIO","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Electronic Health Records Systems","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real world evidence; Health technology; Data science; Environmental planning; Computer science; Medicine; Health care; Political science; Environmental science","score_opus":0.30291084601221,"score_gpt":0.5329287889984506,"score_spread":0.23001794298624062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146368704","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12843789,0.0062342435,0.048062213,0.7957115,0.0030239644,0.017727762,0.000050316277,0.00042702467,0.00032506802],"genre_scores_gemma":[0.75224733,0.0016152338,0.17714775,0.06460191,0.00035570152,0.0034254459,0.00010916716,0.00008821131,0.00040927622],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.989718,0.0034988928,0.0030501299,0.0008547916,0.00037831848,0.002499856],"domain_scores_gemma":[0.99159956,0.005563617,0.0012901993,0.0008471609,0.00024957192,0.0004498968],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006404195,0.00035124726,0.0012385056,0.0011983544,0.0009126157,0.000013278251,0.00042703183,0.0006203427,0.00014276424],"category_scores_gemma":[0.00090621127,0.00036741362,0.00009710917,0.0014908813,0.000048616446,0.0001810144,0.000049375973,0.0038113669,0.000047350022],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00052833266,0.0016441972,0.46135485,0.0063468674,0.000032495307,0.000014141491,0.014205276,0.0052558267,0.000025931782,0.39210886,0.020908143,0.09757507],"study_design_scores_gemma":[0.008367408,0.010860021,0.36212072,0.05675761,0.00001118341,0.0000123611735,0.009900662,0.023646304,0.000006665626,0.14065878,0.38653427,0.0011240331],"about_ca_topic_score_codex":0.33238706,"about_ca_topic_score_gemma":0.34422314,"teacher_disagreement_score":0.7311096,"about_ca_system_score_codex":0.018808847,"about_ca_system_score_gemma":0.036856517,"threshold_uncertainty_score":0.9998778},"labels":[],"label_agreement":null},{"id":"W2146957057","doi":"10.1016/j.jval.2014.08.1594","title":"Family Preferences in the Volume Verse Outcome Debate: Implications for the Delivery of Complex Pediatric Care","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Izaak Walton Killam Health Centre","funders":"","keywords":"Outcome (game theory); Medicine; Absolute risk reduction; Demography; Relative risk; Actuarial science; Medical emergency; Business; Economics; Environmental health; Confidence interval; Microeconomics","score_opus":0.2044707153921128,"score_gpt":0.428977529961082,"score_spread":0.2245068145689692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2146957057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96807766,0.0025229354,0.00041828677,0.024026329,0.0005441751,0.003661995,0.00021753985,0.000035708297,0.00049535505],"genre_scores_gemma":[0.99126524,0.0010255015,0.00029969038,0.0068558687,0.0003716531,0.000093066956,0.000043093038,0.000015113238,0.000030804094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966974,0.0013018427,0.0010150782,0.00024486153,0.0001797711,0.00056101487],"domain_scores_gemma":[0.99612725,0.0027810954,0.00039358356,0.00049202656,0.00011845055,0.00008757804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023307586,0.0001312547,0.0003271519,0.00013874525,0.0006763806,0.0000062298786,0.00046731846,0.000099650184,0.0000135616465],"category_scores_gemma":[0.00026168476,0.00007882284,0.00007165917,0.00043310542,0.000049165898,0.000047506062,0.000059922662,0.000548007,0.000021911495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030317477,0.00008261136,0.9697853,0.0015834238,0.0000020614282,6.664796e-8,0.012313884,0.00036746394,0.000002004066,0.0058531105,0.0047509973,0.0052287686],"study_design_scores_gemma":[0.0008130303,0.00011641313,0.97194636,0.00014242002,0.000009228695,2.924157e-7,0.011975013,0.0019608524,8.3190386e-8,0.0008494663,0.0121117355,0.00007511241],"about_ca_topic_score_codex":0.017297555,"about_ca_topic_score_gemma":0.0026164167,"teacher_disagreement_score":0.023187533,"about_ca_system_score_codex":0.00019781382,"about_ca_system_score_gemma":0.00081969774,"threshold_uncertainty_score":0.98924637},"labels":[],"label_agreement":null},{"id":"W2147052884","doi":"10.1016/j.jval.2014.03.832","title":"Increased In Acute Health Care Use Among People Living With Human Immunodeficiency Virus (Hiv) And Co-Morbid Depression In Ontario: A Longitudinal Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital; Toronto Public Health; Institute for Clinical Evaluative Sciences; Ontario HIV Treatment Network; McMaster University; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Depression (economics); Triage; Cohort; Population; Cohort study; Emergency department; Distress; Longitudinal study; Acute care; Psychiatry; Health care; Internal medicine; Environmental health","score_opus":0.04653396919134637,"score_gpt":0.3660595469849168,"score_spread":0.3195255777935704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147052884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973782,0.0005543592,0.00008349468,0.00011901128,0.000015640422,0.001566859,0.000013728027,0.000026519656,0.00024224428],"genre_scores_gemma":[0.99920106,0.00008154519,0.00024249537,0.00007488419,0.000013356746,0.000107515494,0.00004518533,0.000025974065,0.00020798056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967969,0.00090065,0.0006941925,0.00049067615,0.0004395138,0.0006780536],"domain_scores_gemma":[0.9988401,0.00021492271,0.00015801666,0.00040098236,0.000057769917,0.00032820072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017337017,0.00019354248,0.00059840106,0.000680943,0.00022377736,0.00005347651,0.00012494656,0.00005978426,0.000060085014],"category_scores_gemma":[0.00022984449,0.00016289955,0.000045851633,0.0004805592,0.00006890716,0.00023716775,0.0000942053,0.00078969676,0.0000048336947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018150434,0.0010866706,0.9802921,0.0003050207,0.000013940135,0.000047163372,0.01733916,0.00005920922,0.000052708398,0.000015687105,0.00009676187,0.0005101064],"study_design_scores_gemma":[0.0032364225,0.00657004,0.9820894,0.0030186493,0.000008500501,0.000023872572,0.003437033,0.0014506686,0.000007133682,0.0000045185,0.000027708424,0.00012605173],"about_ca_topic_score_codex":0.92962766,"about_ca_topic_score_gemma":0.94058824,"teacher_disagreement_score":0.013902129,"about_ca_system_score_codex":0.0010919183,"about_ca_system_score_gemma":0.00081945263,"threshold_uncertainty_score":0.6642851},"labels":[],"label_agreement":null},{"id":"W2147121365","doi":"10.1016/j.jval.2014.03.150","title":"Impact Of The Pan Canadian Pricing Alliance On Time To Listing In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Intelligent Mechatronic Systems (Canada)","funders":"","keywords":"Formulary; Listing (finance); Business; Medicine; Negotiation; Accounting; Actuarial science; Family medicine; Political science; Finance","score_opus":0.36086119259712857,"score_gpt":0.5169666617294307,"score_spread":0.15610546913230217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147121365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811692,0.00013380134,8.232376e-7,0.014592488,0.00038354984,0.000599857,0.000079442376,0.000008309675,0.0030324748],"genre_scores_gemma":[0.98503965,0.000026064014,0.00002162471,0.014602814,0.00011072938,0.000015042206,0.0000031148304,0.00001351261,0.0001674328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969033,0.0013259697,0.00051792036,0.00024231979,0.00015347992,0.00085701206],"domain_scores_gemma":[0.9981061,0.00072877866,0.00013152041,0.0002099924,0.00003678832,0.00078677176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017263269,0.00015130664,0.00029744982,0.00010068076,0.00017158536,0.000004551132,0.0003173245,0.00017291264,0.00038938448],"category_scores_gemma":[0.0004901142,0.00012297071,0.000042522337,0.00056417927,0.00003659737,0.00002875123,0.000037023696,0.0015359463,0.00004595739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012208622,0.00008913377,0.76409996,0.00019694521,0.0000167088,0.000017056927,0.0008194912,0.20153242,0.00033153605,0.00058397854,0.006233084,0.025957605],"study_design_scores_gemma":[0.0009080225,0.00030328176,0.8602436,0.00054248783,0.000006644323,0.000007120883,0.00007550343,0.091017395,0.0006805058,0.00017695225,0.045777183,0.00026127533],"about_ca_topic_score_codex":0.99578846,"about_ca_topic_score_gemma":0.98854065,"teacher_disagreement_score":0.11051502,"about_ca_system_score_codex":0.0035923088,"about_ca_system_score_gemma":0.0071772602,"threshold_uncertainty_score":0.9984511},"labels":[],"label_agreement":null},{"id":"W2147408140","doi":"10.1016/j.jval.2012.08.505","title":"MO3 Lessons Learned From a Cross-Validation Between a Discrete-Event Simulation Model and a Markov Model for Personalized Breast Cancer Treatment","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Public Health","funders":"","keywords":"Breast cancer; Markov model; Discrete event simulation; Event (particle physics); Computer science; Medicine; Cohort; Econometrics; Markov chain; Statistics; Cancer; Machine learning; Simulation; Internal medicine; Mathematics","score_opus":0.6086760173766933,"score_gpt":0.5163141255591167,"score_spread":0.09236189181757659,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147408140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76956886,0.0030851823,0.16454053,0.053101297,0.00016140363,0.0017732854,0.0076973843,0.000040415547,0.000031639214],"genre_scores_gemma":[0.98796415,0.00078316696,0.008109417,0.0013006483,0.00038096373,0.00058746396,0.0003027127,0.000049656686,0.0005217887],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99583197,0.00033301147,0.0025186376,0.00059477176,0.00010133503,0.0006202798],"domain_scores_gemma":[0.996856,0.0010441787,0.0014039654,0.0003179423,0.000045750035,0.00033221513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00731423,0.00023945325,0.00095298997,0.00023916399,0.00026508645,0.000079515616,0.00010671523,0.00016552469,0.000049307484],"category_scores_gemma":[0.00039521413,0.00028226714,0.00012053969,0.00011589146,0.000051752377,0.00061700935,0.000030895502,0.00011065222,0.0000286539],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086288164,0.00011674733,0.17233133,0.00026777372,0.000050984247,3.2798514e-8,0.008800055,0.8018526,0.0000010541175,0.014178865,0.00009636759,0.0022179359],"study_design_scores_gemma":[0.0020170896,0.00004402013,0.055095784,0.00010895421,0.000011581462,3.8187721e-7,0.00018792262,0.9253584,8.4187883e-7,0.016283263,0.0006576951,0.0002340483],"about_ca_topic_score_codex":0.02117832,"about_ca_topic_score_gemma":0.00028627293,"teacher_disagreement_score":0.21839531,"about_ca_system_score_codex":0.0022743505,"about_ca_system_score_gemma":0.0004301478,"threshold_uncertainty_score":0.9999629},"labels":[],"label_agreement":null},{"id":"W2147546274","doi":"10.1111/j.1524-4733.2007.00180.x","title":"The Cost-Effectiveness of Stem Cell Transplantations from Unrelated Donors in Adult Patients with Acute Leukemia","year":2007,"lang":"en","type":"review","venue":"Value in Health","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Medicine; Cord blood; Transplantation; Stem cell; Acute leukemia; Cost effectiveness; Haematopoiesis; Leukemia; Hematopoietic stem cell transplantation; Bone marrow; Surgery; Internal medicine; Oncology; Biology","score_opus":0.05235193059888549,"score_gpt":0.34201199137865906,"score_spread":0.2896600607797736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147546274","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08153908,0.9032729,0.0008505086,0.000023315604,0.0003852638,0.012434525,0.0010066088,0.000048859354,0.00043891667],"genre_scores_gemma":[0.0065394416,0.9913354,0.00027114985,0.000023637114,0.000016163818,0.00026890574,0.001450991,0.000073208066,0.000021135626],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99582165,0.0012241796,0.0015545381,0.0004497175,0.00049327227,0.0004566224],"domain_scores_gemma":[0.9951089,0.0035817036,0.00060501264,0.00041212514,0.00013038181,0.00016186322],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012253277,0.00038717923,0.0017352244,0.00039574553,0.00006665735,0.000009112879,0.00018192222,0.00036891038,0.000005348143],"category_scores_gemma":[0.000010576703,0.00025222873,0.00015630628,0.0009726817,0.00007904519,0.0000468593,0.000007231372,0.000781368,0.000014135932],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028959338,0.0010185501,0.03781706,0.3214298,0.0008264877,0.00041618812,0.005727071,0.0015557995,0.0000027122771,0.00051761715,0.000014899328,0.6277779],"study_design_scores_gemma":[0.03475786,0.0026347132,0.0816488,0.84195834,0.005125943,0.00017499224,0.0006850683,0.00075330824,0.00020631864,0.000087886656,0.03029582,0.0016709594],"about_ca_topic_score_codex":0.0068664253,"about_ca_topic_score_gemma":0.00048065526,"teacher_disagreement_score":0.6261069,"about_ca_system_score_codex":0.0012755161,"about_ca_system_score_gemma":0.0020884376,"threshold_uncertainty_score":0.99999297},"labels":[],"label_agreement":null},{"id":"W2147598538","doi":"10.1016/j.jval.2014.08.1028","title":"The Trend of the Prices Of New Marketed Drugs in Turkey","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Christian ministry; Factory (object-oriented programming); Government (linguistics); Business; Quarter (Canadian coin); Health care; Descriptive statistics; Consumption (sociology); Agricultural economics; Agricultural science; Geography; Economics; Economic growth; Mathematics; Political science; Statistics; Computer science; Environmental science","score_opus":0.07080932889010885,"score_gpt":0.30057025108409685,"score_spread":0.229760922193988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147598538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9649689,0.0026061898,0.000013831374,0.012248929,0.00034756731,0.00022137752,0.000045148412,0.0000037021218,0.019544357],"genre_scores_gemma":[0.99782306,0.0012330277,0.00007924136,0.000599051,0.000050827133,0.0000038622447,7.612993e-7,0.000008093636,0.00020205788],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99870616,0.000069079375,0.00082065095,0.00014475039,0.000022113249,0.00023727337],"domain_scores_gemma":[0.99883306,0.0003639905,0.00045748032,0.0002768019,0.000004270021,0.000064374886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018300855,0.00006973708,0.00028927758,0.00011478222,0.0000364033,0.000010400476,0.00030699134,0.000042630003,0.000034290373],"category_scores_gemma":[0.00018096514,0.000052508614,0.00006430538,0.00028632907,0.000059501574,0.000040391966,0.000053747863,0.00014530022,0.000010511515],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055848264,0.00010380261,0.115690425,0.00019612128,0.000017810982,5.8088908e-8,0.0030186852,0.0064674374,0.000006661223,0.85710686,0.002296282,0.015040018],"study_design_scores_gemma":[0.0016023621,0.00009777461,0.33233818,0.000113386865,0.0000018779176,6.690908e-7,0.000107737134,0.15728574,0.00012969249,0.21308903,0.29504803,0.00018551524],"about_ca_topic_score_codex":0.015196534,"about_ca_topic_score_gemma":0.00035434234,"teacher_disagreement_score":0.6440178,"about_ca_system_score_codex":0.00008304321,"about_ca_system_score_gemma":0.00008378011,"threshold_uncertainty_score":0.9913614},"labels":[],"label_agreement":null},{"id":"W2147874776","doi":"10.1016/j.jval.2012.08.1471","title":"PRM7 Increasing Physical Activity in Patients With Chronic Disease: What is the Literature Telling Us?","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; Physical therapy; Psychological intervention; Intervention (counseling); Randomized controlled trial; Aerobic exercise; Clinical trial; Quality of life (healthcare); Internal medicine","score_opus":0.028750937671518022,"score_gpt":0.3192341156498267,"score_spread":0.29048317797830864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2147874776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988825,0.0065454654,0.000008625416,0.0031308255,0.00013457869,0.001173211,0.000009750511,0.000034381657,0.00013815248],"genre_scores_gemma":[0.9982138,0.0006226483,0.00003950819,0.00064197514,0.0003531484,0.000036561956,0.000035107496,0.000026366954,0.00003085044],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982832,0.00027309667,0.00017792328,0.00027099505,0.00042392674,0.0005708259],"domain_scores_gemma":[0.9990536,0.00014724705,0.0001070515,0.00041497333,0.000027168518,0.00024994023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004886093,0.00018515697,0.000270126,0.00012097172,0.00008322773,0.000097136115,0.00009683958,0.000036050445,0.00001901691],"category_scores_gemma":[0.000041910156,0.00012099695,0.000051328803,0.00050263986,0.000068519665,0.0007681046,0.000057885347,0.00038608382,0.000010645242],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010071519,0.0020581246,0.972977,0.0025818276,0.00003971195,0.000015664153,0.0039736,0.0013643559,0.0000037367736,0.0005753043,0.000171856,0.01523167],"study_design_scores_gemma":[0.0017603977,0.00017604078,0.98868936,0.0038867714,0.00003255283,8.8955113e-7,0.00017350951,0.0042154444,0.000008732992,0.00010474154,0.0008248295,0.00012674525],"about_ca_topic_score_codex":0.0007659948,"about_ca_topic_score_gemma":0.000018414366,"teacher_disagreement_score":0.015712347,"about_ca_system_score_codex":0.0008554501,"about_ca_system_score_gemma":0.0004575268,"threshold_uncertainty_score":0.49341124},"labels":[],"label_agreement":null},{"id":"W2149721949","doi":"10.1016/j.jval.2014.03.162","title":"Shortcutting Drug Development: Economic Benefits Of Using Genome-Wide Association Studies (Gwas) To Reposition Existing Drugs To Other Therapeutic Areas","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"Medicine; Genome-wide association study; Denosumab; Drug; Disease; Intensive care medicine; Environmental health; Osteoporosis; Pharmacology; Internal medicine; Single-nucleotide polymorphism; Biology","score_opus":0.4197334507513929,"score_gpt":0.4311975924285054,"score_spread":0.011464141677112516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149721949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9755394,0.0022974978,0.0031356928,0.016538668,0.0005716278,0.0010763069,0.00005216812,0.000044376757,0.00074426085],"genre_scores_gemma":[0.962665,0.00007006727,0.018323803,0.018232346,0.0003546453,0.000094986804,0.0000129530035,0.00006243903,0.00018372947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99275273,0.0007101876,0.005107912,0.0006652796,0.00013741957,0.000626474],"domain_scores_gemma":[0.99298704,0.00305154,0.0032484073,0.0003911906,0.00009740889,0.00022440162],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.03295599,0.00022771012,0.0011798838,0.0006811739,0.00029116296,0.000052321313,0.0002206138,0.000098800694,0.000026698905],"category_scores_gemma":[0.004839205,0.0003120876,0.00007528674,0.00029294993,0.000015568809,0.00025295684,0.00008019638,0.00014992358,0.00030050165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023007053,0.000079187885,0.59198815,0.0009815798,0.00013923144,1.4671414e-7,0.049034394,0.33332136,0.0000069693588,0.021426184,0.000635839,0.002363934],"study_design_scores_gemma":[0.0033287173,0.00048337854,0.70880735,0.006377777,0.000041116193,0.000007874637,0.017569436,0.14545493,0.00033070383,0.02314072,0.0914831,0.0029749111],"about_ca_topic_score_codex":0.0063569234,"about_ca_topic_score_gemma":0.0006305722,"teacher_disagreement_score":0.18786645,"about_ca_system_score_codex":0.0060740397,"about_ca_system_score_gemma":0.00033947223,"threshold_uncertainty_score":0.9999331},"labels":[],"label_agreement":null},{"id":"W2150353433","doi":"10.1016/j.jval.2014.03.1720","title":"Comparison of Contemporaneous EQ-5D and SF-6D Responses Using Scoring Algorithms Derived from Similar Valuation Exercises","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; Simon Fraser University; Vancouver Coastal Health","funders":"","keywords":"Comparability; EQ-5D; Intraclass correlation; Statistics; Valuation (finance); Descriptive statistics; Mathematics; Medicine; Population; Health related quality of life; Psychometrics","score_opus":0.7350037959906607,"score_gpt":0.4650026736951401,"score_spread":0.2700011222955206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150353433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672813,0.0074795154,0.018724253,0.0048996857,0.0004531305,0.0008273286,0.00017433573,0.000037230766,0.0001232433],"genre_scores_gemma":[0.976328,0.00028640465,0.021761386,0.0013173932,0.00019660844,0.000025615369,0.000029964674,0.000035415742,0.000019183903],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99258363,0.0015173601,0.0047173155,0.00061049464,0.00015315689,0.00041804847],"domain_scores_gemma":[0.99303716,0.0033649427,0.0028713995,0.00045291847,0.000071960734,0.00020163716],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.018754985,0.00021157025,0.0015734634,0.0004740233,0.00020166737,0.00005097251,0.00018204884,0.00015264614,0.00003859669],"category_scores_gemma":[0.004524574,0.0002829739,0.00006869294,0.0002022388,0.000097403106,0.00028468666,0.000054987195,0.00019999644,0.00004328049],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022684339,0.00034018152,0.9031373,0.0019700367,0.00007314997,0.0000024362505,0.01644519,0.055921104,0.0002196524,0.0170685,0.00041362862,0.0041819387],"study_design_scores_gemma":[0.0015962155,0.00027151225,0.13287422,0.000803535,0.000009620572,0.0000048253924,0.0024930388,0.8448155,0.00017427425,0.015300746,0.0012790776,0.00037742156],"about_ca_topic_score_codex":0.036512066,"about_ca_topic_score_gemma":0.00029190944,"teacher_disagreement_score":0.7888944,"about_ca_system_score_codex":0.0005597718,"about_ca_system_score_gemma":0.0003194942,"threshold_uncertainty_score":0.9999623},"labels":[],"label_agreement":null},{"id":"W2150483767","doi":"10.1016/j.jval.2013.03.610","title":"Associations between negative impact on employment or relationships and haemophilia treatment centre (HTC) and health care practioner utilisation: Global results from the haemophilia experiences, results and opportunities (HERO) study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Haemophilia; Medicine; Psychology; Pediatrics","score_opus":0.3016209411341109,"score_gpt":0.4207595362603023,"score_spread":0.1191385951261914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2150483767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89276564,0.0014843079,7.0343816e-7,0.10034125,0.00007267,0.003680919,0.0014287757,0.000041519826,0.00018419755],"genre_scores_gemma":[0.99605703,0.001892262,0.00019564222,0.00034176704,0.0002014085,0.00015141336,0.00069797534,0.000018112063,0.00044437824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99613667,0.0013130025,0.0008799398,0.0006319917,0.0005582843,0.00048009696],"domain_scores_gemma":[0.99666595,0.0018563578,0.0003779435,0.0004090871,0.00014735037,0.00054333004],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011941403,0.00031335588,0.0005959948,0.0001200052,0.00090606173,0.000117662275,0.00006730202,0.000120748264,0.000021048692],"category_scores_gemma":[0.0005982277,0.00017720762,0.00004632822,0.00029850905,0.00018504633,0.00022585852,0.000057246583,0.00033324826,0.00000686889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00093612354,0.0006327412,0.74275476,0.000030853487,0.00024858376,0.000030209174,0.22412844,0.00003927185,1.9581766e-7,0.00007217839,0.00293617,0.028190488],"study_design_scores_gemma":[0.005892336,0.0037812453,0.87432337,0.00022766434,0.000044891378,0.000008040816,0.114821635,0.00022914803,0.0000032659418,0.00019737639,0.00034493883,0.00012606088],"about_ca_topic_score_codex":0.11356934,"about_ca_topic_score_gemma":0.0051468103,"teacher_disagreement_score":0.13156864,"about_ca_system_score_codex":0.0020622422,"about_ca_system_score_gemma":0.0011839422,"threshold_uncertainty_score":0.8923335},"labels":[],"label_agreement":null},{"id":"W2151380149","doi":"10.1016/j.jval.2014.03.1128","title":"The impact of two different case definitions of major congenital malformations identified from Quebec (Canada) administrative databases on their association with asthma controller medications taken during pregnancy","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Congenital malformations; Pregnancy; Medical diagnosis; Diagnosis code; Asthma; Epidemiology; Odds ratio; Pediatrics; Cohort; Database; Internal medicine; Environmental health","score_opus":0.09188650106104558,"score_gpt":0.37451128148151624,"score_spread":0.2826247804204707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151380149","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994042,0.0006943495,0.00021557731,0.0017846691,0.000047320802,0.0012728529,0.0017297406,0.000012187466,0.00020130757],"genre_scores_gemma":[0.9992005,0.0002102452,0.00008770537,0.0000610768,0.000041053336,0.0001596323,0.00016734615,0.000016401604,0.000056001143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973207,0.0005967,0.0007943714,0.0002033653,0.00071276724,0.00037209812],"domain_scores_gemma":[0.9952237,0.0031657205,0.0006290898,0.00041037094,0.00028980477,0.00028128747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005718434,0.00015407374,0.00042052843,0.00014960287,0.0003013701,0.000013702609,0.00011365071,0.000042698153,0.000040726864],"category_scores_gemma":[0.0011986679,0.00009410611,0.00006696234,0.0002667681,0.00010829682,0.00010137724,0.000027960612,0.0003631199,0.000002296264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020961985,0.010576925,0.68231493,0.010485107,0.007128263,0.0013208726,0.023015145,0.006255786,0.011742535,0.15656297,0.0026570791,0.06697839],"study_design_scores_gemma":[0.013666719,0.0023950795,0.96347916,0.003355119,0.00008728973,0.00013355512,0.0027476053,0.007646512,0.0050416975,0.0009988613,0.00017418452,0.00027421492],"about_ca_topic_score_codex":0.6601208,"about_ca_topic_score_gemma":0.7985496,"teacher_disagreement_score":0.2811642,"about_ca_system_score_codex":0.0012184005,"about_ca_system_score_gemma":0.0038272568,"threshold_uncertainty_score":0.6789389},"labels":[],"label_agreement":null},{"id":"W2151569515","doi":"10.1016/j.jval.2013.08.1429","title":"Psychoactive Drug Use, Polypharmacy and Co-Morbidities in Newly Diagnosed Patients with Pervasive Development Disorder in the Province of Quebec","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Rivière-des-Prairies; McMaster University; Université de Montréal","funders":"","keywords":"Polypharmacy; Cohort; Medicine; Antipsychotic; Pediatrics; Pervasive developmental disorder; Autism; Population; Psychiatry; Cohort study; Autism spectrum disorder; Internal medicine; Schizophrenia (object-oriented programming)","score_opus":0.03654978086207198,"score_gpt":0.3174010573518409,"score_spread":0.2808512764897689,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151569515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942366,0.0002941927,0.00002066545,0.0028771139,0.00003193705,0.0024614178,0.000008466931,0.000009282915,0.00006035295],"genre_scores_gemma":[0.99831355,0.00014367359,0.00036210087,0.00078493427,0.000008550979,0.00019807366,0.00002487302,0.000019150033,0.00014510773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998331,0.0003332725,0.0004426797,0.0002608373,0.00034392334,0.00028825726],"domain_scores_gemma":[0.9989959,0.00048221977,0.0001917024,0.00018033892,0.00008007911,0.00006976102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031607994,0.0001576244,0.00032832546,0.00023492635,0.00004504851,0.000020808191,0.000075674805,0.00003875234,0.00003349907],"category_scores_gemma":[0.00013869649,0.00011022949,0.000018218147,0.00029708937,0.00009260893,0.00036657669,0.000020634077,0.00032141182,0.0000065934387],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013308878,0.0010181549,0.975687,0.00023632962,0.000011517563,0.00000875162,0.017583562,0.00015550076,0.000004355475,0.00004734823,0.00015612243,0.004958252],"study_design_scores_gemma":[0.004626623,0.00012732476,0.9821634,0.00042396344,0.000004270841,0.0000025235952,0.0119634215,0.00022892302,0.000008825947,0.000022573953,0.00031998346,0.00010816147],"about_ca_topic_score_codex":0.18277378,"about_ca_topic_score_gemma":0.050687414,"teacher_disagreement_score":0.13208638,"about_ca_system_score_codex":0.00022633364,"about_ca_system_score_gemma":0.00070290815,"threshold_uncertainty_score":0.96663505},"labels":[],"label_agreement":null},{"id":"W2151657070","doi":"10.1016/j.jval.2014.03.620","title":"The Use Of Pillbox And Time In Therapeutic Range Among New Users Of Warfarin: A Propective Cohort Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Warfarin; Medicine; Atrial fibrillation; Concomitant; Dyslipidemia; Internal medicine; Cohort; Anticoagulant; Cohort study","score_opus":0.494861419169059,"score_gpt":0.5097098356320982,"score_spread":0.014848416463039138,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2151657070","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937194,0.0009508855,0.000013548685,0.0025271757,0.00020382805,0.002372947,0.000010894432,0.000025201896,0.00017613781],"genre_scores_gemma":[0.9983024,0.0004509101,0.00003186315,0.0008653375,0.000057465637,0.00005754355,0.0000010705444,0.000021344928,0.00021208987],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99482197,0.0033809098,0.0007895275,0.0003116001,0.00019378551,0.00050219015],"domain_scores_gemma":[0.99714935,0.0019556824,0.00028304217,0.00024226953,0.0000680259,0.00030165035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039074435,0.0001787655,0.0005091598,0.00013647466,0.0001526224,0.000010261796,0.00020843477,0.0002504774,0.00005271077],"category_scores_gemma":[0.00027886507,0.00013497824,0.000039869527,0.00041283466,0.0003426934,0.00011518878,0.00007775422,0.0012992958,0.0000065144814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005981254,0.0005076394,0.9832004,0.00016162106,0.00007356847,0.000004495229,0.0030166665,0.0022045034,0.000115902374,0.0015601352,0.00015962127,0.008397365],"study_design_scores_gemma":[0.0027263444,0.0008421843,0.9619609,0.00010309663,0.000044901335,0.0000034936716,0.0004309289,0.027712382,0.00025687186,0.0010673539,0.0047056996,0.00014585792],"about_ca_topic_score_codex":0.009939207,"about_ca_topic_score_gemma":0.0007160516,"teacher_disagreement_score":0.025507879,"about_ca_system_score_codex":0.00016071825,"about_ca_system_score_gemma":0.00034742922,"threshold_uncertainty_score":0.9966537},"labels":[],"label_agreement":null},{"id":"W2152497461","doi":"10.1016/j.jval.2011.02.465","title":"PMD25 THE COST-UTILITY AND VALUE OF INFORMATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION COMPARED TO STANDARD MANAGEMENT AND SURGICAL AORTIC VALVE REPLACEMENT IN PATIENTS WITH SEVERE SYMPTOMATIC AORTIC VALVE STENOSIS","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Valve Diseases and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Stenosis; Aortic valve replacement; Aortic valve; Incremental cost-effectiveness ratio; Cardiology; Quality-adjusted life year; Surgery; Cost-effectiveness analysis; Cost effectiveness; Internal medicine","score_opus":0.019571072331127346,"score_gpt":0.2981575987015084,"score_spread":0.278586526370381,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152497461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952444,0.0002009813,0.00013664676,0.000071452945,0.000054630487,0.0039735464,0.00017506583,0.000014566301,0.00012870548],"genre_scores_gemma":[0.9989818,0.00017757124,0.00045253645,0.00012504535,0.0000043748496,0.0001468281,0.0000950656,0.0000146452485,0.0000021634428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975353,0.00025755403,0.0010150385,0.00027830637,0.0005788714,0.0003349137],"domain_scores_gemma":[0.9988228,0.00013192518,0.00034054337,0.00036862827,0.00011702925,0.00021905298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000651731,0.000222407,0.0006349591,0.0002482467,0.00005805767,0.0000135342325,0.000064866515,0.000050247632,0.000018027058],"category_scores_gemma":[0.000025681487,0.00015689476,0.00030902348,0.00031933896,0.00007880265,0.00015784407,0.00004443857,0.00010672936,0.0000017059766],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026893457,0.00056892,0.9787487,0.0018951853,0.000655488,6.319744e-7,0.0075591593,0.00020965954,2.213732e-7,0.000099128825,0.000007995657,0.007565605],"study_design_scores_gemma":[0.0072842375,0.0015062212,0.9866912,0.000974993,0.0007026139,0.0000044024496,0.0012352706,0.0012993867,0.00001302754,0.00015591932,0.0000049754535,0.00012777938],"about_ca_topic_score_codex":0.0018207297,"about_ca_topic_score_gemma":0.000017008255,"teacher_disagreement_score":0.007942514,"about_ca_system_score_codex":0.00026325596,"about_ca_system_score_gemma":0.000113892456,"threshold_uncertainty_score":0.6397983},"labels":[],"label_agreement":null},{"id":"W2152532978","doi":"10.1016/j.jval.2012.06.005","title":"Cost-Effectiveness Analysis of Antiviral Treatments for HBeAg-Positive Chronic Hepatitis B in Canada","year":2012,"lang":"en","type":"review","venue":"Value in Health","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Canadian Institute for Health Information; St. Joseph’s Healthcare Hamilton","funders":"","keywords":"Telbivudine; Entecavir; Lamivudine; Medicine; Internal medicine; Hepatitis B; Cost-effectiveness analysis; Chronic hepatitis; Cost effectiveness; Virology; Risk analysis (engineering); Virus","score_opus":0.15173603591052232,"score_gpt":0.41691097069973554,"score_spread":0.2651749347892132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2152532978","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0052201524,0.98504645,0.000034063843,0.000030780557,0.0002760421,0.007204248,0.002111914,0.0000088300685,0.00006753257],"genre_scores_gemma":[0.044936124,0.9525515,0.0001102228,0.00004044253,0.000083535786,0.0014575131,0.0007421396,0.0000542442,0.000024281777],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9960893,0.0010300821,0.0013066924,0.0004891977,0.00033816826,0.0007466021],"domain_scores_gemma":[0.99718314,0.0015250089,0.0006617272,0.00037593953,0.00009514609,0.00015906156],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009382524,0.0004400328,0.0050745388,0.00094761123,0.000054082502,0.0000035673822,0.00010993349,0.00016476275,0.000014247268],"category_scores_gemma":[0.00016669459,0.000381156,0.00047129783,0.0017521337,0.0000524101,0.000051451487,0.000051200797,0.000306006,0.0000032348828],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000030289579,0.0001942121,0.29404357,0.035634995,0.0029341418,0.000036275782,0.00017719666,0.000058951155,7.017165e-8,0.00003628673,0.000021269938,0.66683275],"study_design_scores_gemma":[0.003267402,0.0015096331,0.72160864,0.0872044,0.01813715,0.000013165625,0.00002685319,0.0014928103,0.000008542543,0.00001119222,0.16593882,0.00078139466],"about_ca_topic_score_codex":0.99587506,"about_ca_topic_score_gemma":0.9912014,"teacher_disagreement_score":0.6660513,"about_ca_system_score_codex":0.01852701,"about_ca_system_score_gemma":0.0110535715,"threshold_uncertainty_score":0.99986404},"labels":[],"label_agreement":null},{"id":"W2153012086","doi":"10.1111/j.1524-4733.2009.00602.x","title":"Good Research Practices for Comparative Effectiveness Research: Analytic Methods to Improve Causal Inference from Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part III","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":290,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Causal inference; Inference; Confounding; Statistical inference; Comparative effectiveness research; Marginal structural model; Medicine; Propensity score matching; Instrumental variable; Outcomes research; Research design; Computer science; Econometrics; Management science; Statistics; Machine learning; Alternative medicine; Artificial intelligence; Engineering; Mathematics","score_opus":0.8166517374954501,"score_gpt":0.7018213479349174,"score_spread":0.11483038956053271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153012086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5135121,0.0045687314,0.44296417,0.0019162559,0.0002416289,0.03379567,0.0026071286,0.00015840618,0.0002359378],"genre_scores_gemma":[0.6271013,0.00057278504,0.36829084,0.000037828202,0.0002534191,0.0031734058,0.00035529447,0.00006411018,0.00015098325],"study_design_codex":"bench_or_experimental","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.96398586,0.027522448,0.0023144295,0.002406283,0.001956847,0.0018141078],"domain_scores_gemma":[0.7062866,0.28128207,0.0038601086,0.0038667554,0.0043514986,0.00035297967],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.12459832,0.0005535864,0.003031022,0.0017542852,0.0013526665,0.000223041,0.0015076593,0.00023293449,0.0000075857115],"category_scores_gemma":[0.17996778,0.00039510152,0.0002597456,0.0047789086,0.0007757317,0.0013115206,0.0008061209,0.0017699283,0.0000012457767],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16504449,0.023659794,0.0127147725,0.029129004,0.050078597,0.0006806336,0.23950289,0.021550875,0.24601012,0.16053239,0.0053843986,0.045712035],"study_design_scores_gemma":[0.02234323,0.032797474,0.0021800515,0.006125017,0.0036124296,0.000028296476,0.05708302,0.18366449,0.13025023,0.5580377,0.0023625628,0.0015155108],"about_ca_topic_score_codex":0.03160303,"about_ca_topic_score_gemma":0.0064466232,"teacher_disagreement_score":0.3975053,"about_ca_system_score_codex":0.0031838967,"about_ca_system_score_gemma":0.0032124508,"threshold_uncertainty_score":0.9999474},"labels":[],"label_agreement":null},{"id":"W2153034074","doi":"10.1016/j.jval.2014.03.092","title":"Point Of Care Tests: The Long And Winding Road To Reimbursement In The United States And Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Test (biology); Payment; Health care; Health technology; Business; Market access; Actuarial science; Medicine; Medical emergency; Finance; Economics; Economic growth","score_opus":0.21356528357411972,"score_gpt":0.38418255162819087,"score_spread":0.17061726805407115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153034074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9155217,0.0021511847,0.00007951692,0.08119952,0.00011710467,0.00073475804,0.00006154172,0.0000036862514,0.00013099093],"genre_scores_gemma":[0.98215985,0.0003728387,0.00022909854,0.01711532,0.000047652247,0.000039024668,0.000015075043,0.000009743806,0.000011417678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685967,0.00070329395,0.0018157426,0.00025514365,0.00007959209,0.0002865494],"domain_scores_gemma":[0.99749184,0.0014516189,0.0006378372,0.00029680895,0.000023998346,0.00009791285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015528154,0.000095910014,0.00043113096,0.00024612952,0.00012279293,0.000030584677,0.00016233548,0.000033140954,0.0000064714654],"category_scores_gemma":[0.0014379079,0.000082390994,0.000012924964,0.00024337563,0.000036074474,0.000065251224,0.000039021885,0.0001405013,0.0000036586382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009499008,0.000026888487,0.888166,0.0009633276,0.000010761255,8.4162656e-7,0.05312648,0.016568057,1.9180374e-7,0.037030466,0.003184613,0.0009128659],"study_design_scores_gemma":[0.0005752106,0.00019511255,0.9309396,0.00039558797,0.0000015938501,0.0000037738982,0.032015674,0.016270807,0.0000012558777,0.0031873425,0.016255684,0.00015835417],"about_ca_topic_score_codex":0.9496375,"about_ca_topic_score_gemma":0.7492281,"teacher_disagreement_score":0.20040932,"about_ca_system_score_codex":0.0006593423,"about_ca_system_score_gemma":0.00026423033,"threshold_uncertainty_score":0.5381779},"labels":[],"label_agreement":null},{"id":"W2153056334","doi":"10.1016/s1098-3015(10)61559-8","title":"DB1 ACARBOSE FOR THE PREVENTION OF TYPE II DIABETES IN CANADA: AN ECONOMIC EVALUATION","year":2003,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Acarbose; Type 2 diabetes; Medicine; Internal medicine; Diabetes mellitus; Endocrinology","score_opus":0.10449373803712238,"score_gpt":0.3787518018687417,"score_spread":0.2742580638316193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153056334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995791,0.000902564,0.0000026065893,0.0012083056,0.00019166595,0.0014087609,0.0000022227093,0.0000024959315,0.0004903551],"genre_scores_gemma":[0.9994051,0.00009428698,0.00009808302,0.00010752033,0.000029260824,0.000059086662,0.000015963418,0.000007047641,0.00018368024],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99906224,0.00020731849,0.0002474061,0.000112502494,0.00016345414,0.00020708078],"domain_scores_gemma":[0.9995693,0.0001284663,0.00006784039,0.00015506455,0.000036720467,0.000042601416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028810555,0.00004452696,0.0001396541,0.00009732817,0.00003485758,0.0000029371115,0.00005470695,0.000020016983,0.00005980657],"category_scores_gemma":[0.00017614789,0.000033554334,0.000017034092,0.00012901207,0.000012854557,0.000039556657,0.000011438104,0.00007326514,9.588192e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000176493,0.00048414947,0.73374647,0.0016237347,0.000085620595,8.058857e-7,0.0007535417,0.05505741,0.00024956441,0.0073618707,0.0025372182,0.19792314],"study_design_scores_gemma":[0.0027099377,0.001248667,0.29818484,0.00029440402,0.000032158074,1.0047087e-7,0.00047144198,0.6896567,0.00042574212,0.0031483297,0.0037431114,0.00008461504],"about_ca_topic_score_codex":0.2654932,"about_ca_topic_score_gemma":0.33382154,"teacher_disagreement_score":0.63459927,"about_ca_system_score_codex":0.00079146196,"about_ca_system_score_gemma":0.0027610657,"threshold_uncertainty_score":0.73939794},"labels":[],"label_agreement":null},{"id":"W2153343914","doi":"10.1016/j.jval.2012.08.821","title":"PMH31 Genetic Testing in Combination With Preventive Donepezil Treatment for Amnestic Mild Cognitive Impairment Patients: An Exploratory Economic Evaluation of Personalized Medicine","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Hospital for Sick Children; Health Sciences Centre; Mount Sinai Hospital; Sunnybrook Health Science Centre; St. Michael's Hospital","funders":"","keywords":"Donepezil; Medicine; Genetic testing; Cost–utility analysis; Dementia; Cost effectiveness; Intensive care medicine; Internal medicine; Risk analysis (engineering); Disease","score_opus":0.48579837440529383,"score_gpt":0.44838688554465406,"score_spread":0.037411488860639774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153343914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98886186,0.003118993,0.00085604703,0.0014234303,0.0003191666,0.0050906576,0.00022406164,0.000016807491,0.000088966866],"genre_scores_gemma":[0.99441665,0.00012087693,0.0031025014,0.000529469,0.00015275349,0.001440352,0.00018778822,0.000038451974,0.0000111401805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99393845,0.0015245473,0.003355899,0.0005025213,0.000171536,0.0005070603],"domain_scores_gemma":[0.99494106,0.0018044305,0.0025800487,0.00024948097,0.00021201983,0.00021297399],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02191717,0.00023228534,0.0009997383,0.0006042353,0.00010334394,0.000011487203,0.00010306961,0.000088490415,0.00007338804],"category_scores_gemma":[0.0017836632,0.00025321386,0.000049495957,0.000232223,0.0000948625,0.00054175645,0.000014046384,0.00008703616,0.000027311202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002633714,0.0018888675,0.944669,0.0008269434,0.00006552996,1.381844e-7,0.033200014,0.011111224,6.35357e-7,0.0053568934,0.00009244584,0.0025249335],"study_design_scores_gemma":[0.02177048,0.0046405764,0.8196374,0.0012815923,0.00004323926,0.0000015726959,0.0076385383,0.13843149,0.0000063661832,0.00607506,0.00011966386,0.0003539733],"about_ca_topic_score_codex":0.00842747,"about_ca_topic_score_gemma":0.0008641174,"teacher_disagreement_score":0.12732027,"about_ca_system_score_codex":0.004633358,"about_ca_system_score_gemma":0.0007476759,"threshold_uncertainty_score":0.999992},"labels":[],"label_agreement":null},{"id":"W2153434255","doi":"10.1111/j.1524-4733.2009.00600.x","title":"Good Research Practices for Comparative Effectiveness Research: Defining, Reporting and Interpreting Nonrandomized Studies of Treatment Effects Using Secondary Data Sources: The ISPOR Good Research Practices for Retrospective Database Analysis Task Force Report—Part I","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":410,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Comparative effectiveness research; Observational study; Medicine; Outcomes research; Research design; MEDLINE; Management science; Medical education; Alternative medicine; Political science","score_opus":0.827067872307364,"score_gpt":0.6782163137175784,"score_spread":0.1488515585897856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153434255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9424095,0.008197349,0.03010726,0.0011987151,0.00011273366,0.016948294,0.00045576572,0.00012666167,0.00044372698],"genre_scores_gemma":[0.89187384,0.00091050216,0.105256885,0.000020537083,0.00012249079,0.0015128448,0.00016951081,0.000054449545,0.000078963785],"study_design_codex":"qualitative","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97627944,0.0155941285,0.003201846,0.0018800031,0.0015380159,0.0015065509],"domain_scores_gemma":[0.72642016,0.252839,0.013402926,0.003115965,0.003969515,0.0002524306],"candidate_categories":["metaresearch","metaepi_narrow","sts"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.17036594,0.00040283366,0.0022901164,0.0012184435,0.0016352203,0.00020286253,0.00075495784,0.0001686395,0.0000022359307],"category_scores_gemma":[0.31167623,0.0002900872,0.00018371291,0.00250928,0.0008320709,0.0011529517,0.0007538841,0.0015577243,3.187793e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09459944,0.014399395,0.10401883,0.0687189,0.028727667,0.0013768144,0.35222408,0.0078105144,0.05414745,0.23800547,0.004931037,0.031040391],"study_design_scores_gemma":[0.020782903,0.031767022,0.0029186436,0.02324623,0.0026798504,0.00037999637,0.15113427,0.1918347,0.05089434,0.520071,0.0026483908,0.0016426184],"about_ca_topic_score_codex":0.006890359,"about_ca_topic_score_gemma":0.0018912434,"teacher_disagreement_score":0.28206557,"about_ca_system_score_codex":0.0017611458,"about_ca_system_score_gemma":0.0017189129,"threshold_uncertainty_score":0.9999551},"labels":[],"label_agreement":null},{"id":"W2153437086","doi":"10.1016/j.jval.2015.09.896","title":"Economic Evaluation Of A Pharmacogenomic Test For Statin-Induced Myopathy In Cardiovascular High-Risk Patients Initiating A Statin","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Université de Montréal","funders":"","keywords":"Medicine; Statin; Myopathy; Pharmacogenomics; Rhabdomyolysis; Physical therapy; Test (biology); Internal medicine; Intensive care medicine; Pharmacology","score_opus":0.08329011053762649,"score_gpt":0.3353127573321463,"score_spread":0.25202264679451986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2153437086","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99158317,0.0026108094,0.00020730997,0.00012931728,0.00034574128,0.0048089176,0.000225255,0.000021806509,0.000067664725],"genre_scores_gemma":[0.99549776,0.00025695795,0.0032365313,0.00014834144,0.00022170077,0.00044948034,0.00013513646,0.0000524826,0.0000015987665],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.995773,0.0011830293,0.001206929,0.0004743533,0.00085065316,0.0005120416],"domain_scores_gemma":[0.99806273,0.00026737113,0.00048224156,0.0005266838,0.00037040364,0.0002905937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014690424,0.00020854498,0.0009781312,0.0003585901,0.000055336463,0.000009980365,0.000096357675,0.0000939244,0.000008222672],"category_scores_gemma":[0.0016505498,0.00021178486,0.00027392033,0.0002671868,0.000022119351,0.00011183384,0.00003486441,0.00027926936,0.000008836715],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005889585,0.0009953157,0.44907534,0.0023048,0.00047760608,0.000010082619,0.007928424,0.08665741,0.00015692275,0.00009172574,0.00012822422,0.4515852],"study_design_scores_gemma":[0.09381771,0.0063727237,0.64682084,0.001533352,0.0008744802,0.000022157474,0.0029524826,0.24206384,0.0019747852,0.0020079466,0.0008080536,0.0007516223],"about_ca_topic_score_codex":0.050934143,"about_ca_topic_score_gemma":0.00039758914,"teacher_disagreement_score":0.45083356,"about_ca_system_score_codex":0.002216092,"about_ca_system_score_gemma":0.0037023588,"threshold_uncertainty_score":0.95538574},"labels":[],"label_agreement":null},{"id":"W2154184053","doi":"10.1016/j.jval.2014.03.926","title":"Cost Utility Analysis In Child Health: Will The Growth Spurt Be Sustained?","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children","funders":"","keywords":"Medicine; Economic evaluation; Cost–utility analysis; Citation; Cost–benefit analysis; Cost effectiveness; Computer science; Library science; Risk analysis (engineering)","score_opus":0.33921743501037516,"score_gpt":0.41768611312104587,"score_spread":0.07846867811067071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154184053","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15971921,0.0061000125,0.009205713,0.8153908,0.000786739,0.0032448915,0.0004160711,0.00009310045,0.005043458],"genre_scores_gemma":[0.9417247,0.00081444706,0.00075611466,0.056054708,0.0002787708,0.00014601633,0.000077396595,0.00003471271,0.000113110276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98838955,0.002971102,0.006416833,0.00092611974,0.00018441307,0.0011119684],"domain_scores_gemma":[0.99372125,0.002194689,0.002573516,0.0010638968,0.00006147572,0.0003851716],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.07006618,0.0002760773,0.0018375228,0.0011607875,0.00040065718,0.00007769234,0.00054922065,0.00016021561,0.00023686804],"category_scores_gemma":[0.005598304,0.00029629256,0.0002197279,0.0018670431,0.000117187854,0.00037743297,0.00008668689,0.00058812054,0.00016399397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025598707,0.0002797254,0.6261713,0.0010198305,0.00009282797,0.0000010897077,0.006989402,0.009768971,1.2904649e-8,0.34547618,0.009401644,0.0007734456],"study_design_scores_gemma":[0.001548428,0.00019122573,0.6205226,0.00019819483,0.0000096010135,0.000005390448,0.002788656,0.23363246,2.981201e-7,0.033890985,0.10673164,0.0004805005],"about_ca_topic_score_codex":0.103283904,"about_ca_topic_score_gemma":0.0099189365,"teacher_disagreement_score":0.7820055,"about_ca_system_score_codex":0.0021291676,"about_ca_system_score_gemma":0.00058384304,"threshold_uncertainty_score":0.9999489},"labels":[],"label_agreement":null},{"id":"W2154499481","doi":"10.1016/j.jval.2013.03.716","title":"Return Of Incidental Findings In Genomic Medicine: Measuring What Patients Value","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Salience (neuroscience); Comprehension; Disease; Medicine; Set (abstract data type); Genetic testing; Intervention (counseling); Precision medicine; Psychology; Computer science; Internal medicine; Cognitive psychology; Psychiatry; Pathology","score_opus":0.3103361593143038,"score_gpt":0.37963300308310804,"score_spread":0.06929684376880424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154499481","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759324,0.004605518,0.00005095783,0.016380634,0.0010231645,0.0014288214,0.000028950384,0.00002075751,0.0005287932],"genre_scores_gemma":[0.9925507,0.0010540611,0.00080894964,0.0052167317,0.00015263498,0.000097310745,0.00002535857,0.00003977536,0.000054496384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99156696,0.0006862206,0.006333205,0.00058450515,0.00018759035,0.0006415269],"domain_scores_gemma":[0.99619734,0.00090447976,0.0021250343,0.00046988725,0.00006204899,0.0002412204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.018606562,0.00021808132,0.0013101296,0.000989818,0.00008749994,0.000049331335,0.00036958166,0.00016303835,0.00033258728],"category_scores_gemma":[0.0028990307,0.0002725223,0.00007758691,0.00042192006,0.00009145205,0.0011186684,0.00008531006,0.00032999596,0.0005908538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010460751,0.00014384648,0.9734333,0.0009489239,0.000013425869,5.840895e-7,0.010311306,0.0017772244,0.0000093517365,0.01083277,0.0020872685,0.0004315128],"study_design_scores_gemma":[0.0021718768,0.00022021635,0.9577911,0.0015566172,0.000001482349,0.0000023722205,0.0032287796,0.015330816,0.000009314869,0.018329607,0.001044659,0.00031315073],"about_ca_topic_score_codex":0.08426786,"about_ca_topic_score_gemma":0.00053236075,"teacher_disagreement_score":0.0837355,"about_ca_system_score_codex":0.0023749408,"about_ca_system_score_gemma":0.00027075617,"threshold_uncertainty_score":0.9999727},"labels":[],"label_agreement":null},{"id":"W2155067918","doi":"10.1016/j.jval.2014.03.118","title":"A Comparison Of The Medicare Average Sales Price And The Average Wholesaler Price","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicaid; Medicine; Business; Actuarial science; Health care; Economics","score_opus":0.07900655963932553,"score_gpt":0.32525023505912637,"score_spread":0.24624367541980086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155067918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9007217,0.010631665,0.001333864,0.053600956,0.00075114175,0.00091122324,0.00014118683,0.000023639384,0.031884607],"genre_scores_gemma":[0.99399185,0.0011411214,0.00009249021,0.0045449384,0.000099895384,0.000013629322,0.000002410013,0.000014018553,0.00009962998],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984056,0.00017435352,0.00083259505,0.00024353228,0.000043193035,0.00030072586],"domain_scores_gemma":[0.9984739,0.00055302255,0.0004969243,0.00035284684,0.000011552651,0.00011176712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002370687,0.00011447299,0.0005085589,0.000084994484,0.00012160376,0.00002904468,0.0003306656,0.00006753724,0.00004862386],"category_scores_gemma":[0.00032969916,0.00008221453,0.0000759609,0.00019214097,0.00021414075,0.000058189416,0.00012809559,0.00031252144,0.000047271857],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036823945,0.00008963221,0.10017371,0.00028780368,0.000022611424,1.73012e-7,0.0047135893,0.005157426,0.0000022202482,0.886983,0.001176165,0.0013568394],"study_design_scores_gemma":[0.0033615977,0.000082886785,0.14302717,0.00014995926,0.0000044349927,0.0000047914837,0.000119304525,0.42729485,0.00003215824,0.08585084,0.33980796,0.00026406415],"about_ca_topic_score_codex":0.0014532219,"about_ca_topic_score_gemma":0.000045688008,"teacher_disagreement_score":0.80113214,"about_ca_system_score_codex":0.00008900674,"about_ca_system_score_gemma":0.000058904025,"threshold_uncertainty_score":0.33526114},"labels":[],"label_agreement":null},{"id":"W2155097838","doi":"10.1016/j.jval.2013.08.554","title":"Utility Mapping of the EORTC QLQ-C30 onto EQ-5D in Patients with Soft Tissue Sarcoma","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Statistics; Mean squared error; Mathematics; Quality of life (healthcare); Gee; Population; Ordinary least squares; Medicine; Standard error; Linear regression; Soft tissue sarcoma; Generalized estimating equation; Surgery; Soft tissue","score_opus":0.05963277054384196,"score_gpt":0.28651713207416063,"score_spread":0.22688436153031866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155097838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949003,0.00081295404,0.0000053712997,0.0019102215,0.00009501275,0.0012979663,0.000007910778,0.000010318432,0.0009599341],"genre_scores_gemma":[0.9991986,0.000043310323,0.00020634907,0.0003302491,0.00001818516,0.000048576912,0.0000036110553,0.0000086508935,0.00014246558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890274,0.00009182797,0.0003322716,0.00018505655,0.00023384023,0.0002542701],"domain_scores_gemma":[0.9994617,0.00006411619,0.00010978028,0.00023793621,0.00006348909,0.000062982464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017479461,0.00010621395,0.00033481477,0.00006131464,0.00005335016,0.0000037366915,0.00006194006,0.000032244432,0.00005640347],"category_scores_gemma":[0.00005480582,0.0000617373,0.000026864649,0.0002547654,0.00006083157,0.000040232113,0.000048640075,0.0001310535,0.00000480674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011664982,0.00033160864,0.9744534,0.0002060458,0.000017420458,0.00000124412,0.002166925,0.000014570027,0.0000035718256,0.000029266545,0.00016792543,0.02249141],"study_design_scores_gemma":[0.0018251959,0.0006599003,0.9954183,0.00042120804,0.000005409076,7.191943e-7,0.00032674547,0.00015138907,0.000024458825,0.0001269597,0.0009899824,0.000049710765],"about_ca_topic_score_codex":0.050433442,"about_ca_topic_score_gemma":0.0033133083,"teacher_disagreement_score":0.04712013,"about_ca_system_score_codex":0.00026786653,"about_ca_system_score_gemma":0.00020008416,"threshold_uncertainty_score":0.9558898},"labels":[],"label_agreement":null},{"id":"W2155788143","doi":"10.1016/j.jval.2010.11.009","title":"Brief, Valid Measures of Dyspnea and Related Functional Limitations in Chronic Obstructive Pulmonary Disease (COPD)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"Boehringer Ingelheim","keywords":"COPD; Medicine; Intraclass correlation; Physical therapy; Pulmonary function testing; Pulmonary disease; Item response theory; Computerized adaptive testing; Internal medicine; Cardiology; Psychometrics; Clinical psychology","score_opus":0.14041724518298293,"score_gpt":0.3151660855557331,"score_spread":0.17474884037275018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155788143","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752234,0.014994142,0.00003248333,0.0012303853,0.00022260306,0.0014961942,0.000109816625,0.000051627645,0.0066393134],"genre_scores_gemma":[0.99806285,0.0009207036,0.00028731272,0.00007115145,0.00007370831,0.000099057535,0.00007788814,0.000042796863,0.00036453584],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970291,0.00044998663,0.00077399105,0.00057666877,0.00060416845,0.00056604715],"domain_scores_gemma":[0.9983427,0.00028847056,0.00018967084,0.00041780068,0.00018324352,0.00057813036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067734474,0.0002266426,0.0004672458,0.0006042863,0.00009222308,0.0000068251593,0.0001135363,0.00011311234,0.00025664573],"category_scores_gemma":[0.00050403737,0.00023262227,0.000098110206,0.0008105626,0.0004094144,0.0002043085,0.00009042024,0.0005269844,0.000015348907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045601744,0.0017600034,0.9281532,0.0049380823,0.00015511835,0.000867702,0.003069214,0.003218619,0.0006303909,0.01659059,0.00013736683,0.035919525],"study_design_scores_gemma":[0.0017881457,0.0002637245,0.977008,0.0005061345,0.00003170454,0.00005853791,0.00047727645,0.008909951,0.000045314846,0.010518272,0.00022949342,0.0001634355],"about_ca_topic_score_codex":0.004110776,"about_ca_topic_score_gemma":0.00016393236,"teacher_disagreement_score":0.048854794,"about_ca_system_score_codex":0.0016569517,"about_ca_system_score_gemma":0.002978191,"threshold_uncertainty_score":0.94860613},"labels":[],"label_agreement":null},{"id":"W2155814518","doi":"10.1016/j.jval.2011.05.015","title":"The Use of a Decision Board to Elicit Brazilian Patients' and Physicians' Preferences for Treatment: The Case of Lupus Nephritis","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Fundação de Amparo à Pesquisa do Estado de São Paulo","keywords":"Logistic regression; Medicine; Lupus nephritis; Systemic lupus erythematosus; Descriptive statistics; Family medicine; Demography; Internal medicine; Disease; Statistics","score_opus":0.33016596157574774,"score_gpt":0.4136750218684872,"score_spread":0.08350906029273947,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2155814518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902983,0.0018521548,0.000080005506,0.002107335,0.0005011098,0.004813736,0.0002745839,0.000017644477,0.000055182474],"genre_scores_gemma":[0.99051934,0.001472501,0.006092386,0.00095736375,0.000027804163,0.00085588684,0.000010639821,0.00002181542,0.000042249652],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9965284,0.0014452381,0.0011623645,0.00025051436,0.00016627413,0.0004472027],"domain_scores_gemma":[0.99191034,0.0060742004,0.0006705339,0.000864447,0.00034259778,0.00013785277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048067528,0.00014922078,0.0003702556,0.0001111289,0.00090508146,0.00000731301,0.00030676334,0.000097756005,0.000006747979],"category_scores_gemma":[0.0008816272,0.00009118773,0.00005721326,0.0003160805,0.00012663621,0.00012061815,0.00014791958,0.000183759,0.0000033444005],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009446897,0.00040623453,0.3722283,0.0009404183,0.000031080403,0.0000023390123,0.18221545,0.00009413334,0.000005109778,0.0055844034,0.0021651867,0.43538266],"study_design_scores_gemma":[0.013181303,0.015463679,0.6803889,0.009534309,0.0001066592,0.00002489207,0.1179933,0.0099763265,0.00023937643,0.038290367,0.11389935,0.00090151705],"about_ca_topic_score_codex":0.10431041,"about_ca_topic_score_gemma":0.02410736,"teacher_disagreement_score":0.43448114,"about_ca_system_score_codex":0.0002109756,"about_ca_system_score_gemma":0.00039195514,"threshold_uncertainty_score":0.99370015},"labels":[],"label_agreement":null},{"id":"W2156246270","doi":"10.1016/j.jval.2014.03.831","title":"Exploring The Impact Of Clinical, Functional And Social Factors On Hip Fracture Patient Hospitalization Costs: Informing The Design Of A New Case Mix Payment System","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ministry of Health and Long Term Care","funders":"","keywords":"Medicine; Reimbursement; Residence; Case mix index; Hip fracture; Comorbidity; Activities of daily living; Payment; Cohort; Cohort study; Health care; Physical therapy; Demography; Psychiatry; Finance; Osteoporosis; Business","score_opus":0.248287518166459,"score_gpt":0.386733059497946,"score_spread":0.138445541331487,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156246270","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961479,0.00010632299,0.0018037084,0.0007234922,0.00017219588,0.00093894306,0.000006242648,0.000014231635,0.000087022054],"genre_scores_gemma":[0.9995785,0.00007487304,0.00002942034,0.00015135155,0.00012281189,0.000018593806,0.000012216247,0.000008913509,0.0000033574804],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9985989,0.0002707749,0.000591441,0.00012192334,0.0002720677,0.00014493504],"domain_scores_gemma":[0.9987855,0.00054683594,0.00039147615,0.0001693242,0.00003815275,0.000068743386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009582688,0.00010336609,0.00026415533,0.00006511383,0.00009908874,0.000012326843,0.000041235875,0.000030903007,0.000007783473],"category_scores_gemma":[0.00017643388,0.000053244297,0.0000785312,0.00011969142,0.000053145443,0.00007805587,0.000024661158,0.00013243257,4.7677003e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029912754,0.0014320955,0.28145278,0.0071617044,0.0009540871,0.00006861356,0.0683972,0.47079974,0.000011159117,0.028765837,0.010756226,0.12720926],"study_design_scores_gemma":[0.0043035243,0.0053961435,0.88715756,0.0019773687,0.00015290659,0.000032233354,0.049016975,0.05087257,0.000041658488,0.0002023831,0.00064334756,0.00020334405],"about_ca_topic_score_codex":0.0086428085,"about_ca_topic_score_gemma":0.000013173242,"teacher_disagreement_score":0.6057048,"about_ca_system_score_codex":0.00037148813,"about_ca_system_score_gemma":0.00046445188,"threshold_uncertainty_score":0.9979587},"labels":[],"label_agreement":null},{"id":"W2156776528","doi":"10.1111/j.1524-4733.2008.00457.x","title":"The Willingness to Pay for Reducing Pain and Pain-Related Disability","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Willingness to pay; Medicine; Chronic pain; Physical therapy; Psychological intervention; Quality of life (healthcare); Nursing; Economics","score_opus":0.12095091136642114,"score_gpt":0.24863215887101756,"score_spread":0.12768124750459642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156776528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853688,0.0012687359,0.00488864,0.0075038606,0.00020831732,0.00062161795,0.000022083883,0.000012846095,0.00010511575],"genre_scores_gemma":[0.9974331,0.00081795984,0.0008294988,0.0006085128,0.000042110205,0.000073931114,0.0000076618335,0.000013100392,0.00017408874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987176,0.00012311057,0.0006038574,0.00029339944,0.000016615713,0.00024542262],"domain_scores_gemma":[0.99899024,0.000576572,0.00016032635,0.0001892564,0.0000030958831,0.000080484715],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0072910604,0.0000781329,0.00019788713,0.00002672792,0.00029961995,0.000014889583,0.00007746412,0.000045684137,0.000014309579],"category_scores_gemma":[0.00037807395,0.00006713067,0.00003511,0.00008296125,0.00006766782,0.00006680911,0.000017327973,0.00008176288,0.000023772243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012976976,0.000050536546,0.9500178,0.00005651631,0.000006573613,1.4719865e-7,0.0018708574,0.013507184,0.0000010704925,0.014131957,0.0003514884,0.019992866],"study_design_scores_gemma":[0.00044613142,0.0002460865,0.821394,0.000036355526,7.1719654e-7,0.0000017031207,0.00021815825,0.12454186,0.0000033229512,0.03693944,0.016008422,0.00016376407],"about_ca_topic_score_codex":0.0022415747,"about_ca_topic_score_gemma":0.00004780443,"teacher_disagreement_score":0.12862378,"about_ca_system_score_codex":0.00030551787,"about_ca_system_score_gemma":0.00001758948,"threshold_uncertainty_score":0.33886054},"labels":[],"label_agreement":null},{"id":"W2156822431","doi":"10.1016/j.jval.2014.03.1654","title":"Characteristics Of Chronic Plaque Psoriasis In Canada: A Retrospective Database Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Novartis (Canada); Lawson Health Research Institute","funders":"","keywords":"Medicine; Psoriasis; Adalimumab; Infliximab; Acitretin; Ustekinumab; Etanercept; Dermatology; Palmoplantar pustulosis; Retrospective cohort study; Plaque psoriasis; Methotrexate; Internal medicine; Etretinate; Database; Disease; Rheumatoid arthritis","score_opus":0.0229398275402995,"score_gpt":0.2518703270930761,"score_spread":0.2289304995527766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156822431","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99711156,0.0010523633,0.000013128337,0.00015283663,0.0008348983,0.0005074746,0.00024500757,0.000010677426,0.00007205464],"genre_scores_gemma":[0.99931175,0.00034745762,0.000029301784,0.000051008,0.000047995676,0.00004177752,0.00011107993,0.000012544168,0.00004706526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979457,0.0007724517,0.00055112806,0.0003005555,0.000053214753,0.00037692726],"domain_scores_gemma":[0.99915224,0.00022476584,0.00022329003,0.00034197795,0.000027837767,0.000029890787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007436371,0.0001515627,0.0005268669,0.00015556088,0.00005319954,0.0000022065965,0.00015175586,0.00007392299,0.00006931476],"category_scores_gemma":[0.00012866364,0.000143676,0.000027627962,0.00025209293,0.00003122022,0.000037413345,0.000045072793,0.00020459983,0.000017106986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020603141,0.00071647164,0.9821575,0.00011176844,0.000076061086,0.000025320602,0.0011431669,0.000053091797,0.0006704252,0.0006167773,0.00020654836,0.014016823],"study_design_scores_gemma":[0.0029937376,0.00074606785,0.99406284,0.00012674341,0.000018950355,0.000007491015,0.00033733156,0.000104465675,0.00080295297,0.00003890521,0.00062904274,0.00013146653],"about_ca_topic_score_codex":0.93626946,"about_ca_topic_score_gemma":0.88731444,"teacher_disagreement_score":0.048955027,"about_ca_system_score_codex":0.0015264577,"about_ca_system_score_gemma":0.0017669074,"threshold_uncertainty_score":0.58589375},"labels":[],"label_agreement":null},{"id":"W2156885958","doi":"10.1016/j.jval.2013.03.1556","title":"Trends in buprenorphine and methadone sales and utilization in the United States, 1997-2012","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Buprenorphine; Methadone; Medicine; Ambulatory; Pharmacy; Medical prescription; (+)-Naloxone; Quarter (Canadian coin); Emergency medicine; Narcotic; Family medicine; Opioid; Psychiatry; Nursing; Internal medicine; Geography","score_opus":0.06071966891400729,"score_gpt":0.3300558783171848,"score_spread":0.2693362094031775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2156885958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772452,0.008280317,0.000011533177,0.013824409,0.000024801098,0.000548781,0.0000123166465,0.000014736383,0.000037909722],"genre_scores_gemma":[0.9915782,0.0063683796,0.00044474986,0.00096076366,0.000013447623,0.00006168425,0.0004983948,0.000013501374,0.000060872262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887604,0.0002698431,0.00030618673,0.00018670343,0.00013052544,0.00023070532],"domain_scores_gemma":[0.9995274,0.00015901912,0.000056137673,0.00016605944,0.000016052589,0.000075324344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004856682,0.00011121324,0.0002273851,0.00056413416,0.000024963641,0.00001285718,0.000035651923,0.000048202666,0.0000287931],"category_scores_gemma":[0.000038784685,0.000077183555,0.0000095722735,0.00079941435,0.0000383172,0.0000779314,0.000018984703,0.00015204503,0.000003937862],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000090319845,0.0008571332,0.91400677,0.000501252,0.00001611932,0.000018416185,0.030134926,0.0005607234,0.000020046267,0.00083424366,0.0011846668,0.051775377],"study_design_scores_gemma":[0.002311453,0.0003256689,0.9765917,0.00021316769,0.000007977458,0.0000105682,0.0018064332,0.016090395,0.000005492466,0.00092099723,0.0016498115,0.00006631353],"about_ca_topic_score_codex":0.058224514,"about_ca_topic_score_gemma":0.002230335,"teacher_disagreement_score":0.062584944,"about_ca_system_score_codex":0.00010194985,"about_ca_system_score_gemma":0.00005109678,"threshold_uncertainty_score":0.94804686},"labels":[],"label_agreement":null},{"id":"W2157686333","doi":"10.1016/j.jval.2015.09.2634","title":"Zrx Mcdm: A Fully Flexible Tool to Support The Local Adaptation of Multiple-Criteria Decision Criteria In Health Care","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Multiple-criteria decision analysis; Context (archaeology); Decision support system; Decision analysis; Computer science; Management science; Risk analysis (engineering); Operations research; Data mining; Medicine; Mathematics; Engineering; Statistics","score_opus":0.4879166609596166,"score_gpt":0.4695274744499399,"score_spread":0.01838918650967669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2157686333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84802324,0.007999133,0.06814782,0.068094514,0.002321319,0.0041445615,0.0007656832,0.00007529642,0.00042841243],"genre_scores_gemma":[0.96754974,0.00014649423,0.01830566,0.013435766,0.00019723036,0.00017943024,0.00007966975,0.00004424584,0.00006177824],"study_design_codex":"qualitative","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9902518,0.0012479114,0.0068063457,0.00069400744,0.0002403333,0.0007596145],"domain_scores_gemma":[0.9955533,0.0012504805,0.0018843014,0.0007412869,0.0001499557,0.00042068318],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.032367136,0.0002403103,0.0012807238,0.0007796114,0.00012051154,0.000060209863,0.00041991827,0.00015066074,0.00012224488],"category_scores_gemma":[0.004840829,0.0002654145,0.000090231806,0.00068743934,0.000064260516,0.00038096152,0.00010019185,0.0002664067,0.0004384632],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011480798,0.0008065444,0.19764565,0.00677091,0.000047087797,0.000009717401,0.30437785,0.28057832,0.0000038138244,0.05781083,0.08989574,0.060905457],"study_design_scores_gemma":[0.008430105,0.0036556958,0.14011468,0.0022548789,0.000004089101,0.000026957823,0.06759676,0.51939607,0.0000133321055,0.018907623,0.23845619,0.0011435992],"about_ca_topic_score_codex":0.074758135,"about_ca_topic_score_gemma":0.0073498073,"teacher_disagreement_score":0.23881775,"about_ca_system_score_codex":0.00293385,"about_ca_system_score_gemma":0.0021988065,"threshold_uncertainty_score":0.9999798},"labels":[],"label_agreement":null},{"id":"W2158417834","doi":"10.1016/j.jval.2011.02.593","title":"PIH8 THE ECONOMIC IMPACT ATTRIBUTABLE TO THE INAPPROPRIATE PRESCRIPTION OF BENZODIAZEPINES IN THE ELDERLY LIVING IN THE COMMUNITY","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke","funders":"","keywords":"Medical prescription; Health care; Medicine; Cohort; Gerontology; Multivariate analysis; Environmental health; Family medicine; Demography; Nursing; Internal medicine","score_opus":0.34028999296284723,"score_gpt":0.4280999674762898,"score_spread":0.08780997451344258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158417834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843826,0.00058062637,0.0000140808825,0.01245116,0.00014970999,0.0015162207,0.000012915317,0.000006143619,0.0008865049],"genre_scores_gemma":[0.99614483,0.0003109978,0.00003704432,0.0033679178,0.000059022383,0.000055777746,0.0000042009415,0.000008251043,0.000011983178],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956497,0.003220998,0.0005107146,0.00011005809,0.00017904417,0.00032947742],"domain_scores_gemma":[0.9967479,0.0024095366,0.00019445292,0.0005770315,0.000018800796,0.000052283478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009066394,0.00011315716,0.00025667803,0.000082951934,0.0001648903,0.000022834465,0.0004934134,0.000044790864,0.000045608685],"category_scores_gemma":[0.00067846593,0.000045678305,0.0000617978,0.00030622067,0.000055509634,0.00014305714,0.000078510595,0.00093328895,0.000015210071],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047709967,0.00063382316,0.84959006,0.00035222757,0.000030034636,0.0000035268552,0.13382956,0.00611425,0.000032264412,0.0013895115,0.00089403515,0.0066536],"study_design_scores_gemma":[0.00056930917,0.0011243634,0.9758331,0.00029448702,0.000019512101,0.0000139514395,0.008330852,0.010235645,0.000019498484,0.0008439682,0.0026474977,0.00006780291],"about_ca_topic_score_codex":0.1333544,"about_ca_topic_score_gemma":0.0047740387,"teacher_disagreement_score":0.12858036,"about_ca_system_score_codex":0.0002448818,"about_ca_system_score_gemma":0.00023648165,"threshold_uncertainty_score":0.8724167},"labels":[],"label_agreement":null},{"id":"W2158558263","doi":"10.1016/j.jval.2015.05.007","title":"Cost-Effectiveness Analysis of Alternative Antiviral Strategies for the Treatment of HBeAg-Positive and HBeAg-Negative Chronic Hepatitis B in the United Kingdom","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Medtronic (Canada)","funders":"","keywords":"Medicine; Entecavir; HBeAg; Pegylated interferon; Internal medicine; Chronic hepatitis; Hepatitis B; Hepatitis B virus; Immunology; Virus; HBsAg; Lamivudine; Ribavirin","score_opus":0.17890162080293107,"score_gpt":0.41184280708667237,"score_spread":0.2329411862837413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2158558263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99300724,0.0016278995,0.0008963281,0.0007114352,0.00006750829,0.0033321192,0.00027359283,0.000006925357,0.00007696009],"genre_scores_gemma":[0.99630547,0.0029465675,0.00016654603,0.00009052484,0.000043106564,0.0003921305,0.000039850507,0.000012232771,0.0000035469345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768513,0.0010295073,0.00049484393,0.0002446337,0.0002745151,0.0002713864],"domain_scores_gemma":[0.99517363,0.003988407,0.00030533684,0.00022910126,0.0002542384,0.000049274415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013125463,0.00017880551,0.00082774233,0.00048161545,0.000075049065,0.000011170118,0.00008844113,0.000047564063,0.0000015271219],"category_scores_gemma":[0.00029917216,0.000103970684,0.00010742136,0.0013379641,0.00032729638,0.00007685961,0.000022637027,0.0001119556,2.8413075e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087356777,0.0007622946,0.8856109,0.00038832973,0.0020014017,0.000021300937,0.07658977,0.018881325,0.00005107795,0.0067433827,0.000015639122,0.008061021],"study_design_scores_gemma":[0.004139646,0.0058957906,0.9172137,0.00052053924,0.0005253523,0.000002287238,0.0042392295,0.0652144,0.0010029688,0.0009528612,0.00018929804,0.00010392352],"about_ca_topic_score_codex":0.4798791,"about_ca_topic_score_gemma":0.060757585,"teacher_disagreement_score":0.41912153,"about_ca_system_score_codex":0.00083209464,"about_ca_system_score_gemma":0.0005734552,"threshold_uncertainty_score":0.95638114},"labels":[],"label_agreement":null},{"id":"W2159936838","doi":"10.1016/j.jval.2012.08.2223","title":"Constructing Experimental Designs for Discrete-Choice Experiments: Report of the ISPOR Conjoint Analysis Experimental Design Good Research Practices Task Force","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":1809,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; University of Calgary","funders":"","keywords":"Conjoint analysis; Management science; Task (project management); Computer science; Preference; Checklist; Preference elicitation; Health care; Operations research; Engineering; Systems engineering; Psychology; Mathematics","score_opus":0.4394866308800806,"score_gpt":0.3964888750498891,"score_spread":0.0429977558301915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159936838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98292613,0.0028390633,0.008790081,0.0008826608,0.0003122472,0.0025148669,0.000057549947,0.000015313091,0.0016620945],"genre_scores_gemma":[0.98750144,0.000038770064,0.011142184,0.000120754645,0.00006329965,0.00067974516,0.00003143418,0.000031474417,0.00039092437],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9968117,0.00032124613,0.0015552326,0.000654264,0.00013500468,0.0005225453],"domain_scores_gemma":[0.9965353,0.00073786976,0.002005773,0.00056672166,0.000032421776,0.00012190224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004018093,0.00019024214,0.00058339466,0.00032923536,0.00028486867,0.000073341704,0.00032677696,0.00010143521,0.00041165057],"category_scores_gemma":[0.0005602387,0.00018563711,0.00020732026,0.00044627715,0.00022535527,0.00054004893,0.00013642793,0.00020755129,0.000041892967],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096414544,0.0010441408,0.90163624,0.0001455198,0.0005385486,0.0000031292993,0.008396854,0.017526885,0.009232139,0.06024713,0.00089031464,0.00024267455],"study_design_scores_gemma":[0.008386459,0.0030349414,0.2220009,0.00037209608,0.00011767252,0.00009594384,0.10995546,0.3523383,0.28024703,0.018905535,0.0025697642,0.0019759089],"about_ca_topic_score_codex":0.015099248,"about_ca_topic_score_gemma":0.000034153018,"teacher_disagreement_score":0.67963535,"about_ca_system_score_codex":0.0011857166,"about_ca_system_score_gemma":0.00010826799,"threshold_uncertainty_score":0.9914593},"labels":[],"label_agreement":null},{"id":"W2160795370","doi":"10.1016/j.jval.2011.08.258","title":"PIN72 Cost-Effectiveness of Rotavirus Immunization in Vietnam: Results and Challenges","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Immunization; Rotavirus vaccine; Vaccination; Context (archaeology); Rotavirus; Environmental health; Cohort; Pediatrics; Virology; Immunology; Geography","score_opus":0.2580390877728648,"score_gpt":0.38686088713331734,"score_spread":0.12882179936045257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2160795370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98889846,0.007829294,0.000063825995,0.0015338322,0.00005170009,0.00094356434,0.000011235827,0.000010092887,0.0006580186],"genre_scores_gemma":[0.96828306,0.03102662,0.000538041,0.00007248207,0.0000133167005,0.00003988396,0.000013960818,0.000007815252,0.000004850611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978846,0.0011494125,0.00041731462,0.00018032662,0.000085643835,0.0002827129],"domain_scores_gemma":[0.999504,0.000103486214,0.000083583436,0.00016475946,0.000037756072,0.00010639898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002686093,0.00006813822,0.0003674515,0.0001829251,0.000015135215,9.752499e-7,0.00004791475,0.00005914939,0.0000049309688],"category_scores_gemma":[0.00078781595,0.00006167567,0.000017679948,0.00013354089,0.00007057951,0.00004278267,0.000038219314,0.00018457716,0.0000022067047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016987875,0.0012501593,0.8130188,0.00847709,0.000041184783,0.0001422881,0.0057139266,0.000424832,0.0018821794,0.0040308307,0.00006108686,0.14796977],"study_design_scores_gemma":[0.003077776,0.0019248966,0.99150366,0.0013608655,0.0000012714451,0.000025825388,0.00018157432,0.0010722788,0.00013935726,0.00046373127,0.00021234811,0.000036440833],"about_ca_topic_score_codex":0.0081305895,"about_ca_topic_score_gemma":0.0003943956,"teacher_disagreement_score":0.17848486,"about_ca_system_score_codex":0.00010030017,"about_ca_system_score_gemma":0.00009016643,"threshold_uncertainty_score":0.99847436},"labels":[],"label_agreement":null},{"id":"W2162067341","doi":"10.1016/j.jval.2013.08.458","title":"Cost of Care with Everolimus Versus Axitinib for Second-Line Metastatic Renal Cell Carcinoma Patients in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Axitinib; Everolimus; Medicine; Sunitinib; Renal cell carcinoma; Adverse effect; Oncology; Internal medicine","score_opus":0.05688945370193173,"score_gpt":0.2468252040780568,"score_spread":0.1899357503761251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2162067341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99381286,0.0015190882,0.000088197114,0.00017865348,0.00036895619,0.0011292421,0.0010873877,0.0000032865617,0.0018123509],"genre_scores_gemma":[0.99856603,0.00006653921,0.0007662162,0.00030153006,0.000033999087,0.00012281415,0.00006640933,0.000025425985,0.000051061295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982727,0.000020313775,0.00090975757,0.0002970974,0.00003803354,0.00046209627],"domain_scores_gemma":[0.99890065,0.00014899723,0.000548245,0.00019829138,0.00006776381,0.00013603632],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022703165,0.00015013159,0.0005924573,0.0001824095,0.000034499913,0.000012351526,0.00015215628,0.000040204446,0.00013628151],"category_scores_gemma":[0.000052947875,0.00016610516,0.000042602547,0.00016207808,0.000026358828,0.0001806376,0.000019367042,0.000130694,0.000013387144],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008329522,0.0002093355,0.95687133,0.0017624958,0.000029273795,0.0000040636814,0.0026578393,0.024162939,0.0000013323757,0.0050788173,0.0017187161,0.0066709216],"study_design_scores_gemma":[0.02010417,0.0031375682,0.9501926,0.00021903856,0.000008298328,8.768682e-7,0.0017085688,0.009785593,0.0003059901,0.0028717483,0.010951826,0.00071375107],"about_ca_topic_score_codex":0.93752104,"about_ca_topic_score_gemma":0.83906186,"teacher_disagreement_score":0.098459184,"about_ca_system_score_codex":0.0015179733,"about_ca_system_score_gemma":0.001242941,"threshold_uncertainty_score":0.6773572},"labels":[],"label_agreement":null},{"id":"W2164067273","doi":"10.1016/j.jval.2014.03.949","title":"The Canadian Eq-5d Valuation Study: Estimating Time Trade-Off Values For The Eq-5d-5l","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; University of Alberta; Centre for Advancing Health Outcomes; University of British Columbia; St. Joseph’s Healthcare Hamilton; Hospital for Sick Children; McMaster University","funders":"","keywords":"EQ-5D; Akaike information criterion; Statistics; Estimator; Mathematics; Valuation (finance); Standard error; Time-trade-off; Population; Mean squared error; Econometrics; Medicine; Demography; Quality of life (healthcare); Economics","score_opus":0.45905142674650434,"score_gpt":0.4091317431102169,"score_spread":0.04991968363628746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164067273","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29668942,0.012299911,0.02191467,0.6413025,0.0065741325,0.016948272,0.00053406967,0.0002333776,0.0035036379],"genre_scores_gemma":[0.97378486,0.00014948634,0.0066368855,0.016280422,0.0015475493,0.0009365062,0.000048328766,0.00009414245,0.0005218022],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99172455,0.0019090981,0.004421746,0.0006935433,0.00022694572,0.0010241243],"domain_scores_gemma":[0.98733115,0.009271727,0.0020447941,0.0009297675,0.000072097595,0.0003504889],"candidate_categories":["metaresearch","sts"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.08482036,0.00026875213,0.0009026504,0.00034588182,0.0022081537,0.00029220362,0.00065577147,0.00015128791,0.00005231421],"category_scores_gemma":[0.010162501,0.00024209259,0.00013648902,0.0003487063,0.00010554442,0.00028712436,0.000043117205,0.00035625076,0.0006306594],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007551538,0.00051543664,0.13505805,0.0013561045,0.00033031477,0.0000012380244,0.052032493,0.25337747,0.0000010389001,0.40694776,0.09627967,0.054024905],"study_design_scores_gemma":[0.00086224894,0.00027858774,0.037909243,0.00009409594,0.000008147823,0.0000024936855,0.0014551921,0.84388226,3.1780522e-7,0.045707643,0.069549456,0.00025030793],"about_ca_topic_score_codex":0.25975254,"about_ca_topic_score_gemma":0.08482314,"teacher_disagreement_score":0.6770955,"about_ca_system_score_codex":0.00207959,"about_ca_system_score_gemma":0.0013002118,"threshold_uncertainty_score":0.99909085},"labels":[],"label_agreement":null},{"id":"W2164226634","doi":"10.1016/j.jval.2013.03.957","title":"Costs associated with hospital admission for heart failure in two hospitals in the city of bogota, Colombia","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Public Health in Brazil","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Heart failure; Emergency medicine; Medical costs; Indirect costs; Health care; Medical emergency; Internal medicine; Business","score_opus":0.030573509566831924,"score_gpt":0.3596948851986936,"score_spread":0.32912137563186167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164226634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90753335,0.00010915711,0.000005881861,0.08827762,0.00016808951,0.003341579,0.000021925016,0.000025928606,0.0005164457],"genre_scores_gemma":[0.9970632,0.000032752625,0.00074136985,0.0016836482,0.00006037895,0.0003487284,0.000010206564,0.0000146510365,0.000045063935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958315,0.0016355526,0.0007219897,0.00031070822,0.0006084762,0.0008918101],"domain_scores_gemma":[0.9973639,0.0016371117,0.00034056362,0.00023536432,0.00016795396,0.00025506655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0081076985,0.00013680443,0.00042597347,0.00018925722,0.00023048194,0.000054806795,0.00041623454,0.0001517354,0.00005701245],"category_scores_gemma":[0.0036977578,0.0001065735,0.00004178147,0.0012550799,0.00019102993,0.00033803334,0.00003216722,0.00039201835,0.0000057636357],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002006182,0.00045549395,0.96395266,0.00007914011,0.000003655482,0.0000016983736,0.01927917,0.00006395742,0.0000040897735,0.004208112,0.010540752,0.0013912158],"study_design_scores_gemma":[0.0016496724,0.0006782328,0.9806285,0.00051029876,0.0000012841477,3.7225794e-7,0.006070087,0.00050744554,0.0000066061066,0.003599187,0.0061872145,0.00016112636],"about_ca_topic_score_codex":0.24791695,"about_ca_topic_score_gemma":0.06900475,"teacher_disagreement_score":0.1789122,"about_ca_system_score_codex":0.0012362767,"about_ca_system_score_gemma":0.002406357,"threshold_uncertainty_score":0.9479835},"labels":[],"label_agreement":null},{"id":"W2164799229","doi":"10.1016/j.jval.2011.08.445","title":"PMS59 Inadequate Pain Relief in Knee Osteoarthritis and Patient Reported outcomes: A Survey of Osteoarthritis Real World Therapies (SORT) in the United Kingdom","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Osteoarthritis; Physical therapy; Quality of life (healthcare); Observational study; WOMAC; Brief Pain Inventory; Knee pain; Clinical trial; Internal medicine; Chronic pain; Alternative medicine","score_opus":0.08814191868334788,"score_gpt":0.30068884601546303,"score_spread":0.21254692733211517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2164799229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944194,0.0020107925,0.0000025779873,0.0007047483,0.00016914359,0.0021585226,0.00004512489,0.000041069357,0.00044863485],"genre_scores_gemma":[0.997361,0.0007223224,0.00053483195,0.00094624114,0.000013875389,0.00019555574,0.00014075873,0.00004392692,0.000041467032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946447,0.002234335,0.0015564823,0.00048875326,0.00044328053,0.00063242234],"domain_scores_gemma":[0.99789375,0.000796874,0.0004665391,0.00058162754,0.00009963346,0.00016155887],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042683408,0.00032306503,0.00090723584,0.0010492639,0.00006914616,0.000016722212,0.00011732044,0.00014729619,0.000030412191],"category_scores_gemma":[0.00059628644,0.00025446372,0.000075235046,0.0015966842,0.00013874605,0.00010791983,0.000051716037,0.00046515695,0.000002554805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006960596,0.0006012426,0.8526693,0.00014225373,0.000015960284,0.00071666384,0.015978046,0.0000066808448,0.000046557267,0.001003875,0.00001940134,0.12810396],"study_design_scores_gemma":[0.011471956,0.0121075185,0.9701177,0.002225255,0.000015598138,0.00007876459,0.0022675744,0.000056367495,0.00010371613,0.0008558106,0.00044434346,0.00025543192],"about_ca_topic_score_codex":0.18248126,"about_ca_topic_score_gemma":0.11161818,"teacher_disagreement_score":0.12784852,"about_ca_system_score_codex":0.0001857478,"about_ca_system_score_gemma":0.00031020615,"threshold_uncertainty_score":0.99999076},"labels":[],"label_agreement":null},{"id":"W2165145690","doi":"10.1016/j.jval.2012.09.001","title":"Binary Choice Health State Valuation and Mode of Administration: Head-to-Head Comparison of Online and CAPI","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":74,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Medical Research Council; University of Sheffield","keywords":"Valuation (finance); Probit model; Descriptive statistics; Psychology; Population; Medicine; Actuarial science; Social psychology; Econometrics; Statistics; Economics; Environmental health; Accounting; Mathematics","score_opus":0.5023191586192964,"score_gpt":0.5025873552970823,"score_spread":0.0002681966777858813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165145690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91190493,0.0046032215,0.0012992263,0.07980985,0.00016359762,0.0018099957,0.00034945383,0.000016540107,0.00004319299],"genre_scores_gemma":[0.982448,0.00062804465,0.01241568,0.00421414,0.00007220123,0.00008001809,0.00007307119,0.000023606872,0.000045258235],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929667,0.00068174745,0.0053115305,0.0004960211,0.00013739396,0.00040659436],"domain_scores_gemma":[0.995464,0.0009450673,0.0027447515,0.00036626187,0.000107936365,0.00037193668],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0070575,0.00017916207,0.0013415079,0.00050002575,0.00010955361,0.000030348618,0.00012862115,0.00009045088,0.000051966246],"category_scores_gemma":[0.0009778194,0.00022966538,0.000038566475,0.00029718372,0.00007833272,0.00036646344,0.000046396235,0.00018497615,0.000048813217],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053562235,0.0009605152,0.9197875,0.006690146,0.000046484874,2.3926586e-7,0.022736395,0.023881774,0.000031724558,0.0114683565,0.0044494667,0.009893803],"study_design_scores_gemma":[0.0010393363,0.0012626791,0.73160815,0.00046760766,0.0000019046042,0.0000029438502,0.0013120815,0.25320858,0.0000074045174,0.009554389,0.0013191146,0.00021581326],"about_ca_topic_score_codex":0.12934004,"about_ca_topic_score_gemma":0.0060907886,"teacher_disagreement_score":0.22932681,"about_ca_system_score_codex":0.00042068915,"about_ca_system_score_gemma":0.0007481054,"threshold_uncertainty_score":0.93654823},"labels":[],"label_agreement":null},{"id":"W2165222989","doi":"10.1016/j.jval.2012.09.002","title":"Economic Appraisal of a Community-Wide Cardiovascular Health Awareness Program","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Promotion and Cardiovascular Prevention","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa; McMaster University; Université de Montréal; Programs for Assessment of Technology in Health Research Institute; St. Joseph’s Healthcare Hamilton; Élisabeth Bruyère Hospital; Institute for Clinical Evaluative Sciences; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Economic appraisal; Environmental health; Medicine; Public economics; Economics","score_opus":0.06255899736176887,"score_gpt":0.37568634344279295,"score_spread":0.3131273460810241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165222989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97496843,0.005699501,0.0066242893,0.006791906,0.0005343818,0.0046301666,0.000010327058,0.00017691814,0.00056408555],"genre_scores_gemma":[0.9949421,0.0011522124,0.0023711268,0.0008803398,0.00011024339,0.00038374224,0.00008339899,0.00003806053,0.0000387681],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99105215,0.0067448327,0.0010596489,0.00023458067,0.00035476917,0.00055398885],"domain_scores_gemma":[0.9981212,0.00018580536,0.00025044143,0.0009312472,0.0000868252,0.0004244628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01257262,0.00017245825,0.0011076347,0.0002495169,0.00017471523,0.0000130818835,0.00014170258,0.00011987329,0.00007856466],"category_scores_gemma":[0.00018821644,0.00017114414,0.0005459771,0.00026407794,0.00007286474,0.00011067146,0.00005652617,0.00061615865,0.00009976306],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015376116,0.0012425322,0.034775782,0.009255891,0.0004375767,0.0000045230013,0.002934813,0.004726834,0.000007008279,0.00041810414,0.0015029719,0.9446786],"study_design_scores_gemma":[0.006046733,0.00262216,0.9273177,0.001996995,0.000056193363,0.00016406571,0.0019859818,0.0057035545,0.0000793662,0.0005584072,0.053136203,0.00033263417],"about_ca_topic_score_codex":0.086509764,"about_ca_topic_score_gemma":0.00018254407,"teacher_disagreement_score":0.94434595,"about_ca_system_score_codex":0.00057539734,"about_ca_system_score_gemma":0.0018542146,"threshold_uncertainty_score":0.91957325},"labels":[],"label_agreement":null},{"id":"W2165408725","doi":"10.1016/j.jval.2012.08.1169","title":"PSU11 Medical Costs Comparison Between Internal Fixation and Arthoplasty in Patients With Hip Femoral Neck Fractures","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cohort; Femoral neck; Hip fracture; Internal fixation; Surgery; Retrospective cohort study; Cohort study; Total hip replacement; Population; Osteoporosis; Internal medicine","score_opus":0.027724041674508825,"score_gpt":0.3345674907958502,"score_spread":0.30684344912134137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165408725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719036,0.0004608455,0.0001995157,0.0013965965,0.00015375226,0.00041340064,0.0000071315526,0.000019976142,0.00015843267],"genre_scores_gemma":[0.99787265,0.00002572399,0.00054986327,0.0011685285,0.00027790456,0.000006607899,0.000073604875,0.000015509115,0.000009609092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831796,0.00018288611,0.0004369349,0.00018126694,0.0004865909,0.00039437154],"domain_scores_gemma":[0.9990742,0.00018716045,0.0001512294,0.00012621448,0.000027198283,0.00043396075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061408733,0.00013834616,0.00040062334,0.00017809065,0.000038790513,0.000010241397,0.000052515057,0.00014415893,0.00006799467],"category_scores_gemma":[0.00024262157,0.00009981122,0.000018614362,0.00014634556,0.00005424551,0.000114779206,0.000026576663,0.00057764084,0.000009649799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030635708,0.00026361525,0.9694534,0.000098888195,0.000008934864,0.0000037399104,0.0017091183,0.00003199379,2.9330778e-7,0.00002343247,0.0003633231,0.02773693],"study_design_scores_gemma":[0.003111789,0.00053812156,0.99383247,0.00058569765,0.000007926254,0.0000050269227,0.00008564453,0.0005978252,0.000017112476,0.000021451273,0.0011065231,0.00009040776],"about_ca_topic_score_codex":0.002649197,"about_ca_topic_score_gemma":0.00028600334,"teacher_disagreement_score":0.027646521,"about_ca_system_score_codex":0.00019074167,"about_ca_system_score_gemma":0.00015069464,"threshold_uncertainty_score":0.40701833},"labels":[],"label_agreement":null},{"id":"W2165853796","doi":"10.1016/j.jval.2013.03.054","title":"Treating acute heart failure in the elderly: A comparison of three inpatient treatment alternatives in the United States","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Nesiritide; Heart failure; Cardiogenic shock; Propensity score matching; Internal medicine; Mortality rate; Emergency medicine; Myocardial infarction; Natriuretic peptide","score_opus":0.06826388410850617,"score_gpt":0.35295986210938785,"score_spread":0.28469597800088164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2165853796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9329396,0.00025696403,0.00002363586,0.06395003,0.00003307535,0.002670613,0.0000055541122,0.000014860193,0.00010570429],"genre_scores_gemma":[0.99674696,0.00020689215,0.0016921294,0.00080921187,0.000026877648,0.00039760818,0.00008363464,0.000012227311,0.00002446094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978531,0.00057079695,0.00063981034,0.00022333946,0.0003341593,0.00037880975],"domain_scores_gemma":[0.9988618,0.0005543597,0.00014726074,0.00034842585,0.000030681927,0.000057453675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063964626,0.00019049915,0.0004751897,0.00037495888,0.00005847683,0.000023151631,0.00012918781,0.000042261283,0.000026512811],"category_scores_gemma":[0.000034961566,0.0000975446,0.00006136377,0.0006911423,0.000051189647,0.0000691048,0.000023423498,0.00020436446,0.00001343538],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104028724,0.002736905,0.9016894,0.00019457066,0.00010447539,0.000032646076,0.072759934,0.0035393583,0.000028962422,0.0008320349,0.0032204795,0.014757211],"study_design_scores_gemma":[0.011639265,0.017566344,0.8036391,0.0016489676,0.00012616211,0.000024204135,0.063962705,0.0662381,0.00024784042,0.0014211544,0.03314563,0.00034049878],"about_ca_topic_score_codex":0.098602585,"about_ca_topic_score_gemma":0.009211407,"teacher_disagreement_score":0.09805027,"about_ca_system_score_codex":0.00030961266,"about_ca_system_score_gemma":0.00009505144,"threshold_uncertainty_score":0.9073999},"labels":[],"label_agreement":null},{"id":"W2166529181","doi":"10.1016/j.jval.2014.03.714","title":"Economic Impact Of Insertable Cardiac Monitors For Diagnosis Of Unexplained Syncope On The Canadian Health Care System","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiovascular Syncope and Autonomic Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Medtronic (Canada)","funders":"","keywords":"Syncope (phonology); Medicine; Emergency department; Cohort; Emergency medicine; Health care; Medical emergency; Pediatrics; Internal medicine","score_opus":0.018096593499339318,"score_gpt":0.2833671066616564,"score_spread":0.26527051316231703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166529181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905374,0.0035371974,0.000009890174,0.002088692,0.00045570414,0.0019324562,0.00028669043,0.000016104646,0.0011358875],"genre_scores_gemma":[0.9990411,0.00030196412,0.00007646454,0.00025038706,0.00010766198,0.00013180307,0.000045901037,0.000032291195,0.000012435681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998294,0.00030372877,0.00060261734,0.00023653753,0.00013282346,0.0004302812],"domain_scores_gemma":[0.99854434,0.000349371,0.0002448881,0.0005359661,0.000053229724,0.00027222643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015416046,0.0001562628,0.0008941986,0.0002478628,0.000120205026,0.000008767108,0.00012217234,0.00007296508,0.0000073343563],"category_scores_gemma":[0.00010663398,0.000116817464,0.00047811292,0.00014780402,0.00004079385,0.000028498112,0.000012295295,0.000120900986,0.0000074614477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006684716,0.00021685447,0.6433905,0.011477791,0.0017199051,0.0000041780863,0.013903801,0.22267608,0.000014296016,0.01825501,0.023970304,0.06370283],"study_design_scores_gemma":[0.018756108,0.018629437,0.7830325,0.01613566,0.00048557844,0.00003088397,0.03493943,0.03996836,0.0025224036,0.0002304742,0.08365145,0.0016177322],"about_ca_topic_score_codex":0.879864,"about_ca_topic_score_gemma":0.08371191,"teacher_disagreement_score":0.79615206,"about_ca_system_score_codex":0.0037838912,"about_ca_system_score_gemma":0.0051496755,"threshold_uncertainty_score":0.98947436},"labels":[],"label_agreement":null},{"id":"W2166586678","doi":"10.1016/j.jval.2013.03.712","title":"Importance, Anticipated Burden, And Function: Validity Of Utilities For Impotence And Urinary Incontinence","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Sexual function; Urinary incontinence; Prostate cancer; Medicine; Logistic regression; Prostate; Gynecology; Urology; Internal medicine; Cancer","score_opus":0.1333749853497329,"score_gpt":0.2984593673293045,"score_spread":0.1650843819795716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166586678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849444,0.0032619722,0.0008519477,0.009435761,0.00016899007,0.00075470906,0.00006743919,0.000016743816,0.0004980588],"genre_scores_gemma":[0.99614656,0.0021088393,0.00093733927,0.00049629284,0.00006899296,0.00008829901,0.000004424187,0.000008536511,0.00014069413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868876,0.000035183595,0.00069017604,0.0002748029,0.000024847453,0.00028624985],"domain_scores_gemma":[0.9992847,0.00012840999,0.00028573957,0.0001714129,0.000029955909,0.00009979508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010448889,0.000091111084,0.00032864403,0.0001611815,0.000072159164,0.000017613353,0.000064160566,0.000046610694,0.000024834408],"category_scores_gemma":[0.00013962212,0.00010263825,0.000022903669,0.00013829653,0.000070907714,0.00017215773,0.000050265884,0.00007631553,0.000004964289],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056563033,0.00009956268,0.52237076,0.0039151795,0.000023353594,0.000001754109,0.002280264,0.00014051421,0.000008606854,0.45698157,0.0009957139,0.013126166],"study_design_scores_gemma":[0.00081524457,0.00084393896,0.7781156,0.00014482277,0.000002762274,0.000005025991,0.00046606478,0.02671252,0.000009496032,0.16524826,0.027428953,0.00020734704],"about_ca_topic_score_codex":0.043521225,"about_ca_topic_score_gemma":0.00008980388,"teacher_disagreement_score":0.2917333,"about_ca_system_score_codex":0.000042752356,"about_ca_system_score_gemma":0.000042941585,"threshold_uncertainty_score":0.96284807},"labels":[],"label_agreement":null},{"id":"W2166653378","doi":"10.1016/j.jval.2014.03.522","title":"Cost-Utility Analysis of Newer HER2- Testing Technologies to Target Trastuzumab in the Adjuvant Breast Cancer Setting","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Calgary; Ontario Institute for Cancer Research; McMaster University","funders":"","keywords":"CISH; Trastuzumab; Medicine; Chromogenic in situ hybridization; Oncology; Breast cancer; Internal medicine; Cost effectiveness; Cancer; Biology; In situ hybridization","score_opus":0.1293870136368234,"score_gpt":0.426012675525422,"score_spread":0.2966256618885986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166653378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9436251,0.0012750358,0.0005992508,0.051821157,0.0000906023,0.0017215245,0.00012844351,0.000102031365,0.0006368367],"genre_scores_gemma":[0.99518585,0.00008653395,0.0035341836,0.00092193164,0.00005555164,0.00017770485,0.0000074738505,0.00001786047,0.000012929035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969626,0.00059678603,0.00072429754,0.00041881306,0.00063419924,0.00066329236],"domain_scores_gemma":[0.9979646,0.0009581747,0.00016029632,0.0006392616,0.00016203013,0.00011564377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005355961,0.00015215499,0.0006687809,0.00069914275,0.00007028811,0.000013447276,0.00033729646,0.00010033861,0.00006117075],"category_scores_gemma":[0.0023891379,0.00011003249,0.00007398975,0.0040234183,0.0001108938,0.00003799368,0.000094232455,0.00064125186,0.0000040536597],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007846089,0.00015109753,0.76278514,0.00047284577,0.00004612884,0.0000126166515,0.0023903542,0.014727342,0.00011942311,0.00004983142,0.00036959123,0.21879716],"study_design_scores_gemma":[0.0005311334,0.00026242604,0.8615636,0.00079663354,0.00004239155,0.00001689386,0.0023970853,0.1324659,0.00014319977,0.00019972124,0.0014750474,0.00010592502],"about_ca_topic_score_codex":0.0669909,"about_ca_topic_score_gemma":0.0034907833,"teacher_disagreement_score":0.21869124,"about_ca_system_score_codex":0.00074695406,"about_ca_system_score_gemma":0.0008427564,"threshold_uncertainty_score":0.9392221},"labels":[],"label_agreement":null},{"id":"W2166681211","doi":"10.1111/j.1524-4733.2010.00746.x","title":"Health Technology Assessment and Comparative Effectiveness in Sweden","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Health technology; Medicine; Data science; Computer science; Health care; Economics; Economic growth","score_opus":0.4970367936624877,"score_gpt":0.5154297704456807,"score_spread":0.018392976783193016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166681211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9029703,0.0027287214,0.0006330137,0.090419285,0.0006430011,0.0015919295,0.000067432935,0.000048485388,0.00089783635],"genre_scores_gemma":[0.9902513,0.00027526115,0.0056730127,0.003468212,0.000079267746,0.0002006321,0.000012045519,0.000017309922,0.000022967315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941678,0.0010957461,0.0033806036,0.0006638234,0.00007358381,0.00061842555],"domain_scores_gemma":[0.9964833,0.0014274722,0.0014368233,0.0004122148,0.000026003532,0.00021418977],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029935354,0.0001844084,0.0014992141,0.0009859406,0.00015378665,0.00003592268,0.0002031273,0.00018381674,0.000039423543],"category_scores_gemma":[0.0006848334,0.00023850227,0.00003441376,0.00051805034,0.00011381463,0.00022299765,0.00006605877,0.0007056362,0.00013199034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008446228,0.00013452892,0.54086846,0.0006452514,0.000008453596,9.157704e-7,0.0015692511,0.0006113108,0.0000034813365,0.45532474,0.00032486577,0.00050031696],"study_design_scores_gemma":[0.001544095,0.00028573317,0.92901254,0.0003385783,4.6700978e-7,0.000012277198,0.0015224298,0.016418131,0.000003356565,0.042728808,0.00786571,0.00026786458],"about_ca_topic_score_codex":0.021224936,"about_ca_topic_score_gemma":0.005005016,"teacher_disagreement_score":0.41259593,"about_ca_system_score_codex":0.0013399172,"about_ca_system_score_gemma":0.00086464133,"threshold_uncertainty_score":0.9988857},"labels":[],"label_agreement":null},{"id":"W2166839079","doi":"10.1016/j.jval.2012.08.1244","title":"PCN51 Comprehensive Investigation of Adverse Event (AE)-Related Costs in Patients With Metastatic Breast Cancer (mBC) Treated With First- and Second-Line Chemotherapies","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Capecitabine; Taxane; Medicine; Internal medicine; Docetaxel; Oncology; Pharmacy; Metastatic breast cancer; Adverse effect; Cancer; Breast cancer; Colorectal cancer","score_opus":0.027592431451381228,"score_gpt":0.30222845176798424,"score_spread":0.274636020316603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2166839079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99606556,0.0015630424,0.0000012910014,0.0011275192,0.000045375975,0.001086329,0.000082736464,0.000013217858,0.000014945858],"genre_scores_gemma":[0.9987343,0.00034510472,0.00021991263,0.0004729147,0.00001635366,0.0000601884,0.00009187321,0.000019801748,0.000039572296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989655,0.00012308075,0.00034465734,0.00016678392,0.00014276947,0.00025722192],"domain_scores_gemma":[0.9993402,0.000101043704,0.00021811397,0.000096029384,0.0000814952,0.0001631616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000121689,0.0001550606,0.00041452402,0.00017811876,0.000027438595,0.0000011700758,0.000022173614,0.00003919613,0.00015241501],"category_scores_gemma":[0.0000035550959,0.00011069745,0.000017157772,0.0003448195,0.00010470702,0.00009572687,0.000008235395,0.00012714314,0.0000011453919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018107756,0.00051440333,0.99233603,0.0005332075,0.0001637504,0.000003848793,0.0031077925,0.00064249866,0.0000775244,0.000012435506,0.000046605517,0.00075112423],"study_design_scores_gemma":[0.014444132,0.001369468,0.9821452,0.0008127916,0.000086106724,0.000014367534,0.00018324495,0.0004197418,0.00036570043,0.000007830903,0.000057238045,0.000094177885],"about_ca_topic_score_codex":0.011714443,"about_ca_topic_score_gemma":0.0021537666,"teacher_disagreement_score":0.012633357,"about_ca_system_score_codex":0.0004679698,"about_ca_system_score_gemma":0.00023504507,"threshold_uncertainty_score":0.9948666},"labels":[],"label_agreement":null},{"id":"W2167206949","doi":"10.1016/j.jval.2010.10.033","title":"The Association between Statin use and Outcomes Potentially Attributable to an Unhealthy Lifestyle in Older Adults","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":62,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging; Canadian Institutes of Health Research","keywords":"Medicine; Statin; Hazard ratio; Adverse effect; Incidence (geometry); Proportional hazards model; Regimen; Physical therapy; Gerontology; Internal medicine; Confidence interval","score_opus":0.04563419773232072,"score_gpt":0.2963434746695832,"score_spread":0.2507092769372625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167206949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99210536,0.0006217912,0.00017317054,0.0049603074,0.00014944308,0.0018785816,0.000031096944,0.00003609958,0.000044125372],"genre_scores_gemma":[0.9946118,0.00071934133,0.0022957898,0.001989628,0.00013298061,0.00006848688,0.00002652266,0.00002891309,0.00012653868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703115,0.00074168434,0.00068387866,0.00035348596,0.00051080395,0.00067898445],"domain_scores_gemma":[0.9985126,0.00028169068,0.00018712849,0.00044659237,0.0001103886,0.00046154583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005016353,0.0001489211,0.0005524832,0.00016364567,0.00017184303,0.000036566744,0.00008894316,0.0001228294,0.0000059780486],"category_scores_gemma":[0.0006766746,0.00011079598,0.000062732805,0.00037338395,0.00001611361,0.00017323121,0.000035994566,0.00034912696,0.000010526111],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115141185,0.00012692477,0.9703948,0.00022076408,0.000030765033,0.000009155722,0.0032749344,0.00002296155,9.3229664e-7,0.00017744189,0.000082409155,0.025543807],"study_design_scores_gemma":[0.0021216704,0.0005495804,0.99467856,0.00027286925,0.000015333544,0.0000038672483,0.00044039148,0.000112932,0.0000150276555,0.000097873846,0.0015912127,0.00010066041],"about_ca_topic_score_codex":0.12222059,"about_ca_topic_score_gemma":0.0049264147,"teacher_disagreement_score":0.11729418,"about_ca_system_score_codex":0.0006039795,"about_ca_system_score_gemma":0.00059367093,"threshold_uncertainty_score":0.8836246},"labels":[],"label_agreement":null},{"id":"W2167282503","doi":"10.1016/j.jval.2013.11.012","title":"Core Discrete Event Simulation Model for the Evaluation of Health Care Technologies in Major Depressive Disorder","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Discontinuation; Time horizon; Tolerability; Economic evaluation; Medicine; Health care; Major depressive disorder; Adverse effect; Quality-adjusted life year; Actuarial science; Computer science; Psychiatry; Cost effectiveness; Economics; Risk analysis (engineering)","score_opus":0.13057743283339684,"score_gpt":0.424721745264861,"score_spread":0.29414431243146416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167282503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89580727,0.019635571,0.06426641,0.013106617,0.00013438096,0.0068803993,0.00004063719,0.000096356765,0.000032378917],"genre_scores_gemma":[0.99720216,0.00019045746,0.0020209062,0.00010131805,0.000016865883,0.00036682986,0.000068506866,0.000020851618,0.0000121317835],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981109,0.0002650875,0.0005892745,0.00027499985,0.0004899746,0.00026976704],"domain_scores_gemma":[0.99854535,0.0004944343,0.00036135496,0.00042339246,0.00014073026,0.00003475325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001736023,0.00013022976,0.0003536336,0.00018573563,0.000099378325,0.000003978789,0.00009909229,0.000093958704,0.0000021842254],"category_scores_gemma":[0.0008265515,0.00008623515,0.000057142028,0.00019257364,0.00004365897,0.00005501761,0.000040554038,0.00014898238,6.7296895e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013295082,0.00009476562,0.046123162,0.00044066831,0.000008463118,9.630157e-8,0.0020111287,0.80595464,0.000011666089,0.00026583954,0.000023135499,0.14493346],"study_design_scores_gemma":[0.004434716,0.00039934338,0.060248215,0.0006994947,0.0000338603,6.108877e-7,0.0013323083,0.9296355,0.00005547918,0.0030491618,0.00005139038,0.00005987118],"about_ca_topic_score_codex":0.0016214985,"about_ca_topic_score_gemma":0.0005660336,"teacher_disagreement_score":0.14487359,"about_ca_system_score_codex":0.0005725871,"about_ca_system_score_gemma":0.00045671358,"threshold_uncertainty_score":0.35165673},"labels":[],"label_agreement":null},{"id":"W2167984747","doi":"10.1111/j.1524-4733.2010.00738.x","title":"How Do Cost-Effectiveness Analyses Inform Reimbursement Decisions for Oncology Medicines in Canada? The Example of Sunitinib for First-Line Treatment of Metastatic Renal Cell Carcinoma","year":2010,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Sunitinib; Reimbursement; Medicine; Context (archaeology); Oncology; Internal medicine; Tyrosine-kinase inhibitor; Sorafenib; Renal cell carcinoma; Cabozantinib; Kidney cancer; Cancer; Hepatocellular carcinoma","score_opus":0.26172057196591403,"score_gpt":0.41423857386000407,"score_spread":0.15251800189409004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2167984747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98812544,0.0014165529,0.0005599273,0.003092868,0.00022045309,0.0062988666,0.00021276104,0.0000041652725,0.00006898215],"genre_scores_gemma":[0.99490273,0.00028843712,0.0029694478,0.00010315008,0.000063733685,0.00147221,0.00014768455,0.000024044037,0.000028552855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977392,0.00022212684,0.0009232595,0.00030214337,0.00036600116,0.00044724444],"domain_scores_gemma":[0.9920471,0.0064682676,0.00049847906,0.00051596685,0.00027088783,0.00019931402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012655907,0.00023837942,0.001062585,0.00032813862,0.00007701174,0.000005070284,0.00013639606,0.000062403924,0.000013145439],"category_scores_gemma":[0.00053574116,0.00014625887,0.0001595911,0.00037318235,0.00010031268,0.000035127257,0.000023095596,0.00013845872,1.2690612e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020251457,0.01201203,0.5066874,0.013467348,0.0014088784,0.00045318744,0.01654721,0.042950682,0.025647372,0.0040938566,0.0017785031,0.3547021],"study_design_scores_gemma":[0.058788605,0.0506799,0.58970034,0.001457276,0.0014402632,0.00014319089,0.0075247814,0.013372735,0.24010259,0.0017118811,0.034523744,0.0005547058],"about_ca_topic_score_codex":0.8411701,"about_ca_topic_score_gemma":0.8282159,"teacher_disagreement_score":0.35414737,"about_ca_system_score_codex":0.0018169762,"about_ca_system_score_gemma":0.004841865,"threshold_uncertainty_score":0.8589261},"labels":[],"label_agreement":null},{"id":"W2168524487","doi":"10.1016/j.jval.2013.12.011","title":"A Questionnaire to Assess the Relevance and Credibility of Observational Studies to Inform Health Care Decision Making: An ISPOR-AMCP-NPC Good Practice Task Force Report","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":129,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Ottawa","funders":"National Center for Research Resources; Translational Research Institute, University of Arkansas for Medical Sciences; National Pharmaceutical Council","keywords":"Observational study; Credibility; Relevance (law); Observational methods in psychology; Task (project management); Psychological intervention; Psychology; Applied psychology; Consistency (knowledge bases); Medical education; Management science; Medicine; Computer science; Political science; Engineering; Artificial intelligence; Psychiatry","score_opus":0.7929635680932674,"score_gpt":0.6169698499817562,"score_spread":0.1759937181115112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168524487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8133811,0.009074674,0.11478705,0.05668695,0.0008158069,0.0045893295,0.00004260926,0.000019222682,0.0006033072],"genre_scores_gemma":[0.9187684,0.00013048999,0.07476722,0.005980742,0.00008303959,0.00008454202,0.000005795487,0.000010419961,0.0001693456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.96851873,0.01191041,0.012045479,0.0013934826,0.0056706253,0.00046129362],"domain_scores_gemma":[0.96011394,0.022005133,0.008629629,0.004559443,0.004252267,0.00043957445],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.20356002,0.00024795477,0.0023758716,0.00029140944,0.0004096606,0.00022396256,0.00089354475,0.00006330503,0.000021602287],"category_scores_gemma":[0.2891251,0.00012615636,0.00023939033,0.002075262,0.00006257129,0.0005857724,0.00023813758,0.00021611986,0.00002948644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000273416,0.00032050625,0.45770177,0.0028236182,0.00017408955,0.000012782037,0.07298833,0.050491314,0.000010521576,0.070805684,0.030431177,0.31396678],"study_design_scores_gemma":[0.00030992043,0.0010830467,0.7611915,0.0019572976,0.00005427532,0.000101147874,0.018440114,0.017284304,0.0000031390082,0.020422252,0.17884332,0.00030972442],"about_ca_topic_score_codex":0.00065778353,"about_ca_topic_score_gemma":0.0014718632,"teacher_disagreement_score":0.31365708,"about_ca_system_score_codex":0.00034631693,"about_ca_system_score_gemma":0.0008081851,"threshold_uncertainty_score":0.8201026},"labels":[],"label_agreement":null},{"id":"W2168898013","doi":"10.1016/j.jval.2014.03.1185","title":"Hybrid time and motion, patient survey and chart review study methodology: A case study of subcutaneous allergen immunotherapy in the United States and Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Generalizability theory; Observational study; Medicine; Data collection; Chart; Health care; Medical emergency; Psychology; Internal medicine","score_opus":0.06935201784366178,"score_gpt":0.3217893230386833,"score_spread":0.2524373051950215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2168898013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930202,0.004359129,0.000012407937,0.0009103087,0.000026279882,0.0016518069,0.000013430839,0.00000394396,0.0000025242862],"genre_scores_gemma":[0.98481077,0.01363942,0.00005864341,0.0014137733,0.0000062029358,0.000010778216,0.00004720932,0.000009356378,0.000003823858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99507624,0.0039536557,0.00049094507,0.00018695259,0.00016133433,0.00013084796],"domain_scores_gemma":[0.9987197,0.00082412676,0.00014688002,0.00017080674,0.00008217728,0.000056314653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034773548,0.00009906926,0.00043184424,0.00008723616,0.000060141738,0.0000048888187,0.000024690995,0.00001629787,0.000005101372],"category_scores_gemma":[0.00026225636,0.0000695842,0.0000056871563,0.00015196121,0.000026413813,0.000014230572,0.000015631183,0.00010855799,7.238384e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007597147,0.0024810217,0.8557167,0.0016198853,0.0002191982,0.0048137093,0.09812905,0.0016043907,0.000018079058,0.000023565297,0.0011699686,0.03344471],"study_design_scores_gemma":[0.0065731592,0.013277324,0.9091494,0.0009499999,0.000051914943,0.009572338,0.027792962,0.031688157,0.0000025369136,0.0000683328,0.0005856794,0.00028821413],"about_ca_topic_score_codex":0.9443541,"about_ca_topic_score_gemma":0.5965006,"teacher_disagreement_score":0.34785357,"about_ca_system_score_codex":0.00004387468,"about_ca_system_score_gemma":0.00010661973,"threshold_uncertainty_score":0.41086224},"labels":[],"label_agreement":null},{"id":"W2169288904","doi":"10.1016/j.jval.2013.03.1627","title":"Measuring the Quality of a Childhood Cancer Care Delivery System: Quality Indicator Development","year":2013,"lang":"en","type":"review","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; McMaster Children's Hospital; Pediatric Oncology Group; University of Toronto; Hamilton Health Sciences; Hospital for Sick Children","funders":"Canadian Institutes of Health Research; University of Toronto; Ontario Ministry of Health and Long-Term Care","keywords":"Medicine; Quality (philosophy); Health care; Stakeholder; Process management; Business","score_opus":0.23318617317849002,"score_gpt":0.4257284403671275,"score_spread":0.19254226718863746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169288904","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011145165,0.98127687,0.000011397091,0.00053566025,0.00075277366,0.005748433,0.00022505179,0.00011611154,0.00018855564],"genre_scores_gemma":[0.008506527,0.9883737,0.0007149145,0.00050757744,0.00053442206,0.0010772884,0.00013195192,0.00012430025,0.000029298264],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9852636,0.005414198,0.0055453596,0.0009965732,0.001924162,0.0008561283],"domain_scores_gemma":[0.992641,0.0012680135,0.003761303,0.0015589184,0.00028245896,0.00048830797],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0093884235,0.000761031,0.0054372065,0.00045223892,0.00024532533,0.000030391555,0.00074782997,0.00049006235,0.00005031999],"category_scores_gemma":[0.0005911079,0.00053602277,0.0007147446,0.00078312814,0.00015310447,0.00007658523,0.00027255437,0.0014375682,0.000067161985],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000022826545,0.00023318063,0.0020426877,0.4510787,0.00047483415,0.0000030365536,0.018330056,0.00001159857,1.3062856e-7,0.00029615354,0.00016610452,0.5273407],"study_design_scores_gemma":[0.0019625854,0.00018542461,0.044219147,0.3063373,0.0005515709,0.00004786696,0.009846857,0.0000037094464,0.000009713919,0.000009973369,0.63565826,0.0011675755],"about_ca_topic_score_codex":0.12023129,"about_ca_topic_score_gemma":0.002520733,"teacher_disagreement_score":0.63549215,"about_ca_system_score_codex":0.004619722,"about_ca_system_score_gemma":0.016412375,"threshold_uncertainty_score":0.9997091},"labels":[],"label_agreement":null},{"id":"W2169495494","doi":"10.1016/j.jval.2012.08.2213","title":"Cost-Effectiveness Analysis: Stress Ulcer Bleeding Prophylaxis with Proton Pump Inhibitors, H2 Receptor Antagonists","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Nosocomial Infections in ICU","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Stress ulcer; Medicine; Complication; Ventilator-associated pneumonia; Intensive care medicine; Pneumonia; Internal medicine","score_opus":0.044810535994988486,"score_gpt":0.33661048458353743,"score_spread":0.29179994858854896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169495494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862547,0.0002086196,0.00039134966,0.0010615878,0.00042581846,0.011134052,0.000020942562,0.00016670076,0.00033626513],"genre_scores_gemma":[0.99391294,0.00014923672,0.0017555918,0.00016781321,0.00039400806,0.0034300748,0.000055310855,0.000056483565,0.000078541525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970826,0.000575541,0.0006432415,0.000598687,0.00047520702,0.00062474003],"domain_scores_gemma":[0.998348,0.00025508637,0.0002769981,0.0005127958,0.00027802828,0.00032906927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001119484,0.00029300284,0.0007594767,0.0007524023,0.00020540257,0.000074557196,0.00011652692,0.00018081805,0.0001969081],"category_scores_gemma":[0.00017713297,0.00023124996,0.00012564451,0.0023327316,0.00013825431,0.00025317524,0.00005441956,0.0006598154,0.000094939955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038633283,0.0008669075,0.97830254,0.002527844,0.0004325831,0.000017665716,0.0008675687,0.004881225,0.00439765,0.0001391057,0.0004022765,0.0067782933],"study_design_scores_gemma":[0.011905368,0.012557369,0.64610773,0.010133511,0.00073137425,0.00016429649,0.0019026225,0.006140119,0.29549024,0.00041210421,0.0126447175,0.0018105148],"about_ca_topic_score_codex":0.022098657,"about_ca_topic_score_gemma":0.0001636849,"teacher_disagreement_score":0.3321948,"about_ca_system_score_codex":0.001271553,"about_ca_system_score_gemma":0.000519616,"threshold_uncertainty_score":0.98441327},"labels":[],"label_agreement":null},{"id":"W2169789362","doi":"10.1016/j.jval.2014.01.002","title":"Discrete Choice Experiment to Estimate Breast Cancer Patients’ Preferences and Willingness to Pay for Prophylactic Granulocyte Colony-Stimulating Factors","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Amgen","keywords":"Medicine; Febrile neutropenia; Chemotherapy; Willingness to pay; Granulocyte colony-stimulating factor; Breast cancer; Neutropenia; Oncology; Internal medicine; Cancer; Intensive care medicine","score_opus":0.04201486244759908,"score_gpt":0.3745239640668622,"score_spread":0.33250910161926317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169789362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940094,0.000054958295,0.0008700401,0.0022843904,0.00038460016,0.0022697782,0.000049245005,0.000039533807,0.000038076116],"genre_scores_gemma":[0.99764514,0.000010903252,0.0009619192,0.00051587954,0.00013513521,0.0006432392,0.000011358107,0.000025301324,0.00005110633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998694,0.00007439593,0.00033025464,0.0003584323,0.00018172173,0.00036119702],"domain_scores_gemma":[0.9991383,0.00017407713,0.000099300276,0.00015330254,0.00009271923,0.00034229102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020225938,0.00016087863,0.00034018833,0.000089255336,0.0001870165,0.000030146599,0.000054978624,0.000037925744,0.0000125209335],"category_scores_gemma":[0.000111740235,0.00011219707,0.000030516592,0.00020865482,0.000019422405,0.000071654285,0.00003289461,0.000114802126,0.0000021598316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024819942,0.00010241792,0.978008,0.00059916265,0.0000102200165,1.8675978e-7,0.0016846579,0.011852236,0.0003960789,0.00007469247,0.00004112164,0.00698305],"study_design_scores_gemma":[0.0015254302,0.0021661452,0.9876009,0.00063336134,0.000025320118,0.000002054252,0.000067468834,0.00483933,0.00086459226,0.000054270968,0.0020312786,0.00018984752],"about_ca_topic_score_codex":0.014234842,"about_ca_topic_score_gemma":0.0005584739,"teacher_disagreement_score":0.013676369,"about_ca_system_score_codex":0.00029864482,"about_ca_system_score_gemma":0.00017272955,"threshold_uncertainty_score":0.9923295},"labels":[],"label_agreement":null},{"id":"W2169989438","doi":"10.1016/j.jval.2011.02.441","title":"PMD1 IMPACT OF VAGUS NERVE STIMULATION (VNS) THERAPY ON CLINICAL OUTCOMES AND COSTS IN MEDICAID PATIENTS WITH DRUG-RESISTANT EPILEPSY","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Vagus nerve stimulation; Medicaid; Epilepsy; Univariate analysis; Incidence (geometry); Pediatrics; Emergency medicine; Multivariate analysis; Health care; Internal medicine; Psychiatry; Vagus nerve","score_opus":0.10095795357983417,"score_gpt":0.41192736739092123,"score_spread":0.31096941381108706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2169989438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978096,0.0003570441,0.000002794025,0.00034760596,0.000043150096,0.0012171754,0.000024639035,0.00001178877,0.00018618516],"genre_scores_gemma":[0.9987764,0.0006824647,0.00027841027,0.00015476727,0.00001656227,0.000023066323,0.000034966815,0.000017749768,0.000015632462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778014,0.0004477151,0.00066893257,0.00027777863,0.00044665244,0.0003788002],"domain_scores_gemma":[0.9985554,0.000568684,0.00018903062,0.00027952332,0.000072048875,0.00033528527],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011779207,0.00015423335,0.000551229,0.000232403,0.000027095482,0.0000035084536,0.000056736204,0.00006796767,0.000043059594],"category_scores_gemma":[0.00023716823,0.00009076238,0.000074340554,0.0002098111,0.00010046918,0.0000491888,0.00001650178,0.00028830717,0.0000042937822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004773904,0.0021857508,0.97799414,0.000046075966,0.00008119788,0.00003393075,0.0008947565,0.000033252552,8.0679627e-7,0.00009028171,0.000044303913,0.013821579],"study_design_scores_gemma":[0.011745201,0.012537025,0.97483766,0.000435829,0.0000067907094,8.920206e-7,0.000039900406,0.00018320397,0.000009031441,0.00013263959,0.000006007315,0.00006582989],"about_ca_topic_score_codex":0.0278728,"about_ca_topic_score_gemma":0.00061023637,"teacher_disagreement_score":0.027262565,"about_ca_system_score_codex":0.00037384045,"about_ca_system_score_gemma":0.00050020387,"threshold_uncertainty_score":0.9786007},"labels":[],"label_agreement":null},{"id":"W2170239385","doi":"10.1016/j.jval.2012.06.012","title":"Modeling Good Research Practices—Overview: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-1","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":755,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Task (project management); Task force; Computer science; Management science; Best practice; Health care; Work (physics); Data science; Systems engineering; Engineering; Political science","score_opus":0.876793190886648,"score_gpt":0.6051287336837298,"score_spread":0.2716644572029182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170239385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80710745,0.04846793,0.0029276304,0.12482002,0.0016876903,0.0042170812,0.00015866628,0.00006306247,0.010550466],"genre_scores_gemma":[0.98772514,0.0038475497,0.0043497984,0.0017454012,0.000982897,0.00029776886,0.000022167702,0.00008996895,0.0009393019],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97707677,0.0087545095,0.009361793,0.0012789246,0.0011811749,0.0023468244],"domain_scores_gemma":[0.9781798,0.0074638026,0.01060945,0.002409845,0.0007390718,0.0005980439],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.30745947,0.0002903693,0.001378527,0.0011839139,0.00094005733,0.00015261992,0.0011073418,0.00036526518,0.00009370316],"category_scores_gemma":[0.069984026,0.00030514057,0.00020185256,0.0017471326,0.00015749635,0.0021139048,0.0004638732,0.002143849,0.00045251157],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015426947,0.0015056477,0.1861953,0.0072982446,0.00016866277,0.000010692429,0.028863244,0.38595006,0.000019346731,0.38153875,0.0079427315,0.0003530656],"study_design_scores_gemma":[0.000696666,0.00016440956,0.0017328901,0.0008551496,0.0000066393777,0.00006817785,0.008359676,0.92990357,0.000005457713,0.025528112,0.032346833,0.00033240803],"about_ca_topic_score_codex":0.12434118,"about_ca_topic_score_gemma":0.001414179,"teacher_disagreement_score":0.54395354,"about_ca_system_score_codex":0.0024483097,"about_ca_system_score_gemma":0.0027859332,"threshold_uncertainty_score":0.9999401},"labels":[],"label_agreement":null},{"id":"W2170943640","doi":"10.1016/j.jval.2012.08.1026","title":"PCV83 Adherence to Antihypertensive Agents After a Recent Ischemic Stroke and Risk of Cardiovascular Outcomes : A Population Based Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Medicine; Dyslipidemia; Internal medicine; Stroke (engine); Cohort; Diabetes mellitus; Atrial fibrillation; Cohort study; Population; Disease; Coronary artery disease; Logistic regression; Cardiology; Endocrinology","score_opus":0.053487780854221595,"score_gpt":0.3165928188727096,"score_spread":0.26310503801848806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2170943640","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609137,0.001567451,0.00006124858,0.00036643792,0.000112955146,0.0017180715,0.000025120235,0.000017902687,0.000039419167],"genre_scores_gemma":[0.9979954,0.0001663107,0.00078361965,0.00085997616,0.000030746774,0.00009943794,0.000008188565,0.000013956942,0.000042381955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984579,0.00026629196,0.000366503,0.00023976999,0.00038246202,0.00028703775],"domain_scores_gemma":[0.99918306,0.000031294196,0.00008905291,0.0003844864,0.0000547459,0.00025735854],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006618665,0.00012964132,0.00048597925,0.00014264503,0.000026865544,0.000005141072,0.00004127707,0.000025790961,0.00004730203],"category_scores_gemma":[0.00014034088,0.00010738506,0.00008753358,0.00017740882,0.0000086331665,0.000064273074,0.000050403225,0.000089411624,0.000009963408],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016857647,0.000519899,0.987283,0.00022912581,0.00022375325,0.000010451843,0.000939714,0.00069533696,0.00001229514,5.121671e-7,0.00014132379,0.009776001],"study_design_scores_gemma":[0.0016473507,0.00048654788,0.9945808,0.00015353183,0.00019686215,0.0000010926431,0.00042031577,0.000921342,0.000011664193,0.0000011186132,0.0014937274,0.00008561329],"about_ca_topic_score_codex":0.008190843,"about_ca_topic_score_gemma":0.000055227083,"teacher_disagreement_score":0.009690387,"about_ca_system_score_codex":0.00017520499,"about_ca_system_score_gemma":0.000051352625,"threshold_uncertainty_score":0.9984137},"labels":[],"label_agreement":null},{"id":"W2171310617","doi":"10.1016/j.jval.2012.04.013","title":"Modeling using Discrete Event Simulation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-4","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":238,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Task force; Discrete event simulation; Computer science; Task (project management); Event (particle physics); Management science; Simulation; Engineering; Systems engineering; Political science; Physics","score_opus":0.7916444466274899,"score_gpt":0.5722622029564016,"score_spread":0.21938224367108827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171310617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89004093,0.0062575378,0.08399796,0.016627906,0.0008497938,0.0015285418,0.000059130394,0.000023782439,0.0006143884],"genre_scores_gemma":[0.99309117,0.00013941477,0.005226192,0.0007972192,0.0005235118,0.000046140907,0.000010600912,0.000042058047,0.00012368377],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9904075,0.0017047442,0.0060809497,0.0005463776,0.00035998374,0.0009004259],"domain_scores_gemma":[0.99274236,0.0015377426,0.004363087,0.0009426627,0.00017150301,0.00024261895],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.084091835,0.00017490216,0.00083179254,0.0004550523,0.00045274536,0.000048557686,0.00035904426,0.00015872599,0.000034118628],"category_scores_gemma":[0.010365139,0.0001831582,0.00014123115,0.0006004821,0.000054590364,0.0009793207,0.00015094112,0.00053168804,0.00004838616],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011696829,0.00007390632,0.039898377,0.0005302086,0.000016115027,5.062927e-7,0.003906792,0.93683624,0.0000018844345,0.018667039,0.00003520084,0.000022028744],"study_design_scores_gemma":[0.00029508406,0.00003242697,0.0007775261,0.0004168038,0.0000034174707,0.000015274452,0.0018442887,0.9855541,0.0000013600205,0.009937736,0.00096166483,0.00016030017],"about_ca_topic_score_codex":0.036774106,"about_ca_topic_score_gemma":0.0001918135,"teacher_disagreement_score":0.10305022,"about_ca_system_score_codex":0.0015037571,"about_ca_system_score_gemma":0.00088297034,"threshold_uncertainty_score":0.997971},"labels":[],"label_agreement":null},{"id":"W2171436100","doi":"10.1016/j.jval.2015.08.003","title":"Using Decision-Analytic Modeling to Isolate Interventions That Are Feasible, Efficient and Optimal: An Application from the Norwegian Cervical Cancer Screening Program","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"Universitetet i Oslo","keywords":"Context (archaeology); Psychological intervention; Triage; Cervical cancer; Medicine; Norwegian; Cervical screening; Cost–utility analysis; Actuarial science; Decision tree; Incremental cost-effectiveness ratio; Gynecology; Cost-effectiveness analysis; Computer science; Cost effectiveness; Risk analysis (engineering); Cancer; Business; Data mining; Emergency medicine; Internal medicine","score_opus":0.3930505713572423,"score_gpt":0.498982152553361,"score_spread":0.10593158119611867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171436100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80325264,0.0020346344,0.18755716,0.005508704,0.000067488814,0.0014765137,0.000023484856,0.00004379067,0.00003558634],"genre_scores_gemma":[0.9773225,0.00009476323,0.021552656,0.00068256975,0.00017147076,0.00012972913,0.000015206356,0.000024532,0.000006552869],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99815303,0.00015621868,0.0003942686,0.00041366665,0.00050232426,0.00038048148],"domain_scores_gemma":[0.9986021,0.00012336543,0.00007995198,0.0003700723,0.00018882347,0.0006357149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011306199,0.00012387754,0.0003137148,0.00015293901,0.00015870613,0.00007706129,0.0001566449,0.00006398042,0.00005722678],"category_scores_gemma":[0.00012892345,0.000090378475,0.00007276331,0.0005464283,0.000036808397,0.000060264196,0.00013535265,0.00034539745,0.0000055681603],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040161447,0.00023120757,0.036857303,0.00015870479,0.000021096492,0.0000033237652,0.0011192115,0.761093,0.000006006847,0.00004872505,0.000027235996,0.20003255],"study_design_scores_gemma":[0.00082760566,0.00024826356,0.083831,0.0005778035,0.00003101498,0.000004764797,0.0009809763,0.91311836,0.0000024012488,0.00015586418,0.00014100254,0.000080959246],"about_ca_topic_score_codex":0.041769113,"about_ca_topic_score_gemma":0.0027831066,"teacher_disagreement_score":0.19995159,"about_ca_system_score_codex":0.0004341328,"about_ca_system_score_gemma":0.00032854624,"threshold_uncertainty_score":0.9646118},"labels":[],"label_agreement":null},{"id":"W2171436500","doi":"10.1016/j.jval.2015.09.2397","title":"Modeling The Impact of Potential Differences In Real-Wolrd Adherence With Extended-Half-Life Vs. Conventional Factor Viii And Ix on Bleeding","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Regimen; Haemophilia; Haemophilia A; Clinical trial; Internal medicine; Pediatrics","score_opus":0.17797058423390083,"score_gpt":0.40017316550295823,"score_spread":0.2222025812690574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2171436500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99709266,0.00036587837,0.000052475134,0.0017138044,0.00004355447,0.0005126224,0.000010085295,0.000010828921,0.00019806482],"genre_scores_gemma":[0.99912745,0.0005761975,0.00012968818,0.00002944162,0.000064538806,0.000015015959,0.000007852295,0.000010129214,0.00003967942],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99851424,0.00016435157,0.00032388527,0.00021628977,0.0004697771,0.00031147664],"domain_scores_gemma":[0.999346,0.00011279742,0.00007395614,0.00013922778,0.000061991865,0.00026601844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054691464,0.00012517549,0.00033823366,0.00018026379,0.000052063046,0.000013337648,0.000073034935,0.000058365524,0.000022617472],"category_scores_gemma":[0.000100501966,0.0000643519,0.000042539155,0.00020445997,0.00009266351,0.000056716664,0.000027036996,0.00026737328,0.0000021432982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002981681,0.0007309489,0.9748176,0.0003453635,0.00009943116,0.00006304661,0.0032274288,0.013749721,0.00033092423,0.00077033136,0.00003873136,0.0028448456],"study_design_scores_gemma":[0.004705286,0.0053504724,0.56391597,0.0012161654,0.000011734928,0.000029567616,0.0011993496,0.422775,0.00006502054,0.0006195946,0.0000010229853,0.00011085613],"about_ca_topic_score_codex":0.024674462,"about_ca_topic_score_gemma":0.00010524627,"teacher_disagreement_score":0.4109016,"about_ca_system_score_codex":0.00018446022,"about_ca_system_score_gemma":0.0010847314,"threshold_uncertainty_score":0.98182034},"labels":[],"label_agreement":null},{"id":"W2174482767","doi":"10.1016/j.jval.2015.03.050","title":"A Review And Update To The Guidance Document For The Costing Process In The Canadian Health Care Setting","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Operations Management Techniques","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Activity-based costing; Health care; Process (computing); Agency (philosophy); Medicine; Business; Process management; Computer science; Political science; Marketing","score_opus":0.29365138881754643,"score_gpt":0.5430054948231564,"score_spread":0.24935410600560998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2174482767","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.1723e-7,0.86891955,0.00017964184,0.11667675,0.00012300415,0.013809554,0.00010406317,0.000017867396,0.0001690472],"genre_scores_gemma":[0.00005084646,0.96053433,0.0017364551,0.034874022,0.00008907147,0.0026287932,0.000026171705,0.000023690514,0.000036621],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9927626,0.0030981735,0.0019333462,0.00068203785,0.00087481376,0.00064902386],"domain_scores_gemma":[0.9951599,0.0022532179,0.00085953274,0.0012210726,0.00031240392,0.00019384209],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0540494,0.0002873206,0.0011127637,0.00039673588,0.0009189933,0.00060150056,0.0022097877,0.00006718976,0.000004788705],"category_scores_gemma":[0.0049615907,0.00012489097,0.00009101724,0.0022417845,0.000049559858,0.0001460212,0.00018788384,0.00049588835,0.000018883631],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[4.4885e-7,0.00000361796,0.000012250015,0.011900883,0.0000037839764,6.9697285e-7,0.0027185576,0.00012876198,4.0195073e-11,0.0011220318,0.10104357,0.8830654],"study_design_scores_gemma":[0.00004377217,0.0000597176,0.000011558581,0.02382891,0.000025727437,0.000007519173,0.0012439064,0.00013662085,2.232184e-9,0.0006380477,0.9738823,0.00012191021],"about_ca_topic_score_codex":0.1198317,"about_ca_topic_score_gemma":0.38646832,"teacher_disagreement_score":0.8829435,"about_ca_system_score_codex":0.0014223865,"about_ca_system_score_gemma":0.0054039815,"threshold_uncertainty_score":0.97405523},"labels":[],"label_agreement":null},{"id":"W2179942617","doi":"10.1016/j.jval.2015.09.2938","title":"The “Efficacy-Effectiveness Gap”: Historical Background and Current Conceptualization","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Neuroethics, Human Enhancement, Biomedical Innovations","field":"Neuroscience","cited_by":176,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Conceptualization; Randomized controlled trial; Identification (biology); Narrative; Narrative review; Health care; Electroencephalography; Psychology; Computer science; Medicine; Artificial intelligence; Psychotherapist; Psychiatry; Political science","score_opus":0.42939299169784917,"score_gpt":0.4339454096475236,"score_spread":0.0045524179496744255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2179942617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94297206,0.004361085,0.01974441,0.020515632,0.008759724,0.0023750698,0.000016491073,0.00024707316,0.0010084232],"genre_scores_gemma":[0.9979859,0.000625683,0.0000637329,0.0010133976,0.00014469081,0.000046545676,0.0000025878164,0.00001538361,0.00010209906],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99716026,0.0012855409,0.00042274984,0.00037057057,0.0004435061,0.00031739945],"domain_scores_gemma":[0.9971005,0.0022533988,0.00016722409,0.00023308056,0.00006751328,0.00017829219],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018477464,0.00010850164,0.00015718164,0.00009265816,0.00029627094,0.00005344429,0.00019761447,0.000045287394,0.000004618874],"category_scores_gemma":[0.0035049214,0.000084865016,0.000016163629,0.0006228707,0.0003593891,0.000108310516,0.00008732875,0.0003718143,0.000019411184],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015982498,0.00086206634,0.0018868386,0.0003702134,0.0000039497,0.0000127108015,0.004027406,0.000915376,0.004950913,0.92942715,0.010025104,0.04735845],"study_design_scores_gemma":[0.006245169,0.0018440918,0.016244298,0.0007096869,0.00001111841,0.000040443236,0.00066928513,0.020021912,0.006704607,0.110376246,0.8362905,0.00084264606],"about_ca_topic_score_codex":0.00027409501,"about_ca_topic_score_gemma":0.0000149573925,"teacher_disagreement_score":0.8262654,"about_ca_system_score_codex":0.00088988617,"about_ca_system_score_gemma":0.00033684552,"threshold_uncertainty_score":0.41959718},"labels":[],"label_agreement":null},{"id":"W2182580458","doi":"10.1016/j.jval.2015.09.2658","title":"Issues Affecting Quality of Life and Disease Burden in Lipoprotein Lipase Deficiency (Lpld) – First Step Towards a Pro Measure in Lpld","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipid metabolism and disorders","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université du Québec à Chicoutimi","funders":"","keywords":"Medicine; Quality of life (healthcare); Disease; Pancreatitis; Physical therapy; Internal medicine; Nursing","score_opus":0.10602216413324121,"score_gpt":0.35951827755916194,"score_spread":0.2534961134259207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182580458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9596544,0.028581582,0.00002767812,0.009606528,0.00015690281,0.001613692,0.000015247574,0.000031756706,0.00031224967],"genre_scores_gemma":[0.9980173,0.00048439746,0.000829246,0.00036841867,0.0001703334,0.00006877509,0.0000075318335,0.000021248394,0.00003273176],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708,0.00062752306,0.0008608357,0.00040494846,0.000568291,0.0004583574],"domain_scores_gemma":[0.99845976,0.0001412277,0.00021887162,0.0003621287,0.000088083805,0.0007299488],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0045262594,0.00018917199,0.00072287634,0.00034549893,0.000036482532,0.000013049458,0.0001022244,0.00009819751,0.0000074146446],"category_scores_gemma":[0.008458919,0.00016737549,0.00004895382,0.0006674055,0.00007974197,0.00012727868,0.00007090812,0.0003044045,0.0000029623784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021162657,0.001195252,0.93733126,0.009593228,0.000009368608,0.000033010318,0.024533745,0.0014714391,0.000044975168,0.0009305626,0.00037702348,0.022363855],"study_design_scores_gemma":[0.014857482,0.00089544355,0.957638,0.0034799988,0.000025890778,0.0000050480553,0.0130470395,0.0060514035,0.000052883777,0.0017829579,0.0016934079,0.00047041415],"about_ca_topic_score_codex":0.1654295,"about_ca_topic_score_gemma":0.0050702607,"teacher_disagreement_score":0.16035923,"about_ca_system_score_codex":0.00015207264,"about_ca_system_score_gemma":0.001959444,"threshold_uncertainty_score":0.99989325},"labels":[],"label_agreement":null},{"id":"W2182833508","doi":"10.1016/j.jval.2015.09.592","title":"Work Productivity and Activity Impairment Among Chronic Spontaneous/Idiopathic Urticaria Patients: ResultsFrom The First International Burden of Illness Study (Assure-Csu)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Lynde Centre for Dermatology; Novartis (Canada)","funders":"","keywords":"Presenteeism; Medicine; Absenteeism; Observational study; Medical Expenditure Panel Survey; Cohort study; Emergency medicine; Physical therapy; Pediatrics; Health care; Internal medicine","score_opus":0.021654272794636824,"score_gpt":0.2752514868678591,"score_spread":0.2535972140732223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2182833508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98906225,0.00033955916,0.000015574924,0.008036735,0.0006238656,0.0017477954,0.00001792402,0.000029768167,0.00012654367],"genre_scores_gemma":[0.99950844,0.000051625182,0.000021072046,0.000028868146,0.00024142391,0.00006693323,0.000012005633,0.000016024873,0.0000536297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980629,0.00036940715,0.00045734123,0.00034629734,0.00049443846,0.00026963608],"domain_scores_gemma":[0.9988919,0.00013937826,0.00021410298,0.00041029457,0.00016875919,0.00017559338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013042202,0.00014633434,0.0003397832,0.00011742029,0.00012896527,0.000016908783,0.00012846035,0.000088714776,0.000008699592],"category_scores_gemma":[0.00042512408,0.00010122249,0.00004055457,0.00034064904,0.00016844484,0.00009256525,0.0000949375,0.00045712895,0.000003783142],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019357344,0.004790606,0.9257091,0.00015330712,0.00086787075,0.00021198006,0.05343337,0.008266937,0.000038477127,0.00024794892,0.00050072744,0.003843922],"study_design_scores_gemma":[0.004037847,0.0023033104,0.9871408,0.0005199402,0.0002524198,0.000055298813,0.0018670416,0.0031304723,0.000024870289,0.00016370726,0.00037099345,0.00013330214],"about_ca_topic_score_codex":0.010657824,"about_ca_topic_score_gemma":0.00074625236,"teacher_disagreement_score":0.061431676,"about_ca_system_score_codex":0.0006252634,"about_ca_system_score_gemma":0.00053893495,"threshold_uncertainty_score":0.9959303},"labels":[],"label_agreement":null},{"id":"W2183363260","doi":"10.1016/j.jval.2015.09.2463","title":"Systematic Review of Economic Evaluations of Treatments In Epilepsy","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; Université de Montréal","funders":"","keywords":"Medicine; Lamotrigine; Lacosamide; Epilepsy; Oxcarbazepine; Adjunctive treatment; Levetiracetam; Systematic review; Lennox–Gastaut syndrome; Pediatrics; MEDLINE; Meta-analysis; Population; Internal medicine; Psychiatry; Carbamazepine","score_opus":0.12485810096399477,"score_gpt":0.43745510282345057,"score_spread":0.3125970018594558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2183363260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80355465,0.18159689,0.0000112310245,0.00399938,0.00010847977,0.008019192,0.000056910398,0.000014373313,0.002638911],"genre_scores_gemma":[0.97560835,0.02345619,0.00039531506,0.00014531438,0.000010806913,0.00021581427,0.000032678774,0.00000976882,0.00012576913],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99802643,0.00047100848,0.0009157554,0.00012983097,0.00025271502,0.0002042837],"domain_scores_gemma":[0.9990349,0.0001770087,0.00023828859,0.00031891096,0.00006436709,0.00016653302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002273089,0.00007702188,0.0007875108,0.00019825604,0.0000068136774,0.000001000907,0.00005315333,0.000026011821,0.00003222059],"category_scores_gemma":[0.0005732435,0.000058097652,0.00006118662,0.00018436664,0.000025089157,0.00002985431,0.000013473567,0.00007077453,0.000042256244],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105741834,0.0012881083,0.25908223,0.7351873,0.00016783431,0.000020610432,0.00094319554,0.0003761037,0.0000046006694,0.001988384,0.0003643572,0.0004715538],"study_design_scores_gemma":[0.010414303,0.004969305,0.07673111,0.8982262,0.00030215364,0.00004841349,0.0006226399,0.0055646473,0.00015264873,0.0027939302,0.000026453172,0.0001481917],"about_ca_topic_score_codex":0.0048495005,"about_ca_topic_score_gemma":0.00011587413,"teacher_disagreement_score":0.18235111,"about_ca_system_score_codex":0.0009413857,"about_ca_system_score_gemma":0.0015109855,"threshold_uncertainty_score":0.7331027},"labels":[],"label_agreement":null},{"id":"W2184615100","doi":"10.1016/j.jval.2015.09.1516","title":"Exploring Attitudes and Perceptions of Patients and Staff Towards a Fee For Service “After Hours” Clinic Supplementing Free Hiv Services in Uganda: A Qualitative Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Focus group; Medicine; Thematic analysis; Qualitative research; Family medicine; Service delivery framework; Service (business); Nursing; Business; Marketing","score_opus":0.22925083437157096,"score_gpt":0.4711787936409006,"score_spread":0.24192795926932964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184615100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964251,0.0003048716,0.000032969194,0.0013526271,0.000025811454,0.0014997671,0.00030336098,0.0000101436335,0.000045352906],"genre_scores_gemma":[0.9976163,0.00014158506,0.0016026505,0.00007096118,0.000028877357,0.00039843874,0.00005286,0.000015040394,0.000073307056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813825,0.0004074574,0.0006031651,0.00025229595,0.0002881191,0.00031073368],"domain_scores_gemma":[0.99907815,0.0001814007,0.000109149,0.00017117089,0.00024071748,0.00021941842],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020457802,0.000106166575,0.00035236563,0.00029890263,0.000050262213,0.000018195906,0.000077345554,0.000027533857,0.000030552226],"category_scores_gemma":[0.0002903462,0.000095592986,0.000036004552,0.00026302703,0.000035361918,0.00024729344,0.00013639354,0.00015851288,0.0000023917464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003995571,0.0012986015,0.7409663,0.0021570418,0.000035885067,0.0000019284737,0.2531612,0.0000032102193,0.000005753627,0.00001364067,0.00016015444,0.0017966904],"study_design_scores_gemma":[0.006685143,0.006635445,0.6724458,0.0012801894,0.00001652915,6.959355e-7,0.31206477,0.00055460643,0.000004277882,0.00016660348,0.00006775751,0.000078212375],"about_ca_topic_score_codex":0.012864361,"about_ca_topic_score_gemma":0.01107389,"teacher_disagreement_score":0.06852056,"about_ca_system_score_codex":0.00012139327,"about_ca_system_score_gemma":0.00018986208,"threshold_uncertainty_score":0.9937091},"labels":[],"label_agreement":null},{"id":"W2184885738","doi":"10.1016/j.jval.2015.10.010","title":"Changes in Quality of Life Associated with Complications of Diabetes: Results from the ADVANCE Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":121,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Myocardial infarction; Stroke (engine); Diabetes mellitus; Quality of life (healthcare); Heart failure; Amputation; EQ-5D; Disease; Physical therapy; Confidence interval; Heart disease; Internal medicine; Surgery; Health related quality of life","score_opus":0.6296680235757864,"score_gpt":0.4616103344648133,"score_spread":0.16805768911097313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2184885738","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95488304,0.0017190791,0.00006698301,0.040078964,0.000121657504,0.0013388743,0.0014239156,0.000014380551,0.0003531283],"genre_scores_gemma":[0.99603975,0.000054995817,0.00056569837,0.0030926184,0.00004417297,0.000107379004,0.00006450428,0.000015380674,0.000015505124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922276,0.0020409722,0.004857255,0.00041347308,0.00015253258,0.0003081717],"domain_scores_gemma":[0.9892337,0.005290807,0.004495689,0.000716974,0.0001154211,0.00014741533],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03839309,0.00012402752,0.0011413331,0.00020331366,0.000053112868,0.000010045731,0.0003272166,0.00006726697,0.0000069210996],"category_scores_gemma":[0.017605215,0.0001213452,0.000031756736,0.0005432155,0.000086179876,0.00012898208,0.00004258038,0.00018222595,0.000021921327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000398743,0.0005359897,0.97308654,0.00010045451,0.000029551267,4.8758736e-8,0.013379617,0.008003041,3.6780557e-7,0.003913748,0.0008744485,0.00003632439],"study_design_scores_gemma":[0.0027424223,0.00029485268,0.98070276,0.00028610145,0.000001445631,2.071332e-8,0.0066905078,0.0050778994,8.1315716e-7,0.0036718966,0.00041474457,0.000116556206],"about_ca_topic_score_codex":0.06767765,"about_ca_topic_score_gemma":0.02909181,"teacher_disagreement_score":0.041156728,"about_ca_system_score_codex":0.00060154125,"about_ca_system_score_gemma":0.00053647236,"threshold_uncertainty_score":0.9906699},"labels":[],"label_agreement":null},{"id":"W2185447473","doi":"10.1016/j.jval.2015.09.859","title":"The Cost Of Acute Care Hospitalizations Associated With Chronic Heart Failure In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Heart failure; Ambulatory; Emergency medicine; Disease; Demographics; Acute care; Hospital discharge; Intensive care medicine; Health care; Internal medicine","score_opus":0.02067910244001095,"score_gpt":0.2759418896224015,"score_spread":0.2552627871823906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2185447473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92734444,0.0018035329,0.000021966312,0.0678224,0.00016282646,0.0024380719,0.00003956767,0.000026340322,0.0003408671],"genre_scores_gemma":[0.99916476,0.00007418444,0.00021206713,0.00026081238,0.000017017986,0.000054675063,0.000073048854,0.000011554337,0.00013188111],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989643,0.00010715699,0.00025436992,0.000121803074,0.0002711532,0.00028118008],"domain_scores_gemma":[0.99945766,0.00006137271,0.000070724236,0.00019148938,0.00008439544,0.0001343712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026287622,0.00008457744,0.00023060695,0.00006111197,0.000046062578,0.0000051771003,0.000047302245,0.000025914325,0.0000048444535],"category_scores_gemma":[0.00004998731,0.000055418463,0.000016115966,0.00039097565,0.000025286612,0.000027928421,0.000016319102,0.00010557216,0.0000017915467],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049288978,0.00010051697,0.9524487,0.00013594424,0.00010878624,0.00003880192,0.0017471411,0.005950536,0.0000015778047,0.0005414876,0.03821601,0.0006611983],"study_design_scores_gemma":[0.009784084,0.002517244,0.77627856,0.0018058602,0.000121453806,0.000010183722,0.008689153,0.005329402,0.00006283172,0.000050165683,0.19508353,0.00026754857],"about_ca_topic_score_codex":0.8823312,"about_ca_topic_score_gemma":0.9819788,"teacher_disagreement_score":0.17617017,"about_ca_system_score_codex":0.0036435276,"about_ca_system_score_gemma":0.0065461094,"threshold_uncertainty_score":0.99908584},"labels":[],"label_agreement":null},{"id":"W2186044971","doi":"10.1016/j.jval.2015.09.2007","title":"Comparative Analysis of The Reimbursement Landscape of Orphan Drugs on An International Level","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Orphan drug; Reimbursement; Listing (finance); Medicine; Family medicine; Business; Public economics; Health care; Economic growth; Economics; Finance; Bioinformatics","score_opus":0.3080938908832449,"score_gpt":0.39867403604382745,"score_spread":0.09058014516058255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186044971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978322,0.00020133778,0.000051880845,0.003060295,0.0003032862,0.00013159722,0.0005197525,0.0000027523752,0.017407048],"genre_scores_gemma":[0.9988217,0.00009474706,0.00012555697,0.00083853,0.000035144825,0.0000042399756,0.000016542946,0.000003605632,0.000059977807],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989973,0.000051584844,0.000620903,0.00016083402,0.00004156587,0.00012786998],"domain_scores_gemma":[0.9991745,0.000055555032,0.0004223781,0.00023147436,0.000025657699,0.00009046066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010021086,0.00006298313,0.00038484356,0.00033973728,0.000016385118,0.0000075677453,0.00025013147,0.0000271521,0.00009425443],"category_scores_gemma":[0.000037380083,0.0000569622,0.000080255886,0.00037615284,0.00004320814,0.00006126172,0.00003819826,0.000086081935,0.000015802512],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058104448,0.0003356073,0.2114123,0.000018593437,0.0002649252,1.2415158e-7,0.0048658103,0.09414258,0.0000027905692,0.6879229,0.000599852,0.0003764406],"study_design_scores_gemma":[0.0016113991,0.0003150775,0.34301877,0.000040550516,0.000025151316,3.01166e-7,0.00058946107,0.6026945,0.0002685298,0.024035625,0.02720654,0.00019408356],"about_ca_topic_score_codex":0.002361801,"about_ca_topic_score_gemma":0.00011013032,"teacher_disagreement_score":0.66388726,"about_ca_system_score_codex":0.00014693185,"about_ca_system_score_gemma":0.00007808553,"threshold_uncertainty_score":0.35703525},"labels":[],"label_agreement":null},{"id":"W2186241165","doi":"10.1016/j.jval.2015.09.2359","title":"Clinical Responses in Joint and Skin Outcomes and Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Psoriatic Arthritis Patients Treated with Certolizumab Pegol","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Presenteeism; Psoriatic arthritis; Minimal clinically important difference; Physical therapy; Placebo; Internal medicine; Absenteeism; Clinical trial; Arthritis; Randomized controlled trial; Rheumatoid arthritis; Adalimumab; Alternative medicine; Psychology","score_opus":0.05133715215097627,"score_gpt":0.311548618452561,"score_spread":0.2602114663015847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186241165","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992638,0.0018482486,8.122832e-8,0.0032280686,0.000045496592,0.0021637883,0.000035222743,0.000021001366,0.00002009531],"genre_scores_gemma":[0.99892837,0.0005787118,0.000087962675,0.00017676399,0.000007994461,0.00014781166,0.00002747976,0.000025776824,0.000019110876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99638116,0.0012225983,0.0009210375,0.00058893656,0.0004254758,0.0004608032],"domain_scores_gemma":[0.9981942,0.00079964113,0.00042158345,0.0002899641,0.00008801935,0.00020658462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007710978,0.00030189328,0.0011805017,0.00031008676,0.000083036895,0.000023535178,0.00003665794,0.00011213893,0.0000013040507],"category_scores_gemma":[0.0021125206,0.00018427763,0.000027337745,0.0005609375,0.00019391284,0.00011013081,0.00006777096,0.0003424199,4.3911567e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00344537,0.0015407793,0.9845332,0.00006340337,0.00006167185,0.001391321,0.0032654458,0.0000033544452,1.1213116e-7,0.0000035327112,0.000018358387,0.005673479],"study_design_scores_gemma":[0.035308342,0.0028529512,0.9585989,0.0013859986,0.000030099662,0.00019538296,0.0013468988,0.000052822536,0.0000012771046,0.000044195458,0.000009325138,0.00017380751],"about_ca_topic_score_codex":0.015545129,"about_ca_topic_score_gemma":0.03745646,"teacher_disagreement_score":0.03186297,"about_ca_system_score_codex":0.0004849563,"about_ca_system_score_gemma":0.00022362695,"threshold_uncertainty_score":0.9910104},"labels":[],"label_agreement":null},{"id":"W2186348405","doi":"10.1016/j.jval.2015.09.349","title":"Knowledge, Attitude And Practices Towards Medication Use Among Post-Graduate Pharmacy Students","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pharmacy; Discontinuation; Family medicine; Medicine; Quarter (Canadian coin); Feeling; Alternative medicine; Medical prescription; Promotion (chess); Psychology; Nursing; Psychiatry","score_opus":0.17294461812540407,"score_gpt":0.42724365150014293,"score_spread":0.25429903337473886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186348405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98450446,0.01178083,0.000025390795,0.0024273216,0.0007044833,0.0002944409,0.00000854096,0.00003730744,0.00021723716],"genre_scores_gemma":[0.99501646,0.0033362645,0.0001383027,0.00032932768,0.000042051608,0.0000048590928,0.000031134266,0.0000102921795,0.0010913125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857444,0.00052203774,0.00031003339,0.00024956392,0.000071715476,0.00027222774],"domain_scores_gemma":[0.9991964,0.000154975,0.00032106732,0.00016048193,0.00009028078,0.00007678834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011767936,0.00010894276,0.00020585398,0.00009861786,0.00009649937,0.000024079442,0.00016372584,0.00008289927,0.000014663741],"category_scores_gemma":[0.00046099635,0.00009002415,0.000018448827,0.00011677215,0.00015676349,0.00023047919,0.00008409608,0.0002743242,0.000111698646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003945028,0.0009004595,0.96575886,0.00034586227,0.00015392198,0.000017508712,0.011391786,0.0000223132,0.0013971673,0.00039663486,0.008600341,0.010620653],"study_design_scores_gemma":[0.0027335088,0.00022708932,0.96073806,0.00033651976,0.000027247868,0.000030438276,0.0011471556,0.00009962423,0.0008376328,0.00007784204,0.03356868,0.00017620006],"about_ca_topic_score_codex":0.018862545,"about_ca_topic_score_gemma":0.000766178,"teacher_disagreement_score":0.02496834,"about_ca_system_score_codex":0.000079087295,"about_ca_system_score_gemma":0.0003813275,"threshold_uncertainty_score":0.98767096},"labels":[],"label_agreement":null},{"id":"W2186391570","doi":"10.1016/j.jval.2015.09.1142","title":"Economic Burden of Patients with Alk+ Mutation non-Small Cell Lung Cancer After Treatment with Crizotinib: a Canadian Retrospective Observational Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; Novartis (Canada)","funders":"","keywords":"Crizotinib; Ceritinib; Anaplastic lymphoma kinase; Medicine; Lung cancer; ALK inhibitor; Internal medicine; Oncology; Targeted therapy; Cancer","score_opus":0.03972989836728169,"score_gpt":0.32777090872210174,"score_spread":0.28804101035482005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2186391570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957325,0.00022540858,0.000012921871,0.0006887862,0.0000939599,0.0025338542,0.00024006987,0.000009581628,0.00046294509],"genre_scores_gemma":[0.9980544,0.000016105576,0.0008187456,0.00012761077,0.00006502428,0.0005333674,0.00014161122,0.000026007876,0.00021717187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989761,0.000048605518,0.00028455295,0.00027030075,0.00018046226,0.00023997486],"domain_scores_gemma":[0.99916506,0.000022490814,0.00016091739,0.00017185247,0.00018858368,0.00029111098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010130147,0.00014782556,0.00029834695,0.00016515118,0.000044379307,0.000008869041,0.000030290481,0.00003081796,0.000033120952],"category_scores_gemma":[0.000004530445,0.00010573618,0.000020830552,0.00015119067,0.000021658798,0.00007558637,0.0000048911243,0.00006307195,0.000003199716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00041286094,0.0004564122,0.9724449,0.000061458435,0.0001380123,0.000021636492,0.014913278,0.011211374,1.8827222e-7,0.0000090795265,0.000054653985,0.00027617958],"study_design_scores_gemma":[0.009372768,0.0052956506,0.9808981,0.0001741189,0.00016377853,0.0000013503901,0.0017291171,0.0021270642,0.000008134546,0.000010032743,0.00012274174,0.00009716212],"about_ca_topic_score_codex":0.7932094,"about_ca_topic_score_gemma":0.41642776,"teacher_disagreement_score":0.37678158,"about_ca_system_score_codex":0.005641518,"about_ca_system_score_gemma":0.0060250936,"threshold_uncertainty_score":0.9996098},"labels":[],"label_agreement":null},{"id":"W2187996704","doi":"10.1016/j.jval.2015.09.1502","title":"High-Dose Inactivated Influenza Vaccine can Reduce Costs and Improve Outcomes Compared to Standard-Dose Inactivated Influenza Vaccine in Canadian Seniors","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Influenza vaccine; Vaccination; Randomized controlled trial; Quality of life (healthcare); Medical costs; Influenza season; Emergency medicine; Health care; Internal medicine; Immunology","score_opus":0.0953828035936588,"score_gpt":0.40271583590456445,"score_spread":0.30733303231090564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2187996704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9797309,0.0012372514,0.0000017119568,0.013807996,0.00038049207,0.004117932,0.00039600488,0.00014664959,0.00018104812],"genre_scores_gemma":[0.98764265,0.00015459502,0.00074556714,0.010843528,0.00012425627,0.00022447751,0.00005280018,0.00012003413,0.000092069786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.992984,0.0007671935,0.0017552363,0.001057018,0.001084721,0.0023518135],"domain_scores_gemma":[0.994036,0.0004885454,0.00036021377,0.000950816,0.0008433493,0.0033210549],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003064869,0.0007375492,0.0020784696,0.0024367212,0.00026452716,0.0000818745,0.00034441147,0.00030425505,0.000028188715],"category_scores_gemma":[0.005458748,0.0006649651,0.00007467045,0.002549507,0.000090646296,0.00033705315,0.0003220628,0.0014292133,0.000031968655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.01071156,0.00036716386,0.9654908,0.0005933997,0.00022630465,0.000429742,0.008387892,0.0026253776,0.00265602,0.00022985332,0.0035721445,0.004709749],"study_design_scores_gemma":[0.035587754,0.0024349343,0.931885,0.0012175996,0.0000374038,0.00004364909,0.003535329,0.0009841376,0.0032526616,0.0001724183,0.020005293,0.00084380724],"about_ca_topic_score_codex":0.93333274,"about_ca_topic_score_gemma":0.54054546,"teacher_disagreement_score":0.39278728,"about_ca_system_score_codex":0.013344403,"about_ca_system_score_gemma":0.007035149,"threshold_uncertainty_score":0.99958014},"labels":[],"label_agreement":null},{"id":"W2188925989","doi":"10.1016/j.jval.2015.09.762","title":"Modeling Of Risks And Benefits Of Lung Cancer Screening Strategies Using Low-Dose Helical Ct (Ldct) Technology In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Lung cancer; Lung cancer screening; National Lung Screening Trial; Prostate cancer; Cancer; Lung; Radiology; Internal medicine","score_opus":0.13909235477478196,"score_gpt":0.3868244521373954,"score_spread":0.24773209736261345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2188925989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97616225,0.021944253,0.00004904674,0.0014079262,0.000059742513,0.00032995045,0.00002368386,0.000006188369,0.000016975428],"genre_scores_gemma":[0.9969923,0.0016608312,0.0012217194,0.00006878595,0.00002157599,0.00002010774,0.0000027715062,0.000011388898,5.415774e-7],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989046,0.000040918436,0.00043267038,0.00018660846,0.0001934513,0.00024173985],"domain_scores_gemma":[0.9995291,0.00004153197,0.000109723034,0.00013902914,0.00006739905,0.00011320717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024788576,0.000097315984,0.00042383227,0.00019286471,0.000016245045,0.0000026172524,0.000040407398,0.00003880355,0.0000019889255],"category_scores_gemma":[0.000033184744,0.00008689141,0.000015092889,0.000288913,0.000028762026,0.000042788877,0.00003163439,0.0001463208,2.408614e-8],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004847284,0.000046114663,0.4668077,0.00043498314,0.000016867629,0.000012842288,0.0002312449,0.52983767,0.000009078783,0.00025439842,0.0000051027814,0.0022955344],"study_design_scores_gemma":[0.0030302752,0.00018778477,0.055027585,0.0047310996,0.0000359067,0.00002051037,0.0019025061,0.9343723,0.0003896387,0.00020122464,0.0000052873056,0.00009585591],"about_ca_topic_score_codex":0.99007,"about_ca_topic_score_gemma":0.784743,"teacher_disagreement_score":0.41178012,"about_ca_system_score_codex":0.0013501042,"about_ca_system_score_gemma":0.004502339,"threshold_uncertainty_score":0.79869556},"labels":[],"label_agreement":null},{"id":"W2189616167","doi":"10.1016/j.jval.2015.09.2199","title":"The Cost-Effectiveness of Referring Patients With Irritable Bowel Syndrome To A Gastroenterologist In The Uk","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diverticular Disease and Complications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Irritable bowel syndrome; Confidence interval; Referral; Internal medicine; Attendance; Cost effectiveness; Quality-adjusted life year; Nice; Health care; Family medicine; Pediatrics","score_opus":0.07031384614793691,"score_gpt":0.3220204932857413,"score_spread":0.2517066471378044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2189616167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99652183,0.0001585186,0.00011855238,0.0014892069,0.000027796854,0.0014554638,0.000009413411,0.000006385444,0.00021280545],"genre_scores_gemma":[0.9991118,0.000008002288,0.00008681217,0.00053839874,0.00000433716,0.00022769078,0.000011295305,0.000005502615,0.0000061634055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989479,0.00030899755,0.00018368254,0.00012383195,0.00022250175,0.0002130659],"domain_scores_gemma":[0.99935913,0.000119865195,0.000047343743,0.00028870272,0.000073311676,0.00011164183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009325735,0.00005934971,0.0001447787,0.00005466356,0.0000469017,0.000008831122,0.00012693646,0.000013357838,0.0000010221278],"category_scores_gemma":[0.00011320693,0.000032018845,0.000018034614,0.0002356082,0.000034572244,0.000023287354,0.00003132577,0.0000926605,0.000005630738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052071724,0.0003494478,0.9956882,0.00010007852,0.00000999463,0.000007903204,0.00032849007,0.0021210206,0.0000025260956,0.00055002264,0.000100930825,0.0002206876],"study_design_scores_gemma":[0.0013396423,0.0008993858,0.9964679,0.00041670716,0.000008008642,0.000008838321,0.00026479532,0.00020162338,0.0000036317588,0.00018666065,0.00017780748,0.00002501961],"about_ca_topic_score_codex":0.0029382405,"about_ca_topic_score_gemma":0.00019426527,"teacher_disagreement_score":0.0027439753,"about_ca_system_score_codex":0.0001581305,"about_ca_system_score_gemma":0.00015164052,"threshold_uncertainty_score":0.44417605},"labels":[],"label_agreement":null},{"id":"W2190698754","doi":"10.1016/j.jval.2015.09.1650","title":"Cost-Effectiveness Analyses In France, England And Canada: Comparative Analysis Of Structural Choices, Results And Perspectives","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health technology; Actuarial science; Time horizon; Pharmacoeconomics; Cost-effectiveness analysis; Agency (philosophy); Cost effectiveness; Health economics; Economic evaluation; Medicine; Health care; Public economics; Business; Economics; Risk analysis (engineering); Economic growth; Sociology; Finance; Intensive care medicine; Social science","score_opus":0.6384699876591354,"score_gpt":0.49620371452472123,"score_spread":0.1422662731344142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2190698754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794092,0.016316537,0.000062677216,0.002538083,0.00011165488,0.00068327546,0.0006295747,0.000005767644,0.00024320438],"genre_scores_gemma":[0.99887127,0.00025551554,0.0004344678,0.00031028606,0.00003935105,0.000033091812,0.000032977543,0.0000063465145,0.000016672206],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956404,0.0010955741,0.0023806344,0.00050017785,0.00009755454,0.0002856606],"domain_scores_gemma":[0.9962215,0.0019686862,0.0012992008,0.0002240967,0.00007585579,0.00021069852],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010294228,0.00014753742,0.001532432,0.00083328417,0.000060410028,0.000022413324,0.00009743497,0.00006615344,0.000005940637],"category_scores_gemma":[0.0017518246,0.00017026326,0.00003457685,0.0007388657,0.00009438514,0.00021222349,0.000030029429,0.00015907132,0.000001252919],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006342497,0.000029852308,0.929399,0.00026132964,0.00015920788,9.975203e-7,0.02239377,0.042433243,3.7081122e-7,0.0051066997,0.00009326112,0.00005881536],"study_design_scores_gemma":[0.0019857974,0.0000773113,0.9154142,0.00008365435,0.000011092781,0.0000010528877,0.0055831554,0.07483379,0.0000013975024,0.00079822884,0.0010703506,0.0001399497],"about_ca_topic_score_codex":0.9323582,"about_ca_topic_score_gemma":0.7203965,"teacher_disagreement_score":0.21196169,"about_ca_system_score_codex":0.0010678716,"about_ca_system_score_gemma":0.0007078998,"threshold_uncertainty_score":0.69431347},"labels":[],"label_agreement":null},{"id":"W2192127796","doi":"10.1016/j.jval.2015.09.2524","title":"Non-Comparative Trials To Supplement Network Meta-Analyses Using Arm-Specific Meta-Regression: An Application To Combination Therapies In Hiv","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Confidence interval; Medicine; Regimen; Meta-analysis; Efavirenz; Dolutegravir; Odds ratio; Meta-regression; Adverse effect; Randomized controlled trial; Antiretroviral therapy; Internal medicine; Viral load; Human immunodeficiency virus (HIV); Family medicine","score_opus":0.9682328278909286,"score_gpt":0.6638114378019201,"score_spread":0.3044213900890085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2192127796","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.27634034,0.028357279,0.6447102,0.031264927,0.0010151214,0.017563565,0.00010971136,0.000025406165,0.00061348197],"genre_scores_gemma":[0.9280972,0.000042182313,0.06954105,0.0010119254,0.00017610175,0.00079783314,0.00003658103,0.000016606004,0.00028052172],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.92978936,0.047679514,0.015334852,0.0015608907,0.00506901,0.00056636636],"domain_scores_gemma":[0.9858037,0.0044407393,0.0054945266,0.0027787571,0.00093162264,0.0005506456],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.30307588,0.00046204828,0.010186043,0.0011227246,0.0001578468,0.00053495757,0.0012198859,0.00007650145,0.002019191],"category_scores_gemma":[0.0044491487,0.0002052502,0.0015763234,0.0044664466,0.000024255127,0.00035319192,0.00011645799,0.0001697198,0.0005366783],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000074729876,0.00038673283,0.002646015,0.00003202066,0.0023263127,0.0000017356185,0.012975286,0.9090167,0.00009853135,0.0055649807,0.06385345,0.003023499],"study_design_scores_gemma":[0.0024700833,0.001113818,0.0076375073,0.00018215916,0.006810694,0.0000070898395,0.018004514,0.5461469,0.00036956216,0.06539385,0.3506833,0.0011804644],"about_ca_topic_score_codex":0.0014283294,"about_ca_topic_score_gemma":0.00064387964,"teacher_disagreement_score":0.6517569,"about_ca_system_score_codex":0.00035280667,"about_ca_system_score_gemma":0.00025059114,"threshold_uncertainty_score":0.9988931},"labels":[],"label_agreement":null},{"id":"W2197961565","doi":"10.1016/j.jval.2015.09.035","title":"Impact of Financial Incentives on Access to Services and Quality of Care","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Incentive; Context (archaeology); Medicine; Health care; Quality (philosophy); Business; Finance; Emergency medicine; Physical therapy; Actuarial science; Operations management; Economics; Geography; Economic growth","score_opus":0.269063394569115,"score_gpt":0.5791720217777451,"score_spread":0.3101086272086301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2197961565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99408996,0.0022689982,0.0000033556316,0.00080506026,0.00046172942,0.0012206098,0.00023752998,0.000021931024,0.0008908364],"genre_scores_gemma":[0.998444,0.00014192145,0.00025917415,0.0009997445,0.000095631345,0.000024656903,0.000011819031,0.000012072995,0.000010970091],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963392,0.0014932834,0.0010408886,0.00026469832,0.00036500226,0.00049693754],"domain_scores_gemma":[0.99777585,0.00051417656,0.0005445604,0.0003109279,0.0004267357,0.00042775893],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018728299,0.00013668957,0.00061498705,0.00019661398,0.00010433501,0.000003634914,0.0002385296,0.00014307193,0.0000123913605],"category_scores_gemma":[0.00060603773,0.00011647369,0.0000433142,0.00044045123,0.00003939319,0.00012168307,0.0001941632,0.00029314394,0.000017923237],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069364783,0.00008446617,0.94538975,0.006124544,0.0000033943247,6.3533065e-7,0.0436434,0.00043130846,0.000005917683,0.0014586706,0.0008535164,0.0013107278],"study_design_scores_gemma":[0.00087192364,0.0011982783,0.98947024,0.0021111507,0.0000014744007,9.69134e-8,0.005170726,0.000030685904,0.000017978711,0.00045065192,0.0005951428,0.00008165107],"about_ca_topic_score_codex":0.22085302,"about_ca_topic_score_gemma":0.009410846,"teacher_disagreement_score":0.21144217,"about_ca_system_score_codex":0.0007823052,"about_ca_system_score_gemma":0.0021931753,"threshold_uncertainty_score":0.7843354},"labels":[],"label_agreement":null},{"id":"W2198052525","doi":"10.1016/j.jval.2015.09.2591","title":"Contrasting Model Predicted Life Expectancy In Patients With Type 2 Diabetes Across Different Mortality Risk Prediction Models Versus Data From The Canadian Chronic Disease Surveillance System","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Machine Learning in Healthcare","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Diabetes mellitus; Life expectancy; Medicine; Type 2 diabetes; Demography; Gerontology; Framingham Risk Score; Cohort; United Kingdom Prospective Diabetes Study; Disease; Internal medicine; Population; Environmental health; Endocrinology","score_opus":0.1098995386314231,"score_gpt":0.3113615942232346,"score_spread":0.20146205559181152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198052525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875524,0.0014119094,0.006174408,0.0004843412,0.0008932029,0.0010230193,0.0022866977,0.00016164154,0.000012383278],"genre_scores_gemma":[0.998687,0.000029728793,0.00043774242,0.00008339762,0.00014031203,0.000048928603,0.000547714,0.000024414225,7.473686e-7],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9955604,0.0013673009,0.00066456693,0.0008244249,0.0007312322,0.0008520506],"domain_scores_gemma":[0.9963256,0.00046746258,0.00036843863,0.0017372802,0.00018772589,0.0009135061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016695368,0.00023958822,0.0003716422,0.00007761367,0.00033625253,0.00013328467,0.0012870457,0.00008682497,6.9295726e-7],"category_scores_gemma":[0.0010212988,0.00018071358,0.000018660203,0.00051925355,0.000051642233,0.0004637083,0.00031324878,0.0006241436,0.0000018738142],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005822697,0.000028983026,0.6007628,0.00007380714,0.000010244956,0.0000014775543,0.0011706946,0.39756623,8.720976e-9,0.00010492331,0.00003238312,0.00019024318],"study_design_scores_gemma":[0.0010293677,0.00012003631,0.47675824,0.00020603469,0.0000023943585,3.02402e-8,0.00004885746,0.52167493,2.1146484e-8,0.00007891108,0.0000019950048,0.000079175756],"about_ca_topic_score_codex":0.51654035,"about_ca_topic_score_gemma":0.4838072,"teacher_disagreement_score":0.12410871,"about_ca_system_score_codex":0.0024860506,"about_ca_system_score_gemma":0.0039831307,"threshold_uncertainty_score":0.73692864},"labels":[],"label_agreement":null},{"id":"W2198542719","doi":"10.1016/j.jval.2015.03.044","title":"Life At A Premium: Considering An End-Of-Life Premium In Value-Based Reimbursement","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Reimbursement; Willingness to pay; Value (mathematics); Opportunity cost; Health technology; Actuarial science; Value proposition; Equity (law); Economics; Business; Health care; Microeconomics; Marketing; Computer science","score_opus":0.5804740816994101,"score_gpt":0.4403174948757067,"score_spread":0.14015658682370336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2198542719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9452775,0.0065420773,0.00091186416,0.041828997,0.0010953991,0.0020244473,0.00019788847,0.0000798135,0.0020420072],"genre_scores_gemma":[0.97295594,0.00014931569,0.008305084,0.01792462,0.00026265945,0.0001878881,0.000054603737,0.00006601894,0.00009384239],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98912424,0.0016233945,0.007198772,0.0008996775,0.00026502874,0.0008889004],"domain_scores_gemma":[0.9934742,0.0013074055,0.0029564255,0.0009430844,0.00007903761,0.0012398399],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.036987,0.00030397397,0.0016675043,0.0008610663,0.00010558334,0.0000405452,0.0003894896,0.00022490251,0.00019202432],"category_scores_gemma":[0.010522264,0.00041527214,0.00010609635,0.0004603803,0.0001110318,0.00041523157,0.000104499166,0.0003442968,0.0003001182],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017598477,0.00061584834,0.6815681,0.0023141454,0.00003729207,0.000004568385,0.009555782,0.23672988,0.0000052041655,0.0575522,0.011296081,0.00014493529],"study_design_scores_gemma":[0.015912935,0.0017874707,0.12937504,0.0024557353,0.000012828965,0.0000132211035,0.0066768606,0.72398263,0.00009681672,0.033522166,0.08418312,0.0019811543],"about_ca_topic_score_codex":0.038921572,"about_ca_topic_score_gemma":0.0018647012,"teacher_disagreement_score":0.55219305,"about_ca_system_score_codex":0.003643745,"about_ca_system_score_gemma":0.0043501896,"threshold_uncertainty_score":0.9998299},"labels":[],"label_agreement":null},{"id":"W2201411497","doi":"10.1016/j.jval.2015.09.2940","title":"Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Allergy and Infectious Diseases; National Institute on Alcohol Abuse and Alcoholism; York University; NYU Langone Medical Center","keywords":"Human immunodeficiency virus (HIV); Business; Operations management; Medicine; Family medicine; Economics","score_opus":0.16891659550194746,"score_gpt":0.43538842250288023,"score_spread":0.26647182700093275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2201411497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99550915,0.0011238038,0.00015963908,0.00033722367,0.00001547089,0.0020412703,0.000019579546,0.000009426135,0.0007844661],"genre_scores_gemma":[0.9990264,0.000052438274,0.0005255205,0.0000029053208,0.000010213706,0.00024245225,0.000023584189,0.000009003277,0.000107487795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843895,0.0005330348,0.00033346485,0.00020516601,0.00019524312,0.0002941535],"domain_scores_gemma":[0.9993988,0.00006190935,0.000043522214,0.00014010475,0.00007802922,0.00027763564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008954521,0.00009364663,0.00031023595,0.0002763774,0.000012555657,0.000013626052,0.000037772348,0.000046347275,0.0000050623585],"category_scores_gemma":[0.00019531275,0.000071679446,0.000044042892,0.0003985685,0.000054457905,0.000072253584,0.00001761161,0.00013861158,0.0000047779117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006035328,0.005198224,0.6942047,0.0046326597,0.00006825231,0.0001559422,0.09097846,0.0033199368,0.0024908048,0.002145765,0.00016090315,0.19060901],"study_design_scores_gemma":[0.01449103,0.1122344,0.7661522,0.018356096,0.000027000307,0.000069145455,0.066281825,0.016250035,0.0021384032,0.0030013118,0.00057103776,0.00042751076],"about_ca_topic_score_codex":0.010602936,"about_ca_topic_score_gemma":0.0021104817,"teacher_disagreement_score":0.1901815,"about_ca_system_score_codex":0.00093217334,"about_ca_system_score_gemma":0.0006513996,"threshold_uncertainty_score":0.99598557},"labels":[],"label_agreement":null},{"id":"W2204430666","doi":"10.1016/j.jval.2015.03.243","title":"Budget impact of Percutaneous Endovascular Abdominal Aorta Aneurysm (AAA) repair compared to standard Endovascular repair in Canadian Hospitals","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Aortic aneurysm repair treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Endovascular aneurysm repair; Surgery; Aortic repair; Percutaneous; Activity-based costing; Abdominal aortic aneurysm; Aneurysm","score_opus":0.027192418931060523,"score_gpt":0.3174504882971147,"score_spread":0.2902580693660542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2204430666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99310064,0.0023073212,0.00001885813,0.00089218287,0.00019237018,0.0026693172,0.00020411958,0.00020097477,0.00041421648],"genre_scores_gemma":[0.9911458,0.00011669972,0.007824271,0.0005125985,0.000073970325,0.000060462313,0.0000664228,0.00008418663,0.00011562633],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99474007,0.0005970381,0.001487566,0.0008505153,0.00093142304,0.0013933647],"domain_scores_gemma":[0.99565685,0.00014752003,0.0002504856,0.001355895,0.000260806,0.002328438],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00253746,0.00045913566,0.0015501925,0.0009155523,0.000064943924,0.000010422916,0.0002231653,0.0001948053,0.00008462281],"category_scores_gemma":[0.0013057566,0.00042407215,0.0006916733,0.0009354292,0.000111355526,0.00010290005,0.000069256064,0.00042562603,0.000046748257],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0011956535,0.00049641874,0.9534884,0.0005033362,0.00040074566,0.020124922,0.0045491215,0.013385512,0.0000922017,0.000046844358,0.0050756484,0.00064120523],"study_design_scores_gemma":[0.013753872,0.015374102,0.9084362,0.0017965541,0.00035903457,0.016862784,0.0021577477,0.034515016,0.00021853119,0.00026917932,0.0050899843,0.0011670141],"about_ca_topic_score_codex":0.8377105,"about_ca_topic_score_gemma":0.10794836,"teacher_disagreement_score":0.72976214,"about_ca_system_score_codex":0.0059827575,"about_ca_system_score_gemma":0.007095847,"threshold_uncertainty_score":0.9998211},"labels":[],"label_agreement":null},{"id":"W2205841310","doi":"10.1016/j.jval.2015.03.1013","title":"Assure-Csu Canadian Results: Assessing Health Utility In Chronic Spontaneous/Idiopathic Urticaria Using The Eq-5d","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Hamilton Health Sciences; University of Toronto","funders":"","keywords":"Medicine; EQ-5D; Visual analogue scale; Quality of life (healthcare); Cohort; Depression (economics); Anxiety; Disease; DASS; Socioeconomic status; Physical therapy; Internal medicine; Psychiatry; Health related quality of life; Environmental health; Population","score_opus":0.1550900429154329,"score_gpt":0.3523675286360341,"score_spread":0.1972774857206012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2205841310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9150361,0.010895789,0.0002611486,0.06826236,0.0010481857,0.0017744002,0.00007376394,0.00009577925,0.0025524995],"genre_scores_gemma":[0.99667245,0.00022831658,0.00057808275,0.002117404,0.00026154958,0.000013569114,0.000045920824,0.000032358854,0.000050349903],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9957548,0.0011932123,0.0011058861,0.0004504051,0.00042388026,0.0010718335],"domain_scores_gemma":[0.99779963,0.0002063746,0.00022303594,0.00064111914,0.00010358794,0.0010262318],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046900925,0.00020849967,0.00055319734,0.00039028455,0.00030949237,0.000053557138,0.00016457075,0.00024084821,0.000019257657],"category_scores_gemma":[0.0006419829,0.00016290668,0.00006626128,0.00094177615,0.00014058578,0.000113002265,0.00003303027,0.0012892914,0.000021443644],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0038803488,0.0046056565,0.25150293,0.004144819,0.002353662,0.032843277,0.20956847,0.34942305,0.0018510128,0.049201597,0.021476842,0.069148324],"study_design_scores_gemma":[0.011192495,0.0020574934,0.19112398,0.007119615,0.00040792735,0.0056994,0.008886564,0.7543145,0.000027520151,0.004219367,0.014153574,0.00079756],"about_ca_topic_score_codex":0.7390767,"about_ca_topic_score_gemma":0.31040227,"teacher_disagreement_score":0.4286744,"about_ca_system_score_codex":0.0070749074,"about_ca_system_score_gemma":0.029807027,"threshold_uncertainty_score":0.99673676},"labels":[],"label_agreement":null},{"id":"W2211596172","doi":"10.1016/j.jval.2015.03.023","title":"Coverage Limits On Blood Glucose Test Strip Reimbursement For Diabetics In Canada: Utilization Impact For Diabetic Patients In The Ontario Public Drug Program (OPDP)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetes mellitus; Reimbursement; Cohort; Insulin; Glucose test; Emergency medicine; Environmental health; Internal medicine; Health care; Endocrinology","score_opus":0.10288296190582509,"score_gpt":0.30537139815169817,"score_spread":0.2024884362458731,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2211596172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98779196,0.0010011084,0.000024426225,0.0012683531,0.0002888079,0.0093784435,0.00012554323,0.000021618373,0.00009973151],"genre_scores_gemma":[0.9967691,0.00014393077,0.00031452638,0.00082823104,0.000105581894,0.001279743,0.0004898712,0.00003806674,0.000030955747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99699336,0.00029668535,0.0007215378,0.00040657402,0.0007249275,0.0008569386],"domain_scores_gemma":[0.9983084,0.00047096223,0.0001970951,0.0005146783,0.00018775013,0.00032110178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002536221,0.0002526376,0.0006292656,0.00025736872,0.00006364713,0.00004680508,0.00018703645,0.00008497895,0.0000028184782],"category_scores_gemma":[0.0016032697,0.00019552106,0.0001459102,0.0005027769,0.000024995732,0.00009042402,0.000020953272,0.00033789393,0.0000010300674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00014800068,0.0033723877,0.7665932,0.0004898529,0.0000690977,0.000009015913,0.0019490815,0.0023209418,4.6639886e-7,0.00005847633,0.0011727486,0.22381671],"study_design_scores_gemma":[0.013049238,0.005373181,0.9610211,0.00058100617,0.000077357654,0.0000012968443,0.00035528166,0.004443153,0.00012149393,0.00027659195,0.014453387,0.00024686547],"about_ca_topic_score_codex":0.9706626,"about_ca_topic_score_gemma":0.9848154,"teacher_disagreement_score":0.22356984,"about_ca_system_score_codex":0.0041419445,"about_ca_system_score_gemma":0.0062453304,"threshold_uncertainty_score":0.999681},"labels":[],"label_agreement":null},{"id":"W2212133229","doi":"10.1016/j.jval.2015.03.030","title":"Extrapolating All-Cause Mortality Estimates In Economic Evaluations: A Simulation Analysis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; University of Alberta; University of Toronto","funders":"","keywords":"Life table; Estimation; Demography; Mortality rate; Statistics; Intervention (counseling); Duration (music); Medicine; Markov model; Discounting; Quality-adjusted life year; Mathematics; Cost effectiveness; Markov chain; Population; Surgery; Economics","score_opus":0.4465278382060636,"score_gpt":0.6000172579652606,"score_spread":0.153489419759197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2212133229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922655,0.0014846022,0.0006853076,0.0019426565,0.0006491637,0.0018419772,0.000049462593,0.00013065427,0.000950651],"genre_scores_gemma":[0.9952923,0.00011495224,0.0033029611,0.0008254898,0.00015048787,0.00015141311,0.00010771478,0.00002560209,0.00002906087],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9938268,0.0023680471,0.001978479,0.0005068393,0.000406358,0.00091347],"domain_scores_gemma":[0.99624383,0.0019946697,0.0006407634,0.0005301554,0.00016364078,0.00042691999],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008548874,0.00020839987,0.00066199485,0.0007577855,0.00022464855,0.000014372005,0.00018094815,0.00022044423,0.00013611502],"category_scores_gemma":[0.0018358894,0.0002229255,0.000072537914,0.0011090031,0.000033993532,0.00028933157,0.000076725104,0.00057382527,0.0003810363],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018758728,0.000035506968,0.4688133,0.00014269013,0.00005074525,0.000002291903,0.0045855483,0.5251534,5.170002e-7,0.00083945325,0.00016779923,0.00018999877],"study_design_scores_gemma":[0.0007017045,0.000055097742,0.35944644,0.00023618375,0.00006766726,2.1603928e-7,0.0018090416,0.6332988,3.7953444e-7,0.003944013,0.0003243426,0.00011607209],"about_ca_topic_score_codex":0.13538739,"about_ca_topic_score_gemma":0.036083773,"teacher_disagreement_score":0.10936684,"about_ca_system_score_codex":0.0041453773,"about_ca_system_score_gemma":0.0024040795,"threshold_uncertainty_score":0.99967754},"labels":[],"label_agreement":null},{"id":"W2212634673","doi":"10.1016/j.jval.2015.03.025","title":"Economic Value Of Improved Accuracy For Self-Monitoring Of Blood Glucose Devices For Type 1 Diabetes","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Medicine; Statistics; Computer science; Emergency medicine; Mathematics","score_opus":0.09158345175768533,"score_gpt":0.3831031645632488,"score_spread":0.29151971280556344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2212634673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940946,0.0029186807,0.000012507632,0.0006208201,0.00045278997,0.0017179728,0.000017693585,0.000023763594,0.00014115404],"genre_scores_gemma":[0.9888998,0.000212957,0.010335343,0.000048781847,0.000274873,0.00008287526,0.00001726907,0.0000260766,0.00010199712],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987394,0.000055290995,0.00049090246,0.00019625937,0.00013136512,0.0003867747],"domain_scores_gemma":[0.99864614,0.0005778427,0.00024059226,0.00023093751,0.00015381462,0.00015065451],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017017823,0.000100115925,0.0004180605,0.0002010771,0.000026439022,0.000008580904,0.00014227467,0.000056671484,0.0000028002114],"category_scores_gemma":[0.0005101333,0.0000877579,0.000073479794,0.0001386904,0.00002821912,0.00008628796,0.000051890052,0.00007930296,0.00000237681],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00083369843,0.0013983902,0.92218393,0.02422706,0.0006518512,0.0000010086884,0.0016138,0.0015233023,0.007996166,0.0031841581,0.00086802855,0.035518583],"study_design_scores_gemma":[0.0510524,0.034732584,0.22446199,0.0061694845,0.0011484658,0.0000015368056,0.0034225443,0.3398052,0.287314,0.009260059,0.04147522,0.0011565365],"about_ca_topic_score_codex":0.00028117074,"about_ca_topic_score_gemma":0.000008518232,"teacher_disagreement_score":0.69772196,"about_ca_system_score_codex":0.00011065683,"about_ca_system_score_gemma":0.0005810983,"threshold_uncertainty_score":0.35786632},"labels":[],"label_agreement":null},{"id":"W2216744387","doi":"10.1016/j.jval.2015.03.1009","title":"Assure-Csu Canadian Results: Assessing The Impact Of Chronic Spontaneous /Idiopathic Urticaria On Work Productivity And Indirect Costs","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); University of Toronto","funders":"","keywords":"Medicine; Absenteeism; Productivity; Angioedema; Indirect costs; Presenteeism; Work productivity; Cohort; Sick leave; Demography; Gerontology; Physical therapy; Internal medicine","score_opus":0.04496010086699842,"score_gpt":0.3312604726239584,"score_spread":0.28630037175696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2216744387","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9854315,0.0026479186,0.0000036215208,0.009006264,0.00024061018,0.0006894468,0.000029701887,0.000024843672,0.0019261168],"genre_scores_gemma":[0.9994942,0.00009090955,0.00004413166,0.000096402364,0.0001820281,0.000010044989,0.000016688671,0.000017685947,0.000047940048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981363,0.0005256459,0.00040172657,0.00026822079,0.00024080298,0.0004272997],"domain_scores_gemma":[0.99863994,0.00024076422,0.00014326023,0.00039106465,0.00008491113,0.0005000302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018775965,0.00013581477,0.00034975607,0.00022615,0.00012574942,0.00002409185,0.00006910388,0.00013879787,0.000004980817],"category_scores_gemma":[0.0011579418,0.00008748419,0.000048536436,0.00057779485,0.00012338627,0.000052821495,0.000014213867,0.0006429041,0.0000072113867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062667755,0.004827961,0.65092427,0.00088828505,0.004989801,0.009971834,0.06112745,0.10147883,0.0024735965,0.006907451,0.019237604,0.13090612],"study_design_scores_gemma":[0.003544156,0.0039710756,0.97824013,0.0029722142,0.0003594371,0.002019278,0.0004397826,0.0068967612,0.000109854365,0.0006860906,0.0004923671,0.00026884567],"about_ca_topic_score_codex":0.25356802,"about_ca_topic_score_gemma":0.017505182,"teacher_disagreement_score":0.32731584,"about_ca_system_score_codex":0.0022091365,"about_ca_system_score_gemma":0.0061936327,"threshold_uncertainty_score":0.9994403},"labels":[],"label_agreement":null},{"id":"W2217393992","doi":"10.1016/j.jval.2015.03.043","title":"Interventions For Ultra-Rare Disorders (Urds) And The Logic Of Cost Effectiveness","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute","funders":"","keywords":"Psychological intervention; Cost effectiveness; Economic evaluation; Actuarial science; Health technology; Health care; Quality-adjusted life year; Cost-effectiveness analysis; Medicine; Health economics; Cost–benefit analysis; Public economics; Business; Economics; Risk analysis (engineering); Political science; Nursing","score_opus":0.5896618772233545,"score_gpt":0.4867647613279303,"score_spread":0.10289711589542422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2217393992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6230123,0.059718825,0.08957982,0.20383509,0.0027221933,0.01584573,0.0015749194,0.00008776574,0.0036233747],"genre_scores_gemma":[0.99605256,0.00057153107,0.00097514736,0.0017819006,0.0000670164,0.00046448843,0.00002180741,0.000017538601,0.000048032718],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9958771,0.0010748586,0.002432948,0.0002946767,0.00005067818,0.0002697455],"domain_scores_gemma":[0.99475896,0.003517441,0.0012779344,0.000271097,0.000046416124,0.00012813463],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.033954345,0.00010612038,0.00081003853,0.00020368121,0.00010366846,0.000021772961,0.00016416106,0.00006821875,0.000013110942],"category_scores_gemma":[0.0056494833,0.00010275091,0.00012499274,0.00017076713,0.00014578628,0.00014636136,0.000022939998,0.00011066707,0.000030700572],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016711069,0.00017869729,0.074521445,0.006920716,0.0000353457,8.9377636e-8,0.004739545,0.0076828585,2.0168585e-7,0.90275943,0.0022307353,0.0007638324],"study_design_scores_gemma":[0.017319314,0.0008088451,0.09949121,0.002070078,0.000012111512,0.000006157083,0.006201962,0.037711892,0.00000471756,0.81874585,0.01717455,0.00045333029],"about_ca_topic_score_codex":0.008499328,"about_ca_topic_score_gemma":0.0005448578,"teacher_disagreement_score":0.37304026,"about_ca_system_score_codex":0.00038006357,"about_ca_system_score_gemma":0.00019453217,"threshold_uncertainty_score":0.99810314},"labels":[],"label_agreement":null},{"id":"W2218765681","doi":"10.1016/j.jval.2015.03.1772","title":"Canadian retrospective claims data analysis of Biologics switching and retention patterns in Psoriasis Patients","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada); Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Adalimumab; Ustekinumab; Etanercept; Infliximab; Retrospective cohort study; Psoriasis; Concomitant; Internal medicine; Dermatology; Tumor necrosis factor alpha","score_opus":0.5354432688194635,"score_gpt":0.4263239789790373,"score_spread":0.10911928984042618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2218765681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99000734,0.00070978695,0.00047362602,0.0062413076,0.0003415514,0.0004873982,0.0015692131,0.000008420082,0.00016135226],"genre_scores_gemma":[0.9969302,0.0003313888,0.0009307776,0.001340546,0.0000451973,0.000012580359,0.00038986327,0.000011321838,0.000008142511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99529374,0.0005967602,0.0030563795,0.0005938201,0.000083149316,0.00037616308],"domain_scores_gemma":[0.9972342,0.00028724578,0.0015158354,0.00061214215,0.00005671916,0.00029385486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022041865,0.00011764963,0.00097610883,0.0015338617,0.000058573718,0.000025010446,0.00026416412,0.0001280363,0.000021915095],"category_scores_gemma":[0.0029491112,0.00014902181,0.00004002253,0.0008126429,0.00001910918,0.0003284455,0.00007544434,0.00018133901,0.000017759023],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000054428638,0.000039884377,0.98996204,0.00009961236,0.000044982433,3.2279826e-7,0.002230429,0.0012617847,4.1263856e-8,0.0058989367,0.00025073937,0.00020577981],"study_design_scores_gemma":[0.0005626295,0.00008781203,0.9133361,0.000078286095,0.000008042948,1.78761e-7,0.00084269873,0.077175364,9.977679e-8,0.0074725407,0.0003146609,0.00012156769],"about_ca_topic_score_codex":0.8043959,"about_ca_topic_score_gemma":0.45984015,"teacher_disagreement_score":0.34455574,"about_ca_system_score_codex":0.0025547678,"about_ca_system_score_gemma":0.00044827227,"threshold_uncertainty_score":0.7639314},"labels":[],"label_agreement":null},{"id":"W2228393730","doi":"10.1016/j.jval.2015.03.168","title":"Usability Testing Of The Web-Based Versions Of The Standardised Asthma Quality Of Life Questionnaire For 12 Years And Older (Aqlq(S)+12) And The Asthma Control Questionnaire (Acq-6)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Legibility; Session (web analytics); Usability; Test (biology); Font; Quality of life (healthcare); Interview; Quality (philosophy); Asthma; Medicine; Psychology; Applied psychology; Medical education; Computer science; World Wide Web; Advertising; Nursing; Human–computer interaction; Artificial intelligence","score_opus":0.07698931878010727,"score_gpt":0.3966652145707423,"score_spread":0.319675895790635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2228393730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9531952,0.002517008,0.0016182308,0.030168477,0.00057491293,0.011244369,0.0005508025,0.000040485476,0.00009052071],"genre_scores_gemma":[0.9955912,0.00010339543,0.00077757466,0.002003442,0.000082630795,0.0013985753,0.0000045554693,0.000020913469,0.000017660215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9919196,0.0047635697,0.0019496831,0.00035312385,0.0004995447,0.00051452],"domain_scores_gemma":[0.9916158,0.004715663,0.0016830584,0.000849827,0.0007038471,0.00043181612],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.012643031,0.0001805274,0.0007280865,0.0000799438,0.00076943106,0.0000047915128,0.00030030118,0.00019877008,0.0000058661776],"category_scores_gemma":[0.01308763,0.00010806817,0.000106007355,0.00049620285,0.00084573554,0.00006290595,0.00011622545,0.00057009317,5.7712293e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012180343,0.00021802398,0.95774955,0.0061702267,0.000014825283,4.5301285e-8,0.0034919628,0.0016489027,0.00002312687,0.022178503,0.0012803839,0.0060064457],"study_design_scores_gemma":[0.01159854,0.00021437816,0.9657757,0.0021009846,0.00001853436,6.6389947e-7,0.001320705,0.013171547,0.00000703021,0.0032222397,0.0024686223,0.000101007594],"about_ca_topic_score_codex":0.016986452,"about_ca_topic_score_gemma":0.0027634236,"teacher_disagreement_score":0.04239606,"about_ca_system_score_codex":0.00030717402,"about_ca_system_score_gemma":0.007875475,"threshold_uncertainty_score":0.997749},"labels":[],"label_agreement":null},{"id":"W2236351295","doi":"10.1016/j.jval.2015.03.1362","title":"Cost-Utility Analysis of Influenza Vaccines From Societal Perspective: a Comparison of The Human Capital Approach And Friction Costs Approach In The Valuation of Productivity Costs Among Seniors In Ontario Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Productivity; Demography; Population; Cost-effectiveness analysis; Human capital; Indirect costs; Cost effectiveness; Environmental health; Economics; Economic growth","score_opus":0.21641064792101283,"score_gpt":0.40995797525127314,"score_spread":0.1935473273302603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2236351295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635714,0.0008655557,0.000020455207,0.0002279229,0.000036156667,0.0022175042,0.000058749152,0.000004057216,0.00021245905],"genre_scores_gemma":[0.9996701,0.0000089443665,0.00015311195,0.000035776146,0.000017145814,0.000071973154,0.00003128187,0.000007684123,0.0000040012756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99607444,0.0013638564,0.0008733027,0.00038990524,0.0010086482,0.00028982852],"domain_scores_gemma":[0.9982672,0.0002878907,0.0004904133,0.00044762864,0.00042913845,0.00007777013],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038396593,0.00016752457,0.00088930246,0.00033459062,0.00008508247,0.0000069209236,0.00016715517,0.000084985935,0.0000024011642],"category_scores_gemma":[0.0008473766,0.00011414487,0.00008012249,0.0015329577,0.00021933179,0.00011159902,0.00009890613,0.0006433868,2.706976e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018557899,0.0007114215,0.907805,0.00014083003,0.00018037003,3.8832388e-7,0.07857519,0.012039591,0.00006548828,0.000097041855,0.00004030748,0.00015877563],"study_design_scores_gemma":[0.0014825122,0.00013056702,0.9187005,0.00007752084,0.00011621743,5.492605e-7,0.049255073,0.029959435,0.00011104912,0.00009427706,0.000003896465,0.0000683706],"about_ca_topic_score_codex":0.9974563,"about_ca_topic_score_gemma":0.98745817,"teacher_disagreement_score":0.029320111,"about_ca_system_score_codex":0.004537883,"about_ca_system_score_gemma":0.0019595933,"threshold_uncertainty_score":0.9992835},"labels":[],"label_agreement":null},{"id":"W2239810687","doi":"10.1016/j.jval.2015.12.003","title":"Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction: Report 1 of the ISPOR MCDA Emerging Good Practices Task Force","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":721,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Simon Fraser University","funders":"University of Hartford","keywords":"Multiple-criteria decision analysis; Decision analysis; Management science; Health care; Decision aids; Medicine; Process management; Risk analysis (engineering); Operations research; Business; Engineering; Political science; Economics","score_opus":0.29694563709483,"score_gpt":0.4876890487715731,"score_spread":0.19074341167674308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2239810687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6201614,0.005031212,0.1828556,0.18439667,0.003435887,0.003037246,0.0009416776,0.00006279898,0.00007747642],"genre_scores_gemma":[0.9503352,0.000266948,0.04484187,0.0034131259,0.0007802638,0.00014392253,0.000051686628,0.00004484578,0.00012214905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99019957,0.00089208165,0.0069651115,0.0010817759,0.00024302403,0.00061842985],"domain_scores_gemma":[0.98289466,0.003931214,0.011221823,0.0015133283,0.00022393912,0.0002150388],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.031800937,0.00023660749,0.0014337419,0.00081394595,0.00045053303,0.000057603047,0.0004774725,0.00014629713,0.0001269865],"category_scores_gemma":[0.021340167,0.00020339873,0.00029765425,0.00092811795,0.000062260755,0.00075739366,0.000093639035,0.00016450231,0.000027490316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007465172,0.0006405532,0.82551545,0.0035896834,0.0004593455,0.0000039838683,0.021895671,0.03197212,0.000027102315,0.044262033,0.037848797,0.03303872],"study_design_scores_gemma":[0.005104117,0.0012343111,0.46008277,0.0021173595,0.00008755454,0.00008084658,0.009797423,0.08596638,0.0000332566,0.033133898,0.40118888,0.0011731888],"about_ca_topic_score_codex":0.006032805,"about_ca_topic_score_gemma":0.0037792115,"teacher_disagreement_score":0.3654327,"about_ca_system_score_codex":0.0017330212,"about_ca_system_score_gemma":0.00081128126,"threshold_uncertainty_score":0.9969647},"labels":[],"label_agreement":null},{"id":"W2256209496","doi":"10.1016/j.jval.2015.03.931","title":"The Economic Value of Tofacitinib 5 Mg Bid In The Treatment of Moderate To Severe Rheumatoid Arthritis: A Canadian Analysis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; Programs for Assessment of Technology in Health Research Institute; St Joseph's Health Care; Pfizer (Canada)","funders":"","keywords":"Tofacitinib; Medicine; Rheumatoid arthritis; Adverse effect; Internal medicine; Quality of life (healthcare); Physical therapy","score_opus":0.05176418846745655,"score_gpt":0.3124097995938347,"score_spread":0.26064561112637813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256209496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823472,0.009056652,0.000031824293,0.0071038846,0.00018935688,0.00047391822,0.0003364013,0.000004580597,0.00045621165],"genre_scores_gemma":[0.9954388,0.003595758,0.00036763895,0.00047863572,0.0000074418745,0.00002525281,0.00001567859,0.000005508253,0.0000652501],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782234,0.0009910073,0.0005777592,0.00019800101,0.000033498058,0.0003773969],"domain_scores_gemma":[0.9990771,0.00036093238,0.00012582513,0.00032649186,0.000028621771,0.00008102301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016330979,0.00011636518,0.0004775497,0.00024510646,0.000075938806,0.000009278602,0.00020302052,0.000118603966,0.000039427592],"category_scores_gemma":[0.00006904634,0.00006878275,0.00010929223,0.00040307455,0.00011099547,0.000018863388,0.000014130778,0.00011085506,0.000012343431],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033401276,0.0023199362,0.26323712,0.00020746724,0.004664568,0.0000593627,0.068986595,0.20121188,0.0009662942,0.12374383,0.010553098,0.3207097],"study_design_scores_gemma":[0.02439221,0.014925763,0.19710939,0.0011732538,0.00048355525,0.00025583303,0.029806247,0.05691726,0.016897775,0.030093754,0.6257821,0.0021628756],"about_ca_topic_score_codex":0.42456454,"about_ca_topic_score_gemma":0.28841445,"teacher_disagreement_score":0.615229,"about_ca_system_score_codex":0.0003835111,"about_ca_system_score_gemma":0.0008395844,"threshold_uncertainty_score":0.72457016},"labels":[],"label_agreement":null},{"id":"W2256565383","doi":"10.1016/j.jval.2015.03.1019","title":"A review of health-related quality of life (hrql) claims in labels of asthma products – can we consider the asthma quality of life questionnaire (aqlq) as a potentially acceptable measure for qualification?","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Fluticasone propionate; Salmeterol; Quality of life (healthcare); Asthma; Formoterol; Omalizumab; Mometasone furoate; Clinical trial; Physical therapy; Budesonide; Internal medicine; Corticosteroid; Immunoglobulin E","score_opus":0.2317163844128498,"score_gpt":0.44666753894435807,"score_spread":0.21495115453150826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2256565383","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0029499333,0.9762288,0.000034104687,0.009877042,0.0002555165,0.009774504,0.00082919386,0.000030317013,0.000020640184],"genre_scores_gemma":[0.015695853,0.9817453,0.00040912064,0.0012006164,0.00010941676,0.00040131662,0.00029822596,0.000089604684,0.000050527513],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9733086,0.012886227,0.010792179,0.00089062465,0.0014696608,0.00065266754],"domain_scores_gemma":[0.9830298,0.0011372442,0.010963998,0.0017794498,0.0024899351,0.0005995797],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.028087799,0.000609507,0.00817035,0.0004978924,0.00009310429,0.000007092467,0.0005208831,0.0004962915,0.000040684976],"category_scores_gemma":[0.016797844,0.00044114867,0.0007944,0.0019970261,0.0005006126,0.00009404358,0.00010291361,0.0007627221,0.0000036020172],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003294602,0.0012883449,0.00096369756,0.7456632,0.0002464761,0.000001103663,0.0009930875,0.000045360128,0.000003483381,0.0022445463,0.0018329246,0.24638827],"study_design_scores_gemma":[0.005496735,0.0022914074,0.009838383,0.7430786,0.0004649052,0.000027524518,0.001315565,0.000022612276,0.000009740583,0.0011384938,0.23546816,0.00084788667],"about_ca_topic_score_codex":0.02412737,"about_ca_topic_score_gemma":0.00090285175,"teacher_disagreement_score":0.24554038,"about_ca_system_score_codex":0.0005710851,"about_ca_system_score_gemma":0.043637272,"threshold_uncertainty_score":0.999804},"labels":[],"label_agreement":null},{"id":"W2263474571","doi":"10.1016/j.jval.2015.03.1051","title":"Cost-effectiveness of Secukinumab compared to current treatments for the treatment of moderate to severe plaque Psoriasis in Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Secukinumab; Ustekinumab; Medicine; Etanercept; Adalimumab; Infliximab; Ixekizumab; Psoriasis; Quality-adjusted life year; Cost effectiveness; Dermatology; Internal medicine; Psoriatic arthritis; Disease; Tumor necrosis factor alpha","score_opus":0.12951627574653257,"score_gpt":0.33807852997998106,"score_spread":0.20856225423344849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2263474571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98944813,0.004615832,0.00017590229,0.00034847346,0.000941218,0.003679952,0.0007630413,0.000006944507,0.000020495225],"genre_scores_gemma":[0.99814904,0.00044255267,0.00014894486,0.000048148326,0.000011756136,0.0010306351,0.00012255154,0.000014372743,0.00003199387],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9980635,0.0007754954,0.00045874176,0.00027752313,0.00006008315,0.0003646771],"domain_scores_gemma":[0.9985718,0.0008674708,0.00013591105,0.00027321881,0.000075995944,0.0000755922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048517602,0.00020377208,0.0006222573,0.00014362435,0.000048718022,0.0000029280188,0.0001362183,0.0000568791,0.000005655185],"category_scores_gemma":[0.000038366186,0.00014425063,0.0000649491,0.0002640671,0.000017564122,0.000025782248,0.00002037312,0.000048274233,0.000005416891],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030750481,0.005740536,0.17219749,0.0006510691,0.0015533433,0.000019833671,0.03210027,0.43186575,0.0014112272,0.0011593585,0.0015340219,0.3210166],"study_design_scores_gemma":[0.12534219,0.01808875,0.6423878,0.0029480462,0.0006876939,0.00006467909,0.008389001,0.004067683,0.14730808,0.0013946678,0.04766734,0.0016540439],"about_ca_topic_score_codex":0.82466334,"about_ca_topic_score_gemma":0.5918488,"teacher_disagreement_score":0.47019035,"about_ca_system_score_codex":0.0022568041,"about_ca_system_score_gemma":0.0020597174,"threshold_uncertainty_score":0.5901464},"labels":[],"label_agreement":null},{"id":"W2266804440","doi":"10.1016/j.jval.2015.09.2396","title":"Factor Consumption for Prophylaxis and Treatment of Bleeding: Recombinant Factor Ix Fc Fusion Protein Compared With Conventional Recombinant Factor Ix","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Bleed; Medicine; Factor IX; Surgery; Internal medicine","score_opus":0.20293857326682366,"score_gpt":0.3721418863158486,"score_spread":0.16920331304902494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2266804440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99117094,0.0008300477,0.000045422028,0.0017494556,0.00024420134,0.0057351654,0.0001674177,0.000038139755,0.000019235262],"genre_scores_gemma":[0.99627024,0.00043863305,0.001680441,0.00001222139,0.000058286056,0.00031208122,0.00016481585,0.000033791435,0.0010294986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977304,0.00019279096,0.0006191117,0.0004537587,0.00050545787,0.0004985229],"domain_scores_gemma":[0.9985966,0.00017060108,0.00025983193,0.0002412618,0.00024739423,0.00048430194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003347152,0.00027292475,0.0007369373,0.00029578173,0.00011638963,0.000019640836,0.00006289328,0.00014007221,0.00007537416],"category_scores_gemma":[0.000098895805,0.0001741623,0.00008989251,0.00018605863,0.00013575422,0.000091234535,0.000025479065,0.00015184737,0.000012400386],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011246591,0.006766046,0.9229277,0.0043264073,0.0003227689,0.00006409043,0.006162321,0.000018900406,0.009114738,0.00045249215,0.0002632985,0.038334664],"study_design_scores_gemma":[0.086094715,0.14824426,0.7005434,0.0063491683,0.00012364109,0.00016590067,0.0016241985,0.009593014,0.03416671,0.0009990854,0.011027487,0.0010683893],"about_ca_topic_score_codex":0.0014862473,"about_ca_topic_score_gemma":0.000084903164,"teacher_disagreement_score":0.22238426,"about_ca_system_score_codex":0.0009266777,"about_ca_system_score_gemma":0.0009382635,"threshold_uncertainty_score":0.71021324},"labels":[],"label_agreement":null},{"id":"W2267586496","doi":"10.1016/j.jval.2015.03.1358","title":"Cost-Utility analysis of three types of Influenza Vaccines (Trivalent, Trivalent High dose and quadrivalent) in adults aged 65 and Older Under Universal Influenza Immunization Program (UIIP) In Ontario, Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Vaccination; Economic evaluation; Health care; Influenza vaccine; Cost-effectiveness analysis; Cost effectiveness; Family medicine; Environmental health; Demography; Virology; Economic growth","score_opus":0.13718110344870818,"score_gpt":0.37527816981581985,"score_spread":0.23809706636711167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2267586496","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936095,0.0036857687,0.000010140927,0.00029763277,0.000054238426,0.0022391742,0.00004727428,0.00001786689,0.00003840258],"genre_scores_gemma":[0.9987261,0.00053033204,0.0003705446,0.00024987574,0.000010068953,0.000048244652,0.000034203473,0.000018680154,0.000011893011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966644,0.00044729185,0.0012216184,0.00044805618,0.0006939782,0.00052463723],"domain_scores_gemma":[0.9981465,0.00036467388,0.0003789348,0.0004701582,0.00036516567,0.0002745738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016440813,0.00026159504,0.0011157452,0.0011957106,0.0000505511,0.000010136303,0.00015014873,0.00013371288,0.000030781914],"category_scores_gemma":[0.000701031,0.00024208143,0.000054623313,0.0019709992,0.00017725378,0.00016833364,0.00018913059,0.0004992776,2.560049e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020452926,0.00047719872,0.97942996,0.0009135552,0.00026191378,0.000017160626,0.005244988,0.008750694,0.0000126243,0.00008969535,0.00003995427,0.0027169713],"study_design_scores_gemma":[0.0096818805,0.00051884016,0.98068213,0.0007431701,0.00012442628,0.0000015076436,0.0015971296,0.006205868,0.00003147035,0.00008814233,0.00016885,0.00015659763],"about_ca_topic_score_codex":0.98731506,"about_ca_topic_score_gemma":0.9889285,"teacher_disagreement_score":0.007636588,"about_ca_system_score_codex":0.0017761872,"about_ca_system_score_gemma":0.003039801,"threshold_uncertainty_score":0.9871794},"labels":[],"label_agreement":null},{"id":"W2271692729","doi":"10.1016/j.jval.2015.09.609","title":"Published Diagnostic Discordance Of Lymphoma And Potential For Impact On Patient Care","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Becton Dickinson (Canada)","funders":"","keywords":"Medicine; Lymphoma; Confidence interval; Meta-analysis; Pathological; Random effects model; Internal medicine","score_opus":0.0718707913085147,"score_gpt":0.36536190401531066,"score_spread":0.29349111270679595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2271692729","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939449,0.004115477,0.00012554527,0.00090250454,0.00018677925,0.0005595121,0.00004499906,0.000009436502,0.000110856425],"genre_scores_gemma":[0.998555,0.00007802057,0.00080945593,0.00042891823,0.00007355526,0.000021018092,0.000021665759,0.000008450083,0.0000039008396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99905246,0.0000450851,0.00026848054,0.00017019999,0.00023845764,0.00022534026],"domain_scores_gemma":[0.9992672,0.00014028944,0.000107463115,0.00014989456,0.000111306756,0.00022383375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002487422,0.00008322619,0.000252529,0.00007327895,0.000024161589,0.000010700057,0.00004125935,0.000032860375,0.0000027317735],"category_scores_gemma":[0.0008125889,0.00006248085,0.000043182707,0.00012087468,0.000027966182,0.00007853527,0.000018467344,0.000050105733,6.914319e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004090504,0.00035258493,0.7645091,0.0015747746,0.00003886447,0.00008660832,0.009150031,0.018098434,0.000033204924,0.0010034246,0.0075022792,0.19356021],"study_design_scores_gemma":[0.009346555,0.02217456,0.94680685,0.0030637677,0.00003936689,0.0000932255,0.00613942,0.008909921,0.00041070042,0.0017021702,0.0010558243,0.00025765348],"about_ca_topic_score_codex":0.008515503,"about_ca_topic_score_gemma":0.000060174927,"teacher_disagreement_score":0.19330257,"about_ca_system_score_codex":0.0003655998,"about_ca_system_score_gemma":0.00059400004,"threshold_uncertainty_score":0.99808687},"labels":[],"label_agreement":null},{"id":"W2276197862","doi":"10.1016/j.jval.2015.03.1748","title":"Use of infliximab within a Patient support program: positive perception of iv Infusions from Patients’ perspective","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Memorial University of Newfoundland; Dalhousie University; University of Toronto","funders":"","keywords":"Infliximab; Perspective (graphical); Perception; Medicine; Psychology; Internal medicine; Computer science; Tumor necrosis factor alpha; Artificial intelligence; Neuroscience","score_opus":0.4223732349461116,"score_gpt":0.42077679225130254,"score_spread":0.0015964426948090749,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2276197862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911261,0.00025848378,0.00015160361,0.004242875,0.00041314724,0.001906031,0.0013519492,0.000028901923,0.000520873],"genre_scores_gemma":[0.9848333,0.000059193608,0.012943794,0.0017701505,0.00005726049,0.00010752235,0.00017704025,0.00002743585,0.000024280911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935792,0.0007414248,0.0046607824,0.00048380072,0.00019208044,0.00034267516],"domain_scores_gemma":[0.9946695,0.0006230329,0.0036174266,0.00042740378,0.0003863071,0.0002763467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005503495,0.00017735588,0.001025377,0.0004853996,0.00006222097,0.000022430386,0.00015237393,0.00014042825,0.00009174616],"category_scores_gemma":[0.0039196345,0.00021871865,0.000101084945,0.00034692432,0.00010865469,0.0004917521,0.0000736754,0.00020722515,0.00011804503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021306226,0.002315085,0.7293144,0.00036594312,0.00008403445,0.0000011270085,0.20435873,0.007922165,0.0000053969306,0.049709577,0.004415137,0.001295367],"study_design_scores_gemma":[0.0042086095,0.0048725065,0.87019324,0.00082683127,0.000013551936,0.0000024376084,0.048361696,0.03988615,0.00002026191,0.027089963,0.003873494,0.0006512819],"about_ca_topic_score_codex":0.1253228,"about_ca_topic_score_gemma":0.00054427114,"teacher_disagreement_score":0.15599702,"about_ca_system_score_codex":0.0019644066,"about_ca_system_score_gemma":0.00084025133,"threshold_uncertainty_score":0.8919087},"labels":[],"label_agreement":null},{"id":"W2278335914","doi":"10.1016/j.jval.2015.03.1766","title":"Dosing pattern analysis for Biologics in the treatment of Psoriasis in Canada: indication-specific information retrieved from Administrative Claims Database","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada); Novartis (Canada)","funders":"","keywords":"Psoriasis; Dosing; Medicine; Database; Pharmacology; Dermatology; Computer science","score_opus":0.5940231185700675,"score_gpt":0.4298134159621341,"score_spread":0.16420970260793338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2278335914","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9740273,0.001734289,0.006972337,0.012643809,0.00023957853,0.001374382,0.0029521182,0.0000046533164,0.00005156309],"genre_scores_gemma":[0.99477816,0.0008345953,0.001353161,0.0017501876,0.00006334855,0.00017773815,0.0010355137,0.0000058128603,0.000001502043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948628,0.0006558228,0.0038167865,0.00028211364,0.00010249605,0.00028001578],"domain_scores_gemma":[0.9953956,0.0019086963,0.0021419527,0.00041117382,0.00004547792,0.00009712371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010194285,0.00012736126,0.00081202004,0.00040685522,0.00004997595,0.000025647389,0.00020384695,0.0000779537,0.00001675297],"category_scores_gemma":[0.0008423952,0.00012481754,0.000056675293,0.0008598276,0.000024955589,0.00030164135,0.000009761585,0.00009744516,0.000012535448],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049150385,0.00016160076,0.96430475,0.00008592806,0.00004733843,4.8920793e-7,0.021915043,0.0071126535,8.8966e-8,0.003920936,0.00061854,0.0017834988],"study_design_scores_gemma":[0.002660838,0.00038006026,0.905538,0.000093326,0.000009469643,3.4762053e-7,0.02204326,0.053230442,0.000007701555,0.0049688085,0.010844648,0.00022305282],"about_ca_topic_score_codex":0.9307972,"about_ca_topic_score_gemma":0.802706,"teacher_disagreement_score":0.1280912,"about_ca_system_score_codex":0.0047743386,"about_ca_system_score_gemma":0.0019775035,"threshold_uncertainty_score":0.99904615},"labels":[],"label_agreement":null},{"id":"W2283234840","doi":"10.1016/j.jval.2015.11.012","title":"Preferences for Prostate Cancer Outcomes: A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canadian Centre for Applied Research in Cancer Control; University of British Columbia","funders":"National Cancer Institute","keywords":"Prostate cancer; Medicine; Population; Sexual function; Cancer; Prostate; Disease; Gynecology; Demography; Internal medicine; Environmental health","score_opus":0.2942641226204339,"score_gpt":0.4539909077868291,"score_spread":0.1597267851663952,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283234840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92801046,0.005750641,0.00023211287,0.057795435,0.00053110137,0.0051975087,0.0024490335,0.000014553594,0.000019160954],"genre_scores_gemma":[0.99513936,0.0009160079,0.0007825577,0.0009954742,0.00010334699,0.0018076134,0.00001366674,0.000026761309,0.0002152055],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99611574,0.00052251783,0.0023513187,0.00051982387,0.000110862,0.00037972396],"domain_scores_gemma":[0.9951028,0.0011695344,0.0031770421,0.00030581106,0.0001669484,0.00007782123],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046924874,0.00017746714,0.00074849365,0.00014910726,0.00042945467,0.000028461678,0.00014908468,0.00007735412,0.000015657142],"category_scores_gemma":[0.0018622146,0.000115232266,0.00011108666,0.00015671409,0.00007384497,0.00020896271,0.00004759264,0.00009916886,0.0000024254552],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010592792,0.000053309057,0.9439808,0.0002915206,0.00003718723,4.5304316e-9,0.01687535,0.0058211726,0.000001074366,0.031033445,0.00064239814,0.001157813],"study_design_scores_gemma":[0.0014131347,0.0002026537,0.91363126,0.00024167646,0.000009928511,2.4600405e-7,0.0032678973,0.025702605,0.0000051197476,0.054117776,0.0012434183,0.00016426764],"about_ca_topic_score_codex":0.25538966,"about_ca_topic_score_gemma":0.029636206,"teacher_disagreement_score":0.22575346,"about_ca_system_score_codex":0.0030461384,"about_ca_system_score_gemma":0.00024809645,"threshold_uncertainty_score":0.9880704},"labels":[],"label_agreement":null},{"id":"W2283517602","doi":"10.1016/j.jval.2015.03.355","title":"The Cost-Effectiveness of Canagliflozin Versus Sitagliptin as Third-Line Therapy in Type 2 Diabetes Mellitus (T2dm) in a Canadian setting","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Canagliflozin; Sitagliptin; Medicine; Metformin; Internal medicine; Population; Placebo; Type 2 Diabetes Mellitus; Sulfonylurea; Surgery; Diabetes mellitus; Endocrinology; Insulin; Environmental health","score_opus":0.06972131726292441,"score_gpt":0.33978473491633193,"score_spread":0.2700634176534075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2283517602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824332,0.010110736,3.387202e-7,0.002752625,0.00046013444,0.0019701037,0.000006696874,0.000014262586,0.0022518889],"genre_scores_gemma":[0.9977816,0.001493095,0.00007271137,0.000379232,0.000040582752,0.00011908353,0.000028355467,0.000021646258,0.000063737374],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786717,0.0005264565,0.00041791293,0.00024254055,0.0002382589,0.00070764765],"domain_scores_gemma":[0.9985585,0.0006636996,0.000101709826,0.00028785318,0.00007227595,0.0003159683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003564785,0.00015885835,0.00040739923,0.000368877,0.000041568062,0.000013310834,0.00012335446,0.00006752744,0.0000073980855],"category_scores_gemma":[0.0004997199,0.00012099876,0.000034930305,0.0007229198,0.000046583646,0.000050827526,0.000027975522,0.00020589626,0.000017186272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025298225,0.00058142625,0.85595226,0.0006723174,0.00018225053,0.00013926375,0.0035282243,0.006813253,0.000055259643,0.004195224,0.00069647713,0.124654226],"study_design_scores_gemma":[0.047710784,0.012772983,0.81383455,0.004488808,0.0000779926,0.0000027401609,0.004871065,0.022092905,0.0020854624,0.0034380397,0.08781372,0.0008109375],"about_ca_topic_score_codex":0.69116014,"about_ca_topic_score_gemma":0.4702225,"teacher_disagreement_score":0.22093762,"about_ca_system_score_codex":0.0017923793,"about_ca_system_score_gemma":0.0017335007,"threshold_uncertainty_score":0.53944457},"labels":[],"label_agreement":null},{"id":"W2286537043","doi":"10.1016/j.jval.2015.09.2393","title":"Comparisons of Factor Consumption for Routine Prophylaxis And Bleeding During Episodic Therapy With Recombinant Factor Viii Fc Fusion Protein and Conventional Recombinant Factor Viii","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Bleed; Medicine; Haemophilia A; Haemophilia; Internal medicine; Surgery","score_opus":0.13738247714349572,"score_gpt":0.35313786483227244,"score_spread":0.21575538768877672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2286537043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99226975,0.001681047,0.0000770623,0.0018332888,0.0001449144,0.003880601,0.000072869305,0.000033538712,0.0000069209364],"genre_scores_gemma":[0.9971109,0.00095916766,0.0013699743,0.000014309639,0.000045353394,0.00013824496,0.00004964827,0.000032043754,0.00028038153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793416,0.00018953318,0.00057519734,0.00041455586,0.00042380398,0.00046272614],"domain_scores_gemma":[0.9988389,0.000157948,0.00025836483,0.00017976963,0.0001776412,0.00038736756],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005431365,0.00023400884,0.00063358183,0.000291229,0.00017898266,0.000023197317,0.000058350804,0.00013059356,0.000038478753],"category_scores_gemma":[0.00011321049,0.00015802418,0.000053759504,0.00017634938,0.0001584942,0.00011200892,0.000043526168,0.00028300745,0.0000028701909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047447477,0.0011066239,0.96384436,0.002889134,0.00009937631,0.000015001736,0.0021992316,0.0000061601554,0.01717795,0.00016897707,0.00004279859,0.0077056517],"study_design_scores_gemma":[0.029231671,0.017830556,0.9247376,0.0032228571,0.000019875224,0.00008137232,0.0005376678,0.002862782,0.020428482,0.00020109405,0.00048359775,0.0003624944],"about_ca_topic_score_codex":0.0008809103,"about_ca_topic_score_gemma":0.000043444812,"teacher_disagreement_score":0.0391068,"about_ca_system_score_codex":0.0003103666,"about_ca_system_score_gemma":0.0004349297,"threshold_uncertainty_score":0.6444039},"labels":[],"label_agreement":null},{"id":"W2293743219","doi":"10.1016/j.jval.2015.09.1703","title":"Use of Economic Evaluations of Health Technologies In Dutch Healthcare Decision-Making: Barriers And Facilitators","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Work & Health","funders":"","keywords":"Incentive; Health care; Economic evaluation; Ambiguity; Macro; Population; Business; Public economics; Medicine; Economics; Environmental health; Economic growth; Computer science","score_opus":0.49513683150337773,"score_gpt":0.4773785594470162,"score_spread":0.017758272056361546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2293743219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90761375,0.022575611,0.0011698946,0.065586306,0.00052673765,0.0016934429,0.0007189703,0.000056983896,0.0000582896],"genre_scores_gemma":[0.9864975,0.0012576708,0.01076026,0.0013368357,0.000015972704,0.00008030596,0.000012719015,0.000027509961,0.000011213611],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.98932964,0.0012716696,0.007910472,0.0006866017,0.00017962157,0.0006219817],"domain_scores_gemma":[0.9928047,0.0026638114,0.0034994418,0.00069398805,0.00008793408,0.0002501166],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.037023667,0.00022241179,0.0017980128,0.0015231721,0.00010083426,0.000027592645,0.0003070262,0.00021145644,0.000027419544],"category_scores_gemma":[0.014197531,0.00028843232,0.000077552235,0.00053141057,0.00020052202,0.0004955153,0.00011198004,0.0002858967,0.000043087308],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054201184,0.00008690182,0.81669366,0.0016198461,0.000023770746,6.130679e-7,0.012152761,0.04044502,2.301859e-7,0.11641885,0.002925702,0.009578405],"study_design_scores_gemma":[0.0045689214,0.001731486,0.26544437,0.0048298733,0.0000054066295,0.000017947907,0.064184934,0.14959894,0.000007700411,0.4898217,0.018686261,0.001102448],"about_ca_topic_score_codex":0.046059832,"about_ca_topic_score_gemma":0.002928376,"teacher_disagreement_score":0.5512493,"about_ca_system_score_codex":0.0027558024,"about_ca_system_score_gemma":0.0031032409,"threshold_uncertainty_score":0.9999568},"labels":[],"label_agreement":null},{"id":"W2294402265","doi":"10.1016/j.jval.2015.12.016","title":"Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":462,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Simon Fraser University","funders":"","keywords":"Multiple-criteria decision analysis; Checklist; Management science; Task (project management); Decision analysis; Process management; Health care; Computer science; Decision support system; Risk analysis (engineering); Operations research; Medicine; Business; Engineering; Systems engineering; Psychology; Political science; Data mining; Mathematics","score_opus":0.46074126753535605,"score_gpt":0.5493276149831208,"score_spread":0.08858634744776472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2294402265","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047562446,0.9513398,0.024250641,0.011764947,0.0028238995,0.0064053223,0.0026433398,0.000057648405,0.0002387724],"genre_scores_gemma":[0.0036491805,0.95351857,0.03790207,0.002505881,0.00082969654,0.000808573,0.00035613935,0.00021038252,0.00021951056],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9735411,0.003108155,0.019169452,0.0022689987,0.0005616091,0.0013507132],"domain_scores_gemma":[0.89386845,0.022165094,0.08057569,0.0026770981,0.00033945017,0.0003742024],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06494621,0.0008214301,0.007235044,0.0022759978,0.00081581523,0.00018193336,0.0013664931,0.00059644546,0.00013173494],"category_scores_gemma":[0.066960424,0.0007259774,0.0016006562,0.00215143,0.00008446835,0.0010150803,0.00033878797,0.0007515465,0.000098633755],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032670327,0.0008808694,0.03951035,0.23645046,0.003027144,0.00002399715,0.014826758,0.004957209,1.4983009e-7,0.016007893,0.019549482,0.66443896],"study_design_scores_gemma":[0.0008246564,0.00017837052,0.0007976168,0.03016961,0.0002376158,0.00004854481,0.0013437426,0.0048428215,7.1510506e-8,0.0015484783,0.95936036,0.00064813363],"about_ca_topic_score_codex":0.010629715,"about_ca_topic_score_gemma":0.0031478042,"teacher_disagreement_score":0.9398109,"about_ca_system_score_codex":0.004494819,"about_ca_system_score_gemma":0.004549964,"threshold_uncertainty_score":0.9995191},"labels":[],"label_agreement":null},{"id":"W2296758021","doi":"10.1016/j.jval.2015.03.1096","title":"Prioritization of Comparative Effectiveness Research Questions Based On Identification of The Most Relevant Outcomes To Improve Clinical Practice: An Application of Mcda To Dialysis Research Planning","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Multiple-criteria decision analysis; Ranking (information retrieval); Context (archaeology); Prioritization; Medicine; Identification (biology); Management science; Comparative effectiveness research; Computer science; Operations research; Alternative medicine; Mathematics; Engineering; Information retrieval","score_opus":0.7318248946125977,"score_gpt":0.6417965724853991,"score_spread":0.09002832212719858,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2296758021","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93866384,0.00019550274,0.02821324,0.027570123,0.00037722505,0.0044928,0.00023099915,0.000012067145,0.00024422604],"genre_scores_gemma":[0.9947536,0.000015106361,0.0042366837,0.0004990115,0.00007319265,0.0003660377,0.000024959372,0.00001653901,0.000014891967],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9832772,0.010188928,0.0050604274,0.0005960211,0.00054193614,0.00033548166],"domain_scores_gemma":[0.9817119,0.0135452645,0.0023513818,0.001002374,0.0011352443,0.00025378968],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.16151568,0.00010342495,0.00091590214,0.0010410002,0.00016888522,0.000025407337,0.0004036462,0.00012233938,0.0000017053171],"category_scores_gemma":[0.04929595,0.000107460764,0.00006304381,0.0018380618,0.0001383644,0.0002752478,0.000073817595,0.00038223277,0.00004919437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005137652,0.0015512794,0.52533025,0.0011720572,0.00004395607,1.4965855e-7,0.015038619,0.32848734,0.00022174985,0.1257383,0.00078688725,0.0011156681],"study_design_scores_gemma":[0.0009117438,0.0012553036,0.80786765,0.00054755097,0.0000049614277,2.0953176e-7,0.0042507513,0.17524473,0.00031459006,0.008366241,0.0011023268,0.00013397177],"about_ca_topic_score_codex":0.0166709,"about_ca_topic_score_gemma":0.0002355153,"teacher_disagreement_score":0.28253737,"about_ca_system_score_codex":0.0012097579,"about_ca_system_score_gemma":0.0012475987,"threshold_uncertainty_score":0.98987716},"labels":[],"label_agreement":null},{"id":"W2302496677","doi":"10.1016/j.jval.2015.03.1633","title":"“Number Needed to treat” analysis to Assess the comparative outcomes from Teriflunomide and dimethyl fumarate studies in relapsing multiple sclerosis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Teriflunomide; Dimethyl fumarate; Multiple sclerosis; Medicine; Oncology; Immunology; Fingolimod","score_opus":0.6348523267055757,"score_gpt":0.4886598500314978,"score_spread":0.14619247667407786,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2302496677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804985,0.0016797291,0.00010392012,0.015854744,0.00013288177,0.0014829115,0.00005530649,0.00003462592,0.00015736745],"genre_scores_gemma":[0.99117595,0.0007832069,0.0056581534,0.0019036726,0.000060962848,0.00023402998,0.000012365373,0.00002148158,0.00015016538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964103,0.0010435057,0.00077729917,0.00058824464,0.00055935816,0.0006213095],"domain_scores_gemma":[0.9958566,0.0027870142,0.00013577635,0.000492596,0.00021822532,0.0005098185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023236715,0.00029248162,0.0014505038,0.0005704109,0.00017488092,0.00005620155,0.00016520904,0.000060313472,0.000010979617],"category_scores_gemma":[0.0030144923,0.00019168513,0.00009850315,0.0018617765,0.00016470537,0.00011944458,0.00032743934,0.00034457378,0.000038055743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005685852,0.00016143745,0.9347226,0.000067621346,0.00053954485,0.000008701703,0.052185945,0.0065019266,0.0012651822,0.000008731632,0.0021434003,0.0018263191],"study_design_scores_gemma":[0.0029220057,0.00021044476,0.95657563,0.00047272453,0.00010479085,7.120666e-7,0.031778175,0.0070899595,0.00042296096,0.00003643611,0.0002038249,0.00018230645],"about_ca_topic_score_codex":0.09203516,"about_ca_topic_score_gemma":0.009214574,"teacher_disagreement_score":0.08282058,"about_ca_system_score_codex":0.0009345664,"about_ca_system_score_gemma":0.00020058831,"threshold_uncertainty_score":0.91401106},"labels":[],"label_agreement":null},{"id":"W2311957294","doi":"10.1016/j.jval.2015.03.366","title":"Evaluating the Cost of Bringing People with type 2 Diabetes mellitus to multiple targets of Treatment In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Liraglutide; Medicine; Exenatide; Sitagliptin; Pioglitazone; Glycemic; Type 2 diabetes; Insulin glargine; Insulin detemir; Internal medicine; Sulfonylurea; Hypoglycemia; Diabetes mellitus; Endocrinology; Insulin","score_opus":0.07310793442859402,"score_gpt":0.32670698901806644,"score_spread":0.2535990545894724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2311957294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99566346,0.0016999925,0.00000506449,0.0009341523,0.000086868575,0.0013918887,0.0000056301733,0.0000054216007,0.00020752897],"genre_scores_gemma":[0.9982185,0.000069709014,0.001377415,0.0001694379,0.000013483455,0.00006599642,0.000011997564,0.000011597954,0.00006187054],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99890244,0.00009591142,0.00031415772,0.00014764552,0.00025318033,0.0002866389],"domain_scores_gemma":[0.9992998,0.00018774557,0.00011139655,0.00021613917,0.00006222466,0.00012267962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005830662,0.00009926774,0.00035064388,0.000100400845,0.000016271913,0.0000024470646,0.00005417674,0.000011467765,0.0000059167855],"category_scores_gemma":[0.00013462082,0.000062942585,0.000015966056,0.00037430774,0.000011208019,0.000019811692,0.0000251172,0.000043306114,0.0000013278307],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012988839,0.00017033628,0.90931433,0.00022984754,0.0000521469,0.000004041159,0.0026884093,0.06849351,0.000057337264,0.00003347145,0.0001095343,0.018717157],"study_design_scores_gemma":[0.00958252,0.011867617,0.7976474,0.0018271906,0.00012395169,0.0000014222434,0.0046887775,0.16807708,0.0034323575,0.00005604232,0.0024487844,0.00024685217],"about_ca_topic_score_codex":0.90777874,"about_ca_topic_score_gemma":0.76376206,"teacher_disagreement_score":0.14401665,"about_ca_system_score_codex":0.0016134725,"about_ca_system_score_gemma":0.0019232351,"threshold_uncertainty_score":0.42191747},"labels":[],"label_agreement":null},{"id":"W2312811400","doi":"10.1016/j.jval.2014.08.1252","title":"Costs of Employees with Treatment-Resistant Depression Based on a Canadian Private Claims Database","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; Centre for Addiction and Mental Health","funders":"","keywords":"Depression (economics); Treatment-resistant depression; Medicine; Major depressive disorder; Plaintiff; Cohort; Antidepressant; Medical prescription; Psychiatry; Family medicine; Internal medicine; Pharmacology; Mood","score_opus":0.03032870401264633,"score_gpt":0.2944124915454887,"score_spread":0.2640837875328424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312811400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957458,0.00023640346,0.00012055694,0.0017346762,0.00006295369,0.0010618587,0.00009328765,0.000049444214,0.00089506037],"genre_scores_gemma":[0.9951298,0.000059983544,0.0039604013,0.0005053378,0.000036717604,0.000050002942,0.00016441956,0.00003920265,0.000054134547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819183,0.00026648602,0.00035636622,0.0003880349,0.00037118536,0.00042609556],"domain_scores_gemma":[0.9983106,0.00023491505,0.00016009001,0.0007213368,0.00003294924,0.00054011174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032555993,0.00021437966,0.00043465456,0.00039532155,0.00008273629,0.000007111958,0.00008341555,0.00007380729,0.00003250085],"category_scores_gemma":[0.000084854764,0.00014058361,0.00004319105,0.00022987874,0.000044908993,0.000047438738,0.000012035777,0.00012851963,0.000011649779],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040062033,0.0020180482,0.9601874,0.000576042,0.000049298127,0.00022778613,0.0002672304,0.0046537314,0.0017705623,0.0007465636,0.00045333774,0.025043849],"study_design_scores_gemma":[0.03055918,0.024340587,0.86368984,0.016694907,0.00014931786,0.000035062276,0.00008141308,0.03500149,0.018197,0.000109165914,0.010594135,0.00054790784],"about_ca_topic_score_codex":0.3076958,"about_ca_topic_score_gemma":0.061642393,"teacher_disagreement_score":0.24605341,"about_ca_system_score_codex":0.0011403223,"about_ca_system_score_gemma":0.00090777443,"threshold_uncertainty_score":0.95548016},"labels":[],"label_agreement":null},{"id":"W2313074705","doi":"10.1016/j.jval.2012.03.482","title":"PMH37 Cost-Effectiveness of Asenapine in the Treatment of Bipolar I Disorder in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Bipolar Disorder and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Asenapine; Olanzapine; Medicine; Bipolar I disorder; Schizophrenia (object-oriented programming); Antipsychotic; Psychiatry; Bipolar disorder; Mania; Lithium (medication)","score_opus":0.044291764828827386,"score_gpt":0.32002920800584056,"score_spread":0.27573744317701315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313074705","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9331985,0.064527094,0.000007069277,0.0005177837,0.000087559485,0.0015391613,0.000034144367,0.000002359132,0.000086288135],"genre_scores_gemma":[0.9956673,0.0040632403,0.00004533067,0.00004997213,0.000014386614,0.00011725996,0.000027817188,0.000010349868,0.000004386735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844885,0.000518108,0.00038519604,0.00012282019,0.00019962048,0.00032542745],"domain_scores_gemma":[0.9992386,0.0003419961,0.0000846187,0.00024371619,0.00001549902,0.00007558323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006381541,0.000119459844,0.00043161525,0.0001404341,0.000014401721,8.890361e-7,0.000050031274,0.00003529369,0.000012894573],"category_scores_gemma":[0.000026248847,0.00007652411,0.0000394789,0.0003950766,0.000025873976,0.000030081805,0.0000066442485,0.0000911103,9.550379e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014181995,0.0025182788,0.97248435,0.0004489108,0.000021583308,0.00000541918,0.0017814651,0.00031115898,0.000025066398,0.00028422815,0.000003557584,0.021974182],"study_design_scores_gemma":[0.0037790916,0.00074514584,0.9889215,0.00027885629,0.0000149262105,0.000008461059,0.00059438567,0.00021167497,0.00038637104,0.000031796368,0.0049753794,0.000052391904],"about_ca_topic_score_codex":0.9848555,"about_ca_topic_score_gemma":0.90650797,"teacher_disagreement_score":0.07834747,"about_ca_system_score_codex":0.0011001738,"about_ca_system_score_gemma":0.0010252832,"threshold_uncertainty_score":0.3120563},"labels":[],"label_agreement":null},{"id":"W2313172310","doi":"10.1016/j.jval.2013.08.1665","title":"A Bayesian Dynamic Model of Asthma in the Real Life","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medical prescription; Asthma; Observational study; Quarter (Canadian coin); Proxy (statistics); Exacerbation; Demographics; Bayesian probability; Epidemiology; Pediatrics; Emergency medicine; Demography; Internal medicine; Statistics","score_opus":0.02851148503749497,"score_gpt":0.30487583070861735,"score_spread":0.2763643456711224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313172310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298763,0.00063282665,0.000333109,0.004512019,0.000029442006,0.0005985884,0.0000063915054,0.000012993387,0.000886972],"genre_scores_gemma":[0.9970943,0.00016517026,0.00036630177,0.0022395807,0.00003085636,0.00003598183,0.000004138505,0.000010861632,0.000052817748],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99887973,0.00018262713,0.00037166628,0.00013519704,0.00020379212,0.00022696162],"domain_scores_gemma":[0.99943125,0.000069227615,0.00008251414,0.00024503068,0.000024156034,0.00014784015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003843323,0.00007797812,0.00023039969,0.0001230016,0.000024217976,0.0000040704017,0.00008891498,0.00004904875,0.000030999727],"category_scores_gemma":[0.00007683675,0.000049976672,0.000045419736,0.00020094302,0.000047206213,0.000039646085,0.000013955166,0.00015982686,0.000014085191],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070627825,0.0043498655,0.63297325,0.005940391,0.0000486585,0.00013696919,0.024408782,0.21299504,0.0015254887,0.010294579,0.0059379027,0.100682765],"study_design_scores_gemma":[0.00076748367,0.00029192521,0.28678435,0.00025846058,0.000002677745,0.0000037913462,0.0009211552,0.71007085,0.0000029414743,0.00073501596,0.00010562366,0.000055743774],"about_ca_topic_score_codex":0.0056490004,"about_ca_topic_score_gemma":0.000129057,"teacher_disagreement_score":0.4970758,"about_ca_system_score_codex":0.00007514001,"about_ca_system_score_gemma":0.0006819226,"threshold_uncertainty_score":0.8539636},"labels":[],"label_agreement":null},{"id":"W2313368310","doi":"10.1016/j.jval.2013.03.529","title":"Reliability and validity of current perception threshold test in mechanical neck disorder","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Reliability (semiconductor); Neck pain; Construct validity; Physical therapy; Test (biology); Concurrent validity; Physical medicine and rehabilitation; Internal consistency; Psychometrics; Clinical psychology; Pathology","score_opus":0.04321297370014897,"score_gpt":0.33929675444880386,"score_spread":0.2960837807486549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313368310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556476,0.00027433585,0.00007592741,0.0028512778,0.00010071687,0.0010594449,0.0000022382837,0.000013523952,0.00005778084],"genre_scores_gemma":[0.9986011,0.0004158971,0.00079673406,0.00009216859,0.000033263746,0.00003634981,0.000008572135,0.000006960032,0.000008998802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998739,0.00020746829,0.00048009047,0.0002266086,0.00017498725,0.00017183974],"domain_scores_gemma":[0.99925876,0.00031091526,0.00007026969,0.00020335968,0.000050513416,0.00010619797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012195263,0.000080297126,0.00026359298,0.00009469635,0.000019362697,0.0000033223084,0.00002988178,0.00006942962,0.00006856373],"category_scores_gemma":[0.00086976314,0.00006243078,0.000041946834,0.00018109608,0.00006416673,0.00006807971,0.000022347249,0.00023743892,0.000008374024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022670145,0.00092596747,0.97901314,0.003889847,9.563614e-7,1.5458082e-7,0.00076011,0.00015843175,0.002093302,0.00049801596,0.000100395446,0.012537021],"study_design_scores_gemma":[0.0007562938,0.0005684754,0.9708993,0.00051124406,0.0000018656646,7.8353503e-7,0.00020349499,0.022779562,0.000007513445,0.004136078,0.00008455252,0.000050852155],"about_ca_topic_score_codex":0.00392725,"about_ca_topic_score_gemma":0.0000795865,"teacher_disagreement_score":0.02262113,"about_ca_system_score_codex":0.0001403615,"about_ca_system_score_gemma":0.0000943037,"threshold_uncertainty_score":0.5936853},"labels":[],"label_agreement":null},{"id":"W2313419446","doi":"10.1016/j.jval.2014.03.1113","title":"Frontiers in pediatric health technology assessment: Development of a discrete event simulation model for economic evaluation of screening, diagnosis and treatment strategies in autism spectrum disorder","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Autism spectrum disorder; Autism; Population; Discrete event simulation; Medicine; Psychiatry; Psychology; Pediatrics; Computer science; Simulation","score_opus":0.27793461371931627,"score_gpt":0.44910737329610856,"score_spread":0.1711727595767923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2313419446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76827633,0.0037371165,0.21170618,0.013411607,0.00014592713,0.0025833035,0.0001032582,0.000011661418,0.000024642373],"genre_scores_gemma":[0.9538653,0.001268492,0.043990478,0.000110054476,0.00002522255,0.00067130197,0.00004279169,0.00002229411,0.0000040776963],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9936205,0.00057522807,0.004718395,0.0005366978,0.00010850017,0.0004406921],"domain_scores_gemma":[0.99643844,0.0005631593,0.0026215995,0.00026906363,0.000018379442,0.00008932841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02048827,0.00019115604,0.0011897483,0.0015658073,0.000079378886,0.0000155047,0.00012136531,0.00013482086,0.000007957519],"category_scores_gemma":[0.00032406862,0.00024174865,0.000053185362,0.0002538748,0.000040139537,0.00027580315,0.000029192768,0.00010666834,0.0000018656198],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010706255,0.00010399727,0.37814724,0.0004015627,0.000009106573,1.16206165e-8,0.0021370691,0.58873135,2.247972e-8,0.026115349,0.000009114264,0.004334446],"study_design_scores_gemma":[0.002036296,0.00022303352,0.21582581,0.00012229568,0.0000033423817,1.0004805e-7,0.00091983075,0.7365543,5.1765545e-7,0.044085402,0.00010594228,0.00012310038],"about_ca_topic_score_codex":0.007012323,"about_ca_topic_score_gemma":0.007921201,"teacher_disagreement_score":0.18558899,"about_ca_system_score_codex":0.0031057673,"about_ca_system_score_gemma":0.0019210512,"threshold_uncertainty_score":0.99960005},"labels":[],"label_agreement":null},{"id":"W2314849528","doi":"10.1016/j.jval.2012.03.742","title":"PGI15 The Economic Burden of Unmet Treatment Needs in Medicaid Patients with Chronic Constipation","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Gender, Labor, and Family Dynamics","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Constipation; Fecal impaction; Medicaid; Medical prescription; Chronic constipation; Adverse effect; Emergency medicine; Health care; Intensive care medicine; Internal medicine","score_opus":0.03085724378491901,"score_gpt":0.29887209967741946,"score_spread":0.26801485589250046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314849528","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99635017,0.0007220564,0.000019785703,0.00084191,0.0003286009,0.0004908977,0.000018033266,0.000008441504,0.0012201045],"genre_scores_gemma":[0.998658,0.0009680572,0.00008557027,0.00006729242,0.00014180267,0.000020113444,0.000012668894,0.0000058542846,0.000040625808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987996,0.00033504685,0.00027134275,0.000088091285,0.00017460602,0.0003312834],"domain_scores_gemma":[0.9994528,0.00016158957,0.00014517613,0.00012821282,0.000018123223,0.000094069845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092492445,0.000072080664,0.00016022903,0.00010381503,0.000100739664,0.000006888389,0.00010826108,0.00005273749,0.000021799386],"category_scores_gemma":[0.000027288535,0.000049805374,0.00001791489,0.0002293912,0.00016125922,0.000094964824,0.00001052689,0.000067289046,0.000007436095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012432735,0.00008305857,0.90033865,0.000017607046,0.000007369498,9.054617e-8,0.07345592,0.0070319003,2.9789013e-7,0.015250311,0.00002380123,0.003778572],"study_design_scores_gemma":[0.0023681766,0.0006761387,0.9543709,0.000108637185,0.000012200784,2.3551574e-7,0.029467646,0.004729279,0.0000019192878,0.000690496,0.0074102534,0.0001641081],"about_ca_topic_score_codex":0.15014204,"about_ca_topic_score_gemma":0.02010368,"teacher_disagreement_score":0.13003837,"about_ca_system_score_codex":0.0018545722,"about_ca_system_score_gemma":0.0013668496,"threshold_uncertainty_score":0.99777687},"labels":[],"label_agreement":null},{"id":"W2314925473","doi":"10.1016/j.jval.2014.08.139","title":"Incretin Therapy and Risk of Pancreatitis in Type 2 Diabetes Mellitus: Systematic Review of Randomized and Non-Randomized Studies","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McMaster University","funders":"","keywords":"Medicine; Exenatide; Sitagliptin; Internal medicine; Randomized controlled trial; Pancreatitis; Incretin; Type 2 diabetes; Hazard ratio; Type 2 Diabetes Mellitus; Diabetes mellitus; Cohort study; Endocrinology; Confidence interval","score_opus":0.02188000461485413,"score_gpt":0.2939801133482795,"score_spread":0.2721001087334254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314925473","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5430347,0.4527206,0.0000047062863,0.00030778695,0.000030135288,0.0037900116,0.0000017432504,0.000005348359,0.0001049907],"genre_scores_gemma":[0.39671078,0.60217416,0.0006816767,0.00021602275,0.0000068127997,0.00018292452,0.0000036996764,0.0000071763266,0.000016735372],"study_design_codex":"systematic_review","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99648255,0.0018386638,0.0011688861,0.00017117203,0.0001706542,0.00016804533],"domain_scores_gemma":[0.9956201,0.0034509434,0.00058852,0.00021234572,0.00007568787,0.000052403426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009871208,0.00014691637,0.0040630633,0.00017857942,0.000015450503,0.0000031218296,0.00003620394,0.000030681844,0.0000049684563],"category_scores_gemma":[0.0035936374,0.000089804984,0.00009882881,0.0001638875,0.00020926715,0.000027901737,0.00002834554,0.000066629924,7.459114e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028490223,0.00018520394,0.027844362,0.9352242,0.0015767096,0.0000018291743,0.0027689375,0.0000057132415,0.000007880046,0.0011629558,0.00005829515,0.0026736946],"study_design_scores_gemma":[0.6252979,0.00069793157,0.0020206266,0.36680788,0.0013002382,6.7238625e-7,0.00023368838,0.0022153866,0.0000783865,0.0012090881,0.000017790602,0.00012043284],"about_ca_topic_score_codex":0.0011303258,"about_ca_topic_score_gemma":0.000014695928,"teacher_disagreement_score":0.59680766,"about_ca_system_score_codex":0.000035901983,"about_ca_system_score_gemma":0.000032321983,"threshold_uncertainty_score":0.43021792},"labels":[],"label_agreement":null},{"id":"W2315635257","doi":"10.1016/j.jval.2014.03.981","title":"Comparison Of Tools To Evaluate Prescribing In The Elderly","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Medical prescription; Digoxin; Family medicine; Emergency medicine; Internal medicine; Pharmacology","score_opus":0.4741277231895074,"score_gpt":0.5220056716006493,"score_spread":0.047877948411141846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2315635257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97868663,0.0003310058,0.00017833318,0.016972154,0.00013760391,0.00083361636,0.000001577654,0.000008116869,0.0028509775],"genre_scores_gemma":[0.9954581,0.000026474225,0.00062611944,0.0038032797,0.000043288066,0.000013378812,0.0000026101116,0.000005920859,0.000020803564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982312,0.0006226364,0.00047999207,0.0001285713,0.00031087123,0.00022676776],"domain_scores_gemma":[0.99841404,0.001151864,0.000109999746,0.00020723724,0.000022819273,0.000094033385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027345621,0.00006587323,0.0002934588,0.00008873339,0.000024498255,0.000009011,0.00010072238,0.00002851199,0.000022862101],"category_scores_gemma":[0.0010273815,0.000043779364,0.00003008663,0.00024148599,0.000014661536,0.00006220912,0.000020793159,0.0002753366,0.00001828654],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042239585,0.00063231465,0.8545903,0.00081770495,0.000010233764,0.00000302401,0.009616905,0.010162803,0.0002849877,0.0027157078,0.0009771822,0.11976644],"study_design_scores_gemma":[0.005181807,0.0071788304,0.580709,0.0016571078,0.000051682942,0.000011923764,0.0020254203,0.30228165,0.00079555204,0.0011559143,0.09871331,0.0002378425],"about_ca_topic_score_codex":0.0014790499,"about_ca_topic_score_gemma":0.000047068213,"teacher_disagreement_score":0.29211885,"about_ca_system_score_codex":0.000054999276,"about_ca_system_score_gemma":0.00008160576,"threshold_uncertainty_score":0.22358908},"labels":[],"label_agreement":null},{"id":"W2316528672","doi":"10.1016/j.jval.2012.03.336","title":"PRS52 The Stability of Additive Treatment Effects in Multiple Treatment Comparison Meta-Analysis: a Simulation Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; McMaster University","funders":"","keywords":"Additive function; Additive model; Bayesian probability; Mathematics; Statistics; Generalized additive model; Stability (learning theory); Meta-analysis; Econometrics; Treatment effect; Medicine; Computer science; Internal medicine; Machine learning","score_opus":0.894881949415654,"score_gpt":0.5919447796015943,"score_spread":0.3029371698140597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316528672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98503536,0.0059177266,0.0023487706,0.00027781306,0.000082101426,0.006192543,0.000055000954,0.000003456497,0.000087215965],"genre_scores_gemma":[0.99853396,0.000016415588,0.0007078751,0.000034342927,0.000021958906,0.0005842534,0.000010585962,0.000006703622,0.00008387984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.92931676,0.05679708,0.009740553,0.0008406848,0.0028692347,0.00043569336],"domain_scores_gemma":[0.9607118,0.03148392,0.004443378,0.0029321564,0.00026595435,0.00016282624],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.093975835,0.0003333111,0.0073917443,0.00059798185,0.000108401626,0.00008238638,0.00047985243,0.000050273484,0.000896598],"category_scores_gemma":[0.009518245,0.00012270664,0.002762126,0.0030195422,0.00004266091,0.00016242692,0.000044955912,0.00009388699,0.00008350565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021699327,0.0033102152,0.7711632,0.00002824789,0.01156388,5.6554836e-7,0.022059422,0.18791953,6.71611e-7,0.00006215177,0.00002240895,0.003847972],"study_design_scores_gemma":[0.0007895649,0.0008608308,0.530932,0.0000065754125,0.022296261,1.7177321e-7,0.0066776057,0.43743387,0.000028663799,0.00013448669,0.0007305761,0.00010936458],"about_ca_topic_score_codex":0.009421757,"about_ca_topic_score_gemma":0.007522639,"teacher_disagreement_score":0.24951434,"about_ca_system_score_codex":0.0005789501,"about_ca_system_score_gemma":0.00012719288,"threshold_uncertainty_score":0.998825},"labels":[],"label_agreement":null},{"id":"W2316887046","doi":"10.1016/j.jval.2016.02.010","title":"Association between Time since Cancer Diagnosis and Health-Related Quality of Life: A Population-Level Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"National Cancer Institute; National Center for Advancing Translational Sciences; Agency for Healthcare Research and Quality","keywords":"Medicine; Prostate cancer; Quality of life (healthcare); Cancer; Breast cancer; Cancer registry; Cervical cancer; Population; Mental health; Internal medicine; Psychiatry; Environmental health","score_opus":0.12538931497847072,"score_gpt":0.3851906164332247,"score_spread":0.259801301454754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2316887046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94984365,0.0033944747,0.00006957478,0.045815554,0.00008905139,0.00032481644,0.00041531055,0.000025273164,0.000022307939],"genre_scores_gemma":[0.99704933,0.0017807736,0.00007150553,0.00060343096,0.00007360054,0.00004905542,0.00006130039,0.000011139079,0.0002998824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977603,0.00045927917,0.0009139727,0.00025054775,0.00035877933,0.00025713557],"domain_scores_gemma":[0.9982233,0.0005970014,0.00066822686,0.00019295214,0.00009775634,0.00022078342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022054198,0.00009890095,0.00076953386,0.0002368346,0.00005066469,0.000004646023,0.000041634554,0.00010770708,0.00012718841],"category_scores_gemma":[0.0004102636,0.0000788736,0.00009013329,0.00084723707,0.000019101228,0.000059475442,0.000018030987,0.00010712821,0.0000039470765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003067308,0.000038117105,0.9853524,0.00027887055,0.00026412122,1.8051385e-7,0.00070659426,0.00004142852,0.000004796333,0.000080655656,0.00031390126,0.012888251],"study_design_scores_gemma":[0.0008714088,0.00009426965,0.9979317,0.00038911065,0.000103420614,9.798444e-8,0.000032895565,0.00015545427,0.000009982886,0.00016485079,0.00017183663,0.000074968884],"about_ca_topic_score_codex":0.46744704,"about_ca_topic_score_gemma":0.02632993,"teacher_disagreement_score":0.4411171,"about_ca_system_score_codex":0.0011937408,"about_ca_system_score_gemma":0.0004590717,"threshold_uncertainty_score":0.991437},"labels":[],"label_agreement":null},{"id":"W2317105954","doi":"10.1016/j.jval.2014.08.288","title":"Minimum Clinically Important Difference in the Calgary Depression Scale for Schizophrenia","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Schizophrenia (object-oriented programming); Depression (economics); Scale (ratio); Psychiatry; Psychology; Clinical psychology; Medicine; Geography; Cartography; Economics; Keynesian economics","score_opus":0.04792377707150689,"score_gpt":0.3558825864731058,"score_spread":0.30795880940159887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317105954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98974997,0.00092257484,0.00041314156,0.0070194686,0.00011316314,0.0015995159,0.000009107226,0.000024400524,0.00014864033],"genre_scores_gemma":[0.98779905,0.0003847559,0.010137283,0.0011604433,0.00016420792,0.00025460598,0.00003198853,0.000017694774,0.00004997074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974692,0.00042562213,0.00082068535,0.0003754356,0.00038280687,0.00052627455],"domain_scores_gemma":[0.99784744,0.0012264408,0.00013942286,0.0004900601,0.000035516543,0.00026112396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026168944,0.00014601974,0.0003964755,0.00013855123,0.00008946141,0.00001685417,0.00018788177,0.00009364343,0.000010678122],"category_scores_gemma":[0.0008341246,0.000085831736,0.00009348939,0.00022671714,0.00006045696,0.000025429592,0.000040338295,0.00037725957,0.00001117609],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0157777,0.0013482044,0.8491293,0.00045404118,0.000016249875,0.000060704602,0.0006421998,0.000023519558,0.00016472675,0.0024484093,0.0004875506,0.12944737],"study_design_scores_gemma":[0.010703757,0.0021474315,0.9478433,0.00062463613,0.000011854612,0.000036467973,0.000075233926,0.030763013,0.0000814674,0.0071857125,0.0004138338,0.00011327304],"about_ca_topic_score_codex":0.0018213223,"about_ca_topic_score_gemma":0.00081189664,"teacher_disagreement_score":0.1293341,"about_ca_system_score_codex":0.00012339398,"about_ca_system_score_gemma":0.0006059027,"threshold_uncertainty_score":0.35001165},"labels":[],"label_agreement":null},{"id":"W2317694604","doi":"10.1016/j.jval.2014.08.1447","title":"Impact Of A Pharmacological Cardioversion With Vernakalant On The Management Cost Of Recent Atrial Fibrillation In Belgium","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cardiome (Canada)","funders":"","keywords":"Amiodarone; Medicine; Cardioversion; Atrial fibrillation; Sinus rhythm; Emergency department; Internal medicine; Cardiology; Anesthesia","score_opus":0.10577330563873298,"score_gpt":0.38508923422199165,"score_spread":0.27931592858325865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317694604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940895,0.00005881589,0.00008322655,0.002968514,0.00013580717,0.0013913333,0.0000038767284,0.000008916022,0.0012600117],"genre_scores_gemma":[0.9985035,0.0009970274,0.00015705478,0.000073591524,0.0002220471,0.0000011424978,0.000009391423,0.0000065442055,0.000029708426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875176,0.00024748742,0.00038050156,0.00013927527,0.00032211054,0.00015886869],"domain_scores_gemma":[0.9993142,0.0002556156,0.00020854306,0.00014824975,0.000027582322,0.00004584579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009924368,0.000087453554,0.0003323225,0.00015852372,0.000021913544,0.0000026513553,0.00004614405,0.00003324946,0.00005726746],"category_scores_gemma":[0.000052190564,0.000049403934,0.000120779994,0.00034238445,0.000025388377,0.000023883702,0.000028618151,0.00008319286,0.000003283427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004030734,0.000016803664,0.79960686,0.00015952499,0.00014957621,0.000003693239,0.00016535896,0.18084043,0.00003918266,0.0020122896,0.00022202451,0.012753534],"study_design_scores_gemma":[0.004799402,0.0016341547,0.9763923,0.00026595016,0.00006620547,0.0000012341831,0.00006724799,0.013378417,0.00006293359,0.00008540836,0.0031857078,0.00006099669],"about_ca_topic_score_codex":0.000788755,"about_ca_topic_score_gemma":0.000005954772,"teacher_disagreement_score":0.1767855,"about_ca_system_score_codex":0.0002822897,"about_ca_system_score_gemma":0.00006345289,"threshold_uncertainty_score":0.2014634},"labels":[],"label_agreement":null},{"id":"W2317727536","doi":"10.1016/j.jval.2014.08.404","title":"Assesing the Impact of Patent Loss on Overall Revenues and Stocks Price of Pharmaceutical Companies","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Revenue; Total revenue; Business; Quarter (Canadian coin); Stock price; Stock (firearms); Agricultural economics; Commerce; Finance; Economics; Engineering","score_opus":0.2048130438536943,"score_gpt":0.3792123093480543,"score_spread":0.17439926549435997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2317727536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939631,0.0015818621,0.00009323097,0.001938517,0.00009201135,0.00019333904,0.00011220255,0.0000058568744,0.0020198564],"genre_scores_gemma":[0.99763,0.0015551677,0.000081386424,0.00065432244,0.00005507687,0.0000033735143,0.0000017329035,0.000010416023,0.000008526566],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9988449,0.00008666387,0.0006247261,0.00017288789,0.000025628326,0.00024517666],"domain_scores_gemma":[0.9990078,0.00034299697,0.00036092097,0.00017877817,0.00001134081,0.0000981343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001327657,0.000096467535,0.0004025583,0.00011402926,0.000040448358,0.000014153758,0.00012682617,0.00003995439,0.000028440316],"category_scores_gemma":[0.00011503014,0.00008091013,0.00007601821,0.000091261805,0.00009187094,0.000051028066,0.00004158809,0.00018067757,0.000008928402],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018944491,0.00045595563,0.29614702,0.00056586857,0.000094206225,8.6042724e-7,0.0020438826,0.04244609,0.000050350518,0.6515728,0.0008908175,0.005542689],"study_design_scores_gemma":[0.0017698825,0.0008026655,0.47992992,0.00021342818,0.000004996608,0.000006595465,0.00002181826,0.37796497,0.00013544579,0.12647489,0.0124172,0.00025818413],"about_ca_topic_score_codex":0.0034384488,"about_ca_topic_score_gemma":0.0000048257743,"teacher_disagreement_score":0.52509797,"about_ca_system_score_codex":0.00012191559,"about_ca_system_score_gemma":0.0000447731,"threshold_uncertainty_score":0.51979285},"labels":[],"label_agreement":null},{"id":"W2318080223","doi":"10.1016/j.jval.2012.03.234","title":"PMS45 Parents' Preferences for Drug Treatments in Juvenile Idiopathic Arthritis: A Discrete Choice Experiment","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Cancer Agency; Hospital for Sick Children","funders":"","keywords":"Multinomial logistic regression; Medicine; Arthritis; Preference; Juvenile; Discrete choice; Mixed logit; Physical therapy; Sample (material); Logistic regression; Demography; Internal medicine; Statistics","score_opus":0.13427478666760834,"score_gpt":0.43975025230582604,"score_spread":0.3054754656382177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2318080223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9498594,0.039457016,0.00007269982,0.0035651252,0.0019727037,0.004564271,0.00013384927,0.00009057981,0.0002843958],"genre_scores_gemma":[0.9918793,0.0032867177,0.00044122647,0.0009459225,0.0011935219,0.0017991735,0.000076941076,0.00004262962,0.00033458203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942043,0.0017919502,0.0015531018,0.00042667697,0.00032851507,0.001695494],"domain_scores_gemma":[0.9979347,0.0006569198,0.00046677387,0.0003397771,0.000051441795,0.00055038807],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027699664,0.00027516414,0.00070055673,0.00024075877,0.00047053295,0.00000795441,0.00019750673,0.0002263177,0.000064449385],"category_scores_gemma":[0.0002932942,0.0002454179,0.00007874579,0.00035813233,0.000025497711,0.00025280906,0.000077047094,0.0006932185,0.00009942419],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009479151,0.00035614555,0.96018744,0.0015346537,0.0000060601405,0.0000015333991,0.029247046,0.0000251643,0.0000025874053,0.00038275932,0.0014969124,0.006664925],"study_design_scores_gemma":[0.014847079,0.0010314691,0.8722669,0.01258451,0.00002600396,0.0000031539093,0.038622215,0.0010889508,0.000047963516,0.0023404926,0.056043345,0.0010979117],"about_ca_topic_score_codex":0.033512536,"about_ca_topic_score_gemma":0.0037197287,"teacher_disagreement_score":0.08792052,"about_ca_system_score_codex":0.0012285087,"about_ca_system_score_gemma":0.0012979768,"threshold_uncertainty_score":0.9999998},"labels":[],"label_agreement":null},{"id":"W2319188720","doi":"10.1016/j.jval.2014.08.308","title":"Examining Opioid-Dependent Chronic Pain Patients Experiences On Buprenorphine Maintenance Therapy In The Texas Workers Compensation System: Pilot Study - Part 2","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chronic pain; Brief Pain Inventory; Beck Depression Inventory; Physical therapy; Depression (economics); Visual analogue scale; McGill Pain Questionnaire; Buprenorphine; Anxiety; Opioid; Internal medicine; Psychiatry","score_opus":0.06003061404178575,"score_gpt":0.29561340347083476,"score_spread":0.235582789429049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319188720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99448735,0.0005606228,0.000038308433,0.00071002316,0.0003970455,0.003510422,0.0000025439276,0.000051661147,0.00024200112],"genre_scores_gemma":[0.99818385,0.00016344244,0.000053087864,0.00077712367,0.000120807,0.00061266235,0.00003094386,0.000027438122,0.000030667426],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99589366,0.0018331421,0.0006837806,0.00047593637,0.0006389108,0.00047457434],"domain_scores_gemma":[0.99858016,0.00050319615,0.00024275787,0.000541668,0.00003957427,0.00009262767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033549708,0.00024221637,0.00043393834,0.0001799025,0.000116831405,0.000029487857,0.00020626142,0.000036082478,0.000018029195],"category_scores_gemma":[0.00015883768,0.00015719049,0.000026576134,0.00035051667,0.00004226623,0.000056301422,0.000023697197,0.00025752472,0.000024397892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003825746,0.0036522965,0.94559556,0.0002368168,0.000020871812,0.000012128809,0.037368763,0.0019471335,0.000002340938,0.00011989814,0.000114599665,0.010547023],"study_design_scores_gemma":[0.007540401,0.031714335,0.90049624,0.0016949893,0.000007792809,0.0000021642581,0.05372886,0.0043598847,0.000007569063,0.000017565164,0.00026981797,0.00016034802],"about_ca_topic_score_codex":0.009917215,"about_ca_topic_score_gemma":0.000618053,"teacher_disagreement_score":0.04509928,"about_ca_system_score_codex":0.0010939054,"about_ca_system_score_gemma":0.00023790958,"threshold_uncertainty_score":0.99667585},"labels":[],"label_agreement":null},{"id":"W2319467302","doi":"10.1016/j.jval.2014.08.1859","title":"Development Of A Model To Assess The Cost-Effectiveness Of Therapies For Patients With Type 2 Diabetes Mellitus (T2DM) Following A Reference Model Framework","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Comparability; Credibility; Construct (python library); Identification (biology); Consistency (knowledge bases); Computer science; Systematic review; Risk analysis (engineering); Health care; Logic model; Management science; Medicine; MEDLINE; Artificial intelligence; Engineering","score_opus":0.49757006457306285,"score_gpt":0.43968782400359224,"score_spread":0.05788224056947061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2319467302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78659314,0.0005575754,0.2096766,0.0008027445,0.00013000879,0.0020824166,0.00007974033,0.000010212697,0.00006757926],"genre_scores_gemma":[0.8666956,0.000028179235,0.13175748,0.0010253176,0.0000148294575,0.00043065046,0.000017030137,0.000025046382,0.000005881546],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9963841,0.00047228183,0.0022691546,0.00036998384,0.00012621237,0.00037829657],"domain_scores_gemma":[0.99496627,0.0031135688,0.0012432253,0.00042106057,0.00015149586,0.000104359075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018842561,0.00015622746,0.0009350678,0.00020625735,0.00013058414,0.000017276385,0.00028052912,0.00009593635,0.00000262793],"category_scores_gemma":[0.0023392078,0.00014019667,0.000051613122,0.0002786841,0.000031666612,0.00013244512,0.000038735638,0.00012865826,0.0000088725665],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020193166,0.0003931818,0.17145805,0.0035601563,0.0001400755,1.5260945e-8,0.015313767,0.56715465,0.0000069987645,0.23932399,0.00009394182,0.0023532412],"study_design_scores_gemma":[0.0013401755,0.00047486284,0.056843136,0.0017198309,0.0000062533595,3.211854e-8,0.00041884984,0.8715925,0.000040604464,0.06597009,0.0012608686,0.00033280347],"about_ca_topic_score_codex":0.00027999474,"about_ca_topic_score_gemma":0.00004684276,"teacher_disagreement_score":0.30443785,"about_ca_system_score_codex":0.0004356665,"about_ca_system_score_gemma":0.0005956552,"threshold_uncertainty_score":0.65304935},"labels":[],"label_agreement":null},{"id":"W2320313413","doi":"10.1016/j.jval.2014.03.538","title":"Sandostatin Lar Patient Journey","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Medicine and Dermatology Studies History","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Pediatrics; Surgery; Internal medicine; General surgery","score_opus":0.040451993657536156,"score_gpt":0.3070610992098326,"score_spread":0.26660910555229644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320313413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85451114,0.01132453,0.0006273702,0.041696005,0.0012544681,0.00079281756,0.000003298837,0.00010302122,0.08968735],"genre_scores_gemma":[0.9002784,0.000736012,0.0022451803,0.09618513,0.00020790055,0.00002072749,0.000009800203,0.00001993436,0.00029693183],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9988072,0.00020546277,0.0003919445,0.00015302659,0.0001775236,0.0002648646],"domain_scores_gemma":[0.99934065,0.00015449608,0.00010171321,0.00019171293,0.000030757546,0.0001806531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005161937,0.00008267333,0.0003539985,0.00012638766,0.00007220118,0.0000012280318,0.000031303112,0.00004408602,0.00002492566],"category_scores_gemma":[0.00028942994,0.00006631095,0.000031701904,0.00011346527,0.000056569654,0.000014980274,0.00001627751,0.00022381413,0.0000676646],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026778862,0.00044410705,0.12185193,0.0013446086,0.00004656978,0.0002169154,0.010320969,0.00017337826,0.00005773866,0.0033511505,0.8236026,0.03832223],"study_design_scores_gemma":[0.0036628272,0.001454901,0.01876027,0.0005689024,0.00001222273,0.0001440896,0.0009840787,0.002320683,0.00005024636,0.00037714356,0.9715381,0.00012649175],"about_ca_topic_score_codex":0.0004554069,"about_ca_topic_score_gemma":0.000011964154,"teacher_disagreement_score":0.14793552,"about_ca_system_score_codex":0.00012572063,"about_ca_system_score_gemma":0.00018030895,"threshold_uncertainty_score":0.27040824},"labels":[],"label_agreement":null},{"id":"W2320786904","doi":"10.1016/j.jval.2012.03.278","title":"PMS89 Simulation Modeling with System Dynamics (SD) Using Real-World Observational Data to Plan Osteoarthritis Care Delivery in Alberta","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Alberta Health Services; Alberta Bone and Joint Health Institute; University of Saskatchewan; University of Calgary","funders":"","keywords":"Observational study; Health care; Process management; Operations management; Medicine; Engineering","score_opus":0.659170241629875,"score_gpt":0.4448800553627272,"score_spread":0.21429018626714785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2320786904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97255,0.0015771759,0.018044446,0.0042440547,0.0005795271,0.0015600086,0.0008314889,0.000042311545,0.0005710319],"genre_scores_gemma":[0.983735,0.000044077726,0.0132283205,0.0017647699,0.00032216593,0.00005017886,0.00077022007,0.000054048698,0.00003118614],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9941395,0.00054407143,0.0037374953,0.0006756163,0.00016749994,0.0007357991],"domain_scores_gemma":[0.9965282,0.0011267605,0.0011269844,0.00082872127,0.000075422715,0.00031392893],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010169413,0.00022684161,0.0009048054,0.0007776664,0.00019241196,0.000060932216,0.00036165066,0.00012402146,0.0000150931955],"category_scores_gemma":[0.000673013,0.00030348767,0.00003399148,0.00062203116,0.0000181018,0.001119838,0.00012086321,0.0002386552,0.00012341389],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022740029,0.000026975076,0.30038533,0.0006276033,0.000005688012,5.5919605e-7,0.0026631719,0.66258323,7.487493e-8,0.03354321,0.000026522239,0.00011488915],"study_design_scores_gemma":[0.0006964074,0.000056767123,0.026348919,0.001006071,0.0000025660227,0.000003547284,0.00278181,0.96812445,7.485271e-8,0.00016664759,0.00052914233,0.00028359095],"about_ca_topic_score_codex":0.25490448,"about_ca_topic_score_gemma":0.08475819,"teacher_disagreement_score":0.30554122,"about_ca_system_score_codex":0.005099646,"about_ca_system_score_gemma":0.0006125529,"threshold_uncertainty_score":0.9999417},"labels":[],"label_agreement":null},{"id":"W2321364635","doi":"10.1016/j.jval.2015.03.1301","title":"Financial impacts of using Omeprazole oral suspension for preventing upper Gastrointestinal bleeding early after Intensive Care admission","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Omeprazole; Pantoprazole; Medicine; Upper gastrointestinal bleeding; Proton-pump inhibitor; Gastrointestinal bleeding; Pharmacy; Intensive care unit; Intensive care; Randomized controlled trial; Clinical trial; Emergency medicine; Intensive care medicine; Internal medicine; Endoscopy; Nursing","score_opus":0.08354942885343165,"score_gpt":0.3516670995337875,"score_spread":0.26811767068035586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321364635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972151,0.0007608118,0.00026457512,0.0005863437,0.0001718571,0.0009458059,0.000014929477,0.000025065887,0.000015505684],"genre_scores_gemma":[0.95198554,0.000008843721,0.0475742,0.00020348659,0.00014260781,0.000025776966,0.000017008082,0.000031019703,0.000011504331],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981729,0.000067024885,0.000594385,0.00032204654,0.00029778868,0.0005459028],"domain_scores_gemma":[0.9980515,0.00014191777,0.0002922978,0.00016133681,0.000980072,0.00037285223],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059982087,0.0002060717,0.00051742385,0.0002359417,0.000061349034,0.000015178582,0.00005377063,0.00004944258,0.0000066840416],"category_scores_gemma":[0.002412574,0.00017535391,0.00013021276,0.00021694071,0.0000372589,0.00010895867,0.000064971515,0.00020374412,0.0000026721473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011107776,0.00017304823,0.99216324,0.00073067856,0.000008274453,0.0000789926,0.0026207075,0.0005549245,0.00159327,0.0000452483,0.00018736058,0.0007334837],"study_design_scores_gemma":[0.01021418,0.013732582,0.91149145,0.035060897,0.00019898204,0.0013620458,0.008565165,0.013191374,0.0053033987,0.00042334208,0.00008877913,0.00036780635],"about_ca_topic_score_codex":0.0031528622,"about_ca_topic_score_gemma":0.00003152068,"teacher_disagreement_score":0.08067179,"about_ca_system_score_codex":0.00060509297,"about_ca_system_score_gemma":0.0009097588,"threshold_uncertainty_score":0.7150725},"labels":[],"label_agreement":null},{"id":"W2321369595","doi":"10.1016/j.jval.2013.03.742","title":"A Comparison Of Medical Computed Tomographic Utilization And Potential Related Cancer Risks In The United States And In Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Pelvis; Population; Nuclear medicine; Demography; Abdomen; Computed tomography; Radiology; Environmental health","score_opus":0.07496348365208488,"score_gpt":0.37450306100223674,"score_spread":0.29953957735015185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321369595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9830276,0.0025745183,0.000021209667,0.013975418,0.000045180605,0.00034411752,0.0000027652768,0.000003922964,0.0000052643773],"genre_scores_gemma":[0.9956292,0.0032907187,0.000022908464,0.000997099,0.000008042395,0.000008675737,0.00003860564,0.0000040905556,6.6124363e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988667,0.00024256975,0.00039850024,0.00009905897,0.000257436,0.00013573101],"domain_scores_gemma":[0.99962634,0.000121680176,0.000090335925,0.000062443905,0.000023783708,0.000075397584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047227,0.00005221582,0.00019684316,0.00026609644,0.000020977564,0.0000068252934,0.000039558752,0.000037876634,0.00002309943],"category_scores_gemma":[0.000057954807,0.000039603146,0.0000052969044,0.0006898934,0.00003877748,0.000037395275,0.000010809418,0.0002236592,9.087196e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013368753,0.000041440784,0.9812739,0.00010749477,0.0000047627605,0.0000052903815,0.00222136,0.008499514,0.0000037708437,0.000032275246,0.0002636492,0.007533191],"study_design_scores_gemma":[0.00062875473,0.00002075757,0.52625287,0.0001836402,0.0000018613844,0.0000036582012,0.0008532618,0.47195292,0.0000042294982,0.000038703143,0.000042001193,0.000017382134],"about_ca_topic_score_codex":0.9909958,"about_ca_topic_score_gemma":0.6197533,"teacher_disagreement_score":0.46345338,"about_ca_system_score_codex":0.00010515831,"about_ca_system_score_gemma":0.0006450632,"threshold_uncertainty_score":0.38718522},"labels":[],"label_agreement":null},{"id":"W2321379008","doi":"10.1016/j.jval.2014.08.191","title":"Drug Utilization Review of Acid Suppressants (Durable) – an Audit to Assess the Utilization of Proton Pump Inhibitors and Histamine H2-Receptor Antagonists in Canadian Hospitals","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Nosocomial Infections in ICU","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Bolus (digestion); Internal medicine; Proton-pump inhibitor; Drug; Gastroenterology; Pharmacology","score_opus":0.059823437321906224,"score_gpt":0.35758435217423856,"score_spread":0.29776091485233236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321379008","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857188,0.0030200188,0.00008992354,0.0057888743,0.0003487449,0.004716316,0.00005000564,0.000019310683,0.00024803492],"genre_scores_gemma":[0.9901542,0.008308505,0.0003463838,0.0008095464,0.000076379816,0.00016205212,0.00009450639,0.000025073417,0.000023324359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976489,0.0006413043,0.00084336114,0.00027728587,0.00027073285,0.0003184163],"domain_scores_gemma":[0.9987035,0.000109220906,0.0003124188,0.0004122437,0.00019511841,0.00026753198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025825482,0.00014577659,0.0004957318,0.00036739928,0.00007242619,0.000010125688,0.00011240865,0.00007960483,0.00004857417],"category_scores_gemma":[0.0012751897,0.00012110296,0.000028848897,0.0008183382,0.00008687541,0.0001403892,0.000029451485,0.0001779405,0.0000022545103],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013141544,0.0006107607,0.9127551,0.03842711,0.000025080622,0.0000036500307,0.0033173794,0.00047178703,0.011178651,0.002383848,0.007907068,0.022788169],"study_design_scores_gemma":[0.0040342733,0.0032334134,0.5162214,0.069764756,0.00009458899,0.00004655055,0.00075914053,0.006037178,0.28006056,0.00045229512,0.11850489,0.00079092477],"about_ca_topic_score_codex":0.22577763,"about_ca_topic_score_gemma":0.057345055,"teacher_disagreement_score":0.39653367,"about_ca_system_score_codex":0.00053006725,"about_ca_system_score_gemma":0.000784623,"threshold_uncertainty_score":0.9598559},"labels":[],"label_agreement":null},{"id":"W2321480971","doi":"10.1016/j.jval.2014.03.935","title":"Cost Effectiveness Of Hysteroscopic Tubal Sterilization (Hts) Compared To Laparoscopic Tubal Sterilization (Lts) For Permanent Birth Control","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Gynecological conditions and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Protocol (science); Medicine; Sterilization (economics); Laparoscopy; Family planning; Operations management; Gynecology; Obstetrics; Surgery; Business; Population; Environmental health; Research methodology; Economics","score_opus":0.06471390297819084,"score_gpt":0.35544872890796697,"score_spread":0.2907348259297761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321480971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9669779,0.000053499676,0.02826571,0.00020667758,0.00029617318,0.0039346977,0.00014133345,0.000033050874,0.000090961206],"genre_scores_gemma":[0.99823326,0.000005385234,0.00062445324,0.00036915758,0.000024933744,0.0003551182,0.0003195494,0.000018446379,0.000049725782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982124,0.0004868326,0.0005045348,0.00031193608,0.00018373903,0.0003005509],"domain_scores_gemma":[0.99885195,0.0004595963,0.00015099632,0.00022844534,0.00013040239,0.0001786126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005522546,0.00015955692,0.0006125051,0.00015873418,0.00007711608,0.000014026347,0.000064419495,0.0000763168,0.00003618105],"category_scores_gemma":[0.00020369988,0.0001358999,0.00005609018,0.0002234401,0.000034430926,0.000056467536,0.000019124793,0.00006364139,0.000017392824],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016187838,0.0018549515,0.9525717,0.00666728,0.00010336176,0.0000046670593,0.00065474526,0.024403395,0.005871232,0.003019712,0.0000574026,0.0031727608],"study_design_scores_gemma":[0.012334432,0.0037295457,0.9558531,0.0009753182,0.000042241063,0.0000020552798,0.000054722,0.024986476,0.0012980881,0.0002522313,0.0003517999,0.00011999491],"about_ca_topic_score_codex":0.00032095436,"about_ca_topic_score_gemma":0.00006892729,"teacher_disagreement_score":0.031255335,"about_ca_system_score_codex":0.00033319995,"about_ca_system_score_gemma":0.00012215454,"threshold_uncertainty_score":0.5541837},"labels":[],"label_agreement":null},{"id":"W2321591904","doi":"10.1016/j.jval.2012.03.1071","title":"PIH39 Eliciting Preferences to the EQ-5D-5L Health States: Discrete Choice Experiment or Multiprofile Case of Best-Worst Scaling","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Intraclass correlation; Statistics; Set (abstract data type); Task (project management); Random effects model; Psychology; EQ-5D; Mathematics; Test (biology); Computer science; Medicine; Psychometrics; Meta-analysis","score_opus":0.5606600062268362,"score_gpt":0.47342971996031075,"score_spread":0.08723028626652546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321591904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9434858,0.012063574,0.0022732369,0.03757967,0.0009841244,0.0026391018,0.00065042835,0.000047132122,0.0002769356],"genre_scores_gemma":[0.97908264,0.00059255667,0.008340775,0.010780742,0.0006399391,0.00035238868,0.000035660694,0.00005081277,0.00012450652],"study_design_codex":"qualitative","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9909983,0.0013130906,0.0057255076,0.0006051336,0.00016596237,0.0011919806],"domain_scores_gemma":[0.99290246,0.002784454,0.0029299478,0.0007035848,0.000056935107,0.00062260934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.028438777,0.00028115747,0.0012664412,0.0003981465,0.00048566182,0.00006228061,0.0003718313,0.00010354491,0.00020740877],"category_scores_gemma":[0.0031459585,0.00025376835,0.00011498287,0.0004956899,0.00006914722,0.00043004163,0.0001252715,0.00031342733,0.00037156584],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022901788,0.0016853603,0.35798287,0.010571518,0.00025084603,0.00001248824,0.3974391,0.14400032,0.000006593141,0.04732946,0.020581612,0.019910833],"study_design_scores_gemma":[0.0071292752,0.0041028145,0.05000513,0.008555892,0.000030406522,0.00030780616,0.29323694,0.4200439,0.00020862692,0.0055383276,0.20736475,0.003476139],"about_ca_topic_score_codex":0.18262993,"about_ca_topic_score_gemma":0.003652505,"teacher_disagreement_score":0.30797774,"about_ca_system_score_codex":0.0013467361,"about_ca_system_score_gemma":0.0006028251,"threshold_uncertainty_score":0.9999915},"labels":[],"label_agreement":null},{"id":"W2321778362","doi":"10.1016/j.jval.2014.03.1541","title":"Cost Implications Of Early Discontinuation And Restart Of Insulin In The Treatment Of Type 2 Diabetes Mellitus","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Discontinuation; Insulin; Emergency department; Diabetes mellitus; Emergency medicine; Type 2 diabetes; Medical costs; Type 2 Diabetes Mellitus; Drug; Cohort; Ambulatory care; Health care; Intensive care medicine; Internal medicine; Endocrinology; Pharmacology","score_opus":0.20986195255704124,"score_gpt":0.4337609850629297,"score_spread":0.22389903250588847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321778362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938102,0.0017847193,0.000010051575,0.003682714,0.000024391751,0.00052216905,0.000008167113,0.000001487347,0.00015611548],"genre_scores_gemma":[0.9971996,0.0024490592,0.00018430366,0.00013111664,0.000010306438,0.000010172948,0.000008191119,0.0000026883365,0.000004587708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992722,0.0001927371,0.00031070207,0.0000647305,0.000080833204,0.00007876434],"domain_scores_gemma":[0.998988,0.0006775831,0.00015060972,0.00012921018,0.000028136415,0.00002646393],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047281894,0.000038083333,0.00018542729,0.00005595764,0.000009213949,0.0000012655926,0.000026273297,0.00001843453,0.0000032812147],"category_scores_gemma":[0.00015288084,0.000023988807,0.00001551973,0.00015632357,0.00003899892,0.000029524768,0.000003961797,0.000044258013,4.5808048e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010889945,0.0005886175,0.9562902,0.00018110944,0.000007839269,7.73961e-8,0.0032368763,0.00007367345,0.00021871181,0.0019292623,0.0000064109727,0.037358355],"study_design_scores_gemma":[0.0010868516,0.0021587943,0.99040407,0.00012180146,0.000018492039,2.5468208e-7,0.000121097444,0.0028915422,0.0004895174,0.00068105274,0.0020046143,0.000021935071],"about_ca_topic_score_codex":0.0016704263,"about_ca_topic_score_gemma":0.00005612736,"teacher_disagreement_score":0.03733642,"about_ca_system_score_codex":0.000025565403,"about_ca_system_score_gemma":0.000046421665,"threshold_uncertainty_score":0.2525196},"labels":[],"label_agreement":null},{"id":"W2321815323","doi":"10.1016/j.jval.2014.08.916","title":"Humanistic Research Outcomes in Multiple Sclerosis: Review of the Literature from Latin America","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Quality of life (healthcare); Anxiety; Mental health; Cognition; Medicine; Latin Americans; MEDLINE; Depression (economics); Gerontology; Clinical psychology; Psychiatry; Psychology; Nursing","score_opus":0.27839139513768657,"score_gpt":0.42114285717501887,"score_spread":0.1427514620373323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2321815323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.842153,0.095624484,0.000018129265,0.056504406,0.00026406388,0.004348743,0.00016173802,0.0000467827,0.0008786449],"genre_scores_gemma":[0.94406056,0.05245415,0.0011037593,0.0020181634,0.000087141736,0.00012977075,0.00001895845,0.00002249827,0.00010501249],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99512553,0.0021041366,0.0008103086,0.00037219888,0.0010157371,0.0005721047],"domain_scores_gemma":[0.99592996,0.0027028038,0.00017504372,0.0008160436,0.0002341139,0.00014206512],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0034694234,0.0001541754,0.0008172044,0.00025979607,0.00013972231,0.000014922411,0.00031218576,0.000068200396,0.000049581806],"category_scores_gemma":[0.014509924,0.00009688234,0.00010922367,0.0012701042,0.00026175458,0.000040098974,0.00023876085,0.0009791811,0.000021108073],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009762918,0.000568129,0.95493066,0.01666198,0.00003890546,0.000004045704,0.0040398086,0.00008645477,0.0011060345,0.00023755406,0.0054851947,0.01674362],"study_design_scores_gemma":[0.0012103472,0.000204612,0.9317798,0.061112102,0.000004249297,3.2425973e-7,0.00014482225,0.0019161416,0.00006218229,0.00017289452,0.003319993,0.0000725074],"about_ca_topic_score_codex":0.014837136,"about_ca_topic_score_gemma":0.0005832847,"teacher_disagreement_score":0.10190754,"about_ca_system_score_codex":0.00030637273,"about_ca_system_score_gemma":0.0002627304,"threshold_uncertainty_score":0.9937913},"labels":[],"label_agreement":null},{"id":"W2322121107","doi":"10.1016/j.jval.2013.03.1236","title":"Rsv Hospitalization In Infants With Neuromuscular Disease In The Canadian Registry Of Synagis® (Caress) Following Prophylaxis (2005-2012)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Gestational age; Hazard ratio; Observational study; Atopy; Respiratory system; Internal medicine; Asthma; Pregnancy","score_opus":0.030431733453145638,"score_gpt":0.3162749531770787,"score_spread":0.28584321972393306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322121107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944262,0.00086628634,0.0000124633225,0.002271479,0.00007288681,0.0020425308,0.000005977463,0.00001053249,0.00029167772],"genre_scores_gemma":[0.9990794,0.000057235346,0.0000644603,0.0004970173,0.000035369038,0.00019037715,0.000014001967,0.000022495446,0.00003962757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977169,0.0005490186,0.00046402373,0.00026932385,0.00050105545,0.0004996524],"domain_scores_gemma":[0.9988511,0.00007531834,0.000089496636,0.0005674578,0.00008641355,0.00033022216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001101597,0.00012316332,0.0002579409,0.0006661894,0.00007784336,0.000037097714,0.00016500893,0.000080373095,0.000029198538],"category_scores_gemma":[0.0007255712,0.00008878328,0.000040362214,0.0012275736,0.00007572655,0.00022769134,0.000019272284,0.00045371833,0.000009752756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043917407,0.00014424855,0.99281347,0.0004426504,0.0000069278312,0.00020661109,0.0005426162,0.0044558877,0.000038174298,0.00012947206,0.00013710966,0.0010389063],"study_design_scores_gemma":[0.0008757848,0.00051894906,0.9933748,0.000550384,0.0000045539364,0.000004477749,0.00016860968,0.003848195,0.000018240215,0.00010545419,0.00044055397,0.00008998416],"about_ca_topic_score_codex":0.7032965,"about_ca_topic_score_gemma":0.2875611,"teacher_disagreement_score":0.4157354,"about_ca_system_score_codex":0.00063359214,"about_ca_system_score_gemma":0.0023834966,"threshold_uncertainty_score":0.7254391},"labels":[],"label_agreement":null},{"id":"W2322499817","doi":"10.1016/j.jval.2012.03.1257","title":"PCN140 Managing the Risk of Exposure to Low-Ionizing Radiation in Canada: A Population Model","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Ionizing radiation; Medicine; Radiation exposure; Medical radiation; Environmental health; Population; Radiation protection; Nuclear medicine; Medical physics; Irradiation","score_opus":0.029871809854959665,"score_gpt":0.28016753188024995,"score_spread":0.25029572202529027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322499817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927743,0.0012762335,0.0010436976,0.0042558257,0.00013464499,0.00039824436,0.000003902889,0.000007205583,0.00010593866],"genre_scores_gemma":[0.9980806,0.00019954059,0.0005789299,0.0010044033,0.00008724132,0.000016200403,0.000009625791,0.000010065108,0.000013381251],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892336,0.00014078464,0.00038671235,0.00009696492,0.00020550116,0.00024664754],"domain_scores_gemma":[0.99951065,0.00007577649,0.0001414706,0.00015978453,0.000014673702,0.00009763723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093670987,0.00006210206,0.00016318017,0.00017377653,0.000047377573,0.000004046927,0.00004260752,0.000019156234,0.0000046500554],"category_scores_gemma":[0.00015416386,0.000051065774,0.000017969234,0.00034130356,0.0000041569656,0.00012659449,0.000010696104,0.00014890847,0.0000014970748],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011569473,0.000014711244,0.5928786,0.000060234328,0.0000025042957,3.6630615e-7,0.0018965268,0.38931346,0.000013831737,0.0002571958,0.00008263199,0.015468377],"study_design_scores_gemma":[0.00028393907,0.000015032187,0.6389392,0.00014285199,0.0000041075514,0.0000015248148,0.00033151192,0.36005643,0.00003974832,0.000088073015,0.0000644789,0.000033124885],"about_ca_topic_score_codex":0.8815541,"about_ca_topic_score_gemma":0.17393729,"teacher_disagreement_score":0.7076168,"about_ca_system_score_codex":0.0009994728,"about_ca_system_score_gemma":0.0005850416,"threshold_uncertainty_score":0.8411362},"labels":[],"label_agreement":null},{"id":"W2322803466","doi":"10.1016/j.jval.2015.03.272","title":"Cost-effectiveness analyses of Lung Cancer screening strategies using low dose computed tomography – a systematic review","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Simon Fraser University; University of British Columbia","funders":"","keywords":"Medicine; Lung cancer screening; Lung cancer; Quality-adjusted life year; Stage (stratigraphy); MEDLINE; Systematic review; Cost effectiveness; Cancer; Intensive care medicine; Oncology; Internal medicine; Risk analysis (engineering)","score_opus":0.35035322040226513,"score_gpt":0.5270772850067253,"score_spread":0.17672406460446022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2322803466","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000042695454,0.9850888,0.0002249424,0.000037249243,0.00019607012,0.014245833,0.00011266454,0.00003635139,0.000015392789],"genre_scores_gemma":[0.00033234074,0.99690187,0.0006514441,0.0000973863,0.00008064955,0.0017493864,0.000121091776,0.000063957385,0.0000018575608],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9945452,0.0020245737,0.0019086297,0.0005389073,0.00055741984,0.00042524378],"domain_scores_gemma":[0.99655557,0.0006390123,0.0016214136,0.00064262573,0.00027845657,0.00026292627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021524949,0.00053967675,0.0075241746,0.0006088267,0.000052828516,0.000026509642,0.0001737259,0.0001677762,0.000009806186],"category_scores_gemma":[0.00008429457,0.00036825877,0.000742708,0.0017625649,0.000055630615,0.00008386852,0.00005293366,0.0003447263,0.0000011264412],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013636768,0.00021513276,0.0003698707,0.9770529,0.0013402674,0.00003878788,0.00006046652,0.001249625,3.0644312e-8,0.000024462955,0.00005602734,0.019578792],"study_design_scores_gemma":[0.00081971457,0.00016688826,0.00009088448,0.98658955,0.009046897,0.000049443217,0.000028707844,0.0018809831,4.6873564e-7,0.0000042584625,0.0010878145,0.00023440878],"about_ca_topic_score_codex":0.013409361,"about_ca_topic_score_gemma":0.00005282079,"teacher_disagreement_score":0.019344382,"about_ca_system_score_codex":0.0022168811,"about_ca_system_score_gemma":0.0042564604,"threshold_uncertainty_score":0.9998769},"labels":[],"label_agreement":null},{"id":"W2323065943","doi":"10.1016/j.jval.2014.03.465","title":"Cost & Resource Utilization of Cervical Cancer in British Columbia","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; BC Cancer Agency","funders":"","keywords":"Cervical cancer; Resource (disambiguation); Business; Medicine; Operations management; Cancer; Computer science; Economics; Internal medicine; Computer network","score_opus":0.09299818825124438,"score_gpt":0.2945068443549896,"score_spread":0.2015086561037452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323065943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98447317,0.0046227244,0.0012536548,0.0009956547,0.0003419757,0.0004099519,0.00024227593,0.000016572367,0.0076440033],"genre_scores_gemma":[0.9967327,0.0014770252,0.0002635325,0.0008088017,0.00010277106,0.000031682397,0.000013227058,0.0000207381,0.000549503],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983555,0.000048552374,0.00093608303,0.00029600825,0.000028683196,0.00033513992],"domain_scores_gemma":[0.9992128,0.00007222825,0.00039550502,0.00020691995,0.000017566419,0.00009498055],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011462163,0.00006883918,0.0004758644,0.00012485946,0.000040534007,0.000052350708,0.00014805353,0.00010879612,0.00044626123],"category_scores_gemma":[0.00023153736,0.00013571886,0.000043767377,0.0002919331,0.000050782986,0.00012984542,0.000029406383,0.00015674533,0.000036905774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010638977,0.00008259285,0.94633967,0.00015821012,0.0000034396357,6.106623e-7,0.0004084696,0.007835252,3.9910796e-7,0.010444698,0.0022456648,0.03247035],"study_design_scores_gemma":[0.00073648687,0.00004843719,0.7948953,0.00020026893,5.392648e-7,0.0000015564774,0.000027809376,0.008765191,0.000001187995,0.012339808,0.1828418,0.0001416457],"about_ca_topic_score_codex":0.4845306,"about_ca_topic_score_gemma":0.3710247,"teacher_disagreement_score":0.18059613,"about_ca_system_score_codex":0.0003911004,"about_ca_system_score_gemma":0.00010827037,"threshold_uncertainty_score":0.6404525},"labels":[],"label_agreement":null},{"id":"W2323335983","doi":"10.1016/j.jval.2014.03.1168","title":"A systematic review of methodological frameworks for evaluation of ethical considerations in health technology assessment","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Normative; Scope (computer science); Engineering ethics; Context (archaeology); Health technology; Management science; Identification (biology); Value (mathematics); Process (computing); Computer science; Political science; Health care; Engineering","score_opus":0.8187216557482284,"score_gpt":0.6365590466668659,"score_spread":0.1821626090813625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323335983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000038834487,0.9154448,0.015481352,0.051712565,0.00039166276,0.016535044,0.00033990946,0.000023772502,0.00006701339],"genre_scores_gemma":[0.000112378424,0.9371412,0.048736785,0.009436237,0.00007317235,0.0043229833,0.000119924916,0.000050986207,0.000006337149],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9183854,0.036830615,0.041761704,0.0014676792,0.0005687882,0.0009858335],"domain_scores_gemma":[0.9438522,0.030356726,0.023877177,0.0013105558,0.00040467468,0.00019866128],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.3468416,0.00043631863,0.014646885,0.0018563805,0.00010198032,0.000017703696,0.0004398072,0.0019109601,0.0001086018],"category_scores_gemma":[0.13428582,0.00045818125,0.00058072247,0.0010064623,0.00014779367,0.00008032165,0.000078148456,0.0021133292,0.000030346147],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[8.062218e-7,0.00009214584,0.000023265691,0.7056256,0.000055041794,9.0680295e-8,0.00012494158,0.00028724817,1.1843219e-9,0.29186225,0.0005309942,0.0013976574],"study_design_scores_gemma":[0.0006985436,0.00034086753,0.000019672534,0.8740846,0.00011807316,0.000013813785,0.00016567652,0.010906619,1.6299776e-8,0.09420305,0.019126741,0.00032231252],"about_ca_topic_score_codex":0.0012761488,"about_ca_topic_score_gemma":0.00012864813,"teacher_disagreement_score":0.21255577,"about_ca_system_score_codex":0.0036906167,"about_ca_system_score_gemma":0.006703869,"threshold_uncertainty_score":0.9999817},"labels":[],"label_agreement":null},{"id":"W2323376865","doi":"10.1016/j.jval.2014.03.584","title":"An Online Patient-Oriented Radiation Risk Assessment Tool to Project Cancer Risk Following Exposure to Low–Ionizing Radiation in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ionizing radiation; Medicine; Cancer; Nuclear medicine; Incidence (geometry); Risk assessment; Population; Lifetime risk; Radiation exposure; Absolute risk reduction; Attributable risk; Low Dose Radiation; Cancer incidence; Internal medicine; Irradiation; Environmental health","score_opus":0.01975626606883038,"score_gpt":0.32835380701600214,"score_spread":0.30859754094717173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323376865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929116,0.00029068312,0.001690873,0.0025259422,0.0007648552,0.0016820789,0.00007511459,0.00003607946,0.000022768321],"genre_scores_gemma":[0.9921331,0.00028209758,0.0038725073,0.003106638,0.00027606747,0.00013814977,0.00015245313,0.00003186513,0.0000071576687],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721426,0.00059509004,0.0007780988,0.00043595964,0.00050574256,0.00047086805],"domain_scores_gemma":[0.99891305,0.0001312745,0.00029126857,0.00032731565,0.00005842902,0.000278682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010897031,0.0001756695,0.00037385858,0.00048841455,0.00013463847,0.000028736831,0.00007904561,0.000048853242,0.000010167869],"category_scores_gemma":[0.0006332537,0.00017967005,0.000041639167,0.00095913094,0.000003819319,0.00025787577,0.00001712744,0.00034600857,0.00000254483],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040170722,0.00009018369,0.60417044,0.0000449795,0.0000102819295,0.000004030544,0.002168959,0.12488625,0.00007075233,0.000010789587,0.00027722362,0.26822594],"study_design_scores_gemma":[0.0016056995,0.0005757741,0.7632226,0.00037274652,0.000015350886,0.0000010086636,0.00077411864,0.2292318,0.00013556037,0.000007999821,0.0038871525,0.0001702384],"about_ca_topic_score_codex":0.945854,"about_ca_topic_score_gemma":0.56034946,"teacher_disagreement_score":0.38550457,"about_ca_system_score_codex":0.0044929865,"about_ca_system_score_gemma":0.0038941544,"threshold_uncertainty_score":0.9993286},"labels":[],"label_agreement":null},{"id":"W2324160126","doi":"10.1016/j.jval.2014.08.209","title":"Impact of Demographics on Health Preferences in China: An Exploratory Analysis of China EQ-5D-5L Valuation Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Beijing; Demography; Demographics; Valuation (finance); China; Medicine; Descriptive statistics; Bivariate analysis; Logistic regression; Univariate; Time-trade-off; Multivariate statistics; Statistics; Geography; Mathematics; Quality of life (healthcare); Economics; Finance","score_opus":0.4585301583251546,"score_gpt":0.4515130220376479,"score_spread":0.0070171362875066645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324160126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326897,0.00088556693,0.00093876035,0.002776762,0.00020590768,0.0015441877,0.00021744292,0.000024255509,0.00013813908],"genre_scores_gemma":[0.9981581,0.0004298351,0.0005311802,0.0006197246,0.000066067994,0.000085561835,0.00007730401,0.000028067077,0.0000041434664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98659253,0.0047370987,0.007039865,0.00077776634,0.00028027987,0.0005724579],"domain_scores_gemma":[0.99266386,0.0009922449,0.0050775046,0.00091159035,0.000068698406,0.00028608227],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.059903894,0.00026598052,0.0024283999,0.0035215837,0.00011832094,0.000024717547,0.000380442,0.00013835683,0.000058826306],"category_scores_gemma":[0.0022077588,0.00030223187,0.0002392001,0.0023909232,0.000068552974,0.00042318046,0.000037607744,0.00033141233,0.00001851961],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000037662874,0.0011731744,0.8480212,0.0003545095,0.00014773582,8.998068e-8,0.01746101,0.12251892,2.5932528e-7,0.009467788,0.00005706476,0.00076054456],"study_design_scores_gemma":[0.0009263662,0.002692932,0.8553471,0.0001539962,0.0000125697725,1.3606581e-7,0.0015977485,0.13080016,3.033129e-7,0.008279457,0.000015928139,0.00017328173],"about_ca_topic_score_codex":0.088060655,"about_ca_topic_score_gemma":0.0145199215,"teacher_disagreement_score":0.07354073,"about_ca_system_score_codex":0.0011527538,"about_ca_system_score_gemma":0.0009041192,"threshold_uncertainty_score":0.99994296},"labels":[],"label_agreement":null},{"id":"W2324258277","doi":"10.1016/j.jval.2012.03.608","title":"PCV5 Intra-Arterial Thrombolysis Versus Standard Treatment or Intravenous Thrombolysis in Adults with Acute Ischemic Stroke: A Systematic Review and Meta-Analysis","year":2012,"lang":"en","type":"review","venue":"Value in Health","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Medicine; Thrombolysis; Randomized controlled trial; Stroke (engine); Meta-analysis; Relative risk; Internal medicine; MEDLINE; Clinical trial; Anesthesia; Confidence interval; Myocardial infarction","score_opus":0.09391463183452164,"score_gpt":0.36035342872256665,"score_spread":0.266438796888045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324258277","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000131404,0.9845708,0.0000635367,0.0005829967,0.00011743892,0.013252267,0.0008901547,0.000070116424,0.00032127247],"genre_scores_gemma":[0.0002590587,0.9927532,0.002257358,0.00025814737,0.00011385359,0.0032077243,0.00054479885,0.00014817745,0.0004576465],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99131656,0.0013229823,0.003624964,0.0014696319,0.0010653291,0.0012005252],"domain_scores_gemma":[0.9946422,0.00063373544,0.0021004165,0.0019712844,0.000111273286,0.00054107],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0020209113,0.0014934322,0.024267696,0.001381117,0.0000873171,0.000058433743,0.00040439764,0.00040385735,0.0005323321],"category_scores_gemma":[0.00016008936,0.00084219675,0.002074193,0.0028853826,0.00013847988,0.00015139139,0.00016742198,0.0007211142,0.00003175772],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074399065,0.00035807854,0.0000043250875,0.7097717,0.28231668,0.0002354724,0.00068008824,0.0000037198197,1.4968275e-7,0.000009059698,0.00026469192,0.005612053],"study_design_scores_gemma":[0.0032024255,0.00213308,0.0000025890024,0.08540634,0.88353115,0.00019388674,0.00023025005,0.000018622717,0.0000011744168,3.0578838e-7,0.024674416,0.00060577615],"about_ca_topic_score_codex":0.0019466943,"about_ca_topic_score_gemma":0.000754766,"teacher_disagreement_score":0.6243653,"about_ca_system_score_codex":0.003328236,"about_ca_system_score_gemma":0.0013533861,"threshold_uncertainty_score":0.9997815},"labels":[],"label_agreement":null},{"id":"W2324348467","doi":"10.1016/j.jval.2012.03.188","title":"PHP112 Investment and Disinvestment of Health Technologies: The Need for Two Cost-Effectiveness Thresholds","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Disinvestment; Productivity; Health care; Investment (military); Set (abstract data type); Health technology; Economics; Underpinning; Public economics; Actuarial science; Business; Risk analysis (engineering); Microeconomics; Computer science; Engineering; Political science; Incentive; Economic growth","score_opus":0.5229541883152121,"score_gpt":0.46853289646427565,"score_spread":0.05442129185093647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324348467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5391615,0.16788094,0.016342413,0.25508124,0.001895531,0.017706782,0.00073444925,0.00017170397,0.001025467],"genre_scores_gemma":[0.9784261,0.0009836748,0.002789147,0.016416231,0.000067006455,0.0012330016,0.000022249078,0.000024834253,0.000037746504],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.994405,0.000989328,0.0034002585,0.00040166813,0.000084456406,0.0007193098],"domain_scores_gemma":[0.9946678,0.0025643294,0.0020413606,0.0005668521,0.000032783737,0.00012684302],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.042071547,0.00019392517,0.0011302035,0.0003654278,0.00024793542,0.000023442768,0.0002495913,0.000102294085,0.0000061479273],"category_scores_gemma":[0.001927196,0.00018481805,0.000076971926,0.00031435522,0.00016081179,0.00024012827,0.00008502835,0.0001707269,0.000015007698],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023327917,0.00024178196,0.145595,0.0026843005,0.000039733797,3.3111963e-8,0.0029908393,0.0011575896,0.000001009951,0.84272647,0.0022254742,0.002314435],"study_design_scores_gemma":[0.00995112,0.0014647486,0.32404336,0.0028697534,0.000018082534,0.000014164137,0.017415527,0.034378104,0.00011876962,0.3992365,0.20936777,0.0011221174],"about_ca_topic_score_codex":0.007934304,"about_ca_topic_score_gemma":0.0000829201,"teacher_disagreement_score":0.44349,"about_ca_system_score_codex":0.0013261663,"about_ca_system_score_gemma":0.0004517675,"threshold_uncertainty_score":0.99867195},"labels":[],"label_agreement":null},{"id":"W2324485580","doi":"10.1016/j.jval.2014.03.1665","title":"Cost-Effectiveness Analysis Of Insured Eye Care Services By Optometrists In Prince Edwards Island (Pei): An Example Of Diabetic Retinopathy Management","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Imaging and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Diabetic retinopathy; Cohort; Cost effectiveness; Optometry; Health care; Incidence (geometry); Incremental cost-effectiveness ratio; Quality-adjusted life year; Emergency medicine; Diabetes mellitus; Internal medicine; Economics; Risk analysis (engineering)","score_opus":0.02888171654967731,"score_gpt":0.34837967969806394,"score_spread":0.31949796314838663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324485580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974253,0.0011632002,0.00045805617,0.0000735429,0.000033589746,0.0005468889,0.00003399517,0.000015154322,0.00025027755],"genre_scores_gemma":[0.9987054,0.0003031662,0.0006670395,0.0000703668,0.0000132290215,0.00003548727,0.00016652458,0.000015800084,0.00002297697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973723,0.00081451103,0.0006734755,0.0004174861,0.00042854622,0.00029365404],"domain_scores_gemma":[0.99868256,0.00019665853,0.00032502995,0.0005305836,0.00013265063,0.00013252354],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022091088,0.00015553478,0.0009830949,0.0014001003,0.000027888758,0.0000090266785,0.00015890393,0.00005823455,0.000007792837],"category_scores_gemma":[0.000056962985,0.00014132392,0.000117058,0.003232003,0.000051904524,0.000053983567,0.000047974027,0.00015197365,8.348011e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000113032256,0.0003018854,0.97661984,0.0049065817,0.00019042278,0.0000048773195,0.00225552,0.0066594086,0.0003914372,0.000025786934,0.000002107978,0.008529126],"study_design_scores_gemma":[0.001392742,0.00041456165,0.9666519,0.0010403123,0.00039217953,4.2557767e-7,0.0009537344,0.027794577,0.0010230291,0.000014121225,0.00020912876,0.000113274706],"about_ca_topic_score_codex":0.040546276,"about_ca_topic_score_gemma":0.0005181457,"teacher_disagreement_score":0.04002813,"about_ca_system_score_codex":0.00020287301,"about_ca_system_score_gemma":0.000054236127,"threshold_uncertainty_score":0.9658428},"labels":[],"label_agreement":null},{"id":"W2324633634","doi":"10.1016/j.jval.2012.08.681","title":"PHP139 Which Criteria are Considered in Health Care Decisions? Insights from an International Survey of Policy and Clinical Decision Makers","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Snowball sampling; Health care; Stakeholder; Context (archaeology); Actuarial science; Population; Psychology; Medicine; Business; Environmental health; Public relations; Economics; Political science; Geography; Economic growth","score_opus":0.5770856334302498,"score_gpt":0.5438272755373071,"score_spread":0.033258357892942625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2324633634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9713792,0.009866717,0.00046879408,0.014540593,0.00152174,0.00078848086,0.0012782307,0.000019550052,0.00013665846],"genre_scores_gemma":[0.97885907,0.0027996397,0.009097733,0.008553386,0.00039303553,0.00002058393,0.00023649544,0.00003420971,0.0000058429505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98681206,0.0034342161,0.008222619,0.00073583535,0.00019152572,0.00060374045],"domain_scores_gemma":[0.98580647,0.009350342,0.003351441,0.0006766647,0.00018048743,0.0006346035],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.028680716,0.0002234716,0.001611627,0.0010570488,0.00011975353,0.000055659333,0.00032405197,0.0002488492,0.00008944356],"category_scores_gemma":[0.032176215,0.0002763022,0.00006569829,0.0005566315,0.000087769564,0.0007193622,0.00011704274,0.00035651805,0.00008108519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097738535,0.0002717649,0.9792244,0.00014556001,0.00001917813,5.588525e-7,0.0083828475,0.0002835561,1.3310593e-7,0.008961196,0.0009625086,0.0016505921],"study_design_scores_gemma":[0.0018106116,0.00015500154,0.97837085,0.00060148985,8.202571e-7,0.0000024361955,0.0028271677,0.006572152,3.493765e-7,0.0065313424,0.002924464,0.00020329539],"about_ca_topic_score_codex":0.24726631,"about_ca_topic_score_gemma":0.05078414,"teacher_disagreement_score":0.19648217,"about_ca_system_score_codex":0.0016272562,"about_ca_system_score_gemma":0.0014065783,"threshold_uncertainty_score":0.9999689},"labels":[],"label_agreement":null},{"id":"W2325065405","doi":"10.1016/j.jval.2014.03.1378","title":"Consideration For Rare Diseases In Drug Reimbursement Decision-Making","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"","keywords":"Reimbursement; Scopus; Grey literature; Government (linguistics); Medical prescription; EconLit; MEDLINE; Medicine; Business; Orphan drug; Health care; Resource (disambiguation); Actuarial science; Family medicine; Public economics; Political science; Economic growth; Nursing; Economics; Computer science; Bioinformatics","score_opus":0.3119112693452439,"score_gpt":0.44578753927732473,"score_spread":0.13387626993208085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325065405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80221486,0.0093602,0.07920057,0.099478185,0.0025235547,0.0050553945,0.0005298905,0.000110893976,0.0015264296],"genre_scores_gemma":[0.972966,0.0001385878,0.01316367,0.013047395,0.00028380225,0.00027908033,0.000034898232,0.000029297771,0.000057246707],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9941159,0.00058660796,0.0041639707,0.00056251034,0.0000908393,0.00048020188],"domain_scores_gemma":[0.9928371,0.005166446,0.0013959868,0.00040785418,0.000038156086,0.00015448309],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01911535,0.00015265257,0.000833676,0.00053216616,0.00017006675,0.000065340246,0.00015958975,0.00007595237,0.00009280907],"category_scores_gemma":[0.01000586,0.00020248923,0.00007817111,0.00020061547,0.000027341472,0.00028553046,0.000030593477,0.00013081978,0.00017573201],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000790682,0.00030548536,0.27309164,0.001749303,0.000017128103,0.0000013713208,0.004746235,0.068171814,2.6100312e-7,0.60316515,0.041601423,0.0070710895],"study_design_scores_gemma":[0.0026107803,0.00018129668,0.1178778,0.0016556846,0.0000026543805,0.0000026695768,0.0012653082,0.32109284,0.0000012437665,0.49788117,0.05694243,0.00048611267],"about_ca_topic_score_codex":0.003932099,"about_ca_topic_score_gemma":0.0014450864,"teacher_disagreement_score":0.25292104,"about_ca_system_score_codex":0.0011623596,"about_ca_system_score_gemma":0.00032544066,"threshold_uncertainty_score":0.9983333},"labels":[],"label_agreement":null},{"id":"W2325424462","doi":"10.1016/j.jval.2013.03.590","title":"Longitudinal changes in health-related quality of life for chronic diseases: An example from the hemophilia utilization group study part va (HUGS Va)","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Psychosocial; Observational study; Quality of life (healthcare); Population; Longitudinal study; Disease; Health related quality of life; Pediatrics; Gerontology; Physical therapy; Internal medicine; Psychiatry; Environmental health","score_opus":0.3067279196871002,"score_gpt":0.4150973137108014,"score_spread":0.10836939402370116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325424462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769686,0.0056487843,0.000039480292,0.010728671,0.00017097803,0.0063201822,0.00007420972,0.000040577514,0.000008542503],"genre_scores_gemma":[0.9972463,0.000997728,0.00008453743,0.00032642906,0.00026399828,0.0005306292,0.00044584236,0.000030910516,0.00007362361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958295,0.0013445237,0.0011383056,0.0005334884,0.0005294386,0.00062472234],"domain_scores_gemma":[0.99764746,0.0008657208,0.00033014183,0.00062170386,0.00010929056,0.00042565484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026905858,0.0002031545,0.0007784884,0.0001782124,0.00016656725,0.000019340276,0.00018002136,0.0000997943,0.00020862662],"category_scores_gemma":[0.00032765485,0.00014014156,0.00007290714,0.00056310534,0.00009883738,0.000121264944,0.0000544704,0.0002652039,0.000009205968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005097651,0.003116365,0.9792333,0.0011124847,0.000078955825,0.0000038647368,0.006586545,0.0001702125,0.000030460824,0.00027324323,0.00042411484,0.008460656],"study_design_scores_gemma":[0.0062680817,0.003907793,0.9767687,0.00046365327,0.000017895702,7.639875e-7,0.0029605683,0.008349216,0.000009902181,0.000940616,0.00019601661,0.000116793904],"about_ca_topic_score_codex":0.28363785,"about_ca_topic_score_gemma":0.023958981,"teacher_disagreement_score":0.25967887,"about_ca_system_score_codex":0.0006259393,"about_ca_system_score_gemma":0.0010082182,"threshold_uncertainty_score":0.99385124},"labels":[],"label_agreement":null},{"id":"W2325832068","doi":"10.1016/j.jval.2012.03.110","title":"PHP34 Eliciting Preferences for Reimbursed Drugs Selection Criteria in Cote d'Ivoire","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McMaster University; Programs for Assessment of Technology in Health Research Institute","funders":"","keywords":"Formulary; Listing (finance); Transparency (behavior); Health care; Medicine; Population; Actuarial science; Family medicine; Business; Environmental health; Computer science; Economics; Finance; Economic growth","score_opus":0.18082155817440582,"score_gpt":0.37261353063410063,"score_spread":0.19179197245969482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2325832068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98536265,0.002292738,0.00029598008,0.0034725028,0.0007446732,0.0005277815,0.00011678712,0.000026128546,0.007160767],"genre_scores_gemma":[0.9959072,0.0004995282,0.0010235622,0.0020528685,0.00034362776,0.000073744486,0.000013280019,0.000020475305,0.00006574896],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99822766,0.000051872372,0.00081162155,0.0002595144,0.000017893371,0.00063145364],"domain_scores_gemma":[0.999274,0.00017693492,0.00026950694,0.00011186101,0.000010570983,0.00015713455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019113388,0.00011955042,0.00036689354,0.00029237117,0.000078026205,0.000036724196,0.00011818043,0.00008911586,0.00009995634],"category_scores_gemma":[0.00015502203,0.00014967569,0.000054008127,0.00023628681,0.000021256608,0.00025016037,0.00002302687,0.00019106093,0.00007316879],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011725391,0.00046617413,0.4247071,0.0008184809,0.000029823022,3.5750753e-7,0.008324827,0.0033658913,0.00007176814,0.5361667,0.0026528502,0.023278745],"study_design_scores_gemma":[0.0038030907,0.00031407876,0.11530305,0.00027503917,0.000004409567,0.0000049845935,0.0004286136,0.38626605,0.00041085156,0.28418392,0.2081137,0.0008922116],"about_ca_topic_score_codex":0.004404387,"about_ca_topic_score_gemma":0.00008654718,"teacher_disagreement_score":0.38290018,"about_ca_system_score_codex":0.00038373854,"about_ca_system_score_gemma":0.00006846864,"threshold_uncertainty_score":0.6658145},"labels":[],"label_agreement":null},{"id":"W2327578339","doi":"10.1016/j.jval.2013.08.219","title":"Resource Use and Outcomes of Patients Treated with Vancomycin or Linezolid in a Tertiary Hospital in Shanghai","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Antimicrobial Resistance in Staphylococcus","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Linezolid; Vancomycin; Medicine; Internal medicine; Antibiotics; Surgery; Staphylococcus aureus","score_opus":0.01858928770902873,"score_gpt":0.2706803258838304,"score_spread":0.25209103817480166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327578339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997139,0.00011990221,0.00000431448,0.0011525308,0.000021479203,0.0014953758,0.000019584582,0.00001648333,0.00003135297],"genre_scores_gemma":[0.99789435,0.00008644706,0.001168148,0.0006281914,0.000009849007,0.000040818555,0.0000148184845,0.000027259572,0.0001301298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839985,0.00013375768,0.0006287553,0.0002828405,0.00018678192,0.00036801165],"domain_scores_gemma":[0.99912226,0.00027556208,0.00017282879,0.00024503365,0.000058932637,0.00012540288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021257006,0.00016861467,0.00055267167,0.0003580014,0.00001549057,0.000010349875,0.00006587856,0.00008526944,0.00001636192],"category_scores_gemma":[0.00031672322,0.00011715903,0.000024586281,0.00045365086,0.00008451128,0.0001396561,0.000037008096,0.00023035017,0.0000027036017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004720587,0.00053093705,0.99597734,0.0003102021,0.0000082133465,0.00004001586,0.0010594155,0.00005537137,0.00003368545,0.0000060954953,0.00023684718,0.0012698007],"study_design_scores_gemma":[0.0039975108,0.000832395,0.99304044,0.00121034,0.000004534214,0.0000015906669,0.0002011234,0.0003882822,0.00008343674,0.0000112205435,0.00011736965,0.00011174233],"about_ca_topic_score_codex":0.021653196,"about_ca_topic_score_gemma":0.0022115565,"teacher_disagreement_score":0.019441638,"about_ca_system_score_codex":0.00021681312,"about_ca_system_score_gemma":0.00016556715,"threshold_uncertainty_score":0.9848617},"labels":[],"label_agreement":null},{"id":"W2327908421","doi":"10.1016/j.jval.2012.08.2186","title":"PCN146 Trends in Computed Tomography Use in Canada: Low-Dose Ionizing Radiation and the Potential Related Cancer Risk","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Effective dose (radiation); Nuclear medicine; Ionizing radiation; Population; Computed tomography; Collective dose; Cancer; Attributable risk; Radiation exposure; Per capita; Demography; Radiology; Environmental health; Internal medicine; Irradiation","score_opus":0.02078450507690863,"score_gpt":0.2692869405959078,"score_spread":0.24850243551899917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2327908421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98731047,0.007837759,0.0000130859335,0.0041335407,0.00036424238,0.0002857116,0.0000085752745,0.000011784181,0.00003483668],"genre_scores_gemma":[0.9972774,0.0016796951,0.00008123077,0.0008054534,0.00009166281,0.000014347686,0.000023094028,0.00001164371,0.00001547064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847335,0.0004048006,0.00045504596,0.00015172194,0.0001747689,0.0003403122],"domain_scores_gemma":[0.99942017,0.0001507413,0.00015983624,0.0001283361,0.000013605825,0.00012731776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009027811,0.00009383243,0.00025177008,0.0004850173,0.00006227402,0.000014339958,0.000037997313,0.000041773754,0.000014521745],"category_scores_gemma":[0.00007683841,0.00007518813,0.000026226027,0.0009756417,0.00003095888,0.00020204674,0.000013026591,0.0003542957,5.840816e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009420673,0.0000404898,0.9327387,0.000030092986,0.000012306363,0.000007450903,0.0018488796,0.015310227,0.0000070245187,0.00010295207,0.00022068068,0.049586974],"study_design_scores_gemma":[0.0036345604,0.000012136441,0.82585484,0.00015673778,0.000008857528,0.000007691424,0.00014149249,0.1699006,0.000009082318,0.000019511952,0.00019776566,0.000056727662],"about_ca_topic_score_codex":0.9702653,"about_ca_topic_score_gemma":0.49798563,"teacher_disagreement_score":0.4722797,"about_ca_system_score_codex":0.00075374544,"about_ca_system_score_gemma":0.00060318754,"threshold_uncertainty_score":0.5111748},"labels":[],"label_agreement":null},{"id":"W2328765601","doi":"10.1016/j.jval.2014.08.1797","title":"Modelling Dependence Between Disability Status and Health Service Costs of People With Rheumatoid Arthritis in Hungary","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bivariate analysis; Index (typography); Goodness of fit; Medicine; Rheumatoid arthritis; Actuarial science; Quarter (Canadian coin); Statistics; Physical therapy; Demography; Econometrics; Gerontology; Mathematics; Economics; Computer science; Internal medicine; Geography","score_opus":0.03760505716649635,"score_gpt":0.3062275381893089,"score_spread":0.26862248102281255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328765601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791209,0.014012425,0.0012512483,0.0046672295,0.000020983456,0.000827668,0.0000282542,0.000027421509,0.00004383036],"genre_scores_gemma":[0.91833407,0.07909933,0.002247696,0.0002258311,0.00001539878,0.00002581701,0.000028793582,0.000021952364,0.0000011295957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972193,0.0005065447,0.0007392132,0.0003782974,0.00045348515,0.0007031153],"domain_scores_gemma":[0.99855024,0.00039279083,0.00017320071,0.0003353857,0.00007380657,0.00047456066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023748737,0.000158874,0.0007834127,0.00014435731,0.000088386354,0.00001544927,0.00008495653,0.000059315975,0.000010087785],"category_scores_gemma":[0.000086948894,0.00014375547,0.000023534696,0.00045654594,0.00012553844,0.00014406613,0.00004863515,0.00039998893,0.0000025189725],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017032276,0.00016189508,0.9429349,0.0008304149,0.000009661859,0.0000022102897,0.0032931278,0.0053823194,0.000003524394,0.0007745387,0.000005849657,0.046431266],"study_design_scores_gemma":[0.0068674,0.0022537475,0.867301,0.0095678605,6.437806e-7,0.000053979467,0.0015254742,0.10977254,0.000049586037,0.0020908916,0.00026869026,0.00024819656],"about_ca_topic_score_codex":0.18507765,"about_ca_topic_score_gemma":0.029679965,"teacher_disagreement_score":0.1553977,"about_ca_system_score_codex":0.0002926885,"about_ca_system_score_gemma":0.0006918072,"threshold_uncertainty_score":0.98802584},"labels":[],"label_agreement":null},{"id":"W2328991141","doi":"10.1016/j.jval.2012.03.343","title":"PMD3 Does Current Perception Threshold Test Can Differentiate Categories of Mechanical Neck Disorder?","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Musculoskeletal pain and rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Receiver operating characteristic; Logistic regression; Discriminative model; Analysis of variance; Covariate; Audiology; Medicine; Post-hoc analysis; Statistics; Internal medicine; Mathematics; Artificial intelligence","score_opus":0.026933148413723358,"score_gpt":0.317172241587408,"score_spread":0.2902390931736846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2328991141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443626,0.0011235166,0.00023028016,0.0029341516,0.00061127625,0.00057227595,0.000011552447,0.00003286153,0.00004783372],"genre_scores_gemma":[0.99854165,0.00065001455,0.00039025056,0.000086847984,0.00019754113,0.000026694284,0.000052842614,0.000015980315,0.00003819334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986109,0.00013703456,0.00048270772,0.0001741803,0.0002590474,0.0003361279],"domain_scores_gemma":[0.9992602,0.00015498832,0.000120890945,0.00022265811,0.000043952325,0.00019732208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005832424,0.00012549448,0.0003247272,0.00012280427,0.00005104748,0.000004328842,0.000049693244,0.00007104112,0.000069199865],"category_scores_gemma":[0.00023305215,0.00008130327,0.000089605244,0.00017946461,0.000065572465,0.000062083964,0.000025561734,0.00022767343,0.000007869334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053687552,0.0015351013,0.96260303,0.005463064,0.000010674978,2.0655348e-7,0.004502009,0.000053441952,0.003674752,0.005671182,0.000100385405,0.016332451],"study_design_scores_gemma":[0.0007772389,0.0004888805,0.992798,0.000557416,0.000013423479,0.0000014897216,0.0008594058,0.002303905,0.000100060104,0.0016439514,0.0003544834,0.00010174828],"about_ca_topic_score_codex":0.0027724383,"about_ca_topic_score_gemma":0.00022206738,"teacher_disagreement_score":0.030194953,"about_ca_system_score_codex":0.00015787741,"about_ca_system_score_gemma":0.000111238565,"threshold_uncertainty_score":0.4191116},"labels":[],"label_agreement":null},{"id":"W2329257750","doi":"10.1016/j.jval.2014.08.1843","title":"The Oncotyrol Prostate Cancer Outcome and Policy Model - How Latent Prevalence Affects the Benefit-Harm Balance of Screening","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Public Health","funders":"","keywords":"Prostate cancer; Statistics; Cancer; Medicine; Demography; Internal medicine; Mathematics","score_opus":0.050381120872785526,"score_gpt":0.34380930711470165,"score_spread":0.29342818624191613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329257750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88620615,0.017522903,0.00013636748,0.09421122,0.000096947595,0.001666353,0.00006892375,0.00002315662,0.00006800569],"genre_scores_gemma":[0.9697295,0.027667949,0.0003762543,0.0015536491,0.00008545003,0.00027120995,0.0000026157418,0.000018878978,0.00029453222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986987,0.00011596409,0.00028142193,0.0002534819,0.00025823977,0.00039216335],"domain_scores_gemma":[0.9989203,0.00032462052,0.00022595086,0.0003398581,0.000050077426,0.00013918696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008326265,0.00014899267,0.00031980756,0.000051522467,0.00016142243,0.000023344486,0.00010486475,0.000035185392,0.0000012441197],"category_scores_gemma":[0.00010988929,0.00007873971,0.0000473409,0.0001757059,0.00010328243,0.00005189144,0.000055328535,0.00018055993,5.162134e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015443836,0.00009695352,0.89707524,0.0013409688,0.000043730648,0.0000023338412,0.0014563353,0.03258743,0.00004771979,0.003934084,0.00020619671,0.06305455],"study_design_scores_gemma":[0.0026512453,0.0008638666,0.6673792,0.0018085432,0.0000500721,0.000009133817,0.00007742076,0.3243537,0.00043009786,0.0010352085,0.0012050853,0.00013644459],"about_ca_topic_score_codex":0.0035027624,"about_ca_topic_score_gemma":0.00013629267,"teacher_disagreement_score":0.2917663,"about_ca_system_score_codex":0.00024994416,"about_ca_system_score_gemma":0.00027327414,"threshold_uncertainty_score":0.52951527},"labels":[],"label_agreement":null},{"id":"W2329585923","doi":"10.1016/j.jval.2014.08.2320","title":"Nab-Paclitaxel or Docetaxel as Alternatives to Solvent-Based Paclitaxel in Metastatic Breast Cancer (Mbc): A Cost Utility Analysis from a Chinese Health Care Perspective","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Docetaxel; Paclitaxel; Medicine; Metastatic breast cancer; Neutropenia; Oncology; Chemotherapy; Febrile neutropenia; Breast cancer; Internal medicine; Cancer; Pharmacology","score_opus":0.050255009929361424,"score_gpt":0.44049519122943914,"score_spread":0.3902401813000777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329585923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94440997,0.007310534,0.0005806962,0.04194781,0.00033748438,0.0029603974,0.002138941,0.00006936547,0.0002447977],"genre_scores_gemma":[0.98722136,0.00051608385,0.0015361424,0.009489974,0.00023280088,0.0006225277,0.00022158479,0.000042645333,0.00011690549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99538934,0.0012877054,0.00094440125,0.0010019596,0.000496437,0.00088016025],"domain_scores_gemma":[0.99739736,0.0006877729,0.00037891758,0.00053789193,0.00022702401,0.0007710007],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001013666,0.0004510399,0.0016484008,0.0009530402,0.00013971569,0.000027942904,0.00019675614,0.000080498845,0.000865725],"category_scores_gemma":[0.00027023154,0.00035031274,0.00028558832,0.0022620042,0.00010695745,0.00010358242,0.000054989556,0.00047634394,0.000028022434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010061047,0.0038999347,0.896757,0.0011599397,0.0018333278,0.00016878084,0.057401825,0.009725439,0.000088791625,0.00031419352,0.0009432774,0.017646445],"study_design_scores_gemma":[0.01593101,0.0031884315,0.9386417,0.00077821926,0.00060564576,0.00001563015,0.009938947,0.028217996,0.00005870972,0.00068713713,0.0014338779,0.00050264865],"about_ca_topic_score_codex":0.5626936,"about_ca_topic_score_gemma":0.15130733,"teacher_disagreement_score":0.41138625,"about_ca_system_score_codex":0.00466157,"about_ca_system_score_gemma":0.0032804913,"threshold_uncertainty_score":0.99989486},"labels":[],"label_agreement":null},{"id":"W2329982161","doi":"10.1016/j.jval.2014.08.2301","title":"Prioritization of Future Outcomes Research Studies in Chronic Myeloid Leukemia: Value of Information Analysis","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Nilotinib; Value of information; Quality-adjusted life year; Dasatinib; Population; Time horizon; Actuarial science; Oncology; Cost effectiveness; Internal medicine; Myeloid leukemia; Imatinib; Environmental health; Economics; Risk analysis (engineering)","score_opus":0.06702508704875788,"score_gpt":0.4088890275643781,"score_spread":0.34186394051562025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2329982161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945593,0.0028558373,0.00015240567,0.0011119159,0.00014125444,0.0008597416,0.00001160452,0.000018776012,0.00028915668],"genre_scores_gemma":[0.99467856,0.0036622297,0.0013079494,0.000090542984,0.00008426834,0.000035734545,0.000075406504,0.0000117016925,0.000053634736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996814,0.0006030847,0.0012046272,0.0002185504,0.0007530995,0.00040661363],"domain_scores_gemma":[0.9982114,0.0005353518,0.0003785088,0.00047156023,0.00031014264,0.00009305173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033756515,0.00015057695,0.00092871644,0.0016216344,0.000048472317,0.000004632686,0.00012021422,0.00015194109,0.000013108122],"category_scores_gemma":[0.0009516054,0.00012803843,0.000110096145,0.002548089,0.00012943974,0.00019411996,0.00006686312,0.0004086595,0.000007748278],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020487707,0.00023623701,0.80853206,0.008062761,0.00070582755,0.000005790312,0.0152175445,0.12960793,0.00016831321,0.0069224467,0.00022792329,0.0301083],"study_design_scores_gemma":[0.00641277,0.0011061621,0.9037557,0.001329942,0.0001504714,0.0000048347156,0.003114046,0.08190618,0.00069061125,0.0005933283,0.00079295854,0.00014296542],"about_ca_topic_score_codex":0.011964881,"about_ca_topic_score_gemma":0.00091156375,"teacher_disagreement_score":0.09522369,"about_ca_system_score_codex":0.009748168,"about_ca_system_score_gemma":0.0027297568,"threshold_uncertainty_score":0.99461454},"labels":[],"label_agreement":null},{"id":"W2330316144","doi":"10.1016/j.jval.2012.03.510","title":"PMH65 Comparison of Deviation Rates from the Labeled Daily Average Consumption in Patients Initiated on Stimulant Medication for the Treatment of Attention-Deficit/Hyperactivity Disorder","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Stimulant; Medicine; Methylphenidate; Cohort; Logistic regression; Attention deficit hyperactivity disorder; Pediatrics; Dextroamphetamine; Internal medicine; Psychiatry; Amphetamine","score_opus":0.13731344501412718,"score_gpt":0.4012100227276671,"score_spread":0.2638965777135399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2330316144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993823,0.0014058104,0.001078636,0.0011476604,0.00020944404,0.002211895,0.00010559957,0.000012700175,0.0000052566083],"genre_scores_gemma":[0.99842364,0.00061114115,0.00014244966,0.00008459154,0.00003725634,0.000134116,0.0005410902,0.000018040371,0.000007698491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980053,0.00048628193,0.00072295434,0.00019108067,0.00035873137,0.0002357095],"domain_scores_gemma":[0.99652076,0.002427528,0.0005889835,0.00030140887,0.00011065654,0.000050655537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006629065,0.00014993887,0.00044719505,0.000118840115,0.00009668697,0.0000055823543,0.000064353335,0.00008506364,0.000039600585],"category_scores_gemma":[0.0004111758,0.00009508159,0.000077545126,0.00022553568,0.000056581182,0.00012741728,0.00001007342,0.00014824979,0.000009733423],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005460256,0.005077182,0.9816095,0.000102405145,0.00005526969,6.752989e-8,0.0015087421,0.0031972644,0.0001931229,0.00012639827,0.000010209553,0.007573791],"study_design_scores_gemma":[0.005575809,0.00086473016,0.96638876,0.00022912593,0.00006184849,2.3366233e-7,0.00084599236,0.025809044,0.00006356235,0.000024063233,0.00006755043,0.000069270565],"about_ca_topic_score_codex":0.0056778863,"about_ca_topic_score_gemma":0.00043703866,"teacher_disagreement_score":0.02261178,"about_ca_system_score_codex":0.0002853272,"about_ca_system_score_gemma":0.00009532379,"threshold_uncertainty_score":0.85833037},"labels":[],"label_agreement":null},{"id":"W2331163759","doi":"10.1016/j.jval.2012.08.385","title":"PIN16 Cost-Effectiveness of Rotavirus Immunization in Indonesia Taking Breastfeeding Patterns Into Account","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Breastfeeding; Medicine; Rotavirus vaccine; Per capita; Immunization; Rotavirus; Environmental health; Population; Vaccination; Cohort; Demography; Pediatrics; Diarrhea; Immunology","score_opus":0.08780985788658595,"score_gpt":0.3975333606647045,"score_spread":0.30972350277811855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331163759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951672,0.0011216094,0.0018888989,0.0007214515,0.00015283511,0.00088984094,0.0000060633606,0.000013735604,0.000038386075],"genre_scores_gemma":[0.99856305,0.0006648736,0.0003442971,0.00019055144,0.00009909378,0.00008160133,0.000037228496,0.000018040704,0.0000012563512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741375,0.0010673541,0.0005452654,0.00016567555,0.00019073316,0.0006172208],"domain_scores_gemma":[0.999253,0.0001473168,0.00019331292,0.00017609431,0.000055045795,0.00017525416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035657978,0.00010880577,0.00048031757,0.00035193804,0.000033057557,0.000004406929,0.00008886988,0.0000824521,0.00001914239],"category_scores_gemma":[0.000483891,0.0001030424,0.00003931085,0.00033150197,0.000042751642,0.00017060297,0.000070316055,0.00033700024,0.0000050409476],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003948726,0.00018824935,0.9669836,0.0011677607,0.0000075035705,0.000007290064,0.00042566017,0.0005610011,0.0028938928,0.00017683189,0.000003887833,0.027189417],"study_design_scores_gemma":[0.0015445467,0.00034388687,0.9935016,0.0021357592,0.0000021672681,0.000047490274,0.000140916,0.0018491163,0.00028614025,0.000051792475,0.000043235665,0.00005333687],"about_ca_topic_score_codex":0.031632558,"about_ca_topic_score_gemma":0.00024215094,"teacher_disagreement_score":0.031390406,"about_ca_system_score_codex":0.00062224246,"about_ca_system_score_gemma":0.00013698118,"threshold_uncertainty_score":0.9748159},"labels":[],"label_agreement":null},{"id":"W2331485444","doi":"10.1016/j.jval.2012.08.1226","title":"PCN33 Progression-Free Survival as a Surrogate for Overall Survival in Metastatic Breast Cancer","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Institut National d'Excellence en Santé et en Services Sociaux; Université de Montréal","funders":"","keywords":"Medicine; Internal medicine; Metastatic breast cancer; Progression-free survival; Oncology; Breast cancer; Linear regression; Population; Cancer; Overall survival; Statistics; Mathematics","score_opus":0.0920146967092638,"score_gpt":0.43226656311668654,"score_spread":0.3402518664074228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331485444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.972137,0.00720015,0.000011674326,0.015765851,0.0019571483,0.0021544786,0.00022081137,0.000047048674,0.0005058559],"genre_scores_gemma":[0.99499,0.0012502774,0.00081741886,0.0011408177,0.00056993164,0.0006065091,0.000052248386,0.000043954587,0.000528828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978649,0.0002833306,0.00047319193,0.00027541275,0.00029442346,0.0008087545],"domain_scores_gemma":[0.9988345,0.00038833663,0.00014616238,0.00024181443,0.00005174566,0.00033744352],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013823285,0.0002009452,0.00059340027,0.00018886494,0.00005457643,0.000007726173,0.000105420586,0.00006487249,0.000332765],"category_scores_gemma":[0.00006380106,0.0001670648,0.00008865481,0.00027351384,0.00004452843,0.00011464913,0.000045969933,0.00022637259,0.000016240496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035545966,0.002515382,0.96691734,0.0014567879,0.00015692817,0.000043447264,0.0028159434,0.00025716433,0.00019063934,0.0020354653,0.0028646563,0.017191624],"study_design_scores_gemma":[0.039910384,0.001962013,0.92800695,0.0016436294,0.00022362176,0.00015450019,0.00046943926,0.0026148418,0.00031946486,0.0023854251,0.021755906,0.0005538017],"about_ca_topic_score_codex":0.033168264,"about_ca_topic_score_gemma":0.002725442,"teacher_disagreement_score":0.038910393,"about_ca_system_score_codex":0.0007116293,"about_ca_system_score_gemma":0.0008793808,"threshold_uncertainty_score":0.97326994},"labels":[],"label_agreement":null},{"id":"W2331544916","doi":"10.1016/j.jval.2012.03.197","title":"PMS8 Estimating Incidence and Prevalence of Osteoarthritis (OA) in Alberta Using Administrative Claims Data","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health Services; University of Saskatchewan; Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"Medicine; Incidence (geometry); Population; Ambulatory; Diagnosis code; Health care; Demography; Epidemiology; Ambulatory care; Gerontology; Environmental health; Internal medicine","score_opus":0.2007830577198568,"score_gpt":0.43048428077143547,"score_spread":0.22970122305157867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2331544916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935538,0.0039186017,0.00017002085,0.00070364587,0.00011720291,0.0006966782,0.00003271181,0.000010999944,0.00079631264],"genre_scores_gemma":[0.98865217,0.00023118837,0.010879272,0.0001004621,0.00006777088,0.0000083557725,0.000020528294,0.000011185347,0.000029045419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850816,0.00014759,0.0004904238,0.00027800738,0.00022410261,0.00035171112],"domain_scores_gemma":[0.99889237,0.00029392645,0.00019028543,0.00045683156,0.000017806013,0.00014880388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009606343,0.00011274928,0.00028607243,0.000119092554,0.000033765013,0.000011265192,0.00013839823,0.00003708393,0.000039048457],"category_scores_gemma":[0.0004340374,0.0001169462,0.0000125843135,0.00023356394,0.00011645523,0.00043298106,0.00020671837,0.00015306476,0.0000020500836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012865182,0.00038742262,0.96034276,0.013074063,0.000016942398,0.000042885466,0.004677057,0.001448787,0.000094035175,0.005177408,0.000092647315,0.014517331],"study_design_scores_gemma":[0.0034141364,0.00082281523,0.70114964,0.01260313,0.000074609634,0.00012525308,0.0029419067,0.2771631,0.00008041058,0.0011802289,0.00011841566,0.00032639297],"about_ca_topic_score_codex":0.011579212,"about_ca_topic_score_gemma":0.0006360169,"teacher_disagreement_score":0.27571428,"about_ca_system_score_codex":0.0001704257,"about_ca_system_score_gemma":0.0005314981,"threshold_uncertainty_score":0.99500275},"labels":[],"label_agreement":null},{"id":"W2332053036","doi":"10.1016/j.jval.2014.03.692","title":"Real-World Health Care Resource Utilisation Among Patients With Chronic Heart Failure: A Canadian Assessment","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); University of Ottawa; Lawson Health Research Institute","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Medical record; Cohort; Internal medicine; Retrospective cohort study; Population; Emergency medicine; Cohort study; Cardiology","score_opus":0.016190246174759025,"score_gpt":0.2869236777620532,"score_spread":0.2707334315872942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332053036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8444658,0.00032291005,0.00013179771,0.14209585,0.0002381205,0.006234665,0.00003201048,0.00021729553,0.0062615727],"genre_scores_gemma":[0.9902369,0.00003127409,0.005709012,0.0029669532,0.00014569996,0.00010569453,0.00043652684,0.00004431477,0.00032364216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99734783,0.00040691264,0.0004976129,0.00045700016,0.00047609262,0.0008145347],"domain_scores_gemma":[0.9984132,0.00006495157,0.00015417804,0.0004995585,0.00006971532,0.0007983802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007792777,0.0002317589,0.00049032184,0.00053851906,0.0002378895,0.000028249502,0.000072128154,0.00006083671,0.00006025769],"category_scores_gemma":[0.000022297487,0.00019531904,0.000051213956,0.0005150198,0.00004858366,0.00008942114,0.000022963017,0.00028876,0.000023008364],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039183706,0.00014241633,0.9635969,0.0006674222,0.00002919927,0.0000050917274,0.001349023,0.0006037834,3.6624365e-7,0.0015430447,0.024753194,0.0072703674],"study_design_scores_gemma":[0.0021737216,0.0014535843,0.672767,0.00054521754,0.000012843781,7.69906e-7,0.00024903807,0.00093732745,0.0000017156417,0.00000961446,0.32172814,0.00012102461],"about_ca_topic_score_codex":0.68909484,"about_ca_topic_score_gemma":0.7935809,"teacher_disagreement_score":0.29697496,"about_ca_system_score_codex":0.006053449,"about_ca_system_score_gemma":0.0028844946,"threshold_uncertainty_score":0.99776214},"labels":[],"label_agreement":null},{"id":"W2332192593","doi":"10.1016/j.jval.2015.09.1761","title":"Quantitative Assessment of Canadian Provincial Public Funding Decisions for Oncology Drugs Following Pcodr Economic Evaluations for 2013 and 2014","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Negotiation; Medicine; Family medicine; Business; Internal medicine; Finance; Political science; Economic growth; Economics; Health care","score_opus":0.6885981843053318,"score_gpt":0.5449113063524272,"score_spread":0.14368687795290458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332192593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6368378,0.005716108,0.07760741,0.2564087,0.004402555,0.010846668,0.0042588445,0.000048868627,0.003873115],"genre_scores_gemma":[0.8469735,0.00039921046,0.14754947,0.003100916,0.0002997224,0.0013073019,0.00019227096,0.00005970262,0.00011793324],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9941574,0.0006123343,0.003859045,0.0005769209,0.000088821056,0.0007055065],"domain_scores_gemma":[0.99123627,0.005615268,0.0020008562,0.00032161176,0.00014067935,0.0006852878],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.046595983,0.00017543402,0.0011474679,0.0018539423,0.0003257091,0.00006606164,0.00022563897,0.00017170697,0.00002815657],"category_scores_gemma":[0.0074383933,0.00023427777,0.00013737271,0.00024140794,0.00006049943,0.00049182645,0.000038015685,0.00014122539,0.000056560286],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000029505853,0.00010618761,0.036736794,0.0003397179,0.000082146275,2.1011364e-7,0.0062941434,0.010485468,8.76487e-7,0.89777744,0.04708702,0.0010605123],"study_design_scores_gemma":[0.0051187975,0.0016710074,0.014023514,0.00023908462,0.000018091103,0.0000029492487,0.008071565,0.6512004,0.0000010217697,0.14421146,0.17493096,0.00051114964],"about_ca_topic_score_codex":0.40078595,"about_ca_topic_score_gemma":0.28373805,"teacher_disagreement_score":0.75356597,"about_ca_system_score_codex":0.0055442336,"about_ca_system_score_gemma":0.009792586,"threshold_uncertainty_score":0.9982733},"labels":[],"label_agreement":null},{"id":"W2332235717","doi":"10.1016/j.jval.2012.03.1058","title":"PIH26 Public Funding for Infertility Treatments in Canada: Eligibility and Demand for IVF in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Reproductive Health and Technologies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Infertility; Medicine; Fertility; Demography; Population; Family medicine; Gynecology; Obstetrics; Environmental health; Pregnancy","score_opus":0.13707630352228503,"score_gpt":0.36615109839489896,"score_spread":0.22907479487261392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332235717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823333,0.0044368748,0.000028878025,0.010298101,0.00022785776,0.0025913755,0.000041808515,0.000014063546,0.000027714977],"genre_scores_gemma":[0.9981249,0.00022076089,0.00065764395,0.00057711493,0.00004031297,0.00034481566,0.000016592163,0.00001075295,0.000007099937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795616,0.00009288974,0.0005694333,0.00036342317,0.00014507907,0.00087299594],"domain_scores_gemma":[0.9987485,0.000509007,0.00010777817,0.00030012472,0.000045075565,0.0002895136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015871841,0.00013135195,0.00045907902,0.00016289645,0.00006518631,0.0000040477585,0.00005380198,0.000060361865,0.0000017467587],"category_scores_gemma":[0.0022102532,0.00011557012,0.000016513022,0.0002779592,0.000027665765,0.000100503705,0.000026119858,0.00017702706,8.666558e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00014002727,0.000091519505,0.9854114,0.0010255744,0.0000056597482,0.0000018941058,0.00011649914,0.000013644646,0.000005315836,0.0002554324,0.00020196146,0.012731053],"study_design_scores_gemma":[0.0018081302,0.00012831122,0.99421173,0.00009873344,0.0000037100906,0.000004642433,0.00046162977,0.00063984405,0.00008425879,0.00094087777,0.001541241,0.00007689798],"about_ca_topic_score_codex":0.9996586,"about_ca_topic_score_gemma":0.99971706,"teacher_disagreement_score":0.01579158,"about_ca_system_score_codex":0.009342912,"about_ca_system_score_gemma":0.014233436,"threshold_uncertainty_score":0.99446005},"labels":[],"label_agreement":null},{"id":"W2332982938","doi":"10.1016/j.jval.2014.08.1899","title":"The Influence Of Gene Expression Profiling (GEP) On Decisional Conflict In Chemotherapy Treatment Decision-Making For Early-Stage Breast Cancer (BRCA)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre; Ontario Institute for Cancer Research; McMaster University; University of Calgary","funders":"","keywords":"Chemotherapy; Medicine; Oncology; Internal medicine; Stage (stratigraphy); Adjuvant chemotherapy; CLARITY; Breast cancer; Adjuvant; Cancer","score_opus":0.1646164422493876,"score_gpt":0.45516687113779847,"score_spread":0.29055042888841087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2332982938","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893808,0.0016738953,0.0004905232,0.003642245,0.00042679888,0.0040909755,0.00019328637,0.000039960487,0.00006154477],"genre_scores_gemma":[0.98235494,0.0018912202,0.012069366,0.0015309433,0.00012133722,0.0019261596,0.00001224956,0.00005247605,0.00004129325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99461627,0.0017377557,0.0018047207,0.00050120096,0.00053773465,0.00080229406],"domain_scores_gemma":[0.98450786,0.012844124,0.0010071836,0.0011377068,0.00032688503,0.00017626847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019426022,0.00025958955,0.0005390999,0.0002733073,0.0009128393,0.000012235294,0.00058379775,0.00021711884,0.000027181515],"category_scores_gemma":[0.0010771297,0.00018461187,0.00008619727,0.00041164237,0.0000861837,0.00012272828,0.000099121986,0.00056429143,0.0000108091135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032234131,0.00039617883,0.79678583,0.00078747066,0.00001727722,9.53195e-7,0.019582313,0.10411509,0.0006583499,0.004313662,0.00015336368,0.06996609],"study_design_scores_gemma":[0.007945625,0.0012094851,0.9104172,0.015509917,0.0000056095464,0.0000020278253,0.0034850743,0.044821575,0.0009349773,0.0047674654,0.010446154,0.0004548917],"about_ca_topic_score_codex":0.007598022,"about_ca_topic_score_gemma":0.001030035,"teacher_disagreement_score":0.11363136,"about_ca_system_score_codex":0.0015277759,"about_ca_system_score_gemma":0.00148976,"threshold_uncertainty_score":0.99901044},"labels":[],"label_agreement":null},{"id":"W2333056877","doi":"10.1016/j.jval.2012.03.099","title":"PHP22 Exploration of Claims-Based Utilization Measures for Detecting Non-Medical Use of Prescription Drugs","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medical prescription; Ranking (information retrieval); Medicine; Population; Prescription drug; Oxycodone; Drug; Substance abuse; Cohort; Lorenz curve; Measure (data warehouse); Statistics; Computer science; Mathematics; Data mining; Pharmacology; Opioid; Artificial intelligence; Internal medicine; Psychiatry; Environmental health","score_opus":0.5374060750734523,"score_gpt":0.479697506306406,"score_spread":0.057708568767046275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333056877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9209902,0.0005622222,0.07482217,0.0017577327,0.0004505302,0.0013427641,0.000009909904,0.000020647429,0.00004377164],"genre_scores_gemma":[0.99627644,0.00014165918,0.0029085625,0.00050105184,0.00009688484,0.00002999994,0.000024602601,0.000012122154,0.000008663156],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984919,0.00021336766,0.00055628055,0.00010303378,0.0004266544,0.00020879846],"domain_scores_gemma":[0.99856883,0.0007333705,0.00030576516,0.00011921986,0.0001089574,0.00016387975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017203983,0.00007211004,0.00023920057,0.00013000846,0.000034324323,0.000003454153,0.000033156506,0.00007999534,0.000015977323],"category_scores_gemma":[0.0017592568,0.00006308012,0.000053799482,0.00018155584,0.000028319319,0.0004522468,0.000009151431,0.00014114901,8.820004e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004324396,0.002647899,0.7715657,0.010482341,0.00006872344,9.579156e-7,0.009799684,0.01093764,0.0059497273,0.0013409583,0.0004262271,0.1824558],"study_design_scores_gemma":[0.0054952577,0.0014159314,0.0366311,0.0016457209,0.00009474157,0.0000029076234,0.00067442644,0.9139023,0.029193489,0.0002493216,0.010529327,0.00016549644],"about_ca_topic_score_codex":0.00061947526,"about_ca_topic_score_gemma":0.0000108606155,"teacher_disagreement_score":0.90296465,"about_ca_system_score_codex":0.0000831724,"about_ca_system_score_gemma":0.000230729,"threshold_uncertainty_score":0.25723326},"labels":[],"label_agreement":null},{"id":"W2333359243","doi":"10.1016/j.jval.2013.03.394","title":"The use of antimicrobial impregnated catheter to prevent shunt-related cerebrospinal fluid infection in canadian hospitals: An economic analysis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cerebrospinal fluid and hydrocephalus","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Shunt (medical); Medicine; Catheter; Activity-based costing; Emergency medicine; Cerebrospinal fluid; Infection control; Surgery; Intensive care medicine; Internal medicine; Business","score_opus":0.029888220701862738,"score_gpt":0.276486431122755,"score_spread":0.24659821042089228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333359243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99725217,0.00004516869,0.00000755305,0.001281044,0.00032440395,0.0009848144,0.000043831493,0.00002510287,0.000035931374],"genre_scores_gemma":[0.9989275,0.00029482925,0.000042940228,0.000563759,0.000024610545,0.000042246167,0.000009681807,0.000022332006,0.000072136136],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99731153,0.00044940447,0.00082867773,0.00051659654,0.00014050546,0.00075325463],"domain_scores_gemma":[0.998804,0.00012178187,0.00017642653,0.00043883285,0.000035029047,0.00042394613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005581899,0.00018965236,0.00036600212,0.00078770093,0.00019678775,0.00012453271,0.00027680866,0.0001047483,0.00009287905],"category_scores_gemma":[0.00017164255,0.0001650009,0.00011838616,0.0011432058,0.000075082244,0.00042995656,0.00005410517,0.0002331042,0.000092493596],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008988908,0.00070106576,0.39071056,0.00011573242,0.00007095903,0.000009857022,0.0032092128,0.5616576,0.03610066,0.0017248949,0.0006449692,0.004964599],"study_design_scores_gemma":[0.00058784045,0.0010251633,0.7184816,0.00015871215,0.00003118717,0.0000128086085,0.00002362526,0.26793936,0.010221344,0.00019893155,0.00092234893,0.0003970786],"about_ca_topic_score_codex":0.9510996,"about_ca_topic_score_gemma":0.6260865,"teacher_disagreement_score":0.32777107,"about_ca_system_score_codex":0.0010771198,"about_ca_system_score_gemma":0.00062955765,"threshold_uncertainty_score":0.6728541},"labels":[],"label_agreement":null},{"id":"W2333435420","doi":"10.1016/j.jval.2013.03.287","title":"The effects of excluding treatments from network meta-analysis","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health Research Topics","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Meta-analysis; Statistics; Mathematics; Node (physics); Medicine; Internal medicine; Physics","score_opus":0.31138420815061735,"score_gpt":0.47575655145856827,"score_spread":0.16437234330795092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333435420","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91110194,0.07400187,0.00023124076,0.006469276,0.0013020365,0.0035945156,0.000028874876,0.00004187741,0.003228377],"genre_scores_gemma":[0.99422264,0.000794655,0.0010843299,0.0006854069,0.00013516266,0.00061678904,0.00001513271,0.00001967263,0.002426183],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99601185,0.0020508107,0.0006386859,0.0002945975,0.00032287007,0.00068118516],"domain_scores_gemma":[0.9953549,0.0035175341,0.0002564129,0.0006406633,0.000030777646,0.00019973062],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013155257,0.00012804384,0.00071053393,0.00011868379,0.00017741964,0.000017531136,0.00025924906,0.00006977577,0.0010950613],"category_scores_gemma":[0.000116982636,0.0000803405,0.00028864274,0.0007301864,0.00005569796,0.00004185275,0.0000580692,0.00022149547,0.00020327077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036780903,0.0024142112,0.40897256,0.0018444918,0.28698137,0.00009910374,0.01804122,0.007874773,0.00007213328,0.047410972,0.052089214,0.17383213],"study_design_scores_gemma":[0.002772617,0.0017415253,0.9277582,0.00010039023,0.017361062,0.0000022552285,0.0008456158,0.0076123723,0.00011090787,0.03361453,0.007676846,0.0004036652],"about_ca_topic_score_codex":0.13810728,"about_ca_topic_score_gemma":0.00060052774,"teacher_disagreement_score":0.51878566,"about_ca_system_score_codex":0.00020036682,"about_ca_system_score_gemma":0.00007540328,"threshold_uncertainty_score":0.9998181},"labels":[],"label_agreement":null},{"id":"W2333600240","doi":"10.1016/j.jval.2014.08.079","title":"HBA1C Control Predictive Validity of Four Self-Reported Measures of Antidiabetes Medication Adherence","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Glycemic; Receiver operating characteristic; Predictive validity; Likert scale; Medication adherence; Scale (ratio); Physical therapy; Clinical psychology; Internal medicine; Psychology; Insulin","score_opus":0.14447326265526966,"score_gpt":0.33967501669715966,"score_spread":0.19520175404189,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333600240","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97299135,0.0008053512,0.019641416,0.00329821,0.00031236163,0.0012760686,0.00001859697,0.00008727747,0.0015693839],"genre_scores_gemma":[0.99715674,0.00043199986,0.0018382648,0.00039799887,0.00007412756,0.000047522368,0.000011418987,0.000008921298,0.000033014745],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975995,0.0004260286,0.0009085722,0.00024127263,0.0006085073,0.0002161327],"domain_scores_gemma":[0.9978946,0.0003975574,0.0008048333,0.00041605326,0.00030571615,0.00018125247],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024320316,0.0001062824,0.0005204512,0.00012647558,0.000028494916,0.0000018445148,0.00012965711,0.00008391525,0.00008303146],"category_scores_gemma":[0.0016107509,0.00009283785,0.000055859127,0.00030153716,0.00010646707,0.00005028523,0.000011797167,0.0001797581,0.000017994937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021492186,0.0008209419,0.96795195,0.00236205,0.00018387187,0.000002986659,0.0010757159,0.00031925258,0.003513982,0.0020122863,0.0017665932,0.019775448],"study_design_scores_gemma":[0.0034569062,0.0024154088,0.9004547,0.0022307183,0.00012255626,0.000016629432,0.00018226168,0.08106916,0.0050473073,0.003620367,0.0012355701,0.0001483911],"about_ca_topic_score_codex":0.00076827436,"about_ca_topic_score_gemma":0.0000053714903,"teacher_disagreement_score":0.0807499,"about_ca_system_score_codex":0.00006875344,"about_ca_system_score_gemma":0.0007579042,"threshold_uncertainty_score":0.37858176},"labels":[],"label_agreement":null},{"id":"W2333786748","doi":"10.1016/j.jval.2013.03.1315","title":"Does Continuity Of Care Matter?","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"CINAHL; Medicine; Psychological intervention; Emergency department; Continuity of care; MEDLINE; Cochrane Library; Health care; Observational study; Cohort study; Family medicine; Emergency medicine; Meta-analysis; Nursing; Internal medicine","score_opus":0.046253440534179194,"score_gpt":0.2772095580237803,"score_spread":0.2309561174896011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333786748","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89890474,0.0039774454,0.00042180793,0.0509928,0.0011208791,0.0015501142,0.0002092727,0.000042790176,0.042780127],"genre_scores_gemma":[0.99671394,0.00029844092,0.0005277985,0.0019479647,0.000047679383,0.000040591352,0.0000042110782,0.000009721756,0.0004096699],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9987531,0.00004054812,0.0006895144,0.00020199,0.000023911618,0.00029097835],"domain_scores_gemma":[0.99934775,0.000038484464,0.00026076668,0.0002482545,0.000019410309,0.000085328276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044944632,0.00007155798,0.0003222621,0.00017836542,0.000030586452,0.000012981163,0.00012465897,0.000044446355,0.0003838368],"category_scores_gemma":[0.000036693098,0.0000613218,0.000041829815,0.0001383795,0.000022905202,0.00008541402,0.000041714833,0.00009008633,0.0006936255],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004769652,0.00006856919,0.43098032,0.0020142486,0.000009564179,7.203783e-7,0.0055659907,0.00021485687,0.0000010071896,0.5509964,0.0024138268,0.007729715],"study_design_scores_gemma":[0.00065038865,0.00017588801,0.71799254,0.00019157818,8.408662e-7,4.8154243e-7,0.0012404883,0.0009830174,0.00003569328,0.10034636,0.17814076,0.00024198461],"about_ca_topic_score_codex":0.23981503,"about_ca_topic_score_gemma":0.0007354775,"teacher_disagreement_score":0.45065004,"about_ca_system_score_codex":0.00015472533,"about_ca_system_score_gemma":0.000036882164,"threshold_uncertainty_score":0.8915383},"labels":[],"label_agreement":null},{"id":"W2333950381","doi":"10.1016/j.jval.2014.08.734","title":"Examining The Role Of Insulin Pen Devices In Acute Care Settings: A Review And Analysis of Health Resource Utilization","year":2014,"lang":"en","type":"review","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Becton Dickinson (Canada)","funders":"","keywords":"Medicine; Insulin pen; Syringe; Acute care; Context (archaeology); Insulin; Diabetes management; Health care; Glycemic; Diabetes mellitus; Vial; Medical emergency; Emergency medicine; Nursing; Type 2 diabetes; Internal medicine","score_opus":0.1237205158643456,"score_gpt":0.42116565305898085,"score_spread":0.2974451371946353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333950381","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00025058194,0.996191,0.0000037492243,0.0006783906,0.000011235545,0.0024318246,0.000027140792,0.000007848886,0.0003981756],"genre_scores_gemma":[0.0008893428,0.99788404,0.000116286334,0.0005757259,0.000017306356,0.000058552454,0.00039183916,0.000024435536,0.000042482294],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952994,0.0019455099,0.0016433671,0.00036646868,0.00040793698,0.0003373335],"domain_scores_gemma":[0.9975722,0.00048428966,0.0012856865,0.00049344654,0.00007784877,0.00008656124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065890127,0.00020409092,0.0032669108,0.0011035609,0.00004670153,0.000009120091,0.00023293016,0.00010070402,0.000011916588],"category_scores_gemma":[0.00032805128,0.00013163168,0.00016595589,0.0029363122,0.0000654616,0.000028018945,0.00015145527,0.00038977023,0.0000010498283],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002843685,0.000024879782,0.0038247516,0.27173397,0.0002554957,5.6845187e-7,0.00071281765,0.000011561717,7.4041178e-9,0.000032370015,0.000050131497,0.7233506],"study_design_scores_gemma":[0.00026129393,0.0003155214,0.00424046,0.18722935,0.0025484115,8.088565e-7,0.0008552053,0.0009208422,5.818273e-8,0.0000067171,0.80351543,0.00010586628],"about_ca_topic_score_codex":0.0011002142,"about_ca_topic_score_gemma":0.0001065865,"teacher_disagreement_score":0.8034653,"about_ca_system_score_codex":0.000185042,"about_ca_system_score_gemma":0.00058618264,"threshold_uncertainty_score":0.5367784},"labels":[],"label_agreement":null},{"id":"W2333999389","doi":"10.1016/j.jval.2014.08.210","title":"Valuing Health in the Uae: An Investigation of the Feasibility and Cultural Appropriateness of Using the TTO and DCE Methods to Generate Health State Values","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Debriefing; Valuation (finance); Face validity; Public health; Psychology; Protocol (science); Actuarial science; Time-trade-off; Social psychology; EQ-5D; Medicine; Applied psychology; Nursing; Quality of life (healthcare); Clinical psychology; Psychometrics; Alternative medicine; Economics; Accounting","score_opus":0.6242107965641388,"score_gpt":0.5110562733151321,"score_spread":0.11315452324900666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2333999389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92079276,0.0042207,0.0070432564,0.065604776,0.00024534445,0.0020040167,0.000071975934,0.000009017582,0.000008164192],"genre_scores_gemma":[0.9408559,0.0006165735,0.04077182,0.017585631,0.00009380941,0.00004038812,0.000007712604,0.000022644514,0.0000054953807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9823869,0.01202595,0.004303915,0.0006021934,0.00015942533,0.00052160997],"domain_scores_gemma":[0.9946497,0.0014226737,0.0029204958,0.0007184543,0.00007428871,0.00021439877],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.10626031,0.00019071637,0.001071176,0.00021860137,0.00038939514,0.000061798266,0.0003620405,0.000069074165,0.0000018034459],"category_scores_gemma":[0.0020136503,0.0001356069,0.00004995113,0.0005889816,0.000215789,0.00029686943,0.00009588897,0.0002819854,0.000001003554],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000542134,0.00015206852,0.6547465,0.004278462,0.000026729707,6.7223375e-8,0.20048673,0.077078946,0.000068495276,0.054187965,0.00027823783,0.008641625],"study_design_scores_gemma":[0.0009582528,0.00042621675,0.6830781,0.00060935464,0.000003370776,0.000008278866,0.009572713,0.23876877,0.000037824266,0.06595051,0.0003292461,0.00025732577],"about_ca_topic_score_codex":0.07013487,"about_ca_topic_score_gemma":0.0019514448,"teacher_disagreement_score":0.19091402,"about_ca_system_score_codex":0.00068771903,"about_ca_system_score_gemma":0.00071014726,"threshold_uncertainty_score":0.93605715},"labels":[],"label_agreement":null},{"id":"W2334113653","doi":"10.1016/j.jval.2013.03.662","title":"The Impact Of Prostate Cancer On Quality Of Life","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Quality of life (healthcare); Anxiety; Cancer; Prostate; Internal medicine; Depression (economics); Oncology; Gynecology; Psychiatry","score_opus":0.08084443251925662,"score_gpt":0.4115411833551345,"score_spread":0.3306967508358779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334113653","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923841,0.002864627,0.0000012570719,0.0035508364,0.00014908427,0.0005031464,0.000022187327,0.0000064174787,0.00051834824],"genre_scores_gemma":[0.9983075,0.0011421469,0.000006832692,0.00032919654,0.00004927747,0.00004006995,0.0000020294067,0.0000074180407,0.00011548574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99895895,0.00017906728,0.00039776092,0.00009128008,0.00019481413,0.00017814543],"domain_scores_gemma":[0.9991725,0.00019928589,0.00018974801,0.00023781878,0.00009013634,0.00011049497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066314463,0.000060226954,0.0002616288,0.000037982292,0.000022341683,0.0000028164643,0.00005093899,0.000027435428,0.00007943114],"category_scores_gemma":[0.00014460726,0.000034358065,0.000074395015,0.000165009,0.000046739733,0.000018441433,0.000009954822,0.0001196407,0.0000040558566],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064693816,0.00015751623,0.9575474,0.001025413,0.000043295713,3.2163354e-7,0.0070617404,0.0018363683,0.00021153646,0.0006834401,0.002013233,0.028772762],"study_design_scores_gemma":[0.00069745566,0.00067160616,0.99617875,0.0003044136,0.0000022179902,2.771705e-7,0.0007325497,0.00060316536,0.00014988684,0.00035709603,0.00026042137,0.00004213484],"about_ca_topic_score_codex":0.572845,"about_ca_topic_score_gemma":0.0045255944,"teacher_disagreement_score":0.5683194,"about_ca_system_score_codex":0.00019022977,"about_ca_system_score_gemma":0.0007927883,"threshold_uncertainty_score":0.4299995},"labels":[],"label_agreement":null},{"id":"W2334258853","doi":"10.1016/j.jval.2014.03.200","title":"Comparative Analysis Of The Lsht Sector Concerning Wealth Creation And Economic Growth For Selected Lsht Sub-Sectors In Selected Canadian Provinces And United States As Well As European Regions","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"InterDigital (Canada); Montréal InVivo; Université de Montréal","funders":"","keywords":"Christian ministry; Economic sector; Gross domestic product; Private sector; Geography; Economy; Economics; Economic growth; Business; Political science","score_opus":0.07607839639171073,"score_gpt":0.36505440025786284,"score_spread":0.28897600386615213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334258853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98725975,0.00024992003,0.000036631496,0.01027652,0.000032819746,0.0014459556,0.000047901707,0.000017194046,0.00063331454],"genre_scores_gemma":[0.99653745,0.0008919998,0.00006286611,0.0021277184,0.000044674893,0.000022350474,0.00023396486,0.000015604735,0.000063356914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968856,0.0013048374,0.00055419496,0.0003010812,0.00020182514,0.00075245457],"domain_scores_gemma":[0.9961645,0.0012700661,0.00023732372,0.00015129654,0.00021236819,0.0019644587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024240601,0.00014242408,0.00057308126,0.0010246874,0.00016397887,0.000018540806,0.000082625986,0.000068973124,0.00002095973],"category_scores_gemma":[0.0068296166,0.00010821354,0.000028266906,0.0018615925,0.00016997562,0.000057827263,0.00001694257,0.0003558617,0.0000030225444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074312545,0.00013337325,0.9747184,0.0016465326,0.00024974978,0.000007540621,0.013417036,0.0025550171,0.00024174809,0.0017247633,0.0032786902,0.0012840211],"study_design_scores_gemma":[0.0022614792,0.0016079672,0.8322082,0.0005209358,0.00007517209,0.00000799447,0.0007545336,0.15535872,0.0002989612,0.00013489428,0.006644727,0.00012643008],"about_ca_topic_score_codex":0.71577156,"about_ca_topic_score_gemma":0.4833553,"teacher_disagreement_score":0.23241623,"about_ca_system_score_codex":0.0009918072,"about_ca_system_score_gemma":0.010276684,"threshold_uncertainty_score":0.99533415},"labels":[],"label_agreement":null},{"id":"W2334759232","doi":"10.1016/j.jval.2014.03.359","title":"Cost-Effectiveness Of Stiripentol In The Treatment Of Severe Myoclonic Epilepsy In Infancy In Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Dravet syndrome; Medicine; Myoclonic epilepsy; Cost–utility analysis; Clobazam; Pediatrics; Epilepsy; Psychiatry; Cost effectiveness","score_opus":0.12664159487864426,"score_gpt":0.41271527046781853,"score_spread":0.2860736755891743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2334759232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99224854,0.0031919132,0.0000017626929,0.002563626,0.00008957814,0.0013239228,0.000009964002,0.0000015082669,0.0005692005],"genre_scores_gemma":[0.9962536,0.0032110375,0.000025842412,0.0003897388,0.000015747008,0.000092138805,0.0000036716638,0.000005101157,0.0000031374784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99785304,0.0010748171,0.00046021707,0.00014514575,0.0001984739,0.00026827844],"domain_scores_gemma":[0.99733853,0.0023006313,0.00012723783,0.00015842487,0.000017660603,0.000057483576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015409362,0.00009369334,0.00047071738,0.000085269094,0.000013833687,0.0000013922262,0.000069871836,0.000029558796,0.00001385564],"category_scores_gemma":[0.000244712,0.00006312944,0.000023550727,0.00039769083,0.000026022284,0.000031805386,0.000012555028,0.00018133501,6.3787905e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005267112,0.000574703,0.9717522,0.0008135786,0.000011515259,0.000027612356,0.0016522378,0.0026073062,0.000010651515,0.00022069878,0.00001742255,0.02178531],"study_design_scores_gemma":[0.0038616287,0.0007155103,0.9841426,0.0006665986,0.0000081779,0.000005832943,0.00058127765,0.0024469492,0.0000874258,0.00013459643,0.007296759,0.000052630232],"about_ca_topic_score_codex":0.9631335,"about_ca_topic_score_gemma":0.8641923,"teacher_disagreement_score":0.098941244,"about_ca_system_score_codex":0.00096348004,"about_ca_system_score_gemma":0.0008760104,"threshold_uncertainty_score":0.25743437},"labels":[],"label_agreement":null},{"id":"W2335126779","doi":"10.1016/j.jval.2013.08.1696","title":"Meta-Analysis of Quality of Life in Coronary Heart Disease","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Multivariate statistics; Medicine; Quality of life (healthcare); Meta-analysis; Coronary heart disease; Multivariate analysis; EQ-5D; Preference; SF-36; Regression analysis; Statistics; Bayesian multivariate linear regression; Physical therapy; Health related quality of life; Internal medicine; Disease; Mathematics","score_opus":0.7196864791014979,"score_gpt":0.47782325953083665,"score_spread":0.2418632195706612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335126779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9142716,0.015551624,0.0002350964,0.06776934,0.00012300519,0.0011630288,0.000633127,0.000013544122,0.00023962416],"genre_scores_gemma":[0.98544043,0.00015687886,0.0015773713,0.012493973,0.000025702944,0.00016000787,0.000036420708,0.000016939273,0.000092268536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9876806,0.0018905108,0.009360558,0.00051052135,0.00015535655,0.00040243345],"domain_scores_gemma":[0.9929675,0.0022385921,0.0035857647,0.00077645545,0.00007125404,0.00036047475],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.029985977,0.00016686383,0.0037851296,0.0012352352,0.000037180853,0.000012411384,0.00025267812,0.000091436414,0.0014726145],"category_scores_gemma":[0.0036506562,0.00019822657,0.00057473674,0.0010235744,0.00008009394,0.00030177043,0.00004870288,0.00016336965,0.00022196046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024089433,0.00032977742,0.910866,0.0011882711,0.0030338487,1.8882753e-7,0.0012156077,0.029301737,7.760525e-7,0.052603997,0.0014242112,0.000011483709],"study_design_scores_gemma":[0.0004283193,0.00004833003,0.96267986,0.000021114247,0.00035221624,8.4767954e-8,0.00036070487,0.020954499,3.3359953e-7,0.014693773,0.00030126507,0.0001594876],"about_ca_topic_score_codex":0.16447604,"about_ca_topic_score_gemma":0.001253837,"teacher_disagreement_score":0.1632222,"about_ca_system_score_codex":0.00041533864,"about_ca_system_score_gemma":0.000554012,"threshold_uncertainty_score":0.9994402},"labels":[],"label_agreement":null},{"id":"W2335184425","doi":"10.1016/j.jval.2014.03.489","title":"Mobilizing Autologous Hematopoietic Stem Cells in Patients with Myeloma: A Economic Comparison of 4 Common Mobilization Strategies","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Plerixafor; Medicine; Multiple myeloma; Mobilization; Autologous stem-cell transplantation; Transplantation; Adverse effect; Oncology; Internal medicine; CXCR4","score_opus":0.025411076232148,"score_gpt":0.30138548621840466,"score_spread":0.27597440998625666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335184425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983905,0.00011168933,0.00014469775,0.00010051517,0.00012797763,0.00071274064,0.0000042211072,0.000028040964,0.00037960507],"genre_scores_gemma":[0.9997218,0.000017618318,0.00012688256,0.0000529852,0.000014841043,0.000034295885,0.00000864741,0.000015889698,0.0000069968733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987699,0.00016491096,0.0005518607,0.00019798765,0.00010842343,0.00020693008],"domain_scores_gemma":[0.9993745,0.000090479276,0.00021984223,0.00022233813,0.000027046504,0.00006581292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002574432,0.000106006635,0.00048544028,0.00016533406,0.000036412668,0.00000928362,0.000052356838,0.00005340626,0.000010429136],"category_scores_gemma":[0.000002707538,0.00009355009,0.000024591947,0.00017147862,0.00004840407,0.000078884324,0.000014375354,0.0001599652,0.00000659492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013595972,0.00050797145,0.8855048,0.00071392895,0.0000070975257,6.3652675e-7,0.0016093396,0.10733783,0.00006356203,0.0019841937,0.000028836675,0.0021058524],"study_design_scores_gemma":[0.0057119997,0.004319253,0.95054436,0.0013590712,0.000027454247,0.00000722435,0.002796856,0.031597953,0.0027399731,0.000375386,0.00028389832,0.00023655355],"about_ca_topic_score_codex":0.0027234924,"about_ca_topic_score_gemma":0.0009740405,"teacher_disagreement_score":0.075739875,"about_ca_system_score_codex":0.00033874146,"about_ca_system_score_gemma":0.0002979588,"threshold_uncertainty_score":0.41171238},"labels":[],"label_agreement":null},{"id":"W2335677341","doi":"10.1016/j.jval.2014.03.486","title":"Cost-Effectiveness of Arsenic Trioxide + All-Trans Retinoic Acid Compared with All-Trans Retinoic Acid + Idarubicin in the Treatment of Newly Diagnosed Acute Promyelocytic Lymphoma LEUKEMIA in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinoids in leukemia and cellular processes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Acute promyelocytic leukemia; Medicine; Idarubicin; Arsenic trioxide; Internal medicine; Adverse effect; Tretinoin; Oncology; Retinoic acid; Leukemia; Gastroenterology; Cytarabine; Arsenic; Chemistry","score_opus":0.02496892279889427,"score_gpt":0.2736665815657923,"score_spread":0.24869765876689806,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335677341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99473506,0.00230903,0.00041767998,0.00024965787,0.00008587145,0.002038894,0.000050371455,0.00000806397,0.0001053568],"genre_scores_gemma":[0.99640405,0.0024258527,0.000352425,0.00020552908,0.000040017905,0.00033141059,0.00018716659,0.0000442598,0.0000092583405],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99571073,0.0015737275,0.00096823426,0.0006445857,0.00040664512,0.0006960895],"domain_scores_gemma":[0.99838334,0.00032962425,0.00037395488,0.000697977,0.00008027029,0.0001348106],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012441144,0.0004079109,0.00086850964,0.00014484671,0.00004616392,0.000012045991,0.00049375085,0.00019600756,0.000003449374],"category_scores_gemma":[0.00008492047,0.0003076969,0.00011160499,0.0004935446,0.00017251328,0.000010051925,0.00002271828,0.00018963711,4.4384058e-7],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069511887,0.001484607,0.113850035,0.0041817785,0.00048168804,0.00034217694,0.008363031,0.062392082,0.78935915,0.00013699365,0.000107970554,0.012349309],"study_design_scores_gemma":[0.013710534,0.0036857289,0.0572866,0.00091878825,0.00009605815,0.00006991428,0.0010104353,0.002793989,0.91797566,0.000077498946,0.0018844059,0.00049035804],"about_ca_topic_score_codex":0.42800507,"about_ca_topic_score_gemma":0.3461114,"teacher_disagreement_score":0.12861654,"about_ca_system_score_codex":0.0019514223,"about_ca_system_score_gemma":0.0057520033,"threshold_uncertainty_score":0.99993753},"labels":[],"label_agreement":null},{"id":"W2335683441","doi":"10.1016/j.jval.2014.03.861","title":"The Impact Of Pharmacist-Delivered Vaccination On Influenza Immunization Rates And Perception In Canada: An Ecological Study","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Immunization; Vaccination policy; Vaccination; Residence; Medicine; Odds; Logistic regression; Demography; Odds ratio; Environmental health; Immunology","score_opus":0.14163170005954048,"score_gpt":0.45956597883806016,"score_spread":0.31793427877851965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2335683441","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99843657,0.00021083326,0.0000023356117,0.00022345831,0.000029717254,0.0010231779,0.000005027822,0.0000072598987,0.0000616169],"genre_scores_gemma":[0.99917734,0.0005177131,0.000019684992,0.00021677677,0.000022819646,0.000029463437,0.0000057871275,0.00000751798,0.000002929056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979779,0.00089883443,0.0004188144,0.0001640005,0.00028629816,0.00025416873],"domain_scores_gemma":[0.99906075,0.0004372611,0.00011474212,0.000173111,0.00013044936,0.000083696505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018804825,0.00009777207,0.00025390481,0.00014457156,0.00013452323,0.000009929143,0.000069113274,0.000029189541,0.000014210963],"category_scores_gemma":[0.0008241598,0.00006205623,0.000016152166,0.0002657701,0.000026352847,0.00007193341,0.000035178477,0.00023100153,0.0000013812503],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006918023,0.00045404513,0.9683518,0.00006292656,0.00001776165,0.00000244375,0.002596592,0.012535777,0.0002911844,0.000047851176,0.000044135504,0.014903694],"study_design_scores_gemma":[0.0025355576,0.002436227,0.9336877,0.000038089824,0.0000029687378,0.0000013544778,0.001693398,0.059469867,0.000022538232,0.000046727084,0.000020993222,0.000044618726],"about_ca_topic_score_codex":0.84360147,"about_ca_topic_score_gemma":0.35192105,"teacher_disagreement_score":0.4916804,"about_ca_system_score_codex":0.0019088093,"about_ca_system_score_gemma":0.0008860996,"threshold_uncertainty_score":0.6599047},"labels":[],"label_agreement":null},{"id":"W2339084570","doi":"10.1016/j.jval.2015.03.593","title":"Analysis Of Ethical Theories And Principles Embedded In Holistic Mcda: A Primer To Ethics-Based Appraisal Of Value In Healthcare","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Consequentialism; Deontological ethics; Utilitarianism; Beneficence; Economic Justice; Health care; Bioethics; Normative ethics; Respect for persons; Engineering ethics; Autonomy; Sociology; Political science; Law","score_opus":0.6033695268346663,"score_gpt":0.5176661552260051,"score_spread":0.08570337160866115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339084570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8982716,0.002550047,0.0018742793,0.09555705,0.0002664441,0.0010115758,0.0002970381,0.00001561647,0.0001563441],"genre_scores_gemma":[0.9859832,0.000109783694,0.005612044,0.008101944,0.000042774915,0.000083907435,0.000031243446,0.00002447231,0.0000106663265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98853457,0.0038022322,0.0061618495,0.0006859676,0.00025496914,0.0005604274],"domain_scores_gemma":[0.98904914,0.007892107,0.0019416296,0.0005797457,0.00014375041,0.00039364648],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07426124,0.00020852889,0.0021258122,0.002225643,0.000049005153,0.000018931822,0.0002617496,0.0004708574,0.000013885336],"category_scores_gemma":[0.032958716,0.0002601465,0.00009782597,0.0018195492,0.00017686868,0.00011960852,0.00007782241,0.0009191268,0.00001468264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000105617524,0.00013928986,0.48955035,0.0014357769,0.000035546665,9.858027e-7,0.017230958,0.12790391,5.729039e-7,0.36351812,0.000039942915,0.00003893698],"study_design_scores_gemma":[0.0022424236,0.0004922864,0.6976829,0.00083029026,0.000018281613,0.0000011714269,0.0036250034,0.26245064,0.0000087436265,0.031349137,0.00090228877,0.00039682788],"about_ca_topic_score_codex":0.12283276,"about_ca_topic_score_gemma":0.011279008,"teacher_disagreement_score":0.332169,"about_ca_system_score_codex":0.0009468236,"about_ca_system_score_gemma":0.002229687,"threshold_uncertainty_score":0.9999851},"labels":[],"label_agreement":null},{"id":"W2339218474","doi":"10.1016/j.jval.2015.09.797","title":"Management of Statin Intolerance (Si) in Patients at High Risk for Cardiovascular (Cv) Events: Results of a Canadian Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Amgen (Canada); Université de Montréal","funders":"","keywords":"Medicine; Statin; Internal medicine; Rhabdomyolysis; Medical prescription; Incidence (geometry); Population; Cohort; Retrospective cohort study; Pharmacology","score_opus":0.03743217193023744,"score_gpt":0.27884559185169244,"score_spread":0.24141341992145499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2339218474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914159,0.0021463502,0.00007310487,0.00023679172,0.00021494654,0.005554732,0.00023373446,0.000008282942,0.00011612338],"genre_scores_gemma":[0.99598527,0.00066784996,0.0029293103,0.00006508485,0.000040920644,0.0001797082,0.00006333232,0.00002698092,0.000041540487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99660516,0.0005760265,0.0010861731,0.00040546668,0.00085065915,0.00047654632],"domain_scores_gemma":[0.998189,0.000038626175,0.00028755065,0.00086612743,0.00022130653,0.00039739307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056203804,0.0001590001,0.00092654943,0.00060087285,0.00004115237,0.0000019907568,0.00012247924,0.00006726592,0.000001636322],"category_scores_gemma":[0.00019191779,0.00014897616,0.00025646668,0.0008235157,0.000022924625,0.000040437422,0.0000485831,0.00016313254,0.0000021140422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003650686,0.0023098572,0.8605161,0.0053157927,0.0016610288,0.00007691076,0.009611947,0.028012961,3.668023e-7,0.00023694914,0.00058064895,0.088026755],"study_design_scores_gemma":[0.032430146,0.0031244871,0.9563166,0.0010613714,0.000144219,0.0000014659389,0.0017105424,0.0004751563,0.000016641465,0.000181255,0.004387402,0.00015072379],"about_ca_topic_score_codex":0.88378936,"about_ca_topic_score_gemma":0.11915702,"teacher_disagreement_score":0.76463234,"about_ca_system_score_codex":0.0012741494,"about_ca_system_score_gemma":0.00066120405,"threshold_uncertainty_score":0.8969161},"labels":[],"label_agreement":null},{"id":"W2342441589","doi":"10.1016/j.jval.2015.03.318","title":"Ideglira Versus other Intensification Strategies In Patients With Type 2 Diabetes Inadequately Controlled on Basal Insulin – An Indirect Statistical Comparison","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Medicine; Insulin aspart; Liraglutide; Insulin degludec; Insulin glargine; Type 2 diabetes; Hypoglycemia; Basal (medicine); Insulin; Internal medicine; Basal insulin; Diabetes mellitus; Endocrinology","score_opus":0.09327190028223893,"score_gpt":0.33845534585790626,"score_spread":0.24518344557566735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342441589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99649835,0.00015481946,0.000027238644,0.00043851734,0.00022474279,0.0013126035,0.000009476606,0.00004384941,0.0012904058],"genre_scores_gemma":[0.9983179,0.000010360303,0.0009091539,0.0004507178,0.000031729596,0.00005325557,0.0001833092,0.000024284845,0.000019294317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983271,0.00027963065,0.00043673877,0.0002764887,0.00034040702,0.0003396575],"domain_scores_gemma":[0.99913317,0.00020155185,0.00014419573,0.0002192021,0.00011012506,0.00019173196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005866153,0.00016828904,0.00056631555,0.0002664412,0.000022432238,0.000030133904,0.000060405095,0.000056310208,0.000016495169],"category_scores_gemma":[0.00024439307,0.00012557651,0.00001532663,0.0002841627,0.00004674666,0.00011788971,0.000013503199,0.00017839968,0.000035683177],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022740286,0.0035805558,0.9463678,0.00016380774,0.00014243026,0.000009732571,0.0020316255,0.0032311913,0.0000030877059,0.006303355,0.00069694914,0.0147291925],"study_design_scores_gemma":[0.054327797,0.020415602,0.9053404,0.00035654995,0.000052010266,3.5201275e-8,0.0014784584,0.016754705,0.000026918307,0.0005534274,0.00048585323,0.00020828746],"about_ca_topic_score_codex":0.0009770327,"about_ca_topic_score_gemma":0.0002459161,"teacher_disagreement_score":0.04102743,"about_ca_system_score_codex":0.00043369073,"about_ca_system_score_gemma":0.00030179534,"threshold_uncertainty_score":0.5120861},"labels":[],"label_agreement":null},{"id":"W2342537895","doi":"10.1016/j.jval.2015.03.661","title":"Factors Impacting Personalized Medicine Test Adoption: Evaluating Patient Preferences And Willingness To Pay","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Willingness to pay; Ranking (information retrieval); Thematic analysis; Payment; Test (biology); Population; Focus group; Norwegian; Family medicine; Mixed logit; Logistic regression; Medicine; Health care; Psychology; Actuarial science; Marketing; Business; Computer science; Qualitative research; Environmental health; Economics; Internal medicine; Artificial intelligence","score_opus":0.8132172749068709,"score_gpt":0.6162580089685087,"score_spread":0.19695926593836222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342537895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799804,0.0022479426,0.000029389588,0.015081064,0.0010948929,0.00084420183,0.000044644108,0.00007575109,0.00060170004],"genre_scores_gemma":[0.99354935,0.00027751434,0.00027542678,0.005338438,0.0003879309,0.000048307236,0.000019367233,0.000019266743,0.000084415224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961535,0.0015574729,0.00074871856,0.00043301834,0.00037161604,0.0007356948],"domain_scores_gemma":[0.99601376,0.0018474902,0.00023971117,0.00013721532,0.00017231196,0.0015895186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003945393,0.0002629759,0.00046512854,0.00013299989,0.0003354712,0.000017785864,0.00015531929,0.00031342724,0.00031179842],"category_scores_gemma":[0.0023480412,0.00018472,0.000030084982,0.00044453584,0.00018430153,0.00013438138,0.00008155919,0.0015274964,0.000016088758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049507956,0.00036446995,0.8350263,0.0006484085,0.000041528972,0.000020475545,0.055783555,0.00817213,0.00079120777,0.0009111254,0.0019211613,0.095824525],"study_design_scores_gemma":[0.021363981,0.022175938,0.36371574,0.0044561327,0.000324456,0.0001802664,0.11257394,0.2020759,0.0041820663,0.010304147,0.2556961,0.0029513475],"about_ca_topic_score_codex":0.0017731753,"about_ca_topic_score_gemma":0.0000496541,"teacher_disagreement_score":0.47131062,"about_ca_system_score_codex":0.00037174099,"about_ca_system_score_gemma":0.0006111386,"threshold_uncertainty_score":0.75326633},"labels":[],"label_agreement":null},{"id":"W2342574247","doi":"10.1016/j.jval.2015.09.1106","title":"The Cost of Radiotherapy: What Do We Know? a Systematic Search of the Literature Between 1981 and 2015","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Activity-based costing; Systematic review; Medicine; Medical physics; Radiation therapy; MEDLINE; Cost effectiveness; Computer science; Operations management; Risk analysis (engineering); Business; Surgery; Accounting; Economics","score_opus":0.030827967374937922,"score_gpt":0.3431024084104465,"score_spread":0.31227444103550855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342574247","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.109575555,0.8466366,0.026250562,0.01092696,0.00038807406,0.0059392783,0.00013210683,0.00004876017,0.00010209273],"genre_scores_gemma":[0.95938206,0.034550004,0.005324851,0.00007388752,0.00026040233,0.00010917002,0.000004434814,0.000047781872,0.00024741632],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.998358,0.00060664257,0.0004433392,0.00014029692,0.0002370561,0.0002146321],"domain_scores_gemma":[0.99873424,0.00040067878,0.00026987412,0.00043068067,0.000085214284,0.000079344114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013710845,0.00011576149,0.00038788043,0.00005702614,0.000068702815,0.000051901272,0.0002624516,0.000040752693,0.0000019559857],"category_scores_gemma":[0.000013151331,0.000063131374,0.00005271136,0.00031549513,0.000121094025,0.00018821488,0.000036745078,0.00023038432,1.4248015e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027746285,0.0005257003,0.3315692,0.0332903,0.00070852885,0.0000021231333,0.113520175,0.0057878555,0.000867522,0.12605247,0.0045164153,0.38288224],"study_design_scores_gemma":[0.017529152,0.005322751,0.016157107,0.45384315,0.00021287045,0.000055239212,0.056771442,0.03681985,0.021700969,0.2023634,0.18623312,0.002990956],"about_ca_topic_score_codex":0.00046224892,"about_ca_topic_score_gemma":0.0000026762243,"teacher_disagreement_score":0.8498065,"about_ca_system_score_codex":0.00009489745,"about_ca_system_score_gemma":0.00021820753,"threshold_uncertainty_score":0.25744227},"labels":[],"label_agreement":null},{"id":"W2342720801","doi":"10.1016/j.jval.2015.03.1003","title":"Cost-Effectiveness of Tiotropium Vs Glycopyrronium In Moderate To Very Severe Copd In Canada, Sweden And The Uk","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Medicine; COPD; Cohort; Anticholinergic; Relative risk; Clinical trial; Lung function; Emergency medicine; Intensive care medicine; Internal medicine; Lung; Confidence interval","score_opus":0.06231783804597246,"score_gpt":0.3387742684138032,"score_spread":0.27645643036783074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342720801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896748,0.0027006078,0.000020103482,0.004040068,0.00016835095,0.0029198455,0.000057893925,0.000006067853,0.00041223128],"genre_scores_gemma":[0.99909073,0.00013292965,0.00006852653,0.0003894493,0.000043904303,0.00017156897,0.000015037321,0.000021404616,0.000066421715],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970343,0.0010910478,0.00045215164,0.00035146344,0.0005288972,0.00054214476],"domain_scores_gemma":[0.99856114,0.00050321163,0.00007501851,0.0003370818,0.00011621708,0.00040733427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018493216,0.00015853217,0.00060731504,0.00023725635,0.000032179043,0.0000092968,0.0001398724,0.000059319962,0.000018473107],"category_scores_gemma":[0.00033927395,0.00012776442,0.000027127815,0.0005631638,0.00011730342,0.000061292594,0.00012163087,0.0004090397,0.0000041787084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.022276824,0.0002628258,0.89216346,0.004086828,0.00003450859,0.00039883662,0.0023546151,0.07295462,0.000056728582,0.0013274986,0.0009377345,0.0031455453],"study_design_scores_gemma":[0.011769995,0.0002200282,0.9458985,0.0011401807,0.000007031653,0.000046500143,0.0011900921,0.03851178,0.000109461056,0.000737675,0.00022593871,0.0001428286],"about_ca_topic_score_codex":0.94196564,"about_ca_topic_score_gemma":0.6470494,"teacher_disagreement_score":0.2949162,"about_ca_system_score_codex":0.0058605475,"about_ca_system_score_gemma":0.010279219,"threshold_uncertainty_score":0.9979558},"labels":[],"label_agreement":null},{"id":"W2342894105","doi":"10.1016/j.jval.2015.03.211","title":"Advancing Methods Of Hta: Optimising Monitoring Tests To Meet Value Targets","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Quality and Safety in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Cut-point; Population; Confidence interval; Medicine; Test (biology); Statistics; Cut-off; Interval (graph theory); Mathematics; Engineering","score_opus":0.32530382179132933,"score_gpt":0.5769264330535419,"score_spread":0.2516226112622125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342894105","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.831742,0.015340041,0.049331572,0.07106298,0.016669245,0.007553512,0.00013513857,0.00062000315,0.00754551],"genre_scores_gemma":[0.48224044,0.00030197424,0.5135639,0.0026463913,0.00088787347,0.00014200152,0.000007530389,0.0000775094,0.00013238697],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.98759,0.007497221,0.0022717454,0.0005494431,0.0006070701,0.0014845341],"domain_scores_gemma":[0.9935031,0.003602207,0.00065382064,0.0006984614,0.00041951737,0.0011228847],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.019006696,0.00027569145,0.0009417247,0.00040907212,0.00052373734,0.000006972469,0.00032746224,0.0003230375,0.000020180076],"category_scores_gemma":[0.0058191647,0.00028049108,0.00008310285,0.00097112125,0.000045201985,0.0002184792,0.00023798908,0.000905755,0.000041728166],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006082933,0.0004310498,0.36064196,0.012746279,0.000051003288,0.000035278714,0.20324992,0.34430006,0.0010053572,0.035801418,0.005844625,0.03528477],"study_design_scores_gemma":[0.01460467,0.0067860717,0.24255525,0.06342833,0.00010257142,0.000058298578,0.28001714,0.09031755,0.005866091,0.1383313,0.15338266,0.0045500714],"about_ca_topic_score_codex":0.02865376,"about_ca_topic_score_gemma":0.0003728237,"teacher_disagreement_score":0.46423233,"about_ca_system_score_codex":0.0017503607,"about_ca_system_score_gemma":0.003031982,"threshold_uncertainty_score":0.9999647},"labels":[],"label_agreement":null},{"id":"W2342897353","doi":"10.1016/j.jval.2015.03.1741","title":"Kidney involvement in Tuberous Sclerosis Complex: the impact on Health Care resource use and costs in the Netherlands","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Renal function; Kidney disease; Tuberous sclerosis; Population; Cohort; Creatinine; Retrospective cohort study; Stage (stratigraphy); Internal medicine; Pathology","score_opus":0.2693416566261356,"score_gpt":0.39063539476081605,"score_spread":0.12129373813468047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2342897353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9363047,0.0022832109,0.0000029460555,0.058606267,0.00004612159,0.0024651384,0.000052770047,0.000028154618,0.00021072003],"genre_scores_gemma":[0.9788088,0.0004471143,0.00017079776,0.020238038,0.00009855308,0.00010371334,0.000079353464,0.00004194962,0.000011676404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940798,0.002756312,0.00074364024,0.00048122506,0.0009386864,0.0010002978],"domain_scores_gemma":[0.99726444,0.0009765925,0.00014507088,0.0008528636,0.00008102912,0.00067997945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00528575,0.00027468987,0.0005913471,0.0004098878,0.00016559708,0.000103631486,0.00035181222,0.00008982658,0.000010857096],"category_scores_gemma":[0.0006281822,0.00015683076,0.00005965741,0.0010076754,0.00016439057,0.00008014974,0.00013364207,0.0010083112,0.000010971183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011449254,0.00080825674,0.83706945,0.00036872717,0.000022654142,0.000035329373,0.0740521,0.005524325,0.000048289497,0.0003496175,0.0657478,0.014828518],"study_design_scores_gemma":[0.0049782116,0.003090033,0.97040397,0.0017239125,0.0000031647003,0.000040136387,0.010956302,0.0052133626,0.000007320445,0.0000668363,0.00336336,0.00015340759],"about_ca_topic_score_codex":0.22401984,"about_ca_topic_score_gemma":0.012946886,"teacher_disagreement_score":0.21107295,"about_ca_system_score_codex":0.00306963,"about_ca_system_score_gemma":0.0014952502,"threshold_uncertainty_score":0.80269754},"labels":[],"label_agreement":null},{"id":"W2343042405","doi":"10.1016/j.jval.2015.03.276","title":"Screening high-risk populations for Latent Tuberculosis: a systematic review of cost-utility analyses","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Tuberculin; Latent tuberculosis; Interferon gamma release assay; Cost effectiveness; Tuberculosis; Population; Health care; Cost-effectiveness analysis; Intensive care medicine; Environmental health; Mycobacterium tuberculosis; Risk analysis (engineering); Pathology","score_opus":0.48641200468434564,"score_gpt":0.5382376938789364,"score_spread":0.05182568919459074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343042405","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000009307041,0.9823931,0.00053567416,0.001122815,0.00011956762,0.01514962,0.0006139408,0.000035574198,0.000020395479],"genre_scores_gemma":[0.000056832345,0.99184346,0.004262631,0.00051970396,0.0001094512,0.0020651438,0.0010594937,0.000054198357,0.000029095734],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9887726,0.005209966,0.0041055116,0.00060426886,0.0005707454,0.00073690846],"domain_scores_gemma":[0.9941573,0.0019086482,0.001874416,0.0010829931,0.00040118428,0.00057547155],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013507936,0.00043179607,0.008974222,0.00061071065,0.000085372325,0.0000070917995,0.00026318268,0.00032585187,0.000023694],"category_scores_gemma":[0.01489511,0.00029247146,0.001089686,0.0009900336,0.00007158443,0.00004911905,0.00008240287,0.00075910625,0.000016374657],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016931695,0.00011411571,0.00039108022,0.93905115,0.00039606012,0.000003164679,0.000017600849,0.000045171822,5.9491105e-9,0.00013073554,0.0022149566,0.057619043],"study_design_scores_gemma":[0.000438365,0.0003966011,0.0002339379,0.95287675,0.0039342237,0.000050868424,0.000015088277,0.0024595899,3.0218427e-8,0.00014678165,0.03926274,0.00018503297],"about_ca_topic_score_codex":0.015265634,"about_ca_topic_score_gemma":0.00011811054,"teacher_disagreement_score":0.05743401,"about_ca_system_score_codex":0.00069057447,"about_ca_system_score_gemma":0.0016079698,"threshold_uncertainty_score":0.99995273},"labels":[],"label_agreement":null},{"id":"W2343082747","doi":"10.1016/j.jval.2015.03.1145","title":"Systematic Review of Economic Evaluations in allogeneic Hematopoietic Stem Cell Transplantation","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Medicine; Myeloid leukemia; Imatinib; Oncology; Internal medicine; Hematopoietic stem cell transplantation; Transplantation; Leukemia; Population","score_opus":0.0664844557251473,"score_gpt":0.368939050238855,"score_spread":0.3024545945137077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343082747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82206845,0.15631804,0.0011320377,0.006167826,0.00032516796,0.0116065005,0.000054779637,0.00005983723,0.0022673795],"genre_scores_gemma":[0.9793614,0.018984828,0.0005980606,0.0006193458,0.000024627787,0.00020699162,0.000037596885,0.000025279678,0.00014186489],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99719036,0.0006957268,0.0012222953,0.0002064345,0.0004189596,0.0002662393],"domain_scores_gemma":[0.99877775,0.0003618293,0.00025550602,0.00033492807,0.000078341975,0.00019166736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003715615,0.00010845019,0.00075583917,0.00027032176,0.000012699024,0.0000035439698,0.00011347675,0.000060068116,0.000021031427],"category_scores_gemma":[0.00014072718,0.00009419213,0.000055141263,0.0002926738,0.000029411893,0.000050269708,0.00001326164,0.00013788255,0.00009242726],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051984207,0.00013194699,0.0014898597,0.9918911,0.000014985724,0.00002933716,0.0024494764,0.0031585256,0.000045441575,0.00039704377,0.0002786854,0.00006162931],"study_design_scores_gemma":[0.010653592,0.0011576217,0.002388028,0.91345096,0.0003361001,0.0005719452,0.001857745,0.06742079,0.001094716,0.0007104641,0.000023105746,0.00033492202],"about_ca_topic_score_codex":0.0013814007,"about_ca_topic_score_gemma":0.000060394865,"teacher_disagreement_score":0.15729298,"about_ca_system_score_codex":0.0023360446,"about_ca_system_score_gemma":0.0038384553,"threshold_uncertainty_score":0.6809255},"labels":[],"label_agreement":null},{"id":"W2343169668","doi":"10.1016/j.jval.2015.03.486","title":"A Literature review and Micro costing approach to determine the cost of one hour of operating time in Canada","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Cardiac, Anesthesia and Surgical Outcomes","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Activity-based costing; Inclusion (mineral); Total absorption costing; Operations management; Cost driver; Operations research; Total cost; Inclusion and exclusion criteria; Business; Actuarial science; Computer science; Medicine; Economics; Engineering; Marketing; Accounting; Psychology","score_opus":0.1042738472373787,"score_gpt":0.3423772443800925,"score_spread":0.23810339714271378,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343169668","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00021533434,0.9951438,8.6998614e-7,0.0007764948,0.000026214613,0.0031178666,0.000053382697,0.00000302457,0.0006630163],"genre_scores_gemma":[0.000043909786,0.9973638,0.0009988511,0.0012460002,0.000050061055,0.00007022191,0.000057056495,0.000025468258,0.00014463848],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970808,0.0008095792,0.0012677172,0.00026866747,0.00030010383,0.00027310883],"domain_scores_gemma":[0.99807084,0.00092169276,0.00037831653,0.0003334577,0.000094049,0.00020163567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027561549,0.00023774111,0.004229096,0.00013279529,0.000018987952,0.000007353314,0.00012673822,0.00010135163,0.0000032487183],"category_scores_gemma":[0.00082476303,0.00014518831,0.00016836292,0.0007322847,0.00002469805,0.000016670114,0.00005253754,0.00047831537,6.8809754e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012946249,0.0000747686,0.0008577755,0.37558776,0.000059382444,0.00007932564,0.0004941857,0.000021928314,6.3640084e-7,0.000043177773,0.00055667135,0.62221146],"study_design_scores_gemma":[0.00043296363,0.00009843137,0.00030956464,0.3190298,0.0002866634,0.0005760325,0.00003727116,0.000089132875,3.115017e-7,4.953368e-7,0.67896736,0.0001720088],"about_ca_topic_score_codex":0.2244709,"about_ca_topic_score_gemma":0.008146682,"teacher_disagreement_score":0.67841065,"about_ca_system_score_codex":0.0005079392,"about_ca_system_score_gemma":0.0036730075,"threshold_uncertainty_score":0.7806934},"labels":[],"label_agreement":null},{"id":"W2343183069","doi":"10.1016/j.jval.2015.03.731","title":"Use of Attention-Deficit/Hyperactivity Disorder (ADHD) Drugs in Canada, 2010-2014","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada","funders":"","keywords":"Atomoxetine; Medical prescription; Methylphenidate; Medicine; Stimulant; Attention deficit hyperactivity disorder; Atomoxetine hydrochloride; Psychiatry; Drug; Pediatrics; Pharmacology","score_opus":0.0946887750190298,"score_gpt":0.3312450946067302,"score_spread":0.2365563195877004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343183069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99146146,0.00056800345,0.00012990086,0.0064341393,0.00048467994,0.0006980012,0.00003512989,0.000022931055,0.00016577747],"genre_scores_gemma":[0.998354,0.00014139884,0.0004970477,0.0003032279,0.00004622801,0.000026020884,0.000039382598,0.000039391398,0.0005532645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971691,0.00043856676,0.00080081006,0.00040326346,0.00068404095,0.00050423323],"domain_scores_gemma":[0.99832845,0.00038342096,0.00031823097,0.0005029226,0.00016571314,0.00030127147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008926106,0.00021158626,0.0006776196,0.0003335182,0.00003747231,0.0000111619265,0.00009532209,0.000098037795,0.00008570494],"category_scores_gemma":[0.00062547467,0.00021426633,0.00007685201,0.0005626372,0.00005086606,0.0003272593,0.000055586104,0.00049680617,0.000040034287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012707619,0.0005897762,0.9883492,0.0002197861,0.000015232824,0.000016787002,0.00031633832,0.007198448,0.00008521665,0.0001381947,0.0012284437,0.001715493],"study_design_scores_gemma":[0.0024332253,0.0001367834,0.97974336,0.00029752962,0.000013915604,0.000026947231,0.0049650855,0.010825557,0.000004008256,0.000058223497,0.001301141,0.00019421286],"about_ca_topic_score_codex":0.9888163,"about_ca_topic_score_gemma":0.7822831,"teacher_disagreement_score":0.20653322,"about_ca_system_score_codex":0.0013998119,"about_ca_system_score_gemma":0.00468377,"threshold_uncertainty_score":0.8737527},"labels":[],"label_agreement":null},{"id":"W2343203314","doi":"10.1016/j.jval.2015.03.1234","title":"Metastatic Melanoma Patient Characteristics as A Determening Factor for Braf Gene Mutation Testing and Treatment In Canada – A Retrospective Cohort Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Ipilimumab; Metastatic melanoma; Melanoma; Internal medicine; Oncology; Cohort; Retrospective cohort study; Mutation; Cancer; Disease; Stage (stratigraphy); Gene; Cancer research; Immunotherapy; Genetics","score_opus":0.047629491895566256,"score_gpt":0.2770613135548097,"score_spread":0.22943182165924342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343203314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99803585,0.00012875632,0.000068339265,0.000023965875,0.0001126956,0.0014918025,0.000119951466,0.0000035750927,0.0000150657],"genre_scores_gemma":[0.9978919,0.000013086608,0.0017025158,0.000065664426,0.00003438491,0.00021123276,0.00006031323,0.000013928334,0.0000069854195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989005,0.0001423561,0.00032166837,0.00029201142,0.00011567059,0.00022784773],"domain_scores_gemma":[0.9994939,0.0000559908,0.00014787563,0.00012247097,0.00005813302,0.00012163554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023811015,0.00012357725,0.00024282446,0.00004517727,0.0000400207,0.000011225359,0.000035289293,0.000024634079,6.8805775e-7],"category_scores_gemma":[0.0003515812,0.000115296105,0.000012718794,0.0000676369,0.000007967208,0.0000032832795,0.00002320224,0.000039687664,2.3712309e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007848792,0.00011642628,0.98632026,0.000026695936,0.000026313544,0.00005273454,0.0014652538,0.00017018261,0.0020556434,0.0000033914575,0.000004897307,0.009679737],"study_design_scores_gemma":[0.0018929747,0.006710029,0.9815287,0.000032915905,0.000013779592,0.00004283416,0.0012950673,0.0044533326,0.0037231015,0.00006402326,0.000068399466,0.00017482488],"about_ca_topic_score_codex":0.68241996,"about_ca_topic_score_gemma":0.42414144,"teacher_disagreement_score":0.25827852,"about_ca_system_score_codex":0.00069890305,"about_ca_system_score_gemma":0.0015268831,"threshold_uncertainty_score":0.5863665},"labels":[],"label_agreement":null},{"id":"W2343262083","doi":"10.1016/j.jval.2015.03.1422","title":"Cost of Adminstration of a Single dose of Rotavirus Vaccine in Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Rotavirus vaccine; Medicine; Rotavirus; Administration (probate law); Cohort; Schedule; Vaccination; Family medicine; Pediatrics; Virology; Internal medicine; Diarrhea; Economics; Political science","score_opus":0.18745011529479547,"score_gpt":0.3819548649969418,"score_spread":0.19450474970214635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343262083","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974693,0.0003980769,0.00003080996,0.0015620405,0.000049174447,0.0003676938,0.000024753008,0.0000014380033,0.00009669114],"genre_scores_gemma":[0.9989945,0.00011228998,0.0006894692,0.00015371229,0.000015871085,0.0000065992654,0.000014838778,0.000004394283,0.0000082890565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859196,0.00023963618,0.00066303794,0.00009177845,0.00018528575,0.00022832777],"domain_scores_gemma":[0.99939895,0.00004195762,0.00017519793,0.00012678087,0.000081018814,0.00017609281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008240755,0.000049056707,0.0004245947,0.00012463608,0.0000031849888,3.3508397e-7,0.000047319223,0.000027351214,0.000012063435],"category_scores_gemma":[0.000790718,0.00004475662,0.000017810933,0.00016827311,0.000021300266,0.000024833105,0.000015987122,0.00010992848,3.3797215e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015543755,0.00037176948,0.9792782,0.0008478869,0.0000087854205,0.00003451879,0.0002929522,0.0030703256,0.0050388076,0.000100634556,0.0010334731,0.008368268],"study_design_scores_gemma":[0.007435022,0.0062857466,0.9709683,0.0013821782,0.0000041005937,0.00004213166,0.0006662105,0.00876607,0.003741768,0.0002623931,0.00038332553,0.00006275607],"about_ca_topic_score_codex":0.9663187,"about_ca_topic_score_gemma":0.8828855,"teacher_disagreement_score":0.08343325,"about_ca_system_score_codex":0.00050185586,"about_ca_system_score_gemma":0.0029040212,"threshold_uncertainty_score":0.5151609},"labels":[],"label_agreement":null},{"id":"W2343275026","doi":"10.1016/j.jval.2015.03.1168","title":"Bevacizumab for front-Line Treatment of Epithelial Ovarian, Fallopian tube or Primary Peritoneal Cancer Patients With High Risk of Relapse: a Cost Effective option for Canadian Patients","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada); University of Calgary","funders":"","keywords":"Medicine; Bevacizumab; Ovarian cancer; Fallopian tube cancer; Oncology; Internal medicine; Fallopian tube; Debulking; Population; Chemotherapy; Carboplatin; Randomized controlled trial; Gynecology; Surgery; Cancer","score_opus":0.030159287082776955,"score_gpt":0.29893055403457947,"score_spread":0.26877126695180253,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343275026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779024,0.00042805067,0.00018854259,0.0009097557,0.00045964573,0.013210233,0.006870016,0.00001151242,0.000019856558],"genre_scores_gemma":[0.9875707,0.00042849386,0.0063410043,0.00014370034,0.00016738057,0.004213216,0.0010239172,0.00004994136,0.00006164812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816257,0.00013244203,0.0005864963,0.0003956203,0.00029099008,0.00043190512],"domain_scores_gemma":[0.99817413,0.00022313288,0.00040603775,0.0002645789,0.0004813669,0.00045075413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025995803,0.00024649067,0.0007945926,0.00020730156,0.00008732848,0.0000058287646,0.000056351822,0.00011438547,0.000011856293],"category_scores_gemma":[0.00010463069,0.00017037768,0.00009846317,0.00015789884,0.000051752802,0.00006593701,0.00000864639,0.000071561466,8.8180445e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017981343,0.0043352786,0.87503284,0.0009451626,0.0005417581,0.0000051765337,0.0029104503,0.0029618104,0.0000016012132,0.00019311787,0.00029910012,0.09479239],"study_design_scores_gemma":[0.06586495,0.043057222,0.88318235,0.0008843252,0.00041396864,0.0000011637701,0.000077410856,0.0011889024,0.00028767055,0.000081953454,0.0047671986,0.00019288054],"about_ca_topic_score_codex":0.5840001,"about_ca_topic_score_gemma":0.15285987,"teacher_disagreement_score":0.43114024,"about_ca_system_score_codex":0.005348049,"about_ca_system_score_gemma":0.0032277019,"threshold_uncertainty_score":0.99847025},"labels":[],"label_agreement":null},{"id":"W2343292785","doi":"10.1016/j.jval.2015.03.587","title":"Evaluation Of A Pharmaceutical Risk-Sharing Agreement When Patients Are Screened For The Probability Of Success","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Alberta","funders":"","keywords":"Formulary; Subsidy; Stackelberg competition; Outcome (game theory); Listing (finance); Actuarial science; Business; Microeconomics; Welfare; Population; Distribution (mathematics); Prescription drug; Social Welfare; Economics; Medical prescription; Finance; Medicine; Pharmacology","score_opus":0.43066247223099796,"score_gpt":0.40867515345984246,"score_spread":0.021987318771155506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343292785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105394,0.0023024722,0.00070294685,0.0024098938,0.0002793919,0.0017550187,0.000544834,0.0000049927776,0.00094651687],"genre_scores_gemma":[0.99877197,0.00022146343,0.0005339845,0.00029558814,0.000049795704,0.00010254131,0.000009094142,0.0000100021925,0.0000055788582],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981582,0.00013055446,0.0010610265,0.00027285772,0.00011163552,0.00026570685],"domain_scores_gemma":[0.9982549,0.00022881826,0.00088128826,0.00029539812,0.00020493432,0.00013466158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011122038,0.0000945111,0.0003682272,0.00011239747,0.000046776284,0.000012523133,0.00026449462,0.000048305013,0.000055346813],"category_scores_gemma":[0.0011940909,0.000088018045,0.00008023619,0.0001308052,0.000060796392,0.00009412675,0.00007872462,0.00012250197,0.000008582749],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001408748,0.0004983183,0.9002341,0.00033538093,0.00006757259,2.3957641e-8,0.0010952201,0.03913493,6.232117e-7,0.046039067,0.00029445323,0.012159414],"study_design_scores_gemma":[0.0032606465,0.00015077142,0.117660224,0.000044005472,0.00002197676,7.4902005e-8,0.00004377362,0.6777192,0.000072519695,0.19786108,0.0030642801,0.00010148541],"about_ca_topic_score_codex":0.0052088103,"about_ca_topic_score_gemma":0.00013150627,"teacher_disagreement_score":0.7825739,"about_ca_system_score_codex":0.00046772588,"about_ca_system_score_gemma":0.00017985488,"threshold_uncertainty_score":0.7874198},"labels":[],"label_agreement":null},{"id":"W2343330905","doi":"10.1016/j.jval.2015.09.2481","title":"Comparison of Compliance And Discontinuation Rates Among Ms Patients Treated With Fingolimod and Other Disease-Modifying Therapies: A Canadian Retrospective Claims Analysis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Hôpital Notre-Dame; Health Canada; Novartis (Canada)","funders":"","keywords":"Fingolimod; Natalizumab; Discontinuation; Medicine; Teriflunomide; Glatiramer acetate; Internal medicine; Multiple sclerosis; Pharmacy; Physical therapy; Family medicine; Disease; Immunology","score_opus":0.1648320629122082,"score_gpt":0.3993700747735055,"score_spread":0.2345380118612973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343330905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99755734,0.0010075563,0.000036500325,0.00049517746,0.0000075440576,0.00072956696,0.00007334808,0.00001040785,0.00008255246],"genre_scores_gemma":[0.9994555,0.00011740956,0.00026672424,0.00006027603,0.000012634932,0.000032753964,0.000028631222,0.000012427406,0.000013640491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987097,0.00017028478,0.00028911367,0.00026264705,0.00029230566,0.00027597835],"domain_scores_gemma":[0.99897283,0.00009109066,0.00015624388,0.00015970404,0.0001865204,0.00043359678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036706813,0.00011993847,0.00052026554,0.00032910434,0.00009052369,0.000018230969,0.000036256126,0.000029271481,0.000003749461],"category_scores_gemma":[0.00018751627,0.000088713234,0.000023006594,0.0005601146,0.0001897123,0.00006748937,0.000017944949,0.00012119784,2.929102e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002079089,0.00011650585,0.99142474,0.00012882623,0.0001742429,9.137675e-7,0.007004567,0.00032732848,0.000004574856,0.000020276948,0.00002242156,0.00056770147],"study_design_scores_gemma":[0.0017625737,0.00044423973,0.9379023,0.0005112069,0.000053450647,8.9426024e-8,0.0009864405,0.058225133,0.000009695105,0.000021540427,0.000011864994,0.00007146799],"about_ca_topic_score_codex":0.48059645,"about_ca_topic_score_gemma":0.20391273,"teacher_disagreement_score":0.27668372,"about_ca_system_score_codex":0.00037291987,"about_ca_system_score_gemma":0.00019807596,"threshold_uncertainty_score":0.8106138},"labels":[],"label_agreement":null},{"id":"W2343331314","doi":"10.1016/j.jval.2015.03.1425","title":"HIV Antiretroviral drug utilization and Expenditures In Medicaid 1991-2014","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicaid; Reimbursement; Medicine; Quarter (Canadian coin); Human immunodeficiency virus (HIV); Family medicine; Demography; Business; Health care; Geography; Economic growth; Economics","score_opus":0.08934957252520419,"score_gpt":0.3933177646291998,"score_spread":0.3039681921039956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343331314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96525925,0.010858938,0.00030047804,0.013986503,0.00016640604,0.0008197199,0.000026210184,0.000056553035,0.008525911],"genre_scores_gemma":[0.99457484,0.001125044,0.00034798254,0.00030034425,0.00011805154,0.000018882545,0.00009051041,0.000012460986,0.0034119014],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985089,0.00028802847,0.0003566687,0.00019420171,0.00033653196,0.00031569417],"domain_scores_gemma":[0.9993231,0.000061132894,0.00005209676,0.00015644716,0.00002767724,0.00037949605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012382781,0.00007932819,0.00022474291,0.0003488587,0.00003244255,0.000012207511,0.00006177311,0.000049264483,0.000118402866],"category_scores_gemma":[0.0004821667,0.0000679421,0.000029639841,0.00017511805,0.00006743272,0.00010303526,0.000036460573,0.0002597534,0.00005890991],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026831374,0.0005863445,0.3650585,0.0008815208,0.000015273414,0.000111165784,0.006629172,0.000068299734,0.00007940913,0.0036793083,0.5776669,0.044955786],"study_design_scores_gemma":[0.022070004,0.014763333,0.2863815,0.00672413,0.000024176134,0.00023861176,0.012781165,0.20362045,0.0005989671,0.004972437,0.4471322,0.0006930215],"about_ca_topic_score_codex":0.009879468,"about_ca_topic_score_gemma":0.00051465904,"teacher_disagreement_score":0.20355214,"about_ca_system_score_codex":0.00017550566,"about_ca_system_score_gemma":0.00026726362,"threshold_uncertainty_score":0.9967138},"labels":[],"label_agreement":null},{"id":"W2343433672","doi":"10.1016/j.jval.2015.03.430","title":"Analysis of the Drug price reviews performed by the Canadian Patented Medicine Prices review Board (1998-2014)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Notice; Drug prices; Business; Database transaction; Descriptive statistics; Medicine; Economics; Monetary economics; Law","score_opus":0.1724730036183695,"score_gpt":0.34448059725966984,"score_spread":0.17200759364130033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343433672","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0713386,0.6579207,0.00001907898,0.24183261,0.0008590879,0.002163063,0.0003967701,0.000013663405,0.025456417],"genre_scores_gemma":[0.6281013,0.30678847,0.000060826216,0.06412792,0.00013474778,0.000084450534,0.000050447972,0.000025063737,0.00062675227],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976391,0.00018223087,0.0014278545,0.00027863416,0.000060548726,0.0004115868],"domain_scores_gemma":[0.9979937,0.00013465491,0.000902983,0.0005678841,0.00002904294,0.00037172917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062609734,0.00014603401,0.00093236245,0.0002802318,0.00012510899,0.000015985774,0.00054882444,0.00004849097,0.00018449234],"category_scores_gemma":[0.0005351838,0.000092517104,0.00016695105,0.001282372,0.00011453045,0.000073852185,0.00005103584,0.0002725196,0.00014668558],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015534175,0.00011768011,0.21991898,0.0019820828,0.0004055639,7.594057e-7,0.004940164,0.001414331,9.4114876e-7,0.045257337,0.72157836,0.004368245],"study_design_scores_gemma":[0.00027263165,0.000027447233,0.01079282,0.00032977317,0.000051900213,7.204381e-7,0.000036306486,0.015015948,0.0000011096503,0.0011446899,0.97221434,0.00011232198],"about_ca_topic_score_codex":0.50457084,"about_ca_topic_score_gemma":0.09475469,"teacher_disagreement_score":0.5567627,"about_ca_system_score_codex":0.0006372948,"about_ca_system_score_gemma":0.0003676945,"threshold_uncertainty_score":0.92176366},"labels":[],"label_agreement":null},{"id":"W2343465675","doi":"10.1016/j.jval.2015.03.361","title":"Impact Of Weight-Related Utilities On The Cost-Effectiveness Of Canagliflozin (Cana) Versus Sitagliptin (Sita) As Third-Line Therapy In Type 2 Diabetes Mellitus (T2dm) In A Canadian Setting","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Canagliflozin; Medicine; Sitagliptin; Metformin; Weight loss; Type 2 Diabetes Mellitus; Dipeptidyl peptidase-4 inhibitor; Internal medicine; Weight gain; Diabetes mellitus; Endocrinology; Obesity; Body weight","score_opus":0.07152820302960439,"score_gpt":0.3415893340382168,"score_spread":0.2700611310086124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343465675","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898778,0.0038007111,8.837918e-8,0.0013971044,0.00024800765,0.001991879,0.000028953848,0.000013037984,0.002642408],"genre_scores_gemma":[0.999093,0.0005360948,0.000020052608,0.0001539579,0.000019261188,0.00006644898,0.000045212382,0.000024493544,0.000041477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975943,0.0006930568,0.0005174071,0.00025389323,0.00028943658,0.0006518932],"domain_scores_gemma":[0.9982507,0.0008623388,0.00016806004,0.000339331,0.00009796299,0.00028156347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027659342,0.00021171055,0.00059971464,0.0006279924,0.000027924207,0.0000071720083,0.0001317203,0.000094003495,0.000036748424],"category_scores_gemma":[0.00048121138,0.00014981366,0.000077868455,0.0008819279,0.00007056473,0.00005486507,0.000023754625,0.00025414655,0.000008895777],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003363482,0.00076987984,0.95801795,0.0005527007,0.0004487118,0.00006321237,0.004918951,0.011588825,0.000067287525,0.0040715775,0.00043070488,0.015706707],"study_design_scores_gemma":[0.016984256,0.013179005,0.94681364,0.003157871,0.000057755908,9.225734e-7,0.0023207108,0.013070622,0.001520155,0.0015463505,0.001007451,0.00034123164],"about_ca_topic_score_codex":0.7874521,"about_ca_topic_score_gemma":0.2255078,"teacher_disagreement_score":0.5619443,"about_ca_system_score_codex":0.0023565635,"about_ca_system_score_gemma":0.0021526834,"threshold_uncertainty_score":0.78862464},"labels":[],"label_agreement":null},{"id":"W2343468630","doi":"10.1016/j.jval.2015.03.1241","title":"Priority Access for the Biggest – Variable Provincial Access to Oncology Drugs In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Per capita; Population; Demography; Government (linguistics); Medicine; Socioeconomics; Geography; Gross domestic product; Agricultural economics; Economic growth; Economics; Sociology","score_opus":0.5344055687052214,"score_gpt":0.4800827372557793,"score_spread":0.054322831449442055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343468630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5649034,0.0020056183,0.00412983,0.41171637,0.0053674746,0.007804331,0.0008047304,0.00004043318,0.0032277883],"genre_scores_gemma":[0.9260831,0.00014580056,0.0035808573,0.06756099,0.0009816885,0.0013460274,0.00003115253,0.00005529582,0.00021510698],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99419945,0.00065996055,0.0036341334,0.000586552,0.0001344887,0.0007854249],"domain_scores_gemma":[0.99463695,0.0029640729,0.0013747894,0.00050949893,0.00008928744,0.0004254134],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.032962505,0.00017312227,0.0009930203,0.0003443098,0.00016652417,0.00012435779,0.00095406256,0.000119854594,0.00004082391],"category_scores_gemma":[0.0062558693,0.00018818521,0.000037842357,0.0006143861,0.000027828079,0.00052182964,0.00019135942,0.00028685716,0.00006879128],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00018155809,0.00027748168,0.608297,0.0013809856,0.00003158195,0.0000023841637,0.008675546,0.102587104,1.2083795e-7,0.112153,0.1630664,0.0033468413],"study_design_scores_gemma":[0.003045612,0.00030967718,0.2037443,0.00019498351,0.0000033978142,0.000004055976,0.002804368,0.08540996,0.0000021526234,0.024425657,0.6795225,0.00053333846],"about_ca_topic_score_codex":0.99170744,"about_ca_topic_score_gemma":0.95440435,"teacher_disagreement_score":0.51645607,"about_ca_system_score_codex":0.0126883825,"about_ca_system_score_gemma":0.020970713,"threshold_uncertainty_score":0.9957686},"labels":[],"label_agreement":null},{"id":"W2343513074","doi":"10.1016/j.jval.2015.03.1386","title":"Projected Cost Savings of Introducing fecal Microbiota Transplant Treatment for Clostridium Difficile Infection In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Clostridium difficile; Fecal bacteriotherapy; Clostridium Infections; Feces; Medicine; Microbiology; Intensive care medicine; Biology; Antibiotics","score_opus":0.0784325005619221,"score_gpt":0.327169128031578,"score_spread":0.2487366274696559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343513074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99341875,0.00052314036,0.00003673432,0.002568379,0.00028238914,0.0028495453,0.00021576947,0.000021629974,0.00008366642],"genre_scores_gemma":[0.9984568,0.0006110396,0.00023191542,0.00007567469,0.00017494966,0.00015288877,0.00019347483,0.000032761152,0.00007054558],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9974718,0.00017403076,0.00084690744,0.00044590206,0.0003662921,0.00069503306],"domain_scores_gemma":[0.99881375,0.00024064153,0.000156035,0.00031089946,0.00016285073,0.00031579947],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069356227,0.00022886731,0.0006830504,0.00038569706,0.000045661087,0.000009381544,0.0000807059,0.00010400237,0.00001411831],"category_scores_gemma":[0.0002575331,0.00020498707,0.00008372881,0.0007120849,0.00003961785,0.000037721657,0.000021128799,0.00029294574,0.0000022136417],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.01294248,0.006710244,0.7077573,0.0070735468,0.00026643806,0.00033609397,0.009505519,0.026427034,0.17099924,0.00024344801,0.01102433,0.04671433],"study_design_scores_gemma":[0.044557553,0.011938745,0.09594669,0.004262234,0.00014912506,0.00037441615,0.0025262113,0.04648309,0.77170086,0.000035781788,0.020940378,0.0010848972],"about_ca_topic_score_codex":0.9775671,"about_ca_topic_score_gemma":0.7976795,"teacher_disagreement_score":0.6118106,"about_ca_system_score_codex":0.007655563,"about_ca_system_score_gemma":0.011774157,"threshold_uncertainty_score":0.9961539},"labels":[],"label_agreement":null},{"id":"W2343754603","doi":"10.1016/j.jval.2015.03.1279","title":"Optimising market access of Cancer Drugs in Canada: a study of Economic reviews by the Pan-Canadian Oncology Drug review (PCODR) expert committee","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer drugs; Clinical trial; Actuarial science; Order (exchange); Family medicine; Drug; Internal medicine; Pharmacology; Business; Finance","score_opus":0.5066928672916171,"score_gpt":0.49149817194873313,"score_spread":0.01519469534288398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343754603","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38937458,0.45975044,0.0000066486878,0.1412892,0.0010889167,0.0052413563,0.0004535201,0.0000067120363,0.002788624],"genre_scores_gemma":[0.8240786,0.1307577,0.00036006377,0.043455478,0.00016794623,0.00088114344,0.000023675682,0.00005798453,0.00021738691],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9875705,0.0032055557,0.007926209,0.0005337465,0.0001335243,0.00063044654],"domain_scores_gemma":[0.9931534,0.0013032671,0.0043168426,0.00077552657,0.000059623733,0.0003913607],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04674028,0.0002249783,0.00240943,0.00040355313,0.00008163285,0.00001961477,0.0008554596,0.00007685511,0.00027053469],"category_scores_gemma":[0.0015828895,0.00023435286,0.00007301674,0.00042335226,0.000056715322,0.00026355952,0.00009248631,0.00031907228,0.000028361936],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000021232745,0.00020486502,0.2352386,0.00286919,0.00004081711,0.000001213692,0.010879246,0.0026510686,4.596691e-8,0.0006311738,0.7428009,0.0046616704],"study_design_scores_gemma":[0.004153123,0.00035950445,0.049867295,0.0076296753,0.00001769022,0.0000058383403,0.018677237,0.0200065,0.0000019175575,0.0012497413,0.8972096,0.00082190294],"about_ca_topic_score_codex":0.9995417,"about_ca_topic_score_gemma":0.9977207,"teacher_disagreement_score":0.43470404,"about_ca_system_score_codex":0.01622243,"about_ca_system_score_gemma":0.013147921,"threshold_uncertainty_score":0.9924466},"labels":[],"label_agreement":null},{"id":"W2343830121","doi":"10.1016/j.jval.2015.03.1171","title":"Cost-Effectiveness of Radium-223 Dichloride (Radium-223) In Alsympca: A Cost-Effectiveness Analysis of Radium-223+Best Standard of Care (Bsoc) Compared With Placebo+Bsoc In Treatment of Castration-Resistant Prostate Cancer (Crpc) And Symptomatic Bone Metastases In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Bayer (Canada)","funders":"","keywords":"Radium-223; Radium; Prostate cancer; Medicine; Placebo; Internal medicine; Radiochemistry; Chemistry; Cancer","score_opus":0.0750774025053075,"score_gpt":0.30887230809299104,"score_spread":0.23379490558768354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343830121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97325987,0.018745786,0.00007142994,0.00008777429,0.00013280741,0.0032614712,0.004355353,0.0000045443153,0.000080968064],"genre_scores_gemma":[0.9963596,0.0027798666,0.00017963721,0.000013208371,0.000011885337,0.00052383344,0.00009449639,0.000033515887,0.0000039854854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960758,0.00045076423,0.0021651834,0.0005789019,0.00017483899,0.0005545227],"domain_scores_gemma":[0.99679625,0.00082009274,0.0015961215,0.00038839926,0.0001742841,0.00022487257],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002037796,0.00037424493,0.0031837015,0.0011861697,0.000033533168,0.00001550066,0.00016677413,0.000102202626,0.000011220942],"category_scores_gemma":[0.00017389028,0.00038266764,0.000115174786,0.0015710653,0.00020660638,0.00026091142,0.000032166026,0.00015564122,2.875545e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0057109827,0.0006230914,0.8004593,0.0022524057,0.00038460395,0.000022240676,0.005604833,0.18236189,0.000032272026,0.0008957638,0.000005032606,0.0016475499],"study_design_scores_gemma":[0.023547787,0.0024270762,0.95391667,0.0022072028,0.00018528648,0.000003175194,0.0040049837,0.010333548,0.0023183755,0.0003583793,0.00018784593,0.00050967385],"about_ca_topic_score_codex":0.945042,"about_ca_topic_score_gemma":0.9184057,"teacher_disagreement_score":0.17202835,"about_ca_system_score_codex":0.007476009,"about_ca_system_score_gemma":0.003737618,"threshold_uncertainty_score":0.99986255},"labels":[],"label_agreement":null},{"id":"W2343855777","doi":"10.1016/j.jval.2015.03.1174","title":"Use of Abiraterone in The Management of Castration-Resistant Prostate Cancer: a Real-Life Cost-Effectiveness Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Docetaxel; Medicine; Prostate cancer; Internal medicine; Abiraterone acetate; Oncology; Cabazitaxel; Cohort; Proportional hazards model; Chemotherapy; Androgen deprivation therapy; Cancer","score_opus":0.28544486676665515,"score_gpt":0.4453572295609907,"score_spread":0.15991236279433557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343855777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920118,0.0010380801,0.0000032278826,0.0010124871,0.00005700909,0.0057513807,0.000035741592,0.0000064240353,0.00008384827],"genre_scores_gemma":[0.99735934,0.0017669138,0.00008616664,0.000038912487,0.00001241465,0.00064671825,0.000013471405,0.0000107343,0.00006533849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980269,0.00061663555,0.00045756807,0.00019304248,0.00045504718,0.00025081215],"domain_scores_gemma":[0.9992556,0.00011968897,0.00013573108,0.00026962854,0.00011160245,0.00010775293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019246974,0.00009838331,0.0003390249,0.00015012846,0.000023761444,0.000008416818,0.00007795447,0.000023921963,0.0000031646691],"category_scores_gemma":[0.00002439299,0.000062561216,0.000022361919,0.0005036705,0.00005790567,0.00006340077,0.000027989818,0.00012404186,8.569472e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008459797,0.003548798,0.9447293,0.004573997,0.00021475313,0.00031204475,0.022603003,0.008337115,0.00050681893,0.0006319982,0.00012970707,0.005952638],"study_design_scores_gemma":[0.0075993603,0.0028992204,0.979564,0.0012298151,0.000031454507,0.000001850552,0.007561141,0.0005091137,0.00036891177,0.00006123927,0.000112039874,0.00006183372],"about_ca_topic_score_codex":0.070381366,"about_ca_topic_score_gemma":0.0014202789,"teacher_disagreement_score":0.06896109,"about_ca_system_score_codex":0.00051569013,"about_ca_system_score_gemma":0.0008230437,"threshold_uncertainty_score":0.935809},"labels":[],"label_agreement":null},{"id":"W2343886336","doi":"10.1016/j.jval.2015.03.1343","title":"Respiratory Related Hospitalizations In Premature Infants Prophylaxed With Palivizumab In the Canadian Registry of Palivizumab (Caress)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Neonatal Respiratory Health Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Gestational age; Pediatrics; Incidence (geometry); Respiratory system; Internal medicine; Pregnancy; Biology","score_opus":0.07059980997668107,"score_gpt":0.35171558280925036,"score_spread":0.2811157728325693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343886336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813828,0.0077596633,0.0000016900334,0.0049874526,0.00009758455,0.0032578234,0.000051192295,0.000025049205,0.002436772],"genre_scores_gemma":[0.9977596,0.00012196289,0.00016706354,0.0015988932,0.000037541246,0.00016775978,0.000029965186,0.000044345565,0.00007290418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9951071,0.0012886135,0.0010786749,0.0004582825,0.0011897815,0.00087751605],"domain_scores_gemma":[0.9974577,0.0002200663,0.00029348247,0.0009661741,0.0003520384,0.0007105807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00392877,0.00022287406,0.0005643577,0.0010681695,0.00009638158,0.000030947624,0.00039474448,0.00032173505,0.000014582867],"category_scores_gemma":[0.0023635577,0.00016235997,0.00003485955,0.0029388564,0.00022327954,0.00016368086,0.000042878168,0.0013837029,0.000009454908],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019398793,0.00075184024,0.9499771,0.005702351,0.000030426798,0.0022205824,0.022109864,0.0043203733,0.000029739142,0.005693552,0.0015205268,0.005703774],"study_design_scores_gemma":[0.011468367,0.005429508,0.9479448,0.0068704365,0.000012627731,0.00014021038,0.0041005984,0.0019454772,0.00008504281,0.0012475421,0.020283772,0.00047158822],"about_ca_topic_score_codex":0.418418,"about_ca_topic_score_gemma":0.5810849,"teacher_disagreement_score":0.16266693,"about_ca_system_score_codex":0.00224984,"about_ca_system_score_gemma":0.018516215,"threshold_uncertainty_score":0.9870479},"labels":[],"label_agreement":null},{"id":"W2343913309","doi":"10.1016/j.jval.2015.03.212","title":"The Processes For A Common Quality Assurance Approach To Multi-Centre Clinical Trials – The Mars Excite Experience","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University Health Network; University of Toronto; St. Joseph’s Healthcare Hamilton; Occupational Cancer Research Centre; MaRS","funders":"","keywords":"Protocol (science); Reimbursement; Quality assurance; Mandate; Consistency (knowledge bases); Clinical trial; Excellence; Health technology; Harmonization; Patient safety; Quality (philosophy); Directive; Medicine; Process management; Health care; Engineering management; Business; Computer science; Engineering; Operations management; Political science; Alternative medicine","score_opus":0.8958734595184378,"score_gpt":0.6102145894217075,"score_spread":0.2856588700967303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2343913309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43887106,0.029018952,0.077690236,0.43126923,0.0044249827,0.016337184,0.0010858661,0.000153646,0.0011488532],"genre_scores_gemma":[0.92266583,0.0014320001,0.029156743,0.04158493,0.0012911496,0.0027503187,0.00004485898,0.00008603346,0.0009881528],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.97984934,0.007515679,0.010790188,0.0008489205,0.00018319907,0.0008126568],"domain_scores_gemma":[0.96734184,0.02646133,0.0044623553,0.001024577,0.0001947606,0.00051510986],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.23384301,0.00022151701,0.0017282435,0.000115769064,0.00047603203,0.00017044603,0.0007954974,0.00015202463,0.000004095314],"category_scores_gemma":[0.116311856,0.00017173613,0.0001823793,0.00045103257,0.00015241516,0.000257507,0.00007875273,0.0002990186,0.0001443519],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005915766,0.0014414086,0.58810455,0.0033454234,0.000106446285,3.6165275e-7,0.07142537,0.015155618,2.4072088e-7,0.19455793,0.1201675,0.005103564],"study_design_scores_gemma":[0.0075177727,0.0004155376,0.13042642,0.00050232816,0.000008007733,0.0000055035975,0.034627095,0.096736096,0.0000018929369,0.031398762,0.6974453,0.0009152809],"about_ca_topic_score_codex":0.007005131,"about_ca_topic_score_gemma":0.0013417057,"teacher_disagreement_score":0.5772778,"about_ca_system_score_codex":0.00063724275,"about_ca_system_score_gemma":0.0012202545,"threshold_uncertainty_score":0.9996073},"labels":[],"label_agreement":null},{"id":"W2344022877","doi":"10.1016/j.jval.2015.03.1353","title":"Comparing First- and Second-Season Palivizumab Prophylaxis In Patients with Hemodynamically Significant Congenital Heart Disease in the Caress Database (2005-2014)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Congenital Heart Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Heart disease; Demographics; Respiratory system; Internal medicine; Demography","score_opus":0.032058679219712935,"score_gpt":0.2700274605698912,"score_spread":0.23796878135017824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344022877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938426,0.0021367385,0.0000033863855,0.0014540125,0.000076830875,0.002201942,0.00019009731,0.000025191568,0.0000691799],"genre_scores_gemma":[0.99906623,0.000022733688,0.00013124655,0.00046507572,0.00003884931,0.00013568449,0.00009814877,0.000027962666,0.0000140531565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974511,0.0003793314,0.00049413316,0.00049727265,0.0005717407,0.0006063705],"domain_scores_gemma":[0.99854904,0.00021816518,0.0000662135,0.00046625556,0.00010004388,0.0006003007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007704544,0.0002441797,0.0005210425,0.00022015841,0.000082372106,0.000031873427,0.00011430418,0.000043297983,0.000011046165],"category_scores_gemma":[0.00024315661,0.00017519208,0.00003039942,0.00033787134,0.00016790665,0.00014585002,0.00011584669,0.0003996864,0.000009097767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018635418,0.00073500024,0.99375546,0.0007168528,0.000012459089,0.00014065245,0.0020287393,0.00015442689,0.0000012082811,0.000026039774,0.0002847559,0.00028088613],"study_design_scores_gemma":[0.0053736772,0.0008657356,0.9823433,0.0005060191,0.000018025694,0.000004994956,0.00089048146,0.009522347,7.2933193e-7,0.000039994604,0.0002412718,0.00019338331],"about_ca_topic_score_codex":0.0065434473,"about_ca_topic_score_gemma":0.011269368,"teacher_disagreement_score":0.011412097,"about_ca_system_score_codex":0.00048152613,"about_ca_system_score_gemma":0.0007864455,"threshold_uncertainty_score":0.9891778},"labels":[],"label_agreement":null},{"id":"W2344055717","doi":"10.1016/j.jval.2015.03.244","title":"Safety pen needle (SPN) devices in the actue care setting: an analysis of health resource utilization (HRU) in the United States","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Occupational Health and Safety Research","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Becton Dickinson (Canada)","funders":"","keywords":"Vial; Medicine; Insulin; Health care; Acute care; Operations management; Emergency medicine; Internal medicine; Engineering","score_opus":0.27832197914548423,"score_gpt":0.518206704374128,"score_spread":0.23988472522864374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344055717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9515369,0.0020604765,0.00012703284,0.04143671,0.00012984207,0.0035918208,0.00023188686,0.000032822532,0.00085252087],"genre_scores_gemma":[0.9860021,0.00065218227,0.0001913558,0.010235929,0.00007389499,0.00015882206,0.0026441438,0.000020854372,0.000020729043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97696424,0.018657083,0.0019480688,0.00038537703,0.0010270375,0.0010182062],"domain_scores_gemma":[0.9934996,0.004492935,0.0006901872,0.00068910886,0.00033682183,0.00029138752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0243165,0.0001878757,0.0006131921,0.0014164625,0.00066276867,0.000016679538,0.00066181837,0.00017053231,0.000033598433],"category_scores_gemma":[0.0010176108,0.00012387078,0.000058615304,0.0060759466,0.000074172574,0.00016660923,0.00008101691,0.0011600165,0.000010296118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033586562,0.00018101014,0.712579,0.0010207162,0.000011271236,0.000002075434,0.20895183,0.070198774,7.243767e-8,0.0012529705,0.00056611473,0.004900267],"study_design_scores_gemma":[0.000833091,0.0003822137,0.6800076,0.00030678825,0.000008510648,4.305474e-7,0.23393962,0.07057833,1.1166487e-7,0.00022500253,0.0136394305,0.00007888234],"about_ca_topic_score_codex":0.25314897,"about_ca_topic_score_gemma":0.07708753,"teacher_disagreement_score":0.17606145,"about_ca_system_score_codex":0.0012025714,"about_ca_system_score_gemma":0.004275894,"threshold_uncertainty_score":0.93975323},"labels":[],"label_agreement":null},{"id":"W2344056490","doi":"10.1016/j.jval.2015.03.1725","title":"Adherence to Iron Chelation Therapy and associated Healthcare resource Utilization and costs in Medicaid Patients with Thalassemia","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Thalassemia; Medicaid; Deferasirox; Incidence (geometry); Internal medicine; Pediatrics; Health care; Deferiprone","score_opus":0.061214443843849456,"score_gpt":0.3123881805425267,"score_spread":0.25117373669867726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344056490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98970556,0.0031202233,0.000009694019,0.0059576198,0.000040895302,0.00095753267,0.0000050691674,0.000023767301,0.0001796517],"genre_scores_gemma":[0.99693495,0.0014553616,0.00011916727,0.0013581231,0.000010422583,0.000014191202,0.000070476315,0.000014855004,0.000022451602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987161,0.0002259531,0.000294952,0.00023253544,0.00028848654,0.000241936],"domain_scores_gemma":[0.9993417,0.00005878325,0.00010395241,0.000101884325,0.0000735722,0.00032009408],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006741102,0.00010335891,0.0002279744,0.00014482993,0.000041044364,0.000008261711,0.000026228465,0.0001411073,0.0000023971797],"category_scores_gemma":[0.00025621222,0.00008054495,0.0000062813947,0.00042523892,0.00003315965,0.000057653953,0.000015010251,0.00022942945,0.0000013186495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033493896,0.00013748542,0.9369819,0.00008709163,0.000003935291,0.000003578306,0.0049643964,0.00012932361,0.000002307954,0.00004932799,0.00022866298,0.05707703],"study_design_scores_gemma":[0.0059328144,0.0025775696,0.9853237,0.0013380316,0.0000031796324,0.0000033485678,0.0012860944,0.0025059646,0.000005054871,0.00005057142,0.00087476155,0.00009885745],"about_ca_topic_score_codex":0.0062095704,"about_ca_topic_score_gemma":0.00065242645,"teacher_disagreement_score":0.056978174,"about_ca_system_score_codex":0.00040867124,"about_ca_system_score_gemma":0.00030725822,"threshold_uncertainty_score":0.93870544},"labels":[],"label_agreement":null},{"id":"W2344104450","doi":"10.1016/j.jval.2015.03.334","title":"Glycated Hemoglobin (Hba1c) Control In Patients with Type 2 Diabetes Mellitus (T2dm) Treated with Canagliflozin In a real-world setting","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Canagliflozin; Glycemic; Glycated hemoglobin; Internal medicine; Diabetes mellitus; Type 2 Diabetes Mellitus; Type 2 diabetes; Endocrinology; Insulin","score_opus":0.020484828497267325,"score_gpt":0.25867420052536416,"score_spread":0.23818937202809684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344104450","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941305,0.00050809747,0.0000015918885,0.0012080288,0.000064389504,0.0022392522,0.000012636739,0.00007789394,0.0017576363],"genre_scores_gemma":[0.9979331,0.00005755685,0.00043296523,0.0009250248,0.000025342144,0.000104096005,0.00018974484,0.00004670638,0.0002855034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975571,0.00024718227,0.0005586349,0.00044481995,0.00039803126,0.0007942186],"domain_scores_gemma":[0.9989509,0.00009906339,0.00018592067,0.0003373425,0.000111066765,0.00031572173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000710668,0.00028639208,0.0007048649,0.0006806687,0.000028018429,0.000019592264,0.00009079684,0.00006146481,0.000011131929],"category_scores_gemma":[0.000062408304,0.00021195371,0.000022733777,0.0015772808,0.00004603051,0.000107854066,0.000025380732,0.00022782423,0.000015989062],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012894681,0.00077569473,0.99106467,0.00020782916,0.00008270286,0.00008149877,0.00047259932,0.0018187743,0.0000020954635,0.000073717616,0.00046288897,0.0036680405],"study_design_scores_gemma":[0.029617159,0.0038216803,0.9575824,0.0015864994,0.00007254155,4.428736e-7,0.00020183217,0.005573559,0.00003784652,0.00004972459,0.0011733142,0.0002830091],"about_ca_topic_score_codex":0.052167647,"about_ca_topic_score_gemma":0.01680039,"teacher_disagreement_score":0.035367258,"about_ca_system_score_codex":0.0015511017,"about_ca_system_score_gemma":0.0005061409,"threshold_uncertainty_score":0.95414406},"labels":[],"label_agreement":null},{"id":"W2344111754","doi":"10.1016/j.jval.2015.03.855","title":"Drug Use Among Seniors On Public Drug Programs In Canada, 2012","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Drug; Medicine; Drug class; Medical prescription; Gerontology; Prescription drug; Antipsychotic drug; Family medicine; Antipsychotic; Psychiatry; Pharmacology","score_opus":0.32234881585246045,"score_gpt":0.3952171402858316,"score_spread":0.07286832443337116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344111754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742096,0.00037226526,0.0000012249176,0.023189005,0.000565496,0.0008905012,0.0000064779438,0.000026912843,0.0007384885],"genre_scores_gemma":[0.9943357,0.00008314677,0.0001523803,0.0045109335,0.000072357274,0.000023484956,0.000023665618,0.00001946741,0.0007788731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776566,0.00043501833,0.0004658255,0.00024202796,0.00051780837,0.0005736832],"domain_scores_gemma":[0.99833566,0.0003937936,0.00014191799,0.0002426131,0.00004540122,0.00084061216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013062423,0.00013717037,0.00031579562,0.00015984317,0.000030839543,0.000026089818,0.00008894853,0.000037285383,0.000030349847],"category_scores_gemma":[0.0004910251,0.00011258927,0.000029637466,0.00039928727,0.000031393254,0.0003606603,0.00003188732,0.00060948083,0.000020638674],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011003253,0.0002626122,0.9861768,0.00013242156,0.000006712943,0.00006897077,0.0009867644,0.00032682694,2.318111e-7,0.0001710057,0.0069390526,0.0048185755],"study_design_scores_gemma":[0.004964722,0.00036464815,0.72444624,0.00067336264,0.000016604823,0.00001818951,0.0023502517,0.027098197,0.000015165478,0.00015641228,0.2395659,0.00033030135],"about_ca_topic_score_codex":0.9767737,"about_ca_topic_score_gemma":0.8913754,"teacher_disagreement_score":0.26173055,"about_ca_system_score_codex":0.0014494312,"about_ca_system_score_gemma":0.0024506638,"threshold_uncertainty_score":0.45912573},"labels":[],"label_agreement":null},{"id":"W2344132437","doi":"10.1016/j.jval.2015.03.1624","title":"Risk of Cardiovascular events Associated with Necessary Interventions for Parkinson Disease","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Adverse effect; Internal medicine; Stroke (engine); Pharmacotherapy; Myocardial infarction; Heart failure; Disease; Confidence interval; Odds ratio","score_opus":0.07706753949940535,"score_gpt":0.3285573336009148,"score_spread":0.25148979410150946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344132437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810235,0.013779419,0.0027687466,0.00029054904,0.00014741297,0.0014535688,0.00044092152,0.000039489394,0.000056382436],"genre_scores_gemma":[0.9978018,0.00051410985,0.0011574619,0.000058699927,0.00003203865,0.00016166957,0.0001760941,0.00002625047,0.00007186665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846107,0.00027997498,0.00035562585,0.00026710643,0.00036712908,0.0002690914],"domain_scores_gemma":[0.9987793,0.0000695974,0.00021770509,0.00032233848,0.00012014809,0.0004908928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009776228,0.00013168681,0.00048976374,0.00014372708,0.000048870406,0.0000036324989,0.000059481765,0.000042858446,0.0000051816633],"category_scores_gemma":[0.0004194886,0.000106010404,0.00038177107,0.00023261047,0.000021930733,0.00005249843,0.000018749906,0.000088329856,0.0000030832368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016800041,0.0036596304,0.97055924,0.0016924045,0.0025665227,0.000099591,0.00036041814,0.010583484,8.8078093e-7,0.00025279552,0.00046915858,0.008075876],"study_design_scores_gemma":[0.014772913,0.0021773046,0.95739645,0.0042492766,0.0015288116,0.000004501812,0.00019854752,0.007867759,0.00003174356,0.00339429,0.008185706,0.00019272612],"about_ca_topic_score_codex":0.0020384402,"about_ca_topic_score_gemma":0.00004018217,"teacher_disagreement_score":0.016778298,"about_ca_system_score_codex":0.00032727627,"about_ca_system_score_gemma":0.0005662538,"threshold_uncertainty_score":0.4322979},"labels":[],"label_agreement":null},{"id":"W2344145331","doi":"10.1016/j.jval.2015.03.1231","title":"The Disconnect Between Funding Decisions of Cancer Drugs And Companion Diagnostic Tests in Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Companion diagnostic; Diagnostic test; Medicine; Test (biology); Cancer; Cancer drugs; Family medicine; Intensive care medicine; Medical physics; Pediatrics; Internal medicine","score_opus":0.21203949751455525,"score_gpt":0.36278646560157163,"score_spread":0.15074696808701638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344145331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98144704,0.009462362,0.000013110168,0.0077678235,0.0002709035,0.00018832646,0.00020876863,0.0000022579263,0.0006393898],"genre_scores_gemma":[0.995358,0.0040671234,0.000035293746,0.00044858534,0.00005635576,0.000014664389,0.000002896241,0.00000887002,0.000008209409],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876183,0.00004563941,0.00067943556,0.0001737476,0.000026215286,0.00031310826],"domain_scores_gemma":[0.9970426,0.0023884734,0.00022012477,0.00013766873,0.000008282763,0.0002028331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011673906,0.00007661745,0.00032237556,0.00010858932,0.000055407054,0.000018661995,0.0001388825,0.000024709967,0.0000071513587],"category_scores_gemma":[0.00073457725,0.00007155967,0.000016892773,0.00019323526,0.00003549295,0.000057728616,0.000057134268,0.0001463127,0.0000048049756],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003678949,0.000009767311,0.9542123,0.000017358754,0.0000051902935,5.172676e-7,0.00041640905,0.0038333428,9.182432e-8,0.036208868,0.000331898,0.004960581],"study_design_scores_gemma":[0.00076751754,0.00003174989,0.9092453,0.00012389426,0.0000014354978,4.9973113e-7,0.00025841448,0.02472021,0.0000045728543,0.048875205,0.015836004,0.00013518521],"about_ca_topic_score_codex":0.96438545,"about_ca_topic_score_gemma":0.8091171,"teacher_disagreement_score":0.15526837,"about_ca_system_score_codex":0.00093939446,"about_ca_system_score_gemma":0.00071502436,"threshold_uncertainty_score":0.29181185},"labels":[],"label_agreement":null},{"id":"W2344151845","doi":"10.1016/j.jval.2015.03.627","title":"Modelling The Cost Determinants For Older Persons’ Transitions In Care (Optic)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Health care; Ordinary least squares; Emergency department; Estimation; Medicine; Medical emergency; Nursing; Statistics","score_opus":0.20624744831102487,"score_gpt":0.43444665632784274,"score_spread":0.22819920801681787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344151845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97396773,0.002941259,0.005150637,0.011592351,0.0017309714,0.0038808526,0.000117900156,0.000055893506,0.0005624067],"genre_scores_gemma":[0.996827,0.00006312024,0.0018263091,0.00042181282,0.00021352473,0.00043601985,0.000023887063,0.000026230568,0.0001620967],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9979776,0.0005077179,0.0005115598,0.00022655669,0.00015775958,0.00061877427],"domain_scores_gemma":[0.9989729,0.0004214722,0.000108573484,0.00023295972,0.00010600173,0.00015810772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012223396,0.000114592745,0.00026955447,0.00015716211,0.00042276407,0.000007820693,0.0001272035,0.00013023171,0.000009018894],"category_scores_gemma":[0.00007022065,0.00008971216,0.000056237248,0.0002986902,0.000029171679,0.00006363805,0.000014297421,0.00040713916,0.00001725086],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021926485,0.00014344102,0.009746787,0.0015051827,0.000005985065,0.0000110678975,0.7798647,0.18873517,0.0000022412119,0.001186728,0.009005657,0.0095737185],"study_design_scores_gemma":[0.0057541425,0.000366782,0.0038114558,0.0021119697,0.000026578846,0.000009315331,0.5664082,0.40224597,0.0000062481527,0.0018229875,0.01706331,0.00037303724],"about_ca_topic_score_codex":0.016834555,"about_ca_topic_score_gemma":0.001934891,"teacher_disagreement_score":0.21351081,"about_ca_system_score_codex":0.00062673097,"about_ca_system_score_gemma":0.0012002933,"threshold_uncertainty_score":0.9897124},"labels":[],"label_agreement":null},{"id":"W2344162046","doi":"10.1016/j.jval.2015.03.1522","title":"TUBERCULOSIS screening preferences of Healthcare workers in South Africa: a best-worst scaling study to analyze variation by Occupation","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; University of British Columbia","funders":"","keywords":"Tuberculosis; Variation (astronomy); Scaling; Health care; Environmental health; Medicine; Economic growth; Economics; Mathematics","score_opus":0.15148534458644577,"score_gpt":0.40164062202966927,"score_spread":0.2501552774432235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344162046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98842233,0.0011804629,0.00087642786,0.0078794835,0.00006799077,0.0014679456,0.000024290097,0.000023114993,0.000057920977],"genre_scores_gemma":[0.99612015,0.000061203915,0.003300254,0.0003110206,0.0000605167,0.00008002135,0.00003852501,0.000015810636,0.000012502295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995841,0.0015660097,0.0010093005,0.0004436685,0.0005375044,0.00060248096],"domain_scores_gemma":[0.9983997,0.00035925498,0.00021606768,0.00028579056,0.00017918462,0.00056004355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050699203,0.00015478587,0.0006698342,0.0007058648,0.000056488083,0.000010496842,0.00012087955,0.00010287819,0.0000070813135],"category_scores_gemma":[0.0021947073,0.00013802892,0.000046782538,0.001472778,0.00002851294,0.00009161519,0.000059715323,0.0003872524,0.000009665587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056373805,0.0005083132,0.95319796,0.00017735852,0.000030143652,0.0000035934097,0.030847276,0.010360911,0.000016512287,0.000016135265,0.0003314059,0.0039466503],"study_design_scores_gemma":[0.0021278504,0.0034433373,0.9329833,0.0009799992,0.00002174456,0.000002081595,0.036353555,0.023707535,0.0000147655255,0.0001448569,0.000066777066,0.00015419217],"about_ca_topic_score_codex":0.16608271,"about_ca_topic_score_gemma":0.0038333875,"teacher_disagreement_score":0.16224933,"about_ca_system_score_codex":0.00050826214,"about_ca_system_score_gemma":0.00061360653,"threshold_uncertainty_score":0.83947045},"labels":[],"label_agreement":null},{"id":"W2344218605","doi":"10.1016/j.jval.2015.03.1435","title":"HIV treatment strategies In europe (EU): Adoption of Single Tablet Regimen (STR)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tolerability; Medicine; Dosing; Regimen; Family medicine; Quarter (Canadian coin); Human immunodeficiency virus (HIV); Demography; Pediatrics; Geography; Internal medicine; Adverse effect","score_opus":0.08063424318367501,"score_gpt":0.3113629764906792,"score_spread":0.23072873330700416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344218605","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790529,0.0014919288,0.000037473874,0.008460105,0.000117572985,0.0008386963,0.000010462042,0.000045119818,0.009945761],"genre_scores_gemma":[0.98989147,0.0005516559,0.0043534706,0.00010067943,0.00005161804,0.00003491242,0.00011980556,0.00002215151,0.0048742252],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99860466,0.00015633318,0.00048448896,0.00022584363,0.00023088975,0.0002977766],"domain_scores_gemma":[0.99936867,0.00004602501,0.00013245353,0.00021264306,0.00007210232,0.0001680922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043196385,0.00015069426,0.00039643928,0.00024027302,0.000018563793,0.000009712123,0.000043983066,0.000050826613,0.000014798031],"category_scores_gemma":[0.00004734744,0.000121017205,0.00002616191,0.0004878619,0.0000311193,0.00009241803,0.000016448492,0.00007865954,0.000056332257],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002799456,0.016388286,0.809911,0.002009907,0.00035615484,0.001303715,0.068208106,0.021909093,0.0021574437,0.020638136,0.01961546,0.034703214],"study_design_scores_gemma":[0.09587489,0.026116043,0.2567785,0.010913721,0.00033402446,0.00039181908,0.04359376,0.014167422,0.015018746,0.0049497043,0.52964866,0.0022126692],"about_ca_topic_score_codex":0.0019196171,"about_ca_topic_score_gemma":0.00014121104,"teacher_disagreement_score":0.55313253,"about_ca_system_score_codex":0.00090228225,"about_ca_system_score_gemma":0.0013389443,"threshold_uncertainty_score":0.49349383},"labels":[],"label_agreement":null},{"id":"W2344298048","doi":"10.1016/j.jval.2015.03.974","title":"Canadian Public Reimbursement of Subsequent Entry Biologics (Sebs) / Biosimilars","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Infliximab; Biosimilar; Reimbursement; Formulary; Medicine; Family medicine; Health care; Internal medicine; Disease; Political science","score_opus":0.1314074851867528,"score_gpt":0.3296436078192548,"score_spread":0.19823612263250198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344298048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7152494,0.05616772,0.00038802685,0.20668396,0.006090959,0.0020937847,0.00058481796,0.00016042088,0.012580895],"genre_scores_gemma":[0.99330544,0.0008182275,0.0018647219,0.0035385964,0.000028654862,0.000010220198,0.00004616946,0.000011497975,0.00037648578],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9974294,0.0008562258,0.00062078814,0.00030572334,0.00005910863,0.0007288067],"domain_scores_gemma":[0.9990322,0.00012192381,0.00017055323,0.00032254477,0.000097419885,0.0002553785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024148761,0.00016005254,0.000408075,0.00030935675,0.00007172907,0.000008780177,0.00027451437,0.00032824243,0.0002152982],"category_scores_gemma":[0.0003895185,0.00012815821,0.00007338194,0.00040607277,0.00019309379,0.000038342216,0.0000616806,0.00032836548,0.00004007342],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048027004,0.0020488573,0.5377393,0.0006643149,0.0006198277,0.00010433917,0.0020947687,0.0003889373,0.016464626,0.15309891,0.20453785,0.081757985],"study_design_scores_gemma":[0.0037166548,0.0025757884,0.0206564,0.0003471122,0.000040156905,0.00008269189,0.0016930772,0.00035982748,0.021731758,0.009460282,0.9385576,0.0007786144],"about_ca_topic_score_codex":0.09299151,"about_ca_topic_score_gemma":0.021571873,"teacher_disagreement_score":0.73401976,"about_ca_system_score_codex":0.0006304943,"about_ca_system_score_gemma":0.0016205945,"threshold_uncertainty_score":0.99628186},"labels":[],"label_agreement":null},{"id":"W2344331325","doi":"10.1016/j.jval.2015.03.096","title":"Should decision makers embrace non-constant discounting?","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Discounting; Constant (computer programming); Economics; Econometrics; Mathematical economics; Microeconomics; Computer science","score_opus":0.23457006303464598,"score_gpt":0.28773263669557353,"score_spread":0.05316257366092755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344331325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97048414,0.0018463328,0.0055482388,0.0020382747,0.00077833596,0.0003452269,0.0000399981,0.000021091691,0.018898355],"genre_scores_gemma":[0.9950174,0.00034100586,0.0033382007,0.0008510985,0.000071636896,0.00001632266,0.000013762187,0.00002205953,0.0003285103],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843293,0.000024880934,0.00079450547,0.00037423332,0.0000512299,0.00032222643],"domain_scores_gemma":[0.9991814,0.00006894045,0.00031222566,0.00027081964,0.0000050044,0.00016159068],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0021769993,0.000120607205,0.00031985054,0.00017280082,0.000059936116,0.000036582303,0.00014019733,0.00007719061,0.00012568154],"category_scores_gemma":[0.00011410942,0.00014074135,0.00005004414,0.00014564885,0.000041902436,0.00024874762,0.00005534619,0.00014879828,0.0012098221],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034971054,0.00012893946,0.8836919,0.0000426678,0.000009920407,0.000003396457,0.0014601588,0.042430084,0.0000027447502,0.06481529,0.003765391,0.0036145188],"study_design_scores_gemma":[0.004561189,0.0004214102,0.512009,0.00024260483,0.0000040125838,0.000016161672,0.0020414607,0.23617665,0.000031628635,0.19244766,0.05120976,0.00083845446],"about_ca_topic_score_codex":0.003996611,"about_ca_topic_score_gemma":0.00007739357,"teacher_disagreement_score":0.3716829,"about_ca_system_score_codex":0.00078878563,"about_ca_system_score_gemma":0.00007584851,"threshold_uncertainty_score":0.99956787},"labels":[],"label_agreement":null},{"id":"W2344464066","doi":"10.1016/j.jval.2015.03.1329","title":"Serious Adverse Events In Canadian Children Receiving Palivizumab for the Prevention of Respiratory Syncytial Virus Infection","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Tolerability; Pediatrics; Adverse effect; Observational study; Respiratory system; Internal medicine","score_opus":0.10080863401052034,"score_gpt":0.40178518505051664,"score_spread":0.3009765510399963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344464066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99599504,0.00053371943,0.00013772765,0.0003731208,0.00027388745,0.002515392,0.000014502071,0.000019281868,0.00013734121],"genre_scores_gemma":[0.9991709,0.00011386469,0.000074945645,0.00023349684,0.00014251792,0.00017765287,0.0000105210165,0.000023824843,0.000052283714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978,0.0006130418,0.0005837799,0.0002322979,0.00030529636,0.00046560296],"domain_scores_gemma":[0.9989458,0.00013401646,0.0001564238,0.00031989114,0.00013345077,0.00031047422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038030501,0.000112627364,0.00027016012,0.00067631184,0.000103954626,0.000003898621,0.000088938315,0.00012860907,0.000015543397],"category_scores_gemma":[0.0012223852,0.000096553595,0.00007080923,0.00071260706,0.000045497247,0.00013203105,0.0000256637,0.0003678301,0.000012034565],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026465545,0.00017347984,0.9751503,0.00021031233,0.000022745005,0.000003399506,0.00042134218,0.0109268,0.00015337471,0.0000903953,0.00018476388,0.012398443],"study_design_scores_gemma":[0.0027106577,0.0015075617,0.98886204,0.00037433705,0.000011504103,0.0000141875225,0.000058910013,0.0031871018,0.00030669713,0.00020557504,0.002669754,0.000091649956],"about_ca_topic_score_codex":0.8215256,"about_ca_topic_score_gemma":0.61703247,"teacher_disagreement_score":0.20449312,"about_ca_system_score_codex":0.0021561875,"about_ca_system_score_gemma":0.0039510294,"threshold_uncertainty_score":0.70089567},"labels":[],"label_agreement":null},{"id":"W2344586242","doi":"10.1016/j.jval.2015.03.1240","title":"Pcodr – the pointless canadian oncology drug review?","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Excellence; Agency (philosophy); Medicine; Family medicine; Health technology; Cancer drugs; Actuarial science; Health care; Business; Internal medicine; Political science; Cancer","score_opus":0.6382060207309973,"score_gpt":0.4735590873269704,"score_spread":0.16464693340402692,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344586242","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012450804,0.09189855,0.00011240886,0.86229205,0.001850118,0.0017381283,0.000181792,0.00003668872,0.02943944],"genre_scores_gemma":[0.34479088,0.020180026,0.002911117,0.6273778,0.0012661578,0.00046306665,0.00009024978,0.00010032903,0.0028204103],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99314296,0.0016377532,0.0039581615,0.0004492259,0.00009819756,0.0007136982],"domain_scores_gemma":[0.9960239,0.0009542836,0.001540093,0.0006668501,0.00006395696,0.0007509248],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.060280196,0.0001571496,0.0010213241,0.00033855785,0.00018587962,0.000031662144,0.00045020483,0.000103456565,0.00021900513],"category_scores_gemma":[0.0048029106,0.00016171492,0.00007566921,0.0003773259,0.00006972149,0.0001879025,0.000040506304,0.00035182876,0.0034901765],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000051105853,0.000058912407,0.020698879,0.0012375823,0.000015693047,0.000004335303,0.0060714376,0.0011942906,1.685899e-8,0.18273741,0.78712934,0.0008470075],"study_design_scores_gemma":[0.0005076379,0.00007284669,0.00427346,0.0006045246,0.000001687163,0.000015056369,0.0011841145,0.0043656873,1.500127e-7,0.02025085,0.968525,0.00019901589],"about_ca_topic_score_codex":0.7147973,"about_ca_topic_score_gemma":0.1812115,"teacher_disagreement_score":0.5335858,"about_ca_system_score_codex":0.0047915983,"about_ca_system_score_gemma":0.004269797,"threshold_uncertainty_score":0.9990288},"labels":[],"label_agreement":null},{"id":"W2344591572","doi":"10.1016/j.jval.2015.03.101","title":"Assessing The Incremental Predictive Value Of Healthcare Utilization Pathways In Risk Prediction Modeling","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Saskatchewan Health Quality Council; University of Manitoba","funders":"","keywords":"Medicine; Cohort; Emergency department; Health care; Proportional hazards model; Logistic regression; Statistic; Ambulatory; Hazard ratio; Population; Statistics; Akaike information criterion; COPD; Emergency medicine; Demography; Internal medicine; Environmental health; Mathematics; Confidence interval","score_opus":0.223990011396999,"score_gpt":0.39779283503377627,"score_spread":0.17380282363677726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344591572","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857098,0.0021830138,0.006904764,0.001936684,0.0002958554,0.0015036258,0.00005279684,0.00007339076,0.0013401026],"genre_scores_gemma":[0.99847794,0.0006163916,0.0004339987,0.00018986197,0.00011181155,0.000043834665,0.00010151962,0.000020575211,0.0000040706805],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974691,0.0006110399,0.00075723743,0.00028916897,0.0005577305,0.00031570165],"domain_scores_gemma":[0.9990984,0.00008168626,0.00027822258,0.00029396164,0.00009873648,0.00014898778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024615207,0.00013568862,0.00029156805,0.0002580939,0.000077983255,0.000024670448,0.0000940431,0.000068538626,0.0000049803766],"category_scores_gemma":[0.000292346,0.000112412796,0.000042208056,0.0005243222,0.00005584587,0.0003040823,0.00006546553,0.00031751263,0.0000016030276],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021792264,0.00037381696,0.23238142,0.0011677641,0.000030187557,0.000009693558,0.006189187,0.748763,0.000015085587,0.0065773185,0.00012428695,0.004150281],"study_design_scores_gemma":[0.0018749811,0.00040269713,0.07275934,0.0010782249,0.0000255257,0.0000035032808,0.015371604,0.90490645,0.000015752905,0.0034731103,0.000028400082,0.000060421014],"about_ca_topic_score_codex":0.025708508,"about_ca_topic_score_gemma":0.00022944855,"teacher_disagreement_score":0.15962209,"about_ca_system_score_codex":0.0013290198,"about_ca_system_score_gemma":0.001520118,"threshold_uncertainty_score":0.9807794},"labels":[],"label_agreement":null},{"id":"W2344610150","doi":"10.1016/j.jval.2015.03.838","title":"Persistence And Compliance With Lipid- Lowering Drugs In Patients With Chronic Kidney Disease","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Kidney disease; Persistence (discontinuity); Internal medicine; Poisson regression; Cohort; Nephrology; Diabetes mellitus; Disease; Cohort study; Population; Endocrinology; Environmental health","score_opus":0.07547145479782982,"score_gpt":0.3047942212543732,"score_spread":0.2293227664565434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344610150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99334335,0.0008046308,0.00011907076,0.0045933365,0.0000630171,0.0006292881,0.000004852123,0.000023228646,0.00041922915],"genre_scores_gemma":[0.9973016,0.00008090317,0.0006324655,0.0016544701,0.00004139603,0.000036276393,0.000014826471,0.000011265495,0.00022678993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988927,0.00004266787,0.00020941146,0.00027245766,0.0003185378,0.00026420678],"domain_scores_gemma":[0.99882674,0.00002171994,0.00008994973,0.00024623406,0.00006458261,0.00075079175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023350435,0.00010413005,0.00021304378,0.0000733094,0.00003071152,0.000008145605,0.00007045381,0.000020523468,0.00002383046],"category_scores_gemma":[0.00007957463,0.00007939672,0.0000082445395,0.0002753737,0.00008989132,0.000083212006,0.000018363564,0.00016744404,0.00003412606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004709067,0.00015557608,0.9955681,0.0006227721,0.0000036388924,0.000007813376,0.000709375,0.00022341586,7.457815e-7,0.000046811976,0.00041371564,0.0017771395],"study_design_scores_gemma":[0.005526376,0.0009966342,0.98105186,0.0050435965,0.0000061191504,0.000003897126,0.0002606471,0.00519245,0.0000024640644,0.000030877814,0.0017575666,0.00012751712],"about_ca_topic_score_codex":0.0005426162,"about_ca_topic_score_gemma":0.000021367878,"teacher_disagreement_score":0.014516234,"about_ca_system_score_codex":0.00032588313,"about_ca_system_score_gemma":0.0014608798,"threshold_uncertainty_score":0.32377043},"labels":[],"label_agreement":null},{"id":"W2344625650","doi":"10.1016/j.jval.2015.03.086","title":"Comparing the predictive performance of two variants of the elixhauser comorbidity measures for all-cause in-hospital mortality in a large multi-payer u.s. Administrative database","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Insurance, Mortality, Demography, Risk Management","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Comorbidity; Medicine; Confounding; Logistic regression; Emergency medicine; Statistic; Demography; Health care; Medical diagnosis; Internal medicine; Statistics","score_opus":0.23330155053984405,"score_gpt":0.4206595807583505,"score_spread":0.18735803021850647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344625650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99525774,0.00020936815,0.00018464007,0.000534719,0.0005087641,0.0025860171,0.00023438715,0.000014488208,0.00046985148],"genre_scores_gemma":[0.9990476,0.00029911954,0.0003467673,0.000096100266,0.000049434177,0.000133644,0.000009499174,0.000011214671,0.0000066461425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99615395,0.0013802439,0.00082368206,0.0003300161,0.00077031826,0.00054180436],"domain_scores_gemma":[0.99846363,0.00023821174,0.00050513016,0.0005057566,0.00018412272,0.00010314191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009590408,0.00016074744,0.0004206796,0.00012550809,0.00017478518,0.000018643645,0.0006183379,0.000060851235,0.0000027115414],"category_scores_gemma":[0.0005298453,0.00011669475,0.00008059627,0.0007251005,0.00044083086,0.000299388,0.00016241599,0.0003272478,7.1058497e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009603088,0.0008661073,0.9595337,0.00013998513,0.000051933912,0.0000018398943,0.0284496,0.0034341656,0.0000022184706,0.0072999233,0.00008259777,0.000041904717],"study_design_scores_gemma":[0.0018949755,0.00017054014,0.96602774,0.00022833423,0.000021157737,1.3794237e-7,0.006939113,0.023823619,0.00003521941,0.00055286294,0.00019184787,0.00011442727],"about_ca_topic_score_codex":0.079611026,"about_ca_topic_score_gemma":0.13883235,"teacher_disagreement_score":0.059221316,"about_ca_system_score_codex":0.00029698826,"about_ca_system_score_gemma":0.0007631491,"threshold_uncertainty_score":0.9265179},"labels":[],"label_agreement":null},{"id":"W2344659104","doi":"10.1016/j.jval.2015.03.1128","title":"Overall survival in post-menopausal women with hr+/her2- metastatic breast cancer treated with 1st-line endocrine therapy vs. Chemotherapy","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Metastatic breast cancer; Hazard ratio; Internal medicine; Proportional hazards model; Breast cancer; Chemotherapy; Oncology; Cancer; Medical record; Gynecology; Confidence interval","score_opus":0.041236051209525615,"score_gpt":0.3246524755579592,"score_spread":0.28341642434843356,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344659104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98099476,0.0025391444,0.00009978252,0.014329064,0.000098218414,0.0015850405,0.00012308787,0.00013184606,0.00009905533],"genre_scores_gemma":[0.9900952,0.0014932678,0.0022945434,0.0048979707,0.0002208714,0.000424827,0.0000519289,0.00016989354,0.0003514811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965194,0.00033525622,0.0006522185,0.00065483846,0.0007168416,0.0011214691],"domain_scores_gemma":[0.9982281,0.0001116937,0.0002916232,0.00052380917,0.00028296208,0.0005618515],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007097023,0.00051369274,0.0011566305,0.00035896123,0.00004928245,0.000023214001,0.00017841018,0.00005863659,0.0002446533],"category_scores_gemma":[0.000017413706,0.00035474097,0.000023916113,0.0008754974,0.00016632823,0.00023803422,0.000021217244,0.00047849314,0.000007845645],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23576987,0.0056194663,0.48670542,0.001175026,0.0016377987,0.0015155751,0.025723444,0.04563328,0.006070546,0.00041032975,0.00013598321,0.18960327],"study_design_scores_gemma":[0.12197338,0.036581427,0.81924134,0.0023789594,0.000067166045,0.001961894,0.0038120204,0.002252501,0.0014976808,0.0006855437,0.0080281645,0.0015199066],"about_ca_topic_score_codex":0.042528685,"about_ca_topic_score_gemma":0.0021534052,"teacher_disagreement_score":0.33253595,"about_ca_system_score_codex":0.0022618384,"about_ca_system_score_gemma":0.0020272164,"threshold_uncertainty_score":0.99989045},"labels":[],"label_agreement":null},{"id":"W2344728545","doi":"10.1016/j.jval.2015.03.835","title":"Cost Effectiveness of Drugs for Pulmonary Arterial Hypertension: A Canadian Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pulmonary Hypertension Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"","keywords":"Tadalafil; Medicine; Sildenafil; Combination therapy; Riociguat; Placebo; Quality-adjusted life year; Cost-effectiveness analysis; Internal medicine; Pulmonary hypertension; Cost effectiveness; Chronic thromboembolic pulmonary hypertension","score_opus":0.16069031487988508,"score_gpt":0.3779929736393779,"score_spread":0.2173026587594928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344728545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934672,0.0005192401,0.000005888871,0.0011006824,0.00028911617,0.0042486503,0.00006191553,0.00001450455,0.00029279324],"genre_scores_gemma":[0.99909484,0.000025613268,0.00021606019,0.0002142557,0.00007330099,0.00023490425,0.00006956553,0.000020176807,0.00005130237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820924,0.0004287127,0.00030990393,0.00027603988,0.00032168798,0.00045442354],"domain_scores_gemma":[0.99825203,0.00028564857,0.000053105814,0.0002799894,0.00021990601,0.0009093398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014659722,0.00012372593,0.00050747494,0.00029452008,0.00006110544,0.000004872617,0.000069715315,0.00005694272,0.0000074668947],"category_scores_gemma":[0.000287682,0.0000994686,0.000054432807,0.00026512696,0.00003746163,0.00004517813,0.000022142713,0.00011261637,0.000012703833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024319053,0.01741876,0.91120464,0.0027888096,0.00039383123,0.011706524,0.0018950464,0.0005143903,0.0012649684,0.00026051188,0.0028598069,0.02537364],"study_design_scores_gemma":[0.027453253,0.011607622,0.93892086,0.001278118,0.00007079722,0.00072982634,0.0035230005,0.010547413,0.00025842962,0.0008076991,0.0045212484,0.00028173605],"about_ca_topic_score_codex":0.34481287,"about_ca_topic_score_gemma":0.0042964094,"teacher_disagreement_score":0.34051645,"about_ca_system_score_codex":0.0005007538,"about_ca_system_score_gemma":0.0022301534,"threshold_uncertainty_score":0.6595501},"labels":[],"label_agreement":null},{"id":"W2344781650","doi":"10.1016/j.jval.2015.03.945","title":"Biologic Discontinuation In Rheumatoid Arthritis: Experience From Canadian Clinics","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Clinical Research Institute","funders":"","keywords":"Discontinuation; Medicine; Rheumatoid arthritis; Hazard ratio; Proportional hazards model; Internal medicine; Confidence interval; Rheumatology; Cohort; Pharmacy; Prospective cohort study; Cohort study; Family medicine","score_opus":0.07325251117706211,"score_gpt":0.34661689109491295,"score_spread":0.27336437991785084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344781650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9624889,0.032860797,0.000019277764,0.0034865504,0.00022039932,0.00046739343,0.000022840213,0.000026786092,0.00040703916],"genre_scores_gemma":[0.93761307,0.06106737,0.00057849934,0.0005565854,0.000038855844,0.00005495314,0.00006130323,0.000011703621,0.000017653989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810827,0.0002986424,0.000549442,0.00027324006,0.00023672555,0.000533693],"domain_scores_gemma":[0.99888015,0.00012176302,0.00007358194,0.0002338026,0.000049679184,0.00064101646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010607332,0.0001061718,0.00034186663,0.00027983938,0.000048721344,0.00002568056,0.00010096141,0.00008402311,0.000057718575],"category_scores_gemma":[0.00080450316,0.00009732161,0.000029306342,0.0002986606,0.00008933637,0.00012893826,0.0000201788,0.00027439656,0.000075066135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014588815,0.00018048137,0.8905283,0.000012888196,0.0000072092566,0.00013233462,0.013686451,0.00015757883,0.000034673343,0.0013224968,0.0005236254,0.09326807],"study_design_scores_gemma":[0.02091433,0.0034844354,0.7873902,0.008021335,5.48928e-7,0.00013942912,0.029290533,0.026451081,0.00021721465,0.024210412,0.09902924,0.0008512633],"about_ca_topic_score_codex":0.64584506,"about_ca_topic_score_gemma":0.38639358,"teacher_disagreement_score":0.25945148,"about_ca_system_score_codex":0.000396722,"about_ca_system_score_gemma":0.0017351749,"threshold_uncertainty_score":0.6248031},"labels":[],"label_agreement":null},{"id":"W2344793782","doi":"10.1016/j.jval.2015.03.1599","title":"The Burden of Gout in a Canadian Primary Care Population","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Gout; Medicine; Dyslipidemia; Internal medicine; Comorbidity; Population; Cohort; Physical therapy; Retrospective cohort study; Obesity; Environmental health","score_opus":0.04199059418450885,"score_gpt":0.30378038739646335,"score_spread":0.2617897932119545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344793782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848007,0.00397913,0.0000015475974,0.007088986,0.00019117096,0.0005861673,0.000009094498,0.000012144268,0.0033310333],"genre_scores_gemma":[0.9988314,0.00007287482,0.00036088793,0.0004312936,0.00013104564,0.000011457785,0.000040496558,0.000013640893,0.0001068964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873257,0.00014504447,0.00037586226,0.00013747599,0.00025708173,0.00035196322],"domain_scores_gemma":[0.9991775,0.000067250105,0.000090991394,0.00028214284,0.000058327383,0.00032377636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085884274,0.000073479125,0.00022444548,0.00018360566,0.000035536246,0.0000042272786,0.00008558134,0.000074474105,0.0000027588799],"category_scores_gemma":[0.0002787976,0.000057189696,0.000021879774,0.00032440692,0.000023433746,0.000033191227,0.00001743967,0.00020608208,0.000008799282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000087643275,0.000030309657,0.95303875,0.0006664885,0.000010125954,0.000042858046,0.026166823,0.0062480317,0.00001686541,0.00045889858,0.0011255672,0.012107656],"study_design_scores_gemma":[0.0022081514,0.0003617768,0.96050185,0.0007237868,0.0000148152185,0.00004239943,0.0070280917,0.0063219923,0.000011407469,0.00041780653,0.022234302,0.00013364092],"about_ca_topic_score_codex":0.9662868,"about_ca_topic_score_gemma":0.27033618,"teacher_disagreement_score":0.69595057,"about_ca_system_score_codex":0.0025000484,"about_ca_system_score_gemma":0.0028572583,"threshold_uncertainty_score":0.7429783},"labels":[],"label_agreement":null},{"id":"W2344795692","doi":"10.1016/j.jval.2015.03.1573","title":"The market for Hepatitis C services in Alberta","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"","keywords":"Hepatitis C; Activity-based costing; Cirrhosis; Liver disease; Service (business); Medicine; Market segmentation; Business; Family medicine; Internal medicine; Marketing","score_opus":0.08335228341309626,"score_gpt":0.3811638095800761,"score_spread":0.29781152616697987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344795692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.884963,0.0028095131,0.000053174517,0.08243125,0.0004867097,0.003485445,0.000028560587,0.000035828118,0.025706522],"genre_scores_gemma":[0.9896158,0.0026384068,0.0014530005,0.0021901664,0.00016461428,0.00028220902,0.000020752916,0.000035733454,0.0035993354],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983096,0.00030460078,0.00037921168,0.00019021495,0.0003261965,0.000490153],"domain_scores_gemma":[0.9984606,0.00084962184,0.000054135246,0.00029805696,0.00007992754,0.00025769445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025291275,0.00008137801,0.00022479892,0.00012439452,0.000059027963,0.000020670313,0.00014484477,0.00005911465,0.000025353316],"category_scores_gemma":[0.0007819695,0.000059700797,0.000028813032,0.00030079926,0.000035632092,0.00005577709,0.000043470583,0.00020514881,0.000043135846],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038363642,0.00011682405,0.9299533,0.0008314264,0.000010511367,0.000023362576,0.0023485625,0.00007694236,0.0000042704655,0.0014381519,0.017605055,0.04720799],"study_design_scores_gemma":[0.0040186634,0.0009721459,0.18712893,0.0008204085,0.0000034947172,0.00001201243,0.00036264432,0.1497887,0.00003735632,0.0036831463,0.6530269,0.00014565754],"about_ca_topic_score_codex":0.33027965,"about_ca_topic_score_gemma":0.12495183,"teacher_disagreement_score":0.7428243,"about_ca_system_score_codex":0.00042292548,"about_ca_system_score_gemma":0.0008592426,"threshold_uncertainty_score":0.8910155},"labels":[],"label_agreement":null},{"id":"W2344925427","doi":"10.1016/j.jval.2015.03.1665","title":"What are people willing to pay for whole genome sequencing information?","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Bone and Joint Health Institute","funders":"","keywords":"Willingness to pay; Respondent; Contingent valuation; Harm; Medicine; Population; Actuarial science; Family medicine; Psychology; Business; Social psychology; Environmental health; Economics","score_opus":0.47968343518192064,"score_gpt":0.4236131884081372,"score_spread":0.056070246773783416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344925427","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4943835,0.0063860184,0.081830494,0.40347487,0.0056734355,0.006184875,0.0011842952,0.0001944563,0.00068803586],"genre_scores_gemma":[0.8382048,0.00063782494,0.041328885,0.11605447,0.0013943433,0.0010938691,0.00039055583,0.000106283274,0.0007889955],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.994589,0.00024170439,0.0040574614,0.00037718526,0.00011363925,0.000621042],"domain_scores_gemma":[0.99648434,0.00060958986,0.0018468978,0.00043456012,0.00012507488,0.0004995324],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.024203718,0.00016877854,0.0008738477,0.0005780284,0.00017804603,0.00022712217,0.00025587357,0.0001098829,0.000023364752],"category_scores_gemma":[0.003935471,0.00020085202,0.00007300435,0.0003908777,0.0000122851125,0.0021817405,0.000049345403,0.00016749241,0.0017435855],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007047045,0.00012325158,0.117223516,0.004175809,0.000051543833,9.758332e-7,0.14106232,0.61242944,0.0000025553336,0.083846904,0.039917257,0.0010959872],"study_design_scores_gemma":[0.0022206143,0.00037767433,0.02623793,0.00080715865,0.000002728113,0.000007976397,0.044916607,0.13335598,0.0000022739289,0.0398706,0.75145984,0.0007406327],"about_ca_topic_score_codex":0.0069343387,"about_ca_topic_score_gemma":0.00076377415,"teacher_disagreement_score":0.71154255,"about_ca_system_score_codex":0.0030430788,"about_ca_system_score_gemma":0.0008808752,"threshold_uncertainty_score":0.99967855},"labels":[],"label_agreement":null},{"id":"W2344941622","doi":"10.1016/j.jval.2015.03.789","title":"Geographic Differences In Availability Of Antihypertensive Medications: A Comparison Of Australia, Canada, Saudi Arabia, Uk, And The Us","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Food and drug administration; Antihypertensive drug; Pharmaceutical Benefits Scheme; Environmental health; Family medicine; Internal medicine; Pharmacology; Blood pressure; Medical prescription","score_opus":0.12854499033636957,"score_gpt":0.33490604366982846,"score_spread":0.2063610533334589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344941622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9589848,0.030089872,0.0000011199148,0.010320778,0.000085831314,0.00044177388,0.000013098475,0.0000033096685,0.00005941235],"genre_scores_gemma":[0.9980732,0.000964787,0.00011387354,0.0007872487,0.00001719556,0.000013364857,0.0000026715104,0.0000032835796,0.000024349976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983684,0.00028555098,0.00066033204,0.00016975324,0.00034315838,0.00017279369],"domain_scores_gemma":[0.998671,0.0005206499,0.00022930848,0.00024176447,0.00022908073,0.00010817153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010595967,0.00008896314,0.00090984884,0.00010827365,0.000031299875,0.0000018143468,0.00007004521,0.000050136212,0.0000066555003],"category_scores_gemma":[0.00044244662,0.000055042052,0.000027785483,0.0002817735,0.00042805178,0.000015365707,0.0000366835,0.00020157218,2.8979318e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013260957,0.0001250154,0.99452084,0.0002657063,0.00006285413,0.0000031988175,0.0024358619,0.000016231697,0.00000862383,0.0001634277,0.002036674,0.00022894474],"study_design_scores_gemma":[0.0021870444,0.0001737593,0.99329436,0.00036541265,0.00008701274,0.000009404424,0.0021905608,0.00079003203,0.000033849614,0.00041190954,0.00040855384,0.000048098653],"about_ca_topic_score_codex":0.9325324,"about_ca_topic_score_gemma":0.5196011,"teacher_disagreement_score":0.41293132,"about_ca_system_score_codex":0.000022005466,"about_ca_system_score_gemma":0.00064783986,"threshold_uncertainty_score":0.48916492},"labels":[],"label_agreement":null},{"id":"W2344995406","doi":"10.1016/j.jval.2015.03.1631","title":"Teriflunomide Shows Consistent Clinical Efficacy On Severe Relapses Across temso and tower: 2 Phase 3 trials","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Ginseng Biological Effects and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Teriflunomide; Medicine; Placebo; Tolerability; Internal medicine; Post-hoc analysis; Randomized controlled trial; Clinical endpoint; Clinical trial; Physical therapy; Adverse effect; Multiple sclerosis; Immunology; Pathology; Alternative medicine","score_opus":0.24609849403132955,"score_gpt":0.47822724840647296,"score_spread":0.2321287543751434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344995406","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956109,0.0011375331,0.000080292506,0.001978144,0.00019980216,0.0006502865,0.0000854562,0.000016323444,0.0002412705],"genre_scores_gemma":[0.99652284,0.00061214523,0.0004711392,0.0018336686,0.0002640297,0.000034391152,0.00007665379,0.000010770854,0.00017436416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978157,0.0007059426,0.00068799057,0.00042784112,0.000084404004,0.000278103],"domain_scores_gemma":[0.9987899,0.00039615858,0.0001927997,0.0003070415,0.000034644505,0.00027945425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034399815,0.00013913038,0.00041312826,0.000017981143,0.000077576,0.000026089581,0.00010695612,0.00018628662,0.000005447705],"category_scores_gemma":[0.002028939,0.00010162171,0.000090034446,0.000058238038,0.00013174507,0.000001934084,0.00007631996,0.00016473413,0.000009369708],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013400391,0.0133826425,0.072987616,0.00050687836,0.0004009647,0.0000770412,0.0015701366,0.00784232,0.15580973,0.0077144797,0.1478182,0.5784896],"study_design_scores_gemma":[0.027993511,0.018600108,0.0234077,0.00028893893,0.000034084856,0.000100087476,0.00055796857,0.0012579728,0.009224719,0.0008601215,0.916736,0.00093879766],"about_ca_topic_score_codex":0.00019989265,"about_ca_topic_score_gemma":0.00001852287,"teacher_disagreement_score":0.7689178,"about_ca_system_score_codex":0.000027256037,"about_ca_system_score_gemma":0.00017604063,"threshold_uncertainty_score":0.4144013},"labels":[],"label_agreement":null},{"id":"W2344998323","doi":"10.1016/j.jval.2015.03.973","title":"Analysis of Etanercept Treatment Patterns And Reimbursement Gaps In Patients When Transitioning from Private to Public Drug Plans","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); Merck Canada Inc. (Canada)","funders":"","keywords":"Etanercept; Medicine; Reimbursement; Medical prescription; Family medicine; Retrospective cohort study; Internal medicine; Rheumatoid arthritis; Pharmacology; Economic growth","score_opus":0.06513608121172984,"score_gpt":0.332143952977266,"score_spread":0.2670078717655362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2344998323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99607545,0.00017403715,0.000095127805,0.002618586,0.000039587376,0.00078336056,0.00014139798,0.000012122263,0.000060333106],"genre_scores_gemma":[0.99852484,0.00014746367,0.0006081179,0.00029474858,0.000024672012,0.000039814182,0.0003097112,0.000014329366,0.000036318743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979162,0.00026122804,0.0005726338,0.00034518866,0.00052226766,0.00038245803],"domain_scores_gemma":[0.9989672,0.00012270444,0.00008819513,0.0003354397,0.000061148436,0.00042532975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068951363,0.00012948754,0.0005513722,0.0007125901,0.000021599733,0.000013587498,0.00007565444,0.000049210383,0.000051234958],"category_scores_gemma":[0.00008206753,0.000111823654,0.0000504361,0.0005900496,0.000025618225,0.00005591255,0.00003621813,0.000108320004,0.0000043544464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031993366,0.00056358514,0.9608619,0.00013953556,0.0002455053,0.000030932955,0.02665627,0.0045186677,0.000009473333,0.000035696557,0.00007723607,0.0065412507],"study_design_scores_gemma":[0.027601875,0.00163134,0.9166194,0.00066858804,0.00018208138,0.0000022008346,0.0017100691,0.050621305,0.00014594004,0.00010548099,0.00054044387,0.00017125114],"about_ca_topic_score_codex":0.17016253,"about_ca_topic_score_gemma":0.010788224,"teacher_disagreement_score":0.1593743,"about_ca_system_score_codex":0.013410946,"about_ca_system_score_gemma":0.0022960834,"threshold_uncertainty_score":0.9903764},"labels":[],"label_agreement":null},{"id":"W2345038106","doi":"10.1016/j.jval.2015.03.492","title":"Impact of Clinical and Health Economic Publications on Commercial success of Pharmaceutical products in the U.S","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Casual; Asthma; Confounding; Internal medicine; Geography","score_opus":0.5591690276145322,"score_gpt":0.5192826927033346,"score_spread":0.03988633491119764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345038106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94234467,0.0014125071,0.0000071257036,0.052059207,0.00032776676,0.00051611575,0.0002669988,0.000005421064,0.0030602063],"genre_scores_gemma":[0.9957394,0.0016446396,0.00010439631,0.0023180882,0.00014753922,0.000014712886,0.000010879231,0.000011529634,0.000008817556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721366,0.00023706736,0.0018522275,0.0003175087,0.000033901386,0.00034565025],"domain_scores_gemma":[0.9984335,0.00030613376,0.0006521987,0.00033390033,0.000020059591,0.0002542529],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076124156,0.00011475069,0.0007021941,0.00031925368,0.000031077067,0.000020167885,0.00029524876,0.000068753005,0.000027319173],"category_scores_gemma":[0.00031858918,0.000103585524,0.00008319997,0.0002709951,0.00016629335,0.0001204732,0.000050448187,0.00035418506,0.000026544509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006164313,0.0004261075,0.7222936,0.0000816795,0.00001390228,1.7158459e-7,0.00080235634,0.0016814733,8.564795e-8,0.26829585,0.0033323735,0.0030107151],"study_design_scores_gemma":[0.0020704984,0.0006025759,0.94518405,0.00003263288,0.0000013408123,0.0000031442678,0.000039620987,0.021739243,0.0000031552147,0.012952216,0.017249826,0.00012172108],"about_ca_topic_score_codex":0.018242722,"about_ca_topic_score_gemma":0.00027661625,"teacher_disagreement_score":0.25534365,"about_ca_system_score_codex":0.00026967976,"about_ca_system_score_gemma":0.0008330425,"threshold_uncertainty_score":0.9882949},"labels":[],"label_agreement":null},{"id":"W2345152158","doi":"10.1016/j.jval.2015.03.1666","title":"Estimating the value of Whole Exome Sequencing for parents of Children with Rare Genetic Diseases","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Ottawa; University of Calgary; Alberta Bone and Joint Health Institute","funders":"","keywords":"Exome sequencing; Genetic testing; Medicine; Diagnostic test; Exome; Genetic diagnosis; Test (biology); Pediatrics; Mutation; Genetics; Internal medicine; Biology","score_opus":0.028359158034846642,"score_gpt":0.2783447127836063,"score_spread":0.24998555474875964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345152158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99409014,0.0035898124,0.0014026494,0.00009583713,0.00006115748,0.00046672436,0.00028324325,0.000003284135,0.000007155738],"genre_scores_gemma":[0.9926216,0.000033170356,0.0069735358,0.00008934276,0.00008573672,0.000029471805,0.00014224536,0.000017006003,0.000007907051],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99913174,0.000081030106,0.00028776308,0.00019106593,0.00011624898,0.0001921712],"domain_scores_gemma":[0.9993275,0.000021668975,0.00020380918,0.00026202467,0.000079668804,0.00010534669],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019787988,0.00009651076,0.00017043941,0.00003076586,0.000044595698,0.000006255902,0.00016655178,0.00003502738,4.7718885e-7],"category_scores_gemma":[0.000116677635,0.00006741099,0.000051162515,0.00007386508,0.00006115377,0.0000022589609,0.0000494226,0.000032807515,2.5399967e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024205973,0.00020431392,0.41484374,0.00055437506,0.000102416016,0.00000244044,0.0007455128,0.57550734,0.0046438356,0.00014387658,0.00035163655,0.0026584684],"study_design_scores_gemma":[0.0099577885,0.0069824415,0.81787574,0.0016406013,0.00026161695,0.00014519118,0.0037627995,0.12774988,0.024254693,0.005416527,0.0007601602,0.0011925568],"about_ca_topic_score_codex":0.00077784003,"about_ca_topic_score_gemma":0.000019084942,"teacher_disagreement_score":0.44775748,"about_ca_system_score_codex":0.0000298866,"about_ca_system_score_gemma":0.00064261345,"threshold_uncertainty_score":0.27489403},"labels":[],"label_agreement":null},{"id":"W2345167039","doi":"10.1016/j.jval.2015.03.1656","title":"The Cost-Effectiveness of Lisdexamfetamine Dimesylate for The Treatment of Binge Eating Disorder","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Eating Disorders and Behaviors","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Cost effectiveness; Placebo; Binge-eating disorder; Cohort; Randomized controlled trial; Psychiatry; Physical therapy; Internal medicine; Eating disorders; Bulimia nervosa","score_opus":0.13392381945194728,"score_gpt":0.4112252914943482,"score_spread":0.27730147204240096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345167039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98695713,0.009132491,0.00047609577,0.00038723723,0.00054981565,0.002213574,0.000022144686,0.000012568503,0.00024893007],"genre_scores_gemma":[0.99876064,0.0003411174,0.000120923156,0.000017497832,0.000032569642,0.0005003528,0.0000072671514,0.000018920564,0.00020069578],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985179,0.0005282232,0.000399886,0.00016589204,0.00011655806,0.0002715573],"domain_scores_gemma":[0.9967961,0.002517936,0.0002498315,0.0003260775,0.00006554508,0.00004455522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015749073,0.00010867818,0.00026710858,0.000045336124,0.00011470087,0.0000062275913,0.00013928977,0.000047439215,0.000005166119],"category_scores_gemma":[0.0001137934,0.00005789534,0.000076310964,0.00020165456,0.00009976773,0.000016659673,0.0000128302245,0.000060758557,0.0000018964101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067783525,0.002165505,0.6927529,0.00024235311,0.00009522598,0.0000010623166,0.017234793,0.0063419365,0.00006044833,0.006910815,0.00014314154,0.27337396],"study_design_scores_gemma":[0.015853662,0.016710792,0.89347726,0.0007617923,0.00013976776,0.0000065189224,0.018931601,0.0149350315,0.00030407222,0.0032262004,0.035209864,0.00044343856],"about_ca_topic_score_codex":0.014796847,"about_ca_topic_score_gemma":0.0003234763,"teacher_disagreement_score":0.27293053,"about_ca_system_score_codex":0.000090823465,"about_ca_system_score_gemma":0.00009813685,"threshold_uncertainty_score":0.9917637},"labels":[],"label_agreement":null},{"id":"W2345185915","doi":"10.1016/j.jval.2015.03.1243","title":"Reimbursement Approval of Oncology Drugs In Canada Supported By a Data Package Lacking Phase III Trial Data","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Clinical trial; Crizotinib; Family medicine; Randomized controlled trial; Brentuximab vedotin; Oncology; Internal medicine; Hodgkin lymphoma; Lymphoma; Health care; Political science","score_opus":0.21594901015353493,"score_gpt":0.3568086925135758,"score_spread":0.14085968236004084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345185915","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.978557,0.004158207,0.00034620162,0.0028520809,0.0016584238,0.0010951989,0.006187318,0.000010831231,0.0051347488],"genre_scores_gemma":[0.9968356,0.00057479856,0.00047030093,0.00064682803,0.00017646134,0.000017132197,0.0011365749,0.00002392385,0.000118401644],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968336,0.0000845401,0.0018023307,0.00066592783,0.00007257599,0.000541011],"domain_scores_gemma":[0.9972605,0.000117210075,0.0009865807,0.001372506,0.000020964118,0.00024224042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043916334,0.0001566655,0.00090832927,0.0001953476,0.000027649196,0.00001724236,0.0010185187,0.00009572465,0.00007228471],"category_scores_gemma":[0.0004425166,0.0001943702,0.000021743728,0.0002584394,0.000048642647,0.0004318702,0.00036480394,0.00026958605,0.000011959274],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02129107,0.0041040205,0.08479266,0.00062417757,0.00021933943,0.000091596274,0.0090426095,0.0021515705,0.000014338032,0.03074142,0.691954,0.15497318],"study_design_scores_gemma":[0.1640427,0.0017838356,0.001738972,0.00015855016,0.000011168319,0.000005443835,0.00228936,0.10600734,0.000031039308,0.0063721933,0.7167953,0.0007640837],"about_ca_topic_score_codex":0.9724043,"about_ca_topic_score_gemma":0.6424696,"teacher_disagreement_score":0.32993475,"about_ca_system_score_codex":0.002348092,"about_ca_system_score_gemma":0.005975936,"threshold_uncertainty_score":0.99965924},"labels":[],"label_agreement":null},{"id":"W2345211209","doi":"10.1016/j.jval.2015.03.1507","title":"Expected costs and Health outcomes for a Cohort of Albertans diagnosed with Hepatitis C","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"","keywords":"Medicine; Cohort; Hepatitis C; Liver disease; Health care; Demography; Cohort study; Population; Antiviral treatment; Internal medicine; Environmental health; Chronic hepatitis; Virology; Economic growth","score_opus":0.11152671704253161,"score_gpt":0.40058006416226816,"score_spread":0.2890533471197365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345211209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828136,0.0010516581,0.00029129966,0.011912107,0.000067337554,0.003307237,0.0000721601,0.000034797904,0.00044979254],"genre_scores_gemma":[0.99166703,0.0014091324,0.0050107273,0.0013771179,0.000033512268,0.0002732447,0.00005013242,0.000038202168,0.00014089921],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978856,0.00022787946,0.0005736552,0.00030269215,0.00050537643,0.0005048053],"domain_scores_gemma":[0.9982067,0.00048975105,0.00016753598,0.00030541216,0.00020326237,0.0006273741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014253184,0.00014239363,0.00074684876,0.00024287519,0.000047380086,0.000008558915,0.00006920791,0.000062599815,0.000010939285],"category_scores_gemma":[0.0008334219,0.00011379461,0.00003343032,0.00033996307,0.00009320188,0.0000576264,0.000026832797,0.00017604926,0.0000032116266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016713966,0.0001796741,0.9879247,0.00053189497,0.000036806603,0.000020255497,0.0020513346,0.000018246747,0.0000030578958,0.00036381485,0.0019405022,0.0067625777],"study_design_scores_gemma":[0.0057095774,0.0034914915,0.9845982,0.0006897848,0.000008158091,0.000014485083,0.00031575043,0.0026260456,0.000031480926,0.00006772348,0.0023354166,0.00011184969],"about_ca_topic_score_codex":0.25851005,"about_ca_topic_score_gemma":0.028902281,"teacher_disagreement_score":0.22960779,"about_ca_system_score_codex":0.00073652336,"about_ca_system_score_gemma":0.0021431285,"threshold_uncertainty_score":0.9888177},"labels":[],"label_agreement":null},{"id":"W2345676570","doi":"10.1016/j.jval.2016.03.1832","title":"Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria; University of British Columbia","funders":"","keywords":"Galantamine; Hazard ratio; Discontinuation; Rivastigmine; Donepezil; Medicine; Population; Proportional hazards model; Internal medicine; Confidence interval; Cohort; Persistence (discontinuity); Cohort study; Propensity score matching; Dementia; Disease; Environmental health","score_opus":0.06013867219358992,"score_gpt":0.4119118203197864,"score_spread":0.3517731481261965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2345676570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98456377,0.000060448634,0.00009803266,0.013393819,0.0000456747,0.0009210146,0.000024905858,0.00001100047,0.0008813206],"genre_scores_gemma":[0.99836487,0.000104281506,0.0000141626215,0.00028469347,0.00040538728,0.000030872336,0.0000097021075,0.000009587592,0.0007764613],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987514,0.00023894726,0.0003076161,0.00014213206,0.0003204127,0.00023947998],"domain_scores_gemma":[0.99938256,0.00014241626,0.000106392414,0.00017064202,0.00009920674,0.000098815886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007579472,0.00008011148,0.00015406034,0.00019921879,0.000045159453,0.000008809406,0.000055564462,0.000022706456,0.000067489986],"category_scores_gemma":[0.0004436493,0.00003676203,0.00006363082,0.00031482804,0.000058614503,0.000073616175,0.00002188483,0.00008411794,0.000015611758],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000887263,0.0011099658,0.80342174,0.00016193396,0.000025606365,0.0000073020765,0.0012628237,0.00004140543,0.0017053504,0.0017904033,0.0015888481,0.18799734],"study_design_scores_gemma":[0.0025804066,0.0014555615,0.9913667,0.0006825533,0.000003706702,0.000005129058,0.000083950436,0.00038567613,0.0027175115,0.0003164932,0.0003504571,0.00005189904],"about_ca_topic_score_codex":0.0052466705,"about_ca_topic_score_gemma":0.000061446,"teacher_disagreement_score":0.18794544,"about_ca_system_score_codex":0.00028942234,"about_ca_system_score_gemma":0.0013780234,"threshold_uncertainty_score":0.79314315},"labels":[],"label_agreement":null},{"id":"W2346525997","doi":"10.1016/j.jval.2016.03.295","title":"Income Growth Trajectory For Parents Of Children With Down Syndrome In The United States","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Cohort; Medicine; Propensity score matching; Demography; Wilcoxon signed-rank test; Retrospective cohort study; Pediatrics; Internal medicine; Mann–Whitney U test","score_opus":0.02924142829214116,"score_gpt":0.2855053423278418,"score_spread":0.25626391403570065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346525997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964774,0.00020948102,0.0002916229,0.0021489244,0.000023800681,0.0006884518,0.00012345237,0.000016911335,0.000019907366],"genre_scores_gemma":[0.9987534,0.0001852721,0.0005512147,0.00035216025,0.000017662727,0.000036764253,0.000084949956,0.000011443455,0.0000071251716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902517,0.0001301799,0.0002808476,0.00013599958,0.00018320922,0.00024459683],"domain_scores_gemma":[0.99890167,0.0007151074,0.00009345588,0.00017777889,0.00003471443,0.000077298835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058331474,0.00008603735,0.00022814205,0.00018805753,0.000023186136,0.0000028081135,0.00010742048,0.000039221206,0.0000029464109],"category_scores_gemma":[0.00032492296,0.000042182975,0.000022949482,0.00033272244,0.000055975626,0.00003085617,0.0000130533745,0.00010033466,0.0000015486403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002307493,0.00017265693,0.9972199,0.00020728067,0.000016441863,0.000011395054,0.00061997445,0.00022903235,0.0000036767988,0.00043743802,0.000084755426,0.0007666686],"study_design_scores_gemma":[0.003084644,0.0015287321,0.9928426,0.0014868006,0.000010147285,0.000057354613,0.0001234129,0.00024009378,0.000053209194,0.00047966948,0.000030880867,0.00006245998],"about_ca_topic_score_codex":0.012333251,"about_ca_topic_score_gemma":0.00016034952,"teacher_disagreement_score":0.012172901,"about_ca_system_score_codex":0.00007114445,"about_ca_system_score_gemma":0.00013741612,"threshold_uncertainty_score":0.9942437},"labels":[],"label_agreement":null},{"id":"W2346904063","doi":"10.1016/j.jval.2016.03.1855","title":"Regulatory Decision Making in Canada—Exploring New Frontiers in Patient Involvement","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Libin Cardiovascular Institute of Alberta; Health Canada","funders":"Health Canada","keywords":"Transparency (behavior); Context (archaeology); Legislature; Process (computing); Health care; Business; Medicine; Public relations; Process management; Knowledge management; Political science; Computer science","score_opus":0.2721636936292732,"score_gpt":0.37906542746340494,"score_spread":0.10690173383413176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2346904063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9892809,0.0015583538,0.0004926362,0.001673727,0.0044728857,0.0022628277,0.00002248583,0.000022684508,0.00021349035],"genre_scores_gemma":[0.98910075,0.0009891029,0.003881946,0.005447373,0.00011609216,0.0003472689,0.000013315585,0.000035195724,0.00006895184],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99413526,0.0010190185,0.0021497665,0.0005310702,0.00071028864,0.0014545773],"domain_scores_gemma":[0.99787307,0.00068280153,0.00045201607,0.00044469343,0.00003133332,0.00051608717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020796775,0.00023659064,0.0005062646,0.0005744079,0.00021922837,0.0000031900472,0.0002179967,0.00010473759,0.000111238645],"category_scores_gemma":[0.00010048749,0.00019109553,0.0000323323,0.0005521878,0.000016561611,0.00019104015,0.00014917528,0.0005215422,0.000030764306],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00021051022,0.00007428611,0.83009475,0.00076793454,0.000002087503,0.000022388436,0.004846811,0.0008740447,0.0000027808003,0.00036794838,0.004815091,0.15792136],"study_design_scores_gemma":[0.00875065,0.00077354076,0.8450013,0.06521593,0.0000031067575,0.0000010830927,0.021283315,0.003230869,0.000052049785,0.009847494,0.045078754,0.0007619042],"about_ca_topic_score_codex":0.94087464,"about_ca_topic_score_gemma":0.9435389,"teacher_disagreement_score":0.15715945,"about_ca_system_score_codex":0.018156754,"about_ca_system_score_gemma":0.009495635,"threshold_uncertainty_score":0.9961196},"labels":[],"label_agreement":null},{"id":"W2353253986","doi":"10.1016/j.jval.2016.02.012","title":"Health Technology Assessment for Molecular Diagnostics: Practices, Challenges, and Recommendations from the Medical Devices and Diagnostics Special Interest Group","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Health technology; Reimbursement; Medicine; Excellence; Health care; Family medicine; Medical physics; Political science","score_opus":0.429476778660788,"score_gpt":0.4731094845025803,"score_spread":0.043632705841792296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2353253986","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03222547,0.07150583,0.009426738,0.88384986,0.0008237608,0.0014066863,0.00063248444,0.000033879565,0.00009532045],"genre_scores_gemma":[0.4433686,0.46532765,0.03199532,0.055146772,0.0029952636,0.0009120043,0.00014667212,0.00008888481,0.000018811563],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9949632,0.000911654,0.0028582653,0.00066283887,0.00010755446,0.0004964456],"domain_scores_gemma":[0.97809833,0.018259976,0.002873486,0.00042176573,0.000041073774,0.0003053392],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.017699843,0.0001865927,0.00081946934,0.00025159985,0.00025839574,0.000054116033,0.0002912559,0.00020053961,0.00007705364],"category_scores_gemma":[0.024637755,0.00016251458,0.000036770587,0.00011886077,0.00015941777,0.00025268842,0.00014153033,0.00029202548,0.00003417237],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011703844,0.00019782025,0.05199029,0.00047397127,0.00005505283,0.0000025480117,0.0013310619,0.0000028442423,1.538072e-7,0.8617336,0.017803144,0.06639777],"study_design_scores_gemma":[0.0024866622,0.00068247446,0.11121976,0.0019024472,0.000008787457,0.000020092499,0.004158854,0.0024382118,4.977228e-7,0.19512184,0.68156946,0.00039091994],"about_ca_topic_score_codex":0.004886184,"about_ca_topic_score_gemma":0.008744521,"teacher_disagreement_score":0.82870305,"about_ca_system_score_codex":0.00063383614,"about_ca_system_score_gemma":0.0005592457,"threshold_uncertainty_score":0.98357815},"labels":[],"label_agreement":null},{"id":"W2359288261","doi":"10.1016/j.jval.2015.09.1311","title":"Assessing the Gap Between Evidence Based Indications for Radiotherapy and Actual Practice in European Countries","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Reimbursement; Radiation therapy; Medicine; Incidence (geometry); Cancer; Multidisciplinary approach; Population; Family medicine; Health care; Environmental health; Surgery; Economic growth; Political science; Internal medicine; Economics","score_opus":0.19147188405897955,"score_gpt":0.508198003752941,"score_spread":0.31672611969396147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2359288261","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40958986,0.08627681,0.12409528,0.37467122,0.0006808539,0.0035986716,0.000019728328,0.0000948518,0.00097274414],"genre_scores_gemma":[0.8967584,0.007408467,0.0743784,0.020627718,0.0006811612,0.000054583976,0.000009222755,0.000031905805,0.000050160328],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99831456,0.00084820966,0.0003086219,0.00018109239,0.00014255462,0.00020496972],"domain_scores_gemma":[0.9933404,0.006121352,0.00019384176,0.00018769196,0.000056854835,0.00009987429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004585854,0.00008299015,0.00022314474,0.000103008955,0.00012320183,0.000024114215,0.00008799375,0.00005232264,0.0000033293677],"category_scores_gemma":[0.0025049355,0.00005828815,0.000015570486,0.00019501965,0.00019225995,0.0003509208,0.000007560462,0.0002565762,0.0000013199018],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014735672,0.000577526,0.77044845,0.00073320954,0.0001052476,0.000064598076,0.03890964,0.005011467,0.00009354646,0.007074571,0.0045473347,0.17096083],"study_design_scores_gemma":[0.01076444,0.0032537226,0.41364852,0.002422732,0.000063974985,0.00015670015,0.0050261016,0.014583841,0.00006393519,0.0019536158,0.5477195,0.00034292036],"about_ca_topic_score_codex":0.00019300795,"about_ca_topic_score_gemma":0.000011239253,"teacher_disagreement_score":0.5431722,"about_ca_system_score_codex":0.00037369967,"about_ca_system_score_gemma":0.0010952173,"threshold_uncertainty_score":0.29988226},"labels":[],"label_agreement":null},{"id":"W2367707061","doi":"10.1016/j.jval.2016.04.004","title":"Statistical Methods for the Analysis of Discrete Choice Experiments: A Report of the ISPOR Conjoint Analysis Good Research Practices Task Force","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":1312,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Calgary","funders":"","keywords":"Conjoint analysis; Task force; Task (project management); Management science; Computer science; Econometrics; Economics; Microeconomics; Management; Preference; Political science","score_opus":0.3878825092848187,"score_gpt":0.4728920069229144,"score_spread":0.08500949763809568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2367707061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5784411,0.002936676,0.4080064,0.007369265,0.00021519965,0.0013251865,0.0008293185,0.0000061615942,0.0008707147],"genre_scores_gemma":[0.9864957,0.00042888292,0.012372564,0.00007329229,0.000022175209,0.00011623037,0.00002018685,0.000010610533,0.00046036535],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975178,0.00040790034,0.0013364648,0.00038835948,0.00008570486,0.00026374703],"domain_scores_gemma":[0.99334186,0.0039576646,0.0019474393,0.00066705333,0.000033020424,0.000052984295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011650541,0.000088602974,0.000588841,0.00040118457,0.000116323456,0.000013704422,0.00027129412,0.000053706965,0.0002122544],"category_scores_gemma":[0.002644614,0.000054620963,0.00024223955,0.0009801174,0.0001952671,0.00013252675,0.00008939776,0.00010183573,0.0000043973764],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004892892,0.00014767078,0.89251894,0.000071183196,0.0020934623,3.1423988e-7,0.0011173233,0.009120056,0.00017045256,0.09167774,0.0001012953,0.0029326638],"study_design_scores_gemma":[0.00046155415,0.00011507136,0.89676553,0.000023063665,0.00031402108,7.0664015e-7,0.0005370755,0.08938865,0.00030998027,0.008151196,0.003835399,0.00009774934],"about_ca_topic_score_codex":0.013433859,"about_ca_topic_score_gemma":0.00029160618,"teacher_disagreement_score":0.40805462,"about_ca_system_score_codex":0.00032984128,"about_ca_system_score_gemma":0.00007248799,"threshold_uncertainty_score":0.99313575},"labels":[],"label_agreement":null},{"id":"W2383450400","doi":"10.1016/j.jval.2015.03.952","title":"Preferences for New Treatments Diminish In The Face of Ambiguity","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ambiguity; Preference; Respondent; Confidence interval; Population; Point estimation; Medicine; Psychology; Statistics; Mathematics; Internal medicine; Computer science; Environmental health","score_opus":0.7659773916187583,"score_gpt":0.4927104789725335,"score_spread":0.2732669126462248,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2383450400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93513215,0.0038225625,0.0013259263,0.054966405,0.0005123559,0.0023042164,0.00025911548,0.000015208582,0.0016620394],"genre_scores_gemma":[0.9918438,0.00019551023,0.0029661574,0.0044090617,0.00013197551,0.0001550315,0.000023350214,0.000013308057,0.00026178348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956914,0.0005905901,0.002960982,0.0003232555,0.00008782452,0.00034593206],"domain_scores_gemma":[0.99683416,0.001271673,0.0013560061,0.00036128736,0.000025062038,0.00015184152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021106748,0.00011475849,0.0007110307,0.00021047314,0.000046290636,0.000022949076,0.000304237,0.000081281156,0.000014811376],"category_scores_gemma":[0.0028767367,0.00011254084,0.000057469275,0.00022667012,0.000032286025,0.00017750986,0.000020721638,0.00010334101,0.00007655213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011123849,0.00077297515,0.70427054,0.0013434006,0.000049507915,5.499776e-7,0.07640714,0.012954785,2.455146e-7,0.13226548,0.06887946,0.0029446592],"study_design_scores_gemma":[0.008000004,0.001618149,0.48911735,0.0005106074,0.0000071460713,0.0000043114946,0.019560622,0.027959617,0.0000071697536,0.39169833,0.06098851,0.0005281634],"about_ca_topic_score_codex":0.051830593,"about_ca_topic_score_gemma":0.001525091,"teacher_disagreement_score":0.25943288,"about_ca_system_score_codex":0.00057820353,"about_ca_system_score_gemma":0.00075540924,"threshold_uncertainty_score":0.95448333},"labels":[],"label_agreement":null},{"id":"W2394792307","doi":"10.1016/j.jval.2016.03.122","title":"Indirect Costs Associated with Cardiovascular Disease in Canada: A Literature Review","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada); St. Joseph’s Healthcare Hamilton; McMaster University","funders":"","keywords":"Medicine; Indirect costs; Myocardial infarction; Stroke (engine); Coronary artery disease; Disease; Unstable angina; Angina; Population; MEDLINE; Productivity; Cochrane Library; Demography; Emergency medicine; Environmental health; Meta-analysis; Internal medicine","score_opus":0.33434444075730774,"score_gpt":0.3970971816688013,"score_spread":0.06275274091149358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2394792307","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028408558,0.98568404,0.000010690491,0.0060635237,0.0005164616,0.004408012,0.002998049,0.000029559633,0.0002612866],"genre_scores_gemma":[0.00004480048,0.9922437,0.00005482897,0.005924647,0.00019327474,0.00083019136,0.00045434065,0.000112880974,0.00014134438],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9848607,0.004405854,0.008107862,0.0012893336,0.00031926678,0.0010169833],"domain_scores_gemma":[0.9910656,0.0021430326,0.004696961,0.0014052904,0.00006849449,0.00062058296],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.034126185,0.000626113,0.008214716,0.0008416023,0.00009836869,0.000050968538,0.00054482574,0.00028804844,0.00007688048],"category_scores_gemma":[0.00754677,0.0005812959,0.0005630042,0.001440101,0.00003663251,0.00024285252,0.000063813415,0.0008356095,0.00023838526],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000017657792,0.00024099255,0.014794393,0.71983516,0.001627444,0.00037063716,0.00047238855,0.0004844293,7.254996e-11,0.006217725,0.035112977,0.22082621],"study_design_scores_gemma":[0.00040504822,0.000019596228,0.0008683407,0.358918,0.000036402213,0.0000068798763,0.000006016261,0.000060960298,2.5324853e-10,0.00010897141,0.63915825,0.00041154807],"about_ca_topic_score_codex":0.73588645,"about_ca_topic_score_gemma":0.3905695,"teacher_disagreement_score":0.6040453,"about_ca_system_score_codex":0.026873613,"about_ca_system_score_gemma":0.018092737,"threshold_uncertainty_score":0.99966383},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":true,"confidence":"low"},{"model":"opus","categories":[],"domain":null,"study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":true,"confidence":"low"}],"label_agreement":"split"},{"id":"W2395026299","doi":"10.1016/j.jval.2016.03.1617","title":"The Role of Cancer Care on Patient Productivity, Caregiver Burden, and Personal Financial Hardship","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cancer; Population; Family medicine; Quarter (Canadian coin); Health care; Bankruptcy; Gerontology; Demography; Finance; Environmental health; Internal medicine; Business","score_opus":0.02564414515165512,"score_gpt":0.24225326321653262,"score_spread":0.2166091180648775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395026299","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9493757,0.04133293,0.000006797872,0.005677739,0.0004927974,0.0003086963,0.00031551937,0.0000075724906,0.0024822424],"genre_scores_gemma":[0.9959189,0.003406188,0.000017685248,0.0001479924,0.00030851047,0.00004034679,8.124491e-7,0.000014758634,0.00014479159],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99881274,0.00002885016,0.00045422392,0.000331703,0.00004207221,0.00033040924],"domain_scores_gemma":[0.99924034,0.000097676435,0.00035024158,0.00019544012,0.00003528417,0.00008099285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036595546,0.0001191647,0.0003113465,0.00009515482,0.00012679477,0.000017655699,0.0001149681,0.00006573571,0.00002561894],"category_scores_gemma":[0.00019004823,0.000088957204,0.000052326996,0.000086303626,0.00011880602,0.000116909236,0.00004155795,0.0001110707,0.000017038708],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015311262,0.00003676188,0.27530774,0.000116277515,0.000016901682,0.0000010114588,0.01518587,0.0002508142,0.000016400661,0.17645735,0.00048708386,0.5319707],"study_design_scores_gemma":[0.0014657711,0.0008463805,0.4108236,0.0005583464,0.0000035872858,0.0000019218276,0.0013137241,0.00033845453,0.00044816412,0.043424707,0.5403396,0.00043575742],"about_ca_topic_score_codex":0.01449569,"about_ca_topic_score_gemma":0.0008711939,"teacher_disagreement_score":0.5398525,"about_ca_system_score_codex":0.00042952274,"about_ca_system_score_gemma":0.00023985305,"threshold_uncertainty_score":0.99206686},"labels":[],"label_agreement":null},{"id":"W2395194296","doi":"10.1016/j.jval.2016.03.1616","title":"Dalteparin Versus Vitamin K Antagonists for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer and Renal Impairment: Pharmacoeconomic Analysis of a Prospective Randomized Trial","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Randomized controlled trial; Population; Randomization; Internal medicine; Relative risk; Pediatrics; Confidence interval","score_opus":0.02439193084483897,"score_gpt":0.3324162105128729,"score_spread":0.3080242796680339,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395194296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99092925,0.0006606335,0.00010899653,0.0006827222,0.00027186066,0.0072359988,0.000083748855,0.000005660071,0.00002113347],"genre_scores_gemma":[0.99624735,0.0026286894,0.00014571598,0.000033910874,0.000044598477,0.0008594695,0.000018152257,0.000013036414,0.000009049792],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983374,0.00020001481,0.00074533804,0.00028501512,0.00018718964,0.00024506357],"domain_scores_gemma":[0.9986038,0.0005309647,0.0005480664,0.00018994103,0.00006745161,0.000059742822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013705809,0.00013685226,0.0013837813,0.00032821018,0.00004246781,0.0000049909477,0.00006859979,0.000035472105,0.00002046571],"category_scores_gemma":[0.00007486742,0.00007676654,0.0001503464,0.00031397952,0.00011557511,0.000056625133,0.000031583684,0.00006808358,1.6935007e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.93043536,0.0048207375,0.027124934,0.00058558845,0.0034011283,6.705348e-7,0.0025055353,0.0010330098,0.000033134464,0.0012710046,0.00009186823,0.028697],"study_design_scores_gemma":[0.6918248,0.004576635,0.29948047,0.0005758904,0.0015368958,7.942756e-8,0.0000632734,0.0015571241,0.0001326262,0.00012937933,0.000039213108,0.00008358262],"about_ca_topic_score_codex":0.0039026113,"about_ca_topic_score_gemma":0.000697176,"teacher_disagreement_score":0.27235556,"about_ca_system_score_codex":0.0003955408,"about_ca_system_score_gemma":0.00025791902,"threshold_uncertainty_score":0.5899607},"labels":[],"label_agreement":null},{"id":"W2395341313","doi":"10.1016/j.jval.2016.03.520","title":"The Impact of Plaque Psoriasis Severity on Work Productivity and Daily Activities","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology; Vancouver Coastal Health; Novartis (Canada)","funders":"","keywords":"Psoriasis; Medicine; Presenteeism; Psoriasis Area and Severity Index; Interquartile range; Severity of illness; Activities of daily living; Depression (economics); Absenteeism; Physical therapy; Internal medicine; Psychology; Dermatology","score_opus":0.029818509174328312,"score_gpt":0.2788996319676803,"score_spread":0.24908112279335198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395341313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99540037,0.0024609957,0.000004874273,0.0012390137,0.0003983229,0.0002789116,0.000068923975,0.000020516942,0.00012808663],"genre_scores_gemma":[0.9981265,0.0012343682,0.000018139719,0.000011513466,0.00004012445,0.000024391951,0.0000036412962,0.0000088984625,0.0005324171],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99851483,0.0006863367,0.00021946769,0.00023448942,0.00003119977,0.00031369104],"domain_scores_gemma":[0.9985901,0.00094019284,0.00014552377,0.00028554338,0.000014824244,0.000023814246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007166542,0.00013898316,0.0002669749,0.00006892209,0.00017816994,0.000005528226,0.000093766335,0.00010538803,0.000023378001],"category_scores_gemma":[0.00012441754,0.00006913375,0.000066800654,0.00013297363,0.00017546218,0.00006595282,0.000031573607,0.00010359244,0.000018192999],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003380898,0.00054466503,0.4156147,0.000064200656,0.00036881902,0.0000038089104,0.002092286,0.000046482393,0.011347959,0.0011373253,0.00243636,0.5629625],"study_design_scores_gemma":[0.0019041486,0.00090712676,0.9756521,0.00021765968,0.000013673894,0.000019330202,0.00011520635,0.0000011624253,0.018637452,0.0008867834,0.0014926713,0.00015266008],"about_ca_topic_score_codex":0.0022964969,"about_ca_topic_score_gemma":0.00009195718,"teacher_disagreement_score":0.5628098,"about_ca_system_score_codex":0.00014637974,"about_ca_system_score_gemma":0.0001757536,"threshold_uncertainty_score":0.34716317},"labels":[],"label_agreement":null},{"id":"W2395669716","doi":"10.1016/j.jval.2016.03.1121","title":"CHANGES IN QUALITY OF CARE ASSOCIATED WITH CENTRALIZATION OF ELECTIVE ORTHOPAEDIC SURGERY PROCEDURES: A SCOPING REVIEW","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; Alberta Hip and Knee Clinic; University of Calgary","funders":"","keywords":"Medicine; Context (archaeology); CINAHL; Quality (philosophy); Health care; MEDLINE; Orthopedic surgery; Elective surgery; Psychological intervention; Nursing; Surgery","score_opus":0.53976794298189,"score_gpt":0.49305940082444877,"score_spread":0.046708542157441246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395669716","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00027319154,0.9921692,0.00006179126,0.0012360296,0.00018473898,0.0052717207,0.0007119157,0.000019046292,0.00007235815],"genre_scores_gemma":[0.00051513506,0.9977845,0.00008294995,0.00073647464,0.00006988885,0.00048761605,0.00025021183,0.000059936614,0.000013269087],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9833926,0.004075286,0.011006952,0.00072779984,0.0002005681,0.0005967863],"domain_scores_gemma":[0.9759205,0.0066909464,0.016557548,0.0005033882,0.00019063188,0.00013697604],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03508271,0.00036315876,0.0075264205,0.0011487829,0.000049051538,0.000008938217,0.00023929361,0.00031181038,0.000059618436],"category_scores_gemma":[0.025636755,0.00035571065,0.00031668646,0.0012935098,0.00007336924,0.00016592158,0.000033428678,0.00026653515,0.000017410868],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008821556,0.00009650492,0.022911085,0.9645732,0.00006436722,5.1320535e-7,0.0010650484,0.000020217563,2.6878682e-9,0.0023586126,0.00023197873,0.008669634],"study_design_scores_gemma":[0.00036276682,0.00011055433,0.0019530774,0.99163747,0.000017249859,0.0000015213421,0.0001520174,0.000010247093,8.239396e-8,0.00018966952,0.005221147,0.00034419392],"about_ca_topic_score_codex":0.004662808,"about_ca_topic_score_gemma":0.016065767,"teacher_disagreement_score":0.027064258,"about_ca_system_score_codex":0.0028095602,"about_ca_system_score_gemma":0.007465534,"threshold_uncertainty_score":0.9998895},"labels":[],"label_agreement":null},{"id":"W2395935292","doi":"10.1016/j.jval.2016.03.154","title":"A Comparison of Cardiovascular Drugs Approved by the Us Food and Drug Administration and Health Canada (1980-2014)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Food and drug administration; Drug; Medicine; Administration (probate law); Drug administration; Pharmacology; Business; Political science; Law","score_opus":0.07895263609743292,"score_gpt":0.3073892872669409,"score_spread":0.228436651169508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2395935292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9049203,0.03929053,0.00019235586,0.053980783,0.00018196467,0.00045449642,0.000509279,0.0000065987265,0.0004637231],"genre_scores_gemma":[0.9941582,0.0038316646,0.000056796605,0.0018608219,0.00003774193,0.000014086833,0.000005051039,0.00001123766,0.000024378181],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99859256,0.00007473399,0.000728443,0.00027796865,0.000037985596,0.00028830857],"domain_scores_gemma":[0.9991121,0.00012957731,0.00033231746,0.00023927253,0.0000086433965,0.00017803858],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015228746,0.00010548569,0.00051599956,0.00005817421,0.000086240674,0.000019265284,0.00010398129,0.00003453236,0.000006317329],"category_scores_gemma":[0.00003244662,0.00008513397,0.00004403994,0.00007479154,0.00006678326,0.00006106346,0.00003469652,0.0001065764,0.0000024822946],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011065624,0.00039726647,0.28962237,0.0015730255,0.000542744,0.000001080877,0.007268574,0.0014617089,0.000010770378,0.51895356,0.09088399,0.089174256],"study_design_scores_gemma":[0.0027801085,0.0005149457,0.030188909,0.000116512776,0.0000094222,0.0000075672824,0.00031508258,0.020260092,0.0002472155,0.012494805,0.93264234,0.00042298282],"about_ca_topic_score_codex":0.5852434,"about_ca_topic_score_gemma":0.08086071,"teacher_disagreement_score":0.8417584,"about_ca_system_score_codex":0.00026099753,"about_ca_system_score_gemma":0.00041161315,"threshold_uncertainty_score":0.9359112},"labels":[],"label_agreement":null},{"id":"W2396171252","doi":"10.1016/j.jval.2016.03.279","title":"Economic Surveillance For Chronic Obstructive Pulmonary Disease In Alberta, Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Health; Institute of Health Economics","funders":"","keywords":"COPD; Medicine; Smoking cessation; Pulmonary disease; Health care; Medical prescription; Emergency department; Pulmonary rehabilitation; Family medicine; Emergency medicine; Medical emergency; Nursing; Internal medicine; Economic growth","score_opus":0.035380711305421274,"score_gpt":0.25744907507388193,"score_spread":0.22206836376846065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396171252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7579537,0.0072036427,0.00078495336,0.22087134,0.0027995738,0.0029514607,0.0026029407,0.000034883262,0.0047974894],"genre_scores_gemma":[0.99728477,0.000735358,0.00006647938,0.0008491379,0.00016082365,0.00016799166,0.000012231526,0.000021084954,0.0007021446],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99814624,0.000052355466,0.00075127895,0.0004394831,0.000022841627,0.0005878229],"domain_scores_gemma":[0.9989212,0.0003343432,0.0002367278,0.00028995375,0.0000064800934,0.00021126177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068502186,0.00012647136,0.00035026466,0.00018466475,0.000051679348,0.000008791866,0.000168133,0.00004013466,0.00004959102],"category_scores_gemma":[0.00014806664,0.00013046339,0.000042514323,0.000101897014,0.000023357808,0.000105800835,0.000035691057,0.00007062131,0.000052959484],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005527268,0.000040190138,0.45229805,0.0005004574,0.0000087152175,0.0000075259186,0.00012384882,0.004699147,1.7193652e-7,0.53119487,0.0008654578,0.0102062775],"study_design_scores_gemma":[0.0007125412,0.000046964713,0.6614538,0.00009556309,3.6080505e-7,6.194323e-7,0.000014261612,0.010214938,0.0000012276616,0.05189131,0.27532482,0.00024361111],"about_ca_topic_score_codex":0.98829293,"about_ca_topic_score_gemma":0.9679313,"teacher_disagreement_score":0.47930357,"about_ca_system_score_codex":0.0043898723,"about_ca_system_score_gemma":0.0013601708,"threshold_uncertainty_score":0.9994321},"labels":[],"label_agreement":null},{"id":"W2396704791","doi":"10.1016/j.jval.2016.03.1129","title":"COMPARISON OF DOSE ESCALATION AND COSTS OF DOSE ESCALATION BETWEEN PATIENTS WITH RHEUMATOID ARTHRITIS INITIATING BIOLOGIC TREATMENT WITH ETANERCEPT, ADALIMUMAB, OR INFLIXIMAB","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Credit Valley Hospital; Southlake Regional Health Center; Montreal Clinical Research Institute; Centre Hospitalier Universitaire de Sherbrooke; Amgen (Canada)","funders":"","keywords":"Adalimumab; Medicine; Etanercept; Infliximab; Rheumatoid arthritis; Internal medicine; Gastroenterology; Tumor necrosis factor alpha","score_opus":0.06546985798292254,"score_gpt":0.33879417816226476,"score_spread":0.2733243201793422,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396704791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973099,0.0011132625,0.0005253956,0.0002939921,0.000041037252,0.0005385984,0.000119627715,0.000017477501,0.000040679915],"genre_scores_gemma":[0.9960255,0.0008460449,0.0030005854,0.00003158692,0.000007146386,0.000012125367,0.00005627862,0.000010847205,0.000009868118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801826,0.00063967134,0.00072799163,0.00027529622,0.0000653917,0.00027337074],"domain_scores_gemma":[0.99837416,0.00080519065,0.00052103144,0.00016743457,0.0000882568,0.000043897642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004365865,0.00017966615,0.00068167207,0.0001322956,0.00007288146,0.0000044464346,0.00006117795,0.00020210407,0.000044573102],"category_scores_gemma":[0.00009472384,0.00008991236,0.000029629166,0.00021093065,0.00028753545,0.000078378594,0.000027887465,0.00011187526,0.0000018553567],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009229589,0.00032198304,0.7745377,0.000042042782,0.000061793806,3.8118876e-7,0.00036345248,0.000015014676,0.0011625951,0.00013821266,0.000004621537,0.22242928],"study_design_scores_gemma":[0.012015925,0.011447867,0.96657497,0.0018519394,0.000030337049,0.000005612847,0.00023655395,0.00013566912,0.007179897,0.00010261337,0.0001856174,0.00023302247],"about_ca_topic_score_codex":0.00076526444,"about_ca_topic_score_gemma":0.00020232974,"teacher_disagreement_score":0.22219625,"about_ca_system_score_codex":0.00014088105,"about_ca_system_score_gemma":0.00011595991,"threshold_uncertainty_score":0.36665198},"labels":[],"label_agreement":null},{"id":"W2396922882","doi":"10.1016/j.jval.2016.03.1492","title":"Utilization of Radium-223 Dichloride (Ra-223) in Patients with Metastatic Castration-Resistant Prostate Cancer in Canada: A Real-World Retrospective Study","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Canada; Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Denosumab; Prostate cancer; Enzalutamide; Radium-223; Internal medicine; Oncology; Bone metastasis; Abiraterone acetate; Cancer; Retrospective cohort study; Osteoporosis; Androgen deprivation therapy; Androgen receptor","score_opus":0.05146567593889032,"score_gpt":0.34171162970323177,"score_spread":0.2902459537643414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396922882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488294,0.00036578524,0.0000024757378,0.0011820585,0.000076283,0.0032376528,0.00016947745,0.000007783971,0.00007555131],"genre_scores_gemma":[0.9987485,0.0006418854,0.000045278928,0.000033270102,0.00001441525,0.0002443535,0.000021923794,0.00002321368,0.00022718743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976162,0.00025107147,0.00066210516,0.0003606938,0.00065494527,0.00045499968],"domain_scores_gemma":[0.9991411,0.00009588394,0.00022560316,0.00022265874,0.00016776423,0.00014700415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005530024,0.00016412047,0.00051182316,0.00040606744,0.00003702107,0.000005311712,0.000063461615,0.000018593366,0.00002891782],"category_scores_gemma":[0.00007389309,0.0001020032,0.000016536898,0.0011212843,0.00005173924,0.00010864492,0.00001801836,0.00016362382,5.672071e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0028238778,0.0009445238,0.99138594,0.00024109632,0.000043881773,0.00007307169,0.0018399608,0.00027016047,0.000033123077,0.000051919626,0.000026172884,0.0022663036],"study_design_scores_gemma":[0.01483399,0.0014537643,0.98137784,0.0011318786,0.0000161124,3.1478262e-7,0.0006777253,0.00016583983,0.00017361758,0.000059950482,0.000013931123,0.000095009076],"about_ca_topic_score_codex":0.97297376,"about_ca_topic_score_gemma":0.98786014,"teacher_disagreement_score":0.014886366,"about_ca_system_score_codex":0.007758726,"about_ca_system_score_gemma":0.0066035734,"threshold_uncertainty_score":0.9990281},"labels":[],"label_agreement":null},{"id":"W2396967676","doi":"10.1016/j.jval.2016.03.495","title":"The Prevalence And Incidence Of Hidradenitis Suppurativa In Canada: Results From A Population-Based Survey","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Université de Montréal","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Incidence (geometry); Epidemiology; Population; Prevalence; Demography; Pediatrics; Dermatology; Disease; Internal medicine; Environmental health","score_opus":0.03811131224112524,"score_gpt":0.2867204976295783,"score_spread":0.24860918538845306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2396967676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9721103,0.0005745685,0.0000066593607,0.025995575,0.00007526026,0.00048586703,0.0007259194,0.000005798802,0.000020110412],"genre_scores_gemma":[0.99920285,0.00047734618,0.00013030453,0.000016399454,0.0000148861245,0.000016806653,0.000050869323,0.000009337621,0.00008119792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979238,0.00061273883,0.00064373505,0.00025741782,0.00030551953,0.00025679905],"domain_scores_gemma":[0.99604565,0.003321369,0.0001907878,0.00027237853,0.00004716379,0.00012265022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007412692,0.0001116247,0.00028586498,0.00006985329,0.00006055843,0.0000057894918,0.00008042158,0.000038353905,0.000016008948],"category_scores_gemma":[0.0014007427,0.00006541192,0.000014961411,0.00022611152,0.000054623462,0.000076554476,0.000017495498,0.00009871985,0.0000015375273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027982026,0.00003350644,0.99574643,0.000070608156,0.0000051107954,0.0006398537,0.00021945438,0.000003526515,0.000022509874,0.000029645662,0.00003208217,0.0029174287],"study_design_scores_gemma":[0.0022969772,0.00013337338,0.9953276,0.001142696,0.000003878777,0.00018631057,0.00003408583,0.00053138746,0.0001100329,0.0001558002,0.000016670378,0.000061221785],"about_ca_topic_score_codex":0.99238837,"about_ca_topic_score_gemma":0.97109675,"teacher_disagreement_score":0.02709261,"about_ca_system_score_codex":0.00079587,"about_ca_system_score_gemma":0.0027905023,"threshold_uncertainty_score":0.49502313},"labels":[],"label_agreement":null},{"id":"W2397168366","doi":"10.1016/j.jval.2016.03.451","title":"Estimation Of Direct And Indirect Costs Associated With Asthma And Copd: A Canadian Employers Perspective","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Air Quality and Health Impacts","field":"Environmental Science","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; COPD; Asthma; Absenteeism; Indirect costs; Population; Workforce; Physical therapy; Internal medicine; Environmental health","score_opus":0.03202428642657713,"score_gpt":0.29201430169615794,"score_spread":0.2599900152695808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397168366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99023014,0.00015068811,0.000035372028,0.007568635,0.000017776545,0.00032367147,0.000039395625,0.000013401322,0.0016208979],"genre_scores_gemma":[0.9986127,0.00011383071,0.00044729642,0.00076935784,0.000003789853,0.0000056335166,0.00000145701,0.0000073465885,0.000038562353],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989226,0.00024657915,0.00018229951,0.0001898973,0.00015294245,0.00030571088],"domain_scores_gemma":[0.99919266,0.00025369367,0.000120844474,0.00007790493,0.000007671553,0.00034721076],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093059445,0.00007751615,0.00018096047,0.000078001525,0.00010204072,0.00000651592,0.000036710277,0.00005167497,0.000039669674],"category_scores_gemma":[0.0003920336,0.00005585365,0.0000062474455,0.00020254102,0.00016774838,0.00013166732,0.000016145425,0.00006475928,0.000004944658],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107268075,0.00009784884,0.88943696,0.00010227449,0.000019648001,0.000008814591,0.018304419,0.0017134153,0.00003113005,0.0014023262,0.0013188922,0.087457016],"study_design_scores_gemma":[0.0005771222,0.0004713066,0.99499434,0.0003591633,0.000002055699,0.0000042501747,0.00037501176,0.0023695591,0.000040868475,0.00051379413,0.00019950769,0.000093037284],"about_ca_topic_score_codex":0.6732863,"about_ca_topic_score_gemma":0.42022187,"teacher_disagreement_score":0.25306448,"about_ca_system_score_codex":0.0017905867,"about_ca_system_score_gemma":0.00026243014,"threshold_uncertainty_score":0.5903576},"labels":[],"label_agreement":null},{"id":"W2397649954","doi":"10.1016/j.jval.2016.03.655","title":"Evaluating The Cost Effectiveness of Personalised Medicine Co-Dependent Technologies: A Conceptual Framework","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Test (biology); Point (geometry); Personalized medicine; Medicine; Health care; Marginal cost; Actuarial science; Computer science; Mathematics; Economics","score_opus":0.2810152615169229,"score_gpt":0.43742987770943853,"score_spread":0.15641461619251562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397649954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9453673,0.008778394,0.004069115,0.03439109,0.00061657326,0.0015360644,0.000384722,0.00007426942,0.0047825123],"genre_scores_gemma":[0.9974511,0.0012651215,0.00020426823,0.0008728848,0.00007658975,0.00008158068,0.0000021502215,0.000016258069,0.000030026922],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9982142,0.00021770698,0.00080957275,0.00032718017,0.00005718339,0.0003741874],"domain_scores_gemma":[0.996354,0.0027555123,0.00045057957,0.00034642706,0.00002244029,0.00007108434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005475842,0.00013044114,0.000526452,0.00016934721,0.000077599274,0.000008190731,0.0003477092,0.00011777165,0.0002316301],"category_scores_gemma":[0.0018762415,0.00008712456,0.00006133369,0.00022264711,0.00044704293,0.000063974294,0.000058936334,0.0002497284,0.00008870772],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115288945,0.00006410731,0.024610627,0.00017681578,0.000033151508,9.439024e-7,0.001379051,0.00066304696,0.00016126616,0.9640189,0.00015329446,0.008623527],"study_design_scores_gemma":[0.008340635,0.0019810954,0.029884009,0.002609921,0.0000115662915,0.000012294899,0.002049774,0.02540341,0.0013387037,0.89811975,0.029583974,0.00066487084],"about_ca_topic_score_codex":0.0014128188,"about_ca_topic_score_gemma":0.0000057239085,"teacher_disagreement_score":0.06589913,"about_ca_system_score_codex":0.00038782795,"about_ca_system_score_gemma":0.00011093999,"threshold_uncertainty_score":0.35528362},"labels":[],"label_agreement":null},{"id":"W2397714115","doi":"10.1016/j.jval.2016.03.1148","title":"ECONOMIC IMPACT OF A NEUROMUSCULAR TRAINING PREVENTION STRATEGY TO REDUCE INJURIES IN YOUTH SOCCER","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Rate Variability and Autonomic Control","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"Health care; Cluster randomised controlled trial; Randomized controlled trial; Medicine; Bootstrapping (finance); Physical therapy; Rate ratio; Poisson regression; Cluster (spacecraft); Environmental health; Operations management; Business; Population; Surgery; Engineering; Computer science; Economics; Finance","score_opus":0.08566396184917122,"score_gpt":0.36674500053649467,"score_spread":0.2810810386873235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397714115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964065,0.00006577337,0.00008536806,0.0025093853,0.0000681561,0.00069983705,0.000038583268,0.000015818818,0.00011059262],"genre_scores_gemma":[0.99955404,0.00003304039,0.00014881714,0.0001078677,0.00006674609,0.000015272435,0.0000038833496,0.000013028174,0.000057329904],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99843425,0.0002757882,0.000649283,0.0002570452,0.00006832244,0.00031528904],"domain_scores_gemma":[0.9993693,0.00012200821,0.00010294534,0.00023438016,0.000014956464,0.00015638302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014080853,0.00010580707,0.000436271,0.00021883148,0.000016755886,0.0000060382968,0.00005319231,0.00006385173,0.000079031954],"category_scores_gemma":[0.00015811635,0.000078448014,0.00010780387,0.00012417439,0.00003127603,0.00009086989,0.00001615319,0.00011953752,0.000015346051],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015328417,0.0009742155,0.14436804,0.0009159842,0.00017017582,0.000021641921,0.05121801,0.06720259,0.09724738,0.0037697512,0.000115965246,0.6324634],"study_design_scores_gemma":[0.0056333453,0.0047072466,0.9745358,0.001979119,0.000021110827,0.000009623119,0.0012832398,0.0075833043,0.0011468605,0.0025889783,0.00025307684,0.0002582885],"about_ca_topic_score_codex":0.009281417,"about_ca_topic_score_gemma":0.00020850658,"teacher_disagreement_score":0.8301678,"about_ca_system_score_codex":0.0008181997,"about_ca_system_score_gemma":0.002650111,"threshold_uncertainty_score":0.9973159},"labels":[],"label_agreement":null},{"id":"W2397716952","doi":"10.1016/j.jval.2016.03.1611","title":"Cost-Effectiveness of Pembrolizumab (Keytruda®) Versus Ipilimumab in Patients with Advanced Melanoma in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada); Université de Montréal","funders":"","keywords":"Ipilimumab; Pembrolizumab; Medicine; Clinical trial; Internal medicine; Oncology; Cancer; Immunotherapy","score_opus":0.028858743836033228,"score_gpt":0.2887272278546563,"score_spread":0.2598684840186231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397716952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99738485,0.00053251605,0.000005060144,0.00032688555,0.000267102,0.0013269272,0.00003019412,0.0000061385326,0.00012032465],"genre_scores_gemma":[0.9995682,0.00016902332,0.000057196154,0.000099076504,0.000008699887,0.00006399521,0.000009813754,0.000017066382,0.000006914202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846596,0.0002519158,0.00041830275,0.00023964826,0.0002744382,0.00034972417],"domain_scores_gemma":[0.999134,0.00037303683,0.00013252924,0.0002348388,0.00004409161,0.00008150359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041499457,0.00012902255,0.0004171668,0.00018307849,0.000013438374,0.0000013196383,0.00007490274,0.000042719264,0.000021586791],"category_scores_gemma":[0.00006029025,0.000088605404,0.000023595805,0.00040798896,0.00004203517,0.0000609989,0.000013143752,0.000113557595,7.377526e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.068626925,0.00022662498,0.8719839,0.00044115246,0.000022782004,0.000017819146,0.00015163345,0.00021089715,0.00018206918,0.000026041178,0.00001574965,0.05809441],"study_design_scores_gemma":[0.055470873,0.0018794088,0.9392464,0.002224045,0.0000029691964,0.0000014600815,0.00009053541,0.000035046454,0.00065925665,0.000010054872,0.00027932934,0.000100610516],"about_ca_topic_score_codex":0.8303211,"about_ca_topic_score_gemma":0.7156386,"teacher_disagreement_score":0.11468248,"about_ca_system_score_codex":0.0041060247,"about_ca_system_score_gemma":0.0031852697,"threshold_uncertainty_score":0.99971706},"labels":[],"label_agreement":null},{"id":"W2397872810","doi":"10.1016/j.jval.2016.03.1535","title":"A Multi-Criteria Decision Making Approach for Selecting an Optimal Therapy for Metastatic Colorectal Cancer","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Multiple-criteria decision analysis; KRAS; Medicine; FOLFIRI; Cetuximab; Colorectal cancer; Computer science; Oxaliplatin; Cancer; Operations research; Mathematics; Internal medicine","score_opus":0.15329497171018916,"score_gpt":0.4508951441631486,"score_spread":0.29760017245295944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2397872810","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2483008,0.00029031045,0.7496137,0.0003201947,0.00028337986,0.0011046504,0.00003506362,0.00004987728,0.0000020120272],"genre_scores_gemma":[0.333955,0.000019771724,0.6653587,0.00019158189,0.00006497695,0.0003884736,0.0000026380474,0.000015822814,0.000003029089],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99785835,0.00047479087,0.00043568175,0.00056533323,0.00020882754,0.00045700435],"domain_scores_gemma":[0.99670744,0.002707545,0.00018443761,0.0001977965,0.00011378385,0.00008901137],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002853764,0.00014910634,0.0002703624,0.00018082855,0.00017403632,0.000100192075,0.0004542041,0.000032997476,0.000002804414],"category_scores_gemma":[0.00035031827,0.00011187342,0.000072670984,0.00034666742,0.000020756228,0.00050003506,0.000069708025,0.000064821994,3.5400907e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003592435,0.00024725858,0.0002762442,0.00009882585,0.000016276483,5.437667e-7,0.0020597042,0.3184889,0.0012810742,0.0025048542,0.000040478426,0.6746266],"study_design_scores_gemma":[0.0017114518,0.00042426266,0.0020528224,0.00013391403,0.0000015367767,0.0000076614915,0.000034921974,0.9903254,0.00045646654,0.0045539183,0.0001488454,0.00014882359],"about_ca_topic_score_codex":0.00018790133,"about_ca_topic_score_gemma":0.000022164519,"teacher_disagreement_score":0.6744778,"about_ca_system_score_codex":0.00031486969,"about_ca_system_score_gemma":0.00060695835,"threshold_uncertainty_score":0.4562066},"labels":[],"label_agreement":null},{"id":"W2398081229","doi":"10.1016/j.jval.2016.03.1155","title":"SUBCUTANEOUS TOCILIZUMAB: A COST-MINIMIZATION ANALYSIS BASED ON THE POPULATION OF QUEBEC","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Tocilizumab; Medicine; Population; Formulary; Cost-minimization analysis; Tofacitinib; Internal medicine; Pharmacology; Rheumatoid arthritis; Environmental health","score_opus":0.042142510521503945,"score_gpt":0.30883726459955646,"score_spread":0.26669475407805254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398081229","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.869479,0.0014197599,0.030575857,0.09367566,0.0009064786,0.0024066272,0.00031048665,0.00011626938,0.0011098516],"genre_scores_gemma":[0.99826264,0.00003963421,0.0003983666,0.000831369,0.000008218371,0.000009901894,0.000018561339,0.000005036161,0.0004262676],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99822676,0.0009637742,0.00038568382,0.00018082066,0.00004647635,0.00019646477],"domain_scores_gemma":[0.99845207,0.0010697705,0.00017177562,0.00025209328,0.00003675029,0.000017563316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079573755,0.000083603314,0.00026239263,0.0001818546,0.000059289305,0.0000033871445,0.00010180587,0.00013389018,0.00043515422],"category_scores_gemma":[0.0003362617,0.000042491647,0.000095975694,0.0005132277,0.00008318828,0.00001719066,0.000012103079,0.00009329771,0.000011326674],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038337936,0.0015163164,0.3722824,0.00030095622,0.0010229447,0.000015371674,0.0007565964,0.022839382,0.014502222,0.10487632,0.003671115,0.47438258],"study_design_scores_gemma":[0.0060999673,0.003739061,0.8711254,0.0010617684,0.0006722045,0.000021948501,0.00026517778,0.071012765,0.020802487,0.0070681907,0.01720027,0.0009307687],"about_ca_topic_score_codex":0.014986895,"about_ca_topic_score_gemma":0.0027744267,"teacher_disagreement_score":0.49884298,"about_ca_system_score_codex":0.00013923847,"about_ca_system_score_gemma":0.00008755968,"threshold_uncertainty_score":0.9915724},"labels":[],"label_agreement":null},{"id":"W2398115477","doi":"10.1016/j.jval.2016.03.538","title":"Comparison of Arteriovenous Fistula (AVF) Maintenance And Associated Costs Between Traditional Surgical AVF Creation and A New Endovascular Approach","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; University of Toronto","funders":"","keywords":"Medicine; Arteriovenous fistula; Cohort; Propensity score matching; Psychological intervention; Angioplasty; Surgery; Fistula; Catheter; Internal medicine; Nursing","score_opus":0.14127674468636764,"score_gpt":0.3742748583450493,"score_spread":0.23299811365868167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398115477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936212,0.00088449084,0.0016249331,0.0023472232,0.000074513526,0.0007327409,0.0001671046,0.000026666741,0.00052115176],"genre_scores_gemma":[0.99820876,0.00071207475,0.0005635789,0.00009845573,0.00014031622,0.00002438748,0.00008657668,0.000015477272,0.00015036484],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974657,0.00073570287,0.0007612028,0.0003030837,0.00025715595,0.000477142],"domain_scores_gemma":[0.99830335,0.0008665796,0.00036122027,0.00015364378,0.00005021705,0.00026496427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011612615,0.00013509693,0.0006748951,0.000108965934,0.00024509054,0.000006331646,0.000068421374,0.0001660924,0.000039734794],"category_scores_gemma":[0.00013783114,0.0001011431,0.00007042878,0.00016142071,0.00008728887,0.000067430294,0.00003137034,0.00025293513,0.0000039478005],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013176273,0.00057291705,0.9578181,0.00044425818,0.00009598815,0.000005146129,0.008604421,0.000041541563,0.0000678869,0.0051259184,0.0013553383,0.02573673],"study_design_scores_gemma":[0.0052421507,0.0004885017,0.98414934,0.0011798113,0.000048286707,0.000007793784,0.00061831303,0.0022868337,0.000012670176,0.002277442,0.0034738544,0.0002149939],"about_ca_topic_score_codex":0.005723018,"about_ca_topic_score_gemma":0.00017280589,"teacher_disagreement_score":0.026331259,"about_ca_system_score_codex":0.00047685555,"about_ca_system_score_gemma":0.00035554124,"threshold_uncertainty_score":0.86515296},"labels":[],"label_agreement":null},{"id":"W2398216735","doi":"10.1016/j.jval.2016.03.1542","title":"Insights into the Pan-Canadian Pharmaceutical Alliance’s Decision not to Collectively Negotiate Pricing for Drug Products","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Negotiation; Reimbursement; Alliance; Business; List price; Product (mathematics); Actuarial science; Drug; Medicine; Marketing; Economics; Pharmacology; Political science; Finance; Health care","score_opus":0.3931898860967093,"score_gpt":0.44806228740831394,"score_spread":0.054872401311604646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398216735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54506826,0.0030802067,0.0075986786,0.43716076,0.0016206349,0.004816233,0.00011627564,0.000041372114,0.00049759145],"genre_scores_gemma":[0.9473596,0.00063129776,0.008143975,0.04221089,0.0005163133,0.00042500466,0.0000043665946,0.000050079525,0.000658419],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944615,0.0005889812,0.0031532522,0.0008471342,0.00013012222,0.00081906107],"domain_scores_gemma":[0.9942495,0.003652697,0.0008683456,0.0005577616,0.000119379976,0.0005522675],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.016517794,0.00021510237,0.0007778908,0.0005027283,0.0005284535,0.00007056942,0.00044496093,0.00009849839,0.000037805192],"category_scores_gemma":[0.00936093,0.0001784298,0.00007585815,0.0006287906,0.00005975431,0.0003160289,0.00005511668,0.0001808298,0.0010256454],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073158805,0.00040158816,0.034833934,0.0023107396,0.00015080438,0.000004132838,0.10416554,0.006624542,0.00011747799,0.5138939,0.30208394,0.034681823],"study_design_scores_gemma":[0.0034027642,0.00025550008,0.041172687,0.0009239828,0.0000044941917,0.0000028326863,0.0009735666,0.016267007,0.00018558327,0.07159238,0.8645957,0.0006234708],"about_ca_topic_score_codex":0.10943426,"about_ca_topic_score_gemma":0.046075482,"teacher_disagreement_score":0.5625118,"about_ca_system_score_codex":0.00368306,"about_ca_system_score_gemma":0.0016857176,"threshold_uncertainty_score":0.99975216},"labels":[],"label_agreement":null},{"id":"W2398256166","doi":"10.1016/j.jval.2015.09.1266","title":"Cost-Utility Analysis Of Enzalutamide For Patients With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer (Mcrpc) After Failure Of Androgen Deprivation Therapy (Adt)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of Alberta; University of Toronto","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Androgen deprivation therapy; Hazard ratio; Internal medicine; Oncology; Prednisone; Cancer; Confidence interval; Androgen receptor","score_opus":0.08888325761911012,"score_gpt":0.37325963935964823,"score_spread":0.28437638174053814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398256166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932378,0.0018509898,0.00016210155,0.00096276763,0.000021726482,0.0032398165,0.0005077941,0.000009048943,0.000007986678],"genre_scores_gemma":[0.9964017,0.00048053823,0.0021591985,0.0001170209,0.0000115771645,0.00048630824,0.00028765792,0.000019494933,0.000036490117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831635,0.00013463899,0.0005414418,0.00026819654,0.00045548493,0.00028390146],"domain_scores_gemma":[0.9986271,0.00010471003,0.00029691277,0.00026068705,0.0005532755,0.00015729023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062964385,0.00014612828,0.00056616607,0.00031571652,0.000028932602,0.0000073197166,0.000056163284,0.000040305644,0.000027663615],"category_scores_gemma":[0.000048065747,0.00009946047,0.00008754379,0.00087634777,0.00008594345,0.00008884166,0.000008272061,0.00008474813,2.4189936e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012608311,0.0007755242,0.9665713,0.00060748355,0.0010426901,0.0000026682928,0.0046862313,0.0015462352,0.00021295718,0.000014454409,0.00006019372,0.011871961],"study_design_scores_gemma":[0.017522132,0.0031153108,0.96426374,0.00034927228,0.00038228952,5.016851e-7,0.00067159376,0.005956972,0.0067802765,0.00019115637,0.0006072818,0.00015945984],"about_ca_topic_score_codex":0.00457863,"about_ca_topic_score_gemma":0.0009467212,"teacher_disagreement_score":0.011712501,"about_ca_system_score_codex":0.00036347422,"about_ca_system_score_gemma":0.0013193893,"threshold_uncertainty_score":0.69215494},"labels":[],"label_agreement":null},{"id":"W2398693187","doi":"10.1016/j.jval.2016.03.864","title":"HOW EFFECTIVE IS A WORKPLACE WELLNESS PROGRAM IN REDUCING PRESCRIPTION DRUG EXPENDITURES IN CANADA?","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University","funders":"","keywords":"Medical prescription; Prescription drug; Logistic regression; Prescription costs; Intervention (counseling); Medicine; Baseline (sea); Health care; Drug; Business; Nursing; Internal medicine; Pharmacology; Economics","score_opus":0.06705906028951815,"score_gpt":0.3731771056248912,"score_spread":0.30611804533537307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398693187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9549277,0.0011923314,0.000015692265,0.040887155,0.0004769792,0.0022493151,0.0000059786084,0.000021857475,0.0002230105],"genre_scores_gemma":[0.99776715,0.00027518105,0.0001403055,0.0012349687,0.000063847176,0.00018833803,0.0000032448047,0.00001481874,0.00031216748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981197,0.00050408,0.00032887925,0.00030548515,0.00028542432,0.00045641387],"domain_scores_gemma":[0.9988362,0.0006640035,0.00012878943,0.00017382012,0.000012258993,0.00018489835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000733627,0.00013232182,0.00031978212,0.00016738387,0.000028956141,0.000015163807,0.00006922553,0.00004876224,0.000028006658],"category_scores_gemma":[0.00029466106,0.00009212456,0.000027426402,0.00023313383,0.000021811715,0.00020399634,0.000026788033,0.00036503765,0.0000033557012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081917667,0.00038040854,0.79648495,0.00085609406,0.000012578681,0.000100660225,0.0027891037,0.00027022697,0.00012837186,0.00008687941,0.0021739795,0.19589756],"study_design_scores_gemma":[0.01199485,0.00078831974,0.8731631,0.009129425,0.000026080977,0.00003291418,0.0030804672,0.018668646,0.004503246,0.00058074674,0.07747634,0.0005558416],"about_ca_topic_score_codex":0.8543322,"about_ca_topic_score_gemma":0.46912342,"teacher_disagreement_score":0.3852088,"about_ca_system_score_codex":0.0018373252,"about_ca_system_score_gemma":0.00082486006,"threshold_uncertainty_score":0.5405637},"labels":[],"label_agreement":null},{"id":"W2398845959","doi":"10.1016/j.jval.2016.03.374","title":"Independent Factors Affecting Patient Compliance to Private Insurer-Funded Health Case Management in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Internal medicine; Quality of life (healthcare); Body mass index; Disease; Physical therapy","score_opus":0.16512538375178124,"score_gpt":0.4094674109577054,"score_spread":0.24434202720592416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398845959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97809494,0.00043229846,0.0002861101,0.014668682,0.0016691281,0.0045119147,0.00012018545,0.000066346736,0.00015037855],"genre_scores_gemma":[0.99233633,0.00046389044,0.00059928116,0.0062017785,0.00014825362,0.00011156783,0.000011645405,0.000049989627,0.00007729009],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99241304,0.0024020257,0.001866928,0.00070800545,0.0006308685,0.0019791175],"domain_scores_gemma":[0.9968534,0.00086105696,0.0006456314,0.0005442969,0.0000664119,0.0010292039],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021873359,0.00033129007,0.00068877405,0.000431263,0.0006334862,0.0000066113503,0.00025059454,0.00013432578,0.000059464255],"category_scores_gemma":[0.00019660968,0.0002606576,0.00004213522,0.00087474776,0.000014712953,0.0000974342,0.00025711692,0.00090592937,0.000063796375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006753532,0.00008671498,0.95521086,0.0024854792,0.0000073399046,0.00044316897,0.007257403,0.00033036928,6.715739e-7,0.00041266033,0.0020512696,0.031646494],"study_design_scores_gemma":[0.0023848973,0.00034924858,0.96502024,0.005107766,0.0000025767104,0.000021093972,0.013476784,0.00017222906,0.0000037561517,0.00018003877,0.012811429,0.0004699517],"about_ca_topic_score_codex":0.971112,"about_ca_topic_score_gemma":0.9564321,"teacher_disagreement_score":0.031176543,"about_ca_system_score_codex":0.013235139,"about_ca_system_score_gemma":0.005467966,"threshold_uncertainty_score":0.99998456},"labels":[],"label_agreement":null},{"id":"W2398865980","doi":"10.1016/j.jval.2016.03.1947","title":"HEALTH POLICY REVIEW: REGIONAL REFORMS IN HOSPITALS, MEDICAL PERSONNEL SYSTEM, AND MODE OF PAYMENT IN CHINA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Business; Health care; China; Health policy; Economic growth; Incentive; Health care reform; Public health; Public administration; Political science; Medicine; Economics; Nursing","score_opus":0.031602032778113694,"score_gpt":0.29597342528341936,"score_spread":0.26437139250530567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2398865980","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6876755,0.10839813,0.00010352929,0.20105995,0.00035258298,0.0014908502,0.00015760606,0.000023226929,0.0007386353],"genre_scores_gemma":[0.8877483,0.11046986,0.00009319823,0.0014346488,0.00010668139,0.00005388877,0.000005448387,0.000019404932,0.00006853901],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962156,0.00016706924,0.0023661242,0.00045778323,0.0001546829,0.0006387856],"domain_scores_gemma":[0.9985317,0.000037352893,0.0007363636,0.00032444016,0.000015040978,0.0003551065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049227625,0.0001699279,0.0011506556,0.000638989,0.000047780315,0.0000052085197,0.00018646925,0.00016137923,0.000010333378],"category_scores_gemma":[0.00023861704,0.00011039195,0.000065849235,0.0005132331,0.000061998486,0.00012863906,0.000054107495,0.0002431225,0.000014566753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046371082,0.00034846948,0.46923634,0.035696164,0.000018902105,0.000024869949,0.010910712,0.00007444926,6.6675386e-7,0.40861726,0.0005789514,0.07444684],"study_design_scores_gemma":[0.0041718157,0.00093090744,0.9063867,0.06148014,5.1990196e-7,0.000111683046,0.0012330611,0.004770614,0.0000010750483,0.008391631,0.011955076,0.0005668308],"about_ca_topic_score_codex":0.4839155,"about_ca_topic_score_gemma":0.0046432274,"teacher_disagreement_score":0.47927228,"about_ca_system_score_codex":0.0021066812,"about_ca_system_score_gemma":0.0008360293,"threshold_uncertainty_score":0.5508898},"labels":[],"label_agreement":null},{"id":"W2399143411","doi":"10.1016/j.jval.2016.03.1045","title":"BUDGET IMPACT ANALYSIS FOR THE FIRST-LINE AND SECOND-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Ibrutinib; Bendamustine; Chlorambucil; Obinutuzumab; Chronic lymphocytic leukemia; Medicine; Oncology; Rituximab; Incrementalism; Internal medicine; Ofatumumab; Leukemia; Chemotherapy; Lymphoma; Cyclophosphamide","score_opus":0.03223058491051058,"score_gpt":0.32911253656157347,"score_spread":0.2968819516510629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399143411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927316,0.0034388034,0.0007800334,0.00085430196,0.000038417373,0.0019209353,0.00020082147,0.000019001382,0.000016109629],"genre_scores_gemma":[0.99714917,0.0019262865,0.00016599109,0.000112352696,0.000109952736,0.0001292708,0.000046458226,0.00003261949,0.0003279158],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980183,0.00007387775,0.0005601028,0.00038691776,0.00038187703,0.00057887624],"domain_scores_gemma":[0.9975721,0.0012067694,0.00021803992,0.0006286935,0.00013989267,0.0002344878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004971059,0.00022691878,0.0007249111,0.00030973842,0.000091161535,0.0000093634535,0.000111872745,0.00008003587,0.00012577305],"category_scores_gemma":[0.00012083865,0.00009929905,0.00016872895,0.00064983196,0.00017926522,0.00005649812,0.00003390265,0.000058274705,0.000004149611],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.016836325,0.0013485968,0.6513917,0.005330325,0.007498649,0.00006678155,0.0032682777,0.14586543,0.00009588152,0.00024714996,0.000756573,0.16729434],"study_design_scores_gemma":[0.14915176,0.023308387,0.38039824,0.0008114701,0.00088636694,0.00003793797,0.000046238987,0.43944708,0.00103305,0.0001227681,0.004426561,0.00033013785],"about_ca_topic_score_codex":0.020176506,"about_ca_topic_score_gemma":0.003244569,"teacher_disagreement_score":0.29358166,"about_ca_system_score_codex":0.117209226,"about_ca_system_score_gemma":0.02611532,"threshold_uncertainty_score":0.9863482},"labels":[],"label_agreement":null},{"id":"W2399151328","doi":"10.1016/j.jval.2016.03.1438","title":"Cost-Effectiveness and Cost-Utility Analysis Comparing Uterine Artery Embolization and Surgical Methods for the Treatment of Symptomatic Uterine Leiomyomas","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Uterine artery embolization; Hysterectomy; Uterine leiomyoma; Uterine artery; Cost-effectiveness analysis; Cost–utility analysis; Quality-adjusted life year; Cost effectiveness; Quality of life (healthcare); Surgery; Psychological intervention; Gynecology; Leiomyoma; Risk analysis (engineering)","score_opus":0.13106728717411492,"score_gpt":0.451548250599334,"score_spread":0.3204809634252191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399151328","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9115075,0.0011021459,0.08427262,0.000709454,0.00006216121,0.0022753647,0.00003814813,0.000019468494,0.0000131262705],"genre_scores_gemma":[0.99301684,0.0019873271,0.004539896,0.000017848706,0.00003047567,0.0003408349,0.000020957506,0.000012451778,0.000033371925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985966,0.00037957772,0.0004236392,0.00028489143,0.00009050398,0.00022475662],"domain_scores_gemma":[0.99794513,0.0014704119,0.0001370578,0.00027712647,0.000044518485,0.00012576154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074062444,0.0001631923,0.00074993214,0.00016627563,0.00007142967,0.000010992466,0.00003301073,0.000040435,0.000013848685],"category_scores_gemma":[0.000044066368,0.000086116,0.00008954588,0.00026245526,0.0000832184,0.00004901254,0.000028411065,0.000026262838,2.7185365e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006335873,0.0005706824,0.56172603,0.00072292145,0.0007476988,0.000012565597,0.0003705601,0.000103980776,0.00014599472,0.00029967763,0.0000013503858,0.43466496],"study_design_scores_gemma":[0.0070105824,0.0012028454,0.86142474,0.00024540536,0.00035913585,0.00006822177,0.00002356759,0.12566808,0.0005160423,0.00013445078,0.0032662626,0.00008068367],"about_ca_topic_score_codex":0.0009476596,"about_ca_topic_score_gemma":0.00004515738,"teacher_disagreement_score":0.4345843,"about_ca_system_score_codex":0.00017693204,"about_ca_system_score_gemma":0.000045218923,"threshold_uncertainty_score":0.35117087},"labels":[],"label_agreement":null},{"id":"W2399165190","doi":"10.1016/j.jval.2016.03.812","title":"CAN THE ETHICAL DILEMMAS FOR HEALTH CARE DECISION MAKING ON DRUG REIMBURSMENT BE TACKLED THROUGH HOLISTIC MCDA: AN ADAPTATION OF THE EVIDEM FRAMEWORK IN REAL-WORLD SETTING - THE CATALAN EXPERIENCE","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Multiple-criteria decision analysis; Adaptation (eye); Catalan; Psychology; Medicine; Humanities; Operations research; Engineering; Philosophy","score_opus":0.4855523669470758,"score_gpt":0.5086104536596524,"score_spread":0.023058086712576586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399165190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5479495,0.0013858229,0.006901123,0.43922785,0.00095784746,0.0030980995,0.0003798498,0.000024527064,0.000075390955],"genre_scores_gemma":[0.9584382,0.00033725845,0.005179531,0.03529365,0.00026140438,0.00041727678,0.000014272951,0.00003667452,0.000021712605],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9918622,0.0023795047,0.004135748,0.0006837671,0.00027679527,0.0006619877],"domain_scores_gemma":[0.98242277,0.012821034,0.0034551779,0.0011136667,0.000071235896,0.000116138544],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.025791192,0.00022221004,0.00080364087,0.00019401757,0.0006405239,0.0000509465,0.0006754663,0.00016451385,0.00001638761],"category_scores_gemma":[0.010113719,0.00014150169,0.00011229566,0.0004931555,0.000164705,0.00019188906,0.000087685534,0.0006430821,0.000008543638],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014635487,0.00011235349,0.06976888,0.00086918625,0.000015202177,4.8123076e-7,0.31093708,0.025267933,4.0302936e-7,0.5839565,0.0027835073,0.0061421706],"study_design_scores_gemma":[0.0033495813,0.00096684456,0.4607658,0.016593996,0.000011963751,0.0000061741052,0.10835351,0.07511297,0.0000140462425,0.30138204,0.03242885,0.0010142162],"about_ca_topic_score_codex":0.05215166,"about_ca_topic_score_gemma":0.039311558,"teacher_disagreement_score":0.41048872,"about_ca_system_score_codex":0.0029480536,"about_ca_system_score_gemma":0.0010182054,"threshold_uncertainty_score":0.9982245},"labels":[],"label_agreement":null},{"id":"W2399173259","doi":"10.1016/j.jval.2016.03.1274","title":"ANALYSIS OF TRENDS IN UTILIZATION AND COST OF INSULIN IN THE UNITED STATES AND CANADA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin; Unit (ring theory); Quarter (Canadian coin); Business; Medicine; Agricultural economics; Agricultural science; Geography; Economics; Internal medicine; Environmental science","score_opus":0.1408378403607111,"score_gpt":0.3340619785729026,"score_spread":0.1932241382121915,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399173259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99460995,0.00093130756,0.000017706796,0.003793143,0.000016109674,0.00006813999,0.00033524618,6.2012344e-7,0.00022778101],"genre_scores_gemma":[0.99254555,0.006737819,0.0000100346415,0.00066808047,0.00000315539,0.0000030917872,0.000023084187,0.0000027746728,0.000006408122],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991825,0.000047688016,0.0005238169,0.0001117768,0.000013481943,0.000120717246],"domain_scores_gemma":[0.9995148,0.00018214004,0.00017640303,0.000085559324,0.0000056622553,0.000035407484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007351918,0.000044430344,0.00026311088,0.0008248901,0.000008599259,0.000003852199,0.000056096345,0.000023296941,0.000024506773],"category_scores_gemma":[0.00004439318,0.00003580138,0.000011749055,0.0008432206,0.00003359318,0.00003372882,0.000013394892,0.000044213055,1.5751674e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014747801,0.000037815505,0.9480302,0.000032038384,0.000018159382,3.9640435e-7,0.00089743757,0.0054800496,7.5059705e-7,0.0364017,0.0000596585,0.009027073],"study_design_scores_gemma":[0.00059945823,0.000025472824,0.8269954,0.000016889046,0.0000029576852,1.5797248e-7,0.000086878325,0.16223134,0.00000542698,0.0027736595,0.007213825,0.00004857844],"about_ca_topic_score_codex":0.8847222,"about_ca_topic_score_gemma":0.6468949,"teacher_disagreement_score":0.23782733,"about_ca_system_score_codex":0.00010788159,"about_ca_system_score_gemma":0.000051629188,"threshold_uncertainty_score":0.3595484},"labels":[],"label_agreement":null},{"id":"W2399195604","doi":"10.1016/j.jval.2016.03.1931","title":"SF6D VALUE SETS: A SYSTEMATIC REVIEW","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Checklist; Preference; Lottery; Scopus; Population; Index (typography); Actuarial science; Statistics; Demography; Medicine; Econometrics; MEDLINE; Geography; Psychology; Mathematics; Economics; Computer science; Political science; Sociology","score_opus":0.6244155366415018,"score_gpt":0.5045744746090518,"score_spread":0.11984106203245004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399195604","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.5319536e-7,0.9688719,0.00025784693,0.015414952,0.0013900112,0.011390933,0.0011789878,0.000115535215,0.0013794845],"genre_scores_gemma":[7.2729904e-7,0.97674084,0.00081986317,0.018556159,0.00040550958,0.0022282272,0.0001252347,0.00018946973,0.0009339447],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96491164,0.006990055,0.024883907,0.0016126647,0.00027956627,0.0013221737],"domain_scores_gemma":[0.9751869,0.0056201937,0.016262732,0.0022848276,0.00006441289,0.00058092515],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.08027459,0.0008907094,0.015955502,0.0012350156,0.00020924407,0.00009116827,0.0011791781,0.0005975941,0.0004356047],"category_scores_gemma":[0.015227624,0.0008366938,0.00104981,0.0008779163,0.00007921715,0.0003773479,0.00015309913,0.0007659872,0.019153023],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[5.766685e-7,0.000054162076,0.00000849617,0.9235392,0.00010831773,0.0000031684358,0.00014929996,0.000005148539,1.0984308e-10,0.058245864,0.014887852,0.0029979132],"study_design_scores_gemma":[0.00015700466,0.00003928255,0.0000011724568,0.5241062,0.000051431176,0.000031950207,0.000017326136,0.00009238739,5.7400973e-10,0.002705769,0.47237307,0.00042441685],"about_ca_topic_score_codex":0.0027033982,"about_ca_topic_score_gemma":0.00002996261,"teacher_disagreement_score":0.45748523,"about_ca_system_score_codex":0.0056836046,"about_ca_system_score_gemma":0.0024963208,"threshold_uncertainty_score":0.99940836},"labels":[],"label_agreement":null},{"id":"W2399202503","doi":"10.1016/j.jval.2015.09.578","title":"First Real-World Study Assessing Health Utility Values For Chronic Spontaneous/Idiopathic Urticaria Using The Eq-5d","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Lynde Centre for Dermatology; Novartis (Canada)","funders":"","keywords":"Medicine; EQ-5D; Internal medicine; Health related quality of life; Disease","score_opus":0.20342684095568692,"score_gpt":0.3939097600164931,"score_spread":0.19048291906080617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399202503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96681565,0.003868705,0.0022055742,0.020584086,0.0011364709,0.0047613084,0.00002855219,0.0001753778,0.00042425477],"genre_scores_gemma":[0.9967424,0.00022484596,0.0015381225,0.0006687531,0.0005168258,0.00008633527,0.000020384166,0.00005260351,0.0001497257],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9960628,0.000925384,0.0010965508,0.0005326773,0.0005145034,0.0008680704],"domain_scores_gemma":[0.99772114,0.00048633153,0.00032514587,0.0007554993,0.00017476635,0.00053711556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044631227,0.00025878474,0.0007316468,0.00025327379,0.00074984884,0.000070204995,0.00018711922,0.00012301815,0.000018531573],"category_scores_gemma":[0.00044534748,0.00018846552,0.00012663545,0.00074482354,0.00015335438,0.00012345282,0.00006744681,0.0007347908,0.000009368981],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003863118,0.020449338,0.55802286,0.0067195357,0.0047367266,0.0030319612,0.20210077,0.12955746,0.00044253952,0.038549475,0.011460636,0.02106557],"study_design_scores_gemma":[0.011621993,0.0076543726,0.20969476,0.004143108,0.001583577,0.0012808507,0.017640814,0.7330759,0.000023952414,0.009632459,0.0029289639,0.0007192438],"about_ca_topic_score_codex":0.028379329,"about_ca_topic_score_gemma":0.0046419874,"teacher_disagreement_score":0.6035184,"about_ca_system_score_codex":0.0024980395,"about_ca_system_score_gemma":0.006188536,"threshold_uncertainty_score":0.99944544},"labels":[],"label_agreement":null},{"id":"W2399234573","doi":"10.1016/j.jval.2016.03.432","title":"Comparison Of First- And Second-Season Palivizumab Prophylaxis In Patients With Congenital Airway Anomalies (Caa) In The Caress Database (2005-2015)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Gestational age; Population; Demographics; Respiratory system; Airway; Internal medicine; Anesthesia; Pregnancy; Demography","score_opus":0.02883932831126311,"score_gpt":0.29917780399412974,"score_spread":0.2703384756828666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399234573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940734,0.0024878785,0.0000045735446,0.0015103668,0.000059303788,0.0014824071,0.00021222676,0.0000110841465,0.0001587426],"genre_scores_gemma":[0.9994972,0.000090678026,0.00014495772,0.00009115051,0.000019546695,0.00008256918,0.000019707511,0.000018833745,0.000035378118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978831,0.0003212325,0.0006434476,0.00031017835,0.00041723688,0.00042481342],"domain_scores_gemma":[0.99864894,0.0005909747,0.0001802125,0.00038820482,0.000082147126,0.00010949833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072522403,0.00019393343,0.0006158772,0.00022688837,0.000048483966,0.000009845347,0.000119780205,0.000061055995,0.00004443884],"category_scores_gemma":[0.0003342653,0.00010812749,0.00002397167,0.0002973078,0.0001929413,0.00011900028,0.000077264725,0.0002097396,0.000004560769],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041293728,0.0005010516,0.9858555,0.0008233045,0.000025441614,0.000015663101,0.0073646237,0.000005585333,0.000009584934,0.00003730572,0.00017770896,0.004771262],"study_design_scores_gemma":[0.004893741,0.0015661872,0.9893802,0.0010171281,0.000012848411,0.0000036571557,0.0022355013,0.0002051845,0.00004655957,0.000014244252,0.00048983854,0.00013493943],"about_ca_topic_score_codex":0.003378171,"about_ca_topic_score_gemma":0.030246317,"teacher_disagreement_score":0.026868146,"about_ca_system_score_codex":0.00022445033,"about_ca_system_score_gemma":0.00022104823,"threshold_uncertainty_score":0.98744917},"labels":[],"label_agreement":null},{"id":"W2399405744","doi":"10.1016/j.jval.2016.03.666","title":"SINGLE DOSE INTRAOPERATIVE RADIOTHERAPY FOR BREAST CANCER: NICE RECOMMENDATIONS REVISITED","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nice; Medicine; Radiation therapy; Breast cancer; Intraoperative radiotherapy; Medical physics; Cancer; Oncology; Radiology; Internal medicine; Computer science","score_opus":0.03304483866082563,"score_gpt":0.3322148039629425,"score_spread":0.29916996530211687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399405744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54038644,0.03656102,0.012708089,0.39842877,0.0013325451,0.0037209135,0.0063673486,0.00010769959,0.00038720242],"genre_scores_gemma":[0.96992004,0.01890298,0.0064439247,0.0030856573,0.000694268,0.00048510713,0.00011077088,0.00004583688,0.00031140962],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990538,0.000116644536,0.00022763955,0.00029877294,0.000049815815,0.00025336107],"domain_scores_gemma":[0.9995227,0.00006499266,0.000090160574,0.00019016459,0.00007021901,0.000061747436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017963721,0.00012185062,0.0001740828,0.000040240826,0.000100665566,0.000008444983,0.00008031778,0.00005187435,0.000039877083],"category_scores_gemma":[0.000033180393,0.00008826385,0.000044150813,0.0000981847,0.00004199629,0.0000054836,0.00002157478,0.000030853727,0.000001838645],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001272437,0.00072848256,0.030933723,0.00019400236,0.00041866547,0.0000016015018,0.0012735261,0.00020555996,0.09890838,0.001477777,0.032374036,0.8322118],"study_design_scores_gemma":[0.02414272,0.003128654,0.13191347,0.0024885184,0.000071789866,0.00013945306,0.0006224937,0.0004642418,0.058331348,0.0011469632,0.77598596,0.0015644144],"about_ca_topic_score_codex":0.0008577006,"about_ca_topic_score_gemma":0.00026850667,"teacher_disagreement_score":0.8306474,"about_ca_system_score_codex":0.0002912892,"about_ca_system_score_gemma":0.00018026482,"threshold_uncertainty_score":0.35992953},"labels":[],"label_agreement":null},{"id":"W2399424859","doi":"10.1016/j.jval.2016.03.1093","title":"MAPPING THE WESTERN ONTARIO AND MCMASTER UNIVERSITIES ARTHRITIS INDEX (WOMAC) TO THE EQ-5D","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"WOMAC; Categorical variable; Statistics; Osteoarthritis; Mathematics; Linear regression; Medicine; EQ-5D; Regression analysis; Physical therapy; Internal medicine; Health related quality of life","score_opus":0.42363948634078735,"score_gpt":0.3493824603878545,"score_spread":0.07425702595293288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399424859","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62300074,0.0031163385,0.002475248,0.36846521,0.0004811644,0.000859627,0.00008618802,0.000023676406,0.0014918289],"genre_scores_gemma":[0.94750255,0.0009890078,0.00027390145,0.045811962,0.0003026217,0.000061101135,0.0000022325153,0.000024948424,0.0050316527],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967959,0.00048069467,0.0017802215,0.00039795245,0.00008344073,0.0004617715],"domain_scores_gemma":[0.99762374,0.0010881524,0.0006967769,0.0004008307,0.000026040245,0.0001644718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011008566,0.00014188635,0.0005061869,0.00024585996,0.0003077567,0.00007544445,0.0002884968,0.00007204117,0.00027421743],"category_scores_gemma":[0.00028901928,0.000104806284,0.00004160062,0.00018410676,0.00008362495,0.0002821441,0.000110715315,0.00017745802,0.00062873965],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033937642,0.000048212078,0.82852215,0.00024975772,0.00005033066,0.000002961353,0.085245945,0.0009173623,6.031425e-7,0.051407933,0.020789891,0.012730944],"study_design_scores_gemma":[0.00073923374,0.00007697368,0.39548752,0.00036831902,6.380545e-7,0.000010675481,0.005289919,0.0004692832,3.1258034e-7,0.004985017,0.59239227,0.00017981973],"about_ca_topic_score_codex":0.13484234,"about_ca_topic_score_gemma":0.07919585,"teacher_disagreement_score":0.5716024,"about_ca_system_score_codex":0.001504888,"about_ca_system_score_gemma":0.00048160178,"threshold_uncertainty_score":0.93760645},"labels":[],"label_agreement":null},{"id":"W2399436709","doi":"10.1016/j.jval.2016.03.1315","title":"CHARACTERISTICS OF PATIENTS INITIATING TREATMENT WITH DULAGLUTIDE AND OTHER GLP-1 RECEPTOR AGONISTS","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Dulaglutide; Exenatide; Medicine; Liraglutide; Internal medicine; Glucagon-like peptide 1 receptor; Type 2 diabetes; Diabetes mellitus; Endocrinology; Agonist; Receptor","score_opus":0.03022752582593738,"score_gpt":0.27330634948259236,"score_spread":0.24307882365665498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399436709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997789,0.0001228571,0.00001765328,0.00080966786,0.00005409805,0.0005676437,0.00004969815,0.000016683702,0.000572654],"genre_scores_gemma":[0.99760145,0.00042599405,0.0012739463,0.0003212503,0.000031749176,0.000028882636,0.000017795563,0.000017411174,0.00028152528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992093,0.00004626895,0.0002648383,0.00015899345,0.0001204469,0.00020019515],"domain_scores_gemma":[0.9995237,0.00006530118,0.00015369584,0.00014058159,0.000025767187,0.00009096619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011631475,0.000106790605,0.00027781818,0.000078662844,0.000024185147,0.000003974055,0.00001975063,0.000023069408,0.000029841614],"category_scores_gemma":[0.00002380201,0.00005972056,0.000018271086,0.00006679485,0.000038096812,0.00003160506,0.000014238413,0.000021414739,0.000007755918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014122935,0.0004259539,0.89020413,0.00020945002,0.000051008887,0.0000033233691,0.00040885626,2.9253795e-7,0.000041334126,0.00031408056,0.00003672162,0.108163625],"study_design_scores_gemma":[0.007667455,0.0062300772,0.9652483,0.0016290974,0.00005681228,0.0000010268805,0.00006137311,0.000045063014,0.00056105334,0.000050692965,0.018316403,0.00013268366],"about_ca_topic_score_codex":0.0004792668,"about_ca_topic_score_gemma":0.000015794349,"teacher_disagreement_score":0.108030945,"about_ca_system_score_codex":0.00022263727,"about_ca_system_score_gemma":0.0000688644,"threshold_uncertainty_score":0.24353339},"labels":[],"label_agreement":null},{"id":"W2399450583","doi":"10.1016/j.jval.2016.03.171","title":"Health-Related Quality of Life of Patients Suffering an Acute Coronary Syndrome: An Analysis Using Multinational Eq-5d Outcomes from the Pgrx-3 Real-World Dataset","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Acute coronary syndrome; Pharmacoepidemiology; Quality of life (healthcare); Population; Real world evidence; Pediatrics; Internal medicine; Environmental health","score_opus":0.15846213124894643,"score_gpt":0.4114763942298091,"score_spread":0.25301426298086266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399450583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9786155,0.00020734938,0.000069812646,0.0029864493,0.00027592626,0.0012075931,0.01660273,0.000027587606,0.0000070429573],"genre_scores_gemma":[0.98815733,0.00037579564,0.0012989516,0.0020094186,0.000033131215,0.000014791916,0.008072684,0.000028349632,0.000009523024],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936466,0.0018377266,0.0025426932,0.0005182901,0.00082877104,0.00062589534],"domain_scores_gemma":[0.99566704,0.0010690474,0.0013013306,0.0008975944,0.00014271242,0.00092227315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037998615,0.00023660311,0.001607974,0.00044113977,0.0001782792,0.0000051690704,0.00020348506,0.000104395105,0.00009440796],"category_scores_gemma":[0.00029824494,0.00015815589,0.00018262786,0.00091667456,0.00012620163,0.00022941781,0.000087967324,0.0002706469,0.0000028635593],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006210525,0.00073705317,0.9941583,0.0005028258,0.00020235422,0.0000044664434,0.0008172185,0.0002542525,0.000025734873,0.000110474575,0.00007572117,0.002490512],"study_design_scores_gemma":[0.0034402781,0.000775577,0.99251986,0.0003717503,0.000113516646,0.000004112912,0.00021053143,0.002348695,0.000006663967,0.000047529247,0.000036503512,0.0001250116],"about_ca_topic_score_codex":0.3500251,"about_ca_topic_score_gemma":0.008897894,"teacher_disagreement_score":0.34112722,"about_ca_system_score_codex":0.0010864143,"about_ca_system_score_gemma":0.0019674725,"threshold_uncertainty_score":0.65430313},"labels":[],"label_agreement":null},{"id":"W2399580742","doi":"10.1016/j.jval.2016.03.266","title":"A Budget Impact Analysis Establishing The Economic Benefit Of The Sandostatin® Lar® Mobile Administration Program In Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pituitary Gland Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Acromegaly; Administration (probate law); Economic evaluation; Emergency medicine; Demography; Internal medicine; Political science","score_opus":0.014403776425862116,"score_gpt":0.30106372295989325,"score_spread":0.28665994653403115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399580742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99655026,0.00047751406,0.0000033199874,0.001943364,0.000046357316,0.0007398936,0.00010993924,0.0000043719615,0.00012496511],"genre_scores_gemma":[0.9995492,0.00014846957,0.000050803395,0.00012305794,0.000012725237,0.000066107496,0.00002157781,0.000005109902,0.000022935976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914414,0.000079847974,0.0003222256,0.0001318847,0.00011734854,0.00020457103],"domain_scores_gemma":[0.9993647,0.0001841435,0.00013689755,0.00023555313,0.0000122016445,0.00006654583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026633093,0.00007804297,0.00023973627,0.0000723017,0.000038592774,0.000007791335,0.000074724136,0.000020266543,0.000035840585],"category_scores_gemma":[0.000040748142,0.000033680833,0.000069069414,0.00028448156,0.000018082219,0.000054708642,0.000013219828,0.00006300634,6.4138584e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073200325,0.00009221334,0.9790933,0.000024438148,0.00007112537,0.0000041548606,0.00023307507,0.0042318935,0.00000205092,0.00004138681,0.00008227469,0.016050853],"study_design_scores_gemma":[0.0015714843,0.0003888879,0.9930384,0.00010068255,0.000044806668,0.0000033953738,0.000305737,0.0040616114,0.000030435438,0.00024942993,0.0001616029,0.00004351308],"about_ca_topic_score_codex":0.9677398,"about_ca_topic_score_gemma":0.9626638,"teacher_disagreement_score":0.01600734,"about_ca_system_score_codex":0.00096750393,"about_ca_system_score_gemma":0.0030197739,"threshold_uncertainty_score":0.53569496},"labels":[],"label_agreement":null},{"id":"W2399606097","doi":"10.1016/j.jval.2016.03.1496","title":"Reimbursement Recommendations Based on Phase II Clinical Evidence for Oncology Drugs in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Formulary; Reimbursement; Medicine; Clinical trial; Oncology; Family medicine; Population; Listing (finance); Alternative medicine; Clinical Oncology; Internal medicine; Phases of clinical research; Intensive care medicine; Cancer; Pathology; Environmental health; Business; Health care","score_opus":0.8587800858823377,"score_gpt":0.69826068250283,"score_spread":0.16051940337950765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399606097","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13603781,0.00013350189,0.33030924,0.5140121,0.008948023,0.008798792,0.0008718994,0.000103573686,0.0007850301],"genre_scores_gemma":[0.15031548,0.00026295835,0.8416066,0.0070158783,0.00028567505,0.0003919946,0.0000024823335,0.000031373664,0.00008756842],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99178827,0.004299734,0.0025906875,0.0005033487,0.00030985236,0.0005081229],"domain_scores_gemma":[0.7348604,0.26400897,0.00045860562,0.0004229447,0.00006058589,0.0001884559],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.020361822,0.00014594558,0.00078799593,0.000107773325,0.000080902646,0.000004712916,0.00025211056,0.00012276869,0.00024399986],"category_scores_gemma":[0.20262642,0.00010788654,0.00008340675,0.00020860217,0.00006686716,0.000036430345,0.00005302086,0.00031179775,0.0000059397507],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015371419,0.002832415,0.002968092,0.00036831398,0.000017941755,0.000011782347,0.0001618089,0.00012347517,0.0000070220926,0.061017018,0.05524024,0.8757147],"study_design_scores_gemma":[0.023699157,0.010269264,0.0013761884,0.005498937,0.000032144548,9.634773e-7,0.00016793128,0.028683135,0.000096009986,0.894327,0.035427332,0.00042195502],"about_ca_topic_score_codex":0.21642716,"about_ca_topic_score_gemma":0.20920728,"teacher_disagreement_score":0.8752928,"about_ca_system_score_codex":0.002814966,"about_ca_system_score_gemma":0.0060013034,"threshold_uncertainty_score":0.9996337},"labels":[],"label_agreement":null},{"id":"W2399610764","doi":"10.1016/j.jval.2016.03.1999","title":"CANADIAN PUBLIC REIMBURSEMENT OF BIOSIMILARS (REFERRED TO AS SUBSEQUENT ENTRY BIOLOGICS – SEBS – IN CANADA), AN UPDATE","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Biosimilar; Orphan drug; Medicine; Public health; Alliance; Agency (philosophy); Family medicine; Business; Health care; Political science; Internal medicine; Nursing","score_opus":0.06628117005011978,"score_gpt":0.3140064158950997,"score_spread":0.2477252458449799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399610764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66315454,0.00023813677,0.000015013155,0.33576906,0.0002349108,0.0004011575,0.000045736742,0.0000064235983,0.00013502018],"genre_scores_gemma":[0.9882182,0.0006434481,0.0002536624,0.01073241,0.000039564322,0.0000110935025,0.000050604118,0.0000097788015,0.000041230276],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821174,0.00018475486,0.00051526615,0.000252174,0.00034468758,0.00049137074],"domain_scores_gemma":[0.99859303,0.00004532282,0.000095293704,0.00026637258,0.00007126646,0.0009286879],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011111067,0.00010057121,0.00026727084,0.00036304895,0.00003361437,0.0000037544196,0.00010803954,0.00014079749,0.00010668194],"category_scores_gemma":[0.00014143104,0.00006654151,0.000019767365,0.00043044766,0.00007624541,0.0000332079,0.000022234532,0.00016852343,0.0000043405353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004035616,0.000682511,0.6059998,0.000985585,0.00008266757,0.00036292404,0.0017499785,0.0004744253,0.0060905702,0.0678718,0.012569221,0.30272695],"study_design_scores_gemma":[0.0039393962,0.0018811793,0.81880033,0.002180328,0.000012688681,0.0000361081,0.00094497285,0.0023733845,0.0017040332,0.00647934,0.16116916,0.00047905397],"about_ca_topic_score_codex":0.9935924,"about_ca_topic_score_gemma":0.9975606,"teacher_disagreement_score":0.32506368,"about_ca_system_score_codex":0.0038213944,"about_ca_system_score_gemma":0.016005352,"threshold_uncertainty_score":0.99928135},"labels":[],"label_agreement":null},{"id":"W2399640665","doi":"10.1016/j.jval.2016.03.754","title":"Prescription Factors Associated With A Do Not Substitute Prescription In Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medical prescription; Medicine; Specialty; Generic drug; Family medicine; Pharmacist; Brand names; Pharmacy; Drug; Pharmacology; Business; Advertising","score_opus":0.126930399827186,"score_gpt":0.2746551098800359,"score_spread":0.14772471005284987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399640665","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937989,0.00042426167,0.00008552869,0.0032528844,0.00038553518,0.00030613143,0.00035970085,0.000014068214,0.0013729769],"genre_scores_gemma":[0.99840516,0.00041771276,0.00002072842,0.0009594117,0.00003639945,0.000022035309,0.000011605152,0.000018070867,0.00010888222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983859,0.000056281937,0.00070036907,0.0003371248,0.000040812098,0.00047950927],"domain_scores_gemma":[0.99922055,0.000118519885,0.00030147453,0.00018450052,0.000011534156,0.00016343559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006441749,0.00013593664,0.0003578155,0.00021960818,0.00004090143,0.000026118774,0.00014098306,0.00006371985,0.00009165845],"category_scores_gemma":[0.00016604306,0.000118529606,0.000028781693,0.00022031435,0.000026115804,0.00024157086,0.000022183103,0.0001554715,0.000026052243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050220002,0.00008220084,0.918658,0.000043027034,0.000017843699,0.0000038325998,0.00039942458,0.0026431861,0.000026032945,0.07641173,0.00068596745,0.0009785384],"study_design_scores_gemma":[0.0018982595,0.00007777406,0.96542156,0.00022623334,0.0000014601065,6.7483796e-7,0.000034799235,0.008892456,0.000073316885,0.010269735,0.012801528,0.00030218053],"about_ca_topic_score_codex":0.8746451,"about_ca_topic_score_gemma":0.7282126,"teacher_disagreement_score":0.1464325,"about_ca_system_score_codex":0.0033880274,"about_ca_system_score_gemma":0.0005966977,"threshold_uncertainty_score":0.88595736},"labels":[],"label_agreement":null},{"id":"W2399866507","doi":"10.1016/j.jval.2016.03.1524","title":"Pan-Canadian Oncology Drug Review Recommendations for Cancer Products without Statistically Significant Overall Survival Data","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Confounding; Internal medicine; Population; Oncology; Cancer; Environmental health","score_opus":0.6376866463596899,"score_gpt":0.5098763384596184,"score_spread":0.12781030790007142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2399866507","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014630302,0.01712403,0.007025425,0.9535809,0.001970853,0.0038583195,0.014249155,0.000040073293,0.00068818347],"genre_scores_gemma":[0.1452079,0.2922942,0.17702441,0.36383146,0.0041675144,0.0052094096,0.0039271126,0.0004373867,0.007900614],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99230564,0.0011998381,0.0045222486,0.0010284332,0.00009354442,0.000850322],"domain_scores_gemma":[0.99330634,0.002987098,0.0019209322,0.0011580997,0.00013581374,0.00049173663],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03536331,0.0002096931,0.0013330822,0.00031715148,0.00021363981,0.000033163218,0.0006167494,0.00009792183,0.0005276196],"category_scores_gemma":[0.011737989,0.00021300852,0.00004707631,0.00022513705,0.000072113835,0.00042696687,0.0000723082,0.00018010197,0.000498228],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025435336,0.00016487714,0.020321338,0.00532121,0.00006144673,0.0000012122557,0.00070894585,0.000045266755,0.0000015682247,0.20910925,0.7477964,0.016443072],"study_design_scores_gemma":[0.000908593,0.00010100294,0.0058437334,0.0020386742,0.000006858525,0.0000015199265,0.000082149825,0.002254959,5.2194747e-7,0.011294309,0.9771673,0.00030039286],"about_ca_topic_score_codex":0.33988032,"about_ca_topic_score_gemma":0.13446577,"teacher_disagreement_score":0.58974946,"about_ca_system_score_codex":0.0034506307,"about_ca_system_score_gemma":0.005472937,"threshold_uncertainty_score":0.99658656},"labels":[],"label_agreement":null},{"id":"W2400148784","doi":"10.1016/j.jval.2016.03.1811","title":"CAN HOLISTIC MCDA TACKLE ISSUES RAISED BY EVALUATING TREATMENTS FOR RARE DISEASES: AN EXPLORATION FROM THE HTA PERSPECTIVE","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Multiple-criteria decision analysis; Operationalization; Underpinning; Management science; Psychological intervention; Psychology; Weighting; Perspective (graphical); Medicine; Applied psychology; Computer science; Operations research; Psychiatry; Engineering","score_opus":0.6192007478366135,"score_gpt":0.5083943326665649,"score_spread":0.11080641517004863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400148784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.572182,0.01678558,0.011025451,0.37596303,0.0012369525,0.0057914765,0.01666951,0.00013213785,0.00021387548],"genre_scores_gemma":[0.98470604,0.00080121146,0.0025264935,0.008540487,0.0009322341,0.001260212,0.0005344632,0.00007762533,0.00062121125],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99484694,0.0012201517,0.002495671,0.00078598777,0.000136081,0.0005151398],"domain_scores_gemma":[0.9943998,0.0029868714,0.0015971442,0.0006476219,0.000108402186,0.00026017925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007760207,0.0002275254,0.00077210035,0.00014436414,0.0004058889,0.00009228729,0.00030385464,0.000095533826,0.0001781018],"category_scores_gemma":[0.0063292156,0.0001928552,0.00009581981,0.00016718228,0.0000669055,0.00080436666,0.000029054498,0.0000918267,0.00018143424],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006178087,0.001969274,0.27256238,0.0009235125,0.00059158803,0.0000027755427,0.13462946,0.0054454696,0.00005983884,0.39914763,0.1741309,0.009919355],"study_design_scores_gemma":[0.011609733,0.0019419779,0.07381153,0.0011377226,0.00005292545,0.0000015108386,0.041408245,0.08231791,0.000021580085,0.7619709,0.024503205,0.0012227704],"about_ca_topic_score_codex":0.052120198,"about_ca_topic_score_gemma":0.0010885277,"teacher_disagreement_score":0.41252407,"about_ca_system_score_codex":0.0025956745,"about_ca_system_score_gemma":0.00057561486,"threshold_uncertainty_score":0.9541918},"labels":[],"label_agreement":null},{"id":"W2400311525","doi":"10.1016/j.jval.2016.03.188","title":"Antiepileptic Drugs, Risk of Suicide Attempts, and the Impact of Underlying Medical Conditions: Results from the Pgrx Information System","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacological Effects and Toxicity Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Depression (economics); Suicide attempt; Odds ratio; Confidence interval; Psychiatry; Telephone interview; Logistic regression; Major depressive episode; Suicidal ideation; History of depression; Poison control; Pediatrics; Suicide prevention; Emergency medicine; Internal medicine; Cognition","score_opus":0.057461349814338494,"score_gpt":0.37228434285311623,"score_spread":0.31482299303877775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400311525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895198,0.0009974553,0.00011375974,0.008126342,0.0000765519,0.0006854374,0.00031576562,0.000014035099,0.00015090035],"genre_scores_gemma":[0.99777883,0.0017771644,0.00002158148,0.00035585038,0.000036912013,0.0000124295175,0.0000116622405,0.0000030945357,0.0000024489143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812055,0.00067469286,0.00065010745,0.00008962156,0.00030745458,0.00015760065],"domain_scores_gemma":[0.99361336,0.005682152,0.00041619735,0.00015982785,0.00004471464,0.000083770254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029401944,0.00008298973,0.00039921366,0.000045684446,0.00010193612,0.000004349103,0.0000776853,0.000054462045,0.000010767814],"category_scores_gemma":[0.0025600959,0.000029155577,0.00008422961,0.00013329268,0.00029302953,0.00007159105,0.00004285053,0.00016604719,0.0000029987903],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011711554,0.00067051314,0.8500587,0.003684996,0.0027201131,0.000034864177,0.04232055,0.001677088,0.00095196284,0.015429874,0.012811459,0.057928342],"study_design_scores_gemma":[0.013829816,0.0006617013,0.9655005,0.0037497964,0.00009430893,0.000009855565,0.002146622,0.01295958,0.00008050151,0.00085091114,0.000047471385,0.00006898683],"about_ca_topic_score_codex":0.028872207,"about_ca_topic_score_gemma":0.00002916378,"teacher_disagreement_score":0.11544176,"about_ca_system_score_codex":0.00011725363,"about_ca_system_score_gemma":0.00020092199,"threshold_uncertainty_score":0.9775946},"labels":[],"label_agreement":null},{"id":"W2400513728","doi":"10.1016/j.jval.2016.03.062","title":"Does A Web-Based Decision Aid Help Parents in making a Decision to Vaccinate their Child against Hpv: Findings from Alberta","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Alberta Health Services","funders":"","keywords":"Decision aids; Preference; Descriptive statistics; Sample (material); Family medicine; Psychology; Vaccination; Medicine; Session (web analytics); Demography; Alternative medicine; Computer science; Statistics","score_opus":0.02568770224073916,"score_gpt":0.3145284611527088,"score_spread":0.28884075891196964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400513728","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98347986,0.00028660268,0.0006978215,0.0133991325,0.0007347667,0.00067265454,0.000029354867,0.00004455473,0.0006552437],"genre_scores_gemma":[0.9948657,0.0008421419,0.0013352908,0.002635726,0.00018411232,0.000047076348,0.0000038969565,0.000026908274,0.000059153208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970061,0.00044201998,0.0006934769,0.00060488406,0.00049106596,0.0007624304],"domain_scores_gemma":[0.9969551,0.0022003506,0.00015155657,0.0003832951,0.0000493198,0.00026036898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016103535,0.00021618656,0.00040604713,0.00044393478,0.00038767548,0.000082053,0.0005100377,0.00014023388,0.00026063132],"category_scores_gemma":[0.0014209023,0.00012769239,0.00009166209,0.00066754536,0.000009005447,0.0003345013,0.000107168526,0.00019716623,0.0001513475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033544248,0.00015157808,0.73460466,0.00002026266,0.00000441197,0.000019578301,0.008559166,0.0004427553,0.000045113055,0.00048516964,0.0006047745,0.2547271],"study_design_scores_gemma":[0.005437933,0.00022781226,0.9113706,0.0074900445,0.000003978247,4.504467e-7,0.0014770151,0.0013442454,0.00017867102,0.017837659,0.054051243,0.0005803493],"about_ca_topic_score_codex":0.03510476,"about_ca_topic_score_gemma":0.09670717,"teacher_disagreement_score":0.25414675,"about_ca_system_score_codex":0.000770016,"about_ca_system_score_gemma":0.00050152285,"threshold_uncertainty_score":0.97132057},"labels":[],"label_agreement":null},{"id":"W2400637005","doi":"10.1016/j.jval.2016.03.747","title":"Chinese Health System Development From 1949 To 2015: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"EconLit; Political science; China; Government (linguistics); Politics; Context (archaeology); Health policy; Public relations; Health care; MEDLINE; Law; Geography","score_opus":0.11460281494638101,"score_gpt":0.35562115934816135,"score_spread":0.24101834440178033,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400637005","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000030934532,0.98168594,0.00038801492,0.0026007446,0.0022487927,0.011513649,0.0010771863,0.0001151231,0.00036746304],"genre_scores_gemma":[0.000027301889,0.99423116,0.0006975568,0.0016407245,0.00040941904,0.0019873236,0.00014053262,0.0001609886,0.0007049783],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98597825,0.000978364,0.010106491,0.0013880461,0.00022346414,0.0013254184],"domain_scores_gemma":[0.9919859,0.0002186077,0.0051584784,0.001553873,0.000055624096,0.0010274751],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.010387574,0.0008915254,0.012219955,0.0009947774,0.00023001949,0.00006461669,0.00087193423,0.0004341448,0.000047657082],"category_scores_gemma":[0.0004566017,0.00056296156,0.0006041097,0.00117501,0.000017789429,0.000117206655,0.00017858832,0.0005840113,0.00689922],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[8.4170796e-7,0.000034642162,0.000037352766,0.94187534,0.00009357353,0.000007480456,0.00034577434,8.836551e-7,1.8745319e-10,0.002318619,0.0008108194,0.054474667],"study_design_scores_gemma":[0.000101242906,0.000047142483,0.000027827233,0.55054784,0.0000052556443,0.000021146776,0.000014108021,0.000005569235,7.514255e-10,0.000047985646,0.44883674,0.0003451177],"about_ca_topic_score_codex":0.04452809,"about_ca_topic_score_gemma":0.00040251907,"teacher_disagreement_score":0.4480259,"about_ca_system_score_codex":0.007824408,"about_ca_system_score_gemma":0.0029883683,"threshold_uncertainty_score":0.9996822},"labels":[],"label_agreement":null},{"id":"W2400663615","doi":"10.1016/j.jval.2016.03.1497","title":"Trends in Expenditures for Oral Chemotherapy after Market Entry (2007-2013)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Pharmacy; Receipt; Quarter (Canadian coin); Drug prices; Medicare Part D; Prescription drug; Medicare Advantage; Cancer drugs; Medical prescription; Drug; Health care; Business; Public economics; Family medicine; Accounting; Pharmacology; Economics; Economic growth","score_opus":0.03689146752260034,"score_gpt":0.2778020703234234,"score_spread":0.24091060280082308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2400663615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88248044,0.027754309,0.0035060106,0.038099784,0.003941004,0.0013255028,0.0012767536,0.00008376252,0.04153246],"genre_scores_gemma":[0.985836,0.003974255,0.00092533533,0.0028057967,0.00038229782,0.00016134212,0.000006105815,0.000040460833,0.0058683525],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99822885,0.000022575432,0.00075954775,0.0003955737,0.000021704902,0.00057175884],"domain_scores_gemma":[0.999267,0.00009184266,0.00026356804,0.00025368526,0.0000071891454,0.00011670595],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00094528036,0.00015808707,0.00048166004,0.00044635116,0.00002971032,0.000025002138,0.00016129922,0.00013018626,0.0022524246],"category_scores_gemma":[0.00004840644,0.00014690727,0.00009955252,0.00010952602,0.000040659797,0.00026624848,0.000018442948,0.00009147698,0.00009722912],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010562361,0.00029448376,0.6039461,0.0001388769,0.000028262439,0.0000065739496,0.0009835785,0.0001205613,0.000003069658,0.057683326,0.15485363,0.18088531],"study_design_scores_gemma":[0.0026870156,0.00015916898,0.43359786,0.00010006795,5.078357e-7,0.0000012878414,0.000017749171,0.00052935345,0.000012718832,0.02957475,0.5330617,0.00025780412],"about_ca_topic_score_codex":0.004006291,"about_ca_topic_score_gemma":0.00069048116,"teacher_disagreement_score":0.3782081,"about_ca_system_score_codex":0.00050962553,"about_ca_system_score_gemma":0.00006551525,"threshold_uncertainty_score":0.9986597},"labels":[],"label_agreement":null},{"id":"W2401126186","doi":"10.1016/j.jval.2016.03.669","title":"NURSE-LED CARE FOR PATIENTS WITH RHEUMATOID ARTHRITIS: A SYSTEMATIC REVIEW","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Nursing Roles and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary","funders":"","keywords":"CINAHL; Medicine; MEDLINE; Inclusion (mineral); Randomized controlled trial; Rheumatoid arthritis; Family medicine; Health care; Systematic review; Nursing; Physical therapy; Psychological intervention; Internal medicine; Psychology","score_opus":0.07220387224143804,"score_gpt":0.4446594065409786,"score_spread":0.37245553429954054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401126186","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.4662435e-7,0.9682801,0.000018639703,0.0006562089,0.0014028886,0.028661722,0.00041849195,0.000083367864,0.00047773213],"genre_scores_gemma":[0.0000020092389,0.9911021,0.00040351588,0.0007247072,0.00015030913,0.0068581677,0.0002894223,0.00015603467,0.0003137527],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9895994,0.0051283697,0.003147417,0.00065081974,0.0004541188,0.0010198412],"domain_scores_gemma":[0.9903659,0.004223008,0.003850693,0.0009311058,0.0003494396,0.00027982472],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028588467,0.0005726791,0.0055290665,0.00024279815,0.00065100356,0.000017848288,0.00040878388,0.00041634933,0.00010288576],"category_scores_gemma":[0.0013304284,0.0003343065,0.0002986712,0.0003924109,0.000034865112,0.00015178644,0.000034724933,0.00092720124,0.00035496746],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016826987,0.000058675796,0.000037390448,0.8558211,0.000046375862,0.0000011843915,0.00071602414,7.834507e-8,6.408493e-11,0.0003268733,0.002922031,0.14005345],"study_design_scores_gemma":[0.00056899025,0.00019341361,0.000001385664,0.5269811,0.00011314214,0.0000025613258,0.00023223944,4.932788e-7,2.2182134e-10,0.000022008197,0.47169745,0.00018718731],"about_ca_topic_score_codex":0.00039079544,"about_ca_topic_score_gemma":0.00010487644,"teacher_disagreement_score":0.46877542,"about_ca_system_score_codex":0.0012107983,"about_ca_system_score_gemma":0.0032530366,"threshold_uncertainty_score":0.9999109},"labels":[],"label_agreement":null},{"id":"W2401171230","doi":"10.1016/j.jval.2016.03.490","title":"Assessing Severity In Psoriasis: Correlation Of Different Measures (Pasi, Bsa, And Iga) In A Canadian Real-World Setting","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Innovaderm (Canada); Novartis (Canada)","funders":"","keywords":"Psoriasis; Psoriasis Area and Severity Index; Medicine; Rank correlation; Spearman's rank correlation coefficient; Severity of illness; Correlation; Observational study; Internal medicine; Body surface area; Dermatology","score_opus":0.039772160177721824,"score_gpt":0.28787270484287375,"score_spread":0.2481005446651519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401171230","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966189,0.0015227726,0.000012040807,0.0008255152,0.00037053332,0.00028726034,0.000029936085,0.000012137537,0.0003208844],"genre_scores_gemma":[0.99913615,0.000591273,0.000085666295,0.000043968328,0.000016823968,0.000021405052,0.000020276404,0.000010047575,0.00007441718],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979479,0.00081019715,0.0004966376,0.00025648327,0.000039189246,0.00044961888],"domain_scores_gemma":[0.9992491,0.00036618402,0.00016510423,0.00014418413,0.000019281539,0.000056165078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010200036,0.00013726966,0.00036361063,0.00053179346,0.00007023715,0.0000076293395,0.00006679064,0.0001545263,0.000019278035],"category_scores_gemma":[0.00013617812,0.000107097985,0.00002772102,0.00024980615,0.000048743404,0.00011827548,0.000019193129,0.00014196677,0.00000496149],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000070804716,0.000056295212,0.9077537,0.00005049522,0.000014703037,0.0000073188294,0.0010532483,0.000026829894,0.0014717686,0.00044075574,0.000021167814,0.08903292],"study_design_scores_gemma":[0.0017888205,0.00006676857,0.9953355,0.0006937736,0.000008063618,0.0000062513627,0.00020847605,0.00006691551,0.0010356362,0.0005483788,0.00013325467,0.00010811793],"about_ca_topic_score_codex":0.5652125,"about_ca_topic_score_gemma":0.7496735,"teacher_disagreement_score":0.18446101,"about_ca_system_score_codex":0.00063079677,"about_ca_system_score_gemma":0.00043547503,"threshold_uncertainty_score":0.43768278},"labels":[],"label_agreement":null},{"id":"W2401460285","doi":"10.1016/j.jval.2016.03.281","title":"The Service Utilization And Cost Of Hiv Treatment In Mbagathi District Hospital, Kenya","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Activity-based costing; Medicine; Per capita; Quarter (Canadian coin); Emergency medicine; Total cost; Unit cost; Unit (ring theory); Average cost; Environmental health; Pediatrics; Medical emergency; Business; Geography; Population","score_opus":0.056453288762448484,"score_gpt":0.3302134761228075,"score_spread":0.273760187360359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401460285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9655988,0.0023300508,0.00004888285,0.030645356,0.00010044148,0.0005166268,0.000011273038,0.000010128646,0.0007384161],"genre_scores_gemma":[0.9849941,0.014647351,0.000018770132,0.00008490115,0.00003930493,0.00001466889,0.0000013631305,0.0000035857176,0.00019595129],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991675,0.00021668071,0.00020795138,0.000109324305,0.0001108311,0.0001877352],"domain_scores_gemma":[0.99942464,0.00030898763,0.00008505712,0.00009995291,0.000029853445,0.000051541727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005080503,0.00004907243,0.000103798746,0.000035301953,0.00014950916,0.000013014037,0.00007535439,0.000032626947,0.0000096697895],"category_scores_gemma":[0.00012031889,0.00002877783,0.000012385555,0.00027283395,0.000014223429,0.00008642581,0.000012308906,0.000025450607,0.0000044544827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025461495,0.00017748235,0.8122956,0.000048797236,0.0000042428655,0.0000031453853,0.022447158,0.000035315865,0.000008579392,0.023681477,0.0006252188,0.14064753],"study_design_scores_gemma":[0.0014032234,0.00029781458,0.9204321,0.00028555797,0.00000363226,3.3993655e-7,0.0038832058,0.0003965835,0.0000460585,0.0041221688,0.06901087,0.00011847933],"about_ca_topic_score_codex":0.021728465,"about_ca_topic_score_gemma":0.016220797,"teacher_disagreement_score":0.14052905,"about_ca_system_score_codex":0.00026550418,"about_ca_system_score_gemma":0.0002780908,"threshold_uncertainty_score":0.9847859},"labels":[],"label_agreement":null},{"id":"W2401695302","doi":"10.1016/j.jval.2016.03.1507","title":"Oncology Drugs Lag Between Europe and other Countries: Comparaison between EMA and others Agencies (FDA, Health Canada, TGA, and Swissmedic)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Food and drug administration; Drug approval; Agency (philosophy); Regulatory affairs; Drug; Regulatory agency; Family medicine; Internal medicine; Oncology; Pharmacology; Operations management; Political science","score_opus":0.1278358697310247,"score_gpt":0.3378959370583687,"score_spread":0.21006006732734397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401695302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9072931,0.011553367,0.00008535012,0.07529918,0.00019745168,0.00041244703,0.0014461789,0.000019879999,0.0036930873],"genre_scores_gemma":[0.9743453,0.009495461,0.00013716123,0.015505901,0.00024453495,0.000009309288,0.0000050740464,0.000035778186,0.00022145802],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978254,0.00012507672,0.0009301963,0.00046589307,0.000044069668,0.0006094074],"domain_scores_gemma":[0.9981652,0.00065707875,0.00043594994,0.00018938366,0.000012897913,0.00053950096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017170793,0.00019642506,0.0008416882,0.00018485327,0.00015147141,0.000037063037,0.00013560936,0.00009568373,0.00006232489],"category_scores_gemma":[0.00007633914,0.00018364734,0.000020339792,0.00012682399,0.00024005614,0.00009629213,0.00007974638,0.00019002685,0.000029059012],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000185195,0.000019360945,0.90128213,0.00026792786,0.000054748794,0.0000024026924,0.00352891,0.000009274087,8.4114305e-7,0.06529049,0.007579519,0.021945864],"study_design_scores_gemma":[0.001119997,0.00020153017,0.17428993,0.00008574919,0.000002981962,0.0000033141198,0.0001305352,0.00038613257,0.0000027034557,0.0049390565,0.81863594,0.00020212166],"about_ca_topic_score_codex":0.5113867,"about_ca_topic_score_gemma":0.06270328,"teacher_disagreement_score":0.81105644,"about_ca_system_score_codex":0.0006479994,"about_ca_system_score_gemma":0.00078485266,"threshold_uncertainty_score":0.95439994},"labels":[],"label_agreement":null},{"id":"W2401701380","doi":"10.1016/j.jval.2016.03.352","title":"Provider and Payer-Related Indicators of Commercial Price Variation in Professional Services in Vermont","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Copayment; Medicaid; Indemnity; Business; Service (business); Actuarial science; Preferred provider organization; Type of service; Medicine; Utilization management; Payment; Specialty; Deductible; Product (mathematics); Service provider; Health care; Fee-for-service; Quarter (Canadian coin); Family medicine; Managed care; Health insurance; Finance; Marketing","score_opus":0.036867823627027736,"score_gpt":0.28270046372601226,"score_spread":0.24583264009898453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2401701380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9759311,0.0006509255,0.000039785155,0.021926994,0.00027190568,0.00056185573,0.000031027434,0.0000074445634,0.00057896454],"genre_scores_gemma":[0.9985749,0.0004981077,0.00011727382,0.00066809217,0.000017549459,0.000037434627,0.0000026912326,0.000007761798,0.00007618822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847686,0.0001196839,0.0008830556,0.00022852652,0.00003887571,0.0002529683],"domain_scores_gemma":[0.9993253,0.00011391758,0.00037218526,0.00012109223,0.0000064739706,0.00006105277],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017063303,0.00007372179,0.00027229413,0.000610881,0.000024492258,0.00000460682,0.000085965614,0.00009291981,0.00002976744],"category_scores_gemma":[0.00006774202,0.00006655828,0.000013589495,0.00040660874,0.000019161222,0.00013902709,0.00005265673,0.00012193791,0.000011304782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038705424,0.00021511134,0.70915496,0.0008511967,0.000005810193,0.0000018418588,0.007572344,0.00009924256,0.0000031539284,0.26842362,0.000032983964,0.013601012],"study_design_scores_gemma":[0.00096127985,0.0000616133,0.9732899,0.00032633956,2.9336266e-7,2.2618465e-7,0.000064407905,0.0011324936,0.0000019997558,0.019784743,0.0043047755,0.00007193241],"about_ca_topic_score_codex":0.06346546,"about_ca_topic_score_gemma":0.002921874,"teacher_disagreement_score":0.2641349,"about_ca_system_score_codex":0.0002776177,"about_ca_system_score_gemma":0.00011059838,"threshold_uncertainty_score":0.942771},"labels":[],"label_agreement":null},{"id":"W2402007715","doi":"10.1016/j.jval.2016.03.1106","title":"IDENTIFYING FACTORS WHICH INFLUENCE THE SELECTION OF ANTI-TNF TREATMENT IN PATIENTS WITH RHEUMATOID ARTHRITIS IN ENGLAND","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Rheumatoid arthritis; Medicine; Adalimumab; Etanercept; Infliximab; Imputation (statistics); Logistic regression; Internal medicine; Rheumatology; Multinomial logistic regression; Physical therapy; Demography; Tumor necrosis factor alpha; Missing data; Statistics","score_opus":0.021542608853551456,"score_gpt":0.2832496467589208,"score_spread":0.2617070379053693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402007715","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972236,0.0014030463,0.000008349551,0.00048505806,0.000036568188,0.00080772664,0.000009927154,0.000012756944,0.000012968955],"genre_scores_gemma":[0.9680121,0.03185379,0.000047874993,0.000016582191,0.0000060101393,0.00003908377,0.0000053967924,0.000013521602,0.0000056365575],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832433,0.00028369445,0.00047580042,0.00021066076,0.00032768992,0.00037780232],"domain_scores_gemma":[0.9993155,0.00022139061,0.0001192114,0.00016962107,0.00008574388,0.0000885349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050849374,0.00012253612,0.00035949194,0.0003032821,0.00005326439,0.000012236086,0.00006279609,0.000043835265,0.000017840419],"category_scores_gemma":[0.00019382637,0.000064336426,0.000021697202,0.0005519093,0.00006446768,0.00016265643,0.000014388262,0.00014073895,0.0000034509321],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020691419,0.00026860088,0.97359115,0.000046761503,0.000011505309,0.0000033314154,0.003058737,0.000103850245,0.00014133245,0.000049594593,0.0000016868117,0.02251655],"study_design_scores_gemma":[0.007924906,0.0011204277,0.98680073,0.002875724,2.2577684e-7,0.00000553982,0.00016909969,0.00005989885,0.00069824414,0.00008634621,0.0001946628,0.00006418266],"about_ca_topic_score_codex":0.017617652,"about_ca_topic_score_gemma":0.013634624,"teacher_disagreement_score":0.030450745,"about_ca_system_score_codex":0.00031602973,"about_ca_system_score_gemma":0.00036193733,"threshold_uncertainty_score":0.98892415},"labels":[],"label_agreement":null},{"id":"W2402013895","doi":"10.1016/j.jval.2016.03.172","title":"Reported Psychological Symptoms and Quality of Life in Patients Suffering an Acute Coronary Syndrome: New Insights from the Pgrx-3 Real-World Dataset","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Anxiety; Acute coronary syndrome; Depression (economics); Myocardial infarction; Quality of life (healthcare); Medical record; Internal medicine; Psychiatry","score_opus":0.11267742304466523,"score_gpt":0.4093458487964976,"score_spread":0.2966684257518324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402013895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99450994,0.0004227228,0.000005828602,0.0022173224,0.00031376875,0.0012245179,0.001233413,0.000024848288,0.00004762031],"genre_scores_gemma":[0.99312603,0.0015696366,0.00017640299,0.0035851665,0.000067660025,0.000018096935,0.0014197918,0.00001768432,0.000019500196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963614,0.0008007765,0.0014561082,0.0005220264,0.00039861456,0.00046108352],"domain_scores_gemma":[0.9974005,0.0005285525,0.00041518325,0.0007290446,0.000028512957,0.0008982007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012661929,0.00017765876,0.0007837135,0.00014511948,0.000065887325,0.000005068071,0.00011294308,0.00011387611,0.00003350778],"category_scores_gemma":[0.00023234622,0.000105389074,0.000041806295,0.00033875267,0.000094759,0.00012212557,0.00007558493,0.00030333156,0.0000047148033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012514738,0.00042071758,0.9906592,0.00020466279,0.000016469918,0.000039179355,0.0003940237,0.0000011832212,0.000032659307,0.00013194008,0.000865165,0.0059833764],"study_design_scores_gemma":[0.0051189666,0.0015466292,0.99167734,0.0006995407,0.000011949849,0.000022679278,0.00004712746,0.000015882422,0.000003899844,0.00021505126,0.0005389173,0.00010204123],"about_ca_topic_score_codex":0.13859004,"about_ca_topic_score_gemma":0.0048297453,"teacher_disagreement_score":0.13376029,"about_ca_system_score_codex":0.0003833978,"about_ca_system_score_gemma":0.0006687906,"threshold_uncertainty_score":0.8671462},"labels":[],"label_agreement":null},{"id":"W2402014401","doi":"10.1016/j.jval.2015.09.1063","title":"Changes In Glucose Lowering Drug Use Before And After A Cancer Diagnosis Among Individuals With Diabetes","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Metabolism, Diabetes, and Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Cancer; Odds ratio; Colorectal cancer; Internal medicine; Diabetes mellitus; Prostate cancer; Odds; Pancreatic cancer; Breast cancer; Gastrointestinal cancer; Logistic regression; Gastroenterology; Oncology; Endocrinology","score_opus":0.020342466426591016,"score_gpt":0.26439479160198853,"score_spread":0.24405232517539752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402014401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8583492,0.14094953,0.0000011706368,0.00023885584,0.00011209497,0.00027505166,0.00006266418,0.0000065703807,0.0000048378583],"genre_scores_gemma":[0.96146923,0.035822857,0.00015349177,0.001173221,0.00017189117,0.0011338991,0.000019258376,0.000027356884,0.000028790666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987683,0.00011672345,0.00019998073,0.00034774723,0.00014358315,0.0004236541],"domain_scores_gemma":[0.99945337,0.000020281579,0.0000862284,0.00020473165,0.000034222092,0.00020118132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005109214,0.00016030966,0.00025084667,0.000100345285,0.00002370072,0.00003411541,0.00008661537,0.000088410845,0.000009930391],"category_scores_gemma":[0.00006359989,0.00013669462,0.000017920322,0.00015511764,0.00007318249,0.00001426539,0.00007695774,0.00011655576,6.127821e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025520285,0.000039778937,0.9780016,0.00010719387,0.000014080508,0.0000025922425,0.0012128643,0.00018601255,0.000034561843,0.0000032085732,0.00027759443,0.020094998],"study_design_scores_gemma":[0.0016636904,0.0003607921,0.92141515,0.0006240659,0.000014451833,6.820488e-7,0.00025612878,0.00012878374,0.016558565,0.000091815265,0.05854883,0.000337035],"about_ca_topic_score_codex":0.004901099,"about_ca_topic_score_gemma":0.04297283,"teacher_disagreement_score":0.10512668,"about_ca_system_score_codex":0.000057384936,"about_ca_system_score_gemma":0.00017153403,"threshold_uncertainty_score":0.9744904},"labels":[],"label_agreement":null},{"id":"W2402033264","doi":"10.1016/j.jval.2016.03.1491","title":"Real-World Comparison of Metastatic Melanoma Treatments between Academic and Community Hospitals in Canada: A Retrospective Study","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Ipilimumab; Medicine; Dabrafenib; Dacarbazine; Pembrolizumab; Trametinib; Internal medicine; Vemurafenib; Nivolumab; Oncology; Melanoma; Immunotherapy; Chemotherapy; Metastatic melanoma; Cancer","score_opus":0.08628646098148093,"score_gpt":0.38129555611284605,"score_spread":0.2950090951313651,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402033264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966199,0.0010215964,0.0000014066824,0.001067031,0.000045818786,0.0010825052,0.00006492449,0.0000071789304,0.00008962986],"genre_scores_gemma":[0.99930006,0.0004936896,0.00006107136,0.00005767696,0.000012112111,0.000027086751,0.0000052558585,0.000011722313,0.000031310843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99784195,0.0008217425,0.0006953154,0.00016266922,0.00023340361,0.00024494273],"domain_scores_gemma":[0.9989538,0.00043219532,0.00025139234,0.00024708404,0.000018833773,0.00009667957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010399222,0.00012485434,0.0007255119,0.00019306794,0.00005576747,0.0000017120111,0.000080943835,0.000028505481,0.000009335989],"category_scores_gemma":[0.00006897748,0.00008661997,0.000023878267,0.0003631842,0.000059459257,0.00004071439,0.000028858844,0.0003563647,3.010015e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000363217,0.00027175472,0.98752624,0.000091434216,0.00012135825,0.0000059387667,0.0034968425,0.000001102451,0.00014711627,0.000008668672,0.000035194058,0.007931123],"study_design_scores_gemma":[0.0051134713,0.0021023958,0.98863584,0.00059105485,0.000035067795,0.0000013390576,0.0030359314,0.000017033366,0.00029089404,0.00009468622,0.000010780438,0.000071537426],"about_ca_topic_score_codex":0.9895824,"about_ca_topic_score_gemma":0.8922011,"teacher_disagreement_score":0.0973813,"about_ca_system_score_codex":0.0023707906,"about_ca_system_score_gemma":0.0011582817,"threshold_uncertainty_score":0.61995345},"labels":[],"label_agreement":null},{"id":"W2402044355","doi":"10.1016/j.jval.2016.03.1637","title":"Castration-Resistant Prostate Cancer Patients In Quebec: Medication Use In The Last Year Of Life","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Abiraterone; Androgen deprivation therapy; Medical prescription; Cohort; Castration; Internal medicine; Abiraterone acetate; Cancer; Cohort study; Oncology; Pharmacology; Androgen receptor; Hormone","score_opus":0.06220926947193235,"score_gpt":0.3539470846249528,"score_spread":0.29173781515302044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402044355","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98931044,0.00042010687,0.0000010781652,0.009229941,0.000053544652,0.0008945644,0.000040775583,0.000004107235,0.00004546476],"genre_scores_gemma":[0.997513,0.0018568407,0.00003466423,0.00019575538,0.000026095093,0.000108638356,0.00002157058,0.000007389084,0.0002360654],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987558,0.00019761952,0.0003695239,0.00014192684,0.00031778048,0.00021735406],"domain_scores_gemma":[0.99946976,0.00016275745,0.00009642558,0.00014637974,0.00005333317,0.00007132579],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005419459,0.000062213614,0.00015955073,0.00016122713,0.000016998185,0.000005838781,0.000056750043,0.000035160796,0.000020729442],"category_scores_gemma":[0.00019419011,0.000032511518,0.000015088886,0.00028823863,0.00005748763,0.00009388638,0.000010104608,0.00010329165,0.0000042685047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004278387,0.00028252654,0.9911311,0.00019088438,0.0000050342555,0.0000055866076,0.0030426802,0.000026167781,0.00022134784,0.00014217304,0.00036827681,0.0041563613],"study_design_scores_gemma":[0.0035958323,0.0002554462,0.994237,0.00084678986,0.000001925304,1.5645064e-7,0.000316746,0.000044680248,0.00012762779,0.00004879511,0.00049163116,0.000033348024],"about_ca_topic_score_codex":0.21900846,"about_ca_topic_score_gemma":0.11636753,"teacher_disagreement_score":0.10264093,"about_ca_system_score_codex":0.00049214746,"about_ca_system_score_gemma":0.0012055112,"threshold_uncertainty_score":0.8997565},"labels":[],"label_agreement":null},{"id":"W2402389251","doi":"10.1016/j.jval.2016.03.1117","title":"RECENT EVOLUTION OF THE MARKET FOR BIOLOGIC AND NON-BIOLOGIC DRUGS MODIFYING RHEUMATOID ARTHRITIS AMONG ADULT PATIENTS IN CANADA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Golimumab; Medicine; Medical prescription; Rheumatoid arthritis; Infliximab; Etanercept; Internal medicine; Population; Disease; Pharmacology; Environmental health","score_opus":0.014213958857748664,"score_gpt":0.24191585566944912,"score_spread":0.22770189681170044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402389251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98850644,0.008030527,0.000023935772,0.0020103038,0.00014448391,0.0011493536,0.00007122761,0.000006337056,0.00005737202],"genre_scores_gemma":[0.8482678,0.1514374,0.00009734946,0.00009876256,0.0000073646793,0.00007050877,0.0000048245834,0.0000074963946,0.000008489653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984437,0.00025290286,0.0004757416,0.00022053393,0.00019166787,0.00041541996],"domain_scores_gemma":[0.9991244,0.00032402325,0.00015334834,0.00017546384,0.000110890316,0.000111838606],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064859015,0.00010438696,0.0003174425,0.000098388286,0.00007322279,0.0000038039286,0.00008498643,0.00005326375,0.000017067397],"category_scores_gemma":[0.00073405216,0.00005885799,0.00003032414,0.00017580704,0.000117866635,0.000050779763,0.00004320463,0.00011533369,3.994633e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018705653,0.000050831317,0.8979067,0.00009843675,0.000006014455,8.030118e-7,0.00017700337,0.000008774509,0.00006911988,0.00010951287,0.00032476525,0.101060964],"study_design_scores_gemma":[0.004723547,0.0004058849,0.98761463,0.0032557712,2.211946e-7,0.0000033886902,0.00044263504,0.0015559607,0.00014606988,0.0011498872,0.0006174166,0.000084562445],"about_ca_topic_score_codex":0.7032854,"about_ca_topic_score_gemma":0.51380557,"teacher_disagreement_score":0.18947978,"about_ca_system_score_codex":0.0008112598,"about_ca_system_score_gemma":0.0010680157,"threshold_uncertainty_score":0.4950662},"labels":[],"label_agreement":null},{"id":"W2402469839","doi":"10.1016/j.jval.2016.03.175","title":"Clinical Outcomes and Quality of Life After Off-Pump Versus On-Pump Coronary Artery Bypass Grafting in Armenia","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac and Coronary Surgery Techniques","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; EuroSCORE; Off-pump coronary artery bypass; Insulin pump; Hazard ratio; Coronary artery disease; Internal medicine; Cardiology; Myocardial infarction; Artery; Quality of life (healthcare); Diabetes mellitus; Surgery; Bypass grafting; Confidence interval; Type 1 diabetes","score_opus":0.10433066594796642,"score_gpt":0.3929993896336163,"score_spread":0.2886687236856499,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402469839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941652,0.0005610334,0.00001528414,0.0040671886,0.00041217273,0.00043036576,0.000030009933,0.000055239187,0.00026351173],"genre_scores_gemma":[0.9962221,0.0013462099,0.00028810723,0.0019266296,0.00008939897,0.000041179752,0.0000037957634,0.000020118006,0.00006247517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969536,0.00074181135,0.0012872296,0.0003722367,0.00029504418,0.00035007342],"domain_scores_gemma":[0.9967919,0.002320014,0.00023257696,0.00038127575,0.000035043937,0.00023917804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030945644,0.0001704657,0.00092264777,0.00018624228,0.00002076313,0.000003614326,0.00005709384,0.00013753143,0.000035306242],"category_scores_gemma":[0.00069658697,0.00012293007,0.00017796598,0.00013208497,0.00012694279,0.00007219918,0.000061168575,0.00026867606,0.000007954539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003665353,0.00025182884,0.93217564,0.00013245184,0.00003985483,0.00004443497,0.00012378064,0.0000011031428,0.000021628142,0.00015693519,0.00009850247,0.06328848],"study_design_scores_gemma":[0.0037678005,0.0007784668,0.9937723,0.00053443963,0.000008777127,0.0000066607386,0.00008736928,0.000025071367,0.000018114595,0.00013911903,0.00073873193,0.00012309603],"about_ca_topic_score_codex":0.0010960631,"about_ca_topic_score_gemma":0.00010309113,"teacher_disagreement_score":0.06316538,"about_ca_system_score_codex":0.0001568838,"about_ca_system_score_gemma":0.00034543316,"threshold_uncertainty_score":0.5012943},"labels":[],"label_agreement":null},{"id":"W2402649726","doi":"10.1016/j.jval.2016.03.723","title":"ECONOMIC EVALUATIONS OF MEDICAL DEVICES IN CANADA: LENSX® FEMTOSECOND LASER-ASSISTED CATARACT SURGERY","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Spectacle; Phacoemulsification; Cataract surgery; Medicine; Optometry; Randomized controlled trial; Intraocular lens; Ophthalmology; Visual acuity; Surgery; Economics","score_opus":0.3946023341285425,"score_gpt":0.4280521667147428,"score_spread":0.03344983258620027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402649726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8846167,0.0026389798,0.000089940004,0.11009001,0.0009618227,0.00056506833,0.00064188964,0.00001552613,0.00038006587],"genre_scores_gemma":[0.993017,0.0009737534,0.00021011475,0.0054064537,0.00016213839,0.00008407924,0.000038862698,0.00003157267,0.00007600072],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9898886,0.0011482841,0.007355878,0.00064146327,0.00026890542,0.0006968595],"domain_scores_gemma":[0.9896054,0.006542285,0.0028470731,0.00058133027,0.00003977014,0.00038408756],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.03519406,0.0002133785,0.0015736041,0.00076225185,0.00008243404,0.000018251967,0.00041274424,0.00017427863,0.0015513035],"category_scores_gemma":[0.004898435,0.00023028898,0.00010601039,0.00028540398,0.00007438042,0.00039586157,0.000057240613,0.00022042943,0.00041718638],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00001780667,0.00012222382,0.9623626,0.00075079576,0.000033390697,0.0000050226354,0.0005251091,0.0013329794,6.5075284e-7,0.015454336,0.016242292,0.0031527851],"study_design_scores_gemma":[0.0013687592,0.00004807635,0.96974975,0.0011429817,0.0000024220762,0.00001355151,0.0006373778,0.010131902,0.000011586675,0.0031216342,0.01339461,0.00037736737],"about_ca_topic_score_codex":0.9682153,"about_ca_topic_score_gemma":0.9715381,"teacher_disagreement_score":0.10840032,"about_ca_system_score_codex":0.006852496,"about_ca_system_score_gemma":0.015837438,"threshold_uncertainty_score":0.9993614},"labels":[],"label_agreement":null},{"id":"W2402780690","doi":"10.1016/j.jval.2016.03.692","title":"BUDGET IMPACT ANALYSIS OF RETINAL PROSTHESIS IN RETINITIS PIGMENTOSA PATIENTS","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Development and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Retinitis pigmentosa; Visual prosthesis; Retinal Prosthesis; Medicine; Prosthesis; Reimbursement; Population; Retinal; Surgery; Health care; Ophthalmology; Economics; Environmental health","score_opus":0.011752807292929528,"score_gpt":0.27794800092684885,"score_spread":0.2661951936339193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2402780690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99864936,0.00021813907,0.000050735496,0.0003713117,0.000028038703,0.00020642432,0.00003518465,0.000003024668,0.0004377692],"genre_scores_gemma":[0.9987422,0.00069811946,0.00027696986,0.00008953911,0.00001033151,0.000014005518,0.00008976016,0.000009069301,0.00006997966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986853,0.00017939514,0.0004404225,0.00025894953,0.00015706704,0.00027889016],"domain_scores_gemma":[0.99949455,0.000031343952,0.00016868007,0.00019133881,0.00004455601,0.0000695265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00049403985,0.00010941325,0.0002476617,0.00027942675,0.00001768664,0.000004288258,0.00010931328,0.00007341157,0.000038813003],"category_scores_gemma":[0.0001951441,0.00007979611,0.00009761921,0.0004922762,0.000040636256,0.0000037060659,0.00004012565,0.000038687518,0.000002711256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017186497,0.00011285615,0.9920746,0.000030160967,0.00005017835,9.645395e-7,0.00012535027,0.00010266254,0.0028585084,0.000023667795,0.00020845358,0.004240703],"study_design_scores_gemma":[0.000793276,0.00044748347,0.9946376,0.00009465274,0.00001256961,3.122954e-7,0.00003291636,0.000057512178,0.0033140725,0.000079412384,0.00041543032,0.000114727925],"about_ca_topic_score_codex":0.001204353,"about_ca_topic_score_gemma":0.00018615469,"teacher_disagreement_score":0.0041259746,"about_ca_system_score_codex":0.00006896962,"about_ca_system_score_gemma":0.00017634599,"threshold_uncertainty_score":0.3253991},"labels":[],"label_agreement":null},{"id":"W2403128845","doi":"10.1016/j.jval.2016.03.1350","title":"A Comparison Of Antidepressant Drugs Approved By The Us Food And Drug Adminstration And Health Canada (1959-2015)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Food and drug administration; Antidepressant; Drug; Pharmacology; Family medicine; Psychiatry","score_opus":0.37029370940055456,"score_gpt":0.5270848560558867,"score_spread":0.15679114665533217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403128845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8700882,0.011387925,0.000022239894,0.11683471,0.00038425796,0.00083135895,0.0003139808,0.000020252577,0.0001170748],"genre_scores_gemma":[0.9901039,0.002087882,0.000043915414,0.007534117,0.000079624624,0.000033882767,0.000012542794,0.000014310764,0.00008981373],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965329,0.0014600715,0.00082262064,0.0003479692,0.00021674013,0.0006197048],"domain_scores_gemma":[0.9979647,0.0008406209,0.00036972133,0.00018075929,0.00005074921,0.0005934636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023393894,0.00019533535,0.00047359586,0.00005407854,0.00033733292,0.000010462622,0.00016720539,0.00019052038,0.00003903772],"category_scores_gemma":[0.00007921216,0.00013167581,0.000023135808,0.00015113679,0.00026779308,0.000091996786,0.00006643266,0.0009065562,9.985519e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058793114,0.00074552704,0.70915145,0.002285245,0.00013092998,0.0000063823722,0.0063392613,0.0003460841,0.0019889562,0.009860629,0.12988552,0.13867205],"study_design_scores_gemma":[0.017271146,0.0032821791,0.2115926,0.0017314032,0.00012783812,0.00012219166,0.0056669293,0.042127904,0.040462036,0.004109889,0.6720031,0.0015027887],"about_ca_topic_score_codex":0.2466107,"about_ca_topic_score_gemma":0.11768193,"teacher_disagreement_score":0.5421176,"about_ca_system_score_codex":0.00025519318,"about_ca_system_score_gemma":0.0015739682,"threshold_uncertainty_score":0.89841807},"labels":[],"label_agreement":null},{"id":"W2403287053","doi":"10.1016/j.jval.2016.03.128","title":"Identification and Management of Canadian Patients with Symptoms of Statin Intolerance: Results from a Real-World Clinical Practice Survey","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Internal medicine","score_opus":0.04633829713438919,"score_gpt":0.3401803449154095,"score_spread":0.2938420477810203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403287053","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959004,0.0002615996,0.00011511473,0.0017301776,0.00010796214,0.0011293112,0.00039843525,0.000006741079,0.00035027234],"genre_scores_gemma":[0.9930409,0.0038449448,0.0027322248,0.00016569936,0.000033511085,0.000015170797,0.00009016912,0.00001378651,0.00006356118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99722636,0.00071438955,0.0010758148,0.00031816718,0.00044839672,0.00021685225],"domain_scores_gemma":[0.9979903,0.00044155502,0.0005214695,0.0005255898,0.00025567188,0.00026539984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00503499,0.00008791437,0.00042565216,0.00027786163,0.0000285069,0.0000041124763,0.000057466652,0.000047807043,0.0000035681178],"category_scores_gemma":[0.00044609493,0.000059903843,0.000034420475,0.00051925256,0.00006818897,0.000078889774,0.00001692168,0.000103328704,0.0000019146921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017735943,0.00028996676,0.82867646,0.0007020073,0.00019722972,0.000010926512,0.000498592,0.000016647198,0.0000024649996,0.00046088375,0.00020965273,0.16716157],"study_design_scores_gemma":[0.004980822,0.000494603,0.99122566,0.0014794194,0.000034535304,6.107606e-7,0.00007121583,0.000042540836,0.000014455862,0.000029829442,0.0015689515,0.000057365418],"about_ca_topic_score_codex":0.8698951,"about_ca_topic_score_gemma":0.24361993,"teacher_disagreement_score":0.6262752,"about_ca_system_score_codex":0.00020090614,"about_ca_system_score_gemma":0.000608661,"threshold_uncertainty_score":0.770182},"labels":[],"label_agreement":null},{"id":"W2403383676","doi":"10.1016/j.jval.2016.03.119","title":"Development of a Pharmacoeconomic Model to Assess the Cost Effectiveness of Pharmacogenomics Tests in Chronic Heart Failure: The Case of Ivabradine","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; St. Joseph’s Healthcare Hamilton; Université de Montréal","funders":"","keywords":"Medicine; Ivabradine; Pharmacogenomics; Heart failure; Test (biology); Markov model; Internal medicine; Intensive care medicine; Statistics; Heart rate; Markov chain; Mathematics","score_opus":0.10136719221530832,"score_gpt":0.3854345694312964,"score_spread":0.28406737721598807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403383676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885193,0.00023458962,0.0008697781,0.0074637253,0.0000583104,0.0028053431,0.000017700808,0.0000075725366,0.00002369298],"genre_scores_gemma":[0.99543875,0.00009608681,0.003998337,0.0002125383,0.000023446226,0.00019245788,0.000002572424,0.000017636716,0.000018199577],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9983841,0.00031726225,0.00068550056,0.00021209221,0.00010942057,0.0002915814],"domain_scores_gemma":[0.9988016,0.0006030637,0.00016498048,0.00028813008,0.00004292734,0.00009932461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002482839,0.00014338201,0.0004737782,0.00018787912,0.00003782213,0.0000024202557,0.000120372584,0.000030884516,0.00001901621],"category_scores_gemma":[0.00004153311,0.00007663935,0.00005707192,0.000256505,0.00006383349,0.000044925506,0.00007595726,0.000100456135,0.0000060667094],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029630773,0.0027938408,0.06128027,0.010012662,0.0007707508,0.00017174329,0.009674669,0.12438215,0.658258,0.0051072338,0.003158339,0.121427245],"study_design_scores_gemma":[0.044456493,0.0025235575,0.076721504,0.009109747,0.0003348368,0.00039539207,0.0013269905,0.11360845,0.7149941,0.00049708964,0.035159443,0.00087240455],"about_ca_topic_score_codex":0.001308934,"about_ca_topic_score_gemma":0.0006618051,"teacher_disagreement_score":0.12055484,"about_ca_system_score_codex":0.0010548035,"about_ca_system_score_gemma":0.0012326192,"threshold_uncertainty_score":0.3125262},"labels":[],"label_agreement":null},{"id":"W2403443918","doi":"10.1016/j.jval.2016.03.541","title":"Reimbursement-Based Economic Evaluation Of Drugs For The Treatment Of Overactive Bladder","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Oxybutynin; Tolterodine; Solifenacin; Overactive bladder; Medicine; Reimbursement; Cost effectiveness; Risk analysis (engineering)","score_opus":0.4871876779494038,"score_gpt":0.47216199904856404,"score_spread":0.015025678900839778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403443918","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.898684,0.007842496,0.00641842,0.07759594,0.0012598503,0.0058899866,0.001487587,0.000019345582,0.00080236996],"genre_scores_gemma":[0.996123,0.00080038427,0.0011791367,0.0009782572,0.00017624571,0.00058771484,0.000016303364,0.000025549218,0.00011336925],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9949775,0.0006216871,0.0035706917,0.00038995637,0.00012253005,0.00031767596],"domain_scores_gemma":[0.9914079,0.0047576423,0.0031263223,0.0005345879,0.00009692467,0.00007666022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022164991,0.00014426975,0.00079112814,0.00027925786,0.00008335645,0.0000085248985,0.00016302371,0.00007425133,0.00029811385],"category_scores_gemma":[0.0010554255,0.00011625103,0.00015708472,0.000088898036,0.000074434436,0.00016740226,0.000008173839,0.00003481275,0.000086894775],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008266799,0.0029706133,0.116092004,0.0021028675,0.0010458599,2.0013044e-7,0.027322104,0.24328254,0.00006149898,0.50889176,0.015874924,0.08152896],"study_design_scores_gemma":[0.025511349,0.003600004,0.09108684,0.0009033944,0.000101436555,0.0000011172569,0.0043787356,0.6893015,0.0010848005,0.085516095,0.097731166,0.0007835725],"about_ca_topic_score_codex":0.009625534,"about_ca_topic_score_gemma":0.00027219913,"teacher_disagreement_score":0.44601893,"about_ca_system_score_codex":0.003098644,"about_ca_system_score_gemma":0.0011095889,"threshold_uncertainty_score":0.99696946},"labels":[],"label_agreement":null},{"id":"W2403565867","doi":"10.1016/j.jval.2016.03.1994","title":"PCPA/CDR/PCODR CHANGES AND IMPACT TO MARKET ACCESS IN CANADA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Listing (finance); Formulary; Prior authorization; Reimbursement; Market access; Business; Negotiation; Medicine; Accounting; Actuarial science; Geography; Finance; Political science; Health care; Family medicine; Economics; Economic growth","score_opus":0.44997579102469554,"score_gpt":0.45077479412457894,"score_spread":0.0007990030998833997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403565867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8087507,0.00241496,0.0001614916,0.18579066,0.00049814105,0.00090442173,0.00046059804,0.00001489852,0.0010041428],"genre_scores_gemma":[0.97891885,0.0010649321,0.00040700226,0.018999338,0.00017069299,0.00010421374,0.000003991314,0.000029453819,0.00030151504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99569714,0.0005026589,0.0024553633,0.0005534408,0.00008976279,0.00070164],"domain_scores_gemma":[0.99694633,0.0013763979,0.00083174853,0.00039011924,0.00002058431,0.00043480485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013364476,0.00017568441,0.00087431393,0.0005744804,0.000067614965,0.00004524322,0.00028667098,0.00007248036,0.00042539716],"category_scores_gemma":[0.001969393,0.00017495107,0.00002808979,0.000344467,0.000021415291,0.00030427118,0.000089233574,0.00012058631,0.000111824615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002746071,0.000029909035,0.9453439,0.00043399108,0.000011239668,0.0000034818393,0.00072764244,0.0004629535,8.4601373e-7,0.0039962116,0.04405186,0.004910485],"study_design_scores_gemma":[0.0010731933,0.00012987538,0.9477568,0.0005667196,6.339692e-7,0.000006146118,0.0002832553,0.0046171993,0.000002756686,0.005232733,0.039970268,0.0003603919],"about_ca_topic_score_codex":0.9770669,"about_ca_topic_score_gemma":0.9400956,"teacher_disagreement_score":0.17016818,"about_ca_system_score_codex":0.0060083023,"about_ca_system_score_gemma":0.0019275837,"threshold_uncertainty_score":0.99780744},"labels":[],"label_agreement":null},{"id":"W2403568346","doi":"10.1016/j.jval.2016.03.130","title":"Identifying and Managing Patients with Symptoms of Statin Intolerance: Results from a Survey of Clinicians in the United States","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Ezetimibe; Asymptomatic; Internal medicine; Physical therapy","score_opus":0.045341564051060046,"score_gpt":0.31031842399619003,"score_spread":0.26497685994513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403568346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99734336,0.0005873472,0.0003069469,0.0007432934,0.000040590276,0.0007111622,0.0002482426,0.0000062248555,0.000012817308],"genre_scores_gemma":[0.9979937,0.0011265619,0.0004142123,0.00029868868,0.00001512609,0.000008967936,0.00012683883,0.000012861375,0.0000030115152],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99741215,0.000927697,0.00078519294,0.00022861826,0.0004205053,0.00022581709],"domain_scores_gemma":[0.9983848,0.00072456594,0.00031959752,0.00038304282,0.00012497387,0.000063049694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041052266,0.00009482606,0.00044880083,0.00020621407,0.000026192469,0.0000047436606,0.000078131954,0.000039425984,0.00000160765],"category_scores_gemma":[0.00031698565,0.000051151004,0.000028073098,0.00054392556,0.000075477954,0.000047105925,0.000022306844,0.00014448649,3.762604e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009759858,0.00016269561,0.9390509,0.00051475107,0.000043969736,0.0000056856516,0.0073371716,0.00019706965,0.0000035534092,0.000031078504,0.000014726323,0.05166237],"study_design_scores_gemma":[0.0062727733,0.0005898175,0.988639,0.0028150808,0.000010225195,7.821853e-7,0.0007912132,0.0005780787,0.00001577023,0.00018870283,0.00004406496,0.000054469492],"about_ca_topic_score_codex":0.2866449,"about_ca_topic_score_gemma":0.004387317,"teacher_disagreement_score":0.28225762,"about_ca_system_score_codex":0.000071558134,"about_ca_system_score_gemma":0.00018925568,"threshold_uncertainty_score":0.7181054},"labels":[],"label_agreement":null},{"id":"W2403580599","doi":"10.1016/j.jval.2016.03.507","title":"Assure-Csu: Assessing the Impact of Chronic Spontaneous / Idiopathic Urticaria on Work Productivity and Activity","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Lynde Centre for Dermatology","funders":"","keywords":"Presenteeism; Absenteeism; Medicine; Angioedema; Productivity; Work productivity; Demography; Sick leave; Physical therapy; Gerontology; Internal medicine; Psychology","score_opus":0.03151715964130342,"score_gpt":0.33437554599371444,"score_spread":0.302858386352411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403580599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98816836,0.0009379889,0.00015922512,0.009774403,0.0001542373,0.00053021836,0.0000062737145,0.000029799943,0.0002394783],"genre_scores_gemma":[0.9994885,0.0001863446,0.000031522857,0.00003128434,0.00017213236,0.000011390926,8.179257e-7,0.000016356618,0.00006164882],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984548,0.00046182348,0.00027306742,0.0002682391,0.00020913398,0.00033292815],"domain_scores_gemma":[0.9988312,0.00044296283,0.00014851602,0.00039848548,0.000041148433,0.00013768332],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009813521,0.0001318379,0.0003427442,0.000102512415,0.00011367198,0.000012525082,0.00005626663,0.000111670364,0.000021834205],"category_scores_gemma":[0.00042759272,0.00006423605,0.000075131444,0.00031614475,0.0001684648,0.00007688826,0.00002325383,0.00041338874,0.0000070885403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029379884,0.006206996,0.44570836,0.0008992628,0.0027066846,0.0014317895,0.005918157,0.008026268,0.16578114,0.0077990196,0.0007927372,0.3517916],"study_design_scores_gemma":[0.0012365738,0.0017745057,0.9909475,0.0019451237,0.00016983348,0.0006287979,0.00002338096,0.0014329815,0.0007507642,0.0009443728,0.000031002284,0.00011515306],"about_ca_topic_score_codex":0.0012058663,"about_ca_topic_score_gemma":0.000020833217,"teacher_disagreement_score":0.54523915,"about_ca_system_score_codex":0.00056274503,"about_ca_system_score_gemma":0.0010486552,"threshold_uncertainty_score":0.261947},"labels":[],"label_agreement":null},{"id":"W2403798239","doi":"10.1016/j.jval.2016.03.640","title":"The Diffusion of Indirect Comparison Meta-Analytic Methods in the Study of Drugs: A Systematic Review and Co-Authorship Network Analysis","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Scopus; Meta-analysis; Systematic review; Web of science; Empirical research; Citation; MEDLINE; Computer science; Medicine; Statistics; Library science; Mathematics; Political science; Pathology","score_opus":0.866564930708412,"score_gpt":0.6537149492497017,"score_spread":0.21284998145871026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403798239","genre_codex":"review","genre_gemma":"review","domain_codex":"methods","domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040268522,0.9845088,0.00078048115,0.0002623165,0.00008450189,0.014145342,0.000025588668,0.0000024404958,0.00015025382],"genre_scores_gemma":[0.0009232952,0.9966159,0.0010102714,0.000112196605,0.000024980474,0.00098785,0.0000064904516,0.000024799745,0.00029425597],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.26354727,0.64728665,0.075459264,0.0024870685,0.010245936,0.0009737898],"domain_scores_gemma":[0.82772094,0.11725387,0.045780703,0.008546488,0.0005172459,0.00018073205],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.6740342,0.0008809061,0.06454614,0.001832356,0.0002384707,0.0002982953,0.0047378573,0.0002209486,0.00027614099],"category_scores_gemma":[0.05886314,0.0002443335,0.0083543155,0.015390781,0.0001443294,0.00007809625,0.0002787168,0.00072819117,0.000042159896],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003638345,0.0003967272,0.001021322,0.88893104,0.026465224,0.0000023367622,0.0052863467,0.00019644827,4.682887e-9,0.0005415281,0.0014737002,0.0756817],"study_design_scores_gemma":[0.00034512032,0.00043947328,0.00032355243,0.3519327,0.54383844,0.000016948095,0.0055356855,0.004056275,1.9334124e-8,0.002399397,0.090398096,0.0007142807],"about_ca_topic_score_codex":0.00061757833,"about_ca_topic_score_gemma":0.0004204604,"teacher_disagreement_score":0.615171,"about_ca_system_score_codex":0.00015323659,"about_ca_system_score_gemma":0.00041126763,"threshold_uncertainty_score":0.99636304},"labels":[],"label_agreement":null},{"id":"W2403857619","doi":"10.1016/j.jval.2016.03.646","title":"Evidence Gaps In Economic Evaluations For Non-Drug Technologies: A Canadian Cost Perspective","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Reimbursement; Health technology; Economic evaluation; Procurement; Activity-based costing; Business; Risk analysis (engineering); Medicine; Actuarial science; Health care; Economics; Marketing","score_opus":0.44077412387727744,"score_gpt":0.4703464327755811,"score_spread":0.029572308898303645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403857619","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19433585,0.014180005,0.004262041,0.77059555,0.0017455723,0.009718153,0.0020609712,0.0001681676,0.0029336982],"genre_scores_gemma":[0.988214,0.0022391188,0.0031094823,0.0042933384,0.00016676195,0.0015935713,0.000010174207,0.000047093843,0.0003264375],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9939822,0.0004105878,0.0036661876,0.00089919387,0.00007187323,0.00096997933],"domain_scores_gemma":[0.99393195,0.0036915627,0.0013180883,0.00068784895,0.000080903534,0.00028964857],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.026077464,0.00022487559,0.0009650576,0.0015668533,0.00021092183,0.000049688584,0.00047944757,0.00018596306,0.00017421444],"category_scores_gemma":[0.011697093,0.0002539835,0.00010371697,0.0003521232,0.00010729984,0.0006429519,0.000043130924,0.0002097384,0.0013260103],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006224099,0.00016328933,0.23669416,0.0009032966,0.000052434672,0.0000030453004,0.016434226,0.008353301,0.0000046694845,0.6878202,0.045185395,0.004323725],"study_design_scores_gemma":[0.007652522,0.0006292064,0.13552926,0.0072656428,0.0000097381735,0.000017050343,0.035757225,0.127274,0.000033100663,0.59764004,0.08620587,0.0019863076],"about_ca_topic_score_codex":0.57362866,"about_ca_topic_score_gemma":0.42111826,"teacher_disagreement_score":0.7938782,"about_ca_system_score_codex":0.018301895,"about_ca_system_score_gemma":0.0039877025,"threshold_uncertainty_score":0.99999124},"labels":[],"label_agreement":null},{"id":"W2403922878","doi":"10.1016/j.jval.2016.03.1095","title":"THE REAL-WORLD PAIN EXPERIENCE OF ADULTS WITH RHEUMATOID ARTHRITIS USING A MOBILE SURVEY","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; McGill Pain Questionnaire; Depression (economics); Anxiety; Rheumatoid arthritis; Physical therapy; Quality of life (healthcare); Pain catastrophizing; Demographics; Chronic pain; Visual analogue scale; Psychiatry; Internal medicine; Demography; Nursing","score_opus":0.0453238679859663,"score_gpt":0.3363598220800306,"score_spread":0.29103595409406435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2403922878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99513876,0.003310393,0.00021787267,0.0003805799,0.000035798035,0.0007241113,0.000007332051,0.000019285098,0.00016588865],"genre_scores_gemma":[0.9826662,0.01682832,0.00019905134,0.00006218793,0.000010558735,0.000073512005,0.000002795191,0.000018927012,0.00013845367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99767363,0.0007735594,0.00057154667,0.00020577753,0.0003617517,0.0004137297],"domain_scores_gemma":[0.9984179,0.00076461106,0.00018158606,0.00041525994,0.000116370196,0.000104273604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035161006,0.00010030499,0.00033488192,0.00011759942,0.00013141165,0.000007866841,0.00012251608,0.000034295837,0.000041501466],"category_scores_gemma":[0.00046988865,0.00005286825,0.000030824824,0.00044182394,0.00024569445,0.00007578354,0.00003506322,0.00013121616,0.0000055053633],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009813127,0.00013234475,0.8598177,0.00024055583,0.000014375789,0.000016329246,0.0039706123,0.00010176994,0.00041515141,0.0002628304,0.0001752264,0.13387182],"study_design_scores_gemma":[0.007909778,0.002994583,0.94687396,0.014977098,0.0000016642554,0.000039144074,0.006733026,0.0086949635,0.0018661639,0.0001307522,0.009431082,0.0003477674],"about_ca_topic_score_codex":0.04553531,"about_ca_topic_score_gemma":0.0047128387,"teacher_disagreement_score":0.13352405,"about_ca_system_score_codex":0.00013972977,"about_ca_system_score_gemma":0.00086607947,"threshold_uncertainty_score":0.96082056},"labels":[],"label_agreement":null},{"id":"W2404165994","doi":"10.1016/j.jval.2016.03.1536","title":"Evaluation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Metastatic Breast Cancer: Systematic Review and Trial Level Meta-Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Augmentium Pharma Consulting (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology; Surrogate endpoint; Progression-free survival; Rank correlation; Breast cancer; Spearman's rank correlation coefficient; Hazard ratio; Metastatic breast cancer; Clinical endpoint; Meta-analysis; Proportional hazards model; Randomized controlled trial; Cancer; Overall survival; Confidence interval; Statistics","score_opus":0.34436225851649654,"score_gpt":0.48731588217820454,"score_spread":0.142953623661708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404165994","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42276165,0.45200315,0.00024704303,0.07282745,0.0009326389,0.04745064,0.0036159507,0.00005154213,0.000109930785],"genre_scores_gemma":[0.9766977,0.01650999,0.00055288407,0.00057524804,0.00008087104,0.005257634,0.000057697387,0.000033804456,0.0002341642],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99457496,0.0026241904,0.001299672,0.0003689249,0.00082689774,0.00030537008],"domain_scores_gemma":[0.9972973,0.001204053,0.0006661112,0.00037187742,0.0003225255,0.000138139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01311592,0.00020532506,0.0029734012,0.000323208,0.000028766612,0.0000053841254,0.000097433425,0.00004484788,0.00039059264],"category_scores_gemma":[0.0008958758,0.00011724674,0.00044151468,0.0004730435,0.00004381474,0.00007078127,0.00003275329,0.00008025196,0.0000014047282],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04041498,0.0051281783,0.011840764,0.7335207,0.19439982,0.000040998868,0.0020133608,0.000743353,0.00021373946,0.0026343782,0.0007222545,0.008327488],"study_design_scores_gemma":[0.1642586,0.0027811402,0.011857336,0.020999057,0.7921128,0.00003221686,0.00010019377,0.0040826863,0.00008392773,0.0032493847,0.000034055858,0.00040854767],"about_ca_topic_score_codex":0.008816417,"about_ca_topic_score_gemma":0.0033955118,"teacher_disagreement_score":0.7125216,"about_ca_system_score_codex":0.0006023488,"about_ca_system_score_gemma":0.001244295,"threshold_uncertainty_score":0.99778396},"labels":[],"label_agreement":null},{"id":"W2404392077","doi":"10.1016/j.jval.2016.03.1063","title":"ECONOMIC EVALUATION OF BENDAMUSTINE PLUS RITUXIMAB IN THE FIRST-LINE TREATMENT OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Université de Montréal","funders":"","keywords":"Bendamustine; Chlorambucil; Obinutuzumab; Medicine; Ofatumumab; Rituximab; Internal medicine; Oncology; Chronic lymphocytic leukemia; Clinical trial; Fludarabine; Combination therapy; Chemoimmunotherapy; Leukemia; Chemotherapy; Lymphoma","score_opus":0.05512079532798101,"score_gpt":0.33619575051494494,"score_spread":0.2810749551869639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404392077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995434,0.0013851358,0.000018586747,0.0006686147,0.00006755408,0.002232546,0.00004247451,0.000009353061,0.00014172962],"genre_scores_gemma":[0.99880415,0.00076025975,0.000081136306,0.000049461374,0.00008295221,0.00013415342,0.000031873682,0.000024021125,0.000031977277],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9973598,0.00029455157,0.0008093409,0.00032777485,0.00076940964,0.00043911856],"domain_scores_gemma":[0.9983338,0.00051951775,0.00030332163,0.0006125769,0.00014185999,0.00008889649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016259262,0.00017891388,0.00059696066,0.0002786981,0.000031639487,0.0000035694015,0.00015806424,0.00007776439,0.00010049215],"category_scores_gemma":[0.00015309278,0.00009420423,0.00006082398,0.0002850788,0.00015232268,0.00006655432,0.00002740873,0.00007095677,0.000020255828],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.011513176,0.004338644,0.15881947,0.0060563325,0.00038003855,0.00007665425,0.0108098285,0.54093176,0.00007152227,0.0011818184,0.00040842805,0.26541233],"study_design_scores_gemma":[0.33717015,0.008786495,0.13011606,0.0024026826,0.00011896252,0.00003495487,0.00010688477,0.5194552,0.00069414446,0.00021856203,0.00069861877,0.00019729862],"about_ca_topic_score_codex":0.044095468,"about_ca_topic_score_gemma":0.004814442,"teacher_disagreement_score":0.32565695,"about_ca_system_score_codex":0.30210912,"about_ca_system_score_gemma":0.078387685,"threshold_uncertainty_score":0.96226996},"labels":[],"label_agreement":null},{"id":"W2404402986","doi":"10.1016/j.jval.2016.03.615","title":"Model Observational Bridging Study on the Effectiveness of Ezetimibe on Cardiovascular Outcomes","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Ezetimibe; Medicine; Cohort; Myocardial infarction; Cohort study; Population; Confidence interval; Internal medicine; Observational study; Prospective cohort study; Acute coronary syndrome; Statin; Cardiology","score_opus":0.117688988431826,"score_gpt":0.3257108274778754,"score_spread":0.20802183904604937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404402986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99115807,0.0003988834,0.0021224439,0.003315097,0.00012998798,0.0025562856,0.000012654364,0.00002889285,0.00027765974],"genre_scores_gemma":[0.99869204,0.000092551825,0.00013020857,0.0007731887,0.000088468354,0.0001585115,0.000002302556,0.000027924581,0.00003483798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99623597,0.0015481224,0.0004464103,0.0003607604,0.0010941814,0.00031456884],"domain_scores_gemma":[0.9977664,0.0008988224,0.00009428825,0.0010439338,0.0000886115,0.00010795045],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009397702,0.00016887467,0.0007894729,0.00013110909,0.00008937386,0.000004803822,0.00011931191,0.00005417314,0.000004835875],"category_scores_gemma":[0.0005879885,0.00008535886,0.00044233937,0.00023735671,0.000039985534,0.00003672252,0.000032785763,0.00020374569,0.0000105986],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014650365,0.0024962376,0.77305514,0.002003186,0.0019358661,0.000056372628,0.0010584876,0.14954275,0.00029250383,0.027296154,0.000117273754,0.04068099],"study_design_scores_gemma":[0.0035965324,0.0010187086,0.9890958,0.001393999,0.000050736926,0.0000062258673,0.00009580218,0.0035855107,0.00032527474,0.00061399315,0.000108332424,0.00010908739],"about_ca_topic_score_codex":0.0023815406,"about_ca_topic_score_gemma":0.0000066602415,"teacher_disagreement_score":0.21604066,"about_ca_system_score_codex":0.00038224075,"about_ca_system_score_gemma":0.00047799572,"threshold_uncertainty_score":0.36001927},"labels":[],"label_agreement":null},{"id":"W2404563259","doi":"10.1016/j.jval.2016.03.1271","title":"A COMPARISON OF ANTI-TYPE 2 DIABETES MELLITUS DRUGS IN CANADA, UNITED STATES, AND UNITED KINGDOM BETWEEN 1958–2015","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Regulatory agency; Type 2 Diabetes Mellitus; Food and drug administration; Drug; Pharmacology; Diabetes mellitus; Family medicine","score_opus":0.12513342820040843,"score_gpt":0.3400936963470292,"score_spread":0.21496026814662075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404563259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896368,0.002934693,0.00000920689,0.0063867746,0.0001550447,0.00019138503,0.0005683405,0.0000072915127,0.00011049641],"genre_scores_gemma":[0.9959464,0.0029165968,0.000064373795,0.0009468769,0.000034557586,0.0000038864932,0.000059740127,0.000018381294,0.000009191511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979845,0.0000847679,0.0011192838,0.00028156475,0.00003465701,0.00049520406],"domain_scores_gemma":[0.9986631,0.00048766652,0.00040348672,0.00020015988,0.000021988055,0.00022357011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090779335,0.00013451035,0.00070691155,0.0006869209,0.000033148033,0.000013167221,0.0001621105,0.000064517146,0.00003592253],"category_scores_gemma":[0.00010146583,0.00013835162,0.000022546581,0.00068436307,0.000062760504,0.000076107615,0.000056423996,0.0001724423,0.00001347799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009620717,0.000039120143,0.97734857,0.00011047304,0.000016347341,4.4042682e-7,0.00040839275,0.0014191299,0.0000029979012,0.018472498,0.0004661787,0.0017062457],"study_design_scores_gemma":[0.0021389434,0.00015727142,0.7419036,0.00024498088,0.0000040548866,2.6698143e-7,0.00011462723,0.08316202,0.00018352641,0.015057318,0.15663537,0.00039799706],"about_ca_topic_score_codex":0.9213691,"about_ca_topic_score_gemma":0.12336217,"teacher_disagreement_score":0.7980069,"about_ca_system_score_codex":0.0006610706,"about_ca_system_score_gemma":0.0003623282,"threshold_uncertainty_score":0.8926342},"labels":[],"label_agreement":null},{"id":"W2404571533","doi":"10.1016/j.jval.2016.03.526","title":"Comparative Effectiveness of Tacrolimus-Based Steroid Sparing Versus Steroid Maintenance Regimens in Patients with Kidney Transplantation: Results from a Discrete Event Simulation","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Tacrolimus; Adverse effect; Regimen; Population; Kidney transplantation; Internal medicine; Transplantation; Myocardial infarction","score_opus":0.03874152242494355,"score_gpt":0.32612742564687397,"score_spread":0.2873859032219304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2404571533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926623,0.000028550252,0.005032265,0.00028262628,0.00010861477,0.0011913984,0.0006251284,0.00001507146,0.000054020384],"genre_scores_gemma":[0.9986744,0.00004088178,0.00071962323,0.000063657484,0.000010805565,0.000028913226,0.00043640574,0.0000150365695,0.000010290173],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99812466,0.00038060598,0.00058452203,0.0003392761,0.00032117745,0.0002497687],"domain_scores_gemma":[0.99818957,0.00111002,0.00027101254,0.00021167957,0.00007411617,0.00014358824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032601412,0.00017518793,0.0005057736,0.00015656126,0.000029870433,0.0000049764935,0.0000502513,0.00004873254,0.000004404959],"category_scores_gemma":[0.000038396203,0.00011112066,0.000046936908,0.00020782775,0.000042679945,0.000114341354,0.0000041903377,0.00009095847,0.000003562463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07774735,0.00043496044,0.81542206,0.0009760372,0.000096712516,0.000035472895,0.0015676757,0.1032633,0.000114425464,0.000032616324,8.59314e-7,0.0003084961],"study_design_scores_gemma":[0.06712004,0.00186691,0.91427356,0.01163944,0.000037940274,5.562541e-7,0.000028496503,0.0036641222,0.0012345393,0.000021233756,0.0000059825175,0.000107191576],"about_ca_topic_score_codex":0.0017518522,"about_ca_topic_score_gemma":0.00016389122,"teacher_disagreement_score":0.09959918,"about_ca_system_score_codex":0.0003690088,"about_ca_system_score_gemma":0.0002044003,"threshold_uncertainty_score":0.4531369},"labels":[],"label_agreement":null},{"id":"W2405050116","doi":"10.1016/j.jval.2016.03.1777","title":"PROBABILISTIC RECORD MATCHING USING MACHINE LEARNING TECHNIQUES","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Data Quality and Management","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Computer science; Matching (statistics); Data mining; Weighting; Confusion matrix; Set (abstract data type); Metric (unit); Probabilistic logic; Levenshtein distance; Artificial intelligence; Algorithm; Mathematics; Statistics","score_opus":0.31160901547951836,"score_gpt":0.45121663754216795,"score_spread":0.1396076220626496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405050116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6702071,0.00046200067,0.30038032,0.022580396,0.0010181456,0.0016338809,0.000068669746,0.0004647977,0.0031847209],"genre_scores_gemma":[0.897252,0.00035696637,0.09778221,0.0016902538,0.0001766817,0.000032164266,0.00000604266,0.000034518034,0.0026691298],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9965158,0.0011717742,0.0008705731,0.00044418278,0.0006529336,0.0003447385],"domain_scores_gemma":[0.99773747,0.001328517,0.00032686017,0.00046064137,0.000047705817,0.000098820325],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012592945,0.000105221814,0.0002652371,0.00031610436,0.00016420738,0.000104502,0.0004748017,0.000039295344,0.00014412703],"category_scores_gemma":[0.0030731356,0.00006522894,0.00004156864,0.00048264329,0.000050354443,0.0003469094,0.00025714462,0.00015668564,0.00010648487],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052626114,0.00013816525,0.017080974,0.00017498319,0.000007138114,0.000017001634,0.001437368,0.0023101056,0.0006299536,0.055198282,0.0010371547,0.92191625],"study_design_scores_gemma":[0.00050749216,0.00033915756,0.0025633012,0.0011260139,0.0000046991245,0.0000131894685,0.00071468664,0.024809808,0.00026753274,0.6228152,0.34644002,0.0003989084],"about_ca_topic_score_codex":0.013650379,"about_ca_topic_score_gemma":0.0005602226,"teacher_disagreement_score":0.9215173,"about_ca_system_score_codex":0.000244161,"about_ca_system_score_gemma":0.00011723514,"threshold_uncertainty_score":0.99291784},"labels":[],"label_agreement":null},{"id":"W2405143077","doi":"10.1016/j.jval.2016.03.055","title":"Early Impact Of Medicaid Expansion On Prescription Drug Utilization And Spending","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicaid; Quarter (Canadian coin); Medical prescription; Beneficiary; Prescription drug; Demography; Medicine; Tissue expansion; Demographic economics; Health care; Economics; Geography; Economic growth; Finance; Surgery","score_opus":0.15047289106444878,"score_gpt":0.33796745498184094,"score_spread":0.18749456391739217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405143077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930695,0.0007318808,0.0012545856,0.0034930105,0.00018060063,0.00028121535,0.000040362538,0.0000136048975,0.00093521754],"genre_scores_gemma":[0.99675024,0.0028696703,0.0001000742,0.00011510257,0.00003606258,0.0000069591374,0.0000024499845,0.000008859135,0.0001105781],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9989856,0.00005956822,0.0005030615,0.00020408035,0.000039057537,0.00020867193],"domain_scores_gemma":[0.9994319,0.00006946805,0.00024488027,0.00015308034,0.000006936458,0.00009374765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011213165,0.00006850359,0.00020381586,0.00030563978,0.00003546121,0.000007422966,0.00005441315,0.00003801263,0.000048180096],"category_scores_gemma":[0.00013666457,0.000056508885,0.000030148289,0.00012995352,0.000021102887,0.00013240556,0.00002238142,0.00005208029,0.000029900499],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071557435,0.00013007692,0.260652,0.00042173243,0.000016157694,0.0000013934281,0.0033171372,0.0003289194,0.000030345773,0.6740826,0.000581114,0.060367007],"study_design_scores_gemma":[0.0007969003,0.00046027586,0.95982206,0.0004860238,7.611591e-7,7.046655e-7,0.000042119806,0.0033120278,0.000042550473,0.031248834,0.003676222,0.00011150127],"about_ca_topic_score_codex":0.047704007,"about_ca_topic_score_gemma":0.00009440875,"teacher_disagreement_score":0.69917005,"about_ca_system_score_codex":0.00026613817,"about_ca_system_score_gemma":0.000035876,"threshold_uncertainty_score":0.9586374},"labels":[],"label_agreement":null},{"id":"W2405208786","doi":"10.1016/j.jval.2016.03.233","title":"Manager, Health Economics and Patient Access","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame; University of Calgary; Novartis (Canada)","funders":"","keywords":"Fingolimod; Natalizumab; Teriflunomide; Discontinuation; Medicine; Glatiramer acetate; Internal medicine; Medical prescription; Multiple sclerosis; Brace; Physical therapy; Pharmacology; Immunology","score_opus":0.023061253990341028,"score_gpt":0.26396963519501826,"score_spread":0.24090838120467722,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405208786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87938815,0.10214433,0.000095435775,0.0164673,0.0008779247,0.00041053578,0.000027537806,0.00004836253,0.0005403933],"genre_scores_gemma":[0.9807142,0.016770877,0.00002074735,0.0022020275,0.0000017872475,0.000014842495,0.000008708244,0.000011984939,0.00025483948],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984873,0.0002716628,0.0004620266,0.00027825224,0.000014656219,0.00048613758],"domain_scores_gemma":[0.9994405,0.00011583309,0.0001875534,0.0002330914,0.000009498383,0.000013556954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004267323,0.0001230185,0.00026924192,0.00013575211,0.00018756173,0.000013195411,0.00017795534,0.00007995962,0.000061186845],"category_scores_gemma":[0.000030331501,0.00009207741,0.00003173446,0.000091631366,0.00012626991,0.00014009108,0.00010792618,0.00012529138,0.000086296546],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000755506,0.00018951253,0.0022969379,0.00010849332,0.000024112755,0.0000012050646,0.0019786558,0.00024609556,0.00041327858,0.01603782,0.00071488146,0.97791344],"study_design_scores_gemma":[0.004685233,0.0010599085,0.07199978,0.0006637826,0.0000042107154,0.00006417304,0.0014914374,0.00010521924,0.0012502571,0.006247479,0.91185147,0.0005770646],"about_ca_topic_score_codex":0.0046087573,"about_ca_topic_score_gemma":0.00002924947,"teacher_disagreement_score":0.9773364,"about_ca_system_score_codex":0.00012523646,"about_ca_system_score_gemma":0.00022568551,"threshold_uncertainty_score":0.69670933},"labels":[],"label_agreement":null},{"id":"W2405276630","doi":"10.1016/j.jval.2016.03.212","title":"A Life-Course Assessment Of Medication Use And Medical Costs Of Lennox-Gastaut Syndrome (Lgs)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Lennox–Gastaut syndrome; Medicine; Epilepsy; Pediatrics; Clobazam; Medicaid; Antipsychotic; Psychiatry; Health care; Schizophrenia (object-oriented programming)","score_opus":0.05953414159140488,"score_gpt":0.40038879073647815,"score_spread":0.34085464914507324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405276630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752205,0.0010528828,0.00029863205,0.022703074,0.000051544303,0.00055396487,0.000028116852,0.000012002422,0.00007930907],"genre_scores_gemma":[0.9947112,0.0039030313,0.0010212343,0.00024728282,0.000022080036,0.000028013854,0.000010010048,0.000010484153,0.000046665504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794096,0.0002538103,0.00051776716,0.0001972616,0.0008210761,0.00026909896],"domain_scores_gemma":[0.99807745,0.0006449389,0.00016630907,0.00026887737,0.000087224886,0.0007551968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014439961,0.00008710668,0.00039234955,0.0001520182,0.000019394256,0.0000024806327,0.00006267888,0.00007799542,0.00012222963],"category_scores_gemma":[0.0012607572,0.00005395297,0.000033207212,0.00014014014,0.0001760437,0.00006858381,0.00003968425,0.00013634551,0.000003292947],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000096874945,0.0009817017,0.96894455,0.00056261255,0.00009161982,0.00010933982,0.00013566583,0.0000021271085,0.00016042756,0.0027626373,0.00039234807,0.025760088],"study_design_scores_gemma":[0.0038875106,0.0019999996,0.9895689,0.0027968723,0.00002369245,0.00010997453,0.000059380058,0.0011203727,0.00007485751,0.00014534689,0.00016478666,0.000048307258],"about_ca_topic_score_codex":0.003070055,"about_ca_topic_score_gemma":0.00007632042,"teacher_disagreement_score":0.025711782,"about_ca_system_score_codex":0.00020441694,"about_ca_system_score_gemma":0.002576692,"threshold_uncertainty_score":0.46410254},"labels":[],"label_agreement":null},{"id":"W2405377183","doi":"10.1016/j.jval.2016.03.246","title":"Health-Related Quality of Life and Work Productivity in Patients Treated with Onabotulinumtoxina for Cervical Dystonia in a Multicentre, Prospective, Observational Study: Posture","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Allergan (Canada)","funders":"","keywords":"Medicine; Cervical dystonia; Quality of life (healthcare); Observational study; Physical therapy; Work productivity; Rating scale; Prospective cohort study; Botulinum toxin; Internal medicine; Productivity; Surgery; Psychology","score_opus":0.07360094106801386,"score_gpt":0.32248248928804374,"score_spread":0.2488815482200299,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405377183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768626,0.0004400837,0.0000058017936,0.017129388,0.000045968063,0.0054492005,0.000026848622,0.00003085287,0.000009254672],"genre_scores_gemma":[0.9988965,0.00009560361,0.00031372273,0.0004939392,0.000011540768,0.00011350961,0.000017571681,0.000022010197,0.00003562862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967373,0.0007634663,0.0011188231,0.00061083207,0.00032311527,0.00044648375],"domain_scores_gemma":[0.9985763,0.0004951945,0.00036917825,0.00022390012,0.00012180721,0.00021361238],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011282547,0.00020870277,0.0008941131,0.00018864751,0.000047893904,0.0000036650797,0.00006700253,0.00018514646,0.0000066372227],"category_scores_gemma":[0.000934601,0.00012738022,0.000038441198,0.00091087,0.000117113355,0.00007665765,0.000031467305,0.00041357504,9.438875e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0094681475,0.005228605,0.98126614,0.0004062168,0.00003215368,0.0000047041767,0.0011525567,0.00016011491,0.000014964512,0.0001378217,0.00001277668,0.002115796],"study_design_scores_gemma":[0.022130953,0.0039668977,0.9727114,0.00051685807,0.000006274232,0.000001078346,0.000096405965,0.00015830826,0.0000035777357,0.0002758349,0.000008295057,0.00012412971],"about_ca_topic_score_codex":0.0034047493,"about_ca_topic_score_gemma":0.0012725061,"teacher_disagreement_score":0.022033872,"about_ca_system_score_codex":0.00030336741,"about_ca_system_score_gemma":0.000436136,"threshold_uncertainty_score":0.5194415},"labels":[],"label_agreement":null},{"id":"W2405917246","doi":"10.1016/j.jval.2016.03.1242","title":"THE CHANGING EPIDEMIOLOGY OF CHILDHOOD INFECTIOUS DISEASES IN CANADA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Measles; Rubella; Epidemiology; Pediatrics; Vaccination; Population; Meningitis; Poisson regression; Varicella vaccine; Measles-Mumps-Rubella Vaccine; Environmental health; Immunology; Immunization; Internal medicine","score_opus":0.07778729343505858,"score_gpt":0.37940557738568864,"score_spread":0.30161828395063006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2405917246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97351766,0.01164069,0.000011170178,0.0139800655,0.00014399046,0.0004975933,0.000022170647,0.000010605216,0.00017604652],"genre_scores_gemma":[0.994941,0.0035970754,0.000018860004,0.0013001424,0.000062723964,0.000039883515,6.534728e-7,0.00000801755,0.00003164399],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816954,0.0004650215,0.00045976468,0.00014243693,0.00016522742,0.0005979802],"domain_scores_gemma":[0.9968418,0.0026846966,0.00011058243,0.00021020429,0.00003945156,0.00011326391],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013882199,0.00007511929,0.0003613119,0.00016850253,0.000081202146,5.615802e-7,0.00007106874,0.00002164152,0.000007598895],"category_scores_gemma":[0.005240645,0.00003903451,0.00002796353,0.00029618002,0.00008881473,0.000020000498,0.00006139668,0.00013940479,0.0000029869998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003754408,0.000034298144,0.9799838,0.000114647555,0.000013965141,0.000008459771,0.00032021073,0.0001622097,0.0000041955905,0.00095985463,0.00024481624,0.018116005],"study_design_scores_gemma":[0.000984988,0.00014374107,0.99546933,0.00050376187,0.0000020384286,0.0000050691247,0.0002366891,0.00017162257,0.000015934353,0.0009533251,0.001472399,0.000041081956],"about_ca_topic_score_codex":0.9039351,"about_ca_topic_score_gemma":0.70132875,"teacher_disagreement_score":0.20260629,"about_ca_system_score_codex":0.0011780722,"about_ca_system_score_gemma":0.0028480778,"threshold_uncertainty_score":0.627392},"labels":[],"label_agreement":null},{"id":"W2406116237","doi":"10.1016/j.jval.2016.03.478","title":"Trends In Oral Glucocorticoid Utilization Among Older Adults With Respiratory Disease","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; McMaster University; University of Toronto","funders":"","keywords":"Medicine; Asthma; COPD; Prednisone; Internal medicine; Concomitant; Respiratory system; Cumulative dose","score_opus":0.038429322898173385,"score_gpt":0.3164480924625336,"score_spread":0.2780187695643602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406116237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966695,0.0014419116,0.00008127323,0.0009066648,0.00007896262,0.00055295066,0.00001361348,0.000051450977,0.00020372495],"genre_scores_gemma":[0.9982225,0.00006390452,0.00003453471,0.001208344,0.00007332276,0.000051061703,0.000013369179,0.000029450175,0.00030356372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834526,0.00019422869,0.0004277912,0.00036317116,0.00029511595,0.00037444555],"domain_scores_gemma":[0.99902356,0.00005368177,0.00012194069,0.00032252807,0.00004280666,0.0004355147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024301567,0.0001529546,0.0002868655,0.00044199647,0.00003334167,0.000006174508,0.00005708615,0.00005936823,0.00016640183],"category_scores_gemma":[0.00009364306,0.000093031595,0.000048292957,0.0005487541,0.00009005894,0.00013193389,0.000017443263,0.00010805396,0.00001841606],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008672963,0.00031015658,0.9034724,0.0002641996,0.0000034818825,0.00013539472,0.0001812719,0.00014559984,0.000011150964,0.00006677801,0.00022804938,0.09431418],"study_design_scores_gemma":[0.004863297,0.00047534364,0.9886317,0.0027611593,0.000009072929,0.0000018015119,0.00011975407,0.00071549666,0.000029218396,0.000010760951,0.0022580326,0.00012433535],"about_ca_topic_score_codex":0.00039343943,"about_ca_topic_score_gemma":0.00020604629,"teacher_disagreement_score":0.094189845,"about_ca_system_score_codex":0.00023856555,"about_ca_system_score_gemma":0.0007666605,"threshold_uncertainty_score":0.37937182},"labels":[],"label_agreement":null},{"id":"W2406117208","doi":"10.1016/j.jval.2016.03.710","title":"COST EFFECTIVENESS OF SCREENING FOR TYPE 2 DIABETES MELLITUS AND PRE-DIABETES: SYSTEMATIC LITERATURE REVIEW","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Prediabetes; Type 2 diabetes; Psychological intervention; MEDLINE; Cost effectiveness; Type 2 Diabetes Mellitus; Diabetes mellitus; Scopus; Intensive care medicine; Risk analysis (engineering); Nursing","score_opus":0.05370381782965421,"score_gpt":0.327584085634383,"score_spread":0.2738802678047288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406117208","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20189221,0.7891445,0.0006332245,0.00038101498,0.00018022733,0.007662647,0.00004818273,0.000038034173,0.000019926909],"genre_scores_gemma":[0.8501925,0.14481296,0.0028255186,0.0006870578,0.00019696278,0.0010933772,0.000049072383,0.00007886414,0.000063726686],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9974943,0.0008872435,0.0006152102,0.0003295912,0.00026542967,0.00040825008],"domain_scores_gemma":[0.9977186,0.0012139857,0.00022254445,0.0004716391,0.00020056403,0.00017271964],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050332868,0.00019104111,0.0014776079,0.00015030958,0.00004232997,0.000012531745,0.00008320193,0.000101059646,0.0000033235929],"category_scores_gemma":[0.0016861248,0.00012119154,0.00020192777,0.00037168956,0.000059264526,0.00009154053,0.000027957409,0.00012051043,0.0000023450996],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085944455,0.000066873516,0.006893517,0.9043677,0.00024282129,0.000002645049,0.00016090555,0.000014143944,0.0001372307,0.00011022011,0.000075247895,0.08784279],"study_design_scores_gemma":[0.0026955085,0.0011490489,0.030458165,0.9615608,0.00029718594,0.000007406827,0.000016257276,0.0003605867,0.001849623,0.00019963541,0.0012068485,0.0001989341],"about_ca_topic_score_codex":0.00019265487,"about_ca_topic_score_gemma":0.0000063743755,"teacher_disagreement_score":0.64830023,"about_ca_system_score_codex":0.00009398629,"about_ca_system_score_gemma":0.00012411652,"threshold_uncertainty_score":0.49420476},"labels":[],"label_agreement":null},{"id":"W2406123041","doi":"10.1016/j.jval.2016.03.1919","title":"TOCILIZUMAB MONOTHERAPY IN PATIENTS WHERE METHOTREXATE IS CONSIDERED INAPPROPRIATE: A CANADIAN COST-UTILITY ANALYSIS","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Tocilizumab; Adalimumab; Etanercept; Medicine; Rheumatoid arthritis; Methotrexate; Internal medicine; Infliximab; Combination therapy; Tumor necrosis factor alpha","score_opus":0.04089977054338074,"score_gpt":0.31874141961241254,"score_spread":0.2778416490690318,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406123041","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98146474,0.0038495306,0.000071980416,0.012579024,0.000057313835,0.0014405714,0.00013980323,0.000026340695,0.00037070637],"genre_scores_gemma":[0.9866693,0.011563686,0.0005254946,0.000979396,0.000012553624,0.00007910475,0.000017505225,0.000021272477,0.00013165636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708676,0.0006822648,0.000624624,0.00043124115,0.00038125468,0.0007938675],"domain_scores_gemma":[0.99845004,0.00019744683,0.00010772628,0.0004732201,0.00013283803,0.0006387343],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0012427768,0.00017551579,0.0006450962,0.0008701173,0.00008226369,0.00002118777,0.0001152192,0.00011123256,0.00091347704],"category_scores_gemma":[0.00030162252,0.00012901794,0.00011334558,0.0009966823,0.000103927494,0.000107484964,0.000018833194,0.00023679512,0.00004499492],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054734864,0.0001782178,0.8560105,0.00006351016,0.0001603275,0.000025830474,0.0018523957,0.000013394954,0.000013746724,0.0001357599,0.0006645007,0.14033446],"study_design_scores_gemma":[0.012478355,0.00060844386,0.96690345,0.00062835193,0.0000066823077,0.0000035676337,0.000239688,0.0022082664,0.00010447995,0.0018792733,0.014718709,0.00022074324],"about_ca_topic_score_codex":0.6559748,"about_ca_topic_score_gemma":0.4715609,"teacher_disagreement_score":0.18441392,"about_ca_system_score_codex":0.0009024868,"about_ca_system_score_gemma":0.0016261475,"threshold_uncertainty_score":0.9999998},"labels":[],"label_agreement":null},{"id":"W2406158193","doi":"10.1016/j.jval.2016.03.671","title":"BEYOND BUDGET SILOS: BUDGET IMPACT ANALYSIS OF TRANSARTERIAL RADIOEMBOLIZATION WITH YTTRIUM-90 GLASS MICROSPHERES FOR HEPATOCELLULAR CARCINOMA FROM A HOSPITAL PERSPECTIVE","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Mount Sinai Hospital; BC Cancer Agency; Toronto General Hospital","funders":"","keywords":"Hepatocellular carcinoma; Microsphere; Glass microsphere; Perspective (graphical); Yttrium; Medicine; Internal medicine; Materials science; Computer science; Engineering; Chemical engineering","score_opus":0.026591777081331015,"score_gpt":0.270853470834311,"score_spread":0.24426169375297999,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406158193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872584,0.0024343978,0.0046759737,0.0019452113,0.00012343677,0.002161149,0.0013131363,0.000041305746,0.000046998637],"genre_scores_gemma":[0.9965393,0.00015174305,0.0023669442,0.00007997365,0.00019212274,0.00013428304,0.000443794,0.00005709437,0.000034742767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975711,0.00022725183,0.00068598794,0.0006296946,0.00035220815,0.0005337234],"domain_scores_gemma":[0.998356,0.000313131,0.00032225598,0.00043806544,0.00027908105,0.00029147006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003715625,0.0003510218,0.0011990678,0.0004265399,0.00007966233,0.00002134599,0.00012257783,0.00017144573,0.0001472648],"category_scores_gemma":[0.00007360095,0.00023095863,0.00048367368,0.0009466701,0.00012339259,0.00013830514,0.000012402834,0.000101238445,0.0000036019778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002006558,0.0006348953,0.98177415,0.00014234975,0.0015547154,0.000047951824,0.0041703433,0.000048224552,0.008538729,0.00028060115,0.000101234946,0.0007002668],"study_design_scores_gemma":[0.025071679,0.014355055,0.8569267,0.0006473053,0.004761059,0.00001686784,0.0015673802,0.04696836,0.04721242,0.001423821,0.00020569337,0.00084368186],"about_ca_topic_score_codex":0.021864317,"about_ca_topic_score_gemma":0.00027236558,"teacher_disagreement_score":0.12484745,"about_ca_system_score_codex":0.0008043268,"about_ca_system_score_gemma":0.0007032698,"threshold_uncertainty_score":0.9846492},"labels":[],"label_agreement":null},{"id":"W2406198421","doi":"10.1016/j.jval.2016.03.074","title":"Characterization of Statin Effectiveness using Real-World Data in a Canadian Population","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Statin; Framingham Risk Score; Internal medicine; Cohort; Atorvastatin; Hyperlipidemia; Population; Diagnosis code; Cohort study; Physical therapy; Disease; Diabetes mellitus; Endocrinology","score_opus":0.07271361172813516,"score_gpt":0.34943334336236187,"score_spread":0.2767197316342267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406198421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99768937,0.000059191418,0.0005035743,0.00063415844,0.00009108523,0.00090202695,0.00008195839,0.000008876746,0.000029767845],"genre_scores_gemma":[0.99881136,0.0002174893,0.00057970325,0.00008724369,0.00007048295,0.0000094373845,0.00020066567,0.000016373473,0.000007236559],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830854,0.00050588505,0.00041575136,0.00024249291,0.0002166407,0.00031066127],"domain_scores_gemma":[0.9990332,0.000060481925,0.00014283275,0.00054203067,0.000035251916,0.00018619816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029564158,0.000075208336,0.00036975605,0.00045070038,0.000027484984,0.0000032148291,0.000066257824,0.000036094512,0.0000066166167],"category_scores_gemma":[0.0001473113,0.00005907992,0.000024603189,0.0005311722,0.00001656809,0.000118655225,0.000021035163,0.00007672425,0.0000013404135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008043396,0.00003999772,0.93446887,0.0008895843,0.000009722537,0.000010870161,0.00012029722,0.000072496936,0.0032687408,0.00045138603,7.5112115e-7,0.060586855],"study_design_scores_gemma":[0.00092913955,0.00007700188,0.9922439,0.0016811468,0.0000055717906,0.0000050070457,0.000008587571,0.0045216396,0.00023828461,0.000054582946,0.00018014669,0.00005497954],"about_ca_topic_score_codex":0.98638165,"about_ca_topic_score_gemma":0.7237686,"teacher_disagreement_score":0.2626131,"about_ca_system_score_codex":0.0012325798,"about_ca_system_score_gemma":0.0013580399,"threshold_uncertainty_score":0.32231534},"labels":[],"label_agreement":null},{"id":"W2406231314","doi":"10.1016/j.jval.2016.03.1654","title":"Impact Of Initial Local Primary Treatment On Late Regional Complications In Castration-Resistant Prostate Cancer Patients In Quebec","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"Sanofi","keywords":"Medicine; Prostate cancer; Prostatectomy; External beam radiotherapy; Cohort; Proportional hazards model; Logistic regression; Quality of life (healthcare); Radiation therapy; Complication; Surgery; Cancer; Internal medicine","score_opus":0.08621693277562745,"score_gpt":0.4200232491814673,"score_spread":0.3338063164058398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406231314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937278,0.00032252946,0.00000230096,0.004284334,0.000028930921,0.0012557985,0.00019979573,0.000007439817,0.00017108142],"genre_scores_gemma":[0.99791116,0.0013095123,0.000033488213,0.00009487045,0.000019906467,0.0002192667,0.00012257989,0.000012555024,0.00027666587],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986023,0.00013876474,0.00045659798,0.00023488059,0.00024435678,0.00032310217],"domain_scores_gemma":[0.9994278,0.000110343295,0.00010859677,0.00016318027,0.00006605212,0.00012401876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015458783,0.0001234962,0.0002913069,0.00029677525,0.00002658096,0.0000039578913,0.00004113135,0.000046611847,0.000021746284],"category_scores_gemma":[0.000014572119,0.00007352416,0.000049826627,0.00028057725,0.000097497985,0.00006422588,0.000010265412,0.00009620093,0.000005309781],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003431386,0.0026474877,0.9318613,0.00018527896,0.000037033496,0.000037179732,0.0018162898,0.0015878755,0.00092633616,0.0001425869,0.0001258052,0.057201453],"study_design_scores_gemma":[0.00805135,0.0024896003,0.98768336,0.0011538424,0.000003225978,7.7737957e-7,0.000028917239,0.00016192936,0.00019427593,0.00009412778,0.00007618907,0.00006243125],"about_ca_topic_score_codex":0.35318774,"about_ca_topic_score_gemma":0.051339477,"teacher_disagreement_score":0.30184826,"about_ca_system_score_codex":0.0057370304,"about_ca_system_score_gemma":0.0028131604,"threshold_uncertainty_score":0.9980798},"labels":[],"label_agreement":null},{"id":"W2406298188","doi":"10.1016/j.jval.2016.03.1279","title":"PREDICTING NON-INSULIN ANTIDIABETIC DRUG ADHERENCE USING A THEORETICAL FRAMEWORK BASED ON THE THEORY OF PLANNED BEHAVIOR IN ADULTS WITH TYPE 2 DIABETES: A PROSPECTIVE STUDY","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Behavioral Health and Interventions","field":"Psychology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Theory of planned behavior; Medicine; Diabetes mellitus; Type 2 diabetes; Psychological intervention; Psychology; Clinical psychology; Control (management); Psychiatry; Endocrinology","score_opus":0.04699115807319104,"score_gpt":0.36286999317913055,"score_spread":0.3158788351059395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406298188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962356,0.00008835613,0.00007534809,0.00017115816,0.00027132136,0.002807,0.00025233766,0.00002545575,0.00007343092],"genre_scores_gemma":[0.9990581,0.0000037351283,0.00029770448,0.00016433647,0.000028003551,0.00041218725,0.000005602934,0.000025630281,0.0000046563073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965194,0.0015405243,0.00069466495,0.0004263182,0.0002517676,0.0005673378],"domain_scores_gemma":[0.9977775,0.0012408807,0.00028178527,0.0004976737,0.00007981661,0.0001223507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020512056,0.00018688518,0.0003610232,0.00021026407,0.00009259151,0.000006551834,0.00024322665,0.000109212444,0.00037507477],"category_scores_gemma":[0.00028485994,0.00010585175,0.00005101646,0.000623925,0.00026273768,0.000044767276,0.00002901262,0.00051713415,0.000013288255],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002170485,0.0029464215,0.98234373,0.00007299496,0.000008163553,0.0000149432,0.00710168,0.000021831598,0.0000042791416,0.0036913475,0.000012090911,0.0016120253],"study_design_scores_gemma":[0.0023367412,0.009789956,0.973804,0.005883731,0.000021241407,0.000001003893,0.0053062704,0.0012968397,0.000052015286,0.0013682368,4.3032261e-7,0.00013955012],"about_ca_topic_score_codex":0.002260886,"about_ca_topic_score_gemma":0.00020493007,"teacher_disagreement_score":0.008539753,"about_ca_system_score_codex":0.00018243243,"about_ca_system_score_gemma":0.000265749,"threshold_uncertainty_score":0.4316509},"labels":[],"label_agreement":null},{"id":"W2406399824","doi":"10.1016/j.jval.2016.03.219","title":"Impact Of New Entrants To The Market For Multiple-Sclerosis Disease-Modifying Drugs In Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fingolimod; Medical prescription; Glatiramer acetate; Medicine; Teriflunomide; Dimethyl fumarate; Multiple sclerosis; Pediatrics; Family medicine; Pharmacology; Psychiatry","score_opus":0.16186943729508668,"score_gpt":0.32432642627937486,"score_spread":0.16245698898428818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406399824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791911,0.00089546473,0.00030221176,0.01702122,0.00023278782,0.0005652867,0.0015083879,0.0000032788057,0.00028020938],"genre_scores_gemma":[0.9974928,0.0008004311,0.00012999405,0.0013962378,0.000073013915,0.000031588355,0.0000018924071,0.000015070771,0.000059002352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986134,0.00002732113,0.0006549083,0.00022984321,0.00002353561,0.0004509582],"domain_scores_gemma":[0.9988057,0.00044774465,0.00018072934,0.00022013496,0.00000669162,0.00033899504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007136752,0.00009801626,0.00030023506,0.0001328843,0.000032360604,0.000010487443,0.00021245769,0.000022857655,0.00016664363],"category_scores_gemma":[0.00026779372,0.00007598625,0.00008546648,0.00015828,0.000011402151,0.000061855404,0.000031064217,0.00006166755,0.000013301945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028593218,0.00006268949,0.9470824,0.000113042544,0.000025771393,4.3271984e-7,0.0007560587,0.00888707,0.000009452486,0.006392425,0.014639628,0.021745076],"study_design_scores_gemma":[0.0017777495,0.00004935061,0.9374862,0.0001334846,0.0000011223218,1.5300226e-7,0.000020471914,0.041768778,0.000016562924,0.0048696767,0.013724291,0.00015217219],"about_ca_topic_score_codex":0.92357194,"about_ca_topic_score_gemma":0.35801715,"teacher_disagreement_score":0.5655548,"about_ca_system_score_codex":0.0012803967,"about_ca_system_score_gemma":0.0011746788,"threshold_uncertainty_score":0.6536974},"labels":[],"label_agreement":null},{"id":"W2406430614","doi":"10.1016/j.jval.2016.03.807","title":"EARLY STAGE CLINICAL RESEARCH STUDIES IN CANADA: AN ANALYSIS OF THE ECONOMIC IMPACTS OF ATTRACTING MORE STUDIES: A CASE STUDY FOR MONTREAL","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"InterDigital (Canada); Montréal InVivo; Université de Montréal","funders":"","keywords":"Metropolitan area; Private sector; Business; Economic growth; Medicine; Economics","score_opus":0.8626377847964892,"score_gpt":0.6304865484119047,"score_spread":0.23215123638458457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406430614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9879384,0.0023407422,0.000011245228,0.006345158,0.00043323875,0.0021072496,0.0008085531,0.0000049140385,0.000010473179],"genre_scores_gemma":[0.9984746,0.0007206425,0.00016527227,0.00034593203,0.00008578756,0.0001490847,0.0000017845751,0.000022272669,0.00003459726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9874501,0.0030347768,0.007996539,0.0006924833,0.00016825023,0.0006578032],"domain_scores_gemma":[0.9793144,0.015853174,0.0035642423,0.0008764373,0.0001982198,0.00019351201],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.08083441,0.00017272161,0.0023572722,0.00093135133,0.00017890269,0.00001086118,0.00036401066,0.000078946745,0.0000108289105],"category_scores_gemma":[0.0131580075,0.00014207688,0.00017282736,0.0006728421,0.0002088114,0.00028376744,0.00011986778,0.00025866053,0.000003436388],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048975435,0.00019872533,0.96307176,0.00050880655,0.0006030561,0.000010742363,0.025802452,0.0083252555,1.3786939e-7,0.00091876416,0.00023974472,0.000271579],"study_design_scores_gemma":[0.0016747849,0.00052304484,0.8024626,0.00027382118,0.000026454583,0.0000030018039,0.18022665,0.014031494,8.511639e-7,0.0005730676,0.00006079894,0.00014345476],"about_ca_topic_score_codex":0.9919861,"about_ca_topic_score_gemma":0.99131763,"teacher_disagreement_score":0.1606092,"about_ca_system_score_codex":0.008531188,"about_ca_system_score_gemma":0.0043776603,"threshold_uncertainty_score":0.9952749},"labels":[],"label_agreement":null},{"id":"W2406441617","doi":"10.1016/j.jval.2016.03.508","title":"Resource Utilization and Quality of Life of Patients with Hidradenitis Suppurativa in Canada: Results from a Population-Based Survey","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Toronto; Université de Montréal","funders":"","keywords":"Medicine; Hidradenitis suppurativa; Quality of life (healthcare); Population; Likert scale; Physical therapy; Disease; Internal medicine; Environmental health","score_opus":0.09062995522749659,"score_gpt":0.30272240047354515,"score_spread":0.21209244524604856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406441617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99415535,0.000086917076,0.000023735898,0.0030765824,0.000021822852,0.00052224525,0.0020875107,0.000005006839,0.000020837231],"genre_scores_gemma":[0.99872434,0.000020746733,0.00020016688,0.000016732602,0.0000068541317,0.0000063265943,0.0010019765,0.000012290586,0.000010550001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99752855,0.0007828517,0.00089269533,0.0002414829,0.00037779487,0.00017659835],"domain_scores_gemma":[0.9979851,0.0011690067,0.00039270305,0.00021765815,0.000094219984,0.00014126484],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006688599,0.000114521485,0.00047970132,0.00013113393,0.000021720483,0.000001968033,0.00003770101,0.00004741093,0.000016618265],"category_scores_gemma":[0.0010711764,0.000077891396,0.000013621856,0.00028786995,0.00003789969,0.00006376226,0.000009433352,0.00006279257,2.5004232e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016964019,0.0001749528,0.9961432,0.00010367657,0.0000115632065,0.00003191197,0.0003081512,0.000013232305,0.0000059850904,0.000021651034,0.000014816703,0.0014744316],"study_design_scores_gemma":[0.008777873,0.00027405194,0.98984474,0.0006887279,0.000004364557,0.0000029066782,0.00006815211,0.00017069915,0.00007270769,0.000017887245,0.000009468314,0.00006841711],"about_ca_topic_score_codex":0.98638,"about_ca_topic_score_gemma":0.917868,"teacher_disagreement_score":0.068512015,"about_ca_system_score_codex":0.0004949347,"about_ca_system_score_gemma":0.0019855138,"threshold_uncertainty_score":0.3522216},"labels":[],"label_agreement":null},{"id":"W2406521578","doi":"10.1016/j.jval.2016.03.127","title":"Identification and Management of Patients with Symptoms of Statin Intolerance: Results from A Survey of Brazilian Clinicians","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Regimen; Informed consent; Internal medicine; Family medicine; Physical therapy; Alternative medicine","score_opus":0.02553132790576081,"score_gpt":0.2964966045555379,"score_spread":0.2709652766497771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406521578","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99710226,0.00044921858,0.0005804317,0.00026544245,0.000055803514,0.000946349,0.00056631316,0.000005318275,0.000028881579],"genre_scores_gemma":[0.9978791,0.0010983247,0.0008642161,0.000035632434,0.000011202386,0.000010211056,0.00007050324,0.000011184159,0.000019611593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978905,0.00031864108,0.000985305,0.00024245334,0.0004183126,0.00014484243],"domain_scores_gemma":[0.9985576,0.00015105195,0.00054998393,0.00047106788,0.00019213205,0.000078144374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002218816,0.000079279045,0.00046595774,0.00009343127,0.000014265573,0.0000014423142,0.000055445642,0.00004247135,0.0000033426168],"category_scores_gemma":[0.000113370006,0.00005251609,0.000035650617,0.00023663203,0.00007789905,0.000039245493,0.000020187132,0.000054444827,6.605963e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018667052,0.00037924058,0.7772688,0.0021026134,0.0001473346,0.0000014916999,0.0008744228,0.000035423305,0.000043365766,0.00010669854,0.000027972203,0.21714589],"study_design_scores_gemma":[0.0059193983,0.00072965585,0.9904448,0.0023323991,0.00002214531,1.808934e-7,0.00007168395,0.00007403456,0.00026199766,0.000054604985,0.00004364865,0.000045458375],"about_ca_topic_score_codex":0.031704955,"about_ca_topic_score_gemma":0.00065146695,"teacher_disagreement_score":0.21710043,"about_ca_system_score_codex":0.00006203788,"about_ca_system_score_gemma":0.00015985742,"threshold_uncertainty_score":0.974743},"labels":[],"label_agreement":null},{"id":"W2406773265","doi":"10.1016/j.jval.2016.03.999","title":"TIME TRADE OFF STUDY FOR PARENTERAL SUPPORT IN SHORT BOWEL SYNDROME IN CANADA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical Nutrition and Gastroenterology","field":"Nursing","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Short bowel syndrome; Medicine; Bowel function; Population; Quality of life (healthcare); Parenteral nutrition; Demography; Pediatrics; Gerontology; Environmental health; Surgery","score_opus":0.049338727622142635,"score_gpt":0.33365311912133405,"score_spread":0.2843143914991914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2406773265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9167293,0.000023931827,0.0000026027421,0.08172089,0.00048660496,0.0009205223,0.000100717225,0.000011716688,0.000003772695],"genre_scores_gemma":[0.9929914,0.000011597201,0.000040326766,0.006808975,0.000033279175,0.000073376235,0.00001465817,0.000016166416,0.0000102106205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977316,0.000371359,0.0008652838,0.00031832475,0.00014964271,0.0005637588],"domain_scores_gemma":[0.99923426,0.0004003965,0.000049687926,0.00016200729,0.0000074926284,0.00014615944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007531987,0.00011595485,0.00040361207,0.00016124551,0.000021040772,0.0000044396106,0.0001327532,0.000048216498,0.0000329942],"category_scores_gemma":[0.00010973533,0.00009897366,0.000040439238,0.00011595226,0.000027715876,0.00005151042,0.000018587161,0.0001698255,0.000003975179],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059700344,0.000851413,0.98809004,0.000056049812,0.0000041335147,0.00010064338,0.00028656278,0.000067778514,0.000017401107,0.0000017547756,0.006894823,0.0030323847],"study_design_scores_gemma":[0.0045973007,0.0021828664,0.9898932,0.00022041785,0.0000022044248,0.000028284721,0.00021145333,0.0009496682,0.000003105377,0.00008798576,0.0017379967,0.000085529],"about_ca_topic_score_codex":0.43899056,"about_ca_topic_score_gemma":0.900357,"teacher_disagreement_score":0.46136647,"about_ca_system_score_codex":0.0010330668,"about_ca_system_score_gemma":0.0001691839,"threshold_uncertainty_score":0.56474525},"labels":[],"label_agreement":null},{"id":"W2407069932","doi":"10.1016/j.jval.2015.09.1616","title":"Biosimilar Substitution Policies: An Overview","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Interchangeability; Legislation; European union; Medicine; Public economics; Business; International trade; Political science; Law; Economics; Engineering","score_opus":0.25185676392897954,"score_gpt":0.41127787069361604,"score_spread":0.1594211067646365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407069932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7331237,0.20823574,0.0014705877,0.04393826,0.0053884923,0.0015513023,0.0001729912,0.0004562247,0.0056626555],"genre_scores_gemma":[0.97969955,0.0038092637,0.00479299,0.010884573,0.00014036433,0.000015548729,0.000054660002,0.000023850156,0.0005791828],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99808145,0.00084741786,0.0003664202,0.00024784586,0.00004295558,0.00041392635],"domain_scores_gemma":[0.9994246,0.0000781907,0.00008216423,0.000269615,0.000041240954,0.00010420676],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016793648,0.00012224843,0.0002909202,0.00012062832,0.000073567564,0.000010356987,0.00016342252,0.00021261242,0.00010570501],"category_scores_gemma":[0.00018160047,0.000098833014,0.000045178687,0.00030779224,0.0001465141,0.00008290234,0.000039043025,0.00024603985,0.00010273652],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011531346,0.0032454017,0.050241612,0.0010110285,0.00022466849,0.00004864811,0.0071270545,0.001573109,0.016953161,0.7797058,0.05680639,0.08190997],"study_design_scores_gemma":[0.003360177,0.0020488407,0.020087218,0.00041187558,0.000030182093,0.00011941395,0.00083020394,0.0012084577,0.01160853,0.0172926,0.9423724,0.0006300909],"about_ca_topic_score_codex":0.0036699867,"about_ca_topic_score_gemma":0.000083703344,"teacher_disagreement_score":0.885566,"about_ca_system_score_codex":0.00015604323,"about_ca_system_score_gemma":0.0002799557,"threshold_uncertainty_score":0.55479467},"labels":[],"label_agreement":null},{"id":"W2407236015","doi":"10.1016/j.jval.2016.03.048","title":"Economic Evaluation of A Mental Health Engagement Network","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; St. Michael's Hospital","funders":"","keywords":"Medicine; Cost effectiveness; Economic evaluation; Mental health; Cost-effectiveness analysis; Activity-based costing; Health care; Randomized controlled trial; Demography; Gerontology; Psychiatry; Business; Surgery; Economics","score_opus":0.5272073915779727,"score_gpt":0.46577020942683395,"score_spread":0.06143718215113875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407236015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6093792,0.023175256,0.0037290705,0.34879345,0.0040055653,0.005734072,0.0009902488,0.00010060197,0.004092549],"genre_scores_gemma":[0.9851261,0.001922543,0.0038306525,0.008142159,0.0005195308,0.00020208112,0.00003821268,0.000047906764,0.00017081328],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9884277,0.0029398943,0.006885439,0.0007033397,0.00022740877,0.0008162198],"domain_scores_gemma":[0.99430764,0.00090923376,0.0038791255,0.0005976715,0.00004489637,0.00026144998],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.10044415,0.00019987013,0.001177887,0.00039219763,0.00019621153,0.000019341553,0.00026794744,0.0000929533,0.00084186957],"category_scores_gemma":[0.0011970492,0.00021543854,0.000114253075,0.0001871814,0.00006437426,0.00033184615,0.00006534791,0.0001385798,0.0009566812],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006777345,0.0003737457,0.19453107,0.0012247708,0.00013148128,2.859345e-7,0.00867465,0.05386478,0.0000035335827,0.58904546,0.13425007,0.017832372],"study_design_scores_gemma":[0.015354779,0.0015758001,0.24591199,0.0043049855,0.000013750545,0.0000136860235,0.002561793,0.1949944,0.000017351264,0.2351882,0.29852337,0.001539903],"about_ca_topic_score_codex":0.010539129,"about_ca_topic_score_gemma":0.0008638186,"teacher_disagreement_score":0.37574694,"about_ca_system_score_codex":0.005905938,"about_ca_system_score_gemma":0.0017243288,"threshold_uncertainty_score":0.9998212},"labels":[],"label_agreement":null},{"id":"W2407250161","doi":"10.1016/j.jval.2016.03.834","title":"SINGLE-ENTRY MODELS FOR SCHEDULED SERVICES: TOWARDS A ROADMAP FOR THE IMPLEMENTATION OF BEST PRACTICES","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Research in Systems and Signal Processing","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; University of Manitoba; Alberta Bone and Joint Health Institute; Kingston General Hospital; University of Calgary","funders":"","keywords":"Triage; Stakeholder; Process management; Health care; Service (business); Best practice; Operations management; Medicine; Computer science; Knowledge management; Business; Engineering; Medical emergency; Public relations; Management; Political science; Marketing","score_opus":0.1561322101641723,"score_gpt":0.4087031227503152,"score_spread":0.25257091258614284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407250161","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11243699,0.0061069387,0.8755918,0.002482718,0.0003645029,0.002601019,0.00013568644,0.00006775439,0.00021258522],"genre_scores_gemma":[0.9897975,0.0004142532,0.009294985,0.000036297766,0.00012645528,0.0002657227,0.0000037515892,0.000024920026,0.00003614839],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99895287,0.000048053764,0.00039986862,0.00012999553,0.00016620841,0.00030301363],"domain_scores_gemma":[0.99878484,0.00069998903,0.00023335029,0.0001286953,0.00009924202,0.000053881322],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009948022,0.0000838526,0.00016362683,0.000060101065,0.00008775659,0.000022254915,0.0001327435,0.000037486832,0.000004215253],"category_scores_gemma":[0.00008477332,0.000050301733,0.00003840219,0.000105831474,0.000016905531,0.00037504165,0.00001500356,0.000055990207,6.176995e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018360278,0.00010866624,0.00056091323,0.014285023,0.0000932653,5.864871e-7,0.004298242,0.4031776,0.014765926,0.0049109203,0.00014821357,0.55746704],"study_design_scores_gemma":[0.0023462812,0.0004787538,0.00007061306,0.0016516871,0.000012619241,0.000003100842,0.0069754543,0.9596808,0.009759766,0.009546815,0.0092926305,0.00018148882],"about_ca_topic_score_codex":0.0014617788,"about_ca_topic_score_gemma":0.00013941982,"teacher_disagreement_score":0.87736046,"about_ca_system_score_codex":0.00014547515,"about_ca_system_score_gemma":0.00014228772,"threshold_uncertainty_score":0.2209782},"labels":[],"label_agreement":null},{"id":"W2407650244","doi":"10.1016/j.jval.2016.03.1448","title":"Meta-Analysis Followed by Indirect Comparison of Treatments Comparing Uterine Artery Embolization and Surgical Methods for the Treatment of Symptomatic Uterine Leiomyomas","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Uterine Myomas and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Hysterectomy; Uterine artery embolization; Psychological intervention; Uterine fibroids; Uterine artery; Surgery; Pregnancy","score_opus":0.19269452744266832,"score_gpt":0.45384746215997207,"score_spread":0.2611529347173037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407650244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97143996,0.0077610435,0.017688114,0.0012691836,0.00006457174,0.001598702,0.00012496565,0.000024425735,0.000029013974],"genre_scores_gemma":[0.98647314,0.0013452525,0.011475749,0.000016644102,0.000017124074,0.0002404467,0.00006337941,0.000021004735,0.00034724665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792486,0.00033772324,0.0009734706,0.0003162096,0.00018176158,0.00026596797],"domain_scores_gemma":[0.9980847,0.0008929281,0.00045342062,0.0004001707,0.000047538095,0.000121245364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046491585,0.0002494478,0.0022586128,0.00026992493,0.00005966326,0.000008026812,0.000064570246,0.00005373636,0.000045824407],"category_scores_gemma":[0.000017990407,0.00012137655,0.00050492503,0.00039273952,0.000065918866,0.00004910726,0.00002463752,0.000026363512,5.343145e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012385212,0.006361897,0.7202813,0.0011087762,0.17232788,0.000020881329,0.0029521126,0.00046352085,0.0021346416,0.0003388626,0.00006553337,0.092706054],"study_design_scores_gemma":[0.054462846,0.022921365,0.35263076,0.00042922047,0.25435722,0.00016035707,0.0003302335,0.25443113,0.04067823,0.00040359295,0.018337013,0.0008580303],"about_ca_topic_score_codex":0.0011906701,"about_ca_topic_score_gemma":0.000040057635,"teacher_disagreement_score":0.36765057,"about_ca_system_score_codex":0.00017980087,"about_ca_system_score_gemma":0.000048608465,"threshold_uncertainty_score":0.4949592},"labels":[],"label_agreement":null},{"id":"W2407757632","doi":"10.1016/j.jval.2016.03.1791","title":"A NOVEL METHOD USING PRESCRIPTION TREATMENT PATTERNS TO ESTIMATE HEART FAILURE PREVALENCE IN CANADA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada); Novartis (Canada)","funders":"","keywords":"Medicine; Medical prescription; Referral; Heart failure; Diagnosis code; Emergency medicine; Database; Internal medicine; Family medicine; Population; Environmental health","score_opus":0.2582645712173075,"score_gpt":0.5084803843387173,"score_spread":0.25021581312140984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2407757632","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94637823,0.00015733442,0.025090322,0.023866575,0.0009984326,0.0032213167,0.0002185145,0.000052353887,0.00001692036],"genre_scores_gemma":[0.9565813,0.000074640084,0.040575992,0.001919351,0.00018500205,0.00044557848,0.000003922639,0.000050777915,0.0001634646],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944848,0.0017289376,0.001437936,0.000646062,0.00038984258,0.0013124578],"domain_scores_gemma":[0.9972992,0.0012878159,0.00028477758,0.00052542,0.00012194883,0.00048083233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017663329,0.00025932628,0.00051917206,0.0002705517,0.00032229145,0.0000066122802,0.00021488439,0.00015096551,0.00016482014],"category_scores_gemma":[0.0005244533,0.00019931268,0.000039292143,0.00045018358,0.00001668149,0.00016708863,0.00009149096,0.0003817862,0.000061167324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00006443442,0.00007566169,0.9671157,0.0010041927,0.000003692292,0.000008310361,0.0039046796,0.015875475,0.0017361385,0.00033561978,0.00018787084,0.009688223],"study_design_scores_gemma":[0.0018683957,0.0010566765,0.7790525,0.02511467,0.000017821214,0.00003840214,0.009217643,0.16570583,0.001922549,0.0012104225,0.0137066115,0.0010884729],"about_ca_topic_score_codex":0.9972874,"about_ca_topic_score_gemma":0.99593425,"teacher_disagreement_score":0.1880632,"about_ca_system_score_codex":0.014025641,"about_ca_system_score_gemma":0.008982374,"threshold_uncertainty_score":0.9966358},"labels":[],"label_agreement":null},{"id":"W2408318875","doi":"10.1016/j.jval.2016.03.1634","title":"Hypofractionated Radiotherapy For Low-Intermediate Risk Prostate Cancer: Clinical And Economic Evaluation In A Real-Life Setting","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Prostate cancer; Regimen; Radiation therapy; Internal medicine; Oncology; Proportional hazards model; Cohort; Cancer","score_opus":0.03385358057016979,"score_gpt":0.3974672351820683,"score_spread":0.3636136546118985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408318875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772343,0.00065906753,0.018267544,0.0017056076,0.00025025514,0.0016554791,0.0001673875,0.000045034638,0.000015293215],"genre_scores_gemma":[0.9791703,0.010849263,0.008603373,0.00020010272,0.0004269644,0.0006702674,0.000013631023,0.00004059171,0.000025496522],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.998132,0.00040769664,0.0007355185,0.00035507852,0.000078057084,0.0002916813],"domain_scores_gemma":[0.99856424,0.00070433976,0.00045202646,0.0001532724,0.000032379456,0.00009373356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002397853,0.00012920573,0.0003015895,0.00011431115,0.000058498463,0.000013052327,0.00006887285,0.000049674563,0.000051783725],"category_scores_gemma":[0.00006342228,0.00010609398,0.000047292455,0.00006186735,0.00005966282,0.00022490804,0.000009794916,0.00014790139,7.383307e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015715967,0.000049332295,0.5741208,0.000022141438,0.000023694774,1.07317966e-7,0.00024575886,0.0033597597,0.000085104206,0.0005270763,0.00012633204,0.42128274],"study_design_scores_gemma":[0.014551453,0.0006996941,0.3838911,0.0009474084,0.000016142934,8.915834e-7,0.00013761365,0.5684454,0.00043890357,0.021805791,0.0084946975,0.0005708975],"about_ca_topic_score_codex":0.007520594,"about_ca_topic_score_gemma":0.00013783837,"teacher_disagreement_score":0.56508565,"about_ca_system_score_codex":0.0005008179,"about_ca_system_score_gemma":0.00061403797,"threshold_uncertainty_score":0.9990884},"labels":[],"label_agreement":null},{"id":"W2408418438","doi":"10.1016/j.jval.2016.03.1872","title":"INVESTIGATING STRUCTURAL INDEPENDENCE IN PREFERENCE-BASED UTILITY INSTRUMENTS USING GRAPHICAL MODELS","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; University Health Network; University of Toronto","funders":"","keywords":"Conditional independence; Independence (probability theory); Graphical model; Computer science; Multivariate statistics; Function (biology); Data mining; Preference; Bayesian probability; Bayesian network; Bayesian information criterion; Econometrics; Artificial intelligence; Machine learning; Statistics; Mathematics","score_opus":0.3769133944637185,"score_gpt":0.27740152763244696,"score_spread":0.09951186683127156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408418438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963318,0.00017897307,0.0023065142,0.00046178582,0.00014513888,0.00026290864,0.00004102372,0.000012239266,0.0002596254],"genre_scores_gemma":[0.9971054,0.00004874427,0.002545789,0.000248869,0.000016821856,0.000013012919,0.0000044157864,0.000011687582,0.000005259267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982362,0.00008671532,0.0008589418,0.00042314464,0.000054546952,0.00034046057],"domain_scores_gemma":[0.99931353,0.000048036643,0.00032043867,0.00021093144,0.000004136416,0.00010293638],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012278578,0.00012257742,0.00028661595,0.00023229183,0.0000623039,0.000016748407,0.00014723904,0.0001106271,0.00008632957],"category_scores_gemma":[0.00007648793,0.000121045756,0.00003621609,0.00017496292,0.000085616164,0.00041870287,0.000036289955,0.00017547526,0.000024284544],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004490616,0.000020122485,0.95449924,0.000030117244,0.0000018580521,2.0674749e-7,0.00017009785,0.02333712,0.000012265821,0.020151438,6.1316246e-7,0.0017724249],"study_design_scores_gemma":[0.00053376966,0.000022086144,0.49953845,0.00010050666,2.4405668e-7,4.6980898e-7,0.000015312711,0.37393385,0.000018845622,0.12574789,0.0000028780698,0.0000856795],"about_ca_topic_score_codex":0.010642532,"about_ca_topic_score_gemma":0.00022157608,"teacher_disagreement_score":0.4549608,"about_ca_system_score_codex":0.00069912197,"about_ca_system_score_gemma":0.00010267287,"threshold_uncertainty_score":0.9959457},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"grok","categories":[],"domain":null,"study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2408603834","doi":"10.1016/j.jval.2016.03.164","title":"Persistence and Compliance with Cardiovascular Drug Therapy Among Seniors","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Medicine; Persistence (discontinuity); Medical prescription; Drug; Compliance (psychology); Drug class; Pharmacotherapy; Thiazide; Drug adherence; Intensive care medicine; Physical therapy; Emergency medicine; Pharmacology; Internal medicine; Blood pressure; Psychology","score_opus":0.0962179534138825,"score_gpt":0.29678072693088625,"score_spread":0.20056277351700375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408603834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98313254,0.0072349953,0.00087152043,0.007362536,0.00005485868,0.0005085215,0.0000022942118,0.00003804745,0.0007946623],"genre_scores_gemma":[0.9924913,0.0040899753,0.0010635911,0.0010202929,0.000046793386,0.000034915356,9.334201e-7,0.000010563965,0.0012416482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998921,0.00009963286,0.00018899457,0.00027650705,0.00028662945,0.0002272464],"domain_scores_gemma":[0.9992625,0.00006335258,0.00006712866,0.00036947563,0.000045516488,0.00019199708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048584686,0.000094038856,0.00027553493,0.00005045926,0.00005331695,0.000005490836,0.000068969064,0.00002577801,0.00006678629],"category_scores_gemma":[0.000030123432,0.00005472664,0.000041188527,0.00017142716,0.00016225969,0.000060961513,0.000009711563,0.000097625365,0.00004619694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016716536,0.000106823914,0.8780162,0.00043242003,0.00009548919,0.000045754463,0.001438338,0.00006336809,0.00018336554,0.0003416387,0.0012881373,0.1178213],"study_design_scores_gemma":[0.0039909496,0.000414976,0.96414375,0.003905178,0.000012924686,0.000121252146,0.0007453983,0.0008578043,0.00021966756,0.00016450023,0.025221737,0.00020186296],"about_ca_topic_score_codex":0.0010560893,"about_ca_topic_score_gemma":0.000009473643,"teacher_disagreement_score":0.11761943,"about_ca_system_score_codex":0.000068969326,"about_ca_system_score_gemma":0.00016577537,"threshold_uncertainty_score":0.22316876},"labels":[],"label_agreement":null},{"id":"W2408640434","doi":"10.1016/j.jval.2016.03.1690","title":"Determining And Identifying Costs For Economic Evaluations: Guidance From Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Health Economics; Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Activity-based costing; Selection (genetic algorithm); Economic evaluation; Time horizon; Actuarial science; Computer science; Health care; Population; Perfect information; Risk analysis (engineering); Operations research; Data science; Economics; Business; Medicine; Marketing; Microeconomics; Engineering","score_opus":0.4308115233912238,"score_gpt":0.4545053054503063,"score_spread":0.023693782059082513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408640434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89044595,0.0097328825,0.01343378,0.08026994,0.002007105,0.0018168455,0.0018907333,0.000043782533,0.00035895838],"genre_scores_gemma":[0.97975516,0.00064688537,0.010515159,0.0080523845,0.00041776762,0.00032748736,0.000028014752,0.000044802673,0.00021233385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994789,0.00039103653,0.0035927063,0.00065127003,0.00007243964,0.00050354085],"domain_scores_gemma":[0.99390703,0.0037527033,0.0016987725,0.00039307692,0.000027568114,0.0002208697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013857224,0.00016672915,0.00075859507,0.00021424613,0.00020964835,0.00005634997,0.00020202143,0.00008215992,0.00013534422],"category_scores_gemma":[0.0029966035,0.00019128235,0.00004589308,0.000060772774,0.000039593077,0.00043671654,0.000042259468,0.0000777551,0.00016583211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044792287,0.00006130682,0.8030454,0.0011078861,0.00009822998,0.000002258343,0.0028198143,0.0025791992,0.000024658826,0.12457144,0.044363856,0.021281183],"study_design_scores_gemma":[0.0077180415,0.0002689477,0.5928326,0.0030847876,0.0000120287705,0.000010417046,0.0019391442,0.13673916,0.000059879152,0.15279523,0.103072815,0.0014668886],"about_ca_topic_score_codex":0.73918575,"about_ca_topic_score_gemma":0.3855664,"teacher_disagreement_score":0.35361934,"about_ca_system_score_codex":0.004396625,"about_ca_system_score_gemma":0.0015844012,"threshold_uncertainty_score":0.9994253},"labels":[],"label_agreement":null},{"id":"W2408735958","doi":"10.1016/j.jval.2016.03.379","title":"Association between Neighborhood Socioeconomic Status, Stroke Center Admission, and Mortality after Ischemic and Ill-Define Stroke","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Health Information; Alberta Medical Association; Alberta Health Services; Institute of Health Economics; University of Alberta","funders":"","keywords":"Socioeconomic status; Medicine; Stroke (engine); Emergency medicine; Demography; Neighbourhood (mathematics); Household income; Mortality rate; Pediatrics; Internal medicine; Environmental health; Population; Geography","score_opus":0.019119036118266212,"score_gpt":0.2839625645176131,"score_spread":0.2648435283993469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2408735958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840657,0.001043588,0.00011698067,0.012541516,0.000111403286,0.00058002415,0.00045975036,0.000046426798,0.0010345883],"genre_scores_gemma":[0.9932348,0.0021348293,0.00059625553,0.0014235727,0.00022829263,0.00003369013,0.00004025901,0.00003088812,0.0022773754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793863,0.00012666844,0.0006073157,0.0004733198,0.00026547027,0.0005885752],"domain_scores_gemma":[0.99872506,0.0002420651,0.00029188071,0.00028993975,0.000050802675,0.0004002803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008349184,0.000214281,0.0004904933,0.00013572615,0.000049638344,0.000018165381,0.000056981924,0.00016276535,0.00016197961],"category_scores_gemma":[0.00024196343,0.00016466135,0.00005358748,0.000048062615,0.00005021037,0.0001384537,0.00013207784,0.0002512547,0.000023904407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006750557,0.000051216743,0.98379153,0.00021092173,0.00015450752,0.000004288023,0.00025638955,3.570821e-7,0.0005756979,0.000017386825,0.0074540586,0.007416152],"study_design_scores_gemma":[0.0037775524,0.0001761776,0.9677498,0.0002770708,0.000084002684,0.0000038207895,0.00012879721,0.000079064666,0.00034218366,0.000045382287,0.02717087,0.00016532202],"about_ca_topic_score_codex":0.000540948,"about_ca_topic_score_gemma":0.000019908484,"teacher_disagreement_score":0.01971681,"about_ca_system_score_codex":0.000963608,"about_ca_system_score_gemma":0.00017808603,"threshold_uncertainty_score":0.6714695},"labels":[],"label_agreement":null},{"id":"W2409115721","doi":"10.1016/j.jval.2015.09.1199","title":"Cost-Effectiveness Of Ceritinib In Previously Treated Patients With Crizotinib In Anaplastic Lymphoma Kinase-Positive (Alk+) Non-Small Cell Lung Cancer In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Crizotinib; Anaplastic lymphoma kinase; Medicine; Ceritinib; Pemetrexed; Internal medicine; Oncology; Lung cancer; Population; Anaplastic large-cell lymphoma; Lymphoma; Chemotherapy","score_opus":0.025349565040491275,"score_gpt":0.3133472650491722,"score_spread":0.2879977000086809,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409115721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99457824,0.000847182,0.000009781404,0.00009808014,0.00012714302,0.0037581392,0.00019856688,0.0000071954128,0.00037569847],"genre_scores_gemma":[0.9989734,0.0000845011,0.000102159094,0.00010157054,0.000012150176,0.0005481829,0.00013136906,0.000029833076,0.00001678291],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980732,0.00035539144,0.0005203887,0.00034108447,0.00025289663,0.00045699393],"domain_scores_gemma":[0.9990202,0.00028442396,0.00017130845,0.00016830985,0.00013644416,0.0002192971],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003192262,0.00019823745,0.0005832086,0.0003081016,0.000018579181,0.00000469868,0.00006376645,0.000056493995,0.0000062497993],"category_scores_gemma":[0.00005813436,0.00017075807,0.000019700561,0.0007605898,0.000027708931,0.00006544953,0.000016288219,0.0001386099,4.7905735e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.001346937,0.0008256498,0.9726627,0.001081521,0.000023047422,0.00014447395,0.0025832083,0.018870434,0.0000057632024,0.0000060322063,0.000020285474,0.0024299738],"study_design_scores_gemma":[0.020428855,0.0011042369,0.9688767,0.0050526178,0.00003637261,0.0000022002178,0.0005743737,0.0035165527,0.00025165477,0.000004687735,0.000014062577,0.00013766081],"about_ca_topic_score_codex":0.9817974,"about_ca_topic_score_gemma":0.94123477,"teacher_disagreement_score":0.040562622,"about_ca_system_score_codex":0.00903594,"about_ca_system_score_gemma":0.009641924,"threshold_uncertainty_score":0.9959725},"labels":[],"label_agreement":null},{"id":"W2409305992","doi":"10.1016/j.jval.2015.09.924","title":"Managing Patients With Statin-Associated Symptoms: Does Real-World Clinical Practice Align With Clinical Guidelines And Hta Recommendations In Europe?","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Ezetimibe; Medicine; Statin; Family medicine; Concomitant; Clinical Practice; Internal medicine","score_opus":0.12308576949465633,"score_gpt":0.4295672057527932,"score_spread":0.3064814362581369,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409305992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94393235,0.000563393,0.00024875219,0.050816387,0.00044437978,0.002187267,0.00003103633,0.00009317317,0.0016832614],"genre_scores_gemma":[0.85716826,0.018830184,0.09624787,0.02497949,0.0011088053,0.0001643903,0.0004982674,0.00023267206,0.00077004463],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938734,0.0023939642,0.001925736,0.00060783373,0.0007045575,0.00049447815],"domain_scores_gemma":[0.99644077,0.0008103686,0.00064546854,0.0005546973,0.0009728013,0.0005758759],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013003443,0.00021746206,0.00088118354,0.00024060228,0.00008501733,0.000032451757,0.000095783915,0.00009913642,0.000004980573],"category_scores_gemma":[0.0046173707,0.00013928647,0.000055243185,0.0010024881,0.000103940576,0.00022599437,0.00006844647,0.00067640364,0.000006181007],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007528066,0.00082094775,0.93726826,0.000145903,0.00014021753,0.00006718736,0.00042724246,0.00015922695,1.7499188e-8,0.00020890436,0.002677478,0.057331804],"study_design_scores_gemma":[0.015189121,0.0035717224,0.9203168,0.0023714015,0.0001373702,0.000022703429,0.0011477896,0.0024494384,3.5576946e-7,0.00015427715,0.05434196,0.00029702365],"about_ca_topic_score_codex":0.027714849,"about_ca_topic_score_gemma":0.0055904705,"teacher_disagreement_score":0.095999114,"about_ca_system_score_codex":0.0003184646,"about_ca_system_score_gemma":0.0016822848,"threshold_uncertainty_score":0.9787597},"labels":[],"label_agreement":null},{"id":"W2409911183","doi":"10.1016/j.jval.2015.09.1194","title":"Literature Review Of Economic Evaluations Of Screening Tests For Breast Cancer","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Mammography; Breast cancer; Population; Gynecology; Demography; Cancer; Internal medicine; Environmental health","score_opus":0.24292221545576798,"score_gpt":0.4736622964160725,"score_spread":0.23074008096030452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409911183","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13498384,0.8228799,0.00091766694,0.035060074,0.0005027978,0.0034370217,0.001123327,0.00003408851,0.001061278],"genre_scores_gemma":[0.91993964,0.05587527,0.0187667,0.0046724803,0.0003891856,0.00014855208,0.00008035627,0.00002624558,0.00010154688],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99891424,0.000071242415,0.00051811844,0.00014046844,0.00018898195,0.00016691814],"domain_scores_gemma":[0.9990608,0.00007925949,0.0002539932,0.0001825454,0.00029280077,0.000130619],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014599842,0.00007244447,0.00039056147,0.00008807289,0.000016282462,0.0000027372505,0.00006621376,0.000039865623,0.000027385084],"category_scores_gemma":[0.00024756702,0.00006394625,0.00006589129,0.00022123035,0.000023569746,0.00007546723,0.000013875816,0.00009191822,0.0000011066007],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016443986,0.00031139725,0.41614366,0.12166725,0.00018519527,0.00001466516,0.0045019793,0.034814253,0.00028933355,0.007598951,0.07865837,0.33417055],"study_design_scores_gemma":[0.008538056,0.0024817595,0.29863447,0.63141227,0.00027342534,0.0003847115,0.0007167171,0.04089331,0.00038919243,0.0025213812,0.013282461,0.0004722365],"about_ca_topic_score_codex":0.003596966,"about_ca_topic_score_gemma":0.00012910287,"teacher_disagreement_score":0.78495586,"about_ca_system_score_codex":0.0002638761,"about_ca_system_score_gemma":0.001393136,"threshold_uncertainty_score":0.54375607},"labels":[],"label_agreement":null},{"id":"W2409994208","doi":"10.1016/j.jval.2015.09.098","title":"Aretaeus: Retrospective Study Of Medication Usage Patterns Following The Diagnosis Of Type 2 Diabetes In Latin America","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes, Cardiovascular Risks, and Lipoproteins","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Medical record; Medical prescription; Logistic regression; Diabetes mellitus; Statin; Retrospective cohort study; Type 2 diabetes; Pediatrics; Type 2 Diabetes Mellitus; Internal medicine; Family history; Medical history","score_opus":0.053595954010897985,"score_gpt":0.3121373045771011,"score_spread":0.2585413505662031,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2409994208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953227,0.002563204,0.000015880069,0.0005660849,0.00020560599,0.0012049584,0.0000073138553,0.000013642681,0.00010062449],"genre_scores_gemma":[0.9992282,0.0003275548,0.00009976005,0.00013871804,0.00007068105,0.00010297785,0.000009302282,0.000017432902,0.0000054179773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99781907,0.0005569614,0.000561824,0.00022351036,0.0006003529,0.00023826397],"domain_scores_gemma":[0.9989535,0.00015195266,0.0002428965,0.0004679516,0.000084018386,0.0000996741],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022580703,0.00010766313,0.0006646956,0.00018316359,0.000022110044,0.0000038893177,0.00012402904,0.000048291753,0.000008943859],"category_scores_gemma":[0.0011370062,0.00007996896,0.000104500396,0.0006532356,0.000048275117,0.000048255355,0.000040777486,0.00022348428,0.000002475501],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016150336,0.00048576613,0.96372443,0.00013032701,0.00009932309,0.0000047155095,0.008330812,0.0003543934,0.000003835147,0.000005606305,0.000056714485,0.026787922],"study_design_scores_gemma":[0.0017462523,0.0014958687,0.98974943,0.0005536486,0.00005620297,2.552051e-7,0.004981288,0.0009611061,0.00012658825,0.000119997654,0.0001442146,0.00006515246],"about_ca_topic_score_codex":0.09089826,"about_ca_topic_score_gemma":0.0018653567,"teacher_disagreement_score":0.0890329,"about_ca_system_score_codex":0.00021316987,"about_ca_system_score_gemma":0.00022060421,"threshold_uncertainty_score":0.91515553},"labels":[],"label_agreement":null},{"id":"W2410634188","doi":"10.1016/j.jval.2015.09.2251","title":"Compliance With Allopurinol Among Hypertensive Patients With Gout Diagnosis and The Relationship to Onset of End-Stage Renal Disease","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Allopurinol; Internal medicine; Gout; End stage renal disease; Kidney disease; Risk factor; Dyslipidemia; Diabetes mellitus; Hemodialysis; Aspirin; Cohort; Disease; Endocrinology","score_opus":0.087752376779564,"score_gpt":0.29836032800377094,"score_spread":0.21060795122420695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2410634188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9919547,0.0004860106,0.0000728619,0.0055188295,0.00003612642,0.0017229392,0.00007942287,0.000022767761,0.000106372114],"genre_scores_gemma":[0.9964767,0.000035325105,0.0015780086,0.0015624405,0.00002749603,0.00014628445,0.00003477106,0.000025872687,0.00011308105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827695,0.00025114947,0.00036159062,0.0003009333,0.00051341037,0.00029598837],"domain_scores_gemma":[0.99801654,0.0005837833,0.00020818533,0.00044264234,0.00020618712,0.00054265675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046427312,0.00016144909,0.00042016705,0.00011282024,0.00007739823,0.000009243122,0.00009557434,0.00004032724,0.000006515944],"category_scores_gemma":[0.00089528604,0.000095403644,0.000023524999,0.00036649586,0.0002742067,0.00007745269,0.000049821225,0.00025538108,0.000006791522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017141623,0.0001786514,0.9936125,0.00019112905,0.000029595842,0.00003810322,0.0022846411,0.0010800534,1.8325547e-7,0.00021175257,0.00048605833,0.00017313847],"study_design_scores_gemma":[0.005635263,0.00073605956,0.9910213,0.0010394624,0.000065635235,0.000011350609,0.0003925572,0.000614773,0.0000058641945,0.000063400235,0.0003049483,0.000109437766],"about_ca_topic_score_codex":0.0040711355,"about_ca_topic_score_gemma":0.00014416385,"teacher_disagreement_score":0.0045220507,"about_ca_system_score_codex":0.0001738431,"about_ca_system_score_gemma":0.000465346,"threshold_uncertainty_score":0.6154366},"labels":[],"label_agreement":null},{"id":"W2411488224","doi":"10.1016/j.jval.2015.09.1246","title":"The Willingness Of Cancer Outpatients To Complete Patient-Reported Outcome Measures Outside Of The Clinic","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Family medicine; Outpatient clinic; Willingness to accept; Cancer; Willingness to pay; Internal medicine","score_opus":0.26775024784476514,"score_gpt":0.3436538099805708,"score_spread":0.07590356213580568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411488224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9870369,0.0050320565,0.00012231414,0.002811872,0.0022023814,0.000642777,0.000212126,0.000007879631,0.0019317187],"genre_scores_gemma":[0.9983462,0.00035718418,0.00012850956,0.0008833202,0.00005253674,0.000033183274,0.000001313008,0.000019202795,0.00017855916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971519,0.00006632938,0.0020802526,0.00025640934,0.00009366189,0.00035142913],"domain_scores_gemma":[0.9974113,0.0001339119,0.0016579322,0.00052769115,0.00012110076,0.0001480765],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018025335,0.00013069263,0.00060494797,0.00009166291,0.00008631742,0.000014779638,0.00038609374,0.00006512362,0.0000133824],"category_scores_gemma":[0.00096124783,0.00009822743,0.00012177255,0.00029821193,0.0001056826,0.00008618132,0.000092967945,0.0001604166,0.000026370331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007206164,0.000055842018,0.98036796,0.00004367639,0.000024831124,1.979557e-7,0.0017483559,0.0066040587,0.0000010753508,0.005305468,0.0006352218,0.005141224],"study_design_scores_gemma":[0.0012900434,0.0003958626,0.8883445,0.00019483943,0.0000065831864,6.766185e-7,0.00035470005,0.0011891205,0.0000597391,0.015781382,0.09213376,0.00024878592],"about_ca_topic_score_codex":0.035765152,"about_ca_topic_score_gemma":0.0016028313,"teacher_disagreement_score":0.092023484,"about_ca_system_score_codex":0.00034513784,"about_ca_system_score_gemma":0.00031474538,"threshold_uncertainty_score":0.9706558},"labels":[],"label_agreement":null},{"id":"W2411806854","doi":"10.1016/j.jval.2015.09.913","title":"The Quality Of Life In Patients 12 Months After An Acute Coronary Syndrom: Results From The Pgrx-3 Real World Dataset","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Acute coronary syndrome; Quality of life (healthcare); Disease; Coronary heart disease; Pediatrics; Internal medicine; Physical therapy; Myocardial infarction","score_opus":0.1108307801108801,"score_gpt":0.4003534970946386,"score_spread":0.2895227169837585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2411806854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792072,0.00085786707,5.406227e-7,0.0063695693,0.0006253964,0.0017668387,0.010841354,0.00001679432,0.00031439445],"genre_scores_gemma":[0.9869495,0.0011673269,0.00014177768,0.0063520665,0.00016046765,0.000065860586,0.005094719,0.000021733633,0.00004657359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948867,0.0016943858,0.0016483164,0.00040606852,0.0007168416,0.0006476928],"domain_scores_gemma":[0.99657345,0.0009235454,0.00041444952,0.0010666888,0.000066586435,0.00095526257],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058120466,0.00017904925,0.00062756665,0.00009304925,0.000102646416,0.000009971324,0.00020916473,0.0000887184,0.000007385384],"category_scores_gemma":[0.0005416344,0.000112667265,0.00005690328,0.0003278476,0.00011124978,0.000114611306,0.000103853825,0.00051255093,0.000016991917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015166425,0.0005554963,0.9549002,0.00018232442,0.000017137827,0.000021184518,0.00300576,0.00002993864,4.2695697e-7,0.000047602687,0.02178231,0.0042911833],"study_design_scores_gemma":[0.0067683687,0.001051156,0.98184186,0.0003154602,0.000011802472,0.0000024457238,0.000533989,0.00018200863,9.755105e-7,0.0001133629,0.0090863565,0.00009223876],"about_ca_topic_score_codex":0.37287647,"about_ca_topic_score_gemma":0.045361053,"teacher_disagreement_score":0.3275154,"about_ca_system_score_codex":0.00074818864,"about_ca_system_score_gemma":0.0021883785,"threshold_uncertainty_score":0.9720586},"labels":[],"label_agreement":null},{"id":"W2412493407","doi":"10.1016/j.jval.2015.09.2195","title":"Real-World Medical Costs of Antiviral Therapy Among Patients With Chronic Hcv Infection and Advanced Hepatic Fibrosis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Internal medicine; Cirrhosis; Antiviral therapy; Gastroenterology; Medical costs; Hepatitis C virus; Chronic hepatitis; Immunology; Virus; Health care","score_opus":0.04009649260743206,"score_gpt":0.35758776032102774,"score_spread":0.3174912677135957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2412493407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741757,0.00030167613,0.000025686415,0.00039701725,0.00007337565,0.0009863504,0.000008019577,0.000028493885,0.0007618077],"genre_scores_gemma":[0.9958737,0.0035599875,0.00030818334,0.00008794341,0.00004792675,0.00003584002,0.000026555863,0.000025225805,0.0000346221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997792,0.00035442892,0.0004087891,0.00023698786,0.0008625659,0.00034520277],"domain_scores_gemma":[0.9989726,0.00014973337,0.00013516455,0.00022019843,0.00014578048,0.00037653596],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009042685,0.000119723074,0.00038853157,0.00028316185,0.00003603956,0.0000067657734,0.000051591618,0.00007379248,0.000025025989],"category_scores_gemma":[0.0003315414,0.00009308164,0.00002156077,0.0005328068,0.00016936052,0.00013031339,0.000033158318,0.00029605225,0.0000045356915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033480837,0.0001830506,0.9046149,0.00023955412,0.000012197261,0.000006061537,0.0002673574,0.000043428045,0.000012658252,0.000035672627,0.00007853211,0.094171725],"study_design_scores_gemma":[0.005538364,0.0035735646,0.9822583,0.0013683689,0.0000034359264,7.4399867e-7,0.000008395956,0.0064305174,0.00015752537,0.000025160252,0.0005535333,0.00008204727],"about_ca_topic_score_codex":0.07727139,"about_ca_topic_score_gemma":0.012131236,"teacher_disagreement_score":0.09408968,"about_ca_system_score_codex":0.00080815074,"about_ca_system_score_gemma":0.0012737812,"threshold_uncertainty_score":0.9288731},"labels":[],"label_agreement":null},{"id":"W2413468542","doi":"10.1016/j.jval.2015.09.1695","title":"Comparison of current and preferred status of hta implementation in central and eastern europen countries","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Pharmacoeconomics; Agency (philosophy); Mandate; Health technology; Medicine; Transferability; Scope (computer science); Political science; Business; Economic growth; Health care; Economics","score_opus":0.6673983397566747,"score_gpt":0.5327567379794599,"score_spread":0.13464160177721485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413468542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98148584,0.01487377,0.00024833533,0.002056489,0.00026714115,0.00070749363,0.0002296907,0.00000463737,0.00012662733],"genre_scores_gemma":[0.99808425,0.0012246695,0.00039064494,0.00021730147,0.00002920338,0.000013937035,0.000025618425,0.0000094105735,0.0000049752284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9956393,0.0004467684,0.003244223,0.00024589765,0.00007729997,0.0003464884],"domain_scores_gemma":[0.9977381,0.0002699472,0.0016210114,0.00014666156,0.00003480276,0.00018942778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007089153,0.000088564404,0.0007295713,0.00026202243,0.00002233939,0.000016638549,0.0000698141,0.000034921686,0.000012549175],"category_scores_gemma":[0.00048188315,0.00011351817,0.000013718517,0.000117990174,0.000053019146,0.00021427356,0.00004304545,0.00009145144,0.000007376881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024652109,0.00006263195,0.9665409,0.0009166478,0.000004490438,5.8371548e-8,0.014076236,0.00080321095,2.0967666e-7,0.016278952,0.00033943492,0.0009526048],"study_design_scores_gemma":[0.0021833056,0.00023230953,0.9534016,0.0002682361,0.0000016282576,5.029687e-7,0.005143033,0.02619272,0.000005572491,0.0035740018,0.008870573,0.00012652212],"about_ca_topic_score_codex":0.026282215,"about_ca_topic_score_gemma":0.0016866822,"teacher_disagreement_score":0.02538951,"about_ca_system_score_codex":0.0003867971,"about_ca_system_score_gemma":0.00038731183,"threshold_uncertainty_score":0.98020184},"labels":[],"label_agreement":null},{"id":"W2413529821","doi":"10.1016/j.jval.2015.09.284","title":"High-Cost Oncologic Medication Access: Why Is Latin America Falling Behind? Case Study In Non-Small Cell Lung Cancer (NSCLC)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"William Osler Health System","funders":"","keywords":"Reimbursement; Medicine; Government (linguistics); Market access; Latin Americans; Health care; Family medicine; Business; Political science; Geography","score_opus":0.12955812101954917,"score_gpt":0.34338259185180825,"score_spread":0.21382447083225908,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413529821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862586,0.004354319,0.0011076054,0.0040367274,0.0009151036,0.001473935,0.00012313397,0.000027442884,0.0017030834],"genre_scores_gemma":[0.99133617,0.0018762249,0.0006837021,0.005393461,0.0002560884,0.00028064213,0.0000107182705,0.00003659043,0.00012639049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997273,0.00008051239,0.0013594247,0.00062623114,0.000061612154,0.00059918885],"domain_scores_gemma":[0.99823517,0.000121920326,0.00091980933,0.0003753908,0.00005436746,0.00029335407],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017165309,0.00023102765,0.0007597296,0.00047404028,0.0000956015,0.00008936736,0.00038183696,0.00015547364,0.00012594498],"category_scores_gemma":[0.00015306087,0.0002712557,0.000055520813,0.00041472554,0.000045694276,0.0004355833,0.00010618816,0.00042019098,0.000071352166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044819888,0.000450516,0.9382606,0.00012364179,0.000016509377,0.00012556413,0.018233862,0.029509649,3.9054245e-7,0.00027182273,0.0045162956,0.008446315],"study_design_scores_gemma":[0.018316533,0.002357811,0.6522382,0.0007032496,0.000040877287,0.00004581871,0.016104912,0.24343419,0.00004125056,0.010329468,0.05397148,0.0024161898],"about_ca_topic_score_codex":0.41436058,"about_ca_topic_score_gemma":0.021011649,"teacher_disagreement_score":0.39334893,"about_ca_system_score_codex":0.0018278484,"about_ca_system_score_gemma":0.0006444964,"threshold_uncertainty_score":0.99997395},"labels":[],"label_agreement":null},{"id":"W2413612992","doi":"10.1016/j.jval.2015.09.2019","title":"Reversal of Neuromuscular Blockade: A Discrete Event Simulation Model of Clinical and Operating Room Efficiency Outcomes of Sugammadex Versus Neostigmine In Canada","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Anesthesia and Sedative Agents","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Sugammadex; Neostigmine; Neuromuscular Blockade; Medicine; Rocuronium; Anesthesia; Neuromuscular monitoring; Intubation","score_opus":0.15801954546230002,"score_gpt":0.3985121823993605,"score_spread":0.24049263693706047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2413612992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9981952,0.00015919551,0.00044711248,0.00075665745,0.000054537868,0.00036326554,0.000008251745,0.000001972979,0.000013864211],"genre_scores_gemma":[0.9990452,0.000025602534,0.000807642,0.00008276075,0.000009630376,0.0000016472327,0.0000060496964,0.0000077427685,0.000013731777],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99812186,0.00024346416,0.0009818133,0.00016712327,0.00033608358,0.00014964024],"domain_scores_gemma":[0.99901396,0.00035407642,0.0002621981,0.0001576577,0.000076604774,0.00013550278],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094852084,0.000085948646,0.0005985398,0.00007637691,0.000010225716,8.0111596e-7,0.00004933447,0.000042132524,0.0000017975005],"category_scores_gemma":[0.0010806913,0.0000706842,0.000037769078,0.00015513028,0.000044480734,0.000032222946,0.000026293406,0.0001370655,7.246006e-8],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019946718,0.000064182146,0.5765746,0.00014045816,0.000007433821,0.000006976444,0.00055887096,0.422214,0.000028934128,0.00002507903,0.0000030794486,0.00017688684],"study_design_scores_gemma":[0.0025990189,0.0004206902,0.35983306,0.000091713824,0.000016722299,7.255497e-7,0.00030316968,0.636649,0.000039677943,0.000008378217,0.0000032669582,0.000034581255],"about_ca_topic_score_codex":0.5171502,"about_ca_topic_score_gemma":0.034843624,"teacher_disagreement_score":0.48230663,"about_ca_system_score_codex":0.0001069842,"about_ca_system_score_gemma":0.0019437969,"threshold_uncertainty_score":0.98276794},"labels":[],"label_agreement":null},{"id":"W2415373915","doi":"10.1016/j.jval.2015.09.1666","title":"Systematic Review Of Economic Evaluations In Personalized Medicine","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Economic evaluation; Psychological intervention; MEDLINE; Population; Systematic review; Quality-adjusted life year; Cost effectiveness; Cost–benefit analysis; Personalized medicine; Health care; Family medicine; Intensive care medicine; Environmental health; Pathology; Bioinformatics; Psychiatry","score_opus":0.5788776139443731,"score_gpt":0.5101132487640837,"score_spread":0.06876436518028939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415373915","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030756105,0.7060665,0.0010661294,0.24203064,0.0017036282,0.008907168,0.00026670806,0.00006889867,0.0091342265],"genre_scores_gemma":[0.7120215,0.12793405,0.010904726,0.14104392,0.0013414974,0.0033397425,0.00039088418,0.0002995449,0.0027241337],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9865668,0.0021757951,0.01017574,0.00048228246,0.00017740604,0.00042201878],"domain_scores_gemma":[0.99333024,0.0016075842,0.0040644235,0.0006457456,0.00007668405,0.0002753172],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.08430421,0.00018856383,0.0027888394,0.00074098655,0.000040692266,0.000009437989,0.00031907522,0.00009401949,0.0003407804],"category_scores_gemma":[0.016077828,0.00021555721,0.0001005954,0.00040539936,0.000096245945,0.00025290868,0.000033343622,0.00018623544,0.0007986097],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000133910835,0.00013352132,0.011931867,0.60405266,0.00004599368,0.0000012182082,0.008510515,0.0035438447,1.879538e-7,0.35405925,0.017692894,0.000014692645],"study_design_scores_gemma":[0.008634598,0.00075945363,0.006738797,0.7267474,0.00004976918,0.000036167927,0.0084252795,0.12059814,0.0000010592801,0.12081161,0.0061865547,0.0010112022],"about_ca_topic_score_codex":0.018514365,"about_ca_topic_score_gemma":0.0004364155,"teacher_disagreement_score":0.6812654,"about_ca_system_score_codex":0.0028683655,"about_ca_system_score_gemma":0.0012158998,"threshold_uncertainty_score":0.9999794},"labels":[],"label_agreement":null},{"id":"W2415625112","doi":"10.1016/j.jval.2015.09.2325","title":"Economic Analysis of Ustekinumab for Psoriatic Arthritis in Russia","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Ustekinumab; Psoriatic arthritis; Christian ministry; Adalimumab; Euros; Internal medicine; Arthritis; Humanities","score_opus":0.0691526633123643,"score_gpt":0.3625592694153222,"score_spread":0.2934066061029579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415625112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99302447,0.0038137035,0.000120345845,0.0015093762,0.00008531852,0.0006963091,0.000015942012,0.000010023736,0.00072453375],"genre_scores_gemma":[0.9983313,0.00075960974,0.0005609343,0.000119921984,0.000027629294,0.000051791616,0.000032453805,0.000011778179,0.000104565865],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99856097,0.00011393533,0.0007348793,0.00016729154,0.00014263141,0.00028031532],"domain_scores_gemma":[0.9993651,0.000102729464,0.00014260088,0.00024453754,0.000033149154,0.00011191705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001497088,0.00007272575,0.00066176034,0.00074238906,0.000015299533,0.000004616083,0.00007123395,0.00005931391,0.000059314974],"category_scores_gemma":[0.00020059395,0.00007127652,0.00009449659,0.00049854064,0.00003284011,0.000056192577,0.00001840912,0.00012092663,0.000013861538],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013832195,0.00081721676,0.6803398,0.0020131094,0.0006903104,0.00003611029,0.010187729,0.1454885,0.000046149657,0.011184828,0.0037110397,0.14410196],"study_design_scores_gemma":[0.014475476,0.00165793,0.39053294,0.0007246815,0.00010854376,0.0000069502307,0.0025683874,0.57473576,0.000098026256,0.0025560185,0.012292989,0.00024228396],"about_ca_topic_score_codex":0.009046444,"about_ca_topic_score_gemma":0.0011102577,"teacher_disagreement_score":0.42924726,"about_ca_system_score_codex":0.0003930787,"about_ca_system_score_gemma":0.0012993647,"threshold_uncertainty_score":0.9975524},"labels":[],"label_agreement":null},{"id":"W2415727855","doi":"10.1016/j.jval.2015.09.1734","title":"The Clinical and Economic Burden of Medication Errors In The Canadian Acute Care Setting: A Review of Published Studies","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Patient Safety and Medication Errors","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Becton Dickinson (Canada)","funders":"","keywords":"Medicine; Harm; MEDLINE; Health care; Acute care; Adverse effect; Dosing; Emergency medicine; Patient safety; Chart; Intensive care medicine; Medical emergency; Internal medicine; Statistics","score_opus":0.33014109865665187,"score_gpt":0.5633862972637363,"score_spread":0.23324519860708448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2415727855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040812178,0.95510453,3.1855163e-7,0.039546855,0.0009456065,0.0037536635,0.00013578698,0.0000054427737,0.00046698935],"genre_scores_gemma":[0.0002456101,0.9975522,0.000049139202,0.0012739088,0.0001584943,0.0004765522,0.00019396361,0.000016479007,0.000033626133],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9878168,0.007463913,0.0036222965,0.00032517148,0.00034329767,0.00042848673],"domain_scores_gemma":[0.99242955,0.0033174094,0.003058841,0.00070189114,0.00022413048,0.00026815198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023704352,0.00019466822,0.0017753519,0.0002497075,0.00030820636,0.0000013075589,0.0005793228,0.0003332827,0.000009965563],"category_scores_gemma":[0.0040923906,0.00010700872,0.00012824795,0.00035688968,0.00033931495,0.00005944466,0.00009188233,0.0013023702,0.000011156521],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010279843,0.000025410764,0.0024244993,0.4339174,0.00016660546,0.0000020827238,0.03759894,0.000010111198,3.053241e-10,0.0024006427,0.046542846,0.47690117],"study_design_scores_gemma":[0.00022588787,0.00005456636,0.00039387224,0.13769811,0.00010851061,0.0000015678971,0.0077369437,0.0000126092955,4.5629872e-10,0.000113382725,0.85358936,0.0000651778],"about_ca_topic_score_codex":0.12819418,"about_ca_topic_score_gemma":0.1568423,"teacher_disagreement_score":0.80704653,"about_ca_system_score_codex":0.0010996216,"about_ca_system_score_gemma":0.023087185,"threshold_uncertainty_score":0.982451},"labels":[],"label_agreement":null},{"id":"W2416090704","doi":"10.1016/j.jval.2015.09.1283","title":"Quantifying Costs of Medical Personnel Involved with Radiation therapy Using Administrative Databases","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Ontario Institute for Cancer Research; Sunnybrook Hospital","funders":"","keywords":"Medicine; Cohort; Radiation oncologist; Radiation therapy; Total cost; Medical radiation; Radiation treatment planning; Diagnosis code; Cancer registry; Family medicine; Database; Emergency medicine; Cancer; Medical physics; Surgery; Population; Internal medicine; Environmental health","score_opus":0.43715603631681077,"score_gpt":0.39283065841495146,"score_spread":0.04432537790185931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2416090704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98542476,0.009505407,0.0027978737,0.0009799903,0.0002471458,0.00025817615,0.00011477717,0.000011426592,0.00066045165],"genre_scores_gemma":[0.99565536,0.0021724186,0.0015778962,0.00043866492,0.00010879493,0.000006785875,0.000016899685,0.00001676058,0.000006404922],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987251,0.00004688012,0.00064311596,0.00025033913,0.000081388636,0.00025313688],"domain_scores_gemma":[0.99895203,0.000090455,0.0005381648,0.00018277351,0.000031761647,0.00020480152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016879217,0.00011024152,0.00043037647,0.00017828743,0.000046700636,0.000018526078,0.00014413137,0.000069035224,0.000044830726],"category_scores_gemma":[0.00029439028,0.00011257266,0.000031404044,0.00020531773,0.00007749757,0.00031128162,0.000018411656,0.00014668469,0.000010606543],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003050543,0.00023684512,0.6929811,0.00010652107,0.000039476392,0.000008465976,0.008060457,0.003694735,0.0000032963549,0.2879611,0.00026765026,0.006335283],"study_design_scores_gemma":[0.02756173,0.0056725503,0.25805703,0.0030758446,0.0000142024555,0.00005943054,0.025538815,0.62114656,0.0007376448,0.013622492,0.042072635,0.0024411064],"about_ca_topic_score_codex":0.04008059,"about_ca_topic_score_gemma":0.0011168544,"teacher_disagreement_score":0.6174518,"about_ca_system_score_codex":0.0004444333,"about_ca_system_score_gemma":0.0008806888,"threshold_uncertainty_score":0.9663116},"labels":[],"label_agreement":null},{"id":"W2417736320","doi":"10.1016/j.jval.2015.09.2120","title":"Impact of Adherence to Oral Antidiabetics on All-Cause Mortality: A Population Based Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Dyslipidemia; Nested case-control study; Confounding; Internal medicine; Cohort study; Proportional hazards model; Cohort; Population; Mortality rate; Risk of mortality; Logistic regression; Emergency medicine; Disease; Environmental health","score_opus":0.39578362843203835,"score_gpt":0.4934334644400016,"score_spread":0.09764983600796323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417736320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99787116,0.000030745567,0.00012581989,0.00065759325,0.00009431159,0.0010557013,0.0000069826,0.00002275082,0.00013495257],"genre_scores_gemma":[0.9982785,0.0000061899373,0.0006724231,0.0008928866,0.000030117113,0.00003064554,0.000020390398,0.000009365761,0.000059475642],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984836,0.0002012151,0.00044674764,0.00020595554,0.00045404228,0.00020843974],"domain_scores_gemma":[0.99892163,0.00005085132,0.00015614225,0.00040255126,0.0000990868,0.00036971862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008868311,0.000097054755,0.0003136034,0.00014430902,0.0000137393945,0.000004767457,0.000082776816,0.000035190405,0.00006820984],"category_scores_gemma":[0.00037327278,0.00008019583,0.00003514694,0.0004000198,0.000010003175,0.000031310687,0.000012382986,0.00012652836,0.00010052332],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010392851,0.00084891095,0.99372274,0.00006827313,0.00003024241,0.0000050424633,0.0004650161,0.0027765657,0.000022542064,0.000056736975,0.0007590795,0.0011409402],"study_design_scores_gemma":[0.0014790753,0.0068496494,0.9841521,0.00033331366,0.00002021001,7.476558e-7,0.00020939889,0.006744962,0.000018140629,0.00009102874,0.000036719317,0.000064686916],"about_ca_topic_score_codex":0.012938235,"about_ca_topic_score_gemma":0.00008473489,"teacher_disagreement_score":0.0128534995,"about_ca_system_score_codex":0.0002607475,"about_ca_system_score_gemma":0.00078856596,"threshold_uncertainty_score":0.9936347},"labels":[],"label_agreement":null},{"id":"W2417759952","doi":"10.1016/j.jval.2015.09.2018","title":"Hospitalizations In Hyperchylomicronemia Patients In Quebec, Canada; Results From A Real-World Observational Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Erythrocyte Function and Pathophysiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université du Québec à Chicoutimi; Université de Montréal","funders":"","keywords":"Medicine; Abdominal pain; Acute pancreatitis; Observational study; Pancreatitis; Pediatrics; Emergency medicine; Internal medicine","score_opus":0.11462740945632892,"score_gpt":0.32779044191952234,"score_spread":0.2131630324631934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417759952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99463224,0.00005194544,0.0000019154243,0.003435044,0.00047279094,0.00082661054,0.000087788176,0.000015741203,0.00047594434],"genre_scores_gemma":[0.99625677,0.00005184271,0.00023723517,0.0018082571,0.000088633635,0.00003551392,0.00082136336,0.000014589704,0.00068579376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980406,0.0003549879,0.0007529725,0.00032482063,0.00026410085,0.00026250072],"domain_scores_gemma":[0.99914354,0.00020884458,0.00012820093,0.00024294855,0.000100476565,0.00017600543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004363416,0.00011599073,0.0003445223,0.0002596902,0.000026915315,0.000005019741,0.00006505868,0.000058615595,0.000016372898],"category_scores_gemma":[0.0005155632,0.000115773095,0.00001530578,0.0006665778,0.00001903015,0.000061422346,0.000028962499,0.00025187788,0.0000081211765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004164627,0.00068925996,0.9843068,0.000018065362,0.000004289971,0.000024554853,0.0032270018,0.0036863175,0.000008366432,0.000072335264,0.0073607387,0.00018578966],"study_design_scores_gemma":[0.006711243,0.00026799593,0.9882874,0.0001367765,0.0000026336356,2.3582686e-7,0.0010776164,0.00140353,0.0000022715465,0.00011161904,0.0019100959,0.00008861308],"about_ca_topic_score_codex":0.9977653,"about_ca_topic_score_gemma":0.99840283,"teacher_disagreement_score":0.0062947804,"about_ca_system_score_codex":0.002246811,"about_ca_system_score_gemma":0.004004118,"threshold_uncertainty_score":0.7103133},"labels":[],"label_agreement":null},{"id":"W2417885747","doi":"10.1016/j.jval.2015.09.788","title":"Association Between Adherence to Evidence-Based Heart Failure Drug Treatment and One-Year All-Cause Hospitalization and All-Cause Mortality","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Novartis (Canada); Université Laval","funders":"","keywords":"Medicine; Internal medicine; Heart failure; Odds ratio; Cohort; Incidence (geometry); Isosorbide dinitrate; Logistic regression; Cohort study","score_opus":0.3104457396374599,"score_gpt":0.4142869778682186,"score_spread":0.10384123823075869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417885747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9506792,0.00086296047,0.00026414136,0.04681896,0.000075811215,0.0011920958,0.000014653339,0.000052535834,0.000039668525],"genre_scores_gemma":[0.9929304,0.000966954,0.0027301288,0.0026286105,0.00013062629,0.00011310437,0.000055935656,0.000015449814,0.00042878257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981335,0.00028176713,0.00044380457,0.0003904253,0.00045307388,0.00029741979],"domain_scores_gemma":[0.998539,0.00020777139,0.00020380087,0.00030497296,0.00013849605,0.0006059743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011726319,0.00015337787,0.00036431226,0.000104101215,0.000047807283,0.000034873607,0.00005939532,0.000090460366,0.00003744148],"category_scores_gemma":[0.0006255162,0.00014257838,0.000023435345,0.00026382942,0.000030348057,0.00017310797,0.000022704633,0.00012937431,0.00008991823],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038856455,0.00012469836,0.98999256,0.00015942169,0.0001545545,0.0000018888187,0.001086675,0.00006783283,0.000041124695,0.00016414594,0.0074667376,0.0007015205],"study_design_scores_gemma":[0.0035958292,0.0030012575,0.9779702,0.0022618673,0.00045201223,0.0000033428287,0.00079806324,0.001975979,0.00040121237,0.00067139615,0.008552685,0.0003161929],"about_ca_topic_score_codex":0.0046889936,"about_ca_topic_score_gemma":0.000256967,"teacher_disagreement_score":0.04419035,"about_ca_system_score_codex":0.0007155042,"about_ca_system_score_gemma":0.00074207335,"threshold_uncertainty_score":0.7088387},"labels":[],"label_agreement":null},{"id":"W2418647911","doi":"10.1016/j.jval.2015.09.594","title":"Real-World Treatment Patterns of Ranibizumab Among Patients With Retinal Diseases In Canada: 5 Years Of Data","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Ranibizumab; Medicine; Cohort; Demography; Ophthalmology; Pediatrics; Surgery; Internal medicine; Bevacizumab; Chemotherapy","score_opus":0.06158111600708995,"score_gpt":0.3067277650903798,"score_spread":0.24514664908328984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2418647911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99851835,0.000052775173,0.00000271351,0.000288229,0.000033875007,0.0004008501,0.00055391085,0.0000033271128,0.00014597416],"genre_scores_gemma":[0.9992112,0.00007579357,0.00021556314,0.000026959766,0.00001573243,0.000007944613,0.0003803087,0.000007901517,0.00005859043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989525,0.00007546991,0.0003648266,0.00016485347,0.00028353615,0.00015877845],"domain_scores_gemma":[0.9991965,0.00007792894,0.00014601904,0.00035578743,0.000049082937,0.00017464093],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012747105,0.000069777176,0.00030391596,0.00011058643,0.0000075400517,0.000001169584,0.00007892394,0.000011655109,0.000019618681],"category_scores_gemma":[0.00004728514,0.000055017583,0.000012935805,0.00019036829,0.000028890832,0.0000426482,0.000027448647,0.000059310507,4.0647785e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002652724,0.00028795825,0.99640226,0.00013747487,0.000010494522,0.00003819582,0.00024347978,0.00013387202,1.7225608e-7,0.000038161128,0.00013003533,0.002312595],"study_design_scores_gemma":[0.0027593435,0.000703707,0.9949554,0.00067690737,0.000022489452,0.0000011121349,0.0002475701,0.00048178254,0.000004125272,0.000017933524,0.000086699634,0.000042913187],"about_ca_topic_score_codex":0.9894855,"about_ca_topic_score_gemma":0.93622154,"teacher_disagreement_score":0.053263936,"about_ca_system_score_codex":0.0007664822,"about_ca_system_score_gemma":0.0031055533,"threshold_uncertainty_score":0.55091184},"labels":[],"label_agreement":null},{"id":"W2419548009","doi":"10.1016/j.jval.2015.09.1785","title":"A Pitcure of Private Health Insurance Policyholders in Italy","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Management, Economics, and Public Policy","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Euros; Quarter (Canadian coin); Payment; Business; Health insurance; Private insurance; Geography; Private sector; Distribution (mathematics); Health care; Demographic economics; Actuarial science; Economic growth; Economics; Finance; Humanities","score_opus":0.08751209091308484,"score_gpt":0.2911826184889262,"score_spread":0.20367052757584134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2419548009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93936056,0.0006265858,0.00005871407,0.041158468,0.0004927522,0.0007576079,0.000011441522,0.00006699994,0.017466845],"genre_scores_gemma":[0.9858829,0.00022428935,0.0002398008,0.0129783675,0.00046337442,0.000020015497,0.000015227697,0.000026545546,0.00014952653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792683,0.000060634768,0.000907362,0.00030964508,0.00017217663,0.00062335253],"domain_scores_gemma":[0.9988344,0.000030622075,0.0006913042,0.0003416447,0.000038673366,0.000063383464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024338553,0.00016376571,0.00047660747,0.00094632444,0.00004440254,0.00007167553,0.00033671912,0.00005426321,0.000016470589],"category_scores_gemma":[0.00021774786,0.00018337132,0.00004936545,0.0008733161,0.0000342405,0.00073482096,0.0001448137,0.0001793868,0.000056326917],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057865163,0.00030937,0.7190967,0.0025294945,0.000015172901,0.0000042771953,0.0017813109,0.008672975,0.0000011168173,0.23369846,0.019949308,0.013883928],"study_design_scores_gemma":[0.004189863,0.00010728894,0.59112984,0.0006153414,0.0000026167202,0.0000019391136,0.00091165025,0.020951774,0.0000016371554,0.057628132,0.32393995,0.0005199659],"about_ca_topic_score_codex":0.24698599,"about_ca_topic_score_gemma":0.004460165,"teacher_disagreement_score":0.30399063,"about_ca_system_score_codex":0.00047075332,"about_ca_system_score_gemma":0.00030515346,"threshold_uncertainty_score":0.7580284},"labels":[],"label_agreement":null},{"id":"W2421102659","doi":"10.1016/j.jval.2015.09.2180","title":"Quality of Care For Patients With Diabetes Mellitus (Dm) In Canada: Findings From A National Population-Based Survey","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Diabetes mellitus; Health care; Population; Logistic regression; Family medicine; Odds; Demography; Receipt; Demographics; Cohort; Gerontology; Environmental health; Internal medicine","score_opus":0.33393288900011225,"score_gpt":0.47797611365129417,"score_spread":0.1440432246511819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2421102659","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966226,0.000102410144,0.000078112374,0.0011838403,0.00011475983,0.00090337236,0.0009855352,0.0000043483615,0.0000049704677],"genre_scores_gemma":[0.9916549,0.0000019982865,0.003281673,0.0009415273,0.000024820381,0.000026611742,0.0040569985,0.000010737641,7.4820156e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750274,0.00041622826,0.0011143379,0.00018765962,0.0006050363,0.00017401951],"domain_scores_gemma":[0.9942738,0.004453205,0.000371045,0.000117251824,0.0006646252,0.00012008962],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.002514105,0.00007634116,0.00034321417,0.0000905213,0.000017767803,0.0000030528424,0.000042635846,0.00003458458,0.000008395544],"category_scores_gemma":[0.011533323,0.00006974802,0.000018808774,0.00022338424,0.000009805916,0.000062163286,0.000007931954,0.000100721656,3.4754893e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005823057,0.000114046336,0.9934556,0.000190208,0.0000068002114,1.3957091e-7,0.00016974659,0.0046232473,5.1680644e-7,0.000023999308,0.00015682877,0.0006765929],"study_design_scores_gemma":[0.0053442237,0.0003219276,0.9878451,0.00014426853,0.000004693183,1.0407544e-8,0.00028326648,0.0056908485,0.000007038602,0.00024282551,0.000054904704,0.00006087317],"about_ca_topic_score_codex":0.9916174,"about_ca_topic_score_gemma":0.9787993,"teacher_disagreement_score":0.012818056,"about_ca_system_score_codex":0.0021914353,"about_ca_system_score_gemma":0.0073884986,"threshold_uncertainty_score":0.9982387},"labels":[],"label_agreement":null},{"id":"W2424761896","doi":"10.1016/j.jval.2015.09.923","title":"Real-World Identification Of European Patients With Statin-Associated Symptoms: Clinical Practice Compared With Clinical Guidelines","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Clinical Practice; Internal medicine; Clinical trial; Physical therapy; Family medicine","score_opus":0.14872329184930203,"score_gpt":0.4334190002766845,"score_spread":0.28469570842738245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2424761896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930908,0.00029201855,0.0004751653,0.0023773974,0.00033063252,0.001680296,0.000032180833,0.000079710284,0.0016418154],"genre_scores_gemma":[0.9860352,0.0005004439,0.01131576,0.0013724287,0.00035967448,0.000017415996,0.00020562978,0.00006359253,0.00012985269],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99141395,0.003359831,0.0030852878,0.0005172818,0.0012395735,0.00038409536],"domain_scores_gemma":[0.9944042,0.00048432988,0.001668638,0.00083642517,0.0020557824,0.0005506414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019270193,0.0001952172,0.0010194655,0.00016493819,0.000058445094,0.00001739046,0.00014459084,0.000078841,0.0000034984812],"category_scores_gemma":[0.004572332,0.00013978922,0.0001300216,0.0007066668,0.00014783349,0.0001533265,0.000042797237,0.0004945903,0.000018919367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018641046,0.0019735196,0.9756337,0.0002598454,0.00029284117,0.000033051503,0.00043871324,0.00073828327,4.1100432e-7,0.00016818929,0.0024982998,0.01609908],"study_design_scores_gemma":[0.010572876,0.0032070337,0.9762445,0.0009357293,0.00015215563,0.000008977331,0.00039528048,0.0016419064,0.000002393727,0.000019594128,0.006663817,0.00015574064],"about_ca_topic_score_codex":0.011034552,"about_ca_topic_score_gemma":0.0005001638,"teacher_disagreement_score":0.015943341,"about_ca_system_score_codex":0.0003152337,"about_ca_system_score_gemma":0.0019635835,"threshold_uncertainty_score":0.99555105},"labels":[],"label_agreement":null},{"id":"W2427236216","doi":"10.1016/j.jval.2015.09.1754","title":"A Comparison of on-Patent Medicine Prices Using An Eks Method","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Intellectual Property and Patents","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Order (exchange); Agricultural economics; Economics; Business; Econometrics; Geography; Finance","score_opus":0.7406702591304246,"score_gpt":0.42841221753622977,"score_spread":0.31225804159419485,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2427236216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833537,0.0004494305,0.005699181,0.0015138697,0.00084209425,0.0004668314,0.0000011761011,0.000052784042,0.007620941],"genre_scores_gemma":[0.9951254,0.00000698047,0.0025757356,0.0017910571,0.00044736447,0.0000029063006,0.000009647663,0.00001556684,0.000025301859],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99861455,0.00009781701,0.000518196,0.00019988873,0.00032084223,0.00024870434],"domain_scores_gemma":[0.9992793,0.00007809102,0.00031561442,0.00017047806,0.00012388003,0.000032593547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020355152,0.000117307834,0.00035865058,0.0003005437,0.000069705755,0.000021079193,0.00017303259,0.000048789872,0.000068123976],"category_scores_gemma":[0.0002753493,0.000085450294,0.000023292063,0.00043178475,0.000034127108,0.00026475903,0.000050795064,0.00015793674,0.000039919014],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022910647,0.004743387,0.21075134,0.006116569,0.00011088192,0.00003324754,0.03575307,0.5662245,0.0013557277,0.06421727,0.01538798,0.093014926],"study_design_scores_gemma":[0.00094875623,0.00042022043,0.0014058532,0.0006814906,0.000013441751,0.0000015427579,0.0024515304,0.98304456,0.00017228312,0.0027593733,0.007941316,0.00015963444],"about_ca_topic_score_codex":0.061769966,"about_ca_topic_score_gemma":0.00014036863,"teacher_disagreement_score":0.41682002,"about_ca_system_score_codex":0.00007598287,"about_ca_system_score_gemma":0.00007309786,"threshold_uncertainty_score":0.9444778},"labels":[],"label_agreement":null},{"id":"W2428310826","doi":"10.1016/j.jval.2015.09.1178","title":"Cost-Effectiveness Of Directly Mailed Fobt Kits To Previous Responders Being Recalled For Screening","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Psychological intervention; Family medicine; Cost–benefit analysis; Fecal occult blood; Cost effectiveness; Recall; Colorectal cancer; Internal medicine; Nursing; Cancer; Colonoscopy; Psychology","score_opus":0.16424523434306845,"score_gpt":0.3948749453357835,"score_spread":0.23062971099271504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2428310826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9472806,0.00079307175,0.045564514,0.00091662415,0.0003970575,0.0042883903,0.000008548927,0.000106449814,0.00064477796],"genre_scores_gemma":[0.9892132,0.000025496865,0.009910831,0.00023647954,0.0001059349,0.00037840733,0.000010286013,0.00003095568,0.000088403765],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99811256,0.0005022574,0.00043046434,0.00032540015,0.0002833788,0.00034595543],"domain_scores_gemma":[0.99818003,0.0009404228,0.00013422381,0.00022195379,0.0001930071,0.00033038086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003681769,0.00013129353,0.0005151587,0.00032553799,0.000055059,0.0000080114805,0.00006864234,0.00008611233,0.000002596371],"category_scores_gemma":[0.0021394545,0.00012804633,0.00008243171,0.00059313374,0.000020328745,0.000051687675,0.000031629697,0.00016759401,0.0000021968108],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30677164,0.00066933,0.056664575,0.008190223,0.00025736375,0.000052334028,0.014993786,0.09099752,0.007425225,0.0011123857,0.0012993139,0.51156634],"study_design_scores_gemma":[0.089733995,0.1383145,0.3571737,0.042552043,0.0003914349,0.00029045183,0.004912855,0.20778482,0.10695048,0.008822885,0.04067609,0.002396733],"about_ca_topic_score_codex":0.003703576,"about_ca_topic_score_gemma":0.00015796229,"teacher_disagreement_score":0.5091696,"about_ca_system_score_codex":0.00055171107,"about_ca_system_score_gemma":0.00048374367,"threshold_uncertainty_score":0.5598724},"labels":[],"label_agreement":null},{"id":"W2430187105","doi":"10.1016/j.jval.2015.09.2768","title":"The Need to Revise Discount Rates in Belgium, The Netherlands, Poland and the Uk","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Discounting; Context (archaeology); Differential (mechanical device); Psychological intervention; Economics; Cost–benefit analysis; Public economics; Actuarial science; Work (physics); Medicine; Finance; Political science; Engineering; Geography","score_opus":0.3726395742421835,"score_gpt":0.4296086876783587,"score_spread":0.05696911343617517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2430187105","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40812033,0.028594151,0.0001375119,0.5594824,0.000597923,0.0019752642,0.00005310349,0.000012679306,0.0010266196],"genre_scores_gemma":[0.96915483,0.0022780348,0.00018949345,0.027356593,0.00038506193,0.00022094918,0.000005806496,0.000024368761,0.0003848384],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9948309,0.001539992,0.0026819785,0.00034715128,0.00010488259,0.0004950962],"domain_scores_gemma":[0.9948839,0.0034249295,0.00087141857,0.0005848388,0.000030598367,0.0002043401],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.058461223,0.00014952471,0.0006493055,0.00014619638,0.0003211552,0.00016665042,0.00037819298,0.000064547734,0.000013573543],"category_scores_gemma":[0.0044372086,0.000091009955,0.00004355757,0.0003528475,0.00014804992,0.00012094853,0.00008338308,0.00027888038,0.00019275497],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023292503,0.000054015698,0.5055215,0.00024301642,0.00002786949,9.796416e-7,0.035009235,0.005728251,1.3298434e-7,0.38141802,0.07116906,0.00059503457],"study_design_scores_gemma":[0.0077232127,0.00031395906,0.31863248,0.0005730063,0.000005834105,0.000018085655,0.021284703,0.059598844,7.1674145e-7,0.17133947,0.41991287,0.00059681595],"about_ca_topic_score_codex":0.04995672,"about_ca_topic_score_gemma":0.0062749265,"teacher_disagreement_score":0.5610345,"about_ca_system_score_codex":0.00050715567,"about_ca_system_score_gemma":0.0003548613,"threshold_uncertainty_score":0.9695123},"labels":[],"label_agreement":null},{"id":"W2433516676","doi":"10.1016/j.jval.2015.09.1407","title":"Examining Health System And Resource Utilization And Medical Management Of Patients Idiopathic Pulmonary Fibrosis In Ontario: A Preliminary Analysis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Boehringer Ingelheim (Canada); St. Michael's Hospital; Sunnybrook Hospital","funders":"","keywords":"Medicine; Idiopathic pulmonary fibrosis; Cohort; Medical record; Health care; Retrospective cohort study; Emergency medicine; Internal medicine; Lung","score_opus":0.05449425924446007,"score_gpt":0.2874797715381301,"score_spread":0.23298551229367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2433516676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99032474,0.007747049,0.00011914168,0.00057158194,0.00006867657,0.0007416851,0.000019569972,0.00002460844,0.00038297224],"genre_scores_gemma":[0.998703,0.00055500463,0.000339982,0.00019896826,0.000021370362,0.000029073437,0.00009944813,0.000016379458,0.000036784048],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973024,0.0004219937,0.0009092999,0.00041872187,0.00061774626,0.00032984812],"domain_scores_gemma":[0.9988742,0.000050132465,0.00026305183,0.00023530115,0.000052903648,0.00052442827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018804962,0.00016348006,0.00068377494,0.0004953462,0.000052992415,0.0000090565845,0.00007204627,0.0001096883,0.0000053879785],"category_scores_gemma":[0.000051870404,0.00015700722,0.000049569,0.00061002217,0.000068801884,0.00007860776,0.00012519551,0.00023771088,5.421419e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036797267,0.00056497264,0.97206897,0.007981748,0.00009707654,0.00017720953,0.0032325163,0.00042924634,8.4537487e-7,0.0004583648,0.00004300021,0.011266336],"study_design_scores_gemma":[0.0015195897,0.004505417,0.9370212,0.009051837,0.00012599469,0.000029032268,0.0032452217,0.044171434,8.077854e-7,0.000023243203,0.00018680854,0.0001194156],"about_ca_topic_score_codex":0.07977758,"about_ca_topic_score_gemma":0.0019134155,"teacher_disagreement_score":0.07786417,"about_ca_system_score_codex":0.0008761608,"about_ca_system_score_gemma":0.00057366467,"threshold_uncertainty_score":0.92635024},"labels":[],"label_agreement":null},{"id":"W2435474959","doi":"10.1016/j.jval.2015.09.1447","title":"Cost And Resource Utilization Of Uncontrolled And Persistent Asthma In Canada: A Systematic Literature Review","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Asthma; Emergency department; MEDLINE; Emergency medicine; Intensive care medicine; Internal medicine","score_opus":0.6047163424795157,"score_gpt":0.49706156253122596,"score_spread":0.1076547799482897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2435474959","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24714504,0.69940406,0.000017190387,0.04374041,0.00032708157,0.008916472,0.00005910668,0.000021814787,0.0003688357],"genre_scores_gemma":[0.90994096,0.07218424,0.00025647602,0.017007284,0.000063866275,0.00037027313,0.00002971193,0.00003069577,0.00011648078],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9856654,0.011300976,0.0018065117,0.0003104569,0.00044431197,0.0004723897],"domain_scores_gemma":[0.99587864,0.0021284437,0.0009579586,0.00033325804,0.00026532167,0.000436376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0130228,0.00015888791,0.0010320452,0.00018171978,0.00012488701,0.000007983333,0.00010189205,0.00012815004,0.0000052641126],"category_scores_gemma":[0.0062834825,0.0001334288,0.000024788578,0.0006085559,0.00003090304,0.00014094119,0.00006955548,0.00068352243,0.0000018611966],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019370386,0.00006982471,0.12855448,0.84053713,0.000020469686,0.000030068497,0.024971094,0.00013294072,5.9567355e-7,0.0013900871,0.0025813386,0.0015182481],"study_design_scores_gemma":[0.006178468,0.0005219849,0.049573552,0.86347145,0.000051189953,0.00006265206,0.051130835,0.015418769,4.0843332e-7,0.00021207756,0.012983055,0.00039556428],"about_ca_topic_score_codex":0.7874589,"about_ca_topic_score_gemma":0.75582284,"teacher_disagreement_score":0.6627959,"about_ca_system_score_codex":0.0019591714,"about_ca_system_score_gemma":0.0070393872,"threshold_uncertainty_score":0.99858975},"labels":[],"label_agreement":null},{"id":"W2436634292","doi":"10.1016/j.jval.2015.09.1707","title":"Association Between Depression And Discontinuation With Antidiabetic Drugs","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Discontinuation; Depression (economics); Medicine; Hazard ratio; Proportional hazards model; Cohort; Internal medicine; Confidence interval; Cohort study; Psychiatry","score_opus":0.06558384507194429,"score_gpt":0.332178813416621,"score_spread":0.26659496834467666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2436634292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98970914,0.0005141741,0.00042249623,0.007992926,0.00003917704,0.0003076509,0.0000013341615,0.000022215883,0.0009908938],"genre_scores_gemma":[0.9975217,0.00009593024,0.0009073858,0.00041430426,0.000076793876,0.000015021719,0.00001839635,0.0000056408567,0.00094484346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99916834,0.0000952812,0.00018881634,0.0001370902,0.00027305292,0.00013741442],"domain_scores_gemma":[0.9994642,0.00007151389,0.00014359564,0.00010423505,0.000048841102,0.0001676057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007619108,0.000050837807,0.00015920287,0.000053110183,0.00002559523,0.0000074556065,0.000024212859,0.000038388593,0.0000104940855],"category_scores_gemma":[0.000145379,0.000038946935,0.0000063870384,0.00013483151,0.000013358394,0.000064220294,0.000008377696,0.00010742893,0.000038666818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016184487,0.000027369962,0.98712975,0.000051590938,0.0000053407994,6.0860333e-7,0.0005894854,0.000012970533,0.00000874485,0.00003009581,0.0011258931,0.01100198],"study_design_scores_gemma":[0.0017057098,0.00029261055,0.9922126,0.000723161,0.000015012888,0.000002421271,0.00036017265,0.0017873998,0.00014044251,0.00034470164,0.0023558277,0.00005991736],"about_ca_topic_score_codex":0.00060854247,"about_ca_topic_score_gemma":0.0000049832574,"teacher_disagreement_score":0.010942062,"about_ca_system_score_codex":0.00015369919,"about_ca_system_score_gemma":0.00023849109,"threshold_uncertainty_score":0.15882099},"labels":[],"label_agreement":null},{"id":"W2440529192","doi":"10.1016/j.jval.2015.09.2825","title":"Review of Adherence Measures for use in Phase Iv Studies and Recommendations for a new Standardized Generic Measure","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Standardization; Reliability (semiconductor); Medicine; Content validity; Quarter (Canadian coin); Consistency (knowledge bases); Measure (data warehouse); Pharmacy; Evidence-based practice; Clinical psychology; Family medicine; Psychology; Psychometrics; Alternative medicine; Computer science; Data mining; Artificial intelligence; Pathology","score_opus":0.5534317867476899,"score_gpt":0.49880683336420484,"score_spread":0.05462495338348505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2440529192","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020062549,0.84477824,0.057719436,0.06750326,0.00045225024,0.00922035,0.00014827937,0.00004452855,0.00007108726],"genre_scores_gemma":[0.07699161,0.5683831,0.32363623,0.026271239,0.00037008626,0.0028273908,0.00016213453,0.00006566807,0.0012925377],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987609,0.00013481308,0.0005755136,0.00018716403,0.00017934358,0.00016229216],"domain_scores_gemma":[0.99877286,0.00027167454,0.00022154242,0.00018334025,0.00036447647,0.00018609411],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020299237,0.000084891995,0.000514056,0.00008246307,0.000025180356,0.0000037285085,0.000051608265,0.000028586745,0.000009684548],"category_scores_gemma":[0.0033579175,0.00007054852,0.000034106244,0.0002582429,0.00003439843,0.00006485329,0.000010585042,0.00007360191,0.0000014042104],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014262422,0.00043090142,0.004173436,0.033622522,0.00008410738,0.0000015455603,0.0027509443,0.000023260971,0.000120233446,0.0010600026,0.5300801,0.42622674],"study_design_scores_gemma":[0.050670084,0.0066289753,0.0009754109,0.15887249,0.00018037585,0.00003105093,0.0033902503,0.0052724346,0.00029070087,0.0100037465,0.76322037,0.0004641364],"about_ca_topic_score_codex":0.0005003743,"about_ca_topic_score_gemma":0.00008978851,"teacher_disagreement_score":0.4257626,"about_ca_system_score_codex":0.00013069873,"about_ca_system_score_gemma":0.0013772453,"threshold_uncertainty_score":0.40199834},"labels":[],"label_agreement":null},{"id":"W2442713704","doi":"10.1016/j.jval.2015.09.576","title":"Healthcare Resource Utilisation Among Chronic Spontaneous/Idiopathic Urticaria Patients– Findings From The First International Burden of Illness Study (Assure-Csu)","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto; Lynde Centre for Dermatology; Novartis (Canada)","funders":"","keywords":"Medicine; Medical record; Observational study; Health care; Retrospective cohort study; Emergency department; Family medicine; Disease burden; Cross-sectional study; Emergency medicine; Pediatrics; Disease; Internal medicine","score_opus":0.030402362027914055,"score_gpt":0.2819513700659319,"score_spread":0.25154900803801783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2442713704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97900116,0.0007611581,0.000019217892,0.017989872,0.0006360866,0.0013245858,0.000053691972,0.000043322176,0.00017091745],"genre_scores_gemma":[0.99898285,0.000060891056,0.000029232006,0.0003109794,0.0003242312,0.000049245387,0.00016800707,0.00002557871,0.000049005903],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975126,0.00039036621,0.00078303984,0.0003290313,0.0006752035,0.0003097744],"domain_scores_gemma":[0.9986392,0.00025987948,0.00023324264,0.00042523252,0.00022607807,0.00021632048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094565604,0.00015742039,0.00036314005,0.00015045861,0.00016329456,0.000019213921,0.00023016939,0.00015103289,0.00004283583],"category_scores_gemma":[0.0004839346,0.000118413715,0.000064511405,0.00035304885,0.00011510997,0.00007491884,0.00007101854,0.0005432104,0.000017145734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046290288,0.0008498074,0.90620446,0.000081063845,0.00040977888,0.00012642685,0.08282023,0.005673475,0.000013711898,0.0010091617,0.0012066874,0.0011422697],"study_design_scores_gemma":[0.006327503,0.0023702316,0.94616884,0.001354564,0.00037905006,0.000047026253,0.01830923,0.020499991,0.00001957704,0.0006221065,0.0036709413,0.00023092292],"about_ca_topic_score_codex":0.035998505,"about_ca_topic_score_gemma":0.0016565992,"teacher_disagreement_score":0.064511,"about_ca_system_score_codex":0.00087459746,"about_ca_system_score_gemma":0.0007413534,"threshold_uncertainty_score":0.97042084},"labels":[],"label_agreement":null},{"id":"W2460051124","doi":"10.1016/j.jval.2015.09.2518","title":"How To Conduct Economic Evaluations Of New Treatments For Advanced Cancer When Overall Survival Data Are Not Available? Results From A Systematic Literature Review","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Surrogate endpoint; Medicine; Context (archaeology); Economic evaluation; Clinical trial; Population; Clinical endpoint; Cancer; Oncology; Cost effectiveness; Intensive care medicine; Lung cancer; Breast cancer; Internal medicine; Pathology; Environmental health; Risk analysis (engineering)","score_opus":0.7193642556993184,"score_gpt":0.49688215071113534,"score_spread":0.22248210498818305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2460051124","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.042637423,0.47574136,0.0018942122,0.37525517,0.004232747,0.019302329,0.080447435,0.00009257861,0.00039675858],"genre_scores_gemma":[0.13639644,0.3091163,0.2843765,0.16726719,0.008074853,0.012318144,0.027495312,0.0010657455,0.053889535],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.9908321,0.0011153403,0.006064716,0.0012308143,0.00019825816,0.00055879087],"domain_scores_gemma":[0.9897705,0.0021334393,0.005283201,0.0020361335,0.00018755082,0.00058918993],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.023318227,0.0003350853,0.0027446179,0.0003625921,0.00009415283,0.0001197978,0.00078405935,0.00015105304,0.0000764941],"category_scores_gemma":[0.014582389,0.00037718005,0.00012684433,0.0002424237,0.000024031595,0.00093583495,0.00012555943,0.0001704966,0.00035658886],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004779973,0.0003423897,0.0070931884,0.11029194,0.0005981841,0.0000018462412,0.012964563,0.0138485,0.0000035128528,0.010684318,0.8432155,0.0004780249],"study_design_scores_gemma":[0.043097273,0.0019330446,0.0087823495,0.46266434,0.00046928704,0.000014445675,0.0047978475,0.15797035,0.000030673604,0.040820077,0.27597946,0.0034408588],"about_ca_topic_score_codex":0.026873142,"about_ca_topic_score_gemma":0.0032592486,"teacher_disagreement_score":0.56723607,"about_ca_system_score_codex":0.0026402925,"about_ca_system_score_gemma":0.0022156208,"threshold_uncertainty_score":0.99986804},"labels":[],"label_agreement":null},{"id":"W2461634528","doi":"10.1016/j.jval.2015.09.2568","title":"Generating Costing Algorithms For Oncology Drugs Using Administrative Databases","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Institute for Clinical Evaluative Sciences; Ontario Institute for Cancer Research; Sunnybrook Hospital","funders":"","keywords":"Activity-based costing; Formulary; Medicine; Database; Pharmacoeconomics; Drug; Nausea; Reimbursement; Cancer; Cost driver; Oncology; Internal medicine; Intensive care medicine; Family medicine; Pharmacology; Health care; Computer science; Business; Accounting","score_opus":0.6210175027478848,"score_gpt":0.5296016784073136,"score_spread":0.09141582434057116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2461634528","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84591204,0.0031319202,0.12821907,0.014510784,0.001171784,0.0029886325,0.000082342114,0.000118943906,0.003864492],"genre_scores_gemma":[0.38908854,0.00008642294,0.6017626,0.007209794,0.0009277056,0.00015024186,0.00014438835,0.000026527507,0.0006037513],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987876,0.00013468358,0.00041443904,0.0002232363,0.0001778717,0.0002621822],"domain_scores_gemma":[0.99895847,0.0002775643,0.00020475395,0.00016739266,0.00012121757,0.0002706147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011882855,0.000082411076,0.00026372305,0.000061015224,0.00007795459,0.0000063542275,0.000055964432,0.000036153917,0.000024566463],"category_scores_gemma":[0.0008268148,0.00007698347,0.000021264595,0.00016789768,0.000039892988,0.000060425147,0.000018791518,0.0001484315,0.00002104236],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015760935,0.0029382012,0.06600452,0.004867774,0.0001743798,0.00026863097,0.042461406,0.029257718,0.0066300468,0.020049889,0.07041691,0.7553544],"study_design_scores_gemma":[0.0033867038,0.001382791,0.0003456275,0.0011035033,0.000016256743,0.00012249802,0.00862865,0.9361373,0.0006158929,0.0003277952,0.047762185,0.00017080538],"about_ca_topic_score_codex":0.001485138,"about_ca_topic_score_gemma":0.000014293122,"teacher_disagreement_score":0.90687954,"about_ca_system_score_codex":0.00036349046,"about_ca_system_score_gemma":0.0030273146,"threshold_uncertainty_score":0.5370326},"labels":[],"label_agreement":null},{"id":"W2462041422","doi":"10.1016/j.jval.2015.09.2521","title":"How Good Are Physicians And Chart Reviews At Capturing Health Resources And Drug Utilisation By Patients? Results Of The Pgrx-3 Prospective Real World Dataset Validation Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Family medicine; Pharmacy; Depression (economics); Medical record; Alternative medicine; Informed consent; Internal medicine","score_opus":0.12260972437845959,"score_gpt":0.31762735581036905,"score_spread":0.19501763143190948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462041422","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97863674,0.0030893767,0.0000015666093,0.010942512,0.00013812757,0.0014048873,0.0054538096,0.0000064802607,0.00032648342],"genre_scores_gemma":[0.996485,0.0021985811,0.000022060744,0.0008159064,0.00005828819,0.000029618715,0.00023174605,0.00001255522,0.00014624855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983571,0.0002170886,0.0007636835,0.00038107892,0.000048127567,0.00023287986],"domain_scores_gemma":[0.99840194,0.00006962102,0.0011020561,0.00028075642,0.000017055827,0.00012858969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021013513,0.0001249817,0.00046052292,0.00011280958,0.00012131896,0.00004861812,0.000113014125,0.000023999506,0.000001307509],"category_scores_gemma":[0.00015759394,0.00011572786,0.000023540239,0.00019803751,0.000054039858,0.00018743788,0.00010997279,0.00014419435,0.0000034221114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007364624,0.00028822996,0.96194714,0.00019524586,0.000013450048,9.163707e-8,0.013977201,0.0000884374,5.1272843e-7,0.0019752143,0.019963507,0.0014773413],"study_design_scores_gemma":[0.0044227573,0.0003719135,0.74088144,0.00024613916,0.0000073377164,4.8196694e-7,0.0014364023,0.0027498235,0.00004022723,0.0033051232,0.24623442,0.00030392135],"about_ca_topic_score_codex":0.014431816,"about_ca_topic_score_gemma":0.0025464315,"teacher_disagreement_score":0.2262709,"about_ca_system_score_codex":0.00040723776,"about_ca_system_score_gemma":0.00003288972,"threshold_uncertainty_score":0.9921312},"labels":[],"label_agreement":null},{"id":"W2462481570","doi":"10.1016/j.jval.2015.09.700","title":"Examining The Economic Impact of Laboratory Developed Testing In Flow Cytometry Immunophenotyping for Hematologic Malignancies: An Analysis of Health Resource Utilization","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Becton Dickinson (Canada)","funders":"","keywords":"Immunophenotyping; Flow cytometry; Medicine; Immunology","score_opus":0.1469315015132018,"score_gpt":0.3584205553972972,"score_spread":0.21148905388409542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462481570","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99286795,0.0036488182,0.002957147,0.00004122675,0.000044046436,0.00029744164,0.00012809748,0.0000034160782,0.0000118653315],"genre_scores_gemma":[0.9946213,0.00020038115,0.0048473035,0.0001319558,0.000024812323,0.0000171632,0.00014248803,0.000013620222,0.0000010139788],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985313,0.0002489609,0.00068862917,0.00022937795,0.00006095289,0.00024080042],"domain_scores_gemma":[0.9988412,0.00022658547,0.00048078154,0.0002893524,0.00009913154,0.000062893356],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002529058,0.000100865815,0.00038368808,0.00024331665,0.000043787608,0.00000865727,0.00015450042,0.000068817855,8.8954414e-7],"category_scores_gemma":[0.00088580605,0.00008862155,0.000048147904,0.0006512745,0.000038391037,0.0000050210433,0.000049791597,0.00005290012,1.1457292e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000081615624,0.000038662463,0.20673336,0.0001226465,0.0000633611,2.2177025e-7,0.0010933757,0.7855702,0.0033425943,0.00008988767,0.000037889033,0.00282617],"study_design_scores_gemma":[0.002025538,0.002676811,0.39991593,0.00033929912,0.000056811514,0.000003859841,0.0052012843,0.5835068,0.0051999977,0.0002544458,0.00043322102,0.0003859802],"about_ca_topic_score_codex":0.005980438,"about_ca_topic_score_gemma":0.00066660467,"teacher_disagreement_score":0.2020634,"about_ca_system_score_codex":0.00051119603,"about_ca_system_score_gemma":0.0029066734,"threshold_uncertainty_score":0.90406734},"labels":[],"label_agreement":null},{"id":"W2462932418","doi":"10.1016/j.jval.2015.09.2730","title":"Alternatives To Winbugs for Network Meta–Analysis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Guelph","funders":"","keywords":"Computer science; Markov chain Monte Carlo; Software; Bayesian probability; Set (abstract data type); Bayesian network; Inference; Data mining; Machine learning; Artificial intelligence; Programming language","score_opus":0.9529848658246516,"score_gpt":0.6296324465257082,"score_spread":0.3233524192989434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2462932418","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.044094343,0.030473316,0.8664305,0.043858256,0.0014094292,0.006353638,0.00011085984,0.000025263753,0.00724439],"genre_scores_gemma":[0.76125634,0.00006928145,0.20851791,0.008357632,0.00061639445,0.0005809109,0.00001693868,0.000032403572,0.020552175],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.97517705,0.01181683,0.007929897,0.0010049166,0.0035897153,0.0004815913],"domain_scores_gemma":[0.98796797,0.0055343527,0.0027597155,0.0024416752,0.0007525204,0.0005437947],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.22191724,0.00022422409,0.005787257,0.00076202163,0.00009074449,0.00033842644,0.0013560713,0.00004366301,0.0011271025],"category_scores_gemma":[0.022483606,0.000109301174,0.0030964515,0.004973498,0.000018672257,0.00013492342,0.000098079836,0.000088630244,0.00082374754],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016915674,0.000060248574,0.015105022,0.00005233202,0.014505682,0.0000018553847,0.002760785,0.7567126,3.888819e-7,0.013935391,0.19281015,0.0040386356],"study_design_scores_gemma":[0.0003489813,0.00025711712,0.0035251104,0.000020204925,0.013492692,0.0000019381346,0.000995936,0.2682827,0.0000027510073,0.086653866,0.6260947,0.00032402467],"about_ca_topic_score_codex":0.0009970416,"about_ca_topic_score_gemma":0.000385881,"teacher_disagreement_score":0.717162,"about_ca_system_score_codex":0.00009605358,"about_ca_system_score_gemma":0.000209323,"threshold_uncertainty_score":0.9999542},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"not_applicable","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2463859463","doi":"10.1016/j.jval.2015.09.1784","title":"Ethical Requirements for the Conduct of Drug Utilisation Studies Involving AD Hoc Data Collection: An International Cross-Sectional Survey","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Data collection; Legislation; Medicine; Pharmacy; Family medicine; Informed consent; Data extraction; MEDLINE; Alternative medicine; Political science; Pathology; Law","score_opus":0.8808164289114158,"score_gpt":0.6266667740970572,"score_spread":0.2541496548143586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2463859463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845679,0.0031868722,0.00020213169,0.008283263,0.0026375977,0.00090979337,0.00013277499,0.000017745731,0.00006195419],"genre_scores_gemma":[0.9955331,0.0012081275,0.0009686301,0.0016290685,0.00016785823,0.000022425871,0.0003367787,0.00000914779,0.00012487828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980134,0.0005603239,0.0005389444,0.00024722872,0.00048777764,0.00015235374],"domain_scores_gemma":[0.9964747,0.0024166368,0.00024418946,0.00029437887,0.00045432043,0.00011577096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008583436,0.00007805412,0.00020305593,0.0000740087,0.00012619462,0.000022529644,0.00020246323,0.0000636149,0.000020426167],"category_scores_gemma":[0.0070165764,0.000055969518,0.000025621688,0.00018451073,0.00011722881,0.00037108723,0.000103029124,0.00034631905,0.0000017776446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011250444,0.00015904086,0.99452525,0.00016176104,0.00008908059,5.178098e-7,0.0014515602,0.00041724328,0.00001087662,0.00037234213,0.0011875832,0.00049970247],"study_design_scores_gemma":[0.002803447,0.00042187472,0.8557049,0.00007826047,0.000016753675,0.0000076186307,0.00091946847,0.12824301,0.000024937914,0.000573289,0.011140851,0.00006559124],"about_ca_topic_score_codex":0.0012385637,"about_ca_topic_score_gemma":0.0003193863,"teacher_disagreement_score":0.13882035,"about_ca_system_score_codex":0.00028422507,"about_ca_system_score_gemma":0.00056745403,"threshold_uncertainty_score":0.84000045},"labels":[],"label_agreement":null},{"id":"W2464779517","doi":"10.1016/j.jval.2015.09.2366","title":"Adherence and Persistence to Allopurinol among Hypertensive Patients with Gout","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Persistence (discontinuity); Cohort; Allopurinol; Internal medicine; Gout; Logistic regression; Proportional hazards model; Febuxostat; Aspirin; Uric acid; Hyperuricemia","score_opus":0.1316137125790434,"score_gpt":0.3285266063118007,"score_spread":0.1969128937327573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464779517","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99584,0.00020359394,0.0000148884255,0.0016260499,0.0000471944,0.0009967049,0.000007753562,0.000021976204,0.0012418352],"genre_scores_gemma":[0.9967615,0.00006705587,0.0016226446,0.0012682938,0.000026968424,0.00003601481,0.000005381656,0.000016707734,0.00019542643],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984855,0.00011848249,0.00021118904,0.00028986935,0.00050513266,0.0003898309],"domain_scores_gemma":[0.99866265,0.000058400165,0.00004271564,0.00023008962,0.00028132467,0.00072483823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033172808,0.0001003777,0.00027238048,0.00014324153,0.00004027972,0.000013078911,0.00007252102,0.0000429412,0.000010155329],"category_scores_gemma":[0.00050422194,0.00007924776,0.000012259012,0.0002774624,0.0000827089,0.000074071686,0.000059332742,0.00020438815,0.000056836427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014646584,0.00007794324,0.9879167,0.00010294433,0.0000069113753,0.000042514308,0.0024243537,0.00005262111,0.0000042953375,0.000015603197,0.0006418072,0.008567804],"study_design_scores_gemma":[0.0020145692,0.0029589734,0.99044675,0.00057806075,0.000004516379,0.0000073128413,0.0005565989,0.0012425685,0.00002222908,0.000014439027,0.0020418863,0.000112114576],"about_ca_topic_score_codex":0.01270326,"about_ca_topic_score_gemma":0.000523135,"teacher_disagreement_score":0.012180125,"about_ca_system_score_codex":0.00027642344,"about_ca_system_score_gemma":0.0005490584,"threshold_uncertainty_score":0.9938712},"labels":[],"label_agreement":null},{"id":"W2467605331","doi":"10.1016/j.jval.2015.09.1435","title":"Systematic Review On The Correlation Between Lung Function Or Eosinophil Levels And Quality Of Life In Asthma","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Eosinophil; Asthma; Quality of life (healthcare); Sputum; Correlation; Lung function; Pulmonary function testing; Internal medicine; Physical therapy; Lung; Pathology; Mathematics","score_opus":0.18632685399600232,"score_gpt":0.38028728565651776,"score_spread":0.19396043166051544,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2467605331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9447373,0.04953085,0.00015730952,0.0032563051,0.00009383952,0.0021122657,0.000013414926,0.000014536605,0.00008416428],"genre_scores_gemma":[0.99730986,0.00041654948,0.000015034441,0.0021176843,0.000056032382,0.00002900837,0.0000060051398,0.0000074581058,0.000042354117],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99756384,0.0010855361,0.000824814,0.00012875759,0.0002832213,0.000113833856],"domain_scores_gemma":[0.99873954,0.0005127165,0.00033393802,0.00020677857,0.000054706463,0.00015230518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031361054,0.00008122511,0.0005854912,0.00007985189,0.000026158374,0.000003258767,0.000029159226,0.00004652204,0.000009233387],"category_scores_gemma":[0.0024176762,0.000044380755,0.000030895346,0.00024409308,0.000030050107,0.000037876664,0.000011598322,0.00013456013,0.000006026329],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004275526,0.00020601662,0.4424559,0.5528711,0.000032728913,0.0000048874117,0.00084372493,0.00034914995,0.000003946136,0.0011903264,0.0007664029,0.00084828236],"study_design_scores_gemma":[0.0013096544,0.00078618893,0.84037167,0.15533738,0.000056828136,0.000003118967,0.00047402896,0.0013861242,0.0000019034969,0.00010927014,0.0000786662,0.000085162734],"about_ca_topic_score_codex":0.00056311337,"about_ca_topic_score_gemma":0.0000215467,"teacher_disagreement_score":0.3979158,"about_ca_system_score_codex":0.00012759163,"about_ca_system_score_gemma":0.00048849353,"threshold_uncertainty_score":0.28943586},"labels":[],"label_agreement":null},{"id":"W2470444713","doi":"10.1016/j.jval.2016.04.016","title":"Association of Preference-Based Health-Related Quality of Life with Weight Loss in Obese Adults","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Bariatric Surgery and Outcomes","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Innovates","keywords":"Association (psychology); Preference; Medicine; Obesity; Gerontology; Psychology; Internal medicine; Statistics; Mathematics; Psychotherapist","score_opus":0.07230966847754206,"score_gpt":0.3052448171826958,"score_spread":0.23293514870515375,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2470444713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98005694,0.0006383345,0.000043464046,0.01849966,0.00013627441,0.00049754366,0.000028884382,0.000020233714,0.00007865013],"genre_scores_gemma":[0.9986085,0.00039890126,0.00030144083,0.0005127743,0.000026338974,0.000010919436,0.000012732615,0.000010736144,0.00011765303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967378,0.0009149312,0.0013958777,0.00021442141,0.00041262383,0.0003243808],"domain_scores_gemma":[0.9969326,0.001496608,0.0010279011,0.00025099353,0.000120163764,0.0001716808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036829058,0.000110247776,0.0008167553,0.00023762084,0.000018004032,0.0000010186393,0.000059878003,0.00013365138,0.000058837526],"category_scores_gemma":[0.0012361789,0.00007001939,0.00005876586,0.000543466,0.000035608744,0.00005484596,0.000009913553,0.00018201921,0.0000043976174],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015203923,0.0003667925,0.99253875,0.0014684333,0.000023109282,0.000002057763,0.00073560164,0.00006351955,0.000011518477,0.00040987492,0.000121781704,0.002738187],"study_design_scores_gemma":[0.0068688462,0.00050711323,0.98939735,0.0025215861,0.0000054921625,7.282708e-7,0.00004818329,0.0001671515,0.00016014586,0.00018158658,0.00006951844,0.0000722817],"about_ca_topic_score_codex":0.022003787,"about_ca_topic_score_gemma":0.00094753,"teacher_disagreement_score":0.021056255,"about_ca_system_score_codex":0.0005579124,"about_ca_system_score_gemma":0.0020835462,"threshold_uncertainty_score":0.98450875},"labels":[],"label_agreement":null},{"id":"W2471462248","doi":"10.1016/j.jval.2015.09.906","title":"Quality Of Life Of Patients Experiencing Cancer-Associated Thrombosis","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver Coastal Health","funders":"","keywords":"Medicine; Quality of life (healthcare); Cancer; Internal medicine; Thrombosis; Prostate cancer; Venous thrombosis; Venous thromboembolism; Pulmonary embolism; Physical therapy","score_opus":0.1591948061942683,"score_gpt":0.3932760939144002,"score_spread":0.23408128772013193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2471462248","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971598,0.00063619646,0.000009546887,0.0007901667,0.0002466995,0.0005109784,0.000022748478,0.000016665306,0.0006072337],"genre_scores_gemma":[0.9985476,0.00048965943,0.00020331141,0.00066525745,0.000025741414,0.00003292204,0.000013368673,0.00001218555,0.000009913066],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814874,0.0002123401,0.0007962682,0.0001660785,0.00043926467,0.00023728478],"domain_scores_gemma":[0.99885356,0.00007589186,0.0004680027,0.00021577498,0.00018458576,0.00020217607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011465785,0.00008908472,0.0007583944,0.000109713066,0.000020390518,0.0000019685126,0.00007299941,0.000050696937,0.000033123488],"category_scores_gemma":[0.00069317257,0.00008166955,0.000057887246,0.00029499672,0.000039398958,0.00004198022,0.000046711266,0.00007996489,0.0000016074099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005430583,0.0021650589,0.9775164,0.0008574286,0.000066419205,2.996736e-7,0.013476984,0.0008730232,0.000059485985,0.00078166,0.0028760799,0.0012728287],"study_design_scores_gemma":[0.0021242308,0.0006092913,0.9938713,0.000428785,0.00001304611,1.8194072e-8,0.0020087631,0.00026861453,0.0002588842,0.00010937829,0.00023848616,0.00006925585],"about_ca_topic_score_codex":0.08178128,"about_ca_topic_score_gemma":0.00045813585,"teacher_disagreement_score":0.08132315,"about_ca_system_score_codex":0.00040360747,"about_ca_system_score_gemma":0.00059296645,"threshold_uncertainty_score":0.9243332},"labels":[],"label_agreement":null},{"id":"W2474086326","doi":"10.1016/j.jval.2015.09.1777","title":"Methodological Gaps in the Assessment of the Utility and Burden of Risk Minimisation Interventions","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Risk analysis (engineering); Psychological intervention; Certification; Computer science; Medicine; Management science; Nursing; Engineering","score_opus":0.8483123480284182,"score_gpt":0.5652710809114766,"score_spread":0.28304126711694155,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474086326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95702755,0.0021681841,0.0029149442,0.03587354,0.00025909956,0.0008130693,0.00014598265,0.0000045915476,0.0007930189],"genre_scores_gemma":[0.9910434,0.00024738754,0.00794072,0.00067388086,0.000041231207,0.000035276495,0.0000044075837,0.00000457363,0.000009146647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9907124,0.005398502,0.0033758727,0.00023796153,0.00010060116,0.0001746403],"domain_scores_gemma":[0.9938211,0.0035111464,0.0021907717,0.00038238257,0.000035987898,0.000058655267],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.0832019,0.000073784795,0.0005990215,0.00015986094,0.000051168307,0.000010321213,0.00022964041,0.00007190522,0.00003064722],"category_scores_gemma":[0.010302608,0.000058780082,0.000087076514,0.000248883,0.000099773206,0.000090142064,0.000054375338,0.00021089135,0.0000043771256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011271958,0.0002024986,0.872744,0.00095354323,0.00001304724,1.09597e-7,0.017781485,0.0046355883,3.7347286e-7,0.101656295,0.0013452388,0.0006565099],"study_design_scores_gemma":[0.00050934625,0.000093715505,0.8854635,0.00020041974,0.0000024289936,0.000001323385,0.005683055,0.041213445,8.205819e-7,0.065726854,0.0010515959,0.000053502983],"about_ca_topic_score_codex":0.025402242,"about_ca_topic_score_gemma":0.00063906785,"teacher_disagreement_score":0.0728993,"about_ca_system_score_codex":0.00028059699,"about_ca_system_score_gemma":0.00025492944,"threshold_uncertainty_score":0.99803406},"labels":[],"label_agreement":null},{"id":"W2474283084","doi":"10.1016/j.jval.2015.09.1914","title":"The Use of Single-Arm Evidence In The Comparative Efficacy of Interferon-Free Antivirals for Treatment-Naïve Hepatitis C Genotype 1","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Ribavirin; Simeprevir; Sofosbuvir; Medicine; Boceprevir; Telaprevir; Interferon; Hepatitis C; Internal medicine; Clinical trial; Randomized controlled trial; Alpha interferon; Virology; Pharmacology; Gastroenterology; Hepatitis C virus; Virus","score_opus":0.6478963461135071,"score_gpt":0.46985399489420787,"score_spread":0.17804235121929923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474283084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902146,0.0025954542,0.00015530808,0.0041554887,0.000086353844,0.0025942225,0.00006332343,0.000008120663,0.0001271607],"genre_scores_gemma":[0.9964647,0.0017678672,0.0013851041,0.00015864836,0.000043816694,0.00009289731,0.000008807507,0.000014518626,0.000063618034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723977,0.0010122281,0.00070573227,0.00021189844,0.0004580454,0.00037233304],"domain_scores_gemma":[0.99344844,0.0053279623,0.00022744591,0.0006563835,0.0002363495,0.000103405524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019061085,0.00013083985,0.0005345619,0.00015736271,0.00005086684,0.000018704062,0.00030019527,0.00005381685,0.000005823097],"category_scores_gemma":[0.0037512358,0.0000757992,0.00007146047,0.00043660068,0.00022807332,0.00011619906,0.00006237749,0.00013999859,0.0000060519305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007426367,0.0061162417,0.77990276,0.0012513659,0.0002259567,0.000056332745,0.08090278,0.0036011306,0.0034139568,0.0030129636,0.012244636,0.101845525],"study_design_scores_gemma":[0.044501252,0.1525523,0.5554027,0.015583003,0.00019720435,0.000051160143,0.008507746,0.11389458,0.037069526,0.003612661,0.06764128,0.0009865521],"about_ca_topic_score_codex":0.06285525,"about_ca_topic_score_gemma":0.008552111,"teacher_disagreement_score":0.22450003,"about_ca_system_score_codex":0.00053649326,"about_ca_system_score_gemma":0.0008277446,"threshold_uncertainty_score":0.9433853},"labels":[],"label_agreement":null},{"id":"W2474456043","doi":"10.1016/j.jval.2015.09.801","title":"Association of Treatment with Carvedilol, Bisoprolol and Metoprolol on the Risk of Mortality and Hospital Admission Among Older Adults with Heart Failure","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université du Québec à Montréal; Montreal Heart Institute; Université de Sherbrooke; Université de Montréal","funders":"","keywords":"Bisoprolol; Metoprolol; Carvedilol; Metoprolol Tartrate; Medicine; Hazard ratio; Heart failure; Internal medicine; Proportional hazards model; Cardiology; Confidence interval; Propensity score matching","score_opus":0.02463452858014505,"score_gpt":0.277206121427177,"score_spread":0.25257159284703196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474456043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846597,0.00021717697,0.000006452887,0.013063081,0.000018499435,0.0019672618,0.0000124501075,0.000014525316,0.00004085347],"genre_scores_gemma":[0.99857223,0.00019864745,0.00094243785,0.000084679385,0.00002310727,0.000071538794,0.000008789557,0.000011759808,0.00008681224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998782,0.00021525325,0.0002633136,0.00023264291,0.00031714488,0.00018964925],"domain_scores_gemma":[0.9991484,0.00012146899,0.00025242855,0.00021889308,0.00008080818,0.00017799504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075498124,0.00014704924,0.00039089625,0.000081413215,0.000041015202,0.0000058450337,0.000020850024,0.000061269086,0.0000046768982],"category_scores_gemma":[0.00007322765,0.00007202888,0.00002582639,0.00014643456,0.00006012341,0.000052882246,0.000014315765,0.00010712727,4.9837155e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036193282,0.000373066,0.9949146,0.00017721401,0.00016027379,0.000003703795,0.0026942508,0.000047070876,0.0000028114616,0.000040514697,0.0006574295,0.0005671356],"study_design_scores_gemma":[0.005997267,0.015855376,0.97333634,0.0007487056,0.00022017566,0.00000317676,0.0017354405,0.00084725075,0.00028527758,0.000028814018,0.0008537447,0.00008844177],"about_ca_topic_score_codex":0.015236955,"about_ca_topic_score_gemma":0.001408344,"teacher_disagreement_score":0.021578265,"about_ca_system_score_codex":0.0002610777,"about_ca_system_score_gemma":0.00020180053,"threshold_uncertainty_score":0.99132067},"labels":[],"label_agreement":null},{"id":"W2474811130","doi":"10.1016/j.jval.2015.09.1253","title":"The Finnish Versions Of The Lower-Limb Sections Of The Toronto Extremity Salvage Score And The Musculoskeletal Tumor Society Scale: A Pilot Study","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Sarcoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Knowledge translation; Physical therapy; Soft tissue sarcoma; Surgery; Soft tissue; Computer science","score_opus":0.053940665035936065,"score_gpt":0.31584261037075056,"score_spread":0.2619019453348145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2474811130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9844266,0.0040534334,0.0000012546997,0.008986234,0.00038191967,0.0018487385,0.000021977981,0.000010115521,0.0002697092],"genre_scores_gemma":[0.99888855,0.00040531805,0.000040035484,0.00043603327,0.000063665204,0.00008916143,8.2991676e-7,0.000011099063,0.00006528482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99824965,0.0005767417,0.00037221806,0.00018369922,0.00040408137,0.00021359549],"domain_scores_gemma":[0.998239,0.0007089605,0.00020222453,0.00067297573,0.00008404943,0.000092821654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013082249,0.00012154794,0.0002872283,0.000009792756,0.0004113624,0.000010450467,0.00019955552,0.000023809514,0.000007084842],"category_scores_gemma":[0.00025915197,0.00004688658,0.00018364644,0.00023121065,0.00039714115,0.000033854907,0.00017185381,0.00021857585,6.931278e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056900724,0.005904448,0.9701826,0.00015529939,0.00019789996,0.000003068337,0.0109244,0.00016877936,0.000020058522,0.0004705045,0.009140687,0.0022632563],"study_design_scores_gemma":[0.0050749383,0.002150957,0.97877604,0.00024164104,0.00015298455,0.000017547105,0.0117807025,0.0005530888,0.000028469214,0.00018129514,0.0009848529,0.00005747712],"about_ca_topic_score_codex":0.032122236,"about_ca_topic_score_gemma":0.008483685,"teacher_disagreement_score":0.02363855,"about_ca_system_score_codex":0.0003134394,"about_ca_system_score_gemma":0.00048574395,"threshold_uncertainty_score":0.974323},"labels":[],"label_agreement":null},{"id":"W2527943338","doi":"10.1016/j.jval.2016.06.001","title":"Estimating Health-State Utility for Economic Models in Clinical Studies: An ISPOR Good Research Practices Task Force Report","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":159,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Ontario Clinical Oncology Group","funders":"","keywords":"Data collection; Observational study; Clinical trial; Health economics; Research design; Protocol (science); Management science; Outcomes research; Actuarial science; Task (project management); Computer science; Operations research; Risk analysis (engineering); Medicine; Public health; Economics; Statistics; Alternative medicine; Engineering; Nursing","score_opus":0.8850896686782405,"score_gpt":0.6448588139974663,"score_spread":0.2402308546807742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2527943338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73995626,0.007361842,0.025669787,0.21652052,0.0025688235,0.006364521,0.00087666296,0.000112448484,0.000569107],"genre_scores_gemma":[0.92369765,0.003146634,0.0626692,0.0073870295,0.001119253,0.0010765751,0.000059803082,0.00012527901,0.0007185606],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9755104,0.0047186487,0.015911024,0.0019690387,0.00021474563,0.0016761356],"domain_scores_gemma":[0.96936774,0.016866343,0.011414553,0.0015128813,0.0001770922,0.00066140643],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2773229,0.00029413257,0.0022881099,0.00079609395,0.0004277961,0.00008063776,0.0005372134,0.00021865898,0.00003474656],"category_scores_gemma":[0.03173715,0.00031333507,0.00016401809,0.00028308752,0.00022304458,0.0017180342,0.00013815348,0.00058392505,0.00025518765],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069850317,0.0018969709,0.59167117,0.010303344,0.00025843168,0.000031988653,0.028927842,0.071336485,9.5007056e-7,0.23506327,0.028868733,0.030942291],"study_design_scores_gemma":[0.0032435071,0.0011015843,0.022956047,0.0011673057,0.0000022119555,0.000024046505,0.0032982503,0.6166154,6.8030585e-7,0.32948798,0.021578254,0.00052467716],"about_ca_topic_score_codex":0.033540253,"about_ca_topic_score_gemma":0.0073279357,"teacher_disagreement_score":0.56871516,"about_ca_system_score_codex":0.00460025,"about_ca_system_score_gemma":0.0034854226,"threshold_uncertainty_score":0.9999319},"labels":[],"label_agreement":null},{"id":"W2531737797","doi":"10.1016/j.jval.2016.08.003","title":"A Systematic Review of Health Economics Simulation Models of Chronic Obstructive Pulmonary Disease","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; Prevention of Organ Failure; St. Paul's Hospital; Vancouver Coastal Health; University of British Columbia","funders":"Canadian Institutes of Health Research","keywords":"COPD; Exacerbation; Medicine; Intensive care medicine; Comorbidity; Pulmonary disease; Systematic review; MEDLINE; Disease; Natural history; Physical therapy; Internal medicine","score_opus":0.08473290610881909,"score_gpt":0.38636510544835484,"score_spread":0.3016321993395358,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531737797","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016321117,0.98412126,0.0001800901,0.00036729436,0.00018021179,0.013922232,0.0010432515,0.000029772053,0.00013955381],"genre_scores_gemma":[0.00067442463,0.997823,0.0000994051,0.00010884591,0.00015266599,0.0005358859,0.00035402813,0.00014074847,0.00011101396],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9896715,0.0026153135,0.0052314927,0.00092744525,0.00072131713,0.0008328768],"domain_scores_gemma":[0.9919644,0.0011890365,0.0041302852,0.0016675523,0.00030252512,0.0007461966],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003039717,0.00065512233,0.007886906,0.0008261481,0.000067189474,0.0000061424207,0.0004456441,0.00021563642,0.00007720221],"category_scores_gemma":[0.00073491567,0.0005053636,0.0010647174,0.0007510041,0.00023877752,0.00020076375,0.0001892336,0.0005553087,0.000024822248],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00003387821,0.00026690186,0.000008782863,0.82284325,0.00016099852,0.000017276318,0.000030503805,0.0015413057,9.759662e-9,0.0011103626,0.000008439366,0.17397827],"study_design_scores_gemma":[0.00042894788,0.00015842648,0.000075821416,0.9659842,0.0005843042,0.000040285737,0.000018093711,0.026877811,2.9902218e-8,0.0012376389,0.0043058377,0.00028855423],"about_ca_topic_score_codex":0.00053102087,"about_ca_topic_score_gemma":0.0000032787834,"teacher_disagreement_score":0.17368971,"about_ca_system_score_codex":0.008694726,"about_ca_system_score_gemma":0.02147528,"threshold_uncertainty_score":0.9997398},"labels":[],"label_agreement":null},{"id":"W2539551211","doi":"10.1016/j.jval.2016.09.2181","title":"Real-World Treatment Patterns and Costs of Care Among Brentuximab Vendotin-Treated Patients with Hodgkin Lymphoma in The United States","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Brentuximab vedotin; Medicine; Internal medicine; Discontinuation; Bendamustine; Pharmacy; Hodgkin lymphoma; Lymphoma; Rituximab; Family medicine","score_opus":0.018326210568359508,"score_gpt":0.2746963721163278,"score_spread":0.2563701615479683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539551211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735975,0.00022831911,7.9066126e-7,0.0007982407,0.000026535388,0.0012940264,0.00019325984,0.000017431596,0.000081632345],"genre_scores_gemma":[0.9972563,0.002097119,0.000037732865,0.0001423002,0.000012911686,0.00012674223,0.00028999927,0.00002087919,0.000016014437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984596,0.00028202587,0.00039807864,0.000283803,0.00025150063,0.00032501004],"domain_scores_gemma":[0.99895394,0.00036946402,0.00017909087,0.00030666383,0.000070196955,0.00012062206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013575862,0.00020519753,0.00042447573,0.0003162377,0.000043145996,0.00000930614,0.000057015244,0.000038273898,0.000007345033],"category_scores_gemma":[0.000015344844,0.00009581556,0.000035681755,0.00039697616,0.00006983875,0.000042101048,0.000017430402,0.000031172523,0.0000017124755],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037416708,0.0014918833,0.95765424,0.00011562946,0.00004557822,0.00006902125,0.002801005,0.000026177539,7.2813026e-7,0.00006966042,0.000018577324,0.03733336],"study_design_scores_gemma":[0.017924463,0.003103398,0.97571445,0.0020068367,0.000041784388,0.0000042240704,0.00065063685,0.000064813896,0.00025951315,0.000007569684,0.00013286588,0.00008947424],"about_ca_topic_score_codex":0.25727642,"about_ca_topic_score_gemma":0.018339109,"teacher_disagreement_score":0.2389373,"about_ca_system_score_codex":0.0015280327,"about_ca_system_score_gemma":0.00016162032,"threshold_uncertainty_score":0.99957365},"labels":[],"label_agreement":null},{"id":"W2539783054","doi":"10.1016/j.jval.2016.09.1266","title":"Comparison of Direct Healthcare Costs Associated with Chronic Spontaneous /Idiopathic Urticaria in 7 Countries - Results from the Assure-CSU Study","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lynde Centre for Dermatology","funders":"","keywords":"Purchasing power parity; Medicine; Indirect costs; Health care; Purchasing power; Total cost; Environmental health; Demography; Emergency medicine; Medical emergency; Business; Exchange rate; Economic growth; Finance; Economics; Accounting","score_opus":0.03753408558041539,"score_gpt":0.3241156033441729,"score_spread":0.2865815177637575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539783054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9738509,0.004045099,0.000007753393,0.01974832,0.00020370948,0.0016333929,0.00028404107,0.000058021935,0.00016874238],"genre_scores_gemma":[0.9990898,0.00040556933,0.000017083987,0.00023075879,0.00008009065,0.000042841413,0.000055217122,0.0000273458,0.000051343388],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961897,0.0012359029,0.0011302878,0.00039921716,0.000545824,0.0004990439],"domain_scores_gemma":[0.99671894,0.0020377727,0.00039960668,0.00053333526,0.00014635081,0.00016398358],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015607036,0.00019506508,0.0008229567,0.00013953629,0.00012567439,0.000011348496,0.00015053511,0.00018352023,0.000018237788],"category_scores_gemma":[0.0009663801,0.00010523614,0.000046106932,0.00054888456,0.00016732859,0.000045594657,0.00003009036,0.0005700496,0.000013137889],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022221694,0.0016975204,0.9786791,0.000050964514,0.00058771914,0.0006344803,0.013334269,0.0006655829,0.00012581224,0.00068337924,0.0003018933,0.001017108],"study_design_scores_gemma":[0.010463476,0.0053188712,0.9743226,0.005793997,0.00036870752,0.00004840505,0.0016932889,0.0014285947,0.00006741384,0.00014658346,0.00016620252,0.00018184718],"about_ca_topic_score_codex":0.038679976,"about_ca_topic_score_gemma":0.032050725,"teacher_disagreement_score":0.02523883,"about_ca_system_score_codex":0.0015138705,"about_ca_system_score_gemma":0.0017484934,"threshold_uncertainty_score":0.98561186},"labels":[],"label_agreement":null},{"id":"W2539985417","doi":"10.1016/j.jval.2016.09.1549","title":"One-Year Patient-Reported Persistence To Antiresorptive Treatment In A Fracture Liaison Service: The Lucky Bone™ Program","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Discontinuation; Medicine; Osteoporosis; Regimen; Adverse effect; Persistence (discontinuity); Subgroup analysis; Internal medicine; Drug holiday; Pediatrics; Surgery; Family medicine","score_opus":0.08202172270453621,"score_gpt":0.367308252215629,"score_spread":0.2852865295110928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2539985417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.878286,0.00092755666,0.0000033382717,0.11591326,0.000080511614,0.004492262,0.000013233393,0.000056431854,0.00022738744],"genre_scores_gemma":[0.99075043,0.0007091814,0.00079942704,0.00685021,0.00007989197,0.0005732489,0.000010551621,0.000029324994,0.00019772652],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.996984,0.00035515375,0.0006942652,0.0004922547,0.00058632414,0.0008879676],"domain_scores_gemma":[0.99829125,0.00024760776,0.00016938511,0.0005669874,0.00015473829,0.0005700196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007673272,0.00019220654,0.00049299665,0.0002592066,0.00011515652,0.000017616203,0.000112141046,0.00013700443,0.000055338438],"category_scores_gemma":[0.00029526942,0.000107730724,0.00007229516,0.00091420696,0.00005256308,0.00006381197,0.000049954273,0.00032726003,0.000093144685],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030498933,0.0038928345,0.43599755,0.0010713416,0.000054023396,0.00019974294,0.024401776,0.00009982647,0.00062141655,0.00008392583,0.0013548724,0.5291728],"study_design_scores_gemma":[0.0062087732,0.010699125,0.9206577,0.0029283941,0.000019876854,0.000046375775,0.0034845348,0.0006080266,0.000599147,0.000084916035,0.054400407,0.0002627081],"about_ca_topic_score_codex":0.0288341,"about_ca_topic_score_gemma":0.0027757045,"teacher_disagreement_score":0.5289101,"about_ca_system_score_codex":0.0011691934,"about_ca_system_score_gemma":0.0015196375,"threshold_uncertainty_score":0.977633},"labels":[],"label_agreement":null},{"id":"W2540051367","doi":"10.1016/j.jval.2016.09.1295","title":"Assessing Health-Utility Values for Chronic Spontaneous/Idiopathic Urticaria In Real-World Using The EQ-5D: Results From Assure-Csu Study","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lynde Centre for Dermatology","funders":"","keywords":"Medicine; Anxiety; EQ-5D; Observational study; Depression (economics); Quality of life (healthcare); Disease; Physical therapy; Internal medicine; Psychiatry; Health related quality of life","score_opus":0.1585019584030046,"score_gpt":0.38719095070230475,"score_spread":0.22868899229930015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540051367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96976745,0.0017963247,0.0009170518,0.022935601,0.0007204437,0.0034096679,0.00012981388,0.00011046135,0.00021320449],"genre_scores_gemma":[0.9973212,0.00038933574,0.0010449487,0.0004926929,0.0004757397,0.00007793291,0.000036783083,0.00005045549,0.00011094598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943017,0.001762137,0.0017366944,0.00077224016,0.00048295877,0.0009442861],"domain_scores_gemma":[0.9961597,0.0020480275,0.00044997944,0.000925556,0.000106529,0.00031021633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005181815,0.0002850686,0.0008545987,0.00033563224,0.00042734825,0.000057946934,0.00021078999,0.0001807994,0.000027113521],"category_scores_gemma":[0.0009787512,0.00017704227,0.0001248735,0.0007063984,0.00015545455,0.0001722401,0.00006569945,0.00071409903,0.000009594906],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013810479,0.017797189,0.68095875,0.0021061026,0.004250553,0.0043819193,0.1054877,0.01575908,0.012031965,0.012983911,0.0034342858,0.12699807],"study_design_scores_gemma":[0.018045967,0.0029123696,0.8799197,0.0071418267,0.00072748907,0.00019549129,0.0041145245,0.07644682,0.000094943425,0.009177139,0.00068086653,0.00054284395],"about_ca_topic_score_codex":0.06539985,"about_ca_topic_score_gemma":0.011592121,"teacher_disagreement_score":0.19896097,"about_ca_system_score_codex":0.0023046911,"about_ca_system_score_gemma":0.0037112492,"threshold_uncertainty_score":0.94082373},"labels":[],"label_agreement":null},{"id":"W2540111953","doi":"10.1016/j.jval.2016.09.515","title":"The Burden of Parkinson's Disease(Pd) in Japan","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Presenteeism; Medicine; Absenteeism; Quality of life (healthcare); Disease; Work productivity; Parkinson's disease; Gerontology; Health care; Disease burden; Population; Mental health; Quarter (Canadian coin); Productivity; Demography; Environmental health; Internal medicine; Psychology; Psychiatry","score_opus":0.031014052363993454,"score_gpt":0.2963841410564092,"score_spread":0.26537008869241574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540111953","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98350406,0.0033598496,0.000021434686,0.012054505,0.00014524815,0.00056469266,0.000034322413,0.000019451976,0.00029645822],"genre_scores_gemma":[0.997621,0.0015699972,0.00012829243,0.000170505,0.00008500408,0.00005457974,0.0000037238344,0.000016367909,0.00035054947],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99864286,0.00015399956,0.00035142372,0.00023606724,0.00025935099,0.00035631456],"domain_scores_gemma":[0.999031,0.0001941872,0.00011224745,0.00035711864,0.000024362074,0.00028107708],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047303882,0.000113187656,0.00025668752,0.00011596331,0.00005078165,0.0000046359955,0.00009407276,0.000035795372,0.00002982594],"category_scores_gemma":[0.00015473917,0.00006077003,0.000064697975,0.00019720828,0.000052283376,0.000035535944,0.000029022312,0.00007116377,0.000026964539],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014581134,0.0009212457,0.83368653,0.00050989434,0.0000759891,0.00020777469,0.0010398843,0.00018275602,0.00034554512,0.009640407,0.000875905,0.15105596],"study_design_scores_gemma":[0.0039017175,0.00036062227,0.9058283,0.0013028552,0.000020419831,0.000005375927,0.00018735544,0.0009285094,0.00015804425,0.005090691,0.08210955,0.00010656551],"about_ca_topic_score_codex":0.003611319,"about_ca_topic_score_gemma":0.000053834803,"teacher_disagreement_score":0.1509494,"about_ca_system_score_codex":0.00025428174,"about_ca_system_score_gemma":0.0004532291,"threshold_uncertainty_score":0.5459258},"labels":[],"label_agreement":null},{"id":"W2540140777","doi":"10.1016/j.jval.2016.09.988","title":"The Risk of Falls and Fractures Among Those with Overactive Bladder: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Overactive bladder; Odds ratio; Falls in older adults; CINAHL; Prospective cohort study; Odds; Poison control; Internal medicine; Injury prevention; Demography; Emergency medicine; Logistic regression; Psychological intervention","score_opus":0.03370604194456494,"score_gpt":0.3568974206333506,"score_spread":0.32319137868878567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540140777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008273986,0.99068975,0.000004870617,0.00018780115,0.000048701924,0.008696836,0.00007564534,0.000016929034,0.00019672395],"genre_scores_gemma":[0.00006894262,0.99884945,0.000089251575,0.00017900555,0.000026482969,0.0005259028,0.000015738346,0.000055576715,0.00018966247],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9958391,0.0016544086,0.0013094337,0.00040232117,0.000441415,0.00035331835],"domain_scores_gemma":[0.9943722,0.0023753308,0.0021746024,0.0008428948,0.000068744564,0.0001662476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015215105,0.0004341151,0.0039577046,0.00014148641,0.00008952331,0.0000113906635,0.00016043476,0.00015455038,0.000010351683],"category_scores_gemma":[0.0011895613,0.0001726311,0.00024561468,0.00027875826,0.0001539401,0.00005366614,0.000044243123,0.00047927417,0.000015197209],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019830351,0.000091988855,0.00027461152,0.9296369,0.00083368324,0.000018303163,0.00017296973,2.7033792e-7,2.4898126e-9,0.000024385316,0.00016212156,0.06876495],"study_design_scores_gemma":[0.0006806167,0.0003678974,0.00030076312,0.97407407,0.0030286894,0.000083182684,0.000051671475,0.0000044721633,3.9833818e-8,0.00004795512,0.021216588,0.00014407282],"about_ca_topic_score_codex":0.0020008627,"about_ca_topic_score_gemma":0.0001117091,"teacher_disagreement_score":0.06862087,"about_ca_system_score_codex":0.00034260377,"about_ca_system_score_gemma":0.0010495012,"threshold_uncertainty_score":0.7039692},"labels":[],"label_agreement":null},{"id":"W2540214683","doi":"10.1016/j.jval.2016.09.1827","title":"Identification and Management of Patients with Statin Intolerance in Saudi Arabia and the United Arab Emirates: Comparison of Results from a Clinician Survey","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Ezetimibe; Discontinuation; Concomitant; Fibrate; Family medicine; Internal medicine","score_opus":0.05091397687387444,"score_gpt":0.32305111330848535,"score_spread":0.2721371364346109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540214683","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99640733,0.0010043592,0.00029473996,0.00086201867,0.000033956414,0.0012483435,0.00013442,0.0000044208464,0.000010409504],"genre_scores_gemma":[0.99720865,0.002225482,0.00036800271,0.0000823757,0.000009616135,0.000019775865,0.00006925628,0.00000825279,0.000008578887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759,0.00078964117,0.00093259173,0.00024184967,0.000299302,0.00014658364],"domain_scores_gemma":[0.998609,0.00040042627,0.0004590941,0.00036833898,0.000103822786,0.0000592902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036738357,0.0000852816,0.0004940679,0.00012011729,0.000025620793,0.0000043141217,0.000051087107,0.000038887705,8.645454e-7],"category_scores_gemma":[0.00017100206,0.000047402737,0.00002022217,0.00036685762,0.00013408704,0.00003490923,0.000023030263,0.000101386904,3.5385648e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031783415,0.00021293186,0.96098524,0.00077404105,0.0000549528,9.807738e-7,0.0022425645,0.000106092826,0.000004532203,0.00014689006,0.00001733308,0.03227611],"study_design_scores_gemma":[0.012964057,0.0002629357,0.9830553,0.0021430708,0.000015115944,1.6109455e-7,0.0003121751,0.0009897781,0.00004336269,0.0001129212,0.000054676857,0.000046470428],"about_ca_topic_score_codex":0.052575413,"about_ca_topic_score_gemma":0.0026780982,"teacher_disagreement_score":0.049897313,"about_ca_system_score_codex":0.000061220344,"about_ca_system_score_gemma":0.000076585355,"threshold_uncertainty_score":0.95373356},"labels":[],"label_agreement":null},{"id":"W2540353830","doi":"10.1016/j.jval.2016.08.366","title":"Identification of Statin Intolerance: Results From A Survey of Clinicians in Taiwan","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Internal medicine; Creatine kinase; Physical therapy","score_opus":0.06280279987977974,"score_gpt":0.34439576369363706,"score_spread":0.28159296381385734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540353830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994565,0.0009944235,0.0007051152,0.0023750633,0.00015074789,0.0006815381,0.00047520286,0.000009238432,0.000043686756],"genre_scores_gemma":[0.9983813,0.00085305865,0.00049561256,0.000110741945,0.000051926618,0.000013531189,0.00005013974,0.000013168978,0.00003050932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99653345,0.00087681186,0.001692631,0.0002861282,0.00038927371,0.00022173063],"domain_scores_gemma":[0.9983333,0.00030514802,0.0005253693,0.0005986357,0.00014758854,0.00008996683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0076468363,0.000083032646,0.0005947995,0.00017798351,0.000012664496,0.0000018125656,0.000082172875,0.00008268469,0.000007671098],"category_scores_gemma":[0.001643717,0.0000618225,0.00007054634,0.00043690123,0.00005464382,0.000044029977,0.00001626496,0.00013336467,0.000005359589],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028287745,0.0008508119,0.64252174,0.0014515164,0.000074433854,0.000015083318,0.0069797807,0.00043834062,0.004990796,0.00028273853,0.00029023056,0.33927575],"study_design_scores_gemma":[0.004393515,0.00027468646,0.99130183,0.0013956211,0.0000050359104,0.0000010321145,0.00018543495,0.00053849065,0.001406194,0.0003157283,0.00012597308,0.000056480563],"about_ca_topic_score_codex":0.19249828,"about_ca_topic_score_gemma":0.0072184736,"teacher_disagreement_score":0.34878007,"about_ca_system_score_codex":0.00018246911,"about_ca_system_score_gemma":0.00083294214,"threshold_uncertainty_score":0.8128789},"labels":[],"label_agreement":null},{"id":"W2540560381","doi":"10.1016/j.jval.2016.09.223","title":"To Treat or Watch? Identifying Drivers of Decisions for Patients with GEP-NET Using Reflective Multi-Criteria Decision Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Watchful waiting; Lanreotide; Medicine; Actuarial science; Decision quality; Psychological intervention; Intensive care medicine; Surgery; Internal medicine; Economics; Patient satisfaction; Nursing","score_opus":0.14682131390380243,"score_gpt":0.4662197085444857,"score_spread":0.31939839464068326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540560381","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95854837,0.000035950365,0.039216653,0.00048374018,0.00006599092,0.0015300026,0.000095761345,0.000018288874,0.000005271237],"genre_scores_gemma":[0.86052704,0.00011606701,0.1390415,0.000083639,0.000018751454,0.000037579666,0.000008693873,0.000028203622,0.00013853502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99776644,0.00016167886,0.00054864545,0.00046890537,0.0005431138,0.0005112401],"domain_scores_gemma":[0.99736553,0.0013837822,0.00017362591,0.0003954685,0.0003373345,0.00034428382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032789583,0.00015794947,0.0005805984,0.00082117954,0.00009553821,0.000011849868,0.00013545596,0.000012348512,0.00004240632],"category_scores_gemma":[0.0022221012,0.000089545225,0.00009634632,0.0013969026,0.000054570744,0.0001702783,0.0000765899,0.000086220854,0.00000488405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.015004545,0.0013397065,0.9293516,0.00044664866,0.00024612318,0.00026946608,0.0011955149,0.0039893775,0.008747406,0.000019695462,0.0004331088,0.03895679],"study_design_scores_gemma":[0.055985715,0.023178713,0.8587854,0.012131515,0.0009374203,0.0001240849,0.0016839802,0.021773677,0.021737898,0.0010348731,0.0016085907,0.001018158],"about_ca_topic_score_codex":0.0010826308,"about_ca_topic_score_gemma":0.0006417848,"teacher_disagreement_score":0.099824846,"about_ca_system_score_codex":0.00055716117,"about_ca_system_score_gemma":0.00028491748,"threshold_uncertainty_score":0.36515483},"labels":[],"label_agreement":null},{"id":"W2540798315","doi":"10.1016/j.jval.2016.09.1882","title":"Cost Effectiveness of Empagliflozin in Patients with T2DM and High CV Risk in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"LMC Diabetes & Endocrinology (Canada); Boehringer Ingelheim (Canada)","funders":"","keywords":"Empagliflozin; Medicine; Cost–benefit analysis; Quality-adjusted life year; Hazard ratio; Demography; Emergency medicine; Cost effectiveness; Confidence interval; Internal medicine; Type 2 diabetes; Diabetes mellitus; Risk analysis (engineering); Endocrinology","score_opus":0.013972489305047619,"score_gpt":0.24531437140533663,"score_spread":0.231341882100289,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540798315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983863,0.0001267143,0.000006302452,0.00022902415,0.00005769119,0.0011070868,0.000022595152,0.000003668557,0.000060578488],"genre_scores_gemma":[0.99962366,0.00013168041,0.00009783119,0.000067416404,0.000004594695,0.000040834195,0.000008610447,0.000008724626,0.000016655233],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990517,0.00019427967,0.00021590998,0.00016450159,0.000155391,0.00021824354],"domain_scores_gemma":[0.9994821,0.00021884414,0.00007783962,0.00013010924,0.000017301933,0.00007378334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041061122,0.00008420462,0.0002968436,0.0001431919,0.000008680193,0.0000013705439,0.000027184218,0.000017938306,0.0000057919888],"category_scores_gemma":[0.0000444258,0.000052760057,0.0000067691035,0.0001793905,0.000019397457,0.00003449246,0.000018849398,0.0000555155,8.002438e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035844414,0.0001918966,0.97746104,0.00037421708,0.000015747808,0.000009890953,0.00007454406,0.00010274547,0.000001929429,0.00007712136,0.000025002963,0.021307401],"study_design_scores_gemma":[0.0089384215,0.00062159356,0.98857635,0.0015297354,0.000009073133,8.705607e-8,0.000031749707,0.000049694987,0.000058556565,0.00006829354,0.00006531999,0.000051140887],"about_ca_topic_score_codex":0.91473013,"about_ca_topic_score_gemma":0.62222075,"teacher_disagreement_score":0.29250935,"about_ca_system_score_codex":0.0010077133,"about_ca_system_score_gemma":0.00041940334,"threshold_uncertainty_score":0.38467273},"labels":[],"label_agreement":null},{"id":"W2540801981","doi":"10.1016/j.jval.2016.09.1539","title":"Health Care Resource Utilization and Costs Associated with the Management of Non-Infectious Intermediate, Posterior and Panuveitis in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada); Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"Medicine; Uveitis; Emergency medicine; Disease; Retrospective cohort study; Pediatrics; Infectious disease (medical specialty); Health care; Ophthalmology; Internal medicine","score_opus":0.011919829795575406,"score_gpt":0.2560002192787063,"score_spread":0.2440803894831309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540801981","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927091,0.002317824,0.0000082268525,0.004078291,0.000035322548,0.0007296191,0.000048232614,0.0000070114793,0.000066373796],"genre_scores_gemma":[0.99816173,0.0010560297,0.00001578418,0.00068501435,0.0000075298426,0.000014334205,0.000019265399,0.000012131274,0.00002820413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990224,0.0001334915,0.0002564149,0.00017844848,0.00018167128,0.00022757352],"domain_scores_gemma":[0.99949795,0.00006341749,0.00014053029,0.00013678282,0.000028930206,0.00013237626],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024485265,0.00008909174,0.00026089555,0.00007300077,0.000041484913,0.000005058728,0.000032524615,0.000023664228,0.0000041190797],"category_scores_gemma":[0.000015504922,0.000052700023,0.000010765804,0.0001821607,0.000041578067,0.000025495267,0.00003402989,0.00006542337,1.3921314e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001240784,0.00006586524,0.8257952,0.0012176145,0.000043871943,0.00008882329,0.0013696606,0.000011857562,0.0000065363974,0.000017143753,0.00022251993,0.17103687],"study_design_scores_gemma":[0.002222909,0.00059452007,0.9915032,0.003375556,0.000013789039,0.000027813448,0.0017997167,0.00013047027,0.0000052182695,0.0000027596068,0.00026549748,0.000058563113],"about_ca_topic_score_codex":0.59040314,"about_ca_topic_score_gemma":0.66270036,"teacher_disagreement_score":0.17097831,"about_ca_system_score_codex":0.0011150859,"about_ca_system_score_gemma":0.0007047945,"threshold_uncertainty_score":0.41232443},"labels":[],"label_agreement":null},{"id":"W2540885017","doi":"10.1016/j.jval.2016.09.580","title":"Contrasting The Characteristics Of Hta Submissions For Rare Versus Ultra-Rare Diseases","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Congenital Heart Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Medicine; Reimbursement; Rare disease; Disease; Intensive care medicine; Internal medicine; Health care","score_opus":0.06843524395323793,"score_gpt":0.34015275991247335,"score_spread":0.27171751595923543,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540885017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9792824,0.0035179602,0.00014380112,0.012994284,0.000569197,0.0016555757,0.0015117006,0.000056179204,0.00026891308],"genre_scores_gemma":[0.99891055,0.0002858227,0.0001121693,0.00021295839,0.00020498534,0.000070375805,0.0000164867,0.000018235287,0.00016843095],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988434,0.000081588405,0.00040281707,0.00017793242,0.00017789318,0.00031638265],"domain_scores_gemma":[0.9973739,0.0019413026,0.00010534451,0.00024719382,0.00012452694,0.00020775684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020553259,0.000110784065,0.00034015594,0.00005559636,0.000136343,0.000004105005,0.000068380854,0.000030395273,0.000034383025],"category_scores_gemma":[0.0026527562,0.000061271545,0.000095813426,0.00012153233,0.00010592684,0.000033994336,0.000023892064,0.00006826081,0.000004525473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075936317,0.000885954,0.62537843,0.0052984934,0.00028597933,0.000056095483,0.0026069612,0.0000029882494,0.0024438878,0.0024707257,0.006303701,0.3466732],"study_design_scores_gemma":[0.008078599,0.0011956629,0.9756974,0.0033345511,0.00018702052,0.000010654191,0.0013563085,0.0005573693,0.00030208062,0.00050778704,0.008549172,0.00022341673],"about_ca_topic_score_codex":0.00012327629,"about_ca_topic_score_gemma":0.000017749473,"teacher_disagreement_score":0.35031897,"about_ca_system_score_codex":0.00011025138,"about_ca_system_score_gemma":0.0004442007,"threshold_uncertainty_score":0.31757885},"labels":[],"label_agreement":null},{"id":"W2540898917","doi":"10.1016/j.jval.2016.09.1692","title":"Proton Pump Inhibitors and Major Adverse Cardiovascular Outcomes: A Systematic Review","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Clopidogrel; Observational study; Mace; Meta-analysis; Internal medicine; MEDLINE; Adverse effect; Stroke (engine); Population; Concomitant; Intensive care medicine; Systematic review; Myocardial infarction; Percutaneous coronary intervention","score_opus":0.04688973419482255,"score_gpt":0.32791915394278925,"score_spread":0.2810294197479667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540898917","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000013087264,0.9760866,0.000020782909,0.00017400914,0.0002010502,0.0233139,0.00004614065,0.00008423161,0.000060171926],"genre_scores_gemma":[0.0000074049753,0.9961426,0.00003846665,0.000599863,0.00016335242,0.0027149469,0.00004528485,0.00011466158,0.00017339295],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9936368,0.002137267,0.0020108612,0.00077649613,0.0008724364,0.00056616095],"domain_scores_gemma":[0.99708813,0.00023850545,0.00060489326,0.0015691743,0.00006456184,0.00043474103],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0041392604,0.0006832364,0.009988227,0.0003437995,0.00008309612,0.00001300652,0.00018573864,0.00030812382,0.000028170734],"category_scores_gemma":[0.0005510151,0.00039849916,0.0039852676,0.0004555623,0.00008301247,0.00007740268,0.000074268704,0.0004510352,0.0001370053],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000064009982,0.000052238713,0.000039127313,0.8966878,0.002757747,0.00020118583,0.000021772486,2.7236507e-7,2.45268e-9,0.000021595284,0.000048636848,0.10016319],"study_design_scores_gemma":[0.00071936107,0.00007506723,0.000005756977,0.6295025,0.004696847,0.0004889498,0.000010452757,5.832421e-7,5.272153e-8,0.0000064557985,0.36425677,0.00023722353],"about_ca_topic_score_codex":0.00019317605,"about_ca_topic_score_gemma":7.763528e-7,"teacher_disagreement_score":0.36420813,"about_ca_system_score_codex":0.00047164076,"about_ca_system_score_gemma":0.0011257294,"threshold_uncertainty_score":0.9998467},"labels":[],"label_agreement":null},{"id":"W2540988172","doi":"10.1016/j.jval.2016.09.1496","title":"Measuring the Relationship between Hospital Costs and Quality of Care: An Example of Acute Myocardial Infraction in Edmonton, Alberta, Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Health care; Actuarial science; Proxy (statistics); Population; Quality (philosophy); Emergency medicine; Operations management; Medical emergency; Statistics; Business; Environmental health; Economics","score_opus":0.41427154196758803,"score_gpt":0.39648358298344977,"score_spread":0.017787958984138263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2540988172","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867138,0.0008140111,0.00015780868,0.010935923,0.0002634386,0.0006318245,0.00025174837,0.0000048013885,0.00022659232],"genre_scores_gemma":[0.9991429,0.000111969006,0.00020215695,0.00036278446,0.00010000797,0.000031788088,0.000016793922,0.000013685835,0.0000179439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9946518,0.0011453687,0.0034524878,0.00034225587,0.00012706559,0.00028105374],"domain_scores_gemma":[0.99192905,0.0054683425,0.0020029985,0.0004193521,0.00005488559,0.00012539211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014710597,0.00011106153,0.0007705311,0.00019859552,0.00008842269,0.000010109413,0.00015411098,0.00009435183,0.0000074909967],"category_scores_gemma":[0.0028506932,0.00010612001,0.000040237283,0.00019515993,0.00006142278,0.0003478087,0.00002960885,0.00014883444,0.000005039102],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012571847,0.000018405754,0.9699071,0.00022961435,0.000016669728,6.814205e-8,0.0040962473,0.0001208492,8.1963015e-7,0.025187798,0.00009416914,0.0003156729],"study_design_scores_gemma":[0.00066000986,0.00009512484,0.99474734,0.00015426193,0.0000025176737,2.988594e-7,0.0009521447,0.0000937717,0.0000041546346,0.002492442,0.00068674685,0.00011119751],"about_ca_topic_score_codex":0.98738617,"about_ca_topic_score_gemma":0.8169795,"teacher_disagreement_score":0.17040661,"about_ca_system_score_codex":0.0018825119,"about_ca_system_score_gemma":0.000945287,"threshold_uncertainty_score":0.5098429},"labels":[],"label_agreement":null},{"id":"W2541096280","doi":"10.1016/j.jval.2016.09.1826","title":"Identification of Statin Intolerance: Results from a Survey of Clinicians in Six European Countries","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Discontinuation; European commission; myalgia; Family medicine; Internal medicine; Physical therapy; European union","score_opus":0.0547740678631304,"score_gpt":0.3296423393531061,"score_spread":0.2748682714899757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541096280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951842,0.0012605565,0.00050989015,0.0015627004,0.00015484977,0.00059568544,0.0006077337,0.00001163591,0.000112754686],"genre_scores_gemma":[0.997101,0.0022889606,0.00027066574,0.00016119606,0.00006524577,0.000006095601,0.000053178606,0.000017437353,0.00003623599],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99582666,0.0015611239,0.0017082721,0.00028296444,0.00040263863,0.00021836163],"domain_scores_gemma":[0.99808204,0.00053425384,0.000555655,0.0005689351,0.00017805214,0.00008104175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010692611,0.00008845932,0.00054804684,0.00015351927,0.000016845022,0.0000030634403,0.00009175133,0.000051758903,0.0000075935122],"category_scores_gemma":[0.0016574754,0.00006584955,0.00006077637,0.00033462018,0.00007579758,0.00005017489,0.000020038557,0.00012498687,0.000012441898],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00361422,0.0007202155,0.8096603,0.0020715608,0.00009595293,0.000034785622,0.009176149,0.00054255937,0.0023964741,0.00044455784,0.0005467506,0.17069647],"study_design_scores_gemma":[0.0038658406,0.00024488737,0.9923467,0.0015442915,0.000005657719,0.0000011507706,0.00012588149,0.00023851077,0.00093068485,0.00009818144,0.00053943467,0.000058752503],"about_ca_topic_score_codex":0.14164582,"about_ca_topic_score_gemma":0.005157916,"teacher_disagreement_score":0.18268642,"about_ca_system_score_codex":0.00015104661,"about_ca_system_score_gemma":0.000629887,"threshold_uncertainty_score":0.86407006},"labels":[],"label_agreement":null},{"id":"W2541115330","doi":"10.1016/j.jval.2016.09.996","title":"Estimating The Economic and Clinical Benefits of Mirabegron Versus Antimuscarinics for The Treatment of Overactive Bladder (OAB) in The United Kingdom (UK)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Mirabegron; Tolterodine; Overactive bladder; Oxybutynin; Medicine; Solifenacin; Urology; Discontinuation; Persistence (discontinuity); Internal medicine","score_opus":0.23244306501809342,"score_gpt":0.45065249787508915,"score_spread":0.21820943285699573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541115330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98950475,0.0007377728,0.000032472013,0.008104173,0.00014590363,0.0013471823,0.000050406346,0.0000030136225,0.00007430261],"genre_scores_gemma":[0.99626434,0.0031198475,0.0003490146,0.00009375654,0.00010434809,0.000038753948,0.0000064530036,0.000010434169,0.000013042161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985919,0.00035624643,0.0005088557,0.00017353188,0.00013197085,0.00023750168],"domain_scores_gemma":[0.98999566,0.009432091,0.0001801935,0.00030845692,0.000038519203,0.00004507633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001866676,0.00009307156,0.00028640617,0.000087639644,0.00007431409,0.0000062957024,0.00010822808,0.000051294,0.000011411571],"category_scores_gemma":[0.00023797159,0.000037311653,0.000068965535,0.00012926522,0.00016007519,0.000030598825,0.000025021078,0.00013298514,9.5832e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019409714,0.0026227976,0.5028843,0.0007994969,0.0009689631,0.000014791199,0.02622508,0.020309774,0.000062983905,0.010463795,0.0005819135,0.41565636],"study_design_scores_gemma":[0.026666211,0.023133693,0.76968396,0.00088189536,0.00018349517,0.000028446311,0.0025642752,0.17130207,0.00023193438,0.001017834,0.0041256337,0.00018053506],"about_ca_topic_score_codex":0.008403622,"about_ca_topic_score_gemma":0.00028793808,"teacher_disagreement_score":0.41547582,"about_ca_system_score_codex":0.00014404676,"about_ca_system_score_gemma":0.00036682232,"threshold_uncertainty_score":0.9981995},"labels":[],"label_agreement":null},{"id":"W2541118887","doi":"10.1016/j.jval.2016.09.1003","title":"Assessing The Cost-Utility of Etelcalcetide: A Markov Model","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Cinacalcet; Calcimimetic; Medicine; Cost effectiveness; Secondary hyperparathyroidism; Internal medicine; Parathyroid hormone; Risk analysis (engineering)","score_opus":0.11327866254793244,"score_gpt":0.40679142997874657,"score_spread":0.2935127674308141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541118887","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824815,0.0029284328,0.0030513403,0.007462538,0.000052938973,0.0006221382,0.000014555581,0.000016734946,0.0033698694],"genre_scores_gemma":[0.9976338,0.00038620044,0.001278581,0.0004704789,0.000014118878,0.000021987804,0.0000020475081,0.000008554551,0.00018423432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989788,0.00014315083,0.00031022954,0.0001615126,0.00017526974,0.00023104042],"domain_scores_gemma":[0.9992906,0.00019160363,0.00010318969,0.00029536622,0.000031458836,0.000087789704],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063978106,0.000080690144,0.00023211233,0.000045895435,0.00004755148,0.0000050638464,0.000056800603,0.00003991482,0.0000117090785],"category_scores_gemma":[0.00014794289,0.000039761544,0.000050274957,0.00012699656,0.00006793023,0.00006312009,0.000021232776,0.00008073701,0.000008526455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033987622,0.0016064644,0.82038087,0.0002371855,0.00007447671,0.000026182879,0.001169879,0.0006138605,0.0011337418,0.001575992,0.008783979,0.16405751],"study_design_scores_gemma":[0.0071544447,0.00034204294,0.783359,0.00051199197,0.000033552053,0.00002355078,0.00027659346,0.2008108,0.00056436413,0.005807039,0.0009739944,0.00014263569],"about_ca_topic_score_codex":0.0010643337,"about_ca_topic_score_gemma":0.000018972554,"teacher_disagreement_score":0.20019695,"about_ca_system_score_codex":0.00009002978,"about_ca_system_score_gemma":0.00042706,"threshold_uncertainty_score":0.16214286},"labels":[],"label_agreement":null},{"id":"W2541171690","doi":"10.1016/j.jval.2016.08.233","title":"Influence of Cochrane Evidence on Medical Policies of Oncology Drugs in the United States","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Context (archaeology); Cochrane Library; Systematic review; Family medicine; Cochrane collaboration; Guideline; Quarter (Canadian coin); Business; MEDLINE; Internal medicine; Political science; Meta-analysis","score_opus":0.3885955164518271,"score_gpt":0.48894369645763275,"score_spread":0.10034818000580564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541171690","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8329778,0.0019420536,0.000058941107,0.16423832,0.000102371174,0.0004160572,0.000056022258,0.000007075215,0.00020139484],"genre_scores_gemma":[0.97411615,0.0062995018,0.00012918602,0.019327939,0.000050023526,0.000041190116,0.000004210686,0.000010145513,0.000021630667],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99280745,0.0018101747,0.004477855,0.00029452328,0.00022545,0.00038457388],"domain_scores_gemma":[0.9827845,0.014443788,0.002119898,0.00046666097,0.00006398023,0.00012115281],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04079134,0.00011354287,0.00091241556,0.0006920075,0.000028923256,0.000003904241,0.00049105496,0.000134464,0.00011158347],"category_scores_gemma":[0.01605271,0.00008937617,0.000046276768,0.00044748696,0.0002442818,0.00016190353,0.0000394793,0.00019712541,0.0000986999],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001444709,0.00060620194,0.349745,0.002787553,0.00002599659,0.0000028254233,0.063910045,0.029487165,0.000008958514,0.54653996,0.0058407285,0.00090109714],"study_design_scores_gemma":[0.004202263,0.0027292885,0.86170244,0.013542077,0.0000038200933,0.000014480862,0.008462825,0.017457113,0.000050320774,0.056388825,0.034925055,0.0005214856],"about_ca_topic_score_codex":0.091999836,"about_ca_topic_score_gemma":0.000764389,"teacher_disagreement_score":0.51195747,"about_ca_system_score_codex":0.0010712615,"about_ca_system_score_gemma":0.0009826194,"threshold_uncertainty_score":0.9922355},"labels":[],"label_agreement":null},{"id":"W2541374879","doi":"10.1016/j.jval.2016.08.744","title":"A Cost-Utility Analysis of the Risk Model-Guided Antiemetic Prophylaxis Versus Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Net-Benefit Regression Approach","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Nausea and vomiting management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Antiemetic; Breast cancer; Nausea; Vomiting; Randomized controlled trial; Willingness to pay; Cost effectiveness; Quality-adjusted life year; Chemotherapy-induced nausea and vomiting; Cancer; Emergency medicine; Internal medicine","score_opus":0.07089054980597101,"score_gpt":0.34369158779920556,"score_spread":0.2728010379932345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541374879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949726,0.000086493244,0.0012647925,0.0007949033,0.00010909283,0.0024989063,0.0001747736,0.000019955864,0.00007847374],"genre_scores_gemma":[0.9982185,0.00027947236,0.0009887671,0.00017567097,0.000043876076,0.00014851318,0.000010207289,0.00002495591,0.00011008741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979071,0.00022616869,0.0006050699,0.00045134738,0.00039644894,0.0004138518],"domain_scores_gemma":[0.9984337,0.000238101,0.0005205304,0.000587837,0.00013117015,0.00008864775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010417907,0.0001810724,0.00060244085,0.00032007034,0.000085199514,0.000008278573,0.00018136324,0.000076575365,0.000005648321],"category_scores_gemma":[0.00020041388,0.00010594103,0.00018597362,0.0012783072,0.00005632038,0.0000706248,0.000046178775,0.00017544962,2.9537898e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012978774,0.0005248876,0.91586745,0.00047875452,0.000178848,1.3568159e-7,0.0005704568,0.00673968,0.000041614552,0.000032761134,0.000058958274,0.07420858],"study_design_scores_gemma":[0.006648368,0.0002466421,0.8411107,0.00064309576,0.00012571874,3.4431938e-8,0.000036153986,0.15093626,0.00007195528,0.000048948463,0.00004004714,0.00009209147],"about_ca_topic_score_codex":0.018283147,"about_ca_topic_score_gemma":0.00042117303,"teacher_disagreement_score":0.14419658,"about_ca_system_score_codex":0.00055847975,"about_ca_system_score_gemma":0.00017420395,"threshold_uncertainty_score":0.9882542},"labels":[],"label_agreement":null},{"id":"W2541447616","doi":"10.1016/j.jval.2016.09.1541","title":"Follow-Up Imaging After Nephrectomy in Canada: Urologists’ Compliance with Guidelines and Cost of Surveillance","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Nephrectomy; Guideline; Cohort; Renal cell carcinoma; Stage (stratigraphy); Population; Kidney cancer; Surgery; General surgery; Internal medicine; Kidney","score_opus":0.07945701525497316,"score_gpt":0.304048522511601,"score_spread":0.22459150725662785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541447616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98550016,0.00507045,0.00007863768,0.008622174,0.00007593768,0.0005286107,0.000019253534,0.000007885551,0.00009689725],"genre_scores_gemma":[0.9972233,0.0004538354,0.00130567,0.0008811244,0.00002440709,0.000040476567,0.0000026032264,0.000013849657,0.000054686676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986808,0.0001077263,0.00044130237,0.0002535344,0.00021151036,0.00030517846],"domain_scores_gemma":[0.999252,0.00018030453,0.00012361798,0.00022782209,0.00009312888,0.0001231331],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038083032,0.00012506054,0.0003974888,0.0000812792,0.000012504159,0.0000023431928,0.00004565675,0.000018206123,0.000009182353],"category_scores_gemma":[0.000094756484,0.00007599112,0.000015407657,0.00016139589,0.000063053056,0.000030279767,0.000021552423,0.0000752065,0.0000010426463],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005308565,0.000018767107,0.9907637,0.0001696049,0.0000062360587,0.0001752029,0.00005420637,0.00006964233,0.00006434445,0.000008462662,0.00021317585,0.007925774],"study_design_scores_gemma":[0.0033741104,0.00016726031,0.99338764,0.00083631393,0.000003257942,0.000071069946,0.000036447844,0.00084979855,0.00015346428,0.00001727503,0.0010250767,0.00007827323],"about_ca_topic_score_codex":0.88748723,"about_ca_topic_score_gemma":0.7939832,"teacher_disagreement_score":0.09350405,"about_ca_system_score_codex":0.00080337876,"about_ca_system_score_gemma":0.0014554982,"threshold_uncertainty_score":0.30988282},"labels":[],"label_agreement":null},{"id":"W2541492109","doi":"10.1016/j.jval.2016.08.595","title":"The Impact of Duration on EQ‐5D‐5l Value Sets Derived from a Discrete Choice Experiment","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Respondent; Life expectancy; Econometrics; Statistics; Quality of life (healthcare); Quality-adjusted life year; Censoring (clinical trials); Time-trade-off; Valuation (finance); Choice set; Mathematics; Psychology; Demography; Economics; Population; Cost effectiveness","score_opus":0.39091030224383405,"score_gpt":0.45037648218196175,"score_spread":0.059466179938127695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541492109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9491894,0.0025112606,0.0012507831,0.04439737,0.0005580063,0.0010600851,0.0005439367,0.000029961031,0.00045915466],"genre_scores_gemma":[0.9965214,0.0006400189,0.0006905681,0.0016157107,0.00025628533,0.00012802462,0.00002262885,0.00003392247,0.00009144349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936181,0.0010457812,0.0041099833,0.00053804286,0.00014148235,0.00054666284],"domain_scores_gemma":[0.9924897,0.0038514906,0.0026561732,0.0007373941,0.000038944923,0.00022629176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010564769,0.00021734131,0.00082495844,0.00021867936,0.00022956998,0.000046021374,0.000313379,0.00011650907,0.00015125859],"category_scores_gemma":[0.0032705348,0.00016359458,0.00016535717,0.00017473116,0.00008179012,0.00028014538,0.000044943496,0.00014434278,0.0004144017],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067411346,0.0010961884,0.55460083,0.00085225934,0.000646669,0.0000037865161,0.03448378,0.03635167,0.0013142098,0.32881826,0.033020955,0.008137252],"study_design_scores_gemma":[0.0039681736,0.0012558566,0.8942566,0.0012512319,0.00000436466,0.0000023653415,0.001112355,0.041632727,0.00047318503,0.048516598,0.006848416,0.00067815505],"about_ca_topic_score_codex":0.074415475,"about_ca_topic_score_gemma":0.00049075886,"teacher_disagreement_score":0.33965573,"about_ca_system_score_codex":0.0022773102,"about_ca_system_score_gemma":0.0005308416,"threshold_uncertainty_score":0.9317481},"labels":[],"label_agreement":null},{"id":"W2541518521","doi":"10.1016/j.jval.2016.08.364","title":"Identification of Statin Intolerance: Results From A Survey of South Korean Clinicians","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Discontinuation; Internal medicine; Creatine kinase; Elevated transaminases; myalgia; Shoulders; Physical therapy; Surgery","score_opus":0.06689159316587932,"score_gpt":0.33439207756323075,"score_spread":0.2675004843973514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541518521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941683,0.0007627697,0.0019124288,0.0011678057,0.00017844875,0.0006570608,0.0010820518,0.000016051206,0.000055090353],"genre_scores_gemma":[0.9983101,0.0006821677,0.000649464,0.00011650633,0.00008735236,0.000009841501,0.00007715861,0.000016965578,0.000050449413],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99665415,0.00076700887,0.0015879007,0.00030907168,0.00045424342,0.00022764894],"domain_scores_gemma":[0.99782985,0.00039988384,0.0006962482,0.00073440967,0.00021594978,0.00012368344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065921675,0.00009511782,0.00060903706,0.00012900002,0.000022005133,0.0000023617724,0.00009026047,0.00008307456,0.000009269759],"category_scores_gemma":[0.0016254428,0.0000673685,0.00010266722,0.00032868923,0.00007008332,0.000038532133,0.000018314038,0.00011968984,0.000009308434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046128654,0.0009539786,0.53761154,0.002304067,0.0002585438,0.000014174021,0.0167752,0.000385032,0.0058591994,0.00050387275,0.00064341864,0.4300781],"study_design_scores_gemma":[0.004266573,0.0003653281,0.9898378,0.0012274694,0.00001408055,0.0000013492319,0.00023969103,0.00046642157,0.0031172687,0.00027231674,0.00011897028,0.000072680195],"about_ca_topic_score_codex":0.12395297,"about_ca_topic_score_gemma":0.0012353376,"teacher_disagreement_score":0.45222628,"about_ca_system_score_codex":0.00012004969,"about_ca_system_score_gemma":0.00078035623,"threshold_uncertainty_score":0.8818807},"labels":[],"label_agreement":null},{"id":"W2541589956","doi":"10.1016/j.jval.2016.09.1675","title":"Risk of Mortality and Hospital Readmission Among Older Adults with Heart Failure Treated with Carvedilol, Bisoprolol or Metoprolol Tartrate","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Bisoprolol; Carvedilol; Metoprolol Tartrate; Metoprolol; Medicine; Heart failure; Propensity score matching; Clinical endpoint; Internal medicine; Cardiology; Proportional hazards model; Randomized controlled trial","score_opus":0.018642567205404706,"score_gpt":0.27337619893152443,"score_spread":0.25473363172611974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541589956","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988341,0.00013700113,0.000061146035,0.008813831,0.000021615908,0.0024904227,0.000025946158,0.00007301153,0.000036043068],"genre_scores_gemma":[0.9954405,0.00027044865,0.003631492,0.000111438814,0.000040485786,0.0001143998,0.0000144873,0.00003248436,0.00034427992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980806,0.00020678015,0.00044184993,0.00049542,0.0003490504,0.0004263008],"domain_scores_gemma":[0.99881977,0.00009707775,0.0002228318,0.00040935611,0.000090984475,0.00035998764],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052518625,0.00026276676,0.00061322557,0.00017360279,0.000068833724,0.000008921185,0.000042964642,0.000100025456,0.000057825833],"category_scores_gemma":[0.000061950785,0.000118606935,0.000041660045,0.00031109215,0.00015682785,0.00015227549,0.000025294496,0.00015279048,0.000004065551],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014389585,0.00042465533,0.9942194,0.00049933064,0.00014075972,0.00008061236,0.0006349199,0.000008923615,0.000044392986,0.000020477102,0.000909022,0.0015784961],"study_design_scores_gemma":[0.008958273,0.008564205,0.9764151,0.002832251,0.00018154962,0.000026359032,0.00042788492,0.00019967594,0.0010670169,0.000013606877,0.0011119046,0.00020218074],"about_ca_topic_score_codex":0.016063593,"about_ca_topic_score_gemma":0.0023089554,"teacher_disagreement_score":0.017804358,"about_ca_system_score_codex":0.00011649756,"about_ca_system_score_gemma":0.0002585292,"threshold_uncertainty_score":0.9904885},"labels":[],"label_agreement":null},{"id":"W2541597280","doi":"10.1016/j.jval.2016.09.1216","title":"Adding A Decision Aid to Asthma Education: Impact on Decisional Conflict and Appropriate Medication Usage","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Behavioral Health and Interventions","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Asthma; Medicine; Psychology; Internal medicine","score_opus":0.10144733140434008,"score_gpt":0.46872504972176654,"score_spread":0.36727771831742645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541597280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873401,0.0008583642,0.0024582222,0.0065038633,0.0013457795,0.00065737497,0.0000563924,0.00003242908,0.00074747176],"genre_scores_gemma":[0.9941623,0.00016657867,0.0027486826,0.0020623668,0.00019993515,0.000147572,0.000012650322,0.000019144762,0.00048074996],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980247,0.00030170468,0.0006084509,0.0004068388,0.0002620548,0.00039623445],"domain_scores_gemma":[0.99839354,0.00051408866,0.00015955241,0.00034534957,0.00005434363,0.000533125],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0013480275,0.0001356049,0.00021298816,0.0003731391,0.00011638707,0.000016800032,0.00014443212,0.0001079324,0.0012950792],"category_scores_gemma":[0.0002104446,0.00009020679,0.00006014814,0.00026607397,0.000033919616,0.00009089314,0.000033662458,0.00016326352,0.0005601699],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000358289,0.0003518316,0.010030581,0.000012816092,0.0000035331145,0.0000016682385,0.0007218212,0.000011153356,0.000017803472,0.0074408017,0.014817491,0.9662322],"study_design_scores_gemma":[0.001716838,0.0019596412,0.86938226,0.0019843976,0.0000029394685,0.000042596264,0.0001897037,0.00009653881,0.000008339584,0.0023174973,0.122113265,0.00018599481],"about_ca_topic_score_codex":0.0028538608,"about_ca_topic_score_gemma":0.000060837723,"teacher_disagreement_score":0.9660462,"about_ca_system_score_codex":0.00035945605,"about_ca_system_score_gemma":0.0004436623,"threshold_uncertainty_score":0.9996179},"labels":[],"label_agreement":null},{"id":"W2541610978","doi":"10.1016/j.jval.2016.09.465","title":"A Restrospective Non-Interventional Study Among Patients with Relapsing Multiple Sclerosis Switching to Fingolimod or to Other Disease Modifying Therapies","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Fingolimod; Glatiramer acetate; Brace; Cohort; Internal medicine; Multiple sclerosis; Physical therapy; Pediatrics; Disease; Immunology","score_opus":0.10963606316816456,"score_gpt":0.34606819753326173,"score_spread":0.2364321343650972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541610978","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9889075,0.00006651726,0.003715393,0.0028994144,0.00010077975,0.0041586366,0.00006327252,0.00006752743,0.000020924403],"genre_scores_gemma":[0.99545497,0.000021646301,0.003330598,0.00034819127,0.00010551148,0.00053410925,0.0000023280847,0.00006864811,0.00013397416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99680316,0.00029575994,0.00057396083,0.0006999499,0.00089648686,0.0007306625],"domain_scores_gemma":[0.9979889,0.000501448,0.00014960757,0.00047214548,0.00022083307,0.0006670929],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000859884,0.00027291075,0.00051004434,0.00046492406,0.00030514022,0.000046390844,0.00017184758,0.00003455608,0.00004419907],"category_scores_gemma":[0.0016606838,0.00015970417,0.000086504464,0.0005524191,0.000055124216,0.0001926604,0.00020456826,0.000228109,0.00002542201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003974253,0.0018055941,0.97921914,0.00014656062,0.0001146155,0.000009681517,0.008413599,0.000632401,0.00034588916,0.000007899326,0.00010161477,0.0052287597],"study_design_scores_gemma":[0.0072663203,0.0030949125,0.9801337,0.0071910545,0.000013111508,2.4404173e-7,0.0010772273,0.0009476025,0.00002980255,0.00002055119,0.000030568597,0.00019490065],"about_ca_topic_score_codex":0.009331462,"about_ca_topic_score_gemma":0.002493742,"teacher_disagreement_score":0.0073363716,"about_ca_system_score_codex":0.0009863535,"about_ca_system_score_gemma":0.00024488283,"threshold_uncertainty_score":0.99726546},"labels":[],"label_agreement":null},{"id":"W2541695863","doi":"10.1016/j.jval.2016.09.2177","title":"Economic Evaluation of Targeted Therapies in Metastatic Clear Renal Cell Carcinoma in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Pazopanib; Sunitinib; Renal cell carcinoma; Cohort; Axitinib; Metastasectomy; Targeted therapy; Internal medicine; Kidney cancer; Cancer; Temsirolimus; Everolimus; Oncology; Nephrectomy; Metastasis; Kidney","score_opus":0.05884222490641769,"score_gpt":0.28982674212872045,"score_spread":0.23098451722230276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541695863","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420285,0.0031461944,0.0000017911696,0.0014398507,0.00008908744,0.0008501013,0.000018180655,0.0000035586256,0.00024840693],"genre_scores_gemma":[0.99936885,0.0001361573,0.00028390993,0.0000980392,0.000017305094,0.000044320204,0.000009316615,0.000017155791,0.000024938032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99782205,0.0006078128,0.00067735784,0.0002446018,0.00034154265,0.00030663778],"domain_scores_gemma":[0.999226,0.00020165583,0.0001841853,0.00024911063,0.000039452818,0.00009959736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014774296,0.0001254815,0.00041908488,0.0002831221,0.000010548017,0.0000018363353,0.00006193284,0.000027295404,0.00015164513],"category_scores_gemma":[0.00005147569,0.000090927555,0.000033489214,0.00015805163,0.000023192742,0.000046647834,0.000013180813,0.00009947449,0.000008305945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00052064896,0.00021810873,0.96780103,0.00040019193,0.000022558695,0.000083948966,0.001798928,0.013442405,0.0031683154,0.00008407814,0.0001740164,0.012285751],"study_design_scores_gemma":[0.005764726,0.0005323779,0.9741238,0.00028843258,0.000019975389,0.000008166995,0.00046181463,0.009843065,0.008508805,0.0003053854,0.00005013649,0.00009335028],"about_ca_topic_score_codex":0.9528009,"about_ca_topic_score_gemma":0.83589697,"teacher_disagreement_score":0.11690398,"about_ca_system_score_codex":0.006554183,"about_ca_system_score_gemma":0.00699431,"threshold_uncertainty_score":0.9986351},"labels":[],"label_agreement":null},{"id":"W2541744580","doi":"10.1016/j.jval.2016.09.233","title":"What Matters Most? An Exploration of Decision Criteria Considered by Patients with GEP-NET and Physicians Using Holistic Multi-Criteria Decision Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Autonomy; Intervention (counseling); Quality (philosophy); Multiple-criteria decision analysis; Decision support system; Health care; Population; Family medicine; Nursing; Operations research; Computer science; Data mining; Environmental health; Engineering","score_opus":0.4453992910377964,"score_gpt":0.4562850092858128,"score_spread":0.010885718248016374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541744580","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8461503,0.00075136666,0.1479017,0.0036425027,0.00040037124,0.00063589646,0.0005005254,0.000015589401,0.0000017550485],"genre_scores_gemma":[0.96730584,0.0005676855,0.02794569,0.0039602183,0.000046878748,0.000025981533,0.00010205532,0.000036907422,0.0000087443605],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99495834,0.00060286536,0.0032293063,0.00067442807,0.00015172493,0.00038333423],"domain_scores_gemma":[0.99590963,0.0012282092,0.0020217367,0.00052614254,0.00011837471,0.0001959079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055140653,0.00021382948,0.0011299276,0.0007265123,0.00013852645,0.00013340922,0.0001485351,0.00010528444,0.00007960092],"category_scores_gemma":[0.00089394144,0.00020858274,0.000054017455,0.000493025,0.00009689776,0.0029454797,0.000040047613,0.00007487467,0.00002874271],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010277146,0.0024559607,0.8855613,0.001932368,0.00056332425,0.000005058368,0.035799123,0.022657666,0.00029088216,0.0032757644,0.009375182,0.03705567],"study_design_scores_gemma":[0.014624832,0.0014607884,0.4474823,0.0058355657,0.00012568595,0.000004567128,0.0078105596,0.49222273,0.00006641691,0.026475234,0.0022029558,0.0016883803],"about_ca_topic_score_codex":0.004858357,"about_ca_topic_score_gemma":0.00068641076,"teacher_disagreement_score":0.46956506,"about_ca_system_score_codex":0.00055132475,"about_ca_system_score_gemma":0.000120952645,"threshold_uncertainty_score":0.85057575},"labels":[],"label_agreement":null},{"id":"W2541890720","doi":"10.1016/j.jval.2016.09.1489","title":"Impact of Initiation of Long-Acting Injectable Antipsychotics on Resource Utilization In Patients with Schizophrenia","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Schizophrenia (object-oriented programming); Pediatrics; Psychiatry","score_opus":0.06129585616980711,"score_gpt":0.35225707465343087,"score_spread":0.2909612184836238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541890720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99894226,0.00006707557,0.00008406463,0.00017066042,0.000017469436,0.0005874427,0.00001859345,0.000008937607,0.000103523205],"genre_scores_gemma":[0.99915755,0.00006661278,0.00068972196,0.000014610708,0.000014852616,0.0000057860047,0.000029926041,0.000015228947,0.000005686756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986683,0.00016065784,0.0003951863,0.00017275648,0.00035575888,0.00024733585],"domain_scores_gemma":[0.99917096,0.00018963827,0.00022193161,0.00022026671,0.00009478731,0.00010243701],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035522087,0.0000971829,0.00027751297,0.00040674806,0.000019116178,0.0000027311858,0.00004087094,0.000046199515,0.000019040579],"category_scores_gemma":[0.00026690384,0.00005838368,0.000033434895,0.0005103195,0.000032084226,0.00007153569,0.000010011885,0.000104932114,0.0000024985025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025517747,0.00082098343,0.94751215,0.00014116758,0.00002173568,0.000004184654,0.00016256067,0.0005384661,0.000031977455,0.00013250245,0.000009516792,0.025106983],"study_design_scores_gemma":[0.011458584,0.004941528,0.9807856,0.001733801,0.000004460592,0.0000011899516,0.000016873873,0.00028711054,0.0006246452,0.00009962835,0.0000011255307,0.00004543918],"about_ca_topic_score_codex":0.0008857723,"about_ca_topic_score_gemma":0.00010724644,"teacher_disagreement_score":0.033273436,"about_ca_system_score_codex":0.00039859652,"about_ca_system_score_gemma":0.0005289109,"threshold_uncertainty_score":0.23808174},"labels":[],"label_agreement":null},{"id":"W2541931825","doi":"10.1016/j.jval.2016.09.169","title":"Identifying the Key Parameters of the European-Study on Quantifying Utility of Investment in Protection from Tobacco (EQUIPT) Model","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Investment (military); Transferability; Population; Econometrics; Computer science; Actuarial science; Business; Economics; Environmental health; Medicine; Political science","score_opus":0.7010600637857954,"score_gpt":0.43440576057104624,"score_spread":0.2666543032147492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2541931825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838183,0.00040464,0.00213175,0.010463123,0.00037982521,0.0021837736,0.000114037604,0.000012138219,0.0004923976],"genre_scores_gemma":[0.99774873,0.00006464502,0.00065809663,0.001365194,0.0000345124,0.000089987654,0.0000013188251,0.000020676505,0.00001681866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99157554,0.0032363308,0.0042157904,0.00049012975,0.00016003856,0.00032216895],"domain_scores_gemma":[0.99544525,0.0010819063,0.0025419458,0.0008404862,0.000028427521,0.00006196131],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.032417864,0.00014696212,0.0006804153,0.00026196963,0.00011239579,0.000018852279,0.00040934456,0.000057138135,0.000013919996],"category_scores_gemma":[0.0025742839,0.00010601889,0.00009639009,0.00032022296,0.000086939275,0.00019043482,0.000098346674,0.00022090162,0.00005381464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007152341,0.00074742484,0.92581695,0.00045803067,0.00004885438,4.868209e-7,0.029498553,0.023084342,0.000057537287,0.017819459,0.00025346284,0.002143357],"study_design_scores_gemma":[0.00128445,0.00015115435,0.91335213,0.00093750167,0.0000028141646,2.667715e-7,0.0030106963,0.05784019,0.00006174843,0.023100266,0.00010162105,0.00015715553],"about_ca_topic_score_codex":0.041150283,"about_ca_topic_score_gemma":0.0015998541,"teacher_disagreement_score":0.039550427,"about_ca_system_score_codex":0.0006318321,"about_ca_system_score_gemma":0.00021302202,"threshold_uncertainty_score":0.9963294},"labels":[],"label_agreement":null},{"id":"W2542010379","doi":"10.1016/j.jval.2016.09.1432","title":"Linguistic Validation of the Finnish Version of the Body-Q Pro Instrument","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Body Contouring and Surgery","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Debriefing; Cognitive interview; Psychology; Multidisciplinary approach; Cognition; Linguistics; Applied psychology; Medical education; Medicine; Social psychology; Sociology; Social science","score_opus":0.037409939671038124,"score_gpt":0.2822359392181061,"score_spread":0.24482599954706796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542010379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99174595,0.00009287432,0.00001029287,0.006673883,0.0005538498,0.00029020084,0.000004903551,0.0000066125317,0.0006214528],"genre_scores_gemma":[0.999361,0.000049402977,0.00004655994,0.00014084198,0.0001007066,0.00000333538,6.072541e-7,0.0000051022785,0.00029248412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991511,0.00014478217,0.00029000698,0.00008562166,0.00021616333,0.00011230857],"domain_scores_gemma":[0.9993144,0.00015587982,0.00017017499,0.00027621514,0.000053305404,0.000030020154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066283316,0.000044874138,0.00014438399,0.000035772213,0.000036984064,0.0000011943076,0.000070332455,0.000032322347,0.000012630628],"category_scores_gemma":[0.00077177095,0.000020203646,0.000054266704,0.00012721095,0.000048008893,0.000011066544,0.000033535398,0.00007326766,0.0000019849715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019410421,0.00029834197,0.96488446,0.0011985153,0.0000239462,0.0000018310759,0.0019055812,0.00012446764,0.008249681,0.0018663143,0.002378774,0.018873982],"study_design_scores_gemma":[0.0028668144,0.0004269461,0.8606758,0.009692802,0.000037080314,0.000007723566,0.00010027093,0.0008525143,0.108377606,0.0015433797,0.015297829,0.000121229335],"about_ca_topic_score_codex":0.0011707256,"about_ca_topic_score_gemma":0.0000050492176,"teacher_disagreement_score":0.104208656,"about_ca_system_score_codex":0.00010633628,"about_ca_system_score_gemma":0.00039315748,"threshold_uncertainty_score":0.17697947},"labels":[],"label_agreement":null},{"id":"W2542038413","doi":"10.1016/j.jval.2016.09.765","title":"Estimation Of Value Of Life With A Model Approach Depending On Net Present Value For Austria, Canada, Japan And Usa","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Climate Change Policy and Economics","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Per capita; Economics; Population; Value (mathematics); Human capital; Value of life; Present value; Demographic economics; Estimation; Unemployment; Demography; Geography; Socioeconomics; Economic growth; Statistics; Finance; Mathematics","score_opus":0.1586169172566441,"score_gpt":0.27608318737151843,"score_spread":0.11746627011487434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542038413","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986439,0.00027075163,0.009489331,0.0014222559,0.000079860685,0.00061335845,0.00091503066,0.000004811142,0.00076561456],"genre_scores_gemma":[0.99417484,0.00025429126,0.005204063,0.00017673557,0.000047434198,0.000048176782,0.000014985557,0.000020669906,0.000058801143],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985501,0.000022362625,0.0007696227,0.00030298642,0.00004051872,0.0003143845],"domain_scores_gemma":[0.9987829,0.00025890235,0.0005912702,0.00022492964,0.00001331264,0.00012870495],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007853392,0.00012618354,0.00049468735,0.00021393546,0.000049986553,0.000009389596,0.000110499255,0.00006805192,0.0000074064287],"category_scores_gemma":[0.0001544523,0.00011432387,0.00003357749,0.00009840346,0.00004052279,0.000105176056,0.000029181872,0.0000623796,0.000001358045],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014608428,0.00008898509,0.030144025,0.0006729432,0.000025775158,8.8164114e-8,0.000691655,0.6480941,0.0000028063828,0.31851435,0.00023059241,0.0013885923],"study_design_scores_gemma":[0.0012838661,0.00023233189,0.0067763887,0.00014595728,0.0000033420108,0.000001240199,0.000081178376,0.9823828,0.00006203592,0.008728673,0.00016084731,0.00014137883],"about_ca_topic_score_codex":0.43807065,"about_ca_topic_score_gemma":0.018556276,"teacher_disagreement_score":0.41951436,"about_ca_system_score_codex":0.00035008648,"about_ca_system_score_gemma":0.00029197903,"threshold_uncertainty_score":0.9993525},"labels":[],"label_agreement":null},{"id":"W2542087192","doi":"10.1016/j.jval.2016.09.1673","title":"Effect of Spironolactone on The Risk of New Onset of Diabetes Among Patients with Heart Failure: A Population-Based Study","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Hormonal Regulation and Hypertension","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Spironolactone; Medicine; Hazard ratio; Population; Cohort; Diabetes mellitus; Internal medicine; Heart failure; Proportional hazards model; Mineralocorticoid receptor; Cohort study; Endocrinology; Aldosterone; Confidence interval; Environmental health","score_opus":0.01607065464444648,"score_gpt":0.26807162203737805,"score_spread":0.2520009673929316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542087192","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976703,0.000026308571,0.000006521817,0.0011547987,0.000015464006,0.0011049521,0.00001311153,0.0000058095593,0.0000027325468],"genre_scores_gemma":[0.99980146,0.0000016756393,0.00008420466,0.000072141534,0.000008719743,0.0000061477294,0.0000062578347,0.000010482502,0.0000089121795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859446,0.000433466,0.0003682954,0.0001200202,0.00036650576,0.00011727152],"domain_scores_gemma":[0.9984297,0.00089675793,0.00028110016,0.00025246566,0.00006433535,0.00007560448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00078946864,0.00008728804,0.00039649702,0.00012519323,0.000022849896,9.4037136e-7,0.00003690569,0.00003289446,0.000021514232],"category_scores_gemma":[0.00044393263,0.000038198395,0.000045515586,0.00015738503,0.000034487643,0.000021279991,0.0000069228086,0.0000737271,0.0000012584147],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004887942,0.00033788188,0.99689984,0.00009265098,0.000017602473,1.12440375e-7,0.000099062956,0.00029189425,0.0000856724,0.000006964945,0.000060513128,0.0016190116],"study_design_scores_gemma":[0.0035846478,0.0071937335,0.986401,0.0007732122,0.000030710387,4.7865747e-8,0.000019483838,0.0005135461,0.0014264258,0.000011340254,0.0000118025155,0.000034025245],"about_ca_topic_score_codex":0.0047752406,"about_ca_topic_score_gemma":0.00016119581,"teacher_disagreement_score":0.010498814,"about_ca_system_score_codex":0.00005838448,"about_ca_system_score_gemma":0.00013188917,"threshold_uncertainty_score":0.72187674},"labels":[],"label_agreement":null},{"id":"W2542308039","doi":"10.1016/j.jval.2016.09.014","title":"Comparison of Oral Anti-Coagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation: Two Multi-Criteria Decision Analyses","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Dabigatran; Apixaban; Rivaroxaban; Medicine; Edoxaban; Atrial fibrillation; Warfarin; Stroke (engine); Internal medicine","score_opus":0.33158275307815427,"score_gpt":0.5367741989987577,"score_spread":0.2051914459206034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542308039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9634799,0.00045064572,0.032977007,0.0010660646,0.00047907032,0.0014920208,0.000021284013,0.00002057992,0.000013470776],"genre_scores_gemma":[0.9759235,0.00015785749,0.023218196,0.000018020586,0.00044477434,0.0000018911385,0.00003455206,0.000016133608,0.00018510343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979316,0.00017014734,0.0010807412,0.00026934108,0.0002903942,0.00025776002],"domain_scores_gemma":[0.99884516,0.00041685265,0.00036788662,0.00022115659,0.00007227448,0.00007664584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001114514,0.00013443388,0.00075279217,0.00045208575,0.000041750558,0.000009976093,0.000062560335,0.00007501837,0.000039940558],"category_scores_gemma":[0.00041713563,0.00009992147,0.00023790222,0.0003185875,0.000025201112,0.00013945231,0.00003505451,0.000049313447,0.000006827122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009012143,0.000023699182,0.9474702,0.00020984815,0.00003703946,0.0000010961888,0.0001532927,0.00951666,0.002519384,0.00008512678,0.000109117864,0.038973317],"study_design_scores_gemma":[0.018684858,0.00070295937,0.85176855,0.001093227,0.00006721516,0.0000013593964,0.00010639106,0.12386784,0.0014347774,0.0003837682,0.0017347536,0.00015428466],"about_ca_topic_score_codex":0.0007287777,"about_ca_topic_score_gemma":0.00012633283,"teacher_disagreement_score":0.114351176,"about_ca_system_score_codex":0.00014873168,"about_ca_system_score_gemma":0.000120075194,"threshold_uncertainty_score":0.40746793},"labels":[],"label_agreement":null},{"id":"W2542411759","doi":"10.1016/j.jval.2016.08.365","title":"Management of Patients with Statin Intolerance in Japan, South Korea and Taiwan: Comparison of Results From A Clinician Survey","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Statin; Medicine; Ezetimibe; Concomitant; Internal medicine","score_opus":0.04506475591994711,"score_gpt":0.3120484062235498,"score_spread":0.26698365030360266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542411759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973826,0.00063243875,0.00014914546,0.0003273942,0.00005386168,0.0010324938,0.00036115915,0.0000070441315,0.000053874446],"genre_scores_gemma":[0.9974713,0.0002453246,0.0020911596,0.00006971363,0.00001891396,0.000013222712,0.00006387751,0.0000151168615,0.000011414702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997442,0.00045162727,0.0010678179,0.00032951092,0.00045130795,0.00025773168],"domain_scores_gemma":[0.998742,0.00015565654,0.00043371477,0.0004527262,0.000092275455,0.0001236268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022383376,0.00012005317,0.00076207577,0.00012862174,0.000017041368,0.0000022369284,0.00006524611,0.000057056117,0.0000031806699],"category_scores_gemma":[0.000112048016,0.00007883622,0.000037507492,0.00028072693,0.00007462387,0.00003445198,0.000035580106,0.00013101527,0.0000010840347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019551006,0.00031575767,0.92080325,0.0006101084,0.000048098544,0.000003282274,0.0027663289,0.00006128692,0.0000012284991,0.0000371263,0.000012291184,0.07338615],"study_design_scores_gemma":[0.010716299,0.0009204064,0.98450446,0.0028378747,0.000012317529,1.5885189e-7,0.0006083743,0.00017888198,0.000031458658,0.000044131037,0.00007074472,0.00007490364],"about_ca_topic_score_codex":0.04454147,"about_ca_topic_score_gemma":0.0025262686,"teacher_disagreement_score":0.07331125,"about_ca_system_score_codex":0.00010909267,"about_ca_system_score_gemma":0.00018108706,"threshold_uncertainty_score":0.961821},"labels":[],"label_agreement":null},{"id":"W2542428107","doi":"10.1016/j.jval.2016.09.027","title":"Adherence To Treatment And Modifiable Risk Factors In Acute Coronary Syndrome (Acs) Patients Registered In The Pgrx Real World Datasets","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Acute coronary syndrome; Logistic regression; Pharmacoepidemiology; Internal medicine; Multivariate analysis; Bivariate analysis; Medication adherence; Emergency medicine","score_opus":0.12613340774085713,"score_gpt":0.36302375385771235,"score_spread":0.23689034611685522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542428107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963123,0.00011378429,0.000011003718,0.00176497,0.000079027486,0.0012522266,0.00029767532,0.000011368713,0.00015763927],"genre_scores_gemma":[0.99670047,0.001445248,0.00016362533,0.0005453534,0.000008566524,0.00015458059,0.00013168936,0.000008638207,0.00084180984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983654,0.00026910793,0.00045983554,0.00035581406,0.00022461724,0.00032521295],"domain_scores_gemma":[0.99890697,0.0002282698,0.00015200167,0.00051355286,0.000014319833,0.00018489083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046264913,0.00013911798,0.00031021392,0.00018418307,0.000040868916,0.000008186607,0.00015477426,0.0000390835,0.00006758023],"category_scores_gemma":[0.000092998525,0.000077950586,0.000015876863,0.0003900727,0.000044959743,0.00008707569,0.000033976452,0.00013243336,0.00007854048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015073884,0.00033224412,0.98864496,0.000050428993,0.000008039903,0.00004841873,0.001177964,0.000023603807,0.000010581894,0.000061547726,0.0014965504,0.007994951],"study_design_scores_gemma":[0.0024194566,0.0014957199,0.9923756,0.0009728078,0.0000074822806,0.000012463734,0.00016794678,0.00018521593,0.000011524848,0.000175021,0.0020885905,0.00008814229],"about_ca_topic_score_codex":0.04238435,"about_ca_topic_score_gemma":0.0012810803,"teacher_disagreement_score":0.04110327,"about_ca_system_score_codex":0.00039412433,"about_ca_system_score_gemma":0.00021634923,"threshold_uncertainty_score":0.9639925},"labels":[],"label_agreement":null},{"id":"W2542475746","doi":"10.1016/j.jval.2016.09.824","title":"What are the Most Important Decision-Making Criteria For Innovative Health Technology Integration? A National Survey from French Hospitals Decision-Makers","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke","funders":"","keywords":"Likert scale; Context (archaeology); Multidisciplinary approach; Scale (ratio); Health care; Decision analysis; Operations management; Business; Psychology; Economics","score_opus":0.2974729309116838,"score_gpt":0.4656486341177557,"score_spread":0.1681757032060719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542475746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5376231,0.01311408,0.12798458,0.30688304,0.004052548,0.0037332743,0.006469803,0.00009940949,0.000040173865],"genre_scores_gemma":[0.9505904,0.00167367,0.02474342,0.021909343,0.00033027653,0.0005192896,0.00013525502,0.000060418224,0.000037974365],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9895326,0.00089905824,0.0074534896,0.0010502686,0.00028308245,0.000781518],"domain_scores_gemma":[0.9715888,0.021181216,0.005605842,0.00078704307,0.00065189344,0.00018521694],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.046513904,0.00031664755,0.0013612051,0.0010520067,0.0005013297,0.00020980289,0.0006239158,0.00026149146,0.00017528032],"category_scores_gemma":[0.050050374,0.0002603388,0.00009730122,0.0014843623,0.00015876358,0.0009256017,0.000110316694,0.00029256984,0.00017395777],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018570639,0.00034370614,0.63218725,0.00024681273,0.00015253048,0.0000029467299,0.0069199963,0.0005785134,0.000002913731,0.18242268,0.12247455,0.0544824],"study_design_scores_gemma":[0.0015168922,0.00028627086,0.3617961,0.0034278508,0.0000012638017,0.000005894129,0.0052619353,0.009428835,0.0000021244307,0.6094041,0.008437768,0.0004309691],"about_ca_topic_score_codex":0.010171735,"about_ca_topic_score_gemma":0.006910823,"teacher_disagreement_score":0.4269814,"about_ca_system_score_codex":0.0028654954,"about_ca_system_score_gemma":0.0020111245,"threshold_uncertainty_score":0.99998486},"labels":[],"label_agreement":null},{"id":"W2542703735","doi":"10.1016/j.jval.2016.09.1925","title":"The Mosaic Study: Regional Variation in Treatment Patterns Associated with Progression from Initial Insulin Regimen","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Insulin; Medicine; Regimen; Observational study; Internal medicine; Basal (medicine); Diabetes mellitus; Psychosocial; Demography; Endocrinology","score_opus":0.07460817757379205,"score_gpt":0.368022353641351,"score_spread":0.29341417606755893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542703735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850355,0.00017226496,0.000019788005,0.012901548,0.00006474519,0.0016637279,0.000011645164,0.000026274527,0.000104515275],"genre_scores_gemma":[0.9988458,0.0002433029,0.00004060206,0.00012229505,0.00009783987,0.00016641224,0.00004645934,0.00001489226,0.0004223731],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981174,0.0005466197,0.00029919896,0.00024811603,0.00045663049,0.00033206827],"domain_scores_gemma":[0.99908096,0.00044708542,0.00012932906,0.00022438056,0.000037077694,0.000081170016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010477948,0.00010318566,0.00020738589,0.0001327682,0.00009309788,0.000019240013,0.00007953113,0.000046452835,0.000018112221],"category_scores_gemma":[0.000120567194,0.000046405148,0.000019690435,0.00025544676,0.000036297875,0.000058017293,0.00003317514,0.00011732934,0.000010095778],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074336753,0.0019115964,0.86427444,0.000023578104,0.00009673282,0.00006423144,0.0020778927,0.000026073947,0.000017154605,0.000093971925,0.00020261189,0.13046835],"study_design_scores_gemma":[0.008086667,0.0031959754,0.9849758,0.0011554896,0.000012606465,2.2887642e-7,0.0002830234,0.0010887723,0.000011555105,0.00034946782,0.000774296,0.00006608867],"about_ca_topic_score_codex":0.004388309,"about_ca_topic_score_gemma":0.001264456,"teacher_disagreement_score":0.13040227,"about_ca_system_score_codex":0.00074108044,"about_ca_system_score_gemma":0.00028252168,"threshold_uncertainty_score":0.66338396},"labels":[],"label_agreement":null},{"id":"W2542761608","doi":"10.1016/j.jval.2016.09.1073","title":"Assessment of CTX-1 Bone Biomarker As An Indicator of Antiresorptive Therapy Efficacy And of Persistence In A Fracture Liaison Service","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Biomarker; Persistence (discontinuity); Internal medicine; Osteoporosis; Prospective cohort study; Cohort; Bone resorption; Fragility fracture; Urology; Gastroenterology; Bone mineral; Biology","score_opus":0.06347061313387148,"score_gpt":0.37608397767104207,"score_spread":0.3126133645371706,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542761608","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930639,0.0021549999,0.000005976119,0.0038119971,0.000026232461,0.000836047,0.00003124241,0.00000612621,0.00006346119],"genre_scores_gemma":[0.9962974,0.002038683,0.000898168,0.000717292,0.000006503814,0.00001314984,0.0000065367544,0.000012584166,0.000009649113],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99844754,0.00022790705,0.0005799819,0.00024917308,0.0002576088,0.00023777285],"domain_scores_gemma":[0.9988446,0.0002282336,0.00040045416,0.0002637111,0.00006534023,0.00019762512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059396407,0.00011961467,0.0005457187,0.00026633037,0.000017230574,0.0000011210861,0.000054756078,0.00010567589,0.000025192727],"category_scores_gemma":[0.000050139806,0.00007829513,0.000030205121,0.00032790325,0.00007637977,0.00005948094,0.000016431079,0.000112665766,9.508834e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011808207,0.0018874801,0.966388,0.0010479888,0.000040511495,0.000013848153,0.0029479791,0.000003757822,0.00378111,0.00008856819,0.000010421338,0.022609506],"study_design_scores_gemma":[0.007159825,0.0025004866,0.9869076,0.0014632747,0.000009497869,0.0000102510585,0.00025714078,0.00017956394,0.0013040528,0.00006009487,0.00009416292,0.00005405618],"about_ca_topic_score_codex":0.017014185,"about_ca_topic_score_gemma":0.00018115646,"teacher_disagreement_score":0.02255545,"about_ca_system_score_codex":0.00012168419,"about_ca_system_score_gemma":0.0007797513,"threshold_uncertainty_score":0.9895316},"labels":[],"label_agreement":null},{"id":"W2542767025","doi":"10.1016/j.jval.2016.09.939","title":"The European Social Preference Measurement (ESPM) Study: Conceptual Considerations and Implementation","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute","funders":"","keywords":"Valuation (finance); Actuarial science; Preference; Framing (construction); Health care; Social preferences; Resource allocation; Psychology; Public economics; Social psychology; Economics; Microeconomics; Engineering","score_opus":0.7162180975358698,"score_gpt":0.4617709975253506,"score_spread":0.25444710001051923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542767025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77784956,0.0028241302,0.0018204943,0.21100067,0.0006901752,0.0031824512,0.00022853733,0.000069146074,0.0023348657],"genre_scores_gemma":[0.9964748,0.00021420495,0.00022415517,0.0026646422,0.00023411345,0.000112035006,0.0000027466915,0.00001802788,0.000055288885],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99336594,0.0026334757,0.0030212128,0.00042789665,0.00015298031,0.00039849835],"domain_scores_gemma":[0.9972341,0.0011634716,0.0011727845,0.00024451336,0.000070143644,0.00011498403],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03902593,0.00012430012,0.00040005703,0.00011714247,0.00069480797,0.00008803601,0.00011989645,0.00003147097,0.00008954293],"category_scores_gemma":[0.0018645963,0.00010554396,0.000030255247,0.000090189846,0.00012103075,0.00022974166,0.00004960134,0.00010068672,0.00021702466],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015701622,0.00019982853,0.19677007,0.00012375004,0.000068363304,0.000001304562,0.038614996,0.000051445488,0.000009545789,0.73128515,0.024319585,0.008540277],"study_design_scores_gemma":[0.0042562303,0.00046906638,0.86288816,0.00013458749,0.000005253855,0.000004360657,0.0263074,0.00030898183,0.0000043441755,0.057980213,0.04723006,0.0004113214],"about_ca_topic_score_codex":0.0038427494,"about_ca_topic_score_gemma":0.002760413,"teacher_disagreement_score":0.6733049,"about_ca_system_score_codex":0.0008123392,"about_ca_system_score_gemma":0.0003461084,"threshold_uncertainty_score":0.989525},"labels":[],"label_agreement":null},{"id":"W2542811946","doi":"10.1016/j.jval.2016.09.1306","title":"Comparative Analysis of Indirect Costs Associated with Chronic Spontaneous/Idiopathic Urticaria-Results From The Assure-Csu Study In 7 Countries","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lynde Centre for Dermatology","funders":"","keywords":"Presenteeism; Absenteeism; Purchasing power parity; Medicine; Indirect costs; Demography; Productivity; Observational study; Exchange rate; Business; Finance; Economics; Economic growth; Accounting; Internal medicine","score_opus":0.03406700829581941,"score_gpt":0.3057824574717473,"score_spread":0.2717154491759279,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542811946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99386024,0.0009898382,0.00001823218,0.0033446522,0.000075076416,0.0011346793,0.00035034024,0.00003239652,0.00019456548],"genre_scores_gemma":[0.99944985,0.00019425276,0.000011933467,0.00013159568,0.000035293513,0.00003678096,0.00008249699,0.000011378086,0.000046446945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99685824,0.0010972788,0.0008590608,0.00034900923,0.0004745381,0.00036187767],"domain_scores_gemma":[0.9965926,0.002372474,0.00036531256,0.00042370055,0.00013569195,0.000110260175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014123374,0.00017375703,0.0009813262,0.00035524476,0.00008864337,0.000011165542,0.0001308844,0.00012726217,0.00004374236],"category_scores_gemma":[0.000504972,0.000089704205,0.000074828706,0.0016708198,0.00018229251,0.000047256883,0.000023688257,0.00038461998,0.000010551412],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016244142,0.0014657759,0.95784533,0.000010555406,0.009390878,0.0005447447,0.02389505,0.0043285666,0.00019227054,0.000414234,0.00009520017,0.000192963],"study_design_scores_gemma":[0.0061494224,0.0015731935,0.9826637,0.0011813518,0.0032566618,0.000011833406,0.001220249,0.0036953185,0.000053493543,0.000053381194,0.00002445878,0.000116959265],"about_ca_topic_score_codex":0.01708142,"about_ca_topic_score_gemma":0.046771497,"teacher_disagreement_score":0.029690076,"about_ca_system_score_codex":0.0009557622,"about_ca_system_score_gemma":0.001194662,"threshold_uncertainty_score":0.9894639},"labels":[],"label_agreement":null},{"id":"W2542885621","doi":"10.1016/j.jval.2016.09.2202","title":"Use of Net Monetary Benefit Analysis to Comprehensively Understand the Value of Innovative Treatments","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Nivolumab; Value (mathematics); Willingness to pay; Productivity; Cost–benefit analysis; Actuarial science; Medicine; Incremental cost-effectiveness ratio; Quality-adjusted life year; Cost effectiveness; Economics; Risk analysis (engineering); Cancer; Internal medicine; Statistics; Mathematics; Microeconomics; Immunotherapy","score_opus":0.5343160658507669,"score_gpt":0.4181268274163777,"score_spread":0.11618923843438916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2542885621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9533974,0.001106127,0.0051779514,0.03788538,0.0001526471,0.0009871585,0.0010965968,0.000011474614,0.00018527379],"genre_scores_gemma":[0.99110514,0.00041741843,0.0035704623,0.0046431213,0.00003478537,0.000024642144,0.000016630775,0.00001919769,0.0001686146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99454886,0.00043852685,0.0041036964,0.00042895132,0.00012685132,0.00035310583],"domain_scores_gemma":[0.9941018,0.0025005569,0.002504628,0.0006183499,0.00013784766,0.00013681954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005977936,0.0001692413,0.0012758888,0.0008633807,0.00008253615,0.000013463877,0.00023369878,0.0000794518,0.00008914504],"category_scores_gemma":[0.0010841247,0.00013903897,0.00012415762,0.0013115258,0.00009995805,0.0002330965,0.000055323413,0.00008127585,0.00007472994],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007998647,0.00020170491,0.54692733,0.00025310818,0.0009720314,6.004821e-7,0.006197424,0.069820344,0.000012901983,0.37294555,0.0015626684,0.00102637],"study_design_scores_gemma":[0.0010265405,0.00035193667,0.96299505,0.00025202043,0.000027920743,8.485481e-7,0.001085492,0.010895332,0.000027351989,0.020606443,0.0024989347,0.00023210853],"about_ca_topic_score_codex":0.038837813,"about_ca_topic_score_gemma":0.0005516897,"teacher_disagreement_score":0.41606775,"about_ca_system_score_codex":0.00075188075,"about_ca_system_score_gemma":0.00019045502,"threshold_uncertainty_score":0.9675627},"labels":[],"label_agreement":null},{"id":"W2543035678","doi":"10.1016/j.jval.2016.08.243","title":"Risk Share Agreements (RSA), Product Listing Agreements (PLA) or Patient Access Schemes (PAS) - All the Same or Different ?","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Listing (finance); Reimbursement; Negotiation; Business; Government (linguistics); Product (mathematics); Market access; Finance; Accounting; Health care; Political science; Law","score_opus":0.5920221495791247,"score_gpt":0.45508822052241055,"score_spread":0.13693392905671414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543035678","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9132097,0.0024196275,0.00057948614,0.07702479,0.0015760245,0.0032985709,0.0014716812,0.00008363514,0.00033650058],"genre_scores_gemma":[0.97485584,0.0023049058,0.0011617132,0.018822016,0.0006785618,0.0005589457,0.000056902016,0.000083503306,0.00147761],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9907289,0.0012621925,0.005507719,0.0011113356,0.0003019718,0.0010878957],"domain_scores_gemma":[0.99186754,0.0021930207,0.0043790457,0.0011237552,0.000083051986,0.0003535738],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.01238783,0.00039463292,0.0011748992,0.0003847387,0.00046276886,0.00017764143,0.00090230355,0.00011859721,0.001397243],"category_scores_gemma":[0.0077168494,0.00025410665,0.00012057427,0.0003597444,0.000084146865,0.000661704,0.0003403719,0.0003297593,0.00081708585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030107045,0.0007911161,0.91546774,0.002121491,0.00030800942,0.0000078248995,0.008821358,0.0006440241,0.000003919713,0.007273365,0.04170633,0.02255377],"study_design_scores_gemma":[0.0073698694,0.0016229698,0.60244435,0.0044999034,0.000039218536,0.000022227337,0.0028558404,0.014559097,0.00007719516,0.013397456,0.3511481,0.001963787],"about_ca_topic_score_codex":0.013057407,"about_ca_topic_score_gemma":0.0027126297,"teacher_disagreement_score":0.3130234,"about_ca_system_score_codex":0.001932512,"about_ca_system_score_gemma":0.00048720138,"threshold_uncertainty_score":0.9999911},"labels":[],"label_agreement":null},{"id":"W2543134412","doi":"10.1016/j.jval.2016.09.1189","title":"The Cost of Remaining NTM Positive: Health Care Utilization and Costs In A Sample of Patients with Refractory Pulmonary Disease Due To Mycobacterium Avium Complex In Canada, Germany, United Kingdom And France","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Culture conversion; Medicine; Sputum; Sputum culture; Internal medicine; Retrospective cohort study; Cohort; Health care; Regimen; Disease; Pediatrics; Tuberculosis; Pathology","score_opus":0.03656199020766122,"score_gpt":0.3078445204524036,"score_spread":0.2712825302447424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543134412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934554,0.0008865686,0.000023347266,0.0034855243,0.000032309574,0.0013172738,0.00078766525,0.000003981026,0.000007934986],"genre_scores_gemma":[0.99815553,0.00064649316,0.00011395096,0.00082938035,0.000013042732,0.00004161055,0.00018246414,0.000015730144,0.0000017887828],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980588,0.00043316025,0.00050387735,0.00025296755,0.0003447114,0.00040651116],"domain_scores_gemma":[0.9978648,0.0011093641,0.00020089597,0.00022133245,0.00017290273,0.00043072904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004593498,0.00012298606,0.000375484,0.0002764884,0.00006716264,0.0000061305846,0.000064467815,0.000028684859,0.000005354895],"category_scores_gemma":[0.00060937717,0.00008252802,0.000009806067,0.0004888298,0.0000856147,0.000070431975,0.000054521824,0.00013079031,1.1863742e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015338617,0.000105860934,0.984677,0.00081544917,0.0000035947517,0.000023547795,0.00066531874,0.000013518199,0.000049946506,0.000046086403,0.000052404437,0.012013405],"study_design_scores_gemma":[0.0017128875,0.0004878065,0.9936358,0.002754147,0.000002540347,0.0000016256153,0.00029540726,0.00030808098,0.000014078263,0.0000052354194,0.0007087374,0.00007367712],"about_ca_topic_score_codex":0.80110466,"about_ca_topic_score_gemma":0.42529714,"teacher_disagreement_score":0.3758075,"about_ca_system_score_codex":0.0010216743,"about_ca_system_score_gemma":0.0022465207,"threshold_uncertainty_score":0.5851897},"labels":[],"label_agreement":null},{"id":"W2543315468","doi":"10.1016/j.jval.2016.08.094","title":"Two New Cancer-Specific Multi-Attribute Utility Instruments: EORTC QLU-C10D and FACT-8D","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Quality of life (healthcare); Worry; Population; Medicine; Psychology; Actuarial science; Psychiatry; Anxiety; Economics; Environmental health","score_opus":0.5655679964228495,"score_gpt":0.45427419967107885,"score_spread":0.11129379675177065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543315468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8468048,0.020093478,0.007126838,0.12045704,0.0018502472,0.0017522669,0.0013464299,0.00011373234,0.00045517416],"genre_scores_gemma":[0.97628635,0.010635106,0.0045093005,0.0068454146,0.00046781186,0.000114792165,0.000017976705,0.00005366371,0.0010695716],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99311936,0.0006012236,0.0043441486,0.00095797825,0.00012561679,0.00085165113],"domain_scores_gemma":[0.99607897,0.0007956097,0.0018138404,0.00067210244,0.000040715862,0.00059876475],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.011348736,0.00028439288,0.0011866348,0.00038601822,0.00021992231,0.000066892135,0.00029565228,0.00015597437,0.00093277334],"category_scores_gemma":[0.0011184887,0.00029805678,0.00008691415,0.0002785768,0.000107286745,0.0005859974,0.00009472459,0.00024029857,0.00095927273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018817822,0.0001572181,0.9340532,0.00042930507,0.000037000264,0.0000011546999,0.0020087094,0.00011112868,0.0000032930068,0.029700588,0.014722528,0.01875708],"study_design_scores_gemma":[0.007072662,0.00018013032,0.6660576,0.0007904543,0.000003499275,0.000008620159,0.0004955251,0.008220189,0.000014171742,0.012328397,0.30405232,0.000776477],"about_ca_topic_score_codex":0.057138383,"about_ca_topic_score_gemma":0.0017417991,"teacher_disagreement_score":0.2893298,"about_ca_system_score_codex":0.001766391,"about_ca_system_score_gemma":0.0004955949,"threshold_uncertainty_score":0.9999805},"labels":[],"label_agreement":null},{"id":"W2543358959","doi":"10.1016/j.jval.2016.09.1303","title":"Health Outcomes Related to Legal Blindness Caused By Retinal Disorders in Brazil","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Public Health in Brazil","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Anxiety; Hospital Anxiety and Depression Scale; Depression (economics); Visual acuity; Observational study; Diabetic retinopathy; Quality of life (healthcare); Psychiatry; Ophthalmology; Internal medicine; Diabetes mellitus","score_opus":0.032924762263596016,"score_gpt":0.3908778715932861,"score_spread":0.35795310932969004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543358959","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4248329,0.00026990834,0.00007906456,0.56906426,0.0010167069,0.0012971904,0.000045876815,0.00015073452,0.0032433432],"genre_scores_gemma":[0.9852787,0.0007738298,0.0003222034,0.010723155,0.00007663398,0.00010045742,0.0000077824325,0.000042555872,0.0026746553],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9922635,0.0028022174,0.001424981,0.00068202574,0.0008997395,0.0019275472],"domain_scores_gemma":[0.99703676,0.0009951484,0.00035614116,0.00042727584,0.00005942298,0.0011252463],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010271039,0.00023832817,0.0006622864,0.00054094347,0.00052854046,0.000047194364,0.0006076108,0.00023700863,0.00013614983],"category_scores_gemma":[0.0024521041,0.00020062015,0.00006283633,0.0018993464,0.00024412674,0.00045178784,0.000083658946,0.00046999718,0.00015141885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007119185,0.00056602573,0.7986516,0.00020887512,0.000009718951,0.000008612486,0.030512165,0.00013572555,0.000007953936,0.06033167,0.03123616,0.07826034],"study_design_scores_gemma":[0.0028331047,0.00045663485,0.4768295,0.0006166481,0.0000010266125,0.0000014600762,0.0019914403,0.00009265962,0.0000019594447,0.006111016,0.5105862,0.00047833173],"about_ca_topic_score_codex":0.28511253,"about_ca_topic_score_gemma":0.11709243,"teacher_disagreement_score":0.5604458,"about_ca_system_score_codex":0.002949578,"about_ca_system_score_gemma":0.0057392726,"threshold_uncertainty_score":0.99989724},"labels":[],"label_agreement":null},{"id":"W2543659530","doi":"10.1016/j.jval.2016.09.1540","title":"Resource Utilization and Costs Associated with the Investigation of Pulmonary Nodules in Quebec, Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Cegep de Saint Jerome; Centre Hospitalier de l’Université de Montréal; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Nodule (geology); Lung cancer; Watchful waiting; Solitary pulmonary nodule; Health care; Medical record; Radiology; Cancer; Computed tomography; Internal medicine","score_opus":0.030454115229304163,"score_gpt":0.26573616129985494,"score_spread":0.23528204607055078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543659530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687509,0.001078195,0.0000019733513,0.029740926,0.000013379917,0.00031982735,0.000008220762,0.0000042525535,0.00008236017],"genre_scores_gemma":[0.99892265,0.0003528224,0.000009870759,0.00057188317,0.000009722819,0.000019811094,0.0000144033465,0.0000058167147,0.000093015165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937236,0.00012900363,0.00015379264,0.00010514426,0.00013913102,0.00010058677],"domain_scores_gemma":[0.99951106,0.00023357556,0.00009252071,0.000090415415,0.000024125846,0.00004827264],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002251237,0.000049072278,0.00012413987,0.00003804142,0.000020180447,0.000001984477,0.0000181942,0.000021614498,0.000002410453],"category_scores_gemma":[0.000063291365,0.000024882534,0.00000482621,0.00015607777,0.00003868648,0.000023739647,0.000006100919,0.00003775455,9.023316e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045068333,0.000047500558,0.98439384,0.00006901241,0.00000903323,0.000008758125,0.00035537008,0.000047181147,0.000020782545,0.00016855044,0.0008789007,0.013956033],"study_design_scores_gemma":[0.0008379629,0.00009079105,0.9960756,0.0017800605,0.000006693529,0.0000017822366,0.00013497457,0.00034758085,0.00020842874,0.000023271212,0.00046495386,0.000027921897],"about_ca_topic_score_codex":0.9222505,"about_ca_topic_score_gemma":0.96442974,"teacher_disagreement_score":0.042179238,"about_ca_system_score_codex":0.0012338782,"about_ca_system_score_gemma":0.0005969823,"threshold_uncertainty_score":0.32265487},"labels":[],"label_agreement":null},{"id":"W2543692165","doi":"10.1016/j.jval.2016.09.2115","title":"A Systematic Review On The Epidemiology of NRAS-Mutant Melanoma in Europe and Australia","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Neuroblastoma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Neuroblastoma RAS viral oncogene homolog; Melanoma; Medicine; Incidence (geometry); Epidemiology; Oncology; Stage (stratigraphy); Dermatology; Internal medicine; Disease; Cancer; Cancer research; Biology; Colorectal cancer","score_opus":0.2677690281873952,"score_gpt":0.46878631450449404,"score_spread":0.20101728631709886,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543692165","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019313738,0.992002,3.6459778e-7,0.0018659525,0.000046808236,0.0057849716,0.000038629598,0.0000065283593,0.00006159364],"genre_scores_gemma":[0.00019396633,0.99873686,0.000017739365,0.00048179732,0.000022575376,0.00030012487,0.000008193909,0.00002853236,0.00021019382],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9913916,0.0057526384,0.001811032,0.00037083845,0.00021774661,0.0004561736],"domain_scores_gemma":[0.99418116,0.00423109,0.00074116926,0.0006122283,0.000040952196,0.00019338958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004299967,0.00028107592,0.004142259,0.00026647732,0.000020407108,0.0000015477896,0.00016137958,0.000100837555,0.000030880998],"category_scores_gemma":[0.0060156975,0.00011881143,0.00015206305,0.00051343563,0.0000865491,0.000012758396,0.00005430956,0.00048237736,0.00014144726],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013329159,0.000090592366,0.00015762712,0.9895953,0.000074978896,0.00018631476,0.000009993817,4.9366204e-8,5.9133054e-8,0.001200769,0.0001439243,0.008527063],"study_design_scores_gemma":[0.0003253079,0.00090519426,0.00019343627,0.9857011,0.000155088,0.00030759722,0.0000013939441,0.000002082066,1.5435377e-7,0.00005708428,0.012281565,0.00007003182],"about_ca_topic_score_codex":0.00049749744,"about_ca_topic_score_gemma":0.000014091252,"teacher_disagreement_score":0.01213764,"about_ca_system_score_codex":0.00024563342,"about_ca_system_score_gemma":0.0005974963,"threshold_uncertainty_score":0.72017866},"labels":[],"label_agreement":null},{"id":"W2543939459","doi":"10.1016/j.jval.2016.09.1151","title":"Long-Term Improvements in Workplace and Household Productivity and Social Participation Over 4 Years of Certolizumab Pegol Treatment in Patients with Psoriatic Arthritis, with and without Prior Anti-Tnf Exposure","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Psoriatic arthritis; Presenteeism; Randomized controlled trial; Placebo; Internal medicine; Bristol-Myers; Productivity; Physical therapy; Arthritis; Rheumatoid arthritis; Adalimumab; Alternative medicine","score_opus":0.13857463836310696,"score_gpt":0.348152258059836,"score_spread":0.20957761969672906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2543939459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954092,0.0008952146,0.00004015754,0.0018624576,0.00005080924,0.0016333542,0.00009700125,0.00000823354,0.0000036015183],"genre_scores_gemma":[0.99900603,0.00038386357,0.0003253728,0.00009408117,0.000033399963,0.00011832176,0.000005917768,0.000022221531,0.000010771285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973751,0.0003121926,0.0014146545,0.00048422627,0.00009012796,0.00032370884],"domain_scores_gemma":[0.9985631,0.00020607957,0.0009477988,0.00018167432,0.00001693156,0.00008441143],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015991048,0.00015106727,0.00074135954,0.00026886983,0.000051770476,0.000022787266,0.00004043203,0.00007359525,0.000004218828],"category_scores_gemma":[0.00015542436,0.00013941161,0.00001146958,0.00013514023,0.00008363633,0.00034607522,0.000021841102,0.000073772666,0.0000012807368],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018434747,0.00028770146,0.98488647,0.00047225363,0.0000132681425,0.0000011382225,0.003233324,0.00003432922,6.455747e-7,0.00031937042,0.000003585234,0.01056358],"study_design_scores_gemma":[0.0084946,0.0007290511,0.9896296,0.00055400934,0.000002989517,0.0000017120711,0.00007909745,0.0001645037,0.0000023366354,0.00017934848,0.000012980483,0.00014973879],"about_ca_topic_score_codex":0.0043305936,"about_ca_topic_score_gemma":0.004750577,"teacher_disagreement_score":0.010413842,"about_ca_system_score_codex":0.0005413023,"about_ca_system_score_gemma":0.00018659179,"threshold_uncertainty_score":0.6546591},"labels":[],"label_agreement":null},{"id":"W2544016569","doi":"10.1016/j.jval.2016.09.1552","title":"A Real-World Outcome Research Study On Quality of Life, Work Productivity And Healthcare Resource Utilization In Metastatic Breast Cancer For Patients And Caregivers","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre intégré de santé et de services sociaux de la Montérégie-Centre; Santé Montérégie; Université de Montréal; Pfizer (Canada); Hôpital Maisonneuve-Rosemont; Centre hospitalier universitaire de Québec; Kingston General Hospital","funders":"","keywords":"Medicine; Metastatic breast cancer; Quality of life (healthcare); Work productivity; Cohort; Breast cancer; Internal medicine; Cancer; Prospective cohort study; Disease; Cohort study; Physical therapy; Oncology; Productivity; Nursing","score_opus":0.35795054518969815,"score_gpt":0.5272409181921662,"score_spread":0.16929037300246808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544016569","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9804343,0.00040967748,0.0000011424821,0.015859379,0.00007045015,0.0030680697,0.0001324545,0.000007727791,0.000016818973],"genre_scores_gemma":[0.99912435,0.0003285998,0.000030153595,0.000108958804,0.00003832651,0.00022083655,0.000008109273,0.000012465979,0.0001281726],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975664,0.0010812922,0.00045411344,0.0003555306,0.0002618917,0.00028077728],"domain_scores_gemma":[0.9986443,0.0007632035,0.000151213,0.00015681668,0.0001327182,0.0001517547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020702805,0.00009678146,0.00044124085,0.00034254914,0.000058758444,0.0000029607647,0.000031886386,0.000026467878,0.00000538573],"category_scores_gemma":[0.00024392159,0.00006928396,0.000017251692,0.00050607184,0.000083751256,0.000039738898,0.000027670994,0.00013230222,1.802222e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003934147,0.0010723547,0.9769462,0.000933642,0.000023356015,0.0000011375618,0.0037973342,0.000008210493,0.0000069489934,0.00008946778,0.00016982568,0.013017422],"study_design_scores_gemma":[0.007144504,0.0016810425,0.9898128,0.00036189237,0.0000124372045,2.5379978e-7,0.0007082408,0.0000110803485,0.000007170324,0.00007593914,0.000133401,0.00005127548],"about_ca_topic_score_codex":0.06736298,"about_ca_topic_score_gemma":0.01755908,"teacher_disagreement_score":0.0498039,"about_ca_system_score_codex":0.0006596205,"about_ca_system_score_gemma":0.0003888069,"threshold_uncertainty_score":0.9798379},"labels":[],"label_agreement":null},{"id":"W2544050541","doi":"10.1016/j.jval.2016.09.943","title":"Dose Escalation of Biologics in Crohn’s Disease: Summary of Observational Studies in the UK","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Observational study; Adalimumab; Infliximab; Audit; Family medicine; MEDLINE; Referral; Vedolizumab; Internal medicine; Crohn's disease; Disease; Pediatrics","score_opus":0.10781898280713792,"score_gpt":0.35012983698760963,"score_spread":0.2423108541804717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544050541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971823,0.0017950595,0.00001371843,0.00059143745,0.000054804023,0.00027585658,0.00005871632,0.0000015109405,0.00002660198],"genre_scores_gemma":[0.99855506,0.0010003669,0.00011129686,0.00021036172,0.0000344585,0.0000282328,0.000035616653,0.000004241614,0.000020378153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887735,0.00033446282,0.00040032237,0.00014671992,0.00010571849,0.00013543415],"domain_scores_gemma":[0.9994796,0.00010555028,0.00013990107,0.0001959091,0.00005067576,0.000028367112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082413515,0.00006868975,0.00012288244,0.000061809966,0.000013581641,0.0000011217156,0.00011739425,0.00004904245,0.0000031289758],"category_scores_gemma":[0.00047367267,0.00004302848,0.00003306501,0.000108622786,0.00010698004,0.0000037497553,0.00004320386,0.000038224935,5.7100203e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029004135,0.00009958714,0.9932268,0.00019656474,0.000005766644,0.000014823418,0.00019217104,0.0011540038,0.0025765405,0.0015452267,0.00020099733,0.0004974568],"study_design_scores_gemma":[0.00050251494,0.000042964588,0.9974026,0.00018293066,0.0000014743464,2.3756338e-7,0.000087132685,0.00009237291,0.000190292,0.0013431007,0.000106539745,0.00004781857],"about_ca_topic_score_codex":0.00010173558,"about_ca_topic_score_gemma":0.00020107464,"teacher_disagreement_score":0.004175801,"about_ca_system_score_codex":0.000042489537,"about_ca_system_score_gemma":0.00026443627,"threshold_uncertainty_score":0.17546506},"labels":[],"label_agreement":null},{"id":"W2544152081","doi":"10.1016/j.jval.2016.09.2251","title":"Development of a Global Model for the Economic Evaluation of Pharmacogenomics Tests for Early-Stage Breast Cancer Treatment","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Pharmacogenomics; Medicine; Breast cancer; Economic evaluation; Time horizon; Stage (stratigraphy); Christian ministry; Clinical trial; Oncology; Internal medicine; Cancer; Intensive care medicine; Economics; Pharmacology","score_opus":0.5941275241911437,"score_gpt":0.5022858520500565,"score_spread":0.09184167214108718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544152081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9375961,0.0024688812,0.03110229,0.0146865295,0.0004885787,0.004528529,0.009069021,0.000012308815,0.00004778945],"genre_scores_gemma":[0.9847789,0.0005344531,0.012151703,0.0005251552,0.00014394302,0.0017356067,0.000014151796,0.000028031867,0.00008806747],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.995128,0.0001788359,0.0037764513,0.000420656,0.000092744776,0.00040334716],"domain_scores_gemma":[0.99569553,0.0011343396,0.0025937802,0.00034385774,0.00012253415,0.00010995054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017665906,0.00017380752,0.0007800013,0.000118895885,0.00012676834,0.000011083484,0.00022703626,0.000077462464,0.000058935777],"category_scores_gemma":[0.00032913664,0.00014658897,0.00013395118,0.00007946065,0.000051016414,0.0001636124,0.000023787334,0.000029376486,0.000021077518],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004924922,0.00046800633,0.1751091,0.0018869395,0.00049321406,4.023732e-8,0.010378157,0.6395769,0.00005163548,0.11658721,0.0015715896,0.053384684],"study_design_scores_gemma":[0.0045666066,0.00010643502,0.042021923,0.00017547082,0.000021102693,7.667792e-7,0.00021007462,0.9416054,0.000051836152,0.007673357,0.0033680068,0.00019905552],"about_ca_topic_score_codex":0.0077314787,"about_ca_topic_score_gemma":0.0025477426,"teacher_disagreement_score":0.30202845,"about_ca_system_score_codex":0.008617032,"about_ca_system_score_gemma":0.0040110196,"threshold_uncertainty_score":0.9988761},"labels":[],"label_agreement":null},{"id":"W2544190873","doi":"10.1016/j.jval.2016.08.471","title":"Mapping of Existing Data Sources for the Conduct of Real-World Studies on Lung Cancer in China","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Cornerstone; MEDLINE; Medicine; China; Inclusion (mineral); Lung cancer; Family medicine; Clinical trial; Data science; Computer science; Internal medicine; Psychology; Geography; Political science","score_opus":0.29867573564660616,"score_gpt":0.5047160025495164,"score_spread":0.20604026690291027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544190873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752295,0.010058202,0.00006341149,0.01254044,0.000260391,0.0011264312,0.00025052336,0.000009031312,0.00046207756],"genre_scores_gemma":[0.9962223,0.002703099,0.0004455724,0.00010966615,0.00007350791,0.00006890548,0.0000073137653,0.0000087195585,0.00036090336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992089,0.00004920707,0.00035953597,0.00014910263,0.00009760988,0.00013563749],"domain_scores_gemma":[0.99876875,0.000698381,0.00020574007,0.00026858863,0.00003560347,0.000022969287],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005902462,0.000060560094,0.00025919284,0.00011386944,0.000043447217,0.0000012260722,0.00007860569,0.000012229084,0.000005923617],"category_scores_gemma":[0.00023502772,0.000030361043,0.000018245537,0.00018222757,0.000050747833,0.0000332462,0.00003104157,0.000044176944,1.189404e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036254257,0.0003883758,0.86431515,0.0058915447,0.00069433154,0.0000053461813,0.04419783,0.0051461984,0.001021616,0.008674316,0.0020086726,0.067294054],"study_design_scores_gemma":[0.009945757,0.00083511847,0.931128,0.027040733,0.00022585255,0.0000029483517,0.011023725,0.011088631,0.002095558,0.0013788539,0.0050094198,0.0002254045],"about_ca_topic_score_codex":0.022838388,"about_ca_topic_score_gemma":0.0031750482,"teacher_disagreement_score":0.06706865,"about_ca_system_score_codex":0.00026384447,"about_ca_system_score_gemma":0.00034419406,"threshold_uncertainty_score":0.9836686},"labels":[],"label_agreement":null},{"id":"W2544318409","doi":"10.1016/j.jval.2016.09.2250","title":"Development of a Global Model for the Economic Evaluation of Personalized Medicine for the Treatment of Prostate Cancer","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Prostate cancer; Medicine; Christian ministry; Personalized medicine; Economic evaluation; Medical physics; Precision medicine; Prostate; Gynecology; Oncology; Cancer; Internal medicine; Bioinformatics; Political science; Pathology","score_opus":0.23587646054394062,"score_gpt":0.4658859456792348,"score_spread":0.23000948513529418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544318409","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9398253,0.027150724,0.0020218827,0.022552963,0.0001437073,0.007877531,0.00039571046,0.0000046082578,0.000027579923],"genre_scores_gemma":[0.9860418,0.01009173,0.0014819768,0.000040884355,0.00005539328,0.001958936,0.000012757078,0.000009874159,0.0003066916],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99889773,0.000052759286,0.0004556383,0.00013839247,0.000265979,0.00018950774],"domain_scores_gemma":[0.99894863,0.00041610058,0.00022409977,0.0001638476,0.00020402452,0.00004330369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014613417,0.000084724365,0.00031057934,0.0000336949,0.00005377255,8.1499974e-7,0.00006124689,0.000024559933,0.00002352651],"category_scores_gemma":[0.000051386563,0.00003207317,0.000063531406,0.000066346205,0.00014683175,0.000016655895,0.0000067224696,0.000014642754,2.0618411e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009940576,0.0005787373,0.022752415,0.0016524968,0.0008887177,1.805735e-7,0.03287649,0.020010136,0.0015113838,0.0029376966,0.0006262436,0.9062249],"study_design_scores_gemma":[0.046830017,0.0035024583,0.01778415,0.001608785,0.00045957288,0.0000016083094,0.0017520427,0.9148169,0.0058039976,0.0024409739,0.0048943474,0.000105105835],"about_ca_topic_score_codex":0.002326615,"about_ca_topic_score_gemma":0.0005612554,"teacher_disagreement_score":0.9061198,"about_ca_system_score_codex":0.0022080278,"about_ca_system_score_gemma":0.0042862054,"threshold_uncertainty_score":0.7603544},"labels":[],"label_agreement":null},{"id":"W2544320374","doi":"10.1016/j.jval.2016.09.2059","title":"Perioperative Therapies Reducing Homologous Transfusions During Cardiovascular Surgery: A Network Meta-Analysis of Randomized Controlled Trials","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Blood transfusion and management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Continental (Canada)","funders":"","keywords":"Medicine; Perioperative; Randomized controlled trial; Blood transfusion; Odds ratio; Anesthesia; Placebo; Blood management; Meta-analysis; Surgery; Internal medicine","score_opus":0.12920722486443761,"score_gpt":0.3305678877174325,"score_spread":0.2013606628529949,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544320374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.762914,0.18103077,0.010434485,0.030293502,0.00048904837,0.014050367,0.000051058407,0.00012762466,0.00060914905],"genre_scores_gemma":[0.9685519,0.029054286,0.00071800797,0.0003375265,0.000082858365,0.0008090761,0.0000047497074,0.00002304201,0.00041859673],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9875345,0.0083649475,0.0027242475,0.00043295874,0.0005335037,0.00040983118],"domain_scores_gemma":[0.9925323,0.006123933,0.0005013311,0.0005631741,0.00012876772,0.00015046295],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.031900316,0.0002631931,0.017956018,0.0006711283,0.00013156582,0.000011634183,0.0000771838,0.0000886386,0.00069739355],"category_scores_gemma":[0.0019000712,0.00012458145,0.012409316,0.000992508,0.00012651164,0.00004572935,0.000015443658,0.00013831955,0.0000017318854],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06903089,0.00034664568,0.0002672765,0.00030624834,0.8943411,0.000050860843,0.004641049,0.025852738,0.00064486114,0.0016528426,0.000054297037,0.0028112037],"study_design_scores_gemma":[0.40154317,0.00015785657,0.0020162053,0.0003663212,0.593035,0.000013158725,0.0005297553,0.0011512358,0.00033280195,0.00012525647,0.00045917605,0.0002700808],"about_ca_topic_score_codex":0.0046166796,"about_ca_topic_score_gemma":0.00011224581,"teacher_disagreement_score":0.3325123,"about_ca_system_score_codex":0.00008148855,"about_ca_system_score_gemma":0.0002746656,"threshold_uncertainty_score":0.99748117},"labels":[],"label_agreement":null},{"id":"W2544444843","doi":"10.1016/j.jval.2016.09.1074","title":"Results of A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of The Efficacy And Safety of Sirukumab, An Anti-IL-6 Cytokine Monoclonal Antibody, In Patients with Active Rheumatoid Arthritis Despite Disease-Modifying Anti-Rheumatic Drug Treatment (Sirround-D)","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center","funders":"","keywords":"Medicine; Placebo; Rheumatoid arthritis; Internal medicine; Rheumatology; Clinical endpoint; Adverse effect; Randomized controlled trial; Monoclonal antibody; Gastroenterology; Antibody; Immunology; Pathology","score_opus":0.028939958127314966,"score_gpt":0.3266549871393329,"score_spread":0.2977150290120179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544444843","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852585,0.0022909495,0.00003084278,0.0003842416,0.000052229556,0.011662229,0.00029248517,0.00001738606,0.000011093326],"genre_scores_gemma":[0.9779893,0.021596957,0.00010458529,0.000009017503,0.000009014962,0.00020391346,0.000042945358,0.000038412847,0.000005812293],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99425054,0.0017034994,0.0020641405,0.0005353283,0.00090252014,0.0005439546],"domain_scores_gemma":[0.9959142,0.001762963,0.0010803653,0.00066294457,0.00024587064,0.0003336513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022358068,0.00037310482,0.0025518714,0.00053346157,0.00013106996,0.000017321154,0.00018575318,0.00005955228,0.0000083404],"category_scores_gemma":[0.0005884848,0.0001988621,0.00016296883,0.00048269532,0.00049800205,0.0002696891,0.000070902446,0.00019809463,5.3328233e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8563076,0.011734198,0.105609655,0.00024359966,0.0004579654,0.000015627946,0.007457347,0.00030214764,0.00027625205,0.00008577721,7.773023e-7,0.017509047],"study_design_scores_gemma":[0.8522336,0.0050754747,0.13382591,0.0066411123,0.000022065813,0.0000063261296,0.0007299887,0.00084904645,0.00039666763,0.000059815655,0.000003352067,0.0001566448],"about_ca_topic_score_codex":0.0067996,"about_ca_topic_score_gemma":0.000660571,"teacher_disagreement_score":0.028216254,"about_ca_system_score_codex":0.00021637481,"about_ca_system_score_gemma":0.00072639674,"threshold_uncertainty_score":0.9998142},"labels":[],"label_agreement":null},{"id":"W2544452208","doi":"10.1016/j.jval.2016.09.1188","title":"The Economic Burden of Non-Tuberculous Mycobacterial Pulmonary Disease In Canada, France, United Kingdom And Germany","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Culture conversion; Health care; Exacerbation; Mycobacterium abscessus; Total cost; Indirect costs; Retrospective cohort study; Cohort; Family medicine; Emergency medicine; Pediatrics; Tuberculosis; Internal medicine; Sputum","score_opus":0.018953855520342264,"score_gpt":0.27625959904875586,"score_spread":0.25730574352841357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544452208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99045336,0.00049769494,9.633873e-7,0.008148291,0.00022247403,0.0004722274,0.00012103001,0.000005101781,0.000078876794],"genre_scores_gemma":[0.9975543,0.0018712002,0.000013546908,0.0002354475,0.00020389857,0.00003732841,0.000012092755,0.000013765651,0.00005840373],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860793,0.00016008456,0.0004234427,0.00020697326,0.00017432793,0.00042722985],"domain_scores_gemma":[0.998617,0.0005873829,0.000093148104,0.00027520972,0.000025474827,0.00040176208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046707463,0.00010451008,0.00027049144,0.00016164887,0.000049706498,0.000008675366,0.00010090016,0.00003372175,0.000050879342],"category_scores_gemma":[0.00017394475,0.00006478627,0.000025043684,0.0001436599,0.00007319958,0.000052316558,0.000051257368,0.000121763434,0.0000059216522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010166221,0.000044456385,0.9878352,0.0004596523,0.0000133040185,0.00017053112,0.00012298011,0.00020309167,0.0010113434,0.0001872766,0.00079400634,0.008141484],"study_design_scores_gemma":[0.0013453274,0.00009750089,0.9833644,0.0005419181,0.0000043007935,0.000007690004,0.0000269116,0.0046197595,0.000053004977,0.00008528487,0.009776732,0.0000771448],"about_ca_topic_score_codex":0.96769375,"about_ca_topic_score_gemma":0.24624331,"teacher_disagreement_score":0.7214504,"about_ca_system_score_codex":0.000808155,"about_ca_system_score_gemma":0.0038724649,"threshold_uncertainty_score":0.7675108},"labels":[],"label_agreement":null},{"id":"W2544459228","doi":"10.1016/j.jval.2016.09.1275","title":"Direct and Indirect Costs Associated with Legal Blindness Caused by Retinal Disorders in Brazil","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Public Health in Brazil","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Observational study; Indirect costs; Visual acuity; Visual impairment; Pediatrics; Family medicine; Demography; Ophthalmology; Psychiatry","score_opus":0.02628638315084306,"score_gpt":0.3318808093580622,"score_spread":0.3055944262072191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544459228","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9447171,0.0004063397,0.00001543084,0.041954637,0.00027103035,0.0007994482,0.000056910834,0.00011758351,0.011661504],"genre_scores_gemma":[0.9974104,0.000881388,0.000042753472,0.0008500545,0.00006141654,0.00006042998,0.0000074565705,0.000026540552,0.00065953075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99495894,0.002301872,0.0005387108,0.0004810386,0.0006265552,0.0010929019],"domain_scores_gemma":[0.9975368,0.0015075572,0.0002695596,0.00018462302,0.00005635966,0.0004451136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066561033,0.0001774763,0.0004198753,0.00028584403,0.00037445198,0.000069131966,0.00025294092,0.00020232987,0.000039556886],"category_scores_gemma":[0.0025914558,0.00013845939,0.000020712732,0.001237198,0.00042196762,0.0004140037,0.000039507348,0.00028909324,0.000007193202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001259632,0.00044675753,0.93121004,0.00008669937,0.000017308063,0.000016447211,0.012103299,0.000015193327,0.000027536795,0.003776774,0.005400387,0.0467736],"study_design_scores_gemma":[0.006113923,0.00075393834,0.8413255,0.0018691812,0.000005885418,0.0000023605755,0.0018505547,0.00016521948,0.00004417661,0.00101315,0.14611505,0.00074103597],"about_ca_topic_score_codex":0.11945023,"about_ca_topic_score_gemma":0.19194491,"teacher_disagreement_score":0.14071466,"about_ca_system_score_codex":0.0019036809,"about_ca_system_score_gemma":0.002459397,"threshold_uncertainty_score":0.88641346},"labels":[],"label_agreement":null},{"id":"W2544598042","doi":"10.1016/j.jval.2016.09.1444","title":"Comparison of Orphan Drug Market Access in A Sample of EU Countries, Ausralia, Canada and US","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Orphan drug; Revenue; Health technology; Business; Market access; Authorization; European union; Public economics; Cost–benefit analysis; Drug prices; Developed country; Marketing authorization; Health care; Actuarial science; Finance; International trade; Economic growth; Medicine; Economics; Political science; Environmental health; Population","score_opus":0.3440653529581487,"score_gpt":0.4416841600104544,"score_spread":0.09761880705230569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544598042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96762335,0.0030926145,0.00015706773,0.026781293,0.0003399318,0.0005880996,0.0011140223,0.000005748269,0.00029784572],"genre_scores_gemma":[0.99599576,0.00062349124,0.0006779622,0.0024857526,0.000040140632,0.00001910035,0.000007996215,0.000014796767,0.00013498741],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940617,0.00053789886,0.0045397608,0.0003571265,0.000113424845,0.000390109],"domain_scores_gemma":[0.994189,0.0029135714,0.0023567653,0.00034055504,0.000042967713,0.00015711602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012852104,0.00012836272,0.0012363065,0.00035835293,0.00004300708,0.000013551362,0.00025544257,0.0000682472,0.0003020213],"category_scores_gemma":[0.0023264957,0.00013786624,0.000027470895,0.00024536633,0.0000753822,0.00024670738,0.00006288697,0.0000977823,0.000009041799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025651096,0.000053917403,0.96966785,0.0011522805,0.00000822033,3.2943777e-7,0.0010105324,0.00025379265,4.1103257e-7,0.012552748,0.015135109,0.00013912965],"study_design_scores_gemma":[0.0017299565,0.00009244112,0.91889685,0.0009156972,0.0000015820533,0.0000013460398,0.0005233133,0.0064766835,0.000023788798,0.0072296234,0.06384988,0.00025880698],"about_ca_topic_score_codex":0.97689986,"about_ca_topic_score_gemma":0.8547554,"teacher_disagreement_score":0.122144476,"about_ca_system_score_codex":0.0013199269,"about_ca_system_score_gemma":0.0014414109,"threshold_uncertainty_score":0.5622022},"labels":[],"label_agreement":null},{"id":"W2544648193","doi":"10.1016/j.jval.2016.09.1631","title":"Risk of Motor-Vehicle Accidents Increases with Multimorbidity","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Autopsy Techniques and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Health Information; Bruyère; University of Ottawa","funders":"","keywords":"Medicine; Confounding; Odds ratio; Logistic regression; Socioeconomic status; Demography; Environmental health; Internal medicine; Population","score_opus":0.03767953578546405,"score_gpt":0.3307678714438383,"score_spread":0.2930883356583742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544648193","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99764675,0.0001842796,0.0005289395,0.0009608277,0.000029624676,0.0004236519,0.000030709092,0.00007004153,0.00012518278],"genre_scores_gemma":[0.9927146,0.0007197706,0.0060255383,0.00027431274,0.000039586797,0.000011963392,0.0000018196736,0.000014988647,0.00019745997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898183,0.000119103504,0.00031407896,0.00016465069,0.0002065412,0.0002138113],"domain_scores_gemma":[0.9991555,0.00019088393,0.00019340003,0.00029048376,0.000042628148,0.00012707767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004825542,0.00008998623,0.00030868629,0.0000967961,0.000027554173,0.0000019056581,0.00007068272,0.000050543928,0.00004855961],"category_scores_gemma":[0.00025369684,0.000049553793,0.000044069027,0.00012644588,0.0000499261,0.000054611435,0.000029853727,0.00010083195,0.000008532193],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016927248,0.00014632815,0.9911036,0.00010722453,0.000011482749,0.000011659056,0.00005272189,0.000004938164,0.00039540755,0.00014703373,0.0001651918,0.007685166],"study_design_scores_gemma":[0.0016215583,0.0006559608,0.9933246,0.0006600292,0.00001202459,0.000012854672,0.000020311607,0.00029077363,0.0024743509,0.00024789316,0.0006170176,0.00006267193],"about_ca_topic_score_codex":0.030014444,"about_ca_topic_score_gemma":0.000102974074,"teacher_disagreement_score":0.02991147,"about_ca_system_score_codex":0.00013548583,"about_ca_system_score_gemma":0.00018287527,"threshold_uncertainty_score":0.9764448},"labels":[],"label_agreement":null},{"id":"W2544861797","doi":"10.1016/j.jval.2016.09.1171","title":"Comparative Efficacy of Reslizumab and Mepolizumab For The Treatment of Asthma: A Network Meta-Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Mepolizumab; Medicine; Internal medicine; Exacerbation; Population; Asthma; Gastroenterology; Eosinophil","score_opus":0.1694092795294351,"score_gpt":0.3925726666712042,"score_spread":0.22316338714176912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544861797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8900067,0.10028648,0.0015686848,0.005250515,0.000063189436,0.0025142985,0.00018332484,0.00001628225,0.0001104883],"genre_scores_gemma":[0.99832326,0.00076196814,0.00053966354,0.00009569838,0.00006613412,0.000073640294,0.0000035548537,0.00000724288,0.0001288352],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99875826,0.0002154905,0.00049065246,0.00018489343,0.00015577002,0.0001949433],"domain_scores_gemma":[0.99784416,0.0014204474,0.00026586384,0.0002983638,0.00006514425,0.000106031526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029707173,0.00011452767,0.0011775703,0.00010777215,0.000055110842,0.0000019588329,0.000045064164,0.000032266158,0.000035335113],"category_scores_gemma":[0.000050004845,0.000047202157,0.000501662,0.00032264143,0.000135264,0.000016007441,0.000009017832,0.000023803905,6.50035e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030075664,0.016732413,0.11963348,0.0034719442,0.43273094,0.00007117657,0.033204,0.08302241,0.00058655784,0.024797518,0.0075789685,0.24809492],"study_design_scores_gemma":[0.03470961,0.029006923,0.65426356,0.00045132515,0.16758507,0.000024905314,0.0020074784,0.013300718,0.002207859,0.0012556305,0.094618425,0.0005684818],"about_ca_topic_score_codex":0.00072099257,"about_ca_topic_score_gemma":0.00009117335,"teacher_disagreement_score":0.5346301,"about_ca_system_score_codex":0.0000776686,"about_ca_system_score_gemma":0.00023804301,"threshold_uncertainty_score":0.19248481},"labels":[],"label_agreement":null},{"id":"W2544979968","doi":"10.1016/j.jval.2016.09.1067","title":"Gout Diagnosis and Possible Increased Risk of Joint Replacement: A Population-Based Cohort Study of Older Adults","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Gout; Internal medicine; Population; Cohort; Surgery; Physical therapy","score_opus":0.02108006549057902,"score_gpt":0.2851093319278378,"score_spread":0.26402926643725877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2544979968","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961951,0.00044673306,0.000037662918,0.00050736684,0.000060505914,0.0026380832,0.000048488953,0.000027687049,0.00003836736],"genre_scores_gemma":[0.99875546,0.00022387909,0.000629144,0.00014940514,0.00003118978,0.00015220187,0.000011839433,0.000024573605,0.000022301476],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974729,0.00042238424,0.0009583638,0.000392799,0.0004886946,0.000264865],"domain_scores_gemma":[0.9980298,0.0005123508,0.0005871036,0.0005703145,0.000106713625,0.0001937092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015343778,0.00015765194,0.0006484446,0.00029248637,0.00004616455,0.000002854086,0.00006193657,0.00007842427,0.00007158212],"category_scores_gemma":[0.0009333349,0.00011213542,0.000050450526,0.00032700534,0.00004035531,0.000038316186,0.000035876226,0.00013082227,0.0000027890974],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045005127,0.0014062714,0.9941366,0.00062156585,0.00007115281,0.000004505178,0.0014958815,0.000091340895,0.000036673504,0.0000070850724,0.00007788522,0.0016010156],"study_design_scores_gemma":[0.008886428,0.0019094814,0.9848049,0.0018269817,0.00011693532,0.000003939312,0.00045665522,0.001453201,0.00041509132,0.000023001207,0.0000071169757,0.000096261225],"about_ca_topic_score_codex":0.12985945,"about_ca_topic_score_gemma":0.0003507247,"teacher_disagreement_score":0.12950872,"about_ca_system_score_codex":0.00025994744,"about_ca_system_score_gemma":0.00027350325,"threshold_uncertainty_score":0.8759349},"labels":[],"label_agreement":null},{"id":"W2545044819","doi":"10.1016/j.jval.2016.09.2218","title":"Cost-Effectiveness of Everolimus for Patients with Advanced Neuroendocrine Tumors of the Gastrointestinal (GI) or Lung Origin -A Canadian Societal Health Care System Perspective","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Everolimus; Medicine; Health economics; Reimbursement; Population; Health care; Actuarial science; Activity-based costing; Cost effectiveness; Hazard ratio; Indirect costs; Quality-adjusted life year; Internal medicine; Public health; Environmental health; Risk analysis (engineering); Accounting; Economics; Confidence interval","score_opus":0.03604510639432949,"score_gpt":0.3591619625200114,"score_spread":0.3231168561256819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545044819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883103,0.0003375393,0.00012324398,0.0023198696,0.00014840244,0.008124743,0.00055504084,0.00003295696,0.000047927868],"genre_scores_gemma":[0.99834806,0.000028780816,0.0011021894,0.00011388666,0.00003177208,0.00027911065,0.000010778473,0.000053048596,0.0000323803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967916,0.00063767005,0.00057984353,0.00046877147,0.0005657547,0.00095638644],"domain_scores_gemma":[0.9971457,0.00081279833,0.0004251194,0.00043363575,0.0006821407,0.0005005684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003212189,0.00024093044,0.00073997385,0.00023821226,0.00013398529,0.00000440046,0.00023003966,0.000005462801,0.0000049388027],"category_scores_gemma":[0.0008891296,0.00013102248,0.000110453,0.0005190068,0.00020637075,0.000107873275,0.00004916671,0.00024622268,6.3672195e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.009787951,0.00041150057,0.9668977,0.016548146,0.000042311247,0.00032988837,0.00071548985,0.0011678268,0.00020574387,0.0019516898,0.00013017052,0.0018115655],"study_design_scores_gemma":[0.028773285,0.027779931,0.9020094,0.027265571,0.000043146294,0.0020742859,0.008210844,0.00064046885,0.002321127,0.00006120785,0.0004310023,0.00038968876],"about_ca_topic_score_codex":0.060008693,"about_ca_topic_score_gemma":0.015532676,"teacher_disagreement_score":0.064888276,"about_ca_system_score_codex":0.00399218,"about_ca_system_score_gemma":0.0058599324,"threshold_uncertainty_score":0.9998313},"labels":[],"label_agreement":null},{"id":"W2545094283","doi":"10.1016/j.jval.2016.09.1135","title":"Work Productivity/Interference and General Health Status Improvements with Sirukumab, an Anti-Il-6 Cytokine Monoclonal Antibody, in Patients with Active Rheumatoid Arthritis Despite Treatment with Disease-Modifying Anti-Rheumatic Drugs: Results from the Phase 3 Sirround-D Study","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Southlake Regional Health Center","funders":"","keywords":"Medicine; Placebo; Rheumatoid arthritis; Visual analogue scale; Internal medicine; Depression (economics); Physical therapy; Anxiety; Psychiatry","score_opus":0.02846267644605612,"score_gpt":0.31400816876233106,"score_spread":0.28554549231627496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545094283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885041,0.0026903974,0.00015004638,0.0018834982,0.00005803128,0.005687387,0.00095758087,0.00006570802,0.0000032576386],"genre_scores_gemma":[0.980823,0.017629474,0.0007324534,0.000113486196,0.000040521838,0.0002575928,0.0003121937,0.00008146788,0.00000982807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994419,0.0010302329,0.0009690494,0.0012640884,0.0010105468,0.0013070928],"domain_scores_gemma":[0.997152,0.00038702143,0.00054154225,0.00089869736,0.00018094908,0.00083979644],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009320663,0.00058078644,0.0011327359,0.00031041988,0.00040197856,0.0001373006,0.00018826479,0.000047373862,0.000008771878],"category_scores_gemma":[0.000110452056,0.00029976328,0.000039519095,0.0006128652,0.0003799777,0.0006920199,0.00007950452,0.0003587702,0.0000027272322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020633059,0.0062160087,0.7679396,0.0000748902,0.0002254646,0.000068461704,0.011910034,0.000072387964,0.00007027277,0.0000116519295,0.0000037176692,0.19277442],"study_design_scores_gemma":[0.069384694,0.026723364,0.8930656,0.007850831,0.0000070001906,0.000010432645,0.0020642264,0.00033514437,0.000076340446,0.000056980207,0.00005141548,0.00037401062],"about_ca_topic_score_codex":0.03621913,"about_ca_topic_score_gemma":0.0048602982,"teacher_disagreement_score":0.1924004,"about_ca_system_score_codex":0.00083383004,"about_ca_system_score_gemma":0.0016294328,"threshold_uncertainty_score":0.99994546},"labels":[],"label_agreement":null},{"id":"W2545128212","doi":"10.1016/j.jval.2016.08.473","title":"Mapping of Existing Data Sources for the Conduct of Real-World Studies in Progressive Supranulcear Palsy (PSP) in North America, Europe and Japan","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"MEDLINE; Medicine; Family medicine; Real world data; Progressive supranuclear palsy; Systematic review; Disease; Geography; Data science; Political science; Computer science; Pathology","score_opus":0.28916042285846794,"score_gpt":0.41770942456587595,"score_spread":0.12854900170740802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545128212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9894689,0.008313413,0.000015808888,0.0009699633,0.000042348223,0.0009843189,0.00016576082,0.0000069280222,0.00003257128],"genre_scores_gemma":[0.99446845,0.004204597,0.0010975408,0.00008066802,0.000028583489,0.000052181153,0.00002059259,0.0000137894185,0.000033615892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986619,0.00018103067,0.00048652766,0.00028272037,0.00014369035,0.00024418277],"domain_scores_gemma":[0.99851024,0.0007334966,0.00031259184,0.00032997617,0.000060019695,0.000053647334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006694035,0.00011180363,0.00047803108,0.00019409372,0.000039370974,0.0000027565302,0.000113248694,0.000015687785,0.0000028231677],"category_scores_gemma":[0.0005142391,0.00006234356,0.00001940537,0.00041592243,0.00015450138,0.0000568156,0.00010506587,0.00006608244,4.812485e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024044032,0.0002735979,0.95243835,0.0013854381,0.00009362455,0.000029773893,0.0054239826,0.000026161184,0.00017207033,0.00019833852,0.000033208275,0.03968502],"study_design_scores_gemma":[0.004734461,0.0006438822,0.9809844,0.004253216,0.000045832785,0.0000058804653,0.004822769,0.0011496993,0.00021347596,0.00024829363,0.0027765217,0.00012160355],"about_ca_topic_score_codex":0.004190942,"about_ca_topic_score_gemma":0.0015876415,"teacher_disagreement_score":0.039563417,"about_ca_system_score_codex":0.00006407148,"about_ca_system_score_gemma":0.00016501127,"threshold_uncertainty_score":0.6335478},"labels":[],"label_agreement":null},{"id":"W2545168735","doi":"10.1016/j.jval.2016.09.1426","title":"Certolizumab Pegol is Associated with Long-Term Improvements in Patient-Reported Outcomes in Psoriatic Arthritis: 4-Year Outcomes from the Rapid-Psa Study","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Psoriatic arthritis; Internal medicine; Placebo; Randomized controlled trial; Psoriasis; Arthritis; Physical therapy; Etanercept; Dermatology; Rheumatoid arthritis","score_opus":0.03171754063272407,"score_gpt":0.3054579776833389,"score_spread":0.2737404370506148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545168735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895057,0.0007914072,0.0000026251446,0.0069387266,0.0002833077,0.0023176877,0.00006504822,0.00004998633,0.00004552627],"genre_scores_gemma":[0.99797004,0.00022952836,0.000016435799,0.0014570118,0.00001752624,0.0001935396,0.00002839619,0.00003104721,0.00005647487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99659264,0.0007276357,0.001138833,0.00047329668,0.00049592584,0.0005716734],"domain_scores_gemma":[0.9977684,0.0010308822,0.00041100645,0.00057879166,0.000054595446,0.00015632156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032081513,0.00027001006,0.0009334989,0.00022860695,0.00007075375,0.000015404512,0.00016526488,0.000117823794,0.00017726612],"category_scores_gemma":[0.0010101609,0.00014820947,0.00007938114,0.00034114634,0.00007754198,0.00011926207,0.000060523038,0.0002770154,0.00002230231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034461982,0.0022272666,0.9833151,0.000039681334,0.0002214063,0.0019513665,0.0028594001,0.0000017349619,0.0000019565216,0.0000038497296,0.00021133976,0.008822263],"study_design_scores_gemma":[0.018828219,0.00055330497,0.97803557,0.0012420035,0.000045049816,0.000025253454,0.0009123672,0.000024054127,0.000011670016,0.00015474301,0.0000048754096,0.00016286297],"about_ca_topic_score_codex":0.005317165,"about_ca_topic_score_gemma":0.004916632,"teacher_disagreement_score":0.018483598,"about_ca_system_score_codex":0.00036311935,"about_ca_system_score_gemma":0.00052215945,"threshold_uncertainty_score":0.80379987},"labels":[],"label_agreement":null},{"id":"W2545460684","doi":"10.1016/j.jval.2016.09.2308","title":"Castration-Resistant Prostate Cancer (CRPC): Evaluation of The Quality of Care and Disease Management in Real-Life Setting","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Enzalutamide; Docetaxel; Medicine; Cabazitaxel; Abiraterone acetate; Prostate cancer; Abiraterone; Internal medicine; Oncology; Quality of life (healthcare); Cancer; Androgen deprivation therapy; Nursing","score_opus":0.13060201330648763,"score_gpt":0.456727396626098,"score_spread":0.3261253833196104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545460684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862235,0.0049590594,9.951951e-7,0.0068150107,0.00003934578,0.0016718804,0.000090254325,0.0000035937637,0.00019635352],"genre_scores_gemma":[0.99588263,0.0038011658,0.000053383228,0.000046888155,0.000012981603,0.00012482802,0.0000074065347,0.000005957402,0.00006477683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983314,0.00041799774,0.00041098276,0.00016126508,0.0005152752,0.00016306361],"domain_scores_gemma":[0.9993204,0.000077286706,0.0001635492,0.00018822368,0.00014049988,0.000110053326],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015141149,0.000061537175,0.00017111877,0.000081645114,0.00003186478,0.0000024450858,0.000036062935,0.000017625436,0.000010304094],"category_scores_gemma":[0.00017284432,0.00003369021,0.000023634842,0.00018130914,0.000065288485,0.000035434357,0.00002797073,0.000049874907,1.7333889e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015722081,0.00013740305,0.9270798,0.005590452,0.000037463862,0.0000044608787,0.0048802523,0.00078810996,0.0014261239,0.001020195,0.00004707441,0.05741648],"study_design_scores_gemma":[0.0035499467,0.000118650714,0.99196887,0.0019251478,0.00002489507,1.0369552e-7,0.0011371489,0.0005531914,0.00032290863,0.00034488566,0.000018028808,0.000036229078],"about_ca_topic_score_codex":0.008606326,"about_ca_topic_score_gemma":0.0012444158,"teacher_disagreement_score":0.06488909,"about_ca_system_score_codex":0.0005776197,"about_ca_system_score_gemma":0.00144446,"threshold_uncertainty_score":0.99799544},"labels":[],"label_agreement":null},{"id":"W2545691744","doi":"10.1016/j.jval.2016.09.1212","title":"Development of A Global Model For The Economic Evaluation of A Biomarker For The Treatment of Uncontrolled Moderate To Severe Asthma","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Omalizumab; Medicine; Asthma; Context (archaeology); Christian ministry; Economic evaluation; Immunoglobulin E; Intensive care medicine; Internal medicine; Immunology","score_opus":0.2651210136055662,"score_gpt":0.4578383418120825,"score_spread":0.19271732820651627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545691744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9270265,0.0042934716,0.033564076,0.028269965,0.00013889452,0.006396649,0.00021239943,0.0000040352033,0.00009399584],"genre_scores_gemma":[0.9937772,0.000607342,0.0048792055,0.00018597316,0.00002163663,0.00049880845,0.0000011648671,0.0000047015315,0.000023957644],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990818,0.00007681231,0.00043879275,0.00011215255,0.00014195214,0.00014847927],"domain_scores_gemma":[0.99836105,0.0011455073,0.0002074079,0.00012349333,0.00011779847,0.000044723438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018475115,0.00007210186,0.00028612226,0.000015403546,0.00006202975,0.0000016826391,0.000048370097,0.000020883148,0.00000905702],"category_scores_gemma":[0.00014824356,0.000030272553,0.000068967536,0.000046071305,0.000023154542,0.00002120347,0.000011370586,0.000011459193,5.8503684e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014194383,0.0004031901,0.0009094243,0.00029171046,0.0006984608,5.3634047e-8,0.0030198789,0.11727343,0.000350603,0.0014077256,0.00025598836,0.86119515],"study_design_scores_gemma":[0.008859966,0.0005629363,0.0034921377,0.00009332669,0.00012307156,7.214507e-7,0.00016804796,0.98116887,0.0003445009,0.00085460494,0.0042967466,0.000035045912],"about_ca_topic_score_codex":0.00054438604,"about_ca_topic_score_gemma":0.00047071005,"teacher_disagreement_score":0.8638955,"about_ca_system_score_codex":0.00073499983,"about_ca_system_score_gemma":0.0009813815,"threshold_uncertainty_score":0.1921999},"labels":[],"label_agreement":null},{"id":"W2545830314","doi":"10.1016/j.jval.2016.09.1828","title":"Management of Patients with Statin Intolerance: Results from a Survey of Clinicians in Six European Countries","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Ezetimibe; Statin; Medicine; Czech; Family medicine; Fenofibrate; Internal medicine","score_opus":0.03287162819912684,"score_gpt":0.28906069460862405,"score_spread":0.25618906640949723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2545830314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967968,0.00048570294,0.00020184705,0.0005099317,0.00007863532,0.0009417137,0.00062434736,0.000009710251,0.00035129985],"genre_scores_gemma":[0.997022,0.0013392519,0.0013181003,0.00016082826,0.000024383988,0.0000077188815,0.00007935532,0.000021577614,0.000026822603],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99695456,0.0009027002,0.0010721121,0.0002893971,0.00051982957,0.0002613869],"domain_scores_gemma":[0.99862343,0.00023520972,0.00037833885,0.00052017445,0.00015045113,0.000092377944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004205832,0.000111792964,0.0005698141,0.00012017422,0.00001580627,0.0000021762692,0.000088254346,0.000034526656,0.0000085261545],"category_scores_gemma":[0.00015948193,0.00007195394,0.000042617885,0.00031117984,0.00006952364,0.000039371298,0.00003278149,0.000109411376,0.0000054180637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031541418,0.0004071859,0.92752784,0.0010005155,0.00008058009,0.000031819374,0.0012272266,0.00014427373,0.00000128715,0.00008498055,0.00007415629,0.066266],"study_design_scores_gemma":[0.010100549,0.0007278333,0.98455805,0.003625864,0.000010109194,2.2225959e-7,0.00011256151,0.0000306775,0.000022346921,0.000023231949,0.00071924226,0.00006928785],"about_ca_topic_score_codex":0.06991105,"about_ca_topic_score_gemma":0.0026193932,"teacher_disagreement_score":0.067291655,"about_ca_system_score_codex":0.00015203618,"about_ca_system_score_gemma":0.00027683808,"threshold_uncertainty_score":0.9362825},"labels":[],"label_agreement":null},{"id":"W2546045155","doi":"10.1016/j.jval.2016.09.039","title":"HT5 Development of a Multi-Criteria Decision Analysis (MCDA) Framework for Health Care Decision-Making in Catalonia (Spain): Pilot Study Focused in Orphan Drugs","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Multiple-criteria decision analysis; Orphan drug; Weighting; Context (archaeology); Scope (computer science); Health care; Medicine; Decision analysis; Management science; Population; Operations research; Computer science; Statistics; Engineering; Mathematics; Geography; Environmental health","score_opus":0.32014109662810075,"score_gpt":0.4792208494398056,"score_spread":0.15907975281170483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546045155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8176748,0.0029825335,0.17081584,0.004462965,0.0004269407,0.003305963,0.00029855454,0.000026073183,0.0000063132766],"genre_scores_gemma":[0.78282684,0.000083502215,0.21511002,0.0014769082,0.000053582564,0.00037776903,0.00001982602,0.000045746423,0.0000057976035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9863948,0.0011932304,0.00993354,0.0012097402,0.0002699652,0.0009986924],"domain_scores_gemma":[0.987623,0.0077839713,0.0032943743,0.0009099345,0.00010573418,0.00028302436],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.038486436,0.00034457684,0.0025079683,0.0031210408,0.00021311018,0.00004825185,0.0005375371,0.0001633989,0.00007348132],"category_scores_gemma":[0.007530428,0.00036753778,0.00014111279,0.001786812,0.00004378396,0.00031615395,0.00012957017,0.00026032823,0.00006886506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054818613,0.001884319,0.86547095,0.0012255677,0.00012657748,0.0000027545136,0.079790264,0.004066734,8.6194063e-7,0.0030454488,0.00021283263,0.043625522],"study_design_scores_gemma":[0.008859719,0.001689513,0.9392061,0.005411186,0.000011441418,8.736746e-7,0.009504516,0.020681333,0.0000028829124,0.01222213,0.0016179385,0.0007923194],"about_ca_topic_score_codex":0.018838523,"about_ca_topic_score_gemma":0.063577555,"teacher_disagreement_score":0.07373522,"about_ca_system_score_codex":0.005339645,"about_ca_system_score_gemma":0.0019111204,"threshold_uncertainty_score":0.99987763},"labels":[],"label_agreement":null},{"id":"W2546091019","doi":"10.1016/j.jval.2016.09.524","title":"The Impact of Treatment Adherence on Clinical and Economic Outcomes in Multiple Sclerosis: Real-World Evidence from Alberta, Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Cégep de Lévis; Hôpital Notre-Dame; University of Calgary","funders":"","keywords":"Real world evidence; Multiple sclerosis; Medicine; Business; Psychiatry; Internal medicine","score_opus":0.619957445355035,"score_gpt":0.4789490194612332,"score_spread":0.14100842589380186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546091019","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97450006,0.0013477874,0.0000069491734,0.022320759,0.0004550528,0.00077362603,0.00045170906,0.000006384242,0.00013765924],"genre_scores_gemma":[0.9917131,0.0070059304,0.00014473197,0.0006877026,0.00008569674,0.00009227786,0.0000031677368,0.00001835438,0.00024901106],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9931851,0.0009247791,0.004789129,0.00058052124,0.000058928374,0.00046156347],"domain_scores_gemma":[0.97551215,0.021754935,0.0018766278,0.00061101874,0.000014345199,0.0002309476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009415985,0.00020326686,0.0012185829,0.00018409821,0.000106583815,0.000025659803,0.00025387554,0.000077997036,0.00007281726],"category_scores_gemma":[0.003815187,0.00014569916,0.0001145347,0.00009873971,0.000115110844,0.00019951806,0.00003635342,0.000121724275,0.00012469958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005512596,0.000058126105,0.99333656,0.000024453142,0.00003510838,2.636973e-7,0.00039687002,0.0013247015,3.155939e-7,0.0023108185,0.0011197063,0.0013379588],"study_design_scores_gemma":[0.0013918583,0.00046956204,0.9886765,0.0006209286,0.000001251736,1.7748917e-7,0.000118948985,0.0061152168,0.0000017639576,0.0019275725,0.0005307675,0.00014546335],"about_ca_topic_score_codex":0.99762255,"about_ca_topic_score_gemma":0.9872486,"teacher_disagreement_score":0.021633055,"about_ca_system_score_codex":0.0056022424,"about_ca_system_score_gemma":0.0026451605,"threshold_uncertainty_score":0.9982151},"labels":[],"label_agreement":null},{"id":"W2546103895","doi":"10.1016/j.jval.2016.09.2330","title":"The Declining Value of Economics in Canadian Cancer Reimbursement Reviews","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Value (mathematics); Listing (finance); Negotiation; Psychological intervention; Actuarial science; Economic evaluation; Public economics; Institution; Economics; Business; Political science; Medicine; Health care; Finance; Microeconomics; Law; Economic growth","score_opus":0.5256384406449428,"score_gpt":0.4636573011348084,"score_spread":0.0619811395101344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546103895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6458244,0.05988227,0.00019805029,0.28673625,0.0021627243,0.0025109358,0.00038528725,0.000017106166,0.002282992],"genre_scores_gemma":[0.8841498,0.09308096,0.0023705158,0.01871025,0.00043298284,0.0005343609,0.00000859106,0.00006504036,0.000647502],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99099755,0.0009089122,0.0066763377,0.00049748376,0.00004705266,0.00087266474],"domain_scores_gemma":[0.99455124,0.0017037326,0.002741318,0.00062220864,0.000027422584,0.0003540673],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.046975758,0.00017135924,0.0010854308,0.00048066926,0.00016257275,0.000025223597,0.000391114,0.00011361565,0.00011744098],"category_scores_gemma":[0.0037138145,0.00015002013,0.000095943265,0.00025290492,0.00007768354,0.00021002092,0.00003584707,0.00017083704,0.00029858988],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014413609,0.000043757536,0.490706,0.0004722994,0.000021381731,6.1449805e-7,0.0020000332,0.0058572623,5.4723364e-7,0.4836927,0.0068265707,0.010364434],"study_design_scores_gemma":[0.0014663223,0.00011292308,0.103012465,0.0018882155,0.0000023007083,0.0000017277448,0.0004927194,0.015375404,0.000004549807,0.04938166,0.8278607,0.00040103117],"about_ca_topic_score_codex":0.8228115,"about_ca_topic_score_gemma":0.67511094,"teacher_disagreement_score":0.82103413,"about_ca_system_score_codex":0.0045455555,"about_ca_system_score_gemma":0.002125212,"threshold_uncertainty_score":0.9992758},"labels":[],"label_agreement":null},{"id":"W2546256960","doi":"10.1016/j.jval.2016.09.778","title":"Good Enough For Policy Work? Study-Design Challenges In Implementing Stated-Preference Methods For Complex Health-Care Technologies","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Bone and Joint Health Institute","funders":"","keywords":"Respondent; Watchful waiting; Preference; Health care; Medicine; Valuation (finance); Actuarial science; Psychological intervention; Population; Sample (material); Contingent valuation; Willingness to pay; Family medicine; Nursing; Economics; Environmental health; Microeconomics","score_opus":0.6192934447782598,"score_gpt":0.4108913785004863,"score_spread":0.20840206627777347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546256960","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2048528,0.060505576,0.578344,0.13373579,0.0006792657,0.01924385,0.0011867698,0.00040507296,0.0010468623],"genre_scores_gemma":[0.8729281,0.0059145074,0.11997577,0.0001773542,0.000041934803,0.0008751207,0.000020081117,0.000034251203,0.000032874228],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9972218,0.00018607352,0.0012243966,0.00061052694,0.000026566764,0.0007306207],"domain_scores_gemma":[0.9983592,0.0006307175,0.00061051705,0.000331617,0.000011732125,0.00005622548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046393755,0.00018310998,0.000596019,0.00045388736,0.0001457322,0.00002077746,0.0002560988,0.00008821599,0.000015558082],"category_scores_gemma":[0.00028361363,0.00018225111,0.00006032866,0.00019624569,0.000040279752,0.00016067375,0.00009816602,0.00009396654,0.0000161986],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008044718,0.00029541625,0.09677422,0.00041922153,0.0000293573,1.6025271e-7,0.008855773,0.0013457058,0.000009798553,0.14177655,0.00014028169,0.75027305],"study_design_scores_gemma":[0.012017428,0.004834818,0.51582456,0.00051812286,0.0000066894095,0.0000015134932,0.03226673,0.009233531,0.00013109295,0.34004727,0.083932325,0.0011859576],"about_ca_topic_score_codex":0.0020198722,"about_ca_topic_score_gemma":0.00029789627,"teacher_disagreement_score":0.7490871,"about_ca_system_score_codex":0.0015881008,"about_ca_system_score_gemma":0.0001296537,"threshold_uncertainty_score":0.7431985},"labels":[],"label_agreement":null},{"id":"W2546306249","doi":"10.1016/j.jval.2016.09.432","title":"Seasonal Variations of Outpatient Antibiotic use in Austria","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Quarter (Canadian coin); Medicine; Population; Demography; Antibiotics; Defined daily dose; Lincosamides; Pediatrics; Environmental health; Geography; Antibiotic resistance; Biology","score_opus":0.04063148796038186,"score_gpt":0.271867072856534,"score_spread":0.23123558489615215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546306249","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968631,0.0009434187,0.0003653659,0.0010761991,0.00039600118,0.00021229722,0.000053449345,0.000011717395,0.00007842835],"genre_scores_gemma":[0.99858993,0.0002933632,0.00023901023,0.00007360291,0.000008871412,7.141086e-7,0.000008190638,0.000005938935,0.0007803997],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884814,0.0003019379,0.00039186477,0.0001677124,0.000029022025,0.0002613171],"domain_scores_gemma":[0.99934673,0.00030841934,0.00013848669,0.00016499167,0.000023413382,0.000017934683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036366025,0.00007297374,0.00021500036,0.0001251287,0.000032727075,0.0000020222672,0.00008360774,0.00012507653,0.00007313755],"category_scores_gemma":[0.00017737951,0.000050259998,0.00003073336,0.00017433362,0.00008304208,0.000055670695,0.000024355775,0.000114001705,0.00006931871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019888597,0.00079945126,0.938035,0.00019269373,0.000040636998,0.000006996964,0.0009511263,0.00017608897,0.022881009,0.030491697,0.0011769395,0.005049488],"study_design_scores_gemma":[0.0028950926,0.00040020535,0.98520553,0.0015692342,0.000006563827,0.0000071426593,0.00011497074,0.000067959234,0.005840878,0.0004790545,0.0032515898,0.00016175736],"about_ca_topic_score_codex":0.0036939147,"about_ca_topic_score_gemma":0.00031892932,"teacher_disagreement_score":0.047170565,"about_ca_system_score_codex":0.0001039207,"about_ca_system_score_gemma":0.00021388673,"threshold_uncertainty_score":0.5584119},"labels":[],"label_agreement":null},{"id":"W2546702107","doi":"10.1016/j.jval.2016.09.2399","title":"The Association between Depression and Medication Nonpersistence in New Users of Antidiabetic Drugs","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; The Quebec Population Health Research Network","funders":"Fonds de Recherche du Québec - Santé; AstraZeneca Canada; Université Laval","keywords":"Depression (economics); Association (psychology); Medicine; Pharmacology; Psychiatry; Psychology; Psychotherapist; Economics","score_opus":0.025938143039643556,"score_gpt":0.2939749003113782,"score_spread":0.26803675727173465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2546702107","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9780485,0.0005954676,0.000030454683,0.020635009,0.00011076057,0.00027272166,6.879634e-7,0.0000071290237,0.00029928537],"genre_scores_gemma":[0.9980091,0.001197358,0.00014183769,0.000115778006,0.000058633825,0.0000046207315,0.0000039232755,0.0000044478725,0.00046432027],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991698,0.00009894589,0.00026321848,0.00011274138,0.00019405977,0.00016120989],"domain_scores_gemma":[0.9991825,0.00043315528,0.00017944376,0.000118512464,0.000019930709,0.00006646174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013628572,0.000042804073,0.00012709298,0.00010114112,0.000029861421,0.0000046285577,0.000045789588,0.00003792295,0.000003554644],"category_scores_gemma":[0.0003967034,0.000026461632,0.000012772738,0.00017669167,0.00002144604,0.000069116235,0.000015133383,0.000053264554,0.0000035338346],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007375799,0.000016159662,0.9025466,0.000082133774,0.000005430209,4.1402927e-8,0.0006764811,0.0000018445876,0.00008090832,0.0000803824,0.00044589306,0.09605675],"study_design_scores_gemma":[0.00071148475,0.00005537394,0.9963069,0.00070213334,0.000011173908,4.6677542e-8,0.00021740075,0.00014414842,0.0002196212,0.00042226756,0.0011818517,0.0000275752],"about_ca_topic_score_codex":0.001159002,"about_ca_topic_score_gemma":0.000029661993,"teacher_disagreement_score":0.09602917,"about_ca_system_score_codex":0.00024378223,"about_ca_system_score_gemma":0.00019286734,"threshold_uncertainty_score":0.1752072},"labels":[],"label_agreement":null},{"id":"W2549391882","doi":"10.1016/j.jval.2016.09.2403","title":"Limited Effectiveness of Diabetes Risk Assessment Tools in Seniors’ Facility Residents","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alliance for Canadian Health Outcomes Research in Diabetes; University of Alberta","funders":"","keywords":"Glycated hemoglobin; Medicine; Diabetes mellitus; Confidence interval; Risk assessment; Cross-sectional study; Receiver operating characteristic; Type 2 diabetes; Gerontology; Internal medicine; Endocrinology; Pathology","score_opus":0.06189749594463982,"score_gpt":0.3671160115294285,"score_spread":0.3052185155847887,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549391882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966524,0.00031619426,0.00010057452,0.0007824571,0.0001159403,0.0012060942,0.000096639196,0.000035876903,0.00069381756],"genre_scores_gemma":[0.99928606,0.00038515878,0.00013425812,0.000050335064,0.000017625624,0.00006280548,0.000021223539,0.000009417079,0.000033118216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973845,0.0010505,0.00053244893,0.00032618386,0.00033800481,0.0003683906],"domain_scores_gemma":[0.9981811,0.0010777588,0.00017594674,0.00040915766,0.00004320003,0.00011285211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026205946,0.00013388038,0.00046489944,0.00025144636,0.000022602857,0.000010428138,0.00009277949,0.000052871932,0.000052920077],"category_scores_gemma":[0.0006468506,0.00009856395,0.000060964878,0.00033437042,0.00007265889,0.00014681672,0.00006854408,0.00014485103,0.000011904072],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013973466,0.00035997952,0.9862208,0.0030888496,0.000032378524,0.000010835648,0.000070365466,0.000344238,0.0004919599,0.0004684761,0.00006933627,0.0087030865],"study_design_scores_gemma":[0.003459435,0.0003201363,0.9908789,0.0026966424,0.000016060374,2.1080268e-7,0.00007697111,0.00039098682,0.00038491804,0.0016230567,0.00006890216,0.00008378244],"about_ca_topic_score_codex":0.004072155,"about_ca_topic_score_gemma":0.00008544405,"teacher_disagreement_score":0.008619305,"about_ca_system_score_codex":0.00091663824,"about_ca_system_score_gemma":0.00053738564,"threshold_uncertainty_score":0.6155907},"labels":[],"label_agreement":null},{"id":"W2554158039","doi":"10.1016/j.jval.2019.07.005","title":"A Systematic Review and Meta-Analysis of Health Utilities in Patients With Chronic Hepatitis C","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; University Health Network; SickKids Foundation; Hospital for Sick Children; University of Waterloo; Toronto Rehabilitation Institute","funders":"Canadian Institutes of Health Research; Public Health Agency of Canada","keywords":"Meta-analysis; Chronic hepatitis; Medicine; Environmental health; Intensive care medicine; Virology; Data science; Internal medicine; Computer science","score_opus":0.23622803842918885,"score_gpt":0.43879462226470733,"score_spread":0.20256658383551848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554158039","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000030100906,0.98423344,0.000003927344,0.0003876397,0.000019548095,0.014770771,0.00049526093,0.000013229882,0.000046102818],"genre_scores_gemma":[0.00023715333,0.9977215,0.00010802998,0.00049809954,0.000006218978,0.0008238061,0.0003433336,0.00006703779,0.00019484638],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9888738,0.0045746043,0.004049554,0.000708114,0.0010831037,0.00071085466],"domain_scores_gemma":[0.9956391,0.0007857793,0.0018794715,0.0012546054,0.00017719115,0.0002638908],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0055743144,0.0005156566,0.022281474,0.0019511635,0.000035841138,0.000013713043,0.00023539418,0.00017682169,0.00018828933],"category_scores_gemma":[0.0006217582,0.00032847814,0.00097187975,0.003021985,0.00009720218,0.00007112461,0.00009239157,0.00072432787,0.000021450252],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000036442293,0.000120014374,0.0029068263,0.9630266,0.024671318,0.0000044591516,0.000115758165,0.000004543488,6.62248e-11,0.000040035964,0.00003604936,0.009070759],"study_design_scores_gemma":[0.00062402815,0.0014570195,0.0014702344,0.6724935,0.3119696,0.0000044324574,0.000007839161,0.00013931836,2.6050186e-9,0.0000030623492,0.011532397,0.00029853222],"about_ca_topic_score_codex":0.04596633,"about_ca_topic_score_gemma":0.003867128,"teacher_disagreement_score":0.29053307,"about_ca_system_score_codex":0.002060864,"about_ca_system_score_gemma":0.0050486024,"threshold_uncertainty_score":0.99991673},"labels":[],"label_agreement":null},{"id":"W2554271301","doi":"10.1016/j.jval.2016.10.003","title":"Emerging Guidelines for Patient Engagement in Research","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":235,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University; University of British Columbia","funders":"","keywords":"Reciprocity (cultural anthropology); Psychology; General partnership; Process (computing); Dissemination; Value (mathematics); Work (physics); Knowledge management; Public relations; Medical education; Medicine; Social psychology; Business; Political science; Computer science; Engineering","score_opus":0.8460801761068034,"score_gpt":0.6326473521940884,"score_spread":0.213432823912715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2554271301","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93253,0.0018216998,0.0006726714,0.050743695,0.002589917,0.009720217,0.00010828951,0.00006205555,0.0017514557],"genre_scores_gemma":[0.96715575,0.002543066,0.008605762,0.015085937,0.0005971282,0.004475224,0.000069832284,0.00006494628,0.0014023451],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99180245,0.0035350923,0.002003359,0.00044614152,0.0005959298,0.0016170285],"domain_scores_gemma":[0.99617445,0.0025080836,0.0002694806,0.00036158934,0.000366275,0.0003201465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015754519,0.00014588024,0.00031625284,0.00054345274,0.000712684,0.0000032963337,0.00018837552,0.00011056217,0.00017998969],"category_scores_gemma":[0.0009911796,0.000102134676,0.000039750867,0.00045576258,0.000033240674,0.000082820065,0.00016533109,0.0005234766,0.00016356268],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008221885,0.00087580224,0.43621728,0.011825763,0.000011227666,0.000010013166,0.039491393,0.0005680443,0.00020552635,0.031932082,0.09716983,0.38087085],"study_design_scores_gemma":[0.00616909,0.0022836663,0.008668483,0.018404681,0.0000015684442,3.3400264e-7,0.015622211,0.0031323042,0.00013652237,0.014673627,0.93056935,0.00033815525],"about_ca_topic_score_codex":0.013107782,"about_ca_topic_score_gemma":0.0017683032,"teacher_disagreement_score":0.83339953,"about_ca_system_score_codex":0.0019689177,"about_ca_system_score_gemma":0.00095114246,"threshold_uncertainty_score":0.993464},"labels":[],"label_agreement":null},{"id":"W2555523074","doi":"10.1016/j.jval.2016.09.2404","title":"Joint Utility Estimators in Substance Use Disorders","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver; Simon Fraser University","funders":"National Institute on Drug Abuse; National Institutes of Health","keywords":"Estimator; Mean squared error; Context (archaeology); Statistics; Mathematics; Multiplicative function; Econometrics; Medicine","score_opus":0.5234719838194661,"score_gpt":0.4170073309033911,"score_spread":0.10646465291607504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555523074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9193966,0.0020985748,0.004033652,0.07202025,0.0006810271,0.0009818929,0.00018543165,0.0000597406,0.00054283213],"genre_scores_gemma":[0.99150455,0.00077932153,0.0030425119,0.0042799828,0.00006918764,0.00009317972,0.0000060957486,0.00003416011,0.00019103974],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99273753,0.0007707333,0.0049259476,0.00072274,0.00009835606,0.0007447031],"domain_scores_gemma":[0.99599963,0.001604168,0.0014720627,0.0006527777,0.00002064409,0.00025071405],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.021137591,0.00019908794,0.0010051599,0.0005446067,0.00009077835,0.000035429646,0.00022429123,0.0001331673,0.00021892006],"category_scores_gemma":[0.0046721655,0.00021268927,0.00008457996,0.00039793676,0.00009309421,0.0006855133,0.00003128303,0.00020042645,0.00084924843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014452478,0.0001339822,0.9210316,0.00031931524,0.00000568587,0.0000010117174,0.0015253965,0.0009885094,4.9384744e-7,0.07251994,0.0024422295,0.0010173869],"study_design_scores_gemma":[0.0014313579,0.00006887887,0.8968463,0.000588019,5.0050687e-7,0.0000012815792,0.00024012064,0.017843334,0.0000018922854,0.062929235,0.019700343,0.0003487284],"about_ca_topic_score_codex":0.03434282,"about_ca_topic_score_gemma":0.0077004703,"teacher_disagreement_score":0.07210792,"about_ca_system_score_codex":0.0016744133,"about_ca_system_score_gemma":0.0003420966,"threshold_uncertainty_score":0.9999287},"labels":[],"label_agreement":null},{"id":"W2557677183","doi":"10.1016/j.jval.2016.10.010","title":"Costs for Childhood and Adolescent Cancer, 90 Days Prediagnosis and 1 Year Postdiagnosis: A Population-Based Study in Ontario, Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; University of British Columbia; Hospital for Sick Children; Pediatric Oncology Group; University Health Network; University of Toronto; Centre for Addiction and Mental Health; Toronto Public Health; BC Cancer Agency; Institute for Work & Health; Institute for Clinical Evaluative Sciences","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Demography; Childhood cancer; Cancer; Sociology; Internal medicine","score_opus":0.03711258106478269,"score_gpt":0.3136323733191813,"score_spread":0.2765197922543986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2557677183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96945155,0.001389452,0.000006258507,0.025623187,0.00026210054,0.0030868228,0.00015224364,0.000021719232,0.000006659193],"genre_scores_gemma":[0.9944158,0.0003117957,0.00020651099,0.004472011,0.00010971286,0.00041731546,0.000020212274,0.000030055986,0.000016572187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979061,0.00022296769,0.00062142534,0.00048453803,0.0003605635,0.0004044104],"domain_scores_gemma":[0.9985543,0.00066541304,0.00016451818,0.0002608422,0.000046090237,0.00030887377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008024403,0.00019036765,0.00052196736,0.0001615201,0.000069821224,0.000012812445,0.000068257694,0.00006332943,0.000024722685],"category_scores_gemma":[0.00035276567,0.00016213428,0.000027169224,0.00015397575,0.000019871613,0.00006342593,0.00003061677,0.00019098134,3.1603557e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016951554,0.00063743035,0.9925008,0.00033082376,0.000020200712,0.000006283077,0.0015313202,0.000060837057,0.0000010179587,0.000016935073,0.0018708557,0.0028540243],"study_design_scores_gemma":[0.007322927,0.0007276309,0.98745185,0.0031902674,0.000023426755,0.0000019491333,0.0005427795,0.00006157924,0.000011095882,0.000038793554,0.00046381037,0.00016386926],"about_ca_topic_score_codex":0.99678814,"about_ca_topic_score_gemma":0.9987939,"teacher_disagreement_score":0.024964258,"about_ca_system_score_codex":0.0029250553,"about_ca_system_score_gemma":0.0037757268,"threshold_uncertainty_score":0.76489174},"labels":[],"label_agreement":null},{"id":"W2562241265","doi":"10.1016/j.jval.2016.04.021","title":"Making Choices on the Journey to Universal Health Care Coverage: From Advocacy to Analysis","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Toronto","funders":"","keywords":"Universal health care; Universal coverage; Health care; Public relations; Universal design; Political science; Business; Public administration; Internet privacy; Computer science; Law; Health policy; World Wide Web","score_opus":0.443176161521566,"score_gpt":0.4542985715634864,"score_spread":0.011122410041920383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2562241265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50987136,0.001959495,0.009837094,0.4738463,0.00069087703,0.0014471606,0.0009099025,0.000053838885,0.0013839912],"genre_scores_gemma":[0.8922838,0.00025903466,0.0016576154,0.10507,0.00038868815,0.00006004823,0.000018425188,0.000033991513,0.00022838807],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937498,0.001254888,0.00325712,0.0008096778,0.00018109506,0.00074740883],"domain_scores_gemma":[0.99409723,0.0027926052,0.0016814981,0.00087530824,0.000054960943,0.0004983702],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012812547,0.00023046166,0.0011822123,0.0010566344,0.00036980974,0.00009191214,0.0005339376,0.00009186598,0.00047656999],"category_scores_gemma":[0.0026550763,0.00020013622,0.00016490696,0.0010518447,0.000026708965,0.00022677929,0.00008861191,0.00021660172,0.002003517],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002494671,0.00031301368,0.41721684,0.00069554924,0.00057763833,0.0000070537158,0.107304215,0.09595696,0.0000037060222,0.26793596,0.09924677,0.010492821],"study_design_scores_gemma":[0.0023869458,0.0010837646,0.38226733,0.0019819236,0.000024975905,0.0000015547284,0.014636737,0.0040479973,0.0000075957005,0.010358578,0.5820932,0.0011093977],"about_ca_topic_score_codex":0.052893616,"about_ca_topic_score_gemma":0.005199336,"teacher_disagreement_score":0.48284644,"about_ca_system_score_codex":0.0041257627,"about_ca_system_score_gemma":0.000921712,"threshold_uncertainty_score":0.9996972},"labels":[],"label_agreement":null},{"id":"W2563317648","doi":"10.1016/j.jval.2016.09.2398","title":"Health State Preference Weights for the Glasgow Outcome Scale Following Traumatic Brain Injury: A Systematic Review and Mapping Study","year":2016,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Medical Research Council; National Health and Medical Research Council; Department of Health, State Government of Victoria; Transport Accident Commission; National Institute for Health and Care Research; AGE-WELL; U.S. Department of Health and Human Services","keywords":"Traumatic brain injury; Glasgow Outcome Scale; Scale (ratio); Outcome (game theory); Glasgow Coma Scale; Preference; Psychology; Medicine; Psychiatry; Cartography; Geography; Statistics; Mathematics","score_opus":0.634080733168894,"score_gpt":0.5035893229815922,"score_spread":0.13049141018730182,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2563317648","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000059199076,0.9308249,0.002110005,0.029631943,0.00067220145,0.035739075,0.00087833434,0.000062475316,0.000021904618],"genre_scores_gemma":[0.00008587098,0.9821157,0.0009682537,0.010307691,0.00013982347,0.005772775,0.000032519838,0.00012928993,0.0004480924],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97277683,0.005787723,0.018650604,0.0013694542,0.00024227143,0.001173139],"domain_scores_gemma":[0.97446287,0.011627342,0.011883842,0.001558005,0.000047875747,0.00042006365],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.097959995,0.00075552554,0.012556506,0.00079720584,0.0005993554,0.00016315204,0.0008921629,0.00019913186,0.000020528836],"category_scores_gemma":[0.0069579,0.0005666138,0.00066356774,0.00062920083,0.00005926026,0.0003373305,0.00013865232,0.0005520967,0.00031066858],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000001610727,0.000097658514,0.00034408868,0.98206717,0.00022397522,3.8129826e-7,0.0029659146,0.0000018053161,1.8763845e-10,0.0020340187,0.0012534168,0.011009983],"study_design_scores_gemma":[0.0008495791,0.00040238092,0.00017232729,0.81047666,0.00020462957,0.000013007872,0.0008623971,0.00041028374,6.6861244e-10,0.0028675487,0.18297385,0.000767313],"about_ca_topic_score_codex":0.0033071642,"about_ca_topic_score_gemma":0.0004427419,"teacher_disagreement_score":0.18172044,"about_ca_system_score_codex":0.0028678963,"about_ca_system_score_gemma":0.0014206254,"threshold_uncertainty_score":0.99967855},"labels":[],"label_agreement":null},{"id":"W2564509916","doi":"10.1016/j.jval.2016.10.014","title":"Health Technology Assessment (HTA) Case Studies: Factors Influencing Divergent HTA Reimbursement Recommendations in Australia, Canada, England, and Scotland","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":79,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Agency (philosophy); Health technology; Medicine; Population; Jurisdiction; Economic evaluation; Family medicine; Health care; Actuarial science; Public economics; Business; Political science; Environmental health; Economics","score_opus":0.455087065970452,"score_gpt":0.4753060968876979,"score_spread":0.020219030917245917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2564509916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8302228,0.0027568287,0.00020420924,0.16446847,0.0007306639,0.001004093,0.0005710851,0.000023272312,0.000018563935],"genre_scores_gemma":[0.99128103,0.0028378346,0.0016680489,0.0037730911,0.00007708296,0.00013261766,0.000021530814,0.000023634686,0.00018510845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929631,0.0007443165,0.004630899,0.000724967,0.0001250761,0.0008116777],"domain_scores_gemma":[0.9960317,0.0012497167,0.0019052312,0.0004649866,0.00005224893,0.00029612242],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013782845,0.00025020097,0.0012282613,0.00084535533,0.0002958166,0.00002612373,0.00017580933,0.00012075486,0.000084261366],"category_scores_gemma":[0.0015385778,0.00025077752,0.000035717767,0.0004145759,0.0000725735,0.0002533139,0.000112798865,0.00029089206,0.000023839231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000057481766,0.00008977085,0.97305626,0.00061400095,0.000052176307,0.000028012051,0.005780007,0.00047689458,4.986754e-7,0.01155289,0.0067463084,0.0015974259],"study_design_scores_gemma":[0.010351579,0.0013065466,0.7304944,0.0045554107,0.000012045981,0.00029817366,0.051950965,0.0027889905,0.000010214843,0.023543699,0.17284851,0.0018394518],"about_ca_topic_score_codex":0.8698493,"about_ca_topic_score_gemma":0.8476873,"teacher_disagreement_score":0.24256186,"about_ca_system_score_codex":0.008583299,"about_ca_system_score_gemma":0.0016750139,"threshold_uncertainty_score":0.99999446},"labels":[],"label_agreement":null},{"id":"W2566793882","doi":"10.1016/j.jval.2016.10.017","title":"A Cost-Effectiveness Analysis of Reverse Total Shoulder Arthroplasty versus Hemiarthroplasty for the Management of Complex Proximal Humeral Fractures in the Elderly","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Shoulder Injury and Treatment","field":"Medicine","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Advancing Health Outcomes; McMaster University","funders":"","keywords":"Medicine; Arthroplasty; Surgery","score_opus":0.11429479967215045,"score_gpt":0.40803130613426614,"score_spread":0.2937365064621157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2566793882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99084085,0.00041169656,0.0018508242,0.0029832395,0.00016327079,0.0035421473,0.00011181128,0.000010096317,0.000086041895],"genre_scores_gemma":[0.9984522,0.00017985085,0.00074411166,0.00012411934,0.000030019932,0.0004109419,0.000022791997,0.000011645149,0.000024362058],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99827373,0.00030845994,0.0004973438,0.00027414382,0.0003396525,0.00030664125],"domain_scores_gemma":[0.99782723,0.0014394278,0.00020222543,0.00042320113,0.000056984518,0.000050938634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010445559,0.00016387843,0.0005285688,0.00019814735,0.000073600444,0.0000048804086,0.00009544443,0.00006245488,0.000060859227],"category_scores_gemma":[0.000049708906,0.0000773591,0.00020581609,0.0006298098,0.00014857313,0.000045244615,0.000030843537,0.00012515282,8.554385e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.047423076,0.007881298,0.349546,0.005653208,0.014986478,0.00018908374,0.009732953,0.042256974,0.0008539017,0.013140709,0.0014713675,0.50686496],"study_design_scores_gemma":[0.013946262,0.0038430975,0.97258687,0.0005666723,0.0016129026,0.00001061076,0.0018652381,0.002272124,0.0010027069,0.00014249628,0.0020080197,0.00014297816],"about_ca_topic_score_codex":0.0012536102,"about_ca_topic_score_gemma":0.00033994368,"teacher_disagreement_score":0.6230409,"about_ca_system_score_codex":0.00018756925,"about_ca_system_score_gemma":0.00011630019,"threshold_uncertainty_score":0.31546128},"labels":[],"label_agreement":null},{"id":"W2568974466","doi":"10.1016/j.jval.2016.11.015","title":"Instrument-Defined Estimates of the Minimally Important Difference for EQ-5D-5L Index Scores","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":350,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; St. Joseph’s Healthcare Hamilton; University of Alberta","funders":"","keywords":"EQ-5D; Index (typography); Valuation (finance); Statistics; China; Demography; Population; Preference; Quality of life (healthcare); Mean difference; Medicine; Mathematics; Geography; Health related quality of life; Computer science; Confidence interval; Environmental health; Economics","score_opus":0.435524157989484,"score_gpt":0.41001414243607087,"score_spread":0.025510015553413146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2568974466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94872403,0.0015497486,0.000702046,0.045611173,0.0009309987,0.0015986232,0.0004615643,0.00002072518,0.0004010767],"genre_scores_gemma":[0.99233246,0.00021971168,0.0044748196,0.0025327844,0.00012186456,0.00015658233,0.00001031462,0.000029119243,0.00012233225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99429107,0.00017976988,0.004408187,0.0004829869,0.00010959661,0.0005283782],"domain_scores_gemma":[0.991977,0.0011939722,0.0055251666,0.001102595,0.000051238036,0.00015005255],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.011426075,0.00019311848,0.001037812,0.00019942304,0.00047331303,0.00009154998,0.00080944,0.00012418878,0.00003861853],"category_scores_gemma":[0.008731021,0.00018874368,0.00014036278,0.00008998451,0.00017188987,0.000230676,0.00013770912,0.00017104611,0.000031604886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026404017,0.00008035965,0.8944267,0.00092908985,0.000019705163,1.7586476e-7,0.00081637426,0.00025545416,0.000005237697,0.1022314,0.0007829024,0.0004261718],"study_design_scores_gemma":[0.001114124,0.00016077998,0.867272,0.00044802306,0.000002645079,0.0000019362617,0.00017104404,0.04483914,0.000025956575,0.08432287,0.0014468561,0.00019463515],"about_ca_topic_score_codex":0.018424118,"about_ca_topic_score_gemma":0.0011337447,"teacher_disagreement_score":0.044583686,"about_ca_system_score_codex":0.00044962703,"about_ca_system_score_gemma":0.00068270817,"threshold_uncertainty_score":0.9996189},"labels":[],"label_agreement":null},{"id":"W2571282247","doi":"10.1016/j.jval.2016.11.002","title":"Cost-Effectiveness Analysis of Systemic Therapies in Advanced Pancreatic Cancer in the Canadian Health Care System","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre; University of Ottawa","funders":"Sanofi","keywords":"FOLFIRINOX; Gemcitabine; Medicine; Oxaliplatin; Quality-adjusted life year; Willingness to pay; Cost effectiveness; Cost-effectiveness analysis; Pancreatic cancer; Regimen; Capecitabine; Oncology; Health economics; Internal medicine; Public health; Cancer; Economics; Colorectal cancer","score_opus":0.10238186302510534,"score_gpt":0.4460894761690549,"score_spread":0.3437076131439496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2571282247","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770017,0.01669176,0.000010685248,0.0025115423,0.00008961242,0.0031602525,0.000084882595,0.000007704109,0.00044183002],"genre_scores_gemma":[0.99649113,0.002539664,0.000068293186,0.00021836959,0.0000259442,0.0006106408,0.000019864681,0.000012986583,0.0000131033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996332,0.0017557149,0.0006752648,0.0002916116,0.00034127026,0.0006041492],"domain_scores_gemma":[0.9979995,0.00062331534,0.00034349368,0.0007241611,0.00010302082,0.0002065039],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039027587,0.00014380804,0.0014111525,0.0008929485,0.00025569784,0.000017301709,0.00028587398,0.00010865323,0.000009960188],"category_scores_gemma":[0.00024769778,0.00010226091,0.0000776831,0.0007711242,0.0001234309,0.00005919642,0.000019983368,0.00036569175,0.0000018268369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00016683704,0.00004739753,0.96817213,0.0034069417,0.00015297048,0.00005029525,0.020933283,0.0027838007,0.000007565338,0.00064254005,0.000004553005,0.0036316912],"study_design_scores_gemma":[0.0017464947,0.00027808748,0.97032696,0.0048755016,0.00008849111,0.000011161871,0.016362919,0.006201792,0.0000021599612,0.00000894981,0.000029175333,0.00006827989],"about_ca_topic_score_codex":0.9545813,"about_ca_topic_score_gemma":0.8967435,"teacher_disagreement_score":0.057837818,"about_ca_system_score_codex":0.005281286,"about_ca_system_score_gemma":0.005895917,"threshold_uncertainty_score":0.9997397},"labels":[],"label_agreement":null},{"id":"W2587471491","doi":"10.1016/j.jval.2016.11.016","title":"Estimating an EQ-5D-5L Value Set for China","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":725,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Peking University","keywords":"China; Value (mathematics); Set (abstract data type); Statistics; Mathematics; Econometrics; Computer science; Geography; Archaeology","score_opus":0.5958439784398899,"score_gpt":0.47872628673502976,"score_spread":0.11711769170486014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2587471491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8414156,0.0019107996,0.037236366,0.10766193,0.0040892907,0.0034782398,0.0011056098,0.0001555679,0.0029466006],"genre_scores_gemma":[0.90873367,0.00008260676,0.08077384,0.008253157,0.0013352953,0.00029311844,0.000095852105,0.000086161264,0.00034628765],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9934217,0.0004936492,0.004323225,0.00082077796,0.00010392797,0.00083677017],"domain_scores_gemma":[0.9933989,0.00083424104,0.0039628437,0.0013791152,0.000040852236,0.00038401905],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.034462433,0.00024625644,0.0012115306,0.00032995758,0.0010963167,0.00026367657,0.00072543113,0.00017832834,0.00007323582],"category_scores_gemma":[0.00817175,0.00032974413,0.00012648059,0.00008874581,0.00008346907,0.0009322876,0.000084809115,0.00027197978,0.00046817696],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050187882,0.0003259252,0.16025235,0.0038712984,0.000056013832,0.0000027098176,0.012417034,0.09988184,0.0000019436193,0.7056773,0.014085679,0.0033777326],"study_design_scores_gemma":[0.0013215396,0.000278374,0.11756813,0.00032300068,0.000002395092,0.0000058018472,0.0003199005,0.7596118,0.000001728806,0.106296085,0.013883266,0.00038797682],"about_ca_topic_score_codex":0.034618642,"about_ca_topic_score_gemma":0.0004671664,"teacher_disagreement_score":0.65972996,"about_ca_system_score_codex":0.00094936916,"about_ca_system_score_gemma":0.00050818204,"threshold_uncertainty_score":0.9999155},"labels":[],"label_agreement":null},{"id":"W2588398051","doi":"10.1016/j.jval.2016.08.737","title":"Estimating Preferences for Complex Health Technologies: Lessons Learned and Implications for Personalized Medicine","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Human Genome Research Institute; National Institutes of Health; Canada Research Chairs","keywords":"Respondent; Value of information; Value (mathematics); Preference; Valuation (finance); Key (lock); Personalized medicine; Data science; Computer science; Risk analysis (engineering); Medicine; Artificial intelligence; Machine learning; Bioinformatics; Biology; Business; Economics; Microeconomics","score_opus":0.5955930544206002,"score_gpt":0.4086307409876269,"score_spread":0.18696231343297326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588398051","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24028672,0.011365156,0.16397308,0.577673,0.00045539113,0.0037966587,0.0011204769,0.00013325042,0.0011962531],"genre_scores_gemma":[0.95576614,0.0016348441,0.04162167,0.0004138702,0.000042554388,0.00032180245,0.000069304544,0.0000145840995,0.00011525151],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99879485,0.000014667795,0.00056392094,0.0003548963,0.000013347518,0.00025832054],"domain_scores_gemma":[0.99871975,0.00018594161,0.0007440706,0.00029836522,0.0000070647056,0.00004482859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014916132,0.00009315571,0.00038631502,0.00010143089,0.0006345597,0.00003657474,0.00019063281,0.000055387598,0.000015665655],"category_scores_gemma":[0.00048616919,0.000101060665,0.00003159008,0.000027526741,0.00017636323,0.000120675824,0.000042194442,0.00006690728,0.0000050074664],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017106762,0.000054465076,0.18176012,0.0004778259,0.000017863442,1.76408e-8,0.0014372577,0.0011564326,0.0000094461975,0.72230715,0.0010203962,0.09174193],"study_design_scores_gemma":[0.0015779037,0.00031049424,0.39886373,0.00011206016,0.0000020355005,0.0000010922005,0.0006047306,0.10211305,0.0000011253176,0.48498198,0.011295692,0.0001360996],"about_ca_topic_score_codex":0.0027096057,"about_ca_topic_score_gemma":0.00008890991,"teacher_disagreement_score":0.7154794,"about_ca_system_score_codex":0.00021791858,"about_ca_system_score_gemma":0.000045804118,"threshold_uncertainty_score":0.48805848},"labels":[],"label_agreement":null},{"id":"W2588514767","doi":"10.1016/j.jval.2016.08.736","title":"“What Goes Around Comes Around”: Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"National Human Genome Research Institute","keywords":"Personalized medicine; Digital health; Terminology; Precision medicine; Mainstream; Value (mathematics); Health care; Data science; Computer science; Big data; Medicine; Bioinformatics; Data mining; Political science","score_opus":0.24192065959935383,"score_gpt":0.49483608840447074,"score_spread":0.2529154288051169,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2588514767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75216544,0.0024664898,0.00027329053,0.20475757,0.00603752,0.0017036793,0.0005397635,0.00007868356,0.031977564],"genre_scores_gemma":[0.995138,0.00017817575,0.00014801243,0.0011082964,0.0004316556,0.00018067758,0.00018581733,0.000043843957,0.0025855284],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9968106,0.00022705758,0.0013845707,0.00064344046,0.00037446254,0.0005598297],"domain_scores_gemma":[0.99671197,0.0008546087,0.00084631285,0.001125751,0.000054370004,0.00040697661],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0014371289,0.00026436124,0.0008617935,0.00034929192,0.0003287203,0.0001245769,0.0006595113,0.000113894675,0.00092598423],"category_scores_gemma":[0.00039107274,0.00024282683,0.00010091611,0.00012645966,0.00065514556,0.00051065354,0.00014010652,0.00025910386,0.00058663706],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012070953,0.0015412515,0.018512387,0.00060322,0.0004013219,0.00001888605,0.032636803,0.00093498355,0.0000928951,0.56250924,0.014172093,0.3673698],"study_design_scores_gemma":[0.0254928,0.007369311,0.3111939,0.012481055,0.0001784111,0.000044584365,0.09001054,0.0026248062,0.00009331875,0.46976215,0.07936146,0.0013876469],"about_ca_topic_score_codex":0.027907297,"about_ca_topic_score_gemma":0.0012624962,"teacher_disagreement_score":0.36598215,"about_ca_system_score_codex":0.0006690124,"about_ca_system_score_gemma":0.0002604358,"threshold_uncertainty_score":0.9999873},"labels":[],"label_agreement":null},{"id":"W2591677998","doi":"10.1016/j.jval.2017.01.002","title":"A Practical ANOVA Approach for Uncertainty Analysis in Population-Based Disease Microsimulation Models","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"demographic modeling and climate adaptation","field":"Decision Sciences","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; University of Calgary","funders":"Canadian Institutes of Health Research","keywords":"Microsimulation; Econometrics; Computer science; Statistics; Analysis of variance; Economics; Machine learning; Mathematics; Engineering; Transport engineering","score_opus":0.3697161496965331,"score_gpt":0.483039687209071,"score_spread":0.11332353751253788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2591677998","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47762635,0.000040143866,0.5186228,0.0030160365,0.00006982542,0.00050831295,0.000047026664,0.000015708722,0.000053771106],"genre_scores_gemma":[0.9671448,0.0000097159855,0.03232148,0.00025023063,0.000024711937,0.000055399807,0.00016671825,0.00000847604,0.000018505369],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9970714,0.0003906538,0.0009480901,0.00057980086,0.0007068872,0.00030316695],"domain_scores_gemma":[0.99704486,0.001200825,0.0006053393,0.0008017955,0.00018313767,0.00016406675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006263769,0.00011180231,0.00036094524,0.00085611234,0.00035274625,0.00028673036,0.00030475802,0.00007316283,0.000006375794],"category_scores_gemma":[0.0031258666,0.000099312514,0.00016766536,0.0009050712,0.00003698091,0.00044435955,0.000024744966,0.000119766824,0.0000018929611],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012025104,0.000111900925,0.24818966,0.000019059957,0.0000053293106,5.282713e-7,0.000106257,0.74724096,6.2707505e-7,0.0028160051,0.00001756451,0.0013718468],"study_design_scores_gemma":[0.00046137496,0.00001794748,0.25811812,0.000015968264,0.000016538106,6.7851154e-8,0.00007230878,0.70479155,1.4118565e-7,0.036425795,0.000009214177,0.000070971364],"about_ca_topic_score_codex":0.01512483,"about_ca_topic_score_gemma":0.0014025902,"teacher_disagreement_score":0.4895184,"about_ca_system_score_codex":0.0001449836,"about_ca_system_score_gemma":0.00034992758,"threshold_uncertainty_score":0.99143356},"labels":[],"label_agreement":null},{"id":"W2596640152","doi":"10.1016/j.jval.2017.01.013","title":"Constrained Optimization Methods in Health Services Research—An Introduction: Report 1 of the ISPOR Optimization Methods Emerging Good Practices Task Force","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":112,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Services and Policy Research; Alberta Bone and Joint Health Institute; University of Calgary","funders":"National Institutes of Health; National Institute for Health and Care Excellence","keywords":"Computer science; Set (abstract data type); Task (project management); Analytics; Health care; Optimization problem; Management science; Mathematical optimization; Budget constraint; Key (lock); Operations research; Data science; Engineering; Mathematics; Systems engineering","score_opus":0.24410267594782728,"score_gpt":0.6031738184923501,"score_spread":0.35907114254452277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2596640152","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008397976,0.0007701707,0.83593017,0.1452247,0.0030055165,0.005415109,0.000033001477,0.00011129322,0.0011120609],"genre_scores_gemma":[0.052863535,0.0012772946,0.9432731,0.00084094284,0.00064953306,0.00027256523,0.00017324113,0.00006783151,0.00058194035],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.96941864,0.024576467,0.0033205897,0.00092664215,0.00069290923,0.0010647554],"domain_scores_gemma":[0.98940706,0.0015640937,0.0055855657,0.0019479156,0.0011679083,0.00032744627],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.058441553,0.00027020657,0.0007697041,0.00063902856,0.0041335584,0.00011080155,0.0007068455,0.00037492992,0.00015177013],"category_scores_gemma":[0.007287604,0.00023224518,0.00007259775,0.001319207,0.00022010414,0.0012796806,0.00024857942,0.0016725227,0.0000020847126],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006633703,0.00016340007,0.009652803,0.0015775515,0.000011665245,0.0000031151576,0.01121372,0.9652417,0.000053766926,0.005792529,0.00005774699,0.0061656986],"study_design_scores_gemma":[0.00088172255,0.00022533051,0.0038802908,0.0013297789,0.000007061634,0.000021391294,0.012038237,0.977813,0.000043190998,0.00046343883,0.0031088325,0.0001877188],"about_ca_topic_score_codex":0.046412863,"about_ca_topic_score_gemma":0.0029492981,"teacher_disagreement_score":0.14438376,"about_ca_system_score_codex":0.0009884007,"about_ca_system_score_gemma":0.0054197777,"threshold_uncertainty_score":0.99716294},"labels":[],"label_agreement":null},{"id":"W2613265403","doi":"10.1016/j.jval.2017.04.021","title":"Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Ontario Institute for Cancer Research","funders":"Medical Research Council; National Institute for Health and Care Research; Health Technology Assessment Programme; Government of Ontario; University College London; Cancer Research UK","keywords":"Value (mathematics); Breast cancer; Oncology; Medicine; Internal medicine; Statistics; Chemotherapy; Cancer; Mathematics","score_opus":0.3272370129756914,"score_gpt":0.45522858774932023,"score_spread":0.12799157477362882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613265403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96585447,0.00038378834,0.0011366706,0.028857274,0.00036335996,0.0023113932,0.0009945655,0.000006936852,0.00009154556],"genre_scores_gemma":[0.9939716,0.00038411855,0.00313445,0.0020616658,0.000097358585,0.00030307833,0.000020600606,0.000011898102,0.000015219975],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945036,0.00029102387,0.0045285453,0.0002526932,0.00010047983,0.00032363329],"domain_scores_gemma":[0.992414,0.0013501474,0.005328152,0.000753576,0.00008106081,0.0000730551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017403914,0.00013056603,0.0012364924,0.00072765554,0.00013600048,0.000054933585,0.00045560175,0.00011940102,0.000028803106],"category_scores_gemma":[0.0021810806,0.00013280516,0.00019336425,0.00032935114,0.000087098975,0.0006061454,0.00003118141,0.00013111637,0.000010367623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027743275,0.00035851484,0.7838556,0.0013816645,0.0004122554,7.082467e-8,0.015904054,0.15409547,0.0000010057612,0.034644473,0.0009811233,0.005591396],"study_design_scores_gemma":[0.009152039,0.00017806751,0.72267365,0.00012954956,0.000013495079,2.1549847e-7,0.00017798133,0.26483387,0.000002771617,0.0018053316,0.0009204706,0.00011255828],"about_ca_topic_score_codex":0.11775603,"about_ca_topic_score_gemma":0.0014099618,"teacher_disagreement_score":0.11634607,"about_ca_system_score_codex":0.00050382956,"about_ca_system_score_gemma":0.00033214127,"threshold_uncertainty_score":0.8881189},"labels":[],"label_agreement":null},{"id":"W2613948837","doi":"10.1016/j.jval.2017.03.010","title":"Aripiprazole Lauroxil Compared with Paliperidone Palmitate in Patients with Schizophrenia: An Indirect Treatment Comparison","year":2017,"lang":"en","type":"review","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"National Center for Theoretical Sciences","keywords":"Akathisia; Tolerability; Aripiprazole; Medicine; Placebo; Positive and Negative Syndrome Scale; Olanzapine; Paliperidone Palmitate; Antipsychotic; Adverse effect; Internal medicine; Randomized controlled trial; Meta-analysis; Schizophrenia (object-oriented programming); Psychiatry; Psychosis","score_opus":0.17950323415263084,"score_gpt":0.40753957127611296,"score_spread":0.22803633712348212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2613948837","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07385994,0.9185822,0.0000018617499,0.00023398803,0.00012533953,0.0067145196,0.00023807844,0.00009001486,0.00015403477],"genre_scores_gemma":[0.031001791,0.9623718,0.00307193,0.00003177198,0.00013424648,0.00086918834,0.0022523906,0.00016965339,0.000097229],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99430346,0.00094479526,0.0014315092,0.0011635391,0.0009501782,0.0012065225],"domain_scores_gemma":[0.9961955,0.0001882618,0.0009848729,0.001593131,0.0001072955,0.00093093526],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00063945213,0.0009848244,0.004928605,0.0009815353,0.00024042196,0.000104931736,0.00036381854,0.0002716471,0.000028563632],"category_scores_gemma":[0.000060546707,0.0005954824,0.00021789834,0.0006242251,0.00018277514,0.00015680377,0.000064403524,0.0009957594,0.00006446348],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012878909,0.0048163324,0.09867047,0.00699486,0.00053350074,0.00053072453,0.00040415613,0.00008230559,6.810681e-9,0.000033816224,0.00003925297,0.8750157],"study_design_scores_gemma":[0.09471654,0.040191732,0.32058898,0.10151682,0.0013203274,0.00019277511,0.00016296425,0.0005994351,0.0000018912864,0.000046212816,0.4387251,0.0019371947],"about_ca_topic_score_codex":0.007435266,"about_ca_topic_score_gemma":0.009712716,"teacher_disagreement_score":0.87307847,"about_ca_system_score_codex":0.0025675201,"about_ca_system_score_gemma":0.004862361,"threshold_uncertainty_score":0.99964964},"labels":[],"label_agreement":null},{"id":"W2615813500","doi":"10.1016/j.jval.2017.04.007","title":"Testing the External Validity of a Discrete Choice Experiment Method: An Application to Latent Tuberculosis Infection Treatment","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":42,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health; St. Paul's Hospital; Centre for Advancing Health Outcomes; Vancouver Coastal Health Research Institute; University of British Columbia","funders":"","keywords":"Latent tuberculosis; Tuberculosis; Medicine; Computer science; Mycobacterium tuberculosis; Pathology","score_opus":0.3093331670386622,"score_gpt":0.3579243593893773,"score_spread":0.04859119235071507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2615813500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97866255,0.00014852581,0.019040631,0.0010172934,0.00014081558,0.0006051547,0.000023110646,0.00000906457,0.00035286698],"genre_scores_gemma":[0.9921594,0.00013407593,0.0073002093,0.00009589133,0.00008384313,0.00018442248,0.000006177688,0.000011424628,0.000024551406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989008,0.00008242568,0.00052317785,0.00029770072,0.00003132383,0.00016459188],"domain_scores_gemma":[0.9988039,0.00008798294,0.0005317631,0.0004957125,0.000005854906,0.0000747592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013782824,0.00009632089,0.00022699816,0.00006769325,0.00023910051,0.000040451647,0.00013727405,0.00003638717,0.00001964323],"category_scores_gemma":[0.00008574265,0.00008750319,0.00004715027,0.00004637403,0.000023637936,0.00018405859,0.00004548355,0.00005272481,0.000042938078],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000053230406,0.00011244059,0.94664234,0.000016919019,0.0000074069553,5.5974503e-8,0.00079913164,0.034190163,0.00027249006,0.0037094909,0.0000029402627,0.014241288],"study_design_scores_gemma":[0.0002609301,0.0002927019,0.9243901,0.00002264389,0.0000026708701,8.068074e-7,0.000022932712,0.07137781,0.0005892335,0.0025659378,0.0003959871,0.000078280544],"about_ca_topic_score_codex":0.10772618,"about_ca_topic_score_gemma":0.00032686882,"teacher_disagreement_score":0.107399315,"about_ca_system_score_codex":0.0006741013,"about_ca_system_score_gemma":0.00001693859,"threshold_uncertainty_score":0.89821553},"labels":[],"label_agreement":null},{"id":"W2620608893","doi":"10.1016/j.jval.2017.04.015","title":"Cost-Utility Analysis of Extending Public Health Insurance Coverage to Include Diabetic Retinopathy Screening by Optometrists","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Ottawa; Health PEI; Public Health Ontario; University of Toronto; Ottawa Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Optometry; Diabetic retinopathy; Quality-adjusted life year; Public health; Eye care; Cost effectiveness; Retinopathy; Health care; Eye disease; Family medicine; Ophthalmology; Diabetes mellitus","score_opus":0.12586937650483118,"score_gpt":0.41313005615658904,"score_spread":0.28726067965175783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2620608893","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99015164,0.0026250493,0.0013908588,0.0039019166,0.00010408699,0.0010887878,0.00047694737,0.00002824205,0.00023247683],"genre_scores_gemma":[0.9964039,0.0010670578,0.0013355799,0.00090622646,0.000027690934,0.000042843836,0.00014886737,0.000021764821,0.000046108824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700737,0.0003602563,0.0008405261,0.0005201329,0.0005853421,0.00068637234],"domain_scores_gemma":[0.9971163,0.00019452246,0.0006995459,0.00097604404,0.00010768387,0.0009058496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019490551,0.00020286905,0.0010292062,0.00080113887,0.00037694108,0.000059956936,0.00026112498,0.00006155316,0.00003157061],"category_scores_gemma":[0.0013056821,0.00018982249,0.00019587844,0.0013448189,0.00007740509,0.00014090551,0.00013957208,0.00020872246,0.000005933699],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016106767,0.0005027067,0.9412024,0.00042911197,0.0001914172,0.00001806223,0.000322177,0.00016470195,0.000024142233,0.000037818227,0.00010292374,0.05684346],"study_design_scores_gemma":[0.0013088145,0.00055839395,0.99303794,0.0004992884,0.000060268063,0.0000022101663,0.000047067744,0.0037585208,0.00003298974,0.000019391664,0.0005642848,0.00011082633],"about_ca_topic_score_codex":0.014579326,"about_ca_topic_score_gemma":0.000052800002,"teacher_disagreement_score":0.056732632,"about_ca_system_score_codex":0.0005146401,"about_ca_system_score_gemma":0.00040323503,"threshold_uncertainty_score":0.9919827},"labels":[],"label_agreement":null},{"id":"W2621688581","doi":"10.1016/j.jval.2017.04.008","title":"Discordance in Utility Measurement in Persons with Neurological Conditions: A Comparison of the SF-6D and the HUI3","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"University of Manitoba","keywords":"Intraclass correlation; Statistics; Confidence interval; Psychology; Health Utilities Index; Regression analysis; Regression; Medicine; Psychometrics; Mathematics; Health related quality of life; Internal medicine; Disease","score_opus":0.6137064566419875,"score_gpt":0.4507835021211451,"score_spread":0.16292295452084243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2621688581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87936324,0.0022090634,0.000086316075,0.116422236,0.00015784617,0.0012365904,0.00006985873,0.0000049556647,0.00044990022],"genre_scores_gemma":[0.9967748,0.00011025681,0.00018650324,0.002753829,0.000024750296,0.0001301731,0.0000013886811,0.000007950585,0.000010358034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99546415,0.0012870104,0.0024175053,0.00038480453,0.0001295741,0.0003169672],"domain_scores_gemma":[0.9964415,0.00082746166,0.0019352022,0.0007063826,0.00002337093,0.00006611497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02388032,0.00011916322,0.0008538786,0.00012198618,0.00029796048,0.000044876164,0.000392864,0.000062236286,0.000014734126],"category_scores_gemma":[0.0036856844,0.00008722217,0.000045431458,0.00013012037,0.00046776302,0.00017004892,0.000077614466,0.00035934948,0.000008426536],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006467861,0.00013187052,0.9493416,0.00019515911,0.0000049076125,4.125929e-7,0.0034019041,0.0011441543,1.1550017e-7,0.045415226,0.0002280407,0.00007191899],"study_design_scores_gemma":[0.0018043525,0.00008173014,0.9370256,0.00024866185,0.0000011062232,0.000002068624,0.0010105884,0.048445582,4.7042806e-7,0.010726629,0.00057318236,0.00007999606],"about_ca_topic_score_codex":0.03080143,"about_ca_topic_score_gemma":0.016795535,"teacher_disagreement_score":0.117411554,"about_ca_system_score_codex":0.0002958917,"about_ca_system_score_gemma":0.00027025727,"threshold_uncertainty_score":0.9756526},"labels":[],"label_agreement":null},{"id":"W2625079458","doi":"10.1016/j.jval.2016.11.020","title":"Measurement Properties of the Psoriasis Symptom Inventory Electronic Daily Diary in Patients with Moderate to Severe Plaque Psoriasis","year":2017,"lang":"en","type":"review","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"Amgen","keywords":"Psoriasis; Dermatology Life Quality Index; Intraclass correlation; Psoriasis Area and Severity Index; Cronbach's alpha; Medicine; Quality of life (healthcare); Convergent validity; Patient-reported outcome; Severity of illness; Construct validity; Internal medicine; Physical therapy; Dermatology; Psychometrics; Psychology; Clinical psychology; Internal consistency","score_opus":0.10255382474101048,"score_gpt":0.27751853022394274,"score_spread":0.17496470548293225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2625079458","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.032497443,0.9628917,0.000001459197,0.000110061505,0.0010113482,0.0033075265,0.00010042104,0.000024694702,0.000055339486],"genre_scores_gemma":[0.1161523,0.882745,0.000011030873,0.00006843143,0.000052548636,0.0006413082,0.00006564158,0.00007722265,0.00018646277],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942187,0.0027341323,0.0011778506,0.0007086624,0.00023598276,0.0009246759],"domain_scores_gemma":[0.9976821,0.00006669897,0.0009559396,0.0011042937,0.0001276685,0.0000632749],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017944896,0.00063549005,0.002138001,0.0004304059,0.00026961355,0.000021174834,0.0008218139,0.0005126735,0.000011934015],"category_scores_gemma":[0.00016575596,0.00038547744,0.00030286337,0.000366275,0.000111286,0.000099920006,0.00017604437,0.00065428106,0.00004959256],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014800007,0.0013669302,0.015222763,0.019152978,0.0016762102,0.000005307717,0.0021423146,0.00030893355,0.000005405146,0.00023595273,0.00042771804,0.9579755],"study_design_scores_gemma":[0.01741275,0.0031369173,0.02110083,0.20969157,0.002076182,0.00004746829,0.00017374901,0.0000132427085,0.0003118733,0.00019519693,0.7429703,0.0028698987],"about_ca_topic_score_codex":0.0032550613,"about_ca_topic_score_gemma":0.0012045042,"teacher_disagreement_score":0.9551056,"about_ca_system_score_codex":0.0016532885,"about_ca_system_score_gemma":0.00311579,"threshold_uncertainty_score":0.9998597},"labels":[],"label_agreement":null},{"id":"W2660824563","doi":"10.1016/j.jval.2017.05.004","title":"Market Exclusivity Time for Top Selling Originator Drugs in Canada: A Cohort Study","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"York University","funders":"","keywords":"Biosimilar; Competition (biology); Notice; Liberian dollar; Marketing authorization; Business; Generic drug; Product (mathematics); Market share; Authorization; Marketing; Pharmaceutical industry; Interquartile range; Medicine; Advertising; Drug; Finance; Pharmacology; Law","score_opus":0.06924952983056451,"score_gpt":0.32369687843816025,"score_spread":0.25444734860759577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2660824563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98465,0.00038827697,0.000022458684,0.0044511245,0.0005035425,0.0012600989,0.00026971294,0.000007900311,0.008446879],"genre_scores_gemma":[0.9979085,0.00029884995,0.00013468854,0.0010421845,0.000121059245,0.00009892482,0.0000038025569,0.000021916838,0.00037011108],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816626,0.00004525269,0.0007868426,0.00043323997,0.000032712534,0.00053568603],"domain_scores_gemma":[0.9987023,0.00020239924,0.00042350276,0.0004719595,0.000012408825,0.0001874566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002968495,0.00013858845,0.00058817305,0.0001581582,0.00020430177,0.00007002351,0.000373154,0.000047532438,0.00016847179],"category_scores_gemma":[0.00020403869,0.00017617144,0.000047270598,0.000076739634,0.000022247894,0.00014549949,0.00007649591,0.00020044601,0.000050218303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030797943,0.00012797344,0.9834059,0.000081565646,0.000018047029,0.0000031745863,0.00033886477,0.0007067447,1.2630196e-7,0.012759957,0.0018490573,0.00067778304],"study_design_scores_gemma":[0.0017201339,0.0000644327,0.68635035,0.00003544866,0.0000022222537,7.7344134e-7,0.00005479471,0.23359694,0.000003394631,0.012361918,0.0655194,0.00029018553],"about_ca_topic_score_codex":0.93922156,"about_ca_topic_score_gemma":0.50600415,"teacher_disagreement_score":0.43321744,"about_ca_system_score_codex":0.0018530834,"about_ca_system_score_gemma":0.0008721397,"threshold_uncertainty_score":0.71840626},"labels":[],"label_agreement":null},{"id":"W2734526364","doi":"10.1016/j.jval.2017.06.006","title":"Comparison of Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation: A Multicriteria Decision Analysis","year":2017,"lang":"en","type":"review","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Boehringer Ingelheim (Canada)","funders":"","keywords":"Atrial fibrillation; Stroke (engine); Medicine; Internal medicine; Cardiology; Engineering","score_opus":0.4900080508987548,"score_gpt":0.5709273828429426,"score_spread":0.08091933194418782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2734526364","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0040881406,0.9877253,0.0025462452,0.00011440192,0.00064866233,0.0047480194,0.000091167705,0.000019337485,0.000018697916],"genre_scores_gemma":[0.0075675705,0.98064536,0.010119648,0.0000044299213,0.00071414834,0.000006832973,0.0006684294,0.00003587166,0.00023772787],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99609596,0.00040391524,0.0023511802,0.0004397835,0.00040058035,0.00030857863],"domain_scores_gemma":[0.9969182,0.0006824173,0.0016721062,0.00055727334,0.000076134136,0.00009389167],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020650418,0.00028791736,0.0046953843,0.0015137292,0.00007513784,0.00003301798,0.0001522865,0.00028076928,0.00002960171],"category_scores_gemma":[0.000802268,0.00025012376,0.001555801,0.00065818324,0.000029148461,0.0000931126,0.00006718763,0.0001635612,0.0000075345765],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032188345,0.000018336566,0.15727338,0.017045539,0.0006286344,0.0000024337967,0.00008641221,0.0031658122,1.578299e-7,0.000066001296,0.000041705378,0.8213497],"study_design_scores_gemma":[0.00619112,0.000607219,0.03199739,0.026734974,0.006532172,0.000002992868,0.00004231673,0.06766418,7.094947e-7,0.00013756567,0.85966617,0.00042319176],"about_ca_topic_score_codex":0.00076181686,"about_ca_topic_score_gemma":0.00017682079,"teacher_disagreement_score":0.85962445,"about_ca_system_score_codex":0.0002777569,"about_ca_system_score_gemma":0.00044510933,"threshold_uncertainty_score":0.9999951},"labels":[],"label_agreement":null},{"id":"W2750070121","doi":"10.1016/j.jval.2017.05.025","title":"Comparison of Adalimumab and Etanercept for the Treatment of Moderate to Severe Psoriasis: An Indirect Comparison Using Individual Patient Data from Randomized Trials","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"AbbVie","keywords":"Medicine; Etanercept; Adalimumab; Dermatology Life Quality Index; Placebo; Psoriasis; Psoriasis Area and Severity Index; Adverse effect; Internal medicine; Randomized controlled trial; Erythema; Dermatology; Pathology; Disease; Tumor necrosis factor alpha","score_opus":0.3768532601695033,"score_gpt":0.4339955981307294,"score_spread":0.057142337961226086,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2750070121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97338754,0.019621586,0.0003222598,0.00019456302,0.00071915326,0.002676601,0.003060272,0.000011206819,0.0000068304394],"genre_scores_gemma":[0.99558264,0.0009100477,0.0026093675,0.000026588532,0.00005305,0.00010655619,0.00068668165,0.000016531767,0.000008552969],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9953529,0.0025115306,0.0013424108,0.00042279638,0.00007733544,0.0002930121],"domain_scores_gemma":[0.9941185,0.0034254282,0.001353894,0.0010047404,0.000049823368,0.00004760616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025346796,0.00023699622,0.0024625703,0.00011501732,0.00042049828,0.00003269804,0.00043405133,0.00017186574,0.0000236471],"category_scores_gemma":[0.0005104708,0.00015122666,0.00013662646,0.00005251711,0.0001541839,0.000106313244,0.000103260274,0.00007351888,0.0000017237962],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22546749,0.004792385,0.050179698,0.00018468536,0.0062751714,0.0000023188802,0.082646444,0.012770439,0.004378105,0.00017544009,0.0005324454,0.6125954],"study_design_scores_gemma":[0.7053786,0.013513684,0.058882892,0.0011849581,0.008518906,0.000019884394,0.014336449,0.092968665,0.0988207,0.0013045019,0.003764316,0.0013064393],"about_ca_topic_score_codex":0.016927226,"about_ca_topic_score_gemma":0.0010240718,"teacher_disagreement_score":0.6112889,"about_ca_system_score_codex":0.000068533096,"about_ca_system_score_gemma":0.00019058795,"threshold_uncertainty_score":0.98961914},"labels":[],"label_agreement":null},{"id":"W2754746500","doi":"10.1016/j.jval.2017.06.015","title":"The Role of Noncomparative Evidence in Health Technology Assessment Decisions","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":30,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Nice; Health technology; Medicine; Excellence; Health care; Randomized controlled trial; Agency (philosophy); Evidence-based medicine; Family medicine; Surgery; Alternative medicine; Political science","score_opus":0.6517531548830843,"score_gpt":0.547592138895979,"score_spread":0.10416101598710525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2754746500","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46482158,0.048873927,0.0018987535,0.47711012,0.0010166373,0.0028090093,0.0001315214,0.000041925847,0.003296537],"genre_scores_gemma":[0.9873141,0.0051960563,0.0055135433,0.0016515701,0.00006756222,0.00015451771,0.0000023585142,0.000017152162,0.000083121064],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9917107,0.0009776625,0.0059672925,0.0005438163,0.00013859563,0.0006618997],"domain_scores_gemma":[0.98905337,0.003984658,0.0054178787,0.0013201878,0.000058579208,0.00016531358],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04213883,0.00015735862,0.0011822302,0.0005577994,0.0007268141,0.00007587713,0.000910958,0.00012402442,0.000025837082],"category_scores_gemma":[0.010002209,0.00016269914,0.00006913675,0.00029522384,0.00021904282,0.0003856473,0.00015856947,0.00042527277,0.00015591441],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013105762,0.000116456904,0.42696455,0.00016721041,0.000010692187,5.2116303e-7,0.00186841,0.00248718,8.525441e-7,0.56353754,0.00079458806,0.004038886],"study_design_scores_gemma":[0.0010041924,0.00044000987,0.60452116,0.0023177767,8.150243e-7,0.0000043091127,0.0069188043,0.06773105,0.000006492321,0.26882073,0.04795448,0.00028016904],"about_ca_topic_score_codex":0.038854007,"about_ca_topic_score_gemma":0.005517185,"teacher_disagreement_score":0.5224925,"about_ca_system_score_codex":0.00179758,"about_ca_system_score_gemma":0.0016991318,"threshold_uncertainty_score":0.998337},"labels":[],"label_agreement":null},{"id":"W2765090282","doi":"10.1016/j.jval.2017.08.1664","title":"Applying The Institute For Clinical And Economic Review’s (ICER) Methodology To Canada: An Improved Way To Take Into Consideration Drug Affordability Challenges?","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Université de Montréal","funders":"","keywords":"Scrutiny; Economic evaluation; Public economics; Health care; Medicine; Actuarial science; Business; Economic growth; Political science; Economics","score_opus":0.7723680675271503,"score_gpt":0.5464587583068287,"score_spread":0.2259093092203216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765090282","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30906814,0.015361838,0.0043998016,0.65594184,0.0029408708,0.011718771,0.0003382997,0.000029380846,0.00020107496],"genre_scores_gemma":[0.6914058,0.016299013,0.101135656,0.18156873,0.0017072086,0.007621602,0.00006426217,0.00008990312,0.00010784787],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9920664,0.0016488899,0.00476703,0.00096132414,0.000057411882,0.0004989747],"domain_scores_gemma":[0.99268734,0.0032548744,0.002179329,0.0013204811,0.0000639731,0.0004939683],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.08224579,0.00021061634,0.0014537971,0.00013103781,0.00081305817,0.000101228616,0.000495599,0.00011744114,0.000014273293],"category_scores_gemma":[0.018291239,0.0002235764,0.00007818916,0.00004103661,0.00012541638,0.0003689165,0.00013197384,0.00025141073,0.000037648875],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003383073,0.00032023137,0.11141697,0.017987458,0.00021040035,0.0000023007512,0.022727601,0.006991595,0.0000032429145,0.5998965,0.0600284,0.180077],"study_design_scores_gemma":[0.0021090047,0.00060764153,0.18684305,0.0009569805,0.000015481177,0.000010148876,0.0024740992,0.04037207,0.0000035972384,0.06468252,0.70105714,0.00086827006],"about_ca_topic_score_codex":0.78757805,"about_ca_topic_score_gemma":0.9098753,"teacher_disagreement_score":0.64102876,"about_ca_system_score_codex":0.0014857566,"about_ca_system_score_gemma":0.0017384081,"threshold_uncertainty_score":0.98997813},"labels":[],"label_agreement":null},{"id":"W2765147096","doi":"10.1016/j.jval.2017.08.751","title":"Cost Per Response for Abatacept Compared with Adalimumab In the Treatment of Patients with Rheumatoid Arthritis Based on Anti-Citrullinated Protein Antibody Titres In Italy","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada); Université de Montréal","funders":"","keywords":"Abatacept; Medicine; Adalimumab; Rheumatoid arthritis; Internal medicine; Cohort; Physical therapy; Rituximab","score_opus":0.04930851765117299,"score_gpt":0.3540597665934935,"score_spread":0.3047512489423205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765147096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908226,0.00031345506,0.000029689209,0.0018162386,0.00002315383,0.006854053,0.00009623023,0.000012505672,0.000032080334],"genre_scores_gemma":[0.99843067,0.00022733131,0.0005969233,0.00007897418,0.000010973508,0.00046530724,0.00012071356,0.00003701106,0.00003208343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973747,0.0005045789,0.00054980605,0.00039720398,0.00063111004,0.00054256286],"domain_scores_gemma":[0.9979658,0.00061255955,0.00028363412,0.00089857803,0.00012571835,0.00011369534],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011767853,0.00022263988,0.00067242293,0.00036363048,0.00013041064,0.00003502337,0.00022823949,0.00007670964,0.0000130929575],"category_scores_gemma":[0.00029210318,0.00013413801,0.000047262496,0.00024655194,0.00016712192,0.00007933481,0.000015565405,0.00017642265,0.0000036143972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.15180771,0.013853445,0.7986038,0.001980633,0.00009455922,0.00056992826,0.009934018,0.013994804,0.00025445147,0.00009409642,0.00011879591,0.008693773],"study_design_scores_gemma":[0.16418044,0.017045863,0.7401875,0.007554629,0.0000065183526,0.000014943603,0.00055642176,0.0685636,0.0009066763,0.000013725196,0.0007416306,0.00022802218],"about_ca_topic_score_codex":0.030576302,"about_ca_topic_score_gemma":0.0035348898,"teacher_disagreement_score":0.05841626,"about_ca_system_score_codex":0.008203678,"about_ca_system_score_gemma":0.005903534,"threshold_uncertainty_score":0.9997321},"labels":[],"label_agreement":null},{"id":"W2765153777","doi":"10.1016/j.jval.2017.08.3020","title":"Cost-Effectiveness of First-Line Sevelamer and Lanthanum versus Calcium-Based Binders for Hyperphosphatemia of Chronic Kidney Disease","year":2017,"lang":"en","type":"review","venue":"Value in Health","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Impact; Western University","funders":"","keywords":"Sevelamer; Hyperphosphatemia; Medicine; Kidney disease; Dialysis; Cohort; Cost effectiveness; Internal medicine; Phosphate binder; Intensive care medicine; Risk analysis (engineering)","score_opus":0.28332382501806846,"score_gpt":0.4652333992522647,"score_spread":0.18190957423419624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765153777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0007076948,0.9917596,0.00012539662,0.00011663543,0.00033248807,0.0056609972,0.0012551558,0.000011354557,0.000030706567],"genre_scores_gemma":[0.01018177,0.98803806,0.00009052248,0.000024993218,0.00004923899,0.0006365425,0.00088548503,0.000055244873,0.00003813642],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99807215,0.00022882514,0.00068630866,0.00043809364,0.00020392775,0.00037067055],"domain_scores_gemma":[0.99742013,0.0008175209,0.00070786045,0.000535079,0.00007239573,0.00044702346],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006087026,0.00036011392,0.002253046,0.00022214497,0.00008064233,0.0000057902757,0.00012484605,0.00019444633,0.000004924518],"category_scores_gemma":[0.00046891827,0.0002847111,0.00032192847,0.00014393513,0.00014819969,0.00003336483,0.000031259842,0.00018015577,0.000002337267],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0076176054,0.0028036323,0.008193146,0.5678905,0.0011410688,0.000098799836,0.00009282323,0.0004325352,9.1813394e-7,0.00017462943,0.001055524,0.41049883],"study_design_scores_gemma":[0.04752362,0.0047743297,0.0018185102,0.10711072,0.0026655332,0.000010824703,0.000016392547,0.0038026334,0.000028319198,0.00006945212,0.8315473,0.0006323381],"about_ca_topic_score_codex":0.0021766047,"about_ca_topic_score_gemma":0.000040859326,"teacher_disagreement_score":0.8304918,"about_ca_system_score_codex":0.00057293195,"about_ca_system_score_gemma":0.0045919954,"threshold_uncertainty_score":0.9999605},"labels":[],"label_agreement":null},{"id":"W2765163291","doi":"10.1016/j.jval.2017.08.298","title":"What Matters to Spanish Patients and Physicians when Facing Decisions for Gep-Net? An Exploration Using a Reflective Multicriteria Shared-Decisionmaking Framework","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Watchful waiting; Medicine; Lanreotide; Actuarial science; Quality of life (healthcare); Asymptomatic; Family medicine; Internal medicine; Cancer; Nursing; Economics","score_opus":0.22202642757610114,"score_gpt":0.47646787291575976,"score_spread":0.2544414453396586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765163291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9672564,0.00010919963,0.021967124,0.0077631357,0.0005383765,0.0022849354,0.00004228164,0.000033421424,0.00000512774],"genre_scores_gemma":[0.83097357,0.0001841022,0.16506255,0.0034247611,0.00015584109,0.000108584085,0.000019930354,0.000054190252,0.000016479855],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9978763,0.00015536082,0.00043153862,0.0005682872,0.00040502477,0.0005634876],"domain_scores_gemma":[0.9981537,0.0005393741,0.00023706754,0.00057272584,0.00018273309,0.00031443549],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035464615,0.00017854235,0.00038791212,0.00026248567,0.00060796476,0.00045373317,0.00019599247,0.000020347507,0.0000067819133],"category_scores_gemma":[0.002805645,0.00017604223,0.00004166561,0.00011352832,0.00005146558,0.0023536049,0.00016405231,0.00025871495,0.0000057577918],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008657212,0.003065359,0.110725425,0.0024489996,0.00015294009,0.0008659548,0.117628865,0.017672596,0.025122847,0.00092594244,0.00390474,0.7088291],"study_design_scores_gemma":[0.025977233,0.021864573,0.31206173,0.08327692,0.00017379265,0.0003345946,0.049000185,0.30843645,0.009888556,0.17191516,0.013956463,0.003114346],"about_ca_topic_score_codex":0.00083068985,"about_ca_topic_score_gemma":0.00020549413,"teacher_disagreement_score":0.70571476,"about_ca_system_score_codex":0.00031887705,"about_ca_system_score_gemma":0.00011112658,"threshold_uncertainty_score":0.71787935},"labels":[],"label_agreement":null},{"id":"W2765212556","doi":"10.1016/j.jval.2017.08.1922","title":"A Retrospective Claims Analysis on Rates of Compliance and Discontinuation Among Canadian Multiple Sclerosis Patients Treated with Disease-Modifying Therapies at 6, 12 and 24-Month Periods","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Polyomavirus and related diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Notre-Dame; University of Calgary; Novartis (Canada)","funders":"","keywords":"Natalizumab; Discontinuation; Teriflunomide; Medicine; Fingolimod; Glatiramer acetate; Internal medicine; Medical prescription; Retrospective cohort study; Multiple sclerosis; Physical therapy; Disease; Pharmacology; Immunology","score_opus":0.07298604935886653,"score_gpt":0.3027775360402757,"score_spread":0.22979148668140914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765212556","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99737763,0.0013958811,0.0000018230949,0.00040930542,0.000019654715,0.0005287787,0.00018631079,0.000010134733,0.00007048059],"genre_scores_gemma":[0.9989923,0.0007204433,0.000052404903,0.000060211227,0.000011406832,0.00002034937,0.000062028346,0.0000140282855,0.000066788125],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99899256,0.000076733326,0.00022559291,0.00029322444,0.00016858047,0.00024327864],"domain_scores_gemma":[0.9989637,0.000042759733,0.00024778367,0.00027639096,0.000057925074,0.0004114023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012171977,0.0001406385,0.00039533267,0.00022869822,0.00044519,0.000038129358,0.000046609046,0.000049341896,0.000006107999],"category_scores_gemma":[0.00007648336,0.000100874124,0.000044164502,0.00014135384,0.0002428519,0.0001048258,0.000017949997,0.000098175406,3.6147205e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005556537,0.00012930017,0.99665916,0.00009021962,0.00017457885,0.0000056658255,0.000990014,0.00014333377,0.000014784596,0.000016195872,0.0000060541092,0.0012150336],"study_design_scores_gemma":[0.0023005484,0.00042640234,0.9821327,0.0011647098,0.00018647802,2.3663652e-7,0.00013109225,0.013515902,0.000025935213,0.000013128614,0.000004675488,0.00009822945],"about_ca_topic_score_codex":0.36360636,"about_ca_topic_score_gemma":0.17341061,"teacher_disagreement_score":0.19019575,"about_ca_system_score_codex":0.00029017092,"about_ca_system_score_gemma":0.00012882786,"threshold_uncertainty_score":0.8416725},"labels":[],"label_agreement":null},{"id":"W2765259856","doi":"10.1016/j.jval.2017.08.2978","title":"Secukinumab vs Adalimumab for The Treatment of Ankylosing Spondylitis: A Cost Per Responder Analysis at 52 Weeks from A Brazilian Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Adalimumab; Secukinumab; Medicine; Ankylosing spondylitis; Internal medicine; Arthritis; Psoriatic arthritis; Rheumatoid arthritis","score_opus":0.056248322720849155,"score_gpt":0.367150004581591,"score_spread":0.31090168186074185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765259856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97103953,0.0146003235,0.000071167044,0.009305093,0.00021340513,0.0023213353,0.002016994,0.0000226088,0.00040951296],"genre_scores_gemma":[0.99439055,0.0030762183,0.00093103293,0.0002616848,0.00017330839,0.00028691132,0.00014638685,0.00003299176,0.0007008925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980245,0.00014479377,0.0004930398,0.0005361277,0.00030918125,0.0004923293],"domain_scores_gemma":[0.9977032,0.00060146843,0.00036676112,0.0010079053,0.00016013537,0.00016050588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031228492,0.00025918378,0.0009187088,0.0002181365,0.00087087747,0.000038690556,0.00014670209,0.00008919656,0.0002594783],"category_scores_gemma":[0.00016462944,0.00017904719,0.00042491965,0.00020963002,0.00019327961,0.00006765948,0.000053543816,0.00009377755,0.000009256141],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037365977,0.0055344533,0.80339485,0.00032177684,0.014603846,0.00048434082,0.0839974,0.0006978106,0.0001553787,0.0037390704,0.0008739688,0.048831113],"study_design_scores_gemma":[0.025259286,0.006133293,0.9158782,0.00046078902,0.0022042848,0.000032216336,0.009740321,0.0046055494,0.00023948583,0.000960774,0.034185935,0.00029985924],"about_ca_topic_score_codex":0.0926759,"about_ca_topic_score_gemma":0.012954668,"teacher_disagreement_score":0.112483345,"about_ca_system_score_codex":0.0021932528,"about_ca_system_score_gemma":0.00027798786,"threshold_uncertainty_score":0.9133661},"labels":[],"label_agreement":null},{"id":"W2765275096","doi":"10.1016/j.jval.2017.08.1751","title":"Patients Acknowledge Adaptation: The Case Of Amputees","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"inVentiv Health Clinical","funders":"","keywords":"Adaptation (eye); Ordered probit; Public health; Medicine; Test (biology); Perception; Quality of life (healthcare); Psychology; Gerontology; Actuarial science; Economics; Econometrics; Nursing","score_opus":0.1752474473640681,"score_gpt":0.485329844627453,"score_spread":0.3100823972633849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765275096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799268,0.001136248,0.00004407267,0.0070168963,0.0033805326,0.0018218816,0.00006799369,0.000043036533,0.0065625166],"genre_scores_gemma":[0.99753946,0.0002066019,0.00073063263,0.00086342066,0.0002898462,0.00006132384,0.000007295667,0.000017869063,0.0002835671],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99684757,0.001212994,0.0009278328,0.00023643344,0.00019950935,0.0005756633],"domain_scores_gemma":[0.99672645,0.000869112,0.0009178419,0.00092395,0.00038841995,0.00017424594],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0020821795,0.00012595818,0.00032637693,0.00007656345,0.0018405487,0.000010466401,0.00042636355,0.00013050767,0.000075624055],"category_scores_gemma":[0.0014652866,0.00009178719,0.000043346525,0.00012577545,0.0001241171,0.00013843928,0.00019458665,0.0004880292,0.00030635117],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021134921,0.00056912797,0.6838578,0.006009592,0.000028340004,0.0001907924,0.10041013,0.0009947973,0.00000100624,0.066635646,0.080848165,0.060243234],"study_design_scores_gemma":[0.0030873534,0.0006114553,0.8742048,0.0028047995,0.0000109790235,0.00001861856,0.01368443,0.009021206,0.0000049060986,0.006039355,0.09023445,0.000277657],"about_ca_topic_score_codex":0.07475047,"about_ca_topic_score_gemma":0.014776624,"teacher_disagreement_score":0.19034697,"about_ca_system_score_codex":0.0003591519,"about_ca_system_score_gemma":0.0009365706,"threshold_uncertainty_score":0.9994589},"labels":[],"label_agreement":null},{"id":"W2765303786","doi":"10.1016/j.jval.2017.08.2440","title":"Cost-Utility Analysis (CUA) of Targeted Intraoperative Radiotherapy Alone (TARGIT-A) in the Brazilian Early Breast Cancer Patients","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Reimbursement; Breast cancer; Marginal cost; External beam radiotherapy; Incremental cost-effectiveness ratio; Quality-adjusted life year; Randomized controlled trial; Radiation therapy; Health care; Cancer; Medical physics; Surgery; Cost effectiveness; Brachytherapy; Internal medicine; Risk analysis (engineering)","score_opus":0.025575967159484576,"score_gpt":0.32753140166431627,"score_spread":0.3019554345048317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765303786","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99437344,0.0017093066,0.000039843784,0.0027383936,0.00008665731,0.00051988085,0.0004769508,0.000003072742,0.000052442865],"genre_scores_gemma":[0.9980629,0.0012067755,0.00012737463,0.0003457577,0.00006205171,0.00009717733,0.00007823856,0.000010830459,0.000008895296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853545,0.0003155529,0.00033871506,0.00034612484,0.00017452822,0.00028961655],"domain_scores_gemma":[0.99900484,0.000027020218,0.00025319305,0.0005683532,0.00009412963,0.000052457788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039330393,0.00015865373,0.0003648948,0.00008008557,0.00018019401,0.000021969408,0.00031923986,0.000075046286,0.000021393507],"category_scores_gemma":[0.00004286041,0.00011815947,0.00009120711,0.00021555381,0.00017917014,0.000009734356,0.00005206169,0.000110801826,6.0216775e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002493098,0.00032342743,0.990614,0.000023866494,0.00028355842,0.0000011308459,0.0017670353,0.00057991565,0.00020382946,0.000009744276,0.000117606716,0.005826585],"study_design_scores_gemma":[0.0014469633,0.00014312741,0.99679077,0.000028717297,0.000028260223,6.191508e-7,0.000106244,0.00033773287,0.00080909784,0.00001691341,0.00019417988,0.0000973782],"about_ca_topic_score_codex":0.06820973,"about_ca_topic_score_gemma":0.013548244,"teacher_disagreement_score":0.054661483,"about_ca_system_score_codex":0.00012713365,"about_ca_system_score_gemma":0.00016802638,"threshold_uncertainty_score":0.93799514},"labels":[],"label_agreement":null},{"id":"W2765315539","doi":"10.1016/j.jval.2017.08.2802","title":"Ethical Requirements for the Conduct of Drug Utilization Studies in Latin America: A Cross-Sectional Survey","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Observational study; Informed consent; Legislation; Medicine; Declaration of Helsinki; Family medicine; Political science; Latin Americans; Confidentiality; Health care; Legislature; Alternative medicine; Law; Pathology","score_opus":0.8620755115615225,"score_gpt":0.6410397730794198,"score_spread":0.22103573848210267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765315539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98997575,0.0009414423,0.00008947275,0.0073392102,0.0005946757,0.0009082066,0.000033019183,0.0000061162095,0.00011211238],"genre_scores_gemma":[0.99728465,0.00085971405,0.00024102668,0.0014190614,0.00004885067,0.000028309925,0.000015235214,0.0000068317595,0.000096319585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858,0.00037345564,0.00047662505,0.00015446029,0.00024064393,0.0001748338],"domain_scores_gemma":[0.9964288,0.0028333734,0.00034987493,0.00021094624,0.00012718681,0.00004985933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003680586,0.00006769655,0.00025911926,0.000048798633,0.00018136375,0.000014166634,0.00009748659,0.00005307268,0.000013954857],"category_scores_gemma":[0.007176181,0.00004532474,0.000036649893,0.000089087946,0.00023546082,0.00008839532,0.00004521148,0.00033721438,0.0000020793648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042929003,0.000103212165,0.99655163,0.00039937947,0.000027087628,8.2646477e-7,0.0007167359,0.00037186866,0.000012533086,0.00036702136,0.00013647084,0.00088394113],"study_design_scores_gemma":[0.0016191888,0.00015405925,0.9806334,0.00012209789,0.0000057078805,9.256639e-7,0.00014698348,0.015476141,0.00003629399,0.00030626738,0.0014620725,0.000036902013],"about_ca_topic_score_codex":0.0048708525,"about_ca_topic_score_gemma":0.0002937527,"teacher_disagreement_score":0.015918273,"about_ca_system_score_codex":0.00010982385,"about_ca_system_score_gemma":0.00017835615,"threshold_uncertainty_score":0.8591077},"labels":[],"label_agreement":null},{"id":"W2765337144","doi":"10.1016/j.jval.2017.08.2244","title":"Network Meta-Analysis In The Evaluation of Vaccines","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral gastroenteritis research and epidemiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; GlaxoSmithKline (Canada)","funders":"","keywords":"Vaccine efficacy; Medicine; Psychological intervention; Leverage (statistics); Intensive care medicine; Randomized controlled trial; Clinical trial; Meta-analysis; Epidemiology; Risk analysis (engineering); Vaccination; Computer science; Immunology; Surgery; Artificial intelligence; Internal medicine; Psychiatry","score_opus":0.5030887784739609,"score_gpt":0.5056242902308837,"score_spread":0.0025355117569227925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765337144","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93099463,0.0064676087,0.000109472116,0.060844913,0.000057845093,0.0008228832,0.0000065450076,0.000003944202,0.0006921838],"genre_scores_gemma":[0.99792624,0.0003220177,0.00048105684,0.0011069459,0.000077443314,0.000049376325,0.000010315877,0.0000032808216,0.000023337529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99680126,0.0019047259,0.00047414712,0.00014951876,0.00036930147,0.0003010537],"domain_scores_gemma":[0.99899006,0.000107543216,0.00021956277,0.00054473174,0.000082715254,0.000055403652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014068411,0.000058784884,0.0007322127,0.00014308411,0.00006663131,0.0000075940197,0.00018087524,0.00003243859,0.00012029588],"category_scores_gemma":[0.0018453235,0.00003450215,0.00021476664,0.00022334537,0.000037195117,0.000039264327,0.000030033192,0.00016765011,0.000003106033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018943503,0.00015804355,0.91983545,0.00013423387,0.0046236715,0.000012668895,0.00034576055,0.06662794,0.000008200869,0.0005511404,0.0028205905,0.0046928357],"study_design_scores_gemma":[0.0006690162,0.00027847925,0.9495796,0.000018129003,0.0040690782,0.0000047745116,0.000053571795,0.042942874,9.353839e-7,0.0022089905,0.00015361953,0.00002093306],"about_ca_topic_score_codex":0.0147298,"about_ca_topic_score_gemma":0.0038082434,"teacher_disagreement_score":0.06693162,"about_ca_system_score_codex":0.00005972808,"about_ca_system_score_gemma":0.0001394866,"threshold_uncertainty_score":0.9918312},"labels":[],"label_agreement":null},{"id":"W2765388428","doi":"10.1016/j.jval.2017.08.2753","title":"Interrupted Time Series Analysis Evaluating The Impact of A Pro-Generic Policy on Drug Pricing and Utilization In Argentina","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Unit price; Unit (ring theory); Interrupted time series; Interrupted Time Series Analysis; Generic drug; Panel data; Public economics; Economics; Drug; Business; Econometrics; Medicine; Macroeconomics; Statistics; Pharmacology; Mathematics","score_opus":0.25661781000631123,"score_gpt":0.4364669964465159,"score_spread":0.17984918644020464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765388428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99377114,0.0005470284,0.00002625108,0.0031684658,0.000037154598,0.00029060274,0.00005759984,0.0000049913933,0.0020967869],"genre_scores_gemma":[0.9988626,0.0006565518,0.000097205906,0.00022664007,0.000046962236,0.0000124508215,0.0000067756882,0.000010623539,0.000080192534],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99869615,0.00008251358,0.0006889386,0.00023958726,0.00002520956,0.00026762206],"domain_scores_gemma":[0.9988147,0.000082308776,0.00068594824,0.0003362841,0.000013348166,0.00006738498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019152606,0.000105925035,0.00041912595,0.00058913487,0.00013839312,0.000069277135,0.00019508826,0.000034978577,0.000042188214],"category_scores_gemma":[0.00047760544,0.00009255338,0.000090353446,0.00043029312,0.00006038283,0.00015175651,0.00007549736,0.00012977507,0.000013382577],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000111246554,0.00017557945,0.8564481,0.0001357178,0.00016720234,7.1480804e-7,0.004913103,0.07522281,0.000045470573,0.054045178,0.00005943036,0.008675455],"study_design_scores_gemma":[0.00030957785,0.00011935627,0.46811652,0.000034570643,0.0000037809386,5.5213906e-7,0.000020807956,0.5217729,0.000022804761,0.009442353,0.0000812567,0.00007551638],"about_ca_topic_score_codex":0.028919658,"about_ca_topic_score_gemma":0.00019135336,"teacher_disagreement_score":0.4465501,"about_ca_system_score_codex":0.00029517818,"about_ca_system_score_gemma":0.00014813096,"threshold_uncertainty_score":0.9775469},"labels":[],"label_agreement":null},{"id":"W2765405386","doi":"10.1016/j.jval.2017.08.2074","title":"Probabilistic Sensitivity Analysis In Health Economic Models; How Many Simulations Should We Run?","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Probabilistic logic; Convergence (economics); Sensitivity (control systems); Econometrics; Statistics; Cohort; Mathematics; Computer science; Mathematical optimization; Economics","score_opus":0.5674748590167603,"score_gpt":0.4568098896202499,"score_spread":0.11066496939651044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765405386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5399805,0.002943387,0.011195493,0.43902126,0.0009523319,0.003022132,0.0015297455,0.00010126855,0.0012538851],"genre_scores_gemma":[0.99173284,0.0007827466,0.0024448554,0.0043494855,0.00023204097,0.000062052364,0.00007388833,0.000050519826,0.00027159133],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9906567,0.0016294057,0.0053126416,0.0012099979,0.0001394036,0.0010518844],"domain_scores_gemma":[0.9912145,0.0017054221,0.0048150513,0.0017709169,0.000041145697,0.00045293916],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.033941224,0.0003472591,0.0023383356,0.0015043599,0.00072543084,0.00029917387,0.00046480147,0.0002283353,0.00011333488],"category_scores_gemma":[0.002624027,0.00047627656,0.00024702383,0.00038557008,0.00013127933,0.0011081473,0.00012936216,0.0004960776,0.00026904908],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010417128,0.00012583609,0.090513945,0.00067817105,0.000063537715,0.0000021151225,0.0019693605,0.75622547,9.378258e-8,0.149542,0.0006863551,0.00018270304],"study_design_scores_gemma":[0.0007219021,0.00005996752,0.113442086,0.00018011662,0.000006669284,0.000001973682,0.0003206985,0.8235597,1.3152845e-7,0.059341174,0.0020473292,0.00031823837],"about_ca_topic_score_codex":0.11700829,"about_ca_topic_score_gemma":0.045297608,"teacher_disagreement_score":0.45175233,"about_ca_system_score_codex":0.004990834,"about_ca_system_score_gemma":0.0012444365,"threshold_uncertainty_score":0.9997689},"labels":[],"label_agreement":null},{"id":"W2765406418","doi":"10.1016/j.jval.2017.08.1213","title":"Modelling The Burden Of Cardiovascular Disease In Brazil And The Impact Of Reducing Modifiable Risk Factors","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Medicine; Environmental health; Population; Disease; Obesity; Disease burden; Psychological intervention; Absenteeism; Internal medicine","score_opus":0.06896339803205377,"score_gpt":0.32759956384550865,"score_spread":0.2586361658134549,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765406418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9886275,0.0023082367,0.00019479333,0.007815193,0.00010898915,0.00045089994,0.000010855116,0.0000065383892,0.0004769806],"genre_scores_gemma":[0.998164,0.0014347078,0.000024841198,0.00011671582,0.0002357427,0.000008208894,0.0000023318885,0.000009343517,0.0000041281573],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984443,0.0002297858,0.00056751183,0.00018841053,0.0001559123,0.00041405996],"domain_scores_gemma":[0.9983299,0.0003047525,0.0006067564,0.00067468424,0.000050071096,0.000033862896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005166078,0.00011639921,0.00051633635,0.000114234004,0.0003362118,0.000053346826,0.00034667194,0.0000457517,0.0000036435472],"category_scores_gemma":[0.0011806845,0.00006212821,0.00017950269,0.00015964577,0.00022492565,0.0002752992,0.00016904711,0.00020681658,9.083979e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044069253,0.000012506966,0.013494099,0.00025521548,0.000036830363,3.6590828e-7,0.00042194492,0.9811236,1.017817e-7,0.0039761574,0.0004559595,0.00017910944],"study_design_scores_gemma":[0.00060789485,0.000007638841,0.007409702,0.00012703548,0.000018454008,1.443808e-7,0.00027698348,0.9833567,7.725849e-8,0.0058375965,0.0023055205,0.000052218125],"about_ca_topic_score_codex":0.9896983,"about_ca_topic_score_gemma":0.0000298114,"teacher_disagreement_score":0.9896685,"about_ca_system_score_codex":0.00006334655,"about_ca_system_score_gemma":0.00014034062,"threshold_uncertainty_score":0.2585903},"labels":[],"label_agreement":null},{"id":"W2765420062","doi":"10.1016/j.jval.2017.08.545","title":"Persistence and Adherence to Oral Antiresorptive Therapy in a Fracture Liaison Service: 24-Month Results of a Prospective Cohort Study","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Clinical Research Institute; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Cohort; Persistence (discontinuity); Cumulative incidence; Osteoporosis; Internal medicine; Prospective cohort study; Pharmacy; Cohort study; Medical prescription; Incidence (geometry); Fragility fracture; Pediatrics; Family medicine","score_opus":0.2470111422459913,"score_gpt":0.45895994530630446,"score_spread":0.21194880306031316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765420062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98883426,0.0004476302,0.0000020247653,0.0066721844,0.00009794044,0.0034105182,0.000015720048,0.000009682601,0.0005100164],"genre_scores_gemma":[0.99761695,0.0003949364,0.00024259867,0.0016050463,0.00002386539,0.000047760153,0.0000022716956,0.00000966994,0.000056925444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842155,0.00022826291,0.00041663027,0.00037658936,0.0003009451,0.00025605137],"domain_scores_gemma":[0.9987868,0.00023362697,0.00031148366,0.00038817784,0.000099794095,0.00018008362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011525275,0.00013452447,0.0004800334,0.0001005655,0.00009371043,0.000022245753,0.00014319009,0.000056347977,0.00000844866],"category_scores_gemma":[0.00062553317,0.0001035277,0.000026019587,0.00019206904,0.000048000664,0.00016920785,0.000064145905,0.000382917,0.000003426805],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042572063,0.0008069837,0.9761262,0.00014237354,0.00002793275,0.000026565147,0.015988933,0.000077719524,0.00003334615,0.0000084042695,0.000032634263,0.0024716798],"study_design_scores_gemma":[0.006353737,0.0054754484,0.98271525,0.00045583816,0.000013029119,0.0000033413558,0.0020378595,0.0024287163,0.0000708131,0.000044219905,0.0003112594,0.00009046074],"about_ca_topic_score_codex":0.038079105,"about_ca_topic_score_gemma":0.0020764263,"teacher_disagreement_score":0.036002677,"about_ca_system_score_codex":0.00011966517,"about_ca_system_score_gemma":0.00019080185,"threshold_uncertainty_score":0.9683264},"labels":[],"label_agreement":null},{"id":"W2765421581","doi":"10.1016/j.jval.2017.08.2182","title":"Translation And Cultural Adaptation Of The Body-Q Chest Module Into Finnish For Use In Gynecomastia, Weight Loss And FTM Chest Surgery","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Breast Implant and Reconstruction","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Multidisciplinary approach; Medicine; Gynecomastia; Knowledge translation; Test (biology); Medical physics; Physical therapy; Psychology; Linguistics; Computer science; Internal medicine; Sociology; Knowledge management","score_opus":0.0866865391187612,"score_gpt":0.3016297536377145,"score_spread":0.2149432145189533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765421581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961079,0.0005421818,0.00013808321,0.0024959857,0.00025995713,0.00042865443,0.000014111795,0.0000054647994,0.000007693519],"genre_scores_gemma":[0.9978127,0.00034055908,0.0017018574,0.00002147346,0.00007265105,0.000011162264,0.0000192419,0.0000065931767,0.000013773845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99933004,0.000055047505,0.00028478596,0.00013272288,0.000074371725,0.0001230012],"domain_scores_gemma":[0.9994144,0.00020418917,0.00018146355,0.0001212789,0.00003110653,0.00004757672],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039907536,0.000070601636,0.00021244623,0.000070260205,0.00012410207,0.000018960505,0.000028516264,0.00007215623,0.0000012110995],"category_scores_gemma":[0.00008530798,0.00005019286,0.000029000506,0.000048099344,0.00010351413,0.00021415469,0.000008354219,0.00009594636,1.3908145e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013971243,0.000034447523,0.7037148,0.0006462862,0.0000060400716,0.0000010616368,0.0012283027,0.000046272577,0.00010154319,0.000094626565,0.00002385392,0.29396304],"study_design_scores_gemma":[0.0011293957,0.000043749493,0.9649976,0.0005154927,0.000008374131,0.00031408345,0.00013102766,0.032141227,0.00020327875,0.00026370122,0.00019814137,0.000053957494],"about_ca_topic_score_codex":0.007734602,"about_ca_topic_score_gemma":0.0020161078,"teacher_disagreement_score":0.29390907,"about_ca_system_score_codex":0.000041382726,"about_ca_system_score_gemma":0.00010507819,"threshold_uncertainty_score":0.998873},"labels":[],"label_agreement":null},{"id":"W2765427898","doi":"10.1016/j.jval.2017.08.435","title":"Prevalence of Cardiovascular Disease In Type 2 Diabetes: A Global Systematic Review","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Myocardial infarction; Angina; Internal medicine; Coronary artery disease; Stroke (engine); Diabetes mellitus; Heart failure; Cardiology; Disease; Type 2 diabetes; Cause of death; Checklist","score_opus":0.04519239517489385,"score_gpt":0.3158561704397169,"score_spread":0.27066377526482305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765427898","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.303821,0.6897745,0.0000038401627,0.0013776977,0.00017561052,0.0041594137,0.000014572097,0.00001956941,0.00065377564],"genre_scores_gemma":[0.92447245,0.07480627,0.00010927818,0.00035550783,0.00001571129,0.00010937053,0.00000453143,0.0000076156516,0.000119267],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99866086,0.00017339489,0.00044680838,0.00020211037,0.0002859744,0.00023086308],"domain_scores_gemma":[0.9985585,0.000026369777,0.00018837008,0.0010648274,0.000032579086,0.00012934681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011670769,0.0001001248,0.00075405044,0.000046787973,0.00002781955,0.0000075451353,0.00015488778,0.000018572733,0.000008667495],"category_scores_gemma":[0.0006413236,0.00007939021,0.00013826744,0.0001212821,0.00003214783,0.000057185953,0.000056557787,0.000047329147,0.000018235105],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009931199,0.00014889598,0.23512463,0.7634618,0.00016073394,0.000027162816,0.0000235166,0.00014784407,7.3595785e-8,0.00023556717,0.00007031278,0.0005894803],"study_design_scores_gemma":[0.001328742,0.0003156207,0.37122288,0.6235345,0.0014052228,5.889081e-7,0.000009773563,0.0016234624,0.0000018369577,0.00021244747,0.00022486808,0.00012007295],"about_ca_topic_score_codex":0.0007990567,"about_ca_topic_score_gemma":0.000004122001,"teacher_disagreement_score":0.6206514,"about_ca_system_score_codex":0.0002388172,"about_ca_system_score_gemma":0.00015580555,"threshold_uncertainty_score":0.32374388},"labels":[],"label_agreement":null},{"id":"W2765441049","doi":"10.1016/j.jval.2017.08.585","title":"Cost-Utility Analysis Of Antihypertensive Dosage Adjustments By A Pharmacist In A Community Setting","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Pharmacy; Pharmacist; Blood pressure; Pharmacoeconomics; Cohort; Intervention (counseling); Cost effectiveness; Cost–benefit analysis; Emergency medicine; Intensive care medicine; Internal medicine; Family medicine; Nursing; Risk analysis (engineering)","score_opus":0.6086480717448937,"score_gpt":0.502880051012615,"score_spread":0.10576802073227864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765441049","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835024,0.0019561914,0.000281703,0.010481467,0.00025942293,0.0010610713,0.0014900983,0.000016381884,0.0009512637],"genre_scores_gemma":[0.99387145,0.00044309357,0.0005640712,0.004869792,0.000028829445,0.000062900726,0.00010422203,0.000017291983,0.0000383287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923979,0.0019585122,0.0045592706,0.00044512685,0.000108716034,0.0005304537],"domain_scores_gemma":[0.9929714,0.0013836682,0.0041792598,0.0012143943,0.00006170883,0.00018955275],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.035108864,0.00018204522,0.0017327287,0.00074901327,0.0004695429,0.00005650449,0.00058766245,0.00011712488,0.0001154439],"category_scores_gemma":[0.005183671,0.00024393915,0.0001501652,0.0004391373,0.00013333936,0.0003976764,0.0001319014,0.00048751137,0.000085563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026787033,0.00037855192,0.98793715,0.0006226728,0.00016790286,0.0000016628251,0.005663783,0.0013096394,0.0000032452192,0.0009722334,0.0023649442,0.0005514048],"study_design_scores_gemma":[0.0016511459,0.00005613763,0.81399935,0.00019392188,0.000019114965,9.1276127e-7,0.001684946,0.17910568,0.000008298478,0.001153073,0.0019177302,0.00020968335],"about_ca_topic_score_codex":0.15583931,"about_ca_topic_score_gemma":0.0031096155,"teacher_disagreement_score":0.17779604,"about_ca_system_score_codex":0.00090008305,"about_ca_system_score_gemma":0.0002433817,"threshold_uncertainty_score":0.99475497},"labels":[],"label_agreement":null},{"id":"W2765460113","doi":"10.1016/j.jval.2017.08.2973","title":"Secukinumab Shows Higher Symptomatic Improvement and Lower Cost Per Response vs. Adalimumab After One Year Treatment of Active Ankylosing Spondylitis: A Cost Per Responder Analysis from A Chilean Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Adalimumab; Secukinumab; Medicine; Ankylosing spondylitis; Internal medicine; Psoriatic arthritis; Tumor necrosis factor alpha; Arthritis","score_opus":0.03133953096601857,"score_gpt":0.3190984669833122,"score_spread":0.28775893601729363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765460113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98920923,0.0030575413,0.0000117808195,0.0031428945,0.00016441802,0.0022962391,0.0018266249,0.000030148252,0.00026110045],"genre_scores_gemma":[0.9967069,0.000817669,0.0009390269,0.0003244447,0.00012174201,0.0003822939,0.00008382977,0.00005410029,0.0005699878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970473,0.00039991736,0.0006399883,0.00081017026,0.00050020503,0.0006024349],"domain_scores_gemma":[0.99778223,0.00031296854,0.00042287435,0.0009961546,0.00017761585,0.00030815526],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004254819,0.00041302785,0.0012675888,0.0004656105,0.00034748996,0.00006992399,0.00010698049,0.00013730138,0.0011049974],"category_scores_gemma":[0.00011649435,0.00035415668,0.00027799426,0.00021660722,0.00024818463,0.00016416957,0.00010688962,0.00018198976,0.000018937622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.26662463,0.014257307,0.5460405,0.00058513874,0.019545997,0.0016968594,0.10554592,0.000076022974,0.0024348942,0.0008532267,0.00013707424,0.04220248],"study_design_scores_gemma":[0.015991926,0.005502466,0.9697884,0.00077199173,0.0011658628,0.000013781376,0.0046136165,0.00021564713,0.00025019379,0.00017789495,0.001203457,0.000304765],"about_ca_topic_score_codex":0.027063232,"about_ca_topic_score_gemma":0.002009931,"teacher_disagreement_score":0.42374796,"about_ca_system_score_codex":0.002494506,"about_ca_system_score_gemma":0.0003385521,"threshold_uncertainty_score":0.99989104},"labels":[],"label_agreement":null},{"id":"W2765482791","doi":"10.1016/j.jval.2017.08.1592","title":"Trends In Fda Drug Promotion Enforcement Letters Over A Ten-Year Period","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto","funders":"","keywords":"Enforcement; Revenue; Promotion (chess); Business; Advertising; Product (mathematics); Prescription drug; Medical prescription; Marketing; Public relations; Medicine; Finance; Political science; Law; Pharmacology","score_opus":0.4513791833501678,"score_gpt":0.5552794849824366,"score_spread":0.10390030163226882,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765482791","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93287194,0.00034040117,0.000005296023,0.059454545,0.0014399689,0.0006463061,0.000055276945,0.000055799053,0.0051304856],"genre_scores_gemma":[0.9918932,0.0003400662,0.00007888016,0.0061533325,0.00037735005,0.00009525401,0.000031073087,0.000024413448,0.0010064708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99656016,0.0010399043,0.0007090818,0.00046457277,0.00023732973,0.0009889591],"domain_scores_gemma":[0.99862105,0.00011601985,0.0003000219,0.00041752664,0.000026571846,0.0005188196],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0025494525,0.00024809828,0.00039223357,0.00032662088,0.00061680836,0.000052722506,0.00043737405,0.00034721632,0.002476571],"category_scores_gemma":[0.000105623316,0.000250102,0.00008409735,0.00022197586,0.00019933132,0.00026444037,0.0001259619,0.0022052834,0.000089183784],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009092193,0.0016197343,0.8640514,0.00093996985,0.00007041332,0.00033209226,0.008292481,0.007490793,0.001596019,0.01689627,0.015316089,0.0824855],"study_design_scores_gemma":[0.01454406,0.00070016383,0.6786393,0.00077763683,0.000054540822,0.000053071475,0.0008634351,0.066252805,0.0029059087,0.0016287778,0.23239338,0.0011869507],"about_ca_topic_score_codex":0.0044494215,"about_ca_topic_score_gemma":0.0004589847,"teacher_disagreement_score":0.21707729,"about_ca_system_score_codex":0.0006236879,"about_ca_system_score_gemma":0.00024281775,"threshold_uncertainty_score":0.9999951},"labels":[],"label_agreement":null},{"id":"W2765484440","doi":"10.1016/j.jval.2017.08.1223","title":"Cost-Effectiveness of Statin Prioritisation Based on Absolute Risk Reduction For Primary Prevention of Cardiovascular Disease","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Statin; Cohort; Quality-adjusted life year; Cost effectiveness; Primary prevention; Disease; Physical therapy; Internal medicine; Demography; Risk analysis (engineering)","score_opus":0.42949032231917544,"score_gpt":0.44771150180298447,"score_spread":0.018221179483809025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765484440","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8944253,0.0031908622,0.09042257,0.0024324127,0.0010035776,0.006724581,0.0015530107,0.000022841385,0.00022485727],"genre_scores_gemma":[0.9930522,0.00052472635,0.005577854,0.000099442565,0.00012071999,0.00046181036,0.000116830655,0.000026397749,0.000020062567],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.995313,0.0013216061,0.0025478292,0.00043959892,0.00013502564,0.00024294305],"domain_scores_gemma":[0.994158,0.0009850188,0.0037785326,0.00086947397,0.00009113596,0.00011781467],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.035700884,0.00012156113,0.0009303492,0.00030308223,0.00021615015,0.000022476259,0.00017510692,0.00007888746,0.000008572621],"category_scores_gemma":[0.0045796963,0.00016716619,0.000248035,0.00007778093,0.000066467954,0.00030013884,0.000017560249,0.000105880885,0.000010919506],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009971763,0.00087828445,0.10858935,0.023368763,0.00028227043,5.440611e-7,0.0011299591,0.8053217,0.000008394414,0.039840803,0.00029388923,0.019288845],"study_design_scores_gemma":[0.0031662544,0.0004550455,0.85793,0.001480316,0.000024688521,3.251641e-7,0.0000927986,0.10837832,0.00003218776,0.02637923,0.0018607719,0.00020006552],"about_ca_topic_score_codex":0.010100527,"about_ca_topic_score_gemma":0.00002068272,"teacher_disagreement_score":0.74934065,"about_ca_system_score_codex":0.00097254344,"about_ca_system_score_gemma":0.00059497455,"threshold_uncertainty_score":0.9964913},"labels":[],"label_agreement":null},{"id":"W2765553628","doi":"10.1016/j.jval.2017.08.2707","title":"Ixekizumab Treatment Leads to Early Resolution of Bothersome Symptoms Versus Ustekinumab","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Urticaria and Related Conditions","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Itching; Ixekizumab; Visual analogue scale; Internal medicine; Anesthesia; Dermatology; Psoriasis","score_opus":0.0614360303973777,"score_gpt":0.34248773775626107,"score_spread":0.28105170735888335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765553628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98879546,0.00032840628,0.00004261602,0.0061450684,0.0004887048,0.00057064963,0.000018123714,0.000029676257,0.003581268],"genre_scores_gemma":[0.9983799,0.0001362018,0.00037775366,0.000082426566,0.00009540132,0.000027176433,0.000008483011,0.000016285518,0.0008763976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989482,0.00006568244,0.0003054874,0.00019528258,0.0001730884,0.0003122155],"domain_scores_gemma":[0.9990077,0.000057140038,0.00013619856,0.00055521174,0.000036988265,0.00020674587],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016546246,0.00010088806,0.0002801432,0.00016249265,0.00017196056,0.0000128308275,0.000090580885,0.00010139105,0.000037838483],"category_scores_gemma":[0.00009202068,0.000083853316,0.00006927165,0.000098567325,0.000069661364,0.000056235658,0.000019545754,0.00012299378,0.00007558644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028859857,0.010854642,0.43234205,0.0015002999,0.0051330845,0.0009792757,0.074188635,0.025200343,0.015883096,0.1717798,0.0064016916,0.22687723],"study_design_scores_gemma":[0.025711095,0.02052981,0.9384316,0.0016863586,0.0005323868,0.000052636486,0.00043467258,0.0048398017,0.0014436115,0.0006429615,0.0053231837,0.00037188074],"about_ca_topic_score_codex":0.009858333,"about_ca_topic_score_gemma":0.00009969351,"teacher_disagreement_score":0.50608957,"about_ca_system_score_codex":0.0006217885,"about_ca_system_score_gemma":0.00038035784,"threshold_uncertainty_score":0.9967351},"labels":[],"label_agreement":null},{"id":"W2765562164","doi":"10.1016/j.jval.2017.08.2974","title":"Secukinumab vs Adalimumab for The Treatment of Psoriatic Arthritis: A Cost Per Responder Analysis At 48 Weeks from A Chilean Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Secukinumab; Adalimumab; Medicine; Psoriatic arthritis; Internal medicine; Rheumatology; Arthritis; Rheumatoid arthritis","score_opus":0.31348197192613836,"score_gpt":0.43554577432095204,"score_spread":0.12206380239481368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765562164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8492148,0.030708773,0.0032415157,0.10527691,0.0012393985,0.004949852,0.004621422,0.00003748708,0.00070986565],"genre_scores_gemma":[0.9908796,0.0039926358,0.0015321453,0.0019512199,0.00044248914,0.00062158814,0.0000682407,0.000040518815,0.0004715899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99480385,0.0005857146,0.0032359448,0.0007267492,0.00012664111,0.0005210854],"domain_scores_gemma":[0.9922423,0.0025476334,0.003517744,0.0014221615,0.000091835485,0.00017834967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008577538,0.00024040382,0.0016435542,0.00045749397,0.00080719945,0.0001006362,0.0004318074,0.0001347416,0.00039570557],"category_scores_gemma":[0.0019946606,0.0002382362,0.00039973276,0.00018699304,0.00013008338,0.00021699604,0.000046040186,0.00011867464,0.00023380433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025865256,0.0030503513,0.35404542,0.0010018741,0.0069443258,0.000007444721,0.22827184,0.030984912,0.0000023425532,0.34726202,0.015110064,0.010732873],"study_design_scores_gemma":[0.0147287985,0.0017804753,0.60921574,0.00042516278,0.0002435631,0.0000046322593,0.01628785,0.1937364,0.000010651145,0.06310565,0.09956696,0.0008940961],"about_ca_topic_score_codex":0.13075864,"about_ca_topic_score_gemma":0.018736891,"teacher_disagreement_score":0.28415635,"about_ca_system_score_codex":0.003898595,"about_ca_system_score_gemma":0.00043653406,"threshold_uncertainty_score":0.99992526},"labels":[],"label_agreement":null},{"id":"W2765589002","doi":"10.1016/j.jval.2017.08.2990","title":"Assessing the Burden of Disease in Peripheral and Axial Spondyloarthritis in Mexico and Brazil","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Ankylosing spondylitis; Cohort; Psoriatic arthritis; Quality of life (healthcare); Axial spondyloarthritis; Internal medicine; Physical therapy; Disease; Sacroiliitis","score_opus":0.03705310933083487,"score_gpt":0.3578899243783942,"score_spread":0.3208368150475593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765589002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815537,0.010031111,7.16191e-7,0.0074920678,0.00009157114,0.0004049963,0.000013574471,0.0000044310227,0.00040785497],"genre_scores_gemma":[0.99763346,0.0018785535,0.00015588706,0.00020552923,0.000072564486,0.000019605457,0.0000035388712,0.0000101238775,0.000020756062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990151,0.00010401437,0.00029414686,0.00020663204,0.00013565071,0.00024445597],"domain_scores_gemma":[0.99944973,0.00008134008,0.00010448075,0.00024005456,0.000013553379,0.000110848945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039598165,0.000101145415,0.00032671686,0.00006799971,0.00018753081,0.000045373265,0.000052084742,0.000034983233,0.0000085373085],"category_scores_gemma":[0.00014292017,0.00007816698,0.000021851129,0.000058853755,0.00023345459,0.00013661785,0.00007376393,0.00014419861,3.8824044e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019093585,0.00010458269,0.97511065,0.0001734194,0.000007417556,0.00023217667,0.0023658886,0.000050117887,0.000015630369,0.00073523883,0.000011103554,0.021002825],"study_design_scores_gemma":[0.005003798,0.00021961713,0.99055433,0.0011862678,0.000006034708,0.000018423078,0.0006958027,0.0012311176,0.0000056257577,0.0006608973,0.0003571737,0.00006091658],"about_ca_topic_score_codex":0.041646644,"about_ca_topic_score_gemma":0.0026464532,"teacher_disagreement_score":0.03900019,"about_ca_system_score_codex":0.00008458891,"about_ca_system_score_gemma":0.00012654827,"threshold_uncertainty_score":0.9647351},"labels":[],"label_agreement":null},{"id":"W2765635337","doi":"10.1016/j.jval.2017.08.2679","title":"Treatment Patterns and Satisfaction For Rheumatoid Arthritis Patients In Latin America Undergoing Advanced Therapy","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Antirheumatic drugs; Biologic Agents; Rheumatology; Combination therapy; Physical therapy; Antirheumatic Agents","score_opus":0.049543698073820856,"score_gpt":0.3535058204042228,"score_spread":0.30396212233040193,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765635337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964754,0.00079814735,0.00008574182,0.0010445677,0.000095988384,0.0014204645,0.000017257667,0.000014436539,0.000048022463],"genre_scores_gemma":[0.94483197,0.053958178,0.00087335,0.00011015559,0.000024290908,0.0001402041,0.000018597873,0.000020032916,0.000023240817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988407,0.000070587295,0.00031196306,0.0002630373,0.00017027212,0.0003434432],"domain_scores_gemma":[0.9991183,0.0002784545,0.0001533003,0.00030878294,0.000026410033,0.00011473577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000163841,0.000110718094,0.00030740723,0.00010725209,0.0001447987,0.000025915104,0.000042910902,0.000046311485,0.000008901065],"category_scores_gemma":[0.00021068667,0.00009698549,0.000028964729,0.000045560308,0.00004255381,0.00009306936,0.00002096851,0.00008467341,0.0000028061754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002666103,0.00009744202,0.5055489,0.00012548239,0.00000755854,0.0000072934,0.00071265287,0.00012573045,0.00000900001,0.000027327222,0.000008685605,0.4930633],"study_design_scores_gemma":[0.05144626,0.0021645525,0.92807853,0.001051161,7.9220536e-7,0.000011041979,0.00018183311,0.016025947,0.00010687979,0.00018122018,0.0006570726,0.00009469385],"about_ca_topic_score_codex":0.098367825,"about_ca_topic_score_gemma":0.00792834,"teacher_disagreement_score":0.49296862,"about_ca_system_score_codex":0.007653101,"about_ca_system_score_gemma":0.0019926399,"threshold_uncertainty_score":0.99615633},"labels":[],"label_agreement":null},{"id":"W2765645961","doi":"10.1016/j.jval.2017.08.2425","title":"Epidemiology of Psoriasis In Colombia: A Governmental Database Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"","keywords":"Epidemiology; Medicine; Psoriasis; Database; Demography; Population; Prevalence; Health care; Pediatrics; Environmental health; Pathology; Dermatology","score_opus":0.07505115506693723,"score_gpt":0.3351063444301166,"score_spread":0.2600551893631794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765645961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9916333,0.0059721298,0.000024686138,0.0006869876,0.0005377698,0.00028401523,0.00038640195,0.0000116693,0.00046305955],"genre_scores_gemma":[0.99789506,0.0010497825,0.0004464022,0.000117550175,0.000019215466,0.000035037785,0.00018291721,0.0000085903375,0.000245445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731433,0.0010712821,0.00073681667,0.00037978915,0.00003700236,0.00046075135],"domain_scores_gemma":[0.99796546,0.0006659263,0.0005904404,0.0007280543,0.000014072263,0.000036064906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019418687,0.00015571114,0.0008618182,0.00028382122,0.00016089613,0.0000020333898,0.0003392252,0.00019791581,0.00016020001],"category_scores_gemma":[0.00058956153,0.00014575962,0.00015212552,0.00024046491,0.00017811968,0.00008844724,0.000121498015,0.0001771089,0.000052656585],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024221082,0.00033764,0.99212563,0.00004712228,0.00038189313,0.000015853242,0.00023702113,0.00013130097,0.0005757702,0.0012462456,0.00025184828,0.004407447],"study_design_scores_gemma":[0.0025456806,0.00021667319,0.99453086,0.00007061672,0.00013785674,0.000008272373,0.0002445179,0.0001492812,0.0012228868,0.0001582122,0.0005893662,0.00012575692],"about_ca_topic_score_codex":0.05055888,"about_ca_topic_score_gemma":0.0054585673,"teacher_disagreement_score":0.045100313,"about_ca_system_score_codex":0.0003406576,"about_ca_system_score_gemma":0.00013439471,"threshold_uncertainty_score":0.9557635},"labels":[],"label_agreement":null},{"id":"W2765688979","doi":"10.1016/j.jval.2017.08.941","title":"Time to Access: Too Fast, Too Slow, or Just Right? An Evolving Public Reimbursement Landscape of Drugs For Rare Diseases In Canada","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Negotiation; Orphan drug; Alliance; Market access; Public economics; Actuarial science; Business; Economic growth; Political science; Health care; Law; Bioinformatics; Economics","score_opus":0.35014217316110186,"score_gpt":0.424691304518594,"score_spread":0.07454913135749214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765688979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88103455,0.0019162146,0.0002230489,0.10801206,0.0009536974,0.0032817845,0.002574392,0.00003073549,0.0019734933],"genre_scores_gemma":[0.9880808,0.000110929,0.0013349222,0.008495179,0.0003025199,0.0003631972,0.00011482938,0.00004562886,0.001151995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99436986,0.0003382451,0.0037169189,0.00067384256,0.00015806819,0.00074308104],"domain_scores_gemma":[0.9951423,0.000895209,0.0023164847,0.0010333343,0.00010203467,0.00051066437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0089281555,0.00021199115,0.0011952788,0.0005211788,0.0003406717,0.00021939543,0.0009184584,0.00008114531,0.00059304],"category_scores_gemma":[0.004590427,0.00024272106,0.000068682675,0.00020560283,0.000036913294,0.0011702973,0.0001381062,0.00013690251,0.00008594472],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019484489,0.00050570304,0.69771343,0.0041563925,0.000067992376,0.000007582306,0.0048804507,0.011168408,5.930904e-7,0.012562248,0.26511967,0.0036226967],"study_design_scores_gemma":[0.0043518036,0.00059321616,0.6903788,0.0011228655,0.000009805048,0.000002845732,0.004912392,0.18928267,0.0000046811138,0.0039053326,0.10442988,0.0010056933],"about_ca_topic_score_codex":0.78825146,"about_ca_topic_score_gemma":0.503147,"teacher_disagreement_score":0.28510442,"about_ca_system_score_codex":0.0027645845,"about_ca_system_score_gemma":0.00468403,"threshold_uncertainty_score":0.98978776},"labels":[],"label_agreement":null},{"id":"W2765738011","doi":"10.1016/j.jval.2017.08.2323","title":"Health Care Resource Utilization And Costs Associated With HIV-Positive Patients With Comorbidity Versus HIV-Negative Patients With Comorbidity","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada); Université de Montréal","funders":"","keywords":"Comorbidity; Medicine; Internal medicine; Human immunodeficiency virus (HIV); Intensive care medicine; Immunology","score_opus":0.04251783146444847,"score_gpt":0.32151836482720975,"score_spread":0.27900053336276126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765738011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906294,0.00026763137,0.00007553742,0.0032528196,0.000076439675,0.0034879942,0.0009437481,0.000079858095,0.0011865966],"genre_scores_gemma":[0.99526167,0.00014482722,0.00079452223,0.0005010822,0.000024655197,0.00008459716,0.0030768514,0.000060925246,0.000050896408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969323,0.00049189245,0.00054355577,0.0006835248,0.00067499955,0.0006737027],"domain_scores_gemma":[0.9966239,0.0003290433,0.0010333707,0.00076415116,0.0006616893,0.0005878479],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0003256415,0.00037087422,0.0007374219,0.00018650394,0.0014264456,0.00005665326,0.00014998323,0.00014186633,0.000007925995],"category_scores_gemma":[0.00023879608,0.0002766738,0.00002827434,0.0003325095,0.00028756497,0.00022233133,0.000066108354,0.00051792583,0.000011581816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029927748,0.0011785054,0.9859896,0.00019574595,0.00012554115,0.000010741691,0.00341265,0.00007818278,2.1412793e-8,0.000109807064,0.00048894016,0.0054175267],"study_design_scores_gemma":[0.024807373,0.00613936,0.9647102,0.0027194088,0.000069951726,0.0000023971118,0.00042190938,0.0004598625,0.0000029160399,0.000007211522,0.0004244778,0.00023494309],"about_ca_topic_score_codex":0.008773809,"about_ca_topic_score_gemma":0.00286116,"teacher_disagreement_score":0.021814598,"about_ca_system_score_codex":0.0024549242,"about_ca_system_score_gemma":0.0010324764,"threshold_uncertainty_score":0.9999685},"labels":[],"label_agreement":null},{"id":"W2765801098","doi":"10.1016/j.jval.2017.08.2858","title":"Treatment Patterns of Chronic Heart Failure (CHF) In Brazil","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Myocardial infarction; Disease; Blood pressure; Internal medicine; Cardiology; Vital signs; Emergency medicine; Surgery","score_opus":0.04395410500466229,"score_gpt":0.3473847502943221,"score_spread":0.3034306452896598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765801098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91872823,0.00051791524,0.000020125954,0.0788238,0.00014241181,0.0012568278,0.000010793787,0.000026183192,0.00047372357],"genre_scores_gemma":[0.9973222,0.000535469,0.00097265444,0.00025708906,0.00010383025,0.000059150432,0.00001595137,0.000017011529,0.00071665517],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998689,0.000082189435,0.00040717772,0.00026059936,0.00018139867,0.00037965883],"domain_scores_gemma":[0.99901843,0.00003794688,0.00013184568,0.0006610615,0.00001519729,0.00013549974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028257252,0.0001507013,0.00048472726,0.00018973683,0.000074639036,0.00001379979,0.00008667172,0.000061498584,0.00009338149],"category_scores_gemma":[0.000030381514,0.000121347904,0.00007852169,0.00006470829,0.000032610176,0.000074917705,0.000041795614,0.00010662403,0.0000405354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007101364,0.0010209817,0.97857124,0.00071419316,0.00004211494,0.00010201149,0.00065099203,0.0001434933,0.0000953495,0.00088960695,0.0016883385,0.016010698],"study_design_scores_gemma":[0.0081605455,0.0031884722,0.84522194,0.0012434892,0.000025969633,0.000021690428,0.00015675533,0.0012776764,0.00059630856,0.00009723686,0.13985838,0.00015151757],"about_ca_topic_score_codex":0.041376177,"about_ca_topic_score_gemma":0.008123695,"teacher_disagreement_score":0.13817005,"about_ca_system_score_codex":0.00086126744,"about_ca_system_score_gemma":0.00038477918,"threshold_uncertainty_score":0.96500736},"labels":[],"label_agreement":null},{"id":"W2765829869","doi":"10.1016/j.jval.2017.08.2373","title":"The Early Bird Catches The Worm: Measuring The Potential Value Of Mesenchymal Stem Cells Therapy For Septic Shock Using The Early Health Economic Evaluation","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; Ottawa Hospital","funders":"","keywords":"Medicine; Septic shock; Quality-adjusted life year; Cost–benefit analysis; Willingness to pay; Sepsis; Economic evaluation; Health care; Cost-effectiveness analysis; Intensive care medicine; Emergency medicine; Cost effectiveness; Surgery; Risk analysis (engineering); Pathology","score_opus":0.1269467254872112,"score_gpt":0.35639127866096726,"score_spread":0.22944455317375606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765829869","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94359493,0.003963787,0.00033847708,0.04524697,0.0013827028,0.005373661,0.000021058106,0.000036090398,0.000042299976],"genre_scores_gemma":[0.99700713,0.0009816563,0.00028882895,0.0007153428,0.00062643486,0.00016694589,0.0000018385448,0.00007856666,0.00013326116],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9955227,0.0013817301,0.0010594579,0.00042962626,0.0008140578,0.00079246156],"domain_scores_gemma":[0.99557287,0.0011642387,0.0011489893,0.0017697135,0.00019887493,0.00014529582],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.01142869,0.00028430647,0.0005144107,0.00008419499,0.0022161838,0.00022289202,0.0009848212,0.00010873315,0.000007230198],"category_scores_gemma":[0.00019906768,0.00013542376,0.00023630366,0.00012150049,0.00041672273,0.00018741295,0.00011235813,0.0005499422,0.00001154739],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003417292,0.0007152518,0.09292284,0.0018743923,0.0013203174,0.000008261004,0.12590249,0.28433144,0.006040469,0.004756122,0.0029315648,0.47577956],"study_design_scores_gemma":[0.007485213,0.0022472586,0.4519889,0.0015146895,0.00019417709,0.000070063674,0.006578863,0.5216986,0.003144415,0.0033374138,0.0012938693,0.00044651018],"about_ca_topic_score_codex":0.0512818,"about_ca_topic_score_gemma":0.0016920854,"teacher_disagreement_score":0.47533306,"about_ca_system_score_codex":0.0009071364,"about_ca_system_score_gemma":0.0024503588,"threshold_uncertainty_score":0.9990828},"labels":[],"label_agreement":null},{"id":"W2765869121","doi":"10.1016/j.jval.2017.08.1358","title":"Assessing the Burden of Chronic Heart Failure on Caregivers of Patients in Colombia","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Nursing care and research","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Spouse; Medicine; Caregiver burden; Demographics; Depression (economics); Caregiver stress; Heart failure; Medical prescription; Family medicine; Disease; Nursing; Internal medicine; Demography","score_opus":0.119511744836538,"score_gpt":0.49750044767202883,"score_spread":0.37798870283549085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765869121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800642,0.00015131362,9.4199913e-7,0.017029481,0.0006205288,0.0008821967,0.000014660803,0.000006135323,0.0012305276],"genre_scores_gemma":[0.9994933,0.00006105864,0.00005088844,0.00009604208,0.00012145011,0.000017501636,0.0000053316876,0.0000127496605,0.0001416626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973293,0.0011532586,0.0005029339,0.00017613814,0.00037165202,0.00046674823],"domain_scores_gemma":[0.99819183,0.00064698514,0.00040190562,0.0005561292,0.00013200432,0.00007115835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017330808,0.000080249076,0.00030744585,0.00015470343,0.0006006226,0.00001094682,0.00033798037,0.00013098914,0.00003377706],"category_scores_gemma":[0.0004174855,0.000057822046,0.000039915314,0.00014466635,0.00017334263,0.00009805843,0.00009366114,0.00073840073,0.000011206099],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001264153,0.00033998862,0.9060007,0.0029178476,0.000013694371,0.00000382832,0.03291383,0.0025549142,0.00017041946,0.00055999303,0.045432277,0.008966139],"study_design_scores_gemma":[0.002275626,0.00082345837,0.95771164,0.0063489056,0.000003296381,1.7235647e-7,0.01520753,0.001331863,0.00009426458,0.00022804462,0.015873356,0.000101852325],"about_ca_topic_score_codex":0.09073289,"about_ca_topic_score_gemma":0.002018745,"teacher_disagreement_score":0.08871414,"about_ca_system_score_codex":0.0007550117,"about_ca_system_score_gemma":0.0016824107,"threshold_uncertainty_score":0.915322},"labels":[],"label_agreement":null},{"id":"W2765882061","doi":"10.1016/j.jval.2017.08.2143","title":"Predicting EQ-5D Index Scores From Promis Profile 29 In The United Kingdom, France, And Germany","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"EQ-5D; Mean squared error; Statistics; Linear regression; Population; Index (typography); Medicine; Mathematics; Regression analysis; Psychological intervention; Demography; Econometrics; Health related quality of life; Computer science; Environmental health; Internal medicine; Psychiatry","score_opus":0.4971491260232522,"score_gpt":0.4171712345850391,"score_spread":0.0799778914382131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765882061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96388394,0.0013667921,0.00013126222,0.03148635,0.00045650112,0.0014476016,0.00024045748,0.000029940686,0.00095715345],"genre_scores_gemma":[0.9918062,0.00020382903,0.00078080554,0.0064826994,0.00038820674,0.00019790913,0.00003372413,0.00002882728,0.00007777755],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949602,0.00073461543,0.003034226,0.00059700024,0.00012367166,0.00055029587],"domain_scores_gemma":[0.99514115,0.0013072612,0.0025035576,0.0008775506,0.000027682448,0.0001427917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019150103,0.00018907126,0.0007910831,0.00047449532,0.0005583836,0.00022603724,0.0005701837,0.00015981907,0.00006753471],"category_scores_gemma":[0.0035843104,0.00019799829,0.00004540282,0.00021530589,0.00012636711,0.0004720088,0.00010012682,0.00047226917,0.00012872284],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011674487,0.00005902501,0.97631544,0.0003497364,0.000010358566,0.0000020880993,0.0051356885,0.0005222628,4.0234553e-7,0.016488036,0.00093146495,0.00017382122],"study_design_scores_gemma":[0.0010962075,0.000055202363,0.8799947,0.00045929037,0.0000012000016,0.0000023686657,0.00046637436,0.09766401,7.4453334e-7,0.010078972,0.01000107,0.00017986144],"about_ca_topic_score_codex":0.21221773,"about_ca_topic_score_gemma":0.0023746386,"teacher_disagreement_score":0.20984308,"about_ca_system_score_codex":0.000340568,"about_ca_system_score_gemma":0.00026568424,"threshold_uncertainty_score":0.8074136},"labels":[],"label_agreement":null},{"id":"W2765933349","doi":"10.1016/j.jval.2017.08.2847","title":"Assessing The Burden Of Chronic Heart Failure (Chf) On Patients In Brazil","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Depression (economics); Anxiety; Heart failure; Cohort; Physical therapy; Household income; Emergency medicine; Internal medicine; Psychiatry","score_opus":0.08690891637536316,"score_gpt":0.41364413340729894,"score_spread":0.32673521703193575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765933349","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95288545,0.00019343785,0.000014764183,0.044985663,0.00014198624,0.0003985667,0.00000121704,0.0000068863196,0.0013720513],"genre_scores_gemma":[0.9983092,0.00006714242,0.00018551137,0.001089281,0.0001314517,0.00001523837,0.0000037956736,0.0000062579234,0.00019210995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990265,0.00010017307,0.00029801377,0.00014415591,0.0002500328,0.00018112142],"domain_scores_gemma":[0.9990869,0.000076540506,0.0002154409,0.00052147516,0.000034094086,0.00006551481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053161173,0.00006124473,0.0001953007,0.00005659541,0.00010071697,0.000017852612,0.00016832455,0.000040237774,0.00008256956],"category_scores_gemma":[0.00028580351,0.000043025513,0.000022632634,0.00008159986,0.000068011446,0.00007788327,0.000024963743,0.00023795289,0.00008296991],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000489098,0.0005104202,0.93519324,0.0009485035,0.000009362968,0.0000052773753,0.0015488039,0.0010602686,0.00021796614,0.0010275979,0.019463584,0.03996605],"study_design_scores_gemma":[0.0014812319,0.0003767273,0.9756778,0.0026958985,0.0000020802845,0.0000019781035,0.00024850926,0.0060459254,0.00010634711,0.00024303244,0.013067847,0.000052645333],"about_ca_topic_score_codex":0.0057362025,"about_ca_topic_score_gemma":0.00005905459,"teacher_disagreement_score":0.045423783,"about_ca_system_score_codex":0.00016036593,"about_ca_system_score_gemma":0.0005386996,"threshold_uncertainty_score":0.867146},"labels":[],"label_agreement":null},{"id":"W2765943310","doi":"10.1016/j.jval.2017.08.1924","title":"Epidemiology of Multiple Sclerosis: Literature Review for Prevalence and Trend Over Time in 5 European Countries and Canada","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epidemiology; Demography; Observational study; Internal medicine","score_opus":0.13014247802225137,"score_gpt":0.3735685823921938,"score_spread":0.24342610436994244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765943310","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5923573,0.3924304,0.000001808303,0.0131433,0.000055327444,0.0015908252,0.00032991188,0.0000068402733,0.000084312436],"genre_scores_gemma":[0.55958396,0.43817517,0.000540536,0.0014701798,0.000043394597,0.000041563453,0.00001140345,0.000012249453,0.00012151676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982451,0.00047721018,0.0005208014,0.00028520546,0.0001376651,0.0003339974],"domain_scores_gemma":[0.99802464,0.0011952114,0.00025063418,0.0003338589,0.000058178786,0.00013746918],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029242213,0.000116954216,0.0006559501,0.00007139783,0.00011729022,0.000005426365,0.00010190518,0.00003484584,0.0000058380297],"category_scores_gemma":[0.0069016013,0.00009241545,0.00002289833,0.000051573734,0.00019861043,0.00006890399,0.00010168551,0.0001742641,2.9013563e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009704101,0.00002539722,0.9688321,0.023280421,0.0000129564205,0.000005634164,0.00030743174,0.0000038032492,0.000034613156,0.000034703116,0.0042497506,0.0031161807],"study_design_scores_gemma":[0.0014480214,0.00016202536,0.9631976,0.030985625,0.0000074381933,0.000004567387,0.000008575503,0.0011296329,0.000006309668,0.0000123270065,0.0029759647,0.00006193174],"about_ca_topic_score_codex":0.21389227,"about_ca_topic_score_gemma":0.1745003,"teacher_disagreement_score":0.04574478,"about_ca_system_score_codex":0.00011357752,"about_ca_system_score_gemma":0.00025632198,"threshold_uncertainty_score":0.84056294},"labels":[],"label_agreement":null},{"id":"W2765951590","doi":"10.1016/j.jval.2017.08.2856","title":"Treatment Patterns of Chronic Heart Failure (CHF) In Argentina","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Myocardial infarction; Internal medicine; Disease; Blood pressure; Cardiology","score_opus":0.05287494600055623,"score_gpt":0.337469004248144,"score_spread":0.28459405824758777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765951590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9503784,0.00049508247,0.000021417882,0.0473085,0.00015411276,0.0012407545,0.000009672924,0.000022881377,0.00036914457],"genre_scores_gemma":[0.99728525,0.00057232945,0.0010264533,0.00013915364,0.00010095623,0.00006315496,0.000018099301,0.00001629444,0.0007782946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99866873,0.00008006088,0.0004165271,0.0002621452,0.00017754556,0.00039498304],"domain_scores_gemma":[0.9990431,0.000028728282,0.00014408518,0.0006352552,0.000015651935,0.00013316586],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029147996,0.00014959299,0.00047147638,0.00018929118,0.00007452813,0.000012988911,0.00008360378,0.000056069166,0.00010479257],"category_scores_gemma":[0.000028613684,0.00012095169,0.00008502775,0.000064856926,0.000027908794,0.00006656962,0.00004243318,0.000099991375,0.000041587096],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005312729,0.0010329358,0.9867832,0.00067454897,0.000038423317,0.00009285312,0.00048288552,0.00009756026,0.000101134814,0.00085157,0.0010973597,0.008694366],"study_design_scores_gemma":[0.006756164,0.0025260996,0.84375197,0.0011267591,0.000027461456,0.000019409037,0.00015623149,0.0011997302,0.00073260156,0.000082551654,0.14347796,0.0001430657],"about_ca_topic_score_codex":0.029293519,"about_ca_topic_score_gemma":0.004750128,"teacher_disagreement_score":0.14303127,"about_ca_system_score_codex":0.0007462197,"about_ca_system_score_gemma":0.000316682,"threshold_uncertainty_score":0.9771705},"labels":[],"label_agreement":null},{"id":"W2765975035","doi":"10.1016/j.jval.2017.08.2015","title":"Conceptualization, Development, And Internal And External Validation of A ‘Whole Disease’ Model for Chronic Obstructive Pulmonary Disease","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"COPD; Exacerbation; Medicine; Population; Cohort; Tiotropium bromide; Disease; Internal medicine; Lung; Lung function; Environmental health","score_opus":0.05886674890457673,"score_gpt":0.35175803275238937,"score_spread":0.29289128384781266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2765975035","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98384184,0.0057899845,0.0077864346,0.0008809722,0.00007972917,0.0013321964,0.00020954746,0.000015900745,0.00006342696],"genre_scores_gemma":[0.9967375,0.00025681106,0.0021569624,0.00005581692,0.00011235645,0.0001226006,0.00009254263,0.00002928172,0.00043615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99834603,0.00008258142,0.00045556756,0.00044348623,0.00033075016,0.0003415796],"domain_scores_gemma":[0.9985132,0.00007025728,0.00029429345,0.00036452437,0.00015550417,0.0006021862],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034552612,0.00016720759,0.00030867656,0.00015870239,0.0002692055,0.000039464685,0.00014059804,0.000042412357,0.000013526959],"category_scores_gemma":[0.0003501626,0.0001672975,0.000046135523,0.00005657201,0.00037798347,0.00027711794,0.00015214832,0.00013086238,0.0000011756474],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019828947,0.00042278552,0.9166978,0.009103984,0.00006176543,0.00007670997,0.0021117418,0.0051551186,0.0004958593,0.006115848,0.00005243977,0.05772306],"study_design_scores_gemma":[0.0013779334,0.000041457486,0.6427785,0.000735558,0.000021687574,0.0000075891535,0.00008508672,0.35073477,0.00009817416,0.003894012,0.00012478727,0.00010044762],"about_ca_topic_score_codex":0.0002556758,"about_ca_topic_score_gemma":0.000010287649,"teacher_disagreement_score":0.34557965,"about_ca_system_score_codex":0.00054857583,"about_ca_system_score_gemma":0.0020533178,"threshold_uncertainty_score":0.6822194},"labels":[],"label_agreement":null},{"id":"W2766006797","doi":"10.1016/j.jval.2017.08.2708","title":"Ixekizumab Treatment Leads to Early Improvements in Health-Related Quality of Life Versus Ustekinumab","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Ixekizumab; Medicine; Dermatology Life Quality Index; Quality of life (healthcare); Ustekinumab; Internal medicine; Physical therapy; Placebo; Secukinumab; Disease","score_opus":0.10933141652726085,"score_gpt":0.34734586787121413,"score_spread":0.23801445134395327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766006797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914469,0.0036141996,0.0000030788399,0.0016600708,0.001823408,0.0010189929,0.00012800946,0.00003040709,0.00027494458],"genre_scores_gemma":[0.998357,0.00045123926,0.00011146384,0.000121087294,0.000027052325,0.00008765528,0.00006340178,0.000020629714,0.0007604742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965167,0.00097106287,0.0012848928,0.00046631065,0.00007420195,0.0006868072],"domain_scores_gemma":[0.99805367,0.00023526812,0.0007627474,0.000790398,0.000042709773,0.00011519188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012112132,0.0002572173,0.0008831322,0.00025096862,0.0002859965,0.000014684129,0.00031875,0.00023449372,0.00006992167],"category_scores_gemma":[0.00030418969,0.00023456744,0.00011700071,0.00015862386,0.000086646294,0.000095160416,0.00008132909,0.00016830696,0.00017849822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012510268,0.0031994376,0.6486599,0.0005693977,0.00066847145,0.000027514254,0.012637208,0.00060327386,0.004017594,0.0024913226,0.0004478128,0.3141678],"study_design_scores_gemma":[0.023604726,0.0050737993,0.9670475,0.00025832411,0.000016091566,0.0000021998903,0.0002909446,0.000013133974,0.0021064763,0.00013411474,0.0011740779,0.00027859403],"about_ca_topic_score_codex":0.17275846,"about_ca_topic_score_gemma":0.0052164104,"teacher_disagreement_score":0.31838763,"about_ca_system_score_codex":0.00086833927,"about_ca_system_score_gemma":0.0007199879,"threshold_uncertainty_score":0.95653826},"labels":[],"label_agreement":null},{"id":"W2766053761","doi":"10.1016/j.jval.2017.08.2265","title":"Vaccines for Herpes Zoster: A Systematic Review of Randomized Controlled Trials In Adults ≥50 Years of Age","year":2017,"lang":"en","type":"review","venue":"Value in Health","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Randomized controlled trial; Pediatrics; Internal medicine","score_opus":0.1616777751833053,"score_gpt":0.45811497600048945,"score_spread":0.29643720081718417,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766053761","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000029278594,0.9461533,0.000011303732,0.0000745434,0.00027047526,0.053233847,0.000106661995,0.000010484422,0.00011010041],"genre_scores_gemma":[0.000096815755,0.992253,0.0003092678,0.00006259891,0.00006879526,0.0069403807,0.00006831317,0.000043419517,0.00015739643],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98302233,0.0070085605,0.009096028,0.00031816246,0.0002792139,0.00027570812],"domain_scores_gemma":[0.9785617,0.012389413,0.008038083,0.0007744919,0.00013574962,0.00010058003],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.031335425,0.00037535382,0.04652709,0.00068069686,0.00002610647,0.000008800942,0.00015968047,0.00023860333,0.000020528672],"category_scores_gemma":[0.03919551,0.00021870779,0.0036918418,0.00022184411,0.000041210802,0.000030480205,0.000023310708,0.00016759198,0.0000054893594],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006225835,0.00028071474,0.0000016002691,0.8440696,0.0010567111,0.000012660382,0.000059023536,2.486063e-7,3.1717162e-9,0.000052957195,0.000030427062,0.14821024],"study_design_scores_gemma":[0.18346193,0.00018161636,0.000001169233,0.7850494,0.005168093,0.000014160754,0.0000047368003,0.000012064666,5.110073e-8,0.000032495296,0.025984962,0.00008932325],"about_ca_topic_score_codex":0.002602652,"about_ca_topic_score_gemma":0.000059182134,"teacher_disagreement_score":0.1772361,"about_ca_system_score_codex":0.00023910662,"about_ca_system_score_gemma":0.0011197935,"threshold_uncertainty_score":0.99744403},"labels":[],"label_agreement":null},{"id":"W2766088226","doi":"10.1016/j.jval.2017.08.1362","title":"Assessing the Burden of Chronic Heart Failure on Patients in Colombia","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Spouse; Anxiety; Depression (economics); Heart failure; Chronic pain; Body mass index; Physical therapy; Demography; Internal medicine; Psychiatry","score_opus":0.04908035033122704,"score_gpt":0.36159973473367746,"score_spread":0.3125193844024504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766088226","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92373854,0.00008802869,0.0000019114432,0.07440541,0.0001340663,0.0009330474,0.0000014649335,0.000010343488,0.0006871714],"genre_scores_gemma":[0.99889654,0.000044371063,0.00042728754,0.00033488052,0.000096734606,0.000022939339,0.0000066754146,0.000010414887,0.00016015883],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989167,0.00012946929,0.0002988299,0.0001678935,0.0002262808,0.0002608119],"domain_scores_gemma":[0.9992202,0.00008116608,0.00014026712,0.00047370704,0.000022482067,0.00006216034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062141835,0.00008999077,0.00026923657,0.00009882987,0.00012938112,0.00003038041,0.000100682875,0.00004458371,0.000024401748],"category_scores_gemma":[0.00011883778,0.00006151016,0.00003790952,0.00007705813,0.000050689363,0.00008602647,0.000046101897,0.00017375885,0.000021443115],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010176977,0.0013473042,0.91835433,0.0010037711,0.00004569758,0.000031523436,0.0024458312,0.0018386724,0.000085870066,0.00089505315,0.046790037,0.027060125],"study_design_scores_gemma":[0.0035459776,0.0013004403,0.9042325,0.0015649813,0.000011582504,0.0000012856858,0.00031678256,0.0026530032,0.00009142799,0.000070084636,0.08613324,0.000078694604],"about_ca_topic_score_codex":0.017063556,"about_ca_topic_score_gemma":0.0005188479,"teacher_disagreement_score":0.075157985,"about_ca_system_score_codex":0.00039707738,"about_ca_system_score_gemma":0.00026036732,"threshold_uncertainty_score":0.9894819},"labels":[],"label_agreement":null},{"id":"W2766091521","doi":"10.1016/j.jval.2017.08.1030","title":"A Critical Quality Appraisal Of Studies Estimating The Cost Of Radiotherapy","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiation Dose and Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Critical appraisal; Activity-based costing; Concordance; Medicine; Statistics; MEDLINE; Coefficient of variation; Quality (philosophy); Medical physics; Actuarial science; Mathematics; Accounting; Alternative medicine; Pathology; Business","score_opus":0.21329798082026463,"score_gpt":0.5412433320517112,"score_spread":0.3279453512314465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766091521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94434345,0.0074002095,0.0030696657,0.04366949,0.0005313443,0.00046571245,0.00000621857,0.000013285284,0.00050063635],"genre_scores_gemma":[0.991377,0.00024615173,0.0077849617,0.00044219365,0.00012645595,0.000007121463,5.353187e-7,0.000005754152,0.0000098160135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989968,0.00017100475,0.00044435394,0.000089728215,0.00016955093,0.00012853938],"domain_scores_gemma":[0.9982424,0.0010587635,0.0002533078,0.00033890232,0.00006538875,0.000041281175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017415019,0.000049125465,0.00031336583,0.00003793213,0.00011673808,0.000007781965,0.000091541195,0.00001734714,0.000006641389],"category_scores_gemma":[0.005749402,0.00003314402,0.000036966503,0.00004444664,0.000244954,0.00006664345,0.000016799127,0.00010912047,5.684635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029519017,0.0005647607,0.7444919,0.0071269306,0.00019917154,0.0000092517985,0.03270934,0.0047116005,0.00150736,0.03733931,0.0018077061,0.16923748],"study_design_scores_gemma":[0.0025855703,0.00040671043,0.8077298,0.0020411655,0.000021363732,0.00001976843,0.002472227,0.18140694,0.0010186927,0.0012078268,0.0009819533,0.0001079926],"about_ca_topic_score_codex":0.0021359066,"about_ca_topic_score_gemma":0.000009250822,"teacher_disagreement_score":0.17669535,"about_ca_system_score_codex":0.000047144043,"about_ca_system_score_gemma":0.00017939482,"threshold_uncertainty_score":0.68829864},"labels":[],"label_agreement":null},{"id":"W2766091900","doi":"10.1016/j.jval.2017.08.2857","title":"Treatment Patterns of Chronic Heart Failure (CHF) In Mexico","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Heart failure; Ejection fraction; Myocardial infarction; Internal medicine; Disease; Blood pressure; Cardiology; Emergency medicine","score_opus":0.049971201523338754,"score_gpt":0.33920951256411314,"score_spread":0.28923831104077435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766091900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91492057,0.00057578227,0.00002956739,0.08236216,0.00015560412,0.0014152881,0.000011765886,0.000028258439,0.0005010003],"genre_scores_gemma":[0.9974064,0.000536743,0.0010785204,0.00021946951,0.00008926319,0.00006576467,0.000016060307,0.000016882,0.00057086145],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986763,0.000086196465,0.00041088494,0.0002606332,0.00018449071,0.00038147424],"domain_scores_gemma":[0.99901026,0.00003726669,0.00013366627,0.00066642044,0.000015104553,0.000137265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029441636,0.0001521506,0.00049346255,0.00019244227,0.00007128204,0.000012787556,0.000087003056,0.00006188891,0.00008579678],"category_scores_gemma":[0.000030236164,0.00012149651,0.000079457895,0.00006397248,0.000031290772,0.00007090846,0.000041631716,0.000106146086,0.00003693911],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000058283236,0.0008932826,0.98556304,0.0005345768,0.00003851652,0.00008439858,0.0005964791,0.00017124403,0.00006646568,0.0008748601,0.0011080388,0.010010822],"study_design_scores_gemma":[0.00869023,0.003690361,0.8405386,0.0014165044,0.000030768922,0.000023173676,0.00021647563,0.0019317735,0.001044028,0.00012316628,0.14212269,0.00017220045],"about_ca_topic_score_codex":0.032654185,"about_ca_topic_score_gemma":0.006733921,"teacher_disagreement_score":0.1450244,"about_ca_system_score_codex":0.0008985439,"about_ca_system_score_gemma":0.00036316196,"threshold_uncertainty_score":0.9737874},"labels":[],"label_agreement":null},{"id":"W2766123849","doi":"10.1016/j.jval.2017.08.2416","title":"Patient Characteristics and Disease Burden of Psoriasis In Mexico: A Real-World Physician and Patient Survey","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Psoriasis; Dermatology Life Quality Index; Psoriatic arthritis; Body surface area; Medical prescription; Quality of life (healthcare); Disease burden; Concomitant; Body mass index; Disease; Internal medicine; Dermatology","score_opus":0.03611941783254451,"score_gpt":0.28237981687616465,"score_spread":0.24626039904362013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766123849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963055,0.002025796,6.651807e-7,0.0004051603,0.00037331582,0.00035871894,0.0004241519,0.000008255708,0.0000984346],"genre_scores_gemma":[0.99787605,0.0018127396,0.000031021187,0.000091238515,0.000016421101,0.000025577367,0.00009878733,0.000011556215,0.00003660452],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984608,0.0005294547,0.00041908977,0.00027537538,0.000037750873,0.00027750977],"domain_scores_gemma":[0.99899834,0.00019295451,0.00035905832,0.00034759866,0.000028639619,0.00007343274],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003319577,0.00015009231,0.00040309588,0.00014371032,0.00015551945,0.000013975531,0.00008599974,0.000069217764,0.0000070534043],"category_scores_gemma":[0.00017696191,0.00013689781,0.00002841832,0.000072988296,0.00012544957,0.000060779614,0.00008825684,0.000100079145,0.000004778416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000494226,0.00024074566,0.85011053,0.00010811676,0.000038761915,0.000014711952,0.0026727912,0.000011048427,0.00024203923,0.0002733979,0.00007475058,0.14571886],"study_design_scores_gemma":[0.0010966683,0.0002482835,0.9972057,0.0002166648,0.000014198646,0.0000010727589,0.00010557692,0.000048227474,0.0002694327,0.00019612628,0.0004826617,0.00011541004],"about_ca_topic_score_codex":0.034340315,"about_ca_topic_score_gemma":0.0016034327,"teacher_disagreement_score":0.14709513,"about_ca_system_score_codex":0.00006302142,"about_ca_system_score_gemma":0.00012829396,"threshold_uncertainty_score":0.9720901},"labels":[],"label_agreement":null},{"id":"W2766129054","doi":"10.1016/j.jval.2017.08.2845","title":"Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Mexico","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Spouse; Medicine; Caregiver burden; Anxiety; Heart failure; Rehabilitation; Family medicine; Disease; Gerontology; Physical therapy; Psychiatry; Internal medicine","score_opus":0.04604751906998376,"score_gpt":0.34404556662153285,"score_spread":0.2979980475515491,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766129054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90165716,0.00017482559,0.000006387804,0.09569299,0.0001850432,0.0010058545,0.0000024872008,0.000015484839,0.0012597688],"genre_scores_gemma":[0.99895513,0.000059824695,0.0003969977,0.00029695028,0.00010821247,0.000019379377,0.000008628967,0.0000126071645,0.00014224804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987924,0.00013827666,0.00029348859,0.00020478443,0.00027250528,0.00029853827],"domain_scores_gemma":[0.9990939,0.000081367536,0.00015301823,0.0005663272,0.000028262953,0.00007712559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005323922,0.00011244054,0.00029870003,0.00013612764,0.00014862449,0.00003122368,0.0001256185,0.00005065434,0.000027106049],"category_scores_gemma":[0.00010464352,0.000077418656,0.000053801075,0.000090002686,0.000066850895,0.000113292845,0.0000529433,0.0002001275,0.000018398998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012752785,0.0010410725,0.9230413,0.0012795563,0.00008158682,0.000055815595,0.0079722665,0.006220524,0.00007416925,0.0019807797,0.031793352,0.026332092],"study_design_scores_gemma":[0.008426996,0.002314913,0.7954389,0.0036289808,0.000037419686,0.000003536504,0.0031626062,0.0056827785,0.00026673093,0.00016111707,0.18065318,0.00022288348],"about_ca_topic_score_codex":0.017720055,"about_ca_topic_score_gemma":0.00048576336,"teacher_disagreement_score":0.14885983,"about_ca_system_score_codex":0.00056612346,"about_ca_system_score_gemma":0.00030667614,"threshold_uncertainty_score":0.988821},"labels":[],"label_agreement":null},{"id":"W2766143852","doi":"10.1016/j.jval.2017.08.717","title":"Very Low Compliance for Vulvovaginal Atrophy (VVA) Treatment: A Retrospective U.S. Healthcare Claims Database Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Menopause: Health Impacts and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada); Statistics Canada","funders":"","keywords":"Discontinuation; Medicine; Genitourinary system; Internal medicine; Vagina; Menopause; Gynecology; Surgery","score_opus":0.1540388719938162,"score_gpt":0.42050147547177463,"score_spread":0.26646260347795847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766143852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95130175,0.006417356,0.0008087064,0.03294613,0.0007332725,0.0051361374,0.0021270243,0.000116991396,0.00041263306],"genre_scores_gemma":[0.9898736,0.0020604045,0.0050646956,0.0015395408,0.0003185291,0.0002357735,0.0004991241,0.00004992789,0.0003584079],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968095,0.00017165134,0.0007428069,0.0008142325,0.000401364,0.0010604664],"domain_scores_gemma":[0.9965373,0.00013855782,0.00063528615,0.0016300583,0.00015328995,0.0009054562],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006552438,0.0003680162,0.0012683481,0.0004086745,0.00093561166,0.000072093455,0.00020891374,0.0001194847,0.00004106611],"category_scores_gemma":[0.0001781098,0.00030444196,0.00009069973,0.00040951796,0.00011744251,0.00022005546,0.00004628317,0.00027343034,0.000035579887],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051447246,0.002703213,0.9542016,0.006250884,0.0020292124,0.0005638606,0.0016354006,0.0003381841,0.00016270882,0.003464629,0.0010497456,0.022455854],"study_design_scores_gemma":[0.020439489,0.02012608,0.9389951,0.0019411953,0.00087318366,0.000060684364,0.00009155525,0.012019995,0.00010206637,0.0015178301,0.0034000191,0.0004327573],"about_ca_topic_score_codex":0.043140676,"about_ca_topic_score_gemma":0.002005632,"teacher_disagreement_score":0.041135043,"about_ca_system_score_codex":0.0025746145,"about_ca_system_score_gemma":0.001262402,"threshold_uncertainty_score":0.99994075},"labels":[],"label_agreement":null},{"id":"W2766144097","doi":"10.1016/j.jval.2017.08.852","title":"A Budget Impact Model of The Addition of Telotristat Ethyl Treatment In Patients With Uncontrolled Carcinoid Syndrome","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Hospital","funders":"","keywords":"Discontinuation; Carcinoid syndrome; Medicine; Diarrhea; Neuroendocrine tumors; Orphan drug; Incidence (geometry); Internal medicine; Pediatrics","score_opus":0.03307720752923835,"score_gpt":0.3404542266968829,"score_spread":0.30737701916764454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766144097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969064,0.000108223016,0.0000031511863,0.00090402854,0.000026323693,0.0017853489,0.00018431793,0.0000052726323,0.00007694729],"genre_scores_gemma":[0.9995329,0.000075085656,0.00019756707,0.00003184663,0.0000060038437,0.000056010547,0.000012421662,0.000016144899,0.00007204065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984647,0.00018621008,0.0003992556,0.00018856788,0.00043538553,0.0003259067],"domain_scores_gemma":[0.9987033,0.00011382754,0.00036662712,0.0006153743,0.00008440812,0.00011646281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020441067,0.00012573753,0.00052699284,0.00016927514,0.00005898503,0.000005176993,0.00014980153,0.000009027828,0.000008737919],"category_scores_gemma":[0.00031374404,0.00006897553,0.00007039636,0.0001310182,0.00011493401,0.000087522756,0.00003699998,0.0001680742,7.2669224e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025849096,0.0009082788,0.9750972,0.00034932457,0.000026987238,0.00009262576,0.0002485447,0.019745953,0.00011918088,0.000026906153,0.00003141772,0.0007687216],"study_design_scores_gemma":[0.0138747115,0.005570925,0.96951526,0.000513482,0.000011447055,0.000026130618,0.000034173405,0.009560774,0.000554174,0.00027620338,0.0000058901783,0.000056854646],"about_ca_topic_score_codex":0.016824337,"about_ca_topic_score_gemma":0.00063739694,"teacher_disagreement_score":0.01618694,"about_ca_system_score_codex":0.0005207952,"about_ca_system_score_gemma":0.0008410259,"threshold_uncertainty_score":0.9897227},"labels":[],"label_agreement":null},{"id":"W2766150197","doi":"10.1016/j.jval.2017.08.1170","title":"Optimal Usage of Sacubitril/Valsartan For Heart Failure Treatment In Canada Potentially Reduces Mortality, Hospitalizations And Early Discharge Re-Admissions","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Western University; Novartis (Canada)","funders":"","keywords":"Sacubitril, Valsartan; Valsartan; Sacubitril; Medicine; Enalapril; Heart failure; Ejection fraction; Number needed to treat; Internal medicine; Population; Cardiology; Emergency medicine; Angiotensin-converting enzyme; Relative risk; Confidence interval; Blood pressure","score_opus":0.04549424147602688,"score_gpt":0.334384230025348,"score_spread":0.28888998854932113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766150197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96211535,0.00046378834,0.000063527135,0.0350025,0.000116085816,0.0020678882,0.00008145439,0.000011747555,0.000077663026],"genre_scores_gemma":[0.9906245,0.00023886003,0.008445829,0.00011541002,0.000045905323,0.00013159927,0.000037702324,0.000019614394,0.000340593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849397,0.00007694699,0.0005165769,0.00031350198,0.0002245025,0.0003745024],"domain_scores_gemma":[0.99895555,0.00006413249,0.00018703094,0.00042770046,0.000039235387,0.00032637574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003391174,0.00017203737,0.0006397431,0.00013915422,0.00022279823,0.000030869298,0.000084044405,0.00004997546,0.000026666672],"category_scores_gemma":[0.00014149841,0.00014100027,0.00006511258,0.00009397935,0.000043261083,0.000118897566,0.000046551322,0.00007220472,5.7388434e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094207055,0.0006614328,0.989181,0.0004709658,0.00011813972,0.000043864256,0.0011427503,0.00047225424,0.000357685,0.0012022245,0.0048817336,0.0013737341],"study_design_scores_gemma":[0.004255913,0.0014882745,0.9753171,0.00083224004,0.00012203417,0.0000060792618,0.00079135,0.0015562269,0.0010158987,0.00015853374,0.014229915,0.00022643233],"about_ca_topic_score_codex":0.8800167,"about_ca_topic_score_gemma":0.6604758,"teacher_disagreement_score":0.21954085,"about_ca_system_score_codex":0.00050997885,"about_ca_system_score_gemma":0.0022302077,"threshold_uncertainty_score":0.5749824},"labels":[],"label_agreement":null},{"id":"W2766152205","doi":"10.1016/j.jval.2017.08.1171","title":"Preliminary Results of Restarting Oral Anticoagulant Treatment In Patients with Non-Valvular Atrial Fibrillation Following Intracranial Hemorrhage: A Population-Based Cohort Study","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Université de Montréal","funders":"","keywords":"Medicine; Atrial fibrillation; Stroke (engine); Cohort; Internal medicine; Intracerebral hemorrhage; Population; Cardiology; Cohort study; Oral anticoagulant; Warfarin; Subarachnoid hemorrhage","score_opus":0.049837315282472594,"score_gpt":0.34869094795167527,"score_spread":0.2988536326692027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766152205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947081,0.000023525874,0.000038516504,0.00068872503,0.0002770298,0.0042076395,0.000008964283,0.000023045157,0.000024441255],"genre_scores_gemma":[0.99714494,0.0000037165464,0.002365273,0.000012988162,0.00027901886,0.000003861157,0.00014268134,0.000022869885,0.000024648813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976038,0.00022466843,0.0010136629,0.00036355222,0.00051240815,0.00028191655],"domain_scores_gemma":[0.99847305,0.00018829314,0.0006929454,0.0005121546,0.000051680505,0.00008187134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012768782,0.00018476516,0.00069511385,0.00028499495,0.0001872721,0.00003103429,0.00007305215,0.00006275522,0.000002841506],"category_scores_gemma":[0.0005739186,0.00015008499,0.0001348995,0.00019186849,0.000017920613,0.00016766875,0.000031979536,0.00008732818,0.000001527422],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0075877444,0.000086444816,0.9463561,0.000114547576,0.0000524098,0.0000558085,0.00038747568,0.039815202,0.0000016127842,0.000002484631,0.0000012475788,0.005538888],"study_design_scores_gemma":[0.02277867,0.0037083083,0.90894204,0.00028921766,0.00011017528,4.4563004e-7,0.000075284115,0.06396369,0.000005225023,0.000008995425,0.000005271601,0.00011264554],"about_ca_topic_score_codex":0.027347643,"about_ca_topic_score_gemma":0.0004465914,"teacher_disagreement_score":0.037414063,"about_ca_system_score_codex":0.00039116348,"about_ca_system_score_gemma":0.00022736812,"threshold_uncertainty_score":0.9791293},"labels":[],"label_agreement":null},{"id":"W2766154081","doi":"10.1016/j.jval.2017.08.2992","title":"Long-Term work Productivity improvement from Phase 3 Baricitinib Ra-Beam Study: Latin American Subgroup Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Quality and Safety in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"","keywords":"Medicine; Work productivity; Placebo; Presenteeism; Rheumatoid arthritis; Methotrexate; Subgroup analysis; Internal medicine; Adalimumab; Randomized controlled trial; Productivity; Physical therapy; Confidence interval","score_opus":0.17553996103029543,"score_gpt":0.49089193898083794,"score_spread":0.3153519779505425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766154081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97925824,0.00024690237,0.00034874096,0.013738005,0.0012140222,0.0045176083,0.000381511,0.00014617237,0.0001487745],"genre_scores_gemma":[0.9957094,0.0001912064,0.00039534975,0.001641231,0.00092120044,0.00054260204,0.0002130775,0.000052207735,0.0003337025],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9902076,0.0040260353,0.002214764,0.001262626,0.00078557146,0.001503409],"domain_scores_gemma":[0.9925928,0.00150468,0.0022862765,0.002802209,0.00020857913,0.0006054227],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.006805649,0.0004206052,0.0015561245,0.0004102773,0.0033263161,0.00006516634,0.00076841994,0.00020500169,0.0002998805],"category_scores_gemma":[0.0012097367,0.00040379682,0.00021768938,0.0012144382,0.0002570991,0.0002641226,0.00039500545,0.0017876269,0.000119308876],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048489377,0.0017906443,0.9402708,0.00045903653,0.00023786387,0.000025326259,0.019288626,0.00017612125,0.000013973235,0.0001122951,0.00010642759,0.037034012],"study_design_scores_gemma":[0.0029432746,0.0010289071,0.98847085,0.00038051908,0.00012454059,9.687916e-8,0.0056260317,0.0004045442,0.00000963129,0.00035472194,0.00030718461,0.00034971623],"about_ca_topic_score_codex":0.3228382,"about_ca_topic_score_gemma":0.050017353,"teacher_disagreement_score":0.27282083,"about_ca_system_score_codex":0.0011117695,"about_ca_system_score_gemma":0.0011878449,"threshold_uncertainty_score":0.9998414},"labels":[],"label_agreement":null},{"id":"W2766166596","doi":"10.1016/j.jval.2017.12.019","title":"Economic Burden of Cardiovascular Disease in Type 2 Diabetes: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":314,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Type 2 Diabetes Mellitus; Indirect costs; Disease burden; Population; Coronary artery disease; MEDLINE; Type 2 diabetes; Disease; Intensive care medicine; Diabetes mellitus; Emergency medicine; Comorbidity; Environmental health; Internal medicine","score_opus":0.06739378503097723,"score_gpt":0.33144060148306953,"score_spread":0.26404681645209227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766166596","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003806782,0.9910074,3.095551e-7,0.00009081877,0.00024515035,0.008400212,0.000022022574,0.000019278265,0.00017677965],"genre_scores_gemma":[0.000024641511,0.99877024,0.00004902742,0.000111661284,0.00011501315,0.00057305815,0.00013543917,0.000051575567,0.00016934257],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9965743,0.00068469794,0.0016600009,0.00045077383,0.00024715785,0.00038305882],"domain_scores_gemma":[0.9978979,0.00013676724,0.0005262232,0.0012081305,0.00002766849,0.00020329743],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002144309,0.00034136052,0.005701586,0.00041069055,0.000012273545,0.0000064202864,0.00019234426,0.00008646247,0.000031896237],"category_scores_gemma":[0.00023023313,0.000256354,0.00085495185,0.00038229334,0.000034644858,0.00003201108,0.00007391327,0.00015553256,0.00024115296],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002221874,0.00006566185,0.000027122487,0.9756233,0.0010849629,0.000020861953,0.000025002542,0.000054236956,1.7709505e-10,0.000045452758,0.00035305627,0.022698106],"study_design_scores_gemma":[0.000244705,0.00014294763,0.0000034163304,0.7087605,0.0051652393,6.582615e-7,0.0000030589517,0.00010701739,4.695427e-9,0.000010856427,0.28544548,0.000116109455],"about_ca_topic_score_codex":0.0008961181,"about_ca_topic_score_gemma":0.000004092767,"teacher_disagreement_score":0.2850924,"about_ca_system_score_codex":0.0010385294,"about_ca_system_score_gemma":0.0009420442,"threshold_uncertainty_score":0.99998885},"labels":[],"label_agreement":null},{"id":"W2766182174","doi":"10.1016/j.jval.2017.08.2594","title":"Supporting Individual Reflection and Patient-Clinician Shared Decision-Making on GEP-NET Management Options Using Reflective Multi-Criteria Decision Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Decision quality; Lanreotide; Watchful waiting; Population; Actuarial science; Family medicine; Psychology; Nursing; Patient satisfaction; Internal medicine; Business","score_opus":0.1712701435847904,"score_gpt":0.5248776480838744,"score_spread":0.35360750449908396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766182174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955692,0.0004162513,0.0018650887,0.00043017702,0.00054201006,0.00081819255,0.0000463851,0.000030356163,0.0002823089],"genre_scores_gemma":[0.9465986,0.0003833712,0.052107777,0.0007029424,0.000091654794,0.000031036023,0.00003659521,0.000019454965,0.000028566978],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99797523,0.00017233577,0.00067199866,0.0005136386,0.00028450842,0.00038228257],"domain_scores_gemma":[0.9985543,0.00031494992,0.00053572556,0.00038734634,0.000058985843,0.00014872682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079893385,0.00017414233,0.00045490172,0.00078930135,0.00065332116,0.00009219893,0.000099834186,0.00009474558,0.0001231019],"category_scores_gemma":[0.00022631368,0.00016467659,0.00010263165,0.0003869269,0.00004443451,0.00014649674,0.00012236382,0.00023120348,0.0000064567716],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036541088,0.0017084519,0.33348462,0.0002348816,0.0014668187,0.00034700404,0.008225986,0.010741409,0.0002835815,0.000101985504,0.0009888497,0.6387623],"study_design_scores_gemma":[0.0049942113,0.0016193459,0.90613127,0.0015627274,0.00092384464,0.000028468228,0.0006747501,0.08207425,0.000053304393,0.00094517064,0.0007467855,0.0002458534],"about_ca_topic_score_codex":0.0013557589,"about_ca_topic_score_gemma":0.0007228177,"teacher_disagreement_score":0.6385164,"about_ca_system_score_codex":0.0006329984,"about_ca_system_score_gemma":0.00011131145,"threshold_uncertainty_score":0.6715317},"labels":[],"label_agreement":null},{"id":"W2766207394","doi":"10.1016/j.jval.2017.08.1628","title":"Evaluating The Cost-Utility Of Immunosuppressive Regimens In Liver Transplant Recipients In Canada","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal Transplantation Outcomes and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tacrolimus; Medicine; Immunosuppression; Liver transplantation; Quality-adjusted life year; Cost effectiveness; Regimen; Transplantation; Internal medicine","score_opus":0.15095178776877424,"score_gpt":0.40144201143883523,"score_spread":0.250490223670061,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766207394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967952,0.00052122585,0.0000035596079,0.0011814529,0.00015670211,0.00089175144,0.00006197238,0.00000207372,0.00038609497],"genre_scores_gemma":[0.99876314,0.00081362476,0.00016052656,0.00015517962,0.000007716328,0.000031049185,0.000019097628,0.0000067725177,0.00004287971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984841,0.00026234036,0.0005138983,0.00017961478,0.00030694154,0.00025311983],"domain_scores_gemma":[0.9990092,0.00027028428,0.00023598048,0.00039259926,0.000029001052,0.000062922554],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007800584,0.00009603113,0.00031552443,0.000064884734,0.00008066065,0.0000056136278,0.00013794628,0.000032163804,0.000028209648],"category_scores_gemma":[0.0000930058,0.00006583914,0.000032992717,0.00007990497,0.000039008613,0.000049832433,0.000010975515,0.0002124345,0.000001245015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003595794,0.00009859252,0.99191993,0.00026576145,0.000015618873,0.00013002373,0.0019526563,0.00070176483,0.000023197208,0.000028416118,0.00000564722,0.0044988324],"study_design_scores_gemma":[0.0032229936,0.00013771017,0.98276114,0.0023519539,0.0000115161,0.000014961555,0.00013178757,0.011089733,0.00018787991,0.00003504264,0.0000107653495,0.00004451511],"about_ca_topic_score_codex":0.97078264,"about_ca_topic_score_gemma":0.7602767,"teacher_disagreement_score":0.21050596,"about_ca_system_score_codex":0.000462725,"about_ca_system_score_gemma":0.0013660264,"threshold_uncertainty_score":0.2684842},"labels":[],"label_agreement":null},{"id":"W2766277025","doi":"10.1016/j.jval.2017.08.1386","title":"Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Costa Rica","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Sacubitril; Valsartan; Sacubitril, Valsartan; Medicine; Enalapril; Heart failure; Ejection fraction; Internal medicine; Cardiology; Population; Blood pressure; Angiotensin-converting enzyme","score_opus":0.05966566235948348,"score_gpt":0.3549479626983868,"score_spread":0.29528230033890335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766277025","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9745987,0.00083511934,0.00020900335,0.021116301,0.000099050616,0.003076891,0.00002061457,0.000010416213,0.00003392494],"genre_scores_gemma":[0.9925747,0.0014240141,0.0056023495,0.000060432805,0.00008126447,0.00014749165,0.000016075728,0.00001456732,0.00007913349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987856,0.000097313656,0.00040530832,0.00022966982,0.00022576249,0.00025632986],"domain_scores_gemma":[0.9989918,0.000063476175,0.00024152145,0.00058527524,0.000049436316,0.00006853057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055272045,0.00013929019,0.0005717423,0.000104077546,0.00012418011,0.000011988411,0.00007953695,0.000049485316,0.000012093771],"category_scores_gemma":[0.000016524085,0.00008190926,0.0000949783,0.00009916294,0.00011500157,0.00006685886,0.00001040971,0.00006485065,7.415381e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011221518,0.01357702,0.8658293,0.0014772149,0.0012329916,0.00007069666,0.008162969,0.014745778,0.0058563864,0.0017811517,0.006695987,0.06934898],"study_design_scores_gemma":[0.018790608,0.01442248,0.9140503,0.00052256935,0.00019711677,0.000021486208,0.0012271337,0.0046312497,0.006905238,0.00014849329,0.0388762,0.00020712063],"about_ca_topic_score_codex":0.010189891,"about_ca_topic_score_gemma":0.00037006565,"teacher_disagreement_score":0.06914186,"about_ca_system_score_codex":0.00019320806,"about_ca_system_score_gemma":0.0002345407,"threshold_uncertainty_score":0.99640137},"labels":[],"label_agreement":null},{"id":"W2766296243","doi":"10.1016/j.jval.2017.08.2676","title":"Characteristics of Latin American Patients With Rheumatoid Arthritis Receiving Advanced Therapy","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Rheumatoid arthritis; Internal medicine; Demographics; Morning stiffness; Physical therapy; Demography; Psoriatic arthritis","score_opus":0.025266128976147648,"score_gpt":0.2989488968504094,"score_spread":0.2736827678742617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766296243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960755,0.0020286757,0.000021364212,0.0009960885,0.0000739247,0.00057494093,0.000030185134,0.000023533003,0.00017577171],"genre_scores_gemma":[0.8645419,0.13368103,0.0015775239,0.00009826997,0.000016077369,0.000021149222,0.000023097546,0.000025460118,0.000015493708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998464,0.000110196874,0.00045058964,0.00021564818,0.00036986495,0.00038968705],"domain_scores_gemma":[0.9985536,0.00009700265,0.0005073497,0.00052473653,0.00013186382,0.00018546135],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035851455,0.0001307941,0.00055408425,0.000119454,0.00020123096,0.000031526313,0.00014444198,0.000026423259,0.00002961939],"category_scores_gemma":[0.000349716,0.00010651411,0.00003821915,0.00010333044,0.00029068487,0.00012814425,0.000030095993,0.00020989882,0.000007273819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004130588,0.00015933496,0.6277695,0.000041725965,0.000013065812,0.000004909799,0.000507747,0.0000036786712,0.000041108804,0.0000880382,0.0000133365165,0.37094453],"study_design_scores_gemma":[0.0044621886,0.0018097687,0.98896265,0.002215317,1.4556042e-7,0.0000034253485,0.00009207204,0.00010951515,0.000117091375,0.00007022295,0.0020610373,0.00009653561],"about_ca_topic_score_codex":0.003222461,"about_ca_topic_score_gemma":0.00013954684,"teacher_disagreement_score":0.370848,"about_ca_system_score_codex":0.00006107296,"about_ca_system_score_gemma":0.0002622576,"threshold_uncertainty_score":0.48714188},"labels":[],"label_agreement":null},{"id":"W2766309622","doi":"10.1016/j.jval.2017.08.2433","title":"Comparison of the Assessments and Recommendations Issued by Brazil’s Conitec and Canada’s Cadth for Select Oncology Drugs","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cetuximab; Bevacizumab; Medicine; Everolimus; Oncology; Internal medicine; Biosimilar; Clinical trial; Breast cancer; Cancer; Colorectal cancer; Medical physics; Family medicine; Chemotherapy","score_opus":0.422258233729823,"score_gpt":0.5403794349603194,"score_spread":0.11812120123049635,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766309622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.616627,0.0031194661,0.00049901335,0.37413236,0.00095700135,0.0018597606,0.0012919946,0.000009672744,0.0015037386],"genre_scores_gemma":[0.991271,0.00030740397,0.0021330772,0.005831895,0.000050692393,0.00006943508,0.00002798398,0.000015021869,0.0002934554],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99666065,0.00043467217,0.002232385,0.00032324233,0.000054385375,0.00029466255],"domain_scores_gemma":[0.99525,0.0014466705,0.0027384497,0.00039716248,0.00003934088,0.0001284057],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009097862,0.00010628613,0.0007920484,0.000085472624,0.0005979297,0.00004703736,0.00023588091,0.000087176515,0.000020239253],"category_scores_gemma":[0.0015625955,0.00011742498,0.000025341385,0.000040474057,0.00010626634,0.0001517342,0.00006309806,0.0001612693,0.0000025546153],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020375446,0.0001339178,0.7503278,0.00087346183,0.000047013396,6.586667e-8,0.0034726593,0.00012467848,0.0000028899033,0.05893017,0.18340786,0.0026591057],"study_design_scores_gemma":[0.0033173217,0.000448855,0.24040103,0.00030857645,0.000009550328,0.000003536012,0.00345516,0.051883273,0.000028040513,0.013764538,0.6859974,0.00038270504],"about_ca_topic_score_codex":0.8208703,"about_ca_topic_score_gemma":0.47817227,"teacher_disagreement_score":0.5099268,"about_ca_system_score_codex":0.0010636649,"about_ca_system_score_gemma":0.0020957575,"threshold_uncertainty_score":0.5313497},"labels":[],"label_agreement":null},{"id":"W2766317520","doi":"10.1016/j.jval.2017.08.512","title":"Comparison Of Post-Creation Procedures And Related Costs Between Traditional Surgical Versus A New Endovascular Approach To Creating An Arteriovenous Fistula: A Usrds Comparison","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Central Venous Catheters and Hemodialysis","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Arteriovenous fistula; Cohort; Propensity score matching; Emergency medicine; Fistula; Catheter; Hemodialysis; Surgery; Internal medicine","score_opus":0.1734764795781764,"score_gpt":0.42967908214419115,"score_spread":0.25620260256601474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766317520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99364054,0.00042561846,0.00027707763,0.0010452581,0.0001918734,0.0014565834,0.00008734567,0.000042635722,0.0028330535],"genre_scores_gemma":[0.99673516,0.00005930841,0.0024459169,0.000055069366,0.00026381976,0.000050497754,0.0003179852,0.000027259837,0.00004499506],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996712,0.00066919805,0.0011687293,0.00046051192,0.00040358212,0.00058597623],"domain_scores_gemma":[0.9977013,0.0005098514,0.00072866306,0.0004533564,0.000101469406,0.0005053522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011876511,0.00020618977,0.00096576434,0.00018846692,0.0012374059,0.000039941817,0.0002395627,0.000222715,0.000032423268],"category_scores_gemma":[0.0003804896,0.00019989506,0.0001057414,0.00015533897,0.0000842705,0.0001645476,0.00007074185,0.0005310358,0.0000073220767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013036553,0.0018480282,0.8765803,0.0013133308,0.0001951404,0.000006355558,0.087637275,0.0024496524,0.000092670496,0.0059728567,0.00040876085,0.022191955],"study_design_scores_gemma":[0.006123916,0.0020735958,0.96653694,0.0009308145,0.00010111339,0.0000071394907,0.004988894,0.017842958,0.00002359078,0.00035950687,0.0006906878,0.00032086414],"about_ca_topic_score_codex":0.02872853,"about_ca_topic_score_gemma":0.0010087598,"teacher_disagreement_score":0.0899566,"about_ca_system_score_codex":0.00047406543,"about_ca_system_score_gemma":0.0008772807,"threshold_uncertainty_score":0.9777393},"labels":[],"label_agreement":null},{"id":"W2766319621","doi":"10.1016/j.jval.2017.08.137","title":"Overall Survival In Patients With Metastatic Urothelial Cancer By First-Line Therapy","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Carboplatin; Gemcitabine; Medicine; Regimen; Cisplatin; Internal medicine; Oncology; Chemotherapy; Cancer","score_opus":0.05453436083096245,"score_gpt":0.337921771874297,"score_spread":0.28338741104333454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766319621","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920717,0.0012909875,0.00001923562,0.0044225506,0.00032022982,0.0012832468,0.00018244366,0.00001914896,0.0003904693],"genre_scores_gemma":[0.99611396,0.0019169038,0.00017511066,0.0012096424,0.000095288575,0.00011188722,0.000034821052,0.00003976043,0.00030265586],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985123,0.00009758817,0.00032840142,0.00031123593,0.00035429854,0.0003961727],"domain_scores_gemma":[0.9991469,0.000045343804,0.00017606134,0.00043132974,0.000043118464,0.00015728694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024895385,0.00019052002,0.00045792255,0.00008112361,0.00013387312,0.000025621095,0.00013211677,0.000041435505,0.00012644922],"category_scores_gemma":[0.000031830124,0.00013695327,0.000038227387,0.000072701674,0.00005490208,0.00010728251,0.000019217985,0.00019256819,0.000008971164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020003961,0.0008857212,0.9857097,0.00012589138,0.00006225817,0.0000148447425,0.00046816727,0.00021048213,0.0000047445874,0.00003690603,0.00035033186,0.01013051],"study_design_scores_gemma":[0.025475947,0.0020401862,0.96690345,0.00043335493,0.000016445034,9.861233e-7,0.000011641216,0.00023832075,0.00007603441,0.0001713119,0.0044743284,0.00015797689],"about_ca_topic_score_codex":0.07608103,"about_ca_topic_score_gemma":0.0023250678,"teacher_disagreement_score":0.07375596,"about_ca_system_score_codex":0.00036036177,"about_ca_system_score_gemma":0.00048535797,"threshold_uncertainty_score":0.9300714},"labels":[],"label_agreement":null},{"id":"W2766387740","doi":"10.1016/j.jval.2017.08.1218","title":"Cost-Effectiveness Of Sacubitril/Valsartan In The Treatment Of Heart Failure In Colombia","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Sacubitril, Valsartan; Sacubitril; Valsartan; Cohort; Cost effectiveness; Quality-adjusted life year; Heart failure; Clinical trial; Cost-effectiveness analysis; Ejection fraction; Internal medicine; Intensive care medicine; Emergency medicine; Blood pressure","score_opus":0.5222522496897127,"score_gpt":0.48047281140990933,"score_spread":0.041779438279803405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766387740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750149,0.0022590288,0.00003355489,0.019276474,0.00025284433,0.002694101,0.00017292605,0.000005060329,0.00029108953],"genre_scores_gemma":[0.99809206,0.0004647383,0.0005470854,0.00059498654,0.00004845548,0.00021041791,0.000010992025,0.000015513166,0.00001578234],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99377704,0.0018601905,0.0034713738,0.00039331857,0.00009427416,0.00040381923],"domain_scores_gemma":[0.9944133,0.002551738,0.002101585,0.00083045894,0.000028805736,0.00007410185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0275146,0.00015118711,0.00171173,0.00041207956,0.000110576184,0.000029114584,0.0003666952,0.00012455428,0.00002735189],"category_scores_gemma":[0.0015932326,0.00015505358,0.0000957472,0.00021161283,0.00010668649,0.00020941072,0.00002158686,0.00014296475,0.00004504965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006242821,0.00073953293,0.96744823,0.0011146133,0.000011983606,0.000001413445,0.006645809,0.0029523398,0.0000052735,0.020151975,0.00066050224,0.00020589685],"study_design_scores_gemma":[0.0026653316,0.00058918586,0.9737165,0.0005757013,0.0000016335246,0.0000021650976,0.0013720765,0.0031492328,0.00004104076,0.0060421694,0.011697379,0.00014761167],"about_ca_topic_score_codex":0.07817632,"about_ca_topic_score_gemma":0.008125701,"teacher_disagreement_score":0.07005062,"about_ca_system_score_codex":0.0012331434,"about_ca_system_score_gemma":0.0003985466,"threshold_uncertainty_score":0.95360655},"labels":[],"label_agreement":null},{"id":"W2766400217","doi":"10.1016/j.jval.2017.08.2988","title":"Reliability, Validity and Responsiveness of A New Measure of Neck Disability (ND10)","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Practices and Rehabilitation","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Construct validity; Intraclass correlation; Readability; Clinical psychology; Psychology; Reliability (semiconductor); Dash; Medicine; Physical therapy; Psychometrics","score_opus":0.2556462446960754,"score_gpt":0.5001857133928145,"score_spread":0.2445394686967391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766400217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9795478,0.00024901258,0.00011528392,0.017905446,0.00053736375,0.0011044731,0.000017774786,0.000011205937,0.0005116238],"genre_scores_gemma":[0.9967279,0.00023229493,0.0026568975,0.00014108597,0.00010375443,0.000017148912,0.0000020493358,0.000009570114,0.00010929522],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9949563,0.0029385446,0.0011044908,0.00030686974,0.00039134535,0.00030244415],"domain_scores_gemma":[0.9935075,0.004029319,0.0010793218,0.0009190638,0.00019460724,0.00027018625],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.010003415,0.00010147026,0.00051099656,0.00004276827,0.0004291439,0.0000043894515,0.00022232767,0.00019776894,0.000096843134],"category_scores_gemma":[0.026764736,0.00007980719,0.00005503008,0.000097512195,0.0004182673,0.00020467806,0.00015763656,0.0005473248,0.000004132188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00068315014,0.00026639272,0.9730891,0.0067607937,0.00000473091,5.501495e-7,0.007019435,0.00007992329,0.000110340865,0.0017273949,0.0006396308,0.009618544],"study_design_scores_gemma":[0.0010207184,0.0003813615,0.9787592,0.0013525852,0.000007331665,3.6508715e-7,0.0012879622,0.00057559885,0.000013692408,0.01359459,0.002941163,0.000065381086],"about_ca_topic_score_codex":0.059977453,"about_ca_topic_score_gemma":0.00080968783,"teacher_disagreement_score":0.059167765,"about_ca_system_score_codex":0.00014502759,"about_ca_system_score_gemma":0.0014516715,"threshold_uncertainty_score":0.9814332},"labels":[],"label_agreement":null},{"id":"W2766414735","doi":"10.1016/j.jval.2017.08.1081","title":"A Cost-Utility Analysis of Artificial Urinary Sphincter Versus Advance Male Sling In Post Prostatectomy Stress Urinary Incontinence: A Canadian Healthcare Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Artificial urinary sphincter; Sling (weapon); Urinary incontinence; Medicine; Prostatectomy; Stress incontinence; Urology; Surgery; Internal medicine; Prostate cancer; Cancer","score_opus":0.06907056302338273,"score_gpt":0.3787156711099319,"score_spread":0.30964510808654916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766414735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981473,0.0030704169,0.0000034268253,0.0122015355,0.00023891851,0.001850748,0.00082939886,0.000014473765,0.00031804],"genre_scores_gemma":[0.99813205,0.0008778132,0.0003243384,0.00024310379,0.00005822841,0.0002100825,0.00011494496,0.000019739975,0.000019705007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975057,0.00019384238,0.00073101255,0.00060831674,0.00028645364,0.0006746792],"domain_scores_gemma":[0.9979201,0.00014757962,0.00042473484,0.0007621166,0.00029030332,0.00045518577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065308495,0.00022457754,0.00083228765,0.00072672346,0.00024385769,0.000027296666,0.00017500049,0.00009885857,0.00006269537],"category_scores_gemma":[0.00032725095,0.00021934221,0.00014076782,0.0005791608,0.0001438351,0.00017494016,0.00006924454,0.00037624492,0.0000031981372],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002428097,0.0007214888,0.98428696,0.0004406405,0.00020246558,0.00063300075,0.004139452,0.00065784727,0.000009615142,0.00034933863,0.00000527891,0.006125823],"study_design_scores_gemma":[0.0027618443,0.0016550975,0.98775667,0.0007932233,0.00009929001,0.000007800302,0.0030117615,0.0034387487,0.00011371214,0.000105683575,0.00009886749,0.00015729039],"about_ca_topic_score_codex":0.8150507,"about_ca_topic_score_gemma":0.5755473,"teacher_disagreement_score":0.23950347,"about_ca_system_score_codex":0.0028379078,"about_ca_system_score_gemma":0.0025530863,"threshold_uncertainty_score":0.89445156},"labels":[],"label_agreement":null},{"id":"W2766497866","doi":"10.1016/j.jval.2017.08.012","title":"Utilization and Treatment Patterns Among Patients with Advanced Non-Small Cell Lung Cancer Receiving Predictive Molecular Biomarker (BMX) Tests","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Internal medicine; Lung cancer; Medicine; Oncology; Stage (stratigraphy); Biology","score_opus":0.024863729510475538,"score_gpt":0.3383560817909946,"score_spread":0.313492352280519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766497866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99590766,0.0008507751,0.0005009836,0.00028099673,0.00012612819,0.0018421862,0.00009058214,0.000022294875,0.00037839822],"genre_scores_gemma":[0.99757576,0.0011859882,0.00063309434,0.000083400395,0.000021075019,0.000270527,0.00008522018,0.0000309974,0.000113932365],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99898535,0.000044722514,0.00021584971,0.00033895136,0.0001506712,0.00026445356],"domain_scores_gemma":[0.9991583,0.000032475447,0.00023803789,0.00031803595,0.00008309287,0.00017004802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006803161,0.00017036244,0.00024702545,0.000091214126,0.00021920059,0.000030890063,0.00004609034,0.00004908416,0.000009623751],"category_scores_gemma":[0.000021238151,0.00012738236,0.000024449277,0.000069043905,0.000040765965,0.00013437397,0.000021459424,0.000064884,4.8271016e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010686434,0.00029094738,0.9683869,0.00022314844,0.0000779672,0.000016669468,0.0016167735,0.00068100425,0.000016985061,0.0000027082592,0.000008162648,0.028571907],"study_design_scores_gemma":[0.005342974,0.00084272394,0.98446554,0.0012532333,0.0001231194,9.2637197e-7,0.000103185266,0.007493947,0.00022186132,0.000005305694,0.00004308116,0.00010410079],"about_ca_topic_score_codex":0.01613544,"about_ca_topic_score_gemma":0.0013182623,"teacher_disagreement_score":0.028467806,"about_ca_system_score_codex":0.00074928114,"about_ca_system_score_gemma":0.00035657207,"threshold_uncertainty_score":0.9904162},"labels":[],"label_agreement":null},{"id":"W2766513204","doi":"10.1016/j.jval.2017.08.958","title":"Biosimilar Discounts are Not Similar: A Comparison of The Prices and Discounts of Anti-Tnf Biosimilars Between Canada and Europe","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Infliximab; Drug prices; Reimbursement; Agency (philosophy); Medicine; Business; Economics; Public economics; Economic growth; Health care; Tumor necrosis factor alpha; Internal medicine","score_opus":0.06781305736739056,"score_gpt":0.3392838893712127,"score_spread":0.2714708320038221,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766513204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835427,0.0033754408,0.0000101253245,0.0116603505,0.00035727277,0.00034730588,0.00058979343,0.0000045413653,0.00011248904],"genre_scores_gemma":[0.9981988,0.0007766549,0.00028348912,0.00063166587,0.000020179152,0.0000025083934,0.000004740863,0.0000133346475,0.00006859185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793965,0.00044993378,0.00072960934,0.00036574344,0.000118497024,0.0003965948],"domain_scores_gemma":[0.99797094,0.0003706947,0.0009230057,0.00060273113,0.00006933211,0.0000632977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000892133,0.00021707916,0.0008397326,0.00007076407,0.00037403466,0.000024578065,0.00048702265,0.0001811747,0.000018303748],"category_scores_gemma":[0.00042978465,0.00014172048,0.000050397943,0.0001402872,0.00090659305,0.00008074445,0.0003466468,0.00036676426,5.331882e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054169628,0.00009500144,0.99263823,0.0004033046,0.00007963624,0.0000015939065,0.0002564628,0.000009837278,0.003250077,0.0001518189,0.0014548171,0.001605031],"study_design_scores_gemma":[0.0006658942,0.00013714544,0.96744716,0.00047006484,0.00004908805,0.000003887656,0.00022079784,0.00008746488,0.02590324,0.00007861395,0.0047773677,0.00015926553],"about_ca_topic_score_codex":0.13018279,"about_ca_topic_score_gemma":0.0670976,"teacher_disagreement_score":0.06308519,"about_ca_system_score_codex":0.000044766708,"about_ca_system_score_gemma":0.00033032583,"threshold_uncertainty_score":0.9499254},"labels":[],"label_agreement":null},{"id":"W2766539369","doi":"10.1016/j.jval.2017.08.2989","title":"Assessing the Economic and Humanistic Burden of Psoriatic Arthritis in Brazil","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Presenteeism; Psoriatic arthritis; Internal medicine; Psoriasis; Absenteeism; Anxiety; Depression (economics); Arthritis; Physical therapy; Dermatology; Psychiatry","score_opus":0.04398812082373241,"score_gpt":0.323395261109215,"score_spread":0.27940714028548264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766539369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98761624,0.010227891,0.0000032512148,0.0010755624,0.00050892466,0.00018613711,0.000013364519,0.00000612649,0.00036251455],"genre_scores_gemma":[0.99834335,0.0014199195,0.000050988125,0.000032572672,0.000039678183,0.0000122725105,0.0000074085447,0.0000067052456,0.000087089415],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99903184,0.00027780968,0.000316655,0.00015817305,0.0000131107145,0.00020239648],"domain_scores_gemma":[0.99922895,0.00023569915,0.0002322648,0.00028603282,0.0000054461198,0.000011627794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063894887,0.00008324913,0.00025872883,0.00006661319,0.00026533828,0.00003275446,0.00015093408,0.00007755636,0.000038181854],"category_scores_gemma":[0.00007479013,0.00006633341,0.00002449344,0.000018360248,0.0001358207,0.00009352989,0.000044537992,0.000101254635,0.00002727666],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014214721,0.00020593853,0.2407963,0.00040063082,0.00019501286,0.000045843462,0.010965984,0.0012732132,0.0037355593,0.019525928,0.0005205969,0.7221928],"study_design_scores_gemma":[0.0046368926,0.00025732114,0.98448503,0.0006644181,0.000025084899,0.00005993894,0.0008327819,0.00053332985,0.0009572595,0.004911664,0.0024316218,0.00020465955],"about_ca_topic_score_codex":0.015643382,"about_ca_topic_score_gemma":0.0010549907,"teacher_disagreement_score":0.7436887,"about_ca_system_score_codex":0.00008929532,"about_ca_system_score_gemma":0.00016853059,"threshold_uncertainty_score":0.99091154},"labels":[],"label_agreement":null},{"id":"W2766560421","doi":"10.1016/j.jval.2017.08.1780","title":"Early Scientific Advice At Cadth – Options and Recommendations For Future Development","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Interdisciplinary Research and Collaboration","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; Institute of Health Economics","funders":"","keywords":"Advice (programming); Engineering ethics; Medical education; Computer science; Medicine; Engineering","score_opus":0.21430480673009605,"score_gpt":0.4826950680277159,"score_spread":0.26839026129761984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766560421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8950045,0.0003582499,0.0008335985,0.1003475,0.0014812268,0.00081282336,0.000096208794,0.000020716541,0.0010451857],"genre_scores_gemma":[0.951909,0.000046822202,0.02217591,0.00017498377,0.00027790622,0.00018245938,0.00004718947,0.000011075689,0.025174636],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99815434,0.00018167548,0.00045168857,0.00039784558,0.00050776085,0.00030669745],"domain_scores_gemma":[0.9984366,0.00029596532,0.00023200129,0.0005099389,0.00035131242,0.00017416307],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.00487924,0.00007230389,0.00013505091,0.0002727493,0.0037086103,0.00093508395,0.00044898645,0.00004221995,0.00006041717],"category_scores_gemma":[0.00058481627,0.000058219557,0.000023713246,0.00030259995,0.00010223101,0.0005016351,0.00025719046,0.00009575889,0.00008042562],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005858643,0.00045818757,0.06652848,0.00019511928,0.000031986918,0.000008676023,0.06186105,0.00082686037,0.0003756465,0.096740074,0.4089851,0.36340293],"study_design_scores_gemma":[0.00076170714,0.0002572033,0.25876543,0.00009445664,0.0000013744092,0.0000049758405,0.004118079,0.011213001,0.0000948832,0.018118767,0.70640206,0.00016809934],"about_ca_topic_score_codex":0.0002389912,"about_ca_topic_score_gemma":0.0045446223,"teacher_disagreement_score":0.36323485,"about_ca_system_score_codex":0.00022307727,"about_ca_system_score_gemma":0.0006910756,"threshold_uncertainty_score":0.9975884},"labels":[],"label_agreement":null},{"id":"W2766601188","doi":"10.1016/j.jval.2017.08.2343","title":"Burden Of Respiratory Syncytial Virus (RSV) Disease In Adults: Final Analysis From A Retrospective Chart Review","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Retrospective cohort study; Asthma; Mechanical ventilation; Intensive care unit; Pediatrics; Internal medicine; Young adult; Disease; Emergency medicine","score_opus":0.11751060484294505,"score_gpt":0.42398235418095936,"score_spread":0.3064717493380143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766601188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9733119,0.022672324,0.000014786437,0.0020935992,0.0000912296,0.0012166366,0.0001513469,0.000021852227,0.00042635304],"genre_scores_gemma":[0.9922584,0.0064733727,0.00006850402,0.0007224267,0.0002620712,0.00010981218,0.000022257613,0.000021545218,0.00006157274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968196,0.0006201036,0.0009661186,0.00053932384,0.0006429778,0.00041188343],"domain_scores_gemma":[0.99749416,0.00010535453,0.00046278143,0.0013764922,0.00019316292,0.00036804785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018008683,0.00017989431,0.001004568,0.00075331714,0.00015050393,0.000018635152,0.0002941101,0.00009145521,0.000325038],"category_scores_gemma":[0.0028135271,0.0001670535,0.00022154734,0.0009450025,0.0001904749,0.0001775535,0.00011550658,0.00060026045,0.000054166627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076183194,0.00027556342,0.99314344,0.0023675524,0.0001032373,0.00016210029,0.00023970222,0.00028058255,0.00015594743,0.000105488136,0.0002294248,0.0021751155],"study_design_scores_gemma":[0.0017154395,0.00052580377,0.9870626,0.006678945,0.00011614063,5.73187e-7,0.000024578712,0.0024644793,0.00008081492,0.00011236359,0.0010945691,0.0001237359],"about_ca_topic_score_codex":0.09165754,"about_ca_topic_score_gemma":0.0015878009,"teacher_disagreement_score":0.09006974,"about_ca_system_score_codex":0.00086078444,"about_ca_system_score_gemma":0.0011572787,"threshold_uncertainty_score":0.9143912},"labels":[],"label_agreement":null},{"id":"W2766605928","doi":"10.1016/j.jval.2017.08.229","title":"Health-Economics Evaluations in France, England, Canada and Autralia: Comparison of Methodologies and Impact on Drugs’ Access To Patients","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Health technology; Negotiation; Economic evaluation; Medicine; Agency (philosophy); Public health; Access to medicines; Family medicine; Actuarial science; Political science; Business; Public economics; Health care; Economics; Economic growth; Computer science; Sociology; Nursing","score_opus":0.5601480199139278,"score_gpt":0.539275883837461,"score_spread":0.020872136076466874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766605928","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9534676,0.0013945139,0.00010454027,0.042552605,0.0005171576,0.0012405077,0.0005738557,0.000007703836,0.00014148415],"genre_scores_gemma":[0.9924793,0.00075782574,0.002250341,0.004325617,0.000056906905,0.000068290756,0.000021615235,0.000019638748,0.000020453062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942843,0.0008783721,0.0036783505,0.00055421324,0.00009508257,0.0005097012],"domain_scores_gemma":[0.99409217,0.0020129387,0.002943837,0.0005906344,0.000045081866,0.0003153702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016932255,0.00020261954,0.0015760661,0.000482803,0.00029529372,0.000103928316,0.00036714858,0.00009821337,0.00001621825],"category_scores_gemma":[0.0043462412,0.0002372102,0.00003834024,0.00012415378,0.00006989326,0.00039007256,0.00011568869,0.00023693327,0.000007976475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024984914,0.00006627673,0.97148496,0.00041204723,0.0000127731355,8.92123e-8,0.0035324907,0.01570793,2.8355256e-8,0.003271903,0.0014511718,0.004035372],"study_design_scores_gemma":[0.0013848706,0.00025870782,0.98000824,0.00023442057,9.900119e-7,2.9932028e-7,0.00029000454,0.011118589,0.0000013819545,0.004467201,0.002057296,0.00017799827],"about_ca_topic_score_codex":0.9209329,"about_ca_topic_score_gemma":0.5667031,"teacher_disagreement_score":0.35422978,"about_ca_system_score_codex":0.0014968376,"about_ca_system_score_gemma":0.001240822,"threshold_uncertainty_score":0.96731514},"labels":[],"label_agreement":null},{"id":"W2766608852","doi":"10.1016/j.jval.2017.08.999","title":"Estimating the Comparative Accuracy of Diagnostic Tests: AN Example using Typhoid Fever","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Typhoid fever; Salmonella typhi; Widal test; Medicine; Blood culture; Internal medicine; Incidence (geometry); Salmonella; Population; Immunology; Diagnostic test; Veterinary medicine; Virology; Biology; Environmental health; Microbiology; Mathematics; Antibiotics","score_opus":0.9348896130216434,"score_gpt":0.6298666315882766,"score_spread":0.3050229814333668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766608852","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887147,0.0008223994,0.008143133,0.0005739722,0.0003019311,0.0008313878,0.0000083476725,0.0000024273158,0.00060171535],"genre_scores_gemma":[0.96999776,0.00001105613,0.029651523,0.00015782965,0.000076833436,0.0000129278005,0.0000013120136,0.000005974765,0.00008477192],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9817948,0.009688223,0.005647309,0.00056860864,0.0020321738,0.00026891427],"domain_scores_gemma":[0.93717617,0.04454964,0.011548236,0.0059870314,0.00056907476,0.00016986908],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.0908576,0.00016271081,0.0019937127,0.00013950437,0.0005927554,0.00058324955,0.0020224159,0.000034317494,0.00057590834],"category_scores_gemma":[0.13252346,0.00007189995,0.0002890302,0.00040864092,0.00012267032,0.0004288653,0.00015071257,0.00015767277,0.0001672119],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000099849685,0.00032590405,0.62822586,0.00044478662,0.00012118204,0.000009079139,0.030897822,0.28134632,0.00014178733,0.0081697665,0.006241027,0.044066466],"study_design_scores_gemma":[0.00015866422,0.000050422568,0.15417463,0.0002941551,0.000029371131,0.000008358471,0.0013459406,0.83188254,0.000016642693,0.009770782,0.002161587,0.000106907486],"about_ca_topic_score_codex":0.015411485,"about_ca_topic_score_gemma":0.00053620926,"teacher_disagreement_score":0.5505362,"about_ca_system_score_codex":0.00005925833,"about_ca_system_score_gemma":0.00025921292,"threshold_uncertainty_score":0.99114496},"labels":[],"label_agreement":null},{"id":"W2766612740","doi":"10.1016/j.jval.2017.08.2686","title":"Burden of Disease for Rheumatoid Arthritis In Argentina, Brazil, Colombia, Mexico and Venezuela","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"","keywords":"Latin Americans; Medicine; Rheumatoid arthritis; Portuguese; Burden of disease; Diabetes mellitus; Disease; Quality of life (healthcare); Gerontology; Internal medicine; Political science","score_opus":0.032003469156457055,"score_gpt":0.3369848384008826,"score_spread":0.30498136924442554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766612740","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95463353,0.03750852,0.00002489907,0.0064793634,0.00010279915,0.0010502853,0.000063283565,0.0000128245765,0.00012446618],"genre_scores_gemma":[0.897234,0.102056384,0.00042388088,0.000087306806,0.000026682332,0.00008471404,0.000015035403,0.000019424397,0.000052574032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848574,0.00010433298,0.00048485407,0.00025500273,0.00022993205,0.00044013318],"domain_scores_gemma":[0.9988555,0.00015110393,0.00018498047,0.00040080116,0.00005568797,0.00035196415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009200219,0.00011019253,0.00047427684,0.00017874072,0.00017174112,0.000036971614,0.00012850338,0.000049836384,0.000026654692],"category_scores_gemma":[0.0008309255,0.00011341852,0.00005740399,0.00006413154,0.00020722717,0.00012338281,0.000060114686,0.00015161627,0.000004023158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020800661,0.0005392533,0.84614193,0.0018266585,0.000046682035,0.000103359554,0.002521974,0.0001399335,0.00050358457,0.010469052,0.0013095984,0.13431789],"study_design_scores_gemma":[0.019231189,0.0017767396,0.9132975,0.009608251,0.0000016262879,0.000047671943,0.0005140445,0.009229146,0.0005498621,0.015902959,0.029533755,0.00030730123],"about_ca_topic_score_codex":0.007857239,"about_ca_topic_score_gemma":0.0005345479,"teacher_disagreement_score":0.13401058,"about_ca_system_score_codex":0.000060103263,"about_ca_system_score_gemma":0.00047821176,"threshold_uncertainty_score":0.99874955},"labels":[],"label_agreement":null},{"id":"W2766631407","doi":"10.1016/j.jval.2017.08.2410","title":"Assessing The Disease Course And Treatment of Psoriatic Arthritis (PSA) In Canada","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Apremilast; Psoriatic arthritis; Disease; Internal medicine; Physical therapy","score_opus":0.051585399396294744,"score_gpt":0.35965043286646015,"score_spread":0.3080650334701654,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766631407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9543338,0.033575766,0.000001362484,0.011535275,0.00007888053,0.00038269834,0.000012015011,0.000002543007,0.00007766687],"genre_scores_gemma":[0.93466514,0.06513046,0.00005398778,0.00008352078,0.000025572615,0.000021053165,0.0000024206474,0.0000063494285,0.00001147202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99907833,0.00013282527,0.00023293692,0.000113843074,0.00020432875,0.00023773522],"domain_scores_gemma":[0.9992555,0.00013603577,0.00009620999,0.00029981742,0.00001763583,0.00019482747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029732333,0.00006630231,0.00024008297,0.000036807538,0.00014690906,0.000036705067,0.000055976132,0.0000111747595,0.000011250742],"category_scores_gemma":[0.00016354109,0.000045388108,0.000016552742,0.000036233312,0.000092670125,0.00007981975,0.00001369621,0.00007063791,4.54892e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050248775,0.0001344737,0.68177867,0.00008702641,0.000012909998,0.00015591223,0.0005723081,0.000042564072,0.0000045428023,0.00031118398,0.00005313316,0.31679705],"study_design_scores_gemma":[0.0024109962,0.0001965645,0.99133146,0.0010271216,0.0000011013143,0.00001238949,0.0005748265,0.0031323207,0.000012239924,0.00040010904,0.0008620349,0.000038857695],"about_ca_topic_score_codex":0.9427532,"about_ca_topic_score_gemma":0.8246122,"teacher_disagreement_score":0.3167582,"about_ca_system_score_codex":0.0002945721,"about_ca_system_score_gemma":0.0035359215,"threshold_uncertainty_score":0.6272573},"labels":[],"label_agreement":null},{"id":"W2766636502","doi":"10.1016/j.jval.2017.08.1150","title":"The Effect Of Nsaids On Myocardial, Vascular And Renal Risk Categories:Systematic Review Of Randomized Controlled Trial And Observational Studies","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Meloxicam; Rofecoxib; Observational study; Randomized controlled trial; Internal medicine; Relative risk; Confidence interval","score_opus":0.07332535881470767,"score_gpt":0.3601853610210842,"score_spread":0.28686000220637653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766636502","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16651326,0.82031107,0.000002425082,0.0035858008,0.00022125189,0.009282735,0.0000052869423,0.0000050451886,0.00007310846],"genre_scores_gemma":[0.46577895,0.5330497,0.00004555603,0.00045797456,0.00009314467,0.0005386243,0.0000012351169,0.0000073999145,0.00002743787],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.995658,0.0025343578,0.0011600293,0.00014996991,0.00037647516,0.00012119534],"domain_scores_gemma":[0.9886547,0.009627868,0.0011115642,0.00039324997,0.00016785105,0.000044781187],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015521829,0.00013509108,0.0052502947,0.000047590765,0.0002855146,0.000009655453,0.000059034766,0.00003862567,6.0299834e-7],"category_scores_gemma":[0.02285177,0.000059538754,0.00028379928,0.000042220927,0.00032740127,0.000025365533,0.000046673955,0.00012899464,2.3523722e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6379907,0.00006785893,0.002115407,0.3476214,0.0086869635,0.0000041112094,0.00072656455,0.000006774637,0.0000065608533,0.0012857767,0.0011831634,0.00030472758],"study_design_scores_gemma":[0.9113502,0.0016985286,0.0009462873,0.07858816,0.006742548,0.0000044444723,0.0000723808,0.0001339394,0.00002102388,0.00027822927,0.00010054221,0.000063733765],"about_ca_topic_score_codex":0.0005780294,"about_ca_topic_score_gemma":0.000007526264,"teacher_disagreement_score":0.29926568,"about_ca_system_score_codex":0.000008822958,"about_ca_system_score_gemma":0.00008240044,"threshold_uncertainty_score":0.98537916},"labels":[],"label_agreement":null},{"id":"W2766775047","doi":"10.1016/j.jval.2017.08.2848","title":"Assessing The Burden Of Chronic Heart Failure (Chf) On Patients Argentina","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Depression (economics); Anxiety; Heart failure; Cohort; Health insurance; Physical therapy; Emergency medicine; Health care; Internal medicine; Psychiatry","score_opus":0.05811089744045684,"score_gpt":0.362352868378118,"score_spread":0.30424197093766114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766775047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9072795,0.0001724419,0.000014280347,0.0899975,0.00026234158,0.001008984,0.0000025213772,0.000021389791,0.0012410226],"genre_scores_gemma":[0.99819314,0.000050049086,0.0007668871,0.00036280506,0.00023078389,0.000019144967,0.000010534169,0.00001412681,0.00035252963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998804,0.00010961551,0.0003039425,0.00019425793,0.00029028676,0.00029791548],"domain_scores_gemma":[0.99898225,0.000058253903,0.00019234013,0.00064274657,0.000035878766,0.00008852339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005483779,0.00011044223,0.0002715156,0.00008115477,0.00025329308,0.00004292455,0.00012282647,0.00004175056,0.000047649668],"category_scores_gemma":[0.0001108146,0.00007163056,0.000066308196,0.00006233493,0.000055983815,0.00009940206,0.00005886741,0.00016139032,0.00004744118],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016782235,0.002905534,0.78249437,0.0031632825,0.00024335587,0.000050577066,0.0035689012,0.0024415501,0.00038877386,0.0054911803,0.128965,0.07011967],"study_design_scores_gemma":[0.004419411,0.0019213568,0.61916965,0.002243884,0.000047282243,0.000003941142,0.00039677072,0.003920477,0.00037216124,0.00019063329,0.3671477,0.0001666982],"about_ca_topic_score_codex":0.004160586,"about_ca_topic_score_gemma":0.00004501371,"teacher_disagreement_score":0.23818271,"about_ca_system_score_codex":0.00024818536,"about_ca_system_score_gemma":0.00022181004,"threshold_uncertainty_score":0.6289589},"labels":[],"label_agreement":null},{"id":"W2766806935","doi":"10.1016/j.jval.2017.08.1726","title":"Minimally Important Difference: Empirical Comparison Of Estimation Methods Using Orthopaedics And Otolaryngology","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Confidence interval; Statistics; Medicine; Sample size determination; Observational study; Estimation; Otorhinolaryngology; Mathematics; Surgery; Economics","score_opus":0.4339353703206813,"score_gpt":0.6171888009541954,"score_spread":0.18325343063351407,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766806935","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.985114,0.0004638376,0.009410786,0.0039657247,0.00014583666,0.00044972208,0.0000036406768,0.000027657392,0.00041881547],"genre_scores_gemma":[0.8075373,0.0002020037,0.19215344,0.000045639026,0.000034837525,0.000008358226,9.0777195e-7,0.0000065684344,0.000010920936],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997,0.0013817461,0.0006285757,0.00022512565,0.00039463118,0.00036992412],"domain_scores_gemma":[0.9981416,0.000802074,0.0005109709,0.00030433107,0.00008423721,0.00015678375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007269879,0.000078870165,0.0003571524,0.00015853172,0.0005469547,0.000055107666,0.0003527867,0.00015803025,0.000010090336],"category_scores_gemma":[0.0039436286,0.00007761365,0.000031283987,0.00014707356,0.0006675566,0.00010828199,0.00013804424,0.00029101875,4.354723e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019104107,0.00007477425,0.95733696,0.00011239169,0.0000034854845,0.0000045571346,0.006053316,0.00007944412,0.00026607644,0.004156435,0.000045022174,0.03184845],"study_design_scores_gemma":[0.000279583,0.0002615767,0.63566846,0.00021486895,0.000005797088,0.000004472739,0.0013758426,0.34626013,0.00025762143,0.014996245,0.00053778995,0.00013762485],"about_ca_topic_score_codex":0.032875784,"about_ca_topic_score_gemma":0.0014632215,"teacher_disagreement_score":0.34618068,"about_ca_system_score_codex":0.00017773082,"about_ca_system_score_gemma":0.00097510236,"threshold_uncertainty_score":0.9735644},"labels":[],"label_agreement":null},{"id":"W2766867540","doi":"10.1016/j.jval.2017.08.390","title":"The Difference Between Regulatory And Market Access Decisions On Treatment Availability For New Drugs In Six Common Cancers Across Australia, Canada, And Europe","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Population; European union; Market access; Family medicine; Health care; Environmental health; Business; Geography; Economic growth","score_opus":0.5115265019704277,"score_gpt":0.47998978577437584,"score_spread":0.03153671619605186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766867540","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579189,0.0008908363,0.000018355955,0.038738355,0.00032994352,0.0012182944,0.00076078327,0.0000061203605,0.00011842491],"genre_scores_gemma":[0.9955971,0.0011785286,0.0001558147,0.001230592,0.00013065436,0.00009715933,0.000009356356,0.000018143099,0.0015826568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99621826,0.0004127192,0.0021759425,0.00057073927,0.00008364688,0.00053868396],"domain_scores_gemma":[0.9926906,0.0048217583,0.0013611865,0.0007797736,0.000023369443,0.00032329524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010714118,0.00018574084,0.0008033832,0.000080766586,0.000779303,0.00022274851,0.00040662035,0.00008216983,0.000013433941],"category_scores_gemma":[0.0028514103,0.00017446317,0.00003173633,0.00007219569,0.00013987544,0.00018589564,0.00009541729,0.00015991312,0.000007297648],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041552958,0.000019557812,0.98471665,0.000121386984,0.00001203834,3.4158614e-7,0.0010675857,0.00013208184,3.103807e-8,0.0020676835,0.004746645,0.0070744134],"study_design_scores_gemma":[0.0009773433,0.00011820678,0.9723538,0.00016350715,0.0000014586984,4.285072e-7,0.0001576383,0.0015361607,0.0000011944346,0.0062804013,0.018264191,0.00014562592],"about_ca_topic_score_codex":0.96896493,"about_ca_topic_score_gemma":0.95540524,"teacher_disagreement_score":0.03767821,"about_ca_system_score_codex":0.0035437078,"about_ca_system_score_gemma":0.0013022972,"threshold_uncertainty_score":0.9266673},"labels":[],"label_agreement":null},{"id":"W2766879304","doi":"10.1016/j.jval.2017.08.2407","title":"The Patient-Reported Disease Burden In Adults With Atopic Dermatitis: A Cross-Sectional Study In Canada and Europe","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; SCORAD; Atopic dermatitis; Visual analogue scale; Quality of life (healthcare); Anxiety; Depression (economics); Cross-sectional study; Pittsburgh Sleep Quality Index; Internal medicine; Hospital Anxiety and Depression Scale; Dermatology Life Quality Index; Physical therapy; Disease; Sleep quality; Psychiatry; Dermatology; Insomnia","score_opus":0.022317231205276646,"score_gpt":0.2961147211057402,"score_spread":0.2737974899004636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766879304","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963198,0.0009360705,1.7725993e-7,0.0017530036,0.000118317825,0.0007452226,0.000009143134,0.0000062686136,0.0001120213],"genre_scores_gemma":[0.99936914,0.00011404248,0.0000052730848,0.00039381976,0.000019289399,0.000056705325,0.0000063624625,0.0000073941687,0.000027989703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987847,0.00017398859,0.00040039406,0.0002025706,0.00020915242,0.0002291537],"domain_scores_gemma":[0.9991938,0.00010880452,0.00015620163,0.0003237234,0.000041026848,0.00017643138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019773615,0.00008496861,0.00017577499,0.000054204294,0.0002182018,0.00003042934,0.00008129332,0.000018718283,0.0000057638836],"category_scores_gemma":[0.00040923757,0.000059097034,0.000008680061,0.00007829482,0.000087228604,0.000072492985,0.000038620194,0.00017276034,0.0000012262649],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002452581,0.000120385725,0.996207,0.00014317171,0.000009500189,0.0019994946,0.0005115477,0.00015838578,1.904964e-8,0.0000120549785,0.0001317947,0.00046138393],"study_design_scores_gemma":[0.002718036,0.00007906129,0.9953715,0.0003226041,0.000004047216,0.00007255989,0.000315755,0.00084555254,2.0177937e-7,0.000049884522,0.00016532977,0.00005543735],"about_ca_topic_score_codex":0.89950264,"about_ca_topic_score_gemma":0.90032387,"teacher_disagreement_score":0.0030493485,"about_ca_system_score_codex":0.00018029363,"about_ca_system_score_gemma":0.0023269958,"threshold_uncertainty_score":0.41279906},"labels":[],"label_agreement":null},{"id":"W2766879860","doi":"10.1016/j.jval.2017.08.793","title":"Assessing The Burden of Disease In Peripheral And Axial Spondyloarthritis In Mexico","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Ankylosing spondylitis; Psoriatic arthritis; Quality of life (healthcare); Presenteeism; Internal medicine; Axial spondyloarthritis; Disease burden; Disease; Physical therapy; Productivity","score_opus":0.04581180184827871,"score_gpt":0.35745504306898074,"score_spread":0.311643241220702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766879860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848447,0.00645851,9.538609e-7,0.0074289585,0.00013467288,0.00045022677,0.00001305802,0.0000051548463,0.0006637825],"genre_scores_gemma":[0.99821776,0.0012674234,0.00017624351,0.00017658196,0.00009388286,0.000026547394,0.000004480378,0.000010965641,0.000026107433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891084,0.0001165856,0.00033628676,0.00020152859,0.00016030802,0.00027444682],"domain_scores_gemma":[0.99938154,0.00007484035,0.00012021284,0.00030376398,0.00001567754,0.00010394304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043191077,0.00010215467,0.0003386234,0.00007362527,0.00017485087,0.00003801141,0.000073069605,0.000035077344,0.000014171825],"category_scores_gemma":[0.00016101355,0.00007854954,0.000032493237,0.00007198065,0.0001860642,0.00012925637,0.000067015266,0.0001602564,9.2716994e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022591569,0.00017022954,0.97748834,0.0001711238,0.000008652579,0.0003545239,0.0026027956,0.00017621345,0.000015848922,0.0011131087,0.00001458717,0.017658662],"study_design_scores_gemma":[0.0050468505,0.0002274563,0.989486,0.0014385298,0.0000058080145,0.000012951752,0.00082199386,0.0016766578,0.000007709566,0.0006967792,0.0005133838,0.000065894594],"about_ca_topic_score_codex":0.05608776,"about_ca_topic_score_gemma":0.002505776,"teacher_disagreement_score":0.053581983,"about_ca_system_score_codex":0.00013332373,"about_ca_system_score_gemma":0.0001690827,"threshold_uncertainty_score":0.9501978},"labels":[],"label_agreement":null},{"id":"W2766900682","doi":"10.1016/j.jval.2017.08.1084","title":"Cost-Utility Of Novel Tests After A Negative Prostate Biopsy","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Overdiagnosis; Medicine; Prostate cancer; Prostate; Biopsy; Prostate biopsy; Gynecology; Radiology; Internal medicine; Cancer","score_opus":0.11422681531541032,"score_gpt":0.38765849657896384,"score_spread":0.27343168126355355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766900682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905456,0.00086428155,0.000021186865,0.0059531024,0.00014501813,0.0016614994,0.00021598533,0.000014497717,0.0005788788],"genre_scores_gemma":[0.9966701,0.00046402792,0.002121545,0.000352639,0.00003451637,0.00026724022,0.000008591041,0.000012782849,0.00006855309],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889874,0.00003904335,0.00035475678,0.0002587773,0.00016705254,0.00028161352],"domain_scores_gemma":[0.9988534,0.000091129186,0.00026602426,0.0005412199,0.00008301997,0.00016519152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003721726,0.000117757394,0.00035694728,0.00006109877,0.000075769705,0.0000134687825,0.000071845025,0.000040932544,0.000033341927],"category_scores_gemma":[0.0002367584,0.00009292299,0.000052158048,0.000070039525,0.00013642076,0.00007644573,0.00004708598,0.00012239431,0.000006576528],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005059055,0.0010744869,0.9810212,0.0006144078,0.00003044907,0.00005053615,0.0018562074,0.000015652497,0.00005629887,0.0001024734,0.00014784953,0.014524503],"study_design_scores_gemma":[0.003413341,0.0005313848,0.99177855,0.0010367646,0.00001278202,0.000011740616,0.000065023705,0.0010756175,0.0012496744,0.00025753505,0.00050023035,0.00006738092],"about_ca_topic_score_codex":0.010732266,"about_ca_topic_score_gemma":0.0001669172,"teacher_disagreement_score":0.0144571215,"about_ca_system_score_codex":0.00021002881,"about_ca_system_score_gemma":0.0004731738,"threshold_uncertainty_score":0.99585533},"labels":[],"label_agreement":null},{"id":"W2766904337","doi":"10.1016/j.jval.2017.08.2446","title":"The Economic Burden of Varicella in Peru","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GDI Integrated Facility Services (Canada)","funders":"","keywords":"Medicine; Chickenpox; Indirect costs; Varicella vaccine; Pediatrics; Public health; Medical prescription; Varicella zoster virus; Immunization; Environmental health; Virology; Virus; Immunology; Business","score_opus":0.051010488479955915,"score_gpt":0.35147208771698607,"score_spread":0.30046159923703014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766904337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94818884,0.0011060871,0.0000021723827,0.0183968,0.00034534044,0.00019335577,0.0000015804825,0.0000053858976,0.031760428],"genre_scores_gemma":[0.99642247,0.002555592,0.000033379067,0.000053754236,0.00018771992,0.0000035405055,1.3120841e-7,0.0000032613343,0.0007401479],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99921215,0.00017634202,0.00022145992,0.000094518255,0.00007643605,0.00021909733],"domain_scores_gemma":[0.99934655,0.00019737266,0.00015826162,0.00024671966,0.00000962636,0.000041467883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001682087,0.000035748788,0.00011207711,0.000033623306,0.0005040875,0.000048022146,0.0003568771,0.00003386892,0.000035582216],"category_scores_gemma":[0.0001654299,0.000029458815,0.000022696298,0.00003169389,0.000024564519,0.000086106236,0.000032414337,0.00008376154,0.000025242676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045031004,0.000056119672,0.51049495,0.00010828266,0.000008884991,0.000011365166,0.0869289,0.006076857,0.000013368197,0.3483069,0.0030725887,0.044876773],"study_design_scores_gemma":[0.0011115741,0.00014139253,0.7504337,0.00026209446,0.0000031495138,7.4326204e-7,0.010058633,0.0053362306,0.00001967513,0.05352895,0.17887695,0.00022690135],"about_ca_topic_score_codex":0.32230365,"about_ca_topic_score_gemma":0.039452832,"teacher_disagreement_score":0.29477796,"about_ca_system_score_codex":0.00024797436,"about_ca_system_score_gemma":0.00069705315,"threshold_uncertainty_score":0.97807467},"labels":[],"label_agreement":null},{"id":"W2766908455","doi":"10.1016/j.jval.2017.08.046","title":"Cost-Effectiveness of Diagnosis: from Tests to Long-Term Outcomes and Costs","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical Reasoning and Diagnostic Skills","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Watchful waiting; Context (archaeology); Cost effectiveness; Medicine; Decision tree; Cost–benefit analysis; Incremental cost-effectiveness ratio; Cost database; Prostate cancer; Computer science; Cost-effectiveness analysis; Machine learning; Risk analysis (engineering); Cancer","score_opus":0.14750244572191867,"score_gpt":0.4600771578112557,"score_spread":0.312574712089337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766908455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939149,0.00089238567,0.00003409461,0.003527185,0.00029839782,0.0011615762,0.000048378362,0.000018581688,0.000104468825],"genre_scores_gemma":[0.9979613,0.00064931554,0.0004155564,0.0007402883,0.000058664264,0.00013087486,0.000014162545,0.000014865985,0.00001498094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986944,0.00018648637,0.0003842558,0.0002978356,0.00019297306,0.00024404185],"domain_scores_gemma":[0.97807014,0.020779958,0.00017645248,0.0005438822,0.000053882122,0.00037568514],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0010376868,0.000119221855,0.0006139211,0.00007156592,0.000082958395,0.000021645326,0.00011807223,0.0000815414,0.000015331356],"category_scores_gemma":[0.055165313,0.000097670025,0.000051101382,0.000054729502,0.00008565515,0.00003821207,0.0000878211,0.00015469838,0.000015785745],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013764924,0.00030361212,0.9472646,0.00014711243,0.00001867969,0.000039687326,0.00011568794,0.00001632373,0.000010162624,0.00008424057,0.00006309134,0.05179916],"study_design_scores_gemma":[0.0024477788,0.00048718767,0.9834509,0.013053768,0.000021043235,0.0000036480385,0.000009941573,0.000037045207,0.0002200692,0.0001690798,0.000019626927,0.00007993363],"about_ca_topic_score_codex":0.019055499,"about_ca_topic_score_gemma":0.00033386867,"teacher_disagreement_score":0.054127626,"about_ca_system_score_codex":0.00013215553,"about_ca_system_score_gemma":0.00018330781,"threshold_uncertainty_score":0.9874767},"labels":[],"label_agreement":null},{"id":"W2766911482","doi":"10.1016/j.jval.2017.08.2844","title":"Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Argentina","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Spouse; Caregiver burden; Heart failure; Anxiety; Family medicine; Disease; Gerontology; Psychiatry; Internal medicine","score_opus":0.04856459005445351,"score_gpt":0.3426876044657896,"score_spread":0.2941230144113361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766911482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93780845,0.0001592226,0.000004960568,0.059909824,0.00019271566,0.0009342072,0.000002186501,0.000013276043,0.0009751627],"genre_scores_gemma":[0.99900836,0.00006433045,0.00037723975,0.0001932187,0.00012132042,0.00001889466,0.000009799798,0.000012199588,0.00019465946],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879503,0.00012824955,0.000298349,0.00020645953,0.00026207135,0.00030984587],"domain_scores_gemma":[0.9991266,0.00006277121,0.00016455563,0.00054173515,0.000029109364,0.00007518962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052641414,0.000110935944,0.00028638623,0.00013395575,0.00015476045,0.000031586962,0.00012066808,0.00004597358,0.00003340194],"category_scores_gemma":[0.00009819672,0.000077321376,0.00005776216,0.00009109643,0.000059555634,0.0001059259,0.000053907846,0.0001882092,0.000020990119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011782108,0.0012300385,0.929409,0.0016163752,0.00008277052,0.00006260275,0.0064620166,0.0036104613,0.00011144129,0.0019474862,0.03240705,0.022942904],"study_design_scores_gemma":[0.0062806522,0.0015245068,0.8071436,0.0027406844,0.000031841064,0.0000028580978,0.0021365636,0.0033801172,0.0001826618,0.0001033788,0.17629625,0.00017688156],"about_ca_topic_score_codex":0.015605756,"about_ca_topic_score_gemma":0.00034657097,"teacher_disagreement_score":0.14388919,"about_ca_system_score_codex":0.00047175118,"about_ca_system_score_gemma":0.000267052,"threshold_uncertainty_score":0.9909494},"labels":[],"label_agreement":null},{"id":"W2766920003","doi":"10.1016/j.jval.2017.08.1523","title":"Observed Reduction of Healthcare Utilization after Omalizumab Initiation Among Patients with Persistent Asthma Followed in Canadian Clinical Settings","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GDI Integrated Facility Services (Canada); Novartis (Canada); Université Laval; Ottawa Allergy Research Corporation","funders":"","keywords":"Omalizumab; Medicine; Asthma; Emergency department; Pediatrics; Receipt; Observational study; Population; Retrospective cohort study; Clinical endpoint; Emergency medicine; Internal medicine; Clinical trial; Environmental health; Immunoglobulin E","score_opus":0.08250806495527803,"score_gpt":0.3408665259369044,"score_spread":0.2583584609816264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766920003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996188,0.0003096159,0.0000022822587,0.0022931073,0.00027449187,0.00083912804,0.000031321262,0.000011241623,0.000050842937],"genre_scores_gemma":[0.9992652,0.000046242883,0.000110504945,0.0003391595,0.00007358494,0.0000312862,0.000102717735,0.00001907093,0.0000122463725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813277,0.00030110864,0.00067861646,0.0002851966,0.00026693044,0.00033535418],"domain_scores_gemma":[0.9985717,0.00002923545,0.00044327835,0.00035345828,0.00017554291,0.00042681975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062671193,0.000115818366,0.00033575206,0.00023582178,0.00013481076,0.000014293907,0.00007188942,0.00012810121,0.000013918377],"category_scores_gemma":[0.0003959369,0.0001017358,0.0000812942,0.00014143923,0.000101531965,0.00017436659,0.000015514657,0.00019028912,0.0000017150477],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004934525,0.00019407863,0.9924184,0.000421258,0.000008033251,0.000017595848,0.0006089856,0.00012608198,3.831012e-7,0.000015891457,0.000025491792,0.0056703635],"study_design_scores_gemma":[0.0025086426,0.0010217805,0.9928535,0.0013066109,0.000010317273,0.0000018692905,0.0003762106,0.0015184261,0.0000038340495,0.0000062620056,0.00030991164,0.00008260926],"about_ca_topic_score_codex":0.28699812,"about_ca_topic_score_gemma":0.13563935,"teacher_disagreement_score":0.15135877,"about_ca_system_score_codex":0.00053876766,"about_ca_system_score_gemma":0.0016063432,"threshold_uncertainty_score":0.880133},"labels":[],"label_agreement":null},{"id":"W2766924311","doi":"10.1016/j.jval.2017.08.548","title":"Health Care Use Among Incident Cases of Heart Failure: A Population-Based Cohort Study from 1997 To 2010","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Medicine; Heart failure; Atrial fibrillation; Incidence (geometry); Cohort; Mortality rate; Emergency medicine; Population; Diabetes mellitus; Cohort study; Internal medicine","score_opus":0.051261072957602634,"score_gpt":0.348788307715528,"score_spread":0.29752723475792536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766924311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97002935,0.0001639942,0.000024768331,0.0245761,0.00026480894,0.004799994,0.000085786,0.00004905509,0.0000061616474],"genre_scores_gemma":[0.9919054,0.000013545714,0.006147349,0.001346935,0.00009526572,0.0001518945,0.00022697859,0.000029711842,0.000082933526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975531,0.0002857188,0.00073648675,0.0004698961,0.0005373331,0.00041745076],"domain_scores_gemma":[0.9978271,0.00019041602,0.0003359872,0.0011289195,0.000085166466,0.00043242192],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007200228,0.0002121701,0.0008070539,0.00026944507,0.0002867025,0.00005240794,0.00013209919,0.00005965738,0.0000380813],"category_scores_gemma":[0.00035859825,0.00019089547,0.00008659036,0.00014290327,0.000032728673,0.00013909486,0.00008125264,0.00017284592,0.000021198362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001006896,0.00051997625,0.9876359,0.00019200829,0.000045342964,0.00005442132,0.0012850167,0.00040156016,0.0000018935895,0.000012637331,0.009277929,0.00047261457],"study_design_scores_gemma":[0.0019014698,0.0014891343,0.99159455,0.00051663344,0.00003966728,0.0000018007582,0.000902375,0.00019022201,0.000013589743,0.0000047506887,0.0032254138,0.000120362776],"about_ca_topic_score_codex":0.7751638,"about_ca_topic_score_gemma":0.15675241,"teacher_disagreement_score":0.6184114,"about_ca_system_score_codex":0.00079089333,"about_ca_system_score_gemma":0.0005295711,"threshold_uncertainty_score":0.85863465},"labels":[],"label_agreement":null},{"id":"W2766988545","doi":"10.1016/j.jval.2017.08.1819","title":"Characteristics And Approvals Of Regulatory Submissions Based On Non-Randomized Studies In The United States And Europe","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Medicine; Randomized controlled trial; Orphan drug; Placebo; Food and drug administration; Drug approval; Population; MEDLINE; European union; Alternative medicine; Family medicine; Intensive care medicine; Drug; Internal medicine; Pharmacology; Environmental health; Bioinformatics; Business; Law; Political science; Pathology","score_opus":0.6477175901327824,"score_gpt":0.576844853450072,"score_spread":0.07087273668271044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2766988545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920495,0.00016493932,0.0016775986,0.003965791,0.00024269857,0.0015882318,0.000079636244,0.000013439938,0.0002181387],"genre_scores_gemma":[0.789669,0.004337886,0.20471284,0.0010365639,0.00008720693,0.000076662465,0.0000036051078,0.000034922086,0.000041316347],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9941435,0.0040622884,0.0011079177,0.00023649812,0.0002446167,0.00020519426],"domain_scores_gemma":[0.899725,0.09880676,0.0007224301,0.00057709916,0.00008911714,0.00007955506],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018890955,0.00013727794,0.0010724699,0.00013367689,0.00014533482,0.000026403175,0.00019909578,0.00006396703,0.000003840836],"category_scores_gemma":[0.19985071,0.00008291575,0.000034972967,0.00012656047,0.00085894566,0.000021797892,0.00007812886,0.00026411362,5.6750196e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.050690647,0.0038541828,0.05038675,0.02656889,0.00040124886,0.0002008757,0.040428184,0.0006580128,0.0001373736,0.79797226,0.003378313,0.025323244],"study_design_scores_gemma":[0.03886327,0.00043661078,0.04881717,0.0029028787,0.00006150279,0.0000023217722,0.00064811326,0.06686807,0.000049848262,0.8410133,0.00012827819,0.00020861912],"about_ca_topic_score_codex":0.00032961194,"about_ca_topic_score_gemma":0.0000046870273,"teacher_disagreement_score":0.20303525,"about_ca_system_score_codex":0.000023481649,"about_ca_system_score_gemma":0.00008041656,"threshold_uncertainty_score":0.8068893},"labels":[],"label_agreement":null},{"id":"W2767001703","doi":"10.1016/j.jval.2017.08.2959","title":"Comparative Effectiveness of Secukinumab and Adalimumab in Ankylosing Spondylitis as Assessed by Matching-Adjusted Indirect Comparison: An Analysis Based on All Pivotal Phase 3 Clinical Trial Data","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Secukinumab; Adalimumab; BASFI; Ankylosing spondylitis; Placebo; Odds ratio; Internal medicine; BASDAI; Logistic regression; Tumor necrosis factor alpha; Disease; Pathology","score_opus":0.27024685298879236,"score_gpt":0.5160331448616927,"score_spread":0.24578629187290035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767001703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99567604,0.0007592077,0.00006804737,0.0002165032,0.00021379514,0.0016661297,0.0012283149,0.0000217648,0.00015017933],"genre_scores_gemma":[0.99701947,0.00013540639,0.0004852805,0.00011360444,0.000061088394,0.000036830905,0.0021246849,0.000020181375,0.0000034494624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99511695,0.0020966155,0.0011227133,0.0008280214,0.00043005293,0.00040567224],"domain_scores_gemma":[0.99623597,0.0015799534,0.00069517404,0.001167567,0.00006204539,0.00025926388],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034115708,0.00028284502,0.0022703286,0.0003647143,0.00022088167,0.000056864916,0.0002648862,0.00014303067,0.000028824876],"category_scores_gemma":[0.00043815267,0.00025942895,0.00011799839,0.00034070856,0.0002047879,0.00020437318,0.0001272641,0.00041495814,0.0000016500234],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.20347887,0.020049118,0.7613738,0.00072275713,0.0015238117,0.0005143276,0.0019758379,0.00094098476,0.000086058084,0.00011733183,0.00007559113,0.009141474],"study_design_scores_gemma":[0.23925859,0.01632383,0.6349331,0.0014344617,0.0005686942,0.000011352698,0.00066759216,0.10615509,0.00014853073,0.00006674532,0.00015784473,0.00027418227],"about_ca_topic_score_codex":0.02707886,"about_ca_topic_score_gemma":0.0028583487,"teacher_disagreement_score":0.12644075,"about_ca_system_score_codex":0.00025943786,"about_ca_system_score_gemma":0.0003804268,"threshold_uncertainty_score":0.9999858},"labels":[],"label_agreement":null},{"id":"W2767003101","doi":"10.1016/j.jval.2017.08.2979","title":"Secukinumab vs. Adalimumab for the Treatment of Psoriatic Arthritis: A Cost Per Responder Analysis at 48 Weeks from a Brazilian Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Secukinumab; Adalimumab; Medicine; Psoriatic arthritis; Internal medicine; Arthritis; Rheumatoid arthritis","score_opus":0.2898852686510517,"score_gpt":0.43815052363955315,"score_spread":0.14826525498850146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767003101","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.801865,0.034933995,0.003598232,0.1469555,0.0014211205,0.005435416,0.004987957,0.00004142714,0.00076138496],"genre_scores_gemma":[0.99005234,0.0039520906,0.0017707153,0.0024114184,0.00039754613,0.000672096,0.00006408681,0.000041774627,0.0006379393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994697,0.0005673266,0.0033167154,0.00074791186,0.0001306716,0.0005403952],"domain_scores_gemma":[0.99205875,0.0027256687,0.0034569895,0.0014644003,0.00010298986,0.00019122382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008247415,0.00024395948,0.0016628575,0.0004654713,0.0008034582,0.00011026094,0.0004511415,0.00014639585,0.00043796308],"category_scores_gemma":[0.0021669955,0.00024407687,0.0004047747,0.00020107617,0.00014277454,0.00024407041,0.00004614021,0.00011721858,0.00025936178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026923472,0.0029734524,0.40016273,0.0011397895,0.006826925,0.000008934347,0.22595242,0.026173908,0.0000031558275,0.30047187,0.020443743,0.0131507255],"study_design_scores_gemma":[0.014384255,0.0016591767,0.566626,0.00040812805,0.00023262606,0.0000042434585,0.015489015,0.19076903,0.000012339206,0.06379028,0.14573626,0.0008886273],"about_ca_topic_score_codex":0.14968926,"about_ca_topic_score_gemma":0.02713877,"teacher_disagreement_score":0.2366816,"about_ca_system_score_codex":0.0042558806,"about_ca_system_score_gemma":0.0005029498,"threshold_uncertainty_score":0.9995666},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"grok","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2767037589","doi":"10.1016/j.jval.2017.08.273","title":"Characterizing The Utilization of The Trillium Drug Program by An Oncology Patient Population","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Institute for Cancer Research; Sunnybrook Hospital; Princess Margaret Cancer Centre; Cancer Care Ontario; Institute for Clinical Evaluative Sciences","funders":"","keywords":"Medicine; Cancer; Cancer registry; Cohort; Population; Incidence (geometry); Prostate cancer; Cancer drugs; Breast cancer; Internal medicine; Environmental health","score_opus":0.0976468212976088,"score_gpt":0.3281997216850771,"score_spread":0.2305529003874683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767037589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897173,0.0008640603,0.00004145396,0.00575869,0.0008580223,0.0006511573,0.000078630095,0.000010276766,0.0020204063],"genre_scores_gemma":[0.9986338,0.00048017394,0.00008796146,0.00059602986,0.00008086293,0.000033203083,0.00001503107,0.0000112677535,0.00006167552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888253,0.000059208447,0.00063945295,0.0001861659,0.000025275673,0.00020737901],"domain_scores_gemma":[0.9981551,0.000028990235,0.0012881418,0.00046704846,0.000016339101,0.000044359353],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008630069,0.00007666295,0.00026471858,0.00004596623,0.00029739787,0.000051385254,0.00029549893,0.00006145898,0.000014514864],"category_scores_gemma":[0.00015730178,0.00005943978,0.00004840774,0.000058898815,0.000067741246,0.0003021074,0.000045985296,0.0001216498,0.000006415202],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056361892,0.00039291615,0.6036196,0.00009251066,0.000012419141,2.3756051e-7,0.0046079294,0.0007732704,0.00001528065,0.10416093,0.00082376704,0.2854448],"study_design_scores_gemma":[0.00036092757,0.00023198615,0.8587644,0.000043216303,0.0000013078443,6.8203116e-7,0.00008596106,0.00920031,0.00007158176,0.00852668,0.122612804,0.00010015589],"about_ca_topic_score_codex":0.018134668,"about_ca_topic_score_gemma":0.00043249477,"teacher_disagreement_score":0.28534463,"about_ca_system_score_codex":0.00026303995,"about_ca_system_score_gemma":0.000072955954,"threshold_uncertainty_score":0.9884037},"labels":[],"label_agreement":null},{"id":"W2767057806","doi":"10.1016/j.jval.2017.08.2675","title":"Treatment Patterns and Impact of Not Achieving Skin Clearance for Psoriasis Patients In Latin America","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Eli Lilly (Canada)","funders":"","keywords":"Medicine; Psoriasis; Dermatology; Quality of life (healthcare); Incidence (geometry); Systemic therapy; Groin; Surgery; Internal medicine","score_opus":0.04440911577702839,"score_gpt":0.3167958107092912,"score_spread":0.2723866949322628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767057806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99815524,0.0005221065,0.000013076404,0.00017370342,0.00021778671,0.0005690889,0.00031281007,0.000007587704,0.000028576089],"genre_scores_gemma":[0.9982947,0.0012767824,0.00020156443,0.000022558825,0.000018794599,0.00005957828,0.00005837024,0.000012801395,0.0000548553],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988753,0.0001943243,0.00034343218,0.00024612027,0.000022995426,0.00031779738],"domain_scores_gemma":[0.9991545,0.00019652535,0.00031571125,0.00028901533,0.000018257557,0.00002596194],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016587287,0.00015195033,0.0004149815,0.00011365849,0.0001555753,0.000009397294,0.00011093496,0.00009705466,0.000012981295],"category_scores_gemma":[0.00007972378,0.00012162299,0.00009268464,0.00004240835,0.000055538225,0.00006374074,0.000029477387,0.00005987956,0.0000057422426],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048320263,0.0002887974,0.7799602,0.000050039616,0.00005565522,0.0000010592877,0.0010932055,0.00006286458,0.0001877364,0.000019111718,0.000010498627,0.2177876],"study_design_scores_gemma":[0.0046691867,0.0015111743,0.99240047,0.000118397715,0.000013614629,0.0000012717923,0.000049935665,0.0000698299,0.0008853733,0.000020982112,0.00016816604,0.000091591544],"about_ca_topic_score_codex":0.042940486,"about_ca_topic_score_gemma":0.00072479603,"teacher_disagreement_score":0.21769601,"about_ca_system_score_codex":0.00018826732,"about_ca_system_score_gemma":0.00008042797,"threshold_uncertainty_score":0.96343267},"labels":[],"label_agreement":null},{"id":"W2767102936","doi":"10.1016/j.jval.2017.08.771","title":"Secukinumab Vs. Adalimumab for Treatment of Ankylosing Spondylitis: A Cost Per Responder Analysis at 52 Weeks from an Argentinian Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Adalimumab; Secukinumab; Medicine; Ankylosing spondylitis; Internal medicine; Tumor necrosis factor alpha; Arthritis; Psoriatic arthritis","score_opus":0.0735229516493286,"score_gpt":0.3888190182910509,"score_spread":0.31529606664172233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767102936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98735595,0.0043693576,0.00004752046,0.0031548052,0.0002015781,0.0017494478,0.0026996422,0.000029549783,0.0003921256],"genre_scores_gemma":[0.9950313,0.0010102559,0.0023307798,0.00018941077,0.00018349227,0.00019445263,0.0005383596,0.000042532647,0.00047940147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976334,0.00017868607,0.00059757987,0.00070085644,0.00031549306,0.0005739785],"domain_scores_gemma":[0.9978909,0.0001863633,0.00044534952,0.0009947357,0.0001918986,0.0002907843],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00030958868,0.00029515233,0.0011720299,0.0003546938,0.0006374017,0.000038978636,0.00012629532,0.00011273936,0.00033615058],"category_scores_gemma":[0.00013175906,0.00025886064,0.00038218976,0.00019822024,0.00013630284,0.0001211169,0.000055213164,0.0000685173,0.000009502559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019079586,0.0048586475,0.9167487,0.00022518924,0.0053280946,0.00039133168,0.036695924,0.00021298604,0.00021110346,0.0019866917,0.00016895769,0.0140927555],"study_design_scores_gemma":[0.025994474,0.0076236655,0.9396831,0.00039825815,0.0015445075,0.000030100095,0.0059468634,0.0029770061,0.00045902544,0.00079188927,0.014190985,0.0003601176],"about_ca_topic_score_codex":0.068988614,"about_ca_topic_score_gemma":0.009577006,"teacher_disagreement_score":0.05941161,"about_ca_system_score_codex":0.0020774363,"about_ca_system_score_gemma":0.00031084334,"threshold_uncertainty_score":0.99998635},"labels":[],"label_agreement":null},{"id":"W2767117194","doi":"10.1016/j.jval.2017.08.2241","title":"Revisiting Indirect Health Preference Elicitation As A Base Case","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Quality-adjusted life year; Preference; Context (archaeology); Actuarial science; Population; Relative value; Value of life; Quality (philosophy); Value (mathematics); Quality of life (healthcare); Psychological intervention; Resource (disambiguation); Preference elicitation; Resource allocation; Public economics; Economics; Medicine; Microeconomics; Risk analysis (engineering); Cost effectiveness; Computer science; Environmental health","score_opus":0.6696764267156496,"score_gpt":0.4853605800244246,"score_spread":0.18431584669122503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767117194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80548936,0.006333072,0.0013795407,0.1789409,0.0008918053,0.0018684273,0.0002717408,0.00010007385,0.004725058],"genre_scores_gemma":[0.9766341,0.00084218767,0.0048306463,0.016803216,0.00044575613,0.00011574923,0.000029390756,0.00004231118,0.0002566554],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9921187,0.0012239106,0.00496517,0.0007887033,0.00012599764,0.0007774778],"domain_scores_gemma":[0.99130744,0.001149783,0.00593144,0.0011197673,0.00005537779,0.0004362222],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03984106,0.00022487096,0.0012245192,0.0004829907,0.0012786447,0.00023019775,0.00039192385,0.00012721434,0.00015438686],"category_scores_gemma":[0.011738379,0.00030480613,0.00009115428,0.00017007091,0.00006733853,0.00073116005,0.00008206421,0.00036238306,0.001230278],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007610596,0.00040906674,0.3925551,0.0098624565,0.000092991744,0.00020877611,0.03722495,0.0062182317,0.0000019081074,0.49903977,0.015118678,0.039191987],"study_design_scores_gemma":[0.007216213,0.0014057627,0.520703,0.0075757937,0.000010302042,0.0012009004,0.010510711,0.22953431,0.000015027852,0.14527561,0.073977545,0.0025748014],"about_ca_topic_score_codex":0.13051741,"about_ca_topic_score_gemma":0.0012311408,"teacher_disagreement_score":0.35376418,"about_ca_system_score_codex":0.0016958737,"about_ca_system_score_gemma":0.00082622055,"threshold_uncertainty_score":0.9999404},"labels":[],"label_agreement":null},{"id":"W2767133819","doi":"10.1016/j.jval.2017.08.2157","title":"Qualitative Interviews To Inform Development Of A Patient Reported Outcome (PRO) Strategy In RLBP1 Retinitis Pigmentosa (RLBP1 RP)","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Development and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Retinitis pigmentosa; Thematic analysis; Medicine; Quality of life (healthcare); Debriefing; Qualitative research; International Classification of Functioning, Disability and Health; Clinical psychology; Family medicine; Psychology; Physical therapy; Ophthalmology; Nursing; Medical education; Rehabilitation","score_opus":0.1604376732304067,"score_gpt":0.42156493867428174,"score_spread":0.26112726544387505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767133819","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918125,0.00020745253,0.0001361773,0.0007528776,0.00012189193,0.0006890472,0.000006630515,0.000005422406,0.006267994],"genre_scores_gemma":[0.99521524,0.00012848183,0.0039165393,0.00032057086,0.00001185701,0.00009222063,0.00006775796,0.000014856135,0.00023250832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974355,0.00017830818,0.0014319725,0.00035404097,0.00022930077,0.00037087186],"domain_scores_gemma":[0.9986604,0.00002127767,0.0006685569,0.00044061564,0.00007743845,0.00013174042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015093192,0.00018831041,0.00035454571,0.00018962106,0.000114402545,0.000027184473,0.00026916093,0.0000985086,0.000018693372],"category_scores_gemma":[0.00048559773,0.00017960541,0.00005584255,0.00015229221,0.00005164456,0.000011080077,0.00021098764,0.00011699482,0.000007893896],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001511916,0.0011266114,0.55714816,0.001993317,0.00019185383,0.00007230178,0.16069153,0.00094650395,0.00953064,0.0025462173,0.0016089202,0.26263204],"study_design_scores_gemma":[0.0069346526,0.004668851,0.75164646,0.0022136937,0.000014443594,0.000027279786,0.052561115,0.0002476389,0.048554536,0.0018144645,0.1292422,0.0020746524],"about_ca_topic_score_codex":0.0012948847,"about_ca_topic_score_gemma":0.001098153,"teacher_disagreement_score":0.26055738,"about_ca_system_score_codex":0.00010921917,"about_ca_system_score_gemma":0.00054094335,"threshold_uncertainty_score":0.7324096},"labels":[],"label_agreement":null},{"id":"W2767141524","doi":"10.1016/j.jval.2017.08.1197","title":"The Economic Impact of Dietary Sodium Reduction In Canada","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Sodium Intake and Health","field":"Nursing","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Population; Environmental health; Blood pressure; Myocardial infarction; Sodium; Demography; Internal medicine; Chemistry","score_opus":0.06030507970031484,"score_gpt":0.34636784873385446,"score_spread":0.2860627690335396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767141524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98731613,0.000507384,1.3645469e-7,0.009282881,0.002123267,0.00026435422,0.000013048158,0.0000053029125,0.00048747705],"genre_scores_gemma":[0.9993298,0.00030157424,0.000027628614,0.00011909637,0.0001856754,0.0000064069313,0.0000026805697,0.000011345971,0.00001576919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99870676,0.00016405345,0.000477306,0.00015901038,0.00009458454,0.00039831668],"domain_scores_gemma":[0.9989333,0.00012339605,0.0003505997,0.0004889656,0.000011927276,0.000091769565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008025025,0.0000852821,0.00022331985,0.000061268256,0.00032636742,0.000021924487,0.00023448259,0.000036493566,0.000011336702],"category_scores_gemma":[0.000064480795,0.000067148576,0.000042688625,0.00003543818,0.000050874864,0.000100600664,0.000021369673,0.00022942119,0.000005484496],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008374479,0.000051843763,0.89217967,0.000305659,0.000017691304,0.0000063196817,0.002991449,0.030831313,0.00012926929,0.0004382094,0.01429602,0.05791513],"study_design_scores_gemma":[0.00039397893,0.00020956619,0.9885085,0.00010483723,0.000001421753,0.000006847001,0.0004162011,0.008597763,0.00011862422,0.0010535507,0.00051774323,0.0000709703],"about_ca_topic_score_codex":0.99936366,"about_ca_topic_score_gemma":0.9838143,"teacher_disagreement_score":0.09632885,"about_ca_system_score_codex":0.0072035785,"about_ca_system_score_gemma":0.0054551354,"threshold_uncertainty_score":0.9966076},"labels":[],"label_agreement":null},{"id":"W2767145646","doi":"10.1016/j.jval.2017.08.1082","title":"Integrating Novel Screening Methods For Prostate Cancer, Cost-Utility Interventions","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Prostate cancer; Prostate; Biopsy; Quality-adjusted life year; Prostate biopsy; Prostate-specific antigen; Cancer; Cost effectiveness; Gynecology; Radiology; Internal medicine; Risk analysis (engineering)","score_opus":0.7768964640079218,"score_gpt":0.5994020993364176,"score_spread":0.17749436467150415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767145646","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017896438,0.007843183,0.88082,0.084793694,0.0020092013,0.004274603,0.0013434964,0.000074862,0.0009445387],"genre_scores_gemma":[0.28699842,0.00066482666,0.7023956,0.0062190895,0.00053303846,0.0021672929,0.00007558734,0.00008376396,0.0008623421],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9930036,0.0006131816,0.00494162,0.0007029292,0.000059524365,0.00067914464],"domain_scores_gemma":[0.9924944,0.0017345634,0.0045754993,0.0008616984,0.000094433846,0.00023938969],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.054238886,0.00020456697,0.0011178848,0.00031327573,0.0009642887,0.00021522406,0.0005288021,0.00012264546,0.00009716007],"category_scores_gemma":[0.01550213,0.000261741,0.0002505139,0.00011473711,0.00009983355,0.00059805164,0.000113627655,0.0003265268,0.0000416376],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012024325,0.0006077176,0.38201007,0.00990786,0.0001773179,5.8592923e-7,0.011009723,0.0069684656,0.000010398858,0.40598667,0.008635871,0.17456508],"study_design_scores_gemma":[0.003055164,0.0002225196,0.13182147,0.0029696662,0.000008075001,0.0000033591116,0.0019021088,0.7011184,0.000012896278,0.041507244,0.116791226,0.00058785465],"about_ca_topic_score_codex":0.06588484,"about_ca_topic_score_gemma":0.0029300842,"teacher_disagreement_score":0.69415,"about_ca_system_score_codex":0.00089305016,"about_ca_system_score_gemma":0.0004236109,"threshold_uncertainty_score":0.9999835},"labels":[],"label_agreement":null},{"id":"W2767153714","doi":"10.1016/j.jval.2017.08.2677","title":"Characteristics of Psoriasis Patients In Latin America","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Demographics; Psoriasis; Scalp; Groin; Dermatology; Surgery; Pediatrics; Demography","score_opus":0.036731974026227215,"score_gpt":0.27956688195942864,"score_spread":0.24283490793320142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767153714","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979076,0.00036364625,0.0000033172819,0.00021749084,0.00078105426,0.00021259357,0.00010553387,0.000009306799,0.00039950313],"genre_scores_gemma":[0.9986857,0.000797349,0.00015974077,0.000058531317,0.00001970863,0.000014708453,0.00008654061,0.000009092288,0.00016861132],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988572,0.00023760866,0.00042720968,0.00017882942,0.000028527887,0.00027064965],"domain_scores_gemma":[0.99908453,0.00010455304,0.00040669265,0.0003606088,0.000024813753,0.000018799903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002353648,0.000105694024,0.00035670836,0.00012163589,0.00011098268,0.000005758539,0.00019200749,0.00010934657,0.000059322432],"category_scores_gemma":[0.00019456356,0.0000985004,0.00004160551,0.000067422734,0.000081275866,0.00004889174,0.000048140588,0.00010918654,0.00007672032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010937138,0.0003059038,0.87609345,0.00004707953,0.000018145804,0.0000029812643,0.0006911778,0.000005086401,0.00019426583,0.00013820722,0.00009715785,0.12229716],"study_design_scores_gemma":[0.0016661361,0.00020365928,0.9952383,0.000100899415,0.0000061955448,6.01167e-7,0.00003092094,0.000011611866,0.00059375906,0.000076888435,0.0019936312,0.00007736627],"about_ca_topic_score_codex":0.009145459,"about_ca_topic_score_gemma":0.00012844068,"teacher_disagreement_score":0.1222198,"about_ca_system_score_codex":0.00007054749,"about_ca_system_score_gemma":0.00008592111,"threshold_uncertainty_score":0.99745274},"labels":[],"label_agreement":null},{"id":"W2767174961","doi":"10.1016/j.jval.2017.08.2986","title":"Patient-Reported outcomes from Phase 3 Baricitinib Ra-Begin Study: Latin American Subgroup Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Quality of life (healthcare); Visual analogue scale; Rheumatoid arthritis; Internal medicine; Methotrexate; Combination therapy; Physical therapy; Subgroup analysis; Confidence interval","score_opus":0.06600752135216663,"score_gpt":0.3868284313646635,"score_spread":0.32082091001249685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767174961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994074,0.00077504886,0.000078858684,0.003545655,0.00011311669,0.0009861203,0.00007297059,0.00006329621,0.00029096258],"genre_scores_gemma":[0.9974326,0.00123379,0.00064578216,0.00039329266,0.00004426735,0.00006304109,0.00009263563,0.000026472226,0.00006815839],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970798,0.0003965433,0.0008212837,0.0004727555,0.0006601065,0.0005695246],"domain_scores_gemma":[0.9974767,0.00027870387,0.000597384,0.0011455875,0.00008694259,0.00041467624],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007887767,0.00020353195,0.0010412748,0.00044792684,0.00037771216,0.000103280436,0.0002017629,0.000037213875,0.00026674164],"category_scores_gemma":[0.00089248776,0.00017037959,0.00018057703,0.0004676883,0.00020326611,0.000119947246,0.00008200965,0.0003308263,0.000025652507],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028760775,0.0013955005,0.9244908,0.000013651177,0.0007048855,0.00023012132,0.0031066134,0.000040960786,0.000034181638,0.00003109801,0.000101547674,0.06956302],"study_design_scores_gemma":[0.0072342125,0.0017781162,0.9842268,0.000096592215,0.00003452653,0.0000022146148,0.0022740131,0.0028778804,0.000028561106,0.00013137468,0.001167679,0.00014803502],"about_ca_topic_score_codex":0.18962455,"about_ca_topic_score_gemma":0.004968485,"teacher_disagreement_score":0.18465607,"about_ca_system_score_codex":0.00013744051,"about_ca_system_score_gemma":0.00029393414,"threshold_uncertainty_score":0.8157718},"labels":[],"label_agreement":null},{"id":"W2767191336","doi":"10.1016/j.jval.2017.08.881","title":"Healthcare Insurance Spending At Year 2 Between Treatment Groups Following Diagnosis Of Nontuberculous Mycobacterial Lung Disease In The US","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Nontuberculous mycobacteria; Internal medicine; Cystic fibrosis; Tuberculosis; Asthma; Comorbidity; Ethambutol; Ivacaftor; Pharmacy; Rifampicin; Family medicine; Pathology; Mycobacterium","score_opus":0.06283266517973207,"score_gpt":0.36302721634824064,"score_spread":0.30019455116850857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767191336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896906,0.0014249827,7.8907124e-7,0.0065892707,0.0003569505,0.0015457709,0.0002505581,0.00001606106,0.00012501575],"genre_scores_gemma":[0.9957366,0.003159833,0.00006585448,0.00018542088,0.00046354716,0.0002591189,0.00008796215,0.00002784567,0.000013828648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972599,0.0004996181,0.000618448,0.00039636568,0.0005304637,0.00069516874],"domain_scores_gemma":[0.99774575,0.0006058884,0.00025616007,0.0008920597,0.000027018812,0.0004731466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011140668,0.0002111927,0.0006630906,0.00019261295,0.00031132804,0.00005503953,0.00031152688,0.000084721556,0.000040347735],"category_scores_gemma":[0.000674744,0.00015514392,0.00019666631,0.000171556,0.000067346235,0.00015661228,0.00010848985,0.00023567831,0.000015647416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041802498,0.0002757629,0.9944273,0.00071256934,0.000032604483,0.00026155607,0.0012159888,0.000017041502,0.000023578395,0.000093173934,0.000075654345,0.0024467357],"study_design_scores_gemma":[0.0028088975,0.0005657905,0.9944477,0.0012635932,0.000026908656,0.0000031555276,0.000063184045,0.00009719728,0.00010368284,0.000065671295,0.0004412487,0.000112941314],"about_ca_topic_score_codex":0.058262043,"about_ca_topic_score_gemma":0.0017959848,"teacher_disagreement_score":0.056466058,"about_ca_system_score_codex":0.0011384116,"about_ca_system_score_gemma":0.00040944872,"threshold_uncertainty_score":0.9480091},"labels":[],"label_agreement":null},{"id":"W2767198133","doi":"10.1016/j.jval.2017.08.2401","title":"Development of A New Patient-Reported Outcome Instrument To Evaluate Treatments For Stretchmarks: The Body-Q Stretchmark Scale","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Rasch model; Patient-reported outcome; Scale (ratio); Cronbach's alpha; Body contouring; Clinical psychology; Psychology; Item response theory; Operationalization; Distress; Psychosocial; Medicine; Physical therapy; Psychometrics; Quality of life (healthcare); Developmental psychology; Psychiatry; Weight loss; Internal medicine; Obesity; Psychotherapist; Geography","score_opus":0.18237214870573912,"score_gpt":0.4297200905538024,"score_spread":0.24734794184806327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767198133","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846955,0.000181012,0.000033061267,0.01076599,0.0002383732,0.0033849413,0.000020184754,0.000016124299,0.0006648399],"genre_scores_gemma":[0.9846865,0.00006351503,0.013762513,0.00029337767,0.000031191816,0.0002481848,0.000033963806,0.000020392026,0.00086035964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974375,0.00009292022,0.0009973974,0.0003629252,0.0005749224,0.0005343751],"domain_scores_gemma":[0.99815774,0.000087375694,0.0004547511,0.0008290615,0.00009829472,0.00037279897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077280606,0.00020226368,0.0005435802,0.00013441878,0.00037557178,0.000035181107,0.00023572578,0.00007289168,0.000049947077],"category_scores_gemma":[0.00026509693,0.00011526045,0.000103588914,0.00010516929,0.000062867766,0.000053687192,0.00013512069,0.00012618574,0.000011511761],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007435139,0.001082007,0.6027773,0.0003337255,0.00041855266,0.000040388342,0.005291234,0.00006230785,0.00009132047,0.00009325208,0.0015666998,0.3874997],"study_design_scores_gemma":[0.0081827855,0.0015379282,0.97318596,0.0006978098,0.00009289283,0.000037437752,0.0012871472,0.001032304,0.0015325693,0.0003093652,0.01192314,0.00018064237],"about_ca_topic_score_codex":0.003218565,"about_ca_topic_score_gemma":0.00014534591,"teacher_disagreement_score":0.38731906,"about_ca_system_score_codex":0.000504364,"about_ca_system_score_gemma":0.0014760445,"threshold_uncertainty_score":0.48655286},"labels":[],"label_agreement":null},{"id":"W2767203323","doi":"10.1016/j.jval.2017.08.1060","title":"Cost-Effectiveness Of A Supraciliary Micro-Stent Glaucoma Implant Combined With Cataract Surgery In Management Of Primary Open-Angle Glaucoma (POAG) From The Canadian Payer Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Alcon (Canada); Prism Eye Institute","funders":"","keywords":"Medicine; Trabeculectomy; Cataract surgery; Glaucoma; Intraocular pressure; Open angle glaucoma; Incremental cost-effectiveness ratio; Randomized controlled trial; Adverse effect; Glaucoma surgery; Ophthalmology; Clinical trial; Surgery; Quality-adjusted life year; Cost effectiveness; Internal medicine","score_opus":0.05640213813470263,"score_gpt":0.3147829040293632,"score_spread":0.2583807658946606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767203323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884508,0.0011652797,0.00000549617,0.0052866596,0.00017471175,0.0037337053,0.00019453485,0.000007816047,0.0009809445],"genre_scores_gemma":[0.99855614,0.00044599836,0.0002658358,0.0003663718,0.000014704397,0.00013132094,0.00015378787,0.000028985622,0.000036881796],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739915,0.0006598729,0.0006092657,0.0004392198,0.00035723764,0.00053527276],"domain_scores_gemma":[0.9975125,0.00074934814,0.00044477705,0.00091434416,0.00014036855,0.00023864782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020639496,0.0002439109,0.00095393875,0.00022261914,0.00024856548,0.00003691799,0.0005136593,0.000097953816,0.00001760976],"category_scores_gemma":[0.00010249979,0.0001652507,0.000107466585,0.00024053403,0.0002496004,0.00012986359,0.00017244466,0.000356149,0.0000045489132],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037735016,0.0006269752,0.9900763,0.0012842065,0.00016937434,0.00055029354,0.0014491156,0.0000044487397,0.00013435583,0.000721834,0.0003001206,0.00090944953],"study_design_scores_gemma":[0.00376602,0.0006303234,0.9876606,0.0038765906,0.00005629893,0.00005630801,0.002842669,0.00008036992,0.00025889475,0.00035924074,0.00024761003,0.00016508317],"about_ca_topic_score_codex":0.9277232,"about_ca_topic_score_gemma":0.44177014,"teacher_disagreement_score":0.4859531,"about_ca_system_score_codex":0.0012969447,"about_ca_system_score_gemma":0.0019969468,"threshold_uncertainty_score":0.6738728},"labels":[],"label_agreement":null},{"id":"W2767725047","doi":"10.1016/j.jval.2017.09.015","title":"What Impact Does Venous Thromboembolism and Bleeding Have on Cancer Patients’ Quality of Life?","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Marie Curie","keywords":"Medicine; Quality of life (healthcare); Venous thromboembolism; Cancer; Hemostasis; EQ-5D; Major bleeding; Analysis of variance; Repeated measures design; Internal medicine; Thrombosis; Disease; Health related quality of life; Statistics","score_opus":0.07389960248074597,"score_gpt":0.3948794624123354,"score_spread":0.32097985993158945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2767725047","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99131745,0.0015727301,0.0000012631291,0.0048743896,0.0008651882,0.0008184426,0.000026377076,0.000016833172,0.0005073249],"genre_scores_gemma":[0.9855647,0.012971632,0.00004750383,0.0011430761,0.00018004283,0.000031937798,0.0000067783044,0.000023159426,0.00003118804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982596,0.000110924695,0.00056101184,0.00032590437,0.00035117107,0.00039138107],"domain_scores_gemma":[0.9984984,0.000116059164,0.0005341601,0.0005189326,0.00007408558,0.00025839702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089284877,0.00017563075,0.0009892574,0.00013713015,0.00022439122,0.000079070865,0.00013637508,0.00007572005,0.00004891448],"category_scores_gemma":[0.00029783748,0.00012336348,0.00008366628,0.000045188066,0.00010597551,0.0002430499,0.00009968606,0.00018724891,0.0000031118025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001893646,0.0025100762,0.9623136,0.002075972,0.00019406072,0.0000047801555,0.0063518537,0.0003403959,0.00006987316,0.0026932016,0.00093241857,0.022324393],"study_design_scores_gemma":[0.0017062963,0.0010246569,0.9937735,0.0016351223,0.000029157172,2.79808e-7,0.00061104976,0.00020019752,0.000099952624,0.0005411018,0.00025970294,0.000118934215],"about_ca_topic_score_codex":0.06623576,"about_ca_topic_score_gemma":0.0007046039,"teacher_disagreement_score":0.06553115,"about_ca_system_score_codex":0.00026300523,"about_ca_system_score_gemma":0.00023836753,"threshold_uncertainty_score":0.93998224},"labels":[],"label_agreement":null},{"id":"W2768023721","doi":"10.1016/j.jval.2017.09.009","title":"Informing the Tolerability of Cancer Treatments Using Patient-Reported Outcome Measures: Summary of an FDA and Critical Path Institute Workshop","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":124,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada","funders":"","keywords":"Tolerability; Clinical trial; Food and drug administration; Drug development; Medicine; Terminology; Adverse effect; Common Terminology Criteria for Adverse Events; Alternative medicine; Patient-reported outcome; Regulatory science; Drug; Medical physics; Pharmacology; Internal medicine; Pathology; Nursing; Quality of life (healthcare)","score_opus":0.6308552548625395,"score_gpt":0.5046292452090074,"score_spread":0.12622600965353203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768023721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98864985,0.0025464601,0.00020551673,0.006922132,0.00059350417,0.0007528987,0.00017398442,0.000008678539,0.00014696554],"genre_scores_gemma":[0.9964186,0.00028672797,0.0022448937,0.000918224,0.00006179036,0.000040189076,0.000005886933,0.000013865988,0.000009809708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942514,0.0003501379,0.00456976,0.00036563812,0.00012822049,0.0003348846],"domain_scores_gemma":[0.9941631,0.00069322344,0.00401218,0.0008811744,0.00008334341,0.00016696636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011629732,0.00014918613,0.0009851671,0.00016046941,0.00038000089,0.00004706025,0.00024646713,0.00010668758,0.000015571311],"category_scores_gemma":[0.008055276,0.00014447607,0.000068352456,0.00008938492,0.00029676076,0.00075914385,0.00007885503,0.00016736203,0.0000019665208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027454644,0.00015150693,0.98087114,0.000806674,0.00003899697,0.0000011481847,0.003772551,0.0031821406,0.0000016549589,0.006532517,0.000017137165,0.0045970697],"study_design_scores_gemma":[0.0014130656,0.00021942142,0.9255786,0.0009935145,0.000019101095,0.0000070628507,0.0017367986,0.061265733,0.000013510446,0.00736976,0.0010888244,0.0002946372],"about_ca_topic_score_codex":0.108136624,"about_ca_topic_score_gemma":0.002437988,"teacher_disagreement_score":0.10569864,"about_ca_system_score_codex":0.0006004103,"about_ca_system_score_gemma":0.0005395226,"threshold_uncertainty_score":0.96435004},"labels":[],"label_agreement":null},{"id":"W2768414951","doi":"10.1046/j.1524-4733.2001.40202-290.x","title":"PQP7: IS COMPLIANCE WITH DRUG TREATMENT CORRELATED WITH HEALTH RELATED QUALITY OF LIFE?","year":2001,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"","keywords":"Compliance (psychology); Drug; Drug treatment; Quality of life (healthcare); Quality (philosophy); Medicine; Intensive care medicine; Pharmacology; Psychology; Internal medicine; Nursing; Social psychology; Philosophy","score_opus":0.3780971992205958,"score_gpt":0.4672445697107085,"score_spread":0.08914737049011268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2768414951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585921,0.0031209607,0.00007389904,0.035237346,0.00010525208,0.0013184589,0.000022555272,0.00005899055,0.0014704091],"genre_scores_gemma":[0.99134076,0.001629908,0.00094586046,0.005061709,0.000019607249,0.000014528311,0.000032160042,0.000025520998,0.00092993345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99726826,0.0005240121,0.0009939094,0.00033965963,0.00041002463,0.00046412498],"domain_scores_gemma":[0.99788034,0.0004608956,0.00070458296,0.00036775245,0.00007649934,0.00050994306],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009153969,0.00020635255,0.00086382893,0.000106256164,0.000088608875,0.0000058369096,0.00006839427,0.00005624028,0.000120410026],"category_scores_gemma":[0.00007843724,0.00013436946,0.00005465665,0.00061350944,0.00009801922,0.00009547856,0.000012960633,0.0003685508,0.000026490627],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005276055,0.0014576104,0.982033,0.0010166673,0.0001549065,0.00004274407,0.004227652,0.0014090113,0.0000052951605,0.00040101094,0.00044855673,0.0035274806],"study_design_scores_gemma":[0.037992135,0.015305583,0.87312853,0.004833703,0.00013429439,0.00030592392,0.002142961,0.044292,0.00008501185,0.00022253826,0.020909319,0.0006480189],"about_ca_topic_score_codex":0.033780146,"about_ca_topic_score_gemma":0.00030341902,"teacher_disagreement_score":0.108904496,"about_ca_system_score_codex":0.00045818381,"about_ca_system_score_gemma":0.001024939,"threshold_uncertainty_score":0.972654},"labels":[],"label_agreement":null},{"id":"W2770033375","doi":"10.1016/j.jval.2017.10.001","title":"The Use of MCDA in HTA: Great Potential, but More Effort Needed","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":110,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Multiple-criteria decision analysis; Decision analysis; Health technology; Management science; Risk analysis (engineering); Health care; Medicine; Operations research; Political science; Engineering; Economics","score_opus":0.5732722177594017,"score_gpt":0.4426717322215603,"score_spread":0.13060048553784143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770033375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91499394,0.0020709378,0.0002044548,0.08018745,0.0009897597,0.0010242518,0.00015624345,0.00001729861,0.0003556534],"genre_scores_gemma":[0.9908101,0.0017167876,0.0014816571,0.0049971864,0.00020369205,0.00008218961,0.000013093515,0.000035944424,0.0006593615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940554,0.00036919737,0.00442804,0.00044504233,0.000113875336,0.00058845297],"domain_scores_gemma":[0.994352,0.0008999783,0.0032966028,0.0012446526,0.000042302323,0.00016448302],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016870288,0.00016952996,0.0009672562,0.00032855518,0.00049395,0.00016132664,0.00056933484,0.00014145358,0.000038309976],"category_scores_gemma":[0.004073858,0.00017892495,0.00010634936,0.0001299786,0.00017236664,0.00055841595,0.00010634629,0.00026507032,0.00016883628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000878518,0.0002052475,0.8517374,0.0012441973,0.00005192931,0.000008384147,0.0040205526,0.026123255,0.0000023159098,0.093141444,0.021913996,0.0014634206],"study_design_scores_gemma":[0.0021043045,0.00015457081,0.82219166,0.0005295949,0.0000031187935,0.000009119341,0.0016311159,0.1029836,0.000007502265,0.012928639,0.0570532,0.00040357633],"about_ca_topic_score_codex":0.16944255,"about_ca_topic_score_gemma":0.0028978034,"teacher_disagreement_score":0.16654475,"about_ca_system_score_codex":0.0006930219,"about_ca_system_score_gemma":0.0003886568,"threshold_uncertainty_score":0.8360882},"labels":[],"label_agreement":null},{"id":"W2770573141","doi":"10.1016/j.jval.2014.03.1121","title":"Review of models used in economic analyses of new oral treatments for type 2 diabetes mellitus","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Psychological intervention; Diabetes mellitus; Intensive care medicine; Type 2 diabetes; MEDLINE; Time horizon; Type 2 Diabetes Mellitus; Health care; Nursing; Endocrinology","score_opus":0.7243221584177844,"score_gpt":0.5205481949066872,"score_spread":0.2037739635110971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2770573141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73742974,0.24025197,0.0022297862,0.015263251,0.0006842776,0.0030916126,0.00043789155,0.000023520784,0.00058797887],"genre_scores_gemma":[0.91330546,0.062580794,0.015312485,0.008116607,0.00018868833,0.00015174018,0.00012670264,0.00006601537,0.00015148868],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9937033,0.00047791965,0.0050052814,0.00039229594,0.000047969275,0.0003732278],"domain_scores_gemma":[0.9957439,0.00110914,0.002523358,0.00044752617,0.00003339749,0.00014272086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013979913,0.00015590215,0.0018509992,0.0004466849,0.000026350965,0.000007350683,0.00020606362,0.00008755586,0.00007026433],"category_scores_gemma":[0.0013029851,0.00018854602,0.00013564687,0.00023403467,0.000030816704,0.00022492996,0.000020794469,0.00007379938,0.000060805425],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117656746,0.0008932177,0.35611156,0.079381615,0.00045938866,2.2348945e-7,0.00443321,0.21682408,0.000011622168,0.30550113,0.027446609,0.0088197],"study_design_scores_gemma":[0.006250152,0.0014548388,0.025995277,0.014900071,0.000048203212,7.123928e-7,0.0002445388,0.69389004,0.000116854375,0.23423357,0.022100663,0.0007651058],"about_ca_topic_score_codex":0.024111515,"about_ca_topic_score_gemma":0.00045369627,"teacher_disagreement_score":0.47706592,"about_ca_system_score_codex":0.000730203,"about_ca_system_score_gemma":0.0005487918,"threshold_uncertainty_score":0.982387},"labels":[],"label_agreement":null},{"id":"W2772793015","doi":"10.1016/j.jval.2017.10.018","title":"ISPOR Code of Ethics 2017 (4th Edition)","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SKiN Health","funders":"European Organisation for Rare Diseases; Agency for Healthcare Research and Quality; European Federation of Pharmaceutical Industries and Associations; Patient-Centered Outcomes Research Institute","keywords":"Transparency (behavior); Beneficence; Research ethics; Scientific misconduct; Ethical code; Conflict of interest; Political science; Incentive; Medicine; Public relations; Engineering ethics; Alternative medicine; Engineering; Autonomy; Law","score_opus":0.7120559726715702,"score_gpt":0.5139610946457226,"score_spread":0.19809487802584758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772793015","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32775515,0.0075781643,0.0064546065,0.6177,0.006890506,0.0024618774,0.0024328781,0.00010862822,0.028618183],"genre_scores_gemma":[0.9773668,0.0016308682,0.0057888697,0.0133325625,0.0008054074,0.00006608622,0.000042369382,0.000042387666,0.0009246441],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.993981,0.0005380263,0.0043750103,0.0004889753,0.00013853559,0.00047842617],"domain_scores_gemma":[0.99187875,0.0013365076,0.0052800686,0.0012086197,0.00007910942,0.00021697645],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.038751293,0.00015477426,0.0010551424,0.00031802358,0.000539338,0.00006918514,0.0005910846,0.00023926495,0.00020835607],"category_scores_gemma":[0.011167732,0.00020794294,0.00010058157,0.00008067016,0.00016961327,0.000517021,0.00007733433,0.00049116526,0.00088618946],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023071494,0.0002210823,0.16908112,0.0025897222,0.00003325682,0.000002695808,0.006005723,0.002207511,0.0000012984658,0.7561855,0.063374944,0.00027410404],"study_design_scores_gemma":[0.0026052103,0.00033382405,0.5321236,0.0013736725,0.0000045836264,0.000011653406,0.0011776432,0.028510464,0.000015666232,0.17270574,0.26044106,0.000696864],"about_ca_topic_score_codex":0.031033922,"about_ca_topic_score_gemma":0.001092577,"teacher_disagreement_score":0.64961165,"about_ca_system_score_codex":0.00056954246,"about_ca_system_score_gemma":0.00082688144,"threshold_uncertainty_score":0.99989176},"labels":[],"label_agreement":null},{"id":"W2772813269","doi":"10.1016/j.jval.2017.10.014","title":"Agreement among the Productivity Components of Eight Presenteeism Tests in a Sample of Health Care Workers","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"University of Alberta","keywords":"Presenteeism; Context (archaeology); Variance (accounting); Construct validity; Productivity; Sample (material); Test (biology); Psychology; Health care; Construct (python library); Medicine; Statistics; Absenteeism; Psychometrics; Clinical psychology; Social psychology; Mathematics; Computer science; Economics","score_opus":0.08888480415211664,"score_gpt":0.4093968860784344,"score_spread":0.32051208192631775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2772813269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9695563,0.0023636105,0.000044710217,0.02176673,0.0009782739,0.0043959385,0.000058921716,0.000018403469,0.00081711414],"genre_scores_gemma":[0.9980305,0.0004055121,0.00059000996,0.0004739258,0.00014979074,0.00018681136,0.000029951358,0.000028463046,0.000105068284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99234515,0.0034673798,0.0019451584,0.00048317044,0.00055757,0.0012015442],"domain_scores_gemma":[0.9945249,0.0014990695,0.0022108878,0.0013693298,0.00013914792,0.00025665772],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.007026257,0.0002240363,0.00085871,0.00024431784,0.0013746113,0.000008852625,0.00061374047,0.0001569981,0.000027897795],"category_scores_gemma":[0.0012120084,0.00017458359,0.000074746364,0.0003298764,0.00024957623,0.00016072139,0.00029941287,0.0010889687,0.000008610122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012460684,0.00020183214,0.9652242,0.0048470316,0.000008641766,0.0000014817421,0.022724312,0.00069331,0.00000561229,0.00040948746,0.0009909857,0.004768468],"study_design_scores_gemma":[0.0014026307,0.00018539188,0.9847093,0.004354276,0.0000028473762,3.3994903e-7,0.004946289,0.00053149735,0.000013862311,0.00070345565,0.0030350634,0.00011504935],"about_ca_topic_score_codex":0.4183352,"about_ca_topic_score_gemma":0.023831768,"teacher_disagreement_score":0.39450344,"about_ca_system_score_codex":0.00082690717,"about_ca_system_score_gemma":0.0021287936,"threshold_uncertainty_score":0.99992543},"labels":[],"label_agreement":null},{"id":"W2795706072","doi":"10.1016/j.jval.2018.02.007","title":"Minimally Important Difference of the EQ-5D-5L Index Score in Adults with Type 2 Diabetes","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":99,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Index (typography); EQ-5D; Medicine; Baseline (sea); Population; Quality of life (healthcare); Type 2 diabetes; Distress; Demography; Statistics; Diabetes mellitus; Health related quality of life; Mathematics; Clinical psychology; Environmental health; Internal medicine; Computer science","score_opus":0.25439126907890175,"score_gpt":0.3565012307887493,"score_spread":0.10210996170984754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795706072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98710495,0.0019025805,0.00002116661,0.0089259995,0.0004504642,0.00086243585,0.00007706439,0.000014394196,0.0006409244],"genre_scores_gemma":[0.9952026,0.00019693178,0.00050742587,0.0038013437,0.0001421267,0.000041150986,0.000005996908,0.000024991266,0.000077432196],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99479926,0.0004094521,0.0036654477,0.00047958252,0.00012113723,0.00052509987],"domain_scores_gemma":[0.996352,0.00055425504,0.0022810693,0.00060898287,0.00007465735,0.00012901115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0090604285,0.00017051701,0.00085952895,0.00031463755,0.0000894097,0.000018699047,0.0003912393,0.0001147452,0.000078295896],"category_scores_gemma":[0.0017050414,0.00015339123,0.000047481502,0.00060919963,0.00018148702,0.00013405534,0.00006588819,0.00024004445,0.000079175195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044345867,0.00008566658,0.98751354,0.00062654744,0.000008735401,3.5116835e-7,0.0030698958,0.00022431216,0.0000016503028,0.007998537,0.0003120241,0.00011441743],"study_design_scores_gemma":[0.00089222315,0.00046159522,0.97132134,0.001288802,9.64653e-7,0.000001074012,0.0004363486,0.019362414,0.000011669465,0.0053829104,0.0006595876,0.00018106359],"about_ca_topic_score_codex":0.012566656,"about_ca_topic_score_gemma":0.0058370726,"teacher_disagreement_score":0.019138103,"about_ca_system_score_codex":0.0004976879,"about_ca_system_score_gemma":0.0007397436,"threshold_uncertainty_score":0.9940087},"labels":[],"label_agreement":null},{"id":"W2795808606","doi":"10.1016/j.jval.2018.03.010","title":"Can Severity Outweigh Smaller Numbers? A Deliberative Perspective from Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Deliberation; Perspective (graphical); Differential treatment; Thematic analysis; Disease; Psychology; Medicine; Social psychology; Actuarial science; Business; Political science; Sociology; Qualitative research; Internal medicine; Law; Computer science","score_opus":0.30751391417731505,"score_gpt":0.39811182688057445,"score_spread":0.0905979127032594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2795808606","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79431367,0.0024204494,0.00050060096,0.18758944,0.0018802006,0.0010876196,0.0017272383,0.0000578244,0.0104229795],"genre_scores_gemma":[0.9582571,0.00010803985,0.0034656173,0.036735468,0.0008543059,0.00006730942,0.00004265374,0.000039798557,0.00042973377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944024,0.000793766,0.0031375245,0.00083235116,0.0001410452,0.0006929193],"domain_scores_gemma":[0.99650776,0.00091988343,0.0014827423,0.0005524888,0.00015171936,0.0003853807],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0069127325,0.00024060595,0.0010398643,0.00020147557,0.00030463998,0.000053092524,0.0002959463,0.00013381835,0.00080222375],"category_scores_gemma":[0.0021374025,0.0003198906,0.000068596266,0.00030786882,0.00010898669,0.00022560696,0.00006019577,0.0003281031,0.0005328314],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009295609,0.00030699262,0.37301025,0.00034311542,0.00023680924,0.000013786366,0.094721556,0.0012146956,7.8299075e-7,0.369012,0.16075441,0.00029265735],"study_design_scores_gemma":[0.0034535623,0.00046540712,0.5131965,0.00051961833,0.000008051577,0.000012232769,0.03531691,0.043297675,0.000016795697,0.28096396,0.1211066,0.0016426727],"about_ca_topic_score_codex":0.9951434,"about_ca_topic_score_gemma":0.9537935,"teacher_disagreement_score":0.16394342,"about_ca_system_score_codex":0.0072388486,"about_ca_system_score_gemma":0.0033728657,"threshold_uncertainty_score":0.9999253},"labels":[],"label_agreement":null},{"id":"W2803518159","doi":"10.1016/j.jval.2018.03.014","title":"Model Comparisons of the Effectiveness and Cost-Effectiveness of Vaccination: A Systematic Review of the Literature","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Canadian Institutes of Health Research; World Health Organization","keywords":"Vaccination; Systematic review; Medicine; MEDLINE; Cost effectiveness; Meta-analysis; Computer science; Management science; Risk analysis (engineering); Immunology; Pathology","score_opus":0.1512715677482712,"score_gpt":0.4631866427257164,"score_spread":0.3119150749774452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2803518159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038757174,0.9856569,0.000037829064,0.00008003067,0.00009632409,0.013693293,0.00011008884,0.0000034193033,0.00028331246],"genre_scores_gemma":[0.006558142,0.99276614,0.00001900199,0.00005002565,0.000026208121,0.00053288264,0.000011559295,0.00002166142,0.000014388192],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99167305,0.0061516394,0.0011627146,0.00026126034,0.00056019187,0.0001911672],"domain_scores_gemma":[0.9953845,0.0023951977,0.00082688604,0.00081564963,0.0005010322,0.0000767291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068389215,0.00021905446,0.003637332,0.00013117187,0.00004589814,0.000005080234,0.0003337489,0.00016616762,0.000014614312],"category_scores_gemma":[0.0014115503,0.00010170868,0.00043101504,0.0012277971,0.00011039091,0.000022719709,0.00016710383,0.0005678778,4.6635316e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005017809,0.00009720414,0.00010414209,0.99086595,0.00007673102,2.881091e-7,0.00007576699,0.000013409468,1.3974174e-7,0.0006645433,0.00003801526,0.008013612],"study_design_scores_gemma":[0.00050899736,0.00017998509,0.002825758,0.99397737,0.0005590137,0.000025913816,0.0000051751103,0.00052575645,0.0000060843104,0.00012276707,0.0011949202,0.000068261754],"about_ca_topic_score_codex":0.00022036128,"about_ca_topic_score_gemma":0.000011579843,"teacher_disagreement_score":0.01316041,"about_ca_system_score_codex":0.00035380272,"about_ca_system_score_gemma":0.001512091,"threshold_uncertainty_score":0.41475597},"labels":[],"label_agreement":null},{"id":"W2806908842","doi":"10.1016/j.jval.2018.01.013","title":"Qualitative Research to Explore the Patient Experience of X-Linked Hypophosphatemia and Evaluate the Suitability of the BPI-SF and WOMAC® as Clinical Trial End Points","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Ultragenyx Pharmaceutical","keywords":"Debriefing; Physical therapy; Cognitive interview; Population; Psychology; Medicine; WOMAC; Cognition; Clinical psychology; Psychiatry; Osteoarthritis; Alternative medicine; Pathology","score_opus":0.5080128962114483,"score_gpt":0.5933957270194816,"score_spread":0.08538283080803333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2806908842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873005,0.0031518308,0.0000016513062,0.0064652557,0.00018923651,0.0027340942,0.000010853761,0.0000035420164,0.00014302478],"genre_scores_gemma":[0.9986974,0.00050203415,0.00010784226,0.00046785758,0.000043741686,0.00014927439,0.0000010129035,0.000008000313,0.000022820428],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9943158,0.003593045,0.00080901315,0.0003298321,0.0006480755,0.00030426012],"domain_scores_gemma":[0.99613005,0.0027260133,0.00017688471,0.00057376403,0.00024117572,0.00015211925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00836242,0.00011001455,0.00037511904,0.0000439686,0.00021375375,0.00000847322,0.00015943602,0.0000586121,0.000011763718],"category_scores_gemma":[0.004288918,0.00004903291,0.00005720614,0.00037498795,0.0012295498,0.000033814635,0.00017398647,0.0002679261,0.000004655635],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.037162945,0.0017764164,0.1428266,0.00011946819,0.00010009881,0.000004277964,0.8027876,0.0000069012985,0.00020500326,0.0019014226,0.0013468363,0.01176246],"study_design_scores_gemma":[0.04319247,0.022874745,0.7323875,0.00037537082,0.00004753384,0.000011427007,0.17753619,0.0005953055,0.0022403214,0.01987348,0.0006965268,0.00016914692],"about_ca_topic_score_codex":0.0053593093,"about_ca_topic_score_gemma":0.00010860041,"teacher_disagreement_score":0.6252514,"about_ca_system_score_codex":0.000079007244,"about_ca_system_score_gemma":0.00052701146,"threshold_uncertainty_score":0.8101708},"labels":[],"label_agreement":null},{"id":"W2809722184","doi":"10.1016/j.jval.2018.04.387","title":"Three-Part Pricing to Reward Pharmaceutical Innovation and Increase Access: Case of PCSK9 Inhibitors","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Business; Actuarial science; Accrual; Cash flow; Revenue; Public economics; Economics; Finance; Earnings","score_opus":0.185399073756288,"score_gpt":0.3928800009505027,"score_spread":0.20748092719421468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809722184","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9896321,0.0005795216,0.0005912225,0.0057110637,0.00038731107,0.00040147727,0.00010082981,0.000016878417,0.0025795905],"genre_scores_gemma":[0.9931201,0.00017014833,0.00075488235,0.0055338363,0.00037139573,0.000015364107,0.000003933012,0.000018871406,0.000011468589],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9980835,0.000031589127,0.0011336072,0.00035736384,0.000025401461,0.0003685468],"domain_scores_gemma":[0.99908185,0.00011322328,0.00032012345,0.00020547064,0.00004307273,0.00023625793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00180991,0.00012559145,0.00038323004,0.0006218933,0.00008606642,0.00004442897,0.00013551363,0.00007172609,0.00010862752],"category_scores_gemma":[0.00034411345,0.00015108156,0.00002762527,0.0008375873,0.00009389874,0.00021414943,0.00014975722,0.00018062793,0.00007125829],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019539968,0.0002812316,0.19733053,0.00060504186,0.000043135977,0.00004350041,0.0019259168,0.0005110773,0.00008620967,0.76103127,0.0050335224,0.032913193],"study_design_scores_gemma":[0.005535748,0.0013694799,0.037531298,0.0006117854,0.000017605442,0.00036278617,0.00018497182,0.21579906,0.0038488132,0.25690734,0.47637928,0.0014518269],"about_ca_topic_score_codex":0.0111055905,"about_ca_topic_score_gemma":0.00027513405,"teacher_disagreement_score":0.50412387,"about_ca_system_score_codex":0.0001830514,"about_ca_system_score_gemma":0.00009464466,"threshold_uncertainty_score":0.9954795},"labels":[],"label_agreement":null},{"id":"W2809820498","doi":"10.1016/j.jval.2018.04.765","title":"Drivers of Genomic Precision Medicine Adoption in the US: Payer Preferences","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Life expectancy; Actuarial science; Willingness to pay; Health care; Quality (philosophy); Medical Expenditure Panel Survey; Medicine; Business; Health insurance; Economics; Environmental health","score_opus":0.48699798991361704,"score_gpt":0.442559034847695,"score_spread":0.04443895506592205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809820498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9670812,0.0019744018,0.00051994785,0.026216011,0.0005654716,0.00088696566,0.000039133294,0.000011931546,0.0027049286],"genre_scores_gemma":[0.9923227,0.0009573424,0.0011920668,0.0051010577,0.00032216698,0.00003852583,0.0000119452725,0.000012131805,0.00004207784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99442554,0.000993018,0.0037281937,0.00038760935,0.00012709445,0.0003385648],"domain_scores_gemma":[0.99654275,0.0011591063,0.0017369603,0.00044087187,0.00004250033,0.000077826146],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029266447,0.00012327374,0.000703432,0.00049020397,0.00009206097,0.000013087916,0.00036103133,0.00010283671,0.00029778955],"category_scores_gemma":[0.0014976286,0.00011152176,0.00004147537,0.00033566862,0.00015684115,0.000206385,0.00003156294,0.00018257702,0.00038506914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007088935,0.00026069387,0.784583,0.0010582246,0.000023154884,8.418505e-7,0.060834896,0.0048618973,0.0000130554845,0.13257067,0.013128048,0.0025946926],"study_design_scores_gemma":[0.0012504813,0.00070005516,0.9059073,0.00062139874,0.00000209033,0.0000030045594,0.004386489,0.01739733,0.000002991958,0.046453115,0.023082186,0.00019356173],"about_ca_topic_score_codex":0.022442883,"about_ca_topic_score_gemma":0.0014323546,"teacher_disagreement_score":0.12132435,"about_ca_system_score_codex":0.0005554777,"about_ca_system_score_gemma":0.00023022281,"threshold_uncertainty_score":0.9995745},"labels":[],"label_agreement":null},{"id":"W2809845542","doi":"10.1016/j.jval.2018.04.1716","title":"Belimumab for the Treatment of Adults Living with Active Systemic Lupus Erythematosus: A Cost-Effectiveness Analysis in Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Belimumab; Medicine; Quality-adjusted life year; Population; Quality of life (healthcare); Cost–benefit analysis; Incremental cost-effectiveness ratio; Cohort; Cost-effectiveness analysis; Economic evaluation; Cost effectiveness; Internal medicine; Environmental health; Immunology; Risk analysis (engineering)","score_opus":0.03828282117421825,"score_gpt":0.3294544794386287,"score_spread":0.29117165826441044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809845542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99002105,0.0022939073,0.0005757833,0.00020216455,0.00016972047,0.0066304095,0.00005383982,0.000013047225,0.00004007263],"genre_scores_gemma":[0.9979806,0.00038714908,0.00013845455,0.000033792003,0.00007648571,0.0013079343,0.0000071047793,0.00003423663,0.00003426321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99716693,0.00059151213,0.00067296514,0.00042668442,0.0005427506,0.00059918454],"domain_scores_gemma":[0.99467254,0.003958119,0.00030561775,0.00060705515,0.00029346556,0.00016320283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001267862,0.00021842067,0.0010710597,0.00047006772,0.000092743736,0.0000073830975,0.00015013144,0.0000613377,0.000011259539],"category_scores_gemma":[0.00024692155,0.00012961077,0.00011080635,0.0015331934,0.00009069159,0.000039488565,0.000021085394,0.00011986541,0.0000016146239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002456992,0.000334665,0.971201,0.0041675507,0.0007116321,0.00002379767,0.014676143,0.0023499997,0.00002059396,0.0000468138,0.000015160543,0.003995664],"study_design_scores_gemma":[0.046201564,0.018443454,0.44058013,0.07007304,0.0013271394,0.010452591,0.13437334,0.27497768,0.0021908279,0.00005354646,0.00041970392,0.0009070004],"about_ca_topic_score_codex":0.929357,"about_ca_topic_score_gemma":0.8889599,"teacher_disagreement_score":0.5306209,"about_ca_system_score_codex":0.0070893047,"about_ca_system_score_gemma":0.00484334,"threshold_uncertainty_score":0.9967223},"labels":[],"label_agreement":null},{"id":"W2809867426","doi":"10.1016/j.jval.2018.04.525","title":"The Cost of New Oral Anti-Diabetic Drugs in Canada and Internationally","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Canagliflozin; Sitagliptin; Metformin; Business; Market share; Public economics; International economics; Economics; Medicine; Diabetes mellitus; Type 2 diabetes; Health care; Finance; Economic growth; Endocrinology","score_opus":0.07862818365720377,"score_gpt":0.3103516778663703,"score_spread":0.23172349420916655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809867426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874701,0.0011919867,0.000013245906,0.008637389,0.00030803354,0.00013802538,0.000052852516,0.0000015866593,0.0021867908],"genre_scores_gemma":[0.9968506,0.0010945648,0.00006926178,0.0018358119,0.00005919183,0.0000029937346,0.000001376554,0.0000060331345,0.00008017451],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990966,0.000019173633,0.00051560765,0.00013261364,0.000018025883,0.00021803295],"domain_scores_gemma":[0.9995045,0.00012540314,0.00016320519,0.00010249802,0.000008342511,0.0000960557],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006402378,0.00005377851,0.00019627142,0.00008606233,0.00003169728,0.000015077196,0.00013223087,0.000018756,0.000042388743],"category_scores_gemma":[0.000067953006,0.000053772907,0.000012813625,0.00011521022,0.00004873095,0.00004139989,0.0000360182,0.00009245816,0.000015077967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014899689,0.000024674011,0.7030393,0.00004071735,0.0000113107635,5.434272e-7,0.00081290014,0.00062746234,0.000001122067,0.2801425,0.002375206,0.012909387],"study_design_scores_gemma":[0.0010665251,0.00006154318,0.7127048,0.000048542464,6.0989123e-7,0.000001362625,0.00007458362,0.091870196,0.000034709265,0.064727895,0.12926017,0.00014907912],"about_ca_topic_score_codex":0.9556698,"about_ca_topic_score_gemma":0.7797883,"teacher_disagreement_score":0.2154146,"about_ca_system_score_codex":0.0003818777,"about_ca_system_score_gemma":0.0006500172,"threshold_uncertainty_score":0.22422996},"labels":[],"label_agreement":null},{"id":"W2809894823","doi":"10.1016/j.jval.2018.04.726","title":"Potential Impact of Changes to Basket of Comparator Countries from PMPRB7 to Pmprb12 has on Canadian Product List Prices","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sample (material); Product (mathematics); Formulary; Comparator; Economics; Business; Database transaction; Agricultural economics; Actuarial science; Medicine; Computer science; Mathematics; Engineering","score_opus":0.1348878784726197,"score_gpt":0.34733144081204054,"score_spread":0.21244356233942083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809894823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97125894,0.00060564635,0.00003619139,0.022090867,0.00045912756,0.000500578,0.0036273005,0.0000073485726,0.0014139846],"genre_scores_gemma":[0.99404263,0.00013414264,0.00047665337,0.004841842,0.00042365328,0.000012997527,0.000016527118,0.000019132505,0.00003241539],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983874,0.000030557934,0.00069080124,0.00036942228,0.000039254894,0.00048255853],"domain_scores_gemma":[0.9987032,0.00006806029,0.00030692708,0.0003446832,0.000048598446,0.00052854087],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068977143,0.00015069665,0.0005870333,0.00059438875,0.00008049932,0.000036122285,0.00025548186,0.00005321615,0.00047294406],"category_scores_gemma":[0.000112918926,0.00016594492,0.000065857326,0.00033160675,0.000087950204,0.00006342882,0.000041052503,0.000105950625,0.0003016149],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016884975,0.0010665711,0.52117,0.00090457447,0.00048892346,0.00001091664,0.025234846,0.031276096,0.00072257535,0.24518923,0.16696765,0.0052800993],"study_design_scores_gemma":[0.0012814328,0.0028058407,0.41521928,0.00023937577,0.000007360626,0.0000020514196,0.00007577945,0.011730911,0.003075072,0.0066982703,0.55820453,0.0006600847],"about_ca_topic_score_codex":0.7511462,"about_ca_topic_score_gemma":0.13189602,"teacher_disagreement_score":0.6192502,"about_ca_system_score_codex":0.00052838837,"about_ca_system_score_gemma":0.00052732375,"threshold_uncertainty_score":0.88394463},"labels":[],"label_agreement":null},{"id":"W2809912489","doi":"10.1016/j.jval.2018.04.1051","title":"The Economic Burden of Varicella in Mexico","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GDI Integrated Facility Services (Canada)","funders":"","keywords":"Medicine; Medical prescription; Public health; Epidemiology; Health care; Incidence (geometry); Emergency medicine; Indirect costs; Intensive care unit; Varicella vaccine; Pediatrics; Intensive care medicine; Internal medicine; Immunization","score_opus":0.03425352522956795,"score_gpt":0.33063706826115524,"score_spread":0.2963835430315873,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809912489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864386,0.00040397496,0.000013007687,0.0016963821,0.00023249286,0.00027068445,0.0000029386088,0.000008334758,0.010933584],"genre_scores_gemma":[0.99895966,0.00038118428,0.00018246858,0.00010914224,0.00009654859,0.000009606766,0.000001017188,0.0000064358496,0.00025394262],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993646,0.00007232853,0.0002644159,0.0000949895,0.00004597436,0.0001576857],"domain_scores_gemma":[0.99959725,0.00010540665,0.000059210204,0.00018016134,0.000011499958,0.000046474885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046010985,0.00004648173,0.00013871338,0.0000775231,0.000047383874,0.0000031902694,0.000034857705,0.00003101383,0.000053620137],"category_scores_gemma":[0.000024130286,0.000032023676,0.000021056896,0.0001077077,0.00005047405,0.000013437403,0.000011834196,0.00007523559,0.00010258714],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004536622,0.0009053122,0.5956008,0.0003787352,0.00017366867,0.00004146305,0.008307417,0.005038138,0.00010109279,0.02433005,0.0028530667,0.36181659],"study_design_scores_gemma":[0.009667964,0.003845142,0.31275225,0.0011749603,0.00004088041,0.000082900035,0.0009972466,0.05810552,0.0028602774,0.009849427,0.60030687,0.0003165399],"about_ca_topic_score_codex":0.040746924,"about_ca_topic_score_gemma":0.0010152954,"teacher_disagreement_score":0.59745383,"about_ca_system_score_codex":0.00036660125,"about_ca_system_score_gemma":0.00034177574,"threshold_uncertainty_score":0.96564084},"labels":[],"label_agreement":null},{"id":"W2809913281","doi":"10.1016/j.jval.2018.04.1668","title":"Real-World Clinical Effectiveness of Liraglutide 3.0 mg for Weight Management in Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Liraglutide; Weight loss; Prediabetes; Cohort; Weight management; Weight change; Body weight; Internal medicine; Weight gain; Type 2 diabetes; Diabetes mellitus; Obesity; Gastroenterology; Endocrinology","score_opus":0.047210574591376675,"score_gpt":0.3647974245499249,"score_spread":0.31758684995854825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809913281","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842224,0.00018882644,0.000069733396,0.0010504733,0.0006936694,0.0029087774,0.000010240801,0.000016704853,0.010839158],"genre_scores_gemma":[0.9953859,0.0004675127,0.0028546364,0.00044878665,0.000107559055,0.00014528514,0.000022051254,0.000018269631,0.00054999813],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982834,0.0002319398,0.000635233,0.00028588128,0.0001898471,0.00037371804],"domain_scores_gemma":[0.9989897,0.00043802388,0.00012889341,0.0002889685,0.000036105623,0.00011830041],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017615266,0.000116491974,0.000503914,0.00022764996,0.000023544388,0.0000024398898,0.00008158983,0.000026017815,0.000015043055],"category_scores_gemma":[0.000040923005,0.00010237225,0.000058285263,0.00034020236,0.000041663287,0.000025149871,0.000047590165,0.00008034443,0.0000044132225],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000979827,0.0007204378,0.92073435,0.004451496,0.00020982052,0.000071369686,0.000081162245,0.000096780066,0.000006049145,0.016669117,0.0036033918,0.052376222],"study_design_scores_gemma":[0.0057719266,0.0010604567,0.97294605,0.0014162718,0.000053497108,3.828532e-7,0.000066308006,0.0022894528,0.00019330392,0.0009557905,0.015143885,0.00010268498],"about_ca_topic_score_codex":0.82083684,"about_ca_topic_score_gemma":0.7177119,"teacher_disagreement_score":0.10312491,"about_ca_system_score_codex":0.0012193038,"about_ca_system_score_gemma":0.0006894789,"threshold_uncertainty_score":0.41746193},"labels":[],"label_agreement":null},{"id":"W2809943359","doi":"10.1016/j.jval.2018.04.068","title":"Cost-Utility Analysis Comparing Abobotulinumtoxina with Onabotulinumtoxina for the Treatment of Pediatric Lower Limb Spasticity","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Spasticity; Medicine; Cerebral palsy; Tolerability; Botulinum toxin; Dosing; Physical therapy; Physical medicine and rehabilitation; Adverse effect; Surgery; Internal medicine","score_opus":0.11082874778539213,"score_gpt":0.3457163393041222,"score_spread":0.23488759151873007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809943359","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98089665,0.0021498401,0.010710272,0.0032350058,0.00024597495,0.0023962683,0.000028658456,0.00006105967,0.0002762706],"genre_scores_gemma":[0.99451554,0.0031964916,0.0012795292,0.00054362515,0.0002504865,0.000086432905,0.000016747641,0.0000228698,0.00008826107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977419,0.00017866184,0.00070512336,0.00050154486,0.00030813026,0.00056466],"domain_scores_gemma":[0.99769413,0.0010911793,0.00028845333,0.0005365597,0.00015943001,0.00023025768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005362559,0.00025959103,0.0008974406,0.0002556804,0.00019247664,0.0000104277515,0.00015251288,0.00016003501,0.00008153457],"category_scores_gemma":[0.00016160365,0.00014438415,0.00030144845,0.0015566392,0.0003149242,0.000031685704,0.000021618109,0.00025503815,0.0000104789315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017119948,0.0101155415,0.90417,0.0006923934,0.0019447046,0.000052367825,0.002607298,0.04714577,0.000037727514,0.0009973423,0.00049946795,0.014617449],"study_design_scores_gemma":[0.0065699527,0.022241412,0.71222115,0.000069869864,0.0018719546,0.0000115351495,0.00021987424,0.25330088,0.00013790719,0.0003522733,0.0027433294,0.0002598833],"about_ca_topic_score_codex":0.0012989077,"about_ca_topic_score_gemma":0.0004231679,"teacher_disagreement_score":0.20615509,"about_ca_system_score_codex":0.00015536381,"about_ca_system_score_gemma":0.00027812578,"threshold_uncertainty_score":0.5887815},"labels":[],"label_agreement":null},{"id":"W2810063204","doi":"10.1016/j.jval.2018.04.044","title":"Dolutegravir and Rilpivirine to Treat Virologically Suppressed Adults Living with HIV-1: A Canadian Cost-Utility Analysis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Rilpivirine; Dolutegravir; Human immunodeficiency virus (HIV); Medicine; Virology; Antiretroviral therapy; Viral load","score_opus":0.021294070653612593,"score_gpt":0.2763232802801294,"score_spread":0.2550292096265168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810063204","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98445576,0.00013719643,0.0001601493,0.012624642,0.000023668445,0.0010163959,0.00004938915,0.00004185502,0.001490967],"genre_scores_gemma":[0.992999,0.000070564434,0.0042003957,0.0011942842,0.000055426877,0.00006950984,0.000054322998,0.0000148672625,0.0013416167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815893,0.00016648586,0.00035161444,0.00051173323,0.00021872834,0.0005924879],"domain_scores_gemma":[0.99844766,0.00016065386,0.000062486004,0.0003344541,0.00007952661,0.0009152171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053636194,0.00021159978,0.00054432405,0.00056392973,0.00015410235,0.00002067755,0.000073261835,0.00007689483,0.00023332941],"category_scores_gemma":[0.00012730861,0.0001495555,0.000045647237,0.0009753375,0.00008926345,0.000044263,0.000032294593,0.00014474877,0.000052577954],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003817823,0.0002030243,0.98830134,0.00009869412,0.00014867415,0.00009078065,0.0038060374,0.0000444176,0.000007531212,0.000038491627,0.0007809437,0.0060982774],"study_design_scores_gemma":[0.0015597275,0.0008186417,0.9890153,0.00031542906,0.00015671116,0.000019798585,0.00022548491,0.0038978157,0.00003129592,0.0000139092135,0.0037857913,0.00016008507],"about_ca_topic_score_codex":0.19296707,"about_ca_topic_score_gemma":0.35564777,"teacher_disagreement_score":0.16268069,"about_ca_system_score_codex":0.00042852745,"about_ca_system_score_gemma":0.000613377,"threshold_uncertainty_score":0.812407},"labels":[],"label_agreement":null},{"id":"W2810075563","doi":"10.1016/j.jval.2018.04.688","title":"Budget Impact Model of Low Chloride Balanced Intravenous Solutions in Patients with Systemic Inflammatory Response Syndrome from a Hospital Perspective in Colombia","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GDI Integrated Facility Services (Canada)","funders":"","keywords":"Medicine; Systemic inflammatory response syndrome; Observational study; Emergency medicine; Adverse effect; Surgery; Internal medicine","score_opus":0.02703627245170822,"score_gpt":0.29549363244693333,"score_spread":0.26845735999522513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810075563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99733126,0.0003169341,0.00000924845,0.00045839153,0.00008414194,0.0016194051,0.00014916871,0.000019204179,0.000012269312],"genre_scores_gemma":[0.99947506,0.000059991093,0.0001906091,0.00007856344,0.000019723344,0.00012232942,0.000024784702,0.00002548283,0.0000034276673],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981135,0.00024125115,0.00057232677,0.0003506094,0.00028206978,0.00044022294],"domain_scores_gemma":[0.9989239,0.00023126359,0.00021326872,0.0003287258,0.00014610938,0.00015672568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005387193,0.00018472159,0.0006253126,0.0003769248,0.000038057067,0.000005942841,0.00007614105,0.00009782232,0.000010737366],"category_scores_gemma":[0.00021038814,0.00015227331,0.000052937576,0.0003921805,0.000097009644,0.00007652008,0.000027428483,0.00020839558,0.000008508812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043608784,0.0024460321,0.9752232,0.00011391863,0.00006749577,0.000072963856,0.010352244,0.0071817655,0.00006043568,0.000045373716,0.000033954162,0.000041726602],"study_design_scores_gemma":[0.007349446,0.0061148806,0.9737781,0.0024872024,0.000012985342,0.000008714657,0.0008990288,0.00900382,0.0001001986,0.00012377856,2.784771e-7,0.00012155013],"about_ca_topic_score_codex":0.024507465,"about_ca_topic_score_gemma":0.0009115141,"teacher_disagreement_score":0.023595951,"about_ca_system_score_codex":0.0034609553,"about_ca_system_score_gemma":0.0012422497,"threshold_uncertainty_score":0.98198843},"labels":[],"label_agreement":null},{"id":"W2810086625","doi":"10.1016/j.jval.2018.04.1526","title":"Quality of Life of Adults with a History of Juvenile Idiopathic Arthritis: A Systematic Review","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Quality of life (healthcare); Arthritis; Physical therapy; MEDLINE; Disease; Juvenile; Gerontology; Family medicine; Internal medicine","score_opus":0.2443058714598039,"score_gpt":0.4535697120265673,"score_spread":0.20926384056676342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810086625","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027732434,0.98712236,0.000015166284,0.00015501601,0.00061765703,0.011550902,0.00027667,0.000030995507,0.00020352477],"genre_scores_gemma":[0.00032271477,0.9978778,0.00017674798,0.00044182417,0.00029159302,0.0006214212,0.000056511217,0.00006825992,0.0001431581],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9701807,0.015820265,0.011866227,0.00054937997,0.00086848275,0.00071497855],"domain_scores_gemma":[0.9808131,0.0017490401,0.015060993,0.0012965422,0.00067615067,0.0004041699],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.016397549,0.0004857541,0.012277418,0.0004470069,0.00007686003,5.98357e-7,0.0005048343,0.00065768784,0.00006723368],"category_scores_gemma":[0.0040139314,0.00036031735,0.0005126106,0.00083566597,0.00015692512,0.000053913027,0.00010428522,0.0014578629,0.00004120209],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005016103,0.00013254974,0.00035034673,0.98828244,0.000037596783,0.0000019328065,0.0025418154,1.4785795e-7,2.6638696e-9,0.0002217591,0.0032850944,0.0050961813],"study_design_scores_gemma":[0.0006653565,0.00044100653,0.000025782301,0.95286745,0.00020758936,0.0000032815306,0.00032899083,0.000003785607,3.19466e-9,0.000012002695,0.045218226,0.00022652924],"about_ca_topic_score_codex":0.014861578,"about_ca_topic_score_gemma":0.0008708088,"teacher_disagreement_score":0.04193313,"about_ca_system_score_codex":0.0019533073,"about_ca_system_score_gemma":0.034615114,"threshold_uncertainty_score":0.9998849},"labels":[],"label_agreement":null},{"id":"W2810087808","doi":"10.1016/j.jval.2018.04.1042","title":"Respiratory Illness (RI) and Respiratory Syncytial Virus (RSV)-Related Hospitalization (RSVH) in Infants with Congenital Diaphragmatic Hernia (CDH) in the Caress Registry (2005-2017)","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Congenital Diaphragmatic Hernia Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Palivizumab; Medicine; Gestational age; Pediatrics; Hazard ratio; Proportional hazards model; Respiratory system; Confounding; Internal medicine; Confidence interval; Pregnancy","score_opus":0.026615641306224708,"score_gpt":0.29491242927136857,"score_spread":0.2682967879651439,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810087808","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882532,0.006917892,0.000013779888,0.0008284238,0.00030947037,0.002090966,0.00004106761,0.00006012466,0.0014850956],"genre_scores_gemma":[0.99754035,0.0002339015,0.000066743094,0.0016553969,0.00017680819,0.00019851852,0.000013395247,0.000065253706,0.000049652816],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99552244,0.0010213715,0.0012899522,0.00065911043,0.00070903933,0.00079809217],"domain_scores_gemma":[0.9979836,0.00046017117,0.00038758395,0.00077106117,0.0001610227,0.00023658085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024906246,0.00041592823,0.0008442218,0.0005659516,0.00021467418,0.00005499956,0.00026733364,0.00026748076,0.000037589038],"category_scores_gemma":[0.0010238987,0.00031656455,0.000050736206,0.0010554899,0.0006169994,0.0002352226,0.000109174296,0.00067626016,0.00004068455],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014316613,0.00087211555,0.9225952,0.0020652395,0.00021877661,0.0013015452,0.05529273,0.0002652882,0.0004214136,0.00074198743,0.0011544181,0.01363962],"study_design_scores_gemma":[0.0068474947,0.0013216984,0.97868305,0.0019967859,0.00006622954,0.000109184424,0.005739405,0.0019989312,0.00008188975,0.00028027574,0.0022979802,0.0005770597],"about_ca_topic_score_codex":0.0063533215,"about_ca_topic_score_gemma":0.019726077,"teacher_disagreement_score":0.05608786,"about_ca_system_score_codex":0.0005613353,"about_ca_system_score_gemma":0.0009380946,"threshold_uncertainty_score":0.99992865},"labels":[],"label_agreement":null},{"id":"W2810120321","doi":"10.1016/j.jval.2018.04.213","title":"Cost Effectiveness Analysis of Azacitidine in Patients with Acute Myeloid Leukemia With >30% Blasts and who are Not Candidate for Curative-Intend Chemotherapy","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Azacitidine; Medicine; Myeloid leukemia; Hypomethylating agent; Oncology; Internal medicine; Chemotherapy; Leukemia; Cost effectiveness; DNA methylation","score_opus":0.02851383953554438,"score_gpt":0.33395888648280764,"score_spread":0.30544504694726327,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810120321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99465084,0.00006208896,0.0014397416,0.00064558163,0.000022846934,0.0028821754,0.00024283241,0.000017439506,0.000036426092],"genre_scores_gemma":[0.9976252,0.00021193438,0.0012412709,0.00049168285,0.000041903262,0.00017079306,0.000119147364,0.000051410094,0.00004666674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975801,0.00028220887,0.0004957222,0.00057066634,0.00046910177,0.00060218625],"domain_scores_gemma":[0.99816936,0.00037114945,0.0003205307,0.00038781957,0.0005009444,0.00025018802],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097589166,0.00027773684,0.0012213367,0.00086034555,0.00008332194,0.000015272342,0.00012211576,0.000106405525,0.000025726917],"category_scores_gemma":[0.000115804585,0.00019798549,0.00005611009,0.001687231,0.00036298478,0.0001261501,0.00004051612,0.00031233326,0.0000017327128],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021593444,0.00028082775,0.9681831,0.00091522315,0.0012464002,0.000029508707,0.002235192,0.00064239453,0.00032625566,0.00007892056,0.000096973825,0.0043717674],"study_design_scores_gemma":[0.01751844,0.0051276726,0.9453316,0.0015671551,0.00019161335,0.000004740703,0.00021340627,0.025639173,0.004039139,0.000012004926,0.00015110591,0.00020399346],"about_ca_topic_score_codex":0.0051080626,"about_ca_topic_score_gemma":0.0019287175,"teacher_disagreement_score":0.024996778,"about_ca_system_score_codex":0.0017533085,"about_ca_system_score_gemma":0.0011206246,"threshold_uncertainty_score":0.80736136},"labels":[],"label_agreement":null},{"id":"W2810121650","doi":"10.1016/j.jval.2018.04.1439","title":"First Steps in Choosing Appropriate Instruments/Measurements for a Core Outcome Set: An Example from Corehem","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Delphi method; Medicine; Voting; Delphi; Set (abstract data type); Outcome (game theory); Stakeholder; Medical physics; Family medicine; Psychology; Computer science; Artificial intelligence; Mathematics","score_opus":0.7198303027161496,"score_gpt":0.5305209853273261,"score_spread":0.1893093173888235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810121650","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941296,0.00004740308,0.0007316796,0.0014496726,0.00047812297,0.0023815194,0.000038283404,0.000114998045,0.00062869606],"genre_scores_gemma":[0.98912114,0.00003751519,0.009940459,0.00030456219,0.00029321096,0.0002050669,0.0000211048,0.000031389125,0.000045557128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964788,0.0005127056,0.0007167502,0.00053153664,0.00084846496,0.0009117297],"domain_scores_gemma":[0.99863005,0.0003249053,0.00021545733,0.00041454128,0.00013881463,0.00027623444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0065443367,0.00015389228,0.00033679133,0.00028178346,0.0005205811,0.000097770746,0.00061733543,0.00016754489,0.00007731307],"category_scores_gemma":[0.00043754582,0.00016363966,0.000043872296,0.00067127385,0.00025410092,0.00028204554,0.00009589453,0.00028572453,0.000020645164],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022193108,0.000373167,0.8931018,0.00017293832,0.000013573786,0.0000048682014,0.06523573,0.00012355139,0.00009788505,0.0031581584,0.00043582276,0.037060592],"study_design_scores_gemma":[0.01374144,0.0027356439,0.6504129,0.002909459,0.00002020028,0.000003927842,0.049850423,0.07161766,0.0008091628,0.15577206,0.050049227,0.0020779006],"about_ca_topic_score_codex":0.4817437,"about_ca_topic_score_gemma":0.08020057,"teacher_disagreement_score":0.4015431,"about_ca_system_score_codex":0.0013339106,"about_ca_system_score_gemma":0.0006708613,"threshold_uncertainty_score":0.9365834},"labels":[],"label_agreement":null},{"id":"W2810155319","doi":"10.1016/j.jval.2018.04.940","title":"Study of Prevalence of Tobacco Use Among Children and Youth in India","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Public Health and Nutrition","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Environmental health; Population; Tobacco use; Tobacco product; Quarter (Canadian coin); Cross-sectional study; Demography; Geography","score_opus":0.05420497193470426,"score_gpt":0.33210564974297846,"score_spread":0.2779006778082742,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810155319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99826205,0.00033425225,9.941216e-7,0.00013704476,0.000041449188,0.0011460439,0.000033611796,0.0000075455955,0.000037020112],"genre_scores_gemma":[0.9993192,0.00036996527,0.000126662,0.00010833148,0.00004947086,0.0000069796674,0.000008036038,0.0000062497843,0.000005088631],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873334,0.00020201398,0.00050996675,0.000169056,0.00017504753,0.00021055176],"domain_scores_gemma":[0.9993925,0.00006612798,0.00015835809,0.00018557807,0.0000522348,0.00014517891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009883273,0.00006210613,0.00027213586,0.00028212855,0.000017139599,0.0000024816577,0.000046168316,0.00005358219,0.000005561405],"category_scores_gemma":[0.00027143545,0.00005712481,0.000010464363,0.00035359827,0.00007160871,0.00009992329,0.000023774333,0.00013682134,5.202472e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011094691,0.00062802614,0.9905589,0.00050953566,0.0000031222064,0.0000011907656,0.0071507953,0.0000012695749,0.0000033921624,0.000026590538,0.000014526598,0.0009916839],"study_design_scores_gemma":[0.002505376,0.0022892335,0.9935222,0.00069037837,0.000006531655,0.0000026563068,0.0008668367,0.000032242362,0.000032255735,0.000016546333,0.0000011176195,0.000034598823],"about_ca_topic_score_codex":0.029647782,"about_ca_topic_score_gemma":0.00037735523,"teacher_disagreement_score":0.029270427,"about_ca_system_score_codex":0.00006196186,"about_ca_system_score_gemma":0.00022998602,"threshold_uncertainty_score":0.97681385},"labels":[],"label_agreement":null},{"id":"W2810191405","doi":"10.1016/j.jval.2018.04.520","title":"Real-World Comparison of Healthcare Costs Among Patients with Type 2 Diabetes Treated with Dulaglutide Vs. Liraglutide in the United States","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Liraglutide; Dulaglutide; Medicine; Exenatide; Type 2 diabetes; Propensity score matching; Pharmacy; Health care; Internal medicine; Demography; Diabetes mellitus; Emergency medicine; Family medicine; Endocrinology; Economics","score_opus":0.028896201102718882,"score_gpt":0.3041923772416751,"score_spread":0.2752961761389562,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810191405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99477947,0.00018028112,0.0000011050868,0.0026945146,0.00004551466,0.0017682498,0.000016412745,0.000045993722,0.00046846454],"genre_scores_gemma":[0.9979838,0.00014310367,0.0003379918,0.00080421777,0.00002795508,0.000048938087,0.00051264674,0.00003372275,0.00010758714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783206,0.0003072227,0.00056140864,0.00030809108,0.00042951663,0.00056172936],"domain_scores_gemma":[0.99870455,0.00017445128,0.0003005504,0.00043239025,0.00024253066,0.00014553932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045566933,0.00023136883,0.00059858605,0.00073772995,0.00008157184,0.000014827273,0.00013241003,0.000044441702,0.000011083756],"category_scores_gemma":[0.000032534645,0.00013660581,0.000023682998,0.0024991587,0.00017709834,0.000070341724,0.000030095332,0.0002032017,0.000006295256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005872287,0.0008375691,0.9938733,0.0003724881,0.00007137703,0.000007631645,0.0017246718,0.00037057363,8.8878727e-7,0.00024752688,0.0005514487,0.0013552736],"study_design_scores_gemma":[0.0034377128,0.0073272414,0.98248357,0.0019484942,0.000054701934,1.349878e-7,0.00066914374,0.0028943832,0.00012540797,0.00003063124,0.0008980186,0.00013056028],"about_ca_topic_score_codex":0.07034776,"about_ca_topic_score_gemma":0.01923965,"teacher_disagreement_score":0.05110811,"about_ca_system_score_codex":0.00055233703,"about_ca_system_score_gemma":0.0001605287,"threshold_uncertainty_score":0.9986567},"labels":[],"label_agreement":null},{"id":"W2810215276","doi":"10.1016/j.jval.2018.04.115","title":"Long-Term Epidemiological Impact of Pertuzumab+Trastuzmab on Metastatic Breast Cancer Incidence in Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Metastatic breast cancer; Pertuzumab; Breast cancer; Incidence (geometry); Population; Internal medicine; Trastuzumab; Epidemiology; Cancer registry; Oncology; Cancer; Demography; Environmental health","score_opus":0.15389497500984478,"score_gpt":0.4715576909005265,"score_spread":0.31766271589068173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810215276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99253553,0.0011266948,0.000015992107,0.005130082,0.00016681246,0.0007601372,0.00011737082,0.00001060184,0.00013678407],"genre_scores_gemma":[0.9973242,0.000884567,0.0001818207,0.0013409692,0.00014882928,0.000060742626,0.0000069176494,0.00002326631,0.000028686372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964109,0.00079101,0.00085619447,0.000428441,0.0006595719,0.00085386465],"domain_scores_gemma":[0.9979051,0.0008999488,0.00019207604,0.0004285186,0.00013886015,0.0004355241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002100933,0.00020256091,0.0008446553,0.00025230853,0.000040578594,0.0000045858205,0.00022807311,0.000062451516,0.00083472615],"category_scores_gemma":[0.00090005464,0.00014559523,0.00007971408,0.00066876743,0.00018602386,0.000046594603,0.000056170386,0.0006171806,0.0000143201105],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0004986718,0.00016019578,0.9835529,0.00055231515,0.000025905361,0.00016417331,0.0002896105,0.001648312,0.00007228235,0.00003772775,0.0010632899,0.011934649],"study_design_scores_gemma":[0.00095829414,0.0014848805,0.9896837,0.0019085687,0.0000055833934,0.00011430399,0.00005606607,0.0055264183,0.00006239712,0.00007535265,0.000017929771,0.00010652853],"about_ca_topic_score_codex":0.9929209,"about_ca_topic_score_gemma":0.89848727,"teacher_disagreement_score":0.094433606,"about_ca_system_score_codex":0.010804138,"about_ca_system_score_gemma":0.019561281,"threshold_uncertainty_score":0.99299324},"labels":[],"label_agreement":null},{"id":"W2810252118","doi":"10.1016/j.jval.2018.04.1033","title":"The Comparative Efficacy, Safety, And Reactogenicity, of Herpes Zoster Vaccines: A Network Meta-Analysis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences North; GlaxoSmithKline (Canada)","funders":"","keywords":"Reactogenicity; Medicine; Postherpetic neuralgia; Confidence interval; Adverse effect; Randomized controlled trial; Meta-analysis; Internal medicine; Anesthesia; Immunology; Immunization","score_opus":0.16900403461462918,"score_gpt":0.3933269815970516,"score_spread":0.22432294698242242,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810252118","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97695726,0.012373986,0.00046643848,0.0051421546,0.00015281221,0.0012421353,0.000028644836,0.0000352938,0.0036012847],"genre_scores_gemma":[0.99811566,0.0006713637,0.0005377581,0.0003490279,0.0000875955,0.000014806969,0.000006376317,0.000008261043,0.00020914417],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9984773,0.0003537756,0.0005495749,0.00021277246,0.00015491048,0.00025168128],"domain_scores_gemma":[0.99863905,0.00061903946,0.00019995034,0.00034429494,0.00008982887,0.00010785191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009255368,0.00012892653,0.000920729,0.00011055171,0.00020088114,0.000011778922,0.000052285544,0.000048379,0.00009097881],"category_scores_gemma":[0.000041693325,0.00007230332,0.0002663213,0.0007790441,0.00010593831,0.000029183913,0.000042352454,0.000097182776,0.000013184853],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050940085,0.0048080636,0.36770922,0.00049004995,0.4584031,0.000047940117,0.017675798,0.008882899,0.000025347374,0.011517835,0.005322273,0.12002346],"study_design_scores_gemma":[0.0075720707,0.003644304,0.6788344,0.00015627393,0.09669204,0.00007190831,0.00064022164,0.010720934,0.00038445092,0.001746465,0.19907936,0.00045758887],"about_ca_topic_score_codex":0.0066768182,"about_ca_topic_score_gemma":0.002302539,"teacher_disagreement_score":0.36171106,"about_ca_system_score_codex":0.00006692268,"about_ca_system_score_gemma":0.00011028047,"threshold_uncertainty_score":0.99993783},"labels":[],"label_agreement":null},{"id":"W2810253561","doi":"10.1016/j.jval.2018.04.1410","title":"Resource Use Related to Pediatric Lower Limb Spasticity in Canada: Physician Questionnaire","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Spasticity; Medicine; Physical therapy; Cerebral palsy; Population; Orthopedic surgery; Lower limb; Ankle; Outpatient clinic; Surgery; Internal medicine","score_opus":0.02473211436890637,"score_gpt":0.26514577416735985,"score_spread":0.24041365979845347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810253561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9801232,0.00029998922,0.000013879284,0.018155688,0.00033685152,0.0005045925,0.0000040292884,0.000048340247,0.00051338645],"genre_scores_gemma":[0.98346424,0.00020495313,0.00009187008,0.015924957,0.00011809778,0.0000073565525,0.0000038547455,0.00002113818,0.0001635573],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998141,0.00025683377,0.00048840384,0.00036315434,0.0002516502,0.0004989706],"domain_scores_gemma":[0.99915373,0.00015401513,0.00008338818,0.00024089846,0.00004136669,0.0003266266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028892903,0.00014630661,0.0003140988,0.00019346824,0.000064175125,0.0000064634614,0.00008712849,0.00013788295,0.000025477522],"category_scores_gemma":[0.0004973079,0.00012498058,0.000036474157,0.0010718933,0.000046437584,0.000038398142,0.000037605783,0.000621819,0.00006246955],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018110168,0.0012057433,0.9462633,0.00040618074,0.000024236002,0.0007995678,0.0012038425,0.022179857,0.000071461494,0.0011776553,0.017491186,0.0073659304],"study_design_scores_gemma":[0.0011267951,0.0016882081,0.98637605,0.00029858653,0.000011480512,0.0000124014805,0.000058068938,0.006159332,0.000009739508,0.0002883243,0.0038047812,0.00016623839],"about_ca_topic_score_codex":0.67647624,"about_ca_topic_score_gemma":0.33376616,"teacher_disagreement_score":0.3427101,"about_ca_system_score_codex":0.00059701304,"about_ca_system_score_gemma":0.001224622,"threshold_uncertainty_score":0.67839086},"labels":[],"label_agreement":null},{"id":"W2810254284","doi":"10.1016/j.jval.2018.04.1510","title":"1. Indirect Treatment Comparison of Pembrolizumab Versus Standard-of-Care for Relapsed and Refractory Classical Hodgkin’s Lymphoma Using Time-Varying Hazard Ratios","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Pembrolizumab; Medicine; Hazard ratio; Internal medicine; Population; Oncology; Brentuximab vedotin; Proportional hazards model; Refractory (planetary science); Confidence interval; Lymphoma; Cancer; Hodgkin lymphoma","score_opus":0.08550170059292984,"score_gpt":0.37566668849101037,"score_spread":0.29016498789808054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810254284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936754,0.0040916204,0.000040333573,0.00035574363,0.00023403911,0.0012345344,0.00009178838,0.000024120794,0.0002524252],"genre_scores_gemma":[0.9930839,0.00025739893,0.0063657453,0.000039258397,0.00011575859,0.000048917358,0.00004632237,0.00002738706,0.000015310427],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983192,0.00015152634,0.0006414574,0.000319779,0.00026808472,0.0002999294],"domain_scores_gemma":[0.99859536,0.00049970107,0.00033669473,0.0002688055,0.00014077916,0.00015864089],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000209251,0.00019665602,0.0009480187,0.00018291154,0.00012411983,0.000009021547,0.000042801148,0.000117114396,0.000014245522],"category_scores_gemma":[0.00011136552,0.00016135543,0.000109312125,0.00015232801,0.00013059925,0.000051745337,0.00002300634,0.00004309504,0.000002160562],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.096874565,0.0068651866,0.35852328,0.004344165,0.0011674487,0.00006213998,0.034997024,0.0006364751,0.0023475648,0.0010376732,0.001121265,0.49202323],"study_design_scores_gemma":[0.280857,0.23656961,0.19623348,0.00788448,0.001611876,0.0000959866,0.004445568,0.09977794,0.1432241,0.00019689988,0.027977675,0.0011253769],"about_ca_topic_score_codex":0.0006824367,"about_ca_topic_score_gemma":0.00014115608,"teacher_disagreement_score":0.49089783,"about_ca_system_score_codex":0.0020402605,"about_ca_system_score_gemma":0.0011949475,"threshold_uncertainty_score":0.65798837},"labels":[],"label_agreement":null},{"id":"W2810356983","doi":"10.1016/j.jval.2018.04.286","title":"Clinical Characteristics, Treatment Patterns, And Health Care Resource Utilization In Unresectable, Locally Advanced, Stage III Non-Small Cell Lung Cancer: A Medical Record Review Study In The United States And Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Carboplatin; Lung cancer; Medical record; Internal medicine; Etoposide; Stage (stratigraphy); Cisplatin; Cancer; Retrospective cohort study; Oncology; Chemotherapy","score_opus":0.05425463639825754,"score_gpt":0.41486277107407804,"score_spread":0.3606081346758205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810356983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643235,0.023421967,0.000034257933,0.0082529755,0.00012585182,0.0036672067,0.00013694166,0.00000940078,0.000027854696],"genre_scores_gemma":[0.78881574,0.20154051,0.000080303944,0.008793606,0.00008244717,0.00024668206,0.0003664162,0.000020726415,0.000053554966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972468,0.00069242495,0.0009576723,0.00041746098,0.00030651892,0.00037914055],"domain_scores_gemma":[0.99886274,0.0002625022,0.00025035182,0.0002673171,0.00007804641,0.000279031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011865392,0.00018854378,0.00063497014,0.00013452383,0.000108937435,0.000012832894,0.000079556,0.00005372255,0.000020469311],"category_scores_gemma":[0.0000754249,0.00013098586,0.000017244705,0.0003705638,0.00005009096,0.000030176596,0.00003223866,0.00026104192,1.649044e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001420259,0.00043765275,0.93062603,0.002534293,0.000021577544,0.00009244554,0.008201315,0.000028275434,2.1370907e-8,0.000002691679,0.00041464105,0.05749901],"study_design_scores_gemma":[0.008859384,0.003990578,0.9421738,0.0090949815,0.00006501864,0.000007306011,0.01217136,0.0047988263,5.101007e-7,0.0000012053212,0.018687172,0.0001498857],"about_ca_topic_score_codex":0.96795917,"about_ca_topic_score_gemma":0.9734972,"teacher_disagreement_score":0.17811856,"about_ca_system_score_codex":0.0016732287,"about_ca_system_score_gemma":0.0045338487,"threshold_uncertainty_score":0.8042853},"labels":[],"label_agreement":null},{"id":"W2810391398","doi":"10.1016/j.jval.2018.04.833","title":"The Economic Burden of Overactive Bladder (OAB) in Brazil: A Retrospective Observational Study Using Data from the Sistema Unico De Saude (SUS)","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Overactive bladder; Population; Observational study; Healthcare system; Health care; Government (linguistics); Public health; Outpatient visits; Medical prescription; Family medicine; Emergency medicine; Demography; Environmental health; Internal medicine; Alternative medicine; Nursing","score_opus":0.19977847580645897,"score_gpt":0.4170202940239363,"score_spread":0.21724181821747734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810391398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99082255,0.0008182529,0.0000106253665,0.0065241596,0.00020177317,0.0012328463,0.00018982822,0.000012058021,0.00018792259],"genre_scores_gemma":[0.99777174,0.000112444206,0.00051758264,0.00080188806,0.0006840142,0.00001531066,0.00003838923,0.000026192685,0.00003242229],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99759704,0.0006573676,0.0006812313,0.00042968002,0.0003034735,0.00033121023],"domain_scores_gemma":[0.99662095,0.0016904782,0.00036809273,0.0011518364,0.00009298197,0.000075673706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022581588,0.00014097283,0.00039139309,0.00007178956,0.0001651093,0.000023522844,0.00046952034,0.00006625307,0.000056026387],"category_scores_gemma":[0.0008657878,0.000099950295,0.000033287084,0.00026264726,0.00020913346,0.00016820992,0.0002483552,0.00038154307,0.000011642038],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037351623,0.00025548134,0.98260176,0.000032552507,0.00016494529,0.000016996715,0.012713003,0.0013822877,0.00019874534,0.0012651713,0.0007013025,0.0002942501],"study_design_scores_gemma":[0.001607116,0.00039259484,0.9421049,0.00030166932,0.000031455627,0.000011667698,0.0038789131,0.04880255,0.00005142704,0.0025516972,0.00018865085,0.00007736332],"about_ca_topic_score_codex":0.15096131,"about_ca_topic_score_gemma":0.01382424,"teacher_disagreement_score":0.13713707,"about_ca_system_score_codex":0.0019022838,"about_ca_system_score_gemma":0.0019892938,"threshold_uncertainty_score":0.8546925},"labels":[],"label_agreement":null},{"id":"W2810401299","doi":"10.1016/j.jval.2018.04.048","title":"Graphical Probabilistic Models for Risk Prediction and Decision Making Using Real-World Data: A Developing Tool for the Era of Precision Medicine","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Bayesian Modeling and Causal Inference","field":"Computer Science","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Graphical model; Bayesian network; Probabilistic logic; Computer science; Machine learning; Artificial intelligence; Data mining; Representation (politics)","score_opus":0.1946416373609757,"score_gpt":0.3984558518297552,"score_spread":0.20381421446877948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810401299","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06463475,0.00026976335,0.9330233,0.0008014903,0.0002980959,0.0009076421,0.00003060253,0.000031072737,0.0000032904475],"genre_scores_gemma":[0.5543995,0.00031112734,0.44507024,0.00008272748,0.0001065801,0.000020864774,0.0000025596019,0.000006024403,4.0124746e-7],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99823827,0.00012660328,0.00064468937,0.00048235513,0.00024845471,0.00025965142],"domain_scores_gemma":[0.9964572,0.002399418,0.00029456386,0.00060627406,0.00019714225,0.000045379114],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004230863,0.00010906542,0.00024985426,0.00014177506,0.00031003408,0.000041347303,0.0005206777,0.00004559196,2.1327915e-7],"category_scores_gemma":[0.0007154488,0.000074831594,0.000020845688,0.00052027736,0.00014480845,0.000327338,0.00021309625,0.00015561705,6.810094e-8],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022888619,0.000038874427,0.0014453664,0.000335817,0.000013718382,2.398835e-7,0.0016940979,0.09763772,0.000024508412,0.18936595,0.00016448964,0.7090503],"study_design_scores_gemma":[0.0002614825,0.00023530143,0.0017581575,0.00112158,0.000007294708,0.0000027356457,0.000010497707,0.70658654,0.0000034424759,0.28993753,0.000024683262,0.000050782743],"about_ca_topic_score_codex":0.001628582,"about_ca_topic_score_gemma":0.00037003437,"teacher_disagreement_score":0.7089995,"about_ca_system_score_codex":0.000088037654,"about_ca_system_score_gemma":0.00031946728,"threshold_uncertainty_score":0.30515438},"labels":[],"label_agreement":null},{"id":"W2810481689","doi":"10.1016/j.jval.2018.04.180","title":"Cost-Effectiveness Analysis of Midostaurin (MIDO) With Standard of Care (SOC) for Acute Myeloid Leukemia (AML) in Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Incremental cost-effectiveness ratio; Cost effectiveness; Quality-adjusted life year; Economic evaluation; Demography","score_opus":0.039087229412345915,"score_gpt":0.35913062030158643,"score_spread":0.3200433908892405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810481689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945468,0.00055332953,0.0008054167,0.00044843444,0.0000689368,0.0027217264,0.00071510207,0.000010568183,0.00012971039],"genre_scores_gemma":[0.9967563,0.00022512939,0.0024561635,0.00015847529,0.000046431884,0.00016050354,0.00013024265,0.000038455946,0.000028254228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99705684,0.0003590039,0.00075395394,0.00044313827,0.0007272535,0.0006597918],"domain_scores_gemma":[0.9975756,0.00066648936,0.00028999697,0.0005508615,0.00066935713,0.00024774205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012863047,0.00021081546,0.0014195815,0.00087708636,0.000051828607,0.0000044595454,0.00020811068,0.00010031825,0.000029118328],"category_scores_gemma":[0.00021551715,0.0001784332,0.00010772244,0.0024411764,0.00018212928,0.000055195764,0.000059795686,0.000331878,5.133728e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.032798413,0.00017686703,0.8837406,0.008665964,0.002983032,0.00025344125,0.012478833,0.030609073,0.001904914,0.00037926517,0.0008090983,0.0252005],"study_design_scores_gemma":[0.028152492,0.015529732,0.82252485,0.004056831,0.0016229956,0.00004514345,0.014324597,0.051478785,0.057176527,0.000086138694,0.0042634094,0.00073848676],"about_ca_topic_score_codex":0.94334966,"about_ca_topic_score_gemma":0.90554315,"teacher_disagreement_score":0.06121574,"about_ca_system_score_codex":0.018660808,"about_ca_system_score_gemma":0.026705733,"threshold_uncertainty_score":0.98510635},"labels":[],"label_agreement":null},{"id":"W2810515776","doi":"10.1016/j.jval.2018.04.626","title":"Policies and Processes Applicable to Drugs for Very Rare Diseases in Australia, Canada, England, France and Germany","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Reimbursement; CLARITY; Government (linguistics); Medicine; Population; Grey literature; Health technology; Public economics; Business; Economic growth; Political science; Environmental health; MEDLINE; Health care; Economics","score_opus":0.19976115118742885,"score_gpt":0.39614496461826704,"score_spread":0.1963838134308382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810515776","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679925,0.004677505,0.00015053297,0.024825936,0.00019542995,0.0012653909,0.00080629275,0.000013450372,0.00007299398],"genre_scores_gemma":[0.98646694,0.0003079303,0.0008618616,0.01117992,0.00035290178,0.00032136467,0.000014076812,0.00002051367,0.00047446488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972732,0.000103428945,0.0016291621,0.00045246774,0.000058104488,0.0004836571],"domain_scores_gemma":[0.9981696,0.00084020075,0.00046358592,0.00020759457,0.00004205634,0.00027697193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003267506,0.00013870109,0.0006374461,0.00024781146,0.0001394563,0.000045357137,0.00011812948,0.00006188308,0.000018908426],"category_scores_gemma":[0.0011283353,0.00017691069,0.000014592501,0.0002559488,0.0000581355,0.0001854345,0.000034761964,0.000081186554,0.00002333233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006837327,0.0000963279,0.9400889,0.00693563,0.000016140464,0.0000010106551,0.01657056,0.00078237563,9.534618e-7,0.0142202675,0.020470465,0.00074895984],"study_design_scores_gemma":[0.0021368072,0.00028124618,0.6135437,0.00058223103,0.0000025985944,0.0000041701046,0.0017392675,0.004056761,0.000008429599,0.013862382,0.36326337,0.00051905966],"about_ca_topic_score_codex":0.7755214,"about_ca_topic_score_gemma":0.38023964,"teacher_disagreement_score":0.39528176,"about_ca_system_score_codex":0.00045279518,"about_ca_system_score_gemma":0.00071775017,"threshold_uncertainty_score":0.7214208},"labels":[],"label_agreement":null},{"id":"W2810674445","doi":"10.1016/j.jval.2018.04.015","title":"United States Valuation of EQ-5D-5L Health States: An Initial Model Using a Standardized Protocol","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Time-trade-off; Respondent; Population; Logistic regression; Heteroscedasticity; EQ-5D; Medicine; Valuation (finance); Tobit model; Demography; Statistics; Mathematics; Environmental health; Economics; Quality of life (healthcare); Finance","score_opus":0.6670629596829336,"score_gpt":0.5101795922979174,"score_spread":0.15688336738501618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810674445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7378388,0.00032656023,0.16966392,0.020042112,0.00056062965,0.068569124,0.0025549002,0.00015942196,0.0002845496],"genre_scores_gemma":[0.7722876,0.0004069149,0.14715372,0.052877586,0.0014867437,0.023794167,0.0014915325,0.000368239,0.00013348517],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9881628,0.0023373612,0.0075334846,0.00077689,0.000297247,0.0008921824],"domain_scores_gemma":[0.99299735,0.0005950413,0.004913824,0.00072244613,0.00032527602,0.0004460668],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.042909667,0.00029812643,0.0015772635,0.0012345053,0.00036085068,0.0000716474,0.00031898313,0.00016489155,0.00013945172],"category_scores_gemma":[0.0014566593,0.0003799329,0.00009491437,0.00082539645,0.00018784744,0.0006946227,0.00006173874,0.00028210628,0.00007868439],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005622651,0.0008144359,0.011142487,0.0048721577,0.000075471835,0.0000011487242,0.049012896,0.8821104,0.0000059729523,0.04635148,0.003636222,0.0014150476],"study_design_scores_gemma":[0.002744194,0.0010741579,0.0008115748,0.0004811722,0.0000022029396,0.00000272558,0.0017469445,0.9280867,0.000014551016,0.060575325,0.004167441,0.00029303087],"about_ca_topic_score_codex":0.05238125,"about_ca_topic_score_gemma":0.000971148,"teacher_disagreement_score":0.0514101,"about_ca_system_score_codex":0.0026319232,"about_ca_system_score_gemma":0.0031794,"threshold_uncertainty_score":0.99986523},"labels":[],"label_agreement":null},{"id":"W2810748550","doi":"10.1016/j.jval.2018.04.573","title":"Cost-Effectiveness Analysis of Sofosbuvir/Velpatasvir in Genotype 1 Hepatitis C Infected Patients in Mexico","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Sofosbuvir; Medicine; Hepatocellular carcinoma; Internal medicine; Hepatitis C virus; Hepatitis C; Cirrhosis; Cost effectiveness; Clinical trial; Ribavirin; Virology; Virus","score_opus":0.0928255286419245,"score_gpt":0.4034928285793031,"score_spread":0.31066729993737857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810748550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969603,0.00015110333,0.0001385235,0.00014855537,0.000108195934,0.0018975778,0.0001250239,0.000021662961,0.00044908441],"genre_scores_gemma":[0.99844706,0.00066019973,0.0002903792,0.0002137852,0.000029111226,0.00012131248,0.0002002441,0.000029037412,0.000008844293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959265,0.0014056606,0.0009531757,0.00044832542,0.00061443594,0.00065189356],"domain_scores_gemma":[0.9982771,0.0005566895,0.00018332309,0.00048349734,0.00028249327,0.00021689014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002240424,0.00017957897,0.00095285155,0.002549638,0.00003729555,0.000008207611,0.00015155174,0.00015998284,0.00018374728],"category_scores_gemma":[0.0015403824,0.00018148935,0.0000864946,0.0054237586,0.0001468317,0.00011395208,0.00009256549,0.0004341953,0.00004812322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003146739,0.0007136794,0.9752372,0.00032584282,0.000087743254,0.000027779843,0.0011168431,0.00093279814,0.0000858919,0.00006506192,0.000029885836,0.021062626],"study_design_scores_gemma":[0.0027421194,0.0010067397,0.96755964,0.00051309867,0.00002925565,4.115004e-7,0.000017228682,0.027042435,0.00053137785,0.00006331825,0.0003723152,0.00012204398],"about_ca_topic_score_codex":0.23017853,"about_ca_topic_score_gemma":0.06636372,"teacher_disagreement_score":0.16381481,"about_ca_system_score_codex":0.0013194556,"about_ca_system_score_gemma":0.0007786028,"threshold_uncertainty_score":0.9506727},"labels":[],"label_agreement":null},{"id":"W2810762849","doi":"10.1016/j.jval.2018.04.241","title":"Evidence Driven Cancer Drug Approvals In Phase II Versus Phase III Clinical Trials Within A Single-Payer Public Healthcare System","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Clinical trial; Disadvantaged; Health care; Population; Logistic regression; Cancer; Oncology; Internal medicine; Family medicine; Intensive care medicine; Environmental health","score_opus":0.734505048864647,"score_gpt":0.6096282853595097,"score_spread":0.12487676350513721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810762849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8645621,0.023474613,0.000044908986,0.105194084,0.0034340722,0.002838044,0.00004545111,0.00010988813,0.000296861],"genre_scores_gemma":[0.98736525,0.005814377,0.0006042319,0.004024054,0.0018717988,0.00020860635,0.000008851402,0.000035044595,0.00006777564],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9892202,0.0051986757,0.0031827802,0.00080528355,0.00065693574,0.000936144],"domain_scores_gemma":[0.9913205,0.0056638233,0.0013051067,0.0005041646,0.0002828301,0.00092360727],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.024009889,0.00030098602,0.0018491582,0.00023564359,0.00034621597,0.000049317405,0.00024681468,0.00018763615,0.000121463665],"category_scores_gemma":[0.01029719,0.00023624343,0.00018777774,0.0009040817,0.0002510737,0.00036124716,0.00016609252,0.0010343539,0.00003131208],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11382676,0.019294316,0.03968568,0.011648277,0.00094397797,0.0005851115,0.028889205,0.00015518628,0.0007742507,0.0045607165,0.014281263,0.7653552],"study_design_scores_gemma":[0.36831534,0.06574259,0.0022966869,0.04140887,0.00093501364,0.00015778019,0.01756462,0.18715699,0.0013073096,0.00033224665,0.31266743,0.0021151123],"about_ca_topic_score_codex":0.015143807,"about_ca_topic_score_gemma":0.0030364261,"teacher_disagreement_score":0.76324016,"about_ca_system_score_codex":0.0012973595,"about_ca_system_score_gemma":0.0018924854,"threshold_uncertainty_score":0.9980395},"labels":[],"label_agreement":null},{"id":"W2810775937","doi":"10.1016/j.jval.2018.04.317","title":"Benefit Of Abiraterone Acetate Plus Prednisone (AA+P) Added To Androgen Deprivation Therapy (ADT) In Patients With High-Risk, Newly Diagnosed Metastatic Hormone-Sensitive Prostate Cancer (MHSPC): Post Hoc Analysis Of EQ-5D-5L From The Latitude Study","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Abiraterone acetate; Prostate cancer; Visual analogue scale; Androgen deprivation therapy; Post-hoc analysis; Internal medicine; Oncology; Urology; Cancer; Surgery","score_opus":0.04130192865995992,"score_gpt":0.315470123305977,"score_spread":0.2741681946460171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810775937","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918806,0.0012711098,0.000023518134,0.00080146163,0.00004209116,0.0049415296,0.0010232187,0.000014234457,0.0000022194458],"genre_scores_gemma":[0.9964953,0.0017902713,0.00080465514,0.00021351226,0.000028695813,0.00026153785,0.00035174176,0.000034674467,0.00001960466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714035,0.0005027678,0.00075257866,0.0004774661,0.00069450506,0.0004323631],"domain_scores_gemma":[0.9980161,0.00034642254,0.00047026682,0.0004905402,0.0005209813,0.00015564697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074558234,0.00024512128,0.00095244375,0.0004871512,0.00008409426,0.000016093163,0.00014621705,0.000043906617,0.00002288459],"category_scores_gemma":[0.0000825113,0.00015070153,0.000063209154,0.0019075162,0.00013464832,0.00011334151,0.000059789836,0.00020191683,0.0000027678027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018534342,0.0012866479,0.9099711,0.00004960211,0.0020632525,0.00001622884,0.046531428,0.009750897,0.00033089932,0.0000037899995,0.000018260742,0.011443543],"study_design_scores_gemma":[0.021023836,0.009969796,0.9632783,0.00025068707,0.00041570608,1.1842071e-7,0.0017745147,0.0018582352,0.0012681271,0.000027308224,0.0000055964756,0.00012780764],"about_ca_topic_score_codex":0.16564351,"about_ca_topic_score_gemma":0.031442527,"teacher_disagreement_score":0.13420099,"about_ca_system_score_codex":0.0005136372,"about_ca_system_score_gemma":0.0005366729,"threshold_uncertainty_score":0.98623115},"labels":[],"label_agreement":null},{"id":"W2810788589","doi":"10.1016/j.jval.2018.04.370","title":"A Discrete Event Simulation Model For A Pharmacogenomics Test For Statin-Induced Myopathy In Patients Initiating A Statin In Secondary Cardiovascular Prevention","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute; Université Laval; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Medicine; Statin; Pharmacogenomics; Dyslipidemia; Myopathy; Rhabdomyolysis; Internal medicine; Physical therapy; Cardiology; Pharmacology","score_opus":0.06368450406815251,"score_gpt":0.35470105840453175,"score_spread":0.29101655433637924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810788589","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9239319,0.0005318151,0.067066744,0.00014994333,0.00014923647,0.007928541,0.00019481187,0.000025583226,0.000021409465],"genre_scores_gemma":[0.9845842,0.00007871167,0.013485328,0.00040726166,0.00023322314,0.000874823,0.00025796724,0.00006687663,0.000011610791],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99683,0.0003573869,0.0011809024,0.0005470611,0.00043405915,0.0006506307],"domain_scores_gemma":[0.9986818,0.0002613144,0.00028549673,0.00038805994,0.00020809205,0.00017524582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043225326,0.0002278375,0.0007554501,0.00036129256,0.00011218084,0.000016026377,0.00007931667,0.000116191804,0.0000034936957],"category_scores_gemma":[0.00067107927,0.00023703478,0.0003557488,0.00036751624,0.000021043732,0.00016900642,0.000035405614,0.00028712902,0.0000015048316],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016063041,0.0011440315,0.023990182,0.0052233925,0.00019586412,0.000007706903,0.011182159,0.5400775,0.00018147346,0.000058704827,0.000019340754,0.41631332],"study_design_scores_gemma":[0.015318567,0.0018501752,0.034656458,0.0008276588,0.000052738138,0.0000015233504,0.00023688919,0.945633,0.00013386006,0.00091617444,0.00016009665,0.00021288515],"about_ca_topic_score_codex":0.0022721216,"about_ca_topic_score_gemma":0.00037743823,"teacher_disagreement_score":0.41610044,"about_ca_system_score_codex":0.0010522509,"about_ca_system_score_gemma":0.0013774454,"threshold_uncertainty_score":0.96659976},"labels":[],"label_agreement":null},{"id":"W2810813567","doi":"10.1016/j.jval.2018.04.059","title":"Consumer Preferences for Precision Medicine Technologies: Evidence from A Discrete Choice Experiment","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Respondent; Medical Expenditure Panel Survey; Context (archaeology); Mixed logit; Willingness to pay; Health care; Actuarial science; Population; Econometrics; Life expectancy; Medicine; Statistics; Logistic regression; Environmental health; Economics; Mathematics; Geography","score_opus":0.6293071375630176,"score_gpt":0.5050231840894309,"score_spread":0.12428395347358667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810813567","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69456893,0.08399373,0.028309073,0.18333441,0.0028675925,0.005153968,0.00055558153,0.0003367781,0.0008799066],"genre_scores_gemma":[0.97347784,0.0027212983,0.018035593,0.004192956,0.0006709047,0.00067771995,0.000030473024,0.000034887053,0.00015832511],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99397725,0.00041724983,0.0040561534,0.0008593623,0.00013440444,0.0005556093],"domain_scores_gemma":[0.99094695,0.006129747,0.0019463729,0.0007440857,0.00007997628,0.0001528781],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014700747,0.0002164802,0.0010789545,0.00038656703,0.0002241109,0.000039746326,0.000503115,0.00018466762,0.00030118864],"category_scores_gemma":[0.01745035,0.00022253126,0.000062682586,0.00028227665,0.00027248138,0.00040541196,0.00008824765,0.00017912342,0.0004430821],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005160104,0.0005541142,0.5905101,0.0038563446,0.00026251422,0.0000016497006,0.06919557,0.0009311461,0.0001435464,0.1091666,0.20427524,0.020587219],"study_design_scores_gemma":[0.006046905,0.0045646634,0.092707135,0.012559374,0.000018179448,0.0000043203218,0.01698857,0.09318311,0.00046995177,0.35256192,0.4192443,0.001651597],"about_ca_topic_score_codex":0.041609712,"about_ca_topic_score_gemma":0.0009065325,"teacher_disagreement_score":0.4978029,"about_ca_system_score_codex":0.00083805,"about_ca_system_score_gemma":0.0003006262,"threshold_uncertainty_score":0.9908261},"labels":[],"label_agreement":null},{"id":"W2810822711","doi":"10.1016/j.jval.2018.04.684","title":"Cost Drivers in Public Drug Plans in Canada, 2016/17","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Drug; Stakeholder; Business; Public health; Public economics; Medicine; Operations management; Environmental health; Economics; Pharmacology; Public relations; Political science","score_opus":0.44441971562021837,"score_gpt":0.3999781983258125,"score_spread":0.044441517294405875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810822711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8550744,0.0013399158,0.0001370041,0.13297856,0.0014709004,0.0014869313,0.00052966643,0.000026687496,0.0069559],"genre_scores_gemma":[0.97973907,0.00034686946,0.00058368914,0.018448707,0.00024561808,0.00009722766,0.000035043293,0.00002956054,0.00047421135],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99337846,0.00069300446,0.0042615226,0.0006135369,0.000118694006,0.0009347565],"domain_scores_gemma":[0.99706197,0.0008786058,0.0012209876,0.000481397,0.000032338394,0.00032467992],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.017766299,0.000182054,0.0009348001,0.0008872464,0.00010987097,0.000040424762,0.00037572806,0.00009921953,0.00039268297],"category_scores_gemma":[0.0014742324,0.00025566938,0.00003746657,0.00058917375,0.00006788607,0.00037966506,0.000050833798,0.00034934064,0.0007427053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008423454,0.000065973494,0.8930784,0.00019406938,0.0000056853896,0.0000044240296,0.003878497,0.0018353774,5.8815996e-8,0.019517194,0.081135795,0.00027611142],"study_design_scores_gemma":[0.0020879137,0.000076028424,0.7039248,0.0004223672,4.5520156e-7,0.0000041233984,0.004124716,0.043595918,9.50637e-7,0.0064439382,0.23884165,0.00047716394],"about_ca_topic_score_codex":0.98619354,"about_ca_topic_score_gemma":0.9905538,"teacher_disagreement_score":0.18915361,"about_ca_system_score_codex":0.00895703,"about_ca_system_score_gemma":0.0055392105,"threshold_uncertainty_score":0.99998957},"labels":[],"label_agreement":null},{"id":"W2810830875","doi":"10.1016/j.jval.2018.04.094","title":"Approaches for Estimating the Comparative Efficacy of Treatments for Patients with Recurrent Small Cell Lung Cancer (SCLC) within Connected and Disconnected Networks of Evidence","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Topotecan; Medicine; Nivolumab; Internal medicine; Oncology; Ipilimumab; Randomized controlled trial; Hazard ratio; Chemotherapy; Cancer; Confidence interval; Immunotherapy","score_opus":0.2681648071868797,"score_gpt":0.4290487568621788,"score_spread":0.16088394967529912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810830875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859668,0.004103715,0.0033762243,0.00041898846,0.00010235241,0.0059545515,0.000059902115,0.00001021565,0.0000072627577],"genre_scores_gemma":[0.9852339,0.0001523935,0.013876281,0.000025710873,0.00008474069,0.0005806041,0.000019990883,0.000015600112,0.000010746749],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99862814,0.00016362226,0.000444362,0.00027560344,0.00019196016,0.00029632924],"domain_scores_gemma":[0.9971464,0.0018436813,0.00042280057,0.00018565703,0.0003225792,0.00007883014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005258445,0.00014609746,0.0004999672,0.00006123987,0.00013195767,0.000006328255,0.000082278966,0.00003046821,0.0000012157083],"category_scores_gemma":[0.0004586821,0.0000762995,0.000032205375,0.00024264316,0.00024429825,0.00004257649,0.000040590898,0.00010755242,3.143583e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0109109115,0.00131494,0.90229136,0.00864381,0.0006250746,3.6970854e-7,0.041188676,0.026797367,0.00003004982,0.00019308462,0.00028807163,0.0077162655],"study_design_scores_gemma":[0.007958301,0.0067016697,0.32025337,0.005071002,0.0002090411,3.632652e-7,0.0005699639,0.6587668,0.00032607155,0.000032922835,0.0000034363354,0.00010703443],"about_ca_topic_score_codex":0.0016165795,"about_ca_topic_score_gemma":0.0004025942,"teacher_disagreement_score":0.63196945,"about_ca_system_score_codex":0.00021364674,"about_ca_system_score_gemma":0.00038676837,"threshold_uncertainty_score":0.31114033},"labels":[],"label_agreement":null},{"id":"W2810837006","doi":"10.1016/j.jval.2018.04.234","title":"Patterns Of Second-Line (2L) Treatment For Metastatic Urothelial Cancer (MUC) In Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Gemcitabine; Medicine; Carboplatin; Cisplatin; Internal medicine; Chemotherapy; Oncology; Cancer; Performance status; Urothelial cancer; Bladder cancer; Urology","score_opus":0.07991176340706468,"score_gpt":0.35837939078157655,"score_spread":0.27846762737451186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810837006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99390346,0.00091746077,0.00006619112,0.0018880161,0.0004143972,0.0014936511,0.0011785172,0.000007691666,0.00013060184],"genre_scores_gemma":[0.99709165,0.00033143428,0.00046931504,0.0010745422,0.00019967294,0.00041864446,0.000023926166,0.00002648417,0.0003643151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986446,0.0000775128,0.0004960808,0.00024320197,0.000171946,0.00036664677],"domain_scores_gemma":[0.99935853,0.00012016743,0.00012345343,0.00020117109,0.000053356558,0.00014331122],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016412506,0.00015301238,0.0005127706,0.00011157231,0.000027608368,0.000002388942,0.000053472017,0.000025378042,0.0004549028],"category_scores_gemma":[0.000025358184,0.00012185141,0.00005046442,0.0001420144,0.000018561694,0.000024534822,0.0000083393625,0.0000634242,0.0000020093573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025675492,0.0013420667,0.9093274,0.0025714075,0.00038348546,0.000088670946,0.004189172,0.00081813405,0.00036471777,0.0002589973,0.0010882142,0.0770002],"study_design_scores_gemma":[0.07078996,0.022631831,0.77571064,0.004439661,0.00050015777,0.00007995837,0.0022010654,0.012017317,0.055896852,0.001091764,0.053632133,0.0010086452],"about_ca_topic_score_codex":0.9896213,"about_ca_topic_score_gemma":0.9857408,"teacher_disagreement_score":0.13361673,"about_ca_system_score_codex":0.002231346,"about_ca_system_score_gemma":0.006802445,"threshold_uncertainty_score":0.99882805},"labels":[],"label_agreement":null},{"id":"W2810839909","doi":"10.1016/j.jval.2018.04.1027","title":"Risk of Cardiovascular Disease Among Patients with Hepatitis C Virus (HCV) Infection","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Framingham Risk Score; Hepatitis C virus; Obesity; Metabolic syndrome; Hepatitis C; Confounding; Fibrinogen; Disease; Immunology; Virus","score_opus":0.02552159919997815,"score_gpt":0.2956715168264515,"score_spread":0.27014991762647333,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810839909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971834,0.00041885496,0.00040576202,0.000058500387,0.000121941,0.0010565475,0.000083076055,0.000036001744,0.0006359386],"genre_scores_gemma":[0.9958309,0.0035093355,0.00033467636,0.000063733714,0.0001291122,0.000043804594,0.000032602682,0.00003227311,0.000023554017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975708,0.00051975786,0.00039433956,0.00030703295,0.00083328737,0.0003747407],"domain_scores_gemma":[0.9985325,0.00006605601,0.00013146675,0.0005805871,0.00029578086,0.0003936253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009005365,0.00012542565,0.00040279984,0.000280709,0.0000911823,0.000007796981,0.00006005579,0.000059174963,0.00007573629],"category_scores_gemma":[0.00057852233,0.00010566201,0.00011552927,0.00053889334,0.00021127031,0.00010717609,0.000038051636,0.0002615684,0.000045680772],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019843252,0.00023704769,0.9747019,0.00031336895,0.00016077135,0.000014678647,0.00023219486,0.00087424053,9.099305e-7,0.000019168807,0.00012832996,0.023118995],"study_design_scores_gemma":[0.0015761929,0.0011853088,0.9874599,0.00042591838,0.000064324035,3.6811727e-7,0.0000025059164,0.004451035,0.00006122182,0.00004738411,0.0046373755,0.00008847128],"about_ca_topic_score_codex":0.38537002,"about_ca_topic_score_gemma":0.0036950528,"teacher_disagreement_score":0.38167495,"about_ca_system_score_codex":0.00033336104,"about_ca_system_score_gemma":0.00048735156,"threshold_uncertainty_score":0.61872286},"labels":[],"label_agreement":null},{"id":"W2810851952","doi":"10.1016/j.jval.2018.04.273","title":"Positive Cancer Drug Recommendations By The Pan-Canadian Oncology Drug Review Are Not Without Conditions Placed On Cost-Effectiveness","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Family medicine; Cost effectiveness; MEDLINE; Oncology; Internal medicine; Health care; Risk analysis (engineering)","score_opus":0.38887776849728567,"score_gpt":0.4938660210535424,"score_spread":0.10498825255625671,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810851952","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0729015,0.014297859,0.00019083168,0.8902698,0.002144226,0.006936319,0.00812486,0.000057348574,0.0050772415],"genre_scores_gemma":[0.73632663,0.010023667,0.00024024799,0.24891213,0.0005074615,0.0026318822,0.00038079562,0.000064558946,0.000912602],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9923222,0.0034841183,0.002738562,0.000663167,0.000097442025,0.00069450843],"domain_scores_gemma":[0.99281734,0.0039556557,0.0021207232,0.0005723101,0.00013754301,0.00039640118],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.022668965,0.00024156396,0.0011541336,0.00036508412,0.0008062034,0.000046735768,0.0003569587,0.00011610064,0.0007308286],"category_scores_gemma":[0.0021990712,0.00025644305,0.00009625492,0.00045080713,0.00018164216,0.00023734187,0.000032645294,0.00046665914,0.0016594832],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052340954,0.0002765391,0.03386529,0.0015691336,0.00009882907,0.0000014617033,0.004994548,0.00045962157,8.557109e-7,0.056023434,0.9004134,0.0022445433],"study_design_scores_gemma":[0.0018105704,0.00028976527,0.09022472,0.0074023623,0.000017404338,0.000010257231,0.001681554,0.0040006177,0.000018466324,0.0046494207,0.8892806,0.00061422546],"about_ca_topic_score_codex":0.37174714,"about_ca_topic_score_gemma":0.20331004,"teacher_disagreement_score":0.66342515,"about_ca_system_score_codex":0.0063517164,"about_ca_system_score_gemma":0.0018623095,"threshold_uncertainty_score":0.9999888},"labels":[],"label_agreement":null},{"id":"W2810861643","doi":"10.1016/j.jval.2019.08.012","title":"Cost-Effectiveness Analysis of Baseline Testing for Resistance-Associated Polymorphisms to Optimize Treatment Outcome in Genotype 1 Noncirrhotic Treatment-Naïve Patients With Chronic Hepatitis C Virus","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AIDS Vancouver","funders":"Medical Research Council; Imperial College London; Public Health England; University of Bristol; National Institute for Health and Care Research; National Institute for Health Research Health Protection Research Unit; Wellcome Trust","keywords":"Genotype; Baseline (sea); Medicine; Chronic hepatitis; Internal medicine; Hepatitis C virus; Hepatitis a virus; Virology; Outcome (game theory); Virus; Genetics; Biology; Gene","score_opus":0.11046850236747514,"score_gpt":0.37932636186120294,"score_spread":0.2688578594937278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810861643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900823,0.00032130443,0.00040743794,0.00018939137,0.00007136391,0.008053268,0.0007680316,0.000032075033,0.00007478857],"genre_scores_gemma":[0.99286747,0.0001733038,0.005256751,0.00010690126,0.000021431739,0.0008418961,0.00044104058,0.00006243169,0.00022880346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964142,0.0006738096,0.00096708327,0.0006276716,0.00051894673,0.00079832604],"domain_scores_gemma":[0.9966128,0.001884476,0.00031705335,0.00053774676,0.00034020934,0.00030774146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012046281,0.00031532338,0.0015492925,0.0011704059,0.00006307471,0.000012318846,0.00010865056,0.0001159299,0.000071511575],"category_scores_gemma":[0.00091700855,0.00025592232,0.0001587559,0.002839295,0.00003762344,0.00006888116,0.000026499825,0.00013764312,0.000018493485],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015802102,0.0012866245,0.9410826,0.00030954846,0.00050661055,0.0000223607,0.0003724158,0.045093942,0.0001594796,0.000011644252,0.0000027406118,0.009571817],"study_design_scores_gemma":[0.011705672,0.009402317,0.9256302,0.0007277677,0.00027440922,2.639584e-7,0.000009068784,0.05167639,0.00027862258,0.000004673234,0.000097847485,0.0001927516],"about_ca_topic_score_codex":0.19394845,"about_ca_topic_score_gemma":0.08966941,"teacher_disagreement_score":0.10427904,"about_ca_system_score_codex":0.01093965,"about_ca_system_score_gemma":0.0014485422,"threshold_uncertainty_score":0.9999893},"labels":[],"label_agreement":null},{"id":"W2810896877","doi":"10.1016/j.jval.2018.04.1796","title":"The Efficacy and Safety of Mirabegron Relative to Onabotulinumtoxina in Patients with Overactive Bladder Not Appropriately Managed with An Antimuscarinic: A Network Meta-Analysis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Mirabegron; Overactive bladder; Medicine; Population; Relative risk; Meta-analysis; Internal medicine; Confidence interval; Odds ratio; Urology; Alternative medicine","score_opus":0.08105085702441846,"score_gpt":0.34967670686357183,"score_spread":0.2686258498391534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810896877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940032,0.00038057507,0.00023399547,0.002368791,0.000018020639,0.0024591973,0.000024750003,0.000012354151,0.0004991463],"genre_scores_gemma":[0.9959876,0.00013232448,0.0032902125,0.00032269157,0.000039195034,0.000040604482,0.000025942494,0.000026568547,0.00013486842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996874,0.0009176667,0.00055142445,0.0005115811,0.000605642,0.0005396987],"domain_scores_gemma":[0.99808425,0.0006944743,0.00021885995,0.0005251381,0.00022897037,0.00024831388],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018283807,0.00020954556,0.00094720727,0.0002926981,0.00018648121,0.000020151057,0.00012446045,0.00008398933,0.00003099359],"category_scores_gemma":[0.00009958054,0.00011478876,0.00008510098,0.0017589171,0.00021320213,0.0001552589,0.000075810676,0.0005777985,0.0000034078687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.14619729,0.0033748285,0.72895163,0.0004692411,0.05428618,0.00008066059,0.028743228,0.02302821,0.00000927702,0.0016077057,0.000105306244,0.013146433],"study_design_scores_gemma":[0.004223273,0.011220195,0.9787618,0.00006841637,0.0032056342,0.0000021543747,0.00032641093,0.0017107015,0.000014441933,0.000116712166,0.00020789632,0.00014236543],"about_ca_topic_score_codex":0.003658818,"about_ca_topic_score_gemma":0.0012062785,"teacher_disagreement_score":0.24981016,"about_ca_system_score_codex":0.00012999433,"about_ca_system_score_gemma":0.00028313114,"threshold_uncertainty_score":0.5531063},"labels":[],"label_agreement":null},{"id":"W2810900685","doi":"10.1016/j.jval.2018.04.1437","title":"Assessment of Anticholinergic Burden scales and Measures for Estimating Anticholinergic Exposure in Retrospective u.s. Database Analyses","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Vancouver Coastal Health","funders":"","keywords":"Anticholinergic; Medicine; Scale (ratio); Internal medicine","score_opus":0.256364972110458,"score_gpt":0.5112095692867041,"score_spread":0.25484459717624613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810900685","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925202,0.0016739244,0.0028172794,0.0016914059,0.00018887946,0.00080677966,0.00004330722,0.000017472401,0.00024072439],"genre_scores_gemma":[0.94360095,0.000384715,0.055382054,0.0003341084,0.00023041088,0.000015526977,0.000025043084,0.00001569903,0.000011489696],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981402,0.00021341357,0.0006911991,0.0003242924,0.00031646574,0.0003143841],"domain_scores_gemma":[0.99866724,0.00052210316,0.00028039966,0.00022693194,0.0001454081,0.0001579284],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016676395,0.0001445279,0.0005634817,0.00026614228,0.000064531734,0.000013109674,0.000070008806,0.000056416357,0.000010208181],"category_scores_gemma":[0.001130192,0.00011798064,0.000049642964,0.0003917838,0.00012424945,0.00015611055,0.000046503617,0.0002619245,6.1676064e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025303886,0.00030310167,0.9881365,0.0013417811,0.000045929224,0.0000112914795,0.00062379666,0.0030929146,0.0029997479,0.0007047173,0.000043854845,0.0024433378],"study_design_scores_gemma":[0.0031193516,0.0010648943,0.42978644,0.00090148346,0.00005797002,0.0000118078415,0.00019264563,0.5638365,0.00042411342,0.0003170411,0.00016645853,0.00012128227],"about_ca_topic_score_codex":0.0020672572,"about_ca_topic_score_gemma":0.00010640295,"teacher_disagreement_score":0.5607436,"about_ca_system_score_codex":0.00011983822,"about_ca_system_score_gemma":0.0002031048,"threshold_uncertainty_score":0.4811111},"labels":[],"label_agreement":null},{"id":"W2810932342","doi":"10.1016/j.jval.2018.04.530","title":"Assessing the Benefits of Co-Pay Card Usage Among Diabetic Patients in Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Dapagliflozin; Medicine; Cohort; Glycemic; Diabetes mellitus; Emergency medicine; Environmental health; Internal medicine; Type 2 diabetes","score_opus":0.07325382569998956,"score_gpt":0.34670810640418975,"score_spread":0.2734542807042002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810932342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965769,0.00015731898,0.000008211681,0.0012714402,0.00018944283,0.00032373337,0.0000040935,0.0000036672895,0.0014651767],"genre_scores_gemma":[0.99846333,0.000057537563,0.000073934,0.0012491659,0.0000505889,0.000013088273,0.0000066224648,0.0000049919768,0.00008071459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988606,0.00013151123,0.00036250413,0.00012773415,0.00030523038,0.00021241394],"domain_scores_gemma":[0.99933994,0.00012387511,0.00015277616,0.00022778333,0.00006053092,0.00009509831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004594104,0.000058594273,0.00019469246,0.000048653834,0.00003933335,0.0000044750022,0.00009582979,0.000022562157,0.00006452355],"category_scores_gemma":[0.00016335215,0.000038144455,0.000011603217,0.0002584301,0.000069651906,0.000043007898,0.000012017036,0.00015726032,0.000012863116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000032189564,0.000031234995,0.99075276,0.00009538259,0.0000017903379,8.073048e-7,0.00028034867,0.00006157069,0.0000035625324,0.000037767382,0.00078442565,0.007947132],"study_design_scores_gemma":[0.00043376052,0.00008358454,0.9960047,0.00077340886,0.00000203013,4.5102897e-7,0.00028331467,0.0016772612,0.00012379306,0.000023915307,0.0005590623,0.00003472659],"about_ca_topic_score_codex":0.8682305,"about_ca_topic_score_gemma":0.34485,"teacher_disagreement_score":0.5233805,"about_ca_system_score_codex":0.00034442815,"about_ca_system_score_gemma":0.0020234704,"threshold_uncertainty_score":0.6671048},"labels":[],"label_agreement":null},{"id":"W2810938347","doi":"10.1016/j.jval.2018.04.1190","title":"Demographic Variation of Hepatitis C Virus (HCV) Prevalence in the US: Results from the National Health and Nutrition Examination Survey 2009 – 2016","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"National Health and Nutrition Examination Survey; Medicine; Demography; Marital status; Hepatitis C virus; Logistic regression; Cross-sectional study; Hepatitis C; Odds ratio; Multivariate analysis; Sexual orientation; Odds; Internal medicine; Environmental health; Population; Immunology; Virus; Pathology","score_opus":0.09297881753801358,"score_gpt":0.3665450905113663,"score_spread":0.27356627297335273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810938347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98642665,0.0023507462,0.00016663314,0.008033157,0.000093882576,0.0016817012,0.0010383879,0.000012891106,0.00019592592],"genre_scores_gemma":[0.9738291,0.02354105,0.0005038124,0.0015671785,0.00019091733,0.00006165599,0.0002799388,0.00001107767,0.000015275804],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99364203,0.003989877,0.0008126455,0.00032960414,0.0009201364,0.00030568134],"domain_scores_gemma":[0.9967436,0.0022274249,0.00031174254,0.00026066773,0.0003558625,0.000100694706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012103194,0.00010621253,0.00024467846,0.00030217555,0.0001463037,0.000021998378,0.0001592469,0.00008888697,0.000018704895],"category_scores_gemma":[0.0036427812,0.00007504885,0.00002366694,0.0009677156,0.00017506452,0.00014567326,0.00002909174,0.00030125733,0.000008795944],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054296997,0.00055090006,0.9613653,0.0005421865,0.000015303074,0.0000024299727,0.010045336,0.000026460031,0.00009886246,0.0003738244,0.0042173625,0.022219071],"study_design_scores_gemma":[0.0015788472,0.00084231555,0.9862837,0.0010056341,0.0000020591565,0.0000024901503,0.000052770843,0.008685535,0.00001756216,0.0007519554,0.0007216753,0.000055421453],"about_ca_topic_score_codex":0.30586335,"about_ca_topic_score_gemma":0.04741265,"teacher_disagreement_score":0.2584507,"about_ca_system_score_codex":0.0002862439,"about_ca_system_score_gemma":0.0010040004,"threshold_uncertainty_score":0.9699696},"labels":[],"label_agreement":null},{"id":"W2810942974","doi":"10.1016/j.jval.2018.04.110","title":"A Systematic Review and Network Meta-Analysis of Panitumumab with Chemotherapy in the First-Line Treatment of Patients with Wild-Type Ras Metastatic Colorectal Cancer (MCRC) with Left-Sided Tumors","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Panitumumab; Medicine; Bevacizumab; Internal medicine; Cetuximab; Oncology; Hazard ratio; Colorectal cancer; Meta-analysis; Chemotherapy; Subgroup analysis; Progression-free survival; Randomized controlled trial; Cancer; Confidence interval","score_opus":0.10571835447578684,"score_gpt":0.3709600085857512,"score_spread":0.26524165410996436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810942974","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0065307184,0.98207325,0.0000021408198,0.0002816072,0.00001539052,0.010926772,0.00014834959,0.00000802354,0.0000137742145],"genre_scores_gemma":[0.008254233,0.98939466,0.00023062201,0.00028645433,0.000016924725,0.0016199135,0.00011887334,0.000053227595,0.000025080446],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9960008,0.0007593494,0.0017116683,0.0005514894,0.00058390736,0.00039273605],"domain_scores_gemma":[0.9964534,0.00071716314,0.0019387559,0.0005525811,0.00024852366,0.00008954713],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008115369,0.00067759113,0.012439248,0.00033759442,0.00007575852,0.000009496202,0.00013411511,0.000057231737,0.000041430038],"category_scores_gemma":[0.000049696955,0.00025830275,0.0005375881,0.0023427848,0.00019491426,0.000033503296,0.000017718457,0.00015456359,3.783205e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011997103,0.0015422603,0.007931582,0.7573676,0.22643313,0.00003918589,0.0024784785,0.00025327754,1.4415308e-9,0.000009768335,0.000029020483,0.0027159671],"study_design_scores_gemma":[0.0039681173,0.01917255,0.0039605936,0.25374252,0.7167044,0.000038412203,0.00013089011,0.000051720228,1.5211407e-7,0.000004277196,0.0018649121,0.0003613988],"about_ca_topic_score_codex":0.0063605406,"about_ca_topic_score_gemma":0.014220013,"teacher_disagreement_score":0.5036251,"about_ca_system_score_codex":0.0006633788,"about_ca_system_score_gemma":0.0009204822,"threshold_uncertainty_score":0.99998695},"labels":[],"label_agreement":null},{"id":"W2810976272","doi":"10.1016/j.jval.2018.04.1680","title":"Real World Incidence and Prevalence of Systematic Lupus Erythematosus in Alberta, Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Incidence (geometry); Population; Demography; Confidence interval; Odds ratio; Pediatrics; Internal medicine; Environmental health","score_opus":0.03722122577952359,"score_gpt":0.32218528800459756,"score_spread":0.284964062225074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810976272","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933171,0.0021066882,0.000004601347,0.0009725284,0.00026869704,0.0019450525,0.0000055576693,0.000011521136,0.0013682417],"genre_scores_gemma":[0.9955719,0.00063570647,0.00038072714,0.000100059806,0.000058859794,0.00007567865,0.0000010603414,0.000024026323,0.0031519537],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99662995,0.0005105699,0.0012183966,0.00037071167,0.00073324866,0.00053714373],"domain_scores_gemma":[0.9974635,0.001224369,0.00031814515,0.00059631385,0.00015564605,0.00024200983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021598553,0.00016613187,0.00087729783,0.00042225936,0.0000394186,0.000007785793,0.00019764769,0.000061453036,0.000024812247],"category_scores_gemma":[0.0012413936,0.000139084,0.000024529641,0.0008763544,0.00015419773,0.000063592386,0.000084832616,0.00023502368,0.000008448294],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007642795,0.000045013414,0.776915,0.21906531,0.000009415338,0.000050579278,0.002650809,0.000009672388,0.00004192011,0.0008544746,0.00026220642,0.000019149076],"study_design_scores_gemma":[0.008947564,0.0018808206,0.29554442,0.62224025,0.00008427629,0.022530254,0.0058476687,0.039716255,0.0012514462,0.00092434743,0.00017103301,0.0008616462],"about_ca_topic_score_codex":0.9548605,"about_ca_topic_score_gemma":0.90322626,"teacher_disagreement_score":0.4813706,"about_ca_system_score_codex":0.0010802224,"about_ca_system_score_gemma":0.0033221333,"threshold_uncertainty_score":0.5893322},"labels":[],"label_agreement":null},{"id":"W2810977826","doi":"10.1016/j.jval.2018.04.469","title":"Characteristics & Glycemic Response of Patients With Uncontrolled Type 2 Diabetes Initiating Dulaglutide Alone or In Combination with Insulin In US Real World Practice","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Dulaglutide; Type 2 diabetes; Internal medicine; Glycemic; Medical prescription; Diabetes mellitus; Retrospective cohort study; Glucagon-like peptide 1 receptor; Insulin; Exenatide; Agonist; Endocrinology; Pharmacology","score_opus":0.024793714633708025,"score_gpt":0.29655450761118235,"score_spread":0.27176079297747435,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810977826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719274,0.00005544148,0.000005215612,0.0009172142,0.000081382896,0.0014383957,0.00000870343,0.00002165746,0.00027924965],"genre_scores_gemma":[0.9962213,0.00011077854,0.0026834018,0.00067721313,0.000027552995,0.000048851372,0.000118678414,0.000026964104,0.00008528193],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788207,0.0005049755,0.00067671906,0.00025264546,0.00032240438,0.0003611683],"domain_scores_gemma":[0.99820375,0.0008589691,0.0003918893,0.00024674274,0.00021759444,0.000081037404],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013191362,0.00016390937,0.00055359636,0.0006010327,0.00003181584,0.000010604025,0.000059276128,0.000044969438,0.000014729753],"category_scores_gemma":[0.0013193935,0.00012075132,0.0000135335895,0.0011081763,0.000065884815,0.00016148151,0.00003074818,0.00018016773,0.000007993967],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06666436,0.0016131466,0.9285194,0.00027438407,0.0000487706,0.000027365628,0.0010794046,0.00006550343,0.000019811214,0.00006604991,0.000018434657,0.0016033305],"study_design_scores_gemma":[0.021936616,0.009072194,0.96573937,0.0014964645,0.000046499492,4.5719685e-7,0.000096977434,0.001073849,0.00003459047,0.000020097457,0.00036551498,0.00011734151],"about_ca_topic_score_codex":0.0026012736,"about_ca_topic_score_gemma":0.0036897918,"teacher_disagreement_score":0.044727746,"about_ca_system_score_codex":0.00053866697,"about_ca_system_score_gemma":0.00042570994,"threshold_uncertainty_score":0.4924096},"labels":[],"label_agreement":null},{"id":"W2810985327","doi":"10.1016/j.jval.2018.04.1692","title":"Evaluation of Subcutaneous Rituximab Administration Impacts on Canadian Systemic Therapy Suites","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Juravinski Hospital; Roche (Canada); Hôpital du Sacré-Cœur de Montréal; University of Calgary","funders":"","keywords":"Chemoimmunotherapy; Rituximab; Medicine; Follicular lymphoma; Lymphoma; Diffuse large B-cell lymphoma; Population; Oncology; Internal medicine","score_opus":0.08634858034312419,"score_gpt":0.3644915796989373,"score_spread":0.2781429993558131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2810985327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936223,0.0023501662,3.038086e-7,0.0018305074,0.0001602066,0.0010188875,0.000020682244,0.0000119671195,0.0009849704],"genre_scores_gemma":[0.99877775,0.00049039634,0.000046020752,0.0004858905,0.00010905009,0.00003706899,0.00003221166,0.000010581023,0.000011035539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985473,0.00024437183,0.0003297838,0.00016961998,0.00046949406,0.00023940796],"domain_scores_gemma":[0.9990771,0.00012280008,0.00012396587,0.00022166489,0.00023541303,0.00021904925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012510755,0.000095422714,0.00023804957,0.00019404588,0.000052196705,0.000007997978,0.00003388106,0.00006015984,0.00007104125],"category_scores_gemma":[0.00017874893,0.00007641612,0.000034126337,0.00016482579,0.000027435757,0.000025056415,0.0000020438006,0.000034300774,0.000042381405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021214793,0.005739744,0.64230925,0.0010657179,0.00032177288,0.0003639751,0.008178759,0.00052912673,0.0015019987,0.004976427,0.0021396233,0.33075213],"study_design_scores_gemma":[0.021496417,0.032710318,0.90584093,0.0043839854,0.00016179727,0.0013162565,0.0005279585,0.01417286,0.017249694,0.000754833,0.0010486414,0.0003363298],"about_ca_topic_score_codex":0.24710105,"about_ca_topic_score_gemma":0.05957013,"teacher_disagreement_score":0.3304158,"about_ca_system_score_codex":0.0018818332,"about_ca_system_score_gemma":0.004460006,"threshold_uncertainty_score":0.9575903},"labels":[],"label_agreement":null},{"id":"W2811002132","doi":"10.1016/j.jval.2018.04.271","title":"Cancer Drug Recommendations Without Statistically Significant Overall Survival By The Pan-Canadian Oncology Drug Review","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Confounding; Internal medicine; Clinical Oncology; Oncology; Cancer; Drug; Cancer drugs; Health care; Pharmacology","score_opus":0.38546653095419053,"score_gpt":0.4691142313822293,"score_spread":0.08364770042803876,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811002132","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013140575,0.031263497,0.0014227907,0.9384405,0.002598127,0.002687347,0.003117053,0.00004961184,0.0072804964],"genre_scores_gemma":[0.38131964,0.09786114,0.0093554845,0.5009088,0.0020459571,0.0015145909,0.00053851295,0.00018639093,0.006269468],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99158835,0.0023748486,0.004375992,0.0006643012,0.00012607424,0.00087040686],"domain_scores_gemma":[0.99455315,0.0022925003,0.001872033,0.0006425908,0.00011347157,0.0005262475],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.03222402,0.00022917165,0.0011963994,0.00024120523,0.00048700726,0.000060350136,0.00048011242,0.00009530929,0.0018046839],"category_scores_gemma":[0.002795191,0.00023620728,0.00007744056,0.00033016535,0.0001893858,0.0002131621,0.000044618133,0.0004224935,0.0015332232],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008371871,0.00008466571,0.023427492,0.0008397766,0.000035101988,7.0931884e-7,0.0024887118,0.000050649323,2.2989006e-7,0.094277464,0.87567866,0.0031081652],"study_design_scores_gemma":[0.00055642036,0.00009884192,0.010524135,0.0009672974,0.000006573233,0.0000024327812,0.00046651324,0.004891976,4.9840577e-7,0.009589967,0.97258407,0.0003112885],"about_ca_topic_score_codex":0.70293796,"about_ca_topic_score_gemma":0.30485222,"teacher_disagreement_score":0.4375317,"about_ca_system_score_codex":0.003669405,"about_ca_system_score_gemma":0.003187999,"threshold_uncertainty_score":0.9992442},"labels":[],"label_agreement":null},{"id":"W2811010124","doi":"10.1016/j.jval.2018.04.571","title":"Cost-Effectiveness Analysis of Hepatitis C Treatments in Mexico: Genotype 2 and 3","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Sofosbuvir; Medicine; Ribavirin; Daclatasvir; Hepatocellular carcinoma; Internal medicine; Hepatitis C; Cirrhosis; Cost effectiveness; Cost-effectiveness analysis; Gastroenterology; Hepatitis C virus; Virology; Virus","score_opus":0.13113047439261022,"score_gpt":0.4354932396254479,"score_spread":0.3043627652328377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811010124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99741006,0.00055350584,0.00009021616,0.00025620754,0.0000381708,0.00093763863,0.000036739413,0.000009263768,0.0006682191],"genre_scores_gemma":[0.9976124,0.0016652929,0.00045384275,0.00012284947,0.000020084717,0.000056040353,0.000023799761,0.000012303596,0.000033369597],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831116,0.0005159192,0.00035659168,0.000250129,0.000265598,0.0003006131],"domain_scores_gemma":[0.9991907,0.00026418234,0.00006785517,0.00023903478,0.000084167135,0.00015407913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010364384,0.00008986576,0.00053886004,0.0008492174,0.00002953211,0.000004737419,0.00004651145,0.00006421729,0.000090067304],"category_scores_gemma":[0.0002544952,0.0000822498,0.00004077919,0.0015629138,0.0001083476,0.0000409252,0.000032996533,0.00012219234,0.000012988579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001497259,0.00017813014,0.96084225,0.00018319464,0.00016075057,0.000026176038,0.0008078875,0.000119753924,0.00011939927,0.000091262824,0.0000107748065,0.037310693],"study_design_scores_gemma":[0.0013703869,0.00077995955,0.975695,0.00021193808,0.000055519544,0.0000015073601,0.00001950924,0.020792315,0.00060101564,0.000069425405,0.00035294372,0.0000504484],"about_ca_topic_score_codex":0.12111288,"about_ca_topic_score_gemma":0.008420422,"teacher_disagreement_score":0.11269246,"about_ca_system_score_codex":0.0004999375,"about_ca_system_score_gemma":0.00031450615,"threshold_uncertainty_score":0.8847397},"labels":[],"label_agreement":null},{"id":"W2811028687","doi":"10.1016/j.jval.2018.04.816","title":"The Out-Of-Pocket Cost Burden of Prescription Drugs: A Pan-Canadian Comparison","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; University of Manitoba","funders":"","keywords":"Cost sharing; Medical prescription; Reimbursement; Prescription costs; Jurisdiction; Prescription drug; Business; Residence; Public health; Medicine; Public economics; Family medicine; Environmental health; Health care; Economic growth; Demographic economics; Economics; Political science; Pharmacology; Nursing","score_opus":0.42228210617666756,"score_gpt":0.4391225608255413,"score_spread":0.016840454648873737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811028687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8222834,0.018836452,0.002177961,0.12792142,0.006087782,0.0049709845,0.0010260056,0.00005789128,0.016638152],"genre_scores_gemma":[0.9957335,0.00037416743,0.00084841804,0.002322819,0.00039531844,0.00006079611,0.000016763808,0.000021950027,0.00022625408],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99369586,0.0006968711,0.004630991,0.00033763936,0.000107276435,0.00053137314],"domain_scores_gemma":[0.99554074,0.0009922652,0.0025574546,0.00057652284,0.00009783131,0.00023521457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020760246,0.00013056282,0.0008450667,0.00038185593,0.00023791804,0.00003150344,0.0003601081,0.00011802017,0.000102073776],"category_scores_gemma":[0.0020301442,0.00014326829,0.000074701085,0.0002546767,0.0001856854,0.00016591897,0.000032256772,0.00017792429,0.0004524045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014074908,0.0003418125,0.2665824,0.002894965,0.0001626006,6.2269885e-7,0.1382887,0.0051357937,0.0000092756345,0.41615066,0.15328114,0.017011285],"study_design_scores_gemma":[0.0017356635,0.00069892756,0.07734364,0.00083571044,0.0000063829157,0.0000015932046,0.014010893,0.13673776,0.00004186984,0.031440463,0.73664224,0.00050484366],"about_ca_topic_score_codex":0.48759907,"about_ca_topic_score_gemma":0.06648779,"teacher_disagreement_score":0.5833611,"about_ca_system_score_codex":0.0009696766,"about_ca_system_score_gemma":0.0008619564,"threshold_uncertainty_score":0.9505464},"labels":[],"label_agreement":null},{"id":"W2811118039","doi":"10.1016/j.jval.2018.04.062","title":"Long-Term Health Benefit of Ibalizumab In The Treatment of Adults with Multidrug-Resistant HIV-1 Infection","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV Research and Treatment","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada)","funders":"","keywords":"Medicine; Cohort; Population; Human immunodeficiency virus (HIV); Internal medicine; Antiretroviral therapy; Viral load; Pediatrics; Immunology; Environmental health","score_opus":0.028074962668648597,"score_gpt":0.30990236135482774,"score_spread":0.2818273986861791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811118039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938387,0.0040623755,0.000019540146,0.0007221576,0.000075118485,0.0010410018,0.00014734344,0.000010313788,0.00008341669],"genre_scores_gemma":[0.9965528,0.0029885706,0.000088863824,0.000039296072,0.000016361759,0.00007395555,0.00016436174,0.000009363617,0.00006639618],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822474,0.00054014963,0.00048584753,0.00023491144,0.0000740772,0.0004402651],"domain_scores_gemma":[0.99919087,0.00016599298,0.00022754306,0.00032535326,0.000053454638,0.000036772242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041351593,0.00014080376,0.00037854756,0.00020365274,0.000098263175,0.0000029880994,0.00010016054,0.00007161474,0.000049450766],"category_scores_gemma":[0.000014809447,0.00008374873,0.000048290076,0.00028114446,0.00021109413,0.00003185229,0.0000121409,0.00010780601,0.00005339982],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005037345,0.0062379474,0.87371314,0.000696689,0.00018628687,0.000025579135,0.030197714,0.00014659001,0.0006165787,0.00082793896,0.00013665658,0.08217752],"study_design_scores_gemma":[0.0074738176,0.016866583,0.97108984,0.00059581076,0.000007000983,0.000025665633,0.00038179746,0.000023244851,0.0026445258,0.00002780452,0.00078196806,0.00008192585],"about_ca_topic_score_codex":0.0664921,"about_ca_topic_score_gemma":0.025855877,"teacher_disagreement_score":0.097376704,"about_ca_system_score_codex":0.00041969868,"about_ca_system_score_gemma":0.00033446235,"threshold_uncertainty_score":0.9919197},"labels":[],"label_agreement":null},{"id":"W2811199668","doi":"10.1016/j.jval.2018.04.344","title":"Contemporary Natural History Of Heart Failure In Nova Scotia, Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Congenital Heart Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; University of British Columbia; Vancouver Coastal Health; Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Nova scotia; Incidence (geometry); Epidemiology; Population; Natural history; Cohort; Demography; Cohort study; Retrospective cohort study; Heart failure; Pediatrics; Gerontology; Internal medicine; Environmental health; Geography","score_opus":0.043329415506171046,"score_gpt":0.29331401961323705,"score_spread":0.24998460410706602,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811199668","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9702035,0.017039374,2.6774472e-7,0.009140528,0.0010699553,0.0004959854,0.000015561003,0.000015225027,0.0020196005],"genre_scores_gemma":[0.99669325,0.0000069311204,0.000261173,0.0023241872,0.00012892592,0.0000034059162,0.0000058781134,0.000013610825,0.00056260754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998701,0.00010233617,0.00044390862,0.00020355952,0.00026710925,0.00028210017],"domain_scores_gemma":[0.99938816,0.00009344174,0.00005870433,0.00022024165,0.00009225031,0.00014719654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028168148,0.00010795625,0.000411413,0.00016222839,0.000015090283,9.212398e-7,0.00004942722,0.000035630466,0.00007570317],"category_scores_gemma":[0.00015176908,0.00010484596,0.000036864574,0.00022066933,0.00014854733,0.000042740794,0.000036414025,0.00022106312,0.00001233735],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002452012,0.00012886364,0.5620555,0.0008862953,0.000019087613,0.00006667234,0.0013081812,0.0000020842913,0.00019388097,0.000035138128,0.4344008,0.0006582714],"study_design_scores_gemma":[0.0030991691,0.00073200767,0.8330015,0.0015789921,0.000009213131,0.000039444254,0.0011740543,0.0011190389,0.00014143178,0.000039656894,0.1588137,0.0002518147],"about_ca_topic_score_codex":0.95864046,"about_ca_topic_score_gemma":0.9507903,"teacher_disagreement_score":0.27558708,"about_ca_system_score_codex":0.0019106679,"about_ca_system_score_gemma":0.008349366,"threshold_uncertainty_score":0.9972724},"labels":[],"label_agreement":null},{"id":"W2811312889","doi":"10.1016/j.jval.2018.04.020","title":"Economic Guidance Panel Changes to Minimize Post-Progression Treatment Effects by the Pan-Canadian Oncology Drug Review in Economic Evaluations Assessing Cancer Drugs","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Time horizon; Hazard ratio; Life expectancy; Clinical trial; Economic evaluation; Oncology; Cancer; Internal medicine; Intensive care medicine; Actuarial science; Confidence interval; Health care; Environmental health; Economics; Finance","score_opus":0.33241591969907847,"score_gpt":0.5035252615666249,"score_spread":0.17110934186754645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811312889","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3075109,0.100567475,0.000058787704,0.5813473,0.0025842467,0.005446056,0.0008512192,0.000044062625,0.0015899532],"genre_scores_gemma":[0.7005929,0.055334616,0.004875002,0.22817615,0.0022408578,0.00727369,0.0002462832,0.00020458548,0.0010559765],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99159384,0.0022935004,0.0038849926,0.0010381696,0.00009626009,0.0010932343],"domain_scores_gemma":[0.9941948,0.0023268575,0.0020522568,0.00082841347,0.000058820075,0.0005388321],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.02218545,0.00037390462,0.0016244741,0.0006735285,0.00044563363,0.000106479696,0.00050831796,0.00017821981,0.00044182088],"category_scores_gemma":[0.0012201541,0.00038164217,0.00011389339,0.00029617632,0.0001248367,0.0003527384,0.000065626955,0.00024959998,0.0022784362],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014168766,0.00081539195,0.13071169,0.00802762,0.00029011283,0.000010506415,0.053302687,0.008687239,0.000022848433,0.019507587,0.4859506,0.29253203],"study_design_scores_gemma":[0.0045351414,0.0013315876,0.110785365,0.011669128,0.000039635608,0.000016120774,0.0030209974,0.040405817,0.00005958332,0.0032303547,0.8233998,0.0015064875],"about_ca_topic_score_codex":0.60813177,"about_ca_topic_score_gemma":0.45826897,"teacher_disagreement_score":0.39308193,"about_ca_system_score_codex":0.020856751,"about_ca_system_score_gemma":0.0046741394,"threshold_uncertainty_score":0.99986356},"labels":[],"label_agreement":null},{"id":"W2811318987","doi":"10.1016/j.jval.2018.05.008","title":"Cost-Utility Analysis Using EQ-5D-5L Data: Does How the Utilities Are Derived Matter?","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"EuroQol Research Foundation; Chongqing University of Arts and Sciences","keywords":"Medicine; Schema crosswalk; Quality-adjusted life year; Statistics; EQ-5D; Econometrics; Mathematics; Cost effectiveness; Internal medicine; Disease; Geography; Health related quality of life","score_opus":0.7114669972652248,"score_gpt":0.4543631785699398,"score_spread":0.257103818695285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811318987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86416954,0.0029553066,0.013617281,0.11358862,0.0012987873,0.001508279,0.0023815813,0.000063862135,0.00041672913],"genre_scores_gemma":[0.981695,0.00020454492,0.0028786925,0.014156297,0.0006272614,0.000053388932,0.00010665735,0.000033139924,0.00024504118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99295837,0.0016086842,0.0034758039,0.0010140425,0.00015457415,0.0007885217],"domain_scores_gemma":[0.99325234,0.0014992268,0.0027646702,0.0021584514,0.000095067015,0.00023027095],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029037712,0.00025765607,0.0013965907,0.00056068075,0.00059910107,0.00021441407,0.0008923292,0.00014709205,0.0006814376],"category_scores_gemma":[0.0025212774,0.00023335063,0.00014417076,0.00082850945,0.00032364254,0.0006970557,0.00025227002,0.00029702464,0.00054121256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023700873,0.00010790656,0.97372985,0.0007499981,0.00026003478,0.0000010003283,0.007044259,0.0012072737,7.3633413e-7,0.0045600682,0.012065119,0.00025002589],"study_design_scores_gemma":[0.0005339997,0.000048968708,0.52443737,0.0001643787,0.00003714555,0.0000036216347,0.010996316,0.41896868,0.0000045762536,0.008379857,0.03601379,0.00041128762],"about_ca_topic_score_codex":0.035604864,"about_ca_topic_score_gemma":0.006186314,"teacher_disagreement_score":0.44929248,"about_ca_system_score_codex":0.0009265519,"about_ca_system_score_gemma":0.00040962224,"threshold_uncertainty_score":0.99981},"labels":[],"label_agreement":null},{"id":"W2811322614","doi":"10.1016/j.jval.2018.04.748","title":"What US Healthcare Providers Value in Genomic Precision Medicine: A Discrete Choice Experiment","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"BRCA gene mutations in cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Life expectancy; Genetic testing; Willingness to pay; Health care; Test (biology); Mixed logit; Family medicine; Medicine; Preference; Expectancy theory; Actuarial science; Logistic regression; Statistics; Psychology; Environmental health; Business; Social psychology; Mathematics","score_opus":0.03418635957216529,"score_gpt":0.35688717178857926,"score_spread":0.322700812216414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811322614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96662754,0.017245093,0.00027673517,0.0130965905,0.0015283704,0.00105253,0.000009049449,0.000015506483,0.00014856408],"genre_scores_gemma":[0.99079925,0.003425164,0.0016642595,0.002937792,0.0007919551,0.00016110546,0.000055958917,0.000041189553,0.00012331615],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.997602,0.00041250893,0.0006123748,0.00064081326,0.00024056558,0.00049175386],"domain_scores_gemma":[0.9989693,0.00005496727,0.00017675075,0.00056579657,0.00007081966,0.00016232654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084622134,0.00019745223,0.00025900512,0.00016136136,0.00010088178,0.000029765586,0.000263593,0.00016260047,0.0000245703],"category_scores_gemma":[0.00017798219,0.0001874356,0.000041594605,0.0002710485,0.00017167581,0.00001772496,0.00012381088,0.00017724386,0.000013272194],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027626955,0.0011233157,0.1549004,0.003055886,0.00025339646,0.000052773765,0.07927681,0.076010905,0.4587226,0.0033442858,0.04241897,0.17807798],"study_design_scores_gemma":[0.017741255,0.017396968,0.18894178,0.0077424254,0.00004183574,0.00014663638,0.021137552,0.036306173,0.18492594,0.0055789277,0.5169268,0.0031137022],"about_ca_topic_score_codex":0.01437024,"about_ca_topic_score_gemma":0.0022022808,"teacher_disagreement_score":0.47450784,"about_ca_system_score_codex":0.00079270615,"about_ca_system_score_gemma":0.0009917564,"threshold_uncertainty_score":0.99219316},"labels":[],"label_agreement":null},{"id":"W2811367147","doi":"10.1016/j.jval.2018.04.1624","title":"Efficacy of Brodalumab in the Treatment of Moderate-To-Severe Psoriasis: A Network Meta-Analysis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada)","funders":"","keywords":"Ixekizumab; Medicine; Secukinumab; Ustekinumab; Etanercept; Psoriasis Area and Severity Index; Adalimumab; Infliximab; Internal medicine; Randomized controlled trial; Psoriasis; Dermatology; Psoriatic arthritis; Disease; Tumor necrosis factor alpha","score_opus":0.10257215354349344,"score_gpt":0.31986341823037634,"score_spread":0.2172912646868829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811367147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98064965,0.01724283,0.00005291653,0.00064622925,0.00024147348,0.0008467187,0.000081729726,0.000012753655,0.00022569811],"genre_scores_gemma":[0.99836785,0.00059144915,0.00045118327,0.00016612168,0.000057551733,0.000109546534,0.000049766186,0.000010796327,0.0001957249],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.9969289,0.0014792646,0.00075915654,0.00034204975,0.000068130896,0.00042251465],"domain_scores_gemma":[0.99846804,0.0006033166,0.00026842207,0.00058089866,0.000052405554,0.000026912612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009251533,0.00021195962,0.0012840637,0.00031610564,0.000092434115,0.0000046194186,0.0002338292,0.00014079708,0.00020673187],"category_scores_gemma":[0.000034790486,0.00013107431,0.0005367398,0.001299839,0.00008849789,0.000026870463,0.000018826333,0.00007034111,0.000048553673],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019131256,0.0214492,0.1042532,0.00035230882,0.33859125,0.00006215428,0.12806547,0.2704195,0.00158171,0.010673435,0.0034984283,0.101922095],"study_design_scores_gemma":[0.050795168,0.032196436,0.6585309,0.00025354634,0.19845703,0.00009364887,0.0038734253,0.0020928201,0.021740802,0.004574163,0.025353255,0.0020388076],"about_ca_topic_score_codex":0.008782528,"about_ca_topic_score_gemma":0.0017900397,"teacher_disagreement_score":0.55427766,"about_ca_system_score_codex":0.00010545394,"about_ca_system_score_gemma":0.00014473926,"threshold_uncertainty_score":0.99781805},"labels":[],"label_agreement":null},{"id":"W2811394421","doi":"10.1016/j.jval.2018.04.1643","title":"The Cost of Drugs for Age-Related Macular Degeneration in Canada and Internationally","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aflibercept; Macular degeneration; Ranibizumab; Reimbursement; Drug prices; Generic drug; Drug; Business; Medicine; International economics; Economics; Ophthalmology; Monetary economics; Pharmacology; Internal medicine; Economic growth; Bevacizumab; Health care","score_opus":0.06700896132124044,"score_gpt":0.3012974722135881,"score_spread":0.23428851089234765,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811394421","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99037665,0.0011436578,0.00013157837,0.0062656663,0.00031304988,0.0003258492,0.00012316328,0.0000016291242,0.0013187323],"genre_scores_gemma":[0.99797064,0.0006587819,0.00014214838,0.0011030221,0.000040726412,0.000018921402,0.000008366997,0.0000058708333,0.000051513514],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9991838,0.000017210104,0.00051733514,0.00011658005,0.000013293411,0.00015181258],"domain_scores_gemma":[0.99957657,0.00012822042,0.00016447631,0.00007333484,0.00001294877,0.0000444776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007508545,0.000043752763,0.00013914572,0.00007058795,0.000043528144,0.000012941753,0.00007930348,0.000021675985,0.000012383687],"category_scores_gemma":[0.000068812566,0.00004445074,0.000014343923,0.00007624232,0.000037339345,0.000033828273,0.000016156018,0.00005647818,0.000003253108],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028029614,0.000020709098,0.046297822,0.000049883587,0.000013139426,4.6675567e-7,0.00066728966,0.0033153058,0.0000094481,0.9421652,0.0007457696,0.0066869385],"study_design_scores_gemma":[0.0017446387,0.00009108162,0.06084327,0.000044846798,0.0000011578129,0.0000014269901,0.00006615606,0.65189713,0.00020685772,0.15959674,0.12533507,0.00017158478],"about_ca_topic_score_codex":0.765776,"about_ca_topic_score_gemma":0.7036595,"teacher_disagreement_score":0.78256845,"about_ca_system_score_codex":0.00039643215,"about_ca_system_score_gemma":0.00027110547,"threshold_uncertainty_score":0.30174798},"labels":[],"label_agreement":null},{"id":"W2811422218","doi":"10.1016/j.jval.2018.04.1127","title":"Cost Effectiveness of Ultra-Violet Germicidal Irradiation in Canadian Health Region","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiation Effects and Dosimetry","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Emergency medicine","score_opus":0.04774474030455195,"score_gpt":0.29883493373651565,"score_spread":0.2510901934319637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811422218","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961816,0.00031679808,0.0000065342215,0.0023341281,0.00020023844,0.000665999,0.000032802873,0.000012995806,0.00024890804],"genre_scores_gemma":[0.998911,0.00010976709,0.00001714035,0.00075967447,0.0001333644,0.000012375428,0.00005106279,0.00000107978,0.0000045031884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980604,0.0008416518,0.00033589007,0.00021868122,0.00011914587,0.00042423283],"domain_scores_gemma":[0.99910504,0.0004131366,0.00015576913,0.000053709373,0.000029687344,0.00024268955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018446031,0.000087481916,0.00023555456,0.00008881594,0.000103092585,0.0000115919565,0.000102240774,0.00007603521,0.000021405504],"category_scores_gemma":[0.00010762622,0.000043145512,0.00002925987,0.0007086688,0.0000434201,0.000076308286,0.0000047483127,0.000105053405,0.000009636622],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011710345,0.00018232399,0.86550415,0.0002707438,0.000004753627,0.0000057540733,0.00080015056,0.0021601259,0.003793568,0.0033559937,0.000613449,0.12319187],"study_design_scores_gemma":[0.00022385191,0.0005741546,0.99522597,0.00019400728,3.6388298e-7,0.0000028157035,0.00004228031,0.00152175,0.00028979505,0.0002370405,0.0016114494,0.00007653997],"about_ca_topic_score_codex":0.87777036,"about_ca_topic_score_gemma":0.43337104,"teacher_disagreement_score":0.44439933,"about_ca_system_score_codex":0.00055502483,"about_ca_system_score_gemma":0.0002555093,"threshold_uncertainty_score":0.5769685},"labels":[],"label_agreement":null},{"id":"W2811436997","doi":"10.1016/j.jval.2018.04.1634","title":"Cost-Effectivess Analysis of Brodalumab in Moderate-To-Severe Plaque Psoriasis in Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada)","funders":"","keywords":"Medicine; Ixekizumab; Ustekinumab; Adalimumab; Infliximab; Formulary; Secukinumab; Etanercept; Psoriasis Area and Severity Index; Discontinuation; Psoriasis; Internal medicine; Pharmacology; Psoriatic arthritis; Dermatology","score_opus":0.34018676712369283,"score_gpt":0.4183694531234424,"score_spread":0.07818268599974959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811436997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9843387,0.0005640016,0.00078445696,0.011120289,0.0004864201,0.0015169674,0.00044999082,0.000009596829,0.0007295827],"genre_scores_gemma":[0.99334127,0.00010786121,0.00089801854,0.005295895,0.00008691727,0.00018229609,0.000025337613,0.000023808896,0.000038595404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9925698,0.0010907523,0.0048429775,0.00069525465,0.00013546324,0.00066576083],"domain_scores_gemma":[0.9963448,0.001409128,0.001384849,0.00054859795,0.00006442399,0.0002481781],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.015426413,0.00019550284,0.0018388558,0.0020593836,0.00006630745,0.000019750085,0.00029858018,0.0001170972,0.0001745296],"category_scores_gemma":[0.0019931346,0.00027226767,0.0000779176,0.0023421636,0.000038731174,0.00021270169,0.000050549326,0.00024866257,0.000089301975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000089540605,0.000112914015,0.7398563,0.00037305572,0.00008218488,0.0000021606936,0.005191353,0.24291159,3.1194512e-7,0.009731538,0.0011283659,0.0005206667],"study_design_scores_gemma":[0.0013532493,0.00010870546,0.7140346,0.00022732967,0.000005610871,8.0826896e-7,0.0012370471,0.27920207,0.000005521709,0.00221879,0.0013307183,0.00027552462],"about_ca_topic_score_codex":0.9891741,"about_ca_topic_score_gemma":0.98407876,"teacher_disagreement_score":0.036290474,"about_ca_system_score_codex":0.007606193,"about_ca_system_score_gemma":0.0028077725,"threshold_uncertainty_score":0.99997294},"labels":[],"label_agreement":null},{"id":"W2811450988","doi":"10.1016/j.jval.2018.04.1003","title":"Drug Use Among Seniors in Canada, 2016","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Polypharmacy; Medicine; Beers Criteria; Drug class; Drug; Quarter (Canadian coin); Neighbourhood (mathematics); Public health; Gerontology; Environmental health; Family medicine; Psychiatry; Geography; Pharmacology; Nursing","score_opus":0.13779944569602773,"score_gpt":0.3939402055017065,"score_spread":0.25614075980567874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811450988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912014,0.0001998006,0.0000038726575,0.006834049,0.00048654477,0.00037073603,0.0000082194265,0.00001098625,0.0008843627],"genre_scores_gemma":[0.9931186,0.00017313223,0.00018785738,0.005718784,0.00010729684,0.000004464898,0.000003868997,0.0000108837785,0.0006751414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998704,0.00019838793,0.00035295862,0.00016711716,0.00022078831,0.00035672914],"domain_scores_gemma":[0.9990343,0.0004123034,0.000088066176,0.00016666095,0.000024357372,0.00027430058],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052652095,0.000082092956,0.00021663599,0.00009278273,0.00003290802,0.0000066465027,0.000050990464,0.000027134998,0.0001368745],"category_scores_gemma":[0.0002823025,0.000067318004,0.000018432751,0.00021844331,0.000039980598,0.00013736803,0.00002230563,0.00029950507,0.000026049334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008119571,0.000048378515,0.9926714,0.00009816115,0.000003974714,0.000040880204,0.00045840064,0.000069588496,0.0000041796443,0.00004648093,0.005219217,0.0012581605],"study_design_scores_gemma":[0.0012521779,0.00010709146,0.9296115,0.00036904094,0.0000058767037,0.000006957973,0.00022700385,0.017860165,0.000066126435,0.000047093785,0.05035027,0.00009671328],"about_ca_topic_score_codex":0.99275386,"about_ca_topic_score_gemma":0.92277735,"teacher_disagreement_score":0.06997649,"about_ca_system_score_codex":0.0006945616,"about_ca_system_score_gemma":0.0015363485,"threshold_uncertainty_score":0.27451485},"labels":[],"label_agreement":null},{"id":"W2811459770","doi":"10.1016/j.jval.2018.04.1145","title":"The Cost-Effectiveness of a Public Health Nurse Program to Screen for Amblyopia in Ontario","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Ophthalmology and Visual Impairment Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Holland Bloorview Kids Rehabilitation Hospital; University of Toronto","funders":"","keywords":"Medicine; Public health; Public health nurse; Health care; Christian ministry; Cost–benefit analysis; Family medicine; Cost effectiveness; Cohort; Pediatrics; Environmental health; Nursing","score_opus":0.2236896677052986,"score_gpt":0.4786570780213815,"score_spread":0.25496741031608294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811459770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97744083,0.0003242581,0.000159282,0.013826541,0.00026787116,0.007728815,0.000007908441,0.000025902818,0.00021861159],"genre_scores_gemma":[0.9971647,0.000030175323,0.0009505814,0.000733291,0.000055291872,0.0008658892,0.000012145574,0.000013391204,0.00017449354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979275,0.00058338913,0.00046566405,0.0002452296,0.0001451026,0.000633108],"domain_scores_gemma":[0.99876004,0.0005554264,0.00013068704,0.00022978176,0.00012132669,0.00020270994],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048714355,0.00011853825,0.00046440866,0.00016399364,0.00018541026,0.0000073184865,0.00009763943,0.0000611838,0.00000611922],"category_scores_gemma":[0.0004013057,0.00008437527,0.00004811414,0.0003633001,0.00017752961,0.000039527407,0.000034663277,0.00020146671,0.000006262913],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013787037,0.0016944481,0.95391434,0.0007015722,0.000039177718,0.0000023782577,0.0041055134,0.00000803937,0.000005907399,0.0023884028,0.00046053188,0.035301],"study_design_scores_gemma":[0.0023030806,0.021331608,0.964652,0.00075532874,0.0000038185717,0.000011697695,0.00046848177,0.00020998137,0.000020194799,0.00028618771,0.009892979,0.00006465907],"about_ca_topic_score_codex":0.13678563,"about_ca_topic_score_gemma":0.07013339,"teacher_disagreement_score":0.06665224,"about_ca_system_score_codex":0.00082662405,"about_ca_system_score_gemma":0.0015780434,"threshold_uncertainty_score":0.94683427},"labels":[],"label_agreement":null},{"id":"W2811480812","doi":"10.1016/j.jval.2018.04.923","title":"How Values Inform the Health Policy Decision-Making Processes About Health-System Financing in Latin America? A Critical Interpretive Synthesis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Corporate governance; Scope (computer science); Situational ethics; Health policy; Process (computing); Inclusion (mineral); Political science; Business; Health care; Public relations; Sociology; Computer science; Finance; Social science","score_opus":0.041496451469458275,"score_gpt":0.3302488597120274,"score_spread":0.2887524082425691,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811480812","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.31785068,0.06596462,0.06141483,0.5309444,0.005563398,0.007972597,0.0014076454,0.0005678892,0.008313945],"genre_scores_gemma":[0.9892941,0.0016310653,0.0028717574,0.005248712,0.00063322607,0.00021306724,0.0000017808334,0.000056910878,0.00004938868],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.994482,0.00036135988,0.002688963,0.0007539539,0.00020156888,0.0015121712],"domain_scores_gemma":[0.9954588,0.0020021803,0.0013726131,0.0006569559,0.00014587336,0.0003635791],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005512347,0.00035131292,0.0013992408,0.0010545347,0.0006595319,0.00020698558,0.0005157787,0.00018357833,0.000013664555],"category_scores_gemma":[0.013026112,0.0002676189,0.00012218651,0.0020791884,0.00026159413,0.00042261265,0.00014578585,0.00059044256,0.00008617175],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022176055,0.0003188341,0.05236149,0.015058124,0.000044933822,0.00001804056,0.12303342,0.0006574366,2.6422958e-7,0.24658157,0.0010375757,0.56066656],"study_design_scores_gemma":[0.0019162862,0.007542045,0.41826847,0.15902866,0.0000049763394,0.00028357396,0.09681461,0.1105778,0.000015393722,0.07140591,0.13080697,0.003335289],"about_ca_topic_score_codex":0.17979941,"about_ca_topic_score_gemma":0.0060034003,"teacher_disagreement_score":0.6714434,"about_ca_system_score_codex":0.0038851723,"about_ca_system_score_gemma":0.003149566,"threshold_uncertainty_score":0.9999776},"labels":[],"label_agreement":null},{"id":"W2811495265","doi":"10.1016/j.jval.2018.04.741","title":"The Frequency and Availability of Population-Specific Patient Reported Outcome Measures and Minimal Clinically Important Differences Among Approved Drugs in Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Minimal clinically important difference; Patient-reported outcome; Population; Quality of life (healthcare); Prom; Internal medicine; Randomized controlled trial; Environmental health","score_opus":0.3490020649427621,"score_gpt":0.3809580061455704,"score_spread":0.03195594120280831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811495265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893284,0.0030306142,0.0000116885,0.0062214443,0.00039504486,0.0008189883,0.0000762583,0.0000072005546,0.0001103802],"genre_scores_gemma":[0.99791396,0.0006273348,0.0007233414,0.0006289793,0.000050701936,0.000029460372,0.0000060854136,0.000011422773,0.000008703581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98900735,0.0006846689,0.0092661865,0.00053403206,0.00014371224,0.00036403735],"domain_scores_gemma":[0.99332833,0.0020084155,0.0039600055,0.0004604709,0.000068113484,0.00017464538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022486994,0.0001455649,0.000902825,0.00013721641,0.00016600425,0.000030979812,0.00014094143,0.00008160446,0.00001928733],"category_scores_gemma":[0.004860052,0.00013709212,0.000033712535,0.00015401565,0.00021121667,0.0001299699,0.000042227282,0.00019154744,0.0000021020992],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018359147,0.000030027566,0.9939229,0.00014652748,0.000008209307,3.8725463e-7,0.0020792733,0.000009172987,2.138323e-7,0.0031786792,0.00012330718,0.00048293115],"study_design_scores_gemma":[0.00033604965,0.0001257002,0.9862262,0.00007604496,8.8096033e-7,0.0000012526202,0.001504173,0.0037351053,3.1632695e-7,0.0075621987,0.00030948958,0.0001226052],"about_ca_topic_score_codex":0.9410865,"about_ca_topic_score_gemma":0.8194939,"teacher_disagreement_score":0.12159254,"about_ca_system_score_codex":0.0008963086,"about_ca_system_score_gemma":0.0007553209,"threshold_uncertainty_score":0.7793588},"labels":[],"label_agreement":null},{"id":"W2811504378","doi":"10.1016/j.jval.2018.04.1212","title":"A Canadian Cost-Utility Analysis of two Trabecular Micro-Bypass Stents in Patients with Mild-to-Moderate Open-Angle Glaucoma","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Prism Eye Institute","funders":"","keywords":"Medicine; Glaucoma; Quality-adjusted life year; Quality of life (healthcare); Intraocular pressure; Population ageing; Health care; Population; Cost effectiveness; Surgery; Ophthalmology; Economics; Risk analysis (engineering)","score_opus":0.025335773030799993,"score_gpt":0.2982317992226022,"score_spread":0.2728960261918022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2811504378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969846,0.00008933265,0.00003838943,0.00045995536,0.00005317412,0.0019615046,0.00020661356,0.000008749403,0.0001976839],"genre_scores_gemma":[0.9974324,0.000008609143,0.00034269172,0.0019194215,0.000019334026,0.000046980498,0.00018683226,0.000019714045,0.000023995754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978801,0.00029334836,0.00052523037,0.00044145883,0.00034106532,0.0005187893],"domain_scores_gemma":[0.9984211,0.000025760353,0.000103486214,0.0005863255,0.00018889528,0.0006744369],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056885893,0.00017136942,0.00071961887,0.0007465846,0.00007691094,0.000023510816,0.00020929023,0.000046903806,0.00010977836],"category_scores_gemma":[0.000045338045,0.00015137183,0.00012340758,0.0015656154,0.00005877247,0.00008030637,0.00004800805,0.00012456675,0.000011019394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003461444,0.0005642257,0.9965606,0.0000810349,0.00029849354,0.0000052233054,0.00079782546,0.00016789217,0.000010145188,0.000013053818,0.000091022244,0.0010643413],"study_design_scores_gemma":[0.0046740114,0.00059456844,0.99053687,0.0002486392,0.00022629692,8.370745e-7,0.0001385074,0.003075161,0.00012409865,0.000014520177,0.00023340667,0.00013306647],"about_ca_topic_score_codex":0.60410285,"about_ca_topic_score_gemma":0.55531114,"teacher_disagreement_score":0.04879168,"about_ca_system_score_codex":0.0006028549,"about_ca_system_score_gemma":0.0011282888,"threshold_uncertainty_score":0.61727643},"labels":[],"label_agreement":null},{"id":"W2884004329","doi":"10.1016/j.jval.2018.06.007","title":"Performance of a Bayesian Approach for Imputing Missing Data on the SF-12 Health-Related Quality-of-Life Measure","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods and Bayesian Inference","field":"Mathematics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; McGill University","funders":"Canadian Institutes of Health Research","keywords":"Missing data; Imputation (statistics); Statistics; Cohort; Categorical variable; SF-36; Bayesian probability; Medicine; Computer science; Mathematics; Health related quality of life","score_opus":0.4348050802861287,"score_gpt":0.45449927568290693,"score_spread":0.019694195396778247,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884004329","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.046728525,0.00020029652,0.9473069,0.0033682731,0.00015191446,0.0011562753,0.00015228461,0.000032009382,0.0009035262],"genre_scores_gemma":[0.46566603,0.000012349021,0.53394276,0.0002879272,0.000052064235,0.000008672276,0.000008691174,0.00001737947,0.0000041419275],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99585825,0.0014258636,0.0015543671,0.0003546088,0.0003628391,0.0004440936],"domain_scores_gemma":[0.9926722,0.005228103,0.0009663536,0.0008824963,0.000109318265,0.00014150828],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013661492,0.000155093,0.0006691576,0.00008617053,0.00023275193,0.000013149487,0.00049549376,0.00008891542,0.000015579339],"category_scores_gemma":[0.009589711,0.0001089535,0.000047640715,0.00030964226,0.00017710461,0.000054189968,0.00009070157,0.0002742321,8.871509e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041273097,0.00052966323,0.00521584,0.009326032,0.000058645048,2.2184035e-7,0.00577993,0.000064292886,0.0000770928,0.8000911,0.00138329,0.17706116],"study_design_scores_gemma":[0.00091124314,0.001047216,0.0034216503,0.0020322022,0.000011349337,0.0000032779897,0.0005571988,0.80914754,0.00012146137,0.18246293,0.0000692565,0.00021467032],"about_ca_topic_score_codex":0.0014122592,"about_ca_topic_score_gemma":0.000019736797,"teacher_disagreement_score":0.8090833,"about_ca_system_score_codex":0.00008049499,"about_ca_system_score_gemma":0.000702574,"threshold_uncertainty_score":0.99875295},"labels":[],"label_agreement":null},{"id":"W2884520592","doi":"10.1016/j.jval.2018.06.004","title":"Realizing the “Great Potential” of MCDA in HTA","year":2018,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Vancouver Coastal Health Research Institute; Vancouver Coastal Health","funders":"","keywords":"Multiple-criteria decision analysis; Computer science; Operations research; Engineering","score_opus":0.458412775041121,"score_gpt":0.42257971729625765,"score_spread":0.03583305774486334,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2884520592","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00858181,0.007293517,0.0002393214,0.9767462,0.0016410189,0.0016439154,0.0005642818,0.000030412146,0.0032595352],"genre_scores_gemma":[0.01801116,0.0021325345,0.0014755485,0.9714623,0.0048982543,0.0001888062,0.00024151849,0.0001422865,0.0014475556],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9871231,0.0020645005,0.008719107,0.0009175418,0.00021323572,0.0009625671],"domain_scores_gemma":[0.9913419,0.0017587172,0.005449362,0.0012827805,0.000061028757,0.00010623557],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.034879867,0.00035652943,0.0021336216,0.0010775947,0.00014838755,0.000055804117,0.0008182868,0.00072700373,0.0003202015],"category_scores_gemma":[0.0022296614,0.00038578716,0.00020230772,0.0005237159,0.0001792425,0.00020457027,0.00011616161,0.0014191594,0.00072072423],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000854149,0.000038249535,0.008494696,0.0027708083,0.000031356634,0.00001095143,0.001762778,0.0010896244,1.1357477e-7,0.007993751,0.97768676,0.00011237029],"study_design_scores_gemma":[0.0007774816,0.0001504053,0.008582017,0.0015502778,0.00000487791,0.000014957767,0.00045528222,0.00862554,6.340336e-7,0.023357593,0.95600545,0.00047545315],"about_ca_topic_score_codex":0.09470853,"about_ca_topic_score_gemma":0.0011644706,"teacher_disagreement_score":0.093544066,"about_ca_system_score_codex":0.0017728043,"about_ca_system_score_gemma":0.00082039915,"threshold_uncertainty_score":0.9998594},"labels":[],"label_agreement":null},{"id":"W2885318744","doi":"10.1016/j.jval.2018.06.010","title":"Valuation of Health and Nonhealth Outcomes from Next-Generation Sequencing: Approaches, Challenges, and Solutions","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":76,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Canadian Centre for Applied Research in Cancer Control; University of British Columbia","funders":"Canadian Cancer Society Research Institute; Canadian Centre for Applied Research in Cancer Control; Cancer Research Institute","keywords":"Valuation (finance); MEDLINE; Health care; Preference; Actuarial science; Computer science; Data science; Management science; Medicine; Economics; Biology; Accounting; Microeconomics","score_opus":0.9440262427380309,"score_gpt":0.4852302784682474,"score_spread":0.45879596426978353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2885318744","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003219891,0.97857255,0.00095995417,0.01558664,0.00068299676,0.002984064,0.0007020283,0.000039490213,0.00015028493],"genre_scores_gemma":[0.0005200302,0.99021846,0.0059128148,0.001830478,0.00048684317,0.00025818925,0.00065841543,0.00008113693,0.000033649318],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98275286,0.0042631566,0.010577032,0.0013871808,0.00020739235,0.00081238936],"domain_scores_gemma":[0.98784614,0.0019066514,0.008886935,0.0008310794,0.000057965524,0.00047125842],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.046060704,0.00052232033,0.005310892,0.0009645778,0.00035840343,0.00006723393,0.00026350826,0.0004886098,0.000024030149],"category_scores_gemma":[0.0026128278,0.0006066962,0.0001945215,0.000294065,0.00016155124,0.00043834883,0.00011855873,0.00047614414,0.000083320076],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006912223,0.00027698156,0.0009999434,0.11639571,0.00028915252,5.392517e-7,0.019841544,0.00013586515,2.3688916e-8,0.23881085,0.0026906347,0.6205518],"study_design_scores_gemma":[0.001906591,0.0009829312,0.0024980088,0.025406146,0.000080401835,0.000027960938,0.0036588362,0.052197285,3.9904407e-8,0.039444864,0.8721809,0.0016160362],"about_ca_topic_score_codex":0.026508575,"about_ca_topic_score_gemma":0.0012496322,"teacher_disagreement_score":0.86949027,"about_ca_system_score_codex":0.00301948,"about_ca_system_score_gemma":0.0038984776,"threshold_uncertainty_score":0.99963844},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"grok","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":["metaresearch","metaepi_broad"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W2886206370","doi":"10.1016/j.jval.2018.07.003","title":"Response to letter to the editor related to the retraction of a trial included in a meta-analysis of interventions to enhance oral medication adherence titled “Effectiveness and content analysis of interventions to enhance oral antidiabetic drug adherence in adults with type 2 diabetes: Systematic review and meta-analysis”","year":2018,"lang":"en","type":"letter","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Psychological intervention; Scopus; Medicine; Alternative medicine; Systematic review; Meta-analysis; MEDLINE; Content analysis; Family medicine; Nursing; Political science; Internal medicine","score_opus":0.16185768923630062,"score_gpt":0.429318066127496,"score_spread":0.2674603768911954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2886206370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60047257,0.0148523655,0.003853849,0.35769075,0.00048249302,0.022232171,0.00038676924,0.000022222583,0.0000067989026],"genre_scores_gemma":[0.94411045,0.00027205824,0.0009040941,0.048695166,0.00009764258,0.005069831,0.00013523053,0.000029965175,0.00068555895],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98866165,0.005836814,0.0032460184,0.0008995742,0.0010000502,0.000355916],"domain_scores_gemma":[0.9938914,0.0017542753,0.0018419733,0.0014351251,0.0008592208,0.00021800872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013162008,0.00037958985,0.0058069522,0.0027081603,0.000053261705,0.000021104024,0.0005396821,0.00019920988,0.00043273784],"category_scores_gemma":[0.005062454,0.0002240406,0.001247909,0.0122890305,0.00011087367,0.00008283709,0.00014384136,0.00069814164,0.000028634422],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016987609,0.0018732754,0.0028056463,0.26118502,0.58848673,0.000020422047,0.015416287,0.0033222497,0.00061033695,0.000014276672,0.10895751,0.00032061973],"study_design_scores_gemma":[0.00166242,0.0043641804,0.017728124,0.040883835,0.93303144,0.0000010860547,0.00043964392,0.0008164805,0.00025401954,0.000009202786,0.0003926358,0.00041690524],"about_ca_topic_score_codex":0.0040601706,"about_ca_topic_score_gemma":0.007684981,"teacher_disagreement_score":0.3445447,"about_ca_system_score_codex":0.00025046084,"about_ca_system_score_gemma":0.00026053598,"threshold_uncertainty_score":0.91361105},"labels":[{"model":"gemma","categories":["metaresearch","research_integrity"],"domain":"evaluation","study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"gpt","categories":["research_integrity"],"domain":null,"study_design":"not_applicable","genre":"commentary","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2887553020","doi":"10.1016/j.jval.2018.06.017","title":"Methodological Issues in Assessing the Economic Value of Next-Generation Sequencing Tests: Many Challenges and Not Enough Solutions","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":80,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; University of British Columbia; University of Calgary","funders":"National Human Genome Research Institute","keywords":"Economic evaluation; Management science; Delphi method; Value (mathematics); Computer science; Data science; Medicine; Artificial intelligence; Engineering; Machine learning","score_opus":0.5199318264038608,"score_gpt":0.451017848571655,"score_spread":0.06891397783220582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887553020","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.013781669,0.9849515,0.000045587505,0.00047852538,0.00018502823,0.00045877008,0.00004112917,0.0000040608593,0.000053711443],"genre_scores_gemma":[0.0101711815,0.9866052,0.0024964924,0.00007535702,0.00047470263,0.000046309313,0.000095869036,0.000023330484,0.000011559165],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997083,0.00141256,0.00068618194,0.00046591915,0.000063461346,0.0002888735],"domain_scores_gemma":[0.99899447,0.00022698793,0.00036069372,0.00033342766,0.00002398913,0.00006044359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001967643,0.00022046173,0.00072403497,0.00010036034,0.00010224025,0.00003386596,0.00019512043,0.0002695044,0.000002591499],"category_scores_gemma":[0.00027814033,0.00016043837,0.00012863286,0.00005325939,0.00011588497,0.0000068416152,0.00014257824,0.00017281628,0.0000017437285],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017232804,0.00014405865,0.000047445574,0.018089876,0.00020137291,0.000018822264,0.0011060066,0.0028045948,0.0017895012,0.015338826,0.00032761486,0.96011466],"study_design_scores_gemma":[0.00065330224,0.00097258645,0.0011549182,0.01132002,0.0002566842,0.00029946386,0.0013207054,0.008414052,0.00035657262,0.0021263182,0.9719045,0.0012208889],"about_ca_topic_score_codex":0.0010576223,"about_ca_topic_score_gemma":0.00019031431,"teacher_disagreement_score":0.97157687,"about_ca_system_score_codex":0.00022074368,"about_ca_system_score_gemma":0.0010685445,"threshold_uncertainty_score":0.65424865},"labels":[],"label_agreement":null},{"id":"W2887815625","doi":"10.1016/j.jval.2018.06.016","title":"Using “Big Data” in the Cost-Effectiveness Analysis of Next-Generation Sequencing Technologies: Challenges and Potential Solutions","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Institute of Health Economics; Canadian Centre for Applied Research in Cancer Control; University of Alberta; University of Calgary","funders":"","keywords":"Big data; Data science; Key (lock); Computer science; DNA sequencing; Health care; Data mining; Biology; Political science; Computer security","score_opus":0.8757959084535702,"score_gpt":0.48642022198103374,"score_spread":0.3893756864725365,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2887815625","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9457621,0.01850131,0.02040286,0.013194486,0.00044083482,0.0012734683,0.00024855795,0.00002882104,0.0001475733],"genre_scores_gemma":[0.9953572,0.0021966354,0.0017665935,0.00041778316,0.00016184057,0.0000465367,0.000042994227,0.000009319816,0.000001090265],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99583554,0.0011786561,0.0020847851,0.0004916124,0.00008013093,0.00032927614],"domain_scores_gemma":[0.9973436,0.0008076684,0.0010613154,0.00070951576,0.000042049676,0.000035861754],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0333112,0.0001073641,0.0007099401,0.0009599166,0.00018770395,0.00003425802,0.00030756358,0.000117358046,0.0000058463493],"category_scores_gemma":[0.002034024,0.000116022486,0.000039040417,0.00073864206,0.00013696557,0.00034544137,0.00010027073,0.00015260314,0.000007819094],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007394143,0.00069300324,0.13253245,0.004361114,0.0008840776,0.000008467849,0.05545299,0.2561528,0.00042326312,0.50354344,0.00033059047,0.04554384],"study_design_scores_gemma":[0.0003578726,0.00008366378,0.051249716,0.0001480962,0.000020881707,0.0000057061675,0.0075202254,0.9345038,0.0000061804326,0.0055468776,0.00041511495,0.00014189392],"about_ca_topic_score_codex":0.019120332,"about_ca_topic_score_gemma":0.0037411833,"teacher_disagreement_score":0.678351,"about_ca_system_score_codex":0.00073869416,"about_ca_system_score_gemma":0.00028620972,"threshold_uncertainty_score":0.99540955},"labels":[],"label_agreement":null},{"id":"W2892210399","doi":"10.1016/j.jval.2018.05.003","title":"Application of Constrained Optimization Methods in Health Services Research: Report 2 of the ISPOR Optimization Methods Emerging Good Practices Task Force","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":55,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Bone and Joint Health Institute; University of Calgary; Alberta Health Services; Tellabs (Canada)","funders":"","keywords":"Task force; Task (project management); Management science; Computer science; Medicine; Engineering; Political science; Systems engineering; Public administration","score_opus":0.2221371570409141,"score_gpt":0.5923094517570339,"score_spread":0.3701722947161198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2892210399","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0062494883,0.00052095007,0.97229415,0.015250148,0.000575451,0.0042271796,0.000026217162,0.00005244054,0.0008039471],"genre_scores_gemma":[0.15816759,0.0007655134,0.83971065,0.00063245284,0.0001560594,0.0002668696,0.00011936682,0.000045318237,0.00013617074],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97587126,0.018312924,0.0037105225,0.00065845845,0.000632973,0.0008138525],"domain_scores_gemma":[0.98989254,0.0026050638,0.004790962,0.0009534785,0.0015600034,0.00019793063],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.043169554,0.00021299552,0.00069719134,0.0007371448,0.0010567986,0.000017811417,0.00039585392,0.00033072772,0.00006949234],"category_scores_gemma":[0.0032623864,0.00018310838,0.000064943095,0.0033514786,0.00022481415,0.00041054367,0.00015393319,0.0009529694,0.000002162584],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000071762006,0.00016673117,0.01236756,0.002486955,0.000011503954,5.882783e-7,0.015758619,0.95705074,0.00029858877,0.0049181418,0.000025400346,0.006843404],"study_design_scores_gemma":[0.0006583171,0.00023745703,0.0018846918,0.001662391,0.000005980622,0.0000067428414,0.00893013,0.9847746,0.00020042137,0.00038837208,0.00112652,0.00012441467],"about_ca_topic_score_codex":0.043000173,"about_ca_topic_score_gemma":0.0017051203,"teacher_disagreement_score":0.1519181,"about_ca_system_score_codex":0.0007003019,"about_ca_system_score_gemma":0.004353817,"threshold_uncertainty_score":0.9852583},"labels":[],"label_agreement":null},{"id":"W2899561579","doi":"10.1016/j.jval.2018.07.249","title":"Burden of Ischemic Heart Disease And Stroke And Impact of Lipid Control And Modifiable Risk Factors In China","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Medicine; Stroke (engine); Environmental health; Disease; Population; Obesity; Risk factor; Diabetes mellitus; Disease burden; Public health; Demography; Gerontology; Internal medicine","score_opus":0.01394295970635822,"score_gpt":0.28171289580616343,"score_spread":0.2677699360998052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899561579","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926712,0.0059545934,0.000025324434,0.00033624878,0.000029228935,0.0008007985,0.000114005226,0.0000067003975,0.000061909515],"genre_scores_gemma":[0.99826187,0.0013869321,0.00014961221,0.0000358745,0.00012508604,0.0000074573422,0.0000037221344,0.0000130489425,0.00001637265],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873686,0.00018917656,0.00038063573,0.0002275539,0.00019955878,0.00026623675],"domain_scores_gemma":[0.9991725,0.000066679226,0.00012754425,0.00025772292,0.00003461122,0.00034096328],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009991771,0.0001214554,0.00061764446,0.00015638853,0.00003591088,0.0000047209023,0.000026550262,0.000060005197,0.0000090502035],"category_scores_gemma":[0.00017273774,0.00009279252,0.00006748904,0.00012839008,0.00013733307,0.000053461088,0.000024727598,0.00017592005,2.4986616e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055083627,0.00008844845,0.9929183,0.0012900577,0.00006881998,0.0000025377765,0.0015107157,0.0005562296,0.0012596371,0.000016228558,0.00011675464,0.0016214335],"study_design_scores_gemma":[0.0041651,0.0012960798,0.976763,0.00045319519,0.00004049743,0.000011488598,0.00016209402,0.016624426,0.00019572872,0.000060101287,0.00014690748,0.00008138649],"about_ca_topic_score_codex":0.15162691,"about_ca_topic_score_gemma":0.000034555203,"teacher_disagreement_score":0.15159236,"about_ca_system_score_codex":0.00007654527,"about_ca_system_score_gemma":0.00037304198,"threshold_uncertainty_score":0.8540225},"labels":[],"label_agreement":null},{"id":"W2899799073","doi":"10.1016/j.jval.2018.07.056","title":"Towards a More Accurate Budget Impact Analysis: Population-Level Screening for Hepatitis C Virus (HCV) in Ontario, Canada","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Guelph; Toronto Public Health; University of Waterloo","funders":"","keywords":"Medicine; Population; Cohort; Hepatitis C; Hepatitis C virus; Demography; Environmental health; Pediatrics; Virology; Internal medicine; Virus","score_opus":0.12368826849587636,"score_gpt":0.40830744627403137,"score_spread":0.28461917777815504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899799073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993879,0.00014283549,0.0016522859,0.0022363125,0.00012467282,0.0012513335,0.00040349993,0.000024154957,0.00028590337],"genre_scores_gemma":[0.99187106,0.00008717305,0.0059866617,0.0011683688,0.00013704617,0.00010610588,0.00040199497,0.00003581864,0.00020577322],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687093,0.00023140888,0.00084938615,0.0004527463,0.0007118888,0.0008836324],"domain_scores_gemma":[0.9985314,0.00018459834,0.00017712406,0.0004314546,0.00022181107,0.0004535864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013096465,0.00021600879,0.00074245036,0.0008061686,0.00013597243,0.000031900297,0.00016800189,0.00011353777,0.00041866308],"category_scores_gemma":[0.00070201454,0.00020366564,0.00013372077,0.0014861843,0.000046731442,0.00013849321,0.00005233193,0.00044544565,0.0000052389996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00021315881,0.000058037935,0.98116744,0.000101869584,0.00014613102,0.000052676976,0.001063696,0.0037436131,0.000008498365,0.00003342446,0.0014905866,0.011920878],"study_design_scores_gemma":[0.0011696976,0.00039558992,0.8901595,0.00021823308,0.000034226996,0.0000034358495,0.00004969045,0.10591701,0.000026239324,0.000064312895,0.0018113138,0.00015077581],"about_ca_topic_score_codex":0.9999565,"about_ca_topic_score_gemma":0.99992406,"teacher_disagreement_score":0.102173395,"about_ca_system_score_codex":0.0049324594,"about_ca_system_score_gemma":0.00849478,"threshold_uncertainty_score":0.9988874},"labels":[],"label_agreement":null},{"id":"W2899921812","doi":"10.1016/j.jval.2018.07.635","title":"The Relationship Between Socio Economic Status and Traumatic Brain Injuries for Pediatric Populations","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Trauma and Emergency Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"","keywords":"Traumatic brain injury; Medicine; Demography; Incidence (geometry); Injury prevention; Pediatrics; Poison control; Emergency medicine; Psychiatry","score_opus":0.20128737208470174,"score_gpt":0.4164966929250285,"score_spread":0.21520932084032676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2899921812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9808649,0.0022121826,0.0000881244,0.015604878,0.00031971716,0.00057567906,0.000037750266,0.00002757781,0.0002692104],"genre_scores_gemma":[0.9979937,0.00028969982,0.00073607353,0.00013888319,0.0006348598,0.000044904482,0.000018489442,0.000012591392,0.00013081131],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999041,0.00007984571,0.00039380122,0.00013870354,0.000064706,0.0002819136],"domain_scores_gemma":[0.9984834,0.0011868131,0.000088457855,0.00012645549,0.000027122878,0.0000877381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005923481,0.00007794682,0.00018647901,0.00009177988,0.00054861495,0.000010937365,0.000031294534,0.0000412505,0.000004893556],"category_scores_gemma":[0.00055682636,0.000059406444,0.000037075868,0.00010319619,0.00009513277,0.000045328892,0.000013005085,0.0000980843,0.000010059309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015806545,0.0000069183916,0.9754171,0.00017015127,0.000007942808,3.547827e-8,0.0039373985,0.000006618578,7.866795e-8,0.014647794,0.0031805162,0.002609633],"study_design_scores_gemma":[0.0004459816,0.00026972525,0.9731223,0.000027057591,0.0000232303,4.8612327e-7,0.0009929538,0.00012586328,3.2850824e-7,0.02282293,0.0021159663,0.00005320406],"about_ca_topic_score_codex":0.0018574244,"about_ca_topic_score_gemma":0.0010705198,"teacher_disagreement_score":0.017128807,"about_ca_system_score_codex":0.00015208703,"about_ca_system_score_gemma":0.00023763602,"threshold_uncertainty_score":0.42195582},"labels":[],"label_agreement":null},{"id":"W2900040219","doi":"10.1016/j.jval.2018.07.019","title":"Cross-Country Comparison Of Cancer-Specific Multi-Attribute Utility Instruments (Mauis): Relative Weighting And Ranking Of Health-Related Quality Of Life (Hrql) Domains In Country-Specific Utility Algorithms","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Life expectancy; Quality of life (healthcare); Demography; Medicine; Representativeness heuristic; Ranking (information retrieval); Population; Valuation (finance); Statistics; Actuarial science; Gerontology; Econometrics; Mathematics; Computer science; Machine learning; Economics; Accounting; Environmental health","score_opus":0.44500466645428105,"score_gpt":0.46851434396187175,"score_spread":0.0235096775075907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900040219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9596224,0.031704005,0.0020240326,0.0017962112,0.00087884464,0.0016704508,0.0021328398,0.00002825078,0.00014296922],"genre_scores_gemma":[0.99295175,0.0025396708,0.0039141667,0.00033725865,0.00008930048,0.000045897817,0.00007207546,0.000037542515,0.000012311437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9772848,0.002805085,0.017475609,0.0011267839,0.00037734726,0.0009303559],"domain_scores_gemma":[0.9844683,0.0020406086,0.012087208,0.00083299406,0.00027466344,0.00029622143],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.051236473,0.00037348137,0.0037197324,0.0006710075,0.00031968215,0.0000344769,0.00040108565,0.00037746693,0.0002246455],"category_scores_gemma":[0.002384691,0.00048097997,0.0001325218,0.0011472732,0.00084353756,0.00057384407,0.00013892031,0.0006560046,0.000017176859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013030785,0.00056702516,0.97390467,0.002360034,0.00006122147,1.6836823e-7,0.010997164,0.00036090883,0.0000041341686,0.009914034,0.000098515025,0.0016018297],"study_design_scores_gemma":[0.0043216567,0.0002168567,0.92508566,0.00093361456,0.0000022635559,6.721393e-7,0.0016054787,0.06420569,0.000024748822,0.0019736208,0.0013314233,0.0002983281],"about_ca_topic_score_codex":0.14418457,"about_ca_topic_score_gemma":0.0044141356,"teacher_disagreement_score":0.13977043,"about_ca_system_score_codex":0.0017135276,"about_ca_system_score_gemma":0.0008209941,"threshold_uncertainty_score":0.9997642},"labels":[],"label_agreement":null},{"id":"W2900118984","doi":"10.1016/j.jval.2018.07.622","title":"The Health and Economic Burden of Osteoporosis and Impact of Effective Treatment In Singapore","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Osteoporosis; Medicine; Incidence (geometry); Population; Status quo; Total cost; Indirect costs; Health care; Environmental health; Cost–benefit analysis; Demography; Business; Economics; Economic growth; Internal medicine","score_opus":0.38431139445152424,"score_gpt":0.5455991089242566,"score_spread":0.16128771447273232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900118984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97943306,0.0051439637,0.0000020982725,0.012157121,0.00024652178,0.0027503187,0.00007728328,0.000014077131,0.00017556504],"genre_scores_gemma":[0.9929739,0.006038876,0.00020471984,0.00045771958,0.00015731929,0.00011014235,0.0000059255126,0.000023612272,0.000027732483],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99099886,0.006305357,0.001483316,0.00036651656,0.000147187,0.0006987563],"domain_scores_gemma":[0.99221635,0.00571286,0.0012354768,0.00040221395,0.000086482374,0.00034661667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075879535,0.00019329149,0.000755205,0.00022338156,0.00046541324,0.0000074466884,0.00011121836,0.00014809398,0.000015854845],"category_scores_gemma":[0.00078215357,0.00013513221,0.00004845861,0.00021934812,0.00031585383,0.00014129456,0.00008938876,0.00041862897,0.000007862183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006348055,0.0001217034,0.8110409,0.0018450986,0.00004072858,0.0000011435628,0.109619655,0.00006740399,0.000020701968,0.0012527746,0.00017263585,0.07518249],"study_design_scores_gemma":[0.0037128746,0.012314159,0.9439151,0.0022051989,0.0000098000155,0.000007061125,0.030078888,0.0028627277,0.0000352968,0.0023759112,0.00226985,0.0002131201],"about_ca_topic_score_codex":0.5714098,"about_ca_topic_score_gemma":0.034342095,"teacher_disagreement_score":0.5370677,"about_ca_system_score_codex":0.0023965354,"about_ca_system_score_gemma":0.0044793813,"threshold_uncertainty_score":0.98327863},"labels":[],"label_agreement":null},{"id":"W2900137235","doi":"10.1016/j.jval.2018.07.873","title":"Costs and Survival for Dialysis Patients: Real World Evidence Supporting Home Dialysis","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Dialysis and Renal Disease Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Ontario Stroke Network; London Health Sciences Centre; St. Michael's Hospital; Western University; Toronto Public Health; Centre for Addiction and Mental Health; Toronto General Hospital","funders":"","keywords":"Medicine; Home hemodialysis; Dialysis; Hemodialysis; Hazard ratio; Proportional hazards model; Peritoneal dialysis; Population; Cohort; Survival analysis; Internal medicine; Retrospective cohort study; Emergency medicine; Confidence interval; Environmental health","score_opus":0.05310273921355673,"score_gpt":0.3517320114645391,"score_spread":0.29862927225098235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900137235","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934397,0.00042176942,0.00030465488,0.002958936,0.00049627235,0.0011130762,0.000026149772,0.000042054347,0.0011973956],"genre_scores_gemma":[0.99643755,0.0008773261,0.00081325124,0.0007603595,0.0004310191,0.00007222197,0.000061440456,0.00002355388,0.00052330195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977352,0.00022225482,0.0007198768,0.0004515899,0.00040003276,0.0004710203],"domain_scores_gemma":[0.9984868,0.00041754695,0.00027896208,0.00031669153,0.00017169905,0.00032827305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001957467,0.00015977577,0.00058397226,0.0004362192,0.00014892247,0.000040024363,0.00008786808,0.00003807444,0.00006113303],"category_scores_gemma":[0.00069714896,0.00013135481,0.00014900653,0.0007375353,0.000090453825,0.00010494335,0.00008301554,0.00008621904,0.000013258369],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005162184,0.0006246873,0.9085433,0.0011904138,0.00021378395,0.000009838462,0.0011317874,0.00007967729,0.000031984873,0.001183802,0.0017688059,0.08470571],"study_design_scores_gemma":[0.0027765802,0.0011002629,0.98057884,0.0013871028,0.00046630917,3.7606432e-7,0.00027784184,0.0084510455,0.000049701062,0.0004008561,0.0042146943,0.00029641838],"about_ca_topic_score_codex":0.0072800266,"about_ca_topic_score_gemma":0.0014992044,"teacher_disagreement_score":0.08440929,"about_ca_system_score_codex":0.00032723666,"about_ca_system_score_gemma":0.00016519932,"threshold_uncertainty_score":0.9993306},"labels":[],"label_agreement":null},{"id":"W2900203095","doi":"10.1016/j.jval.2018.07.248","title":"Burden of Ischemic Heart Disease And Stroke And The Impact Of Modifiable Risk Factors In Taiwan","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Medicine; Stroke (engine); Disease; Environmental health; Disease burden; Risk factor; Obesity; Population; Diabetes mellitus; Public health; Population ageing; Emergency medicine; Demography; Gerontology; Internal medicine","score_opus":0.03738710247321565,"score_gpt":0.32173634977274773,"score_spread":0.2843492472995321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900203095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98679566,0.00053264864,0.000006185517,0.011432645,0.00005606658,0.00032288418,0.000027565837,0.0000072862404,0.0008190397],"genre_scores_gemma":[0.9988149,0.00012919532,0.000029175411,0.0008205998,0.00017715413,0.0000047668495,0.0000037317407,0.000006742468,0.000013725211],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987792,0.00012340002,0.00048780645,0.00015604707,0.000084080115,0.00036948724],"domain_scores_gemma":[0.99925673,0.00017691957,0.00030557753,0.00016746171,0.000045912995,0.000047392292],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018274677,0.00010053095,0.0003897732,0.00016397327,0.000069890244,0.000014815618,0.00009267019,0.000044994624,0.000018684595],"category_scores_gemma":[0.00075857446,0.00006373751,0.000038770504,0.00025658982,0.00027144115,0.00016654209,0.00009995137,0.0001291813,0.0000020485916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028397437,0.00005472855,0.9183858,0.0007770588,0.000015842801,3.2544787e-7,0.0008099155,0.039236043,0.000025697622,0.006525537,0.033673085,0.00021197331],"study_design_scores_gemma":[0.0021461197,0.00011501597,0.41886854,0.00018782887,0.000012637012,6.764927e-7,0.0011741956,0.55374783,0.0000017569282,0.00538935,0.018221185,0.00013488639],"about_ca_topic_score_codex":0.75933594,"about_ca_topic_score_gemma":0.00016444869,"teacher_disagreement_score":0.7591715,"about_ca_system_score_codex":0.00004270393,"about_ca_system_score_gemma":0.00011525058,"threshold_uncertainty_score":0.25991404},"labels":[],"label_agreement":null},{"id":"W2900324617","doi":"10.1016/j.jval.2018.07.277","title":"Non-Severe Hypoglycemia Episodes (Nshes) Clinical And Economic Outcomes: A Comparison Between Sulfonylurea (Su) And Sodium-Glucose Co-Transporter 2 Inhibitor (Sglt2i) As Add On To Metformin From A Canadian Perspective","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Hypoglycemia; Metformin; Sulfonylurea; Type 2 Diabetes Mellitus; Adverse effect; Reimbursement; Health economics; Environmental health; Demography; Diabetes mellitus; Internal medicine; Health care; Insulin; Economics; Endocrinology; Public health","score_opus":0.04709727888063146,"score_gpt":0.3620011550741379,"score_spread":0.3149038761935064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900324617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898109,0.00028523704,0.0000068922577,0.0053444756,0.00024671873,0.0015859868,0.00019529952,0.00003488029,0.0024896166],"genre_scores_gemma":[0.99466264,0.00015947717,0.0010638698,0.0032689322,0.0004522463,0.000049162816,0.00011503325,0.000037714206,0.00019091512],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976986,0.000092676986,0.0007607422,0.0006806859,0.00017330126,0.0005940066],"domain_scores_gemma":[0.9981061,0.0003205305,0.00014205888,0.00036235826,0.00003854862,0.0010303726],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065543765,0.0003124107,0.0010102406,0.00037742438,0.00012695545,0.000047063502,0.000100657555,0.00016603564,0.00010046266],"category_scores_gemma":[0.000067825364,0.00027061612,0.00008835169,0.0001082574,0.0001704566,0.00010371897,0.000036095065,0.00029217338,0.00024143283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046396448,0.00016282119,0.9798344,0.0000609858,0.00023209346,0.000033510572,0.0036141726,0.000005009948,0.0000015792649,0.00050677266,0.004178211,0.010906472],"study_design_scores_gemma":[0.0065761334,0.003944584,0.9697505,0.00037712153,0.00016768422,0.0000024517217,0.0019337329,0.00030030488,0.00011722828,0.0007645512,0.01574261,0.00032305505],"about_ca_topic_score_codex":0.46261388,"about_ca_topic_score_gemma":0.14713849,"teacher_disagreement_score":0.3154754,"about_ca_system_score_codex":0.00092596945,"about_ca_system_score_gemma":0.0005934377,"threshold_uncertainty_score":0.9999746},"labels":[],"label_agreement":null},{"id":"W2900443357","doi":"10.1016/j.jval.2018.07.409","title":"A Study of Determinants of Hospitalizations in India","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Demography; Logistic regression; Christian ministry; Quarter (Canadian coin); Poverty; Population; Environmental health; Geography; Internal medicine","score_opus":0.07561749740671518,"score_gpt":0.31558603299138577,"score_spread":0.23996853558467057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2900443357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977893,0.00041463648,0.000018145267,0.000056910765,0.00028716098,0.0005243574,0.000029544759,0.000003856299,0.0008760698],"genre_scores_gemma":[0.999712,0.000089050576,0.00007977878,0.00003099392,0.000032311356,0.00001538435,8.944855e-7,0.0000090852345,0.000030529645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982166,0.000048020116,0.0013268747,0.00017332597,0.00003271238,0.00020246718],"domain_scores_gemma":[0.9991669,0.000014557562,0.00052790815,0.00021519209,0.000026039968,0.000049382877],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011669078,0.00006032164,0.00045040666,0.00043253225,0.000025879135,0.00000282422,0.000105677005,0.000058104226,0.000012349121],"category_scores_gemma":[0.000082954946,0.000056908793,0.00002239279,0.00054707425,0.000031391362,0.0000584318,0.000023981165,0.000066179164,0.000013512867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003281473,0.00029570694,0.984415,0.0001944343,0.0000023852392,0.0000013279805,0.009363376,0.000048682155,2.0646283e-7,0.004705988,0.0000049422792,0.00096467417],"study_design_scores_gemma":[0.00051836984,0.00083201757,0.9947964,0.00014284317,1.3183117e-7,8.5884375e-7,0.0011741512,0.00083750795,0.000006834768,0.0015134541,0.000121993515,0.000055441375],"about_ca_topic_score_codex":0.11239133,"about_ca_topic_score_gemma":0.0030788765,"teacher_disagreement_score":0.10931245,"about_ca_system_score_codex":0.00010982505,"about_ca_system_score_gemma":0.00010123872,"threshold_uncertainty_score":0.89351934},"labels":[],"label_agreement":null},{"id":"W2902615909","doi":"10.1016/j.jval.2018.08.008","title":"Evaluating Canadians’ Values for Drug Coverage Decision Making","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health Research Institute; Vancouver Coastal Health; Centre for Advancing Health Outcomes; York University; University of British Columbia; Providence Health Care Research Institute; Providence Health Care; Ministry of Health","funders":"Canadian Institutes of Health Research","keywords":"Drug; Computer science; Medicine; Pharmacology","score_opus":0.4991278213945099,"score_gpt":0.5029373610944847,"score_spread":0.0038095396999748288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2902615909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8919857,0.0055806334,0.047737155,0.042613305,0.0038760772,0.0035709145,0.0006534956,0.00011375252,0.003868974],"genre_scores_gemma":[0.9122013,0.00013040921,0.060626976,0.025005044,0.0012803411,0.00021059168,0.00002608356,0.00007209649,0.0004471584],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99276304,0.00063615944,0.0047718203,0.00079491816,0.0001550816,0.0008789517],"domain_scores_gemma":[0.99294645,0.0040017697,0.002054036,0.0006044051,0.00011287787,0.00028044876],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.046014365,0.00022038637,0.000989731,0.00061065215,0.0005160717,0.00009852106,0.00035077566,0.00012588855,0.0002805895],"category_scores_gemma":[0.009854956,0.0002968343,0.000118956326,0.00035486743,0.00007489259,0.00037006833,0.000049875474,0.00019275917,0.0007436543],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029221032,0.00035614404,0.13341734,0.0039943173,0.00012095064,0.0000043097407,0.044735406,0.03836095,0.0000043992677,0.5368265,0.19593723,0.045950226],"study_design_scores_gemma":[0.0023373186,0.00056417304,0.024387214,0.0015178238,0.0000045042707,0.000007866978,0.0014130872,0.46133244,0.0000039018746,0.4457223,0.062032674,0.0006766873],"about_ca_topic_score_codex":0.048832618,"about_ca_topic_score_gemma":0.007052488,"teacher_disagreement_score":0.4229715,"about_ca_system_score_codex":0.0023173816,"about_ca_system_score_gemma":0.00097057235,"threshold_uncertainty_score":0.9999484},"labels":[],"label_agreement":null},{"id":"W2904484213","doi":"10.1016/j.jval.2018.08.010","title":"Identifying the Need for Good Practices in Health Technology Assessment: Summary of the ISPOR HTA Council Working Group Report on Good Practices in HTA","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":126,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cochrane; Institute of Health Economics; Canadian Agency for Drugs and Technologies in Health; University of Ottawa","funders":"","keywords":"Health technology; Reimbursement; Pharmacoeconomics; Scope (computer science); Health care; Best practice; Medicine; Management science; Health economics; Process management; Business; Political science; Nursing; Computer science; Engineering; Management; Economics; Public health; Intensive care medicine","score_opus":0.7828634860829735,"score_gpt":0.5493517150779043,"score_spread":0.23351177100506926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2904484213","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00093745405,0.9246957,0.000119509365,0.06100648,0.0024841956,0.008859298,0.00022394421,0.000045116827,0.0016283041],"genre_scores_gemma":[0.0026835625,0.9874448,0.0032338998,0.0038543579,0.00060679,0.0015968808,0.00010002179,0.00013880958,0.00034085612],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.97375506,0.005080777,0.017444342,0.0018487382,0.00051052874,0.0013605645],"domain_scores_gemma":[0.92134047,0.011297315,0.06489851,0.0021603308,0.00014839535,0.0001549769],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.17475367,0.0005969771,0.0046544974,0.0015296438,0.0004429253,0.00015709575,0.0015661434,0.0007353247,0.000021780921],"category_scores_gemma":[0.033363897,0.00052681484,0.00039091372,0.002174876,0.00019522823,0.0005876814,0.0002836431,0.0019524957,0.000048737067],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00014507485,0.0026148132,0.1607828,0.27757207,0.0006322592,0.00003652526,0.008476261,0.0006980716,8.3766245e-8,0.4694344,0.016019125,0.06358852],"study_design_scores_gemma":[0.0008117975,0.00029732462,0.0023325349,0.033415765,0.000026077812,0.000057942754,0.0025355124,0.0012114882,3.0084333e-8,0.0075802365,0.9513098,0.0004214603],"about_ca_topic_score_codex":0.04611321,"about_ca_topic_score_gemma":0.016646102,"teacher_disagreement_score":0.9352907,"about_ca_system_score_codex":0.009847582,"about_ca_system_score_gemma":0.012218686,"threshold_uncertainty_score":0.99971837},"labels":[],"label_agreement":null},{"id":"W2905594795","doi":"10.1016/j.jval.2018.09.882","title":"PGI40 - THE ROLE OF PERFORMANCE-BASED RISK-SHARING AGREEMENTS IN MINIMISING PAYER UNCERTAINTY WHEN STANDARD OF CARE IS NOT CLEARLY DEFINED; THE EXAMPLE OF CROHN’S DISEASE RELATED COMPLEX PERIANAL FISTULAS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Anorectal Disease Treatments and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Reimbursement; Medicine; MEDLINE; Cochrane Library; Disease; Systematic review; Health care; Intensive care medicine; Family medicine; Randomized controlled trial; Surgery; Pathology","score_opus":0.0485758511796468,"score_gpt":0.3004503757805898,"score_spread":0.251874524600943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905594795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99704987,0.0008579544,0.0000064147725,0.00073906034,0.0000419136,0.0007274244,0.00031488432,0.00000859707,0.0002538936],"genre_scores_gemma":[0.9992108,0.00009673001,0.00025256086,0.00031091247,0.000022113449,0.000012947913,0.000048745598,0.000018590286,0.000026645952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981197,0.00019603313,0.00071085314,0.00024575347,0.000436123,0.000291537],"domain_scores_gemma":[0.99868846,0.0001680549,0.00039988503,0.0004670604,0.00014978927,0.00012674126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00045349772,0.00016070866,0.0004744436,0.00011823739,0.00013936302,0.000007792749,0.00016833622,0.000043114327,0.00023719818],"category_scores_gemma":[0.00011070944,0.000093856404,0.00012807276,0.00024143723,0.00024443347,0.000043332613,0.000057959693,0.00015270278,0.0000022846716],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039366214,0.00017591483,0.9729946,0.0005922739,0.00006926198,0.000005142462,0.014594767,0.0011136895,0.000036820064,0.00015375605,0.000039080576,0.006288027],"study_design_scores_gemma":[0.002753672,0.00085251743,0.9723612,0.00078118825,0.000097133685,5.203819e-7,0.0022442609,0.01999401,0.00027515102,0.00018655237,0.00037615944,0.00007762732],"about_ca_topic_score_codex":0.037280507,"about_ca_topic_score_gemma":0.0006812873,"teacher_disagreement_score":0.036599223,"about_ca_system_score_codex":0.00026546625,"about_ca_system_score_gemma":0.0005174693,"threshold_uncertainty_score":0.96913034},"labels":[],"label_agreement":null},{"id":"W2905613400","doi":"10.1016/j.jval.2018.09.933","title":"PHP37 - SPEEDING TO MARKET? AN EVALUATION OF ACCELERATED DRUG APPROVAL PATHWAYS IN AUSTRALIA, CANADA, AND SAUDI ARABIA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business; Drug; Medicine; Pharmacology","score_opus":0.407439286169447,"score_gpt":0.4595118803334806,"score_spread":0.05207259416403359,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905613400","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611014,0.00013450126,0.0000034267969,0.0019094053,0.00025157756,0.00088328985,0.000011843389,0.000007353877,0.0006884835],"genre_scores_gemma":[0.9982267,0.00003876328,0.00052918214,0.00096829614,0.000102463644,0.000009531832,0.000009876164,0.000009506276,0.0001056941],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811953,0.00039805888,0.000458691,0.0002354464,0.0004983991,0.0002899001],"domain_scores_gemma":[0.9991507,0.00016899026,0.00013228456,0.00014178304,0.00012872202,0.00027750738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030985167,0.00009927935,0.00026940895,0.00011815729,0.00003373079,0.000009139495,0.00005514603,0.000040261366,0.00018482142],"category_scores_gemma":[0.00046889926,0.0000913361,0.000012125873,0.00034745215,0.000030931373,0.00013225558,0.000023874058,0.00020966466,0.0000023403188],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013611888,0.0004971778,0.94108945,0.0011283844,0.000030071906,0.000020915004,0.0066172886,0.0012629456,0.0022047386,0.00016294673,0.0039668563,0.041658044],"study_design_scores_gemma":[0.0030747594,0.00073376717,0.83312345,0.0005064425,0.00003814828,0.000012364127,0.0005699153,0.15787289,0.0014261774,0.00036405,0.002108554,0.00016951076],"about_ca_topic_score_codex":0.7086257,"about_ca_topic_score_gemma":0.27548486,"teacher_disagreement_score":0.43314084,"about_ca_system_score_codex":0.00040866516,"about_ca_system_score_gemma":0.0008483315,"threshold_uncertainty_score":0.7377356},"labels":[],"label_agreement":null},{"id":"W2905617446","doi":"10.1016/j.jval.2018.09.311","title":"PCN229 - COMPARISON OF SICKNESS BENEFIT AND SICK LEAVE DURATION IN ONCOLOGY ACROSS COUNTRIES","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Sick leave; Absenteeism; Duration (music); Productivity; Medicine; Presenteeism; Workforce; Indirect costs; Economic impact analysis; Family medicine; Demographic economics; Business; Economic growth; Psychology; Economics; Physical therapy; Accounting","score_opus":0.05015643137826087,"score_gpt":0.46488467894569724,"score_spread":0.41472824756743637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905617446","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9909396,0.0036086657,0.0004361657,0.0038070392,0.00046667163,0.00037068,0.0000059786703,0.000013696257,0.0003514725],"genre_scores_gemma":[0.99456173,0.0015616432,0.0023840622,0.0011085536,0.00027846228,0.000010453216,0.000005772648,0.000009174981,0.00008011957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99882793,0.000113256676,0.0005299629,0.00017864189,0.00010012011,0.00025006855],"domain_scores_gemma":[0.9991617,0.00037278343,0.00021767714,0.00013122524,0.000059293132,0.000057282006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070529594,0.000084871615,0.0004973802,0.00008156936,0.00007384074,0.0000023843943,0.00004585928,0.0001537096,0.000027860176],"category_scores_gemma":[0.000084212006,0.00007490034,0.0000142820345,0.00016000251,0.0004798374,0.000064048676,0.000016181259,0.00020620192,0.000004492497],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015328093,0.00047854957,0.89387673,0.00045747534,0.00001705537,0.000016429722,0.031692524,0.000766372,0.0002447432,0.0066033765,0.0002683766,0.06404558],"study_design_scores_gemma":[0.012647952,0.014339731,0.8039334,0.0010545048,0.000018537226,0.0002064776,0.0070931013,0.024181161,0.0038581528,0.0059884996,0.12632757,0.00035093157],"about_ca_topic_score_codex":0.0010994504,"about_ca_topic_score_gemma":0.0017766726,"teacher_disagreement_score":0.1260592,"about_ca_system_score_codex":0.00034354627,"about_ca_system_score_gemma":0.00028947214,"threshold_uncertainty_score":0.3054347},"labels":[],"label_agreement":null},{"id":"W2905623501","doi":"10.1016/j.jval.2018.09.154","title":"PCN72 - BUDGET IMPACT ANALYSIS OF TISAGENLECLEUCEL FOR THE TREATMENT OF ADULT PATIENTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA IN ENGLAND","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Cytokine release syndrome; Diffuse large B-cell lymphoma; Gemcitabine; Rituximab; Hematopoietic stem cell transplantation; Oncology; Salvage therapy; Internal medicine; Lymphoma; Immunotherapy; Transplantation; Chemotherapy; Cancer; Chimeric antigen receptor","score_opus":0.03206869418140544,"score_gpt":0.34377035954052426,"score_spread":0.3117016653591188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905623501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99743354,0.000360654,0.00003213408,0.00014092022,0.000045263132,0.0016894741,0.00022695909,0.0000079882375,0.00006309242],"genre_scores_gemma":[0.9977934,0.0011753836,0.0002088197,0.000094836774,0.000055328204,0.00006914193,0.000084849424,0.00003125481,0.00048702836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806124,0.00024631477,0.0005657069,0.00027059088,0.00041397166,0.00044217665],"domain_scores_gemma":[0.99795693,0.000823323,0.00025778578,0.00058245746,0.00023569172,0.00014378167],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005918409,0.00016588237,0.00069190585,0.0005346867,0.00004921497,0.0000049081527,0.00011205435,0.00008195074,0.00018148252],"category_scores_gemma":[0.0001332281,0.00008724827,0.00015807812,0.0011471504,0.000098195145,0.000033625838,0.000014085311,0.000077898796,0.0000016988091],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024265267,0.024054084,0.89654845,0.00043772798,0.001016454,0.0000111657955,0.017125774,0.00011150039,0.0010612481,0.000009209342,0.00010835167,0.035250764],"study_design_scores_gemma":[0.09134347,0.032029554,0.85236156,0.00021570084,0.0003524511,0.000001368645,0.00037472666,0.016662924,0.0024274064,0.000010694277,0.0040737214,0.0001463951],"about_ca_topic_score_codex":0.012720774,"about_ca_topic_score_gemma":0.00490684,"teacher_disagreement_score":0.0670782,"about_ca_system_score_codex":0.0007809467,"about_ca_system_score_gemma":0.0006116747,"threshold_uncertainty_score":0.9938536},"labels":[],"label_agreement":null},{"id":"W2905623651","doi":"10.1016/j.jval.2018.09.1928","title":"PMU92 - CAN THE EQ-5D-3L PREDICT POST-HOSPITALIZATION HEALTHCARE USE AND OUTCOMES?","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Emergency department; Logistic regression; Depression (economics); Observational study; Anxiety; EQ-5D; Emergency medicine; Health care; Physical therapy; Internal medicine; Psychiatry; Health related quality of life","score_opus":0.45160265575515557,"score_gpt":0.4077404640815757,"score_spread":0.04386219167357985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905623651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.72578806,0.0021955103,0.0005272144,0.268075,0.0011364976,0.001492921,0.00054057763,0.000070320144,0.00017390297],"genre_scores_gemma":[0.9401985,0.00059390086,0.00094971433,0.057395235,0.0004067647,0.00009349841,0.00006461322,0.000048300364,0.0002495098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99395114,0.00094531523,0.0036367532,0.00065529306,0.00013932677,0.0006721482],"domain_scores_gemma":[0.99587876,0.0011996727,0.0017390372,0.0007233471,0.0001339928,0.00032518397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014757182,0.00023127074,0.0008687425,0.00035296174,0.0004842525,0.00014695621,0.0002794542,0.00016460729,0.00008067922],"category_scores_gemma":[0.00432064,0.00023053132,0.00007043861,0.00035220722,0.00017502057,0.00049283693,0.00008037653,0.00026268448,0.00026051505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014961995,0.000058471265,0.850106,0.00049005664,0.000023053488,6.501091e-7,0.008040397,0.0001998267,1.6707662e-7,0.13525349,0.0055448893,0.0002680219],"study_design_scores_gemma":[0.0008300462,0.0004661652,0.9425025,0.00021298506,0.000002826438,0.0000076888855,0.0013355723,0.016151782,8.13732e-7,0.012215361,0.025970994,0.00030324468],"about_ca_topic_score_codex":0.095247015,"about_ca_topic_score_gemma":0.0062459535,"teacher_disagreement_score":0.21441041,"about_ca_system_score_codex":0.0009518643,"about_ca_system_score_gemma":0.00052212476,"threshold_uncertainty_score":0.94007945},"labels":[],"label_agreement":null},{"id":"W2905627404","doi":"10.1016/j.jval.2017.08.769","title":"Secukinumab Vs. Adalimumab for the Treatment of Psoriatic Arthritis: A Cost Per Responder Analysis at 48 Weeks from an Argentinian Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Secukinumab; Adalimumab; Medicine; Psoriatic arthritis; Internal medicine; Arthritis; Rheumatoid arthritis","score_opus":0.34400279589064076,"score_gpt":0.4548185456381139,"score_spread":0.11081574974747316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905627404","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90545285,0.015441392,0.0022334044,0.068384066,0.001098308,0.0034213427,0.0036102296,0.000029692657,0.00032869406],"genre_scores_gemma":[0.9914744,0.0030114271,0.0018543034,0.0020992388,0.00045253747,0.0005498493,0.00010442678,0.00004266864,0.00041116166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945836,0.00067257934,0.0032909424,0.0007795142,0.00012928322,0.00054409704],"domain_scores_gemma":[0.99284875,0.0017267966,0.0035276988,0.0015605091,0.00010629011,0.00022993583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009114419,0.00024049645,0.0015560937,0.00045997096,0.0008361172,0.00012085832,0.000463793,0.0001414197,0.00047715713],"category_scores_gemma":[0.001553563,0.00024351534,0.00035263252,0.00018005849,0.0001229554,0.0003135614,0.000040016876,0.00010983497,0.00020308353],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019982941,0.0034880757,0.49125284,0.00074406713,0.0048985924,0.000006527604,0.21633098,0.021703608,0.0000030539484,0.24348198,0.007221241,0.008870761],"study_design_scores_gemma":[0.010385799,0.00165335,0.6319174,0.00022995475,0.00019421995,0.0000029238142,0.014378836,0.19585371,0.00001143977,0.03799843,0.106628,0.0007458869],"about_ca_topic_score_codex":0.12012239,"about_ca_topic_score_gemma":0.025229987,"teacher_disagreement_score":0.20548354,"about_ca_system_score_codex":0.0030434497,"about_ca_system_score_gemma":0.00044086654,"threshold_uncertainty_score":0.99302673},"labels":[],"label_agreement":null},{"id":"W2905632992","doi":"10.1016/j.jval.2018.09.1558","title":"PMD109 - A CANADIAN COST-UTILITY ANALYSIS OF TWO TRABECULAR MICRO-BYPASS STENTS IMPLANTED AT TIME OF CATARACT SURGERY IN PATIENTS WITH MILD-TO-MODERATE OPEN-ANGLE GLAUCOMA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Cerebrovascular and Carotid Artery Diseases","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Prism Eye Institute","funders":"","keywords":"Medicine; Glaucoma; Quality-adjusted life year; Randomized controlled trial; Cataract surgery; Intraocular pressure; Quality of life (healthcare); Population; Surgery; Emergency medicine; Cost effectiveness; Ophthalmology","score_opus":0.026112480431253242,"score_gpt":0.2848861269923436,"score_spread":0.25877364656109036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905632992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99724066,0.00009794602,0.0000065883037,0.00016270403,0.00004321729,0.001504293,0.0008834299,0.0000074293653,0.00005375725],"genre_scores_gemma":[0.9981627,0.000013220885,0.00007354666,0.000725213,0.000012849482,0.000024955858,0.0009453096,0.000020660942,0.00002158529],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757093,0.0003673563,0.0007576495,0.00042164413,0.00036508165,0.0005173619],"domain_scores_gemma":[0.99829984,0.00009444616,0.00021597922,0.00060184574,0.00021686121,0.00057100656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077574566,0.00019124824,0.0010902935,0.0009130945,0.00007009994,0.000011396364,0.00017585946,0.000055643533,0.00016021015],"category_scores_gemma":[0.00006888988,0.00016885123,0.00018877166,0.001415278,0.00008114133,0.00008257691,0.00005790322,0.00010251062,0.00001393249],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089706614,0.0006120041,0.9963653,0.00014746712,0.00044390679,0.000008861233,0.0006486373,0.00007522022,0.00007653728,0.0000011992935,0.00026808106,0.00045570038],"study_design_scores_gemma":[0.0026931025,0.000368679,0.9931926,0.00038454946,0.00026908485,0.0000030226088,0.00005883098,0.0021584253,0.0006402874,0.0000026128796,0.000089245936,0.00013952602],"about_ca_topic_score_codex":0.5635385,"about_ca_topic_score_gemma":0.33664396,"teacher_disagreement_score":0.22689454,"about_ca_system_score_codex":0.00052680593,"about_ca_system_score_gemma":0.001213534,"threshold_uncertainty_score":0.6885553},"labels":[],"label_agreement":null},{"id":"W2905645767","doi":"10.1016/j.jval.2018.09.090","title":"PCN7 - A TIME WITHOUT SYMPTOMS OR TOXICITY ANALYSIS OF NIRAPARIB COMPARED WITH ROUTINE SURVEILLANCE IN THE MAINTENANCE TREATMENT OF PATIENTS WITH RECURRENT OVARIAN CANCER","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; BC Cancer Agency","funders":"","keywords":"Medicine; Nausea; Cohort; Internal medicine; Ovarian cancer; Vomiting; Adverse effect; Toxicity; Oncology; Cancer; Gastroenterology; Surgery","score_opus":0.041604897005488584,"score_gpt":0.3369448825303392,"score_spread":0.29533998552485063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905645767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996553,0.0002521886,0.00019927834,0.0010106451,0.00005427026,0.0015323666,0.00025838535,0.000015261403,0.000124593],"genre_scores_gemma":[0.99849373,0.00020583678,0.0006042406,0.00034835946,0.000048569684,0.00016128176,0.00007174064,0.000018075347,0.000048161703],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99768394,0.00039822437,0.00070905796,0.0003560433,0.0004913289,0.00036142694],"domain_scores_gemma":[0.99839133,0.00016046503,0.0005716087,0.0005269681,0.0002582019,0.00009145112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000588725,0.00021131836,0.0009990039,0.00031058004,0.000043118558,0.000005022668,0.00012695373,0.00004729308,0.0001298204],"category_scores_gemma":[0.00002514187,0.000109748,0.00006405319,0.0020058511,0.00025772103,0.000039629696,0.00000940907,0.000107726584,0.0000014188183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01418617,0.001445012,0.9763568,0.00011192213,0.00041287675,0.0000035752616,0.0043301545,0.0019398214,0.000017167547,0.000044756223,0.00005939189,0.0010923487],"study_design_scores_gemma":[0.016566958,0.006904148,0.96449256,0.0009160178,0.0001233632,0.0000027227175,0.000116262854,0.010304883,0.00016023163,0.0000102534705,0.00026767017,0.00013493498],"about_ca_topic_score_codex":0.01136696,"about_ca_topic_score_gemma":0.00912114,"teacher_disagreement_score":0.011864251,"about_ca_system_score_codex":0.00078804547,"about_ca_system_score_gemma":0.00062118436,"threshold_uncertainty_score":0.9952164},"labels":[],"label_agreement":null},{"id":"W2905661534","doi":"10.1016/j.jval.2018.09.1985","title":"PND18 - PROGRESSION OF DISABILITY IN PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS: A RETROSPECTIVE COHORT STUDY USING DATA FROM THE MSBASE REGISTRY AND A CONTEXTUALISATION WITH AN EXISTING NATURAL HISTORY DATASET","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Hôpital Notre-Dame","funders":"","keywords":"Natural history; Expanded Disability Status Scale; Medicine; Akaike information criterion; Cohort; Retrospective cohort study; Multiple sclerosis; Pediatrics; Demography; Internal medicine; Statistics; Psychiatry; Mathematics","score_opus":0.29451073122915267,"score_gpt":0.41892886080129244,"score_spread":0.12441812957213977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905661534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910264,0.002353252,0.000009043993,0.00029993785,0.000069009766,0.0049043167,0.0013053253,0.000023334967,0.000009403662],"genre_scores_gemma":[0.9945432,0.00007187374,0.0033661362,0.0001083764,0.00015360051,0.00013650622,0.0015978006,0.000021476473,0.0000010625065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996164,0.0011914124,0.00065092096,0.0008616382,0.00076918944,0.00036281042],"domain_scores_gemma":[0.9971104,0.0006523972,0.0004863952,0.0014172153,0.00019880486,0.00013475462],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034431037,0.00020137121,0.0006101676,0.00007290947,0.00018998256,0.000019851668,0.00028977628,0.000055304685,0.000007932815],"category_scores_gemma":[0.0029772446,0.00013110942,0.000014264717,0.00028789282,0.0013953075,0.00036540948,0.00044038377,0.0004923842,2.8111273e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019418037,0.0011806588,0.98620224,0.00026319036,0.00005060413,0.000010939102,0.0070628226,0.0000045587217,0.00049373746,0.000002353595,0.00023167217,0.0025554437],"study_design_scores_gemma":[0.0034620482,0.0013666496,0.95945424,0.0023123412,0.000029375899,0.000004645223,0.0052837767,0.027915617,0.000023308783,0.0000056983913,0.000029573517,0.00011274483],"about_ca_topic_score_codex":0.061211187,"about_ca_topic_score_gemma":0.010806213,"teacher_disagreement_score":0.050404973,"about_ca_system_score_codex":0.0020770293,"about_ca_system_score_gemma":0.00058487256,"threshold_uncertainty_score":0.9450403},"labels":[],"label_agreement":null},{"id":"W2905662036","doi":"10.1016/j.jval.2018.09.253","title":"PCN170 - COST-EFFECTIVENESS OF TISAGENLECLEUCEL IN PEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA: A CANADIAN SOCIETAL PERSPECTIVE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Salvage therapy; Oncology; Refractory (planetary science); Young adult; Pediatrics; Chemotherapy; Internal medicine","score_opus":0.024353770187356884,"score_gpt":0.31183947846377785,"score_spread":0.28748570827642095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905662036","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959541,0.00034085242,0.00001151626,0.000111096284,0.00013792035,0.0022184947,0.00005534304,0.00001558753,0.0011550707],"genre_scores_gemma":[0.9981113,0.0009877337,0.00017523857,0.00014472948,0.00010120319,0.00007745593,0.000020372805,0.000051697963,0.0003302556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975113,0.00049547816,0.0003823698,0.00048343992,0.00046319718,0.00066421565],"domain_scores_gemma":[0.9982753,0.00040742898,0.0001442711,0.0002894063,0.00042850088,0.00045511543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008679984,0.00020882596,0.0005077674,0.0005851349,0.00009208016,0.000011597152,0.00010721904,0.00017082904,0.000095357325],"category_scores_gemma":[0.00025090636,0.0001720946,0.000042660176,0.00095276075,0.00021637502,0.000095618154,0.000036256246,0.000469744,0.00000976037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.010269214,0.00082428986,0.97100013,0.0021354551,0.00009215682,0.00025306127,0.011737985,0.00006438167,0.0010235069,0.000078412304,0.0002167419,0.0023046746],"study_design_scores_gemma":[0.01935048,0.007219544,0.96960247,0.0005723894,0.000059203627,0.00004448662,0.0010317242,0.0014300627,0.00034481368,0.000052254716,0.00005526942,0.00023732877],"about_ca_topic_score_codex":0.39269707,"about_ca_topic_score_gemma":0.10184767,"teacher_disagreement_score":0.2908494,"about_ca_system_score_codex":0.0064334353,"about_ca_system_score_gemma":0.0063744998,"threshold_uncertainty_score":0.99925846},"labels":[],"label_agreement":null},{"id":"W2905683464","doi":"10.1016/j.jval.2018.09.2294","title":"PRM175 - EQ-5D-3L VS. EQ-5D-5L: A CROSS-SECTIONAL COMPARISON OF MEASUREMENT PROPERTIES AMONG TOTAL HIP AND KNEE REPLACEMENT PATIENTS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"EQ-5D; WOMAC; Medicine; Physical therapy; Body mass index; Knee replacement; Spearman's rank correlation coefficient; Arthroplasty; Statistics; Health related quality of life; Mathematics; Osteoarthritis; Internal medicine; Surgery","score_opus":0.6275389110596924,"score_gpt":0.40456614060292706,"score_spread":0.22297277045676533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905683464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99136496,0.0022199587,0.00025883474,0.002615252,0.0011453739,0.0017743419,0.0001141129,0.00003823326,0.0004689628],"genre_scores_gemma":[0.9974373,0.000048999205,0.0006806521,0.0011802812,0.00029898345,0.00016413184,0.000019032292,0.000035285542,0.0001353485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9920452,0.00059499784,0.0056050573,0.00076320465,0.000377603,0.00061392965],"domain_scores_gemma":[0.99594325,0.0002085802,0.002800001,0.00049833435,0.00028200346,0.0002678048],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.019580698,0.0002512095,0.0011209093,0.00042582751,0.0003538665,0.00009314262,0.00018797375,0.00016732413,0.00014157926],"category_scores_gemma":[0.002218834,0.00029545225,0.00008603709,0.0002201875,0.0002960548,0.0003960079,0.00010608108,0.0002464374,0.00018819471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014188958,0.0003574765,0.9880265,0.0011483827,0.000041600688,9.018443e-8,0.00445095,0.00091133337,0.0000018531618,0.0030469296,0.001739096,0.00013387066],"study_design_scores_gemma":[0.0018235948,0.0012410517,0.9700157,0.00040208406,0.0000026840185,0.0000014551136,0.00042722782,0.022503657,0.000028270459,0.0010590426,0.002219616,0.00027562169],"about_ca_topic_score_codex":0.015224182,"about_ca_topic_score_gemma":0.0005984116,"teacher_disagreement_score":0.021592325,"about_ca_system_score_codex":0.0018009788,"about_ca_system_score_gemma":0.0004723109,"threshold_uncertainty_score":0.99994975},"labels":[],"label_agreement":null},{"id":"W2905687536","doi":"10.1016/j.jval.2018.09.578","title":"PCV31 - ANTICOAGULANTS IN OLDER PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION AFTER INTRACRANIAL HEMORRHAGE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Université de Montréal","funders":"","keywords":"Medicine; Atrial fibrillation; Hazard ratio; Confidence interval; Cohort; Internal medicine; Intracerebral hemorrhage; Stroke (engine); Proportional hazards model; Cardiology","score_opus":0.030059225787707207,"score_gpt":0.31224019076357296,"score_spread":0.28218096497586576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905687536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99605745,0.00009494916,0.000332365,0.0013890979,0.0005327889,0.0013925647,0.0000058174724,0.000034274777,0.000160699],"genre_scores_gemma":[0.9946199,0.000027914803,0.0026761976,0.0003071631,0.002183617,0.0000015465447,0.00004130548,0.000027969427,0.000114403214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982434,0.00011398879,0.0005611657,0.00031433036,0.00038955084,0.00037755622],"domain_scores_gemma":[0.99935603,0.000070725815,0.00015459655,0.00023706417,0.000067076704,0.00011450583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048304815,0.00016698752,0.00043192084,0.00032005252,0.000053226064,0.000020608435,0.000048656602,0.00009206974,0.0001443887],"category_scores_gemma":[0.00009618702,0.0001373424,0.00007677063,0.00047442134,0.000048370857,0.00015862528,0.000034990586,0.00012400968,0.00007643936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015700926,0.000013554086,0.9881673,0.00017887133,0.000012670848,0.000033073142,0.00041617927,0.00047217103,0.000003892203,0.000019943465,0.000034063673,0.009078216],"study_design_scores_gemma":[0.007423807,0.0005799564,0.9750876,0.00026354313,0.00002241186,0.0000038959697,0.000026528925,0.01572189,0.000010536577,0.0000521478,0.00066703785,0.00014064874],"about_ca_topic_score_codex":0.0007842596,"about_ca_topic_score_gemma":0.00007969879,"teacher_disagreement_score":0.015249718,"about_ca_system_score_codex":0.0001750645,"about_ca_system_score_gemma":0.00014133335,"threshold_uncertainty_score":0.56006604},"labels":[],"label_agreement":null},{"id":"W2905693631","doi":"10.1016/j.jval.2018.09.2476","title":"PRS83 - PATIENT PERSPECTIVE ON MEDICATION ADHERENCE IN ASTHMA: A SYSTEMATIC REVIEW OF THE LITERATURE","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Asthma; Discontinuation; Observational study; Inhaler; MEDLINE; Intensive care medicine; Family medicine; Systematic review; Disease; Physical therapy; Pediatrics; Psychiatry; Internal medicine","score_opus":0.04470704873582795,"score_gpt":0.3780196122531596,"score_spread":0.33331256351733163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905693631","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000022153885,0.992323,4.663125e-7,0.00041028138,0.0002285441,0.0067477073,0.000047860096,0.000009984551,0.00021001669],"genre_scores_gemma":[0.0001288416,0.99803203,0.00001750936,0.0011929312,0.000095844094,0.000438379,0.00002568959,0.000024234152,0.000044547105],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99544245,0.001898107,0.0015066514,0.00037694175,0.0005579006,0.0002179609],"domain_scores_gemma":[0.997391,0.00024777418,0.0013103841,0.00074699253,0.00017347248,0.0001303717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010869696,0.00027341922,0.002309806,0.00024070291,0.000033565288,0.000005279853,0.00021503196,0.00018467596,0.000019536397],"category_scores_gemma":[0.0019005788,0.0001374124,0.00035227375,0.0009797089,0.000081974,0.000023828905,0.00004175787,0.0005716708,0.000023292545],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000068277627,0.00018889073,0.0000062980134,0.983851,0.000018141049,0.000010685744,0.00078607834,3.0656054e-7,4.5901825e-9,0.00024025617,0.00047954958,0.01441193],"study_design_scores_gemma":[0.00014505489,0.0006048729,0.00003710145,0.95502543,0.00014608994,0.00003234996,0.00014746116,0.0000049053647,7.6441594e-8,0.000023219374,0.043744195,0.00008920895],"about_ca_topic_score_codex":0.00015259099,"about_ca_topic_score_gemma":0.000008074836,"teacher_disagreement_score":0.043264646,"about_ca_system_score_codex":0.0009634876,"about_ca_system_score_gemma":0.0023933928,"threshold_uncertainty_score":0.5603515},"labels":[],"label_agreement":null},{"id":"W2905731813","doi":"10.1016/j.jval.2018.09.170","title":"PCN88 - NET IMPACT ANALYSIS OF IXAZOMIB IN COMBINATION WITH LENALIDOMIDE AND DEXAMETHASONE IN THE TREATMENT OF ADULTS WITH MULTIPLE MYELOMA FOR QUEBEC","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Takeda (Canada)","funders":"","keywords":"Ixazomib; Lenalidomide; Carfilzomib; Multiple myeloma; Medicine; Dexamethasone; Intensive care medicine; Oncology; Internal medicine","score_opus":0.04407377388686907,"score_gpt":0.3565733311433827,"score_spread":0.3124995572565136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905731813","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966597,0.000500062,0.00012803452,0.00050220825,0.000005931129,0.0021227929,0.000061874794,0.000004175729,0.00001520092],"genre_scores_gemma":[0.99687237,0.00031200587,0.0025010812,0.000027969481,0.00001298553,0.00014967936,0.00010013754,0.0000119721035,0.000011773884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99845976,0.00027565644,0.00041741165,0.00024476755,0.00028591102,0.00031651105],"domain_scores_gemma":[0.99848866,0.00083854445,0.00018976332,0.00027143263,0.000108687906,0.0001029065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066084915,0.00014576787,0.0006540544,0.00067619793,0.000030083665,0.000006873245,0.000054510365,0.00004559692,0.0000070106016],"category_scores_gemma":[0.00014072817,0.000077029574,0.000059363625,0.0010914494,0.0001381108,0.000059667575,0.0000061788087,0.0000655446,2.468384e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012249445,0.0018813094,0.9559809,0.00024897698,0.00037626503,0.000018099621,0.008113316,0.00062979467,0.00006076037,0.00004274727,0.0000037258733,0.020394677],"study_design_scores_gemma":[0.02495791,0.013112571,0.9064336,0.0004192884,0.000108983935,0.0000054866573,0.0009749035,0.053306952,0.0005920643,0.000021731923,0.0000100459665,0.000056463876],"about_ca_topic_score_codex":0.31364703,"about_ca_topic_score_gemma":0.24660146,"teacher_disagreement_score":0.06704557,"about_ca_system_score_codex":0.0004543261,"about_ca_system_score_gemma":0.0003703982,"threshold_uncertainty_score":0.7671461},"labels":[],"label_agreement":null},{"id":"W2905747065","doi":"10.1016/j.jval.2018.09.2288","title":"PRM169 - RESPONSIVENESS OF THE EQ-5D-5L AND EQ-5D-3L IN PATIENTS FOLLOWING TOTAL HIP OR KNEE REPLACEMENT","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"WOMAC; EQ-5D; Medicine; Physical therapy; Osteoarthritis; Total hip replacement; Health related quality of life; Surgery; Internal medicine","score_opus":0.3531582670757215,"score_gpt":0.39037770457500764,"score_spread":0.037219437499286134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905747065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864297,0.00075566693,0.00006068567,0.009290224,0.0012847005,0.0016417777,0.00009367803,0.000014717271,0.0004288367],"genre_scores_gemma":[0.99505174,0.000059283146,0.00072190375,0.0035280033,0.00014273664,0.000085497166,0.000008064783,0.000030191999,0.00037257327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99353665,0.0011664153,0.003991786,0.0005938556,0.00016280584,0.0005485132],"domain_scores_gemma":[0.99617964,0.0011566425,0.0017930499,0.00065956626,0.00005700401,0.00015411696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020029735,0.00018919187,0.000939232,0.0004303798,0.00019101487,0.000031757136,0.00023548983,0.00013737039,0.00009725812],"category_scores_gemma":[0.0045786565,0.0001874659,0.000086510576,0.00045664707,0.00009954589,0.0002602298,0.00013950697,0.00021233903,0.000091971786],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033179994,0.00021400087,0.98072517,0.0007485672,0.000028776103,7.981867e-7,0.0064933468,0.00043416972,0.0000013220069,0.00907753,0.0014664239,0.00047809142],"study_design_scores_gemma":[0.003362345,0.0009967695,0.97756296,0.00085046265,0.000003485498,0.0000024013054,0.0010195661,0.005732096,0.000012990411,0.0037936554,0.0063689686,0.00029430597],"about_ca_topic_score_codex":0.009019816,"about_ca_topic_score_gemma":0.00059782,"teacher_disagreement_score":0.015451078,"about_ca_system_score_codex":0.0011274532,"about_ca_system_score_gemma":0.00062788866,"threshold_uncertainty_score":0.9975792},"labels":[],"label_agreement":null},{"id":"W2905766015","doi":"10.1016/j.jval.2018.09.2303","title":"PRM185 - COMPARISON OF THE MEASUREMENT PROPERTIES OF THE EQ-5D-5L AND EQ-5D-3L IN PATIENTS WITH CROHN’S DISEASE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"EQ-5D; Ceiling effect; Medicine; Crohn's disease; Physical therapy; Internal medicine; Quality of life (healthcare); Gastroenterology; Disease; Health related quality of life","score_opus":0.0674422719778096,"score_gpt":0.25286739843575806,"score_spread":0.18542512645794845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905766015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9982151,0.00062264805,0.0000029523228,0.00018453244,0.00009403818,0.00081769825,0.000019445259,0.0000024243895,0.000041209965],"genre_scores_gemma":[0.9997108,0.000011723532,0.000023512566,0.00017091092,0.000030939416,0.000024309018,0.000002564809,0.000012577172,0.00001263681],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99862313,0.0002717628,0.0003603862,0.00020710871,0.00033368816,0.00020391132],"domain_scores_gemma":[0.9991066,0.0000034810425,0.00021709851,0.0004382295,0.00015324775,0.00008138544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003899984,0.000114172006,0.00015680568,0.000028752524,0.000071818606,0.0000061544274,0.00019922345,0.00004430064,0.0000020316868],"category_scores_gemma":[0.00012619956,0.000064611784,0.00003552015,0.00009124321,0.0002761999,0.0000042806087,0.0001300202,0.0000789168,5.0139334e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009645118,0.00028749276,0.99565303,0.00042250406,0.000013074463,5.791018e-7,0.00067199435,0.0004284355,0.0011820815,0.000042862852,0.000100396624,0.0002330356],"study_design_scores_gemma":[0.0008997569,0.00017640153,0.99190223,0.00043280778,0.000009149573,9.232545e-8,0.000077148696,0.00035661634,0.0058705257,0.00002800001,0.00016868886,0.0000785906],"about_ca_topic_score_codex":0.00040392688,"about_ca_topic_score_gemma":0.0005665626,"teacher_disagreement_score":0.0046884445,"about_ca_system_score_codex":0.00005559149,"about_ca_system_score_gemma":0.00052576757,"threshold_uncertainty_score":0.2634792},"labels":[],"label_agreement":null},{"id":"W2905768002","doi":"10.1016/j.jval.2018.09.1276","title":"PIH11 - ANTIEMETIC USE IN PREGNANCY AND THE RISK OF MAJOR CONGENITAL MALFORMATIONS: A POPULATION-BASED COHORT STUDY","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pregnancy and Medication Impact","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal; Centre Hospitalier Universitaire Sainte-Justine","funders":"","keywords":"Ondansetron; Medicine; Metoclopramide; Pregnancy; Antiemetic; Pyridoxine; Nausea; Cohort; Vomiting; Obstetrics; Anesthesia; Internal medicine","score_opus":0.038751097454649906,"score_gpt":0.3251436682894239,"score_spread":0.28639257083477404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905768002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426556,0.0018727814,0.0002893308,0.000641481,0.000087761495,0.002736042,0.000020747546,0.000015220864,0.00007106798],"genre_scores_gemma":[0.99868405,0.0004008711,0.0004917494,0.00024659454,0.00002275962,0.00009812219,0.000017448821,0.000008151461,0.000030236592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99832463,0.00048772353,0.00061553007,0.0001495273,0.00023877359,0.00018382093],"domain_scores_gemma":[0.99882525,0.00045386766,0.00025152825,0.00031747515,0.00006313731,0.00008875019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015372226,0.00008510648,0.00030559202,0.00022064759,0.00006958654,0.0000076278425,0.000056027147,0.00003995128,0.00002580289],"category_scores_gemma":[0.0015326344,0.000057475398,0.000027455795,0.00035612387,0.00014227245,0.000116025556,0.000014154336,0.00015877375,0.0000034369905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017006359,0.00027112252,0.99553543,0.00014893686,0.000022902821,0.0000017342119,0.0021792292,0.00004009588,9.736402e-7,0.00026784887,0.00001699059,0.0013446799],"study_design_scores_gemma":[0.0060137482,0.00043881976,0.98153436,0.0013921623,0.000048887698,0.00000545265,0.00030165436,0.009953857,0.000008343744,0.00023986767,0.000016194484,0.000046668203],"about_ca_topic_score_codex":0.02491208,"about_ca_topic_score_gemma":0.00091238925,"teacher_disagreement_score":0.023999691,"about_ca_system_score_codex":0.000077707744,"about_ca_system_score_gemma":0.00029045876,"threshold_uncertainty_score":0.9815811},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W2905771584","doi":"10.1016/j.jval.2018.09.428","title":"PCN346 - DISEASE SPECIFIC COST ANALYSIS OF THE NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER AND METASTATIC CASTRATION-RESISTANT PROSTATE CANCER HEALTH STATES","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Prostate cancer; Medicine; Disease; Oncology; Cancer; Radiation therapy; Prostate; Internal medicine; Cohort; Medical prescription; Metastasis; Castration; Pharmacology","score_opus":0.08198804906189198,"score_gpt":0.38275112796108274,"score_spread":0.30076307889919074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905771584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94309825,0.025644965,0.000026817534,0.02270466,0.00024389608,0.0047547515,0.0034607775,0.000032487667,0.0000333991],"genre_scores_gemma":[0.97574717,0.020995347,0.00063018105,0.000692124,0.0000862067,0.0006266352,0.0003166514,0.00005329196,0.0008523976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99547505,0.0005740978,0.0013236135,0.00073667814,0.0009454709,0.0009450655],"domain_scores_gemma":[0.99734384,0.0002416704,0.00069668284,0.00063365995,0.00037956904,0.00070455036],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012917501,0.00038399053,0.0010259011,0.000599143,0.0004559397,0.00008273286,0.00016698494,0.00003930387,0.00018125636],"category_scores_gemma":[0.00007618637,0.00025889018,0.00017106751,0.0024152908,0.00063911104,0.00018343778,0.00006572415,0.00032733087,0.0000042389383],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020133642,0.0035589663,0.76731116,0.017185777,0.007265909,0.0004181986,0.061194833,0.044903636,0.009780043,0.0024225055,0.0064954325,0.059329897],"study_design_scores_gemma":[0.007155513,0.0020927002,0.95207816,0.002702181,0.0012795322,0.000008596903,0.0034377477,0.024158603,0.0011541228,0.0006621784,0.004760194,0.0005104691],"about_ca_topic_score_codex":0.042752568,"about_ca_topic_score_gemma":0.017045392,"teacher_disagreement_score":0.18476701,"about_ca_system_score_codex":0.0012301226,"about_ca_system_score_gemma":0.0047899187,"threshold_uncertainty_score":0.99998635},"labels":[],"label_agreement":null},{"id":"W2905838767","doi":"10.1016/j.jval.2018.09.2310","title":"PRM192 - TYPE 2 DIABETES MELLITUS: LACK OF GOOD PRACTICES FOR REAL-WORLD EVIDENCE STUDIES.","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Psychological intervention; Sample size determination; Protocol (science); Randomized controlled trial; Intervention (counseling); Population; Productivity; Research design; Type 2 Diabetes Mellitus; Clinical study design; Clinical trial; MEDLINE; Family medicine; Environmental health; Intensive care medicine; Alternative medicine; Diabetes mellitus; Surgery; Internal medicine; Nursing","score_opus":0.7956857768788268,"score_gpt":0.5618158084824325,"score_spread":0.2338699683963943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905838767","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6906006,0.13414094,0.00047488126,0.1600513,0.0044874474,0.005090725,0.00037280025,0.00012417916,0.0046571326],"genre_scores_gemma":[0.9429063,0.022343397,0.018753372,0.012731537,0.001478765,0.0002932763,0.000020923755,0.000076834745,0.0013955886],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99323976,0.00069806416,0.004718746,0.0006264527,0.00011341762,0.0006035525],"domain_scores_gemma":[0.98507214,0.007192486,0.0067003896,0.0005997243,0.00026771735,0.00016755878],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03625709,0.00018564845,0.0013256441,0.00046332763,0.00017026009,0.00003174397,0.00032585417,0.000097454904,0.00009144799],"category_scores_gemma":[0.02340369,0.00022345636,0.00008582423,0.00059176696,0.00016962865,0.0006037939,0.00006224833,0.00015509881,0.0004045273],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013846622,0.00038426495,0.3856497,0.012896674,0.00025508145,4.591453e-7,0.012956733,0.0006897993,0.000007800066,0.5250611,0.060696144,0.0012638095],"study_design_scores_gemma":[0.0034462244,0.0049741613,0.10978297,0.008073541,0.000045556688,0.0000024303715,0.0065545654,0.05754528,0.00022723523,0.17808415,0.62970173,0.0015621566],"about_ca_topic_score_codex":0.01409725,"about_ca_topic_score_gemma":0.0024780983,"teacher_disagreement_score":0.5690056,"about_ca_system_score_codex":0.0009389758,"about_ca_system_score_gemma":0.00067485165,"threshold_uncertainty_score":0.99246794},"labels":[],"label_agreement":null},{"id":"W2905843948","doi":"10.1016/j.jval.2018.09.382","title":"PCN300 - MODERN TRENDS OF ORCHIECTOMY FOR PROSTATE CANCER","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Orchiectomy; Medicine; Androgen deprivation therapy; Prostate cancer; Odds ratio; Urology; Logistic regression; Confidence interval; Cohort; Internal medicine; Cancer","score_opus":0.061809588052491475,"score_gpt":0.3756561472565735,"score_spread":0.313846559204082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905843948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97915345,0.007027661,0.00012112295,0.010868251,0.0003382016,0.0013006885,0.00026775783,0.000035197718,0.0008876943],"genre_scores_gemma":[0.99493414,0.0018196602,0.0013885124,0.0006785027,0.00020015314,0.0004447784,0.000027829234,0.000022471666,0.00048394315],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9989864,0.000031536812,0.00032997865,0.00022350506,0.00012704078,0.00030149572],"domain_scores_gemma":[0.9994263,0.000058487338,0.0001227615,0.00019068301,0.000080675236,0.00012111196],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022198094,0.000100889025,0.0003235351,0.00014576336,0.000040869043,0.0000033946465,0.000038628765,0.00003329133,0.000052439475],"category_scores_gemma":[0.000018885088,0.000079784775,0.00005687165,0.00023103689,0.00006466897,0.000029685554,0.0000123575255,0.000058703594,0.0000024107692],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014612213,0.0010178046,0.2696946,0.0020773993,0.00013947228,0.00000999332,0.008106904,0.0006501441,0.00037460952,0.001346219,0.0069670947,0.70815456],"study_design_scores_gemma":[0.042182673,0.031077044,0.60781497,0.008327792,0.00027700752,0.00003473103,0.0004082417,0.08030638,0.041481268,0.01225904,0.1749359,0.00089494215],"about_ca_topic_score_codex":0.008134317,"about_ca_topic_score_gemma":0.00041262273,"teacher_disagreement_score":0.7072596,"about_ca_system_score_codex":0.0003217756,"about_ca_system_score_gemma":0.0005025414,"threshold_uncertainty_score":0.9984706},"labels":[],"label_agreement":null},{"id":"W2905855316","doi":"10.1016/j.jval.2018.09.2292","title":"PRM173 - DISCRIMINATIVE VALIDITY OF THE EQ-5D-5L AND SF-12 IN OLDER ADULTS WITH ARTHRITIS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; EQ-5D; Body mass index; Quality of life (healthcare); Arthritis; Physical therapy; Discriminative model; SF-36; Internal medicine; Health related quality of life; Disease","score_opus":0.35857795981761786,"score_gpt":0.3813336790564049,"score_spread":0.022755719238787053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905855316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754412,0.0014404949,0.00028359875,0.019808333,0.00035348698,0.0013546114,0.0001483032,0.000012924241,0.0011570262],"genre_scores_gemma":[0.9955295,0.00039932664,0.0010567954,0.0026893828,0.00014220971,0.00007421424,0.000005791571,0.000022301854,0.00008049357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954556,0.000823638,0.0026842162,0.0005006969,0.00010611636,0.00042973118],"domain_scores_gemma":[0.99703336,0.0007603852,0.0015740568,0.0004506833,0.000051476036,0.00013002304],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01134178,0.00016145782,0.0008162563,0.0002694981,0.00013578014,0.000022827771,0.00020813834,0.00009894544,0.00007795072],"category_scores_gemma":[0.0013995692,0.00015252159,0.000044935743,0.00030231182,0.00026041578,0.00026752494,0.000067372406,0.00022550771,0.000048729835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007575181,0.00032498364,0.8829791,0.0016069516,0.000017506705,0.0000010922345,0.045135655,0.00017080826,5.013199e-7,0.06597444,0.0020312702,0.0016819274],"study_design_scores_gemma":[0.0024661724,0.00046267684,0.9716859,0.0020956344,0.0000016158059,0.0000066737953,0.0036281284,0.0058153435,0.000017113947,0.011914444,0.001657665,0.00024864942],"about_ca_topic_score_codex":0.021888884,"about_ca_topic_score_gemma":0.009517524,"teacher_disagreement_score":0.08870676,"about_ca_system_score_codex":0.0004415849,"about_ca_system_score_gemma":0.00032391623,"threshold_uncertainty_score":0.98462445},"labels":[],"label_agreement":null},{"id":"W2905885911","doi":"10.1016/j.jval.2018.09.2137","title":"PRM13 - THE FLAWED RECOMMENDATIONS OF THE SECOND PANEL ON COST-EFFECTIVENESS IN HEALTH AND MEDICINE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Health technology; Panel discussion; Equity (law); Actuarial science; Empirical evidence; Discounting; Health economics; Economics; Positive economics; Management science; Health care; Political science; Business; Law","score_opus":0.6070789669914266,"score_gpt":0.48456448744048564,"score_spread":0.12251447955094097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905885911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56010926,0.002975629,0.0002311831,0.42936832,0.0013044248,0.0038222664,0.00021182335,0.000018185257,0.0019588782],"genre_scores_gemma":[0.96672314,0.00056423456,0.00022099206,0.03173557,0.00025116905,0.00020217591,0.000012462743,0.000024522116,0.00026574565],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99286497,0.0027530198,0.003449085,0.0004273008,0.00009260005,0.00041300364],"domain_scores_gemma":[0.99364775,0.0035546073,0.002016973,0.0005852465,0.00004066632,0.00015476813],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.036501892,0.00015044192,0.0008636165,0.00031365978,0.000309722,0.000015214741,0.0002841035,0.00008212653,0.0001516041],"category_scores_gemma":[0.003020272,0.000120817334,0.000041320625,0.00048459362,0.00026228983,0.00012626463,0.000055591674,0.0003126679,0.000068315014],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013821713,0.0004083379,0.20784444,0.0046188436,0.00005458105,3.9254206e-7,0.043519482,0.0012129326,0.0000042642214,0.7038132,0.034080226,0.0043051075],"study_design_scores_gemma":[0.004105185,0.0014308306,0.62220573,0.0032948928,0.0000021662036,0.000010141187,0.005738133,0.01825657,0.000016516431,0.070749104,0.2738299,0.00036082912],"about_ca_topic_score_codex":0.021293411,"about_ca_topic_score_gemma":0.003914441,"teacher_disagreement_score":0.6330641,"about_ca_system_score_codex":0.0009240761,"about_ca_system_score_gemma":0.00053242675,"threshold_uncertainty_score":0.9921241},"labels":[],"label_agreement":null},{"id":"W2905886417","doi":"10.1016/j.jval.2018.09.2530","title":"PSS30 - COST EFFECTIVENESS OF DIMETHYL FUMARATE (DMF) IN THE TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS: A UK PERSPECTIVE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Adalimumab; Ustekinumab; Cohort; Cost effectiveness; Dimethyl fumarate; Cost-effectiveness analysis; Psoriasis; Internal medicine; Physical therapy; Disease","score_opus":0.3661798865923854,"score_gpt":0.4509577385647107,"score_spread":0.08477785197232535,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905886417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98133224,0.0023301456,0.00093328796,0.009663174,0.00045355002,0.003352562,0.00036757128,0.000011830186,0.0015556077],"genre_scores_gemma":[0.9965779,0.00050130876,0.0008967161,0.0014001328,0.00015867839,0.00039799296,0.000009341453,0.00002371824,0.00003418152],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9933543,0.0024684365,0.0030315102,0.00056711154,0.00011159952,0.00046702698],"domain_scores_gemma":[0.9952068,0.0026022764,0.001361829,0.0005813094,0.000117931,0.00012985298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019619118,0.00021175414,0.0013439473,0.00056521216,0.00010167513,0.00002123841,0.00026972164,0.00011727482,0.00005550522],"category_scores_gemma":[0.0010741128,0.00020769073,0.00010544868,0.0006080946,0.00009619131,0.0001422621,0.000023281069,0.00012722824,0.00015889149],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00217494,0.002775268,0.16129175,0.0030159836,0.00027362377,0.0000059384724,0.22245032,0.07068787,0.000023690018,0.5346247,0.0014668785,0.0012090551],"study_design_scores_gemma":[0.018594898,0.012457665,0.6596755,0.003332273,0.000028516231,0.00002770568,0.0373919,0.06655296,0.0007705301,0.18962073,0.010003762,0.0015435807],"about_ca_topic_score_codex":0.07230203,"about_ca_topic_score_gemma":0.0025723937,"teacher_disagreement_score":0.49838373,"about_ca_system_score_codex":0.0025448254,"about_ca_system_score_gemma":0.0005209479,"threshold_uncertainty_score":0.93387556},"labels":[],"label_agreement":null},{"id":"W2905890547","doi":"10.1016/j.jval.2018.09.1917","title":"PMU81 - PHYSICIANS' PREFERENCES WITH RESPECT TO ADHERENCE PROGRAMS: A DISCRETE CHOICE EXPERIMENT","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Psychological intervention; Certificate; Medicine; Family medicine; Quarter (Canadian coin); Compensation (psychology); Nursing; Psychology; Social psychology; Computer science","score_opus":0.3218619123561217,"score_gpt":0.47068049493074166,"score_spread":0.14881858257461994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905890547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95731044,0.00297577,0.0002962746,0.02030808,0.0012330204,0.009927238,0.000045868506,0.00047770614,0.0074255993],"genre_scores_gemma":[0.98016214,0.00009571846,0.011732375,0.0040053,0.00043052374,0.0030935407,0.000028350594,0.000054189528,0.0003978857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937119,0.0025576572,0.0011673172,0.000720917,0.0006042841,0.0012379248],"domain_scores_gemma":[0.9963325,0.00076502725,0.0006000201,0.0014832861,0.0003737184,0.00044541026],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00072190637,0.0002959479,0.00050392514,0.00023073205,0.0010465556,0.000025030033,0.0007936998,0.00014318354,0.000118723045],"category_scores_gemma":[0.0003615099,0.00024548444,0.000039817944,0.0011055428,0.00020132195,0.000216926,0.00030820013,0.0008435199,0.00041587822],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009927006,0.0006433702,0.64657336,0.002268437,0.00004364643,0.000004177806,0.29588255,0.00018345192,0.00012791617,0.0059436667,0.0046868115,0.04264992],"study_design_scores_gemma":[0.008114653,0.032020453,0.41406414,0.043293037,0.000031960535,0.0000066471985,0.18952805,0.0051979222,0.0007624335,0.0058689932,0.29851487,0.0025968368],"about_ca_topic_score_codex":0.05731111,"about_ca_topic_score_gemma":0.012103399,"teacher_disagreement_score":0.29382807,"about_ca_system_score_codex":0.0009500237,"about_ca_system_score_gemma":0.0017759288,"threshold_uncertainty_score":0.99999976},"labels":[],"label_agreement":null},{"id":"W2905900238","doi":"10.1016/j.jval.2018.09.1179","title":"PHP285 - EXPERTS IN HEALTH TECHNOLOGY ASSESSMENT ARE CONCERNED ABOUT THE TRANSLATION FROM EVIDENCE TO DECISION-MAKING","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Reimbursement; Health technology; Knowledge translation; Relevance (law); Government (linguistics); Evidence-based practice; Evidence-based medicine; Psychology; Management science; Medical education; Medicine; Public relations; MEDLINE; Political science; Knowledge management; Health care; Computer science; Alternative medicine; Economics","score_opus":0.19430038570837205,"score_gpt":0.48765147036599216,"score_spread":0.2933510846576201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905900238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6471256,0.011994116,0.008296103,0.32744727,0.0010652875,0.0037105319,0.000027956205,0.00012979574,0.00020333665],"genre_scores_gemma":[0.9684658,0.0011536486,0.010604273,0.018926656,0.00060861977,0.00018031386,0.00000683472,0.000038080514,0.000015746964],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9942971,0.0012710564,0.0019332446,0.0007418361,0.00071368826,0.001043064],"domain_scores_gemma":[0.996317,0.0015827765,0.00051980285,0.000852686,0.00019305066,0.00053468085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006352806,0.00024754184,0.0008833105,0.00065249,0.00030224706,0.000036403675,0.00029609964,0.0002655542,0.00009950504],"category_scores_gemma":[0.0012565624,0.00018659442,0.000059378086,0.0016818871,0.00010538421,0.0001482157,0.000053720105,0.0006534077,0.00003355778],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002854212,0.00019657584,0.18467712,0.0009823574,0.000013759444,0.00003929488,0.018684441,0.0002464213,0.000035420013,0.0024839616,0.0022976105,0.7900576],"study_design_scores_gemma":[0.002823268,0.003549684,0.775458,0.05308433,0.000005372224,0.00008317142,0.0138134835,0.022198275,0.000015870532,0.0038146498,0.12468361,0.000470284],"about_ca_topic_score_codex":0.10974148,"about_ca_topic_score_gemma":0.019674584,"teacher_disagreement_score":0.7895873,"about_ca_system_score_codex":0.002128988,"about_ca_system_score_gemma":0.006604236,"threshold_uncertainty_score":0.9990274},"labels":[],"label_agreement":null},{"id":"W2905902014","doi":"10.1016/j.jval.2018.09.168","title":"PCN86 - VALIDATION OF THE IMPACT OF TREATMENT EVOLUTION IN NON-SMALL CELL LUNG CANCER (NSCLC) MODEL (ITEN): A DISCRETE EVENT PATIENT SIMULATION","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medicine; Cancer registry; Lung cancer; Medical record; Oncology; Internal medicine; Survival analysis; Cancer","score_opus":0.23811520941958197,"score_gpt":0.43236938186880974,"score_spread":0.19425417244922777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905902014","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848134,0.0010663404,0.010264412,0.001251215,0.00024758364,0.0018375271,0.00032901234,0.0000071717686,0.00018337008],"genre_scores_gemma":[0.99885356,0.00012933771,0.00058158976,0.00016815956,0.000077161916,0.000117483476,0.000017008668,0.000020847496,0.000034852812],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9951634,0.00048823957,0.0035453814,0.0003641056,0.000093080795,0.00034578337],"domain_scores_gemma":[0.9961875,0.00032639355,0.0028705592,0.0004449896,0.00008163999,0.000088923865],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047179554,0.00016721114,0.00069770636,0.00037850603,0.0000810617,0.000010097571,0.00014743536,0.00010414543,0.000037034843],"category_scores_gemma":[0.00031216803,0.00015506939,0.00016195759,0.0003762591,0.00004769462,0.00020040083,0.000034180546,0.00009715905,0.000013539867],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025333402,0.00012815803,0.2646959,0.00024471548,0.000011490052,2.1718574e-8,0.0066099754,0.727484,0.0000104437095,0.0006562565,0.000049333325,0.00008438743],"study_design_scores_gemma":[0.0007977178,0.00036722116,0.15482566,0.00034244527,0.0000033717706,1.290292e-7,0.00019242635,0.8411467,0.00005519216,0.0021526064,0.000011614662,0.00010488642],"about_ca_topic_score_codex":0.11047188,"about_ca_topic_score_gemma":0.0010659067,"teacher_disagreement_score":0.11366277,"about_ca_system_score_codex":0.006311531,"about_ca_system_score_gemma":0.0011100022,"threshold_uncertainty_score":0.99750304},"labels":[],"label_agreement":null},{"id":"W2905902881","doi":"10.1016/j.jval.2018.09.2554","title":"PSS54 - ETHICAL VALIDATION PROCESS FOR VIDEO RECORDED QUALITATIVE INTERVIEWS: EXPERIENCE FROM A RESEARCH PROJECT IN DERMATOLOGY IN FRANCE AND CANADA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Big Data and Business Intelligence","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Research ethics; Ethics committee; Informed consent; Qualitative research; Institutional review board; Medical education; Psychology; European commission; Medicine; Family medicine; Political science; Alternative medicine; Sociology; Pathology; Business; Social science; Surgery","score_opus":0.395727625209408,"score_gpt":0.5115420759320097,"score_spread":0.11581445072260171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905902881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99064636,0.00031742957,0.0008469781,0.0068766787,0.0002831699,0.00093570154,0.000015798734,0.000012459556,0.00006543361],"genre_scores_gemma":[0.99660844,0.000057783658,0.00045414027,0.0023046383,0.00017540513,0.0003404121,0.000037843238,0.0000121523235,0.000009186601],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979089,0.00031528997,0.00060050306,0.00046379855,0.0002682287,0.0004432951],"domain_scores_gemma":[0.9986878,0.00069105864,0.0001717914,0.00017857275,0.00025599473,0.000014770863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024001088,0.00012069944,0.0002890905,0.00039700945,0.00011090041,0.00006977444,0.00028068337,0.000116256204,0.000024485294],"category_scores_gemma":[0.0020311,0.00011413061,0.0000100232955,0.0010821405,0.00017941739,0.0005366018,0.000106060674,0.00045015066,0.0000052380774],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014877995,0.0007179488,0.69413424,0.013070297,0.000020959415,0.00008361591,0.20549361,0.00029995368,0.00017591802,0.018475724,0.016602244,0.049437705],"study_design_scores_gemma":[0.0059694643,0.00036303487,0.12179061,0.012878961,0.00001134716,0.000021134189,0.16326252,0.25863576,0.0022458716,0.11553587,0.31732252,0.0019629376],"about_ca_topic_score_codex":0.9544863,"about_ca_topic_score_gemma":0.86370105,"teacher_disagreement_score":0.5723436,"about_ca_system_score_codex":0.0001475661,"about_ca_system_score_gemma":0.0006813925,"threshold_uncertainty_score":0.46541113},"labels":[],"label_agreement":null},{"id":"W2905912394","doi":"10.1016/j.jval.2018.09.535","title":"PCP60 - EVOLVING STRATEGIES FOR GENERATING, SYNTHESIZING, AND VISUALIZING REAL WORLD EVIDENCE IN RARE DISEASES","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Alkaline Phosphatase Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Computer science; Checklist; Data science; Presentation (obstetrics); Data collection; Medicine; Psychology","score_opus":0.16128416007011498,"score_gpt":0.4472253362674338,"score_spread":0.28594117619731885,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905912394","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87293273,0.11852461,0.00062688265,0.0050055273,0.0001747011,0.0023303998,0.000072528084,0.00011854937,0.00021407513],"genre_scores_gemma":[0.98555183,0.0062210113,0.0070926007,0.00037707217,0.0004923616,0.00015111256,0.000013139608,0.000029903314,0.00007094202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796176,0.00022777451,0.0004988928,0.00041242284,0.00030520445,0.0005939614],"domain_scores_gemma":[0.9979307,0.001368168,0.00012525507,0.00023165855,0.00012867934,0.00021551314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013256195,0.00016272023,0.00044335713,0.0003143893,0.00022234996,0.00006285269,0.00008424488,0.00003588902,0.000017098238],"category_scores_gemma":[0.0024992153,0.00014919073,0.000036845555,0.00040500928,0.0001917026,0.0002969905,0.00010011158,0.00017602976,0.00000252211],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011880836,0.00049269485,0.9090868,0.012566513,0.000113174414,0.00020933908,0.011004263,0.00045165003,0.0013610714,0.017829899,0.011257856,0.03443863],"study_design_scores_gemma":[0.005027732,0.004453312,0.62286323,0.04139039,0.0001004,0.000040237675,0.01383421,0.29713085,0.0012022667,0.009259762,0.0036717516,0.0010258331],"about_ca_topic_score_codex":0.014485327,"about_ca_topic_score_gemma":0.003911394,"teacher_disagreement_score":0.2966792,"about_ca_system_score_codex":0.00035128338,"about_ca_system_score_gemma":0.0009603368,"threshold_uncertainty_score":0.9920773},"labels":[],"label_agreement":null},{"id":"W2905933638","doi":"10.1016/j.jval.2018.09.1005","title":"PHP111 - EXPLORING THE LEVELS OF UNDERSTANDING OF PERSONALIZED MEDICINE AMONGST MEDICAL STUDENTS IN SARAJEVO","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Personalized medicine; Medical education; Alternative medicine; Family medicine; Medicine; Population; Subject (documents); Psychology; Environmental health; Computer science; World Wide Web; Bioinformatics; Pathology","score_opus":0.17233357574726696,"score_gpt":0.34127491408433375,"score_spread":0.1689413383370668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905933638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915421,0.00070194283,0.0046781166,0.0017033882,0.0010366527,0.0001480881,0.0000031558034,0.000034848203,0.00015172546],"genre_scores_gemma":[0.99917537,0.00042752348,0.00012873052,0.000059548114,0.00017449974,0.000012094892,0.0000016016833,0.000013449072,0.0000072050466],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9985746,0.00006196408,0.0004793207,0.0000879333,0.0005739961,0.00022214593],"domain_scores_gemma":[0.9995154,0.00019718504,0.00004631436,0.00012948978,0.000015146239,0.00009643605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015913231,0.00008510937,0.0002453662,0.00018256558,0.000020624844,0.0000027006909,0.0002482077,0.000055059845,0.000110215784],"category_scores_gemma":[0.00012310725,0.000061979415,0.000019462499,0.0004916158,0.00020858714,0.00004697625,0.000027092941,0.00019584845,0.0000018311547],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025962637,0.0014123532,0.34535718,0.025953714,0.00043797388,0.000034659297,0.4398913,0.050003327,0.00528072,0.06141097,0.0076902322,0.06226792],"study_design_scores_gemma":[0.0047741784,0.00071626715,0.66927046,0.012138672,0.000018997987,0.000017614237,0.02020859,0.28503898,0.0009819253,0.0041743326,0.0021781814,0.0004817791],"about_ca_topic_score_codex":0.0024082775,"about_ca_topic_score_gemma":0.00016465958,"teacher_disagreement_score":0.41968274,"about_ca_system_score_codex":0.0002500107,"about_ca_system_score_gemma":0.00007125328,"threshold_uncertainty_score":0.36406112},"labels":[],"label_agreement":null},{"id":"W2905953069","doi":"10.1016/j.jval.2018.09.1804","title":"PMS90 - A BONE RESORPTION MARKER TO MONITOR DRUG PROFILE IN PATIENTS WITH OSTEOPOROTIC FRACTURES","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Cohort; Internal medicine; Bone resorption; Bisphosphonate; N-terminal telopeptide; Resorption; Cohort study; Osteoporosis; Urology; Gastroenterology","score_opus":0.014429686661716326,"score_gpt":0.3007155358357491,"score_spread":0.28628584917403277,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905953069","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928832,0.00017573852,0.000004552225,0.0039562266,0.00018920671,0.0024845274,0.000018070625,0.00003160255,0.00025687108],"genre_scores_gemma":[0.9931323,0.0000144602645,0.0032422722,0.0028604572,0.00010052316,0.00013258902,0.00005754885,0.000030135943,0.00042973508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819636,0.00015362039,0.00044967132,0.0003347165,0.00034890842,0.00051672145],"domain_scores_gemma":[0.9990611,0.000048844766,0.00012157651,0.000300529,0.00008169105,0.00038626548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040534456,0.00015735216,0.000343323,0.00030726174,0.00007080364,0.000008001034,0.00004138266,0.000071007824,0.00008639339],"category_scores_gemma":[0.00009181104,0.000119134354,0.000020171596,0.00043456128,0.000033626322,0.00006669644,0.000019822679,0.0002217026,0.00016513575],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025840888,0.0007240992,0.9799018,0.00031875403,0.00000804468,0.000022579774,0.0014733912,0.000010347714,0.0000032406476,0.000008156821,0.0019155792,0.013029901],"study_design_scores_gemma":[0.0044398587,0.0022247208,0.9908736,0.00082874566,0.000006753607,0.000004010624,0.00004500445,0.000114720504,0.000069447226,0.00004613554,0.0012532979,0.00009370573],"about_ca_topic_score_codex":0.021235075,"about_ca_topic_score_gemma":0.0012164058,"teacher_disagreement_score":0.020018669,"about_ca_system_score_codex":0.0004909276,"about_ca_system_score_gemma":0.00031132568,"threshold_uncertainty_score":0.9852826},"labels":[],"label_agreement":null},{"id":"W2905976337","doi":"10.1016/j.jval.2018.09.462","title":"PCN380 - THE PROGNOSTIC SIGNIFICANCE OF HEALTH-RELATED QUALITY OF LIFE FROM CANCER RANDOMIZED CONTROLLED TRIALS: A SYSTEMATIC EVALUATION OF THE STATISTICAL METHODS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Univariate; Sample size determination; Randomized controlled trial; Missing data; Multivariate analysis; Quality of life (healthcare); Multivariate statistics; Systematic review; MEDLINE; Internal medicine; Statistics; Mathematics","score_opus":0.6685403982685437,"score_gpt":0.5508959488733488,"score_spread":0.11764444939519492,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905976337","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.634039,0.17007895,0.07193473,0.06241934,0.003909715,0.05469342,0.0025004374,0.000042289128,0.00038213737],"genre_scores_gemma":[0.98955727,0.00039932845,0.006201453,0.0015423571,0.00013640232,0.002095212,0.000015545305,0.000028669276,0.000023791905],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.6628746,0.27703357,0.05722046,0.0009858035,0.0010831703,0.0008023996],"domain_scores_gemma":[0.7845264,0.16646552,0.04671814,0.0013221866,0.0007677324,0.00020004825],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.60655284,0.000268206,0.01249703,0.00029866718,0.00018440593,0.000021832842,0.0005391986,0.00017569769,0.0004085184],"category_scores_gemma":[0.39265734,0.00017739148,0.00061859866,0.0006059415,0.00063589413,0.00011431989,0.00005510436,0.0002831682,0.000019432002],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.034053005,0.0018013747,0.0667113,0.116673484,0.0060846373,1.3413953e-7,0.071140714,0.04380082,0.00006321416,0.65339124,0.0032526343,0.003027452],"study_design_scores_gemma":[0.16681378,0.00031199056,0.05442759,0.010705792,0.000394511,6.108059e-7,0.0036102762,0.55233693,0.000027682807,0.21094486,0.000033734323,0.00039225412],"about_ca_topic_score_codex":0.1267613,"about_ca_topic_score_gemma":0.0009141128,"teacher_disagreement_score":0.5085361,"about_ca_system_score_codex":0.0009057337,"about_ca_system_score_gemma":0.0042058793,"threshold_uncertainty_score":0.87905365},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"theoretical_or_conceptual","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"design_other","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W2905980782","doi":"10.1016/j.jval.2018.09.2088","title":"PND123 - PATIENT AND CAREGIVER WEB-BASED SURVEY: HEALTH UTILITIES IN TUBEROUS SCLEROSIS COMPLEX (TSC) PATIENT POPULATION","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberous Sclerosis Complex Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Tuberous sclerosis; Medicine; Psychology; Psychiatry","score_opus":0.17796121247498944,"score_gpt":0.3458422233776498,"score_spread":0.16788101090266036,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905980782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99226356,0.0010252633,0.000028922297,0.0043133735,0.00021087576,0.0018295799,0.0001576981,0.00008310449,0.00008764344],"genre_scores_gemma":[0.995603,0.00017273072,0.0010388487,0.0027284615,0.0000690219,0.000068434085,0.0002520503,0.000055025546,0.000012415823],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944418,0.0018209362,0.0011370063,0.0006928858,0.00085589336,0.0010514657],"domain_scores_gemma":[0.9979681,0.00047167836,0.0002567499,0.000580818,0.00021846937,0.00050419266],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0019196338,0.00029170405,0.00078550563,0.00067794614,0.00025338092,0.000042821146,0.00012527975,0.00011747603,0.00010661334],"category_scores_gemma":[0.00032344027,0.00028691345,0.000057952126,0.00086626323,0.00027328325,0.00010354147,0.00012082823,0.00043481,0.00002491214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005881448,0.00065503985,0.934443,0.00080178905,0.000013574669,0.00000846972,0.0073677753,0.00069233426,0.000096653406,0.00015464045,0.0027509837,0.052427586],"study_design_scores_gemma":[0.0026091312,0.003209265,0.9579849,0.0010732609,0.0000024912767,0.00001173286,0.00063458167,0.03351505,0.000037312984,0.00006387751,0.00066300377,0.00019536982],"about_ca_topic_score_codex":0.28890935,"about_ca_topic_score_gemma":0.03147234,"teacher_disagreement_score":0.25743702,"about_ca_system_score_codex":0.0016829534,"about_ca_system_score_gemma":0.0009821339,"threshold_uncertainty_score":0.9999583},"labels":[],"label_agreement":null},{"id":"W2905991609","doi":"10.1016/j.jval.2018.09.1746","title":"PMS32 - ASSESSING DIRECT AND INDIRECT HEALTH SYSTEM COSTS OF THE BUILD BETTER BONES WITH EXERCISE PILOT TRIAL","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Joseph’s Healthcare Hamilton; McMaster University; University of Waterloo; Sunnybrook Hospital","funders":"","keywords":"Medicine; Randomized controlled trial; Physical therapy; Adverse effect; Quality of life (healthcare); Intervention (counseling); Indirect costs; Total cost; Clinical trial; Surgery; Nursing; Internal medicine","score_opus":0.06709747475268046,"score_gpt":0.35007321997119073,"score_spread":0.28297574521851027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2905991609","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619824,0.0031329042,0.000058616253,0.027985431,0.0011242073,0.0042613302,0.00002700676,0.00010328737,0.0013247859],"genre_scores_gemma":[0.9951157,0.00025802272,0.0008901467,0.0027274212,0.00080075173,0.000082516526,0.000006695196,0.00005567577,0.00006306396],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945857,0.0017857775,0.0014785684,0.0005459887,0.00071259466,0.0008913836],"domain_scores_gemma":[0.99724746,0.0003467955,0.00082886074,0.0007008452,0.00019643747,0.0006795889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006525056,0.00028090936,0.0013708294,0.00031904722,0.00039522574,0.00004483403,0.00015120687,0.00014099068,0.000007533256],"category_scores_gemma":[0.00017718962,0.00017509318,0.00006370757,0.0008930631,0.00021434655,0.00013976294,0.000058458758,0.00049638044,0.000004109449],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029651735,0.0022593306,0.54427785,0.060157035,0.00024380139,0.000089191795,0.019901497,0.0000360906,0.00012958255,0.006444279,0.010903233,0.3259064],"study_design_scores_gemma":[0.106856,0.041305818,0.6900655,0.11595242,0.00011587023,0.0011351056,0.0068457704,0.0036439418,0.00041499166,0.00010759945,0.032264475,0.0012924867],"about_ca_topic_score_codex":0.11356476,"about_ca_topic_score_gemma":0.0021293252,"teacher_disagreement_score":0.3246139,"about_ca_system_score_codex":0.0010439026,"about_ca_system_score_gemma":0.0063968464,"threshold_uncertainty_score":0.999236},"labels":[],"label_agreement":null},{"id":"W2906002519","doi":"10.1016/j.jval.2018.09.260","title":"PCN177 - COST-EFFECTIVENESS OF TISAGENLECLEUCEL FOR ADULTS WITH RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA : A CANADIAN SOCIETAL PERSPECTIVE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Oncology; Salvage therapy; Refractory (planetary science); Quality-adjusted life year; Internal medicine; Cost effectiveness; Chemotherapy; Biology","score_opus":0.05165991619322524,"score_gpt":0.3583497100789593,"score_spread":0.3066897938857341,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906002519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911834,0.0005685168,0.00015405337,0.00063328526,0.0001583156,0.005071604,0.00021816378,0.00003639216,0.0019762937],"genre_scores_gemma":[0.99655044,0.00018862926,0.0006217659,0.0003993248,0.00018845958,0.00029887067,0.000040742165,0.00008263255,0.0016291366],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9973063,0.00047483965,0.00036573212,0.0005202338,0.0004202594,0.0009126238],"domain_scores_gemma":[0.99755937,0.00072089094,0.00014973081,0.00047641227,0.0005043928,0.0005891878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017033687,0.00021994609,0.00058382907,0.0003438164,0.00017291211,0.0000114676,0.00015828456,0.00017128339,0.00026115432],"category_scores_gemma":[0.00029908994,0.00017550967,0.000112010086,0.00058568234,0.00022740902,0.00007330203,0.000028422648,0.00025381977,0.000016035621],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.3680882,0.058241047,0.06634948,0.03698099,0.001910038,0.0013232366,0.2699591,0.00010020661,0.08165658,0.0075807143,0.01123187,0.09657857],"study_design_scores_gemma":[0.47273576,0.10360597,0.19562292,0.011640069,0.00025411576,0.00044738228,0.05388362,0.025556633,0.04327698,0.0010330362,0.08979118,0.0021523198],"about_ca_topic_score_codex":0.27913168,"about_ca_topic_score_gemma":0.10906063,"teacher_disagreement_score":0.21607548,"about_ca_system_score_codex":0.0035741364,"about_ca_system_score_gemma":0.0062136687,"threshold_uncertainty_score":0.99942017},"labels":[],"label_agreement":null},{"id":"W2906016239","doi":"10.1016/j.jval.2018.09.2375","title":"PRM258 - METHODOLOGICAL APPROACHES FOR CONDUCTING MATCHING-ADJUSTED INDIRECT COMPARISONS INVOLVING MULTIPLE RANDOMIZED CONTROLLED TRIALS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Dalhousie University","funders":"","keywords":"Randomized controlled trial; Pooling; Matching (statistics); Meta-analysis; Computer science; Medicine; Consistency (knowledge bases); Set (abstract data type); Statistics; Data mining; Medical physics; Artificial intelligence; Mathematics; Internal medicine","score_opus":0.9602785610421709,"score_gpt":0.637073148182864,"score_spread":0.32320541285930693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906016239","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":"methods","model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051112387,0.0007679479,0.92617804,0.0019011381,0.0022348622,0.016993444,0.00010330939,0.00026897131,0.0004398817],"genre_scores_gemma":[0.13890944,0.00006217057,0.858018,0.00035431125,0.0010393375,0.0014825317,0.000006298918,0.000063155596,0.00006478659],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.8996482,0.089370295,0.008393215,0.00094985194,0.0005964967,0.0010419447],"domain_scores_gemma":[0.18020232,0.814815,0.0038594392,0.0005740819,0.00023111944,0.00031803234],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.29497093,0.00047273556,0.013326435,0.0003116831,0.00035175704,0.00009309476,0.0004279436,0.00045095402,0.00013909016],"category_scores_gemma":[0.88810116,0.0003113955,0.0012097446,0.00042229658,0.0005898776,0.00008257153,0.00014141745,0.00072658045,0.000010514469],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30936214,0.0014749471,0.00063995976,0.0027308792,0.0017175163,0.0000064410647,0.0058173807,0.00077151106,0.00035921184,0.661528,0.0029325048,0.012659518],"study_design_scores_gemma":[0.23298495,0.00031398507,0.000026561922,0.00044727928,0.00026836083,0.0000033632123,0.0006809579,0.09455508,0.00033671828,0.67006785,0.000051977335,0.00026293722],"about_ca_topic_score_codex":0.0005478221,"about_ca_topic_score_gemma":0.00005779686,"teacher_disagreement_score":0.72544473,"about_ca_system_score_codex":0.00020971085,"about_ca_system_score_gemma":0.0003676375,"threshold_uncertainty_score":0.99993384},"labels":[],"label_agreement":null},{"id":"W2906035745","doi":"10.1016/j.jval.2018.09.2817","title":"PUK19 - COST-UTILITY OF SUCROFERRIC OXYHYDROXIDE FOR THE TREATMENT OF HYPERPHOSPHATEMIA IN CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING DIALYSIS IN CANADA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Parathyroid Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hyperphosphatemia; Medicine; Dialysis; Kidney disease; Context (archaeology); Intensive care medicine; Renal replacement therapy; Sevelamer; Phosphate binder; Internal medicine; Emergency medicine","score_opus":0.03226915132111558,"score_gpt":0.30377775689931125,"score_spread":0.27150860557819567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906035745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9884755,0.008653972,0.000011577434,0.0005739654,0.00011837183,0.001956704,0.0001642324,0.000003139181,0.00004251529],"genre_scores_gemma":[0.9973743,0.002115214,0.0000390755,0.00017395198,0.000020283598,0.00016580634,0.00007454231,0.000012640287,0.000024215065],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984515,0.00011464345,0.00061524514,0.0002492522,0.00020692796,0.00036244455],"domain_scores_gemma":[0.99887675,0.00033683798,0.00019020354,0.00033257622,0.000048042686,0.00021556336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021072426,0.00014533103,0.0004729316,0.000119588316,0.000043033262,0.0000019625888,0.00007235144,0.000033826294,0.00001188598],"category_scores_gemma":[0.00018600705,0.00010313364,0.00007040494,0.0004053039,0.000057878755,0.00003224803,0.000012484262,0.000053904598,9.5051627e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005753159,0.0010183477,0.9938715,0.00017984687,0.00004340654,0.000005708313,0.0004947881,0.00078245223,0.0000054875254,0.000015980288,0.00026901436,0.0027381538],"study_design_scores_gemma":[0.010910622,0.0011308504,0.95950663,0.00020355634,0.000054224307,1.9351093e-7,0.00015012019,0.027089337,0.00022564596,0.000115626404,0.0005395291,0.00007366642],"about_ca_topic_score_codex":0.93630695,"about_ca_topic_score_gemma":0.8608021,"teacher_disagreement_score":0.07550485,"about_ca_system_score_codex":0.0035603407,"about_ca_system_score_gemma":0.008312983,"threshold_uncertainty_score":0.99730897},"labels":[],"label_agreement":null},{"id":"W2906074521","doi":"10.1016/j.jval.2018.09.179","title":"PCN97 - ASSESSING THE IMPACT OF ACTIVE IDENTIFICATION OF PATIENTS APPROPRIATE FOR PALLIATIVE CARE ON RESOURCE UTILIZATION AND COSTS IN THE FINAL MONTH OF LIFE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ontario Stroke Network; Institute for Clinical Evaluative Sciences; Cancer Care Ontario; Sunnybrook Hospital; University of Toronto","funders":"","keywords":"Medicine; Palliative care; Propensity score matching; Intervention (counseling); Emergency medicine; Demographics; Emergency department; Intensive care unit; Cancer; Health care; Intensive care medicine; Internal medicine; Nursing; Demography","score_opus":0.29629929727656923,"score_gpt":0.4993572707063406,"score_spread":0.2030579734297714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906074521","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775636,0.0007449799,0.00022556123,0.00015124682,0.000026057454,0.000895355,0.00009828117,0.0000019225686,0.000100220976],"genre_scores_gemma":[0.9994538,0.00023026112,0.00015672571,0.000046824265,0.000027827173,0.000016153346,0.000059631086,0.0000068371605,0.0000019329314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99876374,0.00031219158,0.00047613945,0.00012336607,0.00021720323,0.000107333915],"domain_scores_gemma":[0.99829495,0.00056648813,0.000611001,0.00016698237,0.00033381218,0.000026739173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000632871,0.00007482915,0.0002702042,0.00010719468,0.000035140405,0.0000033249275,0.00006908414,0.000045232147,0.0000010267382],"category_scores_gemma":[0.0010770248,0.00004405513,0.000042778433,0.0002605039,0.00011735851,0.000046428537,0.0000115788725,0.0000827446,8.1221394e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012708757,0.0003723859,0.8410236,0.0009461707,0.00004585026,1.4221814e-7,0.12372323,0.00064883474,0.00035497546,0.00025724544,0.000073358286,0.03128329],"study_design_scores_gemma":[0.0013338192,0.0013957021,0.97384924,0.0015013455,0.000015024515,4.1462908e-8,0.013548912,0.004215526,0.003936862,0.00013537858,0.00003451247,0.00003362767],"about_ca_topic_score_codex":0.0030915616,"about_ca_topic_score_gemma":0.00006587256,"teacher_disagreement_score":0.13282561,"about_ca_system_score_codex":0.00015481973,"about_ca_system_score_gemma":0.00022442105,"threshold_uncertainty_score":0.4673537},"labels":[],"label_agreement":null},{"id":"W2906110772","doi":"10.1016/j.jval.2018.09.103","title":"PCN21 - COMPARATIVE EFFICACY OF NIVOLUMAB±IPILIMUMAB VERSUS STANDARD OF CARE (SOC) FOR THIRD-LINE (3L) PATIENTS WITH RECURRENT SMALL CELL LUNG CANCER (SCLC) USING POPULATION-ADJUSTED INDIRECT COMPARISON","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Oncology; Population; Internal medicine; Lung cancer; Hazard ratio; Regimen; Cancer; Immunotherapy; Confidence interval","score_opus":0.146381492280194,"score_gpt":0.4403910053062912,"score_spread":0.29400951302609724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906110772","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98903227,0.0063464404,0.00015158755,0.00009897136,0.00045744475,0.0033875955,0.00041322573,0.00002639164,0.00008609857],"genre_scores_gemma":[0.9954286,0.00020684263,0.0039526513,0.00001743719,0.0001543348,0.000060020102,0.00014061932,0.00003131657,0.000008143073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737585,0.00023558951,0.00084081024,0.0003919611,0.0006716358,0.0004841499],"domain_scores_gemma":[0.99726486,0.00041997706,0.000657114,0.00031278416,0.0011902592,0.00015499567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038867228,0.00023171138,0.0011750079,0.00026561393,0.00015945811,0.000006853971,0.0001261497,0.00007416299,0.000011403789],"category_scores_gemma":[0.0001672756,0.00019124353,0.00007984455,0.0005480672,0.00017334134,0.000056084253,0.00006740109,0.00026162856,3.8464643e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041099038,0.000664835,0.91400033,0.0073853796,0.00024274818,7.3962644e-7,0.024964113,0.008948583,0.000024036108,0.000021090813,0.00060354546,0.0020455685],"study_design_scores_gemma":[0.064114645,0.038828805,0.8259701,0.008364224,0.0005531576,4.4317972e-7,0.0049500894,0.051845197,0.004460738,0.000010804112,0.00037724507,0.0005245207],"about_ca_topic_score_codex":0.011695526,"about_ca_topic_score_gemma":0.0062102443,"teacher_disagreement_score":0.08803019,"about_ca_system_score_codex":0.0020577991,"about_ca_system_score_gemma":0.0012516206,"threshold_uncertainty_score":0.9948857},"labels":[],"label_agreement":null},{"id":"W2906111461","doi":"10.1016/j.jval.2018.09.892","title":"PGI50 - HAPPY TOMORROW BUT GLOOMING ELDERLY? SELF-ESTIMATION OF FUTURE HEALTH IN CROHN’S DISEASE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Life expectancy; Medicine; Demography; Disease; Crohn's disease; Descriptive statistics; Gerontology; Expectancy theory; Multivariate analysis; Psychology; Internal medicine; Statistics; Environmental health; Population","score_opus":0.01079699156998785,"score_gpt":0.2748808890924737,"score_spread":0.26408389752248584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906111461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954972,0.0012582777,0.00034095437,0.0018152882,0.0003138145,0.0006094128,0.00006733472,0.000023581284,0.00007408682],"genre_scores_gemma":[0.9947416,0.00026320515,0.0032043967,0.0011483367,0.0004494646,0.00003071136,0.00008777512,0.000027787735,0.00004670208],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99807024,0.00033923128,0.0005995166,0.00038344396,0.00016753309,0.0004400094],"domain_scores_gemma":[0.99891585,0.000013260506,0.00026631908,0.00044139032,0.000062995314,0.00030019204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000748455,0.0001700984,0.00023427296,0.00013521007,0.000086063104,0.00001213731,0.00017618037,0.000108378656,0.000015003882],"category_scores_gemma":[0.0001255359,0.00018397003,0.00006239382,0.00017367395,0.00006615038,0.00001052605,0.00006025651,0.00012369595,0.000011313802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011652357,0.006712002,0.5748414,0.021236354,0.00027390552,0.0011476027,0.017854588,0.11450491,0.013050723,0.014042982,0.0308434,0.19383977],"study_design_scores_gemma":[0.0017869486,0.0005438549,0.959205,0.0005182112,0.000008633871,0.000007734669,0.000281496,0.03273078,0.0005972627,0.0004334477,0.0035118458,0.00037478772],"about_ca_topic_score_codex":0.00086625526,"about_ca_topic_score_gemma":0.00044856028,"teacher_disagreement_score":0.3843636,"about_ca_system_score_codex":0.00015155973,"about_ca_system_score_gemma":0.0013340554,"threshold_uncertainty_score":0.750208},"labels":[],"label_agreement":null},{"id":"W2906179342","doi":"10.1016/j.jval.2018.09.2751","title":"PSY177 - HEALTH-RELATED QUALITY OF LIFE OF PATIENTS WITH BETA-THALASSEMIA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Thalassemia; Beta thalassemia; Medicine; Chelation therapy; Deferasirox; Quality of life (healthcare); Blood transfusion; Population; Pediatrics; Internal medicine; Environmental health","score_opus":0.03674726007807153,"score_gpt":0.31280917885811466,"score_spread":0.2760619187800431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906179342","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992483,0.0015189883,0.00002663657,0.0042037605,0.00017101046,0.0007374278,0.00003223267,0.00002756479,0.0007993308],"genre_scores_gemma":[0.9980922,0.0002833682,0.0006681414,0.0008172118,0.000024127894,0.000004376647,0.00004094404,0.000022869033,0.0000467826],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971348,0.00035543423,0.0014333328,0.0002519498,0.00043545626,0.00038904618],"domain_scores_gemma":[0.9982323,0.00010690018,0.00076655427,0.00037150184,0.0002126846,0.00031004395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012269157,0.00014388669,0.00082498183,0.00017377481,0.00005804591,0.0000017839623,0.000083197505,0.00015499668,0.00007754963],"category_scores_gemma":[0.00022225628,0.000107266074,0.00006893514,0.000593017,0.00022857924,0.00003934164,0.000024522977,0.00029595135,0.000010692101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009567143,0.0010665563,0.9863372,0.0022518905,0.00009164417,0.0000012517901,0.0031676511,0.00017584507,0.000019128891,0.001013546,0.0013203606,0.0035982432],"study_design_scores_gemma":[0.0058038738,0.0037454702,0.98746336,0.0011556004,0.000014795269,0.0000019250606,0.00046544202,0.00037006446,0.000076454286,0.00015053038,0.00062682724,0.00012564335],"about_ca_topic_score_codex":0.01614643,"about_ca_topic_score_gemma":0.00010437634,"teacher_disagreement_score":0.016042054,"about_ca_system_score_codex":0.00013898809,"about_ca_system_score_gemma":0.0011822942,"threshold_uncertainty_score":0.99040514},"labels":[],"label_agreement":null},{"id":"W2906189161","doi":"10.1016/j.jval.2018.09.1789","title":"PMS75 - SEEKING THE STATE OF THE ART IN STANDARDIZED MEASUREMENT OF HEALTH CARE RESOURCE USE AND COSTS IN JUVENILE IDIOPATHIC ARTHRITIS: A SCOPING REVIEW","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Activity-based costing; Reimbursement; Health care; Productivity; Unit (ring theory); Resource (disambiguation); Medicine; Indirect costs; Unit cost; Cost driver; Resource use; Business; Operations management; Psychology; Marketing; Environmental resource management; Economics; Computer science; Accounting","score_opus":0.23778470500484308,"score_gpt":0.45086921298212745,"score_spread":0.21308450797728437,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906189161","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000294489,0.98114544,0.000016259784,0.0022712557,0.00042546206,0.015546573,0.00025479522,0.000019000918,0.000026733685],"genre_scores_gemma":[0.0012371043,0.99649936,0.00006946277,0.0015127806,0.0001510014,0.00041553628,0.000028626862,0.00007550288,0.000010602807],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9631455,0.026762782,0.006931969,0.0007022559,0.001222052,0.0012354726],"domain_scores_gemma":[0.99250215,0.0013873773,0.0044866945,0.0010290756,0.00037300235,0.00022172213],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.03336337,0.00049026613,0.0046162205,0.0004414436,0.00045603598,0.000011127567,0.00048800462,0.00033414294,0.000007693404],"category_scores_gemma":[0.0025131325,0.0003229745,0.00025086035,0.0016465274,0.00014289907,0.00009005142,0.0003250361,0.0026422462,0.000005120457],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00003089932,0.000040469677,0.004876548,0.6739996,0.000009138224,0.0000040082987,0.0077373297,0.000007337041,1.0520681e-8,0.000015166954,0.0010782346,0.31220126],"study_design_scores_gemma":[0.00085297925,0.00013321935,0.00054407207,0.84033126,0.000024231214,0.0000039697557,0.00072263874,0.000009314881,2.9061633e-8,0.0000128419,0.15718089,0.00018454631],"about_ca_topic_score_codex":0.016500443,"about_ca_topic_score_gemma":0.03220965,"teacher_disagreement_score":0.31201673,"about_ca_system_score_codex":0.0040023825,"about_ca_system_score_gemma":0.022637257,"threshold_uncertainty_score":0.9999222},"labels":[],"label_agreement":null},{"id":"W2906229801","doi":"10.1016/j.jval.2018.09.881","title":"PGI39 - DARVADSTROCEL IN THE MANAGEMENT OF COMPLEX PERIANAL FISTULAS: THE ROLE OF PATIENT REGISTRY DATA COLLECTION TO SUPPORT PERFORMANCE-BASED RISK SHARING AGREEMENTS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Daratumumab; Medicine; Intensive care medicine; Family medicine; Multiple myeloma; Internal medicine","score_opus":0.4197929599770777,"score_gpt":0.4112457840577802,"score_spread":0.008547175919297545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906229801","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98908365,0.0002372981,0.00043189342,0.005402734,0.0002289364,0.0015010167,0.00042874354,0.000007492746,0.0026782644],"genre_scores_gemma":[0.99478143,0.00013043387,0.0027211828,0.0020775904,0.00007412547,0.00008159266,0.00008796528,0.000012987859,0.00003265931],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99542296,0.00039778926,0.0031911612,0.0004567225,0.00018227595,0.00034906305],"domain_scores_gemma":[0.9963805,0.00024481135,0.0020550883,0.0012083004,0.00004201384,0.00006926974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017172923,0.00012619459,0.00051127456,0.0002839051,0.00021283084,0.000027266731,0.00084730284,0.00004744608,0.00013425083],"category_scores_gemma":[0.00027856976,0.0001173207,0.000040575775,0.0004987139,0.00007960779,0.00014952039,0.00017068829,0.00015323568,0.00007027909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015642525,0.0004642877,0.9445149,0.0019175062,0.000081261394,6.9862324e-7,0.015973687,0.014046157,0.0000017204346,0.010552065,0.008957487,0.0033338594],"study_design_scores_gemma":[0.0014160102,0.0010077948,0.56480503,0.0005495337,0.000009910206,0.0000021150877,0.01235327,0.37837806,0.000014171379,0.0020054053,0.03923167,0.00022700553],"about_ca_topic_score_codex":0.018949429,"about_ca_topic_score_gemma":0.00089400064,"teacher_disagreement_score":0.3797098,"about_ca_system_score_codex":0.00054151774,"about_ca_system_score_gemma":0.00022132036,"threshold_uncertainty_score":0.98758346},"labels":[],"label_agreement":null},{"id":"W2906235082","doi":"10.1016/j.jval.2018.09.721","title":"PDB15 - CARDIOVASCULAR SAFETY OF EMPAGLIFLOZIN VERSUS DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS: SYSTEMATIC LITERATURE REVIEW AND INDIRECT COMPARISONS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Saxagliptin; Empagliflozin; Sitagliptin; Medicine; Sitagliptin Phosphate; Internal medicine; Hazard ratio; Myocardial infarction; Type 2 diabetes; Dipeptidyl peptidase-4; Dipeptidyl peptidase-4 inhibitor; Pharmacology; Diabetes mellitus; Endocrinology; Confidence interval","score_opus":0.03487364832103898,"score_gpt":0.295668107964375,"score_spread":0.26079445964333603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906235082","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12457314,0.86304605,0.00003688182,0.0021397506,0.00061399664,0.0067890217,0.00005042281,0.00010503873,0.0026456676],"genre_scores_gemma":[0.8966347,0.09926003,0.0020736838,0.0009928665,0.00031751537,0.00017639459,0.00011369836,0.000051911662,0.0003792068],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99771917,0.00043913335,0.0008033405,0.00033647078,0.00036541666,0.00033647896],"domain_scores_gemma":[0.9987236,0.00014755463,0.00023377131,0.00060389284,0.000094733434,0.00019644883],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016586012,0.00022368316,0.001495214,0.00022950463,0.00006959858,0.000017204893,0.00008032548,0.00007306136,0.000016476648],"category_scores_gemma":[0.00022043366,0.00017287668,0.00021768389,0.0005904028,0.000090314024,0.0000803383,0.000069412104,0.0001725317,0.000021773103],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052515283,0.00081873836,0.013861407,0.950929,0.0031850033,0.00011039926,0.0038463445,0.00004585973,0.000017131006,0.0008239381,0.021908892,0.00392812],"study_design_scores_gemma":[0.017586196,0.00629448,0.02272096,0.91151834,0.005888988,0.00006142481,0.00092730747,0.0009318296,0.00026130254,0.000046660723,0.03299108,0.0007714259],"about_ca_topic_score_codex":0.00022427629,"about_ca_topic_score_gemma":0.000022906961,"teacher_disagreement_score":0.7720615,"about_ca_system_score_codex":0.00022056131,"about_ca_system_score_gemma":0.000104230516,"threshold_uncertainty_score":0.70497066},"labels":[],"label_agreement":null},{"id":"W2906254779","doi":"10.1016/j.jval.2018.09.1178","title":"PHP284 - TIME TO HTA DECISION FOR INTERNATIONALISED MEDICINES IN AUSTRALIA, CANADA AND EUROPE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cohort; Internal medicine","score_opus":0.12341032519558928,"score_gpt":0.3578184141197676,"score_spread":0.23440808892417833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906254779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98305357,0.0002836148,0.00010175187,0.013951234,0.00048362804,0.00033790228,0.00019118158,0.0000044673275,0.0015926831],"genre_scores_gemma":[0.98475885,0.00016834914,0.00093894574,0.012537378,0.0002981135,0.000015217173,0.000012282298,0.000016546725,0.0012542958],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989448,0.000013393171,0.00054206373,0.00023530141,0.000020712932,0.0002436845],"domain_scores_gemma":[0.99943215,0.00017662595,0.00010018584,0.000104900864,0.000023834687,0.00016227804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072623184,0.000074173615,0.00023406203,0.00020169279,0.000027144495,0.000017479751,0.00012267295,0.000028049206,0.00034506398],"category_scores_gemma":[0.00035489185,0.000084924315,0.000011727488,0.00019881487,0.000023150349,0.000051738105,0.00003576249,0.00006456844,0.00020819962],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086135743,0.00035560888,0.23360798,0.00049228687,0.00007158102,0.000018850444,0.004172495,0.0065714484,0.00008540707,0.29274577,0.4296485,0.03136872],"study_design_scores_gemma":[0.0012229496,0.00021618638,0.04742431,0.00008978538,6.8499276e-7,0.0000024490064,0.0000070682145,0.056648873,0.000019977448,0.032886226,0.86130023,0.0001812826],"about_ca_topic_score_codex":0.57995844,"about_ca_topic_score_gemma":0.2048522,"teacher_disagreement_score":0.4316517,"about_ca_system_score_codex":0.00025896408,"about_ca_system_score_gemma":0.0001463267,"threshold_uncertainty_score":0.80965716},"labels":[],"label_agreement":null},{"id":"W2906258950","doi":"10.1016/j.jval.2018.09.2517","title":"PSS17 - COST PER RESPONDER ANALYSIS OF BRODALUMAB COMPARED WITH USTEKINUMAB IN THE TREATMENT OF MODERATE-TO-SEVERE PLAQUE PSORIASIS IN CANADA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Dalhousie University","funders":"","keywords":"Ustekinumab; Medicine; Psoriasis Area and Severity Index; Psoriasis; Plaque psoriasis; Dosing; Placebo; Dermatology; Internal medicine; Adalimumab","score_opus":0.308804429168465,"score_gpt":0.39591576199725853,"score_spread":0.08711133282879352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906258950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856537,0.0005582773,0.00019617553,0.011136828,0.00014235625,0.0014345509,0.0005397838,0.000004236651,0.00033407644],"genre_scores_gemma":[0.9961657,0.0001523441,0.0008518377,0.0025407735,0.00004972523,0.00014467759,0.000034809123,0.00001847138,0.000041648906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937997,0.0011095303,0.003917644,0.00051148207,0.00017877624,0.0004828643],"domain_scores_gemma":[0.99635035,0.0012852805,0.0014621984,0.00069551193,0.00007410349,0.00013253042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007595539,0.00019607128,0.0016817333,0.0012581014,0.00007212354,0.000017720577,0.00029210476,0.000075730284,0.00014487709],"category_scores_gemma":[0.0003046689,0.0001846079,0.00007350955,0.0015367612,0.00005941667,0.00012051826,0.000015483643,0.00012088637,0.000022841894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005780211,0.0004442614,0.6687481,0.0002476811,0.00019400302,0.0000029038567,0.029308798,0.29370835,3.450524e-7,0.0056190556,0.00093772827,0.00021076688],"study_design_scores_gemma":[0.0038064688,0.0007273977,0.8133329,0.00021848864,0.000023843957,0.0000027966119,0.008727386,0.16792953,0.000005902721,0.0005646572,0.0043600723,0.0003005187],"about_ca_topic_score_codex":0.97611487,"about_ca_topic_score_gemma":0.9780157,"teacher_disagreement_score":0.14458485,"about_ca_system_score_codex":0.0051116734,"about_ca_system_score_gemma":0.0026817692,"threshold_uncertainty_score":0.99870753},"labels":[],"label_agreement":null},{"id":"W2906270512","doi":"10.1016/j.jval.2018.09.258","title":"PCN175 - BRENTUXIMAB VEDOTIN COMPARED WITH STANDARD THERAPY FOR PATIENTS WITH ADVANCED-STAGE HODGKIN’S LYMPHOMA: A COST-EFFECTIVENESS ANALYSIS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"","keywords":"ABVD; Brentuximab vedotin; Medicine; Dacarbazine; Hodgkin's lymphoma; Oncology; Internal medicine; Hodgkin lymphoma; Lymphoma; Chemotherapy; Vincristine","score_opus":0.044222356736891504,"score_gpt":0.3657062456429737,"score_spread":0.3214838889060822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906270512","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9869656,0.00042026996,0.005799766,0.00020220093,0.000092647526,0.0061158333,0.00021692873,0.00007684531,0.00010990422],"genre_scores_gemma":[0.9946777,0.00012473497,0.0038284725,0.00027640318,0.00009140824,0.0006445107,0.00021187423,0.00007542879,0.00006942888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964489,0.0003887701,0.00051473215,0.00074406806,0.0009653531,0.00093821005],"domain_scores_gemma":[0.99743146,0.0005684216,0.0002616757,0.0007312126,0.0006367798,0.0003704466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011890152,0.00032561677,0.0010795529,0.00050385325,0.00019775382,0.00003618459,0.00019748794,0.00009140172,0.00004833007],"category_scores_gemma":[0.00012226265,0.00022885989,0.000118213495,0.0016679122,0.00025503733,0.00012287959,0.000043569537,0.00015635294,0.000008319416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.18118657,0.005564077,0.6683757,0.0034947009,0.0028666344,0.00012286751,0.005383791,0.018916268,0.00004867515,0.00045501083,0.000375514,0.113210194],"study_design_scores_gemma":[0.3928901,0.036465023,0.45296276,0.0019302187,0.00031448482,0.000028338978,0.00062161766,0.09697458,0.001172185,0.0000732718,0.015774788,0.0007926499],"about_ca_topic_score_codex":0.0069457185,"about_ca_topic_score_gemma":0.000714057,"teacher_disagreement_score":0.21541294,"about_ca_system_score_codex":0.02233963,"about_ca_system_score_gemma":0.010555488,"threshold_uncertainty_score":0.9996671},"labels":[],"label_agreement":null},{"id":"W2906277950","doi":"10.1016/j.jval.2018.09.2215","title":"PRM94 - ALIGNING TEXT MINING AND MACHINE LEARNING ALGORITHMS WITH BEST PRACTICES FOR STUDY SELECTION IN SYSTEMATIC LITERATURE REVIEWS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Machine learning; Artificial intelligence; Computer science; Algorithm; Systematic review; Support vector machine; Bootstrapping (finance); Population; Naive Bayes classifier; Data mining; Medicine; MEDLINE; Mathematics","score_opus":0.7225400825203923,"score_gpt":0.5514569078851442,"score_spread":0.17108317463524803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906277950","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86348534,0.08975837,0.019964391,0.0015842357,0.0004221086,0.023925621,0.00001075505,0.000025995583,0.00082317495],"genre_scores_gemma":[0.9091752,0.0011518385,0.08326031,0.0003231416,0.0002912953,0.0009381438,0.000007633951,0.000043554424,0.0048088394],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9618134,0.026980238,0.00791605,0.0011050836,0.0017932247,0.00039204067],"domain_scores_gemma":[0.98211414,0.0065138726,0.00994654,0.0007688931,0.0005234652,0.00013310209],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.19899467,0.00030072496,0.0036287562,0.00074614503,0.00030480121,0.0009050256,0.00043948874,0.000072067116,0.0000629108],"category_scores_gemma":[0.05254872,0.00014500608,0.00019201238,0.0027838764,0.000030243365,0.00047738722,0.000052535772,0.00026674132,0.000054341803],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012328761,0.0007442687,0.7937777,0.060273957,0.00024530297,0.000020358011,0.09524838,0.0013645791,0.00003088522,0.00023026971,0.002130594,0.045810394],"study_design_scores_gemma":[0.0020880247,0.0060657733,0.0075722476,0.052412063,0.00048035927,0.00022628512,0.03064233,0.8696958,0.000006261337,0.0003163947,0.029797215,0.00069724565],"about_ca_topic_score_codex":0.0008049651,"about_ca_topic_score_gemma":0.0019745512,"teacher_disagreement_score":0.8683312,"about_ca_system_score_codex":0.00009623811,"about_ca_system_score_gemma":0.00011573435,"threshold_uncertainty_score":0.95543206},"labels":[],"label_agreement":null},{"id":"W2906289752","doi":"10.1016/j.jval.2018.09.2814","title":"PUK16 - COST-EFFECTIVENESS OF TOLVAPTAN IN CANADIAN PATIENTS WITH AUTOSOMAL POLYCYSTIC KIDNEY DISEASE: AN ADAPTATION OF THE ADPKD OUTCOMES MODEL","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tolvaptan; Autosomal dominant polycystic kidney disease; Medicine; Renal function; Population; Placebo; Cost effectiveness; Quality of life (healthcare); Internal medicine; Intensive care medicine; Disease; Heart failure; Nursing; Environmental health","score_opus":0.26199461690141296,"score_gpt":0.39140897932462515,"score_spread":0.1294143624232122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906289752","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906701,0.00017686734,0.0005533548,0.0049953586,0.00030731218,0.001986336,0.0011520259,0.000009122038,0.00014952563],"genre_scores_gemma":[0.9974043,0.000007162587,0.00067341106,0.0016985405,0.000027754373,0.000099703415,0.000049073988,0.000024492536,0.000015566742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99578893,0.00091556006,0.0023239255,0.00037483865,0.00013113345,0.00046559973],"domain_scores_gemma":[0.99706775,0.0004633719,0.0013453956,0.00051720976,0.00009473858,0.00051155844],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0082151145,0.00015021063,0.0007438287,0.0004914964,0.00010564134,0.000012109585,0.00026761522,0.000079786274,0.000021870861],"category_scores_gemma":[0.0023534053,0.00014595961,0.00005073644,0.0003832467,0.000118273245,0.00024439217,0.0000288808,0.0001358388,0.000015982732],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009049469,0.00014939014,0.9176003,0.00059030706,0.000009860275,1.4096332e-7,0.0013621653,0.04478669,1.3874089e-7,0.03527556,0.0000337809,0.000101175996],"study_design_scores_gemma":[0.00097361114,0.00013369625,0.7166812,0.00036400976,0.0000019860838,8.3157275e-8,0.000112136615,0.27665013,8.616804e-7,0.0048751617,0.000103652594,0.000103509024],"about_ca_topic_score_codex":0.6140799,"about_ca_topic_score_gemma":0.22958565,"teacher_disagreement_score":0.38449427,"about_ca_system_score_codex":0.0015930464,"about_ca_system_score_gemma":0.0033607765,"threshold_uncertainty_score":0.7844724},"labels":[],"label_agreement":null},{"id":"W2906311050","doi":"10.1016/j.jval.2018.09.303","title":"PCN221 - STAGE III UNRESECTABLE NON-SMALL CELL LUNG CANCER TREATMENT PATTERNS AND COSTS: AN ONTARIO, CANADA ANALYSIS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); McMaster University; Sunnybrook Hospital","funders":"","keywords":"Medicine; Lung cancer; Activity-based costing; Cohort; Stage (stratigraphy); Cancer registry; Population; Cancer; Radiation therapy; Total cost; Emergency medicine; Internal medicine; Environmental health","score_opus":0.034121309097623266,"score_gpt":0.26013806268134393,"score_spread":0.22601675358372067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906311050","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898099,0.002450015,0.00048436792,0.00039848092,0.0005691588,0.00041081148,0.00077770517,0.000010956953,0.005088617],"genre_scores_gemma":[0.9926572,0.0019591358,0.00017573086,0.00094564195,0.00019239384,0.00005602298,0.000036228917,0.000025780782,0.003951881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799526,0.000028239734,0.0007372344,0.00057750236,0.000036080113,0.0006257085],"domain_scores_gemma":[0.99879235,0.000044310465,0.00041178518,0.00039491514,0.000030408657,0.00032622032],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045076315,0.00022238784,0.00072554813,0.0002971583,0.00017355243,0.00007322777,0.00016704698,0.0000879781,0.001087546],"category_scores_gemma":[0.000009270788,0.00025170844,0.000065117645,0.00030054542,0.000038868406,0.00022757646,0.000037278904,0.00014457709,0.000007515705],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032598855,0.00007771149,0.99251443,0.00005056546,0.00010181298,0.0000050655535,0.002072394,0.0025454182,6.126393e-7,0.0011224729,0.0005125824,0.000964316],"study_design_scores_gemma":[0.002016402,0.0005907666,0.9164278,0.00006617907,0.000041143612,7.4571267e-7,0.0003632225,0.03735198,0.000056961395,0.00018259784,0.04239987,0.0005023194],"about_ca_topic_score_codex":0.99973124,"about_ca_topic_score_gemma":0.99949557,"teacher_disagreement_score":0.07608663,"about_ca_system_score_codex":0.0066151456,"about_ca_system_score_gemma":0.0016599569,"threshold_uncertainty_score":0.9999935},"labels":[],"label_agreement":null},{"id":"W2906312333","doi":"10.1016/j.jval.2018.09.2050","title":"PND84 - PATIENT AND CAREGIVER BURDEN OF BOTULINUM TOXIN A INJECTIONS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Spasticity; Botulinum toxin; Caregiver burden; Stroke (engine); Physical therapy; Etiology; Modified Ashworth scale; Internal medicine; Surgery; Disease","score_opus":0.028652847744912342,"score_gpt":0.2864307632228324,"score_spread":0.25777791547792006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906312333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98928857,0.0012441333,0.000033955628,0.006767833,0.00019393004,0.00037080463,0.00000535265,0.000030751824,0.0020646963],"genre_scores_gemma":[0.9974268,0.0008088933,0.00029759735,0.0012699044,0.00006489258,0.000005950112,0.0000021445026,0.000009616782,0.0001141775],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99904066,0.00010585267,0.0003100618,0.00020234732,0.00012860405,0.00021247352],"domain_scores_gemma":[0.9995238,0.00006687946,0.00008007483,0.00015086702,0.000042236385,0.00013613226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013682265,0.00008334,0.00022970345,0.00011095591,0.000054559405,0.0000026773216,0.000033646098,0.00011307849,0.000058110418],"category_scores_gemma":[0.00008405287,0.00006458723,0.00003652549,0.00026575624,0.00017545039,0.000020962669,0.000032106862,0.00023509747,0.000012747578],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0064955973,0.0070797056,0.17367814,0.0063748946,0.00074556505,0.0006070064,0.24137966,0.016156483,0.019042928,0.021536287,0.04182806,0.46507567],"study_design_scores_gemma":[0.03453308,0.094612956,0.4592954,0.0055866963,0.00036655582,0.0012905635,0.020347578,0.14006184,0.006422352,0.02020411,0.21515615,0.0021227272],"about_ca_topic_score_codex":0.002984806,"about_ca_topic_score_gemma":0.000030529685,"teacher_disagreement_score":0.46295294,"about_ca_system_score_codex":0.000037089892,"about_ca_system_score_gemma":0.00011271422,"threshold_uncertainty_score":0.4512154},"labels":[],"label_agreement":null},{"id":"W2906351675","doi":"10.1016/j.jval.2018.09.2189","title":"PRM68 - IMPUTATION METHODS FOR MISSING DATA IN COST-UTILITY ANALYSES ALONGSIDE RANDOMIZED CONTROLLED TRIALS: AGGREGATE OR NON-AGGREGATE?","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Missing data; Imputation (statistics); Statistics; Quantile; Econometrics; Aggregate data; Aggregate (composite); Medicine; Mathematics; Computer science","score_opus":0.767217208767292,"score_gpt":0.61259766830442,"score_spread":0.15461954046287207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906351675","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07190238,0.021833466,0.8038811,0.06716533,0.0030219944,0.03028577,0.0012023967,0.00012837225,0.00057919143],"genre_scores_gemma":[0.4442166,0.002232156,0.5332716,0.013877444,0.0018104799,0.0033139524,0.00073391444,0.00016061931,0.00038320431],"study_design_codex":"randomized_trial","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.95873255,0.018548628,0.019927893,0.0015364165,0.00017440373,0.0010801329],"domain_scores_gemma":[0.90819025,0.07401305,0.015154491,0.0019050194,0.00025989919,0.00047728515],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.39722213,0.00040889936,0.009459013,0.0012373502,0.000310001,0.00019650334,0.000672008,0.0002793996,0.0002192632],"category_scores_gemma":[0.22333781,0.00037568927,0.0004884309,0.000712977,0.00022444161,0.0008164747,0.00011873855,0.00030726127,0.00010734301],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50629383,0.003536593,0.031492185,0.019386306,0.005025738,0.00003237828,0.048590466,0.02263111,0.00006165624,0.04932676,0.03485581,0.27876717],"study_design_scores_gemma":[0.15216942,0.0001475937,0.0010617444,0.00060584163,0.00004473881,0.0000049365194,0.0004361413,0.8088274,0.000018880228,0.032127064,0.004224283,0.0003319808],"about_ca_topic_score_codex":0.027846292,"about_ca_topic_score_gemma":0.0019800765,"teacher_disagreement_score":0.7861963,"about_ca_system_score_codex":0.0011084895,"about_ca_system_score_gemma":0.0017364024,"threshold_uncertainty_score":0.9998695},"labels":[],"label_agreement":null},{"id":"W2906359407","doi":"10.1016/j.jval.2018.09.2173","title":"PRM51 - A NEW CONCEPTUAL MODEL OF THE COST-EFFECTIVENESS THRESHOLD","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Economic surplus; Economics; Welfare; Microeconomics; Work (physics); Threshold model; Econometrics; Engineering","score_opus":0.6398081143046667,"score_gpt":0.46051423451423984,"score_spread":0.17929387979042682,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906359407","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93485487,0.0030776768,0.015352728,0.035706427,0.0016428501,0.0039198394,0.0003287045,0.000053537526,0.0050633666],"genre_scores_gemma":[0.98989743,0.000075468895,0.0015428152,0.0076829647,0.000326863,0.00008397214,0.0000044144335,0.000028996585,0.000357047],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99522495,0.0006425779,0.0030929695,0.00045767243,0.00011317042,0.0004686316],"domain_scores_gemma":[0.9965247,0.00082078064,0.0017436354,0.0006604844,0.000057440193,0.00019293977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016252704,0.00015745763,0.00087338366,0.00019271542,0.00015783284,0.00001933403,0.00041717401,0.00012713678,0.00011087314],"category_scores_gemma":[0.0017331161,0.00016206932,0.00010638314,0.0003421687,0.00025408092,0.00021599035,0.00008216486,0.00021792197,0.00029160437],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047457757,0.00014155572,0.1008484,0.00062036543,0.000028369515,1.4198264e-7,0.009355138,0.05917745,0.000008486531,0.8172875,0.012215035,0.0002700866],"study_design_scores_gemma":[0.0033780157,0.0004555744,0.07380573,0.0009964594,0.0000049101086,0.0000047947865,0.0011892858,0.69800544,0.00011988366,0.19931644,0.022179944,0.0005435158],"about_ca_topic_score_codex":0.012153461,"about_ca_topic_score_gemma":0.0003984419,"teacher_disagreement_score":0.638828,"about_ca_system_score_codex":0.00084123993,"about_ca_system_score_gemma":0.0012458531,"threshold_uncertainty_score":0.9944247},"labels":[],"label_agreement":null},{"id":"W2906360693","doi":"10.1016/j.jval.2018.09.2482","title":"PRS89 - MEASUREMENT OF MAINTENANCE AND RELIEVER USE IN ASTHMA: A SYSTEMATIC REVIEW OF THE LITERATURE","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Asthma; Medicine; Medical prescription; Systematic review; Inhaled corticosteroids; MEDLINE; Population; Intensive care medicine; Emergency medicine; Pediatrics; Internal medicine; Environmental health; Pharmacology","score_opus":0.07593275818547308,"score_gpt":0.33788342186508674,"score_spread":0.26195066367961367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906360693","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047018926,0.9947385,9.497044e-7,0.00012503257,0.000102149475,0.004915869,0.000047392496,0.0000046595196,0.00001839559],"genre_scores_gemma":[0.000087107226,0.99905217,0.000059257392,0.00053658977,0.000040677158,0.00011966436,0.0000060605985,0.000025455978,0.00007300596],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99568325,0.0014019732,0.0018323397,0.00029211753,0.0005651117,0.00022518252],"domain_scores_gemma":[0.99758875,0.00014648854,0.0012161043,0.0007051561,0.00023410699,0.00010938384],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026677104,0.00025708938,0.003021247,0.0001731825,0.00001868897,0.000005604556,0.00015358524,0.00015170767,0.000003980508],"category_scores_gemma":[0.0021039085,0.00012687003,0.00030531257,0.0006805212,0.00009717597,0.00003616447,0.000059649745,0.0003595505,0.0000018551251],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008154274,0.00009491915,0.00008420943,0.99594754,0.000026370994,0.000011452509,0.00009604751,1.8623601e-7,4.7601365e-8,0.000040146766,0.00057110965,0.0031197942],"study_design_scores_gemma":[0.00021701155,0.0001467815,0.00021236746,0.909372,0.0002138165,0.00005564786,0.000010225264,0.0000025791157,1.2389846e-7,0.00000504239,0.08968621,0.00007824274],"about_ca_topic_score_codex":0.00012863384,"about_ca_topic_score_gemma":0.000016775619,"teacher_disagreement_score":0.0891151,"about_ca_system_score_codex":0.0002997202,"about_ca_system_score_gemma":0.0015341745,"threshold_uncertainty_score":0.5173609},"labels":[],"label_agreement":null},{"id":"W2906366100","doi":"10.1016/j.jval.2018.09.2149","title":"PRM25 - INCORPORATING EXPERT OPINION TO IMPROVE ESTIMATES OF LONG-TERM SURVIVAL WHEN FOLLOW-UP OF EMPIRICAL STUDIES IS SHORT","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Clinical trial; Survival analysis; Medicine; Bayesian probability; Term (time); Statistics; Expert opinion; Econometrics; Actuarial science; Intensive care medicine; Internal medicine; Mathematics","score_opus":0.31266622312522485,"score_gpt":0.5190184818313346,"score_spread":0.20635225870610974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906366100","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97246814,0.008667877,0.00026556192,0.016106417,0.001257332,0.0008041015,0.000017659768,0.000026070837,0.00038681735],"genre_scores_gemma":[0.9904646,0.001966774,0.0052010654,0.001891288,0.00040266302,0.000027023678,0.000004484365,0.000017633223,0.000024463356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817467,0.00014493751,0.0007247455,0.00028950395,0.00035227844,0.00031384703],"domain_scores_gemma":[0.99844974,0.00069584796,0.00021769071,0.0002200634,0.00023098661,0.00018568175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011462818,0.00015298808,0.000684833,0.000087777196,0.00008790663,0.0000055352334,0.00009866862,0.000058959948,0.00003111734],"category_scores_gemma":[0.0010625424,0.0001182734,0.00006408594,0.00023902033,0.00016910805,0.000087348504,0.0001828848,0.00016897696,0.0000057608513],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012805763,0.0004405823,0.91527337,0.0022063341,0.00030428253,0.000010495033,0.019074123,0.000007615568,0.00266188,0.00011444605,0.0033773633,0.05524896],"study_design_scores_gemma":[0.01259986,0.028883146,0.79127294,0.011601762,0.00029443405,0.000064766886,0.012473091,0.01198332,0.10753172,0.0038781138,0.017973745,0.0014430757],"about_ca_topic_score_codex":0.0016858641,"about_ca_topic_score_gemma":0.00009478875,"teacher_disagreement_score":0.12400038,"about_ca_system_score_codex":0.00012814954,"about_ca_system_score_gemma":0.00018401006,"threshold_uncertainty_score":0.4823049},"labels":[],"label_agreement":null},{"id":"W2906374771","doi":"10.1016/j.jval.2018.09.2617","title":"PSY40 - ALL-CAUSE MORTALITY INCREASED WITH NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE IN US MEDICARE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Internal medicine; Cohort; Comorbidity; Proportional hazards model; Lung cancer; Charlson comorbidity index; Nontuberculous mycobacteria; Hazard ratio; Mortality rate; Confidence interval; Tuberculosis; Pathology","score_opus":0.04982570034092148,"score_gpt":0.3604555803989629,"score_spread":0.31062988005804143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906374771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945042,0.00042047197,0.000010943773,0.0029074056,0.00027285793,0.0013015157,0.00012601214,0.000068429545,0.00038816172],"genre_scores_gemma":[0.9957889,0.00067199714,0.00021682835,0.0021071392,0.00079098856,0.00014979356,0.00021664584,0.000039905477,0.000017854369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966834,0.00042315878,0.000612197,0.00055984384,0.0007941199,0.00092727516],"domain_scores_gemma":[0.9972853,0.00023369445,0.00011984083,0.00068167516,0.00012656311,0.0015529317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012529368,0.00024803204,0.0005473661,0.00030161758,0.000074468764,0.00003141273,0.000172217,0.00011497558,0.0005593079],"category_scores_gemma":[0.00089504704,0.00019787,0.00006181722,0.0005348355,0.00020504305,0.00013578273,0.00007506842,0.0004069394,0.000053779233],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024875582,0.0005659942,0.9926346,0.00079041184,0.00009512545,0.0008775836,0.00046704282,0.000012431664,0.00012843955,0.00009494356,0.0015108362,0.00033503585],"study_design_scores_gemma":[0.0043912088,0.00092409336,0.9888981,0.0010897667,0.00007224612,0.000023248796,0.00004818288,0.0031028888,0.00006730711,0.000069995476,0.00111633,0.00019666112],"about_ca_topic_score_codex":0.08162563,"about_ca_topic_score_gemma":0.0055444064,"teacher_disagreement_score":0.076081224,"about_ca_system_score_codex":0.0006098072,"about_ca_system_score_gemma":0.002031773,"threshold_uncertainty_score":0.9244899},"labels":[],"label_agreement":null},{"id":"W2906374798","doi":"10.1016/j.jval.2018.09.675","title":"PCV130 - VALUE OF IMPLEMENTATION OF PHARMACEUTICAL CARE FOR CARDIOVASCULAR DISEASES IN LMICS: A HYPOTHETICAL SIMULATION FOR DECISION MAKING","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Eicosanoids and Hypertension Pharmacology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Net present value; Health care; Return on investment; Epidemiology; Cash flow; Equity (law); Public health; Investment (military); Actuarial science; Emergency medicine; Medical emergency; Business; Finance; Internal medicine; Nursing; Economics","score_opus":0.05476266835415367,"score_gpt":0.4272374999583958,"score_spread":0.37247483160424216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906374798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9590031,0.005064855,0.034285493,0.000081458515,0.00016009404,0.001225624,0.00017060862,0.0000033085505,0.000005479277],"genre_scores_gemma":[0.9906725,0.00021537652,0.008587225,0.00024957446,0.00013809942,0.00006718541,0.000053258293,0.00001619149,5.4032756e-7],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987858,0.00013333277,0.00048052362,0.00026208797,0.000115879404,0.00022235588],"domain_scores_gemma":[0.9993058,0.00020682823,0.00010696442,0.00016066144,0.00016930554,0.000050475726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044642383,0.00008964588,0.0002901938,0.00009675884,0.000039527484,0.0000028480817,0.00007993343,0.00008588638,0.0000072728512],"category_scores_gemma":[0.0001877358,0.00008802174,0.00019142352,0.00008386179,0.0000650775,0.0000038970225,0.000038926155,0.000038556413,1.9870572e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009339317,0.0010344859,0.05875916,0.0043305466,0.0005598858,0.0000048364104,0.0023910678,0.29861104,0.16747622,0.006565427,0.0006136155,0.4503144],"study_design_scores_gemma":[0.037404183,0.011213337,0.047269206,0.0013355064,0.0006877798,0.0000169314,0.0030173655,0.59842753,0.2540077,0.0115991,0.033990428,0.0010309148],"about_ca_topic_score_codex":0.000106465974,"about_ca_topic_score_gemma":0.00003591358,"teacher_disagreement_score":0.44928348,"about_ca_system_score_codex":0.000041367482,"about_ca_system_score_gemma":0.0001866741,"threshold_uncertainty_score":0.35894224},"labels":[],"label_agreement":null},{"id":"W2906378256","doi":"10.1016/j.jval.2018.09.2225","title":"PRM104 - EVALUATION OF DATA COLLECTION DURATION IN RETROSPECTIVE NONINTERVENTIONAL MEDICAL RECORD REVIEW ONCOLOGY STUDIES CONDUCTED IN THE UNITED STATES (US), CANADA, UNITED KINGDOM (UK), GERMANY, FRANCE AND SPAIN","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Medical record; Demography; Retrospective cohort study; Data collection; Family medicine; Emergency medicine; Pediatrics; Internal medicine; Statistics","score_opus":0.22762195149862566,"score_gpt":0.39984836686461217,"score_spread":0.1722264153659865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906378256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700809,0.013695769,0.00009956238,0.014511222,0.00039793365,0.00083845493,0.0001745687,0.000004200444,0.00019739052],"genre_scores_gemma":[0.9709767,0.02559557,0.00015979448,0.002828531,0.00008536598,0.00005776846,0.00026632482,0.000009193388,0.000020731504],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974473,0.00050768524,0.0013366094,0.00034784534,0.00013315187,0.00022738229],"domain_scores_gemma":[0.99835145,0.00032117026,0.00081940676,0.00026147263,0.00019943158,0.000047061138],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010481678,0.00011035987,0.0005328274,0.00044359145,0.00007428219,0.00001045999,0.00022329703,0.00008836369,0.00012768271],"category_scores_gemma":[0.0023475722,0.00010883734,0.000018059049,0.0010923436,0.00015378883,0.00021056835,0.000058207395,0.00026104046,0.000002257835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022562075,0.00039801575,0.9240641,0.0014818213,0.000118723,0.000010689658,0.005149428,0.0010564175,0.0000013115323,0.0370234,0.021489995,0.008980481],"study_design_scores_gemma":[0.0019838498,0.0004696062,0.7889867,0.0018667437,0.000009562793,0.000007295987,0.00030453195,0.15899216,0.0000012489261,0.010349361,0.036859296,0.00016965975],"about_ca_topic_score_codex":0.7806285,"about_ca_topic_score_gemma":0.7651371,"teacher_disagreement_score":0.15793574,"about_ca_system_score_codex":0.0016209658,"about_ca_system_score_gemma":0.0011132824,"threshold_uncertainty_score":0.44382578},"labels":[],"label_agreement":null},{"id":"W2906404816","doi":"10.1016/j.jval.2018.09.219","title":"PCN136 - A COST-EFFECTIVENESS ANALYSIS OF NIVOLUMAB IN COMBINATION WITH IPILIMUMAB FOR THE TREATMENT OF ADVANCED RENAL CELL CARCINOMA IN CANADA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Medicine; Sunitinib; Ipilimumab; Nivolumab; Cost-effectiveness analysis; Oncology; Internal medicine; Renal cell carcinoma; Population; Clinical trial; Discontinuation; Cancer; Cost effectiveness; Immunotherapy","score_opus":0.22874216180549872,"score_gpt":0.3873366656431198,"score_spread":0.15859450383762108,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906404816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927215,0.0015157141,0.0008608132,0.0017702231,0.000141916,0.0025917545,0.00032364271,0.0000026966006,0.00007174569],"genre_scores_gemma":[0.9986573,0.0001381829,0.00046198317,0.00021888237,0.000018101995,0.00044274592,0.000036408175,0.0000137407,0.000012664567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99618435,0.00053469534,0.002517692,0.00035452083,0.00008546564,0.00032324955],"domain_scores_gemma":[0.9954856,0.0024296937,0.0015805988,0.00036564554,0.00007600117,0.000062446576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0064853276,0.00012924876,0.0011302202,0.00069216476,0.00005740443,0.000005594879,0.00014111341,0.00004852093,0.00001797882],"category_scores_gemma":[0.0002659774,0.00012625105,0.000066825356,0.0009675562,0.000055771114,0.00010044515,0.000008629875,0.00006312843,0.0000018633621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003864073,0.00050592615,0.8343787,0.00066938123,0.00008129444,5.6495537e-7,0.004580478,0.15424132,0.000002519056,0.0036523412,0.000039966057,0.0014610911],"study_design_scores_gemma":[0.0046504494,0.0012072001,0.801442,0.00010504386,0.0000144451315,2.2556148e-7,0.0012901608,0.19003287,0.00005919478,0.0004764432,0.00061174575,0.000110183144],"about_ca_topic_score_codex":0.95198035,"about_ca_topic_score_gemma":0.9326144,"teacher_disagreement_score":0.035791554,"about_ca_system_score_codex":0.005530774,"about_ca_system_score_gemma":0.0017917692,"threshold_uncertainty_score":0.99828684},"labels":[],"label_agreement":null},{"id":"W2906421864","doi":"10.1016/j.jval.2018.09.2433","title":"PRS39 - COST-EFFECTIVENESS OF A NEW SINGLE INHALER TRIPLE THERAPY (SITT) VERSUS MULTIPLE INHALER TRIPLE THERAPIES (MITT) TO TREAT CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN CANADA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fluticasone propionate; Medicine; Inhaler; COPD; Exacerbation; Salmeterol; Dry-powder inhaler; Internal medicine; Asthma","score_opus":0.07153174223992449,"score_gpt":0.3123967742672741,"score_spread":0.2408650320273496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906421864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99010026,0.0044434476,0.000039501818,0.00062887446,0.00095971307,0.0033796164,0.000058699312,0.000033794295,0.0003561029],"genre_scores_gemma":[0.998207,0.00019142625,0.00011105504,0.0006265522,0.00033769282,0.000142657,0.0000373116,0.000051831943,0.00029450507],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970109,0.00070606126,0.00070527114,0.0005271694,0.00045828303,0.0005923474],"domain_scores_gemma":[0.9981486,0.0004652547,0.00021216598,0.0004645661,0.00017428858,0.0005351294],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005595885,0.00031220063,0.0007043923,0.0004272389,0.000104105995,0.00001130905,0.0001560289,0.00010959679,0.00014963858],"category_scores_gemma":[0.000255333,0.0002718123,0.00009987111,0.00090840965,0.00011661464,0.00013708518,0.000043038777,0.0002852081,0.000015381429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.12662403,0.0037826097,0.57183117,0.0037769196,0.0003229576,0.0008621651,0.01636202,0.011853035,0.018388832,0.00023711297,0.0032487623,0.24271041],"study_design_scores_gemma":[0.035209756,0.0049209194,0.910533,0.0020794992,0.000044375513,0.000021874153,0.0024082356,0.0076694977,0.01919334,0.000097461794,0.017012587,0.00080945104],"about_ca_topic_score_codex":0.59672016,"about_ca_topic_score_gemma":0.24250205,"teacher_disagreement_score":0.35421813,"about_ca_system_score_codex":0.0041451915,"about_ca_system_score_gemma":0.008248351,"threshold_uncertainty_score":0.9999734},"labels":[],"label_agreement":null},{"id":"W2906423725","doi":"10.1016/j.jval.2018.09.150","title":"PCN68 - BUDGET IMPACT ANALYSIS OF TISAGENLECLEUCEL FOR THE TREATMENT OF PAEDIATRIC AND YOUNG ADULT PATIENTS WITH RELAPSED OR REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKAEMIA IN ENGLAND","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Blinatumomab; Medicine; Fludarabine; Population; Leukapheresis; Pediatrics; Internal medicine; Chemotherapy; CD19; Cyclophosphamide; Stem cell","score_opus":0.022785619237043562,"score_gpt":0.32269402317777024,"score_spread":0.29990840394072665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906423725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973244,0.0008525275,0.000038155886,0.000075395204,0.000054743225,0.0014703096,0.00014037745,0.0000065358695,0.00003757256],"genre_scores_gemma":[0.9956931,0.003509902,0.00027662766,0.000038616286,0.0000637291,0.000055664917,0.000051734627,0.000026761543,0.00028384928],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827033,0.00018969688,0.0005337743,0.00027996002,0.00035995973,0.00036627718],"domain_scores_gemma":[0.9980555,0.00094899745,0.00025593655,0.00038781887,0.00020743976,0.00014429817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005146708,0.00016858571,0.00065395003,0.00064501545,0.00004755147,0.000006294968,0.00008238994,0.00008207571,0.00007725227],"category_scores_gemma":[0.000121560726,0.00009112968,0.000108163455,0.0013242809,0.00012353974,0.000038324266,0.000014695937,0.00009746036,7.747315e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012422695,0.0015101817,0.9593661,0.00031961093,0.0008284427,0.000009124947,0.007013498,0.00030203367,0.0008084503,0.0000024629344,0.000046440564,0.017370986],"study_design_scores_gemma":[0.025830962,0.027595129,0.92174214,0.00013122584,0.0008183977,0.000004177488,0.0001874954,0.022528855,0.00078404375,0.000010169364,0.00024180587,0.00012560008],"about_ca_topic_score_codex":0.013145008,"about_ca_topic_score_gemma":0.0029006153,"teacher_disagreement_score":0.037623934,"about_ca_system_score_codex":0.0007663934,"about_ca_system_score_gemma":0.0006826245,"threshold_uncertainty_score":0.99342656},"labels":[],"label_agreement":null},{"id":"W2906437870","doi":"10.1016/j.jval.2018.09.1691","title":"PMH56 - ACCESS TO DEMENTIA TREATMENTS IN ENGLAND; IS THIS REALLY A PRIORITY AREA FOR PRIMARY CARE?","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Activity-based costing; Dementia; Medicine; Quarter (Canadian coin); Emergency medicine; Family medicine; Pediatrics; Geography; Disease; Internal medicine; Business; Accounting","score_opus":0.40859598737393177,"score_gpt":0.45211445595484256,"score_spread":0.043518468580910796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906437870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9414667,0.005082275,0.0017926615,0.039965764,0.0012164362,0.0048850053,0.0010725114,0.00006323131,0.00445543],"genre_scores_gemma":[0.9307471,0.0007416481,0.013329277,0.052741654,0.0007536324,0.0010111119,0.00018127219,0.00008006142,0.00041427938],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941629,0.000387713,0.003730905,0.00083842437,0.000111821515,0.00076823466],"domain_scores_gemma":[0.9971111,0.00066261814,0.0012220246,0.0006086406,0.00009013719,0.0003055162],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011203863,0.00023584362,0.0010873164,0.0006925073,0.00020344164,0.000097743374,0.0004391344,0.00016332672,0.00018791926],"category_scores_gemma":[0.0010196669,0.00030219456,0.000095338095,0.00042363218,0.000038814596,0.00044289825,0.000103212486,0.0001551534,0.00046151708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015421152,0.0003404914,0.9306825,0.0018970685,0.00008253603,0.0000016787968,0.03690615,0.00021336199,0.0000011754984,0.008335018,0.017241776,0.004144036],"study_design_scores_gemma":[0.0059573804,0.0010909503,0.6912137,0.000731581,0.000011307766,0.0000030575109,0.00058746384,0.0052502337,0.0000136516355,0.012844585,0.28161147,0.00068459415],"about_ca_topic_score_codex":0.041737944,"about_ca_topic_score_gemma":0.0075673866,"teacher_disagreement_score":0.2643697,"about_ca_system_score_codex":0.003132874,"about_ca_system_score_gemma":0.00084232487,"threshold_uncertainty_score":0.999943},"labels":[],"label_agreement":null},{"id":"W2906439904","doi":"10.1016/j.jval.2018.09.330","title":"PCN248 - USE OF CANCER DRUGS IN THE END-OF-LIFE IN MEN DYING OF CASTRATION-RESISTANT PROSTATE CANCER: POPULATION-BASED STUDY","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Prostate cancer; Abiraterone acetate; Internal medicine; Cancer; Oncology; Abiraterone; Cohort; Odds ratio; Confidence interval; Population; Drug; Enzalutamide; Androgen deprivation therapy; Pharmacology; Androgen receptor","score_opus":0.12536312144343623,"score_gpt":0.421221625974369,"score_spread":0.29585850453093276,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906439904","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939376,0.0014776734,7.381849e-7,0.0022703372,0.000055251978,0.0021518304,0.00007250576,0.000004270179,0.000029808984],"genre_scores_gemma":[0.9991156,0.0003945101,0.000108153814,0.000086895154,0.000033826273,0.00019487084,0.000021969196,0.000012173048,0.00003198899],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979089,0.0003743782,0.00077555224,0.00019755424,0.00047079142,0.0002728269],"domain_scores_gemma":[0.99902,0.00027476784,0.00027718203,0.00024064207,0.00012512442,0.0000623086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011039122,0.00010340207,0.00040206502,0.0003093276,0.000038083148,0.0000057370685,0.00008548923,0.00003572495,0.00003403115],"category_scores_gemma":[0.00009135108,0.00007104844,0.000027879298,0.000723172,0.000084037085,0.000066400156,0.000014477504,0.00015722371,2.7088154e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012519559,0.00054268114,0.97475857,0.0006414424,0.00002203706,0.0000053193944,0.017045777,0.003385542,0.00046033473,0.000035654622,0.00002218258,0.0018285356],"study_design_scores_gemma":[0.0043111197,0.00093119737,0.98548913,0.0010692776,0.000012786944,1.3109661e-7,0.0031830505,0.0040282602,0.00086025865,0.000033464556,0.000024549392,0.00005674509],"about_ca_topic_score_codex":0.5436225,"about_ca_topic_score_gemma":0.054418184,"teacher_disagreement_score":0.48920432,"about_ca_system_score_codex":0.0005482729,"about_ca_system_score_gemma":0.0023124153,"threshold_uncertainty_score":0.9628362},"labels":[],"label_agreement":null},{"id":"W2906444991","doi":"10.1016/j.jval.2018.09.2438","title":"PRS44 - INFORMING THE PATHWAY OF COPD TREATMENT (IMPACT STUDY) - SINGLE INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS UMEC/VI IN PATIENTS WITH COPD: COST-EFFECTIVENESS ANALYSIS FROM A SOCIETAL PERSPECTIVE IN QUEBEC","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Fluticasone propionate; COPD; Cost effectiveness; Quality-adjusted life year; Inhaler; Exacerbation; Internal medicine; Asthma","score_opus":0.30460778890449236,"score_gpt":0.4269383488251285,"score_spread":0.12233055992063613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906444991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99179196,0.0010194993,0.000113013826,0.0009253155,0.000307738,0.0050553903,0.0004801221,0.000018575298,0.00028835348],"genre_scores_gemma":[0.99871266,0.0000752499,0.00016730906,0.0003771991,0.000091819,0.00042705814,0.00007343691,0.000035762198,0.000039512408],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935106,0.0017603076,0.0031371699,0.000734882,0.00022286864,0.0006341736],"domain_scores_gemma":[0.99469906,0.0021743795,0.0021519666,0.000669419,0.00015148622,0.00015370439],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0098485835,0.00034997019,0.0017873289,0.0009237739,0.00018000235,0.000068968184,0.00028673332,0.00015207195,0.000116356096],"category_scores_gemma":[0.0007990167,0.00029969303,0.0002085295,0.0015831414,0.00015630662,0.0005118494,0.000045432316,0.00025745374,0.000045332505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011450995,0.0020855272,0.93254083,0.000054076667,0.0005585989,0.0000012291844,0.055914927,0.00541744,4.5494642e-7,0.000820465,0.000036574525,0.0014247558],"study_design_scores_gemma":[0.014401025,0.0037989838,0.9588034,0.00014481589,0.000020618652,1.5448208e-7,0.0149628725,0.006735009,0.000008725338,0.0004169201,0.00040487462,0.00030260254],"about_ca_topic_score_codex":0.653788,"about_ca_topic_score_gemma":0.17772938,"teacher_disagreement_score":0.47605857,"about_ca_system_score_codex":0.009998371,"about_ca_system_score_gemma":0.0011589755,"threshold_uncertainty_score":0.9999455},"labels":[],"label_agreement":null},{"id":"W2906465468","doi":"10.1016/j.jval.2018.09.011","title":"AD4 - ARE PATIENT-REPORTED PERSISTENCE AND ADHERENCE TO TREATMENT FOR A CHRONIC DISEASE VALID OUTCOMES? AN EXAMPLE WITH OSTEOPOROSIS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Persistence (discontinuity); Osteoporosis; Medical prescription; Pharmacy; Internal medicine; Cohort; Predictive value; Disease; Bisphosphonate; Physical therapy; Pediatrics; Family medicine","score_opus":0.24395644706288575,"score_gpt":0.3833767179431372,"score_spread":0.13942027088025147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906465468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99429137,0.00042019552,0.00033680614,0.0027457408,0.00008176243,0.0020126556,0.000022270688,0.000041730185,0.000047445083],"genre_scores_gemma":[0.9931823,0.000073904564,0.0035114917,0.0020892618,0.00007190717,0.00058136886,0.000030341329,0.00001668346,0.0004427471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985349,0.00006100768,0.00035620373,0.00048135346,0.0002345585,0.00033195468],"domain_scores_gemma":[0.99839526,0.00006569873,0.00021144455,0.00049574,0.00012551832,0.0007063395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016178732,0.0001560159,0.00032820745,0.000080275786,0.00011697474,0.000014241469,0.000068020105,0.000030413788,0.00010665884],"category_scores_gemma":[0.00009572095,0.00011378392,0.00003372467,0.00021323648,0.0000831615,0.0000692603,0.000015023509,0.000052958105,0.000031986685],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012862145,0.0010015897,0.9187924,0.000887479,0.000065169574,0.000043844982,0.009704019,0.00007144638,0.00014209333,0.00012107236,0.0006867125,0.067197956],"study_design_scores_gemma":[0.008324566,0.048065703,0.91168135,0.0030357013,0.00013656433,0.000057303427,0.008153909,0.0061622304,0.0004097885,0.00020413511,0.013273418,0.00049532554],"about_ca_topic_score_codex":0.004598541,"about_ca_topic_score_gemma":0.0004996184,"teacher_disagreement_score":0.06670263,"about_ca_system_score_codex":0.00034563956,"about_ca_system_score_gemma":0.0008919511,"threshold_uncertainty_score":0.6951649},"labels":[],"label_agreement":null},{"id":"W2906504932","doi":"10.1016/j.jval.2018.09.857","title":"PGI15 - HEALTHCARE RESOURCE UTILIZATION (HCRU) IN METASTATIC OR UNRESECTABLE GASTRIC OR GASTROESOPHAGEAL JUNCTION CANCER PATIENTS RECEIVING SECOND-LINE TREATMENT","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Concomitant; Cancer; Cohort; Retrospective cohort study; Internal medicine; Emergency department; Medical prescription; Intensive care unit; Emergency medicine; Pediatrics","score_opus":0.12950185169841275,"score_gpt":0.37501043576867993,"score_spread":0.24550858407026718,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906504932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914408,0.0012324002,0.00038652166,0.003196384,0.0007513783,0.0025463079,0.00004471073,0.000094014256,0.00030751782],"genre_scores_gemma":[0.99075705,0.0010708178,0.0012029709,0.0015706167,0.00036839498,0.00018701352,0.00015357694,0.000048341124,0.004641213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99711126,0.00034957635,0.00085672457,0.00051688164,0.0004114066,0.0007541493],"domain_scores_gemma":[0.99889785,0.00014358955,0.00030400808,0.00030257882,0.00011034701,0.00024160589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062520744,0.00027185,0.00061740313,0.0007168268,0.0001405913,0.000025391722,0.000091388814,0.00006116931,0.00078451773],"category_scores_gemma":[0.00016736124,0.00019971997,0.00005899134,0.001675255,0.00004412696,0.00015317762,0.000044393037,0.00021134717,0.000016374768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045723943,0.0011864869,0.8461221,0.0015147505,0.00007602214,0.00008776703,0.0026630324,0.0015722094,0.0000072105386,0.000031602685,0.0034965412,0.13866991],"study_design_scores_gemma":[0.019847848,0.021116875,0.9105191,0.0018895196,0.00011406435,0.000037145877,0.0014789079,0.022893934,0.000090558715,0.000053368934,0.021619745,0.00033891932],"about_ca_topic_score_codex":0.019636152,"about_ca_topic_score_gemma":0.025739603,"teacher_disagreement_score":0.13833098,"about_ca_system_score_codex":0.0029508905,"about_ca_system_score_gemma":0.0009562675,"threshold_uncertainty_score":0.99203813},"labels":[],"label_agreement":null},{"id":"W2906508065","doi":"10.1016/j.jval.2018.09.2728","title":"PSY154 - ECONOMIC BURDEN OF BETA-THALASSEMIA: LITERATURE REVIEW","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Medicine; Observational study; Thalassemia; Beta thalassemia; Intensive care medicine; Pediatrics; Internal medicine","score_opus":0.022354379021380447,"score_gpt":0.3077341515956701,"score_spread":0.28537977257428965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906508065","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36221325,0.56422126,0.000011259707,0.057674494,0.0008413823,0.0014942657,0.000036696358,0.000064293,0.013443103],"genre_scores_gemma":[0.53967386,0.4527006,0.0009876436,0.0051962864,0.00056171376,0.000015951897,0.000048966784,0.000038612998,0.0007763859],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99873435,0.00010437321,0.00056885666,0.00021411336,0.000110570116,0.0002677024],"domain_scores_gemma":[0.9992811,0.000040130843,0.00016418168,0.0003205701,0.00005102344,0.00014301516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005982425,0.000114950686,0.00049004745,0.00011073584,0.000034733283,0.0000044183253,0.00008035885,0.00014874256,0.00015144625],"category_scores_gemma":[0.000060050992,0.00009043161,0.000087199995,0.00025745272,0.00007545125,0.00003993737,0.00002289349,0.0003127709,0.00010145601],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007670599,0.0012867491,0.057093978,0.17393382,0.0005863631,0.00042733276,0.022262232,0.001417272,0.0009560688,0.021504875,0.51920706,0.2005572],"study_design_scores_gemma":[0.007430874,0.005185177,0.01284609,0.21816769,0.00026030102,0.0009531501,0.0008310161,0.007923843,0.0008019425,0.0015678972,0.743197,0.0008350028],"about_ca_topic_score_codex":0.0011216245,"about_ca_topic_score_gemma":0.000010593349,"teacher_disagreement_score":0.22398998,"about_ca_system_score_codex":0.0001372524,"about_ca_system_score_gemma":0.00039180872,"threshold_uncertainty_score":0.36876944},"labels":[],"label_agreement":null},{"id":"W2906536618","doi":"10.1016/j.jval.2018.09.1679","title":"PMH44 - CANADIAN ECONOMIC IMPACT OF IMPROVED WORKPLACE PRODUCTIVITY IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER TREATED WITH VORTIOXETINE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Perfectionism, Procrastination, Anxiety Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Grey Nuns Community Hospital; Université de Montréal","funders":"","keywords":"Presenteeism; Vortioxetine; Absenteeism; Productivity; Major depressive disorder; Medicine; Mental health; Psychiatry; Psychology; Cognition; Physical therapy; Economics","score_opus":0.010973306690792654,"score_gpt":0.2818942331976553,"score_spread":0.2709209265068626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906536618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976972,0.00014095113,0.00002498278,0.0003746608,0.00012730973,0.001134031,0.00006739546,0.000024709156,0.0004088106],"genre_scores_gemma":[0.9993929,0.000008507917,0.0001394923,0.00003113006,0.00006888745,0.00011162454,0.00002287343,0.00003098726,0.00019355795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983001,0.00024088772,0.00037026283,0.00047754418,0.00008917779,0.0005220383],"domain_scores_gemma":[0.9990361,0.0000636095,0.0003022641,0.00031705145,0.00014145613,0.00013954776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035193123,0.00019845332,0.00034335442,0.00031494352,0.00015062519,0.0000102834,0.00009940401,0.00007146068,0.00008439309],"category_scores_gemma":[0.000066993,0.00015753717,0.00002692507,0.0004303367,0.00017140097,0.00012612675,0.000015789334,0.00017702742,0.000013352746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007683119,0.00023190414,0.9935615,0.000036271584,0.00007402405,9.750112e-7,0.0021072864,0.0015432602,0.000002282943,0.00001861121,0.00015632709,0.0014992369],"study_design_scores_gemma":[0.003202171,0.0018831377,0.99392205,0.00007913868,0.000009303771,0.0000030467857,0.00013046451,0.00050507276,0.000016421109,0.000023606819,0.00006992018,0.00015568065],"about_ca_topic_score_codex":0.8401716,"about_ca_topic_score_gemma":0.75080717,"teacher_disagreement_score":0.08936439,"about_ca_system_score_codex":0.0014673071,"about_ca_system_score_gemma":0.0009342491,"threshold_uncertainty_score":0.6424179},"labels":[],"label_agreement":null},{"id":"W2906546777","doi":"10.1016/j.jval.2018.09.718","title":"PDB12 - CARDIOVASCULAR SAFETY OF EMPAGLIFLOZIN VERSUS GLUCAGON-LIKE PEPTIDE-1 (GLP-1) RECEPTOR AGONISTS: SYSTEMATIC LITERATURE REVIEW AND INDIRECT COMPARISONS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Empagliflozin; Semaglutide; Lixisenatide; Liraglutide; Medicine; Dulaglutide; Exenatide; Internal medicine; Glucagon-like peptide 1 receptor; Type 2 diabetes; Hazard ratio; Myocardial infarction; Diabetes mellitus; Cardiology; Pharmacology; Endocrinology; Confidence interval; Agonist; Receptor","score_opus":0.03565310845774038,"score_gpt":0.2958013506025581,"score_spread":0.2601482421448177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906546777","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04239016,0.9441875,0.000052471012,0.0026140327,0.0011378708,0.0061611603,0.00006650629,0.00010906714,0.003281228],"genre_scores_gemma":[0.34847638,0.63546664,0.009245972,0.0032201104,0.0005288245,0.00045427162,0.0004259913,0.00012813554,0.002053688],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975117,0.00048131778,0.00085217314,0.00038571577,0.000384326,0.00038477834],"domain_scores_gemma":[0.99855417,0.00015647462,0.00026832527,0.00070207345,0.000113427195,0.00020555595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014655422,0.00024782334,0.0016591548,0.00020768854,0.00008892044,0.0000209033,0.00011069254,0.000084022126,0.000033676974],"category_scores_gemma":[0.00019748269,0.00019637668,0.00023105677,0.0006211911,0.000103671555,0.000077240955,0.0000719425,0.0001860914,0.00004083206],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069163763,0.0008267109,0.007490894,0.91746825,0.0048615644,0.00006053798,0.003824444,0.000036450565,0.000018574923,0.0013630365,0.058079608,0.005278306],"study_design_scores_gemma":[0.016651632,0.006551019,0.015711552,0.67319715,0.0068252957,0.00006053112,0.0011360412,0.0007319847,0.00020320856,0.000044585777,0.27793792,0.0009490771],"about_ca_topic_score_codex":0.0002820442,"about_ca_topic_score_gemma":0.000027526583,"teacher_disagreement_score":0.3087209,"about_ca_system_score_codex":0.00031825632,"about_ca_system_score_gemma":0.0001476391,"threshold_uncertainty_score":0.80080086},"labels":[],"label_agreement":null},{"id":"W2906550505","doi":"10.1016/j.jval.2018.09.015","title":"CE3 - COST-EFFECTIVENESS OF DEMENTIA CARE MANAGEMENT ALONGSIDE A CLUSTER-RANDOMIZED CONTROLLED INTERVENTIONAL DELPHI TRIAL","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Dementia; Randomized controlled trial; Health care; Cost–utility analysis; Cost effectiveness; Quality-adjusted life year; Cluster randomised controlled trial; Willingness to pay; Delphi; Cost–benefit analysis; Emergency medicine; Surgery; Disease; Internal medicine","score_opus":0.28504094599139745,"score_gpt":0.4460323135968182,"score_spread":0.16099136760542077,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906550505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8898331,0.012411786,0.0424753,0.008442304,0.005055694,0.036092676,0.00046799364,0.000077577475,0.005143592],"genre_scores_gemma":[0.9921936,0.00011819423,0.0034437834,0.0014813686,0.00034341268,0.002230462,0.00008232324,0.000033959812,0.00007291206],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9857662,0.0050191577,0.007871263,0.0006294616,0.00018539763,0.0005285723],"domain_scores_gemma":[0.99053776,0.004788926,0.0038693256,0.00048250228,0.00014792063,0.00017358638],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.06541836,0.00024518216,0.003281331,0.0007292868,0.0001548857,0.000051383362,0.0003118925,0.00013015201,0.00029516814],"category_scores_gemma":[0.0038665757,0.0002766411,0.0005300456,0.00026879626,0.0001829094,0.00022015884,0.000097455886,0.00016257295,0.0002628429],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4533933,0.0010302356,0.005559763,0.0093591735,0.0014760261,0.0000052013047,0.005271896,0.0043805083,4.8692783e-7,0.5167585,0.0022418315,0.00052305177],"study_design_scores_gemma":[0.94607055,0.000805116,0.0030405882,0.0013158047,0.000048782094,0.0000033193087,0.001265091,0.020028697,0.0000038226176,0.024054337,0.0030275497,0.0003363276],"about_ca_topic_score_codex":0.0077517456,"about_ca_topic_score_gemma":0.00032381428,"teacher_disagreement_score":0.49270418,"about_ca_system_score_codex":0.0010634656,"about_ca_system_score_gemma":0.0002785806,"threshold_uncertainty_score":0.9999686},"labels":[],"label_agreement":null},{"id":"W2906554289","doi":"10.1016/j.jval.2018.09.1959","title":"PMU123 - THE RELATIONSHIP BETWEEN INDIVIDUAL-LEVEL DEPRIVATION WITH HEALTH-RELATED QUALITY OF LIFE IN THE GENERAL POPULATION","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; EQ-5D; Logistic regression; Quality of life (healthcare); Visual analogue scale; Population; Demography; Anxiety; Depression (economics); Social deprivation; Multivariate statistics; Index (typography); Gerontology; Health related quality of life; Physical therapy; Statistics; Environmental health; Psychiatry; Internal medicine","score_opus":0.7260924564620357,"score_gpt":0.4691966552861604,"score_spread":0.2568958011758753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906554289","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90971833,0.0009887065,0.001613729,0.08563347,0.0001907426,0.0014433541,0.00021416221,0.000022150014,0.00017536302],"genre_scores_gemma":[0.9883709,0.000026446589,0.0025750652,0.008421831,0.0002800948,0.00007951749,0.00018837166,0.00002486501,0.0000328945],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9873607,0.004145026,0.007258718,0.0004724925,0.00026812922,0.00049492123],"domain_scores_gemma":[0.98918587,0.004909696,0.0049849837,0.00072607014,0.00006080948,0.00013257233],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06930581,0.00017830274,0.0009804058,0.0004752407,0.0003833261,0.00004656452,0.0004325994,0.00016199864,0.00003152807],"category_scores_gemma":[0.0073386477,0.00015021149,0.00006346073,0.0010148988,0.00013670321,0.00034236463,0.00003851128,0.00043286904,0.00010062789],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001499855,0.00004608109,0.8355169,0.00021930003,0.0000123199625,4.2482604e-8,0.008741726,0.0013256887,3.3526856e-8,0.1533987,0.0006102225,0.000113966744],"study_design_scores_gemma":[0.00083568203,0.00015881573,0.95922244,0.00015223701,0.0000016516917,0.0000011100162,0.0010059436,0.0020143448,1.445088e-7,0.0362251,0.00024352905,0.00013898152],"about_ca_topic_score_codex":0.14476955,"about_ca_topic_score_gemma":0.006891877,"teacher_disagreement_score":0.13787767,"about_ca_system_score_codex":0.0007559633,"about_ca_system_score_gemma":0.00062580255,"threshold_uncertainty_score":0.95834553},"labels":[],"label_agreement":null},{"id":"W2906554411","doi":"10.1016/j.jval.2018.09.304","title":"PCN222 - TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILISATION (HCRU) IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC) IN CANADA AND EUROPE","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Cirrhosis; Sorafenib; Internal medicine; Hepatitis C; Cancer; Liver disease; Liver cancer; Adverse effect; Medical record; Hepatitis; Pediatrics","score_opus":0.0511909730936406,"score_gpt":0.23822773814185386,"score_spread":0.18703676504821326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906554411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999476,0.006140399,0.000017157467,0.0025251906,0.00016622174,0.00045016094,0.0001393944,0.0000062242793,0.00056050875],"genre_scores_gemma":[0.99589896,0.0028910462,0.00007434079,0.0009244974,0.000071997274,0.000027238493,0.000013668271,0.00002252618,0.00007569581],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982047,0.00006465679,0.00077850884,0.000466156,0.000028548335,0.0004574356],"domain_scores_gemma":[0.99929297,0.000057743087,0.00025657608,0.00021703364,0.00001395721,0.00016169161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004662293,0.0001648101,0.00050236663,0.00025175934,0.00006206224,0.000021186883,0.000077654804,0.00006111918,0.000022443754],"category_scores_gemma":[0.000054512442,0.00019779881,0.000015349515,0.00021277108,0.000041620977,0.0001539314,0.000034099485,0.00013967913,0.000007729478],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004133532,0.00002865916,0.9870369,0.00008619933,0.0000019167705,0.000015990287,0.0014638078,0.00011344278,4.5830055e-7,0.0030536617,0.000023218734,0.008134403],"study_design_scores_gemma":[0.0012052701,0.00035348826,0.970406,0.000101349186,5.028628e-7,0.0000050001686,0.00027562596,0.011361503,0.000010845303,0.0011251876,0.014977565,0.00017764836],"about_ca_topic_score_codex":0.9820972,"about_ca_topic_score_gemma":0.93771094,"teacher_disagreement_score":0.044386256,"about_ca_system_score_codex":0.0019800044,"about_ca_system_score_gemma":0.0005736559,"threshold_uncertainty_score":0.80660015},"labels":[],"label_agreement":null},{"id":"W2906558033","doi":"10.1016/j.jval.2018.09.2236","title":"PRM116 - GENERAL PERCEPTIONS OF INNOVATIVE METHODS FOR SURVIVAL EXTRAPOLATION IN ONCOLOGY AMONG HTA IN EUROPE, CANADA AND AUSTRALIA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Context (archaeology); Extrapolation; Medicine; Telephone survey; Perception; Psychology; Geography; Marketing; Business; Statistics; Mathematics","score_opus":0.5452247698468845,"score_gpt":0.5335008043305957,"score_spread":0.011723965516288848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906558033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98680645,0.00022895953,0.00494257,0.0058705374,0.0005832764,0.0010368989,0.00017865164,0.0000056352633,0.00034703148],"genre_scores_gemma":[0.95608085,0.00010075932,0.041986424,0.0012958382,0.00018631929,0.00010452392,0.000038234833,0.000020661597,0.00018638182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941179,0.0014129916,0.0036137928,0.00040764647,0.000047312133,0.00040031836],"domain_scores_gemma":[0.9971142,0.0011045688,0.0013334966,0.00020626654,0.00013954069,0.000101950216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02241249,0.00012382238,0.00084037863,0.0005978701,0.000065211745,0.000011020268,0.00012238287,0.00012224627,0.000061376806],"category_scores_gemma":[0.0030851283,0.00016621617,0.000018057553,0.00089804275,0.00011582291,0.00020313957,0.000028438186,0.00019194992,0.0000061948726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020976151,0.00007147006,0.9418223,0.0003120452,0.000008111033,3.568957e-7,0.0039518047,0.001041222,0.000012372856,0.050704464,0.0011092058,0.0009457048],"study_design_scores_gemma":[0.0008833743,0.00020700053,0.9583459,0.0000854751,5.806446e-7,9.370802e-7,0.000694218,0.031246005,0.000003374966,0.0033675916,0.0050264085,0.00013915068],"about_ca_topic_score_codex":0.9038248,"about_ca_topic_score_gemma":0.84756124,"teacher_disagreement_score":0.056263577,"about_ca_system_score_codex":0.0015647716,"about_ca_system_score_gemma":0.0014707085,"threshold_uncertainty_score":0.7767767},"labels":[],"label_agreement":null},{"id":"W2906577617","doi":"10.1016/j.jval.2018.09.094","title":"PCN11 - GLOBAL LONGITUDINAL ASSESSMENT OF TREATMENT OUTCOMES IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (GLANCE-H&N) STUDY","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Cetuximab; Head and neck squamous-cell carcinoma; Interquartile range; Head and neck cancer; Taxane; Internal medicine; Regimen; Oncology; Cancer; Retrospective cohort study; Confidence interval; Colorectal cancer; Breast cancer","score_opus":0.09713192143538302,"score_gpt":0.40555071226183603,"score_spread":0.308418790826453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906577617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556726,0.0011079614,0.0000025982451,0.0011920037,0.00019674188,0.0010488493,0.000026233532,0.0000062824024,0.0008520953],"genre_scores_gemma":[0.9993094,0.000100535864,0.00032773768,0.00011198872,0.00004705663,0.00003054187,0.0000010292487,0.000007530018,0.00006418678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850804,0.00017716148,0.0005435615,0.0002507789,0.00023918517,0.00028127484],"domain_scores_gemma":[0.9992885,0.00009572822,0.00015825138,0.0003272513,0.00005038708,0.00007986215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035542177,0.00014895348,0.0007303115,0.00006308586,0.00005496242,0.0000025840761,0.00006883685,0.000035599114,0.000008099153],"category_scores_gemma":[0.000034590266,0.00009248953,0.000052451145,0.00028087533,0.00011467565,0.000020842557,0.00006179707,0.00009233945,8.196923e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009925665,0.001519756,0.9944413,0.00027332018,0.000015490523,0.0000057820225,0.0026926245,0.000022653265,0.000015337993,0.000055896246,0.000033089484,0.0008255064],"study_design_scores_gemma":[0.0050092167,0.0077676037,0.985936,0.00016567063,0.000021987442,0.000005126912,0.0007000106,0.00013935032,0.00004478173,0.000025408424,0.00012554627,0.000059322276],"about_ca_topic_score_codex":0.046119876,"about_ca_topic_score_gemma":0.01602912,"teacher_disagreement_score":0.030090757,"about_ca_system_score_codex":0.00078759744,"about_ca_system_score_gemma":0.0006460893,"threshold_uncertainty_score":0.9602321},"labels":[],"label_agreement":null},{"id":"W2906604963","doi":"10.1016/j.jval.2018.09.963","title":"PHP69 - A REVIEW OF FUNDING PATHS FOR E-HEALTH SOLUTIONS IN THE EU5, US AND CANADA","year":2018,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"eHealth; Business; Payment; Telemedicine; Health care; Sustainability; Economic growth; Finance; Economics","score_opus":0.29494746443194264,"score_gpt":0.46699937985137785,"score_spread":0.1720519154194352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906604963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018529941,0.95897,0.000026852565,0.030147363,0.0005882633,0.009550897,0.0004975406,0.000013207757,0.00018734107],"genre_scores_gemma":[0.000053748117,0.9841939,0.00033086352,0.0139722265,0.00054455345,0.00059003854,0.00020772523,0.000055460892,0.000051466035],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907197,0.003113776,0.0036082817,0.0006097955,0.0006034088,0.0013450602],"domain_scores_gemma":[0.9955675,0.0014606426,0.0014652172,0.00077909033,0.00016561513,0.0005619407],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.019341478,0.00039572324,0.0038677035,0.00039768178,0.00023655503,0.000011566627,0.00025906367,0.00025886827,0.000012425016],"category_scores_gemma":[0.0016002675,0.00026619417,0.00021836207,0.0009987623,0.00006944238,0.000042157146,0.00004816836,0.000889809,0.0000018005691],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003217006,0.000045374225,0.00007348636,0.6568427,0.000013960957,0.000005262897,0.00031507548,1.13756265e-7,7.5472034e-10,0.0010740889,0.02666966,0.31495705],"study_design_scores_gemma":[0.00024715773,0.00037901444,0.00011262082,0.32093832,0.000026698146,0.00015104537,0.000085907595,0.000029262734,8.211682e-10,0.000020767133,0.6779015,0.00010772089],"about_ca_topic_score_codex":0.95243984,"about_ca_topic_score_gemma":0.6697145,"teacher_disagreement_score":0.6512318,"about_ca_system_score_codex":0.0028756673,"about_ca_system_score_gemma":0.07553708,"threshold_uncertainty_score":0.999979},"labels":[],"label_agreement":null},{"id":"W2906629470","doi":"10.1016/j.jval.2018.09.1353","title":"PIN34 - COMPARING THE ESTIMATED PUBLIC HEALTH IMPACT AND COST-EFFECTIVENESS OF PHID-CV AND PCV-13 IN THE ROUTINE IMMUNISATION PROGRAMME IN GAVI-ELIGIBLE COUNTRIES (SUB-SAHARAN AFRICA AND ASIA/OCEANIA): A MODELLING STUDY","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Vaccination; Pneumococcal conjugate vaccine; Conjugate vaccine; Cohort; Disease burden; Environmental health; Pediatrics; Immunization; Population; Immunology; Internal medicine; Streptococcus pneumoniae","score_opus":0.2750409052276595,"score_gpt":0.4456546928419141,"score_spread":0.1706137876142546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906629470","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784993,0.007443953,0.0002420271,0.005323716,0.0000993709,0.008287818,0.000020987192,0.000041299405,0.000041520547],"genre_scores_gemma":[0.99556726,0.0037254575,0.00009099229,0.00039386255,0.00007373574,0.00009716798,0.000021072105,0.000029037461,0.0000014325491],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99103385,0.005793442,0.0012659025,0.00045620938,0.00034518127,0.0011054289],"domain_scores_gemma":[0.99710035,0.0016292393,0.0005512794,0.00038865948,0.000113067385,0.00021742152],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016181251,0.00027706256,0.0007982187,0.0003702828,0.0009548625,0.00006576879,0.00020841823,0.00011548266,0.0000021599078],"category_scores_gemma":[0.00021347818,0.00018224263,0.000026112131,0.00092650973,0.0002513186,0.00022420468,0.00014386221,0.00097548036,0.0000011632831],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044407338,0.0007152447,0.9016739,0.0024286695,0.000014706131,0.0000021205055,0.08997842,0.001402592,0.0000093795115,0.00084569165,0.000046005352,0.0024391653],"study_design_scores_gemma":[0.004245552,0.0010185074,0.8493006,0.0030764749,0.000006246707,0.000008009126,0.012636318,0.1287717,0.0000017335781,0.0006527614,0.00013566566,0.00014643074],"about_ca_topic_score_codex":0.05518642,"about_ca_topic_score_gemma":0.007257632,"teacher_disagreement_score":0.12736912,"about_ca_system_score_codex":0.00060357957,"about_ca_system_score_gemma":0.0012977306,"threshold_uncertainty_score":0.9511052},"labels":[],"label_agreement":null},{"id":"W2906629779","doi":"10.1016/j.jval.2018.09.611","title":"PCV64 - THE DIRECT RESOURCE USE AND MEDICAL COSTS OF HEART FAILURE IN NOVA SCOTIA, CANADA","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; University of British Columbia; Vancouver Coastal Health; Novartis (Canada); Dalhousie University","funders":"","keywords":"Medicine; Nova scotia; Confidence interval; Emergency medicine; Population; Inpatient care; Cohort; Health care; Retrospective cohort study; Cohort study; Indirect costs; Demography; Environmental health; Pediatrics; Internal medicine; Business; Geography","score_opus":0.1324443529553812,"score_gpt":0.3977724597865986,"score_spread":0.2653281068312174,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906629779","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9218563,0.00055584713,0.0000017462476,0.07656174,0.0001565883,0.0003651789,0.00000776433,0.000005514186,0.0004893458],"genre_scores_gemma":[0.9869398,0.000057218112,0.00014144172,0.012729825,0.00008429651,0.0000013498935,0.0000029957066,0.000008026574,0.000035039382],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842304,0.0003747842,0.0003581038,0.00015367281,0.00043720796,0.00025321898],"domain_scores_gemma":[0.99801785,0.0014518211,0.00007941908,0.00018007036,0.00003009943,0.00024072712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001259065,0.00007657883,0.00026368655,0.000056836503,0.00003264384,0.0000063079497,0.00006675306,0.00005274507,0.00010610953],"category_scores_gemma":[0.0015714073,0.000050402265,0.000016216649,0.0002446357,0.00013534333,0.000054473272,0.000042305015,0.00036400155,0.000003144555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018015814,0.000081664,0.9818572,0.00017612745,0.000009509356,0.000019686267,0.00038977384,0.000018052975,0.000014250891,0.00016606416,0.01592146,0.0011660586],"study_design_scores_gemma":[0.0029056484,0.00066738453,0.5744516,0.0015828642,0.000019427609,0.00008753706,0.00041380353,0.01079661,0.00020053764,0.000025874851,0.40870288,0.0001457846],"about_ca_topic_score_codex":0.8984483,"about_ca_topic_score_gemma":0.83909035,"teacher_disagreement_score":0.40740556,"about_ca_system_score_codex":0.00017182315,"about_ca_system_score_gemma":0.00092785794,"threshold_uncertainty_score":0.20553447},"labels":[],"label_agreement":null},{"id":"W2906638584","doi":"10.1016/j.jval.2018.09.375","title":"PCN293 - WHAT IS THE VALUE OF REAL WORLD EVIDENCE IN ONCOLOGY IN HTA APPRAISALS IN ENGLAND, FRANCE, CANADA AND AUSTRALIA?","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Reimbursement; Medicine; Observational study; Excellence; Health technology; Real world evidence; Family medicine; Agency (philosophy); Economic evaluation; Health care; Political science; Internal medicine","score_opus":0.4504710151510692,"score_gpt":0.46695492943462263,"score_spread":0.016483914283553447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906638584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.940927,0.00520096,0.000009649363,0.05152381,0.00089039485,0.0009787221,0.00006503097,0.0000051578268,0.00039921887],"genre_scores_gemma":[0.9863617,0.004645312,0.0004210857,0.007996514,0.00020156796,0.00009671452,0.0000042045735,0.000018096205,0.000254803],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921658,0.0014871786,0.0049545453,0.0006043396,0.00013117636,0.0006569446],"domain_scores_gemma":[0.9930865,0.004585948,0.0016434914,0.0004980781,0.00003723997,0.00014871126],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.030159093,0.00018231661,0.0011918427,0.0007136749,0.000063639905,0.000031038082,0.00034961413,0.0001521424,0.00013134813],"category_scores_gemma":[0.002246794,0.00020159091,0.000033054635,0.00088103407,0.00016555647,0.0005290709,0.00006601523,0.00042664373,0.000039218347],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034500623,0.0000713348,0.9694725,0.000536604,0.0000057477555,0.0000027638305,0.011626326,0.0013586901,4.6028413e-7,0.014298956,0.0020193348,0.0005727782],"study_design_scores_gemma":[0.0013886834,0.00018654337,0.92763555,0.0014371657,9.510794e-7,0.0000027557437,0.0014974471,0.01003262,0.0000035323046,0.004976315,0.052614614,0.00022383452],"about_ca_topic_score_codex":0.9779319,"about_ca_topic_score_gemma":0.97805333,"teacher_disagreement_score":0.05059528,"about_ca_system_score_codex":0.0019705961,"about_ca_system_score_gemma":0.0018505425,"threshold_uncertainty_score":0.9986553},"labels":[],"label_agreement":null},{"id":"W2906646251","doi":"10.1016/j.jval.2018.09.292","title":"PCN210 - USING REAL WORLD DATA TO DETERMINE HEALTH SYSTEM COSTS OF A 5-YEAR NON-SMALL CELL LUNG CANCER COHORT","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada); McMaster University; Sunnybrook Hospital","funders":"","keywords":"Medicine; Cohort; Activity-based costing; Lung cancer; Total cost; Cancer; Cancer registry; Health care; Emergency medicine; Cohort study; Family medicine; Internal medicine; Business","score_opus":0.12407475187079188,"score_gpt":0.32821576885284254,"score_spread":0.20414101698205067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2906646251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9848362,0.002555558,0.0019120886,0.0008723038,0.0012886167,0.0012524339,0.0011892476,0.000032142805,0.0060614026],"genre_scores_gemma":[0.991589,0.0012234166,0.0053059515,0.0009638839,0.00059521105,0.000028864903,0.000023011846,0.000055592525,0.00021505567],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99681836,0.000053604337,0.0015886526,0.0007297967,0.0000559558,0.00075363746],"domain_scores_gemma":[0.9973413,0.00007082176,0.0011869416,0.0009846619,0.00005738789,0.000358894],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023682492,0.00021995285,0.0010763603,0.00054101547,0.00012620013,0.00003885696,0.0005918697,0.00007309144,0.000045724137],"category_scores_gemma":[0.000054679687,0.00027276922,0.00005753441,0.0006071349,0.000080535625,0.00023679427,0.00021675849,0.00019152946,0.00006492466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000099826546,0.00009063778,0.9793405,0.0009270584,0.000031515232,0.000002703946,0.0009863763,0.0019889227,0.00000951802,0.010513847,0.0032597024,0.0027493897],"study_design_scores_gemma":[0.002875214,0.0010537667,0.5938248,0.003253146,0.000020594243,0.0000067497917,0.00038849335,0.37543094,0.00013325531,0.00029945446,0.021578515,0.0011350721],"about_ca_topic_score_codex":0.3378782,"about_ca_topic_score_gemma":0.027172733,"teacher_disagreement_score":0.38551572,"about_ca_system_score_codex":0.0025407223,"about_ca_system_score_gemma":0.0009170138,"threshold_uncertainty_score":0.99997246},"labels":[],"label_agreement":null},{"id":"W2914185992","doi":"10.1016/j.jval.2013.02.010","title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":681,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Institute of Health Economics; University of Ottawa","funders":"","keywords":"Checklist; Statement (logic); Government (linguistics); Delphi method; Psychological intervention; Economic evaluation; Systematic review; Consolidated Standards of Reporting Trials; Delphi; Public relations; Political science; Medicine; MEDLINE; Medical education; Psychology; Nursing; Computer science; Law","score_opus":0.5301534469288427,"score_gpt":0.5052983449688688,"score_spread":0.02485510195997387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2914185992","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7592997,0.009319145,0.002816713,0.21239275,0.0023666162,0.0077003483,0.0009801545,0.00021055389,0.0049140146],"genre_scores_gemma":[0.9727828,0.00086916366,0.0053020427,0.019356271,0.00035005304,0.0007383388,0.0002458276,0.00008561553,0.00026990904],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9766451,0.0020766482,0.018591154,0.0010987844,0.0003763011,0.0012119882],"domain_scores_gemma":[0.9818825,0.00068420667,0.01583058,0.00084517396,0.00020590032,0.0005516344],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.13395767,0.0003189891,0.0017820641,0.00068645383,0.0003404021,0.00017314088,0.00028812318,0.00014888961,0.0025955804],"category_scores_gemma":[0.0071626822,0.0004220308,0.00013185876,0.0002850638,0.00007202715,0.00080217584,0.00007006667,0.000356091,0.0023590159],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059736718,0.0005955673,0.2078644,0.004440106,0.00026598526,0.0000043598943,0.02274765,0.12545232,0.000006270762,0.16444553,0.46122923,0.012888803],"study_design_scores_gemma":[0.005417275,0.00078786403,0.103503026,0.001181829,0.000008364061,0.000028624712,0.008009262,0.6388165,0.000013421759,0.07477474,0.16604985,0.0014092906],"about_ca_topic_score_codex":0.10267722,"about_ca_topic_score_gemma":0.0011516999,"teacher_disagreement_score":0.51336414,"about_ca_system_score_codex":0.013678524,"about_ca_system_score_gemma":0.0050660055,"threshold_uncertainty_score":0.99982315},"labels":[],"label_agreement":null},{"id":"W2921518676","doi":"10.1016/j.jval.2019.01.006","title":"Bayesian Networks for Risk Prediction Using Real-World Data: A Tool for Precision Medicine","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Bayesian Modeling and Causal Inference","field":"Computer Science","cited_by":195,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Public Health Ontario; University of Toronto","funders":"","keywords":"Bayesian network; Machine learning; Computer science; Artificial intelligence; Graphical model; Bayes' theorem; Estimation; Naive Bayes classifier; Bayesian probability; Data mining; Data science; Support vector machine; Risk analysis (engineering); Engineering; Medicine","score_opus":0.3173173099108415,"score_gpt":0.4416796139974549,"score_spread":0.12436230408661342,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2921518676","genre_codex":"methods","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[3.0538177e-7,0.4425418,0.55353016,0.00009104471,0.001247344,0.002301722,0.00020223884,0.00007304103,0.000012340363],"genre_scores_gemma":[0.000016226602,0.8658133,0.13235134,0.00009263086,0.0010143613,0.00017575943,0.00041322448,0.000053900425,0.00006923179],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9949934,0.0007019273,0.0017918545,0.0014181229,0.00035661642,0.0007380609],"domain_scores_gemma":[0.99404156,0.002153319,0.0013705347,0.002135804,0.00011901488,0.0001797431],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006444766,0.00045078827,0.001971508,0.0005163338,0.00023650036,0.00011139544,0.001818552,0.00027379917,0.0000013819748],"category_scores_gemma":[0.0003961159,0.00036659063,0.00019659333,0.0010168157,0.00004817277,0.0004083185,0.00035597527,0.0006193078,0.0000028225406],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010696346,0.00002715341,0.000013920558,0.008972229,0.000022975299,5.089574e-7,0.000057826786,0.020671925,8.310285e-9,0.0036101425,0.0018882446,0.96472436],"study_design_scores_gemma":[0.00026931262,0.00028715402,0.0000035217133,0.020486917,0.00009850205,0.0000064927294,0.0000016273586,0.7248714,8.457531e-9,0.0018874559,0.25187704,0.00021060104],"about_ca_topic_score_codex":0.0037453899,"about_ca_topic_score_gemma":0.00015186852,"teacher_disagreement_score":0.9645138,"about_ca_system_score_codex":0.0005384236,"about_ca_system_score_gemma":0.0015073521,"threshold_uncertainty_score":0.9998786},"labels":[],"label_agreement":null},{"id":"W2924788313","doi":"10.1016/j.jval.2018.12.005","title":"Impact of Abuse Deterrent Formulations of Opioids in Patients With Chronic Pain in the United States: A Cost-Effectiveness Model","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et de Services Sociaux des Laurentides","funders":"","keywords":"Medicine; Opioid; Chronic pain; Opioid abuse; Opioid overdose; Substance abuse; Psychiatry; Internal medicine","score_opus":0.034042281318582605,"score_gpt":0.3396351064168651,"score_spread":0.3055928250982825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2924788313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99527425,0.00014118286,0.00034229163,0.000054110118,0.000015394806,0.004111663,0.000047629153,0.000005997168,0.0000075061143],"genre_scores_gemma":[0.9992563,0.000110510126,0.00018780376,0.000043978016,0.0000024117674,0.00013968602,0.00024116806,0.000017000679,0.0000011297849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983809,0.00047865216,0.0004462864,0.00016915696,0.00025225492,0.00027274305],"domain_scores_gemma":[0.9990533,0.00033255573,0.00015911095,0.00033737512,0.000067603854,0.000050029732],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008234964,0.00013401388,0.00037799063,0.0004375706,0.000011592957,0.000002490242,0.00007899941,0.000042872314,0.0000050480226],"category_scores_gemma":[0.00003674246,0.00008353592,0.00004774959,0.0007479661,0.000023661838,0.00005353049,0.0000106721045,0.0001573227,0.0000010345432],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003560477,0.0011148675,0.6121705,0.0004967875,0.000015218581,5.867994e-7,0.006085402,0.37900203,0.0000028124198,0.00003546021,0.0000010708741,0.0007191763],"study_design_scores_gemma":[0.005999716,0.0035582571,0.69104105,0.0010987497,0.000006752059,1.8932815e-7,0.00019522099,0.29796496,0.000005786615,0.000081483326,0.0000019064347,0.000045931916],"about_ca_topic_score_codex":0.024844954,"about_ca_topic_score_gemma":0.00075637485,"teacher_disagreement_score":0.081037074,"about_ca_system_score_codex":0.0012438182,"about_ca_system_score_gemma":0.0007356966,"threshold_uncertainty_score":0.9816487},"labels":[],"label_agreement":null},{"id":"W2945144952","doi":"10.1016/j.jval.2018.12.012","title":"Consistency Between Three Different Ways of Administering the Short Form 6 Dimension Version 2","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":43,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Centre Hospitalier Universitaire de Sherbrooke","funders":"Fonds de Recherche du Québec - Santé; Social Sciences and Humanities Research Council of Canada; University of Sheffield","keywords":"SF-36; Consistency (knowledge bases); Ceiling effect; Dimension (graph theory); Quality of life (healthcare); Statistics; Mean difference; Significant difference; Medicine; Demography; Mathematics; Psychology; Health related quality of life; Combinatorics; Confidence interval; Alternative medicine; Internal medicine; Nursing; Discrete mathematics; Sociology","score_opus":0.5010494795401929,"score_gpt":0.40114926710934196,"score_spread":0.0999002124308509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945144952","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92580754,0.0009891214,0.0005000593,0.06956939,0.0005500195,0.0011311054,0.00009979046,0.00002294201,0.001330014],"genre_scores_gemma":[0.99158186,0.000104118466,0.0004206199,0.007639417,0.00013529659,0.000025658328,0.000024846358,0.000023365297,0.000044848963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99516785,0.00025032702,0.0035904427,0.00041822044,0.00013358981,0.00043959077],"domain_scores_gemma":[0.9964412,0.0015051209,0.001249779,0.00065492466,0.00002993443,0.00011908517],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010133798,0.00016408486,0.0009993869,0.00023586555,0.00014116096,0.000020095928,0.00028409596,0.00012612593,0.00013037422],"category_scores_gemma":[0.00047622743,0.00015468006,0.00011480235,0.0001615008,0.000053955642,0.00017789671,0.000099456825,0.00026792398,0.0004325101],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016082044,0.000055822038,0.92837536,0.0010605105,0.000026082393,4.6015742e-7,0.0015995016,0.00040727115,0.000005588929,0.066316694,0.0017262514,0.00041038293],"study_design_scores_gemma":[0.0011472645,0.00062279747,0.92428917,0.00076626684,0.0000067719934,0.000004516154,0.0010327026,0.022695513,0.000037864666,0.029654415,0.019348577,0.00039412122],"about_ca_topic_score_codex":0.0037470332,"about_ca_topic_score_gemma":0.00014905455,"teacher_disagreement_score":0.06577426,"about_ca_system_score_codex":0.0006514341,"about_ca_system_score_gemma":0.00017893374,"threshold_uncertainty_score":0.630767},"labels":[],"label_agreement":null},{"id":"W2945409099","doi":"10.1016/j.jval.2019.02.009","title":"United States Valuation of EQ-5D-5L Health States Using an International Protocol","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":391,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; McMaster University; University of Toronto","funders":"University of Illinois at Chicago; Universitetet i Oslo; National Pharmaceutical Council; Johns Hopkins University; Eli Lilly and Company; Bristol-Myers Squibb; EuroQol Research Foundation; Bristol-Myers Squibb Foundation","keywords":"Respondent; Tobit model; Valuation (finance); Protocol (science); Statistics; Population; Actuarial science; EQ-5D; Willingness to pay; Medicine; Demography; Econometrics; Mathematics; Economics; Environmental health; Accounting; Health related quality of life","score_opus":0.5921958787152075,"score_gpt":0.48178246599350655,"score_spread":0.11041341272170097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2945409099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92521274,0.000247516,0.0048883287,0.025477638,0.0009017509,0.042271152,0.0006400762,0.00006887686,0.00029189582],"genre_scores_gemma":[0.8896975,0.00074856664,0.04224071,0.047266487,0.0008766018,0.01574222,0.0026193385,0.00026528767,0.00054329186],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99144787,0.0013665989,0.0057573505,0.00062488357,0.0002325064,0.000570791],"domain_scores_gemma":[0.9940669,0.00064988085,0.0043071755,0.0005674373,0.00015136163,0.00025722903],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.027774714,0.00020997158,0.0010385017,0.001119126,0.000117965144,0.00005845182,0.00035987602,0.00010999357,0.00036676647],"category_scores_gemma":[0.00080892595,0.00026975843,0.00007322191,0.00052606105,0.0000495271,0.00076487445,0.000054457665,0.00023507894,0.00025080345],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009989392,0.0006890822,0.33389345,0.003529953,0.000060111543,4.6882354e-7,0.013834694,0.567948,0.00000566915,0.077801354,0.0014174441,0.00071989256],"study_design_scores_gemma":[0.0020448563,0.00061179866,0.032333486,0.0005511707,0.0000011432179,0.0000032238354,0.0023040124,0.90854776,0.000007727068,0.026921863,0.026377678,0.00029531092],"about_ca_topic_score_codex":0.06004186,"about_ca_topic_score_gemma":0.00029963092,"teacher_disagreement_score":0.34059975,"about_ca_system_score_codex":0.0020371613,"about_ca_system_score_gemma":0.0010353733,"threshold_uncertainty_score":0.99997544},"labels":[],"label_agreement":null},{"id":"W2946124699","doi":"10.1016/j.jval.2019.04.001","title":"Implications of Nonmarginal Budgetary Impacts in Health Technology Assessment: A Conceptual Model","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"University of Leeds; Rijksuniversiteit Groningen; University of Aberdeen; University of Oxford","keywords":"Equity (law); Economics; Health technology; Health care; Productivity; Marginal cost; Public economics; Microeconomics; Macroeconomics","score_opus":0.35735526573300347,"score_gpt":0.4565311403333935,"score_spread":0.09917587460039001,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946124699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7994368,0.005826163,0.004149937,0.18505895,0.00031395897,0.002269656,0.0005029685,0.000057767393,0.0023838244],"genre_scores_gemma":[0.97851497,0.0007647554,0.011900584,0.008477532,0.000047369635,0.00011959758,0.000046378955,0.000034074354,0.0000947408],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9917303,0.0005260349,0.0061266273,0.00068313285,0.00010721206,0.0008266932],"domain_scores_gemma":[0.99516934,0.0006333143,0.0031229553,0.00078137044,0.000049234357,0.0002438044],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.017164933,0.00020745528,0.0015246691,0.0013591308,0.00008622782,0.000015417918,0.00039136386,0.00020569988,0.0001415959],"category_scores_gemma":[0.00065842894,0.00028129717,0.00008382214,0.00081662094,0.00011946223,0.00033061096,0.000073101124,0.00047278788,0.0003000976],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008562089,0.00019512935,0.37723207,0.0009152962,0.000011358802,2.5254957e-7,0.0019369035,0.0566439,0.0000040974114,0.56201017,0.00086374895,0.00017851709],"study_design_scores_gemma":[0.003430221,0.0007418173,0.35546693,0.0009797856,0.0000016379063,0.000015155353,0.0045396336,0.47570187,0.0000031175696,0.15340193,0.005155168,0.00056274445],"about_ca_topic_score_codex":0.015101765,"about_ca_topic_score_gemma":0.00067726,"teacher_disagreement_score":0.41905797,"about_ca_system_score_codex":0.002329077,"about_ca_system_score_gemma":0.0025142205,"threshold_uncertainty_score":0.99996394},"labels":[],"label_agreement":null},{"id":"W2946511627","doi":"10.1016/j.jval.2019.01.019","title":"Parent Proxy Discrepancy Groups of Quality of Life in Childhood Epilepsy","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hamilton Health Sciences; Queen's University; McMaster University; University of Waterloo; St. Joseph’s Healthcare Hamilton; Toronto Western Hospital","funders":"Canadian Institutes of Health Research; Kids Brain Health Network","keywords":"Proxy (statistics); Epilepsy; Psychology; Cohort; Quality of life (healthcare); Latent class model; Developmental psychology; Clinical psychology; Medicine; Psychiatry; Statistics; Mathematics","score_opus":0.059918623898900465,"score_gpt":0.37121868201895963,"score_spread":0.3113000581200592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946511627","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936861,0.0016434574,0.000005365332,0.0022886477,0.000060168048,0.0015765146,0.000029655303,0.000009563968,0.0007005694],"genre_scores_gemma":[0.9986513,0.0006983886,0.000346247,0.0001364713,0.000028238544,0.000043330507,0.000030474579,0.000012239126,0.00005328652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975812,0.0003879658,0.00093357754,0.00025491737,0.00043511964,0.0004072298],"domain_scores_gemma":[0.9988611,0.00020225917,0.00023753585,0.0004265898,0.000045857683,0.00022669755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014571374,0.00010867886,0.000695696,0.00018887754,0.000010862809,0.0000017285317,0.00008060502,0.000054403798,0.00008390536],"category_scores_gemma":[0.00036510182,0.000084310675,0.0000842489,0.00032005674,0.00004232057,0.00003861217,0.00004161919,0.00023911038,0.000020573914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033045086,0.0020019156,0.98800874,0.0016857679,0.000027912502,0.0000041101403,0.0012372445,0.00005608234,0.00002716066,0.005300638,0.00001891978,0.001301083],"study_design_scores_gemma":[0.0037651164,0.0015223802,0.9916813,0.000854635,0.0000030770411,0.0000016326682,0.00038738793,0.00023386246,0.000066551256,0.001391897,0.000036028992,0.000056159985],"about_ca_topic_score_codex":0.019450301,"about_ca_topic_score_gemma":0.00036533465,"teacher_disagreement_score":0.019084966,"about_ca_system_score_codex":0.00019943641,"about_ca_system_score_gemma":0.00092141074,"threshold_uncertainty_score":0.98707926},"labels":[],"label_agreement":null},{"id":"W2946583077","doi":"10.1016/j.jval.2019.03.016","title":"A Systematic Review of Decision-Analytic Models for Evaluating Cost-Effectiveness of Asthma Interventions","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia; Vancouver General Hospital; Centre for Advancing Health Outcomes","funders":"Genome British Columbia; Canadian Institutes of Health Research; Genome Canada; Novartis; Sanofi; Merck; Michael Smith Health Research BC; GlaxoSmithKline; AstraZeneca; Boehringer Ingelheim","keywords":"Asthma; Psychological intervention; Medicine; MEDLINE; Systematic review; Comorbidity; Economic evaluation; Intensive care medicine; Psychiatry","score_opus":0.3321268090656154,"score_gpt":0.5268106722280252,"score_spread":0.19468386316240982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946583077","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000010568335,0.9690196,0.0058814827,0.0000097710745,0.00015539692,0.024674663,0.0002117207,0.00001070329,0.000026124786],"genre_scores_gemma":[0.00009101224,0.9970083,0.0008132441,0.00005734495,0.00002432149,0.0018085327,0.00010513401,0.000056956105,0.000035131965],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99234104,0.002574671,0.0038113708,0.00042171,0.000569434,0.00028179892],"domain_scores_gemma":[0.9912949,0.0047301133,0.0025568346,0.000822954,0.0004307635,0.00016440514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008963815,0.0003298696,0.0073663224,0.00051938364,0.00003122606,0.000004352277,0.00023161863,0.00015967958,0.00002046804],"category_scores_gemma":[0.004613774,0.0002259487,0.0024004225,0.00063672225,0.00004315766,0.000048665,0.000060806826,0.00023419567,0.000009828233],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029341532,0.00021666019,0.0000016750383,0.9028251,0.00020874954,0.000002228085,0.000012538502,0.0004519754,3.1038677e-8,0.00023154967,0.000021397436,0.09599873],"study_design_scores_gemma":[0.00063726533,0.00092941406,0.0000031022698,0.9875079,0.0036382885,0.000030440211,0.000018425044,0.0053975047,1.1380465e-7,0.00016046519,0.0015428228,0.00013425083],"about_ca_topic_score_codex":0.00006184823,"about_ca_topic_score_gemma":0.0000013243604,"teacher_disagreement_score":0.095864475,"about_ca_system_score_codex":0.00048105195,"about_ca_system_score_gemma":0.0030037342,"threshold_uncertainty_score":0.921392},"labels":[],"label_agreement":null},{"id":"W2946796215","doi":"10.1016/j.jval.2019.02.001","title":"Cost-Effectiveness of Cryoballoon Ablation Versus Radiofrequency Ablation for Paroxysmal Atrial Fibrillation in China: Results Based on Real-World Data","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; Laurentian University","funders":"Medtronic","keywords":"Medicine; Radiofrequency ablation; Paroxysmal atrial fibrillation; Propensity score matching; Atrial fibrillation; Cost effectiveness; Ablation; Cost-effectiveness analysis; Retrospective cohort study; Emergency medicine; Surgery; Internal medicine","score_opus":0.21033455062870782,"score_gpt":0.4212953856727369,"score_spread":0.21096083504402907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946796215","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98510385,0.000110945875,0.0011534523,0.0023023237,0.0016530579,0.008027501,0.0001550407,0.000060601396,0.0014332338],"genre_scores_gemma":[0.9952929,0.00012256108,0.0017851851,0.000022379192,0.0006883621,0.0000054765574,0.0019931886,0.000023343198,0.00006659069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974772,0.00051929464,0.0008872256,0.00047155962,0.00037398847,0.00027078541],"domain_scores_gemma":[0.9966659,0.0021062884,0.0005090471,0.0005930018,0.00006130564,0.00006448],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00354581,0.00016048463,0.0005488431,0.00060526765,0.00004127616,0.000012311493,0.00010334106,0.00008371913,0.000012077074],"category_scores_gemma":[0.0010015348,0.00015832469,0.00010439238,0.0007714056,0.000022519049,0.00023323018,0.000028508215,0.00011581911,0.0000075855382],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02465628,0.000012724713,0.50121105,0.0007352583,0.000018354778,8.0123107e-7,0.000073100746,0.46290985,0.000045520115,0.0026944291,0.000039120987,0.007603511],"study_design_scores_gemma":[0.014626601,0.00087557186,0.6105911,0.00045691535,0.000021965583,1.2410354e-7,0.000011981033,0.37186447,0.000044208675,0.00017514864,0.0012389421,0.000092931405],"about_ca_topic_score_codex":0.0063408995,"about_ca_topic_score_gemma":0.00034898962,"teacher_disagreement_score":0.109380074,"about_ca_system_score_codex":0.0006318985,"about_ca_system_score_gemma":0.00027789755,"threshold_uncertainty_score":0.95855856},"labels":[],"label_agreement":null},{"id":"W2949511939","doi":"10.1016/j.jval.2019.04.1604","title":"PNS249 WHAT ARE THE PRIORITY PATIENT ENGAGEMENT ACTIVITIES IN MEDICINES DEVELOPMENT? RESULTS OF A GLOBAL MULTI-STAKEHOLDER CONSULTATION","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Robarts Clinical Trials","funders":"","keywords":"Outreach; Stakeholder; Public involvement; Stakeholder engagement; Medicine; Relevance (law); Family medicine; Clinical trial; Public engagement; Medical education; Public relations; Political science","score_opus":0.3587521875131387,"score_gpt":0.43136637303915515,"score_spread":0.07261418552601645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2949511939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98913234,0.0013855738,0.00001934322,0.0022100448,0.0018325495,0.004978099,0.000089094676,0.000023861689,0.00032911156],"genre_scores_gemma":[0.99445784,0.00066412246,0.0008803146,0.0034656143,0.000037526363,0.0002875918,0.0001087773,0.000012305902,0.00008589723],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99403083,0.002403955,0.0018907802,0.00036637372,0.0005954194,0.00071262923],"domain_scores_gemma":[0.9970531,0.0012816772,0.0010541914,0.0003436418,0.00010495188,0.00016244553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004126303,0.00019942332,0.0004439997,0.00011941983,0.0003411784,0.000008181557,0.00016894583,0.000122055564,0.00003311621],"category_scores_gemma":[0.00021359128,0.00014527468,0.000028379904,0.00046502595,0.000055994846,0.0002211781,0.00011581692,0.0005769519,0.00004316813],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00072285125,0.0006240897,0.8637467,0.0053834696,0.0000123840455,0.0000029367989,0.10921277,0.00068451767,0.000011286682,0.00049932196,0.00034768227,0.018752],"study_design_scores_gemma":[0.010663767,0.00076264126,0.66390747,0.01582358,0.0000053810595,6.6819734e-7,0.29380134,0.0019726665,0.000109960616,0.00017936742,0.012498796,0.00027435896],"about_ca_topic_score_codex":0.011218913,"about_ca_topic_score_gemma":0.008420469,"teacher_disagreement_score":0.19983922,"about_ca_system_score_codex":0.0015913192,"about_ca_system_score_gemma":0.0015777191,"threshold_uncertainty_score":0.99536544},"labels":[],"label_agreement":null},{"id":"W2950419520","doi":"10.1016/j.jval.2019.05.001","title":"Choosing Video Instead of In-Clinic Consultations in Primary Care in Israel: Discrete Choice Experiment Among Key Stakeholders—Patients, Primary Care Physicians, and Policy Makers","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":44,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Israel National Institute for Health Policy Research; McMaster University","keywords":"Stakeholder; Mixed logit; Primary care; Preference; Key (lock); Family medicine; Logistic regression; Service (business); Business; Medicine; Nursing; Psychology; Marketing; Public relations; Computer science; Political science; Economics","score_opus":0.12869048864886293,"score_gpt":0.3965134190292427,"score_spread":0.26782293038037974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2950419520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97581494,0.012929631,0.0000017865333,0.0018578335,0.00045284565,0.006197025,0.0002276115,0.000047734356,0.002470616],"genre_scores_gemma":[0.9930081,0.0011999913,0.0008142209,0.0035551644,0.00005009626,0.0006420708,0.000611804,0.00007533471,0.00004321376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99170494,0.0032099285,0.0027526366,0.00074693054,0.0005320876,0.0010534585],"domain_scores_gemma":[0.99522966,0.0019740802,0.0011739553,0.0010763905,0.0003182506,0.00022765514],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067364646,0.00036444847,0.001017888,0.001233723,0.00026397288,0.00001312541,0.0004405226,0.00029770093,0.000010779371],"category_scores_gemma":[0.000565091,0.00041662937,0.000067512796,0.0015340146,0.00019083239,0.00048744507,0.0003784911,0.0015971782,0.00001861294],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013278027,0.00016478011,0.8232589,0.007194488,0.0000052596793,0.000001096726,0.16487932,0.0007025676,0.000018831908,0.00015617718,0.000027986825,0.003457841],"study_design_scores_gemma":[0.0057329414,0.00025799416,0.81174064,0.009416032,0.000003313923,1.1935282e-7,0.17181335,0.00029472227,0.0000083841205,0.000053007137,0.00041749037,0.0002619869],"about_ca_topic_score_codex":0.19200663,"about_ca_topic_score_gemma":0.023362614,"teacher_disagreement_score":0.16864403,"about_ca_system_score_codex":0.007110147,"about_ca_system_score_gemma":0.0041155396,"threshold_uncertainty_score":0.9998286},"labels":[],"label_agreement":null},{"id":"W2952018160","doi":"10.1016/j.jval.2019.04.1910","title":"A Beginner's Guide to Understanding Curative Therapies","year":2019,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.4661862497926434,"score_gpt":0.46943729054409455,"score_spread":0.003251040751451162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2952018160","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028005993,0.009411541,0.008883308,0.13925447,0.82992584,0.0034603705,0.0022848023,0.00011815134,0.006381441],"genre_scores_gemma":[0.0036357432,0.0042691603,0.010084833,0.034751564,0.9336201,0.0007518745,0.0008085394,0.00048233147,0.011595865],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98849845,0.0012827024,0.0074302126,0.0013609364,0.00034978543,0.0010778888],"domain_scores_gemma":[0.98643404,0.0076028714,0.0044071963,0.0010591452,0.00008520253,0.00041153445],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03398731,0.0005172845,0.0027500452,0.0013290778,0.00024712822,0.00018224656,0.0006835393,0.00078208203,0.00023896793],"category_scores_gemma":[0.0110030705,0.00067468843,0.0002014554,0.000533645,0.0000648071,0.0003911702,0.00012487761,0.001034746,0.0037739563],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018224659,0.00004290023,0.0005084909,0.0010628672,0.000056800967,0.0000011501689,0.006132275,0.0021310213,3.9207173e-8,0.10750005,0.8825254,0.000020782481],"study_design_scores_gemma":[0.00078580796,0.00025542712,0.000072556526,0.0011794912,0.0000024181913,6.963411e-7,0.0024908104,0.0016160205,1.137711e-7,0.027543886,0.96547866,0.00057412585],"about_ca_topic_score_codex":0.030474452,"about_ca_topic_score_gemma":0.0011262293,"teacher_disagreement_score":0.1045029,"about_ca_system_score_codex":0.011772501,"about_ca_system_score_gemma":0.0028339683,"threshold_uncertainty_score":0.9995704},"labels":[],"label_agreement":null},{"id":"W2953312545","doi":"10.1016/j.jval.2019.01.014","title":"Real-World Evidence in Healthcare Decision Making: Global Trends and Case Studies From Latin America","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Pharmacovigilance and Adverse Drug Reactions","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":72,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Governo Brasil; International Network of Agencies for Health Technology Assessment; Novartis Pharmaceuticals Corporation","keywords":"Real world evidence; Latin Americans; Health care; Political science; Data science; Computer science; Medicine; Economics; Economic growth","score_opus":0.5635607403954428,"score_gpt":0.616140320756119,"score_spread":0.052579580360676226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953312545","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028810566,0.99131525,0.0000027097783,0.0015797418,0.0019121171,0.00104944,0.00092452375,0.00006778145,0.0002674076],"genre_scores_gemma":[0.009571311,0.987591,0.00040046856,0.0017133432,0.00029952294,0.00015870354,0.000069283815,0.00004289006,0.00015344755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9937166,0.0025859943,0.0016177323,0.0009840606,0.00024023783,0.0008553857],"domain_scores_gemma":[0.99287957,0.005435142,0.0008783939,0.00042026507,0.00005356454,0.00033304113],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013817981,0.0006072623,0.0025095316,0.000731885,0.0002355011,0.00002435482,0.00030611188,0.00044106276,0.00010045737],"category_scores_gemma":[0.0002703385,0.00055547385,0.00022600754,0.002030545,0.00017179285,0.00020098113,0.00023283977,0.002127291,0.000104995044],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000104809325,0.00013416866,0.0062057655,0.009036743,0.00012903292,0.0016602562,0.00046157208,0.0006808204,1.4981444e-7,0.00016200464,0.0020524692,0.9793722],"study_design_scores_gemma":[0.0008486627,0.00012132778,0.00068645354,0.028881038,0.0003294152,0.0003616606,0.00019993467,0.0015247049,1.7645074e-7,0.00045826746,0.9660471,0.0005412781],"about_ca_topic_score_codex":0.018400552,"about_ca_topic_score_gemma":0.0039132424,"teacher_disagreement_score":0.97883093,"about_ca_system_score_codex":0.002290255,"about_ca_system_score_gemma":0.0012448193,"threshold_uncertainty_score":0.9996897},"labels":[],"label_agreement":null},{"id":"W2953408360","doi":"10.1016/j.jval.2019.04.056","title":"MT3 THE EFFECTIVENESS OF CAPNOGRAPHY ON CLINICALLY IMPORTANT OUTCOMES FROM OPIOID-INDUCED RESPIRATORY DEPRESSION: A LITERATURE REVIEW","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Becton Dickinson (Canada)","funders":"","keywords":"Capnography; Medicine; Adverse effect; Depression (economics); Intensive care medicine; Emergency medicine; Respiratory arrest; Hazard ratio; Incidence (geometry); Anesthesia; Internal medicine; Confidence interval","score_opus":0.14976732494740577,"score_gpt":0.42732657591205025,"score_spread":0.2775592509646445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953408360","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00079062855,0.9899693,0.0000034575914,0.000101805235,0.0012436268,0.0074816206,0.00016522504,0.000043199227,0.0002011343],"genre_scores_gemma":[0.00014050161,0.99466324,0.00011366654,0.004138244,0.0002257831,0.00039227738,0.00020173297,0.000104252125,0.000020301002],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9891764,0.004674542,0.0038251823,0.0009835295,0.0008087919,0.0005315576],"domain_scores_gemma":[0.9913766,0.0037063798,0.0022606747,0.0021737895,0.0001464061,0.00033616586],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01006057,0.0007367249,0.00596243,0.00044491,0.0000701097,0.00001951369,0.00054727914,0.0007516123,0.0000495168],"category_scores_gemma":[0.0010740623,0.00038960285,0.001621848,0.0010576,0.000048123944,0.000054092863,0.000111851674,0.0019663188,0.000036400867],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028929714,0.00037367205,0.008735362,0.474368,0.0003651212,0.00024685755,0.000111842855,6.8379137e-7,0.0000046951527,0.00026404278,0.00049293664,0.5147475],"study_design_scores_gemma":[0.00075555197,0.0010606257,0.0014037978,0.48620436,0.00049229496,0.000021385331,0.0000060669063,0.0000010307518,0.0000060082652,0.000070740025,0.50973374,0.00024439595],"about_ca_topic_score_codex":0.0001762167,"about_ca_topic_score_gemma":0.000004282681,"teacher_disagreement_score":0.51450306,"about_ca_system_score_codex":0.00018737743,"about_ca_system_score_gemma":0.0029103695,"threshold_uncertainty_score":0.9998556},"labels":[],"label_agreement":null},{"id":"W2953433507","doi":"10.1016/j.jval.2019.04.117","title":"PBI35 QUALITY-OF-LIFE OUTCOMES COMPARING THE PROPOSED BIOSIMILAR MSB11022 TO REFERENCE ADALIMUMAB IN PATIENTS WITH MODERATE-TO-SEVERE CHRONIC PLAQUE-TYPE PSORIASIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Research on Leishmaniasis Studies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Adalimumab; Medicine; Dermatology Life Quality Index; Psoriasis Area and Severity Index; Biosimilar; Psoriatic arthritis; Visual analogue scale; Psoriasis; Bioequivalence; Internal medicine; Quality of life (healthcare); Clinical endpoint; Randomized controlled trial; Physical therapy; Rheumatoid arthritis; Dermatology","score_opus":0.10881923235388875,"score_gpt":0.3679393811453456,"score_spread":0.25912014879145684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953433507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859906,0.00024622583,0.000012447231,0.009576842,0.00014478197,0.0036312698,0.000018217386,0.00003457218,0.00034504186],"genre_scores_gemma":[0.9974221,0.00011973541,0.00063752325,0.00158145,0.000029748504,0.000057999565,0.000015092985,0.000038505394,0.000097832526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99602014,0.0006639615,0.0009491128,0.000538331,0.001081885,0.00074657594],"domain_scores_gemma":[0.99791396,0.00046869103,0.00022688617,0.00079591974,0.00028765816,0.00030686505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001753034,0.00026417317,0.0010968749,0.0003757349,0.00011048656,0.000022984847,0.00034314784,0.00007692764,0.000037069323],"category_scores_gemma":[0.00080027047,0.00016800789,0.00004657878,0.0009795643,0.000064200365,0.00010089798,0.00022416226,0.00054897927,0.000076036435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003215021,0.00033784416,0.98087937,0.00093725906,0.00006541809,0.0000019839276,0.0022925863,0.011104081,0.000027118907,0.00048373826,0.00026636122,0.00038924755],"study_design_scores_gemma":[0.006187761,0.0024191423,0.9878613,0.00090596953,0.000006631796,4.2052343e-7,0.0006057934,0.0014044436,0.00007006369,0.000038378923,0.00030529982,0.00019484319],"about_ca_topic_score_codex":0.010792482,"about_ca_topic_score_gemma":0.0023237714,"teacher_disagreement_score":0.011431511,"about_ca_system_score_codex":0.0010646939,"about_ca_system_score_gemma":0.0014496256,"threshold_uncertainty_score":0.9957947},"labels":[],"label_agreement":null},{"id":"W2953436115","doi":"10.1016/j.jval.2019.04.1774","title":"PSS2 THE EFFICACY OF HALOBETASOL PROPIONATE (0.01%) AND TAZAROTENE (0.045%) FIXED COMBINATION RELATIVE TO OTHER TOPICAL THERAPIES AMONG PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS: A NETWORK META-ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); Health Canada; Vancouver Coastal Health","funders":"","keywords":"Tazarotene; Medicine; Psoriasis; Internal medicine; Randomized controlled trial; Plaque psoriasis; Combination therapy; Meta-analysis; Dermatology; Oncology; Pharmacology","score_opus":0.03505089356395533,"score_gpt":0.2565548362702506,"score_spread":0.22150394270629528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953436115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99380946,0.0015539179,0.00028163957,0.0020626083,0.0001435805,0.0020061717,0.000063301624,0.000020942569,0.000058357517],"genre_scores_gemma":[0.9981899,0.000033622746,0.0006196479,0.00041218783,0.00001350703,0.0001594249,0.000057120767,0.000017655637,0.00049692154],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976973,0.0010406086,0.00043683583,0.00039734034,0.00009474158,0.00033318828],"domain_scores_gemma":[0.998872,0.00041199007,0.00023485564,0.00034514305,0.00008856136,0.000047474685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044540927,0.00022610901,0.0008224217,0.00016625377,0.00014559546,0.000014572995,0.00014652427,0.00013914455,0.000113056725],"category_scores_gemma":[0.000036794943,0.00013005215,0.0001691643,0.00057630317,0.00006013688,0.00008633363,0.000050495637,0.00015866848,0.00002552323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005202671,0.0010872636,0.80644506,0.000106453524,0.061141144,0.0000027525891,0.015741633,0.095528014,0.00014145135,0.009099218,0.0002973499,0.005206967],"study_design_scores_gemma":[0.0060203266,0.0017787826,0.98212016,0.00008045163,0.007108748,0.0000020789953,0.00019884881,0.00047133098,0.0003406704,0.00086328917,0.00066380634,0.00035148553],"about_ca_topic_score_codex":0.0015663684,"about_ca_topic_score_gemma":0.00034836095,"teacher_disagreement_score":0.1756751,"about_ca_system_score_codex":0.00006681862,"about_ca_system_score_gemma":0.0000664042,"threshold_uncertainty_score":0.5303373},"labels":[],"label_agreement":null},{"id":"W2953535203","doi":"10.1016/j.jval.2019.04.1175","title":"PMU12 SCALABLE DECISION-ANALYTIC MODELLING WITH INFLUENCE DIAGRAMS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health Research Topics","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Influence diagram; Computer science; Decision tree; Bayesian network; Graphical model; Decision engineering; Decision analysis; Machine learning; Scalability; Artificial intelligence; Evidential reasoning approach; Decision problem; Representation (politics); Data mining; Decision support system; Business decision mapping; Mathematics; Algorithm","score_opus":0.09826136734443984,"score_gpt":0.4127631678258993,"score_spread":0.3145018004814594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953535203","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873173,0.0011239403,0.004323973,0.0009938264,0.000335159,0.0011659872,0.000006041186,0.00004462793,0.004689118],"genre_scores_gemma":[0.9896631,0.00018074996,0.006904255,0.0011430779,0.000054266042,0.00006386597,0.000004971148,0.000034801236,0.0019508987],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99687713,0.0003944926,0.00061054854,0.00054076227,0.00057985174,0.0009972143],"domain_scores_gemma":[0.997949,0.0006911079,0.00014386546,0.0007521385,0.00006268062,0.00040121033],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0019083226,0.0001620162,0.00036867472,0.00025435138,0.000097813725,0.000029370798,0.000327099,0.00010670148,0.000771733],"category_scores_gemma":[0.00004112423,0.00013457821,0.00003565048,0.0006920691,0.000056765115,0.00013718703,0.000061584695,0.0005586355,0.001977357],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004350053,0.0003716752,0.36070037,0.00069566147,0.000025407906,0.0000592882,0.002205906,0.5856234,0.000003629237,0.026696963,0.0006866435,0.022496091],"study_design_scores_gemma":[0.0073108915,0.00431548,0.17140585,0.003294917,0.000014296075,0.0001235036,0.0017176004,0.74736595,0.000031696258,0.021604797,0.041770972,0.0010440286],"about_ca_topic_score_codex":0.020954557,"about_ca_topic_score_gemma":0.00024557635,"teacher_disagreement_score":0.18929453,"about_ca_system_score_codex":0.00046852222,"about_ca_system_score_gemma":0.00043792065,"threshold_uncertainty_score":0.99879974},"labels":[],"label_agreement":null},{"id":"W2953537532","doi":"10.1016/j.jval.2019.04.904","title":"PIN33 COST-EFFECTIVENESS ANALYSIS OF EFINACONAZOLE FOR THE TREATMENT OF MILD TO MODERATE TOENAIL ONYCHOMYCOSIS IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada; Université de Montréal","funders":"","keywords":"Terbinafine; Medicine; Itraconazole; Formulary; Dermatology; Antifungal; Clinical trial; Internal medicine; Family medicine","score_opus":0.05960679403513741,"score_gpt":0.3476716298323949,"score_spread":0.2880648357972575,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953537532","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99413955,0.0017574386,0.000057458557,0.0006373832,0.000074282376,0.0030119866,0.00029314202,0.0000024692135,0.000026297905],"genre_scores_gemma":[0.9987178,0.0005327094,0.00009073851,0.00021232647,0.000006897222,0.00035375054,0.000040573465,0.00001011496,0.00003509073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894524,0.00009832589,0.0003507828,0.00020618041,0.00016826173,0.00023121123],"domain_scores_gemma":[0.9989138,0.0005113372,0.000104934785,0.00030084353,0.00005477383,0.00011431483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017575707,0.00011196025,0.00064256485,0.00020933496,0.000020209622,0.000001978717,0.000050184495,0.000021517159,0.000019715719],"category_scores_gemma":[0.000018641233,0.00007512222,0.00013218101,0.0006558073,0.000008246342,0.000014999976,0.0000073905194,0.000028918195,0.0000011221258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001634852,0.0009408884,0.8533967,0.00044241652,0.0007264707,0.000004276669,0.000408481,0.1307331,0.000031391697,0.00011448546,0.000027781716,0.011539107],"study_design_scores_gemma":[0.0046795323,0.0012245825,0.94737047,0.00024040054,0.000395015,2.7625254e-7,0.00016150957,0.04472373,0.000662824,0.000028671699,0.00045244183,0.000060577153],"about_ca_topic_score_codex":0.96036774,"about_ca_topic_score_gemma":0.5828751,"teacher_disagreement_score":0.37749267,"about_ca_system_score_codex":0.0016573697,"about_ca_system_score_gemma":0.0012539605,"threshold_uncertainty_score":0.4333964},"labels":[],"label_agreement":null},{"id":"W2953666721","doi":"10.1016/j.jval.2019.04.1682","title":"PRO49 A COMPARISON OF THE NICE HST PROGRAM WITH HEALTH TECHNOLOGY ASSESSMENTS FROM FRANCE, GERMANY, AUSTRALIA, AND CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Health technology; Orphan drug; Medicine; Economic evaluation; Family medicine; Operations research; Health care; Computer science; Economic growth; Engineering; Economics","score_opus":0.297970523444058,"score_gpt":0.4592387894789624,"score_spread":0.1612682660349044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953666721","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95099574,0.0020539078,0.00006043373,0.04349368,0.00042047986,0.002503349,0.00026380568,0.000026667894,0.00018196007],"genre_scores_gemma":[0.99224275,0.000053172214,0.003954757,0.003328395,0.00004278057,0.00013149036,0.000015510368,0.00002250767,0.00020862516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99526525,0.00039735876,0.0031286108,0.0005294218,0.00015200918,0.0005273533],"domain_scores_gemma":[0.9958979,0.00035044394,0.0029364198,0.0006203709,0.0000383985,0.00015646266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045649605,0.00017520774,0.0011945342,0.00020463955,0.00012282733,0.00002394494,0.00032697144,0.00011863033,0.000051913496],"category_scores_gemma":[0.00013378492,0.00016897432,0.00003014019,0.00038295425,0.00008896559,0.00013308701,0.000065720335,0.0003800794,0.000041847095],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000070351566,0.00013575089,0.984354,0.0007898539,0.000029884863,1.8403942e-7,0.000599568,0.000727744,3.5162438e-7,0.01117506,0.0018243471,0.00035619474],"study_design_scores_gemma":[0.0015397432,0.000673515,0.93086874,0.00082085107,0.0000031390234,0.0000036262443,0.0018477107,0.015880344,0.0000052777914,0.001855895,0.046206575,0.00029459907],"about_ca_topic_score_codex":0.91855633,"about_ca_topic_score_gemma":0.42868727,"teacher_disagreement_score":0.48986906,"about_ca_system_score_codex":0.0009968714,"about_ca_system_score_gemma":0.0020159534,"threshold_uncertainty_score":0.6890573},"labels":[],"label_agreement":null},{"id":"W2953684232","doi":"10.1016/j.jval.2019.04.373","title":"PCN252 QUALITY EVALUATION OF PHARMACOECONOMIC STUDIES IN RUSSIAN CANCER RESEARCH: AN OUTSIDE VIEW","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Scope (computer science); Medicine; Quality (philosophy); Economic evaluation; Actuarial science; Medical physics; Family medicine; Computer science; Pathology; Business","score_opus":0.9294760374727394,"score_gpt":0.6743938392265685,"score_spread":0.25508219824617095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953684232","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94274855,0.030407615,0.000007782827,0.02140692,0.0011642544,0.0025784185,0.00017288695,0.000021228323,0.0014923585],"genre_scores_gemma":[0.9909031,0.0047797975,0.0004541276,0.003092191,0.00020741127,0.00039272002,0.00002042304,0.00003837857,0.00011186708],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9816942,0.007973291,0.008048301,0.0010077786,0.00039249728,0.0008838952],"domain_scores_gemma":[0.9940679,0.0020898979,0.0026249376,0.00079864304,0.00019144948,0.00022717964],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.19366784,0.0002159359,0.0017716537,0.0011804875,0.0001083799,0.000029116498,0.00040250624,0.00014148765,0.0007029341],"category_scores_gemma":[0.003135736,0.00027536383,0.00009160583,0.00061313016,0.00013649209,0.00070564897,0.00008222702,0.00047362837,0.0007757082],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098636345,0.0005693032,0.7122473,0.0069186906,0.00010618204,7.9805363e-7,0.036672555,0.07909131,0.000026626665,0.15902944,0.0015720322,0.0036671355],"study_design_scores_gemma":[0.007029406,0.00047874352,0.7142568,0.0026316463,0.000010300477,0.0000026660232,0.015802955,0.14465113,0.000043721415,0.10379286,0.010408942,0.00089081336],"about_ca_topic_score_codex":0.08094319,"about_ca_topic_score_gemma":0.0055596936,"teacher_disagreement_score":0.1905321,"about_ca_system_score_codex":0.005163605,"about_ca_system_score_gemma":0.0016908571,"threshold_uncertainty_score":0.99996984},"labels":[],"label_agreement":null},{"id":"W2953688847","doi":"10.1016/j.jval.2019.04.146","title":"PCN22 CLINICAL HETEROGENEITY AMONG FIRST-LINE SUNITINIB PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC) CATEGORIZED AS INTERMEDIATE RISK (IR) GROUP ACCORDING TO THE INTERNATIONAL MRCC DATABASE CONSORTIUM (IMDC) RISK MODEL","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Health Sciences Centre; Sunnybrook Health Science Centre; University of Calgary","funders":"","keywords":"Sunitinib; Medicine; Discontinuation; Renal cell carcinoma; Internal medicine; Oncology; Gastroenterology","score_opus":0.05839267446960073,"score_gpt":0.31812552893717355,"score_spread":0.2597328544675728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953688847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925184,0.00017433288,0.0011724591,0.0008631888,0.0009917191,0.0033862058,0.000663856,0.00005706557,0.00017277387],"genre_scores_gemma":[0.9941095,0.00035760194,0.002981564,0.0011246293,0.00019015776,0.00018487609,0.0008336294,0.00008987819,0.00012817293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9943956,0.0010663328,0.0016574606,0.001035617,0.0010430322,0.00080191524],"domain_scores_gemma":[0.99574184,0.0010627316,0.0010296473,0.0011893943,0.0002565179,0.00071988505],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028696475,0.00050270685,0.0010031917,0.00035251596,0.00020631586,0.00006173113,0.0005269125,0.00010533844,0.00007591376],"category_scores_gemma":[0.00058363966,0.00033783904,0.000253874,0.00038206764,0.00014804368,0.00023270074,0.00036863043,0.0010939557,0.00017908041],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030161832,0.0010193496,0.97298396,0.00019581789,0.0001649677,0.000094802665,0.0006505611,0.020558836,0.00002375243,0.000026964512,0.00026046354,0.0010043368],"study_design_scores_gemma":[0.018072864,0.0050663,0.83037686,0.00044511887,0.00038518832,0.00002856327,0.00048417153,0.1435731,0.0005907931,0.00008333827,0.0004226345,0.00047107687],"about_ca_topic_score_codex":0.01848553,"about_ca_topic_score_gemma":0.002144898,"teacher_disagreement_score":0.14260712,"about_ca_system_score_codex":0.000733008,"about_ca_system_score_gemma":0.0006474095,"threshold_uncertainty_score":0.9999074},"labels":[],"label_agreement":null},{"id":"W2953738724","doi":"10.1016/j.jval.2019.04.228","title":"PCN104 OBINUTUZUMAB IN PREVIOUSLY UNTREATED FOLLICULAR LYMPHOMA: AN IMPORTANT CLINICAL AND COST-EFFECTIVE OPTION FOR HIGH-RISK (INTERMEDIATE/HIGH FLIPI) PATIENTS IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Follicular lymphoma; Obinutuzumab; Hazard ratio; Internal medicine; Rituximab; Population; Regimen; Oncology; Confidence interval; Surgery; Progression-free survival; Chemotherapy; Lymphoma","score_opus":0.01568608151706712,"score_gpt":0.28868285891160483,"score_spread":0.2729967773945377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953738724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895055,0.00055159116,0.0000025123466,0.00017188792,0.0005597209,0.009044792,0.00014262897,0.000016281965,0.0000050693575],"genre_scores_gemma":[0.9964792,0.0014540901,0.00017185436,0.0004480883,0.00005803649,0.0010031671,0.00034628605,0.000032400912,0.000006877979],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99692804,0.000472377,0.0011466717,0.0006324672,0.00026428,0.0005561502],"domain_scores_gemma":[0.99848425,0.00044182205,0.00034200482,0.0003342847,0.00006911548,0.00032853984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009108524,0.00025755033,0.0008729991,0.00018041159,0.000046503505,0.000016270507,0.00006987878,0.0001449252,0.000007820747],"category_scores_gemma":[0.00022080749,0.00021260126,0.000061911276,0.00024647932,0.000040347448,0.00009908223,0.000032699278,0.00014110617,0.000004147607],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008470646,0.0010139203,0.9528373,0.00021581205,0.00004316038,0.0000834854,0.0003053388,0.00036887397,5.8360496e-7,0.00014212356,0.00006191524,0.044080414],"study_design_scores_gemma":[0.03399312,0.004086136,0.9501626,0.00063642097,0.00004353995,0.000006841254,0.000097161195,0.010440649,0.000037559475,0.0001485015,0.00018082373,0.00016668045],"about_ca_topic_score_codex":0.97205406,"about_ca_topic_score_gemma":0.81986886,"teacher_disagreement_score":0.15218519,"about_ca_system_score_codex":0.0071413103,"about_ca_system_score_gemma":0.0034100546,"threshold_uncertainty_score":0.9966701},"labels":[],"label_agreement":null},{"id":"W2953886592","doi":"10.1016/j.jval.2019.04.301","title":"PCN179 DISPARITY IN COLORECTAL CANCER SCREENING AMONG US VETERANS: RESULTS FROM BEHAVIORAL RISK FACTOR SURVEILLANCE SYSTEM 2014-2016","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Behavioral Risk Factor Surveillance System; Medicine; Colorectal cancer; Logistic regression; Odds; Odds ratio; Demography; Cross-sectional study; Ethnic group; Risk factor; Behavioral risk; Cancer; Gerontology; Internal medicine; Environmental health; Population; Pathology","score_opus":0.0364951497337882,"score_gpt":0.30943125088308787,"score_spread":0.27293610114929967,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953886592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994503,0.0016403715,0.0001576246,0.00015494147,0.0011344597,0.0011499132,0.0009794345,0.00015405679,0.0001261673],"genre_scores_gemma":[0.9987092,0.0003776407,0.0003896349,0.00004817043,0.000247006,0.0000802588,0.00006664969,0.00003700978,0.000044408058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969012,0.0005813644,0.00083207956,0.00069503865,0.00041455397,0.0005757311],"domain_scores_gemma":[0.99858767,0.00036599633,0.00039186655,0.00034740043,0.0000671341,0.00023992381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009975772,0.00025039804,0.00071455835,0.00024262659,0.00008745954,0.00003048357,0.000120808414,0.00021061007,0.000042161737],"category_scores_gemma":[0.00011357535,0.00023429553,0.00010477134,0.00042215516,0.000047163765,0.00017448266,0.00004673663,0.00075392757,0.000028685843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067739617,0.000074526295,0.9786225,0.00017142668,0.000016139342,0.000022132674,0.0010015462,0.0033358762,0.00018664729,0.0000016564584,0.000065911125,0.009727674],"study_design_scores_gemma":[0.004454547,0.0014210946,0.95521903,0.0019779443,0.000010310605,0.000007126469,0.00025533463,0.036073294,0.00023839653,0.00000336589,0.00012450767,0.00021505936],"about_ca_topic_score_codex":0.6875534,"about_ca_topic_score_gemma":0.062104825,"teacher_disagreement_score":0.6254486,"about_ca_system_score_codex":0.00122247,"about_ca_system_score_gemma":0.00038468846,"threshold_uncertainty_score":0.95542943},"labels":[],"label_agreement":null},{"id":"W2953956356","doi":"10.1016/j.jval.2019.04.1826","title":"PSY1 CONCEPTUALIZING A FRAMEWORK FOR MODELING SYSTEMIC LUPUS ERYTHEMATOSUS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Disease; Conceptual model; Conceptual framework; Intensive care medicine; Internal medicine; Computer science","score_opus":0.08770676315568394,"score_gpt":0.36965341817216457,"score_spread":0.28194665501648064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953956356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95084167,0.009094101,0.031752646,0.0012736905,0.0014017831,0.004965516,0.000013780068,0.00015976166,0.0004970814],"genre_scores_gemma":[0.98198247,0.00035072773,0.015765924,0.00047836654,0.00031001747,0.00028490394,0.000013882609,0.00010364285,0.0007100435],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9963103,0.0002874796,0.0011169019,0.0006203005,0.000667697,0.0009973119],"domain_scores_gemma":[0.997391,0.0010432198,0.00023793423,0.00081106304,0.00017623567,0.00034056083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024157725,0.00025653152,0.0010115631,0.00037189602,0.000091339876,0.000031504063,0.00023184608,0.00026443074,0.00005237697],"category_scores_gemma":[0.0007301581,0.00022814368,0.00017398613,0.00048255772,0.00003895945,0.000085365136,0.00006712859,0.0005324264,0.00021438247],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014766218,0.00042862253,0.65368015,0.072338596,0.00020760555,0.00008386837,0.0367162,0.054494664,0.0011200203,0.176541,0.0014026149,0.0015100563],"study_design_scores_gemma":[0.00735582,0.00077886,0.00002168362,0.03650066,0.000023003468,0.022199748,0.01913073,0.9023346,0.00007085907,0.010371661,0.0007795002,0.0004329304],"about_ca_topic_score_codex":0.00074263907,"about_ca_topic_score_gemma":0.0000054507173,"teacher_disagreement_score":0.8478399,"about_ca_system_score_codex":0.0009173941,"about_ca_system_score_gemma":0.0009649799,"threshold_uncertainty_score":0.9303429},"labels":[],"label_agreement":null},{"id":"W2953968008","doi":"10.1016/j.jval.2019.04.1567","title":"PNS210 REVIEW OF CANADIAN VERSUS OTHER GUIDELINES FOR CONDUCTING BUDGET IMPACT ANALYSIS: DO CANADIAN GUIDELINES DIFFER AND WHY?","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Population; Public economics; Actuarial science; Accounting; Health economics; Medicine; Political science; Business; Public health; Environmental health; Economics","score_opus":0.7124043694265298,"score_gpt":0.5210945753044769,"score_spread":0.19130979412205296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953968008","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38146305,0.22006778,0.00021605661,0.3844963,0.0018401671,0.004318074,0.005712624,0.000029901037,0.0018560267],"genre_scores_gemma":[0.5619701,0.062097874,0.029271886,0.34281918,0.001599294,0.00043620684,0.00059657596,0.00025840502,0.00095047295],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.992961,0.0003339064,0.0053323717,0.0005691026,0.00008802165,0.0007155891],"domain_scores_gemma":[0.9955617,0.0008454316,0.0019002787,0.0005932832,0.00039178558,0.00070752256],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.023327367,0.00022678987,0.0017005139,0.0022069134,0.0001228445,0.000040873045,0.00023809064,0.00014149789,0.0005326413],"category_scores_gemma":[0.009317028,0.0002541917,0.00021466815,0.0009955361,0.000033521846,0.00021280443,0.00001775511,0.00013573545,0.00009008644],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050156537,0.000048359183,0.5321851,0.019684931,0.0009380935,0.000001075084,0.002178993,0.010556839,0.0000016835913,0.042143032,0.39095405,0.0012576999],"study_design_scores_gemma":[0.0034238151,0.00048229482,0.030215377,0.007134591,0.00010538688,0.0000057166717,0.0019447713,0.07227953,0.000002048999,0.0032837307,0.8800687,0.0010540376],"about_ca_topic_score_codex":0.9843637,"about_ca_topic_score_gemma":0.8713066,"teacher_disagreement_score":0.5019697,"about_ca_system_score_codex":0.0014335208,"about_ca_system_score_gemma":0.0022054624,"threshold_uncertainty_score":0.99999106},"labels":[],"label_agreement":null},{"id":"W2953974800","doi":"10.1016/j.jval.2019.04.739","title":"PDG60 DID CITIZEN PETITIONS PROLONG THE NUMBER OF APPROVAL DAYS OF GENERIC DRUGS?","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Medicine; Value (mathematics); Food and drug administration; Pharmacology; Geography; Statistics; Mathematics","score_opus":0.07224846029655808,"score_gpt":0.3052642194823649,"score_spread":0.2330157591858068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2953974800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9473473,0.00082040887,0.00004411976,0.0041111847,0.0002885191,0.00041046634,0.00023272447,0.000007612322,0.046737682],"genre_scores_gemma":[0.99752074,0.00070400134,0.00039052122,0.0010234992,0.000075176984,0.000021607,0.000008584399,0.000015991023,0.00023989227],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99860895,0.000046687608,0.00081602146,0.00021888755,0.000028995324,0.00028046107],"domain_scores_gemma":[0.9990147,0.00013744067,0.00043769236,0.0003232725,0.00001505978,0.00007184434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010017466,0.000091185146,0.00039774834,0.000109266184,0.00003640859,0.000010265231,0.00023587882,0.00005293931,0.0004605272],"category_scores_gemma":[0.00004161422,0.00008720073,0.000095262345,0.00023897097,0.000073333016,0.00006522207,0.000060879607,0.00016716144,0.00029983508],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018832852,0.00013333035,0.12472758,0.00032598904,0.000026731914,2.410613e-7,0.0012580055,0.0049613803,0.000016406217,0.8673815,0.00047010908,0.0006799123],"study_design_scores_gemma":[0.004184293,0.0003677929,0.18904105,0.0002550985,0.000014369772,0.000022449876,0.00053375115,0.22100623,0.00045938478,0.40162235,0.18163122,0.0008619969],"about_ca_topic_score_codex":0.002450069,"about_ca_topic_score_gemma":0.000009105116,"teacher_disagreement_score":0.46575913,"about_ca_system_score_codex":0.00009007742,"about_ca_system_score_gemma":0.00009840478,"threshold_uncertainty_score":0.504245},"labels":[],"label_agreement":null},{"id":"W2954103814","doi":"10.1016/j.jval.2019.04.025","title":"CP2 ESTIMATING THE SURVIVAL AND COST IMPACT OF INTRODUCING FIRST-LINE ALECTINIB AND OSIMERTINIB FOR PATIENTS WITH ADVANCED NSCLC: AN ITEN MODEL ASSESSMENT","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Alectinib; Osimertinib; Medicine; Oncology; Lung cancer; Internal medicine; Erlotinib; Crizotinib; Cancer","score_opus":0.04173580079861362,"score_gpt":0.31266619281454017,"score_spread":0.27093039201592656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954103814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878708,0.00047898488,0.009322991,0.0004384662,0.00017376685,0.0011631277,0.00020920622,0.000008317743,0.0003343325],"genre_scores_gemma":[0.98761094,0.00016846765,0.011963266,0.000097997,0.00005670898,0.000038200982,0.000019301486,0.000026432666,0.000018663965],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986184,0.000020914169,0.000631783,0.00037069691,0.000032597593,0.00032555833],"domain_scores_gemma":[0.99880314,0.00022060491,0.0005780864,0.0002552917,0.000044726512,0.0000981739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010400696,0.0001480109,0.0005045431,0.00010500752,0.00010903577,0.000036378646,0.000101870275,0.00004879822,0.000009359058],"category_scores_gemma":[0.00014595196,0.000121327386,0.000038062622,0.00010366273,0.00004554642,0.00033807522,0.000034099216,0.00013564453,0.0000010152048],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017370548,0.00008521103,0.59154624,0.00012774784,0.000019913086,3.530031e-8,0.00065450586,0.39035586,0.0000012414588,0.004875258,0.000012652092,0.012147628],"study_design_scores_gemma":[0.0020377208,0.0010922304,0.3322107,0.00008377959,0.0000025646618,3.5442778e-7,0.000037877122,0.6613243,0.000001105317,0.0030027188,0.00007637552,0.00013026952],"about_ca_topic_score_codex":0.0030529436,"about_ca_topic_score_gemma":0.00015040988,"teacher_disagreement_score":0.27096847,"about_ca_system_score_codex":0.00021217596,"about_ca_system_score_gemma":0.00014299636,"threshold_uncertainty_score":0.49475873},"labels":[],"label_agreement":null},{"id":"W2954105574","doi":"10.1016/j.jval.2019.04.357","title":"PCN236 COST-EFFECTIVENESS OF LENALIDOMIDE PLUS LOW DOSE DEXAMETHASONE IN THE CHINESE PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA BUT INELIGIBLE FOR STEM CELL TRANSPLANT THERAPY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Lenalidomide; Multiple myeloma; Quality-adjusted life year; Cost effectiveness; Cost-effectiveness analysis; Relative risk; Per capita; Cost–benefit analysis; Internal medicine; Confidence interval; Environmental health; Population; Risk analysis (engineering)","score_opus":0.041184977474890576,"score_gpt":0.32130413625237836,"score_spread":0.2801191587774878,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954105574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860033,0.00081882975,0.00023958893,0.00015526963,0.00008146266,0.012434028,0.00021456579,0.000018325045,0.000034628414],"genre_scores_gemma":[0.99741626,0.0005166731,0.00062659883,0.00015745254,0.000028094893,0.0009863642,0.00019874163,0.000045409586,0.000024425448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969372,0.00089459436,0.0005369886,0.00042883537,0.0005657538,0.0006365983],"domain_scores_gemma":[0.995405,0.0036088075,0.00018743011,0.00048162258,0.00012361998,0.00019352658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015463657,0.00028590142,0.00079231383,0.00028307387,0.000057210953,0.000014519088,0.0002079045,0.00009603142,0.000009040086],"category_scores_gemma":[0.00008567101,0.00016110667,0.000108608125,0.0005787266,0.000056677127,0.00009887986,0.000016300059,0.00028393138,0.00000824741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.028169673,0.0021246294,0.9484156,0.002409795,0.00006333082,0.00005005448,0.0024133096,0.005856299,0.0007006824,0.000011475903,0.000005988427,0.009779171],"study_design_scores_gemma":[0.08720881,0.0031786761,0.8958402,0.0011926967,0.000010359499,0.0000051981833,0.00022975604,0.009023464,0.0031000774,0.000025037245,0.000035341924,0.0001503565],"about_ca_topic_score_codex":0.011537192,"about_ca_topic_score_gemma":0.00043140186,"teacher_disagreement_score":0.05903913,"about_ca_system_score_codex":0.00037845233,"about_ca_system_score_gemma":0.00059407967,"threshold_uncertainty_score":0.99504507},"labels":[],"label_agreement":null},{"id":"W2954156255","doi":"10.1016/j.jval.2019.04.412","title":"PCN293 REAL-WORLD PRODUCTIVITY, HEALTHCARE RESOURCE UTILIZATION (HCRU) AND QUALITY OF LIFE (QOL) IN PATIENTS RECEIVING FIRST-LINE TREATMENT FOR ADVANCED GASTRIC CANCER (GC) IN CANADA AND EUROPE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Visual analogue scale; Work productivity; Cancer; Productivity; Population; Disease; Health care; Gerontology; Family medicine; Internal medicine; Physical therapy; Environmental health; Nursing","score_opus":0.10974837712851088,"score_gpt":0.3052322435279914,"score_spread":0.1954838663994805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954156255","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99169964,0.0043479167,0.000013582506,0.0018881744,0.00020948781,0.0012483535,0.0003128908,0.0000047414787,0.00027521755],"genre_scores_gemma":[0.9910042,0.008365431,0.00012485418,0.00023601243,0.000037141326,0.00006274944,0.000023215325,0.000022880893,0.00012349336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99788237,0.00007392156,0.0011333411,0.00049176987,0.000040083723,0.0003785326],"domain_scores_gemma":[0.998755,0.0001802125,0.0006847214,0.00021753971,0.00004002935,0.00012254609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008199952,0.00015574484,0.0007323582,0.00030553917,0.0000412201,0.000010703598,0.000070575734,0.000045495555,0.00000819025],"category_scores_gemma":[0.00031103686,0.00018217032,0.000020596757,0.00043790674,0.0000219548,0.00018110208,0.000034496763,0.000108387576,7.341678e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022312379,0.0000827445,0.9717521,0.00056503183,0.00000462723,1.19167005e-7,0.00045084633,0.0076651275,3.4141775e-7,0.0018176785,0.000021356736,0.017416911],"study_design_scores_gemma":[0.0025828357,0.00031784666,0.99082124,0.00021322409,7.6311994e-7,6.377724e-8,0.000048528567,0.0020664365,0.000004514192,0.00047790518,0.0033171878,0.00014946504],"about_ca_topic_score_codex":0.9654871,"about_ca_topic_score_gemma":0.97618204,"teacher_disagreement_score":0.019069139,"about_ca_system_score_codex":0.0020367221,"about_ca_system_score_gemma":0.0008237124,"threshold_uncertainty_score":0.742869},"labels":[],"label_agreement":null},{"id":"W2954218874","doi":"10.1016/j.jval.2019.04.429","title":"PCN311 CLINICAL CHARACTERISTICS, TREATMENT PATTERNS, AND HEALTHCARE RESOURCE UTILIZATION IN PATIENTS WITH ADVANCED UROTHELIAL CARCINOMA AFTER PROGRESSION ON PLATINUM-BASED THERAPY: A MEDICAL RECORD REVIEW STUDY IN THE UNITED STATES AND CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gemcitabine; Medical record; Internal medicine; Retrospective cohort study; Disease; Regimen; Cisplatin; Cancer; Oncology; Chemotherapy","score_opus":0.048399791486402555,"score_gpt":0.3538531635827382,"score_spread":0.30545337209633566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954218874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9882328,0.0016711412,6.31608e-7,0.0047923187,0.00006369246,0.0051516327,0.00007739995,0.000007705633,0.0000027012782],"genre_scores_gemma":[0.9845394,0.0064561027,0.000021447064,0.008414497,0.000027442375,0.00025792565,0.00025673394,0.00002302001,0.0000034573204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714154,0.00104822,0.0006485624,0.00039990453,0.00049417693,0.0002676072],"domain_scores_gemma":[0.99909824,0.00025592654,0.00016847321,0.00026744444,0.00004025992,0.00016967843],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064082426,0.00020395457,0.0005367695,0.00011264865,0.000034543802,0.000008221303,0.000053090294,0.00006118039,0.000017326836],"category_scores_gemma":[0.000055861692,0.00011565386,0.000016039607,0.00020380635,0.000028285385,0.000023516048,0.000011809793,0.00026395742,3.880285e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003980947,0.0011108271,0.90208036,0.0006009675,0.000009170322,0.000058791637,0.0007947519,0.0000029494201,1.0690111e-8,6.178729e-7,0.000010345042,0.09135026],"study_design_scores_gemma":[0.014118994,0.013739852,0.9651547,0.0053864107,0.000011414953,0.0000016476221,0.00027942617,0.00033976114,5.1651847e-7,0.000001328949,0.0008739772,0.0000919743],"about_ca_topic_score_codex":0.49085826,"about_ca_topic_score_gemma":0.2792838,"teacher_disagreement_score":0.21157448,"about_ca_system_score_codex":0.00039709164,"about_ca_system_score_gemma":0.0010048605,"threshold_uncertainty_score":0.7338674},"labels":[],"label_agreement":null},{"id":"W2954222820","doi":"10.1016/j.jval.2019.04.1552","title":"PNS195 MODELLING HETEROGENEOUS PUBLIC PREFERENCES IN DISCRETE CHOICE EXPERIMENTS: AN APPLICATION TO PRENATAL SCREENING AND DIAGNOSTIC STRATEGIES FOR CHROMOSOMAL ABNORMALITIES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Advancing Health Outcomes","funders":"","keywords":"Population; Miscarriage; Prenatal screening; Medicine; Bayes' theorem; Prenatal diagnosis; Sample (material); Pregnancy; Psychology; Environmental health; Statistics; Bayesian probability; Biology; Genetics","score_opus":0.149757639033529,"score_gpt":0.28136582638758395,"score_spread":0.13160818735405494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954222820","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9639123,0.0013626302,0.033277515,0.00018505333,0.00007141045,0.000986104,0.0000813651,0.000014049155,0.00010955285],"genre_scores_gemma":[0.99601686,0.000222683,0.003131094,0.000118120064,0.00004308483,0.000349627,0.000083063496,0.00001717267,0.000018265824],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99867046,0.000034002165,0.0005523408,0.00041905194,0.000029792196,0.00029432986],"domain_scores_gemma":[0.99939865,0.00015524079,0.00017872883,0.00017068937,0.0000044085027,0.00009226489],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005532622,0.00011414454,0.00025007557,0.00016705332,0.000060632472,0.00009297023,0.00011563424,0.00005605184,0.000022268867],"category_scores_gemma":[0.000022380016,0.00014488627,0.00002204893,0.000071007285,0.000020935468,0.00073182484,0.00003942279,0.00006857475,0.0000210684],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012747553,0.000046530982,0.3309379,0.00012618555,0.0000057118873,1.05407025e-7,0.0019511045,0.63877755,0.000006296779,0.026770331,9.501768e-7,0.0013645631],"study_design_scores_gemma":[0.00083331595,0.00041391153,0.09191914,0.00009748334,0.0000010603671,0.0000017084474,0.0015325051,0.8891784,0.000054087697,0.015394792,0.00030631502,0.00026728612],"about_ca_topic_score_codex":0.0070677707,"about_ca_topic_score_gemma":0.00033907685,"teacher_disagreement_score":0.2504008,"about_ca_system_score_codex":0.00018526957,"about_ca_system_score_gemma":0.000029077526,"threshold_uncertainty_score":0.99954426},"labels":[],"label_agreement":null},{"id":"W2954288090","doi":"10.1016/j.jval.2019.04.958","title":"PIN88 INTERRUPTED TIME SERIES ANALYSIS OF UVGI TECHNOLOGY TO REDUCE INFECTION RATES IN A CANADIAN HEALTH REGION - AN ECONOMIC ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Device Sterilization and Disinfection","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Northern British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Context (archaeology); Interrupted Time Series Analysis; Infection control; Environmental health; Emergency medicine; Intensive care medicine; Geography; Statistics","score_opus":0.018881734878317978,"score_gpt":0.32016355207449304,"score_spread":0.3012818171961751,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954288090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945771,0.00025003986,0.0001675287,0.0040338584,0.00030221828,0.000429579,0.000028846789,0.000041783394,0.00016901153],"genre_scores_gemma":[0.99838126,0.00018660515,0.000038238628,0.00068075035,0.0000070984765,0.000015902751,0.00046321348,0.000008380118,0.00021856082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978414,0.0006067231,0.000728671,0.00037794706,0.000027428612,0.00041778377],"domain_scores_gemma":[0.99918985,0.000045486584,0.00026017363,0.00033343342,0.000040749186,0.00013032205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008261756,0.0001276969,0.0007037464,0.0050991583,0.000060073613,0.000008377564,0.00010556824,0.00022997506,0.0006588833],"category_scores_gemma":[0.000102865604,0.00013379102,0.00008484532,0.0037737114,0.00005949541,0.000121326215,0.000024927367,0.00019367533,0.0001651308],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018344623,0.00013512785,0.9491934,0.00009543447,0.00060024735,0.0000012690106,0.0017603695,0.039182168,0.0013352402,0.0019292139,0.00022042757,0.005363622],"study_design_scores_gemma":[0.0009833057,0.0012858977,0.97395855,0.00016712402,0.00016159112,0.000013611072,0.00056364917,0.016678983,0.00060025876,0.00016408072,0.0051613087,0.00026162362],"about_ca_topic_score_codex":0.76853055,"about_ca_topic_score_gemma":0.72724885,"teacher_disagreement_score":0.041281708,"about_ca_system_score_codex":0.00082106364,"about_ca_system_score_gemma":0.0007825118,"threshold_uncertainty_score":0.721431},"labels":[],"label_agreement":null},{"id":"W2954426845","doi":"10.1016/j.jval.2019.04.663","title":"PDB116 REAL-WORLD ADHERENCE AND PERSISTENCE AMONG ELDERLY PATIENTS WITH T2DM INITIATING DULAGLUTIDE VS. LIRAGLUTIDE OR EXENATIDE ONCE-WEEKLY IN THE US","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Liraglutide; Medicine; Dulaglutide; Discontinuation; Lira; Exenatide; Internal medicine; Hazard ratio; Type 2 diabetes; Diabetes mellitus; Endocrinology; Confidence interval","score_opus":0.03829917965234857,"score_gpt":0.2758031372049166,"score_spread":0.23750395755256803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954426845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99034137,0.00015758259,0.000002989444,0.0012757259,0.00009346583,0.0021053748,0.000006265381,0.00003642067,0.0059808395],"genre_scores_gemma":[0.9959974,0.0002575925,0.0010264447,0.001522544,0.000030010486,0.00009255685,0.000026467602,0.00002489938,0.0010220697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978128,0.00022669646,0.00049590616,0.00044823764,0.00045642772,0.0005599139],"domain_scores_gemma":[0.998812,0.00035897002,0.00023784561,0.00040320173,0.000051589,0.00013637503],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073654874,0.00023097747,0.0004460138,0.00026842425,0.00009207709,0.000042031417,0.00016053006,0.00004414223,0.000035839792],"category_scores_gemma":[0.0001018792,0.00014295774,0.00003739933,0.00062324695,0.00008604361,0.00021471767,0.00006244207,0.00028422082,0.000018485835],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022706247,0.0002837587,0.98879,0.00046027647,0.000026441527,0.00005088671,0.0021951173,0.00019010782,0.0000012097662,0.0002781472,0.00014324885,0.0073537845],"study_design_scores_gemma":[0.0034880063,0.003402127,0.9879665,0.0020805846,0.00003293049,0.0000018711333,0.0011135628,0.001220781,0.000007387791,0.000062600724,0.00046048788,0.00016315616],"about_ca_topic_score_codex":0.015013693,"about_ca_topic_score_gemma":0.0051360014,"teacher_disagreement_score":0.009877692,"about_ca_system_score_codex":0.0003218838,"about_ca_system_score_gemma":0.00022367093,"threshold_uncertainty_score":0.99154544},"labels":[],"label_agreement":null},{"id":"W2954431181","doi":"10.1016/j.jval.2019.04.534","title":"PCV99 BAYESIAN NETWORKS AS AN EMERGING TOOL FOR DISEASE RISK ESTIMATION AND CLINICAL DECISION-MAKING: A REAL-WORLD EXAMPLE IN CORONARY ARTERY DISEASE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Toronto Public Health","funders":"","keywords":"Interpretability; Coronary artery disease; Logistic regression; Machine learning; CAD; Bayesian network; Disease; Artificial intelligence; Receiver operating characteristic; Computer science; Missing data; Medicine; Bayesian probability; Risk assessment; Data mining; Internal medicine; Engineering","score_opus":0.1502559212390691,"score_gpt":0.508387657659241,"score_spread":0.3581317364201719,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954431181","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97550684,0.00050703675,0.014226566,0.001858943,0.0016911434,0.005946428,0.00009040786,0.00012423893,0.000048378715],"genre_scores_gemma":[0.98946935,0.0011694243,0.00540936,0.0027755774,0.00047049992,0.00046496702,0.00009777121,0.000082504564,0.000060575938],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99213195,0.002514721,0.0027180207,0.0010596397,0.0003825463,0.001193153],"domain_scores_gemma":[0.9864681,0.010656117,0.0007709128,0.00092586724,0.0001419645,0.0010370559],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00654784,0.00030824388,0.0006804141,0.0004493951,0.0007861191,0.000029480994,0.000272534,0.00024297136,0.0001449606],"category_scores_gemma":[0.0026119526,0.000315233,0.000109110966,0.0005796755,0.00008955852,0.00044471782,0.00015036852,0.0012460317,0.00007916886],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017851304,0.00019910964,0.84508085,0.0006303103,0.000005529498,0.000029648829,0.0016291694,0.04230111,6.1526414e-8,0.0028619685,0.00018923392,0.1052879],"study_design_scores_gemma":[0.00037433492,0.00020077005,0.42227966,0.0017613372,0.0000094133,4.4655565e-7,0.00079232955,0.54095864,1.9255397e-8,0.033246994,0.00020748444,0.00016856455],"about_ca_topic_score_codex":0.021221308,"about_ca_topic_score_gemma":0.015508454,"teacher_disagreement_score":0.49865755,"about_ca_system_score_codex":0.0007293674,"about_ca_system_score_gemma":0.0021297913,"threshold_uncertainty_score":0.99992996},"labels":[],"label_agreement":null},{"id":"W2954455586","doi":"10.1016/j.jval.2019.04.1777","title":"PSS5 THE COST-EFFECTIVENESS OF HALOBETASOL PROPIONATE (0.01%) AND TAZAROTENE (0.045%) FIXED COMBINATION RELATIVE TO OTHER TOPICAL THERAPIES IN MODERATE-TO-SEVERE PLAQUE PSORIASIS: A CANADIAN ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada; Vancouver Coastal Health","funders":"","keywords":"Medicine; Tazarotene; Plaque psoriasis; Reimbursement; Psoriasis; Relative risk; Cost-effectiveness analysis; Internal medicine; Cost effectiveness; Dermatology; Health care; Confidence interval","score_opus":0.20773328661019286,"score_gpt":0.38207586315887165,"score_spread":0.1743425765486788,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954455586","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9483701,0.0007670566,0.0013772118,0.04453254,0.00021176253,0.004209562,0.00018284618,0.000010952624,0.00033797428],"genre_scores_gemma":[0.994044,0.00006230137,0.0006443649,0.004660044,0.000028031813,0.00041928294,0.000017780896,0.000020758836,0.00010343393],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953043,0.0016606168,0.0019854088,0.00052395504,0.00010257444,0.0004231821],"domain_scores_gemma":[0.9973474,0.0013092819,0.0006391785,0.00039505016,0.00006556598,0.00024351894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011528935,0.00017084008,0.0010276542,0.0010208609,0.00010649167,0.00003973781,0.00020114235,0.00013878687,0.000080473896],"category_scores_gemma":[0.0009274769,0.00017013619,0.00006967506,0.0009089318,0.00003506895,0.00022531004,0.00003343253,0.00022559278,0.000102162114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018129361,0.00011523616,0.67602813,0.0006132412,0.00019038821,7.296114e-7,0.012737833,0.102506794,0.0000032883283,0.20708428,0.00013942953,0.00039935944],"study_design_scores_gemma":[0.0018893817,0.00028633498,0.89080644,0.00040784804,0.00000960222,0.0000013126986,0.0010258071,0.083479755,0.000007743038,0.01884371,0.0029514497,0.00029062442],"about_ca_topic_score_codex":0.35743156,"about_ca_topic_score_gemma":0.101076946,"teacher_disagreement_score":0.2563546,"about_ca_system_score_codex":0.0013716875,"about_ca_system_score_gemma":0.000490804,"threshold_uncertainty_score":0.91532606},"labels":[],"label_agreement":null},{"id":"W2954511636","doi":"10.1016/j.jval.2019.04.1412","title":"PNS52 CAN COST-EFFECTIVENESS ANALYSIS INFORM THE EXTENT OF COVERAGE UNDER PUBLIC HEALTHCARE? A MICROSIMULATION MODEL OF ALTERNATIVE PRENATAL SCREENING AND DIAGNOSTIC STRATEGIES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Medicine; Prenatal screening; Cost-effectiveness analysis; Microsimulation; Population; Cost effectiveness; Quality-adjusted life year; Gynecology; Obstetrics; Pregnancy; Statistics; Prenatal diagnosis; Risk analysis (engineering); Fetus; Environmental health; Mathematics; Biology","score_opus":0.07238440788601408,"score_gpt":0.3416837077488114,"score_spread":0.2692992998627973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954511636","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96203136,0.0009648433,0.034279127,0.0010537476,0.00003912019,0.0014005594,0.00016328617,0.0000143251655,0.00005361013],"genre_scores_gemma":[0.99870706,0.0004407474,0.00048769705,0.00019941051,0.000014562668,0.000034237262,0.00009869883,0.000012344137,0.0000052656214],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99833626,0.00025164895,0.00053261966,0.0002353655,0.00035920533,0.00028488893],"domain_scores_gemma":[0.996393,0.0026565867,0.00034778833,0.00029023484,0.0001717827,0.00014057505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009790453,0.00014129351,0.00052364246,0.00030695053,0.00005591159,0.000023428094,0.000097510354,0.000072985524,0.0000030759409],"category_scores_gemma":[0.00047463007,0.00010966568,0.0000844919,0.0005613707,0.00009702395,0.00016777197,0.000078290795,0.00023543312,3.8456722e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016899013,0.000081884275,0.23272891,0.0008247212,0.00013909118,0.0000014810748,0.0012100235,0.75165313,0.00004199604,0.007494974,8.759693e-7,0.005653901],"study_design_scores_gemma":[0.0014165917,0.0003921626,0.4555465,0.0007822847,0.000074158925,0.000003883688,0.000565809,0.53943783,0.00029979684,0.0014002916,0.000002159859,0.0000785049],"about_ca_topic_score_codex":0.033447582,"about_ca_topic_score_gemma":0.00081236527,"teacher_disagreement_score":0.22281758,"about_ca_system_score_codex":0.00017146749,"about_ca_system_score_gemma":0.0005422882,"threshold_uncertainty_score":0.9729888},"labels":[],"label_agreement":null},{"id":"W2954516837","doi":"10.1016/j.jval.2019.04.1375","title":"PNS9 PROPENSITY SCORE MATCHING AND REWEIGHTING TO ASSESS COMPARATIVE EFFICACY OF SINGLE-ARM TRIALS: A GENERAL FRAMEWORK AND SIMULATION STUDY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Propensity score matching; Replicate; Observational study; Computer science; Inverse probability weighting; Matching (statistics); Weighting; Sample size determination; Flexibility (engineering); Comparative effectiveness research; Average treatment effect; Data mining; Statistics; Mathematics; Medicine","score_opus":0.6619148956200791,"score_gpt":0.5295113976503267,"score_spread":0.13240349796975237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954516837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95531976,0.00006179417,0.041388724,0.00007162307,0.00005233121,0.0029852039,0.0000036469157,0.0000718584,0.000045084173],"genre_scores_gemma":[0.85476637,0.0000059911376,0.14510389,0.00005041783,0.000034499797,0.000016548576,0.0000010256059,0.000015579948,0.000005679755],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9974153,0.0009803588,0.0008429017,0.0003191022,0.00022511088,0.00021721786],"domain_scores_gemma":[0.9942899,0.0047660666,0.00051210646,0.00025638856,0.00009040966,0.00008515083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034615928,0.00015745057,0.0008707635,0.00013819219,0.00006562525,0.000034069108,0.00008075501,0.00007296328,0.0000046429777],"category_scores_gemma":[0.0019555998,0.00013415665,0.00002276932,0.0002250413,0.000027028496,0.00014637578,0.00011447411,0.00026315433,9.3487995e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015416569,0.006352987,0.41290593,0.0037391041,0.00015621768,0.000016472988,0.16606463,0.23384668,0.012085475,0.14215101,0.000024363893,0.021115445],"study_design_scores_gemma":[0.0038563088,0.008224488,0.15855628,0.007040023,0.000068532245,0.0000095584455,0.006075658,0.060223028,0.005166908,0.74983484,0.000028733708,0.0009156266],"about_ca_topic_score_codex":0.00045568577,"about_ca_topic_score_gemma":0.000036882073,"teacher_disagreement_score":0.60768384,"about_ca_system_score_codex":0.00012540357,"about_ca_system_score_gemma":0.00006598604,"threshold_uncertainty_score":0.5470749},"labels":[],"label_agreement":null},{"id":"W2954519816","doi":"10.1016/j.jval.2019.04.1162","title":"PMS52 REAL-WORLD OUTCOMES AND COST OF MANAGEMENT OF OSTEOPOROTIC FRACTURES IN ONTARIO, CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada); Western University; Université Laval; McMaster University","funders":"","keywords":"Medicine; Incidence (geometry); Primary care; Emergency medicine; Cohort; Ambulatory; Medical prescription; Emergency department; Pediatrics; Demography; Family medicine; Internal medicine","score_opus":0.021773941302268247,"score_gpt":0.30148378690816907,"score_spread":0.27970984560590084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954519816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99140006,0.00026284857,0.0000012646182,0.0012005734,0.00014609312,0.0008639328,0.0000072734524,0.0000035392227,0.006114441],"genre_scores_gemma":[0.9973326,0.000121707286,0.00033410633,0.00084922556,0.0000063951848,0.000006697229,0.000011531981,0.000009440218,0.0013283069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988289,0.00005006783,0.0004892901,0.00016404463,0.0002514304,0.00021625169],"domain_scores_gemma":[0.9993739,0.00011678295,0.00015756454,0.000238264,0.000018178607,0.00009529078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032682883,0.00010171364,0.00048948644,0.00018031949,0.000009828215,0.000001743939,0.00005543874,0.00003686645,0.00019622012],"category_scores_gemma":[0.000014408498,0.000081728685,0.000023463435,0.00015209374,0.00002225246,0.000021976692,0.000025802428,0.00021156372,0.0000010449019],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008104893,0.000067055626,0.99461454,0.0010486153,0.000021544212,0.000030706324,0.0008953415,0.00069655874,0.0000054741954,0.00043221776,0.00036599694,0.0017408851],"study_design_scores_gemma":[0.0013454705,0.000119768105,0.994229,0.0006020256,0.000009907429,0.0000019833162,0.0003686501,0.00008015165,0.000063896376,0.00010271937,0.0030186076,0.000057828158],"about_ca_topic_score_codex":0.9970349,"about_ca_topic_score_gemma":0.9950492,"teacher_disagreement_score":0.0059325555,"about_ca_system_score_codex":0.00045573685,"about_ca_system_score_gemma":0.0008285558,"threshold_uncertainty_score":0.3332799},"labels":[],"label_agreement":null},{"id":"W2954562872","doi":"10.1016/j.jval.2019.04.1028","title":"PMD31 SWIPING RIGHT ON MEDICAL TECHNOLOGY; AN ANALYSIS OF DRUG VS. DEVICE HTA APPROVALS IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Health technology; Medicine; Medical device; Drug approval; Medical record; Family medicine; Health care; Drug; Pharmacology; Internal medicine; Political science","score_opus":0.1941737618440383,"score_gpt":0.39292715575708087,"score_spread":0.19875339391304256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954562872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94952744,0.0011074438,0.00008376472,0.047271904,0.00040739644,0.0007304485,0.00012463343,0.00002175514,0.00072521385],"genre_scores_gemma":[0.98855096,0.00015666675,0.00064663374,0.010429299,0.00005155447,0.00004429029,0.000038031634,0.00002242506,0.000060110237],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9925544,0.00071697746,0.0051405733,0.00073193177,0.00025182386,0.0006042402],"domain_scores_gemma":[0.99554497,0.0012459817,0.0020742044,0.00082157494,0.000040280283,0.00027296215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023987224,0.00018588942,0.0018413696,0.0021743588,0.000060659084,0.000013970556,0.00053664384,0.00018892594,0.0005044429],"category_scores_gemma":[0.0020618464,0.0002294817,0.00007121143,0.0018513568,0.000042783602,0.00019042933,0.000053485288,0.00043602134,0.00016360338],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014739974,0.00012694905,0.8994558,0.0005333017,0.00007864012,0.0000029913117,0.001023441,0.038319383,3.3667928e-7,0.059601974,0.00060073193,0.00024174352],"study_design_scores_gemma":[0.0014269958,0.00019426676,0.45402983,0.0007275276,0.000013202658,0.0000026692267,0.0030084746,0.52580404,0.00000914868,0.004745743,0.009553123,0.00048498972],"about_ca_topic_score_codex":0.9538267,"about_ca_topic_score_gemma":0.91178465,"teacher_disagreement_score":0.48748463,"about_ca_system_score_codex":0.0035886455,"about_ca_system_score_gemma":0.0035011168,"threshold_uncertainty_score":0.9384183},"labels":[],"label_agreement":null},{"id":"W2954589792","doi":"10.1016/j.jval.2019.04.1500","title":"PNS143 PREFERENCES IN THE PRESCRIPTION OF INSULINS IN PATIENTS WITH TYPE II DIABETES MELLITUS IN COLOMBIA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Lifestyle Studies","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quarter (Canadian coin); NPH insulin; Diabetes mellitus; Medical prescription; Population; Internal medicine; Pediatrics; Type 2 Diabetes Mellitus; Insulin; Type 2 diabetes; Endocrinology; Insulin glargine; Pharmacology","score_opus":0.0583429957406808,"score_gpt":0.3547013782813226,"score_spread":0.2963583825406418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954589792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931886,0.00110257,1.7294666e-7,0.0013010347,0.0004403776,0.0029386242,0.000018857105,0.000011725954,0.00099799],"genre_scores_gemma":[0.9978624,0.0006655937,0.00008360322,0.0011131538,0.000035270834,0.00016376191,0.000019807781,0.0000124766075,0.0000439332],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954414,0.0021275582,0.001083819,0.00027898522,0.00032256043,0.0007457227],"domain_scores_gemma":[0.99842066,0.0008178513,0.00032387403,0.00027383896,0.000085982785,0.00007779817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028012493,0.0001428595,0.0004956577,0.00031186678,0.00013738655,0.0000028036036,0.00019892018,0.00014859943,0.000036660127],"category_scores_gemma":[0.0003923841,0.00009679782,0.000014371168,0.00095280615,0.00004732091,0.00011266225,0.00007161699,0.00080583856,0.000027710747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019459912,0.0003207902,0.9718697,0.0011789666,0.0000024266806,3.9107286e-7,0.024399614,0.00027193042,0.0000010504366,0.00023883782,0.00021484948,0.0013068316],"study_design_scores_gemma":[0.0022280558,0.0012902579,0.98924124,0.0015780698,0.0000012287985,1.8287665e-8,0.00322307,0.0002419596,8.423243e-7,0.00028480496,0.0018238361,0.00008662438],"about_ca_topic_score_codex":0.028489677,"about_ca_topic_score_gemma":0.017624985,"teacher_disagreement_score":0.021176543,"about_ca_system_score_codex":0.00031299985,"about_ca_system_score_gemma":0.0010018824,"threshold_uncertainty_score":0.9835156},"labels":[],"label_agreement":null},{"id":"W2954628789","doi":"10.1016/j.jval.2019.04.639","title":"PDB91 ADJUSTING THE COMMERCIAL VALUE OF EARLY-STAGE BIOMEDICAL TECHNOLOGIES FOR COST-EFFECTIVENESS: A VALUE-BASED APPROACH USING REAL OPTIONS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Drug Research and Development; University of British Columbia","funders":"","keywords":"Actuarial science; Willingness to pay; Reimbursement; Econometrics; Economics; Microeconomics; Health care","score_opus":0.5067783142808269,"score_gpt":0.458966353943776,"score_spread":0.047811960337050874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954628789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8874879,0.002178711,0.08782972,0.012334123,0.00096994644,0.0076869605,0.00094447425,0.00016169927,0.00040650583],"genre_scores_gemma":[0.9688641,0.00016887306,0.028998302,0.0010505554,0.00017073717,0.000586986,0.00007142148,0.00005861302,0.000030445797],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99302465,0.0016040072,0.0037375388,0.0006962094,0.00018348217,0.00075412175],"domain_scores_gemma":[0.99009764,0.006537821,0.002387729,0.00077161525,0.00007880871,0.00012639501],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.03817006,0.00025606938,0.0013556961,0.00067585317,0.0003383538,0.00004776018,0.00055111374,0.00031393318,0.000018921513],"category_scores_gemma":[0.004437268,0.00026560313,0.00020230851,0.0006735673,0.00025863238,0.00022929758,0.00010124579,0.00042650336,0.00004997914],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013218171,0.00050150487,0.13910033,0.0056734225,0.000069721944,4.6044232e-7,0.0021576409,0.2989431,0.000024904273,0.55236274,0.0002514407,0.0007825346],"study_design_scores_gemma":[0.002436111,0.0004542835,0.041295193,0.00068103854,0.000010932702,0.0000025935428,0.0028931724,0.93913734,0.000018393024,0.009433252,0.0032753462,0.0003623495],"about_ca_topic_score_codex":0.026141949,"about_ca_topic_score_gemma":0.000050066334,"teacher_disagreement_score":0.64019424,"about_ca_system_score_codex":0.0013929415,"about_ca_system_score_gemma":0.0009966193,"threshold_uncertainty_score":0.9999796},"labels":[],"label_agreement":null},{"id":"W2954710002","doi":"10.1016/j.jval.2019.04.1061","title":"PMH16 ECONOMIC BURDEN ASSOCIATED WITH NON-COMMUNICABLE DISEASES AMONG ADULTS WITH DEPRESSION AND ANXIETY IN THE UNITED STATES.","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Depression (economics); Anxiety; Medical Expenditure Panel Survey; Diabetes mellitus; Cohort; Obesity; Medical prescription; Health care; Emergency medicine; Internal medicine; Psychiatry","score_opus":0.015725878820998754,"score_gpt":0.2549591850394295,"score_spread":0.23923330621843075,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954710002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98439217,0.00015993559,0.0000034095108,0.013542865,0.000056365156,0.0007483163,0.000010825133,0.00003312572,0.0010529633],"genre_scores_gemma":[0.9883572,0.00047496593,0.000020645504,0.010820437,0.000085338856,0.00003571568,0.00017204495,0.000017470551,0.000016197258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984229,0.00020271294,0.0003965453,0.00026987883,0.00011442743,0.0005935167],"domain_scores_gemma":[0.9989049,0.0003515444,0.00032379274,0.00034075446,0.000036692596,0.00004230794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014309556,0.00015876276,0.00037670127,0.00020822254,0.0001444965,0.00008023219,0.0002718291,0.000073660725,0.000018665072],"category_scores_gemma":[0.000105049214,0.000097159995,0.000017138273,0.00048330636,0.000077167504,0.00038989543,0.00012081116,0.00027862136,0.000016370843],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000097843236,0.00004317046,0.8440098,0.00025082487,0.0000068760783,0.0000015237573,0.0003593422,0.14935376,5.186087e-8,0.0005167816,0.0051719225,0.00018809875],"study_design_scores_gemma":[0.0014528311,0.000061288985,0.6116794,0.00051333307,0.000005034542,8.2969433e-7,0.0017947563,0.3557895,2.379901e-8,0.00018678831,0.028394822,0.000121399054],"about_ca_topic_score_codex":0.5834752,"about_ca_topic_score_gemma":0.009671648,"teacher_disagreement_score":0.57380354,"about_ca_system_score_codex":0.00015456181,"about_ca_system_score_gemma":0.00010335751,"threshold_uncertainty_score":0.5397007},"labels":[],"label_agreement":null},{"id":"W2954822769","doi":"10.1016/j.jval.2019.04.166","title":"PCN42 THE HEALTH UTILITY BOOK (HUB): TOWARD A CENTRALIZED, SYSTEMATIC APPROACH TO THE IDENTIFICATION, APPRAISAL, AND USE OF HEALTH STATE UTILITY VALUES FOR REIMBURSEMENT DECISION MAKING","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; Canadian Institutes of Health Research; Institute of Health Economics; McMaster University","funders":"","keywords":"Reimbursement; Identification (biology); Health care; Jurisdiction; Quality (philosophy); Actuarial science; Checklist; Risk analysis (engineering); Business; Medicine; Operations management; Management science; Economics; Psychology; Political science","score_opus":0.4701570964053416,"score_gpt":0.4568015764234166,"score_spread":0.013355519981924968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954822769","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2583278,0.062482372,0.40738833,0.22137764,0.0030408883,0.045084458,0.0020409613,0.00012915973,0.00012837844],"genre_scores_gemma":[0.96119964,0.0018506793,0.015364826,0.020404804,0.00009095125,0.0008274433,0.000053835247,0.000060140545,0.00014770191],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98188853,0.0043177567,0.0111868065,0.0011823439,0.0003760299,0.001048508],"domain_scores_gemma":[0.98533034,0.006151397,0.00641554,0.0016595027,0.00014616075,0.00029707482],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.10343228,0.00031965136,0.0021100908,0.00034870458,0.00054024823,0.000192629,0.00059817516,0.00009537402,0.000025300715],"category_scores_gemma":[0.0065089203,0.00026636486,0.0001776376,0.0004577175,0.00011284952,0.0004398661,0.00013998535,0.00027730648,0.00007358697],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007676385,0.0018353398,0.18228586,0.27200636,0.00042057454,2.4859375e-7,0.15425281,0.036734443,7.743003e-7,0.1838887,0.15563972,0.01216753],"study_design_scores_gemma":[0.0034035905,0.0010376223,0.30877897,0.012281436,0.00002265486,0.000015478901,0.01708134,0.53863513,0.0000021793123,0.03310651,0.08467384,0.0009612317],"about_ca_topic_score_codex":0.0115696,"about_ca_topic_score_gemma":0.00024581177,"teacher_disagreement_score":0.7028718,"about_ca_system_score_codex":0.0011948479,"about_ca_system_score_gemma":0.0010553311,"threshold_uncertainty_score":0.99997884},"labels":[],"label_agreement":null},{"id":"W2954830939","doi":"10.1016/j.jval.2019.04.036","title":"CV3 VARIATIONS IN HEALTHCARE RESOURCE USE AND EXPENDITURES BY AGE IN PATIENTS UNDER AGE 65 NEWLY DIAGNOSED WITH PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT) IN THE UNITED STATES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vertex Pharmaceuticals (Canada)","funders":"","keywords":"Medicine; Pediatrics; Age groups; Medical diagnosis; Health care; Internal medicine; Demography","score_opus":0.019393040594343967,"score_gpt":0.2667663555864715,"score_spread":0.24737331499212753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954830939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99371785,0.0009107962,0.000008257713,0.002914605,0.000064746695,0.0022222395,0.000118447235,0.000015863914,0.000027186692],"genre_scores_gemma":[0.9954227,0.00048234995,0.000113677575,0.0022944282,0.000027283942,0.000108173546,0.0014991965,0.000029746272,0.00002242077],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99721,0.0009543322,0.0005115048,0.00040625338,0.0003978855,0.0005200157],"domain_scores_gemma":[0.99866545,0.0006386216,0.00013358441,0.00037761175,0.000023965966,0.00016076857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062392914,0.00022359886,0.00052729115,0.0004776693,0.00005690519,0.000043531745,0.000067267254,0.000115852905,0.0000047134886],"category_scores_gemma":[0.00007587659,0.00015911,0.000046535442,0.0007180935,0.000037501643,0.00010994544,0.000036028243,0.00043931228,0.0000031953457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026908566,0.00045890408,0.98485816,0.00014659044,0.000025535976,0.00095540646,0.0054713637,0.0070069637,4.6850786e-7,0.00024144321,0.0003641298,0.0002019313],"study_design_scores_gemma":[0.008990352,0.0006090452,0.98521495,0.00040677382,0.000014611473,0.000017011107,0.0016555873,0.0005284498,0.00000173299,0.000110127454,0.0023094225,0.00014191694],"about_ca_topic_score_codex":0.10789637,"about_ca_topic_score_gemma":0.005325039,"teacher_disagreement_score":0.10257134,"about_ca_system_score_codex":0.0004920398,"about_ca_system_score_gemma":0.00016444118,"threshold_uncertainty_score":0.8980442},"labels":[],"label_agreement":null},{"id":"W2954838902","doi":"10.1016/j.jval.2019.04.1576","title":"PNS220 CHARACTERISTICS AND METHODS OF INCORPORATING RANDOMIZED AND NON-RANDOMIZED EVIDENCE IN NETWORK META-ANALYSES: A SCOPING REVIEW","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Ottawa","funders":"","keywords":"Randomized controlled trial; Observational study; Pooling; Medicine; Statistics; Artificial intelligence; Computer science; Mathematics; Internal medicine","score_opus":0.9324885607285037,"score_gpt":0.6726216544897671,"score_spread":0.25986690623873665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954838902","genre_codex":"review","genre_gemma":"review","domain_codex":"methods","domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000062586205,0.9618107,0.016362282,0.00024646052,0.00026610112,0.02120088,0.00001672881,0.000003387866,0.00008718233],"genre_scores_gemma":[0.000019590774,0.91387594,0.08439943,0.00036219248,0.000071643706,0.001083936,0.000013971247,0.000038455597,0.00013484785],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.40714577,0.49024257,0.092225105,0.0037467007,0.0056196596,0.0010201986],"domain_scores_gemma":[0.6073562,0.3072797,0.07828217,0.005655909,0.000984951,0.0004410322],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7222409,0.0011270762,0.118545786,0.0013549061,0.00009852352,0.0004069609,0.0015467306,0.0003245123,0.00043995847],"category_scores_gemma":[0.31532338,0.00049947185,0.008672835,0.003781291,0.00038461568,0.00031360638,0.00049406424,0.0008101651,0.000048640057],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014178113,0.000030947238,0.000066960354,0.6231234,0.0036502078,0.000006784082,0.00031838185,0.00012672624,4.580765e-8,0.00045644937,0.00020699862,0.37059528],"study_design_scores_gemma":[0.036544543,0.00004523002,0.0000041260846,0.8960959,0.04056688,0.000032509666,0.000032437314,0.01673034,2.7461233e-8,0.002169379,0.007185879,0.00059274933],"about_ca_topic_score_codex":0.0007123147,"about_ca_topic_score_gemma":0.000049682385,"teacher_disagreement_score":0.40691754,"about_ca_system_score_codex":0.00011619801,"about_ca_system_score_gemma":0.0015983626,"threshold_uncertainty_score":0.99974567},"labels":[],"label_agreement":null},{"id":"W2954881004","doi":"10.1016/j.jval.2019.04.1447","title":"PNS88 IMPACT OF PATIENT-TARGETED FINANCIAL INCENTIVES ON HEALTHCARE COSTS: A SYSTEMATIC REVIEW OF RANDOMIZED CONTROLLED TRIALS","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Health care; Randomized controlled trial; Medicine; Systematic review; Psychological intervention; Incentive; MEDLINE; EconLit; Cochrane Library; Health economics; Family medicine; Business; Nursing; Public health; Political science; Economics","score_opus":0.14979100340319898,"score_gpt":0.39850446512372395,"score_spread":0.24871346172052497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954881004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011767005,0.9551063,0.000025634354,0.0007727975,0.00079159904,0.040985875,0.001827091,0.000017879154,0.00046102013],"genre_scores_gemma":[0.00095703825,0.9953969,0.000060204016,0.0009032228,0.00008439733,0.0023308091,0.00015334951,0.000065205975,0.000048845763],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9659993,0.011594775,0.020598361,0.0007788656,0.0002570473,0.00077164144],"domain_scores_gemma":[0.96658105,0.008017915,0.023908548,0.0010923924,0.00016333495,0.00023677485],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.042723168,0.0007335182,0.05436861,0.0017122668,0.00005313339,0.0000195312,0.00049773074,0.000401315,0.00009376142],"category_scores_gemma":[0.037416905,0.00051781774,0.0063302796,0.0009921298,0.00007729945,0.00008022788,0.000088880595,0.0005907063,0.000095931675],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022192006,0.00019125451,0.0000030571891,0.89888644,0.0008095436,0.000001439305,0.00020109356,0.00001509157,8.70956e-10,0.08824645,0.00018699716,0.009239407],"study_design_scores_gemma":[0.039632026,0.0007531821,0.0000019497834,0.9440354,0.0005621775,0.000001658856,0.000016799735,0.000096329124,3.0281395e-8,0.0010903907,0.013450012,0.000360006],"about_ca_topic_score_codex":0.032856412,"about_ca_topic_score_gemma":0.00003839992,"teacher_disagreement_score":0.08715606,"about_ca_system_score_codex":0.0022558796,"about_ca_system_score_gemma":0.0023594797,"threshold_uncertainty_score":0.99972737},"labels":[],"label_agreement":null},{"id":"W2954897982","doi":"10.1016/j.jval.2019.04.606","title":"PDB57 REAL-WORLD ECONOMIC OUTCOMES AMONG PATIENTS WITH TYPE 2 DIABETES (T2D) TREATED WITH DULAGLUTIDE (DU) VS. BASAL INSULIN (BI) IN THE US: THE DISPELTM STUDY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Type 2 diabetes; Pharmacy; Diabetes mellitus; Basal (medicine); Basal insulin; Dulaglutide; Propensity score matching; Internal medicine; Retrospective cohort study; Exenatide; Insulin; Surgery; Endocrinology; Family medicine","score_opus":0.013326857875443965,"score_gpt":0.2506861155821586,"score_spread":0.23735925770671462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954897982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9921282,0.000059496757,1.3477437e-7,0.0015469795,0.00012739561,0.004333911,0.000009518006,0.000040454135,0.0017539385],"genre_scores_gemma":[0.9979688,0.00007469027,0.00003948831,0.0011323452,0.00003725141,0.00013171311,0.00007110446,0.00004190239,0.00050273695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794066,0.00034445862,0.00046902947,0.00040675135,0.00031870272,0.0005204029],"domain_scores_gemma":[0.9987,0.0002967899,0.00020524909,0.000672623,0.00003220708,0.00009311648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075866195,0.00028748726,0.0005862574,0.00024437095,0.000079452504,0.000043079774,0.0002266634,0.00003339698,0.00004998788],"category_scores_gemma":[0.00002137736,0.00013345493,0.000044572298,0.00047522128,0.000072929426,0.0001276079,0.000059373142,0.00022772474,0.000090739464],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031707552,0.0013026946,0.99481523,0.000078235214,0.0001692351,0.000012268783,0.0011715844,0.0011174344,9.80883e-8,0.00013713709,0.0002957746,0.0005832287],"study_design_scores_gemma":[0.007142324,0.0031322865,0.9872849,0.00022333418,0.00009258053,1.0854597e-7,0.0006111658,0.0009351524,0.0000024630358,0.000022663702,0.00040479816,0.0001482027],"about_ca_topic_score_codex":0.02036538,"about_ca_topic_score_gemma":0.01278695,"teacher_disagreement_score":0.007578429,"about_ca_system_score_codex":0.000458187,"about_ca_system_score_gemma":0.00014321518,"threshold_uncertainty_score":0.9861581},"labels":[],"label_agreement":null},{"id":"W2954918223","doi":"10.1016/j.jval.2019.04.397","title":"PCN278 REAL WORLD TREATMENT PATTERNS FOR FIRST LINE (1L) RECURRENT/METASTATIC (R/M) SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) PATIENTS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Medicine; Cetuximab; Internal medicine; Stage (stratigraphy); Dysphagia; Radiation therapy; Oncology; Cancer; Surgery; Colorectal cancer","score_opus":0.05830342842827169,"score_gpt":0.32448883679989876,"score_spread":0.2661854083716271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954918223","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937357,0.0012563624,0.0000034450402,0.0018994516,0.00043501565,0.0021869286,0.00015885629,0.000010866824,0.00031342165],"genre_scores_gemma":[0.99806017,0.0008501305,0.00016284958,0.0003093641,0.0000641899,0.0000915765,0.000026299707,0.000022715505,0.00041271572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99858785,0.00008256342,0.00049937214,0.00028589717,0.00019435326,0.00034999312],"domain_scores_gemma":[0.9990644,0.00026129247,0.00018663588,0.00030672844,0.000059072063,0.00012188916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018705452,0.00017475638,0.00057168264,0.0001056268,0.00008751275,0.000004199727,0.00006146545,0.000029007415,0.000013269212],"category_scores_gemma":[0.00003625383,0.000113075934,0.00008627534,0.00018975616,0.000034692646,0.000025190751,0.00003978276,0.00010588257,0.0000032981534],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031562956,0.0007428272,0.9859383,0.0022917662,0.00001147205,0.000001451107,0.0023767683,0.000039248287,0.000004693354,0.00003172017,0.00025382751,0.00799229],"study_design_scores_gemma":[0.009771092,0.008357221,0.9761115,0.0008693068,0.000042648193,0.0000014967264,0.00016344461,0.0011552252,0.00032103044,0.000043609733,0.0030463864,0.00011708775],"about_ca_topic_score_codex":0.013517685,"about_ca_topic_score_gemma":0.006772746,"teacher_disagreement_score":0.009826856,"about_ca_system_score_codex":0.0003617421,"about_ca_system_score_gemma":0.000227602,"threshold_uncertainty_score":0.9930514},"labels":[],"label_agreement":null},{"id":"W2954946792","doi":"10.1016/j.jval.2019.04.184","title":"PCN60 FITTING DISTRIBUTIONS OF PARAMETRIC MODELS INTO NON-PARAMETRIC KAPLAN-MEIER CURVE: APPLICATION IN EXCEL AND COMPARISON OF DIFFERENT DATA RECREATION METHODS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario","funders":"","keywords":"Weibull distribution; Parametric statistics; Statistics; Goodness of fit; Mathematics; Distribution fitting; Parametric model; Survival analysis; Computer science; Exponential distribution","score_opus":0.49807697278271973,"score_gpt":0.5119474165045507,"score_spread":0.013870443721830938,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954946792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8170526,0.00452856,0.17404372,0.0019788942,0.00018883379,0.0016328566,0.0003970986,0.00001318052,0.00016425527],"genre_scores_gemma":[0.9546842,0.00074490235,0.043869704,0.00013414078,0.00003292676,0.00008560917,0.0004152828,0.00001991829,0.000013307453],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99199176,0.0011044851,0.0056440136,0.0007466563,0.00013606736,0.00037703017],"domain_scores_gemma":[0.9910619,0.0041396157,0.0035648914,0.0010300648,0.00006409997,0.0001394275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022781573,0.0001867005,0.001551991,0.0014414132,0.00006850114,0.000023394772,0.00040276506,0.00018111702,0.000017392156],"category_scores_gemma":[0.0036252402,0.00023100687,0.00005145816,0.0015222891,0.000056464793,0.0004519256,0.00015373298,0.00028771465,0.000027019501],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025988918,0.00045331442,0.91019577,0.0023631796,0.000024022542,4.7297675e-8,0.0020704137,0.034619033,0.000012056903,0.042170424,0.000174168,0.007891575],"study_design_scores_gemma":[0.000677858,0.000107849475,0.19451524,0.00023213135,0.0000037392838,5.241524e-7,0.00051192567,0.78346336,0.000018581528,0.020053104,0.00026167257,0.00015403831],"about_ca_topic_score_codex":0.03040283,"about_ca_topic_score_gemma":0.00035472415,"teacher_disagreement_score":0.7488443,"about_ca_system_score_codex":0.0007751713,"about_ca_system_score_gemma":0.00020700066,"threshold_uncertainty_score":0.9760538},"labels":[],"label_agreement":null},{"id":"W2955043329","doi":"10.1016/j.jval.2019.04.235","title":"PCN111 OUT-OF-POCKET COSTS IN CANADIAN PROSTATE CANCER PATIENTS : A REMOTE REGION PERSPECTIVE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université du Québec en Abitibi-Témiscamingue; McGill University","funders":"","keywords":"Medicine; Context (archaeology); Medical prescription; Prostate cancer; Demography; Medical costs; Average cost; Total cost; Family medicine; Cancer; Health care; Internal medicine; Geography; Nursing","score_opus":0.03911328808554823,"score_gpt":0.271962246680821,"score_spread":0.23284895859527274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955043329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9730838,0.004146982,0.0000061735627,0.002671886,0.0011297931,0.0008832907,0.00024235953,0.000008280335,0.017827444],"genre_scores_gemma":[0.9963546,0.0019700036,0.00007567077,0.001013969,0.000050274954,0.000013632067,0.00000811792,0.000026602418,0.0004871203],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808097,0.00003384673,0.00080066716,0.0004173524,0.000032051492,0.00063513813],"domain_scores_gemma":[0.99894595,0.000036487967,0.00048108285,0.00025544685,0.000055634766,0.00022540112],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006082618,0.00014568481,0.00053928857,0.00055689376,0.000033900516,0.00001686836,0.0001639935,0.000109494,0.00009904337],"category_scores_gemma":[0.0001481706,0.00018348769,0.000056110573,0.0002927636,0.000035168916,0.0002307324,0.000023418388,0.00022666188,0.00014718281],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000055655433,0.00005355383,0.9503157,0.00008476076,0.000008095669,0.0000025215911,0.005487492,0.0008725683,2.9072783e-7,0.038960617,0.00039630217,0.0037624405],"study_design_scores_gemma":[0.0021010605,0.00034914678,0.9397596,0.0004544823,0.0000011350234,5.255831e-7,0.0004433315,0.0044687483,0.000005542895,0.022477632,0.029564673,0.0003741116],"about_ca_topic_score_codex":0.9482708,"about_ca_topic_score_gemma":0.5541477,"teacher_disagreement_score":0.3941231,"about_ca_system_score_codex":0.004851107,"about_ca_system_score_gemma":0.00084711326,"threshold_uncertainty_score":0.9989691},"labels":[],"label_agreement":null},{"id":"W2955100594","doi":"10.1016/j.jval.2019.04.1384","title":"PNS19 AN APPROACH TO EXAMINING GEOGRAPHIC VARIATION IN HEALTHCARE SPENDING AND UTILIZATION IN THE CANADIAN WORKERS COMPENSATION SYSTEM","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Work & Health; University of British Columbia","funders":"","keywords":"Health care; Incentive; Compensation (psychology); Business; Context (archaeology); Variation (astronomy); Work (physics); Economics; Economic growth; Geography; Psychology","score_opus":0.4016367580259676,"score_gpt":0.42661815371161355,"score_spread":0.024981395685645946,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955100594","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9858736,0.00012813382,0.0004852692,0.007201601,0.00053049263,0.003488887,0.000007820657,0.00004224709,0.0022419814],"genre_scores_gemma":[0.9947993,0.000045207853,0.0007993028,0.00397681,0.0000808615,0.00016623367,0.00010775716,0.000014463529,0.000010063128],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945942,0.0027873719,0.001160339,0.00031468773,0.00039268754,0.00075071293],"domain_scores_gemma":[0.9985175,0.00047131523,0.00029667185,0.00027013783,0.00005270114,0.00039169035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011819068,0.0001317572,0.00031012678,0.0011163041,0.000569003,0.000029829807,0.00015613541,0.00032335246,0.000008338381],"category_scores_gemma":[0.00022213376,0.00011548796,0.000010180631,0.0011885252,0.000013882696,0.00026488936,0.000021574375,0.0011357623,0.000030318015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002597498,0.000019763278,0.9146898,0.0023881,7.999327e-7,7.1404384e-7,0.045054324,0.004573037,4.992189e-7,0.031263456,0.000019866126,0.0019636655],"study_design_scores_gemma":[0.0005578478,0.000100411606,0.8157206,0.0015180311,8.6017087e-7,0.0000018812435,0.0171364,0.16451229,2.6091152e-8,0.0001394824,0.00022958666,0.00008256144],"about_ca_topic_score_codex":0.7515445,"about_ca_topic_score_gemma":0.36984903,"teacher_disagreement_score":0.38169548,"about_ca_system_score_codex":0.0018637698,"about_ca_system_score_gemma":0.0012768091,"threshold_uncertainty_score":0.6416496},"labels":[],"label_agreement":null},{"id":"W2955137575","doi":"10.1016/j.jval.2019.04.1837","title":"PSY12 COST BURDEN OF BREAKTHROUGH HEMOLYSIS IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA ON ECULIZUMAB TREATMENT","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Eculizumab; Medicine; Hemoglobinuria; Dosing; Internal medicine; Hemolysis; Anemia; Gastroenterology; Surgery; Immunology; Complement system","score_opus":0.017046406412129688,"score_gpt":0.26013103467897464,"score_spread":0.24308462826684496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955137575","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99651563,0.0006669327,0.0000026026157,0.00029983444,0.00033973766,0.0015780608,0.00018907884,0.000019121746,0.00038898928],"genre_scores_gemma":[0.99936736,0.000029459903,0.000056488974,0.00008554,0.0000171739,0.000055919456,0.0002085874,0.000018137018,0.00016133419],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794173,0.0004796819,0.0006474292,0.00037416766,0.00009801612,0.0004589845],"domain_scores_gemma":[0.99901325,0.00016671255,0.00030492255,0.0004336919,0.000040875202,0.000040523897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020892378,0.00022264695,0.00057918206,0.00020264591,0.000044701224,0.000005782969,0.00017805165,0.00009468934,0.0005487788],"category_scores_gemma":[0.000017076341,0.0001727411,0.00007322006,0.00024030001,0.000055330172,0.00005343068,0.00003689242,0.00014045375,0.00025539004],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020822966,0.0013508585,0.98298055,0.00023257692,0.00012919286,0.0000053341664,0.0013724666,0.007208591,0.00013990348,0.00029454086,0.00030862718,0.0038950522],"study_design_scores_gemma":[0.028828612,0.007267278,0.95267546,0.0013493993,0.0000391323,0.000015338319,0.0006534048,0.00014467619,0.0011463054,0.000107186774,0.007326313,0.00044689354],"about_ca_topic_score_codex":0.016035302,"about_ca_topic_score_gemma":0.0002631725,"teacher_disagreement_score":0.030305099,"about_ca_system_score_codex":0.0007365396,"about_ca_system_score_gemma":0.0002670144,"threshold_uncertainty_score":0.990517},"labels":[],"label_agreement":null},{"id":"W2955141130","doi":"10.1016/j.jval.2019.04.1775","title":"PSS3 LATANOPROSTENE BUNOD FOR THE TREATMENT OF OPEN-ANGLE GLAUCOMA AND OCULAR HYPERTENSION: SYSTEMATIC LITERATURE REVIEW AND NETWORK META-ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); Health Canada; Université de Montréal","funders":"","keywords":"Dorzolamide; Travoprost; Bimatoprost; Brimonidine; Latanoprost; Medicine; Ocular hypertension; Timolol; Glaucoma; Intraocular pressure; Betaxolol; Ophthalmology; Meta-analysis; Cochrane Library; Placebo; Internal medicine","score_opus":0.06604684013103458,"score_gpt":0.32285602673916414,"score_spread":0.25680918660812957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955141130","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.094089486,0.89096844,0.000016489912,0.008857138,0.000043507305,0.0059743193,0.000018998353,0.0000058897817,0.000025751344],"genre_scores_gemma":[0.49189183,0.4964355,0.0028291165,0.006566288,0.000057564837,0.0006417061,0.000089144894,0.00004415293,0.0014446995],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9985673,0.00025761934,0.00055351784,0.00027292746,0.00014545221,0.00020319606],"domain_scores_gemma":[0.99873245,0.0003843462,0.00022587802,0.0004886851,0.00008120519,0.000087409906],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00090794923,0.00016221452,0.0021100934,0.00006781871,0.00007232395,0.000025044234,0.00008649086,0.00005513705,0.000016708293],"category_scores_gemma":[0.000046773923,0.00007533671,0.00032696465,0.0005471686,0.000028954553,0.000037697075,0.00003109259,0.000064136744,0.0000013288691],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006659189,0.001499929,0.11958128,0.7705648,0.096474566,0.00010751928,0.0030161843,0.00017161755,0.00006755125,0.004630347,0.0020772505,0.001143031],"study_design_scores_gemma":[0.012315551,0.013176984,0.12979227,0.07257529,0.7229012,0.001090503,0.0012973947,0.028900994,0.00003170841,0.0012436279,0.015821703,0.0008527293],"about_ca_topic_score_codex":0.000419957,"about_ca_topic_score_gemma":0.000041298703,"teacher_disagreement_score":0.6979895,"about_ca_system_score_codex":0.000031044077,"about_ca_system_score_gemma":0.000050134102,"threshold_uncertainty_score":0.3072142},"labels":[],"label_agreement":null},{"id":"W2955235983","doi":"10.1016/j.jval.2019.04.1569","title":"PNS212 AUTOMATING VARIABLE SELECTION IN META-REGRESSION","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Confidence interval; Covariate; Ranking (information retrieval); Statistics; Bayesian probability; Computer science; Meta-regression; Meta-analysis; Regression analysis; Regression; Feature selection; Machine learning; Artificial intelligence; Medicine; Mathematics; Internal medicine","score_opus":0.7890056633125838,"score_gpt":0.5528310360976231,"score_spread":0.23617462721496074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955235983","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9487026,0.0054938206,0.017245214,0.003149407,0.0010940846,0.0032763362,0.000007169599,0.000034178298,0.0209972],"genre_scores_gemma":[0.9493314,0.000025473393,0.043580532,0.0005169618,0.000047757712,0.000055106084,0.0000024243668,0.000013242463,0.0064271255],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9669852,0.018808642,0.009401395,0.0009711416,0.0033852812,0.00044832175],"domain_scores_gemma":[0.99132943,0.0037478309,0.0033782749,0.0012240667,0.00020508318,0.00011529315],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.1814489,0.00021389182,0.0033923252,0.00070463005,0.00007614524,0.00024146638,0.00065925077,0.00008511108,0.009090813],"category_scores_gemma":[0.0127173085,0.0000954224,0.00058138586,0.0031988781,0.000008573773,0.00027705447,0.00006766463,0.00024851452,0.0024775073],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018274923,0.00030622157,0.54837906,0.001156399,0.00037383093,0.0000051881802,0.003377826,0.33437663,0.00061265205,0.051592637,0.025309749,0.034491543],"study_design_scores_gemma":[0.00030297862,0.00007956392,0.022316702,0.0002957266,0.0000629922,0.000010064536,0.0003728963,0.92562807,0.00002098565,0.02304396,0.027691742,0.00017431016],"about_ca_topic_score_codex":0.0021920914,"about_ca_topic_score_gemma":0.00011963131,"teacher_disagreement_score":0.59125143,"about_ca_system_score_codex":0.0001719613,"about_ca_system_score_gemma":0.00025040875,"threshold_uncertainty_score":0.9982992},"labels":[],"label_agreement":null},{"id":"W2955253476","doi":"10.1016/j.jval.2019.04.361","title":"PCN240 EVALUATING PARTITIONED SURVIVAL MODEL AND RESPONSE-BASED MODELING APPROACHES FOR USE IN COST-EFFECTIVENESS ANALYSIS: ESTIMATING AND VALIDATING SURVIVAL OUTCOMES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Sunitinib; Medicine; Survival analysis; Oncology; Progression-free survival; Internal medicine; Overall survival; Renal cell carcinoma; Statistics; Mathematics","score_opus":0.756340347782525,"score_gpt":0.4887053661435728,"score_spread":0.2676349816389522,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955253476","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7903726,0.000320439,0.20415469,0.0022977286,0.00019079189,0.0024444563,0.00017020549,0.000032970293,0.000016115597],"genre_scores_gemma":[0.9221409,0.0000117793725,0.076591365,0.0005859273,0.00003546312,0.0005169961,0.000060341936,0.00004403724,0.000013167381],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99129444,0.0030510344,0.003834283,0.0009922781,0.0001700355,0.0006579357],"domain_scores_gemma":[0.9852595,0.012596485,0.0014573146,0.00043375065,0.0000682477,0.00018473629],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.083612435,0.0002814299,0.0018272916,0.0010007486,0.00023762895,0.00015914343,0.0001357793,0.00015564807,0.000006424458],"category_scores_gemma":[0.009588715,0.0003571089,0.00012445092,0.00051899254,0.00004277974,0.00060879707,0.000058699752,0.00024799883,0.000008368999],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011939956,0.000040490893,0.3942808,0.0007187536,0.000037272246,1.11760805e-7,0.00092439144,0.59872884,0.0000012100463,0.005048836,9.2446857e-7,0.00009897895],"study_design_scores_gemma":[0.0023418912,0.00009913076,0.10002187,0.00030375787,0.000016162317,3.4880264e-7,0.0009400767,0.8907377,6.6059397e-7,0.0052496977,0.0000026127866,0.0002860598],"about_ca_topic_score_codex":0.008905186,"about_ca_topic_score_gemma":0.0007773371,"teacher_disagreement_score":0.29425892,"about_ca_system_score_codex":0.0009140481,"about_ca_system_score_gemma":0.00046851666,"threshold_uncertainty_score":0.99988806},"labels":[],"label_agreement":null},{"id":"W2955276946","doi":"10.1016/j.jval.2019.04.173","title":"PCN49 COST-EFFECTIVENESS MODEL COMPARING EXPANDED UMBILICAL CORD BLOOD TRANSPLANTS WITH OTHER HSCT STRATEGIES FOR PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Collège de Maisonneuve","funders":"","keywords":"Medicine; Umbilical cord; Transplantation; Hematopoietic stem cell transplantation; Internal medicine; Intensive care medicine; Immunology","score_opus":0.09297863822422445,"score_gpt":0.28282580944271085,"score_spread":0.1898471712184864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955276946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98086,0.00035121676,0.014518144,0.0000916943,0.00012210029,0.0020724675,0.00026901145,0.00003694054,0.0016784394],"genre_scores_gemma":[0.9977487,0.00006421445,0.0015699287,0.00025586027,0.000023271354,0.00023349779,0.000020883452,0.000040762203,0.000042886266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981757,0.000034475026,0.00062149344,0.0005373462,0.000051857172,0.0005791471],"domain_scores_gemma":[0.99906296,0.00016668212,0.00034203083,0.00025945704,0.000041646923,0.00012722399],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005374772,0.00024090319,0.0009290116,0.00013056317,0.00008449359,0.00006712977,0.00018923894,0.00012430492,0.000022792346],"category_scores_gemma":[0.000019268033,0.00020993678,0.00006548681,0.00012495357,0.00008574652,0.00036936076,0.00001560398,0.00017371924,0.000024633568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014069462,0.00032771856,0.7999209,0.00051352987,0.00003209881,0.0000012472756,0.00035290566,0.048725866,0.0000018397063,0.1485236,0.000010715862,0.00018259097],"study_design_scores_gemma":[0.018520165,0.0049393387,0.84392846,0.0011274633,0.000022993947,0.000017248078,0.00026747532,0.08597472,0.000059311416,0.04301569,0.0009661537,0.0011610038],"about_ca_topic_score_codex":0.001317364,"about_ca_topic_score_gemma":0.0002742564,"teacher_disagreement_score":0.10550791,"about_ca_system_score_codex":0.00017856201,"about_ca_system_score_gemma":0.00021653375,"threshold_uncertainty_score":0.85609734},"labels":[],"label_agreement":null},{"id":"W2955303878","doi":"10.1016/j.jval.2019.04.1379","title":"PNS13 DYNAMIC APPROACHES TO VISUALIZING HEOR DATA: TELLING A COMPLICATED NMA STORY, MORE SIMPLY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Innovation Diffusion and Forecasting","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Visualization; Computer science; Creative visualization; Data visualization; Field (mathematics); Data science; Data mining; Variety (cybernetics); Exploratory data analysis; Sample (material); Human–computer interaction; Artificial intelligence","score_opus":0.5844017364243129,"score_gpt":0.4599355204810647,"score_spread":0.12446621594324825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955303878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96328425,0.00014126944,0.021600144,0.011708462,0.0006341477,0.001031117,0.00005802995,0.00010950528,0.0014330788],"genre_scores_gemma":[0.9871204,0.000007888678,0.008323156,0.0037252626,0.000060245464,0.000012522859,0.00006829529,0.000029003786,0.000653238],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9955849,0.0005345873,0.0012258065,0.0009790595,0.0011097837,0.0005658463],"domain_scores_gemma":[0.99661684,0.0012526993,0.00045793573,0.0013213602,0.00014154865,0.00020960529],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0101130195,0.00019366894,0.00047649734,0.00079618307,0.00025690647,0.00019550034,0.0012944867,0.000088732915,0.00013790697],"category_scores_gemma":[0.001664221,0.00016288208,0.000045900906,0.0025503885,0.000051155217,0.00032561226,0.0004963628,0.00038621263,0.00083816523],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003211869,0.0008889342,0.090718456,0.00052747346,0.00004115805,0.000025283463,0.026336981,0.24613796,0.002577425,0.08209661,0.017849736,0.5324788],"study_design_scores_gemma":[0.00041901227,0.0000981807,0.011190901,0.00015517425,0.0000012485149,0.000010930388,0.0040176697,0.9513691,0.000022182587,0.0021890996,0.030296423,0.00023006725],"about_ca_topic_score_codex":0.00059878145,"about_ca_topic_score_gemma":0.000060443883,"teacher_disagreement_score":0.70523113,"about_ca_system_score_codex":0.00021225167,"about_ca_system_score_gemma":0.00027517843,"threshold_uncertainty_score":0.9999398},"labels":[],"label_agreement":null},{"id":"W2955315974","doi":"10.1016/j.jval.2019.04.1342","title":"PND69 MIGRAINE PROPHYLAXIS WITH VITAMINS AND MINERALS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Migraine; Medicine; Placebo; Randomized controlled trial; Meta-analysis; Adverse effect; Clinical trial; Internal medicine; Physical therapy; Crossover study; Alternative medicine","score_opus":0.2477587662814493,"score_gpt":0.43353778030669543,"score_spread":0.18577901402524613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955315974","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000063265475,0.95439804,0.000010449267,0.0013766141,0.0000075154517,0.04395202,0.00014322475,0.000013648853,0.00009215185],"genre_scores_gemma":[0.00003996728,0.9907478,0.00040442843,0.0005955975,0.000028065546,0.0040086103,0.00006875087,0.000043298332,0.00406346],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97962165,0.011171897,0.007637973,0.0006454022,0.0005674102,0.00035565146],"domain_scores_gemma":[0.9786427,0.01444056,0.0056914226,0.0007754513,0.0002555115,0.00019437015],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03541983,0.0007680259,0.14011869,0.0013566413,0.000043257907,0.00001663613,0.00010405125,0.00020196091,0.00005627622],"category_scores_gemma":[0.01599643,0.00031335422,0.00778026,0.0013566166,0.0001680524,0.000029793713,0.000048863527,0.000391079,0.0000021568328],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015070203,0.00006149382,8.225744e-7,0.7182891,0.27948013,0.000005101586,0.00021259255,5.032276e-7,2.2030951e-8,0.00007827218,0.00023439736,0.00013057927],"study_design_scores_gemma":[0.045317795,0.00045688005,3.0442635e-7,0.18597908,0.7644764,0.00003431303,0.00004260199,0.000039768955,7.862821e-9,0.000004467991,0.003468002,0.00018033803],"about_ca_topic_score_codex":0.0015792423,"about_ca_topic_score_gemma":0.00014877525,"teacher_disagreement_score":0.53230995,"about_ca_system_score_codex":0.00008316657,"about_ca_system_score_gemma":0.00067646103,"threshold_uncertainty_score":0.9999319},"labels":[],"label_agreement":null},{"id":"W2955317597","doi":"10.1016/j.jval.2019.04.459","title":"PCV23 HEALTHCARE RESOURCE USE AND COSTS FOLLOWING CATHETER ABLATION IN PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA (PSVT) PATIENTS AGE <65","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vertex Pharmaceuticals (Canada)","funders":"","keywords":"Medicine; Ablation; Catheter ablation; Tachycardia; Catheter; Cardiology; Emergency medicine; Internal medicine; Surgery","score_opus":0.020741366614907712,"score_gpt":0.27031944291054566,"score_spread":0.24957807629563794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955317597","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99562895,0.0013448624,0.000004210597,0.00074589404,0.00030577366,0.0017351713,0.00003622495,0.000028832395,0.00017010236],"genre_scores_gemma":[0.9984836,0.00017849414,0.00020737301,0.0006486208,0.00007226038,0.000034682023,0.00025957977,0.000036807844,0.00007858314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770904,0.00039536358,0.0005252882,0.00045808285,0.00039483566,0.00051737984],"domain_scores_gemma":[0.99905944,0.00015688858,0.00013054992,0.0003540718,0.00003666826,0.0002624063],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060988823,0.00020482214,0.0005846591,0.00027507843,0.00006433344,0.000028378632,0.000034947374,0.00013527727,0.000005261682],"category_scores_gemma":[0.00011444111,0.00018844189,0.00015493753,0.00032154485,0.000016304322,0.00015421062,0.000049271377,0.0002675544,0.000023138587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010618525,0.00017292213,0.99354607,0.0001806325,0.000035553323,0.00041127575,0.0010832957,0.0003017186,0.000004532083,0.000060564078,0.00006286387,0.0040343655],"study_design_scores_gemma":[0.004876538,0.0005431081,0.9903458,0.00075551163,0.000025546828,0.00003121592,0.000110596644,0.0005598159,0.000017573411,0.000026453354,0.0025536702,0.00015418376],"about_ca_topic_score_codex":0.010170448,"about_ca_topic_score_gemma":0.00020871888,"teacher_disagreement_score":0.009961729,"about_ca_system_score_codex":0.0008794517,"about_ca_system_score_gemma":0.00014947877,"threshold_uncertainty_score":0.9964209},"labels":[],"label_agreement":null},{"id":"W2955329712","doi":"10.1016/j.jval.2019.04.165","title":"PCN41 THE HEALTH UTILITY BOOK (HUB): A REGISTRY OF HEALTH STATE UTILITY VALUES IN ONCOLOGY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research; Institute of Health Economics; Toronto Public Health; McMaster University","funders":"","keywords":"Systematic review; Health technology; Medicine; Actuarial science; MEDLINE; Operations research; Health care; Business; Engineering; Economics","score_opus":0.42942051057808245,"score_gpt":0.4589360608112073,"score_spread":0.029515550233124854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955329712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.58903897,0.052334797,0.0013021519,0.3449077,0.001787604,0.0059492094,0.00087010104,0.00008835587,0.0037210914],"genre_scores_gemma":[0.9386804,0.005274582,0.0020792512,0.05288652,0.00012898889,0.0001355445,0.000056128894,0.00005952102,0.00069908006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97618765,0.0075158323,0.013066033,0.0013342696,0.00028954865,0.0016066905],"domain_scores_gemma":[0.9872648,0.0029271326,0.0075811017,0.001758671,0.0000719611,0.00039629597],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.10877243,0.0003464935,0.0030102574,0.000577665,0.00024845294,0.000035708483,0.0007414655,0.00022161474,0.00040898024],"category_scores_gemma":[0.002621715,0.00037453076,0.00019118712,0.00069318723,0.0002482717,0.00038885445,0.00014637575,0.00086341146,0.00048009405],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00023779641,0.0012681581,0.8368519,0.0091034565,0.00006452666,0.0000022414674,0.03296912,0.0041381307,3.5033455e-7,0.047959965,0.05403423,0.013370119],"study_design_scores_gemma":[0.0031956467,0.0014772243,0.58899534,0.0010647624,0.000001576557,0.000012839942,0.005543089,0.04749877,0.0000016057103,0.044791665,0.30687532,0.0005421498],"about_ca_topic_score_codex":0.14614195,"about_ca_topic_score_gemma":0.0044203787,"teacher_disagreement_score":0.3496414,"about_ca_system_score_codex":0.004126946,"about_ca_system_score_gemma":0.0059412653,"threshold_uncertainty_score":0.99987066},"labels":[],"label_agreement":null},{"id":"W2955338367","doi":"10.1016/j.jval.2019.04.803","title":"PIH2 DEVELOPMENT AND VALIDATION OF A PATIENT CENTERED OUTCOME MEASURE FOR USE IN DEMENTIA DRUG TRIALS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Dementia; Clinical trial; Donepezil; Clinical Dementia Rating; Vascular dementia; Drug trial; Medicine; Construct validity; Content validity; Psychology; Clinical Global Impression; Clinical psychology; Physical therapy; Disease; Psychiatry; Psychometrics; Internal medicine; Alternative medicine; Pathology","score_opus":0.6179477531647908,"score_gpt":0.4426310976051971,"score_spread":0.1753166555595937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955338367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98983234,0.0016556389,0.0008239934,0.0041198274,0.0005012037,0.002871293,0.00014605663,0.000010185323,0.000039441133],"genre_scores_gemma":[0.9864364,0.00006478945,0.01184665,0.0013646377,0.000028699513,0.00015560228,0.000043484633,0.000020029987,0.000039685252],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99094796,0.0009121734,0.0072680195,0.0004300024,0.0000967607,0.0003450773],"domain_scores_gemma":[0.99491185,0.0016663236,0.0030074203,0.00026501378,0.000044738787,0.0001046769],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.039075825,0.0001378786,0.0013132376,0.0005001594,0.000047450118,0.0000319948,0.00010128959,0.00007881844,0.00003898945],"category_scores_gemma":[0.0034899223,0.00016777772,0.00006883452,0.00015248124,0.00001365257,0.00029179628,0.00003188741,0.00009373665,0.0000500895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057389,0.00013307342,0.9791879,0.0014787962,0.00003340595,9.926231e-8,0.0064072413,0.0019385491,0.00000183314,0.009646164,0.00037025308,0.00074528035],"study_design_scores_gemma":[0.018077418,0.00066637096,0.8650841,0.0025930912,0.000018299723,0.0000031469756,0.005586088,0.035060454,0.00036606146,0.013783317,0.057503954,0.0012576835],"about_ca_topic_score_codex":0.0051141847,"about_ca_topic_score_gemma":0.00055007,"teacher_disagreement_score":0.1141038,"about_ca_system_score_codex":0.0006591213,"about_ca_system_score_gemma":0.00028758263,"threshold_uncertainty_score":0.98947364},"labels":[],"label_agreement":null},{"id":"W2955368946","doi":"10.1016/j.jval.2019.04.340","title":"PCN218 PHYSICIAN ATTITUDES AND TREATMENT PATTERNS IN ADVANCED HEPATOCELLULAR CARCINOMA (HCC) IN CANADA AND EUROPE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Sorafenib; Medicine; Family medicine; CHAID; Hepatocellular carcinoma; Guideline; Internal medicine; Oncology","score_opus":0.030896579803201953,"score_gpt":0.22386614706433408,"score_spread":0.19296956726113212,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955368946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99228424,0.005541177,0.0000037183559,0.00051827385,0.00018553271,0.00042656047,0.000090047346,0.0000039517035,0.0009465165],"genre_scores_gemma":[0.99526614,0.003874011,0.00004816703,0.0006283432,0.000029695393,0.000019245255,0.0000059249696,0.000019692056,0.00010878139],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860907,0.000026561444,0.00055992225,0.00039915837,0.000020868976,0.00038443014],"domain_scores_gemma":[0.9994712,0.000047381694,0.00018564427,0.00018865406,0.000006035999,0.00010107155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002403983,0.00015263425,0.0005488053,0.00017485327,0.000022286447,0.000019601292,0.000074284864,0.00003874202,0.000020861213],"category_scores_gemma":[0.000014790311,0.00017855327,0.000017094304,0.000145241,0.000016247835,0.00017028056,0.00003084422,0.00011678448,0.000019626406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018188364,0.000039929426,0.9906375,0.000100049496,0.0000031603752,0.000013018235,0.00036283245,0.00090958294,0.0000018317119,0.003256877,0.000006429685,0.004650606],"study_design_scores_gemma":[0.0012668503,0.00015742435,0.987921,0.00010002882,3.9188194e-7,0.0000011114387,0.000074517106,0.0065164636,0.000009285749,0.00060163735,0.0031792067,0.00017210221],"about_ca_topic_score_codex":0.96780026,"about_ca_topic_score_gemma":0.8660262,"teacher_disagreement_score":0.10177401,"about_ca_system_score_codex":0.0013312461,"about_ca_system_score_gemma":0.00039214257,"threshold_uncertainty_score":0.7281191},"labels":[],"label_agreement":null},{"id":"W2955447147","doi":"10.1016/j.jval.2019.04.424","title":"PCN306 REAL-WORLD STUDY OF HEALTHCARE UTILIZATION AND LONG-TERM PRODUCTIVITY LOSS IN CHRONIC GRAFT VERSUS HOST DISEASE IN SWEDEN","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Folate and B Vitamins Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research","funders":"","keywords":"Medicine; Hematopoietic stem cell transplantation; Graft-versus-host disease; Internal medicine; Disease; Incidence (geometry); Population; Extracorporeal Photopheresis","score_opus":0.12275267947926925,"score_gpt":0.42146343937160263,"score_spread":0.29871075989233337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955447147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992462,0.0021285235,3.379865e-7,0.0021909936,0.00013358144,0.0030173394,0.000009817331,0.0000140559605,0.000043399912],"genre_scores_gemma":[0.99798256,0.0017015357,0.000005562707,0.000022932009,0.00006412817,0.000039994822,0.00003047263,0.000020453313,0.00013236064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976982,0.00047056907,0.00050708535,0.0004728603,0.00041280716,0.00043850945],"domain_scores_gemma":[0.9990411,0.00012519116,0.0001058494,0.00044516003,0.00006416081,0.00021853922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010747229,0.0001355745,0.00044668434,0.00064417295,0.00003294831,0.000007888255,0.000083643965,0.00005274378,0.000015092792],"category_scores_gemma":[0.00012694758,0.00012647666,0.0000214756,0.0010502421,0.00005179963,0.00011914237,0.000076197175,0.0003764228,0.000006111247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015304951,0.0010404874,0.9891546,0.003370217,0.0000088460865,0.000088667,0.0015719293,0.0002126142,0.00006058629,0.00006605819,0.000004347928,0.0028911508],"study_design_scores_gemma":[0.005856024,0.002429582,0.9885874,0.00088333694,0.000005714041,0.000001412802,0.00022265888,0.0018632095,0.000031916275,0.000012544022,0.00001912638,0.00008709],"about_ca_topic_score_codex":0.080436826,"about_ca_topic_score_gemma":0.11764816,"teacher_disagreement_score":0.037211332,"about_ca_system_score_codex":0.0011029918,"about_ca_system_score_gemma":0.0010925537,"threshold_uncertainty_score":0.9256866},"labels":[],"label_agreement":null},{"id":"W2955516289","doi":"10.1016/j.jval.2019.04.1395","title":"PNS33 BUGSNET: A NEW COMPREHENSIVE R PACKAGE FOR NETWORK META-ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Waterloo","funders":"","keywords":"Computer science; Systematic review; Best practice; Completeness (order theory); Data science; MEDLINE; Mathematics","score_opus":0.8786727326830011,"score_gpt":0.5574297508011428,"score_spread":0.3212429818818583,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955516289","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12705682,0.15535066,0.62705266,0.04933438,0.0034494034,0.025321806,0.0004530489,0.000075809265,0.01190539],"genre_scores_gemma":[0.7879018,0.00029849645,0.11671705,0.013171613,0.0006816767,0.00031900816,0.00009383358,0.000078593584,0.08073792],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9683758,0.013911543,0.011568928,0.001565974,0.0038488184,0.0007289134],"domain_scores_gemma":[0.9763768,0.0122088045,0.0055796835,0.004798967,0.00063239346,0.00040337353],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.09440537,0.00038802862,0.011115286,0.0007438373,0.00012811471,0.0004533982,0.0016033917,0.00010677303,0.014492861],"category_scores_gemma":[0.0051349537,0.00019391839,0.008575464,0.0052153114,0.000025002691,0.00016469846,0.00011474085,0.00019804011,0.0037976978],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036268357,0.000112799244,0.033644766,0.00040798617,0.0731686,0.000004542013,0.0017431977,0.432254,0.0000085693155,0.025058977,0.42836177,0.005198528],"study_design_scores_gemma":[0.00067595905,0.00024564646,0.010059618,0.000026697446,0.04430673,0.0000046975474,0.0006571857,0.1770196,0.0000032340772,0.046743557,0.7197587,0.0004984129],"about_ca_topic_score_codex":0.0016588701,"about_ca_topic_score_gemma":0.00033592875,"teacher_disagreement_score":0.660845,"about_ca_system_score_codex":0.000083377505,"about_ca_system_score_gemma":0.00033013657,"threshold_uncertainty_score":0.996978},"labels":[],"label_agreement":null},{"id":"W2955532382","doi":"10.1016/j.jval.2019.04.552","title":"PDB2 COMPARATIVE EFFICACY AND SAFETY OF PHARMACOTHERAPIES FOR THE TREATMENT OF OBESITY AMONG ADULTS: A SYSTEMATLIC LITERATURE AND NETWORK META-ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmacology and Obesity Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Medicine; Phentermine; Orlistat; Liraglutide; Bupropion; Placebo; Topiramate; Overweight; Internal medicine; Meta-analysis; Subgroup analysis; Adverse effect; Obesity; Weight loss; Type 2 diabetes; Diabetes mellitus; Smoking cessation; Endocrinology; Epilepsy; Psychiatry","score_opus":0.08286185006423652,"score_gpt":0.3746949147785509,"score_spread":0.29183306471431436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955532382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86782926,0.12868041,0.00003765892,0.0005676847,0.000039083512,0.0027536852,0.000074607655,0.0000065536124,0.000011036961],"genre_scores_gemma":[0.99090743,0.008367219,0.00034455085,0.00014267808,0.000027475333,0.00009590517,0.00001801499,0.000005657137,0.00009106609],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998726,0.00034836188,0.00043655204,0.0002183509,0.00009964388,0.00017109125],"domain_scores_gemma":[0.99828994,0.0011203309,0.00026874949,0.00018582004,0.000061033286,0.00007412211],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051125337,0.0001520785,0.0014522009,0.00009508194,0.00006950369,0.000004632517,0.000038613878,0.0000548102,0.000025072855],"category_scores_gemma":[0.0000056372146,0.000081357466,0.0002522497,0.0003098879,0.00008782642,0.00003071889,0.0000092384735,0.00007136466,4.362863e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012835429,0.0045712744,0.6362936,0.007859458,0.23730597,0.000012943783,0.07313652,0.02557915,0.00017183358,0.0011280001,0.00023292209,0.0008728987],"study_design_scores_gemma":[0.023613812,0.007622196,0.8135337,0.0008315719,0.11294449,0.00001786967,0.0011461908,0.037880123,0.0010528631,0.00010952485,0.0010149207,0.00023268952],"about_ca_topic_score_codex":0.0007069171,"about_ca_topic_score_gemma":0.00007439363,"teacher_disagreement_score":0.17724015,"about_ca_system_score_codex":0.00007205619,"about_ca_system_score_gemma":0.0000494839,"threshold_uncertainty_score":0.33176613},"labels":[],"label_agreement":null},{"id":"W2955595457","doi":"10.1016/j.jval.2019.04.158","title":"PCN34 MAKING WORDS COUNT: OPPORTUNITIES FOR INNOVATION IN HEALTH TECHNOLOGY ASSESSMENT","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Takeda (Canada); St. Michael's Hospital","funders":"","keywords":"Qualitative research; Multidisciplinary approach; Health technology; Health care; Management science; Qualitative property; Medicine; Knowledge management; Engineering ethics; Psychology; Sociology; Computer science; Social science; Economic growth; Engineering; Economics","score_opus":0.6319355951142256,"score_gpt":0.4943120994513966,"score_spread":0.137623495662829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955595457","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5665622,0.003939824,0.010248247,0.40910965,0.0018502136,0.004872639,0.000350573,0.00012961522,0.0029370347],"genre_scores_gemma":[0.9558414,0.00059930247,0.012849703,0.029375765,0.00016549982,0.00047391874,0.000097685894,0.00005500969,0.00054167514],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99080956,0.00045460585,0.007174726,0.000641654,0.0001156734,0.0008037985],"domain_scores_gemma":[0.99485284,0.0007949385,0.0036692643,0.0005190413,0.00007569322,0.00008825073],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.03963023,0.00020307393,0.0012507701,0.0023580503,0.00014140883,0.000050177838,0.00027220108,0.00020810514,0.00011622784],"category_scores_gemma":[0.0012202734,0.0002851951,0.0000499795,0.0010345886,0.00004520875,0.0003591727,0.000051934017,0.00035962948,0.00013254418],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011594758,0.00009791055,0.15106802,0.0020893193,0.000009841677,5.2208424e-7,0.0013665062,0.003777247,4.4639188e-7,0.8378278,0.0021237927,0.0016270156],"study_design_scores_gemma":[0.005028151,0.0011740668,0.08715392,0.0029812246,0.0000016749926,0.00001116366,0.026750693,0.22635692,0.0000016907597,0.23228659,0.4172399,0.0010139921],"about_ca_topic_score_codex":0.004469317,"about_ca_topic_score_gemma":0.00050061493,"teacher_disagreement_score":0.6055412,"about_ca_system_score_codex":0.0037942291,"about_ca_system_score_gemma":0.001863685,"threshold_uncertainty_score":0.99996},"labels":[],"label_agreement":null},{"id":"W2955606396","doi":"10.1016/j.jval.2019.04.913","title":"PIN43 THE ECONOMIC BURDEN OF ANTIMICROBIAL RESISTANCE: RESULTS FROM A TARGETED LITERATURE REVIEW","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Becton Dickinson (Canada)","funders":"","keywords":"Antimicrobial stewardship; Medicine; Acinetobacter; Antibiotic resistance; Economic cost; Economic impact analysis; Health care; Intensive care medicine; Indirect costs; Environmental health; Business; Economic growth; Biology; Economics; Microbiology","score_opus":0.012498447355532323,"score_gpt":0.24706080147555648,"score_spread":0.23456235412002416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955606396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5405534,0.4410569,0.000004080661,0.014012334,0.0013650627,0.00097377185,0.00090899883,0.000029635321,0.0010958058],"genre_scores_gemma":[0.88352793,0.1109927,0.00015872037,0.0013710464,0.000080678,0.000002396698,0.0003279675,0.000016000771,0.0035225684],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981166,0.0004980189,0.00072214985,0.00033411017,0.00002881101,0.0003003048],"domain_scores_gemma":[0.9987588,0.00026263398,0.00038455208,0.00054728816,0.000029941166,0.000016807848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007176562,0.00014004971,0.00048106973,0.000054778837,0.00006986574,0.000007300544,0.00030738657,0.00017375514,0.00013102932],"category_scores_gemma":[0.00006864375,0.00009495841,0.00009065294,0.00016668598,0.00010233105,0.00004578717,0.000047166235,0.00036628786,0.00034095484],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0060337563,0.00042308238,0.0052990885,0.026011495,0.0008205821,0.000055988356,0.022821365,0.0029629508,0.15437748,0.013076276,0.7648959,0.0032220052],"study_design_scores_gemma":[0.012384333,0.0004980645,0.016667945,0.14705133,0.00010627035,0.0000541132,0.0008501313,0.00014821363,0.024091123,0.001354465,0.7956554,0.0011385533],"about_ca_topic_score_codex":0.0044398177,"about_ca_topic_score_gemma":0.00020292499,"teacher_disagreement_score":0.3429745,"about_ca_system_score_codex":0.00009654766,"about_ca_system_score_gemma":0.0003205638,"threshold_uncertainty_score":0.6711706},"labels":[],"label_agreement":null},{"id":"W2955796504","doi":"10.1016/j.jval.2019.04.196","title":"PCN72 COST OF MANAGING METASTATIC BLADDER CANCER WITH THE INTRODUCTION OF IMMUNOTHERAPIES FROM A CANADIAN HEALTHCARE PERSPECTIVE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Docetaxel; Pembrolizumab; Gemcitabine; Medicine; Atezolizumab; Oncology; Adverse effect; Internal medicine; Paclitaxel; Carboplatin; Prostate cancer; Metastatic Urothelial Carcinoma; Cisplatin; Bladder cancer; Cancer; Immunotherapy; Chemotherapy; Urothelial carcinoma","score_opus":0.02545748039092295,"score_gpt":0.30961575421447696,"score_spread":0.284158273823554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955796504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84197,0.023309762,0.000043406908,0.13124686,0.0002980506,0.002394878,0.00025045723,0.0000142319395,0.00047230293],"genre_scores_gemma":[0.99725235,0.0009707151,0.00028235558,0.0011600839,0.00010218558,0.00005793366,0.000015922005,0.000022165414,0.00013631838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989392,0.0001441169,0.0002506281,0.00021609134,0.00020662672,0.00024334494],"domain_scores_gemma":[0.9992635,0.00005580218,0.00015897884,0.0002935467,0.00013478233,0.000093357216],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021001122,0.00011222177,0.0003666739,0.00015440288,0.000044120483,0.000004061592,0.00006523937,0.00002453162,0.00022713022],"category_scores_gemma":[0.000008823835,0.00007268017,0.00003769044,0.0002953554,0.00006858574,0.00004359676,0.0000066176663,0.00016316408,0.0000038153366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0069365883,0.0010180061,0.62594503,0.004231996,0.0050866315,0.00004976926,0.24685621,0.01809334,0.0018627464,0.02209729,0.0037946056,0.06402779],"study_design_scores_gemma":[0.021118155,0.0075726113,0.7711962,0.0040506534,0.00068023783,0.00007067391,0.16478963,0.0034828007,0.0045170877,0.005115386,0.016640823,0.00076576736],"about_ca_topic_score_codex":0.960374,"about_ca_topic_score_gemma":0.30893108,"teacher_disagreement_score":0.65144295,"about_ca_system_score_codex":0.00083121925,"about_ca_system_score_gemma":0.0017562192,"threshold_uncertainty_score":0.70367914},"labels":[],"label_agreement":null},{"id":"W2955805426","doi":"10.1016/j.jval.2019.04.1562","title":"PNS205 GENERATING A REALISTIC SIMULATED ADMINISTRATIVE CLAIMS DATASET FOR DRUG SAFETY AND EFFECTIVENESS RESEARCH AND TRAINING","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Manitoba","funders":"","keywords":"Interquartile range; Observational study; Concordance; Medicine; Confidence interval; Population; Medical record; Drug; Statistics; Drug-drug interaction; Internal medicine; Environmental health; Mathematics; Pharmacology","score_opus":0.6980787133271151,"score_gpt":0.5421506316945964,"score_spread":0.1559280816325187,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955805426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9750348,0.0023785217,0.0015656053,0.010460072,0.00030247477,0.0036360628,0.006399961,0.000023925339,0.00019857526],"genre_scores_gemma":[0.99423724,0.00025732434,0.0028850979,0.0014452044,0.00014907877,0.00009502024,0.0008233343,0.00003545243,0.000072233786],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9942813,0.0016501703,0.0025715616,0.00078442437,0.00009672909,0.00061582925],"domain_scores_gemma":[0.9880774,0.010442992,0.0008107431,0.00036272293,0.00006413395,0.00024202834],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.055155914,0.0001691256,0.0009888192,0.000360397,0.00036196076,0.00009453881,0.00013733085,0.000114745286,0.000026753356],"category_scores_gemma":[0.003390702,0.00021220958,0.000027006441,0.00024909663,0.00010315265,0.0002701229,0.00006162252,0.0003171408,0.000044998626],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011378059,0.0003751611,0.15520123,0.018244343,0.00017538485,0.0000072046387,0.04656367,0.08021416,0.00003253557,0.6879146,0.0075656706,0.0025682368],"study_design_scores_gemma":[0.0051032044,0.0012359951,0.0556816,0.0012723155,0.0000040359205,0.00001601753,0.006619961,0.8506158,0.0000056439258,0.055078693,0.02374922,0.00061752764],"about_ca_topic_score_codex":0.008028093,"about_ca_topic_score_gemma":0.0004215605,"teacher_disagreement_score":0.77040166,"about_ca_system_score_codex":0.0006561463,"about_ca_system_score_gemma":0.0004935775,"threshold_uncertainty_score":0.99857754},"labels":[],"label_agreement":null},{"id":"W2956015350","doi":"10.1016/j.jval.2019.04.766","title":"PDG87 DRUG UTILIZATION IN PERSISTENT NAMD PATIENTS TREATED WITH LICENSED ANTI-VEGFS IN CANADA: A REAL WORLD STUDY USING THE ONTARIO PUBLIC CLAIMS DATABASE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Aflibercept; Ranibizumab; Medicine; Cohort; Macular degeneration; Retrospective cohort study; Dosing; Cohort study; Medical prescription; Bevacizumab; Pediatrics; Internal medicine; Pro re nata; Ophthalmology; Pharmacology; Chemotherapy","score_opus":0.20157718155231333,"score_gpt":0.2979772143020565,"score_spread":0.09640003274974315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956015350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961997,0.00013616575,0.0000012110831,0.0009932915,0.0001734999,0.0012121224,0.00013093198,0.0000059794056,0.0011470972],"genre_scores_gemma":[0.9986816,0.0001175031,0.000025837657,0.0009461793,0.00001734122,0.000019453448,0.000059835496,0.000022270573,0.00010997549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979243,0.00013208979,0.00089348404,0.00045123868,0.00006287692,0.0005359817],"domain_scores_gemma":[0.9990577,0.000083804494,0.00033348138,0.00036121285,0.000020282465,0.00014349792],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009553723,0.00017064196,0.00047586288,0.0004902526,0.000069745,0.000051448762,0.00021874678,0.00002975403,0.00010825193],"category_scores_gemma":[0.000018588917,0.00015906028,0.00003402515,0.000756219,0.000020597454,0.00021279759,0.000062905536,0.0003457126,0.000015525331],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052424064,0.0003577633,0.9869727,0.000029748247,0.000015056969,0.0000036654276,0.002560149,0.008321365,1.5389936e-7,0.001537138,0.000037250033,0.00011262037],"study_design_scores_gemma":[0.002833626,0.00010985748,0.8752036,0.00006399257,0.0000026544676,5.5813626e-7,0.0005451761,0.11867503,8.114887e-7,0.000055922028,0.002312829,0.00019592939],"about_ca_topic_score_codex":0.9971488,"about_ca_topic_score_gemma":0.99795306,"teacher_disagreement_score":0.11176906,"about_ca_system_score_codex":0.0057225754,"about_ca_system_score_gemma":0.0014552698,"threshold_uncertainty_score":0.99809426},"labels":[],"label_agreement":null},{"id":"W2956079173","doi":"10.1016/j.jval.2019.04.919","title":"PIN49 EXAMINING THE CLINICAL AND ECONOMIC IMPACT OF ANTIMICROBIAL RESISTANCE AT ACUTE CARE FACILITIES: A PRACTICAL TOOL","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University Health Network; Becton Dickinson (Canada)","funders":"","keywords":"Medicine; Antibiotic resistance; Klebsiella pneumonia; Intensive care medicine; Enterococcus faecalis; Pseudomonas aeruginosa; Pneumonia; Antimicrobial stewardship; Enterococcus faecium; Emergency medicine; Staphylococcus aureus; Internal medicine; Antibiotics; Microbiology; Biology","score_opus":0.04440263655330046,"score_gpt":0.3484250662317067,"score_spread":0.30402242967840626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956079173","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948644,0.003239235,0.000008434707,0.00048336707,0.00045600953,0.000384464,0.00016293235,0.000012686494,0.00038844612],"genre_scores_gemma":[0.99597293,0.0016163444,0.000164911,0.00011431762,0.000025705975,0.0000015528019,0.000017256818,0.000010288129,0.0020766843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981527,0.00053491496,0.00062427885,0.0003192082,0.000024831415,0.00034410748],"domain_scores_gemma":[0.9986743,0.0006942959,0.0002474521,0.00033796235,0.000021535045,0.00002447168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007247413,0.00013284417,0.00044763045,0.000044491033,0.00011260347,0.000008160423,0.00012666335,0.00019556064,0.00013640753],"category_scores_gemma":[0.000076380646,0.00009004303,0.00009403537,0.000048955615,0.00037627487,0.00006348832,0.00009608973,0.0003405014,0.00013660024],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033086408,0.000162372,0.95006245,0.0015275015,0.00066229905,0.000021128839,0.013822589,0.00044465467,0.012125974,0.003418985,0.012885171,0.0015582482],"study_design_scores_gemma":[0.008861406,0.002612349,0.9295021,0.0018925846,0.00009993645,0.00028241158,0.008519785,0.00014249963,0.0034194407,0.00017822304,0.043663226,0.0008260074],"about_ca_topic_score_codex":0.002083869,"about_ca_topic_score_gemma":0.0003836949,"teacher_disagreement_score":0.030778054,"about_ca_system_score_codex":0.00021440911,"about_ca_system_score_gemma":0.0007359553,"threshold_uncertainty_score":0.36718482},"labels":[],"label_agreement":null},{"id":"W2956090666","doi":"10.1016/j.jval.2019.04.1079","title":"PMH34 LONG-TERM UTILIZATION OF ANTIDEPRESSANT DRUGS: PREVALENCE AND ASSOCIATED FACTORS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Treatment of Major Depression","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Sherbrooke; Université du Québec à Rimouski","funders":"","keywords":"Medicine; Medical prescription; Polypharmacy; Antidepressant; Defined daily dose; Logistic regression; Cohort; Retrospective cohort study; Population; Pharmacoepidemiology; Cohort study; Psychiatry; Internal medicine; Environmental health; Pharmacology","score_opus":0.05257813352891314,"score_gpt":0.33475845587792147,"score_spread":0.2821803223490083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2956090666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960472,0.0025957706,0.000009769702,0.00018727455,0.00012587768,0.00080747314,0.000016322318,0.00003958474,0.00017070664],"genre_scores_gemma":[0.99780816,0.00171646,0.000079599726,0.000051253097,0.000010158022,0.00000417144,0.00003809619,0.000016105312,0.00027601686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987354,0.00015903021,0.00035722807,0.00025095211,0.0002923212,0.00020506741],"domain_scores_gemma":[0.99920595,0.00016495642,0.00022600242,0.00024221801,0.00003977022,0.0001211126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003309041,0.000112665795,0.00033106218,0.00013146861,0.00002324713,0.0000050237886,0.000049490554,0.00008237271,0.00006823365],"category_scores_gemma":[0.00018883371,0.0000907287,0.000031202013,0.00015885153,0.000025175084,0.00008483768,0.00003480167,0.00011178821,0.000005339858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049920956,0.00024633357,0.9959547,0.0013386715,0.000015715637,0.0000034456473,0.0007360234,0.000077456425,0.00034587283,0.000028682329,0.000024215738,0.0011789867],"study_design_scores_gemma":[0.0016533496,0.00037637283,0.993001,0.002258509,0.000019924146,0.0000031636478,0.00004261533,0.0011890217,0.0013599274,0.000024702827,0.000009373658,0.00006205077],"about_ca_topic_score_codex":0.0007922493,"about_ca_topic_score_gemma":0.0000069584335,"teacher_disagreement_score":0.002953686,"about_ca_system_score_codex":0.00013181406,"about_ca_system_score_gemma":0.00013699973,"threshold_uncertainty_score":0.3699809},"labels":[],"label_agreement":null},{"id":"W2957978461","doi":"10.1016/j.jval.2019.09.1207","title":"PIH26 JUVENILE IDIOPATHIC ARTHRITIS IS ASSOCIATED WITH CONSIDERABLE FINANCIAL BURDEN TO SOCIETY: RESULTS OF A DUTCH COST ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Formulary; Indirect costs; Cohort; Emergency medicine; Health care; Arthritis; Total cost; Pediatrics; Productivity; Family medicine; Accounting; Internal medicine","score_opus":0.06174097908282342,"score_gpt":0.3675661191720163,"score_spread":0.30582514008919287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2957978461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96685857,0.0022164546,0.00012430185,0.025452347,0.000486285,0.003396993,0.00079929293,0.00009021452,0.00057553215],"genre_scores_gemma":[0.9912956,0.0013965656,0.00036105447,0.005075479,0.00031465036,0.0000892862,0.000097601136,0.000037185153,0.0013326043],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941512,0.00147224,0.0019717219,0.0006149545,0.0006253013,0.0011646223],"domain_scores_gemma":[0.996616,0.00094590435,0.0010069088,0.00056321867,0.00042624687,0.00044172214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049838442,0.0002513243,0.0013909205,0.00035797403,0.00042566026,0.000008542922,0.00020053242,0.00043600562,0.00019882964],"category_scores_gemma":[0.0010803718,0.00023643853,0.00019107139,0.0027148903,0.00003697472,0.00009101884,0.0000907534,0.001172915,0.0001868594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000903966,0.00028084326,0.8084802,0.0026531115,0.00019480544,0.000032010375,0.09527927,0.006610647,0.000014464961,0.00035559447,0.08184748,0.003347586],"study_design_scores_gemma":[0.05107041,0.006720952,0.6739597,0.033546664,0.00057613704,0.000011562755,0.048286945,0.038953494,0.00007056512,0.0019698974,0.1417119,0.0031217653],"about_ca_topic_score_codex":0.05973121,"about_ca_topic_score_gemma":0.008880651,"teacher_disagreement_score":0.13452052,"about_ca_system_score_codex":0.0009054667,"about_ca_system_score_gemma":0.0057504666,"threshold_uncertainty_score":0.999886},"labels":[],"label_agreement":null},{"id":"W2967556947","doi":"10.1016/j.jval.2019.05.012","title":"A Cost Analysis and Cost-Utility Analysis of a Community Pharmacist–Led Intervention on Reducing Cardiovascular Risk: The Alberta Vascular Risk Reduction Community Pharmacy Project (RxEACH)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia; University of Alberta; University of Calgary","funders":"Alberta Innovates; Alberta Health; Alberta Health Services; Sanofi","keywords":"Medicine; Pharmacy; Pharmacist; Intervention (counseling); Health care; Emergency medicine; Randomized controlled trial; Relative risk; Emergency department; Cost–benefit analysis; Health economics; Confidence interval; Family medicine; Public health; Internal medicine; Nursing","score_opus":0.24082409729051427,"score_gpt":0.45692213633212886,"score_spread":0.2160980390416146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2967556947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937817,0.0016753781,0.0005092057,0.00043902887,0.00019234398,0.0030652257,0.00008356639,0.000030175157,0.00022339383],"genre_scores_gemma":[0.99568415,0.0036536756,0.00009386853,0.00019555818,0.000028776207,0.00007031481,0.00021445255,0.000020373398,0.00003883216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98015183,0.017448025,0.00106065,0.00033722268,0.0006162025,0.00038607075],"domain_scores_gemma":[0.99471855,0.0024882192,0.0008718369,0.001569298,0.00015405961,0.00019805887],"candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.015993256,0.0002792772,0.0013802338,0.0009074339,0.0005742338,0.000033145297,0.00027222448,0.00008089878,0.00009154409],"category_scores_gemma":[0.0013066921,0.00021126993,0.0013540341,0.0033156283,0.00014471784,0.0002052719,0.00015951155,0.002783189,0.0000068386016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017001441,0.0021401732,0.860441,0.0012151096,0.023889743,0.0000013596405,0.012364864,0.041101906,0.000047783476,0.000008935328,0.000042402557,0.05704654],"study_design_scores_gemma":[0.0056507606,0.0005041402,0.49780726,0.00024308875,0.026408771,0.000008053807,0.0029189016,0.46283856,0.0002494846,0.000024327239,0.0031335168,0.00021311866],"about_ca_topic_score_codex":0.58816826,"about_ca_topic_score_gemma":0.0025162762,"teacher_disagreement_score":0.58565193,"about_ca_system_score_codex":0.00043315178,"about_ca_system_score_gemma":0.00013107229,"threshold_uncertainty_score":0.99951744},"labels":[],"label_agreement":null},{"id":"W2971395672","doi":"10.1016/j.jval.2019.07.010","title":"The Joint Committee on Vaccination and Immunisation’s Advice on Extending Human Papillomavirus Vaccination to Boys: Were Cost-Effectiveness Analysis Guidelines Bent to Achieve a Politically Acceptable Decision?","year":2019,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Vaccination; Advice (programming); Human papillomavirus; Bent molecular geometry; Medicine; Joint (building); Virology; Family medicine; Operations research; Computer science; Engineering; Internal medicine","score_opus":0.44464417776986664,"score_gpt":0.5723809910731553,"score_spread":0.12773681330328868,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2971395672","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15122588,0.0025299112,0.0052759713,0.13026188,0.66274065,0.04318155,0.00178933,0.00067337055,0.0023214866],"genre_scores_gemma":[0.4555314,0.0121835405,0.00815973,0.051852953,0.4485223,0.014718659,0.0037924983,0.0011084084,0.004130496],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9718096,0.01810348,0.0041310913,0.0016575998,0.0025391045,0.0017590973],"domain_scores_gemma":[0.9447681,0.047671262,0.0021487575,0.0020345238,0.002492084,0.0008853184],"candidate_categories":["metaresearch","metaepi_narrow","sts","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.03571098,0.0008239957,0.0019241465,0.0021779882,0.0036100075,0.00025555544,0.0009527734,0.0012752224,0.00016008869],"category_scores_gemma":[0.03676289,0.00068221916,0.00024614186,0.001930799,0.000024771269,0.00044063976,0.00067337975,0.00405944,0.00037347557],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048964536,0.0010580408,0.009203677,0.0061816787,0.00069549115,0.000014739846,0.009359814,0.019646727,0.000026567417,0.036569733,0.72667044,0.18567662],"study_design_scores_gemma":[0.003046943,0.003424119,0.3066343,0.0064082094,0.00025444568,8.4931736e-7,0.0047237515,0.0022558284,0.0000072081693,0.0047063623,0.6674799,0.0010581046],"about_ca_topic_score_codex":0.06916483,"about_ca_topic_score_gemma":0.01328834,"teacher_disagreement_score":0.30430552,"about_ca_system_score_codex":0.0096888635,"about_ca_system_score_gemma":0.0031997317,"threshold_uncertainty_score":0.9995629},"labels":[],"label_agreement":null},{"id":"W2978965473","doi":"10.1016/j.jval.2019.08.008","title":"Quebec Health-Related Quality-of-Life Population Norms Using the EQ-5D-5L: Decomposition by Sociodemographic Data and Health Problems","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":85,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Université de Sherbrooke; Université de Montréal; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke","funders":"Social Sciences and Humanities Research Council of Canada","keywords":"Medicine; Demography; Confidence interval; Quality of life (healthcare); Disadvantaged; Population; Interquartile range; Gerontology; Environmental health","score_opus":0.5531132612288412,"score_gpt":0.457097136029606,"score_spread":0.09601612519923519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2978965473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8434023,0.025338808,0.0022392094,0.1247603,0.0006697811,0.0027189534,0.0007844842,0.000053713506,0.000032417545],"genre_scores_gemma":[0.98056316,0.0017512158,0.0021194834,0.01440384,0.00009423224,0.00003338009,0.0009193837,0.000055845983,0.00005943624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98599774,0.0028083005,0.0091842245,0.0009781605,0.00023571005,0.00079586596],"domain_scores_gemma":[0.9897705,0.0011106038,0.0075101,0.0011963338,0.000047190435,0.00036529443],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.062485754,0.0002788525,0.0018542147,0.00049028057,0.00047181954,0.00007955605,0.0005036819,0.00020377625,0.000053234937],"category_scores_gemma":[0.00068763254,0.00029770876,0.000092805305,0.0005971573,0.00010208055,0.00074365246,0.00014865711,0.00046230445,0.00006744083],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000309746,0.00025662518,0.8925234,0.006340598,0.00008393854,8.234112e-8,0.01017956,0.013300965,0.0000039173797,0.06977087,0.0066212565,0.0008878223],"study_design_scores_gemma":[0.0030406462,0.00040818774,0.5906968,0.0015201363,0.0000049227924,0.000009303543,0.0034006522,0.37409037,3.8837825e-7,0.022322848,0.0038091354,0.0006965774],"about_ca_topic_score_codex":0.6570507,"about_ca_topic_score_gemma":0.03226337,"teacher_disagreement_score":0.6247874,"about_ca_system_score_codex":0.0018996045,"about_ca_system_score_gemma":0.0013787731,"threshold_uncertainty_score":0.9999475},"labels":[],"label_agreement":null},{"id":"W2979237484","doi":"10.1016/j.jval.2018.09.2607","title":"PSY30 - INCIDENCE AND PREVALENCE OF NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE IN US MEDICARE, 2008-2015","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Incidence (geometry); Nontuberculous mycobacteria; Demography; Lung disease; Pediatrics; Internal medicine; Tuberculosis; Lung; Pathology","score_opus":0.022459743634765186,"score_gpt":0.3404490655037625,"score_spread":0.31798932186899737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979237484","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923686,0.0042597675,0.000010794776,0.0020753397,0.00026400693,0.0007742725,0.00007583392,0.000017812552,0.00015357298],"genre_scores_gemma":[0.9926613,0.00609806,0.0003208907,0.000471168,0.0003353874,0.000047983172,0.000013050353,0.000015183736,0.0000369948],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99771947,0.0003075108,0.00056410104,0.00036903613,0.00052075455,0.0005191343],"domain_scores_gemma":[0.9983426,0.00029009796,0.00012115218,0.00037216864,0.00011814896,0.0007558687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012592919,0.00013975179,0.00039320908,0.00026533002,0.00003977986,0.000011326523,0.0001350609,0.00007973135,0.00027020377],"category_scores_gemma":[0.0017457111,0.00012353677,0.000034032837,0.00037124587,0.0002543497,0.0001286515,0.000102051425,0.00023131471,0.000013230815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00078289816,0.00019544868,0.9921283,0.003185946,0.0000064665596,0.00009151175,0.00059054355,0.000005164373,0.00030479283,0.000061753955,0.0012878651,0.0013593198],"study_design_scores_gemma":[0.00155249,0.0006590044,0.99152654,0.0021804667,0.000013012488,0.000017155215,0.000019342891,0.003259186,0.00012681619,0.00011289529,0.0004364246,0.000096638374],"about_ca_topic_score_codex":0.01654953,"about_ca_topic_score_gemma":0.00043573685,"teacher_disagreement_score":0.016113793,"about_ca_system_score_codex":0.0002093987,"about_ca_system_score_gemma":0.0011573327,"threshold_uncertainty_score":0.98999935},"labels":[],"label_agreement":null},{"id":"W2979346316","doi":"10.1016/j.jval.2019.08.004","title":"Development of System Performance Indicators for Adolescent and Young Adult Cancer Care and Control in Canada","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; CancerCare Manitoba; Ottawa Hospital; Izaak Walton Killam Health Centre; BC Children's Hospital; University of Toronto; Pediatric Oncology Group; SickKids Foundation; Canadian Hospice Palliative Care Association; Hospital for Sick Children; McMaster University","funders":"","keywords":"Ranking (information retrieval); Psychosocial; Delphi method; Benchmarking; Medicine; Multidisciplinary approach; Family medicine; Performance indicator; Computer science; Business; Artificial intelligence","score_opus":0.01719475353412628,"score_gpt":0.27802148955567296,"score_spread":0.26082673602154666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2979346316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289584,0.004756971,0.000013041348,0.00055145693,0.00027200818,0.0014353958,0.000043039396,0.0000068246695,0.000025445663],"genre_scores_gemma":[0.99820215,0.00032991706,0.00055096735,0.000790896,0.000032216103,0.00006887368,0.000007016612,0.000013383228,0.0000045847287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99861705,0.00006069144,0.00058295904,0.00022359584,0.00025439297,0.00026130545],"domain_scores_gemma":[0.9994261,0.000058336474,0.00019191438,0.00012638593,0.000053320342,0.00014393903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004476699,0.00010768635,0.00046115072,0.00012743608,0.000031330223,0.0000027228077,0.00004364889,0.000039603543,0.0000014807291],"category_scores_gemma":[0.000019935735,0.00010262052,0.000012159127,0.00012774227,0.000016324293,0.000026811447,0.00001643799,0.00012887835,1.9631032e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015592368,0.000015846701,0.96287084,0.019932209,0.000012831438,8.093965e-7,0.010130924,0.000082034436,0.000011332168,0.0000362082,0.000026020158,0.006725041],"study_design_scores_gemma":[0.0045502083,0.00014872583,0.9713511,0.0077067013,0.000008322361,0.0000069111534,0.012419995,0.003077056,0.0001893212,4.0092885e-7,0.00042367764,0.00011761092],"about_ca_topic_score_codex":0.88934976,"about_ca_topic_score_gemma":0.8754747,"teacher_disagreement_score":0.01387508,"about_ca_system_score_codex":0.0018864187,"about_ca_system_score_gemma":0.0050518243,"threshold_uncertainty_score":0.896172},"labels":[],"label_agreement":null},{"id":"W2980040069","doi":"10.1016/j.jval.2020.02.010","title":"Computing the Expected Value of Sample Information Efficiently: Practical Guidance and Recommendations for Four Model-Based Methods","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":69,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"National Institute of Allergy and Infectious Diseases; Medical Research Council; Norges Forskningsråd; University College London; National Center for Advancing Translational Sciences; University of Bristol; Canadian Institutes of Health Research; National Institute for Health and Care Research; National Cancer Institute; National Institutes of Health; University Hospitals Bristol NHS Foundation Trust","keywords":"Computer science; Value of information; Sample (material); Value (mathematics); Simple (philosophy); Software; Management science; Data science; Operations research; Machine learning; Artificial intelligence; Mathematics; Engineering","score_opus":0.6075820547132345,"score_gpt":0.5162253699919509,"score_spread":0.09135668472128355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2980040069","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.01242396,0.000319918,0.7488422,0.2368463,0.00015689617,0.0010400849,0.0002777516,0.000025072623,0.000067826084],"genre_scores_gemma":[0.2856184,0.000040339917,0.68335706,0.030738471,0.00008810727,0.00008116868,0.00005806837,0.000015900689,0.0000025067025],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99471754,0.0009982209,0.0036126438,0.00028648245,0.0000727987,0.00031231274],"domain_scores_gemma":[0.98954374,0.0076893037,0.0022729065,0.00025881344,0.000085824584,0.00014944382],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.021728098,0.00012039329,0.00061230385,0.00017710667,0.00023439848,0.000046750647,0.00015412507,0.000077004326,0.000013735003],"category_scores_gemma":[0.017138386,0.00013161416,0.00006440745,0.00031328847,0.000051777108,0.00033681112,0.000042375013,0.00017863301,0.000013155154],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052120897,0.00008326462,0.006032821,0.00167019,0.000023920815,4.1352873e-8,0.014876999,0.44738546,0.0000017131875,0.5186122,0.008914389,0.0023468558],"study_design_scores_gemma":[0.0007121096,0.00010561187,0.001233095,0.00008822997,0.0000024819346,7.0359533e-7,0.001011605,0.97321504,0.000006516538,0.010095298,0.013420438,0.00010888792],"about_ca_topic_score_codex":0.0018296973,"about_ca_topic_score_gemma":0.000014866354,"teacher_disagreement_score":0.52582955,"about_ca_system_score_codex":0.00029390815,"about_ca_system_score_gemma":0.0005133595,"threshold_uncertainty_score":0.99114066},"labels":[],"label_agreement":null},{"id":"W2984821753","doi":"10.1016/j.jval.2019.08.013","title":"Community-Based Services by Pharmacists: A Systematic Review of Cost-Utility Analyses","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Canadian Pharmacists Association","funders":"","keywords":"Generalizability theory; Observational study; Context (archaeology); MEDLINE; Systematic review; Medicine; Quality (philosophy); Health care; Family medicine; Actuarial science; Psychology; Business; Political science; Geography","score_opus":0.6363299863112107,"score_gpt":0.594137732421894,"score_spread":0.04219225388931669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2984821753","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000550968,0.98859173,0.000012880541,0.00038054472,0.00018335819,0.010029525,0.00042330744,0.0000333424,0.0003398197],"genre_scores_gemma":[0.00006523001,0.98994106,0.00007358467,0.00851367,0.00001983638,0.0002243475,0.0010527688,0.000043715474,0.00006579975],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9874896,0.008155658,0.0030019819,0.00032091676,0.000632986,0.00039889806],"domain_scores_gemma":[0.9921776,0.0036780105,0.0025182834,0.001191897,0.00012892805,0.00030525317],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005980609,0.00046257194,0.006859127,0.0002571628,0.00007099605,0.00001257583,0.00047040734,0.00017391055,0.00014594368],"category_scores_gemma":[0.00062880246,0.00031836645,0.0007263487,0.0008385251,0.000058469912,0.00008751765,0.00008485752,0.0016564523,0.00008083245],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023714885,0.00049564237,0.00006772975,0.98937005,0.000224706,0.0000046384926,0.000040855444,0.0000019878871,6.868728e-8,0.0000035676048,0.0004923811,0.009274657],"study_design_scores_gemma":[0.00047223354,0.00013447813,5.8305704e-7,0.6679774,0.0032764038,0.000017614862,0.000014979538,0.0008001483,5.184239e-7,0.0000021018075,0.3271653,0.00013826127],"about_ca_topic_score_codex":0.0013822267,"about_ca_topic_score_gemma":0.0000028505463,"teacher_disagreement_score":0.3266729,"about_ca_system_score_codex":0.00038851256,"about_ca_system_score_gemma":0.0010713405,"threshold_uncertainty_score":0.99992687},"labels":[],"label_agreement":null},{"id":"W2994620391","doi":"10.1016/j.jval.2019.09.2150","title":"PNS250 CADTH PARALLEL SCIENTIFIC ADVICE PROGRAMS WITH NICE AND HEALTH CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Nice; Excellence; Advice (programming); Timeline; Agency (philosophy); Computer science; Public relations; Medicine; Operations research; Medical education; Political science; Engineering; Sociology; Mathematics","score_opus":0.32392215033784855,"score_gpt":0.38768589662501723,"score_spread":0.06376374628716869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994620391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80064124,0.013572865,0.00025973696,0.17843829,0.0014325171,0.0035800345,0.00020189764,0.00010062095,0.0017728208],"genre_scores_gemma":[0.9583814,0.00041596027,0.008552239,0.030257512,0.00015896659,0.00015499657,0.000104878345,0.00006824416,0.0019057934],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.993994,0.00049200817,0.0033647357,0.00097543455,0.00020819559,0.0009656504],"domain_scores_gemma":[0.99630225,0.00037763585,0.0020465415,0.00068563287,0.000054755594,0.00053319085],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.021062162,0.00023827261,0.0011416164,0.00032166648,0.00032673188,0.000140482,0.0002775158,0.000085452106,0.00007514317],"category_scores_gemma":[0.00023459208,0.00027380625,0.000035184286,0.0005354556,0.00008747393,0.00034810838,0.000052410775,0.0003114503,0.00026698833],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038430895,0.00019567015,0.8474177,0.004003527,0.000040982264,0.0000031999546,0.0052410406,0.0072926832,1.5313823e-7,0.09832853,0.036061548,0.0013765317],"study_design_scores_gemma":[0.0043056286,0.0011969403,0.30927277,0.0015623033,0.0000034886614,0.00005194761,0.0051921974,0.0695691,4.7524279e-7,0.0057900166,0.60188895,0.0011661651],"about_ca_topic_score_codex":0.92455083,"about_ca_topic_score_gemma":0.7404638,"teacher_disagreement_score":0.5658274,"about_ca_system_score_codex":0.0023934876,"about_ca_system_score_gemma":0.005011206,"threshold_uncertainty_score":0.9999714},"labels":[],"label_agreement":null},{"id":"W2994627824","doi":"10.1016/j.jval.2019.09.510","title":"PCN315 USE OF NOVEL HORMONAL AGENTS IN THE MONTH BEFORE DYING IN MEN DYING OF PROSTATE CANCER","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatologic Treatments and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Odds ratio; Cohort; Androgen deprivation therapy; Internal medicine; Cancer; Hormonal therapy; Abiraterone; Logistic regression; Medical prescription; Cohort study; Cause of death; Androgen receptor; Pharmacology; Disease","score_opus":0.16702729598851532,"score_gpt":0.4021691145844173,"score_spread":0.23514181859590197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994627824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99539405,0.0006589739,0.0000014635598,0.0023236177,0.000039939965,0.0012802888,0.000018752089,0.0000035225314,0.00027941968],"genre_scores_gemma":[0.9987884,0.00050598325,0.00026359118,0.00019732902,0.0000075602006,0.00004324901,0.000009772144,0.000008984522,0.00017513619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986121,0.00012475974,0.00044688454,0.00015956338,0.00034563232,0.00031106934],"domain_scores_gemma":[0.9994868,0.00011203518,0.00012908413,0.0001929492,0.000032220367,0.000046893343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006633219,0.00008333422,0.00033276618,0.00020148067,0.000016849875,0.000004790934,0.00008864956,0.00004949663,0.00001516426],"category_scores_gemma":[0.000042618383,0.000048481445,0.000026085387,0.00033542537,0.000038174225,0.00006206219,0.00003858193,0.0002239359,0.0000014967856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018429638,0.00050504465,0.98278147,0.0006157895,0.000015674603,0.000034871235,0.008716211,0.002997037,0.00017370412,0.00008752486,0.00007561207,0.003812738],"study_design_scores_gemma":[0.003777516,0.00035328267,0.97391176,0.0010687636,0.00000398646,0.000011506372,0.0011110058,0.019422254,0.00008637773,0.000043921416,0.00016574487,0.000043874552],"about_ca_topic_score_codex":0.043276835,"about_ca_topic_score_gemma":0.00046354902,"teacher_disagreement_score":0.042813286,"about_ca_system_score_codex":0.00021522798,"about_ca_system_score_gemma":0.00034635857,"threshold_uncertainty_score":0.96309406},"labels":[],"label_agreement":null},{"id":"W2994659526","doi":"10.1016/j.jval.2019.09.2211","title":"PNS311 PREDICTIVE-ADJUSTED INDIRECT COMPARISON (PAIC): A NOVEL METHOD FOR POPULATION-ADJUSTED INDIRECT COMPARISON","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Covariate; Statistics; Population; Econometrics; Aggregate (composite); Standard error; Computer science; Mathematics; Medicine","score_opus":0.4801097598572617,"score_gpt":0.4623911089460939,"score_spread":0.017718650911167755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994659526","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8004756,0.0075706593,0.14870189,0.020980818,0.004720279,0.012308331,0.002266165,0.00048620687,0.002490082],"genre_scores_gemma":[0.91940314,0.00007871011,0.073215,0.00493395,0.0004713954,0.00056375616,0.00063726556,0.00013788196,0.00055890117],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98740095,0.001454165,0.008383255,0.0013410947,0.00026661603,0.0011539261],"domain_scores_gemma":[0.9892888,0.0040046438,0.005262611,0.00089832756,0.00012708113,0.00041852894],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.030244041,0.00046978862,0.0034637896,0.001287765,0.00031283376,0.00010495754,0.00052126386,0.0004481894,0.00021992794],"category_scores_gemma":[0.003395822,0.0006187631,0.00026451383,0.00091055874,0.000044220065,0.0005319144,0.000086704415,0.0006227039,0.0006747483],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015271631,0.00055018585,0.8946503,0.001980261,0.00012618274,2.384628e-7,0.0052421186,0.06454101,0.0000052306114,0.024348559,0.0076950504,0.00070818746],"study_design_scores_gemma":[0.0028403413,0.0004725514,0.32957092,0.0003963284,0.00001222175,0.00000441917,0.0011805653,0.64332336,0.000009275596,0.0021337108,0.019550595,0.00050573936],"about_ca_topic_score_codex":0.03141487,"about_ca_topic_score_gemma":0.0016102009,"teacher_disagreement_score":0.5787823,"about_ca_system_score_codex":0.002371824,"about_ca_system_score_gemma":0.00058535975,"threshold_uncertainty_score":0.9996264},"labels":[],"label_agreement":null},{"id":"W2994662905","doi":"10.1016/j.jval.2019.09.631","title":"PCN438 ECONOMIC EVALUATION METHODS IN ONCOLOGY: ONWARDS AND UPWARDS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Economic evaluation; MEDLINE; Actuarial science; Time horizon; Sophistication; Sample size determination; Statistics; Pathology; Mathematics; Economics","score_opus":0.5460106175539866,"score_gpt":0.5567845640533401,"score_spread":0.010773946499353482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994662905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9115973,0.009830025,0.0010370577,0.056370188,0.002266039,0.003125784,0.00014270966,0.00005160651,0.0155793065],"genre_scores_gemma":[0.9359832,0.0018757844,0.0471131,0.013674013,0.00040287946,0.00038641697,0.000054144937,0.000082644416,0.00042786417],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9897135,0.0034112073,0.00518158,0.00091099285,0.0001122685,0.00067049044],"domain_scores_gemma":[0.9952137,0.0020787097,0.0018758936,0.00055684027,0.000036979014,0.00023786456],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.10373136,0.00022232364,0.0014503553,0.00090953644,0.00007841665,0.00004833628,0.00023221888,0.0002740887,0.00066948385],"category_scores_gemma":[0.0025202443,0.00030253365,0.00007497107,0.00025369358,0.000056052984,0.00045738576,0.0000760811,0.00039521712,0.0015059398],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009079094,0.0003679051,0.5949008,0.0019884214,0.00007223503,0.000002364439,0.014198866,0.071378164,0.0000140297825,0.27161416,0.0060398667,0.039332446],"study_design_scores_gemma":[0.0045365216,0.0005181361,0.20046373,0.0003482239,0.000005000588,0.000015687088,0.0019895255,0.58275247,0.000009703238,0.088636845,0.12008677,0.0006373612],"about_ca_topic_score_codex":0.023017876,"about_ca_topic_score_gemma":0.00096329226,"teacher_disagreement_score":0.51137435,"about_ca_system_score_codex":0.0065084193,"about_ca_system_score_gemma":0.001746051,"threshold_uncertainty_score":0.99994266},"labels":[],"label_agreement":null},{"id":"W2994673562","doi":"10.1016/j.jval.2019.09.1192","title":"PIH10 ANALYSING PRESCRIBING PATTERNS AND COSTS OF DRUG TREATMENT IN JUVENILE IDIOPATHIC ARTHRITIS IN THE NETHERLANDS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Formulary; Cohort; Arthritis; Methotrexate; Juvenile; Pediatrics; Drug; Internal medicine; Family medicine; Pharmacology","score_opus":0.06680391592013195,"score_gpt":0.3743388889725187,"score_spread":0.30753497305238675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994673562","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.987335,0.0066190166,0.0000115701005,0.003917017,0.00024977163,0.0016927356,0.000027779162,0.00001234074,0.00013476874],"genre_scores_gemma":[0.9950097,0.0040802527,0.000030911968,0.0005927903,0.00015160156,0.00005858459,0.000015536101,0.000017134067,0.000043439],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99465513,0.0030105077,0.0011993323,0.00029762782,0.00022819884,0.00060917763],"domain_scores_gemma":[0.9985134,0.00070675375,0.00034481214,0.00030428253,0.000027790453,0.00010294221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003921528,0.0001507619,0.0005982003,0.00030819207,0.00012687345,0.0000060486705,0.00012289,0.00013637473,0.000025435967],"category_scores_gemma":[0.00008028987,0.000113574904,0.00003904796,0.00048715094,0.000015822638,0.00007604486,0.000039600567,0.0006876655,0.000011359969],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004041231,0.000090534166,0.9484885,0.00080393435,0.0000019463828,0.000013167611,0.03862323,0.00027280147,0.0000026904918,0.0001215026,0.000040207193,0.011501097],"study_design_scores_gemma":[0.0039252155,0.00036052024,0.96041334,0.0073357266,0.000005503332,0.000003910348,0.021333294,0.0056894035,0.0000032523615,0.0002133571,0.00054010045,0.00017639373],"about_ca_topic_score_codex":0.15709183,"about_ca_topic_score_gemma":0.06333633,"teacher_disagreement_score":0.0937555,"about_ca_system_score_codex":0.0006968228,"about_ca_system_score_gemma":0.00080163375,"threshold_uncertainty_score":0.9537553},"labels":[],"label_agreement":null},{"id":"W2994776872","doi":"10.1016/j.jval.2019.09.649","title":"PCN457 THE SISAQOL INITIATIVE: ESTABLISHING INTERNATIONAL STANDARDS AND RECOMMENDATIONS FOR THE ANALYSIS OF PATIENT-REPORTED OUTCOMES AND QUALITY OF LIFE DATA IN ONCOLOGY RANDOMIZED CLINICAL TRIALS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; University of British Columbia","funders":"","keywords":"Missing data; Terminology; Comparability; Standardization; Clinical trial; Data quality; Medicine; Descriptive statistics; Data science; Management science; Computer science; Business; Service (business); Statistics; Pathology; Engineering","score_opus":0.7850245816451625,"score_gpt":0.6153870542944893,"score_spread":0.16963752735067328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994776872","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.815307,0.0028760168,0.0049541127,0.16744123,0.0010008704,0.0037701998,0.004468257,0.0000066434327,0.0001756344],"genre_scores_gemma":[0.9893295,0.0026676776,0.001996306,0.005606838,0.000051238927,0.00013049824,0.00019865412,0.000010151906,0.000009099588],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97083396,0.01233002,0.015826577,0.0005696353,0.0001940408,0.00024576462],"domain_scores_gemma":[0.8005387,0.18422653,0.013899556,0.0009976593,0.00021715426,0.00012038508],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.34580904,0.00011419381,0.0033069237,0.0005225576,0.00007733076,0.00003901829,0.00035215434,0.000112370835,0.00008758083],"category_scores_gemma":[0.18749739,0.00008643143,0.00019156351,0.0003802916,0.0001756701,0.00033906795,0.00015855092,0.0002207632,9.345537e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023011211,0.00019322075,0.9388027,0.00028540406,0.0014309484,4.5851756e-8,0.005934522,0.001381621,1.1692708e-7,0.044124786,0.0008299166,0.004715589],"study_design_scores_gemma":[0.07176543,0.00020678245,0.59319896,0.00019298772,0.00019309351,4.998874e-7,0.01392922,0.29007807,3.7700747e-7,0.010722195,0.019453375,0.00025900148],"about_ca_topic_score_codex":0.016884921,"about_ca_topic_score_gemma":0.0024371333,"teacher_disagreement_score":0.34560373,"about_ca_system_score_codex":0.0002830864,"about_ca_system_score_gemma":0.0008607638,"threshold_uncertainty_score":0.98966175},"labels":[],"label_agreement":null},{"id":"W2994840958","doi":"10.1016/j.jval.2019.09.839","title":"PCV115 SOME APPROACHES FOR THE ESTIMATION OF CENSORED PATIENT REPORTED OUTCOMES: RESULTS USING THE KANSAS CITY CARDIOMYOPATHY QUESTIONNAIRE (KCCQ)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Censoring (clinical trials); Medicine; Hazard ratio; Population; Demography; Statistics; Internal medicine; Confidence interval; Mathematics","score_opus":0.49171937253535586,"score_gpt":0.41389337964587286,"score_spread":0.077825992889483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994840958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9321792,0.0034711775,0.014707762,0.043073367,0.0014255965,0.0045761014,0.00040073882,0.00004092287,0.00012513669],"genre_scores_gemma":[0.99216586,0.0000810158,0.005105567,0.0022433663,0.00011823069,0.00016129432,0.000036344,0.000029282253,0.00005903709],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99281615,0.00073977874,0.0053300974,0.00053088384,0.00016373413,0.0004193484],"domain_scores_gemma":[0.99226624,0.0021806017,0.0043909564,0.0009919748,0.00007878083,0.000091473616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026715165,0.00019163552,0.0009872834,0.00023311895,0.00027063637,0.00004137921,0.00027054746,0.0001263659,0.0000065829],"category_scores_gemma":[0.005791611,0.00015673104,0.000189171,0.0002823307,0.000082277635,0.00029778297,0.000044551845,0.00020436141,0.000025982326],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009040591,0.00013369996,0.11797137,0.0011925439,0.00010604578,3.1646692e-7,0.011121641,0.7887009,5.2673965e-7,0.0785732,0.00078193675,0.0013274264],"study_design_scores_gemma":[0.0013670009,0.00016525897,0.12526989,0.00033800845,0.000011633641,0.000006177782,0.0023890322,0.85235983,0.000004890857,0.016216578,0.0016445509,0.00022715333],"about_ca_topic_score_codex":0.017423892,"about_ca_topic_score_gemma":0.0000804007,"teacher_disagreement_score":0.06365894,"about_ca_system_score_codex":0.00093258225,"about_ca_system_score_gemma":0.00046857068,"threshold_uncertainty_score":0.9891192},"labels":[],"label_agreement":null},{"id":"W2994847507","doi":"10.1016/j.jval.2019.09.2632","title":"PSY4 THE USE OF EQ-5D VISUAL ANALOG SCALE (EQ-VAS) IN DISEASES AREAS WHERE EQ-5D IS INSENSITIVE TO CHANGES IN THE DISEASE STATUS: THE CASE OF LIPODYSTROPHY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada)","funders":"","keywords":"EQ-5D; Visual analogue scale; Medicine; Placebo; Minimal clinically important difference; Statistical significance; Physical therapy; Statistics; Disease; Internal medicine; Randomized controlled trial; Mathematics; Pathology; Alternative medicine","score_opus":0.45032909295852713,"score_gpt":0.3982563434239082,"score_spread":0.052072749534618934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994847507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93617487,0.004028068,0.000037945192,0.05455118,0.00027485128,0.0026200968,0.0022623762,0.000010288012,0.00004033331],"genre_scores_gemma":[0.9842548,0.0009099621,0.00014316011,0.014267871,0.00014209456,0.00017144042,0.000031680236,0.000033993947,0.00004499985],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929434,0.0023247492,0.0031918294,0.00063595636,0.00019255809,0.0007114956],"domain_scores_gemma":[0.9930335,0.0038780768,0.001702967,0.0010105383,0.00008731229,0.00028759788],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009842263,0.0002642249,0.0011109204,0.0006194596,0.00013895363,0.00006520264,0.00041119015,0.00010002544,0.000093628456],"category_scores_gemma":[0.0020857963,0.00020520194,0.00013821566,0.00093695073,0.00016300092,0.00027791815,0.00011477256,0.00035319437,0.000112564514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002609676,0.0006376304,0.9252665,0.0016303662,0.00004268277,0.0000388154,0.04381613,0.015341633,0.0000017458314,0.008455847,0.0035876194,0.00092006975],"study_design_scores_gemma":[0.001553064,0.0005495928,0.91842,0.0010421871,0.000014965984,0.000019649879,0.022228345,0.04606015,0.000003847232,0.0028853193,0.0068181683,0.00040472206],"about_ca_topic_score_codex":0.11325578,"about_ca_topic_score_gemma":0.030841308,"teacher_disagreement_score":0.08241446,"about_ca_system_score_codex":0.00066916173,"about_ca_system_score_gemma":0.00064595474,"threshold_uncertainty_score":0.9868433},"labels":[],"label_agreement":null},{"id":"W2994881204","doi":"10.1016/j.jval.2019.09.2451","title":"PRO121 THE USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT OF MEDICATIONS FOR RARE DISEASES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Nice; Observational study; Tolerability; Health technology; Real world data; Medicine; Randomized controlled trial; Clinical trial; Data extraction; MEDLINE; Family medicine; Health care; Data science; Adverse effect; Computer science; Internal medicine; Political science","score_opus":0.633768669566204,"score_gpt":0.5191857200238837,"score_spread":0.11458294954232029,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994881204","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4127706,0.006160751,0.0048321215,0.5568837,0.0008411134,0.010306914,0.007890458,0.00006249383,0.000251868],"genre_scores_gemma":[0.9674792,0.0023121093,0.02394199,0.005068075,0.00008795375,0.00043074912,0.00042169646,0.000039717448,0.00021850652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99278337,0.00066052476,0.005440674,0.00055996695,0.00011937445,0.0004360947],"domain_scores_gemma":[0.9909799,0.0029882716,0.0042278594,0.0016287987,0.00005875005,0.00011643346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018337632,0.00012773379,0.0012049101,0.00091927015,0.00007872955,0.000013591644,0.0006639241,0.00007013108,0.00004425572],"category_scores_gemma":[0.0021331983,0.00013230748,0.000051958898,0.00082476507,0.00013174476,0.0002884328,0.00013671572,0.00020350145,0.000019422165],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008791257,0.00019947214,0.66111875,0.0022268319,0.000021987331,5.949553e-8,0.0004460484,0.0033464776,1.7241618e-7,0.32903263,0.0031646255,0.0004341886],"study_design_scores_gemma":[0.0014602008,0.00036732038,0.73468995,0.0010615508,0.000004953386,9.923035e-7,0.0017574937,0.18063933,7.742213e-7,0.020045327,0.059754144,0.00021794184],"about_ca_topic_score_codex":0.0419132,"about_ca_topic_score_gemma":0.0065345983,"teacher_disagreement_score":0.5547086,"about_ca_system_score_codex":0.0008286269,"about_ca_system_score_gemma":0.0020550138,"threshold_uncertainty_score":0.9644668},"labels":[],"label_agreement":null},{"id":"W2994893487","doi":"10.1016/j.jval.2019.09.597","title":"PCN402 THE CLINICAL AND ECONOMIC CONSEQUENCES OF DELAYS IN REIMBURSEMENT FOR SELECT NOVEL CANCER THERAPEUTICS IN CANADA, ITALY, AND AUSTRALIA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Reimbursement; Crizotinib; Ipilimumab; Medicine; Trastuzumab; Family medicine; Cancer; Oncology; Health care; Internal medicine; Breast cancer; Lung cancer; Economic growth","score_opus":0.60011601143961,"score_gpt":0.4933354986417834,"score_spread":0.10678051279782663,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994893487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96408755,0.003552066,0.000030071431,0.030131567,0.00044605276,0.001378855,0.00033111515,0.0000023144567,0.00004042279],"genre_scores_gemma":[0.9935425,0.0017856742,0.0005343271,0.0039253826,0.00005096761,0.00009799732,0.000004547064,0.000012715334,0.000045890898],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99529815,0.00030223007,0.0035736945,0.0004099226,0.000045478988,0.00037054988],"domain_scores_gemma":[0.99667686,0.0018229316,0.001173144,0.00022495171,0.000016421356,0.00008569631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014365754,0.0001247244,0.0008451814,0.0001730017,0.00003855735,0.000016426768,0.00014845833,0.00008531545,0.0000373237],"category_scores_gemma":[0.00023382291,0.00013033979,0.00003160862,0.00010207323,0.000106738735,0.00010697516,0.000025680953,0.00019701946,0.000006861395],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021778838,0.00002713877,0.9692222,0.00034999213,0.000018102213,1.2725906e-7,0.0007010706,0.0052832146,0.0000015399588,0.023910517,0.00029313966,0.00017120707],"study_design_scores_gemma":[0.0020692036,0.00017669068,0.9357594,0.00026007666,0.0000030345825,0.0000025944435,0.00134721,0.050508525,0.0000053515014,0.005800778,0.003860015,0.00020710188],"about_ca_topic_score_codex":0.9579708,"about_ca_topic_score_gemma":0.91213983,"teacher_disagreement_score":0.045830984,"about_ca_system_score_codex":0.0013833387,"about_ca_system_score_gemma":0.0024247642,"threshold_uncertainty_score":0.53151023},"labels":[],"label_agreement":null},{"id":"W2994908759","doi":"10.1016/j.jval.2019.09.2296","title":"PNS396 VALUING HEALTH RELATED QUALITY OF LIFE IN MOROCCO: AN EQ-5D-3L VALUE SET","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Representativeness heuristic; Logistic regression; Sample (material); Population; Statistics; EQ-5D; Econometrics; Computer science; Mathematics; Medicine; Environmental health; Health related quality of life","score_opus":0.6290592087948895,"score_gpt":0.4562251904492626,"score_spread":0.17283401834562695,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994908759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9579436,0.006678596,0.00024487768,0.030131705,0.0011349434,0.0022408909,0.0003783143,0.00008494101,0.0011621244],"genre_scores_gemma":[0.9832613,0.00062904955,0.0028817167,0.0126120765,0.00014764426,0.00006837494,0.00012245848,0.00008280495,0.0001945602],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.977044,0.0048939865,0.015142256,0.001303456,0.00031824756,0.001298092],"domain_scores_gemma":[0.9888276,0.002071928,0.0069752056,0.0013619008,0.000075666496,0.00068773],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.08791606,0.0003849777,0.0032939326,0.0011817623,0.00015321386,0.000050400376,0.0006015943,0.00035233732,0.00031084483],"category_scores_gemma":[0.004673391,0.0005246642,0.00019174036,0.0009932653,0.000086309825,0.00078771653,0.00010619698,0.0007439047,0.0011062621],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007175571,0.0004090412,0.7164706,0.0038773979,0.000036960133,9.964288e-7,0.01346785,0.053780347,0.0000035143069,0.21045066,0.0012063371,0.00022456971],"study_design_scores_gemma":[0.005368012,0.00089611305,0.7817913,0.0013903364,0.0000025134168,0.0000076265974,0.0062049036,0.14933532,0.0000031469951,0.05054408,0.0034743971,0.000982222],"about_ca_topic_score_codex":0.21769264,"about_ca_topic_score_gemma":0.0024255186,"teacher_disagreement_score":0.21526712,"about_ca_system_score_codex":0.002743171,"about_ca_system_score_gemma":0.0022137372,"threshold_uncertainty_score":0.9997205},"labels":[],"label_agreement":null},{"id":"W2994926825","doi":"10.1016/j.jval.2019.09.637","title":"PCN445 INDIRECT TREATMENT COMPARISON OF AXICABTAGENE CILOLEUCEL (AXI-CEL) VERSUS TISAGENLECLEUCEL (TISA-CEL) IN RELAPSED/REFRACTORY LARGE B CELL LYMPHOMA (RR-LBCL)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Medicine; Leukapheresis; Population; Internal medicine; Adverse effect; Oncology; Refractory (planetary science); Clinical trial; Surgery; Gastroenterology; Stem cell","score_opus":0.08268486209824036,"score_gpt":0.36535704509718864,"score_spread":0.28267218299894825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994926825","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97767633,0.00790852,0.000007458604,0.00048468847,0.0008240075,0.0022605667,0.00006909401,0.00007796854,0.0106913755],"genre_scores_gemma":[0.99024534,0.002622732,0.00037533173,0.00020413117,0.00014412044,0.00008577411,0.00010091683,0.000117241536,0.0061044022],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9945008,0.00083894626,0.0014254912,0.00087306846,0.0010283641,0.0013333056],"domain_scores_gemma":[0.9969633,0.00083092204,0.0004403097,0.0011668818,0.000096463424,0.00050210377],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0017189723,0.0004751371,0.0015947598,0.0008939256,0.00008345634,0.000019447321,0.0003365909,0.00036647182,0.0014342378],"category_scores_gemma":[0.000111302244,0.0004570594,0.00026468822,0.001034321,0.00010116559,0.00008887623,0.00011987757,0.000611363,0.0004172786],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02196246,0.046958715,0.5706157,0.0044520563,0.0004878305,0.0005401672,0.02526788,0.002178242,0.14848633,0.00034779665,0.003039151,0.17566365],"study_design_scores_gemma":[0.2644543,0.0477658,0.26238862,0.002866857,0.00018706641,0.000073488955,0.007259138,0.029641174,0.19363207,0.00020113509,0.18944228,0.002088093],"about_ca_topic_score_codex":0.010254192,"about_ca_topic_score_gemma":0.000909865,"teacher_disagreement_score":0.30822712,"about_ca_system_score_codex":0.003634623,"about_ca_system_score_gemma":0.001824152,"threshold_uncertainty_score":0.9997881},"labels":[],"label_agreement":null},{"id":"W2994945806","doi":"10.1016/j.jval.2019.09.1643","title":"PMU24 ECONOMIC EVALUATION OF BIOCELLULOSE WOUND DRESSINGS FOR THE MANAGEMENT OF CHRONIC LEG ULCERS IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Agricultural and Food Sciences","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Venous leg ulcer; Wound care; Clinical trial; Wound healing; Physical therapy; Intensive care medicine; Surgery; Internal medicine","score_opus":0.05270500171359643,"score_gpt":0.2601330335013135,"score_spread":0.20742803178771707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994945806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953289,0.001152067,2.594404e-7,0.0023243807,0.000215278,0.0007789992,0.00001772557,0.0000018563261,0.00018054481],"genre_scores_gemma":[0.99966776,0.00016782203,0.000022367154,0.000040608666,0.000028761257,0.000019967161,0.0000069167572,2.9085248e-7,0.000045507746],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99905294,0.00007353931,0.00030404676,0.0001621064,0.00021772561,0.00018962297],"domain_scores_gemma":[0.99957484,0.00014942446,0.00018189581,0.00004128166,0.000025398436,0.00002716943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011483858,0.00006073346,0.00013686133,0.000009918205,0.000046524343,0.00000752683,0.00020821743,0.000020165466,0.00006694025],"category_scores_gemma":[0.0000038925145,0.000019030635,0.000029535915,0.00020158247,0.000029469682,0.0000604566,0.000025963795,0.00004069877,0.0000018454558],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011211101,0.00019818814,0.12383938,0.00090062595,0.0000612053,8.0248554e-7,0.0010861355,0.1741218,0.01116511,0.0042216387,0.0008027561,0.6834902],"study_design_scores_gemma":[0.00047357808,0.00042990682,0.9313002,0.00024020356,0.00001124254,6.680967e-7,0.004711623,0.05961687,0.0008346718,0.00081990083,0.0014327756,0.00012836176],"about_ca_topic_score_codex":0.8116674,"about_ca_topic_score_gemma":0.7908026,"teacher_disagreement_score":0.80746084,"about_ca_system_score_codex":0.00065222516,"about_ca_system_score_gemma":0.00029279693,"threshold_uncertainty_score":0.21301472},"labels":[],"label_agreement":null},{"id":"W2994953762","doi":"10.1016/j.jval.2019.09.776","title":"PCV51 COST-EFFECTIVENESS OF RIVAROXABAN IN THE TREATMENT OF PATIENTS WITH CHRONIC CAD OR PAD IN THE UK","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Rivaroxaban; Medicine; Stroke (engine); Myocardial infarction; Coronary artery disease; Cost effectiveness; Quality-adjusted life year; Internal medicine; Emergency medicine; Warfarin; Atrial fibrillation","score_opus":0.32924311323728783,"score_gpt":0.41870843693616056,"score_spread":0.08946532369887272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994953762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907159,0.0013619506,0.000032514094,0.002586261,0.00016888375,0.0046880115,0.00020460396,0.0000035293403,0.00023834007],"genre_scores_gemma":[0.9983879,0.00038344137,0.000087712804,0.00069450564,0.000034074175,0.00035173516,0.000030723706,0.000014735911,0.0000152270395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945357,0.0020842596,0.0025362966,0.0003476321,0.00012677004,0.00036937147],"domain_scores_gemma":[0.99462944,0.0033268018,0.001384467,0.00058846123,0.00002849095,0.000042336873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016542263,0.00015343036,0.00094516354,0.00032573775,0.000039458788,0.000011716909,0.00030519278,0.00007756089,0.000058996364],"category_scores_gemma":[0.00034386854,0.000103298655,0.000055738714,0.00048510887,0.00005578651,0.00011236478,0.000012121958,0.00014054475,0.000057743167],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013356394,0.00063020893,0.9726761,0.0009879518,0.000013212889,5.409686e-7,0.008936034,0.0060777306,1.5015645e-7,0.010220952,0.000036887148,0.00028667095],"study_design_scores_gemma":[0.0035825386,0.0017592926,0.9880984,0.00040851475,0.0000017225884,7.133088e-7,0.00097173825,0.0020847907,0.0000027813637,0.0010852907,0.0018934854,0.00011073014],"about_ca_topic_score_codex":0.041657906,"about_ca_topic_score_gemma":0.0055997954,"teacher_disagreement_score":0.03605811,"about_ca_system_score_codex":0.0017526014,"about_ca_system_score_gemma":0.00054285227,"threshold_uncertainty_score":0.96472377},"labels":[],"label_agreement":null},{"id":"W2994956998","doi":"10.1016/j.jval.2019.09.2592","title":"PSU5 ECONOMIC IMPACT OF PULMONARY ARTERY CATHETER UTILIZATION AMONG CARDIAC SURGERY PATIENTS: PERSPECTIVES FOR AN ACUTE CARE HOSPITAL AND AN INTEGRATED PAYER-PROVIDER HEALTH SYSTEM","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Pulmonary artery catheter; Perioperative; Cardiac surgery; Emergency medicine; Acute care; Health care; Catheter; Intensive care medicine; Surgery; Cardiac output; Cardiology; Hemodynamics","score_opus":0.04665708739467265,"score_gpt":0.29946249176459333,"score_spread":0.25280540436992066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994956998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922481,0.0023610801,0.00020606234,0.0004369765,0.0006040251,0.0020894946,0.0019075451,0.000038529117,0.00010818415],"genre_scores_gemma":[0.99821967,0.0009102417,0.0001225967,0.00010154985,0.00008738072,0.00009734655,0.00040569025,0.00004355433,0.000011978156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975742,0.00021427608,0.0010623235,0.0006096458,0.000040529612,0.000499002],"domain_scores_gemma":[0.99846745,0.00009644633,0.00071100175,0.0004121834,0.00006732625,0.0002455673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011778888,0.0002153936,0.0008648662,0.0004727385,0.00009297256,0.000043698445,0.00011343632,0.00010643492,0.000007199624],"category_scores_gemma":[0.000028908016,0.0002263999,0.00017619946,0.0001442988,0.000040267576,0.0005782742,0.00003153288,0.00012230646,0.000008883834],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079320664,0.0002522079,0.9514677,0.0022624142,0.00011430034,6.033612e-7,0.02164532,0.0013867437,2.9974788e-7,0.011277851,0.00020996212,0.011303305],"study_design_scores_gemma":[0.0008305761,0.0037383272,0.90844893,0.0004375719,0.000010321469,0.0000013769284,0.019691374,0.064516686,0.0000032899272,0.0006414767,0.0011147853,0.0005652998],"about_ca_topic_score_codex":0.11780183,"about_ca_topic_score_gemma":0.00034111185,"teacher_disagreement_score":0.11746071,"about_ca_system_score_codex":0.0022961323,"about_ca_system_score_gemma":0.00043795138,"threshold_uncertainty_score":0.923232},"labels":[],"label_agreement":null},{"id":"W2994982266","doi":"10.1016/j.jval.2019.09.432","title":"PCN237 IMPACT OF ORAL TARGETED THERAPY ON THE ECONOMIC BURDEN OF CLL IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Foothills Medical Centre; CancerCare Manitoba; Ottawa Hospital; Hôpital Maisonneuve-Rosemont; Université de Montréal","funders":"","keywords":"IGHV@; Chemoimmunotherapy; Medicine; Chronic lymphocytic leukemia; Fludarabine; Watchful waiting; Adverse effect; Incidence (geometry); Internal medicine; Leukemia; Cancer; Chemotherapy","score_opus":0.04563556119087507,"score_gpt":0.33886766914407607,"score_spread":0.293232107953201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2994982266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99671406,0.0005343856,1.4627415e-7,0.001346676,0.0000905421,0.0008384036,0.00002191236,0.0000029783323,0.0004508929],"genre_scores_gemma":[0.99928015,0.00037086604,0.000019970626,0.00020128925,0.000028713477,0.000007298166,0.000005919511,0.000015597669,0.00007017647],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985345,0.00021461296,0.00046554068,0.00016492019,0.00026409898,0.00035631686],"domain_scores_gemma":[0.9988555,0.0004475734,0.00013717393,0.00043874994,0.000025152041,0.00009586467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00092555274,0.000095845506,0.00041992022,0.000134034,0.000008986834,0.0000018775731,0.00016089971,0.00004298729,0.00042527227],"category_scores_gemma":[0.00007410812,0.000060419614,0.00005766556,0.00019044643,0.00003631263,0.000019421508,0.000023250564,0.0002264534,0.000016914362],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0051835957,0.00033620928,0.39319232,0.001524885,0.00029052363,0.00008334527,0.008214978,0.5639294,0.0029925592,0.0019823462,0.009005536,0.013264353],"study_design_scores_gemma":[0.037798196,0.0039895386,0.31558508,0.0011513744,0.000004831723,0.00003402551,0.0011517821,0.63416624,0.004398073,0.0003667715,0.0011144595,0.00023964197],"about_ca_topic_score_codex":0.9983999,"about_ca_topic_score_gemma":0.52093303,"teacher_disagreement_score":0.4774669,"about_ca_system_score_codex":0.05113351,"about_ca_system_score_gemma":0.09195781,"threshold_uncertainty_score":0.95250905},"labels":[],"label_agreement":null},{"id":"W2995016183","doi":"10.1016/j.jval.2019.09.2651","title":"PSY23 DIRECT COSTS OF SYSTEMIC LUPUS ERYTHEMATOSUS IN ALBERTA IN REAL WORLD","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Ambulatory; Indirect costs; Health care; Ambulatory care; Disease; Systemic lupus erythematosus; Emergency medicine; Internal medicine; Business","score_opus":0.03757876475180175,"score_gpt":0.33459525469702217,"score_spread":0.2970164899452204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995016183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97268486,0.0021890507,0.000001030718,0.00080049346,0.0006096756,0.0029002381,0.0000068068257,0.0000307673,0.020777086],"genre_scores_gemma":[0.9925045,0.0010287826,0.000108094195,0.000080997976,0.00005979332,0.000102938124,0.000010845443,0.000061210914,0.0060428604],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99535066,0.0008213613,0.0016316139,0.0005713748,0.00074546266,0.0008795118],"domain_scores_gemma":[0.9970441,0.0014471659,0.00032510777,0.00086392206,0.00007568608,0.00024400245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0032821433,0.00024642894,0.0013971946,0.0015503248,0.00001594324,0.000009026717,0.00026223823,0.00016160775,0.00006566133],"category_scores_gemma":[0.00043354626,0.00022054366,0.00009256021,0.0018416618,0.000054789016,0.000080115344,0.00009067025,0.00055022514,0.00018354236],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039923488,0.00027152733,0.98382735,0.007980433,0.000015186671,0.00009147199,0.004024802,0.00049365923,0.00036425557,0.0019385861,0.00028506972,0.0003084342],"study_design_scores_gemma":[0.088243514,0.004426061,0.34099853,0.41421467,0.00006231414,0.045932464,0.024244202,0.07347847,0.0017607143,0.0015271761,0.0025059974,0.0026058957],"about_ca_topic_score_codex":0.16759293,"about_ca_topic_score_gemma":0.028114008,"teacher_disagreement_score":0.6428288,"about_ca_system_score_codex":0.002493232,"about_ca_system_score_gemma":0.0011963558,"threshold_uncertainty_score":0.9896204},"labels":[],"label_agreement":null},{"id":"W2995067257","doi":"10.1016/j.jval.2019.09.2663","title":"PSY35 A COMPARATIVE ANALYSIS OF HEALTH TECHNOLOGY ASSESSMENTS EVALUATING RECENTLY APPROVED BIOLOGICAL THERAPIES FOR ADULT PATIENTS WITH MODERATE-TO-SEVERE PSORIASIS IN THE US, CANADA AND UK","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ixekizumab; Discontinuation; Psoriasis; Pharmacoeconomics; Population; Clinical trial; Regimen; Intensive care medicine; Internal medicine; Psoriatic arthritis; Dermatology; Secukinumab; Environmental health","score_opus":0.3489291710632158,"score_gpt":0.44264316494841577,"score_spread":0.09371399388519996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995067257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97252727,0.0007970191,0.0006273751,0.022092886,0.00012333524,0.003276517,0.00049419317,0.000008537914,0.000052889827],"genre_scores_gemma":[0.9831122,0.00011255831,0.0067423703,0.009590757,0.000013072006,0.0003149654,0.00009436734,0.000011036339,0.000008646812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944061,0.0011640143,0.0031594397,0.0006149241,0.00015606561,0.00049943186],"domain_scores_gemma":[0.99572814,0.0013990159,0.002190108,0.00040865823,0.00018095064,0.00009314794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01326146,0.0001929193,0.0016457336,0.00072023127,0.00013839605,0.000026771799,0.0002605315,0.0001033766,0.000019985795],"category_scores_gemma":[0.00089684123,0.0001648239,0.000046888905,0.001156212,0.000045239238,0.000098142016,0.00003414988,0.00019541231,0.0000036659555],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013101721,0.00013265411,0.9636607,0.00025395883,0.00016029384,4.3855206e-8,0.004081989,0.020435022,1.6135911e-7,0.010385358,0.000262332,0.00049646513],"study_design_scores_gemma":[0.0028912746,0.0012973313,0.86391884,0.0002000829,0.000010572697,3.6629967e-7,0.00760256,0.12051309,4.546428e-7,0.002831963,0.00048257792,0.00025086175],"about_ca_topic_score_codex":0.4774299,"about_ca_topic_score_gemma":0.30998445,"teacher_disagreement_score":0.16744547,"about_ca_system_score_codex":0.001070793,"about_ca_system_score_gemma":0.0010166134,"threshold_uncertainty_score":0.70260656},"labels":[],"label_agreement":null},{"id":"W2995082013","doi":"10.1016/j.jval.2019.09.1595","title":"PMS51 TRAJECTORIES OF FOLLOW-UP COMPLIANCE AND THEIR PREDICTORS IN A FRACTURE LIAISON SERVICE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Polypharmacy; Medicine; Fragility fracture; Osteoporosis; Logistic regression; Orthopedic surgery; Multinomial logistic regression; Physical therapy; Internal medicine; Bone mineral; Demography; Surgery","score_opus":0.038601018447865704,"score_gpt":0.3012766790900169,"score_spread":0.2626756606421512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995082013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99180824,0.003585748,0.00002573454,0.0033839918,0.00027302495,0.0006058613,0.000018621942,0.000023200893,0.00027556354],"genre_scores_gemma":[0.9973674,0.00023842689,0.00015658363,0.0020198454,0.000065526554,0.0000078448265,0.000013100423,0.000017124703,0.000114170914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99888134,0.00009720371,0.00037684228,0.00022955054,0.00015176069,0.00026330687],"domain_scores_gemma":[0.99928427,0.00019305835,0.0001236407,0.00024293094,0.000041847732,0.00011423894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035617195,0.00014101101,0.0004928979,0.00013421792,0.000020037109,0.0000049304376,0.000073546296,0.00012370301,0.000044399672],"category_scores_gemma":[0.000065958564,0.00010476901,0.0000336574,0.00033824806,0.00002901955,0.00006218915,0.000018451414,0.0003424739,0.000006350909],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036592505,0.00012195961,0.973072,0.0022337444,0.000015490043,0.000004528963,0.021581631,0.00051406265,0.0004403138,0.00011981658,0.00023212878,0.0012984229],"study_design_scores_gemma":[0.0026937842,0.00049181446,0.98244035,0.0016948986,0.000005504993,0.000012468446,0.0017242235,0.0030266729,0.00050741964,0.0003077472,0.0069802213,0.000114876464],"about_ca_topic_score_codex":0.00856372,"about_ca_topic_score_gemma":0.00071946735,"teacher_disagreement_score":0.019857408,"about_ca_system_score_codex":0.00007503135,"about_ca_system_score_gemma":0.0002304455,"threshold_uncertainty_score":0.99803835},"labels":[],"label_agreement":null},{"id":"W2995099757","doi":"10.1016/j.jval.2019.09.2178","title":"PNS278 A REVIEW OF HEALTH TECHNOLOGY ASSESSMENT GUIDELINES ON THE APPROVAL OF BIOSIMILARS","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Biosimilar; Medicine; Drug approval; Health technology; Pharmacology; Political science; Health care; Drug; Internal medicine; Law","score_opus":0.34093109077958933,"score_gpt":0.49828318519403947,"score_spread":0.15735209441445014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995099757","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.361112e-7,0.94819397,0.000053738087,0.04784663,0.00066329027,0.0027300646,0.00021364047,0.000023597207,0.00027421283],"genre_scores_gemma":[0.0000025853408,0.9870925,0.0034390222,0.009096699,0.000023441045,0.00008772572,0.000056750487,0.000036518886,0.0001647651],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9902736,0.0043692766,0.0039383634,0.000632987,0.0001433387,0.00064241426],"domain_scores_gemma":[0.99456376,0.0011773128,0.0028351892,0.0012040772,0.00018468255,0.00003497478],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010545772,0.00048459228,0.004952579,0.00052495254,0.000078522025,0.0000031474622,0.00085934,0.0010586338,0.00017996936],"category_scores_gemma":[0.0010891502,0.0002701235,0.0006407113,0.0012716205,0.00040132346,0.000011722837,0.00021736037,0.0017904631,0.000028231265],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000055542746,0.00016089971,0.0000055050423,0.19772646,0.00017384204,5.806625e-7,0.0000073756705,8.808049e-7,0.0000023546202,0.013848942,0.021345792,0.7667218],"study_design_scores_gemma":[0.0001609345,0.0007036725,0.00000271911,0.20383583,0.00012009305,0.00002399231,0.000027298252,0.00000438355,0.000010270053,0.00019797399,0.794755,0.00015787546],"about_ca_topic_score_codex":0.00022598328,"about_ca_topic_score_gemma":0.0000034645457,"teacher_disagreement_score":0.7734092,"about_ca_system_score_codex":0.0002680241,"about_ca_system_score_gemma":0.0028002984,"threshold_uncertainty_score":0.9999751},"labels":[],"label_agreement":null},{"id":"W2995221331","doi":"10.1016/j.jval.2019.09.2520","title":"PRS30 PRAGMATIC META-ANALYSIS OF PROPORTIONAL ASSIST VENTILATION+ VERSUS PRESSURE SUPPORT VENTILATION AND ITS IMPACT ON COST EFFECTIVENESS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory Support and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Meta-analysis; Mechanical ventilation; Intensive care unit; Emergency medicine; Pressure support ventilation; Intensive care medicine; Internal medicine","score_opus":0.11156407113994983,"score_gpt":0.40559102009987,"score_spread":0.2940269489599202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995221331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99637437,0.0006031984,0.00014417543,0.00013186212,0.00018826753,0.0022294344,0.000092675145,0.000018219698,0.00021777334],"genre_scores_gemma":[0.99924845,0.000010932173,0.000099207886,0.00005763239,0.00002061628,0.00007144332,0.00026119463,0.000015851008,0.00021466448],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808735,0.000289441,0.00058735936,0.0003085468,0.00051218906,0.00021509374],"domain_scores_gemma":[0.99879795,0.00022669243,0.00044423106,0.00026349732,0.00012281416,0.00014481095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018166836,0.00016009356,0.00097451993,0.00046301543,0.000038210674,0.000010305707,0.000046727382,0.00008948185,0.00084458984],"category_scores_gemma":[0.00010441905,0.0001203474,0.00038100677,0.0005383778,0.000016335482,0.0001149129,0.000015732721,0.00015005832,0.000017917511],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01162431,0.0020282047,0.7442276,0.008704489,0.0833339,0.000048117636,0.0010948975,0.1322698,0.005610003,0.008576519,0.0001556883,0.002326497],"study_design_scores_gemma":[0.002273931,0.0022707582,0.9525507,0.000097116914,0.022744548,0.000005516633,0.000032678527,0.016909432,0.002254312,0.000068406414,0.0006579266,0.00013469327],"about_ca_topic_score_codex":0.00010992883,"about_ca_topic_score_gemma":0.000008411923,"teacher_disagreement_score":0.2083231,"about_ca_system_score_codex":0.00013293113,"about_ca_system_score_gemma":0.00047565287,"threshold_uncertainty_score":0.9247666},"labels":[],"label_agreement":null},{"id":"W2995229498","doi":"10.1016/j.jval.2019.09.1393","title":"PIN153 HEALTH OUTCOMES AND HEALTH SYSTEM COSTS ASSOCIATED WITH SEPSIS: A POPULATION-BASED, RETROSPECTIVE COHORT STUDY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Sepsis Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Institute for Clinical Evaluative Sciences; Ottawa Hospital; Ottawa Public Health","funders":"","keywords":"Sepsis; Medicine; Propensity score matching; Organ dysfunction; Retrospective cohort study; Population; Confounding; Cohort; Cohort study; Internal medicine; Emergency medicine; Intensive care medicine","score_opus":0.06678578242228349,"score_gpt":0.36549910260453317,"score_spread":0.29871332018224966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995229498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9764405,0.0015717223,0.0000059356385,0.01389342,0.00020841867,0.007588693,0.000045291352,0.00015397376,0.00009208108],"genre_scores_gemma":[0.9944566,0.00013613336,0.0001957064,0.004659227,0.000027717253,0.00028221056,0.00014068747,0.000053246513,0.000048503076],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99629533,0.00066817785,0.0009124877,0.0007240589,0.0007538078,0.00064611353],"domain_scores_gemma":[0.9979658,0.00029281143,0.00065316854,0.0005127756,0.00011029421,0.000465158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002513628,0.00031832632,0.0015939568,0.00029631803,0.0002016514,0.00003055663,0.000062614556,0.00007715404,0.000015903348],"category_scores_gemma":[0.0000976503,0.00023931554,0.00007090732,0.0005381289,0.000020025793,0.000062735075,0.000022099746,0.00028977968,0.000015684189],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007438284,0.0018229322,0.99548006,0.00044477964,0.00023763116,0.0000147938845,0.0007025887,0.00026957283,2.8637608e-8,0.00034055056,0.00018787383,0.0004248229],"study_design_scores_gemma":[0.0069331564,0.0070960578,0.9801473,0.002665143,0.000039766277,0.000008492966,0.0013905544,0.0015360432,3.1910326e-7,0.000007840082,0.000013918885,0.00016138465],"about_ca_topic_score_codex":0.14181894,"about_ca_topic_score_gemma":0.006950615,"teacher_disagreement_score":0.13486832,"about_ca_system_score_codex":0.009302936,"about_ca_system_score_gemma":0.0012961383,"threshold_uncertainty_score":0.99450016},"labels":[],"label_agreement":null},{"id":"W2995253338","doi":"10.1016/j.jval.2019.09.2180","title":"PNS280 AN ASSESSMENT OF THE LIKELIHOOD OF RECEIVING A POSITIVE RECOMMENDATION THROUGH NICE'S STA PROCESS WITHOUT A PATIENT ACCESS SCHEME OF COMMERCIAL ACCESS AGREEMENT","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical industry and healthcare","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Authorization; Medicine; Quarter (Canadian coin); Order (exchange); Family medicine; Business; Computer science; Finance; Computer security","score_opus":0.4463815778078915,"score_gpt":0.617376192932067,"score_spread":0.17099461512417552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995253338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98818797,0.00018336794,0.000049686227,0.0064911693,0.0008552177,0.0022263352,0.00030726075,0.000015329966,0.0016836826],"genre_scores_gemma":[0.9960058,0.0003044699,0.00037236486,0.0031047498,0.000059335896,0.00007013934,0.000053036496,0.00002067873,0.0000094569],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99463546,0.0026203855,0.001380779,0.00040415194,0.0003965743,0.00056266756],"domain_scores_gemma":[0.9972317,0.00049351796,0.0013328893,0.00035833803,0.00035830535,0.00022521468],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023460656,0.00023701403,0.00064301025,0.00012086006,0.00018102997,0.000016023225,0.00076141546,0.00033802487,0.0006411117],"category_scores_gemma":[0.00009486865,0.00019827163,0.000092297574,0.00065285596,0.00016854692,0.0005724782,0.0003321397,0.0014975632,0.0000018401123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009242603,0.002398952,0.95435363,0.0028958793,0.00012879162,0.000001067619,0.008292163,0.0037296908,0.002372404,0.0014035334,0.00014380737,0.023355799],"study_design_scores_gemma":[0.007913275,0.004227918,0.79508156,0.0029178895,0.0001770564,0.000010877111,0.0040790625,0.06090228,0.11747954,0.00391608,0.002559788,0.0007346802],"about_ca_topic_score_codex":0.0027479117,"about_ca_topic_score_gemma":0.00023214948,"teacher_disagreement_score":0.15927209,"about_ca_system_score_codex":0.00033933093,"about_ca_system_score_gemma":0.0012744942,"threshold_uncertainty_score":0.80852824},"labels":[],"label_agreement":null},{"id":"W2995421171","doi":"10.1016/j.jval.2019.09.2137","title":"PNS237 CLINICAL OUTCOME ASSESSMENTS AS A CONDITION IN HTA RECOMMENDATIONS: THE CANADIAN PERSPECTIVE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Health technology; Family medicine; Internal medicine; Inclusion (mineral); Oncology; Health care; Psychology","score_opus":0.6467678325215246,"score_gpt":0.5822884350383812,"score_spread":0.06447939748314335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995421171","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5441126,0.0011787979,0.000092917006,0.429342,0.0025753912,0.0028606039,0.00033955523,0.000031456795,0.019466674],"genre_scores_gemma":[0.9535369,0.0002773226,0.0008469137,0.044321693,0.0001760991,0.0001350585,0.000065665205,0.000026437285,0.00061387033],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917895,0.00176554,0.0051340554,0.00061755435,0.00010414906,0.0005892029],"domain_scores_gemma":[0.99532115,0.0020739888,0.0016758591,0.0005755965,0.0000597025,0.00029370148],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.04109344,0.00015810752,0.00086661894,0.000654228,0.00021873807,0.0000862705,0.00032753937,0.00018424382,0.0009118967],"category_scores_gemma":[0.0037735312,0.000178196,0.00009828395,0.00041267675,0.00005626253,0.00038249555,0.000035882673,0.0006131259,0.0048657577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000075424023,0.00007693575,0.6390566,0.00007053826,0.000013878922,8.6816925e-7,0.001615533,0.0005984256,1.3218184e-8,0.3535788,0.0048672217,0.000113586335],"study_design_scores_gemma":[0.0019630585,0.00034805312,0.74212354,0.00026355035,0.000002141694,0.0000066687544,0.008909486,0.022597801,8.211839e-8,0.13138539,0.09203882,0.00036143904],"about_ca_topic_score_codex":0.8093805,"about_ca_topic_score_gemma":0.40092432,"teacher_disagreement_score":0.40942433,"about_ca_system_score_codex":0.006387839,"about_ca_system_score_gemma":0.0022339136,"threshold_uncertainty_score":0.9984629},"labels":[],"label_agreement":null},{"id":"W2995421271","doi":"10.1016/j.jval.2019.09.2328","title":"PPM11 TUMOUR-SPECIFIC RANDOMIZED CONTROLLED TRIALS IN RARE ONCOGENE-DRIVEN CANCERS: ASKING FOR THE IMPOSSIBLE?","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Memorial University of Newfoundland","funders":"","keywords":"Medicine; Randomized controlled trial; Sample size determination; Clinical trial; Internal medicine; Oncology; Hazard ratio; Confidence interval; Statistics","score_opus":0.04023934404654731,"score_gpt":0.3192069739619339,"score_spread":0.2789676299153866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995421271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91167676,0.06795701,0.002549581,0.0032736913,0.0020972663,0.011790302,0.00017608816,0.000011879643,0.00046744177],"genre_scores_gemma":[0.975741,0.020996207,0.0007267101,0.0008740378,0.00062790985,0.000810016,0.000058671292,0.000033633914,0.00013179811],"study_design_codex":"simulation_or_modeling","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9967201,0.0010057618,0.0013406822,0.00038305283,0.0001348114,0.00041564574],"domain_scores_gemma":[0.9953579,0.003579846,0.00057509984,0.00034730782,0.00006333336,0.00007656528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008255329,0.00019263708,0.0017797223,0.00010362193,0.000070375354,0.000049959366,0.00023456785,0.00012640216,0.00002386929],"category_scores_gemma":[0.0020194144,0.00013012074,0.00049289566,0.00012458995,0.000047740996,0.000003136848,0.000054807722,0.00013134639,0.000004289062],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.34491992,0.00033367833,0.00783077,0.0006286502,0.0007905248,0.000011868765,0.0018483563,0.5151611,0.09607035,0.00874689,0.010735129,0.012922789],"study_design_scores_gemma":[0.8650191,0.00089012214,0.00065602467,0.0006212246,0.0001057928,0.000010215816,0.00080131437,0.053783823,0.010551547,0.0019504166,0.06492957,0.00068087183],"about_ca_topic_score_codex":0.0025018447,"about_ca_topic_score_gemma":0.00091850356,"teacher_disagreement_score":0.52009916,"about_ca_system_score_codex":0.0002411302,"about_ca_system_score_gemma":0.0010287093,"threshold_uncertainty_score":0.53061694},"labels":[],"label_agreement":null},{"id":"W2995451028","doi":"10.1016/j.jval.2019.09.2395","title":"PRO65 VARIABILITY IN AGE AT LOSS OF AMBULATION BY GENOTYPE AMONG BOYS WITH DUCHENNE MUSCULAR DYSTROPHY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Genotype; Exon; Medicine; Confidence interval; Duchenne muscular dystrophy; Dystrophin; Pediatrics; Internal medicine; Genetics; Biology; Gene","score_opus":0.006206016705310842,"score_gpt":0.2251929632491145,"score_spread":0.21898694654380366,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995451028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99878657,0.00026669574,0.00014002767,0.00009049956,0.000046226734,0.0005054246,0.000011475868,0.00000447357,0.00014861603],"genre_scores_gemma":[0.9993467,0.00006650424,0.000251659,0.00008364857,0.00001667216,0.000018303659,0.00015519158,0.00001174459,0.00004961961],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877185,0.00030664817,0.00027335115,0.00033417274,0.00008279717,0.00023119082],"domain_scores_gemma":[0.99944985,0.00002206695,0.00012334192,0.00032900166,0.000026339363,0.000049419647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004745224,0.000105984545,0.00020320977,0.00003786206,0.000022539336,0.0000022261684,0.0000906629,0.00013434846,0.000018510114],"category_scores_gemma":[0.000047298185,0.00009604052,0.00003216372,0.0001223233,0.00008708397,0.0000046093946,0.000045623892,0.00009944776,0.000003314457],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071076816,0.00027610196,0.84239197,0.00045458585,0.000020780206,0.000002615214,0.00023585626,0.01735261,0.13799311,0.00022792518,0.00008303877,0.00025065933],"study_design_scores_gemma":[0.0018306508,0.0010239041,0.98365045,0.00006857769,0.000004642346,0.0000016791146,0.000047199523,0.0018171098,0.009982728,0.00064939726,0.00070438616,0.00021926186],"about_ca_topic_score_codex":0.0028703916,"about_ca_topic_score_gemma":0.00033521777,"teacher_disagreement_score":0.14125851,"about_ca_system_score_codex":0.0000515455,"about_ca_system_score_gemma":0.00011075147,"threshold_uncertainty_score":0.43391928},"labels":[],"label_agreement":null},{"id":"W2995453878","doi":"10.1016/j.jval.2019.10.012","title":"Ranking the Criteria Used in the Appraisal of Drugs for Reimbursement: A Stated Preferences Elicitation With Health Technology Assessment Stakeholders Across Jurisdictional Contexts","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Canadian Institutes of Health Research","keywords":"Reimbursement; Health technology; Actuarial science; Ranking (information retrieval); Gatekeeping; Multidisciplinary approach; Economic evaluation; Medicine; Public economics; Business; Health care; Economics; Political science; Computer science","score_opus":0.4215895903042945,"score_gpt":0.4946185477543377,"score_spread":0.07302895745004323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995453878","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8972067,0.0009986976,0.0041561523,0.0931948,0.00039610566,0.0035318031,0.00039987353,0.000023714932,0.00009210905],"genre_scores_gemma":[0.9932785,0.00011290507,0.002115387,0.0038085256,0.00005024859,0.00051743624,0.000079597536,0.000021205908,0.000016216338],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941502,0.0010742919,0.003511554,0.00048319492,0.00019803317,0.0005826888],"domain_scores_gemma":[0.99388254,0.0028928167,0.0026531823,0.00043627736,0.00007828614,0.00005687229],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.032782663,0.00016856189,0.0008388431,0.00037521112,0.0002304567,0.000057336765,0.00035724975,0.000097446726,0.000029612595],"category_scores_gemma":[0.00045077511,0.00013745007,0.00005315567,0.00054134784,0.000119231256,0.00024655156,0.000024808665,0.00029615327,0.000013533968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023204101,0.00056119537,0.4595835,0.0030602014,0.000118545206,3.7061895e-7,0.13574766,0.020873042,0.000005155867,0.37457746,0.0022889005,0.0029519564],"study_design_scores_gemma":[0.012207834,0.002833511,0.5930552,0.0018175225,0.0000072184403,0.000008434218,0.2118611,0.10798351,0.000007961997,0.052205093,0.017356861,0.0006557651],"about_ca_topic_score_codex":0.008259913,"about_ca_topic_score_gemma":0.0017280225,"teacher_disagreement_score":0.32237235,"about_ca_system_score_codex":0.0007464876,"about_ca_system_score_gemma":0.00095343334,"threshold_uncertainty_score":0.9983442},"labels":[],"label_agreement":null},{"id":"W2995466058","doi":"10.1016/j.jval.2019.09.2736","title":"SP2 DISCREPANCY IN HEALTH STATE UTILITY VALUES BETWEEN COST-UTILITY ANALYSIS AND REFERENCED ORIGINAL HEALTH UTILITY STUDIES IN CARDIOVASCULAR DISEASE: A REGISTRY-BASED ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Cost–utility analysis; Quality-adjusted life year; Disease; Environmental health; Cost effectiveness; Risk analysis (engineering); Internal medicine","score_opus":0.4555989122277066,"score_gpt":0.4638549586848619,"score_spread":0.008256046457155275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995466058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9193038,0.045071933,0.006168605,0.022575993,0.0002496379,0.0037838407,0.0026957688,0.00007817909,0.00007226343],"genre_scores_gemma":[0.99036765,0.0044371216,0.0023943747,0.0019869676,0.00007164883,0.00021414818,0.00041939729,0.000037914702,0.00007075011],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97765964,0.007479076,0.010058451,0.002606984,0.0005226884,0.0016731706],"domain_scores_gemma":[0.9900779,0.0022159484,0.003956925,0.0025954656,0.00012901459,0.0010247441],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.08899669,0.00060059625,0.00665103,0.002971624,0.00031288233,0.00009433561,0.0005049793,0.00018711369,0.00012997193],"category_scores_gemma":[0.0032709264,0.00071966543,0.0007687207,0.0049769743,0.00029999914,0.00048656636,0.00014925911,0.0008071631,0.00006339151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011096533,0.0002550822,0.9701079,0.00445565,0.0013337991,0.0000032754924,0.0028141814,0.018247433,5.54522e-9,0.00083581323,0.000113871836,0.0017219933],"study_design_scores_gemma":[0.0015640536,0.00013514844,0.86198235,0.00044756482,0.00009376285,3.193917e-7,0.001168347,0.12520409,1.2272231e-7,0.00588925,0.0030859346,0.00042904753],"about_ca_topic_score_codex":0.29293558,"about_ca_topic_score_gemma":0.029456882,"teacher_disagreement_score":0.2634787,"about_ca_system_score_codex":0.0045316783,"about_ca_system_score_gemma":0.0030203795,"threshold_uncertainty_score":0.9995254},"labels":[],"label_agreement":null},{"id":"W2995535198","doi":"10.1016/j.jval.2019.09.1260","title":"PIN15 THE VALUE OF ACHIEVING OPTIMAL ADHERENCE WITH LONG-ACTING DIRECTLY OBSERVED ANTIRETROVIRAL THERAPY (LA DOT ART) AMONGST PATIENTS LIVING WITH HIV-1 INFECTION: A MODELLING STUDY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS Research and Interventions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Dosing; Antiretroviral therapy; Viral load; Cohort; Transmission (telecommunications); Human immunodeficiency virus (HIV); Quality of life (healthcare); Medication adherence; Health care; Intensive care medicine; Internal medicine; Family medicine","score_opus":0.06000358241910445,"score_gpt":0.3252636823510242,"score_spread":0.26526009993191974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995535198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298865,0.00023509147,0.003479457,0.00011647791,0.00005198215,0.002009486,0.0000063307834,0.00005000446,0.0010625364],"genre_scores_gemma":[0.99804646,0.00016882176,0.0009872402,0.00003674828,0.000052826777,0.00007367346,0.000011100423,0.00004435459,0.000578756],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99689686,0.0008666772,0.00061481335,0.00041172164,0.00067892805,0.0005309785],"domain_scores_gemma":[0.9983745,0.00048251136,0.00034533313,0.00045870422,0.00016957187,0.00016937796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014617576,0.00022790967,0.00050429325,0.0002155918,0.00020001104,0.000060485836,0.00017660415,0.00005624295,0.000053010255],"category_scores_gemma":[0.0001572063,0.00014229107,0.00010406644,0.0006870096,0.0001027568,0.00029196506,0.00006777398,0.00069121324,0.000014223656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043905328,0.0012848605,0.9534397,0.00037831944,0.000102597456,0.000007804511,0.0037326866,0.036368098,0.000064037005,0.00002852252,0.000023583056,0.004130731],"study_design_scores_gemma":[0.003590773,0.038813576,0.78861654,0.005636144,0.000026234033,0.000015165323,0.0016210147,0.16134335,0.000085952575,0.0000022258591,0.000045435503,0.00020356753],"about_ca_topic_score_codex":0.008831914,"about_ca_topic_score_gemma":0.00022728155,"teacher_disagreement_score":0.16482314,"about_ca_system_score_codex":0.00014865963,"about_ca_system_score_gemma":0.00040558746,"threshold_uncertainty_score":0.99776834},"labels":[],"label_agreement":null},{"id":"W2995561666","doi":"10.1016/j.jval.2019.09.1541","title":"PMH67 ANALYSIS OF PSYCHOTROPIC MEDICATIONS PRESCRIPTIONS IN TURKEY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Psychological Treatments and Assessments","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Polypharmacy; Medical prescription; Medicine; Psychotropic drug; Family medicine; Psychiatry; Quarter (Canadian coin); Health care; Drug; Pharmacology","score_opus":0.08424708840107599,"score_gpt":0.43444519281258115,"score_spread":0.3501981044115052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995561666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97197884,0.00055610505,0.00013998976,0.0014816464,0.00054983125,0.0004440113,0.00004813948,0.000017752844,0.024783663],"genre_scores_gemma":[0.99775374,0.00015461887,0.0005210335,0.00034622848,0.000014856717,0.00006981204,0.00004005756,0.0000069387397,0.0010927197],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983062,0.0003501197,0.0005636993,0.00033371162,0.00015810235,0.00028815202],"domain_scores_gemma":[0.9990986,0.0001357265,0.00017581503,0.0004880855,0.000016399712,0.00008535859],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00036200095,0.00009432799,0.0003741279,0.0006108794,0.000020294034,0.0000046621913,0.00017972704,0.00008354102,0.0024428766],"category_scores_gemma":[0.000013883197,0.0000794244,0.00008549369,0.0015402273,0.000033337186,0.000040748684,0.000014644274,0.00016946824,0.00013677562],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002464609,0.0015242713,0.96841407,0.000020747531,0.0003515945,0.000003578219,0.0013948081,0.003893211,0.000032841435,0.021804446,0.0006180099,0.0019177523],"study_design_scores_gemma":[0.00094098167,0.00015977674,0.9936402,0.000044372468,0.000037642654,5.512058e-7,0.00028321397,0.0016252451,5.500438e-7,0.0011844607,0.0020213276,0.00006171944],"about_ca_topic_score_codex":0.009568583,"about_ca_topic_score_gemma":0.00011656675,"teacher_disagreement_score":0.025774874,"about_ca_system_score_codex":0.000106163956,"about_ca_system_score_gemma":0.000050625582,"threshold_uncertainty_score":0.99846905},"labels":[],"label_agreement":null},{"id":"W2995580028","doi":"10.1016/j.jval.2019.09.2460","title":"PRO131 WHAT DO WE KNOW ABOUT PATIENT'S AND CAREGIVERS' EXPERIENCE WHEN LIVING WITH THE HEREDITARY RETINAL CONDITION RETINITIS PIGMENTOSA?","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinopathy of Prematurity Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Retinitis pigmentosa; Thematic analysis; Medicine; Quality of life (healthcare); International Classification of Functioning, Disability and Health; RPE65; Qualitative research; Psychology; Clinical psychology; Physical therapy; Ophthalmology; Rehabilitation; Retinal; Nursing","score_opus":0.0152273162949261,"score_gpt":0.26572605024777374,"score_spread":0.25049873395284766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995580028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9324814,0.04750114,0.0000058467203,0.017710522,0.00028835394,0.0014483774,0.000006979245,0.00004327253,0.0005140858],"genre_scores_gemma":[0.9810207,0.017382834,0.00065660715,0.00057121005,0.00012058386,0.000080056714,0.0000068079667,0.000021446545,0.00013976533],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.998102,0.0002962081,0.0003157426,0.0004195692,0.00047782352,0.00038862653],"domain_scores_gemma":[0.9988614,0.0003617582,0.0002095347,0.00034364848,0.000093582545,0.00013011985],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005129,0.00018818054,0.00036098083,0.000088989415,0.0001810445,0.00007260126,0.00009806402,0.000067343855,0.00007659937],"category_scores_gemma":[0.00012730491,0.00012980643,0.00003179635,0.00013320945,0.00022072064,0.00034236696,0.000096582924,0.00035457584,0.000014213902],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053191924,0.00024493516,0.29093552,0.0037808719,0.00007389713,0.0002146025,0.64066386,0.000043718137,0.00016199492,0.00047121834,0.0074979337,0.055379547],"study_design_scores_gemma":[0.0034598454,0.007356322,0.29740715,0.07018104,0.00007415597,0.0010100378,0.5893769,0.00070424756,0.00034646186,0.00047611838,0.028896399,0.00071126083],"about_ca_topic_score_codex":0.00090719486,"about_ca_topic_score_gemma":0.00006449698,"teacher_disagreement_score":0.06640017,"about_ca_system_score_codex":0.00017946826,"about_ca_system_score_gemma":0.00015959,"threshold_uncertainty_score":0.52933526},"labels":[],"label_agreement":null},{"id":"W2995599161","doi":"10.1016/j.jval.2019.09.1565","title":"PMS21 PRELIMINARY RESULTS OF A COST-UTILITY ANALYSIS OF A FRACTURE LIAISON SERVICE BASED ON HEALTH SERVICES INDICATORS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Hôpital du Sacré-Cœur de Montréal; Université de Montréal","funders":"","keywords":"Attendance; Medicine; Health care; Fragility; Actuarial science; Demography; Gerontology; Economics","score_opus":0.2005420108421545,"score_gpt":0.4076456322731381,"score_spread":0.2071036214309836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995599161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91791195,0.0022168162,0.00035658345,0.07278544,0.00032641055,0.0026920214,0.0027615037,0.000042290056,0.00090700603],"genre_scores_gemma":[0.96622777,0.00016700214,0.00108225,0.032070387,0.000041028106,0.00005036711,0.00030378212,0.00002856259,0.000028843348],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9898129,0.0014108013,0.007073646,0.00086124,0.0002600923,0.0005812864],"domain_scores_gemma":[0.98835075,0.002397135,0.007579198,0.0012724431,0.000092761,0.00030772167],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.026854971,0.000260287,0.0024130207,0.00226925,0.00008703226,0.00001694745,0.00047189658,0.00024385597,0.00020800432],"category_scores_gemma":[0.00069074135,0.00031478415,0.00022781083,0.002579431,0.00004063299,0.00021252854,0.000052874093,0.0003628877,0.0001553796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010417801,0.0010567933,0.63560003,0.014257818,0.00027923688,5.5749393e-7,0.01563575,0.32639015,4.584818e-7,0.003373795,0.0017645769,0.0005990495],"study_design_scores_gemma":[0.0017943111,0.00087138213,0.5242475,0.0009212482,0.00001635144,2.3838457e-7,0.0013290284,0.46212995,0.0000052846644,0.00047255747,0.008001605,0.00021053723],"about_ca_topic_score_codex":0.0911461,"about_ca_topic_score_gemma":0.0021764422,"teacher_disagreement_score":0.13573982,"about_ca_system_score_codex":0.00085340417,"about_ca_system_score_gemma":0.0010181237,"threshold_uncertainty_score":0.99993044},"labels":[],"label_agreement":null},{"id":"W2995618478","doi":"10.1016/j.jval.2019.09.1168","title":"PGI46 DISEASE BURDEN, SYMPTOMS ASSOCIATED WITH TREATMENT-SEEKING AND REMISSION DEFINITION: A QUALITATIVE STUDY IN ADULT AND ADOLESCENT PATIENTS WITH CROHN'S DISEASE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Medicine; Abdominal pain; Disease; Diarrhea; Internal medicine; Thematic analysis; Crohn's disease; Young adult; Physical therapy; Qualitative research","score_opus":0.01550078949732708,"score_gpt":0.2756693564290811,"score_spread":0.260168566931754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995618478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978327,0.00028314194,0.0000051966344,0.00011595848,0.000023835662,0.001608776,0.00009994603,0.000012040347,0.000018409279],"genre_scores_gemma":[0.9993143,0.00007207845,0.000032861637,0.00018869585,0.000020975833,0.00008843831,0.0002181661,0.000028524146,0.000035929585],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980715,0.00060670456,0.00028173244,0.00051827455,0.00022013484,0.00030163507],"domain_scores_gemma":[0.999054,0.000037520414,0.0001639364,0.00025441602,0.00008972811,0.00040038614],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023866528,0.00022362296,0.00021593465,0.00008362826,0.00007668044,0.000025596588,0.000052365383,0.000049042486,0.0000031699456],"category_scores_gemma":[0.000117052725,0.00017491171,0.000021249269,0.00010983108,0.00006092168,0.000013072403,0.000044488428,0.000085018335,0.0000013440975],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038431545,0.00094108476,0.99113786,0.00020746648,0.000034376753,0.0001667375,0.0031011,0.00026790609,0.000013724794,0.000028992654,0.000006667299,0.00025095104],"study_design_scores_gemma":[0.0076233232,0.0011210231,0.9878821,0.0008406331,0.000028789347,3.8629125e-7,0.001732885,0.0004989993,0.0000020965642,0.000037063088,0.0000109036255,0.0002218221],"about_ca_topic_score_codex":0.00020170446,"about_ca_topic_score_gemma":0.00016302674,"teacher_disagreement_score":0.0037801685,"about_ca_system_score_codex":0.00015931555,"about_ca_system_score_gemma":0.00036627593,"threshold_uncertainty_score":0.71326923},"labels":[],"label_agreement":null},{"id":"W2995624503","doi":"10.1016/j.jval.2019.09.249","title":"PCN52 ABIRATERONE VERSUS ENZALUTAMIDE IN THE POST-CHEMOTHERAPY SETTING IN METASTATIC CASTRATION-RESISTANT PROSTATE CANCER: POPULATION-BASED STUDY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"","keywords":"Enzalutamide; Abiraterone; Prostate cancer; Medicine; Oncology; Chemotherapy; Internal medicine; Docetaxel; Cancer; Urology; Androgen receptor","score_opus":0.059171874472310246,"score_gpt":0.38392891040404814,"score_spread":0.3247570359317379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995624503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98430085,0.0012097546,7.61779e-7,0.009848267,0.00013914001,0.0044137863,0.00003075971,0.00001742923,0.000039246777],"genre_scores_gemma":[0.9984101,0.00014503133,0.00019386348,0.00072217116,0.00002947418,0.00031577863,0.000088934576,0.000026082158,0.00006856149],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974212,0.0006316813,0.0006062696,0.00035288103,0.0004909354,0.000497023],"domain_scores_gemma":[0.9990163,0.00040629867,0.00013976287,0.00030397743,0.00005584967,0.00007780412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001697403,0.00017496206,0.0003749959,0.00034359208,0.00006589788,0.000032869175,0.00010783229,0.00003504394,0.000048138107],"category_scores_gemma":[0.000063561056,0.000121079414,0.000036713816,0.00069264264,0.000019656336,0.00008985542,0.000010518526,0.00034450207,0.000009402655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037974906,0.0007436517,0.9698681,0.00043319803,0.000029778443,0.000101483325,0.008898688,0.011850211,0.00049598585,0.000025790569,0.000010898939,0.0037446884],"study_design_scores_gemma":[0.017458782,0.0023771853,0.9679105,0.00048362964,0.000011165731,0.0000015685093,0.0053296364,0.0061118174,0.00010394681,0.000048973943,0.00003986759,0.00012291512],"about_ca_topic_score_codex":0.08482641,"about_ca_topic_score_gemma":0.01514232,"teacher_disagreement_score":0.069684096,"about_ca_system_score_codex":0.0010925006,"about_ca_system_score_gemma":0.0012260852,"threshold_uncertainty_score":0.9212678},"labels":[],"label_agreement":null},{"id":"W2995627578","doi":"10.1016/j.jval.2019.09.2397","title":"PRO67 UTILITY VALUES FOR HEALTH STATES ASSOCIATED WITH DUCHENNE MUSCULAR DYSTROPHY: A SYSTEMATIC REVIEW","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Vancouver Coastal Health","funders":"","keywords":"Duchenne muscular dystrophy; Medicine; EQ-5D; Respondent; Quality of life (healthcare); Ambulatory; Health related quality of life; MEDLINE; Physical therapy; Pediatrics; Gerontology; Disease; Internal medicine","score_opus":0.15159876406443257,"score_gpt":0.42624683226003407,"score_spread":0.2746480681956015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995627578","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003182968,0.9524811,0.00013469736,0.0013919733,0.00010398003,0.04552008,0.00023674151,0.00008018005,0.00001939912],"genre_scores_gemma":[0.0000173235,0.99365044,0.00045364385,0.0013298844,0.000048005477,0.0029251743,0.0009990189,0.00018725256,0.00038927325],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9903199,0.0035267705,0.0026103824,0.0011302435,0.0010917267,0.0013209613],"domain_scores_gemma":[0.9952527,0.0008724218,0.0015158436,0.0014569531,0.00033803942,0.00056402833],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006728914,0.00074102037,0.00854452,0.00039340532,0.00014684821,0.000033141,0.0003804284,0.00025936705,0.000021714342],"category_scores_gemma":[0.0019968022,0.00049178785,0.000916748,0.0010536948,0.000107147105,0.000043874566,0.00007955514,0.000936225,0.000034627545],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025614676,0.0003565557,0.000016358628,0.9732794,0.00049065164,0.000017979333,0.00007824202,0.000005030748,8.292624e-9,0.000025475782,0.0007000902,0.02500459],"study_design_scores_gemma":[0.0012157472,0.0020173846,0.000024766152,0.8943721,0.0015259106,0.000077750614,0.000038045517,0.00033955314,3.9148976e-8,0.00003661294,0.10001656,0.0003355506],"about_ca_topic_score_codex":0.00079685374,"about_ca_topic_score_gemma":0.000028943254,"teacher_disagreement_score":0.09931647,"about_ca_system_score_codex":0.0011560355,"about_ca_system_score_gemma":0.0080758175,"threshold_uncertainty_score":0.99975336},"labels":[],"label_agreement":null},{"id":"W2995676398","doi":"10.1016/j.jval.2019.09.085","title":"ON5 DEVELOPMENT AND TESTING OF PATIENT-REPORTED OUTCOME PERFORMANCE MEASURES (PRO-PMS) FOR COMPARING ONCOLOGY PRACTICES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Nausea; Internal medicine; Constipation; Vomiting; Anxiety; Quality of life (healthcare); Physical therapy; Psychiatry","score_opus":0.2590660895548335,"score_gpt":0.39554645827610435,"score_spread":0.13648036872127084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995676398","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996839,0.0007367877,0.000030175332,0.00040345188,0.00032728905,0.00083558005,0.0000010279147,0.000019717036,0.00080699445],"genre_scores_gemma":[0.9947123,0.000034063658,0.0048546335,0.0002736033,0.00002917907,0.00004191979,0.000005124394,0.0000112732205,0.000037936574],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867386,0.00006202793,0.0006372368,0.00019985286,0.00020135271,0.00022565748],"domain_scores_gemma":[0.9985979,0.00036691802,0.0006848551,0.00013704332,0.00012912996,0.0000841478],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010841393,0.00008844394,0.00041227246,0.000101904414,0.00004626992,0.0000048662987,0.00003807096,0.000050641305,0.0000035625822],"category_scores_gemma":[0.000507506,0.00007790738,0.000019246874,0.00014837935,0.00001921413,0.00006086218,0.000028246215,0.00014649559,0.0000013842925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020848638,0.00007261958,0.91660184,0.0019556226,0.00001725193,0.000002013304,0.0042984914,0.00024899252,0.00010340043,0.000027797374,0.000007958536,0.07645551],"study_design_scores_gemma":[0.0037517997,0.0028228993,0.9268749,0.0017631459,0.00004174916,0.00009517875,0.00450152,0.012660856,0.002588514,0.000025622066,0.04462412,0.00024970085],"about_ca_topic_score_codex":0.0046613393,"about_ca_topic_score_gemma":0.00084882166,"teacher_disagreement_score":0.07620581,"about_ca_system_score_codex":0.00025505768,"about_ca_system_score_gemma":0.000779996,"threshold_uncertainty_score":0.7046582},"labels":[],"label_agreement":null},{"id":"W2995697325","doi":"10.1016/j.jval.2019.09.1316","title":"PIN75 WHAT WE KNOW NOW: REVISITING THE COST-EFFECTIVENESS OF CHICKENPOX VACCINATION USING AN AGENT-BASED MODEL","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Animal Disease Management and Epidemiology","field":"Agricultural and Biological Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Alberta","funders":"","keywords":"Chickenpox; Shingles; Medicine; Vaccination; Chickenpox Vaccine; Cost effectiveness; Varicella zoster virus; Pediatrics; Immunology; Immunization; Varicella vaccine; Risk analysis (engineering); Virus","score_opus":0.1413402650637444,"score_gpt":0.34276130102507063,"score_spread":0.20142103596132624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995697325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99420846,0.0014503163,0.00034126535,0.0029702072,0.00008897553,0.00084255496,0.000006833647,0.000019290888,0.00007212799],"genre_scores_gemma":[0.99839294,0.00088191027,0.000107165644,0.00047714377,0.00007813452,0.000014403472,0.000034971275,0.0000012311622,0.000012113849],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99802214,0.0010757284,0.00028898104,0.00024336325,0.00011792687,0.00025183172],"domain_scores_gemma":[0.99911135,0.0005216633,0.00019760375,0.00007377404,0.000037368423,0.000058244997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023268322,0.00009549574,0.00022752538,0.000021494521,0.00011335158,0.000027776017,0.00017898493,0.000050368064,0.000053476386],"category_scores_gemma":[0.000061283004,0.00003701581,0.000060814462,0.0002555306,0.000016886424,0.00023245729,0.000044717333,0.00009415218,0.000010244961],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022592681,0.00016742667,0.09695554,0.000848267,0.000011285595,0.000001006829,0.00013675605,0.6810039,0.011013148,0.005615156,0.000026645706,0.20399493],"study_design_scores_gemma":[0.00015698183,0.00015223751,0.25578046,0.0004637991,0.0000046944383,2.1004018e-7,0.0002759154,0.7419185,0.000043813427,0.000769839,0.00035609986,0.00007741309],"about_ca_topic_score_codex":0.0011818663,"about_ca_topic_score_gemma":0.00011200766,"teacher_disagreement_score":0.20391752,"about_ca_system_score_codex":0.00008136905,"about_ca_system_score_gemma":0.000028404032,"threshold_uncertainty_score":0.17866363},"labels":[],"label_agreement":null},{"id":"W2995728682","doi":"10.1016/j.jval.2019.09.571","title":"PCN376 ACCESS TO ONCOLOGY THERAPIES IN RUSSIA AND VISEGRAD GROUP COUNTRIES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Orphan drug; Czech; Medicine; Family medicine; Oncology; Quarter (Canadian coin); Business; Internal medicine; Economic growth; Health care; Economics; Geography; Bioinformatics","score_opus":0.37961848078322585,"score_gpt":0.4638089895472058,"score_spread":0.08419050876397993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995728682","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8561465,0.0076307906,0.00014698612,0.1317331,0.00071180426,0.0015123371,0.000077980214,0.00002995222,0.0020105215],"genre_scores_gemma":[0.9554538,0.0023736418,0.0017658536,0.039864764,0.00014938558,0.00015769321,0.000011639645,0.000033648612,0.00018956725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950045,0.0006388009,0.0031203565,0.0005963628,0.00007640578,0.0005636058],"domain_scores_gemma":[0.9971466,0.001269712,0.0009780951,0.00037540548,0.000017780967,0.00021241058],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.016872006,0.00017321692,0.0011264322,0.00071908283,0.000083421925,0.00009936776,0.0002971659,0.0001536473,0.00023096215],"category_scores_gemma":[0.0005961484,0.00021254657,0.000037245776,0.00034046336,0.000048767626,0.0005046757,0.00008755378,0.00023185994,0.00096158334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043032534,0.000096065305,0.7825612,0.00074352435,0.0000122875845,0.0000014500896,0.008728151,0.0008859202,6.359731e-7,0.20317677,0.0029192313,0.0008317487],"study_design_scores_gemma":[0.0015995947,0.00042608468,0.6347804,0.00031701569,7.6144505e-7,0.0000052291894,0.001678146,0.0055459323,7.976349e-7,0.029441256,0.3258644,0.00034037916],"about_ca_topic_score_codex":0.02210032,"about_ca_topic_score_gemma":0.002623928,"teacher_disagreement_score":0.32294518,"about_ca_system_score_codex":0.0013600115,"about_ca_system_score_gemma":0.0003639509,"threshold_uncertainty_score":0.9998163},"labels":[],"label_agreement":null},{"id":"W2995755707","doi":"10.1016/j.jval.2019.09.888","title":"PDB6 LONG-TERM ASSOCIATION OF OBSERVED VERSUS PREDICTED MICRO- AND MACROVASCULAR COMPLICATIONS IN TYPE 1 DIABETES MELLITUS: EXTERNAL VALIDATION OF THE CORNERSTONE DIABETES SIMULATION MODEL (CDSM)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Macrovascular disease; Type 1 diabetes; Diabetes mellitus; Incidence (geometry); Term (time); Internal medicine; Physical therapy; Type 2 diabetes; Endocrinology; Mathematics","score_opus":0.07182885755864084,"score_gpt":0.32474521389005545,"score_spread":0.2529163563314146,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995755707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99702245,0.0010543414,0.000050048384,0.000535692,0.00012834958,0.0011294743,0.000013852793,0.000011353,0.000054452903],"genre_scores_gemma":[0.99917597,0.0002572141,0.0002686885,0.00004750508,0.000016368605,0.000012679248,0.000078852754,0.000012967015,0.000129787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99846214,0.00023398666,0.00046895124,0.00019823511,0.00038402106,0.0002526515],"domain_scores_gemma":[0.9988461,0.00035075803,0.00029976887,0.000293746,0.00016085732,0.000048780934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010831419,0.000091294256,0.00030130468,0.00019030384,0.000030643878,0.0000104118635,0.000109047985,0.00007960953,0.000013604853],"category_scores_gemma":[0.00023949023,0.00007614792,0.00005290512,0.00047935295,0.000046241243,0.00009312731,0.000065716595,0.00016750269,0.000003117844],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006770937,0.00015831344,0.89314187,0.0008914149,0.000046203415,6.8636155e-8,0.00021038581,0.09817551,0.0062718154,0.000057387017,0.000009773562,0.00096953375],"study_design_scores_gemma":[0.0016887228,0.00014385318,0.63665503,0.0004842476,0.000023336646,1.0350339e-8,0.000014273452,0.35874155,0.0020869896,0.00011801863,0.000004129286,0.000039824292],"about_ca_topic_score_codex":0.000112852045,"about_ca_topic_score_gemma":0.000013683283,"teacher_disagreement_score":0.26056606,"about_ca_system_score_codex":0.0002506427,"about_ca_system_score_gemma":0.0001152514,"threshold_uncertainty_score":0.31052217},"labels":[],"label_agreement":null},{"id":"W2995767116","doi":"10.1016/j.jval.2019.09.2565","title":"PSS3 INDUCTION COST PER RESPONDER OF BRODALUMAB COMPARED WITH OTHER BIOLOGICS APPROVED FOR PATIENTS WITH MODERATE TO SEVERE PSORIASIS IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Ixekizumab; Ustekinumab; Medicine; Secukinumab; Etanercept; Infliximab; Adalimumab; Psoriasis; Psoriasis Area and Severity Index; Dermatology; Psoriatic arthritis; Internal medicine; Tumor necrosis factor alpha","score_opus":0.2527293837330802,"score_gpt":0.35371938499942923,"score_spread":0.10099000126634905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995767116","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9883056,0.000104031926,0.00092528254,0.005949388,0.00031292392,0.0036368964,0.0006120915,0.000009452193,0.00014432377],"genre_scores_gemma":[0.9893123,0.000010195783,0.0058406196,0.004390004,0.000040751413,0.00021495113,0.00005387509,0.000034526125,0.00010279539],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99630773,0.00035298272,0.0022523676,0.00053123815,0.00010850253,0.00044717756],"domain_scores_gemma":[0.9975125,0.000537027,0.0013152192,0.00038872185,0.00010637214,0.00014011652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004604816,0.00017484927,0.00096335,0.00035173123,0.000056840483,0.0000163931,0.00016096748,0.000087185486,0.00005609689],"category_scores_gemma":[0.00037349178,0.0001760439,0.000026037986,0.00031163395,0.000020177922,0.00017790766,0.000018861114,0.00014783524,0.00003328162],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010479713,0.00015042015,0.8517016,0.0006063842,0.000026768525,8.119855e-8,0.002037397,0.13955763,6.6058766e-7,0.0036939615,0.001019139,0.00015795045],"study_design_scores_gemma":[0.012195959,0.0014977856,0.899258,0.00066520786,0.0000041657954,0.0000018609667,0.0041943546,0.061036397,0.0000066320426,0.001868906,0.018486956,0.0007837582],"about_ca_topic_score_codex":0.79536706,"about_ca_topic_score_gemma":0.55822724,"teacher_disagreement_score":0.23713984,"about_ca_system_score_codex":0.0027592538,"about_ca_system_score_gemma":0.0018375474,"threshold_uncertainty_score":0.72153527},"labels":[],"label_agreement":null},{"id":"W2995792315","doi":"10.1016/j.jval.2019.09.039","title":"AD3 ORAL ANTICOAGULANT PRESCRIPTION TRENDS, PROFILE USE AND DETERMINANTS OF ADHERENCE IN PATIENTS WITH ATRIAL FIBRILLATION","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Montreal Heart Institute; Université de Montréal","funders":"","keywords":"Apixaban; Medicine; Rivaroxaban; Atrial fibrillation; Cohort; Warfarin; Logistic regression; Internal medicine; Medical prescription; Persistence (discontinuity); Oral anticoagulant; Cohort study; Pharmacology","score_opus":0.08758697975023697,"score_gpt":0.3378493194199908,"score_spread":0.25026233966975386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995792315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99869823,0.00007632098,0.000004522568,0.00009346725,0.00014115444,0.0009414514,0.000007940451,0.000011070807,0.000025821164],"genre_scores_gemma":[0.9988676,0.000051627925,0.0007485169,0.000014736713,0.00006445869,4.6380154e-7,0.0000356717,0.000008805846,0.00020813153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989559,0.00009719115,0.00040130646,0.00018076548,0.00020909272,0.0001557276],"domain_scores_gemma":[0.9995255,0.00006380336,0.0001995667,0.00013087742,0.000034885812,0.00004540405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025807347,0.00008495056,0.00032950676,0.00024080547,0.000013709454,0.000009748343,0.000020958401,0.000044224133,0.000026770833],"category_scores_gemma":[0.0000689181,0.000066888606,0.000029454932,0.00024802913,0.000016918251,0.00020455083,0.0000197958,0.000051462317,0.0000038904877],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009776229,0.0000067254064,0.98516047,0.0002591302,0.000005275691,7.445768e-7,0.0001659854,0.000659713,0.000010045379,0.000046441623,0.000011549681,0.0126963],"study_design_scores_gemma":[0.0046147993,0.0009679811,0.98239386,0.00037491263,0.000010833852,5.6906225e-7,0.000020475876,0.011356976,0.000018170102,0.000011598695,0.00016642254,0.00006342527],"about_ca_topic_score_codex":0.001954448,"about_ca_topic_score_gemma":0.00009681285,"teacher_disagreement_score":0.012632875,"about_ca_system_score_codex":0.000054532808,"about_ca_system_score_gemma":0.00005943752,"threshold_uncertainty_score":0.29545537},"labels":[],"label_agreement":null},{"id":"W2995845770","doi":"10.1016/j.jval.2019.09.311","title":"PCN114 ASSESSMENT OF THE SURVIVAL BENEFIT AND COST IMPACT OF NEW TREATMENTS FOR KEY ANSCLC BIOMARKERS USING THE ITEN MODEL","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Dabrafenib; Alectinib; Medicine; Trametinib; Oncology; Pembrolizumab; Osimertinib; Lung cancer; Internal medicine; Erlotinib; Vemurafenib; Crizotinib; Cancer; Immunotherapy","score_opus":0.11917166889007196,"score_gpt":0.3461158137998317,"score_spread":0.22694414490975973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995845770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932458,0.001402248,0.001573219,0.00052098243,0.00025337032,0.0009693744,0.000511252,0.0000027070867,0.0015210866],"genre_scores_gemma":[0.9977611,0.0005541871,0.0013338394,0.00009150052,0.000029317347,0.000008567913,0.0000039108872,0.000017252501,0.00020034093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99884903,0.000017477627,0.000626955,0.00021140312,0.000031381845,0.0002637758],"domain_scores_gemma":[0.9988729,0.00010719802,0.0006235891,0.00030507968,0.0000208032,0.000070427246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000751402,0.000119810305,0.00046390973,0.00009560869,0.00005673316,0.000016427368,0.00017330794,0.000061719045,0.000017582317],"category_scores_gemma":[0.000033193817,0.00008661831,0.0001485055,0.00013844283,0.000047468642,0.0001297784,0.000039819675,0.00007060472,9.807192e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006471797,0.000062942105,0.81674063,0.000080371625,0.00011936784,3.30526e-8,0.0006265505,0.13782689,0.00002678807,0.041522626,0.00010045228,0.0028286402],"study_design_scores_gemma":[0.0013703919,0.00020352183,0.58524853,0.00006989625,0.0000081374355,5.8809775e-7,0.00005819763,0.39740935,0.000010867995,0.015294605,0.00022800623,0.000097888114],"about_ca_topic_score_codex":0.031320777,"about_ca_topic_score_gemma":0.0001775905,"teacher_disagreement_score":0.25958246,"about_ca_system_score_codex":0.00047468717,"about_ca_system_score_gemma":0.00042648712,"threshold_uncertainty_score":0.9751297},"labels":[],"label_agreement":null},{"id":"W2995883695","doi":"10.1016/j.jval.2019.09.633","title":"PCN440 NETWORK META-ANALYSIS USING FRACTIONAL POLYNOMIALS: HEURISTIC FOR MODEL SELECTION INCORPORATING BEYOND-TRIAL EXTRAPOLATIONS (A MELANOMA EXAMPLE)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Model selection; Gompertz function; Weibull distribution; Mathematics; Extrapolation; Deviance (statistics); Boolean model; Statistics; Parametric statistics; Computer science; Econometrics","score_opus":0.796887340975208,"score_gpt":0.5686788188507079,"score_spread":0.22820852212450005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995883695","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.025040237,0.00016507276,0.9705486,0.0003468684,0.0007985971,0.0027113694,0.00017048592,0.00007923296,0.00013951921],"genre_scores_gemma":[0.18008895,0.0000055929386,0.8185264,0.00025294855,0.00077918376,0.00017430088,0.000018117229,0.0000516964,0.000102836864],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9928708,0.002621392,0.0026367009,0.0007267203,0.00054265856,0.0006016947],"domain_scores_gemma":[0.9351819,0.062471528,0.0014833529,0.0004734016,0.00019467625,0.00019511816],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013479733,0.00029824837,0.0021682987,0.0003703621,0.00031257753,0.00006923362,0.0002046387,0.0002667065,0.00032875995],"category_scores_gemma":[0.018472837,0.0002800056,0.00090385316,0.0013351553,0.00005284374,0.00015657955,0.000055305438,0.0004681278,0.00000919105],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00131249,0.00021712952,0.000625669,0.00017592873,0.006222566,4.5055614e-7,0.00010729817,0.73127824,0.00003215671,0.25957587,0.00025100555,0.00020121386],"study_design_scores_gemma":[0.002162504,0.00015175626,0.000029540144,0.000009410071,0.0067602815,0.0000011137046,0.000013678329,0.505093,0.000005102262,0.48562273,0.000014121689,0.00013674222],"about_ca_topic_score_codex":0.0016635134,"about_ca_topic_score_gemma":0.0001430109,"teacher_disagreement_score":0.22618523,"about_ca_system_score_codex":0.00041329037,"about_ca_system_score_gemma":0.00068941887,"threshold_uncertainty_score":0.9999652},"labels":[],"label_agreement":null},{"id":"W2995887845","doi":"10.1016/j.jval.2019.09.2337","title":"PRO5 COMPARING PRODUCTIVITY LOSSES FROM TREATING ATYPICAL HEMOLYTIC UREMIC SYNDROME PATIENTS IN THE UNITED STATES WITH ECULIZUMAB OR RAVULIZUMAB IN AN INFUSION CLINIC OR AT HOME","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Eculizumab; Medicine; Pediatrics; Immunology; Complement system; Immune system","score_opus":0.052469791764286074,"score_gpt":0.30749270376951143,"score_spread":0.25502291200522537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995887845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964263,0.00029776935,0.0000016728321,0.00022135285,0.00021332812,0.0027181206,0.00006219891,0.00005038503,0.000008894767],"genre_scores_gemma":[0.9985141,0.000039274364,0.00005146861,0.00013041095,0.000013117083,0.00010577661,0.0010535069,0.00002668678,0.000065662534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955301,0.0021663096,0.0009202583,0.00064354314,0.00013515372,0.000604583],"domain_scores_gemma":[0.9978516,0.0010879257,0.00036409358,0.00060230406,0.000048748447,0.000045309283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081825093,0.0002752216,0.0006880379,0.00035623572,0.00014093079,0.000024903527,0.0003798906,0.00012299046,0.00031664854],"category_scores_gemma":[0.00021548347,0.00016829885,0.000033488617,0.00075313036,0.000105480205,0.00016755599,0.00016291116,0.00044728155,0.00010727258],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00624592,0.001113925,0.9857476,0.00034485818,0.000022891994,0.00003634987,0.0038009055,0.0022626042,0.00008058285,0.00000787999,0.00006539245,0.00027110378],"study_design_scores_gemma":[0.00738047,0.002464919,0.984841,0.0015700421,0.000012373829,0.000062777006,0.0016568807,0.0015309846,0.00005260153,0.000057228193,0.00012139359,0.00024934227],"about_ca_topic_score_codex":0.01872088,"about_ca_topic_score_gemma":0.01569128,"teacher_disagreement_score":0.0030296005,"about_ca_system_score_codex":0.0006845269,"about_ca_system_score_gemma":0.0003762133,"threshold_uncertainty_score":0.98781353},"labels":[],"label_agreement":null},{"id":"W2995889671","doi":"10.1016/j.jval.2019.09.2661","title":"PSY33 HTA REVIEW OF DECISIONS FOR PRODUCTS INDICATED IN THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) AND LUPUS NEPHRITIS (N) IN UK, GERMANY, FRANCE, ITALY, SPAIN, CANADA AND TURKEY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Belimumab; Medicine; Lupus nephritis; Rituximab; Systemic lupus erythematosus; European union; Reimbursement; Disease; Dermatology; Immunology; Internal medicine; Lymphoma","score_opus":0.04953274642682193,"score_gpt":0.28781476204506123,"score_spread":0.2382820156182393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995889671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.847621,0.14710161,0.0000020909565,0.0030035763,0.0002909983,0.0015154178,0.00030744384,0.0000017041189,0.00015611867],"genre_scores_gemma":[0.8395835,0.15926296,0.00007962718,0.0009105912,0.00001911897,0.00007306507,0.000011253754,0.000011213295,0.000048649134],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99812067,0.00006723023,0.0011670867,0.00031618285,0.0000362766,0.00029255034],"domain_scores_gemma":[0.9987228,0.00043837994,0.00045043824,0.00029551005,0.000015616135,0.00007725488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011620469,0.00013521111,0.00078719016,0.00023339574,0.000022849212,0.000010859098,0.00014354651,0.00005611233,0.000010494817],"category_scores_gemma":[0.00014822645,0.000119983204,0.000037261798,0.00034187266,0.000038506885,0.000050892588,0.000022135378,0.00009706758,0.0000024937224],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009129811,0.00043827636,0.9343131,0.014208797,0.00005214273,0.000009157137,0.0037375467,0.00048186193,0.000011475546,0.037404984,0.0019924094,0.007258915],"study_design_scores_gemma":[0.031983122,0.003394465,0.3503357,0.041370746,0.00006452581,0.001144342,0.0012513732,0.053416062,0.000114132046,0.041717913,0.47298682,0.0022208046],"about_ca_topic_score_codex":0.26635176,"about_ca_topic_score_gemma":0.026780333,"teacher_disagreement_score":0.58397746,"about_ca_system_score_codex":0.00025349436,"about_ca_system_score_gemma":0.00027502966,"threshold_uncertainty_score":0.99097836},"labels":[],"label_agreement":null},{"id":"W2995913988","doi":"10.1016/j.jval.2019.09.2637","title":"PSY9 PREFERENCE WEIGHTS FOR QUALITY-ADJUSTED LIFE-YEARS ESTIMATION FOR TREATMENTS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN THE UNITED KINGDOM","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Censoring (clinical trials); Primaquine; Life expectancy; Demography; Pediatrics; Environmental health; Internal medicine; Population","score_opus":0.19069914004973343,"score_gpt":0.42360172912124805,"score_spread":0.23290258907151462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2995913988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992567,0.00019545482,0.0015085574,0.0015823364,0.00011937665,0.0039043762,0.000083996485,0.000013855976,0.000025072628],"genre_scores_gemma":[0.97540176,0.000030577397,0.023837378,0.0002265855,0.000046129284,0.00021888255,0.00017237001,0.00001550037,0.000050836792],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979482,0.00033611013,0.0006666583,0.00025158416,0.00040355237,0.00039386164],"domain_scores_gemma":[0.99761117,0.00160144,0.0002516707,0.0003063466,0.00011187483,0.00011751698],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014257501,0.000124773,0.00041486337,0.00029278742,0.00003898825,0.000012636041,0.00015629253,0.000070469185,0.000014008159],"category_scores_gemma":[0.0011544495,0.00008770257,0.00006662552,0.00049362436,0.000046439516,0.000083254294,0.000016031223,0.00017103749,0.0000044258845],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041525293,0.006428501,0.638321,0.03218376,0.00047216954,0.000023499035,0.023005394,0.091384314,0.010370245,0.088291,0.0020260187,0.065968834],"study_design_scores_gemma":[0.01781181,0.004446657,0.7439837,0.0020310823,0.000035917757,0.000013735259,0.00060582155,0.22046137,0.0007265256,0.007516019,0.0021706107,0.00019677453],"about_ca_topic_score_codex":0.0054554814,"about_ca_topic_score_gemma":0.000114985574,"teacher_disagreement_score":0.12907706,"about_ca_system_score_codex":0.00028319683,"about_ca_system_score_gemma":0.0005607537,"threshold_uncertainty_score":0.8247092},"labels":[],"label_agreement":null},{"id":"W2996043655","doi":"10.1016/j.jval.2019.09.2125","title":"PNS225 CURRENT STATUS OF OUTCOMES-BASED AGREEMENTS IN SELECTED EUROPEAN COUNTRIES AND CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Demography; Database; Geography; Computer science","score_opus":0.24033668744919628,"score_gpt":0.39441947964327345,"score_spread":0.15408279219407717,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996043655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863991,0.0040979926,0.000050050592,0.0070728436,0.0006010051,0.0008863114,0.00039290884,0.00001115458,0.0004886072],"genre_scores_gemma":[0.99463713,0.0005335927,0.00032363075,0.004347579,0.000024483956,0.0000148315385,0.000039570798,0.00002205614,0.00005710719],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99469537,0.00073594996,0.0034662918,0.00039698437,0.00012173298,0.00058368454],"domain_scores_gemma":[0.9972185,0.0007494678,0.0014750123,0.00031591379,0.000045811696,0.0001953341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0089154625,0.00014873904,0.00089613756,0.00038482307,0.00004252316,0.000017533228,0.00014153875,0.0000378545,0.00009938269],"category_scores_gemma":[0.0010761711,0.00018761365,0.000025377942,0.00025492022,0.000028288485,0.00012217733,0.000030815896,0.00018346187,0.000098751436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010170805,0.000052896263,0.99052477,0.0010961107,0.000007301403,5.475796e-7,0.0006715944,0.002389723,1.6901095e-7,0.0037539129,0.0013551288,0.00013768052],"study_design_scores_gemma":[0.0015389672,0.00008151583,0.95163375,0.00027360723,7.1970226e-7,2.86868e-7,0.00022316686,0.010006192,9.937312e-7,0.000272825,0.03580105,0.00016690155],"about_ca_topic_score_codex":0.86808115,"about_ca_topic_score_gemma":0.42550534,"teacher_disagreement_score":0.4425758,"about_ca_system_score_codex":0.001829333,"about_ca_system_score_gemma":0.002175718,"threshold_uncertainty_score":0.76506627},"labels":[],"label_agreement":null},{"id":"W2996090251","doi":"10.1016/j.jval.2019.09.084","title":"ON4 THE ECONOMIC BURDEN OF RENAL CELL CARCINOMA (RCC) IN CANADA USING REAL-WORLD EVIDENCE; A SOCIETAL PERSPECTIVE.","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Renal cell carcinoma; Nephrectomy; Kidney cancer; Microsimulation; Cancer; Urology; Oncology; Internal medicine; Intensive care medicine; Kidney","score_opus":0.07003359689348444,"score_gpt":0.2786211863205374,"score_spread":0.20858758942705297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996090251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98099715,0.005393775,0.000011419701,0.0015946341,0.00057150755,0.00045880684,0.000098896955,0.0000042449574,0.010869562],"genre_scores_gemma":[0.99811816,0.00089221913,0.0001164726,0.00027846397,0.00016383163,0.0000081714925,0.0000015053342,0.000024575207,0.00039661414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789304,0.00005617822,0.0010701937,0.0004288849,0.00004263881,0.0005090885],"domain_scores_gemma":[0.99857503,0.00020793777,0.0007097935,0.00039172385,0.000020489615,0.00009499498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011557462,0.00016700909,0.0006543385,0.00023705905,0.00005627817,0.000022664988,0.0003375107,0.000060978233,0.00024069652],"category_scores_gemma":[0.000044402805,0.00017721586,0.00009990329,0.00023856053,0.000055959008,0.00026297465,0.00006486429,0.00029647836,0.000055312692],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006109305,0.000019923447,0.66925496,0.0001749462,0.00001384302,0.000003839153,0.0037469468,0.25838745,0.000020020587,0.067502975,0.00061619695,0.000197823],"study_design_scores_gemma":[0.002092701,0.00029988468,0.6781497,0.00045094578,0.000006720093,0.0000055822998,0.0051144427,0.28962713,0.0001419931,0.018586366,0.0047843303,0.00074018625],"about_ca_topic_score_codex":0.99779904,"about_ca_topic_score_gemma":0.87088126,"teacher_disagreement_score":0.1269178,"about_ca_system_score_codex":0.013354972,"about_ca_system_score_gemma":0.005578088,"threshold_uncertainty_score":0.99043256},"labels":[],"label_agreement":null},{"id":"W2996136710","doi":"10.1016/j.jval.2019.09.349","title":"PCN153 OVERVIEW OF ECONOMIC EVALUATIONS OF ONCOLOGY PRODUCTS WITH A FOCUS ON THE KEY CHALLENGES ACROSS, UNITED KINGDOM, FRANCE AND CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Economic evaluation; Agency (philosophy); Key (lock); Strengths and weaknesses; Nice; Funding Agency; Economic impact analysis; Economic model; Operations research; Actuarial science; Computer science; Medicine; Political science; Business; Economics; Public relations; Engineering; Psychology; Sociology; Pathology","score_opus":0.4889677482856861,"score_gpt":0.44810181189483794,"score_spread":0.04086593639084818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996136710","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8574418,0.009213499,0.000008174858,0.13065723,0.00029576695,0.0013610305,0.00027421865,0.0000072372377,0.0007410913],"genre_scores_gemma":[0.9939035,0.0023097445,0.00037943997,0.0031688816,0.00006506491,0.00007754034,0.000010208729,0.000023829938,0.00006179199],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9955415,0.0008160355,0.0026684012,0.00048147194,0.00011252452,0.0003800591],"domain_scores_gemma":[0.9943318,0.002272036,0.0025862632,0.0006349941,0.00007909769,0.00009581457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015208272,0.00016264438,0.0010591897,0.00021675833,0.00009332308,0.000010225903,0.00023583855,0.00008794124,0.000067950714],"category_scores_gemma":[0.0010604472,0.00015293348,0.000031336833,0.000221424,0.00010211636,0.000117257034,0.000040497707,0.00020789648,0.00004561581],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006996297,0.00018337811,0.09002685,0.0036601562,0.00009434413,5.8825407e-7,0.008188983,0.022000073,0.000002045884,0.873064,0.0016329323,0.001076717],"study_design_scores_gemma":[0.007312456,0.003912647,0.5659913,0.003891927,0.000018659173,0.00002575279,0.0075461543,0.05070773,0.00008856721,0.033595536,0.32576683,0.001142487],"about_ca_topic_score_codex":0.7568614,"about_ca_topic_score_gemma":0.35261565,"teacher_disagreement_score":0.8394684,"about_ca_system_score_codex":0.0010662965,"about_ca_system_score_gemma":0.002427297,"threshold_uncertainty_score":0.65919745},"labels":[],"label_agreement":null},{"id":"W2996143033","doi":"10.1016/j.jval.2019.09.1083","title":"PDG70 KNOWLEDGE, ATTITUDES AND PRACTICES OF MOROCCAN COMMUNITY PHARMACISTS TOWARDS THE THIRD-PARTY PAYER SYSTEM","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Profit margin; Medical prescription; Pharmacy; Family medicine; Pharmacist; Observational study; Business; Medicine; Marketing; Nursing; Geography","score_opus":0.3107613983466334,"score_gpt":0.4927608822237867,"score_spread":0.1819994838771533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996143033","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98037523,0.0042578275,0.0000044892513,0.0035145637,0.00039780536,0.0010015104,0.000012024824,0.000035473127,0.010401087],"genre_scores_gemma":[0.99756277,0.0009944162,0.00014028541,0.0009945434,0.00006356903,0.000013354105,0.000005460879,0.000013828098,0.00021177354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974051,0.0013896425,0.00050155,0.00016507668,0.00026981608,0.00026880178],"domain_scores_gemma":[0.99711233,0.0016748024,0.00056375115,0.0003938479,0.00007986141,0.00017541077],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031595728,0.00013770453,0.0004340389,0.00007172007,0.00012793552,0.000017672779,0.00016183856,0.00005572873,0.000044028868],"category_scores_gemma":[0.0003965844,0.000085358275,0.00005230152,0.00021277771,0.00009015166,0.00018540531,0.00011774331,0.0008135168,0.00003603271],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060200074,0.0008946267,0.9717979,0.013292396,0.00011501697,0.0000073285187,0.005752644,0.00014036398,0.00034757407,0.0014188703,0.0006515216,0.0049797897],"study_design_scores_gemma":[0.009783258,0.0024228105,0.82219857,0.003588681,0.0003023748,0.00040384577,0.0073218904,0.07525573,0.001703642,0.0001921378,0.07630755,0.00051948987],"about_ca_topic_score_codex":0.0043420885,"about_ca_topic_score_gemma":0.000042872573,"teacher_disagreement_score":0.14959927,"about_ca_system_score_codex":0.00012795617,"about_ca_system_score_gemma":0.00030574214,"threshold_uncertainty_score":0.65639675},"labels":[],"label_agreement":null},{"id":"W2996151803","doi":"10.1016/j.jval.2019.09.570","title":"PCN375 WHEN EARLY MODELS MAY BE TOO EARLY - PREDICTING SURVIVAL FROM INTERIM ANALYSES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Censoring (clinical trials); Interim; Survival analysis; Interim analysis; Statistics; Medicine; Sample size determination; Clinical trial; Econometrics; Computer science; Mathematics; Internal medicine","score_opus":0.660567735543121,"score_gpt":0.4661269712448579,"score_spread":0.19444076429826307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996151803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9654522,0.002300078,0.002198445,0.022727532,0.0019881043,0.0010596134,0.00073077786,0.00010302389,0.0034402078],"genre_scores_gemma":[0.9859927,0.0001741522,0.0042995964,0.007873791,0.00045076376,0.0000621413,0.00007508886,0.00006960125,0.001002127],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9916197,0.0010863276,0.0052747736,0.0009900867,0.00020925059,0.0008198793],"domain_scores_gemma":[0.9948025,0.0015743953,0.0023258654,0.00089706614,0.00005710875,0.0003431035],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.015962718,0.00029987982,0.0016066595,0.0005742885,0.00015013393,0.00016155481,0.0005171637,0.00022625852,0.00055842515],"category_scores_gemma":[0.0010055904,0.0003899426,0.00017679343,0.00029224937,0.000050812792,0.0010350691,0.00012623027,0.00045437153,0.0016344201],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053616855,0.00017614083,0.8855459,0.0006052107,0.00014766476,0.0000024796245,0.027249882,0.026822332,0.000009586118,0.05417993,0.0050405604,0.00016671259],"study_design_scores_gemma":[0.003346342,0.0007717739,0.4043121,0.0009998563,0.000014632232,0.0000034278362,0.004449242,0.46189526,0.00001695795,0.10778999,0.0151291,0.0012713065],"about_ca_topic_score_codex":0.27484533,"about_ca_topic_score_gemma":0.0009272335,"teacher_disagreement_score":0.48123378,"about_ca_system_score_codex":0.0011446744,"about_ca_system_score_gemma":0.00041962406,"threshold_uncertainty_score":0.9998552},"labels":[],"label_agreement":null},{"id":"W2996166277","doi":"10.1016/j.jval.2019.09.332","title":"PCN136 ECONOMIC VIABILITY OF CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY FOR ADULTS WITH ADVANCED LEUKEMIA: EVIDENCE FROM AN EARLY ECONOMIC MODELLING","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Ottawa Hospital","funders":"","keywords":"Medicine; Blinatumomab; Chimeric antigen receptor; Oncology; Immunotherapy; Salvage therapy; Internal medicine; Leukemia; Chemotherapy; Cancer; Lymphoblastic Leukemia","score_opus":0.04991998451427404,"score_gpt":0.33051687973485416,"score_spread":0.2805968952205801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996166277","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99299204,0.0020372767,0.00042841653,0.00033532106,0.00021123246,0.0038087957,0.00007975845,0.00003523203,0.00007194708],"genre_scores_gemma":[0.9850313,0.005939421,0.008391133,0.00011344465,0.00015013217,0.00009856523,0.000045181583,0.00006975302,0.00016104427],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99762166,0.00022828237,0.0006953091,0.000748927,0.00018737845,0.0005184626],"domain_scores_gemma":[0.99791235,0.0006146703,0.00030752996,0.000856982,0.00006608152,0.00024236001],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011267759,0.0002268951,0.00074747857,0.00015979477,0.000045614743,0.000015628346,0.0002554197,0.0001196462,0.00060110004],"category_scores_gemma":[0.000016139857,0.00020327693,0.00012819895,0.00010886526,0.0000793877,0.00029360317,0.000024686718,0.00031391918,0.00006089108],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029379742,0.0004384488,0.2828641,0.0013152757,0.00011860431,0.0000014308047,0.0074338126,0.5794889,0.05983536,0.00003700096,0.000041927924,0.03904544],"study_design_scores_gemma":[0.018658562,0.017587824,0.038051773,0.0021257256,0.000016825434,0.000003585822,0.0008825543,0.8710328,0.049404174,0.00038373607,0.0012173811,0.0006351117],"about_ca_topic_score_codex":0.036938194,"about_ca_topic_score_gemma":0.00020310488,"teacher_disagreement_score":0.29154387,"about_ca_system_score_codex":0.0015203176,"about_ca_system_score_gemma":0.00202012,"threshold_uncertainty_score":0.9694749},"labels":[],"label_agreement":null},{"id":"W2996166460","doi":"10.1016/j.jval.2019.09.1910","title":"PNS7 PATIENT INPUT TO COST-UTILITY ANALYSES: A REVIEW FROM THE UK, CANADA AND AUSTRALIA","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Nice; CLARITY; Documentation; Health technology; Patient participation; Grey literature; Process (computing); Medicine; Critical appraisal; Psychology; MEDLINE; Health care; Political science; Alternative medicine; Computer science","score_opus":0.7871575636325829,"score_gpt":0.5374722777608169,"score_spread":0.24968528587176608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996166460","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035036713,0.97200495,0.000043665405,0.015013568,0.0010998845,0.006974241,0.0043934626,0.000013319157,0.0001065516],"genre_scores_gemma":[0.0001639806,0.9614806,0.00043074848,0.03672767,0.00021718437,0.00051033706,0.00029377165,0.00004740165,0.00012831492],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98574656,0.0027342518,0.009333235,0.0012203943,0.00021106555,0.0007544825],"domain_scores_gemma":[0.9891669,0.0040005883,0.004734985,0.0015338879,0.000054911427,0.0005086867],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.018792223,0.0005152893,0.0056661023,0.00024956543,0.0001664303,0.000073433745,0.00062509166,0.0002401692,0.00048000528],"category_scores_gemma":[0.004703065,0.00047175147,0.00027484074,0.00063699076,0.000044131568,0.00010188662,0.0001706768,0.0006944426,0.00083630317],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008117429,0.00010657257,0.011549021,0.24541219,0.0003675382,0.000008219567,0.0014814648,0.00023241162,9.420813e-10,0.0031707697,0.49759048,0.2400732],"study_design_scores_gemma":[0.00012890664,0.000048825295,0.0017249482,0.036937628,0.00004603448,0.000005133526,0.00007126938,0.00015336508,2.7878775e-9,0.0003012519,0.9602017,0.00038097097],"about_ca_topic_score_codex":0.96859735,"about_ca_topic_score_gemma":0.5870167,"teacher_disagreement_score":0.46261117,"about_ca_system_score_codex":0.0035651627,"about_ca_system_score_gemma":0.0041747023,"threshold_uncertainty_score":0.99994165},"labels":[],"label_agreement":null},{"id":"W2996286890","doi":"10.1016/j.jval.2019.09.2321","title":"PPM4 COMPREHENSIVE GENOMIC PROFILING FOR NON-SMALL CELL LUNG CANCER (NSCLC): A HEALTH AND BUDGET IMPACT ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; William Osler Health System; Vancouver Coastal Health; Roche (Canada)","funders":"","keywords":"Medicine; Turnaround time; Genetic testing; Hotspot (geology); Profiling (computer programming); Oncology; Bioinformatics; Internal medicine; Computer science; Biology","score_opus":0.01608610984209335,"score_gpt":0.30957089460392595,"score_spread":0.2934847847618326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996286890","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97346014,0.023061734,0.0011401217,0.00037585117,0.00018800297,0.0013783015,0.00035784268,0.000005511433,0.000032494834],"genre_scores_gemma":[0.98538584,0.009169174,0.002982174,0.001798961,0.00018044954,0.000088071705,0.00029363183,0.000036052283,0.00006566449],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984782,0.00006990744,0.00039660325,0.000493518,0.00006859645,0.0004932017],"domain_scores_gemma":[0.9990497,0.00007865218,0.00023584592,0.0003161386,0.000070133174,0.0002494901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029406932,0.00018923424,0.00043749914,0.00014204785,0.00007902729,0.000027745922,0.000119215074,0.00009649655,0.000005929672],"category_scores_gemma":[0.000018963072,0.00018968657,0.00014829136,0.0001948471,0.000020697695,0.000002587898,0.00008180903,0.000105688494,0.0000014663315],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00050831336,0.0001708917,0.7537716,0.0024472983,0.000505789,0.0000017710767,0.0015218604,0.18786976,0.04835318,0.00009627626,0.0021316248,0.0026216386],"study_design_scores_gemma":[0.018109491,0.009543494,0.27328157,0.0008586387,0.0005451085,0.000022697475,0.0029293469,0.6335974,0.029511698,0.00034317112,0.028350769,0.0029066505],"about_ca_topic_score_codex":0.008698628,"about_ca_topic_score_gemma":0.0006872094,"teacher_disagreement_score":0.48049003,"about_ca_system_score_codex":0.00024695628,"about_ca_system_score_gemma":0.0015605836,"threshold_uncertainty_score":0.9979025},"labels":[],"label_agreement":null},{"id":"W2996343063","doi":"10.1016/j.jval.2019.09.605","title":"PCN411 HOW ARE SINGLE-ARM TRIALS PERCEIVED IN HEATH TECHNOLOGY ASSESSMENTS FOR CHRONIC LEUKAEMIA ACROSS THE EU5, AUSTRALIA AND CANADA?","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Venetoclax; Psychological intervention; Medicine; Ponatinib; Nice; Clinical trial; Family medicine; Internal medicine; Psychiatry; Leukemia; Computer science","score_opus":0.5688357697135255,"score_gpt":0.4873895302611391,"score_spread":0.08144623945238633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996343063","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8859856,0.0020536124,0.00011571273,0.10756724,0.0008776704,0.0027985892,0.00053374673,0.000020860203,0.00004693314],"genre_scores_gemma":[0.99443114,0.00021764859,0.00067160674,0.0034978786,0.00020397126,0.00028482443,0.00002603366,0.00003233336,0.0006345536],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939489,0.0007619429,0.0035654542,0.00070744427,0.000105845815,0.0009104127],"domain_scores_gemma":[0.9946422,0.0022741447,0.0023310215,0.00055726746,0.00004369704,0.00015166281],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027614973,0.00023235657,0.0016718059,0.00031218998,0.00019329571,0.0000940491,0.00034252502,0.00024564602,0.00007491973],"category_scores_gemma":[0.0032169106,0.0002406378,0.00007480119,0.0002852014,0.000074920754,0.0002249882,0.0000632256,0.00037696943,0.000037541264],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000066366105,0.0002378418,0.9504822,0.0024801989,0.00007183775,0.0000028471886,0.002589168,0.0044195685,0.000019803525,0.02588907,0.01276831,0.000972806],"study_design_scores_gemma":[0.010186316,0.0016597564,0.7600769,0.0015441618,0.000009800001,0.000024109779,0.015590313,0.040284395,0.000020251862,0.01745086,0.1520231,0.0011300553],"about_ca_topic_score_codex":0.5995571,"about_ca_topic_score_gemma":0.56012046,"teacher_disagreement_score":0.19040531,"about_ca_system_score_codex":0.0057099904,"about_ca_system_score_gemma":0.0015899393,"threshold_uncertainty_score":0.9981069},"labels":[],"label_agreement":null},{"id":"W2996366298","doi":"10.1016/j.jval.2019.09.739","title":"PCV14 COMPARATIVE EFFECTIVENESS AND SAFETY OF ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION: A PROPENSITY SCORE-MATCHED COHORT STUDY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Montreal General Hospital; Université de Montréal","funders":"","keywords":"Apixaban; Rivaroxaban; Medicine; Dabigatran; Warfarin; Atrial fibrillation; Hazard ratio; Internal medicine; Cohort; Stroke (engine); Propensity score matching; Anticoagulant; Proportional hazards model; Cardiology; Anesthesia; Confidence interval","score_opus":0.09799204310040462,"score_gpt":0.35245286258703734,"score_spread":0.25446081948663274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996366298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923215,0.000047692592,0.0000139302565,0.00010384861,0.00012261319,0.007311065,0.0000042525103,0.000013090799,0.00006199581],"genre_scores_gemma":[0.99976045,0.000013436178,0.00012293535,0.000012625462,0.000046366957,0.000001193913,0.000020033123,0.000008795043,0.000014162349],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99825317,0.000492608,0.0004776127,0.00027358247,0.00033148922,0.00017152389],"domain_scores_gemma":[0.999241,0.00022529508,0.00021492524,0.00017967187,0.00008017869,0.0000589337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011768442,0.00012853542,0.00096620986,0.00016651816,0.000030737603,0.000007637018,0.000031536452,0.000037793412,0.000010636435],"category_scores_gemma":[0.000052466836,0.00009643067,0.000036207206,0.00036397428,0.000034751145,0.00009732914,0.000044817978,0.00008757371,0.0000044239123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063874805,0.00003968048,0.98693144,0.00035211554,0.00007929853,0.0000016982771,0.00073610427,0.005116226,0.0000027534095,0.000060370257,0.0000011811363,0.00029164072],"study_design_scores_gemma":[0.013358098,0.0016595862,0.983304,0.00037501554,0.000033318553,5.319884e-7,0.00012432552,0.0010160736,0.000008545157,0.000015382073,0.000014771678,0.00009034982],"about_ca_topic_score_codex":0.0021855927,"about_ca_topic_score_gemma":0.00010883822,"teacher_disagreement_score":0.0074389405,"about_ca_system_score_codex":0.0001307159,"about_ca_system_score_gemma":0.00012826151,"threshold_uncertainty_score":0.39323285},"labels":[],"label_agreement":null},{"id":"W2996421917","doi":"10.1016/j.jval.2019.09.2320","title":"PPM3 GENOMIC SCREENING COSTS IN MODELLING: A PENALTY FOR INNOVATION?","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); Memorial University of Newfoundland","funders":"","keywords":"Medicine; Oncology; Cost-effectiveness analysis; Internal medicine; Cost effectiveness; Risk analysis (engineering)","score_opus":0.5644246595470902,"score_gpt":0.44695344151287586,"score_spread":0.11747121803421434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996421917","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91738516,0.0020789846,0.04833127,0.026977645,0.00064407726,0.0030755901,0.00020103136,0.00004117168,0.0012650595],"genre_scores_gemma":[0.96058947,0.00016879504,0.026109584,0.01211011,0.00021987717,0.0002436344,0.00008978817,0.000057611567,0.00041111608],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99285203,0.00032356568,0.0053943642,0.0006751598,0.000084215935,0.00067068636],"domain_scores_gemma":[0.99623334,0.0011599788,0.0019619477,0.00046241144,0.00006459846,0.00011771679],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.026748048,0.00018435638,0.0010193659,0.0011542654,0.00010064881,0.000049923492,0.0002653908,0.0001464201,0.000107029555],"category_scores_gemma":[0.001041583,0.00026268003,0.00007064403,0.00070541544,0.00002130367,0.00035719114,0.000040713094,0.00027497704,0.00064644706],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004473709,0.000096753916,0.22434007,0.00092649466,0.000013161376,3.668597e-7,0.0018123148,0.37538162,0.0000023015898,0.39550143,0.0015370867,0.00034365637],"study_design_scores_gemma":[0.00216008,0.00013185137,0.026034726,0.0003410345,6.7982876e-7,0.000001726908,0.0005871,0.92005086,0.0000012551461,0.03086704,0.01951059,0.00031303236],"about_ca_topic_score_codex":0.015445431,"about_ca_topic_score_gemma":0.00030490305,"teacher_disagreement_score":0.5446693,"about_ca_system_score_codex":0.0019631155,"about_ca_system_score_gemma":0.0005174346,"threshold_uncertainty_score":0.99998254},"labels":[],"label_agreement":null},{"id":"W2996439492","doi":"10.1016/j.jval.2019.09.1880","title":"PND110 SYMPTOM SEVERITY IN MULTIPLE SCLEROSIS FROM THE PATIENT'S PERSPECTIVE: REVISITING THE PSYCHOMETRIC PROPERTIES OF THE SYMPTOMSCREEN QUESTIONNAIRE (PERCEPTIONS-MS STUDY)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; University of Toronto","funders":"","keywords":"Cronbach's alpha; Item response theory; Physical therapy; Construct validity; Medicine; Anxiety; Hospital Anxiety and Depression Scale; Multiple sclerosis; Clinical psychology; Psychometrics; Psychology; Psychiatry","score_opus":0.10268659292913154,"score_gpt":0.3248727864658438,"score_spread":0.22218619353671223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996439492","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9735023,0.0048436834,0.0000047147364,0.016618231,0.00018655078,0.0046651703,0.00003273219,0.000033644257,0.00011298788],"genre_scores_gemma":[0.99746704,0.0014820081,0.000071037655,0.0005461065,0.00016471703,0.00021226438,0.0000023616858,0.000028212347,0.00002626121],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952189,0.0019679966,0.0008094518,0.0005063303,0.0009992166,0.00049814826],"domain_scores_gemma":[0.99739504,0.00088693696,0.0002920154,0.0010371777,0.00030146996,0.00008738783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022738262,0.0002315733,0.00055291416,0.00024912535,0.00040759382,0.000038842158,0.00047874462,0.00007299051,0.00004254855],"category_scores_gemma":[0.0037355432,0.00011066245,0.00014400916,0.002082341,0.00028656877,0.00012352335,0.0003295135,0.0008193179,0.000020607646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014069857,0.00037770194,0.9658272,0.00016339848,0.00005847958,3.55781e-7,0.023212245,0.0004738588,0.0005421077,0.000029965353,0.000108396634,0.009065566],"study_design_scores_gemma":[0.0017672669,0.0002847639,0.9611729,0.0029052848,0.000015346961,0.0000013837207,0.029230721,0.0043830927,0.000046083605,0.000024643045,0.00006305765,0.00010547754],"about_ca_topic_score_codex":0.10427316,"about_ca_topic_score_gemma":0.0025746366,"teacher_disagreement_score":0.101698525,"about_ca_system_score_codex":0.0008751582,"about_ca_system_score_gemma":0.00031141358,"threshold_uncertainty_score":0.90169156},"labels":[],"label_agreement":null},{"id":"W2996469325","doi":"10.1016/j.jval.2019.09.1619","title":"PMS78 CANADIAN REAL-WORLD EVIDENCE ON EPIDEMIOLOGY, OUTCOMES AND ECONOMICS OF MODERATE-TO-SEVERE OSTEOARTHRITIS: A SYSTEMATIC LITERATURE REVIEW","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Osteoarthritis; MEDLINE; Cochrane Library; Systematic review; Comorbidity; Epidemiology; Population; Physical therapy; Health economics; Evidence-based medicine; Public health; Family medicine; Alternative medicine; Internal medicine; Meta-analysis; Environmental health; Pathology","score_opus":0.06106474913122725,"score_gpt":0.3292774540070096,"score_spread":0.2682127048757823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996469325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78900546,0.19026908,9.2437534e-7,0.01352452,0.0003167665,0.0058862315,0.00008861402,0.00002695628,0.0008814693],"genre_scores_gemma":[0.8900486,0.09429523,0.0010103171,0.01333399,0.000033348355,0.00016083146,0.000035873578,0.000031460266,0.001050311],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99763244,0.00048205565,0.00095429237,0.00040077753,0.00009309453,0.0004373228],"domain_scores_gemma":[0.9979574,0.000724782,0.0002563592,0.00050748256,0.000058592672,0.0004953658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001652626,0.0002200563,0.0015596831,0.0003745252,0.000041520936,0.000009802983,0.00008393848,0.00010260788,0.000022170603],"category_scores_gemma":[0.0006187088,0.00017843646,0.00008904424,0.00025645943,0.000020725678,0.00009443405,0.000022428247,0.00021770202,0.000057970436],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061641954,0.00019827805,0.36171198,0.5682915,0.00010192901,0.00022613912,0.0021923028,0.00059180614,0.00004418481,0.05176358,0.0007179273,0.013543975],"study_design_scores_gemma":[0.003408527,0.005968558,0.017222434,0.970767,0.000094155854,0.00022954846,0.000119976285,0.00037429444,0.00005057221,0.0011519801,0.0002532143,0.00035974005],"about_ca_topic_score_codex":0.024193782,"about_ca_topic_score_gemma":0.04950788,"teacher_disagreement_score":0.4024755,"about_ca_system_score_codex":0.00042823653,"about_ca_system_score_gemma":0.0005661359,"threshold_uncertainty_score":0.9823042},"labels":[],"label_agreement":null},{"id":"W2996471497","doi":"10.1016/j.jval.2019.09.226","title":"PCN29 COMPARATIVE EFFICACY OF NIVOLUMAB VERSUS RELEVANT TREATMENTS IN PRETREATED ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): A SYSTEMATIC LITERATURE REVIEW AND INDIRECT TREATMENT COMPARISON OF RANDOMIZED CONTROLLED TRIALS (RCTS)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Nivolumab; Medicine; Docetaxel; Internal medicine; Oncology; Hazard ratio; Atezolizumab; Lung cancer; Erlotinib; Randomized controlled trial; Population; Cancer; Confidence interval; Immunotherapy; Epidermal growth factor receptor","score_opus":0.050520128968875665,"score_gpt":0.3839835827175796,"score_spread":0.33346345374870395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996471497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5319887,0.4488454,0.0000019431416,0.0001194518,0.000142758,0.018744778,0.00003901819,0.000008678594,0.00010926762],"genre_scores_gemma":[0.81365526,0.18470794,0.0002274582,0.000050960258,0.000012011822,0.0010722571,0.00004076874,0.000019444802,0.00021388981],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9921671,0.003409338,0.0034292254,0.00039788007,0.0002855924,0.00031086983],"domain_scores_gemma":[0.99215984,0.004771054,0.0024574662,0.00038168865,0.00012807183,0.00010190402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003798441,0.00038940267,0.012256144,0.0003825308,0.000025717438,0.000009951386,0.00008001099,0.0001282739,0.00003091662],"category_scores_gemma":[0.0005235331,0.00023139572,0.00061190384,0.00062689144,0.000064171145,0.000049258946,0.000012635072,0.00017024588,0.0000010519915],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7847365,0.0021316493,0.011012376,0.178608,0.0041009225,0.000011210877,0.016092636,0.0004610227,0.001664488,0.0000066650696,0.000041254687,0.0011332565],"study_design_scores_gemma":[0.7596986,0.0029059735,0.002570605,0.22459823,0.0025621178,0.0000034270702,0.00037308031,0.0053005214,0.0018155326,0.0000011832242,0.000005479193,0.00016521975],"about_ca_topic_score_codex":0.0026307777,"about_ca_topic_score_gemma":0.0001808851,"teacher_disagreement_score":0.28166655,"about_ca_system_score_codex":0.0009226788,"about_ca_system_score_gemma":0.00065194716,"threshold_uncertainty_score":0.94360435},"labels":[],"label_agreement":null},{"id":"W2996554616","doi":"10.1016/j.jval.2019.09.2224","title":"PNS324 A NOVEL APPROACH OF USING GRAPHICAL REPRESENTATION OF EQ-5D-3L DIMENSIONS, LEVELS, AND HEALTH STATES FOR ILLITERATE RESPONDENTS IN VALUATION STUDIES - AN EXAMPLE FROM MOROCCO","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Valuation (finance); Functional illiteracy; Respondent; Time-trade-off; Graphics; Population; EQ-5D; Mathematics; Psychology; Statistics; Medicine; Demography; Computer science; Quality of life (healthcare); Health related quality of life; Nursing; Environmental health; Sociology; Economics","score_opus":0.8553870662258464,"score_gpt":0.505834811641362,"score_spread":0.34955225458448436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996554616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98017067,0.0063499156,0.007999124,0.002390973,0.00024844494,0.002222404,0.00060232246,0.000010999024,0.000005165859],"genre_scores_gemma":[0.9609329,0.00067986426,0.03690077,0.0011209154,0.00004695782,0.00007621652,0.00020223908,0.000027807353,0.000012321794],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99278295,0.0009584166,0.004957432,0.0007415302,0.00016426964,0.00039538837],"domain_scores_gemma":[0.9947269,0.0016161231,0.0029472937,0.00045138536,0.00012344027,0.00013483198],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023733446,0.00017505299,0.0014772806,0.00080713467,0.000092166716,0.000022067601,0.00013377945,0.00011023366,0.0000072573353],"category_scores_gemma":[0.00086112285,0.00021500887,0.000060065733,0.00047370666,0.00006716364,0.00048893865,0.00005331707,0.00014353557,0.0000026076243],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026759235,0.00068726286,0.8118323,0.003815281,0.00010215458,1.643051e-7,0.05554093,0.078135945,0.00016113756,0.04896561,0.0001244539,0.00036714977],"study_design_scores_gemma":[0.003649116,0.00039848403,0.36503798,0.000713141,0.0000048219117,0.0000014009584,0.010784891,0.567544,0.00002069531,0.05153715,0.00007333484,0.00023497638],"about_ca_topic_score_codex":0.1129028,"about_ca_topic_score_gemma":0.0008083626,"teacher_disagreement_score":0.48940805,"about_ca_system_score_codex":0.000660528,"about_ca_system_score_gemma":0.00041832443,"threshold_uncertainty_score":0.8930045},"labels":[],"label_agreement":null},{"id":"W2996558002","doi":"10.1016/j.jval.2019.09.2481","title":"PRO152 CONFIRMATORY PSYCHOMETRIC VALIDATION OF THE WESTERN ONTARIO MCMASTER UNIVERSITIES OSTEOARTHRITIS INVENTORY (WOMAC) IN ADULT X-LINKED HYPOPHOSPHATEMIA (XLH)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"WOMAC; Physical therapy; Osteoarthritis; Confirmatory factor analysis; Construct validity; Psychology; Rating scale; Medicine; Clinical psychology; Psychometrics; Structural equation modeling; Statistics; Developmental psychology; Mathematics; Pathology","score_opus":0.06352130796399402,"score_gpt":0.326215959190256,"score_spread":0.26269465122626195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996558002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9891622,0.0023355244,0.0000011731192,0.0029387353,0.00049210014,0.0009938343,0.000006263833,0.000012455314,0.004057715],"genre_scores_gemma":[0.9954562,0.000685814,0.000048042042,0.0019436484,0.000032315198,0.000011294121,0.0000044687595,0.000011592873,0.0018066083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984232,0.00028008907,0.00047855475,0.00021068292,0.00032624215,0.00028118753],"domain_scores_gemma":[0.9991813,0.00018989222,0.00026233852,0.00019714751,0.00007273123,0.00009661561],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005973445,0.00012202443,0.00035256328,0.00019608367,0.000045557044,0.000008906702,0.000118171294,0.00007821944,0.00019639963],"category_scores_gemma":[0.000052589072,0.00009661638,0.00005970377,0.0005327553,0.00006346842,0.00016940768,0.000049213482,0.00042874875,0.0000339885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039793985,0.00012818986,0.99127686,0.00072252215,0.000020770163,0.0000054227235,0.004386422,0.00014888782,0.00009883396,0.00015850503,0.00017554546,0.0024801048],"study_design_scores_gemma":[0.008765013,0.0009043999,0.9164903,0.0019265794,0.000037999427,0.000019855459,0.0033151072,0.00043962005,0.0009060929,0.00012118714,0.066852316,0.00022151724],"about_ca_topic_score_codex":0.040824283,"about_ca_topic_score_gemma":0.0030974478,"teacher_disagreement_score":0.074786544,"about_ca_system_score_codex":0.000703848,"about_ca_system_score_gemma":0.000515642,"threshold_uncertainty_score":0.96556294},"labels":[],"label_agreement":null},{"id":"W2996565854","doi":"10.1016/j.jval.2019.09.1510","title":"PMH36 ST. JOHN'S WORT THERAPY IS ASSOCIATED WITH A REDUCED INCIDENCE OF DEMENTIA IN PATIENTS TREATED IN GENERAL PRACTICES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dementia; Medicine; Incidence (geometry); Odds ratio; Internal medicine; Disease; Psychiatry","score_opus":0.07058589676998091,"score_gpt":0.3660012362672071,"score_spread":0.2954153394972262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996565854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965924,0.0007266442,6.233791e-7,0.0012195854,0.000088793066,0.0011624149,0.000015380117,0.0000096392005,0.00018450158],"genre_scores_gemma":[0.9984454,0.00061341556,0.0001358878,0.0006194542,0.000028139293,0.00002607655,0.000050538372,0.000012464948,0.00006865227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980555,0.0003247694,0.00062667724,0.00028553326,0.00039847894,0.0003090074],"domain_scores_gemma":[0.9988137,0.0002510929,0.0006141004,0.00017324512,0.000089467656,0.000058411864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008308141,0.00014709194,0.00053930684,0.000300577,0.000022995464,0.0000032144542,0.0000820694,0.000018232015,0.00012648944],"category_scores_gemma":[0.00027665918,0.000110903464,0.0000251007,0.0006208117,0.00004019408,0.00010829899,0.000032913205,0.00022887472,0.0000018976689],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007126652,0.00070789736,0.99342036,0.000085185755,0.00009773537,0.000019153546,0.0029940084,0.000068533416,0.00012491959,0.00001311807,0.00009417605,0.0016622694],"study_design_scores_gemma":[0.008359149,0.0032042644,0.9854414,0.0013543857,0.000012883332,0.0000010382382,0.000510559,0.000580938,0.0002760593,0.000021798764,0.0001489614,0.00008858479],"about_ca_topic_score_codex":0.024019158,"about_ca_topic_score_gemma":0.0019362167,"teacher_disagreement_score":0.022082942,"about_ca_system_score_codex":0.00028047094,"about_ca_system_score_gemma":0.00019630522,"threshold_uncertainty_score":0.98248},"labels":[],"label_agreement":null},{"id":"W2996570620","doi":"10.1016/j.jval.2019.09.2408","title":"PRO78 THE CURRENT AND FUTURE COSTS OF ORPHAN DRUGS IN CANADA - A PUBLIC PAYER BUDGET IMPACT ANALYSIS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Medicine; Drug; Population; Public health; Environmental health; Pharmacology; Bioinformatics","score_opus":0.04297398827064129,"score_gpt":0.306910077215501,"score_spread":0.2639360889448597,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996570620","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97895706,0.007471821,0.000002965047,0.01189754,0.00025314203,0.00035292236,0.0002933721,0.000002405194,0.0007687762],"genre_scores_gemma":[0.9959207,0.003099923,0.00000999488,0.00086288684,0.00006447737,0.000011962687,0.0000116648525,0.000008971095,0.000009428875],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857163,0.00006501506,0.00070039195,0.0002554453,0.000033203876,0.00037432014],"domain_scores_gemma":[0.9991409,0.00011183393,0.00031666452,0.00026115897,0.000011614054,0.00015783796],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010583402,0.0001114541,0.00049706333,0.00035595338,0.00002659657,0.000027269367,0.0001767735,0.00003229493,0.00015683747],"category_scores_gemma":[0.000025971603,0.000093178605,0.00007190515,0.0007315917,0.000020797062,0.00009108981,0.000046023477,0.00025512898,0.000014510063],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011150375,0.00004552156,0.9426829,0.00007772796,0.000058351015,2.6056236e-7,0.0005394686,0.0014648823,2.2610544e-7,0.043566454,0.00031218954,0.011240819],"study_design_scores_gemma":[0.00087758905,0.00005608239,0.82183105,0.000024129258,0.0000068217614,8.8582357e-7,0.0001698131,0.10483691,0.000002192542,0.0045848354,0.0673947,0.00021497953],"about_ca_topic_score_codex":0.8667844,"about_ca_topic_score_gemma":0.4326932,"teacher_disagreement_score":0.4340912,"about_ca_system_score_codex":0.0010951498,"about_ca_system_score_gemma":0.0008302782,"threshold_uncertainty_score":0.57765865},"labels":[],"label_agreement":null},{"id":"W2996581514","doi":"10.1016/j.jval.2019.09.2322","title":"PPM5 COSTS OF IN-HOUSE MUTATIONAL-TESTING AND IMPLICATIONS FOR ECONOMIC EVALUATION: A CASE EXAMPLE OF NON-SMALL CELL LUNG CANCER (NSCLC)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; William Osler Health System; Vancouver Coastal Health; Roche (Canada)","funders":"","keywords":"Activity-based costing; Profiling (computer programming); Medicine; Test (biology); Operations management; Business; Computer science; Accounting; Engineering","score_opus":0.39202791417122157,"score_gpt":0.4476798572754144,"score_spread":0.0556519431041928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996581514","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865174,0.0038607696,0.00092650176,0.0038314348,0.00025725385,0.003469893,0.0008041765,0.000012928652,0.00031958564],"genre_scores_gemma":[0.98898196,0.00017251223,0.0094367415,0.00064513774,0.00007475492,0.0005979281,0.000024489002,0.000040377094,0.000026074023],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99502426,0.00029726297,0.0037623474,0.00052454724,0.000053065312,0.0003385216],"domain_scores_gemma":[0.993109,0.0036979264,0.0025618153,0.00039364758,0.00011926469,0.00011838435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015408376,0.00014614085,0.000860017,0.0004960717,0.000073634044,0.000016613323,0.00013723838,0.00009869561,0.00006491917],"category_scores_gemma":[0.0009536154,0.00020668947,0.000057338508,0.0002102476,0.000037867834,0.00020727498,0.000033615404,0.00010864365,0.000026094518],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018036697,0.00011023248,0.86520827,0.002720443,0.000020132522,4.2554154e-7,0.0033048904,0.10381136,0.000016618611,0.023427716,0.00030883448,0.0010530247],"study_design_scores_gemma":[0.0033411444,0.0001694228,0.33539873,0.00054703926,0.00000990385,0.00002138435,0.0008513231,0.6520566,0.00001863388,0.0070922216,0.00021853416,0.0002750654],"about_ca_topic_score_codex":0.10212547,"about_ca_topic_score_gemma":0.004267853,"teacher_disagreement_score":0.54824525,"about_ca_system_score_codex":0.0015291723,"about_ca_system_score_gemma":0.0014928199,"threshold_uncertainty_score":0.90385354},"labels":[],"label_agreement":null},{"id":"W2996622117","doi":"10.1016/j.jval.2019.09.885","title":"PDB3 HETEROGENEITY IN RENAL COMPOSITE ENDPOINTS IN CARDIOVASCULAR OUTCOMES TRIALS IN TYPE 2 DIABETES (T2D)","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Diet and metabolism studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Renal replacement therapy; Creatinine; Internal medicine; Clinical endpoint; Renal function; Randomized controlled trial; Clinical trial; Intensive care medicine","score_opus":0.0794590413743681,"score_gpt":0.3468020962248144,"score_spread":0.2673430548504463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996622117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734725,0.023228435,8.0460904e-7,0.00094619347,0.00077511696,0.0011695771,0.000007729766,0.000018357834,0.00038128605],"genre_scores_gemma":[0.99598247,0.0028430317,0.0003453294,0.0006229526,0.00008415752,0.00003558747,0.00001309238,0.000020853884,0.000052507865],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99635667,0.0011866812,0.001153024,0.00038468066,0.0003548662,0.00056409766],"domain_scores_gemma":[0.9988424,0.00046794827,0.00014100474,0.00041071558,0.00003084817,0.00010704402],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007279383,0.0002022478,0.0023563579,0.000541081,0.00001718877,0.000008830905,0.000099029196,0.000102998594,0.000016554817],"category_scores_gemma":[0.0008550696,0.00016643177,0.00025434518,0.0005756651,0.000031237192,0.000067012836,0.00007296667,0.00034782515,0.00005021729],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015530484,0.00021014371,0.9929093,0.00037935274,0.00008228137,0.000030284626,0.0009150797,0.0010895487,0.00031100618,0.000054669614,0.000050354345,0.0038126432],"study_design_scores_gemma":[0.0049738022,0.00015631951,0.99042743,0.00066974555,0.000023645554,0.0000010324445,0.000100571284,0.00023410203,0.00038061207,0.00013084072,0.0027659757,0.0001359332],"about_ca_topic_score_codex":0.004921687,"about_ca_topic_score_gemma":0.0008077178,"teacher_disagreement_score":0.022509988,"about_ca_system_score_codex":0.00024717778,"about_ca_system_score_gemma":0.00019463591,"threshold_uncertainty_score":0.7440151},"labels":[],"label_agreement":null},{"id":"W2996636335","doi":"10.1016/j.jval.2019.09.2393","title":"PRO63 THE NATURAL HISTORY OF DUCHENNE MUSCULAR DYSTROPHY IN THE CORTICOSTEROID ERA: A SYSTEMATIC REVIEW OF STUDIES FROM CANADA AND THE US","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Vancouver Coastal Health","funders":"","keywords":"Medicine; Natural history; Life expectancy; Pediatrics; Ambulatory; Cause of death; Disease; Internal medicine; Population","score_opus":0.03416032635633043,"score_gpt":0.29450400967540474,"score_spread":0.2603436833190743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996636335","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0072411182,0.9892912,2.7396004e-7,0.00027597655,0.00027893705,0.0028767108,0.000025577652,7.336743e-7,0.000009452136],"genre_scores_gemma":[0.015748654,0.9827593,0.000005637659,0.0011416326,0.000028862512,0.00024432357,0.00004551878,0.000011048799,0.000015027389],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9959266,0.0025070326,0.0009782868,0.0002537039,0.00016002543,0.00017434779],"domain_scores_gemma":[0.9979141,0.0004726934,0.0008578118,0.00068358413,0.00005408183,0.000017733817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013401564,0.00021186612,0.0017084937,0.000025216885,0.000027830567,0.0000018714072,0.00039563014,0.00008959799,9.369115e-7],"category_scores_gemma":[0.00059709843,0.00008972788,0.00018137349,0.00009703475,0.00024904739,0.0000016086087,0.0000934205,0.00031482088,2.404495e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000026317424,0.000024338648,0.000010677832,0.99731755,0.00024236419,0.0000013246487,0.00038265658,0.000007864938,0.000004099396,0.000069451686,0.00050442846,0.0014089487],"study_design_scores_gemma":[0.0015613174,0.00038081477,0.00034880178,0.8932969,0.0015841043,0.000033275544,0.00085846824,0.000041936502,0.0000017433129,0.00013291063,0.10130905,0.00045068437],"about_ca_topic_score_codex":0.21080104,"about_ca_topic_score_gemma":0.043437995,"teacher_disagreement_score":0.16736303,"about_ca_system_score_codex":0.00014117117,"about_ca_system_score_gemma":0.001703294,"threshold_uncertainty_score":0.9740168},"labels":[],"label_agreement":null},{"id":"W2996655326","doi":"10.1016/j.jval.2019.09.489","title":"PCN294 THE IMPACT OF VALUE-BASED CARE ON ONCOLOGY SPECIALTY PHYSICIANS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Status quo; Specialty; Medicine; Workload; Family medicine; Health care; Quarter (Canadian coin); Quality (philosophy); Index (typography); Political science","score_opus":0.045495818099755496,"score_gpt":0.3041986340361171,"score_spread":0.2587028159363616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996655326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9340292,0.0022320785,0.00007926158,0.0019854794,0.0008193908,0.0006284227,0.00028413456,0.0000149718635,0.059927016],"genre_scores_gemma":[0.997682,0.00028562403,0.00011478556,0.0014722075,0.0002599981,0.000013080354,0.000010762703,0.00002666613,0.00013492384],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9983343,0.000067664965,0.0007796598,0.00033436625,0.00003856801,0.000445478],"domain_scores_gemma":[0.9984909,0.00021045147,0.00071001315,0.00048436684,0.000028085222,0.00007618169],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007544269,0.00016509966,0.00069708854,0.00020344857,0.000062255014,0.000016635204,0.00029151968,0.00011865263,0.0002282109],"category_scores_gemma":[0.00008106449,0.00014593868,0.00023594925,0.0002415329,0.000071954855,0.000097464355,0.000024563366,0.00028170354,0.00043341288],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002900426,0.00041877388,0.32372645,0.00022797823,0.00005443095,0.0000026051423,0.0056556314,0.3518425,0.00000899482,0.29452172,0.0033385772,0.019912306],"study_design_scores_gemma":[0.0032418198,0.0042047678,0.88824004,0.00027985137,0.0000040527316,0.000001389932,0.00063594285,0.017864628,0.00010483762,0.02693065,0.057987742,0.0005042784],"about_ca_topic_score_codex":0.023034863,"about_ca_topic_score_gemma":0.0002191584,"teacher_disagreement_score":0.56451356,"about_ca_system_score_codex":0.0015334768,"about_ca_system_score_gemma":0.00059039466,"threshold_uncertainty_score":0.98347086},"labels":[],"label_agreement":null},{"id":"W2996669353","doi":"10.1016/j.jval.2019.09.1786","title":"PND16 A SEMI-STANDARDIZED SYMPTOM MENU TO FACILITATE GOAL ATTAINMENT SCALING IN DEMENTIA DRUG TRIALS: COMPARISON WITH TRADITIONAL APPROACHES","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Goal Attainment Scaling; Donepezil; Dementia; Galantamine; Psychology; Vascular dementia; Disease; Medicine; Psychiatry; Gerontology; Internal medicine","score_opus":0.23451725043372423,"score_gpt":0.3714425484613226,"score_spread":0.13692529802759834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996669353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867829,0.0007521428,0.0017222071,0.0050187344,0.000102079655,0.0038568533,0.00007263313,0.00003481458,0.0016576156],"genre_scores_gemma":[0.9965281,0.00006197069,0.0021103618,0.00047233162,0.00006533943,0.00029349473,0.000119182376,0.00002442828,0.00032477817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953383,0.0011798632,0.001051171,0.00055613276,0.0011416681,0.0007328685],"domain_scores_gemma":[0.9986547,0.00052090926,0.00015984559,0.00023522526,0.000065503744,0.0003637835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007422193,0.0002321289,0.0009775376,0.00044246507,0.00007381484,0.00004233557,0.00011772525,0.00005444927,0.0002842889],"category_scores_gemma":[0.00015111167,0.00018599335,0.000103698505,0.0005028817,0.000054923727,0.0001000587,0.00005119837,0.00038983056,0.00006594026],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052625956,0.0017950041,0.95746696,0.0013175607,0.0003197159,0.00004439332,0.008441902,0.009673919,0.00035575288,0.0010270799,0.0010453345,0.013249781],"study_design_scores_gemma":[0.053438786,0.0071211257,0.8396432,0.0058506145,0.00017353689,0.00004719478,0.019044656,0.053857733,0.0021090384,0.0008635597,0.016893618,0.0009569343],"about_ca_topic_score_codex":0.000975377,"about_ca_topic_score_gemma":0.00009348254,"teacher_disagreement_score":0.11782376,"about_ca_system_score_codex":0.0007488379,"about_ca_system_score_gemma":0.0007295467,"threshold_uncertainty_score":0.75845885},"labels":[],"label_agreement":null},{"id":"W2996686534","doi":"10.1016/j.jval.2019.09.284","title":"PCN87 COST-EFFECTIVNESS ANALYSIS OF DABRAFENIB PLUS TRAMETINIB AS ADJUVANT TREATMENT FOR BRAF V600 MUTATION-POSITIVE MELANOMA AFTER SURGICAL RESECTION IN CANADA- A SOCIETAL PERSPECTIVE","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Dabrafenib; Medicine; Trametinib; Oncology; Internal medicine; Cohort; Placebo; Adverse effect; Adjuvant; Melanoma; Surgery; Metastatic melanoma; Cancer; Pathology; Vemurafenib; Cancer research","score_opus":0.1878447953967277,"score_gpt":0.4213764691044462,"score_spread":0.23353167370771852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996686534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9835947,0.002120335,0.00043388765,0.007646382,0.000381946,0.00413275,0.0012894477,0.0000119629485,0.00038858817],"genre_scores_gemma":[0.99733776,0.00013057637,0.0003726703,0.00084886287,0.000076581135,0.00092786446,0.00013809594,0.000030011593,0.00013760058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944069,0.0009518649,0.0031389869,0.0007924287,0.00015694063,0.0005529262],"domain_scores_gemma":[0.9943735,0.003426109,0.0015328007,0.00035926982,0.00011995834,0.00018838183],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0073026894,0.00024116004,0.001856155,0.0008932308,0.000079337406,0.00002508354,0.00013606931,0.00014602045,0.0002087677],"category_scores_gemma":[0.00073116657,0.00028683664,0.00028478733,0.00093154144,0.000042850086,0.00022841939,0.00001959523,0.00018197384,0.000046054345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020822817,0.0009597485,0.64078546,0.0014053603,0.0015964174,0.000033666623,0.046855908,0.23957579,0.0000018061562,0.06494912,0.00021711663,0.0015373329],"study_design_scores_gemma":[0.009896685,0.0017215614,0.7078458,0.0003259304,0.0000826273,0.00001577975,0.015261312,0.25954524,0.000025535319,0.0036742566,0.0010184979,0.00058675],"about_ca_topic_score_codex":0.94660455,"about_ca_topic_score_gemma":0.75750947,"teacher_disagreement_score":0.18909508,"about_ca_system_score_codex":0.017922021,"about_ca_system_score_gemma":0.0033836628,"threshold_uncertainty_score":0.9999584},"labels":[],"label_agreement":null},{"id":"W2996709796","doi":"10.1016/j.jval.2019.09.896","title":"PDB14 COST-EFFECTIVENESS OF CONTRAVE® IN OBESITY MANAGEMENT IN CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Medicine; Overweight; Economic evaluation; Obesity; Demography; Time horizon; Weight management; Gerontology; Internal medicine; Finance; Economics","score_opus":0.28969815379271635,"score_gpt":0.3963640760027804,"score_spread":0.10666592221006405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996709796","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98881996,0.0015181102,0.00010987906,0.0031858222,0.0006030741,0.003061461,0.00010783983,0.0000064087103,0.002587436],"genre_scores_gemma":[0.99715734,0.00032345802,0.00030231275,0.0019836864,0.00001932555,0.00012878851,0.000013458864,0.000016607375,0.00005500988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940394,0.0011906353,0.003662475,0.00048058492,0.000103332175,0.00052356155],"domain_scores_gemma":[0.99694216,0.0014116837,0.0010964901,0.00041364616,0.00001872206,0.00011727717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02477851,0.00014168472,0.0011928338,0.00043333616,0.000023204417,0.0000089304485,0.00022529453,0.00007219242,0.000098912315],"category_scores_gemma":[0.00041240032,0.00019877686,0.000038908227,0.00040723194,0.000018105093,0.00014767268,0.0000428036,0.00021213226,0.00014690767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030306006,0.00010471369,0.8977297,0.0026723277,0.000010415111,0.000003397016,0.00040190623,0.026651869,3.4907737e-7,0.07202487,0.00016742475,0.00020272074],"study_design_scores_gemma":[0.0021311126,0.000049624217,0.9678022,0.00066266826,5.1848684e-7,7.95078e-7,0.00074859837,0.019995144,0.0000034352884,0.0063294284,0.0021022432,0.00017422787],"about_ca_topic_score_codex":0.9725527,"about_ca_topic_score_gemma":0.79036295,"teacher_disagreement_score":0.18218975,"about_ca_system_score_codex":0.006648348,"about_ca_system_score_gemma":0.0012947922,"threshold_uncertainty_score":0.99716496},"labels":[],"label_agreement":null},{"id":"W2996712851","doi":"10.1016/j.jval.2019.09.2194","title":"PNS294 REVIEW OF ANALYTICAL METHODS FOR ANALYSIS OF PATIENT REPORTED OUTCOME (PRO) DATA IN THE PRESENCE OF CENSORING DUE TO DEATH","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Censoring (clinical trials); Interpretability; Computer science; Statistics; Continuation; Econometrics; Data mining; Mathematics; Machine learning","score_opus":0.6611683677528487,"score_gpt":0.6394010307986849,"score_spread":0.021767336954163774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996712851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9675325,0.0065478478,0.00504763,0.009874102,0.0005645164,0.009882285,0.00029470437,0.000017080465,0.00023931707],"genre_scores_gemma":[0.95403767,0.0019982753,0.04082948,0.002707993,0.000038304923,0.00025551152,0.000075133175,0.000027301718,0.000030304675],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98894763,0.004452704,0.0048843073,0.0005689053,0.0005348778,0.0006115902],"domain_scores_gemma":[0.9867245,0.008543487,0.0017696338,0.0023108514,0.0005072809,0.00014427879],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.020148294,0.00015818179,0.0015720353,0.0007081165,0.00007924085,0.000001716602,0.00083042204,0.00013761532,0.00006979906],"category_scores_gemma":[0.014048311,0.00011689258,0.00015313302,0.003353645,0.000045348395,0.000087518616,0.00030595018,0.0005196739,0.000003583693],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000112110465,0.00017186579,0.9435902,0.030218847,0.00008294625,0.0000026523871,0.007132178,0.004050873,0.000016595115,0.0058014225,0.00014280806,0.008677479],"study_design_scores_gemma":[0.00046904854,0.0014845132,0.3644926,0.042156972,0.0006138976,0.0000037878706,0.016830517,0.5636696,0.00021833883,0.001997935,0.007584995,0.00047779843],"about_ca_topic_score_codex":0.04014711,"about_ca_topic_score_gemma":0.0013656836,"teacher_disagreement_score":0.5790976,"about_ca_system_score_codex":0.00024641267,"about_ca_system_score_gemma":0.00073938584,"threshold_uncertainty_score":0.9942568},"labels":[],"label_agreement":null},{"id":"W2996713596","doi":"10.1016/j.jval.2019.09.509","title":"PCN314 POPULATION BASED STUDY OF BASELINE BONE DENSITY SCREENING IN PROSTATE CANCER PATIENTS TREATED WITH LONG-TERM ANDROGEN DEPRIVATION THERAPY","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Androgen deprivation therapy; Prostate cancer; Cohort; Internal medicine; Logistic regression; Bone mineral; Odds ratio; Population; Osteoporosis; Oncology; Cancer","score_opus":0.03952232571577525,"score_gpt":0.32195357712049316,"score_spread":0.2824312514047179,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996713596","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955326,0.00024422928,0.000012333864,0.0001992736,0.000031661883,0.0039428934,0.000012898719,0.000021851793,0.0000022929519],"genre_scores_gemma":[0.99897265,0.00008362517,0.0002556214,0.00026733708,0.000007951529,0.00007578284,0.00030002525,0.00002297979,0.000014008359],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829316,0.00026401674,0.00056611083,0.0002938778,0.00030989398,0.00027294309],"domain_scores_gemma":[0.9992099,0.000056472934,0.00029169445,0.000219992,0.000103777646,0.00011816739],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044441078,0.00014265017,0.0004281117,0.00026389174,0.000037718182,0.0000036638976,0.000025161773,0.000045965386,0.000013572314],"category_scores_gemma":[0.00002187928,0.0001112536,0.000018948074,0.00046075927,0.000006317748,0.00007417905,0.0000071648033,0.00013009828,0.0000015003611],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028680267,0.00218146,0.9799695,0.00026020795,0.000020345846,0.000015317386,0.0004652307,0.0017464148,0.000010459013,5.273594e-7,8.21337e-7,0.012461693],"study_design_scores_gemma":[0.018876404,0.0028683057,0.9727774,0.00066400063,0.000012615737,0.0000012899688,0.000029397892,0.0045697805,0.00012255606,0.0000016169153,9.2738276e-7,0.000075696684],"about_ca_topic_score_codex":0.09333572,"about_ca_topic_score_gemma":0.006894042,"teacher_disagreement_score":0.08644168,"about_ca_system_score_codex":0.00028200768,"about_ca_system_score_gemma":0.00023941565,"threshold_uncertainty_score":0.91270185},"labels":[],"label_agreement":null},{"id":"W2996718802","doi":"10.1016/j.jval.2019.09.632","title":"PCN439 DEVELOPING A DISCRETE-EVENT SIMULATION TO STUDY THE INFLUENCE OF WAITING TIMES ON THE EFFECTIVENESS AND COST-EFFECTIVENESS OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY IN LARGE B-CELL LYMPHOMA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Guelph; University of Waterloo","funders":"","keywords":"Medicine; Chimeric antigen receptor; Cost-effectiveness analysis; Cost effectiveness; Oncology; Lymphoma; Internal medicine; Immunotherapy; Cancer","score_opus":0.04619662143292034,"score_gpt":0.37127889652554735,"score_spread":0.325082275092627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996718802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98991776,0.00039633602,0.000065841734,0.00019309828,0.00005083443,0.009289921,0.0000075899957,0.000010416459,0.00006820403],"genre_scores_gemma":[0.9993306,0.00023001857,0.000042171665,0.00013300343,0.000016713477,0.00019622852,0.0000038420003,0.000032691434,0.000014739519],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99484503,0.0034317395,0.00049828074,0.0003659022,0.00047753964,0.0003814858],"domain_scores_gemma":[0.9944236,0.004771384,0.0002018192,0.0004183761,0.00011612322,0.00006869441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075304164,0.00018731484,0.00054126215,0.00023653731,0.00008183731,0.00001163272,0.0001863633,0.000057733483,0.000029453613],"category_scores_gemma":[0.00025970058,0.00011680933,0.000054122112,0.0008659881,0.00005117812,0.0000532055,0.000089666326,0.00021941742,0.0000058822366],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048469426,0.0017424442,0.7365907,0.0012574852,0.00006680624,0.0000032244086,0.007511181,0.09725081,0.13513765,0.00019156752,6.614515e-7,0.015400528],"study_design_scores_gemma":[0.0075945472,0.0025754126,0.9302319,0.0013583689,0.0000044643944,0.0000011354397,0.0012964626,0.01109423,0.045616012,0.000050209685,0.000055330078,0.000121896584],"about_ca_topic_score_codex":0.0031001943,"about_ca_topic_score_gemma":0.00002211394,"teacher_disagreement_score":0.19364123,"about_ca_system_score_codex":0.00035663648,"about_ca_system_score_gemma":0.0003650645,"threshold_uncertainty_score":0.4763346},"labels":[],"label_agreement":null},{"id":"W2996732096","doi":"10.1016/j.jval.2019.09.936","title":"PDB54 ECONOMIC EVALUATION OF A NEW POLYGENIC RISK SCORE TO PREVENT NEPHROPATHIES IN TYPE-2 DIABETIC PATIENTS","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Medicine; Diabetic nephropathy; Time horizon; Disease; Type 2 diabetes; Diabetes mellitus; Demography; Internal medicine; Finance; Endocrinology","score_opus":0.290316852410596,"score_gpt":0.4066461255172055,"score_spread":0.11632927310660951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996732096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873106,0.0033913911,0.000034569468,0.0045504863,0.0011637793,0.0029477817,0.00014539868,0.000015841972,0.00044013513],"genre_scores_gemma":[0.9966515,0.00038739172,0.0007764121,0.0017622004,0.000120186894,0.00008068683,0.000030242902,0.000032545493,0.00015888935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99268085,0.0012531736,0.0046766764,0.00065615296,0.00019038457,0.0005427596],"domain_scores_gemma":[0.9962201,0.0005337555,0.0022845035,0.0006401914,0.00006817735,0.00025323385],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.026880933,0.0002007664,0.0010961778,0.0008797388,0.00004790554,0.000024641526,0.00028154737,0.00013025361,0.0004856519],"category_scores_gemma":[0.0025524942,0.00026859954,0.000087105014,0.00041380004,0.000022050866,0.00028592418,0.00006818817,0.00021995515,0.0027128942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003334501,0.00020284412,0.90438306,0.00041460802,0.000018059118,6.3778806e-8,0.004004724,0.08057487,7.6355394e-7,0.006333661,0.0019469478,0.0020870592],"study_design_scores_gemma":[0.0024751576,0.0005506639,0.913453,0.000554801,0.0000067865835,4.255407e-7,0.00042553316,0.06372483,0.000008202196,0.015355882,0.0030992557,0.00034547006],"about_ca_topic_score_codex":0.044620533,"about_ca_topic_score_gemma":0.0020736267,"teacher_disagreement_score":0.042546906,"about_ca_system_score_codex":0.0030394562,"about_ca_system_score_gemma":0.0015244128,"threshold_uncertainty_score":0.99997663},"labels":[],"label_agreement":null},{"id":"W2996735042","doi":"10.1016/j.jval.2019.09.742","title":"PCV17 HEALTHCARE UTILIZATION PRIOR TO AN INITIAL DIAGNOSIS OF PAROXYSMAL SUPRVENTRICULAR TACHYCARDIA IN A LARGE HEALTHCARE SYSTEM","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vertex Pharmaceuticals (Canada)","funders":"","keywords":"Medicine; Medical diagnosis; Emergency department; Paroxysmal supraventricular tachycardia; Pediatrics; Demographics; Health care; Ventricular tachycardia; Tachycardia; Internal medicine; Emergency medicine; Cardiology; Demography; Radiology","score_opus":0.05408101590404009,"score_gpt":0.3605485894862076,"score_spread":0.30646757358216753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996735042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98810077,0.003190746,0.000031927968,0.0039511174,0.0005683849,0.0036944086,0.00033336855,0.000058276113,0.00007100906],"genre_scores_gemma":[0.9978003,0.00035268423,0.00033086166,0.0007432118,0.00017601444,0.00026022262,0.00028021092,0.000046046138,0.0000104439205],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964119,0.00076167396,0.0010141783,0.0005642641,0.00052887853,0.0007191142],"domain_scores_gemma":[0.9983856,0.00011641753,0.00023909414,0.00057814823,0.00015202045,0.00052871916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011688526,0.00023986948,0.0010520521,0.0005290489,0.000064550266,0.00001128376,0.00008123302,0.00018355812,0.00001851557],"category_scores_gemma":[0.00009584,0.00023051378,0.0001732081,0.00091300975,0.000013509638,0.00011478188,0.000058455273,0.00026827992,0.000035934634],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034925182,0.00047352433,0.9830787,0.004093016,0.000030221183,0.00031340568,0.0021784243,0.0007104233,0.0000019547533,0.0020265179,0.00003737834,0.0067071645],"study_design_scores_gemma":[0.0065004844,0.0028861419,0.97922194,0.004116242,0.000034566132,0.00015279492,0.0024511975,0.0027572757,0.00019550994,0.0000324186,0.0013849159,0.00026649138],"about_ca_topic_score_codex":0.031162249,"about_ca_topic_score_gemma":0.0012606018,"teacher_disagreement_score":0.029901646,"about_ca_system_score_codex":0.0012205195,"about_ca_system_score_gemma":0.0008290299,"threshold_uncertainty_score":0.97528934},"labels":[],"label_agreement":null},{"id":"W2996753060","doi":"10.1016/j.jval.2019.09.1323","title":"PIN82 CHOICE OF INFLUENZA IMMUNIZATION PROVIDER AND IMPACT ON IMMUNIZATION COVERAGE IN ALBERTA, CANADA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Alberta Health","funders":"","keywords":"Immunization; Medicine; Multinomial logistic regression; Public health; Pharmacy; Health care; Logistic regression; Family medicine; Population; Demography; Environmental health; Pediatrics; Immunology; Nursing; Internal medicine; Statistics","score_opus":0.051392981099729874,"score_gpt":0.37792022575970946,"score_spread":0.32652724465997957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2996753060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610066,0.0011890973,0.00000285538,0.00090187596,0.000059650534,0.0011348097,0.000012768227,0.0000064045616,0.0005919037],"genre_scores_gemma":[0.9978347,0.00051309715,0.000033047207,0.0014243837,0.000018190747,0.00001357579,0.000020488333,0.000019883524,0.00012262496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983449,0.000231149,0.0005106495,0.00019487459,0.0003790543,0.00033936327],"domain_scores_gemma":[0.99863577,0.00068003597,0.00016042133,0.00031777067,0.000115699266,0.00009027657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005231915,0.00013689346,0.0003951463,0.00027962652,0.000041960848,0.000007985514,0.00007024097,0.000060147493,0.00003063076],"category_scores_gemma":[0.0013307213,0.00011495972,0.000020436768,0.0005309366,0.00003346477,0.00011376556,0.00005450585,0.0002924872,0.000005131794],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033424766,0.00008759072,0.9699805,0.0008528001,0.000023327928,0.0000025963675,0.0011709813,0.025685176,0.00025067045,0.00021966906,0.00012492282,0.0012675398],"study_design_scores_gemma":[0.0024475341,0.0005837876,0.98851633,0.00079779304,0.000003016994,0.0000020839539,0.00011819668,0.005746825,0.0002054962,0.00003997159,0.0014470081,0.00009195669],"about_ca_topic_score_codex":0.9756513,"about_ca_topic_score_gemma":0.35202023,"teacher_disagreement_score":0.62363106,"about_ca_system_score_codex":0.0010415039,"about_ca_system_score_gemma":0.0019521269,"threshold_uncertainty_score":0.6598037},"labels":[],"label_agreement":null},{"id":"W2999858676","doi":"10.1016/j.jval.2019.10.010","title":"Association Between the Use of Surrogate Measures in Pivotal Trials and Health Technology Assessment Decisions: A Retrospective Analysis of NICE and CADTH Reviews of Cancer Drugs","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Nice; Medicine; Surrogate endpoint; Orphan drug; Cancer drugs; Cancer; Excellence; Cost effectiveness; Quality-adjusted life year; Family medicine; Internal medicine; Risk analysis (engineering); Bioinformatics; Computer science","score_opus":0.7453347584734222,"score_gpt":0.5305209856817386,"score_spread":0.21481377279168368,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2999858676","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8550405,0.028064197,0.0005338594,0.11367492,0.00006953915,0.0016947824,0.00090302236,0.0000070162646,0.000012176291],"genre_scores_gemma":[0.95788175,0.038109604,0.0020423664,0.0018258006,0.000035848432,0.000076213124,0.000012398494,0.000010864451,0.000005143443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98744875,0.0031089808,0.008485495,0.0004731827,0.0001820741,0.00030149604],"domain_scores_gemma":[0.98559374,0.0047657806,0.009136151,0.00029100277,0.0001024547,0.00011087579],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06901321,0.00013159472,0.003452017,0.00085882907,0.00006314393,0.000013771887,0.0001439995,0.00013219232,0.000015723837],"category_scores_gemma":[0.0180042,0.00012649705,0.00012160675,0.0016308493,0.00007063319,0.00015624842,0.000057096342,0.00025488005,0.0000010203626],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000106590805,0.000035252382,0.98731446,0.00042143156,0.0002625621,3.561953e-8,0.0036197864,0.001307265,9.0218197e-7,0.0048932303,0.00032615132,0.0018082365],"study_design_scores_gemma":[0.00082249305,0.00019267204,0.9840247,0.0004019821,0.000059337777,7.641886e-8,0.0008968515,0.009977476,0.0000027520357,0.0019017011,0.0016261309,0.00009382631],"about_ca_topic_score_codex":0.062158585,"about_ca_topic_score_gemma":0.005831621,"teacher_disagreement_score":0.11184912,"about_ca_system_score_codex":0.0013221202,"about_ca_system_score_gemma":0.00056539796,"threshold_uncertainty_score":0.9902676},"labels":[],"label_agreement":null},{"id":"W3005936722","doi":"10.1016/j.jval.2019.12.003","title":"Economic Evaluation of Sequences of Biological Treatments for Patients With Moderate-to-Severe Rheumatoid Arthritis and Inadequate Response or Intolerance to Methotrexate in France","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":21,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Rheumatoid arthritis; Methotrexate; Medicine; Internal medicine; Physical therapy","score_opus":0.09013654746989737,"score_gpt":0.34934846832493693,"score_spread":0.2592119208550396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3005936722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99472404,0.001640533,0.00034993727,0.0020111443,0.00004899431,0.001046894,0.00017026404,0.000004857247,0.0000033373485],"genre_scores_gemma":[0.9890447,0.0005738343,0.009836565,0.00045056498,0.0000025541224,0.0000719228,0.000008304036,0.0000058852706,0.000005672573],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99776906,0.0011716522,0.00049980986,0.0003089916,0.000039584174,0.00021089229],"domain_scores_gemma":[0.9991137,0.0005196938,0.00015606712,0.00009335464,0.00006549732,0.00005173346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015662038,0.00011513565,0.00048210283,0.00009043283,0.000029790013,0.0000031522543,0.00008047483,0.000108758286,0.000030835046],"category_scores_gemma":[0.00047435286,0.00007926691,0.000022226479,0.00017392251,0.00008289466,0.000037523765,0.000026858059,0.00008220655,0.0000023354717],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08521817,0.0009709942,0.31590283,0.00043893157,0.00025667957,0.0000036410436,0.007923729,0.028849237,0.023311486,0.00056856085,0.00012681863,0.5364289],"study_design_scores_gemma":[0.029194858,0.028009932,0.84934837,0.0025013944,0.000037327023,0.000009093954,0.00049506343,0.017735148,0.06905112,0.0019915353,0.0009281724,0.0006980241],"about_ca_topic_score_codex":0.000530622,"about_ca_topic_score_gemma":0.000094969364,"teacher_disagreement_score":0.5357309,"about_ca_system_score_codex":0.000080268495,"about_ca_system_score_gemma":0.00021735973,"threshold_uncertainty_score":0.32324108},"labels":[],"label_agreement":null},{"id":"W3010732428","doi":"10.1016/j.jval.2019.11.004","title":"Using Data From Routine Care to Estimate the Effectiveness and Potential Limitations of Outcomes-Based Contracts for Diabetes Medications","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Toronto","funders":"Arnold Ventures","keywords":"Sitagliptin; Medicine; Dulaglutide; Exenatide; Glipizide; Canagliflozin; Hypoglycemia; Diabetes mellitus; Internal medicine; Type 2 diabetes; Endocrinology","score_opus":0.16055804221929282,"score_gpt":0.4034613075485288,"score_spread":0.242903265329236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3010732428","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96599936,0.0005697734,0.007859001,0.023063662,0.00007882734,0.0020483509,0.0003439526,0.000019807258,0.00001724159],"genre_scores_gemma":[0.9848108,0.000010949342,0.012936862,0.0016965286,0.000030527277,0.00006158266,0.00044122318,0.000010558585,9.370355e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992067,0.0001079963,0.00021529899,0.00019421201,0.00011652626,0.00015925383],"domain_scores_gemma":[0.99840647,0.0010935109,0.00007690385,0.0002563482,0.00004464136,0.00012213424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037808807,0.00007536696,0.0002550624,0.000045776866,0.00006293065,0.000009040251,0.000091157824,0.000018761213,0.0000017669909],"category_scores_gemma":[0.00074728404,0.00005348455,0.000023989527,0.00012328505,0.000027046937,0.000037180114,0.000052841042,0.000042644744,8.7631815e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047003155,0.00059138157,0.8883508,0.002902212,0.00064252707,0.000006327654,0.003264261,0.063573085,0.001863844,0.0012599443,0.00027982774,0.036795784],"study_design_scores_gemma":[0.0036325066,0.0004859642,0.75026023,0.00041371305,0.00035734754,6.3412536e-8,0.0002664967,0.24343362,0.00035427336,0.00011593162,0.0006085828,0.00007124763],"about_ca_topic_score_codex":0.00051823905,"about_ca_topic_score_gemma":0.000040783427,"teacher_disagreement_score":0.17986053,"about_ca_system_score_codex":0.000056002304,"about_ca_system_score_gemma":0.00015056937,"threshold_uncertainty_score":0.21810366},"labels":[],"label_agreement":null},{"id":"W3012421263","doi":"10.1016/j.jval.2017.08.248","title":"Economic Evaluation of Nivolumab (NIVO) Plus Ipilimumab (IPI) Combination as First-Line Treatment for Patients with Advanced Melanoma in Canada","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Ipilimumab; Nivolumab; Medicine; Pembrolizumab; Internal medicine; Oncology; Discontinuation; Clinical trial; Population; Cost effectiveness; Cancer; Immunotherapy","score_opus":0.26104725874053547,"score_gpt":0.4041042178493367,"score_spread":0.14305695910880123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3012421263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853825,0.0006957493,0.00009640529,0.00816618,0.0006929304,0.003811316,0.00054040464,0.00000907814,0.0006054249],"genre_scores_gemma":[0.99783397,0.00022202742,0.0006947847,0.00039738673,0.000060551938,0.00053651776,0.00015953998,0.00003562049,0.00005960215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99502164,0.00032992044,0.003391597,0.00059853843,0.00018247428,0.00047585013],"domain_scores_gemma":[0.9943376,0.00071468594,0.0038961545,0.0007663166,0.00013620398,0.00014901698],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0085858675,0.00022622601,0.0011376583,0.0003388743,0.00027596962,0.000037300877,0.00029979256,0.00008887517,0.00007753686],"category_scores_gemma":[0.0014658163,0.00027287356,0.00006162849,0.00007417805,0.000042703345,0.00047388658,0.000028861818,0.000092957576,0.00004002048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0004143463,0.00049270224,0.76700526,0.00071858574,0.000059465237,4.898943e-7,0.0017658843,0.20170979,6.9159455e-8,0.020939285,0.00031577577,0.006578336],"study_design_scores_gemma":[0.024507515,0.001646431,0.62883013,0.0003970229,0.000010244263,7.46815e-7,0.00044039934,0.33123437,0.0000054021148,0.010710209,0.0018571742,0.00036033668],"about_ca_topic_score_codex":0.9278911,"about_ca_topic_score_gemma":0.9150971,"teacher_disagreement_score":0.13817513,"about_ca_system_score_codex":0.021639679,"about_ca_system_score_gemma":0.0060388134,"threshold_uncertainty_score":0.99997234},"labels":[],"label_agreement":null},{"id":"W3013595319","doi":"10.1016/j.jval.2020.01.016","title":"Addressing Challenges of Economic Evaluation in Precision Medicine Using Dynamic Simulation Modeling","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Operations and Scheduling Optimization","field":"Health Professions","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Alberta Bone and Joint Health Institute; University of Calgary","funders":"National Cancer Institute; National Human Genome Research Institute; Arthritis Society; ZonMw; National Institute for Health and Care Research; Genome Canada","keywords":"Computer science; Psychological intervention; Context (archaeology); Risk analysis (engineering); Management science; Discrete event simulation; Precision medicine; Health care; Data science; Simulation; Medicine; Engineering","score_opus":0.637103806670257,"score_gpt":0.563617939581778,"score_spread":0.07348586708847904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3013595319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9219491,0.003798885,0.056953013,0.014698153,0.00042485315,0.0019286494,0.0000070308147,0.000033471966,0.00020687691],"genre_scores_gemma":[0.9904879,0.0011702747,0.007754863,0.00034185528,0.00015450313,0.00003067489,0.000033935605,0.000024461668,0.0000015353976],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9953612,0.0020752607,0.0016024604,0.00034283006,0.00029315142,0.00032509537],"domain_scores_gemma":[0.99852884,0.00056019996,0.0004151188,0.00018375962,0.00018477917,0.00012729403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050317915,0.00012233385,0.0004159604,0.0003177812,0.00022725339,0.0000037385503,0.00008681858,0.00017964469,0.00007478611],"category_scores_gemma":[0.0010273553,0.00012120001,0.000021936969,0.00030576062,0.000018142653,0.00021883311,0.00003269145,0.00041546818,0.000006768856],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004283838,0.000016618613,0.0020480994,0.00055812136,0.0000016942531,2.3715658e-7,0.013968526,0.9718613,0.000050324918,0.000572493,0.0000015365998,0.010878201],"study_design_scores_gemma":[0.0010767634,0.00010621078,0.0014465395,0.002358568,0.0000042038973,1.7279577e-7,0.0032240308,0.9909251,9.889033e-7,0.0007664699,0.000009792073,0.00008119775],"about_ca_topic_score_codex":0.0077950526,"about_ca_topic_score_gemma":0.0011068067,"teacher_disagreement_score":0.06853883,"about_ca_system_score_codex":0.0011680722,"about_ca_system_score_gemma":0.0015541511,"threshold_uncertainty_score":0.99881214},"labels":[],"label_agreement":null},{"id":"W3014922133","doi":"10.1016/j.jval.2020.01.011","title":"How Are Incremental Cost-Effectiveness, Contextual Considerations, and Other Benefits Viewed in Health Technology Assessment Recommendations in the United States?","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Canadian Institutes of Health Research","keywords":"Health technology; Risk analysis (engineering); Actuarial science; Computer science; Business; Economics; Health care; Economic growth","score_opus":0.5350898077037821,"score_gpt":0.46058443854014264,"score_spread":0.07450536916363948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3014922133","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35753912,0.0039423923,0.0007107445,0.6337817,0.00013430757,0.0032130885,0.000598487,0.000034053177,0.00004613642],"genre_scores_gemma":[0.9073755,0.0016495531,0.0015159597,0.08864283,0.000052065563,0.00058494933,0.00014801759,0.000026792946,0.000004335736],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923644,0.0031848885,0.0032121097,0.00060639495,0.00010154967,0.00053066754],"domain_scores_gemma":[0.9953702,0.0023869926,0.0017385045,0.00030030258,0.00003955744,0.00016442181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020653274,0.00020702751,0.0010037614,0.0008555992,0.00023597744,0.00011470686,0.00018232991,0.00012947767,0.000059265527],"category_scores_gemma":[0.0024709264,0.00023222607,0.00003382175,0.00093114184,0.00008835936,0.0002678024,0.00005863071,0.0005265392,0.000027629481],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024434796,0.00030544016,0.5758156,0.0010556764,0.000023884446,0.000003070409,0.008399256,0.00917813,7.3275135e-7,0.40000105,0.004435682,0.0007570322],"study_design_scores_gemma":[0.010163111,0.0011661593,0.47875258,0.0023643605,0.000004257116,0.000031119656,0.08603553,0.17490359,0.0000045098395,0.039307773,0.20631574,0.00095125695],"about_ca_topic_score_codex":0.022775859,"about_ca_topic_score_gemma":0.007809768,"teacher_disagreement_score":0.5498364,"about_ca_system_score_codex":0.0015476051,"about_ca_system_score_gemma":0.0005175924,"threshold_uncertainty_score":0.98373157},"labels":[],"label_agreement":null},{"id":"W3015554102","doi":"10.1016/j.jval.2019.11.003","title":"Critical Appraisal of Published Indirect Comparisons and Network Meta-Analyses of Competing Interventions for Multiple Myeloma","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Health Evaluation and Outcome Sciences","funders":"National Cancer Institute; Amgen","keywords":"Medicine; Credibility; Randomized controlled trial; Psychological intervention; Pharmacoeconomics; Checklist; Outcomes research; Meta-analysis; Relevance (law); Alternative medicine; Family medicine; Medical physics; Psychology; Intensive care medicine; Psychiatry; Internal medicine; Pathology","score_opus":0.5210599431721261,"score_gpt":0.5482646029242919,"score_spread":0.027204659752165794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015554102","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000040966483,0.99525815,0.00087893184,0.00066153554,0.00013783346,0.0022942948,0.00065341574,0.000022864604,0.000052022282],"genre_scores_gemma":[0.00905855,0.9525027,0.037013568,0.000028021455,0.00018210801,0.00040364533,0.000741741,0.000059789716,0.000009822817],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99510163,0.0012632766,0.0021839978,0.0005218606,0.00039872777,0.0005304969],"domain_scores_gemma":[0.9845425,0.013659495,0.0007845056,0.0003794922,0.00019844044,0.0004355725],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018309213,0.0003485772,0.0062718913,0.0003600447,0.000081894126,0.000026263422,0.00018086292,0.00017103969,0.000054414835],"category_scores_gemma":[0.013978428,0.00025194316,0.0016706066,0.00071015273,0.00017872818,0.00006528359,0.00014531518,0.00051123183,0.0000018635982],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035907043,0.0018011716,0.012948689,0.4918999,0.01955181,0.000056699286,0.00031474922,0.0000976221,9.966263e-7,0.0013177397,0.004402502,0.46724904],"study_design_scores_gemma":[0.008330068,0.0047838558,0.0066418382,0.1435049,0.04221664,0.00015845503,0.00039560467,0.017766481,0.000012861358,0.00015364763,0.7752034,0.0008322194],"about_ca_topic_score_codex":0.0016303719,"about_ca_topic_score_gemma":0.00012546846,"teacher_disagreement_score":0.77080095,"about_ca_system_score_codex":0.00011595409,"about_ca_system_score_gemma":0.0008701675,"threshold_uncertainty_score":0.99999326},"labels":[],"label_agreement":null},{"id":"W3017315152","doi":"10.1016/j.jval.2020.03.001","title":"Criteria and Process for Initiating and Developing an ISPOR Good Practices Task Force Report","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":32,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Stakeholder; Outcomes research; Pharmacoeconomics; Relevance (law); Task force; Task (project management); Health care; Transparency (behavior); Health economics; Process (computing); Medicine; Management science; Health technology; Best practice; Process management; Engineering ethics; Computer science; Public relations; Business; Political science; Alternative medicine; Engineering; Management; Economics","score_opus":0.6836882030997739,"score_gpt":0.5277028102109224,"score_spread":0.1559853928888515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3017315152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84625226,0.0029215866,0.008125972,0.14036435,0.0002386614,0.0015440885,0.00014461282,0.000056535482,0.00035192468],"genre_scores_gemma":[0.94668686,0.00027265746,0.026389452,0.0259761,0.00038946207,0.00017076805,0.000051199706,0.000038202797,0.000025266574],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9954478,0.00027262507,0.0031805607,0.0006646259,0.000058107893,0.00037625435],"domain_scores_gemma":[0.9945438,0.0010385638,0.0038991952,0.0001860152,0.000056075103,0.00027638543],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015377335,0.00014629953,0.0007191431,0.00014690968,0.00023193083,0.000107067826,0.00011045087,0.00009264882,0.000010959588],"category_scores_gemma":[0.0114110485,0.0001945039,0.000022308446,0.00016500553,0.00003236306,0.00092418084,0.000035961573,0.00014467681,0.000009661916],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017058883,0.00018497171,0.6245667,0.031933255,0.000095307594,0.00002463847,0.093747504,0.0012290805,0.000019159215,0.24347465,0.002230652,0.002323516],"study_design_scores_gemma":[0.0051130033,0.0016844713,0.13560154,0.0016375869,0.000017884222,0.00028851724,0.02816788,0.6358359,0.00003284006,0.10980994,0.079950154,0.0018603094],"about_ca_topic_score_codex":0.0019879248,"about_ca_topic_score_gemma":0.00011816508,"teacher_disagreement_score":0.6346068,"about_ca_system_score_codex":0.00019575065,"about_ca_system_score_gemma":0.00051302405,"threshold_uncertainty_score":0.99691623},"labels":[],"label_agreement":null},{"id":"W3020992630","doi":"10.1016/j.jval.2012.03.236","title":"PMS47 Parents' Willingness-to-Pay for Biologic Treatments in Juvenile Idiopathic Arthritis","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Cancer Agency; Hospital for Sick Children","funders":"","keywords":"Willingness to pay; Medicine; Etanercept; Confidence interval; Juvenile; Arthritis; Internal medicine; Economics","score_opus":0.14802877914566942,"score_gpt":0.43588684877928724,"score_spread":0.2878580696336178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3020992630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9690615,0.012604307,0.00048411227,0.00896653,0.003301909,0.0051247845,0.00020583266,0.00012186768,0.00012914554],"genre_scores_gemma":[0.990214,0.0029127253,0.00091706845,0.0032819537,0.0014287576,0.0008835282,0.000084184125,0.000046030123,0.00023175016],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99430764,0.0015528314,0.0015664609,0.00043310292,0.00021936791,0.0019205837],"domain_scores_gemma":[0.99793637,0.0006167647,0.0003782515,0.00033919647,0.00007188576,0.00065752823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039893133,0.0002618856,0.00075814873,0.00030035392,0.0004753717,0.000004896543,0.00019070032,0.000376956,0.000050753068],"category_scores_gemma":[0.0005811542,0.00020959416,0.000079434576,0.0006555994,0.000017313987,0.00013928852,0.00007064241,0.0007782014,0.000318145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009729924,0.00026378172,0.97492653,0.0010689835,0.0000031795594,0.000003180227,0.006545941,0.00006897527,0.0000030321041,0.00048355467,0.0010787108,0.015456821],"study_design_scores_gemma":[0.005659947,0.00097571395,0.9184109,0.0040959343,0.000009545508,0.0000035593957,0.0039223866,0.00054230116,0.000006635204,0.0019410291,0.063876845,0.0005551883],"about_ca_topic_score_codex":0.010119868,"about_ca_topic_score_gemma":0.0011574596,"teacher_disagreement_score":0.062798135,"about_ca_system_score_codex":0.0011919743,"about_ca_system_score_gemma":0.0012066544,"threshold_uncertainty_score":0.9964718},"labels":[],"label_agreement":null},{"id":"W3022659013","doi":"10.1016/j.jval.2020.01.021","title":"Associations Between End-of-Life Expenditures and Hospice Stay Length Vary by Clinical Condition and Expenditure Duration","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University","funders":"Federal Office of Rural Health Policy; Office of the Vice President for Research, University of South Carolina; U.S. Department of Health and Human Services","keywords":"Medicine; COPD; Dementia; Reimbursement; Intensive care unit; Emergency medicine; Disease; Gerontology; Demography; Health care; Intensive care medicine; Internal medicine","score_opus":0.21075281912268728,"score_gpt":0.45832047393969183,"score_spread":0.24756765481700455,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3022659013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981128,0.00888632,0.00035433436,0.008400445,0.000105510175,0.00041983227,0.0005309438,0.000026903333,0.00014771704],"genre_scores_gemma":[0.99096566,0.00537547,0.0013021072,0.0014119518,0.00032594914,0.0000073322017,0.0005881782,0.000013046288,0.000010297711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815077,0.00031860196,0.00085124915,0.0002597744,0.00024960184,0.00016999185],"domain_scores_gemma":[0.9982575,0.0008862364,0.00043266563,0.00010410645,0.00004740968,0.00027204235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005885967,0.00012056886,0.0006056039,0.000066392786,0.000052827367,0.0000071547233,0.00004426093,0.00015383426,0.000026252148],"category_scores_gemma":[0.00091417204,0.00011311015,0.000046065717,0.00009827242,0.00009894619,0.00011470612,0.000026671813,0.0002805242,0.0000016250119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008142496,0.00009721494,0.98119366,0.00038020543,0.000080901635,0.0000035915618,0.0050442494,0.000009441147,0.00017985686,0.0004894161,0.00957554,0.002864472],"study_design_scores_gemma":[0.003753032,0.001646594,0.96902066,0.0007751015,0.00008751971,0.000001755919,0.0025648274,0.00060903846,0.0017760393,0.0004549754,0.019090613,0.0002198374],"about_ca_topic_score_codex":0.0011255936,"about_ca_topic_score_gemma":0.000017936358,"teacher_disagreement_score":0.01217302,"about_ca_system_score_codex":0.00005349131,"about_ca_system_score_gemma":0.00022075245,"threshold_uncertainty_score":0.4612498},"labels":[],"label_agreement":null},{"id":"W3024185595","doi":"10.1016/j.jval.2020.03.003","title":"Estimation of an Instrument-Defined Minimally Important Difference in EQ-5D-5L Index Scores Based on Scoring Algorithms Derived Using the EQ-VT Version 2 Valuation Protocols","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Queen's University; Queen's University Belfast; Health Research Board","keywords":"Valuation (finance); Statistics; EQ-5D; Index (typography); Mathematics; Standard deviation; Algorithm; Population; Consistency (knowledge bases); Consistency index; Econometrics; Medicine; Computer science; Economics; Finance; Internal medicine; Physics","score_opus":0.4940096939819453,"score_gpt":0.41816122914842163,"score_spread":0.07584846483352364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024185595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9680958,0.000117295844,0.011243587,0.010940273,0.00014062713,0.00930459,0.00009315377,0.000031577165,0.00003312458],"genre_scores_gemma":[0.982285,0.00002093301,0.013127452,0.0034600794,0.000091213675,0.00093179755,0.000050458286,0.00003132688,0.0000017173354],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9931557,0.0010481741,0.0044364557,0.00063650764,0.0002718755,0.00045128915],"domain_scores_gemma":[0.99551415,0.0008016547,0.0029742315,0.00046153058,0.000050526127,0.00019792137],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012792042,0.00022933463,0.00086881855,0.00047966445,0.00017131795,0.00006359168,0.0003307137,0.00013276514,0.00003560282],"category_scores_gemma":[0.003091341,0.00024746297,0.00006962216,0.0005600449,0.00006199786,0.0004024335,0.000051915868,0.0002965838,0.000022707494],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002584267,0.00031534003,0.37383118,0.0015259926,0.000012674515,0.0000018567143,0.0040013045,0.6113739,0.000114652896,0.0048918617,0.000025171636,0.0036476671],"study_design_scores_gemma":[0.0015375834,0.0005086516,0.17575647,0.0008004791,0.0000018194187,6.585945e-7,0.00042904407,0.8186834,0.000090354784,0.0020038679,0.000019749785,0.0001679334],"about_ca_topic_score_codex":0.0095716035,"about_ca_topic_score_gemma":0.00025598335,"teacher_disagreement_score":0.20730951,"about_ca_system_score_codex":0.0011929246,"about_ca_system_score_gemma":0.0009783693,"threshold_uncertainty_score":0.99999774},"labels":[],"label_agreement":null},{"id":"W3024460317","doi":"10.1016/j.jval.2020.04.046","title":"MS3 PREDICTING OPTIMAL TREATMENT REGIMENS FOR HR+/HER2- BREAST CANCER BASED ON ELECTRONIC HEALTH RECORDS USING RANDOM FOREST","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Regimen; Medicine; Cohort; Proportional hazards model; Breast cancer; Oncology; Random forest; Internal medicine; Cancer; Machine learning; Computer science","score_opus":0.03991685157468309,"score_gpt":0.35201333159086773,"score_spread":0.3120964800161846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024460317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6946063,0.0025987008,0.04747404,0.25035033,0.0005806348,0.003909273,0.0001313701,0.00022424156,0.00012510185],"genre_scores_gemma":[0.9690816,0.0010055908,0.012017891,0.016388882,0.0011317456,0.0001482876,0.000075327465,0.00009781266,0.00005287612],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99728847,0.0002793386,0.00064945826,0.00052941387,0.00030758575,0.0009457659],"domain_scores_gemma":[0.9984792,0.0003611699,0.00029198625,0.00022662643,0.00004448707,0.00059656193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011940632,0.00025526574,0.0007391843,0.0001458469,0.00022946752,0.000022332664,0.00009218541,0.00007509416,0.00003141337],"category_scores_gemma":[0.0002729619,0.00021595618,0.00014996708,0.00030031096,0.0000454335,0.000043198856,0.000014702772,0.0005492008,0.0000017991465],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004629133,0.00048257006,0.112579376,0.0014608692,0.000104337254,0.000029148843,0.001829588,0.8057403,0.00008170919,0.0002027518,0.001670314,0.07118991],"study_design_scores_gemma":[0.0110032195,0.003262615,0.0032455176,0.0011424326,0.000036112437,0.00004102331,0.00009869775,0.9749967,0.000013553298,0.000025462978,0.0059916815,0.00014298875],"about_ca_topic_score_codex":0.020719867,"about_ca_topic_score_gemma":0.00016063251,"teacher_disagreement_score":0.27447528,"about_ca_system_score_codex":0.0021631138,"about_ca_system_score_gemma":0.0031325987,"threshold_uncertainty_score":0.9858012},"labels":[],"label_agreement":null},{"id":"W3024870800","doi":"10.1016/j.jval.2020.04.014","title":"CE2 APPLICATION OF PROPENSITY SCORE MATCHING AND BAYESIAN HIERARCHICAL DESIGN METHODS TO INTEGRATE SINGLE-ARM STUDIES INTO NETWORK META-ANALYSES (NMAS): OPPORTUNITIES AND PITFALLS ILLUSTRATED IN A CASE STUDY ASSESSING ABLATION/RADIATION THERAPIES IN LUNG CANCER","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Observational study; Propensity score matching; Comparative effectiveness research; Covariate; Meta-analysis; Matching (statistics); Medicine; Bayesian probability; Statistics; Randomized controlled trial; Weighting; Mathematics; Internal medicine; Pathology; Radiology","score_opus":0.927848190614603,"score_gpt":0.6171876414016051,"score_spread":0.3106605492129979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024870800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74493563,0.012866807,0.23650849,0.0032567515,0.000029548744,0.002388814,0.0000027736914,0.0000049503756,0.000006233189],"genre_scores_gemma":[0.9233966,0.0003526491,0.07563932,0.00035227844,0.000027256221,0.00021152096,0.0000018126375,0.000011797763,0.0000067728442],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.95567,0.035526387,0.006385931,0.00097413,0.0011521615,0.0002913899],"domain_scores_gemma":[0.9907128,0.0056752996,0.0024534392,0.00056944386,0.0004012275,0.00018773937],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08448912,0.0002976286,0.0036975173,0.00062829285,0.0001687696,0.00036896308,0.00027108146,0.00006224804,0.000027708842],"category_scores_gemma":[0.0051925033,0.00016767206,0.00017368716,0.0025323185,0.00007909353,0.0004004542,0.000113786846,0.00025917136,4.6828725e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008351859,0.0003539997,0.30282024,0.0009998579,0.0017518027,0.00010305171,0.16117464,0.3504971,0.00034750465,0.0007817272,0.00007716148,0.18100941],"study_design_scores_gemma":[0.00067923,0.0005880507,0.07218745,0.00044074617,0.0012639854,0.000032158143,0.10797609,0.80342066,0.00004097478,0.0128526725,0.00006932701,0.00044862682],"about_ca_topic_score_codex":0.010718104,"about_ca_topic_score_gemma":0.0053137993,"teacher_disagreement_score":0.4529236,"about_ca_system_score_codex":0.00016406231,"about_ca_system_score_gemma":0.0002660557,"threshold_uncertainty_score":0.99586964},"labels":[],"label_agreement":null},{"id":"W3025089949","doi":"10.1016/j.jval.2020.04.093","title":"PBI27 TRENDS IN AVERAGE SALES PRICES OF BIOLOGICS REIMBURSED BY THE MEDICARE PART B PROGRAM (FIRST QUARTER 2010-FIRST QUARTER 2020)","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Biosimilar; Medicine; Medicaid; Family medicine; Actuarial science; Business; Internal medicine; Health care; Economics","score_opus":0.048426148946019404,"score_gpt":0.3161614695657245,"score_spread":0.26773532061970506,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025089949","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29574254,0.04520002,0.00033573806,0.6499808,0.002965445,0.0028035084,0.0007534197,0.00031939408,0.0018991416],"genre_scores_gemma":[0.9935315,0.0016603942,0.0008449969,0.003387723,0.00010944688,0.00007081101,0.00017017192,0.00001825852,0.00020664492],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99706274,0.00091612997,0.0008734682,0.00047243977,0.00008314071,0.0005920585],"domain_scores_gemma":[0.9986701,0.0006025209,0.0002880422,0.00032013797,0.00003387042,0.00008532382],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013033071,0.0002392253,0.0006079704,0.00009889976,0.0001259825,0.000013641682,0.00041427417,0.00042620004,0.00044032533],"category_scores_gemma":[0.0001865031,0.0001471338,0.0001322085,0.00066865276,0.00044122478,0.000044195465,0.00007355124,0.0006867231,0.00003224145],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010569998,0.0023311349,0.09858924,0.001138535,0.00034790282,0.000048211794,0.013143524,0.0001501206,0.0023518128,0.0014695723,0.769499,0.109873936],"study_design_scores_gemma":[0.0037725165,0.0057138205,0.05665585,0.00050973723,0.000058797857,0.00003129006,0.002954678,0.0017230156,0.0013645475,0.00041132796,0.9261424,0.0006620248],"about_ca_topic_score_codex":0.0009261159,"about_ca_topic_score_gemma":0.00053293636,"teacher_disagreement_score":0.697789,"about_ca_system_score_codex":0.000054435233,"about_ca_system_score_gemma":0.000082105376,"threshold_uncertainty_score":0.59999424},"labels":[],"label_agreement":null},{"id":"W3025490551","doi":"10.1016/j.jval.2020.04.013","title":"CE1 METHODOLOGICAL CHALLENGES WITH CONDUCTING NETWORK META-ANALYSES ASSESSING LONG-TERM COMPARATIVE EFFICACY IN PSORIASIS: A CRITIQUE OF ASSUMPTIONS UNDERPINNING RECENT INDIRECT TREATMENT COMPARISONS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; EVERSANA (Canada)","funders":"","keywords":"Psoriasis; Term (time); Randomized controlled trial; Placebo; Medicine; Underpinning; Surgery; Alternative medicine; Physics; Engineering","score_opus":0.9900690591832846,"score_gpt":0.6957327199012941,"score_spread":0.29433633928199043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025490551","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79581827,0.09121222,0.08047862,0.026882157,0.00025010356,0.0037470853,0.000024541401,0.00003873111,0.001548274],"genre_scores_gemma":[0.9205584,0.0015921737,0.07733022,0.00028095668,0.0000831756,0.000114737675,0.000009846153,0.000014244085,0.000016262415],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.90673393,0.07850649,0.0102023585,0.0015160345,0.0024196804,0.000621522],"domain_scores_gemma":[0.96633977,0.025215494,0.006259451,0.0013553598,0.0004955433,0.00033438433],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.0797844,0.0004893006,0.010049213,0.00048609648,0.00022212697,0.00029548287,0.0007436474,0.00012216081,0.0006847942],"category_scores_gemma":[0.012748356,0.00023693407,0.0011747574,0.0029784422,0.000118018164,0.000258061,0.000094660914,0.00045352135,0.000032875585],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015484757,0.0018311291,0.1495695,0.000754389,0.009683888,0.000073522795,0.030181147,0.7759686,0.00009959756,0.0053282725,0.0011701208,0.025185],"study_design_scores_gemma":[0.0056029786,0.003752006,0.7191036,0.0026735347,0.012559866,0.00008872615,0.079803735,0.16510864,0.00065914885,0.003596068,0.005087058,0.0019646701],"about_ca_topic_score_codex":0.00041892234,"about_ca_topic_score_gemma":0.00077830866,"teacher_disagreement_score":0.61085993,"about_ca_system_score_codex":0.00024816298,"about_ca_system_score_gemma":0.00044684182,"threshold_uncertainty_score":0.9955677},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"theoretical_or_conceptual","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W3025523126","doi":"10.1016/j.jval.2020.04.057","title":"PAM4 SOCIOECONOMIC DIFFERENTIALS OF CHILD STUNTING IN RURAL AND URBAN AREAS OF ZAMBIA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Child Nutrition and Water Access","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Socioeconomic status; Residence; Geography; Socioeconomics; Malnutrition; Odds; Rural area; Logistic regression; Environmental health; Demography; Quarter (Canadian coin); Household income; Disadvantaged; Medicine; Population; Economic growth; Economics; Sociology","score_opus":0.026606704307170163,"score_gpt":0.27854364178570673,"score_spread":0.25193693747853657,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025523126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9826344,0.0006626286,0.000004627126,0.016171193,0.00012976659,0.00028555558,0.000019341436,0.000013448437,0.00007901454],"genre_scores_gemma":[0.9983452,0.000081908656,0.000049525566,0.0014062915,0.000091381036,0.0000026026635,0.000009885087,0.000011936118,0.000001253638],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99883705,0.00016659603,0.0005819518,0.00015470438,0.00007376163,0.00018592257],"domain_scores_gemma":[0.9995414,0.00008088537,0.00020526117,0.00008374112,0.000013513445,0.000075203745],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023655551,0.00008473258,0.00036510493,0.00011054719,0.00003165537,0.000012221521,0.000086309155,0.000044859848,0.000023548973],"category_scores_gemma":[0.00004573739,0.00008917961,0.000038717804,0.0000955273,0.000041506733,0.000075586344,0.00003863516,0.0001485249,0.0000014913962],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016217423,0.00013639808,0.9902646,0.0009238318,0.0000058842293,6.74291e-7,0.0057832277,0.00009214375,0.00025188716,0.00016885897,0.0003190857,0.0018912283],"study_design_scores_gemma":[0.002557079,0.00022216309,0.9866995,0.000817417,0.0000054482266,0.0000023757445,0.0005287961,0.0033357262,0.004750187,0.0008022577,0.0001525018,0.00012652088],"about_ca_topic_score_codex":0.0027404686,"about_ca_topic_score_gemma":0.00006698406,"teacher_disagreement_score":0.01571079,"about_ca_system_score_codex":0.000052632662,"about_ca_system_score_gemma":0.00001712426,"threshold_uncertainty_score":0.4142787},"labels":[],"label_agreement":null},{"id":"W3025552441","doi":"10.1016/j.jval.2020.04.042","title":"MD4 ERROR PROPAGATION FOR SIMULATED TREATMENT COMPARISONS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Waterloo; McMaster University","funders":"","keywords":"Covariate; Bootstrapping (finance); Statistics; Bayesian probability; Parametric statistics; Econometrics; Survival analysis; Term (time); Mathematics; Computer science","score_opus":0.7038675797499268,"score_gpt":0.48029601840201597,"score_spread":0.22357156134791079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3025552441","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3816195,0.0043133385,0.04256968,0.5614572,0.000881648,0.0071710786,0.00093578425,0.00022436977,0.00082737097],"genre_scores_gemma":[0.9708824,0.000108847344,0.0074399547,0.020748056,0.0003367144,0.0001933572,0.00013133606,0.00004060578,0.00011871915],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99506354,0.00035481498,0.0035386754,0.0005358998,0.00005794513,0.00044913692],"domain_scores_gemma":[0.99710363,0.00082643394,0.0014771683,0.0002648749,0.000034981018,0.00029293864],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005422622,0.00017027435,0.000960074,0.0001824668,0.00016166148,0.00003639167,0.00014272024,0.00009985195,0.00008372731],"category_scores_gemma":[0.0016724664,0.00020965163,0.000101077596,0.00025280906,0.000025618374,0.00018290135,0.000015919359,0.00010581269,0.0006344955],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002461894,0.00088926795,0.13937332,0.00373648,0.00014658256,0.0000021486908,0.030770116,0.51471823,0.000007652734,0.2336246,0.07522355,0.0012618519],"study_design_scores_gemma":[0.0020023056,0.00067781465,0.0057379385,0.000077862824,0.0000027112171,6.937963e-7,0.0005607779,0.81647456,0.0000071304,0.002848151,0.17138521,0.00022485715],"about_ca_topic_score_codex":0.0059121647,"about_ca_topic_score_gemma":0.00012037588,"teacher_disagreement_score":0.5892629,"about_ca_system_score_codex":0.0012946435,"about_ca_system_score_gemma":0.00040576165,"threshold_uncertainty_score":0.8937464},"labels":[],"label_agreement":null},{"id":"W3026036024","doi":"10.1016/j.jval.2020.04.1082","title":"PNS79 MONOPSONY BUYER: A CRITIQUE OF THE NATIONAL PHARMACEUTICAL PROGRAM PROPOSED FOR CANADA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Monopsony; Government (linguistics); Agency (philosophy); Prescription drug; Medical prescription; Investment (military); Business; Public economics; Political science; Public administration; Economic growth; Economics; Politics; Medicine; Law; Labour economics; Sociology","score_opus":0.1793486899776441,"score_gpt":0.37779381546604734,"score_spread":0.19844512548840323,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026036024","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30195674,0.0030369672,0.0004966047,0.6775442,0.0010420308,0.004931735,0.0024506627,0.00006089601,0.008480149],"genre_scores_gemma":[0.970869,0.00015273876,0.00093842746,0.027719384,0.00017453008,0.0000870526,0.0000055506584,0.000017474915,0.00003580783],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99854517,0.000038609727,0.0007729395,0.00025900902,0.000047494024,0.00033679407],"domain_scores_gemma":[0.99929154,0.0001395497,0.00023519555,0.000090990696,0.000037007834,0.00020573233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062129996,0.000101331105,0.0003243444,0.00004814359,0.00006137453,0.0000170224,0.0002528426,0.00004900213,0.000045035827],"category_scores_gemma":[0.00036833395,0.00009969303,0.00008523675,0.00021967757,0.000033482822,0.000052266692,0.000045521017,0.00020188015,0.0000061334954],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001513879,0.00044516218,0.02477724,0.0014560684,0.00006700765,0.0000011447105,0.0007415559,0.007906521,0.00004446936,0.91822946,0.039977822,0.0062021594],"study_design_scores_gemma":[0.0011443781,0.00012827493,0.0033925157,0.000026335756,0.0000019484796,0.000001407816,0.00001584671,0.33932513,0.00036091765,0.024521448,0.63091886,0.00016297725],"about_ca_topic_score_codex":0.14228459,"about_ca_topic_score_gemma":0.008158775,"teacher_disagreement_score":0.893708,"about_ca_system_score_codex":0.0005776845,"about_ca_system_score_gemma":0.00096088497,"threshold_uncertainty_score":0.863427},"labels":[],"label_agreement":null},{"id":"W3026074587","doi":"10.1016/j.jval.2020.04.1700","title":"PCN229 POPULATION BASED ANALYSIS OF RATES OF USE OF NOVEL HORMONAL AGENTS AT THE END-OF-LIFE IN MEN WITH CASTRATION-RESISTANT PROSTATE CANCER","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Enzalutamide; Medicine; Prostate cancer; Odds ratio; Cohort; Abiraterone acetate; Internal medicine; Cancer; Hormonal therapy; Population; Cause of death; Logistic regression; Cohort study; Oncology; Disease; Androgen deprivation therapy","score_opus":0.1936823565217613,"score_gpt":0.40062361726868073,"score_spread":0.20694126074691943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026074587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99509186,0.000742719,0.000014840624,0.0030322564,0.0000064060787,0.00073327776,0.00036409718,0.000002097003,0.000012454079],"genre_scores_gemma":[0.998994,0.00032989768,0.0003241305,0.000088221095,0.0000065871186,0.000027739334,0.00019287587,0.000007567727,0.00002897793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986158,0.00011269617,0.0005690673,0.00014813962,0.00040688843,0.00014742115],"domain_scores_gemma":[0.99916387,0.00015350823,0.00034760553,0.00013608654,0.00011805594,0.00008087583],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031731816,0.0000783796,0.00043078483,0.0002162276,0.000019209117,0.0000022041752,0.00004403081,0.000026441083,0.00004317216],"category_scores_gemma":[0.000068170026,0.000048107468,0.00005035031,0.0010732441,0.0000760772,0.000043769614,0.000014488157,0.00007646736,7.263128e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031307777,0.00019937381,0.9040653,0.00068654085,0.00021150519,0.0000024180968,0.0016071898,0.08324279,0.0065707183,0.000024217577,0.000029436038,0.00022972956],"study_design_scores_gemma":[0.0026126292,0.00052807014,0.90542156,0.00027523303,0.00010167225,1.0170104e-7,0.00018813423,0.08636661,0.0044590994,0.000001971227,0.000011119915,0.00003382185],"about_ca_topic_score_codex":0.08483866,"about_ca_topic_score_gemma":0.0051372605,"teacher_disagreement_score":0.0797014,"about_ca_system_score_codex":0.00022379593,"about_ca_system_score_gemma":0.0009998822,"threshold_uncertainty_score":0.92125547},"labels":[],"label_agreement":null},{"id":"W3026097555","doi":"10.1016/j.jval.2020.04.1618","title":"PCN128 COST-EFFECTIVENESS OF RIBOCILIB PLUS FULVESTRANT (R+F) VS FULVESTRANT (FUL) IN HORMONE RECEPTOR–POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2–NEGATIVE (HR+/HER2-) ADVANCED BREAST CANCER (ABC): A CANADIAN HEALTHCARE PERSPECTIVE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Discontinuation; Fulvestrant; Adverse effect; Internal medicine; Breast cancer; Placebo; Oncology; Cancer; Estrogen receptor","score_opus":0.23368470631295493,"score_gpt":0.3999543408166003,"score_spread":0.16626963450364537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026097555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8078067,0.0064167343,0.00030775974,0.16053067,0.00070104265,0.0069737053,0.016738957,0.00008570236,0.00043877948],"genre_scores_gemma":[0.9893142,0.0017229097,0.0011404387,0.00646345,0.0002981301,0.0007366794,0.0001912762,0.00011373831,0.000019157244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9875979,0.0035180554,0.0053763646,0.0016319698,0.00029125193,0.0015844891],"domain_scores_gemma":[0.9931324,0.0018685231,0.0026442292,0.00051095715,0.00039337654,0.0014505192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008793748,0.00063080416,0.002955937,0.0009447058,0.00037300814,0.000056159643,0.00056063465,0.00039760885,0.0003780883],"category_scores_gemma":[0.002016825,0.0008276537,0.00025096876,0.001269465,0.00028599243,0.0007782969,0.00006699059,0.0010647716,0.00015121113],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005639922,0.0014569255,0.44531083,0.018540688,0.00072878326,0.00006941019,0.18761615,0.03059077,0.00058975024,0.30309698,0.0037849883,0.002574792],"study_design_scores_gemma":[0.008229102,0.0016867127,0.9606375,0.0023543795,0.000010398317,0.00001487717,0.013128618,0.005622254,0.00017515007,0.0056849816,0.0010628547,0.0013931494],"about_ca_topic_score_codex":0.84148407,"about_ca_topic_score_gemma":0.15658449,"teacher_disagreement_score":0.68489957,"about_ca_system_score_codex":0.0150259705,"about_ca_system_score_gemma":0.0047270665,"threshold_uncertainty_score":0.9994174},"labels":[],"label_agreement":null},{"id":"W3026112452","doi":"10.1016/j.jval.2020.04.1031","title":"PNS20 BEST-WORST SCALING IN HEALTH ECONOMICS IN CHINA: PAST, PRESENT AND FUTURE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Identification (biology); Internal validity; External validity; Data extraction; Quality (philosophy); Management science; Psychology; MEDLINE; Statistics; Economics; Social psychology; Political science; Mathematics","score_opus":0.081840291478429,"score_gpt":0.4115494818644264,"score_spread":0.32970919038599744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026112452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.68066245,0.012498549,0.0000106207945,0.30234918,0.0011020859,0.0026778176,0.000066297696,0.0000799751,0.0005530107],"genre_scores_gemma":[0.946052,0.022475354,0.0022371903,0.024131056,0.0047120214,0.00018850624,0.00004632881,0.00009923583,0.00005826313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99239874,0.0024036246,0.0023883283,0.0008325958,0.00025003386,0.0017266616],"domain_scores_gemma":[0.99743575,0.0005307818,0.0006023038,0.0003849014,0.000042481643,0.0010038001],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032406815,0.00033808453,0.0010509138,0.00035158845,0.00037286273,0.00001649631,0.0002869055,0.00035464024,0.000051528496],"category_scores_gemma":[0.00012568041,0.00035557523,0.00004719938,0.0008418705,0.000056592486,0.00019012179,0.00025362006,0.0019386281,0.000121679215],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055925874,0.00044069422,0.7940653,0.017117629,0.000011770235,0.00007195713,0.11113017,0.019164113,0.000001126427,0.008736856,0.01927866,0.029422473],"study_design_scores_gemma":[0.004601784,0.00093848375,0.57685685,0.0044938554,0.0000031121779,0.0000077756795,0.023954242,0.032960393,0.0000011796951,0.0022134192,0.35338834,0.0005805378],"about_ca_topic_score_codex":0.10502009,"about_ca_topic_score_gemma":0.009586031,"teacher_disagreement_score":0.33410966,"about_ca_system_score_codex":0.0020749895,"about_ca_system_score_gemma":0.0023150449,"threshold_uncertainty_score":0.9998896},"labels":[],"label_agreement":null},{"id":"W3026135127","doi":"10.1016/j.jval.2020.04.964","title":"PND72 MICROCOSTING OF CEREBRAL VENOUS THROMBOSIS IN A CANADIAN URBAN TERTIARY HOSPITAL","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Ischemic Stroke Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Northern British Columbia; University of British Columbia","funders":"","keywords":"Medicine; Activity-based costing; Venous thrombosis; Stroke (engine); Emergency medicine; Randomized controlled trial; Thrombosis; Medical emergency; Surgery","score_opus":0.02665056615424881,"score_gpt":0.26694232537910084,"score_spread":0.24029175922485202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026135127","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9689965,0.0005514756,0.000009175168,0.0278713,0.00009191231,0.00075527653,0.000020138272,0.000022769802,0.0016814495],"genre_scores_gemma":[0.99277097,0.00003958773,0.0016765703,0.0053229327,0.000117732154,0.000014206089,0.00001758033,0.000023414359,0.000016983862],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984996,0.000056407513,0.00048124508,0.00026835644,0.00016784662,0.00052659865],"domain_scores_gemma":[0.9992487,0.000043062475,0.000112398535,0.00018108833,0.000018874909,0.0003958628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028137866,0.000120397206,0.0003767586,0.00020858097,0.000024356537,0.0000045522315,0.000120256744,0.00006059605,0.000032989083],"category_scores_gemma":[0.00017444493,0.0001274287,0.000045728182,0.00038677212,0.000031043644,0.000038701903,0.000054311964,0.00026963334,0.000013784653],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019606463,0.0001465396,0.97343034,0.0007838954,0.000024270632,0.00008878607,0.009778091,0.0001138736,0.00057708664,0.0000512738,0.013891956,0.0010942882],"study_design_scores_gemma":[0.002771263,0.0013917024,0.9702781,0.0014396069,0.000031477062,0.000013152479,0.0023733024,0.007602057,0.0011892926,0.000016867913,0.0126072625,0.00028590183],"about_ca_topic_score_codex":0.58248556,"about_ca_topic_score_gemma":0.017082483,"teacher_disagreement_score":0.56540304,"about_ca_system_score_codex":0.0007117208,"about_ca_system_score_gemma":0.00082775985,"threshold_uncertainty_score":0.95324266},"labels":[],"label_agreement":null},{"id":"W3026143491","doi":"10.1016/j.jval.2020.04.775","title":"PMS93 CHARACTERIZING THE NATURAL HISTORY OF DUCHENNE MUSCULAR DYSTROPHY IN THE UNITED STATES IN REAL-WORLD COMMERCIAL AND MEDICAID DATA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicaid; Medicine; Interquartile range; Natural history; Duchenne muscular dystrophy; Pediatrics; Natural history study; Scoliosis; Demography; Physical therapy; Internal medicine; Surgery; Health care","score_opus":0.06040704485812555,"score_gpt":0.2980984236882663,"score_spread":0.23769137883014074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026143491","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98432344,0.0030517196,0.0000037625118,0.012268661,0.00009128361,0.00020015403,0.000023564387,0.0000026505588,0.000034768305],"genre_scores_gemma":[0.9898807,0.0028688754,0.00003461821,0.006503564,0.00006911379,0.000007962548,0.0006249287,0.000006718218,0.0000035144785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99868405,0.00055285485,0.00027454068,0.00022937683,0.0000775357,0.00018162727],"domain_scores_gemma":[0.99944866,0.00008094826,0.00009729039,0.00032429214,0.000011259279,0.000037578528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006690325,0.00008575845,0.00016120741,0.000058556278,0.00002801979,0.0000029048801,0.00034671475,0.000051231134,0.000003493263],"category_scores_gemma":[0.00013359671,0.000058766585,0.000016955943,0.00018649986,0.00016256061,0.000005210287,0.00014107196,0.00026160132,2.8276543e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008638171,0.002367791,0.39309448,0.0050844313,0.00038440083,0.00015250036,0.12824818,0.008625891,0.3452935,0.010409673,0.065905966,0.031795043],"study_design_scores_gemma":[0.003127023,0.00070457946,0.83469486,0.00018787703,0.000015295996,0.000004588694,0.003085746,0.020594222,0.00034033155,0.00040468582,0.13647948,0.00036131538],"about_ca_topic_score_codex":0.013648067,"about_ca_topic_score_gemma":0.0019912028,"teacher_disagreement_score":0.44160038,"about_ca_system_score_codex":0.000029383607,"about_ca_system_score_gemma":0.00016775608,"threshold_uncertainty_score":0.99292016},"labels":[],"label_agreement":null},{"id":"W3026164881","doi":"10.1016/j.jval.2020.04.1209","title":"PNS218 THE PROFILE OF PHYSICAL VIOLENCE AGAINST PREGNANT WOMEN IN BRAZIL: A DESCRIPTIVE ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Intimate Partner and Family Violence","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Descriptive statistics; Medicine; Physical abuse; Public health; Domestic violence; Demography; Poison control; Injury prevention; Environmental health; Geography; Nursing","score_opus":0.050045634199469564,"score_gpt":0.3438313369798677,"score_spread":0.2937857027803981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026164881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990297,0.00037760544,0.00009924498,0.0010079416,0.000051858693,0.0006130009,0.000022940736,0.000026410687,0.007503958],"genre_scores_gemma":[0.99848264,0.0005817114,0.0001059711,0.000677544,0.000061242,0.000068292415,0.0000020137982,0.0000058071782,0.000014748683],"study_design_codex":"qualitative","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99768555,0.000782788,0.0003525276,0.00026658157,0.00035698307,0.00055559253],"domain_scores_gemma":[0.9992842,0.00020317649,0.000147462,0.00015551594,0.00004751881,0.00016209696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001464044,0.00009383091,0.00035239995,0.00010651823,0.00014049181,0.000018577692,0.00035514447,0.000041412735,0.000017587954],"category_scores_gemma":[0.00026610552,0.00007024829,0.000078357836,0.0020756647,0.0002584578,0.0001050039,0.000055762797,0.00021233763,0.000016439237],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000120907316,0.0004633533,0.07272944,0.00026182958,0.00007385762,0.000012188697,0.8449193,0.023662593,0.00036736933,0.03711007,0.00013228672,0.020146793],"study_design_scores_gemma":[0.0011513954,0.0010340528,0.38644943,0.0020762673,0.000053848595,1.881707e-7,0.18915462,0.40960306,0.00051892287,0.007999748,0.0013230911,0.0006353753],"about_ca_topic_score_codex":0.017883053,"about_ca_topic_score_gemma":0.00027134904,"teacher_disagreement_score":0.6557647,"about_ca_system_score_codex":0.00031721094,"about_ca_system_score_gemma":0.0005618495,"threshold_uncertainty_score":0.98865694},"labels":[],"label_agreement":null},{"id":"W3026258989","doi":"10.1016/j.jval.2020.04.225","title":"PDB38 BURDEN OF CARDIOVASCULAR DISEASE AND CARDIOVASCULAR (CV) RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM): AN ANALYSIS OF A US HEALTH INSURANCE DATABASE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Cohort; Type 2 Diabetes Mellitus; Cohort study; Population; Internal medicine; Diabetes mellitus; Environmental health; Endocrinology","score_opus":0.028990527003234512,"score_gpt":0.2586314884798779,"score_spread":0.22964096147664337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026258989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9810837,0.0157327,0.000073969575,0.0020949356,0.00007313202,0.00068020384,0.00021870872,0.00002322725,0.00001943434],"genre_scores_gemma":[0.9921484,0.0039935587,0.00021902498,0.0032369648,0.00014145,0.000013345411,0.0002258707,0.000021194071,2.1098352e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967856,0.00054185494,0.0009829294,0.0005706189,0.00046683152,0.0006521897],"domain_scores_gemma":[0.99828994,0.000097720804,0.0005145226,0.0007162185,0.00017704435,0.00020457648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030242559,0.00021821623,0.0015562489,0.0005104271,0.00008225301,0.000019799221,0.00022855062,0.000060209502,0.000007626339],"category_scores_gemma":[0.0006970313,0.00019154884,0.00022917845,0.0025813286,0.00010089382,0.0004026391,0.00013566445,0.00021612224,0.0000020376012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008703033,0.00006987254,0.5748274,0.0013818569,0.00061148254,0.0000015476193,0.00014164834,0.42001003,7.113026e-8,0.00017400889,0.00011285798,0.002582221],"study_design_scores_gemma":[0.0011898853,0.00015439568,0.80655456,0.00015359743,0.0002886032,3.5506314e-8,0.00013996182,0.17508653,7.5038116e-8,0.000042903015,0.016232254,0.0001571994],"about_ca_topic_score_codex":0.4218386,"about_ca_topic_score_gemma":0.00043294256,"teacher_disagreement_score":0.42140567,"about_ca_system_score_codex":0.00007864743,"about_ca_system_score_gemma":0.00022372126,"threshold_uncertainty_score":0.7811135},"labels":[],"label_agreement":null},{"id":"W3026466697","doi":"10.1016/j.jval.2020.04.743","title":"PMS57 EPIDEMIOLOGIC MODELING TO GUIDE PAYER DECISIONS IN RARE DISEASES: A CASE STUDY OF DUCHENNE MUSCULAR DYSTROPHY IN THE UNITED STATES","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Population; Duchenne muscular dystrophy; Medicine; Epidemiology; Incidence (geometry); Sample size determination; Estimation; Demography; Pediatrics; Statistics; Environmental health; Mathematics; Pathology","score_opus":0.6033858586141566,"score_gpt":0.4710968884644692,"score_spread":0.13228897014968743,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026466697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9414892,0.0015109705,0.003781567,0.050425444,0.00010972425,0.0024064,0.00024412134,0.000019327408,0.000013239836],"genre_scores_gemma":[0.97495836,0.00039713483,0.0019984168,0.022242881,0.000075639444,0.00025802106,0.000042207834,0.000024805215,0.000002562024],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98826087,0.0034527674,0.0068314048,0.0007383022,0.00013039683,0.00058626785],"domain_scores_gemma":[0.99372566,0.0041220277,0.0011206315,0.00064404524,0.000059906215,0.00032772604],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.024622083,0.0002138697,0.0013657366,0.0008865052,0.0001146147,0.00002932191,0.00043916047,0.00009245158,0.000027240727],"category_scores_gemma":[0.017118325,0.00020755065,0.00008938613,0.001523057,0.000025350304,0.00016991586,0.00010029687,0.00035948821,0.00007404738],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028257147,0.0003754931,0.13831395,0.00020094951,0.000011393704,0.00009357576,0.035983574,0.82247305,8.361609e-8,0.0017386382,0.0007062166,0.00007479369],"study_design_scores_gemma":[0.0016219877,0.00052306836,0.017337922,0.00022782112,0.0000036781912,0.000014371442,0.08718386,0.8860137,3.3875274e-8,0.0053777383,0.0014679321,0.00022790967],"about_ca_topic_score_codex":0.22226182,"about_ca_topic_score_gemma":0.004501018,"teacher_disagreement_score":0.21776079,"about_ca_system_score_codex":0.0007440774,"about_ca_system_score_gemma":0.00029556715,"threshold_uncertainty_score":0.9911609},"labels":[],"label_agreement":null},{"id":"W3026476137","doi":"10.1016/j.jval.2020.04.714","title":"PMS27 CONCEPTUAL FRAMEWORK FOR ECONOMIC EVALUATION OF KNEE KINESIOGRAPHY FOR THE MANAGEMENT OF KNEE OSTEOARTHRITIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Osteoarthritis Treatment and Mechanisms","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Osteoarthritis; Medicine; Physical therapy; Grading (engineering); Clinical trial; Health care; Randomized controlled trial; Knee pain; Alternative medicine; Surgery; Internal medicine","score_opus":0.07688610364192276,"score_gpt":0.3318201377192933,"score_spread":0.25493403407737053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026476137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618,0.012777899,0.0048512495,0.00612364,0.0008535659,0.012950209,0.0003415023,0.00004045765,0.00026150793],"genre_scores_gemma":[0.9791889,0.00029593872,0.019090962,0.00045034586,0.00016044932,0.00071656215,0.000059893504,0.000023855786,0.000013098703],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9987295,0.00007427286,0.0005157446,0.00022900384,0.00022610053,0.0002253593],"domain_scores_gemma":[0.9990518,0.00033467822,0.0002315929,0.00021345467,0.00007949925,0.00008898789],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000773307,0.00011836316,0.00037170807,0.000083971856,0.00004916262,0.0000042305915,0.00006667611,0.00007190395,0.000051620675],"category_scores_gemma":[0.000050552862,0.000098440585,0.00017180288,0.00013609107,0.00006256267,0.000034939734,0.000020052976,0.000069042486,0.0000034377038],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021707036,0.0003059939,0.00368573,0.0030012196,0.00031524175,0.0000033857627,0.00519164,0.0034396679,0.0002661297,0.20837025,0.00045441973,0.7727956],"study_design_scores_gemma":[0.259589,0.23531456,0.036920585,0.018524308,0.0062333173,0.00003976229,0.053739883,0.10759133,0.023966838,0.21459107,0.041492745,0.001996598],"about_ca_topic_score_codex":0.0000831454,"about_ca_topic_score_gemma":0.000015759879,"teacher_disagreement_score":0.77079904,"about_ca_system_score_codex":0.000077205324,"about_ca_system_score_gemma":0.00017669986,"threshold_uncertainty_score":0.40142906},"labels":[],"label_agreement":null},{"id":"W3026479502","doi":"10.1016/j.jval.2020.04.188","title":"PCV87 HEART FAILURE RISK FACTORS ANALYSIS ON STABLE CORONARY ARTERY DISEASE PATIENTS IN CHINA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiovascular Health and Risk Factors","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Atrial fibrillation; Internal medicine; Logistic regression; Propensity score matching; Heart failure; Coronary artery disease; Observational study; Retrospective cohort study","score_opus":0.019546882460897728,"score_gpt":0.265733087006147,"score_spread":0.24618620454524928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026479502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99298984,0.00070832006,0.00003543284,0.004796696,0.0001587559,0.0010259337,0.00020443744,0.00005702043,0.00002356119],"genre_scores_gemma":[0.99660605,0.0007389567,0.00012336453,0.0020601253,0.00009884426,0.000017059107,0.00031438645,0.000030481277,0.000010739109],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970178,0.00055326294,0.0006562159,0.0005537937,0.0005946375,0.000624281],"domain_scores_gemma":[0.9979875,0.00012229275,0.00014054816,0.0004532393,0.00003139574,0.0012650008],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051682733,0.00024055624,0.0008886525,0.00048810322,0.00010291817,0.000011783398,0.00008222308,0.00010024073,0.000075070246],"category_scores_gemma":[0.00034417745,0.00019906947,0.00040857334,0.0014534744,0.000030462843,0.00007846295,0.000032024935,0.00066395424,0.000035981495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042605738,0.00033136777,0.97842735,0.00034284632,0.00013437378,0.000044659355,0.0010844073,0.017787233,5.0585373e-7,0.0000060195975,0.0008507404,0.0005644399],"study_design_scores_gemma":[0.0019891157,0.0005345508,0.98867357,0.00013491024,0.00014693568,8.6243574e-7,0.00018233148,0.0051252493,0.0000034115517,0.000016120126,0.0030391896,0.00015376836],"about_ca_topic_score_codex":0.019479671,"about_ca_topic_score_gemma":0.00042980284,"teacher_disagreement_score":0.01904987,"about_ca_system_score_codex":0.00044431494,"about_ca_system_score_gemma":0.00057803706,"threshold_uncertainty_score":0.9870497},"labels":[],"label_agreement":null},{"id":"W3026733513","doi":"10.1016/j.jval.2020.04.1588","title":"PCN87 COST-EFFECTIVENESS OF RIBOCILIB PLUS NONSTEROIDAL AROMATASE INHIBITOR (NSAI) IN HORMONE RECEPTOR–POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2–NEGATIVE (HR+/HER2-) ADVANCED BREAST CANCER (ABC): A CANADIAN HEALTHCARE PERSPECTIVE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Discontinuation; Breast cancer; Internal medicine; Quality-adjusted life year; Population; Placebo; Oncology; Exemestane; Adverse effect; Hazard ratio; Cohort; Cancer; Cost effectiveness; Confidence interval; Pathology; Aromatase; Environmental health","score_opus":0.038519867999389855,"score_gpt":0.33232328371295655,"score_spread":0.2938034157135667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026733513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9421638,0.005877191,0.0001506296,0.033874772,0.00042785224,0.0068892105,0.01038784,0.00013464621,0.00009402401],"genre_scores_gemma":[0.99430335,0.00060252834,0.0014103877,0.0021044507,0.00036886797,0.00071918976,0.00033486122,0.00014329902,0.000013067214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939419,0.0015479408,0.0012432561,0.0012449211,0.00064224907,0.00137974],"domain_scores_gemma":[0.9962433,0.00055801775,0.0005976709,0.00043793969,0.0006635769,0.0014994958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006770489,0.0006775025,0.001782431,0.00061811815,0.00023512947,0.00002051041,0.00029384854,0.00029038795,0.00016253594],"category_scores_gemma":[0.0003685732,0.00070928683,0.00018794835,0.0015491395,0.00042709234,0.0004774493,0.00009206677,0.0012441332,0.000021680178],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.106633805,0.0038317377,0.3769678,0.022689179,0.0016738339,0.0011592192,0.23066323,0.016591769,0.13834871,0.008975331,0.0012592217,0.09120618],"study_design_scores_gemma":[0.032435283,0.005325706,0.91140234,0.00942746,0.000057292124,0.00014966384,0.019134793,0.0010325958,0.017777719,0.00072821905,0.0008282554,0.001700681],"about_ca_topic_score_codex":0.5796829,"about_ca_topic_score_gemma":0.07378025,"teacher_disagreement_score":0.53443456,"about_ca_system_score_codex":0.011499385,"about_ca_system_score_gemma":0.0049670683,"threshold_uncertainty_score":0.9995358},"labels":[],"label_agreement":null},{"id":"W3026734581","doi":"10.1016/j.jval.2020.04.796","title":"PMU20 A DEVICE CATEGORY-BASED ECONOMIC MODEL EXPLORING ELECTROSURGERY TECHNOLOGIES ACROSS PROCEDURE TYPES: A UNITED STATES ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Electrosurgery; Medicine; Operations management; Activity-based costing; Surgery; Engineering; Business","score_opus":0.5098418878074189,"score_gpt":0.4212594018386066,"score_spread":0.0885824859688123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026734581","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83794427,0.003467096,0.012065298,0.14423391,0.00015428047,0.00094927335,0.0006554853,0.0004545468,0.00007580224],"genre_scores_gemma":[0.97607183,0.00091484294,0.0031461415,0.019054946,0.00008899583,0.00039462032,0.00024395027,0.00006162193,0.000023054372],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9933233,0.00033983696,0.0042513646,0.0009907522,0.000099245975,0.0009954642],"domain_scores_gemma":[0.9962068,0.0008766052,0.002019421,0.0005640576,0.000053125605,0.0002799542],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009391901,0.00032064947,0.0016173176,0.001129931,0.000253077,0.00011413966,0.00045090265,0.00020034831,0.00004334182],"category_scores_gemma":[0.0019991773,0.0004181316,0.00020826471,0.001887185,0.00007760169,0.0004745896,0.000075108466,0.00044035507,0.00047800146],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003529197,0.000056381556,0.057268098,0.0009748823,0.00013275306,0.0000014414935,0.0053186268,0.923656,0.0000011042994,0.011061471,0.0014191812,0.00007477575],"study_design_scores_gemma":[0.00051151426,0.000099379016,0.0014461639,0.000076516284,0.000012640178,7.204646e-7,0.0035116128,0.98367655,0.00002018718,0.0043837056,0.005879134,0.00038189304],"about_ca_topic_score_codex":0.014774539,"about_ca_topic_score_gemma":0.0011019086,"teacher_disagreement_score":0.13812754,"about_ca_system_score_codex":0.001713909,"about_ca_system_score_gemma":0.0010560969,"threshold_uncertainty_score":0.999827},"labels":[],"label_agreement":null},{"id":"W3026749736","doi":"10.1016/j.jval.2020.04.1146","title":"PNS146 BEYOND DEFAULTS - ADAPTING PRINCIPLED PRIOR SELECTION IN BAYESIAN NETWORK META-ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; EVERSANA (Canada)","funders":"","keywords":"Prior probability; Computer science; Bayesian probability; Inference; Machine learning; Artificial intelligence; Bayesian inference; Selection (genetic algorithm); Frequentist inference; Data mining","score_opus":0.8066889316083695,"score_gpt":0.5199534122958824,"score_spread":0.2867355193124871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026749736","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.30083132,0.041212793,0.56029624,0.07144312,0.00081471144,0.011422791,0.00006668748,0.00013714272,0.013775192],"genre_scores_gemma":[0.9566402,0.00005319022,0.039904557,0.0025083947,0.00017943502,0.00008432984,0.000008179394,0.000020318601,0.00060142786],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9468396,0.03168742,0.014462891,0.0018171167,0.0044269394,0.00076607114],"domain_scores_gemma":[0.98712057,0.0050880653,0.0055097034,0.0014984307,0.00033710056,0.00044615625],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.16169894,0.000382376,0.007895017,0.0008572808,0.00020741757,0.00043435875,0.0011808851,0.0001263526,0.0029988096],"category_scores_gemma":[0.024174878,0.00021840722,0.00343266,0.013672009,0.000023566317,0.00025404996,0.00013989932,0.00044043717,0.0004284207],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022567132,0.00007897011,0.0876016,0.00016246154,0.010252451,0.0000073013275,0.0026831971,0.8854784,0.000004715018,0.0035829968,0.0036851023,0.0064402334],"study_design_scores_gemma":[0.00022214097,0.00008653413,0.017126357,0.000014753545,0.009359217,0.0000023610235,0.00024955434,0.9547574,0.0000018190327,0.0032170212,0.014742275,0.00022058039],"about_ca_topic_score_codex":0.0014366299,"about_ca_topic_score_gemma":0.0031265833,"teacher_disagreement_score":0.65580887,"about_ca_system_score_codex":0.00017074702,"about_ca_system_score_gemma":0.00029035934,"threshold_uncertainty_score":0.9979126},"labels":[],"label_agreement":null},{"id":"W3026818610","doi":"10.1016/j.jval.2020.04.1223","title":"PPM7 A NOVEL APPROACH TO QUANTITATIVELY SYNTHESIZE SUBGROUP FINDINGS FROM MULTIPLE TRIALS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Subgroup analysis; Meta-analysis; Statistics; Mathematics; Standard error; Treatment effect; Econometrics; Medicine; Confidence interval; Internal medicine; Traditional medicine","score_opus":0.9348229604684398,"score_gpt":0.5632636626395024,"score_spread":0.3715592978289374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026818610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49499938,0.0013542785,0.4873658,0.011092417,0.00033326438,0.0032485095,0.00024297986,0.000018355931,0.0013450114],"genre_scores_gemma":[0.8236709,0.000018660914,0.1719619,0.003890617,0.00014150834,0.00006649592,0.0000093757635,0.00001925456,0.00022126446],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9459081,0.025668224,0.019687153,0.0021651853,0.0058791568,0.00069217355],"domain_scores_gemma":[0.9272094,0.063366756,0.00568308,0.0023586573,0.0004475471,0.0009345545],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.24843402,0.00031684796,0.006028836,0.00044719584,0.00012369666,0.0004624738,0.0016693479,0.00010231873,0.00089691207],"category_scores_gemma":[0.32003886,0.00017043235,0.0011698271,0.00285493,0.000031949712,0.0001705921,0.00014253234,0.00024133548,0.0025497566],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011769019,0.003450056,0.2958628,0.0022384645,0.0015328126,0.000032725904,0.18575141,0.053055428,0.009661111,0.1076494,0.28795144,0.051637445],"study_design_scores_gemma":[0.002801508,0.000622144,0.07771318,0.0005331879,0.00018815677,0.000005321217,0.015629925,0.7157903,0.00033041922,0.00564607,0.17969756,0.0010422426],"about_ca_topic_score_codex":0.002638403,"about_ca_topic_score_gemma":0.00006616235,"teacher_disagreement_score":0.66273487,"about_ca_system_score_codex":0.00009543679,"about_ca_system_score_gemma":0.00021823139,"threshold_uncertainty_score":0.9982269},"labels":[],"label_agreement":null},{"id":"W3026823264","doi":"10.1016/j.jval.2020.04.1566","title":"PCN63 A SYSTEMATIC LITERATURE REVIEW OF THE ECONOMIC BURDEN AMONG PATIENTS WITH HORMONE RECEPTOR-POSITIVE, HER2-NEGATIVE EARLY BREAST CANCER","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Breast cancer; Indirect costs; Population; Economic evaluation; Activity-based costing; Systematic review; Disease burden; Cancer; MEDLINE; Health economics; Economic cost; Disease; Intensive care medicine; Gynecology; Family medicine; Internal medicine; Environmental health; Public health; Pathology","score_opus":0.01557663739878143,"score_gpt":0.22116586987455097,"score_spread":0.20558923247576955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026823264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83635545,0.14292872,0.000032843163,0.011343575,0.00047005463,0.0033690264,0.003685367,0.000026778778,0.0017881925],"genre_scores_gemma":[0.94834054,0.048803978,0.00008878387,0.0023555614,0.00016349526,0.00011088414,0.000013301284,0.000040251405,0.00008319117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978254,0.000110034765,0.0012434312,0.00041991821,0.000057456415,0.00034375198],"domain_scores_gemma":[0.99790066,0.0000810964,0.0014480951,0.00033222954,0.00006791683,0.00016999074],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005188904,0.0002286851,0.0010690766,0.00008696742,0.000075567994,0.000044517074,0.00034674865,0.00008125836,0.000089297755],"category_scores_gemma":[0.00012360506,0.00018303894,0.00013326845,0.00038838797,0.00009920731,0.0003839952,0.00006143694,0.00029876872,0.000060576185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040949628,0.00014920873,0.8046388,0.14796512,0.00033481495,0.0000036032127,0.013367524,0.0040829703,0.0000011128419,0.022462135,0.0055925786,0.0009926052],"study_design_scores_gemma":[0.0014860157,0.00037227632,0.89677346,0.09864486,0.000018122963,0.0000020445125,0.00006729332,0.0011000757,0.0000056601875,0.0005630737,0.0005602079,0.0004069088],"about_ca_topic_score_codex":0.012137256,"about_ca_topic_score_gemma":0.00010390646,"teacher_disagreement_score":0.11198511,"about_ca_system_score_codex":0.00076477707,"about_ca_system_score_gemma":0.00023860863,"threshold_uncertainty_score":0.99444103},"labels":[],"label_agreement":null},{"id":"W3026889703","doi":"10.1016/j.jval.2020.04.220","title":"PDB32 COST-EFFECTIVENESS OF ONCE-WEEKLY SEMAGLUTIDE 1 MG VS. CANAGLIFLOZIN 300 MG IN PATIENTS WITH TYPE 2 DIABETES IN A CANADIAN SETTING","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Canagliflozin; Semaglutide; Medicine; Type 2 diabetes; Cost effectiveness; Quality-adjusted life year; Metformin; Dapagliflozin; Type 2 Diabetes Mellitus; Internal medicine; Diabetes mellitus; Endocrinology; Insulin; Liraglutide; Risk analysis (engineering)","score_opus":0.024046204953987165,"score_gpt":0.26741884943052635,"score_spread":0.2433726444765392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3026889703","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99406135,0.00026032355,5.86188e-7,0.0026178092,0.00008384368,0.0024375238,0.000028427961,0.000018904575,0.00049120456],"genre_scores_gemma":[0.9982263,0.000027160777,0.00020092641,0.0012894694,0.000022129827,0.00008678947,0.00009896871,0.000029430545,0.000018827182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99796915,0.00029695002,0.0004265967,0.0003451604,0.00024808993,0.00071403955],"domain_scores_gemma":[0.99906427,0.00016771442,0.00011923393,0.00018533254,0.00005661011,0.00040682885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074187457,0.00018652197,0.0005703123,0.0003988341,0.00002789826,0.000008024243,0.00009493352,0.000057982365,0.000016166221],"category_scores_gemma":[0.00020390368,0.00016859337,0.000028080463,0.0009602597,0.000034249744,0.000060447102,0.000034804612,0.00021068001,0.000008519087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028031296,0.00022007772,0.99059635,0.0013383963,0.000039634513,0.000036395722,0.0006704376,0.002310272,0.000009672655,0.000096727774,0.00014420072,0.0042575416],"study_design_scores_gemma":[0.0049568363,0.0016741089,0.9852722,0.0018827828,0.000022665736,9.6877805e-8,0.00012085541,0.004794476,0.00008228675,0.000024782987,0.001027494,0.00014140304],"about_ca_topic_score_codex":0.56984913,"about_ca_topic_score_gemma":0.31337902,"teacher_disagreement_score":0.2564701,"about_ca_system_score_codex":0.0014422144,"about_ca_system_score_gemma":0.0010914518,"threshold_uncertainty_score":0.69915},"labels":[],"label_agreement":null},{"id":"W3027016823","doi":"10.1016/j.jval.2020.04.1267","title":"PRO41 A MULTI-CRITERIA DECISION ANALYSIS CONTRIBUTION TO THE CANADIAN INTRAVENOUS IMMUNOGLOBULIN COST-EFFECTIVENESS ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Prednisone; Medicine; Methylprednisolone; Prom; Internal medicine","score_opus":0.05088097463456857,"score_gpt":0.35548980166092736,"score_spread":0.3046088270263588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027016823","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97340554,0.0010790991,0.01130692,0.011152426,0.0000729646,0.0027507823,0.00018461142,0.000028206785,0.000019470575],"genre_scores_gemma":[0.99593467,0.00011889759,0.00093630096,0.0025072955,0.000028421613,0.00013524017,0.00032217533,0.000011847228,0.000005139808],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980866,0.00037947032,0.00042116415,0.00039193526,0.0002507585,0.00047009636],"domain_scores_gemma":[0.9987342,0.00016534561,0.00009049953,0.0003045481,0.00012312345,0.00058233197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008724331,0.00016521655,0.00076659565,0.00046929708,0.00023146947,0.000042570235,0.00011590798,0.00008731616,0.00006136674],"category_scores_gemma":[0.00041818674,0.00011976916,0.00020358886,0.0042346194,0.000021215214,0.00003659589,0.000025193334,0.0001941708,0.000055952532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030466306,0.0014092391,0.7594015,0.00026113656,0.010029084,0.001376139,0.006622547,0.14219259,0.0001800491,0.00026320855,0.00035127057,0.07486658],"study_design_scores_gemma":[0.0030649838,0.0006216586,0.84159124,0.00009666715,0.0015076763,0.000012279506,0.00012745039,0.14994338,0.000069114045,0.000036749523,0.0027777322,0.00015108523],"about_ca_topic_score_codex":0.52025616,"about_ca_topic_score_gemma":0.37906188,"teacher_disagreement_score":0.1411943,"about_ca_system_score_codex":0.0009511481,"about_ca_system_score_gemma":0.00066570385,"threshold_uncertainty_score":0.6322686},"labels":[],"label_agreement":null},{"id":"W3027025576","doi":"10.1016/j.jval.2020.04.958","title":"PND66 RECENT EVOLUTION OF THE MARKET FOR DISEASE-MODIFYING DRUGS FOR MULTIPLE SCLEROSIS IN CANADA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Teriflunomide; Fingolimod; Glatiramer acetate; Medical prescription; Dimethyl fumarate; Medicine; Multiple sclerosis; Ocrelizumab; Pediatrics; Family medicine; Internal medicine; Pharmacology; Psychiatry","score_opus":0.10127915638511291,"score_gpt":0.28736479265838666,"score_spread":0.18608563627327374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027025576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74027145,0.027636599,0.009958549,0.20836717,0.0031694472,0.00753949,0.0028625298,0.000041174382,0.00015357726],"genre_scores_gemma":[0.9962121,0.00023674658,0.0016491391,0.0017849465,0.000019241683,0.00005409235,0.0000081424605,0.000007619046,0.000027942619],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875337,0.00035644608,0.00036888296,0.00019681803,0.00003188176,0.0002925947],"domain_scores_gemma":[0.9990153,0.00066778687,0.00011408388,0.00012313569,0.00003429029,0.000045417644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063749665,0.00007899786,0.00022903986,0.00002770295,0.00007129516,0.0000019242943,0.00013856842,0.0000656094,0.000025219175],"category_scores_gemma":[0.0006772268,0.000058079782,0.0000620695,0.0002023948,0.000043587006,0.000015238402,0.000037577578,0.00013117817,2.4962694e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011389164,0.0008878036,0.60541654,0.007421104,0.00025989916,0.0000015992684,0.0028089613,0.004591803,0.041683614,0.007417884,0.10894034,0.20918131],"study_design_scores_gemma":[0.0125549855,0.0007160387,0.6375237,0.0015691571,0.00009016876,0.0000014167293,0.002698467,0.14026843,0.019446883,0.0040583657,0.18040015,0.0006722026],"about_ca_topic_score_codex":0.38674632,"about_ca_topic_score_gemma":0.14590958,"teacher_disagreement_score":0.25594068,"about_ca_system_score_codex":0.000517431,"about_ca_system_score_gemma":0.0012141628,"threshold_uncertainty_score":0.86967534},"labels":[],"label_agreement":null},{"id":"W3027027909","doi":"10.1016/j.jval.2020.04.1720","title":"PCN252 TIME-TO-TREATMENT INITIATION (TTI) IN COMMUNITY INFUSION CLINICS: DECREASING WAIT TIMES FOR CANADIAN ONCOLOGY PATIENTS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Dr. Georges-L.-Dumont University Hospital Centre; Jewish General Hospital","funders":"","keywords":"Medicine; Interquartile range; Medical prescription; Distress; Breast cancer; Internal medicine; Cancer; Emergency medicine","score_opus":0.09796139484102039,"score_gpt":0.3101762630144521,"score_spread":0.21221486817343171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027027909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98012394,0.0004645172,0.000121830424,0.009202238,0.0002514107,0.0012013314,0.00045207364,0.000017810557,0.008164872],"genre_scores_gemma":[0.9897797,0.0003604066,0.0011540952,0.008327574,0.00010869,0.00006541271,0.00012615592,0.00002585494,0.000052114952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982167,0.000110261666,0.0009453285,0.0002606544,0.000019349365,0.00044769605],"domain_scores_gemma":[0.99877304,0.00026743519,0.000338729,0.00017946925,0.000031998592,0.00040932948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010308544,0.00013835778,0.000548395,0.0003353938,0.00015402233,0.000026399512,0.00015794249,0.00014596796,0.0001585731],"category_scores_gemma":[0.0007070629,0.00017507371,0.0000586455,0.00022323753,0.000019925252,0.00017455425,0.000033913053,0.00020680527,0.0004727936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004207642,0.00070903776,0.81935394,0.00020502656,0.000029288938,0.0000036468505,0.021476464,0.007677399,0.0000011029466,0.019939896,0.0027059892,0.12747745],"study_design_scores_gemma":[0.0052945027,0.004617619,0.52618635,0.00019400088,0.0000042943157,6.249806e-7,0.00032950565,0.05498161,0.000007769527,0.018955443,0.38890722,0.0005210412],"about_ca_topic_score_codex":0.3356518,"about_ca_topic_score_gemma":0.063547805,"teacher_disagreement_score":0.38620123,"about_ca_system_score_codex":0.0029950857,"about_ca_system_score_gemma":0.00078670844,"threshold_uncertainty_score":0.95354},"labels":[],"label_agreement":null},{"id":"W3027084788","doi":"10.1016/j.jval.2020.04.1260","title":"PRO32 PREFERENCE WEIGHTS FOR QUALITY-ADJUSTED LIFE-YEARS ESTIMATION FOR TREATMENTS OF PAROXYSMAL NOCTURNAL HEMOGLOBINURIA IN FIVE COUNTRIES","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; Western University","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Life expectancy; Demography; Estimation; Censoring (clinical trials); Primaquine; Environmental health; Internal medicine","score_opus":0.1414315463800529,"score_gpt":0.39823204591984507,"score_spread":0.25680049953979217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027084788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9852863,0.00094603235,0.0033534428,0.0056670136,0.000076146345,0.004329848,0.00030068558,0.000025360285,0.000015177535],"genre_scores_gemma":[0.94721514,0.0001161678,0.051727343,0.00031915464,0.00007655447,0.00035976086,0.00011921337,0.00001794839,0.00004874056],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980783,0.00015628272,0.00073612545,0.0002948917,0.00035686433,0.00037757802],"domain_scores_gemma":[0.99840575,0.000816103,0.00024831833,0.00014519942,0.00013887818,0.0002457435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058527343,0.00012968466,0.0005256772,0.00012803292,0.000038026556,0.000011110526,0.000094578136,0.0000679389,0.000011969082],"category_scores_gemma":[0.0022066287,0.00011343871,0.00005790103,0.00027177553,0.000066720284,0.00011536221,0.000020083437,0.0001361273,0.000002906226],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.12265241,0.005183508,0.4227123,0.106329925,0.0006983155,0.00007599696,0.07464139,0.083457865,0.007813461,0.035881594,0.0061751753,0.13437806],"study_design_scores_gemma":[0.032034546,0.011622764,0.49907312,0.0034876005,0.00006697744,0.0000108278045,0.0012177039,0.4348572,0.005244907,0.008656045,0.0033218977,0.00040642804],"about_ca_topic_score_codex":0.0015963403,"about_ca_topic_score_gemma":0.000107234,"teacher_disagreement_score":0.35139933,"about_ca_system_score_codex":0.00034141605,"about_ca_system_score_gemma":0.001125953,"threshold_uncertainty_score":0.46258965},"labels":[],"label_agreement":null},{"id":"W3027141167","doi":"10.1016/j.jval.2020.01.022","title":"Acceptability and Validity of the EQ-5D in Patients Living With Dementia","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Hamilton Health Sciences","funders":"Bundesministerium für Gesundheit","keywords":"Dementia; Multivariate statistics; EQ-5D; Quality of life (healthcare); Ceiling effect; Clinical Dementia Rating; Rating scale; Proxy (statistics); Bayesian multivariate linear regression; Convergent validity; Medicine; Multivariate analysis; Clinical psychology; Activities of daily living; Psychology; Linear regression; Gerontology; Psychometrics; Statistics; Physical therapy; Health related quality of life; Internal medicine; Developmental psychology; Mathematics; Disease","score_opus":0.4723344697446466,"score_gpt":0.3779385357160594,"score_spread":0.0943959340285872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027141167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97872573,0.00057946716,0.00016570013,0.019283427,0.00013842373,0.00078484707,0.00006861744,0.000009543514,0.00024425157],"genre_scores_gemma":[0.99407995,0.0000658099,0.00089082576,0.004883988,0.000039500774,0.000021108575,0.0000024479202,0.000012660899,0.000003722262],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99581814,0.0008354058,0.002582514,0.00039128307,0.000087695,0.0002849467],"domain_scores_gemma":[0.9974578,0.00076026755,0.0013249106,0.0003011035,0.000025011572,0.00013087859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010859252,0.0001082581,0.00063368975,0.000099393095,0.0000745575,0.000017503087,0.00019290064,0.000059095066,0.000097686],"category_scores_gemma":[0.0030007458,0.000106406515,0.000036513175,0.00029929852,0.00006286157,0.0002009418,0.00009119603,0.00018348174,0.000020771615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000065932286,0.000082129336,0.99163294,0.00065943925,0.0000065226845,3.477628e-8,0.0035425627,0.00088262965,5.9274534e-8,0.0028770189,0.00019776437,0.00011233289],"study_design_scores_gemma":[0.0005400782,0.00014216512,0.99080694,0.00013580079,0.0000012528544,1.2729566e-7,0.00036920828,0.006182124,9.645075e-7,0.0011159128,0.00061219616,0.00009326054],"about_ca_topic_score_codex":0.0076540983,"about_ca_topic_score_gemma":0.0005673941,"teacher_disagreement_score":0.015354213,"about_ca_system_score_codex":0.00031869675,"about_ca_system_score_gemma":0.00021649893,"threshold_uncertainty_score":0.998954},"labels":[],"label_agreement":null},{"id":"W3027152066","doi":"10.1016/j.jval.2020.04.470","title":"PIH76 ITCH REPORTED OUTCOME TOOL FOR CAREGIVERS OF PEDIATRIC PATIENTS WITH CHOLESTATIC LIVER DISEASE: AN ANALYSIS OF VALIDATION AND SCORING FROM THE ICONIC MARALIXIBAT STUDY","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Evening; Placebo; Concurrent validity; Convergent validity; Randomization; Internal medicine; Randomized controlled trial; Clinical psychology; Psychometrics; Pathology","score_opus":0.07093263383090202,"score_gpt":0.32692815986518725,"score_spread":0.2559955260342852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027152066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977426,0.00048407502,0.00007209884,0.00037245554,0.000024993635,0.0011642228,0.00012836765,0.00001019448,9.750448e-7],"genre_scores_gemma":[0.9994092,0.000052833107,0.000110443856,0.00018193656,0.000018641987,0.00002391482,0.00019298377,0.000008259091,0.0000018086962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987347,0.00019561098,0.0004982547,0.00023560466,0.00021789812,0.00011789904],"domain_scores_gemma":[0.9989004,0.00029471808,0.00033944717,0.00024196197,0.000091148526,0.00013228631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021568744,0.00008735245,0.00041082266,0.00012148661,0.000043088523,0.0000048414195,0.00005908794,0.00002198273,0.000009533186],"category_scores_gemma":[0.0003467113,0.000061264116,0.00005246571,0.0004504425,0.000037381273,0.00007374438,0.000018132985,0.00006385391,1.786866e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000563201,0.00035945376,0.99399054,0.0004143583,0.00023913877,0.000011308099,0.0030424125,0.0011950386,4.483073e-7,0.000005533826,0.000025296578,0.00015328111],"study_design_scores_gemma":[0.0021154562,0.0002989929,0.9883413,0.000039736395,0.0020216366,1.8567152e-7,0.00089763,0.006218038,0.0000023450168,0.00001024041,0.000001584316,0.000052894076],"about_ca_topic_score_codex":0.0015024641,"about_ca_topic_score_gemma":0.000047840993,"teacher_disagreement_score":0.005649269,"about_ca_system_score_codex":0.000033865024,"about_ca_system_score_gemma":0.00017265094,"threshold_uncertainty_score":0.2498278},"labels":[],"label_agreement":null},{"id":"W3027243897","doi":"10.1016/j.jval.2020.04.1816","title":"PCN361 POOR PROGNOSTIC FACTORS AND THEIR IMPACT ON TREATMENT PATTERNS AND OUTCOMES FOR WOMEN WITH HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR-NEGATIVE (HR+/HER2-) ADVANCED BREAST CANCER (ABC) IN CANADA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology; Breast cancer; Chemotherapy; Cancer; Hormone receptor; Metastatic breast cancer; Endocrine system; Disease; Hormone","score_opus":0.026102601444537375,"score_gpt":0.29660249050752663,"score_spread":0.2704998890629893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027243897","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98474896,0.0005402398,0.000035837416,0.008710127,0.000058953938,0.00270093,0.0031616252,0.000038436065,0.0000049080304],"genre_scores_gemma":[0.997111,0.0006007221,0.00025277285,0.0012390862,0.00007738468,0.00055619865,0.000066725814,0.00008188099,0.000014209887],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761033,0.000178471,0.00050104444,0.0006614966,0.00023943503,0.00080921536],"domain_scores_gemma":[0.9981593,0.0006940664,0.00027304178,0.00016102109,0.000081588885,0.0006309697],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000100759244,0.000585728,0.0011399916,0.00013271037,0.00012900557,0.000017637003,0.0000778677,0.000066525376,0.000055629185],"category_scores_gemma":[0.00007112488,0.00034786132,0.000049811886,0.00024998854,0.00009260604,0.0001722174,0.000025583693,0.00027588764,3.5114437e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003939558,0.00014686454,0.9560082,0.00034178517,0.0002121036,0.000010192992,0.011833834,0.00032254332,0.00039809535,0.000009261926,0.000011547672,0.02676601],"study_design_scores_gemma":[0.007036507,0.0050734407,0.98125154,0.00052733166,0.000012463254,0.000010365041,0.0045909206,0.00014607323,0.00093661435,0.000035375437,0.000053687472,0.0003257008],"about_ca_topic_score_codex":0.73157996,"about_ca_topic_score_gemma":0.24346751,"teacher_disagreement_score":0.48811242,"about_ca_system_score_codex":0.0056232875,"about_ca_system_score_gemma":0.001458526,"threshold_uncertainty_score":0.99989736},"labels":[],"label_agreement":null},{"id":"W3027261873","doi":"10.1016/j.jval.2020.04.137","title":"PCV32 ECONOMIC BURDEN OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE AND SPECIFIC EVENTS IN ONTARIO, CANADA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Toronto Rehabilitation Institute; St. Michael's Hospital; Amgen (Canada)","funders":"","keywords":"Medicine; Cohort; Atherosclerosis Risk in Communities; Myocardial infarction; Atherosclerotic cardiovascular disease; Emergency medicine; Demography; Cardiovascular event; Liberian dollar; Total cost; Disease; Internal medicine; Finance; Business","score_opus":0.06000550234280399,"score_gpt":0.24517587991442055,"score_spread":0.18517037757161656,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027261873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9615193,0.0010826743,0.000007281959,0.036323547,0.00026207586,0.00038703342,0.0000065949375,0.000009812901,0.00040169098],"genre_scores_gemma":[0.9918169,0.00022025288,0.000024417448,0.0075819464,0.0003184074,0.000009171124,0.000009964672,0.000011385724,0.000007601158],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9985391,0.00007422625,0.0005643505,0.0002744616,0.000120010365,0.0004278508],"domain_scores_gemma":[0.99949586,0.000052944044,0.00015336991,0.00018674864,0.000014251122,0.00009681593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079771236,0.000115184055,0.00045184643,0.000080925136,0.00004081241,0.000009078297,0.00013901247,0.000035709487,0.000060274517],"category_scores_gemma":[0.0001028141,0.00011809797,0.000053078118,0.0001498406,0.000023398548,0.00013742222,0.00009486528,0.00015726665,0.000011696421],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047940965,0.000021518987,0.38469395,0.0010478845,0.00003296056,0.000010624249,0.00025561792,0.58662343,7.667879e-7,0.0076819696,0.01889047,0.0006928646],"study_design_scores_gemma":[0.0006238376,0.000012784348,0.46007138,0.00010010514,0.000006162797,3.6426675e-7,0.00016196574,0.050062753,4.0879932e-8,0.00066644256,0.48817748,0.00011667128],"about_ca_topic_score_codex":0.9995566,"about_ca_topic_score_gemma":0.8994089,"teacher_disagreement_score":0.53656065,"about_ca_system_score_codex":0.00055295887,"about_ca_system_score_gemma":0.00087039894,"threshold_uncertainty_score":0.48158953},"labels":[],"label_agreement":null},{"id":"W3027285142","doi":"10.1016/j.jval.2020.04.1806","title":"PCN350 USING REAL WORLD DATA TO DETERMINE HEALTH SYSTEM COSTS OF CANADIANS DIAGNOSED WITH CHRONIC LYMPHOCYTIC LEUKEMIA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; AstraZeneca (Canada); Sunnybrook Hospital","funders":"","keywords":"Medicine; Activity-based costing; Chronic lymphocytic leukemia; Cohort; Total cost; Cancer; Cancer registry; Health care; Cost driver; Emergency medicine; Family medicine; Pediatrics; Leukemia; Internal medicine","score_opus":0.1461978433614025,"score_gpt":0.36675676022454073,"score_spread":0.22055891686313822,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027285142","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004984,0.001639472,0.00033373365,0.003990389,0.00014729415,0.0032028672,0.00023705058,0.00012989053,0.00026943936],"genre_scores_gemma":[0.9931084,0.00036227278,0.0030827788,0.0027265947,0.00040345176,0.00003799156,0.00012011394,0.00010342364,0.000054975633],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9950557,0.00044889256,0.0012139304,0.00095657905,0.0009516687,0.0013732642],"domain_scores_gemma":[0.9954219,0.0005037507,0.00041002518,0.0015556329,0.000117562944,0.0019911565],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014545352,0.0003296085,0.0012976179,0.00052378693,0.000121633835,0.000024801087,0.00065552903,0.00007590245,0.000016881053],"category_scores_gemma":[0.00033945355,0.00029938426,0.000051153842,0.0022398618,0.0001590963,0.00012135928,0.00028875784,0.00039231597,0.000027531585],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00973373,0.00041017667,0.050780844,0.08600543,0.00076272566,0.0131594185,0.023399938,0.70682895,0.0013704976,0.002884086,0.02113767,0.083526544],"study_design_scores_gemma":[0.016733782,0.0025985173,0.0021723504,0.0074314335,0.000033465873,0.00033888462,0.0007844776,0.9680558,0.00010042291,8.189402e-7,0.0014653387,0.0002847508],"about_ca_topic_score_codex":0.91810703,"about_ca_topic_score_gemma":0.4170685,"teacher_disagreement_score":0.50103855,"about_ca_system_score_codex":0.39970753,"about_ca_system_score_gemma":0.28504586,"threshold_uncertainty_score":0.9999458},"labels":[],"label_agreement":null},{"id":"W3027312170","doi":"10.1016/j.jval.2020.04.1391","title":"PSS2 A CANADIAN NETWORK META-ANALYSIS OF THE EFFICACY OF HALOBETASOL PROPIONATE (0.01%) AND TAZAROTENE (0.045%) FIXED COMBINATION RELATIVE TO OTHER TOPICAL THERAPIES AMONG PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada; Vancouver Coastal Health","funders":"","keywords":"Tazarotene; Medicine; Psoriasis; Plaque psoriasis; Randomized controlled trial; Psoriasis Area and Severity Index; Dermatology; Internal medicine; Combination therapy","score_opus":0.04641643822411487,"score_gpt":0.24942889753249692,"score_spread":0.20301245930838205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027312170","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922144,0.00076595036,0.000101190206,0.0053469404,0.000077720535,0.0012339742,0.00021538754,0.0000095145015,0.000034945777],"genre_scores_gemma":[0.99856997,0.00001702649,0.00039652633,0.00081008725,0.0000088936995,0.00006457078,0.000046857043,0.000012885254,0.00007320802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99819165,0.00075856067,0.0004011334,0.0002993826,0.000075115604,0.00027413596],"domain_scores_gemma":[0.9991965,0.00020002326,0.00020785524,0.0002152405,0.00008530185,0.000095061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020841381,0.00017202493,0.00074908795,0.00016126428,0.00012882616,0.0000065577065,0.00013723872,0.00011752106,0.00007262605],"category_scores_gemma":[0.00007029321,0.00010663887,0.00015741937,0.00081505184,0.0000643215,0.000050060058,0.0000363716,0.00012092325,0.0000031114619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023681927,0.00042732063,0.82908714,0.00009454992,0.048256114,0.000002731002,0.023652505,0.08761761,0.00013764993,0.0043534636,0.00035438233,0.0036483537],"study_design_scores_gemma":[0.0028714426,0.00089626806,0.9876036,0.000050689323,0.006597873,5.745821e-7,0.00011911245,0.00052873534,0.0004890933,0.00020849289,0.00042580668,0.00020828538],"about_ca_topic_score_codex":0.048893593,"about_ca_topic_score_gemma":0.028501451,"teacher_disagreement_score":0.15851651,"about_ca_system_score_codex":0.0000756817,"about_ca_system_score_gemma":0.00015962776,"threshold_uncertainty_score":0.98922586},"labels":[],"label_agreement":null},{"id":"W3027314007","doi":"10.1016/j.jval.2020.04.1073","title":"PNS70 US “IMPORT-FROM-CANADA” DRUG LEGISLATION: WILL IT LOWER DRUG COSTS FOR AMERICAN CONSUMERS?","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Legislation; European union; Business; Medical prescription; CINAHL; MEDLINE; Public economics; Medicine; International trade; Economics; Political science; Pharmacology; Law","score_opus":0.07922509688112722,"score_gpt":0.30170426512868065,"score_spread":0.22247916824755343,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027314007","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6645003,0.003149574,0.00038354585,0.31733617,0.0013568095,0.0010326632,0.002950267,0.000046369078,0.009244292],"genre_scores_gemma":[0.9407404,0.0010149784,0.0005297238,0.057057384,0.0003355743,0.000039411152,0.00006905735,0.00003882555,0.0001746675],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99770945,0.000044635406,0.0010865151,0.00054684473,0.000045516023,0.00056701305],"domain_scores_gemma":[0.9982973,0.0003278322,0.00058242865,0.00026975118,0.00002056185,0.00050214457],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057243323,0.00019926365,0.0006457387,0.00009874583,0.000104829414,0.000053003747,0.0002799382,0.00004033982,0.0003076032],"category_scores_gemma":[0.00018249112,0.0002576392,0.00010379511,0.00027924363,0.00008194788,0.00019373084,0.000055893503,0.00024759897,0.00011850094],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003878179,0.00031580462,0.39686823,0.00037428635,0.0002255296,0.000027406866,0.004123639,0.009822451,0.00000719016,0.18547267,0.38752306,0.014851921],"study_design_scores_gemma":[0.0010076405,0.00006250575,0.008233032,0.000022862956,0.0000033830884,7.791585e-7,0.00008370085,0.05825362,0.000014431474,0.0058177076,0.9261768,0.00032357598],"about_ca_topic_score_codex":0.67718726,"about_ca_topic_score_gemma":0.09455421,"teacher_disagreement_score":0.5826331,"about_ca_system_score_codex":0.00068639644,"about_ca_system_score_gemma":0.0005819069,"threshold_uncertainty_score":0.9999876},"labels":[],"label_agreement":null},{"id":"W3027324875","doi":"10.1016/j.jval.2020.04.960","title":"PND68 EVOLUTION OF THE CANADIAN MARKET FOR PSYCHOSTIMULANTS FOR ATTENTION DEFICIT HYPERACTIVITY DISORDER","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Methylphenidate; Medical prescription; Attention deficit hyperactivity disorder; Dextroamphetamine; Psychiatry; Amphetamine; Medicine; Stimulant; Psychology; Pharmacology; Internal medicine","score_opus":0.07377258964137429,"score_gpt":0.34609899088351115,"score_spread":0.27232640124213686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027324875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9544105,0.00035447787,0.010147868,0.031094974,0.00028523075,0.0032198296,0.0002043155,0.000023337883,0.00025945893],"genre_scores_gemma":[0.9978549,0.000021167247,0.0010848154,0.0006313609,0.000069287285,0.00011835767,0.000041454037,0.00003144192,0.00014723437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99850225,0.00018693773,0.00040670575,0.00030830377,0.00022799372,0.00036777745],"domain_scores_gemma":[0.99885887,0.00033539743,0.00020719355,0.0002488802,0.00014446388,0.00020522551],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006870725,0.00013205742,0.0003408154,0.00012004895,0.00019403586,0.000009335149,0.000094911346,0.00010751556,0.000034660716],"category_scores_gemma":[0.0010041068,0.00011302828,0.00017250486,0.00036351738,0.00003932139,0.00009586004,0.00001559836,0.00019705348,0.000005216034],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007373399,0.00034456042,0.98818725,0.001736131,0.000038708426,5.861402e-7,0.00013102789,0.0031587875,0.000642838,0.0018868988,0.0009949364,0.0021409239],"study_design_scores_gemma":[0.0035203232,0.00040090428,0.8830124,0.0003157343,0.000044536293,0.000008303017,0.0005200957,0.10731381,0.0000052964956,0.00037083315,0.004350384,0.00013733504],"about_ca_topic_score_codex":0.09652076,"about_ca_topic_score_gemma":0.04785045,"teacher_disagreement_score":0.105174825,"about_ca_system_score_codex":0.000530981,"about_ca_system_score_gemma":0.0010388928,"threshold_uncertainty_score":0.9695238},"labels":[],"label_agreement":null},{"id":"W3027354369","doi":"10.1016/j.jval.2020.04.452","title":"PIH58 GEOGRAPHICAL DISPARITIES IN NON-UTILIZATION OF HEALTH FACILITY DELIVERY AND POSTNATAL SERVICES IN GHANA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Maternal and Child Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Health facility; Environmental health; Poverty; Business; Poisson regression; Community health; Geography; Socioeconomics; Medicine; Health services; Public health; Economic growth; Population; Nursing","score_opus":0.03470844041434358,"score_gpt":0.2910844536127891,"score_spread":0.25637601319844555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027354369","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9772812,0.003685637,0.000015707554,0.018313063,0.000043849595,0.00053256965,0.00008805879,0.000015030639,0.000024857938],"genre_scores_gemma":[0.9910637,0.0022262044,0.00013797363,0.006487464,0.000021919082,0.0000047908406,0.000051223175,0.000005533866,0.0000011650287],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981743,0.00022596815,0.0007511397,0.00027380104,0.00022460615,0.00035018497],"domain_scores_gemma":[0.9994418,0.000048271635,0.00012825933,0.000106631516,0.000029540082,0.00024548656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065695425,0.00011678743,0.0005143514,0.00017408849,0.000033009543,0.000005672158,0.00006365335,0.000076644734,0.0000068879503],"category_scores_gemma":[0.000030707044,0.0001084397,0.000026662232,0.0004459776,0.000051237963,0.00007508473,0.00005129685,0.0002799007,0.0000018389136],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000292725,0.00015349039,0.98771673,0.00674899,0.0000030804615,0.000015108433,0.002283469,0.00013674267,0.000006458671,0.00030260228,0.000012628198,0.002327997],"study_design_scores_gemma":[0.0014260174,0.00056265004,0.98844546,0.0009675254,0.0000016686708,0.00001070225,0.0010092305,0.0072974325,0.000010843776,0.00016668528,0.000038260616,0.00006354088],"about_ca_topic_score_codex":0.16422512,"about_ca_topic_score_gemma":0.0033874887,"teacher_disagreement_score":0.16083762,"about_ca_system_score_codex":0.00011876451,"about_ca_system_score_gemma":0.00026115266,"threshold_uncertainty_score":0.84134036},"labels":[],"label_agreement":null},{"id":"W3027400885","doi":"10.1016/j.jval.2020.04.821","title":"PMU47 NOSOCOMIAL INFLUENZA HOSPITALIZATIONS AMONG END-STAGE RENAL DISEASE PATIENTS DURING THE 2013-2014 THROUGH 2015-2016 INFLUENZA SEASONS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Healthcare and Medical Tourism","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; End stage renal disease; Internal medicine; Emergency medicine; Influenza season; Disease; Intensive care medicine; Pediatrics; Influenza vaccine; Virus; Immunology","score_opus":0.06450895319907456,"score_gpt":0.3984255884052816,"score_spread":0.333916635206207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027400885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92048913,0.00241351,0.00019197223,0.06854144,0.0017049595,0.0043205917,0.0008221611,0.0002964567,0.0012197713],"genre_scores_gemma":[0.9156214,0.0020049491,0.00030662847,0.07781984,0.0022974326,0.00064843916,0.00017271799,0.0001240169,0.0010045773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929027,0.0022510625,0.0015321147,0.00072409696,0.00092809426,0.001661929],"domain_scores_gemma":[0.9958703,0.0005897547,0.00072033046,0.00072080473,0.00025033575,0.0018485001],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.001041689,0.0004021145,0.0006098329,0.00009851319,0.0017693546,0.000026670208,0.000591028,0.00034083467,0.00060116936],"category_scores_gemma":[0.0012583795,0.0003066215,0.00016800727,0.00070922176,0.00024783245,0.00042547684,0.0003991543,0.0017572434,0.0006483941],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018013993,0.00017444504,0.7373229,0.0013488928,0.000022609938,0.000022681297,0.008648825,0.0015589006,0.0000014917812,0.0019014751,0.24863084,0.00018677852],"study_design_scores_gemma":[0.0024026064,0.00017727443,0.5503025,0.0009921697,0.000016338323,2.499541e-7,0.00077275786,0.0007944457,0.0000012964977,0.0004054526,0.4438556,0.00027928498],"about_ca_topic_score_codex":0.025535341,"about_ca_topic_score_gemma":0.00071032444,"teacher_disagreement_score":0.19522476,"about_ca_system_score_codex":0.00076803355,"about_ca_system_score_gemma":0.0028123837,"threshold_uncertainty_score":0.9999386},"labels":[],"label_agreement":null},{"id":"W3027445498","doi":"10.1016/j.jval.2020.04.1157","title":"PNS159 THE UTILITY OF UMBRELLA REVIEWS: A CASE-STUDY ON THE SAFETY OF PROTON PUMP INHIBITORS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Generalizability theory; Observational study; Sample size determination; Systematic review; Population; Scale (ratio); Sample (material); Computer science; Quality (philosophy); Meta-analysis; Medicine; Data science; Risk analysis (engineering); Medical physics; MEDLINE; Statistics; Pathology; Mathematics; Environmental health; Geography; Chemistry","score_opus":0.8534689212612868,"score_gpt":0.5460346040034282,"score_spread":0.30743431725785864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027445498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95934427,0.004174004,0.0003099417,0.018635632,0.00015906994,0.01515081,0.000023921595,0.000003613636,0.0021987634],"genre_scores_gemma":[0.99835527,0.00022753228,0.00010204562,0.0010434389,0.00004653033,0.00015097151,3.7405857e-7,0.0000065464087,0.00006730485],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9167152,0.06082876,0.016896015,0.000949782,0.004301476,0.00030877927],"domain_scores_gemma":[0.982337,0.007551439,0.0063656494,0.0033020952,0.00031610782,0.00012772834],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.22761506,0.0002096557,0.0031485432,0.0001047108,0.0001490301,0.00006244286,0.0013285407,0.00004261924,0.0010940412],"category_scores_gemma":[0.0396895,0.00006852174,0.00092289987,0.0023369633,0.00009676071,0.000047229558,0.00014344593,0.00029230257,0.00020447059],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003211655,0.002697388,0.5474671,0.009718455,0.00054616714,0.00013785131,0.17572458,0.0024200077,0.000058669146,0.006092609,0.13807876,0.116737224],"study_design_scores_gemma":[0.002038117,0.004245781,0.0629541,0.0035706572,0.00051739014,0.00018397546,0.12583119,0.21939042,0.0004631221,0.0062263575,0.5737332,0.0008456974],"about_ca_topic_score_codex":0.0018050874,"about_ca_topic_score_gemma":0.00009035334,"teacher_disagreement_score":0.48451304,"about_ca_system_score_codex":0.000029262319,"about_ca_system_score_gemma":0.00020181938,"threshold_uncertainty_score":0.9998191},"labels":[],"label_agreement":null},{"id":"W3027511647","doi":"10.1016/j.jval.2020.04.1492","title":"RW2 THE USE OF REAL-WORLD DATA IN HEALTH TECHNOLOGY ASSESSMENT OF MEDICATIONS FOR RARE DISEASES IN CANADA AND THE UK","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Nice; Observational study; Medicine; Health technology; Family medicine; Real world data; Disease; Rare disease; Data extraction; MEDLINE; Data science; Health care; Political science; Computer science; Internal medicine","score_opus":0.5814513806912681,"score_gpt":0.47190512632206744,"score_spread":0.10954625436920068,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027511647","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2578586,0.004567125,0.0007089111,0.73064184,0.00014868352,0.002720541,0.0033153761,0.000008367708,0.00003059272],"genre_scores_gemma":[0.98201245,0.002767759,0.0025094675,0.012369464,0.000039771046,0.00018290013,0.00009650894,0.000013012741,0.000008688664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942082,0.000791531,0.0041776295,0.00040306096,0.00009793255,0.0003216305],"domain_scores_gemma":[0.99220324,0.0044322493,0.0024379832,0.00077141233,0.000027988197,0.00012710974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011985566,0.0000993685,0.0009896451,0.00031974528,0.00007958016,0.000010392627,0.00048707178,0.000034485056,0.000013215897],"category_scores_gemma":[0.0034185862,0.0000879729,0.000023554263,0.00070520514,0.00017425245,0.000116346,0.00012707169,0.00020517258,8.23306e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019263443,0.00003896448,0.8198691,0.0010469374,0.000015211484,1.8201253e-7,0.0010403368,0.0041362685,2.2545974e-8,0.16982558,0.0036516616,0.00035647166],"study_design_scores_gemma":[0.0017602108,0.00008669532,0.72950613,0.00032818472,0.000003368604,5.4621603e-7,0.0031088714,0.24646956,1.4541023e-7,0.0067015593,0.011924809,0.00010992815],"about_ca_topic_score_codex":0.9725815,"about_ca_topic_score_gemma":0.9574797,"teacher_disagreement_score":0.7241538,"about_ca_system_score_codex":0.0010600067,"about_ca_system_score_gemma":0.005166828,"threshold_uncertainty_score":0.9165731},"labels":[],"label_agreement":null},{"id":"W3027591386","doi":"10.1016/j.jval.2020.04.1342","title":"PRS17 COST-EFFECTIVENESS OF CASE DETECTION STRATEGIES FOR THE EARLY DETECTION OF COPD","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; COPD; Guideline; Cost effectiveness; Cost-effectiveness analysis; Spirometry; Population; Willingness to pay; Emergency medicine; Inhaler; Economic evaluation; Health care; Physical therapy; Pediatrics; Asthma; Internal medicine; Environmental health","score_opus":0.17538076928570642,"score_gpt":0.3306669253024309,"score_spread":0.1552861560167245,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027591386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77895,0.002034008,0.2119597,0.0029149184,0.00044251792,0.003245392,0.00016653196,0.000024893896,0.00026208672],"genre_scores_gemma":[0.99928576,0.00018728658,0.00009893179,0.00018599161,0.000050786686,0.00017695785,0.0000010990561,0.000010267996,0.000002948533],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99894494,0.00011259084,0.0005590932,0.00017848534,0.000025287625,0.00017961422],"domain_scores_gemma":[0.9990609,0.00036794742,0.0003503981,0.00013806486,0.00002990697,0.000052750416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015742859,0.000069276735,0.00026980776,0.00010790797,0.00007543681,0.000011622587,0.00007459121,0.00004984593,0.0000028485263],"category_scores_gemma":[0.00016886397,0.000068287205,0.000056732362,0.0002756779,0.000029599085,0.00009618962,0.000018073555,0.000099324534,0.0000037556786],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000986569,0.00024262186,0.005622448,0.015921198,0.00014781699,0.000013179831,0.012011611,0.070143834,0.00059035985,0.7921108,0.00003691582,0.10217265],"study_design_scores_gemma":[0.008677218,0.010163088,0.15863565,0.00073685707,0.00004775092,0.000069506015,0.0090407785,0.5721178,0.019138454,0.15457492,0.06578874,0.0010092177],"about_ca_topic_score_codex":0.08923454,"about_ca_topic_score_gemma":0.0012440776,"teacher_disagreement_score":0.63753587,"about_ca_system_score_codex":0.00012272707,"about_ca_system_score_gemma":0.000071669965,"threshold_uncertainty_score":0.9168303},"labels":[],"label_agreement":null},{"id":"W3027623322","doi":"10.1016/j.jval.2020.04.1029","title":"PNS18 IMPROVING THE APPLICATION OF PUBLISHED HEALTH UTILITIES IN COST-UTILITY ANALYSES: DEVELOPMENT OF THE HEALTH UTILITY APPLICATION TOOL (HAT)","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institutes of Health Research; University of Ottawa; Princess Margaret Cancer Centre; University of Toronto; McMaster University","funders":"","keywords":"Relevance (law); Health economics; Context (archaeology); Cost–utility analysis; Population; Reimbursement; Medicine; Population health; Actuarial science; Health care; Public health; Environmental health; Cost effectiveness; Risk analysis (engineering); Business; Economics; Nursing; Political science; Geography","score_opus":0.4635269331228747,"score_gpt":0.44454746574912946,"score_spread":0.01897946737374523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027623322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6026342,0.009978008,0.08418998,0.28879002,0.00050784927,0.012728876,0.000631094,0.00008284313,0.00045711693],"genre_scores_gemma":[0.9836511,0.00012190722,0.0032770042,0.0122718075,0.00012746715,0.00046339183,0.000055393702,0.000023372497,0.000008553762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98623383,0.0021429954,0.009704118,0.0009274878,0.00029555272,0.000696022],"domain_scores_gemma":[0.9907247,0.0010641196,0.006650081,0.0012101589,0.00011304283,0.00023788754],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.046375174,0.00024291035,0.0015327965,0.00027753567,0.00033132255,0.000039102244,0.0007642336,0.00012801003,0.00004416751],"category_scores_gemma":[0.0033622878,0.00022565664,0.00014117682,0.0012222606,0.00016661984,0.0003573773,0.00016463282,0.0004593904,0.00002802283],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018572871,0.001064237,0.7182015,0.016044594,0.0000794357,7.5618665e-8,0.08474204,0.008022293,0.000014552582,0.085927404,0.0049102153,0.0808079],"study_design_scores_gemma":[0.0010831684,0.0001621973,0.61227036,0.000245438,0.0000023279483,7.4540515e-7,0.007308254,0.34850717,0.000053837808,0.006140867,0.023941614,0.0002840481],"about_ca_topic_score_codex":0.05400848,"about_ca_topic_score_gemma":0.003509774,"teacher_disagreement_score":0.3810169,"about_ca_system_score_codex":0.0018944327,"about_ca_system_score_gemma":0.004011368,"threshold_uncertainty_score":0.98195744},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":[],"domain":null,"study_design":"theoretical_or_conceptual","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W3027712008","doi":"10.1016/j.jval.2020.04.1268","title":"PRO42 ASSESSING GLOBAL PEDIATRIC MULTIPLE SCLEROSIS EPIDEMIOLOGY: A SYSTEMATIC LITERATURE REVIEW AND META-ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Epidemiology; Incidence (geometry); Medicine; Meta-analysis; Population; Systematic review; Demography; Disease; Multiple sclerosis; MEDLINE; Pediatrics; Environmental health; Internal medicine; Immunology; Biology","score_opus":0.43310155539118017,"score_gpt":0.44271438963547255,"score_spread":0.009612834244292379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027712008","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006655393,0.9085895,0.00033061174,0.08039264,0.00002292406,0.003771065,0.00011854556,0.00007990058,0.000039429895],"genre_scores_gemma":[0.6429832,0.32328457,0.011404798,0.021500697,0.00016269556,0.00056860707,0.000045254255,0.000027023872,0.00002314126],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99387693,0.0028465684,0.0014967037,0.0007117459,0.00044294394,0.00062510173],"domain_scores_gemma":[0.9965123,0.001746583,0.0005063066,0.0004487415,0.00019093654,0.0005951587],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.004951176,0.0003008385,0.004439457,0.00021708789,0.00014312021,0.000041818494,0.0001495793,0.00011187724,0.00003229484],"category_scores_gemma":[0.016916653,0.0001991631,0.000642477,0.0034398788,0.000067501125,0.00014018512,0.00015606957,0.0004868617,0.000011976463],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030088517,0.00014460029,0.2799984,0.6930892,0.02330446,0.000027140717,0.00078251876,0.0003268937,0.0000068190125,0.000072154064,0.0020880275,0.00012973331],"study_design_scores_gemma":[0.0025256875,0.0006994612,0.5154441,0.022291534,0.40960804,0.00005225964,0.00032164328,0.048148014,0.0000025652457,0.000073854426,0.00015555293,0.0006772579],"about_ca_topic_score_codex":0.00047233835,"about_ca_topic_score_gemma":0.00003070135,"teacher_disagreement_score":0.67079765,"about_ca_system_score_codex":0.00023988384,"about_ca_system_score_gemma":0.00022509682,"threshold_uncertainty_score":0.9913643},"labels":[],"label_agreement":null},{"id":"W3027747692","doi":"10.1016/j.jval.2020.04.1152","title":"PNS152 MODELS USING ARM-BASED DATA ENTRY MAY GIVE MISLEADING INCONSISTENCY RESULTS IN NETWORK META-ANALYSES INVOLVING MULTI-ARM TRIALS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Placebo; Leverage (statistics); Randomization; Inference; Meta-analysis; Clinical trial; Causal inference; Statistics; Contrast (vision); Bayesian probability; Econometrics; Medicine; Computer science; Physical medicine and rehabilitation; Mathematics; Artificial intelligence; Internal medicine","score_opus":0.984981316700297,"score_gpt":0.6454214011592782,"score_spread":0.33955991554101883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027747692","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.08310871,0.18728545,0.64375544,0.06041044,0.0029083462,0.016986128,0.0022126727,0.00012902293,0.0032038128],"genre_scores_gemma":[0.82925177,0.00037964052,0.16545795,0.0041465852,0.0003372776,0.000045372104,0.000105094856,0.00004291972,0.00023338397],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.8245405,0.11880266,0.04376275,0.0043299617,0.0071261507,0.0014379625],"domain_scores_gemma":[0.9231364,0.045973495,0.02027045,0.008899737,0.00079868676,0.00092120457],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.35952258,0.0006239403,0.0123368865,0.0008932379,0.0002647691,0.0007750574,0.003466247,0.00018891595,0.0010043131],"category_scores_gemma":[0.17146964,0.0003484254,0.0023308278,0.005243465,0.00007452793,0.0007427379,0.0005580117,0.0005874909,0.00015320208],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007036615,0.00015580648,0.0028491216,0.00028754343,0.0008876457,0.00002925418,0.0016331334,0.9841742,0.000029521252,0.00032561994,0.008095669,0.0014621074],"study_design_scores_gemma":[0.0010795613,0.000056520552,0.00011577345,0.0003007319,0.0014274277,0.0000025269621,0.0010351045,0.99047333,0.000010720206,0.0023744556,0.002833511,0.0002903202],"about_ca_topic_score_codex":0.004690794,"about_ca_topic_score_gemma":0.00086243765,"teacher_disagreement_score":0.74614304,"about_ca_system_score_codex":0.00026418368,"about_ca_system_score_gemma":0.0011199667,"threshold_uncertainty_score":0.9999089},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"simulation_or_modeling","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W3027757439","doi":"10.1016/j.jval.2020.04.1575","title":"PCN73 COST-EFFECTIVENESS OF BLINATUMOMAB VERSUS STANDARD OF CARE IN ADULT PATIENTS WITH PHILADELPHIA-CHROMOSOME-POSITIVE RELAPSED OR REFRACTORY B-CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA FROM A CANADIAN HEALTHCARE SECTOR PERSPECTIVE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Blinatumomab; Medicine; Population; Internal medicine; Oncology; Lymphoblastic Leukemia; Leukemia","score_opus":0.02414033120568015,"score_gpt":0.30001612231371944,"score_spread":0.2758757911080393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027757439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862614,0.0009535032,0.000047297624,0.0020186605,0.0002253622,0.0053515467,0.004919533,0.000039171857,0.00018350665],"genre_scores_gemma":[0.99797875,0.0002493851,0.00056822546,0.0003510699,0.000082372324,0.0001754306,0.00047673535,0.00011332721,0.0000047018175],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9946406,0.001176251,0.0009811025,0.0009872126,0.0012100909,0.0010047617],"domain_scores_gemma":[0.99414396,0.0019079921,0.0005042151,0.0005179846,0.0017601757,0.0011656441],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039363973,0.0004738401,0.001565933,0.0006978266,0.00009073332,0.000012251947,0.00032785922,0.00035322108,0.000047015663],"category_scores_gemma":[0.001225976,0.00040475736,0.00011745129,0.0017425528,0.00026546535,0.0001754459,0.00009209094,0.0009404605,0.000007773127],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.7598551,0.0017461487,0.112225786,0.019595942,0.001069228,0.0022930037,0.09263108,0.00710432,0.00080330885,0.0005841533,0.0003979665,0.0016939862],"study_design_scores_gemma":[0.33119997,0.20668373,0.35682976,0.031323165,0.0006069404,0.000040547726,0.039290104,0.01680007,0.014932151,0.00012569776,0.00022747708,0.0019403744],"about_ca_topic_score_codex":0.40541196,"about_ca_topic_score_gemma":0.11575713,"teacher_disagreement_score":0.4286551,"about_ca_system_score_codex":0.03722124,"about_ca_system_score_gemma":0.03665667,"threshold_uncertainty_score":0.99984044},"labels":[],"label_agreement":null},{"id":"W3027820444","doi":"10.1016/j.jval.2020.04.1312","title":"PRO91 REDUCTION IN HRQOL WITH INCREASING VOC FREQUENCY AMONG PATIENTS WITH SCD","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Discontinuation; Observational study; Quality of life (healthcare); EQ-5D; Cohort; Cohort study; Pediatrics; Demography; Disease; Internal medicine; Health related quality of life","score_opus":0.015133686863505271,"score_gpt":0.2370791572203594,"score_spread":0.22194547035685414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027820444","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923641,0.00029687036,0.000035123936,0.0053452877,0.0000620102,0.0011791345,0.0000025848817,0.0000535602,0.0006612926],"genre_scores_gemma":[0.9972033,0.000117445496,0.0019729026,0.00056822784,0.000051964318,0.000020350966,0.000026286625,0.000029335348,0.0000101851565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854624,0.00016306799,0.0003658643,0.00030610213,0.00027612623,0.0003426053],"domain_scores_gemma":[0.99941784,0.000020239768,0.00012758114,0.00014299949,0.00005298209,0.00023837875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002878932,0.00013904764,0.00029250284,0.0001390036,0.000058346057,0.000009190351,0.00004588076,0.000096458374,0.000013884351],"category_scores_gemma":[0.00010062936,0.00009908266,0.000018251316,0.00073015405,0.00007466969,0.000114776434,0.000012181593,0.00045963252,0.000006946358],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061662175,0.00025059815,0.99148285,0.00048648522,0.000012827341,0.000038950304,0.0029976305,0.0013089833,0.000026261278,0.000063829655,0.00007354413,0.0026414131],"study_design_scores_gemma":[0.0069146664,0.0029981036,0.98165244,0.0028876488,0.000021921707,0.000037656002,0.0016166819,0.003384636,0.000044950004,0.00007393258,0.00013313627,0.00023421863],"about_ca_topic_score_codex":0.014247193,"about_ca_topic_score_gemma":0.00011382894,"teacher_disagreement_score":0.014133364,"about_ca_system_score_codex":0.00024468193,"about_ca_system_score_gemma":0.00046530511,"threshold_uncertainty_score":0.992317},"labels":[],"label_agreement":null},{"id":"W3027822766","doi":"10.1016/j.jval.2020.04.1799","title":"PCN341 REAL-WORLD TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION (HRU) IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA (MRCC)","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"","keywords":"Medicine; Discontinuation; Internal medicine; Regimen; Ambulatory; Incidence (geometry); Renal cell carcinoma; Retrospective cohort study; Oncology; Emergency medicine","score_opus":0.08793599950874943,"score_gpt":0.29811222298814666,"score_spread":0.21017622347939724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027822766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99141395,0.0008243658,0.000023316177,0.005161584,0.000026191237,0.0021079055,0.000058898706,0.000039214337,0.0003445575],"genre_scores_gemma":[0.99724615,0.0002778615,0.0007108295,0.0011719781,0.000049732997,0.00007827801,0.0003155782,0.000055599958,0.00009399611],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99720097,0.00048106175,0.0006947253,0.0006416643,0.00044949478,0.0005320792],"domain_scores_gemma":[0.99869996,0.000117405805,0.00022805796,0.0003369966,0.00005607046,0.0005614872],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00022966437,0.00032223386,0.0006852875,0.00032485757,0.0000705513,0.000016985105,0.00006288044,0.000051960804,0.00002028552],"category_scores_gemma":[0.00001946282,0.00024896828,0.000049379665,0.0006139981,0.000037649872,0.000065355176,0.000034920013,0.00023106462,0.000006699127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010212038,0.0005290315,0.98837227,0.0011534746,0.00001728464,0.00018468253,0.0035637557,0.00048789312,0.0000050901754,0.000046188685,0.000049597747,0.0045695505],"study_design_scores_gemma":[0.00838444,0.0076029706,0.98037505,0.00041030734,0.000050391922,0.0000066403636,0.00038575285,0.001825209,0.00037521037,0.000013658597,0.0003957909,0.00017455702],"about_ca_topic_score_codex":0.056323994,"about_ca_topic_score_gemma":0.0046070884,"teacher_disagreement_score":0.051716905,"about_ca_system_score_codex":0.001363549,"about_ca_system_score_gemma":0.00047721763,"threshold_uncertainty_score":0.99999624},"labels":[],"label_agreement":null},{"id":"W3027934943","doi":"10.1016/j.jval.2020.04.927","title":"PND34 RESOURCE USE RELATED TO CERVICAL DYSTONIA, PEDIATRIC LOWER LIMB SPASTICITY AND ADULT UPPER LIMB SPASTICITY IN THE UNITED KINGDOM: A PHYSICIAN QUESTIONNAIRE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Spasticity; Cervical dystonia; Gabapentin; Dystonia; Physical therapy; Internal medicine; Psychiatry","score_opus":0.0491245793622048,"score_gpt":0.2890550414252006,"score_spread":0.23993046206299581,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3027934943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8980585,0.0002256936,0.00008710117,0.10038117,0.00009064468,0.0009481298,0.0000082066945,0.00010850288,0.00009208589],"genre_scores_gemma":[0.93368095,0.00034037884,0.00015636206,0.065595165,0.00014004162,0.0000192203,0.000016837912,0.000033573764,0.000017472858],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967828,0.0008957649,0.00069081277,0.00061358995,0.00040833693,0.00060874096],"domain_scores_gemma":[0.9983343,0.0006571264,0.00013490737,0.00028656772,0.00007372514,0.0005133923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046666604,0.0002815988,0.0005005807,0.0003014083,0.00014126638,0.00003581675,0.00018541922,0.000322263,0.000017216176],"category_scores_gemma":[0.0019181767,0.00019846995,0.000093037175,0.002258646,0.000117578464,0.00006664638,0.000099297016,0.0015991118,0.000053244916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009443066,0.004624091,0.8883748,0.0023365007,0.00009723047,0.0017341253,0.015158593,0.056833085,0.00020274361,0.013500393,0.005121893,0.0025734846],"study_design_scores_gemma":[0.0031637165,0.005045959,0.9301556,0.00046645876,0.000083330335,0.000049931074,0.0002824381,0.057096574,0.0000054473753,0.0004892102,0.0028195546,0.00034179905],"about_ca_topic_score_codex":0.002815553,"about_ca_topic_score_gemma":0.00007100027,"teacher_disagreement_score":0.041780785,"about_ca_system_score_codex":0.00009806885,"about_ca_system_score_gemma":0.00013700461,"threshold_uncertainty_score":0.80933696},"labels":[],"label_agreement":null},{"id":"W3028020071","doi":"10.1016/j.jval.2020.04.1540","title":"PCN34 COMPATIBILITY OF CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELL THERAPY STUDIES IN THE TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA (LBCL) FOR INDIRECT TREATMENT COMPARISON (ITC) ANALYSES","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology; Clinical trial; Population; Refractory (planetary science); Chimeric antigen receptor; Transplantation; Salvage therapy; Immunotherapy; Cancer; Chemotherapy","score_opus":0.2432661122207745,"score_gpt":0.42804879365365917,"score_spread":0.18478268143288468,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028020071","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9800627,0.014764527,0.00000987024,0.00038320117,0.00006729622,0.00443757,0.00018102513,0.000019078929,0.00007468201],"genre_scores_gemma":[0.9876263,0.011159838,0.00055713655,0.00016427926,0.000054180036,0.0001880816,0.00016649415,0.000039326784,0.00004437272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99650973,0.00092066446,0.000997255,0.00049832015,0.0005822601,0.0004917725],"domain_scores_gemma":[0.99763674,0.0009705777,0.000516531,0.0005458286,0.00017755004,0.00015275695],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070274074,0.00032675933,0.0014934795,0.00023693831,0.00008241411,0.000006291663,0.00017074002,0.00007939842,0.00005375703],"category_scores_gemma":[0.000051811865,0.00019036572,0.00021438455,0.0008240286,0.00016321495,0.000042766595,0.000017461633,0.00011556319,0.0000024804451],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007781943,0.030905413,0.8911341,0.0008000834,0.0003920842,0.0000037453988,0.046298664,0.00027894715,0.003487664,0.000002000524,0.00015584861,0.018759543],"study_design_scores_gemma":[0.090655014,0.09656534,0.7102589,0.0003888607,0.0001455846,8.2255883e-7,0.011890094,0.0029438792,0.07339211,0.00001579842,0.013345217,0.00039837207],"about_ca_topic_score_codex":0.0046072565,"about_ca_topic_score_gemma":0.00029666146,"teacher_disagreement_score":0.18087515,"about_ca_system_score_codex":0.0010004111,"about_ca_system_score_gemma":0.0005571575,"threshold_uncertainty_score":0.77628887},"labels":[],"label_agreement":null},{"id":"W3028026700","doi":"10.1016/j.jval.2020.04.1519","title":"PCN13 FACTORS THAT MODIFY THE EFFECT OF MONO- OR COMBINATION PD-1/PD-L1 INHIBITOR THERAPIES ON SURVIVAL OUTCOMES IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: A SYSTEMATIC REVIEW AND META-ANALYSIS","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University","funders":"","keywords":"Medicine; Meta-analysis; Hazard ratio; Subgroup analysis; Internal medicine; Renal cell carcinoma; Oncology; Randomized controlled trial; Relative risk; Cochrane Library; Confidence interval","score_opus":0.12982187583047608,"score_gpt":0.3417928850839819,"score_spread":0.21197100925350584,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028026700","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035381,0.9487392,0.0000037513576,0.00028402967,0.000038921247,0.015355427,0.00016759464,0.000016092592,0.000014033895],"genre_scores_gemma":[0.3761134,0.6222477,0.000053828284,0.00012050623,0.0000058968294,0.0010785259,0.0002420238,0.0000826406,0.000055470173],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9889721,0.006516071,0.0021991346,0.0007380883,0.0011707018,0.00040384845],"domain_scores_gemma":[0.99306494,0.00364572,0.0020684407,0.0009289501,0.00008196983,0.00020996373],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.002366577,0.0009603352,0.0153299915,0.0007486456,0.00006415076,0.000027728567,0.00024876985,0.00013105258,0.000021815074],"category_scores_gemma":[0.00026646498,0.00037207844,0.00152735,0.0014951525,0.00007812314,0.000064443804,0.00006434256,0.00061346625,0.000004300931],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001786107,0.00040520783,0.019936789,0.9543277,0.02422745,0.000040029576,0.00048642198,0.000019568888,1.3251901e-8,0.000010067835,0.0000054730763,0.0003626551],"study_design_scores_gemma":[0.0046911864,0.011140149,0.017982598,0.067143135,0.8980462,0.0000097962475,0.00014041032,0.00007134526,0.000009289679,0.000007118305,0.00013961118,0.00061914796],"about_ca_topic_score_codex":0.0017804626,"about_ca_topic_score_gemma":0.00007003781,"teacher_disagreement_score":0.88718456,"about_ca_system_score_codex":0.00074889575,"about_ca_system_score_gemma":0.0003859039,"threshold_uncertainty_score":0.9998731},"labels":[],"label_agreement":null},{"id":"W3028028781","doi":"10.1016/j.jval.2020.04.346","title":"PDG60 OPIOID PRESCRIBING IN CANADA: HOW ARE PRACTICES CHANGING?","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Medical prescription; Medicine; Opioid; Addiction; Chronic pain; Population; Health care; Psychiatry; Environmental health; Pharmacology; Internal medicine","score_opus":0.07838127476695059,"score_gpt":0.30163685747627517,"score_spread":0.22325558270932458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028028781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8567903,0.004657915,0.00000763067,0.1373077,0.0001748287,0.0008460056,0.00001590317,0.00003311457,0.00016656272],"genre_scores_gemma":[0.99276507,0.00048211103,0.00061729626,0.005864663,0.00012347498,0.000048899892,0.000019524416,0.000026027574,0.00005293469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984258,0.00014042959,0.00028886477,0.0003337242,0.0003100243,0.0005011917],"domain_scores_gemma":[0.9990713,0.00012105423,0.00031218978,0.00020381367,0.0000256033,0.00026603957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024465675,0.00014572915,0.0003752784,0.00013933289,0.00004137612,0.000013824726,0.00008262452,0.00003946641,0.000021265236],"category_scores_gemma":[0.0005666143,0.00013914578,0.000026432526,0.00051208667,0.000009086535,0.000092164,0.00004320961,0.0002930657,0.000007647157],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013076674,0.00022204047,0.97717565,0.0020561041,0.000028483382,0.00059017516,0.013245723,0.001161996,0.000034481127,0.00012855565,0.00263074,0.0025952521],"study_design_scores_gemma":[0.0062600677,0.0010155081,0.86654186,0.003150068,0.000049332277,0.000051782095,0.03765532,0.047463503,0.00051612,0.000060623595,0.036724176,0.00051160675],"about_ca_topic_score_codex":0.9248317,"about_ca_topic_score_gemma":0.5642037,"teacher_disagreement_score":0.36062798,"about_ca_system_score_codex":0.0014207241,"about_ca_system_score_gemma":0.0039717304,"threshold_uncertainty_score":0.7045679},"labels":[],"label_agreement":null},{"id":"W3028033786","doi":"10.1016/j.jval.2020.04.1147","title":"PNS147 VISUALIZATION AND COMMUNICATION OF RESULTS FROM BAYESIAN NETWORK META-ANALYSIS: PAST, PRESENT, AND FUTURE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Computer science; Bayesian probability; Visualization; Bayesian network; Data science; Bayesian statistics; Bayesian inference; Data mining; Artificial intelligence","score_opus":0.7322393485829635,"score_gpt":0.5182469085323363,"score_spread":0.21399244005062712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028033786","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.11958437,0.34931752,0.1660742,0.35421273,0.0003336065,0.006343744,0.0008705444,0.000043981872,0.003219301],"genre_scores_gemma":[0.9817196,0.0017991692,0.014509806,0.0012899985,0.0003880306,0.000020846306,0.00010703852,0.000010669573,0.00015483359],"study_design_codex":"not_applicable","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9691368,0.020203833,0.0078097717,0.000808582,0.001856419,0.00018463204],"domain_scores_gemma":[0.98923624,0.003766192,0.004609624,0.001908627,0.00027295802,0.00020636569],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04974454,0.00017586064,0.0038721436,0.0002183197,0.00010512039,0.00020627887,0.00059150445,0.00007357492,0.00042765922],"category_scores_gemma":[0.0022288612,0.000095531235,0.00075072906,0.0027322432,0.00004437486,0.00015491036,0.00013735262,0.000120936485,0.00001294589],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036081576,0.00038708167,0.18750294,0.0011082927,0.09160437,0.0000070366254,0.086088076,0.19794965,0.000012973761,0.051968344,0.34047648,0.042533964],"study_design_scores_gemma":[0.0005247348,0.000102307065,0.0359747,0.000029017981,0.019934872,8.7842847e-7,0.002361074,0.827282,0.000002828551,0.0111913895,0.10238563,0.00021053039],"about_ca_topic_score_codex":0.001309886,"about_ca_topic_score_gemma":0.00014721994,"teacher_disagreement_score":0.86213523,"about_ca_system_score_codex":0.000012114717,"about_ca_system_score_gemma":0.00004426805,"threshold_uncertainty_score":0.97848797},"labels":[],"label_agreement":null},{"id":"W3028075797","doi":"10.1016/j.jval.2020.04.1028","title":"PNS15 IMPROVING UNDERSTANDING OF UNCERTAINTY IN ECONOMIC MODELS THROUGH MACHINE LEARNING : POSSIBILITIES AND RECOMMENDATIONS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Cart; Interpretability; Machine learning; Computer science; Artificial intelligence; Parametric statistics; Sensitivity (control systems); Probabilistic logic; Regression; Selection (genetic algorithm); Parametric model; Econometrics; Data mining; Statistics; Mathematics; Engineering","score_opus":0.5789832477018952,"score_gpt":0.4220951941486235,"score_spread":0.15688805355327173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028075797","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7518279,0.009390015,0.022669852,0.21099962,0.0004826116,0.0016051342,0.0005691741,0.00008335473,0.0023723603],"genre_scores_gemma":[0.99228245,0.0010041248,0.0031746286,0.0033561855,0.00006986748,0.000026194404,0.000031533604,0.000026033138,0.00002898376],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9947319,0.000593903,0.0037202938,0.0005204851,0.000046963232,0.00038647396],"domain_scores_gemma":[0.9969054,0.0011987002,0.0015469156,0.00019463303,0.000011493191,0.00014284925],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009517004,0.00015512177,0.00091309473,0.00028102088,0.00013548083,0.000044474556,0.00014111039,0.00009126661,0.00008550366],"category_scores_gemma":[0.0011464144,0.00021253285,0.000052344556,0.00019349135,0.000066068824,0.0006186222,0.000068665664,0.00032504974,0.000024845913],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021704187,0.00003134715,0.038729295,0.001095589,0.000012445252,3.4155974e-7,0.02613216,0.39855164,9.2718454e-7,0.5350535,0.00019184395,0.00017918379],"study_design_scores_gemma":[0.00077002775,0.00012737622,0.0007043466,0.00016776078,0.0000010031933,0.000001157137,0.010492706,0.8353667,6.3863126e-7,0.15151216,0.0006898788,0.00016620004],"about_ca_topic_score_codex":0.073607415,"about_ca_topic_score_gemma":0.0019029316,"teacher_disagreement_score":0.43681508,"about_ca_system_score_codex":0.001937213,"about_ca_system_score_gemma":0.00036401156,"threshold_uncertainty_score":0.9325615},"labels":[],"label_agreement":null},{"id":"W3028101882","doi":"10.1016/j.jval.2020.04.1748","title":"PCN282 VALIDATION AND CALIBRATION OF A DISCRETE EVENT SIMULATION TREATMENT SEQUENCING MODEL TO ESTIMATE LONG-TERM SURVIVAL OF PATIENTS WITH MULTIPLE MYELOMA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Survival analysis; Proportional hazards model; Calibration; Population; Event (particle physics); Cancer registry; Overall survival; Oncology; Multiple myeloma; Progression-free survival; Term (time); Covariate; Internal medicine; Statistics; Cancer; Mathematics","score_opus":0.5010529218027832,"score_gpt":0.5316223444785074,"score_spread":0.030569422675724267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028101882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5433307,0.0000038498656,0.45567778,0.00012941785,0.000024605042,0.0007312176,0.0000889599,0.000011471159,0.0000020019515],"genre_scores_gemma":[0.6716194,0.0000036976166,0.32829666,0.000022543867,0.000015060055,0.0000149770685,0.000011892043,0.0000147012415,0.0000010590213],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976242,0.0006057973,0.0010221961,0.00026803967,0.0003175665,0.0001622077],"domain_scores_gemma":[0.99271697,0.006394168,0.00047398094,0.00017143077,0.00008788419,0.00015555804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008965019,0.00013298598,0.0005350252,0.00005750725,0.00002910475,0.000008464015,0.000055537083,0.000055849396,0.000004426334],"category_scores_gemma":[0.008268855,0.0001055738,0.000033551863,0.00018402385,0.00003301176,0.00007954814,0.00003382599,0.000061893705,2.658655e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054144114,0.00011985628,0.1441916,0.0008149936,0.000020988498,6.104588e-7,0.0018490808,0.84626603,0.000108374516,0.0023655929,5.7190465e-7,0.0037208775],"study_design_scores_gemma":[0.0016667757,0.0011431924,0.03681279,0.0003072885,0.000028335031,6.523706e-8,0.000019995106,0.93937474,0.0011432476,0.019410541,1.0481117e-7,0.00009294297],"about_ca_topic_score_codex":0.0001812669,"about_ca_topic_score_gemma":0.00002802059,"teacher_disagreement_score":0.1282887,"about_ca_system_score_codex":0.0002196624,"about_ca_system_score_gemma":0.00016688091,"threshold_uncertainty_score":0.9899188},"labels":[],"label_agreement":null},{"id":"W3028105516","doi":"10.1016/j.jval.2020.04.1035","title":"PNS25 METHODS FOR DETECTING TREATMENT EFFECT MODIFIERS IN ANCHORED INDIRECT TREATMENT COMPARISONS: AN OVERVIEW AND SIMULATION STUDY OF MACHINE LEARNING ALGORITHMS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Feature selection; Machine learning; Computer science; Leverage (statistics); Collinearity; Artificial intelligence; Propensity score matching; Selection bias; Random forest; Matching (statistics); Bayesian probability; Statistics; Mathematics","score_opus":0.6766310166177457,"score_gpt":0.5460223350871631,"score_spread":0.13060868153058258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028105516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97027767,0.014099421,0.0095798755,0.0015609672,0.00012302493,0.004238991,0.00007211792,0.000036070054,0.000011857178],"genre_scores_gemma":[0.9756827,0.0007774787,0.022680126,0.0003444869,0.00007415457,0.0003720678,0.0000317184,0.000032627177,0.0000046786795],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9926899,0.0031186969,0.0031377738,0.0006386588,0.000055291708,0.00035967695],"domain_scores_gemma":[0.9941519,0.0038373724,0.0015662835,0.0002248692,0.000019034269,0.00020057308],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.014253416,0.00023541058,0.0017159792,0.00038694456,0.0001466971,0.000028822955,0.00008794655,0.00008910826,0.000007200237],"category_scores_gemma":[0.0019741135,0.00025439917,0.000074560376,0.00033356706,0.00001776371,0.00018923379,0.000020387175,0.00013774874,0.0000037286575],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015178585,0.0006144031,0.36145195,0.000938846,0.00007977144,6.095955e-7,0.031480264,0.5464732,0.0000021137146,0.00020180503,0.000002911954,0.058602322],"study_design_scores_gemma":[0.0045253183,0.007224558,0.031726334,0.00009705431,0.000010033582,4.755735e-7,0.0022147808,0.95295566,0.0000123046375,0.0002525939,0.0008134732,0.00016742757],"about_ca_topic_score_codex":0.031749938,"about_ca_topic_score_gemma":0.0012182584,"teacher_disagreement_score":0.40648243,"about_ca_system_score_codex":0.0013848088,"about_ca_system_score_gemma":0.00012477665,"threshold_uncertainty_score":0.9999908},"labels":[],"label_agreement":null},{"id":"W3028188420","doi":"10.1016/j.jval.2020.04.1534","title":"PCN28 CYCLIN-DEPENDENT KINASE 4/6 INHIBITORS (CDK4/6I) IN HORMONE RECEPTOR-POSITIVE/HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE (HR+/HER2-) ADVANCED/METASTATIC BREAST CANCER (A/MBC): A SYSTEMATIC LITERATURE REVIEW OF REAL-WORLD EVIDENCE (RWE) STUDIES","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Palbociclib; Letrozole; Medicine; Fulvestrant; Metastatic breast cancer; Internal medicine; Oncology; Progression-free survival; Cyclin-dependent kinase 4; Cancer; Breast cancer; Aromatase; Gynecology; Estrogen receptor; Overall survival; Cyclin-dependent kinase 2; Cell cycle","score_opus":0.06409227364805688,"score_gpt":0.3774474890229369,"score_spread":0.31335521537488004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028188420","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16903083,0.7847116,0.00006600754,0.035606507,0.0005749862,0.008795224,0.0009953736,0.00017507758,0.000044406253],"genre_scores_gemma":[0.5461816,0.44405755,0.0035579808,0.004431884,0.00040893056,0.0010341865,0.00005583785,0.00014472762,0.00012729417],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99109393,0.0022356273,0.0032499954,0.0012246824,0.0012042096,0.0009915385],"domain_scores_gemma":[0.9943554,0.0015613709,0.0019302135,0.0006616168,0.000869434,0.00062200066],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017121735,0.00083757733,0.0034980737,0.00057946466,0.00014873953,0.000027988599,0.00038943053,0.00012843151,0.00012133209],"category_scores_gemma":[0.0021940994,0.00070408743,0.00030224747,0.002765805,0.00032746542,0.0007760971,0.00017935234,0.0012254275,0.00002183705],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032351185,0.00091922644,0.015104521,0.92844254,0.0007359446,0.0003805418,0.028843261,0.00071638636,0.01239996,0.00042750497,0.0010719293,0.0077230544],"study_design_scores_gemma":[0.0047917315,0.0018275068,0.027584046,0.95721537,0.00022161285,0.00009452595,0.0026530388,0.00013409129,0.0042413315,0.00029461118,0.00006964021,0.00087250327],"about_ca_topic_score_codex":0.0035898217,"about_ca_topic_score_gemma":0.0004483917,"teacher_disagreement_score":0.37715077,"about_ca_system_score_codex":0.0030204232,"about_ca_system_score_gemma":0.00087619614,"threshold_uncertainty_score":0.99954104},"labels":[],"label_agreement":null},{"id":"W3028188475","doi":"10.1016/j.jval.2020.04.581","title":"PMD12 THE BURDEN OF READMISSIONS IN THE POST-OPERATIVE POPULATION IN THE US: THE INFLUENCE OF MANAGEMENT WITH AN OSCILLATING POSITIVE EXPIRATORY PRESSURE DEVICE","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Congenital Heart Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trudell Medical International (Canada)","funders":"","keywords":"Medicine; Emergency medicine; Health care; Population; Medical emergency; Environmental health","score_opus":0.04013387572327031,"score_gpt":0.33901425033959276,"score_spread":0.29888037461632244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028188475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97236246,0.0010704198,0.0000012024415,0.024256704,0.000008948637,0.0019399475,0.00002188468,0.000005967863,0.0003324667],"genre_scores_gemma":[0.995945,0.000041792537,0.00008704199,0.003799782,0.000043252705,0.00006380618,0.000005826848,0.000008134525,0.0000053867666],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9977718,0.0010700767,0.0004021077,0.00018328054,0.00039761464,0.00017514484],"domain_scores_gemma":[0.9989343,0.00048089138,0.00012644331,0.0003101565,0.000101258374,0.000046914458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095057517,0.00010959432,0.0002175017,0.000054583124,0.00014455398,0.000008844471,0.00019276205,0.000024044208,0.000003398317],"category_scores_gemma":[0.00025035892,0.00004567768,0.00002551058,0.0006054573,0.00010183263,0.00008693498,0.000064169406,0.00026882728,5.915949e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008685407,0.0002702263,0.3931047,0.0011910803,0.000105149615,0.00004829058,0.52931064,0.069073655,0.00019730012,0.0015404243,0.000067816436,0.004222191],"study_design_scores_gemma":[0.00047657226,0.0006471761,0.9167833,0.0007224873,0.00004446649,0.0000041862236,0.07538762,0.005708432,0.000011639546,0.000052518124,0.000110724555,0.00005093012],"about_ca_topic_score_codex":0.014522463,"about_ca_topic_score_gemma":0.0010954064,"teacher_disagreement_score":0.52367854,"about_ca_system_score_codex":0.000046749996,"about_ca_system_score_gemma":0.00016348646,"threshold_uncertainty_score":0.9920399},"labels":[],"label_agreement":null},{"id":"W3028192330","doi":"10.1016/j.jval.2020.04.1239","title":"PRO8 MEDICATIONS FOR ACROMEGALY: COST-UTILITY AND VALUE OF INFORMATION ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"Pegvisomant; Medicine; Lanreotide; Acromegaly; Cost–utility analysis; Per capita; Actuarial science; Cohort; Cost effectiveness; Internal medicine; Economics; Environmental health; Risk analysis (engineering)","score_opus":0.39396429871304967,"score_gpt":0.4385871465986704,"score_spread":0.04462284788562071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028192330","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4011444,0.003876901,0.1965472,0.38690725,0.00037463504,0.006390012,0.0032665604,0.00009557099,0.0013974912],"genre_scores_gemma":[0.9741596,0.00028102315,0.012851715,0.012182942,0.00008181371,0.00024482835,0.00017476303,0.000011162839,0.000012183097],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99475276,0.00030389152,0.0042389203,0.00032106508,0.000087973924,0.00029536715],"domain_scores_gemma":[0.99613017,0.000990159,0.0022381186,0.00030162625,0.00007092466,0.00026899736],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014506927,0.00011432465,0.00095948955,0.0004639769,0.000116358715,0.000029174354,0.00017222023,0.00009970051,0.0000624856],"category_scores_gemma":[0.0036616009,0.00014720751,0.000103651575,0.00075928227,0.00006433431,0.00051695004,0.0000352796,0.00012545177,0.000055315002],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006858014,0.00016439162,0.3875036,0.005899456,0.00047886043,9.8142266e-8,0.026555907,0.018587291,8.232862e-7,0.5517616,0.006525756,0.002453617],"study_design_scores_gemma":[0.0010823993,0.00016101668,0.19013152,0.00006477832,0.000034225577,5.3436594e-7,0.0013622431,0.7584612,0.0000035037463,0.013451159,0.03505033,0.00019708704],"about_ca_topic_score_codex":0.0050585573,"about_ca_topic_score_gemma":0.00011057037,"teacher_disagreement_score":0.7398739,"about_ca_system_score_codex":0.00027673104,"about_ca_system_score_gemma":0.00038184697,"threshold_uncertainty_score":0.7647059},"labels":[],"label_agreement":null},{"id":"W3028249995","doi":"10.1016/j.jval.2020.04.1151","title":"PNS151 USING INSTANT MESSENGER TO RECRUIT RESEARCH PARTICIPANTS IN MEDICAL DECISION MAKING: DOES WECHAT PROVIDE AN ALTERNATIVE SOLUTION?","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Medical Research Impacts","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"China; Socioeconomic status; Family medicine; Population; Pharmacist; Instant messaging; Medicine; Systematic sampling; Medical education; Psychology; Environmental health; Geography; Computer science; World Wide Web","score_opus":0.6845484196820977,"score_gpt":0.6039650139845262,"score_spread":0.0805834056975715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028249995","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82012373,0.00039242415,0.0012356516,0.1755645,0.000181977,0.0023219392,0.0000100415255,0.00004031417,0.00012940814],"genre_scores_gemma":[0.9708722,0.0007630145,0.0048241927,0.02295189,0.00044031694,0.00009151624,0.0000058396026,0.0000383873,0.000012602261],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9893975,0.0021130615,0.0011942663,0.00076014345,0.0036828974,0.0028520962],"domain_scores_gemma":[0.9822896,0.0024462552,0.000116758456,0.0004747312,0.00029806816,0.014374546],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.018130768,0.00019196067,0.0006530488,0.0007171354,0.00016782252,0.000034473553,0.00032919814,0.00023047742,0.00024305466],"category_scores_gemma":[0.15705064,0.00013695557,0.000040720694,0.0018303491,0.00016574742,0.0002115652,0.0002532759,0.0018883324,0.000065053755],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0128434785,0.0029691232,0.039179124,0.0047230297,0.000048344027,0.006730584,0.05113213,0.0020832976,0.0049241325,0.0022106702,0.006979787,0.8661763],"study_design_scores_gemma":[0.010627069,0.011086098,0.027052943,0.032222684,0.000012758301,0.000092323666,0.005782238,0.8421439,0.001537913,0.004456589,0.0643343,0.0006511975],"about_ca_topic_score_codex":0.009296662,"about_ca_topic_score_gemma":0.0015084888,"teacher_disagreement_score":0.8655251,"about_ca_system_score_codex":0.002040981,"about_ca_system_score_gemma":0.018924652,"threshold_uncertainty_score":0.9973005},"labels":[],"label_agreement":null},{"id":"W3028345760","doi":"10.1016/j.jval.2020.04.136","title":"PCV31 COST-EFFECTIVENESS OF EVOLOCUMAB FOR THE TREATMENT OF PATIENTS WITH HYPERCHOLESTEROLEMIA IN THE KINGDOM OF SAUDI ARABIA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Evolocumab; Medicine; Familial hypercholesterolemia; Ezetimibe; PCSK9; Statin; Internal medicine; Population; Atherosclerotic cardiovascular disease; Cohort; Observational study; Gastroenterology; Cholesterol; Lipoprotein; Disease; LDL receptor","score_opus":0.17483326838493118,"score_gpt":0.3406081854431775,"score_spread":0.16577491705824632,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028345760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994803,0.0009790284,0.0001708335,0.0019108545,0.000055741682,0.0015127873,0.00043658094,0.0000017496931,0.00012941919],"genre_scores_gemma":[0.9986746,0.0005785618,0.00008159477,0.00051612494,0.000020741616,0.0001080716,0.0000090020785,0.000010492736,8.2107914e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988842,0.00009238488,0.00063248014,0.00017576394,0.000029456476,0.00018573852],"domain_scores_gemma":[0.9985466,0.00080610043,0.00037593744,0.00020863434,0.000020172647,0.000042578118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008410685,0.00009292513,0.00046287818,0.000063376756,0.000023106817,0.0000052996,0.00018888815,0.000036970854,0.000006340121],"category_scores_gemma":[0.00007154437,0.00006235105,0.00006905515,0.00019672212,0.000067043424,0.000039808114,0.000012788486,0.00007307724,0.0000018629181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010766082,0.0009760172,0.9064401,0.0009378599,0.000071211856,2.687281e-7,0.0047606924,0.024416517,0.0000072745534,0.054723594,0.00003254562,0.006557343],"study_design_scores_gemma":[0.0064029177,0.0024549626,0.9486011,0.00011596761,0.0000100792395,2.2664224e-7,0.00008753053,0.023145754,0.00021679638,0.0051012454,0.013736885,0.00012650546],"about_ca_topic_score_codex":0.0026099086,"about_ca_topic_score_gemma":0.00004970836,"teacher_disagreement_score":0.049622346,"about_ca_system_score_codex":0.00015227613,"about_ca_system_score_gemma":0.00006295376,"threshold_uncertainty_score":0.39454186},"labels":[],"label_agreement":null},{"id":"W3028360824","doi":"10.1016/j.jval.2020.04.809","title":"PMU35 MODELING POTENTIAL HEALTH GAINS AND HEALTH SYSTEM SAVINGS ASSOCIATED WITH VAPORIZED NICOTINE PRODUCTS IN CANADA","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Life expectancy; Environmental health; Context (archaeology); Population; Demography; Public health; Medicine; Geography","score_opus":0.13127850040993652,"score_gpt":0.3739760863222083,"score_spread":0.24269758591227178,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028360824","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7766938,0.0076852916,0.00030673013,0.20746176,0.0012148651,0.0059878174,0.00022461149,0.00032061167,0.000104487735],"genre_scores_gemma":[0.97301006,0.00083925016,0.0013678543,0.02404738,0.00034711993,0.00012454002,0.00012800356,0.00010721269,0.000028579363],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98795265,0.0038556065,0.0031008027,0.001228804,0.0010506079,0.0028115162],"domain_scores_gemma":[0.9955598,0.00037417258,0.0015326408,0.0004936786,0.0003315684,0.001708134],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.005709862,0.0005169564,0.0018790385,0.0002692851,0.00092793274,0.000018495737,0.00033036782,0.00021124184,0.000011223584],"category_scores_gemma":[0.0007160879,0.00049468887,0.000037668142,0.0017020036,0.000042424726,0.00017442211,0.00018619945,0.001957063,0.000016672535],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0020905465,0.00067780825,0.5186397,0.082923196,0.00015390632,0.00043947663,0.08765112,0.25364462,0.00002499637,0.005336809,0.04450317,0.0039146855],"study_design_scores_gemma":[0.0137891285,0.0026431363,0.09411721,0.027259009,0.000018617857,0.000038427253,0.04504506,0.8133516,0.0000031443262,0.00010514186,0.0023731983,0.0012563296],"about_ca_topic_score_codex":0.991188,"about_ca_topic_score_gemma":0.95156956,"teacher_disagreement_score":0.559707,"about_ca_system_score_codex":0.019026943,"about_ca_system_score_gemma":0.050181817,"threshold_uncertainty_score":0.9997505},"labels":[],"label_agreement":null},{"id":"W3028376624","doi":"10.1016/j.jval.2020.04.177","title":"PCV75 IDENTIFYING APPROPIATE HOSPITALS FOR PATIENT RECRUITMENT IN CLINICAL TRIALS FOR CANADA USING MACHINE LEARNING ALGORITHMS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Oversampling; Pharmacy; Machine learning; Artificial intelligence; Computer science; Medicine; Support vector machine; Data mining; Algorithm; Family medicine","score_opus":0.8227583973736148,"score_gpt":0.6122533430454646,"score_spread":0.21050505432815014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028376624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8868044,0.0011612473,0.04254984,0.051987175,0.0019072379,0.015351066,0.0001864941,0.00004674903,0.0000057893167],"genre_scores_gemma":[0.8197422,0.00073806866,0.1585087,0.018315319,0.0012868072,0.0007600831,0.00052051514,0.000104064755,0.000024254035],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99190044,0.0016780926,0.005017754,0.0005358137,0.00038279293,0.0004851113],"domain_scores_gemma":[0.9902764,0.007640172,0.0014267205,0.00016722757,0.00014528765,0.00034419962],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.01634286,0.00017408072,0.00108043,0.00009483162,0.00009553838,0.00002216907,0.00007928177,0.00009441623,0.00001857612],"category_scores_gemma":[0.050062187,0.00016206787,0.00018620458,0.00026309796,0.000017109018,0.00010321041,0.00005646851,0.00048632224,0.0000010697096],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004759144,0.0006100593,0.15926231,0.0038985827,0.00021997717,0.000065333916,0.0030773606,0.04915625,0.00032077733,0.00016938841,0.0033935674,0.77506727],"study_design_scores_gemma":[0.0118557885,0.003117083,0.0043888227,0.0005868003,0.00010016907,0.0000060846814,0.001896716,0.94924116,0.00014358305,0.00024179928,0.028186992,0.0002350019],"about_ca_topic_score_codex":0.4517922,"about_ca_topic_score_gemma":0.053594407,"teacher_disagreement_score":0.9000849,"about_ca_system_score_codex":0.0010572377,"about_ca_system_score_gemma":0.0027876005,"threshold_uncertainty_score":0.963675},"labels":[],"label_agreement":null},{"id":"W3028378442","doi":"10.1016/j.jval.2020.04.264","title":"PDB79 INSULIN PRICES IN CANADA, SAUDI ARABIA, AND THE US.","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Insulin; Pharmacy; Insulin degludec; Insulin detemir; Insulin lispro; Insulin glargine; Medicine; Vial; Insulin pen; Business; Traditional medicine; Human insulin; Family medicine; Hypoglycemia; Internal medicine; Chemistry","score_opus":0.10052263533040784,"score_gpt":0.3564280143713151,"score_spread":0.25590537904090727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028378442","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6960603,0.020179208,0.0000031806064,0.28188068,0.000069744,0.0003705525,0.000004376407,0.000005999195,0.0014259474],"genre_scores_gemma":[0.9486695,0.01165715,0.00012126181,0.03943705,0.000089707704,0.000010375963,9.183149e-7,0.0000051952875,0.000008833762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99901897,0.00014819317,0.00027828972,0.0001524945,0.00017017305,0.00023190182],"domain_scores_gemma":[0.9990334,0.00062781514,0.00007803487,0.00006950439,0.000011236563,0.00018002618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006156301,0.00007051098,0.0002669292,0.000016704926,0.00005707732,0.0000071430427,0.000053382206,0.00001873027,0.00003154719],"category_scores_gemma":[0.00048391736,0.00004487658,0.000012920272,0.0002352874,0.000048553553,0.00003655776,0.000047049416,0.0003470428,0.000004237442],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035935258,0.00019847057,0.877505,0.0028658905,0.00010672827,0.0002816728,0.012433286,0.0016638566,0.000030349029,0.0051069637,0.010678908,0.08553535],"study_design_scores_gemma":[0.0055084173,0.00019586344,0.57710826,0.0001924511,0.00001919789,0.00001533241,0.0009940957,0.027770467,0.000017775972,0.000286264,0.38777745,0.00011440333],"about_ca_topic_score_codex":0.95059645,"about_ca_topic_score_gemma":0.5958798,"teacher_disagreement_score":0.37709856,"about_ca_system_score_codex":0.00019169193,"about_ca_system_score_gemma":0.0007260292,"threshold_uncertainty_score":0.41149437},"labels":[],"label_agreement":null},{"id":"W3028464929","doi":"10.1016/j.jval.2020.04.1154","title":"PNS154 THE PRISMA 2020 STATEMENT: DEVELOPMENT OF AND KEY CHANGES IN AN UPDATED GUIDELINE FOR REPORTING SYSTEMATIC REVIEWS AND META-ANALYSES","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":73,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Systematic review; Checklist; Guideline; Stakeholder; MEDLINE; Statement (logic); Management science; Medicine; Medical education; Computer science; Psychology; Political science; Public relations; Engineering; Pathology","score_opus":0.9380358184741009,"score_gpt":0.6234064317895016,"score_spread":0.3146293866845993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028464929","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.54309887,0.21936944,0.07270355,0.12199928,0.00022763821,0.042318944,0.000097920405,0.000023565475,0.00016080622],"genre_scores_gemma":[0.6543852,0.0025226239,0.33164832,0.009020659,0.000106387866,0.0017393975,0.00008637907,0.000052180632,0.00043886845],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9256093,0.02080446,0.04954561,0.0012172764,0.0024323233,0.00039101258],"domain_scores_gemma":[0.96855927,0.0024599012,0.026931426,0.0013311448,0.0005073638,0.00021089452],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.30130076,0.00027276805,0.007199209,0.00023296532,0.00011670463,0.0002031389,0.0005807007,0.000042249456,0.00025521178],"category_scores_gemma":[0.057144776,0.00010664102,0.0004099934,0.0013104959,0.000031149637,0.00013618181,0.0001236637,0.000107032676,0.000010607315],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019599813,0.0008230888,0.057881676,0.36011216,0.013191413,0.00006372321,0.28412625,0.015855867,0.0016588918,0.004437082,0.16669317,0.094960675],"study_design_scores_gemma":[0.0013443986,0.0006634918,0.0035003398,0.0029291385,0.007996177,0.000034330642,0.02160959,0.7127891,0.0003027963,0.0039473046,0.24396878,0.0009145539],"about_ca_topic_score_codex":0.00015425209,"about_ca_topic_score_gemma":0.00062798674,"teacher_disagreement_score":0.6969332,"about_ca_system_score_codex":0.0000403883,"about_ca_system_score_gemma":0.00017620758,"threshold_uncertainty_score":0.9507973},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"reporting","study_design":"not_applicable","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"gpt","categories":["metaresearch"],"domain":"reporting","study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W3028524412","doi":"10.1016/j.jval.2020.04.510","title":"PIN38 COST-EFFECTIVENESS OF TESAMORELIN IN THE TREATMENT OF LIPOHYPERTROPHY IN THE US","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV-related health complications and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Theratechnologies (Canada)","funders":"","keywords":"Medicine; Discontinuation; Adverse effect; Cost effectiveness; Internal medicine","score_opus":0.09075011246359468,"score_gpt":0.36815019954233863,"score_spread":0.277400087078744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3028524412","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98195547,0.0029725998,0.00001682509,0.011676737,0.000028667739,0.0030228575,0.000021055175,0.0000063022558,0.0002994617],"genre_scores_gemma":[0.9967118,0.001682579,0.00018485042,0.0010363631,0.000025168403,0.0003215314,0.00002592991,0.000009402368,0.0000023772143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980425,0.0008339521,0.00053463347,0.00018441182,0.0001932931,0.00021119155],"domain_scores_gemma":[0.99866223,0.0007941651,0.00012809529,0.00031854378,0.000032500837,0.000064450054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00069602364,0.0001062462,0.0004026162,0.000118920216,0.0000340241,0.0000021959763,0.00011180532,0.000054412598,0.0000070494293],"category_scores_gemma":[0.00007675848,0.000058180914,0.000054324522,0.000793751,0.00004247934,0.0000160429,0.000006846935,0.0001655665,0.000009325914],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001304239,0.0084928,0.91443336,0.002166469,0.000057073405,0.000104128725,0.03650883,0.0077834553,0.00017916033,0.0031756468,0.00010475877,0.025690079],"study_design_scores_gemma":[0.005439589,0.005182283,0.9789611,0.0007651951,0.0000249274,0.000015388743,0.0006119944,0.005853364,0.00009495278,0.0002805128,0.00271204,0.000058632402],"about_ca_topic_score_codex":0.0150043,"about_ca_topic_score_gemma":0.00013493485,"teacher_disagreement_score":0.06452776,"about_ca_system_score_codex":0.00027012668,"about_ca_system_score_gemma":0.00031453074,"threshold_uncertainty_score":0.99155486},"labels":[],"label_agreement":null},{"id":"W3030589008","doi":"10.1016/j.jval.2020.03.011","title":"Let’s Make Sure We Are Doing Authorship Right","year":2020,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Social Media in Health Education","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"History; Computer science","score_opus":0.14263317791247473,"score_gpt":0.42021720386083117,"score_spread":0.2775840259483564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3030589008","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039277182,0.0050013084,0.000008001274,0.10234401,0.88766146,0.0024251468,0.00011570496,0.00024220096,0.0018094181],"genre_scores_gemma":[0.0027721624,0.0077906246,0.00087988324,0.0005529168,0.98681974,0.00065124367,0.00015604531,0.00010359717,0.00027376396],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98932993,0.004684895,0.0012449356,0.000916389,0.0023760393,0.0014477869],"domain_scores_gemma":[0.9824687,0.014507657,0.0012873941,0.00042677837,0.00023416903,0.0010752617],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.006228295,0.00039322407,0.001003427,0.00035483282,0.0010407768,0.00015691179,0.0008350583,0.002056896,0.00013574307],"category_scores_gemma":[0.031288546,0.00045296617,0.00015213434,0.0016440959,0.000256399,0.00013817399,0.00007268931,0.0032756755,0.00016979208],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022549064,0.00006474806,0.001675345,0.0020367708,0.00000949414,0.00001877609,0.09709634,0.0000234794,1.2185032e-7,0.0025547894,0.889434,0.007063588],"study_design_scores_gemma":[0.00023623942,0.000071768314,0.00048196316,0.0016670064,0.000010948665,1.5737481e-7,0.0038634064,0.000013709062,5.1223833e-7,0.0022248595,0.99107945,0.00034995863],"about_ca_topic_score_codex":0.16669479,"about_ca_topic_score_gemma":0.03311158,"teacher_disagreement_score":0.1335832,"about_ca_system_score_codex":0.0031428516,"about_ca_system_score_gemma":0.017487545,"threshold_uncertainty_score":0.9997922},"labels":[],"label_agreement":null},{"id":"W3035049698","doi":"10.1016/j.jval.2020.05.001","title":"Announcing the New Definition of Health Technology Assessment","year":2020,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":54,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Data science; Computer science","score_opus":0.5571480633302464,"score_gpt":0.4431271181544711,"score_spread":0.11402094517577527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3035049698","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002765015,0.0132192485,0.0046040034,0.97721124,0.0011437141,0.0017517289,0.00048114487,0.00008354234,0.0012288508],"genre_scores_gemma":[0.0035194196,0.0018358647,0.013021134,0.9789546,0.0019959677,0.00012976518,0.0003060775,0.00008821182,0.00014895757],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9855546,0.002013472,0.010211791,0.0009794438,0.00026896226,0.00097176665],"domain_scores_gemma":[0.9879214,0.0016731863,0.0092159845,0.00096887565,0.000059990674,0.0001605685],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02384078,0.00036348772,0.002583786,0.000974842,0.000277154,0.000049653885,0.0006918172,0.00058655033,0.00011977553],"category_scores_gemma":[0.0023270028,0.00040510466,0.00018352065,0.0008357392,0.00012163992,0.0001600407,0.00011393391,0.002255293,0.00041394314],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000021699364,0.00002888994,0.0022306524,0.0026247103,0.000035435944,0.0000033359183,0.0012816924,0.00031070138,7.7683794e-8,0.09935615,0.89376944,0.00035672705],"study_design_scores_gemma":[0.0005220519,0.0002962994,0.0010406976,0.0009075772,0.0000031523896,0.00001065801,0.00081224105,0.0022007679,2.071298e-7,0.15424946,0.8396449,0.0003120035],"about_ca_topic_score_codex":0.028010877,"about_ca_topic_score_gemma":0.00018782803,"teacher_disagreement_score":0.0548933,"about_ca_system_score_codex":0.003432607,"about_ca_system_score_gemma":0.005426777,"threshold_uncertainty_score":0.9998401},"labels":[],"label_agreement":null},{"id":"W3038928679","doi":"10.1016/j.jval.2019.09.1573","title":"PMS29 HEALTH STATE UTILITY VALUES FOR JUVENILE IDIOPATHIC ARTHRITIS: A SYSTEMATIC REVIEW","year":2019,"lang":"en","type":"review","venue":"Value in Health","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; EconLit; CINAHL; Etanercept; MEDLINE; Psychological intervention; Population; Quality of life (healthcare); Quality-adjusted life year; Gerontology; Physical therapy; Pediatrics; Family medicine; Cost effectiveness; Psychiatry; Internal medicine; Environmental health","score_opus":0.09139433784859055,"score_gpt":0.39604055883944567,"score_spread":0.30464622099085514,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3038928679","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000028085428,0.96340483,0.0002413712,0.002171302,0.0005107612,0.03331698,0.00022173864,0.00008368635,0.000046486875],"genre_scores_gemma":[0.00001464366,0.9947996,0.0006127212,0.0015715413,0.0000914388,0.0021033664,0.00037566136,0.00011190698,0.0003191319],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99010825,0.00291109,0.0046807523,0.0009005413,0.00057673437,0.0008226533],"domain_scores_gemma":[0.99540526,0.00074450823,0.0021515167,0.0011579323,0.0001642763,0.00037651986],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010564638,0.00060387707,0.010038019,0.000348987,0.0001256919,0.0000213929,0.00021964412,0.00025870907,0.000021606204],"category_scores_gemma":[0.0020213644,0.00044438316,0.0013220434,0.0006574261,0.000061270046,0.00007384069,0.000046648125,0.0007089893,0.00010540686],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000064379556,0.00015783538,0.0000027918973,0.73981106,0.00004911525,0.0000016535981,0.00017362004,0.0000014224393,2.5141798e-9,0.0000989733,0.00089801,0.2587991],"study_design_scores_gemma":[0.0006254486,0.0011562856,0.000010283013,0.8584651,0.00035788424,0.000038067163,0.000049370992,0.00014466328,3.5233376e-9,0.00038894778,0.13849856,0.0002653826],"about_ca_topic_score_codex":0.0012325975,"about_ca_topic_score_gemma":0.00006405486,"teacher_disagreement_score":0.25853372,"about_ca_system_score_codex":0.0010650286,"about_ca_system_score_gemma":0.005400862,"threshold_uncertainty_score":0.9998008},"labels":[],"label_agreement":null},{"id":"W3039168663","doi":"10.1016/j.jval.2020.03.004","title":"Health-Related Quality of Life in Neurological Disorders Most Commonly Associated With Zika-Virus Infection: A Systematic Review","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Mosquito-borne diseases and control","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Toronto Public Health; University Health Network","funders":"Canadian Institutes of Health Research","keywords":"Zika virus; Medicine; Virology; Virus","score_opus":0.09814051525275887,"score_gpt":0.3744254804555154,"score_spread":0.2762849652027565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3039168663","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035866007,0.98223907,0.000005685997,0.0062383143,0.00011372831,0.0107612545,0.00014884604,0.000088020046,0.000046415764],"genre_scores_gemma":[0.0028013655,0.9905134,0.000007915873,0.005588315,0.000033906654,0.0006419357,0.00033472912,0.00006709307,0.000011347219],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98456573,0.008094753,0.005360272,0.000706454,0.0006593455,0.0006134457],"domain_scores_gemma":[0.9934481,0.0013462977,0.0037541117,0.00072863424,0.000090865164,0.00063201087],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003970251,0.00057714595,0.011580054,0.00026090484,0.000067144814,0.000012367473,0.00023522579,0.0003490202,0.000036797894],"category_scores_gemma":[0.005334625,0.00040437139,0.000607008,0.0022177435,0.000082414335,0.000041084502,0.000066137225,0.0014080522,0.000015152155],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010768948,0.0007052086,0.0049225837,0.9667385,0.00024898243,0.000035273297,0.000059554048,0.000026102498,1.5350029e-9,0.00015138781,0.00020871167,0.026795974],"study_design_scores_gemma":[0.0024389504,0.0021587,0.0068025063,0.97622585,0.0010416987,0.0000338902,0.000012909164,0.0004862484,6.7717176e-10,0.00003203264,0.010397944,0.00036928986],"about_ca_topic_score_codex":0.026179211,"about_ca_topic_score_gemma":0.0031454694,"teacher_disagreement_score":0.026426684,"about_ca_system_score_codex":0.0004915663,"about_ca_system_score_gemma":0.0042795185,"threshold_uncertainty_score":0.9998408},"labels":[],"label_agreement":null},{"id":"W3040479255","doi":"10.1016/j.jval.2019.11.009","title":"Health Preference Research in Europe: A Review of Its Use in Marketing Authorization, Reimbursement, and Pricing Decisions—Report of the ISPOR Stated Preference Research Special Interest Group","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Intégré Universitaire de Santé et de Services Sociaux du Saguenay–Lac-Saint-Jean; Centre Intégré Universitaire de Santé et de Services Sociaux du Centre-Sud-de-l'Île-de-Montréal; Centre Hospitalier Universitaire de Sherbrooke","funders":"Agency for Healthcare Research and Quality","keywords":"Reimbursement; Preference; Authorization; Marketing; Health economics; Business; Actuarial science; Economics; Health care; Microeconomics; Computer science","score_opus":0.780389263494015,"score_gpt":0.4427709155179167,"score_spread":0.33761834797609835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3040479255","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.010120579,0.98431766,0.000032631226,0.00087312545,0.0002029607,0.003869979,0.00017709829,0.00000456376,0.00040138184],"genre_scores_gemma":[0.009070078,0.9901517,0.00032168112,0.00005234474,0.00006871459,0.00011432935,0.00010105646,0.00004111202,0.0000789662],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98945236,0.0038945675,0.004744052,0.0010199065,0.00026681347,0.00062231516],"domain_scores_gemma":[0.9951559,0.0017277815,0.0022582007,0.0006077704,0.00010874196,0.00014160841],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.036443178,0.0002470515,0.0019443926,0.0010571402,0.00011047209,0.000038654216,0.0005562755,0.00014973636,0.000064543485],"category_scores_gemma":[0.008486649,0.0002327154,0.000080726604,0.0031138265,0.00013982053,0.00024048156,0.0005826222,0.0013341663,0.000020684447],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008650093,0.0005296003,0.1519188,0.20471299,0.00004515814,0.000028260096,0.001581527,0.00019439211,3.1597025e-7,0.03304801,0.0014050403,0.6064494],"study_design_scores_gemma":[0.000651864,0.0003727953,0.19197115,0.3856425,0.000008599175,0.000020036021,0.00013973341,0.0011707162,3.492705e-7,0.0014449636,0.41819444,0.00038284904],"about_ca_topic_score_codex":0.004457262,"about_ca_topic_score_gemma":0.0008686732,"teacher_disagreement_score":0.6060666,"about_ca_system_score_codex":0.0015521863,"about_ca_system_score_gemma":0.0010589845,"threshold_uncertainty_score":0.9998653},"labels":[],"label_agreement":null},{"id":"W3042405756","doi":"10.1016/j.jval.2020.03.017","title":"Patient-Centered Care for Women: Delphi Consensus on Evidence-Derived Recommendations","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; University of Ottawa; University Health Network; St. Michael's Hospital; Toronto General Hospital","funders":"Ontario Ministry of Health and Long-Term Care","keywords":"Likert scale; Concordance; Delphi method; Residence; Delphi; Medicine; Health professionals; Family medicine; Health care; Nursing; Representativeness heuristic; Medical education; Psychology; Social psychology; Political science","score_opus":0.4705739344627006,"score_gpt":0.45940311900739167,"score_spread":0.011170815455308958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3042405756","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47005126,0.00942626,0.00018448358,0.49949193,0.003005963,0.015215997,0.0010177401,0.00055779755,0.0010485529],"genre_scores_gemma":[0.95419836,0.00078786846,0.0058530276,0.03563556,0.00019201844,0.0030397305,0.00018315969,0.00007222499,0.0000380746],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9925383,0.0034629197,0.0018718744,0.00064118754,0.0003478305,0.001137937],"domain_scores_gemma":[0.99225765,0.0047582216,0.0008807163,0.00090113276,0.0004969524,0.0007053071],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.00052864663,0.00028018668,0.00058026955,0.00021738854,0.0013428505,0.000013602895,0.00044420589,0.00021885692,0.00016982292],"category_scores_gemma":[0.003673534,0.00029439578,0.000091604714,0.0005509502,0.00006554919,0.000112726484,0.00021087204,0.0010398822,0.00018868958],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002249944,0.0003359052,0.026289407,0.011318185,0.00004578782,0.000004880895,0.86912185,0.0025672135,0.00012439981,0.0045111366,0.04714454,0.03628677],"study_design_scores_gemma":[0.0072125485,0.0058505707,0.0035635356,0.009933076,0.000011785321,0.0000018417586,0.5902027,0.0150053445,0.00007487451,0.0018051282,0.36548766,0.0008509374],"about_ca_topic_score_codex":0.0024633955,"about_ca_topic_score_gemma":0.00037463618,"teacher_disagreement_score":0.48414707,"about_ca_system_score_codex":0.0023299963,"about_ca_system_score_gemma":0.0022463768,"threshold_uncertainty_score":0.99995726},"labels":[],"label_agreement":null},{"id":"W3043807864","doi":"10.1016/j.jval.2020.03.007","title":"Heterogeneous Patient Preferences for Modern Antiretroviral Therapy: Results of a Discrete Choice Experiment","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":35,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute of Allergy and Infectious Diseases; Center for AIDS Research, Duke University; University of South Carolina; Center for AIDS Research, University of Washington; Robert Wood Johnson Foundation","keywords":"Interquartile range; Medicine; Pill; Latent class model; Dosing; Mixed logit; Logistic regression; Internal medicine","score_opus":0.20786424438569817,"score_gpt":0.27657637800375756,"score_spread":0.06871213361805939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3043807864","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929107,0.0036897855,0.0010351407,0.0010105438,0.00011389953,0.0005941618,0.0003191533,0.000010580022,0.00031604647],"genre_scores_gemma":[0.9975901,0.00067612785,0.0009676809,0.000602206,0.000043303568,0.00005804197,0.00003589008,0.000014221368,0.0000124090775],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99860185,0.000030086834,0.0008105668,0.00033045255,0.000030029001,0.00019702785],"domain_scores_gemma":[0.99928606,0.000055502045,0.0004364679,0.00014340518,0.0000038180265,0.000074767486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002827612,0.00009906754,0.00030497272,0.000050786577,0.000036493755,0.000010611183,0.00010471524,0.00004210591,0.000021842527],"category_scores_gemma":[0.000045023204,0.000107774154,0.00006845038,0.00005398512,0.000025646488,0.000085117375,0.000027795768,0.000051758572,0.000015495438],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012613416,0.00077317347,0.54414725,0.0005638213,0.00014426101,0.0000012629133,0.047108386,0.3320517,0.0005837509,0.011428595,0.0007545109,0.06118199],"study_design_scores_gemma":[0.010212824,0.012385949,0.10352028,0.00015360917,0.0000048794273,0.0000014925955,0.00084942224,0.82302594,0.007663185,0.02461526,0.016638894,0.00092825905],"about_ca_topic_score_codex":0.002100312,"about_ca_topic_score_gemma":0.000008822449,"teacher_disagreement_score":0.49097425,"about_ca_system_score_codex":0.00013135294,"about_ca_system_score_gemma":0.000022524273,"threshold_uncertainty_score":0.43949026},"labels":[],"label_agreement":null},{"id":"W3046026348","doi":"10.1016/j.jval.2020.03.021","title":"Spending on Hepatitis C Antivirals in the United States and Canada, 2014 to 2018","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute for Clinical Evaluative Sciences; St. Michael's Hospital; Women's College Hospital; University of Toronto","funders":"Ontario Ministry of Health and Long-Term Care; Health Canada; U.S. Department of Veterans Affairs","keywords":"Reimbursement; Medical prescription; Prescription drug; Population; Medicine; Environmental health; Pharmacy; Business; Economic growth; Family medicine; Health care; Economics","score_opus":0.10160303295357649,"score_gpt":0.36168720156351963,"score_spread":0.26008416860994316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046026348","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9208497,0.00013470849,0.000011863383,0.07776147,0.000036928206,0.00066447025,0.000050256633,0.000009372046,0.00048122482],"genre_scores_gemma":[0.97431356,0.0022876933,0.00013775716,0.02310417,0.00006566961,0.000014080472,0.00002929957,0.000014329201,0.00003343046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982622,0.0004443038,0.0002825753,0.00021695557,0.00041505383,0.00037887998],"domain_scores_gemma":[0.99915993,0.00038706826,0.000034323635,0.00013719287,0.000016808044,0.0002646958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008360271,0.0000887386,0.00023089706,0.00020626462,0.000051867042,0.000017705983,0.00009739049,0.00002827734,0.000048774917],"category_scores_gemma":[0.00048943626,0.00006827728,0.00000972959,0.00053069764,0.000024484518,0.000028170609,0.000035684887,0.00031650913,0.000038772378],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007871936,0.000036547885,0.9245095,0.00024938877,0.000005287171,0.0002740519,0.0034034168,0.0007626795,0.00005749808,0.00027693866,0.06692397,0.0034219811],"study_design_scores_gemma":[0.0011135648,0.0014598409,0.85288525,0.00062399416,0.0000026056844,0.0000069377434,0.0007207931,0.02521157,0.00018300251,0.0000732198,0.11756789,0.00015133202],"about_ca_topic_score_codex":0.98847014,"about_ca_topic_score_gemma":0.8161659,"teacher_disagreement_score":0.17230421,"about_ca_system_score_codex":0.00035106917,"about_ca_system_score_gemma":0.00049699284,"threshold_uncertainty_score":0.27842668},"labels":[],"label_agreement":null},{"id":"W3046551175","doi":"10.1016/j.jval.2020.05.010","title":"Improving Academic Biobank Value and Sustainability Through an Outputs Focus","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"BC Cancer Agency; NSW Ministry of Health; Cancer Institute NSW","keywords":"Biobank; Sustainability; Business; Risk analysis (engineering); Computer science; Knowledge management; Bioinformatics; Biology","score_opus":0.4558728335814894,"score_gpt":0.5645469740327095,"score_spread":0.10867414045122009,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3046551175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73774177,0.0040907036,0.0020330667,0.25398824,0.00013882693,0.0015000656,0.000011669268,0.00012842586,0.00036720815],"genre_scores_gemma":[0.98440444,0.0027730148,0.0039076176,0.008424618,0.00037433705,0.000020785896,0.0000045336183,0.000035151756,0.00005550634],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9961309,0.0007042895,0.0008866014,0.0007771094,0.0007804532,0.00072064967],"domain_scores_gemma":[0.9943221,0.0038912117,0.00015733228,0.0005188936,0.00027689713,0.00083354075],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.0075263847,0.00016717507,0.00050883304,0.000075093965,0.00012516008,0.000021501392,0.0002392537,0.0005126582,0.000016728583],"category_scores_gemma":[0.036334597,0.00015087763,0.000056957622,0.00047893208,0.0003334188,0.0002129022,0.00026806895,0.004187198,0.0000108213235],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015751057,0.00066908967,0.43590257,0.023167735,0.000044667646,0.00026632188,0.028431678,0.0006140757,0.0011603695,0.41810593,0.00041735396,0.08964513],"study_design_scores_gemma":[0.0071932967,0.010385535,0.09399291,0.0015392939,0.00004605101,0.000056926085,0.0064363354,0.068733275,0.00186894,0.80266243,0.0063509145,0.00073410285],"about_ca_topic_score_codex":0.012555144,"about_ca_topic_score_gemma":0.000105624094,"teacher_disagreement_score":0.3845565,"about_ca_system_score_codex":0.0005789839,"about_ca_system_score_gemma":0.0033400867,"threshold_uncertainty_score":0.9981102},"labels":[],"label_agreement":null},{"id":"W3047819746","doi":"10.1016/j.jval.2020.06.003","title":"Are We Making a Difference? A Qualitative Study of Patient Engagement at the pan-Canadian Oncology Drug Review: Perspectives of Patient Groups","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health and Patient Involvement","field":"Health Professions","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Canadian Agency for Drugs and Technologies in Health; Canadian Centre for Applied Research in Cancer Control; Sunnybrook Health Science Centre; Cancer Care Ontario","funders":"Canadian Cancer Society; Canadian Centre for Applied Research in Cancer Control","keywords":"Transparency (behavior); Agency (philosophy); Qualitative research; Process (computing); Patient participation; Grounded theory; Resource (disambiguation); Medical education; Psychology; Public relations; Medicine; Knowledge management; Health care; Political science; Sociology; Computer science; Social science","score_opus":0.4094212928421418,"score_gpt":0.49856360630401103,"score_spread":0.08914231346186924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3047819746","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9471883,0.020976748,0.000003939527,0.021844374,0.00040841007,0.008991587,0.00018596454,0.000015796397,0.00038485383],"genre_scores_gemma":[0.97804296,0.005800829,0.00009454931,0.015053764,0.00004654268,0.00088208163,0.000028729532,0.000023053406,0.000027469878],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9825516,0.013158023,0.002305592,0.000498971,0.0006757211,0.0008101357],"domain_scores_gemma":[0.9947706,0.0016989012,0.002434658,0.0004274002,0.00020120287,0.00046727454],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00310269,0.00025664436,0.000924434,0.00017689701,0.0007289507,0.000002020017,0.00027204037,0.00008028003,0.0002717518],"category_scores_gemma":[0.00032941162,0.00018408798,0.0000896148,0.00055965746,0.000093384944,0.000037821923,0.0002903289,0.00084566773,0.000028615386],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021985275,0.0010290798,0.03260256,0.011475367,0.000034598506,0.0000072966236,0.94620204,0.000067008405,0.0000014941945,0.0007021447,0.0031570913,0.004501472],"study_design_scores_gemma":[0.001134269,0.0046033687,0.0055658254,0.010221411,0.000020306396,2.6553752e-7,0.9673997,0.00014452454,0.000004181997,0.00022602754,0.01053206,0.00014806776],"about_ca_topic_score_codex":0.124776356,"about_ca_topic_score_gemma":0.1228782,"teacher_disagreement_score":0.030854654,"about_ca_system_score_codex":0.002782654,"about_ca_system_score_gemma":0.0014535692,"threshold_uncertainty_score":0.89312696},"labels":[],"label_agreement":null},{"id":"W3080701258","doi":"10.1016/j.jval.2020.02.016","title":"Is Multicriteria Decision Analysis a Resource Allocation Framework?","year":2020,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"","keywords":"Multiple-criteria decision analysis; Reimbursement; Resource allocation; Decision analysis; Health technology; Value (mathematics); Cost–benefit analysis; Resource (disambiguation); Health care; Management science; Computer science; Risk analysis (engineering); Actuarial science; Operations research; Medicine; Business; Economics; Engineering; Mathematics; Political science; Statistics","score_opus":0.43422251882991036,"score_gpt":0.4493405050899699,"score_spread":0.015117986260059557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3080701258","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013227855,0.0048257834,0.027571106,0.9625483,0.0008562991,0.0013083331,0.0010123663,0.00009822353,0.0004567725],"genre_scores_gemma":[0.003944875,0.00052848546,0.027069967,0.964067,0.0028915622,0.00015437105,0.00075320306,0.00011815249,0.0004723727],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98629206,0.0016366264,0.009071265,0.0017312468,0.00031811785,0.00095069903],"domain_scores_gemma":[0.9885439,0.004562651,0.005029189,0.0014676033,0.000070013644,0.00032664018],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.014764732,0.0005012587,0.0030680965,0.0020583682,0.00023360217,0.00019122366,0.00075855677,0.0011360366,0.0008969189],"category_scores_gemma":[0.007305142,0.0006916497,0.0004934157,0.001709969,0.000069080816,0.00025624252,0.00009572735,0.002177094,0.0031895428],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000145941685,0.00004332608,0.004979477,0.0014601571,0.0002369289,0.000013287002,0.0052531683,0.0024773828,3.7712145e-8,0.0025973434,0.9827176,0.00020669721],"study_design_scores_gemma":[0.00036970113,0.000080130056,0.0020956837,0.00066431396,0.00003488348,0.0000022716033,0.00022562008,0.08496294,1.8856599e-7,0.020063475,0.8909718,0.00052898884],"about_ca_topic_score_codex":0.013422003,"about_ca_topic_score_gemma":0.00009868163,"teacher_disagreement_score":0.091745794,"about_ca_system_score_codex":0.0023586531,"about_ca_system_score_gemma":0.00054557394,"threshold_uncertainty_score":0.99955344},"labels":[],"label_agreement":null},{"id":"W3083800969","doi":"10.1016/j.jval.2020.06.009","title":"How Good Is Machine Learning in Predicting All-Cause 30-Day Hospital Readmission? Evidence From Administrative Data","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire de Sherbrooke; Université Laval","funders":"Xinjiang University","keywords":"Computer science; Medicine; Emergency medicine","score_opus":0.22221323422341235,"score_gpt":0.38450535892164184,"score_spread":0.16229212469822948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3083800969","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.42792985,0.0036369602,0.00033278763,0.5655054,0.00017086962,0.0019261825,0.0001142399,0.00018913348,0.00019459454],"genre_scores_gemma":[0.9914057,0.0015634521,0.0039545204,0.0021473353,0.00023140201,0.000026642103,0.00029819607,0.000029244324,0.00034349732],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976348,0.0003920857,0.0004615446,0.0007013705,0.00039629205,0.00041385175],"domain_scores_gemma":[0.9984371,0.00042957818,0.00016889178,0.00049038336,0.00002268749,0.00045136685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008556346,0.00021221879,0.00043788075,0.00008835892,0.00006780407,0.000047337628,0.00021388172,0.00007709958,0.00014318421],"category_scores_gemma":[0.0016752506,0.00018170242,0.00003534544,0.0003018325,0.000025460691,0.00032158298,0.00024562978,0.00056642457,0.000038315513],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018361725,0.00049726164,0.95316696,0.0005222367,0.0002399319,0.000879175,0.023496633,0.00012487045,0.00012819185,0.00006982557,0.009648314,0.011042962],"study_design_scores_gemma":[0.010499491,0.012263321,0.3143592,0.011186641,0.0004668029,0.000014893376,0.012471458,0.40628648,0.0006570028,0.00015695173,0.23057869,0.0010590804],"about_ca_topic_score_codex":0.005460423,"about_ca_topic_score_gemma":0.00019286804,"teacher_disagreement_score":0.6388078,"about_ca_system_score_codex":0.00020651969,"about_ca_system_score_gemma":0.00045413396,"threshold_uncertainty_score":0.82545626},"labels":[],"label_agreement":null},{"id":"W3090606661","doi":"10.1016/j.jval.2020.06.013","title":"Prioritizing Additional Data Collection to Reduce Decision Uncertainty in the HIV/AIDS Response in 6 US Cities: A Value of Information Analysis","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; AIDS Vancouver","funders":"National Institute on Drug Abuse; National Institute of Development Administration","keywords":"Human immunodeficiency virus (HIV); Decision aids; Value (mathematics); Data collection; Value of information; Data science; Actuarial science; Computer science; Psychology; Medicine; Statistics; Econometrics; Environmental health; Business; Economics; Family medicine; Mathematics; Alternative medicine; Artificial intelligence","score_opus":0.3479087323139526,"score_gpt":0.42412682563229603,"score_spread":0.07621809331834345,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3090606661","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92904913,0.00030476777,0.007530275,0.056381248,0.0001714688,0.0014021634,0.004939671,0.0000177674,0.0002034886],"genre_scores_gemma":[0.96752656,0.00013281537,0.014516122,0.016445898,0.0001135803,0.00015719507,0.001081864,0.000013407085,0.0000125658735],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99183244,0.001973147,0.0051067346,0.00048245155,0.00023507363,0.00037012913],"domain_scores_gemma":[0.9922824,0.0053990264,0.001468117,0.0006446686,0.000057259873,0.00014854583],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.037697714,0.00014410762,0.0008738559,0.0017696503,0.00011402923,0.00006258696,0.0005543895,0.0001110939,0.00016772542],"category_scores_gemma":[0.0200439,0.0001684075,0.00007432935,0.0034363542,0.000033945515,0.0008134137,0.00010414454,0.0002822345,0.000153182],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018332088,0.00022013349,0.1107947,0.00088912057,0.00008160959,0.0000030622903,0.07110241,0.73205304,0.000002338115,0.031482887,0.050432347,0.0011051147],"study_design_scores_gemma":[0.0012017583,0.0003080675,0.30985755,0.0003726113,0.0000061773835,0.0000026116925,0.008819674,0.65157586,4.050187e-7,0.0033271909,0.024319125,0.0002089519],"about_ca_topic_score_codex":0.016170574,"about_ca_topic_score_gemma":0.0010989832,"teacher_disagreement_score":0.19906285,"about_ca_system_score_codex":0.0015073783,"about_ca_system_score_gemma":0.00096737884,"threshold_uncertainty_score":0.9908927},"labels":[],"label_agreement":null},{"id":"W3093380260","doi":"10.1016/j.jval.2011.08.907","title":"PIH2 Caress: The Canadian Registry of Synagis (2005-2010)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre; University of Calgary; McMaster University","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Observational study; Gestational age; Cystic fibrosis; Adverse effect; Respiratory system; Internal medicine; Pregnancy","score_opus":0.15323497291199784,"score_gpt":0.37451556645950496,"score_spread":0.22128059354750712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3093380260","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8114983,0.008518192,0.000057757825,0.09247373,0.008566975,0.006188667,0.00055220636,0.00020601125,0.071938165],"genre_scores_gemma":[0.9877459,0.0006672229,0.00027296788,0.009861093,0.00034881616,0.0000120212435,0.00001408127,0.000029630333,0.0010482866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962574,0.0011168667,0.0009643575,0.00028285652,0.0002523519,0.0011261569],"domain_scores_gemma":[0.9978115,0.00028106078,0.0004417972,0.0007762468,0.00009385395,0.0005955618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002596636,0.00015399368,0.0003613165,0.00019537656,0.00089333946,0.000004331005,0.00041212924,0.0002131818,0.0003416192],"category_scores_gemma":[0.00027091693,0.00011280378,0.000056098605,0.00031578867,0.0001222075,0.00005308153,0.000056310164,0.0011989648,0.000112156515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013159701,0.0003112467,0.665892,0.004618285,0.000029165982,0.000037104433,0.09331837,0.000119641576,0.000009481173,0.06850757,0.16294512,0.0040804055],"study_design_scores_gemma":[0.0015395968,0.00020126186,0.8164935,0.0045872172,0.0000124086,0.000009230897,0.014073365,0.00065498904,0.000020232643,0.0040328796,0.15800746,0.00036787547],"about_ca_topic_score_codex":0.9465593,"about_ca_topic_score_gemma":0.82602596,"teacher_disagreement_score":0.17624758,"about_ca_system_score_codex":0.0008682773,"about_ca_system_score_gemma":0.0080455365,"threshold_uncertainty_score":0.9975779},"labels":[],"label_agreement":null},{"id":"W3099175750","doi":"10.1016/j.jval.2020.10.004","title":"What We Know Now: An Economic Evaluation of Chickenpox Vaccination and Dose Timing Using an Agent-Based Model","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan; University of Alberta","funders":"Alberta Health; University of Alberta","keywords":"Chickenpox; Vaccination; Medicine; Actuarial science; Virology; Economics; Virus","score_opus":0.24138141308185504,"score_gpt":0.41371211326094587,"score_spread":0.17233070017909083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3099175750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99556714,0.000938737,0.0013886457,0.0013468995,0.00010176216,0.0005956213,0.0000075415037,0.000020429212,0.00003323469],"genre_scores_gemma":[0.9961646,0.00072187086,0.002703787,0.0002903597,0.000053301028,0.000012211334,0.00003503128,0.000015920885,0.000002905472],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9989715,0.00021607263,0.00030730997,0.00022756174,0.00014584068,0.00013172264],"domain_scores_gemma":[0.9994773,0.00002484156,0.00012743741,0.00014726765,0.00005358952,0.00016953633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007521049,0.00008927207,0.00019980478,0.00013472674,0.00006710694,0.000020488587,0.00002349117,0.00005358709,0.00004067284],"category_scores_gemma":[0.000026794532,0.00008953485,0.000022905711,0.000100983074,0.000009788509,0.00036651356,0.000008553639,0.00008192607,0.00000423347],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007290748,0.0003412295,0.0061124875,0.00023511058,0.00001625964,0.0000012815215,0.0018446704,0.73529994,0.00024218191,0.000055664663,0.000004759783,0.25577348],"study_design_scores_gemma":[0.0022795252,0.00039221713,0.005342665,0.00023145087,0.000051965584,0.00000278507,0.00018318751,0.9907538,0.0005003379,0.00014496273,0.000058529193,0.00005852192],"about_ca_topic_score_codex":0.001214646,"about_ca_topic_score_gemma":0.0002799883,"teacher_disagreement_score":0.25571495,"about_ca_system_score_codex":0.0004514218,"about_ca_system_score_gemma":0.0006785603,"threshold_uncertainty_score":0.3651125},"labels":[],"label_agreement":null},{"id":"W3100474061","doi":"10.1016/j.jval.2020.06.017","title":"Childhood Nutrition in Rural China: What Impact Does Public Health Insurance Have?","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"National Office for Philosophy and Social Sciences","keywords":"Environmental health; Propensity score matching; Calorie; Medicine; China; Public health; Consumption (sociology); Health insurance; Health care; Economic growth; Geography; Economics","score_opus":0.05972141688948395,"score_gpt":0.2773414359053089,"score_spread":0.21762001901582495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3100474061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8671937,0.01983118,0.00008655133,0.1105849,0.00072458683,0.001160563,0.00021420556,0.000057116187,0.0001471933],"genre_scores_gemma":[0.97703254,0.018885182,0.00016490092,0.0033715933,0.00037127495,0.000068015244,0.000050957897,0.000038916347,0.000016637778],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963394,0.00020892243,0.0018235225,0.0005250366,0.00009152399,0.0010116186],"domain_scores_gemma":[0.99834585,0.00002543637,0.0006786107,0.00030010004,0.00001930713,0.0006307224],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021915627,0.00024271483,0.00095918856,0.00045355142,0.0001477352,0.00015871828,0.0002477331,0.00016304695,0.000045711673],"category_scores_gemma":[0.0001460414,0.00019391441,0.00014189184,0.00080461113,0.000032763328,0.000981706,0.000044601136,0.0005622358,0.00010090186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025197025,0.00057182077,0.91348046,0.0018544683,0.000017656372,0.000008906298,0.0177662,0.0006686123,8.4578437e-7,0.008159515,0.000204291,0.057242014],"study_design_scores_gemma":[0.0015089139,0.00048312137,0.982766,0.00069286476,7.309758e-8,0.000009340216,0.0016542636,0.003368351,0.0000010622954,0.0044337604,0.0048223566,0.0002599059],"about_ca_topic_score_codex":0.113168746,"about_ca_topic_score_gemma":0.0013118563,"teacher_disagreement_score":0.11185689,"about_ca_system_score_codex":0.0011636233,"about_ca_system_score_gemma":0.0004902823,"threshold_uncertainty_score":0.89273673},"labels":[],"label_agreement":null},{"id":"W3101964747","doi":"10.1016/j.jval.2020.10.006","title":"Independent Registries Are Cost-Effective Tools to Provide Mandatory Postauthorization Surveillance for Orphan Medicinal Products","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":12,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia Hospital; Dalhousie University; University of Toronto; Nova Scotia Health Authority; University of Manitoba; Université de Montréal; University of British Columbia","funders":"","keywords":"Authorization; Medicine; Business; Data quality; Disease registry; Family medicine; Disease; Computer science; Marketing; Pathology","score_opus":0.4344236756413911,"score_gpt":0.42444105680058314,"score_spread":0.009982618840807977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3101964747","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.17447002,0.0044325357,0.0453277,0.7465019,0.001782948,0.024655718,0.0023544198,0.00017829014,0.0002964572],"genre_scores_gemma":[0.9439337,0.00018421363,0.0039223647,0.047647618,0.0013780106,0.002459901,0.00023966505,0.00007501401,0.00015947022],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99445695,0.0007177178,0.0031658178,0.0009248771,0.00015920318,0.00057542935],"domain_scores_gemma":[0.9956527,0.0012636231,0.0021004325,0.00039436028,0.000160041,0.0004288465],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01691029,0.00022037653,0.0010756778,0.0002736922,0.00019667356,0.00007793818,0.00026828502,0.00012551481,0.000028419132],"category_scores_gemma":[0.021266878,0.0002810065,0.000058420756,0.0005058967,0.000043244072,0.00039177746,0.000054540364,0.00022679011,0.00023034652],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011602374,0.0004678166,0.5272218,0.017352356,0.00015509609,0.000012243237,0.035024405,0.023717036,0.000033731187,0.2094606,0.169951,0.015443676],"study_design_scores_gemma":[0.0033804826,0.0016232217,0.22283533,0.0007453066,0.000004825228,0.000008036057,0.0034060143,0.015712759,0.000080459,0.0050086477,0.7463525,0.00084239396],"about_ca_topic_score_codex":0.0017792945,"about_ca_topic_score_gemma":0.000311387,"teacher_disagreement_score":0.7694637,"about_ca_system_score_codex":0.0014435091,"about_ca_system_score_gemma":0.0007216997,"threshold_uncertainty_score":0.99996424},"labels":[],"label_agreement":null},{"id":"W3103710866","doi":"10.1016/j.jval.2020.10.005","title":"Economic Consequences of Adult Living Kidney Donation: A Systematic Review","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; University of Toronto; Public Health Ontario","funders":"","keywords":"Donation; Kidney donation; Indirect costs; Payment; Mandate; Actuarial science; Health economics; Direct Payments; Medicine; Demographic economics; Business; Finance; Public economics; Health care; Economics; Accounting; Economic growth; Kidney transplantation; Transplantation; Political science; Surgery","score_opus":0.07338687701028504,"score_gpt":0.3607495151924245,"score_spread":0.2873626381821395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3103710866","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[9.256809e-7,0.9928072,0.000014376579,0.0033225683,0.00016780486,0.0033182644,0.0000944993,0.000030532028,0.0002438148],"genre_scores_gemma":[0.00006095376,0.99720603,0.00022272462,0.0021155677,0.00006109609,0.00011951601,0.00014312711,0.000025763888,0.00004519723],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968951,0.0006266447,0.0018647591,0.00026107318,0.00021235243,0.00014011453],"domain_scores_gemma":[0.99797696,0.0004902573,0.001068942,0.00021333287,0.000060761868,0.00018973653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007645271,0.00020547691,0.0028262162,0.00022714661,0.000022412405,0.0000071839177,0.00011043594,0.00010395844,0.000121691475],"category_scores_gemma":[0.00095149333,0.00016519116,0.00022905292,0.00029967568,0.000038527767,0.000044187953,0.000009137794,0.00024246052,0.00011348523],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000012832388,0.000018674078,0.000014992172,0.99147147,0.000057893893,0.000009679061,0.00015349439,7.3070595e-7,2.6709312e-8,0.0017593271,0.00013660171,0.006375814],"study_design_scores_gemma":[0.00014597434,0.00007608775,0.0000042559964,0.96992564,0.00072856917,0.0001973982,0.000015179759,0.00004890243,3.2526637e-7,0.00001555172,0.028739221,0.00010287606],"about_ca_topic_score_codex":0.00032604608,"about_ca_topic_score_gemma":0.000009956388,"teacher_disagreement_score":0.028602619,"about_ca_system_score_codex":0.00042336778,"about_ca_system_score_gemma":0.003361796,"threshold_uncertainty_score":0.67363},"labels":[],"label_agreement":null},{"id":"W3105325131","doi":"10.1016/j.jval.2020.07.015","title":"Incidence and Variables Associated With Inconsistencies in Opioid Prescribing at Hospital Discharge and Its Associated Adverse Drug Outcomes","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research","keywords":"Medicine; Confidence interval; Medical prescription; Odds ratio; Opioid; Logistic regression; Emergency medicine; Incidence (geometry); Emergency department; Rate ratio; Cohort study; Internal medicine; Adverse effect; Psychiatry; Pharmacology","score_opus":0.025132959170162592,"score_gpt":0.2601186465083062,"score_spread":0.2349856873381436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3105325131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9865564,0.0026622196,0.0000010786283,0.00936956,0.000054391894,0.0011662992,0.000059265432,0.00006881953,0.00006196255],"genre_scores_gemma":[0.9979003,0.0006536156,0.00021083889,0.0009901925,0.00001061698,0.000049129372,0.00005345385,0.000028655102,0.00010317589],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811715,0.00022408001,0.0004641679,0.00044472003,0.00031476494,0.0004351103],"domain_scores_gemma":[0.998965,0.0003679093,0.00021293761,0.00012904905,0.000054187116,0.00027090544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004732876,0.0002349183,0.0006309521,0.00011419395,0.00010655177,0.000015695443,0.000060478164,0.00008402272,0.000009789737],"category_scores_gemma":[0.0013629462,0.00019076631,0.000029193565,0.0003825443,0.000055262044,0.00017012515,0.00013067125,0.0002571308,0.0000033537574],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006872617,0.00029267216,0.9802071,0.00030316866,0.0000665574,0.00006044813,0.018651156,0.00009538939,0.000031885676,0.00011859907,0.000059112615,0.000045188473],"study_design_scores_gemma":[0.004240684,0.00057474367,0.9857212,0.0012251195,0.00004377239,0.0000039102542,0.0024562194,0.0054243132,0.00004576647,0.00005624328,0.00001974318,0.00018830782],"about_ca_topic_score_codex":0.004319831,"about_ca_topic_score_gemma":0.0011458525,"teacher_disagreement_score":0.016194936,"about_ca_system_score_codex":0.00061221514,"about_ca_system_score_gemma":0.00038495235,"threshold_uncertainty_score":0.7779224},"labels":[],"label_agreement":null},{"id":"W3110688360","doi":"10.1016/j.jval.2020.08.1388","title":"PND63 Knowledge and Understanding of Alzheimer'S Disease: Revisiting the Psychometric Properties of the Adks Questionnaire","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Item response theory; Psychology; Scale (ratio); Nonparametric statistics; Logistic regression; Clinical psychology; Depression (economics); Psychometrics; Statistics; Medicine; Internal medicine; Mathematics","score_opus":0.16588021300344877,"score_gpt":0.36432523585094856,"score_spread":0.1984450228474998,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110688360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8822514,0.07705464,0.00015941932,0.03878019,0.00006003634,0.0011123135,0.0000047999406,0.000013126735,0.0005640656],"genre_scores_gemma":[0.99846417,0.0010699402,0.000017558361,0.0003364539,0.00007614586,0.000011424961,6.746163e-7,0.000007859058,0.000015804442],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987972,0.00032893688,0.00030347903,0.00013603551,0.00026849884,0.00016586359],"domain_scores_gemma":[0.99950373,0.00006772922,0.00011192493,0.00012677936,0.00006748609,0.00012233379],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00081146765,0.00006612378,0.00018440792,0.00010152438,0.00009452273,0.000007490887,0.00007593466,0.00001735352,0.000009106689],"category_scores_gemma":[0.00050921866,0.000035208985,0.00004447313,0.0007973215,0.00015021181,0.000033076885,0.00006410209,0.00016273622,0.0000010422032],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022951388,0.00012005378,0.9611079,0.0043194615,0.00007328527,0.0000019647089,0.003492521,0.000024650331,0.0004605902,0.003118509,0.00017598418,0.026875561],"study_design_scores_gemma":[0.0010117199,0.00036745635,0.9846883,0.005398547,0.00008011155,0.0000037591103,0.001981766,0.0049459552,0.00078160816,0.00038474257,0.0002916561,0.00006440252],"about_ca_topic_score_codex":0.00015578017,"about_ca_topic_score_gemma":0.0000020252085,"teacher_disagreement_score":0.11621273,"about_ca_system_score_codex":0.00005639751,"about_ca_system_score_gemma":0.00032064787,"threshold_uncertainty_score":0.14357807},"labels":[],"label_agreement":null},{"id":"W3110734664","doi":"10.1016/j.jval.2020.08.2023","title":"PSY15 Utilizing Administrative DATA to Determine the Healthcare Burden for Atopic Dermatitis Patients","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Atopic dermatitis; Prednisone; Rash; Health care; Potency; Population; Pediatrics; Dermatology; Internal medicine; Environmental health","score_opus":0.25558768654296843,"score_gpt":0.40771020100773453,"score_spread":0.1521225144647661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110734664","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6388256,0.0022158034,0.00017647131,0.35502508,0.0002472795,0.0027661023,0.00051196694,0.00005966462,0.00017202512],"genre_scores_gemma":[0.96079373,0.0000856033,0.0010729412,0.037517563,0.00015518852,0.00007556431,0.00026889,0.000014607512,0.000015906257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99857783,0.0001875415,0.00043021873,0.0003220389,0.0001638072,0.0003185325],"domain_scores_gemma":[0.99871624,0.0003149449,0.00009847133,0.00044240782,0.00006082973,0.00036713426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019615474,0.00011665746,0.0003088326,0.000041815565,0.00014516049,0.00001103285,0.000265061,0.0000544754,0.000015690914],"category_scores_gemma":[0.000816863,0.00008898048,0.000036292848,0.00018858266,0.00003914039,0.00006851845,0.000103551414,0.00016196026,0.00002037172],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005900778,0.00039067527,0.7381905,0.0059445123,0.00009544736,0.00015931274,0.019222358,0.00008028355,0.000006958117,0.0016589854,0.17097038,0.06269056],"study_design_scores_gemma":[0.006077719,0.0024044402,0.7178623,0.0016343499,0.00007972245,0.000103427585,0.0042799856,0.031595416,0.00014253904,0.0007602157,0.23462652,0.00043334975],"about_ca_topic_score_codex":0.0005541444,"about_ca_topic_score_gemma":0.00011601043,"teacher_disagreement_score":0.32196814,"about_ca_system_score_codex":0.0000642258,"about_ca_system_score_gemma":0.0005141132,"threshold_uncertainty_score":0.36285186},"labels":[],"label_agreement":null},{"id":"W3110753338","doi":"10.1016/j.jval.2020.08.601","title":"PDB4 Evaluation of Quality of Life in PRE-Pubertal Children Using the Quality of Life in Short Stature Youth (QOLISSY) Questionnaire, Following 12 Months of Growth Hormone Treatment with Either a Weekly Somatrogon or a Daily Genotropin Injection Schedule","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Sexual Differentiation and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"OPKO Health (Canada)","funders":"","keywords":"Medicine; Quality of life (healthcare); Short stature; Idiopathic short stature; Pediatrics; Confidence interval; Growth hormone deficiency; Growth hormone; Internal medicine; Hormone","score_opus":0.08308775449079076,"score_gpt":0.35384864155282025,"score_spread":0.2707608870620295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110753338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9958073,0.0022946757,0.00067134347,0.00016647349,0.00002837359,0.00095647876,0.00006199045,0.000004511843,0.000008878095],"genre_scores_gemma":[0.999236,0.000112896494,0.00033887257,0.000090473804,0.000024290697,0.000024078223,0.00015690264,0.000015196035,0.000001279925],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969049,0.0012046018,0.0010277437,0.00028490167,0.00040586104,0.00017195487],"domain_scores_gemma":[0.9991021,0.000031584696,0.0004426325,0.0002249943,0.0001244283,0.000074260126],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011400195,0.0001519442,0.00047624606,0.00009718461,0.00002465771,0.000004594752,0.00009567685,0.0001261123,0.0000022048534],"category_scores_gemma":[0.0006185249,0.00011095914,0.000081531485,0.00033690175,0.00005408151,0.000015291265,0.000028860257,0.00009569239,3.8042366e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026449834,0.000667783,0.9390617,0.00028514952,0.0001224948,7.440745e-8,0.008541993,0.021753335,0.02648003,0.000060754795,0.000002294197,0.00037937824],"study_design_scores_gemma":[0.0037947579,0.0015426787,0.9815477,0.00012741121,0.000036730227,2.406045e-7,0.0027151254,0.0062750517,0.0038119014,0.000033867702,2.1655222e-7,0.00011429935],"about_ca_topic_score_codex":0.0590076,"about_ca_topic_score_gemma":0.0076686773,"teacher_disagreement_score":0.051338922,"about_ca_system_score_codex":0.00009509698,"about_ca_system_score_gemma":0.00095813675,"threshold_uncertainty_score":0.94725853},"labels":[],"label_agreement":null},{"id":"W3110774437","doi":"10.1016/j.jval.2020.08.610","title":"PDB13 Examining Self-Monitoring of Blood Glucose in the NOVA Scotia Public Pharmacare Program","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Dalhousie University","funders":"","keywords":"Nova scotia; Test (biology); Medicine; Diabetes mellitus; Hypoglycemia; Population; Environmental health; Blood test; Emergency medicine; Gerontology; Internal medicine; Endocrinology; Geography; Biology","score_opus":0.3963706619794468,"score_gpt":0.46195742878241347,"score_spread":0.06558676680296666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110774437","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9813385,0.0026699072,0.0000035165283,0.013887237,0.00030213248,0.0011635955,0.0000034870125,0.00006507017,0.00056656403],"genre_scores_gemma":[0.9948885,0.00047282293,0.0018282912,0.0025365106,0.00023177014,0.000017271755,0.000006302773,0.000016544896,0.0000020194345],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99800336,0.00041165037,0.00056559313,0.00023132953,0.00039239938,0.00039568744],"domain_scores_gemma":[0.9989208,0.00044399154,0.00019009228,0.00016942648,0.00004199287,0.00023368142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011085417,0.00012623983,0.0003347094,0.00010473602,0.000032109958,0.000021182334,0.00017518882,0.000049746945,0.0000357789],"category_scores_gemma":[0.00046458724,0.00009280349,0.000045747147,0.0007894658,0.000028380346,0.0001581637,0.000049098453,0.00064749166,0.000012706932],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000895526,0.000876818,0.9724957,0.0014709017,0.000037442274,0.000055875837,0.006068387,0.00007371318,0.0002758935,0.00006953509,0.000033757835,0.01845246],"study_design_scores_gemma":[0.02229465,0.008560785,0.85244185,0.0026369097,0.00045586305,0.00015590762,0.013462126,0.04801191,0.007216855,0.000065890374,0.043964792,0.00073248794],"about_ca_topic_score_codex":0.0009267268,"about_ca_topic_score_gemma":0.000008818778,"teacher_disagreement_score":0.120053835,"about_ca_system_score_codex":0.00005886665,"about_ca_system_score_gemma":0.0002613567,"threshold_uncertainty_score":0.37844166},"labels":[],"label_agreement":null},{"id":"W3110799233","doi":"10.1016/j.jval.2020.08.1768","title":"PRO32 A Treatment Cost MODEL to Estimate TOTAL Annual Costs for Management of Patients with Transthyretin Amyloid Polyneuropathy in Spain","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Context (archaeology); Total cost; Adverse effect; Polyneuropathy; Concomitant; Emergency medicine; Surgery; Internal medicine; Business","score_opus":0.2398097921726874,"score_gpt":0.39360278506548524,"score_spread":0.15379299289279783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110799233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93812543,0.00030715883,0.013324571,0.038337126,0.000105420724,0.0074362047,0.0021363476,0.000030824845,0.00019694323],"genre_scores_gemma":[0.9729263,0.000053857784,0.021347182,0.004638025,0.00003760979,0.0008161583,0.00008042094,0.000050481005,0.000049917107],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9955423,0.00026979344,0.0029205768,0.0006295501,0.00010752276,0.0005302941],"domain_scores_gemma":[0.99826145,0.0002494566,0.0008686846,0.00026828542,0.00003923118,0.00031287776],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004120676,0.00021760653,0.0009575325,0.00029532687,0.00005659303,0.000017143217,0.00016323922,0.00005902176,0.000010049445],"category_scores_gemma":[0.00023038288,0.00025005735,0.000065303146,0.00034142367,0.000025071811,0.00016999178,0.00002548045,0.00009174603,0.00004528618],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011686787,0.0013706892,0.19068773,0.004033959,0.000066657325,0.0000056243757,0.021247216,0.724271,7.852745e-7,0.049797013,0.0006745944,0.0066760667],"study_design_scores_gemma":[0.011529674,0.004282679,0.18075089,0.00081321184,0.000009771148,0.0000010007186,0.0015506305,0.7960763,0.000007925965,0.0010441379,0.0032839596,0.0006498434],"about_ca_topic_score_codex":0.002326547,"about_ca_topic_score_gemma":0.00022372685,"teacher_disagreement_score":0.07180529,"about_ca_system_score_codex":0.0013118159,"about_ca_system_score_gemma":0.00022569115,"threshold_uncertainty_score":0.9999952},"labels":[],"label_agreement":null},{"id":"W3110821288","doi":"10.1016/j.jval.2020.08.289","title":"PCN152 The Burden of Skeletal-Related Events in FOUR LATIN American Countries: Argentina, Brazil, Colombia, and Mexico","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone health and osteoporosis research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada); Amgen (Canada)","funders":"","keywords":"Latin Americans; Medicine; Demography; Geography; Environmental health; Political science","score_opus":0.041234432112897665,"score_gpt":0.34084631647731306,"score_spread":0.2996118843644154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110821288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9028457,0.0014982006,0.0000062867325,0.09418635,0.000051429546,0.0012181582,0.000016294762,0.000018766596,0.00015884486],"genre_scores_gemma":[0.9939237,0.0017922701,0.00014791956,0.0038923328,0.0000568966,0.000031436888,0.000010712399,0.000022884242,0.00012181364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973567,0.00047082902,0.0008221968,0.00030155585,0.00048843975,0.000560245],"domain_scores_gemma":[0.9986268,0.0004009263,0.0002636487,0.00022579303,0.00006920663,0.0004136092],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001391294,0.0001321667,0.0005771057,0.00014456316,0.000078126875,0.0000055626706,0.00012396617,0.00007781964,0.00006426319],"category_scores_gemma":[0.00059676595,0.00010473263,0.000044410313,0.00093648536,0.00020527086,0.000039083963,0.00007196711,0.00057654514,0.000022968312],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007080566,0.0001805748,0.9716394,0.0027062816,0.000034511806,0.000044236727,0.011855359,0.0006065463,0.00022419805,0.00063728105,0.0022235173,0.009140035],"study_design_scores_gemma":[0.004522071,0.0023109242,0.94379777,0.00069574674,0.000012001522,0.00001689377,0.0022019204,0.03189981,0.000080335376,0.00025276162,0.014057745,0.00015202169],"about_ca_topic_score_codex":0.039240245,"about_ca_topic_score_gemma":0.00027164226,"teacher_disagreement_score":0.091078065,"about_ca_system_score_codex":0.00015421721,"about_ca_system_score_gemma":0.0009064347,"threshold_uncertainty_score":0.96715754},"labels":[],"label_agreement":null},{"id":"W3110836949","doi":"10.1016/j.jval.2020.08.885","title":"PIN44 Isavuconazole for the Treatment of Invasive Aspergillosis and Mucormycosis: A Canadian Cost-Utility Analysis","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; Université de Montréal","funders":"","keywords":"Voriconazole; Medicine; Aspergillosis; Internal medicine; Case fatality rate; Population; Intensive care medicine; Mucormycosis; Economic evaluation; Emergency medicine; Surgery; Epidemiology; Antifungal; Environmental health; Immunology; Pathology","score_opus":0.09615228891756904,"score_gpt":0.3281833001406183,"score_spread":0.23203101122304925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110836949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9717231,0.00534535,0.00015890856,0.020793142,0.000027529224,0.0015928608,0.0002368314,0.000009283219,0.00011299408],"genre_scores_gemma":[0.99372715,0.0037285653,0.0002281131,0.0021516227,0.00003513742,0.00007273142,0.000025655521,0.000007114184,0.000023899856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988626,0.00008656967,0.0003691877,0.00027837208,0.00012817854,0.00027509648],"domain_scores_gemma":[0.9987563,0.0004431366,0.00008561846,0.00025724532,0.00007315228,0.00038452866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003375762,0.00010891143,0.00048729163,0.000096705175,0.00011327591,0.000006229706,0.00005466363,0.000051670733,0.00005111611],"category_scores_gemma":[0.00027577378,0.00007359357,0.00015711006,0.00049907237,0.000088912675,0.00002584344,0.000006824727,0.000066041175,0.0000015887254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034743594,0.00015798547,0.9842095,0.0004204977,0.00032194162,0.000004427735,0.004038864,0.00014673344,0.000041234667,0.00019053764,0.00021470824,0.009906141],"study_design_scores_gemma":[0.0012227698,0.0011733348,0.97054017,0.0000608296,0.00037697592,8.0114177e-7,0.0020246997,0.019324265,0.00032805922,0.000066681096,0.0048062224,0.00007517467],"about_ca_topic_score_codex":0.33751798,"about_ca_topic_score_gemma":0.3400493,"teacher_disagreement_score":0.02200406,"about_ca_system_score_codex":0.00033708673,"about_ca_system_score_gemma":0.0009600843,"threshold_uncertainty_score":0.6719931},"labels":[],"label_agreement":null},{"id":"W3110868324","doi":"10.1016/j.jval.2020.08.1985","title":"PSS23 Burden of Dry Eye Disease and Treatment Experience with Lifitegrast: A CROSS-Sectional Patient Survey in US and Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quality of life (healthcare); Cross-sectional study; Mood; Disease; Affect (linguistics); Demographics; Physical therapy; Demography; Psychiatry; Internal medicine; Psychology; Nursing","score_opus":0.04031627114512207,"score_gpt":0.29550984013359965,"score_spread":0.25519356898847756,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110868324","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99777496,0.0011511443,0.0000031419524,0.00063618115,0.000026015112,0.00033317675,0.000064140695,0.0000043043706,0.00000692938],"genre_scores_gemma":[0.9992983,0.00022794017,0.000060698116,0.00034534832,0.000016711952,0.000015775408,0.000016115682,0.0000070116157,0.000012133793],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99914545,0.000087990156,0.00022568784,0.00020777904,0.00017940483,0.00015367885],"domain_scores_gemma":[0.9994829,0.000056331533,0.00005459379,0.00009163936,0.000027663242,0.00028684767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000898783,0.00008626826,0.00020665154,0.00003186271,0.000026705111,0.000006782391,0.000018046905,0.000019612462,0.0000059140816],"category_scores_gemma":[0.000053057458,0.00006655332,0.000009894214,0.00011195837,0.000038223778,0.000028994222,0.00001238409,0.000067645335,1.6927054e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005081684,0.000050209317,0.9955668,0.000107213986,0.00000852135,0.00006921218,0.002459044,0.0007309056,0.000015094552,0.0000066119733,7.084722e-7,0.000477511],"study_design_scores_gemma":[0.0011563493,0.0007814973,0.9957557,0.0001016511,0.0000030270185,4.2122875e-7,0.0003263192,0.0016561507,0.000028063792,0.0000016870799,0.00013489742,0.000054257915],"about_ca_topic_score_codex":0.94415796,"about_ca_topic_score_gemma":0.53318065,"teacher_disagreement_score":0.4109773,"about_ca_system_score_codex":0.00019958375,"about_ca_system_score_gemma":0.0011607705,"threshold_uncertainty_score":0.47533756},"labels":[],"label_agreement":null},{"id":"W3111112701","doi":"10.1016/j.jval.2020.08.079","title":"PBI1 The Psoriasis Study of Health Outcomes (PSOHO) in Biologic-Naive and -Experienced Patients: Results from the First 217 Patients","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Lynde Centre for Dermatology","funders":"","keywords":"Medicine; Secukinumab; Ixekizumab; Internal medicine; Psoriasis; Psoriatic arthritis; Plaque psoriasis; Cohort; Ustekinumab; Population; Observational study; Psoriasis Area and Severity Index; Interleukin 17; Arthritis; Dermatology; Adalimumab; Disease","score_opus":0.055678992256940826,"score_gpt":0.2791351838719384,"score_spread":0.22345619161499758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111112701","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887175,0.001888122,9.025064e-7,0.006855769,0.0005389993,0.00159059,0.0003681142,0.000021134205,0.000018873972],"genre_scores_gemma":[0.99744916,0.00045835384,0.000019581541,0.0017899391,0.000019229135,0.000079807316,0.00016603984,0.000010948287,0.000006967892],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99632394,0.0017178269,0.0009928049,0.00048083154,0.00008152948,0.00040307743],"domain_scores_gemma":[0.9978588,0.00118285,0.00051044143,0.0003658265,0.000042640113,0.00003939364],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007602558,0.00022697424,0.0005978009,0.000065195956,0.00038134944,0.000012056952,0.0003415471,0.00011848892,0.000013308961],"category_scores_gemma":[0.00056570466,0.00012328701,0.00005521619,0.0003503652,0.00015719411,0.000055025725,0.0001432832,0.00022659251,0.000013889957],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005298682,0.0008882996,0.9063559,0.0000133886915,0.00006817621,8.247896e-7,0.07953469,0.000041507577,0.00000395766,0.000025926644,0.00027743104,0.012260039],"study_design_scores_gemma":[0.008538397,0.002310994,0.97742885,0.00005390919,0.000012096604,1.702654e-7,0.010544846,0.000010770865,0.00003208587,0.00004663476,0.00091265683,0.00010861289],"about_ca_topic_score_codex":0.034268934,"about_ca_topic_score_gemma":0.0021062603,"teacher_disagreement_score":0.071072936,"about_ca_system_score_codex":0.00010292275,"about_ca_system_score_gemma":0.00012039409,"threshold_uncertainty_score":0.97216195},"labels":[],"label_agreement":null},{"id":"W3111116262","doi":"10.1016/j.jval.2020.08.546","title":"PCV55 Cost-Effectiveness of Icosapent Ethyl (IPE) for the Reduction of the Risk of Ischemic Cardiovascular Events in Canada.","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montreal Heart Institute; St. Michael's Hospital; Robarts Clinical Trials; Université de Montréal","funders":"","keywords":"Medicine; Placebo; Unstable angina; Internal medicine; Emergency medicine; Revascularization; Cardiology; Myocardial infarction; Alternative medicine","score_opus":0.3390108444763588,"score_gpt":0.38144706280034824,"score_spread":0.042436218323989416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111116262","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97643757,0.00831222,0.0013637478,0.009335269,0.0005785945,0.0034777236,0.00044331496,0.0000031385907,0.000048394413],"genre_scores_gemma":[0.9983196,0.0007791873,0.00020412113,0.00042017305,0.000060902014,0.00019006722,0.0000065882095,0.0000156624,0.0000036611102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948516,0.0014879808,0.0029645378,0.0003068775,0.00014156195,0.00024743128],"domain_scores_gemma":[0.9952014,0.0019873998,0.0021922279,0.0004863781,0.00006186682,0.00007073556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023294501,0.000109231405,0.0010220406,0.000094943534,0.000059833194,0.0000019957922,0.00030909435,0.000064130334,0.000008469935],"category_scores_gemma":[0.0032941515,0.00009958854,0.00021472055,0.00037300363,0.00004474797,0.0000714302,0.000043364184,0.00019988758,0.0000025442057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000151713,0.00011563947,0.53077424,0.0074179107,0.0003096631,9.481105e-8,0.004386855,0.45014933,0.000036810234,0.004473497,0.0012274454,0.00095681153],"study_design_scores_gemma":[0.0035184077,0.00019317721,0.8904201,0.0011153461,0.000037093425,0.000002353958,0.0033144474,0.08274442,0.0010890828,0.003219883,0.01406358,0.00028214598],"about_ca_topic_score_codex":0.8670713,"about_ca_topic_score_gemma":0.06654738,"teacher_disagreement_score":0.80052394,"about_ca_system_score_codex":0.0013599619,"about_ca_system_score_gemma":0.0018000697,"threshold_uncertainty_score":0.9504857},"labels":[],"label_agreement":null},{"id":"W3111185175","doi":"10.1016/j.jval.2020.08.743","title":"PDG60 The IMPACT of International Reference Pricing (IRP) in France, Italy, Spain, United Kingdom, and Canada to New and Existing Marketed Medications","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Negotiation; Publication; International economics; Developing country; Confidentiality; Price index; Business; Economics; International trade; Public economics; Political science; Economic growth; Advertising; Macroeconomics; Law","score_opus":0.17518797701970895,"score_gpt":0.3549262249663573,"score_spread":0.17973824794664833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111185175","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96491975,0.0005601074,0.00015675263,0.031826183,0.00006301432,0.00018581687,0.00012861346,0.0000040452946,0.0021557382],"genre_scores_gemma":[0.9951839,0.00042416118,0.00027967137,0.004022249,0.000052179235,0.0000041946896,0.000008315422,0.00000667689,0.000018688117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990691,0.000030465793,0.0005126117,0.0001840856,0.000024874915,0.00017889474],"domain_scores_gemma":[0.999248,0.00025126737,0.00019471427,0.00008730025,0.00001210049,0.00020657359],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005671754,0.00007111887,0.00021131172,0.00017170484,0.00003550602,0.000018689305,0.0001410386,0.000026263173,0.000040967367],"category_scores_gemma":[0.0004858391,0.00006827604,0.000013205418,0.0003268252,0.000024178955,0.000048862297,0.00006082442,0.00016535417,0.0000018171708],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003399743,0.00002849468,0.8939643,0.000117178475,0.000042060758,0.0000022403149,0.002580193,0.013920728,0.0000135160635,0.08343278,0.0021658966,0.0036986151],"study_design_scores_gemma":[0.0007396188,0.000068542155,0.68140715,0.00010793706,0.000001316185,0.0000023417736,0.00008391508,0.27114615,0.0000031242844,0.0034445543,0.042847637,0.00014774478],"about_ca_topic_score_codex":0.88715345,"about_ca_topic_score_gemma":0.047393024,"teacher_disagreement_score":0.8397604,"about_ca_system_score_codex":0.00019746595,"about_ca_system_score_gemma":0.00031796072,"threshold_uncertainty_score":0.9699896},"labels":[],"label_agreement":null},{"id":"W3111189188","doi":"10.1016/j.jval.2020.08.261","title":"PCN124 Health Utilities for Patients with HR-Positive, HER2-Negative EARLY Breast Cancer: A Systematic Literature Review","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Breast cancer; Disease; Generalizability theory; Cancer; Oncology; Systematic review; MEDLINE; Internal medicine; Family medicine; Meta-analysis; Gynecology; Psychology","score_opus":0.2340163735266508,"score_gpt":0.3874628003376505,"score_spread":0.1534464268109997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111189188","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.049118016,0.33674914,0.0018043796,0.56825197,0.0008799086,0.02437902,0.01832595,0.00019208646,0.00029954864],"genre_scores_gemma":[0.56813264,0.07998726,0.0094382,0.33507356,0.001005119,0.005128158,0.00058529055,0.00029260086,0.0003571721],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9912606,0.0014215751,0.005429969,0.0008827315,0.0002017072,0.0008034039],"domain_scores_gemma":[0.9933232,0.0014699635,0.003952254,0.00046119557,0.00023536618,0.00055803603],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0096883625,0.00036914172,0.0027403359,0.00025480424,0.00027406742,0.00010547761,0.00032424144,0.00011942765,0.000059990947],"category_scores_gemma":[0.002019215,0.00037876665,0.00015773835,0.0007055743,0.000065372726,0.0005331061,0.00004076046,0.00034988695,0.00012585378],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019661835,0.00032743538,0.10635865,0.8025361,0.00018068762,0.0000017457651,0.035030443,0.00041135083,1.2978566e-8,0.033522043,0.021169392,0.00026552848],"study_design_scores_gemma":[0.008677695,0.0044665644,0.31514743,0.63425124,0.000050832645,0.000023219747,0.0030210156,0.017684419,5.81366e-7,0.0077562737,0.006901135,0.0020195993],"about_ca_topic_score_codex":0.010231618,"about_ca_topic_score_gemma":0.0002710652,"teacher_disagreement_score":0.51901466,"about_ca_system_score_codex":0.0016421616,"about_ca_system_score_gemma":0.0009360321,"threshold_uncertainty_score":0.9998664},"labels":[],"label_agreement":null},{"id":"W3111193106","doi":"10.1016/j.jval.2020.08.810","title":"PIH11 Quality of Life and Economic Burden of Erectile Dysfunction","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Sexual function and dysfunction studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Erectile dysfunction; Quality of life (healthcare); Medicine; Psychosocial; Depression (economics); Anxiety; Sexual dysfunction; Observational study; Gerontology; Human sexuality; Clinical psychology; Psychiatry; Internal medicine","score_opus":0.14883802938699991,"score_gpt":0.3558114739756161,"score_spread":0.20697344458861616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111193106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9888735,0.0012153103,0.00026205464,0.0073939366,0.00037427348,0.0002536131,0.000011853434,0.000031104897,0.0015843901],"genre_scores_gemma":[0.9976411,0.00044697273,0.00018826399,0.0013949791,0.000192986,0.000005067168,0.0000052219607,0.0000075242115,0.00011792784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99889547,0.00011734191,0.0005913111,0.00017971157,0.00011069632,0.00010548587],"domain_scores_gemma":[0.9993014,0.00018040855,0.00021142699,0.00010764539,0.000042581218,0.000156592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047715078,0.000071434006,0.0004290303,0.000078045276,0.00002635654,0.0000018214871,0.000018448509,0.00004166123,0.00017215483],"category_scores_gemma":[0.00043883242,0.000065533015,0.00003546126,0.00012810394,0.00005087289,0.00003379926,0.000022193626,0.000100017074,0.000014856814],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052031027,0.0002791074,0.91904247,0.005816799,0.00022614298,0.0000016356208,0.011236456,0.007999768,0.0027581877,0.007639823,0.018748362,0.021048129],"study_design_scores_gemma":[0.011626241,0.0054469327,0.87082916,0.000307705,0.000048794747,0.000013381112,0.015355202,0.018623507,0.0007256923,0.00034988418,0.07634182,0.00033165168],"about_ca_topic_score_codex":0.012144299,"about_ca_topic_score_gemma":0.000032694552,"teacher_disagreement_score":0.05759346,"about_ca_system_score_codex":0.0000622805,"about_ca_system_score_gemma":0.000216327,"threshold_uncertainty_score":0.99443394},"labels":[],"label_agreement":null},{"id":"W3111219757","doi":"10.1016/j.jval.2020.08.144","title":"PCN7 Systematic Differences between Embraca and Olympiad Phase III Physician's Choice Chemotherapy (PCT) Arms: A FOCUS on the First-LINE (1L) Treatment of Metastatic Breast Cancer (MBC) Subpopulations","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Olympiad; Medicine; Internal medicine; Propensity score matching; Hazard ratio; Subgroup analysis; Oncology; Confidence interval","score_opus":0.42864673254123686,"score_gpt":0.43219481286707206,"score_spread":0.003548080325835201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111219757","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76919895,0.0049773036,0.00066887226,0.22104332,0.0001218612,0.002729068,0.0011678651,0.000031846266,0.000060920094],"genre_scores_gemma":[0.99003315,0.0012093539,0.00018357865,0.007715837,0.00032284376,0.00045926613,0.000021130783,0.000034603112,0.000020228888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99458337,0.0006318463,0.003693862,0.0005431094,0.00014371246,0.00040410398],"domain_scores_gemma":[0.99358845,0.003004676,0.0027225944,0.0004218286,0.00003742691,0.00022501487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033286917,0.00028989778,0.0019514209,0.00021191833,0.00022448407,0.00004859144,0.00022728852,0.00006776531,0.000063969135],"category_scores_gemma":[0.0004681762,0.0002418066,0.00012774755,0.0004076584,0.00007998327,0.00017898597,0.000019177278,0.0001314116,0.000047990216],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004411933,0.0047872537,0.66669536,0.06996325,0.002065243,0.0000046356513,0.098788254,0.013927715,0.000009777755,0.1314975,0.0016898479,0.010129948],"study_design_scores_gemma":[0.028267274,0.0057112016,0.54477465,0.013318652,0.00025664165,0.000009891968,0.00837808,0.35575345,0.00007097942,0.039472397,0.0020949657,0.0018917713],"about_ca_topic_score_codex":0.026753949,"about_ca_topic_score_gemma":0.0007776154,"teacher_disagreement_score":0.34182575,"about_ca_system_score_codex":0.0007862764,"about_ca_system_score_gemma":0.00025124676,"threshold_uncertainty_score":0.9860587},"labels":[],"label_agreement":null},{"id":"W3111286950","doi":"10.1016/j.jval.2020.08.1941","title":"PRS61 Targeted Literature Review of Economic Models USED in Health Technology Agency Assessments in Severe Asthma","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Mepolizumab; Omalizumab; Medicine; Asthma; Nice; Health technology; Benralizumab; Exacerbation; Intensive care medicine; Health care; Immunology; Economic growth","score_opus":0.3697345047300995,"score_gpt":0.4512277504731536,"score_spread":0.08149324574305411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111286950","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22518027,0.3281652,0.0010098614,0.43732595,0.0007078092,0.0055528926,0.0010273693,0.00010890912,0.0009217281],"genre_scores_gemma":[0.81643224,0.12078668,0.010015693,0.051885255,0.00017010204,0.00033495302,0.00020908908,0.00009483174,0.000071150855],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9874761,0.001377629,0.009220434,0.0009758279,0.000119437515,0.0008305315],"domain_scores_gemma":[0.99486303,0.00040098812,0.003780671,0.00061208947,0.000038354283,0.0003048793],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01861792,0.0003042258,0.0024942025,0.0012066327,0.00005941493,0.00002606572,0.00049998675,0.00029515082,0.00015480712],"category_scores_gemma":[0.0012479305,0.00041193163,0.000118249394,0.0013542081,0.0000478462,0.000578821,0.00009694933,0.0007296963,0.00017738693],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098136086,0.00082251156,0.31869593,0.15389244,0.00008105646,0.000028112225,0.018601302,0.10504092,0.0000031936129,0.38416404,0.015180886,0.0033914845],"study_design_scores_gemma":[0.0091685215,0.0020350225,0.06232204,0.080133185,0.0000042553274,0.00003990832,0.002174007,0.62726027,0.0000066353687,0.1802658,0.034596756,0.001993597],"about_ca_topic_score_codex":0.0065784235,"about_ca_topic_score_gemma":0.000718812,"teacher_disagreement_score":0.59125197,"about_ca_system_score_codex":0.002658902,"about_ca_system_score_gemma":0.001820235,"threshold_uncertainty_score":0.9998332},"labels":[],"label_agreement":null},{"id":"W3111320730","doi":"10.1016/j.jval.2020.08.1439","title":"PND114 Registries As a Source of Real World DATA (RWD) to Demonstrate the Effectiveness of Therapies for Multiple Sclerosis: A Global Perspective","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Family medicine; Clinical trial; Real world evidence; MEDLINE; Quarter (Canadian coin); Internal medicine; Geography; Political science","score_opus":0.5872572653081088,"score_gpt":0.45002986459435024,"score_spread":0.1372274007137586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111320730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86303246,0.005343677,0.014324324,0.10916508,0.00025896676,0.0043291724,0.0027062444,0.00004759192,0.00079246174],"genre_scores_gemma":[0.9921275,0.00026333026,0.003854058,0.0034058606,0.00012979531,0.00015553313,0.000026064181,0.000023257164,0.000014635675],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9948637,0.0013458194,0.0026487273,0.00065096363,0.00011129929,0.00037952905],"domain_scores_gemma":[0.99195963,0.005004643,0.0019617444,0.00077634235,0.00011352398,0.00018410987],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.021943215,0.00017289704,0.0011514657,0.00014669442,0.00013255094,0.00003080997,0.00066654524,0.000057127203,0.0000090486565],"category_scores_gemma":[0.009369243,0.0001792547,0.00009721982,0.0006938453,0.00018556806,0.00019513059,0.00013437557,0.00013116207,0.000030927105],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016250171,0.00026437832,0.37225962,0.003920549,0.00024765174,3.564195e-7,0.022426791,0.011467398,0.000020086383,0.58300173,0.0035180643,0.0012483328],"study_design_scores_gemma":[0.006620851,0.0026872405,0.7178659,0.002884793,0.00003173179,0.0000041738913,0.057842698,0.09664848,0.00017418669,0.09943973,0.014841354,0.000958874],"about_ca_topic_score_codex":0.11221422,"about_ca_topic_score_gemma":0.004006137,"teacher_disagreement_score":0.48356202,"about_ca_system_score_codex":0.00073736085,"about_ca_system_score_gemma":0.0006868827,"threshold_uncertainty_score":0.9989753},"labels":[],"label_agreement":null},{"id":"W3111325356","doi":"10.1016/j.jval.2020.08.153","title":"PCN16 External Control Analysis of Overall Survival in BRAFV600 Mutated Metastatic NSCLC: Comparing Single-Arm Dabrafenib+Trametinib Clinical Trial Outcomes with Real-World Standards of Care","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Dabrafenib; Trametinib; Medicine; Oncology; Internal medicine; Pemetrexed; Cohort; Carboplatin; Vemurafenib; Progression-free survival; Chemotherapy; Cancer; Metastatic melanoma; Biology","score_opus":0.14629362356321837,"score_gpt":0.4254324990872466,"score_spread":0.2791388755240283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111325356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954168,0.001091933,0.00018050961,0.0012631814,0.00014510876,0.0012469569,0.0002546403,0.000023396215,0.00037748096],"genre_scores_gemma":[0.99859095,0.00019816487,0.0007868545,0.00028466905,0.000046449615,0.000026004353,0.000035756733,0.00002105159,0.000010086187],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960253,0.0006713864,0.0017813888,0.00042378475,0.00074959954,0.00034851002],"domain_scores_gemma":[0.99762917,0.0010782804,0.00062647293,0.00023468888,0.00021933312,0.00021206136],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011306204,0.00023985133,0.0029006607,0.00041269473,0.00003447934,0.000009887756,0.00010190722,0.000043062137,0.000043932934],"category_scores_gemma":[0.00046576324,0.00017267375,0.0003299054,0.0011636999,0.00013584194,0.000043573877,0.0000370646,0.00029713506,2.4845426e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07898475,0.0013515688,0.8995617,0.0005097449,0.002090412,0.00007508135,0.0036665152,0.010073256,0.000007762673,0.00007939212,0.000009664574,0.0035901556],"study_design_scores_gemma":[0.1313661,0.015657654,0.83289105,0.0006203966,0.0017664443,0.0000010310376,0.0012330501,0.016156688,0.00003258029,0.00002004035,0.00006856332,0.00018643346],"about_ca_topic_score_codex":0.026193662,"about_ca_topic_score_gemma":0.01962112,"teacher_disagreement_score":0.06667067,"about_ca_system_score_codex":0.00051278307,"about_ca_system_score_gemma":0.00081397203,"threshold_uncertainty_score":0.99826825},"labels":[],"label_agreement":null},{"id":"W3111345396","doi":"10.1016/j.jval.2020.08.347","title":"PCN210 Estimating the IMPACT of Delayed Access to Oncology Drugs on Patient Outcomes in Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Reimbursement; Medicine; Process (computing); Intensive care medicine; Oncology; Computer science; Economics; Health care; Economic growth","score_opus":0.43150778939808093,"score_gpt":0.47636811682202057,"score_spread":0.04486032742393964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111345396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8454142,0.00019527516,0.00016385855,0.15220597,0.00034960572,0.0010172094,0.0002249701,0.00000813429,0.00042075542],"genre_scores_gemma":[0.95006233,0.000015837408,0.0012565621,0.048504286,0.00005747134,0.000074695316,0.000006932721,0.000018363602,0.0000035162473],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9943437,0.00057084946,0.004112843,0.00039070897,0.00011127713,0.00047063304],"domain_scores_gemma":[0.9951875,0.0023338406,0.0018332768,0.00033168393,0.000027630733,0.00028605768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0068424875,0.0001561314,0.0011071321,0.00022637467,0.00007427093,0.000020910295,0.000401367,0.00005879041,0.00007748541],"category_scores_gemma":[0.0034472584,0.00014613454,0.00007501018,0.0004197209,0.000017954248,0.00013042382,0.000082264254,0.00027218048,0.00007546992],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004332313,0.000077427896,0.39079744,0.00017618157,0.00002316782,0.0000016173545,0.0120502915,0.5840033,1.4906824e-7,0.0026654864,0.008729163,0.0014324571],"study_design_scores_gemma":[0.0013086835,0.0013146976,0.4676477,0.00022833436,0.0000014492072,0.0000014350813,0.003082268,0.5202331,0.0000029384528,0.0032286486,0.0026111454,0.00033957264],"about_ca_topic_score_codex":0.9814879,"about_ca_topic_score_gemma":0.49395743,"teacher_disagreement_score":0.48753044,"about_ca_system_score_codex":0.0060391133,"about_ca_system_score_gemma":0.003969964,"threshold_uncertainty_score":0.9977765},"labels":[],"label_agreement":null},{"id":"W3111458010","doi":"10.1016/j.jval.2020.08.034","title":"HTA4 Clinical Development and HTA Approval of MULTI-Indication Oncology Products: Evidence from Germany, France, England, Scotland, the US, Canada, and Australia","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Timeline; Clinical trial; Orphan drug; Family medicine; Agency (philosophy); Drug approval; Health care; Internal medicine; Political science; Geography; Pharmacology","score_opus":0.5630408906124301,"score_gpt":0.4574362463879819,"score_spread":0.10560464422444821,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111458010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91739345,0.006013992,0.0004106576,0.07480251,0.00035778942,0.00088354584,0.00011907587,0.000008584407,0.0000103958255],"genre_scores_gemma":[0.9815438,0.0012310259,0.008997094,0.007761794,0.0003209918,0.00005277475,0.00002262929,0.000014331607,0.00005559142],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942703,0.0008721504,0.003850731,0.0006016419,0.00010379062,0.0003013537],"domain_scores_gemma":[0.9957305,0.0017173851,0.001978817,0.0002877806,0.000043522832,0.00024198645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013908445,0.00013946017,0.00084196473,0.00007844829,0.0001247562,0.00002083452,0.00021615736,0.00012260834,0.00002200063],"category_scores_gemma":[0.003944934,0.0001394933,0.000021860293,0.00017627128,0.00011878298,0.0001543201,0.00006938963,0.0003065546,0.000028698409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031233325,0.000058364403,0.9865201,0.00071656064,0.00002981648,0.0000011056354,0.007464438,0.0003008375,0.0000015020457,0.0009830138,0.0022665423,0.0016264683],"study_design_scores_gemma":[0.0011540265,0.00013000726,0.88906246,0.00019820778,0.0000034684645,0.000002484732,0.00030570326,0.011064135,0.000007973825,0.00016440595,0.09774532,0.00016181733],"about_ca_topic_score_codex":0.61510664,"about_ca_topic_score_gemma":0.21637857,"teacher_disagreement_score":0.39872807,"about_ca_system_score_codex":0.00038938923,"about_ca_system_score_gemma":0.0018613441,"threshold_uncertainty_score":0.79792047},"labels":[],"label_agreement":null},{"id":"W3111651503","doi":"10.1016/j.jval.2020.08.567","title":"PCV76 NEWLY Introduced Drugs for Second-LINE Treatment of Stable Angina: Approvals and Reimbursement Decisions in the UK, Canada, Australia and Scotland","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Ranolazine; Reimbursement; Trimetazidine; Ivabradine; Medicine; Nicorandil; Angina; Formulary; Health care; Intensive care medicine; Pharmacology; Internal medicine; Political science","score_opus":0.18607472664411934,"score_gpt":0.33849278440518543,"score_spread":0.1524180577610661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111651503","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679545,0.0022938875,0.00006529624,0.027742274,0.0000964573,0.00076323596,0.0008992713,0.0000021095111,0.00018297472],"genre_scores_gemma":[0.9957536,0.0012499612,0.00052461284,0.002212905,0.000094639814,0.000044948683,0.000018215007,0.000009307998,0.00009179429],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99868333,0.000033073575,0.00065623666,0.00029939556,0.00002490152,0.00030307085],"domain_scores_gemma":[0.99923813,0.00026466747,0.00018457144,0.00015088212,0.000009052168,0.00015272245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066981895,0.00011558402,0.00042967626,0.00009400976,0.000050309303,0.000024873292,0.000096089316,0.00003732152,0.000042830805],"category_scores_gemma":[0.0000797181,0.00010291009,0.00002973526,0.00014785971,0.000029191675,0.000042824613,0.000022728182,0.00007732068,0.0000020688392],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00087616296,0.0010290544,0.32768044,0.0014865434,0.00027444857,0.00001639897,0.0284466,0.017899822,0.0001481459,0.55716324,0.042491294,0.022487862],"study_design_scores_gemma":[0.01720941,0.003412782,0.12006545,0.00016429447,0.00003112104,0.000011514943,0.0017617649,0.12876005,0.00087670225,0.051690884,0.6750262,0.0009898607],"about_ca_topic_score_codex":0.33143672,"about_ca_topic_score_gemma":0.092168726,"teacher_disagreement_score":0.63253486,"about_ca_system_score_codex":0.0002067646,"about_ca_system_score_gemma":0.00015686202,"threshold_uncertainty_score":0.9243968},"labels":[],"label_agreement":null},{"id":"W3111690689","doi":"10.1016/j.jval.2020.08.540","title":"PCV49 Cost-Effectiveness of Evolocumab in Patients with Prior Myocardial Infarction in Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Medicine; Evolocumab; Ezetimibe; Statin; Atherosclerotic cardiovascular disease; Internal medicine; Cardiology; Myocardial infarction; Cholesterol; Disease; Total cholesterol","score_opus":0.2259214883881992,"score_gpt":0.3570972620746227,"score_spread":0.13117577368642352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111690689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893435,0.00046596126,0.00012597594,0.0072971145,0.00030005898,0.0021357,0.00016824996,0.000008100039,0.00015532467],"genre_scores_gemma":[0.9963208,0.000047975536,0.00024626657,0.0031584864,0.000046006757,0.00012658405,0.00003117287,0.000021048956,0.0000016635639],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9948789,0.0011032945,0.0030103507,0.00045058658,0.0001475428,0.00040932608],"domain_scores_gemma":[0.9974621,0.0008891939,0.0011785815,0.0002566576,0.0000415031,0.00017197464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009414484,0.00014442895,0.0010502391,0.0003310778,0.000035439367,0.0000094776215,0.00015275537,0.00007549917,0.000028493512],"category_scores_gemma":[0.0016846937,0.00018325413,0.00003788373,0.0005674092,0.000025454947,0.00023089124,0.000029384026,0.0002562732,0.00002826287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016094488,0.000073583535,0.9608792,0.00094537373,0.000011253872,6.632725e-7,0.0010073003,0.034452014,8.978606e-8,0.0020463916,0.00014092095,0.00028223998],"study_design_scores_gemma":[0.0031605416,0.0002216271,0.9850172,0.0003274025,7.844628e-7,2.0626277e-7,0.000292662,0.009475297,0.0000010504917,0.00040704513,0.0009399973,0.00015619176],"about_ca_topic_score_codex":0.93836755,"about_ca_topic_score_gemma":0.5122579,"teacher_disagreement_score":0.4261097,"about_ca_system_score_codex":0.005185016,"about_ca_system_score_gemma":0.0027419121,"threshold_uncertainty_score":0.9986339},"labels":[],"label_agreement":null},{"id":"W3111705182","doi":"10.1016/j.jval.2020.08.180","title":"PCN43 Risk of Recurrence Among Patients with HR-Positive, HER2-Negative, EARLY Breast Cancer Receiving Adjuvant Endocrine Therapy: A Systematic Review and Meta-Analysis","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Oncology; Breast cancer; Meta-analysis; Hazard ratio; Anastrozole; Randomized controlled trial; Tamoxifen; Subgroup analysis; Adjuvant therapy; Adjuvant; Gynecology; Cancer; Confidence interval","score_opus":0.03763970652950111,"score_gpt":0.3181948405284842,"score_spread":0.2805551339989831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111705182","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041843153,0.9924918,0.000012542684,0.00017178124,0.000024022778,0.0036188222,0.0032460028,0.000008077374,0.000008537071],"genre_scores_gemma":[0.004338353,0.9938226,0.00019522599,0.00013164242,0.000022036853,0.0012584779,0.00016408329,0.000052261657,0.000015368674],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99530977,0.0018697733,0.0012693226,0.0008771197,0.00031735576,0.00035667882],"domain_scores_gemma":[0.9967264,0.00020178632,0.0021206904,0.0005727125,0.00022975545,0.00014867388],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000472885,0.00063836266,0.0065392433,0.00015249991,0.00008627022,0.00001647629,0.00025128192,0.00010295566,0.000019967221],"category_scores_gemma":[0.00013528466,0.00039250441,0.00080414745,0.00093134906,0.00013744664,0.000009731062,0.00013416664,0.00028068107,0.0000010392682],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007588453,0.00025253306,0.024215613,0.77179515,0.17500739,0.0000071531113,0.0003275505,0.000025470117,3.9607716e-8,0.0000033205151,0.000038176368,0.02825172],"study_design_scores_gemma":[0.0013225174,0.0009456391,0.066173725,0.21207778,0.71621436,0.00002516862,0.000028554172,0.000007794183,0.000003624584,0.000008434968,0.0020390532,0.0011533633],"about_ca_topic_score_codex":0.015306235,"about_ca_topic_score_gemma":0.00070752966,"teacher_disagreement_score":0.55971736,"about_ca_system_score_codex":0.00015422294,"about_ca_system_score_gemma":0.00035094755,"threshold_uncertainty_score":0.99985266},"labels":[],"label_agreement":null},{"id":"W3111895883","doi":"10.1016/j.jval.2020.08.1892","title":"PRS12 Comparison of Healthcare Costs Associated with the Use of Two Different Dosing Strategies in Asthma Patients in Indonesia, Thailand and Vietnam.","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Formoterol; Salmeterol; Medicine; Fluticasone propionate; Budesonide; Health care; Fluticasone; Asthma; Pediatrics; Internal medicine; Economic growth","score_opus":0.3932886221204399,"score_gpt":0.4055459358805237,"score_spread":0.012257313760083766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111895883","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9731631,0.0015121013,0.0001038472,0.023777608,0.0000654223,0.001182386,0.00017001877,0.000008165774,0.000017350736],"genre_scores_gemma":[0.99776065,0.0001529882,0.0001894023,0.001791002,0.00001881747,0.000032870572,0.000034331384,0.000018656916,0.0000012589754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99451,0.0012007332,0.0034317926,0.00036648082,0.00013071772,0.00036030385],"domain_scores_gemma":[0.9958146,0.0013324388,0.0024680078,0.00020621119,0.00004901433,0.00012970505],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043444256,0.00016479059,0.0012718029,0.0002844575,0.000058444548,0.00003700492,0.00014072968,0.00009291347,0.0000043594055],"category_scores_gemma":[0.00075938564,0.00015457129,0.000031046784,0.00043610565,0.000077830795,0.0002876205,0.000043158674,0.00032235478,0.0000021845892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000056144152,0.00019450908,0.9731024,0.00072021113,0.000010302126,3.158262e-7,0.011992201,0.008210904,3.427437e-7,0.0054288856,0.00008383013,0.00019997363],"study_design_scores_gemma":[0.0022095689,0.00040710677,0.9509611,0.00074517576,0.0000010368116,1.8396088e-7,0.0028089506,0.042362098,0.0000014849353,0.0003026078,0.00007608997,0.00012456124],"about_ca_topic_score_codex":0.04231267,"about_ca_topic_score_gemma":0.027953055,"teacher_disagreement_score":0.034151196,"about_ca_system_score_codex":0.000649549,"about_ca_system_score_gemma":0.0002861273,"threshold_uncertainty_score":0.98978424},"labels":[],"label_agreement":null},{"id":"W3111918987","doi":"10.1016/j.jval.2020.08.1243","title":"PMU31 Defining Clinically Relevant Threshold for Chronic Opioid Use Using NOVEL Modelling Techniques","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Opioid; Emergency department; Proportional hazards model; Cohort study; Prospective cohort study; Emergency medicine; Cohort; Internal medicine; Intensive care medicine; Psychiatry","score_opus":0.71166119968764,"score_gpt":0.4717105230265069,"score_spread":0.23995067666113307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111918987","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14578371,0.007971247,0.7950303,0.04609035,0.00069584686,0.0032498704,0.0006704832,0.0002462453,0.0002619509],"genre_scores_gemma":[0.40464127,0.0014638398,0.55380934,0.038554862,0.0010528056,0.00022406968,0.00006627032,0.00014762337,0.000039933868],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.991122,0.00021393929,0.006864079,0.00090792595,0.00010888085,0.00078315445],"domain_scores_gemma":[0.99429464,0.0021449525,0.0026531178,0.0004737609,0.00006633806,0.0003672105],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.018511798,0.00025600637,0.0013391011,0.0002915629,0.0002517726,0.000110091794,0.0003352202,0.00023794167,0.000028847566],"category_scores_gemma":[0.0036503975,0.00034614233,0.00018428593,0.00030549197,0.000053772037,0.000552024,0.00008243592,0.0004264949,0.00011433994],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010455741,0.00019514009,0.029517222,0.003729025,0.00005265754,0.0000012488133,0.0047430233,0.6938167,0.000025350306,0.2650551,0.0021845254,0.00057541596],"study_design_scores_gemma":[0.00080225023,0.00035276255,0.0002011849,0.00060736685,0.0000034367972,0.000002734088,0.00016303187,0.96119046,0.000007611447,0.01112352,0.025211396,0.00033425947],"about_ca_topic_score_codex":0.005607472,"about_ca_topic_score_gemma":0.00005458718,"teacher_disagreement_score":0.2673737,"about_ca_system_score_codex":0.0017577496,"about_ca_system_score_gemma":0.0011488441,"threshold_uncertainty_score":0.999899},"labels":[],"label_agreement":null},{"id":"W3111989140","doi":"10.1016/j.jval.2020.08.1948","title":"PRS68 The Humanistic Burden of Mild Asthma: Evidence from the Novelty Study","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Vancouver General Hospital","funders":"","keywords":"Medicine; Asthma; Quality of life (healthcare); Internal medicine; Bronchodilator; Physical therapy","score_opus":0.19503699521300255,"score_gpt":0.3912421078211199,"score_spread":0.19620511260811735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3111989140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80196774,0.0054609654,0.00012783117,0.19039829,0.00021743505,0.0016977444,0.000032460826,0.00003773889,0.000059772654],"genre_scores_gemma":[0.9885571,0.00019183128,0.0002096994,0.010117417,0.0008512924,0.000026871388,0.000004772979,0.000022453763,0.000018574623],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9968309,0.0009425972,0.00081613526,0.00037483865,0.0007591454,0.00027642568],"domain_scores_gemma":[0.9965568,0.0022064147,0.00030517604,0.00070244144,0.00006790651,0.00016126102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002298777,0.00015624598,0.0004976747,0.000026167414,0.00013282885,0.000016450658,0.0004355423,0.000042617074,0.000066395005],"category_scores_gemma":[0.001970455,0.00009481698,0.00007970919,0.000388469,0.000115548195,0.000048100082,0.00013544897,0.00052018324,0.000029636576],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012653857,0.0013705089,0.2108152,0.0020513583,0.00035193068,0.000049228714,0.75330585,0.0055564195,0.00022841517,0.0009278242,0.021524455,0.0025534085],"study_design_scores_gemma":[0.0036248006,0.0039306553,0.9318558,0.0034481536,0.000113255956,0.000008035597,0.042794023,0.007328673,0.00009227494,0.00065569155,0.0058644,0.0002842555],"about_ca_topic_score_codex":0.1337956,"about_ca_topic_score_gemma":0.0019455483,"teacher_disagreement_score":0.72104055,"about_ca_system_score_codex":0.00012766279,"about_ca_system_score_gemma":0.0006583604,"threshold_uncertainty_score":0.8719725},"labels":[],"label_agreement":null},{"id":"W3112058853","doi":"10.1016/j.jval.2020.08.393","title":"PCN256 Health Technology Assessment for Chimeric Antigen Receptor (CAR) T-CELL Therapies for Cancer in Europe, US, and Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Chimeric antigen receptor; Nice; Medicine; Clinical trial; Lymphoma; Cancer; Oncology; Immunotherapy; Intensive care medicine; Internal medicine","score_opus":0.06356303064571747,"score_gpt":0.37776048199218754,"score_spread":0.31419745134647004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112058853","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7873308,0.016228825,0.00025908786,0.19079016,0.00025235178,0.004782237,0.00022031779,0.000049597103,0.000086637585],"genre_scores_gemma":[0.9240383,0.04003305,0.012968285,0.020221898,0.0004724607,0.0010928047,0.00010600071,0.00017083423,0.0008963608],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99794364,0.0001730358,0.00050680316,0.0004481672,0.00024940723,0.00067895855],"domain_scores_gemma":[0.9990474,0.00019513197,0.00014674815,0.00021104174,0.00011224574,0.00028742052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076319044,0.0001691224,0.0005857029,0.00020636115,0.00009637,0.000011482001,0.00013251237,0.000072777875,0.00010382106],"category_scores_gemma":[0.00010168562,0.00015757422,0.00002927089,0.00074725575,0.000058458656,0.000027987899,0.00004140189,0.00035883117,6.4513216e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020191853,0.0005479409,0.62564045,0.008231717,0.00016865255,0.000023582788,0.004371586,0.0011294286,0.06376567,0.00095444836,0.030169368,0.262978],"study_design_scores_gemma":[0.009123519,0.0052778833,0.06293564,0.00055634,0.000008969005,0.0000095058185,0.0021936796,0.013227207,0.0028550674,0.00011691292,0.903303,0.0003922248],"about_ca_topic_score_codex":0.6915808,"about_ca_topic_score_gemma":0.3107278,"teacher_disagreement_score":0.87313366,"about_ca_system_score_codex":0.0008702216,"about_ca_system_score_gemma":0.0075440775,"threshold_uncertainty_score":0.9980822},"labels":[],"label_agreement":null},{"id":"W3112066415","doi":"10.1016/j.jval.2020.08.260","title":"PCN123 5-Year Health Care Costs of Sepsis in Cancer Patients: Results from a Population-Based Case-Control Matched Cohort","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Sepsis; Cohort; Population; Cancer; Cancer registry; Health care; Emergency medicine; Cohort study; Intensive care medicine; Internal medicine; Environmental health","score_opus":0.2273304204467554,"score_gpt":0.39825146497253205,"score_spread":0.17092104452577667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112066415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90670943,0.0034405724,0.00028517874,0.07461079,0.00042960755,0.0025317925,0.011855714,0.00004328439,0.00009363327],"genre_scores_gemma":[0.96993804,0.00016254139,0.0017540095,0.02723603,0.00016503189,0.00015873548,0.0005360462,0.000045581895,0.0000039665333],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9900714,0.0012822264,0.007039827,0.0008435383,0.0001749328,0.0005880534],"domain_scores_gemma":[0.9936685,0.0016986213,0.0036690235,0.00046935678,0.00009587416,0.00039864285],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007887908,0.0002412486,0.0017497947,0.0004199971,0.00011196596,0.000026723452,0.00022013306,0.00017097546,0.000118937125],"category_scores_gemma":[0.0034365929,0.00032587087,0.0001100504,0.00056174165,0.000028868482,0.00020807807,0.000026728969,0.00030735787,0.00009981815],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014209314,0.00012316144,0.9493786,0.00073246844,0.000026432694,0.000003483509,0.009038096,0.0375003,7.0834986e-8,0.001007285,0.0017771148,0.00027087666],"study_design_scores_gemma":[0.008224745,0.00034263282,0.90502685,0.00071255123,0.000005085078,5.283509e-7,0.0028040204,0.08121526,0.0000010140735,0.0004648206,0.000829868,0.0003726412],"about_ca_topic_score_codex":0.60255283,"about_ca_topic_score_gemma":0.023143133,"teacher_disagreement_score":0.5794097,"about_ca_system_score_codex":0.0043724147,"about_ca_system_score_gemma":0.0011621724,"threshold_uncertainty_score":0.99991935},"labels":[],"label_agreement":null},{"id":"W3112088125","doi":"10.1016/j.jval.2020.08.066","title":"PA1 Different Levels of Care for Follow-up of Adults with Congenital Heart Disease","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Congenital Heart Disease Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Medicine; Disease; Heart disease; Population; Internal medicine; Medical care; Emergency medicine; Pediatrics; Cardiology","score_opus":0.05046567629784095,"score_gpt":0.3103802315755243,"score_spread":0.25991455527768337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112088125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98672324,0.006427785,0.0000387253,0.0037873946,0.00009002771,0.0019117658,0.00095824985,0.000025990546,0.000036793444],"genre_scores_gemma":[0.9987733,0.000036319918,0.0003797745,0.0005774545,0.00007425145,0.00007988589,0.000029924373,0.000027215357,0.000021904918],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986141,0.0000617428,0.00046281493,0.00027699483,0.0003013752,0.0002830011],"domain_scores_gemma":[0.99886197,0.00016246215,0.000088783665,0.00020939345,0.00021527988,0.00046213248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00006517965,0.00016039635,0.00065149553,0.00007075329,0.0000407215,0.0000021781054,0.000052848947,0.000029460036,0.00001987514],"category_scores_gemma":[0.00023587553,0.00012593878,0.00013233429,0.00017833262,0.00008969732,0.000030575804,0.000042327574,0.000091915535,0.0000018976345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.03842784,0.00094859384,0.8438164,0.04987126,0.00040508268,0.00006381956,0.04823748,0.000080725076,0.0006037571,0.0004045765,0.0008934379,0.01624701],"study_design_scores_gemma":[0.018720252,0.0088856565,0.9551834,0.0027459208,0.0003057703,0.000004531812,0.008807668,0.0029920922,0.0012371938,0.0001061843,0.0006786809,0.00033265015],"about_ca_topic_score_codex":0.00040354326,"about_ca_topic_score_gemma":0.00018486235,"teacher_disagreement_score":0.11136698,"about_ca_system_score_codex":0.000082083745,"about_ca_system_score_gemma":0.0005368436,"threshold_uncertainty_score":0.51356345},"labels":[],"label_agreement":null},{"id":"W3112194058","doi":"10.1016/j.jval.2020.08.1858","title":"PRO122 Challenges in Defining the Burden of RARE Diseases: A Literature Review of Dravet Syndrome","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Epilepsy research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Dravet syndrome; Medicine; Disease burden; MEDLINE; Burden of disease; Caregiver burden; Cohort; Disease; Pediatrics; Psychiatry; Gerontology; Intensive care medicine; Epilepsy; Pathology","score_opus":0.11650596238733464,"score_gpt":0.4054315794879144,"score_spread":0.2889256171005798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112194058","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000063172242,0.9870902,9.517067e-8,0.008064205,0.00003696436,0.0042453343,0.00031103613,0.000011458151,0.00023444383],"genre_scores_gemma":[0.00012458953,0.9987675,0.00010733555,0.000118121185,0.00006701225,0.0004356309,0.00031675628,0.000039980143,0.000023100747],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99604964,0.0012884063,0.0013108943,0.00042589882,0.00053936976,0.00038576522],"domain_scores_gemma":[0.9978544,0.00060750655,0.00055824843,0.0006448846,0.00007654546,0.00025840435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010967546,0.0003131396,0.0032494678,0.0002826774,0.000022059874,0.0000059966987,0.0002615504,0.00014670542,0.000025257868],"category_scores_gemma":[0.0008508318,0.00017668723,0.0003990092,0.001007317,0.00006190025,0.000027918702,0.000102081765,0.0008385299,0.000011943899],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016883536,0.00012592354,0.000050320807,0.6272687,0.000084693434,0.00064485497,0.0006506774,6.8877966e-7,2.121892e-9,0.0004159426,0.0001331564,0.37060818],"study_design_scores_gemma":[0.00036630227,0.0007442937,0.00008998097,0.6819179,0.00016092088,0.0002625136,0.000077876,0.000008116779,1.7250187e-8,0.00005385198,0.31624267,0.00007555231],"about_ca_topic_score_codex":0.00040839548,"about_ca_topic_score_gemma":0.0000064965516,"teacher_disagreement_score":0.37053263,"about_ca_system_score_codex":0.00029782293,"about_ca_system_score_gemma":0.0025692221,"threshold_uncertainty_score":0.7205096},"labels":[],"label_agreement":null},{"id":"W3112223458","doi":"10.1016/j.jval.2020.08.643","title":"PDB46 The Utilisation and Switching Rates of Neutral Protamine Hagedorn (NPH) Insulin and Long-acting Insulin Analogs in Patients with Type 2 Diabetes in the United Kingdom","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Jewish General Hospital; McGill University","funders":"","keywords":"NPH insulin; Medicine; Insulin detemir; Insulin glargine; Insulin; Type 2 diabetes; Internal medicine; Hazard ratio; Cohort; Diabetes mellitus; Protamine; Retrospective cohort study; Endocrinology; Pediatrics; Confidence interval","score_opus":0.07732936425646522,"score_gpt":0.3193085223512552,"score_spread":0.24197915809478995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112223458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99365264,0.00033451366,0.0000044699705,0.0045428416,0.000018736839,0.0014109319,0.0000015310098,0.000008300073,0.000026058526],"genre_scores_gemma":[0.99909484,0.00007955807,0.00006455223,0.00067319063,0.000027269287,0.000017513135,0.000028779628,0.000012212934,0.0000021090377],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985336,0.0004251919,0.00034638707,0.00019669073,0.00022455369,0.00027357496],"domain_scores_gemma":[0.9993198,0.00034624766,0.00010195238,0.00012346408,0.00004799019,0.000060530343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014498906,0.00010543942,0.00024107561,0.00025417996,0.000061502775,0.000028588862,0.00009098428,0.000037980764,0.0000023732287],"category_scores_gemma":[0.00043811076,0.000059250244,0.000009937921,0.0012200817,0.00007209945,0.00009067289,0.000058647023,0.00042809322,4.175312e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022750007,0.00012677022,0.9832713,0.00069161097,0.000011148087,0.0000035346177,0.0037699547,0.0005024131,0.00003998585,0.00006789646,0.0000053539525,0.011282502],"study_design_scores_gemma":[0.0020232813,0.0009275141,0.955267,0.00048253775,0.000007183089,1.1151381e-7,0.0006995593,0.0404035,0.00004501662,0.00004615322,0.000042699103,0.00005541554],"about_ca_topic_score_codex":0.0014357682,"about_ca_topic_score_gemma":0.0001666834,"teacher_disagreement_score":0.03990109,"about_ca_system_score_codex":0.00003601593,"about_ca_system_score_gemma":0.000068391695,"threshold_uncertainty_score":0.24161547},"labels":[],"label_agreement":null},{"id":"W3112228448","doi":"10.1016/j.jval.2020.08.580","title":"PCV89 Risk-Based Treatment Improves Survival in Higher-Risk NON-ST Elevation ACUTE Coronary Syndrome (NSTE-ACS) Patients","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Coronary Interventions and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; Kwantlen Polytechnic University","funders":"","keywords":"Medicine; Acute coronary syndrome; Internal medicine; Cardiac catheterization; Odds ratio; Population; Retrospective cohort study; Revascularization; Cardiology; Myocardial infarction","score_opus":0.047892617782398235,"score_gpt":0.30106399890336355,"score_spread":0.2531713811209653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112228448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383336,0.00027943208,0.00014107792,0.0033781626,0.0004972925,0.0012706382,0.00048523035,0.000053428772,0.0000613715],"genre_scores_gemma":[0.9971676,0.000749315,0.00061501644,0.0006560637,0.00006427536,0.00008964065,0.00054595736,0.000033629458,0.000078489385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979067,0.00026892286,0.00074818026,0.00040853716,0.0002874997,0.00038017202],"domain_scores_gemma":[0.99874866,0.00031644834,0.0003214942,0.00027816783,0.00006324347,0.0002719588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028624464,0.00022742049,0.00049617316,0.00017426416,0.00008075603,0.000013456811,0.00008586776,0.000099858575,0.00012366238],"category_scores_gemma":[0.00017764317,0.00020777222,0.00012294074,0.00040397368,0.000032349304,0.00008127833,0.000033871504,0.00028282846,0.000049905124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047781988,0.0015293313,0.984407,0.00023887542,0.000050512313,0.00018146049,0.00030487592,0.0013213881,0.000022817876,0.000030080999,0.00022467722,0.011211176],"study_design_scores_gemma":[0.006535012,0.00880297,0.9703629,0.00036508444,0.00007163726,0.0000053808894,0.00007916445,0.012923248,0.000025557449,0.00004401331,0.0006308907,0.00015411085],"about_ca_topic_score_codex":0.009186145,"about_ca_topic_score_gemma":0.00032685662,"teacher_disagreement_score":0.014044054,"about_ca_system_score_codex":0.0007518814,"about_ca_system_score_gemma":0.0003988985,"threshold_uncertainty_score":0.9974118},"labels":[],"label_agreement":null},{"id":"W3112327018","doi":"10.1016/j.jval.2020.08.462","title":"PCN325 Health Utility in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (RR-DLBCL) Patients - Results of a Phase II Trial with ORAL Selinexor","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Quality of life (healthcare); Internal medicine; Adverse effect; Refractory (planetary science); Population; Progressive disease; Oncology; Disease; Diffuse large B-cell lymphoma; Lymphoma; Environmental health","score_opus":0.05595646326215171,"score_gpt":0.3238289691381307,"score_spread":0.267872505875979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112327018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98847,0.0010795089,0.000007017734,0.006523881,0.00019981495,0.0029174972,0.000602986,0.000054069296,0.000145213],"genre_scores_gemma":[0.9949509,0.00049652753,0.0006123937,0.003326359,0.00011398149,0.00009591,0.0003295183,0.000040040304,0.000034373297],"study_design_codex":"nonrandomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99562186,0.00063192664,0.0016699195,0.00071797735,0.0006170149,0.0007413149],"domain_scores_gemma":[0.997708,0.00025508233,0.00069013116,0.00053644273,0.00010174264,0.000708577],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011818479,0.00033183047,0.0011801402,0.0002062947,0.000108923,0.000008244774,0.00013481715,0.00013917784,0.000015471565],"category_scores_gemma":[0.00034589553,0.0002556438,0.00012553688,0.0006762939,0.00006088586,0.00007964353,0.00008019302,0.00022946212,0.000011354936],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.27859968,0.46656057,0.16476853,0.0024772068,0.0001145714,0.00027821062,0.018180778,0.000042428393,0.000010591803,0.00009897251,0.008171465,0.060697],"study_design_scores_gemma":[0.8857078,0.0473539,0.051859442,0.00074221776,0.000034321623,0.0000038152484,0.00032612128,0.0032350987,0.00011896704,0.000014154097,0.010387249,0.00021691105],"about_ca_topic_score_codex":0.014717282,"about_ca_topic_score_gemma":0.00068968575,"teacher_disagreement_score":0.6071081,"about_ca_system_score_codex":0.0010233948,"about_ca_system_score_gemma":0.0025343993,"threshold_uncertainty_score":0.99998957},"labels":[],"label_agreement":null},{"id":"W3112338649","doi":"10.1016/j.jval.2020.08.793","title":"PGI27 Systematic Review and Network Meta-Analysis: Topical Corticosteroids for Inducing Histological Remission in Eosinophilic Oesophagitis","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; University of Calgary","funders":"","keywords":"Eosinophilic esophagitis; Medicine; Budesonide; Fluticasone; Placebo; Internal medicine; Corticosteroid; Meta-analysis; Gastroenterology; Odds ratio; Randomized controlled trial; Eosinophil; Asthma; Pathology; Disease","score_opus":0.1818737944557659,"score_gpt":0.3575367436261121,"score_spread":0.1756629491703462,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112338649","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.051066358,0.84592295,0.0005384941,0.09499333,0.000099852805,0.00717895,0.000021401534,0.00010200524,0.00007665011],"genre_scores_gemma":[0.95943964,0.0056897234,0.0031432703,0.03104417,0.00014388333,0.00041158494,0.00003226723,0.000031674186,0.00006376983],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99581,0.00079939276,0.0018264088,0.0006971577,0.00033599653,0.00053106947],"domain_scores_gemma":[0.99793136,0.00065733294,0.00040971203,0.00045497617,0.000064602136,0.00048202422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017211888,0.00027360805,0.0039230455,0.00017097619,0.000069299174,0.000018013961,0.00014191915,0.00017393986,0.000069938185],"category_scores_gemma":[0.0020713713,0.00020761385,0.00043805258,0.0011136272,0.000058801583,0.00006929059,0.000075494754,0.00046978492,0.000005028216],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025216863,0.0005196097,0.039461903,0.935761,0.014349116,0.0006965089,0.0021745227,0.001377761,0.00007253613,0.0025964808,0.0020227786,0.0007156578],"study_design_scores_gemma":[0.014336284,0.011937262,0.13055922,0.15607736,0.59792,0.0016328467,0.00047057422,0.07699477,0.000107392814,0.0061002127,0.0010364539,0.0028276262],"about_ca_topic_score_codex":0.00031009276,"about_ca_topic_score_gemma":0.000026923224,"teacher_disagreement_score":0.9083733,"about_ca_system_score_codex":0.00028585608,"about_ca_system_score_gemma":0.00018219788,"threshold_uncertainty_score":0.84662473},"labels":[],"label_agreement":null},{"id":"W3112404269","doi":"10.1016/j.jval.2020.08.173","title":"PCN36 Systematic Review of Treatments in Metastatic Castration-Resistant Prostate Cancer (mCRPC) with DNA Damage Repair Gene Mutation (DDRm)","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Olaparib; Oncology; Internal medicine; Clinical trial; Taxane; Pembrolizumab; Prostate cancer; Cancer; Breast cancer; Immunotherapy","score_opus":0.08304421118659776,"score_gpt":0.3717929691983274,"score_spread":0.2887487580117296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112404269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.85737133,0.12257957,0.000014323163,0.009509432,0.00004136429,0.010158445,0.00015727102,0.000058418333,0.0001098574],"genre_scores_gemma":[0.95260954,0.041904088,0.0021848036,0.001425502,0.000028821634,0.0012890851,0.00023674202,0.000048414135,0.00027302583],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99741024,0.00045202728,0.00096930575,0.00033301988,0.00050066,0.00033477767],"domain_scores_gemma":[0.99894834,0.00010575643,0.00035204316,0.00025716037,0.00012562472,0.00021107351],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007148711,0.0001859692,0.0009224168,0.00015449274,0.000038603,0.00000781098,0.000060995448,0.000026634802,0.000031854663],"category_scores_gemma":[0.00016709915,0.00012401983,0.000067709414,0.00081896107,0.000047326834,0.00009629145,0.000013707169,0.0001512307,0.0000059960003],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010835432,0.00045398925,0.011218891,0.97922295,0.00031160965,0.0008795883,0.004649138,0.00081681163,0.0009701705,0.000052687185,0.00010172547,0.00023892],"study_design_scores_gemma":[0.021247888,0.010017007,0.055782396,0.88465685,0.0014108239,0.00010890209,0.002697415,0.016798511,0.006523082,0.00010354784,0.000061086634,0.0005925157],"about_ca_topic_score_codex":0.0046844254,"about_ca_topic_score_gemma":0.00030698365,"teacher_disagreement_score":0.0952382,"about_ca_system_score_codex":0.0006910913,"about_ca_system_score_gemma":0.0014647386,"threshold_uncertainty_score":0.7081481},"labels":[],"label_agreement":null},{"id":"W3112452857","doi":"10.1016/j.jval.2020.08.988","title":"PIN147 Geography Variations in Antibiotic Use RATE: Evidence from 8,026 Primary Clinics in Taiwan","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Medicine; Antibiotics; Urbanization; Quarter (Canadian coin); Population; Medical insurance; Demography; Family medicine; Geography; Environmental health; Business; Nursing; Actuarial science","score_opus":0.057126501757598945,"score_gpt":0.2906207310753689,"score_spread":0.23349422931776995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112452857","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9763227,0.014840436,0.00040103623,0.0072142463,0.0005614382,0.00051103387,0.000060177343,0.00004590213,0.000043031076],"genre_scores_gemma":[0.9908057,0.0048963623,0.00096984697,0.0031520387,0.000036699104,0.0000022401525,0.000079633726,0.000016239772,0.00004126842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710536,0.0010651217,0.00082618627,0.00049132924,0.000044206667,0.00046782117],"domain_scores_gemma":[0.9986406,0.0007900981,0.00020588667,0.00028539993,0.000024743202,0.000053272724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008125122,0.0001663064,0.00047515187,0.00022282118,0.00007901471,0.000017942257,0.00024737004,0.00026996317,0.000042836647],"category_scores_gemma":[0.0005471733,0.0001620681,0.00006622081,0.00077340344,0.0001193464,0.0001965807,0.00007784449,0.00066172564,0.00013574329],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002436942,0.0002796667,0.9894221,0.00022735307,0.000027432894,0.000041686286,0.0027042427,0.0007822545,0.0042539677,0.00044201023,0.0005990634,0.00097652],"study_design_scores_gemma":[0.0012556765,0.00019843233,0.99441487,0.0012772135,0.000007999325,0.0000017701858,0.00023044793,0.0005513015,0.00021028433,0.00028732434,0.0013737851,0.00019089764],"about_ca_topic_score_codex":0.012604997,"about_ca_topic_score_gemma":0.000833597,"teacher_disagreement_score":0.014482971,"about_ca_system_score_codex":0.00011007921,"about_ca_system_score_gemma":0.000535341,"threshold_uncertainty_score":0.99397016},"labels":[],"label_agreement":null},{"id":"W3112465969","doi":"10.1016/j.jval.2020.08.1967","title":"PSS5 Cost per Responder Analysis of Latanoprostene Bunod Compared to Prostaglandin Analogs for OPEN-Angle Glaucoma in Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Bausch Health (Canada); Health Canada","funders":"","keywords":"Travoprost; Bimatoprost; Latanoprost; Medicine; Glaucoma; Ophthalmology; Intraocular pressure","score_opus":0.4487912280949728,"score_gpt":0.42915609732484056,"score_spread":0.019635130770132236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112465969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90156823,0.0009156422,0.0013108263,0.08848771,0.00022230901,0.004153477,0.0031267707,0.000012442802,0.0002025788],"genre_scores_gemma":[0.96917415,0.000034350243,0.003411541,0.02663102,0.00006071625,0.00035050412,0.00022838173,0.00003064148,0.00007871153],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99309766,0.00052558724,0.004898552,0.000736593,0.00013068842,0.0006109163],"domain_scores_gemma":[0.99628735,0.0011324488,0.0015982182,0.0004846897,0.000073601885,0.00042370654],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011206403,0.00019251987,0.0020075599,0.0008122805,0.00009748089,0.000048835664,0.00055355526,0.00007981964,0.00017792295],"category_scores_gemma":[0.00200857,0.00024905152,0.0000972276,0.0016838125,0.000021380225,0.00020649908,0.00011754887,0.00016356871,0.000046105444],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024915917,0.00010234284,0.94824535,0.000647053,0.00012675456,0.0000018105169,0.004793184,0.024720155,0.0000034839818,0.010828938,0.010206292,0.00007548473],"study_design_scores_gemma":[0.0031186868,0.0002801637,0.73855937,0.00015985023,0.000019152629,7.5660955e-7,0.0030214575,0.21987295,0.000007955196,0.0010528843,0.03348591,0.0004208642],"about_ca_topic_score_codex":0.9300699,"about_ca_topic_score_gemma":0.90988046,"teacher_disagreement_score":0.20968598,"about_ca_system_score_codex":0.0030297025,"about_ca_system_score_gemma":0.00257441,"threshold_uncertainty_score":0.9999962},"labels":[],"label_agreement":null},{"id":"W3112507268","doi":"10.1016/j.jval.2020.08.1234","title":"PMU22 Cost of Inotersen and Patisiran for the Treatment of Adults with Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Canada, Germany, and Italy","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transthyretin; Polyneuropathy; Amyloidosis; Medicine; Amyloid polyneuropathy; Pediatrics; Internal medicine; Disease; Age of onset","score_opus":0.015310756377109052,"score_gpt":0.23101841232887085,"score_spread":0.2157076559517618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112507268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989718,0.0059304032,0.000018367467,0.0028438608,0.000026082353,0.0009862074,0.00047210327,0.0000018435098,0.000003132129],"genre_scores_gemma":[0.99283737,0.006454623,0.00019392167,0.00035406303,0.000016525222,0.00007719202,0.000047698668,0.000017362823,0.0000012734743],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989366,0.00010025073,0.00042067238,0.00024867512,0.00010876593,0.00018505014],"domain_scores_gemma":[0.9992511,0.00026743708,0.00020078411,0.00015802537,0.000030190271,0.00009246206],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008444419,0.00014863319,0.00036361383,0.0000396267,0.000019615578,0.0000017883171,0.000071810064,0.00004639385,0.0000012914707],"category_scores_gemma":[0.00004835082,0.00010569255,0.000036167923,0.00011507118,0.00006892688,0.0000033280642,0.000014787262,0.00003734966,2.8956837e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013982053,0.00033645183,0.97413003,0.0006382276,0.00013139848,0.000014316437,0.0034988748,0.0006638613,0.0050026095,0.0000056318513,0.00012115117,0.01405923],"study_design_scores_gemma":[0.008856,0.008180978,0.9250411,0.00025593973,0.00007353728,0.000009176013,0.0022655805,0.0019237284,0.05263612,0.000003523777,0.00052569935,0.00022865966],"about_ca_topic_score_codex":0.5203166,"about_ca_topic_score_gemma":0.26185128,"teacher_disagreement_score":0.25846532,"about_ca_system_score_codex":0.000089301386,"about_ca_system_score_gemma":0.0003849879,"threshold_uncertainty_score":0.751618},"labels":[],"label_agreement":null},{"id":"W3112510814","doi":"10.1016/j.jval.2020.08.259","title":"PCN122 Cost-Effectiveness of Brentuximab Vedotin for the Frontline Treatment of Peripheral T-Cell Lymphomas in Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Brentuximab vedotin; Medicine; CHOP; Vincristine; Anaplastic large-cell lymphoma; Internal medicine; Oncology; Population; Prednisone; Lymphoma; CD30; Cyclophosphamide; Chemotherapy; Environmental health","score_opus":0.09055864429809313,"score_gpt":0.34746410205941075,"score_spread":0.2569054577613176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112510814","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988081,0.0043368065,0.000077465316,0.0031995282,0.00012522374,0.003935441,0.00009050476,0.000005870784,0.00014817389],"genre_scores_gemma":[0.9985058,0.0007024864,0.0001633848,0.00020927316,0.00006531928,0.00021212077,0.000024137742,0.000024717217,0.00009277996],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983144,0.0003658256,0.00046091393,0.00022372449,0.00030190442,0.00033324197],"domain_scores_gemma":[0.9984966,0.0009449888,0.00011222263,0.00023812373,0.00006440721,0.00014368155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060925685,0.00012536129,0.000579929,0.00005900777,0.000024042422,0.0000023928148,0.00010572053,0.000035789508,0.00013466728],"category_scores_gemma":[0.000083197854,0.00009058033,0.000079901576,0.00029026563,0.000043531767,0.00001425329,0.000018216999,0.00009552076,4.6447232e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030555557,0.0051455563,0.581339,0.012449266,0.0003150978,0.00011108317,0.011476324,0.05629936,0.08381384,0.00026251312,0.0005867198,0.21764567],"study_design_scores_gemma":[0.08731853,0.016298873,0.48102978,0.0012327501,0.0000795844,0.000023492383,0.0038243358,0.28490257,0.09108557,0.00011196942,0.033670288,0.0004222505],"about_ca_topic_score_codex":0.92808723,"about_ca_topic_score_gemma":0.34434646,"teacher_disagreement_score":0.5837408,"about_ca_system_score_codex":0.0028618136,"about_ca_system_score_gemma":0.0050079543,"threshold_uncertainty_score":0.8883896},"labels":[],"label_agreement":null},{"id":"W3112950326","doi":"10.1016/j.jval.2020.08.1390","title":"PND65 Assessing Knowledge and Perceptions Towards People with Alzheimer'S Disease Among Employees of a Pharmaceutical Company (CONOCE STUDY)","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Quality and Safety in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Checklist; Psychology; Beck Depression Inventory; Bachelor; Perception; Disease; Dementia; Scale (ratio); Intervention (counseling); Medicine; Depression (economics); Gerontology; Clinical psychology; Family medicine; Psychiatry; Anxiety","score_opus":0.2837333545752284,"score_gpt":0.5065411783051593,"score_spread":0.2228078237299309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112950326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97611165,0.0025731388,0.00020983271,0.017895635,0.00019817782,0.002494376,0.0000913516,0.0001181036,0.00030776084],"genre_scores_gemma":[0.99700147,0.00038937284,0.00052794354,0.0016258658,0.00021105866,0.00017222429,0.000020069565,0.000041577878,0.00001044273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99340415,0.0037374445,0.0012511782,0.0005388162,0.00034478796,0.0007236345],"domain_scores_gemma":[0.99698687,0.0010283154,0.00033087778,0.0003215394,0.00019021604,0.0011421645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017023677,0.0002519713,0.0007716922,0.0001393143,0.0007873492,0.00001639343,0.00018740287,0.00012643603,0.00015652782],"category_scores_gemma":[0.00028026276,0.00022166374,0.000056476492,0.0006464053,0.00020053294,0.0002443565,0.00017841574,0.0011309101,0.000026232936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022833208,0.0005314209,0.90697193,0.0026742457,0.000035905636,0.000008174178,0.086262114,0.00026017483,0.0000019315337,0.0010310815,0.00017564827,0.0018190504],"study_design_scores_gemma":[0.0016209839,0.0005480145,0.9415135,0.00095752324,0.00006546556,9.1639276e-7,0.042706795,0.011779323,7.2355016e-7,0.00014004615,0.00046391512,0.00020280578],"about_ca_topic_score_codex":0.013121008,"about_ca_topic_score_gemma":0.002377219,"teacher_disagreement_score":0.04355532,"about_ca_system_score_codex":0.00017588773,"about_ca_system_score_gemma":0.0023244314,"threshold_uncertainty_score":0.9934507},"labels":[],"label_agreement":null},{"id":"W3112951039","doi":"10.1016/j.jval.2020.08.1027","title":"PIT6 Risk Factors and Incidence Following an INDEX HIP Fracture in Ontario, Canada","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Hip fracture; Incidence (geometry); Arthroplasty; Observational study; Population; Cohort; Retrospective cohort study; Cohort study; Multivariate analysis; Surgery; Internal medicine; Osteoporosis","score_opus":0.03170036156280356,"score_gpt":0.2801966250568596,"score_spread":0.24849626349405604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112951039","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953549,0.00052799616,0.000044058725,0.0035258862,0.00013294256,0.0003186312,0.000005350838,0.000019123987,0.00007114844],"genre_scores_gemma":[0.99075127,0.000043422548,0.00014225273,0.008951015,0.00006358966,0.000003564582,0.000014813676,0.000015300036,0.000014792516],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986154,0.00014617931,0.00032992882,0.0002981998,0.0002845565,0.0003257319],"domain_scores_gemma":[0.99912375,0.00015101659,0.000093801915,0.00015660057,0.000011261672,0.00046359183],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029722034,0.00014961654,0.00037441505,0.0000797247,0.00006350606,0.0000116377705,0.000075165066,0.000103867555,0.00006302142],"category_scores_gemma":[0.00029021042,0.00012263024,0.000027368069,0.00019531212,0.000015215461,0.000096865886,0.000022247777,0.0009024688,7.8035686e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004960349,0.000023080842,0.9857699,0.00006258502,0.0000069630164,0.00014193103,0.011463373,0.0016738884,0.0000088036495,0.0000043743007,0.0003041873,0.0004912611],"study_design_scores_gemma":[0.0006938618,0.00021453941,0.99101126,0.00013546845,0.000007056259,0.0000042886354,0.0009236124,0.002229014,0.000030086785,0.000071245486,0.0045721703,0.000107410124],"about_ca_topic_score_codex":0.9990685,"about_ca_topic_score_gemma":0.9956877,"teacher_disagreement_score":0.01053976,"about_ca_system_score_codex":0.0005852114,"about_ca_system_score_gemma":0.0026500914,"threshold_uncertainty_score":0.5000716},"labels":[],"label_agreement":null},{"id":"W3112969174","doi":"10.1016/j.jval.2020.08.501","title":"PCV10 Comparative Effectiveness and Safety of Low Dose of ORAL Anticoagulant in Patients with NON-Valvular Atrial Fibrillation","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Université de Montréal","funders":"","keywords":"Medicine; Apixaban; Atrial fibrillation; Warfarin; Internal medicine; Rivaroxaban; Dabigatran; Hazard ratio; Cohort; Propensity score matching; Stroke (engine); Population; Myocardial infarction; Proportional hazards model; Cardiology; Confidence interval","score_opus":0.06871258715731554,"score_gpt":0.3451663734047593,"score_spread":0.27645378624744377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112969174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99759525,0.000113861504,0.00023116896,0.0005111796,0.000053651216,0.0014539184,0.000008742642,0.000006896516,0.000025327236],"genre_scores_gemma":[0.9992321,0.000046149322,0.0005873158,0.000028892337,0.00007096487,3.4877317e-7,0.000025451845,0.000007365225,0.00000137968],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988066,0.00021690423,0.000466306,0.00016666534,0.00022162416,0.000121889425],"domain_scores_gemma":[0.9993725,0.0001976281,0.00022335327,0.000084906875,0.00005432669,0.000067273744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041797647,0.00009535246,0.0006317817,0.00012048364,0.00001696749,0.000002658299,0.000024089532,0.000038222344,0.000004560275],"category_scores_gemma":[0.00008076395,0.00007613411,0.00004769141,0.00036567484,0.000042013755,0.00006538174,0.000025646379,0.00006601281,8.4914666e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0059059653,0.000010220298,0.9649753,0.0010744655,0.00003360804,0.000001112284,0.0009948299,0.025698816,0.000040334045,0.00016323494,0.0000028683532,0.0010992512],"study_design_scores_gemma":[0.010744008,0.0011749853,0.9720927,0.0004944557,0.000020407133,1.733667e-7,0.00006763508,0.015139614,0.00013943357,0.000022024491,0.000043005773,0.000061575905],"about_ca_topic_score_codex":0.0006214264,"about_ca_topic_score_gemma":0.0000102409695,"teacher_disagreement_score":0.010559202,"about_ca_system_score_codex":0.000054334447,"about_ca_system_score_gemma":0.00009920398,"threshold_uncertainty_score":0.31046587},"labels":[],"label_agreement":null},{"id":"W3112969951","doi":"10.1016/j.jval.2020.08.1721","title":"PPM4 Health and Budget IMPACT of Liquid-Based Comprehensive Genomic Profile Testing (CGP) in Advance NON-SMALL CELL LUNG Cancer (ANSCLC) Patients with Insufficient Tissue, Exhausted Tissue Samples and or Insufficient DNA in Tissue Samples","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; University Health Network; Princess Margaret Cancer Centre; University of Ottawa; Roche (Canada)","funders":"","keywords":"Medicine; Population; Biopsy; Liquid biopsy; Biomarker; Lung cancer; Health care; Cancer; Oncology; Intensive care medicine; Internal medicine; Pathology; Environmental health; Biology","score_opus":0.03154745500702,"score_gpt":0.29905586956367863,"score_spread":0.26750841455665864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3112969951","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855245,0.011070775,0.00039412026,0.00027065337,0.000058366113,0.0018942435,0.00077051687,0.00000876033,0.000008108736],"genre_scores_gemma":[0.9906347,0.002013531,0.0061644474,0.0007586292,0.000052824413,0.000082394865,0.00024024451,0.000049780025,0.0000034911084],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763924,0.00015571098,0.0007563206,0.0007033469,0.00015980854,0.00058559206],"domain_scores_gemma":[0.99862975,0.00020422801,0.00042784383,0.00026184332,0.00013205543,0.0003443016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021486459,0.0003217835,0.00060521724,0.00016994262,0.00007284677,0.000022838716,0.00015753305,0.00011340391,0.0000074614572],"category_scores_gemma":[0.00017970098,0.00029119512,0.000022130715,0.00046871405,0.000100620564,0.0000080571035,0.00014525212,0.00020048543,4.2981387e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024636437,0.0009964578,0.6370621,0.00349934,0.000024010425,0.000016025075,0.0044325236,0.26626486,0.07847215,0.000008584105,0.00017099934,0.006589366],"study_design_scores_gemma":[0.011988386,0.029422957,0.8730731,0.002043853,0.00002389655,0.000007290917,0.0010410801,0.026876837,0.050003976,0.0000062287077,0.004382663,0.0011297151],"about_ca_topic_score_codex":0.025466636,"about_ca_topic_score_gemma":0.0039524008,"teacher_disagreement_score":0.23938802,"about_ca_system_score_codex":0.00033840496,"about_ca_system_score_gemma":0.0020652108,"threshold_uncertainty_score":0.99995404},"labels":[],"label_agreement":null},{"id":"W3113059643","doi":"10.1016/j.jval.2020.08.691","title":"PDG8 A Chart Review Study of Dry Eye Disease Symptoms and Treatment Patterns Among Patients Receiving Lifitegrast in the United States and Canada","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Ocular Surface and Contact Lens","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Blurred vision; Medical prescription; Depression (economics); Demographics; Internal medicine; Pediatrics; Surgery; Demography","score_opus":0.037948362591216575,"score_gpt":0.3171088141172968,"score_spread":0.2791604515260802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113059643","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.44068304,0.55621886,6.7702416e-8,0.00024225893,0.000027783317,0.0027247395,0.00009810791,0.0000037671314,0.0000013388244],"genre_scores_gemma":[0.036634717,0.9622044,0.0000018172201,0.00055071514,0.00002032521,0.00016169905,0.00038971886,0.000028608229,0.000007979795],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997165,0.0010236403,0.00084795064,0.00037596817,0.00032482564,0.0002625957],"domain_scores_gemma":[0.99873424,0.00024921013,0.00036336985,0.00035233848,0.000034399247,0.00026646385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041435522,0.000321604,0.0016880208,0.00015180773,0.00004216518,0.000011180526,0.00008905287,0.000045894387,0.0000035557046],"category_scores_gemma":[0.000100765945,0.00019605136,0.00006899749,0.00040644588,0.000019500781,0.000026732509,0.000040081464,0.0002961281,3.4836754e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008951066,0.00029029453,0.7673878,0.043625347,0.0000647912,0.00008642088,0.0009766435,0.0000010256612,4.885666e-10,5.9413765e-7,0.000004988553,0.18755314],"study_design_scores_gemma":[0.0013446702,0.0013529358,0.69409555,0.17306177,0.0007193853,4.239827e-7,0.0009785735,0.0000741988,5.848515e-9,6.822449e-7,0.12816514,0.0002066735],"about_ca_topic_score_codex":0.8438935,"about_ca_topic_score_gemma":0.42281824,"teacher_disagreement_score":0.42107528,"about_ca_system_score_codex":0.00044799622,"about_ca_system_score_gemma":0.0010684092,"threshold_uncertainty_score":0.79947424},"labels":[],"label_agreement":null},{"id":"W3113091013","doi":"10.1016/j.jval.2020.08.1918","title":"PRS38 Cost-Effectiveness of Once-Daily Single-Inhaler Indacaterol Acetate/Glycopyrronium Bromide/Mometasone Furoate in Patients with Uncontrolled Moderate-to-Severe Asthma","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Novartis (Canada)","funders":"","keywords":"Indacaterol; Medicine; Mometasone furoate; Fluticasone propionate; Asthma; Exacerbation; Inhaler; Salmeterol; Fluticasone; Internal medicine; Corticosteroid; Bronchodilator","score_opus":0.0341880804048101,"score_gpt":0.2796605259224613,"score_spread":0.24547244551765124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113091013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99359304,0.00039276015,0.00021897872,0.0010829701,0.00009953412,0.0043848287,0.00007631302,0.00005031425,0.00010129141],"genre_scores_gemma":[0.9975795,0.000018465254,0.0003241965,0.0016957887,0.00005664548,0.00017917699,0.00005729694,0.00006723658,0.000021703872],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99635005,0.0009452046,0.00085630245,0.00063397613,0.0005753711,0.0006391202],"domain_scores_gemma":[0.9982736,0.00022599222,0.00030908798,0.00033044958,0.00020391901,0.0006569446],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00062356214,0.00035845293,0.0012734439,0.0003335057,0.00006065556,0.000019372792,0.00016061003,0.00013413434,0.00004042987],"category_scores_gemma":[0.00023433055,0.0002795601,0.00009946617,0.00091805746,0.00008900973,0.00016206274,0.00006629801,0.00040250408,0.000031277865],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057323184,0.0027555556,0.8032418,0.0043502566,0.00014216978,0.00017427078,0.0023230633,0.1174655,0.0013286629,0.000029568848,0.00012398636,0.010742011],"study_design_scores_gemma":[0.045579,0.010312317,0.9302648,0.0028139788,0.00004657429,0.00000715886,0.00023963327,0.0073881,0.0021004512,0.000022335465,0.00076106144,0.00046461777],"about_ca_topic_score_codex":0.0005280107,"about_ca_topic_score_gemma":0.000044813638,"teacher_disagreement_score":0.12702301,"about_ca_system_score_codex":0.00044897792,"about_ca_system_score_gemma":0.0008847501,"threshold_uncertainty_score":0.99996567},"labels":[],"label_agreement":null},{"id":"W3113101217","doi":"10.1016/j.jval.2020.08.1102","title":"PMH24 Factors Associated with Receiving Integrated Care Among People with Concurrent Opioid Use Disorder and Mental Illness in a Canadian Setting","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; British Columbia Centre on Substance Use","funders":"","keywords":"Medicine; Opioid use disorder; Mental illness; Odds ratio; Mental health; Psychiatry; Confidence interval; Population; Medical prescription; Proxy (statistics); Opioid; Internal medicine; Environmental health; Nursing","score_opus":0.020906964772381593,"score_gpt":0.2651394919507443,"score_spread":0.24423252717836272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113101217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949585,0.00090846437,0.0000061360065,0.0022348308,0.00007252973,0.0015750316,0.00016945791,0.000055504122,0.000019541607],"genre_scores_gemma":[0.99866915,0.000149243,0.00007645097,0.0002953012,0.000010663788,0.000062131156,0.0006783025,0.000051401243,0.000007341884],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809325,0.00019962831,0.00035916563,0.00045215094,0.00025147805,0.0006443297],"domain_scores_gemma":[0.9989017,0.00013129004,0.00013500315,0.00013722852,0.00006786678,0.00062686385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013238739,0.00028105397,0.00050922803,0.0002181098,0.00013338646,0.000042563082,0.000059303435,0.00008481992,0.000015396501],"category_scores_gemma":[0.00023385514,0.00021119589,0.000023579958,0.00078118616,0.00005353927,0.00013748558,0.000024849342,0.00040093562,8.341942e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050575978,0.0000926721,0.91685706,0.00030013648,0.000040940035,0.000043294145,0.081073426,0.0003662323,0.0000024592935,0.000006259435,0.00001996246,0.0011469859],"study_design_scores_gemma":[0.003434995,0.0007273439,0.94387907,0.0017985334,0.00002347495,0.0000035732155,0.044505205,0.0051605934,0.000016207896,6.679221e-7,0.00022025361,0.00023008132],"about_ca_topic_score_codex":0.8323058,"about_ca_topic_score_gemma":0.8841369,"teacher_disagreement_score":0.05183111,"about_ca_system_score_codex":0.0018389747,"about_ca_system_score_gemma":0.0018989095,"threshold_uncertainty_score":0.8612318},"labels":[],"label_agreement":null},{"id":"W3113127196","doi":"10.1016/j.jval.2020.08.1769","title":"PRO33 Ravulizumab Reduces Productivity Losses Versus Eculizumab for Treating Atypical Hemolytic Uremic Syndrome: A 'cost Consequence' Analysis in 4 Countries","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Eculizumab; Medicine; Dosing; Population; Atypical hemolytic uremic syndrome; Productivity; Pediatrics; Internal medicine; Immunology; Complement system; Environmental health; Economics; Antibody","score_opus":0.07000402329229,"score_gpt":0.32721898669838995,"score_spread":0.25721496340609995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113127196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98600036,0.0045401235,0.000112051355,0.0059827664,0.00033034125,0.0026355346,0.00027880582,0.0000944299,0.000025572292],"genre_scores_gemma":[0.9988374,0.000049393464,0.0002086629,0.00016923102,0.00004180474,0.00041617203,0.00022595981,0.000020874768,0.000030485595],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677974,0.00078052585,0.00089391175,0.0007633836,0.00009674378,0.0006857232],"domain_scores_gemma":[0.99815154,0.0010257534,0.0003379628,0.00032735226,0.00007512327,0.00008226005],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006958087,0.00026925482,0.00087990775,0.00032260947,0.00020549977,0.000033934444,0.0002874818,0.0001356114,0.00014257437],"category_scores_gemma":[0.0014122783,0.00026508627,0.00015585696,0.0010306854,0.0002635269,0.00012603772,0.00007681457,0.00027019464,0.000042676274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.072235465,0.0045324354,0.7526397,0.015984785,0.0070856106,0.0010415557,0.0345774,0.055564463,0.021882957,0.0118234,0.010466466,0.012165724],"study_design_scores_gemma":[0.16712014,0.029673707,0.58107674,0.011644235,0.005631589,0.002576685,0.030520704,0.042361774,0.07297956,0.006260574,0.04025993,0.009894372],"about_ca_topic_score_codex":0.0019931209,"about_ca_topic_score_gemma":0.00061092724,"teacher_disagreement_score":0.17156301,"about_ca_system_score_codex":0.0006298727,"about_ca_system_score_gemma":0.0010967086,"threshold_uncertainty_score":0.99998015},"labels":[],"label_agreement":null},{"id":"W3113130970","doi":"10.1016/j.jval.2020.08.513","title":"PCV22 Trends in Diagnostic Testing Utilization and Expenditures in Patients with NEWLY Diagnosed Paroxysmal Supraventricular Tachycardia in the United States","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vertex Pharmaceuticals (Canada)","funders":"","keywords":"Medicine; Diagnostic test; Stress testing (software); Cohort; Pediatrics; Internal medicine","score_opus":0.04718057191234119,"score_gpt":0.28990666732547565,"score_spread":0.24272609541313445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113130970","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960452,0.0010774063,0.000009714669,0.0018810445,0.000038413655,0.00086482445,0.000031184944,0.000016228189,0.00003603525],"genre_scores_gemma":[0.99781334,0.00035038724,0.0001595694,0.00091104215,0.000045015793,0.00008123229,0.0006196159,0.000018788918,9.80398e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820536,0.00042449438,0.00043843067,0.0003055453,0.00028236417,0.00034378842],"domain_scores_gemma":[0.9984742,0.0011296268,0.00010444263,0.00014332512,0.000022580478,0.00012585272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036362722,0.00016999539,0.00038236863,0.00042121144,0.000037726215,0.000019012512,0.00004349421,0.000056084988,0.000005163998],"category_scores_gemma":[0.0007645068,0.00011870754,0.00002722375,0.0013681847,0.000027892824,0.000066967776,0.000025608524,0.00024883932,0.0000010693686],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001503982,0.00026734223,0.96660024,0.00008479889,0.000010010776,0.0008423692,0.004252477,0.018591616,1.16053364e-7,0.000022690092,0.00006044774,0.009117483],"study_design_scores_gemma":[0.007348926,0.00066128507,0.981985,0.0003740301,0.000016026219,0.000008988384,0.0008079853,0.008377697,0.0000023947903,0.000025344481,0.0002936972,0.00009866628],"about_ca_topic_score_codex":0.014628096,"about_ca_topic_score_gemma":0.00053051696,"teacher_disagreement_score":0.015384708,"about_ca_system_score_codex":0.00017605363,"about_ca_system_score_gemma":0.00008514266,"threshold_uncertainty_score":0.9919336},"labels":[],"label_agreement":null},{"id":"W3113155387","doi":"10.1016/j.jval.2020.08.225","title":"PCN88 Systematic Literature Review (SLR) of Economic and Healthcare Resource Utilization Evidence in the Treatment of Relapsed or Refractory Large B-Cell Lymphoma (LBCL)","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Cochrane Library; Health care; Systematic review; MEDLINE; Database; Family medicine; Internal medicine; Meta-analysis; Political science","score_opus":0.48915247073500495,"score_gpt":0.43620843639404155,"score_spread":0.0529440343409634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113155387","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12552044,0.8010415,0.00007338563,0.068538986,0.00015043787,0.004219352,0.00032582902,0.000018399187,0.000111708825],"genre_scores_gemma":[0.6061041,0.3779727,0.00039690497,0.015087539,0.000100804544,0.00021406513,0.00004150276,0.000032628097,0.00004977744],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9898208,0.002840807,0.006250134,0.00057822163,0.00012882033,0.00038124894],"domain_scores_gemma":[0.99255264,0.0028252325,0.003773902,0.00063487276,0.000043480584,0.00016988513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016248206,0.00022673988,0.0019790193,0.00028866983,0.000079061,0.00002633288,0.00029036019,0.0001475389,0.000023862469],"category_scores_gemma":[0.0026692303,0.00019687864,0.00010874804,0.00052330596,0.000043586864,0.0002785939,0.000026264786,0.0001342752,0.000038507984],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020413415,0.0011119165,0.02665206,0.870029,0.000042473515,0.000009469599,0.06784829,0.00052268885,0.0000010041002,0.02946527,0.003564774,0.00054896524],"study_design_scores_gemma":[0.020626923,0.011666789,0.0369536,0.7099612,0.000103842416,0.00008736065,0.023614354,0.11115191,0.000025110428,0.0038967798,0.08010458,0.0018075602],"about_ca_topic_score_codex":0.0021424808,"about_ca_topic_score_gemma":0.0003715036,"teacher_disagreement_score":0.48058364,"about_ca_system_score_codex":0.0010943523,"about_ca_system_score_gemma":0.0005685192,"threshold_uncertainty_score":0.8028478},"labels":[],"label_agreement":null},{"id":"W3113272092","doi":"10.1016/j.jval.2020.08.500","title":"PCV9 Health IMPACT of Tafamidis in Transthyretin Amyloid Cardiomyopathy Patients: An Analysis from the Attr-ACT and the OPEN-Label Extension Studies","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Cohort; Life expectancy; Population; Environmental health","score_opus":0.07246697400830371,"score_gpt":0.3661639939859637,"score_spread":0.29369701997766,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113272092","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651613,0.024820765,0.000034985263,0.008597599,0.000043725482,0.0010902812,0.00023780238,0.000006691142,0.000006848757],"genre_scores_gemma":[0.98003006,0.016325748,0.00024590472,0.0030493818,0.00004633061,0.00007918533,0.00019851922,0.000023131866,0.0000017629159],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661446,0.0015238471,0.0007105065,0.00058713264,0.00020551805,0.00035851393],"domain_scores_gemma":[0.99858546,0.00026395317,0.00036221533,0.00055252964,0.00007013522,0.000165681],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011510601,0.00025799638,0.0009103914,0.000070500944,0.0001413921,0.000030308782,0.00039010253,0.00007995209,0.0000041585895],"category_scores_gemma":[0.00031675844,0.00014938512,0.00016808997,0.00055823685,0.00020345722,0.000014774667,0.0001971256,0.00015785714,7.462872e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000695329,0.00040818474,0.9834627,0.000052876552,0.0006410896,0.000002126125,0.006050326,0.003895656,0.0002335445,0.000024281433,0.00029585647,0.004238021],"study_design_scores_gemma":[0.0072563263,0.0022432946,0.98582643,0.000089376976,0.00014053797,6.909061e-7,0.0018835706,0.0018563581,0.00028873194,0.000060466722,0.00015773853,0.00019647322],"about_ca_topic_score_codex":0.044419993,"about_ca_topic_score_gemma":0.0022250267,"teacher_disagreement_score":0.042194966,"about_ca_system_score_codex":0.00016248012,"about_ca_system_score_gemma":0.00028267797,"threshold_uncertainty_score":0.96194327},"labels":[],"label_agreement":null},{"id":"W3113325231","doi":"10.1016/j.jval.2020.08.1800","title":"PRO64 Preferences for Hemophilia Treatments in Canada: A General Population Preference-Based Utility Study","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Manitoba; Roche (Canada); Vancouver Coastal Health","funders":"","keywords":"Medicine; Bleed; Clotting factor; Population; Vignette; Pediatrics; Internal medicine; Surgery; Environmental health","score_opus":0.260018410057465,"score_gpt":0.3719096248838227,"score_spread":0.11189121482635767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113325231","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98841876,0.00016624042,0.0000067637116,0.006056369,0.00005937869,0.005149038,0.000047497117,0.000021906375,0.00007402795],"genre_scores_gemma":[0.99840224,0.000018586177,0.00052928494,0.00034837468,0.00006987208,0.00039037078,0.00015038149,0.000014175822,0.000076722186],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790037,0.00027948778,0.00051507703,0.00043932343,0.0004211022,0.00044463814],"domain_scores_gemma":[0.9992693,0.00011289103,0.000079189434,0.00019497782,0.00004753939,0.00029609317],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003760391,0.00016554909,0.00045576555,0.00011212023,0.00006968448,0.000009041452,0.00008598694,0.000051213818,0.000032799715],"category_scores_gemma":[0.00015472094,0.00012598989,0.00003959388,0.00038307664,0.000015505999,0.000043208398,0.000014654311,0.00017867585,0.0000021961928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000658693,0.0007959524,0.9874278,0.00043486984,0.000023088698,0.000023818053,0.00070327724,0.0004668798,0.0000086328155,0.000011872737,0.00007697094,0.009368145],"study_design_scores_gemma":[0.0051469505,0.0021586455,0.93989706,0.00012501895,0.000014652365,6.1616953e-7,0.00036177356,0.051960133,0.00007835722,0.00012208315,0.000047817215,0.00008686939],"about_ca_topic_score_codex":0.91483533,"about_ca_topic_score_gemma":0.64636004,"teacher_disagreement_score":0.26847532,"about_ca_system_score_codex":0.0014038928,"about_ca_system_score_gemma":0.0045729997,"threshold_uncertainty_score":0.81123054},"labels":[],"label_agreement":null},{"id":"W3113356610","doi":"10.1016/j.jval.2020.08.1327","title":"PND2 Indirect Treatment Comparisons of Apomorphine Sublingual Film Versus Apomorphine Subcutaneous Injection for the on-Demand Treatment of \"Off\" Episodes in Patients with Parkinson's Disease","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Apomorphine; Parkinson's disease; Medicine; Placebo; Rating scale; Internal medicine; Anesthesia; Disease; Psychology; Dopamine; Dopaminergic","score_opus":0.061515354360156434,"score_gpt":0.29896833249471916,"score_spread":0.23745297813456273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3113356610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912712,0.0024634388,0.000070781374,0.0018762966,0.00016079746,0.0032776955,0.00082783063,0.000030977983,0.000020972604],"genre_scores_gemma":[0.9979978,0.0006875914,0.00040508306,0.00013347284,0.00007746619,0.00025565908,0.00038529662,0.000041254047,0.00001635421],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99794585,0.00016528148,0.00062011014,0.0004795751,0.00039342712,0.00039573788],"domain_scores_gemma":[0.99823713,0.00055700226,0.00038681994,0.0003533229,0.000083806095,0.00038189118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001516878,0.00034788167,0.0009010746,0.00021676676,0.000095264055,0.000008413717,0.00008455434,0.000063572574,0.000022099406],"category_scores_gemma":[0.00010603129,0.0002187144,0.00015952112,0.00044273646,0.000079122845,0.000039886552,0.0000150322985,0.00008685993,0.0000029040875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08982594,0.013243166,0.84320456,0.0005528739,0.00075326936,0.0001862446,0.002400661,0.021637984,0.000012039804,0.00015438742,0.00015519377,0.02787369],"study_design_scores_gemma":[0.07477018,0.11606248,0.7567333,0.0006810877,0.0007827508,0.000008607465,0.00042783385,0.04223292,0.00096653757,0.00007096991,0.0068640094,0.0003993193],"about_ca_topic_score_codex":0.0025378745,"about_ca_topic_score_gemma":0.00028807615,"teacher_disagreement_score":0.102819316,"about_ca_system_score_codex":0.00072783465,"about_ca_system_score_gemma":0.00052774465,"threshold_uncertainty_score":0.8918914},"labels":[],"label_agreement":null},{"id":"W3115006642","doi":"10.1016/j.jval.2020.10.027","title":"Cost-Effectiveness Analysis of Transcatheter Arterial Embolization Techniques for the Treatment of Gastrointestinal Bleeding in the United States","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Alberta Health; University of Alberta","funders":"","keywords":"Medicine; Confidence interval; Cyanoacrylate; Cost-effectiveness analysis; Surgery; Embolization; Gastrointestinal bleeding; Cost effectiveness; Internal medicine","score_opus":0.17060380702533615,"score_gpt":0.41513460310074934,"score_spread":0.2445307960754132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3115006642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008543218,0.9647023,0.006520521,0.0012160637,0.000099459015,0.018236844,0.0006280026,0.000044660468,0.000008917775],"genre_scores_gemma":[0.010339903,0.98494804,0.001816844,0.000036128265,0.000077106015,0.0019610627,0.000787263,0.000032837586,8.0289385e-7],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976969,0.0005172261,0.0010007132,0.00030249407,0.00021638881,0.0002663113],"domain_scores_gemma":[0.99595135,0.0030769065,0.0005644572,0.00024840934,0.000100268146,0.00005862301],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009133016,0.0003080909,0.002059045,0.00073957146,0.000042221378,0.000012083919,0.00013298875,0.000054302684,0.0000041931767],"category_scores_gemma":[0.000119424505,0.00015772528,0.00077055657,0.0017623391,0.00006600319,0.00001721063,0.0000074110258,0.00013749012,2.2496212e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011694564,0.006711489,0.028794965,0.055087022,0.004092759,0.00005059828,0.006431696,0.006444895,0.000011282431,0.00078602385,0.000032934728,0.8903869],"study_design_scores_gemma":[0.013762113,0.08335972,0.04217229,0.33385912,0.083534256,0.00075849483,0.003134418,0.072064444,0.00020533694,0.00032653552,0.365604,0.0012192408],"about_ca_topic_score_codex":0.0032514273,"about_ca_topic_score_gemma":0.000054993892,"teacher_disagreement_score":0.8891676,"about_ca_system_score_codex":0.00051074603,"about_ca_system_score_gemma":0.00026993247,"threshold_uncertainty_score":0.643185},"labels":[],"label_agreement":null},{"id":"W3116189451","doi":"10.1016/j.jval.2020.10.019","title":"Rasch Analysis of Patient- and Parent-Reported Outcome Measures in the International Consortium for Health Outcomes Measurement Standard Set for Cleft Lip and Palate","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Cleft Lip and Palate Research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Rasch model; Medicine; Patient-reported outcome; Context (archaeology); Nose; Psychosocial; Distress; Polytomous Rasch model; Quality of life (healthcare); Psychometrics; Item response theory; Clinical psychology; Psychology; Psychiatry; Developmental psychology; Nursing; Surgery","score_opus":0.1775950929461954,"score_gpt":0.3945738047265021,"score_spread":0.2169787117803067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3116189451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9814398,0.00044680835,0.0009670192,0.015680788,0.00006199925,0.0010248494,0.00036798013,0.000003407908,0.00000731468],"genre_scores_gemma":[0.99708664,0.0007419644,0.0002877517,0.0016500606,0.000025026433,0.00006119549,0.00013542704,0.0000090180665,0.0000029064572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816847,0.00022436446,0.00068388024,0.00030308287,0.00036777672,0.0002523979],"domain_scores_gemma":[0.9992388,0.00011827858,0.00023209146,0.0001560543,0.00013950835,0.0001152976],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002474679,0.00010919977,0.0003808855,0.000117583506,0.000059225506,0.000021741656,0.000116396244,0.000054165448,0.0000020082146],"category_scores_gemma":[0.0006592696,0.000082509025,0.00009180582,0.00017003351,0.000044797423,0.000003592577,0.000048106973,0.00008244424,4.565838e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028123453,0.00004119934,0.99423766,0.0002278932,0.0002624652,5.4458616e-7,0.0009646104,0.00068335456,0.00046837179,0.000059597398,0.00026664065,0.0025064037],"study_design_scores_gemma":[0.003451253,0.0013878602,0.96824443,0.00006455503,0.000083542036,0.0000025851632,0.0012416543,0.009194367,0.00035348666,0.0001550061,0.015611851,0.00020942782],"about_ca_topic_score_codex":0.00077683287,"about_ca_topic_score_gemma":0.0010987998,"teacher_disagreement_score":0.025993273,"about_ca_system_score_codex":0.000049067854,"about_ca_system_score_gemma":0.00025544796,"threshold_uncertainty_score":0.33646205},"labels":[],"label_agreement":null},{"id":"W3120257392","doi":"10.1016/j.jval.2020.10.023","title":"A Patient-Centric Tool to Facilitate Goal Attainment Scaling in Neurogenic Bladder and Bowel Dysfunction: Path to Individualization","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Capital District Health Authority","funders":"","keywords":"Goal Attainment Scaling; Thematic analysis; Medicine; Stakeholder; Neurogenic bladder dysfunction; Bowel management; Psychology; MEDLINE; Physical therapy; Rehabilitation; Qualitative research; Internal medicine; Constipation; Urinary bladder","score_opus":0.03472075627906216,"score_gpt":0.2743503460624292,"score_spread":0.23962958978336704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120257392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918709,0.0017200949,0.00037112134,0.004481392,0.00019890562,0.0012411824,0.000028910286,0.000029968716,0.000057540656],"genre_scores_gemma":[0.9922668,0.00035156522,0.0017433866,0.005305379,0.000026743937,0.00010819936,0.00007726458,0.000023962835,0.000096738324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99795747,0.0002272944,0.0005231286,0.00048895285,0.00037106717,0.00043207538],"domain_scores_gemma":[0.9993115,0.000057209407,0.000057941266,0.00024732135,0.000049260594,0.00027678],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029450684,0.00016321473,0.0002830874,0.000299397,0.000058111185,0.000020304706,0.00003424677,0.000057810565,0.00004192878],"category_scores_gemma":[0.00027297347,0.00016854197,0.000032929667,0.0008968226,0.000011537952,0.000060614984,0.00008025897,0.00013511305,0.000041638465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005268158,0.001858213,0.8338169,0.0006970766,0.00011327898,0.00053877657,0.025431732,0.016925294,0.00030640583,0.00013130963,0.0013224244,0.11833181],"study_design_scores_gemma":[0.009160624,0.0019102993,0.9700585,0.000785113,0.00005141629,0.000105925545,0.0025210304,0.007022168,0.00020407671,0.00017788835,0.0076186033,0.00038433127],"about_ca_topic_score_codex":0.001106314,"about_ca_topic_score_gemma":0.0001236814,"teacher_disagreement_score":0.13624166,"about_ca_system_score_codex":0.0005637572,"about_ca_system_score_gemma":0.00035667824,"threshold_uncertainty_score":0.6872942},"labels":[],"label_agreement":null},{"id":"W3120408758","doi":"10.1016/j.jval.2020.11.011","title":"Development and Validation of a Hospital Indicator of Activity-Based Costs for Injury Admissions","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Trauma and Emergency Care Studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Université Laval; Hôpital de l'Enfant-Jésus; Institut National d'Excellence en Santé et en Services Sociaux; The Quebec Population Health Research Network","funders":"Fonds de Recherche du Québec - Santé; Australian Research Council; Canadian Institutes of Health Research","keywords":"Medical emergency; Computer science; Medicine","score_opus":0.05218566131556476,"score_gpt":0.35302608824998466,"score_spread":0.3008404269344199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3120408758","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966333,0.0005235691,0.00016543399,0.002152216,0.00012157229,0.00032187323,0.000026014499,0.000006355978,0.000049670933],"genre_scores_gemma":[0.990198,0.0001180433,0.009540289,0.0000699305,0.00001450089,0.00002778367,0.000015038603,0.0000058313167,0.000010588098],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993754,0.00003715336,0.00025268705,0.000116038755,0.00011334067,0.0001053937],"domain_scores_gemma":[0.9995858,0.00007170177,0.00010163599,0.000079059566,0.00007098731,0.00009079174],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022032169,0.00005229935,0.00021813155,0.00008110398,0.00003399904,7.6870856e-7,0.000015073016,0.00003112752,0.00001017147],"category_scores_gemma":[0.00026897204,0.000047798425,0.00002668389,0.00013413817,0.000018087965,0.000017067809,0.000013257774,0.000048611648,2.171025e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014454074,0.0046709715,0.46995175,0.017518643,0.0003438355,0.000023067152,0.036267653,0.00009336761,0.042174377,0.001881778,0.0032589752,0.42237017],"study_design_scores_gemma":[0.0019329417,0.0011214667,0.72876143,0.0011779101,0.000027233684,0.0000012787832,0.0010932701,0.00014690419,0.26024327,0.00005958506,0.0053206715,0.00011405936],"about_ca_topic_score_codex":0.00017000316,"about_ca_topic_score_gemma":0.000012643363,"teacher_disagreement_score":0.4222561,"about_ca_system_score_codex":0.000076519784,"about_ca_system_score_gemma":0.0012181047,"threshold_uncertainty_score":0.21608655},"labels":[],"label_agreement":null},{"id":"W3123064527","doi":"10.1016/s1098-3015(10)70027-9","title":"CA3 A COST-EFFECTIVENESS ANALYSIS OF HEPATITIS C SCREENING AMONG IMMIGRANTS IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Immigration; Medicine; Virology; Demographic economics; Environmental health; Demography; Political science; Economics; Sociology","score_opus":0.0936129543675355,"score_gpt":0.35785491326516716,"score_spread":0.2642419588976317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3123064527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997856,0.00041414332,0.00018790521,0.00020659856,0.00004191986,0.0010202561,0.00007208011,0.000009162313,0.00019193829],"genre_scores_gemma":[0.99833333,0.0010742409,0.00027284469,0.00014895624,0.000013990886,0.00008051481,0.000037569007,0.00001836346,0.000020169118],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710006,0.0007389538,0.0006455152,0.00029656023,0.00068282173,0.00053610164],"domain_scores_gemma":[0.998661,0.0005285334,0.0001277455,0.00031331417,0.00010038504,0.00026906998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011899632,0.00012403658,0.0008421745,0.001017718,0.000054399236,0.0000025993813,0.00010362646,0.000058240996,0.000059552898],"category_scores_gemma":[0.00045986703,0.00012741928,0.00007900249,0.0028963306,0.000074312295,0.000061159466,0.00003561967,0.00035633153,0.0000017579619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008548389,0.00006512235,0.9747744,0.00026041566,0.0001135648,0.00047939862,0.0005676545,0.014882263,0.000024894032,0.000008062416,0.00004058553,0.008698111],"study_design_scores_gemma":[0.0010053638,0.00010496135,0.90798944,0.0004862547,0.000022996877,0.0000050611347,0.00007966452,0.08998958,0.00014110055,0.0000023439727,0.000094922914,0.00007827987],"about_ca_topic_score_codex":0.99980104,"about_ca_topic_score_gemma":0.9976707,"teacher_disagreement_score":0.07510732,"about_ca_system_score_codex":0.0020612038,"about_ca_system_score_gemma":0.00422505,"threshold_uncertainty_score":0.74950576},"labels":[],"label_agreement":null},{"id":"W3129801150","doi":"10.1016/j.jval.2017.08.764","title":"Cost-Effectiveness Analysis of Secukinumab in Ankylosing Spondylitis: A Canadian Perspective","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Medicine; Golimumab; Adalimumab; Secukinumab; BASDAI; Certolizumab pegol; BASFI; Infliximab; Population; Ankylosing spondylitis; Etanercept; Cost effectiveness; Adverse effect; Internal medicine; Disease; Tumor necrosis factor alpha; Environmental health","score_opus":0.08393438153360656,"score_gpt":0.3907806412306049,"score_spread":0.30684625969699836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3129801150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925664,0.0024760219,0.0000052492924,0.0011723855,0.0001103293,0.0009455561,0.0002926048,0.0000075194484,0.0024239072],"genre_scores_gemma":[0.99925506,0.00033893815,0.00015484077,0.00010319307,0.000023149498,0.00005995292,0.00003648664,0.000012332866,0.000016017657],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99860805,0.00017561937,0.0003140351,0.00030942622,0.0001662365,0.00042664947],"domain_scores_gemma":[0.9989867,0.0001171794,0.00015944209,0.00042699435,0.0000978092,0.00021182954],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061933184,0.00012732876,0.0007182974,0.0008661309,0.00019548186,0.000015703827,0.0000833761,0.00006196136,0.000055434233],"category_scores_gemma":[0.0003150966,0.00012627857,0.00011191964,0.0005577862,0.000087494096,0.000067899586,0.000029068053,0.00015358793,0.000002762397],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002973117,0.00021249591,0.9872716,0.00011835153,0.00043539386,0.00047685087,0.003967037,0.0003937036,0.0000065991726,0.00300823,0.0000056245567,0.0038067773],"study_design_scores_gemma":[0.003172854,0.00030237102,0.9917046,0.0007422902,0.00012585937,0.000013055176,0.0019448895,0.0012686168,0.000024069432,0.0003540607,0.0002642401,0.000083105144],"about_ca_topic_score_codex":0.94592994,"about_ca_topic_score_gemma":0.70733935,"teacher_disagreement_score":0.23859061,"about_ca_system_score_codex":0.0023929896,"about_ca_system_score_gemma":0.00073486526,"threshold_uncertainty_score":0.62575847},"labels":[],"label_agreement":null},{"id":"W3131215855","doi":"10.1016/j.jval.2018.09.2182","title":"PRM60 - THE BURDEN OF OSTEOPOROSIS IN FOUR LATIN AMERICAN COUNTRIES: BRAZIL, MEXICO, COLOMBIA, AND ARGENTINA.","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Latin Americans; Medicine; Osteoporosis; Environmental health; Demography; Geography; Political science","score_opus":0.04729401005202691,"score_gpt":0.3283814925033479,"score_spread":0.281087482451321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131215855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95977646,0.00028359646,0.000008582572,0.0390221,0.00007442974,0.00036209912,0.000004582263,0.000008825994,0.00045929584],"genre_scores_gemma":[0.9960865,0.00043102162,0.00035517273,0.0028576087,0.00013124516,0.00000917423,0.0000014839108,0.000002584216,0.00012523473],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986937,0.00018288674,0.0003748082,0.00019460983,0.00027017182,0.0002838436],"domain_scores_gemma":[0.9991936,0.0003536446,0.00015442012,0.000116731564,0.00003390172,0.00014768056],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014548303,0.000069882386,0.00030073008,0.00004784656,0.000059955844,0.000006096371,0.0001064474,0.000043130512,0.00014625855],"category_scores_gemma":[0.0005536794,0.000035782858,0.000019771433,0.00047722663,0.00093232933,0.000018677823,0.000047053058,0.00013667087,0.000007708751],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016185493,0.000119709046,0.9750431,0.0002070914,0.000005752126,0.000007845466,0.003951816,0.000014577707,0.00046631167,0.00086611527,0.0016176624,0.017538171],"study_design_scores_gemma":[0.00095667766,0.0035475076,0.96624696,0.00038925948,0.0000062369195,0.000009130937,0.0022482136,0.0046320898,0.00022790351,0.0015973998,0.020045657,0.00009295648],"about_ca_topic_score_codex":0.0330684,"about_ca_topic_score_gemma":0.0005870832,"teacher_disagreement_score":0.036309987,"about_ca_system_score_codex":0.00004079044,"about_ca_system_score_gemma":0.00018146275,"threshold_uncertainty_score":0.9733705},"labels":[],"label_agreement":null},{"id":"W3131565960","doi":"10.1016/j.jval.2016.03.1598","title":"A Global Economic Model to Assess the Cost Effectiveness of New Treatments for Advanced Breast Cancer in Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hôpital Notre-Dame; Université de Montréal","funders":"","keywords":"Medicine; Lapatinib; Letrozole; Anastrozole; Breast cancer; Context (archaeology); Cost effectiveness; Quality-adjusted life year; Pharmacoeconomics; Oncology; Tamoxifen; Internal medicine; Quality of life (healthcare); Economic evaluation; Cancer; Trastuzumab; Intensive care medicine; Risk analysis (engineering)","score_opus":0.07840256884304636,"score_gpt":0.322367131382007,"score_spread":0.24396456253896065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131565960","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98123115,0.0011304092,0.005449755,0.0038629181,0.0006088219,0.0015533847,0.0056498908,0.00000540819,0.0005082706],"genre_scores_gemma":[0.99838114,0.0006030666,0.00022500509,0.0003677047,0.000051795596,0.00025739308,0.000002461165,0.000017664552,0.00009378326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847156,0.000030422454,0.0006794352,0.0003513481,0.000022279233,0.0004449675],"domain_scores_gemma":[0.9990462,0.00021014907,0.0003204873,0.0002481813,0.00001569729,0.0001592511],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061496795,0.00014868409,0.00056035916,0.00008404084,0.000035448484,0.000010081133,0.00023088469,0.000045875284,0.000027461201],"category_scores_gemma":[0.000049769315,0.000121055025,0.000056870285,0.00013206714,0.000019728324,0.00017555464,0.000030310464,0.000042163352,0.000008241519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00041692893,0.000036197278,0.55679464,0.0000796231,0.000028901468,4.2978704e-7,0.00009033957,0.3586731,0.0000041916487,0.04675599,0.00042514657,0.03669455],"study_design_scores_gemma":[0.003691847,0.00010135181,0.94632936,0.00036321464,0.0000031438403,0.0000015463662,0.000027352851,0.019589474,0.000034862485,0.028015474,0.0016036982,0.00023869007],"about_ca_topic_score_codex":0.94922704,"about_ca_topic_score_gemma":0.8524715,"teacher_disagreement_score":0.3895347,"about_ca_system_score_codex":0.009201899,"about_ca_system_score_gemma":0.0036060729,"threshold_uncertainty_score":0.9946016},"labels":[],"label_agreement":null},{"id":"W3131646276","doi":"10.1016/j.jval.2012.03.483","title":"PMH38 Cost-Effectiveness of Asenapine in the Treatment of Schizophrenia in Canada","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Asenapine; Olanzapine; Quetiapine; Medicine; Schizophrenia (object-oriented programming); Psychiatry; Lurasidone; Antipsychotic; Clozapine","score_opus":0.4165838611011524,"score_gpt":0.42392985867867783,"score_spread":0.007345997577525409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3131646276","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851262,0.0083009275,0.000038598766,0.0041039996,0.00035824548,0.0016367051,0.00020076576,0.0000026884627,0.00023185714],"genre_scores_gemma":[0.9980466,0.00076000835,0.00026663896,0.0006457401,0.0000664798,0.00018079256,0.000016558819,0.000012156672,0.0000050763038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942445,0.0017016712,0.0032751018,0.00023242815,0.00009012862,0.00045613822],"domain_scores_gemma":[0.9957488,0.002562424,0.001206466,0.00036914353,0.000016375056,0.00009680308],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019896442,0.00012700929,0.001009121,0.0003600655,0.000027871249,0.0000041567414,0.00016891476,0.000055971497,0.00003307797],"category_scores_gemma":[0.000664655,0.00012599194,0.00004639214,0.0004095368,0.000030147665,0.00013487223,0.00001057251,0.000108422755,0.000019473655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006713159,0.0004968798,0.957888,0.0009815183,0.000011439403,9.3431885e-7,0.0034356734,0.0067472546,0.0000010006263,0.02955376,0.00013861457,0.00067778584],"study_design_scores_gemma":[0.002202109,0.00020267737,0.98618346,0.000334351,0.0000011404555,0.0000016612441,0.0013357517,0.004285868,0.000021856413,0.0016018923,0.0037025192,0.0001267311],"about_ca_topic_score_codex":0.9727667,"about_ca_topic_score_gemma":0.7490085,"teacher_disagreement_score":0.22375822,"about_ca_system_score_codex":0.003978007,"about_ca_system_score_gemma":0.0014767875,"threshold_uncertainty_score":0.99984556},"labels":[],"label_agreement":null},{"id":"W3132387454","doi":"10.1016/j.jval.2015.09.978","title":"Economic Analysis of Paliperidone Long-Acting Acting Injectable for Chronic Schizophrenia in Portugal","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Paliperidone Palmitate; Medicine; Paliperidone; Risperidone; Cost effectiveness; Schizophrenia (object-oriented programming); Psychiatry","score_opus":0.16933871207313145,"score_gpt":0.4292288433559895,"score_spread":0.25989013128285804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132387454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99120265,0.0043057506,0.00010657369,0.0029057486,0.00020415499,0.0004617018,0.000014119681,0.00001557591,0.00078373216],"genre_scores_gemma":[0.99784684,0.0006989989,0.00097493327,0.00021480316,0.00018627856,0.000024499353,0.0000155131,0.000013196207,0.000024949015],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9985044,0.00011477773,0.00062433805,0.0002402534,0.0001243567,0.00039187114],"domain_scores_gemma":[0.998764,0.00054524216,0.00031872257,0.00015200107,0.00003429405,0.00018573237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020108903,0.00010739292,0.00063755893,0.00028492094,0.000048319285,0.00000901041,0.00006257646,0.000052738167,0.00004616349],"category_scores_gemma":[0.0005005403,0.000100700185,0.00009091676,0.00052254327,0.000026588767,0.0001280613,0.000042185766,0.00024261356,0.0000035374003],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004197286,0.00046947063,0.7525661,0.0020154421,0.0012269309,0.00003263287,0.0035802813,0.11617465,0.00036071893,0.00059269666,0.0002747536,0.11850904],"study_design_scores_gemma":[0.015387851,0.0024370889,0.15838741,0.0009374141,0.001036293,0.000022789187,0.0040305844,0.7926926,0.0013746448,0.0003151118,0.022843411,0.0005348203],"about_ca_topic_score_codex":0.018193338,"about_ca_topic_score_gemma":0.0031625996,"teacher_disagreement_score":0.6765179,"about_ca_system_score_codex":0.0008616944,"about_ca_system_score_gemma":0.0007507826,"threshold_uncertainty_score":0.9883446},"labels":[],"label_agreement":null},{"id":"W3132455626","doi":"10.1016/j.jval.2015.09.736","title":"Budget Impact Analysis Of Bioabsorbable Drug-Eluting Sinus Implants For Endoscopic Sinus Surgery","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Population; Otorhinolaryngology; Chronic rhinosinusitis; Endoscopic sinus surgery; Surgery; Emergency medicine; Environmental health","score_opus":0.4296458436844888,"score_gpt":0.4445677761171849,"score_spread":0.014921932432696072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132455626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817072,0.0061906935,0.0012825591,0.0068334844,0.0008458919,0.0010351415,0.0016172251,0.00004357408,0.00044423918],"genre_scores_gemma":[0.99456984,0.0001576813,0.0027579628,0.0018912528,0.00019325566,0.00008003519,0.00017804546,0.000038919196,0.00013300768],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99173206,0.00066804606,0.0059733903,0.00061852334,0.00014013385,0.0008678172],"domain_scores_gemma":[0.9909948,0.0041896533,0.0036707385,0.00060764863,0.00011246021,0.00042466668],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.038009163,0.00024008284,0.0024302346,0.0019138117,0.0001230735,0.00004549545,0.00025751232,0.00013720676,0.000070168164],"category_scores_gemma":[0.006087424,0.00029366353,0.00038247742,0.0012901966,0.00005380181,0.0003143747,0.000042715154,0.000154962,0.00011611151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000060264356,0.00022799727,0.90784377,0.0012870978,0.0004890353,0.0000030743558,0.004224333,0.05208673,0.000001799584,0.008093349,0.025329627,0.00035294087],"study_design_scores_gemma":[0.0048447046,0.00062524475,0.48508298,0.00095993583,0.0001552614,0.00002828193,0.0045947176,0.45551944,0.00005124119,0.02684196,0.019856969,0.0014392419],"about_ca_topic_score_codex":0.07169881,"about_ca_topic_score_gemma":0.0010718964,"teacher_disagreement_score":0.42276075,"about_ca_system_score_codex":0.0017810834,"about_ca_system_score_gemma":0.0013821203,"threshold_uncertainty_score":0.99995154},"labels":[],"label_agreement":null},{"id":"W3140219234","doi":"10.1016/j.jval.2017.08.637","title":"Resource Utilization And Disaggregated Cost Analysis For Initial Treatment Of Melanoma","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cancer Care Ontario; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"","keywords":"Melanoma; Resource (disambiguation); Computer science; Resource use; Natural resource economics; Economics; Medicine; Cancer research; Computer network","score_opus":0.22265516802860844,"score_gpt":0.4504007556636089,"score_spread":0.22774558763500044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3140219234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99481857,0.00092798827,0.00024263638,0.0020184573,0.00002613522,0.0012567724,0.0000479295,0.00000965535,0.00065187784],"genre_scores_gemma":[0.99784106,0.0010289015,0.00021706092,0.0000423717,0.00006124803,0.000044942914,0.00008901087,0.000011557209,0.00066384714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99915314,0.00009598147,0.00024877305,0.0001723525,0.0001477473,0.00018200812],"domain_scores_gemma":[0.9991753,0.0001582725,0.00014531681,0.0003616681,0.000047959384,0.000111495545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039328958,0.00006922296,0.0003451862,0.00021408085,0.00010902854,0.000015044458,0.000048780264,0.00004666654,0.00007296456],"category_scores_gemma":[0.00014736786,0.000057635003,0.000063620435,0.00016264759,0.00008080572,0.000026475404,0.000013724626,0.000038144855,5.578325e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025394985,0.0005721166,0.5959721,0.00045745712,0.00047055856,0.000014889756,0.0026187806,0.00034800344,0.00096426375,0.00038061527,0.00007135589,0.39559034],"study_design_scores_gemma":[0.014287174,0.006350886,0.81099033,0.00033380502,0.0003524904,0.000016394966,0.00045985432,0.10539953,0.008293555,0.00025543323,0.053079065,0.00018149358],"about_ca_topic_score_codex":0.005490328,"about_ca_topic_score_gemma":0.00038768558,"teacher_disagreement_score":0.39540884,"about_ca_system_score_codex":0.00019170473,"about_ca_system_score_gemma":0.00015109092,"threshold_uncertainty_score":0.82997704},"labels":[],"label_agreement":null},{"id":"W3143265745","doi":"10.1016/j.jval.2012.06.014","title":"State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force-3","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":491,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Context (archaeology); Computer science; Guideline; Health care; Management science; Decision model; Risk analysis (engineering); Medicine; Engineering; Machine learning; Political science","score_opus":0.7140652159236576,"score_gpt":0.5232955978891705,"score_spread":0.1907696180344871,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3143265745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.917584,0.0058217286,0.02228037,0.050132114,0.0008026932,0.0016004614,0.00012940919,0.000033581036,0.0016156326],"genre_scores_gemma":[0.9944297,0.0005241476,0.0024860764,0.0018671178,0.00031593305,0.000099090335,0.000021875365,0.000040402716,0.00021562524],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9905951,0.001813657,0.005763946,0.0005444829,0.0003346782,0.00094810594],"domain_scores_gemma":[0.9937195,0.0010855463,0.0038649475,0.00089368894,0.00017732546,0.00025899493],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.09546572,0.00016736731,0.000817205,0.00050348946,0.0003298167,0.000042995856,0.00036197848,0.00015498296,0.000037285638],"category_scores_gemma":[0.0066126254,0.00017810806,0.00012231123,0.00058522157,0.0000637369,0.0009212041,0.00007592771,0.00061093166,0.00013010597],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044010314,0.0003635669,0.043377392,0.0017320575,0.0000380416,0.0000017932623,0.0221363,0.8674926,0.000007764786,0.06366261,0.0010585157,0.000085319545],"study_design_scores_gemma":[0.0004142207,0.00006614336,0.0011921421,0.00031255832,0.0000025342094,0.000024716202,0.0028251715,0.96213317,0.000004634593,0.030408809,0.0024408158,0.00017506335],"about_ca_topic_score_codex":0.0527199,"about_ca_topic_score_gemma":0.00039182522,"teacher_disagreement_score":0.09464056,"about_ca_system_score_codex":0.0011021309,"about_ca_system_score_gemma":0.000908854,"threshold_uncertainty_score":0.9535881},"labels":[],"label_agreement":null},{"id":"W3146682687","doi":"10.1016/j.jval.2021.01.003","title":"Response Mapping Methods to Estimate the EQ-5D-5L From the Western Ontario McMaster Universities Osteoarthritis in Patients With Hip or Knee Osteoarthritis","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"European Regional Development Fund; Instituto de Salud Carlos III","keywords":"Osteoarthritis; Medicine; Physical therapy; Physical medicine and rehabilitation; Alternative medicine; Pathology","score_opus":0.24094120553758566,"score_gpt":0.3887095910785677,"score_spread":0.147768385540982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3146682687","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9405894,0.0017448091,0.0012001098,0.053784717,0.0005566797,0.0014657008,0.00034409252,0.000027953603,0.00028648652],"genre_scores_gemma":[0.8089345,0.00011003477,0.08300526,0.09677907,0.00042563898,0.0005281385,0.00019766662,0.0001975789,0.009822119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917979,0.003871446,0.002740038,0.00072383985,0.00017145801,0.0006953154],"domain_scores_gemma":[0.992929,0.005036366,0.0009843132,0.00076015363,0.000081498925,0.00020870181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015536841,0.00026411362,0.0009756154,0.0002948973,0.0003367559,0.00016880708,0.00038568478,0.00012651006,0.00040103885],"category_scores_gemma":[0.0014545574,0.00023008599,0.00007490476,0.00057174056,0.000088141605,0.00040067759,0.00017717271,0.00045778256,0.00027259268],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010023186,0.000121703524,0.9156265,0.00015234128,0.00004203295,0.000022863465,0.06607667,0.0050728433,7.5512673e-7,0.001526641,0.0012866947,0.009068615],"study_design_scores_gemma":[0.0037361481,0.0007261904,0.88643384,0.0010513759,0.0000037317477,0.000007318415,0.009471225,0.0004326034,0.000002439935,0.00092853216,0.09685376,0.00035286476],"about_ca_topic_score_codex":0.13194385,"about_ca_topic_score_gemma":0.18814343,"teacher_disagreement_score":0.13165496,"about_ca_system_score_codex":0.0025034146,"about_ca_system_score_gemma":0.0016395658,"threshold_uncertainty_score":0.9382634},"labels":[],"label_agreement":null},{"id":"W3153029604","doi":"10.1016/j.jval.2021.01.002","title":"Critical Appraisal of Systematic Reviews With Costs and Cost-Effectiveness Outcomes: An ISPOR Good Practices Task Force Report","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":107,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"University of Sheffield; Pfizer","keywords":"Systematic review; Critical appraisal; Cost effectiveness; Task force; Psychological intervention; Outcomes research; Cost–benefit analysis; Management science; Task (project management); Comparative effectiveness research; Computer science; Health economics; Health care; Risk analysis (engineering); Medicine; MEDLINE; Alternative medicine; Economics; Nursing; Management; Political science","score_opus":0.5460033851608647,"score_gpt":0.5349296484122177,"score_spread":0.011073736748646978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3153029604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87883323,0.052786432,0.0148756495,0.03605724,0.0020424053,0.01292427,0.00041670527,0.00009579428,0.0019682695],"genre_scores_gemma":[0.9847289,0.0013133362,0.009375557,0.0031419413,0.00013056514,0.0010582888,0.00006731905,0.000060698272,0.00012344998],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9878428,0.0042583076,0.0064535374,0.00081272103,0.0001674315,0.00046517557],"domain_scores_gemma":[0.9759253,0.0155366715,0.0070208726,0.00097615935,0.00018844458,0.00035251293],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.054585546,0.00024348377,0.0027756465,0.00024566587,0.00012769997,0.00007898072,0.0001807524,0.00013457549,0.000029485735],"category_scores_gemma":[0.078626566,0.00024509785,0.0000895718,0.00034239006,0.000099320176,0.0007852193,0.000046701258,0.0002588787,0.000054591394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006106306,0.0007255549,0.5624694,0.22042078,0.000110208224,0.00007776464,0.0033666005,0.00047120164,0.0000046913938,0.21183082,0.0003259136,0.00013597832],"study_design_scores_gemma":[0.0104897255,0.0034704744,0.7601473,0.09684713,0.00020639652,0.0032817095,0.023455739,0.051275354,0.00004579985,0.014661797,0.0329428,0.0031758286],"about_ca_topic_score_codex":0.0057472875,"about_ca_topic_score_gemma":0.0006037968,"teacher_disagreement_score":0.19767784,"about_ca_system_score_codex":0.00064815435,"about_ca_system_score_gemma":0.0007303388,"threshold_uncertainty_score":0.99947995},"labels":[],"label_agreement":null},{"id":"W3160886066","doi":"10.1016/j.jval.2021.03.003","title":"“Looking Under the Hood” of Anchor-Based Assessment of Clinically Important Change: A Machine Learning Approach","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Attribution; Quality of life (healthcare); Psychology; Baseline (sea); Clinical psychology; Medicine; Gerontology; Social psychology","score_opus":0.10079346617120334,"score_gpt":0.38964103719680804,"score_spread":0.2888475710256047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3160886066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.973781,0.010358281,0.004100541,0.0089280335,0.00041716,0.0008638373,0.000028993021,0.000034892575,0.0014872573],"genre_scores_gemma":[0.99535835,0.0006619669,0.0020013638,0.0017307274,0.0001133025,0.0000341786,0.0000453105,0.000019143548,0.000035665194],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997711,0.00047241367,0.00095154106,0.00023729523,0.00039406147,0.00023365748],"domain_scores_gemma":[0.99871147,0.00028150264,0.0004565787,0.00034699184,0.00011188504,0.00009155616],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025341637,0.000103627106,0.00046933367,0.0000764709,0.00004253256,0.0000049319697,0.000081883845,0.00006785708,0.000040984673],"category_scores_gemma":[0.00013247051,0.00007619997,0.00012066295,0.0004341493,0.000050811756,0.000018545628,0.00004020336,0.00049278594,2.0452447e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013854593,0.0005780511,0.9803431,0.0022914167,0.000056780962,0.000021556556,0.0025287948,0.005584863,0.00030729358,0.0019921944,0.00002128167,0.0061361254],"study_design_scores_gemma":[0.006448752,0.0029125577,0.68376803,0.003327261,0.00015809706,0.000067511035,0.010755099,0.28737155,0.0006855592,0.00048651354,0.0036317792,0.00038731183],"about_ca_topic_score_codex":0.008811906,"about_ca_topic_score_gemma":0.0006999837,"teacher_disagreement_score":0.29657507,"about_ca_system_score_codex":0.00013502887,"about_ca_system_score_gemma":0.0013201406,"threshold_uncertainty_score":0.9977885},"labels":[],"label_agreement":null},{"id":"W3161848643","doi":"10.1016/j.jval.2021.02.011","title":"Bias Assessment in Outcomes Research: The Role of Relative Versus Absolute Approaches","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Reliability and Agreement in Measurement","field":"Decision Sciences","cited_by":29,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"Qatar National Research Fund; Fonds National de la Recherche Luxembourg; Australian National University; Qatar Foundation","keywords":"Consistency (knowledge bases); Independence (probability theory); Statistics; Scale (ratio); Relative value; Intraclass correlation; Econometrics; Quality (philosophy); Psychology; Mathematics; Computer science; Artificial intelligence; Psychometrics; Geography","score_opus":0.8214349676296412,"score_gpt":0.5378024960010247,"score_spread":0.2836324716286165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3161848643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9404354,0.0021835808,0.00013096386,0.0346331,0.0005265034,0.0008538275,0.000012077556,0.000008981463,0.021215549],"genre_scores_gemma":[0.99749106,0.0001597937,0.0018869718,0.00010040933,0.000022057218,0.00003762318,0.0000016174664,0.00000523993,0.00029519742],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9889509,0.0057198326,0.001276462,0.00050404796,0.00309403,0.0004547051],"domain_scores_gemma":[0.98822504,0.010273624,0.00026890045,0.0008696183,0.0002789708,0.000083825325],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.046520896,0.00010190754,0.0003727464,0.00027916604,0.00015256005,0.00007057689,0.00062378775,0.000061406456,0.000091948044],"category_scores_gemma":[0.008858708,0.000060754865,0.00009629849,0.0017889059,0.00018090085,0.000157542,0.00024474206,0.0006471804,0.00003329663],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013263733,0.0009929192,0.754216,0.000064990214,0.000038345046,0.000010725178,0.015360805,0.03518652,0.00005439245,0.14959,0.00065439293,0.043698248],"study_design_scores_gemma":[0.0011829353,0.00030252017,0.6536033,0.00016323345,0.0000026584353,6.2666516e-7,0.04187143,0.019431397,0.00021525755,0.27353066,0.009577093,0.000118895114],"about_ca_topic_score_codex":0.0031390954,"about_ca_topic_score_gemma":0.0013369379,"teacher_disagreement_score":0.12394065,"about_ca_system_score_codex":0.00042834162,"about_ca_system_score_gemma":0.0010868073,"threshold_uncertainty_score":0.9994901},"labels":[],"label_agreement":null},{"id":"W3163746986","doi":"10.1016/j.jval.2021.01.007","title":"The Functional Assessment of Cancer Therapy Eight Dimension (FACT-8D), a Multi-Attribute Utility Instrument Derived From the Cancer-Specific FACT-General (FACT-G) Quality of Life Questionnaire: Development and Australian Value Set","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":36,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Simon Fraser University","funders":"National Health and Medical Research Council; EuroQol Research Foundation; Australian Government","keywords":"Quality of life (healthcare); Worry; Logit; Valuation (finance); EQ-5D; Descriptive statistics; Medicine; Population; Psychology; Actuarial science; Statistics; Econometrics; Psychiatry; Nursing; Health related quality of life; Disease; Anxiety; Economics","score_opus":0.5490412816647725,"score_gpt":0.455468135442835,"score_spread":0.09357314622193752,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3163746986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92032874,0.02452948,0.001284715,0.050208814,0.0010892967,0.00100524,0.0015285327,0.000016427786,0.000008729884],"genre_scores_gemma":[0.98071474,0.012589288,0.0036990528,0.0023317537,0.00016373194,0.00025167826,0.00014906212,0.00002545852,0.00007525116],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9908827,0.002307343,0.0051413435,0.0007981106,0.0003351262,0.00053540606],"domain_scores_gemma":[0.9942166,0.0015901242,0.0030241169,0.0007115946,0.0001933613,0.00026420428],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013746958,0.00030336058,0.0011945524,0.00010494326,0.0005153367,0.00007003618,0.00029245045,0.00016996409,0.00025466506],"category_scores_gemma":[0.00066743884,0.00026013315,0.00013087824,0.0002991883,0.00019581098,0.00020158515,0.00011116297,0.0003818455,0.0000124524195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052195384,0.00025378214,0.97947454,0.00029149602,0.00019123364,3.2380768e-7,0.004494997,0.0041948515,0.00006824535,0.0071256156,0.0014869273,0.002365761],"study_design_scores_gemma":[0.0016993162,0.000045375906,0.97486526,0.00026330433,0.0000037679329,5.307474e-7,0.0011369318,0.0069317576,0.00028658833,0.0005982934,0.013934546,0.0002343374],"about_ca_topic_score_codex":0.08928064,"about_ca_topic_score_gemma":0.0071329502,"teacher_disagreement_score":0.082147695,"about_ca_system_score_codex":0.0016481462,"about_ca_system_score_gemma":0.0023671736,"threshold_uncertainty_score":0.9999851},"labels":[],"label_agreement":null},{"id":"W3165898648","doi":"10.1016/j.jval.2021.04.1053","title":"PRO68 Patient-Reported Outcomes in Patients with Pemphigus Vulgaris Treated with Rituximab in the Phase 3 PEMPHIX Study","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune Bullous Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Rituximab; Medicine; Internal medicine; Pemphigus vulgaris; Dermatology Life Quality Index; Prednisone; Quality of life (healthcare); Gastroenterology; Adverse effect; Dermatology; Disease; Lymphoma","score_opus":0.024645869739995482,"score_gpt":0.3074965499189303,"score_spread":0.2828506801789348,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165898648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336207,0.00046604572,0.000002617529,0.0014064166,0.00004800169,0.0045213206,0.00002247195,0.00006311485,0.000107913664],"genre_scores_gemma":[0.9984907,0.000016490876,0.00015325054,0.0007285006,0.000011684787,0.00033220177,0.0001511916,0.00005466796,0.00006130802],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99596167,0.00080928206,0.0010608794,0.0006311077,0.0009085394,0.00062849576],"domain_scores_gemma":[0.9981667,0.0002086549,0.0003719552,0.0009126895,0.0001899867,0.00015005829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059277884,0.00034384223,0.00093177677,0.00037318718,0.00009206978,0.000029322482,0.00015378915,0.000072145536,0.00004125844],"category_scores_gemma":[0.00040971496,0.00020881776,0.00005425349,0.0014210452,0.00007699807,0.00010057643,0.000052764357,0.00046644371,0.0000073755596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020919775,0.039497707,0.947058,0.00015000039,0.00008108319,0.00214682,0.0068088295,0.0001491337,9.048032e-7,0.000006138147,0.000047872956,0.0019614813],"study_design_scores_gemma":[0.05142497,0.006154551,0.93739945,0.00054555445,0.000072614836,0.000040796465,0.0038881123,0.00016416065,0.000011558037,0.000012077226,0.00007693181,0.00020921508],"about_ca_topic_score_codex":0.01293706,"about_ca_topic_score_gemma":0.001473407,"teacher_disagreement_score":0.04933299,"about_ca_system_score_codex":0.0004969722,"about_ca_system_score_gemma":0.001306157,"threshold_uncertainty_score":0.9936359},"labels":[],"label_agreement":null},{"id":"W3165914463","doi":"10.1016/j.jval.2021.04.1210","title":"SM1 The Random Effects Warfarin Days' Supply (REWARDS) Model: Development and Validation of a NOVEL Method to Estimate Exposure to Warfarin Using Administrative Data","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Intraclass correlation; Warfarin; Medical prescription; Medicine; Statistics; Dosing; Mean squared error; Population; Correlation coefficient; Random effects model; Linear regression; Mathematics; Pearson product-moment correlation coefficient; Econometrics; Internal medicine; Pharmacology","score_opus":0.2910005260188193,"score_gpt":0.47007499112169027,"score_spread":0.17907446510287095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3165914463","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49558395,0.0003062108,0.49768233,0.005144792,0.0000644169,0.0011160461,0.000022337748,0.000014212946,0.00006572233],"genre_scores_gemma":[0.47755688,0.000022204904,0.5207409,0.0013892491,0.000022553228,0.000067785426,0.00006515638,0.000011962482,0.00012327882],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9981512,0.0002751368,0.00054875755,0.00042521564,0.00036015594,0.00023952882],"domain_scores_gemma":[0.9985048,0.00039321653,0.00014970115,0.0005950499,0.0001188239,0.00023839231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019178255,0.00013456291,0.00040222533,0.000080759666,0.000085807966,0.000016380585,0.0001870242,0.000048808022,0.000013961418],"category_scores_gemma":[0.00071799103,0.00010444415,0.00001735789,0.00040581275,0.000023343744,0.000066937566,0.0001767202,0.0001632876,0.0000064000064],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033751484,0.002798756,0.032832492,0.010077799,0.000437845,0.00013804328,0.076597586,0.49606776,0.11268333,0.0078929,0.0029899506,0.2541084],"study_design_scores_gemma":[0.007768224,0.0006875489,0.02256811,0.0043013333,0.00008366785,0.00017172493,0.0013103539,0.8714816,0.088701524,0.00034956445,0.0022237976,0.0003525615],"about_ca_topic_score_codex":0.00048889435,"about_ca_topic_score_gemma":0.000035394656,"teacher_disagreement_score":0.37541384,"about_ca_system_score_codex":0.000107717424,"about_ca_system_score_gemma":0.0019498756,"threshold_uncertainty_score":0.4259109},"labels":[],"label_agreement":null},{"id":"W3166447425","doi":"10.1016/j.jval.2021.04.081","title":"PBI10 Economic Impact of Originator-to-Biosimilar Non-Medical Switching on Health Care Resource Utilization in Rheumatic Patients in Quebec, Canada","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Biosimilar; Medicine; Psoriatic arthritis; Productivity; Health care; Rheumatoid arthritis; Indirect costs; Emergency medicine; Family medicine; Business; Accounting; Internal medicine","score_opus":0.021976219381300247,"score_gpt":0.3289181174072616,"score_spread":0.3069418980259614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166447425","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924574,0.0015718195,0.000028766932,0.004983937,0.00035936036,0.0004143032,0.00006759385,0.0000071837794,0.00010965515],"genre_scores_gemma":[0.9968699,0.0003066326,0.00016945812,0.0025037052,0.000010522933,0.0000076181755,0.000081810234,0.000015689084,0.000034649667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968834,0.0010941444,0.0009753735,0.0003914766,0.00009909286,0.0005565175],"domain_scores_gemma":[0.9989399,0.000402385,0.00021230176,0.00027506516,0.000034800043,0.00013558855],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010000148,0.00018151845,0.0006478568,0.00026732948,0.000055531615,0.0000069747553,0.00018036495,0.00023244036,0.00015459469],"category_scores_gemma":[0.0004501947,0.00016325469,0.00006317794,0.0004034126,0.000033949746,0.000032894724,0.00006303031,0.0005164694,0.0000050866356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0007404699,0.0012278856,0.79128116,0.0020628409,0.00011868654,0.00006941646,0.009626451,0.0153634,0.00017559832,0.0011762673,0.02147154,0.1566863],"study_design_scores_gemma":[0.005800298,0.0015694018,0.9648398,0.004803366,0.000007845357,0.000009943619,0.0024444885,0.004440087,0.0014125274,0.00016890823,0.013912658,0.0005906507],"about_ca_topic_score_codex":0.9357038,"about_ca_topic_score_gemma":0.9459985,"teacher_disagreement_score":0.17355868,"about_ca_system_score_codex":0.0039798743,"about_ca_system_score_gemma":0.0072523993,"threshold_uncertainty_score":0.99984366},"labels":[],"label_agreement":null},{"id":"W3166552977","doi":"10.1016/j.jval.2021.04.1112","title":"PSS11 Comparing Patient's Compliance and Persistence on Prostaglandin Analogs Using Real-World Utilization Databases for the Treatment of OPEN-Angle Glaucoma or Ocular Hypertension.","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Latanoprost; Travoprost; Bimatoprost; Medicine; Glaucoma; Intraocular pressure; Prostaglandin analogue; Persistence (discontinuity); Ophthalmology; Database","score_opus":0.3786091611457831,"score_gpt":0.4009362327950256,"score_spread":0.022327071649242525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166552977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99344003,0.0034994513,0.00028132318,0.0011450602,0.00008956314,0.0014281296,0.00003504916,0.00000885371,0.000072512776],"genre_scores_gemma":[0.9928534,0.002706159,0.0038319735,0.00037744973,0.000017715636,0.000029333141,0.00009342319,0.000014134906,0.00007642266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894893,0.00011091837,0.0003205623,0.0002717953,0.000145972,0.0002018229],"domain_scores_gemma":[0.99915224,0.0002743837,0.0001367337,0.00027427982,0.000086827524,0.00007553161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015241509,0.000115486415,0.00038409437,0.000074319534,0.00018911701,0.000016907086,0.000058537353,0.000019384866,0.000007652075],"category_scores_gemma":[0.00008015484,0.000070513306,0.000042934054,0.0003205595,0.00006563696,0.000049185568,0.000037290953,0.000050734383,3.629951e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017255723,0.0016029319,0.9822531,0.0012139658,0.000068980495,0.00008274694,0.0015635762,0.0005397415,0.00057004765,0.0014358282,0.00016148109,0.008782034],"study_design_scores_gemma":[0.0047971215,0.0030367926,0.6987864,0.0029703756,0.00012485137,0.000104150444,0.0038632508,0.27937052,0.0010687077,0.00006971656,0.0056429957,0.00016513123],"about_ca_topic_score_codex":0.008544589,"about_ca_topic_score_gemma":0.0018949242,"teacher_disagreement_score":0.2834667,"about_ca_system_score_codex":0.00014087987,"about_ca_system_score_gemma":0.00023377416,"threshold_uncertainty_score":0.9980576},"labels":[],"label_agreement":null},{"id":"W3166565630","doi":"10.1016/j.jval.2021.04.802","title":"PND18 BoNT-As for Adult Spasticity and Cervical Dystonia: Cost-Effectiveness Analysis and the Cost of Response in the United Kingdom","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Cervical dystonia; Spasticity; Medicine; Observational study; Dosing; Cost effectiveness; Physical therapy; Emergency medicine; Internal medicine; Botulinum toxin; Surgery","score_opus":0.06328015375340351,"score_gpt":0.3558874872140535,"score_spread":0.29260733346065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166565630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96752834,0.0006206329,0.0006424165,0.029590815,0.00003338316,0.0015348268,0.0000132752175,0.0000082516535,0.000028063918],"genre_scores_gemma":[0.9935039,0.0007120723,0.000074365926,0.005583475,0.000009989931,0.00009010093,0.000012020871,0.0000075162084,0.0000065261647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963938,0.0025939671,0.00035612378,0.0002583492,0.00016599393,0.00023179332],"domain_scores_gemma":[0.99327326,0.0062306756,0.00009200285,0.00020587722,0.00011210647,0.000086081054],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024567929,0.00010805702,0.0004849979,0.00018788154,0.00008569787,0.0000105359195,0.00006478174,0.00013503525,0.00000631737],"category_scores_gemma":[0.0028467576,0.000057452413,0.00008049465,0.0013615605,0.00027066245,0.000014293999,0.000036853828,0.0004070468,4.0373004e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.18327539,0.0036020034,0.6675113,0.005022173,0.0013730649,0.0007667013,0.013057956,0.039197385,0.0013846015,0.07504711,0.00011886027,0.009643496],"study_design_scores_gemma":[0.009891109,0.0008863916,0.92353445,0.0002522379,0.0002594844,0.00006162407,0.0006366765,0.062416755,0.000096994896,0.0014684045,0.0004175256,0.00007836906],"about_ca_topic_score_codex":0.0051155193,"about_ca_topic_score_gemma":0.00037866694,"teacher_disagreement_score":0.25602317,"about_ca_system_score_codex":0.000042481683,"about_ca_system_score_gemma":0.00015288574,"threshold_uncertainty_score":0.7733169},"labels":[],"label_agreement":null},{"id":"W3166773323","doi":"10.1016/j.jval.2021.04.567","title":"PIN7 Qualitative Research Methods to Evaluate Healthcare Provider and Adult Vaccine Recipient Attitudes, Barriers, and Facilitators to Completing the Recombinant Zoster Vaccine Regimen in Canada","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; GlaxoSmithKline (Canada)","funders":"","keywords":"Regimen; Thematic analysis; Qualitative research; Medicine; Family medicine; Health care; Vaccination; Modalities; Immunology; Surgery; Political science","score_opus":0.15326142826965736,"score_gpt":0.5099195613806192,"score_spread":0.35665813311096184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166773323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.86906636,0.002677932,0.00006129025,0.12582712,0.00019785286,0.0020608213,0.000036389563,0.00001091018,0.00006131089],"genre_scores_gemma":[0.98091644,0.00055826886,0.012083317,0.0057693347,0.000037797286,0.00035679678,0.0000189804,0.00003159217,0.00022749376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9920616,0.0053390875,0.0007623741,0.0006566458,0.0004636628,0.0007166004],"domain_scores_gemma":[0.996782,0.0015044054,0.00008365325,0.00043929505,0.00044847614,0.0007421702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007896775,0.00020156753,0.00058767624,0.00027911717,0.00033307172,0.00002834061,0.00006630586,0.000056665496,0.000040179293],"category_scores_gemma":[0.002942583,0.000147364,0.000024536415,0.0011142788,0.000021240698,0.000047891393,0.00017725327,0.00055933144,0.0000043953596],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011957648,0.00031185322,0.6905,0.0022145573,0.00021187023,0.00030545998,0.08692936,0.00029348215,0.00008750675,0.0017449082,0.009863114,0.2063421],"study_design_scores_gemma":[0.010339363,0.0039832154,0.79089236,0.005702443,0.00004700465,0.0002239483,0.08715664,0.0019658972,0.00041946827,0.002159443,0.0964634,0.00064681424],"about_ca_topic_score_codex":0.9300324,"about_ca_topic_score_gemma":0.85058343,"teacher_disagreement_score":0.20569529,"about_ca_system_score_codex":0.0027181546,"about_ca_system_score_gemma":0.003632591,"threshold_uncertainty_score":0.71078795},"labels":[],"label_agreement":null},{"id":"W3166908400","doi":"10.1016/j.jval.2021.04.919","title":"PNS64 Canadian Pricing and Reimbursement: Understanding the Biggest Hurdles in the Payer Landscape","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Negotiation; Alliance; Agency (philosophy); Medicine; Health technology; Orphan drug; Public economics; Business; Actuarial science; Health care; Economics; Political science; Economic growth","score_opus":0.5076952837433918,"score_gpt":0.4032474981015994,"score_spread":0.10444778564179241,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3166908400","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.47561458,0.019027645,0.0007476492,0.49387327,0.00066030637,0.0011236398,0.00010600809,0.000018800441,0.008828099],"genre_scores_gemma":[0.9733174,0.0011704015,0.00026500062,0.02493962,0.00015077615,0.000041113995,0.000014164679,0.000016666196,0.00008487392],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99613285,0.0009274321,0.0019380883,0.00038234578,0.00008378523,0.00053552206],"domain_scores_gemma":[0.99740565,0.0014757937,0.00055327726,0.00039861703,0.000014381315,0.0001522702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022088435,0.00012214594,0.00045076248,0.00033312113,0.00036355137,0.00012354957,0.0002025392,0.000077759825,0.000083527804],"category_scores_gemma":[0.0012739763,0.000108383836,0.0000353587,0.00046479376,0.00004520353,0.00014795423,0.000030274447,0.00029372523,0.00006928129],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000353852,0.000044485194,0.39013293,0.00042609888,0.000017824443,0.00001023566,0.025173074,0.004516866,3.0380076e-7,0.5738714,0.005584316,0.00021893752],"study_design_scores_gemma":[0.002197381,0.00014394171,0.5509458,0.0010547793,0.000007227526,0.00006507524,0.13014619,0.06887599,0.0000014389368,0.12636353,0.11947001,0.00072861824],"about_ca_topic_score_codex":0.28592676,"about_ca_topic_score_gemma":0.25356677,"teacher_disagreement_score":0.4977028,"about_ca_system_score_codex":0.0012806945,"about_ca_system_score_gemma":0.0007645585,"threshold_uncertainty_score":0.7655455},"labels":[],"label_agreement":null},{"id":"W3167334836","doi":"10.1016/j.jval.2021.04.1062","title":"PRO77 Preliminary Characterization of Eculizumab Treatment Patterns, Preceding Disease Triggers and Supportive Therapies in Atypical Hemolytic Uremic Syndrome: A US Claims Database Analysis","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Eculizumab; Atypical hemolytic uremic syndrome; Medicine; Internal medicine; Dialysis; Pediatrics; Intensive care medicine; Immunology; Complement system; Antibody","score_opus":0.02884418536160672,"score_gpt":0.28661492116014775,"score_spread":0.25777073579854104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167334836","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937561,0.0038531362,0.00008604625,0.00044926876,0.000104311024,0.00090713066,0.00082239666,0.000019739118,0.0000018660868],"genre_scores_gemma":[0.9957012,0.0009588636,0.000030929616,0.00005183002,0.000006645757,0.00014086028,0.0030556922,0.0000123860555,0.000041576204],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976586,0.0008331505,0.0006904305,0.00043986915,0.00006313361,0.00031479154],"domain_scores_gemma":[0.999126,0.00018723289,0.00026553727,0.00031890112,0.00003502964,0.00006726141],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002680609,0.0001781228,0.0005513331,0.00030302664,0.00008656338,0.000015698917,0.00008401698,0.000065849265,0.00015020306],"category_scores_gemma":[0.00006371139,0.00016432947,0.00009079678,0.00045871356,0.000061329774,0.000097664466,0.00006789668,0.000101000194,0.000003400042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011820305,0.00091792434,0.9835727,0.00080959074,0.00043434606,0.0001442475,0.0015952617,0.00015420502,0.009574662,0.000050055496,0.00000986904,0.0015551131],"study_design_scores_gemma":[0.0020353757,0.00048435264,0.9927962,0.00066517555,0.00020781673,0.000043237113,0.00060499663,0.0008031524,0.0021396086,0.000029152623,0.00004385468,0.0001470872],"about_ca_topic_score_codex":0.0013730298,"about_ca_topic_score_gemma":0.00020769087,"teacher_disagreement_score":0.009223495,"about_ca_system_score_codex":0.00030968155,"about_ca_system_score_gemma":0.00040235915,"threshold_uncertainty_score":0.6701161},"labels":[],"label_agreement":null},{"id":"W3167365590","doi":"10.1016/j.jval.2021.04.1115","title":"PSS14 Qualitative Exploration of Patient Experiences of Visual Function Impairments and Health-Related Quality of Life Impacts Associated with RLBP1 Retinitis Pigmentosa in a Sample of Canadian Patients","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinopathy of Prematurity Studies","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Retinitis pigmentosa; Quality of life (healthcare); Thematic analysis; Activities of daily living; Visual impairment; Qualitative research; Medicine; Psychology; International Classification of Functioning, Disability and Health; Gerontology; Clinical psychology; Physical therapy; Psychiatry; Rehabilitation; Nursing; Ophthalmology","score_opus":0.11024301667418432,"score_gpt":0.3724507974459393,"score_spread":0.262207780771755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167365590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99703294,0.0009928335,0.000008807229,0.00087764626,0.00007947939,0.0008706455,0.000109269866,0.0000058348446,0.000022541226],"genre_scores_gemma":[0.9990372,0.00027709646,0.00039773915,0.00009200469,0.0000035696432,0.000031187712,0.00014949552,0.000010368081,0.0000013526754],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99550885,0.0015520962,0.001812636,0.0002509683,0.00057505333,0.00030037016],"domain_scores_gemma":[0.9970533,0.0005055176,0.0016006182,0.00014680662,0.00046014998,0.00023359682],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021886444,0.00014232221,0.00096817524,0.0005144923,0.000039506613,0.0000027044266,0.00003368942,0.00008443583,0.000010222319],"category_scores_gemma":[0.0032332237,0.00013137076,0.00004220715,0.0010136111,0.0001535176,0.0001439964,0.000027185422,0.00014530367,8.168863e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005280135,0.0008416622,0.48249185,0.0013539627,0.00007008549,0.0000017889915,0.51401895,0.000054355867,0.000090816255,0.00005593999,0.000022875727,0.00046971388],"study_design_scores_gemma":[0.0029086024,0.0060639963,0.73684335,0.0024713194,0.000010314917,6.1745584e-7,0.25054288,0.00009670425,0.0007763128,0.00020148506,0.0000010613771,0.00008334268],"about_ca_topic_score_codex":0.47459713,"about_ca_topic_score_gemma":0.10415552,"teacher_disagreement_score":0.37044162,"about_ca_system_score_codex":0.00042037087,"about_ca_system_score_gemma":0.0016026187,"threshold_uncertainty_score":0.91219133},"labels":[],"label_agreement":null},{"id":"W3167366760","doi":"10.1016/j.jval.2021.04.1207","title":"SC3 The Drivers of Health State Utilities in Duchenne Muscular Dystrophy (DMD): A Study Using the Health Utilities Index Mark 3 (HUI3)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Cerebral Palsy and Movement Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Centre for Advancing Health Outcomes","funders":"","keywords":"Health Utilities Index; Quality of life (healthcare); Physical therapy; Medicine; Proxy (statistics); Physical medicine and rehabilitation; Ambulatory; Psychology; Audiology; Health related quality of life; Disease; Statistics; Internal medicine","score_opus":0.05910006206190667,"score_gpt":0.32651615608504336,"score_spread":0.2674160940231367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167366760","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96881735,0.008766329,0.00011569345,0.019276751,0.0002831037,0.002571099,0.00004549318,0.000027266216,0.00009691699],"genre_scores_gemma":[0.99227387,0.002244614,0.00018782982,0.0049444786,0.000040718416,0.00004002967,0.000020367514,0.000032934277,0.00021517319],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99421644,0.0022488618,0.0014396097,0.0004961055,0.00069315184,0.0009058327],"domain_scores_gemma":[0.9981437,0.0003102863,0.0004786226,0.0007724522,0.000108989196,0.0001859585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004420836,0.00027951063,0.0009461427,0.00026575348,0.00033809143,0.000026699849,0.00021398871,0.000056469602,0.00006773949],"category_scores_gemma":[0.00020823433,0.00019453821,0.0001488871,0.0009567701,0.00027045078,0.000096872114,0.00013587075,0.0006390345,0.0000015961886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080203504,0.0031745087,0.7769349,0.0058044987,0.00030215166,0.000080601356,0.17168,0.01013897,0.000037469643,0.0020769348,0.0006670008,0.028300885],"study_design_scores_gemma":[0.007164909,0.0027781937,0.55068296,0.0019817718,0.000029658238,0.000022523656,0.42481863,0.0065234187,0.000026753192,0.0019167302,0.0037433505,0.00031107367],"about_ca_topic_score_codex":0.1489294,"about_ca_topic_score_gemma":0.0109292725,"teacher_disagreement_score":0.25313863,"about_ca_system_score_codex":0.0007544131,"about_ca_system_score_gemma":0.0036588078,"threshold_uncertainty_score":0.856738},"labels":[],"label_agreement":null},{"id":"W3167413681","doi":"10.1016/j.jval.2021.04.023","title":"CO3 Comparison of Goal Attainment and Measures of Function in Two Dementia Clinical Trials.","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Goal Attainment Scaling; Dementia; Activities of daily living; Clinical trial; Psychology; Physical therapy; Gerontology; Medicine; Disease; Clinical psychology; Internal medicine; Rehabilitation","score_opus":0.7950828561245876,"score_gpt":0.5748109284433855,"score_spread":0.22027192768120207,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167413681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9616384,0.023840176,0.0026952163,0.009873754,0.0008207304,0.00073151384,0.00009079806,0.000007896166,0.00030154453],"genre_scores_gemma":[0.99559724,0.0010418919,0.001944387,0.0012381048,0.00010983768,0.00002449609,0.000017181253,0.000011729686,0.000015151568],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98306865,0.0042219553,0.011829072,0.00045900742,0.00012775241,0.0002935516],"domain_scores_gemma":[0.9927258,0.003007364,0.0037859718,0.00029874317,0.00005575817,0.00012635546],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.08928895,0.00010849255,0.0019925975,0.00028424925,0.00003975433,0.000012286291,0.00008882669,0.00009348307,0.00008768602],"category_scores_gemma":[0.007905204,0.00013955205,0.00010651429,0.00023307554,0.000064303014,0.00010881136,0.000042524724,0.00020898729,0.000021622584],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000586626,0.00034339327,0.95819205,0.0006867306,0.000050484934,3.2145104e-7,0.0011391155,0.0035336784,0.0000037456837,0.03283048,0.0010649894,0.0020963568],"study_design_scores_gemma":[0.0052630166,0.00044999912,0.9215784,0.000534973,0.000015373515,0.0000016404816,0.0028201435,0.044237815,0.000033770128,0.014665984,0.010170848,0.00022800617],"about_ca_topic_score_codex":0.008347912,"about_ca_topic_score_gemma":0.0017324397,"teacher_disagreement_score":0.08138374,"about_ca_system_score_codex":0.0003099451,"about_ca_system_score_gemma":0.00048048486,"threshold_uncertainty_score":0.9982556},"labels":[],"label_agreement":null},{"id":"W3167593734","doi":"10.1016/j.jval.2021.04.047","title":"HT3 What is Value? A Systematic Review of Value Assessment Frameworks","year":2021,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Context (archaeology); Health care; Value (mathematics); Weighting; Actuarial science; Systematic review; Medicine; Psychology; MEDLINE; Computer science; Business; Political science","score_opus":0.49565166486407897,"score_gpt":0.5230396104214051,"score_spread":0.027387945557326154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167593734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000001467053,0.9695258,0.0010662804,0.01616672,0.0027498328,0.009397637,0.00058839907,0.000051158167,0.0004527188],"genre_scores_gemma":[0.0000021332467,0.95807886,0.0058667907,0.033544075,0.00033755242,0.0014685969,0.00026739342,0.00017486927,0.0002597142],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.958975,0.009243506,0.02820871,0.0018411999,0.0005379011,0.0011936389],"domain_scores_gemma":[0.9691464,0.006686228,0.020569298,0.002874413,0.00019929463,0.0005243753],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07885868,0.00095280475,0.019527555,0.0011660948,0.00018589705,0.00023778909,0.0011764356,0.0013021582,0.0005999806],"category_scores_gemma":[0.008719775,0.0010718366,0.0016165086,0.0015159652,0.00009520265,0.00068573456,0.000247888,0.002117354,0.00097187376],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[4.561001e-7,0.00015964128,0.00001725552,0.91165316,0.0002625652,0.0000039423294,0.0004890771,0.000070644164,3.6003994e-10,0.078309014,0.0059226905,0.00311155],"study_design_scores_gemma":[0.00018840231,0.000075292955,0.0000041759763,0.7380812,0.00017470533,0.000027787215,0.00029890166,0.0011556993,8.086278e-9,0.0023727117,0.2570604,0.00056070095],"about_ca_topic_score_codex":0.0031469378,"about_ca_topic_score_gemma":0.000012678798,"teacher_disagreement_score":0.2511377,"about_ca_system_score_codex":0.00516094,"about_ca_system_score_gemma":0.0051247925,"threshold_uncertainty_score":0.99999434},"labels":[],"label_agreement":null},{"id":"W3167827777","doi":"10.1016/j.jval.2021.04.1222","title":"PIN34 COVID-19 Related Knowledge, Attitude and Practices in a Southeastern City in Nigeria: A Cross-Sectional Survey","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 and Mental Health","field":"Psychology","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Cross-sectional study; Bachelor; Quarter (Canadian coin); Medicine; Psychological intervention; Population; Positive attitude; Family medicine; Demography; Environmental health; Psychology; Geography; Nursing; Social psychology; Disease; Internal medicine; Pathology; Infectious disease (medical specialty)","score_opus":0.26725566002035955,"score_gpt":0.5195720081422702,"score_spread":0.25231634812191067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3167827777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99011195,0.0052574975,0.000021144639,0.0020044441,0.0010543714,0.00058258395,0.00008697772,0.00003901377,0.00084202236],"genre_scores_gemma":[0.9964705,0.00036814847,0.00006317968,0.0020291442,0.00006914681,0.000067392466,0.00006532529,0.000022369162,0.0008447955],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99420524,0.003183682,0.0009879334,0.00079559174,0.00019627194,0.00063126726],"domain_scores_gemma":[0.9969068,0.0019120177,0.00040723145,0.0003365985,0.00004942251,0.00038793441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0061959927,0.0001865276,0.00041935235,0.00035568356,0.00012737248,0.000047123965,0.00013830444,0.0002552059,0.00038368985],"category_scores_gemma":[0.0016359502,0.00020841537,0.00003793086,0.0010064855,0.00009789571,0.00013184598,0.0001147202,0.00071107486,0.00007979726],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004338145,0.0008888953,0.9823359,0.0005718611,0.000011229603,0.00013986311,0.014421362,0.00020418431,0.0000057405705,0.00050893467,0.000044927212,0.000433245],"study_design_scores_gemma":[0.0031227355,0.00015852871,0.9916834,0.00010853677,9.661551e-7,0.00009329658,0.0009555108,0.00032004667,8.970592e-7,0.00058567553,0.0028121981,0.00015815627],"about_ca_topic_score_codex":0.18086013,"about_ca_topic_score_gemma":0.3168264,"teacher_disagreement_score":0.13596627,"about_ca_system_score_codex":0.0013451475,"about_ca_system_score_gemma":0.004542628,"threshold_uncertainty_score":0.84989315},"labels":[],"label_agreement":null},{"id":"W3168057438","doi":"10.1016/j.jval.2021.04.234","title":"PCN142 Patient and Caregiver Preferences in Treatment Decision Making in Multiple Myeloma — Results of a Targeted Literature Review","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"CINAHL; Medicine; Family medicine; Psychology; Nursing; Psychological intervention","score_opus":0.321312210181872,"score_gpt":0.4074328189622541,"score_spread":0.08612060878038208,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168057438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.749068,0.24080081,0.00003518005,0.008277085,0.00019994483,0.0010244058,0.00039648445,0.0000075616945,0.0001904827],"genre_scores_gemma":[0.9297484,0.06401394,0.0039428757,0.0020894692,0.0000276348,0.0000865924,0.000059817907,0.000012759018,0.000018509212],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99380744,0.0008804453,0.0043202853,0.0005820189,0.0000860715,0.00032375514],"domain_scores_gemma":[0.99656904,0.0015246401,0.0013973895,0.0003659704,0.00005185135,0.00009109118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006441271,0.0001589004,0.0011163717,0.00043938667,0.00004133916,0.000023545754,0.000092220114,0.0001138315,0.000022337244],"category_scores_gemma":[0.0039039229,0.00017645485,0.000054303448,0.0006105501,0.000023943887,0.00018572617,0.000044158733,0.00016164705,0.000014483859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036784782,0.0011297037,0.78912115,0.0196827,0.000048331553,0.00008758737,0.09721026,0.009340022,0.000002771755,0.007667918,0.0032254776,0.072116226],"study_design_scores_gemma":[0.0085563855,0.0009812433,0.82397383,0.08575516,0.0000055873297,0.000028266531,0.0040469845,0.036621243,0.000022061704,0.017247943,0.022010256,0.0007510519],"about_ca_topic_score_codex":0.0064271605,"about_ca_topic_score_gemma":0.0055853724,"teacher_disagreement_score":0.18068036,"about_ca_system_score_codex":0.0009998108,"about_ca_system_score_gemma":0.00036965398,"threshold_uncertainty_score":0.9715987},"labels":[],"label_agreement":null},{"id":"W3168253197","doi":"10.1016/j.jval.2021.04.282","title":"PCN191 Cost Associated with Implementation of CAR T-Cell Therapy for the Management of Hematologic Cancers in Canada.","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Gilead Sciences (Canada)","funders":"","keywords":"Health care; Leukapheresis; Audit; Chimeric antigen receptor; Medicine; Cost driver; Unit (ring theory); Business; Operations management; Medical emergency; Immunotherapy; Cancer; Internal medicine; Stem cell; CD34","score_opus":0.07457973308357888,"score_gpt":0.3793339968645089,"score_spread":0.30475426378093007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168253197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99313927,0.0019592622,0.000029668498,0.0024625608,0.000050049945,0.00212582,0.0000467569,0.0000030990198,0.00018353738],"genre_scores_gemma":[0.996201,0.002891567,0.00018292185,0.00035160844,0.00000674256,0.00015524689,0.00003655,0.000012886881,0.00016149698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987274,0.00014809526,0.00036926818,0.0001486676,0.0003346239,0.0002719342],"domain_scores_gemma":[0.99920547,0.00028842883,0.00015937557,0.00019576433,0.00010526659,0.00004571922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072722527,0.00007246656,0.00029289623,0.00006143398,0.000024418541,0.0000021269657,0.00007131764,0.000021711723,0.00015286701],"category_scores_gemma":[0.000011363711,0.00005137661,0.000027011227,0.00046787737,0.000025318883,0.000011298453,0.0000132240775,0.0001065921,7.634584e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00223414,0.00063575036,0.8781283,0.0046828743,0.00079928513,0.00017862888,0.0055346345,0.01691106,0.008830221,0.0010394922,0.0020290017,0.07899659],"study_design_scores_gemma":[0.039367512,0.002600132,0.7605934,0.0021741716,0.00008285162,0.0000198991,0.067795984,0.009221297,0.11103435,0.00022409047,0.006534184,0.00035211214],"about_ca_topic_score_codex":0.8950753,"about_ca_topic_score_gemma":0.8531265,"teacher_disagreement_score":0.117534906,"about_ca_system_score_codex":0.0020364034,"about_ca_system_score_gemma":0.00462211,"threshold_uncertainty_score":0.81994253},"labels":[],"label_agreement":null},{"id":"W3168706338","doi":"10.1016/j.jval.2021.04.424","title":"PDB26 Applying the Stages of Implementation Completion (SIC) Framework Retrospectively to a Community Pharmacy Clinical Intervention Implementation Project for Scaling up Future Success","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Documentation; Pharmacy; Intervention (counseling); Qualitative property; Medicine; Qualitative research; Pharmacy practice; Nursing; Medical education; Family medicine; Psychology; Computer science","score_opus":0.44011216483301235,"score_gpt":0.6095084148125154,"score_spread":0.16939624997950303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168706338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96850425,0.00036457664,0.016585441,0.009102438,0.00084961875,0.004429702,0.000122149,0.000025887015,0.000015923302],"genre_scores_gemma":[0.99114144,0.00031771717,0.005353792,0.0022247084,0.0003043271,0.00033901367,0.00029414965,0.000017858274,0.000007019966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99631816,0.0017406422,0.0011036232,0.00022875395,0.0003292713,0.00027954916],"domain_scores_gemma":[0.9974513,0.0014459493,0.00053610286,0.00023295665,0.00023517867,0.0000984896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045197518,0.0001252484,0.00038066666,0.00010683875,0.0002778312,0.000033332326,0.000111396075,0.00004881712,0.00008477474],"category_scores_gemma":[0.00039575447,0.00010241729,0.00016148336,0.0004738299,0.00003347695,0.0002043893,0.000080579564,0.00068479794,0.0000014531676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011094492,0.00058638054,0.8533022,0.0017890603,0.000119161145,0.0000015896527,0.006139943,0.0001155459,0.00027557637,0.0036209505,0.00044010094,0.13250005],"study_design_scores_gemma":[0.010696352,0.0017293361,0.90057164,0.001115335,0.00023950728,0.000013527886,0.053442013,0.007542999,0.0035177576,0.0023353982,0.018538097,0.00025805825],"about_ca_topic_score_codex":0.0062113544,"about_ca_topic_score_gemma":0.0004387937,"teacher_disagreement_score":0.132242,"about_ca_system_score_codex":0.0002672994,"about_ca_system_score_gemma":0.00027122506,"threshold_uncertainty_score":0.93897516},"labels":[],"label_agreement":null},{"id":"W3168865188","doi":"10.1016/j.jval.2021.04.463","title":"PDG15 Trends in Utilization of Amphetamine-Containing Medications Following State Level Restriction Laws for Acute Pain Opioid Prescriptions","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicaid; Medical prescription; Amphetamine; Medicine; Opioid; Quarter (Canadian coin); Stimulant; Emergency medicine; Demography; Psychiatry; Health care; Pharmacology; Internal medicine; Law; Political science","score_opus":0.10912976396203877,"score_gpt":0.3836722561471581,"score_spread":0.27454249218511934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168865188","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94870156,0.0030814144,0.038983975,0.006891766,0.00046205084,0.0013061563,0.00022545825,0.0000722294,0.00027538312],"genre_scores_gemma":[0.9851882,0.0015020239,0.01091787,0.00026830446,0.00003655541,0.00030098477,0.0012643381,0.000030738334,0.0004909699],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980955,0.00029466802,0.00073825737,0.00031179597,0.00025115896,0.0003086321],"domain_scores_gemma":[0.99907696,0.00024404802,0.00018328491,0.0002931303,0.00009300997,0.00010957837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093902566,0.00013061106,0.0003860315,0.0005059199,0.00007627524,0.000008615514,0.00005263691,0.00006954743,0.000014894018],"category_scores_gemma":[0.00036552505,0.00013782157,0.00010521989,0.0010701121,0.00001845361,0.00010095393,0.000019330399,0.00013056732,9.718444e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007086774,0.0054085865,0.68384695,0.0023495257,0.0009297905,0.00013780913,0.040129654,0.015456464,0.0050939987,0.009879234,0.0025569727,0.23350233],"study_design_scores_gemma":[0.0101713715,0.0015401917,0.86118597,0.0020157741,0.00031680736,0.000013896368,0.005165909,0.111985594,0.0010375874,0.002771328,0.0034855062,0.0003100517],"about_ca_topic_score_codex":0.0037977071,"about_ca_topic_score_gemma":0.0010254951,"teacher_disagreement_score":0.23319228,"about_ca_system_score_codex":0.00048199765,"about_ca_system_score_gemma":0.000864675,"threshold_uncertainty_score":0.5741022},"labels":[],"label_agreement":null},{"id":"W3168954433","doi":"10.1016/j.jval.2021.04.800","title":"PND16 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Primary Progressive Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Medicine; Ocrelizumab; Socioeconomic status; Expanded Disability Status Scale; Pharmacy; Family medicine; Expanded access; Environmental health; Multiple sclerosis; Internal medicine; Population; Psychiatry","score_opus":0.2693607032521882,"score_gpt":0.36455428980768195,"score_spread":0.09519358655549376,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168954433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9834096,0.0068784268,0.00005833216,0.0071489974,0.00017989278,0.0015274093,0.0004644533,0.000009401664,0.00032348392],"genre_scores_gemma":[0.993497,0.0011044972,0.0029280682,0.0020420682,0.0000614789,0.00020413216,0.00010968696,0.000029539566,0.000023491299],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941036,0.0009248074,0.0039120787,0.00050710235,0.00012336405,0.00042902655],"domain_scores_gemma":[0.9950612,0.0015257847,0.002649434,0.00059843913,0.000073897536,0.00009120845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050876597,0.00019733609,0.0012701213,0.00029534943,0.00008281423,0.00001918355,0.00022952014,0.00010584553,0.00008597887],"category_scores_gemma":[0.00043545736,0.00018600171,0.000118693635,0.0002783671,0.00010968958,0.00019126797,0.000025192589,0.00012836944,0.00005623326],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008795792,0.0017555994,0.96837443,0.0009011643,0.000054488646,0.0000016410037,0.011247539,0.005532394,7.006688e-7,0.010922765,0.0002958658,0.00082542264],"study_design_scores_gemma":[0.0045796037,0.0008607572,0.9848263,0.0003959931,0.000004685454,0.0000013772524,0.0016916707,0.003517319,0.000020155981,0.0019253938,0.001971917,0.00020482909],"about_ca_topic_score_codex":0.007042905,"about_ca_topic_score_gemma":0.00036754544,"teacher_disagreement_score":0.016451837,"about_ca_system_score_codex":0.001760447,"about_ca_system_score_gemma":0.00087345426,"threshold_uncertainty_score":0.9995693},"labels":[],"label_agreement":null},{"id":"W3168988530","doi":"10.1016/j.jval.2021.04.019","title":"CN4 Patient-Reported Outcomes from the Phase 3, Randomized Study of Acalabrutinib with or without Obinutuzumab Versus Chlorambucil PLUS Obinutuzumab for Treatment-Naïve Chronic Lymphocytic Leukemia (ELEVATE-TN)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Obinutuzumab; Chlorambucil; Medicine; Internal medicine; Chronic lymphocytic leukemia; Randomized controlled trial; Quality of life (healthcare); Oncology; Gastroenterology; Leukemia; Chemotherapy; Cyclophosphamide","score_opus":0.11065497743286437,"score_gpt":0.3871581889329666,"score_spread":0.27650321150010226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3168988530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9840138,0.0023402479,0.000091763286,0.00028961565,0.0005849138,0.0122953225,0.00013530294,0.00012642614,0.00012261055],"genre_scores_gemma":[0.99523014,0.0006911789,0.0006741913,0.00026732875,0.00022696868,0.0016925895,0.0003117364,0.00014694252,0.0007589059],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99224544,0.0012440291,0.0023911777,0.0012743498,0.0015096124,0.0013354098],"domain_scores_gemma":[0.9888413,0.007087135,0.0010516025,0.0019868908,0.00054183777,0.0004912516],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015868815,0.0007371746,0.003549352,0.00023675268,0.00029754013,0.00006914292,0.00038514662,0.0002489678,0.00022148884],"category_scores_gemma":[0.0027489509,0.00041429035,0.0004253863,0.0011196745,0.00043760214,0.0001417412,0.00017235322,0.00037791592,0.000016120284],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.9107211,0.001557553,0.0011291393,0.0011908952,0.0050937645,0.0018945343,0.024523,0.04307416,0.00014861202,0.000104733386,0.00035085235,0.010211636],"study_design_scores_gemma":[0.7293223,0.013183919,0.00009149644,0.0006757715,0.00078722223,0.00016154803,0.0061896956,0.24772938,0.0010380495,0.000026573442,0.00048087622,0.00031317933],"about_ca_topic_score_codex":0.17814216,"about_ca_topic_score_gemma":0.008048084,"teacher_disagreement_score":0.20465522,"about_ca_system_score_codex":0.38513383,"about_ca_system_score_gemma":0.3492581,"threshold_uncertainty_score":0.9998309},"labels":[],"label_agreement":null},{"id":"W3169082367","doi":"10.1016/j.jval.2021.04.1238","title":"PIN50 Leveraging Publicly Available Data to Estimate a Real-Time Reproduction Number (Rt) for Covid-19: A Comparison of Two Methods","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; Vancouver Coastal Health","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Reproduction; Computer science; Data science; Statistics; Biology; Mathematics; Medicine; Virology; Infectious disease (medical specialty)","score_opus":0.24816327956777595,"score_gpt":0.4887703199853104,"score_spread":0.24060704041753445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169082367","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6387225,0.0005249894,0.31291154,0.03180242,0.0007190137,0.0052921595,0.00029219393,0.00027405925,0.009461161],"genre_scores_gemma":[0.12246034,0.00021317544,0.8720237,0.003238339,0.000115236755,0.00018478224,0.0003347285,0.00008211606,0.0013475647],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99420804,0.0017656442,0.0010032549,0.0018024144,0.00044020746,0.00078043033],"domain_scores_gemma":[0.99621916,0.00094607763,0.0003865135,0.0018313153,0.000023067076,0.00059389404],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.014056137,0.00021213878,0.0005588047,0.00009482407,0.00027451446,0.00004246557,0.00044893796,0.00006756325,0.0019056507],"category_scores_gemma":[0.004268738,0.00024445818,0.000045650922,0.00082864927,0.00010435516,0.00046090296,0.00071635883,0.00025911204,0.00047607144],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028263137,0.0015319673,0.43509242,0.0024628895,0.000062577936,0.000030045016,0.009897387,0.35283205,0.056448247,0.0007690804,0.06702912,0.07356159],"study_design_scores_gemma":[0.0035137516,0.000395649,0.03857881,0.00061140856,0.000055919583,0.00011281242,0.001246549,0.65353686,0.014629991,0.005185401,0.2810631,0.0010697291],"about_ca_topic_score_codex":0.045758184,"about_ca_topic_score_gemma":0.00063761824,"teacher_disagreement_score":0.5591122,"about_ca_system_score_codex":0.0015349308,"about_ca_system_score_gemma":0.0006378318,"threshold_uncertainty_score":0.99900675},"labels":[],"label_agreement":null},{"id":"W3169107845","doi":"10.1016/j.jval.2021.04.604","title":"PMD6 Procedure Cost-Comparison Analysis of Liquid Embolic System Techniques Using EVOH and n-BCA in the Embolization of Brain Arteriovenous Malformations","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Vascular Malformations Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Balloon; Embolization; Medicine; Balloon catheter; Surgery; Cyanoacrylate; Arteriovenous malformation; Biomedical engineering; Materials science; Nanotechnology","score_opus":0.044871895607436145,"score_gpt":0.34379141436094046,"score_spread":0.2989195187535043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169107845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99516475,0.0015934446,0.0009465505,0.0012111545,0.000014526425,0.0009042255,0.00002458209,0.000014462235,0.00012627502],"genre_scores_gemma":[0.9975696,0.0002691112,0.001762294,0.00020575784,0.000010515885,0.000076421,0.000098329016,0.0000066564526,0.0000013176924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984407,0.000249749,0.0008263382,0.00012457899,0.00021896383,0.00013970699],"domain_scores_gemma":[0.99918425,0.00009898183,0.00031220424,0.0002497965,0.00011527055,0.000039515657],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000757668,0.00008742363,0.0005743365,0.00051712553,0.000054182077,0.000010342864,0.00004290096,0.000058083173,0.00000420265],"category_scores_gemma":[0.000110347784,0.0000673006,0.00008530874,0.001486949,0.00002229508,0.00008465411,0.0000152076755,0.00008767307,2.8637132e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019431769,0.0046396325,0.76652795,0.013535551,0.0012599257,0.000039040584,0.07561386,0.10789251,0.0011139003,0.018449219,0.00013812698,0.010595947],"study_design_scores_gemma":[0.0013910182,0.0007312662,0.5563713,0.002890692,0.0007571701,0.00015097803,0.013256297,0.42021337,0.0037900296,0.00003573601,0.0002657267,0.00014640759],"about_ca_topic_score_codex":0.0017081873,"about_ca_topic_score_gemma":0.00033657992,"teacher_disagreement_score":0.31232086,"about_ca_system_score_codex":0.00017182023,"about_ca_system_score_gemma":0.00033024445,"threshold_uncertainty_score":0.2744439},"labels":[],"label_agreement":null},{"id":"W3169421399","doi":"10.1016/j.jval.2021.04.1109","title":"PSS8 The Economic Burden of Macular Edema (ME) Associated with Non-infectious Uveitis (NIU) – A US Commercial Payer’s Perspective","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Ocular Diseases and Behçet’s Syndrome","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Pharmacy; Health plan; Health care; Medical costs; Macular edema; Indirect costs; Emergency medicine; Surgery; Family medicine","score_opus":0.017764460271561255,"score_gpt":0.28811739745547454,"score_spread":0.2703529371839133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169421399","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98929995,0.001617791,0.00001748037,0.0066297017,0.00021814842,0.00066565897,0.00009469877,0.000033382963,0.0014231747],"genre_scores_gemma":[0.99823135,0.00035997608,0.00006604749,0.00077326625,0.00020147709,0.000027371312,0.000061025876,0.000036002355,0.00024348842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982703,0.0003059188,0.00041926047,0.0003484597,0.00025995733,0.00039611894],"domain_scores_gemma":[0.99888325,0.00014841018,0.00023076647,0.00039528796,0.00015156502,0.00019074988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046540226,0.0001809527,0.0005994203,0.00009519253,0.00012521892,0.000019675774,0.00009788611,0.00010005372,0.00027814665],"category_scores_gemma":[0.00013621808,0.00013470367,0.00016161546,0.00028448878,0.00010211981,0.000046017416,0.000052146017,0.00029255488,0.00002448018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013348806,0.005056807,0.89856076,0.0021150785,0.003462952,0.0037861879,0.027285876,0.03311865,0.0008144007,0.007220793,0.008359682,0.008883922],"study_design_scores_gemma":[0.015875481,0.0038791953,0.9405718,0.0025188744,0.0006201505,0.0011340049,0.00896419,0.02009625,0.00033261374,0.0014058076,0.003902868,0.0006987581],"about_ca_topic_score_codex":0.041130863,"about_ca_topic_score_gemma":0.0019957412,"teacher_disagreement_score":0.042011037,"about_ca_system_score_codex":0.0012481922,"about_ca_system_score_gemma":0.0017347533,"threshold_uncertainty_score":0.9652543},"labels":[],"label_agreement":null},{"id":"W3169494821","doi":"10.1016/j.jval.2021.04.1221","title":"PIN33 How Does Mortality Differ In Early Vs. Late Diagnosed Nontuberculous Mycobacterial Lung Disease Among Patients With Chronic Obstructive Pulmonary Disease (COPD)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Mycobacterium research and diagnosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; COPD; Internal medicine; Disease; Obstructive lung disease; Nontuberculous mycobacteria; Pediatrics; Tuberculosis; Pathology; Mycobacterium","score_opus":0.01430568836790284,"score_gpt":0.26565550981760727,"score_spread":0.2513498214497044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169494821","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99326086,0.0009004175,0.0000057196407,0.0024636798,0.00048302984,0.0021171018,0.0006785548,0.00006224608,0.000028385426],"genre_scores_gemma":[0.997122,0.00085499045,0.000037769554,0.00034537827,0.00037675514,0.00044727745,0.00067410467,0.0000677038,0.00007406001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957697,0.00072709424,0.0005775843,0.0009213659,0.000880062,0.0011241889],"domain_scores_gemma":[0.99672943,0.0003216411,0.00018523337,0.0007966092,0.00020333273,0.0017637709],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003356499,0.00039782687,0.0007459676,0.0002480597,0.00012245677,0.00010582302,0.00016990498,0.00011518926,0.000150543],"category_scores_gemma":[0.0007663011,0.0002999817,0.00014624912,0.0006253081,0.00017816936,0.0004168055,0.00015559535,0.0005676052,0.0000092592445],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037976443,0.0013920799,0.9880325,0.002063352,0.000058667065,0.003549579,0.00030606048,0.00009866056,0.000026775688,0.00003077283,0.00006406681,0.000579813],"study_design_scores_gemma":[0.0043507977,0.00040196223,0.9912758,0.0014763735,0.00006774582,0.0000013018237,0.000025367393,0.001824358,0.000025281422,0.00016863084,0.00006137207,0.00032104936],"about_ca_topic_score_codex":0.010974945,"about_ca_topic_score_gemma":0.0016704929,"teacher_disagreement_score":0.009304452,"about_ca_system_score_codex":0.0013055018,"about_ca_system_score_gemma":0.001992211,"threshold_uncertainty_score":0.9999452},"labels":[],"label_agreement":null},{"id":"W3169681939","doi":"10.1016/j.jval.2021.04.111","title":"PCN19 Beyond a Binary Endpoint: Longitudinal and Individual Symptom Analyses from the Simplify-1 Study Demonstrate Clinically Comparable Symptomatic Benefit of Momelotinib to Ruxolitinib in JAK Inhibitor Naive Myelofibrosis Patients","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sierra Wireless (Canada); St. Paul's Hospital; University of Toronto; University of British Columbia; University Health Network","funders":"","keywords":"Ruxolitinib; Repeated measures design; Myelofibrosis; Medicine; Population; Clinical endpoint; Random effects model; Clinical trial; Internal medicine; Statistics; Mathematics; Meta-analysis","score_opus":0.0983970036572504,"score_gpt":0.3711097913004383,"score_spread":0.2727127876431879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169681939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931984,0.0010930585,0.000004092586,0.0026814872,0.00012521361,0.0022855818,0.00051773025,0.000021416345,0.00007299941],"genre_scores_gemma":[0.99647903,0.0002773197,0.0015768777,0.0011087822,0.000075259544,0.00022275055,0.0002185196,0.000031232816,0.000010212034],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99535686,0.00073924963,0.0018602195,0.0007891461,0.0006924262,0.00056209386],"domain_scores_gemma":[0.99593246,0.002503525,0.00044693224,0.0005116174,0.00022421368,0.00038125974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010212787,0.00037059846,0.0013558926,0.00027905294,0.00015588832,0.000056250155,0.00016139886,0.000113219176,0.00006115939],"category_scores_gemma":[0.0004942902,0.0002772785,0.00012421508,0.00092115987,0.00010478968,0.00009942672,0.00023334891,0.00037402578,0.000012234793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042092215,0.0049237073,0.98573065,0.00019387495,0.00031491098,0.00007592698,0.0058089592,0.0006348587,0.000041689487,0.00012859555,0.000129009,0.001596906],"study_design_scores_gemma":[0.0059193396,0.0041071437,0.9835155,0.0013674876,0.00018501151,0.00000771379,0.0032383823,0.00057364715,0.0005434185,0.0003268608,0.000017301678,0.00019817529],"about_ca_topic_score_codex":0.0072007016,"about_ca_topic_score_gemma":0.0014881394,"teacher_disagreement_score":0.0057125622,"about_ca_system_score_codex":0.00023130262,"about_ca_system_score_gemma":0.0006062649,"threshold_uncertainty_score":0.99996793},"labels":[],"label_agreement":null},{"id":"W3169869292","doi":"10.1016/j.jval.2021.04.210","title":"PCN118 Estimated Prevalence of Treated Locally Advanced or Metastatic Urothelial Carcinoma in Canada Using Simulation Modeling","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Bladder cancer; Incidence (geometry); Population; Disease; Metastatic Urothelial Carcinoma; Cancer; Stage (stratigraphy); Clinical trial; Internal medicine; Oncology; Demography; Urothelial carcinoma; Environmental health","score_opus":0.12021920660365858,"score_gpt":0.36470048855537374,"score_spread":0.24448128195171515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169869292","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99582046,0.001547716,0.0016176178,0.00011604103,0.000086737695,0.00070271164,0.0000672951,0.000012312629,0.00002908707],"genre_scores_gemma":[0.99498457,0.0001592149,0.0045537404,0.00019432438,0.00001538772,0.000015037116,0.000018778528,0.000024522831,0.00003440218],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982903,0.0001875715,0.00064177543,0.0002862745,0.00028628053,0.000307825],"domain_scores_gemma":[0.9992972,0.00012721916,0.00012066491,0.00021197282,0.00012227382,0.000120688754],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016921877,0.0001466772,0.00044960415,0.00011493499,0.000030805568,0.000003706799,0.00004582697,0.000030799827,0.00006126426],"category_scores_gemma":[0.00015443185,0.00012956797,0.00003037335,0.00051798666,0.000014130584,0.00006628783,0.000015303882,0.00012563304,5.799529e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006208705,0.00009857552,0.08209878,0.0012009905,0.000016115131,0.00020777773,0.0002690375,0.91262907,0.0004992012,0.000004750921,6.0255167e-7,0.0023542296],"study_design_scores_gemma":[0.003776483,0.0002508241,0.022085572,0.0013249444,0.000046890164,0.000027956905,0.00015215999,0.97075826,0.0014514118,0.00003343942,0.000002052361,0.00009003618],"about_ca_topic_score_codex":0.9206912,"about_ca_topic_score_gemma":0.38945824,"teacher_disagreement_score":0.53123295,"about_ca_system_score_codex":0.0019557315,"about_ca_system_score_gemma":0.012616033,"threshold_uncertainty_score":0.9929815},"labels":[],"label_agreement":null},{"id":"W3169975841","doi":"10.1016/j.jval.2021.04.818","title":"PND34 Healthcare Utilization and Costs at End-of-Life Among US Medicaid Beneficiaries with Huntington's Disease","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicaid; Medicine; Cohort; Emergency department; Health care; Quarter (Canadian coin); Emergency medicine; Demography; Gerontology; Family medicine; Internal medicine; Psychiatry","score_opus":0.06893559540573628,"score_gpt":0.308476524921593,"score_spread":0.2395409295158567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3169975841","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99216884,0.002960571,0.000047584228,0.004023249,0.00015781717,0.00042644993,0.00013210364,0.000037515605,0.000045854256],"genre_scores_gemma":[0.99569845,0.0017181833,0.00016980628,0.0022617688,0.000038080118,0.000028754106,0.000028648126,0.000028967706,0.000027340182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99718064,0.00079708674,0.00044904518,0.0006397059,0.00053426845,0.00039926064],"domain_scores_gemma":[0.998323,0.00040324026,0.00024839403,0.0003427204,0.00010184572,0.00058079464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022799127,0.00017828832,0.00029815052,0.00010832905,0.00023631599,0.000033022603,0.00012131894,0.000040529914,0.00004480864],"category_scores_gemma":[0.0018449296,0.00016843846,0.00002960662,0.00047988578,0.00025736363,0.00009871547,0.00013064714,0.0001327031,0.0000026906578],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001544126,0.00018791445,0.982363,0.00071614474,0.0000033415718,0.000043679156,0.00059766794,0.004912434,0.0019599255,0.0054054344,0.000051001014,0.0036050384],"study_design_scores_gemma":[0.0010420473,0.0002603348,0.88051116,0.00063120306,0.000014036184,0.0000069671964,0.0002539096,0.006594311,0.10955809,0.00027287885,0.00057327107,0.00028176137],"about_ca_topic_score_codex":0.001562414,"about_ca_topic_score_gemma":0.0018831555,"teacher_disagreement_score":0.10759816,"about_ca_system_score_codex":0.00013089138,"about_ca_system_score_gemma":0.0014056448,"threshold_uncertainty_score":0.6868721},"labels":[],"label_agreement":null},{"id":"W3170184488","doi":"10.1016/j.jval.2021.04.537","title":"PIH19 Dosing and Safety of Medical Cannabis in Children: Preliminary Findings from a Living Systematic Review","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Dosing; Cannabis; Cannabidiol; MEDLINE; Adverse effect; Population; Psychiatry; Internal medicine; Environmental health","score_opus":0.02391460586121771,"score_gpt":0.3241359134724661,"score_spread":0.30022130761124843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170184488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.731153,0.21929112,0.000011880509,0.047951687,0.00005185789,0.0014638412,0.000018764491,0.000011796449,0.000046023277],"genre_scores_gemma":[0.91945624,0.0762163,0.00021130193,0.00339276,0.00008136036,0.00011618607,0.00003571881,0.000036024536,0.00045411204],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9966616,0.00065763696,0.0010808205,0.0003500532,0.00087490596,0.00037499948],"domain_scores_gemma":[0.9989933,0.00013141095,0.00014135515,0.00034896293,0.00007587957,0.00030908693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034217904,0.00013465564,0.001040435,0.00018131158,0.000044852444,0.000012036629,0.0001178142,0.000120651566,0.0001625473],"category_scores_gemma":[0.0031779152,0.000116282245,0.00007486152,0.0006032122,0.00006958531,0.000044414803,0.00015747389,0.00050096534,0.000002130004],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012765563,0.0005417245,0.24921398,0.73636156,0.000082501254,0.00031517236,0.0034915425,0.00002193967,0.000069034446,0.00032100626,0.00745155,0.0020023321],"study_design_scores_gemma":[0.0010213947,0.00028430764,0.41822076,0.57766855,0.000053554777,0.00040568088,0.00038642206,0.0016736608,0.00004278023,0.000030906915,0.0000886296,0.00012334803],"about_ca_topic_score_codex":0.017233988,"about_ca_topic_score_gemma":0.00024922838,"teacher_disagreement_score":0.1883032,"about_ca_system_score_codex":0.00030460337,"about_ca_system_score_gemma":0.0017130692,"threshold_uncertainty_score":0.9893103},"labels":[],"label_agreement":null},{"id":"W3170379224","doi":"10.1016/j.jval.2021.04.829","title":"PND45 Epidemiology, Treatment Landscape, and Healthcare Utilization for Patients with Migraine in Canada: A Literature Review","year":2021,"lang":"en","type":"review","venue":"Value in Health","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Migraine; Medicine; Epidemiology; MEDLINE; Chronic Migraine; Health care; Disease burden; Disease; Burden of disease; Pediatrics; Emergency medicine; Psychiatry; Internal medicine","score_opus":0.18950456692383275,"score_gpt":0.41593242209848463,"score_spread":0.2264278551746519,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170379224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000045122437,0.98698413,0.0000018737568,0.0074761226,0.0000319137,0.005016607,0.00042055378,0.000008724312,0.000014920735],"genre_scores_gemma":[0.000015308524,0.9928828,0.0004347566,0.0024984404,0.000089600755,0.0006770302,0.0032190874,0.00003851504,0.00014445692],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968441,0.0007333162,0.0012287119,0.0005677661,0.0001237709,0.00050232216],"domain_scores_gemma":[0.9980965,0.0007930211,0.00043591697,0.00030586455,0.00015222598,0.00021645662],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007587295,0.0004076744,0.0039887573,0.00019885229,0.00006062826,0.0000034206464,0.000045275534,0.00016501591,0.000005116805],"category_scores_gemma":[0.0007143341,0.00025731587,0.000155428,0.00066875364,0.000020179323,0.000020021154,0.00002316195,0.00034768588,2.5738484e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034010594,0.00015856547,0.050911944,0.51541615,0.00011181115,0.00003391692,0.00029125746,8.4243885e-7,9.360059e-11,0.0001595683,0.017636457,0.41524544],"study_design_scores_gemma":[0.0010111904,0.00065138243,0.0027568822,0.31445232,0.0001535541,0.000029958028,0.000033839922,0.00001447486,8.977454e-10,0.0000052239966,0.680766,0.00012517329],"about_ca_topic_score_codex":0.43839142,"about_ca_topic_score_gemma":0.7577365,"teacher_disagreement_score":0.66312957,"about_ca_system_score_codex":0.0014773997,"about_ca_system_score_gemma":0.006605093,"threshold_uncertainty_score":0.9999879},"labels":[],"label_agreement":null},{"id":"W3170496984","doi":"10.1016/j.jval.2021.04.1249","title":"PIN61 Switch Patterns Among Patients Claiming Antifungal Therapies for Onychomycosis in Canada","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Terbinafine; Itraconazole; Medicine; Dermatology; Onycholysis; Antifungal; Nail (fastener)","score_opus":0.02905417858433395,"score_gpt":0.28241707516934383,"score_spread":0.2533628965850099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170496984","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968203,0.0011816854,0.000016231883,0.0009108134,0.00026050647,0.000634433,0.00012992557,0.000008743884,0.000037401885],"genre_scores_gemma":[0.9983229,0.00035900594,0.00019072898,0.0008119527,0.000038069746,0.000066072054,0.00014553007,0.00002095072,0.0000447934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987308,0.000074998134,0.0003494219,0.00026143083,0.00021556218,0.000367807],"domain_scores_gemma":[0.99939656,0.00011135614,0.000079553014,0.00018572302,0.000057022167,0.0001698052],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00010037768,0.00011781504,0.0002954914,0.00007653351,0.00005488161,0.000009740028,0.000040314924,0.000032789685,0.00004636373],"category_scores_gemma":[0.00005776714,0.00010798814,0.00005300383,0.00018192158,0.00000711172,0.000043266693,0.000016986522,0.00010432075,0.0000011778966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006527098,0.00033842833,0.98625004,0.0003753004,0.000030907893,0.00007132025,0.00024390085,0.00004484587,0.0000029131425,0.000019407637,0.00017997858,0.012377685],"study_design_scores_gemma":[0.0030834756,0.00013979594,0.9946358,0.0006506325,0.000014111481,0.0000015175567,0.00041264718,0.00060672197,0.00006017844,0.00005992582,0.00025353252,0.00008162578],"about_ca_topic_score_codex":0.9224974,"about_ca_topic_score_gemma":0.7981087,"teacher_disagreement_score":0.12438872,"about_ca_system_score_codex":0.0010458337,"about_ca_system_score_gemma":0.0020063694,"threshold_uncertainty_score":0.44036284},"labels":[],"label_agreement":null},{"id":"W3170732077","doi":"10.1016/j.jval.2021.04.079","title":"PBI8 Economic Impact of an Originator-to-Biosimilar Non-Medical Switch in the Real-World Setting: A Systematic Literature Review","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Biosimilar; Medicine; MEDLINE; Systematic review; Health care; Actuarial science; Business; Political science; Internal medicine","score_opus":0.02852181198879856,"score_gpt":0.3766476230798687,"score_spread":0.34812581109107016,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170732077","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5848048,0.3406521,0.00006134555,0.065500565,0.0015530712,0.005190779,0.00033405764,0.00006971618,0.0018335885],"genre_scores_gemma":[0.9126798,0.062443145,0.0023513238,0.021711461,0.00014834251,0.00013431236,0.00011998908,0.000047142315,0.00036447353],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99472106,0.0031864697,0.0011248878,0.00039621393,0.00008893439,0.0004824426],"domain_scores_gemma":[0.9981725,0.00079636433,0.00024744726,0.0006247623,0.00005355963,0.00010534346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062518255,0.00020865172,0.0010130082,0.00019296864,0.00005592786,0.000019065847,0.00042744237,0.00026276018,0.00024348819],"category_scores_gemma":[0.0006508057,0.00012630856,0.00018981105,0.00083434145,0.00006901732,0.000054112872,0.00006775994,0.0007200945,0.000025976435],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008479611,0.004856313,0.09779911,0.7318565,0.0015307904,0.0021772352,0.0154939825,0.0007027261,0.0061638798,0.037007637,0.082899235,0.018664617],"study_design_scores_gemma":[0.007009524,0.005093241,0.13972355,0.8102829,0.00044172961,0.0023178249,0.001456752,0.0065925126,0.003987993,0.0037062285,0.017246176,0.0021415446],"about_ca_topic_score_codex":0.0013960865,"about_ca_topic_score_gemma":0.00050235813,"teacher_disagreement_score":0.32787505,"about_ca_system_score_codex":0.00035310717,"about_ca_system_score_gemma":0.0011477945,"threshold_uncertainty_score":0.5150714},"labels":[],"label_agreement":null},{"id":"W3170763689","doi":"10.1016/j.jval.2021.04.327","title":"PCN237 Patterns of Healthcare Resource Utilization (HRU) in Unfit Patients with Acute Myeloid Leukemia (AML) Receiving First-line Systemic Treatment or Best Supportive Care (BSC): A Multicenter International Study (CURRENT)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Cytarabine; Internal medicine; Retrospective cohort study; Pediatrics; Myeloid leukemia","score_opus":0.06428564752719745,"score_gpt":0.3636105994002395,"score_spread":0.29932495187304203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170763689","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99325854,0.00095339894,0.000121422716,0.0011374466,0.00024813556,0.0037409333,0.00046392527,0.000036821904,0.000039356328],"genre_scores_gemma":[0.99589795,0.0017186949,0.00024507407,0.00011823133,0.0001145122,0.000259768,0.001323656,0.00007336497,0.0002487538],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953406,0.00074816775,0.001379421,0.000834808,0.0010108523,0.0006861863],"domain_scores_gemma":[0.9974947,0.00030217535,0.00050393865,0.0006164336,0.00076438085,0.000318368],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005026876,0.0003704111,0.0008841381,0.00060777547,0.00010199328,0.00002155062,0.00022904742,0.00013263965,0.00006729897],"category_scores_gemma":[0.00029927664,0.00029086528,0.00008354707,0.0008593012,0.000045948076,0.00014634314,0.00016838773,0.00057857484,0.000009278976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027643559,0.0019498031,0.95100635,0.0026260293,0.00017356683,0.0004850641,0.022676036,0.0014942191,0.000010082636,0.000007359586,0.000021001873,0.016786147],"study_design_scores_gemma":[0.035689645,0.00978804,0.8878703,0.017071677,0.00015681313,0.00012163478,0.04009087,0.007372997,0.00033748918,0.000003532751,0.0010350413,0.00046195285],"about_ca_topic_score_codex":0.020988403,"about_ca_topic_score_gemma":0.017719766,"teacher_disagreement_score":0.063136026,"about_ca_system_score_codex":0.011739385,"about_ca_system_score_gemma":0.004042922,"threshold_uncertainty_score":0.99995434},"labels":[],"label_agreement":null},{"id":"W3170829278","doi":"10.1016/j.jval.2021.04.821","title":"PND37 Cost-Effectiveness of BoNT-A Products for Treatment of Pediatric Spasticity in the United Kingdom","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Spasticity; Physical therapy; Clinical trial; Randomized controlled trial; Surgery; Internal medicine","score_opus":0.1719244336872071,"score_gpt":0.3721468767769931,"score_spread":0.20022244308978598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170829278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931253,0.0011917427,0.0000762558,0.003390586,0.000109130495,0.002046069,0.000013452693,0.000008289697,0.00003914767],"genre_scores_gemma":[0.9980647,0.0013197723,0.00018576671,0.00026052646,0.000041443396,0.000081835526,0.000029179322,0.000008542962,0.000008256509],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984083,0.00066253403,0.00036847338,0.00021235581,0.0001347541,0.00021353684],"domain_scores_gemma":[0.99839157,0.0011695101,0.00011562869,0.00019570433,0.00008652483,0.000041055144],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065580005,0.00009374983,0.0003921911,0.00014611059,0.000021877513,0.0000016151305,0.000048958536,0.0000869813,0.000003342107],"category_scores_gemma":[0.000637622,0.000057446592,0.00006128164,0.0010121656,0.00004335058,0.000010398028,0.000009426132,0.0001117625,5.520103e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007930022,0.023349924,0.8594626,0.018299941,0.00019245828,0.00037576418,0.0052090767,0.054782297,0.0066820653,0.013874782,0.00024474366,0.0095963],"study_design_scores_gemma":[0.012895148,0.0074579506,0.96436656,0.00045299827,0.00013784517,0.000035286255,0.0002694873,0.005955818,0.0052615153,0.0015028362,0.0015150245,0.00014954555],"about_ca_topic_score_codex":0.0019796717,"about_ca_topic_score_gemma":0.00003622978,"teacher_disagreement_score":0.104903914,"about_ca_system_score_codex":0.00008142648,"about_ca_system_score_gemma":0.00033940325,"threshold_uncertainty_score":0.29926845},"labels":[],"label_agreement":null},{"id":"W3170955787","doi":"10.1016/j.jval.2021.04.1019","title":"PRO34 Challenges in the Estimation of Birth Prevalence for Rare Diseases: A Case Study","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Epidemiology; Medicine; Population; Prevalence; Estimation; Pediatrics; Demography; Environmental health; Pathology","score_opus":0.1521987731504998,"score_gpt":0.4141682704890762,"score_spread":0.2619694973385764,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3170955787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97310716,0.018089106,0.00005265189,0.005217533,0.000027522268,0.0034330285,0.000025831852,0.0000107808255,0.00003639413],"genre_scores_gemma":[0.99771684,0.0012965102,0.00039702508,0.00009420602,0.000023779266,0.00042088938,0.0000076999795,0.000011329861,0.00003170924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982999,0.00053754204,0.00033709407,0.00024485966,0.0003499383,0.0002306521],"domain_scores_gemma":[0.99900395,0.00042406327,0.00007142851,0.00033238454,0.00009818606,0.000069989896],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010321195,0.000075563854,0.0002381968,0.00011857517,0.000045994566,0.000007228185,0.000086966545,0.000029090806,0.000012225095],"category_scores_gemma":[0.0011540028,0.000055391225,0.000036600853,0.0003918597,0.000028658033,0.000051356088,0.00003098472,0.00014292462,0.0000011533907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009905657,0.014808975,0.5394157,0.059251416,0.00007075327,0.009891312,0.14622547,0.008221172,0.000019130051,0.0012316544,0.00018398557,0.21968988],"study_design_scores_gemma":[0.014183933,0.007986738,0.5847058,0.003468124,0.00007757982,0.0021567293,0.25037488,0.13426499,0.00006266029,0.0020122407,0.00038215597,0.00032413495],"about_ca_topic_score_codex":0.001961602,"about_ca_topic_score_gemma":0.00070641097,"teacher_disagreement_score":0.21936575,"about_ca_system_score_codex":0.00012641588,"about_ca_system_score_gemma":0.00072025013,"threshold_uncertainty_score":0.29653683},"labels":[],"label_agreement":null},{"id":"W3171123541","doi":"10.1016/j.jval.2021.04.096","title":"PCN4 Carfilzomib in Combination with Dexamethasone (Kd) Versus Pomalidomide in Combination with Bortezomib and Dexamethasone (PVd): A Matching Adjusted Indirect Treatment Comparison (MAIC)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada); University of Alberta","funders":"","keywords":"Lenalidomide; Medicine; Carfilzomib; Hazard ratio; Internal medicine; Oncology; Multiple myeloma; Dexamethasone; Surgery; Confidence interval","score_opus":0.08798981438038964,"score_gpt":0.35239230713077546,"score_spread":0.26440249275038585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171123541","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993173,0.0022659204,0.00012906887,0.0018624365,0.00007692998,0.0021643057,0.000020338615,0.000053280848,0.0002547133],"genre_scores_gemma":[0.99008733,0.0007096245,0.008394918,0.00008374603,0.000020714004,0.00025281607,0.0003151866,0.00005326611,0.000082369465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99609715,0.0010308891,0.00073507626,0.0007137349,0.0006577363,0.00076540007],"domain_scores_gemma":[0.99789715,0.0009605906,0.0002584116,0.0003819878,0.00013645041,0.00036543602],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009817695,0.0003718785,0.0010906685,0.0007880368,0.00010925211,0.00005316077,0.00007467464,0.00015154287,0.000020088946],"category_scores_gemma":[0.00027491534,0.00030396794,0.000043848595,0.0014093621,0.00009540826,0.00020114637,0.000046657788,0.00050557905,0.0000043953532],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010392202,0.0040479396,0.94367677,0.000489998,0.00018321909,0.0013408968,0.0048762164,0.0013660945,0.00023733953,0.00028504452,0.000009303069,0.033094976],"study_design_scores_gemma":[0.09851008,0.007206776,0.866489,0.0016263023,0.000068674926,0.00013818814,0.0029333758,0.020385321,0.0021388966,0.00014043627,0.00006030641,0.00030262535],"about_ca_topic_score_codex":0.040564775,"about_ca_topic_score_gemma":0.037723485,"teacher_disagreement_score":0.088117875,"about_ca_system_score_codex":0.0024969256,"about_ca_system_score_gemma":0.0011724951,"threshold_uncertainty_score":0.99994123},"labels":[],"label_agreement":null},{"id":"W3171180990","doi":"10.1016/j.jval.2021.04.481","title":"PDG33 Awareness and Consideration of Confidential Listing Agreements in Cost-Effectiveness Evaluation By Health Technology Assessment (HTA) Bodies","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux","funders":"","keywords":"Listing (finance); Confidentiality; Jurisdiction; Business; Health technology; Cost–benefit analysis; Actuarial science; Accounting; Health care; Finance; Political science; Law","score_opus":0.4948930189948507,"score_gpt":0.5157849277552804,"score_spread":0.020891908760429678,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171180990","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.946195,0.013135032,0.00602848,0.030907258,0.00062468206,0.0026585402,0.00021406134,0.000026931948,0.00021002565],"genre_scores_gemma":[0.9949386,0.000972068,0.0019579162,0.0015706867,0.00004576546,0.0003437977,0.00013604097,0.000020340332,0.000014754317],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9913987,0.002673936,0.004536939,0.0007052304,0.00020347787,0.00048170902],"domain_scores_gemma":[0.9955388,0.0013199494,0.002500714,0.00033551792,0.00018569939,0.00011933625],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02998384,0.0001799116,0.0012463077,0.00065628963,0.00020821313,0.000052102103,0.00010755645,0.00015807003,0.00006548903],"category_scores_gemma":[0.0036521482,0.00025854522,0.000039279763,0.00039024645,0.00007751841,0.00029391228,0.000071014925,0.00025138917,0.000012385602],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022773502,0.00037798236,0.9038234,0.0032848576,0.000046673955,0.000002395649,0.0032311566,0.00945381,0.00007466341,0.07485269,0.0009383305,0.0038912946],"study_design_scores_gemma":[0.008613157,0.0005654819,0.6564175,0.003030641,0.000010882617,0.00003321734,0.012134648,0.25183645,0.0002934304,0.06333384,0.0029880416,0.0007427204],"about_ca_topic_score_codex":0.021566879,"about_ca_topic_score_gemma":0.0036556937,"teacher_disagreement_score":0.24740589,"about_ca_system_score_codex":0.0022085784,"about_ca_system_score_gemma":0.0022808579,"threshold_uncertainty_score":0.99998665},"labels":[],"label_agreement":null},{"id":"W3171367633","doi":"10.1016/j.jval.2021.04.268","title":"PCN177 Trends in Canadian Oncology Health Technology Assessment","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Reimbursement; Internal medicine; Categorical variable; Oncology; Family medicine; Health care; Statistics; Mathematics","score_opus":0.46681475869174616,"score_gpt":0.5055276278036891,"score_spread":0.03871286911194294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171367633","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09745114,0.013076014,0.00030844216,0.87253016,0.0014032962,0.0006948749,0.00030506746,0.000067851084,0.014163176],"genre_scores_gemma":[0.9239529,0.0016736361,0.01101784,0.061924104,0.00021706721,0.00020405572,0.00015670386,0.000054235075,0.0007995095],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906346,0.0013837595,0.00556707,0.00086287863,0.000091410264,0.0014602594],"domain_scores_gemma":[0.99644274,0.0005150878,0.0016336223,0.00066940533,0.00004487951,0.00069426146],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02632204,0.00020961175,0.0016032727,0.002974973,0.00019792905,0.000035406516,0.00029616803,0.00032526182,0.00065559277],"category_scores_gemma":[0.0012614198,0.00031015516,0.00007874331,0.0017205,0.00006451589,0.00018262683,0.000059198188,0.0006484414,0.00042714964],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000040775253,0.00028462615,0.3584032,0.00042958267,0.000019940124,0.00003941642,0.0023517434,0.0033365379,3.5455628e-7,0.6065003,0.017673992,0.010956174],"study_design_scores_gemma":[0.0018610174,0.00041947796,0.25478035,0.0003284605,9.4080804e-7,0.000050772876,0.0039001326,0.021350993,0.000001030849,0.02931573,0.6875351,0.000455962],"about_ca_topic_score_codex":0.7891159,"about_ca_topic_score_gemma":0.7814704,"teacher_disagreement_score":0.8265017,"about_ca_system_score_codex":0.016572585,"about_ca_system_score_gemma":0.011642429,"threshold_uncertainty_score":0.99993503},"labels":[],"label_agreement":null},{"id":"W3171413946","doi":"10.1016/j.jval.2021.04.276","title":"PCN185 Identification of Gaps and Opportunities for Provincial Reimbursement of Oncology Companion Diagnostics in Canada","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Health technology; Family medicine; Stakeholder; Agency (philosophy); Health care; Oncology; Political science; Public relations","score_opus":0.5090590351128075,"score_gpt":0.4255924511664017,"score_spread":0.08346658394640577,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171413946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95976365,0.0057448503,0.00067170785,0.03145006,0.0005475964,0.0009042944,0.0007395035,0.000003245218,0.0001750711],"genre_scores_gemma":[0.9937343,0.0030540936,0.0011120101,0.001835109,0.00005609766,0.000085791806,0.00007146279,0.000010579786,0.000040540923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950315,0.0004181946,0.004027996,0.00024464418,0.00006424317,0.00021342511],"domain_scores_gemma":[0.9960024,0.0015662157,0.002074864,0.00019441429,0.000082625185,0.0000794831],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009766783,0.00007431629,0.00073365506,0.00020289555,0.000036798054,0.000006311263,0.00007804256,0.00005701972,0.000014424406],"category_scores_gemma":[0.0024485956,0.000107750966,0.000024269693,0.00010319916,0.00003598938,0.00008246477,0.000025629892,0.00007650916,0.0000011484747],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052258998,0.0005393742,0.47845778,0.010699637,0.000041787247,0.000006213731,0.006681631,0.009141712,0.000021733058,0.4774676,0.010180454,0.00670981],"study_design_scores_gemma":[0.004849824,0.0007542951,0.7520241,0.0013787989,0.000012050315,0.000011424583,0.028474625,0.09815729,0.00035326573,0.04079273,0.07259475,0.0005968126],"about_ca_topic_score_codex":0.7727331,"about_ca_topic_score_gemma":0.6565542,"teacher_disagreement_score":0.4366749,"about_ca_system_score_codex":0.0018607285,"about_ca_system_score_gemma":0.0050032474,"threshold_uncertainty_score":0.88755465},"labels":[],"label_agreement":null},{"id":"W3171432099","doi":"10.1016/j.jval.2021.04.453","title":"PDG5 Changes in Canadian Guidelines for Conducting Budget IMPACT Analysis","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transparency (behavior); Best practice; Consistency (knowledge bases); Flexibility (engineering); Population; Presentation (obstetrics); Resource (disambiguation); Cornerstone; Pharmaceutical policy; Risk analysis (engineering); Computer science; Operations research; Actuarial science; Medicine; Accounting; Business; Political science; Engineering; Health policy; Public health; Economics; Environmental health; Geography","score_opus":0.7389327488570064,"score_gpt":0.5343481174377673,"score_spread":0.2045846314192391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171432099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65823835,0.011825972,0.00079521205,0.325246,0.0007831779,0.0011149647,0.0013389202,0.00002948289,0.00062791456],"genre_scores_gemma":[0.9466744,0.0007870531,0.011938783,0.039049715,0.00057782675,0.00020801331,0.00030878957,0.000048977923,0.00040642722],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9938571,0.0005047764,0.0040112054,0.0006291199,0.00006619078,0.0009315954],"domain_scores_gemma":[0.9965673,0.0010686705,0.0012565152,0.0004616533,0.00017545932,0.00047041647],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.028706891,0.0001766949,0.0013309389,0.001604974,0.00015019561,0.00006383015,0.00018153741,0.00014227806,0.00033595748],"category_scores_gemma":[0.012432554,0.00023508801,0.0001740503,0.0013045205,0.000021435213,0.00018839163,0.000023227707,0.00017301332,0.000097674245],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008893376,0.000074017415,0.87483275,0.00081973063,0.00020471665,0.000006806394,0.00396613,0.072433345,0.0000023017494,0.02924246,0.017831216,0.0005776414],"study_design_scores_gemma":[0.0027287793,0.00025470692,0.23645917,0.0005507706,0.000033160137,0.000017261978,0.0078062057,0.5631186,0.00002213773,0.022446642,0.1653961,0.0011664709],"about_ca_topic_score_codex":0.8914953,"about_ca_topic_score_gemma":0.8812015,"teacher_disagreement_score":0.63837355,"about_ca_system_score_codex":0.0032157789,"about_ca_system_score_gemma":0.0025231899,"threshold_uncertainty_score":0.99588615},"labels":[],"label_agreement":null},{"id":"W3171555601","doi":"10.1016/j.jval.2021.04.1074","title":"PRS10 Economic Evaluation of Umeclidinium/Vilanterol Versus Umeclidinium or Salmeterol in a UK COPD Population at Low Risk of Exacerbations Using the GALAXY Model","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Medicine; Salmeterol; COPD; Exacerbation; Discontinuation; Population; Internal medicine; Environmental health","score_opus":0.13333645138141373,"score_gpt":0.39433921915454717,"score_spread":0.26100276777313347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171555601","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99586153,0.0012003059,0.00016062484,0.00046166623,0.00028425767,0.0017024943,0.00018870569,0.000011611494,0.00012880846],"genre_scores_gemma":[0.9981624,0.00048452677,0.0009516051,0.000035599325,0.000077293764,0.000072031005,0.00013284807,0.00003408241,0.00004964265],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9960696,0.0012587842,0.0010709503,0.0004532113,0.00073792675,0.0004094985],"domain_scores_gemma":[0.9979213,0.00057641993,0.00050305156,0.0006300392,0.00022636267,0.00014282244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026954447,0.00018335889,0.0005613542,0.0003477753,0.00010135087,0.000010734959,0.00013497502,0.000120605626,0.00028573003],"category_scores_gemma":[0.0007837055,0.000156828,0.0001263956,0.0004920314,0.0000897864,0.0001302402,0.00011538531,0.00033008528,0.0000063939456],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024958858,0.00032301914,0.36266732,0.0010289781,0.00008728147,0.000008936818,0.0013180922,0.6285293,0.0012745501,0.00018697199,0.000081143655,0.0019984983],"study_design_scores_gemma":[0.0044267476,0.00014239523,0.26720873,0.00043504528,0.00009365868,0.000014985322,0.0003942584,0.726236,0.0005816936,0.00038262003,0.0000032729306,0.0000806311],"about_ca_topic_score_codex":0.008330793,"about_ca_topic_score_gemma":0.0028748352,"teacher_disagreement_score":0.09770665,"about_ca_system_score_codex":0.004239991,"about_ca_system_score_gemma":0.0033920086,"threshold_uncertainty_score":0.9995825},"labels":[],"label_agreement":null},{"id":"W3171594441","doi":"10.1016/j.jval.2021.04.565","title":"PIN5 Immunogenicity and Safety of the COVID-19 Vaccines Compared to Controls in Healthy Adults: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Value in Health","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Immunogenicity; Adverse effect; Vaccination; Seroconversion; Placebo; Randomized controlled trial; Chills; Internal medicine; Neutralizing antibody; Immunization; Immunology; Antibody; Pathology; Alternative medicine","score_opus":0.1385991307620825,"score_gpt":0.4436223027155003,"score_spread":0.30502317195341777,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171594441","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000265247,0.97506976,0.000014088556,0.004872805,0.00014456002,0.019469142,0.000116294184,0.000022893199,0.000025184574],"genre_scores_gemma":[0.0001337162,0.89690953,0.000049289752,0.10177755,0.00005130911,0.0010101119,0.000017885377,0.000045917623,0.000004672458],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9890908,0.004821732,0.0038614387,0.00074987044,0.0007687668,0.00070737256],"domain_scores_gemma":[0.9944064,0.0025549443,0.0011181375,0.0014509823,0.00020447525,0.00026506773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0064667766,0.0004963008,0.008060045,0.00048475325,0.00010349352,0.00001853419,0.0005541892,0.00024402804,0.000007969009],"category_scores_gemma":[0.00793701,0.00031580884,0.0005399955,0.002281851,0.00006711034,0.000033521665,0.0002842681,0.0009802865,0.0000114933155],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043537893,0.00017401096,0.00042802995,0.99233925,0.00010885199,0.000032724944,0.00032235764,0.0000015121477,2.8617745e-7,0.000096356074,0.00019012959,0.0058710976],"study_design_scores_gemma":[0.002290762,0.00034555473,0.000044951306,0.7478814,0.00027601753,0.00022291284,0.00008954845,0.000046698122,2.5316777e-7,0.00000867427,0.24861445,0.0001787387],"about_ca_topic_score_codex":0.01417682,"about_ca_topic_score_gemma":0.0009176722,"teacher_disagreement_score":0.24842432,"about_ca_system_score_codex":0.0020328872,"about_ca_system_score_gemma":0.00982613,"threshold_uncertainty_score":0.9999294},"labels":[],"label_agreement":null},{"id":"W3171647414","doi":"10.1016/j.jval.2021.04.471","title":"PDG23 Comparing Average Time to Listing and Drug Coverage Rates between Provinces in Canada","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada; Dalhousie University","funders":"","keywords":"Listing (finance); Formulary; Reimbursement; Medicine; Family medicine; Business; Health care; Political science; Finance","score_opus":0.2749427207777276,"score_gpt":0.37667107664398813,"score_spread":0.10172835586626056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171647414","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96209973,0.0027842168,0.00013148176,0.03227579,0.00019725713,0.000597193,0.0001665015,0.000016541058,0.0017312912],"genre_scores_gemma":[0.9914452,0.00012000714,0.0009907312,0.006755743,0.00015070551,0.000032639957,0.00003464208,0.00002286362,0.00044747753],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950134,0.0006346401,0.003147903,0.00057091913,0.000092215996,0.00054091326],"domain_scores_gemma":[0.99681544,0.0017704979,0.0008359933,0.00027138513,0.000026889225,0.00027976435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010792154,0.00015712365,0.0010713786,0.0002532989,0.00013553668,0.0000775739,0.00015516163,0.000046857836,0.00012795298],"category_scores_gemma":[0.002158159,0.00022400371,0.000025139316,0.00034592266,0.000016310978,0.00021962447,0.000094141345,0.00023866324,0.00022991768],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000037358022,0.000020306461,0.97511935,0.00063722295,0.000008614912,0.000008104342,0.0019665512,0.016459266,5.331872e-7,0.002292295,0.0030952638,0.00038874586],"study_design_scores_gemma":[0.0012046056,0.00004868073,0.87645954,0.0009683312,0.0000016474137,0.000006723896,0.0012985215,0.086637825,0.000012637961,0.0042531495,0.028532963,0.00057535246],"about_ca_topic_score_codex":0.9423922,"about_ca_topic_score_gemma":0.801489,"teacher_disagreement_score":0.1409032,"about_ca_system_score_codex":0.0030918843,"about_ca_system_score_gemma":0.0027573348,"threshold_uncertainty_score":0.9134607},"labels":[],"label_agreement":null},{"id":"W3171719546","doi":"10.1016/j.jval.2021.04.882","title":"PNS27 Amphetamine-Related Hospitalizations in the United States, 2003-2014: Examining Trends and Factors Associated with Admission Outcomes","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NOSM University; University of Sudbury; University of British Columbia","funders":"","keywords":"Medicine; Amphetamine; Demography; Odds; Odds ratio; Logistic regression; Population; Pediatrics; Environmental health; Internal medicine","score_opus":0.06584952268862525,"score_gpt":0.3350995346757501,"score_spread":0.26925001198712484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171719546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9922799,0.0010473394,0.000009041463,0.0061590467,0.000040015766,0.00031419552,0.000032183605,0.000034289533,0.000084011575],"genre_scores_gemma":[0.9968216,0.0006489716,0.00018667018,0.0003161665,0.0000060943316,0.000022888862,0.001537332,0.000019624726,0.00044064445],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981337,0.0005322671,0.0003438785,0.0002567851,0.00036063945,0.0003727126],"domain_scores_gemma":[0.9989145,0.00043238504,0.00009652512,0.00022674,0.00010620591,0.00022365153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005087818,0.00015454247,0.00032167404,0.00041267206,0.00010734042,0.000027885444,0.000052797022,0.00007182864,0.000072844676],"category_scores_gemma":[0.0007543292,0.000089844325,0.000020252692,0.0022336326,0.00004516797,0.00004965451,0.000023072209,0.0002757031,0.0000017618371],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000109011184,0.0004504915,0.9935223,0.000035908837,0.0000726615,0.00019263738,0.0027119312,0.00068764115,0.0000028157208,0.00033020877,0.0003305756,0.0015538501],"study_design_scores_gemma":[0.004556185,0.0006643998,0.9865898,0.00034137093,0.000022639917,0.000012421192,0.001696926,0.005759056,0.0000147562605,0.00008021143,0.00017794214,0.00008431934],"about_ca_topic_score_codex":0.004421001,"about_ca_topic_score_gemma":0.0015961041,"teacher_disagreement_score":0.006932495,"about_ca_system_score_codex":0.00027727714,"about_ca_system_score_gemma":0.00066082866,"threshold_uncertainty_score":0.6683261},"labels":[],"label_agreement":null},{"id":"W3171955094","doi":"10.1016/j.jval.2021.04.872","title":"PNS17 Value of a Comprehensive Ophthalmology Custom Pack in a Canadian Setting","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Healthcare and Medical Tourism","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Cataract surgery; Operations management; Commodity; Supply chain; Business; Surgery; Engineering; Marketing; Finance","score_opus":0.11033175135646203,"score_gpt":0.4529946908160473,"score_spread":0.34266293945958526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3171955094","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95584613,0.0035694004,0.000004165426,0.028262341,0.0014207117,0.0009390002,0.00008026283,0.000023024408,0.009854936],"genre_scores_gemma":[0.9876261,0.0005144491,0.00097514497,0.010118373,0.0002393335,0.00006205128,0.000036664736,0.000026706242,0.00040120582],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99263555,0.0034909688,0.001393668,0.00044014474,0.00030236997,0.00173729],"domain_scores_gemma":[0.99695796,0.0010205792,0.00031329223,0.00040820683,0.00023163995,0.0010683119],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019864328,0.00017980562,0.00073808315,0.00035516778,0.0002517443,0.000002348292,0.00018549546,0.0004393216,0.00026101808],"category_scores_gemma":[0.0008519994,0.00018615833,0.000066727895,0.0008806118,0.00007491114,0.000046843958,0.0001025983,0.0014490946,0.000094343435],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000137505,0.0005413343,0.8521676,0.012534214,0.000048810372,0.0064492435,0.035696797,0.0033671379,0.0001264347,0.045047674,0.032515123,0.011368109],"study_design_scores_gemma":[0.0025922954,0.000338473,0.8541555,0.0052848356,0.0000068691616,0.00021243116,0.0118330885,0.0039226282,0.0000146644325,0.0065661017,0.11473971,0.00033340845],"about_ca_topic_score_codex":0.949673,"about_ca_topic_score_gemma":0.34377187,"teacher_disagreement_score":0.6059011,"about_ca_system_score_codex":0.0015685031,"about_ca_system_score_gemma":0.016097683,"threshold_uncertainty_score":0.98948014},"labels":[],"label_agreement":null},{"id":"W3172087558","doi":"10.1016/j.jval.2021.04.1197","title":"RE3 Expectations Versus Reality: How Real-World Data Fits into Budget Impact Analyses","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Bevacizumab; Medicine; Actuarial science; Population; Surgery; Economics; Environmental health","score_opus":0.7657741920010389,"score_gpt":0.5634521673753913,"score_spread":0.20232202462564763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172087558","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.45775867,0.01846386,0.0029495414,0.5016962,0.003256839,0.0018163307,0.004635265,0.00027878047,0.009144489],"genre_scores_gemma":[0.9740496,0.002934023,0.014000707,0.0048932014,0.0008577408,0.0001021376,0.0020748784,0.000085376465,0.0010023193],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.992259,0.0016106205,0.0039829025,0.00120955,0.0001846999,0.00075317424],"domain_scores_gemma":[0.99177086,0.0029249357,0.0024634306,0.0022777899,0.000115675146,0.00044732072],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.014735157,0.00027853396,0.0014734224,0.00081631646,0.0003153204,0.00019805363,0.0006343055,0.00011211009,0.00023128552],"category_scores_gemma":[0.00912174,0.0003608652,0.00014905202,0.0014584854,0.00008887332,0.0008548497,0.00022283029,0.00034310584,0.0005316376],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027333965,0.0010277114,0.24575852,0.0031653638,0.0008044767,0.000055383483,0.022181397,0.025886983,0.000014199593,0.26342607,0.43425453,0.0031520524],"study_design_scores_gemma":[0.008826166,0.0009592911,0.42284644,0.0012367509,0.00006484148,0.000028544438,0.029618315,0.25777102,0.000046955112,0.06695778,0.20885265,0.0027912485],"about_ca_topic_score_codex":0.14607573,"about_ca_topic_score_gemma":0.042814422,"teacher_disagreement_score":0.51629096,"about_ca_system_score_codex":0.002487516,"about_ca_system_score_gemma":0.0018079847,"threshold_uncertainty_score":0.9998843},"labels":[],"label_agreement":null},{"id":"W3172282266","doi":"10.1016/j.jval.2021.04.994","title":"PRO9 ADV7103 Treatment Adherence in Patients with Distal Renal Tubular Acidosis (DRTA)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Ion Transport and Channel Regulation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Distal renal tubular acidosis; Internal medicine; Regimen; Renal function; Acidosis; Pediatrics","score_opus":0.012793272988322026,"score_gpt":0.2352269332976978,"score_spread":0.22243366030937578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172282266","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99876165,0.00047437847,0.00012578609,0.00016986318,0.00006003747,0.00032601014,0.000021455067,0.000004612425,0.00005617911],"genre_scores_gemma":[0.9985644,0.00015343656,0.00032358457,0.00005814279,0.00004273505,0.000047920166,0.00063212006,0.00001132507,0.00016634323],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999119,0.00006623017,0.00021213926,0.00027299178,0.00011837861,0.00021130475],"domain_scores_gemma":[0.9996727,0.00000358726,0.000055303317,0.00016689602,0.00004004558,0.00006143121],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007802596,0.00010493573,0.00013094727,0.00003303288,0.000031220083,0.0000066956304,0.000042605363,0.000067994886,0.000013508745],"category_scores_gemma":[0.000006500764,0.00008903871,0.000030362651,0.00013336558,0.000019548625,0.0000036964657,0.00000950565,0.000047326645,0.0000018697316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056058395,0.0010023991,0.97236866,0.00013324185,0.000031443036,0.000029755796,0.000582502,0.0050324034,0.0072913524,0.00010978524,0.00004377219,0.012814123],"study_design_scores_gemma":[0.005011039,0.0032521335,0.90879375,0.00027329844,0.000010186275,0.000004206249,0.000156032,0.00045569104,0.0754917,0.00009393041,0.0061228066,0.0003352528],"about_ca_topic_score_codex":0.00039224865,"about_ca_topic_score_gemma":0.00054656743,"teacher_disagreement_score":0.06820034,"about_ca_system_score_codex":0.00007655613,"about_ca_system_score_gemma":0.00025268103,"threshold_uncertainty_score":0.3630893},"labels":[],"label_agreement":null},{"id":"W3172504610","doi":"10.1016/j.jval.2021.04.1121","title":"PSU1 An Umbrella Review Comparing the Safety and Effectiveness of Femtosecond Laser-Assisted Cataract Surgery with Manual Cataract Surgery","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Intraocular Surgery and Lenses","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Phacoemulsification; Cataract surgery; Randomized controlled trial; Ophthalmology; Capsulorhexis; Visual acuity; Meta-analysis; Capsulotomy; Clinical trial; Surgery; Intraocular lens; Internal medicine","score_opus":0.07538350795345872,"score_gpt":0.33184569055049123,"score_spread":0.2564621825970325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172504610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9647276,0.033115514,0.000015452559,0.001294705,0.00018667078,0.00048731724,0.00002421463,0.000021956774,0.00012656864],"genre_scores_gemma":[0.9775757,0.02069238,0.000049310107,0.0012744246,0.000066451925,0.000014381667,0.00027373128,0.000027104854,0.000026499305],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958,0.002300133,0.00080643507,0.00039787867,0.00029748338,0.00039807713],"domain_scores_gemma":[0.9941247,0.004686109,0.00031514504,0.000539944,0.00014180367,0.00019225822],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006147925,0.00021548542,0.0013946301,0.00012780624,0.0001447458,0.0000154122,0.000059635087,0.00007363578,0.000042164236],"category_scores_gemma":[0.00048778052,0.00015113868,0.00014418922,0.00050168036,0.00012703698,0.0001214209,0.00003057867,0.0003913494,0.000003744185],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023159892,0.0008313916,0.9211572,0.052775774,0.0002158707,0.0011011207,0.0005092362,0.00020840514,0.00023747225,0.00021897207,0.00058354024,0.019845027],"study_design_scores_gemma":[0.0004937839,0.00014197457,0.9694157,0.022573564,0.00008904274,0.0010409772,0.0001648182,0.00017591621,0.0021875242,0.00001174646,0.0034964136,0.00020854487],"about_ca_topic_score_codex":0.004335512,"about_ca_topic_score_gemma":0.00035838014,"teacher_disagreement_score":0.048258495,"about_ca_system_score_codex":0.00010469175,"about_ca_system_score_gemma":0.0012869365,"threshold_uncertainty_score":0.6554026},"labels":[],"label_agreement":null},{"id":"W3172762747","doi":"10.1016/j.jval.2021.04.1050","title":"PRO65 Engaging Patients in Drug Development for Regulatory and HTA Decisions: A Case Study in Patients with Hidradenitis Suppurativa","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Quality of life (healthcare); Reimbursement; Dermatology Life Quality Index; Disease; Physical therapy; Health care; Internal medicine; Nursing","score_opus":0.040126077484995304,"score_gpt":0.30613077415160156,"score_spread":0.26600469666660626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172762747","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99453276,0.00023649726,0.000008264402,0.0010294954,0.00007897299,0.004051749,0.000023726472,0.000017311742,0.00002123048],"genre_scores_gemma":[0.9953408,0.00002381813,0.003982335,0.00002728762,0.000013641355,0.00038077138,0.00012226288,0.000037244325,0.00007183927],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972601,0.0004576243,0.0008279204,0.0005695386,0.0004118863,0.0004729203],"domain_scores_gemma":[0.99884903,0.0004073261,0.00013386067,0.00025742647,0.00013469382,0.00021767303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007562494,0.00024632498,0.00055077474,0.0004063793,0.00015755915,0.000025744694,0.00004887028,0.000058679958,0.000009625337],"category_scores_gemma":[0.00032650173,0.00020844775,0.000023341927,0.0005293785,0.000033361346,0.00019196006,0.00006144314,0.00027985117,0.0000021195356],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002572135,0.0033021949,0.9333086,0.00015440291,0.00002567095,0.024703193,0.022871029,0.0000036785336,6.661876e-7,0.000011614509,0.000018506273,0.015343207],"study_design_scores_gemma":[0.02160706,0.0010719215,0.96434927,0.0015210091,0.000015164544,0.0028870138,0.008078761,0.000106709194,0.00003589855,0.00004559251,0.00007068221,0.00021092912],"about_ca_topic_score_codex":0.0028828664,"about_ca_topic_score_gemma":0.0067262943,"teacher_disagreement_score":0.031040635,"about_ca_system_score_codex":0.0007472019,"about_ca_system_score_gemma":0.0010134816,"threshold_uncertainty_score":0.85002524},"labels":[],"label_agreement":null},{"id":"W3172780154","doi":"10.1016/j.jval.2021.04.1202","title":"RW3 Quantitative Bias Analysis (QBA) for Comparative Effectiveness of Alectinib versus Ceritinib in Non-Small Cell Lung Cancer (NSCLC)","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Alectinib; Ceritinib; Medicine; Lung cancer; Hazard ratio; Internal medicine; Oncology; Crizotinib; Confidence interval","score_opus":0.12709427324781572,"score_gpt":0.45329962642739347,"score_spread":0.3262053531795778,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172780154","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897991,0.004854258,0.0015134355,0.0003781533,0.0002870787,0.0017137241,0.00020755766,0.000011926047,0.0012347761],"genre_scores_gemma":[0.994621,0.00037176453,0.0041497285,0.00007394158,0.000029407789,0.00046187,0.00016655518,0.000017177348,0.000108572785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99827355,0.000420493,0.00047376685,0.0003739984,0.00015473732,0.00030345464],"domain_scores_gemma":[0.9974142,0.0018296466,0.00021111872,0.00019266756,0.0002487696,0.00010361559],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005454989,0.0001549968,0.00083046034,0.0003493382,0.000058808455,0.000008022866,0.00004845958,0.00006102291,0.000027192633],"category_scores_gemma":[0.00011673205,0.00014749709,0.00016486239,0.0015330007,0.000038564296,0.00004668074,0.000016414568,0.00014575453,0.0000011185195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006558414,0.002744309,0.8309806,0.009005711,0.00347524,0.00008377023,0.033412907,0.107732974,0.002285818,0.0022170816,0.00017285155,0.001330356],"study_design_scores_gemma":[0.03284573,0.002795131,0.86565477,0.0035784096,0.0021628914,0.0000030930698,0.009236042,0.057690267,0.02520165,0.0001375633,0.00029919742,0.0003952463],"about_ca_topic_score_codex":0.018885745,"about_ca_topic_score_gemma":0.0067613763,"teacher_disagreement_score":0.050042704,"about_ca_system_score_codex":0.00078592653,"about_ca_system_score_gemma":0.001726242,"threshold_uncertainty_score":0.9876476},"labels":[],"label_agreement":null},{"id":"W3172903954","doi":"10.1016/j.jval.2021.04.1193","title":"PVM1 Dog Owners Preferences for Preventive Antiparasitic Treatment for Their Dogs: A Discrete Choice Experiment (DCE) in the UK","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatological diseases and infestations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Zoetis (Canada)","funders":"","keywords":"Lungworm; Multinomial logistic regression; Veterinary medicine; Animal welfare; Medicine; Mange; Environmental health; Biology; Statistics; Immunology","score_opus":0.10977495508433478,"score_gpt":0.41134380818190197,"score_spread":0.3015688530975672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3172903954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9841535,0.0035082619,0.0006517207,0.007590141,0.0001124969,0.0032948656,0.00020663347,0.000017311486,0.00046504667],"genre_scores_gemma":[0.9947549,0.0007713969,0.0011520631,0.0014335659,0.000049059894,0.0014853537,0.00019153299,0.000008606984,0.00015348966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987567,0.00020796385,0.00035848102,0.00025655754,0.00011045846,0.0003098428],"domain_scores_gemma":[0.99879056,0.0007852855,0.00008444969,0.00019683965,0.000044530178,0.00009833107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020697972,0.00012622989,0.0002986396,0.000041862953,0.000090123576,0.000022583916,0.00006652982,0.000039222337,0.000028905233],"category_scores_gemma":[0.00018842862,0.00006762703,0.000126417,0.00016629507,0.000037264246,0.000042065734,0.000010344226,0.000058935155,0.000002334156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021668053,0.01488026,0.7718549,0.0060912357,0.00074861065,0.00019361475,0.08779351,0.0048442986,0.0008264547,0.04998553,0.007867889,0.05274694],"study_design_scores_gemma":[0.014726478,0.006465226,0.89194995,0.0021626474,0.00018468167,0.00005929208,0.029129377,0.014448481,0.002575245,0.013931755,0.023845138,0.0005217039],"about_ca_topic_score_codex":0.00092200626,"about_ca_topic_score_gemma":0.00017823881,"teacher_disagreement_score":0.12009512,"about_ca_system_score_codex":0.00016710642,"about_ca_system_score_gemma":0.00041625943,"threshold_uncertainty_score":0.27577502},"labels":[],"label_agreement":null},{"id":"W3173427485","doi":"10.1016/j.jval.2021.04.1274","title":"Opioid Prescribing in United States Health Systems, 2015 to 2019","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Women's College Hospital; St. Michael's Hospital","funders":"U.S. Department of Veterans Affairs","keywords":"Oxycodone; Hydrocodone; Fentanyl; Medicine; Opioid; Medical prescription; Pharmacy; Health care; Emergency medicine; Family medicine; Anesthesia; Pharmacology; Internal medicine","score_opus":0.04718630774174696,"score_gpt":0.3448121681259759,"score_spread":0.29762586038422895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173427485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9167782,0.03587952,0.00006739772,0.04392974,0.00064838305,0.0023605884,0.000119754666,0.00009644895,0.00011996615],"genre_scores_gemma":[0.9587358,0.016166557,0.004418938,0.015815312,0.00022062051,0.0002777114,0.0022056908,0.00013690861,0.002022458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99710274,0.0005484374,0.00082445116,0.00046331625,0.00035217265,0.00070888456],"domain_scores_gemma":[0.9986617,0.00014481407,0.00012993248,0.0005006678,0.00010002097,0.00046285425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000876888,0.00019744369,0.00062516145,0.00053996104,0.00005690665,0.000025422496,0.000081761784,0.000067812434,0.000021827072],"category_scores_gemma":[0.00015302892,0.00019349369,0.000038193855,0.0011904734,0.00001260156,0.000052063886,0.000063001375,0.0002825981,0.000088260254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006780147,0.0056420355,0.4875249,0.019403422,0.00017882074,0.001026271,0.08457725,0.2783052,0.00013068301,0.004459096,0.11070004,0.007374282],"study_design_scores_gemma":[0.023720646,0.0070859743,0.5057911,0.039167315,0.000057655707,0.00031297441,0.051048942,0.09655499,0.00040804953,0.0008313673,0.27351123,0.001509717],"about_ca_topic_score_codex":0.14444639,"about_ca_topic_score_gemma":0.0010767711,"teacher_disagreement_score":0.18175021,"about_ca_system_score_codex":0.0015562904,"about_ca_system_score_gemma":0.0025887138,"threshold_uncertainty_score":0.8612508},"labels":[],"label_agreement":null},{"id":"W3188740930","doi":"10.1016/j.jval.2021.03.016","title":"Development and Validation of an Instrument to Measure Health-Related Out-of-Pocket Costs: The Cost for Patients Questionnaire","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Louis-H Lafontaine; McGill University; Institut Universitaire en Santé Mentale de Québec; Université Laval; Université de Montréal; Université de Sherbrooke","funders":"Canadian Institutes of Health Research; Ministère de la Santé; Fonds de Recherche du Québec - Santé; Ministère de la Santé et des Services sociaux","keywords":"Intraclass correlation; Delphi method; Delphi; Test (biology); Kappa; Medicine; Health care; Content validity; Face validity; Sample (material); Indirect costs; Statistics; Computer science; Psychometrics; Clinical psychology; Business; Mathematics","score_opus":0.35456415368130634,"score_gpt":0.4036578623536867,"score_spread":0.04909370867238039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3188740930","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95558524,0.0020759366,0.0017723602,0.036873203,0.0007336959,0.0026193652,0.00026458118,0.000014335996,0.00006129238],"genre_scores_gemma":[0.98081934,0.00013364182,0.013397816,0.005157001,0.000042024472,0.00023911394,0.00016261818,0.000023419232,0.00002503046],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941377,0.00073153543,0.0043010158,0.0003953434,0.00012645489,0.00030792147],"domain_scores_gemma":[0.9968072,0.00040586593,0.0020749317,0.00033103133,0.00017281645,0.00020812213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016480934,0.00012742696,0.0007310738,0.00020777975,0.00018092076,0.000022160575,0.00013256227,0.00008330776,0.00001499917],"category_scores_gemma":[0.0025986526,0.00014187454,0.00003841059,0.0002438789,0.00003185481,0.00017316859,0.000038466806,0.0001050462,0.000017474109],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024525015,0.0023538542,0.48336044,0.009173471,0.00022872054,7.158022e-7,0.119735815,0.010081986,0.0000072516245,0.24859159,0.0059156017,0.120305315],"study_design_scores_gemma":[0.011581079,0.002678542,0.8160909,0.0070459046,0.000015423388,0.0000080581585,0.014805065,0.023456337,0.00067747803,0.023347078,0.09892487,0.001369309],"about_ca_topic_score_codex":0.003002187,"about_ca_topic_score_gemma":0.0007562562,"teacher_disagreement_score":0.33273044,"about_ca_system_score_codex":0.0014234099,"about_ca_system_score_gemma":0.0010762663,"threshold_uncertainty_score":0.57854754},"labels":[],"label_agreement":null},{"id":"W3190464317","doi":"10.1016/j.jval.2021.04.1277","title":"Reimagining Pharmaceutical Market Exclusivities: Should the Duration of Guaranteed Monopoly Periods Be Value Based?","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Novo Nordisk Fonden","keywords":"Tying; Monopoly; Duration (music); Product (mathematics); Competition (biology); Business; Value (mathematics); New product development; Prescription drug; Generic drug; Pharmaceutical industry; Industrial organization; Medical prescription; Marketing; Economics; Drug; Microeconomics; Computer science; Medicine; Pharmacology","score_opus":0.1694680259873237,"score_gpt":0.36037445588318173,"score_spread":0.19090642989585804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3190464317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49811402,0.02359201,0.004317141,0.3737872,0.00324666,0.0014659368,0.0015564141,0.00011523362,0.093805395],"genre_scores_gemma":[0.97181976,0.0015110199,0.0010664373,0.025017345,0.00019903913,0.000030425223,0.000016554077,0.000034619825,0.00030479653],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99742806,0.00022013979,0.001350093,0.00042311748,0.00006730523,0.0005112783],"domain_scores_gemma":[0.9984832,0.0005031699,0.0004065318,0.00041629613,0.000031275416,0.00015953174],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00249702,0.0001840586,0.00053920696,0.00019671877,0.00015730187,0.00007019272,0.00027129045,0.00009641161,0.0009784785],"category_scores_gemma":[0.00036318682,0.00017352555,0.0001526302,0.0003909377,0.00014779018,0.00014798343,0.000094533425,0.0004924743,0.000030730396],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018763603,0.00045636197,0.03275722,0.0008123747,0.000096961565,0.000023673643,0.0038530764,0.019022476,0.00015888401,0.9303454,0.008597454,0.0036884446],"study_design_scores_gemma":[0.0010862839,0.00005870262,0.0044006533,0.00007732601,0.0000060181496,0.000012511088,0.00025705565,0.7410864,0.0005376616,0.015414347,0.23682922,0.00023377925],"about_ca_topic_score_codex":0.0026098336,"about_ca_topic_score_gemma":0.00003552586,"teacher_disagreement_score":0.9149311,"about_ca_system_score_codex":0.00027829612,"about_ca_system_score_gemma":0.0004591329,"threshold_uncertainty_score":0.99993473},"labels":[],"label_agreement":null},{"id":"W3195770982","doi":"10.1016/j.jval.2021.06.008","title":"Adherence to Clinical Practice Guideline Recommendations on Low-Value Injury Care: A Multicenter Retrospective Cohort Study","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre intégré de santé et de services sociaux de Chaudière-Appalaches; Centre Intégré de Santé et Services Sociaux de Chaudière-Appalache; Université de Sherbrooke; Alberta Health Services; Institut National d'Excellence en Santé et en Services Sociaux; Université Laval; Calgary Laboratory Services; Hôpital de l'Enfant-Jésus","funders":"","keywords":"Medicine; Guideline; Retrospective cohort study; Emergency medicine; Decompressive craniectomy; Health care; Psychological intervention; Blunt; Physical therapy; Traumatic brain injury; Surgery; Nursing","score_opus":0.5737211830408306,"score_gpt":0.6405620772311604,"score_spread":0.06684089419032979,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3195770982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7432136,0.0006292054,0.00070205843,0.22057094,0.011488193,0.016910106,0.00041558134,0.00035095628,0.00571936],"genre_scores_gemma":[0.7783188,0.0014204306,0.038722523,0.1768156,0.0016851274,0.0021141488,0.00018436553,0.00013570482,0.00060326],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.953104,0.037098,0.00534573,0.0017394793,0.0013064247,0.00140635],"domain_scores_gemma":[0.9811997,0.011335926,0.0018092021,0.00183029,0.0027759273,0.0010489894],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.029979026,0.00042952527,0.00125748,0.0003314713,0.0011552315,0.000050249473,0.0004929185,0.00042511566,0.0005731175],"category_scores_gemma":[0.068799436,0.00044270372,0.00014008574,0.0015301161,0.0000690392,0.0005574785,0.00052560196,0.0042847903,0.0015245972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0008031544,0.003594899,0.916583,0.0005102615,0.00009233695,0.000082758175,0.02315407,0.00015632868,0.0000034650511,0.0020060232,0.040249627,0.012764061],"study_design_scores_gemma":[0.0031891405,0.0046588583,0.5893411,0.0022136352,0.00006528465,0.0000056654644,0.0910416,0.0006507374,0.000007700273,0.0002075661,0.3080425,0.00057621533],"about_ca_topic_score_codex":0.0567058,"about_ca_topic_score_gemma":0.0069804797,"teacher_disagreement_score":0.3272419,"about_ca_system_score_codex":0.0041175853,"about_ca_system_score_gemma":0.0070683574,"threshold_uncertainty_score":0.9998025},"labels":[],"label_agreement":null},{"id":"W3199103380","doi":"10.1016/j.jval.2021.07.005","title":"What Is Value in Health and Healthcare? A Systematic Literature Review of Value Assessment Frameworks","year":2021,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":58,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Health care; Weighting; Context (archaeology); Systematic review; Computer science; Actuarial science; Medicine; MEDLINE; Business; Economics; Political science","score_opus":0.38132054323708087,"score_gpt":0.5037583313132762,"score_spread":0.12243778807619532,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199103380","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006593913,0.9149616,0.00021306679,0.07159148,0.0023744707,0.010087016,0.0006706236,0.000037143363,0.000058030237],"genre_scores_gemma":[0.000006969411,0.9355554,0.0048127724,0.057516582,0.00028023246,0.0011302079,0.00040350872,0.00015852287,0.00013578241],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9498389,0.016265789,0.029383859,0.0023598268,0.00054945797,0.0016022144],"domain_scores_gemma":[0.9735585,0.0054286295,0.017679965,0.0021839438,0.00019305912,0.0009559395],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.084442094,0.0010547184,0.017805012,0.001935794,0.00020922918,0.00032577082,0.0007847306,0.0014740255,0.000079955935],"category_scores_gemma":[0.0056893197,0.001181425,0.0008192643,0.002478643,0.00010101572,0.00080149143,0.00024810206,0.003295966,0.00009226382],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000016104817,0.00016441676,0.0001434373,0.9082239,0.000102603175,0.000009146348,0.0029514856,0.000056386325,2.8735248e-10,0.07873187,0.0028101795,0.006804911],"study_design_scores_gemma":[0.00034662746,0.00018581563,0.00002161882,0.78203046,0.000026827152,0.00007713939,0.00068137824,0.0014326852,2.4819644e-9,0.0027618667,0.21188056,0.0005549794],"about_ca_topic_score_codex":0.007669572,"about_ca_topic_score_gemma":0.000104854436,"teacher_disagreement_score":0.20907038,"about_ca_system_score_codex":0.0063724723,"about_ca_system_score_gemma":0.008163505,"threshold_uncertainty_score":0.99982226},"labels":[],"label_agreement":null},{"id":"W3199180667","doi":"10.1016/j.jval.2021.07.012","title":"The Health Value of Kidney Exchange and Altruistic Donation","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Donation; Actuarial science; Robustness (evolution); Value (mathematics); Markov decision process; Quality-adjusted life year; Kidney transplant; Public economics; Kidney transplantation; Transplantation; Economics; Cost effectiveness; Internal medicine; Markov process; Risk analysis (engineering); Statistics; Mathematics; Economic growth","score_opus":0.03347727442108214,"score_gpt":0.31631947376211783,"score_spread":0.2828421993410357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199180667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5188949,0.023063945,0.0023138616,0.44914,0.0012923962,0.0017776113,0.00013138444,0.00009387137,0.0032919801],"genre_scores_gemma":[0.9811315,0.010422921,0.0009914618,0.0069588386,0.00007286226,0.000008053056,0.00009328786,0.000011788125,0.00030931164],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9989288,0.00022472162,0.0003458523,0.00013673594,0.00020849424,0.00015541076],"domain_scores_gemma":[0.99929893,0.00019365501,0.00011891459,0.00012274769,0.00006976917,0.00019600434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077786774,0.000058209604,0.00016731038,0.000076779645,0.00009382835,0.000007721487,0.000024074021,0.000030651907,0.000027823142],"category_scores_gemma":[0.00038704826,0.000046825116,0.00001878804,0.00024502014,0.00003434252,0.000027592298,0.0000071418267,0.00010778382,0.0000031332536],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008237463,0.001271076,0.17774251,0.026283804,0.00015676547,0.000104231476,0.035714038,0.00048513725,0.0014555219,0.492971,0.013064981,0.2499272],"study_design_scores_gemma":[0.008411082,0.0013073637,0.8790064,0.002755258,0.000045838333,0.0003283574,0.0014832835,0.02024679,0.0022307562,0.007806361,0.07611456,0.00026396918],"about_ca_topic_score_codex":0.0012223067,"about_ca_topic_score_gemma":0.00011660668,"teacher_disagreement_score":0.70126384,"about_ca_system_score_codex":0.00011069021,"about_ca_system_score_gemma":0.0011363006,"threshold_uncertainty_score":0.20157486},"labels":[],"label_agreement":null},{"id":"W3199242555","doi":"10.1016/j.jval.2021.05.019","title":"Patient Self-Reported Health, Clinical Quality, and Patient Satisfaction in English Primary Care: Practice-Level Longitudinal Observational Study","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":16,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"EuroQol Research Foundation","keywords":"Bivariate analysis; Medicine; Observational study; Patient satisfaction; Random effects model; Family medicine; Clinical Practice; Quality (philosophy); Health care; Nursing; Statistics; Meta-analysis; Internal medicine","score_opus":0.5043776651335483,"score_gpt":0.5361471046057397,"score_spread":0.03176943947219135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199242555","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97612166,0.0026500607,0.0000323836,0.010046816,0.0049055973,0.0053882464,0.00019286314,0.00022555322,0.00043683156],"genre_scores_gemma":[0.98095423,0.001709221,0.006179195,0.009822954,0.0002884604,0.00070584385,0.00026205785,0.000064209526,0.000013810346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.97226644,0.01702018,0.0066383528,0.0013914083,0.0014687731,0.0012148512],"domain_scores_gemma":[0.9883454,0.0054906784,0.0030369824,0.0008559282,0.001589527,0.00068150426],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.006397762,0.00041395886,0.0012418574,0.00041376695,0.0009770383,0.000028083754,0.000104656334,0.0004210133,0.00006606868],"category_scores_gemma":[0.0059372294,0.00045824016,0.0000996944,0.0011822538,0.00006599277,0.0006227066,0.00032754222,0.0026472926,0.000024023999],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00023543769,0.0008887139,0.9028146,0.0019046192,0.000058772264,0.000065651126,0.06473171,0.00036794663,5.4909344e-7,0.00051690923,0.00060129125,0.027813802],"study_design_scores_gemma":[0.0029945788,0.0013891885,0.9350212,0.0009374981,0.000015144582,0.000015287036,0.055315815,0.00011392703,4.615955e-7,0.00021030227,0.0036720585,0.00031451404],"about_ca_topic_score_codex":0.09022647,"about_ca_topic_score_gemma":0.023531554,"teacher_disagreement_score":0.066694915,"about_ca_system_score_codex":0.0055571515,"about_ca_system_score_gemma":0.010949206,"threshold_uncertainty_score":0.9997869},"labels":[],"label_agreement":null},{"id":"W3200895382","doi":"10.1016/j.jval.2021.08.006","title":"Time Costs and Out-of-Pocket Costs in Patients With Chronic Hepatitis C in a Publicly Funded Health System","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo; Toronto Liver Centre; University of Guelph; Toronto East General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Confidence interval; Health care; Emergency medicine; Total cost; Household income; Indirect costs; Family medicine; Pediatrics; Demography; Environmental health; Internal medicine; Geography; Business","score_opus":0.026278283875487755,"score_gpt":0.23635915929628795,"score_spread":0.2100808754208002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3200895382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9859998,0.009375605,0.00004976255,0.0015705181,0.00031676932,0.00068903493,0.000297057,0.000015111498,0.001686316],"genre_scores_gemma":[0.99738747,0.0015513338,0.0002461995,0.0005952612,0.000040632916,0.000032519263,0.000041540865,0.000028495164,0.00007656464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997509,0.00010048796,0.0012640656,0.0004974755,0.000052526335,0.00057645194],"domain_scores_gemma":[0.9987463,0.00008531086,0.0006425141,0.00030349148,0.000040756895,0.00018164958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011485729,0.00017365968,0.00091032777,0.00042286835,0.000042756135,0.00004043453,0.00012335813,0.00010493072,0.000048364076],"category_scores_gemma":[0.000109865985,0.00020827338,0.000033935168,0.0004608411,0.000056985384,0.00030947503,0.000054317923,0.000234326,0.000042112806],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049833405,0.00014718276,0.9737522,0.0004423763,0.000008884105,0.0000053603067,0.0005468126,0.00032154907,8.8445724e-8,0.018239347,0.00018158392,0.0063047996],"study_design_scores_gemma":[0.0032004097,0.0005155817,0.9882928,0.0009146289,6.5816215e-7,0.0000016609498,0.00006208691,0.0040963916,0.0000022503518,0.00050125364,0.002189955,0.00022229266],"about_ca_topic_score_codex":0.08719804,"about_ca_topic_score_gemma":0.05025869,"teacher_disagreement_score":0.03693935,"about_ca_system_score_codex":0.0042967685,"about_ca_system_score_gemma":0.0006705997,"threshold_uncertainty_score":0.99952555},"labels":[],"label_agreement":null},{"id":"W3205845182","doi":"10.1016/j.jval.2021.08.011","title":"Do You Recall?: Results From a Within-Person Recall Study of the Patient-Reported Outcomes Measurement Information System (PROMIS) Short Form v2.0 – Physical Function 8c","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bayer Canada; Janssen Pharmaceuticals; Pfizer UK; Merck; AstraZeneca Korea; Genentech; Pfizer; Novartis Pharmaceuticals Corporation; Amgen; Bristol-Myers Squibb; Bayer Corporation; AbbVie; U.S. Food and Drug Administration","keywords":"Recall; Raw score; Free recall; Medicine; Recall test; Population; Demography; Physical therapy; Statistics; Psychology; Mathematics; Raw data; Cognitive psychology","score_opus":0.08351097887655864,"score_gpt":0.29320404685958756,"score_spread":0.20969306798302892,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3205845182","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947909,0.00011267509,0.000042411768,0.0011369674,0.0016004365,0.001623021,0.0000451187,0.000054569533,0.0005939051],"genre_scores_gemma":[0.9993642,0.0000063437146,0.0000366443,0.0003158461,0.000093173316,0.00008436248,0.000059674927,0.000014826468,0.000024938909],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967085,0.00039007838,0.0010368143,0.00031690497,0.0013230233,0.00022466159],"domain_scores_gemma":[0.998152,0.00007831132,0.0004948449,0.000703929,0.00044775257,0.00012314713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013681516,0.0001755673,0.00053570577,0.00009157307,0.00009022154,0.0000220584,0.000082310034,0.00008383432,0.000003214286],"category_scores_gemma":[0.00045042174,0.00012050439,0.00012923924,0.00048033256,0.000016918842,0.00014592875,0.00004210133,0.00033227346,0.000002743421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007915288,0.0033632696,0.5320685,0.0029599525,0.0009005923,0.000063374326,0.37009114,0.00272483,0.0005074237,0.0004088444,0.001060483,0.07793633],"study_design_scores_gemma":[0.010885716,0.003641891,0.7756235,0.003555473,0.00040048957,0.000028712895,0.1949525,0.0080534145,0.0011901144,0.00006903423,0.0012145598,0.0003845574],"about_ca_topic_score_codex":0.022240411,"about_ca_topic_score_gemma":0.0039541963,"teacher_disagreement_score":0.24355505,"about_ca_system_score_codex":0.0010620331,"about_ca_system_score_gemma":0.0006667033,"threshold_uncertainty_score":0.9842706},"labels":[],"label_agreement":null},{"id":"W3208421062","doi":"10.1016/j.jval.2021.09.015","title":"Rasch Analysis of the Michigan Hand Questionnaire","year":2021,"lang":"fr","type":"article","venue":"Value in Health","topic":"Orthopedic Surgery and Rehabilitation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University","funders":"Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Rasch model; Polytomous Rasch model; Psychology; Construct validity; Differential item functioning; Scale (ratio); Reliability (semiconductor); Construct (python library); Thumb; Clinical psychology; Psychometrics; Item response theory; Medicine; Developmental psychology; Computer science","score_opus":0.025148740710454386,"score_gpt":0.31346259356938366,"score_spread":0.2883138528589293,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3208421062","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87671405,0.07994245,0.0001267673,0.039634157,0.00311756,0.0002180428,0.000021810984,0.000006307446,0.00021887952],"genre_scores_gemma":[0.99179214,0.0027413848,0.00022828647,0.00081317395,0.00026023795,0.0000051282996,0.000020330092,0.000009998335,0.004129302],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969861,0.0014768132,0.00071287336,0.00024483367,0.00029508755,0.00028428194],"domain_scores_gemma":[0.9984711,0.00062394247,0.00021222244,0.00041327436,0.00014630795,0.00013315062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019770274,0.000102134094,0.00050632755,0.00023308795,0.00011060699,0.000008159711,0.000052546286,0.00012440103,0.00019813338],"category_scores_gemma":[0.0015466277,0.000079071884,0.00027328893,0.0027986453,0.00024355973,0.000046768313,0.000029682498,0.00027950597,0.000008304915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003120034,0.00054675736,0.9268144,0.0020601742,0.0003927381,0.000021939715,0.008521578,0.0189058,0.00046647014,0.003685979,0.00014708839,0.038405888],"study_design_scores_gemma":[0.00047418874,0.00012512151,0.96914834,0.004143518,0.0006098661,0.000014163248,0.0014415024,0.015247117,0.0008139697,0.00031374735,0.007587331,0.00008115588],"about_ca_topic_score_codex":0.0061302045,"about_ca_topic_score_gemma":0.0018455874,"teacher_disagreement_score":0.11507813,"about_ca_system_score_codex":0.00014880479,"about_ca_system_score_gemma":0.0017201921,"threshold_uncertainty_score":0.9267076},"labels":[],"label_agreement":null},{"id":"W3216773004","doi":"10.1016/j.jval.2021.10.004","title":"Parametric Survival Extrapolation of Early Survival Data in Economic Analyses: A Comparison of Projected Versus Observed Updated Survival","year":2021,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute","keywords":"Survival analysis; Medicine; Statistics; Randomized controlled trial; Extrapolation; Parametric statistics; Mathematics; Surgery","score_opus":0.8939621023731137,"score_gpt":0.5850169261698159,"score_spread":0.30894517620329776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216773004","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020595195,0.9666077,0.00027705732,0.0003919959,0.0033715405,0.0031777024,0.0051221945,0.000042966865,0.00041365947],"genre_scores_gemma":[0.021795321,0.96818066,0.0022384513,0.000043351905,0.00033207788,0.00014263821,0.007056386,0.00016804569,0.000043087737],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9680021,0.007702207,0.020925581,0.001981397,0.0003702618,0.0010184842],"domain_scores_gemma":[0.9737675,0.008046305,0.015007529,0.002749619,0.00014062355,0.0002883965],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.043199793,0.00073194306,0.011756926,0.0034014639,0.00009077096,0.000082089806,0.0016551336,0.00076900405,0.00019672043],"category_scores_gemma":[0.006882815,0.0009486125,0.00053360214,0.0033492073,0.00013690053,0.00062921277,0.00038103212,0.0009855856,0.00013839811],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009106029,0.0058817687,0.4852642,0.24971195,0.0047679963,0.000024073122,0.008675391,0.032898534,5.3659767e-7,0.12927085,0.0039715734,0.078622505],"study_design_scores_gemma":[0.018761527,0.002485705,0.0772135,0.049684905,0.000751028,0.000009887238,0.0071171992,0.24028109,0.0000013827217,0.0016382942,0.5960142,0.0060412935],"about_ca_topic_score_codex":0.12018709,"about_ca_topic_score_gemma":0.008486632,"teacher_disagreement_score":0.5920426,"about_ca_system_score_codex":0.0030889148,"about_ca_system_score_gemma":0.00535486,"threshold_uncertainty_score":0.9992964},"labels":[],"label_agreement":null},{"id":"W4200113032","doi":"10.1016/j.jval.2021.10.018","title":"Economic Evaluation of In-Hospital Clinical Practices in Acute Injury Care: A Systematic Review","year":2021,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":13,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Université de Montréal; University of Calgary; Université Laval; Hôpital de l'Enfant-Jésus","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Canada Research Chairs","keywords":"Medicine; Psychological intervention; Economic evaluation; MEDLINE; Health care; Randomized controlled trial; Cost effectiveness; Acute care; Protocol (science); Emergency department; Systematic review; Evidence-based medicine; Family medicine; Emergency medicine; Intensive care medicine; Medical emergency; Alternative medicine; Nursing; Internal medicine","score_opus":0.8123009844441162,"score_gpt":0.692925247875254,"score_spread":0.11937573656886225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4200113032","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010428965,0.9636717,5.7528064e-7,0.004255344,0.0031746302,0.027377216,0.0001917765,0.00003447892,0.00025142435],"genre_scores_gemma":[0.00024020404,0.99207914,0.00024294581,0.0019073803,0.00032159517,0.0047975085,0.00026534483,0.00011863428,0.00002724011],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.80833566,0.16845258,0.018829655,0.001638814,0.0013953188,0.0013479989],"domain_scores_gemma":[0.9522621,0.021314552,0.023231545,0.0020774268,0.0007097707,0.00040461804],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["metaresearch","research_integrity"],"category_scores_codex":[0.12636307,0.0006977749,0.010742277,0.0009533293,0.00015874417,0.000021126283,0.0008735597,0.0013507827,0.00016012014],"category_scores_gemma":[0.052705374,0.0006358963,0.00062044704,0.001472855,0.00009157842,0.00058938935,0.00039360698,0.005614823,0.00038501146],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00001114002,0.0002983675,0.0026036277,0.9335197,0.00010807208,0.000021021571,0.0019826167,0.000003996664,9.785511e-10,0.0003776009,0.0004061525,0.060667664],"study_design_scores_gemma":[0.00066539267,0.00033933195,0.00031606678,0.923398,0.0013332465,0.000008574037,0.0018575604,0.00009637842,4.392973e-9,0.00006473878,0.07150585,0.00041480974],"about_ca_topic_score_codex":0.025333295,"about_ca_topic_score_gemma":0.007341996,"teacher_disagreement_score":0.14713801,"about_ca_system_score_codex":0.009577985,"about_ca_system_score_gemma":0.054147683,"threshold_uncertainty_score":0.9999457},"labels":[],"label_agreement":null},{"id":"W4205090700","doi":"10.1016/j.jval.2021.11.1253","title":"POSB390 Characterisation of the Management Pathway for Muscle-Invasive Urothelial Carcinoma (MIUC) from Physician Perspectives in France, Germany, Italy, Spain, UK (EU5), US, Canada, China, and Japan","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Neoadjuvant therapy; Adjuvant therapy; Adjuvant; Workload; Family medicine; Demographics; China; Adjuvant chemotherapy; Disease; Internal medicine; General surgery; Chemotherapy; Cancer; Demography","score_opus":0.014646910119070398,"score_gpt":0.24073067759258132,"score_spread":0.22608376747351092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205090700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99281484,0.0010286951,0.000005260855,0.0027908282,0.00026780376,0.0019418945,0.00088204024,0.000007667328,0.00026095228],"genre_scores_gemma":[0.99765384,0.00012939869,0.00008154002,0.0014955142,0.00014462226,0.0002775188,0.000056848403,0.000025081086,0.00013562362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985609,0.00016990835,0.00033894854,0.00033862426,0.0003158587,0.00027577984],"domain_scores_gemma":[0.9993839,0.000067887195,0.00018142027,0.00026785082,0.000027239366,0.00007165213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021149345,0.00015611795,0.0003382846,0.000105056104,0.00015244394,0.000006406181,0.00011040911,0.000027304146,0.000032158463],"category_scores_gemma":[0.000011895488,0.00013386323,0.000060742153,0.00021838598,0.00003950886,0.000037535414,0.0000705366,0.00018270536,2.8883096e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008905123,0.0011882312,0.91639125,0.0014644283,0.00032152166,0.00006991976,0.05196542,0.00068408553,0.0027125382,0.0017709342,0.00039646882,0.022144686],"study_design_scores_gemma":[0.0028532378,0.00039349587,0.99054235,0.00016139391,0.000032162705,0.000002572886,0.0040256875,0.00035687667,0.00032944846,0.00035433925,0.0008435886,0.0001048292],"about_ca_topic_score_codex":0.69765717,"about_ca_topic_score_gemma":0.08345249,"teacher_disagreement_score":0.61420465,"about_ca_system_score_codex":0.0008367762,"about_ca_system_score_gemma":0.0009079246,"threshold_uncertainty_score":0.9332721},"labels":[],"label_agreement":null},{"id":"W4205130677","doi":"10.1016/j.jval.2021.11.295","title":"POSA154 A Comparison of the Costs of Atrial Fibrillation Ablation Using Radiofrequency and Cryobaloon Technologies in the United Kingdom and Italy","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Atrial fibrillation; Guideline; Catheter ablation; Emergency medicine; Radiofrequency ablation; Ablation; Health care; Cardiology","score_opus":0.16069491005307293,"score_gpt":0.3878266112819413,"score_spread":0.22713170122886836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205130677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991865,0.0020182598,0.00004242414,0.0051459316,0.000092013215,0.0007992222,0.0000037887785,0.0000131466295,0.000020205734],"genre_scores_gemma":[0.99943066,0.00015183083,0.0003308597,0.000028221213,0.000042073705,6.2502977e-7,0.0000084430685,0.000004520888,0.0000027468368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988191,0.000305492,0.00044798496,0.00010302056,0.00022992816,0.00009448355],"domain_scores_gemma":[0.99923015,0.0002914362,0.00031322805,0.00013561094,0.000020033616,0.0000095243195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008993377,0.00005992373,0.00023941451,0.00029887052,0.000094689385,0.0000058705696,0.000052422776,0.000033774322,0.000001949584],"category_scores_gemma":[0.0002602487,0.00004119268,0.000036293673,0.0008443455,0.000047349513,0.000042747302,0.00006304127,0.00011857286,2.796107e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012626956,0.000003903805,0.9466477,0.00011328463,0.000008024253,3.5866026e-7,0.0010316034,0.04224568,0.00018650829,0.0051762424,0.00000809795,0.0044523417],"study_design_scores_gemma":[0.0033114296,0.00057380524,0.7524698,0.00034250368,0.00006270828,0.000016442653,0.0056128823,0.2328167,0.000118743614,0.0024205607,0.0021461723,0.00010825547],"about_ca_topic_score_codex":0.0065855067,"about_ca_topic_score_gemma":0.00003919416,"teacher_disagreement_score":0.1941779,"about_ca_system_score_codex":0.00020144637,"about_ca_system_score_gemma":0.00006356089,"threshold_uncertainty_score":0.99553597},"labels":[],"label_agreement":null},{"id":"W4205164366","doi":"10.1016/j.jval.2021.11.639","title":"POSB201 Effectiveness and Safety of Low Versus High Dose Rivaroxaban and Apixaban for Atrial Fibrillation: Propensity Score-Matched Cohort Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Université de Montréal","funders":"","keywords":"Rivaroxaban; Apixaban; Medicine; Atrial fibrillation; Propensity score matching; Internal medicine; Hazard ratio; Cohort; Stroke (engine); Myocardial infarction; Cardiology; Warfarin; Confidence interval","score_opus":0.09249093714176072,"score_gpt":0.3493307644094097,"score_spread":0.256839827267649,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205164366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9911694,0.00029018513,0.000051597322,0.00096205046,0.00056696724,0.0068835085,0.000025286534,0.000027724882,0.0000232578],"genre_scores_gemma":[0.99921983,0.00007715231,0.00021893445,0.000023175737,0.00035941476,0.0000127142,0.000040106122,0.000016520966,0.00003214433],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822855,0.00047912117,0.00047488618,0.0003248043,0.00030472648,0.00018792241],"domain_scores_gemma":[0.99869746,0.00074227125,0.00021906,0.00019946639,0.00005261958,0.0000891449],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022732955,0.0001288721,0.0006292795,0.00014821604,0.00021550183,0.000011118339,0.000041274372,0.00003292325,0.000017453704],"category_scores_gemma":[0.00023942257,0.0001197532,0.00007329989,0.00025214022,0.000043660144,0.000067120964,0.00013879193,0.000097126635,4.473702e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013430974,0.000019884905,0.9778783,0.00069121976,0.00011572004,0.0000033005979,0.00048962625,0.0045739585,0.00001879194,0.00063888036,0.000012488582,0.0021269026],"study_design_scores_gemma":[0.016556028,0.002451339,0.978817,0.000066926,0.0000878835,0.0000038256717,0.00022413439,0.0011761779,0.000014264419,0.00018609814,0.0003144994,0.000101857484],"about_ca_topic_score_codex":0.0018407021,"about_ca_topic_score_gemma":0.00002931035,"teacher_disagreement_score":0.008050415,"about_ca_system_score_codex":0.00019561789,"about_ca_system_score_gemma":0.0001512549,"threshold_uncertainty_score":0.48833936},"labels":[],"label_agreement":null},{"id":"W4205192480","doi":"10.1016/j.jval.2021.11.1364","title":"Cost-Effectiveness of Extracorporeal Photopheresis for the Treatment of Patients With Erythrodermic (Stage T4, M0) Cutaneous T-Cell Lymphoma in the Australian Setting","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cutaneous lymphoproliferative disorders research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Mallinckrodt Pharmaceuticals","keywords":"Medicine; Extracorporeal Photopheresis; Cutaneous T-cell lymphoma; Quality of life (healthcare); Lymphoma; Intensive care medicine; Disease; Mycosis fungoides; Internal medicine; Graft-versus-host disease","score_opus":0.06604903885238529,"score_gpt":0.34829919069375,"score_spread":0.2822501518413647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205192480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98993975,0.0004520275,0.00002646565,0.00047087442,0.00004797495,0.008580078,0.00038279843,0.000008359334,0.00009165993],"genre_scores_gemma":[0.9979855,0.0001683996,0.00016115559,0.00009525683,0.000015047266,0.0012551297,0.00010353775,0.000035527664,0.00018047809],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99696916,0.0010544688,0.00053728773,0.00033087368,0.0006389557,0.00046927397],"domain_scores_gemma":[0.99694,0.0021721853,0.00027767662,0.00043202945,0.00011101767,0.00006706235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010983087,0.00019447872,0.000504992,0.00017504551,0.00019833396,0.000008280446,0.00021127462,0.000042241987,0.000053128446],"category_scores_gemma":[0.000075110496,0.00011737601,0.0001067751,0.0005438426,0.00014032802,0.000023182693,0.000029196528,0.00013628697,4.893761e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018000461,0.014069392,0.8650639,0.0036785468,0.00016865134,0.00031378242,0.017356971,0.043241594,0.0008075593,0.00013933994,0.00014665592,0.03701317],"study_design_scores_gemma":[0.088315174,0.06714821,0.7266912,0.0013324077,0.00027456312,0.0010556515,0.049682975,0.042272657,0.012941474,0.00043365307,0.008920751,0.00093129446],"about_ca_topic_score_codex":0.013890336,"about_ca_topic_score_gemma":0.00059988344,"teacher_disagreement_score":0.13837269,"about_ca_system_score_codex":0.0011457086,"about_ca_system_score_gemma":0.00094473705,"threshold_uncertainty_score":0.99267626},"labels":[],"label_agreement":null},{"id":"W4205213502","doi":"10.1016/j.jval.2021.11.1323","title":"POSA421 Two Sensitization Methods: to Enhance Participant Engagement During the Conduct on Online Discrete Choice Experiments: A Case Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Sensitization; Respondent; Context (archaeology); McNemar's test; Phone; Medicine; Wilcoxon signed-rank test; Psychology; Statistics; Mathematics; Internal medicine; Immunology; Mann–Whitney U test","score_opus":0.39329200089804156,"score_gpt":0.4288814689573522,"score_spread":0.035589468059310625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205213502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945899,0.00044265427,0.0005997122,0.0025155775,0.00035650586,0.0012898599,0.00008811708,0.00001575154,0.00010192315],"genre_scores_gemma":[0.99627084,0.000035511574,0.0018401034,0.0011781454,0.000075148564,0.00035995318,0.000018251885,0.000024674218,0.00019740422],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.997574,0.0007305846,0.00082373637,0.00049075426,0.000060856553,0.0003201015],"domain_scores_gemma":[0.9989714,0.00022552555,0.00032331378,0.00038705004,0.0000039065285,0.000088804685],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033114033,0.00013829739,0.00029849535,0.00015161897,0.00050496554,0.000029183126,0.00013405991,0.000014301252,0.00032431085],"category_scores_gemma":[0.00011995722,0.0001426914,0.000041610434,0.0002202113,0.000016834034,0.000098162294,0.00018566239,0.00024493897,0.00006358678],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006689486,0.0015295184,0.14974582,0.000052021085,0.00008566935,0.000081290265,0.044544682,0.79660654,0.00032706076,0.0046516606,0.0000664558,0.002242374],"study_design_scores_gemma":[0.0073528565,0.005011448,0.59532183,0.00013069,0.0000437446,0.00025079533,0.15454341,0.2199859,0.0019165133,0.0036679744,0.009975991,0.0017988412],"about_ca_topic_score_codex":0.014826896,"about_ca_topic_score_gemma":0.00033014934,"teacher_disagreement_score":0.57662064,"about_ca_system_score_codex":0.0009887645,"about_ca_system_score_gemma":0.000024450908,"threshold_uncertainty_score":0.99173343},"labels":[],"label_agreement":null},{"id":"W4205227233","doi":"10.1016/j.jval.2021.11.185","title":"POSA39 Cost-Effectiveness Analysis of Nivolumab for the Adjuvant Treatment of Patients with Resected Esophageal Cancer (EC) or Gastroesophageal Junction Cancer (GEJC) in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada); Precision Nanosystems (Canada)","funders":"","keywords":"Nivolumab; Medicine; Esophageal cancer; Population; Internal medicine; Oncology; Cancer; Esophagectomy; Clinical endpoint; Clinical trial; Immunotherapy","score_opus":0.05022544396001486,"score_gpt":0.3513786160326748,"score_spread":0.3011531720726599,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205227233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9825087,0.0097580785,0.000028748702,0.00043517892,0.00017090996,0.0049111624,0.0021763854,0.000007257048,0.0000035395335],"genre_scores_gemma":[0.9943413,0.0006709617,0.000059200815,0.000078514204,0.00003145744,0.004428138,0.00030799158,0.000026888642,0.000055526678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971409,0.00051451445,0.00058421557,0.00039953782,0.0008128054,0.0005480449],"domain_scores_gemma":[0.99834096,0.00061500014,0.0003193427,0.00034673297,0.00020082842,0.00017711574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004609367,0.00020976613,0.00090460933,0.00045917716,0.00015005784,0.0000038620096,0.00011669031,0.000026760956,0.00024542565],"category_scores_gemma":[0.00003890872,0.00012916658,0.0001170526,0.0019321808,0.00005755979,0.00003991603,0.000034335724,0.00018700039,6.409568e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.015953222,0.00095601496,0.8281282,0.0003184555,0.0009784237,0.00006681312,0.0004760947,0.13601285,0.0000035424248,0.000009947106,0.00003964313,0.017056799],"study_design_scores_gemma":[0.0123846475,0.0076477644,0.96444595,0.00012864634,0.0004412674,0.0000015577172,0.00027644224,0.014263248,0.00026126034,0.0000035119865,0.00007246273,0.00007321989],"about_ca_topic_score_codex":0.98551357,"about_ca_topic_score_gemma":0.9518047,"teacher_disagreement_score":0.13631777,"about_ca_system_score_codex":0.013115481,"about_ca_system_score_gemma":0.010149398,"threshold_uncertainty_score":0.9954621},"labels":[],"label_agreement":null},{"id":"W4205278684","doi":"10.1016/j.jval.2021.11.1124","title":"POSB357 Health State Utilities for Patients with Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Myeloid leukemia; Adverse effect; Clinical trial; Quality of life (healthcare); Population; Internal medicine; Demography; Pediatrics; Environmental health","score_opus":0.22660836271440996,"score_gpt":0.3902736951606705,"score_spread":0.16366533244626055,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205278684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8323791,0.0039737057,0.008389036,0.13122158,0.0012844042,0.0102034705,0.01230034,0.00012089112,0.00012746909],"genre_scores_gemma":[0.6460346,0.0035892874,0.03125169,0.3035817,0.0007269444,0.008606448,0.0019786956,0.00050308625,0.0037275215],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99363273,0.00045983703,0.0039122575,0.000828688,0.00016513692,0.00100136],"domain_scores_gemma":[0.9942514,0.0011244066,0.003568566,0.0005243578,0.00023587864,0.00029543953],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012015092,0.00029534256,0.0016569961,0.00056893064,0.0006808237,0.000057625984,0.00034194745,0.00006962904,0.00007375268],"category_scores_gemma":[0.0008819406,0.00036171527,0.00013917925,0.00035231325,0.00006212293,0.00029396513,0.000068640984,0.0002998228,0.000026988224],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003256956,0.0010588351,0.36508292,0.010746502,0.0006406887,0.0000025062839,0.07691942,0.052899785,4.9748894e-7,0.09785489,0.38666338,0.0048736185],"study_design_scores_gemma":[0.025295185,0.008992332,0.11780154,0.0011312386,0.000013349026,0.000013035202,0.025915025,0.080768205,0.000006488132,0.08404343,0.6540899,0.0019302401],"about_ca_topic_score_codex":0.010065663,"about_ca_topic_score_gemma":0.00037177265,"teacher_disagreement_score":0.26742655,"about_ca_system_score_codex":0.0053440435,"about_ca_system_score_gemma":0.0019166168,"threshold_uncertainty_score":0.9998835},"labels":[],"label_agreement":null},{"id":"W4205288848","doi":"10.1016/j.jval.2021.11.612","title":"POSB174 Clinical and Economic Impact of Non-Pharmacological Interventions on the COVID-19 Pandemic: A Predictive Model Based on the Spanish Case","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Psychological intervention; Economic impact analysis; Gross domestic product; Quarter (Canadian coin); Index (typography); Health care; Econometrics; Healthcare system; Economic cost; Economics; Development economics; Medicine; Geography; Economic growth; Disease; Infectious disease (medical specialty); Computer science","score_opus":0.7274146615997276,"score_gpt":0.5643975778910673,"score_spread":0.1630170837086603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205288848","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9233053,0.0003116771,0.0026818714,0.068531774,0.00034719735,0.002030898,0.0024064877,0.000026026755,0.00035879156],"genre_scores_gemma":[0.9646298,0.00014800364,0.00018392362,0.03444928,0.00010062899,0.00041404046,0.000015730891,0.000021563334,0.00003696963],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9918434,0.0031948877,0.0038954169,0.0005788554,0.00009603649,0.00039141858],"domain_scores_gemma":[0.987554,0.00953531,0.0020820433,0.0004996608,0.00001768158,0.00031128115],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.048106253,0.00018781603,0.0008436527,0.0002777928,0.000577852,0.000032477405,0.0003507281,0.00009502798,0.0007945676],"category_scores_gemma":[0.003490834,0.00015205232,0.00035837252,0.00016533314,0.00020257814,0.00008418179,0.00013170434,0.0007516539,0.00005616458],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019373844,0.0003421249,0.13430728,0.00015625285,0.000075247684,0.000007897599,0.0013533054,0.81429404,1.461248e-7,0.03323582,0.015979301,0.000054831893],"study_design_scores_gemma":[0.0012077997,0.0013577321,0.015541391,0.00004931426,0.000007453213,0.000049052964,0.00087759155,0.97075313,8.7421085e-8,0.009443741,0.00057776255,0.00013493413],"about_ca_topic_score_codex":0.013403641,"about_ca_topic_score_gemma":0.00027016475,"teacher_disagreement_score":0.15645908,"about_ca_system_score_codex":0.003161013,"about_ca_system_score_gemma":0.0016819562,"threshold_uncertainty_score":0.9931662},"labels":[],"label_agreement":null},{"id":"W4205289006","doi":"10.1016/j.jval.2021.11.103","title":"POSA30 Canadian Real-World Experience with Nivolumab in Patients with Advanced Non-Small Cell Lung Cancer Previously Treated with Systemic Anticancer Therapy","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Nivolumab; Medicine; Lung cancer; Regimen; Internal medicine; Stage (stratigraphy); Oncology; Population; Cancer; Database; Immunotherapy","score_opus":0.012919443884347018,"score_gpt":0.26732898897647517,"score_spread":0.25440954509212815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205289006","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912847,0.004006004,0.000004810898,0.00043984814,0.000101418875,0.0037087745,0.000056408782,0.00003988648,0.00035814356],"genre_scores_gemma":[0.9951438,0.0018445025,0.00021079057,0.0011831057,0.000026761209,0.0011014845,0.000047794947,0.00007800761,0.0003637766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973415,0.00020452327,0.00051062735,0.00060488156,0.00048823238,0.0008502256],"domain_scores_gemma":[0.9988008,0.000039944378,0.00027971086,0.0004796476,0.00009196155,0.00030791375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031209292,0.00031522382,0.0005973989,0.00048774222,0.0002148771,0.000018141118,0.0001910107,0.00004433761,0.0001395365],"category_scores_gemma":[0.0000023395223,0.00022995617,0.000035319707,0.001612747,0.0000870495,0.00009837771,0.000016639608,0.00039088287,5.571157e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01082009,0.00025906935,0.97433233,0.00037031787,0.000053146883,0.00007686402,0.0066072843,0.0042311884,0.000079918536,0.0000027184037,0.00006380182,0.003103285],"study_design_scores_gemma":[0.022135686,0.0055423197,0.9653641,0.002828822,0.000023563663,0.000024660338,0.0016842228,0.00093146885,0.00018483726,4.4718456e-7,0.0008412649,0.00043859376],"about_ca_topic_score_codex":0.8255104,"about_ca_topic_score_gemma":0.4934447,"teacher_disagreement_score":0.3320657,"about_ca_system_score_codex":0.0047700796,"about_ca_system_score_gemma":0.004384643,"threshold_uncertainty_score":0.99905044},"labels":[],"label_agreement":null},{"id":"W4205351508","doi":"10.1016/j.jval.2021.04.274","title":"PCN183 A Cost-Effectiveness Analysis of Nivolumab plus Ipilimumab plus Two Cycles of Platinum Doublet-Chemotherapy Versus Platinum Doublet Chemotherapy in the First-Line Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer in Canada","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Ipilimumab; Nivolumab; Medicine; Oncology; Internal medicine; Chemotherapy; Progression-free survival; Quality of life (healthcare); Lung cancer; Cancer; Immunotherapy","score_opus":0.2546435512431814,"score_gpt":0.4184204429304267,"score_spread":0.1637768916872453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205351508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9846984,0.006169064,0.0002939402,0.0037959404,0.00048062607,0.002920219,0.0014796316,0.0000067429646,0.0001554023],"genre_scores_gemma":[0.9937765,0.00439193,0.0004325124,0.00066093367,0.00006774802,0.00048147392,0.00009745512,0.000042891774,0.00004856599],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99260503,0.00090030476,0.00488355,0.00073930016,0.00024143804,0.00063034677],"domain_scores_gemma":[0.9924829,0.0033175529,0.0031687578,0.0007949913,0.00010983426,0.0001259351],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006768257,0.00035538318,0.0027363333,0.00080408494,0.00007633313,0.000019708916,0.00036299194,0.00013602404,0.00027157462],"category_scores_gemma":[0.00021447049,0.00035615303,0.00021544524,0.0017975076,0.00006230284,0.00012306971,0.000033776596,0.00023746848,0.000001799074],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0026465594,0.00078192196,0.36379734,0.0030115067,0.00046571164,0.000009280279,0.017948663,0.6087897,0.0000059013933,0.0006585595,0.00009083845,0.0017940042],"study_design_scores_gemma":[0.05101226,0.000927639,0.30833417,0.001108871,0.00007358144,0.0000013838123,0.006505903,0.6291805,0.00035845343,0.00013364357,0.0017694146,0.0005941734],"about_ca_topic_score_codex":0.9399634,"about_ca_topic_score_gemma":0.95019734,"teacher_disagreement_score":0.05546318,"about_ca_system_score_codex":0.011353265,"about_ca_system_score_gemma":0.007027367,"threshold_uncertainty_score":0.999889},"labels":[],"label_agreement":null},{"id":"W4205417271","doi":"10.1016/j.jval.2021.12.002","title":"Cost and Cost-Effectiveness of a Digital Adherence Technology for Tuberculosis Treatment Support in Uganda","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Government of Canada; Bill and Melinda Gates Foundation; United States Agency for International Development","keywords":"Cost effectiveness; Marginal cost; Medicine; Cost–benefit analysis; Time horizon; Randomized controlled trial; Total cost; Operations management; Physical therapy; Risk analysis (engineering); Business; Economics; Surgery; Finance","score_opus":0.1194410942274034,"score_gpt":0.4133505954305272,"score_spread":0.2939095012031238,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205417271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898202,0.00097284163,0.00005345538,0.005253238,0.00005386655,0.003480065,0.00022926662,0.00001839447,0.00011866399],"genre_scores_gemma":[0.99671364,0.0006611019,0.00017982701,0.00015271644,0.000011326834,0.0021487994,0.000089677174,0.000012982877,0.000029915464],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983278,0.0003339883,0.00041647992,0.00032224803,0.00012828468,0.00047122026],"domain_scores_gemma":[0.9985742,0.0009801334,0.00007618739,0.00019433229,0.000035400488,0.00013972036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013844064,0.000110771725,0.0005973763,0.0004359878,0.00005627403,0.000003314673,0.00006812625,0.0000684351,0.00003056396],"category_scores_gemma":[0.0006372535,0.000097019256,0.00005016253,0.00045271058,0.00010329051,0.00003886733,0.00007654818,0.00021357677,0.000001584171],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014879096,0.00074961694,0.9294813,0.00075952266,0.000042281194,0.000039898634,0.00034818926,0.0006371062,0.00030199264,0.0008301152,0.00015116917,0.06517086],"study_design_scores_gemma":[0.03684922,0.07168496,0.8058236,0.0010232008,0.00006380057,0.00093049026,0.0041860323,0.020796392,0.0029135204,0.009427187,0.045683037,0.00061852986],"about_ca_topic_score_codex":0.0039436496,"about_ca_topic_score_gemma":0.00016085517,"teacher_disagreement_score":0.1236577,"about_ca_system_score_codex":0.0008157724,"about_ca_system_score_gemma":0.00054021773,"threshold_uncertainty_score":0.59616446},"labels":[],"label_agreement":null},{"id":"W4205445180","doi":"10.1016/j.jval.2021.11.181","title":"POSC35 Venetoclax Combination Therapies Show Significant Improvements in Overall Survival and Remission in Treatment-Naïve Patients with AML Who Are Ineligible for Intensive Chemotherapy: A Network Meta-Analysis","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University","funders":"","keywords":"Venetoclax; Azacitidine; Decitabine; Cytarabine; Medicine; Myeloid leukemia; Oncology; Internal medicine; Ven; Chemotherapy; Meta-analysis; Lorazepam; Leukemia; Psychiatry; Chronic lymphocytic leukemia; Computer science","score_opus":0.07826583072483097,"score_gpt":0.33380613268509246,"score_spread":0.2555403019602615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205445180","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900158,0.0012366131,0.0000642255,0.004946155,0.00003951801,0.0035757564,0.00008708597,0.000016226968,0.000018597271],"genre_scores_gemma":[0.99630105,0.00051985757,0.00055779907,0.0013250537,0.000024419245,0.00070808723,0.00028644555,0.0000437515,0.00023354622],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723136,0.00056440354,0.00058687717,0.0005497313,0.0005191438,0.0005484787],"domain_scores_gemma":[0.9987255,0.00032116126,0.00030229051,0.00031614007,0.00019639193,0.00013852621],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012838546,0.00024828882,0.0012851357,0.00064527034,0.000121057055,0.000021436255,0.000107438034,0.000067133464,0.000041935524],"category_scores_gemma":[0.00009309809,0.000185656,0.00015322318,0.0012168724,0.00004046032,0.00007851764,0.00006763399,0.00033063415,2.6287967e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005715673,0.00094802596,0.9496889,0.00027356163,0.0069753234,0.000035581063,0.005084485,0.027088124,0.00011893633,0.00016218623,0.0005248252,0.0033843848],"study_design_scores_gemma":[0.041885957,0.010376477,0.81320804,0.00022072639,0.0030608564,0.0000029593784,0.004521605,0.12332958,0.0001337628,0.0014951908,0.001228245,0.0005365854],"about_ca_topic_score_codex":0.015202226,"about_ca_topic_score_gemma":0.00073818996,"teacher_disagreement_score":0.13648084,"about_ca_system_score_codex":0.0036063422,"about_ca_system_score_gemma":0.0006516575,"threshold_uncertainty_score":0.9913556},"labels":[],"label_agreement":null},{"id":"W4205481831","doi":"10.1016/j.jval.2021.11.1147","title":"POSB380 General Population Reference Values for the Promis Global Health in Hungary","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Mental health; Population; Demography; Patient-Reported Outcomes Measurement Information System; Gerontology; Environmental health; Psychometrics; Clinical psychology; Psychiatry; Computerized adaptive testing","score_opus":0.08872762529206583,"score_gpt":0.36976151017928055,"score_spread":0.2810338848872147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205481831","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.414908,0.0024329047,0.00026161314,0.57566,0.0018267933,0.0031308369,0.0001326405,0.0001295565,0.0015176366],"genre_scores_gemma":[0.82793915,0.00027226424,0.000732456,0.1690522,0.0011197452,0.00043925305,0.00033993545,0.00002497392,0.000080006095],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722564,0.0003433252,0.00091676135,0.0003620217,0.0002163118,0.0009359282],"domain_scores_gemma":[0.9989598,0.00021653817,0.00047225307,0.00026901357,0.00004073877,0.00004165767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005516077,0.0001545989,0.0003991473,0.00016588601,0.0006996277,0.000048901566,0.00035643455,0.00005335257,0.000044109936],"category_scores_gemma":[0.00038136396,0.00012941152,0.00005629631,0.0008241246,0.000027994438,0.00023540243,0.00024175472,0.00030840497,0.00000864132],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012229197,0.00015599956,0.06994597,0.00070445886,0.000008058922,0.00000137793,0.00016016935,0.29381832,3.5166846e-7,0.3919418,0.2224054,0.020735797],"study_design_scores_gemma":[0.0006010525,0.0000909284,0.20909642,0.000035172503,0.0000020821885,0.000003462667,0.00037085617,0.2888765,1.0247713e-8,0.03625827,0.4645411,0.00012410955],"about_ca_topic_score_codex":0.5650455,"about_ca_topic_score_gemma":0.0040954296,"teacher_disagreement_score":0.56095004,"about_ca_system_score_codex":0.001089846,"about_ca_system_score_gemma":0.0003971861,"threshold_uncertainty_score":0.5381041},"labels":[],"label_agreement":null},{"id":"W4205492501","doi":"10.1016/j.jval.2021.11.127","title":"POSB17 Ozanimod for the Treatment of Biologic-Experienced Patients with Moderate-to-Severe Ulcerative Colitis: Results from a Systematic Literature Review and Network Meta-Analyses","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Internal medicine; Tofacitinib; Vedolizumab; Ulcerative colitis; Adalimumab; Infliximab; Ustekinumab; Placebo; Golimumab; Clinical trial; Disease; Pathology; Rheumatoid arthritis","score_opus":0.05959311009066321,"score_gpt":0.3249714604986568,"score_spread":0.26537835040799357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205492501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8584902,0.13014492,0.00012930707,0.0004533777,0.00007320076,0.007345982,0.0033403733,0.000008283517,0.000014341042],"genre_scores_gemma":[0.9883311,0.005827983,0.0008462307,0.0014229148,0.00004117611,0.0027980644,0.0006561265,0.00001694511,0.000059484613],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99783343,0.0008900312,0.0005362286,0.00038370807,0.0001377169,0.00021888502],"domain_scores_gemma":[0.99890727,0.00015524297,0.0003283328,0.00040420878,0.0001213866,0.00008355398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046423514,0.00018442812,0.00062344153,0.000026213094,0.00020684137,0.000017726963,0.00013177525,0.000037305548,0.0000062619383],"category_scores_gemma":[0.00013571457,0.00010029742,0.00012040475,0.00016601625,0.000032195898,0.000004135638,0.000047722955,0.00004822472,2.0404677e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.08398438,0.0050164303,0.019870864,0.092453584,0.02750877,0.00014978676,0.044504803,0.71543914,0.00048369163,0.0025434243,0.007146147,0.0008989827],"study_design_scores_gemma":[0.0968229,0.12591803,0.5715784,0.06572594,0.04626396,0.00013500692,0.013574167,0.04721138,0.0026596372,0.0039472794,0.017513856,0.008649472],"about_ca_topic_score_codex":0.00021307894,"about_ca_topic_score_gemma":0.00013702776,"teacher_disagreement_score":0.66822773,"about_ca_system_score_codex":0.000065488246,"about_ca_system_score_gemma":0.00014971684,"threshold_uncertainty_score":0.409001},"labels":[],"label_agreement":null},{"id":"W4205496798","doi":"10.1016/j.jval.2021.11.1090","title":"POSA379 Differences in Cancer Treatment Preferences Among Oncologists, Patients and Family Members: A Discrete Choice Experiment","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Respondent; Mixed logit; Family member; Family medicine; Preference; Lung cancer; Ordered logit; Logistic regression; Demography; Internal medicine","score_opus":0.19245673646556236,"score_gpt":0.2903950607173132,"score_spread":0.09793832425175084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205496798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928083,0.004979865,0.0000037287602,0.00039347107,0.00026270197,0.0005572715,0.00014913369,0.000008854163,0.000836663],"genre_scores_gemma":[0.9959876,0.0029241934,0.0000800352,0.00019490915,0.000019346098,0.00060918,0.000031349035,0.0000102415015,0.00014314459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985805,0.00010282084,0.0005907108,0.000415531,0.000045606776,0.00026481642],"domain_scores_gemma":[0.99943435,0.00007084659,0.00030276232,0.00011930452,0.0000017574471,0.000070974886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000397836,0.00013308601,0.00035375817,0.00015378228,0.00012325069,0.000021763426,0.00010480558,0.00003556599,0.00028262826],"category_scores_gemma":[0.000012903867,0.00014029196,0.00002992553,0.000104276165,0.000052781914,0.00013791361,0.00008554903,0.000107386644,0.000007209816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011874503,0.00024065949,0.9904793,0.0000144240175,0.000009102176,4.0117337e-7,0.0026382308,0.0039984556,6.655692e-7,0.00083954853,0.000026539228,0.0017408157],"study_design_scores_gemma":[0.0010589793,0.0006173249,0.988453,0.000017984361,0.0000012462326,1.1782726e-7,0.00097368675,0.0067583667,0.0000028491982,0.0010577926,0.0009183859,0.00014031124],"about_ca_topic_score_codex":0.13635679,"about_ca_topic_score_gemma":0.0023618767,"teacher_disagreement_score":0.13399492,"about_ca_system_score_codex":0.002074116,"about_ca_system_score_gemma":0.000045657376,"threshold_uncertainty_score":0.8693943},"labels":[],"label_agreement":null},{"id":"W4205499854","doi":"10.1016/j.jval.2021.11.1242","title":"POSA417 Trends of Oral Anticoagulant Use and the Predictors of Initiation Choice between Men and Women with Atrial Fibrillation and Discharged from Hospital to the Community","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Atrial fibrillation; Warfarin; Cohort; Internal medicine; Apixaban; Odds ratio; Rivaroxaban; Comorbidity; Logistic regression; Confidence interval; Anticoagulant; Cardiology","score_opus":0.06247951852073041,"score_gpt":0.32155720498746077,"score_spread":0.25907768646673035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205499854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97940105,0.0003718139,0.00001210794,0.018707907,0.00007544478,0.0010301837,0.00037805148,0.000008896635,0.000014542901],"genre_scores_gemma":[0.99929655,0.00014841648,0.00007857471,0.0001999075,0.0001706326,0.000012126295,0.000076413526,0.000011082389,0.0000062831286],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964993,0.0022536477,0.0005605125,0.00014537325,0.00032339228,0.00021777471],"domain_scores_gemma":[0.9980086,0.0011858669,0.00030224177,0.00025233265,0.000053565956,0.00019739049],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003978855,0.00009603758,0.0004914238,0.0001351544,0.00029397142,0.000016140604,0.000059376987,0.000040030714,0.000005213876],"category_scores_gemma":[0.00035898833,0.000055365057,0.000017552014,0.00034355748,0.0000999886,0.00009149813,0.00009056785,0.00033550814,3.96807e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005018326,0.000017931528,0.9501259,0.00025116807,0.00004558136,3.8926194e-7,0.04312673,0.000071382034,0.0000040908376,0.0001328921,0.000050825256,0.0056713275],"study_design_scores_gemma":[0.003095067,0.0021333767,0.98792523,0.00012119231,0.000019123645,0.000005840891,0.0046844874,0.0008791555,0.0000016047209,0.00005263622,0.0010330366,0.000049260143],"about_ca_topic_score_codex":0.25437564,"about_ca_topic_score_gemma":0.00085273903,"teacher_disagreement_score":0.2535229,"about_ca_system_score_codex":0.0001266974,"about_ca_system_score_gemma":0.00040750785,"threshold_uncertainty_score":0.75058955},"labels":[],"label_agreement":null},{"id":"W4205514480","doi":"10.1016/j.jval.2021.11.751","title":"POSA236 Real-World Treatment (Tx) Characteristics for Advanced Non-Small Cell Lung Cancer (aNSCLC) Without Actionable Mutations After Introduction of Immune Checkpoint Inhibitors (ICIs) in EU4 and UK","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Pemetrexed; Pembrolizumab; Carboplatin; Lung cancer; Nivolumab; Oncology; Medicine; Internal medicine; Atezolizumab; Cancer; Chemotherapy; Immunotherapy; Cisplatin","score_opus":0.017029739607347674,"score_gpt":0.3016004906995064,"score_spread":0.28457075109215874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205514480","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99123937,0.0025817214,0.000039286835,0.0032559542,0.00055743405,0.00211546,0.00015003818,0.000014365927,0.00004637525],"genre_scores_gemma":[0.9930816,0.0028875773,0.00084594195,0.00013054111,0.00021089739,0.001772238,0.00015089473,0.000029842258,0.00089044485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984077,0.00008435534,0.0007842666,0.00030601656,0.00014685423,0.00027080456],"domain_scores_gemma":[0.99929655,0.00005970007,0.00033346895,0.00019674654,0.000052059295,0.00006148466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050822494,0.0001539442,0.00040138583,0.0003265555,0.00010550747,0.0000067257,0.00003603263,0.000036526373,0.00010678401],"category_scores_gemma":[0.000013541589,0.00015045355,0.00008687092,0.000403338,0.000041161486,0.00005420072,0.00002072621,0.00016118691,1.8656914e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030926455,0.002415196,0.78397214,0.0047994186,0.00027751943,0.000021842596,0.017930482,0.010381273,0.091408625,0.00007271829,0.0004004321,0.057393916],"study_design_scores_gemma":[0.012781949,0.002335656,0.9466521,0.0005276522,0.00010606204,0.000018654348,0.001878177,0.0059897113,0.021695575,0.00005220914,0.0076474138,0.0003148121],"about_ca_topic_score_codex":0.031217761,"about_ca_topic_score_gemma":0.0021011431,"teacher_disagreement_score":0.16268,"about_ca_system_score_codex":0.0018763562,"about_ca_system_score_gemma":0.00053969666,"threshold_uncertainty_score":0.97523344},"labels":[],"label_agreement":null},{"id":"W4205536822","doi":"10.1016/j.jval.2021.11.081","title":"POSA6 Use of Real-World Evidence to Evaluate Infliximab Biosimilars: A Scoping Review","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital","funders":"","keywords":"Biosimilar; Medicine; Infliximab; Tolerability; Rheumatoid arthritis; Observational study; Adverse effect; Clinical trial; Internal medicine; Intensive care medicine; Disease","score_opus":0.4610570349245248,"score_gpt":0.4993665742394198,"score_spread":0.038309539314895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205536822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000018226162,0.99220103,0.000013687887,0.0019280668,0.00076083315,0.004776246,0.00016983747,0.00004511489,0.00010337103],"genre_scores_gemma":[4.2560563e-7,0.9914157,0.002916045,0.004704739,0.00003411553,0.0003568624,0.00006038145,0.000059228205,0.0004525531],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98690236,0.007953884,0.0030721312,0.0009943425,0.00020027418,0.0008770041],"domain_scores_gemma":[0.9927407,0.0045945407,0.0013053345,0.0011426195,0.000087250366,0.00012957823],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007660963,0.0005962619,0.0045478432,0.00082164386,0.0001441615,0.000019374536,0.0007751087,0.00038205527,0.0017396428],"category_scores_gemma":[0.0035705238,0.00047795227,0.00066835876,0.0024416333,0.00016409946,0.00011115398,0.00060313806,0.0012938541,0.00007825063],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003531292,0.0001337043,0.000022428114,0.3064878,0.00014306088,0.000010832343,0.00004784762,0.000008910513,0.0000036743213,0.00021118046,0.0065294905,0.6863657],"study_design_scores_gemma":[0.00010398858,0.00027011475,0.0000063720545,0.4483713,0.00025971257,0.000017820143,0.0000022075283,0.0000022101847,0.0000042917336,0.000014142563,0.5507004,0.00024743678],"about_ca_topic_score_codex":0.002121663,"about_ca_topic_score_gemma":0.0001877251,"teacher_disagreement_score":0.6861183,"about_ca_system_score_codex":0.0006841627,"about_ca_system_score_gemma":0.0027474961,"threshold_uncertainty_score":0.99976724},"labels":[],"label_agreement":null},{"id":"W4205539415","doi":"10.1016/j.jval.2021.11.329","title":"POSB56 Cost-Effectiveness of Satralizumab Compared to Eculizumab for the Treatment Neuromyelitis Optica Spectrum Disorders (NMOSD) in Adult and Adolescent Patients Who Are Anti-Aquaporin 4 (AQP4) Seropositive in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Roche (Canada)","funders":"","keywords":"Medicine; Eculizumab; Neuromyelitis optica; Cost effectiveness; Quality of life (healthcare); Clinical trial; Quality-adjusted life year; Pediatrics; Internal medicine; Psychiatry; Immunology; Multiple sclerosis","score_opus":0.15332191501015396,"score_gpt":0.35527819416933787,"score_spread":0.2019562791591839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205539415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96678215,0.000988896,0.00013051048,0.023243707,0.00045742036,0.006380983,0.001979664,0.0000063997104,0.000030284225],"genre_scores_gemma":[0.99590087,0.00068663596,0.00010226349,0.0021374717,0.000025005484,0.0010488885,0.00006244061,0.000030134453,0.0000063071534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99486965,0.0012796504,0.0025106906,0.0006133481,0.0001392697,0.0005873623],"domain_scores_gemma":[0.99671465,0.0017276602,0.0010114503,0.0003432919,0.000030624997,0.00017232492],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.003915832,0.00022684006,0.0012068237,0.00036205593,0.0001875285,0.000019362962,0.00022010072,0.000038115602,0.000016408758],"category_scores_gemma":[0.00041931527,0.000254947,0.000065322645,0.00042304333,0.000035610454,0.00009541683,0.00006468211,0.00019891656,0.00000301799],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028539888,0.00045245452,0.8766255,0.0009457449,0.000024039411,0.0000024501771,0.0031954646,0.11224688,1.2620306e-7,0.005357329,0.00026997575,0.00059467944],"study_design_scores_gemma":[0.004267681,0.00063804036,0.9637095,0.00041203081,0.0000027114997,0.0000012962834,0.003014496,0.025055202,0.000003775155,0.00096601533,0.0017100149,0.00021924356],"about_ca_topic_score_codex":0.92018914,"about_ca_topic_score_gemma":0.7649032,"teacher_disagreement_score":0.15528597,"about_ca_system_score_codex":0.009177904,"about_ca_system_score_gemma":0.0010867887,"threshold_uncertainty_score":0.9999903},"labels":[],"label_agreement":null},{"id":"W4205566294","doi":"10.1016/j.jval.2021.11.1188","title":"POSC363 Engaging Patients and Caregivers in Health Economic Evaluations: Generating Stakeholder Input to Inform the Conduct of an Early Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Ottawa; Ottawa Hospital","funders":"","keywords":"Economic evaluation; Stakeholder; Medicine; Psychology; Political science; Public relations","score_opus":0.4604869906156747,"score_gpt":0.4311957501962077,"score_spread":0.029291240419467013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205566294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98364604,0.0034515047,0.000029827448,0.008033374,0.00064625585,0.00343818,0.00059561955,0.000013253847,0.00014594244],"genre_scores_gemma":[0.9945266,0.00055565574,0.0014691352,0.002862376,0.00007341724,0.00033125837,0.000121660116,0.00004149222,0.000018376619],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9889829,0.0041585583,0.0053600813,0.0006759259,0.00028403028,0.0005384899],"domain_scores_gemma":[0.99443954,0.0008635367,0.0038459979,0.0005692183,0.00008660914,0.00019507406],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.061081033,0.00023460333,0.0010562948,0.0009396501,0.0004704375,0.000045059936,0.0003858579,0.00006606899,0.0003074436],"category_scores_gemma":[0.0006957739,0.00028298792,0.00007003417,0.000386669,0.00006974985,0.0005554516,0.000105766594,0.00033040135,0.000033469427],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008699696,0.00028408802,0.2495615,0.00039321592,0.000044828157,7.135826e-8,0.062231164,0.6730084,0.000022237115,0.003749236,0.0008494583,0.009768809],"study_design_scores_gemma":[0.009683571,0.0027674087,0.448378,0.0002592565,0.000008182413,0.0000024223655,0.02796964,0.50158006,0.00008306453,0.0025197587,0.0058953427,0.0008532862],"about_ca_topic_score_codex":0.061844498,"about_ca_topic_score_gemma":0.001118343,"teacher_disagreement_score":0.1988165,"about_ca_system_score_codex":0.0040484266,"about_ca_system_score_gemma":0.002349368,"threshold_uncertainty_score":0.9999622},"labels":[],"label_agreement":null},{"id":"W4205579936","doi":"10.1016/j.jval.2021.11.955","title":"POSC295 Delay in Shock Wave Lithotripsy and Healthcare Utilization Among Patients with a Stent Placement and Stone Disease","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Shock wave lithotripsy; Stent; Lithotripsy; Medicine; Health care; Shock (circulatory); Surgery; Radiology; Political science","score_opus":0.04196312070066311,"score_gpt":0.29061631122286186,"score_spread":0.24865319052219875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205579936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914355,0.00259379,0.000008384598,0.003995565,0.00006498339,0.0017511073,0.00012001273,0.000018398183,0.000012214786],"genre_scores_gemma":[0.9972811,0.00045647338,0.00031219563,0.0014644872,0.00001221059,0.0001637579,0.00022619487,0.000023811288,0.000059768092],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99823076,0.00027328925,0.0003776845,0.0003890051,0.0003934515,0.00033582133],"domain_scores_gemma":[0.9990566,0.000046242032,0.00012109564,0.00023931186,0.000036705103,0.0005000824],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032276474,0.00015646397,0.00030024254,0.00022030769,0.00015514513,0.000010102629,0.000033013708,0.000028716537,0.000016451597],"category_scores_gemma":[0.000052928743,0.00013273343,0.000017381582,0.00028534236,0.000037856807,0.000059745405,0.00009778159,0.00020770959,3.020317e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012254418,0.00073792273,0.9921766,0.00041028514,0.000015559861,0.000070925555,0.0020937999,0.00042271148,1.95509e-7,0.00008919419,0.00003299302,0.002724368],"study_design_scores_gemma":[0.0062541524,0.0019640517,0.9850612,0.00030659055,0.000022880951,0.00001470106,0.00081011635,0.0051649334,5.650167e-7,0.000051882922,0.00024475076,0.00010416168],"about_ca_topic_score_codex":0.004843366,"about_ca_topic_score_gemma":0.00012414996,"teacher_disagreement_score":0.0071153897,"about_ca_system_score_codex":0.00060917746,"about_ca_system_score_gemma":0.00034332075,"threshold_uncertainty_score":0.7321753},"labels":[],"label_agreement":null},{"id":"W4205606847","doi":"10.1016/j.jval.2021.11.934","title":"POSA297 Preferences for Hemophilia Treatments in Canada: A Discrete Choice Experiment (DCE)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; University of Manitoba; Roche (Canada); Vancouver Coastal Health","funders":"","keywords":"Medicine; Mixed logit; Odds ratio; Subcutaneous injection; Odds; Preference; Logistic regression; Internal medicine","score_opus":0.09231612351512183,"score_gpt":0.368783246722976,"score_spread":0.27646712320785416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205606847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851065,0.0022288784,0.0000013582837,0.009691427,0.00019221807,0.0022524481,0.00009332617,0.000014615531,0.00041918218],"genre_scores_gemma":[0.9963958,0.00019653355,0.00029468443,0.0004119079,0.000062874235,0.0009893148,0.00011668674,0.000020915482,0.0015112854],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99786097,0.00022161275,0.00041902935,0.0003700988,0.00052184146,0.0006064535],"domain_scores_gemma":[0.99919814,0.00022689758,0.00006969063,0.00024618456,0.000019879017,0.0002392303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041672643,0.00015641894,0.00039098645,0.00019391412,0.00016352939,0.000006729526,0.00012260869,0.000027583977,0.00015801421],"category_scores_gemma":[0.000060065464,0.0001265394,0.000052781263,0.00034076182,0.000020684452,0.000034436896,0.00007161009,0.00023199613,0.0000024692938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010418855,0.0014208818,0.9720931,0.00069953536,0.00012652652,0.00025735615,0.0037156157,0.002307859,0.00031314683,0.00034741912,0.0025626523,0.015114026],"study_design_scores_gemma":[0.029432857,0.010903642,0.88792956,0.0009192688,0.00006654801,0.0000911833,0.009852015,0.022169065,0.0030548072,0.0014840368,0.033275064,0.0008219814],"about_ca_topic_score_codex":0.9408894,"about_ca_topic_score_gemma":0.44598892,"teacher_disagreement_score":0.4949005,"about_ca_system_score_codex":0.005152874,"about_ca_system_score_gemma":0.0050959024,"threshold_uncertainty_score":0.99866617},"labels":[],"label_agreement":null},{"id":"W4205695850","doi":"10.1016/j.jval.2021.11.442","title":"POSC37 Economic Cost of Treatment in Canada: A Multi-Centre, Retrospective Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Children's Hospital of Eastern Ontario; Alberta Health Services; Takeda (Canada); McMaster University","funders":"","keywords":"Medicine; Retrospective cohort study; Medical record; Health care; Emergency medicine; Clotting factor; Pediatrics; Emergency department; Internal medicine","score_opus":0.07644320912488124,"score_gpt":0.35097409444697025,"score_spread":0.274530885322089,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205695850","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99462444,0.00036087676,1.7355976e-7,0.0020770992,0.000111280366,0.0025745751,0.00008802107,0.0000059617178,0.0001575902],"genre_scores_gemma":[0.99906796,0.00014204087,0.00004501799,0.00006019163,0.000018985433,0.00014858264,0.00001939443,0.000013144264,0.00048470282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984718,0.00031721458,0.00039253038,0.00026317203,0.000214257,0.00034100522],"domain_scores_gemma":[0.99947417,0.00006828392,0.0000784291,0.00022568113,0.000014623949,0.00013880189],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00042488956,0.00010323647,0.000425582,0.00021187447,0.00006113277,0.0000017917132,0.000063946565,0.000014451276,0.00017654072],"category_scores_gemma":[0.00002322207,0.00008827569,0.000033526783,0.00022620789,0.000015878017,0.000014400941,0.00004620755,0.00018920125,0.000004489535],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0001895315,0.0019474484,0.9909089,0.00003483317,0.000040496263,0.00019287747,0.002482518,0.0027442551,0.000006725172,0.000031747048,0.000101039666,0.0013195918],"study_design_scores_gemma":[0.009544331,0.0028520997,0.9697018,0.000039621096,0.000009436215,0.000010070628,0.007529764,0.009719315,0.00004225961,0.0000113745455,0.000468283,0.000071603805],"about_ca_topic_score_codex":0.99088085,"about_ca_topic_score_gemma":0.9427926,"teacher_disagreement_score":0.04808823,"about_ca_system_score_codex":0.02725021,"about_ca_system_score_gemma":0.008567354,"threshold_uncertainty_score":0.99705315},"labels":[],"label_agreement":null},{"id":"W4205703018","doi":"10.1016/j.jval.2021.11.311","title":"POSB38 Developing a Cost-Effectiveness Analysis for Nivolumab for the Adjuvant Treatment of Patients with Resected Esophageal Cancer (EC) or Gastroesophageal Junction Cancer (GEJC) in the Absence of Overall Survival Data","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Precision Nanosystems (Canada)","funders":"","keywords":"Medicine; Nivolumab; Esophageal cancer; Internal medicine; Clinical trial; Cancer; Oncology; Cancer registry; Population; Clinical endpoint; Adjuvant; Surgery; Immunotherapy","score_opus":0.14257649278531676,"score_gpt":0.40980165906960714,"score_spread":0.2672251662842904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205703018","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97563225,0.0077674203,0.0018683268,0.0010736269,0.00019013135,0.010014402,0.0034403133,0.000011206424,0.000002347676],"genre_scores_gemma":[0.99181706,0.00079385156,0.0005506106,0.00009657442,0.00006107158,0.005891902,0.0007305724,0.000025483512,0.000032849675],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700123,0.00068003475,0.0005590695,0.0005004698,0.00074121944,0.0005180052],"domain_scores_gemma":[0.9972538,0.0014613034,0.00033752967,0.0006367753,0.00022515743,0.000085462314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014688496,0.0002075164,0.0007315187,0.0002898312,0.00024188346,0.000010202124,0.00031800204,0.00003208515,0.00004479111],"category_scores_gemma":[0.000106519525,0.000111219546,0.00011021763,0.0012749697,0.00008032084,0.00008152577,0.00008160937,0.00016817526,8.311047e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025038261,0.0013326509,0.91215175,0.00077314914,0.0010084725,0.000027816668,0.0016514616,0.04119268,0.0000047529134,0.000104690196,0.00004527396,0.016669054],"study_design_scores_gemma":[0.013673962,0.007292656,0.96026015,0.00018125628,0.00027804164,0.0000020989369,0.00039128595,0.017590556,0.00008729702,0.000027568713,0.000133826,0.00008129816],"about_ca_topic_score_codex":0.09203948,"about_ca_topic_score_gemma":0.023137823,"teacher_disagreement_score":0.06890166,"about_ca_system_score_codex":0.00258971,"about_ca_system_score_gemma":0.0027479471,"threshold_uncertainty_score":0.9946874},"labels":[],"label_agreement":null},{"id":"W4205710120","doi":"10.1016/j.jval.2021.11.1117","title":"POSB350 Real-World (RW) Patient-Reported Outcomes (PROs) in Frontline Maintenance Therapy for Advanced Non-Small Cell Lung Cancer (aNSCLC) in France, Germany, and the UK","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Public Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Quality of life (healthcare); Lung cancer; Visual analogue scale; Family medicine; Physical therapy; Internal medicine; Nursing","score_opus":0.025007975140934766,"score_gpt":0.33300384644181724,"score_spread":0.30799587130088246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205710120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9475202,0.009407173,0.00007173129,0.03281508,0.00087247725,0.008735214,0.00011973981,0.000039457787,0.0004189207],"genre_scores_gemma":[0.9767634,0.006578231,0.0006086248,0.011444977,0.00013182295,0.0031687447,0.000042133724,0.000068907706,0.0011931272],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99487185,0.00084798096,0.0019981617,0.0006978394,0.00046051166,0.0011236719],"domain_scores_gemma":[0.99767554,0.0006073473,0.00067138544,0.0005927619,0.00012156576,0.00033143075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047424682,0.00032030616,0.0012489861,0.00051012525,0.00024192719,0.000016145394,0.0001907994,0.00010475556,0.000051396455],"category_scores_gemma":[0.00012183257,0.00023329689,0.00010979171,0.000994555,0.00006568544,0.00007333052,0.000071822404,0.0009624685,6.127989e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001115652,0.00030351314,0.97011304,0.0017490876,0.000024127105,0.000045892917,0.010427059,0.0016192149,0.000017661934,0.00041145092,0.0008882958,0.013285032],"study_design_scores_gemma":[0.027895706,0.0008625377,0.92252076,0.001018439,0.000008841289,0.000019381776,0.0018853437,0.020319326,0.000010046433,0.00023010335,0.024901332,0.00032821155],"about_ca_topic_score_codex":0.32663465,"about_ca_topic_score_gemma":0.028896285,"teacher_disagreement_score":0.29773834,"about_ca_system_score_codex":0.0012810727,"about_ca_system_score_gemma":0.0033871182,"threshold_uncertainty_score":0.98882383},"labels":[],"label_agreement":null},{"id":"W4205878845","doi":"10.1016/j.jval.2021.11.1094","title":"POSB327 Assessing the Benefits of Improving Health-Related Quality of Life in Heart Failure: A Preliminary Analysis in EU, UK, and Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quality of life (healthcare); Medicine; Perspective (graphical); Heart failure; Health related quality of life; Health care; Physical therapy; Disease; Family medicine; Gerontology; Nursing; Pathology; Internal medicine","score_opus":0.14784828911360437,"score_gpt":0.4426767060232651,"score_spread":0.2948284169096607,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205878845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91338366,0.008401533,0.000004338767,0.076264806,0.0002942474,0.0014725039,0.00011418017,0.000010514362,0.000054246226],"genre_scores_gemma":[0.9967137,0.00014462824,0.000329757,0.002582295,0.000030472305,0.00013383255,0.000021484233,0.000020412108,0.000023446783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9746748,0.019454857,0.0039282218,0.00044841834,0.0006741429,0.0008195209],"domain_scores_gemma":[0.99125355,0.0055060578,0.0023993424,0.0004802279,0.00009882073,0.0002619693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025542682,0.00017919339,0.0013118165,0.0006088473,0.0006554745,0.000007749623,0.00022497494,0.00013471046,0.00007801849],"category_scores_gemma":[0.0017462267,0.00015767202,0.00006422477,0.002355612,0.00004357155,0.00015221698,0.00023161876,0.0017567202,3.2060348e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011233811,0.00009173773,0.9648976,0.0032995641,0.000032426044,0.0000025264828,0.013631044,0.01520735,0.000008920469,0.000830631,0.00044384,0.0014420297],"study_design_scores_gemma":[0.0008259944,0.0002552329,0.95786583,0.00062422774,0.000009332553,0.0000027223175,0.03346654,0.005723275,5.4794043e-7,0.000065256216,0.0010387714,0.00012224981],"about_ca_topic_score_codex":0.99767315,"about_ca_topic_score_gemma":0.97381335,"teacher_disagreement_score":0.083330035,"about_ca_system_score_codex":0.0014222268,"about_ca_system_score_gemma":0.013630677,"threshold_uncertainty_score":0.9919611},"labels":[],"label_agreement":null},{"id":"W4205905722","doi":"10.1016/j.jval.2021.11.1061","title":"POSA350 Effect of Filgotinib on EQ-5D-5L and Work Productivity and Activity Impairment Among Patients with Ulcerative Colitis: Results from the Phase 2B/3 Selection Trial","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Work productivity; Placebo; Medicine; Randomized controlled trial; Ulcerative colitis; Physical therapy; Internal medicine; Productivity; Disease","score_opus":0.16785296529215923,"score_gpt":0.36649082633534463,"score_spread":0.1986378610431854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205905722","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98606104,0.0001547184,0.000035158137,0.007307868,0.0003917928,0.0043754806,0.001610608,0.00001885381,0.000044463708],"genre_scores_gemma":[0.9987497,0.00002404121,0.00010115664,0.00045424985,0.00017779363,0.0003747854,0.0000726492,0.000020088633,0.000025564368],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99339914,0.0036034957,0.0017922895,0.00069981243,0.0001731021,0.00033217584],"domain_scores_gemma":[0.9936865,0.0036570253,0.0021683432,0.00032999835,0.00003116021,0.00012699133],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020140035,0.00019142429,0.00085713546,0.00017536015,0.00045709294,0.000039335435,0.00010684227,0.000058971633,0.00002687154],"category_scores_gemma":[0.0021518157,0.00017754262,0.00004103295,0.0003431118,0.00009970135,0.00022827524,0.00006615733,0.00038857068,0.00000394715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.074423976,0.0019222725,0.892981,0.00044233137,0.00013535419,8.442403e-7,0.016198386,0.0064031854,4.877108e-7,0.0010859598,0.0029034673,0.00350273],"study_design_scores_gemma":[0.040804535,0.008562363,0.94586337,0.00016506597,0.0000065474746,6.8609165e-7,0.00024590018,0.0032168864,0.000010969426,0.0004896875,0.00044028996,0.00019369237],"about_ca_topic_score_codex":0.022676747,"about_ca_topic_score_gemma":0.000853784,"teacher_disagreement_score":0.052882366,"about_ca_system_score_codex":0.00090839766,"about_ca_system_score_gemma":0.00022953055,"threshold_uncertainty_score":0.98383135},"labels":[],"label_agreement":null},{"id":"W4205906208","doi":"10.1016/j.jval.2021.11.015","title":"P16 Recent Estimates of Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) in the US (2010-2020)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple and Secondary Primary Cancers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Nivolumab; Stage (stratigraphy); Lung cancer; Internal medicine; Oncology; Ipilimumab; Cancer; Disease; Database; Immunotherapy","score_opus":0.020252863955841333,"score_gpt":0.2807579044830403,"score_spread":0.2605050405271989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205906208","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940863,0.0020928446,0.000008461793,0.0013271221,0.00040574768,0.001449292,0.00006709467,0.000008617656,0.00055446575],"genre_scores_gemma":[0.9960366,0.0012592884,0.00073543505,0.0016065226,0.00002834472,0.00019765348,0.00007576092,0.000025555531,0.000034872002],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811167,0.0002642676,0.00053004624,0.00030023334,0.00039591044,0.0003978877],"domain_scores_gemma":[0.9991866,0.00018577416,0.00019974414,0.0003057663,0.000042905802,0.00007925776],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079969695,0.0001489268,0.00044152763,0.00016675059,0.000059073867,0.0000040081736,0.00017503911,0.00003339869,0.00023583781],"category_scores_gemma":[0.00003329335,0.00011302421,0.000030501285,0.0005961066,0.00003195157,0.000050894345,0.000056561086,0.0005024835,7.0492945e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010261441,0.00041748007,0.94215167,0.00061535655,0.000008071092,0.000022036817,0.0039025007,0.042979322,0.000031542782,0.000005824607,0.00025263111,0.008587424],"study_design_scores_gemma":[0.00760413,0.0009569569,0.98030126,0.00031864096,0.0000104880555,0.0000016818142,0.00075486006,0.008187705,0.00006304821,0.0000110244155,0.0016574048,0.00013278861],"about_ca_topic_score_codex":0.018222876,"about_ca_topic_score_gemma":0.0020231407,"teacher_disagreement_score":0.038149603,"about_ca_system_score_codex":0.0009714575,"about_ca_system_score_gemma":0.0014263573,"threshold_uncertainty_score":0.98831487},"labels":[],"label_agreement":null},{"id":"W4205947264","doi":"10.1016/j.jval.2021.11.810","title":"POSC243 Systemic Challenges in Tele-Health and Structural Solutions to Enhance Access","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Socioeconomic status; Psychological intervention; Health care; Telemedicine; Thematic analysis; Health equity; Ethnic group; Digital divide; Medicine; Qualitative research; Nursing; Political science; Computer science; Population; World Wide Web; Sociology; Environmental health; The Internet","score_opus":0.14941626398079044,"score_gpt":0.43867488101201285,"score_spread":0.2892586170312224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205947264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8817408,0.018683627,0.000055664896,0.09720212,0.00032717694,0.0018455933,0.000032576125,0.000047439225,0.00006498721],"genre_scores_gemma":[0.9873627,0.0037861678,0.00047437934,0.007922616,0.00012325482,0.0002400177,0.000046866833,0.00001952437,0.000024461893],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9973146,0.00045822177,0.00080396136,0.00039530348,0.00036099585,0.0006669505],"domain_scores_gemma":[0.9989858,0.00012949268,0.00020681336,0.00023198442,0.000027121328,0.00041877897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015885528,0.00013235255,0.0004380299,0.0005266061,0.00026228567,0.000008802459,0.00011525342,0.000028691267,0.000052350595],"category_scores_gemma":[0.000113574024,0.00013379166,0.000018581737,0.00058984506,0.000019080622,0.00009335425,0.00013959773,0.0004093768,0.0000026363546],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066213246,0.0003495108,0.33160016,0.011161276,0.00003141296,0.00009358209,0.05914909,0.003278763,0.0001555479,0.008156194,0.005969668,0.5793927],"study_design_scores_gemma":[0.0059876847,0.0088076955,0.90749466,0.0021805896,0.000014192992,0.0012037946,0.041422203,0.0064911363,0.000038367267,0.0015394625,0.024297684,0.0005224956],"about_ca_topic_score_codex":0.016089702,"about_ca_topic_score_gemma":0.0015390933,"teacher_disagreement_score":0.5788702,"about_ca_system_score_codex":0.0010470581,"about_ca_system_score_gemma":0.0011490377,"threshold_uncertainty_score":0.99046224},"labels":[],"label_agreement":null},{"id":"W4205958817","doi":"10.1016/j.jval.2021.11.594","title":"POSA193 Metastatic Non-Small Cell Lung Cancer (NSCLC) Without Driver Mutations: Projections by Line of Therapy (LOT) in Western Europe (WE), 2021-2026","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Lung cancer; Medicine; Incidence (geometry); Stage (stratigraphy); Oncology; Internal medicine; Epidemiology; Population; Cancer; Environmental health; Biology","score_opus":0.037267381836158894,"score_gpt":0.36435690747723504,"score_spread":0.32708952564107613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205958817","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97336316,0.015726347,0.0003612497,0.006199787,0.0003457075,0.0031447746,0.00037557824,0.000029540344,0.00045386096],"genre_scores_gemma":[0.9853928,0.006741376,0.0016277517,0.0010308827,0.00006458898,0.0010406796,0.00023511959,0.000063345586,0.0038034404],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981861,0.00030333354,0.00059559237,0.00033249368,0.00027756658,0.00030492895],"domain_scores_gemma":[0.99921006,0.00010410927,0.000248105,0.00024465818,0.00008765452,0.000105438594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033166105,0.00016831074,0.0004040697,0.0003349917,0.00014113291,0.000009843992,0.00009198518,0.000024046081,0.00021155027],"category_scores_gemma":[0.00001703357,0.00015127206,0.000058350357,0.0009846238,0.00003706475,0.00007069822,0.000035629473,0.0003062407,0.000004423192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004914684,0.0052813333,0.8418208,0.001532905,0.000422453,0.0001057903,0.056158118,0.0759197,0.0019883695,0.00011551306,0.003532931,0.012630667],"study_design_scores_gemma":[0.11791207,0.02073177,0.46476623,0.008044769,0.0021717576,0.00030210754,0.032396577,0.17324968,0.00643248,0.00064159196,0.17038769,0.002963279],"about_ca_topic_score_codex":0.02935912,"about_ca_topic_score_gemma":0.0013647408,"teacher_disagreement_score":0.3770545,"about_ca_system_score_codex":0.0006817697,"about_ca_system_score_gemma":0.0023472058,"threshold_uncertainty_score":0.9771045},"labels":[],"label_agreement":null},{"id":"W4205978338","doi":"10.1016/j.jval.2021.11.526","title":"POSC122 Cost-Effectiveness of ALPHA-2 Adrenergic Agonist (LOFEXIDINE) and Long-Acting Injectables for Treatment of Opioid Use Disorder","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Buprenorphine; Naltrexone; Opioid use disorder; Medicine; Methadone; Opioid; Cost effectiveness; Detoxification (alternative medicine); (+)-Naloxone; Clonidine; Quality-adjusted life year; Pharmacology; Anesthesia; Internal medicine","score_opus":0.06262431295225769,"score_gpt":0.34519507232196955,"score_spread":0.2825707593697119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205978338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98728913,0.008048689,0.00017240037,0.0002549036,0.00016918973,0.003750969,0.0002626689,0.000024310482,0.000027714848],"genre_scores_gemma":[0.99590766,0.0015939897,0.0010416894,0.000044226992,0.000020545665,0.0010358612,0.00023976788,0.000044761193,0.00007149711],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810493,0.00037368972,0.000552552,0.00037454162,0.000237852,0.00035646267],"domain_scores_gemma":[0.998408,0.00082189427,0.00027967597,0.00030894935,0.00006548914,0.00011598341],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048285324,0.00021865545,0.00076649134,0.00023925012,0.00015891952,0.000007856912,0.000059943257,0.000043026215,0.00002024548],"category_scores_gemma":[0.00009780617,0.00019866483,0.00011192292,0.00033128288,0.00006070696,0.00006299401,0.000057102156,0.00007022935,2.430414e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034091077,0.0059659434,0.9367878,0.005889757,0.00028043767,0.000026169007,0.005562427,0.013679029,0.0011767781,0.0012891131,0.000016709806,0.025916753],"study_design_scores_gemma":[0.029702395,0.026062185,0.91107553,0.0013872947,0.00034378294,0.0000906243,0.005133773,0.009479426,0.010104365,0.0005462584,0.0055619352,0.0005124414],"about_ca_topic_score_codex":0.023678752,"about_ca_topic_score_gemma":0.00016976643,"teacher_disagreement_score":0.026293287,"about_ca_system_score_codex":0.0006967768,"about_ca_system_score_gemma":0.0006183944,"threshold_uncertainty_score":0.98282266},"labels":[],"label_agreement":null},{"id":"W4206006624","doi":"10.1016/j.jval.2021.10.008","title":"Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":830,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Institute of Health Economics; University of Ottawa","funders":"National Institute for Health and Care Research","keywords":"Checklist; Context (archaeology); Health care; Stakeholder; Economic evaluation; Public health; Guideline; Public relations; Political science; Psychology; Medicine; Nursing; Law","score_opus":0.3403059080011961,"score_gpt":0.4691500656672357,"score_spread":0.12884415766603963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206006624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8526982,0.006406745,0.00039577106,0.13312674,0.0015436856,0.003307706,0.0013618994,0.00004632123,0.0011129574],"genre_scores_gemma":[0.99310434,0.0003952125,0.0009436192,0.0043718973,0.0001555545,0.0004116566,0.00028921315,0.000038563452,0.00028996856],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98360986,0.0027500545,0.011599089,0.00093264756,0.0005641668,0.0005441656],"domain_scores_gemma":[0.96003425,0.00070376106,0.03813504,0.000761038,0.00019267442,0.0001732437],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.14268294,0.0002095726,0.0011031902,0.00045603118,0.0010203191,0.000056737626,0.0002615783,0.000090381465,0.00033709648],"category_scores_gemma":[0.015389436,0.00025327367,0.000093423645,0.0005499075,0.000076918004,0.0006271968,0.00017387416,0.00043946816,0.0000072231305],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00033273344,0.00081461,0.3737139,0.0043998905,0.0004115416,0.000018476883,0.07147053,0.2627782,0.00006560094,0.20074044,0.08203314,0.003220932],"study_design_scores_gemma":[0.006729777,0.0016925257,0.11871571,0.00069720065,0.000051181254,0.0006219337,0.04530778,0.5500122,0.00006223782,0.026011972,0.2487542,0.0013433052],"about_ca_topic_score_codex":0.019586474,"about_ca_topic_score_gemma":0.0012546891,"teacher_disagreement_score":0.28723398,"about_ca_system_score_codex":0.005973927,"about_ca_system_score_gemma":0.0065186294,"threshold_uncertainty_score":0.99999195},"labels":[],"label_agreement":null},{"id":"W4206084158","doi":"10.1016/j.jval.2021.11.1136","title":"POSB369 Development of the Patient-Reported Impact of Dermatological Diseases (PRIDD) Measure","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Patient-reported outcome; Delphi method; Dermatological diseases; Medicine; Psychology; Family medicine; Dermatology; Quality of life (healthcare); Nursing","score_opus":0.4002255298422964,"score_gpt":0.4141431859737437,"score_spread":0.013917656131447298,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206084158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9893062,0.0032542406,0.00012376212,0.0054470673,0.0003483096,0.0008752459,0.00042666783,0.000016098045,0.0002023919],"genre_scores_gemma":[0.99757916,0.000022282175,0.00090093864,0.0013269194,0.000018572506,0.000100267775,0.000022492572,0.000015271004,0.000014073841],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927525,0.0010780594,0.005273677,0.00033241897,0.00020965895,0.00035369067],"domain_scores_gemma":[0.99490595,0.00051827426,0.003906443,0.00048040418,0.000047372036,0.00014156164],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008302721,0.00013523277,0.0008998173,0.00025179784,0.0002492641,0.000007267366,0.00031935217,0.00005103143,0.00028939638],"category_scores_gemma":[0.001966268,0.0001279118,0.00018853697,0.0004188581,0.000056675002,0.00008539932,0.00015530294,0.00020533867,0.000017162256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003229512,0.00037980458,0.96999073,0.00040127095,0.00006237521,9.718281e-7,0.004597831,0.015078357,0.000002360401,0.0066964505,0.0023555867,0.00040193682],"study_design_scores_gemma":[0.0007228662,0.0001682114,0.9866405,0.00011580183,0.0000032189957,0.000015144002,0.0010215634,0.003998593,0.000012489378,0.0041963467,0.0029231606,0.00018208445],"about_ca_topic_score_codex":0.0037835995,"about_ca_topic_score_gemma":0.000043630214,"teacher_disagreement_score":0.01664976,"about_ca_system_score_codex":0.0014278505,"about_ca_system_score_gemma":0.0018077831,"threshold_uncertainty_score":0.57196957},"labels":[],"label_agreement":null},{"id":"W4206156660","doi":"10.1016/j.jval.2021.11.928","title":"POSA291 Impact of Intrepid® Hybrid Tip on Incidence and Cost of Posterior Capsule Ruptures in Cataract Surgery","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Intraocular Surgery and Lenses","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Phacoemulsification; Cataract surgery; Incidence (geometry); Posterior capsule opacification; Surgery; Vitrectomy; Ophthalmology; Visual acuity","score_opus":0.03675749743531352,"score_gpt":0.3243977628798562,"score_spread":0.2876402654445427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206156660","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99693227,0.0015360896,8.2714087e-7,0.0008598252,0.00013687546,0.00039036575,0.00009154956,0.000007608401,0.000044616958],"genre_scores_gemma":[0.9989547,0.00025596985,0.000027516937,0.0006469258,0.000029564073,0.000014996943,0.00004103844,0.0000130561575,0.00001619954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816465,0.00046195948,0.0006256667,0.00020647381,0.00026448834,0.00027675982],"domain_scores_gemma":[0.9987747,0.0005909025,0.00025315004,0.00024506822,0.00003400491,0.0001021519],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017318113,0.000116361334,0.0005885237,0.00041798118,0.00004290755,0.0000029855228,0.000054407956,0.00002961074,0.00011874787],"category_scores_gemma":[0.0004985695,0.000103727536,0.000098069395,0.00029114078,0.00006209247,0.000048997194,0.00004563302,0.00032500477,0.0000013601563],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016465548,0.0006796261,0.97128457,0.00095710973,0.00003715246,0.00059440424,0.0025748727,0.003612687,0.0039230944,0.00007919179,0.0012052973,0.013405467],"study_design_scores_gemma":[0.0006248621,0.0012422448,0.9909144,0.0007727085,0.000008261658,0.00041859402,0.00024445384,0.0008830722,0.004503433,0.00006722692,0.00019590496,0.00012482844],"about_ca_topic_score_codex":0.0457235,"about_ca_topic_score_gemma":0.00008396775,"teacher_disagreement_score":0.045639534,"about_ca_system_score_codex":0.0002663327,"about_ca_system_score_gemma":0.0008525054,"threshold_uncertainty_score":0.96063113},"labels":[],"label_agreement":null},{"id":"W4206171792","doi":"10.1016/j.jval.2021.11.484","title":"POSC79 Hospital Costs Associated with Cataract, Glaucoma, Vitreoretinal, and Laser Refractive Surgeries in Europe: A Comprehensive Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Intraocular Surgery and Lenses","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Vitrectomy; Cataract surgery; Ophthalmology; Glaucoma; Optometry; Intraocular lens; Glaucoma surgery; Surgery; Visual acuity","score_opus":0.01550587302368212,"score_gpt":0.26438034799005744,"score_spread":0.24887447496637533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206171792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93154633,0.05805385,3.4242706e-7,0.009166447,0.00015079469,0.000824696,0.00009191404,0.000029174442,0.00013642831],"genre_scores_gemma":[0.9612281,0.028964387,0.000067188936,0.00891687,0.000037585352,0.00008028233,0.00045775893,0.000035213627,0.00021264683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972979,0.0012188389,0.00042796708,0.00035461318,0.0003260019,0.00037470562],"domain_scores_gemma":[0.9986984,0.00051516906,0.00024204099,0.00021576838,0.00019740009,0.00013122361],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00093779626,0.00019700546,0.00066243694,0.00018387502,0.0001503076,0.000018273582,0.000054610795,0.00004662174,0.000049042148],"category_scores_gemma":[0.0005710302,0.00016650726,0.000042045485,0.0011842961,0.0000819321,0.000113535294,0.00005551652,0.00088384585,0.0000023254406],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032324863,0.0024138177,0.9307708,0.0073488285,0.0002255405,0.017986542,0.011975503,0.00004579073,0.00010284673,0.00086792064,0.01963895,0.0053909565],"study_design_scores_gemma":[0.0029911278,0.0037528137,0.8619237,0.037643656,0.00007752737,0.0012147631,0.0014985569,0.00021460057,0.000115751485,0.000041613126,0.08989049,0.0006354022],"about_ca_topic_score_codex":0.0012667108,"about_ca_topic_score_gemma":0.000058270183,"teacher_disagreement_score":0.07025154,"about_ca_system_score_codex":0.00035141938,"about_ca_system_score_gemma":0.0004524173,"threshold_uncertainty_score":0.6789969},"labels":[],"label_agreement":null},{"id":"W4206200900","doi":"10.1016/j.jval.2021.11.290","title":"POSA148 Cost Effectiveness of Ofatumumab in Comparison with Other Disease Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland; University of British Columbia; Queen's University; EVERSANA (Canada); Novartis (Canada)","funders":"","keywords":"Relapsing remitting; Ofatumumab; Multiple sclerosis; Medicine; Natalizumab; Physical therapy; Intensive care medicine; Physical medicine and rehabilitation; Internal medicine; Psychiatry; Rituximab","score_opus":0.3750685980621716,"score_gpt":0.390211152634659,"score_spread":0.015142554572487421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206200900","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97667986,0.017903192,0.00021612455,0.0015236097,0.00012238683,0.002622752,0.00091727596,0.0000029339765,0.000011866342],"genre_scores_gemma":[0.9983411,0.00030675798,0.00041355018,0.0001901803,0.000012154128,0.0006893049,0.000022381226,0.000021648522,0.000002952663],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966036,0.0007899843,0.0019187789,0.000319297,0.000084257714,0.00028404687],"domain_scores_gemma":[0.99473447,0.0036693085,0.0012726643,0.00022376518,0.000028520171,0.00007129066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051649297,0.00012623593,0.0008533503,0.00022216438,0.00015132515,0.000008029443,0.00010383876,0.00002329746,0.000008438677],"category_scores_gemma":[0.00033241493,0.00012428094,0.000037383383,0.00022606314,0.00004545066,0.00007035759,0.000020217241,0.00010483559,2.793538e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025843232,0.0002069307,0.8693073,0.0011683638,0.000021732563,2.8798289e-7,0.016921846,0.11065165,0.0000010110617,0.0008242267,0.000005757009,0.0006324708],"study_design_scores_gemma":[0.004502272,0.000674446,0.85611653,0.00089929305,0.0000060657003,4.4667402e-7,0.04330382,0.0934996,0.0000131593315,0.0003249992,0.0004895667,0.00016978814],"about_ca_topic_score_codex":0.9401925,"about_ca_topic_score_gemma":0.69850636,"teacher_disagreement_score":0.24168612,"about_ca_system_score_codex":0.004112168,"about_ca_system_score_gemma":0.001285199,"threshold_uncertainty_score":0.99971086},"labels":[],"label_agreement":null},{"id":"W4206207684","doi":"10.1016/j.jval.2021.11.430","title":"POSB157 Demographics and Treatment Patterns of Onychomycosis Patients Claiming Efinaconazole: A Canadian Retrospective Claims Analysis Stratified By Diabetes Status","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Medicine; Terbinafine; Dermatology; Nail matrix; Diabetes mellitus; Population; Type 2 diabetes; Itraconazole; Internal medicine; Antifungal; Nail plate; Psoriasis","score_opus":0.015025666350614591,"score_gpt":0.2602608489948207,"score_spread":0.24523518264420613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206207684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938926,0.0012774903,0.0000019260037,0.0004921956,0.0000513784,0.0007725494,0.0034534133,0.000012673024,0.000045790854],"genre_scores_gemma":[0.99763113,0.00088795583,0.00007072604,0.0003016637,0.000008275327,0.00011242802,0.00094774086,0.000019193161,0.000020905227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99814236,0.00019045397,0.00043630123,0.00037843047,0.00032966532,0.0005227703],"domain_scores_gemma":[0.99886495,0.00007678518,0.00019309818,0.00024856336,0.000052496296,0.0005640996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015325261,0.00018563116,0.0005651663,0.00065126887,0.00022271174,0.000011481192,0.0000469249,0.000043450695,0.00009144689],"category_scores_gemma":[0.00001861005,0.00017460455,0.0001438635,0.0008922142,0.000028482002,0.00003835698,0.000024340045,0.00015007026,3.8052212e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007580985,0.000823956,0.993549,0.000072353614,0.0006915418,0.000012424611,0.00055795186,0.000110499015,0.0000051835486,0.000097535696,0.00004790409,0.00395584],"study_design_scores_gemma":[0.0029775472,0.0022025213,0.9924958,0.000047195637,0.0004955208,4.815408e-7,0.00045615336,0.0009496984,0.000020461099,0.00008467969,0.00015850023,0.00011148824],"about_ca_topic_score_codex":0.49901384,"about_ca_topic_score_gemma":0.0707132,"teacher_disagreement_score":0.42830065,"about_ca_system_score_codex":0.0017822288,"about_ca_system_score_gemma":0.0005597958,"threshold_uncertainty_score":0.9462439},"labels":[],"label_agreement":null},{"id":"W4206232750","doi":"10.1016/j.jval.2021.11.1129","title":"POSB362 Measuring Patient Preferences: Comparison of Five Discrete Choice Modeling Methods","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Mixed logit; Logit; Akaike information criterion; Statistics; Bayesian information criterion; Bayes' theorem; Ordered logit; Scale (ratio); Logistic regression; Latent class model; Class (philosophy); Econometrics; Bayesian probability; Mathematics; Computer science; Artificial intelligence","score_opus":0.3751476121542434,"score_gpt":0.3393561957265101,"score_spread":0.035791416427733314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206232750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98226905,0.0034507834,0.011940761,0.00021388134,0.00029909267,0.0003011211,0.0000750416,0.000011135626,0.0014391366],"genre_scores_gemma":[0.9901957,0.0001252645,0.009438456,0.00009970836,0.000016831891,0.000057309535,0.000021468819,0.000014114172,0.000031149455],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99813676,0.00019670605,0.0010765106,0.00031193442,0.00005344657,0.00022462127],"domain_scores_gemma":[0.9990774,0.00010764433,0.0005505222,0.0002039317,0.000004397129,0.000056154622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017737148,0.00009464568,0.00040244756,0.00016763099,0.00013863872,0.000008829108,0.00015731348,0.000029328607,0.00020892464],"category_scores_gemma":[0.00006616254,0.000121511905,0.000059662198,0.00013433493,0.000017740413,0.000109636705,0.0001280749,0.00020584084,0.000015658523],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007273395,0.00007453951,0.16097215,0.000044228942,0.000008550159,5.796157e-8,0.0036850201,0.82833177,0.0000045808674,0.0041700276,0.000011774642,0.0026900542],"study_design_scores_gemma":[0.0003070948,0.00020235954,0.02033195,0.000025212792,0.00000164636,4.6111134e-7,0.0017308576,0.96430385,0.00003312517,0.012334333,0.0005969968,0.00013209663],"about_ca_topic_score_codex":0.0129454555,"about_ca_topic_score_gemma":0.000044563043,"teacher_disagreement_score":0.14064018,"about_ca_system_score_codex":0.000619588,"about_ca_system_score_gemma":0.000035073434,"threshold_uncertainty_score":0.9936274},"labels":[],"label_agreement":null},{"id":"W4206245401","doi":"10.1016/j.jval.2021.11.194","title":"POSA49 Projecting the Long-Term Benefits of Venetoclax Combination Therapies for Patients with Newly Diagnosed Acute Myeloid Leukemia Who Are Ineligible for Intensive Chemotherapy: An Assessment of Net Health Benefit","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Princess Margaret Cancer Centre","funders":"","keywords":"Venetoclax; Myeloid leukemia; Medicine; Term (time); Oncology; Intensive care medicine; Internal medicine; Leukemia","score_opus":0.03830778710592713,"score_gpt":0.3585435742328819,"score_spread":0.3202357871269548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206245401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98307854,0.0007146651,0.00041781345,0.005999515,0.000113155686,0.0091880355,0.00045029787,0.000031034582,0.000006959428],"genre_scores_gemma":[0.9903325,0.0007932387,0.0039797844,0.002643663,0.0000768349,0.0013502784,0.0006824842,0.00009564302,0.000045578847],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968904,0.00030590477,0.00090620504,0.0004842407,0.0007644135,0.00064882473],"domain_scores_gemma":[0.99648905,0.0006983328,0.0011282123,0.000530741,0.0009972545,0.00015640873],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018149993,0.0002631852,0.0009025036,0.00038537095,0.00037485763,0.000019598634,0.00033711726,0.0000738956,0.000008995974],"category_scores_gemma":[0.0001493229,0.00019838895,0.00010710427,0.0006938946,0.00009544344,0.00013227333,0.00010490913,0.00047081674,9.05405e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00553455,0.0012442217,0.86854625,0.003930669,0.0005489208,0.0000041794797,0.020189459,0.037821166,0.00016921536,0.002199378,0.00096675014,0.05884522],"study_design_scores_gemma":[0.019405475,0.018451432,0.92247146,0.0012082676,0.00004627101,0.0000113567,0.0041088406,0.033330016,0.00032864377,0.0002937817,0.00011856307,0.00022586322],"about_ca_topic_score_codex":0.005586762,"about_ca_topic_score_gemma":0.0003590227,"teacher_disagreement_score":0.058619354,"about_ca_system_score_codex":0.0042671394,"about_ca_system_score_gemma":0.0045022853,"threshold_uncertainty_score":0.9995553},"labels":[],"label_agreement":null},{"id":"W4206298574","doi":"10.1016/j.jval.2021.11.153","title":"POSC7 Work Productivity and Activity Impairment for Patients with Moderate to Severe Plaque Psoriasis Treated with Certolizumab Pegol: Three-Year Results from Two Phase 3 Trials (CIMPASI-1 AND CIMPASI-2)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Presenteeism; Absenteeism; Placebo; Psoriatic arthritis; Work productivity; Physical therapy; Internal medicine; Productivity; Arthritis; Disease; Adalimumab; Psychology","score_opus":0.04380790334745937,"score_gpt":0.289780443493676,"score_spread":0.2459725401462166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206298574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878432,0.00047214777,0.00009042472,0.002143952,0.00026505382,0.0042282464,0.0048726522,0.00007317419,0.000011129067],"genre_scores_gemma":[0.9976184,0.00005876914,0.0006932193,0.00003984768,0.000068057925,0.0006659891,0.0007174344,0.000048265472,0.000090067166],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.99608576,0.0015577117,0.000575121,0.0010066881,0.00012589259,0.0006488174],"domain_scores_gemma":[0.9980359,0.0008648652,0.00043852732,0.00044977106,0.000073200936,0.00013772835],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00073509756,0.00042011912,0.0010251947,0.0002263024,0.00062464527,0.000038148522,0.00012909913,0.000115208444,0.000030190815],"category_scores_gemma":[0.00015701566,0.00031631166,0.00006632763,0.0004072499,0.00007535383,0.00015272271,0.00011089787,0.0002635369,0.000003237146],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.6096496,0.0065362845,0.23876712,0.0001680874,0.0015401581,0.00008833115,0.007993934,0.0028234306,0.0007828928,0.00007609301,0.0009883964,0.13058567],"study_design_scores_gemma":[0.42408532,0.05882428,0.49938795,0.0006730335,0.0010823527,0.00037178572,0.0011627532,0.0006368043,0.007238066,0.00084505917,0.0032040554,0.0024885712],"about_ca_topic_score_codex":0.008770434,"about_ca_topic_score_gemma":0.000983509,"teacher_disagreement_score":0.2606208,"about_ca_system_score_codex":0.0003778215,"about_ca_system_score_gemma":0.00031864713,"threshold_uncertainty_score":0.9999289},"labels":[],"label_agreement":null},{"id":"W4206322108","doi":"10.1016/j.jval.2021.11.849","title":"POSA282 Oncology Drugs without Phase III Data: Comparison of Reimbursement Recommendations Issued by the Canadian Agency for Drugs and Technologies in Health (CADTH), and the National Institute for Health and Care Excellence (NICE)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada); EVERSANA (Canada)","funders":"","keywords":"Nice; Reimbursement; Excellence; Medicine; Agency (philosophy); Family medicine; Clinical trial; Health care; Internal medicine; Oncology; Political science; Computer science","score_opus":0.43561174244064815,"score_gpt":0.5090414548938318,"score_spread":0.07342971245318364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206322108","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05855115,0.063297056,0.0008863791,0.8599289,0.00053036836,0.0071800095,0.009480573,0.000026269905,0.00011929905],"genre_scores_gemma":[0.9697024,0.005790609,0.004953796,0.016975002,0.000056039673,0.001265435,0.0011773134,0.000022756396,0.000056640547],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.9944355,0.00091344834,0.0033918326,0.0006288058,0.0001228379,0.0005075594],"domain_scores_gemma":[0.99519825,0.0019012374,0.0022729784,0.00039862678,0.000063295476,0.00016558424],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.030625133,0.00015800764,0.0010196855,0.0004322135,0.001338022,0.00004000897,0.0004038978,0.00007717959,0.000008298781],"category_scores_gemma":[0.0014525442,0.00015690309,0.000026301226,0.00026104407,0.00028140747,0.00021089583,0.00017508186,0.00033847758,7.065942e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066294556,0.00071240804,0.022198258,0.006210888,0.00012999246,2.1568565e-7,0.33888835,0.0038048779,4.6870022e-7,0.32485667,0.2365693,0.065965645],"study_design_scores_gemma":[0.009620061,0.0010453229,0.0004854291,0.00019351444,0.000004644715,0.0000048469196,0.10318942,0.092338614,4.843111e-7,0.011771368,0.7811073,0.00023898804],"about_ca_topic_score_codex":0.41865444,"about_ca_topic_score_gemma":0.19583933,"teacher_disagreement_score":0.91115123,"about_ca_system_score_codex":0.0025991136,"about_ca_system_score_gemma":0.003630919,"threshold_uncertainty_score":0.9999621},"labels":[],"label_agreement":null},{"id":"W4206332072","doi":"10.1016/j.jval.2021.11.785","title":"POSB244 Regional Variation in Uptake of Recommended Cancer Treatments in England (2018-2020) - An Osimertinib Case Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osimertinib; Nice; Medicine; Excellence; Quarter (Canadian coin); Family medicine; Cancer; Internal medicine; Political science; Erlotinib; Geography","score_opus":0.1113062868943185,"score_gpt":0.31834692378330126,"score_spread":0.20704063688898278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206332072","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954799,0.0017340486,0.000008464118,0.0011112625,0.00045782264,0.00072253315,0.00025601307,0.000008102667,0.00022186812],"genre_scores_gemma":[0.99843806,0.0005806206,0.00017763473,0.00040804615,0.00007023689,0.00021407861,0.000017565262,0.000021025933,0.00007270798],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997694,0.00015675077,0.0013214863,0.0004364789,0.000045326506,0.00034594163],"domain_scores_gemma":[0.9989711,0.00007154568,0.00059152226,0.000268157,0.000010765984,0.00008688221],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019023068,0.00013870149,0.00053881615,0.00045884177,0.00008486684,0.000013061383,0.00014884205,0.0000535807,0.00027345077],"category_scores_gemma":[0.00004956507,0.00018017333,0.000040620464,0.00043745013,0.000013358667,0.00024040224,0.00004847013,0.00025076006,0.000004805427],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026900964,0.0020679077,0.9206285,0.000042948017,0.00003130006,0.00018074,0.026192252,0.035324953,0.0000019963907,0.0036251892,0.000116351635,0.011518866],"study_design_scores_gemma":[0.006864103,0.00138928,0.9582019,0.000033219272,0.0000038674984,0.000050245937,0.0019652569,0.015752818,0.0000010678374,0.0065853405,0.008881706,0.0002712255],"about_ca_topic_score_codex":0.27792633,"about_ca_topic_score_gemma":0.022330519,"teacher_disagreement_score":0.2555958,"about_ca_system_score_codex":0.0014614771,"about_ca_system_score_gemma":0.00027994523,"threshold_uncertainty_score":0.9955094},"labels":[],"label_agreement":null},{"id":"W4206379445","doi":"10.1016/j.jval.2021.11.064","title":"P66 Epidemiology of Non-Small Cell Lung Cancer (NSCLC) by Histology and Disease Stage in Western Europe (WE): Population-Level Projections 2021-2026","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Lung cancer; Incidence (geometry); Stage (stratigraphy); Epidemiology; Medicine; Histology; Population; Cancer; Oncology; Internal medicine; Demography; Environmental health; Biology","score_opus":0.14929005134298978,"score_gpt":0.3981975554432942,"score_spread":0.24890750410030443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206379445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9667137,0.022330184,0.00044176006,0.008994115,0.0002886896,0.00082957663,0.00027072494,0.000011939671,0.000119266406],"genre_scores_gemma":[0.99407816,0.0018173598,0.0006269782,0.002199677,0.000057588855,0.00015883829,0.000077931574,0.000019222885,0.0009642455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978082,0.000618287,0.0006759355,0.0003727033,0.0001486279,0.00037624725],"domain_scores_gemma":[0.9990321,0.00022108619,0.0002722882,0.0002101923,0.000039464252,0.00022489214],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010248498,0.00012378195,0.0004822894,0.00021629618,0.000105663195,0.000001661495,0.00009013793,0.000045793702,0.00009877473],"category_scores_gemma":[0.0002586929,0.00012876031,0.00003601894,0.0004459624,0.000049657043,0.00004633065,0.000095969255,0.00039515624,9.540177e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021398145,0.000103517494,0.98523945,0.0005285762,0.0000062173026,0.000035273915,0.0008206238,0.00993197,0.000032974902,0.00011237141,0.0019211578,0.0010538737],"study_design_scores_gemma":[0.0013608553,0.0003985105,0.9757568,0.0003599908,0.000023782119,0.00001519562,0.00039184195,0.016131973,0.0000034792354,0.000086238644,0.0053394423,0.00013186429],"about_ca_topic_score_codex":0.12522115,"about_ca_topic_score_gemma":0.0028582194,"teacher_disagreement_score":0.12236293,"about_ca_system_score_codex":0.0006218014,"about_ca_system_score_gemma":0.001025845,"threshold_uncertainty_score":0.8806041},"labels":[],"label_agreement":null},{"id":"W4206389358","doi":"10.1016/j.jval.2021.11.1087","title":"POSA376 Health State Utilities and Willingness to Pay in Patients with Coeliac Disease","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Willingness to pay; Visual analogue scale; Medicine; Coeliac disease; Disease; Cross-sectional study; Environmental health; Internal medicine; Physical therapy; Pathology","score_opus":0.02094277590584004,"score_gpt":0.30247436219227647,"score_spread":0.28153158628643643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206389358","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9753495,0.0015852802,0.000038842012,0.020229675,0.000079380676,0.002414229,0.00022463544,0.00002950757,0.000048968053],"genre_scores_gemma":[0.99399567,0.00062471686,0.00013495129,0.004584275,0.00001708695,0.00020227463,0.00011891471,0.000023019024,0.00029907472],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977173,0.00031611163,0.00034700808,0.00035239538,0.0006559638,0.00061119266],"domain_scores_gemma":[0.9986114,0.000052814474,0.00006381749,0.0002603914,0.000036054884,0.00097555853],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088488276,0.0001244447,0.00030229968,0.00029306798,0.00014165354,0.000015774614,0.00007065164,0.0000073635133,0.000049068014],"category_scores_gemma":[0.000067340225,0.000097751916,0.000020997468,0.00045750543,0.000036876994,0.000051222865,0.00016785743,0.00024009777,0.000003563866],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029300114,0.0009145759,0.9601213,0.0018603887,0.000013960181,0.00007441545,0.0017231244,0.002693329,1.4144365e-7,0.00032494834,0.0018128535,0.027530981],"study_design_scores_gemma":[0.0030515231,0.001933647,0.97290045,0.00032840658,0.0000034849566,5.742882e-7,0.0006912369,0.00079554954,2.6957332e-7,0.0002441845,0.019944474,0.00010619804],"about_ca_topic_score_codex":0.0088513885,"about_ca_topic_score_gemma":0.00022094899,"teacher_disagreement_score":0.027424783,"about_ca_system_score_codex":0.0006648446,"about_ca_system_score_gemma":0.0011626345,"threshold_uncertainty_score":0.99774873},"labels":[],"label_agreement":null},{"id":"W4206406549","doi":"10.1016/j.jval.2021.11.592","title":"POSA191 Transmission Control Outcomes for Tuberculosis in Polar Regions: A Review","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Tuberculosis; Arctic; Environmental health; Epidemiology; Family medicine; Intensive care medicine; Pathology; Ecology","score_opus":0.19195609831026914,"score_gpt":0.45823556044205205,"score_spread":0.2662794621317829,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206406549","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000015594594,0.9350973,0.00007345788,0.05433387,0.0001461909,0.009998241,0.00021116063,0.000042596177,0.000095660485],"genre_scores_gemma":[0.0000027169053,0.980936,0.0006598016,0.014201161,0.000100846766,0.003281918,0.00057851075,0.0000956915,0.00014338366],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9906449,0.0041891257,0.0026404166,0.00085768296,0.00047035524,0.0011975227],"domain_scores_gemma":[0.9936457,0.0045126607,0.0004785964,0.00075694924,0.000041696785,0.00056437455],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007705789,0.00052530994,0.006423452,0.0009116178,0.00011901501,0.0000067061933,0.0003400058,0.0003740395,0.00028365242],"category_scores_gemma":[0.0042856038,0.00038185943,0.0012821842,0.0010005423,0.000053251235,0.000050476192,0.00005099111,0.0017044159,0.000024228175],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006436504,0.00025925995,0.00061792316,0.28216183,0.00013199424,0.00005280608,0.00003875652,0.0000052959613,2.6329744e-8,0.00035142456,0.010759703,0.70555663],"study_design_scores_gemma":[0.0014945945,0.00062018796,0.00018515228,0.11401708,0.00028520456,0.00014124978,0.000010268795,0.00016787843,5.6309326e-9,0.00015800138,0.88269,0.0002303433],"about_ca_topic_score_codex":0.0065531763,"about_ca_topic_score_gemma":0.00007231007,"teacher_disagreement_score":0.8719303,"about_ca_system_score_codex":0.0015418635,"about_ca_system_score_gemma":0.0024619426,"threshold_uncertainty_score":0.9998633},"labels":[],"label_agreement":null},{"id":"W4206423678","doi":"10.1016/j.jval.2021.11.987","title":"POSB303 Systematic Review of Probabilistic Sensitivity Analysis Methods in Microsimulation of Chronic Diseases","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NovAtel (Canada)","funders":"","keywords":"Microsimulation; Probabilistic logic; Sensitivity (control systems); Medicine; Computer science; Operations research; Data mining; Artificial intelligence; Engineering; Transport engineering","score_opus":0.32109451891293583,"score_gpt":0.4845840533272075,"score_spread":0.16348953441427166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206423678","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2819332,0.63745075,0.036719587,0.023700448,0.00093787734,0.015626313,0.0033139943,0.000070811744,0.00024702476],"genre_scores_gemma":[0.98901,0.0026495438,0.0054489267,0.0023478377,0.00003279744,0.0003563198,0.000102781494,0.000023959325,0.000027877306],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9833681,0.00774175,0.007960181,0.00046438095,0.00014976291,0.00031580357],"domain_scores_gemma":[0.9904671,0.0036898607,0.005056698,0.0006363873,0.000057471876,0.00009253967],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.059973538,0.00014055156,0.0028010232,0.0010034153,0.0000758167,0.0000068832087,0.00017111666,0.00004272621,0.00014114824],"category_scores_gemma":[0.00816885,0.00018122586,0.00023704322,0.0016836536,0.000043824963,0.00012267714,0.00007425477,0.00017409226,0.000010387817],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008803526,0.00032717673,0.041176513,0.6599257,0.0001084572,8.374786e-7,0.0009998172,0.28174847,0.0000031021852,0.015584329,0.00008696133,0.000029828305],"study_design_scores_gemma":[0.000899389,0.00031424357,0.07065582,0.04797816,0.00019024307,0.000004991415,0.0006980962,0.8697536,0.0000036934887,0.008989974,0.00011466637,0.00039711094],"about_ca_topic_score_codex":0.009142497,"about_ca_topic_score_gemma":0.00031680753,"teacher_disagreement_score":0.7070768,"about_ca_system_score_codex":0.00262339,"about_ca_system_score_gemma":0.00061322044,"threshold_uncertainty_score":0.9974557},"labels":[],"label_agreement":null},{"id":"W4206436356","doi":"10.1016/j.jval.2021.11.943","title":"POSB294 Delay in Percutaneous Nephrolithotomy and Healthcare Utilization Among Patients with a Stent Placement and Stone Disease","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Kidney Stones and Urolithiasis Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Percutaneous nephrolithotomy; Medicine; Stent; Surgery; Retrospective cohort study; Logistic regression; Cohort; Percutaneous; Internal medicine","score_opus":0.025920826517402566,"score_gpt":0.28040161292705085,"score_spread":0.2544807864096483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206436356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99217933,0.0020670916,0.0000042971697,0.0036434936,0.000050013175,0.0019251376,0.000097651166,0.000021529315,0.000011431902],"genre_scores_gemma":[0.9969887,0.00038282387,0.00032376562,0.0019197864,0.000011120181,0.00013762881,0.00016587785,0.00002577783,0.00004452075],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982409,0.0002663362,0.00035694413,0.0003922708,0.0003924625,0.00035112016],"domain_scores_gemma":[0.9990598,0.00004613559,0.00011160261,0.00024424412,0.000034236724,0.00050400593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026163794,0.00016341949,0.00030337318,0.00021309027,0.0001718257,0.000010845554,0.000041937757,0.000028194125,0.00001922841],"category_scores_gemma":[0.000039793005,0.00013948654,0.000017327035,0.00024907416,0.00004556594,0.000053037616,0.000095611904,0.0002101572,4.1117093e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013714249,0.00067390106,0.9919392,0.00038500712,0.00001647731,0.00021759848,0.00255641,0.00087664794,5.3272885e-7,0.000062748615,0.000022174254,0.0018778866],"study_design_scores_gemma":[0.0042548478,0.0019533392,0.98693633,0.00022564705,0.000025416903,0.0001038531,0.00090114836,0.005013189,2.5262221e-7,0.00004042751,0.00043318333,0.00011234721],"about_ca_topic_score_codex":0.007348536,"about_ca_topic_score_gemma":0.00014394788,"teacher_disagreement_score":0.007204588,"about_ca_system_score_codex":0.00063454104,"about_ca_system_score_gemma":0.00035595652,"threshold_uncertainty_score":0.9992616},"labels":[],"label_agreement":null},{"id":"W4206483067","doi":"10.1016/j.jval.2021.11.759","title":"POSA244 First-Line Maintenance (1L MT) Treatment of Stage IV Non-Small Cell Lung Cancer (NSCLC) in Western Europe (WE): Results of the CancerMPact® Survey 2020","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Pembrolizumab; Pemetrexed; Carboplatin; Internal medicine; Oncology; Medicine; Lung cancer; Chemotherapy; Cancer; Immunotherapy; Cisplatin","score_opus":0.04938723913475337,"score_gpt":0.3179807771920575,"score_spread":0.2685935380573041,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206483067","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703531,0.014331384,0.0000077438235,0.011450037,0.00052006723,0.0016080553,0.0015721878,0.000010257281,0.00014712321],"genre_scores_gemma":[0.9745126,0.021324888,0.00003285726,0.00054201327,0.00006126174,0.000101565165,0.000043012482,0.000037354606,0.0033444737],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973225,0.00061130256,0.00086757104,0.00038573204,0.00036301283,0.00044987988],"domain_scores_gemma":[0.9983902,0.0002480945,0.0006081898,0.0005789282,0.00008011638,0.00009449385],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001308397,0.00021869515,0.00062400405,0.00013168885,0.00008327911,0.0000056761946,0.0002365068,0.00004847851,0.000063075466],"category_scores_gemma":[0.000053971344,0.0001578989,0.00011520156,0.001034434,0.00008316472,0.000032169286,0.00007581889,0.00025714294,4.186486e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013876403,0.0011761162,0.9466524,0.0014028692,0.00009765864,0.00005907687,0.011183588,0.016589154,0.001679202,0.0000029363173,0.001937079,0.005343529],"study_design_scores_gemma":[0.015607377,0.0025974952,0.9542953,0.0013989152,0.000024032805,0.00000899726,0.0004445816,0.003934864,0.0017841029,0.0000019087654,0.019709144,0.00019331952],"about_ca_topic_score_codex":0.33551368,"about_ca_topic_score_gemma":0.08784105,"teacher_disagreement_score":0.24767263,"about_ca_system_score_codex":0.0018062547,"about_ca_system_score_gemma":0.0019838996,"threshold_uncertainty_score":0.92880344},"labels":[],"label_agreement":null},{"id":"W4206518892","doi":"10.1016/j.jval.2021.11.040","title":"P42 Comparison of Estimation Methods for Single-Arm Trials in Rare Diseases with Historical Control Groups","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Propensity score matching; Confidence interval; Confounding; Statistics; Estimator; Sample size determination; Randomization; Weighting; Medicine; Inverse probability weighting; Standard error; Coverage probability; Placebo; Type I and type II errors; Population; Mean squared error; Mathematics; Average treatment effect; Randomized controlled trial; Internal medicine","score_opus":0.7588654549010957,"score_gpt":0.6388849453975496,"score_spread":0.1199805095035461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206518892","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.005808178,0.0008539742,0.9874778,0.0015971384,0.0007405426,0.0031373794,0.00030144962,0.00004829642,0.000035267443],"genre_scores_gemma":[0.18981831,0.0000064586884,0.80934155,0.0001310551,0.000080336176,0.00057268294,0.000007465999,0.000032435473,0.000009718053],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.97336316,0.021065075,0.004120259,0.00047539297,0.0005345103,0.00044159553],"domain_scores_gemma":[0.7263369,0.27140406,0.0016541722,0.00036618012,0.00007842566,0.00016029799],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.031712025,0.0001832748,0.0026043814,0.00024299834,0.000098785305,0.000011521871,0.00023257644,0.00008295539,0.000077048324],"category_scores_gemma":[0.23750795,0.00015654524,0.00018292808,0.0004943672,0.00006215146,0.000042713855,0.00005595753,0.00036546445,3.402958e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013950767,0.018782416,0.01680931,0.007186121,0.00019790711,0.000017954659,0.0036144012,0.075190924,0.000245838,0.4073402,0.0034140088,0.45325014],"study_design_scores_gemma":[0.0066443738,0.0040639485,0.00046882758,0.000247118,0.00010767412,0.0000025441311,0.00023729923,0.15968464,0.00008729696,0.8276915,0.0005744713,0.00019033134],"about_ca_topic_score_codex":0.00038151533,"about_ca_topic_score_gemma":0.000010943922,"teacher_disagreement_score":0.45305982,"about_ca_system_score_codex":0.0014746885,"about_ca_system_score_gemma":0.00032611756,"threshold_uncertainty_score":0.99705625},"labels":[],"label_agreement":null},{"id":"W4206535356","doi":"10.1016/j.jval.2021.11.896","title":"POSC258 Acceptance of Progression-Free Survival 2 (PFS2) By EU5 and Canadian Health Authorities for Cancer Drug Reimbursement","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Overall survival; Business; Cancer; Oncology; Medicine; Internal medicine; Health care; Economic growth; Economics","score_opus":0.05005467635728975,"score_gpt":0.30122836691425137,"score_spread":0.2511736905569616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206535356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5661334,0.3094142,0.0003094676,0.08720165,0.00471411,0.0035980074,0.024439868,0.000054644293,0.0041346787],"genre_scores_gemma":[0.98163646,0.011760947,0.0012588185,0.0031691252,0.00019711349,0.00052342855,0.000081530874,0.000056246627,0.0013163411],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99770105,0.00006676979,0.0010228459,0.0004461411,0.00006916772,0.00069402106],"domain_scores_gemma":[0.9985116,0.000097185584,0.0007067691,0.0003269884,0.00002653952,0.00033087528],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022891785,0.00016496729,0.00067343056,0.00028955803,0.0003803067,0.000029261457,0.00033424317,0.00004721203,0.00022704927],"category_scores_gemma":[0.00011067691,0.00021301313,0.000064481406,0.00021637391,0.00007176743,0.00016059981,0.00009914122,0.00022570555,0.0000017565069],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022980403,0.00028382055,0.23762621,0.0012773256,0.000076573924,0.000002707089,0.00797776,0.0034915041,0.0000026746754,0.46504822,0.20328525,0.08069814],"study_design_scores_gemma":[0.0025514741,0.0008693433,0.06126094,0.0002188133,0.000003424866,0.0000025940183,0.0012771304,0.0034482868,0.000016420958,0.049521178,0.8802576,0.0005727998],"about_ca_topic_score_codex":0.67611945,"about_ca_topic_score_gemma":0.11359209,"teacher_disagreement_score":0.6769723,"about_ca_system_score_codex":0.0016006706,"about_ca_system_score_gemma":0.0012560091,"threshold_uncertainty_score":0.9025825},"labels":[],"label_agreement":null},{"id":"W4206561547","doi":"10.1016/j.jval.2021.11.1006","title":"POSC299 Transportability Analysis: A Principled Method for Transporting Treatment Effects Observed in One Real-World Dataset to Another","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Real world data; Population; Sample (material); Sample size determination; Computer science; Statistics; Data science; Medicine; Environmental health; Mathematics","score_opus":0.5469523301601773,"score_gpt":0.47580667639863894,"score_spread":0.07114565376153836,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206561547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91470176,0.0009551848,0.02257532,0.03850257,0.00034240473,0.007920438,0.014817315,0.00007171648,0.0001132717],"genre_scores_gemma":[0.91019124,0.00011798659,0.06580365,0.014669904,0.0001378418,0.0052453936,0.0035166852,0.00009260777,0.0002246957],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9897376,0.0018943291,0.0062408256,0.0011635204,0.00015102382,0.0008127377],"domain_scores_gemma":[0.994507,0.0024995222,0.0018252975,0.00088126946,0.000021080907,0.00026579405],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.041809913,0.00027427223,0.0021837463,0.0014108289,0.00024724277,0.000025575078,0.00033411072,0.00007193696,0.00027141444],"category_scores_gemma":[0.0007352608,0.00036788874,0.0002652635,0.0018132081,0.000017057728,0.00017101626,0.000026927915,0.0002273506,0.000024332336],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002876963,0.0012124542,0.75479573,0.0018111723,0.00029174692,0.0000046681957,0.010300215,0.2139963,0.0000070100236,0.01633849,0.00039402753,0.0005604996],"study_design_scores_gemma":[0.004348684,0.0010012382,0.8654068,0.00012847842,0.00006851532,6.3885875e-7,0.0006526137,0.09140811,0.000012982464,0.0041580657,0.032242086,0.0005717545],"about_ca_topic_score_codex":0.1817215,"about_ca_topic_score_gemma":0.093493044,"teacher_disagreement_score":0.12258819,"about_ca_system_score_codex":0.0043536024,"about_ca_system_score_gemma":0.0005407304,"threshold_uncertainty_score":0.99987733},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W4206594807","doi":"10.1016/j.jval.2021.11.537","title":"POSC133 Use of Expert Elicitation to Extrapolate Observed Intermediate Clinical Trial Outcomes to Clinically Meaningful Long-Term Outcomes for Use in Health Technology Assessments: A Case Study in a Rare, Lifelong Disease","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Medicine; Physical therapy; Hypophosphatemia; Clinical trial; Pediatrics; Intensive care medicine; Internal medicine","score_opus":0.6183386954103173,"score_gpt":0.5973015759163192,"score_spread":0.021037119493998113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206594807","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9602871,0.00027566624,0.00022490995,0.028774552,0.00089454174,0.009404164,0.000087862274,0.000050567574,6.3600646e-7],"genre_scores_gemma":[0.97722083,0.00040581237,0.0044260942,0.016273092,0.00007514761,0.0015117315,0.00002280088,0.000044398017,0.000020071406],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99141973,0.002531728,0.003915422,0.0008255089,0.0005292456,0.00077836943],"domain_scores_gemma":[0.9902374,0.0075366595,0.0008298758,0.00054540654,0.00011420498,0.0007364617],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0074612983,0.00030677827,0.0017038744,0.0008404342,0.00016161168,0.000036238347,0.00025292992,0.00009723655,0.000017033004],"category_scores_gemma":[0.011349524,0.0002725997,0.00021480117,0.0010926919,0.000059338756,0.00027224273,0.0004435195,0.00092940003,0.0000016038135],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.040306043,0.006257083,0.9334579,0.00027528073,0.000116060415,0.0011623133,0.0031584515,0.00034825926,0.0000016815397,0.000026136411,0.00007201382,0.014818754],"study_design_scores_gemma":[0.04591409,0.014388224,0.9314396,0.0003328401,0.000042398064,0.000018504077,0.0047339355,0.002368758,3.1919956e-7,0.000035618796,0.00050622737,0.00021950246],"about_ca_topic_score_codex":0.016883,"about_ca_topic_score_gemma":0.007520972,"teacher_disagreement_score":0.01693375,"about_ca_system_score_codex":0.00083345454,"about_ca_system_score_gemma":0.00095290627,"threshold_uncertainty_score":0.99997264},"labels":[],"label_agreement":null},{"id":"W4206608028","doi":"10.1016/j.jval.2021.11.1351","title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":997,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Institute of Health Economics; University of Ottawa","funders":"National Institute for Health and Care Research; National Institute for Health Research Health Protection Research Unit","keywords":"Checklist; Economic evaluation; Context (archaeology); Health care; Public health; Stakeholder; Statement (logic); Public relations; Medicine; Political science; Psychology; Nursing; Law","score_opus":0.6187632095078116,"score_gpt":0.5762228648688769,"score_spread":0.042540344638934746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206608028","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00023830404,0.9264675,0.0015172961,0.02530359,0.005534433,0.019849394,0.02025548,0.0002602109,0.0005738441],"genre_scores_gemma":[0.00013812946,0.96492356,0.004604769,0.0068395496,0.00090962264,0.0077369637,0.013917213,0.00047366385,0.000456511],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.861161,0.014663878,0.11298516,0.0056647416,0.0013449582,0.004180263],"domain_scores_gemma":[0.82806706,0.0033090434,0.16475685,0.0025315592,0.00030699556,0.0010285125],"candidate_categories":["metaresearch","metaepi_narrow","sts","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_narrow"],"category_scores_codex":[0.42074898,0.0014216835,0.012175478,0.0028742456,0.0021236269,0.0003647807,0.0011782391,0.00056418125,0.004198102],"category_scores_gemma":[0.03507519,0.0019719698,0.0013168021,0.0010670864,0.00015918184,0.0009258786,0.0003625437,0.0017081237,0.00043667597],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000112329195,0.0005761622,0.0010388467,0.100376375,0.0014282085,0.000010793892,0.007765598,0.082712054,6.663133e-8,0.02795101,0.4811454,0.29688314],"study_design_scores_gemma":[0.0018597094,0.0005421582,0.00007327771,0.006103005,0.000075489035,0.0000630607,0.0011634496,0.061072946,1.05232665e-7,0.0030329616,0.92475146,0.0012624072],"about_ca_topic_score_codex":0.031665675,"about_ca_topic_score_gemma":0.0034038292,"teacher_disagreement_score":0.44360602,"about_ca_system_score_codex":0.09259184,"about_ca_system_score_gemma":0.06905873,"threshold_uncertainty_score":0.9998533},"labels":[],"label_agreement":null},{"id":"W4206610800","doi":"10.1016/j.jval.2021.11.1131","title":"POSB364 Systematic Literature Reviews (SLRS) of Economic Evaluations and Health Utility Studies of AML Treatments for Adults Receiving High Intensity Induction Therapy, with or without Maintenance Therapy","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Systematic review; Gemtuzumab ozogamicin; MEDLINE; Quality-adjusted life year; Induction chemotherapy; Economic evaluation; Cochrane Library; Cost effectiveness; Intensive care medicine; Internal medicine; Meta-analysis; Chemotherapy; Pathology","score_opus":0.17890931844490274,"score_gpt":0.43546477481830104,"score_spread":0.25655545637339827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206610800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93563485,0.050583873,0.00004709831,0.0041057672,0.00014051251,0.009373169,0.00009487371,0.000016504093,0.0000033216331],"genre_scores_gemma":[0.9287651,0.06694905,0.0026154157,0.0004932272,0.00004144611,0.0009391258,0.00004731428,0.000026857924,0.00012243292],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.9966653,0.0011625863,0.001121658,0.00042183674,0.00029991698,0.0003286956],"domain_scores_gemma":[0.997835,0.00033538885,0.00092165946,0.00047942367,0.00031835792,0.00011020546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005454132,0.00020599086,0.0015689677,0.00025855337,0.000208725,0.0000075150847,0.00010611185,0.00004641828,0.000012230194],"category_scores_gemma":[0.00034244184,0.00012723957,0.00007142047,0.0004193478,0.000114153605,0.00009265327,0.00005065157,0.0003233722,3.591039e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057915896,0.0034555492,0.25122356,0.34654704,0.0031344558,0.000019615127,0.20104383,0.0011401144,0.0005709617,0.0007984994,0.0055444124,0.12860608],"study_design_scores_gemma":[0.07067138,0.07658901,0.52151084,0.22269347,0.00035968501,0.0010459948,0.05640152,0.04597444,0.0009918959,0.0019689975,0.0007286061,0.0010641512],"about_ca_topic_score_codex":0.0033085144,"about_ca_topic_score_gemma":0.0003071429,"teacher_disagreement_score":0.27028728,"about_ca_system_score_codex":0.001988817,"about_ca_system_score_gemma":0.0014391418,"threshold_uncertainty_score":0.5200687},"labels":[],"label_agreement":null},{"id":"W4206649529","doi":"10.1016/j.jval.2021.11.638","title":"POSB200 Type of Polypharmacy and the Risk of Mortality Among Patients with Chronic Heart Failure Newly Diagnosed? A Nested Case-Control Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Polypharmacy; Medicine; Internal medicine; Odds ratio; Incidence (geometry); Cohort; Nested case-control study; Logistic regression; Heart failure; Cohort study; Pediatrics","score_opus":0.07061029806713807,"score_gpt":0.38459458133017627,"score_spread":0.3139842832630382,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206649529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99431574,0.0011842591,0.0000031349566,0.0011345746,0.00011206958,0.0031319235,0.0000958706,0.000010463214,0.000011960226],"genre_scores_gemma":[0.99926496,0.000078717465,0.000033682645,0.00052494404,0.000023893077,0.000047985246,0.0000056951912,0.00001423237,0.0000058881838],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99709815,0.001537835,0.0005170327,0.00019938532,0.00042160635,0.00022597566],"domain_scores_gemma":[0.9979833,0.0011451609,0.00040458562,0.00026470522,0.000069009264,0.00013326244],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015236201,0.00012057311,0.0004916393,0.0000831088,0.00013495817,0.0000049021187,0.00006904879,0.000018701227,0.00009538435],"category_scores_gemma":[0.0002665574,0.00007541248,0.000047842255,0.0003873203,0.00012639155,0.0000798371,0.000058419497,0.00048806198,4.562107e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002092075,0.00094944634,0.9919157,0.0002253268,0.00016398673,0.0000587519,0.0016034702,0.0025202692,0.0000018774953,0.00001726368,0.00004874256,0.0004030737],"study_design_scores_gemma":[0.022513738,0.0030435433,0.9632186,0.00004829415,0.00029136392,0.000032064283,0.0007860142,0.009763818,0.0000027917647,0.000010979944,0.0002231418,0.00006563548],"about_ca_topic_score_codex":0.04265531,"about_ca_topic_score_gemma":0.00067036145,"teacher_disagreement_score":0.041984953,"about_ca_system_score_codex":0.00010919738,"about_ca_system_score_gemma":0.0002863337,"threshold_uncertainty_score":0.9637197},"labels":[],"label_agreement":null},{"id":"W4206668685","doi":"10.1016/j.jval.2021.11.469","title":"POSC64 Healthcare Costs and Resource Utilization in 1L Maintenance (1L MT) Treatment (Tx) of Advanced Non-Small Cell Lung Cancer (aNSCLC): A Systematic Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Pemetrexed; Pembrolizumab; Bevacizumab; Gemcitabine; Internal medicine; Oncology; Lenalidomide; Lung cancer; Indirect costs; Emergency medicine; Cancer; Chemotherapy; Multiple myeloma; Immunotherapy","score_opus":0.039606330470159865,"score_gpt":0.28104352964096635,"score_spread":0.24143719917080647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206668685","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1930473,0.79834473,0.000085587104,0.0035635773,0.0003148952,0.0030774497,0.00061633484,0.000015618865,0.00093451375],"genre_scores_gemma":[0.6695798,0.32681334,0.0002114169,0.0021285848,0.000036836067,0.0006604789,0.000043193642,0.000038803595,0.00048755383],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99711776,0.00018179635,0.0016070025,0.0005447382,0.00005815672,0.0004905325],"domain_scores_gemma":[0.998175,0.000105741514,0.0011447457,0.00039369665,0.000039717426,0.0001410734],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013508488,0.00024165839,0.0012147048,0.00034557856,0.00011418442,0.000023251498,0.00019702317,0.00008173784,0.00002906638],"category_scores_gemma":[0.00009505472,0.0002642682,0.00009293694,0.000642672,0.000028499986,0.00015960063,0.0000639241,0.00028061165,0.000002515119],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047291743,0.000994409,0.36285448,0.5084624,0.00009231661,0.00006497599,0.02487741,0.029614823,0.0000137758225,0.055922348,0.0022804618,0.014349685],"study_design_scores_gemma":[0.022320058,0.0066579822,0.23505285,0.49806005,0.000120187964,0.00012529925,0.005251561,0.13307312,0.0000941743,0.007092982,0.08840299,0.003748732],"about_ca_topic_score_codex":0.007389401,"about_ca_topic_score_gemma":0.0009180918,"teacher_disagreement_score":0.4765325,"about_ca_system_score_codex":0.00269788,"about_ca_system_score_gemma":0.00032416175,"threshold_uncertainty_score":0.9999809},"labels":[],"label_agreement":null},{"id":"W4206717734","doi":"10.1016/j.jval.2021.11.871","title":"POSB268 Landscape Review Exploring Acceptability of Oncology Surrogate Endpoints By NICE (England), CADTH (Canada), and PBAC (Australia) from 2010 to 2021","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Medicine; Clinical endpoint; Surrogate endpoint; Health technology; Oncology; Clinical trial; Maturity (psychological); Internal medicine; Family medicine; Psychology; Political science; Health care; Computer science","score_opus":0.465133554621386,"score_gpt":0.4235940712446222,"score_spread":0.04153948337676383,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206717734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90547866,0.029529018,0.000027751072,0.059127454,0.0012601938,0.0011795269,0.003125759,0.000012660967,0.00025896105],"genre_scores_gemma":[0.96286976,0.016873775,0.0015163945,0.017510537,0.00022109337,0.00050229894,0.00023785642,0.00004346512,0.00022483298],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9926341,0.0017485984,0.0041635204,0.000730891,0.00018181329,0.0005410517],"domain_scores_gemma":[0.9956336,0.0016407782,0.0017434089,0.00057222095,0.000039692215,0.00037032503],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.022049664,0.00019265561,0.0015089405,0.00019833459,0.00018010393,0.000014827577,0.00032887704,0.0000684213,0.0034131785],"category_scores_gemma":[0.0019938601,0.00026324086,0.000056384473,0.00036406115,0.00003269945,0.00021169482,0.00018368833,0.00041113928,0.00006567593],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014062005,0.0005567409,0.7350658,0.006763514,0.00011635212,0.000009647587,0.009023112,0.0033664575,0.000010949838,0.0034101496,0.22907028,0.012466364],"study_design_scores_gemma":[0.002151082,0.00066461123,0.2546451,0.00053228135,0.000010750929,0.000010040447,0.0024565447,0.0015051912,0.000014764446,0.0019246795,0.73547775,0.0006071782],"about_ca_topic_score_codex":0.8256563,"about_ca_topic_score_gemma":0.2129566,"teacher_disagreement_score":0.6126997,"about_ca_system_score_codex":0.0017106183,"about_ca_system_score_gemma":0.0010334798,"threshold_uncertainty_score":0.999982},"labels":[],"label_agreement":null},{"id":"W4206739434","doi":"10.1016/j.jval.2021.11.1201","title":"POSC376 Speak up Your Pain: Patient Care Course in Chronic Pain","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Pain Management and Placebo Effect","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Neuropathic pain; Medicine; McGill Pain Questionnaire; Nociception; Discontinuation; Population; Physical therapy; Chronic pain; Visual analogue scale; Anesthesia; Internal medicine","score_opus":0.05314602458588587,"score_gpt":0.3058556171375494,"score_spread":0.25270959255166353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206739434","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98264474,0.0039288346,0.0005200404,0.005280038,0.0018030531,0.0034195054,0.000080713085,0.0001943331,0.0021287643],"genre_scores_gemma":[0.9941482,0.00013407732,0.00003186369,0.005230159,0.00007198665,0.00015462366,0.000017614115,0.000024442912,0.00018703226],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9819757,0.015888035,0.00042104605,0.0005249081,0.0005103581,0.00067996146],"domain_scores_gemma":[0.9975954,0.0017947141,0.00014951518,0.00034759502,0.000008021936,0.00010474357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012501931,0.00016763862,0.00023256462,0.00026463202,0.0002502296,0.00002678873,0.00033878672,0.00003245329,0.00016870664],"category_scores_gemma":[0.001069654,0.00018231355,0.000055385408,0.0007853196,0.000032516302,0.000072559815,0.00018052774,0.00047419613,0.00003274118],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029415317,0.00059701264,0.091705,0.0021644004,0.000008229661,0.0007053273,0.027345669,0.43953973,0.001672433,0.0036212155,0.024681121,0.4076657],"study_design_scores_gemma":[0.002809084,0.004911434,0.011812833,0.00045090346,0.0000071774134,0.0000103354405,0.009360803,0.7499843,0.00048162346,0.0008908878,0.2184191,0.0008615075],"about_ca_topic_score_codex":0.0033992897,"about_ca_topic_score_gemma":0.00031446124,"teacher_disagreement_score":0.40680417,"about_ca_system_score_codex":0.0015959734,"about_ca_system_score_gemma":0.00046849335,"threshold_uncertainty_score":0.7434531},"labels":[],"label_agreement":null},{"id":"W4206764530","doi":"10.1016/j.jval.2021.11.1003","title":"POSB320 Matching-Adjusted Indirect Comparison of Guselkumab Versus Risankizumab in Patients with Moderate-to-Severe Plaque Psoriasis: Change in Baseline PASI from Week 4-40","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Plaque psoriasis; Baseline (sea); Psoriasis; Matching (statistics); Internal medicine; Propensity score matching; Dermatology; Pathology","score_opus":0.36272036851086087,"score_gpt":0.39018630177853797,"score_spread":0.0274659332676771,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4206764530","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986118,0.0013491997,0.0001422207,0.0072865454,0.0008017227,0.0023283,0.0018271921,0.000037100905,0.00010968242],"genre_scores_gemma":[0.9935555,0.00006551264,0.0023311074,0.0029206502,0.000115342526,0.00052422786,0.0004140605,0.00006398541,0.000009645478],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9907118,0.0020466715,0.0053156056,0.0008910791,0.00030122983,0.0007336284],"domain_scores_gemma":[0.9951832,0.0015436029,0.002389744,0.00060310855,0.000046844587,0.00023349098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011388158,0.000310752,0.001978104,0.0013969407,0.00017100778,0.00003052202,0.00043444554,0.00014368191,0.0002856311],"category_scores_gemma":[0.00075957313,0.0004133021,0.00006684375,0.0010520746,0.000028381912,0.00035097857,0.0001490765,0.0006744585,0.000078239325],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031997971,0.0014666477,0.7873927,0.0004473061,0.0000471608,0.00000312174,0.03086148,0.17326696,8.9543576e-8,0.0016931501,0.00097300805,0.00064858707],"study_design_scores_gemma":[0.017050397,0.0017311432,0.8666245,0.0005651924,0.0000063094885,6.9711456e-7,0.006198197,0.103842184,0.0000020395428,0.0020562164,0.0012731525,0.0006500057],"about_ca_topic_score_codex":0.16751157,"about_ca_topic_score_gemma":0.015497889,"teacher_disagreement_score":0.15201367,"about_ca_system_score_codex":0.0034273714,"about_ca_system_score_gemma":0.00053574634,"threshold_uncertainty_score":0.99983186},"labels":[],"label_agreement":null},{"id":"W4210349448","doi":"10.1016/j.jval.2021.11.1373","title":"A Conceptual Framework for Life-Cycle Health Technology Assessment","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"","keywords":"Health technology; Procurement; Certainty; Business; Risk analysis (engineering); Economic evaluation; Net present value; Value (mathematics); Sustainability; Actuarial science; Economics; Health care; Computer science; Marketing; Production (economics); Microeconomics","score_opus":0.42759688667811124,"score_gpt":0.4784584415503076,"score_spread":0.050861554872196346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210349448","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.099290535,0.018824821,0.08482909,0.7862572,0.0029723225,0.0051676147,0.0017263562,0.00026841767,0.0006636169],"genre_scores_gemma":[0.8166555,0.0003922243,0.08706342,0.09269885,0.0004316003,0.0023933055,0.000099897086,0.00008660352,0.0001785707],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9915033,0.001080631,0.0053719385,0.0008575036,0.00016055813,0.001026067],"domain_scores_gemma":[0.9937985,0.0019480247,0.003166723,0.0006839322,0.000033966448,0.00036887173],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.029726362,0.00021663036,0.0014267416,0.0008387578,0.0007938866,0.000035290876,0.0004895988,0.00015145166,0.00059843867],"category_scores_gemma":[0.0033432364,0.00031988058,0.00012621393,0.00071167253,0.000107537795,0.00015807949,0.00016491793,0.0007303104,0.00015601],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013615059,0.00019742113,0.015255557,0.00031874626,0.000020880792,4.77549e-7,0.0027357368,0.016479418,6.819561e-8,0.95242953,0.012140381,0.00040814266],"study_design_scores_gemma":[0.0020506852,0.0013829106,0.0075138914,0.00016702234,0.0000017032334,0.0000100223215,0.020706035,0.061969448,2.7572352e-7,0.5283917,0.37730432,0.0005019546],"about_ca_topic_score_codex":0.005789832,"about_ca_topic_score_gemma":0.00009582709,"teacher_disagreement_score":0.717365,"about_ca_system_score_codex":0.003990148,"about_ca_system_score_gemma":0.0026059153,"threshold_uncertainty_score":0.9999253},"labels":[],"label_agreement":null},{"id":"W4210604834","doi":"10.1016/j.jval.2021.12.004","title":"Validating Restricted Mean Survival Time Estimates From Reconstructed Kaplan-Meier Data Against Original Trial Individual Patient Data From Trials Conducted by the Canadian Cancer Trials Group","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Health Sciences Centre; Canadian Centre for Applied Research in Cancer Control; University of Toronto; Cancer Care Ontario; Queen's University; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Canadian Centre for Applied Research in Cancer Control","keywords":"Survival analysis; Standard deviation; Medicine; Clinical trial; Absolute deviation; Randomized controlled trial; Statistics; Surgery; Mathematics; Internal medicine","score_opus":0.3505452425193095,"score_gpt":0.355994801969507,"score_spread":0.005449559450197483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4210604834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6707416,0.007915759,0.00005098187,0.0029263583,0.0049454905,0.00221292,0.31058335,0.000058959078,0.0005645683],"genre_scores_gemma":[0.864727,0.0022561976,0.0037984606,0.0038673044,0.002938784,0.00050355896,0.12158178,0.00020706735,0.00011984476],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9902047,0.0022277117,0.0046093413,0.0016304124,0.0002675003,0.0010603481],"domain_scores_gemma":[0.98840445,0.0047190003,0.0039574127,0.0023810244,0.000043852553,0.0004942567],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.016355034,0.00046310824,0.002590338,0.00047169736,0.0009994964,0.00045611916,0.002873582,0.00023375098,0.0038537404],"category_scores_gemma":[0.0074975374,0.00045522331,0.00014246267,0.0007464329,0.00014957905,0.0007976413,0.0008602028,0.0009949164,0.00009562289],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.021169733,0.0013395575,0.09806166,0.00011891332,0.0043024207,0.00009647049,0.00838708,0.011051104,0.00022937742,0.014635473,0.6843053,0.1563029],"study_design_scores_gemma":[0.07501866,0.0012183845,0.011948784,0.00031203928,0.00031528767,0.000008428418,0.0016019538,0.10869808,0.000057509955,0.030313333,0.76775646,0.002751057],"about_ca_topic_score_codex":0.90658534,"about_ca_topic_score_gemma":0.2133884,"teacher_disagreement_score":0.6931969,"about_ca_system_score_codex":0.0018688088,"about_ca_system_score_gemma":0.003027506,"threshold_uncertainty_score":0.99978995},"labels":[],"label_agreement":null},{"id":"W4211209444","doi":"10.1016/j.jval.2020.11.007","title":"Engaging the Voices of Children: A Scoping Review of How Children and Adolescents Are Involved in the Development of Quality-of-Life–Related Measures","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":27,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; McMaster University; Western University","funders":"McMaster University","keywords":"Psychology; Developmental psychology; Quality (philosophy); Quality of life (healthcare); Psychotherapist","score_opus":0.530326870832528,"score_gpt":0.4627843983045805,"score_spread":0.06754247252794754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4211209444","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070501575,0.98236275,0.00003296063,0.005203589,0.00010509011,0.0049500396,0.0002709127,0.0000066683424,0.000017805758],"genre_scores_gemma":[0.018656109,0.9793865,0.00044845324,0.0012634464,0.000046656,0.00010559824,0.000059131664,0.00003320643,9.1227486e-7],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9794545,0.006057396,0.013237488,0.000591996,0.00029573738,0.00036288364],"domain_scores_gemma":[0.9801673,0.0021902104,0.016816873,0.00064489496,0.000075607044,0.00010509713],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.06088497,0.00034245235,0.005646931,0.00049921765,0.00010046445,0.000015889698,0.00075080624,0.00019688574,0.0000074929108],"category_scores_gemma":[0.008136199,0.00028159807,0.00028005135,0.00083589327,0.00014211811,0.00011640227,0.00012690379,0.00062619,0.0000051090833],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000068819413,0.00015627644,0.11286762,0.8518141,0.00022219818,1.0402293e-7,0.00836132,0.00003288218,1.6950656e-8,0.001980185,0.00011773539,0.02444069],"study_design_scores_gemma":[0.0007401766,0.000053721942,0.07678377,0.9176356,0.00004205138,0.0000025109123,0.0009226805,0.000054944077,2.8844832e-7,0.00022523849,0.00318861,0.00035040165],"about_ca_topic_score_codex":0.0031948986,"about_ca_topic_score_gemma":0.00048340342,"teacher_disagreement_score":0.06582152,"about_ca_system_score_codex":0.0003283138,"about_ca_system_score_gemma":0.0023740078,"threshold_uncertainty_score":0.99996364},"labels":[],"label_agreement":null},{"id":"W4212830678","doi":"10.1016/j.jval.2022.01.005","title":"Defining a Core Data Set for the Economic Evaluation of Precision Oncology","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; BC Cancer Agency; University of British Columbia; Queen's University; Canadian Centre for Applied Research in Cancer Control","funders":"","keywords":"Core (optical fiber); Set (abstract data type); Data set; Precision oncology; Medical physics; Medicine; Computer science; Internal medicine; Artificial intelligence; Telecommunications; Cancer","score_opus":0.9090435443040895,"score_gpt":0.6118206883164435,"score_spread":0.297222855987646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4212830678","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00002884228,0.9767568,0.0003775063,0.0033464306,0.002310758,0.007169882,0.00947702,0.000019507283,0.00051321357],"genre_scores_gemma":[0.000040315485,0.9917539,0.0020452659,0.0010683398,0.0003505046,0.0019807324,0.0026266933,0.00008793376,0.00004632376],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98123145,0.0040666265,0.01236649,0.0014123163,0.00025735318,0.0006657801],"domain_scores_gemma":[0.9621421,0.023557581,0.011795674,0.0023156067,0.00005187581,0.00013713236],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.188948,0.0003595214,0.004150698,0.000747919,0.00033622747,0.000038098377,0.001683092,0.00033865432,0.00085259264],"category_scores_gemma":[0.013006353,0.00037208732,0.0003301972,0.0003258783,0.0000744971,0.00025913282,0.00045751303,0.00059151085,0.0003312738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000019831055,0.000091956856,0.000105062354,0.025549311,0.00020605899,2.5333455e-7,0.0015734743,0.01591121,6.30169e-10,0.07478737,0.039289773,0.8424657],"study_design_scores_gemma":[0.0004911496,0.00017432169,0.00001678693,0.001867658,0.00008205263,0.000009091844,0.00037792002,0.15685616,2.1865216e-9,0.006224583,0.8336727,0.00022755019],"about_ca_topic_score_codex":0.010177323,"about_ca_topic_score_gemma":0.0006930246,"teacher_disagreement_score":0.8422381,"about_ca_system_score_codex":0.009722957,"about_ca_system_score_gemma":0.010357804,"threshold_uncertainty_score":0.9998731},"labels":[],"label_agreement":null},{"id":"W4220982152","doi":"10.1016/j.jval.2021.12.016","title":"The Cost-Effectiveness of Intermediate-Acting, Long-Acting, Ultralong-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Medicine; Biosimilar; Insulin; Checklist; Diabetes mellitus; Type 2 Diabetes Mellitus; Type 1 diabetes; Intensive care medicine; Cost effectiveness; Meta-analysis; Internal medicine; Endocrinology; Risk analysis (engineering)","score_opus":0.19056836850277048,"score_gpt":0.43366563132549774,"score_spread":0.24309726282272726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220982152","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007950926,0.9761391,0.000015656797,0.0001401634,0.0006701888,0.022711653,0.00005435972,0.000047957965,0.00014140658],"genre_scores_gemma":[0.00023865882,0.99577147,0.000051375282,0.00017305487,0.00009421267,0.003199297,0.00022592478,0.000121901074,0.00012411617],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99295026,0.0027703384,0.0020491926,0.0006773001,0.0006385749,0.000914356],"domain_scores_gemma":[0.98775494,0.009226816,0.0017681372,0.00085330347,0.00015128635,0.00024550682],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.013348849,0.0005416036,0.0044474746,0.00044758772,0.00030585894,0.00006277173,0.00051675434,0.00017945858,0.000039177852],"category_scores_gemma":[0.007620326,0.00034524806,0.00051157526,0.0011227491,0.00017955984,0.0000822222,0.00026527123,0.0010185944,0.000006839591],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032264546,0.000114654475,0.00015723915,0.77839804,0.00035879124,0.0000063686266,0.000066573564,0.0000012034283,1.01550725e-7,0.000047925823,0.00011748705,0.22069936],"study_design_scores_gemma":[0.000484868,0.00091116,0.000033114302,0.6414174,0.0010386282,0.0000036639065,0.0000900765,0.00012293346,0.0000016983931,0.000013331439,0.35565367,0.00022947013],"about_ca_topic_score_codex":0.00011467374,"about_ca_topic_score_gemma":0.000012067631,"teacher_disagreement_score":0.3555362,"about_ca_system_score_codex":0.0006319186,"about_ca_system_score_gemma":0.0008614634,"threshold_uncertainty_score":0.9998999},"labels":[],"label_agreement":null},{"id":"W4221058544","doi":"10.1016/j.jval.2022.01.014","title":"The (Harsh) Reality of Real-World Data External Comparators for Health Technology Assessment","year":2022,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"F. Hoffmann-La Roche; Roche","keywords":"Real world data; Computer science; Data science","score_opus":0.6585661098041051,"score_gpt":0.533671017920227,"score_spread":0.12489509188387815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4221058544","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008051923,0.006973813,0.0016744781,0.9734044,0.0020808794,0.003726687,0.01073973,0.00007652792,0.0005183132],"genre_scores_gemma":[0.004988246,0.009396663,0.015437985,0.9597982,0.0031408847,0.0016200333,0.0039106132,0.00024591672,0.0014614338],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9805793,0.0031416663,0.0126931695,0.0017059282,0.00038089766,0.0014990296],"domain_scores_gemma":[0.97692746,0.0054307445,0.013822331,0.0035465285,0.000082390325,0.00019052543],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.07631657,0.0004459323,0.0032791325,0.0013634936,0.0007905497,0.00008208445,0.0025881578,0.00033827138,0.00012279602],"category_scores_gemma":[0.0016710053,0.0005063415,0.00019847797,0.00090741034,0.00030399344,0.00021329886,0.0005732544,0.0022827717,0.000049535014],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021906248,0.000084124564,0.012092765,0.002581018,0.00006429045,0.0000017578279,0.00023292957,0.0005094913,1.9733372e-8,0.10010341,0.88388234,0.000425924],"study_design_scores_gemma":[0.00063417526,0.00037346248,0.005208389,0.0003456179,0.000004596997,0.0000044196563,0.00041092295,0.011798061,1.02913745e-7,0.025285607,0.9555915,0.00034313876],"about_ca_topic_score_codex":0.08876661,"about_ca_topic_score_gemma":0.0065849004,"teacher_disagreement_score":0.082181714,"about_ca_system_score_codex":0.0054630856,"about_ca_system_score_gemma":0.004034042,"threshold_uncertainty_score":0.9997388},"labels":[],"label_agreement":null},{"id":"W4223462176","doi":"10.1016/j.jval.2021.11.1379","title":"Economic Evaluation of Cognitive Behavioral Therapy for Depression: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"National Office for Philosophy and Social Sciences","keywords":"Medicine; Depression (economics); Economic evaluation; Quality-adjusted life year; Cognitive behavioral therapy; Systematic review; Cost effectiveness; Cognition; MEDLINE; Psychiatry; Clinical psychology","score_opus":0.47844142313795274,"score_gpt":0.5805198222754698,"score_spread":0.1020783991375171,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4223462176","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021806818,0.9699957,0.0000058030214,0.000045488927,0.0015760323,0.026663065,0.0011539459,0.00002078635,0.00051739445],"genre_scores_gemma":[0.00016387625,0.9678866,0.000023545706,0.00015952907,0.000041556883,0.030846633,0.00067253254,0.00006753036,0.00013814917],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9914718,0.0042417375,0.0030405107,0.00052305864,0.00035618522,0.00036666627],"domain_scores_gemma":[0.9953887,0.0014381054,0.002482787,0.0005179188,0.00006482294,0.000107707245],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.007144869,0.00030246068,0.0028322134,0.0003148687,0.00007562948,0.000010016792,0.0003229821,0.00013246831,0.001350048],"category_scores_gemma":[0.00023677484,0.00026784124,0.00070353487,0.00023943094,0.00003184278,0.00006375975,0.000054927197,0.00029753128,0.0000961705],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009983414,0.00044752637,0.0000013266599,0.5656891,0.000054903776,5.887331e-7,0.000100514386,8.7165233e-7,7.907613e-11,0.00028000513,0.00023871586,0.43317652],"study_design_scores_gemma":[0.00087299163,0.0012614512,0.000003863933,0.9542937,0.0010226067,0.000043424872,0.0001158573,0.000021620572,2.397557e-8,0.00026770573,0.041902043,0.00019467909],"about_ca_topic_score_codex":0.0009176915,"about_ca_topic_score_gemma":0.000028842225,"teacher_disagreement_score":0.43298182,"about_ca_system_score_codex":0.0016448025,"about_ca_system_score_gemma":0.0013308186,"threshold_uncertainty_score":0.99997735},"labels":[],"label_agreement":null},{"id":"W4224860695","doi":"10.1016/j.jval.2022.03.017","title":"Healthcare Costs for Pneumococcal Disease in the Era of Infant Immunization With 13-Valent Pneumococcal Conjugate Vaccine: A Population-Based Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Centre for Disease Control; University of British Columbia","funders":"Pfizer","keywords":"Pneumococcal conjugate vaccine; Pneumococcal disease; Medicine; Immunization; Streptococcus pneumoniae; Pediatrics; Immunology; Biology; Microbiology; Antibody","score_opus":0.02402005044632292,"score_gpt":0.316356643054663,"score_spread":0.29233659260834005,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224860695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9775638,0.00020153777,0.000047635804,0.016257066,0.00015110677,0.005631676,0.00010810939,0.000033311724,0.0000057846114],"genre_scores_gemma":[0.9966155,0.000018252018,0.000023279084,0.001777401,0.000046828467,0.0013055541,0.00017869248,0.000029767622,0.000004715093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969855,0.001120887,0.00079144153,0.00031581943,0.0004415305,0.00034484518],"domain_scores_gemma":[0.99862367,0.00035673403,0.00028368545,0.00045627166,0.00010703351,0.00017258603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013805422,0.0001727383,0.00043122555,0.00029795588,0.00035414388,0.000010746199,0.0001417302,0.000034645174,0.00001417405],"category_scores_gemma":[0.00014461565,0.00012628027,0.00007683369,0.00088963454,0.000019243245,0.00005397703,0.000035095523,0.0005706673,6.375439e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007907895,0.001705437,0.9261069,0.0004677002,0.000013237052,0.00002476256,0.0012905295,0.06888992,0.00019462852,0.00023182243,0.0000084629355,0.0002758046],"study_design_scores_gemma":[0.004268322,0.0036813552,0.9776452,0.00026015876,0.000031888012,0.0000103388575,0.0012848419,0.012393138,0.0000067025267,0.00004697529,0.00025571423,0.00011536814],"about_ca_topic_score_codex":0.0118454555,"about_ca_topic_score_gemma":0.0019398446,"teacher_disagreement_score":0.056496788,"about_ca_system_score_codex":0.00064500194,"about_ca_system_score_gemma":0.0012677046,"threshold_uncertainty_score":0.99473476},"labels":[],"label_agreement":null},{"id":"W4225128199","doi":"10.1016/j.jval.2022.01.012","title":"Accounting for Preference Heterogeneity in Discrete-Choice Experiments: An ISPOR Special Interest Group Report","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":78,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Preference; Mixed logit; Preference elicitation; Portfolio; Selection (genetic algorithm); Discrete choice; Econometrics; Actuarial science; Accounting; Psychology; Logistic regression; Economics; Computer science; Statistics; Microeconomics; Mathematics; Financial economics","score_opus":0.5665849309178793,"score_gpt":0.3834187387557521,"score_spread":0.1831661921621272,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225128199","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.036168486,0.95795685,0.00020083829,0.000045112,0.0017512043,0.0025835978,0.00049985544,0.000023619428,0.0007704518],"genre_scores_gemma":[0.0039528934,0.9918688,0.0006901449,0.000114639675,0.00080456765,0.001088641,0.0012789601,0.00008837241,0.000112975664],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99565995,0.00015690768,0.0025716608,0.0010666716,0.00005024105,0.00049456884],"domain_scores_gemma":[0.99730384,0.00020823543,0.0018117215,0.00056574465,0.0000028725444,0.00010760507],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0029373628,0.00034420064,0.0015752654,0.00041337602,0.00012470725,0.00006220129,0.0004227853,0.000189132,0.0005109689],"category_scores_gemma":[0.00019458067,0.00042400966,0.0002489292,0.00019823894,0.000033454668,0.00039956492,0.0001829369,0.00042386135,0.000059252514],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005554858,0.0017745716,0.29011425,0.023599353,0.00018390227,0.00004917542,0.0018157655,0.0015716942,1.9588855e-7,0.046324935,0.0005612258,0.6339494],"study_design_scores_gemma":[0.00043465663,0.00016472401,0.007726193,0.000996949,0.000008415239,0.000013988975,0.00008817898,0.0007055422,1.2615564e-7,0.0012011973,0.9882193,0.0004406829],"about_ca_topic_score_codex":0.0047206073,"about_ca_topic_score_gemma":0.0009148402,"teacher_disagreement_score":0.98765814,"about_ca_system_score_codex":0.002593845,"about_ca_system_score_gemma":0.00011782244,"threshold_uncertainty_score":0.9998212},"labels":[],"label_agreement":null},{"id":"W4229033896","doi":"10.1016/j.jval.2022.03.019","title":"“Bring the Hoses to Where the Fire Is!”: Differential Impacts of Marginalization and Socioeconomic Status on COVID-19 Case Counts and Healthcare Costs","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 epidemiological studies","field":"Mathematics","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; Institute for Clinical Evaluative Sciences; Simon Fraser University; Public Health Ontario; University of British Columbia; University of Waterloo; Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; University Health Network; Toronto General Hospital; Canadian Centre for Applied Research in Cancer Control","funders":"Canadian Institutes of Health Research","keywords":"Socioeconomic status; Comorbidity; Demography; Health care; Medicine; Cohort; Ethnic group; Population; Health equity; Gerontology; Environmental health; Sociology; Psychiatry; Economics; Economic growth; Pathology","score_opus":0.19914484187713516,"score_gpt":0.4368686704032987,"score_spread":0.23772382852616353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229033896","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9486932,0.0029494157,0.00005792955,0.047399092,0.00008153409,0.00064650556,0.00013884286,0.000015584732,0.000017883001],"genre_scores_gemma":[0.9899418,0.0018146506,0.0000454057,0.008105064,0.000027808732,0.00003463043,0.0000022094262,0.00000962993,0.000018842698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853635,0.0006144323,0.00030601953,0.00018721842,0.000117194904,0.00023878655],"domain_scores_gemma":[0.9965483,0.0029710294,0.00017798951,0.00016504466,0.000014597392,0.00012305916],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010601153,0.00009588921,0.00024383201,0.000032230477,0.0004378892,0.0000127000085,0.000068233945,0.000026506557,0.00008115704],"category_scores_gemma":[0.0009550345,0.00006020214,0.000021857146,0.00007708222,0.00006328901,0.000015554619,0.00016830399,0.00017783044,0.0000017907433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066038227,0.00036856902,0.64970016,0.008166168,0.00015376724,0.00011716908,0.08690736,0.005335425,0.000012329791,0.114536665,0.10397039,0.030071639],"study_design_scores_gemma":[0.006617661,0.006143469,0.44444945,0.0013409372,0.00014696662,0.0006572728,0.061437696,0.061179183,0.000025075455,0.2381199,0.1782228,0.0016595931],"about_ca_topic_score_codex":0.022221807,"about_ca_topic_score_gemma":0.0015543529,"teacher_disagreement_score":0.2052507,"about_ca_system_score_codex":0.00080208795,"about_ca_system_score_gemma":0.00019561159,"threshold_uncertainty_score":0.9842893},"labels":[],"label_agreement":null},{"id":"W4229035098","doi":"10.1016/j.jval.2021.09.003","title":"Immunogenicity and Safety of the COVID-19 Vaccines Compared With Control in Healthy Adults: A Qualitative and Systematic Review","year":2021,"lang":"en","type":"review","venue":"Value in Health","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"Medicine; Immunogenicity; Adverse effect; Seroconversion; Vaccination; Placebo; Pandemic; Randomized controlled trial; Neutralizing antibody; Immunology; Coronavirus disease 2019 (COVID-19); Internal medicine; Antibody; Disease; Infectious disease (medical specialty); Pathology","score_opus":0.1421119319798012,"score_gpt":0.4645748723840944,"score_spread":0.3224629404042932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229035098","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00058101653,0.9834307,0.000022706008,0.0031942367,0.000039272014,0.012577758,0.0001287706,0.000013584221,0.0000119906945],"genre_scores_gemma":[0.00052841386,0.95904505,0.00006864905,0.039654076,0.000020537478,0.0006307427,0.000013924998,0.000036482877,0.000002146495],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9878423,0.007925245,0.0025530248,0.0006116854,0.00059177115,0.00047593063],"domain_scores_gemma":[0.99302685,0.0044118874,0.0012039195,0.0010043307,0.00019360262,0.00015938665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006863783,0.00042396312,0.006467777,0.00030904086,0.00009758801,0.00001422711,0.00031237715,0.0001724856,0.000002693609],"category_scores_gemma":[0.004893319,0.00023845208,0.00022784685,0.0013784344,0.0001651912,0.000039185834,0.00014659631,0.00083092356,0.0000012647688],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008025575,0.00012727235,0.00051240943,0.99349916,0.00017899026,0.000027922171,0.0028575505,4.8122104e-7,7.4838226e-8,0.00013583332,0.000042008858,0.001815764],"study_design_scores_gemma":[0.0053989897,0.00075539877,0.000049450657,0.9556675,0.00051875354,0.00040113283,0.0014369556,0.00008759019,1.0567821e-7,0.000024831239,0.03545128,0.0002080028],"about_ca_topic_score_codex":0.012078337,"about_ca_topic_score_gemma":0.0009895467,"teacher_disagreement_score":0.03783163,"about_ca_system_score_codex":0.00097264565,"about_ca_system_score_gemma":0.00707124,"threshold_uncertainty_score":0.99855775},"labels":[],"label_agreement":null},{"id":"W4229065899","doi":"10.1016/j.jval.2022.03.014","title":"Value of Nonpharmacological Interventions for People With an Acquired Brain Injury: A Systematic Review of Economic Evaluations","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"Irish Research Council; Enterprise Ireland","keywords":"Psychological intervention; Checklist; Medicine; Health care; Acquired brain injury; Rehabilitation; Economic evaluation; Systematic review; Population; Multidisciplinary approach; Cost effectiveness; MEDLINE; Nursing; Psychology; Physical therapy; Environmental health","score_opus":0.36394547423926177,"score_gpt":0.5507474374556581,"score_spread":0.18680196321639636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4229065899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009635529,0.9729682,0.00017877633,0.0010140027,0.00015101816,0.024650881,0.0008499468,0.000032607823,0.000058196147],"genre_scores_gemma":[0.00007704646,0.98762363,0.002836045,0.00028646542,0.000055865137,0.008300694,0.0006262419,0.00008525602,0.000108739136],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98960716,0.0045928173,0.0040702084,0.00057444896,0.0006798605,0.00047553732],"domain_scores_gemma":[0.99220645,0.0040130247,0.002326919,0.0010258937,0.0001537843,0.00027391704],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.012593272,0.0003787886,0.00638928,0.00078916695,0.00009491288,0.000009743128,0.00055736967,0.00015577259,0.0010809117],"category_scores_gemma":[0.0026196332,0.00028325326,0.0010224875,0.0009020679,0.00011969117,0.000079017445,0.00012843261,0.00044917729,0.000011087188],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079055986,0.0005772087,0.0000049633995,0.98004186,0.0003141464,0.0000016437285,0.00020144947,0.00002607762,1.5343835e-7,0.0015143126,0.00077945157,0.016459672],"study_design_scores_gemma":[0.0010186854,0.005643376,0.000014045047,0.98028505,0.0023696166,0.00008700173,0.00015564206,0.0014796186,3.2775654e-7,0.0001192747,0.008619535,0.00020783747],"about_ca_topic_score_codex":0.00040114758,"about_ca_topic_score_gemma":0.00004004589,"teacher_disagreement_score":0.016350187,"about_ca_system_score_codex":0.0015291891,"about_ca_system_score_gemma":0.005474527,"threshold_uncertainty_score":0.999962},"labels":[],"label_agreement":null},{"id":"W4230183862","doi":"10.1016/j.jval.2016.03.719","title":"COST EFFECTIVENESS OF DRUG-COATED BALLOON VERSUS PERCUTANEOUS TRANSLUMINAL BALLOON ANGIOPLASTY, BARE METAL STENT, AND DRUG-ELUTING STENT IN THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE IN LOWER LIMBS CANADA","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Medtronic (Canada)","funders":"","keywords":"Medicine; Restenosis; Balloon; Percutaneous; Stent; Angioplasty; Internal medicine; Cardiology; Surgery; Radiology","score_opus":0.027091795592356107,"score_gpt":0.27225588382449806,"score_spread":0.24516408823214195,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230183862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952053,0.00093802036,0.0000047295503,0.0011735283,0.00030413084,0.0021622088,0.00016557243,0.000010767851,0.000035778194],"genre_scores_gemma":[0.999421,0.00024694324,0.000029243902,0.000074682794,0.00004203085,0.00010620461,0.00003309272,0.000023360963,0.00002341166],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703896,0.00090910314,0.00065606216,0.00042563913,0.0004713727,0.0004988735],"domain_scores_gemma":[0.99890894,0.0003845815,0.00010832512,0.00030255996,0.000040287876,0.0002552801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059046363,0.00027748095,0.0006416304,0.00015698814,0.000042498796,0.0000097805205,0.00011858067,0.000035289537,0.000049579696],"category_scores_gemma":[0.000043699427,0.00018055353,0.00010913689,0.00025536437,0.00010343966,0.00007158546,0.000025529343,0.00008991243,5.1827635e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11589816,0.02117663,0.7436276,0.009733148,0.0007527663,0.008260432,0.022209631,0.011394554,0.019272158,0.000223346,0.000103726336,0.047347844],"study_design_scores_gemma":[0.02804507,0.005414282,0.95187,0.0039300458,0.00025112435,0.000048903974,0.0035333082,0.0054265168,0.00041514635,0.000012607187,0.00062533334,0.00042766385],"about_ca_topic_score_codex":0.2643606,"about_ca_topic_score_gemma":0.20110856,"teacher_disagreement_score":0.2082424,"about_ca_system_score_codex":0.0014589434,"about_ca_system_score_gemma":0.00074413914,"threshold_uncertainty_score":0.8134691},"labels":[],"label_agreement":null},{"id":"W4230554561","doi":"10.1016/j.jval.2021.04.823","title":"PND39 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Relapsing Remitting Multiple Sclerosis","year":2021,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Ocrelizumab; Medicine; Expanded Disability Status Scale; Teriflunomide; Cladribine; Multiple sclerosis; Socioeconomic status; Family medicine; Internal medicine; Environmental health; Population; Psychiatry; Fingolimod","score_opus":0.3144445585958653,"score_gpt":0.36695481173962446,"score_spread":0.05251025314375918,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230554561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873109,0.0042013945,0.00016588766,0.0065760496,0.0002502598,0.00091916294,0.00020469802,0.000009997861,0.00036164268],"genre_scores_gemma":[0.9926412,0.0011422103,0.004703112,0.0012847147,0.00006455616,0.000062670995,0.00004773928,0.000030378387,0.000023401275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933502,0.0010327372,0.0045546703,0.0005074125,0.00011314024,0.0004418517],"domain_scores_gemma":[0.99412864,0.002391252,0.0027398348,0.0005939021,0.000062615705,0.00008372806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008709902,0.00018656794,0.0011955154,0.0003204228,0.00011501405,0.000021611486,0.00020415976,0.00011071049,0.000059024307],"category_scores_gemma":[0.0010718526,0.00018677539,0.00012059851,0.0003128494,0.000077564546,0.00019756326,0.000022866128,0.00015500672,0.000044403623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004947805,0.0007820897,0.95552945,0.00054040237,0.000035459198,7.259397e-7,0.014305673,0.015997484,0.0000013790428,0.011973756,0.00016243773,0.00062166865],"study_design_scores_gemma":[0.0055657797,0.0006737224,0.9638679,0.0008762095,0.000006103092,0.0000017789725,0.004780795,0.018500637,0.000035463236,0.0033773181,0.0020354874,0.00027880663],"about_ca_topic_score_codex":0.013977574,"about_ca_topic_score_gemma":0.00068315194,"teacher_disagreement_score":0.013294422,"about_ca_system_score_codex":0.0016451892,"about_ca_system_score_gemma":0.0005646236,"threshold_uncertainty_score":0.99258846},"labels":[],"label_agreement":null},{"id":"W4230911392","doi":"10.1016/j.jval.2020.05.003","title":"A Systematic Review and Meta-Analysis of Health Utilities in Patients With Chronic Hepatitis C","year":2020,"lang":"en","type":"review","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ontario Ministry of Research, Innovation and Science; Canadian Institutes of Health Research; Canadian Liver Foundation; Merck; AbbVie; Public Health Agency of Canada; Gilead Sciences","keywords":"Chronic hepatitis; Medicine; Meta-analysis; Internal medicine; Intensive care medicine; Virology","score_opus":0.20106905520628113,"score_gpt":0.4271879401206643,"score_spread":0.22611888491438317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230911392","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000114130335,0.98616916,0.0000059649437,0.0011263984,0.000012632043,0.012085265,0.0005398158,0.000017605966,0.000031758525],"genre_scores_gemma":[0.00021058784,0.9974858,0.00015616241,0.0007816332,0.0000082854,0.00092567864,0.00031061523,0.00006574372,0.00005546687],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98877925,0.004712526,0.0040881955,0.0007173834,0.0010615191,0.00064110634],"domain_scores_gemma":[0.9961976,0.0006610564,0.0017082009,0.00090810197,0.00014836158,0.00037670776],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0040391153,0.00051291566,0.022036526,0.0014533345,0.000041347965,0.0000140296615,0.00023093936,0.00014965271,0.00016185785],"category_scores_gemma":[0.0008920641,0.00033416122,0.00094283663,0.0037713838,0.000104642815,0.0000615992,0.000100462705,0.00078280515,0.00001271443],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000041913904,0.000100280326,0.0014901364,0.95755625,0.026113758,0.000013306589,0.00017363766,0.0000023706355,7.245094e-11,0.00003920284,0.000042388412,0.0144644845],"study_design_scores_gemma":[0.0006273877,0.0017678662,0.00095087936,0.6386384,0.32907918,0.0000057482607,0.000010849649,0.00019977574,3.6844954e-9,0.000004342993,0.028388109,0.0003275014],"about_ca_topic_score_codex":0.036481675,"about_ca_topic_score_gemma":0.003638583,"teacher_disagreement_score":0.3189179,"about_ca_system_score_codex":0.0019201218,"about_ca_system_score_gemma":0.005077282,"threshold_uncertainty_score":0.99991107},"labels":[],"label_agreement":null},{"id":"W4230986977","doi":"10.1016/j.jval.2016.08.367","title":"Identification of Statin Intolerance: Results From a Survey of Clinicians in Japan","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Rehabilitation Institute","funders":"","keywords":"Medicine; Statin; Creatine kinase; Internal medicine; Physical therapy; Family medicine","score_opus":0.06476042054602767,"score_gpt":0.3441394531380865,"score_spread":0.2793790325920589,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4230986977","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959882,0.0008871688,0.0004239947,0.001441047,0.00014518845,0.0006586876,0.0004064317,0.000008858863,0.000040455692],"genre_scores_gemma":[0.9980671,0.0012629188,0.00040298892,0.00010848392,0.000051593976,0.000013474202,0.00004791253,0.000012926481,0.000032622534],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966208,0.0008176129,0.0016777158,0.0002837248,0.00038084955,0.00021931421],"domain_scores_gemma":[0.9981842,0.00047928165,0.000512326,0.0005967996,0.00013834416,0.00008906266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007486737,0.00008198447,0.0005926214,0.00017646902,0.000012298468,0.0000017375557,0.00008115989,0.000082723185,0.000007666075],"category_scores_gemma":[0.0016408514,0.00006103894,0.00007032032,0.0004273529,0.000052752443,0.000043005417,0.000015754316,0.0001315707,0.0000058584187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019383221,0.00063198525,0.6966311,0.0010695255,0.00005574225,0.0000062803792,0.004895474,0.00029801702,0.0037282784,0.0002028004,0.00018673521,0.29035577],"study_design_scores_gemma":[0.0039944686,0.00026885828,0.9918197,0.0013478677,0.000004838079,9.558283e-7,0.00015445285,0.0005239056,0.001507299,0.00023573238,0.000089415844,0.00005250909],"about_ca_topic_score_codex":0.2694232,"about_ca_topic_score_gemma":0.0074115754,"teacher_disagreement_score":0.29518864,"about_ca_system_score_codex":0.0001702434,"about_ca_system_score_gemma":0.00072850916,"threshold_uncertainty_score":0.7354418},"labels":[],"label_agreement":null},{"id":"W4231347798","doi":"10.1016/j.jval.2018.09.2440","title":"PRS46 - INFORMING THE PATHWAY OF COPD TREATMENT (IMPACT STUDY) - SINGLE INHALER TRIPLE THERAPY (FF/UMEC/VI) VERSUS FF/VI IN PATIENTS WITH COPD: COST-EFFECTIVENESS ANALYSIS FROM A SOCIETAL PERSPECTIVE IN QUEBEC","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Fluticasone propionate; COPD; Exacerbation; Internal medicine; Incremental cost-effectiveness ratio; Cost effectiveness; Quality-adjusted life year; Corticosteroid","score_opus":0.060863748677646975,"score_gpt":0.34872056230772047,"score_spread":0.2878568136300735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231347798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953607,0.00034292255,0.000016312328,0.00010383242,0.00014962946,0.0037072783,0.000054702974,0.000018142126,0.00024649815],"genre_scores_gemma":[0.99948555,0.000029929688,0.000034998877,0.00014736713,0.00006300362,0.0001233238,0.00004778571,0.000023081122,0.000044958244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972999,0.0008484004,0.0006290164,0.0003757055,0.00047049826,0.00037647237],"domain_scores_gemma":[0.99847156,0.0004489496,0.0003373812,0.00037400264,0.00025595777,0.00011214367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008685284,0.0002649673,0.000785068,0.00053898146,0.000110143585,0.00002079755,0.00009987683,0.00010889529,0.000064912434],"category_scores_gemma":[0.000099175195,0.00015923519,0.00016234152,0.0015792208,0.0001604571,0.00016647807,0.000025532852,0.00024950597,0.000005576286],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008551025,0.004522932,0.9144471,0.000032545435,0.0007792025,0.000018345898,0.058138654,0.0028667878,0.00004801755,0.000021549207,0.000010909336,0.010562928],"study_design_scores_gemma":[0.029404141,0.009189409,0.9431263,0.00022060392,0.000100255194,4.2674586e-7,0.0149335265,0.0022692583,0.00043916007,0.000006106233,0.00013200735,0.00017877428],"about_ca_topic_score_codex":0.22178552,"about_ca_topic_score_gemma":0.04284697,"teacher_disagreement_score":0.17893854,"about_ca_system_score_codex":0.0036275492,"about_ca_system_score_gemma":0.0011662836,"threshold_uncertainty_score":0.97461855},"labels":[],"label_agreement":null},{"id":"W4231757079","doi":"10.1016/j.jval.2013.03.1501","title":"Cost-effectiveness of catheter ablation versus antiarrhythmic drug therapy for the treatment of atrial fibrillation in canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Atrial fibrillation; Catheter ablation; Ablation; Internal medicine; Cardiology; Quality of life (healthcare); Cohort; Randomized controlled trial; Clinical trial; Cost-effectiveness analysis; Cardiac Ablation; Atrial flutter; Quality-adjusted life year; Cost effectiveness; Surgery","score_opus":0.37408275044730444,"score_gpt":0.41802445470097255,"score_spread":0.04394170425366811,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4231757079","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833053,0.0063503063,0.00043638193,0.0040933574,0.00078917126,0.0048376713,0.00016395742,0.0000036261495,0.000020280722],"genre_scores_gemma":[0.99722385,0.001978862,0.00028004136,0.00011578271,0.00015486869,0.0002026137,0.00002206963,0.000013836677,0.000008054341],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966453,0.00059393555,0.002234939,0.00023041367,0.00006202337,0.00023338871],"domain_scores_gemma":[0.99283564,0.0054632127,0.0013510684,0.000259218,0.000045615216,0.00004525935],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006538726,0.00010352224,0.0006530144,0.00017248953,0.000050689097,0.000008445879,0.000078465666,0.000038270882,0.00003400292],"category_scores_gemma":[0.0004805865,0.00009895368,0.00009293054,0.00016033824,0.000021846223,0.00013575952,0.000004667703,0.000039118164,0.000009544863],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005842903,0.00010454326,0.5392955,0.00090583524,0.00009632544,1.2018135e-7,0.005671537,0.4342529,0.0000036507888,0.008384669,0.00031459713,0.01038605],"study_design_scores_gemma":[0.0075370995,0.0006978059,0.7250605,0.00022595694,0.000003473779,5.1239357e-7,0.0007801828,0.256633,0.000059890503,0.0036410284,0.0051608104,0.00019969686],"about_ca_topic_score_codex":0.9642372,"about_ca_topic_score_gemma":0.36249185,"teacher_disagreement_score":0.60174537,"about_ca_system_score_codex":0.0026550614,"about_ca_system_score_gemma":0.0011044047,"threshold_uncertainty_score":0.6942894},"labels":[],"label_agreement":null},{"id":"W4233315542","doi":"10.1016/j.jval.2020.10.007","title":"Cost-Effectiveness of First-Line Tyrosine Kinase Inhibitor Therapy Initiation Strategies for Chronic Myeloid Leukemia","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bristol-Myers Squibb Canada; Genentech; University of North Carolina at Chapel Hill; Agency for Healthcare Research and Quality; Cecil G. Sheps Center for Health Services Research, University of North Carolina, Chapel Hill; National Institutes of Health; Arnold Ventures; Leukemia and Lymphoma Society; American Foundation for Pharmaceutical Education; GlaxoSmithKline; Pfizer; Commonwealth Fund","keywords":"Myeloid leukemia; Tyrosine-kinase inhibitor; Tyrosine kinase; Medicine; Cancer research; Oncology; Pharmacology; Internal medicine; Receptor; Cancer","score_opus":0.10672761659228684,"score_gpt":0.3530499165824488,"score_spread":0.24632229999016192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233315542","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9836706,0.0058360402,0.0024363194,0.0025022742,0.00021160342,0.005056632,0.00010702707,0.00008697325,0.00009251278],"genre_scores_gemma":[0.9954153,0.0021545154,0.000753567,0.00048381268,0.00043912715,0.00043000132,0.00026360477,0.000051726947,0.000008379863],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99802494,0.00022556756,0.00065342244,0.0004120692,0.0002721702,0.00041181184],"domain_scores_gemma":[0.9985476,0.00056545757,0.0002668452,0.00027490297,0.00013100491,0.00021416429],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000634584,0.0002440433,0.00066154526,0.00012858016,0.000072181196,0.000013518789,0.00009476959,0.00013254936,0.00003762165],"category_scores_gemma":[0.00021289714,0.00022130032,0.00011327817,0.0004321649,0.00006658212,0.00015134539,0.000026385975,0.00023124758,0.00000808349],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04535718,0.0052218135,0.112431504,0.10606311,0.0011698992,0.00031837198,0.02246134,0.35982338,0.11119703,0.015392374,0.0031573977,0.21740659],"study_design_scores_gemma":[0.18859407,0.05112244,0.16673803,0.014397249,0.00023271238,0.00008813595,0.0016917543,0.2830597,0.2624295,0.0041871453,0.025845826,0.0016134422],"about_ca_topic_score_codex":0.0019499969,"about_ca_topic_score_gemma":0.00009800403,"teacher_disagreement_score":0.21579315,"about_ca_system_score_codex":0.0046771574,"about_ca_system_score_gemma":0.0047867196,"threshold_uncertainty_score":0.9991437},"labels":[],"label_agreement":null},{"id":"W4233609854","doi":"10.1016/j.jval.2017.08.2462","title":"Economic Burden Of Herpes Zoster (“CULEBRILLA”) In Latin America","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Herpesvirus Infections and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GDI Integrated Facility Services (Canada)","funders":"","keywords":"Medicine; Indirect costs; Rash; Postherpetic neuralgia; Latin Americans; Presenteeism; Incidence (geometry); Pediatrics; Demography; Emergency medicine; Surgery; Absenteeism; Alternative medicine","score_opus":0.04773359073251996,"score_gpt":0.3462902319375404,"score_spread":0.2985566412050204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233609854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890557,0.0002230966,0.000006260266,0.0024787039,0.00014686705,0.00029724123,0.000010661801,0.000010396217,0.007771071],"genre_scores_gemma":[0.99854136,0.00034218017,0.00060129,0.00014617309,0.00007920651,0.000012520938,0.000003709787,0.000011865376,0.00026171672],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991695,0.00005817253,0.0003539064,0.00016038714,0.000061004364,0.0001970295],"domain_scores_gemma":[0.9992859,0.00004855832,0.00018459694,0.00039200435,0.000010349991,0.00007863007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021055361,0.00008143771,0.0003257684,0.00013095359,0.000061795916,0.000010173182,0.000058649406,0.00004708202,0.0001054697],"category_scores_gemma":[0.000051552204,0.000072061965,0.00004368869,0.000041655025,0.000056013112,0.00005304051,0.00002902168,0.00007909768,0.00009328669],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000086973145,0.00026619044,0.63657695,0.00021897598,0.00004370969,0.000038797378,0.0014052707,0.0019811138,0.000017468792,0.00037823422,0.00026483013,0.35872146],"study_design_scores_gemma":[0.0043166317,0.0005731418,0.8869576,0.0008580706,0.000013913704,0.000018295164,0.0002035052,0.0060858033,0.00024983266,0.00051371986,0.10005278,0.00015672727],"about_ca_topic_score_codex":0.101551205,"about_ca_topic_score_gemma":0.00069946627,"teacher_disagreement_score":0.35856473,"about_ca_system_score_codex":0.0002609784,"about_ca_system_score_gemma":0.00022043208,"threshold_uncertainty_score":0.90443164},"labels":[],"label_agreement":null},{"id":"W4233770435","doi":"10.1016/j.jval.2013.08.1524","title":"Long-Term Maintenance of Improvements in Multiple Facets of Psoriatic Arthritis with Certolizumab Pegol: 48-Week Patient-Reported Outcome Results of the Rapid-PsA Study","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Certolizumab pegol; Medicine; Psoriatic arthritis; Dermatology Life Quality Index; Placebo; Double blind; Internal medicine; Randomized controlled trial; Psoriasis Area and Severity Index; Psoriasis; Surgery; Arthritis; Etanercept; Rheumatoid arthritis; Dermatology","score_opus":0.04774889429504628,"score_gpt":0.2914950134532094,"score_spread":0.2437461191581631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4233770435","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99357605,0.00095086277,0.0000028941322,0.0006075033,0.00024171684,0.004464097,0.00007470857,0.000010639092,0.00007152365],"genre_scores_gemma":[0.9990444,0.00037600644,0.00027028154,0.000039026916,0.000010335498,0.00017666748,0.000012947205,0.000024652485,0.000045665143],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966326,0.00019727032,0.0018343526,0.00036159746,0.0005412132,0.00043301785],"domain_scores_gemma":[0.99783057,0.00013222915,0.0010956646,0.0006343546,0.00021098909,0.000096170574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019710723,0.00022148357,0.00094964047,0.00017064235,0.000050287614,0.000003817017,0.00012142839,0.0000539332,0.000019013647],"category_scores_gemma":[0.0003792439,0.00014444956,0.0000885144,0.00046904988,0.00012416676,0.00006908674,0.00009150643,0.00018018892,0.0000023572074],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089052337,0.0034692944,0.9646859,0.00042229577,0.00014228522,0.00013869775,0.004165921,0.000033506367,0.0001061496,0.000004131519,0.00003001073,0.025911259],"study_design_scores_gemma":[0.030522004,0.004986019,0.95989054,0.0018233696,0.000031714524,0.00005329174,0.002000445,0.0001636147,0.00040662172,0.000017779612,0.00000494395,0.00009966577],"about_ca_topic_score_codex":0.04239926,"about_ca_topic_score_gemma":0.0047867647,"teacher_disagreement_score":0.037612498,"about_ca_system_score_codex":0.00021165125,"about_ca_system_score_gemma":0.00020595324,"threshold_uncertainty_score":0.96397746},"labels":[],"label_agreement":null},{"id":"W4234084467","doi":"10.1016/j.jval.2017.08.1212","title":"Modelling The Burden Of Cardiovascular Disease In Turkey And The Impact Of Reducing Modifiable Risk Factors","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Medicine; Environmental health; Population; Disease; Disease burden; Obesity; Psychological intervention; Gerontology; Demography; Internal medicine","score_opus":0.0755433532259023,"score_gpt":0.31907866696298776,"score_spread":0.24353531373708545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4234084467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99038416,0.002302939,0.00017212043,0.0061082887,0.00011492931,0.00046386372,0.000011137285,0.000006403935,0.0004361714],"genre_scores_gemma":[0.9982718,0.0013648225,0.000026390782,0.00007102462,0.00024195119,0.000008583269,0.0000024557378,0.000009108131,0.000003828001],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984509,0.00023533338,0.00056195294,0.00018755546,0.00015370456,0.00041057548],"domain_scores_gemma":[0.9983473,0.000299182,0.0005998242,0.00066880323,0.000051115705,0.000033808963],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0050176443,0.00011711351,0.0005166763,0.00011331685,0.00031512565,0.000051557014,0.0003406566,0.000046098725,0.0000033507165],"category_scores_gemma":[0.0011789022,0.00006166652,0.00017928451,0.00015450797,0.00020980579,0.00025874778,0.00016493587,0.00021129852,8.366109e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004335935,0.000011886171,0.007935672,0.00025311296,0.000036869817,3.7160794e-7,0.0004640638,0.98726034,9.913226e-8,0.0035088973,0.00037949687,0.00010583713],"study_design_scores_gemma":[0.0005703292,0.0000074511963,0.003484754,0.00013139304,0.000018938921,1.4081117e-7,0.0003207038,0.98806643,7.630105e-8,0.0052835997,0.0020641694,0.000052024785],"about_ca_topic_score_codex":0.9946392,"about_ca_topic_score_gemma":0.000016289208,"teacher_disagreement_score":0.99462295,"about_ca_system_score_codex":0.00006426749,"about_ca_system_score_gemma":0.00013231157,"threshold_uncertainty_score":0.25146878},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"empirical","about_ca_system":false,"about_ca_topic":true,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4235166966","doi":"10.1016/j.jval.2011.08.910","title":"PIH5 Respiratory Syncytial Virus (RSV) Prophylaxis in Special Populations","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Palivizumab; Medicine; Pediatrics; Gestational age; Observational study; Respiratory system; Internal medicine; Pregnancy; Biology","score_opus":0.2800302140486858,"score_gpt":0.41816500035010795,"score_spread":0.13813478630142217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235166966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862658,0.00039884457,0.00004395771,0.00022995078,0.0005370973,0.0012515462,0.000009412075,0.00006071169,0.011202679],"genre_scores_gemma":[0.99738157,0.00003125602,0.00066461327,0.0006105074,0.001008145,0.00009470462,0.0000046771193,0.00003544073,0.00016911398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99723923,0.000586574,0.0007963936,0.00038665583,0.00043063817,0.0005604805],"domain_scores_gemma":[0.999039,0.000052652344,0.00010333267,0.00045839697,0.000079503814,0.00026711522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013480296,0.00015830493,0.00037775296,0.0010172906,0.0001165459,0.000013920495,0.00012732511,0.0001634652,0.00067607133],"category_scores_gemma":[0.0004748549,0.0001527708,0.00006730965,0.0011621331,0.00010961759,0.0001553432,0.00005740611,0.00076787005,0.00029443673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00084619375,0.0016927349,0.9506174,0.00058559177,0.000014732689,0.00038458704,0.0028086018,0.0004961157,0.0017395536,0.011916192,0.001560995,0.027337316],"study_design_scores_gemma":[0.0020502133,0.0028674123,0.9787405,0.00024183928,0.0000045320808,0.000020709333,0.00011939284,0.0004761389,0.0009821876,0.0016964392,0.012584692,0.00021592379],"about_ca_topic_score_codex":0.021637402,"about_ca_topic_score_gemma":0.003086616,"teacher_disagreement_score":0.028123135,"about_ca_system_score_codex":0.0009516191,"about_ca_system_score_gemma":0.0011238031,"threshold_uncertainty_score":0.9848776},"labels":[],"label_agreement":null},{"id":"W4235301199","doi":"10.1016/j.jval.2017.08.1389","title":"Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Mexico","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Sacubitril; Valsartan; Sacubitril, Valsartan; Enalapril; Medicine; Heart failure; Ejection fraction; Internal medicine; Population; Cardiology; Blood pressure; Angiotensin-converting enzyme","score_opus":0.06002917433916491,"score_gpt":0.3546279566412262,"score_spread":0.29459878230206127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235301199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742634,0.0007716024,0.00024504185,0.0217033,0.00011061514,0.0028496538,0.000015492718,0.000010326201,0.000030556017],"genre_scores_gemma":[0.99254733,0.0010027962,0.006027256,0.00006398715,0.0000850915,0.00014870225,0.000013868133,0.00001473955,0.0000962335],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99879444,0.00009292935,0.00040997536,0.00022611645,0.00022410146,0.00025243574],"domain_scores_gemma":[0.99902904,0.000053851116,0.00023518234,0.00057201524,0.000044877088,0.00006505959],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005935517,0.00014001936,0.0005771985,0.00010521447,0.00011714622,0.000011120822,0.000077628916,0.000051258867,0.000012120511],"category_scores_gemma":[0.000014465717,0.00008177503,0.00010136668,0.000089518675,0.00011260177,0.00007111211,0.000009663623,0.00006207643,6.957185e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0089170495,0.011352859,0.8891674,0.0014418626,0.0011407061,0.00005852857,0.00793054,0.02125556,0.0057045403,0.002147994,0.0038884752,0.046994444],"study_design_scores_gemma":[0.022564985,0.016722495,0.9055589,0.00069071754,0.00023160402,0.000028540297,0.0015452681,0.0066938633,0.016984046,0.0002440812,0.028483076,0.0002524601],"about_ca_topic_score_codex":0.0084821535,"about_ca_topic_score_gemma":0.00045497098,"teacher_disagreement_score":0.046741985,"about_ca_system_score_codex":0.00017034991,"about_ca_system_score_gemma":0.0002259302,"threshold_uncertainty_score":0.9981204},"labels":[],"label_agreement":null},{"id":"W4235888460","doi":"10.1016/j.jval.2017.08.1392","title":"Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Chile","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Sacubitril; Valsartan; Sacubitril, Valsartan; Enalapril; Medicine; Heart failure; Ejection fraction; Internal medicine; Cardiology; Population; Blood pressure; Angiotensin-converting enzyme","score_opus":0.05498248345565799,"score_gpt":0.34901841988879123,"score_spread":0.29403593643313325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4235888460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97964215,0.00071904145,0.00013970214,0.016534999,0.00010110609,0.0028022868,0.000017357148,0.000009686912,0.000033662644],"genre_scores_gemma":[0.9935993,0.0009281123,0.0050487122,0.000051489555,0.000101017686,0.00014663758,0.00001599946,0.000013903168,0.00009483119],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988869,0.00007998179,0.00037843647,0.00021480977,0.00020205718,0.00023780929],"domain_scores_gemma":[0.99909496,0.00004531771,0.00021852498,0.0005432032,0.000038162856,0.000059835314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005110112,0.00013130739,0.0005398077,0.00009620863,0.00011921802,0.000010423406,0.00007226426,0.000046398025,0.000014052776],"category_scores_gemma":[0.000012199326,0.000076750686,0.00009524995,0.00008289201,0.00010230564,0.00006577288,0.000009126161,0.000059657326,7.0014784e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0105181625,0.01602728,0.8501288,0.0019382836,0.0013995838,0.00006493554,0.010861515,0.025002532,0.007458932,0.0023501518,0.0051205466,0.06912927],"study_design_scores_gemma":[0.017847013,0.01315026,0.93094295,0.0005459565,0.00016832491,0.00002317813,0.001064393,0.004373741,0.009263066,0.0001529105,0.022273278,0.00019492621],"about_ca_topic_score_codex":0.0098604,"about_ca_topic_score_gemma":0.0004187619,"teacher_disagreement_score":0.08081415,"about_ca_system_score_codex":0.00014517548,"about_ca_system_score_gemma":0.00020371388,"threshold_uncertainty_score":0.996733},"labels":[],"label_agreement":null},{"id":"W4236892631","doi":"10.1016/j.jval.2012.08.1987","title":"PND63 Effects of BG-12 on Quality of Life in Relapsing–Remitting Multiple Sclerosis: Findings From the Phase 3 Define Study","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Montreal Neurological Institute and Hospital","funders":"","keywords":"Medicine; Placebo; Relapsing remitting; Expanded Disability Status Scale; Quality of life (healthcare); Multiple sclerosis; Internal medicine; Physical therapy; Randomized controlled trial; Psychiatry","score_opus":0.5634492335473503,"score_gpt":0.4438502054138887,"score_spread":0.11959902813346163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4236892631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866632,0.005797404,0.00013508231,0.004457761,0.00076920027,0.0018916121,0.00016744244,0.0000200737,0.000098220546],"genre_scores_gemma":[0.9955588,0.0001928013,0.0008373747,0.003067153,0.00018023561,0.0001052691,0.000016345613,0.000032877128,0.000009138806],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9889646,0.0026509496,0.0070670587,0.0004930607,0.00019583332,0.0006284558],"domain_scores_gemma":[0.98261696,0.012780692,0.0036170918,0.0007286761,0.00003345753,0.00022309992],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.048275873,0.00021706642,0.0016251034,0.00037818242,0.0001294991,0.00001708618,0.00033913634,0.00013945557,0.000034008957],"category_scores_gemma":[0.023721816,0.00022952534,0.00011677625,0.00041243894,0.000068096095,0.0002793413,0.00007205938,0.0003959211,0.00009105367],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008992308,0.0017473912,0.9724167,0.00081271894,0.000030833846,1.1451551e-7,0.018581836,0.0009014941,0.000016376513,0.004779546,0.00042552507,0.00019755651],"study_design_scores_gemma":[0.0060274014,0.00039409954,0.9848484,0.0011490668,0.000003863231,1.3012965e-7,0.003406462,0.002829496,0.000035813246,0.0009405345,0.0001631611,0.00020161687],"about_ca_topic_score_codex":0.0943483,"about_ca_topic_score_gemma":0.0016217974,"teacher_disagreement_score":0.0927265,"about_ca_system_score_codex":0.0007225335,"about_ca_system_score_gemma":0.0002470971,"threshold_uncertainty_score":0.9845018},"labels":[],"label_agreement":null},{"id":"W4237025882","doi":"10.1016/j.jval.2014.03.228","title":"Economic evaluations of treatments for inflammatory bowel diseases","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Medicine; Infliximab; Adalimumab; Azathioprine; Economic evaluation; Inflammatory Bowel Diseases; MEDLINE; Cost effectiveness; Inflammatory bowel disease; Family medicine; Internal medicine; Pathology; Disease","score_opus":0.01603525369785998,"score_gpt":0.30236244143259344,"score_spread":0.2863271877347335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237025882","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998109,0.00029812238,0.00044454916,0.000100211044,0.00014442552,0.00059478433,0.00015613336,0.00000817041,0.00014463799],"genre_scores_gemma":[0.9985432,0.00007896908,0.0006138891,0.00014379086,0.00015285927,0.0001532917,0.0001685459,0.000020130521,0.0001253117],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990386,0.00015603322,0.0003324232,0.00021349208,0.000063832034,0.00019562272],"domain_scores_gemma":[0.9993768,0.000035523848,0.00014612776,0.00029778655,0.000031812055,0.00011195663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033346112,0.000097078584,0.00012426947,0.00005780207,0.00004863325,0.000004780871,0.000100228295,0.000053097596,0.00001048323],"category_scores_gemma":[0.00012420346,0.000102498365,0.00008054084,0.000017599083,0.00004004837,0.000003687947,0.000025331565,0.000022369577,0.000009657515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010035483,0.000590122,0.83968776,0.0012585241,0.0002124595,0.0000037904417,0.00032327123,0.12124567,0.007091733,0.014385611,0.0046358937,0.009561596],"study_design_scores_gemma":[0.0031353382,0.00048898155,0.9647027,0.00009004358,0.000045591136,0.0000013193293,0.00003806284,0.020374518,0.0022997118,0.0026419742,0.0059361625,0.00024559879],"about_ca_topic_score_codex":0.00007677973,"about_ca_topic_score_gemma":0.00006033949,"teacher_disagreement_score":0.12501492,"about_ca_system_score_codex":0.0000694765,"about_ca_system_score_gemma":0.00048471318,"threshold_uncertainty_score":0.4179762},"labels":[],"label_agreement":null},{"id":"W4237085286","doi":"10.1016/j.jval.2017.08.2987","title":"Patient-Reported Outcomes from Phase 3 Baricitinib Ra-Beam Study: Latin American Subgroup Analysis","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Visual analogue scale; Continuous variable; Rheumatoid arthritis; Placebo; Internal medicine; Physical therapy; Imputation (statistics); Categorical variable; Methotrexate; Missing data","score_opus":0.06214276786185622,"score_gpt":0.38303694143057254,"score_spread":0.3208941735687163,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237085286","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955784,0.0007722847,0.000060177743,0.0020954409,0.00011439698,0.0009920748,0.000075153424,0.000063321495,0.00024872323],"genre_scores_gemma":[0.9975527,0.0012763877,0.00048126277,0.00039128534,0.000044601973,0.00006257427,0.00009558188,0.000026284806,0.000069309375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99714535,0.00031425004,0.0008460447,0.00046838782,0.0006627148,0.0005632315],"domain_scores_gemma":[0.9974771,0.00027595976,0.00059818965,0.0011406005,0.000091147405,0.00041698178],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007567913,0.00020120664,0.0010359919,0.0004296469,0.00038934866,0.00010188447,0.00019960018,0.000037379166,0.00026785932],"category_scores_gemma":[0.00092044816,0.00016777616,0.00018267264,0.0004573237,0.0001960763,0.000118975724,0.000083581595,0.00032588307,0.00002555587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029176156,0.0015432612,0.934011,0.000013692392,0.00074288965,0.00020445044,0.0032021122,0.000047547954,0.000040518364,0.000019549703,0.00008897945,0.05979424],"study_design_scores_gemma":[0.0070661753,0.0019602426,0.98558205,0.00009246968,0.00003559661,0.0000021981891,0.0021740138,0.0018620902,0.0000479466,0.00013142395,0.00089996104,0.00014583672],"about_ca_topic_score_codex":0.18034795,"about_ca_topic_score_gemma":0.0038294848,"teacher_disagreement_score":0.17651846,"about_ca_system_score_codex":0.00013338515,"about_ca_system_score_gemma":0.00028856003,"threshold_uncertainty_score":0.8251102},"labels":[],"label_agreement":null},{"id":"W4237096206","doi":"10.1016/j.jval.2013.03.201","title":"Examination of preferences elicited from the general public: Subgroup comparisons of results from the time trade-off and standard gamble instruments","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University; PharmIdeas (Canada); Université de Montréal","funders":"","keywords":"Rank correlation; Correlation; Demography; Medicine; Spearman's rank correlation coefficient; Statistics; Mathematics","score_opus":0.3222879764111123,"score_gpt":0.3765451523510831,"score_spread":0.054257175939970814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4237096206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94363695,0.0025404696,0.00012653013,0.049410414,0.0001787213,0.0009885577,0.0027038858,0.000012395717,0.00040205673],"genre_scores_gemma":[0.99522966,0.00062975386,0.0017246772,0.001977604,0.00011799548,0.000048199796,0.00022386272,0.000013385267,0.00003488774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99411976,0.0013451177,0.003694587,0.00038462767,0.00016002417,0.00029586488],"domain_scores_gemma":[0.993562,0.0032018006,0.0025877182,0.00048801446,0.000053488133,0.000107000444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011792309,0.0001392894,0.00077667943,0.00013116759,0.00014610768,0.00007051442,0.00034763722,0.00010414983,0.0001535721],"category_scores_gemma":[0.0017967622,0.000114718576,0.00004627933,0.00024049926,0.00013316114,0.00035237873,0.000057725043,0.00018593093,0.00005556657],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012306664,0.00037910056,0.84267926,0.00031326961,0.0002308435,1.2075616e-7,0.037032913,0.0014015612,0.00003313914,0.04358293,0.054472927,0.019750878],"study_design_scores_gemma":[0.0012360897,0.00013717583,0.9187686,0.00015844482,0.0000037535413,2.4296924e-7,0.001551622,0.06305541,0.000013958357,0.009191136,0.005764512,0.00011904382],"about_ca_topic_score_codex":0.11597416,"about_ca_topic_score_gemma":0.0012384291,"teacher_disagreement_score":0.11473573,"about_ca_system_score_codex":0.00023056725,"about_ca_system_score_gemma":0.00022546382,"threshold_uncertainty_score":0.88991266},"labels":[],"label_agreement":null},{"id":"W4239324238","doi":"10.1016/s1098-3015(10)70031-0","title":"DH3 THE IMPACT OF DRUG VINTAGE ON PATIENT SURVIVAL: A PATIENT-LEVEL APPROACH USING QUEBEC'S PROVINCIAL HEALTH PLAN DATA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Vintage; Health plan; Plan (archaeology); Medicine; Gerontology; Geography; Economic growth; Health care; Economics; Archaeology","score_opus":0.5182127301852874,"score_gpt":0.465950194362394,"score_spread":0.05226253582289336,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239324238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9930244,0.0007662645,0.00024945356,0.002379275,0.00035358165,0.0022474993,0.00054290995,0.000032680455,0.00040392633],"genre_scores_gemma":[0.9962451,0.00024764237,0.0010549668,0.0020189246,0.00012534966,0.000010710018,0.00023861346,0.000035637167,0.000023048795],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99594,0.0012270705,0.0009962543,0.00046653204,0.0007495458,0.0006205564],"domain_scores_gemma":[0.99724084,0.0007110619,0.00069465046,0.0009188307,0.000052850017,0.0003817426],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016633077,0.00025328252,0.0006640653,0.00016558338,0.00023803432,0.000012118393,0.0002986878,0.00006335833,0.000024696286],"category_scores_gemma":[0.00044570453,0.00015806885,0.0001202564,0.00036482222,0.00011863848,0.00019399179,0.00019139612,0.00067609485,0.000006078764],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062370165,0.009754523,0.81990755,0.0031962972,0.0003473316,0.00010172703,0.046486177,0.030819157,0.00007909987,0.00092719065,0.011433977,0.07070996],"study_design_scores_gemma":[0.009466497,0.009498148,0.36956295,0.0018607639,0.00009836413,0.00031671108,0.004188363,0.5935544,0.00012987126,0.00016767484,0.010228936,0.00092736905],"about_ca_topic_score_codex":0.25851244,"about_ca_topic_score_gemma":0.0011164406,"teacher_disagreement_score":0.5627352,"about_ca_system_score_codex":0.000810694,"about_ca_system_score_gemma":0.0026394452,"threshold_uncertainty_score":0.7464252},"labels":[],"label_agreement":null},{"id":"W4239427141","doi":"10.1016/j.jval.2017.08.2849","title":"Assessing The Burden Of Chronic Heart Failure (Chf) On Patients In Mexico","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Depression (economics); Heart failure; Anxiety; Cohort; Physical therapy; Emergency medicine; Internal medicine; Psychiatry","score_opus":0.05323294192521293,"score_gpt":0.3640354118462159,"score_spread":0.31080246992100297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239427141","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90275586,0.00014096018,0.0000068485665,0.09502473,0.00015852049,0.0009522021,0.0000017629329,0.000013695446,0.0009454208],"genre_scores_gemma":[0.9986315,0.000061993655,0.00056956406,0.00043392816,0.00012413535,0.000022475539,0.000007689565,0.000012738151,0.0001360012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878085,0.00013814385,0.0003322603,0.00019124367,0.00026571698,0.0002918062],"domain_scores_gemma":[0.9991073,0.000078870245,0.00015185762,0.00056662445,0.000023525809,0.0000717933],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006626588,0.00010611027,0.00029293433,0.00012352425,0.00013469302,0.00003202688,0.00011790534,0.000048300855,0.000025826082],"category_scores_gemma":[0.00012359083,0.00007066501,0.00004635444,0.00008473542,0.000051363335,0.00010675506,0.00005360585,0.00019591612,0.000025590129],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007796694,0.0010987282,0.9495747,0.00087612256,0.000045708595,0.000027130669,0.0022728993,0.002714515,0.000064201464,0.0014420168,0.017041165,0.024764827],"study_design_scores_gemma":[0.004444293,0.0013768567,0.90427417,0.0023804267,0.000016704716,0.0000020780808,0.0004381303,0.0051616104,0.00020166526,0.00019059842,0.081393726,0.000119754804],"about_ca_topic_score_codex":0.01256872,"about_ca_topic_score_gemma":0.00040105046,"teacher_disagreement_score":0.09587561,"about_ca_system_score_codex":0.00039484506,"about_ca_system_score_gemma":0.0002553346,"threshold_uncertainty_score":0.9940067},"labels":[],"label_agreement":null},{"id":"W4239543405","doi":"10.1016/j.jval.2017.08.2852","title":"Modelling The Burden of Cardiovascular Disease In Colombia And The Impact of Reducing Modifiable Risk Factors","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Medicine; Environmental health; Disease; Population; Obesity; Disease burden; Psychological intervention; Absenteeism; Internal medicine","score_opus":0.07365659251281628,"score_gpt":0.3187881141388855,"score_spread":0.24513152162606924,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4239543405","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99091715,0.0018774396,0.00010723451,0.0060404926,0.000110575864,0.0005220465,0.000011665083,0.0000062485065,0.00040712196],"genre_scores_gemma":[0.99842405,0.0012527133,0.00002309522,0.00008740087,0.00018691883,0.0000102180375,0.0000024000622,0.000008818621,0.000004404152],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984505,0.00024310226,0.0005629238,0.00018428871,0.00015010727,0.00040907942],"domain_scores_gemma":[0.9983375,0.0003243002,0.00062193535,0.00062960346,0.000053226173,0.000033421406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005242508,0.000112227564,0.00052676443,0.00010336408,0.00033682902,0.000052683554,0.00033484606,0.000047911628,0.0000036251797],"category_scores_gemma":[0.0012032317,0.00006126916,0.00016730488,0.00015814835,0.00023199126,0.00023953563,0.00016543768,0.00020361108,8.112667e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050543913,0.000014112822,0.014314878,0.00023901973,0.000037817863,3.8172004e-7,0.0004231468,0.9815291,1.1238787e-7,0.0024643992,0.00079311104,0.00013337554],"study_design_scores_gemma":[0.000639499,0.000010020252,0.008602828,0.000119758384,0.000020056792,1.3265772e-7,0.00032172023,0.98377913,7.7701124e-8,0.0036777186,0.0027777725,0.000051268482],"about_ca_topic_score_codex":0.9909488,"about_ca_topic_score_gemma":0.000037030102,"teacher_disagreement_score":0.9909118,"about_ca_system_score_codex":0.00007115342,"about_ca_system_score_gemma":0.00014576301,"threshold_uncertainty_score":0.25906506},"labels":[],"label_agreement":null},{"id":"W4240963739","doi":"10.1016/j.jval.2011.08.908","title":"PIH3 Respiratory Syncytial Virus Hospitalizations in the Canadian Registry for Synagis (CARESS)","year":2011,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University","funders":"","keywords":"Palivizumab; Medicine; Bronchopulmonary dysplasia; Pediatrics; Gestational age; Respiratory system; Intubation; Internal medicine; Pregnancy; Anesthesia","score_opus":0.1840139763475343,"score_gpt":0.3977114718368939,"score_spread":0.21369749548935962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4240963739","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9644314,0.0022755323,0.00041184912,0.004989363,0.00060147856,0.0054358654,0.00015537703,0.000083790066,0.021615343],"genre_scores_gemma":[0.99495023,0.00005124306,0.00029966637,0.003956007,0.00018063138,0.0004060811,0.000017946399,0.00003240443,0.00010579414],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978044,0.00044608503,0.0005330889,0.00031189068,0.0003075308,0.00059699465],"domain_scores_gemma":[0.9986912,0.00014965284,0.000092101705,0.00062573573,0.00013963005,0.00030168652],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002002338,0.00013376566,0.00025533745,0.00064065284,0.00030302402,0.00003518549,0.00024402044,0.00015942256,0.00007999328],"category_scores_gemma":[0.0009441448,0.00010984019,0.00006387284,0.00087404076,0.00013737731,0.000102138205,0.000020655505,0.00048322204,0.000031569238],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054708694,0.0014563922,0.8569988,0.002207951,0.00007532332,0.0006596475,0.014497255,0.0017559499,0.00035724085,0.08010758,0.03282828,0.008508485],"study_design_scores_gemma":[0.0047436305,0.0043087592,0.7801383,0.0008910348,0.000036955185,0.0000784475,0.0020465716,0.0049359705,0.00086083374,0.0038662637,0.19746356,0.0006296955],"about_ca_topic_score_codex":0.67010206,"about_ca_topic_score_gemma":0.5826414,"teacher_disagreement_score":0.16463527,"about_ca_system_score_codex":0.0011299415,"about_ca_system_score_gemma":0.0036714892,"threshold_uncertainty_score":0.6513064},"labels":[],"label_agreement":null},{"id":"W4241084954","doi":"10.1016/j.jval.2017.08.957","title":"Real-World Health Care Expenditure In Hemophilia A Patients Using Standard And Extended Half-Life Recombinant Factor VIII Products","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quarter (Canadian coin); Internal medicine; Pediatrics","score_opus":0.09008481767277333,"score_gpt":0.39372915698477035,"score_spread":0.303644339311997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241084954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761957,0.002031227,8.484062e-7,0.018490773,0.0005094003,0.0024444128,0.00005881982,0.00003328252,0.00023556093],"genre_scores_gemma":[0.995749,0.0021670116,0.0012048872,0.00026840673,0.00016196654,0.000031770993,0.0000716097,0.00004647254,0.0002988666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967852,0.00033504667,0.00069744256,0.0006807651,0.0006166327,0.0008848679],"domain_scores_gemma":[0.9980428,0.000068019945,0.00033005656,0.00079930073,0.00013977951,0.0006200255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007339713,0.00027929753,0.00084208365,0.00047284248,0.0005162749,0.00006424541,0.00016649971,0.00011618298,0.000023212215],"category_scores_gemma":[0.00048371434,0.00022208333,0.000050623952,0.0002328275,0.0001238584,0.00017723902,0.00012732326,0.0005377469,0.00000623042],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010585737,0.0008019435,0.95451903,0.00358169,0.0000327579,0.00017493569,0.009480552,0.000014978601,0.000059920614,0.00020513074,0.0009109599,0.029159535],"study_design_scores_gemma":[0.009995359,0.0019999682,0.9793673,0.003000197,0.000010006152,0.0000136662775,0.00093069504,0.0004855395,0.00031141148,0.00020803451,0.0033597038,0.0003181327],"about_ca_topic_score_codex":0.032257073,"about_ca_topic_score_gemma":0.0025196436,"teacher_disagreement_score":0.029737432,"about_ca_system_score_codex":0.0018875588,"about_ca_system_score_gemma":0.0026812046,"threshold_uncertainty_score":0.9741872},"labels":[],"label_agreement":null},{"id":"W4241389844","doi":"10.1016/s1098-3015(10)70320-x","title":"PIN22 PHARMACOECONOMIC ANALYSIS BASED ON GUIDELINES FOR TREATING MILD DIABETIC FOOT INFECTIONS: A DECISION TREE MODEL FOR CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Diabetic foot; Medicine; Decision tree; Intensive care medicine; Tree (set theory); Foot (prosody); Decision tree model; Diabetes mellitus; Traditional medicine; Computer science; Data mining; Mathematics; Endocrinology","score_opus":0.14024203312818365,"score_gpt":0.3908647622137405,"score_spread":0.25062272908555683,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241389844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94557685,0.0002496724,0.04373662,0.008258155,0.0003217501,0.0016481896,0.00003913562,0.00003318786,0.00013646291],"genre_scores_gemma":[0.9742208,0.000100234785,0.0190212,0.005367948,0.00018968771,0.0004697763,0.00017690989,0.000023653007,0.00042975802],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986659,0.000031728134,0.000580022,0.00028115464,0.00012662874,0.0003145221],"domain_scores_gemma":[0.9988033,0.0005665984,0.00015981283,0.00021167763,0.00012927748,0.00012932716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006034668,0.0001280795,0.00036215273,0.0005287107,0.00016903813,0.000008559167,0.000056811874,0.000031145006,0.000013215282],"category_scores_gemma":[0.00051950524,0.00012355216,0.00013453334,0.0004137401,0.000010366893,0.00004662051,0.0000065186728,0.000059663158,0.0000011417005],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013347616,0.00022534528,0.048662107,0.00026704892,0.00008750564,3.2057622e-7,0.00011111757,0.89378846,0.000006184522,0.000034560664,0.034159105,0.022524796],"study_design_scores_gemma":[0.0021689185,0.00029202097,0.009568096,0.00014219833,0.00018358261,1.8277478e-7,0.0000366727,0.9860498,0.000033206237,0.00016562239,0.001262691,0.00009702915],"about_ca_topic_score_codex":0.1311828,"about_ca_topic_score_gemma":0.08391918,"teacher_disagreement_score":0.092261344,"about_ca_system_score_codex":0.00077642576,"about_ca_system_score_gemma":0.001236222,"threshold_uncertainty_score":0.9327969},"labels":[],"label_agreement":null},{"id":"W4241968959","doi":"10.1016/j.jval.2014.08.2267","title":"Cost-Effectiveness of Ofatumumab Plus Chlorambucil in First Line Chronic Lymphocytic Leukemia in Canada","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Ofatumumab; Chlorambucil; Medicine; Fludarabine; Population; Time horizon; Quality-adjusted life year; Cost effectiveness; Chronic lymphocytic leukemia; Internal medicine; Oncology; Leukemia; Chemotherapy; Mathematics; Risk analysis (engineering); Environmental health","score_opus":0.05877112671093143,"score_gpt":0.329355149885676,"score_spread":0.27058402317474456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4241968959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9942989,0.0022421973,0.00009592556,0.0002719132,0.00026705235,0.0023024846,0.000013252131,0.00002169747,0.00048658904],"genre_scores_gemma":[0.99847555,0.0008024241,0.000071429444,0.00021332112,0.00011087058,0.00018426127,0.00003234913,0.000051623334,0.000058146306],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9955929,0.0007368666,0.001130881,0.00058748265,0.00083142234,0.0011204443],"domain_scores_gemma":[0.99688977,0.0017373916,0.0002040129,0.0007304607,0.00009250025,0.00034584766],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033850828,0.0002785963,0.0011601229,0.00053640304,0.00004012477,0.000008166605,0.00029494154,0.00016567906,0.000045198223],"category_scores_gemma":[0.0010483083,0.00027365016,0.0000644721,0.0013128904,0.00011893272,0.00007492243,0.00012772137,0.0006020861,0.000015449916],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0017877357,0.000088889334,0.015806802,0.0131017985,0.000023806737,0.00039328943,0.00067929784,0.9588198,0.000082414816,0.00044529434,0.00013105816,0.008639825],"study_design_scores_gemma":[0.053127512,0.0006807284,0.03833037,0.00570795,0.0000066763537,0.00009550681,0.00010638421,0.8994803,0.0009842692,0.00014707368,0.0011081094,0.00022516547],"about_ca_topic_score_codex":0.9961388,"about_ca_topic_score_gemma":0.968356,"teacher_disagreement_score":0.2905292,"about_ca_system_score_codex":0.71443164,"about_ca_system_score_gemma":0.42390245,"threshold_uncertainty_score":0.99997157},"labels":[],"label_agreement":null},{"id":"W4242632056","doi":"10.1016/j.jval.2014.03.922","title":"Psychiatric Health Care Utilisation And Related Costs In Newly Diagnosed Patients With Autism Spectrum Disorder (Asd) In Quebec (Canada)","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Autism Spectrum Disorder Research","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Hôpital Rivière-des-Prairies; Université de Montréal","funders":"","keywords":"Medicine; Cohort; Psychiatry; Cohort study; Pediatrics; Public health; Autism spectrum disorder; Autism; Internal medicine","score_opus":0.011603267159437824,"score_gpt":0.2606169778665502,"score_spread":0.24901371070711237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4242632056","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9523341,0.0008335526,0.000030885156,0.04437696,0.00021716295,0.0017907139,0.00001917107,0.000043950033,0.00035348142],"genre_scores_gemma":[0.99826705,0.00042168202,0.000075216165,0.001061514,0.000010130365,0.000055597437,0.000022982724,0.00004645539,0.000039377766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950949,0.0014468695,0.0007781922,0.0008362904,0.00079190364,0.0010518597],"domain_scores_gemma":[0.9985914,0.00044224726,0.00027331553,0.00040528795,0.000006999139,0.0002807239],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00065751607,0.00025843343,0.00043853992,0.0007016797,0.00019365868,0.000047766425,0.0002661744,0.00010139216,0.000022141981],"category_scores_gemma":[0.00031073688,0.00025294902,0.000019252835,0.00196749,0.000101592865,0.00024058983,0.000078436075,0.00069706666,0.0000059783506],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009863898,0.00028110947,0.96437865,0.00021873391,0.0000010642115,0.0000137680045,0.0036709614,0.0021427171,0.000001154999,0.017907424,0.00006835586,0.011217388],"study_design_scores_gemma":[0.004680326,0.00049771095,0.9845269,0.00019572997,7.797816e-7,0.0000018221593,0.0003105618,0.0067124637,0.0000047521885,0.0024684041,0.00036831415,0.00023224374],"about_ca_topic_score_codex":0.9630766,"about_ca_topic_score_gemma":0.98872083,"teacher_disagreement_score":0.04593292,"about_ca_system_score_codex":0.0023673528,"about_ca_system_score_gemma":0.0025550886,"threshold_uncertainty_score":0.99999225},"labels":[],"label_agreement":null},{"id":"W4244538003","doi":"10.1016/j.jval.2017.08.2846","title":"Assessing The Burden Of Chronic Heart Failure (Chf) On Patients’ Caregivers In Brazil","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Dalhousie University","funders":"","keywords":"Spouse; Caregiver burden; Medicine; Anxiety; Daughter; Family caregivers; Heart failure; Disease; Family medicine; Psychiatry; Gerontology; Internal medicine","score_opus":0.04086998790194693,"score_gpt":0.3513212728027999,"score_spread":0.31045128490085294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4244538003","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9039537,0.00016083165,0.0000045230636,0.09355549,0.00017332015,0.0009143947,0.0000023394991,0.000014681958,0.0012207624],"genre_scores_gemma":[0.99889684,0.000059495953,0.00035767548,0.00034616978,0.00012419575,0.000017424105,0.000008586587,0.000012686115,0.00017689924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880743,0.0001318971,0.00029082285,0.00020474753,0.0002679194,0.0002972036],"domain_scores_gemma":[0.9990998,0.000082859035,0.00015093916,0.0005618157,0.000028409462,0.000076157405],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000511051,0.000111374255,0.0002934141,0.00013410495,0.00015553641,0.000033633118,0.00012515638,0.00005033522,0.00002941887],"category_scores_gemma":[0.000105106534,0.00007732357,0.00005317033,0.00009098699,0.00006965384,0.000119517994,0.000053146436,0.00020101517,0.000020163827],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001706516,0.0013110669,0.87971604,0.0018665434,0.00009828836,0.00007425859,0.009588205,0.0058513917,0.000115025,0.0022169193,0.05291638,0.0460752],"study_design_scores_gemma":[0.00767965,0.0019435601,0.80766624,0.00309755,0.000030590756,0.0000032166972,0.0022426478,0.0037018445,0.00015050033,0.00012365099,0.17316985,0.00019070141],"about_ca_topic_score_codex":0.02210027,"about_ca_topic_score_gemma":0.00058560673,"teacher_disagreement_score":0.12025347,"about_ca_system_score_codex":0.00054282614,"about_ca_system_score_gemma":0.00032473658,"threshold_uncertainty_score":0.98441166},"labels":[],"label_agreement":null},{"id":"W4246859680","doi":"10.1016/j.jval.2019.04.414","title":"PCN295 PATIENT-CENTERED OUTCOMES IN ARIEL3, A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF RUCAPARIB MAINTENANCE TREATMENT IN PATIENTS WITH RECURRENT OVARIAN CARCINOMA","year":2019,"lang":"en","type":"article","venue":"Value in Health","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Placebo; Internal medicine; Confidence interval; Nausea; Adverse effect; Vomiting","score_opus":0.0278019643634444,"score_gpt":0.31318732152585166,"score_spread":0.28538535716240726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4246859680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9811736,0.0002856978,0.000016547974,0.00054222456,0.0003802235,0.017396687,0.000051221516,0.000018421522,0.00013542673],"genre_scores_gemma":[0.99806,0.0000624724,0.0001907039,0.0002995089,0.000015304962,0.001230432,0.000041938976,0.000034100372,0.000065528024],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99555033,0.0011509621,0.0017100843,0.0005350704,0.00051469734,0.00053885125],"domain_scores_gemma":[0.9980387,0.00048366396,0.00067344477,0.00054547883,0.0000974826,0.00016123381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010125389,0.00033964156,0.0024087455,0.00058704236,0.000024836285,0.00000882129,0.000099406134,0.00007672806,0.000054412685],"category_scores_gemma":[0.0001418466,0.00023268371,0.00013896183,0.00042521372,0.000058457415,0.00006767874,0.000021862728,0.00027551645,0.00000595201],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.40313616,0.011680445,0.57556933,0.000099585384,0.00009253653,0.000018619186,0.0070854807,0.00050660037,0.0000035426858,0.00004668967,0.000008616385,0.0017524235],"study_design_scores_gemma":[0.8291078,0.011980699,0.15435207,0.000831726,0.000032373668,0.0000017757441,0.0010636606,0.002386243,0.000016667556,0.000042430507,0.000025759191,0.00015875141],"about_ca_topic_score_codex":0.012113947,"about_ca_topic_score_gemma":0.0010706646,"teacher_disagreement_score":0.4259717,"about_ca_system_score_codex":0.0016314582,"about_ca_system_score_gemma":0.0005989411,"threshold_uncertainty_score":0.99446446},"labels":[],"label_agreement":null},{"id":"W4248792744","doi":"10.1016/j.jval.2014.08.253","title":"Antithrombotic Therapy and Direct Medical Costs in Patients with Acute Coronary Syndrome in Shanghai, China","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Antiplatelet Therapy and Cardiovascular Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Antithrombotic; Acute coronary syndrome; Medical record; Emergency medicine; Comorbidity; Emergency department; Retrospective cohort study; Internal medicine; Cohort; Hyperlipidemia; Diabetes mellitus; Myocardial infarction","score_opus":0.011740001394551919,"score_gpt":0.25301597810182797,"score_spread":0.24127597670727605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4248792744","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944789,0.003939279,0.00001718959,0.00064778695,0.00006755722,0.0007035543,0.000005810857,0.000025978805,0.00011396637],"genre_scores_gemma":[0.99406314,0.004832148,0.000087037915,0.0009156827,0.0000186372,0.000017351795,0.00003199563,0.000025109266,0.0000088985635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817693,0.000377622,0.00031094256,0.00031537277,0.00047593456,0.00034320937],"domain_scores_gemma":[0.9993932,0.00007837552,0.000055177843,0.0002317464,0.000014071121,0.00022743239],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008559173,0.00015733314,0.00059394934,0.00019302592,0.000032744752,0.000007144353,0.000074114585,0.000095888834,0.00003931598],"category_scores_gemma":[0.000046373854,0.00011877391,0.000050354258,0.00030934263,0.00008889013,0.000070835194,0.000020618032,0.00025582203,0.0000041654894],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007163834,0.00047605683,0.9672953,0.00011441453,0.00008207206,0.00040136944,0.00022157736,0.000059494112,8.827618e-7,0.000060884584,0.0000132456435,0.03055832],"study_design_scores_gemma":[0.008998421,0.0014439882,0.98707193,0.0010793766,0.0000110931005,0.00013630975,0.000017742539,0.0009815185,0.0000022282893,0.00004537047,0.00009229437,0.00011974873],"about_ca_topic_score_codex":0.0014595692,"about_ca_topic_score_gemma":0.0001048677,"teacher_disagreement_score":0.03043857,"about_ca_system_score_codex":0.00013218871,"about_ca_system_score_gemma":0.00021761937,"threshold_uncertainty_score":0.48434594},"labels":[],"label_agreement":null},{"id":"W4249181773","doi":"10.1016/j.jval.2017.08.443","title":"Economic Burden of Cardiovascular Disease In Type 2 Diabetes: A Systematic Review","year":2017,"lang":"en","type":"review","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Indirect costs; Disease burden; Disease; Type 2 diabetes; Population; Burden of disease; MEDLINE; Coronary artery disease; Environmental health; Diabetes mellitus; Demography; Internal medicine; Accounting; Business","score_opus":0.10946144812439924,"score_gpt":0.3608086619003093,"score_spread":0.25134721377591007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249181773","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001821815,0.9907073,1.7783076e-7,0.00012494295,0.00024077533,0.008594037,0.000024475292,0.000015707388,0.00027440532],"genre_scores_gemma":[0.000038485316,0.99871737,0.000029345698,0.000067898705,0.00007884135,0.00062143855,0.00012935074,0.00004851757,0.00026873444],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968386,0.00057552115,0.0015431733,0.00042986468,0.00024147404,0.0003713605],"domain_scores_gemma":[0.99710923,0.0001235342,0.00077806594,0.0017635683,0.00002160676,0.00020397018],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021857037,0.00034194873,0.006584024,0.00037275002,0.000021273312,0.0000114846125,0.00027434254,0.00008722595,0.000018534609],"category_scores_gemma":[0.00033904734,0.00025835537,0.0009451471,0.0001622779,0.000031363645,0.000042564196,0.000086479355,0.00018722413,0.00014189696],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000017915243,0.000055419412,0.00003645417,0.91559565,0.0010413397,0.00003673121,0.000017342989,0.000083756284,1.351374e-10,0.000049545182,0.00013333325,0.08294864],"study_design_scores_gemma":[0.00025164225,0.00007925416,0.0000065203244,0.6644657,0.0050144573,6.303936e-7,0.0000019702288,0.0000828318,2.2745472e-9,0.000009342605,0.32997903,0.00010858131],"about_ca_topic_score_codex":0.0013783643,"about_ca_topic_score_gemma":0.000004998281,"teacher_disagreement_score":0.3298457,"about_ca_system_score_codex":0.00093629345,"about_ca_system_score_gemma":0.0010805434,"threshold_uncertainty_score":0.9999869},"labels":[],"label_agreement":null},{"id":"W4249416452","doi":"10.1016/j.jval.2013.03.1149","title":"Empirical Comparison Of Discrete Choice Experiment And Best-Worst Scaling To Estimate Stakeholders' Risk Tolerance For Hip Replacement Surgery","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Logit; Mixed logit; Medicine; Population; Hip replacement; Arthroplasty; Physical therapy; Logistic regression; Statistics; Surgery; Mathematics; Environmental health","score_opus":0.3436284322013221,"score_gpt":0.3635771169670837,"score_spread":0.019948684765761615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249416452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9900047,0.0021727998,0.005344289,0.001196158,0.00020222619,0.0009233109,0.000060015478,0.000009009906,0.000087498105],"genre_scores_gemma":[0.99271834,0.00022163728,0.006529319,0.00021204034,0.000039830273,0.00019678428,0.000015798032,0.000018250423,0.00004802626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981428,0.00004386662,0.0010779853,0.0003956229,0.000037954043,0.00030180826],"domain_scores_gemma":[0.99882424,0.00032821516,0.0004864219,0.00021523137,0.0000072617863,0.00013862022],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011373443,0.00012572738,0.00051861024,0.00013591998,0.00009171687,0.000028220264,0.00007071711,0.000051144165,0.00006675234],"category_scores_gemma":[0.00012963705,0.00014736727,0.000055775705,0.00008038935,0.000034415723,0.00014082917,0.000040391104,0.00008162299,0.000051239687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020909412,0.00011824504,0.95411754,0.00011232303,0.000008174692,3.148649e-8,0.0015807027,0.04122603,0.0000070783394,0.000496852,0.0006223657,0.0016897647],"study_design_scores_gemma":[0.00086653966,0.00040798658,0.72913206,0.00017013437,0.0000041248754,4.558452e-7,0.00083894946,0.2631931,0.00030825427,0.0021730326,0.002619685,0.00028567793],"about_ca_topic_score_codex":0.0073461765,"about_ca_topic_score_gemma":0.000046098758,"teacher_disagreement_score":0.22498547,"about_ca_system_score_codex":0.00030560582,"about_ca_system_score_gemma":0.000021912576,"threshold_uncertainty_score":0.999264},"labels":[],"label_agreement":null},{"id":"W4249427946","doi":"10.1016/j.jval.2013.08.696","title":"The Impact of Memory Problems on Diabetes Treatment in Canada","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Cognitive Functions and Memory","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Forgetting; Diabetes mellitus; Medicine; Insulin; Internal medicine; Demography; Endocrinology; Psychology","score_opus":0.043670895939709235,"score_gpt":0.31678220050994527,"score_spread":0.273111304570236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249427946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925854,0.00077017595,4.6986096e-7,0.00074922055,0.00034078385,0.0007364484,0.000015500198,0.00000443688,0.004797557],"genre_scores_gemma":[0.9989499,0.000065305154,0.0000037639018,0.00011254157,0.000029529934,0.00023376911,0.0000030787567,0.000008018458,0.0005941063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989664,0.000250767,0.00026109046,0.00013385681,0.000071119226,0.00031675425],"domain_scores_gemma":[0.99919415,0.0004394716,0.0000797951,0.00020007452,0.000020503225,0.00006599158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00024201829,0.000081848615,0.00015619038,0.000074447795,0.000041578623,0.000003977519,0.000054730433,0.000021480815,0.00026555918],"category_scores_gemma":[0.000026959358,0.000048869988,0.00003473938,0.00015488373,0.000021437183,0.000015771397,0.000006534858,0.00009295091,0.000033083696],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049916183,0.00044302232,0.7200628,0.000042048265,0.00006687559,0.000004981721,0.002476169,0.009024867,0.00005552194,0.00034728379,0.00719296,0.26023352],"study_design_scores_gemma":[0.00070709025,0.0010797733,0.9953162,0.000067274595,0.0000013379712,7.5176075e-7,0.001091357,0.00059082743,0.00003772674,0.00038795714,0.0006637342,0.000055972218],"about_ca_topic_score_codex":0.9961895,"about_ca_topic_score_gemma":0.85169303,"teacher_disagreement_score":0.2752534,"about_ca_system_score_codex":0.0012267283,"about_ca_system_score_gemma":0.0010801292,"threshold_uncertainty_score":0.3207852},"labels":[],"label_agreement":null},{"id":"W4249486415","doi":"10.1016/j.jval.2020.08.505","title":"PCV14 Comparative Effectiveness and Safety of High Dose of ORAL Anticoagulant in Patients with NON-Valvular Atrial Fibrillation","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; Université de Montréal","funders":"","keywords":"Medicine; Apixaban; Warfarin; Atrial fibrillation; Rivaroxaban; Internal medicine; Hazard ratio; Dabigatran; Cohort; Propensity score matching; Stroke (engine); Population; Censoring (clinical trials); Confidence interval","score_opus":0.06981529492529387,"score_gpt":0.34197775896764976,"score_spread":0.2721624640423559,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249486415","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99748564,0.000103996455,0.00023331773,0.00067826186,0.00006194588,0.0014005561,0.00001004993,0.000007137798,0.000019095656],"genre_scores_gemma":[0.99903804,0.000045567474,0.0007704689,0.000029185605,0.000076740514,3.692951e-7,0.00003079588,0.0000074215363,0.0000014296313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987945,0.00022700458,0.00046789306,0.00016891044,0.0002213623,0.000120348355],"domain_scores_gemma":[0.9993594,0.00020816569,0.00022762365,0.00008568603,0.000053508564,0.00006557697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004043256,0.000095444484,0.000658611,0.000121443394,0.00001739297,0.000002587216,0.000024040408,0.000037927282,0.0000050287845],"category_scores_gemma":[0.0000744994,0.00007590829,0.00004349378,0.00036338158,0.000040725037,0.00006338183,0.00002653419,0.000063984495,7.959728e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0062031294,0.000009397393,0.9654652,0.00074696576,0.000036710924,0.0000010334525,0.0008459439,0.02522896,0.000030834704,0.0003964207,0.0000032314608,0.0010321669],"study_design_scores_gemma":[0.0116222715,0.0012848328,0.97924036,0.00036107548,0.000025768302,1.7474457e-7,0.000060156377,0.007109137,0.00013677405,0.000045159388,0.000052536107,0.00006174149],"about_ca_topic_score_codex":0.0015948218,"about_ca_topic_score_gemma":0.000013267302,"teacher_disagreement_score":0.018119823,"about_ca_system_score_codex":0.000056919172,"about_ca_system_score_gemma":0.00009445227,"threshold_uncertainty_score":0.30954504},"labels":[],"label_agreement":null},{"id":"W4249632297","doi":"10.1016/j.jval.2017.08.1381","title":"Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Brazil","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Sacubitril; Valsartan; Sacubitril, Valsartan; Enalapril; Heart failure; Medicine; Internal medicine; Ejection fraction; Cardiology; Population; Blood pressure; Angiotensin-converting enzyme","score_opus":0.05380732864162632,"score_gpt":0.36163250280887577,"score_spread":0.3078251741672494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4249632297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97416157,0.0007409567,0.00018639638,0.022039363,0.00010792155,0.0027077424,0.0000151703025,0.0000101843825,0.000030721425],"genre_scores_gemma":[0.9930429,0.0009996181,0.0055065015,0.000073436175,0.000096368276,0.00013553668,0.000013826683,0.000014844852,0.000116988725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99880594,0.00008911801,0.00040667577,0.00022608083,0.00022075739,0.00025143035],"domain_scores_gemma":[0.99903554,0.000054724605,0.0002323488,0.0005679736,0.000045086035,0.000064334155],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005724178,0.00013884189,0.0005681413,0.000103833685,0.0001219654,0.000011879397,0.000077375145,0.000050972616,0.000013034977],"category_scores_gemma":[0.000014522786,0.00008168607,0.00010031268,0.00009038893,0.00011677659,0.000074571195,0.000009696534,0.000062320636,7.5460053e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011652151,0.014055871,0.84612113,0.0020346793,0.0013578684,0.000076080476,0.009425965,0.020301037,0.008503493,0.0023955966,0.0061735595,0.07790256],"study_design_scores_gemma":[0.020874184,0.014387598,0.91981,0.00060297584,0.00019464844,0.000026359141,0.0011440198,0.004595439,0.010275756,0.00019392182,0.027674256,0.00022085839],"about_ca_topic_score_codex":0.010351306,"about_ca_topic_score_gemma":0.00053699827,"teacher_disagreement_score":0.0776817,"about_ca_system_score_codex":0.0001641175,"about_ca_system_score_gemma":0.00023769075,"threshold_uncertainty_score":0.9962388},"labels":[],"label_agreement":null},{"id":"W4250343618","doi":"10.1016/j.jval.2017.08.796","title":"Assessing The Burden of Disease In Peripheral And Axial Spondyloarthritis In Brazil","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Medicine; Ankylosing spondylitis; Psoriatic arthritis; Quality of life (healthcare); Presenteeism; Internal medicine; Axial spondyloarthritis; Psoriasis; Physical therapy; Disease; Absenteeism; Dermatology","score_opus":0.0407107101428829,"score_gpt":0.36507900828323436,"score_spread":0.32436829814035145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250343618","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9847831,0.006276963,7.180039e-7,0.007677365,0.00013315312,0.000432435,0.000012960773,0.0000051573197,0.0006781425],"genre_scores_gemma":[0.9981974,0.0012597574,0.00015915614,0.00020473375,0.00010732446,0.000023924935,0.0000044531625,0.000011021704,0.000032242195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989228,0.00011137098,0.00033333385,0.0002014956,0.00015769784,0.00027325115],"domain_scores_gemma":[0.99938536,0.000076166776,0.000118630414,0.0003014166,0.000015757874,0.000102675585],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041513317,0.00010121632,0.00033282128,0.000072572926,0.00018272774,0.00004085598,0.000072808274,0.00003486339,0.000015345822],"category_scores_gemma":[0.00016171025,0.00007845621,0.00003212421,0.000072747265,0.00019361466,0.00013614893,0.00006726492,0.00016094567,0.0000010132819],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026767212,0.00019011315,0.96774536,0.0002205684,0.000009257241,0.00041759387,0.00278022,0.00014802771,0.000021700549,0.0011091813,0.000021386008,0.027068896],"study_design_scores_gemma":[0.0051978026,0.00021638014,0.9900328,0.0013904411,0.0000053865906,0.000013313985,0.0006634437,0.0012457223,0.000004982359,0.0006076672,0.00055820117,0.00006383924],"about_ca_topic_score_codex":0.068971984,"about_ca_topic_score_gemma":0.003002261,"teacher_disagreement_score":0.06596972,"about_ca_system_score_codex":0.00012800186,"about_ca_system_score_gemma":0.00017872598,"threshold_uncertainty_score":0.9372278},"labels":[],"label_agreement":null},{"id":"W4250372619","doi":"10.1016/j.jval.2017.08.2853","title":"Potential Mortality Reduction With Optimal Usage of Sacubitril/Valsartan Therapy for The Treatment of Heart Failure In Argentina","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Novartis (Canada)","funders":"","keywords":"Valsartan; Sacubitril; Sacubitril, Valsartan; Ejection fraction; Medicine; Heart failure; Internal medicine; Cardiology; Number needed to treat; Population; Blood pressure; Relative risk; Confidence interval","score_opus":0.063597866338838,"score_gpt":0.35326783955731994,"score_spread":0.2896699732184819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4250372619","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9812679,0.0007578389,0.00020523921,0.014786305,0.00012211976,0.0028101695,0.000014582376,0.000009607466,0.000026209338],"genre_scores_gemma":[0.99275655,0.0010757197,0.0057249786,0.000044306296,0.00009483001,0.00014545352,0.000015643918,0.000014532879,0.0001279907],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878025,0.0000876937,0.00041941812,0.00022987276,0.00021871431,0.00026404258],"domain_scores_gemma":[0.99903667,0.000043709784,0.00025338386,0.0005552071,0.000046691446,0.00006436024],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00059056754,0.00013973752,0.000560144,0.00010531311,0.00012269952,0.000011414816,0.00007619418,0.000047626585,0.000014717315],"category_scores_gemma":[0.000014017369,0.000082667146,0.000108785825,0.00009170621,0.000102704464,0.000067803456,0.00001005171,0.000059747435,8.0391663e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008198582,0.0130682485,0.8996874,0.0018065004,0.0011519315,0.00006571548,0.0066689295,0.013156523,0.008084204,0.0021250355,0.00401788,0.041969042],"study_design_scores_gemma":[0.01767078,0.011676021,0.9226948,0.00055916765,0.00020398038,0.000024004217,0.0011242136,0.0043048896,0.012097477,0.00016696428,0.02926643,0.0002112851],"about_ca_topic_score_codex":0.007626177,"about_ca_topic_score_gemma":0.00034183974,"teacher_disagreement_score":0.04175776,"about_ca_system_score_codex":0.00014732433,"about_ca_system_score_gemma":0.00020317071,"threshold_uncertainty_score":0.99898213},"labels":[],"label_agreement":null},{"id":"W4251588635","doi":"10.1016/j.jval.2013.03.304","title":"Nice's selective application of differential discounting: Ambiguous, inconsistent and unjustified","year":2013,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Discounting; Nice; Differential (mechanical device); Life expectancy; Actuarial science; Psychological intervention; Medicine; Economics; Computer science; Psychiatry; Environmental health; Engineering; Finance","score_opus":0.2286926043882996,"score_gpt":0.38317678095816954,"score_spread":0.15448417656986993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251588635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97064024,0.0014692033,0.0054141465,0.019792045,0.00025265382,0.0015844471,0.00006932098,0.000029660046,0.0007482861],"genre_scores_gemma":[0.996373,0.00017432413,0.0014116858,0.0016008281,0.00011144723,0.00020669677,0.000021130914,0.000020852918,0.00008000728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99551636,0.0003437213,0.0032428778,0.00046684113,0.00007855498,0.00035165405],"domain_scores_gemma":[0.9970437,0.00044012844,0.0019798754,0.00032872183,0.000057871217,0.00014964456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005312864,0.0001426662,0.0008025241,0.00030939883,0.00010934508,0.0000388412,0.00013796425,0.000101695696,0.00006154147],"category_scores_gemma":[0.0007860259,0.00017592525,0.00004989836,0.00021805703,0.0000797329,0.00025982282,0.000048919173,0.00016958287,0.00019103175],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004156941,0.00063429575,0.5338984,0.004494314,0.00010754202,3.094321e-7,0.010069816,0.0024866075,0.000122023484,0.43708056,0.005206041,0.005858535],"study_design_scores_gemma":[0.0013522936,0.0001972533,0.81857157,0.00022819264,0.000005434941,0.0000045278907,0.0016065611,0.12375833,0.000027081773,0.05181204,0.0020542303,0.00038246237],"about_ca_topic_score_codex":0.08055957,"about_ca_topic_score_gemma":0.00039277063,"teacher_disagreement_score":0.3852685,"about_ca_system_score_codex":0.00049269135,"about_ca_system_score_gemma":0.00017310456,"threshold_uncertainty_score":0.9255631},"labels":[],"label_agreement":null},{"id":"W4252345673","doi":"10.1016/j.jval.2014.08.2528","title":"Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccine in the United States","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Medicine; Vaccination; Influenza vaccine; Cost effectiveness; Demography; Virology","score_opus":0.2795574574424417,"score_gpt":0.4684477307636322,"score_spread":0.18889027332119052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252345673","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937412,0.0014366523,0.00007910176,0.0018736403,0.00014800433,0.0024665794,0.000016314452,0.000025543446,0.00021296892],"genre_scores_gemma":[0.9965447,0.0015713688,0.00014530176,0.0014006298,0.000059955153,0.00021986752,0.000029484478,0.00002265888,0.0000059979566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952377,0.0025209296,0.0007269895,0.0002819698,0.00064535113,0.000587049],"domain_scores_gemma":[0.99509776,0.003924284,0.00016684513,0.00051294756,0.00017401153,0.00012416956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0067340494,0.00018785104,0.0006152598,0.00062763604,0.000072856485,0.000008554675,0.00022640084,0.00006743156,0.000014070271],"category_scores_gemma":[0.002215382,0.00012777076,0.000070326285,0.0011999104,0.000089450674,0.000049597787,0.00008569125,0.00049408054,0.00001554636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030438038,0.0027336385,0.77029335,0.013399213,0.00028218498,0.00007101383,0.020249683,0.13611999,0.00045878883,0.010511507,0.0012180131,0.014224561],"study_design_scores_gemma":[0.025631042,0.00401065,0.9109569,0.0021688696,0.000027559212,0.0000066129473,0.0019369229,0.016607508,0.00076167384,0.0006082637,0.03706716,0.00021684686],"about_ca_topic_score_codex":0.017462341,"about_ca_topic_score_gemma":0.0001928001,"teacher_disagreement_score":0.14066352,"about_ca_system_score_codex":0.000545459,"about_ca_system_score_gemma":0.0002609665,"threshold_uncertainty_score":0.9890805},"labels":[],"label_agreement":null},{"id":"W4252898622","doi":"10.1016/j.jval.2018.09.1922","title":"PMU86 - VALUING HEALTH-STATE: AN EQ-5D-5L VALUE SET FOR ETHIOPIANS","year":2018,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health","funders":"","keywords":"EQ-5D; Population; Valuation (finance); Context (archaeology); Medicine; Statistics; Psychology; Mathematics; Geography; Environmental health; Economics","score_opus":0.5698953724552035,"score_gpt":0.46620168362564907,"score_spread":0.10369368882955443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252898622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46506408,0.009801927,0.11784722,0.38287377,0.007847999,0.009748275,0.003630455,0.0005838138,0.0026024655],"genre_scores_gemma":[0.69015574,0.0016813736,0.10203494,0.19757195,0.0048095533,0.0010036244,0.0005273111,0.00042826368,0.001787243],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9876736,0.0017703875,0.007336362,0.0013398039,0.00020874618,0.001671107],"domain_scores_gemma":[0.9927355,0.00174711,0.0034258051,0.0011334774,0.00013970063,0.00081841456],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.055012103,0.00040430305,0.0018501291,0.00080203003,0.00078034337,0.00014454778,0.0006066666,0.0002797074,0.00016849433],"category_scores_gemma":[0.003299337,0.00054565223,0.00018715736,0.0005475973,0.00017014863,0.0007307317,0.00007836329,0.0004888219,0.0013288772],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018363481,0.00068775594,0.050720505,0.006550276,0.00012321954,0.0000030857468,0.07259321,0.012691634,0.0000049263017,0.7767274,0.072752684,0.0069616884],"study_design_scores_gemma":[0.004601928,0.0035283165,0.028721202,0.001176446,0.0000067024575,0.000027838198,0.0037386117,0.26570177,0.000015955047,0.22083092,0.47011933,0.001531],"about_ca_topic_score_codex":0.04342968,"about_ca_topic_score_gemma":0.002516339,"teacher_disagreement_score":0.55589646,"about_ca_system_score_codex":0.0026253297,"about_ca_system_score_gemma":0.0018006334,"threshold_uncertainty_score":0.9996995},"labels":[],"label_agreement":null},{"id":"W4252916761","doi":"10.1016/j.jval.2017.08.2678","title":"Burden of Disease for Psoriasis In Argentina, Brazil, Colombia and Mexico","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Eli Lilly (Canada); University of Toronto","funders":"","keywords":"Medicine; Psoriasis; Psoriatic arthritis; Latin Americans; Population; Epidemiology; Depression (economics); Disease; MEDLINE; Anxiety; Psychological intervention; Family medicine; Environmental health; Dermatology; Psychiatry; Internal medicine","score_opus":0.039352777556383604,"score_gpt":0.3087343521731895,"score_spread":0.2693815746168059,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4252916761","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907352,0.0062845927,0.000011030284,0.0015378046,0.000567245,0.0005869013,0.00016734227,0.000010521332,0.000099401426],"genre_scores_gemma":[0.99815017,0.0010091693,0.00018225185,0.000053729178,0.000030441828,0.00007417808,0.000047991627,0.000011067806,0.00044101843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99892014,0.00017818461,0.00032750613,0.0002452729,0.000022785409,0.00030610085],"domain_scores_gemma":[0.99920744,0.00018064462,0.000223445,0.0003231741,0.00002107886,0.000044214787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051535666,0.00011308237,0.00032714597,0.000115243165,0.00018782134,0.000010034163,0.0001612583,0.00010833484,0.000030771545],"category_scores_gemma":[0.00020652005,0.00010812198,0.000054542706,0.00004481643,0.00010414421,0.00006326648,0.000051137915,0.000068439986,0.000010688812],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030489727,0.0007728058,0.87754434,0.00092567544,0.00019255125,0.000021504808,0.0031058441,0.00018701302,0.0055225473,0.00793979,0.0024556615,0.09828329],"study_design_scores_gemma":[0.008845534,0.00056796276,0.9697359,0.00034101118,0.000058932095,0.0000054829297,0.00020367256,0.00019527308,0.004185201,0.0037887297,0.011826421,0.00024586607],"about_ca_topic_score_codex":0.0050097513,"about_ca_topic_score_gemma":0.00026499687,"teacher_disagreement_score":0.09803743,"about_ca_system_score_codex":0.000046627476,"about_ca_system_score_gemma":0.00014690132,"threshold_uncertainty_score":0.7573279},"labels":[],"label_agreement":null},{"id":"W4253038084","doi":"10.1016/j.jval.2017.08.1209","title":"Modelling The Burden Of Cardiovascular Disease In Mexico And The Impact Of Reducing Modifiable Risk Factors","year":2017,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Conference Board of Canada","funders":"","keywords":"Medicine; Environmental health; Population; Disease; Disease burden; Obesity; Psychological intervention; Absenteeism; Internal medicine","score_opus":0.07655966887107223,"score_gpt":0.3211138911252003,"score_spread":0.24455422225412804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4253038084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98879147,0.0023832757,0.00025546792,0.0075002834,0.000110824476,0.00047069933,0.000010999173,0.0000065810473,0.00047040381],"genre_scores_gemma":[0.9984331,0.0012057365,0.00002686562,0.000101774844,0.00020845271,0.000009019091,0.000002343858,0.000009299057,0.000003405751],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99842644,0.00023947182,0.0005718496,0.00018839637,0.00015820075,0.00041564804],"domain_scores_gemma":[0.9983238,0.00029930111,0.0006137109,0.0006792063,0.00004976066,0.000034240158],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005343894,0.000117358235,0.00052434107,0.000115398216,0.00032285176,0.000049897182,0.0003476702,0.000045999903,0.00000338861],"category_scores_gemma":[0.0011713239,0.000062190506,0.00018134103,0.0001577118,0.00021682202,0.00026251154,0.00016836563,0.00020596894,8.380748e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042059513,0.00001260885,0.020849299,0.00022579618,0.0000386046,3.5154144e-7,0.00044223983,0.97352946,8.518306e-8,0.00436879,0.00035688977,0.00013383856],"study_design_scores_gemma":[0.0005725371,0.000007750156,0.0074280435,0.00012701431,0.000019151885,1.365473e-7,0.00032558347,0.9831395,1.1135595e-7,0.0063056187,0.0020224047,0.00005211516],"about_ca_topic_score_codex":0.987396,"about_ca_topic_score_gemma":0.000025277479,"teacher_disagreement_score":0.9873707,"about_ca_system_score_codex":0.00006572197,"about_ca_system_score_gemma":0.0001334289,"threshold_uncertainty_score":0.2536055},"labels":[],"label_agreement":null},{"id":"W4254935015","doi":"10.1016/s1098-3015(10)66761-7","title":"PHC7 COST-EFFECTIVENESS OF RIVAROXABANVERSUS ENOXAPARIN FORTHROMBOPROPHYLAXIS AFTER TOTAL HIP REPLACEMENT IN CANADA","year":2008,"lang":"en","type":"article","venue":"Value in Health","topic":"Orthopaedic implants and arthroplasty","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Total hip replacement; Medicine; Enoxaparin sodium; Surgery; Low molecular weight heparin; Thrombosis","score_opus":0.03896411178915887,"score_gpt":0.2812575138109857,"score_spread":0.2422934020218268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4254935015","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99708104,0.00044626757,0.000014553333,0.00017019807,0.0005887072,0.0013477039,0.000045206933,0.000010327612,0.00029600482],"genre_scores_gemma":[0.9992466,0.00021158204,0.00012627195,0.0001759444,0.00006265039,0.00008433312,0.000018077413,0.000018835168,0.000055680397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979609,0.0002364627,0.0005944985,0.0003175855,0.00041126623,0.0004792704],"domain_scores_gemma":[0.99915177,0.00019434634,0.00013062691,0.00028855028,0.000035932793,0.00019878034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061584794,0.000164259,0.0005499807,0.00015981094,0.000043399006,0.0000018518245,0.000046599533,0.000052360854,0.0001028475],"category_scores_gemma":[0.000082276805,0.00014752058,0.000050152245,0.00028086657,0.000068873705,0.000049376828,0.000041707874,0.00025755595,0.000004883935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002011482,0.00028675026,0.98789084,0.0009899937,0.000022266342,0.00057198195,0.00054842205,0.0008165502,0.000059928705,0.000046098034,0.00015927704,0.006596396],"study_design_scores_gemma":[0.0044045197,0.001005285,0.99138093,0.00063999894,0.0000046381538,0.00026153334,0.00015052942,0.0006084558,0.00030818032,0.0000119023525,0.0010898919,0.0001341158],"about_ca_topic_score_codex":0.90545577,"about_ca_topic_score_gemma":0.3541399,"teacher_disagreement_score":0.5513159,"about_ca_system_score_codex":0.0013232945,"about_ca_system_score_gemma":0.0033394673,"threshold_uncertainty_score":0.65764534},"labels":[],"label_agreement":null},{"id":"W4255419074","doi":"10.1016/s1098-3015(10)73566-x","title":"PDB22 ECONOMIC EVALUATION OF LONG-ACTING INSULIN ANALOGUES FOR THE TREATMENT OF PATIENTS WITH TYPE-1 AND TYPE-2 DIABETES MELLITUS IN CANADA","year":2009,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Type 2 Diabetes Mellitus; Medicine; Insulin; Type (biology); Internal medicine; Diabetes mellitus; Endocrinology; Biology","score_opus":0.05875028572945534,"score_gpt":0.3254283673808369,"score_spread":0.26667808165138157,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255419074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947002,0.0036996685,9.4280585e-7,0.00041490034,0.00005284826,0.0010621268,0.000007434667,0.0000014139283,0.00006045274],"genre_scores_gemma":[0.9990041,0.00081039517,0.00006767138,0.000041849264,0.000015024359,0.000010955874,0.000034788503,0.000004467355,0.000010750329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9992776,0.00007256721,0.00022311813,0.000100655576,0.00016839796,0.00015767693],"domain_scores_gemma":[0.9994932,0.00018145394,0.00009690582,0.000104855906,0.00009030358,0.000033269735],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006128331,0.00005474221,0.00019574068,0.00009111013,0.000018587221,0.000002633294,0.00002994907,0.000013854333,0.0000074238146],"category_scores_gemma":[0.00006044282,0.000034094755,0.000009075108,0.00014710364,0.000017962779,0.000022789098,0.000004305068,0.000032222422,2.0730529e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015019327,0.00014444791,0.7440762,0.00015036145,0.000027914175,2.112232e-7,0.00023795204,0.0040541366,0.0000017970381,0.000018270344,0.000022018357,0.2511165],"study_design_scores_gemma":[0.0021884933,0.0021328703,0.95556617,0.00012747601,0.000028363387,1.45216505e-8,0.00012835262,0.03948668,0.00009391979,0.000062126266,0.00015402307,0.000031509844],"about_ca_topic_score_codex":0.19437085,"about_ca_topic_score_gemma":0.17397536,"teacher_disagreement_score":0.251085,"about_ca_system_score_codex":0.0005766222,"about_ca_system_score_gemma":0.00088177714,"threshold_uncertainty_score":0.8410974},"labels":[],"label_agreement":null},{"id":"W4255505380","doi":"10.1016/j.jval.2020.04.807","title":"PMU32 A DEVICE CATEGORY-BASED ECONOMIC MODEL EXPLORING ELECTROSURGERY TECHNOLOGIES ACROSS PROCEDURE TYPES: A CHINESE ANALYSIS","year":2020,"lang":"en","type":"article","venue":"Value in Health","topic":"Thyroid and Parathyroid Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Electrosurgery; Medicine; Operations management; Surgery; Engineering","score_opus":0.0915492600715045,"score_gpt":0.3285721655058998,"score_spread":0.2370229054343953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4255505380","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98255354,0.004205137,0.0008721732,0.011304212,0.00007257091,0.00041482254,0.000034552326,0.00046218143,0.00008082067],"genre_scores_gemma":[0.9959516,0.00058486126,0.00075141253,0.0023458602,0.000105093764,0.00014723462,0.000048787875,0.00004086515,0.000024308241],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9977816,0.00007978175,0.00067576335,0.00057162496,0.00018357777,0.00070770166],"domain_scores_gemma":[0.99895,0.00018871039,0.00020210062,0.00038421643,0.000038740953,0.00023621757],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00064144196,0.00027131097,0.0009159066,0.00038172936,0.00011121477,0.000029143994,0.00015353349,0.00014232115,0.00000885185],"category_scores_gemma":[0.00032345514,0.00023822565,0.0002459364,0.0016338881,0.000051497027,0.00014072332,0.00004484469,0.00048399006,0.000056409965],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005868066,0.00016539682,0.33410543,0.0008664564,0.00023085678,0.00006666554,0.003910659,0.6561122,0.0018822094,0.00017348638,0.0010254823,0.0008743307],"study_design_scores_gemma":[0.000956709,0.00024106228,0.0109893195,0.00010228524,0.00007940862,0.000011216777,0.00093737536,0.9845291,0.0010747724,0.00016469431,0.0005762281,0.0003378263],"about_ca_topic_score_codex":0.00077691185,"about_ca_topic_score_gemma":0.00017146785,"teacher_disagreement_score":0.32841688,"about_ca_system_score_codex":0.00032851205,"about_ca_system_score_gemma":0.0014706749,"threshold_uncertainty_score":0.971456},"labels":[],"label_agreement":null},{"id":"W4256022211","doi":"10.1016/j.jval.2014.03.226","title":"Comparison costs of ERCP and MRCP in patients with suspected biliary obstruction based on a randomized trial","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Medicine; Magnetic resonance cholangiopancreatography; Endoscopic retrograde cholangiopancreatography; Randomized controlled trial; Indirect costs; Medical costs; Cost analysis; Surgery; General surgery; Pancreatitis","score_opus":0.018268988718558605,"score_gpt":0.288296914815033,"score_spread":0.2700279260964744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256022211","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964333,0.000054749427,0.00006664372,0.00061612454,0.00018328875,0.0024200925,0.000003255595,0.000017626437,0.00020492633],"genre_scores_gemma":[0.99923396,0.000015814232,0.0004143326,0.0002190292,0.000027130574,0.000029938858,0.00004382772,0.000012312202,0.00000363355],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99816656,0.00060236175,0.0005505112,0.00021668914,0.00027376116,0.00019009868],"domain_scores_gemma":[0.9990713,0.00043866612,0.00017800137,0.00017257783,0.000052534593,0.0000869387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000951196,0.00011499726,0.00075345574,0.00028315198,0.000020623658,0.0000041688345,0.000030524145,0.00006385627,0.000013613439],"category_scores_gemma":[0.00047563104,0.000083062434,0.000036704216,0.00027950134,0.00008217884,0.000026341559,0.0000062774648,0.0001903508,7.743127e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.602198,0.0009369589,0.39192814,0.00021083749,0.000010429361,5.629851e-7,0.0003157847,0.0010480644,0.000005509588,0.00009850706,0.00005270758,0.0031944881],"study_design_scores_gemma":[0.67907953,0.002524073,0.28659552,0.00039920057,0.000015226537,3.6778962e-7,0.00008108515,0.03112467,0.000016489417,0.00008526711,0.00001242178,0.000066146975],"about_ca_topic_score_codex":0.0030040236,"about_ca_topic_score_gemma":0.00017348703,"teacher_disagreement_score":0.105332606,"about_ca_system_score_codex":0.00012465044,"about_ca_system_score_gemma":0.0001567407,"threshold_uncertainty_score":0.45412052},"labels":[],"label_agreement":null},{"id":"W4256251854","doi":"10.1016/j.jval.2012.08.2054","title":"PSS7 C-Reality (Canadian Burden of Diabetic Macular Edema Observational Study): 6-Month Findings","year":2012,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St Joseph's Health Care; Novartis (Canada)","funders":"","keywords":"Medicine; Visual acuity; Observational study; Quality of life (healthcare); Macular edema; Diabetes mellitus; Diabetic macular edema; Diabetic retinopathy; Ophthalmology; Visual analogue scale; Telephone interview; Surgery; Internal medicine","score_opus":0.13751446866177175,"score_gpt":0.37339115689902935,"score_spread":0.2358766882372576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256251854","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940526,0.0011603585,0.000002208074,0.0030973363,0.00010642729,0.0009240332,0.00006006117,0.000011240318,0.00058575877],"genre_scores_gemma":[0.99903005,0.000044640594,0.00023774737,0.0003433129,0.00011469805,0.000035512276,0.000082268896,0.000014630149,0.00009715649],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852175,0.00014451315,0.00040261983,0.00016978307,0.00032179293,0.00043954345],"domain_scores_gemma":[0.99894917,0.000067968045,0.00008660285,0.00024293883,0.000043224245,0.0006100903],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056059187,0.0001150236,0.00032698637,0.00013855952,0.00006191137,0.0000050998046,0.00006362119,0.00004584015,0.00012933555],"category_scores_gemma":[0.00011773474,0.00010026342,0.00007083785,0.00023435145,0.000028091648,0.00006380436,0.000016886052,0.00009350168,0.00002496208],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050390125,0.00063074287,0.99634695,0.00023937791,0.00004621082,0.000017163831,0.0010670144,0.00010882412,0.0000070343826,0.00063707615,0.00027800587,0.0005712312],"study_design_scores_gemma":[0.0012260334,0.00046363127,0.9961092,0.00018705933,0.000046705634,0.00000423553,0.00038025074,0.0005173774,0.000009105059,0.00021413063,0.0007761098,0.00006618472],"about_ca_topic_score_codex":0.3981251,"about_ca_topic_score_gemma":0.0024281964,"teacher_disagreement_score":0.3956969,"about_ca_system_score_codex":0.00041763057,"about_ca_system_score_gemma":0.00050516875,"threshold_uncertainty_score":0.6058828},"labels":[],"label_agreement":null},{"id":"W4256475711","doi":"10.1016/j.jval.2016.09.1386","title":"Cost-Effectiveness of Apremilast In Moderate-To-Severe Psoriasis In Canada","year":2016,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Apremilast; Medicine; Adalimumab; Infliximab; Ustekinumab; Psoriasis; Etanercept; Quality-adjusted life year; Cost effectiveness; Internal medicine; Psoriatic arthritis; Dermatology; Disease","score_opus":0.38534836230586117,"score_gpt":0.4053830465265382,"score_spread":0.020034684220677057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4256475711","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98137146,0.00075685105,0.0009281561,0.013599703,0.0005877681,0.0018432235,0.0003865589,0.000009046389,0.00051721575],"genre_scores_gemma":[0.996676,0.00017641425,0.00051961397,0.002254946,0.000049500646,0.00025190559,0.000005612222,0.00002570185,0.000040268616],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9933297,0.0013383633,0.0040457034,0.0005630757,0.00010764719,0.00061548466],"domain_scores_gemma":[0.9954695,0.002897578,0.0009622502,0.0004144221,0.000035670997,0.00022055538],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020675788,0.00016783383,0.0012400082,0.0006610916,0.00003463765,0.000009422432,0.00024762863,0.00009605462,0.00007929095],"category_scores_gemma":[0.0027600944,0.00018864677,0.000039661467,0.0005224229,0.000021753374,0.00022100902,0.000045320845,0.00015904423,0.00011089918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015093225,0.000106979176,0.90419626,0.0013393875,0.000009535981,0.0000030005358,0.0012225407,0.071358874,0.000003970737,0.019477412,0.00087565894,0.0012554644],"study_design_scores_gemma":[0.004312605,0.00012541948,0.95733774,0.0025765074,7.069071e-7,0.000003154756,0.00076624023,0.01708728,0.0000422131,0.013860626,0.0034330145,0.00045451315],"about_ca_topic_score_codex":0.96416736,"about_ca_topic_score_gemma":0.8695376,"teacher_disagreement_score":0.094629794,"about_ca_system_score_codex":0.008744636,"about_ca_system_score_gemma":0.0030108502,"threshold_uncertainty_score":0.9950606},"labels":[],"label_agreement":null},{"id":"W4280647474","doi":"10.1016/j.jval.2022.04.1729","title":"Building a Healthcare Alliance for Resourceful Medicine Offensive Against Neoplasms in Hematology Added Value Framework for Hematologic Malignancies: A Comparative Analysis of Existing Tools","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada); Impact","funders":"Innovative Medicines Initiative; European Commission; European Federation of Pharmaceutical Industries and Associations","keywords":"Offensive; Medicine; Harmony (color); Health care; Alliance; Clinical trial; Family medicine; Political science; Internal medicine; Operations research; Engineering","score_opus":0.2321244757652726,"score_gpt":0.3742485561811349,"score_spread":0.1421240804158623,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280647474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9195391,0.023024306,0.040268697,0.010647487,0.0007050886,0.0031327251,0.0020285891,0.000040756742,0.00061327394],"genre_scores_gemma":[0.96439326,0.0004502759,0.030414118,0.0036479982,0.00008350138,0.0008563062,0.00008874667,0.0000306308,0.000035179895],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9958182,0.00016036721,0.002355908,0.00077451894,0.00007272284,0.00081825856],"domain_scores_gemma":[0.9947167,0.0026304172,0.002014967,0.00040418192,0.000093084425,0.00014065513],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027588056,0.00027206546,0.0025224648,0.0009082338,0.0002781093,0.000016984279,0.00039128694,0.00016787155,0.000040624443],"category_scores_gemma":[0.001999988,0.0003289463,0.00026110234,0.001577619,0.00013808186,0.000113333306,0.00009835603,0.00040417144,0.0000018203864],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002837748,0.00009133028,0.02135117,0.00061485224,0.00013396298,0.0000043258083,0.0064064744,0.11413837,0.000004480675,0.85620207,0.00037384935,0.00039535665],"study_design_scores_gemma":[0.005136423,0.002483647,0.02137728,0.0015828926,0.00007119031,0.000014717792,0.009982477,0.31555644,0.000089499525,0.6108396,0.031847585,0.0010182456],"about_ca_topic_score_codex":0.005532222,"about_ca_topic_score_gemma":0.00049103366,"teacher_disagreement_score":0.24536245,"about_ca_system_score_codex":0.0010182343,"about_ca_system_score_gemma":0.00027068984,"threshold_uncertainty_score":0.99991626},"labels":[],"label_agreement":null},{"id":"W4281251623","doi":"10.1016/j.jval.2022.04.003","title":"Patient and Caregiver Experience Decision Factors in Treatment Decision Making: Results of a Systematic Literature Review of Multiple Myeloma Decision Aids","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Multiple myeloma; Decision aids; Medicine; Intensive care medicine; Management science; Alternative medicine; Internal medicine; Engineering; Pathology","score_opus":0.12025877929423238,"score_gpt":0.41947872882124226,"score_spread":0.29921994952700987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281251623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021014797,0.9698287,0.000025428952,0.000008240443,0.00017450325,0.0084692985,0.00044913817,0.000012210509,0.00001764703],"genre_scores_gemma":[0.01588538,0.979368,0.0037358627,0.00002078436,0.000013524328,0.00064479123,0.0002684487,0.000053286058,0.000009963236],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99184835,0.001437313,0.003735792,0.000946315,0.0014935132,0.00053874694],"domain_scores_gemma":[0.98960465,0.0071637086,0.0015340226,0.0012208782,0.0001476796,0.00032904022],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0014325267,0.0006344355,0.00490667,0.0013748817,0.000080080084,0.000018339499,0.00026011874,0.0002571894,0.000032897013],"category_scores_gemma":[0.0062702578,0.00039454957,0.0005203004,0.0017982273,0.000068702575,0.00009154075,0.00025446402,0.00047786717,0.0000022926436],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047651058,0.0004224071,0.0006262757,0.4190887,0.000047287762,0.0002478169,0.002850323,0.0000082366605,1.3495831e-7,0.000002841659,0.000017518523,0.5762119],"study_design_scores_gemma":[0.0033098874,0.0030287325,0.0008534158,0.9689981,0.000146965,0.00016811499,0.00041628207,0.00017411259,0.000002210747,0.000013647008,0.022677146,0.00021138857],"about_ca_topic_score_codex":0.0012171522,"about_ca_topic_score_gemma":0.00009753236,"teacher_disagreement_score":0.5760006,"about_ca_system_score_codex":0.0021519891,"about_ca_system_score_gemma":0.00092770223,"threshold_uncertainty_score":0.99985063},"labels":[],"label_agreement":null},{"id":"W4281488265","doi":"10.1016/j.jval.2022.04.002","title":"A Data-Driven Approach to Support the Understanding and Improvement of Patients’ Journeys: A Case Study Using Electronic Health Records of an Emergency Department","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Business Process Modeling and Analysis","field":"Business, Management and Accounting","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"National Research Foundation of Korea","keywords":"Emergency department; Health records; Medical emergency; Electronic health record; Data science; Medicine; Computer science; Nursing; Health care; Political science","score_opus":0.16079424607813764,"score_gpt":0.3331459692628482,"score_spread":0.17235172318471054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281488265","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929519,0.00019544589,0.0051846793,0.0004062633,0.00011272274,0.0010684088,0.000047989397,0.000014764947,0.000017789394],"genre_scores_gemma":[0.9990369,0.00005403945,0.00033062694,0.0003315053,0.00006781148,0.000048038084,0.00010507881,0.000023120978,0.0000028637523],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976281,0.00012740752,0.00092107424,0.00044200875,0.00045665764,0.00042473266],"domain_scores_gemma":[0.99861526,0.000017059589,0.0007678416,0.0004786292,0.00008587327,0.000035353456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003089831,0.0001544465,0.00039973218,0.00041254656,0.0005369899,0.00003675069,0.00034696105,0.000015115412,0.000019030149],"category_scores_gemma":[0.000029137826,0.00012938397,0.000035230263,0.0011489105,0.000018212071,0.00035821073,0.00052963255,0.00019820238,1.5056982e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003119337,0.00916896,0.25612932,0.0038927873,0.0003227103,0.000031706517,0.011187459,0.6823076,0.000012430161,0.002619402,0.00046880127,0.033546895],"study_design_scores_gemma":[0.0011744101,0.0009973443,0.0015337602,0.000047019,0.00010158514,0.000015139407,0.05389963,0.94089967,4.0141842e-7,0.000855106,0.0002507865,0.0002251325],"about_ca_topic_score_codex":0.056150742,"about_ca_topic_score_gemma":0.0024049592,"teacher_disagreement_score":0.2585921,"about_ca_system_score_codex":0.00042478569,"about_ca_system_score_gemma":0.00036086288,"threshold_uncertainty_score":0.95013446},"labels":[],"label_agreement":null},{"id":"W4281655166","doi":"10.1016/j.jval.2022.03.018","title":"Designing and Implementing Deliberative Processes for Health Technology Assessment: A Good Practices Report of a Joint HTAi/ISPOR Task Force","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":34,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; University of Ottawa","funders":"Wellcome Trust","keywords":"Deliberation; Scrutiny; Checklist; Management science; Political science; Citizen journalism; Health technology; Process management; Engineering ethics; Psychology; Health care; Engineering","score_opus":0.44967659264047266,"score_gpt":0.49790826696571755,"score_spread":0.04823167432524489,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281655166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43657953,0.02527647,0.09165122,0.43356088,0.0006527899,0.0097901,0.0015207966,0.00017680961,0.000791427],"genre_scores_gemma":[0.8863414,0.00053029635,0.10474247,0.0061415033,0.000105161096,0.0018039785,0.00010535689,0.000057965044,0.00017188613],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99131036,0.0007405916,0.00626612,0.0007945046,0.00013324386,0.00075515447],"domain_scores_gemma":[0.983946,0.0016292768,0.013783818,0.00037428617,0.00012035337,0.00014623276],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.047160104,0.00018902357,0.0012778543,0.0008165625,0.00073251163,0.000043250344,0.00019914565,0.00007049247,0.000031672633],"category_scores_gemma":[0.0068755476,0.00025543207,0.000058577796,0.000667384,0.000056156397,0.00040236718,0.00016743665,0.00033432315,0.0000021349667],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011619195,0.0009728021,0.40362787,0.02504272,0.00028589944,0.000015131441,0.030647729,0.01030867,0.00007931342,0.51866865,0.0075999927,0.0026350191],"study_design_scores_gemma":[0.013099317,0.010396541,0.04772214,0.0027586895,0.00004924662,0.0011146695,0.17319217,0.14128472,0.00022619561,0.33082032,0.27662012,0.0027158768],"about_ca_topic_score_codex":0.0060449773,"about_ca_topic_score_gemma":0.00041596015,"teacher_disagreement_score":0.44976187,"about_ca_system_score_codex":0.0012820059,"about_ca_system_score_gemma":0.0030289858,"threshold_uncertainty_score":0.9999898},"labels":[],"label_agreement":null},{"id":"W4281695053","doi":"10.1016/j.jval.2022.03.011","title":"Systematic Review on the Cost-Effectiveness of Seasonal Influenza Vaccines in Older Adults","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada; Toronto Rehabilitation Institute; St. Michael's Hospital","funders":"Canadian Institutes of Health Research","keywords":"Checklist; Medicine; Trivalent influenza vaccine; Cost effectiveness; Purchasing power parity; Influenza vaccine; Demography; Vaccination; Immunology; Economics; Psychology; Finance","score_opus":0.23675180593529893,"score_gpt":0.4794656861400883,"score_spread":0.24271388020478935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281695053","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008787519,0.9676239,3.4181588e-7,0.00022264924,0.00012479919,0.031657122,0.00009242887,0.000021610564,0.00016929136],"genre_scores_gemma":[0.00002709169,0.9882277,0.000008201784,0.0016019951,0.000047091882,0.009958753,0.00003725204,0.00006911474,0.000022763696],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9853729,0.009691165,0.0024694325,0.0005843402,0.0012141891,0.000667966],"domain_scores_gemma":[0.98747116,0.010160883,0.0010404617,0.0010360399,0.00014633217,0.00014512459],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0130237825,0.00053212023,0.0061354465,0.00059990096,0.00010933531,0.0000085371785,0.00048141755,0.00014478236,0.00015524494],"category_scores_gemma":[0.009557979,0.00030297742,0.0005222541,0.0018499092,0.00006720585,0.00003880298,0.0002578411,0.0016193247,0.000045073717],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117419404,0.00025591065,0.00010649777,0.9729357,0.00017640191,0.000038223785,0.00018320576,0.000017473933,5.994971e-9,0.00030855142,0.00018285168,0.025677769],"study_design_scores_gemma":[0.0009344328,0.00033349983,0.0003862647,0.9073695,0.00027243418,0.00003319949,0.00006779186,0.000028344994,9.899527e-8,0.000010732893,0.09038766,0.00017603951],"about_ca_topic_score_codex":0.0012457377,"about_ca_topic_score_gemma":0.000020799875,"teacher_disagreement_score":0.090204805,"about_ca_system_score_codex":0.0020016665,"about_ca_system_score_gemma":0.0021482208,"threshold_uncertainty_score":0.99994224},"labels":[],"label_agreement":null},{"id":"W4281763642","doi":"10.1016/j.jval.2022.05.001","title":"Patient Expectations About Palliative Treatment for Symptomatic Spinal Metastases: A Qualitative Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Management of metastatic bone disease","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver General Hospital; University of British Columbia","funders":"AOSpine; Medtronic","keywords":"Medicine; Qualitative research; Palliative treatment; Palliative care; General surgery; Intensive care medicine; Physical therapy; Internal medicine; Nursing; Sociology; Social science","score_opus":0.11867797464171849,"score_gpt":0.4408110104406888,"score_spread":0.32213303579897035,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281763642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98401207,0.0013949362,0.0011539987,0.0027697578,0.00017403613,0.0098510515,0.0004388236,0.00006331433,0.00014198716],"genre_scores_gemma":[0.98338693,0.000017522021,0.008215825,0.0007350347,0.000020343254,0.007243241,0.00017768674,0.000030405181,0.0001730339],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9961825,0.0015749254,0.00081767084,0.0004241185,0.0006182131,0.00038256863],"domain_scores_gemma":[0.9985561,0.00047666804,0.00034509422,0.00034601844,0.0000640337,0.00021209015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010861773,0.00020876403,0.00055957213,0.00036435,0.00028389491,0.000014760417,0.00007715344,0.000009840743,0.00017882358],"category_scores_gemma":[0.00026306152,0.00018868335,0.00014017265,0.00045794307,0.000029178738,0.000050194518,0.000056760244,0.00011102814,0.000010967376],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0026916028,0.02239407,0.0037279534,0.0016197182,0.0010695521,0.00017745321,0.940064,0.005209774,0.0000052336245,0.0076780543,0.0012986036,0.014063983],"study_design_scores_gemma":[0.010767723,0.027375609,0.007781646,0.00019767009,0.00034677846,0.0000036871031,0.9393063,0.01101183,0.0000050094577,0.0014721667,0.0015097205,0.00022182215],"about_ca_topic_score_codex":0.0015821104,"about_ca_topic_score_gemma":0.0000340322,"teacher_disagreement_score":0.013842161,"about_ca_system_score_codex":0.0012898352,"about_ca_system_score_gemma":0.0005423837,"threshold_uncertainty_score":0.7694284},"labels":[],"label_agreement":null},{"id":"W4282832845","doi":"10.1016/j.jval.2022.05.003","title":"How Do Treatment Preferences of Patients With Cancer Compare With Those of Oncologists and Family Members? Evidence From a Discrete Choice Experiment in China","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":15,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"National Natural Science Foundation of China","keywords":"Medicine; Latent class model; Mixed logit; Family history; Quality of life (healthcare); Logistic regression; Preference; Lung cancer; Family member; Family medicine; Internal medicine","score_opus":0.17010140186982514,"score_gpt":0.29178897737570464,"score_spread":0.1216875755058795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282832845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905785,0.008097596,0.000016544695,0.00024362048,0.00004856752,0.0005355724,0.00037945778,0.0000026218902,0.000097523705],"genre_scores_gemma":[0.9974884,0.0017279816,0.00050355296,0.000022122174,0.000006278724,0.00019790336,0.000028153547,0.000008104101,0.00001753441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99902385,0.000074217074,0.00039783702,0.00030607323,0.000056788795,0.00014121611],"domain_scores_gemma":[0.9992054,0.00008613228,0.0005111286,0.00015280703,0.0000038607195,0.000040678282],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002457598,0.00010692396,0.00039858083,0.00009321141,0.00004203451,0.000009846727,0.00008719557,0.000017081513,0.00007906975],"category_scores_gemma":[0.000008699887,0.00009242303,0.00001669581,0.00010345777,0.00006282706,0.00014657703,0.000047769834,0.00006688996,3.3641925e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012635106,0.00020623875,0.96561855,0.000036402314,0.0000175554,2.617489e-7,0.004905507,0.028014462,0.0000025688548,0.00019564436,0.000004242093,0.0008722235],"study_design_scores_gemma":[0.0014283578,0.0012236518,0.9929842,0.00014723898,0.000003164321,6.744889e-8,0.0012560965,0.002491537,0.000025592914,0.00024525824,0.0000985978,0.00009628417],"about_ca_topic_score_codex":0.11815249,"about_ca_topic_score_gemma":0.002847934,"teacher_disagreement_score":0.11530456,"about_ca_system_score_codex":0.000838636,"about_ca_system_score_gemma":0.00006289782,"threshold_uncertainty_score":0.8877198},"labels":[],"label_agreement":null},{"id":"W4282927626","doi":"10.1016/j.jval.2022.05.004","title":"No Time to Waste: An Appraisal of Value at the End of Life","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Public Health; Sinai Health System; McMaster University; University of Toronto","funders":"","keywords":"Quality of life (healthcare); CINAHL; Psychological intervention; PsycINFO; Value of life; Quality-adjusted life year; Medicine; End-of-life care; MEDLINE; Economic appraisal; EQ-5D; Gerontology; Psychology; Health related quality of life; Cost effectiveness; Nursing; Palliative care; Public economics; Economics","score_opus":0.5088164664211489,"score_gpt":0.4764487851588149,"score_spread":0.03236768126233397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4282927626","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00043431195,0.9853407,0.00002622927,0.004260687,0.0012397118,0.0030637619,0.0024617354,0.000024608202,0.0031482473],"genre_scores_gemma":[0.00002949103,0.9920377,0.0010583951,0.0035697217,0.00061200635,0.00047504742,0.00031211704,0.00013260324,0.0017728898],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9822319,0.0039989552,0.01178631,0.0009866793,0.000291009,0.0007051451],"domain_scores_gemma":[0.9827682,0.006665567,0.008450247,0.0016064198,0.000050931376,0.00045868004],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.044758514,0.00043646657,0.005314829,0.00087234407,0.00021113538,0.000024199047,0.0010835894,0.0002805559,0.0052868593],"category_scores_gemma":[0.008429847,0.0004509793,0.0004759463,0.00079100055,0.00013055526,0.00016542456,0.0003565005,0.0005742448,0.0035281025],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016593571,0.0019691908,0.001535623,0.37132096,0.0009606596,0.000005152318,0.012880784,0.03305178,2.839659e-7,0.20885253,0.20840374,0.16085337],"study_design_scores_gemma":[0.0002677213,0.00034237013,0.000046699693,0.0022324112,0.000015980626,0.0000053703393,0.00015708835,0.0023044022,3.9208473e-8,0.00029828126,0.9939999,0.00032972224],"about_ca_topic_score_codex":0.012044299,"about_ca_topic_score_gemma":0.00010722347,"teacher_disagreement_score":0.7855962,"about_ca_system_score_codex":0.0020326609,"about_ca_system_score_gemma":0.0027745306,"threshold_uncertainty_score":0.9999226},"labels":[],"label_agreement":null},{"id":"W4283511755","doi":"10.1016/j.jval.2022.04.219","title":"CO123 Characterizing Key Clinical Outcomes Among Patients with Duchenne Muscular Dystrophy (DMD): Results from a 20-Year Population-Based Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba; University of Calgary; Vancouver Coastal Health","funders":"","keywords":"Duchenne muscular dystrophy; Medicine; Muscular dystrophy; Population; Weakness; Key (lock); Physical medicine and rehabilitation; Pediatrics; Physical therapy; Internal medicine; Surgery; Computer science; Environmental health","score_opus":0.021409717025830253,"score_gpt":0.2878411933165251,"score_spread":0.2664314762906948,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283511755","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9983774,0.00003329132,0.000017095283,0.0002582492,0.00026026173,0.0007137538,0.00030987285,0.000016646387,0.000013432793],"genre_scores_gemma":[0.99614716,0.0000058286087,0.00023315793,0.0007831666,0.00006917231,0.00007510353,0.002646052,0.000025353755,0.0000150122505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99738723,0.00085674884,0.00063602225,0.00059262867,0.00022530564,0.0003020914],"domain_scores_gemma":[0.99894935,0.00010087215,0.00030881548,0.000490477,0.000039867646,0.000110631576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065011246,0.00017204987,0.00033278848,0.00006651516,0.00022142158,0.000010701678,0.00019368032,0.00008220977,0.000023893364],"category_scores_gemma":[0.00019004803,0.00015737976,0.00009186741,0.00013513182,0.000039307615,0.0000056935005,0.0001113663,0.0002787197,0.0000028029892],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012853029,0.000990115,0.9906217,0.000010694549,0.00005317387,0.0000031639477,0.00013790432,0.0065914188,0.000077736586,0.0000042017737,0.00006100738,0.00016360931],"study_design_scores_gemma":[0.0055017225,0.0019241711,0.9914935,0.0000128485535,0.0000104414585,5.436549e-8,0.00021578193,0.00027859732,0.000006226425,0.000023710654,0.00036387017,0.00016904627],"about_ca_topic_score_codex":0.008811151,"about_ca_topic_score_gemma":0.0004131179,"teacher_disagreement_score":0.008398033,"about_ca_system_score_codex":0.000050085742,"about_ca_system_score_gemma":0.0001679652,"threshold_uncertainty_score":0.99778926},"labels":[],"label_agreement":null},{"id":"W4283511847","doi":"10.1016/j.jval.2022.04.1440","title":"PCR97 Discrete Choice Experiment Vs. Best-Worst Scaling: An Empirical Comparison in Measuring Treatment Preference of Lung Cancer Patients","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Mixed logit; Multinomial logistic regression; Preference; Lung cancer; Medicine; Statistics; Ordered logit; Random effects model; Demography; Logistic regression; Mathematics; Internal medicine; Meta-analysis","score_opus":0.3568688916061442,"score_gpt":0.3480348468592822,"score_spread":0.008834044746862002,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283511847","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609464,0.0024525246,0.000039884933,0.00023016396,0.0002542941,0.0005374511,0.00011830936,0.0000075727344,0.00026517338],"genre_scores_gemma":[0.9989173,0.0003868274,0.00019099923,0.0000948882,0.000026594567,0.0002765695,0.000051708226,0.000018107175,0.000037005255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981002,0.00012588922,0.0009914417,0.00042016196,0.000072873176,0.00028942456],"domain_scores_gemma":[0.9992018,0.000047667345,0.0004380807,0.00021559828,0.0000040643245,0.000092838956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060010253,0.00013577836,0.00045404094,0.00019235382,0.00010647837,0.0000114671675,0.00015052277,0.000037689984,0.00024014493],"category_scores_gemma":[0.000016048132,0.00016393086,0.00004751524,0.00015115443,0.000025031226,0.00014182314,0.00007981851,0.00014130888,0.000008740421],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027218082,0.00072206144,0.85527724,0.00003276088,0.000008059558,1.5056966e-7,0.0041084765,0.13882668,0.0000018292088,0.00032828667,0.0000114966815,0.0006557531],"study_design_scores_gemma":[0.0012463692,0.0005693553,0.863062,0.000041795247,0.0000023629873,1.18819344e-7,0.00036126433,0.13368978,0.000066270826,0.0002131014,0.00059435534,0.00015321442],"about_ca_topic_score_codex":0.035471663,"about_ca_topic_score_gemma":0.0005600123,"teacher_disagreement_score":0.03491165,"about_ca_system_score_codex":0.003229082,"about_ca_system_score_gemma":0.00006395482,"threshold_uncertainty_score":0.9709512},"labels":[],"label_agreement":null},{"id":"W4283512297","doi":"10.1016/j.jval.2022.04.982","title":"HPR56 Challenges of Funding Orphan Medicinal Products in Canada: Quantification of Approval Rate and Reimbursement","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Medicine; Reimbursement; Drug approval; European union; Family medicine; Business; Health care; Drug; Political science; Pharmacology","score_opus":0.5454051307329327,"score_gpt":0.40045133446491277,"score_spread":0.14495379626801996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283512297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90831286,0.020318652,0.00009693038,0.069386184,0.00055630127,0.0009743745,0.00012524411,0.000005600266,0.00022385266],"genre_scores_gemma":[0.99724674,0.0012890717,0.00064267503,0.0006337763,0.00004969327,0.000088064575,0.000015227497,0.0000128328375,0.000021941347],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9946622,0.00090446987,0.0035582066,0.00043061047,0.00013564149,0.00030886085],"domain_scores_gemma":[0.9968871,0.0005192052,0.0021778843,0.00030170183,0.000030468358,0.00008367669],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.030246068,0.000096775184,0.0007542225,0.00044177912,0.00007735673,0.0000036053864,0.00014970348,0.000026869511,0.000042175372],"category_scores_gemma":[0.0012001268,0.00013235079,0.000017463799,0.00030698747,0.000035447756,0.00009128422,0.000052504514,0.00017379355,0.0000023340574],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011038479,0.000430702,0.32873884,0.010782326,0.000052100866,0.000003798902,0.018951204,0.042994462,0.00005618992,0.5915072,0.0021804257,0.0041923705],"study_design_scores_gemma":[0.0032190136,0.00082408934,0.82356805,0.0008434824,0.0000061879787,0.000015204064,0.042442862,0.097328536,0.00011153638,0.016284775,0.01476908,0.00058719993],"about_ca_topic_score_codex":0.8453459,"about_ca_topic_score_gemma":0.27115047,"teacher_disagreement_score":0.57522243,"about_ca_system_score_codex":0.0021003056,"about_ca_system_score_gemma":0.002024922,"threshold_uncertainty_score":0.99856573},"labels":[],"label_agreement":null},{"id":"W4283512920","doi":"10.1016/j.jval.2022.04.733","title":"EE486 A Cost-Effectiveness Analysis of Azithromycin for the Prevention of Acute Exacerbations of Chronic Obstructive Pulmonary Disease","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Azithromycin; Medicine; Exacerbation; COPD; Guideline; Intensive care medicine; Cost effectiveness; Adverse effect; Internal medicine; Quality of life (healthcare); Quality-adjusted life year; Antibiotics; Pathology","score_opus":0.04916303242893981,"score_gpt":0.37226190545767857,"score_spread":0.32309887302873874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283512920","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820575,0.006284854,0.0022111975,0.00069929083,0.00013685042,0.006169649,0.00236379,0.0000137499155,0.000063112006],"genre_scores_gemma":[0.99762464,0.00028492667,0.00017632345,0.00001426869,0.00003524906,0.0013906308,0.00034433164,0.000025816847,0.000103804145],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9969818,0.000875274,0.00074009097,0.00038560087,0.0006746596,0.00034260104],"domain_scores_gemma":[0.997372,0.001084859,0.00049428246,0.0006182244,0.00026262488,0.0001680476],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013871976,0.00015218298,0.0007263094,0.0007028702,0.00016950622,0.0000026156831,0.00022479601,0.000035644734,0.00022324167],"category_scores_gemma":[0.00017862648,0.00013373481,0.0004515739,0.00241706,0.0002617502,0.00007821893,0.00016261793,0.00025358668,3.3337594e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010415661,0.006622678,0.43210295,0.018135991,0.007777899,0.000054756827,0.002008667,0.43558258,0.0061601847,0.011985689,0.00006968749,0.06908327],"study_design_scores_gemma":[0.0013763746,0.00052417384,0.8196492,0.00020168998,0.0015424973,0.0000049849496,0.0006207999,0.1743401,0.00028499233,0.0012587984,0.000116653566,0.000079697566],"about_ca_topic_score_codex":0.0020970942,"about_ca_topic_score_gemma":0.000039494647,"teacher_disagreement_score":0.3875463,"about_ca_system_score_codex":0.0018277145,"about_ca_system_score_gemma":0.002621833,"threshold_uncertainty_score":0.5453547},"labels":[],"label_agreement":null},{"id":"W4283512986","doi":"10.1016/j.jval.2022.04.781","title":"EPH28 Impact of COVID19 on Mental Health - Focus on Depression & Anxiety","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 and Mental Health","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Anxiety; Pandemic; Mental health; Population; Depression (economics); Psychiatry; Inclusion and exclusion criteria; Medicine; Demography; Psychology; Coronavirus disease 2019 (COVID-19); Disease; Environmental health; Internal medicine; Alternative medicine; Pathology","score_opus":0.10393384563019542,"score_gpt":0.4633761492619452,"score_spread":0.3594423036317498,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283512986","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.983614,0.0023210638,0.00002811073,0.007656943,0.0015831606,0.0017056542,0.00068667385,0.000076509554,0.0023278366],"genre_scores_gemma":[0.9920094,0.00052664895,0.000092778944,0.0066598025,0.00009114073,0.0001096177,0.0001294973,0.0000435013,0.00033762914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955244,0.0016035559,0.0008287411,0.00061775063,0.0005666011,0.000858961],"domain_scores_gemma":[0.99807805,0.0003252559,0.00048054958,0.00067386375,0.000012106639,0.0004301629],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0020537362,0.0002443679,0.00052470923,0.00038171269,0.00043568888,0.000006035736,0.00027178117,0.000074758376,0.001315901],"category_scores_gemma":[0.000029389197,0.00022721679,0.00017982678,0.0005226791,0.000041901607,0.000037250105,0.00012560205,0.0006987908,0.000097546916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009688757,0.010102291,0.4727968,0.0012997815,0.00010969014,0.000027533153,0.044518948,0.02095438,0.0002692807,0.012815963,0.18447475,0.24294183],"study_design_scores_gemma":[0.014659803,0.033134803,0.68602294,0.0010719302,0.000010118234,0.0001662723,0.0033090734,0.0013164385,0.00014275078,0.0029441887,0.2562193,0.0010024001],"about_ca_topic_score_codex":0.17025812,"about_ca_topic_score_gemma":0.000744619,"teacher_disagreement_score":0.24193943,"about_ca_system_score_codex":0.0060228156,"about_ca_system_score_gemma":0.0021884346,"threshold_uncertainty_score":0.999597},"labels":[],"label_agreement":null},{"id":"W4283513648","doi":"10.1016/j.jval.2022.04.586","title":"EE341 Hospital Costs Associated with Cataract, Glaucoma, Vitreoretinal, and Laser Refractive Surgeries: A Targeted Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Imaging and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Trabeculectomy; Cataract surgery; Vitrectomy; Glaucoma; Optometry; Ophthalmology; Phacoemulsification; Indirect costs; Glaucoma surgery; Surgery; Visual acuity","score_opus":0.010789554767928424,"score_gpt":0.27172226699308294,"score_spread":0.2609327122251545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283513648","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90131444,0.06785902,0.0000031907257,0.029795056,0.00006701558,0.0006039078,0.00011360113,0.000059199338,0.00018458955],"genre_scores_gemma":[0.96960306,0.023499478,0.00021567146,0.005335663,0.000043820954,0.00008653007,0.0006752696,0.000034380715,0.00050614896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99770594,0.00065619126,0.0004203839,0.00040689434,0.0004393512,0.00037127093],"domain_scores_gemma":[0.9988006,0.00026390265,0.00032230257,0.00026559312,0.00014032017,0.00020728096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013259077,0.00019584308,0.00068295223,0.00019630641,0.0002178529,0.000028744105,0.00007099891,0.0000378631,0.000075667784],"category_scores_gemma":[0.00054996344,0.00015681282,0.00008176957,0.0012906841,0.00007243305,0.000102561906,0.000051644012,0.00077198236,0.0000023545351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010029677,0.0016543041,0.9357484,0.005304374,0.00046706345,0.0032781656,0.0056435005,0.0000343221,0.00008676634,0.00012103994,0.040657867,0.0060012233],"study_design_scores_gemma":[0.0094011985,0.011631428,0.74813557,0.10869733,0.0011752321,0.0022340398,0.006836983,0.0075931847,0.00027211272,0.00030237515,0.10151567,0.0022048615],"about_ca_topic_score_codex":0.0022515315,"about_ca_topic_score_gemma":0.000024997413,"teacher_disagreement_score":0.18761283,"about_ca_system_score_codex":0.0005119475,"about_ca_system_score_gemma":0.00035035072,"threshold_uncertainty_score":0.63946414},"labels":[],"label_agreement":null},{"id":"W4283513966","doi":"10.1016/j.jval.2022.04.523","title":"EE277 Cost-Effectiveness Analysis of National Smoking Cessation Service Among Chronic Obstructive Pulmonary Disease (COPD) Patients in Thailand","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Smoking cessation; COPD; Psychological intervention; Cost effectiveness; Quality-adjusted life year; Economic evaluation; Cost-effectiveness analysis; Cost–utility analysis; Cost–benefit analysis; Multidisciplinary approach; Health economics; Willingness to pay; Physical therapy; Family medicine; Emergency medicine; Public health; Internal medicine; Psychiatry; Nursing","score_opus":0.22750096609301,"score_gpt":0.3906097163570932,"score_spread":0.1631087502640832,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283513966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931867,0.0010467354,0.00017490321,0.0019912252,0.00037089153,0.0014808831,0.0014407716,0.000015104339,0.00029275054],"genre_scores_gemma":[0.9975619,0.000052421143,0.00005010689,0.0010933115,0.000052514646,0.0005665009,0.00059136265,0.000021154032,0.000010736007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940705,0.0017383384,0.0029685486,0.0005812154,0.0002748707,0.00036653044],"domain_scores_gemma":[0.99588543,0.0013092763,0.0022654743,0.00028617342,0.00010670475,0.00014692731],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.015145154,0.00015588144,0.0008936418,0.0016384549,0.00020233037,0.000019239993,0.00023697993,0.00005955358,0.0002029663],"category_scores_gemma":[0.00096195255,0.000226972,0.00010630524,0.0020357186,0.000036345686,0.00041329002,0.00009855264,0.00026891468,0.000011525782],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045525656,0.00015420045,0.64224494,0.0004752919,0.000049250317,5.5209756e-7,0.0009882221,0.3516126,7.3835395e-8,0.0043419898,0.000018484167,0.000068875925],"study_design_scores_gemma":[0.00065796566,0.00004378455,0.7620386,0.000073790405,0.000008530864,1.2834768e-7,0.00034838656,0.23214228,2.0837871e-7,0.004300487,0.00025131382,0.00013455238],"about_ca_topic_score_codex":0.043655,"about_ca_topic_score_gemma":0.0023445217,"teacher_disagreement_score":0.11979364,"about_ca_system_score_codex":0.006532059,"about_ca_system_score_gemma":0.0007471742,"threshold_uncertainty_score":0.9972817},"labels":[],"label_agreement":null},{"id":"W4283514070","doi":"10.1016/j.jval.2022.04.751","title":"EE505 Canada's Evolving Market for Biosimilars and What It Means for Payers","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Business; Public economics; Medicine; Economics","score_opus":0.03955446445295664,"score_gpt":0.3009156528136979,"score_spread":0.2613611883607413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283514070","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.057372693,0.17561458,0.0074076247,0.72755873,0.015439641,0.010902316,0.004206809,0.00018578711,0.001311797],"genre_scores_gemma":[0.8092,0.008568797,0.0447749,0.12731907,0.000243281,0.0015049971,0.0002992132,0.0001625722,0.0079271775],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982402,0.0004673156,0.0003712102,0.00034180545,0.000045561334,0.0005339057],"domain_scores_gemma":[0.9985007,0.0011409747,0.000107760374,0.0001625847,0.00003338947,0.00005461147],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019487138,0.00013448171,0.00032181345,0.00008810923,0.00043170273,0.000024646732,0.00015397526,0.00009357765,0.00032328043],"category_scores_gemma":[0.00026748434,0.0001246972,0.000063422944,0.00014457197,0.00006974053,0.00006850358,0.00008664342,0.00024244687,2.2646806e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00097521296,0.00022561378,0.0032842064,0.00091475487,0.00022371308,0.0000066662938,0.00094549754,0.0003233835,0.0022370557,0.0027091731,0.9033391,0.08481563],"study_design_scores_gemma":[0.001694455,0.00066870684,0.0014476241,0.000098212135,0.00002776337,0.000025156252,0.003589297,0.0054544006,0.0006129498,0.0013208914,0.9848077,0.00025278822],"about_ca_topic_score_codex":0.055891085,"about_ca_topic_score_gemma":0.048157636,"teacher_disagreement_score":0.7518273,"about_ca_system_score_codex":0.0003249245,"about_ca_system_score_gemma":0.00061401166,"threshold_uncertainty_score":0.969211},"labels":[],"label_agreement":null},{"id":"W4283514695","doi":"10.1016/j.jval.2022.04.300","title":"EE46 Venetoclax in Combination with Azacitidine Is Cost-Effective Vs. AZA for the Treatment of Newly Diagnosed Acute Myeloid Leukemia: A Canadian Perspective","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; Princess Margaret Cancer Centre; ABB (Canada)","funders":"","keywords":"Azacitidine; Venetoclax; Myeloid leukemia; Medicine; Perspective (graphical); Oncology; Internal medicine; Leukemia; Intensive care medicine; Computer science","score_opus":0.03141783833154448,"score_gpt":0.32722244076908236,"score_spread":0.29580460243753787,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283514695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9473761,0.0016770576,0.00014898843,0.03047181,0.00013221113,0.019380081,0.00054099545,0.00002612858,0.00024666602],"genre_scores_gemma":[0.9879634,0.0017887474,0.0003833915,0.0015153446,0.00006775508,0.007966752,0.000106985986,0.000051622512,0.00015602268],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.997559,0.0004509407,0.00039315256,0.00045167384,0.00045795314,0.0006872743],"domain_scores_gemma":[0.99768764,0.00126227,0.00016469593,0.00039959903,0.00020171472,0.0002840986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009579683,0.00022031563,0.0005681028,0.0006356691,0.00026916564,0.000011348028,0.00018028151,0.000082534774,0.000057128465],"category_scores_gemma":[0.00015730847,0.00016597369,0.00009242381,0.0010818964,0.000126736,0.00005887654,0.000033281172,0.0005103146,0.000002863217],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.046089485,0.005992714,0.13835578,0.0020631184,0.0030851667,0.0041718353,0.38282034,0.16251566,0.00054054166,0.031053698,0.023144562,0.20016712],"study_design_scores_gemma":[0.11713257,0.09239077,0.3883028,0.0008316566,0.00046158247,0.0005271284,0.04651425,0.27701706,0.0029224942,0.0036931175,0.069204554,0.0010020254],"about_ca_topic_score_codex":0.7733429,"about_ca_topic_score_gemma":0.13451108,"teacher_disagreement_score":0.63883185,"about_ca_system_score_codex":0.056243476,"about_ca_system_score_gemma":0.010613801,"threshold_uncertainty_score":0.9949951},"labels":[],"label_agreement":null},{"id":"W4283514875","doi":"10.1016/j.jval.2022.04.1609","title":"RWD85 Uptake and Utilization Trends of Direct-Acting Antivirals (DAA) for Hepatitis-C in Manitoba, Canada between 1999 and 2019","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada; University of Manitoba","funders":"","keywords":"Sofosbuvir; Medicine; Medical prescription; Ledipasvir; Internal medicine; Population; Hepatitis C; Chronic hepatitis; Pediatrics; Demography; Virology; Ribavirin; Environmental health; Pharmacology; Virus","score_opus":0.14514847872305828,"score_gpt":0.36510712310036464,"score_spread":0.21995864437730636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283514875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949019,0.0016887499,0.000019520214,0.0015020117,0.00007978467,0.0006519924,0.00038921283,0.0000096781905,0.0007571495],"genre_scores_gemma":[0.99809927,0.001086304,0.0002842183,0.00018111315,0.000042925734,0.00005296829,0.00011482465,0.000020775862,0.00011761285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983183,0.0002752729,0.00047865577,0.00024681652,0.00035027612,0.0003306654],"domain_scores_gemma":[0.9992299,0.00036179554,0.00012540443,0.00013335352,0.000032536936,0.00011699892],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011646987,0.000091461334,0.00039803368,0.00035861507,0.00010304605,0.0000070735373,0.000050735154,0.000034458106,0.000023516668],"category_scores_gemma":[0.00026383714,0.000102317674,0.00001605228,0.00048549104,0.000030244866,0.000054880213,0.00006538515,0.00021247544,1.3384275e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003868185,0.000027856346,0.81819767,0.000376744,0.000007925085,0.000011324833,0.00041805932,0.000058674766,0.00003639196,0.000039276605,0.0010348356,0.17975256],"study_design_scores_gemma":[0.0014606216,0.0005531018,0.9533671,0.0002068781,0.0000067495794,0.0000031412014,0.00034433365,0.009656017,0.00013485833,0.000051013245,0.034114286,0.00010188421],"about_ca_topic_score_codex":0.92979103,"about_ca_topic_score_gemma":0.7268707,"teacher_disagreement_score":0.20292027,"about_ca_system_score_codex":0.00051376247,"about_ca_system_score_gemma":0.00083749514,"threshold_uncertainty_score":0.41723937},"labels":[],"label_agreement":null},{"id":"W4283515283","doi":"10.1016/j.jval.2022.04.1714","title":"SA48 Patient Impact and Economic Burden of Waiting for Cataract Surgery in Canada: A Targeted Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cataract surgery; Medicine; Optometry; Surgery","score_opus":0.061970840104955294,"score_gpt":0.39238078665227666,"score_spread":0.33040994654732136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283515283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8329297,0.15534581,2.4884085e-7,0.00729324,0.00067748904,0.002424136,0.0012910281,0.000011409927,0.000026978558],"genre_scores_gemma":[0.9768062,0.019115781,0.0001036137,0.0032270548,0.0000889648,0.0003800835,0.00024239527,0.000025400728,0.000010479215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99541605,0.001622683,0.0016233606,0.00032519744,0.00020875857,0.00080394826],"domain_scores_gemma":[0.99663925,0.0020438863,0.00076165056,0.00025579784,0.00007006788,0.00022936724],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002952335,0.0001655508,0.00084207865,0.00021196579,0.0002879525,0.000002649275,0.00011562901,0.000059176182,0.00009986597],"category_scores_gemma":[0.0005029118,0.00016210412,0.00006503594,0.00037483926,0.000011443227,0.00006978189,0.00011296609,0.0006709309,0.000001928362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00056615804,0.000115527735,0.5974829,0.0943973,0.000038388873,0.000104491024,0.026207518,0.012996134,0.000005926017,0.00068837515,0.25038585,0.017011398],"study_design_scores_gemma":[0.0040897196,0.0017388288,0.5213627,0.12478713,0.00003828804,0.000093602735,0.027490705,0.050788462,0.000009183335,0.0012262738,0.26690748,0.0014676239],"about_ca_topic_score_codex":0.98369026,"about_ca_topic_score_gemma":0.68253404,"teacher_disagreement_score":0.30115625,"about_ca_system_score_codex":0.005925493,"about_ca_system_score_gemma":0.014681158,"threshold_uncertainty_score":0.9978906},"labels":[],"label_agreement":null},{"id":"W4283515389","doi":"10.1016/j.jval.2022.04.1172","title":"HTA40 Challenges in Evaluating and Paying for Combination Therapies in Oncology - a Canadian Perspective","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Amgen (Canada)","funders":"","keywords":"Perspective (graphical); Medicine; Oncology; Medical physics; Internal medicine; Computer science; Artificial intelligence","score_opus":0.6811056705381711,"score_gpt":0.4993283717805609,"score_spread":0.18177729875761017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283515389","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7052015,0.029261213,0.000033532546,0.2617342,0.0003758325,0.0019528741,0.00011904279,0.000012728393,0.0013090689],"genre_scores_gemma":[0.99079984,0.0013436079,0.0012859908,0.0056088516,0.000049944916,0.0008569639,0.000013399111,0.000021508817,0.000019901743],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9953966,0.0014443891,0.0021175782,0.00049420266,0.000058634323,0.0004885598],"domain_scores_gemma":[0.99701214,0.0018494673,0.00081619935,0.00016696416,0.000030815543,0.00012441016],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.039770495,0.000110206245,0.0006676475,0.0011638829,0.00024523467,0.000018987048,0.00012907459,0.000075260585,0.000052749616],"category_scores_gemma":[0.0024820277,0.00016419428,0.000029433366,0.00027043762,0.000027635006,0.00016883745,0.00003585332,0.00028988422,0.000008319035],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034791596,0.00017523975,0.096806705,0.00042136747,0.000012770665,0.0000021625253,0.12682061,0.009815759,4.8786904e-7,0.76101226,0.00023282772,0.0046650474],"study_design_scores_gemma":[0.004046373,0.0011160509,0.22709249,0.00014708206,0.0000011893543,0.000008944232,0.15292932,0.21551864,1.7190149e-7,0.3845792,0.014206578,0.0003539586],"about_ca_topic_score_codex":0.5839089,"about_ca_topic_score_gemma":0.37207976,"teacher_disagreement_score":0.37643304,"about_ca_system_score_codex":0.009280577,"about_ca_system_score_gemma":0.0013000251,"threshold_uncertainty_score":0.99452263},"labels":[],"label_agreement":null},{"id":"W4283515565","doi":"10.1016/j.jval.2022.04.712","title":"EE464 The Cost-Effectiveness of Subcutaneous Semaglutide 2.4MG Injection in the Management of Obesity in Canada Using the Core Obesity Model","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Semaglutide; Obesity; Core (optical fiber); Medicine; Management of obesity; Internal medicine; Computer science; Endocrinology; Diabetes mellitus; Weight loss; Type 2 diabetes; Telecommunications","score_opus":0.06628811665079676,"score_gpt":0.30435177880656766,"score_spread":0.2380636621557709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283515565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99529994,0.00044203066,0.00007905003,0.00053589017,0.00012473887,0.0031955289,0.000018395787,0.0000051367065,0.00029931316],"genre_scores_gemma":[0.99919015,0.000098279204,0.00009398723,0.0003481387,0.0000068659256,0.00021264901,0.0000105028585,0.000009816585,0.000029612853],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9978895,0.0007664976,0.0003953854,0.00019560906,0.0004686161,0.0002843875],"domain_scores_gemma":[0.9990792,0.00030524604,0.00017610037,0.00039084407,0.00002172813,0.000026861899],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00257597,0.00011829024,0.000307036,0.000114535265,0.00013306386,0.0000037161174,0.00021412125,0.000016445421,0.000007298662],"category_scores_gemma":[0.000013100124,0.000071837625,0.000043880274,0.00067538203,0.000040549818,0.0000201481,0.00014729664,0.00026304126,1.486109e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025912502,0.00045063175,0.2026282,0.0010830032,0.00005578126,0.000104047904,0.0014057516,0.78969395,0.000016784605,0.0024706011,0.000056591987,0.0017755209],"study_design_scores_gemma":[0.0020933603,0.00055794517,0.5287701,0.0006585668,0.00011280529,0.000036684978,0.0088896165,0.45683545,0.00007336192,0.0017020494,0.0001479695,0.00012207103],"about_ca_topic_score_codex":0.8560611,"about_ca_topic_score_gemma":0.35245496,"teacher_disagreement_score":0.50360614,"about_ca_system_score_codex":0.0030602997,"about_ca_system_score_gemma":0.00071718014,"threshold_uncertainty_score":0.80025774},"labels":[],"label_agreement":null},{"id":"W4283515634","doi":"10.1016/j.jval.2022.04.949","title":"HPR23 Analysis of Patient Turnover Data and Patient and Medical Delay Data of Lung Cancer Patients between 2016-2020","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Quarter (Canadian coin); Lung cancer; Medical record; Medical care; Internal medicine; Pediatrics; Emergency medicine","score_opus":0.05772208341555722,"score_gpt":0.3025960606320201,"score_spread":0.24487397721646287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283515634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96487325,0.016569365,0.00006674645,0.00073603267,0.00024355599,0.0002788433,0.017089099,0.0000039846423,0.0001390923],"genre_scores_gemma":[0.9953676,0.0034844342,0.0001334239,0.00039975438,0.000031143034,0.000012606976,0.00055016787,0.000014460613,0.0000064040564],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99763167,0.00006356811,0.0013314526,0.0005772565,0.00012655099,0.0002694803],"domain_scores_gemma":[0.99789655,0.00014860801,0.0009815652,0.00077279145,0.000024184608,0.00017631524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001026256,0.00012545615,0.00079707184,0.00033051625,0.00007749939,0.0000109174825,0.0005212561,0.00006306906,0.00032057517],"category_scores_gemma":[0.00024084358,0.00014230785,0.000035913105,0.00048899435,0.000084016945,0.0002654045,0.0012619859,0.00020366185,7.3172697e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029717334,0.00012219264,0.9770648,0.00009786212,0.00022442528,9.065395e-7,0.001144085,0.0010871505,6.559069e-8,0.0008587415,0.002695341,0.016674746],"study_design_scores_gemma":[0.001160643,0.00044677363,0.8363263,0.00009189976,0.00009673926,6.696989e-7,0.0001524047,0.12555203,0.0000015677781,0.00069362787,0.035191905,0.00028544708],"about_ca_topic_score_codex":0.02750193,"about_ca_topic_score_gemma":0.0005652299,"teacher_disagreement_score":0.14073849,"about_ca_system_score_codex":0.00020374118,"about_ca_system_score_gemma":0.00025485337,"threshold_uncertainty_score":0.97897404},"labels":[],"label_agreement":null},{"id":"W4283516150","doi":"10.1016/j.jval.2022.04.1560","title":"RWD36 Challenges with Identification of Cancer Chemotherapy Regimens and Patient Cohorts in Administrative Claims","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"","keywords":"Identification (biology); Medicine; Cancer chemotherapy; Chemotherapy; Oncology; Family medicine; Internal medicine","score_opus":0.0666314164350095,"score_gpt":0.29037583119194266,"score_spread":0.22374441475693316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283516150","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9700872,0.022948029,0.00001894907,0.005042391,0.00013877782,0.0004091645,0.00013839087,0.0000057168945,0.0012114351],"genre_scores_gemma":[0.9882069,0.011140735,0.00008099792,0.00035126065,0.000016036598,0.00013153156,0.0000034931334,0.0000137080515,0.000055322645],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987692,0.000033294582,0.0006756972,0.00029217705,0.0000336774,0.0001959433],"domain_scores_gemma":[0.9991434,0.00003400864,0.00060217845,0.00015951054,0.000012012397,0.00004887516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056210463,0.00008838664,0.00035777138,0.00018477076,0.000053418607,0.000008469198,0.00007428256,0.000031581247,0.000063121624],"category_scores_gemma":[0.000012247011,0.00010351747,0.000018817616,0.00015515745,0.000049060433,0.00010108069,0.000021724629,0.00013693729,0.0000013947594],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00055204,0.00062409724,0.56379116,0.00039386915,0.00006206678,0.00000899488,0.03804155,0.017816724,0.000019604482,0.32164186,0.00035744454,0.05669059],"study_design_scores_gemma":[0.0018726521,0.0012837397,0.9410112,0.00012101558,0.0000018903094,0.0000053704516,0.0027813378,0.003043001,0.00015544984,0.030340178,0.019055061,0.00032909887],"about_ca_topic_score_codex":0.0068736877,"about_ca_topic_score_gemma":0.000852817,"teacher_disagreement_score":0.37722003,"about_ca_system_score_codex":0.0004210396,"about_ca_system_score_gemma":0.00015940508,"threshold_uncertainty_score":0.99973965},"labels":[],"label_agreement":null},{"id":"W4283516214","doi":"10.1016/j.jval.2022.04.1025","title":"HSD23 Using Natural Language Processing of Unstructured EMR Data to Describe Canadian Patients with ASCVD","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Aortic Thrombus and Embolism","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; St. Michael's Hospital; University of Regina; Novartis (Canada)","funders":"","keywords":"Electronic medical record; Computer science; Medical record; Natural language processing; Epidemiology; Artificial intelligence; Data science; Medicine; Internal medicine; Internet privacy","score_opus":0.06000136648612014,"score_gpt":0.32111070762740707,"score_spread":0.2611093411412869,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283516214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974979,0.00075709267,0.000019135583,0.00083280576,0.00018707954,0.0004702843,0.00017295501,0.000012641556,0.000050083752],"genre_scores_gemma":[0.99350893,0.0000016811827,0.0048044985,0.001382924,0.000047601956,0.0000033944377,0.00020851307,0.000021138507,0.000021300888],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99875516,0.00006748297,0.00027378186,0.00024000427,0.00031061287,0.00035295516],"domain_scores_gemma":[0.9992177,0.0000119200795,0.00010037271,0.00036993116,0.000042659212,0.00025740065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000278168,0.00009123026,0.00026176983,0.00019646577,0.0001461407,0.000006991513,0.00016927053,0.000022306067,0.00005357816],"category_scores_gemma":[0.00006448026,0.00007712604,0.000011771571,0.00044947115,0.000023703717,0.00006534026,0.00010048373,0.000242865,5.94398e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008043497,0.00044252284,0.78001946,0.0022277199,0.00009496357,0.000237382,0.061216906,0.018823093,0.0005918929,0.00019991478,0.0027716802,0.1325701],"study_design_scores_gemma":[0.003280882,0.0007336314,0.9273512,0.0009050837,0.000055122367,0.00008656817,0.007002533,0.05736129,0.000049837516,0.00003314258,0.002804446,0.00033631016],"about_ca_topic_score_codex":0.42286068,"about_ca_topic_score_gemma":0.031368427,"teacher_disagreement_score":0.39149228,"about_ca_system_score_codex":0.00047955438,"about_ca_system_score_gemma":0.0017543834,"threshold_uncertainty_score":0.98630655},"labels":[],"label_agreement":null},{"id":"W4283516257","doi":"10.1016/j.jval.2022.04.601","title":"EE353 The Economic Burden of Anticholinergic Use in Adults with Overactive Bladder in the United States: A Systematic Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Anticholinergic; Overactive bladder; Medicine; Urology; Intensive care medicine; Internal medicine; Alternative medicine; Pathology","score_opus":0.04646744997891307,"score_gpt":0.3342320079571843,"score_spread":0.2877645579782712,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283516257","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92631,0.05541802,0.000001052077,0.013102156,0.000036579255,0.0049301614,0.000098133554,0.000008139001,0.00009574896],"genre_scores_gemma":[0.92415506,0.07274715,0.000027669548,0.002375683,0.00002798803,0.00036826814,0.00019714555,0.000020568017,0.00008046701],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957629,0.002573427,0.00069771335,0.00024028699,0.00039141937,0.00033423936],"domain_scores_gemma":[0.9980426,0.001134544,0.00021692981,0.00048901583,0.00005762987,0.00005932165],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003368371,0.00013952973,0.00054250297,0.00039159352,0.00006825703,0.000021173966,0.00021901075,0.000028079208,0.000041388197],"category_scores_gemma":[0.00016598897,0.00007320335,0.000043424974,0.001426446,0.000046609744,0.000098799566,0.00006348881,0.00093067944,0.0000027178032],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052298354,0.0012575279,0.026744844,0.51587945,0.00023348708,0.0018691745,0.24972104,0.19409065,0.000005817179,0.0012203908,0.0035230059,0.00022477243],"study_design_scores_gemma":[0.014956444,0.009452925,0.03462133,0.6258136,0.00016693446,0.0023907458,0.065983,0.24001548,0.000008084209,0.00055206456,0.0053843814,0.00065500796],"about_ca_topic_score_codex":0.017482568,"about_ca_topic_score_gemma":0.00027729286,"teacher_disagreement_score":0.18373804,"about_ca_system_score_codex":0.00041474515,"about_ca_system_score_gemma":0.0006293806,"threshold_uncertainty_score":0.9890601},"labels":[],"label_agreement":null},{"id":"W4283516308","doi":"10.1016/j.jval.2022.04.177","title":"CO80 Canada National and Provincial Cataract Surgery Wait Times (2017-2021): A Targeted Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal and Optic Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alcon (Canada)","funders":"","keywords":"Medicine; Percentile; Cataract surgery; Coronavirus disease 2019 (COVID-19); Government (linguistics); Family medicine; Demography; Surgery; Internal medicine","score_opus":0.026196942901740235,"score_gpt":0.2794340714533809,"score_spread":0.25323712855164066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283516308","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.34521714,0.40158227,0.000003548589,0.24290965,0.0011361772,0.0028406903,0.0024288984,0.000055606688,0.0038260247],"genre_scores_gemma":[0.92222947,0.03230452,0.0003619681,0.03483725,0.00063692016,0.00031853665,0.0034827353,0.00003300159,0.0057955855],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99869734,0.00017162997,0.0003282109,0.00018802196,0.00041746866,0.00019732676],"domain_scores_gemma":[0.9993405,0.00023402149,0.00010229824,0.000100072415,0.000082455495,0.00014068329],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00075975736,0.00008495939,0.00028549618,0.00009656799,0.00017432366,0.000008291676,0.00003883129,0.00001972145,0.0007620259],"category_scores_gemma":[0.0003543268,0.000076195574,0.000037164635,0.00036112138,0.00001740192,0.00003607855,0.000033415858,0.0003175676,0.0000034597836],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010552766,0.00018716189,0.010309091,0.0060971873,0.000031033447,0.00070013106,0.00041196568,0.000054272437,0.00001278028,0.0025388778,0.9746019,0.0049500475],"study_design_scores_gemma":[0.0008338423,0.00034462145,0.15288295,0.0071652313,0.000041798765,0.0017558542,0.00014893175,0.0022695265,0.000005925579,0.00069521164,0.83352894,0.0003271573],"about_ca_topic_score_codex":0.21292192,"about_ca_topic_score_gemma":0.024675557,"teacher_disagreement_score":0.57701236,"about_ca_system_score_codex":0.00044931594,"about_ca_system_score_gemma":0.006939173,"threshold_uncertainty_score":0.99869055},"labels":[],"label_agreement":null},{"id":"W4283516611","doi":"10.1016/j.jval.2022.04.416","title":"EE167 Use of Cost per Responder Models for CAR-T Therapies in Relapsed or Refractory Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Confidence interval; Internal medicine; Multiple myeloma; Hazard ratio; Adverse effect; Oncology; Pembrolizumab; Immunotherapy","score_opus":0.19992756430541408,"score_gpt":0.38641269888520613,"score_spread":0.18648513457979204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283516611","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204475,0.0014124868,0.00011629569,0.002851075,0.00016845728,0.0031693333,0.00012704598,0.00003207199,0.000078488745],"genre_scores_gemma":[0.98849225,0.0006002415,0.00230743,0.0011037833,0.000066290646,0.0006149328,0.000044552173,0.000079041914,0.006691499],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969556,0.00083474896,0.00067175337,0.0003799857,0.0006141672,0.00054374966],"domain_scores_gemma":[0.9971783,0.0018733249,0.00014996728,0.0005459481,0.00010416482,0.0001482951],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.002336476,0.00015607987,0.0005338838,0.0005968568,0.00010993026,0.000009639456,0.0001617691,0.000087213586,0.00094775896],"category_scores_gemma":[0.00045267635,0.00013733824,0.00010233161,0.00055565604,0.00007610483,0.00009399373,0.000087721215,0.0006279906,0.000002210762],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.16957392,0.00601166,0.11486866,0.004293541,0.00037602184,0.00033676645,0.11267618,0.25579885,0.2044747,0.0027052935,0.010473723,0.118410684],"study_design_scores_gemma":[0.039618175,0.01219333,0.057826072,0.0008678908,0.00002852452,0.00011498384,0.012942014,0.49318558,0.002415858,0.0019855471,0.37804607,0.00077595626],"about_ca_topic_score_codex":0.009124554,"about_ca_topic_score_gemma":0.0007088437,"teacher_disagreement_score":0.36757234,"about_ca_system_score_codex":0.0011375915,"about_ca_system_score_gemma":0.0013787951,"threshold_uncertainty_score":0.9999655},"labels":[],"label_agreement":null},{"id":"W4283518065","doi":"10.1016/j.jval.2022.04.264","title":"EE12 A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab As a First-Line, 12-Month, Fixed Duration Therapy in Chronic Lymphocytic Leukemia (CLL) in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada); Foothills Medical Centre","funders":"","keywords":"Obinutuzumab; Venetoclax; Medicine; Bendamustine; Fludarabine; Rituximab; Chlorambucil; Internal medicine; Ibrutinib; Population; Oncology; Chronic lymphocytic leukemia; Alemtuzumab; Cyclophosphamide; Leukemia; Chemotherapy; Lymphoma; Transplantation","score_opus":0.046311378443070615,"score_gpt":0.3219957015005659,"score_spread":0.2756843230574953,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283518065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926071,0.0031113445,0.000010677608,0.0001496778,0.00009213352,0.0039106603,0.000042901807,0.000015462687,0.000060004633],"genre_scores_gemma":[0.99725676,0.0011767413,0.000026751346,0.00016000337,0.000028757253,0.00117667,0.000105780455,0.000034989218,0.000033556043],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9956607,0.0010639207,0.0010753805,0.0006316034,0.0008500792,0.00071826496],"domain_scores_gemma":[0.9976134,0.0012811399,0.00027028064,0.00054473296,0.00007649811,0.0002139822],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0021281498,0.0002483566,0.0010543314,0.0010171985,0.000105341765,0.000012408103,0.000197417,0.00008552243,0.00010154019],"category_scores_gemma":[0.0005442722,0.0002519458,0.00008327063,0.0029891615,0.00008900964,0.00007237641,0.00012401899,0.00047523293,0.0000010181257],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.001963802,0.000052002822,0.018254371,0.0013998904,0.00012992474,0.00029191768,0.0012555602,0.97259915,0.000109698965,0.00012893588,0.000015567579,0.003799155],"study_design_scores_gemma":[0.022796173,0.0014018496,0.08630548,0.000444298,0.000047232705,0.00006763191,0.00030699017,0.8879925,0.00012350752,0.00014475865,0.00019563848,0.00017392896],"about_ca_topic_score_codex":0.9952351,"about_ca_topic_score_gemma":0.9696834,"teacher_disagreement_score":0.35674846,"about_ca_system_score_codex":0.73643667,"about_ca_system_score_gemma":0.3796882,"threshold_uncertainty_score":0.99999326},"labels":[],"label_agreement":null},{"id":"W4283518363","doi":"10.1016/j.jval.2022.04.285","title":"EE33 Evaluating the Economic Burden of Acute Myeloid Leukemia in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University Health Centre; Princess Margaret Cancer Centre; University of Manitoba; McMaster University; ABB (Canada)","funders":"","keywords":"Medicine; Myeloid leukemia; Total cost; Incidence (geometry); Health care; Productivity; Economic cost; Hematopoietic stem cell transplantation; Intensive care medicine; Transplantation; Emergency medicine; Internal medicine","score_opus":0.309785688474981,"score_gpt":0.4123878680048094,"score_spread":0.10260217952982842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283518363","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9565265,0.0026152916,0.000026735335,0.037009157,0.0010923519,0.0010871948,0.00064173725,0.000011775978,0.0009892338],"genre_scores_gemma":[0.9920469,0.00025692367,0.000540094,0.0064564613,0.00016929537,0.00026698044,0.000031728447,0.00003435987,0.00019728667],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9912519,0.0016491523,0.0056935693,0.0005644804,0.00018700665,0.00065392384],"domain_scores_gemma":[0.99480045,0.0016530108,0.0027652353,0.00063341216,0.000017151066,0.00013076942],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.033854894,0.00017467877,0.0010353412,0.00037882483,0.00027690604,0.000019445466,0.0006086486,0.000047216567,0.00066379196],"category_scores_gemma":[0.0006752691,0.00021360509,0.000078546356,0.0003490316,0.000040597417,0.00015962403,0.00017411596,0.00049688644,0.00009139294],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000029535608,0.000014220109,0.049002837,0.00026689877,0.000039878756,0.0000023544192,0.005412948,0.9074502,0.0000020108662,0.031241016,0.006028447,0.0005096296],"study_design_scores_gemma":[0.0016118935,0.00029991122,0.043414462,0.00012041648,0.000004863722,0.00001617054,0.008906088,0.9125883,0.0000030158426,0.012871931,0.01976291,0.00040003398],"about_ca_topic_score_codex":0.9926885,"about_ca_topic_score_gemma":0.61402875,"teacher_disagreement_score":0.3786597,"about_ca_system_score_codex":0.035143584,"about_ca_system_score_gemma":0.016359508,"threshold_uncertainty_score":0.9948497},"labels":[],"label_agreement":null},{"id":"W4283518383","doi":"10.1016/j.jval.2022.04.242","title":"CO148 Opioid Prescribing Among Commercially Insured Men Undergoing a Procedure for the Treatment Benign Prostatic Hyperplasia","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Urinary Bladder and Prostate Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Université de Montréal; Canadian Institute of Mining, Metallurgy and Petroleum","funders":"","keywords":"Medicine; Opioid; Opioid epidemic; Incidence (geometry); Hyperplasia; Benign prostatic hyperplasia (BPH); Prostate; Internal medicine","score_opus":0.07299414170132784,"score_gpt":0.34096830118201066,"score_spread":0.2679741594806828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283518383","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95772624,0.0065027727,0.00012332344,0.020346949,0.00022576569,0.013483278,0.00016777398,0.000103610386,0.0013203113],"genre_scores_gemma":[0.9940495,0.0012832284,0.00058026245,0.0005527534,0.00010295466,0.0022088815,0.00009691541,0.000050539238,0.0010750045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977154,0.00039753102,0.0004408863,0.00035064816,0.0004679179,0.0006276117],"domain_scores_gemma":[0.99834335,0.0009924916,0.00010991239,0.0003219925,0.00005069136,0.00018156234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012704477,0.00017789654,0.0003584835,0.00015942409,0.0008036368,0.000034803394,0.00015972884,0.00003827458,0.000046164747],"category_scores_gemma":[0.00014409471,0.00012949757,0.00008699527,0.00038049955,0.000061879924,0.00006405589,0.00007729351,0.0003823395,0.0000023616428],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0096118525,0.007181128,0.644366,0.011055713,0.0008945269,0.0003467397,0.19374748,0.040194195,0.00055480644,0.00434312,0.019466262,0.06823818],"study_design_scores_gemma":[0.039851494,0.070003845,0.3591253,0.0021177786,0.0004000039,0.0008060438,0.06458538,0.2962483,0.00076638866,0.004816271,0.16002148,0.0012577418],"about_ca_topic_score_codex":0.0057253446,"about_ca_topic_score_gemma":0.00054805074,"teacher_disagreement_score":0.28524074,"about_ca_system_score_codex":0.0009908453,"about_ca_system_score_gemma":0.0024512839,"threshold_uncertainty_score":0.8655047},"labels":[],"label_agreement":null},{"id":"W4283518453","doi":"10.1016/j.jval.2022.04.724","title":"EE476 Cost-Effectiveness of Emicizumab Prophylaxis in Patients with Hemophilia a without Inhibitors","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Bleed; Clotting factor; Reimbursement; Population; Intensive care medicine; Pediatrics; Internal medicine; Surgery; Health care","score_opus":0.0339048881023621,"score_gpt":0.31997298410178954,"score_spread":0.28606809599942745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283518453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995156,0.00021948172,0.0000018204813,0.00036827222,0.0000949952,0.00395762,0.000025305142,0.000018903256,0.00015760436],"genre_scores_gemma":[0.9992992,0.000017871562,0.0001045495,0.00004549402,0.000022052338,0.0003482989,0.000058323483,0.000030143437,0.00007400986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972929,0.00077174185,0.0004278229,0.0003427977,0.00073110836,0.0004336583],"domain_scores_gemma":[0.99919766,0.00016970048,0.0001143323,0.00029075425,0.00007673306,0.00015082705],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012825425,0.00015262158,0.00051949505,0.0004919549,0.0000838249,0.0000036152921,0.000096442534,0.000051798455,0.00003975447],"category_scores_gemma":[0.000085485575,0.0001161847,0.00004599583,0.001011601,0.000080855985,0.00004502854,0.00008668724,0.0005161133,0.000003755505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003541944,0.0016563663,0.9869567,0.0011782212,0.000020496416,0.000043352673,0.0007874564,0.0010729975,0.000080608166,0.00005556757,0.00001513569,0.0045911125],"study_design_scores_gemma":[0.013687909,0.01032219,0.9728344,0.0010584816,0.000008066553,0.000011373489,0.0002526055,0.00054576783,0.0008051933,0.0001286907,0.00019485148,0.0001504724],"about_ca_topic_score_codex":0.0026904412,"about_ca_topic_score_gemma":0.000028086706,"teacher_disagreement_score":0.014122344,"about_ca_system_score_codex":0.001278934,"about_ca_system_score_gemma":0.0008761053,"threshold_uncertainty_score":0.4737875},"labels":[],"label_agreement":null},{"id":"W4283520061","doi":"10.1016/j.jval.2022.04.286","title":"EE34 Comparing the Cost-Effectiveness of the Otago Exercise Programme Among Older Women and Men: A Secondary Analysis of a Randomized Controlled Trial","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Medicine; Randomized controlled trial; Demography; Rate ratio; Incidence (geometry); Health care; Confidence interval; Physical therapy; Gerontology; Internal medicine","score_opus":0.20346855827437949,"score_gpt":0.3857099857577455,"score_spread":0.18224142748336603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283520061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9752631,0.003868247,0.00015502886,0.0027768223,0.0003847642,0.017025623,0.00013488792,0.000012402892,0.00037907963],"genre_scores_gemma":[0.9912728,0.00015803453,0.000055785276,0.0004462343,0.000032607233,0.007939292,0.000012533459,0.000018267603,0.000064442735],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9843733,0.008685325,0.0058229016,0.00044177182,0.00020681667,0.00046994252],"domain_scores_gemma":[0.98455906,0.009711091,0.0049874587,0.00057010964,0.00005168992,0.000120582685],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.12308804,0.00018091378,0.0050232196,0.00064298115,0.0003168481,0.000034290337,0.00037300363,0.000061319806,0.0001645094],"category_scores_gemma":[0.0031927263,0.00014284921,0.00051751494,0.0009982537,0.00025187962,0.00011241616,0.00016876271,0.00034813333,0.0000017957561],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4331677,0.001494166,0.33244598,0.004215289,0.004781905,9.775447e-7,0.070010014,0.10117268,0.0000017457818,0.051336855,0.0005131888,0.0008594973],"study_design_scores_gemma":[0.6875745,0.00018479269,0.08306443,0.00021652279,0.000149215,9.0580716e-7,0.004916631,0.21903977,0.0000011144468,0.0044103786,0.00024356692,0.00019818028],"about_ca_topic_score_codex":0.010736326,"about_ca_topic_score_gemma":0.0001567145,"teacher_disagreement_score":0.25440678,"about_ca_system_score_codex":0.00087100087,"about_ca_system_score_gemma":0.000486784,"threshold_uncertainty_score":0.9958513},"labels":[],"label_agreement":null},{"id":"W4283520789","doi":"10.1016/j.jval.2022.04.610","title":"EE362 Microcosting of Cataract Surgery Complications from a US Provider Perspective","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Cataract surgery; Perspective (graphical); Intensive care medicine; Surgery; General surgery","score_opus":0.4938335676468563,"score_gpt":0.43453481711336384,"score_spread":0.059298750533492484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283520789","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.896457,0.009928619,0.0007893325,0.08674325,0.0006185341,0.0014436338,0.0025009033,0.00005252099,0.0014661935],"genre_scores_gemma":[0.98622566,0.00012285086,0.0029209445,0.010040134,0.00014106711,0.0003022589,0.00014612386,0.000033434462,0.00006750278],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99394757,0.000943082,0.0040213848,0.0005751784,0.00010935432,0.00040343986],"domain_scores_gemma":[0.99279714,0.0035264867,0.0029603571,0.00051573315,0.00006243023,0.00013785127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013867819,0.00013742878,0.00095738744,0.000514003,0.0003410315,0.000021578022,0.0002586622,0.00004847788,0.00033522822],"category_scores_gemma":[0.0026605963,0.0002043651,0.00012217455,0.00043833215,0.00004994596,0.00019740213,0.00009626095,0.00031636862,0.00017068883],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003892014,0.0006432939,0.794098,0.00073117,0.0000821887,0.0000022696868,0.02178296,0.019856146,0.000014935502,0.1401295,0.022307934,0.00031262945],"study_design_scores_gemma":[0.0013119072,0.000197341,0.7594552,0.00038585754,0.0000067573505,0.000018649152,0.022395177,0.041412305,0.000012420699,0.08463291,0.0894138,0.00075767963],"about_ca_topic_score_codex":0.24529989,"about_ca_topic_score_gemma":0.0006209769,"teacher_disagreement_score":0.24467891,"about_ca_system_score_codex":0.0025030554,"about_ca_system_score_gemma":0.00097066973,"threshold_uncertainty_score":0.8333767},"labels":[],"label_agreement":null},{"id":"W4283521197","doi":"10.1016/j.jval.2022.04.034","title":"P25 Income and Equity Effect of Modelled Sugar Tax and Fruit and Vegetable Subsidy Program across Different Income Groups in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Food Security and Health in Diverse Populations","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Subsidy; Equity (law); Sugar; Economics; Income tax; Gross income; Agricultural economics; Public economics; Business; State income tax; Food science; Chemistry; Tax reform; Political science","score_opus":0.10202356290991975,"score_gpt":0.42831701411650436,"score_spread":0.3262934512065846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283521197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992339,0.0027133587,0.0000026049242,0.0012014171,0.00037641756,0.0029461053,0.00033823395,0.000027726312,0.000055136494],"genre_scores_gemma":[0.9983896,0.00060787995,0.000100084755,0.0002487438,0.000029737825,0.0005419608,0.000035095673,0.000021262624,0.000025646548],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99512327,0.0020868182,0.001038238,0.00041588204,0.00040354324,0.0009322601],"domain_scores_gemma":[0.9979186,0.0010775139,0.00035517837,0.00026648288,0.000032944918,0.00034926098],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028951683,0.00021435106,0.0007874522,0.00018681539,0.0011808152,0.00001037107,0.00015594378,0.00011524111,0.000035968023],"category_scores_gemma":[0.00013967643,0.00020532757,0.000022042106,0.00040670988,0.00008615269,0.00010129535,0.0009153871,0.0011704675,6.0763585e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022276427,0.00009353152,0.98098606,0.005275811,0.000008258571,0.000008113703,0.00854429,0.0015774615,0.0000027540614,0.0019116809,0.000021461075,0.0013477999],"study_design_scores_gemma":[0.003575654,0.0010128653,0.9437759,0.000517244,0.000008330427,0.000004909921,0.002237062,0.046150096,0.0000032106177,0.0021759751,0.00033554164,0.00020321907],"about_ca_topic_score_codex":0.9428388,"about_ca_topic_score_gemma":0.9012768,"teacher_disagreement_score":0.044572633,"about_ca_system_score_codex":0.0014540246,"about_ca_system_score_gemma":0.0013627795,"threshold_uncertainty_score":0.90819955},"labels":[],"label_agreement":null},{"id":"W4283521513","doi":"10.1016/j.jval.2022.04.944","title":"HPR18 The Missing Claimants of 2020: Who Went without Claims in Canada during the First Year of the COVID-19 Pandemic and What Does It Mean for Public and Private Insurers?","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Jurisdiction; Pandemic; Coronavirus disease 2019 (COVID-19); Business; Prescription drug; Public health; Demographic economics; Actuarial science; Medical prescription; Political science; Economics; Medicine; Law","score_opus":0.07219326008814375,"score_gpt":0.26731051966740016,"score_spread":0.1951172595792564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283521513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9590112,0.004160307,0.0000072120633,0.03548354,0.00037717086,0.0008218338,0.00011841005,0.0000033049444,0.000017017066],"genre_scores_gemma":[0.99631065,0.0024195905,0.000016193011,0.0011330026,0.000029982712,0.000049201146,0.0000013915108,0.0000130935605,0.000026896605],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984466,0.0001346967,0.00079566985,0.0002357765,0.000087705776,0.00029958514],"domain_scores_gemma":[0.99893177,0.00013090586,0.0005500009,0.00028203384,0.000012535686,0.000092783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028686803,0.0000919966,0.00035629797,0.00008982593,0.00044961716,0.000039294195,0.00023732215,0.000037687114,0.0000066160533],"category_scores_gemma":[0.00008470617,0.000049594702,0.000033893783,0.00027559823,0.00007528151,0.000112965325,0.00014307236,0.0002513938,9.225648e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021573183,0.000011772526,0.9856995,0.001100523,0.000011111038,5.3835385e-7,0.007061725,0.0008214904,9.42545e-7,0.0035300043,0.000025728466,0.0017151168],"study_design_scores_gemma":[0.0016972681,0.00010255017,0.90020055,0.00037827634,0.0000019669753,0.000032320826,0.031167274,0.00868763,0.000005347516,0.0048790174,0.052650794,0.0001970156],"about_ca_topic_score_codex":0.74495405,"about_ca_topic_score_gemma":0.757541,"teacher_disagreement_score":0.08549894,"about_ca_system_score_codex":0.0011600136,"about_ca_system_score_gemma":0.0007769909,"threshold_uncertainty_score":0.34581372},"labels":[],"label_agreement":null},{"id":"W4283521763","doi":"10.1016/j.jval.2022.04.1448","title":"PCR105 The Impact of Key Health State Transitions on Health-Related Quality of Life (HRQOL) in Duchenne Muscular Dystrophy (DMD): A Qualitative Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Vancouver Coastal Health","funders":"","keywords":"Duchenne muscular dystrophy; Health related quality of life; Quality of life (healthcare); Key (lock); Medicine; Gerontology; Physical medicine and rehabilitation; Physical therapy; Environmental health; Computer science; Nursing; Internal medicine; Disease; Computer security","score_opus":0.05509591619869709,"score_gpt":0.383970738274185,"score_spread":0.3288748220754879,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283521763","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915525,0.002384985,0.00006272473,0.0041578584,0.00006668365,0.0013180561,0.0004283689,0.0000073320803,0.000021513199],"genre_scores_gemma":[0.9985683,0.00034522844,0.000044851746,0.00071746134,0.000011349537,0.00010878903,0.00017851609,0.000019257208,0.0000062456415],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9895444,0.007898137,0.0014000871,0.00043144304,0.00025705103,0.00046886818],"domain_scores_gemma":[0.9983982,0.00018128962,0.0007169391,0.0005043129,0.000047095855,0.00015219035],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047346856,0.00019399013,0.0006749703,0.0001668687,0.00021702948,0.0000027917895,0.00023678607,0.000056737033,0.000026950998],"category_scores_gemma":[0.00016839938,0.00016149372,0.00019819962,0.0004718372,0.00014269551,0.000004630098,0.00006868284,0.00043112613,7.5739223e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073299413,0.010964881,0.00799516,0.00089232536,0.00054431666,0.000004138506,0.32548156,0.633184,0.008088433,0.0018140782,0.0010035037,0.0026976247],"study_design_scores_gemma":[0.019479226,0.0707502,0.5956575,0.00026885665,0.000014874131,0.000006724511,0.2995517,0.002101451,0.0003006202,0.010644877,0.00026681236,0.00095717405],"about_ca_topic_score_codex":0.10694739,"about_ca_topic_score_gemma":0.0020924148,"teacher_disagreement_score":0.6310826,"about_ca_system_score_codex":0.0002005567,"about_ca_system_score_gemma":0.0017431028,"threshold_uncertainty_score":0.8989995},"labels":[],"label_agreement":null},{"id":"W4283521784","doi":"10.1016/j.jval.2022.04.1194","title":"HTA62 Evaluating the Gaps in Health Technology Assessment (HTA) Requirements: A Comparative Analysis of HTA Systems of Europe, Canada, and United States with Asia Pacific Region","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Asia pacific; Health technology; Geography; Political science; International trade; Business; Health care","score_opus":0.4248246450838225,"score_gpt":0.4568233006471045,"score_spread":0.03199865556328202,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283521784","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95641536,0.0053975075,0.00040706838,0.03510835,0.00014662581,0.0018137698,0.00049298606,0.000014282664,0.00020406237],"genre_scores_gemma":[0.9972581,0.00055462855,0.0006133901,0.0011229216,0.000011852195,0.00021595611,0.00014286966,0.000017612128,0.00006264279],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9892267,0.0037516756,0.0056244624,0.0005777899,0.0003162428,0.0005031561],"domain_scores_gemma":[0.99216175,0.0012637186,0.005722267,0.000596196,0.0001433162,0.00011277996],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.029197954,0.00018588714,0.0017098966,0.0020534305,0.0002795749,0.00002046758,0.000305806,0.000046148347,0.000019772977],"category_scores_gemma":[0.0005022822,0.00018917491,0.000036989255,0.0042975456,0.00012445709,0.000109745844,0.000102878745,0.00039198674,8.314416e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048816466,0.00014191242,0.49306104,0.0010170026,0.00022784574,0.0000017939867,0.005902965,0.44307813,6.470837e-7,0.05543328,0.001031277,0.00005530583],"study_design_scores_gemma":[0.0014587956,0.0015773636,0.17069761,0.0005535471,0.00002651925,0.000009613468,0.075626835,0.7430563,7.3983887e-7,0.00080026034,0.0059163696,0.00027602594],"about_ca_topic_score_codex":0.8356302,"about_ca_topic_score_gemma":0.2297183,"teacher_disagreement_score":0.60591185,"about_ca_system_score_codex":0.0028073876,"about_ca_system_score_gemma":0.0025850402,"threshold_uncertainty_score":0.999645},"labels":[],"label_agreement":null},{"id":"W4283521874","doi":"10.1016/j.jval.2022.04.1010","title":"HSD8 Real-World Patient Persistence: A Comparison of Prostaglandin Analogs Used for the Treatment of Open-Angle Glaucoma or Ocular Hypertension","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Travoprost; Bimatoprost; Latanoprost; Medicine; Persistence (discontinuity); Glaucoma; Intraocular pressure; Ophthalmology; Prostaglandin analogue; Internal medicine","score_opus":0.10695162705707968,"score_gpt":0.35653611630490095,"score_spread":0.24958448924782128,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283521874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903834,0.00213218,0.000013072828,0.003582203,0.00014403566,0.0035749981,0.00005717218,0.0000095183195,0.00010340552],"genre_scores_gemma":[0.9982193,0.000400493,0.0005526153,0.00020957166,0.000013728059,0.000274522,0.00006453116,0.000017417815,0.0002478364],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983431,0.00022760531,0.0006043096,0.00023427728,0.0003332893,0.00025743176],"domain_scores_gemma":[0.99889517,0.00031628783,0.00031030198,0.0003311344,0.000064516615,0.00008257834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039686798,0.00012719417,0.0006265264,0.00015842472,0.0002140064,0.0000056472427,0.00015375322,0.000026925834,0.00005223772],"category_scores_gemma":[0.00004103914,0.00007325478,0.00013807428,0.00047963482,0.00006824934,0.00002012723,0.000061933104,0.00009894145,4.7118974e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045474074,0.005585513,0.96461153,0.00075280725,0.00012407685,0.00003016483,0.01434504,0.00036112533,0.0007145654,0.0005932307,0.0018677048,0.006466838],"study_design_scores_gemma":[0.019809399,0.07638079,0.67185163,0.0008412149,0.00040818352,0.00007478274,0.07010349,0.08791947,0.0022363295,0.00025533905,0.06974278,0.00037659277],"about_ca_topic_score_codex":0.02528515,"about_ca_topic_score_gemma":0.001511556,"teacher_disagreement_score":0.2927599,"about_ca_system_score_codex":0.000429514,"about_ca_system_score_gemma":0.0004065469,"threshold_uncertainty_score":0.9812056},"labels":[],"label_agreement":null},{"id":"W4283522130","doi":"10.1016/j.jval.2022.04.801","title":"EPH48 Operationalizing the 2019 GINA Asthma Treatment Steps for Application to Real-World Data from the UK","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Operationalization; Real world data; Asthma; Real world evidence; Proxy (statistics); Asthma management; Medicine; Computer science; Data science; Internal medicine","score_opus":0.10503792245288969,"score_gpt":0.38474080539840766,"score_spread":0.279702882945518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283522130","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77585924,0.0056977803,0.003128532,0.20018673,0.0005546656,0.009464917,0.0045299395,0.00008149648,0.00049668434],"genre_scores_gemma":[0.9777868,0.00025751398,0.0011821343,0.014424735,0.00082961237,0.0013894946,0.0027269793,0.00003429787,0.0013684512],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987237,0.00025871737,0.00027076752,0.00031391103,0.0002420235,0.00019089138],"domain_scores_gemma":[0.9985219,0.00044425172,0.000090029964,0.0008180051,0.000024803367,0.00010098919],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006812118,0.000093820956,0.00017052393,0.00004730034,0.0004661055,0.000017400067,0.00026661652,0.000010836862,0.000067821406],"category_scores_gemma":[0.00004773,0.000053100117,0.000036897818,0.0002562495,0.000026385944,0.000029035298,0.00012288372,0.00009515175,0.000020214267],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018634099,0.0015646458,0.24434201,0.00015269443,0.00017311069,0.00001745489,0.006059504,0.069071814,0.0005306733,0.020346938,0.43041882,0.22545893],"study_design_scores_gemma":[0.00095998676,0.00063285854,0.16872986,0.00004375015,0.000022043507,0.0000023920463,0.0009716797,0.014870775,0.000019051771,0.00021515726,0.81345,0.000082469116],"about_ca_topic_score_codex":0.027576456,"about_ca_topic_score_gemma":0.0026853043,"teacher_disagreement_score":0.38303116,"about_ca_system_score_codex":0.00041220785,"about_ca_system_score_gemma":0.0006473101,"threshold_uncertainty_score":0.978899},"labels":[],"label_agreement":null},{"id":"W4283522197","doi":"10.1016/j.jval.2022.04.1519","title":"PCR176 Time Trade-Off Utility Values for Health States Characterizing Progressive Muscular Degeneration in Duchenne Muscular Dystrophy (DMD)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Vancouver Coastal Health","funders":"","keywords":"Ambulatory; Medicine; Cardiorespiratory fitness; Physical therapy; Duchenne muscular dystrophy; Physical medicine and rehabilitation; Gerontology; Surgery; Internal medicine","score_opus":0.017378348042804168,"score_gpt":0.2821608258928954,"score_spread":0.2647824778500912,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283522197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98714083,0.006927031,0.00031549815,0.0038417792,0.00018774628,0.0013901896,0.00016560689,0.000022403092,0.000008901281],"genre_scores_gemma":[0.99344385,0.00069754315,0.0009076624,0.002247207,0.00014135169,0.000550302,0.001956989,0.00003573762,0.00001938849],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969292,0.0010067071,0.0006075694,0.0006588986,0.00017232471,0.0006252931],"domain_scores_gemma":[0.99915975,0.00004150549,0.00027349126,0.00036623457,0.000029071225,0.00012994149],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014333356,0.00022174744,0.00038495185,0.00012477775,0.00035659614,0.000015366346,0.00020205922,0.0001046672,0.0000344072],"category_scores_gemma":[0.00008727569,0.00024268833,0.00013012758,0.00021200643,0.00007307904,0.000012076216,0.00010397404,0.00024843097,0.0000016691357],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007075788,0.006499154,0.021344297,0.0048320014,0.00039073944,0.0000578681,0.011657555,0.21041472,0.5944184,0.0014157274,0.011502502,0.13039123],"study_design_scores_gemma":[0.029854573,0.032908916,0.29076272,0.00084476825,0.00009374095,0.00011912883,0.0060916794,0.3111354,0.0772327,0.015348371,0.23052901,0.0050789933],"about_ca_topic_score_codex":0.00048713258,"about_ca_topic_score_gemma":0.00004154566,"teacher_disagreement_score":0.51718575,"about_ca_system_score_codex":0.0001507932,"about_ca_system_score_gemma":0.00054026913,"threshold_uncertainty_score":0.9896543},"labels":[],"label_agreement":null},{"id":"W4283522293","doi":"10.1016/j.jval.2022.04.997","title":"HPR71 Regulatory Journey on Vaccination Against COVID-19 in Brazil","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Public Health in Brazil","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Quarter (Canadian coin); Normative; Vaccination; Pillar; Coronavirus disease 2019 (COVID-19); Business; Political science; Medicine; Geography; Virology; Engineering; Law","score_opus":0.10357791320472587,"score_gpt":0.4248794316950125,"score_spread":0.32130151849028665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283522293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6882991,0.0006716013,0.000031866093,0.27416676,0.002114671,0.0014838608,0.000036815658,0.00021023914,0.032985076],"genre_scores_gemma":[0.9510373,0.00038020298,0.00014226798,0.04739855,0.00024945577,0.00013423311,0.000014946079,0.000021593964,0.000621441],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9924597,0.004367261,0.0007614879,0.00042279394,0.0011199142,0.0008688289],"domain_scores_gemma":[0.9978573,0.00080755126,0.00031274813,0.0003150399,0.00003695425,0.00067040964],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.016440796,0.000121969984,0.00026367191,0.00072564103,0.0013602914,0.000044780045,0.0004955681,0.00010347654,0.0006055091],"category_scores_gemma":[0.0029380692,0.00014913685,0.00004210942,0.0017301001,0.00006131167,0.00022615504,0.00009954201,0.00077912875,0.00003147155],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000162269,0.0010162556,0.106741704,0.0005026046,0.000007525219,0.00010366557,0.12162783,0.16072762,0.000006101718,0.40916583,0.11752661,0.082411975],"study_design_scores_gemma":[0.0013137019,0.00020485387,0.11583232,0.000049381702,5.8585175e-7,0.000002708512,0.00690957,0.0032741989,0.0000011929897,0.012010157,0.86017317,0.00022813995],"about_ca_topic_score_codex":0.051933274,"about_ca_topic_score_gemma":0.007959086,"teacher_disagreement_score":0.7426466,"about_ca_system_score_codex":0.011297765,"about_ca_system_score_gemma":0.010652023,"threshold_uncertainty_score":0.9999398},"labels":[],"label_agreement":null},{"id":"W4283522453","doi":"10.1016/j.jval.2022.04.241","title":"CO147 Driving Outcomes in Mild Cognitive Impairment/Alzheimer's Disease - a Review of Association between Driving Simulator Measures and Clinical Outcomes Assessments","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Older Adults Driving Studies","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cognition; Montreal Cognitive Assessment; Cognitive impairment; Psychology; Association (psychology); Driving simulator; Dementia; Physical medicine and rehabilitation; Audiology; Disease; Clinical psychology; Medicine; Psychiatry; Simulation; Computer science; Internal medicine","score_opus":0.3129230384004081,"score_gpt":0.5638753659952257,"score_spread":0.2509523275948176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283522453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00577392,0.9819039,0.0000065147515,0.0010594446,0.0011358953,0.009380667,0.0005983383,0.00009378535,0.00004750173],"genre_scores_gemma":[0.005983623,0.99125916,0.00010882277,0.0009635069,0.00016827071,0.001082818,0.00019395706,0.0001397516,0.00010006386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9734353,0.016157452,0.00650362,0.001154106,0.0014436863,0.0013058379],"domain_scores_gemma":[0.9554148,0.037947956,0.005293693,0.0006314569,0.00020500646,0.0005071309],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.016256357,0.00085632293,0.007569921,0.0007142686,0.0006463584,0.00001782637,0.00048539785,0.00047036124,0.00010026684],"category_scores_gemma":[0.015778817,0.000731933,0.0008451495,0.0009100402,0.000096776,0.00020182124,0.0010096887,0.003284587,0.000018672048],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000035767998,0.00030214852,0.84772605,0.09966028,0.0010414474,0.00000739957,0.00035736346,0.0000020074885,1.5435603e-10,0.000007747983,0.000234125,0.05065786],"study_design_scores_gemma":[0.0010879749,0.00013734197,0.68956286,0.2752472,0.0015742542,1.627675e-7,0.0002148557,0.000021957794,7.3306455e-10,0.00003807149,0.031729955,0.00038539813],"about_ca_topic_score_codex":0.0024510887,"about_ca_topic_score_gemma":0.0010334695,"teacher_disagreement_score":0.17558692,"about_ca_system_score_codex":0.002912562,"about_ca_system_score_gemma":0.003840841,"threshold_uncertainty_score":0.99951315},"labels":[],"label_agreement":null},{"id":"W4283522792","doi":"10.1016/j.jval.2022.04.353","title":"EE100 Treatment-Related Lost Productivity in Paroxysmal Nocturnal Hemoglobinuria: A Comparison of Investigational Subcutaneous Ravulizumab and Pegcetacoplan in the United States","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Greenfield Research (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Internal medicine","score_opus":0.04406080065395183,"score_gpt":0.2992194460803861,"score_spread":0.25515864542643424,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283522792","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925138,0.00366819,9.262701e-7,0.0023074604,0.00019675397,0.0010220362,0.0002516252,0.000013155747,0.00002606491],"genre_scores_gemma":[0.9989957,0.00004161215,0.000016682996,0.00009131964,0.000008448681,0.00007979596,0.0007169502,0.000009144407,0.0000402952],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99573743,0.0027675307,0.0007593012,0.00030304005,0.00009542789,0.00033726904],"domain_scores_gemma":[0.9988406,0.0005942005,0.00030145943,0.00021664459,0.000020377898,0.000026775613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008785922,0.00016039127,0.0004241998,0.00036569283,0.0001557842,0.000007954375,0.00018454011,0.000052827632,0.00019178656],"category_scores_gemma":[0.00008140305,0.00013246015,0.00003144177,0.0006456147,0.00017040946,0.000037224974,0.00007507117,0.00037190533,0.0000055321916],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089484296,0.0014896506,0.9208258,0.00018636268,0.00006470791,0.000055210734,0.020661848,0.05278834,0.00089427194,0.0010919733,0.0005643064,0.00048272786],"study_design_scores_gemma":[0.017312521,0.0061732014,0.91846806,0.0004439913,0.00006400606,0.0017913268,0.026148757,0.014811211,0.0009997198,0.005050496,0.008077422,0.00065926596],"about_ca_topic_score_codex":0.018320259,"about_ca_topic_score_gemma":0.0017628598,"teacher_disagreement_score":0.03797713,"about_ca_system_score_codex":0.00047266332,"about_ca_system_score_gemma":0.00041723184,"threshold_uncertainty_score":0.9882168},"labels":[],"label_agreement":null},{"id":"W4283523166","doi":"10.1016/j.jval.2022.04.485","title":"EE237 The Risk-Based Price: Incorporating Uncertainty and Risk Attitues in Health Technology Pricing","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Alberta","funders":"","keywords":"Value (mathematics); Actuarial science; Value of information; Net present value; Present value; Economics; Risk aversion (psychology); Optimal decision; Risk management; Expected utility hypothesis; Risk analysis (engineering); Microeconomics; Production (economics); Business; Computer science; Financial economics; Decision tree; Statistics; Mathematics; Finance","score_opus":0.2385129450787944,"score_gpt":0.3979705544848342,"score_spread":0.1594576094060398,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283523166","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84713364,0.014309966,0.0015972821,0.1337986,0.00046003275,0.0020590106,0.00033233355,0.00009265396,0.00021650744],"genre_scores_gemma":[0.9841076,0.001391675,0.0046193716,0.009303364,0.00010001673,0.00038457676,0.000022389688,0.000038744533,0.000032254397],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98963815,0.0035367003,0.0050975196,0.00079092674,0.00015651829,0.00078017666],"domain_scores_gemma":[0.99112123,0.0024233751,0.005636839,0.00062612206,0.000026379656,0.00016606304],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.067279615,0.00022002756,0.001084984,0.0010841013,0.0011434214,0.000048555175,0.00039793598,0.00010715393,0.00005886841],"category_scores_gemma":[0.004530176,0.00024598147,0.000059296886,0.0012764123,0.00013047959,0.0001601945,0.00018495227,0.0011614746,0.00004132376],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013385051,0.00008896968,0.7230906,0.00046401165,0.00001090891,0.0000010590363,0.0025382575,0.22301021,9.617799e-8,0.049222127,0.0005117176,0.0010486912],"study_design_scores_gemma":[0.0023213476,0.0006561078,0.23337236,0.00036335405,0.000002996171,0.00001287805,0.009269216,0.644936,7.1654523e-7,0.07722603,0.031329457,0.00050954416],"about_ca_topic_score_codex":0.1222869,"about_ca_topic_score_gemma":0.0035064043,"teacher_disagreement_score":0.4897182,"about_ca_system_score_codex":0.0032821167,"about_ca_system_score_gemma":0.0013466019,"threshold_uncertainty_score":0.9999992},"labels":[],"label_agreement":null},{"id":"W4283523329","doi":"10.1016/j.jval.2022.04.191","title":"CO95 A Matching-Adjusted Indirect Comparison of Filgotinib Versus Tofacitinib for Moderately to Severely Active Ulcerative Colitis","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Tofacitinib; Ulcerative colitis; Medicine; Matching (statistics); Internal medicine; Pathology","score_opus":0.06464436844036901,"score_gpt":0.3386565124043133,"score_spread":0.2740121439639443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283523329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948808,0.0000705575,0.00044104655,0.00022378891,0.0003292648,0.0015029133,0.0022018016,0.000016527516,0.00033332576],"genre_scores_gemma":[0.9971797,0.000007713391,0.0011992693,0.0004322783,0.0000612826,0.000483606,0.00048559447,0.00003273829,0.000117813215],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9979696,0.0005214737,0.00048581662,0.00040543577,0.00022096546,0.00039669813],"domain_scores_gemma":[0.99911445,0.000107411106,0.00025010854,0.0002518352,0.000103717815,0.00017246435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047541724,0.0001731523,0.00034560938,0.00010899917,0.00022181564,0.00001134631,0.00019715913,0.00007247382,0.000051784053],"category_scores_gemma":[0.00016181299,0.00021093182,0.00009244424,0.00017338688,0.000034985937,0.0000054556162,0.00015140003,0.00017408928,0.000002868708],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23205926,0.0018695187,0.006006032,0.0014957254,0.00053560757,0.000077044024,0.03274561,0.6889615,0.004394399,0.0062158504,0.015829273,0.009810187],"study_design_scores_gemma":[0.028528916,0.014748055,0.747081,0.0003541578,0.000105040686,0.00003214918,0.022064866,0.054473177,0.08311112,0.0017598567,0.045406096,0.0023355577],"about_ca_topic_score_codex":0.00060189655,"about_ca_topic_score_gemma":0.00045377007,"teacher_disagreement_score":0.741075,"about_ca_system_score_codex":0.00019451724,"about_ca_system_score_gemma":0.0007842399,"threshold_uncertainty_score":0.860155},"labels":[],"label_agreement":null},{"id":"W4283523373","doi":"10.1016/j.jval.2022.04.356","title":"EE103 Cost-Effectiveness Analysis of the Smart Quit Clinic Program in Cardiovascular Disease Patients in Thailand","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Diverse Scientific Research Studies","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Medicine; Disease; Multidisciplinary approach; Cost-effectiveness analysis; Perspective (graphical); Multidisciplinary team; Gerontology; Population; Health care; Cost effectiveness; Family medicine; Physical therapy; Environmental health; Nursing; Risk analysis (engineering); Computer science; Internal medicine","score_opus":0.16486912780196544,"score_gpt":0.46542616875867265,"score_spread":0.3005570409567072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283523373","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.990453,0.0008825019,0.000002194396,0.00037674702,0.0008554765,0.0067103286,0.00027831495,0.000017246994,0.0004241916],"genre_scores_gemma":[0.996687,0.00023245186,0.000013540833,0.000098885735,0.000011514075,0.0026586333,0.00004813428,0.000011851331,0.00023798361],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98545283,0.011280068,0.0008640413,0.00051013206,0.0011597943,0.00073313067],"domain_scores_gemma":[0.997437,0.0012633471,0.00024377185,0.0007893516,0.00011093316,0.00015561048],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013669036,0.0001272887,0.000731225,0.0008314049,0.0005315131,0.000006762028,0.00042764866,0.000042724016,0.00017044664],"category_scores_gemma":[0.0013419834,0.00009779135,0.0003113302,0.005013275,0.0001267033,0.00006687223,0.00082787423,0.00084642693,0.000014558701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014463019,0.0006608523,0.9562012,0.00052390917,0.00020945135,0.0000072068165,0.0032458873,0.035691593,1.16099955e-7,0.000038091162,0.00029339053,0.0029836725],"study_design_scores_gemma":[0.0016242948,0.000097685144,0.98332715,0.00023401632,0.00006326397,1.3700606e-8,0.0026705028,0.0043961783,1.2398182e-7,0.0000938833,0.0074151494,0.00007771536],"about_ca_topic_score_codex":0.04666507,"about_ca_topic_score_gemma":0.003672936,"teacher_disagreement_score":0.042992134,"about_ca_system_score_codex":0.0013326707,"about_ca_system_score_gemma":0.0011203839,"threshold_uncertainty_score":0.9596833},"labels":[],"label_agreement":null},{"id":"W4283523834","doi":"10.1016/j.jval.2022.04.1092","title":"HSD92 Natural Language Processing (NLP) of Unstructured EMR Data to Describe Treatment Patterns and Achievement of Guideline Recommended LDL-C Targets of Canadian Patients with Ascvd and Hypercholesterolemia","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); University of British Columbia; University of Regina; St. Michael's Hospital","funders":"","keywords":"Ezetimibe; Statin; Medicine; Guideline; Internal medicine; Medical record; Electronic medical record; Family medicine; Pathology","score_opus":0.03963855517563155,"score_gpt":0.29906989038568843,"score_spread":0.2594313352100569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283523834","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960728,0.0018320301,0.00003178376,0.0010630437,0.000037027796,0.00021901588,0.0007393291,0.000002045695,0.0000028819425],"genre_scores_gemma":[0.9923866,0.000088272194,0.006461349,0.00031903107,0.000010044555,0.0000073034275,0.00071491976,0.0000075567254,0.0000049344876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990638,0.00010022006,0.00032123437,0.0002335814,0.00011201404,0.00016918212],"domain_scores_gemma":[0.9994938,0.000010634294,0.0001329152,0.00022799704,0.00003142129,0.00010322565],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025636205,0.000091002854,0.00020382473,0.000120634206,0.000042739834,0.0000028975408,0.00013134915,0.00003711181,0.0000028719785],"category_scores_gemma":[0.00003848503,0.000071078204,0.00000930289,0.00011078577,0.000040205523,0.000002769555,0.00014825452,0.00006495677,9.489209e-9],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047814412,0.0003222103,0.57901424,0.0005690399,0.000112477515,0.000006214394,0.00579872,0.00027351608,0.007340744,0.000004425601,0.0006896767,0.40539062],"study_design_scores_gemma":[0.007920264,0.01176972,0.9340741,0.0005466575,0.00006411516,0.000026448517,0.009955441,0.002015232,0.012944959,0.000018850926,0.020103374,0.0005608201],"about_ca_topic_score_codex":0.08641887,"about_ca_topic_score_gemma":0.03451863,"teacher_disagreement_score":0.4048298,"about_ca_system_score_codex":0.00004970955,"about_ca_system_score_gemma":0.00022425105,"threshold_uncertainty_score":0.98309886},"labels":[],"label_agreement":null},{"id":"W4283524809","doi":"10.1016/j.jval.2022.04.1033","title":"HSD32 Using Natural Language Processing (NLP) of Unstructured EMR Data to Describe Canadian Patients with Familial Hypercholesterolemia (FH) and Their Management","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada); St. Michael's Hospital; University of Regina; University of British Columbia","funders":"","keywords":"Medicine; Ezetimibe; Statin; Medical record; Diabetes mellitus; Electronic medical record; Internal medicine; Familial hypercholesterolemia; Natural history; Pediatrics; Cholesterol; Family medicine","score_opus":0.03412514860987251,"score_gpt":0.27114720835118716,"score_spread":0.23702205974131466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283524809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955175,0.0022831592,0.000049241567,0.0004394429,0.00012517787,0.0013122814,0.00021796189,0.000013972131,0.000041290205],"genre_scores_gemma":[0.9944765,0.000020801317,0.00374273,0.0014378128,0.00005923094,0.000016305688,0.00020852964,0.000027819491,0.0000102678905],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983019,0.00018604784,0.00030887264,0.00039143735,0.00040765235,0.00040404522],"domain_scores_gemma":[0.99894685,0.000009038273,0.0000835525,0.00061484805,0.00003994701,0.00030575146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000765704,0.00014294594,0.0003628476,0.00026485568,0.00020492962,0.0000139766635,0.00017966049,0.000029600063,0.0000057980074],"category_scores_gemma":[0.000018634224,0.00011238418,0.000025992125,0.0004057595,0.000029478397,0.00007799784,0.00019738881,0.0003045038,1.8240048e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00081241503,0.00023454182,0.16032007,0.004963182,0.00021810287,0.00017129527,0.021683512,0.0034755657,0.00020878007,0.00005079933,0.0002646274,0.8075971],"study_design_scores_gemma":[0.0081321895,0.001238743,0.94121873,0.0017116328,0.00011217326,0.00021743597,0.017992364,0.022055924,0.00006603492,0.000020158237,0.0067212717,0.0005133602],"about_ca_topic_score_codex":0.25874323,"about_ca_topic_score_gemma":0.019854402,"teacher_disagreement_score":0.8070837,"about_ca_system_score_codex":0.0006195591,"about_ca_system_score_gemma":0.0008010107,"threshold_uncertainty_score":0.9980307},"labels":[],"label_agreement":null},{"id":"W4283524965","doi":"10.1016/j.jval.2022.04.1726","title":"P8 Patient Prioritisation of Items for the New Patient-Reported Impact of Dermatological Diseases (PRIDD) Measure: A Delphi Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Delphi method; Likert scale; Patient-reported outcome; Qualitative research; Medicine; Psychology; Delphi; Qualitative property; Family medicine; Quality of life (healthcare); Nursing; Computer science","score_opus":0.4281103753495668,"score_gpt":0.4375998081650893,"score_spread":0.009489432815522503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283524965","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9787097,0.0076419096,0.0010299754,0.006731646,0.0005004682,0.004465033,0.0008696169,0.000021450775,0.000030173887],"genre_scores_gemma":[0.9981027,0.000075676144,0.00037584564,0.00085499504,0.00005422937,0.00046853835,0.000043365715,0.000018995708,0.000005607239],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9923707,0.00107094,0.0055358014,0.00041550794,0.00023826012,0.00036876427],"domain_scores_gemma":[0.9927466,0.0020836575,0.0043997397,0.0005101784,0.00008596641,0.0001738689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008719535,0.00015609775,0.0009999152,0.00030055476,0.0002474635,0.000016287491,0.00024137988,0.0000491615,0.000092725786],"category_scores_gemma":[0.0039175367,0.00015317809,0.00021834002,0.00039584326,0.000041367803,0.00013415389,0.000083035164,0.00016407305,0.0000050414433],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021069906,0.0014851058,0.90308,0.00042235377,0.00016272497,0.0000016586127,0.019212456,0.056888826,0.000001390682,0.006857504,0.008739264,0.0029380412],"study_design_scores_gemma":[0.0045106406,0.004716817,0.90412384,0.0001577955,0.000031055748,0.000022640592,0.01613791,0.0499535,0.000002988982,0.01579717,0.0041187564,0.00042690782],"about_ca_topic_score_codex":0.022504013,"about_ca_topic_score_gemma":0.00013233679,"teacher_disagreement_score":0.022371678,"about_ca_system_score_codex":0.0011737049,"about_ca_system_score_gemma":0.0011294603,"threshold_uncertainty_score":0.9840052},"labels":[],"label_agreement":null},{"id":"W4283525681","doi":"10.1016/j.jval.2022.04.366","title":"EE115 Comparing the Cost-Effectiveness of Multimodal Versus Unimodal Interventions That Include Exercise to Prevent Falls Among Community Dwelling Older Adults: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Health and Well-being Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Psychological intervention; Falls in older adults; Medicine; Gerontology; Physical medicine and rehabilitation; Multimodal therapy; Physical therapy; Human factors and ergonomics; Poison control; Environmental health; Psychiatry; Surgery","score_opus":0.25219543217542306,"score_gpt":0.46470774190866826,"score_spread":0.2125123097332452,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283525681","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0008412833,0.9690859,0.00016997801,0.00009133606,0.001615591,0.027845724,0.000113735754,0.00006681547,0.00016968272],"genre_scores_gemma":[0.008839101,0.9780321,0.00004953828,0.00017687435,0.000044405933,0.012595858,0.00013955474,0.00009343881,0.00002909061],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96638227,0.028316056,0.0032004346,0.0006270486,0.00056049705,0.0009136792],"domain_scores_gemma":[0.986395,0.009475547,0.002041852,0.0017261261,0.000091795075,0.00026968945],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.017905522,0.0006697388,0.005702962,0.00045369208,0.00081857236,0.000025546498,0.001426754,0.0002153105,0.000072901115],"category_scores_gemma":[0.0009890007,0.00050539005,0.0010196877,0.0011595311,0.0001349844,0.00006296992,0.0008435251,0.0024396575,0.00004593915],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010219398,0.00086111744,0.00009956156,0.9550852,0.00031139486,0.0000071921695,0.007020311,0.00025800307,8.612046e-10,0.00019544833,0.0001091917,0.035950348],"study_design_scores_gemma":[0.0009525477,0.00035749242,0.0004223842,0.98661757,0.0007925536,0.0000098475475,0.0023808468,0.00007697999,4.4225526e-8,0.000012441592,0.008011075,0.0003662304],"about_ca_topic_score_codex":0.036371548,"about_ca_topic_score_gemma":0.0008940222,"teacher_disagreement_score":0.03558412,"about_ca_system_score_codex":0.0015361399,"about_ca_system_score_gemma":0.00049361784,"threshold_uncertainty_score":0.9998618},"labels":[],"label_agreement":null},{"id":"W4283526695","doi":"10.1016/j.jval.2022.04.464","title":"EE215 Higher Work Impairment and Increased Healthcare Resource Utilization in Patients with Crohn's Perianal Fistula: Results from a Global Burden of Illness Study","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Diverticular Disease and Complications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Crohn's and Colitis Canada","funders":"","keywords":"Medicine; Work productivity; Crohn's disease; Disease; Internal medicine; Physical therapy; Productivity","score_opus":0.030334855686088343,"score_gpt":0.2866943060435277,"score_spread":0.25635945035743934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283526695","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994783,0.0004950012,0.0000035565065,0.002655788,0.000032975928,0.0015528924,0.00041937653,0.00001784342,0.000039570765],"genre_scores_gemma":[0.9989184,0.000007902454,0.00007607718,0.00038224048,0.000022390735,0.000110736444,0.0004582009,0.000010411316,0.000013625992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802625,0.0004963415,0.00046746517,0.00034287514,0.00046233097,0.00020472758],"domain_scores_gemma":[0.9992165,0.000048820624,0.00015978707,0.00033652253,0.000062648825,0.00017575145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034306085,0.000108290835,0.0002850932,0.00009838285,0.00012676715,0.0000086075215,0.00008242299,0.000023596673,0.000028547596],"category_scores_gemma":[0.000036318677,0.00009954916,0.000021798713,0.0007075549,0.000025918558,0.000027644093,0.00009781776,0.00012409345,6.486955e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0044327127,0.0019667088,0.9855832,0.00007958371,0.000031020518,0.000023964838,0.004391241,0.0014537134,2.0549665e-7,0.000051316834,0.00016755982,0.0018187589],"study_design_scores_gemma":[0.0074726786,0.0012611998,0.9865988,0.00021609232,0.000027877712,6.5696986e-7,0.0034269872,0.00041734576,2.8370647e-7,0.000055294327,0.00043913964,0.00008364459],"about_ca_topic_score_codex":0.059365314,"about_ca_topic_score_gemma":0.00028337544,"teacher_disagreement_score":0.059081938,"about_ca_system_score_codex":0.00061697117,"about_ca_system_score_gemma":0.00034159867,"threshold_uncertainty_score":0.94689846},"labels":[],"label_agreement":null},{"id":"W4283526754","doi":"10.1016/j.jval.2022.04.1419","title":"PCR74 Out-of-Pocket Costs and Time/Productivity Losses from Pediatric Emergency Resulting in Resuscitation in Five Niagara Hospitals in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Emergency and Acute Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster Children's Hospital; Brock University","funders":"","keywords":"Productivity; Resuscitation; Emergency department; Medical emergency; Health care; Medicine; Emergency medicine; Operations management; Business; Nursing; Engineering; Economics; Economic growth","score_opus":0.025294904343497248,"score_gpt":0.2909096790845052,"score_spread":0.265614774741008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283526754","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9820621,0.0132710785,3.9005894e-7,0.002957531,0.00074775063,0.00061240024,0.00016522776,0.0000069204184,0.00017657338],"genre_scores_gemma":[0.9952536,0.0042650537,0.00011914247,0.00011536753,0.000107484026,0.000048923583,0.000049917573,0.000012652348,0.000027821226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976621,0.00045514392,0.00083410874,0.00039978547,0.00032289713,0.00032591628],"domain_scores_gemma":[0.9991772,0.00030314768,0.00022774388,0.0001774708,0.00005298237,0.00006141991],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012490046,0.00013118892,0.00044591306,0.0003375976,0.00006777849,0.0000015097844,0.00007102307,0.000031238702,0.00003903433],"category_scores_gemma":[0.0013402794,0.00014286028,0.000020740017,0.00095968664,0.000019004856,0.00007664881,0.00009301521,0.0003896822,6.9132733e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001376132,0.00011048727,0.98560756,0.000306291,0.0000069240928,0.00006481911,0.007875361,0.0013648024,0.000059271122,0.000014177481,0.003274839,0.0011778534],"study_design_scores_gemma":[0.0011285507,0.00020343863,0.99211794,0.00017240779,0.0000074164905,7.7018547e-7,0.0048954263,0.0007943515,0.00003455732,0.00040083152,0.00010582804,0.00013846115],"about_ca_topic_score_codex":0.9166935,"about_ca_topic_score_gemma":0.7413597,"teacher_disagreement_score":0.17533381,"about_ca_system_score_codex":0.0011466065,"about_ca_system_score_gemma":0.0010806924,"threshold_uncertainty_score":0.58256733},"labels":[],"label_agreement":null},{"id":"W4283526908","doi":"10.1016/j.jval.2022.04.1184","title":"HTA52 Comparing the Change from Base Case to Re-Analyzed ICER Values for CADTH Oncology Evaluations","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Reimbursement; Medicine; Oncology; Internal medicine; Actuarial science; Family medicine; Business; Economics; Health care","score_opus":0.7810870673887269,"score_gpt":0.528524047256737,"score_spread":0.25256302013198995,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283526908","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6587224,0.006516386,0.0045831837,0.31556818,0.0023191515,0.007325375,0.0031922162,0.00009357209,0.001679566],"genre_scores_gemma":[0.9345994,0.00008009981,0.007411324,0.052512977,0.0007678204,0.004175373,0.00016127733,0.000056786717,0.00023496135],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9913473,0.0027699762,0.004174699,0.0008187449,0.00017942722,0.0007098297],"domain_scores_gemma":[0.9920689,0.004926109,0.0019044701,0.0007176132,0.00007195404,0.00031094375],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.046484135,0.00021458219,0.0012211774,0.00057668047,0.001205799,0.000058753438,0.00045685796,0.00008756699,0.0009298439],"category_scores_gemma":[0.0033091304,0.0002494452,0.00016095207,0.0005690502,0.000045914087,0.00021608401,0.00019509175,0.00040551403,0.0003693332],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043318272,0.0015302239,0.08830397,0.0012626945,0.00046067362,0.00010195262,0.19570988,0.31069988,0.0000061187966,0.20617616,0.18936862,0.005946622],"study_design_scores_gemma":[0.003173776,0.0007248269,0.018867144,0.00010034023,0.000031485743,0.00008145344,0.019292444,0.7000039,0.0000017432307,0.033828117,0.22328322,0.00061154546],"about_ca_topic_score_codex":0.13981514,"about_ca_topic_score_gemma":0.0064948304,"teacher_disagreement_score":0.389304,"about_ca_system_score_codex":0.0038804812,"about_ca_system_score_gemma":0.0006704911,"threshold_uncertainty_score":0.99999577},"labels":[],"label_agreement":null},{"id":"W4283527250","doi":"10.1016/j.jval.2022.04.1749","title":"MSR5 Visualizing Network Meta-Analyses is not Trivial - A Novel Take on the Network Diagram","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health Research Topics","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Outcome (game theory); Pairwise comparison; Computer science; Visualization; Data mining; Diagram; Data science; Information retrieval; Artificial intelligence; Mathematics; Database","score_opus":0.7312387314201398,"score_gpt":0.5629214554371543,"score_spread":0.16831727598298551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283527250","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4610833,0.052738864,0.0042557707,0.40044764,0.0234102,0.020531999,0.0012220643,0.00074814854,0.035562027],"genre_scores_gemma":[0.9203433,0.00022725663,0.00095364865,0.071072325,0.0021728254,0.0017789123,0.00004354229,0.00009600322,0.0033121824],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9901931,0.005119873,0.0011340773,0.00070922205,0.0011397786,0.0017039176],"domain_scores_gemma":[0.9954778,0.002766065,0.00043120811,0.00096635683,0.0000301055,0.00032846743],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.009677144,0.00028817428,0.0008355484,0.00014256733,0.0011700641,0.0000472424,0.00069945864,0.00009566387,0.0069200555],"category_scores_gemma":[0.00019734535,0.00021125493,0.0003354363,0.001417182,0.00008790759,0.000041214353,0.00030885372,0.0015368918,0.0001700161],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016515468,0.002305546,0.0053291786,0.00034356685,0.002509595,0.00013159486,0.01054907,0.18989448,0.000018751412,0.267699,0.49074128,0.028826356],"study_design_scores_gemma":[0.0035132759,0.0044522863,0.016264128,0.00011987588,0.00042000503,0.0000614749,0.0018364036,0.045311466,0.000029916873,0.008358547,0.91880023,0.00083240337],"about_ca_topic_score_codex":0.01574974,"about_ca_topic_score_gemma":0.00022750905,"teacher_disagreement_score":0.45926002,"about_ca_system_score_codex":0.00066997885,"about_ca_system_score_gemma":0.00041102388,"threshold_uncertainty_score":0.99398774},"labels":[],"label_agreement":null},{"id":"W4283527881","doi":"10.1016/j.jval.2022.04.904","title":"EPH153 A Population-Based Study of the Epidemiology, Healthcare Resource Utilization and Costs of Duchenne Muscular Dystrophy in Alberta, Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Roche (Canada); Libin Cardiovascular Institute of Alberta","funders":"","keywords":"Medicine; Duchenne muscular dystrophy; Diagnosis code; Health care; Medical prescription; Ambulatory; Pediatrics; Epidemiology; Population; Retrospective cohort study; Medical costs; Emergency medicine; Internal medicine; Environmental health","score_opus":0.029643526493535154,"score_gpt":0.288809186208019,"score_spread":0.25916565971448385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283527881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639106,0.0010880906,0.000006271517,0.0019266263,0.000056361736,0.0004995243,0.000024905798,9.712403e-7,0.0000061755436],"genre_scores_gemma":[0.998936,0.000023374598,0.000020936335,0.0008666665,0.000007944315,0.000039592855,0.000094662275,0.0000070491096,0.0000037854202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974111,0.001663036,0.00043309596,0.00023321943,0.0000877549,0.0001718019],"domain_scores_gemma":[0.99929136,0.00015033441,0.00023255301,0.00026618072,0.000020939615,0.000038634797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006454954,0.00007692159,0.00022185847,0.00004960653,0.000090470756,4.6851744e-7,0.00011638181,0.000046657624,0.0000032757412],"category_scores_gemma":[0.00031503878,0.00006964915,0.000024071693,0.00019961057,0.000030860716,0.0000011393901,0.0000760903,0.00012747486,1.1278563e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019396549,0.0001853347,0.8693335,0.00009836256,0.000007736827,3.5035535e-7,0.00021711875,0.12894155,0.00013853933,0.00032443786,0.00005686416,0.00050222466],"study_design_scores_gemma":[0.0010729346,0.00072824705,0.99254125,0.000034493714,0.0000032488724,8.248624e-7,0.0012732026,0.0036207463,0.000063484025,0.00017012504,0.00041550075,0.000075919226],"about_ca_topic_score_codex":0.9468953,"about_ca_topic_score_gemma":0.79905325,"teacher_disagreement_score":0.14784205,"about_ca_system_score_codex":0.00010132179,"about_ca_system_score_gemma":0.000530464,"threshold_uncertainty_score":0.284021},"labels":[],"label_agreement":null},{"id":"W4283528865","doi":"10.1016/j.jval.2022.04.443","title":"EE194 Cost-Effectiveness Analysis of the Oncotype DX Breast Recurrence Score® Test for Postmenopausal Women with HR+/HER2- Node-Positive Early Breast Cancer in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Breast cancer; Oncology; Internal medicine; Cancer","score_opus":0.02652207861705762,"score_gpt":0.2546484479736108,"score_spread":0.22812636935655317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4283528865","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97992444,0.0008816987,0.000062403305,0.0013879447,0.000386268,0.0011962653,0.015872246,0.0000050384438,0.00028371034],"genre_scores_gemma":[0.9985394,0.00014629686,0.000027541397,0.0005153518,0.000036949972,0.00065491867,0.000019342158,0.000026847758,0.00003336454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798054,0.00011026487,0.00074610405,0.00048292978,0.00008442372,0.0005957472],"domain_scores_gemma":[0.9983794,0.00038112333,0.00071824493,0.00032784205,0.000067010296,0.00012635395],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011638931,0.0001911199,0.00082521705,0.00035366783,0.00016880722,0.000020162333,0.0003545449,0.00004264167,0.0001482857],"category_scores_gemma":[0.000054798413,0.00018721691,0.00006196904,0.0015283626,0.00006879975,0.00015649408,0.00008512142,0.00030785176,0.0000012580183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00049211923,0.00013642665,0.9062894,0.00007978524,0.000116997624,0.0000019284075,0.00083983253,0.08588162,0.0000032236912,0.0025870018,0.000034195724,0.0035374437],"study_design_scores_gemma":[0.00092837814,0.00038244907,0.9915208,0.00010844021,0.000016819324,0.000005801092,0.00019388106,0.0057106246,0.000006083472,0.0005564348,0.0003547177,0.00021556485],"about_ca_topic_score_codex":0.963513,"about_ca_topic_score_gemma":0.7215786,"teacher_disagreement_score":0.24193443,"about_ca_system_score_codex":0.007861448,"about_ca_system_score_gemma":0.0029459037,"threshold_uncertainty_score":0.9959472},"labels":[],"label_agreement":null},{"id":"W4289528638","doi":"10.1016/j.jval.2022.02.006","title":"Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":33,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Reimbursement; Health technology; Health care; Transparency (behavior); Comparative effectiveness research; Medicine; Health economics; Business; Political science","score_opus":0.8340480531300055,"score_gpt":0.5396893270750756,"score_spread":0.29435872605492996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4289528638","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006047822,0.9496085,0.00006360076,0.041103616,0.0019982914,0.0054202443,0.0010455704,0.00010249101,0.00059717905],"genre_scores_gemma":[0.0008935712,0.99403375,0.0009457168,0.0013218765,0.0002160806,0.0019062287,0.0004233759,0.00015574641,0.000103672006],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9569341,0.008291389,0.029938204,0.0024661475,0.00069595815,0.0016742217],"domain_scores_gemma":[0.9737624,0.0020083128,0.021420091,0.0022468115,0.0001445322,0.00041784742],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.13477972,0.00070708117,0.010579668,0.0028140633,0.00026149699,0.00004056836,0.0009967902,0.00070068013,0.00010961442],"category_scores_gemma":[0.0046197353,0.000902406,0.000321208,0.0014552451,0.00011888347,0.0002856463,0.00019878376,0.0017930805,0.000075061456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000065455097,0.0006713,0.001565719,0.32814595,0.000102872866,0.000069494425,0.0030821187,0.0015980217,8.9937785e-10,0.5749155,0.0013755811,0.08846687],"study_design_scores_gemma":[0.000493624,0.0006043523,0.000341061,0.018119149,0.00000849833,0.00021383658,0.00517263,0.0015343315,6.788395e-10,0.0035931554,0.969335,0.0005843161],"about_ca_topic_score_codex":0.116157934,"about_ca_topic_score_gemma":0.0054028276,"teacher_disagreement_score":0.96795946,"about_ca_system_score_codex":0.031365197,"about_ca_system_score_gemma":0.02548709,"threshold_uncertainty_score":0.9993427},"labels":[],"label_agreement":null},{"id":"W4290694631","doi":"10.1016/j.jval.2022.06.017","title":"Revising the Suspected-Cancer Guidelines: Impacts on Patients’ Primary Care Contacts and Costs","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval; Centre hospitalier universitaire de Québec","funders":"Cancer Research UK","keywords":"Interquartile range; Medicine; Nice; Guideline; Referral; Colorectal cancer; Confidence interval; Cancer; Primary care; Internal medicine; Family medicine; Pathology","score_opus":0.13012044976738527,"score_gpt":0.3930884307887857,"score_spread":0.2629679810214004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4290694631","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608529,0.02482148,0.0000023208765,0.011823942,0.00027933955,0.00083557155,0.00003915173,0.000029535659,0.0013157415],"genre_scores_gemma":[0.9578115,0.0021009378,0.00013489253,0.039670896,0.00016111736,0.000040135972,0.000044160253,0.000016109647,0.000020247035],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982575,0.00022203404,0.0004151971,0.0002549609,0.00051741267,0.00033287433],"domain_scores_gemma":[0.99915594,0.00013986441,0.00016271997,0.00023544919,0.00015435343,0.00015165612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067939155,0.000119581324,0.00027040864,0.0000827741,0.0002935395,0.000018840137,0.00009231132,0.00002327408,0.00004602601],"category_scores_gemma":[0.0002838493,0.000087640656,0.000035853456,0.00031108106,0.000026600863,0.000057084086,0.00008585935,0.00039010192,0.0000021807418],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001065687,0.00010649492,0.83238304,0.0007380384,0.000026831425,0.000070692535,0.005447046,0.003545848,0.00005158864,0.00051252806,0.019846821,0.13620539],"study_design_scores_gemma":[0.003530242,0.0024653291,0.9256452,0.0042244983,0.000024386292,0.000046813853,0.005426739,0.0007508879,0.000034757315,0.00005568399,0.05756156,0.00023392292],"about_ca_topic_score_codex":0.01645541,"about_ca_topic_score_gemma":0.00017853,"teacher_disagreement_score":0.13597147,"about_ca_system_score_codex":0.002283854,"about_ca_system_score_gemma":0.0007351324,"threshold_uncertainty_score":0.9900941},"labels":[],"label_agreement":null},{"id":"W4291129604","doi":"10.1016/j.jval.2022.07.009","title":"A Guide to Selecting Flexible Survival Models to Inform Economic Evaluations of Cancer Immunotherapies","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":38,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Institute for Health and Care Research; Bristol-Myers Squibb","keywords":"Medicine","score_opus":0.08805298515709291,"score_gpt":0.40495892514454024,"score_spread":0.3169059399874473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291129604","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742306,0.0046936786,0.00052248716,0.015506164,0.000754893,0.0016966071,0.00010927469,0.000056826113,0.0024295],"genre_scores_gemma":[0.98879033,0.0004689364,0.0027472582,0.005006926,0.00010364745,0.00054565846,0.000014834717,0.000039159448,0.0022832432],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.99846965,0.00010934483,0.00064605137,0.0001988845,0.00027324632,0.00030285175],"domain_scores_gemma":[0.99937016,0.00009012044,0.0001425326,0.00025020313,0.000052798794,0.00009418279],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016956141,0.0001043815,0.0003185097,0.0003485208,0.00018757413,0.000008351916,0.00012515497,0.000023138455,0.00054157875],"category_scores_gemma":[0.000022189268,0.0001098958,0.0000694999,0.0006413196,0.000015221017,0.000060376577,0.000060037975,0.00014281372,0.0000058136325],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025140808,0.00013152292,0.0062467325,0.0001998172,0.0001609574,9.3140824e-7,0.019220669,0.8695098,0.005660649,0.0012169392,0.0032192403,0.09191866],"study_design_scores_gemma":[0.01895334,0.009974916,0.07288029,0.0019085546,0.00009853924,0.00006476162,0.0217482,0.20162849,0.012184908,0.0023160758,0.6568316,0.0014103218],"about_ca_topic_score_codex":0.13877681,"about_ca_topic_score_gemma":0.0024864408,"teacher_disagreement_score":0.6678813,"about_ca_system_score_codex":0.001999844,"about_ca_system_score_gemma":0.0020086414,"threshold_uncertainty_score":0.86695814},"labels":[],"label_agreement":null},{"id":"W4291710093","doi":"10.1016/j.jval.2022.06.015","title":"Measuring, Analyzing, and Presenting Work Productivity Loss in Randomized Controlled Trials: A Scoping Review","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Workplace Health and Well-being","field":"Health Professions","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes; University of British Columbia","funders":"Michael Smith Health Research BC","keywords":"Presenteeism; Absenteeism; Randomized controlled trial; Productivity; Medicine; Physical therapy; Psychology; Economics","score_opus":0.2966418737397171,"score_gpt":0.4938031018404098,"score_spread":0.1971612281006927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4291710093","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000038007358,0.9259014,0.000022695303,0.0019118316,0.0016545901,0.06966867,0.000010813205,0.00010856478,0.0006834133],"genre_scores_gemma":[0.0000147347,0.97874963,0.0002736039,0.00067199144,0.0008293982,0.018908478,0.000053679763,0.00014201755,0.00035647713],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.82145286,0.15829435,0.015241053,0.0016962994,0.00097170164,0.0023437508],"domain_scores_gemma":[0.9055182,0.080508,0.012020499,0.0011850718,0.0001113884,0.0006568639],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2484588,0.00096770364,0.03504549,0.0015119145,0.0012295638,0.00003671962,0.00047806924,0.000558572,0.00043206188],"category_scores_gemma":[0.09343435,0.00071661104,0.0016637001,0.0026854053,0.00012010314,0.00016723182,0.00048996677,0.0055342796,0.000029035087],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0050487984,0.00010032254,0.0013801199,0.7943823,0.00016732498,0.000032197393,0.0010392427,0.00004436878,1.0031027e-9,0.00019784312,0.00034780827,0.19725968],"study_design_scores_gemma":[0.06618809,0.000024597692,0.000008079511,0.7702367,0.0005547071,0.000007783477,0.000044611752,0.000072187315,2.2707818e-9,0.00018144031,0.16226408,0.0004177221],"about_ca_topic_score_codex":0.004457604,"about_ca_topic_score_gemma":0.00037903443,"teacher_disagreement_score":0.19684196,"about_ca_system_score_codex":0.0017735108,"about_ca_system_score_gemma":0.010780441,"threshold_uncertainty_score":0.9995285},"labels":[],"label_agreement":null},{"id":"W4293161987","doi":"10.1016/j.jval.2022.07.015","title":"Generic Health-Related Quality of Life Utility Measure for Preschool Children (Health Utilities Preschool): Design, Development, and Properties","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":28,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Dalhousie University; Public Health Ontario; University of Toronto; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Health Utilities Index; Intraclass correlation; Interpretability; Quality of life (healthcare); Reliability (semiconductor); Psychology; Quality (philosophy); Index (typography); Test (biology); Statistics; Developmental psychology; Health related quality of life; Applied psychology; Psychometrics; Mathematics; Artificial intelligence; Computer science","score_opus":0.573156690105205,"score_gpt":0.39172589689531795,"score_spread":0.18143079320988703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293161987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8220986,0.11014667,0.009790411,0.046199612,0.0006710474,0.009416168,0.0014324054,0.00014335373,0.00010171259],"genre_scores_gemma":[0.9776458,0.0005583941,0.01204689,0.008001533,0.00009168589,0.0012536526,0.00012245162,0.000069567475,0.00020998549],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9802363,0.0058154985,0.011360692,0.0011355323,0.00033841864,0.0011135903],"domain_scores_gemma":[0.99148643,0.0011463731,0.005935448,0.0007147154,0.00009742142,0.0006196374],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.08041277,0.0003541581,0.0024175888,0.00055653125,0.0010231688,0.00005061853,0.00045296858,0.00013160829,0.00012858573],"category_scores_gemma":[0.0053259796,0.00044532522,0.0001348228,0.0004608078,0.00013175509,0.00035166508,0.00018718783,0.00052008906,0.000020345693],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001368382,0.0019268686,0.7493389,0.02727596,0.0006571075,4.4908086e-7,0.07841122,0.033993047,0.0000051446405,0.051980067,0.045427874,0.009614969],"study_design_scores_gemma":[0.006890495,0.001693031,0.8971952,0.00071409123,0.000006502828,0.000015208591,0.008703443,0.04426111,0.00001814045,0.016639488,0.022545476,0.0013178058],"about_ca_topic_score_codex":0.04814376,"about_ca_topic_score_gemma":0.00053901365,"teacher_disagreement_score":0.15554723,"about_ca_system_score_codex":0.0020624804,"about_ca_system_score_gemma":0.0062270006,"threshold_uncertainty_score":0.99979985},"labels":[],"label_agreement":null},{"id":"W4293558719","doi":"10.1016/j.jval.2022.07.016","title":"The Use of Generic Patient-Reported Outcome Measures in Emergency Department Surveys: Discriminant Validity Evidence for the Veterans RAND 12-Item Health Survey and the EQ-5D","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Trinity Western University; Ministry of Health; Western University","funders":"Canada Research Chairs; Trinity Western University","keywords":"Mental health; Discriminant validity; Patient Health Questionnaire; Medicine; Comorbidity; Logistic regression; Anxiety; Patient-reported outcome; EQ-5D; Psychiatry; Clinical psychology; Psychology; Psychometrics; Quality of life (healthcare)","score_opus":0.7689206212697642,"score_gpt":0.4870731421387547,"score_spread":0.28184747913100955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4293558719","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.958947,0.009515287,0.0010527346,0.014915577,0.0040043686,0.0107868165,0.0007426421,0.000033690674,0.0000018758324],"genre_scores_gemma":[0.98406285,0.010854993,0.000110712965,0.0012385128,0.00005543258,0.003504241,0.00007370187,0.00004539702,0.000054162],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9372352,0.055044267,0.0045638015,0.00068240863,0.0011798996,0.0012944626],"domain_scores_gemma":[0.96243125,0.03366468,0.0023539523,0.0010549789,0.00027226776,0.00022285752],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.043923978,0.0003096315,0.00085775834,0.00018037521,0.004004393,0.000018445617,0.00043663147,0.00009048043,0.000026754444],"category_scores_gemma":[0.008161128,0.00017215856,0.00014415958,0.00077632396,0.0002009614,0.00017273954,0.00030624805,0.0011112114,0.0000012073015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001178915,0.00006844485,0.9717367,0.00071912596,0.000028011684,0.0000012030521,0.012081566,0.0049849064,0.0000010494651,0.00016511018,0.0015288631,0.0075060967],"study_design_scores_gemma":[0.0022523068,0.0005430233,0.98460895,0.0002583636,0.000013202884,0.0000035034036,0.0026960738,0.006622479,7.473327e-7,0.00023066175,0.0026169096,0.00015376865],"about_ca_topic_score_codex":0.3467637,"about_ca_topic_score_gemma":0.15238428,"teacher_disagreement_score":0.19437942,"about_ca_system_score_codex":0.001317555,"about_ca_system_score_gemma":0.0018268664,"threshold_uncertainty_score":0.9972923},"labels":[],"label_agreement":null},{"id":"W4304183885","doi":"10.1016/j.jval.2022.09.001","title":"HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects: A Good Practices Report of a Joint ISPE/ISPOR Task Force","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Institute for Clinical Evaluative Sciences; University of Toronto","funders":"National Heart, Lung, and Blood Institute; National Institute on Aging; National Institutes of Health; Wellcome Trust","keywords":"Protocol (science); Reproducibility; Task force; Task (project management); Computer science; Joint (building); Medical physics; Data mining; Medicine; Engineering; Alternative medicine; Mathematics; Statistics; Pathology; Systems engineering; Political science","score_opus":0.8858172267355363,"score_gpt":0.6478881162136745,"score_spread":0.23792911052186183,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4304183885","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8702136,0.00088932406,0.00014636804,0.004601005,0.0002283578,0.12353192,0.00002190601,0.000011763213,0.00035569872],"genre_scores_gemma":[0.8392813,0.00008462793,0.031563856,0.000256573,0.000054827196,0.123893626,0.0000011095681,0.000026695729,0.004837354],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.8535279,0.08733271,0.037650295,0.007028876,0.013565466,0.00089474843],"domain_scores_gemma":[0.84007716,0.07139588,0.06760882,0.018311393,0.0022555084,0.00035126306],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.4326069,0.00038412,0.0054669534,0.0007405194,0.0002713997,0.000076464035,0.0009303619,0.000030753923,0.00033233388],"category_scores_gemma":[0.47474024,0.00020685479,0.000942916,0.0033884218,0.000061503626,0.00021408332,0.0003291366,0.00021633093,0.000040852516],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006090563,0.009642976,0.27680242,0.03842282,0.003967627,0.00053846434,0.10178246,0.1795699,0.03473312,0.0012796451,0.014493109,0.3326769],"study_design_scores_gemma":[0.009782608,0.08363158,0.3656632,0.040541504,0.003708225,0.0005142736,0.038884062,0.1097745,0.23717934,0.06306989,0.042885646,0.004365181],"about_ca_topic_score_codex":0.0057646437,"about_ca_topic_score_gemma":0.00047512597,"teacher_disagreement_score":0.3283117,"about_ca_system_score_codex":0.0010461038,"about_ca_system_score_gemma":0.0010064011,"threshold_uncertainty_score":0.87144554},"labels":[],"label_agreement":null},{"id":"W4307955800","doi":"10.1016/j.jval.2022.09.2479","title":"Analyzing Pragmatic Trials to Inform Cost-Effectiveness Analyses","year":2022,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Government of Canada; Bill and Melinda Gates Foundation; United States Agency for International Development","keywords":"Premise; Psychological intervention; Protocol (science); Context (archaeology); Selection (genetic algorithm); Scale (ratio); Psychology; Computer science; Medicine; Epistemology; Alternative medicine; Artificial intelligence; Psychiatry","score_opus":0.7339025097111027,"score_gpt":0.5443817416088326,"score_spread":0.18952076810227014,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4307955800","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0026841848,0.006364737,0.0038863944,0.9713935,0.0027699512,0.008931224,0.0022803647,0.000116786694,0.0015728393],"genre_scores_gemma":[0.0026420655,0.0005432667,0.0027453112,0.98522776,0.0028774925,0.0036952451,0.0012477839,0.00018695291,0.00083410775],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.96845436,0.011796085,0.016424017,0.0014811356,0.0003898374,0.0014545535],"domain_scores_gemma":[0.9718244,0.017298467,0.009153132,0.0012946741,0.00007831866,0.00035097852],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch","insufficient_payload"],"category_scores_codex":[0.1574496,0.0005877487,0.0060198056,0.0032739274,0.00048901263,0.00019881279,0.00084768736,0.00058408856,0.0020165457],"category_scores_gemma":[0.028886408,0.00075084646,0.0005356612,0.0017057746,0.000045467445,0.000413672,0.00021053957,0.00203682,0.0017885516],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045506826,0.00008624525,0.004570889,0.0087147,0.00028245815,0.000020998217,0.0021934756,0.045999862,2.2248724e-7,0.006307862,0.93123245,0.0005453139],"study_design_scores_gemma":[0.0009896206,0.00027600396,0.002106582,0.000863301,0.000019331677,0.000008203338,0.00031421942,0.005050917,5.6135815e-7,0.0063065286,0.9833555,0.0007092288],"about_ca_topic_score_codex":0.026901612,"about_ca_topic_score_gemma":0.000171229,"teacher_disagreement_score":0.1285632,"about_ca_system_score_codex":0.0078180125,"about_ca_system_score_gemma":0.0015639198,"threshold_uncertainty_score":0.99949425},"labels":[],"label_agreement":null},{"id":"W4308949677","doi":"10.1016/j.jval.2022.11.003","title":"Modeling Tiered Pricing Frameworks: A Simulation Approach","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Centre for Advancing Health Outcomes; University of British Columbia; St. Paul's Hospital; University of Toronto","funders":"Institute of Population and Public Health; Canadian Institutes of Health Research","keywords":"Computer science","score_opus":0.1747292760358831,"score_gpt":0.3388581767082557,"score_spread":0.1641289006723726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4308949677","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7753909,0.0072619235,0.18343398,0.007945858,0.001090701,0.0011130412,0.00023639946,0.000111723464,0.023415472],"genre_scores_gemma":[0.99322534,0.00014311027,0.002290708,0.004097485,0.00010638536,0.000048436064,0.000016838292,0.000023164519,0.00004854123],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99847573,0.00006140035,0.0007340861,0.0003282183,0.0000317337,0.00036882347],"domain_scores_gemma":[0.99942285,0.00007926113,0.00018162106,0.0002046839,0.0000055298965,0.00010603972],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014310379,0.00009492031,0.00029904812,0.00028626694,0.00020199835,0.000030709252,0.00017245827,0.00006815624,0.00015536723],"category_scores_gemma":[0.00007342726,0.00013247131,0.000058658305,0.0003255388,0.000010157888,0.00009731097,0.00010129003,0.00062964926,0.000041970492],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009484019,0.00006597398,0.0016105548,0.000037017617,0.000004803999,3.335327e-7,0.0008269672,0.86393744,1.8650105e-7,0.13287716,0.00003990175,0.0005901695],"study_design_scores_gemma":[0.0003110283,0.000032043725,0.00012783411,0.000006380666,4.7572792e-7,0.0000011343959,0.00009836932,0.9210173,1.6900049e-7,0.0688457,0.0094397655,0.00011983274],"about_ca_topic_score_codex":0.002506144,"about_ca_topic_score_gemma":0.0000022018633,"teacher_disagreement_score":0.21783443,"about_ca_system_score_codex":0.0005882072,"about_ca_system_score_gemma":0.00006949568,"threshold_uncertainty_score":0.5402023},"labels":[],"label_agreement":null},{"id":"W4310927699","doi":"10.1016/j.jval.2022.12.002","title":"Development of the Cystic Fibrosis Questionnaire-Revised-8 Dimensions: Estimating Utilities From the Cystic Fibrosis Questionnaire-Revised","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cystic Fibrosis Research Advances","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; St. Paul's Hospital","funders":"","keywords":"Medicine; Quality of life (healthcare); Cystic fibrosis; Physical therapy; Clinical psychology; Internal medicine","score_opus":0.03474663053389354,"score_gpt":0.3214268659082409,"score_spread":0.28668023537434734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4310927699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9433732,0.030156448,0.008216123,0.012045981,0.0014371675,0.004159953,0.00033256973,0.00023141407,0.00004713194],"genre_scores_gemma":[0.86752003,0.000110570625,0.13088545,0.00058235077,0.0001614965,0.0005127767,0.00007033964,0.00005633909,0.00010065547],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99326736,0.0019372319,0.0016773823,0.00065523695,0.0016614822,0.0008012848],"domain_scores_gemma":[0.9950647,0.0026835306,0.0006436881,0.001116561,0.00020153048,0.00029002],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.003071895,0.0003725699,0.00078743347,0.00021230489,0.0013342289,0.000050698924,0.0006171599,0.000073406365,0.00016419149],"category_scores_gemma":[0.007115702,0.00025428797,0.00019711656,0.0012037369,0.00037251457,0.00013791856,0.0006083603,0.00086663937,0.000021034071],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0058472673,0.003911118,0.24496356,0.023867663,0.0008160729,0.00008575793,0.076543815,0.3496898,0.035752907,0.010626537,0.014541639,0.23335384],"study_design_scores_gemma":[0.0046313377,0.0015107346,0.6124995,0.03613784,0.00021641028,0.00011421312,0.0057323193,0.31490022,0.0014553837,0.0060004224,0.015837818,0.00096380763],"about_ca_topic_score_codex":0.0073326323,"about_ca_topic_score_gemma":0.00017003162,"teacher_disagreement_score":0.36753592,"about_ca_system_score_codex":0.001557068,"about_ca_system_score_gemma":0.0027472125,"threshold_uncertainty_score":0.99999094},"labels":[],"label_agreement":null},{"id":"W4311200002","doi":"10.1016/j.jval.2022.11.017","title":"A Comparison of Alternative Network Meta-Analysis Methods in the Presence of Nonproportional Hazards: A Case Study in First-Line Advanced or Metastatic Renal Cell Carcinoma","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"Bristol-Myers Squibb","keywords":"Hazard ratio; Proportional hazards model; Hazard; Medicine; Survival analysis; Event (particle physics); Randomized controlled trial; Meta-analysis; Internal medicine; Statistics; Oncology; Mathematics; Confidence interval; Chemistry; Physics","score_opus":0.8342556377342246,"score_gpt":0.6213187337870495,"score_spread":0.21293690394717513,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311200002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9580776,0.007158542,0.029935678,0.00070353015,0.00009664822,0.003870326,0.00009143867,0.0000014857392,0.00006474988],"genre_scores_gemma":[0.94680005,0.000012885875,0.052321736,0.0000930621,0.000011511012,0.00060288276,0.000006186983,0.0000080917225,0.0001435677],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.8168394,0.147391,0.024888514,0.0016702381,0.008571265,0.0006395775],"domain_scores_gemma":[0.96482885,0.022633055,0.009632852,0.002392794,0.00041801744,0.000094425566],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.2555802,0.0002926864,0.008147528,0.0012809105,0.00015981644,0.00005646316,0.0017048209,0.000023446602,0.0025203142],"category_scores_gemma":[0.00896308,0.0001346304,0.0018773011,0.010990357,0.000069599446,0.00012344524,0.00029336291,0.00046088698,0.0000033802119],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007254397,0.0011752401,0.10531303,0.00011567398,0.0024714062,0.0002253085,0.016915936,0.8725013,0.0000012932596,0.00010354049,0.00017602103,0.00092866796],"study_design_scores_gemma":[0.00095712737,0.0012277337,0.01443874,0.000015042861,0.011112168,0.000062723746,0.051762264,0.91758823,0.000012730618,0.0022545736,0.00038433773,0.00018430901],"about_ca_topic_score_codex":0.017165583,"about_ca_topic_score_gemma":0.017358849,"teacher_disagreement_score":0.2466171,"about_ca_system_score_codex":0.0001425525,"about_ca_system_score_gemma":0.00045053134,"threshold_uncertainty_score":0.9993848},"labels":[],"label_agreement":null},{"id":"W4311331782","doi":"10.1016/j.jval.2022.09.992","title":"EPH70 Transcription Errors in Ophthalmology: Current Burden and the Opportunity for Digital Technologies","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Software; Human error; Computer science; Risk analysis (engineering)","score_opus":0.48562994880418014,"score_gpt":0.43237557081016076,"score_spread":0.053254377994019386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311331782","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7295556,0.015963096,0.00040768975,0.249382,0.00084268657,0.002689624,0.0006965502,0.000064363405,0.0003983786],"genre_scores_gemma":[0.99724406,0.000556862,0.0002547101,0.0008585462,0.00006657004,0.0008880177,0.00004593891,0.000017454351,0.000067865476],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99588645,0.000622567,0.0025782723,0.00042913517,0.00007059829,0.0004129736],"domain_scores_gemma":[0.99754465,0.00112753,0.00093390356,0.00030429335,0.000013683698,0.000075965996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022495108,0.00012690778,0.00069687277,0.00045289067,0.00028643257,0.000039387643,0.00027382892,0.00006729661,0.000045452758],"category_scores_gemma":[0.002575073,0.0001384145,0.00006822231,0.00026829413,0.00014353327,0.00023226523,0.00008561261,0.00038766392,0.000014425342],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00036632802,0.00038451934,0.1240143,0.002474062,0.00004191377,0.000005932002,0.025120068,0.020058252,8.0050893e-7,0.8065654,0.004916192,0.016052248],"study_design_scores_gemma":[0.0066474946,0.00052355276,0.017216545,0.00017202491,0.0000029612024,0.00007851604,0.029774174,0.110314205,5.6234575e-7,0.6964888,0.138269,0.0005121461],"about_ca_topic_score_codex":0.0039085075,"about_ca_topic_score_gemma":0.0000529208,"teacher_disagreement_score":0.26768842,"about_ca_system_score_codex":0.0008337972,"about_ca_system_score_gemma":0.00031749086,"threshold_uncertainty_score":0.77964},"labels":[],"label_agreement":null},{"id":"W4311332319","doi":"10.1016/j.jval.2022.09.760","title":"EE519 Cost Effectiveness Analysis of Avacopan in Antineutrophil Cytoplasm Antibody-Associated Vasculitis - A Canadian Perspective","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Vasculitis and related conditions","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Rituximab; Anti-neutrophil cytoplasmic antibody; Vasculitis; Cyclophosphamide; Medicine; Perspective (graphical); Antibody; Cytoplasm; Immunology; Internal medicine; Chemotherapy; Chemistry; Biochemistry; Disease; Computer science","score_opus":0.021229862549495562,"score_gpt":0.31598453716034847,"score_spread":0.2947546746108529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311332319","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99336755,0.0011108399,0.000008364684,0.0027123704,0.00016660999,0.0010190754,0.00056539796,0.000025909452,0.0010238691],"genre_scores_gemma":[0.99857664,0.00044356912,0.000026378435,0.0002588648,0.000018167535,0.000097147524,0.00051373255,0.0000231234,0.000042385134],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99708736,0.0010391327,0.0005553922,0.00040905428,0.00035962497,0.00054942194],"domain_scores_gemma":[0.9988752,0.0002315282,0.00017797804,0.0002954906,0.00012803529,0.0002917525],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013541479,0.00015836892,0.0008803761,0.0021451558,0.00021968373,0.0000073207666,0.00010967911,0.000100072466,0.00029755797],"category_scores_gemma":[0.00021084,0.00016833204,0.00028110214,0.0045762626,0.000057330253,0.000043958484,0.00003990801,0.0006663642,0.0000044484377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014117196,0.0011246444,0.85076743,0.00022183782,0.0021176548,0.0007611066,0.006221618,0.12800258,0.0005678462,0.009580875,0.00011035672,0.00038285748],"study_design_scores_gemma":[0.0035492494,0.00049599155,0.9812441,0.00028922496,0.0003352206,0.000041500818,0.0019675728,0.0114236055,0.000019571959,0.00025981638,0.00022340847,0.00015072385],"about_ca_topic_score_codex":0.8400685,"about_ca_topic_score_gemma":0.15470155,"teacher_disagreement_score":0.685367,"about_ca_system_score_codex":0.00373549,"about_ca_system_score_gemma":0.001865287,"threshold_uncertainty_score":0.9768176},"labels":[],"label_agreement":null},{"id":"W4311332939","doi":"10.1016/j.jval.2022.09.660","title":"EE414 Cost-Effectiveness of Mobile Intermittent Pneumatic Compression Devices (IPCD) Compared to Traditional IPCD for Early Postoperative Total Knee Replacement: The Hospital’s Perspectives","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Total Knee Arthroplasty Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Reimbursement; Economic evaluation; Cost effectiveness; Quality of life (healthcare); Physical therapy; Health care; Emergency medicine","score_opus":0.050186844731795154,"score_gpt":0.3261354727008441,"score_spread":0.27594862796904895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311332939","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871232,0.00081514154,0.00023630212,0.0030481948,0.00048384455,0.007938816,0.00023751758,0.000038218335,0.00007876003],"genre_scores_gemma":[0.9962428,0.000010082885,0.00046221528,0.00037493967,0.000041221923,0.002696674,0.00006752512,0.000030859577,0.000073653144],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9971722,0.00094505283,0.0006161379,0.00041761823,0.0005023913,0.0003466219],"domain_scores_gemma":[0.9976472,0.0014941435,0.00024652752,0.00033052333,0.0001298495,0.00015174547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012799354,0.00020651528,0.00061587134,0.00020159376,0.00038450485,0.00002178987,0.0001441114,0.000030079533,0.00015123886],"category_scores_gemma":[0.00018564222,0.00015999466,0.00014828627,0.00030558588,0.00010969814,0.0001289895,0.00014468326,0.0003447655,0.0000063837056],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.019106757,0.013024291,0.23660134,0.0070978543,0.00102572,0.00006679436,0.42548183,0.24993673,0.008238096,0.015216206,0.003224522,0.020979883],"study_design_scores_gemma":[0.006254201,0.01473153,0.91471016,0.0012943838,0.00003673049,0.000088677945,0.04800071,0.012988454,0.0004056688,0.00015386948,0.0010621992,0.00027343773],"about_ca_topic_score_codex":0.0011131277,"about_ca_topic_score_gemma":0.000026116071,"teacher_disagreement_score":0.6781088,"about_ca_system_score_codex":0.0008363454,"about_ca_system_score_gemma":0.00030373523,"threshold_uncertainty_score":0.6524393},"labels":[],"label_agreement":null},{"id":"W4311332949","doi":"10.1016/j.jval.2022.09.846","title":"EE607 Healthcare Utilisation of Patients With Eosinophilic Granulomatosis With Polyangiitis (EGPA): A European Perspective","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Medicine; Pediatrics; Granulomatosis with polyangiitis; Cohort; Asthma; Retrospective cohort study; Internal medicine; Vasculitis; Disease","score_opus":0.0168169861265941,"score_gpt":0.24770740156910745,"score_spread":0.23089041544251335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311332949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98760796,0.0014382264,0.000022364817,0.007870658,0.000062799656,0.0011992591,0.00012548575,0.000052351475,0.0016209208],"genre_scores_gemma":[0.9982014,0.00008795112,0.00040560303,0.0010084898,0.00002132889,0.000047504738,0.00010999558,0.00005326294,0.000064509906],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99753016,0.00053133356,0.00046668228,0.00040398235,0.00067853276,0.0003893185],"domain_scores_gemma":[0.9989524,0.000055852775,0.00027953697,0.0003608614,0.00016888711,0.00018250226],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00051657966,0.00018659506,0.00048012537,0.00035549028,0.00021252743,0.000007533471,0.00011289265,0.00002611961,0.00008603044],"category_scores_gemma":[0.00003371101,0.00015297846,0.000056377794,0.0007898775,0.0001054868,0.000070368704,0.000054030246,0.0003124409,0.000003044803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010767417,0.0014557922,0.96916556,0.00076933554,0.00006767646,0.000058564,0.015504573,0.00050723425,0.000006886049,0.0068929987,0.00020111554,0.0042935135],"study_design_scores_gemma":[0.004421153,0.0073643615,0.9780355,0.00043311878,0.000026628022,0.00006359335,0.008243787,0.00022434529,0.000008435023,0.00045186526,0.00053412246,0.00019306206],"about_ca_topic_score_codex":0.01226292,"about_ca_topic_score_gemma":0.00016209146,"teacher_disagreement_score":0.012100829,"about_ca_system_score_codex":0.0005157118,"about_ca_system_score_gemma":0.0004906954,"threshold_uncertainty_score":0.9943145},"labels":[],"label_agreement":null},{"id":"W4311332979","doi":"10.1016/j.jval.2022.09.1209","title":"HPR79 A Qualitative Exploration of Drivers of Cannabis Purchase Decisions in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Legalization; Cannabis; Business; Product (mathematics); Advertising; Marketing; Environmental health; Medicine; Psychiatry","score_opus":0.09933753477325599,"score_gpt":0.39082510555118755,"score_spread":0.2914875707779315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311332979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614862,0.0004793181,0.000043750228,0.036989097,0.000099382996,0.00065578794,0.00012478688,0.0000031098634,0.000118551245],"genre_scores_gemma":[0.998685,0.00016240406,0.00018214366,0.0003646319,0.0000100946545,0.00013142325,0.000028864635,0.000010951296,0.00042448603],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9975883,0.00055064354,0.00063898007,0.00018464286,0.0007602182,0.000277217],"domain_scores_gemma":[0.999236,0.00006892891,0.00016967041,0.00021942612,0.00014962006,0.00015638702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015717982,0.000073453964,0.00035075465,0.0004083312,0.000053522097,0.0000014060876,0.00009876424,0.000018770266,0.00012241886],"category_scores_gemma":[0.00061059033,0.00007451795,0.000041821488,0.0009855326,0.000049755,0.000053232277,0.000070257716,0.0003026337,3.4138176e-7],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003179192,0.002514303,0.050061952,0.0022086357,0.00009438839,0.0005101173,0.4211179,0.19770555,0.0030467934,0.012518145,0.23855893,0.06848408],"study_design_scores_gemma":[0.011219187,0.005547473,0.09374789,0.001002036,0.000020232212,0.000042398544,0.77342623,0.0259628,0.0023535765,0.004198497,0.08199623,0.0004834171],"about_ca_topic_score_codex":0.9851279,"about_ca_topic_score_gemma":0.800551,"teacher_disagreement_score":0.35230836,"about_ca_system_score_codex":0.002343227,"about_ca_system_score_gemma":0.012489463,"threshold_uncertainty_score":0.9931088},"labels":[],"label_agreement":null},{"id":"W4311333153","doi":"10.1016/j.jval.2022.09.1265","title":"HPR136 The Associations of Prescription Drug Insurance and Cost-Sharing With Drug Use, Health Services Use, and Health – A Systematic Review of Canadian Studies","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Cost sharing; Drug; Medical prescription; Prescription drug; Medicine; Actuarial science; Specialty; Environmental health; Business; Family medicine; Pharmacology; Nursing","score_opus":0.33129663583526237,"score_gpt":0.36781962359721515,"score_spread":0.036522987761952785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311333153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010591037,0.98245084,0.0000023414952,0.008067293,0.00015632788,0.0073160897,0.001851925,0.000012200963,0.000037065194],"genre_scores_gemma":[0.00081156223,0.9936936,0.0001280452,0.004397268,0.000018392997,0.0007205358,0.00009198731,0.000040080595,0.00009854907],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9944871,0.0010021796,0.0032472317,0.0005535462,0.00013964606,0.0005702954],"domain_scores_gemma":[0.99363005,0.00067085004,0.0047561456,0.00060754817,0.000064355176,0.0002710623],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0096251685,0.000317344,0.0038853602,0.0010300452,0.00038015022,0.000053778815,0.00030642084,0.000058635367,0.0000026900223],"category_scores_gemma":[0.0003225554,0.00026022992,0.000111722824,0.0013218895,0.00005846837,0.00025872685,0.00014987426,0.00044977502,0.0000010402798],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.374121e-7,0.00002496962,0.0028415069,0.9622815,0.00014865589,5.344629e-7,0.003924684,0.00001868604,4.221124e-11,0.026964922,0.00039635735,0.0033973083],"study_design_scores_gemma":[0.00018499674,0.00010600946,0.003909291,0.60656625,0.00005374481,0.000006839281,0.0007548551,0.00008208647,1.3859508e-9,0.00034334618,0.38776228,0.0002303355],"about_ca_topic_score_codex":0.93830895,"about_ca_topic_score_gemma":0.5818999,"teacher_disagreement_score":0.3873659,"about_ca_system_score_codex":0.0017504203,"about_ca_system_score_gemma":0.0012665439,"threshold_uncertainty_score":0.999985},"labels":[],"label_agreement":null},{"id":"W4311333205","doi":"10.1016/j.jval.2022.09.1193","title":"HPR61 Cannabis Edibles: Using a Discrete Choice Experiment to Explore Patterns of Purchase Preferences Among Canadians","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland","funders":"","keywords":"Cannabis; Consumption (sociology); Advertising; Accidental; Business; Psychology; Sociology; Psychiatry; Social science","score_opus":0.1049600704807775,"score_gpt":0.3759209959704342,"score_spread":0.2709609254896567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311333205","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9818027,0.00082627137,0.00006214252,0.015397314,0.0002548261,0.0013571718,0.00017886359,0.000019608935,0.00010111027],"genre_scores_gemma":[0.9968786,0.00005941222,0.00012372923,0.0008861086,0.00014496926,0.0005824792,0.000036577196,0.000036975813,0.0012511482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972023,0.0002793894,0.00056447345,0.00042164483,0.0008097802,0.00072240765],"domain_scores_gemma":[0.9986192,0.000015363146,0.00013404514,0.00042411024,0.0000789601,0.00072831416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007232424,0.00017095721,0.0004399281,0.0005459588,0.00023086423,0.000017037608,0.00022341899,0.000040569357,0.0004413786],"category_scores_gemma":[0.00010553251,0.00016426858,0.00008361811,0.00067421293,0.000063978354,0.00005652421,0.00019235864,0.00040017982,0.0000011715739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007231881,0.0012161067,0.7214544,0.0038929926,0.00012730496,0.00036121887,0.13703008,0.06606255,0.003954302,0.0003603094,0.05197008,0.012847475],"study_design_scores_gemma":[0.007820559,0.013014386,0.44004694,0.003725521,0.000081601596,0.000178598,0.22095369,0.036758058,0.0066191764,0.00019479507,0.26899126,0.0016154302],"about_ca_topic_score_codex":0.7732109,"about_ca_topic_score_gemma":0.028113246,"teacher_disagreement_score":0.74509764,"about_ca_system_score_codex":0.0014560326,"about_ca_system_score_gemma":0.0023763967,"threshold_uncertainty_score":0.98962116},"labels":[],"label_agreement":null},{"id":"W4311333331","doi":"10.1016/j.jval.2022.09.931","title":"EPH8 Factors Associated With Oral Anticoagulant Switching in Patients With Atrial Fibrillation","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Atrial fibrillation; Medicine; Internal medicine; Vitamin k; Stroke (engine); Cardiology","score_opus":0.08897633262924041,"score_gpt":0.3236349419093532,"score_spread":0.23465860928011278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311333331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9974669,0.000047661677,0.00004033031,0.0011130223,0.00018761889,0.0010431908,0.000008977526,0.000046540754,0.000045765493],"genre_scores_gemma":[0.999366,0.000006101021,0.00013470306,0.00010392214,0.00011298375,8.567687e-7,0.00019785186,0.000022346127,0.000055261604],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982527,0.00027781044,0.00041350245,0.00022711145,0.0005393122,0.00028956286],"domain_scores_gemma":[0.9993521,0.00016898024,0.00024834796,0.00013151273,0.00002755538,0.00007150913],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006452508,0.00012868966,0.000392883,0.00031403007,0.00013510257,0.00001358141,0.00004329312,0.000031321084,0.000045188488],"category_scores_gemma":[0.00013607941,0.0000981271,0.000051922307,0.000665214,0.000010412705,0.00009479933,0.00004307037,0.00019672976,0.0000013228134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00067065615,0.0000125779325,0.9421759,0.00003347445,0.000031536987,0.000004457062,0.00057378114,0.055678733,0.0000010134328,0.00011837595,0.000016379252,0.00068308675],"study_design_scores_gemma":[0.006692665,0.0009592185,0.9851543,0.00011366182,0.000021008227,4.0126855e-7,0.00020888154,0.006215297,0.0000012282391,0.000036275705,0.00048385732,0.00011320989],"about_ca_topic_score_codex":0.0018710993,"about_ca_topic_score_gemma":0.0001379894,"teacher_disagreement_score":0.049463436,"about_ca_system_score_codex":0.00057004293,"about_ca_system_score_gemma":0.00019021641,"threshold_uncertainty_score":0.40015072},"labels":[],"label_agreement":null},{"id":"W4311333885","doi":"10.1016/j.jval.2022.09.682","title":"EE436 General-Purpose Methods for Simulating Survival Data for Expected Value of Sample Information Calculations","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Sample (material); Computer science; Value (mathematics); Term (time); Parametric statistics; Sampling (signal processing); Statistics; Value of information; Sample size determination; Econometrics; Data mining; Mathematics; Machine learning; Artificial intelligence","score_opus":0.6352303352871447,"score_gpt":0.5342563891131628,"score_spread":0.10097394617398192,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311333885","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05185346,0.0013290424,0.9142452,0.012692583,0.0014668104,0.004626336,0.013592378,0.000061411316,0.00013279043],"genre_scores_gemma":[0.09256203,0.000057271576,0.89436555,0.005749506,0.00037462442,0.0013385307,0.0054110507,0.0000637764,0.00007767444],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9917615,0.0013624416,0.00574131,0.00049953064,0.000121624325,0.00051357644],"domain_scores_gemma":[0.9869103,0.008548405,0.003322309,0.000967914,0.00010797261,0.00014311794],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.043396015,0.00016602469,0.0010209171,0.00058752456,0.00052664283,0.00003952162,0.0005266635,0.00008190487,0.00009887872],"category_scores_gemma":[0.014597966,0.00023824284,0.00011854979,0.00046862598,0.000029031211,0.0007340466,0.00020917977,0.00017251818,0.000009082858],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005468962,0.00012940557,0.01016108,0.0013778429,0.000045304307,2.9988982e-8,0.004515479,0.57676154,0.0000032452447,0.40028107,0.0036634195,0.00300686],"study_design_scores_gemma":[0.0011844988,0.00014306826,0.002314519,0.00002881109,0.0000040071654,6.710664e-7,0.0012194389,0.8239684,0.0000022385498,0.027179483,0.14377283,0.00018203707],"about_ca_topic_score_codex":0.018732218,"about_ca_topic_score_gemma":0.00012108388,"teacher_disagreement_score":0.3731016,"about_ca_system_score_codex":0.0010047287,"about_ca_system_score_gemma":0.0006648875,"threshold_uncertainty_score":0.9937025},"labels":[],"label_agreement":null},{"id":"W4311334188","doi":"10.1016/j.jval.2022.09.979","title":"EPH57 Epidemiology of Alopecia Areata Across Global Regions – A Systematic Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Alopecia areata; Medicine; Epidemiology; Incidence (geometry); Systematic review; Prevalence; Dermatology; MEDLINE; Pediatrics; Internal medicine","score_opus":0.08656780890402353,"score_gpt":0.3959142111902736,"score_spread":0.30934640228625004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311334188","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021807127,0.9461097,0.0001565501,0.027615754,0.00030604226,0.002734393,0.00027929334,0.00004852417,0.0009426146],"genre_scores_gemma":[0.8161705,0.13231538,0.0013282886,0.048696946,0.00012983922,0.00059714325,0.00036331624,0.00003561676,0.00036297337],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.996408,0.0016094857,0.0010499149,0.00027569366,0.00021257774,0.00044432018],"domain_scores_gemma":[0.9985347,0.00037169503,0.0003156353,0.00052326935,0.000051658804,0.00020304184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034369407,0.00012767815,0.001130861,0.00006113392,0.00010693892,0.0000015999902,0.0001567418,0.00005665805,0.00004042322],"category_scores_gemma":[0.0023351703,0.00010505438,0.00013762206,0.0009922211,0.000049805672,0.000028554186,0.00008904166,0.00031252432,0.000008595613],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016394905,0.00046530337,0.17329502,0.7616322,0.000067449546,0.00019656755,0.0029750925,0.00047842527,7.5014543e-7,0.027216261,0.03270541,0.00080355577],"study_design_scores_gemma":[0.007537517,0.004008569,0.114250734,0.80247074,0.00027837287,0.005099533,0.0063276053,0.0035301456,0.0000012139758,0.014875234,0.040797323,0.000823029],"about_ca_topic_score_codex":0.00091680535,"about_ca_topic_score_gemma":0.00006853098,"teacher_disagreement_score":0.8137943,"about_ca_system_score_codex":0.00029779717,"about_ca_system_score_gemma":0.0004361278,"threshold_uncertainty_score":0.42839932},"labels":[],"label_agreement":null},{"id":"W4311334508","doi":"10.1016/j.jval.2022.09.475","title":"EE227 Healthcare Resource Utilization and Costs Among Patients with Moderately-to-Severely Active Crohn’s Disease Treated with Ustekinumab: Real-World Evidence","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; McMaster University; University of Calgary; McGill University Health Centre","funders":"","keywords":"Ustekinumab; Crohn's disease; Medicine; Disease; Crohn disease; Health care; Resource (disambiguation); Disease control; Internal medicine; Environmental health; Computer science; Infliximab","score_opus":0.028703573641365374,"score_gpt":0.2765764417257364,"score_spread":0.24787286808437103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311334508","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972626,0.00026483406,0.000035003577,0.00042885143,0.000026540349,0.0016371203,0.0002357077,0.000029583874,0.00007973201],"genre_scores_gemma":[0.9979318,0.00009924401,0.00009004739,0.0009050316,0.000029744866,0.00028209251,0.0003888983,0.000054256405,0.00021892453],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974684,0.000716318,0.00031624376,0.0006762301,0.0003860116,0.0004368065],"domain_scores_gemma":[0.9986456,0.000035246452,0.00020924101,0.00043539068,0.00014138265,0.00053313386],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028070027,0.00023805317,0.00020448031,0.00016992478,0.00036487103,0.000032323707,0.000153684,0.000044446377,0.00000767042],"category_scores_gemma":[0.000070092436,0.00022156982,0.000024799796,0.00038934354,0.0000688018,0.000021608963,0.0001514936,0.0001902617,9.768087e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025061281,0.00020065054,0.9435313,0.00024822718,0.000026500786,0.0001729671,0.00048822488,0.027884027,0.0000073564597,0.00007947441,0.00026876127,0.0020312252],"study_design_scores_gemma":[0.0011415588,0.0006482087,0.994916,0.00030780214,0.000013122222,0.0000016984285,0.00014640274,0.0020330492,0.000046427038,0.000008202985,0.00048197078,0.0002555453],"about_ca_topic_score_codex":0.00669054,"about_ca_topic_score_gemma":0.0040909075,"teacher_disagreement_score":0.051384706,"about_ca_system_score_codex":0.00060727424,"about_ca_system_score_gemma":0.00075619185,"threshold_uncertainty_score":0.999924},"labels":[],"label_agreement":null},{"id":"W4311334543","doi":"10.1016/j.jval.2022.09.930","title":"EPH7 A Survey of the Occurrence and Transmission of COVID-19 in Outdoor Education Settings in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 and Mental Health","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Island University","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Transmission (telecommunications); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Medicine; Family medicine; Psychology; Medical education; Pediatrics; Computer science; Telecommunications; Virology; Disease","score_opus":0.09890239423765883,"score_gpt":0.41777431697071,"score_spread":0.31887192273305115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311334543","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99033415,0.0017020304,0.000006577203,0.0066143423,0.00043281022,0.0006249477,0.00022933763,0.0000022490788,0.00005354138],"genre_scores_gemma":[0.9961432,0.00009142126,0.000018844454,0.0036460117,0.0000036939718,0.000046380523,0.00001988788,0.0000042992174,0.000026268284],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972238,0.0016073112,0.00053466123,0.0002120216,0.00019459087,0.00022761812],"domain_scores_gemma":[0.99891096,0.00057754625,0.00020415288,0.00017826693,0.000012329747,0.00011675532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025431095,0.00006560466,0.00020479404,0.00014915578,0.00005517106,9.892191e-7,0.00014662203,0.000023404844,0.000090157955],"category_scores_gemma":[0.00015150718,0.000059898382,0.000011755643,0.00067523733,0.000028165463,0.00001612852,0.000039352308,0.0002582072,1.5357928e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001338594,0.00023334369,0.964641,0.0008062032,8.876472e-7,0.000001383578,0.012812828,0.00065183785,0.000009248185,0.00024115846,0.0013202642,0.019148],"study_design_scores_gemma":[0.0006985411,0.00011028424,0.9885006,0.00011389428,6.7277966e-7,0.0000041135877,0.0038967452,0.00041156856,0.000006627836,0.00017193054,0.006033282,0.000051726216],"about_ca_topic_score_codex":0.99864435,"about_ca_topic_score_gemma":0.9551779,"teacher_disagreement_score":0.043466453,"about_ca_system_score_codex":0.0027149152,"about_ca_system_score_gemma":0.027049951,"threshold_uncertainty_score":0.9784658},"labels":[],"label_agreement":null},{"id":"W4311334641","doi":"10.1016/j.jval.2022.09.1213","title":"HPR83 Unequal Access of Innovative Dermatology Products Across Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Medicine; Listing (finance); Dermatology; Formulary; Atopic dermatitis; Family medicine; Summary of Product Characteristics; Public health; Psoriasis; Agency (philosophy); Regulatory agency; Actinic keratosis; Drug; Business; Internal medicine; Political science; Pathology; Pharmacology; Finance","score_opus":0.08229528690575083,"score_gpt":0.3893846440052599,"score_spread":0.3070893570995091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311334641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8798074,0.00043759888,0.000033196957,0.1187835,0.0004755023,0.00034249818,0.000041485247,0.000008324974,0.00007049106],"genre_scores_gemma":[0.99685127,0.000025477166,0.00012505447,0.0028298448,0.000043687287,0.000015395619,0.0000564934,0.0000072549838,0.000045544017],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998589,0.0001959094,0.00042016467,0.00016373592,0.0003949178,0.00023627188],"domain_scores_gemma":[0.9993862,0.00008225534,0.00017614877,0.00014426613,0.00014030286,0.00007082442],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007125604,0.000056843743,0.0002453153,0.000055098113,0.00010049439,0.0000020870211,0.000094201474,0.000047405632,0.00003431971],"category_scores_gemma":[0.00014905479,0.000049752314,0.000009462983,0.0011627121,0.00016153128,0.00002184229,0.00011735141,0.00041668434,2.0503317e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002061837,0.0032738356,0.42397684,0.023701834,0.00031695454,0.0011120229,0.05450824,0.03244652,0.0038517385,0.16380522,0.049299184,0.24164578],"study_design_scores_gemma":[0.007804325,0.0017244291,0.7605337,0.0006677913,0.000013629971,0.0005674521,0.0067750737,0.024899136,0.007606187,0.0062238267,0.18264095,0.0005434886],"about_ca_topic_score_codex":0.6950753,"about_ca_topic_score_gemma":0.077974886,"teacher_disagreement_score":0.61710036,"about_ca_system_score_codex":0.00035175637,"about_ca_system_score_gemma":0.0045218132,"threshold_uncertainty_score":0.9388497},"labels":[],"label_agreement":null},{"id":"W4311334862","doi":"10.1016/j.jval.2022.09.769","title":"EE528 Resource Use and Costs Associated With Computerized Decision Support System for Managing Patients With Atrial Fibrillation","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Quality and Safety in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bayer (Canada); Nova Scotia Health Authority; Dalhousie University; Queen Elizabeth II Health Sciences Centre; McMaster University","funders":"","keywords":"Medicine; Activity-based costing; Atrial fibrillation; Nova scotia; Health care; Emergency medicine; Resource use; Emergency department; Randomized controlled trial; Indirect costs; Medical emergency; Nursing; Internal medicine; Business","score_opus":0.09971890078041812,"score_gpt":0.380445567567029,"score_spread":0.2807266667866109,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311334862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.989685,0.00010001547,0.001793568,0.002182842,0.00065285014,0.004862565,0.000537545,0.00014200689,0.000043631037],"genre_scores_gemma":[0.99520564,0.000025260586,0.0026004545,0.0010043924,0.00017777419,0.0000996403,0.00078469975,0.000052660303,0.00004950546],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9937086,0.0034589462,0.0010638471,0.00046515337,0.00061658816,0.00068684336],"domain_scores_gemma":[0.9935451,0.0049698786,0.000755361,0.00030450273,0.0002008843,0.00022424235],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0041001434,0.00018896085,0.0005491116,0.00021843113,0.002016618,0.000021900449,0.00011051718,0.00012252954,0.000013965585],"category_scores_gemma":[0.00035408462,0.00016411395,0.000046390236,0.00045281078,0.000033086984,0.00016405908,0.00014370886,0.00055440655,0.0000022064341],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0073867696,0.000047103444,0.94588363,0.0017852256,0.000042966163,0.000008427052,0.007684656,0.023767998,2.1048248e-7,0.002804164,0.0008393872,0.009749453],"study_design_scores_gemma":[0.030677209,0.0055456585,0.82555926,0.0068380972,0.000049469654,0.0000099365525,0.011684822,0.09226441,2.6497827e-7,0.00035007854,0.026346704,0.0006741201],"about_ca_topic_score_codex":0.0044270344,"about_ca_topic_score_gemma":0.0005143776,"teacher_disagreement_score":0.12032441,"about_ca_system_score_codex":0.0021615291,"about_ca_system_score_gemma":0.0007548332,"threshold_uncertainty_score":0.9992826},"labels":[],"label_agreement":null},{"id":"W4311335052","doi":"10.1016/j.jval.2022.09.968","title":"EPH46 Three-Year Epidemiology, Economic Burden and All-Cause Mortality Among Palmoplantar Pustolosis Patients: A Canadian Incidence Study of Inpatient Care, Emergency Departments, and Hospital- or Community-Based Outpatient Clinics","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Toronto; McMaster University","funders":"","keywords":"Medicine; Epidemiology; Incidence (geometry); Inpatient care; Emergency medicine; Medical emergency; Family medicine; Health care; Internal medicine","score_opus":0.0815685335182627,"score_gpt":0.3247590854359011,"score_spread":0.2431905519176384,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311335052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99395055,0.0019961605,0.0000010177365,0.000112758644,0.0008680165,0.001847838,0.0011945617,0.000018019246,0.000011101978],"genre_scores_gemma":[0.99765956,0.0009520218,0.000053461376,0.00013544431,0.000011228674,0.00032655417,0.000835698,0.000020234665,0.0000058210767],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942791,0.0035772747,0.0011119052,0.00044349738,0.000060676288,0.00052756735],"domain_scores_gemma":[0.9980676,0.00062478724,0.0005911993,0.0005212438,0.000048128444,0.00014702081],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015508526,0.0002664684,0.0006850678,0.00027867683,0.0006047357,0.0000039339266,0.00026181192,0.00015300063,0.00008362064],"category_scores_gemma":[0.00016605193,0.00025033817,0.00005729299,0.0001438358,0.00015166108,0.00006810742,0.00023971987,0.00047383938,0.0000050891526],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025500348,0.00076861144,0.98702013,0.00010858909,0.00045542436,0.000008643849,0.008449776,0.0014346349,6.660695e-7,0.000028317087,0.00010658803,0.0013636238],"study_design_scores_gemma":[0.0034279134,0.0073633925,0.9797133,0.000032575907,0.00021742456,0.0000026147989,0.008330881,0.0001389075,0.0000049864243,0.00007245981,0.00044840458,0.0002471158],"about_ca_topic_score_codex":0.6749937,"about_ca_topic_score_gemma":0.48437715,"teacher_disagreement_score":0.19061658,"about_ca_system_score_codex":0.0006825062,"about_ca_system_score_gemma":0.00045561205,"threshold_uncertainty_score":0.9999949},"labels":[],"label_agreement":null},{"id":"W4311336401","doi":"10.1016/j.jval.2022.09.2338","title":"RWD113 Differences in Adverse Events Reporting Between Natural Products Versus Prescription Products in the United States and Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Quality and Counterfeiting","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medical prescription; Adverse effect; Adverse Event Reporting System; Medicine; Pharmacovigilance; Pharmacy; Natural experiment; Environmental health; Business; Family medicine; Pharmacology","score_opus":0.19805873725713635,"score_gpt":0.3804346809967236,"score_spread":0.18237594373958727,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311336401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980952,0.00046779233,3.1407507e-7,0.017536266,0.00029844287,0.0007071469,0.000011819704,0.000010874133,0.000015313766],"genre_scores_gemma":[0.99872535,0.00008119591,0.00003501164,0.0009146017,0.00008122296,0.00003902006,0.00009636357,0.000006497889,0.000020756288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99733543,0.00083376636,0.00076826935,0.00028590855,0.00044141756,0.00033519178],"domain_scores_gemma":[0.99912155,0.00030611877,0.0003284452,0.00015225328,0.000037143018,0.000054507604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031450698,0.000095070194,0.00024293436,0.00014497689,0.000116523326,0.0000049431833,0.000087487795,0.000017404685,0.0000031249135],"category_scores_gemma":[0.001779205,0.00007589585,0.0000089383275,0.00067229173,0.0000257825,0.00006339189,0.00006195128,0.00069175,1.356021e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004880746,0.00013603535,0.9878972,0.0010064002,0.000012995081,0.000117635886,0.008147861,0.00070560665,0.00010273418,0.00008304932,0.000110078974,0.0011923326],"study_design_scores_gemma":[0.001976436,0.0002185387,0.97698236,0.00036281763,0.000012186252,0.000024323284,0.011245659,0.0078090285,0.00009914389,0.00015354878,0.000993115,0.00012282963],"about_ca_topic_score_codex":0.7716368,"about_ca_topic_score_gemma":0.10671799,"teacher_disagreement_score":0.6649188,"about_ca_system_score_codex":0.00056302495,"about_ca_system_score_gemma":0.00079864485,"threshold_uncertainty_score":0.9095821},"labels":[],"label_agreement":null},{"id":"W4311336419","doi":"10.1016/j.jval.2022.09.2301","title":"RWD76 Real-World Patient Persistence and Compliance: A Comparison of Prostaglandin Analogs Used for the Treatment of Open-Angle Glaucoma or Ocular Hypertension","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Glaucoma and retinal disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Latanoprost; Bimatoprost; Medicine; Persistence (discontinuity); Glaucoma; Intraocular pressure; Travoprost; Ocular hypertension; Ophthalmology","score_opus":0.14980671950648414,"score_gpt":0.36872816248461615,"score_spread":0.218921442978132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311336419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906215,0.0034534084,0.000017871374,0.0027698926,0.000086295775,0.0029397577,0.00005434306,0.0000070025403,0.000049916645],"genre_scores_gemma":[0.99808866,0.0006265723,0.00074060546,0.00018629596,0.000008436662,0.00018060555,0.000037592054,0.000012806189,0.000118400836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986746,0.0001657765,0.00047859404,0.00022574101,0.00024326715,0.00021204072],"domain_scores_gemma":[0.9990565,0.0003026077,0.00025602357,0.0002559507,0.00005251395,0.00007641515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029652708,0.00011342005,0.0005632596,0.000106775726,0.00021099475,0.000006010922,0.00011149587,0.000020679414,0.000021581267],"category_scores_gemma":[0.000028915612,0.000067335415,0.00007398089,0.00033648455,0.00009172812,0.000019625015,0.00006313851,0.000082716186,2.0516954e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029322102,0.0026125717,0.97568315,0.0008765909,0.00006796177,0.000017020733,0.009658189,0.00016867433,0.0006132077,0.0003455955,0.00060304767,0.0064217634],"study_design_scores_gemma":[0.009862355,0.030419925,0.84817797,0.00072242855,0.00015889159,0.000055889028,0.021545488,0.072905175,0.00066568144,0.0001460975,0.015153624,0.00018647559],"about_ca_topic_score_codex":0.013146304,"about_ca_topic_score_gemma":0.0009060848,"teacher_disagreement_score":0.1275052,"about_ca_system_score_codex":0.00019397872,"about_ca_system_score_gemma":0.0002229731,"threshold_uncertainty_score":0.99342525},"labels":[],"label_agreement":null},{"id":"W4311336870","doi":"10.1016/j.jval.2022.09.2470","title":"SA77 Considerations for Patient Identification and Enrolment for Retrospective Studies for the Collection of Long-Term Follow-up Data","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Identification (biology); Outreach; Leverage (statistics); Medicine; Data collection; Retrospective cohort study; Computer science; Political science; Surgery; Artificial intelligence","score_opus":0.6847738698547348,"score_gpt":0.5956522814703781,"score_spread":0.08912158838435669,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311336870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7480802,0.012023846,0.03220014,0.16226006,0.0034460835,0.038452215,0.0034568326,0.000048911086,0.000031746094],"genre_scores_gemma":[0.99130505,0.0016974935,0.0031167718,0.0005415162,0.00007267167,0.0027586508,0.00012336679,0.000014919006,0.00036956999],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99824566,0.00017820363,0.0006504792,0.0003462647,0.0003983633,0.00018103849],"domain_scores_gemma":[0.97356737,0.02489659,0.00029714347,0.000540171,0.0006442814,0.000054450495],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0067403405,0.00006350667,0.00026285113,0.0000920419,0.0006669756,0.000012541039,0.000097675125,0.000044488646,0.000006691774],"category_scores_gemma":[0.025849631,0.000051306528,0.0000475166,0.00016297713,0.000118055905,0.000039171406,0.00017233808,0.00029752412,9.6216986e-8],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.016473856,0.0049607228,0.28526482,0.030795172,0.0027906722,0.0000072386933,0.08484705,0.0046775965,0.0030866163,0.3998689,0.12717761,0.040049728],"study_design_scores_gemma":[0.0206102,0.022118194,0.27816004,0.0010543492,0.00042556852,0.00003051658,0.019294873,0.104927264,0.0023913034,0.5480946,0.0025222332,0.0003708603],"about_ca_topic_score_codex":0.0002719495,"about_ca_topic_score_gemma":0.0009867764,"teacher_disagreement_score":0.24322487,"about_ca_system_score_codex":0.0005270428,"about_ca_system_score_gemma":0.0008230571,"threshold_uncertainty_score":0.9823561},"labels":[],"label_agreement":null},{"id":"W4311337115","doi":"10.1016/j.jval.2022.09.1675","title":"HTA217 Reimbursement of Drugs for Rare Diseases in Canada: Do Treatment Cost and Cost-Effectiveness Ratio Correlate With Epidemiologic Factors?","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Reimbursement; Population; Orphan drug; Incidence (geometry); Emergency medicine; Pediatrics; Family medicine; Environmental health; Health care; Bioinformatics","score_opus":0.38810860723138335,"score_gpt":0.4132467128701277,"score_spread":0.025138105638744357,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311337115","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97818273,0.0065377355,0.00044377433,0.0063256877,0.0003743429,0.0057156617,0.0023449592,0.00001047626,0.00006460579],"genre_scores_gemma":[0.9957681,0.00042950755,0.00020479994,0.0012235199,0.000026827305,0.0021310784,0.00016410308,0.000021260581,0.000030856725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99485505,0.0014599911,0.0026048522,0.0005365945,0.00008940468,0.00045412756],"domain_scores_gemma":[0.99343675,0.0043896367,0.0016667418,0.00029410314,0.000024360661,0.00018837878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009360468,0.0001905159,0.0012782528,0.00026599196,0.00020339082,0.000011621796,0.00012694162,0.000039603754,0.00006145218],"category_scores_gemma":[0.00094869226,0.00019971991,0.00005172417,0.00021189409,0.000040162657,0.00009695081,0.000039742703,0.00013553847,0.0000020425628],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001378183,0.00016173677,0.81750625,0.00066059805,0.000033336502,0.0000015552747,0.0017393182,0.15517652,9.573635e-8,0.02358802,0.00039926154,0.00059547444],"study_design_scores_gemma":[0.0046313005,0.0012104625,0.9187814,0.0002943012,0.000009119901,0.0000030680535,0.0076276516,0.050240822,0.000002006171,0.004856135,0.011986631,0.0003571067],"about_ca_topic_score_codex":0.9021205,"about_ca_topic_score_gemma":0.24899071,"teacher_disagreement_score":0.65312976,"about_ca_system_score_codex":0.009192148,"about_ca_system_score_gemma":0.0024171981,"threshold_uncertainty_score":0.9946114},"labels":[],"label_agreement":null},{"id":"W4311337941","doi":"10.1016/j.jval.2022.09.1483","title":"HTA23 Restrictions and Real-World Evidence Requirements in the Health Technology Assessment of Gene Therapy Medicinal Products in Europe, Canada, Australia, and the United States","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Health technology; Real world evidence; Business; Medicine; International trade; Economic growth; Health care; Economics","score_opus":0.5626067800328953,"score_gpt":0.4797600705352616,"score_spread":0.08284670949763373,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311337941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6767889,0.0053834682,0.000016677639,0.31606907,0.00016696929,0.0014353114,0.00008665119,0.000006038961,0.00004692649],"genre_scores_gemma":[0.9732141,0.014081363,0.00058108417,0.0116717545,0.00003954026,0.00028936766,0.000029592306,0.000013577558,0.000079611236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99251395,0.0030773696,0.0032899503,0.00046541015,0.00020841877,0.00044492367],"domain_scores_gemma":[0.9961507,0.0016304033,0.0016365638,0.00045537195,0.000052020445,0.0000749669],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03815017,0.00013080856,0.0006937421,0.0010134093,0.00028330865,0.000018288796,0.00031617866,0.000029890838,0.000019875852],"category_scores_gemma":[0.0013431855,0.000116570125,0.000011422031,0.0026309541,0.00016426187,0.0001098751,0.000070288894,0.000479211,9.3009356e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000067099885,0.00015769094,0.8411321,0.00048823643,0.00001832694,0.000004734762,0.006608868,0.009805621,9.4713454e-7,0.13510919,0.006378614,0.00022859947],"study_design_scores_gemma":[0.002221863,0.0004955804,0.9500416,0.00028652363,0.000001612236,0.000013329828,0.0071556866,0.013365985,7.6647245e-7,0.004891675,0.021365527,0.00015987578],"about_ca_topic_score_codex":0.9626836,"about_ca_topic_score_gemma":0.4898062,"teacher_disagreement_score":0.4728774,"about_ca_system_score_codex":0.0016242017,"about_ca_system_score_gemma":0.0020571118,"threshold_uncertainty_score":0.99042684},"labels":[],"label_agreement":null},{"id":"W4311338332","doi":"10.1016/j.jval.2022.09.1495","title":"HTA35 Should Health Technology Assessment (HTA) Bodies Utilize Living HTA Tools? Validation of LiveSLR® and LiveNMA™ Tools Using ICER’S Class Review in Relapsed Refractory Multiple Myeloma (RRMM)","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Daratumumab; Ixazomib; Dexamethasone; Carfilzomib; Oncology; Medical physics; Internal medicine; Lenalidomide","score_opus":0.5787481936986596,"score_gpt":0.46973739952004934,"score_spread":0.10901079417861026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311338332","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82904077,0.10586865,0.0005088638,0.059193213,0.0008130923,0.0036253212,0.0005039523,0.000087447814,0.00035871347],"genre_scores_gemma":[0.95731425,0.023753041,0.008246838,0.009988896,0.00009166682,0.00040577777,0.000070875554,0.00006853342,0.00006013124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9872798,0.0030482016,0.0075091026,0.0010328183,0.00028135112,0.00084875844],"domain_scores_gemma":[0.98993975,0.003787604,0.005167823,0.000821046,0.00007494221,0.00020883193],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.03952926,0.0003177447,0.0021742482,0.001343456,0.00043851853,0.000056234396,0.00040519613,0.000201258,0.00019829869],"category_scores_gemma":[0.0078205,0.0004439459,0.00011488894,0.00082132785,0.000114217815,0.0005775414,0.00033767265,0.000927135,0.000019890473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010679544,0.0017474783,0.8082591,0.03738475,0.00015221565,0.000011263302,0.017768146,0.036485184,0.000051332703,0.07140883,0.0063097887,0.02031506],"study_design_scores_gemma":[0.006193712,0.0033865809,0.5037485,0.026948161,0.000035512705,0.00009108364,0.031961206,0.30390936,0.00001936998,0.011976754,0.10936057,0.0023691817],"about_ca_topic_score_codex":0.009980041,"about_ca_topic_score_gemma":0.0006007507,"teacher_disagreement_score":0.30451065,"about_ca_system_score_codex":0.004978108,"about_ca_system_score_gemma":0.0017240692,"threshold_uncertainty_score":0.9998012},"labels":[],"label_agreement":null},{"id":"W4311338536","doi":"10.1016/j.jval.2022.09.2412","title":"SA18 Development and Application of a Taxonomy on the Beneficial Effects of Oral Anticoagulant Switching in Atrial Fibrillation","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Atrial fibrillation; Medicine; Taxonomy (biology); Stroke (engine); Delphi method; Adverse effect; Rivaroxaban; Intensive care medicine; Medical emergency; Warfarin; Internal medicine; Computer science; Artificial intelligence","score_opus":0.0802103012756382,"score_gpt":0.32527594924359643,"score_spread":0.2450656479679582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311338536","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959173,0.00021044486,0.0006314876,0.0015874068,0.000092857495,0.0015177124,8.8913646e-7,0.000006396186,0.000035495104],"genre_scores_gemma":[0.9988311,0.000028606046,0.00095454935,0.000063514875,0.00009541321,0.000008215746,0.000008201124,0.000005337956,0.00000507398],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990124,0.00014954248,0.00041933343,0.00011608488,0.00020502979,0.00009757361],"domain_scores_gemma":[0.9993255,0.0003364055,0.00021551515,0.000092987335,0.000009693043,0.000019900895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008995244,0.00005834603,0.00023722227,0.0001812241,0.00006221382,0.0000024390358,0.00003066625,0.00001770834,0.0000035910493],"category_scores_gemma":[0.000093725335,0.00004652153,0.000033866647,0.0002533266,0.000009097081,0.000018517321,0.00004454888,0.00007572879,4.2269306e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00058328744,0.000014432298,0.84541684,0.00067194056,0.000022256414,0.0000012984202,0.0013769642,0.052230455,0.00033529435,0.012005855,0.000011981249,0.08732939],"study_design_scores_gemma":[0.0035209535,0.00056717044,0.9209223,0.00024033632,0.000021528256,0.0000021964086,0.00039646972,0.062330514,0.00086747226,0.00040844225,0.010615687,0.000106964144],"about_ca_topic_score_codex":0.0011485757,"about_ca_topic_score_gemma":0.00003075036,"teacher_disagreement_score":0.08722243,"about_ca_system_score_codex":0.00012221174,"about_ca_system_score_gemma":0.000112908856,"threshold_uncertainty_score":0.18970929},"labels":[],"label_agreement":null},{"id":"W4311338564","doi":"10.1016/j.jval.2022.09.2165","title":"PCR232 The Use of EuroQol EQ-5D in the Middle East and North Africa Region: A Systematic Review","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"CINAHL; PsycINFO; Data extraction; Systematic review; Medicine; EQ-5D; MEDLINE; Population; Inclusion (mineral); Family medicine; Psychology; Health related quality of life; Environmental health; Psychiatry; Psychological intervention; Political science; Pathology","score_opus":0.9323004053396625,"score_gpt":0.4378622853480493,"score_spread":0.49443811999161325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311338564","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000329975,0.97936386,0.000020888385,0.010567684,0.00029396007,0.009191776,0.00034353268,0.000014307529,0.00017098182],"genre_scores_gemma":[0.00003632871,0.98968416,0.00013447255,0.0079505425,0.00009806204,0.0018502816,0.00005399749,0.00005826424,0.00013387964],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.97578084,0.010413447,0.012147789,0.00079738884,0.00025244462,0.0006080947],"domain_scores_gemma":[0.9806557,0.008419103,0.009082471,0.0016787178,0.000030147172,0.00013383201],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04363389,0.00042084185,0.0059431726,0.0004878268,0.00023537029,0.00007671273,0.00096573215,0.00014421977,0.00007475124],"category_scores_gemma":[0.008659461,0.00031774788,0.00037960493,0.0013331647,0.00010113573,0.00020244044,0.00016381116,0.00085312745,0.00012373058],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000014750889,0.000077583805,0.00015691687,0.9766261,0.000044747856,0.0000047051603,0.0061897393,0.0000603506,2.4485466e-11,0.008988855,0.006655382,0.0011941495],"study_design_scores_gemma":[0.00013688298,0.00006849195,0.000045637556,0.21997452,0.00006128942,0.00008537178,0.00072420423,0.00041847245,3.7964874e-11,0.00024665933,0.7780075,0.00023098488],"about_ca_topic_score_codex":0.003772407,"about_ca_topic_score_gemma":0.00034455297,"teacher_disagreement_score":0.7713521,"about_ca_system_score_codex":0.000989036,"about_ca_system_score_gemma":0.0008687248,"threshold_uncertainty_score":0.99992746},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"grok","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"},{"model":"opus","categories":["metaresearch","metaepi_broad"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4311339045","doi":"10.1016/j.jval.2022.09.2177","title":"PCR244 Burden of Myelodysplastic Syndromes Part I: Systematic Literature Review of Epidemiologic and Humanistic Burden","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Disease burden; Incidence (geometry); Quality of life (healthcare); Myelodysplastic syndromes; Disease; Epidemiology; Anemia; MEDLINE; Cancer; Systematic review; Gerontology; Internal medicine; Family medicine; Bone marrow","score_opus":0.06700767727458984,"score_gpt":0.3471173889155005,"score_spread":0.28010971164091064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311339045","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13327475,0.8483327,0.000036329915,0.01296292,0.0002364864,0.004638959,0.00014603155,0.00004788552,0.00032395768],"genre_scores_gemma":[0.83944625,0.15687111,0.0009636795,0.0011921185,0.00015552928,0.00036929126,0.00010961656,0.000046810695,0.00084562966],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.994967,0.0020593815,0.0015665317,0.0003689874,0.00060995936,0.0004281492],"domain_scores_gemma":[0.9965986,0.0019205088,0.0006120334,0.00055084215,0.00013046741,0.00018751857],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0057323347,0.00019087679,0.001704578,0.00034275357,0.00009731637,0.000005191483,0.00023378874,0.000072891526,0.00017298157],"category_scores_gemma":[0.0043735458,0.00015041063,0.000102277634,0.00080909603,0.00012867572,0.000036309764,0.00022390088,0.0006967192,0.0000057225275],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007701381,0.000068496236,0.0008116577,0.9904526,0.00007627342,0.00022306672,0.0015073431,0.00087707554,0.00008921008,0.002459069,0.0031895232,0.00016868813],"study_design_scores_gemma":[0.0026871697,0.0045191282,0.0025799705,0.9573931,0.0003092789,0.0034467021,0.0017401099,0.02195244,0.000015986798,0.001401616,0.0035622925,0.0003921793],"about_ca_topic_score_codex":0.000736888,"about_ca_topic_score_gemma":0.0000014005659,"teacher_disagreement_score":0.70617145,"about_ca_system_score_codex":0.0005409538,"about_ca_system_score_gemma":0.0006885104,"threshold_uncertainty_score":0.6133567},"labels":[],"label_agreement":null},{"id":"W4311339051","doi":"10.1016/j.jval.2022.09.1458","title":"HSD115 Utilization Trends of Novel Hormonal Agents in Metastatic Castration-Resistant Prostate Cancer in Quebec","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Enzalutamide; Medicine; Abiraterone acetate; Prostate cancer; Taxane; Cohort; Internal medicine; Tolerability; Cabazitaxel; Oncology; Specialty; Population; Retrospective cohort study; Chemotherapy; Cancer; Gynecology; Androgen deprivation therapy; Family medicine; Adverse effect; Breast cancer; Androgen receptor; Environmental health","score_opus":0.20298439713475921,"score_gpt":0.4291731003992639,"score_spread":0.22618870326450466,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311339051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99163973,0.0035341815,0.0000070911474,0.0034920687,0.00008599343,0.00080148317,0.00026378324,0.00000826114,0.00016739807],"genre_scores_gemma":[0.9965653,0.0008408204,0.00018317364,0.000111424844,0.000012245606,0.0003173732,0.00019086835,0.000015410846,0.0017634006],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981978,0.00020399723,0.0005607694,0.0002374885,0.00046692565,0.00033301525],"domain_scores_gemma":[0.99956065,0.00005395943,0.00013396754,0.00012971878,0.000036499936,0.0000851977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007033624,0.000103099024,0.0003039229,0.0006700902,0.000049096976,0.0000062510685,0.00006186481,0.000019718174,0.0002005935],"category_scores_gemma":[0.000028413733,0.00009383337,0.000031621174,0.0012809811,0.000038424092,0.000071367875,0.000034582394,0.00023953881,5.034295e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006358526,0.00583436,0.6594664,0.0027674637,0.0001195762,0.00049516885,0.027928028,0.17181414,0.0070738466,0.0015379861,0.0008787281,0.11572578],"study_design_scores_gemma":[0.010338156,0.000999612,0.9385162,0.00045356274,0.00001404362,0.0000074663253,0.0018624208,0.045986116,0.00034631515,0.00008580161,0.0012594676,0.00013086025],"about_ca_topic_score_codex":0.27764064,"about_ca_topic_score_gemma":0.06732198,"teacher_disagreement_score":0.27904978,"about_ca_system_score_codex":0.0017445049,"about_ca_system_score_gemma":0.0019017627,"threshold_uncertainty_score":0.94969696},"labels":[],"label_agreement":null},{"id":"W4311339315","doi":"10.1016/j.jval.2022.09.1992","title":"PCR57 An Empirical Comparison of Data From Forced vs Non-Forced Choices in a Dual Response Discrete Choice Experiment, With Breast Cancer Patients in Six European Countries","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Two-alternative forced choice; Multinomial logistic regression; Medicine; Task (project management); Payment; Breast cancer; Econometrics; Demography; Physical therapy; Actuarial science; Cancer; Statistics; Mathematics; Computer science; Economics; Internal medicine","score_opus":0.17818193928497023,"score_gpt":0.34239335676456256,"score_spread":0.16421141747959234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311339315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957329,0.0004576984,0.000030626783,0.00051735545,0.000118576885,0.00047624414,0.0025425667,0.0000077009045,0.000116315256],"genre_scores_gemma":[0.9986331,0.00011767465,0.0001924473,0.0003080265,0.000035045785,0.00006512487,0.00058748736,0.000031556192,0.00002956296],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99751157,0.00039046622,0.001092159,0.0005996847,0.00009216153,0.0003139798],"domain_scores_gemma":[0.9986403,0.00018987338,0.00061543344,0.0004643763,0.000005190921,0.000084803956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017270446,0.00015816733,0.0005162777,0.00026080117,0.00009337127,0.000024136709,0.0003212472,0.000035758632,0.00029948237],"category_scores_gemma":[0.000031777607,0.0001809563,0.000021712398,0.00022986619,0.0000618113,0.0005115007,0.000259799,0.00023168522,0.000017179018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000986219,0.0003159438,0.96077704,0.000023183622,0.000009321963,0.0000014051008,0.004493692,0.033139482,0.0000072606567,0.000056290475,0.00007836353,0.000111804206],"study_design_scores_gemma":[0.0025623667,0.00045643086,0.9114689,0.000052913892,0.0000017448007,4.39613e-7,0.0007856758,0.083297394,0.000010720416,0.00003430153,0.0011525077,0.00017659273],"about_ca_topic_score_codex":0.07955632,"about_ca_topic_score_gemma":0.0059364545,"teacher_disagreement_score":0.07361987,"about_ca_system_score_codex":0.0009283078,"about_ca_system_score_gemma":0.00009522806,"threshold_uncertainty_score":0.926573},"labels":[],"label_agreement":null},{"id":"W4311339322","doi":"10.1016/j.jval.2022.09.1369","title":"HSD25 Occupational Burnout Among Pediatric Neurologists Is Associated with Therapeutic Inertia in the Management of Spinal Muscular Atrophy","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"","keywords":"Spinal muscular atrophy; SMA*; Burnout; Medicine; Atrophy; Health care; Physical medicine and rehabilitation; Physical therapy; Clinical psychology; Internal medicine","score_opus":0.04637529546752485,"score_gpt":0.32557207515289815,"score_spread":0.2791967796853733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311339322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9943753,0.002382632,0.00004160085,0.0019046819,0.00003608988,0.0010926875,0.0000073121387,0.0000099224635,0.0001497625],"genre_scores_gemma":[0.99760467,0.00046720254,0.00006445437,0.0016441505,0.000018876957,0.00013819757,0.000019552448,0.000015735272,0.00002714751],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99750346,0.0006684353,0.0003493741,0.0002645855,0.0008809672,0.00033315454],"domain_scores_gemma":[0.99943537,0.00006037796,0.00012833942,0.00028450013,0.000035943085,0.000055466553],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010736298,0.000108808046,0.00022947621,0.00026724755,0.00009490747,0.0000060444136,0.00020041058,0.000027825532,0.000050659968],"category_scores_gemma":[0.000018867278,0.0000784377,0.0000682936,0.0010816405,0.000064235006,0.000016995598,0.000076621945,0.00041757297,0.000001467151],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053274736,0.00071010756,0.9884329,0.0003842047,0.000065922264,0.00026393167,0.0006682652,0.006884425,0.000009558013,0.00034224818,0.00005482984,0.00165087],"study_design_scores_gemma":[0.0019236231,0.0017519974,0.9932517,0.000039287195,0.00003651054,0.000012815318,0.00026121724,0.0022941565,0.000001933826,0.00010419877,0.00026025373,0.000062332874],"about_ca_topic_score_codex":0.00129265,"about_ca_topic_score_gemma":0.000030497817,"teacher_disagreement_score":0.004818783,"about_ca_system_score_codex":0.00011431334,"about_ca_system_score_gemma":0.00027246092,"threshold_uncertainty_score":0.31985965},"labels":[],"label_agreement":null},{"id":"W4311339500","doi":"10.1016/j.jval.2022.09.2113","title":"PCR180 Real-World Impact of Patient-Reported Outcome Measurement on Overall Survival and Healthcare Resource Utilization in Cancer Patients","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cohort; Propensity score matching; Colorectal cancer; Internal medicine; Breast cancer; Logistic regression; Retrospective cohort study; Cancer; Lung cancer; Cohort study; Proportional hazards model; Cancer registry; Population; Health care","score_opus":0.17113242961639882,"score_gpt":0.3820315933152187,"score_spread":0.21089916369881986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311339500","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99735045,0.00045587114,0.0000032613561,0.0007801213,0.00024825297,0.00083768426,0.000032146134,0.000025175988,0.00026704534],"genre_scores_gemma":[0.9994309,0.00011567973,0.000017314698,0.00025399702,0.000026056872,0.000078554054,0.000034113047,0.000017922006,0.000025446241],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997466,0.00046146274,0.0007375533,0.00029943624,0.0007683133,0.0002672329],"domain_scores_gemma":[0.99915767,0.000057566933,0.00036213806,0.00018601138,0.00010158966,0.00013504931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010176738,0.00012611222,0.00038288246,0.0004420128,0.000086384614,0.000004025593,0.0000346165,0.000034045654,0.000030109766],"category_scores_gemma":[0.00014231124,0.00012023456,0.00005528851,0.00063224096,0.000014983043,0.000028448809,0.00004195873,0.00032485533,1.9255661e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003824923,0.0003073587,0.96997595,0.00023291526,0.0000145324975,0.0000046757978,0.0010007229,0.012006412,0.0000097415705,0.000038030343,0.0000955858,0.012489177],"study_design_scores_gemma":[0.0022511524,0.007508762,0.9863425,0.00029132972,0.00000663124,0.000001978316,0.00016540219,0.0029717244,0.00002809287,0.000036224068,0.00031080944,0.00008542487],"about_ca_topic_score_codex":0.22332041,"about_ca_topic_score_gemma":0.010946813,"teacher_disagreement_score":0.2123736,"about_ca_system_score_codex":0.003504182,"about_ca_system_score_gemma":0.00046697445,"threshold_uncertainty_score":0.9163314},"labels":[],"label_agreement":null},{"id":"W4311339610","doi":"10.1016/j.jval.2022.09.1401","title":"HSD58 Country Differences in the Clinical Manifestations and Treatment Patterns of Patients With Eosinophilic Granulomatosis With Polyangiitis (EGPA): A European Perspective","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Eosinophilic Disorders and Syndromes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Granulomatosis with polyangiitis; Eosinophilic; Hypereosinophilia; Medicine; Asthma; Cohort; Disease; Dermatology; Churg-strauss syndrome; Vasculitis; Perspective (graphical); Pathology; Internal medicine; Eosinophilia","score_opus":0.036711804050618996,"score_gpt":0.2950755711097987,"score_spread":0.25836376705917974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311339610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955573,0.00043327548,0.0000055325536,0.0025180308,0.000026632788,0.00087528594,0.00017046364,0.000010121139,0.00040337184],"genre_scores_gemma":[0.99884504,0.00047518214,0.00007523668,0.00044392762,0.000013115696,0.000060985218,0.00004627475,0.000016412727,0.000023804112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981273,0.00067154097,0.00038976813,0.00026718827,0.0003366891,0.00020750824],"domain_scores_gemma":[0.99931765,0.00021402439,0.00015524898,0.00020746939,0.000035270215,0.0000703618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043838154,0.00012998105,0.00035672673,0.00014215345,0.0001268688,0.000010070537,0.00008058701,0.00001628768,0.000022875462],"category_scores_gemma":[0.000019157796,0.00007609893,0.000029772013,0.00026835132,0.00010421408,0.000033024095,0.00002551041,0.00018324074,4.520181e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019899289,0.0014136968,0.9852915,0.00006509385,0.000033039007,0.00007529092,0.010550252,0.000016384603,1.0266875e-7,0.001014962,0.000011845844,0.0013288377],"study_design_scores_gemma":[0.0034128095,0.006323633,0.9765024,0.00016771904,0.000029387678,0.000057761663,0.013189222,0.00006584734,1.17301816e-7,0.00011442195,0.00006164886,0.00007499438],"about_ca_topic_score_codex":0.013675276,"about_ca_topic_score_gemma":0.001214831,"teacher_disagreement_score":0.012460445,"about_ca_system_score_codex":0.00015013249,"about_ca_system_score_gemma":0.00019299577,"threshold_uncertainty_score":0.99289274},"labels":[],"label_agreement":null},{"id":"W4311340638","doi":"10.1016/j.jval.2022.09.2468","title":"SA75 Exploring the Relationship Between Comorbidities and Alzheimer's Disease Progression Assessed Using the Clinical Dementia Rating Scale: A Systematic Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Clinical Dementia Rating; Medicine; Dementia; Internal medicine; Disease; Comorbidity; Cochrane Library; Meta-analysis; MEDLINE","score_opus":0.35663442671034135,"score_gpt":0.4784197933380734,"score_spread":0.12178536662773204,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311340638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7335729,0.251777,0.000069080816,0.01043103,0.00014548101,0.003940577,0.0000151210415,0.000026012482,0.000022806154],"genre_scores_gemma":[0.9899934,0.0077392343,0.00024935158,0.0010512854,0.00014297685,0.00074962,0.000043232827,0.00001735169,0.000013581667],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99358666,0.0042990344,0.0008351322,0.0002573818,0.00071550044,0.00030629992],"domain_scores_gemma":[0.9968515,0.002292736,0.0002858963,0.00031714095,0.000072926414,0.00017977595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008454437,0.00012635105,0.00039867414,0.00009111055,0.0008686266,0.00007998967,0.00013728684,0.000019259453,0.0000176472],"category_scores_gemma":[0.001110463,0.00007152464,0.00008405166,0.00057341444,0.000093348564,0.00013212998,0.00020470537,0.00078166585,0.0000011807921],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031885826,0.00008700937,0.961206,0.036590524,0.000059593953,0.000024999186,0.0006997778,0.000012750876,7.013552e-7,0.00012137242,0.000119460965,0.0010459279],"study_design_scores_gemma":[0.00064692117,0.00027064484,0.8940013,0.100116484,0.00057578646,0.000036606867,0.0017052806,0.0022654927,0.0000017166791,0.00017890877,0.0001114551,0.00008937808],"about_ca_topic_score_codex":0.000047429246,"about_ca_topic_score_gemma":0.0000018009553,"teacher_disagreement_score":0.2564205,"about_ca_system_score_codex":0.000081377766,"about_ca_system_score_gemma":0.00040728517,"threshold_uncertainty_score":0.6680861},"labels":[],"label_agreement":null},{"id":"W4311340667","doi":"10.1016/j.jval.2022.09.1539","title":"HTA79 Time-Driven Activity-Based Costing to Compare the Cost of Administering Bronchodilators by Metered Dose Inhalers and by Nebulization in the Emergency Department","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Inhalation and Respiratory Drug Delivery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Salbutamol; Ipratropium; Medicine; Emergency department; Asthma; Activity-based costing; Anesthesia; Emergency medicine; Bronchodilator; Business; Internal medicine; Nursing","score_opus":0.0482354415398309,"score_gpt":0.3180764359581671,"score_spread":0.2698409944183362,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311340667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946337,0.00035527936,0.00012225143,0.0032061136,0.00010730863,0.001392289,0.000074577154,0.0000129704895,0.00009554674],"genre_scores_gemma":[0.99766403,0.00002537178,0.00007110208,0.0020163388,0.000016825375,0.00010292074,0.00006407994,0.000012726734,0.000026600059],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9982015,0.0007122767,0.0003987828,0.00018577381,0.00030777845,0.00019387652],"domain_scores_gemma":[0.99935985,0.00017160813,0.00017959966,0.00018223167,0.000024445508,0.0000822435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091707485,0.00010165903,0.00021746808,0.00011811372,0.00020030515,0.0000074701743,0.00009555633,0.000018793502,0.00006426625],"category_scores_gemma":[0.00006387538,0.000074123265,0.000029340308,0.00042442634,0.000027506107,0.000032850367,0.000048078477,0.00021099915,0.0000019978324],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002541691,0.0032999446,0.5027403,0.0016996729,0.00010779602,0.000060698603,0.03350315,0.31951505,0.05145401,0.00010481193,0.05789394,0.027078932],"study_design_scores_gemma":[0.015075217,0.0039847572,0.18444252,0.0010792335,0.00011418888,0.000066913155,0.010134569,0.66103315,0.007974838,0.000015087886,0.11511154,0.00096799806],"about_ca_topic_score_codex":0.000516699,"about_ca_topic_score_gemma":0.000047859492,"teacher_disagreement_score":0.3415181,"about_ca_system_score_codex":0.00023888804,"about_ca_system_score_gemma":0.00016871147,"threshold_uncertainty_score":0.3022659},"labels":[],"label_agreement":null},{"id":"W4311341467","doi":"10.1016/j.jval.2022.09.2469","title":"SA76 Burden of Illness in Patients with Alzheimer’s Disease: A Systematic Review of Incidence, Prevalence, Comorbidities, Disability and Mortality","year":2022,"lang":"en","type":"review","venue":"Value in Health","topic":"Frailty in Older Adults","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Dementia; Medicine; Comorbidity; Incidence (geometry); Disease; Diabetes mellitus; Gerontology; Pediatrics; Internal medicine","score_opus":0.08060692880070522,"score_gpt":0.3664804199279967,"score_spread":0.28587349112729143,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311341467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0033082056,0.9821055,4.526417e-7,0.00007990852,0.0001126339,0.013449548,0.00090010697,0.000016766196,0.000026907619],"genre_scores_gemma":[0.0042694984,0.9941665,0.00005247462,0.00006902661,0.000022472146,0.00096821337,0.00038742257,0.0000483912,0.000016013668],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.991872,0.0025242919,0.0033137507,0.00065217534,0.001262345,0.00037545137],"domain_scores_gemma":[0.9950572,0.0010526245,0.002067084,0.0014228652,0.00011621853,0.00028398578],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031437417,0.00046266563,0.005648522,0.00023399157,0.000039313305,0.0000046742334,0.00035431358,0.000108975364,0.000119449665],"category_scores_gemma":[0.0016567296,0.00034207143,0.00022941935,0.0010509696,0.0004151259,0.00009065042,0.00020358316,0.00060012576,9.818489e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031596344,0.00041743103,0.051358555,0.93904406,0.00012982437,0.0000113055,0.00029397104,0.000005549899,2.4746333e-10,0.000032201788,0.000031717154,0.008643779],"study_design_scores_gemma":[0.0006823993,0.00040068242,0.028897153,0.96436995,0.0023385526,0.0000108785425,0.00006615744,0.000025931415,8.668206e-9,0.000017567507,0.0029304617,0.00026023493],"about_ca_topic_score_codex":0.005702162,"about_ca_topic_score_gemma":0.00006678344,"teacher_disagreement_score":0.025325902,"about_ca_system_score_codex":0.00074161624,"about_ca_system_score_gemma":0.001897596,"threshold_uncertainty_score":0.99990314},"labels":[],"label_agreement":null},{"id":"W4311342278","doi":"10.1016/j.jval.2022.09.2105","title":"PCR170 Mapping IWQOL-Lite Onto EQ-5D-5L and SF-6DV2 in Chinese Overweight and Obese Population","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Akaike information criterion; Statistics; Mathematics; Overweight; Population; Bayesian information criterion; Mean squared error; Mean absolute percentage error; Linear regression; EQ-5D; Demography; Medicine; Body mass index; Internal medicine; Health related quality of life","score_opus":0.3244837192577949,"score_gpt":0.3800896128161344,"score_spread":0.0556058935583395,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311342278","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9643653,0.011299251,0.0000954154,0.022041196,0.00050820713,0.00096768065,0.0001999009,0.000029899336,0.000493152],"genre_scores_gemma":[0.99021053,0.0008665235,0.001268445,0.0069999155,0.00016634564,0.00014783735,0.00007432326,0.000033134882,0.00023293935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99426705,0.00091808307,0.003464106,0.0006943009,0.00012750461,0.00052893406],"domain_scores_gemma":[0.9973929,0.00073724997,0.0012744648,0.00036454672,0.000014207272,0.0002166475],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.018494891,0.00020467234,0.0009496412,0.0008409216,0.00032704204,0.00006289636,0.00015473014,0.000091905335,0.00018438134],"category_scores_gemma":[0.0011198662,0.0002743139,0.00004660821,0.00050852005,0.000033240707,0.00043759815,0.0001492149,0.00037676442,0.000051630414],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017898836,0.0000907677,0.9569125,0.00074163795,0.000008661232,0.0000023527443,0.0065843053,0.0036114564,0.0000012373456,0.03089657,0.00066863315,0.0004639726],"study_design_scores_gemma":[0.0011181966,0.00009996285,0.8796102,0.00013381634,7.9361445e-7,0.0000127929625,0.0010576972,0.07479548,6.686475e-8,0.027075922,0.015830982,0.0002641219],"about_ca_topic_score_codex":0.072951145,"about_ca_topic_score_gemma":0.0028100715,"teacher_disagreement_score":0.07730234,"about_ca_system_score_codex":0.001674124,"about_ca_system_score_gemma":0.00017546403,"threshold_uncertainty_score":0.9999709},"labels":[],"label_agreement":null},{"id":"W4311342469","doi":"10.1016/j.jval.2022.09.057","title":"P45 Internal, External, and Cross-Validation of the DEDUCE Model, a Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada); Western University","funders":"","keywords":"Mean absolute percentage error; Continuous glucose monitoring; Type 2 diabetes; Computer science; Type 1 diabetes; Statistics; Medicine; Diabetes mellitus; Mean squared error; Mathematics","score_opus":0.15984441964134768,"score_gpt":0.40083696094883586,"score_spread":0.24099254130748818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311342469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966068,0.0014209447,0.00006813892,0.00015486409,0.00032486793,0.0013964481,0.000014954729,0.000007711669,0.000005271689],"genre_scores_gemma":[0.9992912,0.000031369374,0.000495243,0.00008078654,0.00002334651,0.000024617688,0.000005629304,0.000013665671,0.000034144887],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99833137,0.0003906863,0.00039957924,0.00023253435,0.00039937487,0.0002464317],"domain_scores_gemma":[0.9993333,0.000121584555,0.00013255252,0.00020137368,0.0001459139,0.00006527709],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016014454,0.000091423986,0.00021084191,0.0002115123,0.000112377216,0.00004181067,0.000072240604,0.000027950673,0.0000046621135],"category_scores_gemma":[0.0002756337,0.00007711018,0.000016515154,0.0004978042,0.000038340826,0.00007143724,0.00016876633,0.0001941617,4.0936837e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019267583,0.00007027927,0.5612187,0.00045308686,0.0000052719347,7.7234216e-7,0.00039515784,0.42230776,0.012556503,0.000003947927,0.0000042180436,0.0027916795],"study_design_scores_gemma":[0.0008192184,0.00026743792,0.20584045,0.0006165597,0.00000868378,4.845725e-7,0.00014202786,0.7881928,0.003995989,0.000031319632,0.000026577522,0.00005846512],"about_ca_topic_score_codex":0.0016258928,"about_ca_topic_score_gemma":0.0000032127473,"teacher_disagreement_score":0.36588505,"about_ca_system_score_codex":0.00032098504,"about_ca_system_score_gemma":0.00021231374,"threshold_uncertainty_score":0.31444618},"labels":[],"label_agreement":null},{"id":"W4311342894","doi":"10.1016/j.jval.2022.09.2432","title":"SA38 Mortality Estimates in Patients With Anti-Aquaporin-4 Autoantibody Positive Neuromyelitis Optica Spectrum Disorder","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Advancing Health Outcomes","funders":"","keywords":"Neuromyelitis optica; Spectrum disorder; Autoantibody; Medicine; Aquaporin 4; Multiple sclerosis; Disease; Pediatrics; Immunology; Pathology; Antibody; Psychiatry","score_opus":0.036218474785306,"score_gpt":0.3299394272878361,"score_spread":0.2937209525025301,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311342894","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9920712,0.0002924858,0.00002441191,0.0051770043,0.00012299448,0.0017349172,0.0001672778,0.000056392393,0.0003533048],"genre_scores_gemma":[0.99839467,0.00026655616,0.0006748872,0.0003128228,0.00003588948,0.00011492124,0.00013433277,0.000038482834,0.000027461083],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967629,0.0004058434,0.00055245566,0.0005448783,0.0009286004,0.0008053312],"domain_scores_gemma":[0.99887526,0.0003144008,0.00013264184,0.0004073177,0.000059116075,0.00021127767],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007514957,0.00022649094,0.00061770855,0.00034238142,0.00025020176,0.000017794715,0.0001514525,0.000029247118,0.00014219186],"category_scores_gemma":[0.0003724004,0.00019341457,0.000052594394,0.0008264658,0.00013112683,0.00008905378,0.0002636253,0.0006520423,0.000008711875],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002060787,0.0010507281,0.9908388,0.00025682236,0.00004189393,0.0000820441,0.00086020643,0.0055259326,0.000018214983,0.0001972868,0.0000651395,0.0008568433],"study_design_scores_gemma":[0.003271708,0.0017250243,0.98729324,0.0002415982,0.000008991467,0.000005238399,0.00027156793,0.0067953295,0.000017237582,0.00008118334,0.00013069592,0.00015816526],"about_ca_topic_score_codex":0.02349309,"about_ca_topic_score_gemma":0.00033463028,"teacher_disagreement_score":0.023158459,"about_ca_system_score_codex":0.00061974034,"about_ca_system_score_gemma":0.0004117754,"threshold_uncertainty_score":0.9830096},"labels":[],"label_agreement":null},{"id":"W4311351195","doi":"10.1016/j.jval.2022.09.1658","title":"HTA200 Do Pharmacoeconomic Analyses Impact Price Negotiation Outcomes in Canada? Comparison of Rare Disease and Oncology Drugs","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Negotiation; Medicine; Internal medicine; Alliance; Family medicine; Oncology; Political science","score_opus":0.41548483295136796,"score_gpt":0.516473419995901,"score_spread":0.10098858704453306,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311351195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96798825,0.008711898,0.000037686485,0.020896323,0.0004549068,0.0008516459,0.0008440441,0.00001029944,0.00020493375],"genre_scores_gemma":[0.9951136,0.0003159851,0.00021464081,0.0040930393,0.000047498324,0.00011159244,0.000056676236,0.000020889678,0.000026043179],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993103,0.0012887125,0.004528333,0.00049228786,0.00011494144,0.00047271108],"domain_scores_gemma":[0.9948493,0.0017202742,0.0027818726,0.00031308987,0.000020237589,0.0003152272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009193286,0.00017797732,0.0014993442,0.0006895175,0.00015415034,0.000018062581,0.00023095895,0.0000408548,0.0005034898],"category_scores_gemma":[0.0007798851,0.0002321916,0.00008088876,0.0003419566,0.000031192874,0.00022848172,0.00009205322,0.00030893745,0.000016233926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004711606,0.0001588605,0.84171,0.0003099694,0.000034809313,0.0000014255188,0.0034011672,0.14967744,5.624494e-7,0.0018945165,0.002447031,0.00031713297],"study_design_scores_gemma":[0.0016661057,0.00015892493,0.8275957,0.00004218207,0.0000058119263,0.000001640883,0.0058664866,0.15776458,0.0000011744947,0.0018051366,0.0048417626,0.00025044908],"about_ca_topic_score_codex":0.91640323,"about_ca_topic_score_gemma":0.22202629,"teacher_disagreement_score":0.694377,"about_ca_system_score_codex":0.011863569,"about_ca_system_score_gemma":0.0050762678,"threshold_uncertainty_score":0.9919297},"labels":[],"label_agreement":null},{"id":"W4311351375","doi":"10.1016/j.jval.2022.09.034","title":"P22 Value of Information - Consolidated Health Economic Evaluation Reporting Standards: A Checklist Extension","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; Hospital for Sick Children","funders":"","keywords":"Checklist; Delphi; Likert scale; Delphi method; Psychology; Medical education; Medicine; Computer science; Applied psychology","score_opus":0.34194073805082653,"score_gpt":0.45688222302516546,"score_spread":0.11494148497433893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311351375","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8981822,0.007457254,0.0029619453,0.07681223,0.0027795064,0.0052935015,0.0035765774,0.00014635791,0.002790419],"genre_scores_gemma":[0.9829793,0.00033836198,0.00294104,0.012525281,0.00014013203,0.00037296955,0.0006077578,0.000044950313,0.00005019377],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9743233,0.0029767714,0.020361006,0.0008121131,0.0006370388,0.00088982173],"domain_scores_gemma":[0.97566426,0.00064878707,0.02243386,0.0007989965,0.00018735313,0.00026672077],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.14984517,0.00024935344,0.0016876722,0.0010836171,0.0005845715,0.00006203832,0.00031627636,0.000099780824,0.0007760167],"category_scores_gemma":[0.009017128,0.00035803433,0.00015538165,0.0005061984,0.00006957962,0.0008916485,0.00015496927,0.00044686507,0.00013473125],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00019656158,0.00037260726,0.037046473,0.0032966826,0.000095769894,0.0000021539547,0.03221162,0.654467,0.0000054881666,0.22517066,0.042700395,0.004434632],"study_design_scores_gemma":[0.0037815864,0.00085155974,0.0468691,0.0005059106,0.000008542589,0.00005774955,0.009302746,0.7721757,0.0000118462885,0.02124948,0.14451379,0.0006719902],"about_ca_topic_score_codex":0.043682043,"about_ca_topic_score_gemma":0.00020478015,"teacher_disagreement_score":0.20392117,"about_ca_system_score_codex":0.011303842,"about_ca_system_score_gemma":0.005871846,"threshold_uncertainty_score":0.99988717},"labels":[],"label_agreement":null},{"id":"W4311352505","doi":"10.1016/j.jval.2022.09.2427","title":"SA33 Demographic Characteristics of Patients Initiating Topical Combination Therapies for Plaque Psoriasis in Canada: A Claims-Based Analysis","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Plaque psoriasis; Medicine; Psoriasis; Tazarotene; Dermatology; Calcipotriol; Lotion; Betamethasone dipropionate; Clobetasol propionate; Pharmacology","score_opus":0.02600185905838446,"score_gpt":0.24841278352575952,"score_spread":0.22241092446737507,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311352505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975998,0.0005622984,0.00006948103,0.00039217394,0.00038397525,0.00042973753,0.0005490816,0.000007727381,0.000005757278],"genre_scores_gemma":[0.99854445,0.000053709045,0.00013248724,0.00018904296,0.0000070994856,0.00017802125,0.0008805647,0.000008008391,0.0000066149273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982911,0.00066092197,0.0005396904,0.00019130638,0.00006243838,0.00025457324],"domain_scores_gemma":[0.9990218,0.00051066483,0.0002792077,0.00012994102,0.000041696738,0.00001664848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043556307,0.000105455976,0.00040267457,0.00042443082,0.00014805401,0.000002464395,0.00010662779,0.000059255715,0.000069179354],"category_scores_gemma":[0.000054455082,0.0001090209,0.00008736657,0.00066317327,0.000020742444,0.000021447575,0.00002202522,0.00013556819,2.84343e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026799765,0.00035733756,0.98405635,0.000064646425,0.00018888527,0.0000016150339,0.0005846897,0.0006690852,0.000040124803,0.00044147158,0.000028712408,0.013299103],"study_design_scores_gemma":[0.0028379925,0.0003791934,0.9946388,0.00001841619,0.00007192422,3.2438652e-7,0.000306345,0.00094780594,0.00015496786,0.00015913573,0.00038871964,0.000096393596],"about_ca_topic_score_codex":0.40031314,"about_ca_topic_score_gemma":0.2523913,"teacher_disagreement_score":0.14792185,"about_ca_system_score_codex":0.00050753617,"about_ca_system_score_gemma":0.0007454485,"threshold_uncertainty_score":0.7612506},"labels":[],"label_agreement":null},{"id":"W4311359183","doi":"10.1016/j.jval.2022.09.128","title":"CO49 3D Visualisation Systems: Advantages for Cataract Surgery","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Imaging and Analysis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Cataract surgery; Cataracts; Optometry; Visual acuity; Ophthalmology; Surgery","score_opus":0.0762933706307163,"score_gpt":0.3751060343998624,"score_spread":0.2988126637691461,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311359183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98090565,0.0055469866,0.0014190631,0.01039885,0.0006194294,0.00079842325,0.00007708544,0.000085699154,0.0001488282],"genre_scores_gemma":[0.9975983,0.0002605525,0.0003191733,0.0008275716,0.00014579773,0.00010891197,0.00023742735,0.000016208434,0.00048603996],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987157,0.00026700384,0.0003875048,0.00018335957,0.0002299679,0.00021643778],"domain_scores_gemma":[0.99912506,0.00044749456,0.00015767412,0.00015466333,0.0000356518,0.00007947459],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018682721,0.00006986315,0.00032867317,0.00024852782,0.00014939635,0.000011324946,0.000036527934,0.000014401149,0.000022784878],"category_scores_gemma":[0.00020234074,0.000066712106,0.00008260754,0.00028095703,0.000012895294,0.000040283943,0.000014849851,0.0001326965,0.000004242273],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007979921,0.0010801159,0.8381693,0.00867177,0.00017407577,0.00015932873,0.0040658982,0.07144274,0.0007158941,0.0018546468,0.043793287,0.029074963],"study_design_scores_gemma":[0.002435359,0.0012990668,0.050335903,0.0014812602,0.00018567458,0.00040018006,0.010461324,0.6469963,0.00014538602,0.00024927474,0.28546476,0.00054550066],"about_ca_topic_score_codex":0.008211769,"about_ca_topic_score_gemma":0.0000046285877,"teacher_disagreement_score":0.7878334,"about_ca_system_score_codex":0.00029265016,"about_ca_system_score_gemma":0.00031197563,"threshold_uncertainty_score":0.99839264},"labels":[],"label_agreement":null},{"id":"W4311359312","doi":"10.1016/j.jval.2022.09.077","title":"P65 Impact of COVID-19 on Hospital Screening, Diagnosis and Treatment Activities Among Prostate and Colorectal Cancer Patients in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Prostate cancer; Colorectal cancer; Cancer; Pandemic; Medical diagnosis; Prostate; Internal medicine; Oncology; Emergency medicine; Gynecology; Coronavirus disease 2019 (COVID-19); Disease; Pathology","score_opus":0.04621478754045466,"score_gpt":0.36221524361490054,"score_spread":0.3160004560744459,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311359312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992108,0.0008738358,1.8046616e-7,0.004748774,0.00009042267,0.0015792942,0.00058375177,0.000008799438,0.000006934611],"genre_scores_gemma":[0.99642617,0.0022872896,0.0000120329605,0.0008713583,0.000020894935,0.0003259483,0.00003016919,0.000016856522,0.000009313493],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984713,0.00022034577,0.00033811052,0.0002712327,0.00030615163,0.00039284793],"domain_scores_gemma":[0.9987813,0.00042534494,0.00018238889,0.00009911006,0.000017723769,0.00049410807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026131386,0.00015711371,0.00043524543,0.0002367249,0.0001222945,0.000005965502,0.00003140273,0.000028306928,0.000035735855],"category_scores_gemma":[0.00019269198,0.00013539722,0.000030911433,0.0002323626,0.000050605013,0.000051584262,0.00004259239,0.0002090239,3.2829025e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00067215634,0.00032735933,0.976627,0.00036210025,0.000024245272,0.0000435048,0.007973871,0.0028266665,0.000001302684,0.000004182291,0.00033063162,0.010807003],"study_design_scores_gemma":[0.0032039797,0.008570338,0.9854204,0.00020593755,0.000007862665,0.0000025919228,0.0013823359,0.00082104036,0.000025502317,0.000009873666,0.00025058966,0.00009952436],"about_ca_topic_score_codex":0.9982692,"about_ca_topic_score_gemma":0.9471852,"teacher_disagreement_score":0.05108393,"about_ca_system_score_codex":0.010847568,"about_ca_system_score_gemma":0.011128223,"threshold_uncertainty_score":0.99447775},"labels":[],"label_agreement":null},{"id":"W4311359314","doi":"10.1016/j.jval.2022.09.143","title":"CO64 Comparison of Propensity Score Matching to Inverse Probability Weighting in Obstructive Sleep Apnea Patients With Cardiovascular Diseases","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Discovery Centre","funders":"","keywords":"Propensity score matching; Medicine; Confounding; Atrial fibrillation; Obstructive sleep apnea; Heart failure; Internal medicine; Cardiology; Sleep apnea; Inverse probability weighting; Matching (statistics); Intensive care medicine; Physical therapy","score_opus":0.15405656193558057,"score_gpt":0.35047196049547574,"score_spread":0.19641539855989518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311359314","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99102956,0.00007208542,0.006146708,0.000050410385,0.000049621176,0.002465997,0.000063842934,0.00009121255,0.000030538115],"genre_scores_gemma":[0.94795996,0.000001351303,0.051727973,0.00004366805,0.000008133465,0.00021770883,0.000014397112,0.000025810774,9.85392e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971545,0.0007587888,0.0007044741,0.0004117576,0.000617384,0.00035314614],"domain_scores_gemma":[0.9985986,0.0002959844,0.00033625288,0.00053837197,0.000114420516,0.00011639564],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010887722,0.0001797461,0.00078636484,0.0001831364,0.00013469844,0.000007912973,0.00022088717,0.000033120723,0.000008591716],"category_scores_gemma":[0.0004956447,0.00016536473,0.00007252337,0.000604362,0.00006407772,0.00014681736,0.00030182066,0.0004194252,5.67453e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015890153,0.0006435423,0.910453,0.00084016944,0.000027188344,0.000005130679,0.0061515365,0.07443993,0.0000070291967,0.0043246686,0.000012168862,0.0029367097],"study_design_scores_gemma":[0.0018439614,0.0015773664,0.64716303,0.001008169,0.00005336238,0.0000036230535,0.003411565,0.0074927635,0.00050845224,0.3361963,0.000066780536,0.00067462336],"about_ca_topic_score_codex":0.003873175,"about_ca_topic_score_gemma":0.0003386546,"teacher_disagreement_score":0.33187163,"about_ca_system_score_codex":0.00097655377,"about_ca_system_score_gemma":0.00017898782,"threshold_uncertainty_score":0.6743378},"labels":[],"label_agreement":null},{"id":"W4311359463","doi":"10.1016/j.jval.2022.09.207","title":"CO129 Effectiveness of a Prescription Digital Therapeutic of Cognitive-Behavioral Therapy for Insomnia in 2 Clinical Trials and in Real-World Clinical Settings: A Number Needed to Treat Analysis","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Sleep and related disorders","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut Universitaire en Santé Mentale de Québec","funders":"","keywords":"Number needed to treat; Medicine; Insomnia; Randomized controlled trial; Medical prescription; Clinical trial; Population; Psychiatry; Physical therapy; Internal medicine; Relative risk; Confidence interval; Pharmacology","score_opus":0.20241365686122118,"score_gpt":0.5206924393650006,"score_spread":0.3182787825037795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311359463","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99541783,0.0006625376,0.000079492245,0.00023687797,0.00030172017,0.002960279,0.0001626326,0.000013911232,0.00016472545],"genre_scores_gemma":[0.99869925,0.00035995478,0.000032448934,0.0002955464,0.00002342651,0.00046754413,0.0000723869,0.000023125995,0.000026334465],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98802924,0.008596989,0.002367996,0.0005084397,0.0001808334,0.00031649024],"domain_scores_gemma":[0.9908954,0.0081452215,0.0005985576,0.00021142703,0.000051409697,0.00009801291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0136364,0.00016306079,0.0014483379,0.0007591852,0.000038010334,0.000010336573,0.000119708646,0.00017488403,0.000057977784],"category_scores_gemma":[0.00054756744,0.00014682888,0.00032553414,0.0017113597,0.000113314774,0.00005918334,0.000041830644,0.00043462033,0.0000011563365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017578423,0.0050883195,0.9182293,0.000077023724,0.00038582613,0.0000048039665,0.0045210766,0.0005798005,0.00001928021,0.00014850119,0.000036447178,0.053331185],"study_design_scores_gemma":[0.023480218,0.0033317828,0.96563244,0.00022307542,0.00025158568,0.0000015744763,0.0055734254,0.000619989,0.000013741907,0.0006141076,0.00008533947,0.00017274897],"about_ca_topic_score_codex":0.016599106,"about_ca_topic_score_gemma":0.0006321188,"teacher_disagreement_score":0.05315844,"about_ca_system_score_codex":0.00010740814,"about_ca_system_score_gemma":0.00015980643,"threshold_uncertainty_score":0.98994946},"labels":[],"label_agreement":null},{"id":"W4311481312","doi":"10.1016/j.jval.2022.09.2081","title":"PCR146 Preferences for Toenail Onychomycosis Treatments Among Canadians With and Without Diabetes Mellitus: A Discrete Choice Experiment","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Diabetes mellitus; Medicine; Dermatology; Gerontology; Endocrinology","score_opus":0.03652971868480791,"score_gpt":0.3082840769449951,"score_spread":0.2717543582601872,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311481312","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901612,0.0064045894,0.0000046418745,0.00091804675,0.00006224039,0.0020022758,0.00026374098,0.000029400035,0.00015387006],"genre_scores_gemma":[0.99617904,0.00034112117,0.0006604277,0.0004128361,0.000034610362,0.0018439371,0.00013506104,0.00003102256,0.0003619471],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998499,0.00011034377,0.000253099,0.0004088622,0.00026038132,0.0004683623],"domain_scores_gemma":[0.9991197,0.00009287754,0.00011092803,0.00022820308,0.000020053165,0.00042822026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012677892,0.00019561326,0.0003821163,0.00012644482,0.00026657374,0.000021130505,0.00006169096,0.000023851919,0.000062443374],"category_scores_gemma":[0.000018285788,0.00014752403,0.000050180704,0.00017362478,0.000052806787,0.00006659798,0.000029801577,0.000094535484,7.268645e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026044648,0.00041033578,0.99362874,0.00022087857,0.00019144037,0.000008026614,0.0012939449,0.0001250229,0.000005086376,0.000046409612,0.00014146807,0.0036682088],"study_design_scores_gemma":[0.009692019,0.006722665,0.9743399,0.0005203746,0.00025890244,0.000007356293,0.0021827957,0.002150658,0.00010147707,0.00022598125,0.0035164063,0.0002814693],"about_ca_topic_score_codex":0.113188714,"about_ca_topic_score_gemma":0.0060099894,"teacher_disagreement_score":0.107178725,"about_ca_system_score_codex":0.0006419535,"about_ca_system_score_gemma":0.000419388,"threshold_uncertainty_score":0.89271665},"labels":[],"label_agreement":null},{"id":"W4311481338","doi":"10.1016/j.jval.2022.09.1805","title":"MSR74 Can Artificial Intelligence (AI) Replace a Human Reviewer in Systematic Literature Review (SLR)? Validation of the LIVESTARTTM Tool","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Inclusion and exclusion criteria; Inclusion (mineral); Computer science; Artificial intelligence; Systematic review; Machine learning; Medical physics; Population; Medicine; Natural language processing; Information retrieval; MEDLINE; Alternative medicine; Psychology; Pathology","score_opus":0.1691173899103994,"score_gpt":0.42817319533023207,"score_spread":0.25905580541983264,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311481338","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.625343,0.27490628,0.00010599058,0.084079236,0.00237872,0.012960078,0.00004240786,0.00005943734,0.00012484203],"genre_scores_gemma":[0.96203333,0.02943852,0.00016021557,0.0073395087,0.00018207979,0.000602434,0.00005621321,0.000026780252,0.00016093542],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9943269,0.0020506443,0.0022988194,0.00037661378,0.0005947796,0.00035223883],"domain_scores_gemma":[0.99780357,0.00032841606,0.00068899523,0.0007879021,0.00029525053,0.000095844836],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00574597,0.00016913454,0.0007445764,0.00025765813,0.00023147493,0.00001752921,0.00024575499,0.00006894652,0.000113244525],"category_scores_gemma":[0.0027567465,0.0001328371,0.00012991276,0.0019629393,0.000053747477,0.00008485828,0.00007684222,0.00081649475,0.000008009719],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018429065,0.0013976921,0.021703176,0.8779762,0.000031951196,0.000045424986,0.041409995,0.005796747,0.00024046388,0.02765138,0.003690805,0.019871866],"study_design_scores_gemma":[0.00014126602,0.0021191614,0.0033723274,0.9383648,0.00017652166,0.00024942646,0.009085854,0.006270457,0.005079099,0.030997818,0.0034153238,0.00072797],"about_ca_topic_score_codex":0.003896122,"about_ca_topic_score_gemma":0.000288542,"teacher_disagreement_score":0.3366903,"about_ca_system_score_codex":0.0008552285,"about_ca_system_score_gemma":0.0010042188,"threshold_uncertainty_score":0.5889797},"labels":[],"label_agreement":null},{"id":"W4311481774","doi":"10.1016/j.jval.2022.09.2265","title":"RWD40 Persistence and Switching Patterns of Migraine Prophylactic Medications in Canada: A Retrospective Claims Analysis Comparing Adherence and Evaluating the Economic Burden of Illness","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Migraine and Headache Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Persistence (discontinuity); Migraine; Medicine; Prophylactic treatment; Intensive care medicine; Psychiatry; Pediatrics; Internal medicine","score_opus":0.06985849963981648,"score_gpt":0.32918318267924,"score_spread":0.2593246830394235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311481774","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99488086,0.0018315938,0.000017183263,0.0027966339,0.0000121301855,0.0003985174,0.000018444807,0.0000023805685,0.000042286236],"genre_scores_gemma":[0.99955964,0.00018846965,0.00010195712,0.00006266522,0.000015521275,0.000046782476,0.0000044568656,0.000004735602,0.000015741867],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986959,0.0002204368,0.0004784506,0.00020808258,0.000236164,0.00016096196],"domain_scores_gemma":[0.9991377,0.0003254893,0.0002835614,0.00016798015,0.00003491049,0.00005035457],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012520974,0.00007678444,0.00048005162,0.00018342318,0.00015930984,0.0000025017478,0.00007190689,0.000011181967,0.000019674186],"category_scores_gemma":[0.00016258254,0.00006238221,0.000033325203,0.00036784928,0.000045668105,0.00002223165,0.000095318355,0.0002554411,2.8296581e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040098064,0.000018313096,0.95461446,0.00038615358,0.00011035682,0.0000021700919,0.03623993,0.007800867,0.00008606505,0.0001416967,0.0000075153134,0.00055238476],"study_design_scores_gemma":[0.0004607983,0.00030341107,0.76863045,0.00016770946,0.00011663311,0.000008850246,0.050878912,0.17929037,0.0000061358805,0.00008350922,0.000003031418,0.00005018659],"about_ca_topic_score_codex":0.9644924,"about_ca_topic_score_gemma":0.82982165,"teacher_disagreement_score":0.185984,"about_ca_system_score_codex":0.00087468605,"about_ca_system_score_gemma":0.0014497751,"threshold_uncertainty_score":0.25718388},"labels":[],"label_agreement":null},{"id":"W4311483258","doi":"10.1016/j.jval.2022.09.269","title":"EE15 Cost-Consequence Analysis of Ofatumumab in Comparison With Other Disease-Modifying Therapies and Best Supportive Care for the Treatment of Relapsing-Remitting Multiple Sclerosis in Canada","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"EVERSANA (Canada); Queen's University; Memorial University of Newfoundland; University of British Columbia; Novartis (Canada); Innovative Medicines Canada","funders":"","keywords":"Relapsing remitting; Ofatumumab; Medicine; Multiple sclerosis; Natalizumab; Physical therapy; Internal medicine; Psychiatry; Rituximab","score_opus":0.4139563000556837,"score_gpt":0.39781964934160297,"score_spread":0.016136650714080714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311483258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737753,0.019617258,0.00022796099,0.0033469046,0.00007592925,0.0016117694,0.0013303389,0.000002994442,0.000011519686],"genre_scores_gemma":[0.9977032,0.0005444234,0.00077481556,0.00043393124,0.000009268398,0.00048046553,0.00003145201,0.000016297254,0.0000061546543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962769,0.00046566414,0.0024948558,0.0003589026,0.00010080809,0.00030283685],"domain_scores_gemma":[0.99526334,0.002561737,0.0017802187,0.00028317896,0.000034221415,0.00007732552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003899652,0.00012832104,0.001055136,0.00048570285,0.00015473113,0.00000989134,0.00012763482,0.000023830105,0.00002029886],"category_scores_gemma":[0.0003544335,0.00012771007,0.0000612459,0.00061264844,0.00006314925,0.0000714331,0.000018943441,0.00010405613,2.5632673e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008530429,0.00012395387,0.79502666,0.00028797367,0.00008514728,4.4732712e-7,0.023223845,0.18017077,5.6319436e-7,0.0004491028,0.000008372922,0.0005378759],"study_design_scores_gemma":[0.0021444568,0.0003740431,0.66730714,0.00029731911,0.00003507398,4.3739243e-7,0.066667534,0.26221392,0.0000045377265,0.00018531368,0.0006015688,0.00016865511],"about_ca_topic_score_codex":0.9635177,"about_ca_topic_score_gemma":0.90445065,"teacher_disagreement_score":0.1277195,"about_ca_system_score_codex":0.003961514,"about_ca_system_score_gemma":0.0014757152,"threshold_uncertainty_score":0.9998621},"labels":[],"label_agreement":null},{"id":"W4311496568","doi":"10.1016/j.jval.2022.09.1963","title":"PCR28 Utility Values Derived From Canadian Adults With Toenail Onychomycosis With and Without Comorbid Diabetes Mellitus: A Study Using the Health Utilities Index®","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Nail Diseases and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Medicine; Diabetes mellitus; Nail (fastener); Comorbidity; Gerontology; Pediatrics; Intensive care medicine; Internal medicine; Endocrinology","score_opus":0.043164892350169876,"score_gpt":0.2976046667651237,"score_spread":0.2544397744149538,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311496568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98569226,0.00845675,0.000006257128,0.0024205286,0.00007376142,0.0028714533,0.0004040003,0.000045133536,0.000029832447],"genre_scores_gemma":[0.9971898,0.00025903314,0.0003212316,0.0018429446,0.000038695667,0.00020921692,0.00007966748,0.000044672674,0.000014734752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99675685,0.00086220336,0.00044741808,0.0006053755,0.00058924174,0.0007389098],"domain_scores_gemma":[0.99827456,0.00016001909,0.0002150998,0.0005814993,0.00006344477,0.0007053934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006282434,0.00030212515,0.0006731349,0.00019725972,0.0008992158,0.00004456688,0.00013671117,0.00003060097,0.00007584869],"category_scores_gemma":[0.00002823038,0.00019709748,0.000043545082,0.00044687663,0.0001710003,0.00008393524,0.00007474339,0.0003873296,8.21937e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012748032,0.00073802256,0.9817928,0.00020489955,0.00020906978,0.000034495468,0.0129486,0.00017968987,3.9257682e-7,0.000007602664,0.000033050954,0.0025765512],"study_design_scores_gemma":[0.00585287,0.0039838348,0.9425013,0.0005668306,0.00010740919,0.000013927452,0.036723915,0.00980281,0.0000028048505,0.00010761984,0.00015562361,0.00018102615],"about_ca_topic_score_codex":0.8886883,"about_ca_topic_score_gemma":0.31142238,"teacher_disagreement_score":0.5772659,"about_ca_system_score_codex":0.0010488047,"about_ca_system_score_gemma":0.0029118918,"threshold_uncertainty_score":0.8037402},"labels":[],"label_agreement":null},{"id":"W4311496671","doi":"10.1016/j.jval.2022.09.400","title":"EE148 Canadian Cost-Effectiveness Analysis of Deferiprone Compared to Deferoxamine and Deferasirox for the Treatment of Iron Overload in Patients With Sickle Cell Disease and Other Anemias","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Deferasirox; Deferiprone; Deferoxamine; Medicine; Thalassemia; Disease; Anemia; Beta thalassemia; Internal medicine; Intensive care medicine","score_opus":0.022562213554775005,"score_gpt":0.27061245405231676,"score_spread":0.24805024049754176,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311496671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940633,0.002287939,0.000013312683,0.00025807254,0.000019004656,0.00293061,0.00040727347,0.000003038051,0.000017433531],"genre_scores_gemma":[0.99928063,0.00015493129,0.00005905175,0.00020205803,0.0000025775985,0.00021036848,0.00006613373,0.0000134982265,0.000010749785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9990341,0.00014595696,0.00025140648,0.0002052084,0.00013999206,0.00022330537],"domain_scores_gemma":[0.99928594,0.00019036321,0.00008200417,0.00017635671,0.000028066279,0.00023725492],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00023365804,0.00011000306,0.00041911122,0.00032436033,0.00007917909,0.0000027801543,0.000033457727,0.000025264342,0.000012538015],"category_scores_gemma":[0.000016146629,0.000075128584,0.000037229744,0.0006143661,0.00004511434,0.000010721042,0.0000122006395,0.00006221925,7.043992e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019906482,0.0007307122,0.94736844,0.00031769002,0.000108542336,0.0000028103177,0.0024171963,0.0449609,0.0000122762485,0.000023642635,0.0000060612897,0.0020610597],"study_design_scores_gemma":[0.005993426,0.002478104,0.98377126,0.00007445542,0.00033726761,3.779363e-7,0.0009073543,0.0056924773,0.000017157554,0.0000059020244,0.0006460509,0.00007613418],"about_ca_topic_score_codex":0.22669381,"about_ca_topic_score_gemma":0.035396304,"teacher_disagreement_score":0.1912975,"about_ca_system_score_codex":0.00043103445,"about_ca_system_score_gemma":0.00026545546,"threshold_uncertainty_score":0.9822052},"labels":[],"label_agreement":null},{"id":"W4311497573","doi":"10.1016/j.jval.2022.09.265","title":"EE11 Burden of Myelodysplastic Syndromes Part II: Systematic Literature Review of Economic Burden","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Cytopenia; Myelodysplastic syndromes; Medicine; Disease burden; Disease; Haematopoiesis; Dysfunctional family; Burden of disease; Bone marrow; Intensive care medicine; Oncology; Internal medicine; Stem cell; Psychiatry; Biology; Genetics","score_opus":0.035555775977325975,"score_gpt":0.32383861803766656,"score_spread":0.2882828420603406,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311497573","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38587204,0.58917814,0.0000074539994,0.016509723,0.00067268737,0.0063504144,0.00030653673,0.00006295832,0.0010400811],"genre_scores_gemma":[0.84599745,0.1482192,0.0006600645,0.0009960154,0.00035017135,0.00057512964,0.00018361966,0.00009118397,0.0029271857],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961674,0.00092150876,0.0015364919,0.00034233998,0.0006004441,0.00043181566],"domain_scores_gemma":[0.99789417,0.00053054345,0.0005812054,0.0007080327,0.00009401405,0.00019201946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031315445,0.00018505845,0.001467469,0.00043235012,0.00009829008,0.0000056551353,0.0003336464,0.00006540225,0.00048352306],"category_scores_gemma":[0.00064853387,0.00016250435,0.00015356287,0.0006655059,0.00006756005,0.00005666564,0.0002756602,0.0006365537,0.000024273177],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001085698,0.00009329558,0.00027364463,0.98233324,0.00012262473,0.00014927657,0.0029455996,0.004292526,0.00007787226,0.0015732431,0.00779119,0.00023891889],"study_design_scores_gemma":[0.0035524832,0.0040188855,0.00040675644,0.94780445,0.00023611018,0.0023471173,0.0017630707,0.027635027,0.00008303025,0.00032602073,0.011418171,0.00040889336],"about_ca_topic_score_codex":0.0013510372,"about_ca_topic_score_gemma":0.0000030698484,"teacher_disagreement_score":0.46012542,"about_ca_system_score_codex":0.0014534421,"about_ca_system_score_gemma":0.001923929,"threshold_uncertainty_score":0.66267353},"labels":[],"label_agreement":null},{"id":"W4311497732","doi":"10.1016/j.jval.2022.09.242","title":"CO166 Clinical Outcomes of Patients With Neurotrophic Tyrosine Receptor Kinase (NTRK) Gene Fusion Cancer Treated With Non-Tropomyosin Recepter Kinase Inhibitors: A Systematic Literature Review","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Trk receptor; Medicine; Fusion gene; Tropomyosin receptor kinase B; Tropomyosin receptor kinase C; Tyrosine kinase; Oncology; Receptor tyrosine kinase; Clinical trial; Internal medicine; Kinase; Tropomyosin receptor kinase A; Neurotrophin; Bioinformatics; Cancer research; Gene; Receptor; Biology; Neurotrophic factors; Genetics; Platelet-derived growth factor receptor","score_opus":0.050287907902456706,"score_gpt":0.3700510836361082,"score_spread":0.31976317573365154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311497732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9384205,0.047577653,0.0000057783363,0.005212421,0.0003862736,0.007962181,0.00036139233,0.00005449594,0.000019328969],"genre_scores_gemma":[0.9290903,0.05956921,0.0014328769,0.005963794,0.0002568219,0.0024638246,0.0005439584,0.0002227805,0.00045640158],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9927065,0.0022308934,0.0019336625,0.00079865614,0.0016450923,0.00068519573],"domain_scores_gemma":[0.9967952,0.00032830916,0.00084853463,0.0010205777,0.00052685087,0.00048056175],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0022036687,0.00041960017,0.0019876678,0.0004092119,0.00017208725,0.000024079396,0.00027782345,0.000118545824,0.00040171857],"category_scores_gemma":[0.00046122976,0.00027305595,0.00017504297,0.0020518685,0.00015967364,0.00009323953,0.00016753472,0.0012906044,0.0000104394885],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00268025,0.0019098042,0.82451844,0.16315131,0.00013265556,0.00025499935,0.00044471605,0.00021341941,0.00013378642,0.0000073172064,0.0050064544,0.0015468438],"study_design_scores_gemma":[0.020454926,0.024952695,0.43614715,0.51135945,0.00048430418,0.00008656326,0.00014229566,0.0008292048,0.0003491495,0.0000047862327,0.0042785048,0.0009109465],"about_ca_topic_score_codex":0.0021458457,"about_ca_topic_score_gemma":0.000056584395,"teacher_disagreement_score":0.38837132,"about_ca_system_score_codex":0.0011392751,"about_ca_system_score_gemma":0.0013577335,"threshold_uncertainty_score":0.99997216},"labels":[],"label_agreement":null},{"id":"W4312204106","doi":"10.1016/j.jval.2022.12.009","title":"The European Organisation for Research and Treatment of Cancer Quality of Life Utility-Core 10 Dimensions: Development and Investigation of General Population Utility Norms for Canada, France, Germany, Italy, Poland, and the United Kingdom","year":2022,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Representativeness heuristic; Demography; Population; Quality of life (healthcare); Medicine; Psychology; Sociology","score_opus":0.5791804608984477,"score_gpt":0.4599164838745568,"score_spread":0.11926397702389085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4312204106","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9867384,0.003003342,0.000089336994,0.007621202,0.00009555175,0.0018634939,0.0005747082,0.0000029435803,0.000011011595],"genre_scores_gemma":[0.9983528,0.0002869948,0.00063293637,0.00032333052,0.000034351044,0.00021368056,0.00010973614,0.00001119661,0.000034972636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955307,0.0012929349,0.0025410638,0.0002728525,0.00013914588,0.00022329195],"domain_scores_gemma":[0.9951831,0.0028542115,0.0015410581,0.00022115625,0.00011534446,0.00008511399],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03021945,0.00008885915,0.00051536487,0.00016740787,0.00060105755,0.000011735779,0.00008202713,0.000029113742,0.000006962042],"category_scores_gemma":[0.0010912811,0.00007421797,0.000022308257,0.00019345239,0.00017436831,0.00005805532,0.000053196884,0.000071739814,1.0969399e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002822957,0.000056517398,0.94324934,0.00096011243,0.000052124815,2.006169e-8,0.0073731635,0.0006154597,0.0000061909955,0.045978595,0.00026554702,0.001160654],"study_design_scores_gemma":[0.002041759,0.00015295889,0.95165175,0.000034993853,0.0000033342335,2.2787232e-7,0.0011669021,0.031607088,0.000010862471,0.008884096,0.0043744864,0.00007153816],"about_ca_topic_score_codex":0.7494889,"about_ca_topic_score_gemma":0.14718418,"teacher_disagreement_score":0.6023047,"about_ca_system_score_codex":0.0005221884,"about_ca_system_score_gemma":0.0008192218,"threshold_uncertainty_score":0.99859315},"labels":[],"label_agreement":null},{"id":"W4316035311","doi":"10.1016/j.jval.2022.12.016","title":"Patient-Reported Outcomes During and After Hepatitis C Virus Direct-Acting Antiviral Treatment Among People Who Inject Drugs","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis C virus research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Vancouver Infectious Diseases Centre; University Health Network; Toronto East General Hospital; Université de Montréal; Centre Hospitalier de l’Université de Montréal","funders":"Canadian Institutes of Health Research; Sanofi Pasteur; Seqirus; University of New South Wales; Department of Health and Ageing, Australian Government; Moderna; Sanofi; Indivior; Eisai; AbbVie; Australian Government; Gilead Sciences; ViiV Healthcare; AstraZeneca","keywords":"Medicine; Confidence interval; Odds ratio; Quality of life (healthcare); Hepatitis C; Distress; Hepatitis C virus; Generalized estimating equation; Odds; Internal medicine; Logistic regression; Clinical psychology; Immunology; Virus","score_opus":0.034601238215164254,"score_gpt":0.33547102626649616,"score_spread":0.3008697880513319,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4316035311","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960532,0.00021275163,0.0000010038942,0.0007534547,0.00015677292,0.0011078558,0.00004337087,0.00019306707,0.0014784873],"genre_scores_gemma":[0.9955839,0.00331281,0.000084608604,0.0001603865,0.000055222885,0.00022351828,0.000025949648,0.00005780002,0.00049580634],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971825,0.0003371245,0.0006875898,0.00049606094,0.0005224203,0.00077430956],"domain_scores_gemma":[0.9988399,0.0003025411,0.0001599745,0.00035958498,0.000048456564,0.00028949825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054450723,0.00023729187,0.0007232388,0.00054660824,0.00016418319,0.000040425715,0.00004423949,0.000090394955,0.000046947032],"category_scores_gemma":[0.00041298682,0.00020832862,0.00008866856,0.00080471626,0.00006090114,0.00016204623,0.00010599486,0.00026045865,0.00004648791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009860221,0.00009028549,0.94961685,0.00030906737,0.000054633038,0.0005098626,0.011807914,0.000030591036,0.00005114735,0.0000013027673,0.000046423287,0.03738332],"study_design_scores_gemma":[0.0014823632,0.0005116325,0.9930341,0.00045923167,0.0000102023005,0.000005327459,0.00039124786,0.002834767,0.0005484928,0.000007299712,0.0005540724,0.00016122709],"about_ca_topic_score_codex":0.16808763,"about_ca_topic_score_gemma":0.013469568,"teacher_disagreement_score":0.15461807,"about_ca_system_score_codex":0.00067825057,"about_ca_system_score_gemma":0.00030957002,"threshold_uncertainty_score":0.84953946},"labels":[],"label_agreement":null},{"id":"W4317936571","doi":"10.1016/j.jval.2023.01.008","title":"Generic Price Regulation and Drug Expenditures: Evidence From Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"University of Nottingham Ningbo China","keywords":"Copayment; Per capita; Incentive; Public economics; Government (linguistics); Prescription drug; Medical prescription; Cost sharing; Price elasticity of demand; Economics; Business; Health care; Health insurance; Economic growth; Microeconomics; Environmental health","score_opus":0.1379334060196279,"score_gpt":0.31495871854030644,"score_spread":0.17702531252067855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4317936571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9744055,0.007908102,0.00004650523,0.015894733,0.0005167926,0.00018408356,0.0001732079,0.000026118485,0.00084495486],"genre_scores_gemma":[0.9915165,0.005221063,0.00018848633,0.0026755813,0.00016834661,0.0000151399645,0.00002060445,0.000013707274,0.00018057636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988246,0.000036429283,0.0004968867,0.00031069672,0.000027141357,0.00030427004],"domain_scores_gemma":[0.9991887,0.00028503023,0.00018197662,0.0001819913,0.000004080512,0.00015820355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066546694,0.000087743305,0.00023728788,0.00014197575,0.00007251214,0.000031323267,0.00011859043,0.00003486196,0.00011245387],"category_scores_gemma":[0.00010409716,0.00010866996,0.000019086623,0.00020432647,0.000017749051,0.00012713771,0.00005091884,0.000113875096,0.00010583933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000073019575,0.000088752335,0.50035137,0.00063096447,0.000072813265,0.000032173546,0.007745332,0.083551094,0.0000967781,0.2175911,0.17886715,0.010899447],"study_design_scores_gemma":[0.00047323594,0.000021659387,0.5241464,0.000112829424,0.0000012348764,0.0000016308297,0.00009875835,0.22461131,0.000060804992,0.07000513,0.18015562,0.00031137787],"about_ca_topic_score_codex":0.8753782,"about_ca_topic_score_gemma":0.118845254,"teacher_disagreement_score":0.7565329,"about_ca_system_score_codex":0.000379215,"about_ca_system_score_gemma":0.00022593739,"threshold_uncertainty_score":0.89723355},"labels":[],"label_agreement":null},{"id":"W4319311385","doi":"10.1016/j.jval.2022.12.004","title":"A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health: A Good Practices Report of an ISPOR Task Force","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":82,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Task force; Preference; Task (project management); Outcomes research; Comparative effectiveness research; Medicine; Management science; Psychology; Medical physics; Alternative medicine; Political science; Engineering; Economics; Systems engineering","score_opus":0.6683350970802836,"score_gpt":0.532583760693091,"score_spread":0.1357513363871926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319311385","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9874479,0.004596609,0.00020445988,0.0055265953,0.00021624053,0.0018272183,0.00014998238,0.000013864493,0.000017089504],"genre_scores_gemma":[0.994907,0.0008885284,0.003415691,0.00052563887,0.000039343115,0.00017908012,0.000016044336,0.00002275052,0.0000059111485],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.990948,0.0013475774,0.0064685186,0.00057120866,0.0001375993,0.0005270559],"domain_scores_gemma":[0.98292667,0.008080654,0.008313548,0.0004966805,0.00008008687,0.000102361984],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.05450365,0.00016405334,0.0012922738,0.0008572651,0.0001230873,0.000023818666,0.00019802,0.000090153946,0.0000036676688],"category_scores_gemma":[0.023808753,0.00015911441,0.00007041572,0.0007963181,0.00007416714,0.0005121031,0.00008832425,0.00019587924,0.0000030207727],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003610259,0.00026815748,0.89419585,0.0053320066,0.000050355997,0.0000075079415,0.052973922,0.03319097,0.0000019694205,0.007845822,0.0002580059,0.0055143866],"study_design_scores_gemma":[0.0016745293,0.0010246048,0.8158555,0.0041502137,0.0000028666707,0.000043182157,0.022701157,0.11267703,0.0000026057564,0.04127453,0.0003336627,0.00026013397],"about_ca_topic_score_codex":0.06364265,"about_ca_topic_score_gemma":0.0058368417,"teacher_disagreement_score":0.079486065,"about_ca_system_score_codex":0.00098934,"about_ca_system_score_gemma":0.00084267394,"threshold_uncertainty_score":0.9844141},"labels":[],"label_agreement":null},{"id":"W4319786977","doi":"10.1016/j.jval.2023.01.021","title":"Author Reply","year":2023,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; Institute of Health Economics","funders":"Novartis Pharmaceuticals Canada; Government of Alberta; F. Hoffmann-La Roche; AstraZeneca","keywords":"Health technology; Context (archaeology); Conceptual framework; Scopus; Sustainability; Psychological intervention; Health care; Risk analysis (engineering); Computer science; Knowledge management; Management science; Engineering ethics; Medicine; Political science; MEDLINE; Engineering; Sociology; Economics; Social science; Nursing; Economic growth","score_opus":0.6345184384418253,"score_gpt":0.46674389545876654,"score_spread":0.16777454298305877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4319786977","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004510532,0.004026838,0.00022666194,0.9851301,0.0050677396,0.0015411063,0.0010462884,0.0002771707,0.0022330922],"genre_scores_gemma":[0.0001624819,0.0004611399,0.001711963,0.96647155,0.0065403655,0.00030669672,0.0004769239,0.00022299871,0.023645878],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9846801,0.0017055646,0.010438693,0.0015255229,0.00024049818,0.001409579],"domain_scores_gemma":[0.98947877,0.0032691953,0.005470805,0.0014758131,0.000047611204,0.00025781253],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.044471566,0.00046122188,0.0026098455,0.0015648055,0.0002190525,0.000115847084,0.00069404795,0.00092882506,0.00043714524],"category_scores_gemma":[0.0073005767,0.000651303,0.0002685163,0.0006916952,0.00007584283,0.0002452209,0.00011326149,0.0022886482,0.02048708],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002510038,0.000021604224,0.0018149401,0.0027348897,0.00002964409,0.000029552648,0.0009721837,0.0005034675,9.25734e-9,0.010427091,0.9833998,0.00006430249],"study_design_scores_gemma":[0.00034185097,0.00008570335,0.0016402918,0.0006854132,0.0000020375032,0.000008446422,0.00012644277,0.00449422,5.7797067e-8,0.031412374,0.9607026,0.0005005401],"about_ca_topic_score_codex":0.045110278,"about_ca_topic_score_gemma":0.00018443068,"teacher_disagreement_score":0.04492585,"about_ca_system_score_codex":0.0030423515,"about_ca_system_score_gemma":0.0011595546,"threshold_uncertainty_score":0.9995938},"labels":[],"label_agreement":null},{"id":"W4321254002","doi":"10.1016/j.jval.2023.02.007","title":"Health Utility Analysis of Tepotinib in Patients With Non-Small Cell Lung Cancer Harboring MET Exon 14 Skipping","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; Merck KGaA","keywords":"Lung cancer; EQ-5D; Medicine; Quality of life (healthcare); Cancer; Baseline (sea); Internal medicine; Oncology; Health related quality of life; Political science","score_opus":0.031775053334926036,"score_gpt":0.3563054454033183,"score_spread":0.3245303920683923,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321254002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997021,0.0006926905,0.00008444565,0.0007167996,0.00012377123,0.0010882561,0.000090503745,0.000033514985,0.00014897219],"genre_scores_gemma":[0.99819106,0.00035849304,0.0008499285,0.00026297732,0.000021369151,0.000092452305,0.00014519224,0.00002013141,0.000058372112],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981821,0.00012289928,0.00062384683,0.00034791772,0.00028749817,0.00043569694],"domain_scores_gemma":[0.9990869,0.00009323084,0.0002884943,0.00028725967,0.00007406154,0.00017005025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062639435,0.00013497005,0.0006673956,0.000801285,0.000056299843,0.000005925158,0.00005942637,0.000042031308,0.000021040458],"category_scores_gemma":[0.000026507741,0.00011611141,0.000069094494,0.0027330134,0.000019843274,0.000051770134,0.000024566029,0.00017125605,0.0000012700515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007726496,0.00032186633,0.97267807,0.0009418111,0.0002197469,0.0000058504206,0.004231183,0.016626887,0.0000022567433,0.00000926693,0.00005091038,0.0048348894],"study_design_scores_gemma":[0.0028241228,0.00031849463,0.9761602,0.00080014643,0.00022992295,9.0964356e-8,0.00027895873,0.019232275,0.000017573271,0.000003801562,0.000057452533,0.00007695988],"about_ca_topic_score_codex":0.07517583,"about_ca_topic_score_gemma":0.004333124,"teacher_disagreement_score":0.070842706,"about_ca_system_score_codex":0.00091074454,"about_ca_system_score_gemma":0.0011964012,"threshold_uncertainty_score":0.93098265},"labels":[],"label_agreement":null},{"id":"W4321766341","doi":"10.1016/j.jval.2023.02.010","title":"The Associations of Prescription Drug Insurance and Cost-Sharing With Drug Use, Health Services Use, and Health: A Systematic Review of Canadian Studies","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; McMaster University Medical Centre","funders":"Canadian Institutes of Health Research; Ontario Ministry of Health and Long-Term Care","keywords":"Cost sharing; Drug; Prescription drug; Underinsured; Medicine; Medical prescription; Public health; Actuarial science; Environmental health; Business; Family medicine; Health insurance; Health care; Pharmacology; Nursing; Economic growth","score_opus":0.3750769150385265,"score_gpt":0.4369751328649851,"score_spread":0.0618982178264586,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4321766341","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016759094,0.9865374,0.0000010078253,0.0052931104,0.00009274377,0.007690806,0.00019007857,0.000019345749,0.000007923785],"genre_scores_gemma":[0.00012911212,0.9966253,0.00012907722,0.0019218542,0.000018949471,0.0006191609,0.00007696118,0.000029715726,0.0004498826],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9957558,0.00093458395,0.0021271931,0.00036226676,0.00043155046,0.00038864138],"domain_scores_gemma":[0.9949954,0.0010005053,0.0028290076,0.0005304439,0.00028209385,0.00036250535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004874582,0.00024769525,0.0030670208,0.00039842442,0.00023329473,0.000025814226,0.00017076186,0.000057743542,7.301062e-7],"category_scores_gemma":[0.0006007974,0.00015688551,0.000067687266,0.0012856029,0.000088140856,0.00012268646,0.00004557486,0.00037574698,0.0000029358641],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000016515347,0.000015420885,0.0035251072,0.9891481,0.00012755817,9.071849e-7,0.0012518469,9.632649e-7,1.5778543e-9,0.00032640705,0.001270015,0.004332015],"study_design_scores_gemma":[0.00018985107,0.000081938284,0.0064158197,0.9711939,0.00012869571,0.000016376707,0.0007119903,0.00004064808,7.707411e-9,0.000023671168,0.021105703,0.0000913982],"about_ca_topic_score_codex":0.49103287,"about_ca_topic_score_gemma":0.24590898,"teacher_disagreement_score":0.2451239,"about_ca_system_score_codex":0.0006486591,"about_ca_system_score_gemma":0.0036238953,"threshold_uncertainty_score":0.76785123},"labels":[],"label_agreement":null},{"id":"W4323307189","doi":"10.1016/j.jval.2023.02.013","title":"Do Reimbursement Recommendations by the Canadian Agency for Drugs and Technology in Health Translate Into Coverage Decisions for Orphan Drugs in the Canadian Province of Ontario?","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Reimbursement; Transparency (behavior); Agency (philosophy); Health technology; Medicine; Business; Public economics; Family medicine; Political science; Economic growth; Health care; Economics","score_opus":0.2429961041087212,"score_gpt":0.41485228067937063,"score_spread":0.17185617657064944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323307189","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2608832,0.0025485102,0.00023756479,0.72801524,0.00033949676,0.006160164,0.0015604302,0.000014621759,0.00024072906],"genre_scores_gemma":[0.9827038,0.00088966097,0.0018116073,0.012717653,0.00003538439,0.0013120641,0.00022431,0.00003208839,0.0002734409],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99467,0.000489452,0.0033933192,0.0005108573,0.00008811806,0.0008482547],"domain_scores_gemma":[0.9963272,0.0019589067,0.0009343932,0.00047847934,0.000044495268,0.00025648193],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.033280782,0.0001631015,0.0006888744,0.0015332054,0.00068988214,0.00005869581,0.0004236135,0.00016500197,0.000024679197],"category_scores_gemma":[0.0013140183,0.000164738,0.000052910513,0.00093398814,0.00008053767,0.0001407665,0.000019255778,0.0003402843,0.000015974456],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000050095292,0.00023601005,0.12870637,0.0019437444,0.000057182042,0.00000214424,0.26057196,0.0045290976,5.592719e-7,0.4466782,0.119891554,0.037333097],"study_design_scores_gemma":[0.0028307599,0.00047619815,0.03949998,0.0007372221,0.0000035750538,0.0000031181903,0.009043646,0.014234241,0.0000011408428,0.28170675,0.65104955,0.00041383988],"about_ca_topic_score_codex":0.9968609,"about_ca_topic_score_gemma":0.999634,"teacher_disagreement_score":0.7218206,"about_ca_system_score_codex":0.007373101,"about_ca_system_score_gemma":0.011594906,"threshold_uncertainty_score":0.99643743},"labels":[],"label_agreement":null},{"id":"W4324067497","doi":"10.1016/j.jval.2023.02.017","title":"A Rapid Review on the Value of Biobanks Containing Genetic Information","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Centre for Advancing Health Outcomes; University of British Columbia","funders":"Canadian Institutes of Health Research; Genome British Columbia","keywords":"Biobank; Data sharing; Data science; Computer science; MEDLINE; Medicine; Risk analysis (engineering); Knowledge management; Bioinformatics; Alternative medicine; Biology; Pathology","score_opus":0.08505933344486308,"score_gpt":0.34281268738137427,"score_spread":0.2577533539365112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324067497","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016987049,0.9977468,0.00000768395,0.00020315716,0.00017007871,0.0013773917,0.00017387555,0.000007551106,0.00014358546],"genre_scores_gemma":[0.00012191486,0.997838,0.00006015657,0.0012566238,0.00009202223,0.00013461738,0.00044914204,0.000029359702,0.00001811711],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978857,0.00047243497,0.0010022671,0.00022857514,0.00015407341,0.0002569543],"domain_scores_gemma":[0.99858373,0.00010564227,0.0006692615,0.0005215568,0.000045880424,0.0000739179],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00095242553,0.00023594566,0.0007904382,0.00011748932,0.000055418088,0.000012544819,0.00031695716,0.00016370259,0.00000876972],"category_scores_gemma":[0.00033868582,0.00015658211,0.00030522107,0.00026809168,0.000037969603,0.000001853713,0.00009825124,0.00018211803,0.000042186544],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000106226025,0.000033952165,0.0000032758446,0.09987195,0.00008462202,0.00000324838,0.0000442298,0.0000913706,7.6873147e-7,0.0008452665,0.0030272994,0.8959834],"study_design_scores_gemma":[0.000090421716,0.0002939538,0.000021293863,0.04341344,0.00006234536,0.000011794844,0.000019607773,0.000031339372,0.0000014649149,0.00004045807,0.95586234,0.00015152515],"about_ca_topic_score_codex":0.00024142276,"about_ca_topic_score_gemma":0.000003705286,"teacher_disagreement_score":0.9528351,"about_ca_system_score_codex":0.000054997912,"about_ca_system_score_gemma":0.0009985904,"threshold_uncertainty_score":0.63852334},"labels":[],"label_agreement":null},{"id":"W4328103233","doi":"10.1016/j.jval.2023.03.004","title":"EUreccA 2025: A Multistakeholder Effort to Further Real-World Evidence in Healthcare Decision Making","year":2023,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real world evidence; Health care; Clinical decision making; Data science; Computer science; Medicine; Political science; Intensive care medicine; Law","score_opus":0.5745583756137145,"score_gpt":0.5052156346191224,"score_spread":0.06934274099459203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4328103233","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006505225,0.010611161,0.00066036376,0.09479029,0.8793563,0.0055233627,0.0019070542,0.00026283693,0.00038339512],"genre_scores_gemma":[0.038251504,0.026011935,0.029213874,0.03187278,0.86180043,0.0036022887,0.0008401837,0.0014345379,0.006972483],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9804963,0.0017151727,0.012649193,0.002479443,0.00071687973,0.0019429981],"domain_scores_gemma":[0.97150624,0.021192888,0.004715859,0.0016958773,0.00019881455,0.00069033145],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06388603,0.00072090415,0.0035215674,0.00371251,0.0002394913,0.00019343548,0.0010791561,0.0010467294,0.00016078175],"category_scores_gemma":[0.03558605,0.0009864129,0.00025484766,0.0023218044,0.000055705812,0.0004790307,0.00029438818,0.0019852023,0.0046095964],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011353617,0.000086563785,0.033926673,0.004136755,0.000021095597,0.00002314179,0.0033836456,0.007313693,3.022373e-8,0.002507163,0.946941,0.0015466985],"study_design_scores_gemma":[0.0012828439,0.00031945005,0.044896927,0.024145829,0.0000045355378,0.0000012769126,0.00042579518,0.007920495,7.2460026e-8,0.009598157,0.9102167,0.0011879532],"about_ca_topic_score_codex":0.28024727,"about_ca_topic_score_gemma":0.13017103,"teacher_disagreement_score":0.15007624,"about_ca_system_score_codex":0.010987038,"about_ca_system_score_gemma":0.0037253825,"threshold_uncertainty_score":0.99925864},"labels":[],"label_agreement":null},{"id":"W4360999208","doi":"10.1016/j.jval.2023.03.009","title":"Frameworks for Health Technology Assessment at an Early Stage of Product Development: A Review and Roadmap to Guide Applications","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Centre for Advancing Health Outcomes; University of British Columbia","funders":"NanoMedicines Innovation Network","keywords":"Terminology; Scope (computer science); Health technology; Multidisciplinary approach; Stakeholder; Computer science; New product development; Process (computing); Management science; Relevance (law); Process management; Product (mathematics); Knowledge management; Data science; Health care; Engineering; Business; Political science","score_opus":0.5853200366028672,"score_gpt":0.5640251301456641,"score_spread":0.02129490645720311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4360999208","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000025296815,0.9391302,0.005223325,0.03773221,0.00019059262,0.0161898,0.0013677953,0.000090915135,0.00004990481],"genre_scores_gemma":[0.000001964315,0.92966765,0.05347918,0.006524116,0.00011977131,0.008553775,0.00027486106,0.00011553866,0.0012631161],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.98511225,0.0008158393,0.011650644,0.0014536007,0.0001303684,0.00083727884],"domain_scores_gemma":[0.990051,0.0010528325,0.0070503186,0.0012910598,0.00010424828,0.00045055346],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.03491106,0.0004406836,0.005607638,0.0014913414,0.00029364676,0.000033250602,0.00059189246,0.00046570052,0.00003304077],"category_scores_gemma":[0.0017850985,0.0005346341,0.00016078685,0.0013105635,0.00006301851,0.00013881315,0.00021251563,0.0006531119,0.00024622487],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002764169,0.00018984418,0.00082802057,0.6498416,0.00014127333,3.137679e-7,0.00084317947,0.00007584468,5.291554e-9,0.08878537,0.010936229,0.24835555],"study_design_scores_gemma":[0.00016423572,0.00019460767,0.00024179547,0.027170891,0.000015104439,0.0000031537552,0.00007818939,0.00006928243,2.0930441e-8,0.0010652042,0.9706382,0.0003592866],"about_ca_topic_score_codex":0.0025216746,"about_ca_topic_score_gemma":0.0005166782,"teacher_disagreement_score":0.959702,"about_ca_system_score_codex":0.0040689176,"about_ca_system_score_gemma":0.0042464323,"threshold_uncertainty_score":0.9997543},"labels":[],"label_agreement":null},{"id":"W4365452602","doi":"10.1016/j.jval.2023.04.001","title":"Resurrecting Multiattribute Utility Function: Developing a Value Set for Health Utility for Glaucoma","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"Glaucoma Research Society of Canada; Glaucoma Research Foundation","keywords":"Glaucoma; Population; Medicine; Scale (ratio); Statistics; Quality of life (healthcare); Set (abstract data type); Quality-adjusted life year; Standard error; Optometry; Actuarial science; Computer science; Environmental health; Mathematics; Cost effectiveness; Risk analysis (engineering); Economics; Geography","score_opus":0.6489430105830064,"score_gpt":0.48852018688162996,"score_spread":0.16042282370137645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365452602","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.23752673,0.0051884586,0.32774258,0.40105566,0.0076648947,0.012989471,0.006728886,0.00082142826,0.00028190087],"genre_scores_gemma":[0.8700467,0.0008337554,0.06218295,0.059473533,0.00191905,0.0031831155,0.0015572028,0.00022940784,0.00057428866],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9882138,0.0013003992,0.0073685735,0.0013541005,0.00016474018,0.0015984221],"domain_scores_gemma":[0.98949355,0.006038172,0.003129702,0.00077604427,0.00015049026,0.0004120193],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.08908262,0.000346542,0.0017941635,0.0006996201,0.000991909,0.00008811513,0.00035587375,0.00024182822,0.00003308304],"category_scores_gemma":[0.012284057,0.00047565412,0.00027088786,0.0010158306,0.00005833126,0.0004017752,0.00009445801,0.00034619574,0.00030764728],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00060073304,0.0003356795,0.4065314,0.021913784,0.00020538458,0.000001280157,0.012632785,0.0037235636,7.200906e-7,0.28707245,0.25766432,0.009317911],"study_design_scores_gemma":[0.0026934748,0.00036141367,0.2220302,0.0005361808,0.0000036631345,0.0000035707847,0.0016320184,0.3940489,0.000002390431,0.060666356,0.31750476,0.00051706715],"about_ca_topic_score_codex":0.012720933,"about_ca_topic_score_gemma":0.0011188616,"teacher_disagreement_score":0.63251996,"about_ca_system_score_codex":0.0024553456,"about_ca_system_score_gemma":0.002041903,"threshold_uncertainty_score":0.9997695},"labels":[],"label_agreement":null},{"id":"W4365816846","doi":"10.1016/j.jval.2023.04.002","title":"“What’s Sex and Gender Got to Do With It?” A Scoping Review of Sex- and Gender-Based Analysis in Pharmacoepidemiologic Studies of Medication Adherence","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Arthritis Research Centre of Canada; Centre for Advancing Health Outcomes; Research Canada; University of British Columbia","funders":"Canadian Institutes of Health Research; Institute of Gender and Health; Michael Smith Health Research BC","keywords":"Medicine","score_opus":0.6250718421632692,"score_gpt":0.56661426865861,"score_spread":0.05845757350465919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4365816846","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00033965602,0.9951678,0.00024013576,0.0012039396,0.00006453357,0.0029307262,0.000012199946,0.000014345782,0.000026690455],"genre_scores_gemma":[0.00032771225,0.99564165,0.0011354729,0.002232693,0.000027983095,0.0005119717,0.000052386058,0.000017212602,0.00005292484],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99552524,0.0011666835,0.0019799848,0.00061415066,0.00043337047,0.0002805557],"domain_scores_gemma":[0.996507,0.0014604183,0.0012429687,0.00044072946,0.00012644553,0.00022244926],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0056108874,0.00027941665,0.0035813889,0.00064376125,0.000028789887,0.0000045466536,0.00015191201,0.000111313915,0.00005583797],"category_scores_gemma":[0.0012872337,0.00019684318,0.00010648674,0.002158422,0.0001512962,0.000047717414,0.000059156933,0.00033312736,0.0000075303974],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011803571,0.000059313075,0.0036395204,0.79455024,0.00033456367,0.000006669297,0.0007659288,0.000037483205,1.843394e-7,0.000022186003,0.0003986603,0.20017345],"study_design_scores_gemma":[0.0006084106,0.00035284468,0.0008027452,0.9921509,0.0012348256,0.00001203602,0.00095225073,0.000492089,8.3312926e-7,0.000076975106,0.003103548,0.00021252238],"about_ca_topic_score_codex":0.00026455199,"about_ca_topic_score_gemma":0.000036263416,"teacher_disagreement_score":0.19996093,"about_ca_system_score_codex":0.00014938545,"about_ca_system_score_gemma":0.0015840553,"threshold_uncertainty_score":0.8027032},"labels":[],"label_agreement":null},{"id":"W4376613432","doi":"10.1016/j.jval.2023.04.013","title":"Impacts of Chronic Obstructive Pulmonary Disease Care Pathway on Healthcare Utilization and Costs: A Matched Multiple Control Cohort Study in Saskatchewan, Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Regina; Saskatchewan Health Quality Council; Saskatchewan Health Authority; University of Saskatchewan; Saskatchewan Health","funders":"Ministry of Health, Saskatchewan","keywords":"Medicine; COPD; Health care; Spirometry; Pulmonary disease; Cohort; Emergency medicine; Clinical pathway; Internal medicine; Physical therapy; Family medicine; Nursing","score_opus":0.028972792278288268,"score_gpt":0.313842896047916,"score_spread":0.28487010376962774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4376613432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.984316,0.006600595,0.000001823093,0.0015299954,0.00016560183,0.006389181,0.00091348717,0.000053300326,0.00003002128],"genre_scores_gemma":[0.99861896,0.00032278663,0.0000087006865,0.00020037366,0.00007974789,0.00033562162,0.00034748483,0.000059709615,0.00002658495],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958467,0.0007856334,0.0008052991,0.0007505443,0.0009680139,0.0008438338],"domain_scores_gemma":[0.99763954,0.0004896709,0.00021884797,0.0005677092,0.00023280013,0.0008514326],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00069463486,0.0003037451,0.0008093586,0.0005193787,0.00010981923,0.000010435358,0.000132755,0.000089281006,0.000015647252],"category_scores_gemma":[0.000425521,0.00030274026,0.00005713695,0.0011907767,0.000113067814,0.00009123627,0.00008396726,0.0004918489,0.0000027680085],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0013889935,0.0005071181,0.9718576,0.004020395,0.000037921487,0.0010536984,0.0022913665,0.001459866,0.00003676548,0.0000321641,0.00002489154,0.017289188],"study_design_scores_gemma":[0.0044217394,0.00051666243,0.9360252,0.0010305571,0.000018916231,0.0000096499525,0.03699595,0.020710792,0.000020345782,0.000045020246,0.00002876752,0.00017639974],"about_ca_topic_score_codex":0.85427326,"about_ca_topic_score_gemma":0.8335601,"teacher_disagreement_score":0.035832435,"about_ca_system_score_codex":0.01010752,"about_ca_system_score_gemma":0.01383614,"threshold_uncertainty_score":0.9999425},"labels":[],"label_agreement":null},{"id":"W4379390644","doi":"10.1016/j.jval.2023.05.019","title":"Whose Time Trade-Off Should Be Used? Anchoring Discrete Choice Experiment Latent Utilities in Health State Valuation","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University","funders":"National Natural Science Foundation of China","keywords":"Intraclass correlation; Statistics; Anchoring; Mean difference; Valuation (finance); Mathematics; Sample (material); Econometrics; Sample size determination; Psychology; Confidence interval; Social psychology; Economics; Psychometrics","score_opus":0.5658238044292196,"score_gpt":0.4622320659100591,"score_spread":0.10359173851916054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379390644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75067925,0.009677901,0.00037101092,0.23411244,0.0011775204,0.00288395,0.00050328934,0.00023865869,0.0003559867],"genre_scores_gemma":[0.97624165,0.004202644,0.0016025548,0.014544824,0.0005559531,0.0006963222,0.00031522568,0.00015217248,0.0016886266],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98861,0.00177008,0.006890417,0.0010329616,0.0003351654,0.0013613593],"domain_scores_gemma":[0.9950976,0.0016683446,0.0020912515,0.0006850247,0.000023789202,0.0004340278],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.04038618,0.00034885865,0.0015200246,0.0011811949,0.0002785275,0.00010431243,0.00033026983,0.00015248886,0.00018406387],"category_scores_gemma":[0.0016188496,0.00046216967,0.00013040996,0.0009234574,0.000065944725,0.00063841575,0.000092343296,0.00045628074,0.00082602806],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012348098,0.0008278164,0.37544852,0.007545952,0.00014028852,0.000019763376,0.1762585,0.31635115,0.00002089206,0.07273618,0.04399885,0.006528612],"study_design_scores_gemma":[0.003946582,0.0007316227,0.2828361,0.0018135584,0.0000030674794,0.0000060905527,0.005876543,0.5621928,0.000026342217,0.022596868,0.1187768,0.0011936321],"about_ca_topic_score_codex":0.037542038,"about_ca_topic_score_gemma":0.0010262529,"teacher_disagreement_score":0.24584164,"about_ca_system_score_codex":0.003922782,"about_ca_system_score_gemma":0.00086035766,"threshold_uncertainty_score":0.99995196},"labels":[],"label_agreement":null},{"id":"W4380091268","doi":"10.1016/j.jval.2023.03.028","title":"P15 Indirect Treatment Comparisons of Time-to-Event Outcomes with Mis-Matched \"Time Zero\": Methodology and Application in Resectable Non-Small Cell Lung Cancer","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Vancouver Coastal Health","funders":"","keywords":"Atezolizumab; Medicine; Nivolumab; Oncology; Adjuvant; Lung cancer; Internal medicine; Adjuvant chemotherapy; Cancer; Immunotherapy","score_opus":0.06422358985551754,"score_gpt":0.40355901932712707,"score_spread":0.33933542947160955,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380091268","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912149,0.0008947529,0.0007701127,0.0041871225,0.000034515877,0.002349569,0.000055158165,0.000041578238,0.0004523269],"genre_scores_gemma":[0.98178893,0.00044892577,0.012704305,0.00029772738,0.000023009447,0.0010674475,0.00011410903,0.00004011721,0.0035154528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99867463,0.00019500667,0.00038331968,0.00030858748,0.00012628283,0.00031216381],"domain_scores_gemma":[0.99908924,0.00035870925,0.00014571442,0.00022472575,0.000035746485,0.00014588817],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000478696,0.00014732823,0.0006503028,0.00033505904,0.00004603182,0.0000044575854,0.000045146466,0.000058659152,0.000026468295],"category_scores_gemma":[0.000020596992,0.00010986521,0.00003177809,0.0006108122,0.000025410813,0.000021802454,0.00001712904,0.00008738697,0.000025311816],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032868443,0.0006264028,0.94530994,0.0006589149,0.00018936119,0.000015327534,0.009866303,0.035887275,0.0015740487,0.000015939395,0.0012296148,0.0042981682],"study_design_scores_gemma":[0.009500315,0.0020738526,0.931826,0.0007796476,0.00027507293,0.000008103209,0.0007565628,0.049528472,0.003186527,0.000066685294,0.0017484792,0.00025026494],"about_ca_topic_score_codex":0.04874762,"about_ca_topic_score_gemma":0.0019306133,"teacher_disagreement_score":0.04681701,"about_ca_system_score_codex":0.0007449177,"about_ca_system_score_gemma":0.0006419581,"threshold_uncertainty_score":0.9575868},"labels":[],"label_agreement":null},{"id":"W4380091322","doi":"10.1016/j.jval.2023.03.043","title":"P31 The Association between Patient- and Caregiver-Reported Utility Values in Duchenne Muscular Dystrophy (DMD)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Vancouver Coastal Health","funders":"","keywords":"Duchenne muscular dystrophy; Medicine; Muscular dystrophy; Association (psychology); Physical medicine and rehabilitation; Psychology; Internal medicine; Psychotherapist","score_opus":0.05538977007114077,"score_gpt":0.32189522714853497,"score_spread":0.2665054570773942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380091322","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9603741,0.00042335625,0.000029265328,0.038359668,0.00018071724,0.0005102955,0.000012715011,0.000044027714,0.00006586484],"genre_scores_gemma":[0.9990216,0.0003565748,0.000058695387,0.0002855829,0.000109042456,0.000011777638,0.00008667283,0.000009841364,0.000060244754],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99810624,0.0003813323,0.0004930959,0.00024055701,0.0004920446,0.00028670553],"domain_scores_gemma":[0.99906546,0.00033386977,0.00019468377,0.00020820263,0.0000752671,0.00012251594],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027085827,0.000088397,0.00026869416,0.0001618774,0.00009495016,0.000011006647,0.000042624717,0.00020632624,0.0000064444703],"category_scores_gemma":[0.00048341457,0.00006166353,0.000041975007,0.000721338,0.00012600952,0.00003585277,0.000042064865,0.0004388886,0.000004690181],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000059812075,0.00015260883,0.88740206,0.0008235016,0.00009973352,0.000055360553,0.014181012,0.00025883282,0.00012761504,0.00082745834,0.0008241676,0.09518783],"study_design_scores_gemma":[0.00081335043,0.00016715996,0.9820085,0.0002118357,0.000019750238,0.0000023901137,0.0005726788,0.009094128,0.000021713713,0.004406676,0.0026228367,0.000058963127],"about_ca_topic_score_codex":0.007533908,"about_ca_topic_score_gemma":0.00010320975,"teacher_disagreement_score":0.095128864,"about_ca_system_score_codex":0.00031693256,"about_ca_system_score_gemma":0.00025363595,"threshold_uncertainty_score":0.999075},"labels":[],"label_agreement":null},{"id":"W4380148858","doi":"10.1016/j.jval.2023.03.2771","title":"PCR229 Impact of Fibrodysplasia Ossificans Progressiva on Living Adaptations and Employment: Burden of Illness Survey Results from the United States and Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Imaging and Pathology Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Fibrodysplasia ossificans progressiva; Medicine; Surgery; Heterotopic ossification","score_opus":0.09229519149242431,"score_gpt":0.3544175803240869,"score_spread":0.26212238883166256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380148858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923284,0.000575425,0.0000026781559,0.0058425656,0.000059427988,0.00024039471,0.0009234863,0.000013589403,0.000014038046],"genre_scores_gemma":[0.9981498,0.0013472273,0.000045163448,0.00011675385,0.000023149545,0.000006567282,0.0002638995,0.000007938836,0.000039507497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986084,0.00047078065,0.00036488718,0.00016779298,0.00019515475,0.00019299502],"domain_scores_gemma":[0.99513495,0.0043772003,0.0001538172,0.00016319337,0.00006474612,0.00010611995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011097062,0.000086304695,0.0002844048,0.000097567725,0.000094405084,0.000003831634,0.000043974585,0.000028982358,0.0000020256416],"category_scores_gemma":[0.0023139338,0.00005361071,0.00001351136,0.00036441514,0.00022043454,0.0000109599805,0.000030353494,0.00015638408,1.9541663e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023061034,0.00004699336,0.96335924,0.00016725074,0.0000877926,0.000025314695,0.02534852,0.00322137,0.00003065385,0.000014072117,0.004137034,0.003331149],"study_design_scores_gemma":[0.00058432715,0.00030130096,0.98448336,0.0010203981,0.000011970792,0.0000033427104,0.0035416428,0.009889164,0.000011466488,0.000023027767,0.000086562206,0.000043448068],"about_ca_topic_score_codex":0.98012006,"about_ca_topic_score_gemma":0.26733708,"teacher_disagreement_score":0.712783,"about_ca_system_score_codex":0.000052770974,"about_ca_system_score_gemma":0.0005495659,"threshold_uncertainty_score":0.7460321},"labels":[],"label_agreement":null},{"id":"W4380148911","doi":"10.1016/j.jval.2023.03.2673","title":"MSR87 Reviewing Elements to Inform Re-Running Searches: Refreshing Systematic Literature Reviews","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Citation; Systematic review; Information retrieval; Computer science; Data science; World Wide Web; MEDLINE; Political science","score_opus":0.8685452736614624,"score_gpt":0.5913280332634462,"score_spread":0.2772172403980162,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380148911","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19223545,0.63093907,0.010004777,0.06042347,0.0057300054,0.07367601,0.00015218575,0.00038122293,0.026457831],"genre_scores_gemma":[0.41239902,0.11286401,0.24087468,0.06274147,0.002672583,0.008562106,0.00042212312,0.0005691479,0.15889487],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9088424,0.036806714,0.03986435,0.0021985266,0.010676271,0.0016117278],"domain_scores_gemma":[0.9814748,0.0051691257,0.0070364857,0.005079538,0.00065619533,0.0005838558],"candidate_categories":["metaresearch","scholarly_communication","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.47206926,0.00045047232,0.006823443,0.0018197008,0.00039424447,0.0015495636,0.0023676576,0.0001130519,0.0006623924],"category_scores_gemma":[0.13021679,0.00023225835,0.0012650565,0.014290167,0.000016920829,0.00056739704,0.00039014305,0.0005313023,0.01281342],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014446363,0.000080737555,0.028285097,0.3634398,0.00021276997,0.00008199876,0.06217446,0.0060950937,0.00004037981,0.005918279,0.4895853,0.044071622],"study_design_scores_gemma":[0.00034732127,0.00014554172,0.0024964097,0.228629,0.00009208435,0.000021560087,0.004766958,0.051249463,0.000004646904,0.0027741657,0.70884514,0.00062772277],"about_ca_topic_score_codex":0.00010718754,"about_ca_topic_score_gemma":0.000039336384,"teacher_disagreement_score":0.51807505,"about_ca_system_score_codex":0.00036156928,"about_ca_system_score_gemma":0.00020035708,"threshold_uncertainty_score":0.9994869},"labels":[],"label_agreement":null},{"id":"W4380148927","doi":"10.1016/j.jval.2023.03.2661","title":"HTA95 Building a Lifecycle Ethics Framework for the Assessment of Artificial Intelligence Technologies in Health: A Scoping Review of Reviews","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Sociotechnical system; Engineering ethics; Health technology; Knowledge management; Value (mathematics); Management science; Health care; Computer science; Engineering; Political science","score_opus":0.7557564526278353,"score_gpt":0.6519334106088249,"score_spread":0.10382304201901038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380148927","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000025401093,0.9436698,0.020589419,0.02001601,0.0008228975,0.014812264,0.00002278886,0.000061093284,0.000003167651],"genre_scores_gemma":[0.000020352434,0.96346897,0.033401344,0.00085683353,0.00020883836,0.0019506341,0.000028099561,0.000060976112,0.00000392963],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98928845,0.0016378947,0.0071619963,0.0006385692,0.0005430271,0.0007300838],"domain_scores_gemma":[0.98019373,0.014616867,0.0037045076,0.0010952374,0.00026523648,0.000124388],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.02256645,0.00038395906,0.004154711,0.00071494066,0.00016362248,0.000012386398,0.0005022035,0.0006501734,0.00001143663],"category_scores_gemma":[0.025877338,0.00027791606,0.0005005961,0.0029695078,0.00019983911,0.000048520706,0.00011913221,0.0025630728,0.000007690877],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000036802155,0.00006521608,0.000015996102,0.48327184,0.000010260641,5.050606e-7,0.00041613542,0.00003969125,3.2397185e-8,0.008364556,0.00003623582,0.50777584],"study_design_scores_gemma":[0.000009750925,0.00038962348,0.0000021343903,0.9448935,0.00007376685,0.0000057473508,0.0008521062,0.0007974347,0.00000508246,0.011585512,0.041229356,0.00015599641],"about_ca_topic_score_codex":0.004972237,"about_ca_topic_score_gemma":0.00041904402,"teacher_disagreement_score":0.50761986,"about_ca_system_score_codex":0.0009944981,"about_ca_system_score_gemma":0.01169095,"threshold_uncertainty_score":0.9999673},"labels":[],"label_agreement":null},{"id":"W4380149017","doi":"10.1016/j.jval.2023.03.2772","title":"PCR230 Estimating Utility Values Using the Duchenne Muscular Dystrophy-Quality of Life Measure (DMD-QOL): A New Preference-Based Measure for Duchenne Muscular Dystrophy","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Vancouver Coastal Health","funders":"","keywords":"Duchenne muscular dystrophy; Measure (data warehouse); Medicine; Preference; Physical medicine and rehabilitation; Muscular dystrophy; Quality of life (healthcare); Physical therapy; Computer science; Statistics; Internal medicine; Mathematics; Data mining","score_opus":0.3225282216474105,"score_gpt":0.3865191215701263,"score_spread":0.06399089992271578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.897416,0.0016482084,0.07478651,0.022741998,0.00063039147,0.0025237603,0.00007647503,0.0001628005,0.000013860752],"genre_scores_gemma":[0.9680906,0.000038234368,0.030629942,0.00043062618,0.00057239225,0.00005218957,0.00010501017,0.000055528202,0.000025457672],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9942264,0.0011848451,0.001592922,0.00069436186,0.001526091,0.00077540777],"domain_scores_gemma":[0.99638325,0.00079875335,0.000690505,0.0009060448,0.0006338899,0.0005875337],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.009389804,0.00035345962,0.0010482593,0.00028424308,0.00036185657,0.000034764453,0.00028248245,0.00047199693,0.000024680165],"category_scores_gemma":[0.0042330762,0.00024905166,0.00040302172,0.001349472,0.000553054,0.00008973668,0.000072352115,0.00083183905,0.0000032240907],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010113924,0.005144139,0.04143979,0.10110171,0.0026242929,0.00009325332,0.029037954,0.44306976,0.094590254,0.023581443,0.0034364494,0.24576703],"study_design_scores_gemma":[0.006500434,0.0007538503,0.07519676,0.0033384967,0.00020454779,0.000007500808,0.00067038415,0.898879,0.0006155428,0.012920473,0.00050236465,0.00041068392],"about_ca_topic_score_codex":0.008552146,"about_ca_topic_score_gemma":0.000100145815,"teacher_disagreement_score":0.4558092,"about_ca_system_score_codex":0.00032521502,"about_ca_system_score_gemma":0.0038222573,"threshold_uncertainty_score":0.9999962},"labels":[],"label_agreement":null},{"id":"W4380149081","doi":"10.1016/j.jval.2023.03.2755","title":"MSR100 Validation of a Mixed Model for Repeated Measures Approach to Including Trials with Varying Follow-up in Indirect Treatment Comparisons of Long-Term Outcomes","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Repeated measures design; Term (time); Clinical trial; Medicine; Statistics; Mathematics; Internal medicine","score_opus":0.8189508191169114,"score_gpt":0.5024172141915285,"score_spread":0.31653360492538285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149081","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9583792,0.0003627997,0.0334592,0.0032512385,0.00022421277,0.0037664792,0.00039119268,0.00004533246,0.00012036252],"genre_scores_gemma":[0.987516,0.00011066036,0.011152813,0.0002270908,0.000032200725,0.00069320935,0.00014573785,0.00003930232,0.00008300368],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9913427,0.0010937081,0.0063445577,0.00057937426,0.0001540054,0.0004856223],"domain_scores_gemma":[0.993467,0.0027055414,0.0031753958,0.00043572742,0.00007242088,0.00014394605],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0371237,0.00022190562,0.002719076,0.0014890257,0.00010129874,0.000021450543,0.00019526975,0.00012005251,0.0000034222783],"category_scores_gemma":[0.004387269,0.00023112856,0.00016946891,0.0008455107,0.000026640402,0.00017469695,0.000037135527,0.00009521566,0.000011558925],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002127776,0.00028328283,0.5875119,0.00121059,0.00011119711,2.6378194e-7,0.010121779,0.39803782,0.000009813403,0.0019273241,0.0002601081,0.0003131405],"study_design_scores_gemma":[0.010171161,0.0007303959,0.27990827,0.0010747511,0.000029615123,0.0000016300495,0.0011105158,0.70335966,0.0005037106,0.0025513174,0.000052895808,0.0005060898],"about_ca_topic_score_codex":0.007688204,"about_ca_topic_score_gemma":0.0006405562,"teacher_disagreement_score":0.30760363,"about_ca_system_score_codex":0.0013005879,"about_ca_system_score_gemma":0.00056203426,"threshold_uncertainty_score":0.99891967},"labels":[],"label_agreement":null},{"id":"W4380149104","doi":"10.1016/j.jval.2023.03.1894","title":"PCR118 Quantifying Patient Preferences for Targeted Therapies in Metastatic Melanoma: A Discrete-Choice Experiment","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Computational Drug Discovery Methods","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"University of Illinois at Chicago; University of Illinois at Urbana-Champaign; University of Pennsylvania","keywords":"Metastatic melanoma; Melanoma; Medicine; Targeted therapy; MEK inhibitor; Oncology; V600E; Internal medicine; Mutation; Cancer research; Cancer; MAPK/ERK pathway; Biology; Genetics","score_opus":0.1896000257103892,"score_gpt":0.40708443497224944,"score_spread":0.21748440926186025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149104","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8854489,0.0018903096,0.108259685,0.0024853777,0.0005949053,0.0011297973,0.000019341955,0.00014033327,0.00003139104],"genre_scores_gemma":[0.8811461,0.00006134232,0.11817841,0.00020351936,0.00002089569,0.00035106685,0.000016564987,0.0000132117275,0.000008907483],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99710447,0.00090140745,0.00062554487,0.00050106045,0.0003757926,0.00049175735],"domain_scores_gemma":[0.9969189,0.0024775807,0.00018050299,0.00029852134,0.000037988248,0.00008650646],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001704423,0.00016580586,0.00031601478,0.00043352225,0.00010262495,0.00009375638,0.00045322883,0.000026517118,0.00000381059],"category_scores_gemma":[0.00031585686,0.00014816171,0.00006249276,0.0011604022,0.000026728241,0.00033874347,0.00017309423,0.000124802,0.000009090762],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006139685,0.00034593424,0.008903071,0.0005473541,0.000046112633,0.000018047558,0.052308936,0.799281,0.00037307688,0.069726124,0.00030774574,0.068081215],"study_design_scores_gemma":[0.00074083987,0.00043466364,0.03748399,0.00021886808,0.0000016617103,0.000001956027,0.0013741711,0.91665256,0.00070857734,0.041281987,0.0008512735,0.00024947964],"about_ca_topic_score_codex":0.0028986288,"about_ca_topic_score_gemma":0.00021250764,"teacher_disagreement_score":0.11737155,"about_ca_system_score_codex":0.00020694762,"about_ca_system_score_gemma":0.00039020096,"threshold_uncertainty_score":0.6041859},"labels":[],"label_agreement":null},{"id":"W4380149107","doi":"10.1016/j.jval.2023.03.1885","title":"PCR107 A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Patient Reported Outcome Measures Part I: Instrument Development and Content Validity","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Content validity; Medicine; Patient-reported outcome; Quality of life (healthcare); Health related quality of life; Disease; Content (measure theory); Physical therapy; Intensive care medicine; Psychometrics; Clinical psychology; Pathology; Nursing","score_opus":0.9256591917202315,"score_gpt":0.49881490904595216,"score_spread":0.4268442826742793,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006294466,0.9859022,0.00020175184,0.001140333,0.0005750687,0.010933979,0.0005307139,0.00005428417,0.000032202082],"genre_scores_gemma":[0.00023002758,0.9955651,0.00092123006,0.0007712254,0.00005497385,0.002186506,0.00014112607,0.00008165452,0.00004816974],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9677359,0.005739255,0.023911322,0.001418845,0.0005529629,0.0006417447],"domain_scores_gemma":[0.98361963,0.0018335363,0.012154252,0.0016739083,0.00013151052,0.0005871455],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.08547961,0.00064966624,0.012748068,0.00063187984,0.00019374694,0.00006833125,0.00029981285,0.0002295136,0.000013427248],"category_scores_gemma":[0.0059167044,0.0006542033,0.000723691,0.00048214724,0.00009613737,0.0001523436,0.000211676,0.0004498402,0.000048320635],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000016842283,0.00010651304,0.0022560528,0.9858213,0.0010105175,0.0000053268736,0.0003079318,0.00003834157,4.1404333e-10,0.0053443825,0.00017540179,0.004932515],"study_design_scores_gemma":[0.0005243391,0.00009429989,0.0028279233,0.5010521,0.00072697323,0.000017514467,0.0003146245,0.00009378933,1.235891e-8,0.00024086991,0.4932669,0.00084067235],"about_ca_topic_score_codex":0.0029515629,"about_ca_topic_score_gemma":0.000041486972,"teacher_disagreement_score":0.4930915,"about_ca_system_score_codex":0.0029381134,"about_ca_system_score_gemma":0.0015669698,"threshold_uncertainty_score":0.99959093},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"grok","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":["metaresearch","metaepi_broad"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"split"},{"id":"W4380149109","doi":"10.1016/j.jval.2023.03.2773","title":"PCR231 The Mosaic Study: A Clinical and Humanistic Burden of Illness Study Among Patients with Geographic Atrophy (GA) and Their Caregivers in the United States (US) and Canada (CA)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Morinda citrifolia extract uses","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geographic atrophy; Humanism; Medicine; Mosaic; Atrophy; Gerontology; Family medicine; Geography; Pathology; Psychiatry; Political science; Archaeology","score_opus":0.03209713117121181,"score_gpt":0.29571615598813783,"score_spread":0.263619024816926,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99639285,0.00021116743,5.721123e-7,0.00068298454,0.00006412138,0.0025726464,0.00005898749,0.0000134162565,0.000003287812],"genre_scores_gemma":[0.99941194,0.00029874846,0.000004154925,0.0001527338,0.0000256693,0.000050127448,0.00003188974,0.000019677915,0.000005048552],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99740803,0.0010253697,0.00051765295,0.00033091038,0.00041810097,0.0002999095],"domain_scores_gemma":[0.9981162,0.0011412826,0.00018695639,0.00034878752,0.00008182166,0.00012494181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017685613,0.00017824887,0.00046418197,0.00027682155,0.00018484054,0.000021568223,0.00013147685,0.000039327642,0.0000019238064],"category_scores_gemma":[0.00020926134,0.000095716154,0.000016222752,0.00082918233,0.00033656313,0.00003574978,0.000074717485,0.00039617723,1.04874836e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015534341,0.00028836384,0.96881205,0.0001551878,0.000064720014,0.00006035439,0.029663574,0.00035050692,1.3662931e-7,0.00001148189,0.00007458821,0.00036367562],"study_design_scores_gemma":[0.0034457145,0.0020192957,0.89964414,0.00015200894,0.00004696385,0.0000028552736,0.09301204,0.0013942628,1.4238977e-7,0.000033140626,0.00016297943,0.00008648099],"about_ca_topic_score_codex":0.92604786,"about_ca_topic_score_gemma":0.5810068,"teacher_disagreement_score":0.345041,"about_ca_system_score_codex":0.00005312451,"about_ca_system_score_gemma":0.0003308168,"threshold_uncertainty_score":0.4266387},"labels":[],"label_agreement":null},{"id":"W4380149112","doi":"10.1016/j.jval.2023.03.1783","title":"PCR3 Pain-Free Injections for Growth Hormone Deficiency (GHD) Improve Quality of Life: A Time Trade-Off (TTO) Study in the UK and Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"SickKids Foundation; Markham Stouffville Hospital; Hospital for Sick Children","funders":"","keywords":"Quality of life (healthcare); Growth hormone; Medicine; Growth hormone deficiency; Hormone; Internal medicine; Pediatrics; Endocrinology; Nursing","score_opus":0.059696646969894254,"score_gpt":0.3358211887015872,"score_spread":0.276124541731693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9665914,0.001299496,0.000033540626,0.028805368,0.00016454465,0.0027706504,0.00023436069,0.000040091,0.000060524213],"genre_scores_gemma":[0.9955023,0.00013097882,0.00013602382,0.0038615433,0.00012294258,0.00017396592,0.000022295102,0.000023093175,0.000026879785],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958969,0.0013785467,0.0011539918,0.0004069209,0.00067731994,0.0004863346],"domain_scores_gemma":[0.9962626,0.0026212437,0.00027814528,0.00059144595,0.000055643184,0.00019093743],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010944484,0.00017584479,0.0006505914,0.00022086986,0.00014097204,0.000011567643,0.0002451183,0.00006714543,0.000004403292],"category_scores_gemma":[0.0042695305,0.00014627178,0.00006202345,0.0009541303,0.00007258457,0.00004188669,0.00006424681,0.00033890133,8.832246e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011073711,0.0027789802,0.8395611,0.0045919195,0.00013176425,0.000023962866,0.08791913,0.00026739226,0.00020248964,0.001919715,0.056674443,0.004821727],"study_design_scores_gemma":[0.00484011,0.0025491256,0.96790236,0.00013928353,0.000022399603,0.0000047661088,0.02131077,0.0014868825,0.0000062934496,0.0012081009,0.00034744164,0.00018248473],"about_ca_topic_score_codex":0.9407523,"about_ca_topic_score_gemma":0.80647427,"teacher_disagreement_score":0.13427804,"about_ca_system_score_codex":0.00034938648,"about_ca_system_score_gemma":0.0027743005,"threshold_uncertainty_score":0.59647894},"labels":[],"label_agreement":null},{"id":"W4380149121","doi":"10.1016/j.jval.2023.03.1488","title":"HTA59 Anticipating Market Access Challenges in Canada for Lecanemab: Learnings from Previous Health Technology Assessments of Disease-Modifying Therapies in Neurodegenerative Diseases","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Commercialization; Medicine; Disease; Health technology; Intensive care medicine; Health care; Business; Political science; Internal medicine; Marketing","score_opus":0.5703338503532178,"score_gpt":0.48509432609956143,"score_spread":0.08523952425365638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8932706,0.027487382,0.00016633677,0.07585807,0.00036807163,0.0018453225,0.0009277636,0.000043683653,0.000032769924],"genre_scores_gemma":[0.9869968,0.009609626,0.0007606903,0.0020888404,0.00006974462,0.00032159672,0.00008366337,0.000047154103,0.000021864242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99307936,0.0011586269,0.0040323567,0.0007925297,0.00013918476,0.0007979392],"domain_scores_gemma":[0.9943877,0.0025336477,0.0024125192,0.0004189348,0.000039155075,0.00020803192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008668006,0.00022699706,0.0014480783,0.0011183778,0.0001322559,0.00003134285,0.00040229285,0.00008051038,0.00002711791],"category_scores_gemma":[0.0029687523,0.00029765093,0.000056517747,0.0007849612,0.00004530076,0.00030290682,0.00010579837,0.00027584255,0.00000558187],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006291669,0.00012773539,0.9514125,0.0032159772,0.000026706555,0.0000042965653,0.0037272447,0.029314758,4.2382163e-7,0.0063340436,0.0009941811,0.0047792033],"study_design_scores_gemma":[0.0013300643,0.00015763493,0.8260497,0.0012076529,0.0000020080374,2.8152888e-7,0.007074625,0.14874111,0.0000012484641,0.014209475,0.00094526826,0.00028092184],"about_ca_topic_score_codex":0.8412349,"about_ca_topic_score_gemma":0.688472,"teacher_disagreement_score":0.15276293,"about_ca_system_score_codex":0.0027129517,"about_ca_system_score_gemma":0.003759768,"threshold_uncertainty_score":0.99994755},"labels":[],"label_agreement":null},{"id":"W4380149137","doi":"10.1016/j.jval.2023.03.1687","title":"MT42 HTA Landscape of Medical Devices in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Health technology; Business; Environmental planning; Environmental resource management; Health care; Political science; Geography; Economics","score_opus":0.4165548739745294,"score_gpt":0.4320107335899042,"score_spread":0.015455859615374823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.874105,0.0031658025,0.00002968792,0.12032386,0.00069623877,0.000402632,0.0001519313,0.000023083552,0.00110176],"genre_scores_gemma":[0.99030125,0.00091751234,0.00018344041,0.008314181,0.00012183606,0.000039476286,0.000029684044,0.000019174295,0.00007344356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99398553,0.00047950842,0.0044017923,0.00037145946,0.00023922785,0.00052250084],"domain_scores_gemma":[0.99673486,0.0015288546,0.0011599074,0.00031810693,0.000017172713,0.00024109599],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.026892813,0.00011038845,0.0008998521,0.0005617446,0.00004427201,0.000010836417,0.00035010237,0.00010682685,0.0004254465],"category_scores_gemma":[0.0029325008,0.0001422684,0.000037265763,0.0007470909,0.000023147004,0.00011752045,0.000058642996,0.00023003714,0.0003334052],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000048323777,0.000034601875,0.9329082,0.0011586592,0.00000847938,0.0000068091617,0.0013711909,0.0058923354,4.303858e-8,0.03355234,0.02473425,0.00032830818],"study_design_scores_gemma":[0.0011251394,0.00005317585,0.76093197,0.0006306231,6.03903e-7,0.0000035906685,0.0032441395,0.18963994,7.653375e-7,0.005962371,0.038162414,0.00024523793],"about_ca_topic_score_codex":0.98261905,"about_ca_topic_score_gemma":0.94454414,"teacher_disagreement_score":0.1837476,"about_ca_system_score_codex":0.0012839522,"about_ca_system_score_gemma":0.0045624943,"threshold_uncertainty_score":0.9320566},"labels":[],"label_agreement":null},{"id":"W4380149197","doi":"10.1016/j.jval.2023.03.2280","title":"SA64 Comparative Effectiveness of Bimekizumab in Patients with Psoriatic Arthritis: Results from a Systematic Literature Review and Network Meta-Analysis","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Psoriatic arthritis; Medicine; Meta-analysis; Systematic review; Internal medicine; Arthritis; Oncology; MEDLINE; Biology","score_opus":0.049348241419072084,"score_gpt":0.28872810596136006,"score_spread":0.239379864542288,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149197","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4866217,0.51072097,0.0000051574975,0.000071054244,0.00009854083,0.001867343,0.0005815667,0.000023614493,0.000010019522],"genre_scores_gemma":[0.978869,0.019484999,0.00010319087,0.00005230633,0.0000064417945,0.00025307643,0.0011988244,0.000010752524,0.00002140979],"study_design_codex":"meta_analysis","study_design_gemma":"observational","domain_scores_codex":[0.99373096,0.0045755445,0.0009010473,0.0004145326,0.000070531656,0.00030737178],"domain_scores_gemma":[0.99717706,0.001901432,0.00046608955,0.0003573693,0.00006973163,0.000028307139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001965625,0.0002299398,0.0028171318,0.00032366056,0.0000610821,0.000008787322,0.00010166227,0.00012270115,0.000011807756],"category_scores_gemma":[0.00011882429,0.00015485348,0.00019741514,0.0022764567,0.000045872366,0.000062736,0.000032117325,0.00015754727,0.00001988528],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01191118,0.0029666948,0.19686833,0.30399638,0.42477703,0.00016907435,0.028026294,0.025197117,0.00004608577,0.0014711677,0.0011924624,0.003378194],"study_design_scores_gemma":[0.015149216,0.0013904094,0.83034503,0.08385826,0.06773216,0.000006592015,0.00021080066,0.00014833249,0.00007606196,0.00051253184,0.000022205582,0.00054838735],"about_ca_topic_score_codex":0.0011084216,"about_ca_topic_score_gemma":0.00034909387,"teacher_disagreement_score":0.63347673,"about_ca_system_score_codex":0.000063352934,"about_ca_system_score_gemma":0.000062209285,"threshold_uncertainty_score":0.6314742},"labels":[],"label_agreement":null},{"id":"W4380149209","doi":"10.1016/j.jval.2023.03.1585","title":"MSR50 A Practical Method for Determining the Optimal Allocation between Computation Time and Accuracy in Probabilistic Patient-Level Microsimulation Models","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Probabilistic logic; Microsimulation; Computation; Computer science; Software; Statistical model; Operations research; Machine learning; Artificial intelligence; Algorithm; Engineering; Transport engineering","score_opus":0.6480269135571526,"score_gpt":0.5125421770265757,"score_spread":0.1354847365305769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149209","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.775866,0.0001535126,0.18393703,0.03641798,0.00014198724,0.0031353766,0.00027141196,0.00004797059,0.000028785225],"genre_scores_gemma":[0.8980481,0.000034432705,0.09953134,0.0017226118,0.00010321163,0.00027612565,0.00023769269,0.00003138421,0.000015070585],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99531645,0.000862913,0.0028843172,0.00047045154,0.00008275221,0.00038313703],"domain_scores_gemma":[0.9877847,0.010510587,0.0013621855,0.00018925464,0.00006232413,0.0000909605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019865435,0.00012930871,0.0005585759,0.00037998983,0.0001814579,0.000072937386,0.0000918994,0.00010967034,0.0000039690567],"category_scores_gemma":[0.007303955,0.00015016505,0.000039192644,0.00036052446,0.000031138024,0.0005157806,0.000043226923,0.00016754575,0.00006895769],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000028494384,0.000069197304,0.01982172,0.0005621695,0.000012517051,2.1952425e-7,0.008654199,0.94889194,0.0000014716693,0.0148131335,0.0005958552,0.006549062],"study_design_scores_gemma":[0.0007193381,0.00010538197,0.06948213,0.00010054932,0.00000244632,9.756118e-7,0.000254972,0.89613074,6.7443824e-7,0.032850128,0.00022871283,0.00012395663],"about_ca_topic_score_codex":0.0020173828,"about_ca_topic_score_gemma":0.00008399255,"teacher_disagreement_score":0.122182176,"about_ca_system_score_codex":0.0006217787,"about_ca_system_score_gemma":0.00029368416,"threshold_uncertainty_score":0.87440443},"labels":[],"label_agreement":null},{"id":"W4380149217","doi":"10.1016/j.jval.2023.03.995","title":"EPH113 Healthcare Utilization Remains Elevated Among People Living with Post-COVID-19 Condition More Than One Year after Acute COVID-19 Illness","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; BC Centre for Disease Control","funders":"","keywords":"Medicine; Poisson regression; Health care; Coronavirus disease 2019 (COVID-19); Emergency department; Cohort; Healthcare system; Acute care; Emergency medicine; Cohort study; Demography; Internal medicine; Population; Environmental health; Disease","score_opus":0.06722746693682904,"score_gpt":0.37034355241222755,"score_spread":0.3031160854753985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149217","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94888,0.00018607256,0.00088995247,0.0462668,0.00018629525,0.0024693878,0.00023007742,0.0007025157,0.00018890797],"genre_scores_gemma":[0.9877032,0.00076438993,0.000113190275,0.008786627,0.00013226301,0.0003039804,0.0017127511,0.000079163045,0.00040443978],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968609,0.00041174857,0.000594931,0.0006666893,0.0007092509,0.00075645745],"domain_scores_gemma":[0.9978052,0.00028389628,0.0002696706,0.00058433093,0.00012594994,0.0009309505],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010498251,0.000285248,0.0005046633,0.0006840321,0.00027706914,0.000059508715,0.00014150036,0.00013509952,0.00031455222],"category_scores_gemma":[0.0006569864,0.0002773881,0.00007377152,0.0018223398,0.00013653057,0.00025978216,0.000103001184,0.00030284948,0.00006730394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013025568,0.000524726,0.92831993,0.019017946,0.00029549006,0.00067591027,0.027348142,0.012106205,0.000032900913,0.006259805,0.0037440856,0.00037231002],"study_design_scores_gemma":[0.003109302,0.0007233312,0.96725965,0.0018672638,0.00014013136,0.000020209009,0.017461613,0.0075835884,0.0000064023366,0.0005260624,0.00091415044,0.00038828625],"about_ca_topic_score_codex":0.017979905,"about_ca_topic_score_gemma":0.006547094,"teacher_disagreement_score":0.038939737,"about_ca_system_score_codex":0.0020340579,"about_ca_system_score_gemma":0.003521462,"threshold_uncertainty_score":0.9999678},"labels":[],"label_agreement":null},{"id":"W4380149232","doi":"10.1016/j.jval.2023.03.1463","title":"HTA34 A Review of Real-World Evidence in Health Technology Assessment Decision-Making of Gene Therapies in the US, Canada, UK, EU4, and Japan","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real world evidence; Health technology; Clinical decision making; Medicine; Economic growth; Family medicine; Health care; Economics","score_opus":0.5663168932045964,"score_gpt":0.531492625671388,"score_spread":0.03482426753320844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149232","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00089524273,0.9638866,0.000037572157,0.030493421,0.0002900397,0.003985029,0.0003215423,0.000012784713,0.000077740384],"genre_scores_gemma":[0.0014634135,0.98996854,0.0027041337,0.0052599222,0.00005873863,0.000453249,0.000021779839,0.00005231971,0.000017914721],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9785176,0.0035816708,0.01581203,0.0009695794,0.00032158988,0.0007975571],"domain_scores_gemma":[0.98000944,0.009067004,0.00961695,0.001139073,0.000062209576,0.000105306295],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.07465469,0.0003965233,0.0060243467,0.0022661428,0.000095889,0.000020356667,0.00085059163,0.00022938175,0.000036577017],"category_scores_gemma":[0.0059862672,0.0003828239,0.00016227544,0.0027784402,0.00011086554,0.00012318206,0.00012686702,0.00081312243,0.000010637358],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000007707471,0.0001459172,0.050681103,0.7165609,0.00009162193,0.0000086248765,0.0019504603,0.00035801894,6.0157497e-9,0.05481617,0.004902217,0.17047727],"study_design_scores_gemma":[0.00032791667,0.00019375393,0.022206692,0.69089425,0.000013495395,0.000017280076,0.00094102055,0.0006232988,7.263095e-9,0.005958922,0.27838108,0.00044226655],"about_ca_topic_score_codex":0.76354843,"about_ca_topic_score_gemma":0.6787012,"teacher_disagreement_score":0.27347887,"about_ca_system_score_codex":0.004446959,"about_ca_system_score_gemma":0.009971344,"threshold_uncertainty_score":0.9998624},"labels":[],"label_agreement":null},{"id":"W4380149263","doi":"10.1016/j.jval.2023.03.1472","title":"HTA43 Do Complexities of Combination Oncology Submissions Impact Reimbursement Outcomes: An Evaluation of Multi-Therapy Oncology Regimens in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Medicine; Oncology; Regimen; Alliance; Internal medicine; Agency (philosophy); Health care; Political science","score_opus":0.718435995987888,"score_gpt":0.5454551394674425,"score_spread":0.17298085652044548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149263","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757768,0.0013160222,0.000050441064,0.019805698,0.0005935985,0.0017208133,0.0003184988,0.000018070636,0.00040006707],"genre_scores_gemma":[0.9968517,0.0006055168,0.0008025387,0.0013502454,0.000031388125,0.0001636296,0.00014051255,0.000024622304,0.000029881063],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99023944,0.0031037931,0.0053849476,0.0004558467,0.000287162,0.0005288334],"domain_scores_gemma":[0.9937818,0.002095475,0.0032404643,0.00050029566,0.00017888502,0.0002030831],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04251353,0.00017486757,0.0015131807,0.0010207733,0.0000836519,0.000007796282,0.0002527368,0.000147378,0.00024118467],"category_scores_gemma":[0.002497852,0.00021232534,0.00008128683,0.0006221185,0.00006949311,0.00019737807,0.00003548951,0.0002195637,0.000027137905],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000059902995,0.00093221554,0.84338117,0.00045851647,0.000068543115,0.0000020455398,0.0128771635,0.10518283,0.000009603601,0.028577734,0.0033809463,0.005069314],"study_design_scores_gemma":[0.003989599,0.00073440594,0.79045534,0.00014541486,0.0000029195685,0.0000013567084,0.007983711,0.18491958,0.000006383897,0.009854621,0.00173756,0.00016909136],"about_ca_topic_score_codex":0.93924826,"about_ca_topic_score_gemma":0.68170345,"teacher_disagreement_score":0.25754482,"about_ca_system_score_codex":0.0109183835,"about_ca_system_score_gemma":0.009519878,"threshold_uncertainty_score":0.99609524},"labels":[],"label_agreement":null},{"id":"W4380149284","doi":"10.1016/j.jval.2023.03.1855","title":"PCR77 “It Shocks Me That There Is Not Something like This Already in Place”: Patient Perspectives for Enhancing Pan-Canadian Data Sharing for Precision Oncology","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Data sharing; Precision oncology; Qualitative property; Patient data; Limit (mathematics); Qualitative research; Medicine; Internet privacy; Cancer; Computer science; Alternative medicine; Internal medicine; Sociology; Pathology","score_opus":0.6926131779362804,"score_gpt":0.5897458583175645,"score_spread":0.10286731961871587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7256849,0.0028775497,0.0016154436,0.25393865,0.0015803754,0.010680904,0.0009222214,0.00017281863,0.0025271985],"genre_scores_gemma":[0.9741879,0.00450849,0.010246785,0.008415157,0.00031689252,0.00045703672,0.0001931456,0.000107041225,0.0015675359],"study_design_codex":"qualitative","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9951738,0.0003985743,0.0010755796,0.0012953797,0.00083333376,0.0012233369],"domain_scores_gemma":[0.9619293,0.03562219,0.00024393626,0.0013779006,0.00028549953,0.0005411397],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.024342615,0.00020958653,0.0007052092,0.00083831075,0.00028367617,0.000049661023,0.00081500405,0.00060863874,0.000105924875],"category_scores_gemma":[0.032147847,0.0001944654,0.00010152201,0.0006505053,0.00010153535,0.00018785743,0.0005978017,0.0022093037,0.00003895542],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00708647,0.002036914,0.06407315,0.015213037,0.00044409046,0.00045357394,0.5540771,0.0037913811,0.0017060321,0.022038648,0.05102818,0.27805144],"study_design_scores_gemma":[0.015651673,0.013692882,0.018272169,0.019455647,0.00010441135,0.00004218163,0.17799202,0.5444229,0.002796874,0.08211809,0.12399857,0.0014525985],"about_ca_topic_score_codex":0.1612978,"about_ca_topic_score_gemma":0.36993766,"teacher_disagreement_score":0.54063153,"about_ca_system_score_codex":0.0028050584,"about_ca_system_score_gemma":0.0059933406,"threshold_uncertainty_score":0.9996418},"labels":[],"label_agreement":null},{"id":"W4380149295","doi":"10.1016/j.jval.2023.03.2270","title":"SA54 A Scoping Review of Economic Evaluation of Breast Cancer Screening in China","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Breast cancer; Mammography; Medicine; China; Mammography screening; Breast cancer screening; Genetic testing; Population; Oncology; Gynecology; Cancer; Internal medicine; Environmental health; Political science","score_opus":0.7405862422499305,"score_gpt":0.5755986582167099,"score_spread":0.16498758403322067,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149295","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001594393,0.98849106,0.00003673745,0.002613433,0.0006622275,0.0063279737,0.0014411216,0.000022711247,0.0002452875],"genre_scores_gemma":[0.00007071009,0.9974396,0.00044745434,0.0005684636,0.00024813626,0.0009816266,0.00012574258,0.00009799855,0.00002022048],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97535485,0.0044581294,0.018227706,0.0010047227,0.0002851832,0.00066938146],"domain_scores_gemma":[0.9835978,0.0020326285,0.013313569,0.0008187953,0.00007856502,0.00015863996],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.111274965,0.00041750865,0.0072229253,0.0017772121,0.000059894428,0.000018323115,0.0005061337,0.00032761466,0.00050258345],"category_scores_gemma":[0.0033548828,0.00052775885,0.0004481294,0.00096111995,0.00008002382,0.00026680875,0.000105027255,0.0004963456,0.00023028892],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000033987187,0.000060142884,0.0019341157,0.90750986,0.00008460338,3.6620636e-7,0.00038857487,0.0054020938,1.9996147e-9,0.00386248,0.0007407631,0.080013596],"study_design_scores_gemma":[0.0006136836,0.000034638648,0.002504429,0.97717714,0.00005477839,0.000006673764,0.00005273655,0.009179013,1.5827847e-8,0.0014258362,0.008552178,0.0003988995],"about_ca_topic_score_codex":0.05532321,"about_ca_topic_score_gemma":0.0015834197,"teacher_disagreement_score":0.10792008,"about_ca_system_score_codex":0.0038366634,"about_ca_system_score_gemma":0.0063933134,"threshold_uncertainty_score":0.9999874},"labels":[],"label_agreement":null},{"id":"W4380149336","doi":"10.1016/j.jval.2023.03.1270","title":"HPR124 A Review of Managed Entry Agreements and Innovative Payment Models Established for Gene Therapies in the UK, EU4, US, Canada, and Japan","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Payment; Business; Transformative learning; Process (computing); Actuarial science; Finance; Computer science","score_opus":0.14002874336732274,"score_gpt":0.3846746761567369,"score_spread":0.24464593278941416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022897396,0.98810387,0.00003073836,0.0075338683,0.000096636824,0.0038639451,0.00011071067,0.0000041975118,0.000027074479],"genre_scores_gemma":[0.00023585356,0.9964495,0.00029231433,0.0023746444,0.000048779206,0.00022226723,0.00027956688,0.000021532138,0.00007557392],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9975174,0.0004238792,0.0010623949,0.0002918606,0.0004567908,0.00024765477],"domain_scores_gemma":[0.99868566,0.0004464069,0.0004610802,0.00023405664,0.00009191386,0.00008091182],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034332576,0.00020428347,0.0012957955,0.00021074738,0.000047068526,0.000008664947,0.000100331665,0.00016627522,0.0000042650854],"category_scores_gemma":[0.0001360695,0.000116807445,0.000050523515,0.00089514535,0.00013589929,0.000022371847,0.00005050309,0.00042232958,1.0455383e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012683178,0.00005127609,0.00006811049,0.43860206,0.00011176656,0.0000060799393,0.00089176564,0.0000025153633,1.1150625e-7,0.002140185,0.0014566835,0.5566568],"study_design_scores_gemma":[0.0017138612,0.00034583054,0.0021001238,0.50714093,0.00028035938,0.00002739936,0.00041699954,0.0010690333,2.0899716e-7,0.003607537,0.4829993,0.00029840012],"about_ca_topic_score_codex":0.23182315,"about_ca_topic_score_gemma":0.04316579,"teacher_disagreement_score":0.5563584,"about_ca_system_score_codex":0.0002449806,"about_ca_system_score_gemma":0.0018567599,"threshold_uncertainty_score":0.97429395},"labels":[],"label_agreement":null},{"id":"W4380149351","doi":"10.1016/j.jval.2023.03.1018","title":"EPH136 Available Screening Programs for the Early Identification of Cancers: A Targeted Literature Review","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Cancer Incidence and Screening","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Identification (biology); Medicine; Incidence (geometry); Cancer; Environmental health; Internal medicine; Biology","score_opus":0.17926116964922653,"score_gpt":0.3911789751035352,"score_spread":0.2119178054543087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149351","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10539227,0.8390473,0.0026760323,0.040185716,0.00077660737,0.011142504,0.00014452277,0.00030378686,0.00033127956],"genre_scores_gemma":[0.8089373,0.17497934,0.006344562,0.005202784,0.00046978774,0.0012681807,0.00039840984,0.00006191954,0.002337702],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99846125,0.00008412178,0.00058384944,0.00022945096,0.00031351892,0.00032779574],"domain_scores_gemma":[0.9990292,0.00013070778,0.00025516286,0.00031468057,0.00019123114,0.00007897794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021817482,0.00009387029,0.00030486681,0.00009599238,0.00009175765,0.00002262076,0.00013105683,0.000051501513,0.000014225402],"category_scores_gemma":[0.00034924233,0.000067445966,0.000090537585,0.0014860885,0.00003383177,0.00010147358,0.000020671072,0.00018407589,0.000016466336],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013591693,0.00019480291,0.14977026,0.075932026,0.000297828,0.00007958299,0.009898221,0.0054539316,0.0016570353,0.0027448302,0.24298841,0.5096239],"study_design_scores_gemma":[0.0065023634,0.004104959,0.2708058,0.3076563,0.00043975151,0.00013888783,0.0025713386,0.1574807,0.0015694353,0.0020075694,0.24579751,0.0009254011],"about_ca_topic_score_codex":0.004511278,"about_ca_topic_score_gemma":0.000082234255,"teacher_disagreement_score":0.70354503,"about_ca_system_score_codex":0.0001529588,"about_ca_system_score_gemma":0.00037738966,"threshold_uncertainty_score":0.6819733},"labels":[],"label_agreement":null},{"id":"W4380149416","doi":"10.1016/j.jval.2023.03.1671","title":"MT25 Assessing the Impact of a Patient Portal Application for Cancer Patients on Missed Appointments","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; McGill University","funders":"","keywords":"Patient portal; Medicine; Electronic health record; Health records; Family medicine; Medical physics; Medical emergency; Health care","score_opus":0.31713300889339857,"score_gpt":0.577605929251769,"score_spread":0.26047292035837044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149416","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9915959,0.000027327658,0.00019227997,0.0054868297,0.0001488149,0.002421748,0.00006244645,0.000023837305,0.00004076654],"genre_scores_gemma":[0.99784374,0.00005288355,0.00034634332,0.0011285467,0.00006784548,0.00025745836,0.00027613697,0.00001817716,0.00000888354],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998247,0.00012766662,0.00092769065,0.00019337855,0.00028527342,0.00021896951],"domain_scores_gemma":[0.99801075,0.0009878713,0.0005785264,0.00020682237,0.00013789574,0.000078149744],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001085524,0.00008778729,0.00021287739,0.00010795022,0.000059819504,0.0000068777044,0.00004898744,0.000036849746,0.000016020762],"category_scores_gemma":[0.0013372106,0.000059259728,0.00008815971,0.00036492807,0.00001700424,0.000064793014,0.000017198337,0.00011859916,0.000007346261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00082603295,0.0018561721,0.60714436,0.0005927624,0.0001163642,0.0000021909675,0.001944,0.02293337,0.0006888488,0.00017233338,0.012366698,0.3513569],"study_design_scores_gemma":[0.0041968483,0.0030212654,0.90810657,0.0004224245,0.00003773773,0.0000012444439,0.0008178793,0.080945276,0.00027932427,0.00071676116,0.0013482946,0.00010638929],"about_ca_topic_score_codex":0.010843362,"about_ca_topic_score_gemma":0.000042025265,"teacher_disagreement_score":0.3512505,"about_ca_system_score_codex":0.00034035908,"about_ca_system_score_gemma":0.00060469576,"threshold_uncertainty_score":0.9957435},"labels":[],"label_agreement":null},{"id":"W4380149429","doi":"10.1016/j.jval.2023.03.1432","title":"HTA3 Analysis of Canadian and International Health Technology Assessment Uncertainty for Spinal Muscular Atrophy Therapies","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Spinal muscular atrophy; SMA*; Medicine; Physical medicine and rehabilitation; Computer science","score_opus":0.08823189869798545,"score_gpt":0.42165982530605,"score_spread":0.33342792660806453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149429","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89882165,0.0023003498,0.00030820305,0.09751182,0.00007710432,0.00084256486,0.000056371795,0.000023466138,0.000058483143],"genre_scores_gemma":[0.99250346,0.004959981,0.0016471667,0.0006459642,0.00001963705,0.00006769897,0.00008677359,0.000011843562,0.000057481688],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99878925,0.00008766141,0.00031258995,0.00023823317,0.00021303738,0.0003592158],"domain_scores_gemma":[0.9994146,0.000042982716,0.000074176234,0.00019176363,0.00008261598,0.00019381875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007749361,0.00007735038,0.00035299957,0.0034210547,0.000071645205,0.0000060769735,0.00008975318,0.000050579507,0.000020603597],"category_scores_gemma":[0.00006800496,0.00007093167,0.00008981926,0.002393583,0.000078701574,0.000011806603,0.000027682447,0.00013296043,8.43411e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002825694,0.0003084047,0.71163785,0.0017400736,0.0024136424,0.000044071927,0.00162315,0.016950905,0.00058143825,0.024633426,0.0011521601,0.23863229],"study_design_scores_gemma":[0.0022442413,0.0020569183,0.86093,0.00018719902,0.00008891269,0.000009460956,0.0026428194,0.09492848,0.000017151822,0.0015054288,0.035259996,0.00012938654],"about_ca_topic_score_codex":0.1579843,"about_ca_topic_score_gemma":0.034606915,"teacher_disagreement_score":0.2385029,"about_ca_system_score_codex":0.00023207034,"about_ca_system_score_gemma":0.0014163132,"threshold_uncertainty_score":0.983009},"labels":[],"label_agreement":null},{"id":"W4380149462","doi":"10.1016/j.jval.2023.03.2536","title":"EE558 Key Methodological Considerations for Developing Cost-Offset Budget Impact Models for a Range of Medical Technologies and Cost Perspectives in Ophthalmology","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Activity-based costing; Offset (computer science); Key (lock); Health technology; Computer science; Management science; Risk analysis (engineering); Operations research; Business; Engineering; Economics; Marketing; Health care; Computer security","score_opus":0.8183538183289807,"score_gpt":0.5655483587990042,"score_spread":0.25280545952997646,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.65617937,0.0069052563,0.06809528,0.25943565,0.000363764,0.0067702574,0.0020136705,0.00014142797,0.000095313226],"genre_scores_gemma":[0.9320536,0.0018377986,0.063025996,0.0012613591,0.000058841353,0.0016740711,0.000047147132,0.000027131082,0.000014025971],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99493426,0.00079501636,0.0030409668,0.00057045236,0.00009406732,0.00056526385],"domain_scores_gemma":[0.9836632,0.014933464,0.00097032235,0.00024353791,0.000080783095,0.00010867128],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.038129725,0.0001656811,0.0013103088,0.0009018214,0.0001456503,0.000025141897,0.0001889125,0.00035746614,0.000027850641],"category_scores_gemma":[0.03734823,0.00018476241,0.00009322141,0.0004016965,0.0001804835,0.0001923894,0.000080488644,0.00022658822,0.000008150154],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008324534,0.000108781416,0.042277988,0.0012664109,0.000045926135,0.000004269171,0.008605746,0.0129289115,9.502445e-7,0.9305171,0.0035432517,0.0006174711],"study_design_scores_gemma":[0.0021313322,0.00029443542,0.025156604,0.00023486973,0.000002018949,0.000041899853,0.009764417,0.35212886,0.0000027228966,0.60958785,0.00042914166,0.00022582858],"about_ca_topic_score_codex":0.0044350936,"about_ca_topic_score_gemma":0.00042275205,"teacher_disagreement_score":0.33919996,"about_ca_system_score_codex":0.0007986948,"about_ca_system_score_gemma":0.00091355987,"threshold_uncertainty_score":0.9904479},"labels":[],"label_agreement":null},{"id":"W4380149464","doi":"10.1016/j.jval.2023.03.1843","title":"PCR65 Psychometric Assessment of the Psoriatic Arthritis Impact of Disease-12 (PsAID-12) Questionnaire Using Pooled Data from the Phase 3 BE OPTIMAL and BE COMPLETE Trials of Bimekizumab in Patients with Psoriatic Arthritis","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Psoriatic arthritis; Medicine; Disease; Pooled analysis; Arthritis; Physical therapy; Internal medicine; Dermatology","score_opus":0.17268626101470816,"score_gpt":0.4282699343671551,"score_spread":0.2555836733524469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149464","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897538,0.004838086,0.00010242583,0.0011372049,0.00012363988,0.0022564223,0.0017699802,0.000013042267,0.0000054116085],"genre_scores_gemma":[0.99573725,0.0033101186,0.0003812492,0.0000697619,0.00003917619,0.00002786064,0.0004028878,0.000029372875,0.0000022894558],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99489766,0.0015787731,0.0017907752,0.00037099526,0.0009648574,0.00039694223],"domain_scores_gemma":[0.9967523,0.0009494092,0.0009670606,0.0010514085,0.00012960398,0.00015019876],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037369677,0.00021028152,0.001253338,0.00054788246,0.00010774548,0.000017829523,0.0003510725,0.00006877939,0.00005939773],"category_scores_gemma":[0.0023512861,0.00012877029,0.00012661504,0.0016504588,0.00023535377,0.00018704255,0.00018807517,0.00032908365,5.1467515e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0028084365,0.0020142624,0.90791893,0.0011666424,0.0004061094,0.000010738195,0.0015090196,0.0048485505,0.00011305769,0.000096792064,0.0005477503,0.078559734],"study_design_scores_gemma":[0.019604022,0.0015538994,0.9150392,0.0038674097,0.000074032774,0.0000012016737,0.00027911775,0.059297904,0.0000071663017,0.0001451043,0.000026523723,0.00010445676],"about_ca_topic_score_codex":0.012902606,"about_ca_topic_score_gemma":0.00028656906,"teacher_disagreement_score":0.07845528,"about_ca_system_score_codex":0.00020415202,"about_ca_system_score_gemma":0.0018913265,"threshold_uncertainty_score":0.9936706},"labels":[],"label_agreement":null},{"id":"W4380149473","doi":"10.1016/j.jval.2023.03.1261","title":"HPR114 Formulary Management of Biologics in Plaque Psoriasis in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Biosimilar; Formulary; Plaque psoriasis; Medicine; Psoriasis; Dermatology; Intensive care medicine; Family medicine; Internal medicine","score_opus":0.05714793715616513,"score_gpt":0.3078940492575455,"score_spread":0.25074611210138037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9914855,0.0022812786,0.00002378989,0.004441498,0.0006453556,0.0004276924,0.000054867825,0.00001823302,0.00062181073],"genre_scores_gemma":[0.99553674,0.0027960367,0.000913716,0.0005560545,0.0000061638416,0.00001613316,0.000022649137,0.00000646086,0.00014605443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831444,0.00043531903,0.0005504294,0.00021924888,0.000034539593,0.0004460159],"domain_scores_gemma":[0.9994615,0.00025645155,0.000083805964,0.00016781359,0.000008657402,0.000021814394],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012738166,0.00009889623,0.00034059474,0.00022871596,0.000020728292,0.0000012711034,0.00015937637,0.0001403338,0.000050370698],"category_scores_gemma":[0.00004421268,0.00008289768,0.000029773471,0.000776862,0.00004147857,0.000016519443,0.000085759515,0.00026225817,0.000008769273],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007073727,0.00067705143,0.752891,0.0027212133,0.00022565201,0.0005500554,0.0010361338,0.0063025863,0.0029392675,0.04123638,0.011601403,0.17911188],"study_design_scores_gemma":[0.0038963987,0.00044232563,0.9496293,0.0009876832,0.0000123544105,0.000011497446,0.002630861,0.002406007,0.004769314,0.008352511,0.02642752,0.00043423564],"about_ca_topic_score_codex":0.7902571,"about_ca_topic_score_gemma":0.54173917,"teacher_disagreement_score":0.24851793,"about_ca_system_score_codex":0.00037796507,"about_ca_system_score_gemma":0.00036235922,"threshold_uncertainty_score":0.46662286},"labels":[],"label_agreement":null},{"id":"W4380149491","doi":"10.1016/j.jval.2023.03.1066","title":"EPH185 Clinical, Humanistic, and Economic Benefits of Early Cancer Diagnosis: A Systematic Literature Review","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Narrative review; Quality of life (healthcare); Cancer; Intensive care medicine; Humanism; Narrative; Nursing; Internal medicine; Political science","score_opus":0.1341357470523731,"score_gpt":0.42168135602369583,"score_spread":0.28754560897132275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149491","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50904036,0.47473717,6.1113303e-7,0.013937033,0.00041397553,0.001652364,0.00013075664,0.00005469494,0.000033010743],"genre_scores_gemma":[0.24135232,0.75172114,0.00012030033,0.0057968544,0.00034733236,0.00052368373,0.000023121176,0.00003650295,0.00007871277],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99665034,0.00062944286,0.0017924875,0.00038554944,0.00024353914,0.0002986513],"domain_scores_gemma":[0.99766237,0.0010071539,0.000563081,0.0004764473,0.000059348175,0.00023161665],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038745045,0.00016759508,0.0014322401,0.00017164994,0.00004715733,0.000018079672,0.00011559712,0.00010022804,0.00003495378],"category_scores_gemma":[0.00075504073,0.00014914387,0.00012127656,0.0003812052,0.00006204118,0.00006203414,0.00005587192,0.00030506885,0.000039350234],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004805835,0.00014530227,0.20092374,0.77677625,0.00011972545,0.00001977235,0.0037661665,0.00008606626,2.8283088e-7,0.0018838552,0.014840045,0.0013907475],"study_design_scores_gemma":[0.0011772887,0.000651815,0.26673898,0.72971004,0.00013136634,0.00002029162,0.00012016529,0.00026435705,0.0000026079865,0.0001543782,0.00085380615,0.00017493273],"about_ca_topic_score_codex":0.0054211775,"about_ca_topic_score_gemma":0.00071102666,"teacher_disagreement_score":0.27698398,"about_ca_system_score_codex":0.00016229777,"about_ca_system_score_gemma":0.00047753486,"threshold_uncertainty_score":0.8195235},"labels":[],"label_agreement":null},{"id":"W4380149493","doi":"10.1016/j.jval.2023.03.1454","title":"HTA25 Factors Including Real-World Evidence (RWE) That Play a Role in the HTA Recommendation of Oncology Drug Submissions Based on Phase II and/or Single Arm Trial Data","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Real world evidence; Oncology; Real world data; Medicine; Drug; Anticancer drug; Precision oncology; Internal medicine; Drug trial; Clinical trial; Pharmacology; Data science; Computer science; Cancer","score_opus":0.830896354530937,"score_gpt":0.5539287354849298,"score_spread":0.2769676190460072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149493","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88111585,0.00027165044,0.00007292998,0.11383761,0.00068909244,0.0020940767,0.00068184617,0.000045037596,0.0011918974],"genre_scores_gemma":[0.994234,0.0007301215,0.00044657048,0.0038085936,0.00016964569,0.00010857783,0.00036500912,0.000025654872,0.00011178823],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.992615,0.0023418416,0.0036764722,0.00072551286,0.00013821828,0.0005029706],"domain_scores_gemma":[0.9839677,0.012782976,0.0022225154,0.00084396463,0.000020983362,0.00016181715],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.047629073,0.00018915064,0.0009814511,0.0011308821,0.0003326698,0.0000404117,0.00056685053,0.00011463436,0.00015233242],"category_scores_gemma":[0.008923691,0.00017717764,0.00005171619,0.00095210946,0.000060111386,0.00043626686,0.00019519159,0.0003639237,0.000037209487],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022082217,0.023399381,0.43349794,0.006712597,0.00018190242,0.000025694353,0.2137359,0.026128868,0.000048934155,0.08243666,0.1523914,0.03935851],"study_design_scores_gemma":[0.038271196,0.0075607756,0.032928128,0.0028001363,0.000014882729,0.0000029287855,0.016318295,0.8010027,0.000026912076,0.013553782,0.08673651,0.000783749],"about_ca_topic_score_codex":0.03234261,"about_ca_topic_score_gemma":0.0081391735,"teacher_disagreement_score":0.77487385,"about_ca_system_score_codex":0.0012807407,"about_ca_system_score_gemma":0.0009112067,"threshold_uncertainty_score":0.9994246},"labels":[],"label_agreement":null},{"id":"W4380149502","doi":"10.1016/j.jval.2023.03.1275","title":"HPR129 Is Cost-Effectiveness Analysis a Tool to Exercise Value-Based Pricing or Monopsony Power? Evidence from Canada and Other Countries","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Incentive; Monopsony; Value (mathematics); Health care; Economics; Population; Business; Actuarial science; Cost-effectiveness analysis; Public economics; Microeconomics; Operations management; Cost effectiveness; Computer science; Medicine; Economic growth; Environmental health","score_opus":0.34254730141015777,"score_gpt":0.4281455441476438,"score_spread":0.08559824273748601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96436024,0.002733438,0.00271991,0.025950216,0.00043719885,0.0023495255,0.0013457733,0.00007274421,0.00003096742],"genre_scores_gemma":[0.9667057,0.00045188077,0.0019155185,0.030128337,0.000087763365,0.0005148114,0.000025609183,0.00005538481,0.00011501697],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9942172,0.0008109302,0.0030562265,0.0009657151,0.00022486148,0.000725071],"domain_scores_gemma":[0.9921575,0.0055819424,0.0011438215,0.00068407884,0.00006634826,0.0003662914],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.018630683,0.00027566054,0.0015942473,0.000940178,0.00025269686,0.00012126044,0.00028689762,0.00012419147,0.00027331273],"category_scores_gemma":[0.0033429726,0.00032009362,0.00009305933,0.0018777176,0.00004163939,0.0002763201,0.00007047776,0.00018491995,0.0002949016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022543957,0.000047872058,0.86653876,0.001299695,0.00017012625,0.000009325447,0.007253792,0.11635893,0.0000015885814,0.0019598396,0.0057559153,0.00037869794],"study_design_scores_gemma":[0.0011162439,0.00016342761,0.79562247,0.0018774637,0.00003753555,8.448324e-7,0.0011941197,0.1784672,0.000024597733,0.001372411,0.019478962,0.0006447494],"about_ca_topic_score_codex":0.9566722,"about_ca_topic_score_gemma":0.39619377,"teacher_disagreement_score":0.56047845,"about_ca_system_score_codex":0.0027336127,"about_ca_system_score_gemma":0.0023114765,"threshold_uncertainty_score":0.99992514},"labels":[],"label_agreement":null},{"id":"W4380149523","doi":"10.1016/j.jval.2023.03.2388","title":"PCR209 Comparing the Value of Daily Measurement of Wellbeing for Individuals with Alcohol Use Disorder Versus Reimbursement-Based Timing","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University of Alberta","funders":"","keywords":"Medicaid; Reimbursement; Alcohol use disorder; Payment; Medicine; Quality assurance; Skilled Nursing Facility; Nursing homes; Nursing; Family medicine; Psychiatry; Psychology; Alcohol; Business; Health care","score_opus":0.2578126394764068,"score_gpt":0.4159053060127521,"score_spread":0.1580926665363453,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149523","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927955,0.00047798507,0.0011261908,0.0022898386,0.00083578425,0.0022312761,0.00004031571,0.00006589887,0.00013718296],"genre_scores_gemma":[0.9963149,0.00007271274,0.003119042,0.00011260366,0.000074405085,0.00018204912,0.00003645322,0.00003934572,0.00004848352],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966834,0.0007467705,0.00095347984,0.00027827185,0.00065838866,0.0006797],"domain_scores_gemma":[0.99668694,0.001937237,0.0006172928,0.00042297484,0.00024299191,0.000092572875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004711537,0.00016798585,0.0005027085,0.00030913725,0.000545414,0.000009102173,0.00022660758,0.00008651756,0.000009799218],"category_scores_gemma":[0.00048523492,0.00012437534,0.00008344266,0.00085501134,0.00009451479,0.00007872705,0.00006361798,0.00030279203,0.00000462088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015942003,0.0003022801,0.83298606,0.0052823634,0.0001800588,0.0000018144721,0.03232833,0.1136574,0.0002655854,0.0026192938,0.0062144296,0.0045682047],"study_design_scores_gemma":[0.025657026,0.002533284,0.8403756,0.010466611,0.00027449953,7.076283e-7,0.0538221,0.049001325,0.00071710534,0.00079473644,0.01573058,0.0006264482],"about_ca_topic_score_codex":0.016492518,"about_ca_topic_score_gemma":0.0010478334,"teacher_disagreement_score":0.06465607,"about_ca_system_score_codex":0.00036971734,"about_ca_system_score_gemma":0.00096876564,"threshold_uncertainty_score":0.99005675},"labels":[],"label_agreement":null},{"id":"W4380149544","doi":"10.1016/j.jval.2023.03.2468","title":"EE489 The Economic Burden of Caring for a Child with Duchene Muscular Dystrophy in Canada: A Caregiver Survey","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Social Policies and Family","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Duchenne muscular dystrophy; Muscular dystrophy; Medicine; Disease; Child health; Neuromuscular disease; Psychology; Physical therapy; Gerontology; Pediatrics; Pathology; Internal medicine","score_opus":0.0447936984588629,"score_gpt":0.2921372469343314,"score_spread":0.24734354847546852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99328893,0.00029579573,0.000002265245,0.005162537,0.0002043471,0.0005420217,0.00007188797,0.0000097098855,0.00042252667],"genre_scores_gemma":[0.99927497,0.00030588708,0.000012171125,0.00017415315,0.00015613041,0.00003278719,0.000005384362,0.000009889856,0.000028601853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987857,0.00030717632,0.00022179601,0.00014007749,0.00015766516,0.0003876029],"domain_scores_gemma":[0.9993381,0.00035217492,0.00009775424,0.00012174342,0.00002448998,0.000065724285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013979796,0.00006369501,0.00020681851,0.000061487604,0.00022182609,0.000010773642,0.0001898702,0.00003502528,0.0000022132758],"category_scores_gemma":[0.000094461706,0.000051322368,0.000029720166,0.0004024476,0.00008460104,0.000028483795,0.000023808814,0.00009741564,9.752312e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012270361,0.000024057708,0.39499444,0.0003164308,0.00007440555,0.000015086917,0.27890366,0.29666913,0.0000042495526,0.020316103,0.0034870256,0.005072719],"study_design_scores_gemma":[0.0006304187,0.0000680002,0.92827743,0.00013295081,0.0000039268375,3.1470665e-7,0.061256103,0.0041084853,0.0000019091412,0.0004984052,0.004888047,0.00013399126],"about_ca_topic_score_codex":0.9998792,"about_ca_topic_score_gemma":0.9982476,"teacher_disagreement_score":0.533283,"about_ca_system_score_codex":0.0015431516,"about_ca_system_score_gemma":0.004508789,"threshold_uncertainty_score":0.79983985},"labels":[],"label_agreement":null},{"id":"W4380149549","doi":"10.1016/j.jval.2023.03.1267","title":"HPR120 The Pan-Canadian Tiered Pricing Framework and Chinese National Volume-Based Procurement: A Comparative Study Using Donabedian's Structure-Process-Outcome Framework","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Procurement; Pooling; Purchasing; Business; Process (computing); Outcome (game theory); Purchasing power; Process management; Economics; Marketing; Computer science; Microeconomics","score_opus":0.18835347595039248,"score_gpt":0.4017387286497625,"score_spread":0.21338525269937003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868492,0.0007509884,0.0004420055,0.00961785,0.00041936213,0.0011286888,0.0003875639,0.000033864802,0.0003704871],"genre_scores_gemma":[0.9936073,0.000044614524,0.0008622646,0.005134159,0.00024723983,0.000045482164,0.000016129015,0.000028422415,0.000014385601],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978285,0.000091679736,0.0008936978,0.0004765415,0.00009462711,0.0006149866],"domain_scores_gemma":[0.9986034,0.00047651882,0.0003602404,0.00023358336,0.00004220669,0.0002840485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014969939,0.00022714197,0.0005356077,0.0005715255,0.0003969347,0.00013892692,0.00028122554,0.0001324745,0.0000928658],"category_scores_gemma":[0.00057768414,0.00021020646,0.0000538509,0.0011698978,0.000078937665,0.00013327021,0.000049604478,0.0006391474,0.000067480585],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002058863,0.00007857942,0.8723401,0.00014119524,0.00004606435,0.0000029581765,0.008647112,0.061501015,2.9658366e-7,0.056915935,0.00015940674,0.00014677772],"study_design_scores_gemma":[0.00058658066,0.000079603305,0.26873192,0.00006354592,0.0000036503486,0.0000013995435,0.00044032873,0.4744651,7.140767e-7,0.25327256,0.002088696,0.00026589097],"about_ca_topic_score_codex":0.028898802,"about_ca_topic_score_gemma":0.0048773373,"teacher_disagreement_score":0.60360813,"about_ca_system_score_codex":0.0006260327,"about_ca_system_score_gemma":0.00049678714,"threshold_uncertainty_score":0.97756785},"labels":[],"label_agreement":null},{"id":"W4380149593","doi":"10.1016/j.jval.2023.03.719","title":"EE418 Cost-Effectiveness Analysis of Halobetasol and Tazarotene (DUOBRIITM) Compared to Standard of Care for Adult Patients with Moderate-to-Severe Plaque Psoriasis in Québec","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health; Bausch Health (Canada); Health Canada","funders":"","keywords":"Tazarotene; Plaque psoriasis; Psoriasis; Medicine; Dermatology","score_opus":0.026973085544685683,"score_gpt":0.28754943763129465,"score_spread":0.26057635208660895,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149593","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99383914,0.00057511474,0.00020475402,0.00018890797,0.0001185631,0.002508169,0.0025350717,0.000021736847,0.000008536373],"genre_scores_gemma":[0.9984082,0.00008382845,0.00032824805,0.000061524,0.000004910783,0.0004158694,0.00066418987,0.000019533865,0.0000137262705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981673,0.00046762827,0.00050624774,0.00040446312,0.00007470846,0.00037969492],"domain_scores_gemma":[0.9986546,0.0005232028,0.00017412679,0.00024845146,0.00033670233,0.00006288314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003826265,0.00020247871,0.0010571298,0.00081038766,0.00008430897,0.0000047990943,0.00011385966,0.00012814393,0.000009283546],"category_scores_gemma":[0.00012687499,0.00017572241,0.00008481286,0.0013655963,0.000046382986,0.000041093106,0.00004461083,0.00007742242,0.0000038256458],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.020302722,0.00030114755,0.8378775,0.00091230305,0.0011878564,0.000003921337,0.009001224,0.11023468,0.00067426945,0.00014804961,0.00009562977,0.019260658],"study_design_scores_gemma":[0.012614167,0.0027682793,0.97222465,0.0006569848,0.00037286014,9.519315e-7,0.0014562603,0.0006576269,0.0086251255,0.00002929099,0.00029061834,0.0003032039],"about_ca_topic_score_codex":0.045002617,"about_ca_topic_score_gemma":0.056316208,"teacher_disagreement_score":0.1343471,"about_ca_system_score_codex":0.00030299815,"about_ca_system_score_gemma":0.00036704398,"threshold_uncertainty_score":0.9613568},"labels":[],"label_agreement":null},{"id":"W4380149641","doi":"10.1016/j.jval.2023.03.2157","title":"RWD128 A Retrospective Claims Analysis Characterizing Health Care Resource Use Among Patients with Friedreich Ataxia in the United States","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Ataxia; Medicine; Scoliosis; Resource use; Health care; Physical medicine and rehabilitation; Retrospective cohort study; Resource (disambiguation); Pediatrics; Physical therapy; Surgery; Psychiatry; Economics; Computer science; Natural resource economics; Economic growth","score_opus":0.04581371773125673,"score_gpt":0.29166533557567764,"score_spread":0.24585161784442092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9965457,0.000045244873,0.000016917444,0.0015709484,0.00005860276,0.0011926473,0.0004651623,0.0000941911,0.000010588126],"genre_scores_gemma":[0.99407744,0.00014653838,0.000047634116,0.0050487444,0.000023323273,0.00009462797,0.0004996,0.000041098254,0.000020992562],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99420524,0.0027372506,0.0005988069,0.000873847,0.0007766814,0.00080820656],"domain_scores_gemma":[0.9980223,0.00064223935,0.00037064793,0.0006646273,0.00009318427,0.00020700737],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065306696,0.00026748024,0.00045513964,0.0011029933,0.0003746018,0.00013767219,0.00041171798,0.00004429338,0.0000071389804],"category_scores_gemma":[0.00051565765,0.00020280789,0.0000721949,0.007889908,0.00014374775,0.00017522792,0.00010141111,0.00042379336,0.000011172754],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007544913,0.00012095351,0.94411683,0.00006949248,0.000010861161,0.00002301371,0.016440999,0.038754456,0.000062469524,0.0000862491,0.00017037647,0.000068823174],"study_design_scores_gemma":[0.00057843595,0.00039362628,0.98954463,0.000093916824,0.000014160825,4.4094264e-7,0.002184851,0.0062467474,0.00040101883,0.000031824293,0.00033011814,0.0001802349],"about_ca_topic_score_codex":0.011297347,"about_ca_topic_score_gemma":0.0014818433,"teacher_disagreement_score":0.045427766,"about_ca_system_score_codex":0.00044081343,"about_ca_system_score_gemma":0.00026199414,"threshold_uncertainty_score":0.9952865},"labels":[],"label_agreement":null},{"id":"W4380149657","doi":"10.1016/j.jval.2023.03.1016","title":"EPH134 Accurately Counting Cancer Patients: An Epidemiologic Model to Estimate the Prevalence of Epithelial Ovarian Cancer (EOC) While Accounting for Cure","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; Disease; Epithelial ovarian cancer; Ovarian cancer; Cancer; Internal medicine; Estimation; Oncology; Cure rate","score_opus":0.1665433368578929,"score_gpt":0.43834770719090455,"score_spread":0.27180437033301164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9737645,0.0012304685,0.00034673003,0.020161578,0.00053469156,0.002792838,0.001051999,0.00008013062,0.0000370636],"genre_scores_gemma":[0.98965013,0.002582011,0.0030831832,0.0025175428,0.00029784057,0.0016856762,0.000048517108,0.00004536344,0.00008975329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758023,0.00015505766,0.0007785381,0.0005287305,0.0002975708,0.00065985706],"domain_scores_gemma":[0.9982304,0.0005580644,0.0004224686,0.00038175928,0.0002395885,0.00016774161],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019028548,0.00022139652,0.00055844156,0.00013841351,0.00020002411,0.000020262938,0.00020783303,0.0000937663,0.000042213323],"category_scores_gemma":[0.00048072092,0.0001520361,0.000091963426,0.00057147146,0.00004355032,0.00015054105,0.00006655146,0.00018901502,0.0000066015473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002396629,0.00031014808,0.58494955,0.0026573404,0.000057307712,0.0000024115577,0.0022304666,0.38798395,0.00006597887,0.0010712482,0.0020428984,0.018389054],"study_design_scores_gemma":[0.0023016229,0.00070787634,0.5304053,0.0023034825,0.000108121545,0.0000010704305,0.00010832248,0.46123412,0.00020008805,0.0010446307,0.001378301,0.00020708721],"about_ca_topic_score_codex":0.015853852,"about_ca_topic_score_gemma":0.00067111175,"teacher_disagreement_score":0.073250175,"about_ca_system_score_codex":0.0005437314,"about_ca_system_score_gemma":0.0008908316,"threshold_uncertainty_score":0.99069965},"labels":[],"label_agreement":null},{"id":"W4380149693","doi":"10.1016/j.jval.2023.03.1650","title":"MT3 Delphi Panel on the Recommended Use of the Cue COVID-19 at Home Diagnostic Test","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Test (biology); Medicine; Delphi method; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Family medicine; Population; Internal medicine; Disease; Computer science; Artificial intelligence; Environmental health","score_opus":0.4396154849915233,"score_gpt":0.4449518178797979,"score_spread":0.005336332888274564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92175144,0.00010439558,0.0000055952833,0.076287694,0.00022281682,0.0013691426,0.000049566945,0.000069749745,0.00013962548],"genre_scores_gemma":[0.98831445,0.00058684684,0.000017297018,0.010053395,0.00008394923,0.00014201521,0.000009031246,0.000028332734,0.0007646689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974913,0.0009094555,0.0004669896,0.00024538327,0.00046930666,0.00041754084],"domain_scores_gemma":[0.98311454,0.015682176,0.00012625288,0.0007770757,0.00005936759,0.00024060719],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0020673312,0.00011997028,0.00025261717,0.00027063093,0.00028662445,0.00001643013,0.00020184595,0.00007620385,0.00014564347],"category_scores_gemma":[0.025054123,0.000067977555,0.000078465695,0.0015090633,0.00013510635,0.000043334505,0.00016634034,0.0005087942,0.00025645582],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022628956,0.0006750552,0.8502181,0.0011990775,0.000038354945,0.00009177361,0.001841512,0.014402172,0.0010104259,0.0022967977,0.12435634,0.0036441118],"study_design_scores_gemma":[0.0026293749,0.0024842976,0.8498843,0.00091460865,0.000022985469,0.000094246076,0.0005214641,0.010632278,0.0013450903,0.0017940556,0.12942041,0.00025689768],"about_ca_topic_score_codex":0.006581747,"about_ca_topic_score_gemma":0.0004172813,"teacher_disagreement_score":0.06656305,"about_ca_system_score_codex":0.00091162033,"about_ca_system_score_gemma":0.00084377837,"threshold_uncertainty_score":0.99496764},"labels":[],"label_agreement":null},{"id":"W4380149697","doi":"10.1016/j.jval.2023.03.994","title":"EPH112 Economic Impact of Rapid Treatment Initiation of HIV with Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) from a Canadian Healthcare Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Tenofovir alafenamide; Emtricitabine; Medicine; Human immunodeficiency virus (HIV); Virology; Antiretroviral therapy; Viral load","score_opus":0.03494687805753612,"score_gpt":0.3124821156191319,"score_spread":0.2775352375615958,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98356736,0.0009734322,0.0000056912154,0.012504846,0.00006813679,0.0012882047,0.0008316129,0.000046573412,0.00071413175],"genre_scores_gemma":[0.9967447,0.0011000445,0.0007413563,0.000080325335,0.00006134142,0.00007021354,0.00074111583,0.00004001111,0.00042091572],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998013,0.00018154831,0.00065905566,0.000390415,0.00020981119,0.00054613943],"domain_scores_gemma":[0.9985858,0.00021144576,0.0002948734,0.00033074507,0.00011217627,0.00046492522],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029161875,0.0002694999,0.000777561,0.0010775966,0.00007101729,0.0000063085554,0.00007087642,0.00009506608,0.00009553377],"category_scores_gemma":[0.000041723535,0.00020125911,0.00014061923,0.00071052683,0.000055107204,0.00007696143,0.000012246509,0.00012983728,0.000066154316],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00075587654,0.00036979155,0.9579498,0.00022285577,0.0007108601,0.0001712436,0.02673642,0.0042262916,0.00005058322,0.0015134946,0.00075273257,0.0065400456],"study_design_scores_gemma":[0.007105086,0.003646818,0.9758749,0.0007947078,0.0001024465,0.000021083155,0.0046873954,0.005961577,0.00036834506,0.0008831506,0.00028106503,0.00027340226],"about_ca_topic_score_codex":0.8120945,"about_ca_topic_score_gemma":0.17693618,"teacher_disagreement_score":0.63515836,"about_ca_system_score_codex":0.01182348,"about_ca_system_score_gemma":0.013263806,"threshold_uncertainty_score":0.9923301},"labels":[],"label_agreement":null},{"id":"W4380149702","doi":"10.1016/j.jval.2023.03.1164","title":"HPR17 PDCI's Biopharmaceutical Ecosystem Index: Where Does Canada Rank on Its Attractiveness for New Medicine Launch?","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Biotechnology and Related Fields","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Attractiveness; Rank (graph theory); Index (typography); Biopharmaceutical; Comparator; Business; Marketing; Psychology; Computer science; Engineering; Biotechnology; Biology; Mathematics; World Wide Web","score_opus":0.07971240240055555,"score_gpt":0.3611136865954009,"score_spread":0.28140128419484534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149702","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36733383,0.0038419738,0.0001324648,0.62299687,0.0030916499,0.0018743788,0.00008340344,0.00027441862,0.00037101714],"genre_scores_gemma":[0.9904361,0.003404884,0.00004635562,0.00381456,0.0004654791,0.00004117796,0.000033772016,0.000032791755,0.0017249221],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982326,0.00011681787,0.0004734807,0.00036287916,0.00027808506,0.00053610967],"domain_scores_gemma":[0.99873483,0.00052688166,0.00011021234,0.0002599914,0.000050707153,0.00031737602],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007702835,0.00018135482,0.0005147788,0.00026517344,0.00012292886,0.0000031941827,0.00012922299,0.00120876,0.000112994734],"category_scores_gemma":[0.00026657325,0.00011958949,0.00004583412,0.00058663177,0.000044712724,0.000027773318,0.000025518915,0.0017773504,0.000031775773],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012480984,0.0012559434,0.059047885,0.033958763,0.001483483,0.0038242443,0.0036495961,0.0115687335,0.0068201125,0.071185246,0.6519546,0.14277042],"study_design_scores_gemma":[0.0143919485,0.0016114877,0.031176016,0.0066769775,0.00009692728,0.00019437773,0.0012318753,0.027244044,0.0048830044,0.0009172131,0.91108084,0.00049529],"about_ca_topic_score_codex":0.16624016,"about_ca_topic_score_gemma":0.11549265,"teacher_disagreement_score":0.62310225,"about_ca_system_score_codex":0.00040492366,"about_ca_system_score_gemma":0.0018118395,"threshold_uncertainty_score":0.9323064},"labels":[],"label_agreement":null},{"id":"W4380149737","doi":"10.1016/j.jval.2023.03.951","title":"EPH69 Economic Impact of Clozapine Treatment Persistence: A Canadian Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Douglas Mental Health University Institute","funders":"","keywords":"Clozapine; Persistence (discontinuity); Schizophrenia (object-oriented programming); Perspective (graphical); Psychiatry; Medicine; Psychology; Computer science; Engineering; Artificial intelligence","score_opus":0.18758604027506046,"score_gpt":0.3728724681580302,"score_spread":0.18528642788296976,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149737","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96971023,0.0021047841,0.0000021921574,0.007856493,0.0003069676,0.0003708661,0.001491449,0.00002543556,0.018131569],"genre_scores_gemma":[0.9944977,0.004719379,0.000044526976,0.0003543334,0.00010592394,0.000021736001,0.000020230838,0.00002160315,0.0002145334],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99838215,0.000029609353,0.00065147365,0.00034461453,0.000013499545,0.0005786374],"domain_scores_gemma":[0.99903524,0.000074100004,0.00022340858,0.00025145974,0.000011138258,0.00040466187],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0005961249,0.00014820846,0.00050869177,0.00078377465,0.0000682758,0.00001938788,0.00016026084,0.000070451744,0.0004772283],"category_scores_gemma":[0.00004580109,0.00016526008,0.00021945768,0.0003121368,0.000051599727,0.00008306663,0.000021141195,0.00010422536,0.0010934918],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000645291,0.00012191741,0.17617755,0.000074268166,0.00023145977,0.000014133411,0.00852519,0.12229903,0.0000047577096,0.68692744,0.0037736092,0.0017861429],"study_design_scores_gemma":[0.0038162612,0.0016273812,0.3226631,0.00007437376,0.000008035825,0.0000150862625,0.0010956011,0.4566111,0.00002623921,0.14987591,0.06342999,0.0007569322],"about_ca_topic_score_codex":0.8965977,"about_ca_topic_score_gemma":0.06597067,"teacher_disagreement_score":0.830627,"about_ca_system_score_codex":0.0084588425,"about_ca_system_score_gemma":0.0013037116,"threshold_uncertainty_score":0.9996843},"labels":[],"label_agreement":null},{"id":"W4380149798","doi":"10.1016/j.jval.2023.03.1433","title":"HTA4 Pembrolizumab Vs. Standard of Care Chemotherapy As First-Line Treatment for Advanced Non-Small Cell Lung Cancer with High Pd-L1 Expression Levels: A Cost-Utility Analysis from the Ontario, Canada Public Payer Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network; Sunnybrook Health Science Centre; York University; University of Toronto","funders":"","keywords":"Pembrolizumab; Medicine; Lung cancer; Chemotherapy; Oncology; Internal medicine; Cancer; Intensive care medicine; Immunotherapy","score_opus":0.0349656346771366,"score_gpt":0.3159447320730994,"score_spread":0.28097909739596283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149798","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9799268,0.004749693,0.00021162447,0.010196994,0.00016116387,0.0030063833,0.0016590952,0.000030221801,0.000057985344],"genre_scores_gemma":[0.9959635,0.0015828696,0.00043077095,0.0007905602,0.00007243499,0.0005929205,0.00024802596,0.000037884445,0.00028099702],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979013,0.00011551583,0.0004999881,0.0005482707,0.00044347064,0.00049144746],"domain_scores_gemma":[0.9982798,0.00034256498,0.00031453354,0.0005598725,0.00033997715,0.0001632461],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002906015,0.00028589243,0.0008334322,0.00015316044,0.0002094712,0.000017009654,0.0001544255,0.00008592894,0.00034131596],"category_scores_gemma":[0.000025285624,0.00017871651,0.00019695681,0.00092200434,0.00006205297,0.00005139058,0.00002012742,0.00017988958,1.9140806e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.14781009,0.0008208732,0.6677866,0.0015423477,0.0044234684,0.000052538526,0.12179687,0.025406675,0.0010432719,0.000025816207,0.0035620383,0.025729418],"study_design_scores_gemma":[0.044529986,0.00622257,0.8750171,0.0014372331,0.0007757915,0.0000024893072,0.021716537,0.0047945385,0.019565232,0.000061018232,0.025334956,0.0005425385],"about_ca_topic_score_codex":0.9931314,"about_ca_topic_score_gemma":0.9932381,"teacher_disagreement_score":0.20723051,"about_ca_system_score_codex":0.008848595,"about_ca_system_score_gemma":0.008769466,"threshold_uncertainty_score":0.9968499},"labels":[],"label_agreement":null},{"id":"W4380149799","doi":"10.1016/j.jval.2023.03.759","title":"EE458 Economic Evaluation of Lifestyle Interventions to Promote Cognition in Older Adults with Chronic Stroke","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Vancouver Coastal Health Research Institute; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Cognition; Stroke (engine); Cognitive training; Perspective (graphical); Psychological intervention; Physical medicine and rehabilitation; Physical therapy; Medicine; Gerontology; Health care; Chronic stroke; Psychology; Rehabilitation; Psychiatry; Computer science","score_opus":0.20140413197429213,"score_gpt":0.5073952337859001,"score_spread":0.305991101811608,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842338,0.0005510005,0.00005277832,0.0081434725,0.0006533157,0.00546059,0.00011638978,0.000061538696,0.0007271117],"genre_scores_gemma":[0.9978145,0.00021651818,0.00023447067,0.00016593539,0.00019969838,0.001033422,0.000075699776,0.000028941971,0.00023081167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99307525,0.004209681,0.0013896914,0.00036261883,0.0003714649,0.0005912638],"domain_scores_gemma":[0.9980272,0.0006985651,0.000618398,0.0002843586,0.0001848496,0.00018664231],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013153426,0.00012895254,0.00037470763,0.00061506935,0.0001779482,0.000006411355,0.00010873957,0.00014156826,0.00030285542],"category_scores_gemma":[0.0005445853,0.00012087243,0.000046909216,0.0005490324,0.00001640077,0.00021385845,0.00004829164,0.0005021312,0.00048188522],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014805439,0.0011664985,0.37998444,0.0773918,0.0001143194,0.000025751544,0.14072761,0.089576945,0.00010638329,0.0045386082,0.006858962,0.2980281],"study_design_scores_gemma":[0.008699128,0.0021155297,0.8579884,0.049757726,0.00003647906,0.000005051481,0.013743944,0.06020124,0.00002787044,0.00047867937,0.0065746615,0.00037129442],"about_ca_topic_score_codex":0.039836574,"about_ca_topic_score_gemma":0.053375192,"teacher_disagreement_score":0.47800395,"about_ca_system_score_codex":0.0014264476,"about_ca_system_score_gemma":0.003330198,"threshold_uncertainty_score":0.96655726},"labels":[],"label_agreement":null},{"id":"W4380149805","doi":"10.1016/j.jval.2023.03.2254","title":"SA38 Approaches to Comparing Treatments from Meta-Analyses of Single-Arm Studies from a Systematic Literature Review: Case Example of Non-Surgical Technologies for Treatment of Lung Cancer","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Microwave ablation; Radiofrequency ablation; Lung cancer; Meta-analysis; Ablation; Radiology; Systematic review; Medical physics; Surgery; Oncology; MEDLINE; Internal medicine","score_opus":0.48189212663009995,"score_gpt":0.4685687475370384,"score_spread":0.013323379093061527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149805","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56332326,0.4320623,0.00015591636,0.0020780638,0.00006565129,0.002074232,0.00019443294,0.000038905604,0.000007216633],"genre_scores_gemma":[0.937364,0.050264344,0.011298832,0.000059307127,0.000040311734,0.0007898344,0.00011571008,0.000026241622,0.000041414736],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.997781,0.00021927214,0.0011624598,0.0003464843,0.00025650312,0.0002342742],"domain_scores_gemma":[0.9975348,0.0013454008,0.00053511374,0.00042353428,0.00008227994,0.00007887204],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068372744,0.00021624028,0.0029497908,0.0002952901,0.000040499024,0.0000055416804,0.0000946494,0.0000618648,0.000003525779],"category_scores_gemma":[0.0005919007,0.00012997707,0.00032799307,0.00067704986,0.00007180028,0.00002609399,0.000047687096,0.00008746816,3.0747836e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00075372256,0.005759507,0.057837408,0.7747995,0.05733377,0.0015460149,0.045764472,0.02831921,0.0033361805,0.0002719027,0.001599476,0.022678835],"study_design_scores_gemma":[0.015168727,0.007782774,0.0030533185,0.48449817,0.05445186,0.0003082336,0.012072397,0.4070708,0.013383438,0.0008107956,0.00054854347,0.00085093],"about_ca_topic_score_codex":0.017518943,"about_ca_topic_score_gemma":0.00008352816,"teacher_disagreement_score":0.38179797,"about_ca_system_score_codex":0.00026911413,"about_ca_system_score_gemma":0.00008639889,"threshold_uncertainty_score":0.9890235},"labels":[],"label_agreement":null},{"id":"W4380149838","doi":"10.1016/j.jval.2023.03.2185","title":"RWD157 Healthcare Resource Utilization and Cost of Care in Patients with BRAF-Mutated Unresectable/Metastatic Melanoma in the US","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Metastatic melanoma; Melanoma; Medicine; Health care; Oncology; Mutant; Internal medicine; Cancer research; Biology; Gene; Genetics; Political science","score_opus":0.05831661155919933,"score_gpt":0.27630889138393905,"score_spread":0.21799227982473973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9931265,0.0038784924,0.000013724264,0.0011592621,0.00006467485,0.00086083217,0.00023855885,0.000010618776,0.00064734096],"genre_scores_gemma":[0.99847853,0.000801277,0.000047666756,0.00048663918,0.000012239582,0.000036188994,0.00010223363,0.000019503308,0.000015722953],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983987,0.00011294195,0.00076764263,0.0002904525,0.000050423445,0.00037982056],"domain_scores_gemma":[0.9992179,0.00013416745,0.0003449859,0.00021362856,0.000027618904,0.000061643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009936885,0.00011908672,0.00043919697,0.0005223954,0.000051192783,0.000022120319,0.00014054921,0.000058261907,0.000008415917],"category_scores_gemma":[0.00013140177,0.00011162315,0.000019499777,0.0010041232,0.000049903512,0.00015310831,0.000028283916,0.00018516356,0.0000097943475],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014710113,0.000051525763,0.97532326,0.00035801542,0.0000037938346,0.0000035128448,0.0058926004,0.0058978894,3.3501482e-8,0.006369805,0.00006909958,0.0058833472],"study_design_scores_gemma":[0.0019303585,0.00050390034,0.9885204,0.00020649875,8.4939626e-7,6.321096e-7,0.0009834532,0.00299929,0.0000016242433,0.0018403952,0.0028969268,0.000115683506],"about_ca_topic_score_codex":0.022404233,"about_ca_topic_score_gemma":0.007287777,"teacher_disagreement_score":0.015116457,"about_ca_system_score_codex":0.00031487484,"about_ca_system_score_gemma":0.00014577576,"threshold_uncertainty_score":0.98410565},"labels":[],"label_agreement":null},{"id":"W4380149871","doi":"10.1016/j.jval.2023.03.100","title":"CO26 Impact in Health Outcomes of Anti-PD(L)1 Inhibitors to Treat Early-Stage Cancers in Belgium","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Adjuvant; Stage (stratigraphy); Internal medicine; Cancer; Oncology; Incidence (geometry); Overall survival","score_opus":0.06355808240718473,"score_gpt":0.3210031120379493,"score_spread":0.25744502963076454,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902262,0.0016393608,0.000019656529,0.004892402,0.00065070303,0.00078419305,0.00055989163,0.000033959055,0.0011936194],"genre_scores_gemma":[0.99562705,0.002720752,0.000105307496,0.0009025133,0.00007513925,0.000044676766,0.000014977136,0.00004590461,0.00046368624],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962657,0.00007148803,0.0020216224,0.0005497436,0.0000639472,0.0010274847],"domain_scores_gemma":[0.9984598,0.0001499995,0.00067808205,0.00038670358,0.000015923286,0.0003094588],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0023086143,0.00026032928,0.0013838122,0.0017197708,0.000051481966,0.000028001803,0.0002621242,0.00013733402,0.0000658623],"category_scores_gemma":[0.00025208664,0.00029943493,0.00014068966,0.0016221148,0.00005114967,0.000293066,0.00007225031,0.00030716014,0.00015493411],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042486357,0.00006483271,0.93365884,0.0002219727,0.0000075392786,0.000006619617,0.0029203747,0.05473546,0.0000017039811,0.0065153562,0.00071660546,0.0011082266],"study_design_scores_gemma":[0.0012669277,0.00037348142,0.9905832,0.00021211141,4.13476e-7,4.0932997e-7,0.00022589903,0.0016232578,0.000014461338,0.0018045256,0.0036445765,0.0002507365],"about_ca_topic_score_codex":0.44358185,"about_ca_topic_score_gemma":0.013325728,"teacher_disagreement_score":0.43025613,"about_ca_system_score_codex":0.0031356248,"about_ca_system_score_gemma":0.00078945525,"threshold_uncertainty_score":0.99994576},"labels":[],"label_agreement":null},{"id":"W4380149964","doi":"10.1016/j.jval.2023.03.2074","title":"RWD44 Use of Real-World Data for Hard-to-Identify Patient Population: Methodology and a Case Study","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Real world data; Real world evidence; Medicine; Matching (statistics); Psychological intervention; Computer science; Intensive care medicine; Data science; Internal medicine; Psychiatry","score_opus":0.8950720303877125,"score_gpt":0.6683719799046978,"score_spread":0.22670005048301478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875992,0.000018414177,0.00079707074,0.008430502,0.00027495867,0.0026738711,0.00017197547,0.000032892232,0.0000011332015],"genre_scores_gemma":[0.9258623,0.00007338255,0.07221089,0.0012358164,0.000095107214,0.000060197115,0.000405284,0.00002089498,0.000036140547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968158,0.00094787066,0.0014196226,0.00039824814,0.00020819911,0.00021024587],"domain_scores_gemma":[0.9917717,0.0069216588,0.00039909416,0.0006498746,0.0001133358,0.00014435861],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0065735574,0.00008293678,0.00042418647,0.00036188893,0.000053898508,0.000010938153,0.000060509883,0.000026310907,0.000008112445],"category_scores_gemma":[0.013896478,0.000079571735,0.000022246992,0.00067124766,0.000019202245,0.00014758558,0.00019050839,0.00012124776,0.000003422934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008442391,0.0005106894,0.8950492,0.00056356,0.00007028436,0.00038956938,0.0033960983,0.0012169767,0.00005989042,0.00016577609,0.008910362,0.08882333],"study_design_scores_gemma":[0.0026130006,0.002527892,0.9625516,0.00012321399,0.00011857243,0.00017045504,0.007500219,0.021054745,0.0000061096075,0.00029489887,0.0029393667,0.00009994201],"about_ca_topic_score_codex":0.22626036,"about_ca_topic_score_gemma":0.02760873,"teacher_disagreement_score":0.19865163,"about_ca_system_score_codex":0.000091935995,"about_ca_system_score_gemma":0.00016082,"threshold_uncertainty_score":0.9944099},"labels":[],"label_agreement":null},{"id":"W4380149975","doi":"10.1016/j.jval.2023.03.1596","title":"MSR61 AI Support Reduced Screening Burden in a Systematic Review with Costs and Cost-Effectiveness Outcomes (SR-CCEO) for Cost-Effectiveness Modeling","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Impact of AI and Big Data on Business and Society","field":"Decision Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Critical appraisal; Cost effectiveness; Computer science; Process (computing); Resource (disambiguation); Medicine; Risk analysis (engineering); Alternative medicine; Pathology","score_opus":0.4568049397514221,"score_gpt":0.5197233834991778,"score_spread":0.06291844374775568,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380149975","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019485246,0.9560493,0.010587936,0.0005368235,0.00040007755,0.031547405,0.00059674593,0.000076174154,0.000010649835],"genre_scores_gemma":[0.00096901186,0.99218845,0.00030336808,0.00046092228,0.00007907022,0.005516463,0.00030440403,0.0001264294,0.000051888383],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98688895,0.005084338,0.0036353897,0.0015805278,0.0016647737,0.0011459998],"domain_scores_gemma":[0.9837095,0.0125223035,0.001630389,0.0012040676,0.00055027695,0.00038347594],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.038954634,0.0009214595,0.008733517,0.0009521437,0.00034449215,0.0004560563,0.0011223973,0.00045046437,0.000008050435],"category_scores_gemma":[0.00776114,0.0005651327,0.0006502033,0.003170981,0.00010408445,0.00061091845,0.00029669298,0.00083616923,0.000025424033],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054752192,0.00006510145,0.0002187369,0.83840114,0.00012116682,0.00003136204,0.00018421546,0.0014448756,4.2524732e-8,0.00015882643,0.000093484006,0.15922628],"study_design_scores_gemma":[0.001596278,0.0003107734,0.0002491733,0.97134686,0.00048263033,0.00008500523,0.00031990674,0.0138361035,8.866989e-8,0.00026373714,0.010680882,0.0008285846],"about_ca_topic_score_codex":0.0032354232,"about_ca_topic_score_gemma":0.00013865148,"teacher_disagreement_score":0.1583977,"about_ca_system_score_codex":0.0010311184,"about_ca_system_score_gemma":0.0022373819,"threshold_uncertainty_score":0.99968004},"labels":[],"label_agreement":null},{"id":"W4380150010","doi":"10.1016/j.jval.2023.03.1557","title":"MSR21 Impact of Correlated Outcomes in Probabilistic Sensitivity Analyses When Treatment Effects Are Derived from a Network Meta-Analysis","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"scientometrics and bibliometrics research","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Meta-analysis; Econometrics; Probabilistic logic; Sensitivity (control systems); Regression; Meta-regression; Correlation; Regression analysis; Statistics; Computer science; Mathematics; Medicine; Internal medicine; Engineering","score_opus":0.8169312145311791,"score_gpt":0.6222054501852085,"score_spread":0.19472576434597066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949395,0.0024051378,0.0006657197,0.00074153283,0.00013537273,0.00081771903,0.00024497384,0.00003009552,0.000019958983],"genre_scores_gemma":[0.9988569,0.000241552,0.0006371689,0.000044161363,0.000015665204,0.000040648796,0.00003296096,0.000011547477,0.00011937213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98831755,0.004279966,0.0015852775,0.0009770476,0.003913506,0.00092662516],"domain_scores_gemma":[0.9607709,0.036395635,0.0007949861,0.0010136749,0.00061525806,0.00040951962],"candidate_categories":["metaresearch","bibliometrics"],"consensus_categories":["bibliometrics"],"category_scores_codex":[0.023489887,0.0002779617,0.0028071548,0.05016882,0.00011076492,0.00030574514,0.0005957318,0.00013388881,0.00018774832],"category_scores_gemma":[0.028563483,0.00015894359,0.0015222502,0.25833273,0.00009402051,0.00018081213,0.00026588532,0.00023942637,0.0000716926],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024151628,0.00021077953,0.5946194,0.000008785345,0.004694311,0.0000644961,0.00033221702,0.39856616,0.000029773026,0.0000056373137,0.0001571842,0.0012871017],"study_design_scores_gemma":[0.0003944056,0.00024496618,0.71212494,0.000008100429,0.0012747728,3.476837e-7,0.00006439638,0.28252068,0.000021683894,0.0032454128,0.000004531525,0.000095736905],"about_ca_topic_score_codex":0.14168762,"about_ca_topic_score_gemma":0.007673277,"teacher_disagreement_score":0.20816392,"about_ca_system_score_codex":0.00086297153,"about_ca_system_score_gemma":0.0005809473,"threshold_uncertainty_score":0.9796193},"labels":[],"label_agreement":null},{"id":"W4380150026","doi":"10.1016/j.jval.2023.03.381","title":"EE76 Budget Impact of Faricimab in Patients with Diabetic Macular Edema and Neovascular Age Related Degeneration in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Aflibercept; Macular degeneration; Diabetic macular edema; Medicine; Pro re nata; Clinical trial; Ophthalmology; Ranibizumab; Bevacizumab; Clinical Practice; Optometry; Internal medicine; Diabetic retinopathy; Physical therapy; Diabetes mellitus; Chemotherapy","score_opus":0.12314040411303451,"score_gpt":0.33776208573596267,"score_spread":0.21462168162292816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99467385,0.0016277019,0.000018536162,0.0024359857,0.00012945494,0.0009348994,0.00011558472,0.0000112192365,0.00005276489],"genre_scores_gemma":[0.99884695,0.00019519936,0.00018834685,0.00055791467,0.000010913118,0.000044522076,0.000116284515,0.000024568304,0.000015292935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995444,0.0005352888,0.0030110495,0.00041394136,0.00012229882,0.0004734268],"domain_scores_gemma":[0.99827015,0.00035253575,0.000940507,0.00030311453,0.000026469448,0.00010721714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008192956,0.00015379024,0.00091283466,0.00071936275,0.000046656533,0.000016145756,0.00010949318,0.00008896035,0.000027923954],"category_scores_gemma":[0.00070878916,0.00017720519,0.00004115549,0.0008785395,0.00002794612,0.00017460188,0.000028365776,0.00018314992,0.000019899311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011709648,0.000048559312,0.9135362,0.00028951242,0.000015550542,0.0000039551933,0.001285218,0.083575696,3.7268325e-7,0.00088253623,0.00021267693,0.00013799226],"study_design_scores_gemma":[0.0018799016,0.00012825355,0.9328742,0.00019182557,0.0000012064361,4.6679983e-7,0.00019884198,0.06311094,8.765073e-7,0.0013680666,0.000091444585,0.00015394982],"about_ca_topic_score_codex":0.93070555,"about_ca_topic_score_gemma":0.50044656,"teacher_disagreement_score":0.430259,"about_ca_system_score_codex":0.0031430472,"about_ca_system_score_gemma":0.0013687941,"threshold_uncertainty_score":0.8218959},"labels":[],"label_agreement":null},{"id":"W4380150158","doi":"10.1016/j.jval.2023.03.216","title":"CO143 Impact of Investigational, at-Home, Self-Administered, Intranasal Etripamil on the Need for Additional Medical Intervention in Patients with Supraventricular Tachycardia","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Medicine; Intervention (counseling); Paroxysmal supraventricular tachycardia; Emergency department; Supraventricular tachycardia; Psychological intervention; Tachycardia; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.026004385502460314,"score_gpt":0.30779506948395896,"score_spread":0.28179068398149865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994468,0.00006418308,0.000008766587,0.0024317002,0.00012342168,0.0013678736,0.0014582967,0.000027961543,0.000049851864],"genre_scores_gemma":[0.9956676,0.00004157946,0.00012132075,0.00032157823,0.00008829297,0.00019520143,0.0035221863,0.000021749232,0.000020532156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980271,0.00022559488,0.00052301685,0.000230456,0.00070289423,0.00029092937],"domain_scores_gemma":[0.9983832,0.0009816007,0.00017987262,0.00018805117,0.00009291008,0.00017434504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008139688,0.00014472862,0.00038323604,0.0003237574,0.00006135015,0.0000059277786,0.000055729855,0.0000897641,0.00025074903],"category_scores_gemma":[0.00052331266,0.00009226204,0.00022933618,0.0006784774,0.000060888553,0.000038489117,0.000028954959,0.000174923,0.000012810715],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014640009,0.00090003136,0.97527677,0.00030213865,0.00030574962,0.000076825294,0.00033414224,0.001160193,4.0156235e-7,0.0007731828,0.018348979,0.001057591],"study_design_scores_gemma":[0.007882138,0.0023301293,0.9855472,0.00078196294,0.000025668365,0.000014101677,0.00004656411,0.002493324,0.0000075653197,0.00024330881,0.0005501728,0.0000779065],"about_ca_topic_score_codex":0.00064743235,"about_ca_topic_score_gemma":0.000046236717,"teacher_disagreement_score":0.017798806,"about_ca_system_score_codex":0.0007430827,"about_ca_system_score_gemma":0.0006445914,"threshold_uncertainty_score":0.37623367},"labels":[],"label_agreement":null},{"id":"W4380150175","doi":"10.1016/j.jval.2023.03.482","title":"EE181 The Economic Burden of Preterm Labor (PTL): A Systematic Literature Review","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Preterm Birth and Chorioamnionitis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Preterm labor; Medicine; Obstetrics; Preterm labour; Economics; Pregnancy; Fetus; Gestation; Biology","score_opus":0.028214016319805975,"score_gpt":0.3070589685119456,"score_spread":0.2788449521921396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150175","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.352004,0.6065227,0.0000025784511,0.033625823,0.00080327364,0.0055419803,0.00021007944,0.00015778038,0.0011317796],"genre_scores_gemma":[0.6468101,0.3482388,0.000085481755,0.003412465,0.0003386484,0.00024677764,0.000068178815,0.000032851807,0.00076668465],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9984109,0.0003206474,0.00066983706,0.00017620633,0.00015780094,0.0002646096],"domain_scores_gemma":[0.9989169,0.0002191134,0.00022816227,0.0004903372,0.000035777135,0.00010970215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001178387,0.0001113756,0.00058600924,0.00011399047,0.000039206774,0.000012156648,0.00015048424,0.00005770028,0.000028957653],"category_scores_gemma":[0.00023765398,0.000071007504,0.00009180358,0.00041826398,0.000029545085,0.000043107735,0.000033546483,0.00021558287,0.00008647098],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004858192,0.000018194918,0.002518942,0.97834414,0.000058213416,0.00008774359,0.005442252,0.00016945328,0.000026073747,0.0015020295,0.01039004,0.0013943411],"study_design_scores_gemma":[0.0016010115,0.0006852635,0.010279401,0.9672674,0.000119345495,0.00039934003,0.00045361742,0.011382752,0.000053614942,0.00064989255,0.0068579027,0.00025047874],"about_ca_topic_score_codex":0.00039141576,"about_ca_topic_score_gemma":0.000010294609,"teacher_disagreement_score":0.29480612,"about_ca_system_score_codex":0.00015173259,"about_ca_system_score_gemma":0.00039317142,"threshold_uncertainty_score":0.2895602},"labels":[],"label_agreement":null},{"id":"W4380150183","doi":"10.1016/j.jval.2023.03.512","title":"EE211 Guidelines for the Economic Evaluation of Vaccination Programs in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada; Canadian Agency for Drugs and Technologies in Health; University of British Columbia; BC Centre for Disease Control; University of Toronto","funders":"","keywords":"Mandate; Vaccination; Immunization program; Context (archaeology); Advisory committee; Immunization; Health care; Medicine; Political science; Public administration; Business; Economic growth; Virology; Economics; Immunology; Geography","score_opus":0.78773921110202,"score_gpt":0.5120014130453933,"score_spread":0.2757377980566268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150183","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83258146,0.004681634,0.00067550887,0.15438996,0.001849532,0.0052321027,0.0002939016,0.000033338158,0.0002625292],"genre_scores_gemma":[0.9941716,0.0005703368,0.0009946427,0.0029356985,0.00022484123,0.0009166001,0.00009143892,0.000028584951,0.00006626084],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9934012,0.00053982186,0.005061927,0.00039633442,0.00015830429,0.00044239796],"domain_scores_gemma":[0.9957835,0.0017397399,0.0018686915,0.0003759332,0.00015983662,0.00007228446],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.06131326,0.0001207954,0.0006309005,0.0004046574,0.000092091155,0.000019510706,0.0002504602,0.00006234384,0.000074856536],"category_scores_gemma":[0.005182011,0.0001324889,0.0000590161,0.0004016473,0.00001291757,0.00017549469,0.000026893853,0.00010025633,0.000082081744],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017739727,0.000037612517,0.18756698,0.00090055313,0.000027776228,1.6520572e-7,0.0019496038,0.69087744,2.3181e-7,0.0647111,0.03417342,0.019737354],"study_design_scores_gemma":[0.00091395836,0.000040476523,0.12735035,0.00010018625,0.0000022744832,4.5071843e-7,0.001795203,0.84300625,0.0000012230483,0.015852451,0.010827476,0.00010968932],"about_ca_topic_score_codex":0.9494743,"about_ca_topic_score_gemma":0.87024575,"teacher_disagreement_score":0.16159011,"about_ca_system_score_codex":0.0067214346,"about_ca_system_score_gemma":0.0054146736,"threshold_uncertainty_score":0.9970916},"labels":[],"label_agreement":null},{"id":"W4380150191","doi":"10.1016/j.jval.2023.03.513","title":"EE212 Comprehensive Review of Methods to Estimate Market Share Uptakes in Budget Impact Models","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NovAtel (Canada)","funders":"","keywords":"Market share; Intervention (counseling); Business; Environmental economics; Econometrics; Economics; Marketing; Medicine","score_opus":0.5983251675744082,"score_gpt":0.5634925773266871,"score_spread":0.03483259024772112,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150191","genre_codex":"review","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32479122,0.38348264,0.020981781,0.23975746,0.002560217,0.013749957,0.005631221,0.00042829447,0.008617211],"genre_scores_gemma":[0.25318474,0.20752797,0.36213484,0.17053469,0.0008295707,0.0026423484,0.0009689197,0.0006052722,0.0015716762],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99033195,0.0019205222,0.0062302817,0.00065627554,0.0001114405,0.00074951677],"domain_scores_gemma":[0.99467844,0.0023973766,0.0018513375,0.0006719671,0.00008044238,0.0003204093],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.039356288,0.00024012159,0.0020456112,0.00109829,0.00006496532,0.000022190645,0.00035843713,0.00011695776,0.0003976291],"category_scores_gemma":[0.0046483455,0.00029453434,0.00016405337,0.0013110458,0.000030561703,0.0003118813,0.00009960782,0.00025070505,0.0005329789],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009758617,0.00033370926,0.077077664,0.11346765,0.00012064854,0.0000106394245,0.009415487,0.41804862,0.000005015047,0.07147661,0.30399537,0.00595102],"study_design_scores_gemma":[0.0012424574,0.00033315108,0.16987807,0.020870948,0.0000048208076,0.000008910626,0.0007678269,0.7074311,0.0000030761614,0.05071921,0.048028395,0.0007120493],"about_ca_topic_score_codex":0.0106595745,"about_ca_topic_score_gemma":0.00014510247,"teacher_disagreement_score":0.34115306,"about_ca_system_score_codex":0.0011501895,"about_ca_system_score_gemma":0.00052589277,"threshold_uncertainty_score":0.9999507},"labels":[],"label_agreement":null},{"id":"W4380150199","doi":"10.1016/j.jval.2023.03.1945","title":"PCR169 A Systematic Literature Review (SLR) of Health State Utility Values (HSUV) in Metastatic Castration-Resistant Prostate Cancer (MCRPC)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Oncology; Systematic review; Cancer; Internal medicine; Gynecology; MEDLINE; Biology","score_opus":0.4235380140617159,"score_gpt":0.46106455717523254,"score_spread":0.037526543113516664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150199","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1764214,0.71176785,0.00022187157,0.09503521,0.0010355051,0.012003302,0.0031817872,0.00015529168,0.00017777886],"genre_scores_gemma":[0.56278336,0.40968588,0.0032952612,0.019968512,0.0001380175,0.002591828,0.00040713564,0.00016513815,0.00096485944],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97932297,0.0047403546,0.01356699,0.00095962855,0.0003263024,0.0010837608],"domain_scores_gemma":[0.9910157,0.0016242355,0.0060559143,0.0008758099,0.00013596893,0.00029237632],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.072911054,0.00036645902,0.0035204345,0.0011145314,0.00016837503,0.00007088494,0.0003604732,0.00009048252,0.00007777643],"category_scores_gemma":[0.004296892,0.00040911016,0.00018161416,0.0023901756,0.00007888622,0.0004866421,0.00006022134,0.00042644204,0.00021798415],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045430115,0.00029004252,0.022801057,0.92396235,0.000098319215,0.000015792206,0.024222063,0.0070557846,0.0000015847788,0.012074676,0.00880264,0.00063027587],"study_design_scores_gemma":[0.004524298,0.00091208617,0.1906186,0.65405303,0.00003652881,0.000029444844,0.006398574,0.08060973,0.000005698777,0.05521203,0.005947505,0.0016524385],"about_ca_topic_score_codex":0.02374421,"about_ca_topic_score_gemma":0.0027347712,"teacher_disagreement_score":0.38636196,"about_ca_system_score_codex":0.0017148462,"about_ca_system_score_gemma":0.0019513231,"threshold_uncertainty_score":0.9998361},"labels":[],"label_agreement":null},{"id":"W4380150200","doi":"10.1016/j.jval.2023.03.1833","title":"PCR54 A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Patient Reported Outcome Measures (PROMS): Part II Psychometric Properties","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Patient-reported outcome; Medicine; Quality of life (healthcare); Disease; Health related quality of life; Physical therapy; Systematic review; Psychometric testing; Psychometrics; MEDLINE; Intensive care medicine; Clinical psychology; Pathology; Nursing","score_opus":0.851519320718531,"score_gpt":0.4987643617179948,"score_spread":0.35275495900053616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150200","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011345943,0.9818114,0.000094970834,0.001698575,0.0008477258,0.0145501625,0.00070973655,0.000093958624,0.00008002078],"genre_scores_gemma":[0.00020587508,0.99473524,0.0003044361,0.0008491159,0.00011901115,0.0033959954,0.00010400589,0.00013746461,0.00014886798],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.96159405,0.007123628,0.028148355,0.0016715857,0.00067122857,0.00079116767],"domain_scores_gemma":[0.9792459,0.0015854891,0.015616151,0.0028298036,0.00018131876,0.00054136454],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.09528072,0.0007493423,0.01650327,0.0017857354,0.00026864334,0.00007401458,0.00054613064,0.00030455488,0.00002957274],"category_scores_gemma":[0.014222204,0.0007128632,0.001465193,0.0020424332,0.00011313535,0.00022269406,0.00020787201,0.00062636787,0.00012113848],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000020370755,0.00016791599,0.0006753143,0.9906738,0.0011308866,0.0000029397738,0.00024190257,0.00013793872,4.8695564e-10,0.0037765738,0.0007721796,0.0024185483],"study_design_scores_gemma":[0.00036476602,0.0001579282,0.0006184503,0.5532076,0.00084897166,0.000013681261,0.00013585103,0.0001731474,2.8699163e-9,0.0003477994,0.4433335,0.0007983371],"about_ca_topic_score_codex":0.0037795713,"about_ca_topic_score_gemma":0.000019887353,"teacher_disagreement_score":0.44256133,"about_ca_system_score_codex":0.0026295474,"about_ca_system_score_gemma":0.0014030068,"threshold_uncertainty_score":0.9995322},"labels":[],"label_agreement":null},{"id":"W4380150210","doi":"10.1016/j.jval.2023.03.754","title":"EE453 Baseline Cognitive Performance Is a Determinant of Prospective Health Resource Utilization Among Adults with Chronic Stroke: A Secondary Analysis","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo; Vancouver Coastal Health Research Institute; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Stroke (engine); Chronic stroke; Prospective cohort study; Medicine; Public health; Cognition; Gerontology; Cognitive impairment; Baseline (sea); Resource (disambiguation); Health care; Physical therapy; Psychiatry; Nursing; Political science; Internal medicine; Computer science","score_opus":0.04158020078950074,"score_gpt":0.2708718675230642,"score_spread":0.22929166673356344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150210","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99204844,0.0033567918,0.001063223,0.00073221856,0.000100571604,0.0013897854,0.0008381706,0.000056692184,0.0004141129],"genre_scores_gemma":[0.9959866,0.0029192762,0.000105373016,0.00024151395,0.00007651067,0.00010659069,0.0001502503,0.000035641217,0.0003782832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968465,0.0001453763,0.001563229,0.00064183737,0.0001301464,0.0006728841],"domain_scores_gemma":[0.998071,0.0000682074,0.0012109766,0.00033771258,0.00009463554,0.00021745835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028870867,0.00021269337,0.0009927975,0.0012080857,0.00018646354,0.00001772192,0.00013721365,0.00011935498,0.000051925304],"category_scores_gemma":[0.00007325008,0.00018353343,0.0001221829,0.0028319408,0.000089059766,0.00019825736,0.000043125183,0.0003313621,0.000037062775],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001621008,0.00010599822,0.9418629,0.0038235248,0.00016515338,0.0000064472906,0.011129971,0.0039263433,2.0946854e-7,0.000373674,0.00007103438,0.03837267],"study_design_scores_gemma":[0.0014031786,0.0012866976,0.8175146,0.0013151891,0.0000059607482,0.0000036367594,0.0013074876,0.1762904,0.000025087445,0.000058431524,0.0005865971,0.0002027618],"about_ca_topic_score_codex":0.054630566,"about_ca_topic_score_gemma":0.0044212937,"teacher_disagreement_score":0.17236404,"about_ca_system_score_codex":0.0008114225,"about_ca_system_score_gemma":0.00075267814,"threshold_uncertainty_score":0.95166475},"labels":[],"label_agreement":null},{"id":"W4380150246","doi":"10.1016/j.jval.2023.03.605","title":"EE304 Induction Cost per Responder of Biologic Therapies for Plaque Psoriasis in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada; Université de Montréal","funders":"","keywords":"Plaque psoriasis; Psoriasis; Medicine; Psoriasis Area and Severity Index; Induction therapy; Biologic Agents; Internal medicine; Dermatology; Chemotherapy","score_opus":0.5355696792310978,"score_gpt":0.43386758548700805,"score_spread":0.10170209374408973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94319516,0.0014326011,0.00018895506,0.05217182,0.0010461638,0.0014026841,0.0004481203,0.000022631715,0.000091850845],"genre_scores_gemma":[0.9935362,0.00091778865,0.00092332956,0.0039272266,0.00015301381,0.00032437415,0.00005888421,0.000024623392,0.00013457981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99533993,0.00054875825,0.0031833532,0.00039461837,0.00006804262,0.0004652828],"domain_scores_gemma":[0.9964963,0.0018760798,0.0012174952,0.00028433974,0.000035076908,0.00009071132],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016952373,0.00012462182,0.00078392174,0.0006540066,0.00007914105,0.000010803994,0.0001673394,0.00011259198,0.00007995676],"category_scores_gemma":[0.0019545315,0.00015135831,0.0000510006,0.00051765784,0.000029985878,0.00014151708,0.00002163684,0.00015516784,0.00007946267],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016180922,0.000117217205,0.8006109,0.0019589288,0.000053357053,0.0000014326425,0.00972096,0.03988295,0.000012681993,0.11783139,0.027678637,0.0019697535],"study_design_scores_gemma":[0.0024592043,0.00025989529,0.831894,0.0003038837,0.0000016632207,0.000002674119,0.010763519,0.028143283,0.000017555505,0.04161842,0.08408393,0.00045198662],"about_ca_topic_score_codex":0.9230221,"about_ca_topic_score_gemma":0.72121644,"teacher_disagreement_score":0.20180565,"about_ca_system_score_codex":0.0025516055,"about_ca_system_score_gemma":0.001976544,"threshold_uncertainty_score":0.667236},"labels":[],"label_agreement":null},{"id":"W4380150287","doi":"10.1016/j.jval.2023.03.2385","title":"PCR206 Effectiveness and Cost-Effectiveness of a Comprehensive Package Based on Electronic Medication Monitors at Improving Treatment Outcomes Among Tuberculosis Patients in Tibet: A Multi-Centre Randomised Controlled Trial","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Tuberculosis; Complement (music); Real world evidence; Physical therapy; Internal medicine","score_opus":0.042868138807674136,"score_gpt":0.3606872950935974,"score_spread":0.3178191562859233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98156697,0.00019924836,0.000029825218,0.00045367112,0.00016302167,0.017509902,0.000028078399,0.000042034037,0.000007237181],"genre_scores_gemma":[0.9968958,0.00052135094,0.00001990008,0.00007981701,0.000023472508,0.0022517506,0.00016828055,0.00003284626,0.0000067977817],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99161816,0.0058054724,0.00084975583,0.0005468979,0.00038390397,0.000795814],"domain_scores_gemma":[0.98785174,0.011166276,0.00029383085,0.00030164138,0.000106765096,0.00027971953],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033788942,0.00029855056,0.0018054813,0.0006945189,0.00008456368,0.000005667971,0.000071195565,0.0001835355,0.000006216497],"category_scores_gemma":[0.002559957,0.00021694232,0.00021620122,0.0004901569,0.00011585313,0.000047590824,0.000038071015,0.0002994545,0.00000589904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25692603,0.0012862008,0.73546886,0.0010137374,0.00014865017,0.000011615212,0.00019706278,0.0020473327,0.00038587174,0.0000063975303,0.0000048054067,0.0025034598],"study_design_scores_gemma":[0.41427603,0.002155097,0.5334373,0.00049838034,0.000032101325,3.2140565e-7,0.00004901092,0.04920692,0.00026175356,0.0000065197346,0.0000021301444,0.00007444289],"about_ca_topic_score_codex":0.01588021,"about_ca_topic_score_gemma":0.0005734913,"teacher_disagreement_score":0.20203154,"about_ca_system_score_codex":0.0019995633,"about_ca_system_score_gemma":0.00043186525,"threshold_uncertainty_score":0.9906731},"labels":[],"label_agreement":null},{"id":"W4380150317","doi":"10.1016/j.jval.2023.03.2446","title":"CO221 Efficacy and Safety of Personalized Topography-Guided-Lasik Laser Refractive Correction: A Targeted Literature Review","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Corneal surgery and disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"LASIK; Keratomileusis; Medicine; Refractive surgery; Optometry; Visual acuity; Ophthalmology; Laser; Patient safety; Optics; Cornea","score_opus":0.03878480766650315,"score_gpt":0.3296877372726271,"score_spread":0.29090292960612396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150317","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7187812,0.2436345,0.00002420248,0.030271184,0.0012503667,0.0029978354,0.000088691704,0.00024888452,0.0027031733],"genre_scores_gemma":[0.53915364,0.4524677,0.00020937403,0.0060418225,0.00013011393,0.000062846,0.00028948914,0.00003620328,0.0016088414],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.9984764,0.00029245755,0.0004944175,0.00027316363,0.00021199835,0.0002515548],"domain_scores_gemma":[0.9989089,0.00047057023,0.00016206363,0.00019511007,0.00009880291,0.00016458689],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009292574,0.00013368845,0.0005422608,0.00023823194,0.0000687889,0.0000057651614,0.000034491517,0.000080399936,0.00010176403],"category_scores_gemma":[0.00062934356,0.000115378,0.000107387954,0.0018249548,0.00006691366,0.000058113586,0.000021458492,0.00029116165,0.000008841824],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011870993,0.0021601478,0.22648787,0.06388624,0.0004931878,0.0007164686,0.019752158,0.000698552,0.00036317465,0.0019214739,0.4388325,0.23281723],"study_design_scores_gemma":[0.011573754,0.0018033246,0.5646673,0.076943874,0.00016539263,0.0004279604,0.0015017012,0.0023716139,0.00017369387,0.00056906405,0.33918464,0.0006177102],"about_ca_topic_score_codex":0.0004884739,"about_ca_topic_score_gemma":0.000014046326,"teacher_disagreement_score":0.33817938,"about_ca_system_score_codex":0.000059360995,"about_ca_system_score_gemma":0.00022365726,"threshold_uncertainty_score":0.47049785},"labels":[],"label_agreement":null},{"id":"W4380150346","doi":"10.1016/j.jval.2023.03.356","title":"EE51 A Cost-Consequence Analysis of Adopting Chimeric Antigen Receptor T-Cell Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma in Saudi Arabia: a Multi-Center Comparison","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"","keywords":"Chimeric antigen receptor; Refractory (planetary science); Lymphoma; Medicine; Referral; Oncology; Immunotherapy; Internal medicine; Family medicine; Cancer; Biology","score_opus":0.08135585999482925,"score_gpt":0.36770681570183034,"score_spread":0.2863509557070011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950861,0.00065663015,0.00016602788,0.00024343032,0.00010353714,0.0034788023,0.00016615154,0.00005975589,0.000039594517],"genre_scores_gemma":[0.9917783,0.0027646266,0.0037905574,0.00033880578,0.000030763822,0.0002474447,0.00042402963,0.000078067125,0.0005473695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962758,0.0005195214,0.001054357,0.00061843963,0.00062096503,0.0009109384],"domain_scores_gemma":[0.997735,0.00074487395,0.00051462505,0.0005571148,0.00021692405,0.00023141445],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018339432,0.0002723488,0.0011389205,0.0013501989,0.000089562964,0.0000145294725,0.00021447668,0.0001473888,0.00013958968],"category_scores_gemma":[0.00021141239,0.00021678039,0.00017934779,0.0038855362,0.00009146215,0.00007893178,0.000046788246,0.00033942232,0.00001498671],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0089187035,0.01132788,0.9516895,0.00079950667,0.00026229772,0.000028019442,0.0050010877,0.0009127382,0.0054308292,0.000001209123,0.00029944888,0.015328773],"study_design_scores_gemma":[0.117690556,0.008343038,0.7376749,0.0014062189,0.00010983627,0.0000036519943,0.00169439,0.11423219,0.0025708391,0.0000030376198,0.015664361,0.0006069654],"about_ca_topic_score_codex":0.0028852047,"about_ca_topic_score_gemma":0.00050016236,"teacher_disagreement_score":0.21401459,"about_ca_system_score_codex":0.0006974096,"about_ca_system_score_gemma":0.000911533,"threshold_uncertainty_score":0.8840048},"labels":[],"label_agreement":null},{"id":"W4380150563","doi":"10.1016/j.jval.2023.03.2452","title":"CO227 An Updated Umbrella Review Comparing the Safety and Effectiveness of Femtosecond Laser-Assisted Cataract Surgery with Manual Cataract Surgery","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Intraocular Surgery and Lenses","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Cataract surgery; Medicine; Surgery; Narrative review; Ophthalmology; Optometry; Intensive care medicine","score_opus":0.07885190400231591,"score_gpt":0.33674010799105175,"score_spread":0.25788820398873585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99087346,0.00670252,0.000006258087,0.0012407968,0.00019888488,0.00078996987,0.000043911063,0.0000690691,0.00007513614],"genre_scores_gemma":[0.98614216,0.011919559,0.00001428769,0.00082141213,0.000053371343,0.000019749845,0.00096366147,0.00003470219,0.000031079995],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99598324,0.001960057,0.00085480674,0.00039502888,0.00032198662,0.00048487599],"domain_scores_gemma":[0.9949417,0.0039022244,0.00034564902,0.00050839887,0.0001027189,0.00019931793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0085856505,0.00023433684,0.0013847696,0.00026976658,0.00016873404,0.000014304638,0.000080215985,0.00008113932,0.00003723959],"category_scores_gemma":[0.00029451196,0.00016085162,0.0001239745,0.0009616391,0.00015264524,0.0001283068,0.000033719483,0.00038610562,0.000013685046],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0038892822,0.0005265155,0.94191486,0.034572337,0.0002545508,0.0007291558,0.0005867619,0.0005056537,0.00019055598,0.00015705016,0.003805807,0.012867502],"study_design_scores_gemma":[0.0005080406,0.00017024306,0.9807149,0.012547911,0.00007292051,0.00031551492,0.00013979417,0.0006370423,0.00067758287,0.000009707481,0.00400215,0.00020415761],"about_ca_topic_score_codex":0.006246111,"about_ca_topic_score_gemma":0.00024173476,"teacher_disagreement_score":0.038800105,"about_ca_system_score_codex":0.00009941333,"about_ca_system_score_gemma":0.00075046805,"threshold_uncertainty_score":0.9442293},"labels":[],"label_agreement":null},{"id":"W4380150585","doi":"10.1016/j.jval.2023.03.209","title":"CO136 Efficacy and Safety of Roflumilast Cream 0.15% in Adults and Children Aged 6 and Older with Mild to Moderate Atopic Dermatitis in Two Phase 3 Integument Trials","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Probity Medical Research; Queen's University","funders":"","keywords":"Roflumilast; Atopic dermatitis; Medicine; Dermatology; Internal medicine","score_opus":0.030405791412619995,"score_gpt":0.3500039181887003,"score_spread":0.3195981267760803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150585","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912933,0.0027399724,0.00001450381,0.0042149564,0.00002913305,0.0016232227,0.000047066995,0.000019436218,0.000018387433],"genre_scores_gemma":[0.99699396,0.0018286646,0.00017266684,0.0008672293,0.000017136737,0.000047655925,0.0000433616,0.000012309911,0.000016991877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817723,0.00047021938,0.00067670154,0.00028492927,0.00012619124,0.00026472367],"domain_scores_gemma":[0.99910724,0.00042130644,0.00010811749,0.00014486874,0.000017449518,0.00020100414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008813236,0.00014153696,0.00073979085,0.0003512154,0.000041137002,0.000008375086,0.000035221954,0.000053427702,0.000009810999],"category_scores_gemma":[0.00029498336,0.000116204974,0.000016443633,0.00033516085,0.00008457418,0.000055265195,0.000042052037,0.0001701595,0.000001335446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036084128,0.0007592574,0.97645104,0.0011204294,0.00004524148,0.00014552899,0.0076408545,0.00045169718,0.000017201377,0.00007800687,0.0014976285,0.008184686],"study_design_scores_gemma":[0.029275304,0.00038583198,0.9650646,0.002910651,0.000016015638,0.000065058346,0.00027386032,0.0016620182,0.00013079513,0.000099516095,0.00002002251,0.000096347074],"about_ca_topic_score_codex":0.0031501048,"about_ca_topic_score_gemma":0.0010120551,"teacher_disagreement_score":0.02566689,"about_ca_system_score_codex":0.00004245971,"about_ca_system_score_gemma":0.00013407285,"threshold_uncertainty_score":0.47620374},"labels":[],"label_agreement":null},{"id":"W4380150610","doi":"10.1016/j.jval.2023.03.106","title":"CO32 Heterotopic Ossification in Palovarotene-Treated and Untreated Individuals with Fibrodysplasia Ossificans Progressiva: Matched and Weighted Analyses","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Heterotopic Ossification and Related Conditions","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Fibrodysplasia ossificans progressiva; Heterotopic ossification; Medicine; Ossification; Heterotopic bone; Myositis ossificans; Surgery","score_opus":0.06962022869461355,"score_gpt":0.35814500665615673,"score_spread":0.2885247779615432,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9907337,0.00047610825,0.000020176305,0.0065899086,0.000028279292,0.0018326419,0.000021160728,0.00017304035,0.00012498246],"genre_scores_gemma":[0.9975522,0.00086191326,0.00051758706,0.00013513473,0.000022576223,0.00031216015,0.00022172568,0.000023840508,0.000352849],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981226,0.0002445796,0.00057624734,0.00046041934,0.00021814893,0.00037802372],"domain_scores_gemma":[0.9991148,0.00012890482,0.00017100219,0.00029836065,0.000055434306,0.00023147555],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029704213,0.00019720092,0.00043395793,0.00070779916,0.00012528828,0.00004565535,0.000055847195,0.00017654203,0.000026688576],"category_scores_gemma":[0.00005583041,0.00014909594,0.000024291568,0.0014576981,0.000154106,0.00008700263,0.000019568906,0.00029699015,0.00001574619],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009032341,0.00023522602,0.9881534,0.0006097712,0.00009782235,0.0001311818,0.0023946024,0.000106193904,0.0024928567,0.00041960325,0.00006153169,0.005207495],"study_design_scores_gemma":[0.003222436,0.00030610798,0.986372,0.000966058,0.00003841996,0.00007463992,0.00042478222,0.0068808272,0.00093085034,0.00018651695,0.00043927366,0.00015812089],"about_ca_topic_score_codex":0.0013678975,"about_ca_topic_score_gemma":0.00006782745,"teacher_disagreement_score":0.006818511,"about_ca_system_score_codex":0.00012278986,"about_ca_system_score_gemma":0.00020602746,"threshold_uncertainty_score":0.6079956},"labels":[],"label_agreement":null},{"id":"W4380150642","doi":"10.1016/j.jval.2023.03.2490","title":"EE511 Modeling Approaches in the Cost-Effectiveness Analysis of Cancer Treatments: A Review of Submissions Made to the Canadian Agency for Drugs and Technologies in Health","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Agency (philosophy); Cancer drugs; Health technology; Medicine; Cancer; Risk analysis (engineering); Medical physics; Health care; Internal medicine; Political science; Sociology","score_opus":0.7904782343008674,"score_gpt":0.5436824659390989,"score_spread":0.24679576836176853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150642","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038347766,0.95442134,0.00015193099,0.031318616,0.00009455132,0.011556219,0.002039984,0.000012058165,0.000021794789],"genre_scores_gemma":[0.001483457,0.98994017,0.0003649969,0.0012663924,0.000020490976,0.006750785,0.00012469075,0.00003530213,0.0000137000825],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98967564,0.0024210198,0.006478187,0.00069060165,0.00011694711,0.00061762583],"domain_scores_gemma":[0.9930726,0.003145723,0.0028548455,0.00074854214,0.00003795045,0.0001403174],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.050882917,0.0002962497,0.004507984,0.0026276996,0.00016509088,0.000019691448,0.0005488477,0.00022042614,0.0000056894924],"category_scores_gemma":[0.0033605816,0.0002324513,0.0003034837,0.0034447764,0.00005239579,0.00007018979,0.000056559024,0.00035641884,0.000005137629],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000093163335,0.00018223183,0.005704192,0.6059783,0.0007060144,7.743029e-7,0.009884311,0.047332373,1.3729701e-9,0.023967816,0.00040128504,0.30583337],"study_design_scores_gemma":[0.0012527793,0.00037166712,0.006954808,0.41443,0.00058075186,0.0000029871467,0.007539873,0.16383581,3.236327e-8,0.0072253766,0.3967612,0.0010446953],"about_ca_topic_score_codex":0.7301794,"about_ca_topic_score_gemma":0.40579686,"teacher_disagreement_score":0.39635992,"about_ca_system_score_codex":0.0039981394,"about_ca_system_score_gemma":0.0034809483,"threshold_uncertainty_score":0.99982536},"labels":[],"label_agreement":null},{"id":"W4380150697","doi":"10.1016/j.jval.2023.03.347","title":"EE41 Cost-Utility of Nivolumab Versus Observation for the Adjuvant Treatment of Urothelial Carcinoma (UC) for Patients Who Are at High-Risk of Recurrence: A Canada Public Payer Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada); McGill University Health Centre","funders":"","keywords":"Nivolumab; Medicine; Urothelial carcinoma; Adjuvant; Perspective (graphical); Oncology; Internal medicine; Cancer; Immunotherapy; Bladder cancer; Computer science","score_opus":0.46517240906319957,"score_gpt":0.4034397641697604,"score_spread":0.06173264489343916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96884096,0.0015429198,0.00028024416,0.01152805,0.0010861844,0.004402122,0.012290369,0.000008904505,0.000020255944],"genre_scores_gemma":[0.9979784,0.00059620145,0.00029545178,0.00016952428,0.00008775756,0.0006397643,0.00015033886,0.00002150585,0.000061082355],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.995637,0.00040225583,0.002948988,0.00043214267,0.00014534782,0.00043424917],"domain_scores_gemma":[0.99130654,0.004015514,0.0037108446,0.00047640403,0.0003834032,0.00010727778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006325928,0.00015845327,0.001076298,0.00021673036,0.00020038348,0.000007752624,0.0002019253,0.00008662371,0.000023131308],"category_scores_gemma":[0.005407698,0.00015830326,0.00014240968,0.000363509,0.000070272225,0.00011807854,0.000032338776,0.0000665016,0.0000040704344],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046162307,0.0002687867,0.972493,0.0010941855,0.00009726508,6.324715e-8,0.0047353404,0.0017190127,1.3776474e-7,0.011935257,0.0055141766,0.0016811696],"study_design_scores_gemma":[0.0054668174,0.0011456535,0.9122047,0.000104913604,0.000013624067,7.845645e-8,0.0035653822,0.0696911,0.000012169292,0.0025066636,0.005150533,0.00013839979],"about_ca_topic_score_codex":0.7775515,"about_ca_topic_score_gemma":0.33240426,"teacher_disagreement_score":0.44514722,"about_ca_system_score_codex":0.003591715,"about_ca_system_score_gemma":0.001739719,"threshold_uncertainty_score":0.9392209},"labels":[],"label_agreement":null},{"id":"W4380150699","doi":"10.1016/j.jval.2023.03.374","title":"EE69 Extended Cost-Effectiveness Analysis of Varenicline for Smoking Cessation in Patients with Chronic Obstructive Pulmonary Disease in Thailand","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Public Health Policies and Epidemiology","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Varenicline; Medicine; COPD; Pulmonary disease; Smoking cessation; Disease; Internal medicine; Physical therapy; Intensive care medicine; Environmental health; Pathology","score_opus":0.04764366028635881,"score_gpt":0.33184384341611556,"score_spread":0.28420018312975676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150699","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592507,0.000091542635,0.00015429198,0.0020785085,0.00015864766,0.0014477813,0.00005833494,0.000027919337,0.00005791379],"genre_scores_gemma":[0.9985211,0.000032811266,0.000023384535,0.00057253015,0.00008755145,0.00022369296,0.0005225439,0.000014094794,0.0000023062864],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998086,0.00018187688,0.00066425273,0.000333985,0.00017045587,0.00056344667],"domain_scores_gemma":[0.99878335,0.00050029694,0.00039590418,0.00017870285,0.0001048904,0.00003687344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021926872,0.00013653447,0.0005399295,0.0013234576,0.000061189785,0.000014983598,0.000121226374,0.00006467923,0.000007245382],"category_scores_gemma":[0.000536579,0.00012071384,0.000057897767,0.0035204277,0.000036187,0.0003259519,0.000063572064,0.00012880607,0.0000014526214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022976269,0.00008768953,0.6656162,0.0007756743,0.000018495972,0.0000015322264,0.000029014844,0.32958433,1.5103271e-7,0.0016854176,0.000038807524,0.0019329265],"study_design_scores_gemma":[0.0009896152,0.00002581238,0.66206753,0.00013853307,0.00002287451,1.552559e-8,0.000042478925,0.33460435,5.2467556e-8,0.0012484019,0.00079026265,0.000070034774],"about_ca_topic_score_codex":0.078826435,"about_ca_topic_score_gemma":0.0028376842,"teacher_disagreement_score":0.07598875,"about_ca_system_score_codex":0.0004727222,"about_ca_system_score_gemma":0.0001757971,"threshold_uncertainty_score":0.9273077},"labels":[],"label_agreement":null},{"id":"W4380150724","doi":"10.1016/j.jval.2023.03.166","title":"CO93 A Qualitative Investigation of the Impact of the Sars-Cov-2 Pandemic on Goal Attainment Scaling in a Clinical Research Setting","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Resilience and Mental Health","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Goal Attainment Scaling; Medicine; Virology; Disease; Physical therapy; Internal medicine; Infectious disease (medical specialty)","score_opus":0.48801306908659803,"score_gpt":0.6483330795490284,"score_spread":0.16032001046243038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150724","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956292,0.00007731677,0.0000012980666,0.0028037135,0.000246879,0.0010073854,0.000017974418,0.000009240785,0.00020700044],"genre_scores_gemma":[0.9993821,0.000069700865,0.00002242685,0.00040650278,0.000037975024,0.000039309394,0.000002567188,0.000010549565,0.00002890222],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9887376,0.008848601,0.0011092552,0.00028657302,0.00050376233,0.00051422516],"domain_scores_gemma":[0.9962926,0.002830238,0.0003704601,0.00039824325,0.00004970395,0.00005876649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019936772,0.00008646067,0.00027739818,0.00020723,0.00010602235,0.0000039558663,0.00029121997,0.000103964056,0.0000038340618],"category_scores_gemma":[0.0009222943,0.000051287127,0.00010006832,0.0016847503,0.0003405018,0.00003136868,0.000096242096,0.00075569446,0.000018462439],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021812598,0.00017150427,0.87484336,0.00019168874,0.000010324069,0.0000016667104,0.11391594,0.0016055532,0.0011562967,0.0016159547,0.001093223,0.0051763873],"study_design_scores_gemma":[0.0007476554,0.00066603284,0.96971077,0.0010869344,9.488018e-7,0.0000021580436,0.020315398,0.002218859,0.00047114075,0.004725515,0.000008942498,0.000045649096],"about_ca_topic_score_codex":0.03973293,"about_ca_topic_score_gemma":0.00053514645,"teacher_disagreement_score":0.09486744,"about_ca_system_score_codex":0.00059204525,"about_ca_system_score_gemma":0.001015028,"threshold_uncertainty_score":0.9666616},"labels":[],"label_agreement":null},{"id":"W4380150835","doi":"10.1016/j.jval.2023.03.2238","title":"SA22 The Complexity Of Finding Fit-For-Purpose Real-World Data on Oncology Patients with Rare NTRK Gene Fusions and a Novel Solution","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada); Thermo Fisher Scientific (Canada)","funders":"","keywords":"Real world data; Fusion gene; Gene; Solid tumor; Oncology; Internal medicine; Clinical trial; Bioinformatics; Medicine; Cancer research; Computational biology; Biology; Computer science; Data science; Genetics; Cancer","score_opus":0.18076789470356933,"score_gpt":0.36776784074736274,"score_spread":0.1869999460437934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995274,0.00011254461,0.00045400203,0.0018321417,0.000126426,0.0005704141,0.0015656457,0.0000054733096,0.000059347858],"genre_scores_gemma":[0.9953492,0.0010086406,0.001740192,0.00041177563,0.00008992739,0.000024418458,0.0013405577,0.000013424023,0.000021817357],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991884,0.00005442952,0.0002119728,0.00026036,0.00007723436,0.00020758044],"domain_scores_gemma":[0.999211,0.00014966866,0.0001468213,0.00039775454,0.00004113345,0.00005362936],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040883446,0.00007889498,0.00015086094,0.00006154433,0.00012946375,0.0000066683942,0.00016243414,0.000040959425,0.000001067343],"category_scores_gemma":[0.00013693364,0.00006134657,0.000015776553,0.00017248899,0.00013747232,0.000001980327,0.0002206762,0.00006826941,5.899521e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0068768053,0.0035002697,0.6223471,0.0017013358,0.00039228733,0.000014049624,0.0035376148,0.0701581,0.05436709,0.055480655,0.068457864,0.113166794],"study_design_scores_gemma":[0.0053083748,0.004326864,0.90880865,0.00022885398,0.00003436626,0.0000040325067,0.00023500348,0.027077664,0.0020910222,0.0012109701,0.05030247,0.00037174913],"about_ca_topic_score_codex":0.0034388672,"about_ca_topic_score_gemma":0.006317536,"teacher_disagreement_score":0.2864615,"about_ca_system_score_codex":0.000060409613,"about_ca_system_score_gemma":0.00027964538,"threshold_uncertainty_score":0.51985615},"labels":[],"label_agreement":null},{"id":"W4380150846","doi":"10.1016/j.jval.2023.03.646","title":"EE345 Strengths and Limitations of Different Costing Approaches Used for Hospital Budget Impact Models: Application to Imaging Guidance in Left Atrial Appendage Occlusion Procedures","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Activity-based costing; Strengths and weaknesses; Reimbursement; Left atrial appendage occlusion; Occlusion; Medicine; Medical physics; Computer science; Operations management; Business; Surgery; Atrial fibrillation; Engineering; Economics; Psychology; Accounting; Cardiology","score_opus":0.3384203410352223,"score_gpt":0.4207580905936663,"score_spread":0.08233774955844403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9587951,0.0015029475,0.016408717,0.01917009,0.00018602143,0.0033605993,0.00044504754,0.00005232784,0.00007916978],"genre_scores_gemma":[0.99551183,0.0002830476,0.003522946,0.00031204915,0.00011836286,0.00008320949,0.0001240836,0.00003365848,0.000010833713],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9956489,0.00024016491,0.0029666515,0.0005758629,0.000095879586,0.0004725212],"domain_scores_gemma":[0.99481994,0.0034051244,0.0012892775,0.0002820405,0.00003859003,0.00016503531],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009224805,0.00017973897,0.00076836336,0.00069730147,0.00014476944,0.00004114837,0.00017542268,0.00007664043,0.0000024910198],"category_scores_gemma":[0.0068687983,0.00021756129,0.000089945475,0.00034664775,0.00003146256,0.00031257758,0.00007278613,0.00012749224,0.00001594453],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006729432,0.00020467934,0.53744847,0.002592405,0.000026933256,4.0885246e-7,0.026529167,0.37896112,0.000018595701,0.049410935,0.0013506189,0.0033893576],"study_design_scores_gemma":[0.0010611973,0.0001459145,0.13303751,0.0002986718,0.0000020666992,9.001648e-7,0.001938362,0.83567756,0.000005649056,0.027413951,0.00020503509,0.00021317278],"about_ca_topic_score_codex":0.00347723,"about_ca_topic_score_gemma":0.0010863354,"teacher_disagreement_score":0.45671645,"about_ca_system_score_codex":0.000729347,"about_ca_system_score_gemma":0.00029246192,"threshold_uncertainty_score":0.8871892},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"opus","categories":[],"domain":null,"study_design":"simulation_or_modeling","genre":"methods","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W4380150848","doi":"10.1016/j.jval.2023.03.178","title":"CO105 The Association of Sars-Cov-2 Infection and Tuberculosis Disease with Unfavorable Treatment Outcomes: A Systematic Review","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Tuberculosis Research and Epidemiology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; University of British Columbia","funders":"","keywords":"Coinfection; Medicine; Tuberculosis; Disease; Disease management; Intensive care medicine; MEDLINE; Internal medicine; Human immunodeficiency virus (HIV); Immunology; Pathology","score_opus":0.18618067222810938,"score_gpt":0.44812224148817265,"score_spread":0.2619415692600633,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150848","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024506805,0.98572963,0.0000020355722,0.00569526,0.000058305584,0.008128113,0.00007129595,0.000039393148,0.000030867628],"genre_scores_gemma":[0.00005801649,0.99707067,0.000017839046,0.0009666238,0.00003520108,0.00148677,0.0001160469,0.000047019035,0.00020179711],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9935918,0.0035199446,0.001584882,0.0003921448,0.00043728677,0.0004739559],"domain_scores_gemma":[0.9952679,0.002787355,0.0010670399,0.0005965222,0.000092883274,0.00018825025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0046785497,0.00034901698,0.0046897586,0.0003009669,0.00008021438,0.000011111251,0.00008421843,0.00016081895,0.0000025390823],"category_scores_gemma":[0.004257342,0.00016360499,0.0003827258,0.0008420161,0.000046960587,0.000038412596,0.0000366886,0.00038799967,0.00004095391],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012813401,0.00013342171,0.011988509,0.98206866,0.0007374065,0.000011605522,0.00004340389,0.000004031418,1.8949923e-8,0.0000694619,0.0006262241,0.004304475],"study_design_scores_gemma":[0.00055013923,0.0007735346,0.0029214644,0.95440894,0.0040952973,0.000040429306,0.000010961819,0.00014832115,7.8318e-8,0.000032553962,0.03685604,0.00016226312],"about_ca_topic_score_codex":0.015536459,"about_ca_topic_score_gemma":0.0006664728,"teacher_disagreement_score":0.03622982,"about_ca_system_score_codex":0.0020617137,"about_ca_system_score_gemma":0.0012406496,"threshold_uncertainty_score":0.9910192},"labels":[],"label_agreement":null},{"id":"W4380150957","doi":"10.1016/j.jval.2023.03.472","title":"EE171 Time to Diagnosis and Cost Effectiveness of Whole Exome Sequencing (WES) Position in the Diagnostic Pathways of Patients with Suspected Rare Genetic Disease","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Children's Hospital; Children's Hospital of Eastern Ontario; University of Calgary; Institute for Clinical Evaluative Sciences; SickKids Foundation; University of Ottawa; Hospital for Sick Children","funders":"","keywords":"Exome sequencing; Diagnostic test; Genetic diagnosis; Medicine; Genetic testing; Exome; Rare disease; Disease; Diagnostic accuracy; DNA sequencing; Bioinformatics; Pediatrics; Pathology; Genetics; Mutation; Biology; Internal medicine; Gene","score_opus":0.014862761692949356,"score_gpt":0.24222299703425193,"score_spread":0.22736023534130256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978013,0.0006460432,0.000013765636,0.0000864621,0.000018562649,0.0010086596,0.00041645,0.0000041496783,0.000004597758],"genre_scores_gemma":[0.9990927,0.00021838049,0.00003573177,0.00008197423,0.000013157019,0.00015589836,0.00038693566,0.000013569868,0.000001641641],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99894464,0.0003196897,0.00021149918,0.00022328974,0.00011785484,0.0001830448],"domain_scores_gemma":[0.99933887,0.00024341811,0.0000767759,0.00019142129,0.000055179684,0.00009435403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028150663,0.000095759475,0.00015870034,0.00010079844,0.000034911,0.000007043602,0.000092124465,0.000034341225,0.0000024791893],"category_scores_gemma":[0.00024695433,0.00007436896,0.000025285213,0.00029350826,0.00003567674,0.0000029678897,0.000050792347,0.000039873667,0.000002762166],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042312665,0.0003211359,0.9593698,0.0008929529,0.000018161338,0.00004371107,0.00049351825,0.025522398,0.0117916055,0.000024270632,0.00006665732,0.0010326906],"study_design_scores_gemma":[0.0006683486,0.0005085665,0.9967151,0.0003680199,0.00000908367,9.004915e-7,0.00007994265,0.00027421972,0.001178299,0.00008550434,0.00002686093,0.00008514883],"about_ca_topic_score_codex":0.00036938908,"about_ca_topic_score_gemma":0.000035289155,"teacher_disagreement_score":0.037345335,"about_ca_system_score_codex":0.000046731417,"about_ca_system_score_gemma":0.00017559863,"threshold_uncertainty_score":0.3032678},"labels":[],"label_agreement":null},{"id":"W4380150987","doi":"10.1016/j.jval.2023.03.1581","title":"MSR45 Identifying Longitudinal Treatment Effect Trajectories Using Flexible Outcome Modeling and Clustering","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Outcome (game theory); Cluster analysis; Interpretation (philosophy); Computer science; Longitudinal data; Treatment effect; Longitudinal study; Statistical power; Econometrics; Data mining; Artificial intelligence; Statistics; Medicine; Mathematics","score_opus":0.5678470637420231,"score_gpt":0.5187338618576554,"score_spread":0.04911320188436774,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380150987","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8420736,0.00027743643,0.15626061,0.00007114677,0.00014870732,0.00053154357,0.0000045292827,0.00060094934,0.000031434804],"genre_scores_gemma":[0.9513351,0.00026187056,0.048185248,0.000014329913,0.000059356993,0.000053112653,0.0000030893502,0.00004543779,0.000042513293],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99824405,0.00017254059,0.00057517446,0.00032890635,0.00019044991,0.00048885826],"domain_scores_gemma":[0.9989124,0.00059463916,0.00013066572,0.0002452234,0.00002159171,0.00009549227],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011669454,0.00022599619,0.00049775565,0.00030141714,0.00018054333,0.000050953386,0.0000834506,0.00007225632,0.0000036083436],"category_scores_gemma":[0.00025660446,0.00019759455,0.000053196218,0.000407139,0.00002905044,0.00021531225,0.000091678856,0.00016208686,0.0000038771327],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018035724,0.00021130596,0.26413888,0.008840149,0.00011334482,0.00018874391,0.011879824,0.6575922,0.0033121898,0.030165546,0.000025307509,0.023352193],"study_design_scores_gemma":[0.00051921967,0.0003724899,0.00081601186,0.0008185295,0.000019100582,0.000029175515,0.00031220962,0.9184168,0.0011992137,0.07723133,0.000008058856,0.00025784565],"about_ca_topic_score_codex":0.0030018734,"about_ca_topic_score_gemma":0.0001579938,"teacher_disagreement_score":0.2633229,"about_ca_system_score_codex":0.0006440785,"about_ca_system_score_gemma":0.00006970979,"threshold_uncertainty_score":0.8057672},"labels":[],"label_agreement":null},{"id":"W4380151004","doi":"10.1016/j.jval.2023.03.1434","title":"HTA5 Variation in Health Technology Assessments for Nivolumab Plus Chemotherapy Vs Chemotherapy in First-Line Gastric Cancer","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Reimbursement; Nivolumab; Medicine; Chemotherapy; Cancer; Oncology; First line; Internal medicine; Political science; Health care","score_opus":0.33470217407681796,"score_gpt":0.46869174006400766,"score_spread":0.1339895659871897,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151004","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5567247,0.003976274,0.008790574,0.4239402,0.0011153098,0.004823691,0.00036198468,0.00018422939,0.000082974875],"genre_scores_gemma":[0.92654747,0.021397438,0.012052773,0.035486497,0.0005617661,0.0029300984,0.0001715386,0.00019041599,0.00066202536],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.991992,0.00042534037,0.005397494,0.00091133657,0.00013252838,0.0011413222],"domain_scores_gemma":[0.9960387,0.0008500461,0.0023723645,0.0005235659,0.000045054425,0.00017027785],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.022125402,0.00027583714,0.0015613334,0.002608955,0.00016716513,0.000039271,0.000360812,0.00029698058,0.0001146745],"category_scores_gemma":[0.00088673766,0.00038379722,0.00008341458,0.0023999154,0.00004033361,0.00028087888,0.000037276102,0.00039329208,0.00014827789],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051576813,0.0009840813,0.6673868,0.006743855,0.000089815636,0.00000411769,0.012617976,0.21930718,0.000004524431,0.062023427,0.015519005,0.014803468],"study_design_scores_gemma":[0.011746354,0.0007465675,0.36360103,0.0009068073,0.0000010240743,0.0000030388376,0.00070076744,0.54177445,0.0000023279993,0.04126215,0.038750414,0.0005050732],"about_ca_topic_score_codex":0.059745293,"about_ca_topic_score_gemma":0.008891601,"teacher_disagreement_score":0.38845372,"about_ca_system_score_codex":0.0072942954,"about_ca_system_score_gemma":0.0016893728,"threshold_uncertainty_score":0.9998614},"labels":[],"label_agreement":null},{"id":"W4380151031","doi":"10.1016/j.jval.2023.03.761","title":"EE460 A Budget Impact Model to Evaluate the Economic Impact of Treating Walking Impairment in Chronic Stroke, A US Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Reimbursement; Perspective (graphical); Chronic stroke; Rehabilitation; Stroke (engine); Physical medicine and rehabilitation; Economic impact analysis; Medicine; Physical therapy; Economics; Economic growth; Computer science; Engineering; Health care","score_opus":0.29192499509371406,"score_gpt":0.476929972208334,"score_spread":0.18500497711461994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151031","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98418,0.0016084526,0.00026843548,0.010056434,0.00020858184,0.0022609967,0.00075988064,0.000053802254,0.0006034397],"genre_scores_gemma":[0.9975824,0.0003735796,0.00054091564,0.00084128394,0.0001980286,0.0002851467,0.0000196727,0.000060709375,0.000098313474],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9921123,0.0010211976,0.0047297836,0.00081752916,0.00015486068,0.0011643644],"domain_scores_gemma":[0.9958558,0.001438817,0.0015903326,0.0007545568,0.000053375483,0.00030713153],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.03191851,0.00033781867,0.0014957564,0.0014311589,0.00017941983,0.00006430112,0.00044734814,0.00012832579,0.00014196764],"category_scores_gemma":[0.0016053917,0.00032723637,0.0003640543,0.00078256725,0.000055340544,0.00033171123,0.00012477709,0.0003691811,0.00064019434],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004768061,0.00004346122,0.065185115,0.00018770613,0.00006653232,0.000001066489,0.015190396,0.9108596,0.0000068004783,0.0070436937,0.0012164428,0.00015152103],"study_design_scores_gemma":[0.0012075233,0.0006322086,0.17517112,0.00025246633,0.0000029933349,0.0000033161175,0.0020914997,0.81071496,0.0000024475407,0.009652503,0.00003331449,0.0002356574],"about_ca_topic_score_codex":0.23481849,"about_ca_topic_score_gemma":0.004595117,"teacher_disagreement_score":0.23022337,"about_ca_system_score_codex":0.04320144,"about_ca_system_score_gemma":0.005081279,"threshold_uncertainty_score":0.999918},"labels":[],"label_agreement":null},{"id":"W4380151052","doi":"10.1016/j.jval.2023.03.145","title":"CO71 The Impact of Socioeconomic Status (SES), Insurance Type, and Treatment Facility on Survival in Metastatic Prostate Cancer (MPC): A Systematic Literature Review (SLR) of Social Determinants of Health (SDOH)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Cutaneous Melanoma Detection and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Melanoma; Nevus; Medicine; Blue nevus; Dermatology; Malignancy; Pathology; Cancer research","score_opus":0.05854703843497897,"score_gpt":0.37991226960415453,"score_spread":0.32136523116917554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151052","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96665466,0.028921323,3.6803684e-7,0.0007820273,0.00009342308,0.003083664,0.00044067632,0.00001034069,0.000013516586],"genre_scores_gemma":[0.9144416,0.085251726,0.000008242071,0.000103861894,0.0000069701337,0.0000851022,0.000017680939,0.000009461135,0.00007537418],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99744505,0.0007957246,0.0010935853,0.00020411199,0.00017676137,0.00028479606],"domain_scores_gemma":[0.998749,0.0002165326,0.0006793703,0.00022068259,0.00006520961,0.00006921509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016480101,0.00015375478,0.0012325249,0.00018564244,0.000040636172,0.000004489413,0.000047254412,0.000029637818,0.0000112135685],"category_scores_gemma":[0.00011617775,0.000096119365,0.00009434474,0.00052849215,0.000059476668,0.000023531782,0.000019222554,0.000120533965,0.000002579597],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015086195,0.0009220645,0.26491258,0.657418,0.00041360108,0.000073958945,0.030537542,0.0016785114,0.000052916203,0.00011890826,0.0004221629,0.04194112],"study_design_scores_gemma":[0.0038886217,0.0051535293,0.90859133,0.07697652,0.000088066205,0.000041931467,0.0021988414,0.002642042,0.00004086662,0.00006639778,0.00012437894,0.00018748577],"about_ca_topic_score_codex":0.012580195,"about_ca_topic_score_gemma":0.0011809705,"teacher_disagreement_score":0.6436788,"about_ca_system_score_codex":0.00068787637,"about_ca_system_score_gemma":0.0007325642,"threshold_uncertainty_score":0.99399513},"labels":[],"label_agreement":null},{"id":"W4380151155","doi":"10.1016/j.jval.2023.03.727","title":"EE426 A Comparison of the Cost-Saving Impact of Biosimilar Switching Policies across Canadian Provinces: A Case-Study for a Ranibizumab Biosimilar","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Biosimilar; Ranibizumab; Business; Plan (archaeology); Medicine; Public economics; Economics; Internal medicine; Geography","score_opus":0.5020097557805653,"score_gpt":0.5113061537833411,"score_spread":0.009296398002775819,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.980926,0.0009011708,0.0001130873,0.010848691,0.0003894274,0.00480782,0.0019341847,0.000034906243,0.0000447534],"genre_scores_gemma":[0.9981835,0.00004147087,0.00028863084,0.0010830257,0.000090059744,0.00023896672,0.000012586232,0.000045057874,0.000016725158],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99276006,0.00066901546,0.004973904,0.0005044481,0.00013051534,0.00096203503],"domain_scores_gemma":[0.9943587,0.0016097001,0.0029508104,0.0007048497,0.00008868917,0.00028723688],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021168584,0.00023737416,0.0015145532,0.00071327295,0.0005227149,0.000052202824,0.0004527507,0.0001375625,0.000013389803],"category_scores_gemma":[0.0031869705,0.00023531423,0.00027329184,0.0010477133,0.000076909804,0.0002057157,0.0000844746,0.00024836013,0.00001968461],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000297429,0.00024320239,0.86476594,0.0015256323,0.000095982105,0.000005188588,0.098246105,0.03058851,0.000005503813,0.0014642046,0.0026244638,0.00040555216],"study_design_scores_gemma":[0.0042989403,0.0012748468,0.5363943,0.0011095275,0.000017433375,0.000060015907,0.122420415,0.32852805,0.000022337126,0.0023155094,0.002872756,0.00068585016],"about_ca_topic_score_codex":0.88980985,"about_ca_topic_score_gemma":0.49113393,"teacher_disagreement_score":0.39867595,"about_ca_system_score_codex":0.0025463444,"about_ca_system_score_gemma":0.0023591712,"threshold_uncertainty_score":0.9595836},"labels":[],"label_agreement":null},{"id":"W4380151340","doi":"10.1016/j.jval.2023.03.1155","title":"HPR8 Accelerating Access to Promising New Pediatric Medicines in Canada: Comparing International Approaches to Regulation and Reimbursement","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Reimbursement; Relevance (law); Public economics; Access to medicines; Business; Risk analysis (engineering); Medicine; Economic growth; Health care; Political science; Economics; Public health; Nursing","score_opus":0.5678122409767149,"score_gpt":0.4430175279265617,"score_spread":0.12479471305015322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151340","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8822052,0.00041844824,0.000060598024,0.115869984,0.0002703602,0.00065473747,0.0000010152072,0.000023911587,0.00049576454],"genre_scores_gemma":[0.9958023,0.0003343189,0.0010251945,0.002356467,0.00040372374,0.000023518445,0.0000068164404,0.000010252596,0.000037406062],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987886,0.000062133884,0.00037486418,0.0002230065,0.00029392348,0.00025749652],"domain_scores_gemma":[0.99937725,0.00021505335,0.00007663137,0.00006777594,0.000017184686,0.00024611558],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008028972,0.000080802965,0.00022179303,0.00021202741,0.00006449611,0.000030336148,0.00007623143,0.000016291373,0.000011803447],"category_scores_gemma":[0.0003739222,0.00007243784,0.000007472819,0.0006335366,0.0000043851055,0.0001098398,0.00013735505,0.00015446065,0.0000027653205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000110894696,0.000022356291,0.9435677,0.00029372537,0.0000106779335,0.000013103508,0.0014721872,0.020285692,0.000018913228,0.00010772003,0.004699852,0.029397214],"study_design_scores_gemma":[0.000718812,0.00005642311,0.92055845,0.000264361,0.000008242,0.000003848344,0.000614679,0.07328941,0.000024898665,0.000080753634,0.0043071243,0.000073012525],"about_ca_topic_score_codex":0.67358154,"about_ca_topic_score_gemma":0.35547474,"teacher_disagreement_score":0.3181068,"about_ca_system_score_codex":0.00064537633,"about_ca_system_score_gemma":0.00064220536,"threshold_uncertainty_score":0.6562862},"labels":[],"label_agreement":null},{"id":"W4380151393","doi":"10.1016/j.jval.2023.03.119","title":"CO45 Durability of Efficacy and Safety of Roflumilast Cream 0.3% in Adults with Chronic Plaque Psoriasis from a 52-Week, Phase 2 Open-Label Safety Trial","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Probity Medical Research; University of British Columbia; Queen's University","funders":"","keywords":"Roflumilast; Open label; Medicine; Psoriasis; Dermatology Life Quality Index; Plaque psoriasis; Safety profile; Adverse effect; Psoriasis Area and Severity Index; Body surface area; Dermatology; Internal medicine","score_opus":0.136141081805109,"score_gpt":0.428183312101855,"score_spread":0.29204223029674603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9873383,0.002086248,0.000011372137,0.0069039916,0.00016730661,0.0028649147,0.00029133854,0.000022706241,0.00031379133],"genre_scores_gemma":[0.9874866,0.011780634,0.00028384812,0.00017537094,0.00013286377,0.000050381732,0.000058997328,0.000018344826,0.0000129874325],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.997176,0.0005575224,0.0010911797,0.00044651525,0.00032515894,0.00040362694],"domain_scores_gemma":[0.996327,0.0026768728,0.00038267352,0.00031769378,0.00006643371,0.00022933254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002228781,0.00018441246,0.0009856359,0.00011321295,0.000082181105,0.000008215595,0.00015565356,0.00009639318,0.000083906336],"category_scores_gemma":[0.0010543747,0.00014422263,0.000031448897,0.00076200784,0.00019041893,0.0001298917,0.00017517319,0.00042976462,0.000004183835],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8775389,0.016067343,0.017572666,0.0035691203,0.00027893242,0.00007056203,0.0049381703,0.00047160554,0.0003046825,0.00030349533,0.00043066507,0.078453854],"study_design_scores_gemma":[0.7539229,0.030951286,0.18563034,0.005025482,0.0001524167,0.000010215071,0.0011035635,0.011327858,0.00060318626,0.00022064355,0.010709105,0.00034302304],"about_ca_topic_score_codex":0.035302404,"about_ca_topic_score_gemma":0.0023091177,"teacher_disagreement_score":0.16805768,"about_ca_system_score_codex":0.00031115056,"about_ca_system_score_gemma":0.0007013559,"threshold_uncertainty_score":0.9711216},"labels":[],"label_agreement":null},{"id":"W4380151448","doi":"10.1016/j.jval.2023.03.1648","title":"MT1 Challenges and Opportunities with Quantifying Comprehensive Health Economics of Diagnostic Imaging Modalities Using Radiopharmaceuticals: A Case Study in Coronary Artery Disease","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Coronary artery disease; Modalities; Positron emission tomography; Myocardial perfusion imaging; Medicine; Medical physics; Single-photon emission computed tomography; Emission computed tomography; CAD; Radiology; Internal medicine; Engineering","score_opus":0.3610492235762827,"score_gpt":0.4122719971330515,"score_spread":0.0512227735567688,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151448","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9369666,0.056268327,0.000015067392,0.0053699748,0.00014397048,0.0011024817,0.000065216394,0.00005843493,0.000009934695],"genre_scores_gemma":[0.9601921,0.03867658,0.00019121553,0.00078772864,0.00005475457,0.000037816062,0.000017250488,0.000040031795,0.0000025294441],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977921,0.000507872,0.00067861035,0.0003657998,0.00016643081,0.0004891409],"domain_scores_gemma":[0.99612004,0.0029569124,0.00018059759,0.00026928916,0.000057988564,0.0004151937],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009935633,0.00021202335,0.00076571864,0.0005476763,0.00009469365,0.000018090079,0.000040060684,0.000022899492,0.000001213082],"category_scores_gemma":[0.00028199257,0.00021194608,0.0000428585,0.00016886997,0.00018536026,0.00011698291,0.00007063618,0.00024599573,6.4860154e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040238732,0.00067373074,0.8865776,0.0059114234,0.00008688915,0.029385364,0.02886293,0.023732748,0.000002003639,0.00058669393,0.000029335493,0.023748895],"study_design_scores_gemma":[0.005920864,0.0006913942,0.6219958,0.0042415345,0.000109161505,0.005339379,0.20006944,0.16092478,0.0000020669538,0.00025913605,0.0000929412,0.00035347827],"about_ca_topic_score_codex":0.006333317,"about_ca_topic_score_gemma":0.00019118852,"teacher_disagreement_score":0.2645818,"about_ca_system_score_codex":0.00026768516,"about_ca_system_score_gemma":0.0011096346,"threshold_uncertainty_score":0.9574123},"labels":[],"label_agreement":null},{"id":"W4380151573","doi":"10.1016/j.jval.2023.03.1559","title":"MSR23 Improving the Interpretability of Ordinal Endpoints in NMAs","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Interpretability; Ordinal data; Odds; Medicine; Ordinal regression; Statistics; Mathematics; Computer science; Machine learning; Logistic regression","score_opus":0.44049555592682,"score_gpt":0.4383808703812958,"score_spread":0.0021146855455241864,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151573","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9613013,0.0014336096,0.0004120984,0.03397004,0.00070219696,0.0009818189,0.00011830064,0.000044887358,0.0010357152],"genre_scores_gemma":[0.99655277,0.00019039135,0.0005172214,0.0024183334,0.000098353295,0.00008688688,0.000009713865,0.000021369782,0.00010498447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9929728,0.0010091073,0.004875024,0.0004933534,0.00009927733,0.00055043766],"domain_scores_gemma":[0.995548,0.0021172566,0.0015958688,0.00060564815,0.000025814563,0.000107375745],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.04872103,0.00013704471,0.00086432364,0.00055896083,0.00008732135,0.000022332079,0.000358202,0.00009615826,0.000112161615],"category_scores_gemma":[0.0060598403,0.00014590473,0.00009129658,0.00078371575,0.000085256186,0.00021809363,0.000105981664,0.0003166474,0.00052274636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046660916,0.00018665397,0.8622511,0.0028479612,0.000020580008,0.000002557185,0.017564606,0.011472276,0.000008706299,0.09939189,0.0037954687,0.002411535],"study_design_scores_gemma":[0.0013628037,0.00022838377,0.6596952,0.0006108117,0.0000017447151,0.0000049702044,0.005428199,0.2606651,0.000017613691,0.063287884,0.008317054,0.0003802556],"about_ca_topic_score_codex":0.037499655,"about_ca_topic_score_gemma":0.001346835,"teacher_disagreement_score":0.2491928,"about_ca_system_score_codex":0.0009344913,"about_ca_system_score_gemma":0.00041695885,"threshold_uncertainty_score":0.9795419},"labels":[],"label_agreement":null},{"id":"W4380151862","doi":"10.1016/j.jval.2023.03.1263","title":"HPR116 US List Prices for Maine’S High-Cost Highly Prescribed Drugs Were over 7-Fold Higher Than the Lowest Canadian Prices","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transparency (behavior); Legislation; Medical prescription; Drug prices; Business; Economics; Public economics; Medicine; Political science; Pharmacology; Law","score_opus":0.2831185888249872,"score_gpt":0.3922508095959677,"score_spread":0.1091322207709805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151862","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.62759924,0.0038251034,0.0001451054,0.3512152,0.0048622745,0.0056298887,0.003446801,0.00023730515,0.003039104],"genre_scores_gemma":[0.95576423,0.00080905925,0.0010571656,0.034735307,0.0014891586,0.0011763179,0.0003637298,0.00013928373,0.004465719],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9930311,0.0004541163,0.003916724,0.00094387174,0.00017610514,0.0014781146],"domain_scores_gemma":[0.9939181,0.0024499376,0.0019908873,0.00094396493,0.000069156056,0.00062795065],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.019844726,0.00036262692,0.0011503091,0.0008895133,0.000675014,0.00024303567,0.0007813467,0.00025785112,0.00034780017],"category_scores_gemma":[0.0012367653,0.00036990465,0.00017550052,0.00084977946,0.000098741846,0.0005082865,0.00008329418,0.00036485042,0.0013458671],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051259274,0.00013370672,0.14112799,0.0020012478,0.00011148888,0.000005152371,0.0061376262,0.0063353195,9.168947e-7,0.54618305,0.29762575,0.00028650984],"study_design_scores_gemma":[0.0011528926,0.00011737893,0.33035123,0.00021549055,0.0000058867117,0.0000014915001,0.0005942539,0.011911783,0.0000015331551,0.014835216,0.6403707,0.0004421419],"about_ca_topic_score_codex":0.73087305,"about_ca_topic_score_gemma":0.24108215,"teacher_disagreement_score":0.5313478,"about_ca_system_score_codex":0.0023413694,"about_ca_system_score_gemma":0.0013605702,"threshold_uncertainty_score":0.9998753},"labels":[],"label_agreement":null},{"id":"W4380151866","doi":"10.1016/j.jval.2023.03.2128","title":"RWD99 The Clinical Burden of Friedreich Ataxia: A Retrospective Claims Analysis in the United States","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Ataxia; Medicine; Retrospective cohort study; Cohort; Scoliosis; Pediatrics; Cardiomyopathy; Diabetes mellitus; Internal medicine; Physical medicine and rehabilitation; Physical therapy; Surgery; Heart failure; Psychiatry; Endocrinology","score_opus":0.1333431285981183,"score_gpt":0.39916298336723555,"score_spread":0.26581985476911724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151866","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912653,0.000082446364,0.00003156176,0.00772051,0.00012180355,0.0005778368,0.00011425026,0.000031260002,0.0000550508],"genre_scores_gemma":[0.9969444,0.0009479617,0.00002644435,0.0018947476,0.000057445563,0.000045013036,0.000024200897,0.000013763816,0.000045990593],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9936862,0.004071324,0.00077689165,0.0005171943,0.0005430827,0.00040529715],"domain_scores_gemma":[0.9960617,0.0028863284,0.0002555591,0.00065971655,0.00005942822,0.0000772901],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025092175,0.00013781899,0.00037073053,0.00048722545,0.00014059445,0.000030539857,0.00062984496,0.000046246965,0.000021957685],"category_scores_gemma":[0.00219748,0.00008458804,0.0001378744,0.007500858,0.00027638435,0.000035372752,0.00011682538,0.0004056746,0.000027710992],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000098544864,0.00031218005,0.4820924,0.000063649364,0.000042428477,0.00005439173,0.011826639,0.4973433,0.0009211286,0.0049537895,0.0019766055,0.00031492894],"study_design_scores_gemma":[0.0005123085,0.00034335817,0.8579378,0.000033746393,0.00004422294,0.000001735287,0.002729863,0.12972364,0.0023823543,0.0056363633,0.0005230576,0.00013156245],"about_ca_topic_score_codex":0.0067068953,"about_ca_topic_score_gemma":0.000326151,"teacher_disagreement_score":0.37584537,"about_ca_system_score_codex":0.000065869994,"about_ca_system_score_gemma":0.00022079972,"threshold_uncertainty_score":0.99990755},"labels":[],"label_agreement":null},{"id":"W4380151925","doi":"10.1016/j.jval.2023.03.2759","title":"MSR107 Assessment of the Power of ITCs to Detect Minimally Important Treatment Effects in Subsequent Head-to-Head Trials","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Placebo; Medicine; Leverage (statistics); Head (geology); Randomization; Clinical trial; Internal medicine; Computer science; Artificial intelligence; Alternative medicine; Pathology","score_opus":0.48481004003162703,"score_gpt":0.5006952098182541,"score_spread":0.015885169786627074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380151925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9619251,0.0010410163,0.00018816425,0.031020949,0.0009076208,0.004337115,0.0003291759,0.000024209223,0.00022665423],"genre_scores_gemma":[0.9925076,0.0002886336,0.0031751231,0.0033521298,0.00007067581,0.00047281233,0.000009917807,0.00003789583,0.00008520787],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98691,0.0023316238,0.009175167,0.00065652037,0.00022039078,0.000706333],"domain_scores_gemma":[0.99189913,0.0039212215,0.003023167,0.0008278513,0.000046108984,0.00028252913],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.050268065,0.00024761003,0.0023713177,0.0010385892,0.00006994314,0.000018129263,0.0003517884,0.00012984489,0.000047210633],"category_scores_gemma":[0.006418703,0.00023198748,0.00025029,0.0012360686,0.000034876506,0.00008471778,0.000085180734,0.00015859111,0.00012756471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018254602,0.00069664605,0.89077264,0.00295133,0.00014377158,0.000009752701,0.014191646,0.048525814,0.00025365953,0.03816217,0.002634245,0.0014757704],"study_design_scores_gemma":[0.0023803003,0.001691909,0.9784892,0.0009449382,0.0000059399176,0.0000017636934,0.00055606285,0.0060857316,0.00018570495,0.004997557,0.004384391,0.0002764977],"about_ca_topic_score_codex":0.024810245,"about_ca_topic_score_gemma":0.004599086,"teacher_disagreement_score":0.08771656,"about_ca_system_score_codex":0.0027824778,"about_ca_system_score_gemma":0.0012943682,"threshold_uncertainty_score":0.9816836},"labels":[],"label_agreement":null},{"id":"W4380152124","doi":"10.1016/j.jval.2023.03.2433","title":"CO208 Recurrence Rates and Survival Among Patients with Early-Stage Cancers: A Systematic Literature Review","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Stage (stratigraphy); Medicine; Oncology; Internal medicine; Biology","score_opus":0.03182598772810142,"score_gpt":0.34936151797824433,"score_spread":0.3175355302501429,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380152124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.907686,0.08700614,0.000005746648,0.0011880707,0.00022903462,0.0035023177,0.00011672521,0.000065533255,0.00020045333],"genre_scores_gemma":[0.9143781,0.08316681,0.00018339232,0.00069469074,0.000041944048,0.0004078871,0.00023582623,0.000029439634,0.0008619167],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988621,0.000161551,0.00031006563,0.00022113818,0.00022254564,0.00022259311],"domain_scores_gemma":[0.9993298,0.00011423598,0.00014121577,0.00018932705,0.00008765514,0.00013774697],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035566298,0.000117810305,0.00042507245,0.00010267748,0.00006443487,0.000022282724,0.000034923436,0.00003011986,0.0000065112717],"category_scores_gemma":[0.00010528297,0.000077143115,0.000021284624,0.00073032005,0.000031233147,0.00009010514,0.000012794798,0.00012861352,0.000007375431],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003141159,0.00005282256,0.80046433,0.19587177,0.00005752057,0.000045781297,0.0025000656,0.000045987064,1.0519107e-7,0.00012997098,0.00049907935,0.00030112828],"study_design_scores_gemma":[0.0015026575,0.00047984035,0.6828806,0.31426165,0.00008084026,0.0000036456527,0.00014656989,0.00034625485,7.132147e-7,0.0000138748055,0.00018508687,0.00009828207],"about_ca_topic_score_codex":0.0026973241,"about_ca_topic_score_gemma":0.00018784669,"teacher_disagreement_score":0.118389875,"about_ca_system_score_codex":0.00026437404,"about_ca_system_score_gemma":0.00031561544,"threshold_uncertainty_score":0.4077565},"labels":[],"label_agreement":null},{"id":"W4380154583","doi":"10.1016/j.jval.2023.03.1183","title":"HPR36 Utilization of Glucagon-like Peptide-1 Receptor Agonists in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Reimbursement; Glucagon-like peptide-1; Glucagon-like peptide 1 receptor; Medicine; Diabetes mellitus; Receptor; Business; Internal medicine; Type 2 diabetes; Endocrinology; Economics; Agonist; Health care; Economic growth","score_opus":0.058496546352470515,"score_gpt":0.30340409613507235,"score_spread":0.24490754978260185,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380154583","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941878,0.00039505627,0.0000042515535,0.0029594167,0.00041502842,0.0006202806,0.000010877569,0.000031103125,0.0013762283],"genre_scores_gemma":[0.99662346,0.000998597,0.00020779102,0.0005514512,0.000025643925,0.00003194935,0.0001400688,0.0000149197485,0.0014061376],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988907,0.00006363408,0.00036316746,0.0001690716,0.00022375178,0.00028968597],"domain_scores_gemma":[0.99957234,0.000059110374,0.0000851308,0.00017704585,0.000020336089,0.00008601577],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035037848,0.00008301419,0.00025592258,0.00022263911,0.000017932165,0.000002825405,0.0000482578,0.000024111741,0.00004802413],"category_scores_gemma":[0.000049051494,0.000079457954,0.000021707774,0.0006913608,0.000012019194,0.000029183388,0.000027321817,0.00006545185,0.000025000212],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013708227,0.000419478,0.8488346,0.0027545781,0.000069488706,0.00009372275,0.001623473,0.005422547,0.00014786604,0.0022042915,0.066239186,0.072053745],"study_design_scores_gemma":[0.004001826,0.0006163618,0.869047,0.0015854507,0.000024497549,0.0000012534648,0.0015565126,0.016878858,0.00072795915,0.00027427092,0.105065644,0.00022035328],"about_ca_topic_score_codex":0.8669577,"about_ca_topic_score_gemma":0.57557315,"teacher_disagreement_score":0.29138455,"about_ca_system_score_codex":0.00096051255,"about_ca_system_score_gemma":0.0012204068,"threshold_uncertainty_score":0.43217152},"labels":[],"label_agreement":null},{"id":"W4380184426","doi":"10.1016/j.jval.2023.03.2607","title":"EPH262 Preventing COVID-19 Outbreaks Using Wastewater Surveillance at Long-Term Care Facilities: A Pilot Modelling Study","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Outbreak; Wastewater; Coronavirus disease 2019 (COVID-19); Long-term care; Medicine; Infection control; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Environmental science; Environmental health; Virology; Environmental engineering; Intensive care medicine; Infectious disease (medical specialty); Disease; Internal medicine","score_opus":0.21380927732753016,"score_gpt":0.388897964553323,"score_spread":0.17508868722579282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380184426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99603146,0.0005445945,0.0008721804,0.00017735663,0.00038921158,0.0014497422,0.000024148545,0.00041890377,0.00009241209],"genre_scores_gemma":[0.9985153,0.000022352595,0.00040514107,0.00049373996,0.00015293727,0.0000432009,0.000022197039,0.00005255182,0.00029254207],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99706733,0.00046714154,0.00077395135,0.0005696294,0.00042355215,0.0006983957],"domain_scores_gemma":[0.9987214,0.00038290245,0.0002010205,0.00040245746,0.00007807541,0.00021413887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017021974,0.00023599225,0.0005086586,0.000403585,0.00037472995,0.000033822922,0.00010321239,0.00006743875,0.00002160493],"category_scores_gemma":[0.00043950128,0.00022944607,0.00007843862,0.0006842419,0.000038049184,0.00007372897,0.0001411617,0.0003225869,0.000047775633],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002146726,0.00019230923,0.8231228,0.0039240085,0.000039117553,0.00026340145,0.034374498,0.13459879,0.0026037619,0.0000032916262,0.000016296071,0.0006470732],"study_design_scores_gemma":[0.012323272,0.003131359,0.04341675,0.0027809185,0.000060907903,0.00055352575,0.040301457,0.8907473,0.0045267963,0.00013037435,0.00090913003,0.0011181963],"about_ca_topic_score_codex":0.019482622,"about_ca_topic_score_gemma":0.0012566588,"teacher_disagreement_score":0.77970606,"about_ca_system_score_codex":0.0013288568,"about_ca_system_score_gemma":0.0005039449,"threshold_uncertainty_score":0.9870467},"labels":[],"label_agreement":null},{"id":"W4380184439","doi":"10.1016/j.jval.2023.03.2621","title":"HPR144 Coverage of Biologics for Rheumatoid Arthritis in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Medicine; Guideline; Rheumatoid arthritis; Antirheumatic drugs; Equity (law); Actuarial science; Antirheumatic Agents; Business; Internal medicine","score_opus":0.05111866706465138,"score_gpt":0.30295467291690203,"score_spread":0.25183600585225063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380184439","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98385507,0.008985282,0.00019517414,0.0046445196,0.00104598,0.00060058606,0.00042299827,0.000028075596,0.00022229904],"genre_scores_gemma":[0.98837614,0.010252758,0.00053955894,0.0006673881,0.0000068005547,0.000019516347,0.000040469775,0.000007098167,0.000090294896],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99859834,0.00030195172,0.00049986923,0.00018402375,0.000022960672,0.00039284994],"domain_scores_gemma":[0.99902004,0.00070878403,0.00010259911,0.00012712512,0.000018842717,0.000022611173],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010468485,0.00008366152,0.00037767453,0.00011120953,0.0000348606,0.0000015920851,0.00010791679,0.00012713813,0.000053884884],"category_scores_gemma":[0.000309538,0.000071571696,0.000039201666,0.00036124288,0.000054789743,0.000012694125,0.00003438962,0.00016752776,0.000005851047],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073885004,0.000451967,0.446559,0.0012798494,0.00015175785,0.000058503978,0.00082470995,0.0034528845,0.017470697,0.033866983,0.05053761,0.44460717],"study_design_scores_gemma":[0.0135991825,0.0026670054,0.46617308,0.002414318,0.000008625675,0.000071730334,0.0019857828,0.0062123677,0.03530935,0.037423402,0.43288937,0.0012457998],"about_ca_topic_score_codex":0.742477,"about_ca_topic_score_gemma":0.5368046,"teacher_disagreement_score":0.44336137,"about_ca_system_score_codex":0.00017383612,"about_ca_system_score_gemma":0.0008837198,"threshold_uncertainty_score":0.47164747},"labels":[],"label_agreement":null},{"id":"W4380201856","doi":"10.1016/j.jval.2023.03.2592","title":"EPH246 Real-World Evaluation of Health Disparities in Treatment Patterns for Systemic Lupus Erythematosus","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Systemic lupus; Biologic Agents; Ethnic group; Race (biology); Systemic therapy; Systemic lupus erythematosus; Lupus erythematosus; Internal medicine; Immunology; Disease; Antibody","score_opus":0.1702458433476343,"score_gpt":0.42013165861879,"score_spread":0.2498858152711557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380201856","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98354435,0.0030061577,0.00006645579,0.005436643,0.0004506605,0.00717119,0.00007746729,0.00009808038,0.00014899592],"genre_scores_gemma":[0.9930369,0.0038913456,0.00014225178,0.000084451596,0.000105199164,0.0015624252,0.00017343853,0.00006457404,0.0009394065],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9942002,0.0013778746,0.0018154852,0.0005173278,0.0011472424,0.0009418231],"domain_scores_gemma":[0.9975215,0.00092228537,0.0004773223,0.0006375753,0.00022290027,0.00021840684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010218114,0.00024477125,0.0012448039,0.0013592439,0.00007878037,0.000012874138,0.00013808314,0.00009681722,0.000017697317],"category_scores_gemma":[0.00035323916,0.00020857257,0.00013570492,0.0011937344,0.000044752524,0.00006156828,0.000036752623,0.00016289469,0.000022166112],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020418558,0.00030780927,0.96560746,0.018021587,0.000046107263,0.000017882932,0.0062509547,0.0023456188,0.000028777022,0.0012358564,0.0009100048,0.0050237295],"study_design_scores_gemma":[0.06206904,0.0074233846,0.38634917,0.0887595,0.00016562016,0.009579142,0.032294143,0.40482295,0.0004811554,0.006044148,0.00093025336,0.0010815195],"about_ca_topic_score_codex":0.06776524,"about_ca_topic_score_gemma":0.0060696728,"teacher_disagreement_score":0.5792583,"about_ca_system_score_codex":0.0048132404,"about_ca_system_score_gemma":0.0028712088,"threshold_uncertainty_score":0.9990071},"labels":[],"label_agreement":null},{"id":"W4380261239","doi":"10.1016/j.jval.2023.03.064","title":"P53 Budget Impact Analysis of Adopting Primary Care-Based COPD Case Detection in the Canadian General Population","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"COPD; Primary care; Population; Medicine; Primary (astronomy); Business; Environmental health; Family medicine; Internal medicine","score_opus":0.03970856907619333,"score_gpt":0.35398832634081673,"score_spread":0.3142797572646234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380261239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997652,0.00053723645,0.000012287305,0.0006395637,0.00006143167,0.0008162838,0.00014529245,0.000022987813,0.00011292148],"genre_scores_gemma":[0.9987432,0.000023041783,0.00013767308,0.0002349578,0.00007231999,0.000036872745,0.0007238433,0.000018729297,0.000009390045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772537,0.0005601644,0.00046395275,0.0002739422,0.00046109033,0.00051549816],"domain_scores_gemma":[0.99896306,0.0001918834,0.0001210264,0.00035436492,0.0000960509,0.00027362295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013299126,0.00012223529,0.00036741208,0.0019255643,0.00015186463,0.000014743717,0.00008342797,0.00008247967,0.000026176353],"category_scores_gemma":[0.00016890625,0.0001023823,0.00014572869,0.0040395604,0.00004151724,0.000055463104,0.000016722763,0.00032249108,0.0000035835646],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011404655,0.00005208604,0.7805309,0.0009505051,0.00006551555,0.0010111902,0.0012598676,0.1949036,0.00005774257,0.000019583707,0.000020822828,0.021014133],"study_design_scores_gemma":[0.00056219776,0.00008623989,0.7520884,0.00007762144,0.00005999562,0.000036399364,0.0005787348,0.2464116,0.000010630999,0.000011030106,0.000020582758,0.000056512454],"about_ca_topic_score_codex":0.93516886,"about_ca_topic_score_gemma":0.7031609,"teacher_disagreement_score":0.23200803,"about_ca_system_score_codex":0.00595556,"about_ca_system_score_gemma":0.0026071318,"threshold_uncertainty_score":0.9978604},"labels":[],"label_agreement":null},{"id":"W4383100478","doi":"10.1016/j.jval.2023.06.014","title":"Consolidated Health Economic Evaluation Reporting Standards - Value of Information (CHEERS-VOI): Explanation and Elaboration","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":38,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; University of Toronto; SickKids Foundation; Institute of Health Economics; University of Ottawa; Public Health Ontario; Hospital for Sick Children","funders":"Hospital for Sick Children; Natural Sciences and Engineering Research Council of Canada; Government of Canada","keywords":"Checklist; Delphi; Delphi method; Transparency (behavior); Medicine; Computer science; Psychology","score_opus":0.5949654745968979,"score_gpt":0.5350122596358549,"score_spread":0.059953214961043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383100478","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010203655,0.97946,0.0013451278,0.005801165,0.0014253608,0.006237172,0.00420432,0.00012438567,0.0003820789],"genre_scores_gemma":[0.0006593291,0.9933216,0.0014686813,0.00095767685,0.00023435075,0.00046822673,0.0027785394,0.000084941326,0.000026674705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.96413565,0.0034937647,0.030102316,0.00097227754,0.0005054706,0.00079054147],"domain_scores_gemma":[0.955004,0.001493654,0.042259578,0.0006986773,0.00026072812,0.00028337195],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.1415991,0.0004820674,0.004657993,0.0022052096,0.00025745385,0.00014531164,0.00026365207,0.00047231448,0.00007336904],"category_scores_gemma":[0.01561517,0.0006189561,0.00022116075,0.0008169022,0.000078696045,0.0013089725,0.000079905374,0.00050648965,0.00029647173],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00004567713,0.00016458436,0.0015052967,0.26125574,0.0005304898,0.0000019714907,0.015032463,0.024855234,3.9377884e-8,0.31466863,0.023780202,0.35815966],"study_design_scores_gemma":[0.0016435885,0.00036000804,0.00080390956,0.024854615,0.00006935614,0.00002895086,0.001826855,0.09387482,2.3001739e-7,0.01252829,0.86304647,0.00096288585],"about_ca_topic_score_codex":0.01755519,"about_ca_topic_score_gemma":0.0005114907,"teacher_disagreement_score":0.8392663,"about_ca_system_score_codex":0.009460407,"about_ca_system_score_gemma":0.010143288,"threshold_uncertainty_score":0.99962616},"labels":[],"label_agreement":null},{"id":"W4383466085","doi":"10.1016/j.jval.2023.06.019","title":"Perspectives on Patient-Reported Outcome Data After Treatment Discontinuation in Cancer Clinical Trials","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada; National Institute for Health and Care Research","keywords":"Discontinuation; Clinical trial; Excellence; Medicine; Data collection; Intensive care medicine; Family medicine; Internal medicine; Political science","score_opus":0.5425764741298827,"score_gpt":0.4782558540473472,"score_spread":0.06432062008253553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383466085","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9863538,0.0042254888,0.00002959542,0.005711506,0.0011817586,0.0008256339,0.0006950744,0.000035416975,0.0009416823],"genre_scores_gemma":[0.9894649,0.009051585,0.00008600732,0.0005016562,0.00028519772,0.0001766908,0.00006653382,0.000025697196,0.0003417499],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99573606,0.00022409885,0.0028479213,0.0007324009,0.00004152354,0.00041796637],"domain_scores_gemma":[0.99771744,0.00047234027,0.0010268991,0.00065351784,0.00001375963,0.00011606612],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0062368903,0.00017068052,0.0010690787,0.0004462413,0.000039285216,0.000040111736,0.00016907882,0.00011725837,0.00014756437],"category_scores_gemma":[0.0019810186,0.00016705146,0.00012439978,0.00036767253,0.000041986386,0.00029391632,0.000062346604,0.0001888599,0.0002352993],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019976166,0.00035802374,0.945246,0.000014329868,0.000034982444,0.000013192166,0.0025729814,0.0016362702,8.890028e-8,0.007368687,0.000580361,0.041975353],"study_design_scores_gemma":[0.002041167,0.00048390587,0.96591514,0.00009230965,0.000004030449,3.3946512e-7,0.0005918341,0.008394062,8.679494e-7,0.0032794701,0.018981462,0.0002154323],"about_ca_topic_score_codex":0.021408368,"about_ca_topic_score_gemma":0.0020418507,"teacher_disagreement_score":0.04175992,"about_ca_system_score_codex":0.0009796912,"about_ca_system_score_gemma":0.0002132474,"threshold_uncertainty_score":0.98510814},"labels":[],"label_agreement":null},{"id":"W4383874821","doi":"10.1016/j.jval.2023.06.010","title":"Challenges of Health Technology Assessment in Pluralistic Healthcare Systems: An ISPOR Council Report","year":2023,"lang":"en","type":"erratum","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"","keywords":"Health care; Outcomes research; Healthcare system; Health technology; Medicine; Political science; Alternative medicine","score_opus":0.6781235203538044,"score_gpt":0.4868992296090297,"score_spread":0.1912242907447747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4383874821","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0032686742,0.35374764,0.0002656682,0.576807,0.0481567,0.008246258,0.0030816065,0.00052390347,0.0059025125],"genre_scores_gemma":[0.40592977,0.45638478,0.009998594,0.03413755,0.010504264,0.009020224,0.009278519,0.0025143884,0.062231906],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.96550006,0.0040249256,0.024892053,0.0026669914,0.0008434408,0.0020725392],"domain_scores_gemma":[0.97790873,0.0011727954,0.017578945,0.0024228508,0.00040843053,0.00050822383],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.12155158,0.00071802485,0.006474995,0.0032743358,0.00022736631,0.000058646547,0.0009569185,0.0014551085,0.000030574683],"category_scores_gemma":[0.007246677,0.00097513583,0.00019457626,0.0014260713,0.00017156333,0.00033601146,0.0001676018,0.002421858,0.0002241655],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000022386404,0.00067467475,0.017855141,0.068068564,0.00011746735,0.0001292153,0.007613084,0.0068703177,3.86673e-8,0.55286866,0.3447962,0.0009842289],"study_design_scores_gemma":[0.0028168769,0.002431262,0.06828428,0.025597991,0.0000110823,0.00023703011,0.036156084,0.05623394,4.7035275e-8,0.048897628,0.7571212,0.0022125803],"about_ca_topic_score_codex":0.28030324,"about_ca_topic_score_gemma":0.04154341,"teacher_disagreement_score":0.5426695,"about_ca_system_score_codex":0.022450954,"about_ca_system_score_gemma":0.025031503,"threshold_uncertainty_score":0.9998796},"labels":[],"label_agreement":null},{"id":"W4385552805","doi":"10.1016/j.jval.2023.07.004","title":"Toward Best Practices for Economic Evaluations of Tumor-Agnostic Therapies: A Review of Current Barriers and Solutions","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"Health Innovation Network South London; Terry Fox Research Institute; Genome British Columbia; Genome Canada; Roche; AstraZeneca; Roche Canada","keywords":"Current (fluid); Intensive care medicine; Management science; Medicine; Risk analysis (engineering); Engineering ethics; Psychology; Economics; Engineering","score_opus":0.813869672095695,"score_gpt":0.5795392842646053,"score_spread":0.23433038783108973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385552805","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000020689973,0.98075414,0.0003218993,0.0068568033,0.0009955273,0.0062049436,0.00472397,0.000024104904,0.000097896445],"genre_scores_gemma":[0.000021509046,0.99611795,0.000995164,0.00067350094,0.00021770719,0.0016486166,0.00019659223,0.00008200955,0.00004697525],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9855041,0.001718428,0.011233391,0.00082990184,0.00013019456,0.0005840221],"domain_scores_gemma":[0.9692095,0.010472225,0.019204352,0.00072134973,0.00010442637,0.00028817065],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.04403351,0.00039016592,0.0051126624,0.00097028026,0.00017038341,0.000028062574,0.00042632007,0.00017691802,0.00013810818],"category_scores_gemma":[0.026029538,0.00046139205,0.00047501747,0.0004022441,0.00014824329,0.00027964162,0.000094091054,0.00035587925,0.0002615211],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003979117,0.000103500846,0.00012180944,0.8856824,0.00021883681,2.006252e-7,0.0011633828,0.00020748127,3.5473062e-9,0.06674598,0.007295378,0.038457055],"study_design_scores_gemma":[0.00035692993,0.00018978461,0.000016756849,0.16229525,0.00013895896,0.000006486958,0.00037358256,0.0017545838,1.095282e-8,0.0057945126,0.8287494,0.00032371352],"about_ca_topic_score_codex":0.006133255,"about_ca_topic_score_gemma":0.00022302216,"teacher_disagreement_score":0.82145405,"about_ca_system_score_codex":0.0014415787,"about_ca_system_score_gemma":0.0054013557,"threshold_uncertainty_score":0.99978375},"labels":[],"label_agreement":null},{"id":"W4386935853","doi":"10.1016/j.jval.2023.09.001","title":"Comparative Efficacy of Venetoclax-Based Combination Therapies and Other Therapies in Treatment-Naive Patients With Acute Myeloid Leukemia Ineligible for Intensive Chemotherapy: A Network Meta-Analysis","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; McMaster University; Impact","funders":"","keywords":"Ven; Medicine; Internal medicine; Cytarabine; Hazard ratio; Myeloid leukemia; Oncology; Confidence interval","score_opus":0.20436581651139224,"score_gpt":0.42398445399190704,"score_spread":0.2196186374805148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386935853","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015418556,0.9714085,0.00012886453,0.00055775436,0.000042478674,0.011907791,0.00046163832,0.000055667268,0.000018789166],"genre_scores_gemma":[0.0038337868,0.9896558,0.0023129315,0.0006695325,0.000068494606,0.0020519819,0.0009955815,0.00019121425,0.00022066737],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99556744,0.0010251503,0.0014105034,0.00081348245,0.00050170376,0.00068172865],"domain_scores_gemma":[0.99509,0.002551938,0.0011109773,0.00061152776,0.00047533071,0.00016024082],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0010993103,0.00072345405,0.007309011,0.0015369549,0.00008778245,0.000029050885,0.000214601,0.00030221173,0.000022769156],"category_scores_gemma":[0.00008604009,0.0004543398,0.0009815434,0.0030280277,0.00024523833,0.000059514176,0.000037093272,0.0004764755,0.0000041356598],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010694942,0.0022635364,0.014407307,0.04224985,0.72249424,0.00007527225,0.03466871,0.022508603,0.0000018151663,0.0008850286,0.00142756,0.14832313],"study_design_scores_gemma":[0.11391778,0.03432604,0.021562006,0.034891933,0.4086825,0.00003040707,0.0036249824,0.041599322,0.00004349265,0.0014141058,0.33573276,0.004174657],"about_ca_topic_score_codex":0.0063051856,"about_ca_topic_score_gemma":0.0004777771,"teacher_disagreement_score":0.3343052,"about_ca_system_score_codex":0.0036844113,"about_ca_system_score_gemma":0.003899564,"threshold_uncertainty_score":0.99979085},"labels":[],"label_agreement":null},{"id":"W4386968516","doi":"10.1016/j.jval.2023.08.008","title":"Real-World Cost-Effectiveness of Pulmonary Vein Isolation for Atrial Fibrillation: A Target Trial Approach","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Servier; Schweizerische Herzstiftung; Universität Basel; Biosense Webster; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Foundation for Cardiovascular Research; Daiichi Sankyo Europe; European Commission; Sanofi; AstraZeneca; Amgen; Pfizer; Boston Scientific Corporation; National Science Foundation","keywords":"Medicine; Context (archaeology); Cost effectiveness; Atrial fibrillation; Randomized controlled trial; Hazard ratio; Quality-adjusted life year; Observational study; Cohort; Incremental cost-effectiveness ratio; Internal medicine; Emergency medicine; Confidence interval; Intensive care medicine","score_opus":0.1724954474430679,"score_gpt":0.4085436308525736,"score_spread":0.2360481834095057,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386968516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9256545,0.00080536335,0.015515236,0.0054520406,0.0037432527,0.04055705,0.00010016948,0.00058204634,0.007590358],"genre_scores_gemma":[0.9905642,0.00018041226,0.003247954,0.000022418571,0.002787072,0.000051740935,0.00084134634,0.000039798782,0.0022650056],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980303,0.00041031136,0.0007056853,0.0002892427,0.00025829242,0.00030618993],"domain_scores_gemma":[0.9981517,0.0012169605,0.0002757594,0.00020987612,0.00007584326,0.000069829475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030652003,0.00013127497,0.00056582957,0.00056562375,0.00008124604,0.000010668057,0.000051888983,0.0000813915,0.00001635918],"category_scores_gemma":[0.00042026865,0.00012544813,0.0002523027,0.0012069631,0.00002474682,0.000111626345,0.000035602883,0.0000797437,0.000010056162],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1567235,0.00006160174,0.47325572,0.009938064,0.0002210497,0.000008585984,0.0007247045,0.30999795,0.00031487178,0.03385003,0.0013831059,0.013520823],"study_design_scores_gemma":[0.082183875,0.0015401632,0.34581116,0.00055164634,0.00009890853,0.000003098099,0.00022953689,0.53432083,0.000142844,0.0052124346,0.029571922,0.00033356724],"about_ca_topic_score_codex":0.0008874245,"about_ca_topic_score_gemma":0.0000031991785,"teacher_disagreement_score":0.22432292,"about_ca_system_score_codex":0.00022638951,"about_ca_system_score_gemma":0.00027254387,"threshold_uncertainty_score":0.51156265},"labels":[],"label_agreement":null},{"id":"W4388486850","doi":"10.1016/j.jval.2023.10.015","title":"Microsimulation Models on Mental Health: A Critical Review of the Literature","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"demographic modeling and climate adaptation","field":"Decision Sciences","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Centre for Addiction and Mental Health","funders":"Economic and Social Research Council; UK Research and Innovation","keywords":"Microsimulation; Mental health; EconLit; PsycINFO; Checklist; Psychological intervention; Quality (philosophy); Psychology; MEDLINE; Applied psychology; Psychiatry; Engineering; Political science; Transport engineering","score_opus":0.5414938261332398,"score_gpt":0.5376371266359655,"score_spread":0.0038566994972742963,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388486850","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003954115,0.9896095,0.0001469255,0.007342729,0.0009031425,0.0015399455,0.00034858382,0.000027938228,0.00007731649],"genre_scores_gemma":[0.00004148345,0.99721086,0.00023714914,0.0021711446,0.000058852977,0.000045744106,0.000095563206,0.000032501794,0.00010671292],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9911997,0.00304275,0.0030644627,0.0006664957,0.0016406897,0.00038592055],"domain_scores_gemma":[0.9947408,0.0027607381,0.0012316729,0.00093119586,0.00020085058,0.00013477584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011248914,0.0002698157,0.0018096851,0.00055980636,0.00019651606,0.000081984545,0.00071473955,0.00019525153,0.000011532125],"category_scores_gemma":[0.0024662458,0.00016016886,0.00062045245,0.003439263,0.00006918718,0.0001177494,0.00010038096,0.0006277221,0.000053763702],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000054065717,0.00008580027,0.0000015011361,0.18119073,0.00000982092,9.65268e-7,0.0007783543,0.0034981119,1.1412464e-8,0.00898681,0.007161627,0.7982809],"study_design_scores_gemma":[0.0000885985,0.00009615215,0.0000039534307,0.6579468,0.000017309809,0.000008793659,0.00003889898,0.020945305,1.0492908e-8,0.018488318,0.30222473,0.00014114396],"about_ca_topic_score_codex":0.00027101053,"about_ca_topic_score_gemma":0.000017078422,"teacher_disagreement_score":0.79813975,"about_ca_system_score_codex":0.00023014349,"about_ca_system_score_gemma":0.0010171013,"threshold_uncertainty_score":0.6531496},"labels":[],"label_agreement":null},{"id":"W4389279525","doi":"10.1016/j.jval.2023.11.009","title":"Logical Inconsistencies in the Health Years in Total and Equal Value of Life-Years Gained","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Calgary; University of Alberta","funders":"Medical Research Council; Queen's University; Canadian Institutes of Health Research; Queen's University Belfast","keywords":"Counterfactual thinking; Consistency (knowledge bases); Value (mathematics); Medicine; Quality of life (healthcare); Actuarial science; Value of life; Regret; Axiom independence; Ranking (information retrieval); Quality-adjusted life year; Quality (philosophy); Axiom; Computer science; Economics; Risk analysis (engineering); Psychology; Mathematics; Microeconomics; Social psychology; Artificial intelligence; Statistics; Epistemology; Cost effectiveness","score_opus":0.4485692626853146,"score_gpt":0.42085538631396635,"score_spread":0.027713876371348256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389279525","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94299066,0.0033232193,0.00004224009,0.05211353,0.00025761622,0.00092152826,0.00011457084,0.000026528929,0.00021009355],"genre_scores_gemma":[0.9878992,0.00092285755,0.000642136,0.01030091,0.00009281383,0.00007138667,0.00001973122,0.000020120196,0.000030843214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922673,0.0018210841,0.004549847,0.00051572017,0.00016021349,0.00068580103],"domain_scores_gemma":[0.99574006,0.002444115,0.0012332831,0.0003817583,0.000014201439,0.00018659403],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.040795516,0.0001540858,0.001150576,0.00089355593,0.00006953542,0.000031808402,0.00025723447,0.00013515625,0.00002671022],"category_scores_gemma":[0.0037858367,0.00017385451,0.00006573775,0.0009973026,0.00012234112,0.00016629773,0.00008670251,0.00036117283,0.00013776895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062112675,0.00028439783,0.59479314,0.0015648421,0.000017693337,0.0000146997945,0.04106585,0.017731573,7.4223624e-7,0.33907998,0.0043069692,0.0010780082],"study_design_scores_gemma":[0.0012046312,0.000277058,0.94215894,0.00024178483,5.0006065e-7,0.0000058952696,0.006483365,0.02766179,7.310736e-8,0.020627063,0.0011675465,0.00017134665],"about_ca_topic_score_codex":0.040504,"about_ca_topic_score_gemma":0.001768018,"teacher_disagreement_score":0.3473658,"about_ca_system_score_codex":0.0006257022,"about_ca_system_score_gemma":0.0008151543,"threshold_uncertainty_score":0.98770285},"labels":[],"label_agreement":null},{"id":"W4389989768","doi":"10.1016/j.jval.2023.11.011","title":"Unanchored Population-Adjusted Indirect Comparison Methods for Time-to-Event Outcomes Using Inverse Odds Weighting, Regression Adjustment, and Doubly Robust Methods With Either Individual Patient or Aggregate Data","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada); Precision Nanosystems (Canada); University of British Columbia","funders":"Medical Research Council; Bristol-Myers Squibb","keywords":"Inverse probability weighting; Statistics; Propensity score matching; Weighting; Confidence interval; Regression; Population; Hazard ratio; Proportional hazards model; Standard error; Medicine; Econometrics; Mathematics","score_opus":0.5243210205611497,"score_gpt":0.5456246118675028,"score_spread":0.021303591306353065,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389989768","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37067893,0.000451718,0.62135154,0.0006230507,0.00031687264,0.0053868573,0.00027923787,0.00087714323,0.00003462819],"genre_scores_gemma":[0.0060279504,0.000048902624,0.99291754,0.00023419646,0.00004299376,0.00019164369,0.00027204579,0.00010919182,0.00015554641],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.995415,0.001584957,0.0011629007,0.0007829939,0.0003860508,0.000668144],"domain_scores_gemma":[0.99524015,0.0024673443,0.001016898,0.0009234487,0.00009895619,0.0002531957],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00457551,0.00041272034,0.0010608245,0.000608028,0.00023004705,0.000050333154,0.0004048183,0.00018103335,0.00003153757],"category_scores_gemma":[0.0018252168,0.00028803386,0.000047554004,0.0011032406,0.000058825644,0.00031753615,0.00051956106,0.00032666334,0.0000037395803],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013516172,0.000834629,0.040525716,0.0026563278,0.00046078075,0.000028296648,0.013993484,0.046521634,0.0006322464,0.002831681,0.0093615325,0.88080204],"study_design_scores_gemma":[0.003221322,0.0020499525,0.017395223,0.004865019,0.0002735489,0.000030319066,0.0012371725,0.93611705,0.0030999049,0.027622273,0.0028569705,0.0012312669],"about_ca_topic_score_codex":0.0010704673,"about_ca_topic_score_gemma":0.00022520642,"teacher_disagreement_score":0.8895954,"about_ca_system_score_codex":0.0003876157,"about_ca_system_score_gemma":0.00022809776,"threshold_uncertainty_score":0.9999572},"labels":[],"label_agreement":null},{"id":"W4390009972","doi":"10.1016/j.jval.2023.12.002","title":"Scoring the Value Assessment Framework for China: A Factorial Survey","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Factorial analysis; Factorial; Value (mathematics); China; Statistics; Mathematics; Geography; Archaeology","score_opus":0.6268504498657739,"score_gpt":0.5128430012630208,"score_spread":0.11400744860275303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390009972","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6488237,0.0023418623,0.15504177,0.16677825,0.017316418,0.006500239,0.0020267465,0.00035777158,0.00081327045],"genre_scores_gemma":[0.98018,0.0005238928,0.010066404,0.006166315,0.0020033168,0.0006155847,0.00013876708,0.00008448789,0.0002212302],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99279714,0.001503153,0.0039926297,0.00067611993,0.00015820214,0.0008727856],"domain_scores_gemma":[0.9890612,0.008306444,0.0017033861,0.00069011905,0.000039198938,0.00019967319],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07046309,0.00021180784,0.0009822744,0.0003865218,0.0004684134,0.00011689019,0.00044772943,0.00018262884,0.000058469963],"category_scores_gemma":[0.011042606,0.00022286973,0.00013787691,0.0007386694,0.000047041565,0.00022012078,0.00008402839,0.00044452626,0.00052164675],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000020080734,0.0000641429,0.19584104,0.00058974954,0.000033874996,4.4476124e-7,0.0031407317,0.02653494,2.0913158e-7,0.76251906,0.011053954,0.00020178297],"study_design_scores_gemma":[0.00066783,0.0001308043,0.65096474,0.00021778086,0.000001444405,8.0068753e-7,0.00039520534,0.08621181,4.7626574e-7,0.24265411,0.018508725,0.0002462438],"about_ca_topic_score_codex":0.03466491,"about_ca_topic_score_gemma":0.00049411226,"teacher_disagreement_score":0.5198649,"about_ca_system_score_codex":0.001356269,"about_ca_system_score_gemma":0.0007502302,"threshold_uncertainty_score":0.9972878},"labels":[],"label_agreement":null},{"id":"W4390124513","doi":"10.1016/j.jval.2023.09.2695","title":"PCR258 Baseline Demographic and Clinical Characteristics of Patients with Plaque Psoriasis Treated with Brodalumab in the Canadian Real-World Setting: Results from the Care Study","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada; Covenant Health; University of Toronto; SKiN Health; University of British Columbia","funders":"","keywords":"Plaque psoriasis; Baseline (sea); Medicine; Psoriasis; Dermatology; Political science","score_opus":0.034849143537404266,"score_gpt":0.282796456769974,"score_spread":0.24794731323256974,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955672,0.0002287781,1.7004687e-7,0.0009793276,0.0001522153,0.0011799906,0.0018306567,0.000023949326,0.000037707785],"genre_scores_gemma":[0.99726874,0.0004097027,0.000026631895,0.00015480432,0.000037720663,0.00004526284,0.0020135383,0.000018671819,0.000024947138],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99606264,0.002318283,0.0007251363,0.00040456152,0.000088386565,0.00040098734],"domain_scores_gemma":[0.9972732,0.0018493546,0.00028997014,0.00045292894,0.00008119077,0.000053362215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017115589,0.00019998885,0.0004423748,0.00027745168,0.00026684016,0.000014083471,0.0002116672,0.00013277128,0.0000053606905],"category_scores_gemma":[0.00016803472,0.00010742374,0.00003685538,0.0009537072,0.0001466908,0.000029064653,0.000026154383,0.00032833,0.0000058520086],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014033437,0.0002680329,0.9820571,0.0000147608,0.00013694358,0.000030423364,0.00638554,0.00001659199,6.743769e-7,0.000012441928,0.00015913234,0.0095150005],"study_design_scores_gemma":[0.0068239085,0.0011408604,0.9884959,0.00014388586,0.00009445585,0.0000011902625,0.002796884,0.00001883635,0.0000042088363,0.0000062254376,0.00036339302,0.00011027227],"about_ca_topic_score_codex":0.66057307,"about_ca_topic_score_gemma":0.85946846,"teacher_disagreement_score":0.1988954,"about_ca_system_score_codex":0.0001067808,"about_ca_system_score_gemma":0.00047144035,"threshold_uncertainty_score":0.43806127},"labels":[],"label_agreement":null},{"id":"W4390124534","doi":"10.1016/j.jval.2023.09.2578","title":"PCR139 'We Have Conversations That Other Couples Don′t Have to Have:' A Qualitative Study of the Impact of Caregiving in Friedreich Ataxia (FA)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Ataxia; Psychology; Gerontology; Medicine; Psychiatry","score_opus":0.19821881146564405,"score_gpt":0.42535055676750094,"score_spread":0.2271317453018569,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124534","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.996605,0.00009225868,0.000022984781,0.0008768465,0.00011474215,0.0017931366,0.0004117602,0.000024274072,0.000059007005],"genre_scores_gemma":[0.9994813,0.000044292752,0.000027877584,0.00020190378,0.000014661778,0.000088226785,0.0000022846955,0.000035041936,0.000104409824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99548936,0.002339441,0.00060556614,0.0005418269,0.0005863736,0.00043743316],"domain_scores_gemma":[0.99742264,0.0014139714,0.00035189904,0.000595083,0.00007801538,0.00013837079],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085384614,0.0002103725,0.00042059933,0.00039810402,0.00012295265,0.000022072516,0.00043598333,0.000039847637,0.00003114863],"category_scores_gemma":[0.0014279176,0.00016382498,0.00010504444,0.000878816,0.00015472954,0.00007717845,0.00018964848,0.00018635158,0.000008203304],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006801193,0.0005537,0.5032866,0.00011559099,0.000012568419,0.0000072279927,0.35149348,0.12899885,0.014893822,0.00017965143,0.000296825,0.000093654926],"study_design_scores_gemma":[0.0017595878,0.0012468542,0.54302657,0.0004280057,0.0000126074,0.000002028006,0.3613788,0.01818289,0.072863646,0.00076425873,0.000030825777,0.0003039309],"about_ca_topic_score_codex":0.037665207,"about_ca_topic_score_gemma":0.0051315473,"teacher_disagreement_score":0.11081596,"about_ca_system_score_codex":0.00022980403,"about_ca_system_score_gemma":0.0004944053,"threshold_uncertainty_score":0.9687431},"labels":[],"label_agreement":null},{"id":"W4390124642","doi":"10.1016/j.jval.2023.09.2523","title":"PCR84 The Daily Life and Psychosocial Impacts of Friedreich Ataxia: A Qualitative Study of Patient Lived Experiences","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Psychosocial; Ataxia; Qualitative research; Psychology; Gerontology; Medicine; Psychiatry; Sociology; Social science","score_opus":0.13606213559689534,"score_gpt":0.4065440204105064,"score_spread":0.2704818848136111,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9978409,0.0002968704,0.0000016830435,0.00066639844,0.00019889587,0.00092489313,0.000031765918,0.000018402514,0.000020208801],"genre_scores_gemma":[0.999295,0.00015507583,0.000018464696,0.0003762277,0.000020363948,0.00011743548,7.7283704e-7,0.000011454529,0.0000052293353],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99591905,0.002368699,0.00056099304,0.0003763554,0.00049566326,0.00027923926],"domain_scores_gemma":[0.9981143,0.0011017765,0.00034470108,0.00025375598,0.000049999002,0.00013549262],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00058838853,0.00012510501,0.00027913356,0.00012270165,0.00014676026,0.0000144261185,0.00021534425,0.000022524224,0.000010262136],"category_scores_gemma":[0.001925935,0.00009100029,0.000031675318,0.0007655509,0.00024555702,0.00005210669,0.000103576094,0.000103842314,0.0000034297168],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009718669,0.00050468853,0.006414606,0.0000788617,0.000005011267,0.0000032684848,0.9856654,0.0006481145,0.005886,0.00016036825,0.0003278267,0.00020869327],"study_design_scores_gemma":[0.0009127009,0.0027382025,0.04911239,0.00006159733,0.000004730504,7.8200753e-7,0.9193052,0.0005366031,0.026708694,0.00046942636,0.000025339394,0.00012433516],"about_ca_topic_score_codex":0.0019374262,"about_ca_topic_score_gemma":0.00005798521,"teacher_disagreement_score":0.066360176,"about_ca_system_score_codex":0.000020394613,"about_ca_system_score_gemma":0.00027728596,"threshold_uncertainty_score":0.37108845},"labels":[],"label_agreement":null},{"id":"W4390124644","doi":"10.1016/j.jval.2023.09.2629","title":"PCR192 Content Validity of the EQ-5D and Health Utilities Index (HUI) to Assess Health-Related Quality-of-Life (HRQoL) Impact in Duchenne Muscular Dystrophy (DMD)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Duchenne muscular dystrophy; Health related quality of life; EQ-5D; Index (typography); Muscular dystrophy; Content validity; Gerontology; Quality of life (healthcare); Health Utilities Index; Medicine; Physical medicine and rehabilitation; Physical therapy; Computer science; Clinical psychology; Psychometrics; Internal medicine; World Wide Web; Nursing","score_opus":0.8408987447331119,"score_gpt":0.47673210207243377,"score_spread":0.3641666426606781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124644","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90448195,0.0043690186,0.00027589794,0.08664881,0.00079123664,0.0025091872,0.0008162091,0.000052848343,0.00005486803],"genre_scores_gemma":[0.99146414,0.0010535448,0.00038161632,0.0067252596,0.00008399775,0.000116154944,0.000044311342,0.000053752512,0.000077227814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98081005,0.004742177,0.011877252,0.0009353165,0.00036693556,0.0012683006],"domain_scores_gemma":[0.9903175,0.002282599,0.0055148085,0.0010558924,0.00011722424,0.0007119668],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.073745474,0.00036618326,0.0031256652,0.001209936,0.00025277337,0.000042778498,0.0005085631,0.00022904837,0.000059238013],"category_scores_gemma":[0.0066131707,0.00037939634,0.00027588374,0.0016631985,0.00017925203,0.000290342,0.00020630084,0.00058459135,0.00006831402],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007562012,0.0002571183,0.9282717,0.0051234905,0.000068860885,7.441503e-7,0.011830894,0.014776575,0.0000034185725,0.036805727,0.0024567298,0.0003291028],"study_design_scores_gemma":[0.0017388208,0.00047320692,0.97390085,0.0008116623,0.0000014275981,0.0000022430067,0.004558831,0.009662488,0.0000022511067,0.007802229,0.00076346594,0.00028253222],"about_ca_topic_score_codex":0.32127246,"about_ca_topic_score_gemma":0.005402074,"teacher_disagreement_score":0.3158704,"about_ca_system_score_codex":0.0025458666,"about_ca_system_score_gemma":0.0028884849,"threshold_uncertainty_score":0.9998658},"labels":[],"label_agreement":null},{"id":"W4390124666","doi":"10.1016/j.jval.2023.09.2662","title":"PCR225 The Added Value of the Cognition, Dining, Gastrointestinal Problems, Sleep, and Tiredness Bolt-Ons for the EQ-5D-5L in Patients With Coeliac Disease","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Fibromyalgia and Chronic Fatigue Syndrome Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Cognition; Coeliac disease; Medicine; Disease; Value (mathematics); Sleep (system call); Physical medicine and rehabilitation; Psychiatry; Internal medicine; Computer science; Machine learning","score_opus":0.05487262209103292,"score_gpt":0.29920280237462277,"score_spread":0.24433018028358985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860392,0.00045193685,0.0000496447,0.009851436,0.000082708975,0.003338932,0.00013222011,0.000026612533,0.000027286727],"genre_scores_gemma":[0.9991886,0.000074778,0.00011843609,0.00007255608,0.000022074475,0.0002954621,0.000069368005,0.000029459725,0.00012929096],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99793607,0.00029945464,0.0004197853,0.00027216697,0.0005493233,0.00052320573],"domain_scores_gemma":[0.9983054,0.0008246395,0.00015360191,0.0004084084,0.00014407355,0.00016388446],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012109409,0.00014944324,0.00026886,0.000115095914,0.0002357139,0.000016881715,0.00020729756,0.000031531723,0.000018387414],"category_scores_gemma":[0.0006543911,0.00007235071,0.000052932955,0.00074049743,0.0003257635,0.00004262677,0.00009884065,0.00034465856,0.0000037767568],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009397624,0.00044445222,0.9821636,0.0068800747,0.000050199716,0.000009263747,0.0023663072,0.0019994094,0.000026415355,0.0011201518,0.0028413977,0.0011589514],"study_design_scores_gemma":[0.003936922,0.0011093245,0.95900655,0.0051790355,0.000041384974,0.000014017883,0.0006379079,0.029214606,0.000011997732,0.0006513807,0.00011098436,0.000085904976],"about_ca_topic_score_codex":0.00092973775,"about_ca_topic_score_gemma":0.000037030153,"teacher_disagreement_score":0.027215196,"about_ca_system_score_codex":0.00012643055,"about_ca_system_score_gemma":0.0009662556,"threshold_uncertainty_score":0.29503766},"labels":[],"label_agreement":null},{"id":"W4390124680","doi":"10.1016/j.jval.2023.09.2762","title":"RWD45 Describing Medication Switching Patterns Among Adults With Rheumatoid Arthritis From 2016-2022 Using Real-World Data","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"","keywords":"Rheumatoid arthritis; Medicine; Real world data; Computer science; Internal medicine; Data science","score_opus":0.09259842473848416,"score_gpt":0.3330869123943982,"score_spread":0.24048848765591402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9910968,0.0040486353,0.0009901724,0.0023951854,0.00019858524,0.00079533644,0.00017592535,0.0002337888,0.00006557344],"genre_scores_gemma":[0.8518728,0.14535476,0.001456431,0.00013940113,0.00012277691,0.000033468095,0.00094134297,0.00006184895,0.000017175047],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965511,0.00036523436,0.00073645014,0.0006967616,0.0008458961,0.0008045624],"domain_scores_gemma":[0.9978515,0.00036208436,0.00027610932,0.001009772,0.000065648805,0.0004348878],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017688278,0.00022078546,0.0005556038,0.0005834313,0.00028116477,0.00007106719,0.00033230934,0.000056619392,0.00010315036],"category_scores_gemma":[0.00026214521,0.00019924456,0.00003786813,0.0009253595,0.000107876425,0.00045117404,0.00021482205,0.0005485052,0.000052188465],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038704136,0.00012733758,0.82192254,0.00024354902,0.00008377793,0.00026843263,0.0047607585,0.0003537703,0.00028053435,0.0001715326,0.0011273196,0.17027342],"study_design_scores_gemma":[0.0076352325,0.0005619588,0.6734311,0.045029465,0.0000040766117,0.00009144915,0.0055827303,0.26498568,0.0001805372,0.00057116715,0.0014137763,0.00051282346],"about_ca_topic_score_codex":0.29864568,"about_ca_topic_score_gemma":0.04213356,"teacher_disagreement_score":0.26463193,"about_ca_system_score_codex":0.00026365527,"about_ca_system_score_gemma":0.00076819916,"threshold_uncertainty_score":0.975345},"labels":[],"label_agreement":null},{"id":"W4390124693","doi":"10.1016/j.jval.2023.09.2540","title":"PCR101 Patient-Centric-Approach and Personalized Clinical Trials to Increase Patients Participation in Drug Development: Insight from a Targeted Literature Review (TLR)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Centre for Advancing Health Outcomes","funders":"","keywords":"Drug development; Clinical trial; Drug; Medicine; Personalized medicine; Intensive care medicine; Pharmacology; Bioinformatics; Internal medicine; Biology","score_opus":0.5070844340435421,"score_gpt":0.4871521168423514,"score_spread":0.019932317201190708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124693","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93324935,0.04692156,0.00010269925,0.014508977,0.0005679109,0.0038830717,0.00053359754,0.00006117655,0.0001716595],"genre_scores_gemma":[0.8619983,0.055282626,0.012752532,0.06428293,0.0004498453,0.0017891193,0.0031112588,0.00011393765,0.00021941242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98054427,0.006947032,0.010630483,0.0010007533,0.00020972111,0.00066773716],"domain_scores_gemma":[0.99265194,0.0035685073,0.0027292294,0.0004091413,0.000085033666,0.0005561676],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06088318,0.0002660467,0.00225904,0.00083808735,0.00013833091,0.00007782502,0.0001964793,0.00018536621,0.00008062579],"category_scores_gemma":[0.030523192,0.00030064394,0.00011714401,0.0014653805,0.00003218095,0.00033978958,0.00010393366,0.0003718547,0.00046399774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002589665,0.0013172298,0.8656506,0.007006717,0.00009176542,0.000009318737,0.05702877,0.000505586,2.983046e-7,0.0058415956,0.04919542,0.013093743],"study_design_scores_gemma":[0.008028827,0.00024106624,0.77828425,0.009641704,0.000013903103,0.0000011168713,0.00078914186,0.018972823,0.0000013681189,0.0032824543,0.1798473,0.00089603063],"about_ca_topic_score_codex":0.0048925257,"about_ca_topic_score_gemma":0.00020553378,"teacher_disagreement_score":0.13065188,"about_ca_system_score_codex":0.0007818295,"about_ca_system_score_gemma":0.0004894252,"threshold_uncertainty_score":0.99994457},"labels":[],"label_agreement":null},{"id":"W4390124712","doi":"10.1016/j.jval.2023.09.2743","title":"RWD25 Healthcare Resource Utilization and Costs in Patients Experiencing Severe Cardiac Events Following a COPD Exacerbation: Results from EXACOS-CV Studies in Spain, Germany, the Netherlands and Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Heart Failure Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); University of British Columbia","funders":"","keywords":"Exacerbation; COPD; Copd exacerbation; Resource use; Health care; Medicine; Resource (disambiguation); Emergency medicine; Business; Medical emergency; Natural resource economics; Internal medicine; Economics; Economic growth; Computer science; Acute exacerbation of chronic obstructive pulmonary disease","score_opus":0.06440937331467148,"score_gpt":0.323999661133497,"score_spread":0.25959028781882554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9822315,0.0035266222,8.802029e-7,0.012617498,0.00019613138,0.001339566,0.000026415892,0.00002587786,0.000035482815],"genre_scores_gemma":[0.99701214,0.0017191834,0.000055403005,0.00078873633,0.000048323785,0.0000836977,0.00016575599,0.00001637604,0.00011041274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979509,0.00048844895,0.00050818274,0.0003546295,0.0003482887,0.00034956707],"domain_scores_gemma":[0.99915904,0.00039510615,0.00009683269,0.00020977137,0.000028425922,0.00011081845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011276683,0.00015123995,0.00037598494,0.00016853161,0.00012807075,0.000010407693,0.00004098623,0.000053451942,9.441377e-7],"category_scores_gemma":[0.00023721163,0.000120371005,0.000020108777,0.00043836475,0.000020997086,0.00006624364,0.00007790883,0.00015469216,7.5544597e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020916332,0.000044143904,0.9511533,0.00022209296,0.000042168987,0.00005445854,0.030549292,0.00036199242,9.706711e-7,0.00001754464,0.0036651776,0.013679725],"study_design_scores_gemma":[0.0041512237,0.00017992365,0.96735364,0.0015235672,0.00001183348,6.77427e-7,0.01746326,0.0015643458,0.0000021133426,0.000024295154,0.0076110717,0.000114021095],"about_ca_topic_score_codex":0.6267004,"about_ca_topic_score_gemma":0.37706393,"teacher_disagreement_score":0.24963649,"about_ca_system_score_codex":0.0011172525,"about_ca_system_score_gemma":0.00030154313,"threshold_uncertainty_score":0.63430303},"labels":[],"label_agreement":null},{"id":"W4390124723","doi":"10.1016/j.jval.2023.09.2583","title":"PCR145 Dupilumab Reduces Systemic Corticosteroid Use in Children with Uncontrolled Moderate-to-Severe Asthma Regardless of Prior Exacerbation History","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Dupilumab; Exacerbation; Medicine; Asthma; Asthma exacerbations; Corticosteroid; Copd exacerbation; Immunology; Internal medicine","score_opus":0.033270086964335414,"score_gpt":0.266753867250361,"score_spread":0.23348378028602557,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99535275,0.0019778383,0.000024544865,0.00034536273,0.00013435858,0.0020232499,0.000020920903,0.00008020662,0.00004078299],"genre_scores_gemma":[0.9986856,0.00013536411,0.00011587242,0.00033509114,0.000067741035,0.00010718236,0.000036746576,0.0000415284,0.00047490225],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976745,0.00036215785,0.00076973654,0.00040081106,0.00040868757,0.00038408962],"domain_scores_gemma":[0.9988822,0.00011360609,0.0003006096,0.00035081845,0.00009676552,0.00025601475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005349302,0.00019098089,0.00068791135,0.0005565159,0.000045098273,0.00001005073,0.00009274875,0.0000927656,0.000014230385],"category_scores_gemma":[0.00018741208,0.00015498021,0.000058110974,0.0004992563,0.000052105668,0.00012534871,0.000029956502,0.00019846266,0.000020421934],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007579251,0.000673697,0.8720588,0.0017636837,0.00009894127,0.00013491274,0.003700219,0.099336475,0.0019937716,0.000087993256,0.0015611652,0.011011082],"study_design_scores_gemma":[0.00967516,0.0014441477,0.975365,0.0035492524,0.000026605105,0.00009853997,0.00060312124,0.0085728355,0.00015123098,0.0000099628,0.00026484337,0.00023929277],"about_ca_topic_score_codex":0.0022198744,"about_ca_topic_score_gemma":0.00020367035,"teacher_disagreement_score":0.103306204,"about_ca_system_score_codex":0.0009769044,"about_ca_system_score_gemma":0.0014435143,"threshold_uncertainty_score":0.63199097},"labels":[],"label_agreement":null},{"id":"W4390124743","doi":"10.1016/j.jval.2023.09.2546","title":"PCR107 (How) Should Cost-Effectiveness Analysis Accommodate Heterogeneity in Patient Preferences?","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Computer science; Risk analysis (engineering); Business","score_opus":0.6588872030235842,"score_gpt":0.4794505031011653,"score_spread":0.17943669992241884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779291,0.0010795936,0.00074440846,0.016889978,0.00052894774,0.0019836007,0.00042779036,0.00009524575,0.00032132806],"genre_scores_gemma":[0.9953398,0.00049852446,0.00033456908,0.0029375763,0.00006980164,0.0005989517,0.0001555727,0.000032211985,0.000033007247],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99188864,0.0023990374,0.0037564263,0.00092214614,0.00016750714,0.0008662686],"domain_scores_gemma":[0.9953272,0.0019705233,0.0016621177,0.0007300733,0.00004071851,0.00026941154],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.029468637,0.0002553709,0.0016396092,0.0019929723,0.00014779475,0.00008639121,0.0003521937,0.00019406897,0.000084306834],"category_scores_gemma":[0.0019910317,0.00032267615,0.00019082648,0.0027082628,0.00004712068,0.00039315224,0.00012156696,0.00036218675,0.00072316156],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027146061,0.00016746594,0.8627939,0.0007230689,0.00011225707,0.000005117399,0.0022648203,0.123598546,7.464845e-7,0.008281049,0.0007455546,0.0012802915],"study_design_scores_gemma":[0.00090305763,0.00014073709,0.84291136,0.00019903935,0.000007733306,0.0000012734587,0.0006363865,0.1393093,0.000009927509,0.00788365,0.007613759,0.00038376867],"about_ca_topic_score_codex":0.027971491,"about_ca_topic_score_gemma":0.005347538,"teacher_disagreement_score":0.027477605,"about_ca_system_score_codex":0.0018323223,"about_ca_system_score_gemma":0.00030041777,"threshold_uncertainty_score":0.9999225},"labels":[],"label_agreement":null},{"id":"W4390124903","doi":"10.1016/j.jval.2023.09.2673","title":"PCR236 Treatment Preferences Among Patients With Relapsed/Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) in France, Germany, Italy, Japan, Spain, the United States, and the United Kingdom","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Diffuse large B-cell lymphoma; Refractory (planetary science); Medicine; Lymphoma; Demography; Internal medicine; Sociology; Biology","score_opus":0.027145006543339806,"score_gpt":0.26055075679010387,"score_spread":0.23340575024676405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124903","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9944174,0.0008818209,0.0000012364321,0.002067902,0.00011906604,0.0022178139,0.000094555064,0.00008879152,0.0001113899],"genre_scores_gemma":[0.9916941,0.005601937,0.000019089628,0.0012488101,0.00003649544,0.00038839874,0.0007148258,0.00004449352,0.0002518458],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970752,0.00067882857,0.00060629175,0.000473024,0.00047049593,0.0006961759],"domain_scores_gemma":[0.9977155,0.0011351007,0.00028622375,0.0005627059,0.00008204689,0.00021845283],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007715102,0.00036236868,0.0005806647,0.00055922556,0.0002669983,0.000048796075,0.0001541151,0.00011050469,0.0000094686375],"category_scores_gemma":[0.0000607,0.00017343387,0.00006798054,0.0016610306,0.00024971704,0.0000871117,0.00007663679,0.0001816465,0.00002096623],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005002073,0.0072690975,0.9830524,0.00014631989,0.00011320899,0.0000685703,0.0059162336,0.0003803585,2.8007094e-7,0.0003611499,0.00028778677,0.0019044105],"study_design_scores_gemma":[0.0703916,0.0013009409,0.90971655,0.00052890467,0.000078297315,0.0000035109463,0.0009133295,0.0073142266,0.000008052967,0.000093418974,0.009481265,0.00016990087],"about_ca_topic_score_codex":0.084031984,"about_ca_topic_score_gemma":0.001843853,"teacher_disagreement_score":0.08218814,"about_ca_system_score_codex":0.0006575251,"about_ca_system_score_gemma":0.00029174055,"threshold_uncertainty_score":0.9220675},"labels":[],"label_agreement":null},{"id":"W4390124954","doi":"10.1016/j.jval.2023.09.2693","title":"PCR256 Correlation of Patient-Reported Vitiligo Noticeability Scale With Physician-Assessed Facial Vitiligo Area Scoring Index Responses: Post Hoc Analyses From the True-V Trials of Ruxolitinib Cream in Vitiligo","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Barrie Urology Group","funders":"","keywords":"Vitiligo; Medicine; Post-hoc analysis; Dermatology; Post hoc; Correlation; Internal medicine; Mathematics","score_opus":0.08675642530319132,"score_gpt":0.3663956141107383,"score_spread":0.27963918880754696,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390124954","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99785393,0.00019432887,0.00028954123,0.00017653764,0.00016983488,0.00090660463,0.0003182462,0.000015557198,0.000075385935],"genre_scores_gemma":[0.99859864,0.00012561747,0.00023155738,0.00015163586,0.00008044589,0.000050440995,0.00073209836,0.00002131862,0.000008221648],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99576145,0.001534059,0.001512731,0.00047262234,0.00040110055,0.00031800658],"domain_scores_gemma":[0.9972853,0.00096217985,0.001007828,0.00050488557,0.0001656147,0.000074213895],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023095123,0.0002046359,0.0006504982,0.00019554253,0.000073455885,0.000016761504,0.00016346325,0.00015504411,0.000012220676],"category_scores_gemma":[0.001338383,0.00016165293,0.00013557784,0.000672224,0.0001254232,0.000018566774,0.000054961463,0.0001561928,0.000001188876],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008297431,0.0011540129,0.42829192,0.0003040993,0.0001580409,0.000014984805,0.0038219283,0.026189102,0.52283216,0.00004292402,0.00009110791,0.008802271],"study_design_scores_gemma":[0.0032749644,0.001840367,0.73829746,0.00057333085,0.00005505529,0.0000024615751,0.010607193,0.005777213,0.23890564,0.00036262424,0.000051592953,0.00025209234],"about_ca_topic_score_codex":0.01145969,"about_ca_topic_score_gemma":0.0016866751,"teacher_disagreement_score":0.31000552,"about_ca_system_score_codex":0.000076597724,"about_ca_system_score_gemma":0.0005493772,"threshold_uncertainty_score":0.9951231},"labels":[],"label_agreement":null},{"id":"W4390125005","doi":"10.1016/j.jval.2023.09.2290","title":"MT64 The Role of Digital Health Technologies in Out-of-Hospital Management of Mental Health Disorders in the UK","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Digital Mental Health Interventions","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Mental health; Digital health; Health management system; Medicine; Psychiatry; Psychology; Alternative medicine; Political science; Health care; Pathology","score_opus":0.03966932086109155,"score_gpt":0.37933598816397296,"score_spread":0.3396666673028814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125005","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89288205,0.0074678995,0.000017186634,0.08703622,0.0017190065,0.004707137,0.0005590949,0.00011542789,0.0054959715],"genre_scores_gemma":[0.9986245,0.00076520955,0.00007693293,0.00016369976,0.0000069462817,0.00021722958,0.000051234354,0.000023560528,0.00007069294],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9961884,0.000444952,0.0017871556,0.00036805274,0.00041549996,0.0007959368],"domain_scores_gemma":[0.99832875,0.0002609477,0.0007182815,0.00062541163,0.000014581227,0.000052055046],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023252165,0.00019024922,0.00051680824,0.0005339223,0.000075467244,0.000013437052,0.00070121035,0.00007455608,0.0000112916105],"category_scores_gemma":[0.000039302526,0.00014313182,0.00012406199,0.0015594119,0.000274848,0.00010902901,0.000231188,0.00036047053,0.00002854829],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026318632,0.0052296463,0.22190204,0.0033369698,0.00008541597,0.000008579005,0.05309673,0.00045836234,7.880624e-7,0.17408463,0.00251565,0.539018],"study_design_scores_gemma":[0.0040164394,0.011197134,0.43872005,0.005482642,0.000005491169,0.000005678051,0.41940922,0.00055430224,0.000027101705,0.111688145,0.008463586,0.00043023517],"about_ca_topic_score_codex":0.010496089,"about_ca_topic_score_gemma":0.0025091078,"teacher_disagreement_score":0.53858775,"about_ca_system_score_codex":0.00039346985,"about_ca_system_score_gemma":0.00017803728,"threshold_uncertainty_score":0.9960931},"labels":[],"label_agreement":null},{"id":"W4390125246","doi":"10.1016/j.jval.2023.09.2687","title":"PCR250 Management of Osteogenesis Imperfecta: Self-Reported Funding Sources for Healthcare, Consumables and Services Across the EU5 and Nordics","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Consumables; Osteogenesis imperfecta; Business; Medicine; Marketing; Pathology","score_opus":0.05284334681061882,"score_gpt":0.3669621924580889,"score_spread":0.3141188456474701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125246","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98127586,0.01626677,0.000027394759,0.0014223382,0.00004084405,0.0008746011,0.000063020816,0.000015142033,0.0000140086195],"genre_scores_gemma":[0.9793515,0.020097308,0.00019525379,0.0000990245,0.000025739524,0.000101415964,0.000050790164,0.000019025436,0.000059918515],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987301,0.00014670474,0.0002770169,0.0003253035,0.00012594671,0.00039489107],"domain_scores_gemma":[0.99939024,0.00013258758,0.00011658208,0.00021874536,0.00006811987,0.00007369118],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012499557,0.00010605439,0.00017620089,0.00006110186,0.0002243917,0.000023306508,0.00011478096,0.00006313583,9.739625e-7],"category_scores_gemma":[0.000037425,0.00008975261,0.000028668946,0.0002536069,0.000080812584,0.000003573363,0.0002253794,0.000056153414,4.7550262e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079674483,0.00021811595,0.7648698,0.029456198,0.0011795848,0.000025954181,0.012444555,0.00132881,0.042245753,0.0014849305,0.00031960916,0.14562994],"study_design_scores_gemma":[0.009359558,0.0037855706,0.80246085,0.0014586184,0.00014119175,0.000106100655,0.064679734,0.020344598,0.03613778,0.0026691197,0.057617493,0.0012394038],"about_ca_topic_score_codex":0.0036120873,"about_ca_topic_score_gemma":0.0011162754,"teacher_disagreement_score":0.14439054,"about_ca_system_score_codex":0.000020821424,"about_ca_system_score_gemma":0.00008102493,"threshold_uncertainty_score":0.54604197},"labels":[],"label_agreement":null},{"id":"W4390125469","doi":"10.1016/j.jval.2023.09.1344","title":"HPR25 Germany: Leading the Way for Digital Health Technology Assessment in Europe","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Health technology; Political science; Health care; Law","score_opus":0.45876416220943367,"score_gpt":0.476087155703371,"score_spread":0.017322993493937344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125469","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.25985044,0.0033244141,0.0030462728,0.7261916,0.0013018772,0.0035535228,0.0004799955,0.00025076553,0.0020011587],"genre_scores_gemma":[0.97782344,0.0011952509,0.0018833994,0.016985098,0.00030122438,0.000608914,0.00009664058,0.00008435793,0.0010216894],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9933094,0.0004401006,0.0045006527,0.0006513317,0.00009886948,0.000999663],"domain_scores_gemma":[0.9958758,0.0017242605,0.0016355576,0.0005664332,0.00004229026,0.00015565653],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.028547266,0.00018837693,0.0010204995,0.0011661596,0.00028680384,0.000093768904,0.0004240274,0.00012295083,0.000021812295],"category_scores_gemma":[0.00293047,0.00020496201,0.000069025715,0.0016837553,0.000071763476,0.00030550556,0.00009893677,0.00042667167,0.0010470763],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012230023,0.00015966952,0.1433659,0.0015864674,0.000024290131,0.0000031984998,0.0038389475,0.011425119,7.708253e-7,0.79699713,0.038160264,0.004426028],"study_design_scores_gemma":[0.0025527268,0.0006275414,0.17061807,0.0008356982,0.0000014617254,0.000014026506,0.0062595066,0.19442119,0.0000012481395,0.0970107,0.5269855,0.00067230937],"about_ca_topic_score_codex":0.0024901314,"about_ca_topic_score_gemma":0.00036654677,"teacher_disagreement_score":0.717973,"about_ca_system_score_codex":0.0016368326,"about_ca_system_score_gemma":0.000968818,"threshold_uncertainty_score":0.9997307},"labels":[],"label_agreement":null},{"id":"W4390125519","doi":"10.1016/j.jval.2023.09.1316","title":"PT8 Five-Year Healthcare Resource Consumption and Direct Costs of Women with a New Diagnosis of Hr+/HER2- Breast Cancer Primary or Advanced: Analysis of a Large Italian Administrative Database","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Breast cancer; Consumption (sociology); Resource consumption; Medicine; Database; Health care; Resource (disambiguation); Cancer; Business; Computer science; Internal medicine; Economics; Economic growth","score_opus":0.06180095294210449,"score_gpt":0.3222798541341488,"score_spread":0.2604789011920443,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125519","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9837588,0.0036337287,0.000029060007,0.0012976831,0.000047072368,0.00043517258,0.010553352,0.000013904494,0.00023119978],"genre_scores_gemma":[0.9865961,0.012524872,0.00027034883,0.000258442,0.00002501358,0.00007953867,0.000090710855,0.000021724582,0.00013324874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99806696,0.000056550612,0.00096453645,0.00040505882,0.00006468893,0.00044223276],"domain_scores_gemma":[0.9981105,0.00025179735,0.0010385084,0.00031042795,0.000049545426,0.00023924494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009866572,0.00015840727,0.0011161822,0.00063547865,0.000044086577,0.000008963036,0.00012845855,0.00007577588,0.0001495117],"category_scores_gemma":[0.00011396433,0.0001595388,0.000060962244,0.0011720181,0.000109485845,0.00021190205,0.00005285944,0.00012080129,0.0000035027958],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011374891,0.00013957666,0.9805127,0.0010109233,0.00026272135,0.0000031505936,0.0042888867,0.0016160157,0.0000025473096,0.005340188,0.00036842944,0.005317409],"study_design_scores_gemma":[0.0015583135,0.0006515218,0.9929312,0.0006550458,0.000030137691,0.0000012976998,0.0011040228,0.00080629135,0.000026076648,0.00019392249,0.0018502169,0.00019196954],"about_ca_topic_score_codex":0.040268727,"about_ca_topic_score_gemma":0.007832979,"teacher_disagreement_score":0.032435745,"about_ca_system_score_codex":0.00069416093,"about_ca_system_score_gemma":0.0005674998,"threshold_uncertainty_score":0.9661222},"labels":[],"label_agreement":null},{"id":"W4390125524","doi":"10.1016/j.jval.2023.09.1372","title":"HPR54 Policy Approaches to the Regulation and Reimbursement of Pediatric Medicines: Comparing Canadian, European, and UK Health Systems","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Reimbursement; Business; Public economics; Family medicine; Medicine; Political science; Health care; Economics; Law","score_opus":0.3992960127610062,"score_gpt":0.4098861714505228,"score_spread":0.010590158689516627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125524","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.63548255,0.0261422,0.00003203491,0.33242682,0.00029043216,0.001820815,0.000014923246,0.00003605429,0.0037541843],"genre_scores_gemma":[0.9889245,0.008051961,0.000053123324,0.0024090935,0.00047356397,0.000012374409,0.0000071792556,0.000009950611,0.000058222766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985615,0.00034507402,0.00040324876,0.00017479979,0.00019341995,0.00032194416],"domain_scores_gemma":[0.9990676,0.00024512093,0.00013663524,0.00012997544,0.000020004189,0.000400655],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029079455,0.00008123054,0.0002823097,0.0002484314,0.00016488058,0.000011072743,0.000045288172,0.000017032728,0.0000018953288],"category_scores_gemma":[0.00024726728,0.000055651144,0.00001054504,0.0006508058,0.000031863892,0.000023008068,0.000051942516,0.00014315062,0.000004564028],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002333137,0.00010308275,0.83799887,0.010410012,0.0001234736,0.000024087954,0.0247795,0.015192777,0.000011089354,0.018644644,0.041040435,0.05143873],"study_design_scores_gemma":[0.0007875764,0.00035931086,0.91659856,0.00035307568,0.00002713296,0.000020332955,0.0026814945,0.027136674,7.981497e-7,0.00006303107,0.051894944,0.00007709367],"about_ca_topic_score_codex":0.33373335,"about_ca_topic_score_gemma":0.010617337,"teacher_disagreement_score":0.353442,"about_ca_system_score_codex":0.0001844555,"about_ca_system_score_gemma":0.0003490044,"threshold_uncertainty_score":0.67070335},"labels":[],"label_agreement":null},{"id":"W4390125527","doi":"10.1016/j.jval.2023.09.1396","title":"HPR78 From Submission to Reimbursement: Navigating the COVID-19 Ripple Effect on Therapy Access in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Coronavirus disease 2019 (COVID-19); Ripple; Business; Internet privacy; Medicine; Computer science; Economics; Internal medicine; Engineering; Economic growth; Health care","score_opus":0.17823753359767747,"score_gpt":0.47125299226925815,"score_spread":0.2930154586715807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80189645,0.00048840337,0.000009584968,0.19540618,0.0003767846,0.0016914028,0.000038032253,0.00005785534,0.000035278434],"genre_scores_gemma":[0.9009637,0.0004614819,0.000020583924,0.09814808,0.00019203068,0.00009578128,0.00006133149,0.00002885959,0.000028127988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969513,0.00070927636,0.0005582301,0.00042783644,0.0006330587,0.0007202971],"domain_scores_gemma":[0.99590755,0.0025907129,0.00013131982,0.00049986783,0.000023677061,0.0008468804],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024469963,0.00019389357,0.00044105473,0.00019196999,0.00020924161,0.00002839169,0.0002536774,0.0000709557,0.000070603644],"category_scores_gemma":[0.0017160261,0.00013308127,0.00004150393,0.0013279123,0.000015215215,0.00004627312,0.00007169387,0.0007259298,0.00002445972],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0010908331,0.0000833596,0.8164909,0.00091013155,0.000017680568,0.00034581928,0.011513988,0.018318139,0.00026847722,0.000051348772,0.023464167,0.12744519],"study_design_scores_gemma":[0.0040528723,0.001566634,0.93912446,0.0025421996,0.0000047537724,0.000006373817,0.00071707205,0.0039717145,0.0006956901,0.00049414,0.046592098,0.00023200667],"about_ca_topic_score_codex":0.99709743,"about_ca_topic_score_gemma":0.9109042,"teacher_disagreement_score":0.12721318,"about_ca_system_score_codex":0.0051608384,"about_ca_system_score_gemma":0.011265587,"threshold_uncertainty_score":0.9986582},"labels":[],"label_agreement":null},{"id":"W4390125633","doi":"10.1016/j.jval.2023.09.1434","title":"HPR116 Is Payment Innovation Keeping Up With Therapy Innovation? A New Taxonomy of Innovative Payment Solutions to Aid Effective Implementation","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Payment; Business; Finance","score_opus":0.18683578292174954,"score_gpt":0.4635676073281766,"score_spread":0.2767318244064271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125633","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87057894,0.000223683,0.012990776,0.09545221,0.0014519653,0.017264226,0.0002514397,0.0003071602,0.0014795851],"genre_scores_gemma":[0.85630274,0.00060784887,0.0071232864,0.12585647,0.00055659143,0.0073103122,0.0010388161,0.00011627397,0.0010876701],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9949602,0.0007734512,0.0021664053,0.00051174377,0.0005445829,0.0010436054],"domain_scores_gemma":[0.996558,0.00069318403,0.0011254417,0.0004103802,0.0010758947,0.00013707971],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00363022,0.0002786452,0.0006274186,0.0021653327,0.0006855912,0.000011532007,0.00018747845,0.0001373453,0.00024434229],"category_scores_gemma":[0.00016163237,0.00024720974,0.00003021615,0.013199631,0.000038076883,0.00027600935,0.00014790933,0.00057957624,0.00011753346],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008711508,0.00023109908,0.32335186,0.0015501694,0.00018127017,0.0000038898443,0.053413507,0.0008230178,0.00081797864,0.09957229,0.1757277,0.34345606],"study_design_scores_gemma":[0.011837692,0.0032311503,0.62745947,0.0013675212,0.000012063307,0.0000017489558,0.019780658,0.00033696802,0.0012075334,0.0050690467,0.32897702,0.00071913237],"about_ca_topic_score_codex":0.020776758,"about_ca_topic_score_gemma":0.00084786135,"teacher_disagreement_score":0.34273693,"about_ca_system_score_codex":0.002861472,"about_ca_system_score_gemma":0.007659581,"threshold_uncertainty_score":0.99999803},"labels":[],"label_agreement":null},{"id":"W4390125642","doi":"10.1016/j.jval.2023.09.1296","title":"EPH255 Healthcare Resource Consumption of Patients with Cardiovascular Events after Exacerbations of Chronic Obstructive Pulmonary Disease in Italy: Results from the EXACOS-CV Study","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Pulmonary disease; Medicine; Intensive care medicine; Disease; Resource consumption; Health care; Internal medicine; Cardiology; Economic growth; Economics","score_opus":0.055644098638278794,"score_gpt":0.36136678470511346,"score_spread":0.30572268606683467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125642","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98271686,0.0057364535,0.0000043036753,0.0019190771,0.00043402487,0.006451991,0.0026425212,0.00006698699,0.000027779524],"genre_scores_gemma":[0.99796325,0.00047616218,0.000051532184,0.0001780478,0.00012062169,0.0006048819,0.00051941874,0.00005056686,0.000035546032],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9900127,0.005233004,0.0019869735,0.00072612875,0.0011591419,0.00088204065],"domain_scores_gemma":[0.9953872,0.0018959102,0.00076425273,0.0012958363,0.00033828203,0.00031850833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0030874037,0.0002822015,0.000827318,0.00035163123,0.00032069415,0.000003272175,0.00033895575,0.00016488429,0.0000234642],"category_scores_gemma":[0.00067222904,0.00022300765,0.00012397727,0.0014370956,0.00012451308,0.00014547083,0.0002286127,0.0007902636,0.000059815324],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018207541,0.0004778133,0.9723882,0.0014220707,0.000056515782,0.000022137596,0.015502993,0.00716224,2.2622967e-7,0.00003713874,0.00019317937,0.0009166977],"study_design_scores_gemma":[0.003255318,0.00038041003,0.9847193,0.0028370235,0.000036954036,1.1841704e-7,0.006900069,0.00064958417,3.68745e-7,0.00032861164,0.0007366011,0.00015566849],"about_ca_topic_score_codex":0.08410098,"about_ca_topic_score_gemma":0.0071259784,"teacher_disagreement_score":0.076975,"about_ca_system_score_codex":0.0016983805,"about_ca_system_score_gemma":0.0016159075,"threshold_uncertainty_score":0.9219981},"labels":[],"label_agreement":null},{"id":"W4390125944","doi":"10.1016/j.jval.2023.09.1818","title":"HTA134 The Impact of Non-Comparative Data for Non-Orphan Drugs on HTA and Pricing Outcomes in Germany: Can an Added Benefit Ever be Proven?","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Orphan drug; Economics; Actuarial science; Public economics; Medicine; Bioinformatics; Biology","score_opus":0.5317275469605763,"score_gpt":0.5061777442554654,"score_spread":0.02554980270511098,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761807,0.00018199308,0.00005558332,0.018335702,0.00020521253,0.0026895835,0.0021557054,0.000018938696,0.00017658118],"genre_scores_gemma":[0.99645096,0.000109408735,0.000509374,0.0022809198,0.00010447091,0.00018201908,0.00019815679,0.000033216176,0.0001314632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99527574,0.00031190374,0.003029997,0.00069328863,0.000104398845,0.00058469496],"domain_scores_gemma":[0.9948776,0.0022739498,0.0016061242,0.0010284623,0.000036436264,0.00017744533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018577246,0.00022416397,0.0013005248,0.00061716157,0.00016389665,0.00004480028,0.00051324914,0.00009941416,0.000018137333],"category_scores_gemma":[0.00088943937,0.00020782679,0.00007586652,0.00046073945,0.00005734007,0.00038219086,0.00011849151,0.00022418732,0.00003568701],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031668725,0.00084237556,0.76522845,0.0026679316,0.00026569818,0.000002157467,0.1352521,0.059353173,0.000014055738,0.018993562,0.015707832,0.0013559727],"study_design_scores_gemma":[0.0014549344,0.0005086486,0.6424385,0.00021583463,0.0000026335342,6.8261625e-7,0.0028053054,0.34807035,0.0000032660118,0.0038368425,0.00044748292,0.0002155562],"about_ca_topic_score_codex":0.06064232,"about_ca_topic_score_gemma":0.0036419192,"teacher_disagreement_score":0.28871718,"about_ca_system_score_codex":0.0007764306,"about_ca_system_score_gemma":0.0005373347,"threshold_uncertainty_score":0.94561297},"labels":[],"label_agreement":null},{"id":"W4390125958","doi":"10.1016/j.jval.2023.09.391","title":"EE121 Cost-Efficiency and the Opportunity for Expanded Treatment Access with Incremental Increases in Biosimilar Adalimumab and Tocilizumab Use: A European Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Biosimilar; Tocilizumab; Adalimumab; Perspective (graphical); Medicine; Internal medicine; Computer science; Rheumatoid arthritis; Artificial intelligence","score_opus":0.15026313276785994,"score_gpt":0.3781046183827965,"score_spread":0.22784148561493658,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125958","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9872188,0.0032057543,0.00009331321,0.006288185,0.00006147115,0.0025865484,0.00020552859,0.000052591604,0.00028783156],"genre_scores_gemma":[0.9962391,0.0023742232,0.0002054779,0.0008805325,0.000014506228,0.00013163117,0.00002805648,0.000015768665,0.00011066175],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99728703,0.0015498145,0.00032497072,0.00038844722,0.0000433106,0.00040642903],"domain_scores_gemma":[0.99849737,0.0011083591,0.00010368655,0.00018167256,0.00003917002,0.00006974235],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017759266,0.0001837613,0.00038715612,0.00016981494,0.00022840695,0.000044482997,0.00012886425,0.00007959392,0.000018445347],"category_scores_gemma":[0.00037087128,0.0001067007,0.00003878907,0.00037607434,0.00048137916,0.000088926725,0.00012453072,0.00017026396,0.0000013823652],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06394411,0.009746188,0.49785042,0.0017387415,0.002189774,0.00059696694,0.049938925,0.00062859803,0.0059535094,0.11352906,0.00663393,0.24724978],"study_design_scores_gemma":[0.14626433,0.018499255,0.72757083,0.00171902,0.0003993555,0.0006397187,0.055607464,0.011260926,0.0060323295,0.010621608,0.019176872,0.0022082673],"about_ca_topic_score_codex":0.015283137,"about_ca_topic_score_gemma":0.0011304688,"teacher_disagreement_score":0.2450415,"about_ca_system_score_codex":0.00022797172,"about_ca_system_score_gemma":0.00021395269,"threshold_uncertainty_score":0.9912742},"labels":[],"label_agreement":null},{"id":"W4390125967","doi":"10.1016/j.jval.2023.09.654","title":"EE388 Cost of Illness for Advanced Hepatocellular Carcinoma (aHCC) in Ontario, Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; AstraZeneca (Canada); Sunnybrook Hospital","funders":"","keywords":"Hepatocellular carcinoma; Medicine; Oncology; Internal medicine","score_opus":0.059121993882623965,"score_gpt":0.2473479164425411,"score_spread":0.18822592255991713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940437,0.0012286938,0.00017274056,0.00092100276,0.0008715671,0.0008385196,0.0003068001,0.000012112761,0.001604863],"genre_scores_gemma":[0.9983703,0.00023775594,0.00018852796,0.00035724457,0.000038558243,0.00012597181,0.00003821296,0.00002632995,0.0006170963],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980086,0.000015316413,0.0010437067,0.0003468545,0.000033328874,0.00055215554],"domain_scores_gemma":[0.9990733,0.0001248618,0.0004048847,0.0002587311,0.00002302806,0.00011517156],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008760889,0.00013696308,0.000636003,0.00030897124,0.0000536402,0.0000094488005,0.00019265417,0.000079326026,0.000069620466],"category_scores_gemma":[0.00013824356,0.00018169485,0.000062346924,0.00036217817,0.000028483943,0.00013551013,0.000032095846,0.00016653081,0.000016420163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007117365,0.000040538962,0.92726696,0.00024204387,0.0000068018276,0.0000089345185,0.001807783,0.017715406,0.000003233385,0.048832517,0.0016346177,0.0023699687],"study_design_scores_gemma":[0.00278087,0.00018647204,0.77405155,0.00015085375,0.0000013418953,0.0000014062863,0.00055128516,0.034432616,0.00012630194,0.021665528,0.16558936,0.00046243696],"about_ca_topic_score_codex":0.99385566,"about_ca_topic_score_gemma":0.97693753,"teacher_disagreement_score":0.16395475,"about_ca_system_score_codex":0.0020307489,"about_ca_system_score_gemma":0.0016384893,"threshold_uncertainty_score":0.74093014},"labels":[],"label_agreement":null},{"id":"W4390125989","doi":"10.1016/j.jval.2023.09.620","title":"EE354 Value for Money: Evaluating the Economic Benefit of a Hypothetical Disease Modifying Therapy for Alzheimer's Disease From Canadian Payer and Societal Perspectives","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Disease; Value for money; Value (mathematics); Medicine; Economics; Intensive care medicine; Psychology; Public economics; Computer science; Internal medicine","score_opus":0.4749751899164508,"score_gpt":0.45748576411303055,"score_spread":0.017489425803420278,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390125989","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8831715,0.022639532,0.0004490645,0.084097765,0.00041592174,0.0036775698,0.0054658214,0.000040202693,0.000042632237],"genre_scores_gemma":[0.99107414,0.0012899357,0.0022667854,0.0037449168,0.00040422592,0.0009806379,0.00011988483,0.00007184335,0.00004760378],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99569595,0.000354405,0.0023651198,0.0007713544,0.00009553842,0.00071761356],"domain_scores_gemma":[0.99397737,0.0038060376,0.000997907,0.00050038693,0.0000529219,0.00066538487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01295497,0.0002326294,0.00082574453,0.00033358095,0.00048027447,0.000075437165,0.00027814254,0.00009510158,0.000038729333],"category_scores_gemma":[0.0018188192,0.00024720683,0.00022942293,0.00015318912,0.00013803007,0.0002097596,0.000040602103,0.00014409711,0.000049492908],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006027233,0.00018192777,0.0909189,0.0010016096,0.00044060664,0.0000012279485,0.031775724,0.15418032,0.000003143501,0.71124613,0.0051697833,0.004477921],"study_design_scores_gemma":[0.0015176687,0.00014512448,0.099256404,0.00011000099,0.000018094986,2.401701e-7,0.0029679902,0.73627245,7.6653816e-7,0.15788391,0.0015776383,0.00024968522],"about_ca_topic_score_codex":0.15109374,"about_ca_topic_score_gemma":0.0037645996,"teacher_disagreement_score":0.58209217,"about_ca_system_score_codex":0.0011088783,"about_ca_system_score_gemma":0.00192852,"threshold_uncertainty_score":0.99999803},"labels":[],"label_agreement":null},{"id":"W4390126012","doi":"10.1016/j.jval.2023.09.349","title":"EE77 The Cost-Effectiveness of Tradition Chinese Medicine Icaritin Versus Cinobufotalin in Patients with Unresectable Advanced Hepatocellular Carcinoma in China","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Medicinal Plant Pharmacodynamics Research","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centennial College","funders":"","keywords":"Hepatocellular carcinoma; China; Medicine; Traditional Chinese medicine; Oncology; Traditional medicine; Internal medicine; Alternative medicine; History; Pathology","score_opus":0.14768610125522946,"score_gpt":0.4517254448553063,"score_spread":0.30403934360007684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126012","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99375767,0.0004954676,0.000012388932,0.0011788063,0.00068999315,0.0033049881,0.0001503373,0.000031425716,0.00037893106],"genre_scores_gemma":[0.9986571,0.00042537943,0.000010831102,0.000108081935,0.00006545934,0.0003022204,0.00038286945,0.000031578995,0.000016450416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9936866,0.0037156148,0.00076860277,0.00042859872,0.00061953283,0.000781011],"domain_scores_gemma":[0.99488026,0.004358696,0.00020376696,0.00026081176,0.00007653248,0.00021994075],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073899063,0.00025495762,0.0006156167,0.0007575249,0.000107899505,0.0000050226117,0.00040689413,0.00017223683,0.00010830395],"category_scores_gemma":[0.0005700164,0.0001811981,0.00003685543,0.0025456112,0.00027754618,0.000119746386,0.00007609395,0.0015496279,0.000010861491],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010075393,0.00046424856,0.91045624,0.0010066743,0.000027933913,0.00014723546,0.001249482,0.07306405,0.0013241357,0.00041008374,0.000085925356,0.0016885898],"study_design_scores_gemma":[0.015258945,0.0009922887,0.7615768,0.00049018994,0.000010159519,0.0000030500494,0.00017227224,0.22070833,0.00030871353,0.0002603541,0.000086834494,0.00013206709],"about_ca_topic_score_codex":0.0070621446,"about_ca_topic_score_gemma":0.00047147745,"teacher_disagreement_score":0.14887945,"about_ca_system_score_codex":0.00057661126,"about_ca_system_score_gemma":0.00036484763,"threshold_uncertainty_score":0.9995499},"labels":[],"label_agreement":null},{"id":"W4390126073","doi":"10.1016/j.jval.2023.09.1034","title":"PT44 Cost-Effectiveness of Olaparib Vs. Rucaparib for Patients with Metastatic Castration-Resistant Prostate Cancer – the Canadian Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"PARP inhibition in cancer therapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal; McGill University Health Centre; McGill University","funders":"","keywords":"Olaparib; Prostate cancer; Medicine; Oncology; Perspective (graphical); Internal medicine; Gynecology; Cancer; Poly ADP ribose polymerase; Computer science; Biology; Artificial intelligence","score_opus":0.07375261166157042,"score_gpt":0.37935217719536884,"score_spread":0.3055995655337984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9791242,0.0005351259,0.0000561063,0.008723544,0.00033022897,0.009637145,0.0013454771,0.000043985776,0.00020420873],"genre_scores_gemma":[0.9967991,0.00011964942,0.00027391998,0.00048915105,0.000038442777,0.002062654,0.00013152628,0.000035767414,0.000049779497],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981838,0.00032710546,0.00037939087,0.00029580682,0.00035136586,0.0004625538],"domain_scores_gemma":[0.998316,0.0005355939,0.0002075433,0.00025037685,0.00048522913,0.00020525987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011856278,0.00015484706,0.00039549396,0.00026137382,0.00021322064,0.000016378042,0.000082361825,0.0000388152,0.000019986002],"category_scores_gemma":[0.00014337646,0.00010892352,0.00005177125,0.00080743246,0.00013557958,0.00006786176,0.0000072300454,0.0001836979,0.0000037729842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.035576023,0.0017928297,0.68185234,0.01143821,0.0015215825,0.000084349565,0.06122033,0.110140726,0.0013086889,0.08193716,0.0064633545,0.0066643897],"study_design_scores_gemma":[0.017379083,0.0037479308,0.95803547,0.0029554847,0.000110822606,0.00000674002,0.003130823,0.004082786,0.0013293817,0.004801804,0.0040690354,0.00035062796],"about_ca_topic_score_codex":0.5572669,"about_ca_topic_score_gemma":0.2667785,"teacher_disagreement_score":0.29048836,"about_ca_system_score_codex":0.0025466406,"about_ca_system_score_gemma":0.004483235,"threshold_uncertainty_score":0.7953067},"labels":[],"label_agreement":null},{"id":"W4390126123","doi":"10.1016/j.jval.2023.09.656","title":"EE390 Optimizing the Use of Risk Factors to Guide the Cost-Effective Use of Palivizumab Prophylaxis Against Severe Respiratory Syncytial Virus Infection in Korean Infants Born 32–35 Weeks’ Gestational Age","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Palivizumab; Medicine; Gestational age; Pediatrics; Virus; Virology; Biology; Pregnancy","score_opus":0.16633067683303307,"score_gpt":0.3960097912728213,"score_spread":0.22967911443978825,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932861,0.00006198465,0.0002463186,0.00018980399,0.00022818931,0.0056017595,0.00026974097,0.00006660969,0.00004953401],"genre_scores_gemma":[0.9981346,0.00042474913,0.000279841,0.0004310368,0.00009614118,0.0005038692,0.00003905135,0.000056125828,0.000034553992],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99401754,0.0028377902,0.0012027564,0.00046765755,0.00088337593,0.0005908503],"domain_scores_gemma":[0.99443674,0.0038698968,0.00043867828,0.00073410716,0.00032054825,0.0002000475],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003207658,0.00027139866,0.0005724065,0.0012376774,0.00026788758,0.000057459307,0.00018996849,0.00018336216,0.000016015696],"category_scores_gemma":[0.0077070566,0.00018358913,0.00014115887,0.003035488,0.00026615863,0.00035900393,0.00017975413,0.001050741,0.000019037647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00059506565,0.00026387014,0.58617777,0.00031715698,0.000062797495,0.000043193162,0.0041529858,0.37886864,0.0019582056,0.00006458126,0.0006884476,0.026807271],"study_design_scores_gemma":[0.0013193924,0.0015853404,0.9819416,0.0005938154,0.000016233334,0.000004758232,0.00028452944,0.0067719175,0.0023744476,0.00003400092,0.0049008327,0.0001731658],"about_ca_topic_score_codex":0.09763893,"about_ca_topic_score_gemma":0.007964033,"teacher_disagreement_score":0.39576378,"about_ca_system_score_codex":0.0012029188,"about_ca_system_score_gemma":0.0010940923,"threshold_uncertainty_score":0.9226623},"labels":[],"label_agreement":null},{"id":"W4390126168","doi":"10.1016/j.jval.2023.09.319","title":"EE46 BoNT-As for Cervical Dystonia: Cost of Treatment and Response to Therapy in Canadian Patients","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Botulinum Toxin and Related Neurological Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Cervical dystonia; Medicine; Dystonia; Physical medicine and rehabilitation; Physical therapy; Psychiatry","score_opus":0.0537677110640155,"score_gpt":0.34135118690507277,"score_spread":0.28758347584105726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126168","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97242993,0.00023466897,5.2209026e-7,0.025492309,0.0000691375,0.001664443,0.000025821964,0.000014515436,0.00006864886],"genre_scores_gemma":[0.99507785,0.0012624222,0.000039981118,0.0033887147,0.000007134381,0.0000846889,0.000012747975,0.000011800458,0.000114634015],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989627,0.00015853647,0.00025871833,0.00019149817,0.00006826303,0.0003602842],"domain_scores_gemma":[0.9992094,0.0002645481,0.00002845315,0.00010824215,0.000018478204,0.00037089296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038122418,0.00008257366,0.00024416498,0.00027813262,0.000032087573,0.0000022339846,0.000031739168,0.000105278865,0.0000098929495],"category_scores_gemma":[0.00018454996,0.000060639908,0.000029062938,0.000378172,0.000024574247,0.000008799826,0.000007340148,0.00009501917,0.000010659022],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018256465,0.0011872607,0.8878385,0.00033447132,0.0000487761,0.0001324915,0.008433158,0.0029129821,0.00043320676,0.0005101167,0.0012030705,0.07870951],"study_design_scores_gemma":[0.006519462,0.011098823,0.9647385,0.0001243313,0.000003277407,0.0000029819996,0.00011452796,0.0019576803,0.000042159034,0.00028816014,0.0150387,0.00007143793],"about_ca_topic_score_codex":0.26780328,"about_ca_topic_score_gemma":0.050390657,"teacher_disagreement_score":0.21741262,"about_ca_system_score_codex":0.00035137616,"about_ca_system_score_gemma":0.000588483,"threshold_uncertainty_score":0.96693724},"labels":[],"label_agreement":null},{"id":"W4390126243","doi":"10.1016/j.jval.2023.09.598","title":"EE332 Evaluation of Hospital Pandemic Control Strategies of a Chinese Tertiary Care Hospital During the Late Phase of COVID-19 Pandemic","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Disaster Response and Management","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Pandemic; Coronavirus disease 2019 (COVID-19); Tertiary care; 2019-20 coronavirus outbreak; Phase (matter); Medicine; Control (management); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medical emergency; Emergency medicine; Virology; Computer science; Infectious disease (medical specialty); Disease; Artificial intelligence; Internal medicine; Outbreak","score_opus":0.09191689034729571,"score_gpt":0.4647197002811461,"score_spread":0.3728028099338504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126243","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9937875,0.0009991089,0.00008062966,0.001093257,0.0004804986,0.0031657824,0.00015648996,0.00007013774,0.00016654785],"genre_scores_gemma":[0.9988971,0.00041874053,0.0000095133355,0.00018250069,0.00006121797,0.00029578936,0.000034476318,0.000021516584,0.00007916022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9954681,0.0021218685,0.0011475575,0.00022858955,0.0005968853,0.00043699742],"domain_scores_gemma":[0.99772847,0.00077163073,0.0007664583,0.00042552114,0.00019162925,0.00011628441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004513626,0.00016286793,0.00045467485,0.00028895304,0.00018464791,0.000004452038,0.00025438942,0.000100365374,0.00005084141],"category_scores_gemma":[0.0006575206,0.00011631953,0.00009632652,0.0005077622,0.000100285535,0.00013395557,0.000120094424,0.00029862227,0.000009890206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034369307,0.0002773332,0.7856755,0.0060844882,0.00008220998,0.000004301888,0.18514812,0.019549333,0.00058998074,0.00046155902,0.00013766307,0.0016457863],"study_design_scores_gemma":[0.014784704,0.00088978565,0.78345954,0.0010150471,0.00007867492,6.926082e-7,0.18242246,0.013058337,0.000011538165,0.0038604068,0.0002143858,0.0002044125],"about_ca_topic_score_codex":0.005095242,"about_ca_topic_score_gemma":0.00035637905,"teacher_disagreement_score":0.0144410115,"about_ca_system_score_codex":0.0003846621,"about_ca_system_score_gemma":0.001889593,"threshold_uncertainty_score":0.77025163},"labels":[],"label_agreement":null},{"id":"W4390126259","doi":"10.1016/j.jval.2023.09.476","title":"EE208 A Total Cost of Care Analysis of Immune-Oncology (IO) Treatments for Unresectable Hepatocellular Carcinoma (uHCC): A Canadian Payer Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hepatocellular carcinoma; Perspective (graphical); Oncology; Medicine; Internal medicine; Computer science","score_opus":0.06253045675848833,"score_gpt":0.30213991439623,"score_spread":0.23960945763774166,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126259","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9817319,0.008319079,0.000109294866,0.00056248077,0.00029556704,0.001013318,0.003051127,0.0000117359605,0.004905486],"genre_scores_gemma":[0.9984991,0.0006221157,0.00015578816,0.000076570366,0.000039987404,0.00013429589,0.000121931604,0.000025534286,0.00032470818],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979202,0.00003633741,0.0010274696,0.00039288556,0.00003287877,0.0005902019],"domain_scores_gemma":[0.9986246,0.00014026368,0.00059862976,0.0003270318,0.0001112075,0.00019824307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00066048605,0.00015550877,0.0011432265,0.0015261467,0.000088089175,0.000010460601,0.0001745206,0.00014801849,0.00009134613],"category_scores_gemma":[0.00017153354,0.00018922352,0.00031543017,0.0012935374,0.00006383439,0.00010849722,0.00003069256,0.00010533871,0.00002193334],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017123243,0.00012080148,0.8886809,0.00024688343,0.0007460446,0.000010912754,0.0135682095,0.019869499,0.000014175491,0.074993365,0.00022674467,0.0013512858],"study_design_scores_gemma":[0.0032845195,0.0015915924,0.8635492,0.00007524921,0.00015979676,0.0000020796924,0.0074902056,0.10901267,0.00020785032,0.0069229505,0.0072679115,0.0004360138],"about_ca_topic_score_codex":0.81639254,"about_ca_topic_score_gemma":0.113274485,"teacher_disagreement_score":0.7031181,"about_ca_system_score_codex":0.0029854097,"about_ca_system_score_gemma":0.0010969824,"threshold_uncertainty_score":0.90290594},"labels":[],"label_agreement":null},{"id":"W4390126269","doi":"10.1016/j.jval.2023.09.502","title":"EE234 Economic Analysis of the Pronto Study","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TD Bank Group; Sunnybrook Hospital; Health Sciences Centre; Queen's University; Ontario Institute for Cancer Research; Sunnybrook Health Science Centre","funders":"","keywords":"Computer science","score_opus":0.19176115659049378,"score_gpt":0.2778787533060494,"score_spread":0.0861175967155556,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9968514,0.00020851295,0.000018544666,0.00074120006,0.0002578179,0.00044096864,0.00006665305,0.000013326469,0.0014015911],"genre_scores_gemma":[0.9992449,0.00015026818,0.00002920301,0.00008790785,0.000019486031,0.000033064924,0.0000105900235,0.0000095753885,0.00041496428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987252,0.000056644672,0.0007495317,0.00026126628,0.000022813207,0.00018457735],"domain_scores_gemma":[0.99920684,0.00004976617,0.00036616996,0.00034243186,0.0000015304607,0.00003325083],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016526363,0.00007108969,0.00036047612,0.0003555551,0.00005554058,0.000008992642,0.0001790281,0.000030221187,0.0002128913],"category_scores_gemma":[0.000023209408,0.0000704597,0.00010876086,0.00051198754,0.000025790483,0.000074504635,0.00006496526,0.00006528701,0.00040887765],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000017613409,0.00005611198,0.8157612,0.000009563776,0.000072552364,9.270772e-8,0.0011122911,0.17489061,3.5531895e-7,0.007830151,0.000100634265,0.00016467342],"study_design_scores_gemma":[0.00023578371,0.000048244576,0.89472073,0.000004250662,0.000010449365,5.866441e-8,0.00045171301,0.10178865,0.0000018962742,0.002267557,0.00041290608,0.000057740806],"about_ca_topic_score_codex":0.016128434,"about_ca_topic_score_gemma":0.0012615335,"teacher_disagreement_score":0.078959554,"about_ca_system_score_codex":0.0004730602,"about_ca_system_score_gemma":0.00003174274,"threshold_uncertainty_score":0.99042326},"labels":[],"label_agreement":null},{"id":"W4390126273","doi":"10.1016/j.jval.2023.09.317","title":"EE44 Health Care Resource Utilization and Cost in Parkinson's Disease Patients in a Real-World Setting in Quebec, Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Disease; Parkinson's disease; Medicine; Resource (disambiguation); Health care; Resource use; Gerontology; Business; Environmental health; Natural resource economics; Economic growth; Economics; Computer science; Internal medicine","score_opus":0.2552703499515529,"score_gpt":0.39745832381049645,"score_spread":0.14218797385894355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126273","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9412067,0.0034894086,0.0000073443666,0.052068368,0.00029497663,0.002141115,0.00044626897,0.000035778725,0.00031006662],"genre_scores_gemma":[0.98700285,0.0017035691,0.00012085539,0.010227918,0.000070226015,0.00022048331,0.00043894333,0.00004372591,0.000171456],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927413,0.0013422433,0.0041622194,0.00074413436,0.00015329653,0.0008568244],"domain_scores_gemma":[0.99698853,0.0009368054,0.0013038161,0.00035819097,0.000024766294,0.0003878927],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.011543033,0.000201643,0.0009083958,0.0014860906,0.00012472342,0.000043708907,0.00016601267,0.000079068705,0.000013889311],"category_scores_gemma":[0.0019630909,0.00029428923,0.000026868138,0.001461588,0.000028957402,0.00024860204,0.000067686284,0.00031821054,0.000024894061],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022943994,0.000050248447,0.96946245,0.0012948824,0.000001646076,0.000005747697,0.0074575245,0.010977789,3.0495049e-9,0.0020126756,0.006957104,0.0017569514],"study_design_scores_gemma":[0.0012477695,0.000022932958,0.89672303,0.00071454013,2.8989083e-7,9.43801e-8,0.003190207,0.02959042,2.9999956e-8,0.00043007094,0.06788383,0.00019681302],"about_ca_topic_score_codex":0.9913003,"about_ca_topic_score_gemma":0.99734205,"teacher_disagreement_score":0.07273948,"about_ca_system_score_codex":0.008825648,"about_ca_system_score_gemma":0.0031108428,"threshold_uncertainty_score":0.99995095},"labels":[],"label_agreement":null},{"id":"W4390126283","doi":"10.1016/j.jval.2023.09.569","title":"EE303 Cost-Utility Analysis of Roflumilast Cream for Plaque Psoriasis, Including Intertriginous, From the Canadian Societal Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Intertriginous; Roflumilast; Medicine; Psoriasis; Tolerability; Plaque psoriasis; Dermatology; Perspective (graphical); Intensive care medicine; Adverse effect; Pharmacology; Internal medicine; COPD; Disease; Computer science","score_opus":0.49500513229894355,"score_gpt":0.46462465527978847,"score_spread":0.030380477019155083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126283","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7889606,0.004063515,0.0025883415,0.18388087,0.001581614,0.003965179,0.013198734,0.00010239001,0.0016587668],"genre_scores_gemma":[0.9926219,0.00037488033,0.0006561823,0.0054521486,0.00025695347,0.00022117658,0.00031030667,0.000028584047,0.00007784207],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944727,0.00067374704,0.0033713114,0.0006671285,0.0001195946,0.00069550844],"domain_scores_gemma":[0.9928752,0.0045146234,0.0016068324,0.00058010896,0.00012728262,0.0002959229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.023862554,0.00018948325,0.0013125316,0.0009535804,0.0005018944,0.00006041455,0.000418839,0.00017491316,0.00014807648],"category_scores_gemma":[0.004918472,0.00021230079,0.00032607597,0.0015561893,0.0001109851,0.00018844733,0.00006186531,0.00028669788,0.0001367859],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007583753,0.0002302396,0.6007632,0.00051123666,0.0015953832,0.0000015280712,0.066222,0.023860397,0.0000010482162,0.24165909,0.064527415,0.00055263616],"study_design_scores_gemma":[0.0012496051,0.00014559405,0.4724311,0.00016981618,0.00006783388,6.091202e-7,0.022086611,0.42781612,0.0000040896684,0.03793425,0.037699558,0.00039479273],"about_ca_topic_score_codex":0.9085363,"about_ca_topic_score_gemma":0.6616087,"teacher_disagreement_score":0.40395573,"about_ca_system_score_codex":0.0042306446,"about_ca_system_score_gemma":0.0016907837,"threshold_uncertainty_score":0.99959195},"labels":[],"label_agreement":null},{"id":"W4390126285","doi":"10.1016/j.jval.2023.09.326","title":"EE53 An Investigation of Value for Money of Oncology Drugs in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Value for money; Value (mathematics); Medicine; Internal medicine; Oncology; Family medicine; Economics; Computer science; Public economics","score_opus":0.0767024081748256,"score_gpt":0.28984539239443036,"score_spread":0.21314298421960476,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959435,0.000537867,0.000042511132,0.0016385489,0.0003946224,0.0003530697,0.00025803116,0.000006327425,0.00082554505],"genre_scores_gemma":[0.99838984,0.00048416454,0.0005655152,0.00040475055,0.0000440782,0.000031757816,0.000024873762,0.000014490345,0.00004054842],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99837786,0.000035537123,0.0010526639,0.00021590757,0.000024580706,0.00029346943],"domain_scores_gemma":[0.9989529,0.0001774447,0.00057871896,0.00017397098,0.00002221675,0.00009473339],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014062019,0.000078184814,0.00052277057,0.00033329875,0.0000203496,0.0000030613999,0.00013634344,0.000073146846,0.000009803568],"category_scores_gemma":[0.0001476319,0.00010320329,0.00003392951,0.0003636402,0.00003741747,0.00013732148,0.000018314118,0.00009100856,0.0000051280067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006932105,0.000050590654,0.65502673,0.00047318047,0.000010759011,9.557057e-7,0.004806346,0.053766903,0.000017420249,0.27750158,0.0012616664,0.007014561],"study_design_scores_gemma":[0.0016368886,0.00054747035,0.78425545,0.00011616082,0.000001431267,4.792194e-7,0.000849378,0.07880954,0.00023638208,0.12700863,0.006325177,0.00021299413],"about_ca_topic_score_codex":0.961154,"about_ca_topic_score_gemma":0.58556634,"teacher_disagreement_score":0.37558767,"about_ca_system_score_codex":0.001188123,"about_ca_system_score_gemma":0.0020723976,"threshold_uncertainty_score":0.421996},"labels":[],"label_agreement":null},{"id":"W4390126297","doi":"10.1016/j.jval.2023.09.972","title":"EE707 Modelling the Cost Effectiveness and Budget Impact of Uterine Botulinum Toxin Injections in Severe Dysmenorrhoea: A France Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; Centre hospitalier de l'Université Laval","funders":"","keywords":"Perspective (graphical); Botulinum toxin; Medicine; Toxin; Gynecology; Surgery; Biology; Computer science","score_opus":0.18882333438025434,"score_gpt":0.5097049883689522,"score_spread":0.32088165398869783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126297","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98856467,0.00034389328,0.0027894732,0.0064199325,0.00013906806,0.0015893641,0.0000637565,0.000035265493,0.000054565124],"genre_scores_gemma":[0.9980784,0.00079362065,0.00062111934,0.00027332932,0.00008442028,0.00007840817,0.000015990501,0.00002135255,0.00003337787],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99784565,0.00057154,0.00078413857,0.00029886427,0.00019707637,0.0003027501],"domain_scores_gemma":[0.99665743,0.002642067,0.00022900428,0.0002428332,0.00013285251,0.00009582422],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003174625,0.00013151333,0.0003949309,0.00025001098,0.00007288002,0.000010034851,0.00006272348,0.00006381252,0.00002036318],"category_scores_gemma":[0.0013998287,0.00010138226,0.000066288165,0.001070612,0.000062336956,0.00013217037,0.00005847881,0.00044260494,0.000006288506],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00091464625,0.00029538153,0.17164637,0.00062449946,0.000066649656,0.000023288687,0.005090722,0.8132232,0.0003509586,0.0005194547,0.00015623451,0.007088621],"study_design_scores_gemma":[0.003884702,0.0010851189,0.47689697,0.0004968594,0.000017578754,0.000067147215,0.0034788002,0.5113807,0.000029481156,0.002342595,0.00020082977,0.00011924085],"about_ca_topic_score_codex":0.08220958,"about_ca_topic_score_gemma":0.00055314635,"teacher_disagreement_score":0.3052506,"about_ca_system_score_codex":0.00066033326,"about_ca_system_score_gemma":0.00055011315,"threshold_uncertainty_score":0.92390203},"labels":[],"label_agreement":null},{"id":"W4390126302","doi":"10.1016/j.jval.2023.09.214","title":"CO142 A Retrospective Study Characterizing Age at Key Clinical Disease Indicators Among Patients With Friedreich Ataxia Using Health Administrative Claims Data in the United States","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Ataxia; Key (lock); Retrospective cohort study; Medicine; Disease; Gerontology; Environmental health; Demography; Family medicine; Computer science; Psychiatry; Internal medicine; Sociology; Computer security","score_opus":0.22687381343874513,"score_gpt":0.4176494520205479,"score_spread":0.19077563858180274,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9934412,0.000026563566,0.000009130681,0.0009829801,0.000212517,0.0035113601,0.0017291601,0.00008230036,0.000004755207],"genre_scores_gemma":[0.99598485,0.00015564151,0.000048963717,0.0026696576,0.000053095573,0.00009450648,0.0009255067,0.0000576274,0.000010177218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9890288,0.006285285,0.0011857625,0.0015296431,0.0010776436,0.0008928805],"domain_scores_gemma":[0.996246,0.0009983354,0.00076895114,0.0013822949,0.000052638636,0.0005517934],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0024532704,0.00036478383,0.0005873942,0.0005859984,0.0005815268,0.00012155522,0.0010221943,0.000049126145,0.000010007279],"category_scores_gemma":[0.0015853478,0.00027658298,0.000045032455,0.0034372504,0.00041508122,0.00026706743,0.0005753242,0.0006552079,0.000014543681],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033667087,0.0013666959,0.9898147,0.00006663286,0.000008322198,0.00021450325,0.0067763617,0.0011734975,0.00001730675,0.00004433326,0.000123013,0.00005793546],"study_design_scores_gemma":[0.001578683,0.0013327579,0.9875254,0.0001702916,0.000011688699,8.916626e-7,0.0017897333,0.007174162,0.000037316015,0.00006744511,0.00007152603,0.00024012853],"about_ca_topic_score_codex":0.00280678,"about_ca_topic_score_gemma":0.0009555329,"teacher_disagreement_score":0.0072172014,"about_ca_system_score_codex":0.00049929606,"about_ca_system_score_gemma":0.0011449541,"threshold_uncertainty_score":0.99996865},"labels":[],"label_agreement":null},{"id":"W4390126313","doi":"10.1016/j.jval.2023.09.292","title":"EE19 Cost Utility Analysis of the Flash Glucose Monitoring System in the Management of People With Type 2 Diabetes Mellitus on Basal Insulin Therapy—An Italian Healthcare System Perspective","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Perspective (graphical); Flash (photography); Basal insulin; Basal (medicine); Medicine; Type 2 Diabetes Mellitus; Health care; Diabetes mellitus; Continuous glucose monitoring; Diabetes management; Intensive care medicine; Type 2 diabetes; Internal medicine; Endocrinology; Computer science; Type 1 diabetes; Economics; Artificial intelligence; Economic growth; Art","score_opus":0.06278408498487052,"score_gpt":0.34595576695782315,"score_spread":0.2831716819729526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126313","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.992764,0.002300689,0.0000014239255,0.0014859128,0.00019248236,0.0024885796,0.000026660891,0.000044685836,0.000695579],"genre_scores_gemma":[0.9989695,0.0007035192,0.00003300308,0.000049808288,0.000043547647,0.000112249436,0.00002020188,0.000021129339,0.00004703481],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9966172,0.0010207298,0.0005584527,0.0003801795,0.00092454697,0.0004989022],"domain_scores_gemma":[0.99845976,0.00022880218,0.0002137846,0.0008203858,0.00017666406,0.00010059524],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031463143,0.00016961213,0.00062966894,0.0006660579,0.00010412133,0.000018712628,0.00036239627,0.00005823831,0.0000036383042],"category_scores_gemma":[0.000027376203,0.00009488505,0.00010992542,0.0055176443,0.00007109062,0.000048044913,0.000082199665,0.0003049623,0.0000061471087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005662221,0.0005762448,0.9529831,0.009526614,0.00090676313,0.000025935198,0.010896205,0.0061575877,0.00001350649,0.006239145,0.000032105738,0.012076569],"study_design_scores_gemma":[0.0010255957,0.00094846135,0.8896757,0.0026245692,0.00011880675,1.4744596e-7,0.07630221,0.029029012,0.00012679675,0.000023045344,0.000046345827,0.00007936004],"about_ca_topic_score_codex":0.0053970274,"about_ca_topic_score_gemma":0.00048088122,"teacher_disagreement_score":0.065406,"about_ca_system_score_codex":0.00067963067,"about_ca_system_score_gemma":0.00015819244,"threshold_uncertainty_score":0.81587267},"labels":[],"label_agreement":null},{"id":"W4390126321","doi":"10.1016/j.jval.2023.09.524","title":"EE257 Real-World, Longitudinal, Retrospective Study of Healthcare Resource Utilization of Patients With Atopic Dermatitis Under the Public Health Insurance Plan of Quebec, Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université Laval; Hôtel-Dieu de Québec; McGill University Health Centre; ABB (Canada)","funders":"","keywords":"Atopic dermatitis; Plan (archaeology); Health care; Health insurance; Health plan; Public health; Environmental health; Business; Family medicine; Resource (disambiguation); Medicine; Economic growth; Geography; Dermatology; Nursing; Economics; Computer science; Archaeology","score_opus":0.06004624865925035,"score_gpt":0.3109220224604371,"score_spread":0.25087577380118675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126321","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855195,0.0007463116,0.0000072256485,0.012202045,0.00008772761,0.0012300804,0.00013773903,0.000023704271,0.00004560887],"genre_scores_gemma":[0.9987978,0.00025392717,0.000011562749,0.00071411754,0.00001203813,0.00002717817,0.00013316346,0.000017146742,0.00003311102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972501,0.0007146514,0.000844672,0.0002478992,0.00059374847,0.00034891916],"domain_scores_gemma":[0.9982919,0.00018594351,0.00066992396,0.0004388746,0.00024937157,0.00016399588],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047230712,0.00013542813,0.00064299797,0.00027694993,0.000121969395,0.0000032960363,0.00013344803,0.00004220125,0.000007690841],"category_scores_gemma":[0.00011100779,0.00010031741,0.000029222023,0.0014384538,0.000121682846,0.000057329413,0.00003622657,0.00019841008,3.8787297e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007747251,0.00047192274,0.99133766,0.0013741971,0.000051241863,0.000010090548,0.0025102543,0.00027686352,6.698898e-8,0.00071205123,0.0028459085,0.00033225675],"study_design_scores_gemma":[0.0016213768,0.00044879242,0.9931764,0.0005042189,0.000007750011,0.0000026629782,0.003862968,0.000101455465,0.000005272286,0.00006479501,0.00014396576,0.00006033472],"about_ca_topic_score_codex":0.8763731,"about_ca_topic_score_gemma":0.96290714,"teacher_disagreement_score":0.08653403,"about_ca_system_score_codex":0.0005033053,"about_ca_system_score_gemma":0.0030879271,"threshold_uncertainty_score":0.54778504},"labels":[],"label_agreement":null},{"id":"W4390126357","doi":"10.1016/j.jval.2023.09.807","title":"EE542 Assessment of the Cost-Effectiveness of Risk Factor Guided Prophylaxis with Palivizumab for the Prevention of Severe Respiratory Syncytial Virus Infection in Colombian Infants Born at 32–35 Weeks’ Gestational Age","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Palivizumab; Medicine; Gestational age; Pediatrics; Risk factor; Respiratory system; Intensive care medicine; Pregnancy; Internal medicine; Biology","score_opus":0.12902002488907793,"score_gpt":0.4397569434015834,"score_spread":0.31073691851250546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926048,0.00007835358,0.00032938187,0.000056825542,0.00016327084,0.006392826,0.00030149432,0.000020726597,0.00005233645],"genre_scores_gemma":[0.99887085,0.00013633491,0.00010001062,0.00002284986,0.000033323227,0.0007568664,0.000023541052,0.000028796057,0.000027418366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99555635,0.0022160609,0.0008822024,0.0003011741,0.0007298503,0.0003143447],"domain_scores_gemma":[0.9966151,0.0019122441,0.00062001334,0.00045235624,0.0003316356,0.00006864311],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003931688,0.00015929167,0.0004891239,0.00048580876,0.00015977513,0.000008493989,0.0001361931,0.00013416131,0.000024693414],"category_scores_gemma":[0.0012180567,0.0001039201,0.00012114491,0.0015822941,0.0002238037,0.00010691492,0.000089616566,0.00041667873,0.0000014420201],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014741498,0.00049276144,0.94115645,0.0026835282,0.0000798769,0.000004009656,0.00044607968,0.037651975,0.009130018,0.00019733094,0.00004499761,0.0066388575],"study_design_scores_gemma":[0.0037172597,0.003326567,0.98209435,0.0010028235,0.00002293973,0.0000042172546,0.000058325648,0.0026780986,0.0066665723,0.00019461618,0.0001507129,0.00008353597],"about_ca_topic_score_codex":0.012802426,"about_ca_topic_score_gemma":0.0073010605,"teacher_disagreement_score":0.040937915,"about_ca_system_score_codex":0.0012165506,"about_ca_system_score_gemma":0.0019921865,"threshold_uncertainty_score":0.99377143},"labels":[],"label_agreement":null},{"id":"W4390126372","doi":"10.1016/j.jval.2023.09.357","title":"EE85 Health System Costs and Resources for Stage-Specific Breast Cancer: A Population-Based Approach (Updated)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; TD Bank Group; University of Ottawa; Public Health Ontario; Sunnybrook Hospital; Sunnybrook Health Science Centre","funders":"","keywords":"Breast cancer; Stage (stratigraphy); Computer science; Medicine; Actuarial science; Cancer; Business; Internal medicine; Biology","score_opus":0.06274836336562925,"score_gpt":0.27583831508370776,"score_spread":0.2130899517180785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126372","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93533975,0.025080778,0.005082618,0.019135803,0.0014599372,0.0032097546,0.008233632,0.00038451471,0.0020732295],"genre_scores_gemma":[0.99525344,0.0020325002,0.0008548883,0.00090410694,0.0002558364,0.00021184751,0.0001603918,0.000054339536,0.00027261773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976331,0.000050936967,0.0010408176,0.0005792224,0.000043978012,0.0006519745],"domain_scores_gemma":[0.99867463,0.00011156243,0.00066210865,0.00028882164,0.000025355983,0.00023753931],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017942354,0.000189124,0.0007025331,0.00048738878,0.0002580233,0.00008657395,0.00016216656,0.00010652658,0.000021586675],"category_scores_gemma":[0.000026859745,0.0002259916,0.00007058576,0.0004906783,0.00003655306,0.00016888975,0.000027988815,0.00015227255,0.00003298856],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029535184,0.00011697288,0.54137135,0.0024281454,0.000034842556,0.0000020502132,0.0015804337,0.0701444,4.0217472e-7,0.35237262,0.011361094,0.02029234],"study_design_scores_gemma":[0.002385836,0.00019212798,0.6382429,0.00040290898,0.0000018182078,0.0000048347115,0.0006710528,0.23709556,7.26473e-7,0.0017599931,0.11876491,0.0004773347],"about_ca_topic_score_codex":0.05450998,"about_ca_topic_score_gemma":0.00048624334,"teacher_disagreement_score":0.35061264,"about_ca_system_score_codex":0.0016195276,"about_ca_system_score_gemma":0.00023633137,"threshold_uncertainty_score":0.9517861},"labels":[],"label_agreement":null},{"id":"W4390126459","doi":"10.1016/j.jval.2023.09.676","title":"EE410 Retrospective Database Analysis of Healthcare Resource Utilization and Costs in Patients With Vitiligo in Quebec, Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"melanin and skin pigmentation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre de Recherche Dermatologique du Québec Métropolitain; University of British Columbia","funders":"","keywords":"Vitiligo; Health care; Resource (disambiguation); Business; Medicine; Database; Computer science; Economic growth; Economics; Dermatology","score_opus":0.016446085424430507,"score_gpt":0.27406209967042905,"score_spread":0.25761601424599856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126459","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99903435,0.00021909573,0.00001488246,0.0003115786,0.000023148632,0.00025256848,0.000120895085,0.0000023666598,0.000021116444],"genre_scores_gemma":[0.9977638,0.00021496153,0.000039435297,0.00016852768,0.000006491359,0.000009350318,0.0017694558,0.0000068007307,0.000021166014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989774,0.00019944315,0.00026574192,0.00023911451,0.00015570612,0.00016255035],"domain_scores_gemma":[0.99964076,0.000020877062,0.000098826655,0.00015303468,0.00003496837,0.000051540017],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003034034,0.00006742642,0.00017351923,0.00024219221,0.00001935555,0.0000036674269,0.00004224817,0.00004263112,0.000001954004],"category_scores_gemma":[0.00006139427,0.000067304594,0.000008991715,0.00094517437,0.000016993245,0.000004094805,0.00002563927,0.000060298305,8.102637e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010719919,0.000033200966,0.99660647,0.00006299124,0.000014405909,0.0000026169362,0.00027857607,0.0016471281,0.00010810406,0.00006032182,0.00017729931,0.0009016669],"study_design_scores_gemma":[0.00070185744,0.00011194814,0.995607,0.000086007334,0.000005098569,7.3331364e-8,0.0004895232,0.002459492,0.00035229858,0.000004157465,0.00012315017,0.000059354647],"about_ca_topic_score_codex":0.9195286,"about_ca_topic_score_gemma":0.98749137,"teacher_disagreement_score":0.06796281,"about_ca_system_score_codex":0.00026534428,"about_ca_system_score_gemma":0.0003327325,"threshold_uncertainty_score":0.27446017},"labels":[],"label_agreement":null},{"id":"W4390126460","doi":"10.1016/j.jval.2023.09.182","title":"CO110 Systematic Literature Review and Network Meta-Analysis to Assess the Comparative Efficacy of Topical Fixed-Dose Combinations for Moderate to Severe Acne Vulgaris as Measured By Lesion Counts","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Windsor; Western University","funders":"","keywords":"Meta-analysis; Acne; Medicine; Dermatology; Lesion; Systematic review; Internal medicine; Surgery; MEDLINE; Biology","score_opus":0.23064222845716525,"score_gpt":0.4289315749864708,"score_spread":0.19828934652930552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126460","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26244983,0.57780033,0.007481065,0.10825781,0.00056937867,0.041412115,0.00080575416,0.00018645314,0.0010372666],"genre_scores_gemma":[0.9894738,0.0037138662,0.0004678844,0.0036808548,0.00002898166,0.00041472644,0.00017333453,0.000012179963,0.0020343428],"study_design_codex":"not_applicable","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99877644,0.00036796488,0.00034450056,0.0001709701,0.00018494594,0.00015518501],"domain_scores_gemma":[0.9989407,0.0005367392,0.00009694292,0.0002066647,0.000108506196,0.00011044088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00091148535,0.00010729371,0.0010938168,0.000070914175,0.00011642015,0.000016787993,0.000050426417,0.00003872193,0.000009586307],"category_scores_gemma":[0.00015466182,0.000056902274,0.00015444445,0.00087762525,0.00001046849,0.000020067679,0.000020607808,0.000084760635,0.000010147926],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011308333,0.00236196,0.0027094726,0.22254267,0.076549105,0.00006248751,0.023631392,0.052350093,0.000100564605,0.011942032,0.6055325,0.0010868795],"study_design_scores_gemma":[0.025857393,0.013647341,0.06532343,0.13591206,0.5090824,0.00021180874,0.002751588,0.21060795,0.0004424554,0.0034222868,0.030148316,0.0025929755],"about_ca_topic_score_codex":0.00009097395,"about_ca_topic_score_gemma":0.000017648068,"teacher_disagreement_score":0.727024,"about_ca_system_score_codex":0.000046685065,"about_ca_system_score_gemma":0.00006017916,"threshold_uncertainty_score":0.23204073},"labels":[],"label_agreement":null},{"id":"W4390126533","doi":"10.1016/j.jval.2023.09.142","title":"CO70 COPD Exacerbations Pre, During, and Post COVID-19 Pandemic in the US","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Pandemic; COPD; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Intensive care medicine; Virology; Internal medicine; Infectious disease (medical specialty); Disease","score_opus":0.06418947601148334,"score_gpt":0.3799944225302698,"score_spread":0.3158049465187865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832719,0.0024455704,0.000004607878,0.012296821,0.00006890257,0.0014544858,0.00008197496,0.00007938075,0.0002963789],"genre_scores_gemma":[0.9954088,0.0016700282,0.000028411314,0.0018704539,0.00009075448,0.0001356695,0.000075548356,0.000022113942,0.0006982665],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978998,0.00048069583,0.00035050654,0.0003406823,0.00042087294,0.0005074808],"domain_scores_gemma":[0.99862695,0.00054901454,0.00005986125,0.0003628755,0.000039092196,0.00036220453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012721227,0.0001195222,0.00023543433,0.00036174746,0.00016800807,0.000017760298,0.00013581559,0.000068884394,0.0001172646],"category_scores_gemma":[0.0007633949,0.000096620446,0.00003468483,0.0009224028,0.00015151477,0.00006179645,0.00008864554,0.00043540073,0.000049090577],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018489841,0.00011823112,0.9894837,0.0020188172,0.000010183288,0.00020896988,0.0038321582,0.0014382895,0.000081906386,0.00059147016,0.0009801512,0.0010512188],"study_design_scores_gemma":[0.0020267772,0.00010840383,0.98643875,0.00016499942,0.000005998458,0.00012757674,0.0012371693,0.005295772,0.0000022555987,0.0005683201,0.003945938,0.00007804037],"about_ca_topic_score_codex":0.01196934,"about_ca_topic_score_gemma":0.00094645185,"teacher_disagreement_score":0.012136877,"about_ca_system_score_codex":0.0010784833,"about_ca_system_score_gemma":0.0017311841,"threshold_uncertainty_score":0.9946101},"labels":[],"label_agreement":null},{"id":"W4390126566","doi":"10.1016/j.jval.2023.09.1704","title":"HTA19 Insights Into NICE Technology Appraisal Outcomes in Oncology","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Nice; Oncology; Medicine; Medical physics; Internal medicine; Computer science","score_opus":0.4071762311421113,"score_gpt":0.4930174094996413,"score_spread":0.08584117835752997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126566","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7758332,0.0029954095,0.00024992853,0.2163787,0.0017234032,0.00092229067,0.000029430468,0.00021840505,0.0016492668],"genre_scores_gemma":[0.98281467,0.0012667776,0.0033340817,0.011554022,0.00019211213,0.00036766517,0.000037196358,0.000058258356,0.00037520917],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921768,0.00080614584,0.0053053764,0.0007818374,0.000098789125,0.00083109445],"domain_scores_gemma":[0.9944748,0.0031328034,0.0015440828,0.0006250177,0.000028837936,0.00019442971],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.017726997,0.00022159853,0.0016131075,0.0028803202,0.0001394606,0.000023686125,0.00044900473,0.00040174884,0.00007013012],"category_scores_gemma":[0.006908719,0.0002830417,0.000080210884,0.00179597,0.00010422799,0.00027435337,0.00013978012,0.00052917306,0.0044334456],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014585173,0.00025711936,0.6172034,0.00064744067,0.00002499318,0.000016123098,0.010062351,0.0057913405,0.0000016280635,0.35699478,0.007356472,0.0016297284],"study_design_scores_gemma":[0.0028758938,0.0004862008,0.31849292,0.0002633928,0.0000016386941,0.000009044089,0.0056792,0.03886293,0.0000030335575,0.19192341,0.44076344,0.000638917],"about_ca_topic_score_codex":0.023791544,"about_ca_topic_score_gemma":0.0054278397,"teacher_disagreement_score":0.43340695,"about_ca_system_score_codex":0.0021552942,"about_ca_system_score_gemma":0.000785529,"threshold_uncertainty_score":0.99996215},"labels":[],"label_agreement":null},{"id":"W4390126595","doi":"10.1016/j.jval.2023.09.121","title":"CO49 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Ixekizumab at 52 Weeks for the Treatment of Radiographic Axial Spondyloarthritis","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Ixekizumab; Axial spondyloarthritis; Medicine; Matching (statistics); Internal medicine; Pathology; Arthritis; Secukinumab","score_opus":0.06100829648213404,"score_gpt":0.3312366531993723,"score_spread":0.27022835671723827,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126595","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9770395,0.018774753,0.0000033091208,0.0012356542,0.0003000946,0.002339732,0.0002517258,0.000024837562,0.000030384286],"genre_scores_gemma":[0.99145126,0.008092316,0.00013022192,0.000025622448,0.000048989947,0.00011958632,0.000035997924,0.000025874726,0.000070142094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99816644,0.00016618853,0.00074711116,0.00026287907,0.0003085172,0.00034887905],"domain_scores_gemma":[0.99797076,0.0010964278,0.00039574242,0.00039750116,0.00006172871,0.000077837314],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033567022,0.0001964911,0.0009517978,0.0002520402,0.00021743512,0.0000037460682,0.00009722525,0.00007812931,0.000010192359],"category_scores_gemma":[0.00008379804,0.000118685486,0.00025846812,0.000861222,0.00027202425,0.00001727339,0.00005497739,0.00008979967,0.0000012355029],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007443659,0.004194788,0.6766784,0.002024939,0.0014049613,0.000037011472,0.033993926,0.0010563815,0.0006998041,0.00083545956,0.00084922265,0.27078146],"study_design_scores_gemma":[0.02438166,0.00780519,0.9578693,0.0011012665,0.00026397788,0.00004673474,0.001812212,0.0018861115,0.002379434,0.00019649367,0.002124203,0.00013344645],"about_ca_topic_score_codex":0.0061427243,"about_ca_topic_score_gemma":0.001032349,"teacher_disagreement_score":0.28119087,"about_ca_system_score_codex":0.00016484894,"about_ca_system_score_gemma":0.00014851891,"threshold_uncertainty_score":0.92860025},"labels":[],"label_agreement":null},{"id":"W4390126613","doi":"10.1016/j.jval.2023.09.099","title":"CO26 Efficacy of the Dupilumab 200 Mg Dose Every 2 Weeks in Children with Moderate-to-Severe Asthma during Voyage and Excursion","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Travel-related health issues","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital","funders":"","keywords":"Dupilumab; Excursion; Asthma; Medicine; Pediatrics; Internal medicine; Political science; Law","score_opus":0.02223058562201335,"score_gpt":0.291016622937088,"score_spread":0.26878603731507467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99190664,0.0010023265,0.0000029711994,0.0049375435,0.0000991317,0.0018718477,0.000017687687,0.0000796724,0.00008216221],"genre_scores_gemma":[0.9982687,0.0006584296,0.00023634356,0.00039402742,0.000063730324,0.000024228946,0.000013869955,0.00004686221,0.0002937923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997673,0.0002612481,0.00063345826,0.00041854507,0.00040515204,0.00060861383],"domain_scores_gemma":[0.998942,0.00014895569,0.00016166421,0.00043304317,0.000041445946,0.0002728799],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076743594,0.00019755283,0.00050818356,0.00041014713,0.00012986978,0.000009208937,0.00012490399,0.00014704892,0.000015310316],"category_scores_gemma":[0.00014012994,0.00014501707,0.000032572872,0.0011606546,0.000068312904,0.0000667891,0.000092036586,0.0006246866,0.000025476675],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002883994,0.00042545874,0.941395,0.0017516647,0.000045210898,0.00006828477,0.009531515,0.038898226,0.00030183897,0.00017442793,0.00044777733,0.004076595],"study_design_scores_gemma":[0.006294579,0.0005083676,0.98687494,0.0028533675,0.0000079293795,0.00008858732,0.00018757586,0.0028038803,0.00014205018,0.000058457616,0.000052222706,0.00012806006],"about_ca_topic_score_codex":0.007447336,"about_ca_topic_score_gemma":0.00025846536,"teacher_disagreement_score":0.045479916,"about_ca_system_score_codex":0.00029114194,"about_ca_system_score_gemma":0.00053211895,"threshold_uncertainty_score":0.99916214},"labels":[],"label_agreement":null},{"id":"W4390126617","doi":"10.1016/j.jval.2023.09.124","title":"CO52 Comparative Analysis of Tabelecleucel Versus Standard of Care in Patients with EBV+ PTLD Following Hematopoietic Cell Transplant (HCT) or Solid Organ Transplant (SOT)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Hematopoietic cell; Solid organ; Medicine; Haematopoiesis; Standard of care; Internal medicine; Organ transplantation; Oncology; Transplantation; Biology; Stem cell; Genetics","score_opus":0.04066198766973922,"score_gpt":0.3452641387185456,"score_spread":0.3046021510488064,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126617","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9976853,0.00039985537,0.000039184702,0.00008886727,0.000080945756,0.0011552009,0.0003710985,0.000031567655,0.00014794264],"genre_scores_gemma":[0.99906915,0.00027537762,0.0001865219,0.000024392455,0.000009705317,0.000026569473,0.00034886246,0.000030430465,0.000029001676],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9964564,0.00026764703,0.0010014627,0.00043050092,0.0011604897,0.0006835378],"domain_scores_gemma":[0.9983621,0.0006052988,0.00021827164,0.00042382083,0.00015761556,0.00023285006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068023807,0.0002407783,0.0015911012,0.001040976,0.000051318846,0.000006141567,0.0001855902,0.00011212771,0.000043265343],"category_scores_gemma":[0.000035752597,0.00018507673,0.00017093385,0.0037171126,0.00010514735,0.00005526523,0.000023203596,0.00031950284,0.0000047259728],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.12678175,0.0019063626,0.4706923,0.02153601,0.0029759172,0.001416886,0.27017438,0.10295456,0.00062344375,0.0001983014,0.00012408047,0.00061600044],"study_design_scores_gemma":[0.4488604,0.05406552,0.22405934,0.018964909,0.0044252905,0.000023818806,0.04357137,0.15423597,0.049925737,0.00003107031,0.0001961666,0.001640396],"about_ca_topic_score_codex":0.0064942506,"about_ca_topic_score_gemma":0.0053154062,"teacher_disagreement_score":0.32207865,"about_ca_system_score_codex":0.0058219405,"about_ca_system_score_gemma":0.008330503,"threshold_uncertainty_score":0.99799454},"labels":[],"label_agreement":null},{"id":"W4390126628","doi":"10.1016/j.jval.2023.09.207","title":"CO135 A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of Pharmaceutical Interventions for First-Line (1L) Patients with Asymptomatic/Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer (MCRPC)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Prostate cancer; Asymptomatic; Oncology; Internal medicine; First line; Psychological intervention; Cancer; Psychiatry","score_opus":0.17517301786223566,"score_gpt":0.4448476951343678,"score_spread":0.2696746772721321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126628","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15159847,0.8071821,0.0004975607,0.013804042,0.00014281773,0.024997883,0.0016323747,0.00012774057,0.000017014481],"genre_scores_gemma":[0.8073885,0.174062,0.005109847,0.0010516376,0.000067371904,0.00969903,0.0017034666,0.00011521321,0.00080296426],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99641865,0.00047941905,0.0015152683,0.00041461398,0.0006281269,0.0005439125],"domain_scores_gemma":[0.997469,0.0008879052,0.0005836953,0.00037861604,0.00041091625,0.00026988605],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019895376,0.00029545408,0.002455632,0.00047898386,0.00014628083,0.00004120448,0.00010017589,0.000046647478,0.000051898296],"category_scores_gemma":[0.00028803,0.00017919474,0.0006049527,0.0028101988,0.00008822724,0.00011346132,0.000038634094,0.00019971924,0.0000027170106],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048426312,0.000569735,0.010014095,0.9368166,0.045404997,0.000039367078,0.0011969268,0.00435927,0.0000034591635,0.00021939658,0.0006427562,0.00024918155],"study_design_scores_gemma":[0.0150981555,0.005718106,0.030739443,0.5208408,0.3273994,0.000032170195,0.0003686877,0.09801402,0.000048166337,0.0008303624,0.0001447807,0.0007658614],"about_ca_topic_score_codex":0.00016746878,"about_ca_topic_score_gemma":0.00026539725,"teacher_disagreement_score":0.65579003,"about_ca_system_score_codex":0.00022419484,"about_ca_system_score_gemma":0.00033956498,"threshold_uncertainty_score":0.73073494},"labels":[],"label_agreement":null},{"id":"W4390126634","doi":"10.1016/j.jval.2023.09.028","title":"P20 Matching-Adjusted Indirect Treatment Comparison (MAIC) of Teclistamab Vs Belantamab Mafodotin for the Treatment of Patients with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Medicine; Matching (statistics); Class (philosophy); Refractory (planetary science); Oncology; Internal medicine; Computer science; Physics; Artificial intelligence; Pathology","score_opus":0.0862507112215568,"score_gpt":0.3333338324338619,"score_spread":0.24708312121230508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390126634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9899552,0.0010720136,0.00005297252,0.0006417471,0.00019834713,0.007018472,0.0009004887,0.00010603122,0.000054770262],"genre_scores_gemma":[0.9951578,0.0012353049,0.0010861031,0.000037298243,0.00006352133,0.00070529705,0.0011182608,0.00008904743,0.00050738885],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99602056,0.0004202155,0.0012300084,0.00059801125,0.0008209179,0.0009102934],"domain_scores_gemma":[0.99576056,0.0022330706,0.00067319645,0.00079397444,0.00019372442,0.0003454769],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052814826,0.00047165458,0.0014380363,0.000600076,0.0002305885,0.000014821,0.00019301673,0.00016002635,0.00003313523],"category_scores_gemma":[0.00020073228,0.00028227712,0.00027470654,0.0008973883,0.00015579385,0.00007133747,0.00003554076,0.00019381633,0.000018195322],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02125068,0.0099415295,0.8899534,0.0009750807,0.00094324746,0.000056496687,0.006951593,0.001063443,0.00024280522,0.000036043122,0.0003326525,0.06825307],"study_design_scores_gemma":[0.056039855,0.026320186,0.8956702,0.00055853504,0.00019718245,0.000004471894,0.0011836019,0.011245957,0.004521023,0.00002383133,0.0040073707,0.00022781959],"about_ca_topic_score_codex":0.00926929,"about_ca_topic_score_gemma":0.0016057913,"teacher_disagreement_score":0.068025246,"about_ca_system_score_codex":0.0015369862,"about_ca_system_score_gemma":0.00078245334,"threshold_uncertainty_score":0.9999629},"labels":[],"label_agreement":null},{"id":"W4390127024","doi":"10.1016/j.jval.2023.09.033","title":"P24 Improving Efficiency of Living Systematic Literature Reviews (SLR) with Artificial Intelligence (AI): Assisted Extraction of Population, Intervention/Comparator, Outcome, and Study Design (P-I/C-O-S)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Outcome (game theory); Intervention (counseling); Medicine; Extraction (chemistry); Comparator; Population; Engineering; Environmental health; Psychiatry; Mathematics; Chemistry; Chromatography; Electrical engineering","score_opus":0.31446627410944494,"score_gpt":0.4808376401205651,"score_spread":0.16637136601112018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9523214,0.0046927463,0.037784636,0.00034248817,0.0004246857,0.004371247,0.0000031329607,0.000054782075,0.0000048784345],"genre_scores_gemma":[0.99773854,0.00032000718,0.0016489644,0.000045471123,0.00006447155,0.00012604074,0.0000098653,0.00001901341,0.000027610824],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952996,0.0010502298,0.0026546388,0.00035383226,0.00036110403,0.00028060732],"domain_scores_gemma":[0.997049,0.0011364324,0.00104952,0.00035557878,0.00028783016,0.00012166516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005797046,0.00017934601,0.000856496,0.00065200264,0.00011667321,0.00003096852,0.00009015643,0.00009252092,0.00001106384],"category_scores_gemma":[0.0029440904,0.0001412246,0.00007457174,0.0018095156,0.00004661124,0.00018434445,0.00002566878,0.00031148485,0.000007631753],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032275813,0.0021397742,0.7862137,0.14571956,0.00004616338,0.000014470178,0.029053835,0.005987671,0.000475491,0.00073302933,0.00003711198,0.02925646],"study_design_scores_gemma":[0.00019821283,0.007887407,0.47642076,0.24393103,0.0003188199,0.0001909014,0.058695085,0.2093973,0.0013161362,0.0010110143,0.000007008419,0.00062632764],"about_ca_topic_score_codex":0.004502684,"about_ca_topic_score_gemma":0.00025951356,"teacher_disagreement_score":0.3097929,"about_ca_system_score_codex":0.000193207,"about_ca_system_score_gemma":0.00017678221,"threshold_uncertainty_score":0.68067414},"labels":[],"label_agreement":null},{"id":"W4390127055","doi":"10.1016/j.jval.2023.09.100","title":"CO27 The Feasibility of Systematic Goal Quality Assurance During Goal Attainment Scaling in a Rare Disease","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Goal Attainment Scaling; Quality assurance; Goal setting; Quality (philosophy); Goal orientation; Disease; Computer science; Medicine; Risk analysis (engineering); Psychology; Physical therapy; Internal medicine; Pathology; Social psychology; Physics","score_opus":0.4857534074856333,"score_gpt":0.4654239281577498,"score_spread":0.020329479327883482,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9652228,0.0042744144,0.00014608772,0.02633054,0.00044526224,0.0031022865,0.00034133627,0.000057281668,0.0000800205],"genre_scores_gemma":[0.997793,0.00028996964,0.00018537055,0.0011582216,0.00009770662,0.00035024493,0.000019343595,0.000028215265,0.000077934914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98734415,0.0028316816,0.008139822,0.0007076989,0.0002601123,0.00071652426],"domain_scores_gemma":[0.9924658,0.0032550485,0.0029417817,0.0010312118,0.000044899472,0.00026128005],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.061140448,0.00021441789,0.0016221728,0.00042627155,0.0001995881,0.000042602926,0.0004343501,0.00009554779,0.000028987113],"category_scores_gemma":[0.009445193,0.00022299982,0.00016565598,0.0008397219,0.000090943424,0.00023191785,0.000101869395,0.00029685927,0.000279996],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005448966,0.00016130373,0.86139584,0.076343365,0.000018668527,0.0000036178515,0.0050986973,0.037638817,0.0000015667588,0.019051358,0.00022453451,0.000007750829],"study_design_scores_gemma":[0.0010892942,0.00003342998,0.9412387,0.0050304444,0.0000025662405,0.0000012851917,0.0029144178,0.042232595,0.0000013128339,0.0071970066,0.00004092348,0.00021799396],"about_ca_topic_score_codex":0.010799481,"about_ca_topic_score_gemma":0.0007564542,"teacher_disagreement_score":0.0798429,"about_ca_system_score_codex":0.0021499463,"about_ca_system_score_gemma":0.00055573083,"threshold_uncertainty_score":0.9988987},"labels":[],"label_agreement":null},{"id":"W4390127084","doi":"10.1016/j.jval.2023.09.110","title":"CO37 Inventory-Facilitated Goal Setting Interview Conducted by Disease Experts Yields a Broader Range of Goal Areas","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; University of Alberta","funders":"","keywords":"Goal setting; Goal orientation; Goal programming; Psychology; Range (aeronautics); Applied psychology; Operations research; Engineering; Social psychology","score_opus":0.40282029590413954,"score_gpt":0.41973673308607024,"score_spread":0.0169164371819307,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9135624,0.014489197,0.00035471117,0.066941515,0.00097170426,0.0016360325,0.0015452333,0.00017817153,0.00032100157],"genre_scores_gemma":[0.98668677,0.0008538857,0.00024770055,0.010599353,0.00016524494,0.00027014135,0.00032749778,0.00006441582,0.00078500994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9915438,0.001539025,0.0052548596,0.00072341936,0.00017350736,0.00076534104],"domain_scores_gemma":[0.9957948,0.0011473951,0.0019259221,0.0005414134,0.00007133459,0.0005191384],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.018579585,0.00026578247,0.0012920133,0.00060674496,0.00014003455,0.00003772005,0.00031880214,0.00016880079,0.0003947166],"category_scores_gemma":[0.0040248646,0.0003439699,0.00016874731,0.0007326448,0.000110061745,0.00034158977,0.0000946489,0.00026722837,0.0007096637],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010512837,0.00048179118,0.5523342,0.008736924,0.00013008519,0.000012724382,0.020956298,0.002096752,0.000016688908,0.010466159,0.40364593,0.0010173357],"study_design_scores_gemma":[0.011126509,0.0008668586,0.38339984,0.0068055363,0.000028114388,0.0000149286625,0.02101502,0.31794637,0.000021376936,0.024759952,0.23142017,0.00259531],"about_ca_topic_score_codex":0.012108344,"about_ca_topic_score_gemma":0.00014881298,"teacher_disagreement_score":0.31584963,"about_ca_system_score_codex":0.00084863015,"about_ca_system_score_gemma":0.0005426611,"threshold_uncertainty_score":0.99990124},"labels":[],"label_agreement":null},{"id":"W4390127085","doi":"10.1016/j.jval.2023.09.813","title":"EE548 Data Availability and Modelling Approaches in Health Economic Evaluation of Cystic Fibrosis: A Systematic Literature Review","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Efficiency Analysis Using DEA","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Cystic fibrosis; Systematic review; Data science; Field (mathematics); Computer science; Medicine; Intensive care medicine; Management science; MEDLINE; Economics; Political science; Internal medicine; Mathematics","score_opus":0.493393444492352,"score_gpt":0.44966258476300053,"score_spread":0.04373085972935148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127085","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.3299334,0.65059716,0.0044337153,0.008911937,0.0003351785,0.005400796,0.00024843006,0.000068461835,0.00007092398],"genre_scores_gemma":[0.9775255,0.019085752,0.0029444213,0.00023309106,0.000024228746,0.00006786068,0.00008248663,0.0000145675,0.000022136212],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9836512,0.008606227,0.0041610426,0.0012993921,0.0017938243,0.00048827264],"domain_scores_gemma":[0.99344546,0.0030531574,0.0012525136,0.0019729543,0.00015053117,0.00012540219],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.13185573,0.00017039484,0.0012237027,0.0008619516,0.000099452154,0.00010877173,0.0008389652,0.00007342734,0.000011900701],"category_scores_gemma":[0.007966081,0.00013425076,0.00006564656,0.0031315691,0.000073172945,0.00038877953,0.00022890985,0.00023462121,0.000046961664],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007385641,0.000057967864,0.0019447628,0.07833119,0.0000068177383,7.4350805e-7,0.0022280572,0.91450673,5.783324e-7,0.000422111,0.0003106638,0.0021829763],"study_design_scores_gemma":[0.00018966994,0.000040761075,0.0010271122,0.05652868,0.000019684141,0.0000039830843,0.0003619126,0.9369919,3.316969e-7,0.004731126,0.00001869129,0.000086189204],"about_ca_topic_score_codex":0.0016271246,"about_ca_topic_score_gemma":0.00034342209,"teacher_disagreement_score":0.64759207,"about_ca_system_score_codex":0.0005005011,"about_ca_system_score_gemma":0.0012516084,"threshold_uncertainty_score":0.9536718},"labels":[],"label_agreement":null},{"id":"W4390127095","doi":"10.1016/j.jval.2023.09.036","title":"P26 Drug Utilization, Adherence, and Persistence in Parkinson's Disease Patients in a Real-World Setting in Quebec, Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Parkinson's Disease Mechanisms and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Persistence (discontinuity); Medicine; Disease; Drug; Parkinson's disease; Intensive care medicine; Gerontology; Psychiatry; Internal medicine; Engineering","score_opus":0.04709858550269786,"score_gpt":0.296608719596008,"score_spread":0.24951013409331013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9966642,0.0005913689,5.543996e-7,0.0015510697,0.00012034737,0.0008448265,0.000056792785,0.00002660105,0.00014421211],"genre_scores_gemma":[0.99771184,0.0010324557,0.00006500052,0.0004891987,0.000014991148,0.00010822014,0.00014283734,0.000019815283,0.0004156475],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802023,0.00023883762,0.00048523038,0.00045577652,0.00029446173,0.0005054866],"domain_scores_gemma":[0.99918485,0.00011619704,0.00010970888,0.0001963843,0.000029972372,0.00036291967],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004049165,0.00016946963,0.00033173253,0.0005869458,0.000050553903,0.0000134361935,0.0000667997,0.00003253063,0.000013930314],"category_scores_gemma":[0.00017565189,0.00017138253,0.000022724389,0.0014291056,0.000022110255,0.00009167655,0.00004443647,0.00016940065,0.0000037484276],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000117351075,0.00023544402,0.99289775,0.00037301442,0.000003975789,0.00040623033,0.0009906464,0.00044762678,3.886019e-7,0.00008536551,0.00044244467,0.0039997543],"study_design_scores_gemma":[0.0025602614,0.00003856393,0.9815302,0.0012761798,0.00000601663,3.3638202e-7,0.0006109735,0.011428924,0.000002297983,0.00022260874,0.0022044422,0.00011923515],"about_ca_topic_score_codex":0.9695443,"about_ca_topic_score_gemma":0.9910923,"teacher_disagreement_score":0.02154802,"about_ca_system_score_codex":0.0013457199,"about_ca_system_score_gemma":0.002135847,"threshold_uncertainty_score":0.6988777},"labels":[],"label_agreement":null},{"id":"W4390127102","doi":"10.1016/j.jval.2023.09.062","title":"P47 How Do HTA Agencies Manage Uncertainties in the Long-Term Clinical Benefit of Gene Therapies? An Analysis of Recent Gene Therapy HTAs in England, Germany, France, Italy, Canada, and the United States","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Term (time); Medicine; Political science; Physics","score_opus":0.322493166513005,"score_gpt":0.4149761842089676,"score_spread":0.09248301769596257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127102","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9629587,0.008747338,0.000035737146,0.026675293,0.00018562173,0.00091479445,0.00045416597,0.000009182411,0.000019186395],"genre_scores_gemma":[0.9410621,0.054075494,0.00010090748,0.0043537198,0.000060237373,0.000078555546,0.00021388105,0.00001885543,0.00003622962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930918,0.002012562,0.003791676,0.00046367734,0.00019341847,0.00044684683],"domain_scores_gemma":[0.99385214,0.0034152928,0.0018563492,0.0007153593,0.00007028012,0.0000905669],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.03387638,0.00019268041,0.0014310222,0.001223702,0.00010381195,0.00005030921,0.0004907161,0.00010742997,0.000042935953],"category_scores_gemma":[0.00064529834,0.0001557725,0.00010539562,0.0022529245,0.00022074943,0.00014645071,0.000044325014,0.00026570927,0.0000025768736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008154384,0.00009266938,0.9290143,0.00022427253,0.00021323345,0.00000347559,0.026884846,0.037693262,3.7869745e-7,0.0044821375,0.000121903024,0.0011879425],"study_design_scores_gemma":[0.0017668464,0.0000969431,0.92876196,0.000052784995,0.000010224133,6.56343e-7,0.0051632156,0.059630767,0.0000013007781,0.0021830732,0.0021897987,0.00014245708],"about_ca_topic_score_codex":0.70670784,"about_ca_topic_score_gemma":0.5906245,"teacher_disagreement_score":0.116083294,"about_ca_system_score_codex":0.00038399594,"about_ca_system_score_gemma":0.00032811877,"threshold_uncertainty_score":0.99482757},"labels":[],"label_agreement":null},{"id":"W4390127158","doi":"10.1016/j.jval.2023.09.132","title":"CO60 Predicting Treatment Effects from Surrogate Endpoints in First-Line (1L) Metastatic Castration-Resistant Prostate Cancer (MCRPC)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Oncology; Internal medicine; Surrogate endpoint; Cancer","score_opus":0.09172677733241291,"score_gpt":0.3858182695491741,"score_spread":0.2940914922167612,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127158","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9850782,0.004974001,0.0000028204845,0.0062887,0.0003033308,0.0028124365,0.0003519966,0.00011468385,0.00007383766],"genre_scores_gemma":[0.9866788,0.010603884,0.00024987813,0.000103306935,0.00011642205,0.00088367786,0.0004553476,0.000047457448,0.00086123525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972071,0.00032349516,0.0006663411,0.0005283132,0.00046047106,0.000814283],"domain_scores_gemma":[0.99845695,0.00074564014,0.00015166732,0.00029267458,0.00005461823,0.00029845975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00073097285,0.00026635986,0.0006236315,0.0004153233,0.00013607989,0.000027974585,0.0000738835,0.0000595259,0.000054434964],"category_scores_gemma":[0.00016145573,0.00020525788,0.00007428568,0.0009750244,0.0000582985,0.00009741392,0.00003627155,0.00025954898,0.00005401452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046916394,0.0017710032,0.8779268,0.004975568,0.00054728147,0.00520916,0.022413163,0.027408767,0.004141051,0.000074611664,0.00048145768,0.050359495],"study_design_scores_gemma":[0.035836827,0.005829157,0.863712,0.007862076,0.00016700219,0.00001872363,0.0015077341,0.07007975,0.011554164,0.001053319,0.0018538336,0.0005254278],"about_ca_topic_score_codex":0.09496929,"about_ca_topic_score_gemma":0.017122423,"teacher_disagreement_score":0.07784686,"about_ca_system_score_codex":0.0019547052,"about_ca_system_score_gemma":0.0012579064,"threshold_uncertainty_score":0.95547146},"labels":[],"label_agreement":null},{"id":"W4390127191","doi":"10.1016/j.jval.2023.09.1717","title":"HTA32 When Should the Conduct of RWE Studies Be Prioritized for Reimbursement: Insights from Canadian and Global Stakeholders","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Reimbursement; Business; Public economics; Actuarial science; Accounting; Public relations; Political science; Economics; Law","score_opus":0.5122569694828171,"score_gpt":0.37295231799855466,"score_spread":0.1393046514842624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127191","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92442465,0.0070285383,0.000026256104,0.06365192,0.00067087787,0.0007754539,0.0018704316,0.00002127307,0.0015306135],"genre_scores_gemma":[0.9944875,0.0011410256,0.00028403354,0.0037413368,0.000079953104,0.00003656802,0.000044949797,0.000009530715,0.00017508277],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9988695,0.000032886794,0.000583151,0.00021147254,0.000033548935,0.00026947854],"domain_scores_gemma":[0.9993378,0.00017200508,0.00021584252,0.00017185551,0.000037044076,0.000065447464],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007424698,0.00008520033,0.00031019674,0.00020535722,0.0001613875,0.00001729526,0.000108280845,0.000058157337,0.000011550035],"category_scores_gemma":[0.00021973911,0.00007577409,0.000030537532,0.00040695284,0.000080293445,0.00006871954,0.000024030249,0.00008105025,0.0000066031917],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015497648,0.000014273089,0.014032261,0.00015032422,0.00007405651,0.0000012392602,0.008241023,0.00035246258,0.0000022898441,0.9585563,0.018002125,0.00055813655],"study_design_scores_gemma":[0.0017442245,0.00012292607,0.054376423,0.000103383914,0.000005310417,6.2153816e-7,0.004283289,0.004022433,0.000021733304,0.7045945,0.23051122,0.00021394095],"about_ca_topic_score_codex":0.3675418,"about_ca_topic_score_gemma":0.06822684,"teacher_disagreement_score":0.29931495,"about_ca_system_score_codex":0.00023564494,"about_ca_system_score_gemma":0.00019196609,"threshold_uncertainty_score":0.9487756},"labels":[],"label_agreement":null},{"id":"W4390127197","doi":"10.1016/j.jval.2023.09.1196","title":"EPH154 Modeled Head-to-Head Comparison of Nirsevimab and Rsvpref Maternal Vaccine in the US","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Head (geology); Computer science; Medicine; Geology; Geomorphology","score_opus":0.24723519965376098,"score_gpt":0.4945282484013186,"score_spread":0.24729304874755761,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9622232,0.0024380994,0.000010254624,0.034273308,0.000092457216,0.00052859087,0.000007960783,0.000018230921,0.0004079114],"genre_scores_gemma":[0.9954099,0.001963593,0.0002076823,0.0022965905,0.00006070787,0.000020989884,0.0000033799329,0.00000922859,0.000027923923],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852866,0.00024950394,0.00047389048,0.00018074273,0.00024190873,0.00032528467],"domain_scores_gemma":[0.9991583,0.00045264387,0.00009424908,0.00015527234,0.000021527869,0.00011798718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012696062,0.000097049386,0.00042676227,0.000121662335,0.000057151443,0.000008598585,0.000086127184,0.00003633452,0.000019358275],"category_scores_gemma":[0.00013781454,0.00006383055,0.000024769706,0.0005055453,0.000017879816,0.00004179088,0.00006488726,0.000300053,0.000020441796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010240069,0.00034378323,0.96215725,0.000987909,0.000028489203,0.00004564616,0.0044981237,0.0059764697,0.00019255377,0.0002700165,0.0012881496,0.023187606],"study_design_scores_gemma":[0.002407215,0.0006931093,0.8608796,0.00040051492,0.000019592131,0.000023438155,0.0005664973,0.12091651,0.00011001667,0.0003977518,0.013506935,0.00007882931],"about_ca_topic_score_codex":0.01039688,"about_ca_topic_score_gemma":0.00064957544,"teacher_disagreement_score":0.11494004,"about_ca_system_score_codex":0.000060107745,"about_ca_system_score_gemma":0.00005499801,"threshold_uncertainty_score":0.996193},"labels":[],"label_agreement":null},{"id":"W4390127244","doi":"10.1016/j.jval.2023.09.1144","title":"EPH102 Potential Public Health Impact of Bivalent Respiratory Syncytial Virus Prefusion F (RSVpreF) Maternal Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Illness (LRTI) Among Canadian Infants","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Respiratory system; Virus; Lower respiratory tract infection; Respiratory illness; Virology; Respiratory tract infections; Respiratory tract; Pediatrics; Immunology; Internal medicine","score_opus":0.10860903853609306,"score_gpt":0.4102578771591319,"score_spread":0.3016488386230389,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127244","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9902578,0.0014877483,0.00022948379,0.00042894957,0.0012546038,0.00531039,0.00074982486,0.00018892511,0.00009228723],"genre_scores_gemma":[0.99741524,0.00031558741,0.00008106393,0.0006511145,0.00072668376,0.00041395158,0.00009441842,0.00020749113,0.0000944648],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98840415,0.0024918544,0.0037089412,0.0012523445,0.001759051,0.0023836594],"domain_scores_gemma":[0.99374557,0.00033346305,0.0016321595,0.0014869611,0.0008245347,0.0019773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008988151,0.00072467735,0.0018922747,0.004870045,0.00058952096,0.0000807164,0.00063547044,0.00065434526,0.00043381902],"category_scores_gemma":[0.0014297663,0.0006900695,0.0007803054,0.002898012,0.00030882953,0.00076457975,0.0002290689,0.0012013771,0.0000546841],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.007253588,0.0040202374,0.7677755,0.008589604,0.00062788365,0.00040969337,0.0013948723,0.014681221,0.13061549,0.00035251756,0.00682181,0.057457592],"study_design_scores_gemma":[0.0076301373,0.012793377,0.9612937,0.0015431714,0.00005513692,0.000023489534,0.000113493596,0.0023801792,0.008610456,0.00015794073,0.004793013,0.000605935],"about_ca_topic_score_codex":0.23165067,"about_ca_topic_score_gemma":0.041435257,"teacher_disagreement_score":0.19351818,"about_ca_system_score_codex":0.0045995233,"about_ca_system_score_gemma":0.014326445,"threshold_uncertainty_score":0.99955505},"labels":[],"label_agreement":null},{"id":"W4390127502","doi":"10.1016/j.jval.2023.09.1093","title":"EPH51 Artificial Intelligence (AI) Tools for Outbreak Detection and Response: A Transnational Platform for Surveillance, Monitoring and Decision Support","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Risk and Safety Analysis","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Outbreak; Computer science; Artificial intelligence; Data science; Medicine; Virology","score_opus":0.22684601517586042,"score_gpt":0.4382117484402083,"score_spread":0.2113657332643479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7309203,0.00008161965,0.26246142,0.005449813,0.0003852359,0.00053303776,0.00013452469,0.000029602881,0.0000043927635],"genre_scores_gemma":[0.9939282,0.00032304352,0.005448667,0.00004872674,0.000101595666,0.00008497688,0.000010272084,0.000010761354,0.00004378814],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9974607,0.00014650502,0.00095647195,0.00048901,0.0006157407,0.00033152194],"domain_scores_gemma":[0.9861632,0.013153542,0.00016535263,0.00019071967,0.00019840413,0.00012876536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.013216662,0.00011586832,0.0003285878,0.00068302813,0.00036159172,0.0002192858,0.00016264303,0.000095549105,0.000007662948],"category_scores_gemma":[0.0044073947,0.00009890451,0.00008964673,0.0011394616,0.000052952793,0.00039852242,0.000032776254,0.00010434873,0.0000049297046],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001867513,0.000017355233,0.0037991495,0.000023627848,0.0000065534023,0.0000012260656,0.0009464876,0.009899183,0.00017344196,0.0040610996,0.000057816513,0.97914654],"study_design_scores_gemma":[0.00040794982,0.00051655166,0.12193701,0.000030103403,0.00000518667,0.000008555186,0.00202074,0.37348518,0.0006153747,0.49577752,0.0050154952,0.0001803477],"about_ca_topic_score_codex":0.00011192998,"about_ca_topic_score_gemma":0.00037582807,"teacher_disagreement_score":0.9789662,"about_ca_system_score_codex":0.000094740164,"about_ca_system_score_gemma":0.00021391742,"threshold_uncertainty_score":0.5276382},"labels":[],"label_agreement":null},{"id":"W4390127584","doi":"10.1016/j.jval.2023.09.1846","title":"HTA162 Canadian HTA and Early-Phase Evidence in Oncology: Current Trends and the Path Ahead","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Current (fluid); Path (computing); Oncology; Medicine; Intensive care medicine; Computer science; Engineering; Electrical engineering","score_opus":0.5850161206492978,"score_gpt":0.5025133678377591,"score_spread":0.08250275281153863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127584","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75825006,0.02477053,0.00001770883,0.21500687,0.00061361684,0.0007333337,0.00013429577,0.000027169057,0.00044643442],"genre_scores_gemma":[0.9854537,0.0088270735,0.00015021604,0.0050675846,0.00015585979,0.00016632727,0.00001122664,0.00002141162,0.00014659038],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99477655,0.0011398693,0.0028032188,0.00054029655,0.000073207644,0.0006668582],"domain_scores_gemma":[0.99587387,0.0025397753,0.00080449856,0.0003554928,0.00001724523,0.00040914703],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.036012784,0.00015375682,0.000880872,0.0011329055,0.00020891445,0.00006340966,0.00019691755,0.000114041126,0.00003987654],"category_scores_gemma":[0.0031681403,0.00016078624,0.00004039606,0.0007551456,0.0001499366,0.0002683104,0.000058768634,0.0003661665,0.00019691871],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010063209,0.00014576077,0.72849184,0.0012520741,0.000022184198,0.000016736492,0.033999603,0.00083531084,1.899383e-7,0.15480039,0.021361751,0.058973536],"study_design_scores_gemma":[0.005603993,0.000363722,0.75059205,0.00097090355,0.000003350594,0.000011515347,0.0014284789,0.08191995,1.2130346e-7,0.022325292,0.13639343,0.00038716092],"about_ca_topic_score_codex":0.5224131,"about_ca_topic_score_gemma":0.15007186,"teacher_disagreement_score":0.37234122,"about_ca_system_score_codex":0.0013761078,"about_ca_system_score_gemma":0.0009366364,"threshold_uncertainty_score":0.9926277},"labels":[],"label_agreement":null},{"id":"W4390127626","doi":"10.1016/j.jval.2023.09.1192","title":"EPH150 Impact CKD: The Growing Burden of CKD in Spain","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Energy, Environment, and Transportation Policies","field":"Energy","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Environmental health","score_opus":0.03430081154451731,"score_gpt":0.30114747536467523,"score_spread":0.2668466638201579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127626","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9941762,0.0003519464,0.00001742891,0.0039395816,0.00010349065,0.00012572232,0.000013581487,0.000044024076,0.0012280054],"genre_scores_gemma":[0.998191,0.00095518475,0.0000631766,0.00042074686,0.000074861295,0.000018543375,0.00002765385,0.000022776296,0.00022607319],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9985539,0.0002501759,0.00046072254,0.0001602991,0.00020527159,0.00036967086],"domain_scores_gemma":[0.9993038,0.00026833665,0.000109576424,0.00024941412,0.000004966984,0.00006386139],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010077774,0.00010879873,0.00021163006,0.00022188183,0.000051314822,0.0000063030166,0.00015142778,0.000054651184,0.00006627317],"category_scores_gemma":[0.00004645884,0.00008383995,0.00006875768,0.00059263076,0.000052400694,0.00010436348,0.0000141515375,0.00014845934,0.000034707133],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000104496785,0.00002514778,0.021094805,0.000070687,0.000010181037,0.000007635295,0.0053777057,0.93201613,0.00025410793,0.03916262,0.00008493862,0.0018855999],"study_design_scores_gemma":[0.0010450535,0.00015121642,0.9453124,0.00027244567,0.0000067436567,0.0000023549617,0.0033204076,0.024509639,0.0005561761,0.011570481,0.013020806,0.00023228882],"about_ca_topic_score_codex":0.2475184,"about_ca_topic_score_gemma":0.003026133,"teacher_disagreement_score":0.9242176,"about_ca_system_score_codex":0.00012775787,"about_ca_system_score_gemma":0.00008299487,"threshold_uncertainty_score":0.7574924},"labels":[],"label_agreement":null},{"id":"W4390127706","doi":"10.1016/j.jval.2023.09.1797","title":"HTA113 How Have Manufacturers Maximised Their Digital Health Technologies’ Chances of Successful Reimbursement in Germany?","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Medical Studies","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Reimbursement; Business; Health technology; Actuarial science; Economics; Health care; Economic growth","score_opus":0.11329061689698565,"score_gpt":0.41084237333234436,"score_spread":0.2975517564353587,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69265336,0.006908086,0.00007785531,0.29208285,0.0014501482,0.004400551,0.00021447532,0.00061499566,0.0015976866],"genre_scores_gemma":[0.9815873,0.013539955,0.00011486578,0.003593261,0.00010357101,0.00047460588,0.000049247534,0.000036818365,0.00050037995],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9945521,0.0007188921,0.0015457686,0.000567602,0.00057009334,0.0020455937],"domain_scores_gemma":[0.9973056,0.0010712838,0.00073684554,0.00048310077,0.00006503286,0.0003381398],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035056402,0.00030259808,0.0010400623,0.0006764428,0.00047174896,0.000010055711,0.00041351272,0.00030802048,0.000035284473],"category_scores_gemma":[0.0009786738,0.00023507907,0.00007985258,0.0010830071,0.000204525,0.00014567317,0.0002830473,0.0013055407,0.000061571656],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003493791,0.00058263197,0.2759518,0.019406838,0.00007665754,0.00007904849,0.04756138,0.0004425552,0.00001766071,0.0018847042,0.04057018,0.61307716],"study_design_scores_gemma":[0.007989824,0.0019384525,0.38666356,0.011115881,0.0000072597495,0.000004202585,0.20546842,0.0042936113,0.00014003443,0.01145519,0.36997217,0.0009514188],"about_ca_topic_score_codex":0.00944181,"about_ca_topic_score_gemma":0.001802384,"teacher_disagreement_score":0.61212575,"about_ca_system_score_codex":0.0009412303,"about_ca_system_score_gemma":0.0018713125,"threshold_uncertainty_score":0.9971544},"labels":[],"label_agreement":null},{"id":"W4390127717","doi":"10.1016/j.jval.2023.09.1101","title":"EPH59 An Evidence Gap Analysis of the Epidemiology and Burden of Obstructive Hypertrophic Cardiomyopathy","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Epidemiology; Obstructive cardiomyopathy; Hypertrophic cardiomyopathy; Cardiology; Internal medicine; Cardiomyopathy; Heart failure","score_opus":0.14508085559372463,"score_gpt":0.3766464503121173,"score_spread":0.23156559471839266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127717","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98553,0.010813648,0.000022071212,0.0030119622,0.00017317115,0.00032936936,0.00002743401,0.000018142964,0.000074162635],"genre_scores_gemma":[0.99412817,0.00532802,0.00023796556,0.00016713094,0.000085083215,0.000016246662,0.000004201461,0.0000083226905,0.00002487165],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99778956,0.000870266,0.0005949895,0.000285888,0.00018878467,0.000270517],"domain_scores_gemma":[0.99782544,0.001273033,0.00024880812,0.0004605341,0.00010257239,0.000089629546],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026944194,0.000107910055,0.0011592738,0.00039981946,0.00006400261,0.00000115501,0.00009094143,0.000065588385,0.0000027315866],"category_scores_gemma":[0.0020559204,0.000074609175,0.0002216498,0.0018812744,0.00028350932,0.000040514216,0.00011140845,0.00015907412,7.9875656e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017109119,0.000024625622,0.9643977,0.00065921666,0.0006413391,0.000015064578,0.00732804,0.018514626,0.00083697017,0.0013802465,0.00006878625,0.0059622475],"study_design_scores_gemma":[0.00030567098,0.0002766186,0.9889989,0.00041660137,0.00051206903,0.000023472574,0.0020152295,0.006381315,0.000054391097,0.0008648441,0.00009223786,0.00005864522],"about_ca_topic_score_codex":0.010609089,"about_ca_topic_score_gemma":0.000053668657,"teacher_disagreement_score":0.024601158,"about_ca_system_score_codex":0.00007511872,"about_ca_system_score_gemma":0.0001603137,"threshold_uncertainty_score":0.99597937},"labels":[],"label_agreement":null},{"id":"W4390127723","doi":"10.1016/j.jval.2023.09.1705","title":"HTA20 Predicting Post-AMNOG Price for a New Product Launch in Germany","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Product (mathematics); Business; Economics; Mathematics","score_opus":0.11154586051683021,"score_gpt":0.30773938563539766,"score_spread":0.19619352511856744,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94669586,0.0011225599,0.0004769251,0.043637015,0.001095559,0.0014004379,0.00023161429,0.00013659023,0.005203457],"genre_scores_gemma":[0.99093235,0.00021088491,0.0012831062,0.0027992383,0.00060006604,0.000086793465,0.000041739582,0.000034072367,0.004011779],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9982713,0.000023051583,0.00084655965,0.00034032777,0.00003271157,0.00048608266],"domain_scores_gemma":[0.9993042,0.00011965463,0.00028028648,0.000204394,0.00002630492,0.000065190914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021833726,0.00009382812,0.00026870985,0.0006813733,0.0000806617,0.000022666023,0.0001321649,0.00006227431,0.000031016694],"category_scores_gemma":[0.00063905487,0.000112208996,0.000037693917,0.0013249712,0.00001189393,0.00013822148,0.0000335372,0.00017522367,0.00020441212],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006225086,0.0001947229,0.1519357,0.0011239229,0.000017660184,0.0000051075112,0.010768675,0.009564084,0.000035043722,0.80483764,0.017496942,0.0039582583],"study_design_scores_gemma":[0.002292359,0.0003491285,0.51829505,0.00023187898,9.756832e-7,0.0000063115745,0.00026215464,0.074790955,0.000062162966,0.108381644,0.29487777,0.0004496436],"about_ca_topic_score_codex":0.011002898,"about_ca_topic_score_gemma":0.00015769772,"teacher_disagreement_score":0.69645596,"about_ca_system_score_codex":0.00021120557,"about_ca_system_score_gemma":0.00023733168,"threshold_uncertainty_score":0.99558294},"labels":[],"label_agreement":null},{"id":"W4390127855","doi":"10.1016/j.jval.2023.09.2194","title":"MSR136 IPECAD Modeling Workshop 2023 Cross Comparison Challenge on Cost-Effectiveness Models in Alzheimer's Disease and Related Dementias","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Disease; Medicine; Gerontology; Computer science; Internal medicine","score_opus":0.6457526558320349,"score_gpt":0.4940366541097025,"score_spread":0.1517160017223324,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94783694,0.0236344,0.0016155784,0.02165431,0.0008878096,0.0031962155,0.0002359096,0.00014057667,0.0007982926],"genre_scores_gemma":[0.9953566,0.0027117627,0.0001458103,0.0010129529,0.000091849724,0.00048734221,0.000089809524,0.000058862228,0.000044972116],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9925872,0.0012353644,0.004193541,0.0009832911,0.00015482094,0.00084579247],"domain_scores_gemma":[0.99618816,0.0018122068,0.0010211585,0.00052334135,0.00003692443,0.0004182045],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02432872,0.00027923088,0.0012108929,0.00096000306,0.0002402376,0.000086921245,0.00024214937,0.00020729566,0.000038873746],"category_scores_gemma":[0.0011483356,0.0003816781,0.00008651461,0.00073696254,0.00006002489,0.00048348118,0.00010086101,0.0004978011,0.0005795632],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000829593,0.00019035736,0.033480216,0.00048604677,0.000041700256,0.0000059692798,0.0022818104,0.90508866,4.4156902e-8,0.05755272,0.0002873272,0.00050217967],"study_design_scores_gemma":[0.0015004616,0.00007731113,0.04136018,0.00070093165,0.0000042619145,6.0618686e-7,0.00057033246,0.89908755,1.7527346e-7,0.0561179,0.0002896168,0.00029068568],"about_ca_topic_score_codex":0.0067732045,"about_ca_topic_score_gemma":0.00047746403,"teacher_disagreement_score":0.047519732,"about_ca_system_score_codex":0.00094022043,"about_ca_system_score_gemma":0.00027772086,"threshold_uncertainty_score":0.9998635},"labels":[],"label_agreement":null},{"id":"W4390127895","doi":"10.1016/j.jval.2023.09.155","title":"CO83 Disease Burden of Moderate to Severe Ulcerative Colitis in Chinese Patients Under Current Care: A Model Simulation Study","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Ulcerative colitis; Medicine; Disease; Current (fluid); Burden of disease; Internal medicine; Intensive care medicine; Engineering","score_opus":0.02596179047694591,"score_gpt":0.33175967105117693,"score_spread":0.305797880574231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127895","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977655,0.00007566468,0.00021931269,0.0000675643,0.000093681185,0.0015067615,0.00024418122,0.000012074917,0.000015271246],"genre_scores_gemma":[0.9993897,0.000026653948,0.000029474948,0.00009042046,0.000043246986,0.0001146634,0.00025980474,0.000021410717,0.00002463247],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9984954,0.00030407961,0.00038563012,0.0003411522,0.00021087767,0.000262834],"domain_scores_gemma":[0.99930084,0.00001931274,0.00008708833,0.00026422192,0.0001312111,0.00019735581],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021873014,0.00014318692,0.00017403136,0.00014032901,0.00004654263,0.000009323604,0.0000998729,0.000040768922,0.0000019461147],"category_scores_gemma":[0.00012633544,0.00014651881,0.00003863687,0.0002582512,0.000015391535,0.0000070372976,0.00010353957,0.00007550765,0.0000061120154],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089955755,0.00021311508,0.13060823,0.0001669343,0.0000060098555,0.0000070762467,0.0030644229,0.8646397,0.000012036305,0.00002513614,0.000029759423,0.00032802287],"study_design_scores_gemma":[0.0012959575,0.00011953249,0.5535048,0.000052842377,0.0000027475,2.486243e-8,0.00029953013,0.44439644,0.0000032489995,0.0002120702,0.0000081034805,0.00010470442],"about_ca_topic_score_codex":0.00040114258,"about_ca_topic_score_gemma":0.00048563434,"teacher_disagreement_score":0.4228966,"about_ca_system_score_codex":0.00013570048,"about_ca_system_score_gemma":0.00049595407,"threshold_uncertainty_score":0.5974864},"labels":[],"label_agreement":null},{"id":"W4390127909","doi":"10.1016/j.jval.2023.09.2170","title":"MSR111 Causal Inference and Statistical Considerations for Indirectly Comparing Time-to-Event Endpoints for Treatments with Different Starting Points for Outcome Assessment in Resectable NSCLC","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Outcome (game theory); Causal inference; Inference; Event (particle physics); Statistical inference; Medicine; Internal medicine; Computer science; Statistics; Artificial intelligence; Mathematics; Pathology","score_opus":0.31694711317792057,"score_gpt":0.49713635470914014,"score_spread":0.18018924153121957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390127909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6057858,0.00000989019,0.38609773,0.0011832545,0.00004656269,0.006187222,0.0004459026,0.00020208528,0.000041575604],"genre_scores_gemma":[0.69083256,0.0000062953027,0.3062473,0.00011368765,0.000016723341,0.002582547,0.00007162769,0.00004475812,0.00008453056],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99742514,0.00017848895,0.00095517805,0.00047893813,0.00022896097,0.0007332787],"domain_scores_gemma":[0.9908798,0.008332556,0.00025494813,0.00023779052,0.0001041401,0.00019080995],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014935823,0.0002630056,0.00072488724,0.00034400178,0.00020306928,0.000059241316,0.000085660766,0.000071807895,0.000014130031],"category_scores_gemma":[0.0026349216,0.0002301465,0.00003450648,0.0002190111,0.00004124893,0.0001242138,0.000078837176,0.00019080877,0.0000023664081],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018148398,0.0024722498,0.33339205,0.0072280397,0.00028715478,0.000045486933,0.010656842,0.012294509,0.0017050861,0.6168423,0.0034880624,0.009773364],"study_design_scores_gemma":[0.0045644892,0.0027840084,0.030732669,0.0012505812,0.000039543364,0.000004040906,0.0005206371,0.19054219,0.0011568905,0.76787716,0.000049034155,0.00047877044],"about_ca_topic_score_codex":0.00044628966,"about_ca_topic_score_gemma":0.0012503532,"teacher_disagreement_score":0.3026594,"about_ca_system_score_codex":0.00070372806,"about_ca_system_score_gemma":0.00032089886,"threshold_uncertainty_score":0.9385102},"labels":[],"label_agreement":null},{"id":"W4390128002","doi":"10.1016/j.jval.2023.09.451","title":"EE182 Costs and Health Impact of Wastewater Surveillance to Guide Respiratory Syncytial Virus Prophylaxis in Canada, Compared to Clinical Surveillance","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of Ottawa","funders":"","keywords":"Medicine; Environmental health; Respiratory system; Intensive care medicine; Internal medicine","score_opus":0.15133295131608016,"score_gpt":0.4667479452092924,"score_spread":0.31541499389321226,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128002","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933835,0.00045381053,0.0000069616794,0.0033938163,0.00029939163,0.0021927396,0.00015673526,0.00004167489,0.00007136326],"genre_scores_gemma":[0.9975214,0.00014456932,0.000114214716,0.0018963752,0.00014259007,0.00007178838,0.000014027547,0.000041635125,0.000053411437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99400216,0.0017438118,0.0018940835,0.0006581748,0.000691789,0.0010099717],"domain_scores_gemma":[0.99734896,0.00053844356,0.00021209933,0.0006711166,0.00019216602,0.0010372036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007859377,0.00023707183,0.0011876627,0.00086045644,0.00008278495,0.00001734516,0.0001942567,0.000098178796,0.000025856592],"category_scores_gemma":[0.0013430696,0.00020853094,0.00007700435,0.0023347968,0.00007901769,0.000053660835,0.00016595231,0.0005790506,0.00004390155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000538786,0.0001050809,0.9735164,0.000415265,0.000016500608,0.000071802206,0.00019387869,0.0065906947,0.00042448338,0.0000061082064,0.011351986,0.0067690085],"study_design_scores_gemma":[0.0014965292,0.0034249667,0.989739,0.0003090284,4.7312446e-7,0.000007281742,0.00007428027,0.0012368442,0.000109839115,0.000003832856,0.0034420402,0.00015590157],"about_ca_topic_score_codex":0.97445893,"about_ca_topic_score_gemma":0.9442295,"teacher_disagreement_score":0.030229488,"about_ca_system_score_codex":0.005657749,"about_ca_system_score_gemma":0.013546535,"threshold_uncertainty_score":0.99815935},"labels":[],"label_agreement":null},{"id":"W4390128004","doi":"10.1016/j.jval.2023.09.1839","title":"HTA155 The Impact of Phase 2 Clinical Trials on Reimbursement Recommendations in Oncology By Canadian Health Technology Assessment Agencies","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Reimbursement; Clinical trial; Health technology; Medicine; Family medicine; Business; Internal medicine; Health care; Economic growth; Economics","score_opus":0.8350915822005727,"score_gpt":0.6717757189770044,"score_spread":0.16331586322356828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128004","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37139478,0.0018271458,0.00018183887,0.6199668,0.001049383,0.0027492696,0.0019454507,0.000045740893,0.0008395784],"genre_scores_gemma":[0.96854466,0.00818455,0.0013231623,0.020615598,0.00021158089,0.000483989,0.00040181002,0.00004411404,0.00019052361],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.97820026,0.0074850377,0.012502751,0.00067345204,0.000119217766,0.0010192845],"domain_scores_gemma":[0.98760664,0.006792289,0.004536263,0.0006731349,0.000041345935,0.00035030453],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.16934338,0.00019368039,0.0021251594,0.0018524656,0.00023579838,0.000022620417,0.00039941032,0.00025143294,0.00027024694],"category_scores_gemma":[0.010255669,0.00018764159,0.00020314252,0.0013119786,0.000115247356,0.00010251388,0.000045480392,0.00064585754,0.0002763268],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000055218108,0.0011642948,0.095693186,0.00026309906,0.00014145473,0.000003982623,0.0042999946,0.0127174,0.0000013452319,0.09995403,0.7591795,0.026526516],"study_design_scores_gemma":[0.014488464,0.012175353,0.2038806,0.0011498326,0.000009578717,0.000009716807,0.022746032,0.13669598,0.000003307455,0.05129726,0.55658686,0.0009570091],"about_ca_topic_score_codex":0.5077628,"about_ca_topic_score_gemma":0.075649664,"teacher_disagreement_score":0.5993512,"about_ca_system_score_codex":0.009082847,"about_ca_system_score_gemma":0.0077543426,"threshold_uncertainty_score":0.9980814},"labels":[],"label_agreement":null},{"id":"W4390128058","doi":"10.1016/j.jval.2023.09.177","title":"CO105 A Retrospective Study Characterizing Age at Loss of Ambulation Among Patients With Friedreich Ataxia Using Health Administrative Claims Data in the United States","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Ataxia; Medicine; Retrospective cohort study; Gerontology; Demography; Psychiatry; Surgery; Sociology","score_opus":0.18487250582154063,"score_gpt":0.3781800547029752,"score_spread":0.1933075488814346,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99611545,0.000012159487,0.000020444546,0.00038307332,0.00008887678,0.0024786924,0.00086140976,0.000035952282,0.0000039698775],"genre_scores_gemma":[0.9986276,0.00005013855,0.000061442624,0.0005421145,0.00001859934,0.000037935144,0.0006242281,0.000031885018,0.000006031367],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944964,0.0026999174,0.0007225649,0.0008074474,0.00076170574,0.00051194435],"domain_scores_gemma":[0.99793625,0.00043907817,0.0006229864,0.00080871524,0.00007475811,0.00011821242],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011997743,0.00022525081,0.00039439762,0.00037105495,0.00029540324,0.00004915975,0.00051291334,0.000030208617,0.0000051505376],"category_scores_gemma":[0.00044226274,0.00017599342,0.000019235687,0.0023376483,0.00019466724,0.0002305521,0.0002545112,0.00026855484,0.0000031325155],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001597436,0.0005750873,0.9764731,0.000084162195,0.000004568675,0.000041395506,0.013307865,0.008831785,0.00042455943,0.00005090996,0.000018837773,0.00002797371],"study_design_scores_gemma":[0.0010263069,0.0011277967,0.9757276,0.00015864572,0.000004861099,0.0000012837638,0.0021324924,0.018836778,0.0007698517,0.00006995574,0.000008735737,0.00013569128],"about_ca_topic_score_codex":0.0082029095,"about_ca_topic_score_gemma":0.0018840035,"teacher_disagreement_score":0.011175373,"about_ca_system_score_codex":0.0004012029,"about_ca_system_score_gemma":0.0004069634,"threshold_uncertainty_score":0.9984016},"labels":[],"label_agreement":null},{"id":"W4390128074","doi":"10.1016/j.jval.2023.09.1852","title":"HTA168 Widening the Value Lens for Child Health Technologies: Development of a Child-Tailored HTA Value Assessment Framework Using Multi-Criteria Decision Analysis Incorporating Patient, Public, and Expert Perspectives","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency; Canadian Respiratory Research Network; Sunnybrook Health Science Centre; Pediatric Oncology Group; University of Toronto; Hospital for Sick Children","funders":"","keywords":"Value (mathematics); Health technology; Medicine; Psychology; Knowledge management; Management science; Political science; Computer science; Engineering; Health care; Machine learning","score_opus":0.41169293837486043,"score_gpt":0.46800534590760956,"score_spread":0.05631240753274913,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.53469527,0.0150593715,0.343256,0.1021806,0.0005986311,0.0036681185,0.00025012015,0.0002422285,0.00004969274],"genre_scores_gemma":[0.7199698,0.0008961704,0.27636245,0.0023385275,0.00006806045,0.0002652426,0.000049287668,0.00004795612,0.0000024848948],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99070954,0.00095879304,0.0060458416,0.0011140209,0.00026869724,0.00090307934],"domain_scores_gemma":[0.99162275,0.0027622995,0.0045070075,0.0008108399,0.00013385969,0.0001632546],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.026539369,0.00035584928,0.001765857,0.0019440823,0.0013689502,0.00016491978,0.0004644127,0.0002454274,0.000011901866],"category_scores_gemma":[0.007066029,0.00036682736,0.0002046813,0.0022751137,0.00016022168,0.00048912724,0.00029499753,0.00048905297,0.0000091913325],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011366021,0.001139231,0.23398054,0.003113147,0.001509384,0.00000274721,0.23145318,0.11501862,0.000011330747,0.39076707,0.0011860789,0.02170501],"study_design_scores_gemma":[0.0013919324,0.0003121076,0.062724166,0.0018712616,0.000018240267,0.000006633468,0.07999998,0.83235115,0.000008718065,0.017720643,0.0029924165,0.0006027365],"about_ca_topic_score_codex":0.004418235,"about_ca_topic_score_gemma":0.00030776794,"teacher_disagreement_score":0.71733254,"about_ca_system_score_codex":0.002232592,"about_ca_system_score_gemma":0.0010738574,"threshold_uncertainty_score":0.99993116},"labels":[],"label_agreement":null},{"id":"W4390128212","doi":"10.1016/j.jval.2023.09.1693","title":"HTA8 Health Technology Assessment (HTA) Case Studies: Comparing Acceptability of Real-World Evidence (RWE) in Appraisals for Oncology Medicines","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Surrey Memorial Hospital","funders":"","keywords":"Real world evidence; Health technology; Medicine; Medical physics; Oncology; Intensive care medicine; Internal medicine; Health care; Economics; Economic growth","score_opus":0.7638739125985797,"score_gpt":0.6161334100116591,"score_spread":0.14774050258692062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128212","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.73464936,0.009216113,0.0010514598,0.24861163,0.0014591153,0.004238767,0.00016674183,0.00015335447,0.00045346605],"genre_scores_gemma":[0.980491,0.0055855736,0.009139915,0.0036294954,0.00017889745,0.0008672905,0.000021806482,0.00003842496,0.00004759752],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9863766,0.0016228764,0.009775659,0.0010197436,0.00015233638,0.00105282],"domain_scores_gemma":[0.98281103,0.011642159,0.0043710954,0.0008082836,0.0001314554,0.00023595002],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.08153844,0.00025923736,0.003165015,0.0023165175,0.00021447967,0.000013771671,0.00039427177,0.00019135071,0.000046393932],"category_scores_gemma":[0.013017994,0.00031851095,0.00010989564,0.0020142733,0.0002423768,0.00028832458,0.00017285586,0.00043468046,0.000052076317],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049919538,0.0003436493,0.8388493,0.010025322,0.00006561994,0.000024828092,0.011245305,0.011950049,8.3772426e-7,0.113499954,0.009729204,0.0042159837],"study_design_scores_gemma":[0.00642192,0.0029119467,0.56942064,0.0038439909,0.000013261048,0.00011591244,0.089222826,0.21091267,0.000006540191,0.089301445,0.026792945,0.0010359164],"about_ca_topic_score_codex":0.05232165,"about_ca_topic_score_gemma":0.03541516,"teacher_disagreement_score":0.2694287,"about_ca_system_score_codex":0.0053040427,"about_ca_system_score_gemma":0.002217244,"threshold_uncertainty_score":0.9999267},"labels":[],"label_agreement":null},{"id":"W4390128256","doi":"10.1016/j.jval.2023.09.1767","title":"HTA83 Economic Evaluations in Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Challenges for Health Technology Assessment (HTA) Submissions","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Follicular lymphoma; Refractory (planetary science); Health technology; Follicular phase; Medicine; Oncology; Lymphoma; Medical physics; Internal medicine; Health care; Economics; Biology; Economic growth","score_opus":0.49528498971328,"score_gpt":0.508883211188328,"score_spread":0.013598221475048022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128256","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32466638,0.016871607,0.0014343807,0.64602625,0.0021763337,0.006598087,0.00089369214,0.0004577054,0.0008755646],"genre_scores_gemma":[0.92823625,0.02854717,0.02002264,0.014793989,0.0007199843,0.0054946127,0.0004357121,0.00029430998,0.001455327],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98857206,0.0012761074,0.007237683,0.0013273096,0.00017695542,0.0014098731],"domain_scores_gemma":[0.9926484,0.002823208,0.0029565531,0.0010896464,0.00005869011,0.00042345736],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.04329168,0.0003687838,0.0019468734,0.0028842408,0.00045684684,0.000049412814,0.00053564826,0.00041092891,0.00016444633],"category_scores_gemma":[0.0038878177,0.00045349365,0.0001839377,0.0010187591,0.00008843569,0.00030146775,0.00011213757,0.00036870124,0.00091382075],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018093297,0.0014238755,0.04283611,0.0050365664,0.0001792468,0.000014891599,0.009775931,0.05897716,0.0000049662694,0.8049279,0.05059784,0.026044609],"study_design_scores_gemma":[0.010295179,0.001880194,0.19963503,0.001540614,0.000008648617,0.000021543243,0.011262609,0.3348748,0.0000034663276,0.13267381,0.30656072,0.0012433707],"about_ca_topic_score_codex":0.005192741,"about_ca_topic_score_gemma":0.003913606,"teacher_disagreement_score":0.672254,"about_ca_system_score_codex":0.00797762,"about_ca_system_score_gemma":0.004939239,"threshold_uncertainty_score":0.9998641},"labels":[],"label_agreement":null},{"id":"W4390128316","doi":"10.1016/j.jval.2023.09.1080","title":"EPH38 Exploring the Relationship Between Hemochromatosis and Fracture Risk: A Population-Based Matched Cohort Study Stratified on Ferritin Levels","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Hemochromatosis; Ferritin; Cohort; Medicine; Internal medicine; Demography; Pediatrics; Sociology","score_opus":0.15622680918982387,"score_gpt":0.3576634433343067,"score_spread":0.20143663414448285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927018,0.00010545777,0.000055871547,0.0051815277,0.00010731524,0.0016553861,0.000029579653,0.000114227565,0.00004878225],"genre_scores_gemma":[0.9988878,0.000028157447,0.00015754082,0.00052010856,0.00010816658,0.00014475775,0.00008668362,0.000027831149,0.000038983988],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799013,0.0005318098,0.00047662438,0.0003128517,0.0003964806,0.00029207848],"domain_scores_gemma":[0.9977486,0.0015997158,0.00014323767,0.00035913743,0.000020531164,0.00012875396],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017481472,0.00015452056,0.0003730452,0.00023921423,0.00031015748,0.000027662645,0.00006794421,0.00006735217,0.000017436367],"category_scores_gemma":[0.00083711377,0.00011619709,0.000039643797,0.0005931231,0.000023884748,0.00006557586,0.000015372863,0.00043129685,0.000020945694],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003170768,0.00008246575,0.9938314,0.00015531675,0.000008453495,0.00000407211,0.001719565,0.0032889333,0.000001378575,0.00018896963,0.00009151695,0.00059624255],"study_design_scores_gemma":[0.0014550278,0.00016216433,0.99447906,0.00014179552,0.000043670647,8.037272e-7,0.002026973,0.00063532696,0.00000744262,0.0009291827,0.000021252315,0.000097315395],"about_ca_topic_score_codex":0.00942342,"about_ca_topic_score_gemma":0.00018583778,"teacher_disagreement_score":0.009237583,"about_ca_system_score_codex":0.00007817106,"about_ca_system_score_gemma":0.000169191,"threshold_uncertainty_score":0.9971729},"labels":[],"label_agreement":null},{"id":"W4390128371","doi":"10.1016/j.jval.2023.09.825","title":"EE560 A Comparison of Time-Driven Activity-Based Costs for Patients and Caregivers Receiving Intravitreal Treatments for Neovascular Age-Related Macular Degeneration","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada); University of Windsor; Ottawa Hospital","funders":"","keywords":"Macular degeneration; Medicine; Ophthalmology; Optometry; Gerontology","score_opus":0.24911130776865745,"score_gpt":0.4091125458603099,"score_spread":0.16000123809165243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98932874,0.00038776247,0.0022752902,0.003827089,0.00028053139,0.0031254415,0.0007020247,0.000044635446,0.000028511256],"genre_scores_gemma":[0.9929683,0.00011115633,0.00532664,0.00034344918,0.00004981172,0.00039982883,0.00066966267,0.000043597,0.00008753864],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99648005,0.00039823298,0.0021354768,0.0004936627,0.00008950266,0.00040306489],"domain_scores_gemma":[0.9968583,0.001223293,0.0014624074,0.0002467629,0.00006826837,0.00014097197],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00526206,0.00017155363,0.0009800856,0.0004921602,0.00019062818,0.00002840703,0.000105512256,0.0001488137,0.0000098298715],"category_scores_gemma":[0.0010723518,0.00022689061,0.00012619578,0.00029183502,0.00004396638,0.00018383305,0.000019435356,0.000086679625,0.000029777344],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005011906,0.0016214092,0.68378377,0.0056418735,0.0006768738,0.0000022343636,0.024048207,0.24270108,0.00018784919,0.008783433,0.0143436715,0.017708432],"study_design_scores_gemma":[0.006974367,0.0010829427,0.08218689,0.00034644097,0.000027555934,3.0819496e-7,0.00034354994,0.90527046,0.00007572586,0.0018496962,0.0015099512,0.00033211],"about_ca_topic_score_codex":0.0052971994,"about_ca_topic_score_gemma":0.00022751636,"teacher_disagreement_score":0.6625694,"about_ca_system_score_codex":0.0011249245,"about_ca_system_score_gemma":0.00021384307,"threshold_uncertainty_score":0.92523307},"labels":[],"label_agreement":null},{"id":"W4390128438","doi":"10.1016/j.jval.2023.09.160","title":"CO88 A Matching-Adjusted Indirect Comparison of the Efficacy of Bimekizumab and Secukinumab at 52 Weeks for the Treatment of Radiographic Axial Spondyloarthritis","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Secukinumab; Axial spondyloarthritis; Medicine; Matching (statistics); Radiography; Nuclear medicine; Orthodontics; Radiology; Internal medicine; Ankylosing spondylitis; Pathology; Arthritis","score_opus":0.05772239883084474,"score_gpt":0.32962091304604074,"score_spread":0.271898514215196,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128438","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97945315,0.016678693,0.0000031967184,0.001036818,0.00028392125,0.002234036,0.00025794466,0.000023110642,0.000029150842],"genre_scores_gemma":[0.99242413,0.0071535837,0.00012328014,0.000025640009,0.000047260073,0.00010890415,0.000034703917,0.000024262408,0.00005824308],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982808,0.00015514359,0.0006956077,0.00024887608,0.00029256885,0.00032700752],"domain_scores_gemma":[0.99809664,0.0010348505,0.00037174043,0.0003694386,0.000055961966,0.00007133584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003256733,0.00018461463,0.00089645514,0.00023375136,0.00019961508,0.0000034415893,0.00008906773,0.00007335657,0.000010583385],"category_scores_gemma":[0.000070107795,0.0001113084,0.00023954998,0.00081689993,0.0002412361,0.00001559514,0.00005086091,0.00008543827,0.0000010754559],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00610031,0.0036630547,0.7895134,0.0018784745,0.001276043,0.00003459726,0.036529962,0.00086008746,0.0007746964,0.00073950214,0.0007290169,0.15790083],"study_design_scores_gemma":[0.02659645,0.007900642,0.9545944,0.0011852614,0.0002720949,0.000050291772,0.0020099941,0.0019335612,0.0026822805,0.0002122823,0.002425042,0.00013769811],"about_ca_topic_score_codex":0.005878193,"about_ca_topic_score_gemma":0.0011665225,"teacher_disagreement_score":0.16508096,"about_ca_system_score_codex":0.00015710277,"about_ca_system_score_gemma":0.00013602829,"threshold_uncertainty_score":0.88861084},"labels":[],"label_agreement":null},{"id":"W4390128441","doi":"10.1016/j.jval.2023.09.1763","title":"HTA79 CADTH Reimbursement Recommendations for Mental Illness Health Products: 10-Year Trends in Relation to Non-Mental Illness Health Products and Recommendations From Other HTA Bodies","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Multiple Sclerosis Society of Canada; EVERSANA (Canada)","funders":"","keywords":"Reimbursement; Mental illness; Mental health; Medicine; Psychiatry; Environmental health; Health care; Political science; Law","score_opus":0.339166958989266,"score_gpt":0.44347530709181965,"score_spread":0.10430834810255363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128441","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12795764,0.0018889015,0.00041073657,0.85586345,0.0026740597,0.0052887164,0.0055755214,0.00013359633,0.00020737716],"genre_scores_gemma":[0.76267934,0.014416725,0.07138775,0.1067566,0.003090289,0.0076627247,0.023016509,0.0006475562,0.010342526],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99068713,0.0010751715,0.005409786,0.0014965119,0.00019390948,0.0011374626],"domain_scores_gemma":[0.9958209,0.000648291,0.0023227197,0.00073548575,0.00008442981,0.00038821204],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.021997139,0.0003836663,0.0013755577,0.0018212072,0.0009069802,0.0001097564,0.00028236894,0.00013796109,0.00025933763],"category_scores_gemma":[0.0013223268,0.00050412794,0.00007448058,0.0014312512,0.00006103052,0.0006273608,0.00012885428,0.00032135102,0.0003321379],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014356917,0.00067282934,0.02527537,0.0017294888,0.00009069281,4.6683817e-7,0.101018,0.0016920582,0.000004034392,0.015940532,0.82560295,0.02783003],"study_design_scores_gemma":[0.0038979296,0.00083678204,0.07524565,0.0013412908,0.0000047770845,0.0000031056181,0.02179435,0.013522114,0.000012032742,0.00495345,0.8774328,0.00095571944],"about_ca_topic_score_codex":0.046938434,"about_ca_topic_score_gemma":0.0062723355,"teacher_disagreement_score":0.7491069,"about_ca_system_score_codex":0.0041239997,"about_ca_system_score_gemma":0.0008952937,"threshold_uncertainty_score":0.999741},"labels":[],"label_agreement":null},{"id":"W4390128467","doi":"10.1016/j.jval.2023.09.1179","title":"EPH137 Healthcare Resource Consumption and Direct Costs of Patients Newly Diagnosed with Acute Myeloid Leukemia from a Large Italian Administrative Database","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Care Foundation","funders":"","keywords":"Myeloid leukemia; Resource consumption; Consumption (sociology); Health care; Medicine; Resource (disambiguation); Database; Business; Operations management; Intensive care medicine; Computer science; Internal medicine; Economics; Computer network; Economic growth; Biology","score_opus":0.05861001445377408,"score_gpt":0.29106940854868874,"score_spread":0.23245939409491465,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9857816,0.0020344076,0.00007372091,0.0008746073,0.00015327249,0.0005974024,0.00977841,0.00003761437,0.0006689549],"genre_scores_gemma":[0.99424404,0.0038804663,0.00034723038,0.0006534143,0.000054097323,0.000044370994,0.0006643186,0.000031161784,0.00008088881],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981051,0.000069302754,0.00080132694,0.000502265,0.000055171655,0.0004668474],"domain_scores_gemma":[0.9985595,0.00023932473,0.00062989956,0.00031435,0.000030182931,0.00022675774],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006553346,0.00018366372,0.0006177608,0.00025882624,0.00010521926,0.00003019171,0.0001329974,0.00010123106,0.000035679772],"category_scores_gemma":[0.00014295647,0.00020378351,0.000039677412,0.00030481425,0.00008592716,0.0002772352,0.00006127217,0.00019693641,0.00006392678],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033646886,0.00009639218,0.97690755,0.00019452978,0.00005275336,0.000022100014,0.002748902,0.00015452137,0.0000015199965,0.015263986,0.0016232345,0.0025980405],"study_design_scores_gemma":[0.003545822,0.000678212,0.978364,0.00043491847,0.000006745704,0.0000010705076,0.0003912197,0.0021786096,0.000022241016,0.0016142717,0.012442966,0.00031992924],"about_ca_topic_score_codex":0.028420351,"about_ca_topic_score_gemma":0.002927288,"teacher_disagreement_score":0.025493063,"about_ca_system_score_codex":0.0006182196,"about_ca_system_score_gemma":0.00029754292,"threshold_uncertainty_score":0.97804946},"labels":[],"label_agreement":null},{"id":"W4390128515","doi":"10.1016/j.jval.2023.09.163","title":"CO91 Association Between Progression-Free Survival (PFS) and Overall Survival (OS) in Patients with Relapsed/Refractory (RR) Multiple Myeloma (MM)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Progression-free survival; Multiple myeloma; Medicine; Refractory (planetary science); Oncology; Internal medicine; Overall survival; Biology","score_opus":0.04410244819865129,"score_gpt":0.3251122891990199,"score_spread":0.28100984100036863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9957103,0.00018061724,0.0000042465535,0.0016690961,0.00019991113,0.0017471057,0.0001709454,0.00011075994,0.00020699692],"genre_scores_gemma":[0.9981733,0.00026693864,0.00038447074,0.000067019624,0.00012838826,0.00008689255,0.00057407987,0.0000540405,0.00026485964],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99588907,0.00068859884,0.00059978815,0.0005402825,0.0013546827,0.0009275764],"domain_scores_gemma":[0.99736595,0.0013392792,0.00025923533,0.0004425382,0.00013006492,0.00046290996],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018934513,0.00025115057,0.0006553519,0.0004677009,0.0001367015,0.00003046774,0.0001418491,0.00019483601,0.000018925113],"category_scores_gemma":[0.0016994033,0.00020867553,0.000048431342,0.0006855737,0.000051829407,0.00017460066,0.00014613708,0.0005649082,0.00004657302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009747305,0.00050913217,0.98165,0.0003048906,0.00008650479,0.00005983053,0.0004341929,0.000044118693,0.0000056204785,0.000022211952,0.00034301972,0.015565746],"study_design_scores_gemma":[0.020097237,0.001390053,0.9757905,0.00060111226,0.000014108242,5.4759835e-7,0.00007423317,0.0012365386,0.000012163661,0.00011602907,0.0005002077,0.00016726206],"about_ca_topic_score_codex":0.00517991,"about_ca_topic_score_gemma":0.0010379413,"teacher_disagreement_score":0.019122507,"about_ca_system_score_codex":0.0011827366,"about_ca_system_score_gemma":0.00046475104,"threshold_uncertainty_score":0.8509541},"labels":[],"label_agreement":null},{"id":"W4390128516","doi":"10.1016/j.jval.2023.09.2269","title":"MT40 Trends of Use of Knotless Tissue Control Devices and Smooth Sutures in Robotic Ventral Hernia Repair: A Retrospective Database Analysis","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Hernia repair and management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Custom Security Industries (Canada)","funders":"","keywords":"Ventral hernia; Medicine; Surgery; Hernia","score_opus":0.0455359024825187,"score_gpt":0.33510054316516696,"score_spread":0.28956464068264826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969122,0.0010535131,0.00015219497,0.0011532507,0.000055448887,0.0004448093,0.00009301193,0.00006958074,0.00006599572],"genre_scores_gemma":[0.9984406,0.00045602984,0.00067803863,0.00015980157,0.000026395554,0.00001768146,0.00005446416,0.000014509699,0.0001524678],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99822396,0.00025925727,0.00060679147,0.00032053608,0.00028806445,0.00030141487],"domain_scores_gemma":[0.9991107,0.00017520144,0.00019372665,0.00035803643,0.00004069467,0.00012162958],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009824364,0.00012408574,0.00076227,0.0009801339,0.000020207908,0.0000056351805,0.00005678009,0.000054054526,0.00003249434],"category_scores_gemma":[0.00018084393,0.00011109088,0.00010874012,0.0017731792,0.000055671455,0.00007401938,0.000043942306,0.00014859054,0.0000016525182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031294435,0.00025780962,0.97356486,0.001188376,0.0003575627,0.00010431992,0.0014239567,0.01987601,0.00009775681,0.0004501455,0.0003887119,0.0019775468],"study_design_scores_gemma":[0.0017008326,0.00037098158,0.9268707,0.00032397496,0.00025021393,0.0000017423675,0.0002608446,0.06941085,0.000023260636,0.000021727616,0.0006917848,0.00007310044],"about_ca_topic_score_codex":0.02356385,"about_ca_topic_score_gemma":0.0073360875,"teacher_disagreement_score":0.049534842,"about_ca_system_score_codex":0.00014074387,"about_ca_system_score_gemma":0.000110185516,"threshold_uncertainty_score":0.98293835},"labels":[],"label_agreement":null},{"id":"W4390128568","doi":"10.1016/j.jval.2023.09.1881","title":"HTA198 Comparisons of Economic Evaluation Guidelines Between Japan and Six Countries (England, France, Germany, Sweden, Canada and Australia)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography; Political science; Demography; Sociology","score_opus":0.20151999857550057,"score_gpt":0.3665210341295877,"score_spread":0.16500103555408713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128568","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926382,0.0008779424,0.000019637195,0.005147989,0.00030275513,0.00024867666,0.0005513126,0.000011377442,0.00020216637],"genre_scores_gemma":[0.9984526,0.0005434596,0.00012345584,0.00034791394,0.0001543884,0.000013098132,0.00005953788,0.0000097834845,0.00029577914],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99843156,0.00003720458,0.0010051326,0.00022824743,0.000054322492,0.00024353154],"domain_scores_gemma":[0.9991974,0.0001373457,0.00041068054,0.00014229919,0.000050119168,0.00006210755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001908711,0.0000985867,0.00038807254,0.00028709823,0.00009533974,0.000020928654,0.000074898075,0.00006539666,0.00004175144],"category_scores_gemma":[0.000079228375,0.0001158257,0.0000149451025,0.00024318349,0.00005517299,0.00009398154,0.00002911366,0.00009811858,0.000024447354],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000039228416,0.0000041288176,0.9405812,0.00013951772,0.0000166044,2.115393e-7,0.00034212237,0.004460432,6.2240457e-7,0.045538493,0.008629758,0.0002829602],"study_design_scores_gemma":[0.00075626315,0.000035369616,0.90199023,0.000047136513,0.000003594971,0.0000012466231,0.00006684708,0.030227806,0.0000110151595,0.006052531,0.06066899,0.00013895021],"about_ca_topic_score_codex":0.779673,"about_ca_topic_score_gemma":0.23984987,"teacher_disagreement_score":0.5398231,"about_ca_system_score_codex":0.000161256,"about_ca_system_score_gemma":0.00029026784,"threshold_uncertainty_score":0.7740209},"labels":[],"label_agreement":null},{"id":"W4390128709","doi":"10.1016/j.jval.2023.09.204","title":"CO132 A Real-World Evidence Analysis of the Impact of Patient-Physician Sex Concordance on Cancer Treatment Practices and Outcomes","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Sex and Gender in Healthcare","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Concordance; Cancer; Medicine; Real world evidence; Family medicine; Internal medicine","score_opus":0.21637236000319132,"score_gpt":0.4932190053436516,"score_spread":0.2768466453404603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924746,0.0014995701,1.6924831e-7,0.005044729,0.00009596805,0.000667134,0.00007617003,0.000016147502,0.00012547972],"genre_scores_gemma":[0.9942227,0.0049593444,0.000026856915,0.0005524334,0.000026079897,0.000045146426,0.000006760991,0.00001028537,0.00015041544],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982985,0.00034736755,0.0005095622,0.00028495025,0.0003082566,0.0002513458],"domain_scores_gemma":[0.99737185,0.0012505068,0.0007291458,0.00047186296,0.00006996905,0.00010669263],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046520645,0.00013235374,0.00066841015,0.00033567564,0.000054885586,0.0000037510288,0.000067326764,0.00003322275,0.0000098466535],"category_scores_gemma":[0.0002762004,0.00007679335,0.00016912252,0.0019452668,0.00006259169,0.00004483159,0.000023723453,0.00011823099,9.376896e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015122624,0.0001277124,0.9669923,0.0003483233,0.00041090618,0.00000358565,0.0053617833,0.007145259,0.00004690143,0.00006214248,0.00007835546,0.019271476],"study_design_scores_gemma":[0.00036107854,0.0012274189,0.9900379,0.00068064267,0.00016112196,4.8368975e-7,0.0012903044,0.005754128,0.00031473313,0.000054055716,0.00006607348,0.000052052],"about_ca_topic_score_codex":0.3511354,"about_ca_topic_score_gemma":0.008562898,"teacher_disagreement_score":0.3425725,"about_ca_system_score_codex":0.0005136921,"about_ca_system_score_gemma":0.0007921657,"threshold_uncertainty_score":0.6531854},"labels":[],"label_agreement":null},{"id":"W4390128716","doi":"10.1016/j.jval.2023.09.165","title":"CO93 Matching-Adjusted Indirect Treatment Comparison (MAIC) of Teclistamab Versus Selinexor-Dexamethasone for the Treatment of Patients with Triple-Class Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Cancer Research; University of Calgary","funders":"","keywords":"Dexamethasone; Medicine; Matching (statistics); Refractory (planetary science); Class (philosophy); Oncology; Multiple myeloma; Internal medicine; Computer science; Physics; Pathology; Artificial intelligence","score_opus":0.13386070313518275,"score_gpt":0.35811897525514064,"score_spread":0.22425827211995789,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128716","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98999006,0.0017118666,0.00007987288,0.0004378322,0.0003142543,0.0064852084,0.0008383066,0.000102964135,0.00003964636],"genre_scores_gemma":[0.9943807,0.001417316,0.0019363327,0.000021982161,0.00007379396,0.00090452394,0.00092066365,0.0000843759,0.00026031444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99615794,0.00043692536,0.0011555005,0.00058242073,0.00082228717,0.00084492535],"domain_scores_gemma":[0.9942151,0.0037225243,0.00062541146,0.0007961257,0.0002948609,0.0003459844],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00057343295,0.00045632356,0.0013696315,0.00054329867,0.00018120211,0.00001304648,0.0001660161,0.00016137378,0.000032322303],"category_scores_gemma":[0.00042774098,0.00027607597,0.0002445412,0.0011408824,0.00017290674,0.00007070981,0.00003141487,0.00019227208,0.000014477351],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.087187834,0.015420521,0.73063815,0.0012448817,0.0019505313,0.00008043183,0.010290065,0.002494907,0.00025630806,0.00003349543,0.00030096882,0.15010192],"study_design_scores_gemma":[0.12102344,0.04443377,0.80020857,0.0005512268,0.00033295024,0.0000024287424,0.0020362814,0.023096938,0.003509397,0.000018527422,0.0044937143,0.0002927396],"about_ca_topic_score_codex":0.0078318985,"about_ca_topic_score_gemma":0.0016377647,"teacher_disagreement_score":0.14980918,"about_ca_system_score_codex":0.001597283,"about_ca_system_score_gemma":0.00093835767,"threshold_uncertainty_score":0.9999691},"labels":[],"label_agreement":null},{"id":"W4390128878","doi":"10.1016/j.jval.2023.09.2976","title":"SA67 Considerations for Including Different Routes of Administration in Network Meta-Analysis: A Comprehensive Review","year":2023,"lang":"en","type":"review","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Meta-analysis; Computer science; Administration (probate law); Computational biology; Risk analysis (engineering); Management science; Medicine; Engineering; Biology; Political science; Internal medicine","score_opus":0.9665901220411067,"score_gpt":0.6431554478636285,"score_spread":0.3234346741774782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128878","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000031482373,0.98814386,0.0017727526,0.0013177136,0.00019177188,0.0082240915,0.00030158635,0.000007207866,0.000037845937],"genre_scores_gemma":[0.00009628197,0.9918961,0.0051301573,0.00048133705,0.0000792516,0.0017845253,0.00019399174,0.000033231583,0.0003051189],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.89895093,0.050602164,0.043630663,0.0020525707,0.0040869312,0.0006767272],"domain_scores_gemma":[0.9138647,0.05855909,0.022721242,0.0036616165,0.0009852911,0.0002080867],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaresearch","metaepi_broad"],"category_scores_codex":[0.123197354,0.00075416686,0.043021344,0.0018809793,0.00016212343,0.00027764446,0.0011260527,0.00022588758,0.0010901414],"category_scores_gemma":[0.037617743,0.0003767535,0.015194759,0.007962088,0.000049104467,0.00011148895,0.00018477936,0.000414715,0.00013877447],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008304516,0.00044252543,0.00039741013,0.6054725,0.16884947,0.00002545146,0.00068373105,0.019862,2.7365866e-8,0.0379163,0.074507445,0.09183484],"study_design_scores_gemma":[0.00017322152,0.00014466814,0.00007561533,0.032422956,0.26018867,0.000011961936,0.00012164253,0.007342163,3.1332267e-8,0.023348222,0.6755977,0.00057310745],"about_ca_topic_score_codex":0.00026367963,"about_ca_topic_score_gemma":0.0012618847,"teacher_disagreement_score":0.6010903,"about_ca_system_score_codex":0.00022174125,"about_ca_system_score_gemma":0.0010953655,"threshold_uncertainty_score":0.99986845},"labels":[],"label_agreement":null},{"id":"W4390128944","doi":"10.1016/j.jval.2023.09.2080","title":"MSR21 Methodological Aspects of a COVID-19 Vaccine Discrete Choice Experiment Survey in Canada, Germany, UK, and US General Populations","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Waterloo","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Geography; Virology; Medicine; Outbreak","score_opus":0.2932547004535566,"score_gpt":0.45281437651957795,"score_spread":0.15955967606602134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128944","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98741186,0.0009589554,0.00006115327,0.010771637,0.00019407435,0.00035547334,0.000034524615,0.000019176467,0.0001931289],"genre_scores_gemma":[0.9978763,0.0005229462,0.00045759956,0.00091277406,0.000083776285,0.000018838728,0.000019543108,0.0000067571737,0.00010145891],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9965312,0.002084831,0.0004544452,0.00025230602,0.00027179642,0.00040544476],"domain_scores_gemma":[0.9980637,0.001374944,0.0001287633,0.00014151544,0.000025929881,0.0002651787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033082245,0.00009175854,0.00032650057,0.0001551597,0.0001871556,0.000012994608,0.00013230118,0.00005481078,0.000084612424],"category_scores_gemma":[0.002204462,0.00008742459,0.000022636246,0.0007946637,0.000010062783,0.000060353992,0.000057286365,0.00012873803,0.000001353266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017354196,0.00001606444,0.98323435,0.00004082135,0.0000029316693,0.000020414795,0.0036865582,0.0039948584,0.0000193563,0.0073616286,0.0014691863,0.00013649129],"study_design_scores_gemma":[0.0003939508,0.000043173237,0.99428624,0.000021795948,0.0000013923376,7.1643007e-7,0.00044594432,0.00097474037,0.0000073731244,0.0023720458,0.0013650212,0.000087624445],"about_ca_topic_score_codex":0.997668,"about_ca_topic_score_gemma":0.99713063,"teacher_disagreement_score":0.011051888,"about_ca_system_score_codex":0.0009684585,"about_ca_system_score_gemma":0.003085687,"threshold_uncertainty_score":0.54738766},"labels":[],"label_agreement":null},{"id":"W4390128947","doi":"10.1016/j.jval.2023.09.2915","title":"SA5 Innovative Direct-to-Physician Retrospective Chart Review Approach: Synthesized Learnings from Completed and Ongoing","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Advances in Oncology and Radiotherapy","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Chart; Medicine; Statistics; Mathematics","score_opus":0.05275576394830567,"score_gpt":0.38320639282315727,"score_spread":0.3304506288748516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128947","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8449003,0.06247286,0.002695163,0.06269823,0.001129937,0.0074501988,0.00013833887,0.001014394,0.017500592],"genre_scores_gemma":[0.8191479,0.08125579,0.02641268,0.07010008,0.0013078172,0.00038406855,0.000241736,0.000157125,0.0009928436],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9982389,0.00035234337,0.00041268987,0.00045059074,0.00018956637,0.00035591648],"domain_scores_gemma":[0.9987806,0.00060160656,0.00018987861,0.00023314342,0.000070675924,0.00012409435],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010236098,0.00016563729,0.00086111866,0.0001959715,0.00014334092,0.0000049329756,0.00007582781,0.000075851836,0.0000236594],"category_scores_gemma":[0.0007094828,0.00014266542,0.000036219924,0.0015743331,0.00012458228,0.000054248492,0.000036662346,0.00045492777,0.000038248123],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027455504,0.0015255408,0.34005484,0.012932304,0.0010147869,0.00037980257,0.04950769,0.0013132243,0.0055257105,0.012080985,0.053752057,0.5191675],"study_design_scores_gemma":[0.005656079,0.0026291276,0.81332016,0.02177343,0.00006711292,0.000046255187,0.002161293,0.014835243,0.00023054323,0.0024171285,0.13605565,0.00080795825],"about_ca_topic_score_codex":0.0004943326,"about_ca_topic_score_gemma":0.000009263649,"teacher_disagreement_score":0.51835954,"about_ca_system_score_codex":0.0003638333,"about_ca_system_score_gemma":0.00017417638,"threshold_uncertainty_score":0.5817727},"labels":[],"label_agreement":null},{"id":"W4390128966","doi":"10.1016/j.jval.2023.09.2670","title":"PCR233 Socioeconomic Impact of Muscular Dystrophies on Patients and Their Caregivers in the Czech Republic","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical and Biological Ozone Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Czech; Socioeconomic status; Medicine; Environmental health","score_opus":0.07733253474938878,"score_gpt":0.3544088935728361,"score_spread":0.27707635882344733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390128966","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9918224,0.00020145485,3.0099363e-7,0.007379295,0.000027833392,0.00040592378,0.000014165851,0.000010772532,0.00013785812],"genre_scores_gemma":[0.9985197,0.0011010205,0.000006788484,0.00028520898,0.000026817952,0.000011379377,0.000023516135,0.0000041830926,0.000021367956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988255,0.00030377958,0.0002553981,0.00016702067,0.00016486479,0.00028347338],"domain_scores_gemma":[0.9993242,0.0003409154,0.00005325706,0.00014645858,0.000020823845,0.00011435453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013088442,0.00007567562,0.0002678804,0.00018446142,0.000032057706,0.0000045295023,0.00008788154,0.000068784,0.000038791062],"category_scores_gemma":[0.00035072744,0.000034220222,0.0000671569,0.00028701406,0.00011642382,0.000016474325,0.000036143792,0.00027933615,0.000011916857],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052164914,0.00077156676,0.9062719,0.001044316,0.000074954754,0.000062383006,0.008458392,0.00032867637,0.0002882133,0.00080622506,0.005145115,0.07622661],"study_design_scores_gemma":[0.0011809751,0.0024473004,0.99299985,0.00013714434,0.0000012149261,0.0000022516995,0.0011840385,0.0012184805,0.000017178178,0.00047329313,0.00029728882,0.00004097528],"about_ca_topic_score_codex":0.004112515,"about_ca_topic_score_gemma":0.0000142311765,"teacher_disagreement_score":0.08672796,"about_ca_system_score_codex":0.00015624186,"about_ca_system_score_gemma":0.00018404564,"threshold_uncertainty_score":0.621692},"labels":[],"label_agreement":null},{"id":"W4390129057","doi":"10.1016/j.jval.2023.09.2579","title":"PCR140 Management of Osteogenesis Imperfecta: Self-Reported Access Challenges to Consumables and Services Across the EU5 and Nordics","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Consumables; Osteogenesis imperfecta; Business; Medicine; Marketing; Pathology","score_opus":0.0669434768531372,"score_gpt":0.3861540756883674,"score_spread":0.3192105988352302,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390129057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9767635,0.02008204,0.0000048315933,0.00239314,0.0000346393,0.00059795403,0.000024747855,0.000013240753,0.00008594485],"genre_scores_gemma":[0.9248189,0.07487362,0.000058731024,0.00009627897,0.000016541173,0.0000644363,0.000015433581,0.00001426261,0.00004180797],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99886537,0.00014853275,0.00021335197,0.0003314819,0.00013885158,0.0003024389],"domain_scores_gemma":[0.9994531,0.00006616487,0.00006773381,0.00027756236,0.000058558748,0.00007685943],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086661015,0.00009977266,0.00015357224,0.000061613595,0.000107497806,0.00002543372,0.00018529705,0.000052126707,0.0000020964246],"category_scores_gemma":[0.00003033358,0.00008282253,0.000017674338,0.0002697754,0.000055789213,0.000004340528,0.0005470232,0.00005131231,0.0000016310089],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070333894,0.00040065573,0.39328864,0.019318251,0.0014602812,0.00010283983,0.020831918,0.0025186117,0.031941824,0.0009001138,0.0005755191,0.527958],"study_design_scores_gemma":[0.0020583498,0.0009409569,0.94316137,0.00042333762,0.000036552978,0.000032540906,0.015920693,0.0017949832,0.013153619,0.00042543578,0.0216161,0.00043608656],"about_ca_topic_score_codex":0.0020410144,"about_ca_topic_score_gemma":0.0015009762,"teacher_disagreement_score":0.5498727,"about_ca_system_score_codex":0.000014238754,"about_ca_system_score_gemma":0.00005334796,"threshold_uncertainty_score":0.33774045},"labels":[],"label_agreement":null},{"id":"W4390129169","doi":"10.1016/j.jval.2023.09.2620","title":"PCR182 Patient Preferences for Tumor-Agnostic Therapies: Qualitative Insights and Challenges","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Data science; Medicine; Psychology; Computer science","score_opus":0.09726597006983073,"score_gpt":0.33900825115550437,"score_spread":0.24174228108567364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390129169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9595392,0.03802879,0.00005006354,0.0015800396,0.00017713105,0.00044989277,0.000068590816,0.000011423665,0.00009492001],"genre_scores_gemma":[0.9420041,0.056920506,0.00036620526,0.0004059698,0.00008834609,0.00013197727,0.00005497072,0.000014179797,0.000013743691],"study_design_codex":"qualitative","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991029,0.00011896308,0.00021817554,0.00027497805,0.000067827255,0.00021714212],"domain_scores_gemma":[0.9993063,0.0003680286,0.000080441896,0.00013663771,0.000037712598,0.000070868184],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028543308,0.00009925174,0.00014468873,0.000062310566,0.000062568746,0.000011932433,0.000065243265,0.000047711772,0.000001165279],"category_scores_gemma":[0.0002812775,0.00009018313,0.000025659594,0.00007446271,0.000043180255,0.000002018784,0.00004955229,0.0000427963,0.000002539705],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014784732,0.0011658862,0.006834932,0.007176962,0.000478644,0.00003657485,0.53237873,0.020787315,0.017719569,0.0821587,0.017839275,0.31194493],"study_design_scores_gemma":[0.006379966,0.01843574,0.035497326,0.0011861807,0.00003565851,0.00001824664,0.11339439,0.0065001007,0.015339932,0.16327742,0.6380304,0.00190464],"about_ca_topic_score_codex":0.00039844142,"about_ca_topic_score_gemma":0.00032098364,"teacher_disagreement_score":0.62019116,"about_ca_system_score_codex":0.000022435574,"about_ca_system_score_gemma":0.00016096042,"threshold_uncertainty_score":0.36775616},"labels":[],"label_agreement":null},{"id":"W4390129341","doi":"10.1016/j.jval.2023.09.2917","title":"SA7 Emerging Biomarkers in Metastatic Castration Resistant Prostate Cancer As Evaluated in Early Phase Clinical Trials: A Targeted Literature Review","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Prostate cancer; Medicine; Oncology; Clinical trial; Cancer; Internal medicine","score_opus":0.33183232689851033,"score_gpt":0.574591972933008,"score_spread":0.24275964603449768,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390129341","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7895887,0.181358,8.6560107e-7,0.023316951,0.00025302218,0.0052519743,0.00014749166,0.000051726714,0.000031281797],"genre_scores_gemma":[0.5002218,0.49608204,0.000261347,0.0009601673,0.0001013033,0.0010538226,0.00087105075,0.00005245841,0.00039603966],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99124026,0.0046594325,0.0022410862,0.00056377077,0.0005987878,0.00069666444],"domain_scores_gemma":[0.9982181,0.00071646593,0.00036480036,0.00028699654,0.00014014813,0.00027344975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021570655,0.000222068,0.0011788534,0.0008606986,0.000054136297,0.000032456966,0.000086642045,0.00009728129,0.00007702116],"category_scores_gemma":[0.0032955823,0.0001668535,0.00013935678,0.004092101,0.00005800189,0.00014215139,0.000027388462,0.00066642615,0.000024334118],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.064204566,0.0057548555,0.21790484,0.07814852,0.0016485917,0.019034915,0.03478369,0.0019073241,0.0078010755,0.00018931352,0.022895133,0.5457272],"study_design_scores_gemma":[0.17672512,0.016111618,0.34118447,0.3442084,0.00069576176,0.00010888834,0.00317608,0.100046925,0.0008584352,0.0028143157,0.012453447,0.001616564],"about_ca_topic_score_codex":0.009956621,"about_ca_topic_score_gemma":0.001013834,"teacher_disagreement_score":0.5441106,"about_ca_system_score_codex":0.00080378837,"about_ca_system_score_gemma":0.0027197439,"threshold_uncertainty_score":0.99663615},"labels":[],"label_agreement":null},{"id":"W4390129371","doi":"10.1016/j.jval.2023.09.2239","title":"MT10 Clinical and Economic Impact of Point-of-Care (POC) Molecular Testing in Patients Presenting With Viral Respiratory Symptoms: A Systematic Literature Review (SLR)","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Point-of-care testing; Medicine; Intensive care medicine; Respiratory system; Internal medicine; Pathology","score_opus":0.07614595598284403,"score_gpt":0.43187442420636535,"score_spread":0.35572846822352133,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390129371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9708446,0.026327074,0.000001552149,0.000048553058,0.000040559073,0.0026101228,0.000015761021,0.00002741673,0.000084350715],"genre_scores_gemma":[0.9982811,0.0012524251,0.00015291301,0.000157317,0.000030378824,0.00007587118,0.000010449654,0.00003431226,0.0000052158366],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99598575,0.0013050108,0.0016619485,0.00036054,0.0003101897,0.0003765606],"domain_scores_gemma":[0.99807173,0.0005671376,0.0004977626,0.0004686152,0.0002201943,0.00017457716],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031877733,0.00017507434,0.0010642707,0.0006601367,0.00003448411,0.000016793845,0.000106565196,0.00010938518,0.000003770062],"category_scores_gemma":[0.002703831,0.00013251418,0.00011741506,0.0011787245,0.000109975386,0.00013897147,0.00008967187,0.00051862624,0.0000062622803],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080107275,0.00006805106,0.8320059,0.16624284,0.000035089284,0.000041135503,0.00026283143,0.00074580894,0.000027691507,0.00002204318,0.000030423796,0.00043807138],"study_design_scores_gemma":[0.002595685,0.00509006,0.7807111,0.20736836,0.0000379888,0.00001562247,0.00008040641,0.003882225,0.000039197912,0.000025069165,0.000007023124,0.000147233],"about_ca_topic_score_codex":0.00056540046,"about_ca_topic_score_gemma":0.000016835924,"teacher_disagreement_score":0.05129479,"about_ca_system_score_codex":0.00040999742,"about_ca_system_score_gemma":0.0009630057,"threshold_uncertainty_score":0.54037714},"labels":[],"label_agreement":null},{"id":"W4390129418","doi":"10.1016/j.jval.2023.09.2631","title":"PCR194 A Global Perspective on Self-Reported Productivity Losses Associated With Osteogenesis Imperfecta","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Osteogenesis imperfecta; Perspective (graphical); Productivity; Economics; Medicine; Computer science; Anatomy; Macroeconomics; Artificial intelligence","score_opus":0.042972883126205126,"score_gpt":0.3522900619581048,"score_spread":0.3093171788318997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390129418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954296,0.00059869426,0.000019321591,0.0020693697,0.00007268349,0.00084072736,0.00007829376,0.00009124876,0.0008001033],"genre_scores_gemma":[0.99914503,0.00021609386,0.000060183123,0.000087818975,0.000076546894,0.0000881238,0.00011581948,0.000030173866,0.00018019161],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99761736,0.0005134851,0.00022235235,0.00073372584,0.0003392862,0.00057379936],"domain_scores_gemma":[0.9990022,0.00008087512,0.00012063868,0.00042637953,0.00024791557,0.00012198922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094150443,0.00019019414,0.0002417028,0.00011845979,0.00012885554,0.000018200675,0.00015610285,0.000113162954,0.0000102601025],"category_scores_gemma":[0.0016043498,0.00017726707,0.00005517886,0.0011908154,0.000072022536,0.00000475043,0.00009824798,0.00015310643,0.00001875847],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030859034,0.0039768405,0.8928612,0.0005284002,0.0020395815,0.0004401885,0.004398077,0.028883558,0.039360918,0.0018310566,0.006750588,0.015843702],"study_design_scores_gemma":[0.0051619955,0.009565096,0.9474851,0.00035623732,0.00005349805,0.00008642719,0.0039761104,0.005295631,0.02248454,0.0013877855,0.0029688259,0.0011787617],"about_ca_topic_score_codex":0.006589427,"about_ca_topic_score_gemma":0.0029861503,"teacher_disagreement_score":0.054623906,"about_ca_system_score_codex":0.0006806545,"about_ca_system_score_gemma":0.0009287358,"threshold_uncertainty_score":0.9961287},"labels":[],"label_agreement":null},{"id":"W4390129453","doi":"10.1016/j.jval.2023.09.2689","title":"PCR252 Early Steps Towards a Huntington's Disease Burden-of-Illness Model: Estimating Out-of-Pocket Costs for Patients Showing Clinical Symptoms","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Prioris.ai (Canada)","funders":"","keywords":"Disease; Huntington's disease; Medicine; Psychiatry; Internal medicine","score_opus":0.12715279846376984,"score_gpt":0.38546986048155946,"score_spread":0.2583170620177896,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390129453","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932567,0.000036758272,0.002810816,0.0003546365,0.001451238,0.0015326949,0.00042788364,0.00010400466,0.00002528699],"genre_scores_gemma":[0.9962023,0.00004053021,0.0030272987,0.00032331323,0.00012857483,0.00015045886,0.000023635574,0.00006781741,0.0000361069],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99560606,0.0008214447,0.0013676615,0.0008203411,0.0006967073,0.0006878097],"domain_scores_gemma":[0.9968367,0.0015072022,0.00057369785,0.0005024423,0.00017392513,0.00040603688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012197208,0.00025789998,0.0005792342,0.00026013303,0.00018460776,0.000036833422,0.00046285932,0.0000708513,0.000005013008],"category_scores_gemma":[0.008169337,0.00026340716,0.00021518726,0.0005695065,0.0001642767,0.00016260489,0.00023254399,0.00019905955,0.000010952242],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053172733,0.0012047997,0.1601608,0.0025299094,0.000020019432,0.0000104891715,0.005447125,0.75503004,0.002372952,0.001969195,0.00044344115,0.0702795],"study_design_scores_gemma":[0.0015718762,0.00056601793,0.033842452,0.0006457637,0.000022960752,9.7954754e-8,0.00010292256,0.95431304,0.007253938,0.0013420867,0.000030999377,0.00030784094],"about_ca_topic_score_codex":0.00027594442,"about_ca_topic_score_gemma":0.0000028314548,"teacher_disagreement_score":0.199283,"about_ca_system_score_codex":0.0000972464,"about_ca_system_score_gemma":0.00076211256,"threshold_uncertainty_score":0.9999818},"labels":[],"label_agreement":null},{"id":"W4390145879","doi":"10.1016/j.jval.2023.09.444","title":"EE175 Cost-Effectiveness of Sequencing Vedolizumab as First-Line Biologic in Ulcerative Colitis and Crohn's Disease in Canada","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; Takeda (Canada)","funders":"","keywords":"Vedolizumab; Ulcerative colitis; Medicine; Crohn's disease; Inflammatory bowel disease; Disease; Internal medicine; Immunology","score_opus":0.3722231881897124,"score_gpt":0.4148038158103087,"score_spread":0.04258062762059628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390145879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98746693,0.0014959897,0.000037565704,0.008078584,0.00030225163,0.0019171523,0.000565709,0.000016344657,0.00011948766],"genre_scores_gemma":[0.99671865,0.0013985106,0.00007537062,0.0013591851,0.00003947984,0.00031546477,0.00005405838,0.000019144376,0.00002014266],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944253,0.0015042207,0.0028854758,0.0005420401,0.00008047114,0.0005625216],"domain_scores_gemma":[0.9952363,0.003333021,0.0008917413,0.00026797,0.000031514446,0.00023948195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016086172,0.00016762511,0.0010632566,0.0006462947,0.000080636375,0.000015873613,0.00014498993,0.00008037483,0.000036952966],"category_scores_gemma":[0.004079043,0.00021802988,0.000033225064,0.0007319097,0.00005914299,0.0001724283,0.000056700203,0.00021862847,0.00004489741],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016562191,0.000049878152,0.8582072,0.002907569,0.000009762021,0.000060397626,0.0020352218,0.111557186,3.3566587e-7,0.024491282,0.00014601556,0.00036947834],"study_design_scores_gemma":[0.0012670414,0.00007888142,0.9182034,0.0007947617,6.280814e-7,0.000001698455,0.0007827234,0.06262253,0.0000017033564,0.015674708,0.0003981694,0.0001737557],"about_ca_topic_score_codex":0.9733928,"about_ca_topic_score_gemma":0.89154404,"teacher_disagreement_score":0.08184878,"about_ca_system_score_codex":0.0069362577,"about_ca_system_score_gemma":0.0039587156,"threshold_uncertainty_score":0.99687594},"labels":[],"label_agreement":null},{"id":"W4390234051","doi":"10.1016/j.jval.2023.12.011","title":"Financial Characteristics of Outcomes-Based Agreements: What Do Canadian Public Payers and Pharmaceutical Manufacturers Prefer?","year":2023,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Natural Sciences and Engineering Research Council of Canada","funders":"Roche; AstraZeneca; Pfizer","keywords":"Business; Finance; Marketing; Accounting","score_opus":0.4420792321178288,"score_gpt":0.4359132093285135,"score_spread":0.006166022789315273,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390234051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88307005,0.0015884073,0.0001110227,0.112109594,0.0012494439,0.0010118729,0.0006794967,0.000033677054,0.00014640464],"genre_scores_gemma":[0.9795964,0.001581226,0.00036981952,0.018086936,0.00009407387,0.00006632896,0.00011231548,0.00002992249,0.00006302041],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99490446,0.0004316858,0.003231186,0.0005064364,0.00012749787,0.0007987387],"domain_scores_gemma":[0.9971654,0.0007684423,0.0011223609,0.00037608235,0.000039040708,0.0005286688],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.012992762,0.00019787122,0.000988691,0.0010483336,0.00016927425,0.000107376516,0.00022604575,0.00016153054,0.00024229636],"category_scores_gemma":[0.0024426056,0.00024633904,0.00007791079,0.00041143788,0.000083569954,0.00043388226,0.0000369233,0.00026237525,0.00037053818],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001956613,0.000097728975,0.9330676,0.001667563,0.00003748475,0.000005969521,0.001884562,0.00056933437,4.0063375e-7,0.049347904,0.004482015,0.008819836],"study_design_scores_gemma":[0.001764748,0.00013289333,0.8613698,0.00038150468,0.0000041250187,0.000001621295,0.0009731304,0.021628045,0.0000027980225,0.0053626145,0.107978195,0.00040054484],"about_ca_topic_score_codex":0.05731712,"about_ca_topic_score_gemma":0.010131946,"teacher_disagreement_score":0.10349618,"about_ca_system_score_codex":0.0011661533,"about_ca_system_score_gemma":0.0014216867,"threshold_uncertainty_score":0.99999887},"labels":[],"label_agreement":null},{"id":"W4391067028","doi":"10.1016/j.jval.2024.01.003","title":"Validation of China Health-Related Outcomes Measures-Cardiovascular Disease","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; Population Health Research Institute; McMaster University","funders":"","keywords":"China; Disease; Medicine; Environmental health; Geography; Internal medicine","score_opus":0.3169411900246095,"score_gpt":0.40275922901701255,"score_spread":0.08581803899240303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391067028","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5419974,0.22708982,0.008510205,0.21292391,0.0037776262,0.0032206653,0.0008451947,0.00031963026,0.0013155679],"genre_scores_gemma":[0.9943674,0.0018957072,0.0009196858,0.0022258435,0.00013422746,0.00009157717,0.00007853656,0.000058795686,0.00022823417],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99066424,0.0014138552,0.006357927,0.00074342743,0.00025802496,0.00056249474],"domain_scores_gemma":[0.99671954,0.0006774725,0.0013472881,0.0008253301,0.00003447242,0.00039590878],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.04294316,0.00022983574,0.0016639603,0.00080414297,0.00013409732,0.00006032824,0.00024756673,0.00011308417,0.00014102095],"category_scores_gemma":[0.0027011025,0.0002761709,0.0004416807,0.00062245136,0.000056131266,0.00039589408,0.000040097,0.00030305333,0.0006431776],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041432424,0.00045092794,0.21483874,0.014793842,0.0010559405,0.000014922562,0.0120269405,0.2150144,8.2317945e-7,0.52220434,0.012891289,0.0066663898],"study_design_scores_gemma":[0.0026954291,0.00037265892,0.53173685,0.003452786,0.00004098879,0.000016285645,0.00065035466,0.17547838,0.00000779521,0.16530307,0.119079754,0.0011656352],"about_ca_topic_score_codex":0.02429385,"about_ca_topic_score_gemma":0.000028238357,"teacher_disagreement_score":0.45237002,"about_ca_system_score_codex":0.00138708,"about_ca_system_score_gemma":0.001096921,"threshold_uncertainty_score":0.99996907},"labels":[],"label_agreement":null},{"id":"W4391311572","doi":"10.1016/j.jval.2023.12.015","title":"The Cost of Atrial Fibrillation: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Population and Public Health","funders":"Horizon 2020; Horizon 2020 Framework Programme; European Commission","keywords":"Atrial fibrillation; Cardiology; Medicine; Internal medicine","score_opus":0.2530119251001974,"score_gpt":0.46035595482517216,"score_spread":0.2073440297249748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391311572","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[5.532124e-8,0.9854143,0.0000059206104,0.0024477078,0.000844991,0.010976229,0.000013413558,0.000035745277,0.00026161334],"genre_scores_gemma":[7.747501e-7,0.9967099,0.00004381495,0.00008539841,0.0013190622,0.00001800642,0.000051780105,0.000037199654,0.0017340515],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958076,0.0007675101,0.0025207028,0.00024744758,0.0004311108,0.00022564421],"domain_scores_gemma":[0.99698764,0.0012855459,0.0010463857,0.00055465515,0.000046764853,0.00007902213],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031511118,0.00025435115,0.0036202706,0.00020974867,0.000057892907,0.000022129425,0.0001331602,0.0001120658,0.000016825403],"category_scores_gemma":[0.0012032657,0.0001317184,0.0011967516,0.000891284,0.00003188238,0.000023460841,0.00006643399,0.00023875422,0.00016256995],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000048520137,4.0433733e-7,0.0000092056825,0.91927385,0.00016775038,0.000003249735,0.000014097439,0.000008844321,1.7166901e-10,0.002245812,0.0012702179,0.07700169],"study_design_scores_gemma":[0.0000841424,0.000031478306,6.3640533e-7,0.48952878,0.0018574139,0.000014047563,0.0000039886686,0.000058264337,8.52174e-10,0.000027450817,0.50834435,0.000049433573],"about_ca_topic_score_codex":0.000079712794,"about_ca_topic_score_gemma":0.000003135545,"teacher_disagreement_score":0.5070741,"about_ca_system_score_codex":0.00030759725,"about_ca_system_score_gemma":0.00084109674,"threshold_uncertainty_score":0.5371321},"labels":[],"label_agreement":null},{"id":"W4391427137","doi":"10.1016/j.jval.2024.01.010","title":"The Determination of Diabetes Utilities, Costs, and Effects Model: A Cost-Utility Tool Using Patient-Level Microsimulation to Evaluate Sensor-Based Glucose Monitoring Systems in Type 1 and Type 2 Diabetes: Comparative Validation","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Abbott (Canada); Diabetes Canada; Western University; EVERSANA (Canada)","funders":"Abbott Diabetes Care","keywords":"Type 2 diabetes; Type I and type II errors; Diabetes mellitus; Medicine; Microsimulation; Research design; Statistics; Computer science; Mathematics; Engineering; Transport engineering","score_opus":0.14499602180401525,"score_gpt":0.39717440088558253,"score_spread":0.25217837908156726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391427137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99034786,0.0065060514,0.00021965969,0.00012884005,0.00030109315,0.0024509514,0.0000144129945,0.000020702913,0.000010448715],"genre_scores_gemma":[0.9990903,0.00010270016,0.00065366615,0.000030369849,0.000024397594,0.000044959063,0.000023574872,0.000014644121,0.000015370222],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99819046,0.0004938423,0.00042272764,0.0002649999,0.0003185934,0.00030937704],"domain_scores_gemma":[0.99849904,0.0009781255,0.00008103316,0.00015931705,0.00020438703,0.00007813088],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017692476,0.00012682956,0.0002956191,0.0002963486,0.00008847678,0.00008059739,0.00003979726,0.000055504817,5.4252246e-7],"category_scores_gemma":[0.0003729219,0.000100532845,0.000016080616,0.000597193,0.000060008715,0.000117958414,0.000045639168,0.00015639447,9.846026e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005111802,0.000248967,0.63276786,0.014363851,0.00006741667,0.000004512785,0.00476057,0.14227927,0.023382628,0.00017357993,0.000042202555,0.18139799],"study_design_scores_gemma":[0.0005754493,0.00042573267,0.0510026,0.0026391337,0.000020565345,8.7288235e-8,0.00025214208,0.94096565,0.003936039,0.0000614833,0.000044070595,0.000077042954],"about_ca_topic_score_codex":0.00035117214,"about_ca_topic_score_gemma":0.000007997275,"teacher_disagreement_score":0.7986864,"about_ca_system_score_codex":0.0003998965,"about_ca_system_score_gemma":0.00022033938,"threshold_uncertainty_score":0.40996104},"labels":[],"label_agreement":null},{"id":"W4391486916","doi":"10.1016/j.jval.2024.01.014","title":"Meaningful Symptomatic Change in Patients With Myelofibrosis From the SIMPLIFY Studies","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Paul's Hospital; Princess Margaret Cancer Centre; University of Toronto; University of British Columbia; University Health Network","funders":"Sierra Oncology; Cancer Research UK; GlaxoSmithKline","keywords":"Myelofibrosis; Medicine; Computer science; Internal medicine","score_opus":0.07058585056676162,"score_gpt":0.3383343008064327,"score_spread":0.2677484502396711,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391486916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.974417,0.010510487,0.0000025233967,0.013241782,0.00019227427,0.0014863494,0.00004222048,0.000050644507,0.00005671949],"genre_scores_gemma":[0.9955951,0.0012750401,0.00039025594,0.002104321,0.00012838292,0.00042414086,0.000041473846,0.000027209202,0.000014064293],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99848557,0.00017851702,0.00037637274,0.0003321724,0.00032032246,0.00030705234],"domain_scores_gemma":[0.9987911,0.0007783472,0.00006165615,0.00023841154,0.000043019023,0.00008746725],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031962962,0.0001858588,0.00043673525,0.00011961639,0.000069074245,0.000025892805,0.00005747878,0.000042311993,0.000031737905],"category_scores_gemma":[0.00009016597,0.0000989322,0.000038761045,0.00041432132,0.000042527397,0.000073535404,0.000036497488,0.00019830243,0.000041622614],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007660238,0.000281922,0.9721336,0.00043538772,0.00013348162,0.000028885246,0.01446265,0.000036686095,5.24441e-7,0.0006271854,0.00043063003,0.01135244],"study_design_scores_gemma":[0.0016317972,0.0010342584,0.98894703,0.00555904,0.00004210729,0.0000016815586,0.00052157027,0.0012617043,0.000022695305,0.00032230167,0.0005580626,0.0000977258],"about_ca_topic_score_codex":0.0045918818,"about_ca_topic_score_gemma":0.00065090257,"teacher_disagreement_score":0.021178111,"about_ca_system_score_codex":0.00047440268,"about_ca_system_score_gemma":0.00014177593,"threshold_uncertainty_score":0.6941582},"labels":[],"label_agreement":null},{"id":"W4392028671","doi":"10.1016/j.jval.2024.02.004","title":"Economic Evaluations of Establishing Opioid Overdose Prevention Centers in 12 North American Cities: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; St. Michael's Hospital","funders":"National Institute on Drug Abuse; National Institutes of Health; University of Toronto","keywords":"Opioid overdose; Medicine; Systematic review; Opioid; Business; MEDLINE; Political science; (+)-Naloxone","score_opus":0.07448866278652824,"score_gpt":0.4043321234471943,"score_spread":0.32984346066066605,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392028671","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00050215615,0.9874178,0.000004970319,0.00022108454,0.0003191847,0.01121977,0.00019804535,0.000037411126,0.00007958526],"genre_scores_gemma":[0.00012335632,0.9970774,0.00023328724,0.00015071542,0.000046006637,0.0014946278,0.00066622905,0.0000843187,0.00012404485],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9943485,0.0012300252,0.0030620915,0.00057549175,0.00037302793,0.00041085182],"domain_scores_gemma":[0.99721354,0.00035579698,0.001486862,0.00076144515,0.000033507342,0.00014885806],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0017019921,0.0004501429,0.00475694,0.00091159,0.00002555151,0.000025872503,0.00020288157,0.000078728146,0.000021364636],"category_scores_gemma":[0.00039478365,0.00036799096,0.00056302996,0.0009039601,0.000048103633,0.00010304065,0.00007067697,0.0004758924,0.00006468566],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000034767088,0.00020188473,0.00046371366,0.9700474,0.0001815141,0.000010415052,0.0007465272,0.00004669448,1.394667e-9,0.00005753753,0.00019218415,0.02804863],"study_design_scores_gemma":[0.00036679264,0.0003450328,0.00022259545,0.98903733,0.0028551552,0.000027050959,0.0002628851,0.0002709488,9.868219e-9,0.000029405157,0.006385961,0.0001968514],"about_ca_topic_score_codex":0.008608687,"about_ca_topic_score_gemma":0.0015913527,"teacher_disagreement_score":0.027851779,"about_ca_system_score_codex":0.0040481086,"about_ca_system_score_gemma":0.0044447384,"threshold_uncertainty_score":0.9998772},"labels":[],"label_agreement":null},{"id":"W4392121583","doi":"10.1016/j.jval.2024.02.002","title":"A Systematic Review of Value Criteria for Next-Generation Sequencing/Comprehensive Genomic Profiling to Inform Value Framework Development","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"AstraZeneca; Queen's University Belfast; Queen's University; London School of Economics and Political Science; GlaxoSmithKline; Eli Lilly and Company","keywords":"Profiling (computer programming); Value (mathematics); Computational biology; Computer science; Data science; Biology; Machine learning","score_opus":0.1610115643105598,"score_gpt":0.3944901206891907,"score_spread":0.2334785563786309,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392121583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00039526576,0.9896509,0.001066108,0.000064158085,0.0006546029,0.007901035,0.00024259176,0.000013657473,0.000011661],"genre_scores_gemma":[0.00006050167,0.9743841,0.021224644,0.0010560999,0.00034818152,0.0015605092,0.0012267862,0.00009544235,0.00004371544],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99595624,0.00034622,0.0023472453,0.00068291463,0.00021605352,0.00045131284],"domain_scores_gemma":[0.9981014,0.000091798785,0.0007675103,0.00063438696,0.00020014084,0.00020472766],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0011877316,0.00050942734,0.0021569144,0.00024691515,0.000103981074,0.000057780475,0.00038607436,0.00033621312,0.0000032109417],"category_scores_gemma":[0.00054519053,0.00041908078,0.00049890415,0.00034471703,0.000020662404,0.0000050853423,0.00020052746,0.00021318485,0.000021481972],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000056723775,0.000023164925,1.2805847e-7,0.9930652,0.00019251916,0.000003101705,0.00016374463,0.00018868108,0.0001834735,0.0010490132,0.00030259675,0.00482271],"study_design_scores_gemma":[0.00009386605,0.00024654984,2.663241e-7,0.81454605,0.0006036781,0.00004557672,0.00006448568,0.00037212056,0.00011244785,0.00012726802,0.18327518,0.00051252916],"about_ca_topic_score_codex":0.00007042672,"about_ca_topic_score_gemma":0.0000038115033,"teacher_disagreement_score":0.18297258,"about_ca_system_score_codex":0.0005804537,"about_ca_system_score_gemma":0.0042687776,"threshold_uncertainty_score":0.9998261},"labels":[],"label_agreement":null},{"id":"W4393188460","doi":"10.1016/j.jval.2024.03.011","title":"Do Quality-Adjusted Life Years Discriminate Against the Elderly? An Empirical Analysis of Published Cost-Effectiveness Analyses","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact; McMaster University; Hamilton Health Sciences","funders":"","keywords":"Medicine; Odds ratio; Confounding; Logistic regression; Demography; Meta-analysis; Subgroup analysis; Age groups; Odds; MEDLINE; Gerontology; Pediatrics; Internal medicine","score_opus":0.6650695136716447,"score_gpt":0.5484186205318805,"score_spread":0.11665089313976418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393188460","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95898044,0.008341442,0.0030539713,0.026355896,0.0007302447,0.0013332941,0.0005806046,0.00008709778,0.0005370264],"genre_scores_gemma":[0.99465615,0.00041066195,0.00039667418,0.0039444775,0.00016142431,0.00017945626,0.00016986574,0.00004074933,0.000040569397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9878814,0.0047305874,0.005566326,0.0009832159,0.00023932918,0.00059914304],"domain_scores_gemma":[0.99193084,0.004898044,0.0016287903,0.0010889979,0.00008831098,0.00036499824],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.05337178,0.00025079414,0.0019656222,0.0019396492,0.00015255903,0.00028062082,0.0005446851,0.00018782569,0.00018304696],"category_scores_gemma":[0.005634382,0.00024275116,0.0003879644,0.0032126226,0.00014064815,0.00071306207,0.00007456546,0.00044582214,0.000118304124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001406798,0.0009422657,0.4795949,0.006091842,0.0028844625,0.000011820268,0.02792266,0.25567853,0.000012018084,0.21067964,0.0061548813,0.009886314],"study_design_scores_gemma":[0.0005974275,0.00022945816,0.74742013,0.00031827236,0.00009865987,9.896884e-7,0.0036817482,0.23406477,0.0000028151162,0.0070591304,0.0061534387,0.000373138],"about_ca_topic_score_codex":0.023959847,"about_ca_topic_score_gemma":0.0011692685,"teacher_disagreement_score":0.26782525,"about_ca_system_score_codex":0.0009936212,"about_ca_system_score_gemma":0.0008110289,"threshold_uncertainty_score":0.9899105},"labels":[],"label_agreement":null},{"id":"W4393230612","doi":"10.1016/j.jval.2024.03.012","title":"Development of a Value Assessment Framework for Pediatric Health Technologies Using Multicriteria Decision Analysis: Expanding the Value Lens for Funding Decision Making","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster Children's Hospital; SickKids Foundation; Pediatric Oncology Group; University of Toronto; Institute for Clinical Evaluative Sciences; Hospital for Sick Children","funders":"Garron Family Cancer Centre; Canadian Institutes of Health Research; Hospital for Sick Children; Terry Fox Research Institute; Canada Research Chairs; Pediatric Oncology Group of Ontario; Canadian Centre for Applied Research in Cancer Control","keywords":"Value (mathematics); Lens (geology); Through-the-lens metering; Decision analysis; Management science; Health technology; Computer science; Medicine; Economics; Engineering; Health care; Economic growth; Machine learning","score_opus":0.531572701120929,"score_gpt":0.5353072476770473,"score_spread":0.003734546556118268,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393230612","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22653022,0.015351087,0.7468728,0.0070470762,0.0013641571,0.0025008416,0.00021850414,0.00010805545,0.000007258773],"genre_scores_gemma":[0.48612002,0.0005163639,0.5122231,0.0006680234,0.00014467453,0.00026822518,0.000015445858,0.000041773714,0.000002343276],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99004185,0.00042915336,0.0072537493,0.0010305876,0.00025530145,0.0009893331],"domain_scores_gemma":[0.9838041,0.01249632,0.0028273836,0.0006878106,0.00008300625,0.00010139914],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.04689976,0.00033027513,0.0016953977,0.002372292,0.00080892176,0.00021040777,0.00051267626,0.0002717802,0.000013161074],"category_scores_gemma":[0.0060358215,0.00033064737,0.00035191522,0.0018077672,0.000049664166,0.00039005303,0.00015909057,0.00038519464,0.000012042369],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012045682,0.00027811373,0.035785582,0.01071647,0.00052709715,0.0000012182873,0.019917991,0.20249574,0.000008474237,0.6954131,0.00064563577,0.034090076],"study_design_scores_gemma":[0.00066706183,0.00017253288,0.0074409614,0.0034421082,0.00005622979,0.0000032406003,0.0059019416,0.8302808,0.000006881209,0.1473945,0.0042180773,0.0004156826],"about_ca_topic_score_codex":0.0008535848,"about_ca_topic_score_gemma":0.0001021374,"teacher_disagreement_score":0.627785,"about_ca_system_score_codex":0.003972156,"about_ca_system_score_gemma":0.00176475,"threshold_uncertainty_score":0.9999146},"labels":[],"label_agreement":null},{"id":"W4394718423","doi":"10.1016/j.jval.2024.04.001","title":"A Systematic Review and Quality Assessment of Cardiovascular Disease-Specific Health-Related Quality-of-Life Instruments Part I: Instrument Development and Content Validity","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Impact; Hamilton Health Sciences","funders":"","keywords":"Content validity; Medicine; Quality of life (healthcare); Disease; Quality (philosophy); Health related quality of life; Measure (data warehouse); Clinical trial; Psychometrics; Clinical psychology; Pathology; Computer science; Data mining; Nursing","score_opus":0.8279116208096137,"score_gpt":0.4835983604582665,"score_spread":0.3443132603513472,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394718423","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016215093,0.9829285,0.0001101681,0.0028796839,0.0007500341,0.010313975,0.0013088906,0.000040230923,0.000046972473],"genre_scores_gemma":[0.00074310816,0.9953686,0.0011843143,0.0010972873,0.00004919513,0.0011759222,0.00024390282,0.00008507249,0.000052597803],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9561483,0.009617472,0.03138808,0.0015350805,0.00057237945,0.000738687],"domain_scores_gemma":[0.9810252,0.001555001,0.014895598,0.0015583142,0.00010352455,0.00086232106],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.10911964,0.0007751511,0.017397802,0.00081565615,0.00018280589,0.000066709574,0.00042307173,0.00029571587,0.00002914291],"category_scores_gemma":[0.0033912188,0.00078466506,0.00090730045,0.0006512749,0.00016774467,0.00020761669,0.00027598167,0.00066339626,0.00005844059],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000033223214,0.00015756764,0.0006898919,0.9584372,0.0014971115,7.6602294e-7,0.0005331813,0.000016431812,7.330081e-10,0.033170257,0.00019847759,0.0052958145],"study_design_scores_gemma":[0.0009892837,0.00014597182,0.0014535573,0.76445854,0.0006386536,0.000009249988,0.000436074,0.00015792598,1.2201291e-8,0.00072640297,0.23007922,0.0009051385],"about_ca_topic_score_codex":0.007207668,"about_ca_topic_score_gemma":0.000041516225,"teacher_disagreement_score":0.22988074,"about_ca_system_score_codex":0.003411437,"about_ca_system_score_gemma":0.0042621642,"threshold_uncertainty_score":0.9994604},"labels":[],"label_agreement":null},{"id":"W4394844963","doi":"10.1016/j.jval.2024.04.007","title":"The Inflation Reduction Act: An Opportunity to Accelerate Confidence in Real-World Evidence in the United States","year":2024,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Canada; McMaster University; Public Health Ontario; University of Toronto","funders":"","keywords":"Negotiation; Context (archaeology); Health care; Emulation; Inflation (cosmology); Risk analysis (engineering); Business; Public economics; Economics; Political science; Economic growth; Law","score_opus":0.5934029367515828,"score_gpt":0.4991643235408627,"score_spread":0.09423861321072013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394844963","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16359654,0.0064887945,0.000088979876,0.28511378,0.53533554,0.0075519052,0.0008703391,0.00015051657,0.0008035749],"genre_scores_gemma":[0.23490861,0.12593669,0.0010557394,0.0350986,0.5902949,0.004407325,0.0043890784,0.00051856524,0.0033905152],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9852602,0.004644953,0.0075898254,0.001163982,0.00043828145,0.0009027906],"domain_scores_gemma":[0.9827945,0.012294963,0.0030495317,0.0012757283,0.00018149213,0.00040377918],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.09578616,0.00038454257,0.0011856428,0.0021385015,0.00032333023,0.00051188696,0.0010251355,0.00043916542,0.000048909784],"category_scores_gemma":[0.022488343,0.00036591815,0.00007668309,0.0023373652,0.00009832608,0.0008574733,0.00010296082,0.0018940832,0.00032685054],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000106951265,0.00010518405,0.003522776,0.001605829,0.000016371596,0.0000070420474,0.022021886,0.03620522,2.520372e-7,0.031122357,0.904828,0.00045813373],"study_design_scores_gemma":[0.00046036177,0.00030587942,0.01144017,0.0043001724,0.0000051387105,0.000002216532,0.0048438553,0.037770018,4.592511e-7,0.037479058,0.9027996,0.00059307774],"about_ca_topic_score_codex":0.37750083,"about_ca_topic_score_gemma":0.07600164,"teacher_disagreement_score":0.3014992,"about_ca_system_score_codex":0.0045215846,"about_ca_system_score_gemma":0.0038157173,"threshold_uncertainty_score":0.9998793},"labels":[],"label_agreement":null},{"id":"W4394858765","doi":"10.1016/j.jval.2024.04.006","title":"Author Reply","year":2024,"lang":"en","type":"letter","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics; University of Calgary; University of Alberta","funders":"","keywords":"Medicine","score_opus":0.548553088300252,"score_gpt":0.45762668304780696,"score_spread":0.090926405252445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394858765","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00028430214,0.02234468,0.00021292716,0.9633641,0.0059561715,0.0014184362,0.0010436203,0.00019718296,0.005178552],"genre_scores_gemma":[0.00028634403,0.00044759284,0.0020860494,0.9656394,0.0071477895,0.00025405159,0.0003219291,0.00019048317,0.023626354],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9854681,0.0013348504,0.010117265,0.0016297026,0.00021900103,0.0012310664],"domain_scores_gemma":[0.99277586,0.0019033322,0.003683735,0.0013521976,0.000039011982,0.00024585045],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.037027873,0.00048569645,0.0024628297,0.0015039082,0.00015500565,0.00018729028,0.00061278086,0.0009199137,0.00067528524],"category_scores_gemma":[0.0035365808,0.00065018295,0.00029970193,0.0005450483,0.00007607182,0.00024503467,0.00011305483,0.0028521754,0.019627644],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000021638616,0.000021626316,0.0005739824,0.0054591107,0.000038203518,0.000040379695,0.0011841428,0.00023030266,9.627746e-9,0.025914038,0.96646476,0.000071276074],"study_design_scores_gemma":[0.0002204461,0.00008172496,0.0002811464,0.0011277528,0.0000035708883,0.000018198583,0.00009203673,0.0052208034,7.3107735e-8,0.056974728,0.9354937,0.00048580053],"about_ca_topic_score_codex":0.027234182,"about_ca_topic_score_gemma":0.00009794103,"teacher_disagreement_score":0.03349129,"about_ca_system_score_codex":0.0035189085,"about_ca_system_score_gemma":0.0013355465,"threshold_uncertainty_score":0.9995949},"labels":[],"label_agreement":null},{"id":"W4394893537","doi":"10.1016/j.jval.2024.04.004","title":"Economic Evaluations of Chimeric Antigen Receptor T-Cell Therapies for Hematologic and Solid Malignancies: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre; Ottawa Public Health; Ottawa Hospital; University of Ottawa","funders":"","keywords":"Hematologic Neoplasms; Medicine; Intensive care medicine; Internal medicine; Cancer","score_opus":0.16152575852155565,"score_gpt":0.4577174283364431,"score_spread":0.2961916698148874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394893537","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000051392763,0.9819552,0.000011811805,0.0005234444,0.00021621762,0.016949398,0.00015831727,0.000036263362,0.00009798654],"genre_scores_gemma":[0.000010756502,0.9954795,0.00060105807,0.0001729866,0.00008160984,0.0022826712,0.00010700827,0.00009828725,0.0011660978],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9954589,0.0009778115,0.00224725,0.00056323624,0.00029873374,0.00045404708],"domain_scores_gemma":[0.997186,0.0010149416,0.0008595149,0.00069482136,0.00008774837,0.0001569842],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00440349,0.0004140231,0.0054631005,0.000509978,0.00005559849,0.000022140688,0.0002241622,0.0001959925,0.00028581874],"category_scores_gemma":[0.00035563397,0.00028498756,0.00058822107,0.00046468695,0.00009893971,0.000031160762,0.00006269812,0.00037069115,0.000104268634],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007661036,0.000060371865,0.0000023990438,0.9820045,0.00024492198,0.0000019995964,0.00027255085,0.0000010480768,0.0000071850964,0.00015069038,0.0010816364,0.016165037],"study_design_scores_gemma":[0.00033461943,0.0005140201,5.547029e-7,0.8802804,0.001257655,0.00013673551,0.00008541075,0.00018812527,0.000003902637,0.00012975188,0.116863556,0.00020528518],"about_ca_topic_score_codex":0.00019069585,"about_ca_topic_score_gemma":0.000007799341,"teacher_disagreement_score":0.115781926,"about_ca_system_score_codex":0.00064407405,"about_ca_system_score_gemma":0.0028545617,"threshold_uncertainty_score":0.99996024},"labels":[],"label_agreement":null},{"id":"W4394989576","doi":"10.1016/j.jval.2024.04.010","title":"Health Fluctuations in Dementia and its Impact on the Assessment of Health-Related Quality of Life Using the EQ-5D-5L","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Impact","funders":"EuroQol Research Foundation","keywords":"Dementia; Quality of life (healthcare); EQ-5D; Health related quality of life; Environmental health; Medicine; Gerontology; Nursing","score_opus":0.5423338103566373,"score_gpt":0.4999210226402113,"score_spread":0.04241278771642598,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4394989576","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7954255,0.032731473,0.0008901231,0.16830336,0.0004076758,0.0017385172,0.00035882744,0.000018869567,0.0001256892],"genre_scores_gemma":[0.9923229,0.0014842545,0.0005965049,0.005434954,0.000051493524,0.00004965836,0.000019391615,0.000027723918,0.000013124957],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.985494,0.004375215,0.008807399,0.00052272336,0.00021408842,0.0005865275],"domain_scores_gemma":[0.9916281,0.0039808787,0.0036298567,0.0005240953,0.000045864497,0.0001911662],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.080381505,0.00020422331,0.001483775,0.00058313773,0.00026047445,0.00004668562,0.00025374672,0.00009740035,0.00010955874],"category_scores_gemma":[0.002137099,0.00016705091,0.00012712485,0.00080341374,0.000085622014,0.00020353883,0.000059153455,0.000458175,0.000020244304],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021431877,0.00031929906,0.19061083,0.0051576663,0.00020187708,3.014801e-7,0.013705643,0.07610758,0.0000044820113,0.7110665,0.0020747948,0.00072961615],"study_design_scores_gemma":[0.00057763903,0.00028408167,0.618304,0.0010617201,0.0000028992115,0.0000019037788,0.0016840728,0.36379308,7.70409e-7,0.01377164,0.0003585861,0.00015960624],"about_ca_topic_score_codex":0.08636415,"about_ca_topic_score_gemma":0.0011869062,"teacher_disagreement_score":0.69729483,"about_ca_system_score_codex":0.0017921577,"about_ca_system_score_gemma":0.0034774097,"threshold_uncertainty_score":0.9469408},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":[],"domain":null,"study_design":"observational","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"agree"},{"id":"W4395701643","doi":"10.1016/j.jval.2024.04.017","title":"Implementing Multilevel Network Meta-Regression for Time-To-Event Outcomes: A Case Study in Relapsed Refractory Multiple Myeloma","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"Bristol-Myers Squibb Canada; Bristol-Myers Squibb","keywords":"Multilevel model; Meta-analysis; Event (particle physics); Randomized controlled trial; Meta-regression; Multiple myeloma; Regression; Computer science; Aggregate (composite); Regression analysis; Medicine; Statistics; Internal medicine; Machine learning; Mathematics","score_opus":0.1678395498886775,"score_gpt":0.442002677789358,"score_spread":0.2741631279006805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395701643","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98749435,0.0021981855,0.00023940716,0.0015722027,0.00022925746,0.00801177,0.00009628394,0.00011952423,0.00003899792],"genre_scores_gemma":[0.9906426,0.000026130756,0.006068659,0.00027654183,0.00014084157,0.0014788507,0.00005987077,0.00007771682,0.0012287721],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9957259,0.00058090803,0.0010933197,0.0007581794,0.0005268733,0.0013147979],"domain_scores_gemma":[0.9969573,0.001847039,0.00012517419,0.0004916342,0.000066230365,0.0005126265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036104412,0.00036073293,0.0010499775,0.00058637455,0.00021238388,0.000040717936,0.00011471014,0.00009251432,0.00016142095],"category_scores_gemma":[0.0007865891,0.00024243491,0.000270268,0.0006000158,0.000017925764,0.00007895765,0.0001575044,0.00045217518,0.00011075793],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021264462,0.005596024,0.70294964,0.002710466,0.0028205945,0.026926491,0.011698991,0.0076342695,0.00018655781,0.000030557756,0.003646469,0.23367348],"study_design_scores_gemma":[0.033546455,0.00753838,0.30194193,0.0034214386,0.0006215436,0.0007007298,0.004027157,0.6225834,0.00007000762,0.000113450325,0.024658885,0.00077660655],"about_ca_topic_score_codex":0.014581014,"about_ca_topic_score_gemma":0.0026494076,"teacher_disagreement_score":0.6149491,"about_ca_system_score_codex":0.0009062608,"about_ca_system_score_gemma":0.00056955667,"threshold_uncertainty_score":0.99198097},"labels":[],"label_agreement":null},{"id":"W4399359799","doi":"10.1016/j.jval.2024.05.016","title":"A Direct Comparison Between Discrete Choice With Duration and Composite Time Trade-Off Methods: Do They Produce Similar Results?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences","funders":"EuroQol Research Foundation","keywords":"Duration (music); Composite number; Computer science; Mathematics; Algorithm; Physics","score_opus":0.2968331479096414,"score_gpt":0.4574507379959681,"score_spread":0.1606175900863267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399359799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5699287,0.060086276,0.008465705,0.34588486,0.0009957297,0.0052860896,0.0022452332,0.000512383,0.0065949783],"genre_scores_gemma":[0.9618741,0.0007552938,0.033708595,0.002261327,0.00072340964,0.00012871053,0.00019239096,0.00008845712,0.00026770204],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9915651,0.0019252778,0.004801493,0.0010452392,0.00013173722,0.0005311395],"domain_scores_gemma":[0.99353725,0.0042075478,0.0014510391,0.0005244062,0.00002188568,0.00025784975],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.032988638,0.00027432916,0.0013658531,0.00047353999,0.00022911243,0.00024199662,0.00019748758,0.00013902568,0.000016526878],"category_scores_gemma":[0.0018800835,0.00028580058,0.00006569672,0.0004090986,0.00007119599,0.0005250184,0.000042678694,0.00039414217,0.00020189316],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006151255,0.0006680267,0.6586836,0.017927295,0.0010028468,0.000019148112,0.12104882,0.042696673,0.00010361417,0.07045636,0.047101982,0.039676487],"study_design_scores_gemma":[0.0029694668,0.0011416085,0.30776912,0.0034870175,0.00004783317,0.000024450419,0.0010541792,0.33681995,0.00008497825,0.012829536,0.33232537,0.0014465018],"about_ca_topic_score_codex":0.0052734325,"about_ca_topic_score_gemma":0.0002140907,"teacher_disagreement_score":0.3919454,"about_ca_system_score_codex":0.0007044398,"about_ca_system_score_gemma":0.00028272378,"threshold_uncertainty_score":0.9999594},"labels":[],"label_agreement":null},{"id":"W4399360099","doi":"10.1016/j.jval.2024.05.019","title":"Qualitative and Psychometric Evaluation of 29-Item Patient-Reported Outcomes Measurement Information System® to Assess General Health-Related Quality of Life in Patients With Moderately to Severely Active Inflammatory Bowel Disease","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"Janssen Research and Development; Janssen Scientific Affairs","keywords":"Inflammatory bowel disease; Medicine; Quality of life (healthcare); Health related quality of life; Internal medicine; Disease; Gastroenterology; Nursing","score_opus":0.09568167379995042,"score_gpt":0.3609008066811436,"score_spread":0.2652191328811932,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399360099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960147,0.00035249544,0.00026684912,0.00017427567,0.0001614297,0.0027624145,0.00022364185,0.000016561882,0.000027605907],"genre_scores_gemma":[0.9991392,0.00000828352,0.00026485082,0.00020692343,0.000008630574,0.00020102052,0.00014956253,0.000019652409,0.0000018728973],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9945253,0.0018332682,0.0017970678,0.0003778912,0.0011779116,0.00028852734],"domain_scores_gemma":[0.9976508,0.00005297261,0.0006982133,0.00032246773,0.0008712208,0.00040432956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044940053,0.00021779274,0.00041741843,0.0006779343,0.00004426013,0.00002226875,0.00008933295,0.00008731079,0.000001722206],"category_scores_gemma":[0.001357868,0.00019874284,0.00005423615,0.000601075,0.000031094405,0.000054788372,0.000053573112,0.0001152188,0.0000016936231],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012686021,0.00047845085,0.80676645,0.0067997808,0.0003256715,0.000003131911,0.021675337,0.14475591,0.000083499006,0.00056220265,0.00010383588,0.0057597277],"study_design_scores_gemma":[0.0020179986,0.00040249902,0.98797464,0.00058751885,0.000017087505,2.007841e-7,0.001199373,0.00752484,0.000055584933,0.000025625526,0.0000073552,0.00018726618],"about_ca_topic_score_codex":0.0014045432,"about_ca_topic_score_gemma":0.00018296571,"teacher_disagreement_score":0.18120822,"about_ca_system_score_codex":0.0006570487,"about_ca_system_score_gemma":0.0021961555,"threshold_uncertainty_score":0.8104498},"labels":[],"label_agreement":null},{"id":"W4399360696","doi":"10.1016/j.jval.2024.05.015","title":"A Targeted Review of Worldwide Indirect Treatment Comparison Guidelines and Best Practices","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada); Ottawa Hospital","funders":"Janssen Japan; Janssen Pharmaceuticals","keywords":"Transparency (behavior); Credibility; Circumstantial evidence; Psychological intervention; Health care; Risk analysis (engineering); Key (lock); Health professionals; Computer science; Medicine; Management science; Data science; Economics; Political science; Computer security; Nursing; Economic growth","score_opus":0.8375545604246099,"score_gpt":0.5958803910116529,"score_spread":0.24167416941295694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399360696","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016465541,0.9749336,0.00001217007,0.019423176,0.0007894367,0.0033028354,0.0008157794,0.000038636892,0.0006678845],"genre_scores_gemma":[0.0000034870027,0.992444,0.0032559652,0.0025902574,0.00034037995,0.00045929672,0.00019294409,0.000080219215,0.00063345867],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9813528,0.0019109348,0.015094348,0.0010013827,0.00013652476,0.00050400884],"domain_scores_gemma":[0.97974265,0.0026214144,0.016593574,0.00071594754,0.00007813768,0.00024826164],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.028851492,0.00053053285,0.007972308,0.0010611634,0.00008337269,0.000058070756,0.0002954095,0.00026614626,0.00010616786],"category_scores_gemma":[0.010056741,0.0005159982,0.00039251157,0.0007886397,0.000060850056,0.00020215356,0.0000803133,0.00042835274,0.0008058337],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000002855987,0.00023193074,0.00039046287,0.768229,0.00026362322,0.0000030330848,0.00060347794,0.000018547313,1.3690342e-9,0.004509111,0.036524672,0.18922327],"study_design_scores_gemma":[0.00014565936,0.00019051827,0.000008133238,0.2052393,0.0001250522,0.000012795255,0.000077093035,0.0005372195,1.4028348e-8,0.0003697245,0.7930261,0.0002683886],"about_ca_topic_score_codex":0.021139,"about_ca_topic_score_gemma":0.000595247,"teacher_disagreement_score":0.75650144,"about_ca_system_score_codex":0.0019099698,"about_ca_system_score_gemma":0.0019642639,"threshold_uncertainty_score":0.99997216},"labels":[],"label_agreement":null},{"id":"W4399699327","doi":"10.1016/j.jval.2024.03.1118","title":"HPR49 Real World Evidence and Rare Disease Considerations Across Regulatory and Health Technology Assessment Frameworks in the US, UK, and Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real world evidence; Health technology; Business; Medicine; Risk analysis (engineering); Environmental health; Health care; Economics; Economic growth; Internal medicine","score_opus":0.34061264663378626,"score_gpt":0.470888007017026,"score_spread":0.13027536038323972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699327","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5703574,0.04641839,0.00009708134,0.38166586,0.00027533295,0.0009048127,0.00020619453,0.000025116075,0.00004981937],"genre_scores_gemma":[0.96964705,0.0062010153,0.0011621899,0.02267088,0.000092302034,0.0001500253,0.000010094857,0.00001824864,0.000048176917],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99564993,0.0006503132,0.0024001147,0.00066595,0.00011141714,0.0005222619],"domain_scores_gemma":[0.9963225,0.0024100917,0.0005544298,0.00040874947,0.000021137937,0.00028309246],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017023208,0.00017205955,0.00065964134,0.00039297857,0.00037501185,0.00018960325,0.00011638538,0.00013174511,0.000023158986],"category_scores_gemma":[0.001172971,0.000184113,0.000019528652,0.0003736329,0.00016671699,0.00025495898,0.00007643329,0.00071141415,0.0000037803359],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000034634854,0.000022017559,0.6501298,0.0012862476,0.000009332761,0.000012678198,0.0024358912,0.0005467464,3.870876e-8,0.33741596,0.0076990314,0.0004387756],"study_design_scores_gemma":[0.00027887675,0.00006134862,0.9164019,0.0014483393,0.0000018235871,0.000018412393,0.0024859274,0.022956397,5.3353876e-8,0.050430845,0.0057198666,0.00019616452],"about_ca_topic_score_codex":0.71231097,"about_ca_topic_score_gemma":0.7829429,"teacher_disagreement_score":0.39928967,"about_ca_system_score_codex":0.001591489,"about_ca_system_score_gemma":0.003370372,"threshold_uncertainty_score":0.750791},"labels":[],"label_agreement":null},{"id":"W4399699334","doi":"10.1016/j.jval.2024.03.952","title":"EPH123 Incorporating Social Determinants of Health Into Transmission Modeling of COVID-19 Vaccine in the US: A Scoping Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Transmission (telecommunications); Virology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Social determinants of health; Data science; Medicine; Computer science; Public health; Telecommunications; Disease; Nursing; Outbreak; Infectious disease (medical specialty)","score_opus":0.24453236922974325,"score_gpt":0.4945930043339134,"score_spread":0.25006063510417015,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699334","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010753395,0.9909166,0.00024651684,0.004868522,0.0001433136,0.003622729,0.000012098618,0.00002209478,0.000060556104],"genre_scores_gemma":[0.0010587004,0.99720126,0.00037686358,0.0010302833,0.00017347765,0.00010268647,0.000014872645,0.0000349033,0.0000069681355],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9904094,0.004353296,0.0035805975,0.0004885151,0.00063549785,0.00053274195],"domain_scores_gemma":[0.9972312,0.00052159966,0.0017443695,0.00028246053,0.0000591168,0.00016128932],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016207755,0.00032108938,0.0030882368,0.00043636933,0.00042459441,0.000026071553,0.0006370099,0.00023839311,0.000020779511],"category_scores_gemma":[0.0006414572,0.0002323879,0.00038481638,0.0020069631,0.000020974087,0.00013131008,0.0000694346,0.0006718313,0.0000037137156],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000033475085,0.000049320297,0.00013743193,0.60124236,0.0000060436937,0.000009641479,0.01688863,0.000096987365,7.895007e-9,0.0004057605,0.00016970163,0.3809908],"study_design_scores_gemma":[0.0002442585,0.00013209521,0.000005668068,0.96274287,0.00009762355,0.0000057265956,0.0009567792,0.0011855026,1.8115772e-8,0.002518293,0.031855814,0.0002553367],"about_ca_topic_score_codex":0.05618478,"about_ca_topic_score_gemma":0.011178836,"teacher_disagreement_score":0.38073546,"about_ca_system_score_codex":0.0009500336,"about_ca_system_score_gemma":0.01652168,"threshold_uncertainty_score":0.9890537},"labels":[],"label_agreement":null},{"id":"W4399699353","doi":"10.1016/j.jval.2024.03.958","title":"EPH129 Tobacco Product Experience: Which Consumer Reported Outcome Measures for Real World Evidence Studies?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Consumer Attitudes and Food Labeling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"RealNetworks (Canada)","funders":"","keywords":"Tobacco product; Real world evidence; Outcome (game theory); Product (mathematics); Business; Medicine; Economics; Environmental health; Microeconomics; Internal medicine; Mathematics","score_opus":0.35774794630503665,"score_gpt":0.47662940342966986,"score_spread":0.11888145712463322,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699353","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.695112,0.2759734,0.000094789975,0.022944879,0.0024234662,0.0028489907,0.000011720318,0.00032165615,0.00026910083],"genre_scores_gemma":[0.9894598,0.006209753,0.002345832,0.0005592488,0.00027431376,0.0003011312,0.0000061994733,0.0000395859,0.0008041462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99703085,0.00011759033,0.0011456272,0.0007255323,0.00044094192,0.00053945155],"domain_scores_gemma":[0.99807316,0.00068760966,0.00014970636,0.0005522989,0.0003397879,0.00019741373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002692061,0.00021749087,0.00064277585,0.00029585382,0.00013061281,0.00004663776,0.00010977176,0.000049607774,0.000026905282],"category_scores_gemma":[0.0030542659,0.00017629164,0.00009815695,0.0010219604,0.000078474055,0.00014426264,0.000058626898,0.00036204013,0.000014983949],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045056888,0.000202808,0.91648376,0.0070994785,0.00070949644,0.00020468226,0.010695246,0.00018904427,0.0007062849,0.0018035006,0.0034955125,0.057959605],"study_design_scores_gemma":[0.007944335,0.003671607,0.5382555,0.07504903,0.0023560482,0.0010471904,0.008810584,0.020364093,0.0024941915,0.0020415154,0.33479157,0.0031743145],"about_ca_topic_score_codex":0.0045119207,"about_ca_topic_score_gemma":0.0023750206,"teacher_disagreement_score":0.37822825,"about_ca_system_score_codex":0.00049322547,"about_ca_system_score_gemma":0.0010509632,"threshold_uncertainty_score":0.7188964},"labels":[],"label_agreement":null},{"id":"W4399699364","doi":"10.1016/j.jval.2024.03.1130","title":"HPR61 Impact of Changes in US Medicaid Reimbursement for Long-Acting Reversible Contraceptives in the Immediate Postpartum Period","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Reproductive Health and Contraception","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Coquitlam College","funders":"","keywords":"Medicaid; Reimbursement; Period (music); Postpartum period; Medicine; Obstetrics; Pregnancy; Economics; Health care; Economic growth","score_opus":0.05710677695906973,"score_gpt":0.379801602499189,"score_spread":0.32269482554011925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699364","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93491215,0.010697609,0.000075051976,0.051204424,0.0004209082,0.0025320007,0.000021758025,0.000020021744,0.000116070485],"genre_scores_gemma":[0.9959197,0.0026636922,0.00013893026,0.00053477497,0.00043462607,0.00020864191,0.000027562426,0.000019553916,0.00005253878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977774,0.0003514358,0.0006267537,0.00039248104,0.00029841886,0.0005535368],"domain_scores_gemma":[0.99900085,0.00039483956,0.00016127386,0.00026214108,0.00005804142,0.00012283458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0040553245,0.00015154872,0.0004625684,0.0003939401,0.00004585332,0.000013640833,0.00008851408,0.00008565942,0.00004003382],"category_scores_gemma":[0.00060022995,0.00010570228,0.00009445852,0.000542301,0.00006503157,0.00009566072,0.000014094456,0.0004224046,0.0000037150205],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049376227,0.0013944225,0.731411,0.016019007,0.00014008328,0.0003236105,0.09891615,0.0014349766,0.0036516536,0.0011040268,0.0021425635,0.13852492],"study_design_scores_gemma":[0.0033429863,0.0037353516,0.96974736,0.004527903,0.00002565244,0.000061503284,0.007508993,0.008438541,0.00024138705,0.00038546333,0.0018133363,0.00017151675],"about_ca_topic_score_codex":0.007981124,"about_ca_topic_score_gemma":0.0013696857,"teacher_disagreement_score":0.23833641,"about_ca_system_score_codex":0.0006266128,"about_ca_system_score_gemma":0.00096978113,"threshold_uncertainty_score":0.9986248},"labels":[],"label_agreement":null},{"id":"W4399699367","doi":"10.1016/j.jval.2024.03.1095","title":"HPR25 Current Reimbursement Landscape for Re-Treatment with Anti-PD-(L)1 Agents after Treatment in Early-Stage Cancers: A Payer Survey","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Reimbursement; Stage (stratigraphy); Medicine; Current (fluid); Oncology; Intensive care medicine; Economic growth; Health care; Economics; Engineering; Biology","score_opus":0.11120627164368715,"score_gpt":0.3262660429919882,"score_spread":0.21505977134830104,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95356214,0.039184447,0.00049906765,0.0008658467,0.0011319952,0.0018212189,0.0021913738,0.000037925383,0.0007059874],"genre_scores_gemma":[0.9833568,0.014287339,0.00018251574,0.0001818182,0.00018215293,0.00085551164,0.000087556626,0.00005641847,0.00080989976],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975065,0.000056612505,0.0009210893,0.00074994157,0.000042289445,0.00072359113],"domain_scores_gemma":[0.99907655,0.00013525772,0.00023143513,0.0003588804,0.000019484836,0.00017841773],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008986366,0.0003287792,0.00079104514,0.00043170506,0.00005719886,0.00011187598,0.00011297851,0.000090121874,0.00015709513],"category_scores_gemma":[0.000023235889,0.00028590212,0.00012755945,0.00032483504,0.000033083157,0.0002368095,0.000021689157,0.00013170057,0.00009417183],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034992708,0.00034974114,0.9687314,0.00031029916,0.0000951373,0.000026117343,0.0036114948,0.0040045097,1.3411608e-7,0.0024715702,0.00065475504,0.019394906],"study_design_scores_gemma":[0.0029881448,0.0025198245,0.6985695,0.0006949688,0.000009228006,0.0000014090384,0.00012796644,0.016690232,0.000012547464,0.0012757394,0.27656177,0.000548703],"about_ca_topic_score_codex":0.09425877,"about_ca_topic_score_gemma":0.023471713,"teacher_disagreement_score":0.275907,"about_ca_system_score_codex":0.003772627,"about_ca_system_score_gemma":0.00060682534,"threshold_uncertainty_score":0.9999593},"labels":[],"label_agreement":null},{"id":"W4399699781","doi":"10.1016/j.jval.2024.03.944","title":"EPH115 Sex Differences on Limitations in Physical Functioning and Overall Quality of Life of People Living with Myasthenia Gravis from the MGFA Global MG Patient Registry (MGFAPR) in the US","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"","keywords":"Myasthenia gravis; Quality of life (healthcare); Medicine; Physical therapy; Gerontology; Physical medicine and rehabilitation; Internal medicine; Nursing","score_opus":0.0707042737589452,"score_gpt":0.30959976434639774,"score_spread":0.23889549058745255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699781","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9953543,0.0007434646,0.000026103462,0.0031839092,0.000061697145,0.0003756708,0.000053972155,0.000009857398,0.000191025],"genre_scores_gemma":[0.99936587,0.00008678525,0.000100243604,0.00033768057,0.00006014667,0.000023816503,0.000009369992,0.000008032384,0.000008088021],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981379,0.00056616537,0.00049058703,0.00024491377,0.00037329562,0.00018714435],"domain_scores_gemma":[0.99770045,0.0017903793,0.0001591518,0.0002647941,0.000025596859,0.000059627717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072720245,0.00012311722,0.00039032332,0.000058857328,0.000048002225,0.000021887805,0.000087087166,0.000041966367,0.0000049035666],"category_scores_gemma":[0.00032501668,0.000067086716,0.000046509547,0.000414915,0.00008061562,0.000038189977,0.000028760385,0.0002975201,7.3096066e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018804568,0.0003660722,0.95550936,0.00033094184,0.000021076894,0.0000043193522,0.032371,0.00051563577,0.000024154138,0.007522813,0.000039689072,0.0031069028],"study_design_scores_gemma":[0.0005143473,0.00070619123,0.98371696,0.0015819977,0.000010431339,0.000004034007,0.0055772094,0.005294154,0.0000025671086,0.0025018232,0.00003139117,0.0000589017],"about_ca_topic_score_codex":0.038988877,"about_ca_topic_score_gemma":0.004834611,"teacher_disagreement_score":0.034154266,"about_ca_system_score_codex":0.00008792911,"about_ca_system_score_gemma":0.00028128317,"threshold_uncertainty_score":0.96741056},"labels":[],"label_agreement":null},{"id":"W4399699830","doi":"10.1016/j.jval.2024.03.671","title":"EE375 Cost Savings and the Opportunity for Expanded Treatment Access with Increased Use of Biosimilar Adalimumab in the United States","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada); Brampton Civic Hospital","funders":"","keywords":"Biosimilar; Adalimumab; Business; Medicine; Expanded access; Internal medicine","score_opus":0.16194609539653945,"score_gpt":0.37661123023996423,"score_spread":0.21466513484342478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699830","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97121626,0.004222571,0.00027505882,0.021658551,0.00011242011,0.0021119877,0.0003510261,0.000026380472,0.000025771878],"genre_scores_gemma":[0.9917388,0.0035167572,0.00042968994,0.003984721,0.000011397647,0.00013898165,0.00011594893,0.000013249094,0.000050457416],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99769276,0.0013973671,0.00037034845,0.00022230386,0.000038471215,0.00027876123],"domain_scores_gemma":[0.9961478,0.0034754348,0.00009007015,0.0002184876,0.00003437716,0.00003379636],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018931787,0.0001458448,0.0003484096,0.00016959044,0.00009908018,0.00004665477,0.00016359439,0.00010884593,0.000017139397],"category_scores_gemma":[0.00019782477,0.000063690655,0.00004859846,0.0004417747,0.0003991469,0.00006418968,0.00003710409,0.00020334838,3.1744528e-7],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07211459,0.010617365,0.25179276,0.010304904,0.0056495583,0.0003607354,0.10134153,0.0035799518,0.00846216,0.18170199,0.036907814,0.31716663],"study_design_scores_gemma":[0.06621282,0.014756819,0.104611225,0.005169086,0.00101125,0.0004444774,0.017021254,0.06158455,0.02506264,0.021111643,0.6812089,0.0018053446],"about_ca_topic_score_codex":0.02934546,"about_ca_topic_score_gemma":0.0009099032,"teacher_disagreement_score":0.64430106,"about_ca_system_score_codex":0.00007525202,"about_ca_system_score_gemma":0.0002485062,"threshold_uncertainty_score":0.9771182},"labels":[],"label_agreement":null},{"id":"W4399699851","doi":"10.1016/j.jval.2024.03.911","title":"EPH82 Risk Perception of Tobacco and Nicotine Products: Which Consumer Reported Outcome Measures for Evidence Generation in Support of Regulatory Engagement?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Consumer Attitudes and Food Labeling","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"RealNetworks (Canada)","funders":"","keywords":"Outcome (game theory); Nicotine; Risk perception; Perception; Environmental health; Business; Medicine; Psychology; Economics; Microeconomics; Psychiatry","score_opus":0.19765481171184202,"score_gpt":0.3888102563686999,"score_spread":0.1911554446568579,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699851","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97920185,0.017029807,0.00013717895,0.0023326841,0.00019036824,0.0010642402,0.000015370153,0.000019521456,0.000009006332],"genre_scores_gemma":[0.9939052,0.002677634,0.003164308,0.00008312105,0.000060904786,0.000032853117,0.000022578639,0.000015282369,0.000038102316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99809617,0.00017753498,0.0010036435,0.0003257588,0.00023103536,0.00016587065],"domain_scores_gemma":[0.9990984,0.00016358325,0.00021950844,0.0002552047,0.00021192471,0.00005137988],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00458119,0.000097541895,0.0003578944,0.00023695854,0.000029944258,0.000008185164,0.000032286764,0.00005736686,0.000017884468],"category_scores_gemma":[0.0015837008,0.00008831724,0.000032425087,0.00033801355,0.000036550955,0.00009445207,0.000021516647,0.00019721642,6.6156406e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001713473,0.00014042138,0.9329748,0.0056148088,0.000102362246,0.000003957705,0.0021999136,0.0005094381,0.029907662,0.00018128373,0.0004352148,0.027758764],"study_design_scores_gemma":[0.0023512181,0.001362535,0.9575306,0.00389382,0.00047425932,0.000054625187,0.00048494196,0.026478698,0.0039220694,0.00010964889,0.0030602543,0.00027733744],"about_ca_topic_score_codex":0.0022769447,"about_ca_topic_score_gemma":0.00042582833,"teacher_disagreement_score":0.027481427,"about_ca_system_score_codex":0.00012953242,"about_ca_system_score_gemma":0.00046956644,"threshold_uncertainty_score":0.36014724},"labels":[],"label_agreement":null},{"id":"W4399699870","doi":"10.1016/j.jval.2024.03.894","title":"EPH65 Burden of Illness of Osteogenesis Imperfecta in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical and Biological Sciences","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Osteogenesis imperfecta; Medicine; Pathology","score_opus":0.03903258136192295,"score_gpt":0.28806712907986065,"score_spread":0.2490345477179377,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99206454,0.0016817196,0.0000019862998,0.0053046765,0.0002494104,0.00018060292,0.000007010312,0.000004519639,0.00050554017],"genre_scores_gemma":[0.99932724,0.0001144863,0.000074999625,0.00023187211,0.000035096586,0.000004289627,0.000004005435,0.000001904565,0.00020611547],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99891776,0.00007713869,0.00038343776,0.00015772505,0.0002661958,0.00019772709],"domain_scores_gemma":[0.9995285,0.00020697144,0.000039797986,0.00008139676,0.000014537751,0.00012878909],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072914857,0.000054492422,0.00028142723,0.000063823376,0.000010218943,0.000001400793,0.000079025085,0.00004696222,0.00048567518],"category_scores_gemma":[0.00015531913,0.00003169677,0.000025631796,0.0003807101,0.00006361607,0.000011716281,0.000023766232,0.00014088431,9.657956e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019084042,0.00023840809,0.8555695,0.004018191,0.000021137359,0.00026925516,0.0053680954,0.0007177091,0.00860513,0.0021196506,0.0018046935,0.12107739],"study_design_scores_gemma":[0.0012513308,0.0022944163,0.9417796,0.0047405395,0.000017728988,0.000046761394,0.0021011354,0.006888151,0.003831572,0.001687471,0.035093598,0.00026770352],"about_ca_topic_score_codex":0.9988633,"about_ca_topic_score_gemma":0.98087454,"teacher_disagreement_score":0.12080968,"about_ca_system_score_codex":0.00028885674,"about_ca_system_score_gemma":0.0031812214,"threshold_uncertainty_score":0.56433505},"labels":[],"label_agreement":null},{"id":"W4399699874","doi":"10.1016/j.jval.2024.03.729","title":"EE434 Benefits of a Polymer Tip in Torsional Phacoemulsification: A Targeted Literature Search and Budget Impact Model","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Anorectal Disease Treatments and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Phacoemulsification; Medicine; Computer science; Ophthalmology","score_opus":0.03416768209898266,"score_gpt":0.35480705527448747,"score_spread":0.32063937317550484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9406377,0.055997174,0.0000090987405,0.0027342017,0.000038789105,0.0003099387,0.00017319055,0.000018497234,0.00008141438],"genre_scores_gemma":[0.99793285,0.0009818553,0.00026516477,0.00025529996,0.000040434436,0.000011962789,0.000110031106,0.000014246885,0.00038812705],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99906695,0.000056464523,0.00025854495,0.00021689446,0.00019196067,0.00020919871],"domain_scores_gemma":[0.99960023,0.00006360418,0.00002018822,0.000117102805,0.000027048301,0.00017180466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017558521,0.00010859412,0.00024344969,0.00026708617,0.00001988536,0.00001311553,0.000030158055,0.000060945058,0.00004377457],"category_scores_gemma":[0.00001754271,0.000076020915,0.000057766025,0.00041369844,0.000025219506,0.000070122274,0.000016915059,0.00015894842,0.0000034640925],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024276795,0.0023162602,0.8570959,0.0075988555,0.00031747395,0.00032373567,0.029820904,0.0239348,0.0034547949,0.023020672,0.0018286236,0.047860324],"study_design_scores_gemma":[0.0018421466,0.00052450696,0.6517039,0.002493468,0.000023709312,0.000041152023,0.00011768491,0.34207755,0.00046769172,0.0005448312,0.00003086032,0.00013249602],"about_ca_topic_score_codex":0.0014737225,"about_ca_topic_score_gemma":0.000014867752,"teacher_disagreement_score":0.31814274,"about_ca_system_score_codex":0.00016614271,"about_ca_system_score_gemma":0.0004509588,"threshold_uncertainty_score":0.3100043},"labels":[],"label_agreement":null},{"id":"W4399699905","doi":"10.1016/j.jval.2024.03.633","title":"EE334 The Diagnostic Odyssey and Cost-Effectiveness of Genomic Testing in Indigenous Children in British Columbia, Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Prenatal Screening and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Indigenous; Medicine; Geography; Gerontology; Biology; Ecology","score_opus":0.022882367039779996,"score_gpt":0.26908562287808807,"score_spread":0.24620325583830807,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9856316,0.012380893,0.0000055576415,0.00022539582,0.000109868066,0.0014891468,0.00008462483,0.000017206437,0.000055721106],"genre_scores_gemma":[0.9990284,0.0005340359,0.000087442626,0.00019305499,0.00003910955,0.00006690834,0.000025591324,0.000017960303,0.000007522777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985932,0.0003003575,0.0003705798,0.00023995015,0.00015984771,0.00033603187],"domain_scores_gemma":[0.99352896,0.0061643017,0.00004994765,0.00013350444,0.000019718645,0.00010355653],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012097373,0.000076417804,0.0003073037,0.00007921578,0.000048164748,0.000039806026,0.00007895979,0.000054363667,0.0000030962485],"category_scores_gemma":[0.0027312522,0.000093017756,0.000013915615,0.00045176287,0.000049771363,0.000029373447,0.000052083476,0.0003752313,6.888933e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009720048,0.000055198623,0.9680155,0.0007410349,0.000007587195,0.00034758126,0.0003334389,0.0020866354,0.00001235827,0.00000924734,0.00006230246,0.0283194],"study_design_scores_gemma":[0.0006403321,0.00017801882,0.99172544,0.0052035716,0.000007797807,0.00020901873,0.00006843901,0.001686749,0.000008162699,0.00016276594,0.00003196794,0.000077733894],"about_ca_topic_score_codex":0.99799275,"about_ca_topic_score_gemma":0.9850562,"teacher_disagreement_score":0.028241666,"about_ca_system_score_codex":0.0005828978,"about_ca_system_score_gemma":0.0020921875,"threshold_uncertainty_score":0.3793154},"labels":[],"label_agreement":null},{"id":"W4399699907","doi":"10.1016/j.jval.2024.03.595","title":"EE296 A United States Payer Budget Impact Analysis of Myocardial Perfusion Imaging Modalities Positron Emission Tomography with Flurpiridaz Compared to Single Photon Emission Computed Tomography in Coronary Artery Disease Diagnosis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced X-ray and CT Imaging","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Single-photon emission computed tomography; Coronary artery disease; Positron emission tomography; Myocardial perfusion imaging; Perfusion; Radiology; Computed tomography; Emission computed tomography; Modalities; Nuclear medicine; Cardiology","score_opus":0.010687081297178155,"score_gpt":0.25754633614442607,"score_spread":0.2468592548472479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699907","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98688734,0.0056059943,0.005777992,0.00036488718,0.00016430127,0.00058138976,0.00027928906,0.0003212148,0.000017600276],"genre_scores_gemma":[0.99759626,0.0003668452,0.001076652,0.00016937288,0.00003496293,0.00006551542,0.0006217108,0.00006625479,0.000002406086],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9974817,0.0002528227,0.000727098,0.00049513165,0.00040367775,0.00063958624],"domain_scores_gemma":[0.9987267,0.00032302926,0.00008283219,0.00034671914,0.00006724649,0.00045344257],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003764547,0.00039744767,0.00071143796,0.0034657966,0.00009645759,0.000077716184,0.00016638209,0.00005358143,0.000018183022],"category_scores_gemma":[0.000017160362,0.0003489813,0.0002690237,0.005435554,0.00005970935,0.00032039563,0.000061263185,0.00033874833,8.0307984e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030565276,0.00015258697,0.33497962,0.00044753985,0.00016315056,0.000076317134,0.0031147085,0.65602195,0.002022213,0.000004586604,0.00015018291,0.0025614896],"study_design_scores_gemma":[0.0005242852,0.00015958308,0.19709632,0.002307658,0.00013536998,0.0000049306827,0.00074378535,0.79732865,0.0010393723,0.00015135146,0.00015892318,0.00034978183],"about_ca_topic_score_codex":0.0025762895,"about_ca_topic_score_gemma":0.000047129655,"teacher_disagreement_score":0.1413067,"about_ca_system_score_codex":0.00041622287,"about_ca_system_score_gemma":0.000102295424,"threshold_uncertainty_score":0.9998962},"labels":[],"label_agreement":null},{"id":"W4399699955","doi":"10.1016/j.jval.2024.03.687","title":"EE391 Cost-Effectiveness of Radar: An Innovative Model to Organize Diabetes Care in First Nations Communities in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Radar; Business; Economic growth; Medicine; Computer science; Economics; Telecommunications","score_opus":0.17253072495586613,"score_gpt":0.4592812236006933,"score_spread":0.28675049864482716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699955","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9868942,0.0021071462,0.000040551113,0.0051426687,0.00075354305,0.00342332,0.0005819634,0.00003573839,0.0010208968],"genre_scores_gemma":[0.99781317,0.00023195789,0.00040317848,0.00070219254,0.000046374054,0.00065101235,0.00009527003,0.000039998067,0.000016864064],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99089974,0.006632442,0.0012197064,0.00027164302,0.00030107406,0.0006754115],"domain_scores_gemma":[0.9895874,0.009304931,0.00020092935,0.00036655107,0.00035433954,0.00018583481],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052555325,0.00017838874,0.00058076496,0.0008433607,0.00037192812,0.000012065021,0.00023911535,0.00014128935,0.000036734287],"category_scores_gemma":[0.0009984055,0.00017591563,0.000014999784,0.0029149568,0.000026165952,0.00030524234,0.00009651241,0.0011679283,0.000013020723],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000095045616,0.00009336263,0.68569237,0.028164594,0.000014571305,0.000014875135,0.22902015,0.03809845,0.000025182551,0.015030414,0.00031538555,0.0034355924],"study_design_scores_gemma":[0.002518451,0.00083084597,0.4095038,0.05204931,0.000007366982,0.0000021726864,0.38458976,0.08402273,0.00010174709,0.0014505708,0.06409141,0.00083183864],"about_ca_topic_score_codex":0.9919411,"about_ca_topic_score_gemma":0.99860966,"teacher_disagreement_score":0.27618858,"about_ca_system_score_codex":0.005650698,"about_ca_system_score_gemma":0.020777205,"threshold_uncertainty_score":0.99816644},"labels":[],"label_agreement":null},{"id":"W4399699997","doi":"10.1016/j.jval.2024.03.551","title":"EE252 Economic Impact of Relapses in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD): A Systematic Literature Review","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Neuromyelitis optica; Spectrum disorder; Medicine; Dermatology; Psychiatry; Multiple sclerosis","score_opus":0.11816038725278714,"score_gpt":0.3801620968771069,"score_spread":0.26200170962431973,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399699997","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6083388,0.36405578,0.00013564635,0.019758038,0.000817546,0.0051607285,0.0010504903,0.00007523301,0.0006077379],"genre_scores_gemma":[0.9613905,0.03490155,0.00063913956,0.0023146083,0.000135814,0.00027609972,0.00011410371,0.000097687785,0.00013053209],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99160844,0.0009266158,0.0060170055,0.0007315176,0.00011868989,0.00059775787],"domain_scores_gemma":[0.9962345,0.0011541367,0.001682538,0.0006981462,0.000029786512,0.00020088897],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010875169,0.0003187627,0.0022164576,0.0008563899,0.000053447195,0.000095329495,0.00028417632,0.00012489971,0.00016311677],"category_scores_gemma":[0.0012714567,0.00030091283,0.00021177958,0.0007173659,0.000049157854,0.00054940814,0.000042723088,0.00038788852,0.0003977163],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000051241324,0.0002636417,0.39956427,0.5061615,0.00015384148,0.000014334646,0.0033636878,0.014699403,3.583673e-8,0.07156028,0.004047275,0.00012052142],"study_design_scores_gemma":[0.0029329907,0.0020238254,0.4726319,0.4617441,0.000029324481,0.0000410037,0.00023310931,0.046711482,2.0103046e-7,0.010367292,0.002187067,0.0010977163],"about_ca_topic_score_codex":0.007154955,"about_ca_topic_score_gemma":0.00032843923,"teacher_disagreement_score":0.3530517,"about_ca_system_score_codex":0.00264785,"about_ca_system_score_gemma":0.000852168,"threshold_uncertainty_score":0.99994427},"labels":[],"label_agreement":null},{"id":"W4399700011","doi":"10.1016/j.jval.2024.03.528","title":"EE229 Characterizing the Clinical and Economic Burden of COVID-19 Among Individuals with Immunocompromising Conditions in Ontario, Canada – A Matched, Population-Based Observational Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 Clinical Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"AstraZeneca (Canada); Vancouver Coastal Health","funders":"","keywords":"Observational study; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Population; 2019-20 coronavirus outbreak; Medicine; Demography; Environmental health; Sociology; Virology; Internal medicine","score_opus":0.18947407318832457,"score_gpt":0.4565111227434797,"score_spread":0.26703704955515517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.961692,0.00010741956,0.000012213135,0.03627311,0.00009735272,0.0017292561,0.000067066896,0.000016085747,0.0000055017595],"genre_scores_gemma":[0.997411,0.00003139469,0.00016911801,0.0020914057,0.000058082725,0.00011640124,0.00007571651,0.000014457531,0.000032413347],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99739015,0.00047997237,0.0011235141,0.00036683417,0.00036795967,0.00027155693],"domain_scores_gemma":[0.9887872,0.010535622,0.00018699765,0.0002521238,0.000037603077,0.00020046902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035593193,0.00012938566,0.00054936757,0.0001814147,0.00012964387,0.000031870844,0.000107607724,0.000049253642,0.0000655829],"category_scores_gemma":[0.0027472181,0.000094612784,0.000042373056,0.00023746389,0.00016830159,0.000076963624,0.000072876624,0.00063098007,7.6509093e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009937778,0.00010608645,0.98434675,0.0005034429,0.00007595014,0.00003252942,0.001794863,0.0127402395,0.0000024768601,0.00013737525,0.000054209133,0.00010671007],"study_design_scores_gemma":[0.00179853,0.0003428466,0.98447955,0.0006753987,0.000021758295,0.0000011117434,0.0007331476,0.010967111,4.933076e-7,0.00023944034,0.00066374306,0.000076849064],"about_ca_topic_score_codex":0.99599254,"about_ca_topic_score_gemma":0.97353363,"teacher_disagreement_score":0.03571902,"about_ca_system_score_codex":0.002198551,"about_ca_system_score_gemma":0.020000177,"threshold_uncertainty_score":0.9855555},"labels":[],"label_agreement":null},{"id":"W4399700046","doi":"10.1016/j.jval.2024.03.682","title":"EE386 Restoration of Endodontically Treated Teeth: A Cost-Effectiveness Analysis of Endocrown Versus Complete Crown","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Dental Health and Care Utilization","field":"Dentistry","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Brock University","funders":"","keywords":"Crown (dentistry); Dentistry; Orthodontics; Medicine","score_opus":0.0963703021587135,"score_gpt":0.3892349885933153,"score_spread":0.2928646864346018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9926678,0.0018411691,0.0023203397,0.000038546055,0.0011034518,0.000932349,0.0003614992,0.00007199155,0.00066285126],"genre_scores_gemma":[0.99921924,0.00011947271,0.00012694429,0.000029567096,0.000031595326,0.000049438204,0.00034455012,0.00001841992,0.000060785434],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973191,0.00078564417,0.00085312466,0.00033403313,0.00040480687,0.00030327347],"domain_scores_gemma":[0.9982338,0.0009900742,0.00020797199,0.00029229312,0.00014902862,0.00012684813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010240012,0.00013938046,0.0005535562,0.0007433544,0.00004908917,0.00002531448,0.000120186116,0.00009779768,0.00009015137],"category_scores_gemma":[0.00026183657,0.00013975422,0.00016515516,0.0025031965,0.00007604972,0.0001220835,0.000028954772,0.00016715332,0.000016958473],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014582945,0.002085451,0.6091746,0.031194288,0.0030145196,0.00060175435,0.0036501603,0.09782363,0.01690961,0.10171976,0.0015359689,0.117707305],"study_design_scores_gemma":[0.0032274912,0.0011131995,0.7595326,0.001260936,0.0005640406,0.00001518238,0.00028379288,0.22796892,0.0031430314,0.00022678051,0.0023908396,0.00027324597],"about_ca_topic_score_codex":0.015861444,"about_ca_topic_score_gemma":0.0041544107,"teacher_disagreement_score":0.15035793,"about_ca_system_score_codex":0.00046861946,"about_ca_system_score_gemma":0.00032524354,"threshold_uncertainty_score":0.990692},"labels":[],"label_agreement":null},{"id":"W4399700048","doi":"10.1016/j.jval.2024.03.611","title":"EE312 Cost-Effectiveness of Bivalent Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine (RSVpreF) in Pregnant Individuals for the Prevention of Respiratory Tract Disease (RTD) Caused by RSV Among Infants in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Bivalent (engine); Respiratory system; Medicine; Virology; Disease; Virus; Respiratory tract; Immunology; Internal medicine; Chemistry","score_opus":0.09917410144493902,"score_gpt":0.40010343432196954,"score_spread":0.3009293328770305,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9736603,0.014983438,0.000076793694,0.00013437876,0.00027535995,0.010404253,0.0004224414,0.000027350763,0.000015700389],"genre_scores_gemma":[0.9975119,0.0005176811,0.000010013256,0.00008929656,0.000047889298,0.0017017479,0.000040214825,0.000063334555,0.000017928263],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99259955,0.0032416556,0.0018791356,0.00063540513,0.0009757834,0.0006684777],"domain_scores_gemma":[0.9958975,0.0024900085,0.00038856053,0.00071642635,0.00019476733,0.00031276894],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007949646,0.000309751,0.00095815066,0.0010869922,0.00008463697,0.000021473234,0.00026808013,0.0001591036,0.000059177255],"category_scores_gemma":[0.0017013598,0.00024308612,0.00015489304,0.0016369235,0.00011368944,0.00027442354,0.00010785565,0.00075777376,0.0000011173895],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002446595,0.0012435493,0.95184445,0.01025311,0.00007364759,0.00004462782,0.00035615987,0.0076078987,0.018207872,0.00007676916,0.00019466059,0.00765064],"study_design_scores_gemma":[0.005951523,0.0015140483,0.9658361,0.00809098,0.00005674227,0.0000010461446,0.00013051291,0.0045529003,0.012151284,0.00012204823,0.0013898769,0.0002029497],"about_ca_topic_score_codex":0.49683768,"about_ca_topic_score_gemma":0.40658098,"teacher_disagreement_score":0.09025669,"about_ca_system_score_codex":0.0031863493,"about_ca_system_score_gemma":0.010058875,"threshold_uncertainty_score":0.9955532},"labels":[],"label_agreement":null},{"id":"W4399700057","doi":"10.1016/j.jval.2024.03.616","title":"EE317 Cost-Effectiveness of Adjuvant Olaparib in Germline BRCA1/2-Mutated, High-Risk, Human Epidermal Growth Factor-2-Negative Early Breast Cancer: A Canadian Perspective","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Alberta; AstraZeneca (Canada)","funders":"","keywords":"Germline; Oncology; Olaparib; Human Epidermal Growth Factor Receptor 2; Adjuvant; Medicine; Breast cancer; Germline mutation; Perspective (graphical); Internal medicine; Cancer research; Cancer; Gynecology; Mutation; Biology; Genetics; Gene; Computer science; Poly ADP ribose polymerase","score_opus":0.2185593523519791,"score_gpt":0.4178131281998663,"score_spread":0.19925377584788723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700057","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9639752,0.006555479,0.00018905658,0.016109584,0.00093861454,0.0028936795,0.008795093,0.00006333656,0.0004799663],"genre_scores_gemma":[0.9973197,0.00075153686,0.00019953451,0.000895625,0.00023547481,0.00042788457,0.00005893964,0.00007618086,0.000035132598],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9908696,0.002591227,0.004237433,0.0010950983,0.00016184668,0.0010448013],"domain_scores_gemma":[0.9945754,0.0027309996,0.0015123697,0.00043852007,0.00018701154,0.0005557322],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.017213173,0.00037561476,0.0018884301,0.0018578328,0.00022878501,0.00008624298,0.00035421006,0.0002544901,0.00031155904],"category_scores_gemma":[0.0017868938,0.00047530496,0.00016144816,0.0010604309,0.00015213189,0.00061231235,0.00005112381,0.00085311447,0.00020446126],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009402357,0.0002149104,0.6641484,0.0030418835,0.00018497778,0.000034939323,0.02151879,0.010266667,0.00000446734,0.2994499,0.0004307459,0.0006102882],"study_design_scores_gemma":[0.0016526406,0.00019614582,0.9418919,0.0014538382,0.000006767848,0.000012248821,0.00142556,0.011798728,0.000016790631,0.04092471,0.00019069204,0.00042999227],"about_ca_topic_score_codex":0.98942417,"about_ca_topic_score_gemma":0.55791146,"teacher_disagreement_score":0.4315127,"about_ca_system_score_codex":0.011516523,"about_ca_system_score_gemma":0.0029552304,"threshold_uncertainty_score":0.99976987},"labels":[],"label_agreement":null},{"id":"W4399700058","doi":"10.1016/j.jval.2024.03.415","title":"EE116 Budget Impact Model Framework of Positron Emission Tomography Compared to Single Photon Emission Computed Tomography Myocardial Perfusion Imaging for Coronary Artery Disease Diagnosis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced X-ray and CT Imaging","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Single-photon emission computed tomography; Coronary artery disease; Positron emission tomography; Medicine; Perfusion; Myocardial perfusion imaging; Radiology; Emission computed tomography; Computed tomography; Preclinical imaging; Perfusion scanning; Nuclear medicine; Cardiology","score_opus":0.014889862366188849,"score_gpt":0.2813073021295894,"score_spread":0.26641743976340054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8031758,0.009792002,0.18415003,0.0004285634,0.00068805437,0.0010404793,0.00025738063,0.00044222662,0.00002545691],"genre_scores_gemma":[0.98334455,0.00026189894,0.015682481,0.00021477795,0.00014560364,0.00012602551,0.00012515658,0.000096904034,0.0000026094801],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99774414,0.00009593803,0.00066619064,0.0005032596,0.0003205055,0.0006699389],"domain_scores_gemma":[0.9985318,0.00040708447,0.000073416835,0.00036423822,0.000057680896,0.0005657889],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00034491956,0.00037299958,0.00052349747,0.0007271942,0.00015199749,0.00006244985,0.00020238904,0.000090098874,0.0000074128097],"category_scores_gemma":[0.000047636495,0.00036617758,0.0003669953,0.0009634079,0.000039136117,0.00028474908,0.00007095547,0.00037380843,0.0000015300934],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037625685,0.0002283835,0.049674235,0.0014361666,0.000044544697,0.000023888339,0.0015713038,0.9142205,0.014781856,0.000047347126,0.0017813644,0.01581412],"study_design_scores_gemma":[0.0004518406,0.00016858696,0.010757414,0.004351975,0.000032551838,0.0000067327287,0.000096223586,0.977047,0.0033266295,0.0031169602,0.00026701746,0.0003770247],"about_ca_topic_score_codex":0.000106367115,"about_ca_topic_score_gemma":0.0000016235244,"teacher_disagreement_score":0.18016873,"about_ca_system_score_codex":0.00033741575,"about_ca_system_score_gemma":0.00012911715,"threshold_uncertainty_score":0.999879},"labels":[],"label_agreement":null},{"id":"W4399700099","doi":"10.1016/j.jval.2024.03.481","title":"EE182 Mepolizumab Impact on Healthcare Resource Utilization and Work Productivity in Patients with Severe Asthma: REALITI-A 2-Year Analysis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Saskatchewan","funders":"","keywords":"Work productivity; Mepolizumab; Productivity; Work (physics); Asthma; Resource (disambiguation); Health care; Business; Medicine; Economics; Computer science; Economic growth; Engineering; Internal medicine; Eosinophil","score_opus":0.06175518250044026,"score_gpt":0.4184292006471413,"score_spread":0.356674018146701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98137236,0.0029174816,0.00001558953,0.011484362,0.0003425267,0.0027879756,0.0002560821,0.0002063192,0.00061727915],"genre_scores_gemma":[0.9978662,0.00027075657,0.00022485704,0.0008766076,0.00018105198,0.000100455574,0.00026407343,0.000064883185,0.00015109444],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99256855,0.0032627077,0.001135777,0.0010247615,0.0007351266,0.0012730878],"domain_scores_gemma":[0.99754834,0.0007749888,0.00031184067,0.0006767934,0.00019201396,0.00049603166],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027731457,0.000365614,0.00084820634,0.0011114428,0.00039583995,0.000030747808,0.00015266892,0.0002968142,0.000047176312],"category_scores_gemma":[0.00035122517,0.00029061342,0.000075925294,0.004768578,0.00006426309,0.00021040424,0.00009022763,0.0013309406,0.000056664558],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010104029,0.00017522008,0.975165,0.0025684168,0.00005652398,0.000015666135,0.006448283,0.0034625747,2.4296474e-8,0.0020566282,0.0034439154,0.0055973637],"study_design_scores_gemma":[0.0010875189,0.00090678997,0.98585844,0.0038470514,0.00002173839,0.000001353422,0.00093598873,0.0007370223,2.2685721e-7,0.00042649344,0.0059380564,0.00023932748],"about_ca_topic_score_codex":0.05178246,"about_ca_topic_score_gemma":0.0076503977,"teacher_disagreement_score":0.04413206,"about_ca_system_score_codex":0.0032645403,"about_ca_system_score_gemma":0.0016091478,"threshold_uncertainty_score":0.9999546},"labels":[],"label_agreement":null},{"id":"W4399700156","doi":"10.1016/j.jval.2024.03.374","title":"EE74 Economic Burden and Healthcare Resource Utilization in Patients with Systemic Lupus Erythematosus (SLE): A Systematic Literature Review (SLR)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Systematic review; Health care; Intensive care medicine; Resource use; Healthcare system; MEDLINE; Natural resource economics; Economics; Economic growth; Political science","score_opus":0.02971455548070498,"score_gpt":0.31341779392093755,"score_spread":0.2837032384402326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700156","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.38284633,0.60447836,0.000015165356,0.0042043817,0.0003756629,0.0078020124,0.00003975438,0.00012644344,0.00011191064],"genre_scores_gemma":[0.9175353,0.08005166,0.00014466017,0.00051859446,0.00021312672,0.00055436,0.00015071331,0.00014474544,0.00068683445],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99502957,0.001195743,0.0016482798,0.0007902456,0.0006530524,0.0006831071],"domain_scores_gemma":[0.9980479,0.00043655833,0.0002917279,0.00074203825,0.00012106775,0.00036069014],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002924314,0.00036159257,0.0015121493,0.0008524368,0.0000693479,0.00010290558,0.00017150339,0.0001985866,0.00001052779],"category_scores_gemma":[0.00026349525,0.0002648892,0.00007577443,0.0011085481,0.000053278294,0.00017237462,0.00007245989,0.00062873843,0.00004959409],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014432915,0.000038611266,0.12639989,0.8658976,0.00004178933,0.00016496374,0.005278211,0.00008180567,7.78482e-7,0.00075754034,0.00078361377,0.00041087295],"study_design_scores_gemma":[0.0023418649,0.00053793355,0.0006502357,0.97311825,0.000041751337,0.013960263,0.00107558,0.0074508227,7.6367365e-7,0.000047246755,0.00054554763,0.00022972285],"about_ca_topic_score_codex":0.0006005957,"about_ca_topic_score_gemma":0.00008035942,"teacher_disagreement_score":0.53468895,"about_ca_system_score_codex":0.0019070118,"about_ca_system_score_gemma":0.0009127025,"threshold_uncertainty_score":0.99998033},"labels":[],"label_agreement":null},{"id":"W4399700197","doi":"10.1016/j.jval.2024.03.473","title":"EE174 Assessing the Cost-Effectiveness of an mRNA-Based Rsv Vaccine (mRNA-1345) Amongst Canadian Adults Aged ≥60 Years","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Viral Infections and Immunology Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Messenger RNA; Virology; Medicine; Business; Biology; Genetics; Gene","score_opus":0.05510052040738759,"score_gpt":0.390559022766845,"score_spread":0.3354585023594574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700197","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9933774,0.0021057425,0.000049792387,0.002359183,0.00043118387,0.0012995937,0.000025970852,0.000051274732,0.00029984716],"genre_scores_gemma":[0.999157,0.00014921455,0.00010033917,0.00027786044,0.000085774365,0.0000874323,0.000052398,0.00003240765,0.00005754502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99757457,0.0010417965,0.0003680281,0.00029948243,0.00020838513,0.00050773844],"domain_scores_gemma":[0.9987168,0.0004825498,0.00005872974,0.0004039706,0.00009255736,0.00024539675],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026675153,0.00013245986,0.000344729,0.0005662327,0.00017650978,0.000051523017,0.00013752506,0.00012750289,0.00007089815],"category_scores_gemma":[0.0002469004,0.00010019024,0.00007554186,0.0009367386,0.00009463291,0.00014628061,0.000022615643,0.0007766709,0.000022392274],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018201832,0.0016046892,0.6411719,0.00939927,0.00047848848,0.0026483415,0.0042003165,0.013123715,0.011833585,0.0014679886,0.0019745224,0.31027704],"study_design_scores_gemma":[0.0017038054,0.0011078361,0.95461774,0.002423088,0.000018989254,0.00004672468,0.00033169062,0.036374763,0.00083439867,0.00007984864,0.0023534507,0.0001076922],"about_ca_topic_score_codex":0.5429743,"about_ca_topic_score_gemma":0.05916997,"teacher_disagreement_score":0.48380435,"about_ca_system_score_codex":0.0007057952,"about_ca_system_score_gemma":0.0024749166,"threshold_uncertainty_score":0.95799774},"labels":[],"label_agreement":null},{"id":"W4399700239","doi":"10.1016/j.jval.2024.03.575","title":"EE276 Understanding Trends in Launch Prices across Canada, EU4, UK and the US for High-Revenue Drugs","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Revenue; Business; Economics; Finance","score_opus":0.1167373823229765,"score_gpt":0.33843671197016073,"score_spread":0.22169932964718425,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700239","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9112405,0.017394742,0.00023430042,0.06444228,0.0012566044,0.0004736922,0.0022636962,0.00001510178,0.0026790807],"genre_scores_gemma":[0.9955267,0.0013034774,0.00006436507,0.0025954056,0.000115622606,0.000040298175,0.000010629651,0.000017989487,0.00032553382],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99863434,0.000028332492,0.0005671684,0.0003014156,0.000022737784,0.00044602386],"domain_scores_gemma":[0.999243,0.0004091395,0.00011510223,0.00013315008,0.0000032679716,0.00009630298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017673465,0.00010916896,0.0003450906,0.00013516824,0.0001119258,0.000107547276,0.00013428947,0.000052697556,0.000037264603],"category_scores_gemma":[0.000043984128,0.0001027862,0.000041576925,0.00031124608,0.00006438411,0.00007407739,0.00004229532,0.00020594081,0.0000060270963],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032940945,0.000011604348,0.0047270944,0.00021719343,0.000017552367,0.0000023542984,0.0025601597,0.0013336499,1.3453e-7,0.9848344,0.0031319861,0.00313097],"study_design_scores_gemma":[0.0031753061,0.000062045794,0.017274242,0.00014920798,0.000003592257,0.000004821818,0.00043585536,0.1692797,0.000004472961,0.5055474,0.30371374,0.0003496112],"about_ca_topic_score_codex":0.69774544,"about_ca_topic_score_gemma":0.40056145,"teacher_disagreement_score":0.47928697,"about_ca_system_score_codex":0.0009908266,"about_ca_system_score_gemma":0.00017184991,"threshold_uncertainty_score":0.6103768},"labels":[],"label_agreement":null},{"id":"W4399700251","doi":"10.1016/j.jval.2024.03.524","title":"EE225 Economic Modeling of Topical and Systemic Treatments for Atopic Dermatitis: A Structured Literature Review","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Atopic dermatitis; Dermatology; Medicine","score_opus":0.03160962964795953,"score_gpt":0.33052971752373433,"score_spread":0.2989200878757748,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5103912,0.48694834,0.00011395292,0.0016316804,0.00014859118,0.000666009,0.000045160377,0.000019139277,0.00003592913],"genre_scores_gemma":[0.95183337,0.046956524,0.000423061,0.0006240897,0.000039905943,0.000047780028,0.000033534525,0.000007091721,0.00003467119],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99930555,0.00006042425,0.0003371822,0.00014622606,0.000036695972,0.00011390337],"domain_scores_gemma":[0.9997154,0.00006423557,0.000034016204,0.00010823942,0.000011129654,0.00006698073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000090213965,0.00007369827,0.0003318533,0.00006369467,0.0000194608,0.0000064863634,0.000025408966,0.00005928809,0.0000050851486],"category_scores_gemma":[0.00002789095,0.000057703826,0.000052627645,0.00004801581,0.000014481954,0.00003716465,0.000007879841,0.00007151133,0.0000013172048],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016533255,0.00021427608,0.28967115,0.6260039,0.0006540971,0.0006186593,0.00582734,0.0021424764,0.000025854595,0.021925956,0.008390278,0.044360656],"study_design_scores_gemma":[0.0043989136,0.00048001736,0.054528736,0.2666679,0.0005965198,0.0059323474,0.00018545317,0.65157855,0.00004452488,0.013348033,0.0018876408,0.00035134354],"about_ca_topic_score_codex":0.00012525324,"about_ca_topic_score_gemma":0.000014632564,"teacher_disagreement_score":0.64943606,"about_ca_system_score_codex":0.000106185464,"about_ca_system_score_gemma":0.00018941099,"threshold_uncertainty_score":0.23530938},"labels":[],"label_agreement":null},{"id":"W4399700293","doi":"10.1016/j.jval.2024.03.626","title":"EE327 Public Preferences for Improving Health Equity: A Qualitative Focus Group Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Focus group; Equity (law); Qualitative research; Group (periodic table); Business; Focus (optics); Health equity; Public health; Public economics; Psychology; Public relations; Medicine; Marketing; Economics; Political science; Sociology; Nursing; Social science; Chemistry","score_opus":0.4027611082193925,"score_gpt":0.5878414974418823,"score_spread":0.18508038922248982,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.66021067,0.090357736,0.009739781,0.15834379,0.017890824,0.053628508,0.0016226601,0.0030561052,0.00514994],"genre_scores_gemma":[0.98956347,0.00038297666,0.0033815121,0.003020575,0.0007189312,0.0024232413,0.000072187286,0.00009890253,0.00033822082],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.98478866,0.0076781623,0.002698947,0.0012159273,0.00088314747,0.0027351708],"domain_scores_gemma":[0.9921261,0.005383041,0.0006861433,0.0006353461,0.0002916949,0.00087764853],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.022197478,0.00043665784,0.001128351,0.0006893248,0.0013562342,0.00010473291,0.000561626,0.0002687542,0.000097362994],"category_scores_gemma":[0.0017466674,0.0003890995,0.0001310146,0.0013954074,0.00008467869,0.00047230706,0.00043506103,0.0014911606,0.00027278005],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00031478712,0.0012825246,0.011299398,0.037402894,0.0001034254,0.000025668387,0.5746621,0.00003804717,0.000005221015,0.16365269,0.03854204,0.17267124],"study_design_scores_gemma":[0.0057163085,0.016676359,0.020508254,0.009312631,0.00004064392,0.000008124301,0.68653363,0.010321711,0.000001703996,0.12979017,0.11979449,0.0012959526],"about_ca_topic_score_codex":0.13343422,"about_ca_topic_score_gemma":0.03943212,"teacher_disagreement_score":0.3293528,"about_ca_system_score_codex":0.0043351646,"about_ca_system_score_gemma":0.008753822,"threshold_uncertainty_score":0.99994385},"labels":[],"label_agreement":null},{"id":"W4399700326","doi":"10.1016/j.jval.2024.03.202","title":"CO114 Clinical Characteristics, Diagnosis, and Impact on Employment in Patients With Obstructive Hypertrophic Cardiomyopathy: Results From a Real-World Survey in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiomyopathy and Myosin Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Hypertrophic cardiomyopathy; Medicine; Obstructive cardiomyopathy; Cardiology; Internal medicine; Cardiomyopathy; Heart failure","score_opus":0.055938082650987694,"score_gpt":0.3297976663299205,"score_spread":0.2738595836789328,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700326","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945108,0.001246207,3.9963416e-7,0.0005656425,0.0006890527,0.0009203148,0.0019976848,0.000018574723,0.00005128772],"genre_scores_gemma":[0.99594027,0.0031816901,0.000032563465,0.00026742482,0.0001620121,0.000058428486,0.00031683245,0.00003141123,0.000009340412],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99680156,0.00073301845,0.0009777177,0.00064670655,0.0004039871,0.00043699518],"domain_scores_gemma":[0.99741375,0.0018384425,0.00012957436,0.0003233608,0.00006627499,0.00022858955],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014409288,0.00025552194,0.0010742263,0.00029828094,0.000036357178,0.000019650004,0.000054299308,0.000062435014,0.0000024088154],"category_scores_gemma":[0.00057628227,0.00019202339,0.000059579696,0.00056028366,0.00006560232,0.00004624807,0.00005382409,0.00056056486,0.0000017519656],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029094357,0.00016879718,0.9853471,0.00009343708,0.00007545666,0.00041377242,0.0005913471,0.00012159224,1.10904566e-7,0.0000094717125,0.00035420322,0.009915272],"study_design_scores_gemma":[0.0035903316,0.0009781363,0.9927012,0.002049348,0.000024005369,0.0000027093095,0.00008581822,0.00017100417,0.000001092783,0.00001687949,0.00021218638,0.00016730052],"about_ca_topic_score_codex":0.9869181,"about_ca_topic_score_gemma":0.89211214,"teacher_disagreement_score":0.09480599,"about_ca_system_score_codex":0.0024621473,"about_ca_system_score_gemma":0.0017697635,"threshold_uncertainty_score":0.7830487},"labels":[],"label_agreement":null},{"id":"W4399700336","doi":"10.1016/j.jval.2024.03.247","title":"CO160 Relationship between Loss of Ambulation (LoA), Disease Burden, and Physical Functioning Among Boys with Duchenne Muscular Dystrophy (DMD)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Duchenne muscular dystrophy; Medicine; Disease; Physical therapy; Physical medicine and rehabilitation; Internal medicine","score_opus":0.018578472915209403,"score_gpt":0.2698509861516758,"score_spread":0.2512725132364664,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700336","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963215,0.0014375085,0.0014889279,0.00044336452,0.00005066232,0.00019493439,0.00001752962,0.000014920783,0.000030646162],"genre_scores_gemma":[0.9993272,0.000049770824,0.000116060495,0.000024693412,0.00025531303,0.000016503487,0.00016511812,0.000015499683,0.000029887919],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909765,0.00014684016,0.00019399828,0.0003020595,0.000090457055,0.00016901562],"domain_scores_gemma":[0.99955916,0.00007488033,0.00006377376,0.00017308272,0.00002561443,0.00010347431],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019318535,0.000106552776,0.00014923753,0.000066227934,0.00007780638,0.000011611843,0.000044300923,0.00007076185,0.0000023359296],"category_scores_gemma":[0.00007740446,0.000096129,0.00004228105,0.00015343785,0.00013534645,0.000010561249,0.000027506714,0.00013587036,0.0000015536305],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002722625,0.00005184811,0.96247613,0.0008084741,0.000055989083,0.0000062143836,0.0004565501,0.030175736,0.0018531242,0.002558563,0.000063561776,0.0012215342],"study_design_scores_gemma":[0.00043362676,0.00039841075,0.9903976,0.00017019185,0.000028309527,0.000001235415,0.00008454132,0.0055642473,0.00016273074,0.0023493255,0.00028192851,0.00012786314],"about_ca_topic_score_codex":0.00055022165,"about_ca_topic_score_gemma":0.000016584547,"teacher_disagreement_score":0.027921448,"about_ca_system_score_codex":0.000017416849,"about_ca_system_score_gemma":0.00013546657,"threshold_uncertainty_score":0.39200267},"labels":[],"label_agreement":null},{"id":"W4399700346","doi":"10.1016/j.jval.2024.03.213","title":"CO125 Disease Burden of Epithelial Ovarian Cancer in Chinese Patients Under Current Care: A Model Simulation Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Medicine; Ovarian cancer; Disease; Current (fluid); Epithelial ovarian cancer; Oncology; Internal medicine; Cancer; Engineering","score_opus":0.044646887089065446,"score_gpt":0.38984965393459586,"score_spread":0.3452027668455304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700346","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98606527,0.009146445,0.00011909442,0.0020790705,0.00053073006,0.0017740651,0.000244617,0.000022162547,0.000018519531],"genre_scores_gemma":[0.9989052,0.00057154795,0.000044509994,0.00007191708,0.00014363021,0.00018712199,0.00004115513,0.000022836612,0.000012073235],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99858683,0.00010693799,0.0004569433,0.00032751207,0.00031455242,0.00020723054],"domain_scores_gemma":[0.9994291,0.00007314809,0.00006656261,0.00021351587,0.000057946432,0.000159747],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017515733,0.00014172494,0.00031670096,0.00022125008,0.000023235463,0.000010289358,0.000042545602,0.000029103638,0.000024645797],"category_scores_gemma":[0.00003164474,0.00011100081,0.000055984987,0.00037529288,0.000014123475,0.000054410106,0.000025264495,0.00014813371,0.0000034433608],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016193966,0.0010630662,0.38981494,0.0006876279,0.00002290447,0.000010756732,0.0050758645,0.5870853,4.2046892e-7,0.000117290816,0.00001139238,0.015948521],"study_design_scores_gemma":[0.0029734427,0.00027824347,0.528721,0.0010255802,0.000040398794,6.1977204e-8,0.00012680475,0.46639842,5.068554e-7,0.00031440606,0.000058943515,0.000062259045],"about_ca_topic_score_codex":0.014503193,"about_ca_topic_score_gemma":0.0005245657,"teacher_disagreement_score":0.13890602,"about_ca_system_score_codex":0.0010859639,"about_ca_system_score_gemma":0.0010915409,"threshold_uncertainty_score":0.9920593},"labels":[],"label_agreement":null},{"id":"W4399700370","doi":"10.1016/j.jval.2024.03.666","title":"EE369 Healthcare Resource Utilization Among Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Vaso-occlusive crisis; Occlusive; Disease; Intensive care medicine; Health care; Internal medicine; Sickle cell anemia; Economic growth; Economics","score_opus":0.017313884699478733,"score_gpt":0.252610551551214,"score_spread":0.23529666685173525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700370","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98268,0.010064789,0.000022255992,0.005246126,0.00020364247,0.0013455705,0.000070871625,0.000049176433,0.00031753513],"genre_scores_gemma":[0.9976424,0.00087346893,0.000055620232,0.0010363873,0.000030040437,0.00003410482,0.0002057062,0.00004394217,0.00007830695],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797446,0.00018593452,0.00042756682,0.00042829826,0.0004917837,0.00049198396],"domain_scores_gemma":[0.9990217,0.0000809437,0.00009509018,0.00024511133,0.000075019496,0.0004821307],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018330953,0.00019935917,0.00030734658,0.00021129499,0.000085565385,0.000016173051,0.00006442714,0.000060901177,0.000021492588],"category_scores_gemma":[0.000040504652,0.00014346394,0.000024878245,0.0008061286,0.00004794574,0.00007098858,0.000025040967,0.0004695676,0.0000029913108],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006634754,0.0002894536,0.9729812,0.0039620423,0.000013951562,0.00033583335,0.0022558798,0.011049885,1.6910585e-7,0.00008368045,0.0021475337,0.006216884],"study_design_scores_gemma":[0.0039489362,0.0015433626,0.9389725,0.011273347,0.00005612339,0.00000616368,0.0046661478,0.026991678,0.000007908329,0.000060349816,0.012070409,0.0004030874],"about_ca_topic_score_codex":0.810143,"about_ca_topic_score_gemma":0.60433364,"teacher_disagreement_score":0.20580938,"about_ca_system_score_codex":0.0015867922,"about_ca_system_score_gemma":0.0061780377,"threshold_uncertainty_score":0.999456},"labels":[],"label_agreement":null},{"id":"W4399700374","doi":"10.1016/j.jval.2024.03.832","title":"EPH3 Potential Public Health Impact of Bivalent Respiratory Syncytial Virus Stabilized Prefusion F Subunit Vaccine (RSVpreF) Among Older Adults in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Bivalent (engine); Virology; Protein subunit; Virus; Respiratory system; Medicine; Biology; Chemistry; Genetics; Internal medicine; Gene","score_opus":0.0641322713054791,"score_gpt":0.3746595154767892,"score_spread":0.3105272441713101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700374","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887644,0.006230825,0.000050038776,0.0015807704,0.0005053733,0.0026070606,0.000106741136,0.00007922137,0.00007557415],"genre_scores_gemma":[0.99841946,0.00071529264,0.000036675352,0.00038548058,0.00018637047,0.00010577232,0.000036494603,0.00007628009,0.000038156417],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99332064,0.0017132307,0.0018395022,0.00074336556,0.0011395883,0.0012436861],"domain_scores_gemma":[0.9976089,0.0002598166,0.00027896537,0.0007508701,0.00022450082,0.00087695714],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0034671964,0.0003467022,0.0009752282,0.0017282197,0.00011827494,0.00004521906,0.00023512328,0.00016325155,0.0006543997],"category_scores_gemma":[0.0005022069,0.0002936521,0.0001929454,0.0023090008,0.000074686475,0.00031056762,0.00014247624,0.0012088912,0.000013785261],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0017388446,0.0015328069,0.92757785,0.009216961,0.00014146198,0.0005555928,0.0019542146,0.007751768,0.0032033673,0.000090811336,0.0034630862,0.042773236],"study_design_scores_gemma":[0.004576842,0.0026335816,0.96992743,0.0026340592,0.0000088774095,0.000028898545,0.00028019064,0.018240081,0.0004224678,0.000020514353,0.0009807447,0.0002463165],"about_ca_topic_score_codex":0.9752088,"about_ca_topic_score_gemma":0.8549724,"teacher_disagreement_score":0.12023639,"about_ca_system_score_codex":0.0108691575,"about_ca_system_score_gemma":0.032568216,"threshold_uncertainty_score":0.99995154},"labels":[],"label_agreement":null},{"id":"W4399700417","doi":"10.1016/j.jval.2024.03.200","title":"CO112 A Systematic Literature Review (SLR) and Network Meta-Analysis (NMA) of Ruxolitinib Cream 1.5% Vs Other Pharmacologic Agents in the Treatment of Atopic Dermatitis (AD)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Probity Medical Research; University of British Columbia; EVERSANA (Canada); SKiN Health","funders":"","keywords":"Ruxolitinib; Atopic dermatitis; Medicine; Meta-analysis; Dermatology; Systematic review; Internal medicine; MEDLINE; Chemistry; Myelofibrosis","score_opus":0.12135399332976005,"score_gpt":0.4014528283245953,"score_spread":0.28009883499483523,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700417","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.061589375,0.9310955,0.000008158788,0.0051866146,0.00006177493,0.001803718,0.000060244296,0.0000135632445,0.00018107556],"genre_scores_gemma":[0.82393485,0.17017972,0.00011262514,0.0053526713,0.000021118654,0.00025970032,0.000024653991,0.000008595278,0.00010608275],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9970662,0.0014388167,0.00088962785,0.0002032578,0.00019205306,0.00021003705],"domain_scores_gemma":[0.9986811,0.00071783183,0.00021052732,0.00028730114,0.000031128973,0.00007207342],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008900235,0.00015581689,0.0017938865,0.00019409049,0.00002598753,0.000009982218,0.00008015156,0.00006644471,0.00015032664],"category_scores_gemma":[0.00006655585,0.00008328116,0.00043082298,0.0009907932,0.00005662052,0.000034416327,0.00000960864,0.00011144949,0.000003461911],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006926462,0.0021397732,0.06531367,0.86816674,0.037039712,0.0011667752,0.009227133,0.000512557,0.0000010330276,0.0015816914,0.014392458,0.00038921242],"study_design_scores_gemma":[0.006243721,0.0032756731,0.22934169,0.2670324,0.4424142,0.0016186137,0.0011088894,0.02138804,0.00005850735,0.0035610707,0.023157889,0.0007992998],"about_ca_topic_score_codex":0.0001721721,"about_ca_topic_score_gemma":0.000028933538,"teacher_disagreement_score":0.76234543,"about_ca_system_score_codex":0.000052205,"about_ca_system_score_gemma":0.00010269271,"threshold_uncertainty_score":0.3396107},"labels":[],"label_agreement":null},{"id":"W4399700445","doi":"10.1016/j.jval.2024.03.268","title":"CO182 Intelligence Quotient (IQ) Scores Among Early-Treated Phenylketonuria (PKU) Patients: Results from a Systematic Literature Review (SLR)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Metabolism and Genetic Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Intelligence quotient; Quotient; Pediatrics; Medicine; Psychiatry; Cognition; Mathematics","score_opus":0.012969849902688695,"score_gpt":0.26631071328015166,"score_spread":0.253340863377463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700445","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5033476,0.49347553,0.00016078944,0.00028545648,0.00068652316,0.0014651326,0.00033337183,0.000033939887,0.0002116987],"genre_scores_gemma":[0.82860255,0.16854353,0.0003181738,0.0008005377,0.00015833927,0.000118901604,0.0010797546,0.0000426344,0.00033556047],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99693376,0.00057972304,0.0010688961,0.00072466856,0.00029360963,0.00039934675],"domain_scores_gemma":[0.99874943,0.000082372215,0.00021425069,0.0006695835,0.00011070557,0.0001736335],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008081829,0.0002825169,0.0005081912,0.00011419952,0.000056693447,0.00009364016,0.0003005878,0.00016008037,0.000014953156],"category_scores_gemma":[0.0005405767,0.0002277608,0.00012169656,0.00052079203,0.00006507936,0.000010496333,0.00009151242,0.00020903414,0.00003939025],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013332461,0.0022571771,0.10965906,0.7390626,0.0011357958,0.00019937145,0.019660922,0.003280208,0.0015096072,0.0032596954,0.07831193,0.04033036],"study_design_scores_gemma":[0.003117881,0.0021626868,0.07246101,0.88521105,0.00036763406,0.000017343673,0.0005131068,0.0043940954,0.0049797054,0.002030213,0.022537917,0.0022073444],"about_ca_topic_score_codex":0.0017444367,"about_ca_topic_score_gemma":0.00011995689,"teacher_disagreement_score":0.325255,"about_ca_system_score_codex":0.000025238573,"about_ca_system_score_gemma":0.00015990935,"threshold_uncertainty_score":0.92878157},"labels":[],"label_agreement":null},{"id":"W4399700451","doi":"10.1016/j.jval.2024.03.171","title":"CO83 Screening Articles in a Qualitative Literature Review Using Large Language Models: A Comparison of GPT Versus Open Source, Trained Models Against Expert Researcher Screening","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Computer science; Open source; Medical physics; Data science; Natural language processing; Psychology; Medicine; Programming language; Software","score_opus":0.6808479755722152,"score_gpt":0.6032836486369278,"score_spread":0.07756432693528736,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700451","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5858857,0.35367617,0.04585645,0.010969698,0.00021113253,0.0028496387,0.00005439269,0.00008032682,0.0004164653],"genre_scores_gemma":[0.97144735,0.008807012,0.01810748,0.0012290453,0.00013063008,0.0000825497,0.0000947945,0.000045445413,0.000055674096],"study_design_codex":"qualitative","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99601555,0.0012351136,0.0012426411,0.00044203154,0.00046481218,0.0005998546],"domain_scores_gemma":[0.9981881,0.00091688446,0.000168155,0.00032038987,0.0001772052,0.00022928175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00545141,0.00018340701,0.0007047593,0.00048008937,0.00010473833,0.00007347523,0.00020313132,0.00013395837,0.00002420084],"category_scores_gemma":[0.0007057989,0.00016853475,0.000088395645,0.0016247345,0.000061931816,0.0004942714,0.000099270976,0.00075076474,0.0000025828838],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011694683,0.00045349036,0.0003505478,0.009577512,0.000050191302,0.00006312478,0.7739561,0.050038535,0.00026612214,0.0027489658,0.00085655716,0.16046935],"study_design_scores_gemma":[0.0003173433,0.00026778466,0.000016968383,0.049413197,0.000009418455,0.0000043964615,0.1059493,0.8425442,0.00019344673,0.00092509534,0.00023454613,0.00012429556],"about_ca_topic_score_codex":0.026499087,"about_ca_topic_score_gemma":0.00085618906,"teacher_disagreement_score":0.7925057,"about_ca_system_score_codex":0.00036356415,"about_ca_system_score_gemma":0.0007907895,"threshold_uncertainty_score":0.97998357},"labels":[],"label_agreement":null},{"id":"W4399700467","doi":"10.1016/j.jval.2024.03.183","title":"CO95 Growing Acceptance of Minimal Residual Disease (MRD) As a Primary Endpoint in Multiple Myeloma (MM) Clinical Trials","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Middlesex London Health Unit","funders":"","keywords":"Minimal residual disease; Multiple myeloma; Medicine; Clinical endpoint; Residual; Oncology; Primary (astronomy); Clinical trial; Internal medicine; Mathematics; Algorithm; Bone marrow","score_opus":0.23198385353040846,"score_gpt":0.47397725614956016,"score_spread":0.2419934026191517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700467","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98150206,0.010163212,0.000022920687,0.005394757,0.00036853776,0.0019875094,0.0001652344,0.000064912754,0.0003308356],"genre_scores_gemma":[0.99464226,0.0016915228,0.0022354247,0.00056776014,0.00036890467,0.00012756378,0.000115703275,0.0000427398,0.00020811592],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9934932,0.0022138024,0.0021931278,0.0006622203,0.0007427568,0.0006949014],"domain_scores_gemma":[0.99375457,0.0047651273,0.00021120776,0.0004603891,0.000051452203,0.0007572436],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0082957465,0.00023236059,0.0012379906,0.0004879812,0.000048497175,0.00002707706,0.00015758358,0.00013354149,0.00014273968],"category_scores_gemma":[0.00951879,0.00019009212,0.00029287493,0.0005611054,0.00014404826,0.00018381815,0.0001111934,0.000637242,0.0000669976],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017215066,0.0023674709,0.7745917,0.006070623,0.000248112,0.005650208,0.001204858,0.0001426215,0.0007144957,0.0010626273,0.0015978777,0.18913436],"study_design_scores_gemma":[0.009219126,0.0012468742,0.9735578,0.0030484048,0.00004208566,0.000022837592,0.00021527761,0.0098685855,0.00037398885,0.00054138945,0.0016952488,0.00016843133],"about_ca_topic_score_codex":0.0030082376,"about_ca_topic_score_gemma":0.00012681725,"teacher_disagreement_score":0.19896607,"about_ca_system_score_codex":0.00054529175,"about_ca_system_score_gemma":0.0030171112,"threshold_uncertainty_score":0.9988245},"labels":[],"label_agreement":null},{"id":"W4399700479","doi":"10.1016/j.jval.2024.03.691","title":"EE395 Cost-Effectiveness Analysis of Nivolumab Plus Relatlimab (NIVO+RELA) Versus Current Standard of Care (SOC) for Patients with Unresectable or Metastatic Melanoma in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Nivolumab; Medicine; Metastatic melanoma; Oncology; Internal medicine; Standard of care; Cancer; Immunotherapy","score_opus":0.2754352336219331,"score_gpt":0.4260363249080076,"score_spread":0.15060109128607446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97080415,0.014921803,0.002280698,0.000861303,0.0010988893,0.0036569072,0.006271006,0.000015335676,0.00008992365],"genre_scores_gemma":[0.99790025,0.0003156506,0.0010529059,0.000073174255,0.00002112828,0.00035420607,0.00023437191,0.00003842992,0.000009868811],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9944076,0.0007158084,0.0035128575,0.00060107774,0.00024239639,0.00052027265],"domain_scores_gemma":[0.9938067,0.0043320954,0.0011278518,0.0004149432,0.00016620879,0.00015220768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0078225555,0.00021472799,0.002068229,0.0011667557,0.000068946865,0.000024765755,0.00022383907,0.00006334442,0.00006104142],"category_scores_gemma":[0.0015176135,0.0002258619,0.00013445957,0.0015807024,0.00004322202,0.00022327348,0.00003679803,0.00022304161,0.0000046867976],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0046916683,0.00026434305,0.65707767,0.024088373,0.001216249,0.0000049579617,0.0068173916,0.27888164,7.43427e-8,0.02350931,0.0008199411,0.0026283856],"study_design_scores_gemma":[0.031220017,0.007304516,0.404695,0.0062631057,0.00048145204,0.0000010461561,0.011164174,0.5157817,0.000012512067,0.0018473421,0.019951195,0.0012779012],"about_ca_topic_score_codex":0.7896317,"about_ca_topic_score_gemma":0.8020969,"teacher_disagreement_score":0.25238267,"about_ca_system_score_codex":0.011145111,"about_ca_system_score_gemma":0.0074110753,"threshold_uncertainty_score":0.998216},"labels":[],"label_agreement":null},{"id":"W4399700487","doi":"10.1016/j.jval.2024.03.154","title":"CO66 Optimizing GPT-4 Prompts for Population Eligibility Screening in COA Landscape Reviews of Qualitative Studies","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Computer science","score_opus":0.24189336401062306,"score_gpt":0.48143394229360004,"score_spread":0.23954057828297698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700487","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796065,0.009385337,0.0057564205,0.0015893569,0.00014124147,0.003220126,0.000031832406,0.000035597244,0.00023359091],"genre_scores_gemma":[0.9685691,0.0033078801,0.02753996,0.0002698878,0.000028406306,0.00021359927,0.0000224139,0.000020891985,0.00002784871],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99651086,0.0012257252,0.001007946,0.0005911663,0.00025606027,0.00040825648],"domain_scores_gemma":[0.99841714,0.0010589422,0.00023027809,0.00020723548,0.000007066844,0.00007931536],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010183,0.00015417697,0.0004942397,0.00012368157,0.000084542065,0.000010859566,0.000097635966,0.00005287769,0.00004465949],"category_scores_gemma":[0.0008635657,0.00014267044,0.00005924456,0.00044213867,0.000089305424,0.00023950834,0.00008718742,0.0002202926,0.000019066365],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018651897,0.0004101618,0.4459072,0.011076553,0.000048951708,0.0000135244045,0.18155129,0.14015414,0.00053626613,0.0011260908,0.000979419,0.21800987],"study_design_scores_gemma":[0.0027752903,0.0011135135,0.56022006,0.0131743485,0.000042284864,0.0000077226005,0.029925307,0.3607306,0.00046724445,0.017312154,0.013105579,0.0011259147],"about_ca_topic_score_codex":0.0063257194,"about_ca_topic_score_gemma":0.0007863459,"teacher_disagreement_score":0.22057647,"about_ca_system_score_codex":0.00052895484,"about_ca_system_score_gemma":0.000040885257,"threshold_uncertainty_score":0.9562638},"labels":[],"label_agreement":null},{"id":"W4399700840","doi":"10.1016/j.jval.2024.03.149","title":"CO61 Analysis of Healthcare Resource Utilization in the NODE-303 Clinical Trial to Terminate Paroxysmal Supraventricular Tachycardia Episodes","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Arrhythmias and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vertex Pharmaceuticals (Canada); Université de Montréal","funders":"","keywords":"Paroxysmal supraventricular tachycardia; Medicine; Supraventricular tachycardia; Node (physics); Tachycardia; Anesthesia; Engineering","score_opus":0.1269412799053382,"score_gpt":0.4387795245726505,"score_spread":0.3118382446673123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97959334,0.0039814585,0.00012887715,0.013930716,0.0003794309,0.0016806533,0.000102935395,0.000028496865,0.00017408331],"genre_scores_gemma":[0.9976218,0.00050961634,0.00021320589,0.001084836,0.0002588837,0.00007444671,0.0001856317,0.000018538183,0.00003307343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99621284,0.001372651,0.0011508578,0.00044507306,0.000460209,0.00035839554],"domain_scores_gemma":[0.998436,0.0007345387,0.00012977372,0.0004699397,0.000047658406,0.00018213526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037026873,0.00015611635,0.00090972293,0.0006975052,0.00004836572,0.000022166572,0.000084724175,0.00012868254,0.000010923572],"category_scores_gemma":[0.00037674868,0.00010957141,0.00047248742,0.002501206,0.00004101576,0.000034931967,0.000037447353,0.0003215385,0.000009375734],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0132331755,0.0019956683,0.80479836,0.0020217584,0.00190959,0.0043370477,0.009938613,0.013401252,0.0000017122082,0.005113955,0.0017922986,0.14145656],"study_design_scores_gemma":[0.02735061,0.003506639,0.8811228,0.0015432355,0.0017195891,0.00014236032,0.0015135283,0.04899852,0.000021223446,0.00029687933,0.033465736,0.0003188412],"about_ca_topic_score_codex":0.0072929263,"about_ca_topic_score_gemma":0.00027373177,"teacher_disagreement_score":0.14113772,"about_ca_system_score_codex":0.0002590633,"about_ca_system_score_gemma":0.00039639996,"threshold_uncertainty_score":0.9993176},"labels":[],"label_agreement":null},{"id":"W4399700935","doi":"10.1016/j.jval.2024.03.101","title":"CO12 A Review of Goal Attainment Scaling Implementation As a Personalized Clinical Outcome Assessment over the Last Decade","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Policy Implementation Science","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Goal Attainment Scaling; Outcome (game theory); Scaling; Medicine; Computer science; Medical physics; Physical therapy; Economics; Mathematics","score_opus":0.7904399536261281,"score_gpt":0.7891882727611013,"score_spread":0.0012516808650268052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700935","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00012660929,0.96630865,0.00010505327,0.018092474,0.0019860282,0.012434912,0.00056275545,0.000064559834,0.0003189602],"genre_scores_gemma":[0.000031627947,0.9537297,0.00093136117,0.041956343,0.00055624853,0.0023752535,0.0001383383,0.00009115942,0.00018998054],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9635219,0.020309582,0.011709314,0.0010412508,0.0018316716,0.001586267],"domain_scores_gemma":[0.9837285,0.009836039,0.0047025094,0.00095287204,0.00019894374,0.0005810981],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.04765008,0.0005974597,0.0036463116,0.00049353694,0.0006300094,0.000028880282,0.0008582523,0.00037156235,0.0015875167],"category_scores_gemma":[0.0023111145,0.00038656275,0.00077152334,0.0018852779,0.00022444561,0.00013085199,0.00049471523,0.0030602035,0.00057417434],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000064360133,0.00007473144,0.003830084,0.64369917,0.00010000092,0.000007945112,0.003256354,0.0000014670502,2.0173163e-8,0.010022653,0.03257074,0.3064304],"study_design_scores_gemma":[0.0006848346,0.00015026686,0.000993551,0.17001474,0.00026444014,0.000008308384,0.0013205427,0.00004447063,5.4597638e-9,0.000114054106,0.8261815,0.00022334105],"about_ca_topic_score_codex":0.0059119263,"about_ca_topic_score_gemma":0.00036594408,"teacher_disagreement_score":0.7936107,"about_ca_system_score_codex":0.003901749,"about_ca_system_score_gemma":0.021456812,"threshold_uncertainty_score":0.9999221},"labels":[],"label_agreement":null},{"id":"W4399700957","doi":"10.1016/j.jval.2024.03.093","title":"CO3 Prediction of Long-Term Factor IX Durability Among Hemophilia B Patients Treated with Fidanacogene Elaparvovec Gene Therapy","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Factor IX; Term (time); Medicine; Internal medicine; Gene; Oncology; Gastroenterology; Genetics; Biology; Physics","score_opus":0.0521258914473271,"score_gpt":0.3194084514015421,"score_spread":0.267282559954215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399700957","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9952378,0.0018659296,0.000009397536,0.0006109759,0.00013271983,0.0017716109,0.0001864001,0.000095871306,0.000089267174],"genre_scores_gemma":[0.99766624,0.0014344143,0.00006364088,0.000035673784,0.00009361188,0.000051757957,0.00026544408,0.000038827253,0.00035036873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99780273,0.00020775446,0.00055408693,0.00045591907,0.00055732904,0.00042219635],"domain_scores_gemma":[0.99901366,0.00012492073,0.00008528883,0.00037967862,0.00013021064,0.00026625366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035812485,0.0002145939,0.0004580792,0.00028118162,0.00006173167,0.000015546553,0.000078220044,0.00013067356,0.00013704844],"category_scores_gemma":[0.0000406452,0.00014032204,0.00009409007,0.0006047574,0.00014637306,0.000102014215,0.00001934671,0.000278268,0.000013982676],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000561056,0.0008265413,0.9836478,0.0009017091,0.00014464186,0.00007704938,0.0005475282,0.000043150263,0.0009261532,0.000004924637,0.00004856878,0.012270879],"study_design_scores_gemma":[0.002611347,0.0026430436,0.9815641,0.00071714417,0.000022692851,0.000011143938,0.000011421109,0.0013762598,0.010907933,0.000012680043,0.00003414181,0.00008807873],"about_ca_topic_score_codex":0.0017338595,"about_ca_topic_score_gemma":0.000055009175,"teacher_disagreement_score":0.012182801,"about_ca_system_score_codex":0.00053968624,"about_ca_system_score_gemma":0.0004730202,"threshold_uncertainty_score":0.57221663},"labels":[],"label_agreement":null},{"id":"W4399701034","doi":"10.1016/j.jval.2024.03.106","title":"CO17 Systematic Literature Review (SLR) of Randomized Controlled Trials (RCTs) of Immuno-Oncology (IO) for First-Line (1L) Esophageal Squamous Cell Carcinoma (ESCC) in Adult Patients","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Oncology; Internal medicine; Esophageal squamous cell carcinoma; Randomized controlled trial; Basal cell; Carcinoma; Systematic review; MEDLINE; Biology","score_opus":0.03664657047182473,"score_gpt":0.3673744158189047,"score_spread":0.33072784534707994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399701034","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09627233,0.86876893,0.000035282137,0.0019364578,0.00041266158,0.032238718,0.0002236864,0.000020751466,0.000091178146],"genre_scores_gemma":[0.9124835,0.08296612,0.00029512207,0.0003446321,0.0000858885,0.0034811024,0.00016314746,0.00003515896,0.00014532883],"study_design_codex":"systematic_review","study_design_gemma":"randomized_trial","domain_scores_codex":[0.98948467,0.0042832657,0.00468915,0.0004119552,0.0006182381,0.0005127519],"domain_scores_gemma":[0.98561066,0.0120022865,0.0012054907,0.00043143978,0.0005366711,0.0002134684],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.014306624,0.00032125018,0.009191783,0.0006014825,0.000035451638,0.000014639255,0.00015443264,0.00017960883,0.000037695096],"category_scores_gemma":[0.012616387,0.0001939775,0.00106226,0.000648024,0.00008124987,0.00005957692,0.00003509845,0.00035011434,0.0000044107037],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13478647,0.0016148139,0.0014456187,0.8577704,0.00034103284,0.00028820228,0.0018840426,0.00008341643,0.00001294967,0.0006219847,0.00048261945,0.0006684594],"study_design_scores_gemma":[0.75143737,0.008011652,0.00035281858,0.23086317,0.0011827936,0.000025741707,0.00006644386,0.007114104,0.0003862126,0.00036795367,0.000026801472,0.00016496945],"about_ca_topic_score_codex":0.0013391858,"about_ca_topic_score_gemma":0.000086922286,"teacher_disagreement_score":0.81621116,"about_ca_system_score_codex":0.00082346203,"about_ca_system_score_gemma":0.0013912434,"threshold_uncertainty_score":0.9957008},"labels":[],"label_agreement":null},{"id":"W4399701061","doi":"10.1016/j.jval.2024.03.034","title":"P8 Projections of Costs and Prevalence of Opioid Drug Prescriptions in the U.S. from 2025 - 2050","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dillon Consulting","funders":"","keywords":"Medical prescription; Drug; Opioid; Medicine; Prescription drug; Psychiatry; Pharmacology; Internal medicine","score_opus":0.03280515905273208,"score_gpt":0.3281673315761785,"score_spread":0.29536217252344643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399701061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9538654,0.039822053,0.000007857102,0.0041270265,0.0001976312,0.0012857876,0.00012275207,0.000017343771,0.0005541502],"genre_scores_gemma":[0.990772,0.008091669,0.0006105601,0.000099716766,0.000027375958,0.000108437926,0.00002518544,0.0000076180986,0.0002574469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896485,0.0001663013,0.00036310556,0.00019864568,0.00017216855,0.00013496008],"domain_scores_gemma":[0.99940026,0.0002381982,0.000051332674,0.0002507086,0.000022550028,0.00003693806],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000358285,0.000077798795,0.00019285058,0.00017728751,0.000023690205,0.000006628158,0.000054047276,0.000031338477,0.000030327878],"category_scores_gemma":[0.0000676018,0.000055645312,0.000031007705,0.0003790716,0.00005447008,0.000047976795,0.000021223812,0.00016938585,0.0000033155688],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014180134,0.002685787,0.8463585,0.018018996,0.0001259539,0.000050168077,0.10524217,0.0004326994,0.0007179328,0.006483193,0.008142047,0.0116007645],"study_design_scores_gemma":[0.00083997194,0.00042933592,0.9809662,0.0050298646,0.00007841614,0.000011543159,0.0034315693,0.003958523,0.00020779403,0.0019252071,0.003043492,0.000078046345],"about_ca_topic_score_codex":0.05583658,"about_ca_topic_score_gemma":0.0005545885,"teacher_disagreement_score":0.13460775,"about_ca_system_score_codex":0.00013732816,"about_ca_system_score_gemma":0.00041179816,"threshold_uncertainty_score":0.95045066},"labels":[],"label_agreement":null},{"id":"W4399701066","doi":"10.1016/j.jval.2024.03.052","title":"P26 Analyzing Drug Shortages and Pricing: Lessons from Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Economic shortage; Drug pricing; Business; Drug; Actuarial science; Medicine; Pharmacology","score_opus":0.09840679164151186,"score_gpt":0.32820577453091004,"score_spread":0.22979898288939818,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399701066","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8988318,0.046068862,0.00011488501,0.049234416,0.000772877,0.00015374426,0.00059614494,0.000031093234,0.004196216],"genre_scores_gemma":[0.9932118,0.0038447168,0.00017079379,0.002447861,0.00015557389,0.000006214181,0.000012215901,0.000018602344,0.00013218763],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9987361,0.000022611343,0.00053399743,0.00036538922,0.000015996726,0.00032590594],"domain_scores_gemma":[0.9993737,0.00021364751,0.000079112106,0.00014670509,0.0000033030549,0.0001835488],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056899106,0.000106475825,0.00031146593,0.00017697948,0.00006406534,0.00008822783,0.00010459487,0.000035080397,0.00009799891],"category_scores_gemma":[0.00004083317,0.00012615682,0.000031830365,0.00019326655,0.000021493275,0.000092780545,0.000044041684,0.00022867211,0.00003305702],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000067092233,0.000036332138,0.15289794,0.00036149423,0.00007956654,0.000032956268,0.0018699573,0.0036147148,0.000006361792,0.81619835,0.01073899,0.014156613],"study_design_scores_gemma":[0.0003512455,0.000022329765,0.06026569,0.00018324825,0.0000053607523,0.0000037345537,0.00011747653,0.31027272,0.000037116948,0.12971945,0.4985916,0.0004300427],"about_ca_topic_score_codex":0.91504616,"about_ca_topic_score_gemma":0.28404453,"teacher_disagreement_score":0.6864789,"about_ca_system_score_codex":0.00041088345,"about_ca_system_score_gemma":0.00028876006,"threshold_uncertainty_score":0.7290198},"labels":[],"label_agreement":null},{"id":"W4399706167","doi":"10.1016/j.jval.2024.03.2436","title":"PT22 Consistency Between Comparative Efficacy Estimates from Target Trial Emulations and Their Origin Target Trials: A Meta-Epidemiological Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Cascades (Canada); University of Toronto; McMaster University","funders":"","keywords":"Consistency (knowledge bases); Epidemiology; Meta-analysis; Medicine; Computer science; Artificial intelligence; Internal medicine","score_opus":0.8587779294536831,"score_gpt":0.5553820052404167,"score_spread":0.30339592421326644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.895419,0.05088916,0.008739827,0.03279048,0.0014644269,0.006842552,0.0033174318,0.00021426592,0.0003228446],"genre_scores_gemma":[0.98237634,0.00021062329,0.014163466,0.0015312701,0.0008761144,0.0005252817,0.00023298764,0.00003711964,0.00004678574],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.980971,0.007441257,0.009615462,0.0012237977,0.00012071989,0.0006277608],"domain_scores_gemma":[0.9430918,0.0535888,0.0023258235,0.0005660908,0.000045939687,0.0003815511],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07689719,0.00045948406,0.0059252903,0.00056109397,0.00032681212,0.00018183723,0.00027372432,0.00021394233,0.00056017796],"category_scores_gemma":[0.017929804,0.00039092588,0.00042316903,0.0004511617,0.00014035654,0.00036122825,0.000081132224,0.00054106215,0.0003754278],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020985182,0.0030180505,0.55668366,0.0014897777,0.008946856,0.000017146514,0.07890541,0.043765772,0.0000014462406,0.27696255,0.027427321,0.0006834951],"study_design_scores_gemma":[0.0277661,0.0024872741,0.15934792,0.00044425082,0.00031553768,0.0000043453,0.007610914,0.31410107,0.0000026650148,0.4365639,0.050061826,0.0012942067],"about_ca_topic_score_codex":0.014017604,"about_ca_topic_score_gemma":0.00014861539,"teacher_disagreement_score":0.39733574,"about_ca_system_score_codex":0.0005914538,"about_ca_system_score_gemma":0.0005807551,"threshold_uncertainty_score":0.99985427},"labels":[{"model":"gemma","categories":["metaresearch","metaepi_broad","metaepi_narrow"],"domain":"methods","study_design":"meta_analysis","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch","metaepi_broad"],"domain":"methods","study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"medium"}],"label_agreement":"split"},{"id":"W4399706189","doi":"10.1016/j.jval.2024.03.2360","title":"HPR129 Real-World Policy Effects of Implementing Multi-Gene Panel Sequencing for Advanced Cancers in British Columbia, Canada: An Interrupted Time Series Analysis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; BC Cancer Agency; Canada's Michael Smith Genome Sciences Centre","funders":"","keywords":"Interrupted time series; Series (stratigraphy); Interrupted Time Series Analysis; Time series; Computational biology; Oncology; Medicine; Computer science; Biology; Statistics; Machine learning; Mathematics; Nursing","score_opus":0.23996804968621555,"score_gpt":0.41967433279083527,"score_spread":0.17970628310461972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897055,0.0025560784,0.0008072668,0.003300705,0.00039894495,0.0016673796,0.0014241218,0.000049055372,0.00009093816],"genre_scores_gemma":[0.9893814,0.0004373862,0.007124027,0.0015759344,0.00016337252,0.0003196471,0.00020946459,0.000052664738,0.0007361038],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9936727,0.00047603922,0.004255144,0.0007066443,0.00009931767,0.00079013477],"domain_scores_gemma":[0.99696404,0.0011278345,0.0012768998,0.00036014267,0.00005635777,0.00021470568],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010183523,0.0001605397,0.0014209239,0.0009919703,0.00014481154,0.00010283798,0.00022457543,0.00007660409,0.000056724264],"category_scores_gemma":[0.0015793827,0.00031062172,0.00012611129,0.0016413996,0.000038879374,0.0004480034,0.00004550237,0.00018231958,0.0000057698385],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003613238,0.00013821258,0.8620803,0.016120842,0.00070272316,0.000032436536,0.012179421,0.095477186,0.00009314869,0.00523019,0.0022904545,0.005618997],"study_design_scores_gemma":[0.0022243708,0.00031879786,0.42333642,0.0021562718,0.000041031355,0.000006513657,0.0031944937,0.5614169,0.000050184495,0.0022473533,0.004258899,0.0007487598],"about_ca_topic_score_codex":0.9983705,"about_ca_topic_score_gemma":0.99870884,"teacher_disagreement_score":0.46593973,"about_ca_system_score_codex":0.011972345,"about_ca_system_score_gemma":0.0055417353,"threshold_uncertainty_score":0.9999346},"labels":[],"label_agreement":null},{"id":"W4399706319","doi":"10.1016/j.jval.2024.03.2419","title":"MSR104 Use of Stochastic Search Variable Selection for Dimension Reduction in Large NMAs","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Neural Networks and Applications","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Reduction (mathematics); Selection (genetic algorithm); Dimensionality reduction; Dimension (graph theory); Variable (mathematics); Feature selection; Mathematics; Computer science; Mathematical optimization; Artificial intelligence; Combinatorics","score_opus":0.07256519078660467,"score_gpt":0.3319942968801131,"score_spread":0.25942910609350844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706319","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10748875,0.00027951552,0.8896873,0.0015908262,0.00031848415,0.00056933356,0.000005266428,0.000055875647,0.000004657822],"genre_scores_gemma":[0.95900494,0.000030302439,0.040695406,0.000055224507,0.00006741298,0.000060044807,0.0000050655153,0.0000073877322,0.000074237825],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9990731,0.00008216401,0.00024863068,0.00025383823,0.00010887816,0.00023341738],"domain_scores_gemma":[0.9995474,0.00020326539,0.000033354216,0.0001419701,0.000033760687,0.000040247458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006751784,0.000052878073,0.00010123876,0.00017823264,0.00005915013,0.00003988971,0.00009205266,0.000035226174,0.0000018714529],"category_scores_gemma":[0.000019476247,0.00005151244,0.000018976953,0.0011063322,0.000007926761,0.00022797195,0.00003667258,0.00013886354,0.0000025422346],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009478573,0.00010141081,0.000115812385,0.00019700687,0.0000021842127,3.141485e-7,0.0004093527,0.6060579,0.0022362617,0.38293788,0.0007508159,0.0071816063],"study_design_scores_gemma":[0.000105795436,0.000082805054,0.0002762431,0.00018677396,7.5339716e-7,0.0000067792907,0.000007641049,0.9883111,0.00022718772,0.010049692,0.0007023116,0.000042906322],"about_ca_topic_score_codex":0.0017520909,"about_ca_topic_score_gemma":0.000031537835,"teacher_disagreement_score":0.8515162,"about_ca_system_score_codex":0.00012699665,"about_ca_system_score_gemma":0.00018357689,"threshold_uncertainty_score":0.2648649},"labels":[],"label_agreement":null},{"id":"W4399706325","doi":"10.1016/j.jval.2024.03.2422","title":"MT48 Assessment of a Patient-Centric Web Application Tool for Potential Adverse Events of Oral Corticosteroids","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Adverse effect; Web application; Medicine; Intensive care medicine; Computer science; World Wide Web; Pharmacology","score_opus":0.025073692238496686,"score_gpt":0.34496624451340396,"score_spread":0.31989255227490726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96455455,0.0032725427,0.027720379,0.00123571,0.0012450814,0.001584684,0.00029501462,0.000032490498,0.00005954923],"genre_scores_gemma":[0.9925814,0.00017450353,0.006985117,0.00011289675,0.000009963915,0.000037980273,0.000035854024,0.000008246695,0.000054036587],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9986668,0.00026271492,0.00059539854,0.00021100484,0.000047671307,0.00021636026],"domain_scores_gemma":[0.9994882,0.00014220287,0.00015363934,0.00015071507,0.00004572021,0.00001954618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00061926845,0.0000866493,0.00027835614,0.00013409159,0.000026514082,0.000001496427,0.000082114224,0.0001290886,0.000043871823],"category_scores_gemma":[0.00003739247,0.00007154599,0.000101955644,0.00023592135,0.00005420796,0.000029749854,0.00003669109,0.00013511885,0.0000035235516],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001213525,0.0036428017,0.098019704,0.0067861504,0.00074033457,0.000008176408,0.000637715,0.001995436,0.41768453,0.04122127,0.0029817054,0.42506865],"study_design_scores_gemma":[0.022100536,0.018776469,0.29209784,0.0041600335,0.0009937054,0.00013771658,0.0011667552,0.38039532,0.11909038,0.019866759,0.13929287,0.0019216336],"about_ca_topic_score_codex":0.00019445425,"about_ca_topic_score_gemma":0.0000038421613,"teacher_disagreement_score":0.42314702,"about_ca_system_score_codex":0.000087495086,"about_ca_system_score_gemma":0.00024848938,"threshold_uncertainty_score":0.2917561},"labels":[],"label_agreement":null},{"id":"W4399706335","doi":"10.1016/j.jval.2024.03.2443","title":"PT30 Real-World Cost-Effectiveness of Publicly Reimbursed Multi-Gene Panel Sequencing to Inform Therapeutic Decisions for Advanced Non-Small Cell Lung Cancer in British Columbia, Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Medicine; Business; Family medicine; Oncology","score_opus":0.04949426996328008,"score_gpt":0.32646239065105276,"score_spread":0.27696812068777266,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706335","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98861456,0.00501141,0.002385188,0.00014258591,0.00062843517,0.0023135424,0.00083829026,0.000007501258,0.00005850803],"genre_scores_gemma":[0.99393207,0.0027549318,0.0017030383,0.00047715535,0.00006632996,0.00070008554,0.0001107965,0.000042051477,0.00021357184],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99840796,0.000071498216,0.00050525955,0.00043857386,0.00012221427,0.0004545085],"domain_scores_gemma":[0.9989494,0.0003797479,0.000095707124,0.0002754463,0.00012989501,0.00016981042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006785571,0.00012764125,0.00031049605,0.0001017854,0.000069312344,0.00007210109,0.00018925671,0.000087027955,0.000005140162],"category_scores_gemma":[0.00015354293,0.00019172799,0.000061333674,0.00047802547,0.000019388399,0.0000067683677,0.00007099859,0.00013083583,2.0225113e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004080815,0.0002853861,0.21261825,0.0044201585,0.0001362973,0.00007059704,0.0008542107,0.4663863,0.17987855,0.00009969308,0.0020238494,0.13281862],"study_design_scores_gemma":[0.013834752,0.002055255,0.6432402,0.009763689,0.00010937936,0.000030522508,0.0014425935,0.13132031,0.14150274,0.0004996923,0.053817134,0.0023837332],"about_ca_topic_score_codex":0.9727756,"about_ca_topic_score_gemma":0.99546057,"teacher_disagreement_score":0.43062195,"about_ca_system_score_codex":0.0013043968,"about_ca_system_score_gemma":0.006189372,"threshold_uncertainty_score":0.9994446},"labels":[],"label_agreement":null},{"id":"W4399706339","doi":"10.1016/j.jval.2024.03.2258","title":"EE494 A Budget Impact Analysis of Newer Pneumococcal Conjugate Vaccine Use in All US Adults Aged 50-64 Years Old Compared to Current Recommendations from US Payer Perspective","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Perspective (graphical); Pneumococcal conjugate vaccine; Current (fluid); Medicine; Conjugate vaccine; Conjugate; Intensive care medicine; Immunology; Streptococcus pneumoniae; Computer science; Biology; Engineering; Microbiology; Mathematics; Immunization; Artificial intelligence","score_opus":0.12293757276709803,"score_gpt":0.469257618067366,"score_spread":0.34632004530026794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.981612,0.002308824,0.00010402367,0.010032665,0.0012999256,0.00222401,0.002297565,0.00009705542,0.000023929513],"genre_scores_gemma":[0.99493223,0.0018404468,0.0003883285,0.0015696302,0.00038289317,0.000114895316,0.00066340633,0.000049917307,0.000058222315],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99356854,0.0024793572,0.0018065374,0.0007678428,0.00037240502,0.0010053247],"domain_scores_gemma":[0.9963977,0.0018165973,0.00036825475,0.00054037094,0.0002188534,0.0006582251],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0016260096,0.00031982936,0.0011001322,0.0016653043,0.00015939743,0.000026200825,0.00024364701,0.00023031548,0.0005679437],"category_scores_gemma":[0.00046860718,0.00029545982,0.00024629626,0.0029634433,0.000018874152,0.00020236183,0.00013566126,0.0016517112,0.00012374965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052892795,0.00031561079,0.9398116,0.00054869446,0.00020360129,0.000020490808,0.044340886,0.00382089,0.000016086473,0.00017032126,0.008960483,0.0012624334],"study_design_scores_gemma":[0.0015124087,0.00017177063,0.96676725,0.0017900058,0.0001264673,3.4119887e-7,0.003455086,0.018810041,6.138523e-7,0.00015467426,0.006962308,0.00024905958],"about_ca_topic_score_codex":0.39879364,"about_ca_topic_score_gemma":0.06766881,"teacher_disagreement_score":0.33112484,"about_ca_system_score_codex":0.0022908326,"about_ca_system_score_gemma":0.0015933383,"threshold_uncertainty_score":0.99994975},"labels":[],"label_agreement":null},{"id":"W4399706401","doi":"10.1016/j.jval.2024.03.2444","title":"PT31 Self-Rated Health: Predictors of Poor Health Status and Associations With 5-Year Mortality Among UK Adults","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Medicine; Demography; Environmental health; Gerontology; Sociology","score_opus":0.03545223807488488,"score_gpt":0.35038063519618917,"score_spread":0.31492839712130427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706401","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96804607,0.0048900237,0.000014469426,0.023925753,0.0006659814,0.001316841,0.00036833994,0.00021188668,0.00056061056],"genre_scores_gemma":[0.98871344,0.008345905,0.00043635268,0.0021544644,0.00016861473,0.000031990236,0.00004438788,0.000024164237,0.00008070107],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9955648,0.0011783005,0.00096995424,0.00040913545,0.0006656631,0.0012121435],"domain_scores_gemma":[0.99790704,0.0005377129,0.00039013915,0.0001860679,0.000094562056,0.00088446203],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041237827,0.00016868066,0.0005801953,0.00020609693,0.000593275,0.00007539407,0.00012412752,0.0001228546,0.000033838554],"category_scores_gemma":[0.0002836274,0.00015259247,0.000049370592,0.0009761802,0.00018441583,0.000207839,0.00003062633,0.0003684761,0.0000034428417],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012694605,0.00007532687,0.93885595,0.0019649512,0.000033509314,0.0000017435914,0.043869685,0.00009286371,1.5269073e-8,0.012927606,0.0016596952,0.0005059554],"study_design_scores_gemma":[0.0004677743,0.00033455147,0.9828069,0.00117559,0.000005988989,2.9025946e-7,0.009590783,0.00093927776,2.9803326e-7,0.00033406686,0.004214151,0.00013032414],"about_ca_topic_score_codex":0.7321468,"about_ca_topic_score_gemma":0.19794616,"teacher_disagreement_score":0.53420067,"about_ca_system_score_codex":0.0015192841,"about_ca_system_score_gemma":0.008559437,"threshold_uncertainty_score":0.99706113},"labels":[],"label_agreement":null},{"id":"W4399706490","doi":"10.1016/j.jval.2024.03.2084","title":"PCR206 Comparison of the Measurement Properties of EQ-5D-Y-3L and CHU-9D Among Chinese High School Students with Myopia","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Skin Protection and Aging","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Optometry; Medicine; Statistics; Psychology; Mathematics","score_opus":0.14558643335813928,"score_gpt":0.3244456473636058,"score_spread":0.17885921400546653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706490","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99293363,0.0039492995,0.00002807557,0.0019026304,0.00020850313,0.000858885,0.0000010642963,0.000027495642,0.00009039941],"genre_scores_gemma":[0.9995579,0.00005681069,0.00008313205,0.00013765383,0.000049323564,0.000026488779,3.1538372e-7,0.000013229672,0.000075106036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985917,0.00010958055,0.00037721655,0.00016849955,0.0006110023,0.00014197722],"domain_scores_gemma":[0.9995339,0.000014809177,0.000105533305,0.00018189332,0.00007051532,0.00009336034],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00076786045,0.000098604185,0.000300934,0.00011018032,0.00004984876,0.000014847557,0.0000772167,0.00003093808,0.000010838088],"category_scores_gemma":[0.0001365346,0.00005115526,0.000027679811,0.0003153927,0.00008098464,0.00004344082,0.00004481245,0.00025587558,0.0000012709295],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012604758,0.00016281044,0.99103576,0.0025495356,0.00005123495,0.0000016541877,0.0028603885,0.00036608215,0.0015675587,0.00010258348,0.000089443616,0.001086914],"study_design_scores_gemma":[0.0011238687,0.0004443859,0.9794062,0.00946001,0.000025289573,0.000007597321,0.00087424,0.004522801,0.0038627635,0.00010852062,0.00009396942,0.0000703537],"about_ca_topic_score_codex":0.0044248803,"about_ca_topic_score_gemma":0.00015643648,"teacher_disagreement_score":0.011629547,"about_ca_system_score_codex":0.00014293252,"about_ca_system_score_gemma":0.0002988954,"threshold_uncertainty_score":0.6689125},"labels":[],"label_agreement":null},{"id":"W4399706494","doi":"10.1016/j.jval.2024.03.2004","title":"PCR125 Measuring and Valuing Health for Children: A Series of Reviews to Inform Health Technology Assessment","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health; McMaster University","funders":"","keywords":"Series (stratigraphy); Health technology; Psychology; Data science; Environmental health; Medicine; Computer science; Health care; Economics; Economic growth","score_opus":0.4954744113412234,"score_gpt":0.4765249184628291,"score_spread":0.018949492878394314,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706494","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.086021975,0.22377664,0.02318806,0.6549916,0.0012763377,0.009613254,0.0006873023,0.00021235638,0.0002324667],"genre_scores_gemma":[0.6976354,0.042408384,0.19934101,0.056940556,0.0007495589,0.002195154,0.00013645756,0.00021365893,0.00037980077],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9909116,0.00044669432,0.006959099,0.0007383762,0.000120502955,0.0008237493],"domain_scores_gemma":[0.9965151,0.0005180142,0.0020646185,0.00050014316,0.000044233562,0.00035787703],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.045550663,0.00024861674,0.0019856347,0.0013725931,0.00029311358,0.00006933552,0.00023527336,0.00012360158,0.00001604813],"category_scores_gemma":[0.0016945737,0.00029989015,0.000109842666,0.0008854993,0.000058731664,0.00038688534,0.00009036681,0.00030920428,0.000058114896],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022981772,0.00012819703,0.056872994,0.026403641,0.00007788926,4.0249756e-7,0.013410875,0.0017235324,0.0000013297511,0.84822595,0.017395614,0.0357366],"study_design_scores_gemma":[0.0024701103,0.0043650186,0.10154529,0.015268621,0.000008496271,0.00008175212,0.004745358,0.026877882,0.000010261281,0.072718374,0.7706243,0.0012845475],"about_ca_topic_score_codex":0.0072160703,"about_ca_topic_score_gemma":0.000641252,"teacher_disagreement_score":0.77550757,"about_ca_system_score_codex":0.0021256327,"about_ca_system_score_gemma":0.0017372613,"threshold_uncertainty_score":0.99994534},"labels":[],"label_agreement":null},{"id":"W4399706516","doi":"10.1016/j.jval.2024.03.2110","title":"PCR232 Do QALYs Discriminate Against the Elderly?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Elder Abuse and Neglect","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine","score_opus":0.06756255542973048,"score_gpt":0.3596736629620583,"score_spread":0.29211110753232783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706516","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75304306,0.052653562,0.000119370576,0.114578694,0.0026175843,0.00090127584,0.000009371158,0.0003598168,0.07571725],"genre_scores_gemma":[0.9842542,0.01328456,0.000058204034,0.0010701863,0.0003623675,0.000019912228,0.000001619134,0.000012977324,0.0009359689],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982228,0.00057866157,0.00023006227,0.00022840074,0.0002992281,0.0004408423],"domain_scores_gemma":[0.9992638,0.00039978416,0.000031664084,0.00018729796,0.000014803189,0.000102641265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016586207,0.00008243399,0.00012394712,0.000094240975,0.0004477485,0.0001501959,0.0002563595,0.00005778424,0.00006856837],"category_scores_gemma":[0.00009281646,0.0000563821,0.00006286946,0.0006466248,0.00011872175,0.00012361794,0.000027419279,0.00027755275,0.00012529352],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010195536,0.00008435524,0.0016484709,0.0002860539,0.000026887225,0.000067747365,0.20081767,0.0005703344,0.000055261058,0.14960565,0.021635823,0.62519157],"study_design_scores_gemma":[0.0003003482,0.0003323134,0.0015191243,0.0025572323,0.000018207245,0.0000036270214,0.018828923,0.0029125146,0.00010077872,0.066183485,0.90684783,0.0003956271],"about_ca_topic_score_codex":0.022145094,"about_ca_topic_score_gemma":0.0051309546,"teacher_disagreement_score":0.885212,"about_ca_system_score_codex":0.0001779629,"about_ca_system_score_gemma":0.0005985397,"threshold_uncertainty_score":0.98436654},"labels":[],"label_agreement":null},{"id":"W4399706518","doi":"10.1016/j.jval.2024.03.2070","title":"PCR191 Patient-Centric Assessment of Treatment Experience in Breast Cancer: Development and Validation of a Patient Questionnaire","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer survivorship and care","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); Alberta Health Services; Canadian Breast Cancer Network; Princess Margaret Cancer Centre; Mount Sinai Hospital; University Health Network; McGill University","funders":"","keywords":"Medicine; Breast cancer; Cancer; Medical physics; Internal medicine","score_opus":0.03421528658475379,"score_gpt":0.34250571319385803,"score_spread":0.3082904266091042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706518","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9924635,0.005929754,0.00003535382,0.000695338,0.00029471613,0.0005068896,0.000023024224,0.000013472386,0.00003793907],"genre_scores_gemma":[0.99784404,0.0016381486,0.0002636209,0.00005807752,0.000014967656,0.00015371553,0.000012774632,0.000008970282,0.000005687652],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987689,0.00009626966,0.00052372116,0.00022081392,0.00022659218,0.00016367661],"domain_scores_gemma":[0.99962133,0.000034175795,0.00010420724,0.000111124195,0.000046639092,0.000082531515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00015427952,0.00010091389,0.00026230345,0.0002431262,0.000017732056,0.000005552672,0.00002235154,0.000035767316,0.0000161881],"category_scores_gemma":[0.0000071661834,0.00008518711,0.000025531233,0.00042874843,0.00002647028,0.000048095782,0.000017230841,0.00006908164,2.649877e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007603205,0.00034164402,0.6586966,0.0016640608,0.000018264902,0.000016145785,0.05569744,0.0012216656,0.00008591983,0.00036864917,0.000009230949,0.28180438],"study_design_scores_gemma":[0.0023917465,0.0024953338,0.94549227,0.015169713,0.000035674013,0.00006434831,0.010041924,0.011276552,0.009369935,0.000084835294,0.0032607997,0.00031687293],"about_ca_topic_score_codex":0.034407042,"about_ca_topic_score_gemma":0.0009597964,"teacher_disagreement_score":0.2867957,"about_ca_system_score_codex":0.0016663127,"about_ca_system_score_gemma":0.0014303415,"threshold_uncertainty_score":0.97202295},"labels":[],"label_agreement":null},{"id":"W4399706544","doi":"10.1016/j.jval.2024.03.1979","title":"PCR100 Health-Related Quality of Life of Adolescents with Asymptomatic Convergence Insufficiency in China","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health, Environment, Cognitive Aging","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Asymptomatic; China; Convergence (economics); Medicine; Quality of life (healthcare); Convergence insufficiency; Environmental health; Economics; Internal medicine; Political science; Economic growth; Nursing","score_opus":0.03292574262077953,"score_gpt":0.29546372575087493,"score_spread":0.2625379831300954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706544","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99524003,0.0012899305,0.0005148433,0.0013502206,0.00013810655,0.0009979529,0.000018865981,0.00003769074,0.0004123475],"genre_scores_gemma":[0.99844676,0.0005912107,0.00048495617,0.00040605557,0.0000066478706,0.000019990313,0.000003997116,0.000025776924,0.000014604852],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950264,0.0011982804,0.0017981739,0.00063795765,0.00069900264,0.00064019574],"domain_scores_gemma":[0.9986065,0.00016993174,0.0005303701,0.0003939453,0.0000053889453,0.00029383568],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00464357,0.00020455415,0.0006105731,0.00021651971,0.000060790084,0.0000069482326,0.000263614,0.00008256324,0.0002280808],"category_scores_gemma":[0.0002373755,0.00018819855,0.000047444457,0.0013317605,0.00030918806,0.00020244705,0.00011351206,0.0004605153,0.000085189116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000052411713,0.0008069937,0.9595778,0.0036439353,0.0000066032794,0.000008480434,0.007570508,0.022253646,0.0002303655,0.00035874476,0.000023812067,0.0054666954],"study_design_scores_gemma":[0.0006218655,0.00044510516,0.97229314,0.0028219467,0.0000017572333,0.0000033719464,0.0003238385,0.022912294,0.00007233883,0.00031996123,0.000025921963,0.00015844977],"about_ca_topic_score_codex":0.068726726,"about_ca_topic_score_gemma":0.0010157734,"teacher_disagreement_score":0.06771096,"about_ca_system_score_codex":0.00097355875,"about_ca_system_score_gemma":0.0005416766,"threshold_uncertainty_score":0.9374747},"labels":[],"label_agreement":null},{"id":"W4399706553","doi":"10.1016/j.jval.2024.03.2238","title":"EE473 Health Care Resource Use in the Management of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Ottawa Hospital; University of Ottawa; Hôpital Maisonneuve-Rosemont; ABB (Canada)","funders":"","keywords":"Refractory (planetary science); Diffuse large B-cell lymphoma; Medicine; Lymphoma; Health care; Intensive care medicine; Oncology; Internal medicine; Political science; Materials science","score_opus":0.014958049802229171,"score_gpt":0.24436470290524887,"score_spread":0.2294066531030197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706553","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988351,0.007972906,8.843668e-7,0.0017217887,0.00011114045,0.001418624,0.0001233756,0.0000136273275,0.0002866433],"genre_scores_gemma":[0.9964213,0.00095267454,0.00015111266,0.0021598542,0.000014933454,0.00009688618,0.00012786254,0.000028767472,0.000046641275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976493,0.00031010032,0.00060644577,0.00036908578,0.0005519673,0.00051307585],"domain_scores_gemma":[0.9990272,0.0002314313,0.00012499218,0.00044945165,0.0000223777,0.0001445604],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043315918,0.00018946773,0.00040648266,0.00022179962,0.000044437613,0.000015046462,0.00011441982,0.000041072366,0.0000055602245],"category_scores_gemma":[0.000009223439,0.00012328166,0.00003844444,0.00057028845,0.000018259218,0.00005749688,0.00004074475,0.00015372153,0.000002806739],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027397706,0.005558794,0.9645312,0.0037561646,0.000041959727,0.00081663986,0.009525913,0.00017216217,5.8833553e-8,0.00046926222,0.0023172877,0.012536609],"study_design_scores_gemma":[0.015360684,0.00071877555,0.9521714,0.0026979775,0.000018296734,0.000003231219,0.0051489254,0.00019336813,0.0000036795986,0.000005634505,0.02357243,0.000105602936],"about_ca_topic_score_codex":0.8717494,"about_ca_topic_score_gemma":0.69521785,"teacher_disagreement_score":0.17653157,"about_ca_system_score_codex":0.0056317016,"about_ca_system_score_gemma":0.002598318,"threshold_uncertainty_score":0.9981855},"labels":[],"label_agreement":null},{"id":"W4399706571","doi":"10.1016/j.jval.2024.03.2224","title":"CO202 Relationship between Loss of Ambulation (LoA) and Timing of Pulmonary Outcomes Among Boys with Duchenne Muscular Dystrophy (DMD)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical and Biological Ozone Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Duchenne muscular dystrophy; Medicine; Physical medicine and rehabilitation; Muscular dystrophy; Physical therapy; Pediatrics; Internal medicine","score_opus":0.12103626897268888,"score_gpt":0.36434238956924797,"score_spread":0.2433061205965591,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706571","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945129,0.0012228129,0.0003103057,0.0034116844,0.000024640638,0.00037707033,0.000011372853,0.000019840116,0.00010935751],"genre_scores_gemma":[0.9989183,0.00011797398,0.0007242933,0.000030088428,0.000059619204,0.0000075006587,0.00003378465,0.00000873478,0.0000997281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985726,0.0001835628,0.00045693936,0.0002095428,0.00036940182,0.000207976],"domain_scores_gemma":[0.9987234,0.00084512954,0.00007837835,0.00013091868,0.000043807195,0.00017838777],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010431666,0.00008808638,0.00039917833,0.00017697501,0.00003156704,0.0000047503668,0.000043590902,0.00010203142,0.000024900026],"category_scores_gemma":[0.00042495588,0.000052653417,0.00004506362,0.00039979923,0.00019953557,0.000045078486,0.000032151387,0.00033673673,0.0000021498927],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000054851313,0.00005671271,0.99298775,0.0021210993,0.000024192566,0.000051373623,0.000120388904,0.000043352862,0.000083401545,0.0006232177,0.000009558025,0.0038241213],"study_design_scores_gemma":[0.00034376682,0.00055179227,0.9907929,0.0011047333,0.000021163156,0.000010798464,0.000059209342,0.0063079135,0.000052177103,0.0006519863,0.00005492788,0.00004866556],"about_ca_topic_score_codex":0.0018029809,"about_ca_topic_score_gemma":0.000005886193,"teacher_disagreement_score":0.0062645604,"about_ca_system_score_codex":0.000056183988,"about_ca_system_score_gemma":0.00015685814,"threshold_uncertainty_score":0.27255797},"labels":[],"label_agreement":null},{"id":"W4399706654","doi":"10.1016/j.jval.2024.03.2059","title":"PCR180 Measuring and Valuing Child Health in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; University of Toronto; McMaster University","funders":"","keywords":"Data science; Geography; Psychology; Computer science","score_opus":0.08862372594407637,"score_gpt":0.3659786101130777,"score_spread":0.27735488416900134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706654","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7833931,0.053976502,0.00007986059,0.15343969,0.003666849,0.00264075,0.00008631281,0.00019247054,0.0025244753],"genre_scores_gemma":[0.9788586,0.005970167,0.00018958798,0.014325742,0.0004728212,0.00001188771,0.00001337112,0.00004705471,0.00011078369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99495953,0.0013763104,0.0013355316,0.0005798691,0.00035105355,0.0013977039],"domain_scores_gemma":[0.9984251,0.0005589906,0.00017564955,0.0002735386,0.000021371368,0.00054531905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037552773,0.00022719981,0.00058089616,0.00036989187,0.00059486943,0.00001702604,0.00013807765,0.00009223763,0.000053415435],"category_scores_gemma":[0.00014120051,0.00021796935,0.00003128641,0.00066511903,0.000021977894,0.00011598179,0.00009775694,0.0018925974,0.000030462008],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000113989874,0.00022805114,0.67473483,0.040195562,0.000031354717,0.00024076448,0.04955097,0.0043609445,0.0000074500776,0.037998773,0.030609854,0.16192746],"study_design_scores_gemma":[0.00248271,0.00017529872,0.80235445,0.056266967,0.000004391546,0.00005192728,0.010056402,0.033270016,0.0000023009388,0.0023139955,0.09236413,0.00065740844],"about_ca_topic_score_codex":0.97981733,"about_ca_topic_score_gemma":0.9613658,"teacher_disagreement_score":0.19546549,"about_ca_system_score_codex":0.005395979,"about_ca_system_score_gemma":0.014529312,"threshold_uncertainty_score":0.99842215},"labels":[],"label_agreement":null},{"id":"W4399706670","doi":"10.1016/j.jval.2024.03.1994","title":"PCR115 Health States Utilities for Allergic Rhinitis - an AI-Supported Systematic Review","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Systematic review; Medicine; MEDLINE; Political science","score_opus":0.07972725377632305,"score_gpt":0.36008560843981646,"score_spread":0.2803583546634934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706670","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.03024833,0.77868176,0.00756266,0.15920262,0.0018991353,0.02001232,0.00054001866,0.0010119147,0.00084123894],"genre_scores_gemma":[0.62477845,0.2996733,0.0029104298,0.066006884,0.00045744464,0.0006935588,0.003127324,0.00019487165,0.0021577429],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99671626,0.0005333483,0.0014416393,0.00042439872,0.00036556477,0.00051877886],"domain_scores_gemma":[0.99861306,0.00032185548,0.00021251844,0.00038332096,0.00013436945,0.00033488957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002412484,0.00022168235,0.0011677219,0.00021657441,0.00012187686,0.00005084707,0.000078134646,0.00007344275,0.000101222315],"category_scores_gemma":[0.0002787699,0.00018232933,0.00012712802,0.00035302283,0.000038878086,0.00016504552,0.000014255451,0.00023675343,0.000030369261],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003855594,0.00013290005,0.000055288518,0.96563274,0.0000794988,0.00009767061,0.004935779,0.00016025711,0.0000015504547,0.009607613,0.017862175,0.0013959515],"study_design_scores_gemma":[0.0015613991,0.0032023494,0.00048776323,0.6721128,0.00015670375,0.0007947266,0.0031360923,0.2991676,0.0000075997623,0.0059990557,0.012899248,0.0004746136],"about_ca_topic_score_codex":0.002378863,"about_ca_topic_score_gemma":0.0001490335,"teacher_disagreement_score":0.5945301,"about_ca_system_score_codex":0.0003816673,"about_ca_system_score_gemma":0.001340579,"threshold_uncertainty_score":0.7435174},"labels":[],"label_agreement":null},{"id":"W4399706706","doi":"10.1016/j.jval.2024.03.1961","title":"PCR82 Fostering Peer-Reviewed Publication of Patient Engagement Activities: Multistakeholder Perspectives on Priorities, Motivators and Challenges","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Glycemic Index Laboratories","funders":"","keywords":"Peer review; Medical education; Public relations; Psychology; Medicine; Political science","score_opus":0.19058289955122956,"score_gpt":0.29730132940354476,"score_spread":0.1067184298523152,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7373003,0.2372384,0.00014043877,0.012066385,0.0007266884,0.00075692526,0.00021246362,0.000052667525,0.011505743],"genre_scores_gemma":[0.9528619,0.046403643,0.00028113808,0.00014797774,0.00007237423,0.00004504835,0.0000040669124,0.000021610356,0.00016225249],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99862266,0.00004590904,0.0006485928,0.0003969008,0.000046938076,0.00023901316],"domain_scores_gemma":[0.9992967,0.00014680499,0.00025342478,0.00020439376,0.000026321146,0.00007232575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011104662,0.00013310615,0.00038906987,0.0003282285,0.000053593474,0.00006054095,0.000078643454,0.00005703351,0.000048409045],"category_scores_gemma":[0.00026788888,0.00015035747,0.000051875926,0.00012233868,0.000048776998,0.00032743468,0.000054427423,0.00017825908,0.000012020091],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024233252,0.0001449597,0.0025894307,0.0021558416,0.000042530974,0.0000017950947,0.04626941,0.00028601178,0.0000028096267,0.7628703,0.0005226171,0.18509007],"study_design_scores_gemma":[0.0012470402,0.001530796,0.07010746,0.0026201212,0.00000737573,0.0000059495023,0.021072311,0.0061270967,0.00012771125,0.025097057,0.8712357,0.0008213631],"about_ca_topic_score_codex":0.0011414036,"about_ca_topic_score_gemma":0.000024544755,"teacher_disagreement_score":0.8707131,"about_ca_system_score_codex":0.0004897321,"about_ca_system_score_gemma":0.000086079584,"threshold_uncertainty_score":0.61314},"labels":[],"label_agreement":null},{"id":"W4399706707","doi":"10.1016/j.jval.2024.03.1968","title":"PCR89 Impact of Dosing and Administration on HRQoL Among People With Hemophilia: A Time Trade-Off Study Including 2.250 Respondents in the UK, Canada and the US","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Dosing; Administration (probate law); Medicine; Political science; Pharmacology","score_opus":0.041635450020204454,"score_gpt":0.358100841241163,"score_spread":0.3164653912209585,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99208254,0.0008740122,1.9572272e-7,0.005293407,0.000022380265,0.0016279304,0.000008991329,0.0000065144814,0.00008403334],"genre_scores_gemma":[0.9996204,0.00014321851,0.0000068461877,0.00007495636,0.000036931164,0.000031914635,0.0000057861353,0.000011849156,0.000068098336],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982766,0.0004990363,0.00028881335,0.0002201886,0.00047113872,0.00024422226],"domain_scores_gemma":[0.9989281,0.0007384229,0.00004911545,0.00018007134,0.000012309563,0.00009195758],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017716977,0.00012181166,0.00030272256,0.0001702844,0.00011173046,0.000037858554,0.00006125213,0.00003599783,0.0000056938607],"category_scores_gemma":[0.00009671832,0.000056267803,0.0000234074,0.00049294933,0.000082492355,0.000043850458,0.00002211483,0.00032797214,3.52037e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016692304,0.00022650606,0.98296624,0.00025635472,0.000055428067,0.00029877934,0.012853351,0.00011489482,0.000050897233,0.000036681722,0.00008118457,0.0013904292],"study_design_scores_gemma":[0.00283555,0.0026756902,0.9848475,0.00073136896,0.000025475105,0.00008084213,0.0014014994,0.0072793006,0.000027540273,0.00003408088,0.00000716316,0.000054015258],"about_ca_topic_score_codex":0.4883472,"about_ca_topic_score_gemma":0.27921396,"teacher_disagreement_score":0.20913325,"about_ca_system_score_codex":0.00039219623,"about_ca_system_score_gemma":0.0014665923,"threshold_uncertainty_score":0.7339385},"labels":[],"label_agreement":null},{"id":"W4399706723","doi":"10.1016/j.jval.2024.03.1957","title":"PCR78 Treatment Preferences of Adult Patients With Attention-Deficit/Hyperactivity Disorder in Canada: A Discrete Choice Experiment","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Attention Deficit Hyperactivity Disorder","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Attention deficit hyperactivity disorder; Attention deficit; Psychology; Psychiatry; Attention deficit disorder; Medicine; Clinical psychology","score_opus":0.03744461332359615,"score_gpt":0.31665999968529795,"score_spread":0.2792153863617018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706723","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954249,0.0011822177,0.0000532431,0.0016676182,0.00018310153,0.0012228732,0.00006958563,0.000028274288,0.00016817798],"genre_scores_gemma":[0.999162,0.0002269485,0.00016016552,0.00005243894,0.000021699629,0.0001568251,0.00007706672,0.00003313043,0.00010973164],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978081,0.00019817971,0.0005775179,0.0004766062,0.0005455887,0.00039401653],"domain_scores_gemma":[0.99906415,0.00026527044,0.00015036803,0.00029669766,0.000088404646,0.00013508902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012730355,0.00024520865,0.00055174285,0.00023600149,0.0000449294,0.000014763869,0.000063971725,0.00005322794,0.00007570227],"category_scores_gemma":[0.00008192153,0.00018280327,0.00006446371,0.00051669154,0.000039262526,0.00018692673,0.000024393363,0.00024038994,0.0000065039712],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001450801,0.0010107971,0.9911425,0.00048758736,0.000058086247,0.000014945457,0.00037375087,0.0017519353,0.000036714624,0.00014175368,0.000008368439,0.0048284642],"study_design_scores_gemma":[0.0028879915,0.00080890185,0.9884104,0.0012756665,0.00002957586,0.000004224622,0.002477247,0.0036845498,0.000013716347,0.000011558464,0.00022097664,0.0001751839],"about_ca_topic_score_codex":0.94997615,"about_ca_topic_score_gemma":0.8192419,"teacher_disagreement_score":0.13073426,"about_ca_system_score_codex":0.0019762109,"about_ca_system_score_gemma":0.0026628408,"threshold_uncertainty_score":0.7454501},"labels":[],"label_agreement":null},{"id":"W4399706730","doi":"10.1016/j.jval.2024.03.1930","title":"PCR50 Estimating Meaningful Change Thresholds (MCTs) for EORTC Scales in a Phase 3 Trial in Participants With Inoperable or Metastatic Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Oncology; Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Internal medicine; Medicine; Breast cancer; Hormone receptor; Hormone; Epidermal growth factor receptor; Cancer","score_opus":0.1675889357521036,"score_gpt":0.417013020828297,"score_spread":0.2494240850761934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706730","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98713994,0.0032156948,0.00004093521,0.0035867565,0.0003179867,0.0048711104,0.0007110291,0.000060381928,0.000056184228],"genre_scores_gemma":[0.9915478,0.0007727929,0.0030340524,0.00028503616,0.00033378607,0.0038401592,0.00006080318,0.00006098859,0.00006458043],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99704003,0.00027983004,0.0008626119,0.00063312246,0.00032784682,0.0008565258],"domain_scores_gemma":[0.9987379,0.0006300342,0.00017393567,0.00014522918,0.00009689624,0.00021603974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0007545652,0.00036019293,0.0010694206,0.00039067716,0.00017054516,0.000048222035,0.00007795459,0.00006927529,0.000112465925],"category_scores_gemma":[0.00024330546,0.0002470625,0.00007670124,0.00083280914,0.00011027611,0.00029936232,0.000035969206,0.00035360956,0.000003756311],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4471302,0.012157535,0.15483467,0.012817776,0.0025251608,0.0013731102,0.20050995,0.0021402922,0.0017160709,0.0020058556,0.0023951835,0.16039419],"study_design_scores_gemma":[0.46856758,0.06787131,0.30179366,0.03346214,0.0007705127,0.0001759321,0.012431784,0.10780576,0.002715248,0.0013285482,0.00048688948,0.0025906353],"about_ca_topic_score_codex":0.03424172,"about_ca_topic_score_gemma":0.018987836,"teacher_disagreement_score":0.18807817,"about_ca_system_score_codex":0.001523617,"about_ca_system_score_gemma":0.00069447386,"threshold_uncertainty_score":0.99999815},"labels":[],"label_agreement":null},{"id":"W4399706750","doi":"10.1016/j.jval.2024.03.1932","title":"PCR52 Early Real-World Experience With Abrilada Within the Canadian Patient Population","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Geography; Medicine","score_opus":0.04722766304208774,"score_gpt":0.34167395004473894,"score_spread":0.2944462870026512,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901931,0.0006685519,0.0000061125074,0.0050072013,0.00028147094,0.0009308777,0.00000608856,0.000059250448,0.0028473334],"genre_scores_gemma":[0.9979727,0.000055276705,0.0002657119,0.0007674945,0.00012046612,0.00007603618,0.000015157665,0.000031557767,0.0006955989],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99799323,0.00014969814,0.0003833036,0.00033353586,0.0006282791,0.00051194703],"domain_scores_gemma":[0.9989305,0.00015885738,0.000052096053,0.00042140918,0.00004459067,0.00039251195],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00065752125,0.00012405297,0.00019572771,0.00030971022,0.00017361228,0.000074350486,0.000109962086,0.00005045826,0.000042173542],"category_scores_gemma":[0.000079108744,0.00007738701,0.000028055958,0.000947439,0.000091881375,0.00008810942,0.00002404772,0.00038160893,0.0000400319],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0014045563,0.0002981397,0.5136594,0.005118247,0.000209502,0.005880409,0.25270143,0.04337799,0.000068550435,0.118524,0.009346208,0.04941158],"study_design_scores_gemma":[0.006534598,0.0025250888,0.48082483,0.0069957045,0.00003604527,0.0008188603,0.0032883247,0.47089365,0.0003091837,0.00138855,0.02574001,0.00064517156],"about_ca_topic_score_codex":0.987791,"about_ca_topic_score_gemma":0.8699887,"teacher_disagreement_score":0.42751566,"about_ca_system_score_codex":0.029691428,"about_ca_system_score_gemma":0.022273751,"threshold_uncertainty_score":0.98326904},"labels":[],"label_agreement":null},{"id":"W4399706808","doi":"10.1016/j.jval.2024.03.1852","title":"SA5 A Scoping Review of Barriers and Facilitators to Implementation of Intravenous Cardiovascular Treatments in Ambulatory Settings","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Ambulatory; Medicine; Intensive care medicine; Internal medicine","score_opus":0.05306144353238059,"score_gpt":0.4387485216392059,"score_spread":0.38568707810682534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706808","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0027422123,0.98723793,0.0000023686403,0.00018789737,0.00026598564,0.009265383,0.0002645661,0.0000138632995,0.000019789413],"genre_scores_gemma":[0.0002680254,0.99822253,0.0003159611,0.0006105185,0.000047141875,0.00037134468,0.00011492525,0.00004587902,0.0000036529489],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9953653,0.000638009,0.002426647,0.00056013896,0.00047281393,0.0005370829],"domain_scores_gemma":[0.9983283,0.00015431753,0.0003940764,0.00042696123,0.00004099548,0.00065531937],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035859768,0.00034196762,0.0041109785,0.00064335385,0.000029386953,0.0000030653355,0.000059997827,0.00014656923,0.000012862693],"category_scores_gemma":[0.00015264546,0.00029624873,0.00064405164,0.00090784667,0.00003817742,0.000031227177,0.000056890494,0.0003671212,0.000004787764],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006085512,0.000013988933,0.00014125886,0.5783239,0.00008079815,0.000011238664,0.0007397282,0.0000010514998,4.0545405e-8,0.0000046176287,0.00006929586,0.420608],"study_design_scores_gemma":[0.00068799366,0.00068950735,0.00016635691,0.9271927,0.0007482738,0.000082570405,0.00059051276,0.0000017451963,0.0000011696027,0.0000034671607,0.069684334,0.00015135562],"about_ca_topic_score_codex":0.012377553,"about_ca_topic_score_gemma":0.00007945426,"teacher_disagreement_score":0.42045665,"about_ca_system_score_codex":0.0017470825,"about_ca_system_score_gemma":0.006523268,"threshold_uncertainty_score":0.999949},"labels":[],"label_agreement":null},{"id":"W4399706812","doi":"10.1016/j.jval.2024.03.1725","title":"RWD71 The Burden of Haemophilia in 5 European Countries: Methods and Results from the Cost of Haemophilia in Europe: A Socioeconomic Survey (CHESS) 2022","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"","keywords":"Haemophilia; Socioeconomic status; Haemophilia A; Medicine; Environmental health; Pediatrics; Population","score_opus":0.102848967000319,"score_gpt":0.40409903953532295,"score_spread":0.30125007253500397,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706812","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9523086,0.014424178,0.000007839924,0.030337809,0.0001998951,0.0014110834,0.0005264956,0.000016688256,0.00076741126],"genre_scores_gemma":[0.9892379,0.009372685,0.00031725332,0.00025436652,0.00017953866,0.000020904072,0.00010873958,0.00004627057,0.00046231766],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99259156,0.0048245424,0.0013079748,0.00051181455,0.00032054106,0.00044354761],"domain_scores_gemma":[0.9936912,0.0053338334,0.00018336886,0.0005922324,0.00008655538,0.00011278485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017031047,0.00019878398,0.00064000196,0.00026587702,0.00006477978,0.000028764885,0.0003026496,0.000086150074,0.000051688425],"category_scores_gemma":[0.0015024808,0.000118448144,0.000058194906,0.00079725735,0.00040653435,0.00006158425,0.00017376113,0.00072741474,0.000027318301],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0063374974,0.0009934598,0.6745234,0.004423565,0.0006110237,0.0011051906,0.15318416,0.0047919434,0.002034394,0.0015765361,0.023029622,0.12738921],"study_design_scores_gemma":[0.0055344505,0.00063065015,0.93963104,0.002828009,0.00003989079,0.000023868068,0.0025459393,0.028104192,0.0004944106,0.0007118258,0.019219402,0.0002362932],"about_ca_topic_score_codex":0.07509273,"about_ca_topic_score_gemma":0.0021316318,"teacher_disagreement_score":0.26510766,"about_ca_system_score_codex":0.00028720437,"about_ca_system_score_gemma":0.0009521405,"threshold_uncertainty_score":0.93106633},"labels":[],"label_agreement":null},{"id":"W4399706835","doi":"10.1016/j.jval.2024.03.1760","title":"RWD106 Psychological Burden in People Living with Myasthenia Gravis: Prevalence and Associated Risk Factors of Depression and Anxiety from the MGFA Global MG Patient Registry (MGFAPR) in the US (2017-2022)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Providence Health Care","funders":"","keywords":"Anxiety; Depression (economics); Myasthenia gravis; Medicine; Psychiatry; Environmental health","score_opus":0.018887714599980003,"score_gpt":0.2914144274550714,"score_spread":0.2725267128550914,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98981893,0.00832126,0.000008818893,0.0008285578,0.00008278014,0.00071313744,0.00014813863,0.000021700547,0.0000566613],"genre_scores_gemma":[0.9965818,0.0030782323,0.00009582241,0.00014750392,0.000037745045,0.000025748932,0.0000134459215,0.000012440037,0.0000072439843],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975158,0.0007999182,0.00048667178,0.0004805136,0.0003917249,0.0003253601],"domain_scores_gemma":[0.99863666,0.0006677098,0.00020160203,0.00037372747,0.000023977542,0.000096338845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013023871,0.00018967458,0.00038361078,0.000058373913,0.000080305894,0.000037470512,0.00015906584,0.00013784933,0.000013769073],"category_scores_gemma":[0.0003423389,0.000095908676,0.000040032173,0.0005092333,0.00010871479,0.00005381635,0.00008121591,0.000588312,6.543574e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011806131,0.00015829755,0.9822675,0.00019614885,0.000014616595,0.000022517352,0.012897794,0.000067539935,0.0000178538,0.000049654765,0.000083392166,0.0041066213],"study_design_scores_gemma":[0.00070216274,0.000547284,0.99068284,0.0030041505,0.000027077922,0.000051368275,0.0019062179,0.0024305258,0.000002438051,0.00048125544,0.00007025829,0.000094416675],"about_ca_topic_score_codex":0.037653632,"about_ca_topic_score_gemma":0.0026719116,"teacher_disagreement_score":0.034981724,"about_ca_system_score_codex":0.00013901501,"about_ca_system_score_gemma":0.00011233152,"threshold_uncertainty_score":0.9687547},"labels":[],"label_agreement":null},{"id":"W4399706871","doi":"10.1016/j.jval.2024.03.1797","title":"RWD143 Update of Our Review of Real-World Evidence in HTA Decision-Making of Gene Therapies in the US, Canada, UK, EU4, and Japan","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real world evidence; Medicine; Intensive care medicine; Internal medicine","score_opus":0.07591041349255336,"score_gpt":0.3951075412605367,"score_spread":0.31919712776798337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706871","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6431855,0.28063765,0.00002876259,0.07538685,0.0001450944,0.0005510302,0.00001235854,0.000002923139,0.000049842427],"genre_scores_gemma":[0.88211334,0.11564406,0.00067761575,0.0015216067,0.000025352745,0.0000038220196,0.000002625716,0.000005263693,0.000006310263],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9983374,0.00020840114,0.00074741937,0.00014341075,0.00043712906,0.00012623002],"domain_scores_gemma":[0.99896795,0.0005899838,0.00015697295,0.00019973212,0.000049915216,0.00003546312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037564412,0.00006605536,0.00036772867,0.00019522873,0.000011645632,0.0000023037635,0.00008702566,0.000051749103,0.000010598605],"category_scores_gemma":[0.00034709656,0.00004043192,0.000024721103,0.000779071,0.000087511944,0.000023363677,0.00002144272,0.00025371186,1.0509668e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037076254,0.00030756125,0.184724,0.1615392,0.0000847164,0.00012362338,0.017935261,0.00062070764,0.0014798474,0.029108582,0.0056640413,0.5980417],"study_design_scores_gemma":[0.00045931776,0.0002518028,0.65781623,0.3231701,0.000026308062,0.000021373336,0.00070865755,0.007619988,0.00007148707,0.007164327,0.0025875275,0.00010289526],"about_ca_topic_score_codex":0.4671149,"about_ca_topic_score_gemma":0.3329164,"teacher_disagreement_score":0.59793884,"about_ca_system_score_codex":0.00011439215,"about_ca_system_score_gemma":0.001363861,"threshold_uncertainty_score":0.67925614},"labels":[],"label_agreement":null},{"id":"W4399706971","doi":"10.1016/j.jval.2024.03.1391","title":"HTA40 Nirmatrelvir/Ritonavir for Non-Hospitalized Adults With Mild/Moderately Severe COVID-19: A Systematic Evidence Review of Randomized Controlled Trials and Real-World Studies With Meta-Analysis and Trial Sequential Analysis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Thermal Regulation in Medicine","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Meta-analysis; Randomized controlled trial; Coronavirus disease 2019 (COVID-19); Medicine; Real world evidence; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Internal medicine; Virology; Disease","score_opus":0.20009822854441722,"score_gpt":0.46455313871670395,"score_spread":0.26445491017228673,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399706971","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09800817,0.8095219,0.0101133445,0.0261911,0.00018639436,0.055702586,0.00012194844,0.0001388071,0.000015718759],"genre_scores_gemma":[0.86569405,0.12077658,0.0045407484,0.0016398333,0.00014890797,0.0067236936,0.000059795664,0.00006412387,0.00035226342],"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9861413,0.006586927,0.005062815,0.00077180925,0.0010932168,0.00034392477],"domain_scores_gemma":[0.9666547,0.029091727,0.0026169687,0.0006060375,0.00059195724,0.0004385971],"candidate_categories":["metaresearch","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.040689625,0.00049387454,0.02522301,0.0015808822,0.00009685785,0.000049155147,0.00010281981,0.00008885213,0.00005901024],"category_scores_gemma":[0.020614646,0.00023408297,0.0023650497,0.0028470505,0.00034387846,0.00016129235,0.000030804298,0.00020126949,3.3846936e-7],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.4773486,0.000068905225,0.00013304279,0.25515205,0.26402423,0.000025921085,0.0017140899,0.0012589141,0.000002570473,0.00018361745,0.00007131991,0.000016725231],"study_design_scores_gemma":[0.38204005,0.0010941089,0.00006656396,0.056561563,0.53250086,0.000018287039,0.00030440028,0.027142487,0.000003845121,0.00008887749,0.000005627872,0.00017333195],"about_ca_topic_score_codex":0.004456646,"about_ca_topic_score_gemma":0.0006499736,"teacher_disagreement_score":0.7676859,"about_ca_system_score_codex":0.00030167814,"about_ca_system_score_gemma":0.0012598794,"threshold_uncertainty_score":0.9892486},"labels":[],"label_agreement":null},{"id":"W4399707126","doi":"10.1016/j.jval.2024.03.1649","title":"PCR42 Health State Utilities in Duchenne Muscular Dystrophy (DMD): A Longitudinal Study Using the EQ5D and Health Utilities Index (HUI)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Duchenne muscular dystrophy; Index (typography); Muscular dystrophy; Medicine; Physical therapy; Physical medicine and rehabilitation; Computer science; Internal medicine; World Wide Web","score_opus":0.16963609280507952,"score_gpt":0.4058800498188812,"score_spread":0.2362439570138017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707126","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8971906,0.030709011,0.0007332651,0.068912834,0.0004933368,0.0018427568,0.000030165678,0.00007256555,0.000015520312],"genre_scores_gemma":[0.9953042,0.0024737914,0.00034200243,0.0015213728,0.00018650715,0.000030093177,0.00001667027,0.000037409118,0.00008790511],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959734,0.00080349884,0.0011212687,0.0005884915,0.0007217708,0.00079154124],"domain_scores_gemma":[0.99876666,0.0002375728,0.0001740323,0.0003739483,0.000060027036,0.00038773887],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060961484,0.00025882965,0.00071735616,0.00051101303,0.0002847603,0.000078714605,0.00010259444,0.00012671533,0.000019773699],"category_scores_gemma":[0.0000625458,0.0001782885,0.000072628995,0.00087236206,0.00055976136,0.00010910516,0.000095810145,0.0011292931,0.0000017421867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008765144,0.0028468522,0.41132632,0.036072977,0.000410119,0.0005464891,0.25616628,0.004609702,0.000028987886,0.024705756,0.0006922587,0.26171774],"study_design_scores_gemma":[0.0027438733,0.0032242192,0.80360097,0.004858069,0.000021545835,0.0001424281,0.024682904,0.14728832,0.0000020045522,0.0099656265,0.003180555,0.00028946355],"about_ca_topic_score_codex":0.10709143,"about_ca_topic_score_gemma":0.004024032,"teacher_disagreement_score":0.39227465,"about_ca_system_score_codex":0.0009673314,"about_ca_system_score_gemma":0.0031810813,"threshold_uncertainty_score":0.89885455},"labels":[],"label_agreement":null},{"id":"W4399707296","doi":"10.1016/j.jval.2024.03.1583","title":"MT45 Analytical Performance, Quality of Life and Costs Related to Allergy Testing: Results from Two Systematic Literature Reviews","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Allergic Rhinitis and Sensitization","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Systematic review; Quality (philosophy); Medicine; MEDLINE; Biology","score_opus":0.09231796247507693,"score_gpt":0.36353378600095454,"score_spread":0.2712158235258776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9585903,0.035337545,0.000053945143,0.002943827,0.00020552766,0.00114497,0.000036267375,0.000051863055,0.0016357412],"genre_scores_gemma":[0.99123347,0.005855892,0.0017424313,0.0007174564,0.00008339854,0.000008155738,0.00011092543,0.000015643884,0.0002325999],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9971659,0.00054732466,0.0015429583,0.0003124662,0.00025285102,0.0001784773],"domain_scores_gemma":[0.9984195,0.00076604285,0.00019740353,0.00027076938,0.00010695799,0.00023929191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023610624,0.00012698639,0.0007755805,0.00017086216,0.000033642882,0.00002718073,0.00003972805,0.00008594675,0.0000051940838],"category_scores_gemma":[0.0037450173,0.00009393398,0.000043932152,0.00076871313,0.000023082948,0.000057997393,0.000023317041,0.00025454874,0.000015808999],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045707,0.0009334519,0.065624,0.6829066,0.0010551331,0.0007443598,0.09647626,0.013125887,0.0009606679,0.056083735,0.018850237,0.05866893],"study_design_scores_gemma":[0.0026580053,0.00065661856,0.06825738,0.233914,0.000038589682,0.00007384467,0.00023327884,0.6923907,0.0000057579928,0.0001954485,0.0013287541,0.00024763553],"about_ca_topic_score_codex":0.0012959798,"about_ca_topic_score_gemma":0.000028086259,"teacher_disagreement_score":0.6792648,"about_ca_system_score_codex":0.0001314256,"about_ca_system_score_gemma":0.00021834679,"threshold_uncertainty_score":0.4483406},"labels":[],"label_agreement":null},{"id":"W4399707316","doi":"10.1016/j.jval.2024.03.1245","title":"HSD22 Extending External Validity of Rcts and Meta-Analysis through Transportability Analysis and Integration of Mechanistic Research Evidence","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Meta-analysis; External validity; Psychology; Computer science; Medicine; Social psychology; Internal medicine","score_opus":0.9461070641044819,"score_gpt":0.6505937680397718,"score_spread":0.2955132960647101,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707316","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6017638,0.03238577,0.36374283,0.0010703618,0.00005634877,0.000826953,0.00008564999,0.0000044164276,0.00006392853],"genre_scores_gemma":[0.9848554,0.0010693881,0.013794924,0.000021293154,0.000011161007,0.00003156224,0.0000036584665,0.000005914094,0.00020669436],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.95400363,0.028639289,0.00986799,0.0015023593,0.005646542,0.0003402027],"domain_scores_gemma":[0.975007,0.019861478,0.0020614183,0.0020112172,0.00089963817,0.0001592213],"candidate_categories":["metaresearch","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.28410214,0.0002295814,0.0061565307,0.002203806,0.00011250101,0.00029444078,0.000622152,0.00006879959,0.0020649447],"category_scores_gemma":[0.019759642,0.00011713968,0.002407014,0.011873562,0.00018717846,0.00042418274,0.00007711261,0.000300173,0.00000808783],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019896399,0.00089374173,0.4571855,0.0148633,0.19211635,0.00006718229,0.03531068,0.029513158,0.004875284,0.24175805,0.00047378868,0.02274401],"study_design_scores_gemma":[0.00012576919,0.0004874565,0.16135205,0.00027592506,0.22483999,0.000006804441,0.0017251066,0.44664457,0.00064701785,0.16343461,0.000165365,0.00029531438],"about_ca_topic_score_codex":0.009148088,"about_ca_topic_score_gemma":0.002091948,"teacher_disagreement_score":0.41713142,"about_ca_system_score_codex":0.00007303222,"about_ca_system_score_gemma":0.00018793005,"threshold_uncertainty_score":0.9988473},"labels":[],"label_agreement":null},{"id":"W4399707339","doi":"10.1016/j.jval.2024.03.1290","title":"HSD67 A Retrospective Study Assessing Clinical and Economic Impacts of a Multidisciplinary Approach for Reducing Risk of Catheter-Related Thrombosis in a U.S. Health System","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Multidisciplinary approach; Medicine; Thrombosis; Intensive care medicine; Operations management; Risk analysis (engineering); Surgery; Economics; Political science","score_opus":0.13165110625517149,"score_gpt":0.39469706189298204,"score_spread":0.2630459556378105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707339","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887115,0.004936757,0.0014634244,0.001402306,0.000403338,0.0024859048,0.000327725,0.000033019347,0.00023604705],"genre_scores_gemma":[0.99533325,0.0015244848,0.0029172115,0.000023844488,0.000052051197,0.00010201423,0.0000065482195,0.000034051136,0.0000065338513],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953544,0.00046120165,0.0029676834,0.0007122131,0.000044463155,0.00046001867],"domain_scores_gemma":[0.9980229,0.00037918778,0.0010879821,0.00034071447,0.000015678686,0.00015350312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0118897455,0.0001738171,0.0012432954,0.000742737,0.000090598,0.000035597404,0.00012805963,0.00011694447,0.0000018328],"category_scores_gemma":[0.00025275443,0.00018951492,0.00013404059,0.00040074004,0.00006948591,0.00017982862,0.0000979984,0.0003666419,0.000002117256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048761496,0.0009973979,0.876127,0.010103023,0.00017061389,0.0000019363433,0.023161264,0.007604278,4.5050996e-7,0.079858765,0.000026395863,0.0019000839],"study_design_scores_gemma":[0.0013358286,0.0016823119,0.6053522,0.0016684942,0.000009867463,0.0000026273897,0.0048157685,0.381421,9.1465375e-7,0.0034903646,0.000045763984,0.00017483719],"about_ca_topic_score_codex":0.18789278,"about_ca_topic_score_gemma":0.0010410124,"teacher_disagreement_score":0.37381673,"about_ca_system_score_codex":0.0012550193,"about_ca_system_score_gemma":0.00046970492,"threshold_uncertainty_score":0.81751513},"labels":[],"label_agreement":null},{"id":"W4399707341","doi":"10.1016/j.jval.2024.03.1466","title":"MSR33 Health State Transition Probabilities for Duchenne Muscular Dystrophy: Estimation from Published Data","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Duchenne muscular dystrophy; State (computer science); Estimation; Transition (genetics); Computer science; Medicine; Genetics; Biology; Internal medicine; Algorithm; Engineering","score_opus":0.08834666782223398,"score_gpt":0.3642321675107141,"score_spread":0.2758854996884801,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707341","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.13095635,0.008875507,0.29828322,0.5552513,0.0013139164,0.0035105809,0.0014974595,0.00029213555,0.000019520343],"genre_scores_gemma":[0.91959786,0.0008631854,0.066250846,0.0023361922,0.00052822416,0.00009390974,0.010206715,0.0000502956,0.00007279535],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99790365,0.00018659685,0.00066899747,0.0005270557,0.00038343927,0.00033028622],"domain_scores_gemma":[0.9988915,0.00022596058,0.00009190094,0.00048759094,0.00007324515,0.00022980427],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025815878,0.00012664113,0.00033913192,0.00019324377,0.00009165028,0.0000762477,0.00010443637,0.00013129762,0.000031649884],"category_scores_gemma":[0.00019709507,0.000102672755,0.00005496194,0.00032958263,0.00014364097,0.00032080492,0.000024662068,0.00035231397,0.0000047345284],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00071375835,0.0008770122,0.000099042714,0.04002493,0.00024024014,0.00003322854,0.026413284,0.027813738,0.00049145793,0.04292509,0.0129117165,0.8474565],"study_design_scores_gemma":[0.0010557824,0.00053611386,0.0016743722,0.0018607749,0.000019976846,0.000007072835,0.00017833909,0.89753246,0.000017272516,0.08249174,0.014522817,0.000103292055],"about_ca_topic_score_codex":0.013122221,"about_ca_topic_score_gemma":0.00020214281,"teacher_disagreement_score":0.86971873,"about_ca_system_score_codex":0.00040062363,"about_ca_system_score_gemma":0.0016855869,"threshold_uncertainty_score":0.9934495},"labels":[],"label_agreement":null},{"id":"W4399707353","doi":"10.1016/j.jval.2024.03.1525","title":"MSR92 Quantitative Bias Analysis Under the Marginal Structural Modelling Framework","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Psychometric Methodologies and Testing","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Marginal structural model; Econometrics; Marginal model; Computer science; Economics; Machine learning; Causal inference; Regression analysis","score_opus":0.7966582806538572,"score_gpt":0.563932937089473,"score_spread":0.23272534356438423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707353","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.37691107,0.0066677695,0.6089005,0.00604667,0.00092507264,0.00012322642,0.000010147632,0.000048269318,0.00036728766],"genre_scores_gemma":[0.83432525,0.00016666093,0.16482864,0.00044442818,0.00009368386,0.000004735751,0.000001235242,0.000008703197,0.00012668986],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9948993,0.0020835653,0.0009132392,0.00060074584,0.001064786,0.00043841582],"domain_scores_gemma":[0.9078073,0.091150485,0.00024796603,0.00058716635,0.00009843932,0.00010866882],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.017274708,0.00014248959,0.00043059347,0.0013403186,0.00026115304,0.00042640913,0.0006666655,0.00008138624,0.00019283574],"category_scores_gemma":[0.016194737,0.00007701696,0.00020182409,0.013075447,0.00009706869,0.00015723646,0.000094745665,0.0005913191,0.000049120976],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010085666,0.000004259756,0.013903984,0.000013324749,0.00005509391,0.000005309552,0.0014061618,0.8374964,3.4222637e-7,0.1368763,0.0002295702,0.0099991895],"study_design_scores_gemma":[0.000025081532,0.00003496261,0.014637263,0.000048673974,0.000012419534,0.000002761747,0.0023345144,0.6098952,4.5503145e-7,0.37244597,0.0005050642,0.000057584693],"about_ca_topic_score_codex":0.0036111167,"about_ca_topic_score_gemma":0.000050351373,"teacher_disagreement_score":0.45741415,"about_ca_system_score_codex":0.00012171696,"about_ca_system_score_gemma":0.0002129822,"threshold_uncertainty_score":0.99209225},"labels":[],"label_agreement":null},{"id":"W4399707361","doi":"10.1016/j.jval.2024.03.1564","title":"MT26 HTA Requirements for Medical Technologies in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Quality and Safety in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Health technology; Business; Risk analysis (engineering); Economics; Economic growth; Health care","score_opus":0.23321602281303846,"score_gpt":0.5049669612891023,"score_spread":0.2717509384760639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707361","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32284606,0.01859418,0.00048373395,0.6414889,0.008669534,0.0054820827,0.00039759598,0.00065486727,0.0013830481],"genre_scores_gemma":[0.99003357,0.0022942394,0.000542991,0.0059352266,0.00020335184,0.0006727867,0.000041824715,0.000033307082,0.00024269162],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953866,0.0009908079,0.0015296305,0.00042512533,0.00057249086,0.0010953463],"domain_scores_gemma":[0.99640954,0.002873887,0.00012033023,0.00034603747,0.000049660368,0.00020057868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005237413,0.00015205583,0.00042522524,0.0002591569,0.00029482448,0.0000055222786,0.0003028759,0.00034751673,0.00015130936],"category_scores_gemma":[0.0019316754,0.00013840602,0.00003714634,0.00063373847,0.00004364,0.00008218317,0.00011586037,0.0014193843,0.000038417],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0002562547,0.00016187104,0.4214645,0.050857358,0.000039106548,0.0003152047,0.017520957,0.00064878055,0.0000042889865,0.23663788,0.088884644,0.18320915],"study_design_scores_gemma":[0.00328231,0.00050342904,0.042067472,0.030003306,0.000007927515,0.00001227135,0.07236202,0.09158035,0.000013300572,0.082802996,0.676563,0.0008015711],"about_ca_topic_score_codex":0.982239,"about_ca_topic_score_gemma":0.984325,"teacher_disagreement_score":0.6671875,"about_ca_system_score_codex":0.005512368,"about_ca_system_score_gemma":0.027936997,"threshold_uncertainty_score":0.9983053},"labels":[],"label_agreement":null},{"id":"W4399707392","doi":"10.1016/j.jval.2024.03.1416","title":"HTA65 How Does Conditional Regulatory Approval Affect the Reimbursement of Drugs in Canada?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Affect (linguistics); Business; Actuarial science; Medicine; Public economics; Economics; Political science; Psychology; Law; Health care","score_opus":0.05515011141921904,"score_gpt":0.284748897095249,"score_spread":0.22959878567602993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707392","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94869596,0.004281339,0.000030970794,0.042865872,0.0008475677,0.00039609833,0.0004524815,0.000008014923,0.0024216722],"genre_scores_gemma":[0.9977182,0.0004978822,0.000038394184,0.0014304005,0.00011468625,0.00003189863,0.000013276254,0.000013354531,0.00014190514],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9987928,0.000046691566,0.0005541242,0.00025816396,0.00004252309,0.00030565987],"domain_scores_gemma":[0.999363,0.0002141514,0.00014107344,0.00019296358,0.000005417102,0.000083377934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013671723,0.00009798183,0.00029733384,0.00018601322,0.00003353454,0.000026920148,0.00016483509,0.00003616905,0.000099362755],"category_scores_gemma":[0.000032016054,0.00008100053,0.00005583105,0.00020891393,0.000050307157,0.000071069175,0.000035611458,0.00023221376,0.000016595506],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012188091,0.000046062854,0.02871211,0.0005438391,0.00003420707,0.000004926031,0.0007973018,0.0052521722,0.000005424066,0.9549425,0.00795802,0.0016912167],"study_design_scores_gemma":[0.0011379009,0.0000962393,0.26273084,0.0003226405,0.000004519666,0.0000057496427,0.0005673977,0.3152925,0.00023194875,0.21015702,0.20900165,0.00045159433],"about_ca_topic_score_codex":0.5720229,"about_ca_topic_score_gemma":0.13960208,"teacher_disagreement_score":0.7447855,"about_ca_system_score_codex":0.0010847509,"about_ca_system_score_gemma":0.0009531361,"threshold_uncertainty_score":0.8760979},"labels":[],"label_agreement":null},{"id":"W4399707403","doi":"10.1016/j.jval.2024.03.1422","title":"HTA71 Cost-effectiveness of The Top 100 Drugs By Public Spending in Canada, 2015-2021: A Repeated Cross-sectional Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Cross-sectional study; Public spending; Medicine; Public economics; Environmental health; Economics; Political science; Law","score_opus":0.3557305371060618,"score_gpt":0.4518579696283128,"score_spread":0.09612743252225103,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707403","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827435,0.0037783682,0.00006816814,0.007749078,0.0020547183,0.0025458722,0.00059099955,0.00001872739,0.00045053934],"genre_scores_gemma":[0.9987601,0.000059536243,0.000030344767,0.000601561,0.00010408957,0.00021741644,0.000033384385,0.000030173338,0.00016337022],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9922146,0.0020803243,0.0042110723,0.0007126917,0.00022162059,0.0005596793],"domain_scores_gemma":[0.9957101,0.002589715,0.0009841832,0.0005127056,0.000045558416,0.00015778207],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.039755657,0.00018001412,0.0008397027,0.0005149282,0.00015350523,0.000115274015,0.0003618017,0.00009484794,0.00026129597],"category_scores_gemma":[0.0019446642,0.00019575833,0.000082249375,0.000978047,0.000048579364,0.00034747386,0.000084037936,0.0004246189,0.00008657912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014948017,0.00012082509,0.9831971,0.0007454324,0.000028976432,0.0000013246513,0.0009410112,0.0034463047,7.710017e-7,0.009655093,0.0017655042,0.00008274067],"study_design_scores_gemma":[0.00082562206,0.000058203186,0.97744125,0.00030386908,0.0000010795452,0.0000023595169,0.0008164509,0.012962742,0.0000035736198,0.001761837,0.005648203,0.00017483595],"about_ca_topic_score_codex":0.9446397,"about_ca_topic_score_gemma":0.43963224,"teacher_disagreement_score":0.50500745,"about_ca_system_score_codex":0.008598191,"about_ca_system_score_gemma":0.0038055917,"threshold_uncertainty_score":0.9952076},"labels":[],"label_agreement":null},{"id":"W4399707424","doi":"10.1016/j.jval.2024.03.1545","title":"MT7 Measures of ‘Life-Sustaining Medical-Technology’ for Caregivers of Children with Medical Complexity (CO-CMC)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Children's Hospital of Eastern Ontario; Queen's University","funders":"","keywords":"Psychology; Medicine; Computer science","score_opus":0.10915264787600246,"score_gpt":0.3828103692896667,"score_spread":0.2736577214136643,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91102797,0.007892856,0.003486577,0.07510238,0.00028047728,0.0015238272,0.00012777424,0.00022492371,0.00033319287],"genre_scores_gemma":[0.9959247,0.00042976206,0.0021935466,0.0010964258,0.00021659643,0.000033535147,0.00004814995,0.000043307045,0.000013953889],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959804,0.00025117132,0.0010787923,0.00045999273,0.0017430162,0.00048664692],"domain_scores_gemma":[0.99785125,0.0007609303,0.00026216282,0.00043855706,0.00016565551,0.0005214714],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038312222,0.00020568573,0.0010144212,0.00052753446,0.00005988235,0.000005709756,0.0003216205,0.00030548475,0.00012282825],"category_scores_gemma":[0.0036283892,0.00017219303,0.0001270649,0.0007736269,0.000761522,0.00004800959,0.00006827425,0.0006647373,0.0000021247542],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031130502,0.0017841284,0.7138006,0.033145048,0.0024553554,0.00019220897,0.04249949,0.00061189587,0.0000395565,0.08921289,0.018513376,0.094632424],"study_design_scores_gemma":[0.08489429,0.034341063,0.4735676,0.16954242,0.0012814404,0.0021871487,0.08740079,0.06650944,0.0055703525,0.034275997,0.036352295,0.0040771565],"about_ca_topic_score_codex":0.01436728,"about_ca_topic_score_gemma":0.0015217804,"teacher_disagreement_score":0.24023297,"about_ca_system_score_codex":0.00024257941,"about_ca_system_score_gemma":0.0062153907,"threshold_uncertainty_score":0.99941844},"labels":[],"label_agreement":null},{"id":"W4399707429","doi":"10.1016/j.jval.2024.03.1502","title":"MSR69 Systematic Review and Meta-Analysis of Fecal Incontinence Prevalence and Population Estimates","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pelvic floor disorders treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University; McGill University; Medtronic (Canada)","funders":"","keywords":"Meta-analysis; Fecal incontinence; Medicine; Systematic review; Population; Demography; Statistics; Environmental health; MEDLINE; Mathematics; Biology; Internal medicine; Surgery; Sociology","score_opus":0.06232413853045688,"score_gpt":0.36367108001422616,"score_spread":0.3013469414837693,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707429","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.14439914,0.8508624,0.000053586715,0.0030068024,0.000016168882,0.0015731436,0.00003330705,0.000030669296,0.000024783663],"genre_scores_gemma":[0.9797421,0.01864413,0.0010639046,0.00033762373,0.000002285463,0.000073388444,0.000018370381,0.000008575839,0.00010963206],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99872494,0.00016396902,0.00058176153,0.00023847118,0.0001752689,0.00011561334],"domain_scores_gemma":[0.99932957,0.000245939,0.00012614281,0.0002051621,0.000023716892,0.00006947042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008105727,0.00010691474,0.001421125,0.00022765722,0.000017164311,0.00000918945,0.000030466184,0.000028584758,0.00003105283],"category_scores_gemma":[0.0003259669,0.00007247607,0.00011855832,0.0005680608,0.0000283169,0.00006372282,0.000019337254,0.000065199914,0.000001890412],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004848342,0.00005679701,0.055910185,0.9317317,0.011593603,0.000009278839,0.00027473227,0.000072892704,0.000002970183,0.00027646785,0.000018420678,0.000048105212],"study_design_scores_gemma":[0.0004101226,0.00028929661,0.17906132,0.047683895,0.7029626,0.00005870786,0.000030386538,0.06875902,0.000005002603,0.000584868,0.0000024378373,0.00015235852],"about_ca_topic_score_codex":0.0025583673,"about_ca_topic_score_gemma":0.00006391338,"teacher_disagreement_score":0.8840478,"about_ca_system_score_codex":0.000056071145,"about_ca_system_score_gemma":0.00004947459,"threshold_uncertainty_score":0.3867503},"labels":[],"label_agreement":null},{"id":"W4399707497","doi":"10.1016/j.jval.2024.03.1418","title":"HTA67 Assessing Relationships Between the Canadian Agency for Drugs and Technologies in Health (CADTH) Revised ICERs and Unmet Need, Clinical Benefit, Price Reductions, and Listing Negotiation Timelines","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Timeline; Listing (finance); Negotiation; Agency (philosophy); Actuarial science; Business; Public economics; Economics; Political science; Finance; Geography; Sociology; Law","score_opus":0.5188958453963128,"score_gpt":0.4778721342510462,"score_spread":0.04102371114526665,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707497","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6072843,0.053320784,0.0010089994,0.3354281,0.000505545,0.0020123615,0.00020895185,0.00009977382,0.00013120417],"genre_scores_gemma":[0.9821181,0.0058187535,0.010167239,0.0013529082,0.00030657087,0.000101802434,0.000050561852,0.000032659995,0.00005139151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9941406,0.0008023574,0.0038876801,0.0006298213,0.00006634441,0.00047315925],"domain_scores_gemma":[0.9934641,0.004873759,0.0011418262,0.00026358906,0.00003886278,0.00021786446],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.043447934,0.00016241448,0.000722626,0.000834231,0.0007785441,0.00026641513,0.0001166842,0.00022694618,0.0000030561632],"category_scores_gemma":[0.008635169,0.000177836,0.00003914898,0.00057978195,0.00013029658,0.0004997934,0.000040529616,0.00059022446,0.000007808239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000069045723,0.000024797851,0.83625066,0.0038642408,0.00003648306,5.411042e-7,0.009568792,0.001383493,1.06141066e-7,0.11661546,0.0027012667,0.02954722],"study_design_scores_gemma":[0.00080724363,0.00015024758,0.71467334,0.0019441616,0.000010674941,0.000011003811,0.012146554,0.16315618,1.5301529e-7,0.07868698,0.028019186,0.00039427943],"about_ca_topic_score_codex":0.15761825,"about_ca_topic_score_gemma":0.022419302,"teacher_disagreement_score":0.37483382,"about_ca_system_score_codex":0.0011602768,"about_ca_system_score_gemma":0.0010897974,"threshold_uncertainty_score":0.9997155},"labels":[],"label_agreement":null},{"id":"W4399707525","doi":"10.1016/j.jval.2024.03.1401","title":"HTA50 A Review of Real-World Evidence in Non-Oncology Submissions Made to Four Health Technology Assessment (HTA) Agencies","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"ABB (Canada)","funders":"","keywords":"Real world evidence; Health technology; Medicine; Oncology; Medical physics; Internal medicine; Political science; Health care","score_opus":0.7504357945697503,"score_gpt":0.5934445643209937,"score_spread":0.1569912302487566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707525","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000019258674,0.8310605,0.00018629509,0.15949427,0.0011367315,0.0066535994,0.00041471847,0.00006744678,0.0009671366],"genre_scores_gemma":[0.000042990803,0.9740145,0.008704446,0.014155033,0.0002347993,0.0019863874,0.000058999874,0.00012052044,0.00068227627],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9723751,0.00334108,0.020630633,0.001867393,0.0003000697,0.0014857515],"domain_scores_gemma":[0.98525286,0.0035175313,0.008852818,0.0016397769,0.00009751541,0.0006394906],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.070309214,0.0007099149,0.010485792,0.005600562,0.0001454488,0.00003830308,0.0011740878,0.0006068572,0.00019976574],"category_scores_gemma":[0.0070178024,0.0007852674,0.00052802055,0.0046653314,0.00011759606,0.00022690183,0.00040918382,0.0017278126,0.0011348684],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000004182704,0.00019189437,0.0007121865,0.78881073,0.00008366077,0.000020179443,0.0013128414,0.000096843,2.7305704e-8,0.05422008,0.050407335,0.10414003],"study_design_scores_gemma":[0.0001301239,0.00031433554,0.00027118574,0.32726547,0.000022521981,0.000019336368,0.00022356774,0.00029940435,1.178904e-8,0.0016510065,0.66944146,0.00036157033],"about_ca_topic_score_codex":0.026135815,"about_ca_topic_score_gemma":0.003048675,"teacher_disagreement_score":0.6190341,"about_ca_system_score_codex":0.018659756,"about_ca_system_score_gemma":0.016671399,"threshold_uncertainty_score":0.99964285},"labels":[],"label_agreement":null},{"id":"W4399707539","doi":"10.1016/j.jval.2024.03.1238","title":"HSD15 The Economic and Humanistic Burden of Glioma in the United States and Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Humanism; Glioma; Medicine; Political science; Law; Cancer research","score_opus":0.03665541927340735,"score_gpt":0.25438938924989407,"score_spread":0.21773396997648672,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707539","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97388774,0.014957879,0.000013085324,0.009784255,0.00022553872,0.00019974218,0.00017111034,0.0000043042564,0.00075632223],"genre_scores_gemma":[0.9959667,0.0032884446,0.000014309739,0.0005840222,0.00006902687,0.000010124261,0.000007152565,0.000010102399,0.00005013243],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990407,0.000033737382,0.000511705,0.00019079991,0.000016219285,0.00020682727],"domain_scores_gemma":[0.9993837,0.00029875198,0.00012468724,0.0001499695,0.0000041417265,0.000038783706],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009833534,0.00008489163,0.00023842324,0.00018408059,0.000055902125,0.000059442496,0.00013424344,0.000032157164,0.00002223964],"category_scores_gemma":[0.00004280873,0.00006716288,0.000015208104,0.00013193484,0.00008036286,0.00007655277,0.000027122667,0.00014418809,0.0000050041253],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002386756,0.000014614553,0.036987737,0.0005079391,0.000029330386,0.000019807934,0.0113306,0.024477921,9.333653e-7,0.9182149,0.0062852926,0.0021070566],"study_design_scores_gemma":[0.0009257067,0.00027834298,0.17455761,0.0003301771,0.0000067447063,0.000039320304,0.0036903478,0.26949114,0.000006066247,0.17897955,0.37127656,0.00041843991],"about_ca_topic_score_codex":0.9664006,"about_ca_topic_score_gemma":0.46991676,"teacher_disagreement_score":0.73923534,"about_ca_system_score_codex":0.0003600771,"about_ca_system_score_gemma":0.00031829337,"threshold_uncertainty_score":0.5397559},"labels":[],"label_agreement":null},{"id":"W4399707546","doi":"10.1016/j.jval.2024.03.1410","title":"HTA59 Reception of RWE: A Deep Dive Into Recent Trends in CADTH Reimbursement Reviews","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Radiotherapy Techniques","field":"Physics and Astronomy","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Reimbursement; Medicine; Economics; Economic growth","score_opus":0.038839850277751296,"score_gpt":0.3766706451288825,"score_spread":0.3378307948511312,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707546","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22101595,0.25261304,0.48178178,0.022257114,0.0031321528,0.007480922,0.00013337885,0.0007014117,0.010884268],"genre_scores_gemma":[0.7934519,0.05723037,0.1464273,0.00052923826,0.000663652,0.000720309,0.00018771607,0.000116651,0.0006728488],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99847686,0.00024526473,0.00063997856,0.00027692138,0.00012498906,0.0002359879],"domain_scores_gemma":[0.9995096,0.000041744304,0.00014861446,0.00022901774,0.000016675564,0.000054396518],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008115581,0.00013267103,0.00033350187,0.00029961063,0.00002457249,0.000009666779,0.000102464866,0.00003453089,0.00033626435],"category_scores_gemma":[0.0000067416026,0.00011975275,0.00006377752,0.00069616694,0.000023875597,0.00009511314,0.000024326611,0.00023817125,0.000004114767],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014675492,0.00010759214,0.0058461125,0.00021307648,0.000009634789,0.000001096474,0.0032495677,0.000754063,0.00027596214,0.00776306,0.0011144,0.9806508],"study_design_scores_gemma":[0.0011418628,0.00097316847,0.0055357395,0.005229863,0.000016648573,0.0000017266422,0.0005483061,0.019984554,0.0030090862,0.047036406,0.91586393,0.00065873086],"about_ca_topic_score_codex":0.005790498,"about_ca_topic_score_gemma":0.00013038276,"teacher_disagreement_score":0.97999203,"about_ca_system_score_codex":0.00053869205,"about_ca_system_score_gemma":0.00008094845,"threshold_uncertainty_score":0.875354},"labels":[],"label_agreement":null},{"id":"W4399707548","doi":"10.1016/j.jval.2024.03.1468","title":"MSR35 Item Performance and Structural Validity of the Quick Motor Function Test Among Late Onset Pompe Disease Patients","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Motor function; Test (biology); Disease; Medicine; Physical medicine and rehabilitation; Pediatrics; Psychology; Internal medicine; Biology","score_opus":0.0333405642869374,"score_gpt":0.2990191846627695,"score_spread":0.2656786203758321,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720764,0.0007337786,0.0000021086828,0.0008220357,0.0003148673,0.0007750622,0.000078530786,0.000028289958,0.00003766098],"genre_scores_gemma":[0.99936336,0.00018662467,0.000015863505,0.00012725199,0.00004995901,0.0000149280995,0.000022462318,0.000016447326,0.00020309984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998675,0.00015203463,0.00028122793,0.0002257797,0.0004067841,0.00025918914],"domain_scores_gemma":[0.99926585,0.00020530086,0.000059688515,0.00021803899,0.000060308645,0.0001908362],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00033895957,0.000101278856,0.00017285935,0.0001087807,0.000095716256,0.000017514596,0.00007273023,0.000041710915,0.000029229725],"category_scores_gemma":[0.00043734338,0.00006790872,0.00004509641,0.00034301262,0.00011173063,0.0001137952,0.00006667888,0.00028206807,0.0000055957084],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014679677,0.000057414058,0.9948835,0.0017808109,0.000007065424,0.0000048306692,0.0002700262,0.00008834776,0.000014278152,0.000010183171,0.00017909557,0.002557655],"study_design_scores_gemma":[0.0005086061,0.0004719705,0.93759835,0.0005613053,0.000011704853,0.0000022233507,0.000025327497,0.06052427,0.000014237099,0.00009774917,0.00013177458,0.000052503794],"about_ca_topic_score_codex":0.0016769264,"about_ca_topic_score_gemma":0.00003393431,"teacher_disagreement_score":0.06043592,"about_ca_system_score_codex":0.00020897527,"about_ca_system_score_gemma":0.00033202706,"threshold_uncertainty_score":0.27692372},"labels":[],"label_agreement":null},{"id":"W4399707561","doi":"10.1016/j.jval.2024.03.1423","title":"HTA72 Molnupiravir for Treatment of Non-Hospitalized Adults With Laboratory-Confirmed, Mild/Moderately Severe COVID-19: A Systematic Evidence Review With Meta-Analysis and Trial Sequential Analysis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Meta-analysis; Coronavirus disease 2019 (COVID-19); Medicine; Pooled analysis; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Randomized controlled trial; Internal medicine; Virology; Disease","score_opus":0.175861346611818,"score_gpt":0.44529553063205407,"score_spread":0.2694341840202361,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399707561","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59114057,0.36883765,0.0099449735,0.0068137245,0.0000782896,0.022576518,0.0004773972,0.000112948735,0.000017950644],"genre_scores_gemma":[0.9761814,0.004959989,0.002253468,0.012072392,0.00008296337,0.0042857123,0.000047380225,0.00006588836,0.00005082869],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.995257,0.00095864886,0.0013928814,0.00094521965,0.00094742817,0.00049882114],"domain_scores_gemma":[0.9966882,0.0013663002,0.00045333084,0.00082362007,0.00039529233,0.00027326014],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029871895,0.00042408064,0.0042571146,0.0011170835,0.000104338294,0.00007700694,0.00015552949,0.00011507222,0.00003064305],"category_scores_gemma":[0.00061035465,0.00024439328,0.00096219237,0.0049283826,0.00013357066,0.00014976389,0.000022712497,0.00014229259,0.0000033571528],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06642845,0.0010851774,0.006198979,0.62828684,0.29001215,0.0005968549,0.005587122,0.001208608,0.00009065856,0.0001348524,0.00013515877,0.00023516013],"study_design_scores_gemma":[0.0559759,0.023792734,0.00044019206,0.034486387,0.7959318,0.00009010621,0.000697899,0.08550896,0.0008715784,0.000061861414,0.0012431387,0.0008994032],"about_ca_topic_score_codex":0.0143573405,"about_ca_topic_score_gemma":0.0015941396,"teacher_disagreement_score":0.5938004,"about_ca_system_score_codex":0.000735437,"about_ca_system_score_gemma":0.004424446,"threshold_uncertainty_score":0.9966068},"labels":[],"label_agreement":null},{"id":"W4400381667","doi":"10.1016/j.jval.2024.06.005","title":"Traditional Methods Hold Their Ground Against Machine Learning in Predicting Potentially Inappropriate Medication Use in Older Adults","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Practices and Patient Outcomes","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre hospitalier de l'Université Laval; Université du Québec à Rimouski; Université Laval; Institut Universitaire en Santé Mentale de Québec; Centre de Santé et de Services Sociaux de la Vieille-Capitale; Institut National de Santé Publique du Québec","funders":"Fonds de Recherche du Québec - Santé; Canadian Institutes of Health Research; Ministère de l'Enseignement supérieur, de la Recherche et de l'Innovation; Institut National de Santé Publique du Québec","keywords":"Machine learning; Medicine; Logistic regression; Pharmacoepidemiology; Artificial intelligence; Psychological intervention; Random forest; Psychiatry; Computer science; Medical prescription","score_opus":0.21793360919109364,"score_gpt":0.4235287174755394,"score_spread":0.20559510828444574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400381667","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9851724,0.0031579204,0.0017731596,0.00804567,0.0006068435,0.0008759549,0.000016756294,0.000091662114,0.0002596268],"genre_scores_gemma":[0.9917387,0.0015037943,0.00487634,0.0014340949,0.00015340462,0.000040780407,0.0001752275,0.000028679302,0.000048996495],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9971382,0.0010528847,0.00074253685,0.00037717776,0.00032898763,0.00036022346],"domain_scores_gemma":[0.99799883,0.0015416293,0.00013629781,0.0001280257,0.000021667649,0.00017352997],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037356364,0.00015494734,0.00032293753,0.00043963,0.000051953513,0.00004017508,0.00007444136,0.00010780828,0.000043205517],"category_scores_gemma":[0.0009321548,0.00012862308,0.000058748457,0.0005696579,0.000034727196,0.00039048868,0.000033325552,0.0013280133,0.0000061139162],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000868906,0.0010614198,0.69628155,0.003783287,0.00006652005,0.00027001614,0.012462897,0.011140176,0.0004447155,0.0014303596,0.000046952508,0.27214321],"study_design_scores_gemma":[0.0020297065,0.0001715475,0.3120509,0.0025090836,0.00001107982,0.000024932033,0.0003082242,0.6806763,0.00002536351,0.00032813745,0.0017607997,0.0001039317],"about_ca_topic_score_codex":0.00406882,"about_ca_topic_score_gemma":0.00018095315,"teacher_disagreement_score":0.6695361,"about_ca_system_score_codex":0.0003616869,"about_ca_system_score_gemma":0.00033705853,"threshold_uncertainty_score":0.61508656},"labels":[],"label_agreement":null},{"id":"W4401475055","doi":"10.1016/j.jval.2024.07.018","title":"Cost-Effectiveness Analysis of Bevacizumab Biosimilars Versus Originator Bevacizumab for Metastatic Colorectal Cancer: A Comparative Study Using Real-World Data","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; Canadian Centre for Applied Research in Cancer Control; Health Sciences Centre; Cancer Care Ontario; Sunnybrook Health Science Centre","funders":"Kementerian Kesihatan Malaysia; Institute for Clinical Evaluative Sciences; Ontario Ministry of Health and Long-Term Care; Ontario Institute for Cancer Research; Ministry of Long-Term Care; Johns Hopkins University; Ministry of Health, Ontario","keywords":"Bevacizumab; Biosimilar; Medicine; Colorectal cancer; Oncology; Internal medicine; Cancer; Chemotherapy","score_opus":0.37779171903743725,"score_gpt":0.5155538795367467,"score_spread":0.13776216049930945,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401475055","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98179317,0.0066243857,0.0016708826,0.00041904522,0.0015295035,0.0035505553,0.0043109534,0.000066365596,0.00003515471],"genre_scores_gemma":[0.9963563,0.00030385057,0.0027975116,0.000042121974,0.000025164638,0.00018770577,0.00023937384,0.000024107547,0.000023872482],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9954215,0.0021839528,0.00084909983,0.0008654263,0.00010776452,0.0005722343],"domain_scores_gemma":[0.9952929,0.0037030391,0.00027633252,0.00053868204,0.00012235239,0.00006671535],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031216894,0.00030108157,0.0015292976,0.0010070292,0.00015931645,0.000030802905,0.00045048923,0.000099508245,0.00007749989],"category_scores_gemma":[0.0001613582,0.00025083005,0.00020737993,0.003260199,0.00029948898,0.0001286771,0.00017902761,0.00037127789,0.0000028733007],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.11485667,0.02323089,0.20711325,0.016415602,0.20282188,0.00036400228,0.038428593,0.09733974,0.061440576,0.04902101,0.007769264,0.18119854],"study_design_scores_gemma":[0.027682682,0.013675533,0.07879355,0.0020611952,0.026278092,0.000020472076,0.009457589,0.7817259,0.033419922,0.0009099975,0.023725824,0.0022492472],"about_ca_topic_score_codex":0.016727006,"about_ca_topic_score_gemma":0.011010646,"teacher_disagreement_score":0.68438613,"about_ca_system_score_codex":0.00075277046,"about_ca_system_score_gemma":0.00081237586,"threshold_uncertainty_score":0.9999944},"labels":[],"label_agreement":null},{"id":"W4402911985","doi":"10.1016/j.jval.2024.08.006","title":"Cancer Drug Wastage and Mitigation Methods: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Safe Handling of Antineoplastic Drugs","field":"Health Professions","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; Sunnybrook Health Science Centre; University of Waterloo","funders":"Natural Sciences and Engineering Research Council of Canada","keywords":"Drug; Cancer drugs; Medicine; Risk analysis (engineering); Computer science; Pharmacology","score_opus":0.19274743006600628,"score_gpt":0.5552582697846506,"score_spread":0.3625108397186444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402911985","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000013086167,0.9851069,0.00009339927,0.0017083824,0.0024119236,0.010196227,0.00012531035,0.0001468372,0.00020971063],"genre_scores_gemma":[2.265745e-7,0.98970246,0.0031394705,0.0014724709,0.0003203139,0.002964516,0.000053179883,0.00013222132,0.0022151165],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9844859,0.009927751,0.0037120418,0.0007440795,0.00036342294,0.00076678285],"domain_scores_gemma":[0.9913223,0.005979627,0.0017309313,0.0006129182,0.00008726681,0.00026699947],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01198091,0.0005562945,0.005215107,0.00047849398,0.00027369516,0.000020101601,0.00028492123,0.00032121866,0.000073304254],"category_scores_gemma":[0.002588772,0.00038810185,0.0002763258,0.00093588466,0.000047236754,0.00006557752,0.00020162103,0.0019842023,0.00043701287],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[7.9518986e-7,0.000010041486,0.0000038162743,0.9617913,0.00006782629,0.000008471735,0.0010140974,7.793229e-7,3.8009143e-9,0.0007209346,0.0041737873,0.032208156],"study_design_scores_gemma":[0.00008469639,0.000010601697,5.940023e-7,0.72166663,0.0011929411,0.000011332481,0.00014666126,0.00013586137,5.254081e-9,0.00014395284,0.27640465,0.00020209601],"about_ca_topic_score_codex":0.0042173257,"about_ca_topic_score_gemma":0.00016139826,"teacher_disagreement_score":0.27223083,"about_ca_system_score_codex":0.00094669545,"about_ca_system_score_gemma":0.0071047167,"threshold_uncertainty_score":0.99985707},"labels":[],"label_agreement":null},{"id":"W4403312365","doi":"10.1016/j.jval.2024.08.010","title":"Practicality, Validity, and Responsiveness of Using the Proxy Version of the Child Health Utility–9 Dimensions With Children Aged 2 to 5 Years","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Dermatology and Skin Diseases","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Institute of Genetics; St. George's, University of London; King's College London; Health Technology Assessment Programme; Imperial College London; University of Southampton; University of Bristol; Department of Health and Social Care; University of East Anglia; National Institute for Health and Care Research","keywords":"Proxy (statistics); Psychology; Statistics; Mathematics","score_opus":0.054092718845381284,"score_gpt":0.36197360373863696,"score_spread":0.30788088489325566,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403312365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9724884,0.0017443089,0.000027357317,0.024505284,0.00009813232,0.0010506738,0.000038914048,0.000013960019,0.00003294014],"genre_scores_gemma":[0.9983746,0.00013037563,0.0002692667,0.0011805419,0.000017394608,0.0000047937197,0.000004461602,0.000009944636,0.000008651012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99815434,0.0009019115,0.00031233192,0.00019720386,0.0002502254,0.00018396488],"domain_scores_gemma":[0.99893975,0.00046599924,0.00010474658,0.00033638254,0.00003521184,0.00011789003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001211655,0.00007971942,0.0002798404,0.00009911405,0.00012898332,0.000006068106,0.00007829341,0.000042568063,0.000006823599],"category_scores_gemma":[0.00036810245,0.000044637934,0.00004109387,0.0004378259,0.00019281697,0.000038025926,0.00010148822,0.00025959144,8.604518e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012547647,0.00040415884,0.9884352,0.0016782075,0.00006482112,0.000028391933,0.0036682389,0.00039336478,0.000058301783,0.00089720107,0.0025644857,0.00055284984],"study_design_scores_gemma":[0.00044532152,0.00022416914,0.9950039,0.0023525706,0.000040798353,0.00026063362,0.00027204864,0.00066698407,0.00015681807,0.00024309818,0.00029109424,0.000042593867],"about_ca_topic_score_codex":0.0018832652,"about_ca_topic_score_gemma":0.00003874672,"teacher_disagreement_score":0.02588614,"about_ca_system_score_codex":0.0000549682,"about_ca_system_score_gemma":0.000980515,"threshold_uncertainty_score":0.2846946},"labels":[],"label_agreement":null},{"id":"W4403541333","doi":"10.1016/j.jval.2024.09.014","title":"Virtual/Mobile Overdose Response in Canada: A Social Return on Investment Analysis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Opioid Use Disorder Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Constellation Brands (Canada); University of Saskatchewan; University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; Health Canada","keywords":"Value (mathematics); Computer science; Machine learning","score_opus":0.02501470561577147,"score_gpt":0.3134173058057576,"score_spread":0.28840260018998615,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403541333","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9866627,0.0023193257,0.000003525962,0.009725467,0.00021151194,0.0007786918,0.000057395155,0.000039467614,0.00020191149],"genre_scores_gemma":[0.9956274,0.00022045136,0.00007083702,0.0035237207,0.000053706375,0.00015524933,0.000049999533,0.000026246189,0.00027239523],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99779046,0.0004804732,0.0004940779,0.0004075616,0.00042475548,0.0004026677],"domain_scores_gemma":[0.9991731,0.00030904144,0.000054578803,0.00027275845,0.000015323729,0.00017520097],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007694139,0.00017100266,0.00047649542,0.0006893681,0.000043918382,0.000013659846,0.000059883416,0.000061102706,0.000071446935],"category_scores_gemma":[0.00008942523,0.00015258159,0.00009954472,0.001626036,0.000019207953,0.000029022127,0.00002427378,0.00031209883,0.00002003529],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.022152454,0.0071495376,0.60195184,0.004209195,0.0040469808,0.011342277,0.15407695,0.096272856,0.0004280081,0.017726192,0.040726617,0.03991711],"study_design_scores_gemma":[0.003221627,0.0031854194,0.93052053,0.0011162055,0.0002613923,0.000010778329,0.0055629797,0.039190564,0.00010985825,0.0003389586,0.016134532,0.00034712657],"about_ca_topic_score_codex":0.9112122,"about_ca_topic_score_gemma":0.60816866,"teacher_disagreement_score":0.32856873,"about_ca_system_score_codex":0.0084272,"about_ca_system_score_gemma":0.009076991,"threshold_uncertainty_score":0.9965406},"labels":[],"label_agreement":null},{"id":"W4403848153","doi":"10.1016/j.jval.2024.08.011","title":"A Systematic Review and Quality Assessment of Cardiovascular Disease–Specific Health-Related Quality-of-Life Instruments: Part II Psychometric Properties","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Cardiac Health and Mental Health","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Population Health Research Institute; McMaster University; Impact; Hamilton Health Sciences","funders":"","keywords":"Quality (philosophy); Medicine; Health related quality of life; Disease; Quality of life (healthcare); Internal medicine; Nursing; Physics","score_opus":0.3208061537794114,"score_gpt":0.45973373501746206,"score_spread":0.13892758123805066,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403848153","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00041395638,0.9764348,0.000004985048,0.0012904393,0.0009686219,0.020184847,0.00051763986,0.000069787544,0.00011490655],"genre_scores_gemma":[0.0009318958,0.9960552,0.00015316745,0.0009791002,0.0000995514,0.0012789197,0.00028803133,0.00011159817,0.00010252118],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.97680515,0.00792744,0.011360358,0.0011633342,0.0017800421,0.0009636612],"domain_scores_gemma":[0.9922211,0.00037853693,0.0034675347,0.0019289413,0.00017470005,0.0018291466],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.02363722,0.00079097925,0.017288987,0.0013070904,0.00017056266,0.000015444728,0.00023973912,0.0003012561,0.00001594131],"category_scores_gemma":[0.0011967894,0.00056468253,0.0020615316,0.003208519,0.00016219476,0.0000775121,0.00018599578,0.0012468074,0.0000127505145],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000306775,0.0004093961,0.00008946919,0.94786364,0.001099505,0.0000031188752,0.00016541689,0.000002323503,6.380617e-9,0.0006878266,0.00027950632,0.049369123],"study_design_scores_gemma":[0.00095678546,0.0006002902,0.00023979125,0.85990494,0.0033419512,0.000043072472,0.000104825536,0.000010084941,1.0343494e-8,0.000018376217,0.13445227,0.00032758998],"about_ca_topic_score_codex":0.008630621,"about_ca_topic_score_gemma":0.00000830134,"teacher_disagreement_score":0.13417275,"about_ca_system_score_codex":0.0025664775,"about_ca_system_score_gemma":0.012417929,"threshold_uncertainty_score":0.99968046},"labels":[],"label_agreement":null},{"id":"W4404033981","doi":"10.1016/j.jval.2024.07.027","title":"Recommendations on the Use of Structured Expert Elicitation Protocols for Healthcare Decision Making: A Good Practices Report of an ISPOR Task Force","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Agency for Drugs and Technologies in Health","funders":"Zorginstituut Nederland","keywords":"Task force; Task (project management); Health care; Expert elicitation; Management science; Knowledge management; Computer science; Engineering; Political science; Systems engineering","score_opus":0.7180426693790085,"score_gpt":0.5606838886825213,"score_spread":0.15735878069648723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404033981","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40547916,0.0027114085,0.045561675,0.4754255,0.0020459339,0.065533474,0.0029208148,0.0001395275,0.00018248925],"genre_scores_gemma":[0.850474,0.00022810575,0.1253131,0.011594341,0.00038641202,0.011534708,0.00024437552,0.0000917411,0.0001331868],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99288195,0.0008118541,0.0052577686,0.00057867245,0.00015489971,0.00031487673],"domain_scores_gemma":[0.9853399,0.007947996,0.0057551796,0.00071099185,0.0001452214,0.000100706624],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.019902013,0.00016066863,0.00073202106,0.0005062124,0.00016945446,0.000084999214,0.00022590821,0.00013275175,0.00004454196],"category_scores_gemma":[0.014185988,0.00015528967,0.00010955449,0.00041451387,0.000038909253,0.0007079345,0.00002413691,0.0002095586,0.000011749004],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004966183,0.0005759949,0.007769058,0.008432636,0.00011599406,0.0000047910353,0.027258314,0.0145526165,0.000027152786,0.87854534,0.034634024,0.027587479],"study_design_scores_gemma":[0.0013162496,0.0021589992,0.01269906,0.007280996,0.000008250934,0.000045207686,0.004661438,0.35057762,0.00006620791,0.16755618,0.45311496,0.0005148262],"about_ca_topic_score_codex":0.0064194137,"about_ca_topic_score_gemma":0.0007086305,"teacher_disagreement_score":0.7109891,"about_ca_system_score_codex":0.0006531212,"about_ca_system_score_gemma":0.0007992742,"threshold_uncertainty_score":0.9941179},"labels":[],"label_agreement":null},{"id":"W4405430941","doi":"10.1016/j.jval.2024.11.006","title":"A Systematic Literature Review of Important and Meaningful Differences in the EQ-5D Index and Visual Analog Scale Scores","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"EuroQol Research Foundation; University of Alberta","keywords":"Visual analogue scale; Index (typography); EQ-5D; Scale (ratio); Psychology; Systematic review; Information retrieval; Data science; Computer science; Medicine; MEDLINE; Physical therapy; Geography; Cartography; World Wide Web; Political science; Internal medicine; Health related quality of life","score_opus":0.41921742846961346,"score_gpt":0.45090343827925894,"score_spread":0.03168600980964548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405430941","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006048645,0.9918153,0.000011284581,0.003048312,0.00027182608,0.0038452472,0.00032655633,0.000013157932,0.00006344665],"genre_scores_gemma":[0.00093591196,0.99614066,0.00008667229,0.0021951057,0.0001194104,0.00041248725,0.000044669276,0.000037491187,0.000027579961],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9850371,0.002844053,0.010715843,0.0007915114,0.00017753869,0.000433952],"domain_scores_gemma":[0.99180543,0.0025067425,0.005041934,0.00046955142,0.000032874414,0.00014346866],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.041828696,0.00042432413,0.0061463816,0.0010097441,0.00007536957,0.0001405318,0.0003427774,0.0002847335,0.0000117582595],"category_scores_gemma":[0.002840741,0.00031589365,0.00021973212,0.000999086,0.000098516626,0.00016213323,0.000094230316,0.0007051158,0.000025930369],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000109578,0.000035749174,0.003496757,0.98420775,0.000049438648,0.0000052342084,0.0021044258,3.3492987e-7,4.5400347e-10,0.008241233,0.00046204767,0.0013959548],"study_design_scores_gemma":[0.00014796479,0.00011232747,0.0009776865,0.98163766,0.00007220028,0.00008707775,0.0003628862,0.0013164098,9.821426e-10,0.0026167296,0.012380199,0.00028886495],"about_ca_topic_score_codex":0.001754123,"about_ca_topic_score_gemma":0.0003083147,"teacher_disagreement_score":0.038987957,"about_ca_system_score_codex":0.00039569466,"about_ca_system_score_gemma":0.0005795581,"threshold_uncertainty_score":0.9999293},"labels":[],"label_agreement":null},{"id":"W4405747884","doi":"10.1016/j.jval.2024.10.1188","title":"EPH58 Potential Public Health Impact of Respiratory Syncytial Virus (RSV) Vaccines for Prevention of Lower Respiratory Tract Disease (LRTD) Due to RSV Among Older Adults in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Respiratory system; Medicine; Virology; Respiratory tract; Virus; Respiratory tract infections; Disease; Public health; Immunology; Intensive care medicine; Internal medicine; Pathology","score_opus":0.064567905199115,"score_gpt":0.3947542920701955,"score_spread":0.33018638687108054,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405747884","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988629,0.004664986,0.0004302087,0.0011720785,0.0006177906,0.0041223485,0.00029546148,0.000045291297,0.000022839424],"genre_scores_gemma":[0.99847573,0.00006808287,0.000084520114,0.00061717327,0.00029798388,0.0003080524,0.00002914895,0.00008287845,0.000036447127],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9944136,0.0010211711,0.0019358419,0.00073515816,0.0008752806,0.0010189139],"domain_scores_gemma":[0.99721,0.0002984769,0.00036521602,0.00068007753,0.00032800753,0.0011181805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0031148149,0.00033297137,0.00097973,0.0017173381,0.00009681774,0.0000346692,0.00022931119,0.00014201544,0.00014871708],"category_scores_gemma":[0.0010312443,0.00030627137,0.00032594393,0.0017549234,0.000069644775,0.00036381383,0.000073632036,0.0006117874,0.0000053890044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.009047639,0.0059284614,0.8114002,0.029262071,0.00033731625,0.0011999221,0.0016150934,0.019063726,0.0045323954,0.00051045546,0.01258707,0.104515694],"study_design_scores_gemma":[0.0030277134,0.004662874,0.9837372,0.0030727815,0.000018744075,0.000010210205,0.00013452063,0.0038797099,0.00031728836,0.000080279075,0.00081938045,0.00023935299],"about_ca_topic_score_codex":0.7332069,"about_ca_topic_score_gemma":0.40496865,"teacher_disagreement_score":0.3282383,"about_ca_system_score_codex":0.004823196,"about_ca_system_score_gemma":0.029524013,"threshold_uncertainty_score":0.99993896},"labels":[],"label_agreement":null},{"id":"W4405747899","doi":"10.1016/j.jval.2024.10.1134","title":"EPH1 Universal Health Coverage and Education Are the Decisive Socio-Economic Disparities in Cervical Cancer Mortality in the Dominican Republic: A Multi-Dimensional Ecological Approach in a Middle-Income Caribbean Country","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Systems and Reforms","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Socioeconomics; Geography; Caribbean island; Cervical cancer; Low and middle income countries; Development economics; Economic growth; Demography; Economics; Ecology; Cancer; Medicine; Developing country; Sociology; Biology","score_opus":0.08496243427694809,"score_gpt":0.3199091532595594,"score_spread":0.23494671898261127,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405747899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9658523,0.0118051525,0.000013062261,0.019856993,0.00067862606,0.0012192714,0.00043017566,0.000013554406,0.00013083556],"genre_scores_gemma":[0.99486583,0.0022729356,0.000079082405,0.0023177708,0.00013277859,0.0002412865,0.000037631642,0.000017915116,0.000034746812],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99673367,0.00051648146,0.0014417465,0.0006424033,0.000087917026,0.0005777688],"domain_scores_gemma":[0.99880105,0.00036311735,0.0003664753,0.0003165701,0.000012609564,0.0001401455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005533226,0.00019641916,0.00070057734,0.0003856547,0.00014688936,0.00010536371,0.00026305846,0.00021114608,0.00001467372],"category_scores_gemma":[0.00008718716,0.00013358306,0.000067255605,0.00049163983,0.00013503498,0.00016752655,0.000083110186,0.0008261104,0.0000052342243],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000024223998,0.0003337713,0.9227988,0.00083984184,0.000013724468,0.000012228984,0.0068599754,0.0040128287,1.1740526e-8,0.06348452,0.0000887899,0.0015312711],"study_design_scores_gemma":[0.0006662136,0.00006530973,0.95133317,0.000398065,6.7845247e-7,0.0000136380195,0.004996852,0.035686795,1.2601188e-8,0.0059082475,0.0007861029,0.00014493556],"about_ca_topic_score_codex":0.51841956,"about_ca_topic_score_gemma":0.10863422,"teacher_disagreement_score":0.40978536,"about_ca_system_score_codex":0.003294091,"about_ca_system_score_gemma":0.0017784524,"threshold_uncertainty_score":0.90763086},"labels":[],"label_agreement":null},{"id":"W4405747902","doi":"10.1016/j.jval.2024.10.1105","title":"EE825 Induction Cost Per Responder of Brodalumab Compared With Other Biologic Therapies for Patients With Moderate to Severe Plaque Psoriasis in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Plaque psoriasis; Medicine; Psoriasis; Intensive care medicine; Internal medicine; Dermatology","score_opus":0.2690856578362003,"score_gpt":0.37022759550900247,"score_spread":0.10114193767280216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405747902","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781483,0.00092725275,0.0012474017,0.015989618,0.0003897734,0.00233597,0.0008693602,0.000018225286,0.00007410234],"genre_scores_gemma":[0.9926347,0.000045774144,0.0033014545,0.003477543,0.00006498108,0.00031524643,0.000047211004,0.00003769127,0.00007540727],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996617,0.00037198374,0.0020064965,0.0005086578,0.000097145145,0.00039867495],"domain_scores_gemma":[0.9981937,0.000738409,0.0006135222,0.0002711209,0.00006829336,0.00011500298],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0043922095,0.00017472202,0.0007867914,0.00047782002,0.00007230005,0.000032703596,0.00013335951,0.0000765703,0.00006608505],"category_scores_gemma":[0.0002344352,0.0001649526,0.000027971015,0.00037556636,0.00002786667,0.00019924658,0.000013792007,0.00015559443,0.000020801452],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021869405,0.00027520893,0.7337536,0.0024743737,0.00015370938,0.0000011043637,0.01565668,0.21238908,0.0000010322865,0.02562348,0.0064524245,0.0010323471],"study_design_scores_gemma":[0.011068954,0.0024729539,0.762233,0.0031387499,0.000011932329,0.000008216082,0.011204224,0.107553795,0.000013256194,0.011721064,0.08905349,0.0015203467],"about_ca_topic_score_codex":0.77905595,"about_ca_topic_score_gemma":0.64259255,"teacher_disagreement_score":0.13646342,"about_ca_system_score_codex":0.0026815124,"about_ca_system_score_gemma":0.0020609554,"threshold_uncertainty_score":0.70120615},"labels":[],"label_agreement":null},{"id":"W4405747907","doi":"10.1016/j.jval.2024.10.786","title":"EE505 Cost-Effectiveness Analysis of Contemporary Advanced Prostate Cancer Management: A Markov Model for the Canadian Context","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; Université de Montréal","funders":"","keywords":"Prostate cancer; Context (archaeology); Markov model; Medicine; Computer science; Markov chain; Cancer; Internal medicine; Machine learning; Geography","score_opus":0.37672867186323644,"score_gpt":0.4511636758316838,"score_spread":0.07443500396844738,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405747907","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1865017,0.3379319,0.0893492,0.29298583,0.0055533377,0.047206607,0.029818973,0.00027794944,0.010374521],"genre_scores_gemma":[0.98938894,0.001436163,0.0008543168,0.005056315,0.000047106238,0.0024856504,0.000081602215,0.00003907293,0.0006108013],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99553174,0.00041482877,0.002847839,0.0005925859,0.000091595655,0.00052140787],"domain_scores_gemma":[0.99629265,0.0020878054,0.0008807562,0.00045600158,0.00006560263,0.0002171589],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019487299,0.00018429158,0.0011026519,0.0012353366,0.0002274315,0.000071999115,0.00026225112,0.00009005135,0.000047374895],"category_scores_gemma":[0.0003600266,0.00019198914,0.00021245204,0.0010393928,0.00007069904,0.00026563072,0.000028027725,0.00017480884,0.000029108971],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011878325,0.00006183119,0.034005556,0.0062633725,0.0014134595,0.000002656797,0.007107067,0.5846498,2.56641e-7,0.34846237,0.005669672,0.012245203],"study_design_scores_gemma":[0.00070238824,0.000040942676,0.016909672,0.0004850507,0.000040623774,2.8435068e-7,0.00086313556,0.94243425,5.629809e-7,0.005945719,0.03239552,0.0001818239],"about_ca_topic_score_codex":0.51727355,"about_ca_topic_score_gemma":0.28504643,"teacher_disagreement_score":0.80288726,"about_ca_system_score_codex":0.0025270826,"about_ca_system_score_gemma":0.0016686606,"threshold_uncertainty_score":0.782909},"labels":[],"label_agreement":null},{"id":"W4405747910","doi":"10.1016/j.jval.2024.10.801","title":"EE520 Cost-Effectiveness Analysis of the Use of the 20-Valent Anti-Pneumococcal Vaccine (PCV20) in the Spanish Pediatric Population","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Pneumococcal vaccine; Pediatrics; Intensive care medicine; Streptococcus pneumoniae; Biology; Microbiology","score_opus":0.13102963057697772,"score_gpt":0.41824267927377085,"score_spread":0.2872130486967931,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405747910","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98660374,0.0009776859,0.000031815285,0.0074351304,0.0011463108,0.0036200357,0.00014231693,0.000023474231,0.000019500283],"genre_scores_gemma":[0.99788886,0.0008410644,0.000014979162,0.00091185106,0.00023884683,0.000031512915,0.000025172192,0.000021244567,0.00002646454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99150133,0.0058417153,0.0013045591,0.0003499206,0.00049258507,0.000509887],"domain_scores_gemma":[0.99628246,0.0023704045,0.0005062662,0.0006967772,0.000069656,0.00007443866],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041173263,0.00017795386,0.0006036106,0.00044562173,0.00034372334,0.000012302057,0.00038481748,0.00014481563,0.000024594501],"category_scores_gemma":[0.00038293435,0.000091385824,0.00025134505,0.0042731967,0.000029661347,0.000101771904,0.00014429365,0.0011182233,0.00000443798],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035377398,0.00019563381,0.96569324,0.0024372751,0.000028064467,0.000001138318,0.0032556455,0.025944594,0.00002287453,0.0015220266,0.00032385386,0.0005402553],"study_design_scores_gemma":[0.00046213684,0.000041887513,0.9796324,0.0013608291,0.00013075693,8.195778e-7,0.00035523673,0.017093387,0.0000044235558,0.0001890009,0.00065318175,0.0000759477],"about_ca_topic_score_codex":0.022143118,"about_ca_topic_score_gemma":0.0042634765,"teacher_disagreement_score":0.01787964,"about_ca_system_score_codex":0.00047486747,"about_ca_system_score_gemma":0.0008043232,"threshold_uncertainty_score":0.9843685},"labels":[],"label_agreement":null},{"id":"W4405747922","doi":"10.1016/j.jval.2024.10.1135","title":"EPH2 Costs of Hospitalizations Due to Respiratory Syncytial Virus (RSV) Illness Among Children and Adolescents in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Respiratory illness; Respiratory system; Pediatrics; Virus; Virology; Internal medicine","score_opus":0.029481057406308814,"score_gpt":0.3386658753839869,"score_spread":0.3091848179776781,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405747922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99289185,0.0016686993,0.000054413158,0.001412256,0.0014578359,0.0021612667,0.00019313995,0.000042336633,0.000118223456],"genre_scores_gemma":[0.99748343,0.00014434307,0.000037586407,0.0018489118,0.00025577305,0.00006725109,0.000042477583,0.000039470528,0.00008074344],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9963272,0.00090861827,0.0011694145,0.00046052889,0.00037323037,0.000760964],"domain_scores_gemma":[0.9987532,0.00023862356,0.00017250699,0.00027783858,0.0000795849,0.00047823694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011743627,0.00020490994,0.00048774632,0.0004320336,0.00027732877,0.0000090325975,0.00017039722,0.00022041758,0.00007088391],"category_scores_gemma":[0.00018206742,0.00020947983,0.000029180595,0.00080380007,0.000039184848,0.00010808622,0.00011600331,0.0010702212,0.000011390057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003504473,0.000047416834,0.98444784,0.0012255313,0.0000046697464,0.000030943163,0.0060303723,0.0002546715,0.000001070716,0.0005280166,0.005842967,0.0015514604],"study_design_scores_gemma":[0.000555923,0.00008122392,0.99180055,0.004341417,0.000004827484,0.0000010577057,0.00057621434,0.00020942157,0.0000020082207,0.000052682433,0.0021829864,0.00019167863],"about_ca_topic_score_codex":0.9977863,"about_ca_topic_score_gemma":0.9983867,"teacher_disagreement_score":0.008719596,"about_ca_system_score_codex":0.0034014406,"about_ca_system_score_gemma":0.012121037,"threshold_uncertainty_score":0.9934793},"labels":[],"label_agreement":null},{"id":"W4405748058","doi":"10.1016/j.jval.2024.10.846","title":"EE566 Real-World Evidence of Multi-Gene Panel Sequencing Effectiveness and Cost-Effectiveness for Advanced Cancers: A Tumor-Agnostic Target Trial Emulation","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Emulation; Computational biology; Real world evidence; Computer science; Oncology; Medicine; Internal medicine; Biology; Psychology","score_opus":0.5757605894262776,"score_gpt":0.4958585673932267,"score_spread":0.07990202203305091,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9351495,0.0186306,0.0331109,0.0014277565,0.0018334591,0.00929134,0.0004495211,0.000077411336,0.000029495299],"genre_scores_gemma":[0.99028236,0.0008451225,0.0064123687,0.00037378073,0.00024176663,0.0017406782,0.000029660296,0.000054173874,0.000020114512],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9935285,0.0016091203,0.0033452467,0.00087805983,0.00011368975,0.0005253959],"domain_scores_gemma":[0.98286116,0.015183646,0.0013288783,0.00035293383,0.0000908671,0.00018254099],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.030923681,0.00025074577,0.0014158604,0.0006824464,0.00015473286,0.000047308204,0.00016277967,0.00010186321,0.000014464539],"category_scores_gemma":[0.0072223363,0.00031476017,0.000120083634,0.00055905216,0.00007426156,0.0006271637,0.000039815048,0.00021645945,0.000020549927],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008337288,0.00027555687,0.09222537,0.06811209,0.00020436688,0.00001167215,0.0075794747,0.7526724,0.00053497736,0.066372596,0.00014056319,0.0035336707],"study_design_scores_gemma":[0.022331174,0.001546284,0.111185126,0.0144533105,0.000022177754,0.000008880865,0.00045290717,0.8269271,0.00048757638,0.020939127,0.0008987978,0.0007475137],"about_ca_topic_score_codex":0.036971543,"about_ca_topic_score_gemma":0.0011105677,"teacher_disagreement_score":0.07425475,"about_ca_system_score_codex":0.0049900096,"about_ca_system_score_gemma":0.0016509261,"threshold_uncertainty_score":0.99993044},"labels":[],"label_agreement":null},{"id":"W4405748096","doi":"10.1016/j.jval.2024.10.1112","title":"EE832 The Lifetime Return on Investment of Measles, Mumps, and Rubella Vaccination in Belgium and Poland","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Measles; Rubella; Vaccination; Medicine; Virology; Investment (military); Pediatrics; Political science; Law","score_opus":0.032204484932622644,"score_gpt":0.31657135712466133,"score_spread":0.2843668721920387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9464414,0.01951835,0.000003245806,0.030268151,0.00018207844,0.00042757997,0.0000062541453,0.000016648895,0.0031362765],"genre_scores_gemma":[0.9939888,0.0050626695,0.000033217606,0.00065744756,0.00010368867,0.0000062586855,0.0000015440393,0.0000057352563,0.00014063275],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99892884,0.00032535646,0.00022650033,0.00016235888,0.00018248403,0.00017446655],"domain_scores_gemma":[0.999522,0.00026975147,0.00004673234,0.000084803534,0.000014290855,0.00006247631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014618944,0.000062405634,0.00012662413,0.00012491402,0.00011024661,0.000037519025,0.00006232516,0.000050729584,0.000014482045],"category_scores_gemma":[0.00011559356,0.00004659495,0.000013092511,0.00028715815,0.000012896266,0.00008059783,0.000021637652,0.0001374716,0.0000018033489],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010233501,0.00024796036,0.36421654,0.0012110177,0.000026329355,0.000037037356,0.14812352,0.0002176907,0.00007518545,0.43348595,0.008413889,0.04384255],"study_design_scores_gemma":[0.0013617072,0.00079417886,0.826886,0.0016997567,0.000016563767,0.00000583525,0.0046625813,0.00803005,0.00008690579,0.090592146,0.065543465,0.00032082756],"about_ca_topic_score_codex":0.020647017,"about_ca_topic_score_gemma":0.0077270293,"teacher_disagreement_score":0.46266946,"about_ca_system_score_codex":0.00013661137,"about_ca_system_score_gemma":0.00024232929,"threshold_uncertainty_score":0.9858746},"labels":[],"label_agreement":null},{"id":"W4405748112","doi":"10.1016/j.jval.2024.10.905","title":"EE625 Cost-Effectiveness Analysis of 20-Valent Pneumococcal Conjugate Vaccine (PCV20) to Prevent Pneumococcal Disease in the Greek Pediatric Population","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Pneumococcal disease; Pneumococcal conjugate vaccine; Medicine; Pediatrics; Conjugate vaccine; Conjugate; Pneumococcal vaccine; Streptococcus pneumoniae; Immunology; Immunization; Microbiology; Biology; Mathematics; Immune system","score_opus":0.03895033056563186,"score_gpt":0.35852965256530167,"score_spread":0.3195793219996698,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99004084,0.00095191825,0.00016059408,0.00537269,0.00038217622,0.002914362,0.000090323134,0.000054276676,0.000032842665],"genre_scores_gemma":[0.9985579,0.00029618366,0.0000112496655,0.00041484108,0.00018321381,0.0004108075,0.00007995935,0.000023501112,0.00002232869],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9968349,0.0010270412,0.00085542793,0.00046874533,0.00040825407,0.0004056385],"domain_scores_gemma":[0.99848926,0.0005783616,0.00012045542,0.0004215601,0.00006159904,0.00032875547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001898476,0.00021405412,0.0006363628,0.0015158706,0.00008228195,0.000023024606,0.00012609284,0.00008339542,0.000025599262],"category_scores_gemma":[0.00020732205,0.00015438054,0.00026399468,0.0037762239,0.000018985438,0.0000824094,0.00004273469,0.0004112071,0.00001956088],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017421014,0.000901093,0.90470535,0.0017041978,0.00013226135,0.0001624263,0.0006820824,0.08858987,0.0010642996,0.00042740043,0.000029940022,0.0014268702],"study_design_scores_gemma":[0.0005284519,0.00045877136,0.97464013,0.00040789772,0.00056570675,0.000013625686,0.00004261335,0.02235624,0.000015374368,0.00016012456,0.00068074313,0.00013031131],"about_ca_topic_score_codex":0.0025184357,"about_ca_topic_score_gemma":0.00045967769,"teacher_disagreement_score":0.06993479,"about_ca_system_score_codex":0.00052388094,"about_ca_system_score_gemma":0.00044270817,"threshold_uncertainty_score":0.6295456},"labels":[],"label_agreement":null},{"id":"W4405748113","doi":"10.1016/j.jval.2024.10.739","title":"EE458 Evaluating Utilization Patterns, Financial Impact, and Access Delay Caused by Reimbursement Criteria on Public Drug Plans for Primary Care Topical Treatments in Canada: Case Study With HP/TAZ Combination for Plaque Psoriasis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada; Université de Montréal","funders":"","keywords":"Reimbursement; Primary care; Drug; Medicine; Business; Finance; Family medicine; Pharmacology; Health care; Economics; Economic growth","score_opus":0.4135314945157764,"score_gpt":0.4753705630889779,"score_spread":0.06183906857320148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748113","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98119235,0.0014866397,0.0020520817,0.0063738497,0.00056107505,0.005496987,0.0028015804,0.000021642865,0.000013768572],"genre_scores_gemma":[0.9959952,0.000101553225,0.00026272266,0.0013658255,0.00010828927,0.0014338068,0.00067575515,0.000038199785,0.00001863384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959256,0.0005236411,0.002234295,0.0006940521,0.0001455957,0.0004768405],"domain_scores_gemma":[0.9976776,0.0012137475,0.0006241066,0.0002422976,0.0000724232,0.00016977666],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0056659975,0.00023101486,0.0007335157,0.00040912995,0.0002120272,0.00017164511,0.00012537283,0.00007889408,0.000013518978],"category_scores_gemma":[0.0005299856,0.0002504948,0.000040264185,0.00021896558,0.000012324033,0.00040189206,0.000027511127,0.00014691624,0.0000012904362],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030602142,0.0007300217,0.94807297,0.006275715,0.00013459397,0.000062596795,0.018762302,0.0040482427,4.401359e-7,0.0035699366,0.0048063826,0.0132308025],"study_design_scores_gemma":[0.020258704,0.007317816,0.6648036,0.002207801,0.00006198881,0.00006316924,0.02184038,0.2767652,0.0000082161605,0.0028209884,0.0026338284,0.0012182647],"about_ca_topic_score_codex":0.7254965,"about_ca_topic_score_gemma":0.73052317,"teacher_disagreement_score":0.2832693,"about_ca_system_score_codex":0.008405294,"about_ca_system_score_gemma":0.002982312,"threshold_uncertainty_score":0.99999475},"labels":[],"label_agreement":null},{"id":"W4405748120","doi":"10.1016/j.jval.2024.10.559","title":"EE277 Cost of Stroke in Latin America: A Multicentric Time-Driven Activity-Based Costing Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Activity-based costing; Stroke (engine); Latin Americans; Medicine; Business; Operations management; Physical medicine and rehabilitation; Economics; Political science; Accounting; Engineering; Mechanical engineering","score_opus":0.3670552491537332,"score_gpt":0.4380620193520799,"score_spread":0.07100677019834667,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748120","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98075676,0.001871898,0.001995119,0.010940703,0.00046973358,0.0029517093,0.00043272052,0.000073535666,0.0005078207],"genre_scores_gemma":[0.9955031,0.00007034704,0.0026437466,0.0013423642,0.00010041376,0.00016470361,0.00001637396,0.000042385527,0.000116558185],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99328583,0.0012918153,0.0040176264,0.00067476084,0.00014630608,0.0005836483],"domain_scores_gemma":[0.99426,0.0036607804,0.0014543064,0.00042118938,0.000031737432,0.00017197308],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.014350578,0.00020297103,0.0012444139,0.0012633372,0.00007754815,0.000053314954,0.00022890556,0.0000965162,0.0001354495],"category_scores_gemma":[0.0028766324,0.00026782718,0.000091960705,0.0010027589,0.000050181952,0.0002568656,0.00004869705,0.00041723758,0.0006781117],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007536795,0.002158669,0.78263724,0.00333118,0.000070810194,0.000019702024,0.011884631,0.19029072,0.000017657327,0.0030347677,0.0013666393,0.0051125973],"study_design_scores_gemma":[0.0017128465,0.00029455693,0.10926783,0.00059355714,0.0000034025472,7.5458604e-7,0.0011846314,0.8837107,0.0000041552785,0.00020180366,0.0027936955,0.00023209665],"about_ca_topic_score_codex":0.028169082,"about_ca_topic_score_gemma":0.00056994864,"teacher_disagreement_score":0.69341993,"about_ca_system_score_codex":0.0017640033,"about_ca_system_score_gemma":0.0007521876,"threshold_uncertainty_score":0.9999774},"labels":[],"label_agreement":null},{"id":"W4405748122","doi":"10.1016/j.jval.2024.10.670","title":"EE389 Cost Savings Analysis of Implementing Benchmark Best Practices for TAVI Patients in Europe","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Benchmark (surveying); Computer science; Econometrics; Business; Economics; Geography; Cartography","score_opus":0.1692553593638412,"score_gpt":0.3835656926831935,"score_spread":0.21431033331935231,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748122","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96193665,0.0050807535,0.0010420863,0.015728865,0.00078345725,0.002430176,0.001419461,0.000036963338,0.011541606],"genre_scores_gemma":[0.9963653,0.001646779,0.0008143848,0.0006509193,0.000049089642,0.00008699735,0.00011541088,0.000019178677,0.00025192968],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977645,0.000070227914,0.0012582757,0.0003901746,0.000049497485,0.0004672977],"domain_scores_gemma":[0.99861515,0.00033389873,0.0007327267,0.00020313798,0.0000406315,0.000074444666],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031327016,0.00010277789,0.00044724866,0.0012826101,0.0000557648,0.000047474146,0.00014338351,0.000042694053,0.000053437885],"category_scores_gemma":[0.0007673108,0.00012284274,0.00007950268,0.0021261992,0.000013640596,0.00020337616,0.00006925375,0.00013610316,0.000025095682],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002226558,0.00034100286,0.6118835,0.002495233,0.00021813097,0.000003454689,0.0034375428,0.0029092394,6.3652857e-7,0.34079185,0.001219896,0.03667725],"study_design_scores_gemma":[0.0005968989,0.00028465458,0.15380922,0.00029630162,0.00004132826,1.514628e-7,0.0002920085,0.09288778,0.000003621419,0.0031942853,0.7483658,0.00022791619],"about_ca_topic_score_codex":0.19914003,"about_ca_topic_score_gemma":0.008083749,"teacher_disagreement_score":0.74714595,"about_ca_system_score_codex":0.00028198992,"about_ca_system_score_gemma":0.00010982504,"threshold_uncertainty_score":0.806193},"labels":[],"label_agreement":null},{"id":"W4405748128","doi":"10.1016/j.jval.2024.10.707","title":"EE426 Cost-Effectiveness of Switching From PCV13 to PCV20 in the Portuguese Childhood National Immunization Program","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Portuguese; Immunization program; Immunization; Political science; Business; Medicine; Immunology; Philosophy","score_opus":0.05565572391763007,"score_gpt":0.3876690808970631,"score_spread":0.332013356979433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98727196,0.0032370638,0.00047733588,0.0049389615,0.00033228728,0.002103274,0.000021587297,0.000058344154,0.0015591768],"genre_scores_gemma":[0.9987779,0.00032673773,0.00027209622,0.0002957192,0.00016480009,0.00012037929,0.000025164389,0.0000087219805,0.000008482697],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99792343,0.0009784875,0.00030135905,0.00018439617,0.00039723763,0.00021505893],"domain_scores_gemma":[0.9989437,0.00078852655,0.00005478013,0.00010545617,0.000059718128,0.000047823825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036373858,0.00006932331,0.00015263261,0.00017227666,0.00011442058,0.000047021345,0.00020789243,0.0000512443,0.00002170832],"category_scores_gemma":[0.00044968212,0.000057464444,0.000034830824,0.0010065062,0.000006353858,0.00018659187,0.000023914821,0.00018983787,0.000010555201],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008064997,0.0012032785,0.13547784,0.00056497735,0.000036938156,0.00003312356,0.25700316,0.01133545,0.00014988588,0.2057491,0.00056597166,0.38779962],"study_design_scores_gemma":[0.00026371918,0.000116611285,0.9673459,0.0008783271,0.000002895197,6.8511844e-7,0.0022409912,0.0013046549,0.000018319728,0.025062682,0.002672723,0.000092471644],"about_ca_topic_score_codex":0.033294536,"about_ca_topic_score_gemma":0.0040862947,"teacher_disagreement_score":0.8318681,"about_ca_system_score_codex":0.00030040758,"about_ca_system_score_gemma":0.00086800667,"threshold_uncertainty_score":0.97314286},"labels":[],"label_agreement":null},{"id":"W4405748163","doi":"10.1016/j.jval.2024.10.833","title":"EE553 Model-Projected Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) in Patients With Sickle Cell Disease With Recurrent Vaso-Occlusive Crises in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Occlusive; Medicine; Disease; Internal medicine; Pediatrics","score_opus":0.026869804717029763,"score_gpt":0.2960737791799688,"score_spread":0.26920397446293903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748163","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9935137,0.0030682117,0.000024421082,0.0014181661,0.00027190492,0.0014097535,0.000110393295,0.00003103922,0.00015238166],"genre_scores_gemma":[0.99785596,0.00093859254,0.00041970884,0.00055805815,0.000015087899,0.000033593824,0.00007257363,0.00004295882,0.00006346395],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970571,0.00025868742,0.0010729115,0.000527412,0.0005407962,0.0005431026],"domain_scores_gemma":[0.9987766,0.00023174807,0.00017350966,0.0003482021,0.000087773566,0.00038215425],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044015868,0.0002637666,0.00076629245,0.000322155,0.00003129239,0.000007673901,0.00011314194,0.000107189735,0.000014544184],"category_scores_gemma":[0.00011994137,0.00017902133,0.00006556081,0.000821455,0.00007949647,0.000059383183,0.000048849433,0.00066824775,0.0000021844355],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001043241,0.0011443358,0.9580627,0.0014285345,0.000036890244,0.00021754309,0.0007905397,0.03450233,7.084646e-7,0.000028554237,0.00042723664,0.002317371],"study_design_scores_gemma":[0.0062139784,0.0012467934,0.8917358,0.0025924193,0.00006192425,0.0000016632574,0.00053244125,0.09711815,0.0000059376634,0.000043551405,0.00018909495,0.00025823366],"about_ca_topic_score_codex":0.62584084,"about_ca_topic_score_gemma":0.3265611,"teacher_disagreement_score":0.29927975,"about_ca_system_score_codex":0.0010432646,"about_ca_system_score_gemma":0.011312243,"threshold_uncertainty_score":0.9942927},"labels":[],"label_agreement":null},{"id":"W4405748187","doi":"10.1016/j.jval.2024.10.574","title":"EE292 Cost-Effectiveness Analysis of PCV20 3+1 Versus PCV15 2+1 Vaccination of the Pediatric Population in the Netherlands","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Vaccination; Pediatrics; Demography; Virology; Sociology","score_opus":0.07159558361299687,"score_gpt":0.39134914810956095,"score_spread":0.3197535644965641,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748187","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956264,0.0015548345,0.000065217544,0.0013317721,0.00038600594,0.00053770706,0.000007330298,0.000009071678,0.00048166607],"genre_scores_gemma":[0.99930185,0.0005199481,0.000008073896,0.000027938393,0.00010143198,0.000018181003,0.0000055898536,0.000004046462,0.00001293819],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977586,0.0013339319,0.0003227779,0.00013009885,0.0003053274,0.00014922758],"domain_scores_gemma":[0.9985984,0.0010684532,0.00012824185,0.00014823713,0.000038293187,0.000018397031],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003181057,0.00005436606,0.00019208825,0.000344682,0.00009225095,0.000017433094,0.00017908086,0.000055222965,0.000026335452],"category_scores_gemma":[0.00022226828,0.00003593568,0.000092082,0.0036452631,0.000004861763,0.000105027,0.000014173719,0.00012503,8.939427e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003549557,0.000045029134,0.9548743,0.00015353203,0.000021690203,6.891035e-7,0.0128399925,0.01517847,0.0000015654273,0.012815279,0.00003917916,0.0039947913],"study_design_scores_gemma":[0.00024590504,0.000048018785,0.9916915,0.000040009003,0.000067783614,5.7180024e-8,0.00081667607,0.005278589,0.0000030293688,0.0016783768,0.00009495107,0.00003507251],"about_ca_topic_score_codex":0.041623864,"about_ca_topic_score_gemma":0.013381482,"teacher_disagreement_score":0.036817245,"about_ca_system_score_codex":0.00023843902,"about_ca_system_score_gemma":0.00023976796,"threshold_uncertainty_score":0.96475804},"labels":[],"label_agreement":null},{"id":"W4405748254","doi":"10.1016/j.jval.2024.10.642","title":"EE361 Long-Term Remission (LTR) Assumptions in Health Technology Assessments (HTAs) of Bispecific Treatments for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL) Following Two or More Lines of Systemic Therapy (3L+)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Refractory (planetary science); Diffuse large B-cell lymphoma; Medicine; Oncology; Term (time); Lymphoma; Internal medicine; Cancer research; Physics","score_opus":0.1088455886547828,"score_gpt":0.4519538653960237,"score_spread":0.3431082767412409,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9715983,0.021549856,0.00025378694,0.0016074792,0.0005520934,0.004145395,0.00012278293,0.0001348088,0.000035476252],"genre_scores_gemma":[0.9699126,0.024012363,0.0015312093,0.00013181275,0.00011111965,0.0003720776,0.00015595999,0.00013562641,0.003637268],"study_design_codex":"observational","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99527687,0.0005319078,0.0018204034,0.0007603545,0.00069683645,0.0009136071],"domain_scores_gemma":[0.9974113,0.0008287783,0.0004777704,0.000879139,0.00012514129,0.00027787374],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002080808,0.0003720467,0.001322124,0.0017942804,0.000117379546,0.000020512352,0.00029144503,0.0003236204,0.00011620093],"category_scores_gemma":[0.00018915,0.00027057747,0.00026270282,0.0017505423,0.000084114006,0.00012459443,0.000072455165,0.00045932524,0.0000056394174],"study_design_candidate":"randomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017258009,0.041151866,0.3539001,0.0351589,0.0010945408,0.0011415787,0.008053357,0.000127611,0.24646522,0.00037290328,0.0010043326,0.2942716],"study_design_scores_gemma":[0.49910042,0.059635274,0.13302614,0.16509978,0.00048214075,0.0011402697,0.015981767,0.054305308,0.046360318,0.00071146304,0.021480426,0.0026766853],"about_ca_topic_score_codex":0.001467024,"about_ca_topic_score_gemma":0.00019481324,"teacher_disagreement_score":0.48184243,"about_ca_system_score_codex":0.0022782,"about_ca_system_score_gemma":0.0033838884,"threshold_uncertainty_score":0.99997467},"labels":[],"label_agreement":null},{"id":"W4405748287","doi":"10.1016/j.jval.2024.10.507","title":"EE225 Burden of Chronic Obstructive Pulmonary Disease (COPD) Healthcare Costs in Patients with Moderate-to-Severe Disease","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Pulmonary disease; COPD; Medicine; Disease; Intensive care medicine; Health care; Internal medicine","score_opus":0.021309638993003786,"score_gpt":0.3043008487857156,"score_spread":0.2829912097927118,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748287","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96754175,0.017973337,0.0000257221,0.008123565,0.0003017744,0.004591589,0.0011130816,0.00010565644,0.00022352293],"genre_scores_gemma":[0.9979026,0.0003117851,0.00015243691,0.00030078087,0.0002577644,0.0003070489,0.00040894063,0.00013048002,0.00022818104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99477446,0.00051327696,0.0009435475,0.0012359271,0.0013167713,0.0012159892],"domain_scores_gemma":[0.99627364,0.00022174312,0.00013907641,0.0008967352,0.0002990211,0.0021698133],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044527024,0.00046835298,0.00081688224,0.0009916839,0.000107558444,0.00003686052,0.000289695,0.00011274463,0.00013211972],"category_scores_gemma":[0.00020234304,0.00042424476,0.00014552282,0.0017271878,0.00022219952,0.00030634005,0.0002064022,0.0008395425,0.000055959328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.020393446,0.0015449928,0.8763016,0.025292851,0.000090384965,0.002144967,0.001040393,0.03126938,0.0000072501007,0.0022016491,0.00016544157,0.039547656],"study_design_scores_gemma":[0.0025654926,0.0007309931,0.92349076,0.0065165665,0.000038727267,0.0000071637683,0.00022758688,0.064727075,0.000002660632,0.0010215258,0.0003188055,0.00035262413],"about_ca_topic_score_codex":0.012204062,"about_ca_topic_score_gemma":0.0002820926,"teacher_disagreement_score":0.047189187,"about_ca_system_score_codex":0.0080976235,"about_ca_system_score_gemma":0.008379069,"threshold_uncertainty_score":0.99982095},"labels":[],"label_agreement":null},{"id":"W4405748296","doi":"10.1016/j.jval.2024.10.535","title":"EE253 Health Care Visits and Out-of-Pocket Costs in People With Chronic Hand Eczema","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Queen's University","funders":"","keywords":"Hand eczema; Medicine; Health care; Environmental health; Family medicine; Allergy; Immunology; Economics; Economic growth; Contact dermatitis","score_opus":0.018283768425964356,"score_gpt":0.3061301049303482,"score_spread":0.28784633650438385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748296","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89395607,0.09513112,0.000028547292,0.00961502,0.0002318733,0.00071613025,0.000026875128,0.000033106775,0.00026127204],"genre_scores_gemma":[0.9942186,0.004592807,0.00017701657,0.0007975773,0.000082324485,0.000019385267,0.00002477103,0.000022433645,0.00006509477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869704,0.000099567325,0.00041874553,0.00025679625,0.00019877488,0.0003291012],"domain_scores_gemma":[0.9994605,0.000108358,0.00007087781,0.0001753521,0.000030261777,0.00015465413],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002932351,0.00013144109,0.00047728262,0.00023632318,0.000048102014,0.000029201476,0.000040872317,0.000046717236,0.000025397716],"category_scores_gemma":[0.00002122258,0.00010576333,0.000025657086,0.00029422145,0.00003102979,0.00007058101,0.000027519163,0.00023707567,0.0000052091636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044635785,0.00034370643,0.39575854,0.052035566,0.00012702741,0.00064268,0.15463105,0.0007035278,0.00022089407,0.0043448485,0.005550095,0.3851957],"study_design_scores_gemma":[0.0057291384,0.004859437,0.9127443,0.026273804,0.00001960029,0.00019551514,0.0051253247,0.008549785,0.00024788862,0.000075910546,0.035790835,0.00038848293],"about_ca_topic_score_codex":0.015503729,"about_ca_topic_score_gemma":0.038886406,"teacher_disagreement_score":0.5169857,"about_ca_system_score_codex":0.00056717073,"about_ca_system_score_gemma":0.0015691752,"threshold_uncertainty_score":0.9910521},"labels":[],"label_agreement":null},{"id":"W4405748345","doi":"10.1016/j.jval.2024.10.700","title":"EE419 Systematic Literature Review of Cost-Effectiveness Evaluations of Freestyle Libre Continuous Glucose Monitoring Systems","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Continuous glucose monitoring; Computer science; Medicine; Internal medicine","score_opus":0.06839238249222915,"score_gpt":0.4086984338077665,"score_spread":0.3403060513155374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748345","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06847566,0.92182016,0.000089297195,0.00050904125,0.0008351572,0.0076073892,0.00002671946,0.000053396114,0.00058314175],"genre_scores_gemma":[0.9245259,0.073851384,0.00011824454,0.000034259367,0.00016243146,0.00055563106,0.000035993293,0.0000339465,0.0006822196],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99704033,0.0010532473,0.0008221291,0.00022218002,0.0006038701,0.00025823875],"domain_scores_gemma":[0.99833053,0.0007602045,0.00017656313,0.00037789412,0.00025609706,0.00009868062],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0052790884,0.00012343194,0.00088824035,0.00037011303,0.00002618127,0.00003306382,0.00012451902,0.0000632289,0.000007502371],"category_scores_gemma":[0.0006938902,0.00009137631,0.00011026362,0.0011481179,0.00003293739,0.00009694456,0.000048961014,0.00025936938,0.00001158432],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015778704,0.00011773318,0.004004215,0.99104595,0.000093685594,0.00002935345,0.00029398498,0.00030633988,0.00022064529,0.0011958424,0.00025632133,0.002420173],"study_design_scores_gemma":[0.00048206866,0.00036951734,0.0039915256,0.9841649,0.00011256509,0.000008246879,0.00013253065,0.010012994,0.00025454035,0.00004115202,0.00036164193,0.00006835089],"about_ca_topic_score_codex":0.00014632894,"about_ca_topic_score_gemma":5.4101315e-7,"teacher_disagreement_score":0.85605025,"about_ca_system_score_codex":0.00020576332,"about_ca_system_score_gemma":0.00032530958,"threshold_uncertainty_score":0.37262177},"labels":[],"label_agreement":null},{"id":"W4405748357","doi":"10.1016/j.jval.2024.10.472","title":"EE188 Cost-Effectiveness of Rivaroxaban and Acetylsalicylic Acid Combination Therapy in Stable Cardiovascular Disease: A Global Perspective","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Rivaroxaban; Perspective (graphical); Medicine; Disease; Intensive care medicine; Internal medicine; Computer science; Artificial intelligence","score_opus":0.10481337094114629,"score_gpt":0.351128353095938,"score_spread":0.2463149821547917,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748357","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88408875,0.10981446,0.0003016771,0.0019401511,0.00027666625,0.0010124217,0.00048802322,0.000023581697,0.0020542643],"genre_scores_gemma":[0.98851186,0.011126631,0.0000351993,0.00017964165,0.000033269767,0.00008059835,0.000009432001,0.000016199105,0.0000071939744],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9985932,0.00016816378,0.00046609266,0.00043076187,0.00003852242,0.00030324457],"domain_scores_gemma":[0.9994106,0.00012640216,0.00007930625,0.0002229311,0.000017948996,0.00014276142],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002116492,0.00013000706,0.00049908826,0.0002515509,0.000031843618,0.00004484093,0.00010483895,0.00005919514,0.000017673903],"category_scores_gemma":[0.0000847739,0.00015300399,0.00012048083,0.00049369293,0.00006114986,0.00017819129,0.00003971343,0.00016037967,0.00001630887],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008576077,0.00015519746,0.04451819,0.000517879,0.00011506505,0.0000060289685,0.00059386657,0.0055904756,0.000006845392,0.9447042,0.000019364006,0.0036871526],"study_design_scores_gemma":[0.0032444869,0.00023903378,0.43518156,0.0003869807,0.000008403741,0.0000051806874,0.0001237941,0.12304667,0.000088444984,0.41723725,0.020066213,0.00037198537],"about_ca_topic_score_codex":0.015589716,"about_ca_topic_score_gemma":0.00003790331,"teacher_disagreement_score":0.52746695,"about_ca_system_score_codex":0.0011714462,"about_ca_system_score_gemma":0.00017750617,"threshold_uncertainty_score":0.99096555},"labels":[],"label_agreement":null},{"id":"W4405748418","doi":"10.1016/j.jval.2024.10.812","title":"EE532 Budget Impact Analyses of Hemoglobin a1C and Lipid Panel Point-of-Care Testing With Afinion™ 2 in Italy and Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Abbott (Canada); EVERSANA (Canada)","funders":"","keywords":"Point of care; Hemoglobin; Point-of-care testing; Point (geometry); Medicine; Internal medicine; Mathematics; Nursing; Immunology","score_opus":0.13227492991107148,"score_gpt":0.3457175300520665,"score_spread":0.21344260014099503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9832846,0.013565688,0.000012477907,0.0012867722,0.000083483836,0.00015383594,0.00042851595,0.0000057338375,0.0011788853],"genre_scores_gemma":[0.99830335,0.0009781794,0.00038621106,0.00026294027,0.00003384388,0.000004160133,0.000009704851,0.000014635371,0.000006999094],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987392,0.000026063663,0.00067653117,0.0002692615,0.000024331972,0.00026460527],"domain_scores_gemma":[0.9992379,0.0003082492,0.0001820647,0.00012385265,0.000014154868,0.00013380116],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004805334,0.00011925357,0.00048105777,0.00030450497,0.000021977263,0.000025483956,0.00007115135,0.00004143068,0.000015851014],"category_scores_gemma":[0.00010461668,0.0001163281,0.00002731015,0.0003448271,0.000050574214,0.00010015286,0.000037857168,0.0001561616,0.0000011891309],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000062657666,0.00005752698,0.95700735,0.0026734355,0.000072596355,0.00001737319,0.001934832,0.01059792,0.000052527335,0.020629596,0.00025695542,0.0066372263],"study_design_scores_gemma":[0.0024621855,0.0011344864,0.7020805,0.0015623444,0.000018344494,0.000060183127,0.001020499,0.26766625,0.00032000808,0.01613945,0.006746981,0.00078876223],"about_ca_topic_score_codex":0.80315095,"about_ca_topic_score_gemma":0.10424437,"teacher_disagreement_score":0.6989066,"about_ca_system_score_codex":0.00028035164,"about_ca_system_score_gemma":0.0005137291,"threshold_uncertainty_score":0.91210085},"labels":[],"label_agreement":null},{"id":"W4405748432","doi":"10.1016/j.jval.2024.10.499","title":"EE216 Potential Budget Impact of Using a Cyanoacrylate Polymer Barrier Film Compared to Traditional Methods for the Prevention and Management of Incontinence-Associated Dermatitis in a Canadian Hospital Setting","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pressure Ulcer Prevention and Management","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Cyanoacrylate; Medicine; Materials science; Nanotechnology","score_opus":0.06006695531943868,"score_gpt":0.4336381869858246,"score_spread":0.37357123166638595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748432","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9286798,0.0028688957,0.05119189,0.007715581,0.0011750028,0.0072954358,0.00072889135,0.00004166005,0.00030284133],"genre_scores_gemma":[0.99113464,0.00011025713,0.0080240965,0.00025086498,0.000030011375,0.00021515947,0.00004437059,0.000017540295,0.00017304781],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99724895,0.0010374219,0.0008558169,0.00022500615,0.00015412288,0.0004786791],"domain_scores_gemma":[0.99902487,0.00037716635,0.00023978777,0.00013727076,0.00005068194,0.000170237],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034847714,0.00012233992,0.0003010337,0.00042254728,0.00019814452,0.000013993838,0.00012032319,0.000072035866,0.00008859471],"category_scores_gemma":[0.000073828705,0.00010475321,0.00010676303,0.00041580468,0.00002759924,0.00011155916,0.000075241034,0.00019707915,9.220357e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00076620525,0.0021678878,0.24959701,0.057214923,0.0058562607,0.00013651945,0.14794482,0.2155685,0.0026031462,0.08493383,0.038047735,0.19516316],"study_design_scores_gemma":[0.0019076166,0.0001977296,0.5389773,0.0052537844,0.00010014608,0.000001934888,0.0020215327,0.44662908,0.00002894197,0.0033500823,0.0013241065,0.00020770547],"about_ca_topic_score_codex":0.28970563,"about_ca_topic_score_gemma":0.044102903,"teacher_disagreement_score":0.28938034,"about_ca_system_score_codex":0.0005950469,"about_ca_system_score_gemma":0.00078937,"threshold_uncertainty_score":0.97333974},"labels":[],"label_agreement":null},{"id":"W4405748454","doi":"10.1016/j.jval.2024.10.380","title":"EE96 Cost-Effectiveness of Finerenone in Chronic Kidney Disease Associated With Type 2 Diabetes: Impact of Recent Guideline Implementation on Results of the FINE-CKD Model","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Mount Sinai Hospital","funders":"","keywords":"Guideline; Medicine; Kidney disease; Type 2 diabetes; Intensive care medicine; Diabetes mellitus; Internal medicine; Endocrinology; Pathology","score_opus":0.37561303563688536,"score_gpt":0.48405771936737096,"score_spread":0.1084446837304856,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748454","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98447126,0.0019413466,0.00018547993,0.007092064,0.0002287698,0.0020027305,0.003965003,0.00001293353,0.00010042865],"genre_scores_gemma":[0.99862456,0.00029821842,0.00014434008,0.0004025892,0.00003322872,0.00007099818,0.00038455214,0.00002568672,0.000015817479],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99428713,0.0009695273,0.0039101695,0.0003721651,0.00013528585,0.00032569966],"domain_scores_gemma":[0.99621415,0.0012300198,0.0018734827,0.00042159262,0.00012066901,0.00014010543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01780196,0.00015475591,0.0008361711,0.0004192108,0.000031027896,0.00000911047,0.0001750001,0.00006937045,0.00007056528],"category_scores_gemma":[0.0036414538,0.0001365095,0.00009525478,0.0008094299,0.000048389487,0.00012717275,0.00003158307,0.00017524969,0.000007890026],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003497727,0.0002847894,0.09884042,0.0025191677,0.000104891296,3.8549365e-7,0.0010631013,0.8857047,0.000026570426,0.005804333,0.004768759,0.0005331067],"study_design_scores_gemma":[0.00314733,0.0008767995,0.25394812,0.003188358,0.000010315723,1.1309967e-7,0.000059694503,0.7341821,0.0000678266,0.0039017452,0.0004432929,0.00017430073],"about_ca_topic_score_codex":0.008809575,"about_ca_topic_score_gemma":0.00086387526,"teacher_disagreement_score":0.15510769,"about_ca_system_score_codex":0.0035715473,"about_ca_system_score_gemma":0.0037707482,"threshold_uncertainty_score":0.9977909},"labels":[],"label_agreement":null},{"id":"W4405748456","doi":"10.1016/j.jval.2024.10.550","title":"EE268 Interim Burden of Disease Findings for Myasthenic Gravis-Resource Utilization Epidemiology, Survival, and Treatment Patterns (MG-REST) Study in Ontario, Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital","funders":"","keywords":"Myasthenia gravis; Interim; Epidemiology; Rest (music); Medicine; Interim analysis; Disease; Gerontology; Pediatrics; Internal medicine; Political science; Clinical trial","score_opus":0.1350739069430453,"score_gpt":0.36845275303944097,"score_spread":0.23337884609639567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748456","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99301535,0.0012848133,0.00006234272,0.003573052,0.00019242807,0.0017477887,0.000088572604,0.00001655267,0.000019112438],"genre_scores_gemma":[0.9990787,0.00013198874,0.000057257268,0.00014973745,0.000052696447,0.00011309038,0.00010878454,0.000023955658,0.0002837783],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99802,0.000324447,0.0007326436,0.00041586728,0.0001497544,0.00035727545],"domain_scores_gemma":[0.99882066,0.00056677934,0.00009221413,0.0002483789,0.000025298408,0.00024666346],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010410452,0.00018818765,0.0006301139,0.00021629092,0.000038977192,0.00000842445,0.000067532856,0.000048130372,0.00003638306],"category_scores_gemma":[0.00017974719,0.00015174445,0.000060046223,0.00016313395,0.00003192436,0.000027925164,0.000032670654,0.00015950695,4.9530615e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000486009,0.00030818107,0.9871284,0.00067995396,0.00005066974,0.0000658059,0.0049557243,0.0003775844,0.000006800768,0.00081173895,0.00019489821,0.0049342816],"study_design_scores_gemma":[0.0022192781,0.0021879587,0.9737118,0.001216428,0.000053226107,0.000007568841,0.0019760542,0.009786058,0.0000044700337,0.00038298778,0.008329588,0.00012461552],"about_ca_topic_score_codex":0.98945683,"about_ca_topic_score_gemma":0.9731922,"teacher_disagreement_score":0.01626463,"about_ca_system_score_codex":0.0011991984,"about_ca_system_score_gemma":0.0016289509,"threshold_uncertainty_score":0.61879593},"labels":[],"label_agreement":null},{"id":"W4405748469","doi":"10.1016/j.jval.2024.10.481","title":"EE197 The Acute and Long-Term Healthcare Costs Attributable to COVID-19 in Ontario, Canada: A Population-Based Matched Cohort Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Medicine; Cohort; Term (time); Cohort study; Population; 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Demography; Environmental health; Virology; Internal medicine; Disease; Outbreak","score_opus":0.29916564747546304,"score_gpt":0.427069615745116,"score_spread":0.12790396826965295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.824505,0.002359591,0.00028146847,0.16768202,0.0006970937,0.0040307883,0.0003707104,0.000042128697,0.00003124326],"genre_scores_gemma":[0.9608451,0.000057663292,0.00017165994,0.03797059,0.00007757239,0.0005070485,0.00012650329,0.000035768157,0.00020806775],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9935646,0.00097296765,0.0036685362,0.0008821878,0.00020149743,0.000710193],"domain_scores_gemma":[0.9964189,0.0017543442,0.0006225605,0.0005770737,0.00003223978,0.00059489795],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.021034941,0.00024021645,0.0011498025,0.000525791,0.00028284645,0.00014257028,0.00026649283,0.000106570806,0.0001608538],"category_scores_gemma":[0.0011698978,0.00026188596,0.00004506571,0.0006316059,0.00002240014,0.00018266737,0.00006224412,0.00047057145,0.0000710774],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000020230014,0.00006917466,0.9821383,0.0006646805,0.00003304429,0.000020068952,0.0034017605,0.006540439,2.5835853e-8,0.003954389,0.003103988,0.000053897464],"study_design_scores_gemma":[0.00065267953,0.00013428192,0.98670256,0.0002491517,0.0000045645234,0.000006492298,0.00061284634,0.00755886,6.456435e-8,0.0007263077,0.003123061,0.00022912306],"about_ca_topic_score_codex":0.99867666,"about_ca_topic_score_gemma":0.9986646,"teacher_disagreement_score":0.13634017,"about_ca_system_score_codex":0.023558393,"about_ca_system_score_gemma":0.0096357055,"threshold_uncertainty_score":0.9999833},"labels":[],"label_agreement":null},{"id":"W4405748494","doi":"10.1016/j.jval.2024.10.664","title":"EE383 Model-Projected Clinical Outcomes of Exagamglogene Autotemcel (exa-cel) in Patients With Transfusion-Dependent Beta-Thalassemia in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Beta thalassemia; Thalassemia; BETA (programming language); Intensive care medicine; Pediatrics; Internal medicine; Computer science","score_opus":0.026058857572268435,"score_gpt":0.29280428000657566,"score_spread":0.2667454224343072,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748494","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99477404,0.0011190878,0.000038575803,0.002247054,0.00036514347,0.0011591478,0.000049634178,0.000029925473,0.00021736031],"genre_scores_gemma":[0.9979019,0.001096864,0.0003700253,0.00044554114,0.000012485412,0.000022252443,0.000038681046,0.000037893304,0.0000743615],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967465,0.00026385553,0.0014175132,0.00047867023,0.00057675637,0.0005167155],"domain_scores_gemma":[0.9990833,0.00022997776,0.00011394821,0.00030324727,0.000051609975,0.00021795875],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00086966174,0.00022530966,0.0008527046,0.0003684998,0.000023946319,0.0000058565747,0.000113509996,0.00021198086,0.000021606536],"category_scores_gemma":[0.00008098493,0.00016462141,0.0000828478,0.0007600243,0.000047032878,0.000049725717,0.00002709421,0.00085203693,0.000002387571],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024885905,0.00055793225,0.96979195,0.0006406651,0.00004794022,0.00012761189,0.000725807,0.022322636,0.000007515042,0.000041204476,0.00015386807,0.005334038],"study_design_scores_gemma":[0.005198273,0.00057946955,0.9253571,0.0014060539,0.00002934969,0.000004863618,0.00033016715,0.06677982,0.00002091649,0.00003744838,0.000074785385,0.00018174465],"about_ca_topic_score_codex":0.8665177,"about_ca_topic_score_gemma":0.6474615,"teacher_disagreement_score":0.21905628,"about_ca_system_score_codex":0.0011327427,"about_ca_system_score_gemma":0.0074820463,"threshold_uncertainty_score":0.9981446},"labels":[],"label_agreement":null},{"id":"W4405748558","doi":"10.1016/j.jval.2024.10.297","title":"EE13 A Cost-Consequence Analysis of Chimeric Antigen Receptor T-Cell Therapy in Patients With Relapsed or Refractory Large B-Cell Lymphoma Across Gulf Cooperation Council Countries","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Gilead Sciences (Canada)","funders":"","keywords":"Chimeric antigen receptor; Refractory (planetary science); Medicine; Lymphoma; Oncology; Cancer research; Internal medicine; Immunotherapy; Biology; Cancer","score_opus":0.051855495934935936,"score_gpt":0.33293342912135687,"score_spread":0.28107793318642094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748558","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923165,0.0046281368,0.00007856466,0.0003592307,0.00017032414,0.0019256197,0.00029011891,0.000053675514,0.00017781746],"genre_scores_gemma":[0.98676026,0.010130231,0.00023737519,0.00061401795,0.000042407468,0.00009592408,0.0002389309,0.00006114151,0.0018196853],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99610865,0.0004844532,0.0008500003,0.0005936383,0.0012646733,0.0006985756],"domain_scores_gemma":[0.99804145,0.00044984306,0.00020848212,0.0005586576,0.0005570445,0.00018450373],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0028454042,0.00026278105,0.00082105387,0.0005371954,0.000098493605,0.000057750833,0.00017300464,0.0001591692,0.0008324714],"category_scores_gemma":[0.00014867283,0.00019604861,0.00010156297,0.003424884,0.00017855232,0.00017802941,0.0000307839,0.00035250463,0.000032669446],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038683087,0.0118492115,0.81535053,0.0037174018,0.0013590492,0.00037194285,0.05179177,0.0040774043,0.03230282,0.000076029224,0.002621809,0.037798963],"study_design_scores_gemma":[0.11227487,0.028603088,0.4753992,0.0047119986,0.00036404474,0.00003365295,0.00368777,0.06508475,0.021248989,0.000029417612,0.28658372,0.0019784998],"about_ca_topic_score_codex":0.0075183697,"about_ca_topic_score_gemma":0.0012946973,"teacher_disagreement_score":0.3399513,"about_ca_system_score_codex":0.0025383497,"about_ca_system_score_gemma":0.005937465,"threshold_uncertainty_score":0.9996979},"labels":[],"label_agreement":null},{"id":"W4405748612","doi":"10.1016/j.jval.2024.10.194","title":"CO118 Indirect Treatment Comparison (ITC) of Avalglucosidase Alfa (AVA) vs Cipaglucosidase Alfa Plus Miglustat (Cipa+mig) in Late-Onset Pompe Disease (LOPD): An Updated Analysis Using Mixed-Model Repeated Measures (MMRM) Data","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lysosomal Storage Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Medicine; Repeated measures design; Meta-analysis; Internal medicine; Statistics; Mathematics","score_opus":0.18313315669010735,"score_gpt":0.4152520589535186,"score_spread":0.23211890226341123,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748612","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9781364,0.015162939,0.00081891485,0.0012029544,0.00014927426,0.0022800518,0.0019945668,0.00021040144,0.0000444836],"genre_scores_gemma":[0.98828,0.0012955068,0.0014231424,0.00026136386,0.000056258657,0.00007699648,0.008353909,0.00013506785,0.00011778452],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99122494,0.0019177344,0.0020736693,0.0018352094,0.0015531571,0.001395287],"domain_scores_gemma":[0.99526757,0.00034552198,0.00038585247,0.0024313906,0.0002596022,0.0013100813],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0028921457,0.00069007446,0.0021793593,0.002872157,0.00019605852,0.00013286294,0.00070709747,0.00026788676,0.00011154161],"category_scores_gemma":[0.0004725725,0.00062514184,0.00031140377,0.0052157105,0.00025323793,0.0004981098,0.00034619134,0.000795971,0.00002215674],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008139758,0.0050637773,0.36011142,0.002283614,0.0021898,0.0028377578,0.007358211,0.6008026,0.0013078521,0.00003830636,0.0017056161,0.008161306],"study_design_scores_gemma":[0.004138286,0.0008458771,0.039633565,0.0008924396,0.0010197943,0.000015011362,0.0004697077,0.9512182,0.00090270874,0.000119470395,0.00027342202,0.00047155147],"about_ca_topic_score_codex":0.084671125,"about_ca_topic_score_gemma":0.013556445,"teacher_disagreement_score":0.35041556,"about_ca_system_score_codex":0.0032834953,"about_ca_system_score_gemma":0.004728705,"threshold_uncertainty_score":0.99961996},"labels":[],"label_agreement":null},{"id":"W4405748614","doi":"10.1016/j.jval.2024.10.912","title":"EE632 Early Cost-Effectiveness of SPECTRISTM (Gamma Band Stimulation) in Mild-Moderate Alzheimer's Disease Patients","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Neuroscience and Neural Engineering","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Disease; Stimulation; Medicine; Alzheimer's disease; Audiology; Internal medicine","score_opus":0.08826970400360652,"score_gpt":0.3375529165096493,"score_spread":0.2492832125060428,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748614","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975593,0.00042518377,0.000100929254,0.00013094954,0.00066574523,0.0009705067,0.00003259888,0.000058304926,0.000056496225],"genre_scores_gemma":[0.99964386,0.00012002747,0.000014857724,0.00012227583,0.000023918416,0.00004166496,0.0000022042314,0.000022037144,0.000009153821],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.9980255,0.00038318572,0.00038857723,0.0004997824,0.0003238201,0.0003791774],"domain_scores_gemma":[0.998868,0.00071320945,0.00005511081,0.00018676068,0.000014648339,0.0001622609],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046359326,0.0001463915,0.00022468314,0.0003387102,0.0000548411,0.000048574082,0.00016493163,0.00003002918,0.000005267665],"category_scores_gemma":[0.00029079712,0.00014048368,0.000045248184,0.0010108983,0.0000545533,0.00035806332,0.000031955205,0.0002291571,0.0000138915875],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009776197,0.0008578411,0.17939208,0.002064616,0.000006165421,0.00040906534,0.0010595615,0.7296222,0.06717567,0.009721834,0.000031251886,0.008682116],"study_design_scores_gemma":[0.0009459283,0.0003141038,0.59745944,0.0009422502,0.0000059114795,0.000002040131,0.0000027055255,0.30824456,0.090472855,0.0012642052,0.000110899666,0.00023513852],"about_ca_topic_score_codex":0.0004209916,"about_ca_topic_score_gemma":0.0000045252286,"teacher_disagreement_score":0.42137763,"about_ca_system_score_codex":0.00012397309,"about_ca_system_score_gemma":0.00017816442,"threshold_uncertainty_score":0.5728758},"labels":[],"label_agreement":null},{"id":"W4405748627","doi":"10.1016/j.jval.2024.10.104","title":"CO27 Comparative Effectiveness of the mRNA-1273 and BNT162b2 COVID-19 Vaccines Among Canadians: A Systematic Literature Review and Meta-Analysis Using the Grade Framework","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"SARS-CoV-2 and COVID-19 Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Meta-analysis; Coronavirus disease 2019 (COVID-19); Medicine; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); 2019-20 coronavirus outbreak; Systematic review; Virology; MEDLINE; Internal medicine; Political science","score_opus":0.1561629036415784,"score_gpt":0.4464693482229846,"score_spread":0.2903064445814062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748627","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2603512,0.72985053,0.0001942251,0.0057643377,0.000060625673,0.0036924442,0.0000514654,0.00001798179,0.000017156508],"genre_scores_gemma":[0.9724642,0.0026347546,0.00008959114,0.024546314,0.00003041677,0.00020430938,0.000002456129,0.000017814073,0.000010148883],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99591696,0.0023994627,0.00060457276,0.00038813546,0.00039616405,0.00029470032],"domain_scores_gemma":[0.9958339,0.0032160524,0.0001800405,0.0005417044,0.000103301456,0.00012503026],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004186735,0.00021844871,0.001899096,0.00034088988,0.0001727914,0.00008281747,0.00017462406,0.00010268607,0.000004189074],"category_scores_gemma":[0.0008732928,0.00010401608,0.00033297055,0.0029828243,0.00015841414,0.0000817539,0.00006321069,0.00061411946,5.3136364e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006751227,0.00007361406,0.074633546,0.8823864,0.023770671,0.0001172912,0.014494006,0.00040241444,0.000058525668,0.0038284305,0.00015935567,0.000008258636],"study_design_scores_gemma":[0.0028958595,0.0010048015,0.06780074,0.3407921,0.46017453,0.0012775455,0.0064544235,0.10433713,0.00069742417,0.008718948,0.004478369,0.0013681474],"about_ca_topic_score_codex":0.030662619,"about_ca_topic_score_gemma":0.002924037,"teacher_disagreement_score":0.72721577,"about_ca_system_score_codex":0.00031483127,"about_ca_system_score_gemma":0.0009283987,"threshold_uncertainty_score":0.9757923},"labels":[],"label_agreement":null},{"id":"W4405748638","doi":"10.1016/j.jval.2024.10.149","title":"CO72 Bimekizumab: Matching-Adjusted Indirect Comparison (MAIC) to Establish 1-Year Comparative Efficacy in Moderate-to-Severe Hidradenitis Suppurativa (HS)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Women's College Hospital; University of Toronto","funders":"","keywords":"Hidradenitis suppurativa; Medicine; Matching (statistics); Dermatology; Internal medicine; Pathology; Disease","score_opus":0.09017976404629989,"score_gpt":0.3667754024634378,"score_spread":0.2765956384171379,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748638","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9650827,0.0011554168,0.00020883282,0.026258009,0.0006277298,0.0035984807,0.00023157714,0.00033183754,0.0025054128],"genre_scores_gemma":[0.9953435,0.00006701322,0.0027640488,0.00018240734,0.00016607171,0.00020142773,0.00027769085,0.00009573891,0.00090210355],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99518114,0.00074957754,0.0012720826,0.0010193851,0.00071393687,0.0010638586],"domain_scores_gemma":[0.9977494,0.000719128,0.000119389304,0.0004909375,0.00009212157,0.0008290128],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.000094914416,0.00055254984,0.0015710643,0.001397414,0.00017645818,0.00020815978,0.00023548103,0.00021453368,0.0002916497],"category_scores_gemma":[0.00015010287,0.0005127386,0.00012981714,0.0025746159,0.00006464003,0.0003690777,0.000110429406,0.0009835516,0.0010245154],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01196295,0.013356994,0.2210098,0.006232872,0.0012895004,0.11733947,0.48359787,0.030908195,0.0016729377,0.013208724,0.054589923,0.044830758],"study_design_scores_gemma":[0.06270503,0.022894377,0.5616856,0.052224915,0.00059642794,0.049953982,0.045911822,0.14651975,0.009401477,0.004435225,0.03626176,0.007409609],"about_ca_topic_score_codex":0.010378437,"about_ca_topic_score_gemma":0.0020840194,"teacher_disagreement_score":0.43768606,"about_ca_system_score_codex":0.0014892393,"about_ca_system_score_gemma":0.0010869777,"threshold_uncertainty_score":0.9997533},"labels":[],"label_agreement":null},{"id":"W4405748641","doi":"10.1016/j.jval.2024.10.146","title":"CO69 Indirect Treatment Comparison of Iptacopan Versus Eculizumab and Ravulizumab for Patients With Paroxysmal Nocturnal Hemoglobinuria Naive to C5 Inhibitors","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Eculizumab; Medicine; Hemoglobinuria; Pediatrics; Nocturnal; Internal medicine; Anemia; Immunology; Antibody","score_opus":0.03893164327873158,"score_gpt":0.3228429782890934,"score_spread":0.2839113350103618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9890362,0.006726986,0.000030360843,0.00026974102,0.0014406833,0.0019449496,0.000453118,0.000050873663,0.00004708539],"genre_scores_gemma":[0.99918795,0.00002854659,0.00029844735,0.000024841605,0.000041154566,0.00015109262,0.00019096155,0.00002341483,0.00005360001],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982272,0.00026836575,0.000608979,0.00040387336,0.00007660657,0.0004150018],"domain_scores_gemma":[0.9990584,0.00044901812,0.00016522389,0.00019270682,0.00005458056,0.00008007068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019279658,0.00022957516,0.0005561065,0.00023302696,0.000118538665,0.00002000535,0.00010582686,0.0000862822,0.000047847534],"category_scores_gemma":[0.00005232046,0.00018104997,0.00006854783,0.00021180604,0.00007554881,0.000053074196,0.000047338344,0.00010820429,0.00001973928],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.029856244,0.003754265,0.8226822,0.004450759,0.0018869147,0.000021924803,0.029250532,0.002266304,0.0011158313,0.0018749075,0.022618594,0.080221504],"study_design_scores_gemma":[0.11347999,0.11469439,0.49412057,0.009876157,0.0008569255,0.000070763024,0.009502243,0.0020005936,0.03837414,0.00048886123,0.2138293,0.0027060981],"about_ca_topic_score_codex":0.0013310816,"about_ca_topic_score_gemma":0.00028409128,"teacher_disagreement_score":0.32856166,"about_ca_system_score_codex":0.0005666248,"about_ca_system_score_gemma":0.00038840156,"threshold_uncertainty_score":0.7383003},"labels":[],"label_agreement":null},{"id":"W4405748662","doi":"10.1016/j.jval.2024.10.035","title":"P27 Considerations for Model Conceptualisation When Using Surrogate Outcomes to Inform HTA Decision-Making","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Management science; Surrogate endpoint; Computer science; Medicine; Economics; Internal medicine","score_opus":0.6727815166926427,"score_gpt":0.5096488769537425,"score_spread":0.16313263973890024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748662","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36855054,0.003657677,0.50128067,0.11699043,0.0027893477,0.0042910078,0.0015025301,0.0002205398,0.0007172416],"genre_scores_gemma":[0.80487955,0.00003761178,0.17206755,0.022412946,0.00018247309,0.00019714449,0.000024080304,0.000050986604,0.0001476332],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.993974,0.0001891048,0.0045685363,0.0005950254,0.00012894745,0.0005443937],"domain_scores_gemma":[0.9920858,0.0063846717,0.0008156599,0.00041373895,0.000084654996,0.00021545653],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.016100157,0.00020638363,0.0008954374,0.0008227931,0.0003712206,0.00024564326,0.00015875013,0.00013414904,0.00015960766],"category_scores_gemma":[0.009392548,0.00025890346,0.00013394411,0.00030418628,0.000036388756,0.0007277523,0.000052915024,0.0001745448,0.00036823543],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009789927,0.000029055002,0.0052553103,0.00058017723,0.000028103386,6.9139907e-7,0.017719248,0.3925566,7.3208804e-7,0.5727349,0.010483674,0.00060174],"study_design_scores_gemma":[0.0003098078,0.000040405193,0.00082871504,0.000461879,0.0000025054367,0.0000028754632,0.00071508175,0.6923655,4.775067e-7,0.29891312,0.0061648665,0.00019475003],"about_ca_topic_score_codex":0.0028358651,"about_ca_topic_score_gemma":0.0005590797,"teacher_disagreement_score":0.43632904,"about_ca_system_score_codex":0.0018739556,"about_ca_system_score_gemma":0.0010860562,"threshold_uncertainty_score":0.9999863},"labels":[],"label_agreement":null},{"id":"W4405748680","doi":"10.1016/j.jval.2024.10.157","title":"CO81 Pregabalin Utilization and Side Effects Among Hemodialysis Patients Diagnosed With Pruritus or Neuropathic Pain in US Claims Data","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Anesthesia and Pain Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Pregabalin; Medicine; Neuropathic pain; Hemodialysis; Side effect (computer science); Intensive care medicine; Anesthesia; Internal medicine; Computer science","score_opus":0.04647238403271562,"score_gpt":0.29839163782303063,"score_spread":0.251919253790315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748680","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443954,0.0015862869,0.0010420285,0.0009229023,0.00005606669,0.0018353804,0.0000043459154,0.00007164428,0.000041781423],"genre_scores_gemma":[0.99606717,0.0013305076,0.00039922615,0.0017913404,0.000046229343,0.00006639378,0.00020376034,0.00003335199,0.00006203295],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970134,0.0015140723,0.0003987238,0.0004979147,0.00028617785,0.0002897012],"domain_scores_gemma":[0.99821657,0.001119408,0.00007634612,0.000433449,0.000019169685,0.00013508383],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033953576,0.00015925089,0.00033395976,0.00027688337,0.000042947446,0.0000372194,0.0001005238,0.0000649931,0.000003990159],"category_scores_gemma":[0.000652059,0.000117084004,0.000016593911,0.00065108394,0.000050016104,0.00013040441,0.000051028237,0.0002217402,0.0000042621245],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017446678,0.00023444148,0.9076348,0.0039726594,0.00001770291,0.00085895596,0.0009092397,0.000596699,0.000001087741,0.00006470971,0.00023435967,0.0853009],"study_design_scores_gemma":[0.001365361,0.0009025395,0.7493445,0.0029234076,0.000042462296,0.0000057800125,0.000070632654,0.24232379,0.000003351335,0.000044482054,0.0028628157,0.00011086083],"about_ca_topic_score_codex":0.0029033467,"about_ca_topic_score_gemma":0.00087076996,"teacher_disagreement_score":0.24172708,"about_ca_system_score_codex":0.00011682387,"about_ca_system_score_gemma":0.00019552933,"threshold_uncertainty_score":0.47745472},"labels":[],"label_agreement":null},{"id":"W4405748686","doi":"10.1016/j.jval.2024.10.090","title":"CO13 Impact on Health Outcomes and Productive Work of Anti-PD-(L)1 Inhibitors to Treat Early-Stage Cancers in England","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Stage (stratigraphy); Medicine; Oncology; Internal medicine; Biology","score_opus":0.03250610740754499,"score_gpt":0.35414556125140906,"score_spread":0.32163945384386405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748686","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97757804,0.007408068,0.0000015801822,0.013221893,0.00038426288,0.0012565932,0.00006264636,0.000030372474,0.000056542107],"genre_scores_gemma":[0.99673045,0.0020530657,0.00007824985,0.0007927559,0.000100856465,0.000027023594,0.000007070048,0.000026494661,0.00018405073],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831116,0.00016887738,0.00052113464,0.0003835707,0.00022200825,0.0003932309],"domain_scores_gemma":[0.9993056,0.00017387318,0.00009168057,0.00021856875,0.00001834679,0.00019193986],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097325514,0.00018788388,0.0005920733,0.0004937978,0.000033041855,0.00001532546,0.00004521691,0.000059409882,0.000013359544],"category_scores_gemma":[0.000056616696,0.0001354649,0.00007179528,0.0009043789,0.000059658225,0.000053481675,0.000014988961,0.00025522927,0.0000021817186],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037790993,0.00016286212,0.9032182,0.0017361894,0.00007861433,0.00004127252,0.02767752,0.0009119811,0.00020154392,0.00002684213,0.0011698558,0.060996037],"study_design_scores_gemma":[0.0024601137,0.0026291998,0.98695433,0.0030644329,0.0000054762268,0.0000067496335,0.0003913286,0.000061293256,0.0004713497,0.000013207744,0.0038150374,0.00012747677],"about_ca_topic_score_codex":0.089272246,"about_ca_topic_score_gemma":0.0012025341,"teacher_disagreement_score":0.08806971,"about_ca_system_score_codex":0.0015858673,"about_ca_system_score_gemma":0.0011791777,"threshold_uncertainty_score":0.9167924},"labels":[],"label_agreement":null},{"id":"W4405748689","doi":"10.1016/j.jval.2024.10.043","title":"P33 Transportability Analysis Methods for External Validity Assessment of Randomized Clinical Trial Evidence for Health Technology Assessment Decision-Making: A Simulation Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Randomized controlled trial; Clinical decision making; External validity; Medical physics; Medicine; Psychology; Family medicine; Internal medicine; Social psychology","score_opus":0.7853713964655666,"score_gpt":0.7015007708221598,"score_spread":0.08387062564340686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748689","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19806841,0.0034853118,0.7686364,0.014743445,0.0015274506,0.013199454,0.0002698025,0.00006317879,0.000006548188],"genre_scores_gemma":[0.6550678,0.00028099588,0.34216896,0.0005815805,0.00020411788,0.0016470905,0.000017238513,0.000026125384,0.0000060830534],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.962672,0.011327057,0.023018006,0.0018584947,0.00031986722,0.0008045777],"domain_scores_gemma":[0.8850789,0.107779875,0.0057125334,0.0009805476,0.00021920992,0.00022891004],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.37732056,0.00029955362,0.0054001734,0.001781729,0.0002237677,0.00008579673,0.00043062598,0.0002710053,0.00007006139],"category_scores_gemma":[0.039592423,0.00032565062,0.001230241,0.0013749455,0.00013542433,0.0003474348,0.00004639217,0.00044261187,0.000003367266],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.057136465,0.0045931498,0.3859498,0.0074183717,0.0020259062,0.0000012904181,0.0037188896,0.35207102,2.9076244e-7,0.14286418,0.00025154406,0.04396911],"study_design_scores_gemma":[0.06866655,0.001861552,0.032560267,0.0006460973,0.00013931713,3.033951e-7,0.0004318276,0.82555914,9.6868e-8,0.069364935,0.00056273997,0.00020715974],"about_ca_topic_score_codex":0.002104084,"about_ca_topic_score_gemma":0.000378223,"teacher_disagreement_score":0.47348812,"about_ca_system_score_codex":0.0022311015,"about_ca_system_score_gemma":0.003051077,"threshold_uncertainty_score":0.99991953},"labels":[],"label_agreement":null},{"id":"W4405748692","doi":"10.1016/j.jval.2024.10.918","title":"EE638 Long COVID: A Costly Condition Imposing Substantial Burden on Society","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Intensive care medicine; Virology; Internal medicine; Outbreak; Disease","score_opus":0.10056519723844838,"score_gpt":0.43358254830686316,"score_spread":0.3330173510684148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748692","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.881494,0.0063299513,0.00084834575,0.10768833,0.0012407913,0.0014378129,0.00008143804,0.00038686825,0.00049246615],"genre_scores_gemma":[0.98222286,0.0013181651,0.00020408208,0.014971222,0.0009990198,0.000015554377,0.00008782817,0.000043466553,0.00013779262],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978138,0.0001772826,0.0005284603,0.0004237606,0.0004522515,0.0006044016],"domain_scores_gemma":[0.99858165,0.00052999356,0.00008140662,0.00026016906,0.00004360592,0.00050320406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012635806,0.00018269321,0.00037814036,0.00023358654,0.00015901194,0.000060445615,0.00006354029,0.00016402731,0.00011105739],"category_scores_gemma":[0.00020283765,0.00016875884,0.00014802643,0.0005255925,0.00005630772,0.000090705624,0.000020027626,0.0006638956,0.000099500234],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00549451,0.0018974603,0.07628909,0.1028165,0.0007285541,0.0065248776,0.14040051,0.015518643,0.012213591,0.046916243,0.1511429,0.44005713],"study_design_scores_gemma":[0.016323762,0.0132085355,0.30809206,0.041864965,0.00028898794,0.0013905739,0.00433927,0.19530475,0.0024100952,0.0069666966,0.40784553,0.0019647558],"about_ca_topic_score_codex":0.015484129,"about_ca_topic_score_gemma":0.00024215871,"teacher_disagreement_score":0.43809238,"about_ca_system_score_codex":0.002311972,"about_ca_system_score_gemma":0.003842264,"threshold_uncertainty_score":0.9910718},"labels":[],"label_agreement":null},{"id":"W4405748696","doi":"10.1016/j.jval.2024.10.065","title":"P51 The State of the Art in Antimicrobial Resistance Economic Modelling: Is the STEDI Framework Being Used to Capture Value?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Antibiotic Use and Resistance","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NovAtel (Canada)","funders":"","keywords":"Value (mathematics); State (computer science); Antimicrobial; Resistance (ecology); Economics; Computer science; Biology; Microbiology; Machine learning; Ecology; Algorithm","score_opus":0.022300133294799806,"score_gpt":0.26338667335583443,"score_spread":0.24108654006103464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92714506,0.012030765,0.0031133094,0.05393152,0.002206784,0.0010440564,0.00011612886,0.00003644313,0.00037594925],"genre_scores_gemma":[0.9934911,0.0008165338,0.00028846145,0.0023682266,0.00005112966,0.0000061824962,0.000003959645,0.000024110674,0.0029502672],"study_design_codex":"simulation_or_modeling","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979674,0.00057294156,0.00057241286,0.00035608845,0.000052729458,0.00047840227],"domain_scores_gemma":[0.99868983,0.00059494027,0.00013288706,0.0005463392,0.000016056321,0.000019961108],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012023128,0.00016873344,0.00030715813,0.000087765206,0.00020934227,0.00002816833,0.0005194846,0.00017120155,0.00002483192],"category_scores_gemma":[0.000036046782,0.00008946609,0.000105084306,0.00035901816,0.00023679399,0.000042914133,0.000096874835,0.00087368686,0.00011178484],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069329946,0.00022798688,0.0045524617,0.0017205105,0.00033806227,0.000029187642,0.123094544,0.68687826,0.006191808,0.10649286,0.0687473,0.0010336866],"study_design_scores_gemma":[0.004513603,0.0005550273,0.016043896,0.038397767,0.00022078476,0.00012554154,0.007763764,0.06924038,0.048942693,0.17049196,0.6412664,0.0024381606],"about_ca_topic_score_codex":0.0026521327,"about_ca_topic_score_gemma":0.0014779465,"teacher_disagreement_score":0.61763793,"about_ca_system_score_codex":0.0001674002,"about_ca_system_score_gemma":0.0004350881,"threshold_uncertainty_score":0.4009249},"labels":[],"label_agreement":null},{"id":"W4405748699","doi":"10.1016/j.jval.2024.10.086","title":"CO9 Systematic Literature Review (SLR) of Disease Burden Related to First-Line (1L) Unresectable, Locally Advanced, or Metastatic Esophageal Squamous Cell Carcinoma (ESCC)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Esophageal Cancer Research and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Esophageal squamous cell carcinoma; Oncology; Internal medicine; Basal cell; Radiology; Carcinoma","score_opus":0.02869704540771885,"score_gpt":0.344214212341326,"score_spread":0.31551716693360715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748699","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.035420474,0.94948626,0.00008109098,0.006669944,0.00021887418,0.007663725,0.00025901906,0.000094845396,0.00010576818],"genre_scores_gemma":[0.94475526,0.05018435,0.0007100838,0.00079003634,0.00006582542,0.00062085787,0.00013363345,0.0000725104,0.0026674555],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99576896,0.0005926339,0.0013734931,0.0006453332,0.00089336693,0.0007261813],"domain_scores_gemma":[0.99702454,0.0007423401,0.00018258423,0.0007462097,0.00020861335,0.0010957039],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012909507,0.00036616434,0.0013251754,0.00046313272,0.00007670836,0.000040162267,0.0002135583,0.00006657403,0.0001691421],"category_scores_gemma":[0.00088251155,0.0002465246,0.00020387975,0.0021071176,0.000047851423,0.0001283221,0.000081575774,0.0005510097,0.00010315316],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016007674,0.0004648089,0.0007485492,0.9767484,0.00008644118,0.010971901,0.0012755175,0.0053957086,0.000006681657,0.00025110634,0.0015110384,0.00093908113],"study_design_scores_gemma":[0.010216232,0.01838602,0.0027391897,0.9354466,0.0010543455,0.00058490585,0.0002053902,0.029062027,0.0002599864,0.0005514483,0.0008475156,0.0006463354],"about_ca_topic_score_codex":0.0010567957,"about_ca_topic_score_gemma":0.00007913591,"teacher_disagreement_score":0.9093348,"about_ca_system_score_codex":0.00086276693,"about_ca_system_score_gemma":0.0019540985,"threshold_uncertainty_score":0.9999987},"labels":[],"label_agreement":null},{"id":"W4405748702","doi":"10.1016/j.jval.2024.10.234","title":"CO158 Loss of Ambulation (LOA) in Patients With Limb-Girdle Muscular Dystrophy (LGMD) Sarcoglycanopathy Subtypes: A Systematic Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Genetic Neurodegenerative Diseases","field":"Neuroscience","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Limb-girdle muscular dystrophy; Physical medicine and rehabilitation; Medicine; Muscular dystrophy; Physical therapy; Biology; Internal medicine; Genetics; Mutation","score_opus":0.05578913662193507,"score_gpt":0.31759178252274456,"score_spread":0.2618026459008095,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748702","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006716273,0.9839204,0.000011235204,0.00004171614,0.00028192383,0.008681696,0.0002921405,0.000040317656,0.000014300883],"genre_scores_gemma":[0.009050368,0.9898159,0.000073839445,0.00025966534,0.000030015179,0.0005448371,0.00006856961,0.00012369783,0.000033141463],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99115705,0.0036829738,0.0024387394,0.0011475134,0.0010097311,0.0005639663],"domain_scores_gemma":[0.9968905,0.0004416019,0.0013444866,0.0010133296,0.00010648578,0.00020363992],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00088487833,0.00064839725,0.003523426,0.0006958641,0.0000523746,0.000041443283,0.0005478775,0.00013370464,0.0000129462705],"category_scores_gemma":[0.0012939685,0.00046975032,0.00035883466,0.0020276213,0.000113569105,0.00008891828,0.000119610944,0.00050771446,0.000094430616],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013933896,0.00026350323,0.00028850144,0.99739784,0.000015216159,0.000046948557,0.00006947552,0.00027151985,7.0668284e-7,0.00013118217,0.000023046987,0.0014781475],"study_design_scores_gemma":[0.00044473758,0.0008248089,0.0002420481,0.99492484,0.00075010996,0.000016164491,0.0000049960054,0.00015719999,0.000012939246,0.00003574917,0.00210376,0.00048265813],"about_ca_topic_score_codex":0.00023628252,"about_ca_topic_score_gemma":0.00002036812,"teacher_disagreement_score":0.008136858,"about_ca_system_score_codex":0.0005606226,"about_ca_system_score_gemma":0.0013067801,"threshold_uncertainty_score":0.9997754},"labels":[],"label_agreement":null},{"id":"W4405748706","doi":"10.1016/j.jval.2024.10.328","title":"EE44 The Economic and Environmental Burden of Hydrophilic and Hydrophobic IOLs in the UK","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Water Resources and Management","field":"Environmental Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Natural resource economics; Medicine; Economics","score_opus":0.01262310359533814,"score_gpt":0.2199379437897915,"score_spread":0.20731484019445337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99435276,0.0016848346,0.00000156335,0.002989227,0.000037899725,0.00035609273,0.000006251307,0.0000038709063,0.0005674915],"genre_scores_gemma":[0.9984054,0.0011974912,0.000014888046,0.00024293792,0.00002298191,0.00001528808,0.0000014833103,0.0000059013814,0.00009361365],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992443,0.000110815214,0.0001924184,0.00019480051,0.000093376446,0.00016430113],"domain_scores_gemma":[0.999721,0.00006499973,0.000029524585,0.00015466292,6.373245e-8,0.000029773728],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006321773,0.00007115364,0.00009147008,0.000032191823,0.00004545764,0.000026318101,0.0001387432,0.000017435916,0.000103713115],"category_scores_gemma":[0.0000012415456,0.00004157625,0.000015106881,0.000054779397,0.00014661904,0.000037852824,0.00016047581,0.00009455707,0.000030487216],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007596867,0.00019323014,0.20050745,0.000877207,0.00006111693,0.00013186265,0.1448755,0.5445497,0.004633176,0.0055918046,0.0040983655,0.094404645],"study_design_scores_gemma":[0.0010207809,0.00064638874,0.30532488,0.0003032896,0.000021883248,0.00008808417,0.0075778905,0.5122547,0.00017903694,0.011398373,0.16074991,0.00043477773],"about_ca_topic_score_codex":0.02199725,"about_ca_topic_score_gemma":0.00024319079,"teacher_disagreement_score":0.15665154,"about_ca_system_score_codex":0.00016325865,"about_ca_system_score_gemma":0.000005595579,"threshold_uncertainty_score":0.98451537},"labels":[],"label_agreement":null},{"id":"W4405748713","doi":"10.1016/j.jval.2024.10.235","title":"CO159 Challenges on Outcomes Selection Along Early to Late Phase Clinical Trials of Drug Development: Survey to Experts in Neurosciences Drug Development","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"TRIUMF","funders":"","keywords":"Drug development; Drug; Selection (genetic algorithm); Drug trial; Medicine; Clinical trial; Intensive care medicine; Pharmacology; Computer science; Internal medicine; Artificial intelligence","score_opus":0.7950016488013655,"score_gpt":0.5719902155305575,"score_spread":0.22301143327080797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748713","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9625468,0.002048996,0.0003267229,0.0305503,0.0026223497,0.0016962768,0.00007805905,0.000049916147,0.00008055247],"genre_scores_gemma":[0.99055785,0.00052337453,0.0031218731,0.005046186,0.00011279015,0.00022524262,0.000012409789,0.000034983434,0.0003652924],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9822176,0.0046135024,0.011193586,0.0010843073,0.00024037776,0.0006506305],"domain_scores_gemma":[0.98957837,0.008234068,0.0014345734,0.00029866485,0.000050629773,0.0004037222],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.17113303,0.00025243856,0.0019591423,0.0014887461,0.00013304364,0.000086897286,0.00032692004,0.00010938016,0.000034299603],"category_scores_gemma":[0.015616428,0.00027692586,0.000102181766,0.00081376266,0.000032444026,0.00027078527,0.00006868489,0.00026348347,0.00039757587],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000192963,0.0010721793,0.87368476,0.0013802265,0.00006312264,0.000005395347,0.080815926,0.0066299043,0.0000024791286,0.008662903,0.0042395312,0.02325061],"study_design_scores_gemma":[0.001359996,0.00033934592,0.9619856,0.0009541175,0.0000012002839,8.272716e-7,0.0008363243,0.0036941243,0.000042260195,0.00060634554,0.029762292,0.00041758825],"about_ca_topic_score_codex":0.013715661,"about_ca_topic_score_gemma":0.010871609,"teacher_disagreement_score":0.1555166,"about_ca_system_score_codex":0.0010919227,"about_ca_system_score_gemma":0.0015096755,"threshold_uncertainty_score":0.9999683},"labels":[],"label_agreement":null},{"id":"W4405748745","doi":"10.1016/j.jval.2024.10.020","title":"P16 Standardized Implementation of a Personalized Endpoint: Inventory-Facilitated Goal Attainment Scaling","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Complex Systems and Decision Making","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Goal Attainment Scaling; Scaling; Computer science; Psychology; Mathematics; Neuroscience","score_opus":0.19447428401088468,"score_gpt":0.4728301859456369,"score_spread":0.27835590193475224,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748745","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93750805,0.013450835,0.042999454,0.0024115168,0.0015133228,0.0011897807,0.00031101945,0.00010727248,0.0005087262],"genre_scores_gemma":[0.99793124,0.000034787594,0.001510825,0.00012733611,0.00006508438,0.000024170688,0.0000053998733,0.000015140037,0.0002860377],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9932993,0.0011359957,0.002252533,0.0006200604,0.0022885895,0.0004035346],"domain_scores_gemma":[0.99754995,0.0013568134,0.00036953107,0.0003680809,0.00018623944,0.00016936027],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0132232895,0.00016617727,0.0006136819,0.00080047344,0.00012098483,0.00020971017,0.0002789556,0.000051813342,0.0012306959],"category_scores_gemma":[0.00062924105,0.0001289933,0.00022060267,0.0013911433,0.000069852715,0.00020800719,0.000121851765,0.00016793946,0.00007926395],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000862764,0.00028585398,0.049968585,0.0017015851,0.00018106001,0.00017814549,0.097504586,0.019418882,0.002128714,0.32629913,0.050859895,0.45061082],"study_design_scores_gemma":[0.006087659,0.00076403935,0.032306906,0.0023544242,0.000020445332,0.000045628385,0.061129734,0.39441612,0.0005028012,0.15081929,0.35082403,0.00072895567],"about_ca_topic_score_codex":0.004033219,"about_ca_topic_score_gemma":0.00016308317,"teacher_disagreement_score":0.44988185,"about_ca_system_score_codex":0.00053045794,"about_ca_system_score_gemma":0.00073803857,"threshold_uncertainty_score":0.9996823},"labels":[],"label_agreement":null},{"id":"W4405748749","doi":"10.1016/j.jval.2024.10.199","title":"CO123 Patient Characteristics, Treatment Pattern, Treatment Outcomes, and Survival Prognosis of Elderly Patients With Myelodysplastic Syndromes in China: A Systematic Literature Review","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Myelodysplastic syndromes; Medicine; China; Intensive care medicine; Internal medicine; Oncology; History","score_opus":0.024337493309489422,"score_gpt":0.30066767158811003,"score_spread":0.2763301782786206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748749","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93624943,0.055224404,0.00000864806,0.0019331906,0.00015549228,0.0061312076,0.00024341533,0.000039851537,0.000014361714],"genre_scores_gemma":[0.9533649,0.045331236,0.0001406738,0.00011865402,0.000019478952,0.00067862676,0.0002191433,0.000050913364,0.000076375],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677336,0.00053147814,0.0011509837,0.0005218996,0.000538606,0.00048364644],"domain_scores_gemma":[0.99862134,0.0004318398,0.0002296306,0.0003819549,0.00009414773,0.0002410629],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048134036,0.00038496568,0.0016903463,0.00045537367,0.000035176636,0.000039559498,0.00007262446,0.000092417766,0.00001182354],"category_scores_gemma":[0.00017726855,0.0002229606,0.000093340605,0.00066107913,0.000054676977,0.00008200607,0.00003452453,0.00026350893,0.000007737259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013480698,0.0011926059,0.6774128,0.29679415,0.00027125448,0.0006998246,0.003017539,0.000005118651,0.0000010839962,0.00002871559,0.0000323112,0.020409789],"study_design_scores_gemma":[0.003313272,0.011058521,0.6586765,0.32513157,0.0002042499,0.00010529103,0.00007718691,0.0011431549,0.0000048635316,0.000004832776,0.00008224709,0.00019833],"about_ca_topic_score_codex":0.0019003104,"about_ca_topic_score_gemma":0.00010401772,"teacher_disagreement_score":0.028337441,"about_ca_system_score_codex":0.0020583128,"about_ca_system_score_gemma":0.0006800208,"threshold_uncertainty_score":0.9092069},"labels":[],"label_agreement":null},{"id":"W4405748759","doi":"10.1016/j.jval.2024.10.134","title":"CO57 Clinical and Patient-Reported Outcomes Associated With Oral Semaglutide Use in Adults With Type 2 Diabetes: A Pooled Analysis of Six Pioneer Real Prospective Real-World Studies","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Semaglutide; Medicine; Type 2 diabetes; Pooled analysis; Meta-analysis; Diabetes mellitus; Internal medicine; Endocrinology","score_opus":0.05708299758418476,"score_gpt":0.3627923401509598,"score_spread":0.305709342566775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748759","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9969436,0.0007873713,7.024172e-7,0.0006121862,0.00008498489,0.0013356215,0.000020467305,0.00007742119,0.00013766014],"genre_scores_gemma":[0.9980548,0.00084717735,0.00036104035,0.00021117259,0.000008510522,0.0000704105,0.00007463116,0.00002679131,0.00034546078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976711,0.00023569405,0.0008917069,0.00049050216,0.00035426658,0.00035669908],"domain_scores_gemma":[0.9984738,0.00068091706,0.0002783597,0.00025892415,0.00018440097,0.00012359823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00077481224,0.00022213759,0.0012582887,0.00081593054,0.000028816794,0.000017608072,0.000033650933,0.000054261433,0.000004822958],"category_scores_gemma":[0.0004140072,0.00014184648,0.0000812224,0.0024837372,0.00014302378,0.00009012109,0.000045231813,0.00020433097,9.164269e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005930696,0.0006853587,0.9856451,0.00038213358,0.0085746115,0.00016877803,0.002056112,0.000369255,8.1455767e-7,0.00017392701,0.00014248308,0.0012083504],"study_design_scores_gemma":[0.003456369,0.0028604756,0.9836425,0.0024906446,0.0024103392,2.8562332e-7,0.0006236759,0.004318865,0.000004973718,0.000038966922,0.000022429695,0.00013045322],"about_ca_topic_score_codex":0.008668601,"about_ca_topic_score_gemma":0.028324798,"teacher_disagreement_score":0.019656198,"about_ca_system_score_codex":0.00039748763,"about_ca_system_score_gemma":0.00022757247,"threshold_uncertainty_score":0.99793273},"labels":[],"label_agreement":null},{"id":"W4405748788","doi":"10.1016/j.jval.2024.10.218","title":"CO142 Systematic Literature Review of Real-World Evidence on Overall Survival in Cancer Patients Before and After the Approval of Anti-PD-(L)1 Therapy","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Medicine; Cancer therapy; Real world evidence; Systematic review; Cancer; Intensive care medicine; Internal medicine; MEDLINE; Political science; Law","score_opus":0.048171533939200456,"score_gpt":0.3644565754983334,"score_spread":0.31628504155913295,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748788","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.61276275,0.38353577,1.01428256e-7,0.002043405,0.00015496662,0.0013952781,0.000029415447,0.000005103402,0.0000732283],"genre_scores_gemma":[0.65948546,0.33987257,0.000007690315,0.0003929041,0.00002408985,0.00015205,0.0000028982954,0.0000076638335,0.000054691543],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99857014,0.0002464411,0.0005419159,0.00020539542,0.00028323763,0.00015288996],"domain_scores_gemma":[0.99932134,0.00026155633,0.00012869382,0.00018285093,0.000070198905,0.00003536923],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00068316236,0.00013068144,0.00068443787,0.00011739691,0.000018081042,0.000007879599,0.00004768651,0.000027865808,0.000008328758],"category_scores_gemma":[0.00007926272,0.00006685461,0.000060984392,0.00045249236,0.000043943972,0.000044096683,0.000022457365,0.00016238529,3.2591302e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005846006,0.00025323665,0.44964865,0.5380219,0.00010709494,0.000028150847,0.006976212,0.0000081833705,0.0000037613559,0.000417383,0.00016280277,0.0037880205],"study_design_scores_gemma":[0.0004565329,0.0008910967,0.50882447,0.4895063,0.000026960768,0.000001786559,0.000032790984,0.00009950974,0.000006682479,0.0000482094,0.00006445622,0.000041179905],"about_ca_topic_score_codex":0.004008795,"about_ca_topic_score_gemma":0.001378581,"teacher_disagreement_score":0.05917584,"about_ca_system_score_codex":0.00024135133,"about_ca_system_score_gemma":0.00018060992,"threshold_uncertainty_score":0.6060126},"labels":[],"label_agreement":null},{"id":"W4405748795","doi":"10.1016/j.jval.2024.10.136","title":"CO59 Do Asthma Patients Prescribed a GLP1 Have Improved Asthma and Weight Loss Outcomes?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Markham Stouffville Hospital","funders":"","keywords":"Asthma; Medicine; Weight loss; Physical therapy; Internal medicine; Obesity","score_opus":0.01689629746621388,"score_gpt":0.28326133280996835,"score_spread":0.26636503534375444,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748795","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9842038,0.003912153,0.000038453552,0.0063740523,0.0007387847,0.0018767638,0.000037657348,0.00014977252,0.002668532],"genre_scores_gemma":[0.99354166,0.0005581623,0.0008379767,0.0012003704,0.00008896926,0.000095770796,0.00007193637,0.00004178087,0.0035633459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983381,0.00008112163,0.0004139312,0.00044069134,0.0002641108,0.00046203154],"domain_scores_gemma":[0.99928886,0.000093143724,0.000065339875,0.00028487964,0.00003203453,0.00023576243],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036143087,0.00021435678,0.0004117299,0.00024029396,0.000049402617,0.00005883221,0.00006290086,0.00006772515,0.00005692278],"category_scores_gemma":[0.000049793445,0.00016449078,0.00007451945,0.00018146515,0.000042095344,0.00010952463,0.00008791968,0.00018208273,0.00004847145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022780758,0.0012188177,0.82234716,0.0035219234,0.00036756112,0.00021084434,0.002380636,0.000020109748,0.00001967914,0.005141352,0.008278375,0.15626575],"study_design_scores_gemma":[0.009071252,0.003071514,0.72122866,0.0018408009,0.000089364126,0.00000878886,0.0001607801,0.016633425,0.000069610694,0.0011434535,0.24628165,0.00040072136],"about_ca_topic_score_codex":0.0009771414,"about_ca_topic_score_gemma":0.000040670133,"teacher_disagreement_score":0.23800328,"about_ca_system_score_codex":0.00029029587,"about_ca_system_score_gemma":0.00011655919,"threshold_uncertainty_score":0.6707739},"labels":[],"label_agreement":null},{"id":"W4405748806","doi":"10.1016/j.jval.2024.10.002","title":"P1 Indirect Treatment Comparison of Larotrectinib vs Entrectinib in NTRK-Fusion Solid Tumors: Demonstration of a Novel Bayesian Hierarchical Modelling Approach for Basket Trials","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Bayesian probability; Medicine; Bayesian network; Bayesian inference; Oncology; Internal medicine; Computer science; Cancer research; Artificial intelligence","score_opus":0.16389463171589036,"score_gpt":0.44161497162682145,"score_spread":0.2777203399109311,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.80954087,0.0035762358,0.17778893,0.0015152972,0.00033441006,0.0062092654,0.00029101523,0.00007196031,0.000672044],"genre_scores_gemma":[0.96005666,0.00025380575,0.03895039,0.00002648314,0.00010889731,0.0003121286,0.00022251999,0.000025830115,0.00004328347],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99740607,0.0002914781,0.0014076896,0.00036967476,0.00023403471,0.00029104282],"domain_scores_gemma":[0.9984704,0.0009025034,0.00030123332,0.00016904753,0.00004390241,0.00011290794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013981299,0.00018265253,0.0011432082,0.00049928075,0.000050321883,0.0000128961465,0.000045146295,0.00010680034,0.0000098586415],"category_scores_gemma":[0.0001308645,0.00014279984,0.00017842161,0.00047893758,0.000035280907,0.000060365997,0.0000093226245,0.00017328595,3.2404364e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0052414243,0.0152795585,0.065773025,0.0075112027,0.0007386235,0.000019069194,0.056067828,0.68623394,0.002416197,0.00470267,0.00018748466,0.15582898],"study_design_scores_gemma":[0.0061916723,0.0024793176,0.0013284856,0.0019565532,0.00016508698,0.000013384062,0.00084422337,0.98145473,0.005025358,0.00025909985,0.00017162474,0.00011044688],"about_ca_topic_score_codex":0.0046450193,"about_ca_topic_score_gemma":0.00020799784,"teacher_disagreement_score":0.29522082,"about_ca_system_score_codex":0.0006142739,"about_ca_system_score_gemma":0.0012540824,"threshold_uncertainty_score":0.70219105},"labels":[],"label_agreement":null},{"id":"W4405748826","doi":"10.1016/j.jval.2024.10.044","title":"P34 Transportability Analyses in Action: A Landscape Assessment of Application Studies Using Real Data","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Urban Transport and Accessibility","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Action (physics); Computer science; Physics","score_opus":0.5106494172413965,"score_gpt":0.5836752466775649,"score_spread":0.07302582943616842,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748826","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948117,0.002717252,0.00072482124,0.0008000099,0.0001676853,0.0003675865,0.000049067636,0.000037904923,0.00032393023],"genre_scores_gemma":[0.99754757,0.0013481574,0.0009425418,0.000011253775,0.00008577186,0.000011043492,0.0000415835,0.0000044789717,0.0000075729195],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983332,0.00027544523,0.00055118697,0.00036809742,0.00027878166,0.00019329692],"domain_scores_gemma":[0.9993054,0.00019034171,0.00009534922,0.0003257135,0.00003545997,0.00004768535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029397078,0.000069814036,0.000268163,0.0001240147,0.000091189926,0.000016527429,0.00021268957,0.0000497267,0.00002169438],"category_scores_gemma":[0.00003195424,0.000063385865,0.000033426397,0.0009063294,0.000117853786,0.0003330378,0.000014654209,0.00014708875,3.229521e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009174056,0.00012697013,0.9857989,0.00081150845,0.000015070704,0.0000024099172,0.0065753954,0.0015813576,0.00007994256,0.0012939782,0.000012437076,0.0036928873],"study_design_scores_gemma":[0.00014586803,0.000023226004,0.9420758,0.0002527237,0.000021173251,8.569432e-8,0.006891221,0.04772976,0.000013107403,0.0022649707,0.00049115415,0.00009094133],"about_ca_topic_score_codex":0.14085363,"about_ca_topic_score_gemma":0.08565912,"teacher_disagreement_score":0.055194512,"about_ca_system_score_codex":0.00030507916,"about_ca_system_score_gemma":0.0010038138,"threshold_uncertainty_score":0.9310252},"labels":[],"label_agreement":null},{"id":"W4405748840","doi":"10.1016/j.jval.2024.10.075","title":"P59 Measuring Health Inequality Aversion in Canada: An Equity-Efficiency Trade-Off Experiment","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Western University; University of Toronto","funders":"","keywords":"Equity (law); Health equity; Inequality; Economics; Inequity aversion; Demographic economics; Public economics; Health care; Economic growth; Political science; Mathematics","score_opus":0.2258956237756933,"score_gpt":0.3484681315728448,"score_spread":0.12257250779715148,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748840","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81431884,0.05398545,0.0018340338,0.12000695,0.0030097202,0.0018932587,0.00025908207,0.0001499341,0.0045427564],"genre_scores_gemma":[0.9936072,0.0021153637,0.0002378468,0.0038307009,0.00009943775,0.00004221159,0.000014218667,0.000023828798,0.000029195244],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99660295,0.00028569522,0.0014351379,0.0006411998,0.00013988602,0.0008951181],"domain_scores_gemma":[0.99897414,0.00008456451,0.00020760158,0.00036752658,0.0000054127877,0.0003607545],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005475243,0.00017588142,0.0005178406,0.0005098759,0.00013306536,0.00004888392,0.00025205428,0.000058278303,0.00004744203],"category_scores_gemma":[0.000072854855,0.00021333637,0.00004678953,0.0006301337,0.00001691021,0.00019855649,0.00010903175,0.00037810416,0.000033022963],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003145869,0.0005274997,0.017735317,0.004310658,0.000018960744,0.000069889655,0.022860756,0.01884262,0.0000026836474,0.78662074,0.0020040039,0.14697541],"study_design_scores_gemma":[0.0019350667,0.0011651686,0.11740931,0.0020339254,0.0000021976266,0.000011168656,0.005934661,0.42382628,0.000060542596,0.026457224,0.41984966,0.0013147822],"about_ca_topic_score_codex":0.9926967,"about_ca_topic_score_gemma":0.82332754,"teacher_disagreement_score":0.7601635,"about_ca_system_score_codex":0.009428971,"about_ca_system_score_gemma":0.0030684746,"threshold_uncertainty_score":0.9943737},"labels":[],"label_agreement":null},{"id":"W4405748861","doi":"10.1016/j.jval.2024.10.251","title":"CO175 Clinical Outcomes of Interventions in Patients With Newly Diagnosed Chronic Myeloid Leukemia: A Systematic Literature Review","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amorfix (Canada)","funders":"","keywords":"Medicine; Myeloid leukemia; Systematic review; Psychological intervention; Intensive care medicine; Chronic leukemia; Internal medicine; Oncology; Leukemia; MEDLINE; Acute leukemia; Psychiatry; Biology","score_opus":0.04815711128303091,"score_gpt":0.36623023945130506,"score_spread":0.31807312816827416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748861","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.56187254,0.4290669,0.000033139906,0.0018638511,0.0005273023,0.0063718962,0.00007061925,0.00009138911,0.00010240384],"genre_scores_gemma":[0.9136427,0.08318002,0.00088857615,0.0009886218,0.00009083774,0.00043792452,0.00022363784,0.000075251715,0.00047242432],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9956278,0.00067710417,0.0023170009,0.00049320405,0.00047169498,0.00041317727],"domain_scores_gemma":[0.9978185,0.0008618521,0.00038417568,0.0006472066,0.00009239493,0.00019583208],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017098899,0.00028183399,0.0017284226,0.00038166842,0.000023849263,0.000019480462,0.00015033125,0.00015696819,0.000047158974],"category_scores_gemma":[0.00082032796,0.00018944536,0.00037263057,0.0010858711,0.00006589238,0.0001188585,0.000053228887,0.0007559698,0.000040798746],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006402106,0.00066812104,0.3988498,0.5964465,0.00023540367,0.00025388508,0.0004120769,0.00009904669,1.4012247e-7,0.00023694585,0.0007093728,0.002024678],"study_design_scores_gemma":[0.0062331636,0.0015006311,0.33592665,0.65515816,0.00019520946,0.00002213117,0.000021369324,0.00067938794,5.489644e-7,0.000019845149,0.00012470174,0.00011819697],"about_ca_topic_score_codex":0.000817641,"about_ca_topic_score_gemma":0.00029194515,"teacher_disagreement_score":0.3517702,"about_ca_system_score_codex":0.005131826,"about_ca_system_score_gemma":0.0028267922,"threshold_uncertainty_score":0.99868727},"labels":[],"label_agreement":null},{"id":"W4405748868","doi":"10.1016/j.jval.2024.10.008","title":"P6 Projected Increase of the Clinical, Economic, Societal, and Environmental Burdens of Chronic Kidney Disease in Switzerland: Insights from Impact-CKD","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare cost, quality, practices","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Kidney disease; Disease; Medicine; Environmental health; Natural resource economics; Development economics; Economics; Internal medicine","score_opus":0.33299300312866176,"score_gpt":0.5114236650110323,"score_spread":0.17843066188237056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9777281,0.0098520275,0.0000027171377,0.008140988,0.00085096667,0.0020519376,0.0012776841,0.000034862085,0.00006067282],"genre_scores_gemma":[0.991461,0.006301697,0.00006529998,0.0015297849,0.00035184546,0.00008144759,0.00011395,0.0000417236,0.000053258525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98938835,0.006854547,0.002324365,0.0005861128,0.00028742923,0.00055922556],"domain_scores_gemma":[0.9940242,0.0037659735,0.00083078636,0.000666404,0.000019879593,0.0006927537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036502043,0.00023812002,0.0007221368,0.00019072481,0.00020344568,0.000012810141,0.00027804385,0.00027723497,0.00022697686],"category_scores_gemma":[0.0012496917,0.00017525422,0.00015687004,0.00025061477,0.00031700908,0.0002547616,0.00029034197,0.0014535604,0.000042745738],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003331888,0.00045665764,0.9798428,0.0038333214,0.00006967285,0.000014536815,0.010940096,0.00015778228,0.00014396867,0.00043483186,0.0022295376,0.0015436289],"study_design_scores_gemma":[0.0021646516,0.00041366098,0.958462,0.0039556567,0.000041977437,0.0000012017423,0.0023207073,0.022222875,0.000013977704,0.0024316686,0.007729222,0.0002424209],"about_ca_topic_score_codex":0.16954242,"about_ca_topic_score_gemma":0.004908824,"teacher_disagreement_score":0.16463359,"about_ca_system_score_codex":0.0017197356,"about_ca_system_score_gemma":0.012321342,"threshold_uncertainty_score":0.9932779},"labels":[],"label_agreement":null},{"id":"W4405748941","doi":"10.1016/j.jval.2024.10.1563","title":"HPR137 Evaluating the Clinical and Socioeconomic Impact of Improved CKD Diagnosis and Adherence to Guideline-Directed Medical Therapy in Australia, Brazil, and China: An Impact CKD Analysis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Guideline; Medicine; Socioeconomic status; China; Family medicine; Intensive care medicine; Environmental health; Geography; Population; Pathology","score_opus":0.5338292246245695,"score_gpt":0.5944169081069948,"score_spread":0.06058768348242527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748941","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97215694,0.009719999,0.00011050868,0.016223712,0.00021200471,0.0012470114,0.00028113043,0.000037588274,0.000011099048],"genre_scores_gemma":[0.9908492,0.0051710145,0.0016550871,0.0019225784,0.00019461883,0.00013207212,0.000024497615,0.000032956217,0.000017962082],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9903219,0.0018874845,0.0061154994,0.00096558017,0.00013841073,0.0005711404],"domain_scores_gemma":[0.99418944,0.00349228,0.0011778888,0.000500392,0.000048511305,0.0005915042],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.054508347,0.0002925582,0.0017284023,0.00081510673,0.00012489439,0.0001482996,0.00027205463,0.000266123,0.00042945478],"category_scores_gemma":[0.004275747,0.00025594325,0.00022185103,0.0006777889,0.00021250543,0.00038774332,0.00009098029,0.0005168862,0.000024482793],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000635036,0.00010568886,0.9773134,0.00021073439,0.00027111525,0.0000012275292,0.004527976,0.0020965948,0.0000020538591,0.00053978036,0.00087733235,0.013990584],"study_design_scores_gemma":[0.00070573634,0.0012837979,0.6460405,0.00012828878,0.0000121895955,0.000004071545,0.0001972114,0.34883198,3.3201056e-7,0.0025650244,0.00006364462,0.00016721015],"about_ca_topic_score_codex":0.17116125,"about_ca_topic_score_gemma":0.0057995026,"teacher_disagreement_score":0.3467354,"about_ca_system_score_codex":0.00060274557,"about_ca_system_score_gemma":0.0010244771,"threshold_uncertainty_score":0.9999893},"labels":[],"label_agreement":null},{"id":"W4405748988","doi":"10.1016/j.jval.2024.10.1686","title":"HSD3 Real-World Treatment Patterns in Sickle Cell Disease (SCD) in Europe, Africa, Eastern Mediterranean Region (EMR), and India: A Systematic Literature Review (SLR)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Disease; Geography; Mediterranean climate; Medicine; Pathology; Archaeology","score_opus":0.03034951924497465,"score_gpt":0.28728556622409857,"score_spread":0.2569360469791239,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405748988","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22722475,0.7539582,0.000005755908,0.01250019,0.00042428964,0.004441523,0.00004244249,0.00009442158,0.0013084159],"genre_scores_gemma":[0.59865206,0.39905795,0.000016702323,0.0007941848,0.00007153174,0.00013756289,0.00006329724,0.00004264345,0.0011640539],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9970507,0.0006868993,0.0009820589,0.000526176,0.00027848015,0.00047565508],"domain_scores_gemma":[0.99887604,0.00016662166,0.00013566173,0.00039925336,0.00003200594,0.0003903928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072376383,0.00030005732,0.000866449,0.0006457866,0.000032785134,0.00004476928,0.00008228498,0.0001058434,0.0000105169165],"category_scores_gemma":[0.0001006993,0.00020984685,0.000076339726,0.0017488198,0.000031692536,0.000094762894,0.0000365106,0.0005155991,0.00002565983],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018532686,0.0008885502,0.07214854,0.88264096,0.000043983266,0.014462742,0.02162453,0.00009034389,0.0000033352696,0.00019449886,0.001729933,0.0059872647],"study_design_scores_gemma":[0.003020159,0.00082769763,0.02620027,0.95292133,0.00018605562,0.00017405118,0.0006145857,0.011099982,0.000001881288,0.000087339606,0.0044900915,0.00037655205],"about_ca_topic_score_codex":0.0025184501,"about_ca_topic_score_gemma":0.00044091063,"teacher_disagreement_score":0.37142733,"about_ca_system_score_codex":0.00044194373,"about_ca_system_score_gemma":0.00039545176,"threshold_uncertainty_score":0.85573065},"labels":[],"label_agreement":null},{"id":"W4405749009","doi":"10.1016/j.jval.2024.10.1805","title":"HSD122 Burden of Low Molecular Weight Heparin Switching in the UK and Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Business","score_opus":0.012783779704307139,"score_gpt":0.26876528395918853,"score_spread":0.25598150425488136,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97619617,0.0064001014,0.000025846959,0.0158118,0.00016849514,0.00048529383,0.0000028125285,0.000008254795,0.0009012299],"genre_scores_gemma":[0.9966953,0.0013187432,0.00009825764,0.0017750422,0.000056439945,0.000020299476,0.000003291219,0.000010649421,0.000021977346],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99898976,0.000092200775,0.00029370943,0.00017326053,0.00023661464,0.00021443923],"domain_scores_gemma":[0.9996158,0.00010228322,0.00003476243,0.0001806277,0.0000084496005,0.000058109345],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006998335,0.00007946798,0.0002705677,0.000111900335,0.0000231159,0.000011999273,0.00007185624,0.000024537576,0.000015484955],"category_scores_gemma":[0.000032598833,0.000056985064,0.00002119952,0.00019606913,0.000012467327,0.000017204866,0.00003459459,0.00018201729,0.0000010323761],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020905958,0.0021172878,0.2162191,0.055331778,0.0007312601,0.009315958,0.14043139,0.032103244,0.0034966676,0.27796945,0.101703055,0.16037175],"study_design_scores_gemma":[0.005207028,0.0018011219,0.67585105,0.022117555,0.0002466045,0.0002315551,0.011913103,0.15058902,0.0015408765,0.010012685,0.11950355,0.0009858505],"about_ca_topic_score_codex":0.94339675,"about_ca_topic_score_gemma":0.31167227,"teacher_disagreement_score":0.6317245,"about_ca_system_score_codex":0.00018370304,"about_ca_system_score_gemma":0.00054197566,"threshold_uncertainty_score":0.7008879},"labels":[],"label_agreement":null},{"id":"W4405749123","doi":"10.1016/j.jval.2024.10.1442","title":"HPR15 Innovative Rebate Management in Oncology Drug Budgets: Streamlining Operations and Enhancing Financial Efficiency Through Technology in Newfoundland and Labrador's Cancer Care Program","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Amgen (Canada); St. John’s Health Sciences Centre","funders":"","keywords":"Cancer drugs; Precision oncology; Business; Operations management; Finance; Cancer; Engineering management; Medicine; Internal medicine; Engineering","score_opus":0.028462491863441297,"score_gpt":0.32327932840885804,"score_spread":0.29481683654541674,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749123","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94452304,0.044809457,0.00026513488,0.0059726234,0.00051159103,0.0009179796,0.00006761694,0.000050059152,0.0028825023],"genre_scores_gemma":[0.9849053,0.0114975795,0.0027139573,0.00042270284,0.00007547736,0.0002797135,0.000008494958,0.000021534934,0.000075222146],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99795514,0.000032985237,0.0009190452,0.0005867862,0.00002528646,0.00048074237],"domain_scores_gemma":[0.9995805,0.000070346,0.00013471543,0.00014045513,0.000025365372,0.000048641086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007074429,0.00017551873,0.0005433392,0.00082730723,0.000094102834,0.00007781085,0.00010887269,0.00015456333,0.000010637586],"category_scores_gemma":[0.00009649776,0.00020523924,0.000017570868,0.0012126605,0.00010159707,0.0003354894,0.00009772152,0.00042151054,0.0000065832846],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003763699,0.00014920215,0.16539632,0.0007376645,0.000019330002,0.00006284316,0.02779824,0.006761557,0.0000025369932,0.53805494,0.00006568592,0.26091403],"study_design_scores_gemma":[0.009280453,0.0024065091,0.49485695,0.0052115223,0.000018186549,0.000037318645,0.018329432,0.078366004,0.000057455316,0.20483266,0.18442905,0.0021744564],"about_ca_topic_score_codex":0.05918479,"about_ca_topic_score_gemma":0.07669831,"teacher_disagreement_score":0.3332223,"about_ca_system_score_codex":0.0015676379,"about_ca_system_score_gemma":0.00041302765,"threshold_uncertainty_score":0.9470802},"labels":[],"label_agreement":null},{"id":"W4405749136","doi":"10.1016/j.jval.2024.10.1541","title":"HPR115 Oncology Branded Multi-Company Combinations (MCCs): Assessment of the Availability in France, Germany, Italy, Spain, England, Scotland, Canada, and Australia","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Geography","score_opus":0.0541589831845331,"score_gpt":0.31255779777771875,"score_spread":0.25839881459318564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749136","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901264,0.0027973016,0.00014306167,0.0036029199,0.0010660007,0.00050849613,0.00032038905,0.000009545359,0.0014259394],"genre_scores_gemma":[0.99825126,0.0004674234,0.00023938705,0.00034048196,0.000044596563,0.000027810158,0.0000063349426,0.000013081435,0.00060961937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981631,0.00009134439,0.0010033167,0.0003547272,0.00004437243,0.00034312665],"domain_scores_gemma":[0.9991287,0.00022168014,0.0002708564,0.0002610574,0.000021192616,0.00009653569],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015474162,0.00013727343,0.00055229716,0.0001926534,0.00006390955,0.000029951525,0.00018148056,0.00010649758,0.00008101102],"category_scores_gemma":[0.000086158034,0.00013260433,0.000055119708,0.00030840992,0.000108256936,0.00014372358,0.000051581646,0.0003674986,0.000008664213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000068435024,0.00017243515,0.9397274,0.00029801176,0.000018228207,0.0000041213816,0.000624294,0.0015444311,0.00000228435,0.056096014,0.00044687357,0.0010590188],"study_design_scores_gemma":[0.0014831721,0.00007006129,0.9414847,0.000115462586,0.0000022015074,0.0000028840443,0.00003303489,0.020460462,0.0000033476804,0.0047813132,0.03143324,0.00013014967],"about_ca_topic_score_codex":0.77290404,"about_ca_topic_score_gemma":0.6548568,"teacher_disagreement_score":0.1180472,"about_ca_system_score_codex":0.0010988417,"about_ca_system_score_gemma":0.0010229921,"threshold_uncertainty_score":0.5407447},"labels":[],"label_agreement":null},{"id":"W4405749195","doi":"10.1016/j.jval.2024.10.1447","title":"HPR20 Collaborative Demonstration Project in the Province of Québec for the Operationalization of Value-Based Agreement: Moving From a Vision to Implementation","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Social Sciences and Governance","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Montréal InVivo; InterDigital (Canada)","funders":"","keywords":"Operationalization; Value (mathematics); Computer science; Physics; Machine learning; Quantum mechanics","score_opus":0.051447056943411354,"score_gpt":0.4232668292684664,"score_spread":0.3718197723250551,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749195","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83266777,0.0011948688,0.048781544,0.10799266,0.0003804297,0.008418514,0.0002757617,0.000017278366,0.00027117704],"genre_scores_gemma":[0.99731094,0.000043740456,0.0017855453,0.0005746683,0.00007072033,0.0001834405,0.000010157311,0.0000030565718,0.000017722423],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.99849343,0.00040998452,0.00034272493,0.00016242967,0.00045212233,0.00013930957],"domain_scores_gemma":[0.99888444,0.0007968122,0.00013104468,0.00006950223,0.00009663241,0.000021551477],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022498758,0.000049226917,0.00009022447,0.000066448505,0.00021751077,0.00006254892,0.00017177772,0.000023666584,0.0000092153405],"category_scores_gemma":[0.00028460438,0.000033165696,0.000021666014,0.0012769079,0.00005351156,0.00016522632,0.000009932886,0.000038246246,6.235709e-7],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013470788,0.0001783,0.035438146,0.00022323937,0.000013675005,7.763124e-7,0.48396656,0.14440909,0.0010042691,0.25878447,0.00562035,0.070226416],"study_design_scores_gemma":[0.0015942138,0.0022430255,0.24307002,0.0018022791,0.000033146414,1.2049367e-7,0.3831901,0.30061272,0.002009044,0.009446727,0.05555848,0.00044012943],"about_ca_topic_score_codex":0.7586142,"about_ca_topic_score_gemma":0.75410676,"teacher_disagreement_score":0.24933773,"about_ca_system_score_codex":0.00035408672,"about_ca_system_score_gemma":0.0049865535,"threshold_uncertainty_score":0.8845932},"labels":[],"label_agreement":null},{"id":"W4405749254","doi":"10.1016/j.jval.2024.10.1445","title":"HPR18 Unmet Medical Need in Patients With Paroxysmal Noctural Hemoglobinuria Treated With Complement 5 Inhibitors: Results From a Cross-Sectional Survey in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Complement (music); Hemoglobinuria; Family medicine; Intensive care medicine; Internal medicine; Anemia; Genetics; Biology","score_opus":0.03169271260389206,"score_gpt":0.2789218733864838,"score_spread":0.24722916078259172,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749254","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9936788,0.0006844507,0.0000022609086,0.000340736,0.0007190916,0.00095157465,0.003562432,0.00004051597,0.000020157873],"genre_scores_gemma":[0.9944627,0.000006079607,0.000023631666,0.00015763992,0.000039482227,0.00006249355,0.005196518,0.000023465363,0.000027964832],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957907,0.0013494454,0.0012237887,0.0006603136,0.0003090634,0.0006666636],"domain_scores_gemma":[0.99844843,0.0009306703,0.00017178997,0.0002775894,0.000065430046,0.00010610248],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011497687,0.0002742361,0.00049340224,0.00026035323,0.00007844008,0.00003380063,0.00023399934,0.00011821514,0.00043738855],"category_scores_gemma":[0.00016991342,0.00021121174,0.000028250395,0.00064668036,0.00010429943,0.00008452488,0.000080625236,0.0004589877,0.00002017697],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027543087,0.00021702213,0.993478,0.00008607496,0.00006925872,0.000064816566,0.0002500367,0.001164989,0.0000048124716,0.000018567214,0.0017498301,0.00014226059],"study_design_scores_gemma":[0.009114141,0.0003952173,0.9883686,0.00079030823,0.0000035461503,0.0000066543735,0.00011772152,0.00036351633,0.000023836596,0.000011378722,0.00058244367,0.00022264011],"about_ca_topic_score_codex":0.9882066,"about_ca_topic_score_gemma":0.97702575,"teacher_disagreement_score":0.011180865,"about_ca_system_score_codex":0.0025241182,"about_ca_system_score_gemma":0.004185133,"threshold_uncertainty_score":0.8612965},"labels":[],"label_agreement":null},{"id":"W4405749258","doi":"10.1016/j.jval.2024.10.1244","title":"EPH115 Estimating the Public Health Impact of Pediatric Vaccination Programs on Invasive Pneumococcal Disease in France","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Pneumococcal disease; Vaccination; Disease; Medicine; Pneumococcal vaccination; Public health; Environmental health; Pediatrics; Intensive care medicine; Immunology; Streptococcus pneumoniae; Biology; Internal medicine; Pathology; Microbiology","score_opus":0.0644160513302726,"score_gpt":0.37309325657982423,"score_spread":0.3086772052495516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749258","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9742361,0.0021028542,0.00010375611,0.02172805,0.0003823783,0.0013212392,0.000013385205,0.000070254486,0.000042008396],"genre_scores_gemma":[0.99860346,0.00036410807,0.000068217145,0.0005114976,0.00028805656,0.00011388841,0.000016602276,0.000021053855,0.000013121405],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99808335,0.0003770374,0.0005887466,0.00026710934,0.00026874267,0.0004149821],"domain_scores_gemma":[0.9988948,0.0003488038,0.00016274326,0.0002452538,0.000048685433,0.00029969952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012851808,0.0001384894,0.0002891026,0.0005066886,0.000101722086,0.000030234876,0.0000807289,0.000051498213,0.000012687005],"category_scores_gemma":[0.00054526114,0.00009036659,0.00011520935,0.0014521567,0.000025042404,0.00010636605,0.000019706848,0.00049109384,0.000014583148],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017067425,0.00067339255,0.94626087,0.0025093167,0.000017788021,0.0000429786,0.001784346,0.015895195,0.000045569184,0.0006777223,0.00009423657,0.03198153],"study_design_scores_gemma":[0.00047492873,0.0011841665,0.94055724,0.00074848154,0.000007799082,0.000013920491,0.000047668695,0.05631191,0.0000017141623,0.00031794416,0.0002584284,0.00007578185],"about_ca_topic_score_codex":0.0015743825,"about_ca_topic_score_gemma":0.00007626439,"teacher_disagreement_score":0.040416714,"about_ca_system_score_codex":0.0006983119,"about_ca_system_score_gemma":0.0035985594,"threshold_uncertainty_score":0.63836896},"labels":[],"label_agreement":null},{"id":"W4405749271","doi":"10.1016/j.jval.2024.10.1336","title":"EPH210 Landscape of Intrahepatic Cholangiocarcinoma (IHC) in Brazilian Public Healthcare System and Monitoring of the Technological Horizon","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Aegera Therapeutics (Canada)","funders":"","keywords":"Intrahepatic Cholangiocarcinoma; Horizon; Immunohistochemistry; Public healthcare; Geography; Business; Medicine; Internal medicine; Public health; Pathology; Astronomy","score_opus":0.0408384055041803,"score_gpt":0.2900443348354722,"score_spread":0.2492059293312919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93684447,0.05273535,0.0000046974305,0.009308333,0.00031175307,0.0005502262,0.000011676228,0.00005570093,0.00017780307],"genre_scores_gemma":[0.9987025,0.0009779512,0.00012871662,0.000034470933,0.000090930946,0.000036477453,0.0000019656554,0.00001619463,0.00001074288],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983765,0.0001639024,0.0005859906,0.00029062206,0.0002614395,0.0003215345],"domain_scores_gemma":[0.9993195,0.0001485469,0.000101012534,0.0002986646,0.000043487424,0.00008879851],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00072766934,0.0001380113,0.0005086667,0.00036083342,0.00004368477,0.000012322813,0.00012126172,0.00011760797,0.0000017867721],"category_scores_gemma":[0.00011833787,0.000093727846,0.00007318707,0.0009213847,0.000118353986,0.000052033018,0.00009452393,0.00042196817,8.428417e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002936246,0.00004429391,0.9740834,0.0052884156,0.000025225849,0.000029937597,0.0012823734,0.0000053418307,0.000113523005,0.0029730638,0.00003661161,0.016088413],"study_design_scores_gemma":[0.0005968885,0.0004880007,0.9903015,0.004022956,0.000015877371,0.00007108725,0.0028781255,0.0009769197,0.00028662503,0.00012900909,0.00015588365,0.00007715685],"about_ca_topic_score_codex":0.0031871435,"about_ca_topic_score_gemma":0.00018876881,"teacher_disagreement_score":0.06185809,"about_ca_system_score_codex":0.0002837014,"about_ca_system_score_gemma":0.00031916235,"threshold_uncertainty_score":0.48180288},"labels":[],"label_agreement":null},{"id":"W4405749360","doi":"10.1016/j.jval.2024.10.1366","title":"EPH241 Impact of COVID-19's Cancer Screenings in the United States of America, Canada, and Brazil: An International Comparative Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Political science; 2019-20 coronavirus outbreak; Geography; Medicine; Virology; Pathology; Outbreak","score_opus":0.15555769764841093,"score_gpt":0.5090995113705663,"score_spread":0.3535418137221554,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749360","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97898287,0.0009829821,0.000031485626,0.018854098,0.00007212091,0.0007731671,0.00027512913,0.000010572543,0.000017559063],"genre_scores_gemma":[0.9939186,0.0006122343,0.00004808513,0.005273478,0.000039315153,0.0000178511,0.000072611445,0.000009117964,0.0000086835735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826974,0.0004140043,0.0005042058,0.00020688631,0.0003714836,0.0002336854],"domain_scores_gemma":[0.9984938,0.0008288514,0.00014363353,0.00017064958,0.00008623259,0.00027684684],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00089534384,0.00011563105,0.00039686883,0.0004458031,0.000034123237,0.000011569323,0.00011414837,0.000027083937,0.00004394263],"category_scores_gemma":[0.00023030117,0.000078483325,0.000026976382,0.000854308,0.000084897,0.000072454124,0.000023251368,0.00027887334,1.663637e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047339636,0.00029636527,0.9039651,0.00076100236,0.0000805307,0.00006410596,0.073585585,0.016623192,0.00001610129,0.00010815482,0.0018227531,0.0022037285],"study_design_scores_gemma":[0.0011102874,0.002048828,0.93545187,0.00043550672,0.000013130058,0.00001183936,0.013291104,0.044389553,0.000004937946,0.00008390114,0.0030889646,0.00007008551],"about_ca_topic_score_codex":0.99817395,"about_ca_topic_score_gemma":0.8725668,"teacher_disagreement_score":0.12560713,"about_ca_system_score_codex":0.0013399747,"about_ca_system_score_gemma":0.008983656,"threshold_uncertainty_score":0.9966345},"labels":[],"label_agreement":null},{"id":"W4405749371","doi":"10.1016/j.jval.2024.10.1283","title":"EPH155 The Impact of Adjuvant Alectinib in Reducing Recurrences and Recurrence-Related Treatment Costs in Resected Early-Stage ALK+ Non-Small Cell Lung Cancer Across Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Alectinib; Medicine; Lung cancer; Stage (stratigraphy); Oncology; Adjuvant; Internal medicine; Crizotinib; Biology","score_opus":0.030710343570659878,"score_gpt":0.39518242157878847,"score_spread":0.3644720780081286,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9679972,0.028493183,7.552613e-7,0.0011046614,0.00037039613,0.0014525069,0.0002647089,0.000013097277,0.00030351456],"genre_scores_gemma":[0.9931769,0.006258243,0.000035574343,0.00002614491,0.00003049182,0.00017017807,0.000037052967,0.000018580153,0.00024682868],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99817955,0.0001962369,0.0005875396,0.00038180244,0.00017822727,0.00047661221],"domain_scores_gemma":[0.9991554,0.00032305002,0.00013329457,0.00020386829,0.000043095784,0.00014130813],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00044593902,0.00019328481,0.00042159067,0.00014589749,0.00007514563,0.000023597724,0.00006787559,0.000067838475,0.000024920615],"category_scores_gemma":[0.000049842514,0.00012267227,0.00004887178,0.0009899697,0.000051673138,0.00006146875,0.000020862135,0.00033555104,4.2576752e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00020404223,0.0003199089,0.87745064,0.00084538286,0.00015457273,0.00023684389,0.056445915,0.009742849,0.00012981596,0.0000132634195,0.00043290202,0.054023862],"study_design_scores_gemma":[0.0039135544,0.0014863545,0.94580317,0.007261244,0.000059486727,0.000019006391,0.0026793412,0.037891854,0.0004456448,0.000022891652,0.00021815296,0.00019928513],"about_ca_topic_score_codex":0.99132025,"about_ca_topic_score_gemma":0.8692616,"teacher_disagreement_score":0.12205866,"about_ca_system_score_codex":0.00471028,"about_ca_system_score_gemma":0.006034057,"threshold_uncertainty_score":0.9996008},"labels":[],"label_agreement":null},{"id":"W4405749454","doi":"10.1016/j.jval.2024.10.1463","title":"HPR36 Balancing Trade-Offs With Simulation-Guided Negotiation: A Probabilistic Tipping Point Analysis for Comparison of Value-Based Contracts and Flat Discount Reimbursement Models for Cell and Gene Therapies","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Tipping point (physics); Negotiation; Reimbursement; Probabilistic logic; Value (mathematics); Point (geometry); Actuarial science; Economics; Microeconomics; Computer science; Mathematics; Engineering; Machine learning; Health care; Artificial intelligence","score_opus":0.3216825028714397,"score_gpt":0.4179906795299628,"score_spread":0.09630817665852315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749454","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46450835,0.013380821,0.5018583,0.016551487,0.00014180907,0.0031346984,0.00037034345,0.000031185566,0.000023010889],"genre_scores_gemma":[0.9762888,0.000090323374,0.022134723,0.0010118521,0.00007890481,0.00026700972,0.00008830531,0.000030514486,0.000009542152],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9956591,0.00022127628,0.0030924121,0.00058097765,0.00010459074,0.0003416259],"domain_scores_gemma":[0.9949422,0.0033524884,0.0012599028,0.00025359343,0.000065481385,0.00012634671],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009246465,0.00019159839,0.0011840658,0.0005061515,0.00016410173,0.000102112856,0.00007674817,0.00008295708,0.0000056691924],"category_scores_gemma":[0.0004687626,0.00020306649,0.00009079839,0.0003331239,0.00005230872,0.00029558293,0.000011038082,0.00009641989,8.6846336e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053467505,0.00006977393,0.022033917,0.003499893,0.0001468269,1.2614022e-7,0.006144431,0.94264215,0.0000048944644,0.025180941,0.00007315495,0.00015043702],"study_design_scores_gemma":[0.0013275148,0.00030609884,0.009098303,0.00035896877,0.000058608523,4.7493606e-7,0.00065963145,0.97575885,0.00001616337,0.011948903,0.00027422988,0.00019224231],"about_ca_topic_score_codex":0.0028928577,"about_ca_topic_score_gemma":0.0003233154,"teacher_disagreement_score":0.51178044,"about_ca_system_score_codex":0.0005876368,"about_ca_system_score_gemma":0.00040694835,"threshold_uncertainty_score":0.82808113},"labels":[],"label_agreement":null},{"id":"W4405749546","doi":"10.1016/j.jval.2024.10.3630","title":"RWD72 The Association of Hemophilia Related Joint Problems, Healthcare Resource Usage, and Patient Adherence to Prophylactic Treatment: Results From a Multinational Real-World Survey","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Multinational corporation; Medicine; Health care; Association (psychology); Business; Psychology; Economic growth; Finance; Economics","score_opus":0.09870577380198317,"score_gpt":0.3547071965123443,"score_spread":0.2560014227103611,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9518603,0.0021944337,0.0000010436577,0.042223826,0.00011863736,0.0026330273,0.0004887562,0.00005054394,0.00042944035],"genre_scores_gemma":[0.9958556,0.0008789637,0.0002876067,0.00016017002,0.000050794442,0.00010478818,0.00033817807,0.000024543848,0.0022993074],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99645823,0.001107957,0.0008907459,0.0005011388,0.00065487693,0.0003870616],"domain_scores_gemma":[0.9974979,0.0015552397,0.00022528964,0.00031089372,0.0001716918,0.00023895575],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002116382,0.00017636728,0.00040708738,0.00032207696,0.00012872987,0.000031973945,0.000054035045,0.0001042878,0.000014629564],"category_scores_gemma":[0.0009828731,0.0001115523,0.000057779438,0.0010244988,0.000046396235,0.00005121724,0.000047410653,0.00034734068,0.000019246196],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037721284,0.0024003661,0.7178981,0.0036205952,0.00055498583,0.00027609276,0.072442435,0.0017292425,0.0009398062,0.0011435628,0.0033043423,0.19191836],"study_design_scores_gemma":[0.003486255,0.005456768,0.9708224,0.0031448873,0.000037102334,0.000011128196,0.00031739587,0.011382455,0.000460004,0.0007550684,0.003942682,0.00018384891],"about_ca_topic_score_codex":0.111788556,"about_ca_topic_score_gemma":0.0060565574,"teacher_disagreement_score":0.25292432,"about_ca_system_score_codex":0.0017138068,"about_ca_system_score_gemma":0.00093301403,"threshold_uncertainty_score":0.8941261},"labels":[],"label_agreement":null},{"id":"W4405749549","doi":"10.1016/j.jval.2024.10.3646","title":"RWD88 The Psychosocial Impact of Chronic Hand Eczema: Findings From the Population-Based Check (Chronic Hand Eczema Epidemiology, Care, and Knowledge of Real-Life Burden) Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital; Queen's University","funders":"","keywords":"Psychosocial; Hand eczema; Epidemiology; Medicine; Population; Family medicine; Psychiatry; Environmental health; Allergy; Immunology; Internal medicine","score_opus":0.051167830816928356,"score_gpt":0.38568546598382336,"score_spread":0.33451763516689503,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749549","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9231062,0.07149494,0.000024843865,0.0036791943,0.00033925896,0.0011803041,0.00010425373,0.000019885349,0.00005112729],"genre_scores_gemma":[0.9967316,0.0024281295,0.000022054775,0.000115849456,0.0005590937,0.000038782473,0.00005519472,0.000026277052,0.000023051392],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99758434,0.0006529777,0.00091630337,0.00032830428,0.00017395531,0.0003441377],"domain_scores_gemma":[0.99702907,0.0021372219,0.00024191517,0.0003993624,0.00007614264,0.000116276504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013467153,0.00021096288,0.0007761323,0.00012731583,0.00021381426,0.000030052244,0.00015072802,0.00011276274,0.0000711016],"category_scores_gemma":[0.00043701753,0.00012107321,0.00018319314,0.00032749632,0.00021389654,0.000054504475,0.000048671107,0.00036629968,0.0000041648495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022791249,0.00030626776,0.9384493,0.002446055,0.00043693677,0.000009344379,0.039732803,0.0025343427,0.00025872706,0.00065495836,0.003105391,0.011837935],"study_design_scores_gemma":[0.0022124322,0.0017517296,0.97695315,0.0018393672,0.00008204074,0.0000038295834,0.0015335643,0.014788141,0.000023576586,0.0002694186,0.0004384403,0.00010430789],"about_ca_topic_score_codex":0.16608706,"about_ca_topic_score_gemma":0.011734526,"teacher_disagreement_score":0.15435253,"about_ca_system_score_codex":0.0006751302,"about_ca_system_score_gemma":0.002046946,"threshold_uncertainty_score":0.83946604},"labels":[],"label_agreement":null},{"id":"W4405749557","doi":"10.1016/j.jval.2024.10.3560","title":"PCR318 Unmet Needs of Patients With Severe Von Willebrand Disease and Their Caregivers: A Qualitative Study on Current Standard of Care in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; Takeda (Canada); Queen's University; Inro Consultants (Canada)","funders":"","keywords":"Medicine; Disease; Current (fluid); Von Willebrand disease; Intensive care medicine; Family medicine; Gerontology; Von Willebrand factor; Immunology; Internal medicine; Engineering","score_opus":0.020071549186148174,"score_gpt":0.30948921071570856,"score_spread":0.2894176615295604,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749557","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99083537,0.006736219,0.0000011373684,0.00017315321,0.00006605469,0.0010634748,0.0010935543,0.000004322149,0.00002673497],"genre_scores_gemma":[0.9996766,0.00019644573,0.000005994294,0.000020512698,0.0000034801049,0.000015615626,0.00006792395,0.000011236582,0.0000022171785],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.99897987,0.00017482546,0.000258859,0.00016208467,0.00026864122,0.00015571402],"domain_scores_gemma":[0.9995282,0.00011468904,0.00005339339,0.00012129032,0.000057069403,0.00012530337],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011918914,0.00012654901,0.0004352947,0.00019670566,0.000017004708,0.0000030550875,0.000027287968,0.000013561938,0.0000033013687],"category_scores_gemma":[0.00002196407,0.00008429291,0.000019248006,0.0003230915,0.00002702577,0.00003354983,0.000013210951,0.00011244343,9.211466e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033058096,0.0006048099,0.6921599,0.0026622557,0.00010465414,0.00009180523,0.29329678,0.00025603024,1.7861701e-7,0.00004959768,0.00007384069,0.007394325],"study_design_scores_gemma":[0.013616666,0.010390618,0.41767916,0.0060038567,0.000085562366,0.0000013300241,0.5514986,0.00017169415,0.000014768566,0.00013668762,0.00020631801,0.00019477222],"about_ca_topic_score_codex":0.44810793,"about_ca_topic_score_gemma":0.28905547,"teacher_disagreement_score":0.27448076,"about_ca_system_score_codex":0.00068568205,"about_ca_system_score_gemma":0.0020060274,"threshold_uncertainty_score":0.7239174},"labels":[],"label_agreement":null},{"id":"W4405749615","doi":"10.1016/j.jval.2024.10.3540","title":"PCR298 COVID-19 Vaccines Relative Attribute Importance: Insights on Preference Heterogeneity Identified Through Latent Class Modeling","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"","keywords":"Latent class model; Coronavirus disease 2019 (COVID-19); Preference; Class (philosophy); 2019-20 coronavirus outbreak; Econometrics; Computer science; Virology; Biology; Statistics; Mathematics; Medicine; Artificial intelligence; Internal medicine; Outbreak","score_opus":0.23172675177043484,"score_gpt":0.39725364001927743,"score_spread":0.1655268882488426,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96640265,0.012021423,0.0047299643,0.013162794,0.0013404902,0.0008512705,0.00002799759,0.00026540723,0.0011979981],"genre_scores_gemma":[0.9937038,0.003684095,0.0001458361,0.0015803067,0.00033961266,0.0000523906,0.00001954903,0.000023044677,0.00045140967],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9968631,0.0006527483,0.0006880004,0.0006743373,0.00051366823,0.000608108],"domain_scores_gemma":[0.9987106,0.00042644556,0.00014329707,0.00032751908,0.00007925139,0.00031288658],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012806086,0.00021394706,0.00035419248,0.00016349794,0.000639258,0.00015154768,0.00029264548,0.00017869315,0.00008292497],"category_scores_gemma":[0.00039812343,0.00019411359,0.00011606094,0.00078941224,0.000017993321,0.0006889485,0.00006149262,0.0004617566,0.00009565781],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017892313,0.0003218596,0.10434055,0.0009991013,0.00013045983,0.0005485284,0.14378865,0.14552984,0.000026665275,0.5957468,0.0075808563,0.0008077323],"study_design_scores_gemma":[0.003469771,0.0012451923,0.04229078,0.0036989881,0.00011091633,0.000030326357,0.010403729,0.22249268,0.00020547699,0.6493042,0.06441397,0.002333979],"about_ca_topic_score_codex":0.018189425,"about_ca_topic_score_gemma":0.008087099,"teacher_disagreement_score":0.13338493,"about_ca_system_score_codex":0.0012894168,"about_ca_system_score_gemma":0.0016149674,"threshold_uncertainty_score":0.98834854},"labels":[],"label_agreement":null},{"id":"W4405749647","doi":"10.1016/j.jval.2024.10.3490","title":"PCR248 Patient and Physician Preferences for Pain Relief Treatment for Knee Osteoarthritis: Formative Qualitative Research for a Discrete Choice Experiment","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient Satisfaction in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Formative assessment; Osteoarthritis; Physical therapy; Pain relief; Qualitative research; Medicine; Alternative medicine; Psychology; Family medicine; Surgery; Mathematics education; Sociology","score_opus":0.34839992140562404,"score_gpt":0.5660262602311968,"score_spread":0.2176263388255728,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8513531,0.026350897,0.015049208,0.020392338,0.003999711,0.07379728,0.008132643,0.00040515652,0.00051964656],"genre_scores_gemma":[0.91638196,0.000448757,0.008511289,0.0010598757,0.00047447017,0.07231855,0.00043044754,0.000091234135,0.0002834093],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9915506,0.0046705524,0.0013500317,0.00073663716,0.00041158372,0.001280591],"domain_scores_gemma":[0.97532105,0.02336032,0.00031924635,0.00029345995,0.00040429036,0.00030162072],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.0058640493,0.000297541,0.00058059243,0.00040199334,0.0014957874,0.00003636419,0.00010242565,0.00019672618,0.000008480159],"category_scores_gemma":[0.0012043454,0.00025017615,0.000120420744,0.00035747327,0.00011312278,0.00029655595,0.000057899644,0.00045309684,0.000010095801],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010805671,0.00016044569,0.002280018,0.014480328,0.0000817144,7.111167e-7,0.6626103,0.00011832739,0.000025092218,0.025250258,0.0053348946,0.28857738],"study_design_scores_gemma":[0.009615217,0.07600518,0.0021676198,0.019077465,0.000032538548,9.739684e-7,0.55892354,0.03375748,0.00026174024,0.088706955,0.2105816,0.0008697105],"about_ca_topic_score_codex":0.008251503,"about_ca_topic_score_gemma":0.0016466961,"teacher_disagreement_score":0.28770766,"about_ca_system_score_codex":0.002249713,"about_ca_system_score_gemma":0.0014603422,"threshold_uncertainty_score":0.99999505},"labels":[],"label_agreement":null},{"id":"W4405749672","doi":"10.1016/j.jval.2024.10.3453","title":"PCR211 Quantifying Patient Preferences for Type 2 Diabetes Basal Insulin Treatments: A Discrete Choice Experiment","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Diabetes Canada","funders":"","keywords":"Basal insulin; Basal (medicine); Type 2 diabetes; Discrete choice; Internal medicine; Insulin; Medicine; Endocrinology; Computer science; Diabetes mellitus; Machine learning","score_opus":0.6068682333033152,"score_gpt":0.48226030041247114,"score_spread":0.12460793289084404,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749672","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9100985,0.063258804,0.00065567944,0.019884026,0.0026245173,0.0023109894,0.00052341877,0.00012122409,0.00052281545],"genre_scores_gemma":[0.98960614,0.00094272,0.0044207093,0.003730224,0.00033284724,0.0007002046,0.00008694752,0.000053890195,0.00012631342],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9948391,0.0003923013,0.0033009404,0.0007379289,0.00009940284,0.0006303774],"domain_scores_gemma":[0.9967992,0.0018296482,0.0007782883,0.0003560697,0.000033166667,0.0002036695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.006341293,0.00023203992,0.00083986286,0.00041246298,0.00017070929,0.00013625278,0.0001835858,0.000112190944,0.00012443554],"category_scores_gemma":[0.0015080131,0.00025608504,0.000112091075,0.00032690275,0.00003651971,0.00037591613,0.00004254771,0.00016155552,0.00043759105],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000189541,0.0015191695,0.35762274,0.018284524,0.0008448774,0.0000062227555,0.068047896,0.014593357,0.000043133354,0.46949735,0.050740913,0.018610261],"study_design_scores_gemma":[0.0041729095,0.0049636196,0.05865663,0.005696459,0.000031767253,0.0000029830235,0.006868539,0.48208013,0.00023102068,0.096737236,0.33847323,0.0020854608],"about_ca_topic_score_codex":0.006508754,"about_ca_topic_score_gemma":0.00016800492,"teacher_disagreement_score":0.46748677,"about_ca_system_score_codex":0.0012827507,"about_ca_system_score_gemma":0.00043413744,"threshold_uncertainty_score":0.99998915},"labels":[],"label_agreement":null},{"id":"W4405749694","doi":"10.1016/j.jval.2024.10.3470","title":"PCR228 Clinical and Socioeconomic Burden of Multiple Myeloma in the Czech Republic: A Cross-Sectional Study on 190 Patients","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Health Economics","funders":"","keywords":"Czech; Socioeconomic status; Multiple myeloma; Cross-sectional study; Medicine; Environmental health; Internal medicine; Pathology","score_opus":0.12557055603808595,"score_gpt":0.4393535523587843,"score_spread":0.3137829963206984,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749694","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99659055,0.00029447625,9.711658e-7,0.0011143076,0.00019699946,0.0015858512,0.000042174088,0.000018840676,0.00015584847],"genre_scores_gemma":[0.9993421,0.00010501121,0.00006543267,0.00015113298,0.00013654555,0.000083497966,0.000030363515,0.000015375921,0.000070578455],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976051,0.0005264327,0.0007974383,0.00040983863,0.00035946557,0.00030171307],"domain_scores_gemma":[0.99828994,0.0011751866,0.000077239325,0.0002762604,0.000043178417,0.00013817102],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025559512,0.000116710704,0.00031922915,0.00025902304,0.00006374,0.000044018736,0.0000999855,0.00008209725,0.000031099295],"category_scores_gemma":[0.00055952027,0.00007894145,0.000071682894,0.00017878262,0.000113232345,0.000064902895,0.00005074617,0.00046992803,0.000034386543],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045143333,0.0012311253,0.9858984,0.00017731373,0.000052204818,0.000047978658,0.0018956743,0.00004736495,0.0000012666156,0.00008856112,0.00009856391,0.010010142],"study_design_scores_gemma":[0.0052907076,0.0024713883,0.9847607,0.000119629585,0.000004007091,0.0000073666456,0.0004133836,0.0064777914,0.0000024198866,0.00012649315,0.0002766541,0.000049437607],"about_ca_topic_score_codex":0.0076003936,"about_ca_topic_score_gemma":0.00019443671,"teacher_disagreement_score":0.0099607045,"about_ca_system_score_codex":0.00023292744,"about_ca_system_score_gemma":0.00039848068,"threshold_uncertainty_score":0.99900806},"labels":[],"label_agreement":null},{"id":"W4405749704","doi":"10.1016/j.jval.2024.10.3516","title":"PCR274 Exploring Drivers for Treatment Preferences in Canadian Patients With Type 2 Diabetes: A Qualitative Interview Study to Inform a Discrete Choice Experiment","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Diabetes Canada","funders":"","keywords":"Type 2 diabetes; Qualitative research; Psychology; Medicine; Applied psychology; Diabetes mellitus; Sociology; Endocrinology; Social science","score_opus":0.3587980577137058,"score_gpt":0.3433170351235492,"score_spread":0.015481022590156601,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749704","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9964307,0.0008265768,0.000029123015,0.0004218249,0.00024832244,0.0016741063,0.00013441236,0.000009678484,0.00022523767],"genre_scores_gemma":[0.99858606,0.00014087069,0.00026351196,0.00012139468,0.000016151695,0.0007612267,0.000041180738,0.00001615034,0.000053433905],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987508,0.00004794696,0.00050048484,0.00033463462,0.000029517896,0.00033662745],"domain_scores_gemma":[0.99953735,0.00009491931,0.00008204876,0.00012634617,0.000005441109,0.00015389003],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007413898,0.00012925212,0.00029511095,0.00035176365,0.000053372183,0.00004038021,0.00008057401,0.000019847344,0.00004907028],"category_scores_gemma":[0.00002999768,0.00012280965,0.00002750093,0.00023299029,0.000011932303,0.00026725483,0.000018729947,0.0000436651,0.00007006933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013083004,0.00017577848,0.87414443,0.00009781707,0.00004193658,3.507401e-7,0.11651901,0.0031790978,6.746315e-8,0.001795248,0.000018236518,0.0040149344],"study_design_scores_gemma":[0.0018011278,0.0056643374,0.9476695,0.0004783924,0.0000059106383,3.488766e-8,0.02519056,0.006480267,0.000006285668,0.00095822354,0.01138244,0.00036293126],"about_ca_topic_score_codex":0.26750597,"about_ca_topic_score_gemma":0.15144095,"teacher_disagreement_score":0.116065025,"about_ca_system_score_codex":0.0029532455,"about_ca_system_score_gemma":0.00011253203,"threshold_uncertainty_score":0.86404306},"labels":[],"label_agreement":null},{"id":"W4405749750","doi":"10.1016/j.jval.2024.10.3396","title":"PCR153 Burden of Disease in Patients With Chronic Hand Eczema: Systematic Literature Reviews of Healthcare Resource Use and Health-Related Quality of Life","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Contact Dermatitis and Allergies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Health care; Systematic review; Medicine; Quality of life (healthcare); Resource (disambiguation); Burden of disease; Disease burden; Quality (philosophy); Resource use; Disease; MEDLINE; Nursing; Computer science; Environmental resource management; Pathology; Political science; Economics; Economic growth","score_opus":0.055953021540556445,"score_gpt":0.3183818254048829,"score_spread":0.2624288038643265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749750","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.77496195,0.21917497,0.0000024967844,0.0035882925,0.00004508303,0.0021195163,0.0000942298,0.0000104390465,0.0000030338122],"genre_scores_gemma":[0.9896371,0.0099125225,0.00007286247,0.00021209156,0.000020369129,0.000030109584,0.000069837304,0.00001963655,0.000025501344],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99584275,0.0010140473,0.002274242,0.0002666644,0.00035432665,0.00024797252],"domain_scores_gemma":[0.99813116,0.0003355989,0.0007443386,0.00040042188,0.00011183118,0.00027667073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017243095,0.0001710547,0.0015764853,0.00030991586,0.000028434697,0.000018810653,0.00006272519,0.00007090035,0.000007114232],"category_scores_gemma":[0.00052549405,0.000121063094,0.00007680671,0.00060759974,0.00007055374,0.00011320364,0.00003149434,0.00027891167,6.40903e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003613514,0.00016732421,0.22118692,0.76623803,0.000045509758,0.000009900944,0.010451663,0.00022357356,0.000004534669,0.0005520009,0.00013920624,0.0006199663],"study_design_scores_gemma":[0.0024243575,0.0010694485,0.639309,0.35545576,0.000022716591,0.0000024289097,0.00020161066,0.0011670996,0.0000031258496,0.000044695615,0.00019119927,0.000108583976],"about_ca_topic_score_codex":0.01891003,"about_ca_topic_score_gemma":0.000919733,"teacher_disagreement_score":0.41812205,"about_ca_system_score_codex":0.00025884432,"about_ca_system_score_gemma":0.0010913558,"threshold_uncertainty_score":0.98762316},"labels":[],"label_agreement":null},{"id":"W4405749860","doi":"10.1016/j.jval.2024.10.3098","title":"SA17 Adapted Targeted Literature Review (ATLR) Methods for Robust Quantitative Survey Instrument Development: The AGAP (Abbott Global Assessment of Patients Unmet Needs) Multinational Survey Study in Chronic Liver Disease (CLD)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Multinational corporation; Medicine; Survey instrument; Psychology; Political science; Applied psychology","score_opus":0.1371440868037071,"score_gpt":0.4470044804033987,"score_spread":0.3098603935996916,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.74281037,0.23624241,0.0016065651,0.0015242624,0.00051263656,0.01327318,0.003972488,0.00004405829,0.00001401494],"genre_scores_gemma":[0.9665278,0.011739763,0.016166005,0.00036978256,0.000022150229,0.0009207061,0.004212562,0.000029246037,0.000011937459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.993812,0.0036461973,0.0010589382,0.0005164076,0.0005780378,0.00038837537],"domain_scores_gemma":[0.9970153,0.0017207685,0.00025898218,0.00031758775,0.00043512788,0.00025222497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005296268,0.00030698467,0.00069869164,0.0002494056,0.0000978766,0.000039781655,0.0001619715,0.000058479254,0.000034231136],"category_scores_gemma":[0.0008816879,0.00021225061,0.00012728483,0.0016384883,0.00004280385,0.00012781685,0.00009002644,0.00023659645,0.0000027416702],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035917477,0.004001982,0.966558,0.006266287,0.00039624414,0.0000275448,0.0011884698,0.0010516586,2.4673724e-7,0.0007954371,0.00038025796,0.018974725],"study_design_scores_gemma":[0.0030089011,0.00090434944,0.9580005,0.0085297385,0.00012009309,4.7300094e-7,0.00007998218,0.028879687,0.0000018050206,0.000029641022,0.00028277823,0.00016208977],"about_ca_topic_score_codex":0.004401443,"about_ca_topic_score_gemma":0.0016818179,"teacher_disagreement_score":0.22450264,"about_ca_system_score_codex":0.00265248,"about_ca_system_score_gemma":0.003507872,"threshold_uncertainty_score":0.8655329},"labels":[],"label_agreement":null},{"id":"W4405749862","doi":"10.1016/j.jval.2024.10.3254","title":"PCR11 Patient Reported Symptoms, Functioning, and Quality of Life (QoL) in Patients Treated With Chimeric Antigen Receptor T Cells for Hematologic Malignancy: A Systematic Review and Meta Analysis","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Hematologic malignancy; Medicine; Chimeric antigen receptor; Meta-analysis; Quality of life (healthcare); Malignancy; Oncology; Internal medicine; Immunotherapy; Cancer; Nursing","score_opus":0.15851327232871035,"score_gpt":0.39514214647368007,"score_spread":0.23662887414496972,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749862","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0070353877,0.97773015,0.000005264461,0.00007101614,0.000036041503,0.014909899,0.00016657241,0.000033303662,0.000012383927],"genre_scores_gemma":[0.0007364253,0.99676853,0.00019657762,0.00013221055,0.0000082545075,0.0015015177,0.00033421358,0.000072471455,0.0002497844],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9922196,0.0020517954,0.0037290782,0.0009425006,0.00059394614,0.00046307218],"domain_scores_gemma":[0.99588835,0.0005905841,0.0021813689,0.0008266407,0.00022703753,0.00028598701],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0033150122,0.00055995054,0.0114403255,0.0010795126,0.000046674864,0.000023053852,0.00010855251,0.00023522026,0.000099267876],"category_scores_gemma":[0.0005452346,0.00033885453,0.0007461428,0.0030597073,0.000089932786,0.000039350267,0.00006724279,0.00043090945,0.0000024576264],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091525275,0.00025399606,0.0041405414,0.9721585,0.021729203,0.0000069630737,0.00014753884,0.0000020615919,4.0744823e-7,0.000007582463,0.000052957646,0.001408739],"study_design_scores_gemma":[0.0023565092,0.0043462925,0.0008465716,0.6080509,0.3771841,0.000055035805,0.00008934843,0.0001093778,0.0000036190338,0.0000083525365,0.006057364,0.0008925381],"about_ca_topic_score_codex":0.002667367,"about_ca_topic_score_gemma":0.000057147317,"teacher_disagreement_score":0.36410758,"about_ca_system_score_codex":0.00037166645,"about_ca_system_score_gemma":0.000802925,"threshold_uncertainty_score":0.99990636},"labels":[],"label_agreement":null},{"id":"W4405749878","doi":"10.1016/j.jval.2024.10.3112","title":"SA31 Systematic Literature Review (SLR) of Randomized Controlled Trials (RCTs) of Treatments for First-Line (1L) Gastric Cancer/Gastroesophageal Junction Adenocarcinoma (GC/GEJ) in Adult Patients","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Randomized controlled trial; Cancer; Gastroesophageal Junction; Internal medicine; Systematic review; Adenocarcinoma; Gastroenterology; MEDLINE; Biology","score_opus":0.035451650994144775,"score_gpt":0.336272807396145,"score_spread":0.30082115640200024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749878","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15094844,0.79348135,0.0005610304,0.004264419,0.0019723875,0.048421565,0.000237929,0.000060905983,0.000051980223],"genre_scores_gemma":[0.80817425,0.18646343,0.0004755065,0.00048490486,0.00020119213,0.0035217176,0.00018197275,0.000039829934,0.0004572007],"study_design_codex":"systematic_review","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9931555,0.0013529133,0.0041781478,0.00039022707,0.00054398266,0.0003792331],"domain_scores_gemma":[0.9953117,0.0025151637,0.0014690729,0.00030307833,0.00028688333,0.00011411023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006470284,0.0003259825,0.007186309,0.0009128829,0.000028129909,0.0000181204,0.000104981205,0.00009477572,0.00003160628],"category_scores_gemma":[0.004845547,0.00020363246,0.0009874406,0.0011660688,0.000033424494,0.000094039606,0.000022998507,0.00018995791,0.0000016934107],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.078756735,0.0007572066,0.043742243,0.8672419,0.0019346568,0.000040422536,0.0009631687,0.00063684635,0.0000045361335,0.00043102595,0.0018045596,0.0036866695],"study_design_scores_gemma":[0.525327,0.0020530364,0.009905576,0.44559944,0.0046848673,0.000008734787,0.00006260837,0.012041146,0.000011326951,0.00013311043,0.000020637111,0.00015248709],"about_ca_topic_score_codex":0.0010766005,"about_ca_topic_score_gemma":0.00007250757,"teacher_disagreement_score":0.65722585,"about_ca_system_score_codex":0.0006287112,"about_ca_system_score_gemma":0.00033548046,"threshold_uncertainty_score":0.830389},"labels":[],"label_agreement":null},{"id":"W4405749911","doi":"10.1016/j.jval.2024.10.3381","title":"PCR138 Inequalities in the Impact of Dermatological Diseases Across the Globe: Impact Results From the GRIDD Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"","keywords":"Globe; Medicine; Inequality; Impact evaluation; Dermatology; Ophthalmology; Mathematics; Pathology","score_opus":0.5138766555187833,"score_gpt":0.5089710780481833,"score_spread":0.004905577470599942,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749911","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92309874,0.014949762,0.000029673485,0.052644983,0.00038321604,0.0017069448,0.007024035,0.000033051594,0.00012958115],"genre_scores_gemma":[0.9959389,0.00045216572,0.000022513772,0.0029622337,0.0003745709,0.00013510775,0.00007695135,0.000021500358,0.000016032916],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9891872,0.0041470607,0.005176781,0.0005858168,0.00020784263,0.0006953382],"domain_scores_gemma":[0.98295474,0.0146251805,0.0012587137,0.001008154,0.00003010578,0.00012309894],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.035718385,0.00025159633,0.0010280403,0.00014681405,0.00027025686,0.0002283438,0.0008306276,0.000103004226,0.000067025954],"category_scores_gemma":[0.0062581,0.00013692828,0.0002777058,0.00068867515,0.00016624626,0.00027888612,0.00011043418,0.0004960827,0.00015776302],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010881769,0.00043632378,0.86167604,0.00020975144,0.000106770676,0.000009232898,0.09172807,0.012684138,7.9999836e-8,0.0121397665,0.020688348,0.00021267393],"study_design_scores_gemma":[0.000850716,0.0002725708,0.9359586,0.00021324305,0.0000041861845,0.000007026524,0.025098167,0.017509054,1.0852832e-7,0.01891083,0.0010203908,0.00015510015],"about_ca_topic_score_codex":0.24631572,"about_ca_topic_score_gemma":0.0029005287,"teacher_disagreement_score":0.24341519,"about_ca_system_score_codex":0.0009845793,"about_ca_system_score_gemma":0.00071747584,"threshold_uncertainty_score":0.9929308},"labels":[],"label_agreement":null},{"id":"W4405749913","doi":"10.1016/j.jval.2024.10.3272","title":"PCR29 EQ-5D Utility According to Patient Self-Reported Health on the Visual Analogue Scale (VAS) in Duchenne Muscular Dystrophy (DMD)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Vancouver Coastal Health","funders":"","keywords":"Duchenne muscular dystrophy; Visual analogue scale; Medicine; EQ-5D; Scale (ratio); Physical medicine and rehabilitation; Physical therapy; Internal medicine; Geography; Cartography; Health related quality of life; Disease","score_opus":0.1038421637394123,"score_gpt":0.34819465719872555,"score_spread":0.24435249345931326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88148767,0.0009975999,0.00041290928,0.11501681,0.00062686246,0.0012607545,0.000012754822,0.00010188249,0.00008273336],"genre_scores_gemma":[0.99302214,0.0002714814,0.000496912,0.005881327,0.00019426785,0.000041945044,0.000052841613,0.00002758022,0.000011515915],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9966344,0.0005479809,0.0009789759,0.0005613821,0.0007115044,0.0005657389],"domain_scores_gemma":[0.99869204,0.00028245358,0.00013822116,0.00039541503,0.00006532574,0.0004265603],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003802873,0.00019108708,0.0004586114,0.0004109973,0.00013870808,0.000031439227,0.00009217776,0.00019491225,0.00002875664],"category_scores_gemma":[0.0002222536,0.00012688292,0.00010526932,0.0014068832,0.000112128124,0.000043008065,0.000064821,0.00094497297,0.00002289788],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012909344,0.006775873,0.059008252,0.014512609,0.00057646795,0.0010462564,0.055946622,0.0064299214,0.0016691479,0.026178932,0.0056818924,0.8208831],"study_design_scores_gemma":[0.003227936,0.008502849,0.46489158,0.012045825,0.00008316851,0.00015411808,0.0045223464,0.4475028,0.00040361143,0.006632738,0.05125283,0.0007802059],"about_ca_topic_score_codex":0.0111348005,"about_ca_topic_score_gemma":0.00036194624,"teacher_disagreement_score":0.8201029,"about_ca_system_score_codex":0.0008470787,"about_ca_system_score_gemma":0.0013265827,"threshold_uncertainty_score":0.99545014},"labels":[],"label_agreement":null},{"id":"W4405749923","doi":"10.1016/j.jval.2024.10.3298","title":"PCR55 The Burden of Long COVID on Quality of Life and Daily Functioning","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Long-Term Effects of COVID-19","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVRAZ (Canada)","funders":"","keywords":"Coronavirus disease 2019 (COVID-19); Quality of life (healthcare); 2019-20 coronavirus outbreak; Gerontology; Medicine; Psychology; Virology; Internal medicine; Disease; Nursing; Outbreak","score_opus":0.06961561696759487,"score_gpt":0.38110298965179407,"score_spread":0.3114873726841992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96365017,0.0041183187,0.00029446225,0.030730037,0.00026807075,0.0005802832,0.000008192112,0.00003861758,0.00031185438],"genre_scores_gemma":[0.99749804,0.00016473226,0.00012201203,0.0018791631,0.00021409805,0.000009651871,0.0000044175777,0.000014065239,0.000093808994],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842095,0.0003991733,0.00049139536,0.00020516623,0.00031578232,0.00016753422],"domain_scores_gemma":[0.9966031,0.0027793567,0.00013101807,0.00030039076,0.000032004275,0.0001541465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026066273,0.00008972817,0.00034062975,0.00014213438,0.000043528442,0.000010861944,0.00006616391,0.000054594242,0.000023879971],"category_scores_gemma":[0.001993335,0.00006136026,0.000050873394,0.00024620525,0.000099180026,0.000043281925,0.000035129797,0.0002444616,0.0000061971873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029464157,0.00045799784,0.7773385,0.08200661,0.00035304885,0.0001281999,0.033291284,0.036506567,0.0022141354,0.02591074,0.0068740435,0.031972457],"study_design_scores_gemma":[0.0052028834,0.004414898,0.9300918,0.010134064,0.00009287918,0.000057269,0.002033971,0.038201585,0.00063376693,0.0026471247,0.006146649,0.0003431211],"about_ca_topic_score_codex":0.013973998,"about_ca_topic_score_gemma":0.0000407362,"teacher_disagreement_score":0.1527533,"about_ca_system_score_codex":0.00014261091,"about_ca_system_score_gemma":0.000870418,"threshold_uncertainty_score":0.99259204},"labels":[],"label_agreement":null},{"id":"W4405749925","doi":"10.1016/j.jval.2024.10.3202","title":"SA121 Can Living Systematic Literature Reviews Reduce Research Wastage? An Evaluation of LiveSLR®","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"NovAtel (Canada)","funders":"","keywords":"Systematic review; MEDLINE; Political science","score_opus":0.5751630191119229,"score_gpt":0.6100987112752647,"score_spread":0.0349356921633418,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48874542,0.43841255,0.00013309013,0.024646856,0.001810856,0.025009958,0.00006134895,0.00054476125,0.020635156],"genre_scores_gemma":[0.98503584,0.01221451,0.001131167,0.000044216606,0.00028537988,0.00051662856,0.0000054715647,0.000027834272,0.0007389769],"study_design_codex":"qualitative","study_design_gemma":"systematic_review","domain_scores_codex":[0.9681785,0.02638154,0.0010588024,0.0005085621,0.0030976566,0.00077495724],"domain_scores_gemma":[0.99589515,0.0023415096,0.00015818937,0.00060171797,0.00075065356,0.00025278484],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.13958332,0.000120754514,0.0004449741,0.0009390357,0.00033056614,0.00028481186,0.0006314662,0.00016783828,0.00010231192],"category_scores_gemma":[0.013453684,0.00010684906,0.0000725445,0.0034430393,0.00022521999,0.0003369427,0.00009690693,0.0008789522,0.000030176014],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017511964,0.000415988,0.00071927573,0.24530545,0.000030429303,0.00004578744,0.59398764,0.0007994075,0.0007191753,0.09941786,0.012109742,0.04643174],"study_design_scores_gemma":[0.00030604316,0.0010059332,0.0015172254,0.77399564,0.00005234646,0.00002442095,0.06853259,0.09741287,0.0002503726,0.04305711,0.013132854,0.0007126182],"about_ca_topic_score_codex":0.022031918,"about_ca_topic_score_gemma":0.00292511,"teacher_disagreement_score":0.52869016,"about_ca_system_score_codex":0.0017083947,"about_ca_system_score_gemma":0.0035002897,"threshold_uncertainty_score":0.9948564},"labels":[],"label_agreement":null},{"id":"W4405749933","doi":"10.1016/j.jval.2024.10.3143","title":"SA62 Evaluating Generative Artificial Intelligence (GenAI) in Health Technology Assessment (HTA) Content Generation: A Proof-of-Concept Using Canadian Agency for Drugs and Technologies in Health (CADTH) Reimbursement Dossier Forms","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Reimbursement; Health technology; Agency (philosophy); Proof of concept; Generative grammar; Regulatory agency; Medicine; Computer science; Artificial intelligence; Political science; Public administration; Health care; Sociology; Law","score_opus":0.628704518258548,"score_gpt":0.5007668926854623,"score_spread":0.12793762557308574,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5621256,0.07987531,0.06281542,0.28286693,0.0013883122,0.010156425,0.0005872196,0.00012313739,0.000061614235],"genre_scores_gemma":[0.9425331,0.0012074325,0.05262603,0.0024436475,0.00016409732,0.0008837467,0.00006247799,0.000052648145,0.000026824106],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98846257,0.0007784523,0.008143616,0.0011678804,0.00019846993,0.0012489933],"domain_scores_gemma":[0.99644554,0.0005422362,0.0021806324,0.00047745742,0.000095577394,0.00025856544],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.032524433,0.0003377426,0.0015456704,0.0026962396,0.0003489813,0.00010483441,0.00029350485,0.0002923663,0.000028309523],"category_scores_gemma":[0.0015655019,0.00040009592,0.00008411457,0.0014048582,0.00017808523,0.00037614457,0.00008188811,0.00058755087,0.000005417016],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000027353844,0.00028936393,0.011750257,0.007685363,0.0000666585,0.0000057260636,0.031888433,0.0708858,0.00002400281,0.7011896,0.00039798132,0.17578946],"study_design_scores_gemma":[0.00051982346,0.0009805367,0.0009744451,0.002269907,0.000002295551,0.00000842395,0.020188715,0.88951373,0.00014470407,0.08375224,0.0012296976,0.00041548515],"about_ca_topic_score_codex":0.19932161,"about_ca_topic_score_gemma":0.10025546,"teacher_disagreement_score":0.81862795,"about_ca_system_score_codex":0.009362381,"about_ca_system_score_gemma":0.007087917,"threshold_uncertainty_score":0.9998451},"labels":[],"label_agreement":null},{"id":"W4405749935","doi":"10.1016/j.jval.2024.10.3161","title":"SA80 A New Process Model for Study Identification in Systematic Review: Separating Studies From Reports","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Victoria","funders":"","keywords":"Identification (biology); Computer science; Process (computing); Data science; Computational biology; Data mining; Management science; Engineering; Biology; Programming language","score_opus":0.4231419412241073,"score_gpt":0.6024569520220492,"score_spread":0.17931501079794188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749935","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.36016402,0.5250377,0.012036051,0.035147768,0.0013812748,0.06487401,0.00003386705,0.00094997004,0.00037532544],"genre_scores_gemma":[0.9904474,0.0049180416,0.001166255,0.00014367544,0.000086700355,0.0025632032,0.0000041672356,0.000020095822,0.00065047987],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9961347,0.00091701833,0.0014078994,0.00046367224,0.0007219767,0.00035476187],"domain_scores_gemma":[0.99816525,0.0010020967,0.000279993,0.00031532726,0.0001509949,0.00008633414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016655913,0.000101802056,0.0005263448,0.00022463425,0.00017032104,0.00011038903,0.0002356012,0.000051141382,0.0000022274298],"category_scores_gemma":[0.0064209215,0.00009256021,0.000045502686,0.0009646196,0.000038196133,0.00023891538,0.000039489172,0.00020147544,0.000005252928],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000137266825,0.00036885278,0.0032597622,0.5750448,0.000078590965,0.000114003975,0.39509687,0.010219345,0.00001811798,0.002712329,0.011739604,0.0013340143],"study_design_scores_gemma":[0.00024226485,0.00016615464,0.0001832384,0.3100503,0.000072418625,0.0000041354383,0.07811528,0.47307438,0.000017236183,0.13761784,0.00009842058,0.0003583466],"about_ca_topic_score_codex":0.022671746,"about_ca_topic_score_gemma":0.0068770326,"teacher_disagreement_score":0.63028336,"about_ca_system_score_codex":0.0007906109,"about_ca_system_score_gemma":0.001668009,"threshold_uncertainty_score":0.98383635},"labels":[],"label_agreement":null},{"id":"W4405749949","doi":"10.1016/j.jval.2024.10.2549","title":"OP8 What Do HTA Agencies Across the Globe Need for Generating Health-Related Quality of Life Evidence? Findings From a Global Survey","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Globe; Real world evidence; Health related quality of life; Quality of life (healthcare); Medicine; Business; Political science; MEDLINE; Nursing","score_opus":0.6426619097120122,"score_gpt":0.49952404247352644,"score_spread":0.14313786723848576,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749949","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7713356,0.15068255,0.0021484552,0.06850207,0.002227459,0.0017426267,0.0032790645,0.000065185246,0.000016992422],"genre_scores_gemma":[0.97967196,0.00516616,0.0026619919,0.011665016,0.00038484402,0.00018728066,0.00015591536,0.000046138954,0.000060702383],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98411435,0.0034456903,0.010153841,0.0010264349,0.0002499633,0.0010096942],"domain_scores_gemma":[0.98405224,0.011534795,0.0031085692,0.00081971945,0.000120593824,0.00036410018],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.1098671,0.0003035188,0.001872907,0.00016625956,0.0005079464,0.00053547765,0.0006011222,0.000238703,0.00009581818],"category_scores_gemma":[0.019918134,0.00031416203,0.00025224045,0.000920691,0.00014755093,0.0010323111,0.00012967078,0.00035159037,0.00016497471],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022946866,0.00019886225,0.7249052,0.009163654,0.00036228058,0.0000014516569,0.069988325,0.022865929,0.000007526279,0.13703199,0.031391513,0.00385384],"study_design_scores_gemma":[0.0017615063,0.0004208877,0.705853,0.005349103,0.0000068401337,0.0000046821665,0.022659507,0.21610373,0.000003356431,0.041931983,0.0050937952,0.00081163767],"about_ca_topic_score_codex":0.29318652,"about_ca_topic_score_gemma":0.010487245,"teacher_disagreement_score":0.2826993,"about_ca_system_score_codex":0.002791586,"about_ca_system_score_gemma":0.0025276286,"threshold_uncertainty_score":0.99993104},"labels":[],"label_agreement":null},{"id":"W4405749959","doi":"10.1016/j.jval.2024.10.3392","title":"PCR149 Burden of Childhood Arthritis: Work Productivity Loss and Activity Impairment of Parents and Caregivers","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Autoimmune and Inflammatory Disorders Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Calgary","funders":"","keywords":"Work productivity; Productivity; Functional impairment; Arthritis; Work (physics); Medicine; Psychology; Gerontology; Clinical psychology; Economics; Engineering; Economic growth; Internal medicine","score_opus":0.02095037834043378,"score_gpt":0.2975777865978548,"score_spread":0.276627408257421,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749959","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97559327,0.021487026,0.000007835615,0.0020589463,0.00006571353,0.00066683674,0.000012566096,0.000017619699,0.00009016596],"genre_scores_gemma":[0.9941973,0.0056445505,0.000046029974,0.0000087560375,0.00003376404,0.000013237564,0.0000029939451,0.000011547137,0.00004181786],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9988312,0.00013917126,0.00028958588,0.0002578875,0.00025496978,0.00022715743],"domain_scores_gemma":[0.99953884,0.00006588582,0.000073258845,0.00019367768,0.000033757024,0.00009459254],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006953571,0.000095751224,0.00039060306,0.00016617225,0.000034358076,0.0000075299354,0.000038200797,0.000051188978,0.000010696131],"category_scores_gemma":[0.00008175672,0.000086293374,0.000034029268,0.00028868212,0.00016606355,0.00009233461,0.00006434926,0.00023538052,0.000001091153],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00070807437,0.0009919911,0.43984035,0.012949757,0.00020646272,0.00011397762,0.04125636,0.00038885462,0.0009962934,0.00033604947,0.00042413082,0.5017877],"study_design_scores_gemma":[0.002468703,0.0015450488,0.98274213,0.0059512863,0.00001843094,0.000056909423,0.0031218382,0.000912785,0.0014694221,0.00037237778,0.001182077,0.00015898659],"about_ca_topic_score_codex":0.0035419108,"about_ca_topic_score_gemma":0.000017636643,"teacher_disagreement_score":0.54290175,"about_ca_system_score_codex":0.000074273936,"about_ca_system_score_gemma":0.00048717373,"threshold_uncertainty_score":0.5354333},"labels":[],"label_agreement":null},{"id":"W4405749963","doi":"10.1016/j.jval.2024.10.3166","title":"SA85 Treatment Switching in Evidence Synthesis in Oncology: A Comprehensive Review of Current Meta-Analytical Practices","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Current (fluid); Meta-analysis; Medical physics; Medicine; Oncology; Intensive care medicine; Internal medicine; Engineering; Electrical engineering","score_opus":0.9253042468417044,"score_gpt":0.645814128525625,"score_spread":0.2794901183160794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749963","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050103903,0.9720688,0.000013420085,0.02245442,0.00060287636,0.00430789,0.0002936715,0.000017128512,0.00019170022],"genre_scores_gemma":[0.000056447418,0.99565685,0.0006371582,0.0017499371,0.00014702139,0.0016421657,0.000022782544,0.000061202154,0.000026413862],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.97098356,0.008519034,0.018020637,0.0014942873,0.0002227789,0.0007596859],"domain_scores_gemma":[0.96003205,0.024416486,0.014267721,0.000977555,0.000059390593,0.00024683037],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.05358069,0.00063022925,0.013450203,0.0019855911,0.000045509085,0.00004430134,0.0005256029,0.0003446223,0.00019176234],"category_scores_gemma":[0.02526902,0.0005835722,0.0010703462,0.0012985321,0.000058537873,0.00035768072,0.00012618398,0.0010657082,0.00072065135],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009020772,0.0005544477,0.0003328697,0.8048184,0.0008340877,0.000021856344,0.0009924095,0.00011777771,1.4025434e-9,0.013531504,0.0018871163,0.17690052],"study_design_scores_gemma":[0.00016421815,0.0001425686,0.00004169562,0.24825613,0.00095829484,0.00001453942,0.000099297235,0.0013094026,5.6917164e-9,0.00085872906,0.74785036,0.00030475415],"about_ca_topic_score_codex":0.018764889,"about_ca_topic_score_gemma":0.0010218972,"teacher_disagreement_score":0.7459633,"about_ca_system_score_codex":0.009790033,"about_ca_system_score_gemma":0.0044958703,"threshold_uncertainty_score":0.99966156},"labels":[{"model":"gemma","categories":["metaresearch"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["metaresearch"],"domain":"methods","study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"}],"label_agreement":"agree"},{"id":"W4405749969","doi":"10.1016/j.jval.2024.10.3282","title":"PCR39 Health State Utility Values for Patients With Paroxysmal Nocturnal Hemoglobinuria Using EQ-5D-5L","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Medicine; Nocturnal; Hemoglobinuria; Pediatrics; Internal medicine; Anemia","score_opus":0.0684285550573929,"score_gpt":0.3222735697635755,"score_spread":0.2538450147061826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749969","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9898514,0.0022660957,0.003933197,0.0012700048,0.0004437665,0.001684495,0.0004169791,0.00009619088,0.00003787827],"genre_scores_gemma":[0.9939905,0.00029484747,0.004372562,0.0008307727,0.00015016427,0.000021926231,0.00026787713,0.000036959475,0.000034439596],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997985,0.00017957,0.00053141563,0.00040799292,0.000373965,0.0005220273],"domain_scores_gemma":[0.99912244,0.00013824842,0.00011158355,0.00019059535,0.0000846477,0.00035250367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00067798863,0.00018739274,0.00037467896,0.00016545782,0.00013774307,0.00003719417,0.000055894827,0.000048002916,0.000022916662],"category_scores_gemma":[0.000011438297,0.00014791741,0.00007787076,0.00028047027,0.000045570818,0.00017071837,0.000009261854,0.00021988212,0.000006899933],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005485579,0.0012140733,0.9205862,0.026843214,0.00046309436,0.00011444609,0.012616438,0.003039748,0.000019831188,0.00066525553,0.0007669438,0.028185168],"study_design_scores_gemma":[0.011295719,0.0048015187,0.85158354,0.0075509995,0.00035687123,0.00006062395,0.00041437565,0.116927125,0.00016265656,0.004365991,0.0019401057,0.0005404974],"about_ca_topic_score_codex":0.0039161886,"about_ca_topic_score_gemma":0.00006674641,"teacher_disagreement_score":0.11388738,"about_ca_system_score_codex":0.00045462136,"about_ca_system_score_gemma":0.0017985643,"threshold_uncertainty_score":0.6031897},"labels":[],"label_agreement":null},{"id":"W4405749979","doi":"10.1016/j.jval.2024.10.3258","title":"PCR15 Exploring the Development, Evaluation, and Impact of Researcher-Led Patient and Family Advisory Councils in Cancer Research","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Research development; Political science; Medicine; Family medicine","score_opus":0.8874092172338767,"score_gpt":0.6719718284874874,"score_spread":0.2154373887463893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749979","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9710771,0.021163175,0.000003326933,0.0058547896,0.00009094475,0.0014022073,0.0000083014775,0.000010673952,0.000389489],"genre_scores_gemma":[0.975476,0.023599518,0.00026396976,0.000091955284,0.000052189844,0.00039038435,0.0000028022466,0.00002187047,0.00010129845],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99283767,0.0020445667,0.0008765072,0.00047739138,0.0031150787,0.00064877025],"domain_scores_gemma":[0.9820721,0.016121764,0.00005407899,0.00036757588,0.0011036624,0.00028080336],"candidate_categories":["metaresearch","research_integrity"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.0636621,0.00010258945,0.00029437483,0.0005348597,0.00011656997,0.00004051865,0.00013407621,0.00012007922,0.00003585458],"category_scores_gemma":[0.017426318,0.000068147376,0.000029576975,0.0011745222,0.00039295485,0.00009733935,0.00017747852,0.0025861033,0.0000042621823],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013375984,0.0005374099,0.38922212,0.010082493,0.00017276684,0.0000697206,0.13437878,0.0016983002,0.0027369226,0.0035231595,0.0014534242,0.4547873],"study_design_scores_gemma":[0.0015430956,0.0014434571,0.9483227,0.008369519,0.0000064305764,0.0000051057946,0.004771946,0.017930409,0.00027150218,0.0159766,0.0012398952,0.00011932875],"about_ca_topic_score_codex":0.024212506,"about_ca_topic_score_gemma":0.0039694905,"teacher_disagreement_score":0.55910057,"about_ca_system_score_codex":0.0022621318,"about_ca_system_score_gemma":0.012163283,"threshold_uncertainty_score":0.999715},"labels":[],"label_agreement":null},{"id":"W4405749997","doi":"10.1016/j.jval.2024.10.3323","title":"PCR80 Barriers and Facilitators to the Recruitment and Engagement of Diverse Populations Into Patient Engagement Groups: A Scoping Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Primary Care and Health Outcomes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Psychology","score_opus":0.4836314720961907,"score_gpt":0.5453850882236009,"score_spread":0.061753616127410205,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749997","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007996045,0.967005,0.000018092454,0.008903468,0.0014120592,0.022146363,0.0002223419,0.000046572655,0.00016614691],"genre_scores_gemma":[0.000040678213,0.983596,0.0006796503,0.011007893,0.00009336854,0.0044032363,0.00006816448,0.00004829632,0.000062669955],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9884244,0.0066600265,0.0029611248,0.00072814163,0.00049010734,0.0007361721],"domain_scores_gemma":[0.99671185,0.0011509288,0.00081474986,0.0006927982,0.00007397182,0.00055571686],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00805382,0.00048327714,0.0022596223,0.00048312882,0.0010749385,0.00001499634,0.00025897066,0.00019867212,0.00012122912],"category_scores_gemma":[0.0008963376,0.00031893517,0.00020101827,0.0007346101,0.00006550059,0.00007446436,0.0009656759,0.0015470344,0.00006232505],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000037883788,0.0000126929435,0.00018093803,0.4710615,0.00004080899,0.0000036413628,0.008860084,0.0000040544787,3.4376633e-9,0.001276692,0.009380123,0.5091757],"study_design_scores_gemma":[0.00011155773,0.00017702223,0.000043931217,0.33892006,0.00021218564,0.0000011218024,0.0018068353,0.0000037961393,3.827388e-9,0.00011179829,0.6584459,0.00016578939],"about_ca_topic_score_codex":0.006078669,"about_ca_topic_score_gemma":0.0012815128,"teacher_disagreement_score":0.6490658,"about_ca_system_score_codex":0.0024330423,"about_ca_system_score_gemma":0.005970507,"threshold_uncertainty_score":0.99992627},"labels":[],"label_agreement":null},{"id":"W4405749999","doi":"10.1016/j.jval.2024.10.3140","title":"SA59 Evaluating the Optimal TKI for Patients With ALK Positive Advanced Non-Small-Cell Lung Cancer (aNSCLC) in the First Line (1L) Setting: An Updated Systematic Literature Review (SLR) and Network Meta-Analysis (NMA)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Luminex (Canada)","funders":"","keywords":"Medicine; Meta-analysis; Lung cancer; Systematic review; Oncology; Internal medicine; MEDLINE; Chemistry","score_opus":0.04057041200427511,"score_gpt":0.39568381005014447,"score_spread":0.3551133980458694,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405749999","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15062448,0.8117029,0.00069995335,0.018818442,0.00016821743,0.017424589,0.00043030904,0.000045446963,0.000085671934],"genre_scores_gemma":[0.9583025,0.016945824,0.008556792,0.009180207,0.00019973316,0.005022588,0.0014719974,0.00008098397,0.00023939059],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9976376,0.00053510675,0.000695245,0.00044938957,0.00033264753,0.00034995546],"domain_scores_gemma":[0.9984298,0.0006190553,0.00027693436,0.00038554534,0.00020248296,0.00008622418],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019476293,0.0002510956,0.001017367,0.00012754399,0.00022473146,0.00008820696,0.000114633425,0.00005218804,0.000013016103],"category_scores_gemma":[0.000056315243,0.00011575785,0.00020671169,0.0014888515,0.000022902086,0.00012154638,0.000018854924,0.00028117027,4.194808e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00080465415,0.0013120471,0.032065168,0.38285437,0.062061697,0.00010521537,0.06963205,0.4449362,0.0000042745,0.00040805837,0.0022825974,0.0035336614],"study_design_scores_gemma":[0.0052490653,0.004169159,0.014297776,0.12437395,0.24568194,0.00002625126,0.0011527276,0.6039931,0.0000043533655,0.00006698888,0.00046964377,0.0005150161],"about_ca_topic_score_codex":0.0005698547,"about_ca_topic_score_gemma":0.0005346702,"teacher_disagreement_score":0.807678,"about_ca_system_score_codex":0.00029214425,"about_ca_system_score_gemma":0.0003852401,"threshold_uncertainty_score":0.47204682},"labels":[],"label_agreement":null},{"id":"W4405750004","doi":"10.1016/j.jval.2024.10.3157","title":"SA76 Systematic Literature Review of the Economic Burden of Hemophilia A and B","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.03521936318916204,"score_gpt":0.3462762214218782,"score_spread":0.31105685823271617,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750004","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.20298322,0.7774057,2.9069824e-7,0.017245587,0.00012844554,0.0016365907,0.000018897928,0.000009408122,0.00057191384],"genre_scores_gemma":[0.7689403,0.22967571,0.00006731349,0.00019081382,0.000072342926,0.000024266597,0.000004218246,0.000010850217,0.001014132],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9989784,0.00018864275,0.0004429979,0.00012688039,0.00014229663,0.000120821576],"domain_scores_gemma":[0.99943626,0.00016936306,0.000065396125,0.00024695357,0.000022500004,0.000059551814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009341367,0.000068243215,0.00044801531,0.000097710705,0.00001459699,0.0000058038504,0.000057825117,0.000038647777,0.000020340709],"category_scores_gemma":[0.000111774694,0.00003538504,0.0000724069,0.00023775724,0.000044944307,0.000021715252,0.00002893877,0.00014903284,0.000006445405],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008933186,0.00001639409,0.00075257855,0.995369,0.00003590823,0.000017138611,0.0010562773,0.000009145972,0.000058261285,0.0016341391,0.0005925382,0.00044969132],"study_design_scores_gemma":[0.0003223585,0.00021794198,0.0006894738,0.9936434,0.00004933095,0.00013777381,0.0000732599,0.0037593548,0.00014132311,0.00025177703,0.00067348214,0.000040506246],"about_ca_topic_score_codex":0.000304452,"about_ca_topic_score_gemma":0.0000025301522,"teacher_disagreement_score":0.5659571,"about_ca_system_score_codex":0.00011387741,"about_ca_system_score_gemma":0.0004504464,"threshold_uncertainty_score":0.144296},"labels":[],"label_agreement":null},{"id":"W4405750040","doi":"10.1016/j.jval.2024.10.3427","title":"PCR184 Comparing the Humanistic and Economic Impact of Osteogenesis Imperfecta Affected and Non-Affected Caregivers, When Caring for an Individual With Osteogenesis Imperfecta","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Connective tissue disorders research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Osteogenesis imperfecta; Humanism; Medicine; Psychology; Philosophy; Pathology","score_opus":0.03538762545217594,"score_gpt":0.3234109496368739,"score_spread":0.28802332418469795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750040","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99070615,0.007454566,0.00013585553,0.00007656929,0.00004996194,0.0013099064,0.00022955639,0.000015389902,0.000022019254],"genre_scores_gemma":[0.9991103,0.00034932818,0.00014821919,0.000010432033,0.00007369786,0.000067209505,0.000180327,0.000051431947,0.000009044661],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9983314,0.00029353212,0.00025300295,0.0005757863,0.00011659557,0.00042964655],"domain_scores_gemma":[0.999178,0.00021005094,0.000081153165,0.00033625553,0.00005642689,0.00013810978],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006749636,0.00023650067,0.0003591149,0.00018126532,0.00017560238,0.00008856465,0.00020010059,0.00010477253,0.000008130624],"category_scores_gemma":[0.00007672186,0.00018364038,0.000073091236,0.0001334972,0.00015042402,0.00001446588,0.00017095727,0.0001315804,5.233969e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018322752,0.00021375426,0.45047528,0.0047265985,0.0017408481,0.000020817402,0.017699959,0.026559314,0.46357155,0.00020453177,0.00075184053,0.032203227],"study_design_scores_gemma":[0.0069184275,0.019887695,0.74942976,0.00090947945,0.000313259,0.00021438715,0.004026152,0.18277779,0.033779725,0.00015475108,0.00030676695,0.0012817978],"about_ca_topic_score_codex":0.024201542,"about_ca_topic_score_gemma":0.006107094,"teacher_disagreement_score":0.42979184,"about_ca_system_score_codex":0.00017574792,"about_ca_system_score_gemma":0.0006259796,"threshold_uncertainty_score":0.9822964},"labels":[],"label_agreement":null},{"id":"W4405750046","doi":"10.1016/j.jval.2024.10.2403","title":"MSR169 Health Technology Decision-Making in an Imperfect World: A Unifying Framework of Value of Information and Implementation Metrics Based on a Narrative Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Imperfect; Narrative; Value (mathematics); Perfect information; Narrative review; Value of information; Computer science; Data science; Management science; Knowledge management; Artificial intelligence; Engineering; Medicine; Mathematics; Machine learning; Mathematical economics; Intensive care medicine; Philosophy; Linguistics","score_opus":0.34017328847322487,"score_gpt":0.5373478880985447,"score_spread":0.19717459962531986,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750046","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00051862246,0.9852275,0.0030176295,0.005576797,0.00040105116,0.0046508824,0.0005354551,0.00003343232,0.000038584745],"genre_scores_gemma":[0.003288897,0.97336215,0.01888679,0.0038765813,0.000049781363,0.00034755492,0.00013647908,0.000050398947,0.0000013726146],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.98255086,0.0021107565,0.013754746,0.0007448002,0.00024958837,0.0005892714],"domain_scores_gemma":[0.98427963,0.0047662635,0.009943398,0.00075501436,0.000092088914,0.00016362433],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.040958125,0.00044295716,0.0050057285,0.008996105,0.00010955096,0.00004614737,0.0003843584,0.0003732358,0.00004126688],"category_scores_gemma":[0.0068730316,0.00049022306,0.00022447777,0.0054361927,0.00007029955,0.00049328635,0.00009143765,0.0009580776,0.000035942023],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000141864,0.00011884722,0.001791549,0.33995444,0.000049735932,0.000001012281,0.0052586575,0.0011688906,1.6879695e-9,0.12791622,0.0006793865,0.5230471],"study_design_scores_gemma":[0.001003705,0.0015382285,0.0005813484,0.70422643,0.000073398754,0.000012188866,0.004270888,0.027219221,6.1091235e-8,0.042059414,0.21809594,0.0009191881],"about_ca_topic_score_codex":0.0032908975,"about_ca_topic_score_gemma":0.0006607344,"teacher_disagreement_score":0.52212787,"about_ca_system_score_codex":0.0031575835,"about_ca_system_score_gemma":0.0029970813,"threshold_uncertainty_score":0.99975497},"labels":[],"label_agreement":null},{"id":"W4405750051","doi":"10.1016/j.jval.2024.10.3348","title":"PCR105 Impact of CAR T-Cell Therapy on Health Utilities for Patients Diagnosed With Diffuse Large B-Cell Lymphoma in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; University of Ottawa; Princess Margaret Cancer Centre; University of Waterloo; University of Toronto","funders":"","keywords":"Diffuse large B-cell lymphoma; Lymphoma; Medicine; Pediatrics; Oncology; Internal medicine","score_opus":0.03961365323178231,"score_gpt":0.3331608637186762,"score_spread":0.2935472104868939,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750051","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99053246,0.0048945537,0.000004769574,0.00086638913,0.00018268888,0.00284401,0.0004461874,0.00002561785,0.00020329721],"genre_scores_gemma":[0.9944823,0.0038259749,0.00005917596,0.0008334648,0.00006164151,0.00014114364,0.00010062567,0.00008007833,0.0004156155],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99697083,0.00032405922,0.0006539864,0.00043676648,0.0006583221,0.0009560422],"domain_scores_gemma":[0.99805236,0.00093256985,0.00012667124,0.00043768322,0.000083531006,0.00036719633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008876785,0.00025863393,0.00069960265,0.0004156857,0.000053551255,0.000015130122,0.00013850712,0.0000676375,0.00009943713],"category_scores_gemma":[0.000054090306,0.0001917735,0.000119661076,0.0005691929,0.00004001579,0.00004660985,0.00001945147,0.00028141588,0.000002416998],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.012355489,0.020830924,0.8148026,0.012784937,0.00019559235,0.00024839863,0.024853578,0.0010263623,0.0005993551,0.00020414067,0.013405322,0.09869329],"study_design_scores_gemma":[0.18279833,0.063208506,0.6662469,0.0072695184,0.00002185414,0.000019073392,0.0053960816,0.032645177,0.0036107216,0.00026547562,0.037399326,0.0011190778],"about_ca_topic_score_codex":0.9586266,"about_ca_topic_score_gemma":0.5500959,"teacher_disagreement_score":0.4085307,"about_ca_system_score_codex":0.0055421893,"about_ca_system_score_gemma":0.015478031,"threshold_uncertainty_score":0.99827534},"labels":[],"label_agreement":null},{"id":"W4405750065","doi":"10.1016/j.jval.2024.10.3154","title":"SA73 Augmenting Expertise: A Classifier Algorithm's Ability to Identify and Categorize Health Economics and Outcomes Research (HEOR) Publications","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Medical Coding and Health Information","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Central City Brewers and Distillers (Canada)","funders":"","keywords":"Categorization; Classifier (UML); Text categorization; Computer science; Artificial intelligence; Machine learning; Data science","score_opus":0.47929886186595966,"score_gpt":0.5797002768496395,"score_spread":0.10040141498367988,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.50560886,0.007621622,0.0061243544,0.4697519,0.0025632617,0.0053518084,0.00013124936,0.00041333438,0.0024336288],"genre_scores_gemma":[0.95956606,0.010583254,0.009740967,0.015814468,0.0006132419,0.0013377786,0.00008778334,0.000071208175,0.002185269],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9941782,0.0018288248,0.0017684224,0.0005937893,0.00038088346,0.0012498851],"domain_scores_gemma":[0.99587566,0.0022869566,0.0002004793,0.00041510063,0.00014583592,0.0010759849],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.018593736,0.00017771032,0.0004866693,0.0007568857,0.0016303908,0.00013016838,0.0001689206,0.0002165122,0.000092865164],"category_scores_gemma":[0.0012610428,0.00015954096,0.000032606353,0.0007153871,0.00011950294,0.0003885596,0.00024077376,0.0014891,0.0001438652],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004088033,0.00013953185,0.07394194,0.013636335,0.000025464331,0.0000024740311,0.09823528,0.0000851424,0.000006643712,0.108826086,0.038340613,0.6667196],"study_design_scores_gemma":[0.0015819147,0.00051493087,0.43043208,0.0029819186,0.0000066277244,0.000011012582,0.017115837,0.17246759,0.0000018287193,0.019240644,0.35516268,0.00048292908],"about_ca_topic_score_codex":0.017891252,"about_ca_topic_score_gemma":0.00072025607,"teacher_disagreement_score":0.6662367,"about_ca_system_score_codex":0.0017647434,"about_ca_system_score_gemma":0.003526434,"threshold_uncertainty_score":0.9996694},"labels":[],"label_agreement":null},{"id":"W4405750084","doi":"10.1016/j.jval.2024.10.3110","title":"SA29 Pathways to Value and Impact for Child Health and Wellness","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Child and Adolescent Health","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Innovates; University of Calgary","funders":"","keywords":"Value (mathematics); Environmental health; Business; Medicine; Computer science","score_opus":0.07831392966728959,"score_gpt":0.4248969674783401,"score_spread":0.3465830378110505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750084","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81523657,0.038177937,0.0012804328,0.13327268,0.0025580167,0.007887277,0.00064455485,0.00039768667,0.0005448541],"genre_scores_gemma":[0.9674841,0.005339405,0.00087220094,0.024876598,0.0010687392,0.00006703744,0.000056849083,0.000092422146,0.0001426271],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9956117,0.00090652757,0.0010808319,0.0007554512,0.0002423946,0.0014030756],"domain_scores_gemma":[0.9970832,0.0009939495,0.00017283896,0.00033121894,0.000033817047,0.0013849958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036248704,0.0003101931,0.0006936296,0.0004140119,0.0011444751,0.00004292808,0.00012868438,0.00017563147,0.000025422662],"category_scores_gemma":[0.00024828073,0.00025803962,0.00007843894,0.00051179604,0.000044438308,0.00012990368,0.00012650568,0.0009596082,0.00004263656],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089000544,0.0005829717,0.073383585,0.06862728,0.000085689215,0.000030421894,0.16754632,0.001087838,0.00003946248,0.2954391,0.096416466,0.29587087],"study_design_scores_gemma":[0.009276244,0.0070424895,0.2886553,0.06697342,0.000033453143,0.00014417387,0.022125032,0.04787891,0.000019510991,0.034377884,0.5214034,0.002070207],"about_ca_topic_score_codex":0.008396248,"about_ca_topic_score_gemma":0.00036844396,"teacher_disagreement_score":0.4249869,"about_ca_system_score_codex":0.0008098122,"about_ca_system_score_gemma":0.0030518167,"threshold_uncertainty_score":0.9999872},"labels":[],"label_agreement":null},{"id":"W4405750169","doi":"10.1016/j.jval.2024.10.2428","title":"MSR194 Qualitative Literature Reviews: A Comparison of Researcher and AI Screening of Articles to Inform Conceptual Model Development","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Computational and Text Analysis Methods","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Data science; Computer science; Management science; Psychology; Engineering","score_opus":0.4634870499803747,"score_gpt":0.5872027738509282,"score_spread":0.12371572387055352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750169","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8908984,0.016584286,0.08456151,0.007173229,0.000030395082,0.00042572487,0.000009116403,0.000015688835,0.00030165815],"genre_scores_gemma":[0.8665212,0.0001360741,0.13310061,0.00012967981,0.000013155394,0.0000096577005,0.000002441119,0.0000023660843,0.00008482349],"study_design_codex":"qualitative","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980059,0.0008643847,0.0005169314,0.00012459073,0.00033804754,0.00015010599],"domain_scores_gemma":[0.9989828,0.0006738429,0.00007666996,0.000047104462,0.00012125272,0.00009831483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.006007176,0.000050997463,0.0002556689,0.00017930612,0.0000912453,0.000029708792,0.00007368158,0.000030368628,0.000007660272],"category_scores_gemma":[0.0005215556,0.000042789037,0.00003100295,0.0009782064,0.00012303895,0.00010153855,0.000050163504,0.00013618976,0.0000011396522],"study_design_candidate":"qualitative","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000131670795,0.00002240595,0.0010077297,0.00024596503,0.000010294509,2.0997582e-7,0.78548515,0.0157031,0.000015661588,0.089236856,0.00013156244,0.1081279],"study_design_scores_gemma":[0.0002543238,0.00016922486,0.0051860493,0.0040535214,0.000009517843,2.2064752e-7,0.13150457,0.7797962,0.00020560647,0.06388674,0.014733933,0.00020013486],"about_ca_topic_score_codex":0.0024940777,"about_ca_topic_score_gemma":0.0005027407,"teacher_disagreement_score":0.76409304,"about_ca_system_score_codex":0.00006658857,"about_ca_system_score_gemma":0.00047043004,"threshold_uncertainty_score":0.37703162},"labels":[],"label_agreement":null},{"id":"W4405750175","doi":"10.1016/j.jval.2024.10.2510","title":"MT40 Systematic Review Tools Integrated with Artificial Intelligence for Data Extraction: Feature Analysis","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Text Mining and Ontologies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Micropharma (Canada)","funders":"","keywords":"Computer science; Data extraction; Artificial intelligence; Data mining; Pattern recognition (psychology); Chemistry; MEDLINE","score_opus":0.14167520564103186,"score_gpt":0.40468179563162077,"score_spread":0.2630065899905889,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750175","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.003845679,0.44053516,0.5347954,0.016867127,0.0005996518,0.002657455,0.00048751239,0.00012904705,0.000082988176],"genre_scores_gemma":[0.74633265,0.094166584,0.13628833,0.006753446,0.0012267111,0.0011532224,0.0114835715,0.00014226987,0.0024532576],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9986159,0.00017748414,0.00042991972,0.00044360597,0.00012554385,0.0002075441],"domain_scores_gemma":[0.9990591,0.00015910361,0.000097241296,0.00057217747,0.000046313296,0.00006609285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013539142,0.00012249414,0.00041764835,0.00009086149,0.00004524351,0.00005370919,0.0002864581,0.00011851166,0.000007978821],"category_scores_gemma":[0.0007836609,0.00008074316,0.000071234936,0.00069639244,0.000052753105,0.0000059002487,0.000047129437,0.00016186107,0.0000048357483],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00037656527,0.00031875586,0.00022239416,0.7347681,0.0024738454,0.00006491462,0.00038560326,0.0013385355,0.0010746274,0.0034733147,0.034042504,0.22146082],"study_design_scores_gemma":[0.00055155787,0.0046074977,0.00023673895,0.366567,0.0050737583,0.00042004365,0.0033861161,0.36005625,0.0033428466,0.0018973114,0.25180206,0.0020588299],"about_ca_topic_score_codex":0.0001478155,"about_ca_topic_score_gemma":0.00015901987,"teacher_disagreement_score":0.74248695,"about_ca_system_score_codex":0.00003478697,"about_ca_system_score_gemma":0.00028882094,"threshold_uncertainty_score":0.32926103},"labels":[],"label_agreement":null},{"id":"W4405750198","doi":"10.1016/j.jval.2024.10.2422","title":"MSR188 A Predictive Patient-Level Surrogacy Model Between Progression-Free Survival (PFS) and Overall Survival (OS) in Patients With Pre-Treated Advanced or Metastatic (A/M) Non-Small-Cell Lung Cancer (NSCLC) With a KRASG12C Mutation","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Oncology; Medicine; non-small cell lung cancer (NSCLC); Overall survival; Internal medicine; Progression-free survival; Lung cancer","score_opus":0.027523443073903427,"score_gpt":0.338721106796708,"score_spread":0.3111976637228046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750198","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897114,0.0014299848,0.0018457341,0.0005044371,0.0001423818,0.0051776622,0.0009496966,0.00010177199,0.00013694871],"genre_scores_gemma":[0.9911706,0.00023811928,0.006784807,0.00008961343,0.000039549403,0.0009256198,0.00046481256,0.000096369666,0.00019050943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99700624,0.00023392451,0.0006651019,0.00077671226,0.00071057316,0.0006074594],"domain_scores_gemma":[0.9985173,0.00035713965,0.00024340153,0.00035415837,0.00021129666,0.00031674432],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032427345,0.00041700518,0.00072293537,0.00039412227,0.00011650429,0.00005541637,0.000100739955,0.000085383464,0.000013878103],"category_scores_gemma":[0.000056405246,0.00027108585,0.000044266293,0.000764376,0.00007465983,0.00037358733,0.00005782354,0.0003540347,0.0000010914033],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049759257,0.0011154956,0.9242349,0.0027733021,0.00050651317,0.00015660019,0.012521912,0.038037296,0.0000070778888,0.000041379193,0.00005482106,0.015574775],"study_design_scores_gemma":[0.027215509,0.005976703,0.7934511,0.008542561,0.0007168468,0.000007034248,0.00074217946,0.16267647,0.00005945021,0.00012252756,0.000024717385,0.0004649558],"about_ca_topic_score_codex":0.00904726,"about_ca_topic_score_gemma":0.0026189783,"teacher_disagreement_score":0.13078386,"about_ca_system_score_codex":0.0010952211,"about_ca_system_score_gemma":0.0024822266,"threshold_uncertainty_score":0.99997413},"labels":[],"label_agreement":null},{"id":"W4405750237","doi":"10.1016/j.jval.2024.10.2413","title":"MSR179 Automated Extraction of Cost-Effectiveness Models Data from Health Technology Assessment Submissions Using Large-Language Models (LLMS): Does the Prompting Approach Matter ?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Computer science; Data extraction; Data science; MEDLINE; Chemistry","score_opus":0.5891400164229476,"score_gpt":0.5241108448239848,"score_spread":0.06502917159896271,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750237","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4662454,0.016713522,0.4512408,0.053670987,0.0012743794,0.0056867795,0.004286372,0.0005029716,0.00037876132],"genre_scores_gemma":[0.9715371,0.00032569305,0.025779642,0.0014241138,0.00015262535,0.00026773787,0.0004182518,0.000070214286,0.000024626395],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99200857,0.0018417698,0.004122448,0.0010997175,0.00018309837,0.0007443842],"domain_scores_gemma":[0.99491423,0.0015991137,0.0019319457,0.0013417476,0.0000462291,0.00016670329],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.031205906,0.00026761318,0.0012141995,0.0007573467,0.00040538632,0.000112918686,0.0006492471,0.00022858844,0.000075331714],"category_scores_gemma":[0.00037851007,0.00023763732,0.000079024416,0.0007175509,0.00007617662,0.0010308217,0.0002548311,0.0006277205,0.000053688967],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003850971,0.00087717606,0.020067086,0.0092005115,0.0002457983,0.0000053413196,0.013473749,0.784425,0.000072568684,0.16687356,0.003315629,0.0014050324],"study_design_scores_gemma":[0.00042053426,0.00003591401,0.0033057416,0.0010483171,0.0000061184564,0.000010402954,0.004049688,0.96522343,0.0000044159283,0.025233215,0.00045969238,0.00020249891],"about_ca_topic_score_codex":0.032807603,"about_ca_topic_score_gemma":0.00026005373,"teacher_disagreement_score":0.50529164,"about_ca_system_score_codex":0.0023117089,"about_ca_system_score_gemma":0.0013715212,"threshold_uncertainty_score":0.99757737},"labels":[],"label_agreement":null},{"id":"W4405750238","doi":"10.1016/j.jval.2024.10.2378","title":"MSR144 Group-Based Multivariate Trajectory Methods to Assess Patient-Reported Outcomes in Acute Myeloid Leukaemia: An Evaluation of Published Methods and Results","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Reliability and Agreement in Measurement","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Geomechanica (Canada); Luminex (Canada)","funders":"","keywords":"Myeloid leukaemia; Multivariate statistics; Multivariate analysis; Medicine; Trajectory; Oncology; Internal medicine; Computer science; Machine learning; Physics","score_opus":0.40039424581550326,"score_gpt":0.5382868660662405,"score_spread":0.13789262025073729,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9311159,0.0005705833,0.0602182,0.004245875,0.0014455274,0.0021125285,0.00004919458,0.000056091216,0.00018610015],"genre_scores_gemma":[0.6406746,0.000017074544,0.35874942,0.00035884048,0.000020666113,0.00012895091,0.000017548495,0.00001570087,0.000017190321],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.96906453,0.020564085,0.0044551785,0.0016500527,0.0036723262,0.0005938215],"domain_scores_gemma":[0.9903333,0.006997318,0.000692706,0.001077518,0.00060439063,0.0002947286],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.174031,0.0002670331,0.00085143495,0.0013353303,0.00008929769,0.0002940428,0.00048277684,0.0001746331,0.00004923984],"category_scores_gemma":[0.026468204,0.00019674022,0.00012108919,0.0023585467,0.00007432526,0.00071426627,0.00011073494,0.0004479808,0.0000032808648],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048854674,0.000860226,0.05057903,0.00024080124,0.00008708733,0.000014295339,0.008986162,0.0958443,0.011957301,0.0005039935,0.00032741102,0.83011085],"study_design_scores_gemma":[0.0027608052,0.001025158,0.46344322,0.0004342184,0.000063204425,0.0000026927885,0.0012632882,0.50558835,0.0037705745,0.020064846,0.0012416594,0.00034201393],"about_ca_topic_score_codex":0.005862232,"about_ca_topic_score_gemma":0.00061860256,"teacher_disagreement_score":0.82976884,"about_ca_system_score_codex":0.00073413947,"about_ca_system_score_gemma":0.0011711693,"threshold_uncertainty_score":0.98173225},"labels":[],"label_agreement":null},{"id":"W4405750255","doi":"10.1016/j.jval.2024.10.3082","title":"SA1 Systematic Literature Review of the Humanistic Burden of Hemophilia A and B","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Optimism, Hope, and Well-being","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Humanism; Medicine; Systematic review; Intensive care medicine; MEDLINE; Philosophy; Political science; Law; Theology","score_opus":0.023486003418322347,"score_gpt":0.328853738493063,"score_spread":0.30536773507474063,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750255","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.030084679,0.9593192,0.000016702468,0.0030706404,0.0008803583,0.0013298984,0.000020366722,0.000024159914,0.0052540065],"genre_scores_gemma":[0.95126104,0.046729572,0.00011437406,0.0006836019,0.00011238699,0.000033841647,0.0000030369756,0.000021843927,0.0010403274],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99837136,0.0005251919,0.0006208988,0.00018723104,0.00013673624,0.0001586045],"domain_scores_gemma":[0.9991307,0.0002767748,0.00015324853,0.0003699263,0.000030902105,0.000038432547],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012027571,0.000094312985,0.00042876144,0.00007892665,0.000030127205,0.000013630949,0.00014012243,0.0000580542,0.00004797786],"category_scores_gemma":[0.00010759871,0.00006119829,0.00006504854,0.00037609265,0.00004355613,0.000024128236,0.000031792446,0.00019900085,0.000010304377],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005392218,0.000028042039,0.00009975358,0.9237013,0.000033068,0.000020183326,0.015597294,0.000036056586,0.000014449988,0.058670215,0.0013078598,0.00048639174],"study_design_scores_gemma":[0.00023848383,0.00018011878,0.00066255423,0.99130166,0.00007351016,0.0001409414,0.0004490901,0.0014778408,0.0000078864805,0.003892914,0.0014527646,0.0001222356],"about_ca_topic_score_codex":0.00038500698,"about_ca_topic_score_gemma":0.0000031565098,"teacher_disagreement_score":0.9211763,"about_ca_system_score_codex":0.000035103552,"about_ca_system_score_gemma":0.00007586191,"threshold_uncertainty_score":0.2495594},"labels":[],"label_agreement":null},{"id":"W4405750302","doi":"10.1016/j.jval.2024.10.2386","title":"MSR152 A Literature Review to Identify Prognostic Factors and Treatment Effect Modifiers in Population-Adjusted Indirect Comparisons for Multiple Myeloma","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Multiple myeloma; Medicine; Oncology; Internal medicine","score_opus":0.17357693465477037,"score_gpt":0.46261786494067525,"score_spread":0.2890409302859049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009493742,0.9647504,0.000003541808,0.00031750067,0.00022099967,0.024450157,0.00068391085,0.00007148135,0.00000824063],"genre_scores_gemma":[0.006532806,0.98480064,0.0004280699,0.000065286935,0.000086111846,0.0042878273,0.003581513,0.00010734564,0.00011037436],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9955379,0.0009774407,0.0012879214,0.0009771533,0.0003967074,0.00082289334],"domain_scores_gemma":[0.99672586,0.001834777,0.00025475197,0.00047247278,0.000051503193,0.0006606366],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00090337335,0.00079603837,0.004005459,0.001318878,0.00009362803,0.0000814557,0.00012696779,0.00032108408,0.00000510258],"category_scores_gemma":[0.0015570221,0.00048578653,0.0005015598,0.0016038577,0.000025922767,0.00006206965,0.000066034416,0.0006210262,0.000025471109],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012635118,0.0003258098,0.07343017,0.3772317,0.00040193176,0.0002689507,0.00039818577,0.000005898341,8.379065e-8,0.000009501577,0.0006504873,0.5471509],"study_design_scores_gemma":[0.0037450627,0.0032462035,0.068992056,0.7302063,0.0016370834,0.00012936335,0.000018561093,0.0010245448,7.969962e-7,0.0000096968415,0.19045413,0.00053622224],"about_ca_topic_score_codex":0.003965123,"about_ca_topic_score_gemma":0.0011575258,"teacher_disagreement_score":0.5466147,"about_ca_system_score_codex":0.0020829325,"about_ca_system_score_gemma":0.00068079756,"threshold_uncertainty_score":0.9997594},"labels":[],"label_agreement":null},{"id":"W4405750345","doi":"10.1016/j.jval.2024.10.2216","title":"HTA391 ≥95% Discounts!? Is Canada a Commercially Viable Market for Orphan Medicines?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Orphan drug; Business; Commerce; Bioinformatics; Biology","score_opus":0.3138635600669174,"score_gpt":0.4255141501482088,"score_spread":0.11165059008129141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750345","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06007352,0.05333582,0.006909173,0.84979004,0.009228589,0.0047509065,0.0047596237,0.00015555239,0.010996807],"genre_scores_gemma":[0.6723492,0.0039084726,0.007887966,0.29885122,0.0034000948,0.0012195854,0.0003090505,0.00028089705,0.011793479],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938334,0.0003380107,0.004159975,0.0007196048,0.00015840547,0.00079059694],"domain_scores_gemma":[0.9959843,0.002282491,0.00085817155,0.00049924245,0.00004549788,0.00033026037],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.020863183,0.00023853478,0.0011291552,0.00032884756,0.0002145131,0.00009891656,0.0003236865,0.00012392014,0.0010858887],"category_scores_gemma":[0.0017508776,0.00028732396,0.000099635035,0.00041769558,0.000046581066,0.00031531442,0.000040656338,0.00025665623,0.00026944984],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001805842,0.000043349108,0.010838765,0.0032732626,0.00004021081,0.000003554311,0.0017096142,0.00035914793,2.0444476e-7,0.06185953,0.92146415,0.0003901458],"study_design_scores_gemma":[0.00065881904,0.000110998044,0.0045488533,0.00071194203,0.0000040418986,0.000006634308,0.0007113188,0.11468273,8.7474797e-7,0.018830813,0.85942686,0.000306103],"about_ca_topic_score_codex":0.82894665,"about_ca_topic_score_gemma":0.3711434,"teacher_disagreement_score":0.6122757,"about_ca_system_score_codex":0.0029468436,"about_ca_system_score_gemma":0.0039307466,"threshold_uncertainty_score":0.9999579},"labels":[],"label_agreement":null},{"id":"W4405750350","doi":"10.1016/j.jval.2024.10.2421","title":"MSR187 Automated Data Extraction in Systematic Literature Reviews (SLRs): Assessing the Accuracy and Reliability of a Large Language Model (LLM)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Computer science; Data extraction; Reliability (semiconductor); Natural language processing; Artificial intelligence; Data mining; MEDLINE; Chemistry","score_opus":0.27148360576928654,"score_gpt":0.5738235770727436,"score_spread":0.302339971303457,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8330544,0.14567226,0.0014164856,0.00889916,0.0012672936,0.008793271,0.00033239886,0.00039535438,0.00016938076],"genre_scores_gemma":[0.9891622,0.0076993587,0.0018091754,0.0007309973,0.00012489091,0.00027268092,0.000087238855,0.000036737492,0.00007670117],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98933166,0.006396514,0.0026884659,0.00062303495,0.00031796686,0.0006423612],"domain_scores_gemma":[0.9921486,0.005548198,0.0006600237,0.0014032823,0.00011629846,0.00012362334],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01904538,0.00021298892,0.0007820838,0.00026991888,0.00035546225,0.00006012166,0.00043058235,0.0002868671,0.000021209367],"category_scores_gemma":[0.007836827,0.00014140684,0.000047490717,0.0011594951,0.00005395871,0.000788587,0.00025359416,0.001732249,0.000032407665],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050067683,0.00032179945,0.027641129,0.7902298,0.000012535254,0.000051525894,0.16388837,0.0058824443,0.00020908783,0.004442436,0.003479119,0.0037916796],"study_design_scores_gemma":[0.00007738034,0.000024918372,0.0017832419,0.099104896,0.000010238304,0.000006075278,0.008141849,0.8895165,0.0000058842074,0.00092465937,0.00030530296,0.00009911262],"about_ca_topic_score_codex":0.010609748,"about_ca_topic_score_gemma":0.002242185,"teacher_disagreement_score":0.883634,"about_ca_system_score_codex":0.00054852583,"about_ca_system_score_gemma":0.0012319649,"threshold_uncertainty_score":0.9959787},"labels":[],"label_agreement":null},{"id":"W4405750379","doi":"10.1016/j.jval.2024.10.2319","title":"MSR85 Development of an Ordinal NMA Model Allowing for Testing of the Proportional Odds Assumption","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Fault Detection and Control Systems","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Odds; Ordinal data; Ordinal regression; Statistics; Ordered logit; Econometrics; Mathematics; Computer science; Medicine; Logistic regression","score_opus":0.06310659688642593,"score_gpt":0.29512687169146606,"score_spread":0.23202027480504012,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9443313,0.00026726598,0.054303534,0.00008692697,0.00041271502,0.00039352503,0.0000058571904,0.00008047749,0.00011838673],"genre_scores_gemma":[0.99008036,0.000001463938,0.009761782,0.000011427073,0.00004475705,0.000049983453,0.0000021823478,0.000012807373,0.00003526221],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99918324,0.000030331164,0.00042781653,0.00008972752,0.00014656622,0.00012229178],"domain_scores_gemma":[0.99977297,0.00005010553,0.000043571334,0.000071662944,0.00003433986,0.000027325412],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007147187,0.000057761707,0.0001164939,0.00007144256,0.000039991613,0.0000077613395,0.000055766748,0.00003307184,0.0000016011364],"category_scores_gemma":[0.000048149344,0.00004616688,0.00003335447,0.0001622664,0.0000068194145,0.00005935799,0.000006518683,0.000077972196,7.424378e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005838275,0.000013720737,0.00019233547,0.0012219425,0.000011260731,1.6632036e-7,0.0006934904,0.96218157,0.008334555,0.0006450437,0.000015820486,0.026684247],"study_design_scores_gemma":[0.00013360953,0.000029155988,0.001227728,0.0004160714,0.0000020847685,0.0000025234142,0.00006680952,0.99572307,0.0018224212,0.00020738812,0.00032575967,0.00004335467],"about_ca_topic_score_codex":0.00014172484,"about_ca_topic_score_gemma":0.000033346067,"teacher_disagreement_score":0.04574902,"about_ca_system_score_codex":0.00015343277,"about_ca_system_score_gemma":0.00024501115,"threshold_uncertainty_score":0.18826306},"labels":[],"label_agreement":null},{"id":"W4405750438","doi":"10.1016/j.jval.2024.10.2135","title":"HTA310 Are Global Health Technology Assessment (HTA) Processes Inclusive and Equitable? A Scoping Review","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Health technology; Business; Political science; Economic growth; Economics; Health care","score_opus":0.5361905848991605,"score_gpt":0.5743759344859303,"score_spread":0.03818534958676978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000030167175,0.89674556,0.00026493223,0.092253625,0.00088681706,0.007938051,0.0012576462,0.00016275613,0.00048756588],"genre_scores_gemma":[0.000012218897,0.9814462,0.0025207596,0.01382546,0.00034110158,0.0015489149,0.0001329365,0.00009605533,0.00007636016],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9813001,0.0016189612,0.013362401,0.0019558081,0.00023745037,0.0015252734],"domain_scores_gemma":[0.98698753,0.0011864875,0.010214723,0.0010070789,0.00010847087,0.0004957181],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.03724405,0.0007902061,0.009289215,0.0012626086,0.00041566225,0.00015940196,0.0006939288,0.0005746537,0.00006421296],"category_scores_gemma":[0.0052249045,0.00087965355,0.0002704172,0.0025746068,0.00013790003,0.00033673947,0.0006705798,0.0010992283,0.00064600556],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[7.5158187e-7,0.000069350885,0.00031502632,0.88724977,0.000076387376,0.000006487728,0.00014088744,0.000012031328,9.0686e-11,0.05313373,0.008861572,0.050134014],"study_design_scores_gemma":[0.0001709654,0.00012852534,0.000014045873,0.55906475,0.000035867604,0.000069728194,0.00020774809,0.00010570694,8.6136426e-10,0.0084873345,0.43128031,0.00043498233],"about_ca_topic_score_codex":0.003776377,"about_ca_topic_score_gemma":0.0011870136,"teacher_disagreement_score":0.42241874,"about_ca_system_score_codex":0.009849113,"about_ca_system_score_gemma":0.01804747,"threshold_uncertainty_score":0.9993654},"labels":[],"label_agreement":null},{"id":"W4405750458","doi":"10.1016/j.jval.2024.10.2187","title":"HTA362 The Cost of Innovation: Evaluating the Evolution of Willingness-to-Pay for CAR-T Therapies in Germany","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Willingness to pay; Business; Economics; Marketing; Industrial organization; Microeconomics","score_opus":0.10340659088591199,"score_gpt":0.4114694174890013,"score_spread":0.3080628266030893,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750458","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9174209,0.027326947,0.011399772,0.039922826,0.0014922083,0.0021862355,0.00009436141,0.000024365318,0.00013235355],"genre_scores_gemma":[0.99803245,0.00010068518,0.0011586439,0.00046076905,0.000036862915,0.000055942975,0.000003738636,0.0000070037654,0.00014391654],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9984166,0.00058081356,0.00060994644,0.00015085115,0.00004534753,0.00019644998],"domain_scores_gemma":[0.99840796,0.0011848807,0.000122008896,0.00016955072,0.00010977196,0.0000058550922],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049778745,0.000074115174,0.00020758488,0.0001288383,0.0000697804,0.0000056313593,0.00015133688,0.0000980742,0.000022142449],"category_scores_gemma":[0.0003718203,0.000035929548,0.000039396644,0.0009964705,0.00012582558,0.000023666906,0.000029392382,0.00023512897,0.0000018995341],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00074440136,0.00030102968,0.028264133,0.0019175283,0.00025954688,8.986416e-7,0.015292407,0.004285468,0.22258799,0.45092627,0.0019361177,0.2734842],"study_design_scores_gemma":[0.0050234236,0.0065616574,0.5394963,0.005755268,0.00018679097,0.00004798871,0.01197931,0.093894064,0.048435755,0.1632821,0.12441872,0.00091864786],"about_ca_topic_score_codex":0.0010789421,"about_ca_topic_score_gemma":0.00006675741,"teacher_disagreement_score":0.51123214,"about_ca_system_score_codex":0.000109414555,"about_ca_system_score_gemma":0.00032148705,"threshold_uncertainty_score":0.17252418},"labels":[],"label_agreement":null},{"id":"W4405750488","doi":"10.1016/j.jval.2024.10.2181","title":"HTA356 Operationalizing Life-Cycle HTA: A Tumor-Agnostic Precision Oncology Index Economic Evaluation From Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Operationalization; Index (typography); Precision oncology; Oncology; Medicine; Medical physics; Internal medicine; Computer science; World Wide Web; Cancer","score_opus":0.31507428392506004,"score_gpt":0.43706974701806195,"score_spread":0.12199546309300191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750488","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8727558,0.026237866,0.0017333613,0.087209605,0.0059554996,0.0022677851,0.0010847565,0.00010247268,0.002652854],"genre_scores_gemma":[0.98289615,0.00042197353,0.0010831063,0.013920945,0.0009946178,0.00031484934,0.00022588749,0.000058561745,0.000083920306],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99142015,0.0012555495,0.0053758076,0.001061912,0.0002506148,0.00063596474],"domain_scores_gemma":[0.9928635,0.0049272426,0.0012145181,0.00052805874,0.000060701954,0.00040598246],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.021726247,0.00027066577,0.0011167452,0.0005464428,0.00024247782,0.00017419728,0.00033041014,0.00017817126,0.0016146336],"category_scores_gemma":[0.0053488533,0.00035773986,0.00009188766,0.00028729156,0.00004274806,0.00061465043,0.00007671312,0.00043352213,0.0014220802],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000049585695,0.00016136363,0.05469309,0.00088750484,0.00014256492,0.00001872733,0.0044439007,0.78554577,0.0000028835573,0.072013356,0.07731687,0.0047244146],"study_design_scores_gemma":[0.00090019737,0.00010495715,0.038152896,0.00050093833,0.0000070220344,0.000008447096,0.0005546856,0.8487498,0.0000018809268,0.03401757,0.07664456,0.00035702303],"about_ca_topic_score_codex":0.91106945,"about_ca_topic_score_gemma":0.5180114,"teacher_disagreement_score":0.39305806,"about_ca_system_score_codex":0.013514366,"about_ca_system_score_gemma":0.014920867,"threshold_uncertainty_score":0.99988747},"labels":[],"label_agreement":null},{"id":"W4405750502","doi":"10.1016/j.jval.2024.10.2370","title":"MSR136 Feasibility of GPT-4-Based Content Extraction to Identify Eligible Titles and Abstracts in a Systematic Literature Review (SLR)","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Extraction (chemistry); Systematic review; Information retrieval; Computer science; Medicine; Chromatography; Chemistry; MEDLINE; Biochemistry","score_opus":0.3434334851512722,"score_gpt":0.5186745876162016,"score_spread":0.17524110246492935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750502","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7732063,0.21368836,0.00006966447,0.010014525,0.00044989455,0.0024611957,0.000007798611,0.000026725114,0.00007554734],"genre_scores_gemma":[0.9760366,0.022216296,0.0003277211,0.001186396,0.000062190855,0.00008137358,0.000013552072,0.000011036374,0.00006481713],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9979829,0.00023539575,0.0011090594,0.0002662422,0.00020977689,0.00019660022],"domain_scores_gemma":[0.9989596,0.00040955917,0.00013027903,0.00023341026,0.00011860429,0.0001485576],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025600041,0.000099905395,0.00045076373,0.00031118747,0.000022296512,0.000025657051,0.000039532664,0.00007988748,0.000018296772],"category_scores_gemma":[0.0010051768,0.00008175531,0.00004845183,0.00063338206,0.000018353232,0.000089158035,0.000007385309,0.00026247362,0.000028594415],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009393354,0.00029532908,0.015641447,0.9711325,0.000009876852,0.000041945186,0.0043354393,0.00028561836,0.0012594542,0.00033594295,0.0009404856,0.0056279968],"study_design_scores_gemma":[0.000109003064,0.0005464718,0.058840886,0.9321711,0.00004278681,0.00008207225,0.0013262922,0.0031956604,0.0025030384,0.0006481536,0.00037487136,0.00015963377],"about_ca_topic_score_codex":0.0067935283,"about_ca_topic_score_gemma":0.00048530585,"teacher_disagreement_score":0.20283031,"about_ca_system_score_codex":0.00037261404,"about_ca_system_score_gemma":0.0005424476,"threshold_uncertainty_score":0.9998203},"labels":[],"label_agreement":null},{"id":"W4405750530","doi":"10.1016/j.jval.2024.10.2296","title":"MSR62 Considerations for Censoring Methods Used to Reconstruct Pseudo Patient-Level Data From Kaplan–Meier Curves: Does the Indirect Treatment Comparison Method Influence the Choice of Censoring Distribution?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods and Inference","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Geomechanica (Canada); Luminex (Canada)","funders":"","keywords":"Censoring (clinical trials); Statistics; Survival analysis; Econometrics; Medicine; Mathematics; Computer science","score_opus":0.5219080402043837,"score_gpt":0.535100541608528,"score_spread":0.013192501404144297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750530","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.1568478,0.001272821,0.81913406,0.005992394,0.00076167256,0.002389125,0.013491236,0.00007908971,0.000031781932],"genre_scores_gemma":[0.09258527,0.00015103017,0.906537,0.00030529813,0.00008331196,0.00021518362,0.00008942106,0.00002485487,0.00000861404],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9952257,0.0024180517,0.0011533137,0.00054425147,0.00026000146,0.00039864623],"domain_scores_gemma":[0.9335948,0.064960726,0.00027907485,0.0009330265,0.0001135373,0.00011879207],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0034884973,0.00022925725,0.00063960557,0.000069666115,0.0002871504,0.00009769005,0.00036320696,0.000067893496,0.000043422642],"category_scores_gemma":[0.016954524,0.00012506844,0.000071166614,0.0003863826,0.000094748255,0.00011712544,0.00014456536,0.00028236635,0.000002602923],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00016292772,0.000772453,0.026070163,0.0043796157,0.0009043286,0.000009830775,0.03684511,0.0062387697,0.0018556853,0.36508125,0.0094863055,0.5481936],"study_design_scores_gemma":[0.0012179703,0.0008521633,0.028830802,0.006233562,0.00047165347,0.00002418443,0.003040528,0.29726377,0.015636409,0.63159066,0.01404614,0.0007921728],"about_ca_topic_score_codex":0.0058248276,"about_ca_topic_score_gemma":0.00075579406,"teacher_disagreement_score":0.54740137,"about_ca_system_score_codex":0.00024424208,"about_ca_system_score_gemma":0.00030557922,"threshold_uncertainty_score":0.9913261},"labels":[],"label_agreement":null},{"id":"W4405750563","doi":"10.1016/j.jval.2024.10.2150","title":"HTA325 Stakeholder Perspectives on the Draft Implementation Act for Joint Clinical Assessments: Key Insights and Concerns","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Clinical practice guidelines implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Key (lock); Stakeholder; Joint (building); Process management; Stakeholder engagement; Business; Political science; Computer science; Public relations; Computer security; Engineering","score_opus":0.6586294812627639,"score_gpt":0.614225794773354,"score_spread":0.044403686489409844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8841908,0.0013416548,0.0029714792,0.10713746,0.000808701,0.0031679273,0.000060774095,0.00007440144,0.00024682475],"genre_scores_gemma":[0.9884774,0.0014905247,0.0028667678,0.006067505,0.00080058473,0.00012114681,0.00007106214,0.000031031133,0.00007397251],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99701,0.0005659719,0.0013798339,0.00046753153,0.00031542205,0.00026122807],"domain_scores_gemma":[0.9942849,0.004985256,0.00023877181,0.00024340303,0.00011185068,0.0001358134],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041496484,0.00014131704,0.00031700853,0.0001258914,0.00011504822,0.000075830336,0.00005307238,0.00006715345,0.00012185705],"category_scores_gemma":[0.001901219,0.00009600167,0.00009061821,0.00019401484,0.000077480014,0.0001995399,0.000033995944,0.00044943186,0.000012585332],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024887845,0.0024129709,0.067188025,0.0028910637,0.0010009226,0.00009598061,0.051578533,0.00028143296,0.0005991426,0.24839759,0.108940564,0.514125],"study_design_scores_gemma":[0.02045586,0.018914646,0.31066543,0.0029752692,0.00052807754,0.00007023969,0.21599281,0.1049522,0.00032560935,0.022028172,0.30223525,0.0008564293],"about_ca_topic_score_codex":0.0015591265,"about_ca_topic_score_gemma":0.00024326987,"teacher_disagreement_score":0.5132686,"about_ca_system_score_codex":0.000396835,"about_ca_system_score_gemma":0.0009153619,"threshold_uncertainty_score":0.39148343},"labels":[],"label_agreement":null},{"id":"W4405750564","doi":"10.1016/j.jval.2024.10.2293","title":"MSR59 Evaluating Systematic Literature Review Screening Performance of Seven Large Language Models in Response to Different Prompting Strategies","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Systematic review; Computer science; Psychology; Natural language processing; MEDLINE; Biology","score_opus":0.18945690421520323,"score_gpt":0.5058841504226887,"score_spread":0.3164272462074855,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9040546,0.08823192,0.00052031485,0.0032779688,0.00007437501,0.003391571,0.000015413663,0.00011909926,0.00031477743],"genre_scores_gemma":[0.9908655,0.0059374445,0.0025835652,0.0001234624,0.000040781713,0.00030526047,0.0000030787962,0.000020359876,0.000120547906],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99305147,0.0040664673,0.00092407677,0.00032931755,0.0010057309,0.00062292744],"domain_scores_gemma":[0.99821836,0.0011463043,0.00014180288,0.0002791908,0.00009905684,0.000115311275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02821369,0.00013480731,0.00049307366,0.0004993632,0.000129594,0.0001408258,0.00037033678,0.00008526122,0.000011396995],"category_scores_gemma":[0.0018910299,0.00011399638,0.000054505108,0.0017171864,0.000028743785,0.00037615513,0.00011038819,0.0005017894,0.0000043114096],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014563111,0.00012059642,0.0012142748,0.67388356,0.00001779138,0.00010813752,0.28602633,0.019330384,0.0006164979,0.009391707,0.0001621134,0.0089829685],"study_design_scores_gemma":[0.0001399587,0.0002632425,0.0008087282,0.68892324,0.000005750423,0.000005276343,0.017118126,0.2919579,0.000026191306,0.0005488709,0.000032024487,0.00017067547],"about_ca_topic_score_codex":0.0018092179,"about_ca_topic_score_gemma":0.0004552273,"teacher_disagreement_score":0.27262753,"about_ca_system_score_codex":0.00046454198,"about_ca_system_score_gemma":0.0008127108,"threshold_uncertainty_score":0.97783583},"labels":[],"label_agreement":null},{"id":"W4405750982","doi":"10.1016/j.jval.2024.10.3731","title":"RWD174 Investigation of Input Precision in Predicting Serotype-Specific Vaccine Effectiveness for Pneumococcal Conjugate Vaccines From Immunological Predictors in Children","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Pfizer (Canada)","funders":"","keywords":"Serotype; Pneumococcal conjugate vaccine; Medicine; Conjugate; Virology; Streptococcus pneumoniae; Immunology; Biology; Microbiology; Mathematics; Antibiotics","score_opus":0.029108116590041148,"score_gpt":0.2990956094033729,"score_spread":0.26998749281333173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405750982","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929666,0.0026807461,0.00019759234,0.00081685197,0.0005173371,0.0026344045,0.0000674481,0.00010487289,0.000014134999],"genre_scores_gemma":[0.9986351,0.0005932566,0.0001324125,0.000066397086,0.00019005389,0.00024236199,0.0001040303,0.000032291053,0.000004063049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99737483,0.0005551601,0.0010028265,0.0005136563,0.00019526827,0.0003582555],"domain_scores_gemma":[0.9982948,0.0011396761,0.00014172842,0.00024729205,0.00005988189,0.00011664593],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015205542,0.00021362526,0.0006283321,0.00069783663,0.000054663647,0.000017401158,0.00010294649,0.00024854657,0.000013166711],"category_scores_gemma":[0.00037615365,0.00017629717,0.00009213612,0.0009287335,0.00004042782,0.0001497371,0.000050548966,0.0005695658,0.000004844429],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035287513,0.00015949136,0.9518499,0.0005141758,0.00003352702,0.000009092651,0.0006242937,0.0029735663,0.04083546,0.00013215277,0.000009895981,0.002505584],"study_design_scores_gemma":[0.002708785,0.0010497724,0.9788609,0.0037562323,0.000015258679,0.000022672657,0.00005050685,0.009161803,0.0029078918,0.0012100925,0.00013483493,0.00012121791],"about_ca_topic_score_codex":0.0018344519,"about_ca_topic_score_gemma":0.000116726085,"teacher_disagreement_score":0.037927564,"about_ca_system_score_codex":0.00042595383,"about_ca_system_score_gemma":0.0003622698,"threshold_uncertainty_score":0.718919},"labels":[],"label_agreement":null},{"id":"W4405751011","doi":"10.1016/j.jval.2024.10.3836","title":"PT5 Structural Uncertainty in Evidence Synthesis: A Case Study Applying Model Averaging in Bayesian Multi-Level Network Meta-Regression","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Computational and Text Analysis Methods","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Bayesian network; Meta-regression; Bayesian probability; Computer science; Econometrics; Regression; Bayesian inference; Meta-analysis; Statistics; Machine learning; Artificial intelligence; Mathematics; Medicine; Internal medicine","score_opus":0.3870796255532057,"score_gpt":0.48490395925628127,"score_spread":0.09782433370307558,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9526946,0.008473921,0.035237487,0.0019302423,0.00031434954,0.001234142,0.0000051222937,0.00007563356,0.000034489512],"genre_scores_gemma":[0.9783408,0.000120009456,0.021091614,0.00009529883,0.000107868174,0.00019084074,8.1001843e-7,0.000012293685,0.00004047339],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9943713,0.0033720774,0.00069336593,0.0005162428,0.00053145597,0.0005155705],"domain_scores_gemma":[0.99656105,0.0030017595,0.000114306145,0.00015194368,0.000039924475,0.00013102338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009773358,0.0001822599,0.00053979986,0.00041347425,0.00035175585,0.000114558265,0.0002090242,0.00006953779,0.000027297943],"category_scores_gemma":[0.00075097295,0.0001408546,0.0001215608,0.0017957855,0.00005045278,0.00029509017,0.00007684983,0.0004276802,0.0000019388233],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010554051,0.000045328317,0.015846698,0.00007371054,0.0000393565,0.0004586324,0.031971797,0.8945609,5.542497e-7,0.000859838,0.000005164616,0.056127522],"study_design_scores_gemma":[0.00015382838,0.000013165715,0.0035326243,0.0007077902,0.000046523317,0.000011316176,0.010077879,0.9778266,2.2294579e-7,0.007478749,0.000012031717,0.00013924969],"about_ca_topic_score_codex":0.25802174,"about_ca_topic_score_gemma":0.11199395,"teacher_disagreement_score":0.14602779,"about_ca_system_score_codex":0.00075904164,"about_ca_system_score_gemma":0.0009141652,"threshold_uncertainty_score":0.90420985},"labels":[],"label_agreement":null},{"id":"W4405751065","doi":"10.1016/j.jval.2024.10.3708","title":"RWD150 First Patient Enrolled in Pilot Phase of the Economics and Patient Outcomes in China in Hemophilia (EPOCH) Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Epoch (astronomy); China; Medicine; Phase (matter); Pediatrics; Family medicine; Political science; Astronomy; Physics; Quantum mechanics","score_opus":0.03346837752971393,"score_gpt":0.3145139233185352,"score_spread":0.2810455457888213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751065","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864976,0.0014898456,1.641774e-7,0.008724603,0.00021713407,0.0029544234,0.000030117473,0.000008029,0.000078112986],"genre_scores_gemma":[0.9984665,0.0008396163,0.000048585665,0.0003276379,0.000009614918,0.000272808,0.0000046792024,0.000018019957,0.000012562012],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980506,0.00024450055,0.00092400145,0.00036176635,0.0001545181,0.00026464232],"domain_scores_gemma":[0.9992768,0.00025879493,0.00011703696,0.0002500438,0.0000120156865,0.00008528633],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043757755,0.00018935143,0.00064801244,0.00034610266,0.000031891002,0.000012465635,0.000054854983,0.00004005334,0.000015272248],"category_scores_gemma":[0.00011169006,0.0001258245,0.000046519446,0.0003381213,0.00003250815,0.000044371485,0.00006834328,0.00025258222,0.0000028430195],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00034774485,0.0071588242,0.9644554,0.0002649414,0.000030386364,0.00009155138,0.01834925,0.002357487,0.0000021578792,0.00042208476,0.0000351458,0.006485008],"study_design_scores_gemma":[0.010047722,0.005640538,0.97544223,0.0009385349,0.000010514917,0.000007681169,0.0009843248,0.0061076423,0.000094549025,0.00042399432,0.00019153622,0.00011075559],"about_ca_topic_score_codex":0.010819277,"about_ca_topic_score_gemma":0.0101220375,"teacher_disagreement_score":0.017364925,"about_ca_system_score_codex":0.00061346526,"about_ca_system_score_gemma":0.00028372498,"threshold_uncertainty_score":0.9957678},"labels":[],"label_agreement":null},{"id":"W4405751087","doi":"10.1016/j.jval.2024.10.3840","title":"PT41 Benefits of Inhaled Corticosteroids (ICS) in COPD Maintenance Combinations: Real-World Evidence Using Longitudinal Targeted Maximum Likelihood Estimation","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Inhaled corticosteroids; COPD; Estimation; Medicine; Real world evidence; Internal medicine; Economics; Asthma","score_opus":0.082099897935082,"score_gpt":0.36943886714957813,"score_spread":0.28733896921449614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751087","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9769372,0.016626598,0.0009640436,0.0031820256,0.00033362277,0.001681258,0.00005917982,0.00007229251,0.00014377401],"genre_scores_gemma":[0.99549633,0.0014320416,0.002682326,0.0000872001,0.000058776768,0.000065171655,0.000053095424,0.00004480975,0.00008027429],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99661255,0.00032816775,0.0010830818,0.00057707797,0.00072961004,0.00066954177],"domain_scores_gemma":[0.99836296,0.0005254397,0.00020122877,0.00038781785,0.0002557456,0.0002668305],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013584847,0.00022094068,0.00055123324,0.0010304066,0.000069161375,0.000035225563,0.0001537079,0.00008833448,0.000074375115],"category_scores_gemma":[0.00055667164,0.00022637642,0.00008496981,0.0021216131,0.00015387486,0.0003753178,0.00010694284,0.0005506883,0.00002107232],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011998144,0.0023766144,0.7802225,0.030209277,0.0001349739,0.001768754,0.0022806453,0.058877412,0.0015162659,0.0139229,0.00049190555,0.10699894],"study_design_scores_gemma":[0.0012012932,0.0001940375,0.52268684,0.010954045,0.00002281422,0.00008271768,0.00008646169,0.4610176,0.00013464129,0.003483771,0.00001057586,0.00012515603],"about_ca_topic_score_codex":0.011193858,"about_ca_topic_score_gemma":0.0008582772,"teacher_disagreement_score":0.4021402,"about_ca_system_score_codex":0.003117334,"about_ca_system_score_gemma":0.0022297963,"threshold_uncertainty_score":0.9953907},"labels":[],"label_agreement":null},{"id":"W4405751098","doi":"10.1016/j.jval.2024.10.3839","title":"PT30 Navigating the New European Member State Coordination Group on Health Technology Assessment Quantitative Evidence Synthesis Guidelines","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Member state; Member states; Group (periodic table); Health technology; Business; Political science; Chemistry; European union; International trade; Health care","score_opus":0.6061181779801952,"score_gpt":0.5384622452864588,"score_spread":0.06765593269373638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751098","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04561117,0.029033672,0.02170238,0.89962053,0.0013117174,0.0016432711,0.00013730898,0.00023925703,0.000700671],"genre_scores_gemma":[0.9085208,0.0065933187,0.043480262,0.039727986,0.00063711614,0.0003062753,0.000030343179,0.00015549814,0.00054836646],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98985994,0.002617754,0.0057031447,0.0009135772,0.00021124422,0.00069432217],"domain_scores_gemma":[0.9908493,0.006136857,0.002099384,0.0006162454,0.000083666295,0.00021452425],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.058819313,0.00026429445,0.00091022806,0.00056554715,0.00038807653,0.00018270568,0.00043971662,0.000082500796,0.00008061892],"category_scores_gemma":[0.010408828,0.00025863474,0.000101025034,0.0009503458,0.00008733557,0.000469055,0.000089320936,0.00073722354,0.0009892759],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001702332,0.00010494431,0.0058384803,0.001994604,0.00007755847,0.000007116445,0.0073287874,0.022576835,0.0000040639056,0.8441323,0.07657839,0.04133992],"study_design_scores_gemma":[0.000918677,0.0015483102,0.02258125,0.022934576,0.0000124009,0.000032834258,0.011453731,0.5908241,0.000012438686,0.15328722,0.1952555,0.0011389396],"about_ca_topic_score_codex":0.0210394,"about_ca_topic_score_gemma":0.00077136635,"teacher_disagreement_score":0.8629097,"about_ca_system_score_codex":0.0023999657,"about_ca_system_score_gemma":0.0012268602,"threshold_uncertainty_score":0.9999866},"labels":[],"label_agreement":null},{"id":"W4405751121","doi":"10.1016/j.jval.2024.10.3844","title":"PT18 Preferences for and Importance of Early Oncology Trial Endpoints to Canadians With Early-Stage Cancer: An Interim Analysis of a Qualitative Patient Preference Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; Custom Security Industries (Canada); Ontario Institute for Cancer Research; AstraZeneca (Canada); Vancouver Coastal Health","funders":"","keywords":"Interim; Stage (stratigraphy); Interim analysis; Preference; Oncology; Internal medicine; Medicine; Cancer; Family medicine; Psychology; Clinical trial; Political science; Economics; Biology","score_opus":0.6555732753305159,"score_gpt":0.5356692492799525,"score_spread":0.11990402605056338,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751121","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9895479,0.0010854253,0.00067361334,0.002314515,0.0002491963,0.0033667944,0.0026654373,0.000013809035,0.00008330917],"genre_scores_gemma":[0.99629945,0.000089235225,0.00218016,0.0005317888,0.000040521398,0.0007762963,0.000020287067,0.000019407185,0.000042833526],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.9940541,0.0010740223,0.0037084813,0.0006857245,0.00011297701,0.00036473005],"domain_scores_gemma":[0.99601525,0.0015883478,0.0016823784,0.0003486087,0.00009602285,0.00026937466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011930971,0.00017032957,0.0015324841,0.0010606257,0.000058600523,0.000034710927,0.00019504702,0.00008113808,0.00005567727],"category_scores_gemma":[0.000735709,0.00018024279,0.00006916043,0.00078844005,0.000074568554,0.00025018232,0.00003036319,0.00013964204,0.000003047893],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0031888923,0.0006624918,0.36121702,0.0016373482,0.00090945966,0.0000021397927,0.602994,0.0032110312,0.000001167292,0.024002431,0.0001534357,0.0020205742],"study_design_scores_gemma":[0.019052343,0.079411626,0.6393865,0.0017127884,0.0002935029,0.0000013552218,0.20545782,0.038405783,0.000013463471,0.011672513,0.0033255531,0.0012667793],"about_ca_topic_score_codex":0.46523732,"about_ca_topic_score_gemma":0.3111103,"teacher_disagreement_score":0.3975362,"about_ca_system_score_codex":0.00088074117,"about_ca_system_score_gemma":0.0013672397,"threshold_uncertainty_score":0.7350088},"labels":[],"label_agreement":null},{"id":"W4405751125","doi":"10.1016/j.jval.2024.10.3833","title":"PT2 Real-Life Benefit-Risk Assessment of Medical Products Using Bayesian Multi-Criteria Augmented Decision Analysis (MCADA) in Oncology","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Bayesian probability; Medicine; Oncology; Risk analysis (engineering); Medical physics; Internal medicine; Computer science; Artificial intelligence","score_opus":0.09652506312156546,"score_gpt":0.39674107847871914,"score_spread":0.3002160153571537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751125","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9509057,0.006725799,0.036585003,0.0032490941,0.0011205213,0.00041837062,0.00021251268,0.000026483041,0.00075654534],"genre_scores_gemma":[0.9770392,0.009519426,0.012934366,0.00027459857,0.00014158104,0.000017195218,0.000018763358,0.000028211149,0.00002663188],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9966206,0.00010528073,0.0019942913,0.000670402,0.00012487947,0.0004845582],"domain_scores_gemma":[0.9985096,0.00025680335,0.00058189995,0.0003708551,0.000036216803,0.00024461566],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0049346406,0.00018523683,0.0011076068,0.0014239287,0.00005685701,0.000049862847,0.00027961945,0.00026341333,0.00028848404],"category_scores_gemma":[0.0006693617,0.00021068566,0.00013702195,0.0015043183,0.00006674196,0.00026047556,0.00009300614,0.00043481126,0.0000125829665],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010630308,0.0007658309,0.77455765,0.00065822183,0.00033658685,0.00005523154,0.0019065585,0.07480827,0.000014244108,0.1116314,0.00031487324,0.034844834],"study_design_scores_gemma":[0.000702603,0.00013579769,0.30051118,0.00024031442,0.000015894158,0.0000017582017,0.00006332092,0.69241834,0.0000039462284,0.0036503782,0.0021032155,0.00015324615],"about_ca_topic_score_codex":0.056516152,"about_ca_topic_score_gemma":0.0037693619,"teacher_disagreement_score":0.61761004,"about_ca_system_score_codex":0.0016171864,"about_ca_system_score_gemma":0.0012567289,"threshold_uncertainty_score":0.9497666},"labels":[],"label_agreement":null},{"id":"W4405751219","doi":"10.1016/j.jval.2024.10.1034","title":"EE754 Challenges in Identifying Information to Build Economic Evaluations in Hereditary Angioedema","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Hereditary angioedema; Angioedema; Medicine; Data science; Business; Computer science; Dermatology","score_opus":0.09617091488341284,"score_gpt":0.37302099225035973,"score_spread":0.2768500773669469,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9314922,0.032971777,0.00013945412,0.031464633,0.0012886401,0.001291416,0.000022340784,0.00012358317,0.0012059336],"genre_scores_gemma":[0.9956424,0.0025036782,0.00064446917,0.0006855546,0.00027977314,0.000090184054,0.00006707553,0.00002137677,0.00006549053],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99810135,0.00012473045,0.0008889034,0.00028203797,0.00022469646,0.00037827782],"domain_scores_gemma":[0.99930775,0.00021288758,0.000072387935,0.00022979417,0.000024591063,0.00015259515],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017151048,0.00014848312,0.00032882483,0.0011276836,0.000043221597,0.000042686457,0.00008330199,0.00009986163,0.00008237267],"category_scores_gemma":[0.0001433109,0.00015966383,0.000065734785,0.00048402318,0.000017059976,0.0005633237,0.000038153772,0.00021016652,0.00024207076],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002523024,0.00038677664,0.17765439,0.006146919,0.000076895914,0.00015727952,0.08147376,0.13068397,0.000061424354,0.03943554,0.0062189996,0.5574517],"study_design_scores_gemma":[0.0016352162,0.0003076202,0.8060364,0.004641642,0.000015930154,0.000067059125,0.0029428964,0.16566755,0.000061969076,0.0053745043,0.012946005,0.0003031737],"about_ca_topic_score_codex":0.008314633,"about_ca_topic_score_gemma":0.0039188387,"teacher_disagreement_score":0.628382,"about_ca_system_score_codex":0.0009336609,"about_ca_system_score_gemma":0.0007103966,"threshold_uncertainty_score":0.9982891},"labels":[],"label_agreement":null},{"id":"W4405751634","doi":"10.1016/j.jval.2024.10.1070","title":"EE790 Cost-Effectiveness and Cost Utility Analysis of an eHealth Peer-Led Wheelchair Training Program Compared to the Existing Wheelchair Training Practice in Canadian Rehabilitation Centers: Economic Evaluation of a RCT","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Telemedicine and Telehealth Implementation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Université Laval","funders":"","keywords":"Wheelchair; eHealth; Randomized controlled trial; Rehabilitation; Cost effectiveness; Training (meteorology); Economic evaluation; Physical medicine and rehabilitation; Physical therapy; Medicine; Computer science; Risk analysis (engineering); Health care; Economics; World Wide Web","score_opus":0.20075204359796323,"score_gpt":0.4897428907647322,"score_spread":0.288990847166769,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751634","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9757359,0.00045911316,0.0001868535,0.015360211,0.00021932786,0.0077403295,0.00013951954,0.00003949246,0.00011923307],"genre_scores_gemma":[0.99583614,0.000035177563,0.0026155359,0.00044317712,0.00006798669,0.0006476895,0.00033140832,0.00002169217,0.0000011722701],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99434376,0.002550697,0.0013946214,0.00052622886,0.0005880319,0.0005966884],"domain_scores_gemma":[0.9960092,0.0024748063,0.00039760888,0.000309241,0.00034558153,0.00046358397],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02506947,0.00018019546,0.00077715464,0.0014083402,0.000109033506,0.0000260894,0.0000868998,0.000072368726,0.000021312122],"category_scores_gemma":[0.003339878,0.00016369576,0.00006770981,0.0015933611,0.00006805895,0.00026319406,0.00001576329,0.00032558446,5.899732e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039508348,0.000192027,0.10961766,0.0018015547,0.0001465911,0.000005576552,0.11778537,0.020260185,0.000014369724,0.0002964533,0.000042661577,0.74944246],"study_design_scores_gemma":[0.0016889208,0.0010810259,0.51408356,0.0007863264,0.00022289794,0.000009535656,0.028419625,0.4520897,0.0000048476813,0.00005690629,0.0014861558,0.00007051688],"about_ca_topic_score_codex":0.64183265,"about_ca_topic_score_gemma":0.6530362,"teacher_disagreement_score":0.74937195,"about_ca_system_score_codex":0.0025948288,"about_ca_system_score_gemma":0.0050680083,"threshold_uncertainty_score":0.89904296},"labels":[],"label_agreement":null},{"id":"W4405751655","doi":"10.1016/j.jval.2024.10.1963","title":"HTA138 NICE vs SMC: Reimbursement Differences for Non-Oncology Orphan Drugs","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Nice; Reimbursement; Orphan drug; Medicine; Internal medicine; Family medicine; Oncology; Bioinformatics; Economics; Biology; Computer science; Economic growth; Health care","score_opus":0.13097741370356253,"score_gpt":0.3695815115593293,"score_spread":0.23860409785576675,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751655","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.75943446,0.023084743,0.0027349337,0.15145656,0.008274988,0.002649683,0.0013445608,0.00018069836,0.05083938],"genre_scores_gemma":[0.9868478,0.0035837204,0.0007928259,0.007311967,0.00049066835,0.00017130049,0.000019034695,0.000034573484,0.0007481041],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.997899,0.0000331119,0.00094733125,0.00051010837,0.000024991952,0.00058548164],"domain_scores_gemma":[0.9989772,0.00039518398,0.00018371038,0.00022086148,0.00001053008,0.00021254444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015527174,0.00016270077,0.0005458219,0.00032371876,0.00008664016,0.00007848917,0.0002460212,0.00011473349,0.00023233132],"category_scores_gemma":[0.000060835693,0.00018010385,0.00012261455,0.00022747756,0.000048778646,0.00011473368,0.000058536567,0.00024567163,0.00049071957],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007628791,0.00022164756,0.007181615,0.0009900565,0.00007003841,0.0000057217694,0.0043621273,0.00070320076,0.0000072718058,0.95451784,0.0134307835,0.018433385],"study_design_scores_gemma":[0.0006813078,0.00037998334,0.0024186627,0.00009045413,0.000003513439,0.0000025336055,0.00006194211,0.17187162,0.00002198199,0.09186725,0.73237234,0.00022842566],"about_ca_topic_score_codex":0.0028784524,"about_ca_topic_score_gemma":0.00005484799,"teacher_disagreement_score":0.86265063,"about_ca_system_score_codex":0.00063078967,"about_ca_system_score_gemma":0.00026069288,"threshold_uncertainty_score":0.7344422},"labels":[],"label_agreement":null},{"id":"W4405751697","doi":"10.1016/j.jval.2024.10.1939","title":"HTA114 Characterizing Oncology Outcomes in Canada's Drug Agency (CDA-AMC) Reviews From 2022 -2023","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Agency (philosophy); Drug; Medicine; Precision oncology; Oncology; Internal medicine; Pharmacology; Intensive care medicine; Business; Sociology; Cancer","score_opus":0.07559420549601341,"score_gpt":0.2958813911792266,"score_spread":0.2202871856832132,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751697","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8576321,0.10756309,0.000046380534,0.019353995,0.0051724995,0.0006944872,0.0007900491,0.0000314193,0.008716001],"genre_scores_gemma":[0.9544151,0.03630219,0.00032358558,0.0065490496,0.00041129286,0.0001197227,0.000052100015,0.00005517897,0.0017718173],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687856,0.00009610454,0.0017580839,0.0006001433,0.000039006758,0.0006281099],"domain_scores_gemma":[0.9987914,0.00025762882,0.00042581922,0.00034448912,0.000007254377,0.00017343865],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0018159745,0.00022195748,0.0011714112,0.0003551091,0.000056152316,0.000050752937,0.00028965602,0.00009838719,0.00071298424],"category_scores_gemma":[0.00022189929,0.00025271327,0.0001138475,0.0003633231,0.000025222753,0.0002844489,0.00006822259,0.0004941873,0.0005526353],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000033556924,0.00013736861,0.8012575,0.00066370296,0.00005776989,0.0001518312,0.004687613,0.00045909386,0.000011891393,0.047445998,0.027909752,0.11718392],"study_design_scores_gemma":[0.00032036763,0.000039702085,0.3578182,0.00026447783,0.0000017804658,0.000001418928,0.00007713076,0.0030657656,0.000002833025,0.012215049,0.62591594,0.00027735336],"about_ca_topic_score_codex":0.97913677,"about_ca_topic_score_gemma":0.8743768,"teacher_disagreement_score":0.5980062,"about_ca_system_score_codex":0.004494532,"about_ca_system_score_gemma":0.0018592854,"threshold_uncertainty_score":0.9999925},"labels":[],"label_agreement":null},{"id":"W4405751773","doi":"10.1016/j.jval.2024.10.2046","title":"HTA221 Market Access Challenges for Gene Therapies in Inherited Blood Disorders: A Retrospective Evaluation of HTA Outcomes for Sickle Cell Disease and Thalassemia","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"CRISPR and Genetic Engineering","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Thalassemia; Disease; Intensive care medicine; Pediatrics; Internal medicine","score_opus":0.03847742794805487,"score_gpt":0.3742099856130437,"score_spread":0.33573255766498883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92368877,0.072920546,0.001110647,0.0009589444,0.000113316935,0.0010749218,0.0000899958,0.000008104073,0.000034766545],"genre_scores_gemma":[0.9890173,0.009904046,0.00062993704,0.000024124434,0.0000541474,0.00028472548,0.0000379062,0.000022153814,0.000025655418],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99912673,0.000076542354,0.00022285913,0.0002939809,0.000103745,0.00017616389],"domain_scores_gemma":[0.9996385,0.0000781112,0.000042163065,0.00014889297,0.000045788463,0.000046564786],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008075393,0.0001098793,0.00016813683,0.00008816254,0.000019284003,0.000015711348,0.000075844655,0.00006151013,0.00000258568],"category_scores_gemma":[0.00012805643,0.00010411951,0.00005042773,0.00007959529,0.000019014708,0.000005985012,0.00003435948,0.00004598539,3.817968e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00173791,0.0022086531,0.61202043,0.026874093,0.0008989061,0.00000599038,0.011298615,0.04744881,0.1902418,0.0017580149,0.0012028292,0.10430398],"study_design_scores_gemma":[0.004394964,0.00096102536,0.8599905,0.00042899564,0.00011927845,0.0000015778031,0.00065117877,0.09979017,0.023748133,0.008093495,0.0014019553,0.00041874716],"about_ca_topic_score_codex":0.00011323812,"about_ca_topic_score_gemma":0.00024779883,"teacher_disagreement_score":0.24797007,"about_ca_system_score_codex":0.00003256196,"about_ca_system_score_gemma":0.00014018605,"threshold_uncertainty_score":0.42458704},"labels":[],"label_agreement":null},{"id":"W4405751784","doi":"10.1016/j.jval.2024.10.1997","title":"HTA172 Type of Clinical Evidence and Its Impact on Price Reductions for Oncology Drugs: A Review of Reimbursement Submissions in Canada","year":2024,"lang":"en","type":"review","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information","funders":"","keywords":"Reimbursement; Real world evidence; Medicine; Oncology; Actuarial science; Internal medicine; Intensive care medicine; Business; Economics; Health care; Economic growth","score_opus":0.40304230889478543,"score_gpt":0.5154586961081905,"score_spread":0.11241638721340508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751784","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00053769513,0.9937966,0.0000020880905,0.0012999118,0.0012113178,0.0017952991,0.00068008096,0.0000033000686,0.0006737252],"genre_scores_gemma":[0.001580431,0.9975972,0.00012151866,0.00028363647,0.00013213698,0.00010915469,0.000017056369,0.000030607614,0.00012821663],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9950708,0.00015605963,0.003850225,0.0005235416,0.00004531231,0.0003540745],"domain_scores_gemma":[0.9962059,0.0010672031,0.0021396312,0.00034083726,0.000058548114,0.00018784315],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004232653,0.00024693957,0.0034851898,0.00037230414,0.000024223906,0.0000055047635,0.0002272625,0.00019522142,0.000060155864],"category_scores_gemma":[0.0023188787,0.00022206767,0.00030903754,0.00054227456,0.000037548165,0.000075434655,0.000054896427,0.0005035379,0.000010936193],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008332516,0.00027773398,0.0007554902,0.375448,0.00019180562,0.0000053809767,0.00022705607,0.00015087862,1.0912722e-8,0.035697386,0.022960842,0.5642021],"study_design_scores_gemma":[0.00017793878,0.0006243085,0.00044380338,0.15964688,0.000051657018,0.0000040070463,0.000017365133,0.00017005682,4.6486342e-8,0.0008878213,0.83779746,0.00017862873],"about_ca_topic_score_codex":0.41847324,"about_ca_topic_score_gemma":0.027050763,"teacher_disagreement_score":0.8148366,"about_ca_system_score_codex":0.0027079154,"about_ca_system_score_gemma":0.01297215,"threshold_uncertainty_score":0.9926234},"labels":[],"label_agreement":null},{"id":"W4405751787","doi":"10.1016/j.jval.2024.10.2026","title":"HTA201 A Quantitative Assessment of the Economic Decision Drivers Outlined in HTA Outcomes Through Stratification and Sentiment Analysis: Evidence From Canada, England, Scotland, and Sweden","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stratification (seeds); Medicine","score_opus":0.08993924340797652,"score_gpt":0.353250845876212,"score_spread":0.2633116024682355,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751787","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991297,0.0019681123,0.0011131378,0.0047257617,0.0002743575,0.00026752788,0.0002598964,0.0000039522492,0.00009025255],"genre_scores_gemma":[0.9974391,0.00074903626,0.0015714609,0.00016525546,0.000014319796,0.000010469209,0.000011982912,0.0000054706547,0.000032897042],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99863786,0.000072970506,0.0007919338,0.00031021045,0.00005199592,0.00013502226],"domain_scores_gemma":[0.99898523,0.00050732127,0.00027868873,0.00018825282,0.000012552976,0.000027954948],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00097187463,0.00009183194,0.00034328896,0.00025213556,0.000053787084,0.000046678517,0.00009491093,0.000042968448,0.000022571674],"category_scores_gemma":[0.00007901137,0.000076856486,0.000034573608,0.0004018344,0.000035779038,0.00018386751,0.000036480596,0.00012228418,0.000002267213],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00000832814,0.000013206877,0.8863338,0.000050700917,0.00008028463,6.951684e-7,0.0022411041,0.01080541,0.0000035587468,0.10015535,0.00005971489,0.00024782334],"study_design_scores_gemma":[0.00030723118,0.000025382948,0.86052424,0.00015021546,0.0000099495355,2.0465073e-7,0.00030479848,0.1260061,0.000010930245,0.012296792,0.00029041874,0.00007373884],"about_ca_topic_score_codex":0.8067544,"about_ca_topic_score_gemma":0.5318336,"teacher_disagreement_score":0.27492082,"about_ca_system_score_codex":0.0005359636,"about_ca_system_score_gemma":0.0004140106,"threshold_uncertainty_score":0.4767092},"labels":[],"label_agreement":null},{"id":"W4405751835","doi":"10.1016/j.jval.2024.10.1000","title":"EE720 Cost-Effectiveness of Faricimab in Canada for the Treatment of Patients With Macular Edema Secondary to Retinal Vein Occlusion","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Roche (Canada)","funders":"","keywords":"Macular edema; Medicine; Retinal Vein; Ophthalmology; Occlusion; Central retinal vein occlusion; Retinal; Edema; Surgery","score_opus":0.05709161194486376,"score_gpt":0.30844445534623777,"score_spread":0.251352843401374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751835","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9905245,0.0041843713,0.00032278974,0.0018291555,0.0002358584,0.0015192524,0.0011506275,0.0000027915169,0.00023071094],"genre_scores_gemma":[0.99907994,0.0003694625,0.00007868956,0.00035652053,0.000014821068,0.00005495691,0.000021635235,0.0000147353,0.000009256297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9989565,0.000045006476,0.00049770257,0.00023143656,0.000028569484,0.00024077675],"domain_scores_gemma":[0.99919325,0.0004599077,0.000123211,0.00014935572,0.000016046833,0.000058199872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062453124,0.00010073455,0.00038478183,0.00016384474,0.000028893543,0.0000087237,0.00010218651,0.000028007456,0.00002713089],"category_scores_gemma":[0.000022131051,0.00008176357,0.000045841087,0.00023792467,0.000018024179,0.000035892674,0.000019692383,0.000070660935,0.0000029481912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002872262,0.0017748459,0.5778193,0.0064698663,0.00033664797,0.000022286127,0.0077927927,0.17247812,0.000020523243,0.13157865,0.0010226629,0.09781203],"study_design_scores_gemma":[0.0050547756,0.002308336,0.63774455,0.0004901578,0.000012483304,0.0000013062661,0.0001769214,0.14136113,0.0003888713,0.0049776183,0.20712386,0.00035998956],"about_ca_topic_score_codex":0.66041064,"about_ca_topic_score_gemma":0.11775257,"teacher_disagreement_score":0.54265803,"about_ca_system_score_codex":0.0014888663,"about_ca_system_score_gemma":0.000662666,"threshold_uncertainty_score":0.8983461},"labels":[],"label_agreement":null},{"id":"W4405751865","doi":"10.1016/j.jval.2024.10.1879","title":"HTA54 Review of Cell and Gene Therapies by NICE, HAS, and G-BA: How Did They Fare?","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Nice; Gene; Computational biology; Medicine; Genetics; Biology; Computer science; Programming language","score_opus":0.01822757348480167,"score_gpt":0.2358524111575357,"score_spread":0.21762483767273402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751865","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.114465125,0.87619954,0.0005773001,0.007999201,0.00040819414,0.00015350172,0.000025247327,0.000098952165,0.000072943534],"genre_scores_gemma":[0.67847914,0.32060617,0.0006377777,0.00014201525,0.00004842309,0.000010997663,0.000010678745,0.000015901935,0.000048876533],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995491,0.00002075214,0.00014352612,0.00009829988,0.00006793816,0.00012040204],"domain_scores_gemma":[0.9997901,0.0000538593,0.000011573666,0.00007640906,0.000005457081,0.00006263751],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026614877,0.0000724856,0.00014411585,0.000046978697,0.000013046906,0.000015842543,0.00003432823,0.00003752401,0.0000059110776],"category_scores_gemma":[0.000010630769,0.000059148322,0.000012154892,0.00011051204,0.00002043832,0.000037290654,0.00000828663,0.00010501998,0.0000012889635],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000067208516,0.00015230637,0.0012221835,0.58312577,0.00011594699,0.0000070822566,0.010747481,0.0012230168,0.025478916,0.0013356373,0.13873915,0.2378458],"study_design_scores_gemma":[0.0006642851,0.00032068894,0.009324444,0.036646016,0.00004237771,0.000041738083,0.00030051108,0.110985935,0.004375883,0.0016122016,0.8349176,0.0007683216],"about_ca_topic_score_codex":0.00022291542,"about_ca_topic_score_gemma":0.0000030504814,"teacher_disagreement_score":0.69617844,"about_ca_system_score_codex":0.00002911864,"about_ca_system_score_gemma":0.000027783713,"threshold_uncertainty_score":0.24119985},"labels":[],"label_agreement":null},{"id":"W4405751880","doi":"10.1016/j.jval.2024.10.2094","title":"HTA269 Submission Processes and Requirements for Health Technology Assessment in Australia, Canada, England, and Spain","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Library science; Geography; Computer science","score_opus":0.4019794365760658,"score_gpt":0.4774393686292591,"score_spread":0.07545993205319335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751880","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7139762,0.023143826,0.0012102688,0.25852096,0.0005815314,0.002082749,0.00038105255,0.000047648406,0.00005578753],"genre_scores_gemma":[0.988337,0.001871705,0.0044652354,0.0045832237,0.000116108014,0.00025955294,0.00003664406,0.000030004965,0.00030054842],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9955783,0.00027498565,0.0028338789,0.0006448985,0.00008342758,0.00058453035],"domain_scores_gemma":[0.9980796,0.0008210489,0.00064826186,0.00020311716,0.000024879455,0.00022309233],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01641663,0.00016612429,0.0007759321,0.00065858883,0.00012482845,0.000060764924,0.000109960565,0.000121247394,0.000018921688],"category_scores_gemma":[0.0012621064,0.00020206091,0.000016614456,0.00041979368,0.000040693074,0.0002068503,0.00003878171,0.00026029238,0.0000064240453],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047506215,0.00022904006,0.7245627,0.04264268,0.000057040383,0.000013427806,0.008485083,0.000913307,0.0000033814824,0.19625865,0.016013075,0.010774085],"study_design_scores_gemma":[0.0051221354,0.0013068956,0.20207627,0.006135495,0.0000053197587,0.000044713357,0.0044795037,0.08546144,0.00000727674,0.11238771,0.5818612,0.001112032],"about_ca_topic_score_codex":0.6198008,"about_ca_topic_score_gemma":0.45917097,"teacher_disagreement_score":0.5658481,"about_ca_system_score_codex":0.0021994598,"about_ca_system_score_gemma":0.003155937,"threshold_uncertainty_score":0.82398045},"labels":[],"label_agreement":null},{"id":"W4405751905","doi":"10.1016/j.jval.2024.10.2064","title":"HTA239 Streamlining Systematic Review Feasibility Assessments With Large Language Models: A Novel AI-Driven Workflow","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Workflow; Computer science; Software engineering; Systems engineering; Data science; Engineering; Database","score_opus":0.26677516770749116,"score_gpt":0.49613943865608207,"score_spread":0.2293642709485909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5076282,0.35133088,0.07375051,0.042586036,0.0022195447,0.019893637,0.00015407367,0.00092393294,0.0015131693],"genre_scores_gemma":[0.98660254,0.003931212,0.004279577,0.004489998,0.00017125839,0.00023025792,0.000067206325,0.00004121717,0.00018673748],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9972708,0.00028471267,0.0010583338,0.00046687183,0.00042571788,0.0004935127],"domain_scores_gemma":[0.9985729,0.00036953567,0.00015719146,0.00053174974,0.00011989343,0.00024877288],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023671766,0.00018970807,0.00072749885,0.00017948628,0.00008927446,0.000042074687,0.00010477019,0.00009017388,0.000045297074],"category_scores_gemma":[0.0003282357,0.00014137951,0.00008135228,0.00072285655,0.000026051563,0.0002023929,0.000023754115,0.0005237898,0.000051081537],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000080825565,0.0007572442,0.010279711,0.9691695,0.00008201154,0.00008733622,0.009087021,0.0023019132,0.000011984889,0.0031322106,0.0004918508,0.0045184116],"study_design_scores_gemma":[0.00015574429,0.00064480974,0.00030053724,0.59979373,0.00016633079,0.00009764231,0.00377499,0.3938111,0.000021722659,0.00094702735,0.000064618675,0.00022174924],"about_ca_topic_score_codex":0.004257241,"about_ca_topic_score_gemma":0.00038697224,"teacher_disagreement_score":0.4789743,"about_ca_system_score_codex":0.0008028346,"about_ca_system_score_gemma":0.0016176279,"threshold_uncertainty_score":0.6435703},"labels":[],"label_agreement":null},{"id":"W4405751933","doi":"10.1016/j.jval.2024.10.3591","title":"RWD33 Physician Perception of Patient Unmet Needs and Optimism Towards Gene Therapy: Results From a Multinational Real-World Survey","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Adolescent and Pediatric Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Optimism; Multinational corporation; Perception; Medicine; Family medicine; Psychology; Business; Finance; Psychotherapist","score_opus":0.13439103746630374,"score_gpt":0.42383788764767927,"score_spread":0.2894468501813755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751933","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9860533,0.0023253756,0.00009416271,0.0072018835,0.00095847703,0.0011606651,0.0016772074,0.000084381034,0.0004445474],"genre_scores_gemma":[0.9862645,0.008336157,0.0018468844,0.0017640417,0.0007047631,0.00003981128,0.0008587008,0.000037284437,0.0001478244],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952465,0.0022381824,0.0012087583,0.0004120933,0.0004070378,0.00048742458],"domain_scores_gemma":[0.9976911,0.0013548556,0.00031657817,0.00026370006,0.00015944632,0.00021432363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026274591,0.00018876618,0.0004038092,0.00046818436,0.0002487212,0.000010377459,0.00010480659,0.00017942069,0.000048976526],"category_scores_gemma":[0.00018399167,0.00016829155,0.00005273507,0.00089937757,0.00004447867,0.000103653816,0.00006658635,0.0006886915,0.000026235122],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017686146,0.00058129005,0.4283086,0.0030358343,0.000073236464,0.000015528942,0.17068271,0.0016706238,0.00023457423,0.001881345,0.017734801,0.37401283],"study_design_scores_gemma":[0.0015010718,0.0002480289,0.9723168,0.001223913,0.000005421619,2.6385965e-7,0.003026796,0.0150388945,0.000010972393,0.00060666766,0.0058169607,0.00020423139],"about_ca_topic_score_codex":0.22611448,"about_ca_topic_score_gemma":0.0024975077,"teacher_disagreement_score":0.54400814,"about_ca_system_score_codex":0.00048462328,"about_ca_system_score_gemma":0.0014886912,"threshold_uncertainty_score":0.7790389},"labels":[],"label_agreement":null},{"id":"W4405751943","doi":"10.1016/j.jval.2024.10.2049","title":"HTA224 A Roadmap to the Use of Value of Information Analysis in Health Technology Assessment: An International Study of Barriers, Facilitators, and Potential Applications","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Health information technology; Health technology; Value (mathematics); Technology roadmap; Knowledge management; Business; Medicine; Risk analysis (engineering); Process management; Computer science; Political science; Health care; Marketing","score_opus":0.21285160995898897,"score_gpt":0.43917083488562925,"score_spread":0.22631922492664028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751943","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9405625,0.00082333863,0.024131458,0.031000905,0.00019623205,0.0021274704,0.001117419,0.000020284411,0.000020416657],"genre_scores_gemma":[0.99426836,0.0002176612,0.0045543057,0.0006740957,0.00002384057,0.00019551054,0.000049585,0.000008156758,0.000008459993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938767,0.00061897334,0.0047824015,0.00033935756,0.0001541686,0.00022837707],"domain_scores_gemma":[0.99737394,0.00041434902,0.0015273382,0.0004802689,0.00007663767,0.00012746727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012834148,0.00011194829,0.00081307907,0.0026006452,0.00006850984,0.000037110185,0.00027511557,0.00008029359,0.000024683442],"category_scores_gemma":[0.00072819623,0.00012166043,0.00005829846,0.001690671,0.000058566944,0.0006198435,0.00007323319,0.00018968157,0.000009140886],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000186854,0.00022060117,0.5600841,0.001188699,0.00022575582,1.9379169e-7,0.01523026,0.23506518,0.0000012417258,0.18519285,0.0002215907,0.0025508618],"study_design_scores_gemma":[0.00082339806,0.000760707,0.5004819,0.00023004692,0.00001793648,0.0000018814567,0.016039798,0.45619705,0.0000010792397,0.0049159797,0.020347405,0.00018281427],"about_ca_topic_score_codex":0.031410433,"about_ca_topic_score_gemma":0.0015169599,"teacher_disagreement_score":0.22113188,"about_ca_system_score_codex":0.00056541397,"about_ca_system_score_gemma":0.0005922645,"threshold_uncertainty_score":0.9750395},"labels":[],"label_agreement":null},{"id":"W4405751999","doi":"10.1016/j.jval.2024.10.983","title":"EE703 Comparison of Administrative Burden Associated With Kesimpta and Ocrevus Among Multiple Sclerosis (MS) Clinics in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Novartis (Canada)","funders":"","keywords":"Multiple sclerosis; Medicine; Family medicine; Psychiatry","score_opus":0.5657072368614837,"score_gpt":0.43923118308260956,"score_spread":0.12647605377887416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405751999","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9845897,0.005684357,0.000085251384,0.007827482,0.00031182813,0.0007834951,0.00044001557,0.000019820965,0.00025802682],"genre_scores_gemma":[0.99825996,0.00037170906,0.00047754328,0.0006762608,0.000057609705,0.00004925366,0.000033856173,0.00002826181,0.000045554763],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940615,0.0006027188,0.00424661,0.0005250885,0.000121713805,0.00044232595],"domain_scores_gemma":[0.99460816,0.003372587,0.0015219725,0.0002587068,0.000035386645,0.00020319848],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010177067,0.00017780055,0.0012594656,0.00033562127,0.000071644885,0.00004280187,0.00015532413,0.00011437815,0.000036229896],"category_scores_gemma":[0.0023702157,0.00021419031,0.000038478982,0.00046813392,0.00007861942,0.00020167694,0.000031289746,0.0003564045,0.000013872015],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001724594,0.00006019204,0.9829804,0.0007485318,0.00003694996,0.000002315686,0.005136935,0.0068008774,1.9843026e-7,0.0027867595,0.0011219464,0.00030765618],"study_design_scores_gemma":[0.0008423287,0.00021448491,0.71421665,0.0015068279,0.0000031410088,7.0510964e-7,0.004033527,0.27728602,0.0000027711294,0.0006952416,0.0009815007,0.00021679887],"about_ca_topic_score_codex":0.94487166,"about_ca_topic_score_gemma":0.9111348,"teacher_disagreement_score":0.27048516,"about_ca_system_score_codex":0.0025172269,"about_ca_system_score_gemma":0.0030568135,"threshold_uncertainty_score":0.8734427},"labels":[],"label_agreement":null},{"id":"W4405752013","doi":"10.1016/j.jval.2024.10.1942","title":"HTA117 Sentiment Analysis of Clinical Evaluations in HTA: Evidence From Canada, England, Scotland, Sweden, France, and Germany","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Real world evidence; New england; Medicine; Political science; Internal medicine; Law","score_opus":0.44116751953350725,"score_gpt":0.4984612808864975,"score_spread":0.05729376135299025,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405752013","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93763936,0.035448305,0.0005192173,0.02401771,0.0009853811,0.00065892097,0.0006072457,0.000022941458,0.0001008922],"genre_scores_gemma":[0.9933837,0.002859458,0.00091248896,0.0023686576,0.00022033419,0.00006284631,0.00004324184,0.00002378391,0.00012548242],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99048746,0.0012180153,0.006907739,0.0007778301,0.0002112884,0.00039769092],"domain_scores_gemma":[0.99231386,0.005617168,0.0013138765,0.00048044193,0.00004619075,0.0002284456],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.031992175,0.00017003095,0.0016261612,0.0009553401,0.00006199197,0.0000522615,0.0001995829,0.00013242896,0.00020465672],"category_scores_gemma":[0.0031181776,0.00020676258,0.00013272537,0.0010951104,0.00005928525,0.00028855266,0.000052476018,0.0003319506,0.00005562912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000114880495,0.000062248066,0.9788374,0.0004894041,0.00021608082,0.000004203998,0.0023747056,0.011940988,5.298549e-7,0.0029203768,0.002421543,0.0007210352],"study_design_scores_gemma":[0.00049862044,0.000040109328,0.7344444,0.00065583014,0.00003020658,5.575026e-7,0.0002139761,0.2547251,6.610347e-7,0.0013945334,0.007848643,0.00014740441],"about_ca_topic_score_codex":0.90167665,"about_ca_topic_score_gemma":0.6620007,"teacher_disagreement_score":0.24439305,"about_ca_system_score_codex":0.0007344741,"about_ca_system_score_gemma":0.0019009102,"threshold_uncertainty_score":0.99676776},"labels":[],"label_agreement":null},{"id":"W4405752074","doi":"10.1016/j.jval.2024.10.1840","title":"HTA15 Oncology Patient and Caregivers’ Perspectives on Value Assessment Frameworks: A Qualitative Study","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa; University of Toronto; Canadian Centre for Applied Research in Cancer Control; University of Calgary","funders":"","keywords":"Value (mathematics); Medicine; Qualitative research; Oncology; Internal medicine; Computer science; Sociology; Social science","score_opus":0.34618724015683344,"score_gpt":0.5178286450618302,"score_spread":0.1716414049049968,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405752074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8873849,0.016636718,0.0016360781,0.085639685,0.0015491801,0.002770268,0.00026547033,0.00011374899,0.004003944],"genre_scores_gemma":[0.99068934,0.00081421674,0.0032484136,0.0046230014,0.00020608741,0.00027182934,0.000010259757,0.00004175334,0.00009508609],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9917859,0.0032548786,0.0031722405,0.0010795875,0.00017228881,0.0005351271],"domain_scores_gemma":[0.9938028,0.0045177964,0.0009437484,0.00042611,0.00004893084,0.00026064942],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.022145566,0.00025509403,0.0011394772,0.0007417415,0.000206947,0.00011627479,0.00016674808,0.00024013282,0.00011828457],"category_scores_gemma":[0.0016014676,0.00030172756,0.00008713802,0.00039930735,0.00010103405,0.00027694256,0.000071377915,0.0009019624,0.00029835757],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018405,0.00049931643,0.00238632,0.00039228977,0.000075215175,0.000010992719,0.58859694,0.001995006,6.730833e-8,0.40261534,0.0026933006,0.0007168216],"study_design_scores_gemma":[0.0009873011,0.0034788367,0.0076834196,0.0006189158,0.0000063963107,0.000006103983,0.89722955,0.025378799,1.7908779e-7,0.04266818,0.021551296,0.0003910517],"about_ca_topic_score_codex":0.015131385,"about_ca_topic_score_gemma":0.00023934757,"teacher_disagreement_score":0.35994714,"about_ca_system_score_codex":0.004792642,"about_ca_system_score_gemma":0.0008865872,"threshold_uncertainty_score":0.9999435},"labels":[],"label_agreement":null},{"id":"W4405752264","doi":"10.1016/j.jval.2024.10.1007","title":"EE727 Determining Survival Impact and Cost-Effectiveness of Multi-Gene Panel Sequencing in Metastatic Colorectal Cancer With Super Learning Approaches","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Colorectal cancer; Oncology; Medicine; DNA sequencing; Internal medicine; Gene; Computational biology; Cancer; Biology; Genetics","score_opus":0.12513240189624802,"score_gpt":0.34467479421995806,"score_spread":0.21954239232371003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405752264","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9912876,0.007155351,0.00094315433,0.000017071414,0.00008800532,0.00043785054,0.000052514653,0.0000056368945,0.000012828566],"genre_scores_gemma":[0.9975153,0.0013655246,0.00091739127,0.000011928364,0.00003309158,0.000084842875,0.000040102594,0.000027418495,0.0000043764508],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988246,0.00028554758,0.00023427904,0.0003147573,0.000078063,0.00026277307],"domain_scores_gemma":[0.9995399,0.00022944972,0.000055344022,0.000082289815,0.000021392272,0.000071631286],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088365725,0.00013754387,0.00026853423,0.0000970932,0.000030310299,0.000021865384,0.0000530367,0.000052746196,0.0000015913694],"category_scores_gemma":[0.000095823096,0.00011869406,0.00003329401,0.0001631499,0.000056809127,0.0000056894582,0.000045669112,0.00015513077,1.7882024e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033305504,0.000050975632,0.27531096,0.0011871824,0.00008796682,0.000038249633,0.0014786823,0.5901907,0.12243114,0.000045662837,0.0000012759642,0.00884415],"study_design_scores_gemma":[0.004662559,0.003202973,0.3012114,0.0023865334,0.000066879846,0.00014651477,0.0023343777,0.5389777,0.14589106,0.0000750138,0.00022361494,0.00082144013],"about_ca_topic_score_codex":0.010200063,"about_ca_topic_score_gemma":0.0016221062,"teacher_disagreement_score":0.05121303,"about_ca_system_score_codex":0.00027397144,"about_ca_system_score_gemma":0.000986156,"threshold_uncertainty_score":0.9963911},"labels":[],"label_agreement":null},{"id":"W4405752305","doi":"10.1016/j.jval.2024.10.944","title":"EE664 Cost-Effectiveness Analysis of IDP-126, a Topical Triple Therapy, for the Treatment of Acne Vulgaris From the Perspective of Canadian Public Payers","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Acne and Rosacea Treatments and Effects","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bausch Health (Canada); Health Canada","funders":"","keywords":"Perspective (graphical); Acne; Medicine; Dermatology; Computer science; Artificial intelligence","score_opus":0.10032830645296655,"score_gpt":0.37493109365823807,"score_spread":0.27460278720527154,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405752305","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9608847,0.019884901,0.00021152849,0.015308771,0.00020862196,0.0029150634,0.00045986322,0.000009010826,0.00011752755],"genre_scores_gemma":[0.9951196,0.0042940853,0.000061589315,0.00014684683,0.000065589295,0.00019320776,0.000052537212,0.000011345109,0.000055213935],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988406,0.00024832605,0.00030535794,0.00021745177,0.00015390702,0.0002344016],"domain_scores_gemma":[0.99774384,0.0016606917,0.00009052892,0.00030162997,0.00009094775,0.00011233962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047455126,0.00012546305,0.0005815754,0.00038435977,0.000088471796,0.000009111796,0.00007881272,0.00006928108,0.000038457434],"category_scores_gemma":[0.00007411741,0.000057206253,0.00030927415,0.0012309914,0.000086155276,0.000024397932,0.000006372358,0.00007712903,4.4220553e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037275467,0.0052687414,0.45460352,0.0010683528,0.03396846,0.00006729142,0.08840814,0.0024830103,0.000635043,0.037828833,0.0018323372,0.37010872],"study_design_scores_gemma":[0.010456187,0.012367006,0.86541605,0.00070603227,0.0036317036,0.000005189458,0.012702445,0.04456093,0.002759796,0.0009729059,0.04617368,0.00024806045],"about_ca_topic_score_codex":0.70848143,"about_ca_topic_score_gemma":0.073199764,"teacher_disagreement_score":0.6352816,"about_ca_system_score_codex":0.00058298133,"about_ca_system_score_gemma":0.0009132652,"threshold_uncertainty_score":0.94371194},"labels":[],"label_agreement":null},{"id":"W4405756564","doi":"10.1016/j.jval.2024.10.970","title":"EE690 The Impact of Caring for an Infant With Respiratory Syncytial Virus on Work-Related Outcomes: Insights From Caregivers Recruited From Canada, Germany, Italy, and Netherlands","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Work (physics); Medicine; Gerontology; Pediatrics; Engineering","score_opus":0.07482004803703257,"score_gpt":0.37787575678429647,"score_spread":0.3030557087472639,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405756564","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9951735,0.0026291055,0.000013133871,0.00031330736,0.00017543249,0.0012369823,0.00019601558,0.000043865282,0.00021862384],"genre_scores_gemma":[0.99934506,0.000045129193,0.000028430775,0.00031036552,0.00009494443,0.000058743004,0.000042219155,0.000044694945,0.000030423425],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99797374,0.00037277868,0.0005012946,0.00041293332,0.0003983132,0.00034091467],"domain_scores_gemma":[0.99803025,0.0010303215,0.00011018516,0.0004838772,0.000082450024,0.0002629095],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004146709,0.00021479568,0.0004839315,0.00041301883,0.00013013785,0.000042964017,0.00012452946,0.00012806251,0.000022097327],"category_scores_gemma":[0.0001652181,0.00012480702,0.00007429878,0.0006230793,0.00011147454,0.00011258774,0.000033936456,0.0005894983,0.0000017086953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043192743,0.00033234648,0.9290469,0.0005326534,0.0013730384,0.00039044116,0.01730827,0.02521499,0.0051610796,0.00029980796,0.0024600571,0.013561112],"study_design_scores_gemma":[0.0032676454,0.004613363,0.97728884,0.0016454924,0.00007414269,0.000004833164,0.00065310573,0.009401505,0.0006539696,0.00018069863,0.0019444961,0.00027193112],"about_ca_topic_score_codex":0.9440755,"about_ca_topic_score_gemma":0.37495884,"teacher_disagreement_score":0.5691167,"about_ca_system_score_codex":0.0011496439,"about_ca_system_score_gemma":0.0029137072,"threshold_uncertainty_score":0.63644654},"labels":[],"label_agreement":null},{"id":"W4405756616","doi":"10.1016/j.jval.2024.10.1071","title":"EE791 Cost-Effectiveness Analysis of 1.5% Ruxolitinib Cream for the Treatment of Patients With Atopic Dermatitis in Canada","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Transgenic Plants and Applications","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Ruxolitinib; Atopic dermatitis; Medicine; Dermatology; Internal medicine","score_opus":0.021303022874412294,"score_gpt":0.28973816829487836,"score_spread":0.2684351454204661,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405756616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963658,0.0011500404,0.0007883297,0.00011915376,0.000023801247,0.0006569946,0.0008844331,0.0000010332483,0.000010446439],"genre_scores_gemma":[0.99895567,0.0005331289,0.00005774297,0.000030712723,0.000006551633,0.00017906408,0.00022826552,0.000004203669,0.0000046663313],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995247,0.000041901294,0.00017128348,0.0001122232,0.000051294628,0.00009858887],"domain_scores_gemma":[0.9996809,0.00012066273,0.00003743612,0.00012116194,0.000018673069,0.000021194215],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000071782655,0.0000504626,0.00014458381,0.000041380972,0.000015093897,0.0000019700956,0.00004487398,0.000018144867,0.0000020924008],"category_scores_gemma":[0.0000037328114,0.000032872194,0.00003587503,0.00019932569,0.000014527632,9.088438e-7,0.0000027853143,0.000015866786,3.5836937e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000085933796,0.0006173812,0.9133482,0.0006313221,0.00078159646,0.0000013043388,0.00046683513,0.046805434,0.0003459514,0.001271147,0.00007061189,0.035574265],"study_design_scores_gemma":[0.0005236001,0.0002654121,0.9851155,0.00004554545,0.000062514766,1.7748005e-7,0.000045110046,0.0030975856,0.0022767899,0.000016256352,0.0085101165,0.000041387288],"about_ca_topic_score_codex":0.6084495,"about_ca_topic_score_gemma":0.636828,"teacher_disagreement_score":0.071767285,"about_ca_system_score_codex":0.00010206833,"about_ca_system_score_gemma":0.000533764,"threshold_uncertainty_score":0.39415783},"labels":[],"label_agreement":null},{"id":"W4405792284","doi":"10.1016/j.jval.2024.10.1010","title":"EE730 Health Care Resource Utilization (HCRU) in Chronic Obstructive Pulmonary Disease (COPD), and Asthma Patients With Moderate-to-Severe Disease","year":2024,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Pulmonary disease; Medicine; COPD; Asthma; Intensive care medicine; Disease; Health care; Physical therapy; Internal medicine; Political science","score_opus":0.026187173430239824,"score_gpt":0.3104954771529877,"score_spread":0.28430830372274785,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405792284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93276095,0.055937182,0.000094643554,0.005244871,0.00015310824,0.004600819,0.0008130473,0.0001509995,0.00024436114],"genre_scores_gemma":[0.99674463,0.00061051565,0.00019957946,0.00076716463,0.00019405826,0.00026691027,0.00090877415,0.00013346624,0.00017489895],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99513215,0.000595177,0.0007358329,0.0013735399,0.0010082743,0.0011550536],"domain_scores_gemma":[0.9967323,0.00015548781,0.00011792309,0.0006589024,0.00017158533,0.002163805],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00039171876,0.0004600089,0.0006381672,0.00085332396,0.00023315591,0.00007956021,0.00017372976,0.00009331285,0.000064973014],"category_scores_gemma":[0.00015196209,0.00042501758,0.00008316706,0.0014406944,0.0001914861,0.00032369996,0.00019667103,0.0006954509,0.000024918087],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.017389465,0.0012988755,0.7676766,0.035594445,0.00007815557,0.0021008581,0.005807345,0.035292786,0.0000029155037,0.0017040909,0.00057923,0.13247521],"study_design_scores_gemma":[0.0022374426,0.0006917366,0.923738,0.0039025682,0.000020617661,0.000013401717,0.00079889817,0.06463627,0.0000010168134,0.00035358747,0.0032540879,0.00035239037],"about_ca_topic_score_codex":0.002135228,"about_ca_topic_score_gemma":0.00022300927,"teacher_disagreement_score":0.15606137,"about_ca_system_score_codex":0.007545969,"about_ca_system_score_gemma":0.0076536685,"threshold_uncertainty_score":0.9998202},"labels":[],"label_agreement":null},{"id":"W4406085563","doi":"10.1016/j.jval.2024.09.001","title":"Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Australian Hand Therapy Association; National University of Singapore; Postgraduate Institute of Medical Education and Research, Chandigarh; Fu Jen Catholic University; Cairo University; Pontificia Universidad Católica de Chile; Radboud Universitair Medisch Centrum; Health Technology Assessment international; Imperial College London; Radboud Universiteit; Taipei Medical University; Wellcome Trust; London School of Hygiene and Tropical Medicine","keywords":"Task force; Guideline; Health technology; Engineering management; Process management; Task (project management); Medicine; Engineering; Health care; Political science; Systems engineering; Public administration","score_opus":0.2951766661112889,"score_gpt":0.5180968313048391,"score_spread":0.22292016519355018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406085563","genre_codex":"commentary","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.026570484,0.0045504933,0.030713648,0.9294425,0.0025691849,0.004058638,0.00035484083,0.000080108905,0.0016600875],"genre_scores_gemma":[0.43008292,0.0044848723,0.48572823,0.0725217,0.001396592,0.0019580093,0.00040368224,0.00013029296,0.0032936886],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9882375,0.0005279124,0.00937941,0.0009378975,0.00020217341,0.0007151173],"domain_scores_gemma":[0.98559827,0.0007473999,0.012515445,0.00079582987,0.0001992634,0.00014379167],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.03699394,0.00026264435,0.0015183121,0.0014499387,0.0004670054,0.000049316004,0.00061479793,0.00026109014,0.000032100324],"category_scores_gemma":[0.0045907996,0.000284224,0.000091771304,0.00090030715,0.00015317611,0.00023686158,0.0002605477,0.0004913625,0.000007214469],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000025395098,0.00041801727,0.14597867,0.0019592647,0.00014836558,0.0000017335503,0.0009905072,0.00047877198,0.0000019100414,0.80960774,0.03182539,0.008564198],"study_design_scores_gemma":[0.002052767,0.00037069162,0.029338652,0.00085491984,0.0000050621366,0.00004797759,0.0044186674,0.009641973,0.000008365044,0.046947442,0.9060252,0.0002882915],"about_ca_topic_score_codex":0.004082589,"about_ca_topic_score_gemma":0.00143721,"teacher_disagreement_score":0.8741998,"about_ca_system_score_codex":0.0035352078,"about_ca_system_score_gemma":0.008378982,"threshold_uncertainty_score":0.999961},"labels":[],"label_agreement":null},{"id":"W4406864915","doi":"10.1016/j.jval.2024.12.009","title":"Rare Disease Policy in High-Income Countries: An Overview of Achievements, Challenges, and Solutions","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Economic and Social Research Council","keywords":"High income countries; Business; Economics; Economic growth; Developing country","score_opus":0.6140998848265642,"score_gpt":0.5021421526689726,"score_spread":0.11195773215759164,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406864915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010517274,0.97679675,0.00001704342,0.016839927,0.0003875111,0.0025045297,0.0031587787,0.000026520662,0.0001637407],"genre_scores_gemma":[0.00018954212,0.9964504,0.00030596353,0.0020492428,0.00023295697,0.00039195968,0.00022801783,0.000049219434,0.0001026891],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9875883,0.0022412895,0.008310027,0.000970259,0.00013353418,0.00075658056],"domain_scores_gemma":[0.9928998,0.001809962,0.003813726,0.0010052924,0.00003600479,0.00043523192],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.020072708,0.00043284858,0.0045953603,0.0022264451,0.00013253262,0.000034652716,0.00046674313,0.00032152588,0.00004999018],"category_scores_gemma":[0.0026872114,0.0005460923,0.00019660978,0.0006739013,0.00009331643,0.0003534152,0.00017725522,0.00043476815,0.0000846117],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005863653,0.00016581205,0.0016122193,0.29221192,0.000039987248,0.000001886733,0.0006629424,0.00009258277,9.972992e-11,0.6804319,0.00022247435,0.024552397],"study_design_scores_gemma":[0.0007900338,0.000116348834,0.011109561,0.07152392,0.000025064639,0.000002095116,0.00013971579,0.00035357446,7.377735e-10,0.026572019,0.88885945,0.000508206],"about_ca_topic_score_codex":0.024901185,"about_ca_topic_score_gemma":0.0015568626,"teacher_disagreement_score":0.888637,"about_ca_system_score_codex":0.0026998066,"about_ca_system_score_gemma":0.004228917,"threshold_uncertainty_score":0.99969906},"labels":[],"label_agreement":null},{"id":"W4406865557","doi":"10.1016/j.jval.2025.01.007","title":"A Comparison of International Modeling Methods for Evaluating Health Economics of Colorectal Cancer Screening: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Data Research UK; Queen's University; University College Dublin; Queen's University Belfast; Department for the Economy; Cancer Focus Northern Ireland","keywords":"Colorectal cancer; Colorectal cancer screening; Medicine; Health economics; Oncology; Cancer; Internal medicine; Pathology; Public health","score_opus":0.36941107484683594,"score_gpt":0.5776860011631733,"score_spread":0.20827492631633732,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406865557","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000018296154,0.9403327,0.05102345,0.00029797855,0.0005039424,0.007665461,0.00010356667,0.000024283068,0.000030338375],"genre_scores_gemma":[0.000073461044,0.9181773,0.07998215,0.00014026387,0.00005921354,0.0014188422,0.00009273117,0.000034902845,0.00002111708],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9937356,0.0013468305,0.003907626,0.00045926406,0.0002449202,0.00030572517],"domain_scores_gemma":[0.9945661,0.0015530381,0.0031607882,0.00030484606,0.00029690884,0.00011836485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0075807665,0.000307636,0.006400765,0.00059104845,0.000056813864,0.0000072506905,0.00021906888,0.00017219862,0.000006007799],"category_scores_gemma":[0.0021343566,0.00027411076,0.00065537076,0.00056570914,0.000024621193,0.000034529006,0.00007063797,0.0004260518,1.8778141e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013440114,0.00004236302,0.000009003734,0.65527284,0.00016551105,4.6329447e-8,0.00012628433,0.004334237,5.649138e-8,0.000034946763,0.00001629629,0.339864],"study_design_scores_gemma":[0.00033635795,0.0010335403,5.5483366e-7,0.610244,0.00059864373,0.000008863471,0.000045722303,0.3861335,0.0000011512456,0.000015590396,0.0014895931,0.00009253486],"about_ca_topic_score_codex":0.003976986,"about_ca_topic_score_gemma":0.00011043699,"teacher_disagreement_score":0.38179925,"about_ca_system_score_codex":0.0014212544,"about_ca_system_score_gemma":0.005488831,"threshold_uncertainty_score":0.9999711},"labels":[],"label_agreement":null},{"id":"W4406865725","doi":"10.1016/j.jval.2025.01.004","title":"Social Return on Investment Analysis: A Mixed Methods Approach to Assessing the Value of Adult Hospice Services","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Palliative Care and End-of-Life Issues","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University College of the North","funders":"Bangor University","keywords":"Value (mathematics); Investment (military); Business; Actuarial science; Statistics; Mathematics; Political science","score_opus":0.1566442049746247,"score_gpt":0.5140601388480527,"score_spread":0.35741593387342796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406865725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9701262,0.0026780257,0.0064055976,0.010825528,0.00018852431,0.0007482576,0.000010172688,0.00002805886,0.008989649],"genre_scores_gemma":[0.8911168,0.00026221905,0.097883575,0.010446865,0.00010456286,0.000053323016,0.000023220578,0.000013013562,0.00009640362],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975265,0.0010484082,0.00059836527,0.00027298048,0.0003150026,0.00023871494],"domain_scores_gemma":[0.9986556,0.00052607426,0.00026193136,0.00031046994,0.00016535287,0.000080564634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017170536,0.0001371589,0.0006797164,0.00038254273,0.00008111631,0.000011403556,0.00016710677,0.00008493468,0.0000017608301],"category_scores_gemma":[0.00032634698,0.00009552734,0.0001513005,0.0018406356,0.000050384122,0.000034713306,0.00005225003,0.00022698544,6.8208044e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00086945324,0.0031037491,0.49750638,0.019453635,0.00493993,0.000011540895,0.2139437,0.024769092,0.0020151604,0.17739937,0.0035291542,0.052458823],"study_design_scores_gemma":[0.003975079,0.001336092,0.7169637,0.012177463,0.002189313,0.0000018000025,0.08088712,0.14399192,0.017740684,0.0073870174,0.012816347,0.0005334599],"about_ca_topic_score_codex":0.007588454,"about_ca_topic_score_gemma":0.00005776096,"teacher_disagreement_score":0.21945733,"about_ca_system_score_codex":0.00021900273,"about_ca_system_score_gemma":0.00035191324,"threshold_uncertainty_score":0.9990201},"labels":[],"label_agreement":null},{"id":"W4407218103","doi":"10.1016/j.jval.2024.12.010","title":"Do Machine Learning Approaches Perform Better Than Regression Models in Mapping Studies? A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Urban Transport and Accessibility","field":"Social Sciences","cited_by":11,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Natural Science Foundation of Tianjin City; Natural Science Foundation of Tianjin-Science and Technology Correspondent Project; National Natural Science Foundation of China","keywords":"Computer science; Machine learning; Regression; Artificial intelligence; Statistics; Mathematics","score_opus":0.33778302718081404,"score_gpt":0.4250146218540537,"score_spread":0.08723159467323965,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407218103","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000047097306,0.99279326,0.000021503414,0.00064048043,0.00020824243,0.0053729345,0.000010153782,0.000058565707,0.0008477779],"genre_scores_gemma":[0.00047542012,0.9980018,0.00019174727,0.00016344282,0.00009624296,0.00059784146,0.000045276345,0.000025550407,0.00040268],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9915342,0.004084803,0.0023587833,0.0007492883,0.0006014636,0.00067148654],"domain_scores_gemma":[0.99731493,0.0008714773,0.0011505288,0.000490459,0.00004710472,0.00012549959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0124248,0.00044720795,0.0044511785,0.00046378613,0.00041734654,0.000055340908,0.0006420018,0.0002857319,0.000015790385],"category_scores_gemma":[0.0008189588,0.00030809286,0.00041730903,0.0016971414,0.000105551335,0.00025756162,0.000102088605,0.0012781537,0.000006614083],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[9.2680125e-7,0.000040949,0.0013426065,0.93091005,0.000030750496,0.0000060853217,0.0046134186,0.000031056145,1.2641212e-10,0.00025227253,0.000018329261,0.06275353],"study_design_scores_gemma":[0.00008403149,0.000013596594,0.000013790147,0.9864487,0.00016590317,5.330449e-7,0.0009421106,0.00063696684,1.2537058e-9,0.0006296966,0.010803611,0.00026105042],"about_ca_topic_score_codex":0.006233547,"about_ca_topic_score_gemma":0.0014662048,"teacher_disagreement_score":0.06249248,"about_ca_system_score_codex":0.0012448152,"about_ca_system_score_gemma":0.0014200505,"threshold_uncertainty_score":0.9999371},"labels":[],"label_agreement":null},{"id":"W4407397530","doi":"10.1016/j.jval.2025.01.019","title":"Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis: An ISPOR Special Interest Group Report","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Open source; Data science; Systematic review; Computer science; Database; MEDLINE; Political science","score_opus":0.6561956353900955,"score_gpt":0.49541310661532884,"score_spread":0.16078252877476668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407397530","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016749316,0.9772429,0.0022988394,0.0076505644,0.0005108713,0.010050538,0.0017998908,0.000027994121,0.00040166106],"genre_scores_gemma":[0.00002875992,0.99031705,0.0012325295,0.0054894686,0.0004132556,0.0009001322,0.0012740393,0.000065554035,0.0002791862],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9730263,0.00538151,0.019199112,0.0015683923,0.00012737846,0.00069730566],"domain_scores_gemma":[0.9760017,0.0026054145,0.018412607,0.002554198,0.00004597592,0.00038012592],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0938065,0.0005982396,0.012792303,0.0018374807,0.00027947442,0.00021833945,0.0016967865,0.00023082684,0.00011098899],"category_scores_gemma":[0.0022786094,0.00055774936,0.0005649593,0.0013003474,0.000085313295,0.0007212861,0.00058953674,0.0006223134,0.000089731],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000028148672,0.00009973352,0.00020644118,0.9524559,0.0006447308,0.000003132252,0.0010471144,0.00045455067,1.2300692e-10,0.03336089,0.007613236,0.0041115033],"study_design_scores_gemma":[0.00053756137,0.00016012625,0.000063863015,0.5312222,0.00073982176,0.000109608445,0.0014963964,0.025045233,6.3959454e-10,0.0024323785,0.43736425,0.0008285541],"about_ca_topic_score_codex":0.021018587,"about_ca_topic_score_gemma":0.0029349308,"teacher_disagreement_score":0.429751,"about_ca_system_score_codex":0.0018418839,"about_ca_system_score_gemma":0.003138319,"threshold_uncertainty_score":0.9996874},"labels":[],"label_agreement":null},{"id":"W4407485191","doi":"10.1016/j.jval.2025.02.001","title":"Statistical Methods for Analyzing EQ-5D in Randomized Clinical Trials: A Systematic Literature Review","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":7,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; Population Health Research Institute; McMaster University; Impact","funders":"EuroQol Research Foundation","keywords":"Randomized controlled trial; Systematic review; EQ-5D; Medicine; Management science; Computer science; Medical physics; Statistics; MEDLINE; Mathematics; Internal medicine; Engineering; Political science","score_opus":0.8564160676064599,"score_gpt":0.6643266082298847,"score_spread":0.1920894593765753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407485191","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.8210932e-8,0.847695,0.11493174,0.0056961165,0.0018648898,0.028359797,0.0012990801,0.00003728521,0.000116041614],"genre_scores_gemma":[1.2547603e-7,0.8982822,0.086618364,0.006352629,0.00043654896,0.0075344183,0.00046459047,0.00007832704,0.00023283783],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.6406783,0.2507461,0.10382052,0.0028744119,0.00023645817,0.0016442572],"domain_scores_gemma":[0.59217864,0.37878132,0.026776316,0.0016188393,0.00014510448,0.0004997678],"candidate_categories":["metaresearch","metaepi_narrow","metaepi_broad"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.7283102,0.000784111,0.05010142,0.0023006895,0.00012639418,0.00016753716,0.0007662341,0.00096088706,0.000079458536],"category_scores_gemma":[0.5629893,0.00073502405,0.0029104187,0.0016642661,0.000101445505,0.00020821119,0.00010612683,0.0014671534,0.00016458724],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014615542,0.00009411156,0.000013252258,0.8609028,0.0002511102,0.0000021358908,0.0001660704,0.000014131317,3.9887642e-11,0.077702336,0.0043005147,0.056407385],"study_design_scores_gemma":[0.011791498,0.000049140242,0.0000015515415,0.727526,0.00032036987,0.000007636788,0.000022006485,0.006288936,2.9920455e-10,0.010910864,0.24265599,0.00042602362],"about_ca_topic_score_codex":0.0007238596,"about_ca_topic_score_gemma":0.000044041626,"teacher_disagreement_score":0.23835547,"about_ca_system_score_codex":0.0023421384,"about_ca_system_score_gemma":0.0036353017,"threshold_uncertainty_score":0.9995101},"labels":[],"label_agreement":null},{"id":"W4408140017","doi":"10.1016/j.jval.2025.02.005","title":"Economic Evaluations of Treatment of Depressive Disorders in Adolescents: A Scoping Review","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Child and Adolescent Psychosocial and Emotional Development","field":"Psychology","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health","funders":"Cundill Centre for Child and Youth Depression","keywords":"Psychology; Medicine; Psychiatry; Psychotherapist; Clinical psychology","score_opus":0.09405248303937447,"score_gpt":0.44107307791381456,"score_spread":0.3470205948744401,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408140017","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00001995944,0.99424404,0.000006306183,0.00025057932,0.0007737433,0.0036916365,0.00008900816,0.0000062213085,0.0009184923],"genre_scores_gemma":[0.00013035563,0.99925727,0.000025543599,0.00008585423,0.000050242463,0.00026023856,0.00008426161,0.000014135922,0.00009211772],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99677384,0.0007172493,0.0017430806,0.00039762154,0.00010569127,0.00026250078],"domain_scores_gemma":[0.9987173,0.00016262796,0.0007740599,0.0002730767,0.000018187573,0.000054757205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000436519,0.00025517365,0.0019066619,0.00038479484,0.000028742113,0.0000025180336,0.00016579941,0.00012701037,0.000104131126],"category_scores_gemma":[0.00003501537,0.00022348388,0.00033744492,0.00036663245,0.000036406203,0.00002060256,0.000025030171,0.0001346331,0.000020765989],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000057717475,0.00052011566,0.0012268616,0.30644017,0.000044033302,3.9612598e-7,0.0002406825,0.000046720208,1.4931575e-9,0.00063186,0.00010868096,0.6907347],"study_design_scores_gemma":[0.00063273567,0.0000979607,0.0026562125,0.96716225,0.000073099116,0.0000010392326,0.000018663774,0.0000023683394,1.4913834e-8,0.00019585571,0.029017618,0.00014219031],"about_ca_topic_score_codex":0.0026603476,"about_ca_topic_score_gemma":0.0008596014,"teacher_disagreement_score":0.6905925,"about_ca_system_score_codex":0.00079218805,"about_ca_system_score_gemma":0.0026920424,"threshold_uncertainty_score":0.9113408},"labels":[],"label_agreement":null},{"id":"W4408914134","doi":"10.1016/j.jval.2025.02.015","title":"When Do Value-Based Contracts Add Value? Insights From Probabilistic Simulations","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; NeuroDevNet; Centre for Advancing Health Outcomes","funders":"","keywords":"Probabilistic logic; Value (mathematics); Computer science; Machine learning; Artificial intelligence","score_opus":0.29582577331247695,"score_gpt":0.4076649677282029,"score_spread":0.11183919441572593,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408914134","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.76971567,0.025961844,0.025856087,0.15382573,0.0043020598,0.0070721908,0.0023602014,0.00039122146,0.010515005],"genre_scores_gemma":[0.9618703,0.00007639325,0.008722152,0.028310806,0.0003086981,0.00017753645,0.00019590375,0.0000505286,0.00028768613],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9903305,0.0015356899,0.006107125,0.0010910501,0.00018578827,0.0007498214],"domain_scores_gemma":[0.9898971,0.0064700237,0.0021134021,0.0010680644,0.00010137285,0.00035009283],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008619384,0.0003486417,0.0015424168,0.0009482626,0.0003752685,0.00015734925,0.0004722286,0.00029645764,0.00040192562],"category_scores_gemma":[0.008114255,0.0004497431,0.00016205634,0.0006079003,0.000109172215,0.00041256298,0.00006377792,0.0004606701,0.0007516958],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000038768536,0.00037090594,0.027937308,0.00073362555,0.000059837435,0.00000207494,0.0023503827,0.33625883,0.0000022510717,0.6233324,0.008701995,0.00021165413],"study_design_scores_gemma":[0.002282354,0.00009871307,0.042657293,0.0008304614,0.000009850567,4.232618e-7,0.00022729074,0.4430269,0.0000041722096,0.45701322,0.053438973,0.00041035246],"about_ca_topic_score_codex":0.03441213,"about_ca_topic_score_gemma":0.0011564685,"teacher_disagreement_score":0.19215463,"about_ca_system_score_codex":0.002464961,"about_ca_system_score_gemma":0.0019067039,"threshold_uncertainty_score":0.99979544},"labels":[],"label_agreement":null},{"id":"W4409374630","doi":"10.1016/j.jval.2025.03.010","title":"Cost-Effectiveness of Enfortumab Vedotin and Pembrolizumab for First-Line Metastatic Urothelial Cancer in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"National Cancer Institute","keywords":"Pembrolizumab; Urothelial cancer; Oncology; Medicine; Metastatic Urothelial Carcinoma; Internal medicine; Cancer; Urothelial carcinoma; Bladder cancer; Immunotherapy","score_opus":0.0888941128100231,"score_gpt":0.40198297474328815,"score_spread":0.313088861933265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409374630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9864439,0.0033317397,0.0009385025,0.003695071,0.00017083515,0.0049530016,0.00035189712,0.000014391984,0.000100693454],"genre_scores_gemma":[0.9958851,0.0020561935,0.00014364392,0.00090492517,0.000022933347,0.0008682154,0.00006497548,0.0000139325,0.000040080482],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874604,0.000297579,0.00037240976,0.00019704476,0.00013522232,0.000251692],"domain_scores_gemma":[0.9986999,0.0009534014,0.00008291785,0.00015697935,0.00005831286,0.00004847498],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083923695,0.00012966564,0.0004123326,0.00026467963,0.000053276664,0.0000069961643,0.00006958649,0.000033788285,0.000010379376],"category_scores_gemma":[0.00011356526,0.00008941838,0.000042009768,0.0004962421,0.000058413076,0.000027600236,0.000015025378,0.00012874232,3.084095e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.049070194,0.006131859,0.510269,0.06777154,0.0013749021,0.00012308941,0.034890156,0.15582152,0.00040080486,0.028662719,0.0010373429,0.14444688],"study_design_scores_gemma":[0.112624705,0.009063341,0.6932807,0.013977225,0.00072739035,0.00005526858,0.003395336,0.11505697,0.0054717446,0.026626062,0.019091196,0.00063008815],"about_ca_topic_score_codex":0.041588884,"about_ca_topic_score_gemma":0.0014657604,"teacher_disagreement_score":0.18301168,"about_ca_system_score_codex":0.00025722853,"about_ca_system_score_gemma":0.0007291536,"threshold_uncertainty_score":0.96479326},"labels":[],"label_agreement":null},{"id":"W4410031582","doi":"10.1016/j.jval.2025.04.2159","title":"Cost-Utility Analysis of Durvalumab and Tremelimumab Versus Best Supportive Care in Refractory Metastatic Colorectal Cancer","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Queen's University; Sunnybrook Health Science Centre; Kingston Health Sciences Centre","funders":"","keywords":"Durvalumab; Tremelimumab; Refractory (planetary science); Colorectal cancer; Medicine; Oncology; Internal medicine; Cancer; Immunotherapy; Nivolumab; Biology","score_opus":0.06745000253906976,"score_gpt":0.3929510278730196,"score_spread":0.32550102533394987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410031582","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97872794,0.019198315,0.000006877808,0.00063463725,0.00020722345,0.00072033465,0.00015242869,0.000008828584,0.00034340308],"genre_scores_gemma":[0.99638575,0.0031766028,0.00009092424,0.00018512875,0.000007986487,0.000060169463,0.00004872314,0.0000069658518,0.000037719747],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842006,0.00026023522,0.00060146215,0.0002863163,0.00018624884,0.00024566214],"domain_scores_gemma":[0.9992155,0.0002799917,0.00016910746,0.0001859637,0.00008153868,0.00006792987],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000616711,0.00012260757,0.0006541423,0.0006319159,0.00003430648,0.0000044998483,0.00005257872,0.0000581878,0.00010128599],"category_scores_gemma":[0.000110262765,0.00011369432,0.00010272122,0.0015242359,0.00012269773,0.00004008479,0.000020345704,0.00018418377,3.4109985e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038247112,0.00081246765,0.71955574,0.0024125224,0.002400138,0.00003927419,0.014776081,0.0006910642,0.0007394915,0.00005809575,0.00012922185,0.22013882],"study_design_scores_gemma":[0.010013263,0.001239498,0.9733811,0.00058816886,0.0006480076,9.4596373e-7,0.00796521,0.004411217,0.0006006305,0.000012916432,0.001025314,0.00011371673],"about_ca_topic_score_codex":0.07168014,"about_ca_topic_score_gemma":0.03449343,"teacher_disagreement_score":0.2538254,"about_ca_system_score_codex":0.00102833,"about_ca_system_score_gemma":0.0013799778,"threshold_uncertainty_score":0.98312455},"labels":[],"label_agreement":null},{"id":"W4410116754","doi":"10.1016/j.jval.2025.01.022","title":"Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Medication Adherence and Compliance","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Amgen (Canada)","funders":"","keywords":"Psychological intervention; Medication adherence; Medicine; Business; Psychology; Nursing","score_opus":0.43223379218892055,"score_gpt":0.4869311639051029,"score_spread":0.05469737171618233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410116754","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000040675664,0.99004316,0.0012034163,0.0012242103,0.0004266276,0.0016927454,0.000014565402,0.000065684064,0.0053255484],"genre_scores_gemma":[0.00011749161,0.9923178,0.0005732675,0.0004020283,0.00013557701,0.00043728497,0.00010425813,0.000019617872,0.0058926754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99707633,0.00044291283,0.0011965493,0.0005845355,0.0003894131,0.00031026037],"domain_scores_gemma":[0.99801815,0.00045850305,0.000610698,0.00063125166,0.00007505593,0.00020631622],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010529243,0.00026235412,0.0013067513,0.0005592737,0.00007798316,0.000013429838,0.00024181788,0.00018653613,0.00057146006],"category_scores_gemma":[0.00095867494,0.00022422874,0.00035583595,0.00078695256,0.00006755522,0.000039005663,0.000034769622,0.0008066031,0.0006127677],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000060895477,0.00028963748,0.000007839241,0.102211766,0.000040314717,0.0000066679595,0.00059252005,0.000002166279,6.4314825e-8,0.0041781436,0.0039581656,0.8887066],"study_design_scores_gemma":[0.00034512737,0.00040736454,0.00006352216,0.46132156,0.00011465738,0.000016610493,0.0014308101,0.0000364069,3.7558e-7,0.0001486682,0.53595114,0.00016378693],"about_ca_topic_score_codex":0.00034780064,"about_ca_topic_score_gemma":0.000020864076,"teacher_disagreement_score":0.88854283,"about_ca_system_score_codex":0.00078193744,"about_ca_system_score_gemma":0.003469623,"threshold_uncertainty_score":0.9143783},"labels":[],"label_agreement":null},{"id":"W4410119251","doi":"10.1016/j.jval.2025.04.2162","title":"Distributional Cost-Effectiveness Analysis in Genomic Medicine: Considerations for Addressing Health Equity","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":5,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; Hospital for Sick Children; Canadian Centre for Applied Research in Cancer Control; Institute for Clinical Evaluative Sciences; SickKids Foundation; Alberta Children's Hospital","funders":"National Human Genome Research Institute; National Institutes of Health; Canada Research Chairs","keywords":"Equity (law); Health equity; Personalized medicine; Health care; Precision medicine; Context (archaeology); Psychological intervention; Business; Medicine; Biology; Economics; Political science; Bioinformatics; Genetics; Economic growth; Nursing","score_opus":0.6557474363198706,"score_gpt":0.5463105303038358,"score_spread":0.10943690601603484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410119251","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19818145,0.024885612,0.28033817,0.47575572,0.0023369628,0.011616938,0.0045357356,0.00013301165,0.002216406],"genre_scores_gemma":[0.980055,0.00028474236,0.0030814386,0.015270357,0.00014976024,0.00074313034,0.00034374086,0.00001819032,0.000053657113],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9912945,0.0016638811,0.005434067,0.0007665487,0.00010285811,0.0007381492],"domain_scores_gemma":[0.9902917,0.0071848184,0.0017862605,0.00044236128,0.00008013063,0.00021474076],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.047445662,0.00020777654,0.001821654,0.0015727811,0.00042724158,0.00005742088,0.00018936464,0.00013656932,0.00013217035],"category_scores_gemma":[0.008143443,0.00027161025,0.00015179932,0.0012401987,0.00011254676,0.00021774047,0.00007041587,0.0002745756,0.0000355167],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035860863,0.00017905327,0.22262344,0.0020022665,0.00014046587,6.340586e-7,0.0012103444,0.06131274,0.0000013993475,0.7052446,0.0067560077,0.00049319223],"study_design_scores_gemma":[0.0029211172,0.00013067188,0.64067596,0.00091374345,0.000016247799,0.0000018140773,0.0006022611,0.12639317,0.0000015698776,0.21949367,0.00855093,0.00029885053],"about_ca_topic_score_codex":0.033218335,"about_ca_topic_score_gemma":0.0044400855,"teacher_disagreement_score":0.7818735,"about_ca_system_score_codex":0.0065396437,"about_ca_system_score_gemma":0.0023892275,"threshold_uncertainty_score":0.9999736},"labels":[],"label_agreement":null},{"id":"W4410197714","doi":"10.1016/j.jval.2024.11.016","title":"Use of Real-World Data to Support Economic Evaluations of Tumor-Agnostic Therapies: Challenges Remain","year":2025,"lang":"en","type":"letter","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"Merck Sharp and Dohme; Merck","keywords":"Real world data; Real world evidence; Computer science; Data science; Medicine; Internal medicine","score_opus":0.28280658269084086,"score_gpt":0.36532573612631436,"score_spread":0.0825191534354735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410197714","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020749273,0.012782966,0.00023708375,0.9155324,0.0032821954,0.0031891218,0.026215255,0.00006333949,0.01794835],"genre_scores_gemma":[0.16691668,0.16801351,0.012213207,0.6304995,0.005468266,0.00047154565,0.0036993586,0.00052288856,0.012195063],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99532276,0.00014322913,0.0027947328,0.0010251283,0.00007556222,0.0006385705],"domain_scores_gemma":[0.9942655,0.0011995633,0.0022255566,0.002136788,0.000058203917,0.000114375296],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0027977321,0.00036733274,0.0019668313,0.0015983173,0.000052469903,0.000037861257,0.0010960653,0.00025190128,0.00026296635],"category_scores_gemma":[0.000776088,0.00047041528,0.00015862545,0.0003363233,0.00013525986,0.0003724665,0.00028594682,0.00069480913,0.00014142743],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005527545,0.00010734222,0.011045567,0.0020394032,0.0001782273,0.000011328705,0.0010964245,0.006180189,3.8445688e-7,0.067007005,0.9065029,0.0057759453],"study_design_scores_gemma":[0.0004177542,0.0003934154,0.023468308,0.00086335826,0.00001759204,0.0000014476982,0.00003857148,0.0017074934,0.0000034307584,0.013361536,0.9592746,0.0004525206],"about_ca_topic_score_codex":0.05836795,"about_ca_topic_score_gemma":0.008039646,"teacher_disagreement_score":0.28503293,"about_ca_system_score_codex":0.0010250483,"about_ca_system_score_gemma":0.0015615574,"threshold_uncertainty_score":0.99977475},"labels":[],"label_agreement":null},{"id":"W4410398465","doi":"10.1016/j.jval.2025.05.001","title":"Evaluation of Health Technology Assessment Frameworks for In Vivo Diagnostics: Assessing Methodological Gaps and Implications for Market Access","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"GE Healthcare","keywords":"Market access; Business; Geography","score_opus":0.7102973243612392,"score_gpt":0.6094041621924942,"score_spread":0.100893162168745,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410398465","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10749084,0.025231052,0.48784506,0.3698073,0.0006607958,0.0077521196,0.0005659528,0.000044650038,0.00060221826],"genre_scores_gemma":[0.7579115,0.004014424,0.22290193,0.010652488,0.00009193021,0.0043175034,0.000046938076,0.000033959663,0.000029305766],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9903112,0.0026277532,0.005599473,0.000764125,0.00011017697,0.0005872666],"domain_scores_gemma":[0.9832964,0.013396918,0.00254545,0.0004428054,0.00023054291,0.00008788288],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.12527287,0.0001612518,0.0013310794,0.0012141165,0.00020627103,0.000062999774,0.00028251513,0.00038171912,0.000030303845],"category_scores_gemma":[0.031537518,0.00020474172,0.00006748409,0.00066444493,0.00008295307,0.00026933622,0.00008073114,0.0003320717,7.6299415e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000015489812,0.00028192432,0.34362385,0.0029347404,0.00003906544,3.2961026e-8,0.0003320855,0.0052228514,0.000002041705,0.6176975,0.006727427,0.023123048],"study_design_scores_gemma":[0.0013871894,0.00014135189,0.31844968,0.0007152405,0.00000830594,7.53532e-7,0.0007068842,0.11315006,0.0000036208196,0.56141055,0.003883634,0.00014275713],"about_ca_topic_score_codex":0.0018567858,"about_ca_topic_score_gemma":0.00035772167,"teacher_disagreement_score":0.65042067,"about_ca_system_score_codex":0.0022655851,"about_ca_system_score_gemma":0.0019910885,"threshold_uncertainty_score":0.97662026},"labels":[],"label_agreement":null},{"id":"W4410629806","doi":"10.1016/j.jval.2025.05.005","title":"Implementing the Generalized Risk-Adjusted Cost-Effectiveness Model for Sickle Cell Disease: A Case Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemoglobinopathies and Related Disorders","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"bluebird bio","keywords":"Life expectancy; Valuation (finance); Medicine; Quality of life (healthcare); Willingness to pay; Disease; Quality-adjusted life year; Value of life; Actuarial science; Disease burden; Gerontology; Environmental health; Cost effectiveness; Risk analysis (engineering); Internal medicine; Business; Economics; Population; Finance; Nursing","score_opus":0.061308718678224995,"score_gpt":0.3704827966689697,"score_spread":0.3091740779907447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410629806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98002315,0.002826278,0.0065147956,0.0016061004,0.00019437479,0.008616778,0.000059477166,0.000055183395,0.000103893646],"genre_scores_gemma":[0.99759245,0.0003052563,0.00031631291,0.0006343157,0.00003345897,0.00076952134,0.000020398793,0.000023917406,0.00030433995],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978601,0.0006116669,0.0004800637,0.00033446646,0.00015509252,0.0005586384],"domain_scores_gemma":[0.9988308,0.0004212878,0.00014390745,0.00036944944,0.0000758511,0.00015869019],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023092574,0.00016283718,0.00035597212,0.00013463464,0.00048662425,0.000017818158,0.00008498457,0.000058590223,0.000006015822],"category_scores_gemma":[0.00018750767,0.00011213307,0.000109117485,0.00042410995,0.000031166248,0.000028484166,0.000070039074,0.0002956915,0.0000015879682],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032201097,0.0054220045,0.3029432,0.0073946267,0.00039966032,0.0014192538,0.015854316,0.6164411,0.00013358243,0.0021309757,0.0026860011,0.04195519],"study_design_scores_gemma":[0.011097617,0.0003113967,0.005331285,0.0002781975,0.00023571716,0.00003114167,0.008396953,0.97230196,0.000031580606,0.0004983162,0.0013544502,0.00013138987],"about_ca_topic_score_codex":0.015588215,"about_ca_topic_score_gemma":0.0005413197,"teacher_disagreement_score":0.3558609,"about_ca_system_score_codex":0.00024056612,"about_ca_system_score_gemma":0.00079911033,"threshold_uncertainty_score":0.9909671},"labels":[],"label_agreement":null},{"id":"W4411196932","doi":"10.1016/j.jval.2025.05.017","title":"Is There a General Preference for the Worse Off? A Discrete Choice Experiment Using Individually Calibrated Health State Valuations","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University","funders":"EuroQol Research Foundation","keywords":"Preference; Discrete choice; Econometrics; Psychology; Statistics; Computer science; Economics; Mathematics","score_opus":0.6147560954283843,"score_gpt":0.49158773971070446,"score_spread":0.12316835571767981,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411196932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5691616,0.049547914,0.08718838,0.2811025,0.0016246134,0.008608863,0.0022038734,0.0001246454,0.0004376037],"genre_scores_gemma":[0.8173447,0.0042207967,0.041500308,0.13019799,0.00062879786,0.0024811858,0.00020395535,0.00015676123,0.0032655075],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99242043,0.0012028175,0.00459143,0.0007702891,0.00015864808,0.00085638097],"domain_scores_gemma":[0.9945868,0.0021085485,0.002232349,0.000761579,0.000079777295,0.00023092821],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.019068489,0.00027721736,0.0010143575,0.00045648287,0.0007118759,0.00015792623,0.00048049656,0.000112090165,0.0001218441],"category_scores_gemma":[0.0013727446,0.00028132604,0.00013600568,0.00067339145,0.00008091745,0.00033646348,0.00009974805,0.0002942789,0.000054165208],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015814134,0.00081277505,0.2269961,0.004708444,0.00065381156,8.822103e-7,0.071323015,0.28526872,0.000009656492,0.3326045,0.070089415,0.007374528],"study_design_scores_gemma":[0.0024098777,0.0002539202,0.07466926,0.0008932937,0.0000104662795,0.0000015693571,0.0021308495,0.79769325,0.000012787835,0.029230207,0.09221222,0.00048231563],"about_ca_topic_score_codex":0.055278253,"about_ca_topic_score_gemma":0.0016376635,"teacher_disagreement_score":0.51242447,"about_ca_system_score_codex":0.0018964281,"about_ca_system_score_gemma":0.0029141621,"threshold_uncertainty_score":0.9999639},"labels":[],"label_agreement":null},{"id":"W4412079466","doi":"10.1016/j.jval.2025.06.015","title":"Strong Preferences or Simplifying Heuristics? Using Internal Validity Tests and Latent Class Analysis to Better Understand Stated Preference Survey Results. A Case Example in Health Preferences Research","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Canadian Institutes of Health Research; Crohn's and Colitis Canada; McMaster University","keywords":"Latent class model; Heuristics; Preference; Class (philosophy); Internal validity; Econometrics; Psychology; Computer science; Data science; Social psychology; Statistics; Machine learning; Artificial intelligence; Mathematics","score_opus":0.7731893391534402,"score_gpt":0.4203014965966582,"score_spread":0.352887842556782,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412079466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99346274,0.00045711777,0.0035213984,0.000660065,0.00011501885,0.0007223351,0.0008476386,0.0000130002045,0.00020068657],"genre_scores_gemma":[0.9971949,0.00080316374,0.0015122803,0.00024218517,0.000015738948,0.000024037765,0.0001007524,0.000012838965,0.00009412527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957363,0.00093825086,0.0016702677,0.0008835359,0.0001060852,0.0006655371],"domain_scores_gemma":[0.99782795,0.0011307074,0.0004558508,0.00034566727,0.00003301267,0.00020680016],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009261741,0.00019868463,0.0006910805,0.0012534544,0.00024128401,0.00015030941,0.00020895115,0.000101639554,0.000038024147],"category_scores_gemma":[0.0005404945,0.00020754784,0.000037162474,0.0013209576,0.0000967634,0.00021130666,0.00020141352,0.0004317062,0.000009254881],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015253879,0.000100848636,0.9384523,0.00017393004,0.000058167283,0.000008669355,0.0017631864,0.057320017,6.392169e-7,0.0008744386,0.00006466083,0.0010305848],"study_design_scores_gemma":[0.0007507727,0.00030103108,0.8790221,0.00019785785,0.000005823656,0.0000032400108,0.000833524,0.11280021,0.0000026882706,0.0058421893,0.00006485541,0.00017568885],"about_ca_topic_score_codex":0.28479573,"about_ca_topic_score_gemma":0.07780329,"teacher_disagreement_score":0.20699245,"about_ca_system_score_codex":0.0017932791,"about_ca_system_score_gemma":0.00027752473,"threshold_uncertainty_score":0.9390244},"labels":[],"label_agreement":null},{"id":"W4412432137","doi":"10.1016/j.jval.2025.04.2113","title":"EE517 Willingness to Pay for a Quality Adjusted Life Year Across Different Time Horizons: Direct Elicitation in Quebec","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Montréal","funders":"","keywords":"Willingness to pay; New horizons; Quality (philosophy); Economics; Actuarial science; Econometrics; Microeconomics; Engineering; Physics","score_opus":0.3376034317907446,"score_gpt":0.4659224696043358,"score_spread":0.12831903781359122,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9113627,0.0013952331,0.0071169836,0.07465188,0.0010306123,0.0032275026,0.0007210344,0.00008059421,0.00041345574],"genre_scores_gemma":[0.9792685,0.0001789618,0.0022531447,0.014783721,0.0002581397,0.0009542396,0.00011422115,0.00004782002,0.002141274],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9919674,0.0010654961,0.0052819913,0.0008041454,0.00010831819,0.00077264657],"domain_scores_gemma":[0.99469805,0.0031162002,0.0012947755,0.00054323475,0.000076639684,0.00027112142],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.022558767,0.00023937869,0.0014770901,0.0005281425,0.00018534133,0.00009124952,0.0002912733,0.00019369347,0.0000384751],"category_scores_gemma":[0.010177322,0.00027325161,0.00012258021,0.00067362,0.000032109252,0.00024876298,0.0000611917,0.00022990898,0.00035013698],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005124441,0.0010998636,0.6658798,0.008134104,0.00012752798,0.0000010817051,0.034565102,0.0297017,0.000015171157,0.23245353,0.020448368,0.007061331],"study_design_scores_gemma":[0.003156969,0.00023425483,0.90338403,0.0011028561,0.0000034665684,1.9511123e-7,0.003311965,0.04096115,0.000008603959,0.013836383,0.033428587,0.0005715167],"about_ca_topic_score_codex":0.16784571,"about_ca_topic_score_gemma":0.036071494,"teacher_disagreement_score":0.23750427,"about_ca_system_score_codex":0.0024116873,"about_ca_system_score_gemma":0.0007269349,"threshold_uncertainty_score":0.999972},"labels":[],"label_agreement":null},{"id":"W4412432185","doi":"10.1016/j.jval.2025.04.2123","title":"EE527 Therapeutic Options for Changing the Course of Disease in Generalized Myasthenia Gravis (gMG) and Fiscal Consequences for the Canadian Governments","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Myasthenia Gravis and Thymoma","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; St. Michael's Hospital; University of Toronto; University Health Network","funders":"","keywords":"Myasthenia gravis; Fiscal year; Course (navigation); Disease; Medicine; Political science; Economics; Intensive care medicine; Immunology; Internal medicine; Law; Engineering","score_opus":0.04487503611104476,"score_gpt":0.3403934950411208,"score_spread":0.29551845893007606,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8632166,0.0093953265,0.0006075816,0.12242341,0.0002485592,0.0037005632,0.00035784388,0.000008935969,0.00004122307],"genre_scores_gemma":[0.99621814,0.00032769726,0.00029624946,0.0025779954,0.00003730038,0.00030763002,0.0000151518325,0.000009999598,0.00020981264],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9989564,0.00010795547,0.00029339019,0.0001613003,0.00011920976,0.00036176384],"domain_scores_gemma":[0.99919367,0.00036336633,0.00007802028,0.00020376827,0.000030369438,0.0001308258],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009917878,0.000098771896,0.00023000337,0.0001190046,0.00028612415,0.000016272168,0.000100214456,0.00003658171,0.000005728008],"category_scores_gemma":[0.00007267209,0.00005746993,0.00006103106,0.00023315342,0.00015292772,0.000018011775,0.00001584337,0.00009511555,1.6725542e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019571797,0.00042901878,0.38781756,0.0019072697,0.00029679792,0.000012443705,0.008902993,0.0018712957,0.00034973994,0.5622121,0.0012264844,0.033017136],"study_design_scores_gemma":[0.012179449,0.0009261405,0.68935686,0.002379994,0.0003610029,0.000017104765,0.0062423027,0.18082196,0.00018670922,0.07006152,0.037082024,0.00038492584],"about_ca_topic_score_codex":0.065738425,"about_ca_topic_score_gemma":0.050944272,"teacher_disagreement_score":0.49215057,"about_ca_system_score_codex":0.00019213896,"about_ca_system_score_gemma":0.0009489945,"threshold_uncertainty_score":0.9663735},"labels":[],"label_agreement":null},{"id":"W4412432201","doi":"10.1016/j.jval.2025.04.1781","title":"SA26 Economic Burden of Hairy Cell Leukemia: A Systematic Review","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Hairy cell leukemia; Leukemia; Medicine; Internal medicine","score_opus":0.07323545756030579,"score_gpt":0.3921173375359674,"score_spread":0.3188818799756616,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432201","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000018305092,0.9852448,0.000004615729,0.0001820535,0.00028397297,0.0109988805,0.00006478428,0.000041030788,0.0031780102],"genre_scores_gemma":[0.0000059111017,0.99524814,0.0001892634,0.00025768878,0.0001775927,0.0006638203,0.00009897666,0.00007934356,0.0032792538],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99260855,0.0014611309,0.0038951624,0.00073289307,0.0005529569,0.00074933266],"domain_scores_gemma":[0.9944498,0.0019893288,0.0013794757,0.0017862102,0.00007422423,0.00032095605],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039191325,0.0005429062,0.009104217,0.00074972847,0.000038410606,0.000011809821,0.00061186583,0.00045232364,0.000098277706],"category_scores_gemma":[0.001045923,0.0004238827,0.00088106096,0.0007452374,0.0000885736,0.000037676207,0.00023835209,0.0009880911,0.0003592116],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000061895544,0.000034269993,1.3693477e-7,0.98454,0.00010780253,0.00007061825,0.000062099556,0.000055525332,8.225126e-9,0.00016258938,0.0024473227,0.012513441],"study_design_scores_gemma":[0.0018103273,0.00014004046,2.7963646e-8,0.8710348,0.0011077654,0.0002327409,0.000019976673,0.001346713,2.3404002e-7,0.000011720011,0.12410292,0.00019270611],"about_ca_topic_score_codex":0.01388706,"about_ca_topic_score_gemma":0.000028039847,"teacher_disagreement_score":0.1216556,"about_ca_system_score_codex":0.09784956,"about_ca_system_score_gemma":0.17345752,"threshold_uncertainty_score":0.9998213},"labels":[],"label_agreement":null},{"id":"W4412432219","doi":"10.1016/j.jval.2025.04.543","title":"EPH12 Estimating Epidemiological Estimates of Rare Diseases in Reimbursement Submissions to Canada's Drug Agency: A Comparison of Approaches in the Absence of Local Real-World Data","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Agency (philosophy); Epidemiology; Drug; Medicine; Actuarial science; Business; Pharmacology; Economic growth; Economics; Pathology; Social science; Sociology; Health care","score_opus":0.6230134319841203,"score_gpt":0.49243528163689504,"score_spread":0.13057815034722525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432219","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92660254,0.005004414,0.007424876,0.05740359,0.00025109138,0.0018527932,0.0010067102,0.000010336642,0.00044364776],"genre_scores_gemma":[0.9832171,0.000073464755,0.015390579,0.001132849,0.000019594872,0.00007355682,0.000075229094,0.0000076069473,0.000009989369],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9915136,0.001264413,0.0061555067,0.00052531954,0.00013883447,0.0004023253],"domain_scores_gemma":[0.9900287,0.0067041595,0.002228544,0.00088663894,0.000028485549,0.0001234732],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.021910084,0.0001508868,0.0015798289,0.00050506985,0.00006021323,0.000006858426,0.0007486593,0.00004587833,0.000012667512],"category_scores_gemma":[0.008699541,0.00014482056,0.000042307496,0.0008796515,0.00012313748,0.00008022882,0.0001778008,0.00022354818,0.0000017022192],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018803486,0.00024576133,0.80246913,0.0015967084,0.000008634811,6.6529526e-7,0.0024213316,0.15286683,1.6847622e-7,0.035981745,0.0030605725,0.0013296405],"study_design_scores_gemma":[0.00020624886,0.000036596353,0.5851723,0.0009995205,0.00000187386,1.397522e-7,0.003392981,0.40298524,0.000002250953,0.0069466587,0.00017556653,0.000080647646],"about_ca_topic_score_codex":0.8779966,"about_ca_topic_score_gemma":0.6264713,"teacher_disagreement_score":0.25152534,"about_ca_system_score_codex":0.0007769911,"about_ca_system_score_gemma":0.0015605735,"threshold_uncertainty_score":0.9996506},"labels":[],"label_agreement":null},{"id":"W4412432233","doi":"10.1016/j.jval.2025.04.1205","title":"MSR53 Development and Validation of an LLM-Based Study Selection Tool for Automating Systematic Literature Reviews: Achieving Time Efficiency and Maintaining Gold Standard Accuracy","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Impact of AI and Big Data on Business and Society","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Selection (genetic algorithm); Gold standard (test); Systematic review; Computer science; Systematic error; Machine learning; Statistics; MEDLINE; Mathematics; Chemistry","score_opus":0.08687134925101475,"score_gpt":0.4070922405465321,"score_spread":0.32022089129551734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432233","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9749718,0.0015758068,0.02108077,0.00025049315,0.00007841599,0.001995998,0.00001843156,0.000021184514,0.000007118705],"genre_scores_gemma":[0.98582655,0.000042059255,0.013850448,0.00016625704,0.000015729896,0.000053131134,0.000016363389,0.000005565165,0.00002392295],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99693406,0.0007670535,0.0012838602,0.00034642775,0.00045902483,0.0002095627],"domain_scores_gemma":[0.99736553,0.0015511236,0.00059356133,0.00020767582,0.00022720543,0.000054879416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016325904,0.00013580311,0.00059786387,0.0002845571,0.00030491035,0.00036446963,0.00016116524,0.00005883123,0.0000021242113],"category_scores_gemma":[0.00530634,0.00009434145,0.000035587822,0.001023494,0.000017515085,0.00044701577,0.000047160527,0.000102964135,4.7174822e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077256083,0.0027967917,0.1980174,0.16923903,0.0001469783,0.000007311379,0.14459507,0.024325406,0.0013571909,0.0040935026,0.0007885503,0.4538602],"study_design_scores_gemma":[0.00552337,0.003102767,0.12229655,0.08570806,0.000093620634,0.0000124988455,0.018540682,0.7608631,0.0007455834,0.0015474072,0.0007494213,0.00081692915],"about_ca_topic_score_codex":0.000041716088,"about_ca_topic_score_gemma":0.000004728974,"teacher_disagreement_score":0.7365377,"about_ca_system_score_codex":0.0001300214,"about_ca_system_score_gemma":0.00045032642,"threshold_uncertainty_score":0.63525677},"labels":[],"label_agreement":null},{"id":"W4412432271","doi":"10.1016/j.jval.2025.04.1240","title":"MSR88 Key Considerations in the Use of Large Language Models for Data Extraction in Health Economics and Outcomes Research","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Disease Management Strategies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Key (lock); Data extraction; Data science; Outcomes research; Computer science; Econometrics; Economics; MEDLINE; Medicine; Political science; Alternative medicine; Computer security","score_opus":0.44093672674516715,"score_gpt":0.5246048573887429,"score_spread":0.0836681306435757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8725905,0.004305252,0.0011564487,0.11575957,0.00014308468,0.0048644026,0.0003676192,0.000021532325,0.00079163455],"genre_scores_gemma":[0.9933075,0.0022530605,0.0018263735,0.0022589408,0.000015221656,0.00006461004,0.00014326132,0.00000760737,0.00012342488],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9984766,0.0003814445,0.0005122438,0.00024125766,0.00010744932,0.0002809865],"domain_scores_gemma":[0.99792385,0.0014204078,0.00008197245,0.000509812,0.000023474202,0.000040482177],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035304057,0.00006573381,0.00025446905,0.00040966517,0.00006640088,0.000033631364,0.00009020492,0.00003238813,0.000005094355],"category_scores_gemma":[0.0005730521,0.000055661614,0.000014982483,0.00022173533,0.000044190525,0.00023999094,0.00008479242,0.00020402452,3.749315e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002858409,0.001587407,0.057853214,0.00801129,0.00006193157,0.000024472474,0.01430366,0.055656422,0.000007143706,0.83668965,0.019416085,0.006102879],"study_design_scores_gemma":[0.0050681722,0.00021120081,0.1318441,0.0009764516,0.000012444922,0.0000032830083,0.013508977,0.8091575,0.0000029867108,0.02948036,0.009635548,0.00009900043],"about_ca_topic_score_codex":0.026521804,"about_ca_topic_score_gemma":0.018952334,"teacher_disagreement_score":0.8072093,"about_ca_system_score_codex":0.0002987898,"about_ca_system_score_gemma":0.0011596218,"threshold_uncertainty_score":0.9989492},"labels":[],"label_agreement":null},{"id":"W4412432466","doi":"10.1016/j.jval.2025.04.1792","title":"SA37 Reporting Standards in Predictive Modeling of Cancer Outcomes: An Umbrella Review of Adherence to the TRIPOD SR MA Reporting Guideline","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Tripod (photography); Guideline; Medicine; Engineering; Pathology; Mechanical engineering","score_opus":0.1648007782186044,"score_gpt":0.419078703277567,"score_spread":0.25427792505896263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7182841,0.23360015,0.018790357,0.014414694,0.0014496925,0.0025635574,0.000887946,0.000035311623,0.009974186],"genre_scores_gemma":[0.9599449,0.03482638,0.0019238495,0.0029948798,0.000066548455,0.000082461156,0.0000074672053,0.000021265427,0.00013222476],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98882616,0.00007002689,0.010130534,0.00048382668,0.00009626448,0.00039320145],"domain_scores_gemma":[0.9903454,0.0000958403,0.008668747,0.0005731242,0.0002308217,0.00008607103],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.015415392,0.00016973948,0.0014105327,0.00032589084,0.000056668687,0.000013206561,0.0002955695,0.00008658958,0.000048523758],"category_scores_gemma":[0.009977212,0.00015868124,0.0001391401,0.0006945303,0.000034588145,0.00017228253,0.00008297883,0.00026703317,0.0000013626101],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001263429,0.00014160432,0.60679084,0.006247775,0.00005678623,0.000005627317,0.0020135008,0.33414862,0.0000031557236,0.012778197,0.0018064593,0.035881072],"study_design_scores_gemma":[0.003119148,0.0012495525,0.17570572,0.062762015,0.000042215357,0.000007384347,0.001477998,0.67856944,0.000096488366,0.03857284,0.037392385,0.0010048457],"about_ca_topic_score_codex":0.06318074,"about_ca_topic_score_gemma":0.0026429114,"teacher_disagreement_score":0.43108517,"about_ca_system_score_codex":0.0008317699,"about_ca_system_score_gemma":0.0012581544,"threshold_uncertainty_score":0.9983622},"labels":[],"label_agreement":null},{"id":"W4412432566","doi":"10.1016/j.jval.2025.04.1759","title":"SA3 Methodologic Considerations to Guide Clinician Interpretation and Assessment of Network Meta-Analyses in Psoriasis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Delphi Technique in Research","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University; EVERSANA (Canada); Canadian Orthopaedic Trauma Society; McMaster University; Novartis (Canada); Probity Medical Research","funders":"","keywords":"Interpretation (philosophy); Psoriasis; Computer science; Data science; Medicine; Dermatology; Programming language","score_opus":0.7516441895489605,"score_gpt":0.6805254455457066,"score_spread":0.07111874400325391,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412432566","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19637908,0.013276386,0.2647034,0.3839637,0.0020863572,0.011199195,0.00005994035,0.0003432263,0.12798873],"genre_scores_gemma":[0.74668014,0.00047700576,0.25108737,0.0014959865,0.000026823072,0.000116598734,0.0000010624148,0.0000037781585,0.00011123887],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9921625,0.005964154,0.00096376747,0.00027673948,0.00032192515,0.0003108601],"domain_scores_gemma":[0.99259853,0.006818199,0.00017315216,0.0002031636,0.00012763373,0.000079316036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019096795,0.00007722766,0.000530514,0.00046502845,0.00014390332,0.000039063147,0.00015355198,0.00008696366,0.000058330017],"category_scores_gemma":[0.007819795,0.0000705948,0.000074172436,0.001217908,0.00012181046,0.000076914905,0.00008287986,0.00023375463,7.909921e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005818766,0.00027949698,0.082398385,0.0002783887,0.00056962157,0.000012264246,0.017945923,0.14029598,0.00011645202,0.6947268,0.01674789,0.046570618],"study_design_scores_gemma":[0.00069957244,0.0005667983,0.14701246,0.00065233064,0.00037605508,0.0000010037655,0.01724673,0.040426783,0.00018841065,0.7768587,0.015582582,0.0003885725],"about_ca_topic_score_codex":0.07289795,"about_ca_topic_score_gemma":0.029548611,"teacher_disagreement_score":0.5503011,"about_ca_system_score_codex":0.00035757583,"about_ca_system_score_gemma":0.0013499197,"threshold_uncertainty_score":0.9881596},"labels":[],"label_agreement":null},{"id":"W4412442563","doi":"10.1016/j.jval.2025.04.1021","title":"HTA10 Patient Voice in Rare Disease Health Technology Assessments: Recent Trends in the Use of Qualitative Research in Reimbursement Submissions to Canada's Drug Agency","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Agency (philosophy); Medicine; Qualitative research; Family medicine; Business; Health care; Economic growth; Economics; Sociology; Social science","score_opus":0.7376645871629269,"score_gpt":0.5926684626600632,"score_spread":0.1449961245028637,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442563","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5102833,0.0038172258,0.00006623804,0.48274308,0.00032410718,0.0020979117,0.00043497144,0.000009187376,0.00022401013],"genre_scores_gemma":[0.9765755,0.0014099079,0.0015076308,0.019321313,0.00002266725,0.00085317343,0.00007750001,0.0000221716,0.00021011772],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98202777,0.00857849,0.006956141,0.0009085261,0.00038328816,0.0011457996],"domain_scores_gemma":[0.9942533,0.003252104,0.0012171828,0.0008692366,0.00010708303,0.00030113108],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.044861596,0.00020085576,0.0010648327,0.004206764,0.00016418757,0.000030754672,0.0005073793,0.00009870798,0.000043960044],"category_scores_gemma":[0.0054657604,0.00022089892,0.00004424538,0.004753043,0.00006907665,0.00015679694,0.00014568756,0.0007667617,0.000013094119],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00025203545,0.0026121568,0.5217473,0.00294399,0.000036876452,0.000032263353,0.13852352,0.03593149,4.3680845e-7,0.16323844,0.100612074,0.03406945],"study_design_scores_gemma":[0.0020501323,0.00047702572,0.687444,0.0035389485,0.0000015929055,6.388893e-7,0.07786847,0.009060318,0.0000012402713,0.02760243,0.19152889,0.0004263226],"about_ca_topic_score_codex":0.9061074,"about_ca_topic_score_gemma":0.8300409,"teacher_disagreement_score":0.46629226,"about_ca_system_score_codex":0.0104216905,"about_ca_system_score_gemma":0.006076858,"threshold_uncertainty_score":0.9995578},"labels":[],"label_agreement":null},{"id":"W4412442574","doi":"10.1016/j.jval.2025.04.1023","title":"HTA12 Navigating Uncertainty in Overall Survival Data: Insights from Positive Canadian HTAs on Lung Cancer Therapies","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Lung cancer; Oncology; Medicine; Internal medicine; Data science; Computer science","score_opus":0.03571097321427342,"score_gpt":0.3928041791517588,"score_spread":0.3570932059374854,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442574","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9687165,0.008747521,0.000008707952,0.018030701,0.00064276904,0.0008899961,0.00072201225,0.000021817053,0.002219949],"genre_scores_gemma":[0.9929377,0.0005868157,0.0001456932,0.0051801368,0.00012736965,0.000062247884,0.00081245555,0.000014260717,0.00013330893],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986688,0.00017331833,0.00031133625,0.00037287356,0.00015784151,0.0003158113],"domain_scores_gemma":[0.99913764,0.00024972938,0.00006720943,0.0003463363,0.00003908866,0.00015999241],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00016317055,0.00013944467,0.00030506664,0.00017075025,0.00012161031,0.000019879344,0.000108964865,0.00006505631,0.000029839095],"category_scores_gemma":[0.000048395996,0.0001180641,0.000022968008,0.00032861458,0.000026658478,0.00008997288,0.000026331165,0.00031803775,0.0000026432067],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00073956454,0.0006283627,0.86120886,0.00051909016,0.0008617879,0.0003152408,0.044985246,0.031476993,0.000077922305,0.020350207,0.0053344257,0.033502318],"study_design_scores_gemma":[0.009057483,0.0002681659,0.93445617,0.00960862,0.00011765592,0.0000013532762,0.0025366761,0.033676226,0.000053012503,0.0022742553,0.007630661,0.00031973235],"about_ca_topic_score_codex":0.9748042,"about_ca_topic_score_gemma":0.7461914,"teacher_disagreement_score":0.22861287,"about_ca_system_score_codex":0.0028745926,"about_ca_system_score_gemma":0.003455835,"threshold_uncertainty_score":0.75169593},"labels":[],"label_agreement":null},{"id":"W4412442577","doi":"10.1016/j.jval.2025.04.1054","title":"HTA43 Assessing the Added Value of Fixed-Dose Combinations in Non-Communicable Diseases: A Comparative HTA Analysis Across Canada, Scotland, France, and Germany (2014-2024)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Value (mathematics); Medicine; Regional science; Geography; Statistics; Mathematics","score_opus":0.16059038748122936,"score_gpt":0.44281843525064984,"score_spread":0.28222804776942045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442577","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9618773,0.010281106,0.00094938895,0.023248388,0.0004079796,0.0011688431,0.00087142334,0.0000123810005,0.0011832105],"genre_scores_gemma":[0.9942186,0.0004694321,0.00053708727,0.0041937213,0.000026158477,0.00012600565,0.00005567185,0.000012660012,0.00036066966],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9938793,0.0012418508,0.0037305814,0.00048641532,0.0001306558,0.000531189],"domain_scores_gemma":[0.99410105,0.0031929477,0.0016760165,0.00080608204,0.00007096935,0.00015292068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011131086,0.00019910646,0.0016335569,0.0005140397,0.00041586725,0.00009805828,0.00045036807,0.00008171332,0.000049068778],"category_scores_gemma":[0.00085495383,0.00021724866,0.00009957391,0.001564486,0.00016100626,0.00031585013,0.00013964096,0.00037761047,0.00001378854],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010464593,0.00024819552,0.92463064,0.00073955895,0.00018622745,9.623444e-7,0.005622518,0.039994795,3.457006e-7,0.02165668,0.0068210023,0.00008862075],"study_design_scores_gemma":[0.0011383574,0.000020711772,0.7733433,0.00026990255,0.000016614755,3.9773332e-7,0.0034067798,0.21556939,6.952124e-7,0.0027538042,0.003327894,0.00015210742],"about_ca_topic_score_codex":0.81613827,"about_ca_topic_score_gemma":0.47877106,"teacher_disagreement_score":0.33736718,"about_ca_system_score_codex":0.0010487768,"about_ca_system_score_gemma":0.0014080708,"threshold_uncertainty_score":0.8859143},"labels":[],"label_agreement":null},{"id":"W4412442605","doi":"10.1016/j.jval.2025.04.1188","title":"MSR36 Methods for Handling Non-Proportional Hazards in Economic Modeling","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Forecasting Techniques and Applications","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Computer science; Econometrics; Environmental science; Economics","score_opus":0.2781657839513743,"score_gpt":0.5524978219188288,"score_spread":0.2743320379674545,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442605","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.088118255,0.0001771116,0.90569615,0.0045148334,0.00021201787,0.00058851036,0.000013238562,0.00003300152,0.0006468661],"genre_scores_gemma":[0.46259955,0.000030590614,0.536729,0.0002814838,0.00003681195,0.00017867278,0.000004171739,0.0000063362186,0.00013339345],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9980369,0.00014630676,0.0010165797,0.00040407013,0.00013753575,0.00025857953],"domain_scores_gemma":[0.9983007,0.0010948533,0.00016754192,0.00031996163,0.0000662711,0.000050698465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.010338372,0.00008136777,0.00026758303,0.00047458606,0.00013311225,0.00006222499,0.00035421265,0.00006400349,0.00001617674],"category_scores_gemma":[0.0009289716,0.00007326271,0.00006842684,0.00048520492,0.000024744539,0.00008256166,0.000074800475,0.0001395395,0.000008030685],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021309226,0.000045191126,0.0024591149,0.0000368113,0.0000022513198,1.8729156e-7,0.0001850366,0.7045025,0.0000362293,0.07641799,0.0014315745,0.21486175],"study_design_scores_gemma":[0.00013647407,0.00001791089,0.00021713827,0.00006823546,5.411991e-7,4.8103414e-7,0.00005008109,0.6878486,0.000063319596,0.3085114,0.0030435591,0.00004223845],"about_ca_topic_score_codex":0.0029618782,"about_ca_topic_score_gemma":0.00021079418,"teacher_disagreement_score":0.3744813,"about_ca_system_score_codex":0.00029453548,"about_ca_system_score_gemma":0.0008024405,"threshold_uncertainty_score":0.44774935},"labels":[],"label_agreement":null},{"id":"W4412442610","doi":"10.1016/j.jval.2025.04.1514","title":"PCR197 Impact of Cirrhosis on Health-Related Quality of Life and Activity Among Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Steatohepatitis; Cirrhosis; Medicine; Quality of life (healthcare); Gerontology; Environmental health; Fatty liver; Internal medicine; Disease; Nursing","score_opus":0.01460210440658291,"score_gpt":0.27602931189764907,"score_spread":0.2614272074910662,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442610","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9962209,0.0018583834,5.415206e-7,0.0006201172,0.00005258399,0.0008983786,0.00029493534,0.00000741855,0.000046763816],"genre_scores_gemma":[0.9987981,0.000873132,0.0000064701107,0.000228368,0.000002659471,0.000031569063,0.00004066231,0.000009114012,0.000009932725],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99826163,0.000374918,0.00060082297,0.0002521792,0.00027468015,0.00023579145],"domain_scores_gemma":[0.99879205,0.00030395898,0.00042085082,0.00017724413,0.000080410435,0.00022545783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037836924,0.00015009925,0.0008337062,0.00021203067,0.00004586598,0.000003771434,0.000026500255,0.000057832753,0.000008185429],"category_scores_gemma":[0.00014675363,0.00011805995,0.000043906664,0.00042070274,0.000054265864,0.00005913155,0.000017943748,0.0001457794,8.115377e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026382142,0.0012251653,0.99526274,0.00051750435,0.0002799661,0.0000022480208,0.00026528258,0.00018607633,7.946144e-7,0.000045911656,0.0000963397,0.0018541187],"study_design_scores_gemma":[0.0056020897,0.0008034832,0.99226654,0.00086331356,0.000033639135,9.1971515e-8,0.000035418125,0.00029353704,0.000010466087,0.000020156725,0.0000032083396,0.000068073925],"about_ca_topic_score_codex":0.9827734,"about_ca_topic_score_gemma":0.4983373,"teacher_disagreement_score":0.4844361,"about_ca_system_score_codex":0.00061982294,"about_ca_system_score_gemma":0.0019453884,"threshold_uncertainty_score":0.51081675},"labels":[],"label_agreement":null},{"id":"W4412442635","doi":"10.1016/j.jval.2025.04.1025","title":"HTA14 Empowering Healthcare Decision-Making: Leveraging Standardized Template for Enhanced Reliability and Efficiency in Budget Impact Analysis by Health Technology Assessment Agency","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux","funders":"","keywords":"Agency (philosophy); Reliability (semiconductor); Health care; Regulatory agency; Business; Risk analysis (engineering); Economics; Public administration; Political science; Economic growth","score_opus":0.14081713913385924,"score_gpt":0.48929138768468206,"score_spread":0.3484742485508228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442635","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6773108,0.010010622,0.24770845,0.061376933,0.00038263272,0.002442714,0.00060040934,0.000071502785,0.00009594199],"genre_scores_gemma":[0.9731943,0.0011463818,0.021621665,0.0036249608,0.000025655558,0.0002932091,0.00004278083,0.000029996645,0.000021037258],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9895642,0.0009135893,0.0068492484,0.0013717877,0.00016510746,0.0011361141],"domain_scores_gemma":[0.99349856,0.0029253159,0.002380912,0.0008324179,0.00010444893,0.00025834178],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.03992422,0.00033689704,0.0024784063,0.002825332,0.00044471188,0.00008482103,0.00035182686,0.00025054568,0.00003506916],"category_scores_gemma":[0.004455628,0.00041478162,0.00020878026,0.0026498483,0.00008363257,0.00026304132,0.000115692135,0.0004957623,0.0000062660915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002449428,0.0005602038,0.8381786,0.0050404626,0.00026678355,0.000001994241,0.008382692,0.09797738,0.000009340024,0.029533854,0.003183568,0.016620217],"study_design_scores_gemma":[0.0072584325,0.0013224384,0.44696403,0.0034442507,0.000027031854,0.0000043159603,0.0050889216,0.34631655,0.0000136528615,0.18024887,0.008050078,0.0012614434],"about_ca_topic_score_codex":0.017142618,"about_ca_topic_score_gemma":0.0012936506,"teacher_disagreement_score":0.39121455,"about_ca_system_score_codex":0.006945374,"about_ca_system_score_gemma":0.0023914247,"threshold_uncertainty_score":0.9998304},"labels":[],"label_agreement":null},{"id":"W4412442771","doi":"10.1016/j.jval.2025.04.1044","title":"HTA33 Streamlined Success or Missed Opportunity: Evaluating the Impact of Simplified Economic Approaches on HTA Recommendations Across CDA-AMC, INESSS and NICE","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Innovation Policy and R&D","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Nice; Risk analysis (engineering); Computer science; Medicine","score_opus":0.44728133773571593,"score_gpt":0.4502847403448255,"score_spread":0.0030034026091095845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442771","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9761056,0.00021623936,0.00018889736,0.018667322,0.0002341727,0.0005304599,0.00056911324,0.00001804499,0.003470169],"genre_scores_gemma":[0.9977422,0.00022612161,0.00023444934,0.0011763729,0.000058805104,0.00004084023,0.00006854884,0.000014698437,0.00043798093],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9979629,0.00013754041,0.0012009504,0.0003347702,0.000029905752,0.00033395542],"domain_scores_gemma":[0.99808395,0.000700728,0.00071700895,0.00039411878,0.000033607197,0.00007057962],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0033432099,0.00015838926,0.00044897923,0.0003071032,0.00028580785,0.00006316005,0.0002380205,0.00009723036,0.00010037885],"category_scores_gemma":[0.00064055005,0.00012640457,0.00006605701,0.0005334152,0.000078884215,0.00014765232,0.00007322798,0.00023744396,0.000009691273],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008102998,0.00059413706,0.09321634,0.0006912666,0.00025756808,9.580367e-7,0.006472693,0.07825369,0.000016872556,0.7824777,0.0039518164,0.033256676],"study_design_scores_gemma":[0.005551452,0.0015804917,0.25490463,0.0004927986,0.000014318775,0.000007385184,0.0029771305,0.62125564,0.00015622891,0.108319454,0.0040290277,0.00071141834],"about_ca_topic_score_codex":0.016871078,"about_ca_topic_score_gemma":0.0002416364,"teacher_disagreement_score":0.6741582,"about_ca_system_score_codex":0.00032276553,"about_ca_system_score_gemma":0.0005892274,"threshold_uncertainty_score":0.98967564},"labels":[],"label_agreement":null},{"id":"W4412442816","doi":"10.1016/j.jval.2025.04.398","title":"EE106 Pressures Behind the Rising Costs in Canadian Private Drug Plans: 2018-2023","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Government of Canada","funders":"","keywords":"Business; Drug; Natural resource economics; Economics; Pharmacology; Medicine","score_opus":0.06595050093101903,"score_gpt":0.3183061291014316,"score_spread":0.25235562817041257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84819394,0.017450655,0.000025717662,0.07034803,0.0014970271,0.0009510188,0.00086666626,0.000022618646,0.06064432],"genre_scores_gemma":[0.98809546,0.002024798,0.000043243646,0.009156379,0.000085137166,0.000026404163,0.000010346457,0.000014185772,0.0005440698],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981485,0.00007648238,0.0007600732,0.0003176639,0.00002029285,0.0006769711],"domain_scores_gemma":[0.9990987,0.0002216192,0.00016106619,0.00030425529,0.000005406655,0.00020891787],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019246637,0.00012592379,0.00033144467,0.0005332626,0.00013915279,0.00007859457,0.00034717596,0.00007708671,0.00007414432],"category_scores_gemma":[0.00014970049,0.0001311114,0.000045161407,0.0003020814,0.000047955487,0.000100979196,0.000057180623,0.00037471933,0.00016277225],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000019429137,0.00006072171,0.34461164,0.00014487951,0.000028787943,0.000006896751,0.0016733928,0.011122774,8.874886e-7,0.6216325,0.018390294,0.00230775],"study_design_scores_gemma":[0.00065519335,0.000014852546,0.18787163,0.00014696139,0.0000016783725,0.0000010987709,0.000056062345,0.05955341,0.000011085491,0.06462779,0.6868588,0.00020145622],"about_ca_topic_score_codex":0.8734664,"about_ca_topic_score_gemma":0.546375,"teacher_disagreement_score":0.6684685,"about_ca_system_score_codex":0.00096451456,"about_ca_system_score_gemma":0.00041511818,"threshold_uncertainty_score":0.53465676},"labels":[],"label_agreement":null},{"id":"W4412442819","doi":"10.1016/j.jval.2025.04.1395","title":"PCR74 Utility of Mobile Health Applications, Wearable Devices, and Patient Generated Health Data in Menopause Research","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Mobile Health and mHealth Applications","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Wearable computer; Menopause; Wearable technology; Computer science; Data science; Medicine; Embedded system; Internal medicine","score_opus":0.21026169906963751,"score_gpt":0.5201982472269892,"score_spread":0.3099365481573516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442819","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2611901,0.44427785,0.003687376,0.12228,0.0014607189,0.15827149,0.0033728492,0.0005384537,0.004921156],"genre_scores_gemma":[0.84670615,0.07408114,0.00688871,0.016532414,0.00012543515,0.0545863,0.0007196386,0.00007163968,0.0002885541],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98366266,0.007342096,0.004451639,0.0014653405,0.00070159417,0.0023766363],"domain_scores_gemma":[0.9929238,0.0019882128,0.0011749873,0.0025237722,0.00037888135,0.0010103623],"candidate_categories":["metaepi_narrow","sts"],"consensus_categories":[],"category_scores_codex":[0.019049784,0.00030251805,0.0012430795,0.0011686508,0.0016666722,0.00001493203,0.0007827833,0.00029343204,0.000077551194],"category_scores_gemma":[0.00043343633,0.00031269056,0.000026210755,0.0036828127,0.00021783408,0.000188442,0.00070129364,0.0021121008,0.00003885538],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033679203,0.002341881,0.1594198,0.034822598,0.000023695728,0.0000018518851,0.0057879305,0.0005183067,0.000019075007,0.032186624,0.06285095,0.7016905],"study_design_scores_gemma":[0.002522712,0.0009590074,0.05361563,0.0040578786,0.000003490511,0.0000019824909,0.0066322517,0.0149698155,0.000007462149,0.0034611903,0.9135141,0.00025448753],"about_ca_topic_score_codex":0.1845263,"about_ca_topic_score_gemma":0.024034154,"teacher_disagreement_score":0.8506631,"about_ca_system_score_codex":0.0016199449,"about_ca_system_score_gemma":0.018831538,"threshold_uncertainty_score":0.9999325},"labels":[],"label_agreement":null},{"id":"W4412442827","doi":"10.1016/j.jval.2025.04.424","title":"EE132 Creation of a Novel Canadian Policy Model for Bladder Cancer","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre; University of British Columbia; University of Waterloo; Princess Margaret Cancer Centre","funders":"","keywords":"Bladder cancer; Computer science; Business; Cancer; Medicine; Internal medicine","score_opus":0.0708554990239001,"score_gpt":0.3963069757825291,"score_spread":0.325451476758629,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442827","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.51646894,0.014912902,0.07357918,0.3071191,0.0016138903,0.015186525,0.0044679893,0.00017077052,0.06648072],"genre_scores_gemma":[0.98915875,0.00033143393,0.0023231755,0.005103795,0.00008970917,0.00019282664,0.000024463225,0.000013761237,0.0027620988],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9992369,0.000013611174,0.00025234642,0.00015301057,0.000083745654,0.0002604236],"domain_scores_gemma":[0.99955744,0.000031927477,0.00004999358,0.00014482325,0.0000695266,0.00014628847],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012860638,0.00007929185,0.00022694633,0.00034948712,0.00004393335,0.0000030484787,0.000039832805,0.00005759546,0.000014030585],"category_scores_gemma":[0.000054764663,0.00007360315,0.000043786433,0.00030162826,0.000020525118,0.00002360247,0.000005326994,0.000060884326,5.8311554e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024957831,0.0028822916,0.20322847,0.00875464,0.0010221887,0.000008578996,0.01889161,0.375995,0.0017980798,0.184633,0.029861303,0.17042904],"study_design_scores_gemma":[0.010220362,0.00046378715,0.04239578,0.001341014,0.000106155945,0.0000033391318,0.00016218013,0.93139106,0.0007560942,0.0041373945,0.008854935,0.00016790614],"about_ca_topic_score_codex":0.87543786,"about_ca_topic_score_gemma":0.19572163,"teacher_disagreement_score":0.6797162,"about_ca_system_score_codex":0.00097166863,"about_ca_system_score_gemma":0.009026788,"threshold_uncertainty_score":0.9965911},"labels":[],"label_agreement":null},{"id":"W4412442846","doi":"10.1016/j.jval.2025.04.731","title":"HPR7 Software as a Medical Device: Current Regulations in North America and Europe","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Esri (Canada)","funders":"","keywords":"Current (fluid); Software; Business; Computer science; Engineering; Electrical engineering; Operating system","score_opus":0.29829731337154536,"score_gpt":0.4503374318390006,"score_spread":0.15204011846745524,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7979294,0.034767546,0.0041947705,0.15777639,0.0012497023,0.0015890405,0.00019373196,0.00009716203,0.0022022368],"genre_scores_gemma":[0.9095731,0.013633116,0.007892235,0.06702693,0.0004287548,0.0003803344,0.00018495809,0.000077222605,0.0008033459],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99452895,0.0007020743,0.0036237792,0.000568107,0.00012058517,0.00045647824],"domain_scores_gemma":[0.9970981,0.0013467771,0.000867106,0.0003799531,0.000039546667,0.00026855108],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0074529108,0.00015448105,0.00080267707,0.00072330836,0.0001393695,0.00003607172,0.00022365688,0.000095800395,0.00015632538],"category_scores_gemma":[0.009025404,0.00020244213,0.000039882507,0.0010105661,0.000082789134,0.00018603471,0.000090098656,0.00037546747,0.0004909714],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011293919,0.00018855561,0.90572304,0.0012899501,0.0000126596915,0.0000029983885,0.0025633338,0.0027577907,1.8272472e-8,0.06824808,0.008528524,0.010673734],"study_design_scores_gemma":[0.0009964246,0.00006699274,0.621966,0.00071320694,0.0000016071997,0.000003718081,0.00034572018,0.032520097,5.846943e-8,0.01010154,0.33304647,0.00023813802],"about_ca_topic_score_codex":0.015496117,"about_ca_topic_score_gemma":0.0039753243,"teacher_disagreement_score":0.32451794,"about_ca_system_score_codex":0.00066475925,"about_ca_system_score_gemma":0.0012851611,"threshold_uncertainty_score":0.999322},"labels":[],"label_agreement":null},{"id":"W4412442860","doi":"10.1016/j.jval.2025.04.1411","title":"PCR91 Patient Reported Outcomes in BRUIN CLL-321: A Phase 3 Trial of Pirtobrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in BTK Inhibitor Pretreated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Lymphocytic Leukemia Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CancerCare Manitoba","funders":"","keywords":"Bendamustine; Idelalisib; Chronic lymphocytic leukemia; Rituximab; Ibrutinib; Bruton's tyrosine kinase; Medicine; Ofatumumab; Internal medicine; Immunology; Oncology; Lymphoma; Leukemia","score_opus":0.07727139236211535,"score_gpt":0.3782010551301899,"score_spread":0.3009296627680746,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442860","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9838394,0.004017555,0.000046795278,0.00054159126,0.0019130053,0.008526754,0.00012145036,0.00024150478,0.00075196096],"genre_scores_gemma":[0.9954903,0.0012162178,0.00060573284,0.0004347869,0.0002675267,0.0007874359,0.0002471762,0.00017482566,0.0007759869],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9856944,0.0012636185,0.006294402,0.0020965685,0.0019341371,0.002716865],"domain_scores_gemma":[0.99220586,0.002927759,0.0014270827,0.0022636093,0.00040833958,0.0007673382],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0035721336,0.0011566757,0.0043110815,0.0033072196,0.00016863806,0.00007563451,0.00076564215,0.0008949184,0.00011779528],"category_scores_gemma":[0.0069730147,0.001046285,0.00049918174,0.005356021,0.0005288258,0.0002803818,0.0005839135,0.00095394265,0.00004522983],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.84237504,0.013867112,0.00188516,0.014705584,0.0010657115,0.014356601,0.0065562334,0.05953889,0.00047346964,0.0005603757,0.0014070083,0.04320882],"study_design_scores_gemma":[0.68475115,0.007053185,0.00047465845,0.004845211,0.00015298754,0.00028058578,0.00059704005,0.29916772,0.0015396705,0.00006463231,0.0005027808,0.00057036534],"about_ca_topic_score_codex":0.20172884,"about_ca_topic_score_gemma":0.010748327,"teacher_disagreement_score":0.23962882,"about_ca_system_score_codex":0.5082533,"about_ca_system_score_gemma":0.3457488,"threshold_uncertainty_score":0.99919873},"labels":[],"label_agreement":null},{"id":"W4412442870","doi":"10.1016/j.jval.2025.04.1074","title":"HTA63 Trends in Use of Cost-Minimization Analyses in CDA-AMC Reimbursement Submissions","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Manufacturing Process and Optimization","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Reimbursement; Cost-minimization analysis; Minification; Actuarial science; Business; Computer science; Economics; Medicine; Internal medicine; World Wide Web; Economic growth; Health care","score_opus":0.10668303668197975,"score_gpt":0.35785272257686135,"score_spread":0.2511696858948816,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95015407,0.0027522934,0.0404753,0.0020780044,0.00068949047,0.0010232789,0.000034739278,0.0002101215,0.002582695],"genre_scores_gemma":[0.9963806,0.0007781878,0.0025409977,0.000060638362,0.000006941949,0.00002553747,0.000039135328,0.000010353076,0.0001575867],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99901944,0.000068198126,0.0004982767,0.00013636437,0.0000945064,0.00018323175],"domain_scores_gemma":[0.9996821,0.00007105604,0.00005375239,0.00014028006,0.000016679276,0.000036112047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002060095,0.00008751376,0.00020928768,0.00089755334,0.000016554663,0.000011620992,0.00006228724,0.000058574547,0.000035236175],"category_scores_gemma":[0.00006324123,0.00009041695,0.000020222646,0.0009877677,0.000008171929,0.00009832884,0.000015029423,0.000117145966,4.1544305e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000008276723,0.000045650417,0.013568413,0.0002486531,0.0000034602538,9.2636145e-7,0.00040700278,0.9745421,0.000015136099,0.00020529488,0.0001930379,0.010762085],"study_design_scores_gemma":[0.0004508434,0.000019486775,0.13070151,0.00048687967,0.0000035076855,1.2547616e-7,0.00007258001,0.8660473,0.00095016666,0.000114530434,0.0010695461,0.00008350021],"about_ca_topic_score_codex":0.003130977,"about_ca_topic_score_gemma":0.0007036773,"teacher_disagreement_score":0.117133096,"about_ca_system_score_codex":0.00021765525,"about_ca_system_score_gemma":0.000060463666,"threshold_uncertainty_score":0.47331217},"labels":[],"label_agreement":null},{"id":"W4412442873","doi":"10.1016/j.jval.2025.04.1388","title":"PCR67 Assessing the Feasibility of Using an Electronic Platform for Personalized Outcome Assessment: GoalNav for Goal Attainment Scaling","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Evaluation and Performance Assessment","field":"Decision Sciences","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Goal Attainment Scaling; Outcome (game theory); Scaling; Computer science; Medicine; Physical therapy; Mathematics","score_opus":0.5023063607248556,"score_gpt":0.610520864269291,"score_spread":0.1082145035444354,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442873","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78743833,0.00028111247,0.20494272,0.004247203,0.00045111438,0.002385481,0.000033882916,0.000018656268,0.00020148902],"genre_scores_gemma":[0.98028964,0.00002165722,0.01832826,0.0009835372,0.00006336263,0.00013031883,0.000017043612,0.000013187019,0.00015299958],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9951053,0.0006369037,0.001851238,0.00056963967,0.0011844318,0.0006524438],"domain_scores_gemma":[0.9948155,0.0033401165,0.00072580116,0.00063492736,0.00038905884,0.00009457831],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.030923927,0.0001878123,0.00057412876,0.00031112123,0.0006036054,0.00022459465,0.00059906405,0.00008768862,0.00005383812],"category_scores_gemma":[0.0011446766,0.00012807093,0.000215235,0.0007803905,0.00010833675,0.0005606821,0.00007524153,0.00025251554,9.3928185e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002841621,0.0007023512,0.6728553,0.00062499713,0.00005358967,2.1336304e-7,0.0026520204,0.11889099,0.0006359453,0.16305722,0.00014657932,0.04009662],"study_design_scores_gemma":[0.0022627746,0.00030154563,0.061256643,0.00014335952,0.000021619675,0.0000011727853,0.00444767,0.8822128,0.000108505745,0.046764255,0.002337246,0.0001424066],"about_ca_topic_score_codex":0.00047888476,"about_ca_topic_score_gemma":0.00011472738,"teacher_disagreement_score":0.7633218,"about_ca_system_score_codex":0.0015387553,"about_ca_system_score_gemma":0.003721489,"threshold_uncertainty_score":0.99786776},"labels":[],"label_agreement":null},{"id":"W4412442879","doi":"10.1016/j.jval.2025.04.1941","title":"EE342 Healthcare Utilization and Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Ontario, Canada: An Observational Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Observational study; Medicine; Liver dysfunction; Health care; Liver disease; Disease; Intensive care medicine; Environmental health; Internal medicine; Economics; Economic growth","score_opus":0.18819265237134516,"score_gpt":0.3493950312016761,"score_spread":0.16120237883033092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442879","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99047947,0.005335302,0.0000023876403,0.0020216524,0.00013397315,0.001918748,0.00007605529,0.0000099219105,0.000022481767],"genre_scores_gemma":[0.9978942,0.0004139594,0.000019529716,0.0011118202,0.000009502576,0.00013893886,0.00030742597,0.000008079517,0.00009651248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839556,0.00032107686,0.00047971506,0.0002885227,0.00030386102,0.00021128653],"domain_scores_gemma":[0.99916005,0.00013416585,0.00011787518,0.00019202674,0.00013049657,0.00026539934],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000322124,0.00012419384,0.0003810545,0.00018767564,0.00006809746,0.0000071301565,0.000037394024,0.00003486736,0.00004108357],"category_scores_gemma":[0.0001230974,0.000118198375,0.000024556568,0.00041239706,0.00001783257,0.00007913348,0.000020334233,0.00012842056,3.4144026e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017745455,0.0024297405,0.9922894,0.00025493294,0.00006461738,0.00003841678,0.0009149588,0.0006200423,1.4356431e-7,0.0017286433,0.000113819595,0.0013678181],"study_design_scores_gemma":[0.003093449,0.00026699764,0.991734,0.00043250987,0.00009941434,3.338558e-7,0.0006010007,0.0034257136,0.0000013766023,0.00009656719,0.00018569599,0.00006288752],"about_ca_topic_score_codex":0.9940521,"about_ca_topic_score_gemma":0.99429476,"teacher_disagreement_score":0.0074147535,"about_ca_system_score_codex":0.00154053,"about_ca_system_score_gemma":0.008384167,"threshold_uncertainty_score":0.9972374},"labels":[],"label_agreement":null},{"id":"W4412442946","doi":"10.1016/j.jval.2025.04.1405","title":"PCR84 Health Utility Values of Canadian Patients with Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Metastatic Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Human Epidermal Growth Factor Receptor 2; Metastatic breast cancer; Oncology; Medicine; Breast cancer; Internal medicine; Cancer; Epidermal growth factor receptor; Cancer research","score_opus":0.053677189279302526,"score_gpt":0.28247372324823516,"score_spread":0.22879653396893262,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442946","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97152317,0.0027388905,0.00018425676,0.010103809,0.0006997479,0.0012932217,0.008134109,0.000029211007,0.0052935835],"genre_scores_gemma":[0.996122,0.00083072146,0.0007017183,0.001982576,0.0000474286,0.000046178142,0.000043158532,0.000029760775,0.00019645339],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99702054,0.00012643552,0.0014393666,0.0005563294,0.00006308671,0.0007942211],"domain_scores_gemma":[0.9980687,0.00012231976,0.00094780326,0.0003453829,0.00012361148,0.00039220715],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009099243,0.0002662404,0.0010755697,0.0011081658,0.00023087201,0.00003148744,0.00027339053,0.000085674495,0.0005960817],"category_scores_gemma":[0.00015389436,0.00028321965,0.000094541414,0.00089886115,0.00015946744,0.00033905936,0.000035284713,0.00028948652,0.000024964287],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006920527,0.00019907333,0.9444843,0.00048968,0.000084488325,4.829693e-7,0.0015351437,0.00023335216,1.4539513e-7,0.045690387,0.0028783337,0.0043354384],"study_design_scores_gemma":[0.0013114254,0.00021382836,0.9815611,0.00026385428,0.0000034562336,2.703556e-7,0.000109788154,0.00027883268,0.0000116719775,0.012915315,0.003094353,0.00023608589],"about_ca_topic_score_codex":0.8993521,"about_ca_topic_score_gemma":0.21036199,"teacher_disagreement_score":0.6889901,"about_ca_system_score_codex":0.0017745948,"about_ca_system_score_gemma":0.0018263996,"threshold_uncertainty_score":0.999962},"labels":[],"label_agreement":null},{"id":"W4412442958","doi":"10.1016/j.jval.2025.04.1017","title":"HTA6 Real-World Evidence (RWE) in Health Technology Assessment (HTA): Global Guidelines on the Use of RWE in Evidence Generation for HTA Evaluation","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Esri (Canada)","funders":"","keywords":"Real world evidence; Health technology; Medicine; Business; Risk analysis (engineering); Health care; Economic growth; Internal medicine; Economics","score_opus":0.8745974336899165,"score_gpt":0.5982575559383363,"score_spread":0.2763398777515802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442958","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.43051007,0.010605268,0.0067877807,0.5441649,0.0010463224,0.0065766904,0.00016208043,0.000039696835,0.00010718281],"genre_scores_gemma":[0.9394696,0.00854746,0.023238573,0.026670862,0.00022006783,0.0016043371,0.000044170232,0.000030370067,0.00017459164],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98542136,0.0026729314,0.009779036,0.001065544,0.00031252266,0.0007486337],"domain_scores_gemma":[0.9902171,0.0049066544,0.0034732674,0.000993764,0.00030864228,0.00010057963],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.07880021,0.00025604872,0.0012655454,0.0015056509,0.0001871132,0.000066782275,0.00047568782,0.00020089794,0.000038027927],"category_scores_gemma":[0.02718262,0.00027971793,0.00009318135,0.0020167734,0.00008473118,0.0005872869,0.000086423286,0.0003441558,0.000025671401],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000057578905,0.00021179643,0.3135584,0.0015412256,0.000017143197,3.4210825e-7,0.0005324847,0.1974175,0.000004548593,0.46468818,0.01741843,0.004552398],"study_design_scores_gemma":[0.0011604712,0.00035392167,0.13027856,0.0057827285,0.0000037790483,7.7988625e-7,0.00048805567,0.8243503,0.0000080541995,0.031164767,0.0061737048,0.0002348802],"about_ca_topic_score_codex":0.085358396,"about_ca_topic_score_gemma":0.041399073,"teacher_disagreement_score":0.6269328,"about_ca_system_score_codex":0.008680954,"about_ca_system_score_gemma":0.004226485,"threshold_uncertainty_score":0.9999655},"labels":[],"label_agreement":null},{"id":"W4412442996","doi":"10.1016/j.jval.2025.04.337","title":"EE45 Economic and Healthcare Impacts of Public Funding for Intermittent Catheters in Nova Scotia","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Institute of Cosmetic and Laser Surgery; Government of Canada; McMaster University","funders":"","keywords":"Nova scotia; Nova (rocket); Health care; Business; Medicine; Political science; Economic growth; Economics; Geography; Engineering; Aeronautics; Archaeology","score_opus":0.4846556010325948,"score_gpt":0.4636928838564241,"score_spread":0.02096271717617071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412442996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8730747,0.0070068687,0.0008992839,0.11580835,0.0010786698,0.0015986142,0.00023847194,0.00001867563,0.00027632667],"genre_scores_gemma":[0.9906161,0.0004501912,0.0015151568,0.0071926164,0.00007036019,0.000060942843,0.000022263563,0.000024605806,0.00004780526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99340755,0.00044980992,0.0047989613,0.00059434585,0.00004253828,0.00070678996],"domain_scores_gemma":[0.99639136,0.0012769507,0.001679178,0.00039569373,0.00003028299,0.00022655258],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.020899106,0.00018587484,0.0012002627,0.0014014536,0.0000741048,0.000050707116,0.00023468639,0.00014058096,0.000022890716],"category_scores_gemma":[0.0017194361,0.00025222707,0.000094827636,0.00027964942,0.00006995958,0.00032660557,0.00006967277,0.00020126216,0.000044672488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035123623,0.0001108442,0.71177447,0.0052060634,0.00003575985,3.7833493e-7,0.0030185457,0.0008459202,0.0000021735482,0.27457434,0.0024058593,0.001990525],"study_design_scores_gemma":[0.005473634,0.000655482,0.83902127,0.0032857663,0.0000053877166,0.0000083576815,0.0051425095,0.07089101,0.000016605756,0.061030332,0.013726676,0.00074298424],"about_ca_topic_score_codex":0.07306771,"about_ca_topic_score_gemma":0.01669695,"teacher_disagreement_score":0.213544,"about_ca_system_score_codex":0.0027503234,"about_ca_system_score_gemma":0.0009753977,"threshold_uncertainty_score":0.999993},"labels":[],"label_agreement":null},{"id":"W4412443002","doi":"10.1016/j.jval.2025.04.1015","title":"HTA4 The Use of QALYs in Decision-Making in Europe, Canada, and the US: A Qualitative Review of Methodological Guidance","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Evaluation and Performance Assessment","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Political science","score_opus":0.7805227888960862,"score_gpt":0.6676755933455265,"score_spread":0.11284719555055966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443002","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00011732493,0.99506366,0.0005520925,0.002086042,0.00017258506,0.0017471485,0.00004983477,0.0000016230176,0.00020970301],"genre_scores_gemma":[0.00009688163,0.9911184,0.0061457334,0.0024586245,0.000010106921,0.00009553043,0.0000026704943,0.0000063146526,0.000065787106],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9428338,0.048132095,0.0058589904,0.00064944837,0.0021799966,0.00034571168],"domain_scores_gemma":[0.8567747,0.13947342,0.0023258196,0.0008934972,0.00048540186,0.00004715602],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.09945641,0.00022396534,0.0026900347,0.0004361561,0.0000584404,0.000031735406,0.000942742,0.00008552775,0.00006755526],"category_scores_gemma":[0.10361816,0.00009741698,0.00014422307,0.0050231996,0.00021183277,0.00010197716,0.00026778926,0.0005639596,0.0000015015886],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000029962248,0.000026814732,0.00042659987,0.020635812,0.000010313217,0.000002971971,0.0018116134,0.0013759453,2.4894613e-9,0.004285357,0.0019130628,0.9694815],"study_design_scores_gemma":[0.00035091012,0.00004908941,0.0021336745,0.3062806,0.00003186554,0.0000043676323,0.00047504416,0.0022568775,1.9749729e-8,0.0036536693,0.68463045,0.00013340604],"about_ca_topic_score_codex":0.20572124,"about_ca_topic_score_gemma":0.25346228,"teacher_disagreement_score":0.96934813,"about_ca_system_score_codex":0.00027382883,"about_ca_system_score_gemma":0.0082020955,"threshold_uncertainty_score":0.9974205},"labels":[],"label_agreement":null},{"id":"W4412443009","doi":"10.1016/j.jval.2025.04.1166","title":"MSR13 TransportHealth: A Novel, Flexible, Open-Source R Package for Transportability and Generalizability Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Hip and Femur Fractures","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact; Simon Fraser University; Centre for Advancing Health Outcomes","funders":"","keywords":"Generalizability theory; Computer science; Open source; Programming language; Psychology; Software","score_opus":0.05653228051721084,"score_gpt":0.3679502064654591,"score_spread":0.3114179259482483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89289194,0.0018522582,0.08663227,0.014824458,0.000111243484,0.0029607252,0.00022791055,0.00008247212,0.00041672052],"genre_scores_gemma":[0.9873065,0.00031948762,0.0062257377,0.0053433357,0.000043204505,0.00013762587,0.00016907518,0.00002015096,0.00043490014],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99754745,0.00015511272,0.00093893294,0.00067873433,0.00018304655,0.0004967121],"domain_scores_gemma":[0.99853325,0.0003197557,0.0001346065,0.00062262727,0.00007726649,0.00031248078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024332874,0.000215459,0.0010027644,0.00037289568,0.00016681364,0.0000255672,0.00017459902,0.00016024006,0.000058793747],"category_scores_gemma":[0.00013240946,0.00018659171,0.0002026639,0.0013159777,0.00011178805,0.000081784594,0.000017644888,0.00027789883,5.564706e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012664413,0.0010893422,0.9717993,0.0040286905,0.00029084712,0.0000042985857,0.0033783743,0.0029687046,0.00018005441,0.0028967278,0.0002968996,0.011800322],"study_design_scores_gemma":[0.004211164,0.00040608877,0.9548579,0.0002073677,0.00041307358,0.00000313308,0.00024544806,0.00619158,0.0002471774,0.0017804545,0.031230705,0.00020593994],"about_ca_topic_score_codex":0.022682855,"about_ca_topic_score_gemma":0.0034795331,"teacher_disagreement_score":0.09441454,"about_ca_system_score_codex":0.00019752061,"about_ca_system_score_gemma":0.00081088213,"threshold_uncertainty_score":0.9838252},"labels":[],"label_agreement":null},{"id":"W4412443090","doi":"10.1016/j.jval.2025.04.1393","title":"PCR72 Optimizing Communication Strategies for COPD Management: Effectiveness of Educational Video and Pamphlet Interventions","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Nursing Diagnosis and Documentation","field":"Nursing","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Psychological intervention; COPD; Medicine; Computer science; Nursing; Internal medicine","score_opus":0.04200459058565332,"score_gpt":0.39959304473836554,"score_spread":0.35758845415271223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443090","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8976539,0.02375397,0.030217838,0.035013344,0.002341657,0.0054726,0.000064516775,0.00007166493,0.005410515],"genre_scores_gemma":[0.98503727,0.00022716697,0.014261231,0.00014419045,0.000009274757,0.00021155814,0.00007304489,0.0000071224367,0.00002915915],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9989865,0.0003579219,0.00033438785,0.00014321739,0.00006080126,0.00011719031],"domain_scores_gemma":[0.99859095,0.0010584977,0.00013238536,0.00015441593,0.000043002485,0.000020728381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088735117,0.00006469508,0.0001520757,0.00020872061,0.00013310475,0.00004624466,0.0000782401,0.000027689643,0.000005407464],"category_scores_gemma":[0.000053074902,0.000073302406,0.00004350499,0.00019306043,0.00004833471,0.000173503,0.00002232519,0.00005366664,4.455158e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046577767,0.00084837223,0.016886123,0.017207209,0.000061535335,1.2029844e-7,0.0020889596,0.020483792,0.00016946449,0.90801376,0.0021005627,0.03167433],"study_design_scores_gemma":[0.004843421,0.0006468713,0.4077214,0.030923756,0.000111374975,0.0000026879572,0.0060769324,0.010559016,0.0012305145,0.5362654,0.0013432987,0.00027534927],"about_ca_topic_score_codex":0.0011894426,"about_ca_topic_score_gemma":0.00004916467,"teacher_disagreement_score":0.39083526,"about_ca_system_score_codex":0.00018609564,"about_ca_system_score_gemma":0.0000508333,"threshold_uncertainty_score":0.29891855},"labels":[],"label_agreement":null},{"id":"W4412443105","doi":"10.1016/j.jval.2025.04.721","title":"PT29 Increased Incidence of Parkinson Disease Associated with Antiseizure Medication Use","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Incidence (geometry); Medicine; Parkinson's disease; Disease; Intensive care medicine; Internal medicine; Mathematics","score_opus":0.08512808076206865,"score_gpt":0.4010828595814415,"score_spread":0.31595477881937284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443105","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9784069,0.0033277653,0.000102096186,0.01724651,0.00007142394,0.00047594187,0.000028561559,0.000028209906,0.0003125975],"genre_scores_gemma":[0.99400723,0.0026968555,0.00023060183,0.0029398946,0.000018649556,0.000015713402,0.000026380832,0.000005631395,0.000059062593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99877304,0.00027724914,0.0003122032,0.00017344253,0.0002716429,0.000192401],"domain_scores_gemma":[0.9984639,0.0009151417,0.00019446429,0.00015832936,0.00007752659,0.00019061245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00082108687,0.00007963143,0.00026347916,0.00008690759,0.00006256013,0.000006226825,0.00005558219,0.00003869963,0.000020707215],"category_scores_gemma":[0.0026495792,0.000060756898,0.000023393177,0.00047803955,0.00007266439,0.00009933951,0.000028174949,0.00020204853,0.0000015533849],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007559525,0.00032462736,0.9941222,0.00049429503,0.00005280569,0.000030544852,0.00013668263,0.000074890595,0.0000339933,0.00043595742,0.0008199078,0.0027181278],"study_design_scores_gemma":[0.001294388,0.00014195463,0.9775635,0.0016502485,0.00007046069,0.0000012589669,0.000047122696,0.0050265566,0.000059959435,0.00013013175,0.013964983,0.000049444454],"about_ca_topic_score_codex":0.0049438686,"about_ca_topic_score_gemma":0.00012758795,"teacher_disagreement_score":0.016558724,"about_ca_system_score_codex":0.0001637745,"about_ca_system_score_gemma":0.0006097976,"threshold_uncertainty_score":0.7473684},"labels":[],"label_agreement":null},{"id":"W4412443161","doi":"10.1016/j.jval.2025.04.1547","title":"PCR230 Patient-Reported Outcomes From a Phase 3 Study of Givinostat in Patients With Duchenne Muscular Dystrophy","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Holland Bloorview Kids Rehabilitation Hospital","funders":"","keywords":"Duchenne muscular dystrophy; Medicine; Muscular dystrophy; Phase (matter); Physical medicine and rehabilitation; Physical therapy; Pediatrics; Internal medicine; Physics","score_opus":0.012332178577988538,"score_gpt":0.2777343353976588,"score_spread":0.2654021568196703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987309,0.00023245906,0.000032281798,0.00008230592,0.00010038532,0.00075306935,0.000035702422,0.00000546887,0.000027451279],"genre_scores_gemma":[0.99944055,0.000020161457,0.00010245184,0.0002351451,0.000005908204,0.000037896745,0.00014271434,0.00000973589,0.0000054561115],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99854964,0.00024310304,0.00048922584,0.0003696048,0.000115522016,0.00023290099],"domain_scores_gemma":[0.9992889,0.000030840994,0.00018329413,0.00039388283,0.000054346485,0.000048720103],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012972578,0.00014336019,0.00031300678,0.000121588506,0.00003323775,0.0000032765747,0.000106868196,0.00007894489,0.0000074133513],"category_scores_gemma":[0.000100907935,0.000121774756,0.000038709983,0.00021161351,0.000043435135,0.0000039946012,0.00006139921,0.00010683303,4.7293645e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012065709,0.0044064634,0.9892687,0.000051891024,0.00010516897,0.0000042893384,0.0004826134,0.001779424,0.0010139323,0.000014814718,0.00004395554,0.001622157],"study_design_scores_gemma":[0.0123222815,0.003563663,0.98240066,0.000060662107,0.000012802438,5.1421587e-8,0.000603989,0.00006985608,0.00061344303,0.00010460281,0.00011918838,0.00012879228],"about_ca_topic_score_codex":0.006150273,"about_ca_topic_score_gemma":0.00039531628,"teacher_disagreement_score":0.011115711,"about_ca_system_score_codex":0.000027539914,"about_ca_system_score_gemma":0.00016818603,"threshold_uncertainty_score":0.92974144},"labels":[],"label_agreement":null},{"id":"W4412443185","doi":"10.1016/j.jval.2025.04.1898","title":"EE299 Cost Per PFS-Based Responder for TKI-Naive Patients Receiving Repotrectinib or Entrectinib in ROS1 Fusion Positive Non-Small Cell Lung Cancer (NSCLC) in the United States (US)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Vancouver Coastal Health","funders":"","keywords":"Medicine; ROS1; Oncology; Internal medicine; Lung cancer; Cancer; Adenocarcinoma","score_opus":0.026787791570512417,"score_gpt":0.37073762019562845,"score_spread":0.343949828625116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443185","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.986372,0.00062679325,0.00023857263,0.005853273,0.0004578456,0.005515298,0.000168868,0.00002678248,0.00074057275],"genre_scores_gemma":[0.98911667,0.00043599276,0.00072399277,0.007060217,0.00005035952,0.0011540406,0.00056825066,0.000036537815,0.0008539647],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99765074,0.0004885661,0.00065691845,0.00046615323,0.00022954411,0.0005080845],"domain_scores_gemma":[0.9976538,0.0015243981,0.00022873431,0.0002777996,0.00022120909,0.00009406645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00084704027,0.0002247753,0.00038995294,0.0007194984,0.00017628478,0.000029012936,0.000106769265,0.000107976215,0.000037438218],"category_scores_gemma":[0.00032983188,0.00015817986,0.000066243345,0.001315463,0.00003072154,0.000060218546,0.000025390935,0.00035604564,0.0000016730937],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039628884,0.0015777443,0.92139274,0.00096413825,0.00006031852,0.000041177565,0.042034186,0.01957127,0.000052815114,0.000026021113,0.0024758924,0.007840781],"study_design_scores_gemma":[0.021783242,0.0013649502,0.9102147,0.0063686,0.00015635775,0.0000027681472,0.0069397716,0.04688559,0.00073661096,0.00008049787,0.005162913,0.00030394775],"about_ca_topic_score_codex":0.06782783,"about_ca_topic_score_gemma":0.012231468,"teacher_disagreement_score":0.055596363,"about_ca_system_score_codex":0.0020455145,"about_ca_system_score_gemma":0.0020571507,"threshold_uncertainty_score":0.9383796},"labels":[],"label_agreement":null},{"id":"W4412443194","doi":"10.1016/j.jval.2025.04.733","title":"HPR9 From Data to Actionable Insight: A Collaborative Monitoring & Evaluation (M&E) Initiative Convened by Canada’s Drug Agency (CDA-AMC) - Piloting Plans for Diabetes and Contraception","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Agency (philosophy); Medicine; Business; Sociology","score_opus":0.13151000977082555,"score_gpt":0.3770333245496041,"score_spread":0.24552331477877853,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443194","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97948134,0.0015412762,0.0004065315,0.013976429,0.0009918192,0.0026572645,0.000535691,0.000028928049,0.00038074967],"genre_scores_gemma":[0.99108714,0.00017044338,0.0026354296,0.0017820491,0.00021251055,0.00031789462,0.0032179877,0.000016978369,0.00055956346],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982934,0.00024755197,0.0004256551,0.00043121955,0.0002907037,0.00031145566],"domain_scores_gemma":[0.9985336,0.0006104339,0.00018727726,0.00030101466,0.00024036183,0.00012732667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013410589,0.0001449425,0.00030529522,0.00019071926,0.00020565785,0.000048583133,0.00009900959,0.000044837652,0.000024843559],"category_scores_gemma":[0.001085557,0.0001553173,0.000011691975,0.00042818743,0.000019660829,0.00027711285,0.00005509335,0.0001228057,0.0000030599394],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066005916,0.0007104381,0.5536681,0.0022639856,0.0005751852,8.4536526e-7,0.041100584,0.0023900801,0.007819234,0.00048222014,0.3300842,0.06024509],"study_design_scores_gemma":[0.008531467,0.00042220234,0.6351038,0.003882913,0.00047509372,2.0003806e-7,0.013177773,0.030015092,0.002881813,0.0025712168,0.30223772,0.0007006928],"about_ca_topic_score_codex":0.15393592,"about_ca_topic_score_gemma":0.12228539,"teacher_disagreement_score":0.08143574,"about_ca_system_score_codex":0.00096083194,"about_ca_system_score_gemma":0.0022658077,"threshold_uncertainty_score":0.89373064},"labels":[],"label_agreement":null},{"id":"W4412443207","doi":"10.1016/j.jval.2025.04.2140","title":"PT39 Best Practices and Standards to Enhance the Quality of Rare Disease Registries in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Genomics and Rare Diseases","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Public Health Agency of Canada; McMaster University","funders":"","keywords":"Quality (philosophy); Business; Medicine; Environmental health","score_opus":0.03039165845495346,"score_gpt":0.3784252633777155,"score_spread":0.34803360492276203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443207","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9831381,0.009990505,0.000025154322,0.0060838573,0.000069001595,0.00021968069,0.00033184048,7.596129e-7,0.00014111516],"genre_scores_gemma":[0.99752474,0.001446313,0.00004692042,0.0008331832,0.000015326861,0.000013821826,0.000013417986,0.0000032156702,0.00010305601],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99913245,0.00016799817,0.0002525174,0.00018233007,0.00013190348,0.0001327863],"domain_scores_gemma":[0.99940276,0.0000654627,0.00015121543,0.0002294624,0.00007172148,0.00007939696],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006371347,0.000060897106,0.00011644298,0.000024064408,0.000041788157,0.00000880546,0.000102897255,0.000019010513,0.0000014853883],"category_scores_gemma":[0.0012453502,0.00004859657,0.000014237354,0.00010410318,0.000033585977,0.0000018323171,0.000066405686,0.0000481237,5.732439e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003242112,0.0005018032,0.9130774,0.00438448,0.00009325622,0.000051308492,0.0011807302,0.011103975,0.010597951,0.0051210057,0.02136447,0.0292815],"study_design_scores_gemma":[0.0009721172,0.00032478166,0.7279068,0.0007512222,0.00001883883,0.0000023146306,0.005431151,0.00022310871,0.010074498,0.0010743695,0.2528197,0.00040107255],"about_ca_topic_score_codex":0.8423274,"about_ca_topic_score_gemma":0.8282769,"teacher_disagreement_score":0.23145522,"about_ca_system_score_codex":0.00013696565,"about_ca_system_score_gemma":0.0062323906,"threshold_uncertainty_score":0.99940133},"labels":[],"label_agreement":null},{"id":"W4412443222","doi":"10.1016/j.jval.2025.04.640","title":"EPH109 Association of Cognitive Impairment With Benzodiazepine Use in the U.S.: An Analysis of Medical Expenditure Panel Survey","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Medical Expenditure Panel Survey; Association (psychology); Benzodiazepine; Cognitive impairment; Cognition; Psychology; Medicine; Psychiatry; Clinical psychology; Economics; Internal medicine; Psychotherapist","score_opus":0.09669738816828798,"score_gpt":0.36153233569651294,"score_spread":0.26483494752822495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443222","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.991239,0.0017664054,0.000035749006,0.006350364,0.000037192756,0.0004325448,0.00008848524,0.000005840504,0.000044426346],"genre_scores_gemma":[0.99584746,0.00060089363,0.000057133704,0.0032950246,0.000016540862,0.000016684913,0.00013171436,0.000003999646,0.00003056049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9974937,0.00097164273,0.000497669,0.00017674302,0.00068549416,0.00017477055],"domain_scores_gemma":[0.99738973,0.0019596743,0.00022027367,0.00018567387,0.00018945035,0.000055217617],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038910639,0.00008707973,0.0007550897,0.00038385816,0.000029343488,0.000004428276,0.000080167134,0.00010422726,0.000023436729],"category_scores_gemma":[0.0008643541,0.00005264402,0.000053853917,0.0010692924,0.000041077634,0.00003997918,0.000026910182,0.00023932515,2.649362e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029240473,0.00078087545,0.99241215,0.00012710896,0.0008669897,0.000015327936,0.004088667,0.0001321162,0.0000030407905,0.00008312062,0.0008426123,0.0003555606],"study_design_scores_gemma":[0.001690095,0.00044092178,0.9922698,0.0006193512,0.0007521703,0.0000013501211,0.0025394065,0.0015318489,0.000023848053,0.000011816898,0.00008003421,0.000039318224],"about_ca_topic_score_codex":0.04900593,"about_ca_topic_score_gemma":0.024288066,"teacher_disagreement_score":0.024717864,"about_ca_system_score_codex":0.00004789017,"about_ca_system_score_gemma":0.00035613758,"threshold_uncertainty_score":0.99351615},"labels":[],"label_agreement":null},{"id":"W4412443224","doi":"10.1016/j.jval.2025.04.1913","title":"EE314 Cost-Effectiveness Analysis of HIV Prevention and Treatment Portfolios in US Prison Settings","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Criminal Justice and Corrections Analysis","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ivey Foundation; Western University","funders":"","keywords":"Prison; Human immunodeficiency virus (HIV); Medicine; Actuarial science; Business; Psychology; Family medicine; Criminology","score_opus":0.041448652643138656,"score_gpt":0.3918457593222411,"score_spread":0.3503971066791024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9971819,0.00057959417,0.0007252795,0.00048815602,0.00006369757,0.0004400661,0.0000046661416,0.000010019598,0.0005066415],"genre_scores_gemma":[0.9980545,0.0015517919,0.00009419023,0.000033333326,0.000011219691,0.00005854908,0.00000838132,0.0000022662578,0.00018578146],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9985332,0.00063720025,0.00031954405,0.00020371962,0.00012740635,0.00017896711],"domain_scores_gemma":[0.9993128,0.00036989796,0.00012875706,0.000104566876,0.00003988964,0.000044078755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001329739,0.00006600574,0.00032633857,0.0008643772,0.00012142656,0.000015395239,0.00004876299,0.000049364528,0.000015438824],"category_scores_gemma":[0.00013775009,0.000065795466,0.00009034885,0.0027602785,0.000044435696,0.00006183916,0.000012937966,0.00005708665,5.6442076e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053433858,0.0003868378,0.7583281,0.00016259732,0.00018466778,0.000002833164,0.013398467,0.017320426,0.000013480373,0.0019939784,0.000014463765,0.20814072],"study_design_scores_gemma":[0.00084366975,0.00025561353,0.87096655,0.00057334406,0.0013780086,3.079763e-7,0.08871931,0.032806117,0.000073217445,0.0004101827,0.003820652,0.00015303645],"about_ca_topic_score_codex":0.26459336,"about_ca_topic_score_gemma":0.097382456,"teacher_disagreement_score":0.20798767,"about_ca_system_score_codex":0.0006004861,"about_ca_system_score_gemma":0.00034409878,"threshold_uncertainty_score":0.91908795},"labels":[],"label_agreement":null},{"id":"W4412443247","doi":"10.1016/j.jval.2025.04.1877","title":"EE278 A Systematic Scoping Review of Published Economic Analyses of Public Cord Blood Banking: Is It Time to Re-Assess?","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Blood Services; Ottawa Hospital","funders":"","keywords":"Cord blood; Business; Economics; Medicine; Internal medicine","score_opus":0.1833499891098888,"score_gpt":0.44966082932872176,"score_spread":0.26631084021883294,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443247","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06652505,0.21814376,0.0016085556,0.6924178,0.0007771431,0.0114047015,0.00004416431,0.00008887785,0.008989947],"genre_scores_gemma":[0.9575681,0.019825464,0.0025726084,0.01896767,0.000086257875,0.00010514426,0.00005660226,0.00002824975,0.0007898673],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99711925,0.00039649414,0.0016696381,0.00026523074,0.0003272902,0.00022209132],"domain_scores_gemma":[0.9981634,0.00043122497,0.0005810941,0.0004706222,0.00019288555,0.00016075827],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004670388,0.00010983723,0.0011663313,0.00055649737,0.000031164578,0.000017206941,0.00014950764,0.00012697215,0.00058110646],"category_scores_gemma":[0.0012675188,0.00008637342,0.00011465842,0.00093397195,0.00009281678,0.00007684403,0.00005955421,0.00018495611,0.000014846886],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016616588,0.00016665051,0.00049902516,0.9923719,0.0001382812,0.0000016405498,0.00019481158,0.000030570507,0.00020663865,0.0024976563,0.0029399076,0.00093627017],"study_design_scores_gemma":[0.00074061635,0.00033961926,0.00083039294,0.9917941,0.00019141918,0.0000058913356,0.00006767567,0.0048448364,0.000318935,0.0006418339,0.00013714399,0.00008751751],"about_ca_topic_score_codex":0.0010389647,"about_ca_topic_score_gemma":0.000035998513,"teacher_disagreement_score":0.89104307,"about_ca_system_score_codex":0.00017566745,"about_ca_system_score_gemma":0.002318269,"threshold_uncertainty_score":0.6362709},"labels":[],"label_agreement":null},{"id":"W4412443264","doi":"10.1016/j.jval.2025.04.1100","title":"HTA89 Health Technology Assessment in Saudi Arabia - Expectations for Oncology Product Eligibility Based on Predicate Canadian HTA","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Product (mathematics); Predicate (mathematical logic); Oncology; Family medicine; Internal medicine; Medical physics; Computer science; Mathematics","score_opus":0.3230237608809736,"score_gpt":0.4972436110623803,"score_spread":0.17421985018140668,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443264","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07692762,0.0032935126,0.0049086716,0.9031059,0.0013365474,0.0063436977,0.0008025731,0.0000983081,0.0031831847],"genre_scores_gemma":[0.94866705,0.00020678605,0.013421023,0.035544444,0.000110291134,0.0017406564,0.00013299272,0.000031451087,0.00014529075],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9913487,0.0010703936,0.005290297,0.001130485,0.00009068551,0.0010694517],"domain_scores_gemma":[0.995304,0.0016606229,0.0016921067,0.00091070187,0.00007357224,0.0003589988],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.027182765,0.00023284649,0.0014068786,0.0029025862,0.0003355727,0.00003027863,0.00038555753,0.00024359026,0.000047280162],"category_scores_gemma":[0.005231134,0.00031810266,0.0000854872,0.0011779709,0.00010121835,0.0001323157,0.000030378,0.00055311585,0.000085775406],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00006079719,0.0009795531,0.44355628,0.0029734354,0.000036097674,0.0000021723997,0.0024033124,0.035812628,5.8708207e-7,0.46253788,0.047229324,0.004407938],"study_design_scores_gemma":[0.0046832794,0.0014730769,0.36575812,0.001170632,0.0000040035766,0.0000025537308,0.003688569,0.29234678,0.000004457384,0.112735644,0.21749274,0.00064012635],"about_ca_topic_score_codex":0.32033494,"about_ca_topic_score_gemma":0.23387484,"teacher_disagreement_score":0.87173945,"about_ca_system_score_codex":0.014120808,"about_ca_system_score_gemma":0.015111918,"threshold_uncertainty_score":0.9999271},"labels":[],"label_agreement":null},{"id":"W4412443290","doi":"10.1016/j.jval.2025.04.1910","title":"EE311 The Equitable Quality-Adjusted Life-Year","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Global Health Care Issues","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal","funders":"","keywords":"Quality (philosophy); Philosophy","score_opus":0.20397294327296345,"score_gpt":0.5200313178884265,"score_spread":0.31605837461546304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443290","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5354459,0.022531766,0.00046877642,0.28437945,0.01144575,0.00813466,0.00015056971,0.0008118917,0.13663116],"genre_scores_gemma":[0.9420113,0.0009522028,0.0007688499,0.046508852,0.00045272335,0.0002852973,0.00002081222,0.000038460472,0.008961527],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9907017,0.004855833,0.0017534442,0.00047034817,0.00046302812,0.0017556689],"domain_scores_gemma":[0.995027,0.0030647716,0.0004135416,0.00092968135,0.00021741084,0.00034759947],"candidate_categories":["sts","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.008867727,0.00022179159,0.00061196304,0.0002376982,0.0013712752,0.000015139153,0.00055120955,0.0002925424,0.0002976719],"category_scores_gemma":[0.00251802,0.00016885634,0.00007522841,0.0013616759,0.00008887957,0.00010045145,0.0003507205,0.0014154067,0.0013165617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023347876,0.00017646787,0.16550478,0.005380561,0.00002801887,0.000005192522,0.008542966,0.0008383254,0.000009206637,0.5125477,0.30508712,0.0016462315],"study_design_scores_gemma":[0.00267352,0.0001918699,0.313392,0.0034275702,0.0000134716765,8.406574e-7,0.026886718,0.0012217805,0.0000066592897,0.01768852,0.63417214,0.0003249226],"about_ca_topic_score_codex":0.09866057,"about_ca_topic_score_gemma":0.003677559,"teacher_disagreement_score":0.49485913,"about_ca_system_score_codex":0.0012200796,"about_ca_system_score_gemma":0.004386374,"threshold_uncertainty_score":0.99992883},"labels":[],"label_agreement":null},{"id":"W4412443315","doi":"10.1016/j.jval.2025.04.631","title":"EPH100 Acute eGFR Dip with SGLT2 Inhibitors vs. Other Antihyperglycemic Medications Among People with HIV","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Human immunodeficiency virus (HIV); Medicine; Traditional medicine; Pharmacology; Internal medicine; Family medicine","score_opus":0.009097476905995877,"score_gpt":0.26470780283417383,"score_spread":0.25561032592817795,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443315","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96589905,0.00048377822,0.00037845375,0.02274916,0.00014087098,0.001361559,0.000010295444,0.00012780567,0.008849038],"genre_scores_gemma":[0.98831165,0.00033005013,0.0021000376,0.0025406044,0.00006653424,0.00018422087,0.00006112516,0.000034297485,0.006371462],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986005,0.0000613393,0.00031096526,0.00033902435,0.00029013294,0.00039804316],"domain_scores_gemma":[0.99920005,0.000066069835,0.00011160407,0.00041846733,0.00003852348,0.00016527782],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002542101,0.00018319262,0.00038722064,0.0003268628,0.00009300511,0.000016542343,0.0000953935,0.000055705746,0.000053197626],"category_scores_gemma":[0.000012598718,0.00012562194,0.00003620814,0.00076605467,0.00009290644,0.00008404442,0.000036321133,0.00017658922,0.000031326912],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030621738,0.00045010884,0.9841095,0.00046891443,0.00040399833,0.000031789514,0.0009248731,0.00023311855,0.000010375576,0.0029111272,0.008037655,0.0021123015],"study_design_scores_gemma":[0.012733674,0.0030640555,0.9320987,0.0057695745,0.0008851635,0.000016312484,0.0010486203,0.003825944,0.00028088837,0.0002785329,0.039531592,0.0004669672],"about_ca_topic_score_codex":0.003079287,"about_ca_topic_score_gemma":0.00079512136,"teacher_disagreement_score":0.052010845,"about_ca_system_score_codex":0.0002978737,"about_ca_system_score_gemma":0.00042001475,"threshold_uncertainty_score":0.5122714},"labels":[],"label_agreement":null},{"id":"W4412443331","doi":"10.1016/j.jval.2025.04.1019","title":"HTA8 Trends in Indirect Treatment Comparison (ITC) Methods Used in Reimbursement Submissions in Canada and the US","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Lumerical Solutions (Canada); Geomechanica (Canada); Luminex (Canada)","funders":"","keywords":"Reimbursement; Actuarial science; Business; Economics; Economic growth; Health care","score_opus":0.4775992639382661,"score_gpt":0.5012781598183944,"score_spread":0.02367889588012828,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443331","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92453814,0.009197496,0.00010795143,0.06323198,0.0004904312,0.001126805,0.000061416205,0.000009679568,0.0012360958],"genre_scores_gemma":[0.9923935,0.00083300617,0.0019610922,0.0041702776,0.00002759136,0.0003144255,0.000019377696,0.000015131627,0.0002656151],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99088705,0.0030212332,0.004826411,0.0005791851,0.000083687446,0.00060240814],"domain_scores_gemma":[0.9956117,0.0028679993,0.00093546155,0.0004339916,0.000009438187,0.00014135543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.025326543,0.00020329627,0.0015597395,0.0013202905,0.00009522187,0.000030227173,0.00019743646,0.00009850111,0.000058114736],"category_scores_gemma":[0.0010579025,0.00020214618,0.000049837075,0.0010496691,0.000048670325,0.000095369614,0.00004763871,0.0003221367,0.000007022272],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040512125,0.00014137708,0.96382535,0.00014520118,0.000014380714,0.0000022025147,0.0046591964,0.012999534,1.10063226e-7,0.011463918,0.0008487249,0.005859515],"study_design_scores_gemma":[0.004344492,0.000058504167,0.88373196,0.0003105701,0.0000020652617,6.995215e-7,0.0016794024,0.09350231,0.0000029500254,0.0040169144,0.012179248,0.0001708716],"about_ca_topic_score_codex":0.99085206,"about_ca_topic_score_gemma":0.985113,"teacher_disagreement_score":0.08050278,"about_ca_system_score_codex":0.009796057,"about_ca_system_score_gemma":0.0022094296,"threshold_uncertainty_score":0.99400514},"labels":[],"label_agreement":null},{"id":"W4412443332","doi":"10.1016/j.jval.2025.04.1947","title":"EE348 A Systematic Review of Economic Evaluations of Healthcare Associated Infection Prevention and Control Interventions in Long Term Care Facilities","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Geriatric Care and Nursing Homes","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; University of Ottawa; Université du Québec en Outaouais","funders":"","keywords":"Psychological intervention; Term (time); Health care; Medicine; Infection control; Control (management); Long-term care; Intensive care medicine; Nursing; Computer science; Economic growth; Economics","score_opus":0.12180151678768786,"score_gpt":0.503997644270465,"score_spread":0.38219612748277715,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443332","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017335078,0.9854814,0.00004456737,0.00026275602,0.00078377244,0.012429751,0.0007428295,0.000026739935,0.000054862863],"genre_scores_gemma":[0.00318177,0.9941786,0.000013599203,0.000025373405,0.000023677152,0.0016509879,0.0006011766,0.000022190188,0.00030264782],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9854205,0.008846722,0.004765176,0.00037015884,0.0002178013,0.00037962492],"domain_scores_gemma":[0.9942643,0.0015972472,0.0033507734,0.00042760867,0.00028027006,0.00007979971],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004579304,0.00030048293,0.0042506843,0.0010823872,0.0001570601,0.000005541804,0.00013980719,0.0004036274,0.00004018515],"category_scores_gemma":[0.0015134303,0.00028159388,0.000608321,0.0006510426,0.00005149931,0.00008119098,0.00005929884,0.0006748726,0.0000053550852],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000042217566,0.00006559191,0.0010666632,0.97425324,0.00007591966,3.1575297e-7,0.0020208643,0.000006026327,4.4850195e-9,0.00018696445,0.000058842346,0.022261325],"study_design_scores_gemma":[0.00063861767,0.00021653742,0.0025865948,0.99414796,0.00080367754,0.000001470346,0.000998104,0.000010915338,9.395031e-9,0.00012815355,0.0003316004,0.00013639053],"about_ca_topic_score_codex":0.024382455,"about_ca_topic_score_gemma":0.014556968,"teacher_disagreement_score":0.022124935,"about_ca_system_score_codex":0.0029066338,"about_ca_system_score_gemma":0.004867161,"threshold_uncertainty_score":0.99996364},"labels":[],"label_agreement":null},{"id":"W4412443334","doi":"10.1016/j.jval.2025.04.341","title":"EE49 Comparing the Cost-Utility of Renal Replacement Therapies Delivered to Critically Ill Patients With Acute Kidney Injury in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Organ Donation and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Critically ill; Acute kidney injury; Medicine; Renal replacement therapy; Intensive care medicine; Internal medicine","score_opus":0.02665921618615296,"score_gpt":0.3232365259809613,"score_spread":0.29657730979480834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443334","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674892,0.00001868243,0.00096745504,0.030059202,0.000040330404,0.0011559346,0.000079726706,0.000011383426,0.00017811665],"genre_scores_gemma":[0.9745009,0.00009907956,0.00036164492,0.024791095,0.00000438159,0.00002540425,0.000199594,0.000004525658,0.000013406228],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988182,0.0003037242,0.00035089708,0.00013050537,0.00024678267,0.00014988873],"domain_scores_gemma":[0.9992301,0.00017034488,0.00005250972,0.00018977579,0.00030011602,0.000057168512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00070224557,0.00007354407,0.00016270988,0.00017095782,0.000057494784,0.0000089285795,0.00008518606,0.000021619464,0.000019162098],"category_scores_gemma":[0.00016886214,0.000041596417,0.000014115914,0.0005700989,0.000050769966,0.000026845142,0.000011146589,0.00015793167,0.0000010949858],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004874387,0.00068161165,0.96919,0.00048171746,0.00009545062,0.000004203123,0.017862823,0.0005865125,0.000040555293,0.002425874,0.001988535,0.0017683015],"study_design_scores_gemma":[0.0026097598,0.00050877535,0.9866901,0.0006258772,0.000027431248,9.0776524e-7,0.0010722313,0.0063048447,0.00021424325,0.00018804446,0.0017109149,0.000046863486],"about_ca_topic_score_codex":0.0029263594,"about_ca_topic_score_gemma":0.0001364275,"teacher_disagreement_score":0.017500078,"about_ca_system_score_codex":0.00008134027,"about_ca_system_score_gemma":0.00022189513,"threshold_uncertainty_score":0.44237995},"labels":[],"label_agreement":null},{"id":"W4412443344","doi":"10.1016/j.jval.2025.04.1983","title":"EE384 Cost Trends of Potentially Inappropriate Medications Among Older Adults between 2012 and 2021 in Quebec, Canada: A Population-Based Repeated Cross-Sectional Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Université de Sherbrooke; Institut National de Santé Publique du Québec; Université Laval; Université du Québec à Rimouski","funders":"","keywords":"Medicine; Cross-sectional study; Demography; Gerontology; Population; Environmental health; Pathology","score_opus":0.12870778238003644,"score_gpt":0.3903189278355892,"score_spread":0.26161114545555275,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98540294,0.0008466818,0.00053405657,0.011023879,0.00039775498,0.0012974228,0.00034455073,0.000013050442,0.00013964936],"genre_scores_gemma":[0.9979422,0.00003055471,0.00033652273,0.00067587604,0.00007629232,0.00017522552,0.00026085178,0.000015830872,0.0004866661],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99301374,0.00077575,0.00506569,0.00060537073,0.0001681556,0.00037128394],"domain_scores_gemma":[0.99657327,0.00094659004,0.0018089492,0.00041630672,0.00008762798,0.0001672487],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011982061,0.0001651893,0.0008885428,0.0010904967,0.00016085063,0.000042600004,0.00018593276,0.00014629406,0.00015873412],"category_scores_gemma":[0.001335272,0.00021925438,0.00004623654,0.0008584085,0.00005800877,0.00026387395,0.0000391311,0.00025917386,0.0000059440586],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000016841255,0.00017019015,0.9913159,0.00033239703,0.00003123349,6.7827546e-7,0.000695058,0.0049894806,2.4196776e-8,0.0013579796,0.00044680623,0.0006434041],"study_design_scores_gemma":[0.0020055354,0.000033821416,0.9836427,0.0002776561,0.0000035441174,1.5870457e-7,0.000396124,0.012944613,2.0617118e-7,0.00032232213,0.00023183948,0.00014145827],"about_ca_topic_score_codex":0.98867255,"about_ca_topic_score_gemma":0.9670734,"teacher_disagreement_score":0.021599177,"about_ca_system_score_codex":0.0021527337,"about_ca_system_score_gemma":0.0021631706,"threshold_uncertainty_score":0.8940934},"labels":[],"label_agreement":null},{"id":"W4412443347","doi":"10.1016/j.jval.2025.04.647","title":"EPH116 Informing Blood Donor Safety and Blood Supply Management in the United States: Factors Affecting Donor Time-To Return After Low Hemoglobin Deferral","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Deferral; Hemoglobin; Blood management; Medicine; Blood donor; Intensive care medicine; Business; Operations management; Blood transfusion; Surgery; Internal medicine; Finance; Economics; Immunology","score_opus":0.014667390000906992,"score_gpt":0.2511360351856662,"score_spread":0.23646864518475919,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443347","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849508,0.00018037521,0.00005854227,0.009588281,0.00016197027,0.0012673059,0.000008163312,0.00007899762,0.00370557],"genre_scores_gemma":[0.9857733,0.00028446337,0.00030802964,0.013143655,0.0000701462,0.000051489893,0.00007756523,0.000021579513,0.00026975136],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980181,0.0001377705,0.00068142626,0.0003814193,0.00029192842,0.0004893738],"domain_scores_gemma":[0.9990334,0.00040585877,0.00020936009,0.00026270773,0.00005469713,0.000033972607],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001923572,0.00025344314,0.00029364956,0.0011409532,0.0002650373,0.0003745511,0.000266846,0.00007798765,0.00014044032],"category_scores_gemma":[0.00011878984,0.00020061132,0.00005127097,0.0020155516,0.000036731453,0.0007970123,0.00016984837,0.0003672451,0.000039155588],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018939092,0.0025023045,0.8921148,0.007971519,0.0005419263,0.00028473788,0.017519912,0.013479406,0.00004925091,0.020096574,0.0016036853,0.04194198],"study_design_scores_gemma":[0.013678973,0.00020108833,0.73005474,0.0035681534,0.0005209327,0.00001800742,0.021902548,0.030318277,0.000110849396,0.0024295133,0.1958497,0.0013472419],"about_ca_topic_score_codex":0.01026189,"about_ca_topic_score_gemma":0.0012064589,"teacher_disagreement_score":0.19424601,"about_ca_system_score_codex":0.000056635206,"about_ca_system_score_gemma":0.00004756012,"threshold_uncertainty_score":0.9963289},"labels":[],"label_agreement":null},{"id":"W4412443371","doi":"10.1016/j.jval.2025.04.1899","title":"EE300 Ferric Derisomaltose for the Treatment of Iron Deficiency Anemia: A Real-World Evidence Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Anemia; Ferric; Medicine; Iron-deficiency anemia; Internal medicine; Chemistry; Inorganic chemistry","score_opus":0.07503608602692598,"score_gpt":0.38997321688262815,"score_spread":0.3149371308557022,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443371","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.95909923,0.032165118,0.00019876951,0.0041913553,0.00027592859,0.003480048,0.0000057938987,0.00002449708,0.00055927184],"genre_scores_gemma":[0.9881456,0.009757363,0.000454926,0.00039872024,0.00004079569,0.0002371459,0.000002524146,0.000010806378,0.00095212477],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856204,0.00016195574,0.0005005378,0.00027015337,0.00019252537,0.00031277243],"domain_scores_gemma":[0.9986226,0.0006930565,0.00012141136,0.00045409644,0.00004299103,0.000065866814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006343309,0.00013397883,0.00038652495,0.00023467174,0.00012172749,0.0000064604187,0.000110364206,0.000035678157,0.00001186039],"category_scores_gemma":[0.00017871,0.00008558979,0.000073855794,0.00067049975,0.000056468296,0.00003374287,0.000015868545,0.00008012862,0.0000024671583],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013892945,0.0076859454,0.86900157,0.0045334273,0.000015769238,0.000013219931,0.013757888,0.0027954974,0.00010096193,0.005832754,0.0013032631,0.093570404],"study_design_scores_gemma":[0.005708185,0.0048349337,0.9789131,0.00047215115,0.00023533573,0.0000021887581,0.00626217,0.0010536968,0.000103178354,0.000443286,0.0018481971,0.00012352296],"about_ca_topic_score_codex":0.026643788,"about_ca_topic_score_gemma":0.0017836782,"teacher_disagreement_score":0.10991158,"about_ca_system_score_codex":0.00023499607,"about_ca_system_score_gemma":0.0007429647,"threshold_uncertainty_score":0.9798379},"labels":[],"label_agreement":null},{"id":"W4412443391","doi":"10.1016/j.jval.2025.04.1178","title":"MSR25 NMCP Delayed Time to Hospital Encounter and Reduced Cost compared to OMCP in Patients with Gastroparesis - A Real World Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Enhanced Recovery After Surgery","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Gastroparesis; Medicine; Internal medicine","score_opus":0.011957397404969025,"score_gpt":0.2817394799176129,"score_spread":0.26978208251264385,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443391","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993871,0.00003102795,0.000039805338,0.0017275366,0.0002039524,0.0036663122,0.000030038322,0.000041539653,0.0003888283],"genre_scores_gemma":[0.99654734,0.0000064175283,0.0010925013,0.001342582,0.00003207408,0.00022107284,0.000023251601,0.000026290698,0.0007084911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775386,0.00023251216,0.0006306996,0.0005410968,0.00032620542,0.0005156155],"domain_scores_gemma":[0.9989337,0.00017783286,0.00009301617,0.0003903532,0.000091119764,0.0003140038],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00055085385,0.00021865324,0.00065675064,0.0008317578,0.00004824269,0.000024261732,0.00009803715,0.00003866012,0.000030893076],"category_scores_gemma":[0.00009924217,0.00019537228,0.000026777607,0.0011898223,0.000023719873,0.00008523897,0.000096987555,0.00024842063,0.000035718123],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0033751298,0.001280679,0.98722637,0.00010173777,0.00004143259,0.000037605765,0.0023043859,0.0006255903,0.000035337704,0.0000017709843,0.0030826854,0.0018873011],"study_design_scores_gemma":[0.0033189917,0.0022523212,0.99209887,0.0014080362,0.000014728156,7.0163793e-7,0.00025528437,0.00022384268,0.00003209695,0.0000040390923,0.00023514048,0.0001559518],"about_ca_topic_score_codex":0.0049085673,"about_ca_topic_score_gemma":0.0019979498,"teacher_disagreement_score":0.004872522,"about_ca_system_score_codex":0.0007389637,"about_ca_system_score_gemma":0.00037162108,"threshold_uncertainty_score":0.796705},"labels":[],"label_agreement":null},{"id":"W4412443423","doi":"10.1016/j.jval.2025.04.1993","title":"EE394 Health Economic Impact of Introducing an Adult-Focused 21-valent PCV in the Canadian Adult Population","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cardiac Imaging and Diagnostics","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Environmental health; Development economics; Economic growth; Socioeconomics; Demography; Medicine; Economics; Sociology","score_opus":0.02201738456089472,"score_gpt":0.34461987266519606,"score_spread":0.32260248810430137,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443423","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9703431,0.0006920753,0.000012792606,0.027329793,0.00039609004,0.0007818463,0.00005856967,0.000018587672,0.00036712037],"genre_scores_gemma":[0.99516815,0.00021604507,0.0003662956,0.0039300895,0.00017392791,0.000015611295,0.00010549876,0.000014285317,0.000010090606],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99804676,0.0004112832,0.00066527934,0.0002748861,0.00014457332,0.00045722697],"domain_scores_gemma":[0.9987945,0.00023651494,0.00016197163,0.0004963347,0.00006464952,0.00024604483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015795268,0.00013073494,0.0004505294,0.0005673736,0.00009652237,0.000020112911,0.00010089639,0.00006287604,0.0000068265563],"category_scores_gemma":[0.0006918709,0.00010770041,0.00009376932,0.00034014843,0.000027911123,0.00005995715,0.0000118799235,0.00032184162,0.0000050222293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006110978,0.00007802834,0.95475113,0.0003477356,0.000013820309,0.0000054016496,0.0030148192,0.026678832,0.0000017152876,0.0026338308,0.0032358698,0.009177715],"study_design_scores_gemma":[0.0012694172,0.00033315067,0.9817115,0.00075271714,0.000009578815,0.000009389573,0.00038659142,0.014882046,0.000006058603,0.00047107562,0.00009446605,0.00007401463],"about_ca_topic_score_codex":0.9778444,"about_ca_topic_score_gemma":0.65076274,"teacher_disagreement_score":0.32708162,"about_ca_system_score_codex":0.0043699765,"about_ca_system_score_gemma":0.0052748756,"threshold_uncertainty_score":0.99945205},"labels":[],"label_agreement":null},{"id":"W4412443433","doi":"10.1016/j.jval.2025.04.1156","title":"MSR3 Parametric Model Selection: Beyond AIC/BIC in Health Economic Context","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Parametric statistics; Context (archaeology); Selection (genetic algorithm); Model selection; Econometrics; Parametric model; Computer science; Economics; Statistics; Mathematics; Machine learning; Geography","score_opus":0.3415811954755114,"score_gpt":0.43774120962852325,"score_spread":0.09616001415301184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443433","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.57941043,0.042991582,0.015233554,0.3415087,0.0036724715,0.005542727,0.00056607067,0.00027341518,0.010801051],"genre_scores_gemma":[0.9450817,0.0021684738,0.0038031007,0.0467564,0.000199099,0.0002784663,0.0000382335,0.000056173605,0.00161835],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9878963,0.0011718982,0.008586091,0.0010409332,0.00010999862,0.0011947306],"domain_scores_gemma":[0.9947053,0.0015601994,0.0026544796,0.00067827775,0.00003865598,0.00036306086],"candidate_categories":["metaresearch","metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.029653108,0.00035469106,0.002042389,0.002823346,0.00029212632,0.00009800794,0.00044863267,0.0002704256,0.00019098674],"category_scores_gemma":[0.0017177709,0.0005128668,0.00015698806,0.001409985,0.00007761679,0.00049851177,0.00007990466,0.00064871466,0.0011016182],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034918994,0.00023603799,0.12154409,0.0016154776,0.00003336834,6.9057194e-7,0.0021845233,0.33268386,1.4278336e-7,0.51090974,0.029127933,0.0016292185],"study_design_scores_gemma":[0.0023621793,0.0002000729,0.024282077,0.00052931224,0.000001741616,0.0000054115644,0.0011014962,0.82824224,0.0000015325872,0.104262,0.03853357,0.00047837358],"about_ca_topic_score_codex":0.07306431,"about_ca_topic_score_gemma":0.007602157,"teacher_disagreement_score":0.49555835,"about_ca_system_score_codex":0.008828967,"about_ca_system_score_gemma":0.003661476,"threshold_uncertainty_score":0.9997323},"labels":[],"label_agreement":null},{"id":"W4412443449","doi":"10.1016/j.jval.2025.04.066","title":"P49 A Health Technology Assessment Framework for Ethics Analysis in Drug Reimbursement Reviews at Canada's Drug Agency","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia","funders":"","keywords":"Reimbursement; Agency (philosophy); Drug; Health technology; Medicine; Business; Actuarial science; Public administration; Political science; Pharmacology; Law; Health care; Sociology; Social science","score_opus":0.07265714092482854,"score_gpt":0.4462006529284476,"score_spread":0.37354351200361907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443449","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"commentary","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.017442226,0.025060073,0.017776765,0.9360078,0.0006409664,0.0028612511,0.000025233852,0.000036368278,0.00014931723],"genre_scores_gemma":[0.8588569,0.0340428,0.05866589,0.04577166,0.00013054868,0.00047312045,0.00024053482,0.000030314828,0.0017882133],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.99648786,0.00061014865,0.0013613321,0.00048241692,0.0005091589,0.00054909947],"domain_scores_gemma":[0.9981713,0.0005985354,0.00039370952,0.0005164193,0.00009726449,0.00022272674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0075418856,0.00017204975,0.00095358794,0.000888785,0.00020765475,0.0000067267747,0.00014581527,0.00036135892,0.000028781436],"category_scores_gemma":[0.000680087,0.00014419416,0.00011933936,0.0025479393,0.00014498502,0.000014042337,0.00007808538,0.0015953921,8.4059394e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00017382661,0.0010613325,0.07378176,0.01948729,0.00047953022,0.00003561956,0.008739939,0.0027357698,0.000023210938,0.64533985,0.036527343,0.21161453],"study_design_scores_gemma":[0.0032289647,0.0005087061,0.16788343,0.013536247,0.00029298774,0.0000048237816,0.0017685408,0.044029158,0.0000391941,0.14332557,0.62489617,0.00048621665],"about_ca_topic_score_codex":0.57558584,"about_ca_topic_score_gemma":0.76311135,"teacher_disagreement_score":0.89023614,"about_ca_system_score_codex":0.0039151744,"about_ca_system_score_gemma":0.009836649,"threshold_uncertainty_score":0.9999086},"labels":[],"label_agreement":null},{"id":"W4412443466","doi":"10.1016/j.jval.2025.04.2076","title":"EE479 Modeling in R: Tutorial for Beginner Using a Cost-Effectiveness Analysis Made With Microsoft Excel","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Impact of AI and Big Data on Business and Society","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Microsoft excel; Computer science; Software engineering; Ms excel; Data science; World Wide Web; Operating system","score_opus":0.29936328249314825,"score_gpt":0.45905638066722076,"score_spread":0.1596930981740725,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443466","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7403183,0.00026124337,0.25734332,0.0008344755,0.00044857603,0.0006874283,0.00007251188,0.000011561187,0.000022611932],"genre_scores_gemma":[0.99520695,0.000040575283,0.0041049058,0.0004252084,0.00010340061,0.000043510678,0.000022318754,0.000008884764,0.0000442358],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9973942,0.0003696909,0.00070858345,0.00053588906,0.0005081677,0.00048348884],"domain_scores_gemma":[0.99799246,0.0011212967,0.00017310181,0.00039789072,0.00022840212,0.00008683347],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060876324,0.00016381501,0.00065370323,0.00076387444,0.00022023138,0.00021760992,0.0003426668,0.00011659969,0.000007888754],"category_scores_gemma":[0.0006468565,0.000115945,0.00015558103,0.0039196596,0.000048888796,0.00031219737,0.00006896094,0.00017474925,0.0000012818617],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003845622,0.00016963828,0.08215087,0.00013314225,0.00006218105,0.0000035124638,0.0007993346,0.90601903,0.00026022687,0.0011249549,0.0001075694,0.008785002],"study_design_scores_gemma":[0.0018415182,0.00006111576,0.017907282,0.00025334166,0.000038389997,0.0000010558683,0.00061124633,0.9746547,0.000060297218,0.0031021878,0.0013008694,0.0001679936],"about_ca_topic_score_codex":0.0133979805,"about_ca_topic_score_gemma":0.00040647713,"teacher_disagreement_score":0.25488868,"about_ca_system_score_codex":0.00037073888,"about_ca_system_score_gemma":0.00086652435,"threshold_uncertainty_score":0.9931719},"labels":[],"label_agreement":null},{"id":"W4412443507","doi":"10.1016/j.jval.2025.04.2033","title":"EE435 Integration of Environmental Considerations in Economic Evaluations: Significant Shift or Token Gesture? Insights From Severe Asthma Treatments","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux","funders":"","keywords":"Security token; Gesture; Asthma; Psychology; Computer science; Business; Medicine; Artificial intelligence; Computer security; Internal medicine","score_opus":0.23387883174058552,"score_gpt":0.40626474496035103,"score_spread":0.1723859132197655,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443507","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97050387,0.004515615,0.0008551898,0.018820332,0.00068842823,0.002167632,0.0013639653,0.000029057166,0.0010559229],"genre_scores_gemma":[0.99231124,0.00064306357,0.0033247857,0.0029474213,0.000077777906,0.00025874958,0.00021796065,0.000022405222,0.0001965754],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99272686,0.0010372635,0.0051033003,0.00068649754,0.0001003749,0.000345681],"domain_scores_gemma":[0.9954871,0.0022209021,0.0016276432,0.00052832335,0.000013836719,0.00012222864],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.004657998,0.00024645022,0.0010949388,0.0008730436,0.00015229917,0.00004998724,0.00017930176,0.00019081635,0.0007316981],"category_scores_gemma":[0.0011718244,0.00028342602,0.00009128009,0.00022736572,0.00007828968,0.00045745555,0.000045644327,0.00023790797,0.00034283812],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021636822,0.0019073907,0.365305,0.0007073959,0.0003207071,0.000009359144,0.030785497,0.08550283,0.00009235706,0.50624865,0.0063158697,0.002588553],"study_design_scores_gemma":[0.0031997617,0.00024173752,0.7838747,0.0006348715,0.000009746726,0.0000019955173,0.0028829093,0.043594725,0.00005100937,0.16339292,0.0017402831,0.00037532015],"about_ca_topic_score_codex":0.030774396,"about_ca_topic_score_gemma":0.008054925,"teacher_disagreement_score":0.4185697,"about_ca_system_score_codex":0.0035498333,"about_ca_system_score_gemma":0.0011876407,"threshold_uncertainty_score":0.9999618},"labels":[],"label_agreement":null},{"id":"W4412443540","doi":"10.1016/j.jval.2025.04.1292","title":"MSR141 Reconciling Discrepancies in Results with Different Population-adjusted Indirect Comparison (PAIC) Methods","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"","keywords":"Statistics; Econometrics; Mathematics","score_opus":0.6762797987268713,"score_gpt":0.6112923117581431,"score_spread":0.06498748696872814,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443540","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7334126,0.0007801249,0.25269148,0.0054194736,0.0017241122,0.0030225073,0.00013503918,0.000305479,0.00250918],"genre_scores_gemma":[0.27640873,0.000052438394,0.72309417,0.00017407225,0.000055177163,0.00006590251,0.000008074214,0.00002401146,0.00011745758],"study_design_codex":"observational","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.987883,0.0074873175,0.0030041493,0.0006671414,0.00037531304,0.0005831075],"domain_scores_gemma":[0.91370046,0.0848103,0.00066564925,0.00061540323,0.00006719031,0.00014102628],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.013947453,0.00027232355,0.0016086077,0.0003961515,0.00009380683,0.000036545443,0.00025243472,0.00020112672,0.000017448334],"category_scores_gemma":[0.09656158,0.00021007411,0.00008057717,0.0010173181,0.00008531064,0.000055507975,0.00009510284,0.00072007364,0.000001928747],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030478025,0.0016976291,0.46432412,0.0038646199,0.00016303231,0.000025120215,0.0045518144,0.005784277,0.00003086687,0.3258679,0.0006576828,0.18998516],"study_design_scores_gemma":[0.0034687927,0.00035752344,0.22981332,0.0031808144,0.000038965365,0.0000015446238,0.000514391,0.0355617,0.00030557165,0.72613734,0.00029872704,0.00032131586],"about_ca_topic_score_codex":0.006000277,"about_ca_topic_score_gemma":0.002491762,"teacher_disagreement_score":0.47040266,"about_ca_system_score_codex":0.00061085704,"about_ca_system_score_gemma":0.00024105905,"threshold_uncertainty_score":0.9110485},"labels":[],"label_agreement":null},{"id":"W4412443554","doi":"10.1016/j.jval.2025.04.228","title":"CO143 Outcomes In Patients With Asthma and Coexisting Allergic Rhinitis Who Started Dupilumab Treatment In Real-World Clinical Practice: A RAPID Registry Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"Incyte; Sanofi; Regeneron Pharmaceuticals; Teva Pharmaceutical Industries; Genentech; AstraZeneca; Pfizer; Amgen","keywords":"Dupilumab; Medicine; Asthma; Allergic asthma; Family medicine; Internal medicine","score_opus":0.053912521869073485,"score_gpt":0.40098024290196144,"score_spread":0.34706772103288797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443554","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993752,0.00063254393,0.0000015898431,0.0021880884,0.000108923065,0.0023140276,0.00002052082,0.0000359124,0.0009463884],"genre_scores_gemma":[0.9974227,0.0004030963,0.0003087412,0.0013565941,0.000033736284,0.00009426288,0.000024903635,0.000021890832,0.00033409437],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996505,0.0010611607,0.0011651883,0.00053570565,0.0003364982,0.00039643957],"domain_scores_gemma":[0.99791825,0.0010804473,0.0003257574,0.0003914089,0.00008072119,0.0002034323],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010573067,0.00023962735,0.0009063203,0.0004238095,0.000082821614,0.000021009962,0.000066737295,0.00008077622,0.000012778099],"category_scores_gemma":[0.00090735906,0.00017982005,0.000048151258,0.0006015613,0.00009449665,0.00009673924,0.000045685236,0.000378803,0.0000020851767],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021028551,0.0058294944,0.9731494,0.00019636421,0.00006687258,0.00042592752,0.0010871699,0.00006146332,5.2489362e-8,0.00003688111,0.00015347372,0.016889997],"study_design_scores_gemma":[0.01884465,0.0052320864,0.968886,0.0010254072,0.000030095785,0.0000022683619,0.0025254767,0.0003380421,2.0230368e-7,0.00001012895,0.002976587,0.00012904905],"about_ca_topic_score_codex":0.013944437,"about_ca_topic_score_gemma":0.0066517317,"teacher_disagreement_score":0.016760949,"about_ca_system_score_codex":0.0005605421,"about_ca_system_score_gemma":0.0012206872,"threshold_uncertainty_score":0.9926218},"labels":[],"label_agreement":null},{"id":"W4412443577","doi":"10.1016/j.jval.2025.04.023","title":"P16 The Impact of Hallucinations in Synthetic Health Data on Prognostic Machine Learning Models","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Machine Learning in Healthcare","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Computer science; Machine learning; Artificial intelligence; Psychology","score_opus":0.11100579402999132,"score_gpt":0.39154064078494666,"score_spread":0.2805348467549553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443577","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2977275,0.022647997,0.33292398,0.33209187,0.0013734502,0.008235759,0.00021561698,0.00074512436,0.0040386883],"genre_scores_gemma":[0.9944383,0.0003610914,0.0043301294,0.0007192949,0.000017044142,0.000034304783,0.000027411086,0.000015349948,0.000057071895],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99475974,0.0025466098,0.0009886541,0.000673368,0.00039943957,0.00063220045],"domain_scores_gemma":[0.9957088,0.001993851,0.00043179272,0.0016726127,0.00006266247,0.00013027871],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005442759,0.00019749085,0.00046349873,0.0006342779,0.0002550861,0.000051743857,0.0019169626,0.000066818,0.000005157145],"category_scores_gemma":[0.0017225608,0.00014579338,0.000058325488,0.0017314424,0.000050444003,0.00026024497,0.00055212167,0.001156236,0.0000054600964],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010586238,0.00017379574,0.052883852,0.0003602992,0.0000070836104,0.0000027832496,0.0019901195,0.8500856,4.4772253e-7,0.06276101,0.00010698059,0.03161745],"study_design_scores_gemma":[0.0002783704,0.00043709253,0.07718691,0.0009854552,9.255083e-7,0.00000445955,0.000041567182,0.9130757,5.902328e-7,0.0078102555,0.00009585529,0.000082828774],"about_ca_topic_score_codex":0.12403985,"about_ca_topic_score_gemma":0.0016098089,"teacher_disagreement_score":0.6967108,"about_ca_system_score_codex":0.00069064216,"about_ca_system_score_gemma":0.0026991365,"threshold_uncertainty_score":0.88179326},"labels":[],"label_agreement":null},{"id":"W4412443590","doi":"10.1016/j.jval.2025.04.877","title":"HPR153 The Reimbursement Status of Ustekinumab Across HTAs: A Global Perspective","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical Economics and Policy","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Ustekinumab; Reimbursement; Perspective (graphical); Medicine; Data science; Computer science; Internal medicine; Economics; Economic growth; Artificial intelligence; Disease","score_opus":0.10754833739723527,"score_gpt":0.40213819708472887,"score_spread":0.2945898596874936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7699216,0.032663707,0.00064883905,0.0616656,0.001538023,0.0012372688,0.0022839156,0.000036872483,0.1300042],"genre_scores_gemma":[0.99262714,0.0025387492,0.00014218596,0.004452697,0.000050890652,0.000023850302,0.0000032829764,0.000007392197,0.00015380359],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9981796,0.000054234177,0.0008102962,0.0003089951,0.000027224893,0.0006196634],"domain_scores_gemma":[0.9991212,0.00011170117,0.00029717415,0.0003319046,0.000026713647,0.00011131784],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001049541,0.00011527597,0.00038594494,0.00008654187,0.00009988426,0.00003255985,0.00025386416,0.00005785169,0.00006635565],"category_scores_gemma":[0.00017499128,0.00011184591,0.000093752846,0.0004448911,0.00010276392,0.00006103795,0.00010950112,0.00018963916,0.000058985697],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030002453,0.00009757842,0.034994826,0.000069773574,0.000036800087,5.6274945e-7,0.0013961282,0.001825631,4.2172329e-7,0.9588049,0.0012051864,0.0015381793],"study_design_scores_gemma":[0.0019821494,0.00015460096,0.109710865,0.00010606229,0.000004382416,0.0000018657659,0.002599956,0.023938853,0.0000235123,0.53383833,0.32739732,0.00024211],"about_ca_topic_score_codex":0.033286877,"about_ca_topic_score_gemma":0.00048710458,"teacher_disagreement_score":0.4249666,"about_ca_system_score_codex":0.0017535466,"about_ca_system_score_gemma":0.0002864002,"threshold_uncertainty_score":0.97315055},"labels":[],"label_agreement":null},{"id":"W4412443616","doi":"10.1016/j.jval.2025.04.1291","title":"MSR140 Adapting PRISMA For System Dynamics Models In Healthcare: A Case Study Of Transcatheter Aortic Valve Implantation In Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Complex Systems and Decision Making","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"System dynamics; Healthcare system; Health care; Medicine; Cardiology; Business; Computer science; Economics; Artificial intelligence; Economic growth","score_opus":0.1839496556691747,"score_gpt":0.41089611836339907,"score_spread":0.22694646269422436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97092867,0.0006038199,0.025070246,0.0004100055,0.0005049096,0.0023835849,0.000049952596,0.000010409025,0.0000384214],"genre_scores_gemma":[0.9989796,0.000002617252,0.00074216095,0.000104399274,0.000012197598,0.00013070928,0.0000014078018,0.000012038703,0.0000148607105],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9936804,0.0011561248,0.0031856648,0.00060607825,0.0008929338,0.00047879815],"domain_scores_gemma":[0.99525553,0.0033219575,0.000624018,0.00050981046,0.00018669924,0.0001019552],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007141145,0.00016771292,0.00081649446,0.0010703196,0.00011027659,0.00004944238,0.00035265202,0.00006317002,9.2988375e-7],"category_scores_gemma":[0.00034051767,0.00014721723,0.00011012992,0.0017837683,0.0000098969585,0.00014803665,0.000054536347,0.00021270938,3.5407817e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023156118,0.0003149932,0.21763128,0.0013133035,0.00001816704,0.00021719447,0.017805485,0.68560565,0.000002017988,0.021717573,0.000057239442,0.055085517],"study_design_scores_gemma":[0.0013741947,0.00016281572,0.0132448245,0.00060855097,0.0000035879627,0.00009656431,0.060370885,0.9164475,3.8382385e-7,0.007583144,0.000006007103,0.00010154647],"about_ca_topic_score_codex":0.99041337,"about_ca_topic_score_gemma":0.9932967,"teacher_disagreement_score":0.23084183,"about_ca_system_score_codex":0.0025570262,"about_ca_system_score_gemma":0.0029004014,"threshold_uncertainty_score":0.6686534},"labels":[],"label_agreement":null},{"id":"W4412443681","doi":"10.1016/j.jval.2025.04.1108","title":"HTA97 Is the Assumption of Treatment Waning Applied Consistently Across Canada’s Drug Agency Reimbursement Reviews? Reviewing Pharmacoeconomic Assessments of Disease Modifying Therapies for the Treatment of Multiple Sclerosis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Agency (philosophy); Medicine; Multiple sclerosis; Disease; Intensive care medicine; Drug; Pharmacology; Psychiatry; Internal medicine; Economics; Economic growth; Health care","score_opus":0.5639303812046019,"score_gpt":0.4766881942556768,"score_spread":0.0872421869489251,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443681","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7718395,0.18440768,0.0016014668,0.02962841,0.00091937155,0.009645961,0.0018029917,0.000012502778,0.00014212367],"genre_scores_gemma":[0.9268718,0.068333596,0.0010002583,0.0023676078,0.000056531015,0.0011727378,0.000028256753,0.00002066887,0.00014854339],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99344087,0.00055233133,0.005023509,0.00047679478,0.00010623901,0.0004002684],"domain_scores_gemma":[0.9928749,0.0023932802,0.0038528335,0.0007128754,0.000072860756,0.00009321363],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012236046,0.00024575696,0.0014785365,0.00010850774,0.00032595798,0.000022222415,0.00027361888,0.000039549384,0.000034506527],"category_scores_gemma":[0.00038288566,0.00019409158,0.00027970917,0.00017907651,0.00008063275,0.00009802801,0.000029311504,0.00006682805,0.0000041064363],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001003036,0.0036445025,0.41624328,0.040351536,0.003870606,5.6225275e-7,0.1065238,0.08796035,0.0002117904,0.044178452,0.019392075,0.27662],"study_design_scores_gemma":[0.018526783,0.0013565759,0.2315838,0.009338158,0.0005058284,6.4110276e-7,0.019846287,0.20761326,0.0009572204,0.0054122363,0.50360274,0.0012564816],"about_ca_topic_score_codex":0.35093766,"about_ca_topic_score_gemma":0.028161608,"teacher_disagreement_score":0.48421064,"about_ca_system_score_codex":0.00410817,"about_ca_system_score_gemma":0.0013299327,"threshold_uncertainty_score":0.9997149},"labels":[],"label_agreement":null},{"id":"W4412443712","doi":"10.1016/j.jval.2025.04.1579","title":"PT31 Psychometric Testing of the ICECAP-A in Patients With Coeliac Disease: A Comparative Analysis With EQ-5D-5L","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Celiac Disease Research and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Montreal General Hospital","funders":"","keywords":"Coeliac disease; Psychometric testing; Medicine; Reliability engineering; Disease; Internal medicine; Psychometrics; Clinical psychology; Engineering; Internal consistency","score_opus":0.06971808862903847,"score_gpt":0.349959236373983,"score_spread":0.2802411477449446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99363744,0.0013995371,0.00012310133,0.0013513587,0.00002771979,0.0017057754,0.000032330525,0.000014263606,0.0017084534],"genre_scores_gemma":[0.99896824,0.00006853223,0.00035497238,0.00033678487,0.0000082045435,0.00006400513,0.00002639669,0.000006585492,0.00016625677],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980842,0.0002320405,0.00038280003,0.00030162185,0.00063769316,0.0003616404],"domain_scores_gemma":[0.9987803,0.00022479083,0.0001528395,0.00044480438,0.0001694372,0.00022779961],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047753565,0.00012897806,0.00046807883,0.0012963429,0.00005764616,0.000011552896,0.00013300737,0.00001849577,0.000015120065],"category_scores_gemma":[0.00025622075,0.00007726299,0.00006193002,0.009997919,0.00008764922,0.000042117834,0.00006453408,0.00020278143,0.0000017503918],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010318157,0.00096091244,0.9877398,0.0007968933,0.00023902264,0.0000053496397,0.00018371826,0.0066367546,5.153804e-7,0.00017183257,0.0003088396,0.0019245573],"study_design_scores_gemma":[0.0031206694,0.00044747433,0.9883377,0.0011318484,0.00018256204,6.615203e-8,0.00020593061,0.0061714416,0.0000027651124,0.00004528695,0.0002880279,0.00006620713],"about_ca_topic_score_codex":0.0035571533,"about_ca_topic_score_gemma":0.00038822702,"teacher_disagreement_score":0.008701576,"about_ca_system_score_codex":0.00029313355,"about_ca_system_score_gemma":0.0007739033,"threshold_uncertainty_score":0.53773755},"labels":[],"label_agreement":null},{"id":"W4412443741","doi":"10.1016/j.jval.2025.04.1566","title":"PCR249 Impact of Cardiovascular, Renal and Metabolic Comorbidities on Activity and Health-Related Quality of Life in Patients with Metabolic Dysfunction-Associated Steatohepatitis in France, Italy, Germany, and Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McGill University","funders":"","keywords":"Steatohepatitis; Medicine; Gerontology; Quality of life (healthcare); Metabolic syndrome; Environmental health; Internal medicine; Fatty liver; Obesity; Disease; Nursing","score_opus":0.02140937164230646,"score_gpt":0.2751149044740203,"score_spread":0.2537055328317139,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443741","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.975695,0.022753155,5.192387e-7,0.0003301549,0.000043476615,0.00084649376,0.00030090238,0.0000053886615,0.000024892468],"genre_scores_gemma":[0.99497604,0.0047840695,0.000008388393,0.00013869519,0.0000038060152,0.00003278501,0.000041656713,0.000009232685,0.000005308986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979919,0.00054918096,0.0006128487,0.00027415875,0.0003294435,0.00024247683],"domain_scores_gemma":[0.99908394,0.00019973425,0.0002704621,0.00019899549,0.00006695931,0.00017990563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071179017,0.00016944093,0.0012632443,0.00028684913,0.000041061558,0.000005066288,0.000025285548,0.000058324327,0.000003309512],"category_scores_gemma":[0.000096484204,0.00013491763,0.0000650431,0.00040298098,0.000068138914,0.00006642633,0.000023453684,0.00017054095,3.8534022e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026856802,0.00072045904,0.9945334,0.0004853133,0.0007774624,0.0000047275157,0.0003530763,0.00052504305,5.664707e-7,0.00010668136,0.000033093598,0.002191582],"study_design_scores_gemma":[0.008469313,0.00052129844,0.98981273,0.00075632776,0.00008532046,3.914885e-7,0.00005249944,0.00017230329,0.000013070935,0.000024693947,0.000012704999,0.000079354984],"about_ca_topic_score_codex":0.98214006,"about_ca_topic_score_gemma":0.42864046,"teacher_disagreement_score":0.55349964,"about_ca_system_score_codex":0.0003778933,"about_ca_system_score_gemma":0.001707776,"threshold_uncertainty_score":0.5817854},"labels":[],"label_agreement":null},{"id":"W4412443773","doi":"10.1016/j.jval.2025.04.469","title":"EE177 Cost-Minimization: Consequences of Using the Lowest Cost Comparator Over the Weighted Average Cost (WAC)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Manufacturing Process and Optimization","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institut National d'Excellence en Santé et en Services Sociaux","funders":"","keywords":"Cost-minimization analysis; Comparator; Minification; Statistics; Mathematics; Medicine; Mathematical optimization; Electrical engineering; Engineering; Internal medicine","score_opus":0.038209145996135625,"score_gpt":0.2924418483735544,"score_spread":0.2542327023774188,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443773","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7054232,0.0072176754,0.2682922,0.004961314,0.003237482,0.005867917,0.00017928207,0.00038467493,0.004436259],"genre_scores_gemma":[0.9980135,0.00060893124,0.0007306147,0.00048597474,0.000042184736,0.000040753806,0.000016238739,0.000014926101,0.000046849764],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9988871,0.00013075977,0.00044658929,0.0001437849,0.00015951949,0.00023221655],"domain_scores_gemma":[0.99931544,0.00022850065,0.000116557196,0.0002442272,0.00005436947,0.000040889066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037108708,0.00013390536,0.00022076104,0.00009671195,0.0001815678,0.000049249593,0.00021307118,0.0000606405,0.0000673941],"category_scores_gemma":[0.00003522912,0.00009041548,0.000029832761,0.00047042733,0.000111694615,0.000085017244,0.00002789669,0.00019465627,0.0000023987782],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000099560375,0.000016154981,0.0028382463,0.00026279804,0.00001250122,8.1907103e-7,0.0004852634,0.9930112,0.00001480919,0.0020442866,0.00053291686,0.00077109976],"study_design_scores_gemma":[0.0004005353,0.000011614818,0.0045722057,0.00031849166,0.000008815402,0.0000029641628,0.00012875922,0.9824923,0.0015313595,0.00024987533,0.010177118,0.00010594106],"about_ca_topic_score_codex":0.0009889214,"about_ca_topic_score_gemma":0.0000871006,"teacher_disagreement_score":0.29259032,"about_ca_system_score_codex":0.00016744752,"about_ca_system_score_gemma":0.0002265102,"threshold_uncertainty_score":0.36870363},"labels":[],"label_agreement":null},{"id":"W4412443816","doi":"10.1016/j.jval.2025.04.497","title":"EE206 Cost-Effectiveness of a Hypothetical Dementia Prevention Treatment for Stroke Survivors","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Dementia; Medicine; Stroke (engine); Physical medicine and rehabilitation; Internal medicine; Engineering","score_opus":0.4660858779480102,"score_gpt":0.4778538709705853,"score_spread":0.011767993022575085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8738207,0.0075022127,0.08833248,0.0151381465,0.0016207966,0.009996205,0.0010206716,0.00005658466,0.0025121842],"genre_scores_gemma":[0.9928307,0.00033027903,0.0044541843,0.00072318397,0.00005637697,0.0010754997,0.000049649443,0.000022135024,0.0004579874],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.99483156,0.001108261,0.0031581554,0.00045341946,0.00005599866,0.00039258288],"domain_scores_gemma":[0.99575394,0.0027065247,0.0010565302,0.0003425555,0.00004437798,0.00009605623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019671192,0.00014884732,0.0009991946,0.00045586194,0.0000968491,0.000017930974,0.00013811969,0.00010877765,0.000039158946],"category_scores_gemma":[0.0012821825,0.00018492123,0.00016129055,0.00021822505,0.00004427296,0.00011561821,0.000021888827,0.00007252594,0.00004181468],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022135128,0.0010359705,0.20617312,0.0051298914,0.0002503201,2.5604652e-7,0.00086454017,0.00713343,0.000007932208,0.7736478,0.0006491379,0.0048862575],"study_design_scores_gemma":[0.017189058,0.0033833547,0.39470616,0.0032831216,0.00006747326,0.00000312115,0.0015344712,0.13269918,0.00039322983,0.34925854,0.096551724,0.00093057577],"about_ca_topic_score_codex":0.010638764,"about_ca_topic_score_gemma":0.0006644136,"teacher_disagreement_score":0.42438924,"about_ca_system_score_codex":0.0013862012,"about_ca_system_score_gemma":0.0005529137,"threshold_uncertainty_score":0.9959495},"labels":[],"label_agreement":null},{"id":"W4412443820","doi":"10.1016/j.jval.2025.04.1303","title":"MSR152 A Checklist to Facilitate Reporting of Real-World Evidence (RWE) Submitted to Canada's Drug Agency (CDA-AMC) for a Drug Product Under Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Checklist; Agency (philosophy); Drug; Real world evidence; Product (mathematics); Medicine; Pharmacology; Business; Psychology; Internal medicine","score_opus":0.5622885618138144,"score_gpt":0.46825309431633366,"score_spread":0.09403546749748071,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443820","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.24007137,0.051341485,0.0021946682,0.69099385,0.0016714201,0.0110569885,0.0009570299,0.00007570922,0.0016374489],"genre_scores_gemma":[0.7654718,0.0105345305,0.019261375,0.172679,0.00044505522,0.002828726,0.00009554066,0.00012714218,0.028556813],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.982548,0.00083265867,0.014327299,0.0012103786,0.00020998085,0.0008716891],"domain_scores_gemma":[0.9891278,0.002344893,0.0066058496,0.001217102,0.00027741873,0.00042693186],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06254801,0.00029688087,0.0022941434,0.00074780034,0.00021139567,0.00002764303,0.00049568544,0.000047400383,0.000048797134],"category_scores_gemma":[0.039705835,0.0003782195,0.00016562906,0.0016083845,0.000035536177,0.00018533196,0.00011156732,0.00024069843,0.000055968372],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010168553,0.00021211804,0.09690035,0.07836917,0.00012175949,0.000004449668,0.011096453,0.011563441,0.000009927513,0.049478166,0.7488444,0.003298083],"study_design_scores_gemma":[0.0014915541,0.00024438428,0.3797926,0.05389038,0.0000421908,0.0000061904093,0.0023229253,0.0058112964,0.00008347521,0.02263725,0.5319875,0.0016902584],"about_ca_topic_score_codex":0.9240184,"about_ca_topic_score_gemma":0.73362404,"teacher_disagreement_score":0.52540046,"about_ca_system_score_codex":0.0039444673,"about_ca_system_score_gemma":0.005408231,"threshold_uncertainty_score":0.99987924},"labels":[],"label_agreement":null},{"id":"W4412443867","doi":"10.1016/j.jval.2025.04.1831","title":"SA76 Indication Screening: Using Early Health Technology Assessment to Prioritize Potential Target Indications for Platform Health Technologies","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Health technology; Medicine; Risk analysis (engineering); Data science; Computer science; Health care; Economic growth; Economics","score_opus":0.3595916467732638,"score_gpt":0.4807475242151035,"score_spread":0.12115587744183975,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443867","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06288595,0.0060367063,0.49820918,0.42638862,0.0006278798,0.0048882286,0.00052655564,0.00033521693,0.00010167931],"genre_scores_gemma":[0.69436085,0.0004959124,0.28718555,0.01674966,0.00009485458,0.0008468741,0.00013005876,0.000051394785,0.00008481797],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99113595,0.00035592786,0.0060792184,0.0010483413,0.00016871376,0.0012118358],"domain_scores_gemma":[0.9944872,0.0005466544,0.0037701153,0.00086279365,0.00009755703,0.00023567096],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.020368442,0.00029940365,0.0015350915,0.003599592,0.00090883195,0.00009959617,0.0006274412,0.00034876008,0.000015296071],"category_scores_gemma":[0.0022452811,0.0004141205,0.0001170791,0.0018598005,0.000117724354,0.0003698026,0.00016944119,0.00054099015,0.000045858804],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031460448,0.0003467022,0.087084495,0.0020787173,0.0000825398,4.3951263e-7,0.0022130967,0.012160451,0.0000037928885,0.87646717,0.0064579905,0.013073166],"study_design_scores_gemma":[0.0053470437,0.0022575774,0.23659892,0.0032552278,0.000011469383,0.000018114033,0.017861849,0.15772311,0.000023943145,0.4750232,0.10043343,0.0014461003],"about_ca_topic_score_codex":0.011002106,"about_ca_topic_score_gemma":0.00025709785,"teacher_disagreement_score":0.6314749,"about_ca_system_score_codex":0.0048373523,"about_ca_system_score_gemma":0.004075742,"threshold_uncertainty_score":0.9998311},"labels":[],"label_agreement":null},{"id":"W4412443876","doi":"10.1016/j.jval.2025.04.227","title":"CO142 Association Between Event-Free/Distant Relapse-Free Survival and Overall Survival in Patients With Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Luminex (Canada)","funders":"","keywords":"Estrogen receptor; Oncology; Human Epidermal Growth Factor Receptor 2; Breast cancer; Stage (stratigraphy); Internal medicine; Medicine; Overall survival; Estrogen; Association (psychology); Cancer; Biology; Psychology; Psychotherapist","score_opus":0.021796428215652187,"score_gpt":0.3126796995815,"score_spread":0.2908832713658478,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9876352,0.00025729847,0.000009440695,0.006300174,0.00059972407,0.0016430327,0.0031465772,0.000047787493,0.0003607477],"genre_scores_gemma":[0.9973915,0.0003751667,0.00018150268,0.000291962,0.00021123071,0.000108948465,0.00039923177,0.000046247413,0.000994213],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9964717,0.00091915816,0.0007496436,0.00061463733,0.0005484074,0.0006964372],"domain_scores_gemma":[0.99811095,0.00063453015,0.00044187694,0.00032895544,0.0002167833,0.0002668775],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00070964056,0.0003615823,0.00089836936,0.000288376,0.00017204207,0.000028645438,0.00019047676,0.00021657998,0.00025111414],"category_scores_gemma":[0.00017415915,0.0003300927,0.000075858006,0.0004969128,0.00009032232,0.00019658558,0.00012925966,0.0006005176,0.0000042220404],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001832997,0.000507758,0.99329466,0.00026074683,0.00035357662,0.0000070840674,0.0010921865,0.000023524073,0.00005120454,0.00070659834,0.0012665518,0.00060309126],"study_design_scores_gemma":[0.017106961,0.0011235737,0.9799847,0.00056976406,0.00009231037,3.3707676e-7,0.00009782477,0.000018039811,0.00020955823,0.00029450297,0.00025681124,0.00024563872],"about_ca_topic_score_codex":0.074909285,"about_ca_topic_score_gemma":0.0040836185,"teacher_disagreement_score":0.070825666,"about_ca_system_score_codex":0.0036577347,"about_ca_system_score_gemma":0.00071940874,"threshold_uncertainty_score":0.9999151},"labels":[],"label_agreement":null},{"id":"W4412443922","doi":"10.1016/j.jval.2025.04.202","title":"CO117 Prenatal Exposure to Antiseizure Medications and Congenital Malformation Risk in Offspring:A Population-Based Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Manitoba Health; University of Manitoba","funders":"","keywords":"Offspring; Medicine; Prenatal exposure; Obstetrics; Pediatrics; Pregnancy; Genetics; Biology","score_opus":0.052135066205723696,"score_gpt":0.3979382680527687,"score_spread":0.34580320184704505,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9853417,0.0013007809,0.00018082032,0.0115229115,0.00011673357,0.0012472018,0.000020112777,0.00002141152,0.00024828556],"genre_scores_gemma":[0.9981196,0.00020632644,0.0005115348,0.0010331911,0.00002525962,0.000055885434,0.000018854986,0.0000045602264,0.00002476827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99887586,0.00020437138,0.00039532452,0.00017560535,0.00017276798,0.00017608263],"domain_scores_gemma":[0.999279,0.00034850123,0.00008874909,0.00012759685,0.000039375045,0.000116760166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00083225756,0.00007984543,0.00020922026,0.00019539076,0.000114988936,0.000013041001,0.000042704425,0.000038203136,0.000015603571],"category_scores_gemma":[0.0005789973,0.00007154632,0.000012730683,0.00049254484,0.000013604421,0.00008633936,0.000034745,0.00024766952,0.000003879505],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013369347,0.0002914445,0.9877666,0.000215868,0.000020910551,0.000005885444,0.0010564377,0.001040141,0.000002887027,0.00016740784,0.00006315649,0.009235536],"study_design_scores_gemma":[0.0020145755,0.00032248654,0.983044,0.00020161805,0.000033153236,0.000001578344,0.00084085244,0.012203557,0.000009519309,0.000050803115,0.0012235139,0.000054292042],"about_ca_topic_score_codex":0.010535418,"about_ca_topic_score_gemma":0.0014422958,"teacher_disagreement_score":0.012777877,"about_ca_system_score_codex":0.00013704777,"about_ca_system_score_gemma":0.00017627125,"threshold_uncertainty_score":0.9960535},"labels":[],"label_agreement":null},{"id":"W4412443923","doi":"10.1016/j.jval.2025.04.122","title":"CO37 A Clinical Prediction Model of Asymptomatic Left Ventricular Dysfunction in Survivors of Childhood Cancer in Ontario, Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network; Hospital for Sick Children","funders":"","keywords":"Asymptomatic; Childhood cancer; Medicine; Internal medicine; Cancer; Cardiology; Pediatrics","score_opus":0.03625909761759944,"score_gpt":0.3256033927102128,"score_spread":0.2893442950926134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99404854,0.0010023429,0.00018991313,0.0026983847,0.00080056104,0.0010214979,0.00005256765,0.000015561267,0.00017064999],"genre_scores_gemma":[0.9984222,0.000294286,0.00021791818,0.0008780082,0.00003763686,0.000028697013,0.00002615277,0.000014614469,0.00008048218],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9960149,0.00053403934,0.0021886386,0.00036776444,0.0005549105,0.00033972782],"domain_scores_gemma":[0.9986413,0.0003462866,0.0004404846,0.00036605485,0.000079889905,0.00012597957],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002610572,0.00016414814,0.00095410744,0.000454955,0.000021663387,0.0000025114268,0.000112232265,0.00015331601,0.000037883743],"category_scores_gemma":[0.0004231541,0.00017438167,0.00008982669,0.00062844605,0.00004936638,0.000061290004,0.0000384905,0.00061076594,2.7526121e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015981856,0.00063782214,0.89547586,0.0011027307,0.00004261871,0.000005943098,0.0021025217,0.09935006,0.0000070381875,0.00010340378,0.00023570524,0.0007764737],"study_design_scores_gemma":[0.0033784518,0.0002282304,0.92250127,0.0036865138,0.000026370188,0.0000029611977,0.0003724815,0.06927377,0.00006287218,0.00031181832,0.00006764474,0.000087622895],"about_ca_topic_score_codex":0.9978533,"about_ca_topic_score_gemma":0.99866676,"teacher_disagreement_score":0.030076288,"about_ca_system_score_codex":0.0026687838,"about_ca_system_score_gemma":0.014578042,"threshold_uncertainty_score":0.9910084},"labels":[],"label_agreement":null},{"id":"W4412443927","doi":"10.1016/j.jval.2025.04.520","title":"EE230 The Real-World Cost-Effectiveness of Faricimab Versus Existing and Future Biosimilars in Patients with Neovascular Age-Related Macular Degeneration in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Macular degeneration; Biosimilar; Medicine; Ophthalmology; Optometry; Internal medicine","score_opus":0.18672636671109538,"score_gpt":0.3700463229583275,"score_spread":0.18331995624723213,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443927","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98859113,0.002916692,0.0000590124,0.0054719453,0.00051761494,0.0019319789,0.00006235865,0.000006885745,0.00044240043],"genre_scores_gemma":[0.9982098,0.00029874803,0.0002570087,0.0010224744,0.000019755338,0.00011208741,0.000053823132,0.00001526864,0.000011080237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99560624,0.0012124517,0.0023262743,0.00041167066,0.00010297881,0.00034036182],"domain_scores_gemma":[0.9976046,0.0011395083,0.0008455927,0.00032095623,0.00003926456,0.000050064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011024135,0.0001530776,0.00076604943,0.0005186617,0.000095960895,0.000020192374,0.0001419623,0.00007860626,0.000007782949],"category_scores_gemma":[0.0005001556,0.00015679037,0.000029258728,0.00093084126,0.000042831456,0.0001275948,0.000032556338,0.0002568879,0.0000014824664],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012887242,0.00006523978,0.9350036,0.0007830047,0.000031720076,0.0000022160998,0.00080914394,0.03908363,2.7126242e-7,0.02320925,0.000073730844,0.0008093245],"study_design_scores_gemma":[0.0039588762,0.00006500382,0.9768395,0.0005080903,0.000003672772,1.479001e-7,0.00047531794,0.015492877,0.0000034370917,0.0011566426,0.001347757,0.00014866746],"about_ca_topic_score_codex":0.8961107,"about_ca_topic_score_gemma":0.8018665,"teacher_disagreement_score":0.09424427,"about_ca_system_score_codex":0.0036145516,"about_ca_system_score_gemma":0.0013087641,"threshold_uncertainty_score":0.9451927},"labels":[],"label_agreement":null},{"id":"W4412443976","doi":"10.1016/j.jval.2025.04.868","title":"HPR144 Factors Delaying the Public Listing of New Drugs in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto","funders":"","keywords":"Listing (finance); Business; Finance","score_opus":0.4317824058761227,"score_gpt":0.4091372046130519,"score_spread":0.02264520126307079,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443976","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8910357,0.0043802327,0.00034398402,0.10127071,0.00085139455,0.0005844021,0.000057028446,0.000011684531,0.0014648903],"genre_scores_gemma":[0.9914077,0.00016242186,0.00054885296,0.0075667487,0.0000617121,0.000019637746,0.000008335951,0.000013550516,0.00021107502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99410665,0.0005311317,0.0043806946,0.00035924974,0.00009507365,0.0005272085],"domain_scores_gemma":[0.99543786,0.0024031906,0.0015760203,0.00041088654,0.000026893646,0.00014513769],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014729591,0.00013293211,0.0007899213,0.0004767058,0.00013224356,0.000032209267,0.0003585688,0.00006579732,0.000061680665],"category_scores_gemma":[0.004353068,0.00014442355,0.00004979626,0.00072041794,0.000027342792,0.00017957903,0.00005738367,0.00028537092,0.000018118337],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.0000026933508,0.000021199316,0.8755064,0.00048615749,0.000011737813,2.774031e-7,0.004302474,0.004095439,9.908972e-8,0.107811294,0.007118886,0.0006433557],"study_design_scores_gemma":[0.001351375,0.000042546006,0.81941366,0.0008988421,0.0000022411348,0.0000013329922,0.021805314,0.070471756,0.0000041257963,0.028941114,0.056671295,0.0003964059],"about_ca_topic_score_codex":0.9905832,"about_ca_topic_score_gemma":0.858727,"teacher_disagreement_score":0.1318562,"about_ca_system_score_codex":0.003952935,"about_ca_system_score_gemma":0.007861759,"threshold_uncertainty_score":0.9998707},"labels":[],"label_agreement":null},{"id":"W4412443996","doi":"10.1016/j.jval.2025.04.087","title":"CO2 Differential Effect of Transdiagnostic Cognitive-Behaviour Therapy on Health-Related Quality of Life According to the Number of Anxiety Comorbidities","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health Research Topics","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval; La Boîte à lettres; Université de Sherbrooke","funders":"","keywords":"Anxiety; Cognitive behaviour therapy; Quality of life (healthcare); Psychology; Clinical psychology; Cognition; Psychotherapist; Psychiatry","score_opus":0.13571995501308673,"score_gpt":0.48072394851149997,"score_spread":0.34500399349841326,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412443996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9897216,0.0013456403,0.000102522215,0.0044409703,0.00082409236,0.0027431753,0.00026660768,0.000018877554,0.0005365153],"genre_scores_gemma":[0.997818,0.000979188,0.000018268038,0.0008671538,0.000032359152,0.00015724984,0.000023704224,0.000019621188,0.00008446124],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9909994,0.0059760935,0.0016346455,0.00033819303,0.0004892834,0.0005623872],"domain_scores_gemma":[0.9933314,0.005421581,0.0005189657,0.00043349044,0.00009217393,0.00020239061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044167326,0.00019671969,0.000983358,0.00021909716,0.000116478375,0.000005315396,0.0003095754,0.00013521287,0.00029619422],"category_scores_gemma":[0.00061639724,0.00014816893,0.0001375671,0.0006249901,0.00017573158,0.000025550742,0.0000458463,0.0005584389,0.000013837509],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0046461043,0.0012043839,0.9266518,0.0037720758,0.00011301514,0.0000015881989,0.009332882,0.00010709564,0.000053726882,0.008437407,0.00073527684,0.044944648],"study_design_scores_gemma":[0.004887999,0.0025461486,0.98727965,0.0017446289,0.000008393048,0.0000015322759,0.0019460155,0.00007104479,0.0010549767,0.0002691722,0.00007804304,0.00011239765],"about_ca_topic_score_codex":0.06646447,"about_ca_topic_score_gemma":0.00038809446,"teacher_disagreement_score":0.066076376,"about_ca_system_score_codex":0.00019106863,"about_ca_system_score_gemma":0.0005457178,"threshold_uncertainty_score":0.93975204},"labels":[],"label_agreement":null},{"id":"W4412444010","doi":"10.1016/j.jval.2025.04.018","title":"P12 Development and Prospective Evaluation of the Bladder Utility Symptom Scale (Utility): A Novel Tool to Measure Utilities and Quality of LIfe in Bladder Cancer Patients","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Health Sciences Centre; University of Waterloo; McGill University Health Centre; Sunnybrook Health Science Centre; London Health Sciences Centre; University of British Columbia; Princess Margaret Cancer Centre","funders":"","keywords":"Bladder cancer; Measure (data warehouse); Quality of life (healthcare); Scale (ratio); Medicine; Quality (philosophy); Intensive care medicine; Cancer; Computer science; Data mining; Internal medicine; Nursing; Geography; Cartography","score_opus":0.09442651486090517,"score_gpt":0.36225017490191336,"score_spread":0.2678236600410082,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444010","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.993424,0.0022498418,0.000029976449,0.00076052913,0.00012426027,0.0028599116,0.00009647127,0.0000073422893,0.00044764884],"genre_scores_gemma":[0.99893314,0.00005560671,0.0002627749,0.00043178527,0.000010391216,0.00024403949,0.000003979171,0.000007852266,0.00005040911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976304,0.00035797484,0.00079326803,0.00036593789,0.0006241091,0.00022828346],"domain_scores_gemma":[0.99898195,0.00011176844,0.00016492292,0.00026100816,0.00038928614,0.000091065915],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020094546,0.00015383796,0.0004998521,0.00014139964,0.00006139197,0.000005670238,0.00006237203,0.000078487625,0.000024450464],"category_scores_gemma":[0.0005482445,0.00011574124,0.00003449781,0.00045788678,0.00012035709,0.000053877124,0.00007620093,0.00014593049,1.8073547e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054843165,0.00062367984,0.97078407,0.000739942,0.00008128236,3.0253283e-8,0.007960375,0.000027068447,0.00003584627,0.00010519393,0.00002112449,0.019072948],"study_design_scores_gemma":[0.0048728697,0.0001208447,0.99134636,0.00075394864,0.00004685931,1.3647434e-7,0.0007173786,0.0005732135,0.0011380705,0.00029421487,0.000059822556,0.00007625907],"about_ca_topic_score_codex":0.018166723,"about_ca_topic_score_gemma":0.0055545126,"teacher_disagreement_score":0.020562304,"about_ca_system_score_codex":0.0004900629,"about_ca_system_score_gemma":0.0027364062,"threshold_uncertainty_score":0.9883714},"labels":[],"label_agreement":null},{"id":"W4412444043","doi":"10.1016/j.jval.2025.04.1603","title":"RWD19 Persistence Patterns of Antidepressants in Mood, Anxiety, and Related Disorders: A Retrospective Cohort Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Mental Health Research Topics","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Manitoba","funders":"","keywords":"Persistence (discontinuity); Mood; Anxiety; Mood disorders; Retrospective cohort study; Cohort; Psychiatry; Medicine; Clinical psychology; Psychology; Internal medicine","score_opus":0.04959838992795079,"score_gpt":0.3978190027805907,"score_spread":0.3482206128526399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444043","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98887086,0.0012583907,0.000009798869,0.001083051,0.0003119475,0.0024531235,0.00002628224,0.000018170056,0.0059683765],"genre_scores_gemma":[0.9979696,0.0012337678,0.000035122062,0.00009420839,0.0000075468233,0.00010740173,0.0000040438185,0.000011852759,0.00053644314],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9969066,0.0010594621,0.0006955502,0.00053754996,0.00029797934,0.000502907],"domain_scores_gemma":[0.99910223,0.00018721336,0.00014630861,0.00042461694,0.00003484758,0.00010480647],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021171514,0.00012799283,0.00043661345,0.00037975638,0.000064088,0.000007841596,0.0001936582,0.00010120773,0.0001593471],"category_scores_gemma":[0.00014843761,0.00013316722,0.000027957032,0.00067317794,0.000072636336,0.000060431194,0.0001299545,0.0005175932,0.000007774521],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009661081,0.00086968584,0.9868099,0.00037936197,0.000029469498,0.000010393146,0.006982804,0.000026340738,0.0000021250612,0.00093874667,0.000055635595,0.0037988976],"study_design_scores_gemma":[0.0018418329,0.0004994997,0.9899775,0.0003697367,0.0000037119785,0.000003332802,0.005396772,0.00052803895,0.0000025051668,0.0012724198,0.00002876667,0.00007589232],"about_ca_topic_score_codex":0.052305788,"about_ca_topic_score_gemma":0.0055826902,"teacher_disagreement_score":0.046723098,"about_ca_system_score_codex":0.0004010248,"about_ca_system_score_gemma":0.00016480898,"threshold_uncertainty_score":0.954005},"labels":[],"label_agreement":null},{"id":"W4412444103","doi":"10.1016/j.jval.2025.04.1255","title":"MSR103 Regularized MAIC As a Modern Solution for Indirect Treatment Comparison Challenges","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Machine Learning in Materials Science","field":"Materials Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Computer science","score_opus":0.07728493398125805,"score_gpt":0.3653947029000212,"score_spread":0.28810976891876316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444103","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9651339,0.0039800615,0.014819863,0.011231964,0.0016211364,0.0017420764,0.000024881903,0.00025486943,0.0011912568],"genre_scores_gemma":[0.9629149,0.0004417331,0.035258483,0.00030733307,0.00008333699,0.00031515234,0.000011846769,0.000019858304,0.0006473996],"study_design_codex":"bench_or_experimental","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99721396,0.0007218131,0.00061069394,0.0006008175,0.00025360633,0.0005991272],"domain_scores_gemma":[0.9988302,0.00035521842,0.00026171032,0.00041703344,0.000040964293,0.000094885036],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0026368424,0.00019891754,0.00052986044,0.00023201901,0.00027294204,0.000083536346,0.0003212641,0.00009835015,0.00005891545],"category_scores_gemma":[0.00034564987,0.00017678752,0.000059981932,0.00021896223,0.00008204861,0.00011278036,0.000073140334,0.000091470574,0.000061997904],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001658376,0.001982656,0.005016758,0.0034431028,0.000047239508,0.000013366667,0.026915468,0.20817846,0.55808866,0.05854051,0.0011618981,0.1349535],"study_design_scores_gemma":[0.0029745006,0.0014417266,0.0075883255,0.0006766715,0.000019732566,0.000009177188,0.00019942803,0.904542,0.033167265,0.03793099,0.011041469,0.00040870794],"about_ca_topic_score_codex":0.004702272,"about_ca_topic_score_gemma":0.00034309496,"teacher_disagreement_score":0.69636357,"about_ca_system_score_codex":0.000653897,"about_ca_system_score_gemma":0.0005478238,"threshold_uncertainty_score":0.7209186},"labels":[],"label_agreement":null},{"id":"W4412444163","doi":"10.1016/j.jval.2025.04.1272","title":"MSR120 Estimating Sample Size for Training Ensemble Machine Learning Models","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Machine Learning and Data Classification","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Children's Hospital of Eastern Ontario","funders":"","keywords":"Training (meteorology); Ensemble learning; Computer science; Machine learning; Sample (material); Artificial intelligence; Sample size determination; Statistics; Mathematics; Geography; Chemistry; Chromatography","score_opus":0.11542284370992471,"score_gpt":0.34130861622580205,"score_spread":0.22588577251587733,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444163","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021489148,0.00032501252,0.9891714,0.0067028734,0.00029090417,0.00029771673,0.0000081107,0.00022296135,0.0008321247],"genre_scores_gemma":[0.40420738,0.000019769248,0.5949642,0.00051269215,0.000037283342,0.000037267575,0.00001971936,0.000008070671,0.000193645],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99830586,0.00028700865,0.00043812665,0.00042932678,0.00014732935,0.00039237062],"domain_scores_gemma":[0.9965425,0.0028098493,0.00017862386,0.00035718983,0.000036999776,0.00007481403],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020468927,0.00012047432,0.0002317781,0.00015927585,0.0003299208,0.00010872734,0.00042561284,0.000050033304,0.0000030318697],"category_scores_gemma":[0.0020357268,0.00012377017,0.000041943826,0.00047495324,0.000013606741,0.00027570053,0.000101983154,0.00031838284,0.0000036321592],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000007438635,0.000026894424,0.001191304,0.00020973092,0.0000050285416,4.5718824e-7,0.002151968,0.6329671,0.000040657076,0.178125,0.00012497966,0.18514945],"study_design_scores_gemma":[0.0003503382,0.00006763106,0.0004920779,0.00015945955,0.0000016280987,0.0000016791838,0.000062568804,0.9339303,0.000010484074,0.061338603,0.003492929,0.00009229801],"about_ca_topic_score_codex":0.004665253,"about_ca_topic_score_gemma":0.00006230322,"teacher_disagreement_score":0.40205845,"about_ca_system_score_codex":0.00011682998,"about_ca_system_score_gemma":0.00036002434,"threshold_uncertainty_score":0.70524985},"labels":[],"label_agreement":null},{"id":"W4412444215","doi":"10.1016/j.jval.2025.04.1266","title":"MSR114 Exploring the Impact of Data Availability on Time-Course Model-Based Network Meta-Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Simulation Techniques and Applications","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Course (navigation); Computer science; Data science; Engineering","score_opus":0.6871830130721395,"score_gpt":0.5494683091067032,"score_spread":0.13771470396543628,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444215","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.32982892,0.001774238,0.6364606,0.02494455,0.00011041704,0.0027553604,0.00084351137,0.00019119607,0.003091247],"genre_scores_gemma":[0.99299866,0.000013076519,0.0061938395,0.0004338792,0.000016215838,0.00007011185,0.00002186659,0.0000048631455,0.00024750488],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9969253,0.00070073473,0.0010296094,0.0005305226,0.000593975,0.00021986396],"domain_scores_gemma":[0.9922219,0.00406374,0.00035086117,0.0031325703,0.00016677892,0.00006417437],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011695505,0.00011390785,0.000662069,0.00027459313,0.00016248367,0.000055884364,0.0012937335,0.000035655125,0.0002920495],"category_scores_gemma":[0.00075083826,0.00006248055,0.0004880005,0.0038204796,0.00006761035,0.00016217688,0.00015368508,0.00015675137,0.00002538217],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011848019,0.000087293345,0.0039706132,0.0000026872574,0.0006472541,3.731562e-8,0.000040499486,0.98565745,9.867638e-7,0.001693218,0.0050004306,0.002887664],"study_design_scores_gemma":[0.00006039136,0.000027618542,0.0104771685,0.0000044545354,0.000962119,1.8278264e-8,0.000014209463,0.95967734,0.00001297857,0.02837585,0.0003432074,0.00004463464],"about_ca_topic_score_codex":0.0027487022,"about_ca_topic_score_gemma":0.00005698097,"teacher_disagreement_score":0.66316974,"about_ca_system_score_codex":0.00009712522,"about_ca_system_score_gemma":0.0005352055,"threshold_uncertainty_score":0.41552338},"labels":[],"label_agreement":null},{"id":"W4412444224","doi":"10.1016/j.jval.2025.04.1224","title":"MSR72 Integrating Artificial Intelligence (AI) and Machine Learning (ML) Techniques With Real-World Data (RWD) and Real-World Evidence (RWE) to Inform Precision Medicine: A Scoping Review","year":2025,"lang":"en","type":"review","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Esri (Canada)","funders":"","keywords":"Real world data; Real world evidence; Artificial intelligence; Computer science; Machine learning; Data science; Medicine","score_opus":0.5187334153853591,"score_gpt":0.5633874671654828,"score_spread":0.044654051780123716,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412444224","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000024005969,0.97692096,0.002659248,0.011108413,0.00028133276,0.008399237,0.000020965392,0.00017385851,0.00041195276],"genre_scores_gemma":[0.00010443973,0.98757625,0.008698185,0.0020216017,0.0004906386,0.00044801502,0.00029150295,0.00007406876,0.00029531456],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99204236,0.0010119582,0.0038855583,0.0015176095,0.0007439848,0.0007985106],"domain_scores_gemma":[0.9914083,0.0047715534,0.0013774292,0.0014449824,0.00038675556,0.00061097636],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.008715476,0.00074798707,0.0035162787,0.001862147,0.00044262115,0.0000947967,0.0005642164,0.00022244234,0.000049357637],"category_scores_gemma":[0.0074201464,0.00054858695,0.00008619732,0.004390866,0.00028654555,0.00042649586,0.000531463,0.002092044,0.000011342304],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005709135,0.00002884233,0.00078614586,0.21601222,0.000017775303,0.000010734944,0.0005933911,0.0000035256344,1.643336e-7,0.0006336727,0.00022751115,0.7816289],"study_design_scores_gemma":[0.000017630427,0.0011061365,0.00002841123,0.9556088,0.00032285118,0.00006380306,0.00033064547,0.0008597315,0.000010738984,0.00027818698,0.04096019,0.0004129118],"about_ca_topic_score_codex":0.14346106,"about_ca_topic_score_gemma":0.06126181,"teacher_disagreement_score":0.781216,"about_ca_system_score_codex":0.0009336415,"about_ca_system_score_gemma":0.0047412245,"threshold_uncertainty_score":0.99969655},"labels":[],"label_agreement":null},{"id":"W4412447238","doi":"10.1016/j.jval.2025.06.021","title":"Measuring Aversion to Income-Related Health Inequality in Canada: An Equity-Efficiency Trade-Off Experiment","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Rehabilitation Institute; Toronto Public Health; Western University; University of Toronto; London Health Sciences Centre; Public Health Ontario","funders":"Canadian Institutes of Health Research","keywords":"Equity (law); Economics; Health equity; Inequity aversion; Economic inequality; Inequality; Demographic economics; Public economics; Health care; Economic growth; Political science; Mathematics","score_opus":0.4189182093835194,"score_gpt":0.43540011068874657,"score_spread":0.016481901305227142,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412447238","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.87089705,0.0065098777,0.0010889547,0.11666414,0.0013967236,0.0020478715,0.00013140886,0.000053472064,0.0012104777],"genre_scores_gemma":[0.97540474,0.0002567682,0.00093600585,0.023138357,0.000052754884,0.00010856885,0.000024997415,0.00002582872,0.000051967334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.988319,0.0020902553,0.007250607,0.000975672,0.00024870536,0.0011157822],"domain_scores_gemma":[0.9964484,0.0006798988,0.001521613,0.00073746865,0.000025813613,0.00058680505],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.040136702,0.00026685468,0.0014687155,0.0010918328,0.00029395882,0.000045750305,0.0005082392,0.00012806749,0.00007406538],"category_scores_gemma":[0.0017050073,0.0003686349,0.000064772255,0.0011681564,0.000028362376,0.00030846748,0.00016832078,0.0004601053,0.00008818785],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.000104232655,0.0011434788,0.5718793,0.004258648,0.00004907922,0.000009458909,0.03874641,0.1569038,0.0000061496307,0.20722647,0.007927903,0.011745039],"study_design_scores_gemma":[0.00411395,0.0006724378,0.7646653,0.0027864908,0.0000022529202,0.0000043232244,0.012831782,0.18086688,0.000027547623,0.012851085,0.020060716,0.0011172505],"about_ca_topic_score_codex":0.9694847,"about_ca_topic_score_gemma":0.7330647,"teacher_disagreement_score":0.23641996,"about_ca_system_score_codex":0.025180556,"about_ca_system_score_gemma":0.009021926,"threshold_uncertainty_score":0.99987656},"labels":[],"label_agreement":null},{"id":"W4412822684","doi":"10.1016/j.jval.2025.07.016","title":"Testing the Valuation of the EQ-5D-Y-5L in Adults and Adolescents: Results From a 5-Country Study and Implications for the Descriptive System","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Hamilton Health Sciences; McMaster University","funders":"Erasmus Universitair Medisch Centrum Rotterdam; Guizhou Medical University; EuroQol Research Foundation","keywords":"Respondent; Valuation (finance); EQ-5D; Descriptive statistics; Psychology; Logit; Randomness; Demography; Logistic regression; Ordered logit; Medicine; Econometrics; Statistics; Health related quality of life; Mathematics; Economics","score_opus":0.4410937936272542,"score_gpt":0.40122949762028787,"score_spread":0.03986429600696634,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412822684","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94926924,0.0048552654,0.0009107959,0.03820488,0.00040113344,0.0054437984,0.0007826308,0.000014822493,0.00011744892],"genre_scores_gemma":[0.9973305,0.00010348452,0.00039556154,0.0016494662,0.000069159214,0.00042100032,0.000007642984,0.000010924647,0.000012283733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99526775,0.00092167035,0.0030406741,0.0004508219,0.00006820912,0.00025088436],"domain_scores_gemma":[0.99191725,0.0057281824,0.0016441692,0.00058120204,0.00008737185,0.00004184061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.021207776,0.00012168604,0.00049172173,0.00016647865,0.00037953464,0.000048633927,0.0002744756,0.00006687229,4.2500815e-7],"category_scores_gemma":[0.00788195,0.00009104604,0.00003058609,0.0004985167,0.000081946484,0.00012306936,0.00008404467,0.00018864882,0.000002171021],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000094571405,0.00014689355,0.93454915,0.001031534,0.00003270554,3.9078945e-8,0.019408362,0.002027761,0.0000011808761,0.040857892,0.00042303253,0.0014268815],"study_design_scores_gemma":[0.0017889087,0.000060168237,0.892969,0.0014543751,0.0000072280836,5.3418546e-7,0.015761377,0.0801056,2.9951124e-7,0.007609229,0.00017596655,0.000067292895],"about_ca_topic_score_codex":0.06358233,"about_ca_topic_score_gemma":0.0041021113,"teacher_disagreement_score":0.07807784,"about_ca_system_score_codex":0.00066350837,"about_ca_system_score_gemma":0.00035867255,"threshold_uncertainty_score":0.94359994},"labels":[],"label_agreement":null},{"id":"W4414105061","doi":"10.1016/j.jval.2025.08.019","title":"Cost-Effectiveness of the 15 Drugs Selected for Initial Price Applicability Year 2027 by Centers for Medicare and Medicaid Services Drug Price Negotiation Program","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Negotiation; Medicaid; Transparency (behavior); Drug prices; Consistency (knowledge bases); Drug pricing","score_opus":0.14858128023420425,"score_gpt":0.4313074401399257,"score_spread":0.2827261599057215,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414105061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8834624,0.0041784286,0.019776473,0.058490913,0.0014442194,0.029595284,0.0025029655,0.00011271657,0.00043659296],"genre_scores_gemma":[0.9889475,0.00017545896,0.0032401097,0.0036201489,0.00012543943,0.0035929105,0.00022944357,0.00002873362,0.000040242223],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99572,0.0008897557,0.0023362506,0.00054073497,0.000110055655,0.00040317958],"domain_scores_gemma":[0.993662,0.004292685,0.0014211102,0.00034114794,0.00015367793,0.00012936507],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.019663675,0.00015362904,0.0007886625,0.00016857249,0.0001894856,0.000029666056,0.00028747672,0.00013508067,0.000009296072],"category_scores_gemma":[0.0026213008,0.00016099443,0.0000768173,0.0005122716,0.00009530153,0.00015871915,0.000059538637,0.00016512396,0.000003228434],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013406294,0.0026932359,0.59693897,0.15153906,0.00052027503,1.3500352e-7,0.03530408,0.0018102814,0.000035944122,0.14366505,0.04849069,0.017661665],"study_design_scores_gemma":[0.019201498,0.001141288,0.44598636,0.0049760942,0.00005954437,0.0000020793975,0.012368972,0.19442606,0.00031789078,0.060051177,0.26034415,0.0011248732],"about_ca_topic_score_codex":0.0047223293,"about_ca_topic_score_gemma":0.00020140794,"teacher_disagreement_score":0.21185346,"about_ca_system_score_codex":0.00083411345,"about_ca_system_score_gemma":0.0005951213,"threshold_uncertainty_score":0.71387804},"labels":[],"label_agreement":null},{"id":"W4414106751","doi":"10.1016/j.jval.2025.08.016","title":"Unlocking Patient Preferences: The Potential of Stated-Preference Methods in Clinical Decision Making","year":2025,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Relevance (law); Clinical decision making; Quality (philosophy); Medical decision making; Clinical Practice; Clinical decision support system","score_opus":0.37024698167445275,"score_gpt":0.5634809392125011,"score_spread":0.19323395753804834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414106751","genre_codex":"editorial","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008638635,0.01647133,0.004255898,0.0016085029,0.9599205,0.0073746247,0.000634909,0.00014377586,0.00095178006],"genre_scores_gemma":[0.38308275,0.058022037,0.28753567,0.0038740353,0.26040128,0.0047860206,0.0014693085,0.00046639444,0.0003625037],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9491241,0.037602223,0.008999327,0.0012220157,0.0016472351,0.0014051024],"domain_scores_gemma":[0.9258559,0.0648154,0.005003606,0.002891582,0.0012020525,0.00023148648],"candidate_categories":["metaresearch","metaepi_narrow","research_integrity"],"consensus_categories":["research_integrity"],"category_scores_codex":[0.01206011,0.00054808706,0.0018673923,0.00092311023,0.0007630801,0.00002346868,0.0022519743,0.0020555812,0.000069782815],"category_scores_gemma":[0.02575591,0.00043444053,0.00023451069,0.0015059484,0.00022550373,0.0001420282,0.0017489061,0.009506718,0.000016545893],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015669134,0.0007018881,0.03102502,0.013657693,0.0000877256,0.000010046655,0.030390337,0.010475519,0.0000015376839,0.0011200585,0.42181626,0.489147],"study_design_scores_gemma":[0.0061742044,0.0021559498,0.029669033,0.15441945,0.000101892845,0.0000010808075,0.032362506,0.035927385,0.0000034375062,0.05081298,0.686863,0.0015091004],"about_ca_topic_score_codex":0.03146345,"about_ca_topic_score_gemma":0.003927214,"teacher_disagreement_score":0.6995193,"about_ca_system_score_codex":0.0020123993,"about_ca_system_score_gemma":0.015639424,"threshold_uncertainty_score":0.99981076},"labels":[],"label_agreement":null},{"id":"W4414480124","doi":"10.1016/j.jval.2025.09.008","title":"Validating Loon Lens 1.0 for Autonomous Abstract Screening and Confidence-Guided Human-in-the-Loop Workflows in Systematic Reviews","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Public Health; University of Ottawa; Dalhousie University; Ottawa Hospital; Life Prediction Technologies (Canada)","funders":"","keywords":"Workflow; False positive paradox; Sensitivity (control systems); Lens (geology); True positive rate; Through-the-lens metering","score_opus":0.8436006557405845,"score_gpt":0.572996590528697,"score_spread":0.2706040652118875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414480124","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8106672,0.09176664,0.036454316,0.011201951,0.0009401978,0.040609777,0.000022722721,0.000030019668,0.008307154],"genre_scores_gemma":[0.9822487,0.000634684,0.012153338,0.0019386705,0.00006241103,0.0010086799,0.0000067114916,0.00001826556,0.0019284926],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.952891,0.021240918,0.021885863,0.001286916,0.0020287333,0.00066655927],"domain_scores_gemma":[0.9711503,0.02034391,0.005746529,0.002427474,0.00023700528,0.000094773895],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.31152272,0.00032326195,0.005099387,0.00094428664,0.00022263324,0.00065252656,0.0012833572,0.00010331786,0.00013105974],"category_scores_gemma":[0.051376022,0.00016754658,0.0006259647,0.0021509044,0.00004205978,0.0002467609,0.00007881729,0.0003286896,0.000076077355],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000063862426,0.0008658576,0.21997914,0.35440084,0.00039539792,0.00010670957,0.03654221,0.047254875,0.0003279165,0.18289375,0.06158577,0.09558368],"study_design_scores_gemma":[0.0055313087,0.00044743854,0.067714036,0.23839988,0.00059409055,0.000107739026,0.022118498,0.52238184,0.000048549893,0.090393044,0.05034292,0.0019206592],"about_ca_topic_score_codex":0.0014299948,"about_ca_topic_score_gemma":0.00094022293,"teacher_disagreement_score":0.47512695,"about_ca_system_score_codex":0.00016081789,"about_ca_system_score_gemma":0.00020725146,"threshold_uncertainty_score":0.9566146},"labels":[],"label_agreement":null},{"id":"W4414480137","doi":"10.1016/j.jval.2025.09.009","title":"Comparing Psychometric Properties of 6 of the 5-Level and 3-Level EQ-5D Bolt-Ons in a Large, Multinational, Longitudinal General Population Sample","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Assistive Technology in Communication and Mobility","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"EuroQol Research Foundation","keywords":"Sample (material); Ceiling effect; Ceiling (cloud); Population; Longitudinal data; Psychometrics","score_opus":0.45666636744405903,"score_gpt":0.4574874650875644,"score_spread":0.000821097643505353,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414480137","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929553,0.0009364024,0.0014522366,0.0033705395,0.00016101175,0.0008791833,0.00006516025,0.000019972347,0.00016019536],"genre_scores_gemma":[0.9948085,0.00013829926,0.004626061,0.00020479634,0.0000076135225,0.0000973851,0.00001193588,0.000005554877,0.00009987623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976837,0.0008672918,0.000876463,0.00018825465,0.0001459374,0.00023832274],"domain_scores_gemma":[0.99840385,0.0006271566,0.00038038887,0.00042628255,0.0001361946,0.000026148091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0019056619,0.0000866644,0.0003223956,0.0005156974,0.00029452902,0.0000017472868,0.00024428277,0.000126185,0.000008808612],"category_scores_gemma":[0.0017402954,0.00006764361,0.000030129835,0.0011476255,0.00012108436,0.00004632686,0.00026622694,0.0004984613,5.367852e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032441454,0.000227054,0.9771088,0.0004921534,0.0000061909504,1.7763623e-8,0.00053857116,0.00022868745,0.000056303288,0.020400992,0.00007451479,0.0008343207],"study_design_scores_gemma":[0.00091950473,0.000019062863,0.98570454,0.00072272134,0.0000029802143,1.6319852e-7,0.00051205634,0.010178701,0.00003343629,0.0017077797,0.00015339686,0.000045634293],"about_ca_topic_score_codex":0.024152247,"about_ca_topic_score_gemma":0.008878965,"teacher_disagreement_score":0.018693212,"about_ca_system_score_codex":0.0002986948,"about_ca_system_score_gemma":0.0003713721,"threshold_uncertainty_score":0.982346},"labels":[],"label_agreement":null},{"id":"W4414579224","doi":"10.1016/j.jval.2025.09.010","title":"Cost-Effectiveness of Reorganizing the Approach to Diabetes Through the Application of Registries: An Innovative Model to Organize Diabetes Care in First Nations Communities in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Alberta Health; South Health Campus; Alliance for Canadian Health Outcomes Research in Diabetes","funders":"Lawson Foundation; Canadian Institutes of Health Research; Alberta Innovates - Health Solutions","keywords":"Agency (philosophy); Diabetes mellitus; Value (mathematics); Health care; Health services","score_opus":0.06341318063131146,"score_gpt":0.3256609945013752,"score_spread":0.26224781387006374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414579224","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9906205,0.00026339028,0.0005752005,0.0043288437,0.00005722711,0.0030367756,0.00002809773,0.000008298054,0.0010816697],"genre_scores_gemma":[0.99767226,0.00003119076,0.0006799876,0.00088056497,0.000009653828,0.00059028785,0.00011536519,0.000012137824,0.000008537859],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986391,0.00034704473,0.00045183842,0.00015740874,0.00017282859,0.00023178871],"domain_scores_gemma":[0.998096,0.0010054599,0.00013299982,0.00047265613,0.00026440364,0.000028472297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011685413,0.000103335,0.00030545084,0.00030031655,0.0001186476,0.000009554858,0.00026543703,0.000030355537,7.951874e-7],"category_scores_gemma":[0.00054517516,0.00007899809,0.000010663834,0.0036600677,0.000056496243,0.00008314363,0.00008433224,0.00017948331,3.3173876e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000043554428,0.0002587489,0.7597548,0.0034175161,0.000024243369,4.031025e-8,0.07485705,0.14123905,0.00011271555,0.01806835,0.00022647475,0.0019974653],"study_design_scores_gemma":[0.001239139,0.000260984,0.7092458,0.0034099931,0.000026575473,5.6670643e-8,0.22175272,0.05690097,0.0033852279,0.0018333116,0.0017369945,0.00020823666],"about_ca_topic_score_codex":0.61763686,"about_ca_topic_score_gemma":0.60634506,"teacher_disagreement_score":0.14689568,"about_ca_system_score_codex":0.0013038234,"about_ca_system_score_gemma":0.0016059079,"threshold_uncertainty_score":0.40083808},"labels":[],"label_agreement":null},{"id":"W4415679345","doi":"10.1016/j.jval.2025.10.005","title":"The Uneven Path of Psychological Distress: How Socioeconomic Status Shapes Distress Transitions in Australian Adults","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"Melbourne Institute, University of Melbourne","keywords":"Socioeconomic status; Psychological distress; Path (computing); Reimbursement; Distress","score_opus":0.23977851133572656,"score_gpt":0.4325071496425308,"score_spread":0.19272863830680423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415679345","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.79387313,0.0033121728,0.0003074887,0.19829841,0.0005021778,0.0011016553,0.0018907585,0.00002843267,0.0006857824],"genre_scores_gemma":[0.995634,0.0013375559,0.0004613478,0.0019414955,0.00006724275,0.00017111759,0.00007974378,0.00001669652,0.0002907912],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9939879,0.00082936796,0.003779555,0.0006047376,0.000070402646,0.0007279918],"domain_scores_gemma":[0.99679136,0.001213962,0.0013450854,0.0004577738,0.000028462517,0.0001633673],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008148518,0.00020166773,0.0009538636,0.0003262326,0.00021488023,0.00006551885,0.00039033245,0.00017954633,0.00007382729],"category_scores_gemma":[0.0008737933,0.00021142588,0.0001361206,0.0003078481,0.00019429492,0.00020915498,0.000034614164,0.00036819634,0.00007640573],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021266629,0.0010623755,0.43285692,0.0030263145,0.000084279076,0.0000045393595,0.011917381,0.010723797,0.0000023803482,0.51429164,0.019639572,0.0061781695],"study_design_scores_gemma":[0.002784095,0.00022088445,0.90068984,0.0010613012,0.0000038845033,0.0000018040355,0.009178116,0.017990757,0.0000014927577,0.04756201,0.020117491,0.00038829987],"about_ca_topic_score_codex":0.010235414,"about_ca_topic_score_gemma":0.0036234977,"teacher_disagreement_score":0.46783295,"about_ca_system_score_codex":0.0010660704,"about_ca_system_score_gemma":0.00021765094,"threshold_uncertainty_score":0.99635553},"labels":[],"label_agreement":null},{"id":"W4415913729","doi":"10.1016/j.jval.2025.09.3055","title":"Health Economics and Outcomes Research in the New Era of Artificial Intelligence: Catch Me If You Can","year":2025,"lang":"en","type":"editorial","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Health economics; Outcomes research; Medical economics; MEDLINE","score_opus":0.24376798857061435,"score_gpt":0.5078744946077316,"score_spread":0.2641065060371173,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415913729","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04635972,0.010146542,0.00009636413,0.44427723,0.49347517,0.005127772,0.0002294218,0.00003743977,0.00025034236],"genre_scores_gemma":[0.22602037,0.15682964,0.0019888317,0.005699281,0.60642374,0.00039476692,0.0010678885,0.00017513019,0.0014003804],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9935902,0.0013660202,0.002517952,0.0007376324,0.00079623086,0.000991994],"domain_scores_gemma":[0.99222475,0.0056898994,0.00053518114,0.0008254287,0.00034034092,0.0003844195],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.010506419,0.00031323117,0.0012858112,0.0009085446,0.00022826162,0.000054322343,0.00042929218,0.00068199524,0.000014129905],"category_scores_gemma":[0.0028297533,0.00025952535,0.00009998862,0.0011270235,0.00023344705,0.000059131195,0.0000913159,0.0035808168,0.0000089716505],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035199593,0.00052201335,0.006683141,0.005041556,0.00003564492,0.000009168492,0.05270896,0.00073509343,4.1569805e-7,0.0060423356,0.42209262,0.50577706],"study_design_scores_gemma":[0.00045754947,0.005662642,0.0049127815,0.015553113,0.00007032044,0.000023856725,0.092531584,0.00737775,0.00020799926,0.172216,0.699851,0.0011354263],"about_ca_topic_score_codex":0.55895275,"about_ca_topic_score_gemma":0.046500016,"teacher_disagreement_score":0.5124527,"about_ca_system_score_codex":0.0018502234,"about_ca_system_score_gemma":0.03281122,"threshold_uncertainty_score":0.9999857},"labels":[],"label_agreement":null},{"id":"W4416293245","doi":"10.1016/j.jval.2025.10.015","title":"Developing an Accessible Discrete Choice Survey to Identify Supportive Care Preferences of Older Adults With Dementia","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Dementia and Cognitive Impairment Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"National Institute on Aging; National Institutes of Health","keywords":"Dementia; Discrete choice; Survey data collection; Aged care","score_opus":0.0706076007581129,"score_gpt":0.4398641969518226,"score_spread":0.3692565961937097,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416293245","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99496627,0.0006229896,0.0014735017,0.0006407295,0.00007532046,0.0014994381,0.0000368213,0.000020934558,0.00066398794],"genre_scores_gemma":[0.997796,0.000109411245,0.001286065,0.0003606938,0.000016660126,0.000100018005,0.00016176738,0.000012109879,0.00015730185],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99775493,0.00043133777,0.00048766483,0.00040986642,0.0004640529,0.00045212626],"domain_scores_gemma":[0.99882734,0.00015673276,0.00012433878,0.00023003486,0.00046857807,0.00019296823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009741616,0.0001420306,0.0003626318,0.00039788132,0.00008297055,0.000033594217,0.00017804369,0.000046066365,0.00007841384],"category_scores_gemma":[0.00019385958,0.00011165952,0.000026183618,0.0009558731,0.000047982176,0.00017500941,0.00010248919,0.00017191144,0.0000037421303],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00045591246,0.00012572295,0.98387396,0.002114161,0.00006906157,0.0000060664297,0.0032411078,0.000017429466,0.000032755564,0.000070526316,0.0000646988,0.00992861],"study_design_scores_gemma":[0.0017507721,0.0009633368,0.985135,0.0041677747,0.000025935728,8.981701e-7,0.00504051,0.000065376946,0.0026358138,0.000041139836,0.00006850194,0.00010491487],"about_ca_topic_score_codex":0.025487823,"about_ca_topic_score_gemma":0.007533011,"teacher_disagreement_score":0.017954811,"about_ca_system_score_codex":0.00016343997,"about_ca_system_score_gemma":0.0017034643,"threshold_uncertainty_score":0.98100156},"labels":[],"label_agreement":null},{"id":"W4416410498","doi":"10.1016/j.jval.2025.10.016","title":"Return-on-Investment in Health Economic Evaluation: An Exploratory Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":2,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Toronto","funders":"","keywords":"Scope (computer science); Exploratory analysis; Variation (astronomy); Measure (data warehouse); Pareto principle; Exploratory research","score_opus":0.44929216899026797,"score_gpt":0.4701920806746715,"score_spread":0.020899911684403527,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416410498","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7576449,0.017031511,0.0013369402,0.2073742,0.0024843419,0.0047590802,0.00042359368,0.00013708437,0.008808366],"genre_scores_gemma":[0.9132492,0.001056832,0.002045166,0.082178004,0.0002625416,0.0006663968,0.00018824346,0.000045078636,0.00030852453],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9859714,0.003754621,0.007944586,0.0012726717,0.00019115036,0.00086558424],"domain_scores_gemma":[0.99470824,0.0009946513,0.0026177627,0.0012291056,0.00004573787,0.0004045011],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.073001064,0.0003115584,0.0019163851,0.0031208815,0.00023420999,0.00008718911,0.0004320126,0.00018168568,0.0004241247],"category_scores_gemma":[0.0013442134,0.00042892824,0.00017899975,0.0013730144,0.00006429435,0.0005285736,0.000056478424,0.0004049156,0.00062664715],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045387784,0.0004866109,0.19410057,0.0009188971,0.00019310365,0.0000014783021,0.007856988,0.32281008,1.6989642e-7,0.46121582,0.011466852,0.0009040435],"study_design_scores_gemma":[0.0031638932,0.0005035065,0.14742292,0.0006764642,0.000018657418,9.329538e-7,0.004142985,0.71163297,0.0000023350892,0.0920461,0.039726544,0.000662701],"about_ca_topic_score_codex":0.025091702,"about_ca_topic_score_gemma":0.009484911,"teacher_disagreement_score":0.38882285,"about_ca_system_score_codex":0.010748779,"about_ca_system_score_gemma":0.003399376,"threshold_uncertainty_score":0.99981624},"labels":[],"label_agreement":null},{"id":"W4416682870","doi":"10.1016/j.jval.2025.11.002","title":"Validity, Reliability, and Framing Effects in Equity-Efficiency Trade-Off Studies: A Systematic Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre for Addiction and Mental Health; Western University","funders":"Canadian Institutes of Health Research","keywords":"Framing (construction); Key (lock); Framing effect","score_opus":0.17614855243889055,"score_gpt":0.33108663006205313,"score_spread":0.15493807762316258,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416682870","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5620888,0.42786843,0.000699868,0.0046531493,0.00046595928,0.0028862944,0.000011626931,0.000023383625,0.001302495],"genre_scores_gemma":[0.9217314,0.07583673,0.00028458718,0.0018843408,0.0000115638095,0.00017210029,0.0000028694747,0.00000978841,0.00006657851],"study_design_codex":"systematic_review","study_design_gemma":"observational","domain_scores_codex":[0.99763256,0.00025573635,0.0013557283,0.00043315004,0.000037725855,0.00028509332],"domain_scores_gemma":[0.9986644,0.0006489448,0.00033895185,0.00029576625,0.0000030070848,0.000048970447],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0066678855,0.00013615614,0.0009782871,0.00023274751,0.00007366645,0.000018800953,0.00014245081,0.00006396682,0.0000076022134],"category_scores_gemma":[0.0012565479,0.0001491076,0.000054452714,0.00031045126,0.00005231047,0.00012196756,0.00014591085,0.00018155895,0.000037847003],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000003795584,0.00026611597,0.25948685,0.6700237,0.000023788083,0.0000030097933,0.0019490202,0.0025152443,4.9343106e-7,0.06471654,0.00020770282,0.0008037634],"study_design_scores_gemma":[0.0027660362,0.0005808121,0.36313775,0.27906665,0.0000643625,0.000008704901,0.0010647434,0.110738665,0.000007945295,0.24125463,0.000449455,0.0008602425],"about_ca_topic_score_codex":0.00061273435,"about_ca_topic_score_gemma":0.000033814904,"teacher_disagreement_score":0.39095703,"about_ca_system_score_codex":0.00096128124,"about_ca_system_score_gemma":0.000041644544,"threshold_uncertainty_score":0.60804313},"labels":[],"label_agreement":null},{"id":"W4416866909","doi":"10.1016/j.jval.2025.11.006","title":"Strengthening Methods and International Evidence on Health Inequality Aversion","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health disparities and outcomes","field":"Social Sciences","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Fondation Brocher","keywords":"Inequity aversion; Inequality; Risk aversion (psychology); Politics; Health equity; Economic inequality","score_opus":0.21689714951140138,"score_gpt":0.5371227487341702,"score_spread":0.32022559922276883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416866909","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29858086,0.0070958426,0.004142251,0.6794193,0.0033141095,0.00086835644,0.000015405405,0.00011159457,0.0064522754],"genre_scores_gemma":[0.9345927,0.014164249,0.016491855,0.033726864,0.0001635677,0.00001476088,0.000002996312,0.000006564887,0.0008364029],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9966403,0.0020295312,0.00045817238,0.00023615474,0.00022912577,0.00040666584],"domain_scores_gemma":[0.9972525,0.002266399,0.00013734317,0.00012159846,0.00003154175,0.00019060992],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008926571,0.00007215592,0.00021180339,0.00016253136,0.00046718284,0.000042822638,0.00016508996,0.000056635814,0.00003656385],"category_scores_gemma":[0.0024646327,0.000070976035,0.00002573555,0.00028641208,0.00006662882,0.00013355336,0.000057333684,0.00021713195,0.000002934523],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053909618,0.00006846826,0.17698185,0.0007982142,0.00000716696,9.3609384e-7,0.018831529,0.00030879182,7.249566e-7,0.41480365,0.0031063121,0.38503844],"study_design_scores_gemma":[0.0012048538,0.0003153619,0.4874376,0.009074336,0.0000039971087,7.453287e-7,0.02619746,0.008057626,0.000019117475,0.042029984,0.42528835,0.0003705566],"about_ca_topic_score_codex":0.18126166,"about_ca_topic_score_gemma":0.0041876533,"teacher_disagreement_score":0.6456924,"about_ca_system_score_codex":0.0007946206,"about_ca_system_score_gemma":0.0013319197,"threshold_uncertainty_score":0.8241904},"labels":[],"label_agreement":null},{"id":"W4417479565","doi":"10.1016/j.jval.2025.09.2561","title":"PCR88 Explaining Psychiatric Comorbidities in Patients With Skin Conditions: The Importance of Clinical Characteristics and Patient-Reported Disease Impact","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Depression (economics); Anxiety; Comorbidity; Disease; Mental health; Psychiatric comorbidity; Dermatological diseases","score_opus":0.03386724474695558,"score_gpt":0.3262418296832556,"score_spread":0.29237458493630003,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479565","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99577093,0.0027613873,0.0000028784527,0.00024822625,0.00043039594,0.0004950941,0.00024596782,0.000010938346,0.000034207824],"genre_scores_gemma":[0.9989613,0.00045026664,0.000031429376,0.00022683915,0.000009722382,0.000040480125,0.00025685155,0.000006915936,0.000016184542],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981712,0.0004988402,0.0008524265,0.00021556058,0.000039515184,0.00022243337],"domain_scores_gemma":[0.9987875,0.00045314035,0.00045016457,0.00023735205,0.000040069062,0.000031761465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041737332,0.00012941976,0.0003801676,0.00015999032,0.0001033259,0.000005351998,0.000073101684,0.00007976741,0.00002183191],"category_scores_gemma":[0.00016663897,0.00008493227,0.000052790278,0.00026743818,0.00014098463,0.000047645954,0.000026910684,0.00016763339,0.0000017018519],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006834324,0.00040654998,0.9919949,0.00005084576,0.000083712664,0.000005368404,0.00036549073,0.000016797447,0.0000013778349,0.00028773106,0.00016908879,0.005934711],"study_design_scores_gemma":[0.0026148397,0.0003806635,0.9961664,0.00017444606,0.000036432284,0.0000015162752,0.00020265939,0.000016817858,0.0000064914443,0.00020714395,0.000120698096,0.00007185674],"about_ca_topic_score_codex":0.00055915385,"about_ca_topic_score_gemma":0.00006578438,"teacher_disagreement_score":0.0058628544,"about_ca_system_score_codex":0.000047341833,"about_ca_system_score_gemma":0.00036417088,"threshold_uncertainty_score":0.34634376},"labels":[],"label_agreement":null},{"id":"W4417479590","doi":"10.1016/j.jval.2025.09.1037","title":"EE655 Saving Money Improving Outcomes: A Two-Year Cost-Utility Analysis of Emergency Department Care Models for Managing Persons Presenting With a Musculoskeletal Disorder","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Musculoskeletal Disorders and Rehabilitation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université Laval","funders":"","keywords":"Emergency department; Health care; Primary care; Musculoskeletal disorder; Musculoskeletal injury","score_opus":0.023467133519546154,"score_gpt":0.3468189455294943,"score_spread":0.32335181200994817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96534306,0.0015466235,0.027846843,0.0012409028,0.0001164558,0.0031176645,0.00006478519,0.00004190299,0.00068176346],"genre_scores_gemma":[0.99390894,0.000084053914,0.00537862,0.000059424026,0.000013469302,0.0003222972,0.00012941711,0.000023158918,0.00008059288],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9977628,0.00016454163,0.00077131076,0.00051796174,0.00031737462,0.00046603533],"domain_scores_gemma":[0.9988535,0.00018932791,0.00024223606,0.00042083958,0.00017891327,0.000115202645],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063273415,0.00021777437,0.0007346571,0.0006659027,0.00017453666,0.000010033323,0.00009610067,0.00006335459,0.000017048475],"category_scores_gemma":[0.00019342206,0.00017539445,0.00045828416,0.0012504169,0.000045384397,0.00011891767,0.000056742745,0.0001768651,2.2904337e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014858475,0.0003679586,0.890348,0.00895759,0.0006692557,0.0000010155525,0.004552563,0.078549325,0.00002962415,0.0014459591,0.000016663982,0.014913423],"study_design_scores_gemma":[0.0020385864,0.00028502225,0.43947202,0.00030200646,0.0007510495,1.3766719e-7,0.01412241,0.5424034,0.0000022706975,0.00043957448,0.000031683365,0.00015182543],"about_ca_topic_score_codex":0.010967878,"about_ca_topic_score_gemma":0.0029672678,"teacher_disagreement_score":0.46385407,"about_ca_system_score_codex":0.00024703605,"about_ca_system_score_gemma":0.00028541032,"threshold_uncertainty_score":0.99561816},"labels":[],"label_agreement":null},{"id":"W4417479592","doi":"10.1016/j.jval.2025.09.686","title":"EE302 Cost-Utility Analysis of Iptacopan for Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Previously Treated With C5 Inhibitor in the Brazilian Private Healthcare System","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Hemoglobinuria; Anemia; Healthcare system; Hematologic disease; Disease","score_opus":0.015467003973979718,"score_gpt":0.27616674710473144,"score_spread":0.2606997431307517,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479592","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99186254,0.0010469693,0.00011000955,0.0007715709,0.00016764729,0.005212891,0.0007478141,0.000043785207,0.00003680476],"genre_scores_gemma":[0.99843603,0.000013488953,0.00009009601,0.00033925285,0.000011626174,0.00048346748,0.00058336515,0.000015210603,0.000027458844],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99581766,0.0016811052,0.0011889623,0.00052969076,0.00013471144,0.00064784504],"domain_scores_gemma":[0.9979367,0.00044269167,0.00058161217,0.000649823,0.00033441297,0.000054719512],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010543709,0.00028406622,0.00094103,0.00051613565,0.000193102,0.000017375323,0.0003891706,0.0001337088,0.000018353232],"category_scores_gemma":[0.00011998397,0.0001823649,0.00013112671,0.0015934425,0.00013250492,0.00006717585,0.000047916943,0.0002616609,0.0000023161842],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022990217,0.00048297684,0.9909167,0.002402426,0.00049459835,0.0000021933095,0.0009253449,0.00054430525,0.000016374077,0.00076156174,0.00032620382,0.00082825316],"study_design_scores_gemma":[0.006394343,0.001194637,0.98676324,0.0021432224,0.00034117413,0.0000032716116,0.0015344179,0.0007325458,0.00020150331,0.000020063842,0.0004809412,0.00019065403],"about_ca_topic_score_codex":0.011918859,"about_ca_topic_score_gemma":0.0085042445,"teacher_disagreement_score":0.006573526,"about_ca_system_score_codex":0.00054101757,"about_ca_system_score_gemma":0.00061233074,"threshold_uncertainty_score":0.99466085},"labels":[],"label_agreement":null},{"id":"W4417479607","doi":"10.1016/j.jval.2025.09.1447","title":"HPR37 Bridging the Gap: How Early Access Shapes Pricing and Reimbursed Populations in France","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Bridging (networking); Mode (computer interface)","score_opus":0.31934627059427295,"score_gpt":0.47770535900780214,"score_spread":0.1583590884135292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9136276,0.00076169457,0.07209385,0.0117962025,0.000086659,0.00092158164,0.000003706424,0.00018195286,0.0005266993],"genre_scores_gemma":[0.9832215,0.00014313297,0.015880784,0.00050471484,0.000026117877,0.00006390754,8.459829e-7,0.000014100187,0.00014493517],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99879646,0.00019387947,0.00036190922,0.00022614657,0.00013067522,0.00029093216],"domain_scores_gemma":[0.9989176,0.0006252339,0.00015400325,0.00023759826,0.00003144039,0.000034160115],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007989224,0.00011642639,0.00024457357,0.00021987177,0.00012681556,0.000077742225,0.00022015443,0.00005810673,0.0000028731033],"category_scores_gemma":[0.00072849885,0.0000963414,0.000018818633,0.00060806464,0.00004903915,0.00026821473,0.0000991751,0.0003394629,4.1307317e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012156787,0.00009765671,0.33488882,0.0009311315,0.000008950223,0.000008788811,0.0037132679,0.0028494732,0.00023856855,0.63142866,0.0005242891,0.025298264],"study_design_scores_gemma":[0.00026652988,0.00003660029,0.2560689,0.0015015405,0.0000042065276,0.0000022122347,0.00018837738,0.0244679,0.0002264655,0.71691716,0.00017846093,0.000141665],"about_ca_topic_score_codex":0.0032833891,"about_ca_topic_score_gemma":0.0004175484,"teacher_disagreement_score":0.085488506,"about_ca_system_score_codex":0.00014764532,"about_ca_system_score_gemma":0.00008816953,"threshold_uncertainty_score":0.49635243},"labels":[],"label_agreement":null},{"id":"W4417479690","doi":"10.1016/j.jval.2025.09.3474","title":"MSR197 The Effects of Pooling Treatment Effects Targeting Treatment Policy and Hypothetical Estimands With Rank-Preserving Structural Failure Time Model in Oncology Aggregate-Level Meta-Analyses","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Simon Fraser University; McGill University","funders":"","keywords":"Pooling; Clinical trial; Randomized controlled trial; Event (particle physics); Treatment effect; Cancer treatment","score_opus":0.5258736131249707,"score_gpt":0.5693965461418977,"score_spread":0.043522933016927,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479690","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.942586,0.0037120222,0.04003205,0.008261439,0.00017537689,0.0047455183,0.00008975385,0.00007715317,0.00032067],"genre_scores_gemma":[0.44884086,0.00017430221,0.55041724,0.00018348986,0.0000537443,0.00020226196,0.0000018396789,0.000030082227,0.00009615013],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9932574,0.00396322,0.001352582,0.00054318376,0.00029647918,0.00058711896],"domain_scores_gemma":[0.88694465,0.11192117,0.00044503028,0.00048677405,0.000055934066,0.00014642891],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0028171088,0.00040313418,0.0022826868,0.00031387812,0.00012657593,0.000028239145,0.00023628815,0.00019330734,0.000010315384],"category_scores_gemma":[0.04215293,0.00020911955,0.00022458335,0.0005552155,0.00023474015,0.000047518264,0.00012240114,0.00029244018,9.069728e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0067826062,0.005174921,0.0057993857,0.021023596,0.019175164,0.0005958469,0.019571668,0.2347197,0.0063097663,0.42629415,0.00039624772,0.25415695],"study_design_scores_gemma":[0.006328258,0.002924494,0.00056576036,0.00079966336,0.002207324,0.000010339092,0.000077388424,0.3803654,0.004133831,0.6023383,0.000013872925,0.00023537278],"about_ca_topic_score_codex":0.0038833932,"about_ca_topic_score_gemma":0.00020321461,"teacher_disagreement_score":0.5103852,"about_ca_system_score_codex":0.0008139994,"about_ca_system_score_gemma":0.0007628653,"threshold_uncertainty_score":0.96591544},"labels":[],"label_agreement":null},{"id":"W4417479696","doi":"10.1016/j.jval.2025.09.2066","title":"HTA283 Reference Framework, Key Decision-Making Factors, and the Impact of Critical Parameters on Listing Recommendations for Nononcologic Drugs for Rare Diseases Issued by Canadian HTA Bodies","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Université de Montréal","funders":"","keywords":"Listing (finance); Agency (philosophy); Key (lock); Orphan drug; Drug","score_opus":0.3686087400044351,"score_gpt":0.5030737261538087,"score_spread":0.13446498614937363,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479696","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.60925424,0.012670546,0.04395812,0.3034386,0.0016422155,0.0073601725,0.020646602,0.00006416992,0.0009653453],"genre_scores_gemma":[0.9772013,0.00026747002,0.016211836,0.0058255405,0.00004759292,0.00031022567,0.00009377368,0.000017009143,0.000025275405],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9960246,0.0004655232,0.0024888762,0.0004682611,0.000050004273,0.00050272717],"domain_scores_gemma":[0.9513606,0.047094252,0.00089512573,0.00035589398,0.000082641876,0.0002114891],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.008110108,0.00018267143,0.0009587153,0.00042351914,0.00048125142,0.00008507181,0.00024112793,0.00015160363,0.000037237663],"category_scores_gemma":[0.05178258,0.00016316502,0.0001360357,0.00017643541,0.00014860496,0.00014589971,0.00003297857,0.00021089728,0.0000045743345],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00048268284,0.000294031,0.14878513,0.0024511789,0.00014110876,2.6564464e-7,0.012756758,0.004948313,1.0369778e-7,0.7199186,0.104303025,0.0059188004],"study_design_scores_gemma":[0.0027586012,0.00074166193,0.047060255,0.0032463884,0.000025205183,7.0372676e-7,0.007965447,0.10840766,0.0000010588609,0.812378,0.016903015,0.0005119945],"about_ca_topic_score_codex":0.15149793,"about_ca_topic_score_gemma":0.006145559,"teacher_disagreement_score":0.36794704,"about_ca_system_score_codex":0.0013803235,"about_ca_system_score_gemma":0.0009196433,"threshold_uncertainty_score":0.95620465},"labels":[],"label_agreement":null},{"id":"W4417479712","doi":"10.1016/j.jval.2025.09.363","title":"PT3 Radiographic Progression-Free Survival (rPFS) as a Surrogate Endpoint for Overall Survival (OS) in First-Line (1L) Metastatic Castration-Resistant Prostate Cancer (mCRPC): A Meta-Analysis and Surrogate Threshold Effect","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Surrogate endpoint; Overall survival; Prostate cancer; Clinical endpoint; Survival analysis; Radiography","score_opus":0.08465402437305819,"score_gpt":0.4039227690628208,"score_spread":0.31926874468976263,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479712","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9202788,0.046735696,0.00008095215,0.022381095,0.00033467193,0.0088776145,0.0010669224,0.000089026085,0.00015521917],"genre_scores_gemma":[0.9861735,0.008439464,0.00070267287,0.0002715749,0.00005109346,0.0030515075,0.00038790875,0.00006011378,0.0008621632],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99451166,0.0009875189,0.0013220428,0.001089443,0.0009359663,0.0011533683],"domain_scores_gemma":[0.99652094,0.0017046822,0.0003473504,0.0007822334,0.00022975728,0.0004150579],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0054281927,0.00057101616,0.002552363,0.0017661275,0.00027237498,0.00010595733,0.0002489317,0.00013285254,0.00009311426],"category_scores_gemma":[0.0004436051,0.00040441606,0.0007937645,0.0029017136,0.00018458499,0.00018072434,0.0001334342,0.00054447027,0.0000023190223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.041758724,0.0035193977,0.78477687,0.023062347,0.10612352,0.0015537771,0.004504414,0.020405004,0.0010536625,0.005700644,0.0006714125,0.006870229],"study_design_scores_gemma":[0.15450548,0.019226566,0.5448653,0.0053046173,0.13588008,0.000058805308,0.0013517871,0.10093145,0.006366217,0.022731781,0.005381486,0.0033964212],"about_ca_topic_score_codex":0.03057456,"about_ca_topic_score_gemma":0.03985755,"teacher_disagreement_score":0.23991156,"about_ca_system_score_codex":0.00062886963,"about_ca_system_score_gemma":0.0014516418,"threshold_uncertainty_score":0.9998408},"labels":[],"label_agreement":null},{"id":"W4417479725","doi":"10.1016/j.jval.2025.09.2516","title":"PCR43 Characterizing and Quantifying Impacts of Neuromyelitis Optica Spectrum Disorder (NMOSD) on Patients and Caregivers","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Neuromyelitis optica; Spectrum disorder; Autism spectrum disorder; Spectrum (functional analysis); MEDLINE","score_opus":0.06482622003747328,"score_gpt":0.3480659234120079,"score_spread":0.28323970337453463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479725","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98989904,0.00091865245,0.0000049018104,0.008199431,0.000094856,0.00059041556,0.000022209728,0.000013991015,0.00025648292],"genre_scores_gemma":[0.9930208,0.006411067,0.00014376182,0.0003626484,0.000017857961,0.000008466905,0.0000067831497,0.0000104021465,0.000018216275],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99874204,0.00012282436,0.00030219878,0.0002630555,0.00022589385,0.00034395963],"domain_scores_gemma":[0.9992609,0.00032097514,0.000081089485,0.0001557813,0.000040609662,0.00014065293],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002956382,0.00011836081,0.00037040655,0.0002662573,0.00009370817,0.000012896965,0.00003990892,0.000035857054,0.0000044538992],"category_scores_gemma":[0.0007258167,0.000101370446,0.000024688727,0.00022850023,0.000100222234,0.000051713,0.000094920564,0.00019952444,7.910459e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029561247,0.0001451547,0.9755731,0.0022040654,0.000032799366,0.0000060054617,0.0021389632,0.000013378653,0.00086508243,0.00034674388,0.00009050845,0.018288566],"study_design_scores_gemma":[0.0019076909,0.0007811794,0.99383557,0.0014832111,0.000005667433,9.376753e-7,0.0004160789,0.000849156,0.00020296403,0.00002149171,0.0004373385,0.00005872925],"about_ca_topic_score_codex":0.0051190695,"about_ca_topic_score_gemma":0.00011209442,"teacher_disagreement_score":0.018262435,"about_ca_system_score_codex":0.00011147641,"about_ca_system_score_gemma":0.00012270657,"threshold_uncertainty_score":0.7738536},"labels":[],"label_agreement":null},{"id":"W4417479737","doi":"10.1016/j.jval.2025.09.3466","title":"MSR187 Simulation-Guided Trial Planning of a Cluster Randomized Trial With Probabilistic Covariate-Constrained Randomization for Vaccine Coverage","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Simon Fraser University","funders":"","keywords":"Randomization; Covariate; Cluster randomised controlled trial; Cluster (spacecraft); Randomized controlled trial; Sample size determination; Probabilistic logic; Outcome (game theory)","score_opus":0.4089605287641479,"score_gpt":0.5466162763627133,"score_spread":0.13765574759856536,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479737","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.031608645,0.00003385367,0.94069105,0.00061386375,0.0013571684,0.025233813,0.00007900206,0.00006154444,0.00032106088],"genre_scores_gemma":[0.34058794,0.000013002222,0.65692014,0.00035569834,0.0004698048,0.0014712112,0.000021722843,0.000045575503,0.0001148753],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9893821,0.0055303895,0.00387385,0.0004699206,0.00036506949,0.000378665],"domain_scores_gemma":[0.6913544,0.30638626,0.0013781771,0.00039666108,0.0003877663,0.00009673017],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0240595,0.00026061482,0.0027596443,0.00027126048,0.000091725524,0.00003269783,0.00017378615,0.00021529617,0.00004581621],"category_scores_gemma":[0.44424233,0.00019398952,0.00026122874,0.00050946634,0.00011251224,0.000059838883,0.00003625395,0.00023914772,5.4090395e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.7574896,0.0003489073,0.0000086073605,0.0010057393,0.000117614276,7.903606e-7,0.00019942396,0.1564763,0.0000010162572,0.083826296,0.00013361368,0.00039207598],"study_design_scores_gemma":[0.4968893,0.0005946754,0.0000016572238,0.00050045067,0.000118175696,1.9781429e-7,0.000007721662,0.15797365,0.0000064803253,0.34381214,0.000013397853,0.00008214832],"about_ca_topic_score_codex":0.00012724608,"about_ca_topic_score_gemma":0.0000056299014,"teacher_disagreement_score":0.42018282,"about_ca_system_score_codex":0.00016597123,"about_ca_system_score_gemma":0.00092035753,"threshold_uncertainty_score":0.8338591},"labels":[],"label_agreement":null},{"id":"W4417479756","doi":"10.1016/j.jval.2025.09.2151","title":"HTA368 When Less Is More? Learnings From a Recent NICE Submission Utilizing a Novel Predictive Individual-Level Surrogacy Approach to Predict Overall Survival (OS) in the Absence of Trial-Level Evidence","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Nice; Overall survival; Survival analysis; Baseline (sea); MEDLINE","score_opus":0.5191381405924437,"score_gpt":0.45008090499140646,"score_spread":0.06905723560103721,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479756","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.69272435,0.0009110413,0.2924463,0.0049309796,0.0003521545,0.006506106,0.000571553,0.00026100007,0.0012965555],"genre_scores_gemma":[0.86369264,0.0010545327,0.13316938,0.0012617547,0.00007834718,0.00052394025,0.00003120075,0.0000559595,0.00013225722],"study_design_codex":"qualitative","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99432,0.0012146039,0.0016358014,0.000898023,0.001207957,0.00072364236],"domain_scores_gemma":[0.9922172,0.005642985,0.0007531846,0.00097498426,0.00024951826,0.00016214485],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0069967965,0.00040808928,0.00095305836,0.00047117518,0.00013254181,0.00006222711,0.001180807,0.0002630813,0.000017957904],"category_scores_gemma":[0.008260297,0.0003389634,0.000104743245,0.0011656145,0.00013672546,0.00044367244,0.00045130108,0.0010567518,0.0000015481182],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032793816,0.013015374,0.11484,0.009790625,0.00054323545,0.000033995842,0.48858875,0.0134856785,0.0053893435,0.23378798,0.017774418,0.06995679],"study_design_scores_gemma":[0.034715146,0.0032162564,0.23415522,0.04186789,0.00018833371,0.000015873919,0.046962366,0.059791643,0.005868131,0.56905615,0.001976561,0.0021864225],"about_ca_topic_score_codex":0.015238278,"about_ca_topic_score_gemma":0.0002947017,"teacher_disagreement_score":0.44162637,"about_ca_system_score_codex":0.0006671291,"about_ca_system_score_gemma":0.0011192574,"threshold_uncertainty_score":0.99990624},"labels":[],"label_agreement":null},{"id":"W4417479766","doi":"10.1016/j.jval.2025.09.3046","title":"SA105 Where Is AI in Evidence Synthesis for NICE HTA Submissions?","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Roche (Canada)","funders":"","keywords":"Nice; Excellence; Health technology; Position statement; Systematic review; Evidence-based medicine; Evidence-based practice; Health care","score_opus":0.2890360559946231,"score_gpt":0.5122815167313057,"score_spread":0.2232454607366826,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5227864,0.016353603,0.0014451972,0.45533034,0.00117496,0.0023901558,0.000009233382,0.00006121284,0.0004489248],"genre_scores_gemma":[0.97986263,0.0043219826,0.0012184827,0.013139395,0.00016082321,0.0002795683,0.0000031447398,0.000015117442,0.0009988543],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9980442,0.00019581096,0.0007949756,0.00035857808,0.00016729772,0.0004391556],"domain_scores_gemma":[0.99699926,0.0022246283,0.000101653415,0.00036682477,0.00013700924,0.00017061296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016643767,0.000117961215,0.0003408747,0.0003504162,0.000114999995,0.0000153484,0.00012159019,0.00014278894,0.000093823764],"category_scores_gemma":[0.003389747,0.00011273931,0.0000610963,0.00073231955,0.000034888148,0.000114475355,0.000021487083,0.00030174086,0.000032919084],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095060834,0.00072199485,0.43760422,0.009586245,0.000021351689,0.000010106218,0.009415707,0.0007411462,0.00034697933,0.004189603,0.08242214,0.4539899],"study_design_scores_gemma":[0.0012840122,0.0026822858,0.3037795,0.12199987,0.00018109637,0.00004867318,0.02610711,0.15710428,0.043923676,0.07660819,0.2648477,0.0014335946],"about_ca_topic_score_codex":0.03950636,"about_ca_topic_score_gemma":0.001565786,"teacher_disagreement_score":0.45707625,"about_ca_system_score_codex":0.0006812612,"about_ca_system_score_gemma":0.002366582,"threshold_uncertainty_score":0.9668897},"labels":[],"label_agreement":null},{"id":"W4417479775","doi":"10.1016/j.jval.2025.09.687","title":"EE303 Cost-Utility Analysis of Iptacopan vs. C5 Inhibitors in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria Naïve to Complement Inhibitors in the Brazilian Private Healthcare System","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Hemoglobinuria; Eculizumab; Complement (music); Healthcare system; Complement system; Clinical trial","score_opus":0.01584302565479924,"score_gpt":0.2848360759610005,"score_spread":0.2689930503062013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479775","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9904615,0.0006654243,0.000024849745,0.0030006245,0.00068669533,0.0044349735,0.00062381354,0.00003679813,0.00006530341],"genre_scores_gemma":[0.9982585,0.000012454266,0.000063414656,0.00092202664,0.000019340512,0.0003108047,0.00038763828,0.000016261758,0.000009576709],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9928695,0.0030072809,0.0022241503,0.0007210847,0.00027215964,0.00090581825],"domain_scores_gemma":[0.99787277,0.00042076336,0.0006062115,0.0007961545,0.00020480684,0.000099305274],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0020804787,0.00037251413,0.0011761081,0.0013502354,0.00018771195,0.000023632827,0.00059790484,0.00015779912,0.000047150043],"category_scores_gemma":[0.00015832233,0.0002884969,0.00016089847,0.0032087907,0.0001274637,0.00008197121,0.00020051794,0.0005079928,0.000011327027],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008684258,0.0006180915,0.98898435,0.0012348474,0.00021100223,0.0000055357873,0.0028288316,0.0019845082,0.000028316686,0.0010520994,0.0010196699,0.0011643458],"study_design_scores_gemma":[0.003643083,0.00052891055,0.98752487,0.002304299,0.00008445841,0.0000015684428,0.003659179,0.00035853512,0.00022158195,0.000025375437,0.0014222478,0.00022587307],"about_ca_topic_score_codex":0.038465045,"about_ca_topic_score_gemma":0.03149421,"teacher_disagreement_score":0.0077969646,"about_ca_system_score_codex":0.0013927114,"about_ca_system_score_gemma":0.00058564154,"threshold_uncertainty_score":0.9999567},"labels":[],"label_agreement":null},{"id":"W4417479777","doi":"10.1016/j.jval.2025.09.648","title":"EE264 Cost-Effectiveness of Nivolumab Plus Platinum Doublet Chemotherapy as Neoadjuvant Treatment for Resectable NSCLC in Greece","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Nivolumab; Chemotherapy; Platinum; Complete response","score_opus":0.05804817109753496,"score_gpt":0.3793686892482297,"score_spread":0.32132051815069473,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97901314,0.009118531,0.00030634008,0.0032202855,0.00040081586,0.0063472274,0.000043872336,0.00003396451,0.0015158447],"genre_scores_gemma":[0.99501425,0.001875921,0.00055764447,0.0007436262,0.000047369515,0.0006593538,0.000042971315,0.000029221206,0.0010296217],"study_design_codex":"design_other","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9983003,0.00022363498,0.0005646941,0.0003381723,0.0001636727,0.0004095375],"domain_scores_gemma":[0.9988778,0.00052563223,0.00014121315,0.00033260218,0.000057135065,0.00006561028],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012363701,0.00018075855,0.0006794494,0.00032712417,0.000052897805,0.000008007124,0.00009181941,0.00011715398,0.00003539875],"category_scores_gemma":[0.00005576421,0.00015668847,0.0001195249,0.00061511603,0.000058057198,0.00004396673,0.000013121814,0.0001257105,0.00000159498],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.23828983,0.0034546913,0.06572621,0.009459933,0.0006912948,0.000062356004,0.0059984303,0.0062283347,0.03010216,0.0035637612,0.0018086573,0.63461435],"study_design_scores_gemma":[0.36524168,0.025751678,0.29334888,0.028050428,0.000111703725,0.00008506547,0.0019761978,0.031187763,0.14128679,0.0050139623,0.106881775,0.0010640556],"about_ca_topic_score_codex":0.05414676,"about_ca_topic_score_gemma":0.0009996238,"teacher_disagreement_score":0.6335503,"about_ca_system_score_codex":0.0023315887,"about_ca_system_score_gemma":0.0018230763,"threshold_uncertainty_score":0.9521518},"labels":[],"label_agreement":null},{"id":"W4417479800","doi":"10.1016/j.jval.2025.09.1841","title":"HTA56 Beyond the Surface: Health Technology Assessment and Reimbursement for Inflammatory or Autoimmune Disorders With Cosmetic and Dermatological Manifestations","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Reimbursement; Health technology; Technology assessment; Risk assessment; MEDLINE","score_opus":0.022669601554001044,"score_gpt":0.3114611157838242,"score_spread":0.28879151422982313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93618435,0.018560411,0.0006796001,0.04222863,0.00025657553,0.0018950686,0.00004475924,0.000074433854,0.00007619395],"genre_scores_gemma":[0.9913111,0.004688168,0.0024854986,0.0007937292,0.0000039684246,0.00031333728,0.000060827853,0.000012281622,0.00033111664],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998385,0.0004106277,0.00043291252,0.00032112485,0.00003320999,0.0004171154],"domain_scores_gemma":[0.9989839,0.00056286296,0.00016675319,0.00023402025,0.000025922209,0.000026523127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006484655,0.0001797909,0.0003620478,0.00016812742,0.00055315305,0.000014542564,0.00010462325,0.00014632281,0.000010494945],"category_scores_gemma":[0.000030328045,0.00011042337,0.000023800636,0.00026465327,0.0002935076,0.000035150635,0.000063586944,0.00020286445,0.0000018630436],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011109394,0.0009768119,0.6229498,0.0014881003,0.000820997,0.00003169128,0.0027506892,0.00086058275,0.00074132223,0.1933975,0.0029490688,0.17192253],"study_design_scores_gemma":[0.009606096,0.0024932614,0.9420159,0.00050245784,0.00014066759,0.0002686076,0.0075578718,0.00068590406,0.00018621692,0.011588575,0.024532141,0.0004222871],"about_ca_topic_score_codex":0.00039025184,"about_ca_topic_score_gemma":0.0006558678,"teacher_disagreement_score":0.31906617,"about_ca_system_score_codex":0.00014727096,"about_ca_system_score_gemma":0.00068027055,"threshold_uncertainty_score":0.45029342},"labels":[],"label_agreement":null},{"id":"W4417479806","doi":"10.1016/j.jval.2025.09.2555","title":"PCR82 Evaluating the Feasibility and Acceptability of a Personalized Endpoint: A Prospective Mixed Methods Study of Inventory-Facilitated Goal Attainment Scaling","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Resilience and Mental Health","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Goal Attainment Scaling; Scaling; Goal orientation","score_opus":0.16300363047407418,"score_gpt":0.5397753056234789,"score_spread":0.3767716751494047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99207926,0.0022569664,0.00031579938,0.00040352478,0.00030461367,0.0042626853,0.000018941293,0.00001695167,0.00034124596],"genre_scores_gemma":[0.99734044,0.000036274356,0.0021910793,0.00011652932,0.000009476653,0.00024016535,0.0000018356959,0.000007601168,0.00005661922],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9896697,0.007679861,0.0012375916,0.0006237053,0.0003730801,0.0004160732],"domain_scores_gemma":[0.9977013,0.0011835635,0.00040008,0.00051235216,0.000104579325,0.000098119366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014534093,0.0001703831,0.0006225103,0.00014874813,0.00016482729,0.000007501998,0.0002002451,0.00007318725,0.00010997221],"category_scores_gemma":[0.0006211946,0.00012871421,0.000076797805,0.0006717503,0.0003306596,0.000054354136,0.00013359622,0.00032029612,8.4706903e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001276857,0.002098118,0.81612235,0.00084921933,0.00006101136,7.0653965e-7,0.10632638,0.00015123562,0.00016572628,0.001473731,0.000010805469,0.07146384],"study_design_scores_gemma":[0.0029071358,0.002261152,0.8722152,0.000105701256,0.000020879228,0.0000011879569,0.11665325,0.003030366,0.00015702448,0.0025595352,0.000013685187,0.00007488785],"about_ca_topic_score_codex":0.020378802,"about_ca_topic_score_gemma":0.00040019443,"teacher_disagreement_score":0.071388945,"about_ca_system_score_codex":0.0006987429,"about_ca_system_score_gemma":0.0004951955,"threshold_uncertainty_score":0.9861446},"labels":[],"label_agreement":null},{"id":"W4417479847","doi":"10.1016/j.jval.2025.09.1087","title":"EE707 The Economic Value of Self-Administered Subcutaneous Immunoglobulin G (SCIg) in Canada: A Scoping Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Immunodeficiency and Autoimmune Disorders","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Takeda (Canada)","funders":"","keywords":"Value (mathematics); Antibody; Immunoglobulin G; MEDLINE","score_opus":0.015657070331597193,"score_gpt":0.2683271140454936,"score_spread":0.2526700437138964,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479847","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4178538,0.5757594,0.0000056468116,0.003232022,0.0010457906,0.001233176,0.000020899499,0.000021028152,0.000828218],"genre_scores_gemma":[0.9665727,0.03128488,0.000018796274,0.001909467,0.0000016095695,0.000048264686,0.000020920761,0.000010984671,0.00013239647],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9968717,0.0008498873,0.0013529835,0.0003165784,0.00004293017,0.0005659138],"domain_scores_gemma":[0.9985899,0.00048215274,0.00035920448,0.0005400668,0.000021449288,0.000007226982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001405005,0.00019819882,0.00072247285,0.00014414391,0.00016194122,0.0000064550322,0.0005362526,0.00010298397,0.00008564455],"category_scores_gemma":[0.00010888893,0.00016744247,0.000086552405,0.00037386632,0.000107982,0.00004141186,0.00010980718,0.00042925501,0.000029293064],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049997554,0.0048178914,0.0924185,0.20574574,0.002538216,0.0004694692,0.03347547,0.13549365,0.013341175,0.17771475,0.012507538,0.31647784],"study_design_scores_gemma":[0.02530676,0.0031546112,0.18802276,0.6319716,0.00042874034,0.0013219218,0.016117504,0.0077476343,0.011068312,0.0045820363,0.1056557,0.0046224007],"about_ca_topic_score_codex":0.8850082,"about_ca_topic_score_gemma":0.25162733,"teacher_disagreement_score":0.63338083,"about_ca_system_score_codex":0.0012393871,"about_ca_system_score_gemma":0.011706172,"threshold_uncertainty_score":0.99389654},"labels":[],"label_agreement":null},{"id":"W4417479853","doi":"10.1016/j.jval.2025.09.1849","title":"HTA64 Canadian HTA Decisions (2020-2023): Comparing CDA-AMC and INESSS Recommendations on Drug Reimbursement","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Drug; MEDLINE; Real world evidence","score_opus":0.42063882912983697,"score_gpt":0.44732286347020545,"score_spread":0.02668403434036848,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479853","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.33441275,0.0062925643,0.0012089304,0.62770253,0.0030176563,0.0021070682,0.0005298808,0.000076166456,0.024652468],"genre_scores_gemma":[0.9512609,0.0019298026,0.0036064081,0.040872104,0.00019290292,0.0001943637,0.0001241518,0.000034440127,0.0017849267],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9942344,0.0005931475,0.0037287062,0.0007005176,0.00008623586,0.0006570343],"domain_scores_gemma":[0.99601626,0.001971537,0.00088360667,0.00061247917,0.000045908673,0.00047021365],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.015763571,0.00020720187,0.0009217876,0.0012033446,0.00053521123,0.000103346894,0.0002889136,0.00010780825,0.000210713],"category_scores_gemma":[0.0030344569,0.00028008007,0.0000597061,0.0006621428,0.000049649796,0.00020648107,0.00007632098,0.00036759544,0.0004891351],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017178658,0.00017575533,0.19134502,0.00046567817,0.000057441695,0.0000026383032,0.0032321573,0.008838937,1.6641215e-7,0.49634647,0.29638174,0.0031368055],"study_design_scores_gemma":[0.001978775,0.000108359854,0.24491054,0.0019522118,0.000006924866,0.0000043331406,0.0032562506,0.07016422,0.000001371526,0.06083511,0.6161832,0.00059867295],"about_ca_topic_score_codex":0.45000058,"about_ca_topic_score_gemma":0.22965135,"teacher_disagreement_score":0.6168482,"about_ca_system_score_codex":0.0025517736,"about_ca_system_score_gemma":0.0012096236,"threshold_uncertainty_score":0.99996513},"labels":[],"label_agreement":null},{"id":"W4417479855","doi":"10.1016/j.jval.2025.09.1538","title":"HPR131 Launches of Oncology Products in LATAM vs. the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Radiation oncology; Clinical Oncology; MEDLINE","score_opus":0.09250560443434454,"score_gpt":0.41100032086951166,"score_spread":0.31849471643516714,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479855","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8811574,0.0038464542,0.0000022684405,0.11310661,0.000110406094,0.00088768586,0.000009380826,0.000012717148,0.0008670584],"genre_scores_gemma":[0.9895078,0.0068508023,0.00022801168,0.0017008112,0.000035643756,0.00005836817,0.00009006902,0.000008305272,0.0015201932],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988629,0.00027398366,0.00029989632,0.0001619012,0.00013275996,0.0002685429],"domain_scores_gemma":[0.9992922,0.00031250162,0.000055397693,0.0002227012,0.00007410919,0.00004312086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009987109,0.00006740944,0.0002598091,0.0003495702,0.000031672967,0.0000029794783,0.00008052335,0.000046811885,0.000010613001],"category_scores_gemma":[0.00021706798,0.000040660183,0.00001656531,0.0011567958,0.00011295378,0.000017859984,0.00003953202,0.00025379288,0.0000034229945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003999797,0.0024977922,0.8820858,0.0069006328,0.00016128377,0.00016838199,0.018589538,0.0046082335,0.0006521058,0.008090416,0.02427284,0.047973182],"study_design_scores_gemma":[0.015854951,0.005270606,0.54900134,0.003768356,0.000044667555,0.000017533115,0.005848761,0.011576231,0.01207178,0.0067952126,0.38951954,0.00023103009],"about_ca_topic_score_codex":0.017126469,"about_ca_topic_score_gemma":0.00033702003,"teacher_disagreement_score":0.3652467,"about_ca_system_score_codex":0.00043797094,"about_ca_system_score_gemma":0.0016239159,"threshold_uncertainty_score":0.98941857},"labels":[],"label_agreement":null},{"id":"W4417479867","doi":"10.1016/j.jval.2025.09.2782","title":"RWD32 Characterizing Comorbidities and Co-Occurring Conditions in Adults with Generalized Anxiety Disorder in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Generalized anxiety disorder; Anxiety; Functional impairment; Comorbidity; Generalized anxiety; Anxiety disorder","score_opus":0.040365765914622195,"score_gpt":0.3647807128856907,"score_spread":0.3244149469710685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479867","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9913517,0.004295084,0.00014760495,0.0020612846,0.00023534159,0.0008817381,0.00019049883,0.00004353814,0.0007931784],"genre_scores_gemma":[0.9711032,0.024648158,0.0001485028,0.0031952134,0.000034819313,0.00040545387,0.00038774143,0.000021266795,0.000055625733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99772835,0.0007011192,0.00048039717,0.00045919698,0.000163484,0.00046745234],"domain_scores_gemma":[0.9987276,0.0007120183,0.0001749913,0.00025975434,0.000065376924,0.000060258826],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006762778,0.00022332821,0.00032416242,0.0011440406,0.00017071137,0.000048795646,0.00017807129,0.00009003649,0.000063114865],"category_scores_gemma":[0.00011776044,0.00017030435,0.000023092587,0.0021150333,0.00015259856,0.00013628749,0.000034689496,0.00038817004,0.0000056009158],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026173974,0.0005046068,0.9721067,0.00030188612,0.000027914373,0.000012095565,0.01875356,0.00022737596,0.0000027734711,0.0022575175,0.000636835,0.004907006],"study_design_scores_gemma":[0.005086177,0.00018240356,0.95079696,0.0013136156,0.00000965873,0.000013147608,0.021146476,0.00087614683,0.00001166974,0.0016617291,0.018684965,0.00021705998],"about_ca_topic_score_codex":0.024289275,"about_ca_topic_score_gemma":0.0014306233,"teacher_disagreement_score":0.022858651,"about_ca_system_score_codex":0.00012174899,"about_ca_system_score_gemma":0.000107952925,"threshold_uncertainty_score":0.9822081},"labels":[],"label_agreement":null},{"id":"W4417479875","doi":"10.1016/j.jval.2025.09.3428","title":"MSR144 Measuring Health-Related Quality of Life and Food Insecurity in the General Population in Lebanon During the Third Worst Socioeconomic Crisis in History","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Food Security and Health in Diverse Populations","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Socioeconomic status; Food insecurity; Population; Quality of life (healthcare); Quality (philosophy)","score_opus":0.2311882861250552,"score_gpt":0.4146046459041123,"score_spread":0.18341635977905707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479875","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9582057,0.007855247,0.0000022494246,0.030952513,0.0006326772,0.0020189679,0.000028362734,0.000028444454,0.00027583385],"genre_scores_gemma":[0.9948843,0.0010760773,0.00007283529,0.0036842641,0.000054281594,0.0001682624,0.000019625297,0.000015047653,0.00002527069],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98835564,0.007046083,0.0031184582,0.00044071252,0.0002699377,0.000769185],"domain_scores_gemma":[0.99733186,0.0011589916,0.00090114045,0.00045050663,0.0000410782,0.00011642107],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011872222,0.00020142697,0.0007751782,0.00074833346,0.000608468,0.0000076813685,0.00029473088,0.00031740515,0.00002904448],"category_scores_gemma":[0.000559994,0.00017594371,0.00006476761,0.0006339661,0.00008671392,0.00019316898,0.00013093543,0.0019158856,0.000004689512],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001289848,0.00016394733,0.8985314,0.0028516832,0.000007198997,5.988256e-7,0.06805275,0.004069056,0.000001596107,0.025728226,0.00036226917,0.00010234364],"study_design_scores_gemma":[0.00191595,0.00006396956,0.9775652,0.00075465837,0.0000018862514,3.273786e-7,0.008627263,0.00223037,3.2213688e-7,0.008484518,0.00023664319,0.000118849806],"about_ca_topic_score_codex":0.40695876,"about_ca_topic_score_gemma":0.27161047,"teacher_disagreement_score":0.13534829,"about_ca_system_score_codex":0.004120616,"about_ca_system_score_gemma":0.0018469203,"threshold_uncertainty_score":0.9997024},"labels":[],"label_agreement":null},{"id":"W4417479886","doi":"10.1016/j.jval.2025.09.644","title":"EE260 Cost-Effectiveness of Mixed Maternal RSVpreF/Infant Nirsevimab Immunization Approach vs. Nirsevimab Alone for the Prevention of Respiratory Syncytial Virus in Chile","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Innovation Cluster (Canada)","funders":"","keywords":"Immunization; Respiratory system; Virus; Respiratory tract; Lower respiratory tract infection; Respiratory tract infections","score_opus":0.08362415419365703,"score_gpt":0.4066670076131796,"score_spread":0.32304285341952255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793125,0.002454195,0.010462258,0.00014591355,0.0002731341,0.006902879,0.000043848646,0.000025813659,0.00037946407],"genre_scores_gemma":[0.99818385,0.00023088792,0.0004408598,0.000082634746,0.000046611298,0.0008963644,0.000035359346,0.000028683284,0.000054751057],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99610066,0.001642405,0.0011233009,0.0003541949,0.0003977973,0.00038162945],"domain_scores_gemma":[0.99806374,0.00069023046,0.00033609732,0.0005906353,0.00025652195,0.000062744904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005326521,0.00017988888,0.0007298934,0.00078899076,0.00011232687,0.000014650484,0.00022741874,0.00015636622,0.000014638769],"category_scores_gemma":[0.00071289594,0.0001455194,0.00013671682,0.001265724,0.00016371055,0.00013343553,0.00009623318,0.00040877506,0.0000021914489],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022205798,0.007306375,0.58177954,0.04118716,0.00052557356,0.00001378482,0.0011737668,0.10763608,0.13420522,0.013204514,0.0003665409,0.09039564],"study_design_scores_gemma":[0.010031194,0.0021683536,0.85677063,0.0030975104,0.000060161696,0.000008717556,0.00014138702,0.026504368,0.09920494,0.00057382375,0.0012669769,0.00017190314],"about_ca_topic_score_codex":0.006315796,"about_ca_topic_score_gemma":0.00016442689,"teacher_disagreement_score":0.2749911,"about_ca_system_score_codex":0.00067789917,"about_ca_system_score_gemma":0.001201537,"threshold_uncertainty_score":0.95476365},"labels":[],"label_agreement":null},{"id":"W4417479923","doi":"10.1016/j.jval.2025.09.2554","title":"PCR81 Evaluating Patient Preferences for Clinical Trial Endpoints in Early Stage Cancer: A Discrete Choice Experiment in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; AstraZeneca (Canada)","funders":"","keywords":"Clinical trial; Stage (stratigraphy); Patient choice; Clinical endpoint; Discrete choice; Preference","score_opus":0.23949834063713513,"score_gpt":0.49113249469838155,"score_spread":0.25163415406124645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479923","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9862909,0.0054153977,0.000003852701,0.0027151983,0.00093034393,0.0044426755,0.00010450673,0.000007648643,0.00008951129],"genre_scores_gemma":[0.9931649,0.002455067,0.00037182125,0.0009350546,0.00007759433,0.0029168911,0.000021924181,0.000011639539,0.000045122324],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99719185,0.00037387587,0.0012122102,0.00045851376,0.00030435284,0.00045919392],"domain_scores_gemma":[0.99852496,0.0008406849,0.00022322568,0.0002233709,0.000039847153,0.00014788497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010604284,0.0001579383,0.00060184527,0.00013650689,0.000038562343,0.000011678719,0.00007742338,0.000053416294,0.000021269985],"category_scores_gemma":[0.0004101411,0.00013296031,0.00005792664,0.0002641766,0.000020668398,0.00004257242,0.00003984324,0.00023521704,3.7422086e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.007007222,0.0005340262,0.92117006,0.0004105542,0.000035951354,0.000016155273,0.0016647879,0.0011615631,0.0000030564713,0.00007371199,0.00030849726,0.06761442],"study_design_scores_gemma":[0.095891,0.007500642,0.877482,0.0048895534,0.000030245412,3.0234906e-7,0.0016229469,0.007558187,0.0006026765,0.00021584345,0.003963747,0.00024288383],"about_ca_topic_score_codex":0.97823983,"about_ca_topic_score_gemma":0.9112686,"teacher_disagreement_score":0.08888378,"about_ca_system_score_codex":0.004589382,"about_ca_system_score_gemma":0.009742269,"threshold_uncertainty_score":0.9992318},"labels":[],"label_agreement":null},{"id":"W4417479925","doi":"10.1016/j.jval.2025.09.2572","title":"PCR99 Framing Matters! Implications of Loss Aversion for Communicating Benefits to Patients in Preference Studies (and Beyond)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Environmental Valuation","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Framing (construction); Loss aversion; Prospect theory; Framing effect; Preference; Health economics; Preference elicitation; Meaning (existential)","score_opus":0.2011801648857067,"score_gpt":0.30076401422172466,"score_spread":0.09958384933601797,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479925","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9779128,0.019082427,0.0004137979,0.0017904828,0.000051798364,0.00054434815,0.000053418164,0.000003617448,0.0001473119],"genre_scores_gemma":[0.9742249,0.021841805,0.0031551255,0.0006745452,0.0000024102114,0.00007788347,0.000009704172,0.0000051439824,0.000008444327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99909055,0.000019768437,0.00057199073,0.00018118817,0.000009638952,0.00012687389],"domain_scores_gemma":[0.9994258,0.00017038784,0.00020161804,0.00017162174,0.0000071250693,0.00002340755],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046223996,0.00005917465,0.0002624149,0.00020149656,0.00006472797,0.0000053949243,0.00010275606,0.000030517065,0.0000020045259],"category_scores_gemma":[0.00007233564,0.00007353476,0.000019212044,0.00012820688,0.000022893237,0.000073800344,0.0001019865,0.000050945753,0.0000061704163],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004328154,0.00005125925,0.9262986,0.00038439472,0.0000068520817,4.990613e-9,0.0016294692,0.0032337569,6.5421744e-7,0.053619064,0.00001957366,0.014752049],"study_design_scores_gemma":[0.0005008838,0.000060968392,0.9742189,0.00045788227,0.0000016502354,5.260968e-8,0.00036655966,0.0017419824,0.000007647746,0.021925833,0.0006420338,0.00007558938],"about_ca_topic_score_codex":0.0012109483,"about_ca_topic_score_gemma":0.00013040574,"teacher_disagreement_score":0.04792032,"about_ca_system_score_codex":0.0002849673,"about_ca_system_score_gemma":0.000012358099,"threshold_uncertainty_score":0.29986605},"labels":[],"label_agreement":null},{"id":"W4417479967","doi":"10.1016/j.jval.2025.09.917","title":"EE535 Impact of Indirect Treatment Comparison (ITC) Methodology on Cost-Effectiveness of Quizartinib in Acute Myeloid Leukemia (AML) in Canada and the United Kingdom (UK)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Myeloid leukemia; Reimbursement; Cohort; Cohort study; Leukemia","score_opus":0.15447653828251615,"score_gpt":0.4388684027220284,"score_spread":0.28439186443951225,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479967","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99546313,0.00054419646,0.000050944567,0.00087347405,0.00008794454,0.0027882732,0.00004661446,0.0000075229214,0.00013791703],"genre_scores_gemma":[0.9986875,0.00052060006,0.00031977956,0.00022254093,0.000010550309,0.00015842976,0.000044345292,0.000018055422,0.000018198058],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99239343,0.005333779,0.0009967228,0.0003766193,0.00031616943,0.00058326335],"domain_scores_gemma":[0.9905626,0.008500723,0.00028610698,0.00043350333,0.00008178343,0.00013525372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004995901,0.00024116313,0.0015696539,0.0011608491,0.000038561877,0.0000043985274,0.00017394079,0.0001349399,0.000010252865],"category_scores_gemma":[0.001054024,0.00016018307,0.00008254603,0.0019691668,0.0002125491,0.000023099628,0.00007882363,0.0006587639,4.5154042e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.012500353,0.00021131743,0.94378805,0.00067634834,0.00025463387,0.00007077083,0.0016466763,0.031577364,0.00084173447,0.00081839587,0.000084652725,0.007529717],"study_design_scores_gemma":[0.017715326,0.0015412064,0.9462836,0.0014081304,0.000042307285,0.000016615933,0.00038176894,0.02612032,0.006087564,0.00022452178,0.00007555471,0.000103086306],"about_ca_topic_score_codex":0.99451363,"about_ca_topic_score_gemma":0.7500633,"teacher_disagreement_score":0.24445036,"about_ca_system_score_codex":0.01711772,"about_ca_system_score_gemma":0.015175357,"threshold_uncertainty_score":0.9904077},"labels":[],"label_agreement":null},{"id":"W4417479984","doi":"10.1016/j.jval.2025.09.192","title":"CO90 Efficacy and Safety of Antibody-Drug Conjugates (ADCs) in Pretreated Locally Advanced/Metastatic (LA/m) Non-Small Cell Lung Cancer (NSCLC): A Systematic Literature Review (SLR)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agricultural Research Institute of Ontario","funders":"","keywords":"Lung cancer; Toxicity; Systematic review; Cytotoxic T cell; Conjugate; Cancer; Clinical trial","score_opus":0.0194310146393124,"score_gpt":0.3837935148397427,"score_spread":0.3643625002004303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417479984","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.10629334,0.88014615,0.00016365158,0.0029706715,0.00014872417,0.009326532,0.00008385102,0.000038465467,0.0008286175],"genre_scores_gemma":[0.28559119,0.71059406,0.0012839845,0.0013926085,0.00002332328,0.00039364945,0.000034133554,0.000051949537,0.00063510996],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9953651,0.001324324,0.0016513548,0.0005799739,0.0004598957,0.000619396],"domain_scores_gemma":[0.997122,0.0013982602,0.00036465752,0.00060880795,0.00025888236,0.0002474174],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0032305904,0.00032303992,0.0017461615,0.0005243901,0.000052590214,0.000027815879,0.00022195945,0.00011171479,0.000026917973],"category_scores_gemma":[0.00082881306,0.00026446453,0.00008283758,0.0020159741,0.00012552795,0.000079626516,0.000093509225,0.0008179367,0.0000031654324],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004701403,0.00032384341,0.02572166,0.96743083,0.0000732459,0.00016230014,0.0018738377,0.0007127753,0.00043104097,0.00012151958,0.0006572033,0.0020215823],"study_design_scores_gemma":[0.0056560906,0.0003091934,0.011069774,0.9715045,0.00012957827,0.000029780618,0.00015230279,0.010287125,0.0003740127,0.000030922838,0.00026239682,0.00019432374],"about_ca_topic_score_codex":0.0021366833,"about_ca_topic_score_gemma":0.00020208652,"teacher_disagreement_score":0.17929785,"about_ca_system_score_codex":0.000575301,"about_ca_system_score_gemma":0.002436028,"threshold_uncertainty_score":0.99998075},"labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":[],"domain":null,"study_design":"systematic_review","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"agree"},{"id":"W4417480004","doi":"10.1016/j.jval.2025.09.251","title":"CO149 Increased Functional Impairment Associated With Generalized Anxiety Disorder (GAD): Findings From a Systematic Literature Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Systematic review; Generalized anxiety disorder; Functional impairment; Anxiety; Generalized anxiety","score_opus":0.029583266549297597,"score_gpt":0.3233192747896388,"score_spread":0.2937360082403412,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480004","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28210267,0.70421433,0.0017414317,0.0027460442,0.0016449433,0.0051872167,0.0005038907,0.00026936526,0.0015901171],"genre_scores_gemma":[0.6814952,0.3016603,0.000729916,0.010034542,0.00015343132,0.0022812518,0.0013878599,0.000085329404,0.0021721981],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99511987,0.001798822,0.0010418261,0.00089958485,0.0005224971,0.00061740936],"domain_scores_gemma":[0.99734634,0.0010058847,0.00054390955,0.00056484743,0.00034245756,0.00019654246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0015271459,0.00044372102,0.0010578835,0.0005568408,0.00022430712,0.00007371393,0.00025975902,0.00024095076,0.0005224811],"category_scores_gemma":[0.0010657529,0.00033642372,0.00015551283,0.0034086802,0.00006407052,0.00013908402,0.000060795348,0.00048140393,0.00006716977],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007472469,0.0033696122,0.879066,0.057422116,0.0012937282,0.000033308304,0.0022157845,0.000065828375,0.000006238846,0.0019499124,0.05149228,0.0023379314],"study_design_scores_gemma":[0.012915987,0.0006985667,0.6488388,0.32386762,0.00054969284,0.000035845485,0.0007027953,0.00044772992,0.000009766001,0.002701324,0.008391167,0.0008406891],"about_ca_topic_score_codex":0.0029029034,"about_ca_topic_score_gemma":0.0001248687,"teacher_disagreement_score":0.402554,"about_ca_system_score_codex":0.00065180747,"about_ca_system_score_gemma":0.00040139307,"threshold_uncertainty_score":0.9999088},"labels":[],"label_agreement":null},{"id":"W4417480012","doi":"10.1016/j.jval.2025.09.317","title":"CO216 Safety and Efficacy of Antibody Drug Conjugate (ADCs) in Pretreated Locally Advanced/Metastatic (LA/m) Triple-Negative Breast Cancer (TNBC): Systematic Literature Review (SLR)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Agricultural Research Institute of Ontario","funders":"","keywords":"Breast cancer; Antibody-drug conjugate; Systematic review; Drug; Conjugate","score_opus":0.021433026575349914,"score_gpt":0.40031154003912167,"score_spread":0.37887851346377177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480012","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07178023,0.89275795,0.00013358485,0.016016694,0.00034434287,0.01697178,0.00061602745,0.00008562675,0.0012937571],"genre_scores_gemma":[0.41382566,0.582449,0.00065464154,0.0017673079,0.000030183039,0.00034879646,0.00005278839,0.000054614622,0.00081695575],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99422425,0.0022170644,0.001795727,0.00059311604,0.00057814503,0.000591681],"domain_scores_gemma":[0.9965946,0.0017888638,0.0004344324,0.00057639315,0.00034745102,0.00025822938],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0036718042,0.00032628738,0.001953097,0.0005714368,0.0000593505,0.000025088419,0.00020214163,0.00010133948,0.000056628523],"category_scores_gemma":[0.0016899467,0.00025930884,0.00009482628,0.002643166,0.00021322009,0.00012170237,0.00008163694,0.000840513,0.0000042968118],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019825564,0.00050569663,0.012671139,0.96980953,0.00017945598,0.00029479893,0.0028306968,0.0006354432,0.00013656249,0.00096752355,0.0005505991,0.009436012],"study_design_scores_gemma":[0.008773669,0.00032137107,0.046055235,0.9387275,0.00011258696,0.00011593956,0.00024448632,0.004965734,0.00009674265,0.00016743166,0.00020935215,0.00020995566],"about_ca_topic_score_codex":0.003320163,"about_ca_topic_score_gemma":0.00027292594,"teacher_disagreement_score":0.34204546,"about_ca_system_score_codex":0.00083812175,"about_ca_system_score_gemma":0.0022955963,"threshold_uncertainty_score":0.99998593},"labels":[],"label_agreement":null},{"id":"W4417480024","doi":"10.1016/j.jval.2025.09.1924","title":"HTA139 Evolution of Acceptance of Evidence and PMA Outcomes by HTA Authorities for ATMPs in the EU4 and the UK 2017-2025","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"","score_opus":0.5471278348373917,"score_gpt":0.48423169276578937,"score_spread":0.06289614207160232,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480024","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6855548,0.0960891,0.0035718614,0.21066007,0.00048807624,0.002822266,0.00036055906,0.000009607037,0.00044366188],"genre_scores_gemma":[0.9929612,0.0028867598,0.0007140385,0.0029103977,0.000025506622,0.00016976334,0.000003129931,0.0000064459305,0.00032272466],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99574524,0.00077058154,0.002846379,0.0003082852,0.0000737248,0.00025581277],"domain_scores_gemma":[0.9911705,0.0071052765,0.0012828016,0.00036463878,0.0000422659,0.00003450508],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028529573,0.00011381743,0.00085328094,0.00024403035,0.00012909889,0.000026257963,0.00025925,0.00008366697,0.000007656717],"category_scores_gemma":[0.0056525962,0.00008857509,0.00005616377,0.00025474868,0.0002363304,0.00019893813,0.000047594018,0.00013967605,0.0000025839677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000048091737,0.000035866287,0.4935652,0.0017587923,0.0000152366365,3.8904034e-8,0.0048125866,0.00023014258,4.5316926e-7,0.4910136,0.008241593,0.00027842104],"study_design_scores_gemma":[0.0022754888,0.00012272282,0.8076888,0.0010819655,0.0000067542605,0.0000012303886,0.0060500647,0.02104453,0.0000021926296,0.15678707,0.0047880295,0.00015115846],"about_ca_topic_score_codex":0.021347638,"about_ca_topic_score_gemma":0.0011945637,"teacher_disagreement_score":0.33422652,"about_ca_system_score_codex":0.00031536157,"about_ca_system_score_gemma":0.0002890535,"threshold_uncertainty_score":0.9887838},"labels":[],"label_agreement":null},{"id":"W4417480074","doi":"10.1016/j.jval.2025.09.1136","title":"EPH7 A Real-World Survey of Health Inequalities as Drivers for Burden on Male Hemophilia Patients in the US, EU5, and Asia","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Inequality; Public health; Survey data collection; Social inequality","score_opus":0.09599436895553216,"score_gpt":0.3972385713632871,"score_spread":0.30124420240775496,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480074","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9765335,0.0005861655,0.000001576455,0.01863221,0.00009003194,0.0022140893,0.00008404028,0.000009618795,0.0018487797],"genre_scores_gemma":[0.9942596,0.0022021865,0.00010714688,0.0009548679,0.000029369203,0.00006756704,0.00014495126,0.000012790361,0.0022215385],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972395,0.0010373739,0.0006279703,0.00028274587,0.00036771837,0.00044470245],"domain_scores_gemma":[0.9982271,0.0011469208,0.00012999441,0.00029498994,0.000095698786,0.00010527763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036258968,0.00013970939,0.0005194141,0.00051203097,0.00010341186,0.000010243007,0.00011536544,0.00006236179,0.000012257836],"category_scores_gemma":[0.0005239169,0.0000967602,0.0000425606,0.00069805083,0.0000924652,0.000032256266,0.0000366806,0.000235616,0.0000033197077],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004997673,0.00041124527,0.9801201,0.0015014759,0.000022898821,0.0000058061364,0.0026187848,0.000047458157,0.0000017615464,0.0042595924,0.0022000307,0.008311058],"study_design_scores_gemma":[0.0033819608,0.0017881119,0.9903889,0.0010447028,0.000004948073,0.0000014455176,0.00059586833,0.00041661906,0.000022880364,0.00088746566,0.0014021497,0.00006496843],"about_ca_topic_score_codex":0.18791324,"about_ca_topic_score_gemma":0.0060472856,"teacher_disagreement_score":0.18186595,"about_ca_system_score_codex":0.00039453772,"about_ca_system_score_gemma":0.0011273008,"threshold_uncertainty_score":0.8174945},"labels":[],"label_agreement":null},{"id":"W4417480109","doi":"10.1016/j.jval.2025.09.2689","title":"PCR216 Significant Burden of Chronic Obstructive Pulmonary Disease (COPD) on Health Status and Well-Being Persists Among Patients Experiencing One Severe or Two or More Moderate Exacerbations of COPD (ECOPD) and Their Caregivers (CGs)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Chronic Obstructive Pulmonary Disease (COPD) Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen Elizabeth II Health Sciences Centre; Dalhousie University","funders":"","keywords":"Pulmonary disease; COPD; Disease; Severity of illness","score_opus":0.024783594487331858,"score_gpt":0.3025102543734594,"score_spread":0.27772665988612755,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480109","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99078774,0.0042048753,0.000037761336,0.0012613557,0.0001357241,0.0028126934,0.00035918245,0.00003774256,0.00036293067],"genre_scores_gemma":[0.9968128,0.002236017,0.00018235868,0.00012871795,0.00006211189,0.00011903744,0.00012061122,0.000053082684,0.00028525878],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961251,0.00052106316,0.00093633,0.0009016602,0.0006170134,0.00089883985],"domain_scores_gemma":[0.99729574,0.00050180074,0.00044199216,0.0005836159,0.00029438574,0.00088245],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040124287,0.0004051897,0.000986887,0.0006249399,0.00032343395,0.000023220196,0.00016710824,0.00009754379,0.00009252874],"category_scores_gemma":[0.000304307,0.00033869033,0.00010122424,0.0007934665,0.000687384,0.0002342769,0.00021146376,0.00046409867,9.126468e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027741818,0.003412521,0.664997,0.04639292,0.00069930014,0.00027428463,0.12518401,0.04603205,0.00044263861,0.0020555619,0.00030093265,0.08246697],"study_design_scores_gemma":[0.0072061145,0.0016883541,0.83318424,0.0062986496,0.00007767534,0.0000064721617,0.04701995,0.10319299,0.00023743637,0.00058206153,0.00008181801,0.0004242374],"about_ca_topic_score_codex":0.018175112,"about_ca_topic_score_gemma":0.00031795632,"teacher_disagreement_score":0.16818725,"about_ca_system_score_codex":0.0030504633,"about_ca_system_score_gemma":0.0057056956,"threshold_uncertainty_score":0.99993104},"labels":[],"label_agreement":null},{"id":"W4417480112","doi":"10.1016/j.jval.2025.09.230","title":"CO128 Health Technology Assessment, Reimbursement, and Funding Landscape Challenges for Oncology Companion Diagnostics in Europe and Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Precision oncology; Biomarker; Selection (genetic algorithm); Precision medicine; Biomarker discovery; Health technology","score_opus":0.0730116779306706,"score_gpt":0.38458019095373086,"score_spread":0.31156851302306027,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480112","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28941476,0.26919064,0.0016581385,0.4315854,0.0025538863,0.00284248,0.0002166449,0.0000988436,0.0024391983],"genre_scores_gemma":[0.9130694,0.077774875,0.0044713113,0.004371617,0.000023355466,0.00006191581,0.000032637006,0.000015264079,0.00017961899],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978009,0.0007607851,0.0005122397,0.0003753941,0.000025120273,0.00052557496],"domain_scores_gemma":[0.99817276,0.0014358257,0.00015388445,0.0001476905,0.00004210119,0.00004774027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001807742,0.00014432904,0.00054589205,0.00030683886,0.00016618795,0.0000070898263,0.00010462702,0.00022138408,0.0000070019923],"category_scores_gemma":[0.0004519838,0.00013176957,0.0000122044885,0.00030906478,0.00013354207,0.000019958376,0.00010836083,0.0004875531,2.4265304e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019489894,0.00057258236,0.44865227,0.0020427692,0.00014896605,0.000022742059,0.00046344317,0.000044274675,0.00057800283,0.2535388,0.017891604,0.27584967],"study_design_scores_gemma":[0.005940397,0.0024922518,0.3197528,0.0011314926,0.000031464144,0.000053273798,0.0045251027,0.0014130087,0.00023059118,0.0049732877,0.6590507,0.00040557925],"about_ca_topic_score_codex":0.10086971,"about_ca_topic_score_gemma":0.29113707,"teacher_disagreement_score":0.6411591,"about_ca_system_score_codex":0.0003107895,"about_ca_system_score_gemma":0.0013280065,"threshold_uncertainty_score":0.9051177},"labels":[],"label_agreement":null},{"id":"W4417480146","doi":"10.1016/j.jval.2025.09.864","title":"EE481 Global Economic Burden of Metabolic Dysfunction-Associated Steatohepatitis With Cirrhosis: A Systematic Literature Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Steatohepatitis; Systematic review; Nonalcoholic steatohepatitis; Fatty liver; Liver enzyme; Liver damage","score_opus":0.01307669027968675,"score_gpt":0.2808598386346247,"score_spread":0.26778314835493794,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480146","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22548755,0.7653888,0.0000053800995,0.0045512104,0.00020705308,0.0032017562,0.00022157643,0.00004123804,0.00089547015],"genre_scores_gemma":[0.83644366,0.16139534,0.0000828388,0.0014440186,0.000028751125,0.00038393363,0.0000856968,0.000010307462,0.00012543518],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.9983551,0.0003061068,0.0006795242,0.00026470848,0.00017506145,0.00021952942],"domain_scores_gemma":[0.9990314,0.00010427641,0.00029666844,0.00034410105,0.0000945796,0.0001289686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003980659,0.0001695496,0.0010522649,0.00011838579,0.00003852583,0.000014359006,0.000067698835,0.000059206886,0.00003144653],"category_scores_gemma":[0.00009461508,0.00012186426,0.00012657353,0.00055469485,0.000020329075,0.000056378027,0.00001803573,0.00009281292,0.000016415403],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001145057,0.0008674059,0.57770383,0.40375513,0.0015973436,0.00008496684,0.0005438314,0.00031082865,3.9154432e-7,0.011281232,0.0027407082,0.000999814],"study_design_scores_gemma":[0.003682221,0.00056288124,0.29595795,0.69648993,0.0015928269,0.000026818043,0.00012894675,0.0008427458,0.000008097037,0.00017725652,0.000375943,0.0001543441],"about_ca_topic_score_codex":0.006249994,"about_ca_topic_score_gemma":0.00016069315,"teacher_disagreement_score":0.61095613,"about_ca_system_score_codex":0.0006297423,"about_ca_system_score_gemma":0.00081168883,"threshold_uncertainty_score":0.9448163},"labels":[],"label_agreement":null},{"id":"W4417480151","doi":"10.1016/j.jval.2025.09.2642","title":"PCR169 Patient and Caregiver Recommendations for Person-Centered Oncology Clinical Trial Design: A Qualitative Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Ethics in Clinical Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC; Dalhousie University; Nova Scotia Health Authority; Simon Fraser University","funders":"","keywords":"Clinical trial; Accrual; Qualitative research; Cancer; Alternative medicine; Clinical Oncology; Clinical Practice; Clinical research","score_opus":0.9089390174599398,"score_gpt":0.7251771522530572,"score_spread":0.18376186520688254,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480151","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7433232,0.00063042657,0.0063261944,0.23234472,0.002045012,0.014540985,0.000059849008,0.000044406777,0.0006852244],"genre_scores_gemma":[0.9761722,0.00090311153,0.016685208,0.0047338605,0.00016463875,0.0006402168,0.00001915161,0.000018062668,0.0006635186],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9918376,0.0056031407,0.0013032509,0.0005483214,0.00033898512,0.00036868],"domain_scores_gemma":[0.93403584,0.064760484,0.00023517627,0.00034028446,0.00036310105,0.00026514241],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.02207098,0.00010865836,0.000639515,0.00020954988,0.00014438177,0.000013432338,0.00010752722,0.0002728763,0.000020838339],"category_scores_gemma":[0.030575642,0.00009540459,0.00009677694,0.00026428577,0.00020080674,0.000029611432,0.00008883583,0.0013746601,0.0000037487591],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1898003,0.019902453,0.008580629,0.0018418272,0.0005893147,0.000050174658,0.55561215,0.000044791457,0.000003143736,0.024308475,0.03844296,0.16082379],"study_design_scores_gemma":[0.25644532,0.13742663,0.003035847,0.0018659788,0.0001276864,0.000004075993,0.53640485,0.005164809,0.000006642457,0.034039497,0.025200823,0.00027782546],"about_ca_topic_score_codex":0.001705945,"about_ca_topic_score_gemma":0.00049625355,"teacher_disagreement_score":0.23284905,"about_ca_system_score_codex":0.0005630643,"about_ca_system_score_gemma":0.0033717987,"threshold_uncertainty_score":0.9775902},"labels":[],"label_agreement":null},{"id":"W4417480163","doi":"10.1016/j.jval.2025.09.3322","title":"MSR31 Applying Simulation-Guided Trial Design Principles to Prospectively Plan Target Trial Emulation of a Cluster Randomized Trial for Vaccine Coverage","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; McGill University; Simon Fraser University","funders":"","keywords":"Emulation; Randomized controlled trial; Cluster randomised controlled trial; Design elements and principles; Cluster (spacecraft); Vaccine trial","score_opus":0.6018879378595969,"score_gpt":0.568326293465835,"score_spread":0.03356164439376197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480163","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04042508,0.000024420855,0.89087737,0.0006896066,0.0022900912,0.06541191,0.00010330433,0.00007064409,0.00010758818],"genre_scores_gemma":[0.122619286,0.000011282537,0.8707574,0.00031979656,0.0010520706,0.005027187,0.000010257041,0.00004859761,0.00015414557],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9863321,0.0070772166,0.0048900233,0.00066028844,0.0005483278,0.00049199635],"domain_scores_gemma":[0.75599223,0.24169514,0.0014416106,0.00046281048,0.000257225,0.00015098396],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.034106445,0.0003032931,0.0027580492,0.0003967423,0.00013535378,0.00004533688,0.00025932855,0.00027718127,0.000036767713],"category_scores_gemma":[0.3755703,0.00025888407,0.0003794991,0.0005735954,0.000045063716,0.00007535012,0.000087200286,0.00027683095,0.0000021333894],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8127009,0.00055475323,0.000007415199,0.00048110264,0.000088461034,4.5847008e-7,0.00025686927,0.12670207,0.0000062420063,0.058126897,0.00022613503,0.0008486407],"study_design_scores_gemma":[0.48697862,0.0014139484,0.0000057356306,0.0002007633,0.000050880535,7.1580594e-8,0.0000069133725,0.14091417,0.000051790208,0.37019736,0.00007822668,0.00010152955],"about_ca_topic_score_codex":0.00015420327,"about_ca_topic_score_gemma":0.000005437516,"teacher_disagreement_score":0.34146386,"about_ca_system_score_codex":0.00037214055,"about_ca_system_score_gemma":0.0008547372,"threshold_uncertainty_score":0.99998635},"labels":[],"label_agreement":null},{"id":"W4417480164","doi":"10.1016/j.jval.2025.09.1344","title":"EPH215 Site-Specific Wastewater-Based Surveillance in Early Detection of COVID-19 New Cases and Prediction of Mass Testing Outcomes in Long-Term Care Facilities","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; Simon Fraser University; University of Alberta","funders":"","keywords":"Outbreak; Diagnostic test; Health care; Patient care; Mass vaccination","score_opus":0.09155860615795273,"score_gpt":0.32956723370341934,"score_spread":0.2380086275454666,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480164","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720544,0.0013980153,0.0003400907,0.00019727612,0.00016435378,0.000563911,0.000045869405,0.00005351001,0.000031513267],"genre_scores_gemma":[0.9994194,0.00003396472,0.00036444425,0.00011093946,0.00001781815,0.000014535822,0.0000078846515,0.000009738991,0.000021258156],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99839944,0.00022897376,0.0007186415,0.00026519265,0.00016892806,0.0002188465],"domain_scores_gemma":[0.9983873,0.0011268952,0.0001822382,0.00017435125,0.00006972489,0.00005950691],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005626541,0.00012939371,0.00044149833,0.0007038777,0.000039958377,0.000008560199,0.000036301553,0.00008817197,0.0000022188322],"category_scores_gemma":[0.0018978888,0.00012895079,0.000032842996,0.00068470853,0.00006531327,0.000054805078,0.000016011501,0.00020847342,3.7316346e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017888797,0.00004308073,0.96199745,0.0030179408,0.0000037471198,0.000024387453,0.0019783447,0.0013336535,0.028277138,0.0000033344604,0.0000011695566,0.0031408882],"study_design_scores_gemma":[0.0027673936,0.00054692966,0.9596124,0.0011970394,0.0000036289357,0.000016634043,0.0011251285,0.0024467472,0.03215177,0.000027119228,0.000031293795,0.00007390634],"about_ca_topic_score_codex":0.056939743,"about_ca_topic_score_gemma":0.0073240334,"teacher_disagreement_score":0.04961571,"about_ca_system_score_codex":0.00049964484,"about_ca_system_score_gemma":0.00052510045,"threshold_uncertainty_score":0.94934016},"labels":[],"label_agreement":null},{"id":"W4417480167","doi":"10.1016/j.jval.2025.09.103","title":"P64 Patient Engagement in Economic Evaluations of Cancer Care: Mapping the Landscape and Advancing Practice","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Cancer; Key (lock); Patient participation; Economic evaluation; MEDLINE","score_opus":0.29124807340967107,"score_gpt":0.4591832805652473,"score_spread":0.16793520715557625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8098742,0.058243994,0.0006613771,0.12389165,0.0010516834,0.0022096846,0.00015625704,0.000018544793,0.0038926343],"genre_scores_gemma":[0.9844561,0.0037745847,0.0024117623,0.008912595,0.00006601596,0.0003167751,0.000009364195,0.000014294467,0.000038465623],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99463344,0.0011591344,0.0033805107,0.0004069281,0.00006813384,0.00035184022],"domain_scores_gemma":[0.99535775,0.0026030503,0.0015755681,0.00035355202,0.000044739583,0.00006535367],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02008743,0.0001239671,0.0006061378,0.0005363158,0.00016849866,0.000029916915,0.00015260109,0.0000628496,0.00006230918],"category_scores_gemma":[0.0028166075,0.00013881433,0.00003995245,0.00029844383,0.0000385163,0.000257618,0.0000768915,0.00024404518,0.00002753044],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000333709,0.0001395589,0.55231535,0.0023569353,0.00007573659,6.9874807e-7,0.057186294,0.21413265,0.0000017639785,0.15863146,0.0042893155,0.010836853],"study_design_scores_gemma":[0.0037696774,0.0003064875,0.42398518,0.0026391877,0.000019889774,0.0000032242065,0.09967136,0.22561595,0.000013011019,0.020365309,0.22299914,0.00061158166],"about_ca_topic_score_codex":0.038956966,"about_ca_topic_score_gemma":0.003953661,"teacher_disagreement_score":0.21870983,"about_ca_system_score_codex":0.0017978561,"about_ca_system_score_gemma":0.00096642965,"threshold_uncertainty_score":0.9674427},"labels":[],"label_agreement":null},{"id":"W4417480189","doi":"10.1016/j.jval.2025.09.316","title":"CO215 Roflumilast Foam 0.3% in Patients With Psoriasis of the Scalp and Body: Improvements in Patient-Reported Outcomes and Quality of Life","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University; Probity Medical Research","funders":"","keywords":"Roflumilast; Quality of life (healthcare); Scalp; Psoriasis; Apremilast","score_opus":0.022511249125088943,"score_gpt":0.2719900967506689,"score_spread":0.24947884762557992,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480189","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973505,0.0014095639,0.0000012580626,0.00018257945,0.0002498482,0.0006989333,0.000060592814,0.0000050600156,0.000041647152],"genre_scores_gemma":[0.9995842,0.00015591712,0.00003272088,0.00013569393,0.0000013680153,0.000026614422,0.000018854736,0.000005808519,0.000038852773],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981199,0.00053660007,0.0008169767,0.00024319981,0.000057890735,0.00022544996],"domain_scores_gemma":[0.9990757,0.0002500739,0.0003770172,0.00023653111,0.000040368897,0.000020292267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000512748,0.00013647809,0.0005158899,0.00019659796,0.000042885877,0.0000025502163,0.00007897874,0.0001163641,0.0000040007176],"category_scores_gemma":[0.00022503569,0.00009260959,0.000031276144,0.00032153973,0.00011671362,0.00004220441,0.000080411555,0.00011585424,3.00852e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005352671,0.00049376296,0.9868246,0.00015783157,0.00009208561,3.7791864e-7,0.0006465198,0.000008201878,0.00031010737,0.00014631823,0.000011648716,0.010773296],"study_design_scores_gemma":[0.0073488546,0.0002799863,0.9906335,0.00019481711,0.000015970105,1.9160568e-7,0.00021515157,0.0000034899235,0.001122784,0.000084991414,0.00003188693,0.00006835984],"about_ca_topic_score_codex":0.012362301,"about_ca_topic_score_gemma":0.0013219177,"teacher_disagreement_score":0.011040384,"about_ca_system_score_codex":0.00006824632,"about_ca_system_score_gemma":0.00019202745,"threshold_uncertainty_score":0.9942145},"labels":[],"label_agreement":null},{"id":"W4417480252","doi":"10.1016/j.jval.2025.09.599","title":"EE215 Cost-Effectiveness Analysis of Pediatric and Adult Pneumococcal Conjugate Vaccine Strategies in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Pneumococcal conjugate vaccine; Pneumococcal disease; Pneumococcal vaccine; Pneumococcal infections; MEDLINE","score_opus":0.02268381399550877,"score_gpt":0.3228783492182144,"score_spread":0.3001945352227056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480252","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9970388,0.0005558273,0.000042641095,0.0013574216,0.00012318206,0.00063351874,0.000023778039,0.0000105343115,0.00021430374],"genre_scores_gemma":[0.99883443,0.0006845668,0.000007557899,0.0003795962,0.00002060322,0.000047229205,0.000009911978,0.000005493057,0.000010610502],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986604,0.00027776137,0.00048382735,0.00021758082,0.00012274495,0.00023767877],"domain_scores_gemma":[0.99920094,0.0003438521,0.00010090675,0.00016514503,0.000083433406,0.00010574886],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041215675,0.00011049179,0.0005858491,0.00084972015,0.00004080047,0.0000059820654,0.00004076201,0.00005428195,0.0000078850935],"category_scores_gemma":[0.00011466777,0.00009784816,0.000044326745,0.0021621324,0.00001557552,0.000043160282,0.000020295538,0.00022431476,3.0965066e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005881584,0.00008729025,0.98145974,0.0007629017,0.00010642272,0.00002248562,0.00008860085,0.015498402,0.00053670275,0.0008262654,0.000015914573,0.00053645094],"study_design_scores_gemma":[0.0012541256,0.00012705362,0.9905778,0.00013219111,0.0001863675,0.0000030908625,0.0003422236,0.007009396,0.00006591721,0.000086330925,0.00015069498,0.00006477657],"about_ca_topic_score_codex":0.89122045,"about_ca_topic_score_gemma":0.8509718,"teacher_disagreement_score":0.040248632,"about_ca_system_score_codex":0.0007404244,"about_ca_system_score_gemma":0.0041420213,"threshold_uncertainty_score":0.7347768},"labels":[],"label_agreement":null},{"id":"W4417480293","doi":"10.1016/j.jval.2025.09.2511","title":"PCR38 Care Partner Burden and Experiences With Schizophrenia: A National Canadian Survey","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Family Caregiving in Mental Illness","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre for Addiction and Mental Health; St. Joseph’s Healthcare Hamilton; Canadian Mental Health Association; Schizophrenia Society of Ontario; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University; Boehringer Ingelheim (Canada)","funders":"","keywords":"Primary care; MEDLINE; Survey data collection; Patient care","score_opus":0.043399493133265306,"score_gpt":0.3427074949418557,"score_spread":0.2993080018085904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480293","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98419374,0.0024898408,0.000008129899,0.0013764366,0.0007588846,0.0003126186,0.000051351293,0.000023530067,0.01078549],"genre_scores_gemma":[0.9982874,0.000009330765,0.00016737799,0.0008369018,0.00005695385,0.0001469841,0.000030359806,0.000011027853,0.00045366123],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847543,0.0004285512,0.00020984428,0.00033758237,0.00018925809,0.00035931787],"domain_scores_gemma":[0.99932486,0.00022325097,0.000046384564,0.00017431674,0.00007651752,0.00015465927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060701673,0.000113827424,0.00017470113,0.00027185885,0.00016202952,0.000031977455,0.00014772498,0.00007687743,0.00006958833],"category_scores_gemma":[0.0000744899,0.00010379695,0.000011511145,0.00044083656,0.0001224155,0.0000462451,0.000024866966,0.00017046001,0.000012284016],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031828028,0.000051645155,0.6748475,0.00030960442,0.00006753742,0.00006651731,0.27381536,0.00094374205,0.0000020818848,0.025519604,0.01131351,0.012744639],"study_design_scores_gemma":[0.0013983804,0.00017479795,0.8603615,0.0003517887,0.0000029240903,0.000015733074,0.13153188,0.00021834078,0.00000640429,0.00021292185,0.0054871854,0.00023813311],"about_ca_topic_score_codex":0.81646174,"about_ca_topic_score_gemma":0.51761335,"teacher_disagreement_score":0.29884842,"about_ca_system_score_codex":0.00048423145,"about_ca_system_score_gemma":0.0012901952,"threshold_uncertainty_score":0.49118897},"labels":[],"label_agreement":null},{"id":"W4417480295","doi":"10.1016/j.jval.2025.09.3422","title":"MSR138 Linking Specialty Pharmacy Data With Healthcare Claims Data in a Rare Disease: Comprehensively Characterizing Patients With Hereditary Angioedema Treated With Berotralstat","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Hereditary angioedema; Specialty; Health care; Pharmacy; Patient care; Angioedema","score_opus":0.07664844442951928,"score_gpt":0.33702660373973375,"score_spread":0.26037815931021446,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480295","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97820556,0.0052367924,0.00008837654,0.011805625,0.00017772411,0.002726215,0.0015494261,0.00014641647,0.00006388198],"genre_scores_gemma":[0.979609,0.0007268846,0.0016315626,0.0033120867,0.0002918951,0.000039364197,0.01422315,0.00008571063,0.00008032273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959671,0.0002834277,0.00093098445,0.0012826062,0.0006873459,0.00084852986],"domain_scores_gemma":[0.9968376,0.0002331569,0.00038989226,0.001819025,0.0002137995,0.0005065171],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004864454,0.00047904658,0.00095285504,0.00046849845,0.00024856706,0.000058565063,0.00058259873,0.000083527106,0.000036996615],"category_scores_gemma":[0.000051316674,0.00036920956,0.00003648965,0.0011530772,0.00014725076,0.00072174374,0.00029632397,0.00050594454,0.000004167263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0042235893,0.00050700636,0.9795942,0.0019680604,0.00011250092,0.00035947582,0.00055777276,0.0002029436,0.0000029234307,0.00012857496,0.0003044955,0.012038492],"study_design_scores_gemma":[0.009207211,0.00057011115,0.96423674,0.0113971,0.0001121511,0.000024173358,0.00023841068,0.009284231,0.000011924258,0.00003503419,0.00451001,0.00037291777],"about_ca_topic_score_codex":0.013443389,"about_ca_topic_score_gemma":0.0047862665,"teacher_disagreement_score":0.015357439,"about_ca_system_score_codex":0.00036240055,"about_ca_system_score_gemma":0.0016725123,"threshold_uncertainty_score":0.99987596},"labels":[],"label_agreement":null},{"id":"W4417480298","doi":"10.1016/j.jval.2025.09.1986","title":"HTA201 Influence of NICE Real-World Evidence Framework on HTA Submissions: Sensitivity Analyses in Real-World External Control Arm Studies","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Traumatic Brain Injury Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Nice; Sensitivity (control systems); Control (management); Control theory (sociology)","score_opus":0.31352318199468227,"score_gpt":0.5323299685771551,"score_spread":0.21880678658247282,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480298","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9796493,0.0034938836,0.00017637845,0.0140524395,0.00017118714,0.0015224888,0.000018841014,0.00006354605,0.0008519059],"genre_scores_gemma":[0.9888388,0.0056902044,0.002648899,0.0020295489,0.000087620385,0.00008296692,0.0000014778007,0.00002324136,0.00059727224],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9939429,0.0020870364,0.0015537433,0.0006725303,0.0009791473,0.0007646441],"domain_scores_gemma":[0.9795806,0.018361013,0.0004218112,0.0010435424,0.00034701495,0.00024602245],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0058974912,0.00029766007,0.0013826842,0.0016687901,0.00011560958,0.000019389974,0.00025800752,0.00012805383,0.0000327243],"category_scores_gemma":[0.014927723,0.00025305746,0.00012398505,0.003027303,0.0003295075,0.00015850572,0.0001305691,0.0013220154,0.000015027057],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0045354036,0.0012361351,0.93611914,0.0056393016,0.00025061402,0.00032543612,0.0024844578,0.022126777,0.0024659925,0.016846467,0.0011074119,0.0068628895],"study_design_scores_gemma":[0.00141352,0.0006667952,0.93776953,0.048543613,0.000044568504,0.0000056597105,0.00040111816,0.0046208827,0.00060128974,0.005714138,0.00005621075,0.0001626453],"about_ca_topic_score_codex":0.07298037,"about_ca_topic_score_gemma":0.009452172,"teacher_disagreement_score":0.063528195,"about_ca_system_score_codex":0.0013132183,"about_ca_system_score_gemma":0.0017055323,"threshold_uncertainty_score":0.9999922},"labels":[],"label_agreement":null},{"id":"W4417480320","doi":"10.1016/j.jval.2025.09.2967","title":"SA25 Cross-Sectional Cohort Design Offers an Efficient Alternative to Prospective Cohort Design in Real-World Studies (RWS)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Thermo Fisher Scientific (Canada)","funders":"","keywords":"Prospective cohort study; Cohort; Clinical study design; Cohort study; Rheumatoid arthritis; Research design","score_opus":0.09933216415059573,"score_gpt":0.4248866211346665,"score_spread":0.3255544569840708,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9833265,0.0025846425,0.005546009,0.0011003015,0.0005176494,0.0059643434,0.000015989222,0.000087079105,0.00085750094],"genre_scores_gemma":[0.98684835,0.0072773537,0.0038296115,0.00050290464,0.000092156886,0.00083964603,0.000010339544,0.000028099896,0.0005715449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961122,0.0010098518,0.0007637033,0.00070840144,0.00068273343,0.00072305754],"domain_scores_gemma":[0.9981197,0.000809606,0.00010301214,0.00033647657,0.0003239859,0.00030723316],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0045009074,0.00024230636,0.0006801601,0.0010158963,0.000229153,0.000055356213,0.00017435847,0.00006416109,0.000030813957],"category_scores_gemma":[0.0008236645,0.00022027388,0.000059372553,0.0011833007,0.00023134633,0.000100217265,0.000075968455,0.00046090857,0.000024082345],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015552917,0.00045563336,0.9008366,0.000116786316,0.00018474809,0.00005774615,0.0024848098,0.089434884,0.000062471656,0.0037295998,0.00035549048,0.0007259454],"study_design_scores_gemma":[0.0025662475,0.0012270416,0.97754896,0.00092704064,0.000002459358,0.000009361369,0.0004118536,0.013746349,0.00077394577,0.0025016125,0.0001259795,0.00015912892],"about_ca_topic_score_codex":0.013384862,"about_ca_topic_score_gemma":0.0012327504,"teacher_disagreement_score":0.076712385,"about_ca_system_score_codex":0.0022527848,"about_ca_system_score_gemma":0.0013413493,"threshold_uncertainty_score":0.9931851},"labels":[],"label_agreement":null},{"id":"W4417480349","doi":"10.1016/j.jval.2025.09.147","title":"CO45 Clinical Efficacy and Safety of Targeted Therapies for HER2 Mutant Advanced or Metastatic Non-Small Cell Lung Cancer: A Systematic Literature Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Bayer (Canada)","funders":"","keywords":"Clinical efficacy; Systematic review; Clinical trial; Mutant; Lung; Cell","score_opus":0.03639967329631678,"score_gpt":0.41791284638852894,"score_spread":0.38151317309221217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480349","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05604073,0.923364,0.0009531924,0.0060031917,0.00035522744,0.012961945,0.00022555166,0.000028384131,0.00006781383],"genre_scores_gemma":[0.2744832,0.6998873,0.017722799,0.005138434,0.000055314813,0.0014815166,0.000117176285,0.000043484084,0.0010708122],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9980024,0.00027134767,0.0011276021,0.00027201796,0.00011063672,0.00021600531],"domain_scores_gemma":[0.9981582,0.0009845624,0.00035384073,0.00026138301,0.00013978507,0.00010223456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00085071364,0.00016016925,0.0011572388,0.00010350959,0.0000631566,0.000008687386,0.000058966016,0.00004775154,0.000009248613],"category_scores_gemma":[0.0003093159,0.00010009616,0.00010057501,0.00044621792,0.00003376478,0.00003465705,0.000014150833,0.00014422354,2.7785777e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010873065,0.00065697735,0.0037158818,0.98287976,0.00066643517,0.000022870061,0.0032384864,0.00027551976,0.00004673493,0.00035612372,0.0005886367,0.0064652846],"study_design_scores_gemma":[0.024025368,0.0024853447,0.010793125,0.9465068,0.002834961,0.000021215012,0.00081533036,0.009151607,0.000121060926,0.00011441748,0.0028572446,0.0002735012],"about_ca_topic_score_codex":0.00024061646,"about_ca_topic_score_gemma":0.00006192613,"teacher_disagreement_score":0.22347671,"about_ca_system_score_codex":0.00020150853,"about_ca_system_score_gemma":0.0011773405,"threshold_uncertainty_score":0.40818027},"labels":[],"label_agreement":null},{"id":"W4417480375","doi":"10.1016/j.jval.2025.09.2882","title":"RWD132 Out of Sight, Out of Mind? A Simulation Study Assessing the Use of Quantitative Bias Analysis for Outcome Misclassification in Single-Arm Trials With External Control Comparisons","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Outcome (game theory); Control (management); External validity; Clinical trial; Range (aeronautics)","score_opus":0.8275028844107982,"score_gpt":0.5910186809017658,"score_spread":0.23648420350903243,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480375","genre_codex":"methods","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.4428477,0.000034442146,0.5551343,0.00014282166,0.000026291827,0.0017620547,0.000034404242,0.00001051779,0.0000074576296],"genre_scores_gemma":[0.87667495,0.0000031495413,0.12317827,0.000018113495,0.000005625975,0.00009048429,0.000004910613,0.000011302199,0.000013192426],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9950082,0.0017797708,0.0024665506,0.00024456775,0.0003134652,0.00018748836],"domain_scores_gemma":[0.9758632,0.020791983,0.0025414005,0.00040644777,0.0003705945,0.000026373966],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004983213,0.00016164192,0.0014712146,0.00066536805,0.00004263335,0.000022703289,0.00016393527,0.00006915144,0.000002543589],"category_scores_gemma":[0.006905961,0.00011158053,0.00014252581,0.0007314112,0.00010224808,0.00017639034,0.000020224848,0.00015725664,7.6297155e-8],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007940276,0.0038236466,0.5597974,0.0006923853,0.00047366403,6.0360463e-7,0.010775908,0.40525144,0.0028460366,0.014009046,0.0000068663057,0.0015289518],"study_design_scores_gemma":[0.0043322076,0.002295236,0.12495268,0.0015198695,0.00092229893,8.769291e-8,0.0071740146,0.8324628,0.004270299,0.021827273,0.00002151654,0.00022173804],"about_ca_topic_score_codex":0.0009105237,"about_ca_topic_score_gemma":0.0017886739,"teacher_disagreement_score":0.43484473,"about_ca_system_score_codex":0.00021444271,"about_ca_system_score_gemma":0.00022511512,"threshold_uncertainty_score":0.8267579},"labels":[],"label_agreement":null},{"id":"W4417480382","doi":"10.1016/j.jval.2025.09.112","title":"CO9 An Adjusted Indirect Comparison of Once-Weekly Insulin Efsitora Alfa vs. Insulin Icodec for Adults With Type 2 Diabetes Mellitus Previously Treated With Basal-Bolus Insulin","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Type 2 Diabetes Mellitus; Insulin; Type 2 diabetes; Diabetes mellitus; Randomized controlled trial","score_opus":0.04254034607437609,"score_gpt":0.33385640049216075,"score_spread":0.2913160544177847,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480382","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9828311,0.010100024,0.00004740553,0.0014171362,0.00016647775,0.0046698847,0.00004772023,0.00014342903,0.0005767727],"genre_scores_gemma":[0.9941462,0.001268653,0.002668281,0.00042207987,0.000107047796,0.00021518048,0.0004420185,0.000076018536,0.00065449334],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959795,0.00050732394,0.0010741074,0.0007583186,0.0006767695,0.0010040165],"domain_scores_gemma":[0.99745685,0.0004920209,0.00043110235,0.0007173237,0.0005280298,0.00037468478],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.001307432,0.00041457196,0.0015034479,0.0008911401,0.00014795114,0.00004443838,0.00035344207,0.00022358526,0.000025019493],"category_scores_gemma":[0.00031240922,0.0003095716,0.00008141072,0.0023630445,0.00021487825,0.00016388671,0.00008792986,0.00055351824,0.000010137441],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.024240294,0.0057008704,0.7019927,0.014517931,0.000767118,0.000032286545,0.005037962,0.004588641,0.00014097201,0.00031476465,0.0033178765,0.23934858],"study_design_scores_gemma":[0.048741337,0.057946038,0.622277,0.020065317,0.0006114658,0.0000018794569,0.0024395501,0.22524954,0.009452131,0.00019993838,0.011856954,0.001158851],"about_ca_topic_score_codex":0.0024066179,"about_ca_topic_score_gemma":0.0005906605,"teacher_disagreement_score":0.23818971,"about_ca_system_score_codex":0.00037642888,"about_ca_system_score_gemma":0.0012445548,"threshold_uncertainty_score":0.9999356},"labels":[],"label_agreement":null},{"id":"W4417480386","doi":"10.1016/j.jval.2025.09.667","title":"EE283 Cost-Minimization Analysis of Aripiprazole 2-Month Ready-to-Use vs. Other Long-Acting Injectable Antipsychotics: Evidence From Ontario","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Aripiprazole; Real world evidence; MEDLINE","score_opus":0.09147220058310773,"score_gpt":0.37636342066633616,"score_spread":0.2848912200832284,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99272835,0.00067337195,0.003039367,0.002086824,0.00014469652,0.0010572232,0.00004079874,0.000031061634,0.00019829675],"genre_scores_gemma":[0.98577046,0.0004112298,0.012377834,0.00068132824,0.000027204054,0.000042827556,0.000093542985,0.000015908992,0.0005796827],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99792373,0.00021193147,0.0006528846,0.0004248493,0.00038896446,0.00039764796],"domain_scores_gemma":[0.9981414,0.0007195647,0.0001875089,0.0005656349,0.00014553452,0.00024032297],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006237352,0.00015377348,0.0006256782,0.000888477,0.00007253182,0.00003510367,0.00011588792,0.00007850374,0.00018315483],"category_scores_gemma":[0.00075531163,0.00013819021,0.00009484099,0.0019073002,0.000029445317,0.00014904485,0.000041847838,0.00025153655,0.000015995018],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006664748,0.00035539514,0.97151524,0.00011087449,0.0005683132,0.00002234411,0.0017111122,0.012215605,0.00006925812,0.00014623241,0.00026754878,0.006353359],"study_design_scores_gemma":[0.0017644018,0.00045686192,0.9773004,0.001446432,0.00030489123,8.543238e-7,0.00013148201,0.017235462,0.0006541592,0.00009025998,0.0005231058,0.000091706],"about_ca_topic_score_codex":0.582784,"about_ca_topic_score_gemma":0.31081563,"teacher_disagreement_score":0.27196833,"about_ca_system_score_codex":0.0010538473,"about_ca_system_score_gemma":0.0015994167,"threshold_uncertainty_score":0.7017602},"labels":[],"label_agreement":null},{"id":"W4417480396","doi":"10.1016/j.jval.2025.09.1053","title":"EE671 Stakeholder Engagement in the Economic Evaluation of Site-Specific Wastewater-Based Surveillance for Preventing COVID-19 Outbreaks in Long-Term Care Facilities","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Infection Control and Ventilation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Outbreak; Economic evaluation; Stakeholder; Pandemic; Stakeholder engagement; Coronavirus disease 2019 (COVID-19); Disease surveillance; Control (management)","score_opus":0.14506957646383364,"score_gpt":0.37477185912795136,"score_spread":0.2297022826641177,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925033,0.0010321819,0.0016294892,0.001492351,0.0002532192,0.002859825,0.000057177956,0.000012009847,0.00016046276],"genre_scores_gemma":[0.9991309,0.000038189708,0.000055460714,0.00022905623,0.000039604154,0.00026594184,0.00017294328,0.0000061697265,0.000061734856],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99783283,0.0008945109,0.0006566076,0.00022204932,0.00018738228,0.00020663526],"domain_scores_gemma":[0.9990856,0.00043389056,0.00016748668,0.00020621152,0.00007793131,0.000028880548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0060112705,0.00009537534,0.00026486904,0.0003333771,0.00006587252,0.000013735008,0.00005399886,0.000052419393,0.000045333065],"category_scores_gemma":[0.00023557722,0.00008121186,0.00005792052,0.00014631143,0.000024257977,0.000039214396,0.000010361947,0.00013896913,0.0000014965899],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028600192,0.00011691724,0.74932003,0.0030967768,0.000008380082,9.745183e-7,0.008089748,0.23182504,0.00006419702,0.00030693956,0.0000647273,0.006820268],"study_design_scores_gemma":[0.009203237,0.00025128172,0.882802,0.0006675445,0.000016046091,8.9260226e-7,0.0034580992,0.10141708,0.00021858771,0.0002333724,0.0016257428,0.000106124295],"about_ca_topic_score_codex":0.003603718,"about_ca_topic_score_gemma":0.00591125,"teacher_disagreement_score":0.13348196,"about_ca_system_score_codex":0.0015409939,"about_ca_system_score_gemma":0.0010532996,"threshold_uncertainty_score":0.54477674},"labels":[],"label_agreement":null},{"id":"W4417480467","doi":"10.1016/j.jval.2025.09.2969","title":"SA27 Data Reliability in Retrospective Chart Review Studies: Results and Considerations From a Novel Data Review Methodology","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Reliability (semiconductor); Chart; Data quality; Key (lock); Data validation; Quality (philosophy)","score_opus":0.9702351135248084,"score_gpt":0.6875387359740056,"score_spread":0.2826963775508028,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480467","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005809826,0.8531283,0.0034861628,0.13619524,0.00040180658,0.0036169495,0.0020867824,0.000006478363,0.00049728516],"genre_scores_gemma":[0.0038015316,0.8395051,0.12734714,0.028217632,0.00006578957,0.00012349893,0.00045637996,0.00001092487,0.00047204408],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.84798735,0.1049888,0.03542983,0.0068908636,0.0039384044,0.0007647435],"domain_scores_gemma":[0.5995923,0.275611,0.024220485,0.09519397,0.0046194876,0.0007627165],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.44718108,0.00028104824,0.006982194,0.00030822717,0.00014235884,0.000114410956,0.0023756865,0.000078211095,0.00040216776],"category_scores_gemma":[0.6533862,0.00015880895,0.00019155878,0.0025864874,0.00014249638,0.00039513598,0.0016561906,0.00041829055,0.00009579975],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014725832,0.00016413012,0.015896767,0.012399124,0.00021152284,0.000007123785,0.0008172906,0.000031384883,0.000001906769,0.0071581313,0.9533022,0.009995685],"study_design_scores_gemma":[0.0017199023,0.00012228763,0.08047569,0.09619289,0.0008270152,0.000024099156,0.0015384696,0.029445024,8.3950334e-7,0.15067406,0.6383905,0.0005892708],"about_ca_topic_score_codex":0.0036520853,"about_ca_topic_score_gemma":0.0030464274,"teacher_disagreement_score":0.31491175,"about_ca_system_score_codex":0.0001989232,"about_ca_system_score_gemma":0.0007613197,"threshold_uncertainty_score":0.6476041},"labels":[],"label_agreement":null},{"id":"W4417480469","doi":"10.1016/j.jval.2025.09.790","title":"EE407 EIGER: Cost Impact of Progression to Metastatic Disease Amongst US Patients With Gastric and Gastroesophageal Junction Cancer (GCGEJC)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Disease; Gastroesophageal Junction; Cancer; Disease burden; Burden of disease; Overall survival","score_opus":0.018228040083336127,"score_gpt":0.34252972916796215,"score_spread":0.32430168908462603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480469","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9955666,0.000743439,0.0005870779,0.00081463583,0.00014793467,0.002028765,0.00003571614,0.000022530725,0.000053278312],"genre_scores_gemma":[0.99816686,0.00016272203,0.000932814,0.00039054154,0.00002622592,0.000115717456,0.00003594266,0.000013513539,0.00015567674],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986577,0.000076214536,0.00035635452,0.0002687335,0.00030476679,0.0003362361],"domain_scores_gemma":[0.9992381,0.000041635463,0.00015686167,0.00019051423,0.00006957565,0.00030333357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022062787,0.00015814911,0.00037773547,0.0005698789,0.000051579435,0.000013087171,0.000048731887,0.000014634093,0.000028860824],"category_scores_gemma":[0.000052085295,0.00011109366,0.00005200094,0.0010085648,0.000039278395,0.000073382485,0.000043494987,0.00011817213,0.0000010353997],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012934429,0.00023044938,0.9439736,0.00063568546,0.000053962925,0.000011884717,0.000067741625,0.0018674771,0.0000022528309,0.000015441961,0.00079526275,0.051052794],"study_design_scores_gemma":[0.0032593594,0.0012838778,0.9926252,0.0009346104,0.00010142507,7.089363e-7,0.000027781965,0.001578703,0.0000033385722,0.000011654365,0.000116017516,0.00005733508],"about_ca_topic_score_codex":0.0046707247,"about_ca_topic_score_gemma":0.00010134998,"teacher_disagreement_score":0.050995458,"about_ca_system_score_codex":0.0005274198,"about_ca_system_score_gemma":0.0004934702,"threshold_uncertainty_score":0.706077},"labels":[],"label_agreement":null},{"id":"W4417480483","doi":"10.1016/j.jval.2025.09.063","title":"P20 The Frequency of Mentions and Impact of Patient Input in HTA Decision Making in Cell and Gene Therapies Across the UK, Canada, and Australia","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Excellence; Agency (philosophy); Advisory committee; Regulatory agency; Health care; Gene technology; Health technology; Drug","score_opus":0.22028382789820106,"score_gpt":0.43742560122138135,"score_spread":0.2171417733231803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480483","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98421335,0.010099389,0.000051482424,0.0046857684,0.00010607268,0.00060696225,0.00020030508,0.0000013081095,0.000035357793],"genre_scores_gemma":[0.99781805,0.00096683885,0.0004950467,0.0006685866,0.0000084167095,0.000024074976,0.000002047665,0.0000052326436,0.000011690971],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99691683,0.00036560177,0.0021886828,0.00022903139,0.000055596687,0.0002442722],"domain_scores_gemma":[0.9975742,0.0012934903,0.00083343196,0.00023910977,0.000019204263,0.000040546533],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0077066915,0.00009501638,0.00047024642,0.00019756699,0.00009756715,0.000022020666,0.00010836835,0.000054621985,0.000012344851],"category_scores_gemma":[0.00045850937,0.00007801325,0.000024068157,0.00026886523,0.0000847192,0.00007580366,0.000054603417,0.00014386798,4.3815604e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009396781,0.000029380139,0.9824869,0.0002453826,0.000009937025,2.5170024e-7,0.009958052,0.001750293,0.0000035513485,0.0047594593,0.00019530332,0.0005520929],"study_design_scores_gemma":[0.00045815785,0.00005912353,0.97979665,0.0002907025,9.145147e-7,9.946101e-7,0.0022910547,0.0021866716,0.0000038654366,0.014776302,0.00007504487,0.000060524777],"about_ca_topic_score_codex":0.86659247,"about_ca_topic_score_gemma":0.64863116,"teacher_disagreement_score":0.21796133,"about_ca_system_score_codex":0.00052687345,"about_ca_system_score_gemma":0.00045241878,"threshold_uncertainty_score":0.35778043},"labels":[],"label_agreement":null},{"id":"W4417480489","doi":"10.1016/j.jval.2025.09.111","title":"CO8 An Adjusted Indirect Comparison of Once-Weekly Insulin Efsitora Alfa vs. Insulin Icodec for Adults With Type 2 Diabetes Mellitus Previously Treated With Basal Insulin","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"LMC Diabetes & Endocrinology (Canada)","funders":"","keywords":"Type 2 Diabetes Mellitus; Insulin; Basal (medicine); Basal insulin; Diabetes mellitus","score_opus":0.043915710933798216,"score_gpt":0.33493330382646846,"score_spread":0.29101759289267026,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480489","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98584193,0.0076223025,0.000050132272,0.0013504452,0.00015002904,0.004266367,0.00004471711,0.00012726124,0.00054681534],"genre_scores_gemma":[0.99460274,0.0009534562,0.0026899963,0.0003902603,0.00010642764,0.00019161939,0.00042797453,0.00006746297,0.0005700805],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962584,0.0004715592,0.0009972719,0.0007009529,0.00063870987,0.0009331294],"domain_scores_gemma":[0.9976818,0.00046168655,0.00038818514,0.0006393754,0.00048205926,0.00034688448],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0012458863,0.00038174615,0.001383663,0.00081940053,0.00013543588,0.00004058527,0.00032555818,0.00020623067,0.000023456494],"category_scores_gemma":[0.00028371572,0.00028185832,0.00007412969,0.0021489677,0.00021176727,0.00015560833,0.000078353885,0.0005225025,0.000008746953],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.02059367,0.0047208,0.76312745,0.011270537,0.0005987531,0.00002391525,0.003689117,0.0030691496,0.00012615856,0.00027333008,0.0023515515,0.19015557],"study_design_scores_gemma":[0.04821831,0.06226772,0.6285987,0.019329133,0.000561903,0.0000016398402,0.0028166848,0.2161576,0.008776278,0.00019546424,0.011985083,0.0010915183],"about_ca_topic_score_codex":0.0020247512,"about_ca_topic_score_gemma":0.0005850963,"teacher_disagreement_score":0.21308845,"about_ca_system_score_codex":0.00032976494,"about_ca_system_score_gemma":0.0011779843,"threshold_uncertainty_score":0.99996334},"labels":[],"label_agreement":null},{"id":"W4417480520","doi":"10.1016/j.jval.2025.09.2013","title":"HTA229 Maximizing Acceptance of Patient-Reported Outcome Data in German HTA Decision Making: Results From a Horizon Scan","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Outcome (game theory); German; Time horizon; Clinical trial; Quality (philosophy); Key (lock); Data quality; Horizon","score_opus":0.4822416653151922,"score_gpt":0.4825239585800524,"score_spread":0.00028229326486023387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480520","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9754944,0.0037286165,0.0021683343,0.013126785,0.0013466527,0.0012250249,0.0014198943,0.00004062244,0.0014496744],"genre_scores_gemma":[0.9815778,0.00031542493,0.014625143,0.0030861928,0.00008480683,0.000034626803,0.00020341149,0.00002863876,0.000043962627],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9858013,0.0006894127,0.011533539,0.0011965381,0.00018162074,0.0005976189],"domain_scores_gemma":[0.98991716,0.0029496732,0.0047671343,0.0021812639,0.000052039748,0.00013275917],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.022227714,0.00023718966,0.001530946,0.0011119043,0.00010824574,0.000052396845,0.0008416797,0.00019797323,0.000056499386],"category_scores_gemma":[0.012201661,0.00031427635,0.00007724684,0.00088423473,0.00005796849,0.00052397436,0.00034069322,0.00037590647,0.00008033001],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000409383,0.00045460972,0.9224904,0.0010983482,0.000068587775,0.00001313069,0.0062461724,0.007083683,0.0000028795096,0.032796048,0.007611995,0.021724759],"study_design_scores_gemma":[0.0054209963,0.00023369152,0.7764379,0.004190441,0.000008455765,0.000003339078,0.001747972,0.11563216,0.0000071188906,0.06916507,0.026480887,0.00067199284],"about_ca_topic_score_codex":0.046420854,"about_ca_topic_score_gemma":0.003499493,"teacher_disagreement_score":0.14605254,"about_ca_system_score_codex":0.0014985688,"about_ca_system_score_gemma":0.00068094267,"threshold_uncertainty_score":0.9999309},"labels":[],"label_agreement":null},{"id":"W4417480587","doi":"10.1016/j.jval.2025.09.570","title":"EE186 Cost per Responder of TAR-200 vs. Other FDA-Approved Novel and Generic Treatments Among Bacillus Calmette-Guérin-Unresponsive High-Risk Non-Muscle Invasive Bladder Cancer With Carcinoma in Situ in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Carcinoma in situ; Food and drug administration; Bladder cancer; Bacillus (shape); Drug; Carcinoma","score_opus":0.029656904322169757,"score_gpt":0.29236009972322824,"score_spread":0.26270319540105846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480587","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9928371,0.0013165072,0.000057278306,0.0024948216,0.00008631124,0.002722451,0.0003055983,0.000013279346,0.00016668571],"genre_scores_gemma":[0.9939474,0.0010851433,0.00034419537,0.0036411884,0.00003367697,0.00050167105,0.000071822295,0.000045718913,0.00032919683],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99735653,0.0005678471,0.0006135592,0.0005627006,0.00034527897,0.00055405684],"domain_scores_gemma":[0.9984569,0.00058463437,0.00023237555,0.0004638532,0.0001230716,0.00013917296],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053512474,0.0003571789,0.0007166918,0.0007878039,0.00008805928,0.000018537583,0.00014558628,0.00013700401,0.000044487442],"category_scores_gemma":[0.000087860986,0.00023882401,0.00005171401,0.0014177759,0.00020767582,0.00008646446,0.00004855338,0.000393338,0.0000017482254],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004433076,0.00095850305,0.96772265,0.00032861548,0.0002769897,0.00011432899,0.01647653,0.0065505435,0.00082489627,0.000040809202,0.00028721144,0.0019858195],"study_design_scores_gemma":[0.01492252,0.0013928023,0.97570574,0.00062988925,0.0001483482,0.000008016419,0.003498941,0.0018938859,0.0010868659,0.00006451676,0.0004512312,0.0001972696],"about_ca_topic_score_codex":0.44691792,"about_ca_topic_score_gemma":0.06604498,"teacher_disagreement_score":0.38087294,"about_ca_system_score_codex":0.00093068084,"about_ca_system_score_gemma":0.0014420621,"threshold_uncertainty_score":0.973896},"labels":[],"label_agreement":null},{"id":"W4417480598","doi":"10.1016/j.jval.2025.09.466","title":"EE82 Budget Impact Analysis of Direct Oral Anticoagulants vs. Vitamin K Antagonists in Algeria: A Public Payer Perspective","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Community Development and Social Impact","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Vitamin k; Perspective (graphical); Public health; Alternative medicine","score_opus":0.061547177406557324,"score_gpt":0.33776131754581673,"score_spread":0.2762141401392594,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98892754,0.0014418756,0.00007137926,0.0030555471,0.00016749074,0.0002666306,0.00019335831,0.000018699771,0.005857493],"genre_scores_gemma":[0.99841034,0.0010016364,0.00016674698,0.00022051545,0.000010389578,0.0000092916425,0.000040132178,0.0000110888195,0.00012987248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980289,0.00022086862,0.0009158912,0.00030284104,0.0000555331,0.000475998],"domain_scores_gemma":[0.9989538,0.000224256,0.00033960328,0.00033911242,0.00004906589,0.00009412372],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020704241,0.0001657948,0.0012270235,0.0024049054,0.000096902826,0.00006520063,0.00026952615,0.000109295266,0.00010331742],"category_scores_gemma":[0.00048839237,0.00018533753,0.0002090568,0.0039291345,0.000058864538,0.00018658991,0.00009082434,0.00025385682,0.00001063416],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000036975318,0.00030866463,0.964488,0.000043903572,0.00042398527,0.0000033492254,0.005434615,0.00040589203,0.000004503507,0.028022261,0.00018604525,0.0006417633],"study_design_scores_gemma":[0.0005904649,0.00007386333,0.98601973,0.000049042003,0.00001478791,2.4007673e-7,0.0007699131,0.0060338317,0.000009043846,0.0059205256,0.00035678738,0.00016174572],"about_ca_topic_score_codex":0.13663723,"about_ca_topic_score_gemma":0.008414821,"teacher_disagreement_score":0.1282224,"about_ca_system_score_codex":0.0014193332,"about_ca_system_score_gemma":0.00046887112,"threshold_uncertainty_score":0.86911196},"labels":[],"label_agreement":null},{"id":"W4417480599","doi":"10.1016/j.jval.2025.09.871","title":"EE488 Health Economic Analysis of Risk- and Age-Based Pneumococcal Vaccination With PCV21 vs. PCV20 in France","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Pneumonia and Respiratory Infections","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Pneumococcal vaccination; Vaccination; Pneumococcal disease; Pneumococcal conjugate vaccine; Serotype; Pneumococcal infections","score_opus":0.013692807849383853,"score_gpt":0.3065944956887193,"score_spread":0.29290168783933546,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480599","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923204,0.0005417124,0.0004998153,0.0058817617,0.00008314913,0.00050472835,0.000028242426,0.000023047816,0.000117151576],"genre_scores_gemma":[0.9978797,0.00047177897,0.00015346149,0.0013986769,0.000017429695,0.00002900025,0.000018335673,0.0000087664375,0.000022886508],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99847996,0.00029128717,0.0005954719,0.00028875796,0.00009680037,0.00024771554],"domain_scores_gemma":[0.9991274,0.00022407016,0.00025908204,0.00024251163,0.000028557979,0.00011840336],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008134525,0.00011865098,0.00065604324,0.0012807482,0.00007755568,0.0000069098623,0.000046045534,0.00007163455,0.000015228836],"category_scores_gemma":[0.000068030095,0.000104095954,0.000060371363,0.0012508323,0.000039499417,0.00004344455,0.000011225513,0.00027716332,0.0000015078482],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006205414,0.00017360118,0.9375564,0.00042767506,0.00006921531,0.0000055669575,0.00031756677,0.057215918,0.0000629788,0.00033561094,0.000011945195,0.0037615036],"study_design_scores_gemma":[0.001745115,0.00041172488,0.95509493,0.0003118761,0.00006958299,0.000001612961,0.000052887757,0.041346688,0.000042422424,0.00006620893,0.0007908759,0.0000660454],"about_ca_topic_score_codex":0.011869517,"about_ca_topic_score_gemma":0.00543585,"teacher_disagreement_score":0.017538596,"about_ca_system_score_codex":0.00044319066,"about_ca_system_score_gemma":0.0011094676,"threshold_uncertainty_score":0.9947105},"labels":[],"label_agreement":null},{"id":"W4417480615","doi":"10.1016/j.jval.2025.09.1988","title":"HTA203 Insights on Progress Toward Patient-Centered HTA Through Evaluation of PRO Integration, Value Disconnects, and Policy Change in the EU5","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Value (mathematics); Health technology; Technological change","score_opus":0.5532195293571966,"score_gpt":0.48349061658448506,"score_spread":0.0697289127727116,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8465863,0.011255838,0.00020118436,0.13456045,0.00054385467,0.004999613,0.000111066096,0.000020932288,0.001720754],"genre_scores_gemma":[0.9840444,0.00069226883,0.00049625547,0.013757143,0.00015637874,0.0007779979,0.000047094847,0.000017496845,0.000011014848],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9927489,0.0024079739,0.0035912693,0.0005916908,0.0002478058,0.00041232954],"domain_scores_gemma":[0.9968264,0.0008779348,0.0016012195,0.00052481727,0.00010195684,0.00006767415],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.016414521,0.00021120088,0.00079472613,0.0008132427,0.00013172597,0.00005873837,0.0002740539,0.00013318661,0.000014822089],"category_scores_gemma":[0.0035273102,0.00019733328,0.000060114096,0.00083684904,0.00010216831,0.00044238873,0.00005333802,0.00026025882,0.000022423052],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000049320264,0.00050067424,0.04772624,0.0011739787,0.00002555371,4.6943356e-7,0.10729295,0.00081016886,4.6839708e-7,0.8324203,0.00090708915,0.009092777],"study_design_scores_gemma":[0.005867527,0.0012472864,0.41275918,0.004506697,0.000018832898,0.0000047436383,0.019317575,0.1690084,0.000042048352,0.37537608,0.011189567,0.0006620709],"about_ca_topic_score_codex":0.022911256,"about_ca_topic_score_gemma":0.0012039045,"teacher_disagreement_score":0.45704424,"about_ca_system_score_codex":0.0013168645,"about_ca_system_score_gemma":0.00077470054,"threshold_uncertainty_score":0.98359525},"labels":[],"label_agreement":null},{"id":"W4417480624","doi":"10.1016/j.jval.2025.09.3438","title":"MSR155 New Developments in the Psychometric Testing of the Patient-Reported Impact of Dermatological Diseases (PRIDD) Questionnaire: Responsiveness and Minimally Important Change","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Global Affairs Canada","funders":"","keywords":"Reliability (semiconductor); Psychometric testing; Dermatological diseases; Measure (data warehouse); Test (biology); Selection (genetic algorithm)","score_opus":0.06838099945994429,"score_gpt":0.31892377081317025,"score_spread":0.25054277135322595,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480624","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9790849,0.019666813,0.0000023212046,0.0004095944,0.00020502749,0.0005705228,0.000031927844,0.000008727007,0.000020160447],"genre_scores_gemma":[0.9992389,0.00043655216,0.00011486135,0.0001369423,0.000004600476,0.000039869876,0.000013018047,0.000004146857,0.00001110594],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99803054,0.0008231052,0.0006673978,0.00019417077,0.000052381547,0.00023242089],"domain_scores_gemma":[0.99869585,0.00064824213,0.00037902358,0.00021074775,0.00004487127,0.000021257662],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048445546,0.00012818721,0.00032024333,0.00030937523,0.000082232735,0.0000038865373,0.00015663895,0.00010047108,0.0000036528168],"category_scores_gemma":[0.0010452758,0.000071134105,0.00006074063,0.0013365473,0.0000824052,0.000034170724,0.000054027358,0.00010366258,5.2362475e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028395062,0.00023523817,0.9733398,0.00007552692,0.000058410056,0.000008948204,0.0008611138,0.000007809492,0.0005842547,0.00009130044,0.000054087828,0.024399573],"study_design_scores_gemma":[0.0010077143,0.00019208071,0.99738765,0.00045876892,0.000025220055,0.0000523253,0.00009782583,0.000006298911,0.00040677717,0.00026292272,0.00004540095,0.000057009205],"about_ca_topic_score_codex":0.003639305,"about_ca_topic_score_gemma":0.0000933245,"teacher_disagreement_score":0.024342563,"about_ca_system_score_codex":0.00008540217,"about_ca_system_score_gemma":0.00076803507,"threshold_uncertainty_score":0.5501565},"labels":[],"label_agreement":null},{"id":"W4417480662","doi":"10.1016/j.jval.2025.09.668","title":"EE284 Cost-per-Remission of Vedolizumab vs. Risankizumab for the Treatment of Moderate-to-Severely Active Crohn’s Disease in Italy, France, and Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Takeda (Canada)","funders":"","keywords":"Vedolizumab; Disease; MEDLINE; Value (mathematics); Complete remission","score_opus":0.01171200381823341,"score_gpt":0.27427130096146396,"score_spread":0.26255929714323056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480662","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99592245,0.0014318841,0.00013866446,0.00059828523,0.00010543778,0.0014059525,0.000352936,0.0000020354487,0.00004237767],"genre_scores_gemma":[0.99867034,0.0005093529,0.00009325989,0.00028475968,0.000021068441,0.00019632094,0.000037001126,0.000010973005,0.00017692636],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998991,0.00010013061,0.00032437043,0.0002601456,0.00010011438,0.00022419821],"domain_scores_gemma":[0.99935216,0.00007483353,0.0000979906,0.00028201545,0.000060176037,0.00013284618],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000114220304,0.00013051946,0.00021399496,0.00006314785,0.000060222246,0.000004507114,0.000101973834,0.00005431696,0.0000028099037],"category_scores_gemma":[0.00008844943,0.000104494626,0.000045399778,0.00007871439,0.00004434042,0.0000031946083,0.000031183354,0.00004070468,1.0970167e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.13348192,0.0036685916,0.37943932,0.0062364917,0.00055890216,0.00024830402,0.004359295,0.35028982,0.00540217,0.0022608575,0.008399441,0.10565489],"study_design_scores_gemma":[0.0032305857,0.00030289765,0.9705052,0.0002186288,0.000021834307,4.5341199e-7,0.00012751267,0.009340775,0.0064542023,0.0001675668,0.009484271,0.00014606763],"about_ca_topic_score_codex":0.18627033,"about_ca_topic_score_gemma":0.0793824,"teacher_disagreement_score":0.5910659,"about_ca_system_score_codex":0.00022082112,"about_ca_system_score_gemma":0.0022971586,"threshold_uncertainty_score":0.9374165},"labels":[],"label_agreement":null},{"id":"W4417480674","doi":"10.1016/j.jval.2025.09.127","title":"CO25 Baseline Characteristics and Treatment Persistence in UK Patients With Moderate-to-Severe UC Following 12-Week Mirikizumab Induction: Real-World Data From IBD BioResource","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nutrasource","funders":"","keywords":"Persistence (discontinuity); Baseline (sea); Term (time)","score_opus":0.0421911509496882,"score_gpt":0.27845938811363324,"score_spread":0.23626823716394504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480674","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99813193,0.00013605357,0.00007982536,0.00037715363,0.00012601752,0.00056747685,0.00048279788,0.000010285378,0.00008845807],"genre_scores_gemma":[0.99630797,0.00014250739,0.0010468026,0.00051301345,0.00006832684,0.000033666514,0.0016685085,0.000018857418,0.00020034416],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99835134,0.00022238777,0.00036961483,0.00062857673,0.00013425905,0.0002938296],"domain_scores_gemma":[0.9990137,0.000036213005,0.00010576921,0.00065511453,0.000034017008,0.00015518707],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026443083,0.00020011057,0.00025718872,0.00014398746,0.00009628817,0.00003379395,0.00018978227,0.000067170404,0.00000403437],"category_scores_gemma":[0.00009061675,0.00018703943,0.000026987098,0.00019132692,0.000043634296,0.000010442542,0.00015253325,0.0000955976,0.000002566853],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024602995,0.00034332284,0.99177516,0.0000652824,0.00006160926,0.00006190182,0.00030704288,0.0008048801,0.00011484647,0.000011844097,0.00031006464,0.0036837284],"study_design_scores_gemma":[0.0023750474,0.00029942024,0.98985976,0.00027850972,0.000024328934,6.074658e-7,0.0001278747,0.0048093093,0.000070751106,0.000011615742,0.0019297476,0.00021300396],"about_ca_topic_score_codex":0.004798658,"about_ca_topic_score_gemma":0.0065598288,"teacher_disagreement_score":0.004004429,"about_ca_system_score_codex":0.00019560775,"about_ca_system_score_gemma":0.00044816738,"threshold_uncertainty_score":0.7627247},"labels":[],"label_agreement":null},{"id":"W4417480720","doi":"10.1016/j.jval.2025.09.154","title":"CO52 Comparative Analysis of Patient-Reported Outcomes (PROs) in Asthma Biologic Late-Phase Studies and Approved Labels: Implications for Entry and Product Differentiation","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sanofi (Canada)","funders":"","keywords":"Asthma; Product (mathematics); Product differentiation; Allergic asthma; New product development","score_opus":0.08423960676986965,"score_gpt":0.41536066802214056,"score_spread":0.3311210612522709,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98825175,0.008271838,0.000054054017,0.0019833497,0.00003367008,0.001322059,0.00006135711,0.00001309756,0.000008828639],"genre_scores_gemma":[0.99891686,0.00038380217,0.00021878426,0.00022213081,0.000005014567,0.00014949369,0.00007602068,0.0000028109484,0.000025103807],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988548,0.00012804226,0.0005551067,0.00027011632,0.000055354198,0.00013658982],"domain_scores_gemma":[0.9991934,0.0002480529,0.00024449674,0.00015336738,0.000108010616,0.000052703188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002259859,0.00010271506,0.0006274816,0.00041875726,0.000057676152,0.0000045341585,0.00002192352,0.000033702396,8.194881e-7],"category_scores_gemma":[0.00030852857,0.00007326317,0.000045514567,0.0006100235,0.000086117914,0.000029429102,0.000025388323,0.000058470083,4.4441535e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001959931,0.0005812181,0.9882247,0.00066269294,0.0004278773,6.441906e-7,0.0018077568,0.00020696048,0.0004698292,0.00038147814,0.000037181515,0.0070036612],"study_design_scores_gemma":[0.0021897382,0.0003892499,0.9922219,0.00015846398,0.00020000106,3.2186225e-7,0.0014626583,0.0027722607,0.00013903214,0.00032696975,0.000083218336,0.000056165376],"about_ca_topic_score_codex":0.00017271587,"about_ca_topic_score_gemma":0.00010518287,"teacher_disagreement_score":0.010665093,"about_ca_system_score_codex":0.00006118685,"about_ca_system_score_gemma":0.0001187034,"threshold_uncertainty_score":0.29875854},"labels":[],"label_agreement":null},{"id":"W4417480726","doi":"10.1016/j.jval.2025.09.202","title":"CO100 EQ-5D Utility Impact of Worsening NYHA Class and CV Hospitalization (CVH) on Health-Related Quality of Life (HRQoL) of Patients With ATTR-CM Based on the ATTRibute-CM Trial","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Quality of life (healthcare); Heart failure; Cardiomyopathy; Disease; Health related quality of life; Transthyretin","score_opus":0.06346557234012515,"score_gpt":0.3288952402722454,"score_spread":0.2654296679321203,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480726","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.995813,0.00048723095,0.00012142834,0.001628299,0.00010289174,0.001471031,0.00032986596,0.000008544202,0.00003772513],"genre_scores_gemma":[0.99888706,0.00018968574,0.00007619195,0.0004948523,0.000011868088,0.000037608217,0.00027772042,0.000016391115,0.00000859147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99677354,0.0011368294,0.0011115213,0.00039171157,0.00029433114,0.0002920781],"domain_scores_gemma":[0.997634,0.0005205894,0.0010222687,0.00056502485,0.00014714756,0.000111000154],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013796452,0.00022344558,0.00067413994,0.00012323362,0.00008282381,0.000006374813,0.00014785091,0.00016943255,0.000011157432],"category_scores_gemma":[0.0011279352,0.00015625668,0.00014315818,0.00037277333,0.00015257821,0.000005666718,0.00005382285,0.00014387579,3.0691928e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009423806,0.0012012476,0.98286813,0.00033054507,0.00013785942,1.3640806e-7,0.00015658629,0.0046666963,0.00007335122,0.00023439234,0.00035891152,0.0005483603],"study_design_scores_gemma":[0.015272456,0.0051725344,0.97648627,0.00036304002,0.000019025292,4.5440192e-8,0.00008686018,0.0010036855,0.0014069212,0.00004643297,0.000025159465,0.00011758128],"about_ca_topic_score_codex":0.006559069,"about_ca_topic_score_gemma":0.00014847069,"teacher_disagreement_score":0.006410598,"about_ca_system_score_codex":0.00018363324,"about_ca_system_score_gemma":0.00088027545,"threshold_uncertainty_score":0.99153936},"labels":[],"label_agreement":null},{"id":"W4417480732","doi":"10.1016/j.jval.2025.09.074","title":"P31 Comparative Performance of the EQ-5D-5L and PROMIS-10 in the Elderly: Data From the EQ-DAPHNIE Project in Five Countries","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"","score_opus":0.5254202712899588,"score_gpt":0.4417274547773113,"score_spread":0.08369281651264754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480732","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.91766524,0.0074137435,0.00001998372,0.0702931,0.00027889528,0.002538836,0.0007536924,0.000007947584,0.0010285444],"genre_scores_gemma":[0.9905846,0.0015067523,0.00024854255,0.007149195,0.00007910618,0.00018188583,0.00005173068,0.000010582538,0.00018761496],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99425596,0.0017009828,0.0029932223,0.00053572474,0.00012386979,0.00039025256],"domain_scores_gemma":[0.993234,0.004233995,0.00131557,0.0011487708,0.000035279732,0.00003242648],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022802377,0.00017368395,0.00085665844,0.00023543484,0.00022426166,0.000067766065,0.0010514895,0.00010113762,0.00003247808],"category_scores_gemma":[0.0015813109,0.00012575834,0.000035207348,0.00063519215,0.00021671611,0.0003468648,0.00021655721,0.00042997336,0.000039486127],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013328691,0.00023293361,0.84204227,0.0013886554,0.000049200797,5.7157985e-7,0.063034944,0.002470544,3.4501298e-7,0.049194217,0.04109284,0.00036021697],"study_design_scores_gemma":[0.001872757,0.00022785958,0.78235745,0.0013222808,0.000005725912,0.0000017314616,0.01383568,0.1311148,0.0000037993125,0.008861419,0.060151555,0.000244932],"about_ca_topic_score_codex":0.06192437,"about_ca_topic_score_gemma":0.013252408,"teacher_disagreement_score":0.12864426,"about_ca_system_score_codex":0.0004289491,"about_ca_system_score_gemma":0.0011458864,"threshold_uncertainty_score":0.94432235},"labels":[],"label_agreement":null},{"id":"W4417480743","doi":"10.1016/j.jval.2025.09.452","title":"EE68 Assessment of the Cost Utility of Palivizumab for Preventing Severe Respiratory Syncytial Virus (RSV) Infection in Preterm Infants Born 29-35 Weeks' Gestational Age in the Philippines","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Respiratory viral infections research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Palivizumab; Cost–utility analysis; Gestational age; Respiratory system; Virus","score_opus":0.10368039981470174,"score_gpt":0.4461511830921953,"score_spread":0.3424707832774936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9940491,0.00023536808,0.00020746652,0.0004934648,0.00020122362,0.0038395962,0.00005749731,0.0000115818,0.000904736],"genre_scores_gemma":[0.9988896,0.000072158866,0.00012843274,0.0003767262,0.00005300967,0.00042687217,0.000011519491,0.000012218792,0.000029410714],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9961278,0.0015763927,0.0011380727,0.00030643627,0.0005079618,0.00034337267],"domain_scores_gemma":[0.99809706,0.00089245266,0.00032556712,0.00048766288,0.00015484913,0.000042386742],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047819787,0.0001460439,0.00042015032,0.0005273811,0.0001214068,0.000015464897,0.00019212923,0.00012469373,0.000022518368],"category_scores_gemma":[0.0014203873,0.000106351225,0.000108040935,0.00124801,0.00015271654,0.00012828954,0.000091292764,0.0005934968,3.791648e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025389876,0.00061213854,0.9821205,0.002298596,0.000020614647,0.0000035877501,0.0005716791,0.0022384222,0.0010212285,0.00073168986,0.00010625003,0.010021402],"study_design_scores_gemma":[0.0021977564,0.00039828775,0.98650485,0.0012348234,0.000011054275,0.0000026077953,0.00009293604,0.0073561356,0.0006415206,0.0006586062,0.00083424663,0.000067199886],"about_ca_topic_score_codex":0.0065656286,"about_ca_topic_score_gemma":0.0064752623,"teacher_disagreement_score":0.009954201,"about_ca_system_score_codex":0.00054949423,"about_ca_system_score_gemma":0.0020727934,"threshold_uncertainty_score":0.992531},"labels":[],"label_agreement":null},{"id":"W4417480751","doi":"10.1016/j.jval.2025.09.525","title":"EE141 Comparing Alternative Extrapolation Methods Using Standard Partitioned Survival Model Functionality in the Presence of Converging Survival Data: A Case Study in Renal Cell Carcinoma","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Statistical Methods in Clinical Trials","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Extrapolation; Renal cell carcinoma; Survival analysis; Parametric statistics; Equivalence (formal languages); Overall survival; Cell survival","score_opus":0.8253920294109419,"score_gpt":0.6337543514233877,"score_spread":0.19163767798755427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480751","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5217125,0.000038181137,0.4767876,0.000091671725,0.00031934606,0.0008611377,0.00009580288,0.000007555103,0.00008621753],"genre_scores_gemma":[0.6576937,0.0000054330785,0.34220514,0.000022527873,0.0000348314,0.00002381456,0.0000033297688,0.000008644031,0.0000026173943],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.97772366,0.018279446,0.0023171934,0.00063247717,0.0006533798,0.00039386595],"domain_scores_gemma":[0.9408438,0.05766417,0.00054679846,0.00076065806,0.00012459724,0.000059926315],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.044016518,0.00017812506,0.000914677,0.00024388656,0.00010540051,0.000030085317,0.0004010333,0.000078560486,0.000008179079],"category_scores_gemma":[0.020098994,0.00015452356,0.000047342062,0.00080787373,0.00012062184,0.0001635251,0.0002499076,0.00057374174,1.4334779e-7],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014387941,0.002489047,0.4546526,0.0017649474,0.00006568366,0.0002939857,0.013361344,0.42866483,0.00013107006,0.09479851,0.000033321314,0.002305862],"study_design_scores_gemma":[0.0019775166,0.00009402181,0.010535121,0.0002121891,0.000025666644,0.0000044933367,0.0037791815,0.72628814,0.00005917803,0.25693023,0.0000011411495,0.00009311843],"about_ca_topic_score_codex":0.023117935,"about_ca_topic_score_gemma":0.0028444063,"teacher_disagreement_score":0.4441175,"about_ca_system_score_codex":0.0003770894,"about_ca_system_score_gemma":0.0006146168,"threshold_uncertainty_score":0.9881551},"labels":[],"label_agreement":null},{"id":"W4417480800","doi":"10.1016/j.jval.2025.09.3393","title":"MSR108 Feasibility Assessment of an Indirect Treatment Comparison of Seladelpar vs. Elafibranor in Patients With Primary Biliary Cholangitis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"","keywords":"Primary (astronomy); Primary sclerosing cholangitis; Primary care; Baseline (sea)","score_opus":0.04073650694666539,"score_gpt":0.35997456501930436,"score_spread":0.31923805807263894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480800","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99716526,0.00051593664,0.0000074004242,0.00019559174,0.00005268895,0.0014809724,0.000110615845,0.000015925923,0.00045558732],"genre_scores_gemma":[0.9980961,0.0000940309,0.0013082052,0.00013953265,0.0000069332773,0.000022162387,0.0003066032,0.000010127664,0.000016281698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99811584,0.00045081537,0.0006731499,0.00026162842,0.00026997537,0.00022861283],"domain_scores_gemma":[0.99899614,0.000111909176,0.0002170592,0.00048030572,0.00007231053,0.0001222977],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041350012,0.00014350929,0.00075627083,0.00026944457,0.000033176813,0.0000038530843,0.00008703055,0.000062473344,0.000017002822],"category_scores_gemma":[0.000026292668,0.00011154467,0.00006071424,0.00048016518,0.00006552298,0.00010155386,0.000033430177,0.00017829692,2.971771e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010675117,0.0073439465,0.98398626,0.0012519314,0.00005380433,0.0000021108403,0.00065893267,0.0003258524,0.000015145582,0.000026828904,0.000022019802,0.005245629],"study_design_scores_gemma":[0.0062671416,0.0047392664,0.98648363,0.0007548131,0.00004643243,3.2631579e-7,0.0001723674,0.0011855316,0.00021337764,0.000029191142,0.00003655682,0.00007134919],"about_ca_topic_score_codex":0.011319595,"about_ca_topic_score_gemma":0.00015989509,"teacher_disagreement_score":0.0111597,"about_ca_system_score_codex":0.0010330615,"about_ca_system_score_gemma":0.001375746,"threshold_uncertainty_score":0.9952641},"labels":[],"label_agreement":null},{"id":"W4417480803","doi":"10.1016/j.jval.2025.09.1188","title":"EPH59 Development and Validation of a Case Identification Algorithm for Hand Trauma Patients Using Health Administrative Data and the Epidemiology of Hand Trauma in a Universal Healthcare System","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Trauma and Emergency Care Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; McMaster University; University of Toronto","funders":"","keywords":"Medical diagnosis; Epidemiology; Identification (biology); Healthcare system; Health care; Public health","score_opus":0.2207098430597351,"score_gpt":0.4256360483483085,"score_spread":0.2049262052885734,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480803","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9816393,0.006174552,0.0077309213,0.0020509963,0.00017148895,0.0019626706,0.00025742725,0.0000053667754,0.000007235385],"genre_scores_gemma":[0.99183226,0.00026421432,0.0076427385,0.00007114326,0.0000133884205,0.000033754557,0.00013059773,0.0000069047683,0.0000049936853],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9974237,0.00067044504,0.0012231516,0.000341805,0.00010496209,0.0002359245],"domain_scores_gemma":[0.998498,0.0005629873,0.00048019245,0.00023287786,0.00015259939,0.00007332825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027646227,0.00012198625,0.0007023401,0.00023277498,0.00022053502,0.0000038385306,0.000063349085,0.00006492534,2.734813e-7],"category_scores_gemma":[0.0002845736,0.00009687973,0.000024016372,0.00027975254,0.00023767959,0.00006345952,0.000047096644,0.00010893098,2.765746e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015478751,0.00044856482,0.20204797,0.019742742,0.0002395101,0.00001866127,0.0754747,0.0001559869,0.000012761132,0.0048179217,0.00008410468,0.6954092],"study_design_scores_gemma":[0.02288017,0.0018310457,0.78129005,0.007636176,0.00015778565,0.00017341382,0.07172115,0.11217258,0.0009656563,0.0005800095,0.00030333526,0.00028864588],"about_ca_topic_score_codex":0.017692203,"about_ca_topic_score_gemma":0.0027356383,"teacher_disagreement_score":0.6951205,"about_ca_system_score_codex":0.00031629682,"about_ca_system_score_gemma":0.00062653294,"threshold_uncertainty_score":0.98884904},"labels":[],"label_agreement":null},{"id":"W4417480811","doi":"10.1016/j.jval.2025.09.1238","title":"EPH109 Exploring the Impact of Socioeconomic Factors on COVID-19 Vaccine Hesitancy in India: What Can We Learn From the COVID-19 Pandemic? A Scoping Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Vaccine Coverage and Hesitancy","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Network for Business Sustainability","funders":"","keywords":"Herd immunity; Vaccination; Socioeconomic status; Context (archaeology); Intervention (counseling); Vaccine safety","score_opus":0.17067256125335453,"score_gpt":0.4168911014285767,"score_spread":0.24621854017522218,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480811","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.832754,0.085852735,0.0000192564,0.07908216,0.00035727597,0.001772098,0.000025121228,0.00004192439,0.00009539324],"genre_scores_gemma":[0.72795403,0.25821158,0.0000065540244,0.013587425,0.000114284616,0.00007796498,0.000007439093,0.000012619051,0.000028136576],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959194,0.0019389322,0.0008969105,0.00041498698,0.00024301918,0.00058675016],"domain_scores_gemma":[0.9940463,0.004771916,0.00041735967,0.00046212334,0.000026182603,0.00027613807],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039976235,0.00022565828,0.0006948709,0.00019425659,0.00065932213,0.00008891754,0.00062152476,0.00010503113,0.00023015004],"category_scores_gemma":[0.0023002224,0.00014783368,0.0001974255,0.00069734803,0.000033423614,0.00037594794,0.00008229808,0.0005612441,0.00001037037],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039852643,0.000051148178,0.93948966,0.0013342408,0.00003072949,0.000005285758,0.050836902,0.0019879097,0.0000013903859,0.0012527333,0.0017799373,0.0031901917],"study_design_scores_gemma":[0.0028433288,0.00035674573,0.8690435,0.049544908,0.000053687632,0.000001969238,0.05048785,0.0000991417,0.000008333112,0.021954786,0.0049879015,0.0006178364],"about_ca_topic_score_codex":0.22452554,"about_ca_topic_score_gemma":0.060044453,"teacher_disagreement_score":0.17235884,"about_ca_system_score_codex":0.0037069265,"about_ca_system_score_gemma":0.007597847,"threshold_uncertainty_score":0.99802816},"labels":[],"label_agreement":null},{"id":"W4417480839","doi":"10.1016/j.jval.2025.09.2621","title":"PCR148 Listening to the Voice of the Patient: Insights From a Survey on the Burden of Recurrent Respiratory Papillomatosis in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Recurrent Respiratory Papillomatosis; Active listening; Quality of life (healthcare); Disease; Papillomatosis; Disease burden","score_opus":0.10146678835213119,"score_gpt":0.3678655708611876,"score_spread":0.2663987825090564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480839","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97076607,0.0021107006,0.0000030763954,0.024966447,0.00012779808,0.0011990395,0.00007899881,0.0000050252215,0.0007428506],"genre_scores_gemma":[0.9929239,0.0002887043,0.0000047830927,0.0066386913,0.000044191904,0.000055812365,0.000018620187,0.000008060423,0.000017230013],"study_design_codex":"qualitative","study_design_gemma":"observational","domain_scores_codex":[0.99578494,0.0026625695,0.0005463084,0.0001897711,0.00058813184,0.00022829998],"domain_scores_gemma":[0.99527425,0.0037247227,0.00012844776,0.0006482483,0.00017130462,0.000053024574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021698002,0.00010059893,0.0002672806,0.00019327589,0.0001184398,0.000012227036,0.00042620543,0.000045099816,0.00003204752],"category_scores_gemma":[0.0013282157,0.000040002185,0.000056566827,0.0019476832,0.000098217,0.0000125995475,0.00013665635,0.00052833,0.000003149973],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008675918,0.00210238,0.336524,0.0030466407,0.00032407124,0.000016961892,0.4180028,0.039310858,0.00037824523,0.01128416,0.046447877,0.13388607],"study_design_scores_gemma":[0.0008501611,0.00078924315,0.95560586,0.0012438245,0.000011963481,1.8215553e-7,0.006221587,0.003970507,0.00046393016,0.0007972966,0.02998194,0.00006351252],"about_ca_topic_score_codex":0.20608038,"about_ca_topic_score_gemma":0.008681882,"teacher_disagreement_score":0.61908185,"about_ca_system_score_codex":0.00017400448,"about_ca_system_score_gemma":0.00044928637,"threshold_uncertainty_score":0.7992064},"labels":[],"label_agreement":null},{"id":"W4417480846","doi":"10.1016/j.jval.2025.09.451","title":"EE67 Assessment of Health State Utilities Associated With Treatment for Chronic Hepatitis B Virus (HBV) Infection","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Hepatitis B virus; Chronic hepatitis; Virus; Hepatitis B; Chronic infection; Oligonucleotide","score_opus":0.06352760309217137,"score_gpt":0.38702385300873193,"score_spread":0.32349624991656056,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9855005,0.0035644642,0.0029972983,0.0037027933,0.0002993218,0.0031342986,0.00029474773,0.00009679584,0.00040974756],"genre_scores_gemma":[0.9844386,0.012813849,0.0010688391,0.00051084865,0.000030095018,0.00042585915,0.00009474832,0.000025051637,0.00059208384],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976686,0.00038206732,0.0008552817,0.00031356685,0.00025574214,0.0005246895],"domain_scores_gemma":[0.998711,0.000394328,0.00038907115,0.00025033706,0.00016204156,0.00009321687],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010324615,0.00020940664,0.00090591394,0.0003075304,0.00018692875,0.000008781095,0.00003749982,0.000057166162,0.000013394638],"category_scores_gemma":[0.00015542851,0.00017513633,0.00008384876,0.0004428953,0.000085447384,0.000055598157,0.000022365119,0.0001400682,0.0000011332965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000833239,0.0006450491,0.96666145,0.0016684898,0.00026661818,0.000003032336,0.0011646142,0.0010237648,0.000016816297,0.00080631394,0.0004639116,0.027196595],"study_design_scores_gemma":[0.0035191237,0.00797407,0.9750904,0.0025071402,0.000038728973,0.0000015424453,0.000037729835,0.0064761653,0.00021224849,0.00034690337,0.0036850977,0.00011084581],"about_ca_topic_score_codex":0.48152533,"about_ca_topic_score_gemma":0.25461605,"teacher_disagreement_score":0.2269093,"about_ca_system_score_codex":0.00670414,"about_ca_system_score_gemma":0.004756788,"threshold_uncertainty_score":0.99710894},"labels":[],"label_agreement":null},{"id":"W4417480868","doi":"10.1016/j.jval.2025.09.286","title":"CO184 Predictors of Postoperative Complications Following Cytoreductive Surgery With HIPEC: A Real-World Analysis of 493 Patients in Québec","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Intraperitoneal and Appendiceal Malignancies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Thermo Fisher Scientific (Canada); Université de Montréal; McGill University","funders":"","keywords":"Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; Intraperitoneal chemotherapy; Complication; Chemotherapy","score_opus":0.021056536786096175,"score_gpt":0.29928689882267817,"score_spread":0.278230362036582,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480868","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9956645,0.00016459289,0.000016134922,0.002476502,0.00007706738,0.000560333,0.00006541142,0.0000129335085,0.0009625311],"genre_scores_gemma":[0.9991808,0.00006207913,0.00021287611,0.00031429657,0.0000067180677,0.00004000392,0.00008640166,0.000007987933,0.000088869085],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984105,0.00016052865,0.0007386675,0.00023563945,0.00023056667,0.00022408896],"domain_scores_gemma":[0.99893963,0.00040208275,0.0002316969,0.0002129203,0.00014558886,0.000068081914],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003435097,0.00012065039,0.0008272836,0.0011237118,0.000048115668,0.0000028776979,0.00006400765,0.000038663893,0.000007949271],"category_scores_gemma":[0.00010276321,0.000097888056,0.0001284447,0.0028057864,0.0001161975,0.000054698823,0.000020416826,0.00014203475,4.208114e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00021209473,0.0004810315,0.9926361,0.00019365996,0.0003355089,0.0000047111544,0.0030579504,0.0010761946,0.00011971447,0.0015254358,0.000087731336,0.000269906],"study_design_scores_gemma":[0.000582466,0.0002360514,0.99563205,0.0011732627,0.00015952847,3.573025e-7,0.0008675969,0.0007120486,0.00045545714,0.000027347969,0.000089094334,0.000064759864],"about_ca_topic_score_codex":0.35300702,"about_ca_topic_score_gemma":0.049899973,"teacher_disagreement_score":0.30310705,"about_ca_system_score_codex":0.00041456753,"about_ca_system_score_gemma":0.0013816621,"threshold_uncertainty_score":0.96743685},"labels":[],"label_agreement":null},{"id":"W4417480899","doi":"10.1016/j.jval.2025.09.3350","title":"MSR64 Country-Related Differential Item Functioning in the EQ-5D-5L: Insights From the EuroQol Data Assessment of Population Health Needs and Instrument Evaluation (EQ-DAPHNIE)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Differential item functioning; Differential (mechanical device); Item response theory; Population; Population health; Rasch model","score_opus":0.41861316107142255,"score_gpt":0.4242891282015441,"score_spread":0.005675967130121529,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.92773175,0.0061488813,0.0015975446,0.06010438,0.0011167239,0.0026696299,0.0002729614,0.000022824008,0.00033529158],"genre_scores_gemma":[0.9894548,0.00091999496,0.00045446356,0.007866719,0.00012158066,0.000108221,0.0010383424,0.000018486018,0.00001737469],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9896659,0.0036976894,0.005213852,0.0006782474,0.00033835843,0.0004059076],"domain_scores_gemma":[0.99368113,0.0025936668,0.0025421919,0.0010440113,0.000054746433,0.00008427905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027149027,0.0002115334,0.00088106457,0.0005923239,0.00037140583,0.0001109207,0.00050403917,0.00013789308,0.000053970904],"category_scores_gemma":[0.0015812009,0.00019027026,0.000043238604,0.00089563796,0.00006227692,0.00043461216,0.00014241904,0.00043813259,0.000010292867],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030989795,0.0002808324,0.76527363,0.0006353879,0.00008213838,2.3035973e-7,0.010711516,0.0129376855,0.0000016031506,0.20375118,0.0027404109,0.0035543838],"study_design_scores_gemma":[0.0011086129,0.00006838201,0.639611,0.00039546753,0.000007388699,7.343153e-7,0.002223333,0.34487802,1.12320315e-7,0.0090487,0.0025587527,0.00009949826],"about_ca_topic_score_codex":0.111740254,"about_ca_topic_score_gemma":0.006486031,"teacher_disagreement_score":0.33194032,"about_ca_system_score_codex":0.0014072849,"about_ca_system_score_gemma":0.0008742295,"threshold_uncertainty_score":0.9409365},"labels":[],"label_agreement":null},{"id":"W4417480948","doi":"10.1016/j.jval.2025.09.1715","title":"HSD54 Guideline-Driven Off-Label Oncology Use: The Role of Clinical Evidence and Reimbursement Dynamics in the EU4+UK, Switzerland, and Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Dynamics (music); MEDLINE; Clinical Oncology","score_opus":0.09949145858012742,"score_gpt":0.36107443986228466,"score_spread":0.26158298128215723,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417480948","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9478918,0.022789678,0.00009478467,0.02588328,0.0004393983,0.00051780196,0.000091922266,0.0000030223969,0.0022883343],"genre_scores_gemma":[0.9777504,0.017170118,0.0003921879,0.0045071077,0.000055049375,0.000018352455,0.0000034550192,0.000006762901,0.00009657271],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.997644,0.00013641504,0.0016037377,0.00030050633,0.000037288664,0.0002780611],"domain_scores_gemma":[0.99807966,0.0009880651,0.0005397739,0.00030312457,0.000029304305,0.000060085946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035658877,0.00010991034,0.0005474698,0.00010429419,0.00007381898,0.00002789183,0.0002514472,0.00010054374,0.0000080640475],"category_scores_gemma":[0.0008647952,0.000087575994,0.00002931854,0.00016367184,0.0001208607,0.000106486885,0.000084801686,0.00031047084,0.0000011543704],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000042288542,0.000046094632,0.8342122,0.000038010126,0.000012422654,0.0000019150555,0.00026519812,0.00055116933,1.3397535e-7,0.13767539,0.0019783892,0.025176786],"study_design_scores_gemma":[0.0012308699,0.00031183113,0.6769713,0.0002410985,0.000006873353,0.000004255856,0.0010697108,0.12070942,9.088163e-7,0.023428593,0.17586064,0.00016446358],"about_ca_topic_score_codex":0.8259648,"about_ca_topic_score_gemma":0.8023417,"teacher_disagreement_score":0.17388226,"about_ca_system_score_codex":0.0005885471,"about_ca_system_score_gemma":0.0011442483,"threshold_uncertainty_score":0.35712454},"labels":[],"label_agreement":null},{"id":"W4417481005","doi":"10.1016/j.jval.2025.09.1727","title":"HSD66 Is There Sufficient Economic Evidence for Reimbursing Behavioral Interventions? A Targeted Literature Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dalhousie University","funders":"","keywords":"Systematic review; MEDLINE; Real world evidence; Dynamic inconsistency","score_opus":0.6306543205926481,"score_gpt":0.5402262152273164,"score_spread":0.09042810536533175,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481005","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06302271,0.71990013,0.0041466854,0.20595022,0.0019346352,0.0039314744,0.00071304815,0.00007321443,0.00032787494],"genre_scores_gemma":[0.6135004,0.21968165,0.021526508,0.13600223,0.0008698978,0.0025955688,0.0004092813,0.00017825112,0.005236185],"study_design_codex":"not_applicable","study_design_gemma":"systematic_review","domain_scores_codex":[0.99208695,0.0006715114,0.005715636,0.00084361905,0.00006822619,0.00061407284],"domain_scores_gemma":[0.9958591,0.0010917645,0.002071548,0.0007315321,0.00007687037,0.00016921778],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.02173491,0.00024938548,0.0013198161,0.00062798604,0.0002493856,0.00012448522,0.00040440285,0.00016567865,0.0002598407],"category_scores_gemma":[0.002077073,0.00031791205,0.00040177116,0.00048093908,0.000050898034,0.00047145665,0.00006385927,0.00031994696,0.0002804001],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012558971,0.0009863067,0.071514785,0.118972994,0.00014651433,0.000004679208,0.008815222,0.0037354995,0.0000018337757,0.34351972,0.4485386,0.0036382475],"study_design_scores_gemma":[0.0048533827,0.0015564183,0.06385692,0.43658414,0.000094713105,0.00002775092,0.0021729008,0.08352074,0.000022953338,0.073319815,0.33190283,0.0020874161],"about_ca_topic_score_codex":0.003360397,"about_ca_topic_score_gemma":0.00020023069,"teacher_disagreement_score":0.5504777,"about_ca_system_score_codex":0.0026080015,"about_ca_system_score_gemma":0.00072261563,"threshold_uncertainty_score":0.9999273},"labels":[],"label_agreement":null},{"id":"W4417481042","doi":"10.1016/j.jval.2025.09.2611","title":"PCR138 Increased Adherence to Biologic Therapies Leads to Lower All-Cause and Asthma-Related (HCRU) Costs in Severe Asthma","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Asthma and respiratory diseases","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"GlaxoSmithKline (Canada)","funders":"","keywords":"Acute severe asthma; Asthma; Adrenergic beta-Agonists; MEDLINE","score_opus":0.03765173837226746,"score_gpt":0.33338809029976857,"score_spread":0.29573635192750114,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481042","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9878658,0.0046595866,0.000019047351,0.005245829,0.00020358576,0.0013259116,0.000026053032,0.00007376496,0.00058044156],"genre_scores_gemma":[0.98702395,0.0003376302,0.0003175247,0.011769294,0.000037277718,0.00007899662,0.000014703974,0.000019493302,0.0004011487],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9977906,0.00039872722,0.0005771271,0.00051876955,0.00019175878,0.00052301626],"domain_scores_gemma":[0.9988478,0.00022484692,0.00007947589,0.0003376072,0.00006120731,0.0004491042],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006161851,0.0002451555,0.00052171055,0.0004967747,0.00007099703,0.000020344718,0.00013185079,0.00016611982,0.00009645582],"category_scores_gemma":[0.0003801302,0.00019624642,0.000052807627,0.0009115814,0.000075468466,0.00005717381,0.000096675365,0.00031043915,0.000073726194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027022162,0.0012387064,0.8603201,0.00083400053,0.00012774339,0.0005029836,0.0025963872,0.001191905,0.0032086594,0.001433461,0.005478257,0.1203656],"study_design_scores_gemma":[0.0037040366,0.0039307815,0.96442646,0.002807538,0.00001626529,0.000030632098,0.000885455,0.0004244949,0.00013823112,0.00022447508,0.02304688,0.0003647723],"about_ca_topic_score_codex":0.0030765873,"about_ca_topic_score_gemma":0.00058140105,"teacher_disagreement_score":0.120000824,"about_ca_system_score_codex":0.0003392396,"about_ca_system_score_gemma":0.0006203058,"threshold_uncertainty_score":0.80026966},"labels":[],"label_agreement":null},{"id":"W4417481050","doi":"10.1016/j.jval.2025.09.3352","title":"MSR66 Dealing With Missing Data in Health Economic Studies of Small to Moderate Size: How to Minimize Bias","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre hospitalier universitaire de Québec; Université Laval","funders":"","keywords":"Missing data; Imputation (statistics); Sample size determination; Matching (statistics); Sample (material); Propensity score matching","score_opus":0.538504278450313,"score_gpt":0.49361757745006957,"score_spread":0.044886701000243445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481050","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6153342,0.0024687895,0.30848202,0.06911458,0.00022365847,0.0036199302,0.0001567031,0.0003137826,0.00028630652],"genre_scores_gemma":[0.30609107,0.0005036948,0.6915506,0.0016451511,0.00002212356,0.00005555881,0.000004731225,0.000035010475,0.00009202996],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.9974214,0.0003315868,0.0010237214,0.00055606244,0.00013505026,0.00053221977],"domain_scores_gemma":[0.9962448,0.0021939941,0.0003966976,0.0009336582,0.00006747062,0.00016341406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029087104,0.00023322043,0.00093072676,0.00038845907,0.00008109345,0.000030385589,0.00043583903,0.000059350758,0.0000026988216],"category_scores_gemma":[0.0023208626,0.00021814671,0.00002143916,0.0003971944,0.000045415454,0.00014014526,0.00033675713,0.00023809298,0.0000015380848],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":"theoretical_or_conceptual","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0021848148,0.0011060617,0.023861166,0.03161312,0.00038520593,0.00007130557,0.0459206,0.35809433,0.00077286107,0.41620064,0.008139092,0.111650795],"study_design_scores_gemma":[0.004187784,0.0025155284,0.0029691074,0.044704903,0.000044252458,0.000018258628,0.012894304,0.14279383,0.0077869263,0.77756613,0.0027657636,0.001753184],"about_ca_topic_score_codex":0.004478184,"about_ca_topic_score_gemma":0.0040615094,"teacher_disagreement_score":0.38306862,"about_ca_system_score_codex":0.0009159761,"about_ca_system_score_gemma":0.0010268028,"threshold_uncertainty_score":0.8895765},"labels":[],"label_agreement":null},{"id":"W4417481054","doi":"10.1016/j.jval.2025.09.160","title":"CO58 Comparative Efficacy of Iptacopan Monotherapy vs. Danicopan Add-on to C5i in Paroxysmal Nocturnal Hemoglobinuria (PNH) Results From an Indirect Treatment Comparison (ITC)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Paroxysmal nocturnal hemoglobinuria; Clinical trial; Anemia; Hemoglobinuria; Complement (music)","score_opus":0.08828687517448482,"score_gpt":0.38900357143197956,"score_spread":0.30071669625749475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481054","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9929118,0.0021988694,0.000021376725,0.00085469085,0.0007506834,0.0019318031,0.00091776554,0.000059687107,0.00035333735],"genre_scores_gemma":[0.9984583,0.000050232844,0.00018987244,0.00045448952,0.000041237046,0.00009228487,0.0005603396,0.000017745397,0.00013545877],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950036,0.0020223681,0.0015807946,0.0007130976,0.00009754329,0.00058263825],"domain_scores_gemma":[0.9975708,0.0011464135,0.0004690097,0.0006699452,0.000045520414,0.00009827627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000618496,0.00036259386,0.0012514709,0.00051481224,0.0001259481,0.000018742834,0.00040940908,0.00015937067,0.0001510427],"category_scores_gemma":[0.000089861984,0.00033180686,0.000107585474,0.00052190834,0.000087997185,0.00005938812,0.00006238042,0.00029118318,0.000078088204],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.06860885,0.016852055,0.7063902,0.0002638526,0.001068891,0.00003135224,0.06734399,0.061314926,0.021671448,0.0017741988,0.027793486,0.02688675],"study_design_scores_gemma":[0.023591606,0.005463745,0.9205685,0.0015070722,0.00003597385,0.0000025083355,0.001822687,0.0010728949,0.034105465,0.00017695346,0.011241862,0.00041069076],"about_ca_topic_score_codex":0.03729736,"about_ca_topic_score_gemma":0.0066859624,"teacher_disagreement_score":0.21417834,"about_ca_system_score_codex":0.0009522537,"about_ca_system_score_gemma":0.0005566834,"threshold_uncertainty_score":0.9999134},"labels":[],"label_agreement":null},{"id":"W4417481068","doi":"10.1016/j.jval.2025.09.246","title":"CO144 Improvements in Scalp Outcomes With Roflumilast Foam 0.3% for Psoriasis of the Scalp and Body From the Phase 3 ARRECTOR Trial","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Hidradenitis Suppurativa and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Dermatrials Research","funders":"","keywords":"Scalp; Roflumilast; Psoriasis; Phase (matter); Clinical trial","score_opus":0.031707650005507335,"score_gpt":0.351020697173431,"score_spread":0.31931304716792364,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98200697,0.000395554,0.000051208517,0.013388939,0.00047902533,0.0034132556,0.00017914051,0.000009662703,0.00007623251],"genre_scores_gemma":[0.99878347,0.000056825345,0.00028958765,0.00033764687,0.00006874017,0.0002203294,0.000024589956,0.0000132007335,0.00020562192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986105,0.00019405058,0.00048535454,0.0002510151,0.00020604153,0.0002530242],"domain_scores_gemma":[0.9988048,0.0006473315,0.00014395732,0.00030220218,0.00003376402,0.00006791823],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013201722,0.0001503942,0.0004783768,0.00008344612,0.0000973706,0.000012055445,0.00010197301,0.000059405513,0.000010208535],"category_scores_gemma":[0.00025248845,0.00007519229,0.00006765504,0.00027997012,0.000086404645,0.000044358287,0.00003409184,0.00015698746,7.1595736e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017724833,0.0018190683,0.9530003,0.00026418013,0.00024554436,0.000028075934,0.0017708183,0.0000030407796,0.00023914216,0.00028164271,0.0006405132,0.023982856],"study_design_scores_gemma":[0.34501654,0.0046219947,0.63989514,0.0019285406,0.00023642159,0.00001799843,0.0013532273,0.0011891326,0.003012391,0.0013254847,0.0012047519,0.00019840011],"about_ca_topic_score_codex":0.0085296165,"about_ca_topic_score_gemma":0.0012369584,"teacher_disagreement_score":0.3272917,"about_ca_system_score_codex":0.00015348646,"about_ca_system_score_gemma":0.00044416555,"threshold_uncertainty_score":0.9980727},"labels":[],"label_agreement":null},{"id":"W4417481073","doi":"10.1016/j.jval.2025.09.2698","title":"PCR225 The Burden of Cognitive Impairment Associated With Schizophrenia (CIAS) on People With Lived Experience (PWLE): A National Canadian Survey","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Schizophrenia research and treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Joseph’s Healthcare Hamilton; Centre for Addiction and Mental Health; Canadian Mental Health Association; Schizophrenia Society of Ontario; Health Sciences Centre; Sunnybrook Health Science Centre; McMaster University; Boehringer Ingelheim (Canada)","funders":"","keywords":"Lived experience; Schizophrenia (object-oriented programming); Cognitive impairment; Psychosis; Cognition","score_opus":0.05382091528229445,"score_gpt":0.3379574904043439,"score_spread":0.2841365751220495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481073","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925967,0.00020610372,0.000007358674,0.0049351077,0.000032041058,0.0014620668,0.00015749362,0.000015892369,0.0005872444],"genre_scores_gemma":[0.99885327,0.0000462048,0.00013095012,0.0004335484,0.000026570448,0.00020838372,0.0001371451,0.000013069622,0.00015083328],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978152,0.00048185422,0.0002817435,0.00028964726,0.0006785917,0.0004529815],"domain_scores_gemma":[0.99783075,0.0011728228,0.00011563424,0.00018636587,0.0003963524,0.00029805218],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009980373,0.00015767093,0.00032869764,0.00035011346,0.0001712545,0.000016650387,0.00011140973,0.00005157664,0.0000416943],"category_scores_gemma":[0.00094514835,0.00009349316,0.000032210057,0.0010403983,0.00011632148,0.000032138043,0.000019974153,0.00027558985,0.0000068615855],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.05104132,0.0018393366,0.9146832,0.00020756532,0.0009191681,0.00017216042,0.021742664,0.0022274882,0.0000067423553,0.0035564976,0.00087295164,0.0027308543],"study_design_scores_gemma":[0.007503154,0.002534558,0.98414546,0.0018124037,0.000017209906,0.000007670687,0.0016800485,0.001969349,0.000060556347,0.00017651406,0.000010143643,0.00008292775],"about_ca_topic_score_codex":0.6417637,"about_ca_topic_score_gemma":0.58524776,"teacher_disagreement_score":0.06946221,"about_ca_system_score_codex":0.0012299898,"about_ca_system_score_gemma":0.010199973,"threshold_uncertainty_score":0.9954113},"labels":[],"label_agreement":null},{"id":"W4417481091","doi":"10.1016/j.jval.2025.09.2655","title":"PCR182 Patient-Reported Outcomes After Total Knee Arthroplasty: Comparisons Across TKA Procedures and PRO Domains","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Total Knee Arthroplasty Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Total knee arthroplasty; MEDLINE; Total knee replacement; Physical activity","score_opus":0.023128832904976106,"score_gpt":0.3205867209214541,"score_spread":0.29745788801647804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98627627,0.0018441111,0.00007494591,0.008620755,0.0008264539,0.0018421372,0.000036019606,0.00017530566,0.00030399815],"genre_scores_gemma":[0.9943581,0.000077706994,0.0015776777,0.0024376335,0.00005126033,0.00018723999,0.000014567949,0.000038141403,0.0012576303],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.996951,0.00016047341,0.00105745,0.0006033098,0.0004036241,0.0008241869],"domain_scores_gemma":[0.99857354,0.00030704596,0.00024312006,0.0004837019,0.000078393285,0.00031421133],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004329702,0.00034782622,0.0008875374,0.00026750335,0.00023032671,0.00004981634,0.000044307762,0.0001475568,0.000031151194],"category_scores_gemma":[0.0007010297,0.00029325442,0.00011819024,0.000504121,0.00024613267,0.00013745356,0.00017278986,0.00051269936,0.000025925616],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039691408,0.00042574067,0.98903,0.0009276368,0.0001067094,0.00012704787,0.003358325,0.00014704012,0.000020299814,0.00019800919,0.0016246315,0.0036376617],"study_design_scores_gemma":[0.004264981,0.00051683484,0.9855921,0.00080011354,0.000031343738,0.0002010734,0.001805457,0.00047863353,0.000037422113,0.000106498665,0.005935305,0.00023022441],"about_ca_topic_score_codex":0.0012985424,"about_ca_topic_score_gemma":0.0010011571,"teacher_disagreement_score":0.008081868,"about_ca_system_score_codex":0.00024276847,"about_ca_system_score_gemma":0.00084148627,"threshold_uncertainty_score":0.99995196},"labels":[],"label_agreement":null},{"id":"W4417481095","doi":"10.1016/j.jval.2025.09.1774","title":"HSD114 Treatment Characteristics of Breast Cancer Patients per HER2/HR Status in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Breast cancer; Cancer; MEDLINE; Real world evidence","score_opus":0.08004581664081484,"score_gpt":0.41839420921166537,"score_spread":0.33834839257085053,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481095","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9751299,0.0017666871,0.000021707445,0.012282784,0.00013088589,0.0011278751,0.009438674,0.00001274063,0.00008874822],"genre_scores_gemma":[0.96005756,0.034792997,0.00015497507,0.0016358856,0.000043959808,0.00014519262,0.0030224137,0.000016789063,0.0001302316],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99509656,0.0021897473,0.0011074793,0.0005156021,0.0003620192,0.00072857615],"domain_scores_gemma":[0.99654245,0.0020726242,0.00031157627,0.00067678146,0.0001814276,0.00021511884],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004189945,0.00021049779,0.0009581421,0.0010192312,0.000072357885,0.000009426154,0.00015140633,0.00009038351,0.000073963136],"category_scores_gemma":[0.0009451906,0.00014566194,0.00007016259,0.002418682,0.00020840012,0.00003701331,0.00007964709,0.00039570619,0.0000019913407],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011264334,0.00058550003,0.98470646,0.0005632099,0.00020780768,0.000014095707,0.0019402866,0.00062951335,0.0000039315737,0.000053947108,0.0018036194,0.00836522],"study_design_scores_gemma":[0.003032535,0.00054583803,0.97414196,0.0004010126,0.000067923735,0.000002098903,0.0005191917,0.009926963,0.0000022939043,0.000026398875,0.011241826,0.00009193438],"about_ca_topic_score_codex":0.31246483,"about_ca_topic_score_gemma":0.015884524,"teacher_disagreement_score":0.29658028,"about_ca_system_score_codex":0.001250188,"about_ca_system_score_gemma":0.0011893644,"threshold_uncertainty_score":0.8863937},"labels":[],"label_agreement":null},{"id":"W4417481121","doi":"10.1016/j.jval.2025.09.245","title":"CO143 Importance of Adjudication Committees in Retrospective Chart Review Studies for Outcomes Event Data Collection","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Meta-analysis and systematic reviews","field":"Decision Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Adjudication; Data collection; Event data; Chart","score_opus":0.848705380411406,"score_gpt":0.6368005529917615,"score_spread":0.21190482741964445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481121","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09419659,0.71734565,0.017917795,0.14834906,0.0018241948,0.018504743,0.00032410858,0.000017832399,0.0015199994],"genre_scores_gemma":[0.8783332,0.09565882,0.011565612,0.007851361,0.00005693983,0.0009995792,0.000100420286,0.00001915702,0.0054148855],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9815261,0.005838539,0.009995071,0.0008463489,0.0015871556,0.00020679539],"domain_scores_gemma":[0.9860604,0.005232933,0.0048153563,0.0031217579,0.0007342587,0.00003532015],"candidate_categories":["metaresearch"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.11614315,0.0001490524,0.0036192439,0.00044516093,0.00008361967,0.000030211786,0.0010344783,0.000036769175,0.0001005961],"category_scores_gemma":[0.07656105,0.00008432631,0.0003256134,0.0026722138,0.000039856,0.00014549328,0.00014463675,0.0001052788,0.000017677403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000057290936,0.00008131011,0.80899143,0.0026519003,0.000092401795,1.8887292e-7,0.0003307885,0.00006882934,9.3663346e-7,0.004465459,0.17976892,0.0035421199],"study_design_scores_gemma":[0.0005372551,0.000104946776,0.89784324,0.005419552,0.00010816642,7.903624e-7,0.0010518543,0.019257626,0.0000044727503,0.03068339,0.044850636,0.00013806726],"about_ca_topic_score_codex":0.00037532937,"about_ca_topic_score_gemma":0.0012933951,"teacher_disagreement_score":0.78413665,"about_ca_system_score_codex":0.00029617484,"about_ca_system_score_gemma":0.00029600962,"threshold_uncertainty_score":0.9312175},"labels":[],"label_agreement":null},{"id":"W4417481186","doi":"10.1016/j.jval.2025.09.159","title":"CO57 Comparative Efficacy of First-Line (1L) Therapies for Patients With Asymptomatic/Mildly Symptomatic Metastatic Castration-Resistant Prostate Cancer (mCRPC): An Updated Systematic Literature Review (SLR) and Bayesian Network Meta-Analyses (NMAs)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Prostate cancer; Systematic review; Clinical trial; Bayesian network; Clinical Practice; Meta-analysis","score_opus":0.11106918028399532,"score_gpt":0.4253436144722152,"score_spread":0.3142744341882199,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481186","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.35776755,0.6129913,0.0004445022,0.0049328515,0.00010509543,0.023052497,0.00059887493,0.000072118426,0.00003522851],"genre_scores_gemma":[0.96414495,0.02658579,0.0053653726,0.00063167425,0.000026749422,0.0020452063,0.00092708704,0.000042622643,0.00023057299],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9962091,0.0008766672,0.0014554814,0.00047096083,0.00050818344,0.0004796036],"domain_scores_gemma":[0.99722886,0.000803056,0.0007046621,0.0004828145,0.0005794,0.00020121381],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011725447,0.00040273895,0.00249904,0.00029448126,0.00020048575,0.00006175168,0.00012970972,0.00005592106,0.000026947617],"category_scores_gemma":[0.00012108167,0.00022711576,0.0001713531,0.0013049549,0.00013015118,0.00018303923,0.000023965953,0.00019839205,5.0196246e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0047269235,0.0031000962,0.032494184,0.9085848,0.026505971,0.00004056978,0.012284986,0.008608156,0.000046789395,0.0010252636,0.0017731118,0.00080919015],"study_design_scores_gemma":[0.040642425,0.015332163,0.073152244,0.73846155,0.041494515,0.000029088253,0.0019047827,0.08515309,0.00036672963,0.0017502266,0.00036293428,0.0013502174],"about_ca_topic_score_codex":0.00040709515,"about_ca_topic_score_gemma":0.00041147665,"teacher_disagreement_score":0.60637736,"about_ca_system_score_codex":0.00025146862,"about_ca_system_score_gemma":0.00062673975,"threshold_uncertainty_score":0.9261512},"labels":[],"label_agreement":null},{"id":"W4417481206","doi":"10.1016/j.jval.2025.09.1958","title":"HTA173 Health Technology Assessment (HTA) Systems and Risk Identification Strategies: A Comparative Analysis Across Western European Countries, Canada, and Australia","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Reimbursement; Health technology; Christian ministry; Identification (biology); Action plan; Risk assessment; Technology assessment; Plan (archaeology)","score_opus":0.3248788019343251,"score_gpt":0.4840225715622174,"score_spread":0.15914376962789228,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481206","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9542001,0.00984428,0.006771058,0.025666011,0.00051201455,0.0013265426,0.0014269432,0.000047991573,0.00020507397],"genre_scores_gemma":[0.995616,0.0019384885,0.00040647856,0.0014406964,0.00004622764,0.00008110919,0.00007032368,0.000012881717,0.00038778267],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921142,0.0016352067,0.004695613,0.0008107023,0.00012377254,0.0006205053],"domain_scores_gemma":[0.99534285,0.00063009514,0.0031869074,0.00054060406,0.000079967554,0.00021958929],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.022564609,0.0002301553,0.0015061727,0.0007705536,0.0004837597,0.00029228657,0.00022836322,0.00010584641,0.000011661624],"category_scores_gemma":[0.00027201392,0.00029519122,0.000039169925,0.0009807984,0.00014264588,0.00029521988,0.00007651553,0.00035388875,0.000024588677],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000006144724,0.00003952799,0.89100176,0.001092015,0.00022965144,0.0000011877406,0.0030757796,0.008484617,1.3273419e-7,0.09393901,0.0020499546,0.00008024087],"study_design_scores_gemma":[0.00064564805,0.000082317376,0.94344276,0.00023606588,0.000017726097,0.0000031299005,0.016810946,0.021907,1.9165877e-7,0.0013912056,0.015231012,0.00023197207],"about_ca_topic_score_codex":0.9095146,"about_ca_topic_score_gemma":0.7694127,"teacher_disagreement_score":0.14010188,"about_ca_system_score_codex":0.0024595591,"about_ca_system_score_gemma":0.0018990799,"threshold_uncertainty_score":0.99995005},"labels":[],"label_agreement":null},{"id":"W4417481242","doi":"10.1016/j.jval.2025.09.2620","title":"PCR147 Is There a Lack of Dietary Data Collection in Real-World IBD Studies? Literature Review and Future Considerations","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Inflammatory bowel disease; Observational study; Data collection; Disease; Inflammatory Bowel Diseases; Crohn disease","score_opus":0.08068206926287089,"score_gpt":0.38445614192305777,"score_spread":0.30377407266018686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481242","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.292239,0.6818827,0.0000039271185,0.0225397,0.00029862236,0.0014962769,0.000317766,0.000012773607,0.0012092376],"genre_scores_gemma":[0.16445889,0.82205415,0.00093347277,0.010985134,0.00016176385,0.000065518085,0.0003944537,0.000017031212,0.0009296032],"study_design_codex":"not_applicable","study_design_gemma":"observational","domain_scores_codex":[0.99885625,0.0002878075,0.00036779046,0.0002992772,0.00005713592,0.00013171839],"domain_scores_gemma":[0.9992692,0.000031198953,0.00010034214,0.00048377668,0.000076832584,0.000038649225],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047566718,0.00010147131,0.00023330872,0.00009306225,0.000057970497,0.0000088145425,0.00008472864,0.00006899525,0.000008313258],"category_scores_gemma":[0.0001367373,0.00009451952,0.00002255526,0.00032865425,0.000043620938,0.0000074271593,0.00011715137,0.00012353646,4.490778e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006366478,0.00067475357,0.24486102,0.06781812,0.0005394863,0.00026166104,0.0036705665,0.0002062098,0.0015609561,0.008550565,0.66660565,0.0046143816],"study_design_scores_gemma":[0.0031277142,0.00032994777,0.85706115,0.017745296,0.00017594898,0.000025505062,0.00077886943,0.0013357282,0.0004066294,0.0042064507,0.1141818,0.00062495266],"about_ca_topic_score_codex":0.00024116797,"about_ca_topic_score_gemma":0.0022559797,"teacher_disagreement_score":0.61220014,"about_ca_system_score_codex":0.00003668108,"about_ca_system_score_gemma":0.00041436838,"threshold_uncertainty_score":0.38543943},"labels":[],"label_agreement":null},{"id":"W4417481250","doi":"10.1016/j.jval.2025.09.081","title":"P42 A Systematic Review of Economic Modeling Challenges and Proposed Solutions for Rare Disease Technologies: An HTAi RDIG Initiative","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Notre-Dame","funders":"","keywords":"Rare disease; Health technology; Systematic review; Work (physics); Rare events; Population; Economic evaluation","score_opus":0.5853046093798203,"score_gpt":0.46045324594064796,"score_spread":0.12485136343917236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481250","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0088608265,0.8410516,0.010524746,0.12771809,0.00035243123,0.01001082,0.0008821214,0.00015168612,0.00044770978],"genre_scores_gemma":[0.8003708,0.18472852,0.005063837,0.007918221,0.00006962909,0.0016742018,0.000079087346,0.000051012,0.000044693035],"study_design_codex":"systematic_review","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9936169,0.0006209958,0.0046820445,0.00058106804,0.000049330294,0.0004496706],"domain_scores_gemma":[0.9961845,0.0011017955,0.0018721289,0.00063750945,0.00007276719,0.00013126012],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017830594,0.00018989005,0.0017613536,0.0005813934,0.00018594312,0.000021774755,0.00026759677,0.00011331862,0.000006152075],"category_scores_gemma":[0.0062807137,0.00022484218,0.00010529492,0.00015044393,0.00007195772,0.00035667655,0.00007599946,0.00014222522,0.000018566087],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012581639,0.00008592566,0.00021802085,0.6027039,0.000044580363,1.9152284e-7,0.001249137,0.003168575,4.443159e-8,0.39219907,0.0001597147,0.00015823945],"study_design_scores_gemma":[0.00094259274,0.00018776419,0.00024752796,0.15002042,0.00003345615,0.0000014362339,0.006995275,0.65559644,5.029423e-7,0.18538833,0.00027028428,0.00031596152],"about_ca_topic_score_codex":0.0005898411,"about_ca_topic_score_gemma":0.00012208696,"teacher_disagreement_score":0.79151,"about_ca_system_score_codex":0.0009360738,"about_ca_system_score_gemma":0.00094333553,"threshold_uncertainty_score":0.91687983},"labels":[],"label_agreement":null},{"id":"W4417481252","doi":"10.1016/j.jval.2025.09.2756","title":"RWD6 A Record-Level Risk Metric for Partially Synthetic Clinical Data Using Inverse-Square Similarity Decay","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Privacy-Preserving Technologies in Data","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Institute for Energy Training","funders":"","keywords":"Pairwise comparison; Metric (unit); Similarity (geometry); Synthetic data; Confidence interval","score_opus":0.3608035342835096,"score_gpt":0.43693002632169853,"score_spread":0.07612649203818894,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481252","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.020813825,0.0007471012,0.95137745,0.023040503,0.0018609932,0.0010592587,0.0005322741,0.00051254244,0.000056040437],"genre_scores_gemma":[0.07409601,0.0010326469,0.9236734,0.0010331484,0.00006688756,0.000034191627,0.00003496263,0.000019518731,0.000009263757],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99501723,0.0010880867,0.0013079685,0.0014435026,0.0003483524,0.0007948769],"domain_scores_gemma":[0.97889906,0.004325445,0.0005415431,0.015951952,0.000115680254,0.00016631458],"candidate_categories":["metaresearch","open_science"],"consensus_categories":["open_science"],"category_scores_codex":[0.009458101,0.00023463505,0.0005820373,0.0006719734,0.00029956314,0.00014458758,0.027741244,0.00029160446,0.000003876108],"category_scores_gemma":[0.10576316,0.00023923398,0.0000967519,0.0025228886,0.00014825533,0.0006512448,0.05475678,0.00077249564,0.0000091631555],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011361853,0.000858578,0.14240222,0.0011528846,0.00013731065,0.000034956734,0.0001360427,0.004559894,0.000009053756,0.012169718,0.21754235,0.62088335],"study_design_scores_gemma":[0.0005804011,0.00012395486,0.0038292948,0.00033734116,0.00001623717,0.0000029421765,0.00002208302,0.8911034,0.000044167627,0.09566711,0.00807954,0.00019357356],"about_ca_topic_score_codex":0.0055493177,"about_ca_topic_score_gemma":0.00090455095,"teacher_disagreement_score":0.88654345,"about_ca_system_score_codex":0.00041652372,"about_ca_system_score_gemma":0.0016295492,"threshold_uncertainty_score":0.97751915},"labels":[],"label_agreement":null},{"id":"W4417481256","doi":"10.1016/j.jval.2025.09.1993","title":"HTA208 Integrating Real-World Evidence for Advanced Therapies in Inflammatory Bowel Disease Into Reimbursement Submissions: Insights and Considerations From the UK","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Inflammatory bowel disease; Reimbursement; Inflammatory Bowel Diseases; Disease; MEDLINE; Infliximab","score_opus":0.030052203194830214,"score_gpt":0.333570141311032,"score_spread":0.3035179381162018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9819744,0.011735586,0.00027693802,0.0044722515,0.00016008916,0.0012881554,0.000023037099,0.000014019093,0.000055517965],"genre_scores_gemma":[0.9933322,0.0020947214,0.00198451,0.0019114406,0.00009067777,0.00044132222,0.00004871214,0.000014476008,0.00008193956],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983822,0.0003425278,0.000522837,0.0004069868,0.00010776485,0.00023770255],"domain_scores_gemma":[0.9987306,0.0005105526,0.00013322612,0.00042631326,0.00007153385,0.00012780153],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00054143334,0.00016842799,0.00015053884,0.00010579686,0.00026335026,0.000049175942,0.00013439667,0.000058203514,0.0000058551805],"category_scores_gemma":[0.0010774602,0.00013363376,0.00004844984,0.00010887822,0.000107156186,0.000015363976,0.00009515549,0.00013916708,6.1059364e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014929731,0.00014837107,0.9210709,0.00068946095,0.00007170274,0.000048042584,0.0047148797,0.0056714546,0.012846428,0.046631567,0.002927646,0.003686618],"study_design_scores_gemma":[0.0014950872,0.00007319721,0.9562175,0.0021705772,0.000017379107,2.8983948e-7,0.001274551,0.0032940966,0.0008684837,0.031091115,0.0032357755,0.0002619088],"about_ca_topic_score_codex":0.0018869656,"about_ca_topic_score_gemma":0.008077601,"teacher_disagreement_score":0.035146683,"about_ca_system_score_codex":0.00011731461,"about_ca_system_score_gemma":0.0011368089,"threshold_uncertainty_score":0.5449426},"labels":[],"label_agreement":null},{"id":"W4417481269","doi":"10.1016/j.jval.2025.09.977","title":"EE595 Obstructive Sleep Apnea (OSA) Phenotypes and the Personalized Impact of Positive Airway Pressure (PAP) Therapy on Healthcare Resource Use","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Obstructive Sleep Apnea Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Greenfield Research (Canada)","funders":"","keywords":"Obstructive sleep apnea; Continuous positive airway pressure; Disease; Health care; Positive airway pressure; Resource use; Resource (disambiguation)","score_opus":0.033670800100909004,"score_gpt":0.3457973608278947,"score_spread":0.3121265607269857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481269","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9627529,0.011532863,0.00008274821,0.021214975,0.000110950445,0.003229584,0.00028192517,0.00003888317,0.0007552177],"genre_scores_gemma":[0.99747807,0.00054469,0.0003451561,0.0011822016,0.00007456751,0.00006034074,0.000027518601,0.000035469366,0.00025196298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9959544,0.0017841678,0.00054653134,0.0005295955,0.0006001438,0.00058518775],"domain_scores_gemma":[0.996695,0.0019979002,0.00023796035,0.0005577089,0.00028124228,0.00023023205],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012602413,0.00028339328,0.00081576797,0.00038382175,0.00020943675,0.00003123956,0.0001916355,0.0001537037,0.00003604145],"category_scores_gemma":[0.0007109743,0.00018119023,0.00019529295,0.00073089986,0.00071109226,0.00009782185,0.00008694749,0.0007929948,0.0000024093872],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.10301663,0.0016125715,0.38690585,0.0036368642,0.0038398919,0.000077910765,0.07447468,0.0044303625,0.0015401525,0.1638694,0.00073132454,0.25586438],"study_design_scores_gemma":[0.021368742,0.0033745742,0.94898176,0.0010509831,0.000081590144,0.000033723067,0.0027994467,0.01749618,0.0010533504,0.002020411,0.0014656085,0.0002736233],"about_ca_topic_score_codex":0.017681306,"about_ca_topic_score_gemma":0.000051334926,"teacher_disagreement_score":0.5620759,"about_ca_system_score_codex":0.00048244023,"about_ca_system_score_gemma":0.0004183211,"threshold_uncertainty_score":0.98886},"labels":[],"label_agreement":null},{"id":"W4417481284","doi":"10.1016/j.jval.2025.09.2610","title":"PCR137 Improving Time to Patient: Insights From the Canadian Cancer Treatment Hackathons","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical and Engineering Education","field":"Engineering","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute of Mining, Metallurgy and Petroleum","funders":"","keywords":"Reimbursement; Process (computing); Cancer treatment; Key (lock); Cancer drugs","score_opus":0.012600924467720464,"score_gpt":0.22758963444119543,"score_spread":0.21498870997347497,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481284","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9445912,0.010606031,0.0007726022,0.035638787,0.0039319936,0.0010974199,0.0001845764,0.00032040616,0.0028569433],"genre_scores_gemma":[0.99771667,0.000101532816,0.0005173342,0.0011442746,0.00012869353,0.00011505549,0.000022505808,0.000013853186,0.00024010234],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99942404,0.00002262872,0.00015504943,0.00011340345,0.00006035189,0.00022453174],"domain_scores_gemma":[0.9995951,0.00006178492,0.0000090734875,0.00015013578,0.0000084469775,0.00017546376],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000045911358,0.000083245905,0.00009822455,0.00010612838,0.00007968654,0.000018595856,0.00007635916,0.000049420323,0.000040507344],"category_scores_gemma":[0.00001885626,0.00006127287,0.000015615151,0.00030959444,0.000007853112,0.000020810796,0.000007875726,0.00009389727,0.00006753302],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000058034093,0.00007170965,0.0011549973,0.00029428664,0.000066714725,0.000005081256,0.014725544,0.33762568,0.00061100005,0.00084197574,0.032221165,0.61237603],"study_design_scores_gemma":[0.00035986395,0.000102219274,0.04179709,0.0007023674,0.000012463216,5.2616355e-7,0.00014848512,0.3859198,0.00045523694,0.0006032096,0.56961757,0.00028116044],"about_ca_topic_score_codex":0.7836181,"about_ca_topic_score_gemma":0.2873233,"teacher_disagreement_score":0.6120949,"about_ca_system_score_codex":0.0014048513,"about_ca_system_score_gemma":0.00050727854,"threshold_uncertainty_score":0.7256812},"labels":[],"label_agreement":null},{"id":"W4417481294","doi":"10.1016/j.jval.2025.09.710","title":"EE326 Development and Validation of a Novel Patient Microsimulation Cost-Effectiveness Model to Evaluate Automated Insulin Delivery Systems in Type 2 Diabetes","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Type 2 diabetes; Microsimulation; Insulin delivery; Diabetes mellitus; Delivery system","score_opus":0.08906174192864924,"score_gpt":0.37666497209969374,"score_spread":0.2876032301710445,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481294","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99544513,0.00095332734,0.00042196506,0.00017706168,0.00012047501,0.0027900834,0.000004133522,0.000034188568,0.00005360465],"genre_scores_gemma":[0.99842316,0.00004714473,0.0012248098,0.0001025514,0.0000041754506,0.00012148122,0.000038534166,0.00000908053,0.000029045534],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99861485,0.00021158064,0.0004659947,0.00022060079,0.00024428873,0.00024268824],"domain_scores_gemma":[0.9993966,0.00017083992,0.00007951923,0.000121298835,0.00016679514,0.0000649065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016635885,0.000093765855,0.0002947382,0.00062750734,0.000033350803,0.000014429501,0.000043799537,0.00005308789,8.0413133e-7],"category_scores_gemma":[0.00017142111,0.0000863883,0.000012266771,0.00073861214,0.000016169357,0.0000510653,0.00007255538,0.00008966778,0.0000020914736],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026660797,0.000411931,0.07793195,0.0036168268,0.000030296273,8.1929846e-7,0.0009372451,0.8845058,0.005249226,0.00014991956,0.00003507427,0.02686428],"study_design_scores_gemma":[0.0017987927,0.00020469088,0.1338826,0.002410352,0.000006953414,4.863246e-8,0.000052089577,0.8579429,0.0035363783,0.000019128589,0.000086611435,0.000059466645],"about_ca_topic_score_codex":0.00045384205,"about_ca_topic_score_gemma":0.000010108263,"teacher_disagreement_score":0.05595065,"about_ca_system_score_codex":0.00046748883,"about_ca_system_score_gemma":0.00043910425,"threshold_uncertainty_score":0.35228127},"labels":[],"label_agreement":null},{"id":"W4417481307","doi":"10.1016/j.jval.2025.09.529","title":"EE145 Comparison of Time-Driven Activity-Based Costs Incurred by Patients and Caregivers Related to Intravitreal Injections for Retinal Vein Occlusion","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Retinal Diseases and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Heart Institute; Toronto Rehabilitation Institute; University of Toronto; Hôpital du Sacré-Cœur de Montréal; Roche (Canada)","funders":"","keywords":"Retinal Vein; Occlusion; Retinal; Central retinal vein occlusion; Branch retinal vein occlusion","score_opus":0.01256123840818585,"score_gpt":0.3394553903704145,"score_spread":0.32689415196222865,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481307","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99613947,0.00016391918,0.00012257052,0.0016110847,0.00009129826,0.0014285723,0.000248785,0.000020641368,0.00017364457],"genre_scores_gemma":[0.99907243,0.000025317271,0.00040438987,0.00013392787,0.0000043749633,0.000029686722,0.00022989334,0.000010204169,0.00008975221],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99896395,0.00012164281,0.0003117169,0.00024692315,0.00015656336,0.00019921082],"domain_scores_gemma":[0.9993059,0.00016697771,0.00012896517,0.00013113277,0.000091097296,0.00017590805],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001106087,0.00011494362,0.0003521741,0.00021175877,0.00010060016,0.0000057352513,0.000039552142,0.00006896206,0.000005000132],"category_scores_gemma":[0.00012543624,0.00010964484,0.000050431714,0.00032898918,0.000037664293,0.000028596412,0.000030070214,0.00011297561,0.0000021739263],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0034928122,0.002392075,0.96393824,0.00082228234,0.00007107508,0.000004204479,0.0009675259,0.00079923635,0.0009023726,0.000070507005,0.0054550986,0.021084573],"study_design_scores_gemma":[0.01212249,0.0070526307,0.9338971,0.0022872973,0.00016534224,0.0000016735106,0.00031056674,0.04181248,0.0011052032,0.00009963635,0.00095364556,0.00019194525],"about_ca_topic_score_codex":0.004907984,"about_ca_topic_score_gemma":0.000040975447,"teacher_disagreement_score":0.04101324,"about_ca_system_score_codex":0.00047753743,"about_ca_system_score_gemma":0.00029160938,"threshold_uncertainty_score":0.7419436},"labels":[],"label_agreement":null},{"id":"W4417481329","doi":"10.1016/j.jval.2025.09.3307","title":"MSR16 Advancing the Science of Qualitative Patient Preference Assessment Using Large Language Models","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Patient-Provider Communication in Healthcare","field":"Health Professions","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Preference; Language understanding; Qualitative research; Preference elicitation; Qualitative analysis","score_opus":0.4773357941813946,"score_gpt":0.5643687605175031,"score_spread":0.08703296633610846,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97347987,0.0054009855,0.006327502,0.006293037,0.000900207,0.003486649,0.00010910484,0.0000699672,0.003932679],"genre_scores_gemma":[0.9828842,0.00016614533,0.015028637,0.0016128751,0.00001552281,0.00023198703,0.000008077557,0.000013871346,0.000038626335],"study_design_codex":"qualitative","study_design_gemma":"qualitative","domain_scores_codex":[0.9911354,0.005467372,0.0015016646,0.00039129533,0.00061234273,0.0008919293],"domain_scores_gemma":[0.9945681,0.0028048996,0.0008573548,0.0011446691,0.0004885601,0.00013638202],"candidate_categories":["sts"],"consensus_categories":[],"category_scores_codex":[0.0049659847,0.00015466237,0.00037954334,0.00038755412,0.0014466584,0.000008665336,0.0007142794,0.00008664573,0.000018266946],"category_scores_gemma":[0.001098334,0.00012101128,0.00004070355,0.0015164248,0.00022618615,0.0003056564,0.000612413,0.0009420929,0.0000036264155],"study_design_candidate":"qualitative","study_design_consensus":"qualitative","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005669561,0.00026548968,0.010412343,0.0027241847,0.000012839415,7.2789504e-7,0.7227622,0.033820424,0.0005947183,0.226779,0.00018284954,0.0023884918],"study_design_scores_gemma":[0.0010265749,0.00018831377,0.0056218407,0.0052370364,0.0000073014303,4.076482e-7,0.59005207,0.37431994,0.00014328545,0.022904383,0.0003078177,0.00019103299],"about_ca_topic_score_codex":0.025563732,"about_ca_topic_score_gemma":0.0006439335,"teacher_disagreement_score":0.34049952,"about_ca_system_score_codex":0.0020513474,"about_ca_system_score_gemma":0.007906601,"threshold_uncertainty_score":0.9998533},"labels":[],"label_agreement":null},{"id":"W4417481338","doi":"10.1016/j.jval.2025.09.1063","title":"EE682 Targeted Literature Review Informing Economic Model Structures in Atherosclerotic Cardiovascular Disease","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Atherosclerosis and Cardiovascular Diseases","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Novartis (Canada); EVERSANA (Canada)","funders":"","keywords":"Disease; Atherosclerotic cardiovascular disease; Economic model; MEDLINE; Targeted therapy","score_opus":0.017294943330443995,"score_gpt":0.25238284496015145,"score_spread":0.23508790162970747,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481338","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.16525562,0.832171,0.00023225715,0.00055909203,0.00042484177,0.0010432086,0.00010993153,0.00005624309,0.00014775245],"genre_scores_gemma":[0.8361304,0.16156766,0.0001026692,0.0017079083,0.00002309998,0.00013014064,0.00015598636,0.000024502304,0.00015763327],"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","domain_scores_codex":[0.99766314,0.00056683837,0.00068209553,0.0004968838,0.00006672884,0.000524342],"domain_scores_gemma":[0.9989598,0.000053040836,0.00010357643,0.00078711647,0.000027541657,0.00006894016],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009727921,0.00027080116,0.000817781,0.00023650202,0.0001176742,0.000025430974,0.00028623632,0.0001709275,0.00003902099],"category_scores_gemma":[0.000108195236,0.00024843356,0.00060947903,0.0003457322,0.000075122305,0.00014133257,0.00009672092,0.00040330488,0.00003389176],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024139261,0.00030086114,0.020391846,0.013300444,0.0017719812,0.00003623225,0.0012079485,0.88054276,0.0005642478,0.017208437,0.004409667,0.0600242],"study_design_scores_gemma":[0.022816954,0.00036196588,0.6095249,0.13970333,0.0017818084,0.0000772334,0.000730833,0.045264643,0.00097198715,0.030041493,0.14448272,0.0042421604],"about_ca_topic_score_codex":0.0007033049,"about_ca_topic_score_gemma":0.000020544232,"teacher_disagreement_score":0.8352781,"about_ca_system_score_codex":0.0003474815,"about_ca_system_score_gemma":0.00064093666,"threshold_uncertainty_score":0.9999968},"labels":[],"label_agreement":null},{"id":"W4417481350","doi":"10.1016/j.jval.2025.09.3481","title":"MSR205 Transportability of Overall Survival Estimates From the United States to Germany in eGFR+ Advanced NSCLC Patients Post-Tyrosine Kinase Inhibitor (TKI) Treatment","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario","funders":"","keywords":"Overall survival; German; Lung cancer; Medical record; MEDLINE; Health records","score_opus":0.01765356673892164,"score_gpt":0.33530550878238613,"score_spread":0.3176519420434645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9871426,0.0007863283,0.00002672596,0.009141342,0.00024231715,0.0018113939,0.00075576047,0.000026650849,0.000066886154],"genre_scores_gemma":[0.99583554,0.0002605602,0.0008338125,0.0015494251,0.000019526158,0.0001227163,0.0013155312,0.00001542246,0.000047472735],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984406,0.00012952871,0.00063220976,0.000314615,0.00019513976,0.0002879094],"domain_scores_gemma":[0.9988549,0.00041836544,0.000107782835,0.0003394439,0.00015716426,0.00012237082],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018034175,0.0001870063,0.00044650113,0.00019714586,0.000059411734,0.0000073679375,0.00007050355,0.000047796562,0.000023992212],"category_scores_gemma":[0.00012179079,0.00012749727,0.00006342922,0.000553033,0.000043406322,0.000054652628,0.000014473138,0.00010324371,0.0000022547247],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015125013,0.0029927376,0.96548694,0.00028831867,0.00010911037,0.00001384992,0.009120177,0.012188136,0.00022943727,0.0004269912,0.00011590373,0.0075158803],"study_design_scores_gemma":[0.0074920533,0.001184054,0.98625886,0.000874428,0.00006954408,1.4672645e-7,0.0005566497,0.00083328504,0.000994781,0.00033183282,0.0013095625,0.00009480003],"about_ca_topic_score_codex":0.1451441,"about_ca_topic_score_gemma":0.0051925653,"teacher_disagreement_score":0.13995154,"about_ca_system_score_codex":0.0011493947,"about_ca_system_score_gemma":0.0005847907,"threshold_uncertainty_score":0.86054844},"labels":[],"label_agreement":null},{"id":"W4417481378","doi":"10.1016/j.jval.2025.09.428","title":"EE44 All-Cause Healthcare Resource Use in Recurrent Respiratory Papillomatosis: A Claims-Based Comparison With Matched Controls","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cervical Cancer and HPV Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Recurrent Respiratory Papillomatosis; Resource use; Health care; Respiratory system; Disease; Human papillomavirus; Disease control","score_opus":0.15961040604483132,"score_gpt":0.422769252663708,"score_spread":0.2631588466188767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481378","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9098769,0.01973456,0.00015201977,0.064288415,0.00016660214,0.004430319,0.000051071976,0.00017967676,0.0011204686],"genre_scores_gemma":[0.9833531,0.00029912998,0.0003077836,0.015532529,0.000064741165,0.00029881374,0.000034105407,0.000037220387,0.000072622104],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9957999,0.001002086,0.0010392127,0.0006024784,0.000678421,0.00087788264],"domain_scores_gemma":[0.9978487,0.00068973366,0.0001596112,0.00066312903,0.00016024821,0.0004786145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017219257,0.00025120535,0.0009742247,0.0006656246,0.00008937509,0.00004434037,0.00017916832,0.00017838275,0.00008216378],"category_scores_gemma":[0.0002587301,0.00021089034,0.00007733078,0.0011534947,0.00010689544,0.000065962886,0.0000559886,0.0011385254,0.000012379338],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.014349714,0.0015747912,0.93219787,0.0066266214,0.00012359819,0.00018438694,0.001422684,0.0023058222,0.000057623376,0.0025398352,0.0063886247,0.032228403],"study_design_scores_gemma":[0.022842355,0.0044872086,0.847154,0.0050457814,0.000061297476,0.0000064868814,0.0013759858,0.018147891,0.00023454169,0.00029473339,0.099933505,0.00041618053],"about_ca_topic_score_codex":0.012622732,"about_ca_topic_score_gemma":0.008367584,"teacher_disagreement_score":0.09354488,"about_ca_system_score_codex":0.001450724,"about_ca_system_score_gemma":0.0025012526,"threshold_uncertainty_score":0.9939523},"labels":[],"label_agreement":null},{"id":"W4417481393","doi":"10.1016/j.jval.2025.09.299","title":"CO198 Quantifying the Therapeutic Benefit of External Beam Radiotherapy in Uterine Serous Carcinoma: A Real-World Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada); McGill University","funders":"","keywords":"External beam radiotherapy; External beam radiation; Serous fluid; Radiation therapy; Endometrial cancer; Uterine cancer; Adjuvant","score_opus":0.0983298780420549,"score_gpt":0.4044564827645568,"score_spread":0.3061266047225019,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481393","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98752034,0.008817416,0.00004612457,0.001647801,0.00025687684,0.0014147743,0.0000063314587,0.000017741604,0.00027257044],"genre_scores_gemma":[0.9968012,0.0014048486,0.00016673336,0.001045096,0.00007464598,0.000079241945,0.0000022493464,0.000015293268,0.00041068505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99833673,0.00020101255,0.00063517643,0.0002625055,0.0002616837,0.00030286398],"domain_scores_gemma":[0.99909055,0.00032742962,0.000130023,0.00035335048,0.00003221683,0.00006641222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007579416,0.00014840417,0.0005867095,0.00041384026,0.0000508471,0.000008989816,0.00014327347,0.000035467743,0.00004147855],"category_scores_gemma":[0.000021310183,0.00009761951,0.00006953003,0.0013517133,0.000035232308,0.00002732042,0.000032697964,0.00023699627,0.0000011484744],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010331548,0.0011128671,0.97791916,0.00035300982,0.00006217703,0.000036641788,0.0015789837,0.00040162477,0.0002670012,0.0007594717,0.0000043991718,0.016471513],"study_design_scores_gemma":[0.00843946,0.0013910535,0.9876758,0.00042512777,0.00002661612,0.000005256017,0.0003792942,0.00075785775,0.0002453512,0.00036134783,0.00022733734,0.0000655052],"about_ca_topic_score_codex":0.11090178,"about_ca_topic_score_gemma":0.004665562,"teacher_disagreement_score":0.10623622,"about_ca_system_score_codex":0.00053606974,"about_ca_system_score_gemma":0.0002607004,"threshold_uncertainty_score":0.8950188},"labels":[],"label_agreement":null},{"id":"W4417481396","doi":"10.1016/j.jval.2025.09.331","title":"CO230 Systematic Review of Prognostic Factors and Treatment Effect Modifiers for Transthyretin Amyloid Cardiomyopathy","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Transthyretin; Cardiomyopathy; Amyloid (mycology); Treatment effect","score_opus":0.017695493375171234,"score_gpt":0.30100191468617504,"score_spread":0.2833064213110038,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481396","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83827853,0.15428692,0.00023909728,0.0005887755,0.00011643057,0.0063037486,0.000117802105,0.0000142347535,0.000054434797],"genre_scores_gemma":[0.95901215,0.03896236,0.00018125978,0.00030128114,0.000011953141,0.0013553814,0.00010250976,0.000020480544,0.00005264541],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99816024,0.00045728055,0.00061796163,0.00037411685,0.00010395708,0.00028643062],"domain_scores_gemma":[0.9989154,0.000404912,0.0002051272,0.00034762267,0.000040584193,0.000086401255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00062054984,0.00026754857,0.0010065554,0.00009854675,0.00005513583,0.000008036458,0.00010392643,0.0000992307,0.0000016671845],"category_scores_gemma":[0.0005304004,0.00018866391,0.00023622542,0.00014965617,0.000054212825,0.000002747442,0.000020644196,0.000041944717,6.067406e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013510163,0.0003485364,0.28248566,0.7130631,0.00065967225,0.0000035201329,0.0003037096,0.00015884647,0.0011555218,0.00031587863,0.00030306308,0.001067346],"study_design_scores_gemma":[0.024737418,0.031046707,0.11294644,0.6271475,0.0061482647,0.000051301056,0.0014854528,0.0010609822,0.18925424,0.0002583627,0.0033827836,0.0024805772],"about_ca_topic_score_codex":0.0005581903,"about_ca_topic_score_gemma":0.00003106552,"teacher_disagreement_score":0.18809871,"about_ca_system_score_codex":0.00017067716,"about_ca_system_score_gemma":0.00021174166,"threshold_uncertainty_score":0.7693491},"labels":[],"label_agreement":null},{"id":"W4417481417","doi":"10.1016/j.jval.2025.09.3482","title":"MSR206 Transporting Treatment Effects for Survival Outcomes Under Informative Censoring: A Simulation Study Using Summary-Level Data in the Target Population","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Causal Inference Techniques","field":"Mathematics","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"York University; Simon Fraser University","funders":"","keywords":"Censoring (clinical trials); Weighting; Population; Inverse probability weighting; Aggregate data; Data source","score_opus":0.5533582391859345,"score_gpt":0.5444820383462802,"score_spread":0.008876200839654347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481417","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6938322,0.000033955315,0.30165023,0.00023848594,0.000105373896,0.003965913,0.00005813801,0.00008245426,0.000033229026],"genre_scores_gemma":[0.94274175,0.00000739232,0.05687261,0.00009843277,0.000016342503,0.00012744688,0.00010567302,0.000016321057,0.000014040145],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9978336,0.0004516976,0.0009027787,0.00026186075,0.00022929788,0.00032075885],"domain_scores_gemma":[0.99531347,0.0037510607,0.00033265437,0.0005356399,0.00004086597,0.000026332891],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022564156,0.00019749795,0.00047129698,0.00023736706,0.00013652751,0.000026190399,0.00023782178,0.000064707805,7.245128e-7],"category_scores_gemma":[0.0007966927,0.00014537231,0.000039768332,0.00038263976,0.000013790863,0.000389251,0.000041331212,0.0001514914,1.7214616e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011038888,0.0010849228,0.61639935,0.0010620048,0.000059187245,0.0000035111186,0.015175395,0.32190272,0.000008048455,0.039636303,0.0000070475144,0.0045511085],"study_design_scores_gemma":[0.0023292834,0.00043655396,0.38526657,0.00061404466,0.000045504206,3.423785e-7,0.005257261,0.42634442,0.00004684268,0.17939216,0.00003141825,0.00023560143],"about_ca_topic_score_codex":0.0053917044,"about_ca_topic_score_gemma":0.0015447141,"teacher_disagreement_score":0.24890952,"about_ca_system_score_codex":0.00072677294,"about_ca_system_score_gemma":0.00014180191,"threshold_uncertainty_score":0.815068},"labels":[],"label_agreement":null},{"id":"W4417481418","doi":"10.1016/j.jval.2025.09.3405","title":"MSR120 How Chinese Restaurants Can Help With Robust Preference Insights: A Novel Dirichlet Mixture Model to Account for Complex Heterogeneity in Individual Preference Weights","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Sensory Analysis and Statistical Methods","field":"Agricultural and Biological Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Preference; Mixture model; Sample (material); Dirichlet distribution; Key (lock); Latent Dirichlet allocation","score_opus":0.26859798688179776,"score_gpt":0.3470187803756831,"score_spread":0.07842079349388537,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481418","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97701776,0.00014918252,0.014323072,0.006688273,0.000049677237,0.0010065775,0.00068667013,0.00002847592,0.00005032407],"genre_scores_gemma":[0.9533016,0.000053967735,0.04465324,0.0016286622,0.000047810056,0.00012787267,0.0001252767,0.0000021930528,0.000059362836],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99756855,0.00038135357,0.0004690337,0.0006919244,0.0003501008,0.0005390553],"domain_scores_gemma":[0.99846864,0.00090773724,0.00014061786,0.00015062196,0.00011861388,0.00021379667],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007035411,0.00027749315,0.0005836405,0.0000962692,0.0002124277,0.00011386479,0.00046847525,0.00013144268,0.000008599706],"category_scores_gemma":[0.0003664145,0.00010649152,0.0000613374,0.0012944778,0.00005838735,0.000096320546,0.00009865668,0.00025862263,7.072248e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0037867033,0.0045225336,0.390197,0.001721734,0.00032296445,0.000036878944,0.0068804836,0.37146255,0.052755576,0.042066026,0.0024881465,0.123759404],"study_design_scores_gemma":[0.000700382,0.0005713229,0.7874895,0.00035747394,0.000016244825,0.0000017987408,0.0002194457,0.2032163,0.00017078225,0.0060983906,0.0008032823,0.0003551081],"about_ca_topic_score_codex":0.0042283214,"about_ca_topic_score_gemma":0.04384634,"teacher_disagreement_score":0.39729246,"about_ca_system_score_codex":0.0001326298,"about_ca_system_score_gemma":0.000110379886,"threshold_uncertainty_score":0.973601},"labels":[],"label_agreement":null},{"id":"W4417481461","doi":"10.1016/j.jval.2025.09.376","title":"EE753 What Is the Cost of Preventing Tuberculosis a Cost-Effectiveness Analysis of Household Contact Tracing With 3HP Preventive Therapy in High-Burden Areas of Nepal?","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Facilities Design and Sustainability","field":"Social Sciences","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Ottawa","funders":"","keywords":"Contact tracing; Tuberculosis; Tracing; Tuberculosis prevention","score_opus":0.052352439899365596,"score_gpt":0.3593289371448182,"score_spread":0.30697649724545256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481461","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99105066,0.0018729338,0.00038936408,0.0027394223,0.000068039386,0.0036604058,0.00007391138,0.000013682715,0.00013155497],"genre_scores_gemma":[0.99755555,0.002004757,0.00004894795,0.00013937338,0.000010597229,0.0001821278,0.000004545895,0.000008347249,0.000045741133],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9921421,0.0055384133,0.0009681698,0.00036709313,0.00049625145,0.0004879682],"domain_scores_gemma":[0.99490345,0.0038324783,0.00046333895,0.0004051759,0.00030879892,0.00008676355],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008684544,0.00016296595,0.00094884104,0.0005199939,0.00017150518,0.000030320554,0.00030316907,0.00012990259,0.000020278545],"category_scores_gemma":[0.0006560759,0.00012527111,0.00019827526,0.0033069893,0.00030323476,0.00027838082,0.00003599285,0.00026783498,7.1866204e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005836624,0.00040485818,0.8052518,0.0018702411,0.00045937646,0.0000024490278,0.116273515,0.013386609,0.000026420135,0.005173895,0.000006269804,0.056560937],"study_design_scores_gemma":[0.0010346427,0.00044763155,0.8744311,0.003360976,0.00010576223,1.5649077e-7,0.11572044,0.002562503,0.0004540974,0.0015250909,0.0001953458,0.00016229942],"about_ca_topic_score_codex":0.4359035,"about_ca_topic_score_gemma":0.02339291,"teacher_disagreement_score":0.41251057,"about_ca_system_score_codex":0.0009884979,"about_ca_system_score_gemma":0.002031731,"threshold_uncertainty_score":0.9944276},"labels":[],"label_agreement":null},{"id":"W4417481468","doi":"10.1016/j.jval.2025.09.1050","title":"EE668 Spain Leveling Up: A Comparison of Spain’s New National Health Economic Evaluation Guideline With Those of England, France, Germany, Italy, Portugal, Sweden, Ireland, Canada, Australia, and Japan","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Guideline; Christian ministry; Economic evaluation; Health policy; National Policy","score_opus":0.35628606422470666,"score_gpt":0.4598973702311669,"score_spread":0.10361130600646024,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481468","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.919074,0.011628192,0.0030020818,0.061476436,0.001019737,0.0022890412,0.0008524116,0.000021770416,0.00063635013],"genre_scores_gemma":[0.99056596,0.00029432378,0.004301586,0.0037233327,0.00018995529,0.00005074357,0.00017095587,0.000025960131,0.00067719206],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9902953,0.000779397,0.0073781153,0.00067860994,0.00032364685,0.0005449324],"domain_scores_gemma":[0.99374455,0.0010103824,0.004347873,0.00041051462,0.00019559832,0.0002911063],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.029500883,0.00027093713,0.0017066568,0.0007087559,0.00015471496,0.000028583156,0.00024580286,0.0001429252,0.00017033052],"category_scores_gemma":[0.0010694399,0.00032939855,0.000067915986,0.0003300086,0.0000764705,0.000247712,0.000047586087,0.00028379806,0.000019758718],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000102531296,0.00017136999,0.77640605,0.002271971,0.00016526089,4.0812367e-7,0.004304157,0.112548694,0.0000016457416,0.04521895,0.0556183,0.0031906734],"study_design_scores_gemma":[0.009093151,0.0006583166,0.41661623,0.0023859919,0.00002589907,0.000011569915,0.0030834663,0.4882894,0.000012431632,0.011484473,0.06752046,0.00081862183],"about_ca_topic_score_codex":0.83170396,"about_ca_topic_score_gemma":0.47290656,"teacher_disagreement_score":0.3757407,"about_ca_system_score_codex":0.0026270198,"about_ca_system_score_gemma":0.009557711,"threshold_uncertainty_score":0.9999158},"labels":[],"label_agreement":null},{"id":"W4417481473","doi":"10.1016/j.jval.2025.09.3487","title":"MSR212 Use of a Nonparametric Bayesian Method to Model Health State Preferences: An Application to UAE EQ-5D-5L Valuations","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Nonparametric statistics; Bayesian probability; State (computer science); Bayesian inference","score_opus":0.56137335002672,"score_gpt":0.4861612806287469,"score_spread":0.07521206939797304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481473","genre_codex":"methods","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"methods","genre_consensus":"methods","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.06312052,0.00065850804,0.8789138,0.051930208,0.00023475479,0.0040811077,0.0007274351,0.00006887978,0.00026474163],"genre_scores_gemma":[0.3498702,0.00025577485,0.6094856,0.03869721,0.000079137084,0.001036424,0.00010917712,0.000058671758,0.00040778163],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.98893094,0.0019730295,0.0068357796,0.0011792583,0.00023439738,0.0008466231],"domain_scores_gemma":[0.9937031,0.001848273,0.002345067,0.0012084665,0.00018749003,0.00070759293],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.034437697,0.00028954173,0.0015991353,0.0027130346,0.00025277075,0.000094189076,0.0005228963,0.0001509148,0.000031397405],"category_scores_gemma":[0.0035792438,0.00038567316,0.000104641294,0.0027464365,0.00003218984,0.0005505936,0.00010084574,0.00029368827,0.00020258779],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00004490839,0.00034938622,0.011549167,0.0011040189,0.000029687597,7.4091126e-8,0.006817227,0.8327479,0.0000049579367,0.13119437,0.0040788366,0.012079503],"study_design_scores_gemma":[0.0005711216,0.00045825957,0.018753257,0.00035882735,0.0000040336326,7.5118555e-7,0.00044779482,0.89299554,0.0000060338066,0.07868049,0.0074027823,0.00032110847],"about_ca_topic_score_codex":0.05985003,"about_ca_topic_score_gemma":0.004095074,"teacher_disagreement_score":0.2867497,"about_ca_system_score_codex":0.002296615,"about_ca_system_score_gemma":0.0026714595,"threshold_uncertainty_score":0.9998595},"labels":[],"label_agreement":null},{"id":"W4417481479","doi":"10.1016/j.jval.2025.09.346","title":"CO245 The Mirage of Stability: Challenges of Predicting Disease Activity Over Time in Systemic Lupus Erythematosus (SLE)","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Disease; Lupus erythematosus; Connective tissue disease; Systemic disease","score_opus":0.04786949227443706,"score_gpt":0.32901687723359485,"score_spread":0.2811473849591578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481479","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97787267,0.01582906,0.00001716331,0.002599237,0.00028431677,0.0025193084,0.00003835868,0.0000362787,0.0008036289],"genre_scores_gemma":[0.9982679,0.0012515974,0.00003278829,0.000037314196,0.000035964364,0.00009844418,0.0000026401585,0.000024540646,0.0002488],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9958943,0.0012975552,0.0011267044,0.00043659154,0.0007290384,0.0005157879],"domain_scores_gemma":[0.99634606,0.0019526342,0.00038667448,0.0010134001,0.00012585429,0.00017535845],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047099716,0.0001990951,0.000983313,0.00045532515,0.000045926277,0.0000059741337,0.0002655214,0.00011867019,0.00002440861],"category_scores_gemma":[0.001414636,0.00014547858,0.00012552476,0.0007678591,0.00018117625,0.00006885551,0.0001609482,0.00044824064,0.000004691966],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0011996633,0.000562869,0.9428714,0.043415904,0.00006906513,0.000034637942,0.0073862765,0.0003619013,0.0016480234,0.0015693037,0.00013913191,0.0007418613],"study_design_scores_gemma":[0.028368887,0.0022035788,0.4757475,0.18226553,0.0002483441,0.0034131897,0.031064618,0.26629847,0.0049409275,0.0042066514,0.00029547795,0.00094681676],"about_ca_topic_score_codex":0.0027508289,"about_ca_topic_score_gemma":0.00014833373,"teacher_disagreement_score":0.46712387,"about_ca_system_score_codex":0.0009281806,"about_ca_system_score_gemma":0.00187715,"threshold_uncertainty_score":0.59324443},"labels":[],"label_agreement":null},{"id":"W4417481513","doi":"10.1016/j.jval.2025.09.123","title":"CO21 Association Between Invasive Disease-Free Survival/Distant Recurrence-Free Survival and Overall Survival in Patients With Early Stage Triple-Negative Breast Cancer","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Luminex (Canada)","funders":"","keywords":"Overall survival; Breast cancer; Stage (stratigraphy); Surrogate endpoint; Adjuvant; Survival analysis","score_opus":0.016965898952696006,"score_gpt":0.2703437340483931,"score_spread":0.2533778350956971,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481513","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98995143,0.00087946164,0.000028688026,0.0026808584,0.0005001664,0.0009012512,0.004851595,0.00001548735,0.00019104965],"genre_scores_gemma":[0.9977562,0.0012667926,0.000089465226,0.00012275926,0.00011611568,0.00012585282,0.00029908618,0.000028404476,0.00019533777],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972035,0.00060665904,0.00048683648,0.0006872752,0.00045718273,0.00055851636],"domain_scores_gemma":[0.9984525,0.00031970994,0.00033114906,0.0005151436,0.00021197973,0.00016956039],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00061685167,0.0003220059,0.00054579886,0.00013526119,0.00013715062,0.00003723577,0.00028182872,0.0001321769,0.000006567251],"category_scores_gemma":[0.00055274705,0.00029694245,0.000053595355,0.0003679622,0.000098523815,0.000022580856,0.0002958008,0.00022472485,7.359315e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001126258,0.00019477085,0.9965292,0.0001803547,0.00021905456,0.0000029643088,0.00029394252,0.000102947226,0.000004412403,0.00026352823,0.00026451435,0.00081803085],"study_design_scores_gemma":[0.0078692315,0.0002288852,0.99011886,0.00039764383,0.00004136835,6.829559e-8,0.00016913889,0.0000113410115,0.0000418009,0.00070724124,0.00015237983,0.0002620405],"about_ca_topic_score_codex":0.03769555,"about_ca_topic_score_gemma":0.024219986,"teacher_disagreement_score":0.013475565,"about_ca_system_score_codex":0.000912151,"about_ca_system_score_gemma":0.00094818464,"threshold_uncertainty_score":0.99994826},"labels":[],"label_agreement":null},{"id":"W4417481531","doi":"10.1016/j.jval.2025.09.1372","title":"EPH243 The Incidence and Survival of HPV-Positive and HPV-Negative Malignant Head and Neck Squamous Cell Carcinoma (HNSCC) in the United States: A Surveillance Epidemiology and End Results SEER 2000-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Head and Neck Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Surveillance, Epidemiology, and End Results; Incidence (geometry); Epidemiology; Head and neck; Head and neck squamous-cell carcinoma","score_opus":0.048790783977282925,"score_gpt":0.3437473579499198,"score_spread":0.29495657397263686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481531","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9671745,0.021275451,0.000033170247,0.009990137,0.000047829275,0.0007173315,0.0005392792,0.000006438787,0.00021589872],"genre_scores_gemma":[0.9850166,0.012505999,0.00016225367,0.0021312525,0.000021499862,0.00003312518,0.00008234586,0.000007887013,0.000039077397],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99557775,0.0025210918,0.00076891365,0.00049381296,0.00017990779,0.00045854202],"domain_scores_gemma":[0.990631,0.008566218,0.00024356137,0.00033704616,0.00009513503,0.00012702578],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058293263,0.00021246924,0.0009744188,0.0003955415,0.00017593006,0.000009399377,0.000086203225,0.00007054103,0.0000035109556],"category_scores_gemma":[0.0015996386,0.0001302161,0.000031965454,0.0014442273,0.0005012847,0.000057133682,0.00015913216,0.00037413026,1.2097071e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00094650884,0.0000988166,0.97299606,0.000578974,0.000072500065,0.000030893618,0.02330633,0.00018931969,0.000017367485,0.00026718475,0.00023024112,0.0012657882],"study_design_scores_gemma":[0.0026943914,0.00064214226,0.98073125,0.0001894422,0.0000794429,0.000016188673,0.0066141775,0.008492788,0.00003941536,0.0001647492,0.00023024243,0.000105760475],"about_ca_topic_score_codex":0.13081308,"about_ca_topic_score_gemma":0.021844575,"teacher_disagreement_score":0.10896851,"about_ca_system_score_codex":0.00011924571,"about_ca_system_score_gemma":0.0003011464,"threshold_uncertainty_score":0.9960042},"labels":[],"label_agreement":null},{"id":"W4417481533","doi":"10.1016/j.jval.2025.09.350","title":"CO250 Therapeutic Benefit of Radiotherapy in Uterine Serous Carcinoma (USC): A Real-World Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Endometrial and Cervical Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada); McGill University","funders":"","keywords":"Radiation therapy; Serous fluid; Serous carcinoma; Carcinoma","score_opus":0.05664852011188023,"score_gpt":0.38360746414779145,"score_spread":0.32695894403591125,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481533","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99032515,0.004781346,0.00001669379,0.0021591312,0.00021715219,0.0014919671,0.000010188476,0.0000238019,0.0009745801],"genre_scores_gemma":[0.996165,0.0012860992,0.00024996654,0.0011290013,0.000055826913,0.00008128731,0.0000059523445,0.000016268685,0.0010106327],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998376,0.000173705,0.000635591,0.00028584045,0.00022491193,0.00030396605],"domain_scores_gemma":[0.9992372,0.00019746972,0.00010594888,0.00033284293,0.0000339953,0.000092539005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047823435,0.00015017501,0.00068409013,0.0006447772,0.000025218584,0.000004785514,0.00009864167,0.000043672764,0.00007933289],"category_scores_gemma":[0.000018645476,0.00012261211,0.00006175151,0.0017131651,0.000025427908,0.000025375004,0.00002486306,0.00017880695,0.0000017175311],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012905204,0.0017141921,0.9575243,0.00050478877,0.00008482576,0.0000498663,0.0010988616,0.00019381834,0.000064477026,0.0008272438,0.000014869509,0.036632244],"study_design_scores_gemma":[0.012177724,0.002398054,0.98296356,0.00030765164,0.000021375974,0.0000027790725,0.00019816951,0.00037109497,0.00009591782,0.0005636956,0.0008264301,0.0000735227],"about_ca_topic_score_codex":0.109433025,"about_ca_topic_score_gemma":0.0068957107,"teacher_disagreement_score":0.10253732,"about_ca_system_score_codex":0.00074211374,"about_ca_system_score_gemma":0.00032482765,"threshold_uncertainty_score":0.8964973},"labels":[],"label_agreement":null},{"id":"W4417481546","doi":"10.1016/j.jval.2025.09.342","title":"CO241 The Impact of Generalized Anxiety Disorder on Comorbid Conditions: A Systematic Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Comorbidity; Generalized anxiety disorder; Psychiatric comorbidity; Anxiety; Anxiety disorder; Generalized anxiety","score_opus":0.061835820369736685,"score_gpt":0.4327974654228455,"score_spread":0.3709616450531088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481546","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.12930521,0.837878,0.0010975765,0.0064209206,0.0016487404,0.010535804,0.0004891492,0.00015158059,0.012473041],"genre_scores_gemma":[0.747288,0.24812806,0.000061964,0.002880541,0.00003548222,0.00092695147,0.00005243103,0.000024769286,0.0006018047],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9961761,0.0017703014,0.00100183,0.00041441614,0.00025448296,0.00038283062],"domain_scores_gemma":[0.99721813,0.0011440434,0.00059007516,0.0007818681,0.00018288026,0.0000830053],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014388754,0.00025658574,0.000881909,0.0003987834,0.00015124971,0.000016174934,0.00034334007,0.00009355147,0.00041995768],"category_scores_gemma":[0.0010847262,0.00015605886,0.00024031111,0.0019762102,0.000110900684,0.000050970775,0.0000410698,0.00026849846,0.000097456905],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005203215,0.007096332,0.3057286,0.4332861,0.0021033725,0.000012589299,0.0049306015,0.0011695419,0.000011453419,0.046353597,0.18701735,0.011770108],"study_design_scores_gemma":[0.013637728,0.0029131144,0.42295167,0.5107056,0.0010592149,0.00010126512,0.0035016837,0.0014194531,0.00004343974,0.031852037,0.010510161,0.0013046092],"about_ca_topic_score_codex":0.005668909,"about_ca_topic_score_gemma":0.000025603857,"teacher_disagreement_score":0.6179828,"about_ca_system_score_codex":0.00025706773,"about_ca_system_score_gemma":0.00027869822,"threshold_uncertainty_score":0.85697323},"labels":[],"label_agreement":null},{"id":"W4417481548","doi":"10.1016/j.jval.2025.09.899","title":"EE517 Healthcare Resource Utilization for Patients With Transthyretin Amyloid Cardiomyopathy: A Real-World Study in Europe, Canada, and Japan","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transthyretin; Health care; Amyloid (mycology); Resource (disambiguation); Disease; Amyloidosis","score_opus":0.019780249860593294,"score_gpt":0.28814014611377403,"score_spread":0.26835989625318074,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481548","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.994729,0.00096914865,0.000033232005,0.0016726,0.0000699012,0.0022641062,0.00011193446,0.000011295445,0.00013882548],"genre_scores_gemma":[0.9976388,0.00048514208,0.00015840527,0.0009622422,0.000023346096,0.000281907,0.00023918666,0.000031651787,0.00017930457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980404,0.00039366388,0.00045467654,0.000551182,0.00017092357,0.00038916993],"domain_scores_gemma":[0.999243,0.00007691465,0.00012729329,0.00033120962,0.000109104716,0.000112426984],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00038577136,0.00021025841,0.00035224168,0.00018171518,0.00010652109,0.000015635522,0.00012172111,0.000061990635,6.988386e-7],"category_scores_gemma":[0.00010595951,0.00019724292,0.000024412264,0.00057708746,0.000032465385,0.000004610615,0.00004174047,0.00010185752,1.317649e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000275287,0.00027582468,0.9948057,0.00019429096,0.000029974639,0.000002804184,0.00038228006,0.00046820467,0.000008033594,0.000088309775,0.00040042005,0.003068902],"study_design_scores_gemma":[0.003247701,0.0010344432,0.98672676,0.00015544717,0.000016282733,4.0154802e-7,0.0004822037,0.00006833592,0.00011232377,0.0000080690215,0.007983887,0.00016416339],"about_ca_topic_score_codex":0.5744055,"about_ca_topic_score_gemma":0.84187204,"teacher_disagreement_score":0.26746657,"about_ca_system_score_codex":0.00027096405,"about_ca_system_score_gemma":0.0011221169,"threshold_uncertainty_score":0.80433327},"labels":[],"label_agreement":null},{"id":"W4417481590","doi":"10.1016/j.jval.2025.09.209","title":"CO107 Evaluating the Health Impact of Anti-PD-(L)1 Agents for Early Stage Cancer Treatment in the Czech Republic","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Merck Canada Inc. (Canada)","funders":"","keywords":"Czech; Stage (stratigraphy); Renal cell carcinoma; Cancer; Cancer treatment; Breast cancer; Disease; Cancer stage","score_opus":0.17715392520786227,"score_gpt":0.4943118286976621,"score_spread":0.31715790348979983,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481590","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9674122,0.007406285,0.00002544922,0.021363256,0.00020064805,0.0033722557,0.0001090255,0.000012122535,0.00009876445],"genre_scores_gemma":[0.993126,0.002710617,0.00011371447,0.0031122742,0.000052693973,0.00032980702,0.000018418466,0.0000140077445,0.00052248593],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99773735,0.0006143577,0.0006973935,0.00024590208,0.00026678943,0.00043819204],"domain_scores_gemma":[0.9987058,0.00043428468,0.0003018722,0.00044901404,0.000055675628,0.000053348467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004009602,0.00014797277,0.00044915144,0.00019673315,0.0001391415,0.00001872004,0.00015775762,0.000051849063,0.000040387124],"category_scores_gemma":[0.00011412207,0.000077484285,0.00017820107,0.00074634526,0.000057286285,0.000039184597,0.000014316051,0.00016112968,3.6162442e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005421599,0.0011056598,0.65709984,0.0015863057,0.00046731235,0.000005023493,0.027699996,0.0018655034,0.0005285665,0.00046450843,0.0044971453,0.29925856],"study_design_scores_gemma":[0.0050363485,0.00544182,0.9779615,0.0009170318,0.000020667738,0.0000031596785,0.0011994487,0.0054200343,0.00010032521,0.000099357036,0.003725123,0.00007520582],"about_ca_topic_score_codex":0.26721358,"about_ca_topic_score_gemma":0.002331696,"teacher_disagreement_score":0.32086167,"about_ca_system_score_codex":0.0019571616,"about_ca_system_score_gemma":0.0040793368,"threshold_uncertainty_score":0.73766613},"labels":[],"label_agreement":null},{"id":"W4417481598","doi":"10.1016/j.jval.2025.09.1076","title":"EE695 The Cost-Effectiveness of Using Site-Specific Wastewater-Based Surveillance to Monitor COVID-19 in Long-Term Care Facilities","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"SARS-CoV-2 detection and testing","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Alberta Health Services; University of Alberta","funders":"","keywords":"Patient care; MEDLINE; Health care; Remote patient monitoring","score_opus":0.11316122308424238,"score_gpt":0.3895455525870014,"score_spread":0.27638432950275904,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9947864,0.0014656094,0.0009776389,0.00047150638,0.00038983088,0.0017582659,0.00004324279,0.000050658047,0.00005688716],"genre_scores_gemma":[0.99893445,0.000013336848,0.00017980533,0.0007240573,0.000038286136,0.00007371787,0.000009683572,0.000013290145,0.000013359321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979742,0.0007695976,0.00045333995,0.00029347342,0.0001986061,0.0003107528],"domain_scores_gemma":[0.99813753,0.0012595747,0.00009193119,0.00033012003,0.00009628317,0.00008455124],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00127165,0.00014264132,0.00040427744,0.00037860798,0.000101012614,0.000015175458,0.00009446954,0.00006850325,0.000006046842],"category_scores_gemma":[0.00066951086,0.000116367075,0.00005401434,0.00076158094,0.00007915407,0.000022690207,0.000035311186,0.00023065145,0.0000034477182],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00069670484,0.00009084787,0.9315069,0.0062313774,0.000007928796,0.00003284931,0.0031144917,0.026120894,0.02908204,0.00003337015,0.000009837072,0.003072765],"study_design_scores_gemma":[0.006565154,0.00059755216,0.78751385,0.0058947685,0.000010474468,0.000027024787,0.0045337854,0.008829351,0.18362263,0.000060489394,0.002009453,0.00033547418],"about_ca_topic_score_codex":0.015749713,"about_ca_topic_score_gemma":0.0010497391,"teacher_disagreement_score":0.15454058,"about_ca_system_score_codex":0.0013817428,"about_ca_system_score_gemma":0.0007114921,"threshold_uncertainty_score":0.9908045},"labels":[],"label_agreement":null},{"id":"W4417481616","doi":"10.1016/j.jval.2025.09.1749","title":"HSD88 Physician Perspectives on Unmet Need and Treatment Options Among Patients With Relapsed Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) in Canada: Findings From Qualitative Interviews","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto; AstraZeneca (Canada)","funders":"","keywords":"Lung cancer; Docetaxel; Chemotherapy; Qualitative research; Cancer","score_opus":0.01800251392389317,"score_gpt":0.31700324929279095,"score_spread":0.29900073536889776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99025327,0.0044173836,0.00001354104,0.002445353,0.00013747306,0.0022130979,0.0002039312,0.000012484983,0.00030343662],"genre_scores_gemma":[0.9959492,0.001927682,0.0005250572,0.00067990384,0.00001685387,0.00070752064,0.000065523534,0.000023329832,0.00010489774],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99831504,0.00022556099,0.00040414592,0.0005282128,0.00018236745,0.00034464977],"domain_scores_gemma":[0.99906737,0.00033155194,0.00015169181,0.00024762691,0.00005878473,0.00014295176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012698532,0.00026533194,0.0006044623,0.00021978102,0.0000834517,0.00001145956,0.000054582164,0.000043899403,0.000009610986],"category_scores_gemma":[0.000017403516,0.00020248724,0.000046449222,0.0004059926,0.00004325087,0.000058517853,0.000019938525,0.00019287276,7.631609e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005423218,0.0015246219,0.9267408,0.00026469826,0.00016906207,0.000018960314,0.063478895,0.002226323,0.000006076373,0.00014884197,0.00021766424,0.0046617175],"study_design_scores_gemma":[0.012000648,0.001422925,0.95116675,0.0043712445,0.00010454181,6.30072e-8,0.029368786,0.0011005884,0.00018298296,0.000031047584,0.00006412472,0.0001863022],"about_ca_topic_score_codex":0.95465714,"about_ca_topic_score_gemma":0.881147,"teacher_disagreement_score":0.07351008,"about_ca_system_score_codex":0.010706962,"about_ca_system_score_gemma":0.002095542,"threshold_uncertainty_score":0.99309075},"labels":[],"label_agreement":null},{"id":"W4417481624","doi":"10.1016/j.jval.2025.09.2054","title":"HTA271 Predicting PICOs for EU HTA: The Validated PICO Planner Approach Based on Retrospective Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Planner; Data modeling; Algorithm design","score_opus":0.31814343102231324,"score_gpt":0.4196315146495237,"score_spread":0.10148808362721046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481624","genre_codex":"commentary","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.2323281,0.0044450993,0.3228857,0.38949835,0.0034882785,0.013696141,0.003924127,0.00046792033,0.029266285],"genre_scores_gemma":[0.9494236,0.00004779232,0.005921473,0.0429208,0.00026314726,0.0006674732,0.00020016111,0.00003618767,0.0005193287],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9936536,0.0008857718,0.0038214724,0.0008677547,0.00013443545,0.00063694525],"domain_scores_gemma":[0.99448955,0.0026595844,0.0017630613,0.0008294946,0.00009625329,0.00016203453],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.027909206,0.0002369747,0.0012779456,0.0011284422,0.00046841035,0.00009623133,0.0004024086,0.00017514719,0.0000589645],"category_scores_gemma":[0.0070092813,0.0002400015,0.0002531748,0.0015532061,0.000050584284,0.00014965064,0.000038397364,0.00037437418,0.000059542555],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008369374,0.00038710135,0.42169222,0.0010176309,0.00040286971,3.719027e-7,0.0021243873,0.33804622,2.895105e-7,0.21332563,0.022796946,0.00012263007],"study_design_scores_gemma":[0.0011973213,0.00015773205,0.108272634,0.00013967993,0.000031200125,2.9473088e-7,0.00082038075,0.87043,0.0000020185018,0.007578149,0.011159169,0.00021140628],"about_ca_topic_score_codex":0.0054270723,"about_ca_topic_score_gemma":0.00016655713,"teacher_disagreement_score":0.71709555,"about_ca_system_score_codex":0.0018704056,"about_ca_system_score_gemma":0.0006129021,"threshold_uncertainty_score":0.97869766},"labels":[],"label_agreement":null},{"id":"W4417481646","doi":"10.1016/j.jval.2025.09.895","title":"EE513 Healthcare Resource Utilization and Economic Burden Among Adults With Alopecia Areata in the Kingdom of Saudi Arabia","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Activation Laboratories","funders":"","keywords":"Alopecia areata; Health care; Resource (disambiguation); Kingdom; Healthcare system","score_opus":0.0334197929785795,"score_gpt":0.2977319860987775,"score_spread":0.264312193120198,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98308164,0.0025237605,0.000028236185,0.011979967,0.00003184833,0.00088712823,0.00000960062,0.000013577631,0.0014442719],"genre_scores_gemma":[0.9979168,0.0006522759,0.00008964205,0.001206586,0.000033258566,0.000023093575,0.000034759065,0.000009523739,0.000034050965],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987921,0.00020820458,0.00040165574,0.00024310655,0.00011525251,0.0002396929],"domain_scores_gemma":[0.99937487,0.0001516439,0.0001055912,0.00026726568,0.000022543718,0.00007810928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005445511,0.000101954545,0.0002906149,0.0001908424,0.000049887512,0.000008143382,0.00008439042,0.00006641269,0.00000531576],"category_scores_gemma":[0.000096242235,0.000074628675,0.000018091163,0.0003316227,0.00008138964,0.000043001633,0.000020270281,0.00018621981,0.0000010310495],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006056258,0.000059135546,0.9727225,0.0016880247,0.000008755879,0.000008597094,0.007413664,0.0013755889,9.172396e-7,0.0026600389,0.000547834,0.012909317],"study_design_scores_gemma":[0.0032715667,0.00044746758,0.9733336,0.0029926337,0.000009518968,0.000007779158,0.0069245566,0.007901086,0.000010196896,0.00040122005,0.004615513,0.000084881525],"about_ca_topic_score_codex":0.052967213,"about_ca_topic_score_gemma":0.0135842115,"teacher_disagreement_score":0.039383,"about_ca_system_score_codex":0.00013436576,"about_ca_system_score_gemma":0.00039113712,"threshold_uncertainty_score":0.95333916},"labels":[],"label_agreement":null},{"id":"W4417481649","doi":"10.1016/j.jval.2025.09.592","title":"EE208 Cost-Effectiveness Analysis of Intermittently Scanned Continuous Glucose Monitoring in Individuals With Type 2 Diabetes Using Insulin in Sweden: A National Real-World Evidence Perspective","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Type 2 diabetes; Perspective (graphical); Continuous glucose monitoring; Diabetes mellitus; Insulin; Population; Type 2 Diabetes Mellitus","score_opus":0.1056490702653705,"score_gpt":0.42992391178038336,"score_spread":0.32427484151501285,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481649","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949038,0.0023454726,0.000014864582,0.0005220162,0.00010478164,0.0015722185,0.0000070670035,0.000015397856,0.00051437464],"genre_scores_gemma":[0.99899036,0.00037775628,0.00034059354,0.000064982094,0.000028999837,0.0000836027,0.0000101268015,0.000013320019,0.000090249814],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9973305,0.0006665428,0.00057572086,0.00041548983,0.00056473294,0.00044703827],"domain_scores_gemma":[0.9981065,0.001042388,0.00018715984,0.00020683266,0.00037882227,0.00007832693],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003344232,0.00015887602,0.0007948371,0.004106869,0.000040334482,0.000026643362,0.0001622562,0.000060655624,0.000008887644],"category_scores_gemma":[0.0009862751,0.00014152366,0.00006539879,0.0075113666,0.00009950037,0.0001629405,0.00011763094,0.00036599475,0.0000010456079],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004083777,0.0003723862,0.9741163,0.0007194005,0.0003810545,0.00001486557,0.0008369901,0.019577568,0.00032040337,0.00047348227,0.0000042803254,0.0027748449],"study_design_scores_gemma":[0.0017480608,0.00032419877,0.95929694,0.007738739,0.00010538824,1.1089106e-7,0.0010580384,0.028758196,0.0006378243,0.00022224097,0.000009048722,0.0001012069],"about_ca_topic_score_codex":0.010974449,"about_ca_topic_score_gemma":0.0014687269,"teacher_disagreement_score":0.0148194,"about_ca_system_score_codex":0.0021039636,"about_ca_system_score_gemma":0.00090328965,"threshold_uncertainty_score":0.99561155},"labels":[],"label_agreement":null},{"id":"W4417481657","doi":"10.1016/j.jval.2025.09.2638","title":"PCR165 Navigating Uncertainty and Pragmatic Acceptance: Canadian Patient and Public Perspectives on Radiopharmaceutical Therapy in the Context of Whole Health","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Radiopharmaceutical Chemistry and Applications","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Institute of Population and Public Health","funders":"","keywords":"Context (archaeology); Public health; Health care; MEDLINE","score_opus":0.052774126831590114,"score_gpt":0.3860167601323014,"score_spread":0.3332426333007113,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481657","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8615934,0.010542215,0.000005028409,0.12642969,0.00001999364,0.0009925931,0.000023628902,0.000008285214,0.00038516056],"genre_scores_gemma":[0.98741263,0.0026762171,0.000120587574,0.009669047,0.000021360638,0.00007810791,0.00000964566,0.000006291122,0.0000061364294],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.9985788,0.00028035886,0.00041306418,0.00024756687,0.0001498506,0.0003304005],"domain_scores_gemma":[0.99900085,0.00041747253,0.00008788365,0.00018625542,0.000035319088,0.0002722349],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008084532,0.000110054265,0.00029379784,0.000087634115,0.0001341391,0.000017928396,0.00007810019,0.00004953611,0.000010107326],"category_scores_gemma":[0.00019748669,0.00008198876,0.000022660222,0.00044965124,0.00017818385,0.00003272281,0.0000109188095,0.000521239,4.3537497e-7],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00052022975,0.00188306,0.07529518,0.003868382,0.00010437037,0.000030613715,0.095990494,0.0005758832,0.0015645666,0.08690026,0.001434461,0.7318325],"study_design_scores_gemma":[0.027529243,0.004582926,0.24751034,0.010847835,0.00005950991,0.00024943004,0.5020613,0.11204631,0.0027418868,0.006721491,0.084581695,0.0010680438],"about_ca_topic_score_codex":0.02966576,"about_ca_topic_score_gemma":0.0015538888,"teacher_disagreement_score":0.73076445,"about_ca_system_score_codex":0.00041748118,"about_ca_system_score_gemma":0.00091035815,"threshold_uncertainty_score":0.9767958},"labels":[],"label_agreement":null},{"id":"W4417481700","doi":"10.1016/j.jval.2025.09.3032","title":"SA91 Targeted Literature Review Examining the Inclusion of Caregiver Costs and Quality of Life in Published Economic Models for Neurological Conditions","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Inclusion (mineral); Caregiver burden; Quality of life (healthcare); Neurology; Health care; Quality-adjusted life year; Health economics; Quality (philosophy)","score_opus":0.11090402035775546,"score_gpt":0.3911991160681404,"score_spread":0.2802950957103849,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481700","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94280916,0.027740765,0.000036999194,0.02769035,0.000044606313,0.0014989541,0.00007909248,0.000006620837,0.0000934272],"genre_scores_gemma":[0.9824001,0.014738869,0.0001827079,0.0025219633,0.000015747706,0.000065976594,0.000051987743,0.0000052747323,0.000017325912],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99801713,0.00070090755,0.00071975216,0.00022634408,0.0001422904,0.00019360024],"domain_scores_gemma":[0.99870884,0.00069711765,0.00017590061,0.00024208655,0.00009543924,0.000080597834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023571155,0.000079473306,0.00053248915,0.00014629896,0.00007049051,0.000007806983,0.000117864256,0.00009038118,0.000016497783],"category_scores_gemma":[0.0010823066,0.000051941908,0.00004058087,0.00031662555,0.00009607376,0.000096344695,0.0002290916,0.00030260478,1.2894759e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00558774,0.0017058033,0.6548041,0.1218363,0.00024739315,0.000025081972,0.023536779,0.023434982,0.0060769506,0.122262195,0.01968041,0.020802272],"study_design_scores_gemma":[0.0035424228,0.0006750792,0.925741,0.01214416,0.000013941388,0.0000024613357,0.00010929846,0.051368378,0.000018959126,0.006039522,0.00024948057,0.00009528056],"about_ca_topic_score_codex":0.0022643788,"about_ca_topic_score_gemma":0.00011575917,"teacher_disagreement_score":0.2709369,"about_ca_system_score_codex":0.00016411312,"about_ca_system_score_gemma":0.00044567694,"threshold_uncertainty_score":0.34230784},"labels":[],"label_agreement":null},{"id":"W4417481745","doi":"10.1016/j.jval.2025.09.314","title":"CO213 Review of Index Line Selection Methods in Hemato-Oncology Externally Controlled Trials: A Secondary Analysis of the Hermans et al Systematic Review","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Treatment and Pharmacology","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Statistics Canada","funders":"","keywords":"Selection (genetic algorithm); Index (typography); Line (geometry); Time line","score_opus":0.10674046071374535,"score_gpt":0.5357651114473563,"score_spread":0.42902465073361096,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481745","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006390734,0.93697023,0.0009594619,0.04494375,0.00032171476,0.009654246,0.000026136458,0.000013352226,0.0007203613],"genre_scores_gemma":[0.04595399,0.8392426,0.0021469253,0.11054885,0.000034322813,0.0014036881,0.000037316433,0.000020180833,0.00061216234],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98439187,0.011875651,0.0031548499,0.00021400306,0.00019249835,0.00017112095],"domain_scores_gemma":[0.99426264,0.0036698373,0.0015995271,0.0002791653,0.000141975,0.0000468872],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.022552846,0.00014607777,0.005840387,0.0005093011,0.000017523302,0.0000015629448,0.000111919864,0.00007316404,0.00021861204],"category_scores_gemma":[0.002747403,0.00008742561,0.0006067194,0.0022067204,0.00003573368,0.000021690726,0.000028538316,0.000329874,4.627779e-7],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009304484,0.0007706557,0.0064683887,0.98152214,0.0035011722,0.0000068036584,0.00035271447,0.00031172432,0.0003410321,0.00022684055,0.002817443,0.002750609],"study_design_scores_gemma":[0.020798253,0.0011411456,0.00623848,0.93065804,0.020714369,0.00004118889,0.000073106195,0.015935605,0.00028177694,0.00016109455,0.0038131736,0.00014379217],"about_ca_topic_score_codex":0.0018191827,"about_ca_topic_score_gemma":0.0005634127,"teacher_disagreement_score":0.09772768,"about_ca_system_score_codex":0.00048569203,"about_ca_system_score_gemma":0.0018666005,"threshold_uncertainty_score":0.7816411},"labels":[],"label_agreement":null},{"id":"W4417481806","doi":"10.1016/j.jval.2025.09.1378","title":"EPH249 The Incidence, Mortality, and Survival of Nonmetastatic Colorectal Cancer (CRC) per TNM Stages in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Colorectal cancer; Survival analysis; Overall survival; Cancer; MEDLINE","score_opus":0.09000746503453931,"score_gpt":0.4066629052450658,"score_spread":0.3166554402105265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481806","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9766261,0.011019296,0.000021920667,0.01009533,0.000104949664,0.0008343577,0.0011635793,0.0000086241225,0.00012585433],"genre_scores_gemma":[0.9696777,0.028850943,0.00009023757,0.0009354984,0.000019612931,0.00012644043,0.00023889427,0.000006870144,0.000053844255],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99643964,0.0017008071,0.00082485727,0.00041607473,0.00024598493,0.00037263214],"domain_scores_gemma":[0.9948416,0.004413262,0.00026422692,0.00033536568,0.00007410292,0.00007148952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0055699795,0.00019463322,0.00091078185,0.0004575888,0.00015024246,0.0000107194355,0.0001208929,0.00004610857,0.000015978918],"category_scores_gemma":[0.0009460184,0.00010830447,0.00006228115,0.0018499419,0.000440098,0.000042825708,0.0001414384,0.00029209311,2.2182373e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00064601185,0.00013483544,0.9917325,0.00030301872,0.0005882243,0.000016175496,0.0036933003,0.001404027,0.0000051716793,0.00030176106,0.00044959984,0.0007253817],"study_design_scores_gemma":[0.0015890725,0.00037495213,0.98609364,0.00016275016,0.00023620772,0.000003382338,0.0037058743,0.0068254382,0.0000029864632,0.00025480826,0.0006699432,0.0000809289],"about_ca_topic_score_codex":0.262674,"about_ca_topic_score_gemma":0.16881928,"teacher_disagreement_score":0.093854725,"about_ca_system_score_codex":0.00020546932,"about_ca_system_score_gemma":0.00035151694,"threshold_uncertainty_score":0.84634763},"labels":[],"label_agreement":null},{"id":"W4417481810","doi":"10.1016/j.jval.2025.09.1922","title":"HTA137 Evidence of Mapping Malpractice? A Review of Mapping Algorithm Usage in NICE Health Technology Appraisals","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Nice; Excellence; Key (lock); Quarter (Canadian coin); Quality (philosophy); Health technology","score_opus":0.5136203462949277,"score_gpt":0.5025888836986924,"score_spread":0.01103146259623533,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481810","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02224595,0.5618442,0.024077393,0.3858518,0.00086675753,0.0035683725,0.00014510707,0.00006542561,0.0013349643],"genre_scores_gemma":[0.268991,0.44852203,0.18635455,0.09445873,0.0002428462,0.00079727825,0.000039914776,0.000111983856,0.0004816637],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.98505193,0.0018599768,0.011331024,0.0008134783,0.00016752226,0.0007760835],"domain_scores_gemma":[0.98748773,0.004102658,0.00721205,0.00094093964,0.000113379734,0.00014321035],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":["metaresearch"],"category_scores_codex":[0.06784825,0.00024187716,0.002706477,0.0023678304,0.000097013246,0.000014979612,0.00056542776,0.00021126798,0.000076920456],"category_scores_gemma":[0.017855275,0.0003306111,0.00013004159,0.0027284247,0.00011882571,0.00048099103,0.00015142554,0.0005515365,0.000080121055],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045466946,0.000976008,0.24298365,0.39337167,0.00016589175,0.000007922068,0.008820362,0.0018721785,0.00001558888,0.2886848,0.014962746,0.04809372],"study_design_scores_gemma":[0.0042854254,0.000961827,0.12256759,0.509535,0.000016095824,0.000051064682,0.014360304,0.07459232,0.00003025317,0.05535177,0.21672906,0.0015192446],"about_ca_topic_score_codex":0.020632131,"about_ca_topic_score_gemma":0.0002467992,"teacher_disagreement_score":0.29139307,"about_ca_system_score_codex":0.0015482155,"about_ca_system_score_gemma":0.0021591047,"threshold_uncertainty_score":0.9999146},"labels":[],"label_agreement":null},{"id":"W4417481816","doi":"10.1016/j.jval.2025.09.896","title":"EE514 Healthcare Resource Utilization and Economic Burden Among Adults With Alopecia Areata in the United Arab Emirates","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Hair Growth and Disorders","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Activation Laboratories","funders":"","keywords":"Alopecia areata; Hair loss; Health care; Resource (disambiguation); Resource constraints","score_opus":0.03280994515759296,"score_gpt":0.2961452468542208,"score_spread":0.26333530169662783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481816","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97653073,0.0021899375,0.00002175155,0.018875698,0.000028837017,0.00093876687,0.000009252168,0.00002713841,0.0013779115],"genre_scores_gemma":[0.9955868,0.00080501905,0.000048309506,0.0032668402,0.000038412225,0.0000363376,0.00013540545,0.000011445656,0.00007141762],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99873656,0.00026669953,0.00034198485,0.00026922073,0.000100577716,0.00028497772],"domain_scores_gemma":[0.99937314,0.00016937804,0.00007071407,0.00026022637,0.000024383316,0.00010217968],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005339429,0.00011952822,0.00024096295,0.00038158428,0.00008270964,0.000018192379,0.00008569725,0.000075626296,0.000005221159],"category_scores_gemma":[0.000094185634,0.00008598947,0.000013905851,0.00060984713,0.00007085035,0.000049653427,0.000018931154,0.00023702564,0.000003047409],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006063848,0.00005781954,0.97570074,0.0010188229,0.000009222846,0.000017646766,0.009320126,0.0023508559,3.8085153e-7,0.0021434242,0.00087171124,0.007902857],"study_design_scores_gemma":[0.004590146,0.0005584926,0.92002153,0.0029711942,0.000011802174,0.000014652225,0.020714559,0.035405193,0.0000069275643,0.00045118883,0.015106371,0.00014793355],"about_ca_topic_score_codex":0.058584966,"about_ca_topic_score_gemma":0.012935552,"teacher_disagreement_score":0.055679206,"about_ca_system_score_codex":0.00016598063,"about_ca_system_score_gemma":0.00045811798,"threshold_uncertainty_score":0.947684},"labels":[],"label_agreement":null},{"id":"W4417481838","doi":"10.1016/j.jval.2025.09.2582","title":"PCR109 Health Utility and Indirect Costs of Neuromuscular Disease Through a Patient-Centered Lens: A National Patient and Caregiver Survey","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyotrophic Lateral Sclerosis Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of Calgary; University of Ottawa; Cégep de Jonquière; Muscular Dystrophy Canada; Ottawa Hospital","funders":"","keywords":"Neuromuscular disease; Indirect costs; Health economics; Psychological intervention; Disease; Economic cost","score_opus":0.109995538136111,"score_gpt":0.3521337539313818,"score_spread":0.24213821579527078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481838","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.988014,0.004867302,0.000022280357,0.0054060956,0.00008550583,0.001285059,0.00023107234,0.000016397202,0.00007232264],"genre_scores_gemma":[0.99533385,0.0022032117,0.00012174832,0.002212506,0.000009412369,0.000026842446,0.00007185383,0.000011547923,0.000009040782],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687314,0.0011855308,0.0005664414,0.00042300005,0.0005825373,0.0003693251],"domain_scores_gemma":[0.9988802,0.00027091097,0.0001546924,0.00023673002,0.00019543908,0.00026204291],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00088308356,0.00014102094,0.00044648588,0.00016934142,0.00009370489,0.000011750485,0.000055578923,0.000050833027,0.000011376472],"category_scores_gemma":[0.00068232534,0.00012250849,0.000040951505,0.00040744524,0.00014664873,0.00008802496,0.00012754898,0.00024586252,7.029362e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010129906,0.00059087033,0.9733041,0.0016861939,0.000046037097,0.000015616984,0.0029895445,0.000056468776,0.000022658698,0.0002749943,0.0009959138,0.019004604],"study_design_scores_gemma":[0.0015769807,0.000614116,0.99361336,0.0009772716,0.000004447284,0.0000025756592,0.000074874406,0.0023207765,0.0000090798385,0.00019017591,0.00055057957,0.0000657702],"about_ca_topic_score_codex":0.027737154,"about_ca_topic_score_gemma":0.00039112748,"teacher_disagreement_score":0.027346026,"about_ca_system_score_codex":0.000516387,"about_ca_system_score_gemma":0.0013832008,"threshold_uncertainty_score":0.97873724},"labels":[],"label_agreement":null},{"id":"W4417481845","doi":"10.1016/j.jval.2025.09.707","title":"EE323 Developing a Multi-Indication Wider Societal Value Model to Estimate the Economic Impact of Semaglutide in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa","funders":"","keywords":"Economic impact analysis; Semaglutide; Value (mathematics); Economic model; Social impact","score_opus":0.04039985240993782,"score_gpt":0.37305973423590383,"score_spread":0.332659881825966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481845","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9901979,0.00022415096,0.0012623398,0.0070503573,0.00007782251,0.00094541546,0.000009768637,0.000010002922,0.00022223272],"genre_scores_gemma":[0.99014425,0.00004878848,0.008298783,0.0012561274,0.000006884408,0.000053777494,0.00001157137,0.000009148319,0.00017065954],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99899966,0.00005314916,0.00038710548,0.0001789885,0.000094270305,0.00028681752],"domain_scores_gemma":[0.99955,0.00008020292,0.000093787654,0.00019747786,0.000013355277,0.00006520387],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043437153,0.0001045913,0.00026688792,0.00014860056,0.00003713419,0.000005623645,0.00008382305,0.000022389366,0.0000037473446],"category_scores_gemma":[0.000041945812,0.000078501376,0.000045563207,0.00020884993,0.000013470354,0.00002774209,0.000047656486,0.000083782616,0.0000036287631],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00002453986,0.00003836332,0.13760455,0.000255337,0.000071393086,0.000002391714,0.0006675347,0.8534981,0.000018743516,0.0021201763,0.0010406735,0.004658185],"study_design_scores_gemma":[0.0008616586,0.000046323257,0.31892425,0.00036376202,0.000015125964,3.607811e-7,0.000110991146,0.6791378,0.000060792492,0.00037572448,0.000050590126,0.00005257326],"about_ca_topic_score_codex":0.8792262,"about_ca_topic_score_gemma":0.54321545,"teacher_disagreement_score":0.33601078,"about_ca_system_score_codex":0.00783582,"about_ca_system_score_gemma":0.008585204,"threshold_uncertainty_score":0.9970352},"labels":[],"label_agreement":null},{"id":"W4417481846","doi":"10.1016/j.jval.2025.09.2635","title":"PCR162 Multinational Qualitative Testing of the Experimental EuroQol Toddler and Infant Populations (EQ-TIPS) Instrument","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Toddler; Multinational corporation; Quality of life (healthcare); Quality (philosophy); Descriptive statistics; Content validity","score_opus":0.6537076198830977,"score_gpt":0.4979136964753126,"score_spread":0.15579392340778508,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481846","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9633279,0.0023079417,0.0007485671,0.030195732,0.00054248766,0.0010283077,0.00016337076,0.000017302918,0.0016683979],"genre_scores_gemma":[0.9854351,0.00001961865,0.010350219,0.0038822407,0.000040920215,0.000087672975,0.000009217227,0.000011026038,0.00016395679],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9953926,0.0008627941,0.0030526116,0.00034294237,0.00009627499,0.00025277925],"domain_scores_gemma":[0.9967083,0.0015074897,0.0013944244,0.00026722564,0.00005122535,0.00007138592],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009789748,0.000121701494,0.00050645624,0.00031540066,0.00022321782,0.000024342979,0.00015853511,0.000061403654,0.00003347678],"category_scores_gemma":[0.0043238597,0.00013111027,0.000048044214,0.0004142732,0.00009060913,0.00018527538,0.0000949991,0.00015802658,0.000018705952],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009445502,0.00017722748,0.36221942,0.0004364868,0.000019274474,1.045765e-7,0.022377145,0.003626087,0.000012172778,0.6097595,0.0010777226,0.00028541056],"study_design_scores_gemma":[0.0018656537,0.00013615962,0.8378639,0.00086016854,0.0000031760446,0.000004610351,0.014111105,0.087886326,0.000058864636,0.05215827,0.0047579315,0.00029379956],"about_ca_topic_score_codex":0.017384565,"about_ca_topic_score_gemma":0.00023148087,"teacher_disagreement_score":0.5576012,"about_ca_system_score_codex":0.00065704697,"about_ca_system_score_gemma":0.00036359997,"threshold_uncertainty_score":0.98915875},"labels":[],"label_agreement":null},{"id":"W4417481868","doi":"10.1016/j.jval.2025.09.1882","title":"HTA97 Cost-Effectiveness Modeling Challenges and Trends in the Neoadjuvant and Perioperative Settings: A Review of NICE Oncology Submissions","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"MD Precision (Canada)","funders":"","keywords":"Nice; Perioperative; Excellence; Neoadjuvant therapy; MEDLINE","score_opus":0.1350012068585183,"score_gpt":0.3678000506117023,"score_spread":0.232798843753184,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481868","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18732095,0.766507,0.00024039256,0.02839499,0.00015430768,0.0007931456,0.00005049976,0.000006663466,0.016532034],"genre_scores_gemma":[0.70368516,0.29427883,0.000114665265,0.0017976887,0.000015199705,0.00007447505,0.0000023112937,0.000005512814,0.000026177217],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9986657,0.00017176564,0.00064807176,0.00028313842,0.000016576145,0.00021478692],"domain_scores_gemma":[0.9992777,0.00028876239,0.00021222362,0.00015685357,0.000019477822,0.000044966582],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029533755,0.00010507782,0.0006345923,0.00025752868,0.00006130018,0.000010531957,0.00010392668,0.000074772965,0.000008972374],"category_scores_gemma":[0.0002722881,0.00009344459,0.000033129418,0.00021641719,0.000056882734,0.000112003654,0.000042509328,0.00020564675,0.0000010134743],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008443624,0.00018946985,0.007403619,0.006826553,0.000026200185,0.0000041055027,0.012633695,0.0027208156,0.0000022648949,0.45981568,0.00012700897,0.51016617],"study_design_scores_gemma":[0.007160176,0.0016743945,0.4384644,0.036870196,0.0000298867,0.000038226386,0.0073136967,0.21402618,0.00001220976,0.072418846,0.22101703,0.0009747428],"about_ca_topic_score_codex":0.0023583493,"about_ca_topic_score_gemma":0.00028297585,"teacher_disagreement_score":0.5163642,"about_ca_system_score_codex":0.00021647965,"about_ca_system_score_gemma":0.0001267469,"threshold_uncertainty_score":0.38105598},"labels":[],"label_agreement":null},{"id":"W4417481876","doi":"10.1016/j.jval.2025.09.2634","title":"PCR161 Mobility and Upper Extremity Function in Duchenne Muscular Dystrophy: A Longitudinal Survey Using PROMIS","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Muscle Physiology and Disorders","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Duchenne muscular dystrophy; Proxy (statistics); Patient-Reported Outcomes Measurement Information System; Longitudinal data; Upper limb","score_opus":0.036823687505549055,"score_gpt":0.30168438743003617,"score_spread":0.26486069992448713,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481876","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99663967,0.001999249,0.00074532116,0.00012957005,0.00012105352,0.00031350623,0.000010413819,0.0000055843893,0.000035605968],"genre_scores_gemma":[0.9992875,0.0001973956,0.0002299867,0.00017124513,0.000024319083,0.000017618937,0.000049841005,0.000006297904,0.000015794443],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99852556,0.00048210655,0.0002628417,0.00042515385,0.000048863352,0.00025549374],"domain_scores_gemma":[0.9995888,0.00003225284,0.000055004664,0.00024028445,0.000033110664,0.000050564726],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00094562717,0.00011490905,0.00019091913,0.00007885993,0.000069986614,0.0000073684973,0.00006202965,0.00014075011,0.0000065202435],"category_scores_gemma":[0.00018721582,0.00011726469,0.000034635606,0.00019039499,0.00007844604,0.0000051163424,0.000067361296,0.00014598265,5.0267704e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005826848,0.0002145426,0.9760928,0.00023422806,0.000018330084,0.0000011722876,0.000042653388,0.0037542745,0.017626243,0.00012041106,0.000042020176,0.001270644],"study_design_scores_gemma":[0.00073438836,0.00013683601,0.994775,0.00004978279,0.0000038676003,0.0000013148765,0.000040587853,0.002936837,0.00035571365,0.00072342716,0.00014545834,0.000096810116],"about_ca_topic_score_codex":0.014595068,"about_ca_topic_score_gemma":0.0016457909,"teacher_disagreement_score":0.01868218,"about_ca_system_score_codex":0.000057589255,"about_ca_system_score_gemma":0.0002570514,"threshold_uncertainty_score":0.99196684},"labels":[],"label_agreement":null},{"id":"W4417481889","doi":"10.1016/j.jval.2025.09.3463","title":"MSR184 Second- or Later-Line Treatments for Advanced and Metastatic Gastric Cancer: A Network Meta-Analysis Comparing Treatments to Paclitaxel","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Trinity College","funders":"","keywords":"Paclitaxel; Cancer; Safety profile; Clinical trial; Cancer treatment","score_opus":0.18701898790266813,"score_gpt":0.4184574357632065,"score_spread":0.23143844786053835,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481889","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9502708,0.023347327,0.0063927374,0.011657422,0.00040698098,0.00725955,0.00025229188,0.00010923119,0.00030369908],"genre_scores_gemma":[0.94512707,0.0015692589,0.028162464,0.004314862,0.00007161902,0.0016292728,0.00013083922,0.0000348268,0.018959811],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99791133,0.000114987015,0.0007013375,0.00051501475,0.00018508059,0.0005722633],"domain_scores_gemma":[0.998858,0.00035760071,0.00018965422,0.00033056104,0.000044410903,0.00021980783],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004465684,0.00028112438,0.0018197784,0.0006421952,0.00011715014,0.000027847505,0.00008395343,0.000030220102,0.0001484503],"category_scores_gemma":[0.00005984687,0.0001992972,0.00036935136,0.0019121234,0.000017406446,0.00006581379,0.000058969035,0.00008832529,0.0000023957873],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036044181,0.00093620375,0.5618957,0.002167964,0.23876719,0.00007100284,0.00089419057,0.14027555,0.000013850613,0.000558973,0.003563932,0.047251016],"study_design_scores_gemma":[0.031396803,0.0056638294,0.47155526,0.000574399,0.41574585,0.000012197073,0.00060724467,0.056963135,0.00005402811,0.0012433998,0.01545983,0.0007240245],"about_ca_topic_score_codex":0.0028035128,"about_ca_topic_score_gemma":0.0027242,"teacher_disagreement_score":0.17697866,"about_ca_system_score_codex":0.0005497139,"about_ca_system_score_gemma":0.00020828842,"threshold_uncertainty_score":0.8127104},"labels":[],"label_agreement":null},{"id":"W4417481916","doi":"10.1016/j.jval.2025.09.264","title":"CO162 Matching-Adjusted Indirect Comparison Between Garadacimab and Donidalorsen for Long-Term Prophylaxis in Hereditary Angioedema","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Coagulation, Bradykinin, Polyphosphates, and Angioedema","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Hereditary angioedema; Authorization; Angioedema; Orphan drug; Randomized controlled trial; C1-inhibitor","score_opus":0.0547682523391218,"score_gpt":0.341133780404957,"score_spread":0.2863655280658352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481916","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98344946,0.01018825,0.00039880112,0.003344769,0.00033401808,0.0020093548,0.000035274814,0.00009203793,0.00014801291],"genre_scores_gemma":[0.9975405,0.00015106381,0.0010475349,0.000446926,0.00024136549,0.00007563357,0.00017793594,0.000034541332,0.00028449748],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975271,0.00019009928,0.00096029753,0.0005081548,0.0002468013,0.0005675436],"domain_scores_gemma":[0.9987117,0.0005457073,0.00020360295,0.0002959162,0.000054898228,0.0001881721],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000906797,0.0002634091,0.0009768704,0.00057715754,0.00013388475,0.000028362827,0.00011347069,0.00020912019,0.00001168107],"category_scores_gemma":[0.00012742211,0.00025707326,0.00010194431,0.0006568489,0.00008291475,0.00010340704,0.000046782785,0.00031193934,0.000003669836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00025356916,0.00021614776,0.96538246,0.0019870494,0.000051215116,0.000024201392,0.002346888,0.00013976592,0.000016157084,0.00024245786,0.00045843516,0.028881649],"study_design_scores_gemma":[0.0035682407,0.00065490295,0.98953795,0.0017126064,0.00004282743,0.000014934391,0.0003379474,0.002339316,0.00021279875,0.0009457761,0.00043064228,0.00020207613],"about_ca_topic_score_codex":0.0052754916,"about_ca_topic_score_gemma":0.0008428554,"teacher_disagreement_score":0.028679574,"about_ca_system_score_codex":0.0003149808,"about_ca_system_score_gemma":0.0005039927,"threshold_uncertainty_score":0.99998814},"labels":[],"label_agreement":null},{"id":"W4417481973","doi":"10.1016/j.jval.2025.09.1374","title":"EPH245 The Incidence Mortality and Survival of Malignant Chondrosarcoma in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2000-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Bone Tumor Diagnosis and Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Chondrosarcoma; Incidence (geometry); Survival analysis; MEDLINE","score_opus":0.08287571108265293,"score_gpt":0.3801908644862514,"score_spread":0.2973151534035985,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481973","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815388,0.0057505416,0.000019148169,0.011394794,0.00005253162,0.00063455856,0.00054668356,0.000007924044,0.00005504637],"genre_scores_gemma":[0.98715806,0.010839523,0.00010343345,0.0013863902,0.000010208147,0.0000458486,0.00042213127,0.00000547008,0.000028909784],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99581623,0.0023140134,0.000918059,0.00040504042,0.0002028861,0.0003437782],"domain_scores_gemma":[0.99447334,0.004483452,0.00027316174,0.00063530705,0.000047791906,0.00008695321],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.008840166,0.00015527615,0.00074449024,0.00038923946,0.00009012933,0.0000081132985,0.00013139509,0.00004761404,0.0000059536524],"category_scores_gemma":[0.0014249705,0.000087115244,0.00005374891,0.002047329,0.00025831934,0.000036598518,0.0000926022,0.00027326465,3.8443466e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017903537,0.000266815,0.9963377,0.00018812886,0.00015732451,0.0000528229,0.000876348,0.0004501903,0.000003291971,0.0008635949,0.00021915538,0.0004056005],"study_design_scores_gemma":[0.0015697714,0.00017418027,0.9873668,0.00026261195,0.00010743298,0.0000102399035,0.0006237375,0.008999545,0.0000051533293,0.00047128234,0.0003504272,0.00005881523],"about_ca_topic_score_codex":0.19758159,"about_ca_topic_score_gemma":0.025494194,"teacher_disagreement_score":0.1720874,"about_ca_system_score_codex":0.00010923617,"about_ca_system_score_gemma":0.00025832196,"threshold_uncertainty_score":0.992288},"labels":[],"label_agreement":null},{"id":"W4417481994","doi":"10.1016/j.jval.2025.09.848","title":"EE465 Financial and Mental Health Burden on Caregivers of Patients With Neuromyelitis Optica Spectrum Disorder (NMOSD) in the United States","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"AstraZeneca (Canada)","funders":"","keywords":"Neuromyelitis optica; Spectrum disorder; Mental health; Depression (economics); Autism spectrum disorder","score_opus":0.022236171375031547,"score_gpt":0.30387501551070967,"score_spread":0.28163884413567813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417481994","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9464097,0.00040927704,0.0000067221627,0.051484495,0.000052365318,0.001409207,0.00010318602,0.0000092906075,0.0001157587],"genre_scores_gemma":[0.9946866,0.0037227925,0.000109147,0.001301532,0.000019081415,0.000028318109,0.00009817804,0.000009696825,0.00002464454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982271,0.00036201358,0.00034484325,0.00025105473,0.00040714766,0.00040784403],"domain_scores_gemma":[0.9992386,0.0003307182,0.00008944027,0.00020956149,0.000044201417,0.00008746674],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047661713,0.00013225284,0.00036021095,0.00037111185,0.000120849254,0.000008563198,0.000093752154,0.000027750459,0.0000058043397],"category_scores_gemma":[0.0002708643,0.00008629454,0.000020949425,0.0007276752,0.00015894468,0.000027407823,0.00006024538,0.00029272566,6.110978e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016454216,0.0007061571,0.9500977,0.0017481644,0.000039193077,0.000011118933,0.025877614,0.002676601,0.000002806033,0.0012373495,0.00277059,0.0131873],"study_design_scores_gemma":[0.0042092563,0.0022114078,0.983154,0.000946225,0.0000026066266,4.9880794e-7,0.0033276463,0.0017473944,0.0000029447963,0.000065699474,0.0042712926,0.000061013354],"about_ca_topic_score_codex":0.046634927,"about_ca_topic_score_gemma":0.0017524218,"teacher_disagreement_score":0.05018296,"about_ca_system_score_codex":0.0002657458,"about_ca_system_score_gemma":0.00042112687,"threshold_uncertainty_score":0.95971364},"labels":[],"label_agreement":null},{"id":"W4417482017","doi":"10.1016/j.jval.2025.09.1068","title":"EE687 The Budget Impact and Time Savings of Introducing Subcutaneously Administered Nivolumab and Hyaluronidase (NIVO SC) to Patients Receiving Intravenously Administered Nivolumab (NIVO IV) Across Indications in Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Bristol-Myers Squibb (Canada)","funders":"","keywords":"Nivolumab; Drug; Pharmacokinetics; Adverse effect; Clinical trial","score_opus":0.07352480237645068,"score_gpt":0.3594821933912759,"score_spread":0.2859573910148252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482017","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97169596,0.0014974228,0.000078960635,0.0237723,0.00031090926,0.0017183303,0.0006568069,0.000017737591,0.00025154554],"genre_scores_gemma":[0.99425435,0.00016984537,0.00073451514,0.0044672093,0.000055584547,0.00008001424,0.00004070227,0.00003760661,0.00016020102],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9930158,0.0007924841,0.0043015005,0.0008750039,0.00016493855,0.0008502694],"domain_scores_gemma":[0.99513257,0.0017936504,0.0018757472,0.0007659198,0.00008673242,0.00034539562],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0093301935,0.0003048039,0.0012899974,0.0005775558,0.00036031395,0.00011390244,0.0004156384,0.00013380432,0.000048689897],"category_scores_gemma":[0.0041547874,0.0003486161,0.000060028586,0.00073423906,0.00011805675,0.0002435686,0.00020344609,0.00039142533,0.000026092252],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018458736,0.00026286213,0.9604094,0.0013466477,0.00007347366,0.000005728322,0.02302578,0.0017066478,0.000007870113,0.0021169866,0.0040080952,0.0068519423],"study_design_scores_gemma":[0.0024827842,0.00071628985,0.97308004,0.0011376841,0.000007898497,0.000022130238,0.0028624942,0.015016037,0.000007417222,0.0017188918,0.0024578073,0.0004905124],"about_ca_topic_score_codex":0.85367453,"about_ca_topic_score_gemma":0.649328,"teacher_disagreement_score":0.20434651,"about_ca_system_score_codex":0.0041509205,"about_ca_system_score_gemma":0.0037064585,"threshold_uncertainty_score":0.9998966},"labels":[],"label_agreement":null},{"id":"W4417482048","doi":"10.1016/j.jval.2025.09.1419","title":"HPR9 A Review of the UK's International Recognition Procedure and Its Role in Expediting Access to Innovative Treatments","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Biomedical Ethics and Regulation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Health Canada; U.S. Food and Drug Administration","keywords":"Expediting; Access to medicines; Market access; MEDLINE","score_opus":0.08331723117820085,"score_gpt":0.4194053903561479,"score_spread":0.33608815917794704,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.81943154,0.008920799,0.000021205342,0.16840133,0.0002722999,0.0016113472,0.000017430233,0.00000730199,0.0013167555],"genre_scores_gemma":[0.9878311,0.0041079973,0.00011799998,0.007756879,0.00004097141,0.000050641585,0.000024061761,0.0000029613338,0.0000673822],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9992681,0.00006590011,0.0003168013,0.00011409672,0.00015959228,0.000075465476],"domain_scores_gemma":[0.9996276,0.000055964614,0.00010350139,0.000051052757,0.00013275599,0.000029128683],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000512485,0.00004484248,0.00014290072,0.00014279819,0.000019734875,0.0000037182388,0.000048506274,0.000050595954,0.000012865043],"category_scores_gemma":[0.0005017365,0.000029552513,0.000011200721,0.0007761737,0.00002300406,0.000034701832,0.000045778277,0.00014110816,4.0204668e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003819841,0.00093880866,0.145113,0.048596043,0.00012017938,0.000009907822,0.008368074,0.000039786995,0.0014597037,0.012074517,0.002707189,0.7801908],"study_design_scores_gemma":[0.0023604247,0.00019519386,0.83773136,0.14505926,0.000017735785,0.000011614046,0.00042642548,0.0037289723,0.0011254014,0.007727466,0.0015193961,0.000096740536],"about_ca_topic_score_codex":0.00034630665,"about_ca_topic_score_gemma":0.0000383844,"teacher_disagreement_score":0.7800941,"about_ca_system_score_codex":0.00012404485,"about_ca_system_score_gemma":0.0003509199,"threshold_uncertainty_score":0.12051165},"labels":[],"label_agreement":null},{"id":"W4417482058","doi":"10.1016/j.jval.2025.09.3410","title":"MSR126 Identifying Risk Profiles for Early Treatment Discontinuation in Geographic Atrophy Using Machine Learning and SHAP Clustering","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Machine Learning in Healthcare","field":"Computer Science","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thermo Fisher Scientific (Canada)","funders":"","keywords":"Cluster analysis; Discontinuation; Atrophy; Geographic atrophy","score_opus":0.04520430159392593,"score_gpt":0.34510718653821887,"score_spread":0.29990288494429296,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482058","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8616073,0.0023596042,0.13351032,0.0010470795,0.0002628246,0.0010990604,0.000005732345,0.00009199946,0.000016056423],"genre_scores_gemma":[0.9371182,0.00048539008,0.062138062,0.00006023531,0.0000409732,0.00009447303,0.0000075982916,0.000016760107,0.000038331527],"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99731845,0.0007826434,0.00062833447,0.00059826276,0.0001670724,0.0005052133],"domain_scores_gemma":[0.9988988,0.0004225256,0.00030087566,0.0002532959,0.000037758462,0.000086748085],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015069866,0.00019692806,0.0003473933,0.0007748496,0.00038441768,0.00017499061,0.00022709704,0.00007550243,9.695458e-7],"category_scores_gemma":[0.00022266973,0.00019433892,0.000059472837,0.0007372386,0.00002784476,0.00029503184,0.00017370308,0.0003897818,5.5863654e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00002086887,0.000037638827,0.89253706,0.00033607846,0.000007827926,0.000003196118,0.0023617574,0.043520484,0.000026397245,0.0015484863,2.2683017e-7,0.059600003],"study_design_scores_gemma":[0.00071342825,0.00027036754,0.24244662,0.0004858689,0.0000033296476,0.0000023436432,0.00006502259,0.75479174,0.000010961899,0.0010074908,0.00009362407,0.000109177774],"about_ca_topic_score_codex":0.07773529,"about_ca_topic_score_gemma":0.00316965,"teacher_disagreement_score":0.7112713,"about_ca_system_score_codex":0.00041013354,"about_ca_system_score_gemma":0.0001952321,"threshold_uncertainty_score":0.9284061},"labels":[],"label_agreement":null},{"id":"W4417482061","doi":"10.1016/j.jval.2025.09.629","title":"EE245 Cost-Effectiveness of Direct Oral Anticoagulants vs. Vitamin K Antagonists in Algeria: A Public Payer Perspective","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Agency of Canada","funders":"","keywords":"Perspective (graphical); Vitamin k; Public health; Rivaroxaban","score_opus":0.11373709873762738,"score_gpt":0.4123682431736518,"score_spread":0.2986311444360244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482061","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98137784,0.00077600457,0.00021776979,0.010374195,0.0005137418,0.0026040624,0.000014140791,0.00005427784,0.0040679597],"genre_scores_gemma":[0.99894977,0.000230044,0.00022605261,0.00023593412,0.000060558028,0.000016170106,0.000019050474,0.000013694165,0.00024871822],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99790686,0.00067690277,0.00051817583,0.00032653037,0.00022311817,0.00034839855],"domain_scores_gemma":[0.9989088,0.0005388475,0.00013762862,0.00023878139,0.00009686236,0.0000790654],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018153762,0.00015116541,0.0008272216,0.00066993013,0.00004377623,0.000016083257,0.00008124223,0.000083601495,0.000020239315],"category_scores_gemma":[0.000638519,0.00013588431,0.00009270066,0.0011062135,0.000059790582,0.0000984183,0.000050164675,0.00015699866,0.000006394145],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007687235,0.0000906296,0.9752225,0.0009902418,0.00006913889,0.000022609149,0.00045779962,0.00022807505,0.00035504752,0.019487249,0.00010137819,0.00220659],"study_design_scores_gemma":[0.0038108346,0.00022501501,0.98974824,0.0008128328,0.000022783197,0.0000022326356,0.0004977689,0.0014533508,0.000640815,0.000688856,0.0019893849,0.00010787912],"about_ca_topic_score_codex":0.006183062,"about_ca_topic_score_gemma":0.00020991541,"teacher_disagreement_score":0.018798394,"about_ca_system_score_codex":0.0006919245,"about_ca_system_score_gemma":0.0005155788,"threshold_uncertainty_score":0.9346982},"labels":[],"label_agreement":null},{"id":"W4417482068","doi":"10.1016/j.jval.2025.09.591","title":"EE207 Cost-Effectiveness Analysis of Intermittently Scanned Continuous Glucose Monitoring in Individuals With Type 1 Diabetes in Sweden: A National Real-World Evidence Perspective","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Diabetes Management and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Continuous glucose monitoring; Type 1 diabetes; Perspective (graphical); Diabetes mellitus; Type 2 diabetes; Continuous monitoring; Reduction (mathematics)","score_opus":0.0827810196486077,"score_gpt":0.41962445844975405,"score_spread":0.3368434388011463,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482068","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405247,0.0017889391,0.0000060213333,0.0010844518,0.00010196662,0.0015998167,0.00000667589,0.00001657224,0.0013431064],"genre_scores_gemma":[0.9988965,0.00039075094,0.00013499914,0.000078473284,0.00002515295,0.0001550544,0.000011845871,0.000011446379,0.00029581468],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99749106,0.0005977036,0.00051166984,0.00040295278,0.0005622276,0.00043439106],"domain_scores_gemma":[0.9980074,0.0012094505,0.00015370014,0.00021162779,0.0003400352,0.00007779494],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0034081964,0.00014726966,0.0007490831,0.0037635295,0.000031863656,0.000023231869,0.0001679613,0.00005386239,0.000012554328],"category_scores_gemma":[0.0009232792,0.0001272681,0.000065604756,0.00672712,0.000093911374,0.00013758164,0.00010395686,0.00034272,0.0000018413114],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003761454,0.00036824908,0.9884431,0.0007022613,0.00040525812,0.000013534535,0.0007216165,0.005004675,0.00013521656,0.0009297516,0.000018412877,0.0028818306],"study_design_scores_gemma":[0.0015933847,0.00040785247,0.9821393,0.0063156476,0.00009079464,7.0952204e-8,0.000991111,0.007545128,0.0005194995,0.0002852168,0.00002063776,0.0000913651],"about_ca_topic_score_codex":0.008167909,"about_ca_topic_score_gemma":0.0019898582,"teacher_disagreement_score":0.006303757,"about_ca_system_score_codex":0.0016358629,"about_ca_system_score_gemma":0.00071703206,"threshold_uncertainty_score":0.9984368},"labels":[],"label_agreement":null},{"id":"W4417482091","doi":"10.1016/j.jval.2025.09.2545","title":"PCR72 Enhancing Equity in Cancer Clinical Trials: A Synthesis of Patient-Reported Barriers and Sustainable Solutions","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"CARE Canada; Simon Fraser University; Nova Scotia Health Authority","funders":"","keywords":"Equity (law); Cancer; Sustainable development; Health equity","score_opus":0.0925695034679627,"score_gpt":0.4329994140769479,"score_spread":0.3404299106089852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482091","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98832625,0.009529754,0.00037374502,0.0008256291,0.00023494179,0.00042679204,0.0000333864,0.0000029945088,0.00024653206],"genre_scores_gemma":[0.9908019,0.008481602,0.00020460963,0.0003472383,0.0000426112,0.000072391966,0.000005205517,0.0000064877513,0.000038007685],"study_design_codex":"observational","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9978249,0.00049438764,0.0010161204,0.0002651109,0.00006323592,0.00033623725],"domain_scores_gemma":[0.9988698,0.0005020775,0.00026590461,0.00020109712,0.00006200453,0.0000991129],"candidate_categories":["metaresearch"],"consensus_categories":[],"category_scores_codex":[0.0046673464,0.00008081411,0.00037466688,0.00010557979,0.000060998067,0.0000091749735,0.000069303365,0.000117048425,0.0000054335633],"category_scores_gemma":[0.009221599,0.000084010935,0.00006290226,0.0001846855,0.000066523826,0.000002351801,0.00019753345,0.0001023385,7.8543934e-8],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020714824,0.0011901766,0.65705514,0.0041721184,0.00049301947,0.000055519802,0.0017338676,0.036934495,0.026887845,0.020849122,0.00916301,0.23939417],"study_design_scores_gemma":[0.027905116,0.0068174875,0.31401336,0.009662304,0.00075635745,0.00003111203,0.03703068,0.034512274,0.32203776,0.042299163,0.20134349,0.0035909095],"about_ca_topic_score_codex":0.017191358,"about_ca_topic_score_gemma":0.0027747718,"teacher_disagreement_score":0.3430418,"about_ca_system_score_codex":0.00015131851,"about_ca_system_score_gemma":0.0022575073,"threshold_uncertainty_score":0.99912417},"labels":[],"label_agreement":null},{"id":"W4417482096","doi":"10.1016/j.jval.2025.09.2763","title":"RWD13 AI for Precision Oncology Evidence: Case Study Research From British Columbia, Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC; Simon Fraser University","funders":"","keywords":"Precision oncology; Precision medicine; Electronic health record; Health records; Equity (law); Health care; Health data; Healthcare system","score_opus":0.47773180749417155,"score_gpt":0.5830969546897224,"score_spread":0.1053651471955509,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482096","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9663577,0.002778766,0.000114305,0.024991682,0.0017300165,0.0038959729,0.000026364445,0.00001947074,0.00008573769],"genre_scores_gemma":[0.99328387,0.0004174826,0.00048336372,0.003706505,0.00038218268,0.00045073556,0.000017370907,0.000013808564,0.0012446637],"study_design_codex":"design_other","study_design_gemma":"qualitative","domain_scores_codex":[0.99670124,0.00091348577,0.00090447126,0.0004944271,0.00042436644,0.00056203274],"domain_scores_gemma":[0.99337125,0.0052378303,0.00008976578,0.0003887525,0.0006565509,0.00025584793],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004385274,0.000075112286,0.00039021598,0.00015445791,0.00048103608,0.000077897246,0.00012759936,0.00013963961,0.00010529227],"category_scores_gemma":[0.004346438,0.00010862789,0.000032723492,0.0007536339,0.00005737461,0.000076529184,0.000049818136,0.00062024035,0.0000051178554],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022161052,0.00088211795,0.3834505,0.00053961686,0.000020910109,0.0011381643,0.005054798,0.000123279,0.00000796377,0.000017831673,0.18842618,0.420117],"study_design_scores_gemma":[0.0024671752,0.021118017,0.3068278,0.01614113,0.00014574477,0.0016227475,0.336636,0.025798613,0.0003317635,0.033514537,0.25453028,0.000866153],"about_ca_topic_score_codex":0.99984473,"about_ca_topic_score_gemma":0.9993625,"teacher_disagreement_score":0.41925085,"about_ca_system_score_codex":0.003536259,"about_ca_system_score_gemma":0.02274386,"threshold_uncertainty_score":0.98279625},"labels":[],"label_agreement":null},{"id":"W4417482111","doi":"10.1016/j.jval.2025.09.050","title":"P7 Life-Cycle Economic Modeling to Determine the Evolving Value of a Tumor-Agnostic Precision Oncology Therapy With Conditional Marketing Authorization","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Economic and Financial Impacts of Cancer","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Spinal Cord Injury BC","funders":"","keywords":"Authorization; Value (mathematics); Prior authorization; Precision medicine; Economic analysis","score_opus":0.04194795071044223,"score_gpt":0.2919768208515324,"score_spread":0.2500288701410902,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482111","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93580365,0.002504869,0.052839294,0.0041426574,0.0004902057,0.0007954094,0.0000840758,0.00002038741,0.0033194544],"genre_scores_gemma":[0.9951122,0.0006218171,0.002402549,0.0015965813,0.00012295089,0.00006548499,0.00000934188,0.000021788026,0.00004733346],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.997998,0.00011041629,0.0011118362,0.00039893237,0.000035645877,0.00034515295],"domain_scores_gemma":[0.9983256,0.000766556,0.0005280524,0.00023181956,0.000044956236,0.00010304466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0022287143,0.00015369339,0.00053237425,0.0003707256,0.00015711009,0.00003906134,0.00024492497,0.000080002865,0.0000916322],"category_scores_gemma":[0.00087347714,0.00014496942,0.000060975053,0.00025218923,0.000047924423,0.00021347076,0.00005546064,0.00018526283,0.00003070937],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002678263,0.000067412664,0.020808205,0.00006277342,0.000024487706,9.2955764e-7,0.00049611845,0.86499125,0.0000068907857,0.106623024,0.00017498713,0.0064761047],"study_design_scores_gemma":[0.0009981926,0.00034298975,0.058434747,0.00029714036,0.0000029950459,0.000002877997,0.00008107986,0.8942496,0.000016296328,0.043054875,0.0023523036,0.00016687866],"about_ca_topic_score_codex":0.0033731149,"about_ca_topic_score_gemma":0.00017299835,"teacher_disagreement_score":0.06356815,"about_ca_system_score_codex":0.00077961636,"about_ca_system_score_gemma":0.00073018385,"threshold_uncertainty_score":0.59116817},"labels":[],"label_agreement":null},{"id":"W4417482112","doi":"10.1016/j.jval.2025.09.1377","title":"EPH248 The Incidence, Mortality, and Survival of Metastatic Colorectal Cancer (CRC) per TNM Stages in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Colorectal Cancer Treatments and Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Colorectal cancer; Survival analysis; Overall survival; Cancer; MEDLINE","score_opus":0.10534408944795977,"score_gpt":0.41657935106519123,"score_spread":0.3112352616172315,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482112","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9728139,0.013927647,0.00001879598,0.01101007,0.000103374485,0.00084162795,0.0011541004,0.000009250605,0.00012122422],"genre_scores_gemma":[0.9689017,0.029548747,0.00008883893,0.0010093158,0.000017870056,0.00013540132,0.00023740985,0.0000067269893,0.00005400833],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962554,0.0018902514,0.00082830957,0.0004122958,0.0002459814,0.0003677394],"domain_scores_gemma":[0.9947145,0.0045365863,0.00026434174,0.00033091195,0.00008265291,0.00007097983],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005924083,0.00019428832,0.00093959173,0.00046416093,0.00014907969,0.000010802873,0.00012072692,0.000039349692,0.00001528376],"category_scores_gemma":[0.0010597806,0.00010669197,0.00006446422,0.0019039892,0.0004276208,0.000043695505,0.00013848832,0.0002869022,1.8332214e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00066896854,0.00013745969,0.9915705,0.00033487554,0.00074326375,0.000017994642,0.0035982416,0.0013354813,0.000004947513,0.00042781155,0.000497541,0.00066296826],"study_design_scores_gemma":[0.0016223297,0.00036997756,0.9861023,0.0001605482,0.00027724178,0.0000037335453,0.004081641,0.006226246,0.0000033989404,0.0003265647,0.00074551284,0.00008052436],"about_ca_topic_score_codex":0.289232,"about_ca_topic_score_gemma":0.1886623,"teacher_disagreement_score":0.100569695,"about_ca_system_score_codex":0.00020121632,"about_ca_system_score_gemma":0.00037133653,"threshold_uncertainty_score":0.8261425},"labels":[],"label_agreement":null},{"id":"W4417482146","doi":"10.1016/j.jval.2025.09.2673","title":"PCR200 Qualitative Trial Interviews to Explore the Experience of Adult and Pediatric Patients Participating in a Pivotal Phase 3 Trial of DTX401 for Glycogen Storage Disease Type Ia","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Glycogen Storage Diseases and Myoclonus","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal Children's Hospital","funders":"","keywords":"Glycogen storage disease; Disease; Qualitative research; Glycogen; Clinical trial; Glycogen storage disease type I","score_opus":0.16146988414498478,"score_gpt":0.4761719006811432,"score_spread":0.31470201653615837,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482146","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99339354,0.0009986203,0.000112238886,0.00046784425,0.00046198268,0.0044322778,0.00011865344,0.000007011167,0.000007841923],"genre_scores_gemma":[0.9979717,0.000095934905,0.00022624456,0.0003824558,0.00010892019,0.0011604549,0.000024851382,0.000012013628,0.000017387787],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9977764,0.00044982202,0.0009724075,0.00028226207,0.00023695115,0.0002821809],"domain_scores_gemma":[0.9985529,0.00049849856,0.000290118,0.00024945257,0.00018856024,0.00022046105],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00074593106,0.00013921988,0.0005139005,0.00021790202,0.000045484896,0.0000058777277,0.000100756886,0.000038749735,0.000009226514],"category_scores_gemma":[0.003447746,0.00010432392,0.000100799676,0.0005767259,0.000051482002,0.00004995243,0.000057342673,0.00009945429,5.145142e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.78285724,0.0044683395,0.008487014,0.0026339225,0.000038097693,0.000038873928,0.19056678,0.00014430685,0.00003382443,0.0004319426,0.0004278511,0.009871788],"study_design_scores_gemma":[0.8918213,0.030609217,0.0077529675,0.002291427,0.00035952884,0.0000014731567,0.058719475,0.006420408,0.00016838088,0.0006831431,0.00073030347,0.000442379],"about_ca_topic_score_codex":0.0014587092,"about_ca_topic_score_gemma":0.00004575122,"teacher_disagreement_score":0.13184729,"about_ca_system_score_codex":0.00010078067,"about_ca_system_score_gemma":0.0005312766,"threshold_uncertainty_score":0.42542058},"labels":[],"label_agreement":null},{"id":"W4417482148","doi":"10.1016/j.jval.2025.09.1376","title":"EPH247 The Incidence, Mortality, and Survival of Malignant Non-Small Cell Lung Cancer (NSCLC) in the United States: A Surveillance Epidemiology and End Results (SEER) 2000-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Surveillance, Epidemiology, and End Results; Epidemiology; Lung cancer; Epidemiological surveillance; Cancer; Lung","score_opus":0.08724169503674144,"score_gpt":0.42320669820038004,"score_spread":0.3359650031636386,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482148","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9603875,0.020991618,0.00010471508,0.016559208,0.000085481355,0.0011691632,0.00053143356,0.000008858249,0.00016202278],"genre_scores_gemma":[0.93376195,0.064173914,0.00009131041,0.0015791925,0.000039673836,0.00012588971,0.0001311326,0.000009167626,0.00008775211],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.994817,0.0027058348,0.0010046717,0.00052776776,0.0003497309,0.00059497915],"domain_scores_gemma":[0.9932031,0.005569676,0.0003000118,0.0006811094,0.00013590376,0.00011018521],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014288037,0.00019045461,0.0008903853,0.0006205333,0.00013158518,0.000010687248,0.00025740126,0.000061838015,0.000007499572],"category_scores_gemma":[0.0017471523,0.0001116909,0.000054556294,0.002912012,0.00034900985,0.000038136382,0.00028611152,0.0005135084,1.9688717e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032579695,0.00007881077,0.98913646,0.0015129787,0.00023086272,0.000028856733,0.0039020244,0.0034309502,0.000013971197,0.0001602864,0.0010215627,0.00015742648],"study_design_scores_gemma":[0.0015522209,0.00013497144,0.9579537,0.0004968931,0.00013371362,0.000002064283,0.0013747262,0.03775838,0.0000116035935,0.00012699656,0.0003679406,0.00008679265],"about_ca_topic_score_codex":0.37707993,"about_ca_topic_score_gemma":0.093785256,"teacher_disagreement_score":0.28329468,"about_ca_system_score_codex":0.00032233086,"about_ca_system_score_gemma":0.0011471296,"threshold_uncertainty_score":0.9227508},"labels":[],"label_agreement":null},{"id":"W4417482155","doi":"10.1016/j.jval.2025.09.935","title":"EE553 Informing the Sustainable Development of Novel Therapies Using Value-Based Real Options Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Reimbursement; Prioritization; Upstream (networking); New product development; Sustainability; Product (mathematics); Investment (military); Downstream (manufacturing)","score_opus":0.3787016718012835,"score_gpt":0.44068472197235037,"score_spread":0.06198305017106687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482155","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.84399664,0.0063630566,0.11728361,0.02850271,0.00032624608,0.0015500283,0.00008295047,0.00004812079,0.001846652],"genre_scores_gemma":[0.9140403,0.00033158195,0.07887912,0.006006124,0.00006493042,0.00012964435,0.000035371242,0.000024392837,0.0004884852],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9940622,0.00036120124,0.0045642992,0.00035978682,0.000113954455,0.0005385884],"domain_scores_gemma":[0.9961208,0.0012221785,0.0019402007,0.0005315171,0.0000996352,0.00008562837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024963148,0.00016375235,0.00094260526,0.0014383141,0.00050740206,0.000056082423,0.00032163443,0.00010054737,0.000039039678],"category_scores_gemma":[0.0010510926,0.00017273935,0.00014731307,0.0018012163,0.00007793128,0.00024341911,0.000065190216,0.00017971186,0.000013644461],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013027828,0.00016082419,0.057177566,0.0010609062,0.00024719676,2.452495e-7,0.00867449,0.36385703,0.0000021910566,0.56844527,0.00014873823,0.00021250876],"study_design_scores_gemma":[0.0013793231,0.00004783412,0.11402,0.00037520027,0.000036322566,6.199301e-7,0.016014997,0.8404511,0.000016747545,0.009017447,0.018302172,0.0003382376],"about_ca_topic_score_codex":0.039068688,"about_ca_topic_score_gemma":0.00061920745,"teacher_disagreement_score":0.5594278,"about_ca_system_score_codex":0.0019276474,"about_ca_system_score_gemma":0.0025321904,"threshold_uncertainty_score":0.9673302},"labels":[],"label_agreement":null},{"id":"W4417482167","doi":"10.1016/j.jval.2025.09.2588","title":"PCR115 Health-Related Quality of Life for Patients With Transthyretin Amyloid Cardiomyopathy: A Real-World Study in Europe, Canada, and Japan","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Amyloidosis: Diagnosis, Treatment, Outcomes","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Transthyretin; Amyloidosis; Quality of life (healthcare); Cardiac amyloidosis; Amyloid (mycology); Cardiomyopathy","score_opus":0.022636544301547316,"score_gpt":0.2965336298193469,"score_spread":0.27389708551779957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482167","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469477,0.001325469,0.000013425643,0.0013861276,0.00009043971,0.002199126,0.00018515445,0.000008344224,0.000097121025],"genre_scores_gemma":[0.9982148,0.00047374604,0.00018040041,0.0006899292,0.000010839596,0.00017983594,0.00012582856,0.000025575358,0.00009903543],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9971556,0.00072154263,0.0010095537,0.0005136484,0.00019754653,0.00040212815],"domain_scores_gemma":[0.99887025,0.00014908703,0.00033454076,0.0003665094,0.00012134636,0.0001582748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009805908,0.000218225,0.00068836985,0.00016994562,0.000071283604,0.0000075572907,0.00013618804,0.00006347375,0.000001262526],"category_scores_gemma":[0.0002527079,0.00020010106,0.000040374805,0.00058609364,0.000052981617,0.0000042994984,0.000044770906,0.0001166539,1.18502115e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047343568,0.00058639154,0.99621147,0.0003342068,0.000085852655,0.0000010307091,0.00043638528,0.0004362364,0.00002083138,0.000101677404,0.00031512254,0.0009973708],"study_design_scores_gemma":[0.0051754927,0.0012250745,0.99235284,0.00012716881,0.000012705498,1.6320355e-7,0.00032889855,0.000025742791,0.00009290909,0.0000111441,0.0004971055,0.0001507473],"about_ca_topic_score_codex":0.84327936,"about_ca_topic_score_gemma":0.83981913,"teacher_disagreement_score":0.004702057,"about_ca_system_score_codex":0.00023691947,"about_ca_system_score_gemma":0.0024684188,"threshold_uncertainty_score":0.8159884},"labels":[],"label_agreement":null},{"id":"W4417482196","doi":"10.1016/j.jval.2025.09.584","title":"EE200 Cost-Effectiveness Analysis of FreeStyle Libre Systems vs. Self-Monitoring of Blood Glucose in People With Type 2 Diabetes on Basal Insulin: An Israeli Healthcare System Perspective","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Perspective (graphical); Type 2 diabetes; Healthcare system; Basal (medicine); Basal insulin; Type 2 Diabetes Mellitus","score_opus":0.14540369326413388,"score_gpt":0.39110989245672323,"score_spread":0.24570619919258935,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98147345,0.0128332805,0.000089868096,0.0018206771,0.00070765865,0.0023887835,0.00039422026,0.000061918785,0.00023015887],"genre_scores_gemma":[0.9982212,0.00047223803,0.0005303412,0.00031646097,0.000097697804,0.00027672332,0.00003702172,0.000039029987,0.000009243993],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9917798,0.0024502387,0.004106479,0.00086366775,0.0001959454,0.0006038702],"domain_scores_gemma":[0.9940752,0.0021811507,0.0024054768,0.0008239444,0.00030250824,0.00021174752],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.01548522,0.000295282,0.0026993735,0.002400178,0.00011943057,0.00004004877,0.0003496968,0.000226083,0.00000470668],"category_scores_gemma":[0.0009392964,0.00034823234,0.00012437798,0.0034083482,0.000050718158,0.0003122866,0.00004927272,0.00035806518,0.000012199025],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00013721218,0.00051675213,0.8588602,0.00727361,0.0004348889,0.0000013263809,0.0041099996,0.07392263,0.0000021465933,0.0546971,0.000012378049,0.000031741354],"study_design_scores_gemma":[0.0020139564,0.0012915785,0.89883006,0.003796927,0.000083074636,7.444599e-7,0.012781858,0.0804782,0.000057437723,0.00029049875,0.00006557423,0.00031008944],"about_ca_topic_score_codex":0.098505974,"about_ca_topic_score_gemma":0.002732248,"teacher_disagreement_score":0.09577373,"about_ca_system_score_codex":0.003139157,"about_ca_system_score_gemma":0.0012431695,"threshold_uncertainty_score":0.99989694},"labels":[],"label_agreement":null},{"id":"W4417482274","doi":"10.1016/j.jval.2025.09.2859","title":"RWD109 Integrating Mendelian Randomization With Real-World Evidence: Cost-Effectiveness of Lipoprotein Testing for Primary Prevention of Cardiovascular Disease in High-Income Countries","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Lipoproteins and Cardiovascular Health","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill Genome Centre","funders":"","keywords":"Mendelian randomization; Primary prevention; Disease; Primary care; Mendelian inheritance; Leverage (statistics); Atherosclerotic cardiovascular disease","score_opus":0.03510096090607259,"score_gpt":0.3224504170256981,"score_spread":0.2873494561196255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482274","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9170009,0.020626202,0.044817146,0.00039636757,0.00016705401,0.016731888,0.000032039054,0.000049836894,0.00017860216],"genre_scores_gemma":[0.98762614,0.0021734426,0.008776971,0.000037112535,0.00006477352,0.0012308155,0.00004323958,0.00002815734,0.00001932273],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9962378,0.0013186091,0.0010565149,0.00043086795,0.00061918277,0.00033698406],"domain_scores_gemma":[0.9975247,0.0009739626,0.00036498802,0.0005979346,0.00042082253,0.00011763084],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.009976342,0.0002013058,0.0013667081,0.00066624174,0.00007456308,0.000008260878,0.00009503266,0.00007628579,0.0000014422894],"category_scores_gemma":[0.0014644625,0.00016686648,0.00028009154,0.0015358492,0.00007479294,0.00015651641,0.000034353412,0.0002186985,1.4633973e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022457737,0.00055176386,0.43988732,0.13372311,0.0011596036,0.000030972344,0.00045641983,0.19824995,0.00026093476,0.0053323708,0.000004180129,0.19788563],"study_design_scores_gemma":[0.030762525,0.001742081,0.83123773,0.11950725,0.0006945659,0.000005655518,0.00015743152,0.011166512,0.0025145507,0.0016739606,0.00022516403,0.00031253666],"about_ca_topic_score_codex":0.066391535,"about_ca_topic_score_gemma":0.00059642916,"teacher_disagreement_score":0.39135045,"about_ca_system_score_codex":0.0008880565,"about_ca_system_score_gemma":0.0028645096,"threshold_uncertainty_score":0.9398254},"labels":[],"label_agreement":null},{"id":"W4417482291","doi":"10.1016/j.jval.2025.09.1373","title":"EPH244 The Incidence, Mortality, and Survival of Breast Cancer per HER2/HR Status in the United States: A Surveillance, Epidemiology, and End Results (SEER) 2018-2022 Database Analysis","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Research Canada","funders":"","keywords":"Breast cancer; Survival analysis; Cancer; Overall survival","score_opus":0.07087840206212208,"score_gpt":0.4005935166910704,"score_spread":0.3297151146289483,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482291","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9614565,0.013947981,0.0002459413,0.021083666,0.00013070052,0.0007441782,0.0023034348,0.000018112896,0.000069537025],"genre_scores_gemma":[0.96790445,0.028056346,0.00024042613,0.0032689993,0.000052987532,0.000073143194,0.00035051187,0.000014462278,0.000038676626],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9953239,0.0022990303,0.00095220556,0.0005245976,0.0003110265,0.0005892556],"domain_scores_gemma":[0.99517334,0.0034508854,0.00038082074,0.0007410559,0.0001215491,0.0001323537],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0073586265,0.00022777182,0.00090022996,0.00061083713,0.00011586172,0.000010775849,0.00019800666,0.00007696581,0.000025557938],"category_scores_gemma":[0.00066350616,0.00014003087,0.00006010422,0.0026771063,0.0005855443,0.00008936197,0.00013919093,0.0005017574,3.3913446e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00088445237,0.000094336065,0.9853114,0.00034979577,0.00028955095,0.00000969608,0.0022990452,0.006934594,0.000013616895,0.0007804826,0.0002797978,0.002753224],"study_design_scores_gemma":[0.001917859,0.00009231259,0.98327035,0.000323727,0.00009715179,0.000017265875,0.0028695045,0.007277101,0.0000019002445,0.0008747277,0.0031479315,0.00011014402],"about_ca_topic_score_codex":0.310498,"about_ca_topic_score_gemma":0.07365453,"teacher_disagreement_score":0.23684347,"about_ca_system_score_codex":0.0002770453,"about_ca_system_score_gemma":0.00062063645,"threshold_uncertainty_score":0.94324887},"labels":[],"label_agreement":null},{"id":"W4417482362","doi":"10.1016/j.jval.2025.09.2585","title":"PCR112 Health-Related Quality of Life (HRQoL) and Its Associated Factors among Chinese Gout Patients: Baseline Findings From a Survey Study","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Gout, Hyperuricemia, Uric Acid","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Gout; Quality of life (healthcare); Baseline (sea); Survey research; SF-36","score_opus":0.06505056225190656,"score_gpt":0.3467195600442234,"score_spread":0.2816689977923168,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482362","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9939099,0.0016371087,0.00001215862,0.000979523,0.00040312982,0.0023371608,0.00059629296,0.000096968026,0.000027784501],"genre_scores_gemma":[0.99808925,0.0001347213,0.000042615397,0.0008188987,0.000020246223,0.000021661685,0.00071292045,0.00003845393,0.000121234356],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99183923,0.003680214,0.0025012204,0.000680595,0.0006990314,0.0005997255],"domain_scores_gemma":[0.99521273,0.0025609338,0.0009418963,0.0004995853,0.00029716583,0.00048767612],"candidate_categories":["metaresearch","metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.007552734,0.00036496064,0.0017576681,0.00043744053,0.00014901714,0.000014429776,0.00017949929,0.0002567984,0.00004715259],"category_scores_gemma":[0.018338116,0.00031226838,0.00009346361,0.0016523016,0.000066044624,0.00012307908,0.00014310241,0.000747562,0.000004814293],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030207995,0.0021333024,0.9904148,0.00041371424,0.0002345239,0.0000029924151,0.0059913676,0.00006523551,0.000010756294,0.00000714733,0.00029912774,0.00012496232],"study_design_scores_gemma":[0.0069650155,0.0007452862,0.9884477,0.00050956337,0.000037156664,1.8440018e-7,0.0007493503,0.0023124926,0.0000059626063,0.000042035317,0.00000543813,0.0001798135],"about_ca_topic_score_codex":0.3034176,"about_ca_topic_score_gemma":0.0063323425,"teacher_disagreement_score":0.29708526,"about_ca_system_score_codex":0.0007917746,"about_ca_system_score_gemma":0.0011473529,"threshold_uncertainty_score":0.99993294},"labels":[],"label_agreement":null},{"id":"W4417482366","doi":"10.1016/j.jval.2025.09.2049","title":"HTA266 Patient Preference Studies in HTA for Rare Diseases: A Cross-Country Analysis of EU-4, UK, and Canada","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Health Systems, Economic Evaluations, Quality of Life","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Preference; Health technology; MEDLINE; Alternative medicine; Patient assessment","score_opus":0.42336154965823797,"score_gpt":0.4643302983469428,"score_spread":0.040968748688704815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482366","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96583116,0.022148635,0.00012290644,0.00737866,0.00043179333,0.0011391399,0.0027408854,0.000008069022,0.00019876227],"genre_scores_gemma":[0.99263537,0.00079525006,0.00041850648,0.0057304036,0.000024380483,0.00023215394,0.00006672127,0.000009211235,0.00008799342],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9950472,0.00025068945,0.0037533916,0.0005002206,0.00007841339,0.0003700805],"domain_scores_gemma":[0.9961627,0.0019617183,0.0013233235,0.00035717324,0.0000835105,0.00011154818],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.005207841,0.0001438547,0.0013589296,0.0007972481,0.00010591262,0.000024511355,0.00015412604,0.000067127956,0.000017698118],"category_scores_gemma":[0.0036161852,0.0001779186,0.000063584404,0.00074633723,0.00007759068,0.00012367565,0.00005894197,0.000103244354,0.0000014062915],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003258379,0.00006555699,0.9439874,0.0028256953,0.00021616882,5.597255e-7,0.0022996294,0.018258965,4.528406e-8,0.028303549,0.0038905833,0.00011921341],"study_design_scores_gemma":[0.0012388203,0.00011245909,0.9149089,0.0007086744,0.00003583131,2.0935585e-7,0.0040939166,0.05967805,9.4745275e-7,0.0103354165,0.008630929,0.0002558768],"about_ca_topic_score_codex":0.7485233,"about_ca_topic_score_gemma":0.6729742,"teacher_disagreement_score":0.07554907,"about_ca_system_score_codex":0.0016874634,"about_ca_system_score_gemma":0.0014903712,"threshold_uncertainty_score":0.725531},"labels":[],"label_agreement":null},{"id":"W4417482367","doi":"10.1016/j.jval.2025.09.3312","title":"MSR21 AI-Assisted Systematic Literature Screening According to NICE, UK, and CDA (Canada) Position Papers: An HTA Submission Use Case","year":2025,"lang":"en","type":"article","venue":"Value in Health","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Systematic review; Position (finance); Position paper; Systematic error","score_opus":0.13110065638241694,"score_gpt":0.41378594049129225,"score_spread":0.2826852841088753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417482367","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9815523,0.0019890831,0.0005762145,0.013788956,0.0005020452,0.001471315,0.0000103351595,0.000041773936,0.00006797592],"genre_scores_gemma":[0.9894555,0.00014922828,0.0017818386,0.008213435,0.00012905915,0.00005318157,0.000049940132,0.00001625077,0.00015152714],"study_design_codex":"observational","study_design_gemma":"systematic_review","domain_scores_codex":[0.99775267,0.0004303148,0.0007956365,0.00038729314,0.00025787757,0.0003762316],"domain_scores_gemma":[0.99840295,0.00046264738,0.00014072069,0.00035739774,0.00019736419,0.00043889694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010199229,0.00016502621,0.00041990328,0.00037220668,0.0003228069,0.00011589148,0.00006006662,0.00013921167,0.0000076561955],"category_scores_gemma":[0.0009141208,0.00014925608,0.000030732663,0.0008766494,0.000015884973,0.00021495605,0.00002836393,0.00036625136,0.0000012541948],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018236225,0.0008309789,0.56600076,0.2052047,0.0001552567,0.0035504955,0.0415965,0.0030542433,0.0045579597,0.0045462144,0.0045352024,0.16414405],"study_design_scores_gemma":[0.001257215,0.0035713841,0.21964757,0.5216637,0.00040217032,0.009144289,0.1098455,0.12605795,0.0035688912,0.0012521094,0.001938847,0.0016503248],"about_ca_topic_score_codex":0.45418376,"about_ca_topic_score_gemma":0.09826568,"teacher_disagreement_score":0.35591808,"about_ca_system_score_codex":0.0006669657,"about_ca_system_score_gemma":0.0012202506,"threshold_uncertainty_score":0.91818863},"labels":[],"label_agreement":null},{"id":"W634015159","doi":"10.1016/j.jval.2015.03.1506","title":"Out-of-pocket medical costs for parents with Children with down Syndrome in the United States","year":2015,"lang":"en","type":"article","venue":"Value in Health","topic":"Healthcare Policy and Management","field":"Economics, Econometrics and Finance","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"","keywords":"Medicine; Demography; Health insurance; Medical diagnosis; Wilcoxon signed-rank test; Pediatrics; Diagnosis code; Health care; Internal medicine; Environmental health; Mann–Whitney U test; Population","score_opus":0.11982750751406006,"score_gpt":0.3207780535264735,"score_spread":0.2009505460124134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W634015159","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96596974,0.0006294931,0.0010174373,0.030216476,0.0001364421,0.0014014702,0.00019808348,0.00001539842,0.00041548084],"genre_scores_gemma":[0.9948569,0.0003558396,0.0004490667,0.004040763,0.000027951774,0.00011498966,0.0001184142,0.000015951902,0.000020134526],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984919,0.00011853207,0.0006256996,0.00024636695,0.00011641538,0.00040108748],"domain_scores_gemma":[0.9991224,0.00014676459,0.00026159114,0.00026195668,0.000026018879,0.00018128628],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002987095,0.00011289207,0.0003540909,0.00034367293,0.000038085866,0.00001574819,0.00026418723,0.000059933693,0.000008647595],"category_scores_gemma":[0.00015840401,0.00008170013,0.000019379111,0.00047670066,0.000053474494,0.000066116576,0.000027809901,0.0001766139,0.000013369687],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020247737,0.00047952004,0.81802326,0.0004158971,0.00006427814,0.000019120518,0.009120051,0.005570681,3.1976073e-9,0.16174527,0.0021804334,0.0021790164],"study_design_scores_gemma":[0.013235271,0.006555633,0.8089667,0.001351074,0.000011875633,0.00007323503,0.003947662,0.031184088,0.000001622471,0.036764257,0.097092025,0.00081654254],"about_ca_topic_score_codex":0.11534966,"about_ca_topic_score_gemma":0.0050478317,"teacher_disagreement_score":0.12498101,"about_ca_system_score_codex":0.0002187188,"about_ca_system_score_gemma":0.00023033706,"threshold_uncertainty_score":0.8905413},"labels":[],"label_agreement":null},{"id":"W650957064","doi":"10.1016/j.jval.2014.12.020","title":"A Systematic Review of the Cost-Effectiveness of Long-Term Mechanical Circulatory Support","year":2015,"lang":"en","type":"review","venue":"Value in Health","topic":"Mechanical Circulatory Support Devices","field":"Engineering","cited_by":24,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Alberta Health Services","keywords":"Medicine; Cost effectiveness; Quality of life (healthcare); Bridge to transplantation; Intensive care medicine; Transplantation; Cost–benefit analysis; Cost-effectiveness analysis; Quality-adjusted life year; Destination therapy; Surgery; Heart transplantation; Risk analysis (engineering)","score_opus":0.1068833423904469,"score_gpt":0.36126540978001,"score_spread":0.2543820673895631,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W650957064","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021234942,0.98883015,0.000118991295,0.0000036677586,0.00072343874,0.010074435,0.000087201915,0.0000658866,0.00007497955],"genre_scores_gemma":[0.0014386089,0.9975772,0.000019005913,0.00004568318,0.000031219075,0.0007219174,0.000045906283,0.000116527066,0.000003920714],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9912064,0.0035235777,0.0035427622,0.0004241966,0.00084055477,0.00046250876],"domain_scores_gemma":[0.9958352,0.0009025756,0.0013021188,0.0015671357,0.0001362623,0.0002567112],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.010016398,0.0005242795,0.006511322,0.000206694,0.000021352103,0.000006613528,0.0009704293,0.00038627206,0.000050832547],"category_scores_gemma":[0.00063316355,0.00036255477,0.0008669851,0.0008859684,0.000049242197,0.00006304667,0.00013757039,0.00070638565,0.000032352724],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[8.251989e-7,0.000040840205,0.000021476046,0.9948223,0.00016194793,0.000008985885,0.000013412381,0.00007424376,2.8954565e-7,0.00052086514,0.000023224931,0.004311587],"study_design_scores_gemma":[0.00014468451,0.00004953786,0.000029295905,0.99514383,0.00076868467,0.000106408545,0.000002374793,0.00017050003,0.0000035795424,0.000057177833,0.0032438168,0.0002800963],"about_ca_topic_score_codex":0.00003918083,"about_ca_topic_score_gemma":0.0000036294,"teacher_disagreement_score":0.009383234,"about_ca_system_score_codex":0.0009810182,"about_ca_system_score_gemma":0.001517941,"threshold_uncertainty_score":0.99988264},"labels":[],"label_agreement":null},{"id":"W73663598","doi":"10.1016/j.jval.2014.08.1515","title":"The Association of Hosptial Type and Stroke Centre With Mortality, Length of Stay and Hospital Cost of Ischemic Stroke Patients in Alberta","year":2014,"lang":"en","type":"article","venue":"Value in Health","topic":"Health and Well-being Studies","field":"Psychology","cited_by":0,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Institute for Health Information; Alberta Medical Association; Institute of Health Economics; University of Alberta","funders":"","keywords":"Medicine; Stroke (engine); Ischemic stroke; Emergency medicine; Association (psychology); Demography; Medical emergency; Internal medicine; Ischemia; Psychology; Engineering","score_opus":0.01258738448593256,"score_gpt":0.2928312329261772,"score_spread":0.28024384844024464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W73663598","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99720716,0.00030744902,0.0000028624545,0.00078093156,0.00018239483,0.00042194105,0.000043956872,0.000002421023,0.001050856],"genre_scores_gemma":[0.9992973,0.00044713504,0.00003649802,0.000049411392,0.000018440634,0.0000048826905,0.0000063325083,0.000007858098,0.00013210943],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986188,0.00029682508,0.00046871696,0.00015767652,0.0001866497,0.00027132046],"domain_scores_gemma":[0.9986267,0.00063873763,0.00043926795,0.00014289773,0.00010109548,0.00005129005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008776573,0.00008444058,0.00030574284,0.000052847245,0.000038518505,0.000002910619,0.000058478956,0.00007053108,0.0000024928122],"category_scores_gemma":[0.00033320417,0.00006310647,0.00001226351,0.000118666256,0.0000769281,0.000026928605,0.00002921048,0.00014039372,5.397981e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000115381095,0.00014401383,0.9910694,0.00017046262,0.000035148587,1.1296965e-7,0.004440337,0.000013759377,0.000003335658,0.00067828526,0.0004167136,0.0029130538],"study_design_scores_gemma":[0.0017391758,0.0008009111,0.99570405,0.00009615851,0.000008470775,1.0060951e-7,0.0004979136,0.00012647972,0.0000349567,0.000029404917,0.00090734777,0.000055015284],"about_ca_topic_score_codex":0.04555725,"about_ca_topic_score_gemma":0.006582838,"teacher_disagreement_score":0.03897441,"about_ca_system_score_codex":0.000063429005,"about_ca_system_score_gemma":0.00008717044,"threshold_uncertainty_score":0.96079844},"labels":[],"label_agreement":null}]}